primaryid,caseid,drug_seq,role_cod,drugname,prod_ai,val_vbm,route,dose_vbm,cum_dose_chr,cum_dose_unit,dechal,rechal,lot_num,exp_dt,nda_num,dose_amt,dose_unit,dose_form,dose_freq,year_x,quarter_x,pt,drug_rec_act,year_y,quarter_y,caseversion,i_f_code,event_dt,mfr_dt,init_fda_dt,fda_dt,rept_cod,auth_num,mfr_num,mfr_sndr,lit_ref,age,age_cod,age_grp,sex,e_sub,wt,wt_cod,rept_dt,to_mfr,occp_cod,reporter_country,occr_country,year,quarter,age_group
109982197,10998219,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (300 UNIT/ ML (1.5 ML) INSULIN PEN),,,,,,,,,,,,2021,Q1,Blindness,,2021,Q1,7,F,20050414.0,20210318.0,20150408,20210319,EXP,,US-PFIZER INC-2015119344,PFIZER,,44.0,YR,,M,Y,75.0,KG,20210319.0,,HP,US,US,2021,Q1,Adult
109982197,10998219,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (300 UNIT/ ML (1.5 ML) INSULIN PEN),,,,,,,,,,,,2021,Q1,Diabetic coma,,2021,Q1,7,F,20050414.0,20210318.0,20150408,20210319,EXP,,US-PFIZER INC-2015119344,PFIZER,,44.0,YR,,M,Y,75.0,KG,20210319.0,,HP,US,US,2021,Q1,Adult
109982197,10998219,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (300 UNIT/ ML (1.5 ML) INSULIN PEN),,,,,,,,,,,,2021,Q1,Myocardial infarction,,2021,Q1,7,F,20050414.0,20210318.0,20150408,20210319,EXP,,US-PFIZER INC-2015119344,PFIZER,,44.0,YR,,M,Y,75.0,KG,20210319.0,,HP,US,US,2021,Q1,Adult
109982197,10998219,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (300 UNIT/ ML (1.5 ML) INSULIN PEN),,,,,,,,,,,,2021,Q1,Off label use,,2021,Q1,7,F,20050414.0,20210318.0,20150408,20210319,EXP,,US-PFIZER INC-2015119344,PFIZER,,44.0,YR,,M,Y,75.0,KG,20210319.0,,HP,US,US,2021,Q1,Adult
109982197,10998219,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (300 UNIT/ ML (1.5 ML) INSULIN PEN),,,,,,,,,,,,2021,Q1,Steroid diabetes,,2021,Q1,7,F,20050414.0,20210318.0,20150408,20210319,EXP,,US-PFIZER INC-2015119344,PFIZER,,44.0,YR,,M,Y,75.0,KG,20210319.0,,HP,US,US,2021,Q1,Adult
110646532,11064653,13,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,10 UNITS/M*2,,,,,,,,,,UNKNOWN,QD,2021,Q1,Rib fracture,,2021,Q1,2,F,20130121.0,20210131.0,20150424,20210202,EXP,,US-CELGENEUS-163-21880-13042938,CELGENE,,69.0,YR,,,Y,73.09,KG,20210202.0,,HP,US,US,2021,Q1,Elderly
113963433,11396343,15,C,GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,UNKNOWN,,2021,Q1,Acute kidney injury,,2021,Q1,3,F,20141117.0,20210126.0,20150819,20210201,EXP,,US-JNJFOC-20150803741,JOHNSON AND JOHNSON,,62.0,YR,A,M,Y,,,20210201.0,,CN,US,US,2021,Q1,Adult
113963433,11396343,15,C,GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,UNKNOWN,,2021,Q1,Gastrointestinal haemorrhage,,2021,Q1,3,F,20141117.0,20210126.0,20150819,20210201,EXP,,US-JNJFOC-20150803741,JOHNSON AND JOHNSON,,62.0,YR,A,M,Y,,,20210201.0,,CN,US,US,2021,Q1,Adult
115935082,11593508,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q1,Acute kidney injury,,2021,Q1,2,F,20141117.0,20210126.0,20151005,20210201,EXP,,US-BAYER-2015-396279,BAYER,,62.0,YR,A,M,Y,,,20210201.0,,HP,US,US,2021,Q1,Adult
115935082,11593508,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q1,Gastrointestinal haemorrhage,,2021,Q1,2,F,20141117.0,20210126.0,20151005,20210201,EXP,,US-BAYER-2015-396279,BAYER,,62.0,YR,A,M,Y,,,20210201.0,,HP,US,US,2021,Q1,Adult
122327953,12232795,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Agranulocytosis,,2021,Q1,3,F,,20210127.0,20160402,20210208,EXP,,US-LUPIN PHARMACEUTICALS INC.-2015-01903,LUPIN,,45.0,YR,,M,Y,,,20210208.0,,CN,NL,US,2021,Q1,Adult
122327953,12232795,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Drug level increased,,2021,Q1,3,F,,20210127.0,20160402,20210208,EXP,,US-LUPIN PHARMACEUTICALS INC.-2015-01903,LUPIN,,45.0,YR,,M,Y,,,20210208.0,,CN,NL,US,2021,Q1,Adult
124124017,12412401,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Agranulocytosis,Agranulocytosis,2021,Q1,7,F,,20210127.0,20160527,20210203,EXP,,US-PFIZER INC-2016274551,PFIZER,"ISKANDAR, J.. TRANSIENT AGRANULOCYTOSIS ASSOCIATED WITH ZIPRASIDONE IN A 45?YEAR?OLD MAN ON HEMODIALYSIS. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY. 2015?35(3):347?348",45.0,YR,,M,Y,,,20210203.0,,MD,US,US,2021,Q1,Adult
1327014118,13270141,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2021,Q1,Anaemia,,2021,Q1,18,F,2015.0,20210127.0,20170224,20210205,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20210205.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Elderly
1327014118,13270141,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2021,Q1,Blood pressure systolic increased,,2021,Q1,18,F,2015.0,20210127.0,20170224,20210205,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20210205.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Elderly
1327014118,13270141,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2021,Q1,Diarrhoea,,2021,Q1,18,F,2015.0,20210127.0,20170224,20210205,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20210205.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Elderly
1327014118,13270141,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2021,Q1,Fall,,2021,Q1,18,F,2015.0,20210127.0,20170224,20210205,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20210205.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Elderly
1327014118,13270141,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2021,Q1,Hyperglycaemia,,2021,Q1,18,F,2015.0,20210127.0,20170224,20210205,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20210205.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Elderly
1327014118,13270141,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2021,Q1,Hypoglycaemia,,2021,Q1,18,F,2015.0,20210127.0,20170224,20210205,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20210205.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Elderly
1327014118,13270141,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2021,Q1,Hypotension,,2021,Q1,18,F,2015.0,20210127.0,20170224,20210205,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20210205.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Elderly
1327014118,13270141,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2021,Q1,Injection site mass,,2021,Q1,18,F,2015.0,20210127.0,20170224,20210205,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20210205.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Elderly
1327014118,13270141,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2021,Q1,Injection site pain,,2021,Q1,18,F,2015.0,20210127.0,20170224,20210205,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20210205.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Elderly
1327014118,13270141,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2021,Q1,Metastases to liver,,2021,Q1,18,F,2015.0,20210127.0,20170224,20210205,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20210205.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Elderly
1327014118,13270141,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2021,Q1,Nausea,,2021,Q1,18,F,2015.0,20210127.0,20170224,20210205,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20210205.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Elderly
1327014118,13270141,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2021,Q1,Pneumonia,,2021,Q1,18,F,2015.0,20210127.0,20170224,20210205,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20210205.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Elderly
1327014118,13270141,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2021,Q1,Renal failure,,2021,Q1,18,F,2015.0,20210127.0,20170224,20210205,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20210205.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Elderly
1327014118,13270141,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2021,Q1,Skin lesion,,2021,Q1,18,F,2015.0,20210127.0,20170224,20210205,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20210205.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Elderly
1327014118,13270141,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2021,Q1,Urinary tract infection,,2021,Q1,18,F,2015.0,20210127.0,20170224,20210205,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20210205.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Elderly
132950843,13295084,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,D,,,,,,,,,2021,Q1,Lower gastrointestinal haemorrhage,,2021,Q1,3,F,20150625.0,20210208.0,20170303,20210210,PER,,US-JNJFOC-20170219968,JOHNSON AND JOHNSON,,82.0,YR,E,F,Y,,,20210210.0,,CN,US,US,2021,Q1,Elderly
134738752,13473875,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Lower gastrointestinal haemorrhage,,2021,Q1,2,F,20150625.0,20210208.0,20170424,20210212,EXP,,US-BAYER-2017-035153,BAYER,,82.0,YR,E,F,Y,,,20210212.0,,CN,US,US,2021,Q1,Elderly
144398064,14439806,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"12 INTERNATIONAL UNIT, DAILY",,,Y,,,,,12.0,IU,,QD,2021,Q1,Disorientation,,2021,Q1,4,F,20171121.0,20210121.0,20180125,20210127,EXP,IT-MINISAL02-450031,IT-ELI_LILLY_AND_COMPANY-IT201801006768,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20210127.0,,MD,IT,IT,2021,Q1,Elderly
144398064,14439806,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"12 INTERNATIONAL UNIT, DAILY",,,Y,,,,,12.0,IU,,QD,2021,Q1,Hypoglycaemia,,2021,Q1,4,F,20171121.0,20210121.0,20180125,20210127,EXP,IT-MINISAL02-450031,IT-ELI_LILLY_AND_COMPANY-IT201801006768,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20210127.0,,MD,IT,IT,2021,Q1,Elderly
1457669018,14576690,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Hyperglycaemia,,2021,Q1,18,F,20170812.0,20210128.0,20180227,20210207,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-100377,BRISTOL MYERS SQUIBB,,70.0,YR,,F,Y,53.3,KG,20210207.0,,HP,DE,DE,2021,Q1,Elderly
1457669018,14576690,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Hypothyroidism,,2021,Q1,18,F,20170812.0,20210128.0,20180227,20210207,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-100377,BRISTOL MYERS SQUIBB,,70.0,YR,,F,Y,53.3,KG,20210207.0,,HP,DE,DE,2021,Q1,Elderly
1457669018,14576690,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Lipase increased,,2021,Q1,18,F,20170812.0,20210128.0,20180227,20210207,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-100377,BRISTOL MYERS SQUIBB,,70.0,YR,,F,Y,53.3,KG,20210207.0,,HP,DE,DE,2021,Q1,Elderly
1457669018,14576690,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Malignant neoplasm progression,,2021,Q1,18,F,20170812.0,20210128.0,20180227,20210207,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-100377,BRISTOL MYERS SQUIBB,,70.0,YR,,F,Y,53.3,KG,20210207.0,,HP,DE,DE,2021,Q1,Elderly
1457669018,14576690,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Metastases to pancreas,,2021,Q1,18,F,20170812.0,20210128.0,20180227,20210207,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-100377,BRISTOL MYERS SQUIBB,,70.0,YR,,F,Y,53.3,KG,20210207.0,,HP,DE,DE,2021,Q1,Elderly
1457669018,14576690,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Nausea,,2021,Q1,18,F,20170812.0,20210128.0,20180227,20210207,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-100377,BRISTOL MYERS SQUIBB,,70.0,YR,,F,Y,53.3,KG,20210207.0,,HP,DE,DE,2021,Q1,Elderly
1457669018,14576690,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Vulvovaginal candidiasis,,2021,Q1,18,F,20170812.0,20210128.0,20180227,20210207,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-100377,BRISTOL MYERS SQUIBB,,70.0,YR,,F,Y,53.3,KG,20210207.0,,HP,DE,DE,2021,Q1,Elderly
148792523,14879252,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,QD,2021,Q1,Condition aggravated,,2021,Q1,3,F,,20210108.0,20180511,20210115,EXP,,CA-ROCHE-2120607,ROCHE,,64.0,YR,,M,Y,140.0,KG,20210115.0,,MD,CA,CA,2021,Q1,Adult
148792523,14879252,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,QD,2021,Q1,Diabetes mellitus inadequate control,,2021,Q1,3,F,,20210108.0,20180511,20210115,EXP,,CA-ROCHE-2120607,ROCHE,,64.0,YR,,M,Y,140.0,KG,20210115.0,,MD,CA,CA,2021,Q1,Adult
148792523,14879252,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,QD,2021,Q1,Drug hypersensitivity,,2021,Q1,3,F,,20210108.0,20180511,20210115,EXP,,CA-ROCHE-2120607,ROCHE,,64.0,YR,,M,Y,140.0,KG,20210115.0,,MD,CA,CA,2021,Q1,Adult
148792523,14879252,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,QD,2021,Q1,Drug intolerance,,2021,Q1,3,F,,20210108.0,20180511,20210115,EXP,,CA-ROCHE-2120607,ROCHE,,64.0,YR,,M,Y,140.0,KG,20210115.0,,MD,CA,CA,2021,Q1,Adult
148792523,14879252,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,QD,2021,Q1,Glycosylated haemoglobin increased,,2021,Q1,3,F,,20210108.0,20180511,20210115,EXP,,CA-ROCHE-2120607,ROCHE,,64.0,YR,,M,Y,140.0,KG,20210115.0,,MD,CA,CA,2021,Q1,Adult
148792523,14879252,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,QD,2021,Q1,Hypertension,,2021,Q1,3,F,,20210108.0,20180511,20210115,EXP,,CA-ROCHE-2120607,ROCHE,,64.0,YR,,M,Y,140.0,KG,20210115.0,,MD,CA,CA,2021,Q1,Adult
148792523,14879252,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,QD,2021,Q1,Hypoglycaemia,,2021,Q1,3,F,,20210108.0,20180511,20210115,EXP,,CA-ROCHE-2120607,ROCHE,,64.0,YR,,M,Y,140.0,KG,20210115.0,,MD,CA,CA,2021,Q1,Adult
148792523,14879252,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,QD,2021,Q1,Increased appetite,,2021,Q1,3,F,,20210108.0,20180511,20210115,EXP,,CA-ROCHE-2120607,ROCHE,,64.0,YR,,M,Y,140.0,KG,20210115.0,,MD,CA,CA,2021,Q1,Adult
148792523,14879252,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,QD,2021,Q1,Infection,,2021,Q1,3,F,,20210108.0,20180511,20210115,EXP,,CA-ROCHE-2120607,ROCHE,,64.0,YR,,M,Y,140.0,KG,20210115.0,,MD,CA,CA,2021,Q1,Adult
148792523,14879252,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,QD,2021,Q1,Insulin-like growth factor increased,,2021,Q1,3,F,,20210108.0,20180511,20210115,EXP,,CA-ROCHE-2120607,ROCHE,,64.0,YR,,M,Y,140.0,KG,20210115.0,,MD,CA,CA,2021,Q1,Adult
148792523,14879252,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,QD,2021,Q1,Pain,,2021,Q1,3,F,,20210108.0,20180511,20210115,EXP,,CA-ROCHE-2120607,ROCHE,,64.0,YR,,M,Y,140.0,KG,20210115.0,,MD,CA,CA,2021,Q1,Adult
148792523,14879252,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,QD,2021,Q1,Weight increased,,2021,Q1,3,F,,20210108.0,20180511,20210115,EXP,,CA-ROCHE-2120607,ROCHE,,64.0,YR,,M,Y,140.0,KG,20210115.0,,MD,CA,CA,2021,Q1,Adult
151215119,15121511,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,UNKNOWN,,2021,Q1,Abdominal distension,,2021,Q1,9,F,201805.0,20210305.0,20180709,20210315,EXP,FR-AFSSAPS-NY20181156,FR-JNJFOC-20180703429,JOHNSON AND JOHNSON,,66.0,YR,E,M,Y,58.0,KG,20210315.0,,HP,FR,FR,2021,Q1,Elderly
151215119,15121511,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,UNKNOWN,,2021,Q1,Abdominal pain,,2021,Q1,9,F,201805.0,20210305.0,20180709,20210315,EXP,FR-AFSSAPS-NY20181156,FR-JNJFOC-20180703429,JOHNSON AND JOHNSON,,66.0,YR,E,M,Y,58.0,KG,20210315.0,,HP,FR,FR,2021,Q1,Elderly
151215119,15121511,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,UNKNOWN,,2021,Q1,Ascites,,2021,Q1,9,F,201805.0,20210305.0,20180709,20210315,EXP,FR-AFSSAPS-NY20181156,FR-JNJFOC-20180703429,JOHNSON AND JOHNSON,,66.0,YR,E,M,Y,58.0,KG,20210315.0,,HP,FR,FR,2021,Q1,Elderly
151215119,15121511,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,UNKNOWN,,2021,Q1,Diabetes mellitus,,2021,Q1,9,F,201805.0,20210305.0,20180709,20210315,EXP,FR-AFSSAPS-NY20181156,FR-JNJFOC-20180703429,JOHNSON AND JOHNSON,,66.0,YR,E,M,Y,58.0,KG,20210315.0,,HP,FR,FR,2021,Q1,Elderly
151215119,15121511,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,UNKNOWN,,2021,Q1,Eschar,,2021,Q1,9,F,201805.0,20210305.0,20180709,20210315,EXP,FR-AFSSAPS-NY20181156,FR-JNJFOC-20180703429,JOHNSON AND JOHNSON,,66.0,YR,E,M,Y,58.0,KG,20210315.0,,HP,FR,FR,2021,Q1,Elderly
151215119,15121511,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,UNKNOWN,,2021,Q1,Hepatic cirrhosis,,2021,Q1,9,F,201805.0,20210305.0,20180709,20210315,EXP,FR-AFSSAPS-NY20181156,FR-JNJFOC-20180703429,JOHNSON AND JOHNSON,,66.0,YR,E,M,Y,58.0,KG,20210315.0,,HP,FR,FR,2021,Q1,Elderly
151215119,15121511,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,UNKNOWN,,2021,Q1,Hepatic lesion,,2021,Q1,9,F,201805.0,20210305.0,20180709,20210315,EXP,FR-AFSSAPS-NY20181156,FR-JNJFOC-20180703429,JOHNSON AND JOHNSON,,66.0,YR,E,M,Y,58.0,KG,20210315.0,,HP,FR,FR,2021,Q1,Elderly
151215119,15121511,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,UNKNOWN,,2021,Q1,Hepatocellular carcinoma,,2021,Q1,9,F,201805.0,20210305.0,20180709,20210315,EXP,FR-AFSSAPS-NY20181156,FR-JNJFOC-20180703429,JOHNSON AND JOHNSON,,66.0,YR,E,M,Y,58.0,KG,20210315.0,,HP,FR,FR,2021,Q1,Elderly
151215119,15121511,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,UNKNOWN,,2021,Q1,Hepatorenal syndrome,,2021,Q1,9,F,201805.0,20210305.0,20180709,20210315,EXP,FR-AFSSAPS-NY20181156,FR-JNJFOC-20180703429,JOHNSON AND JOHNSON,,66.0,YR,E,M,Y,58.0,KG,20210315.0,,HP,FR,FR,2021,Q1,Elderly
151215119,15121511,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,UNKNOWN,,2021,Q1,Off label use,,2021,Q1,9,F,201805.0,20210305.0,20180709,20210315,EXP,FR-AFSSAPS-NY20181156,FR-JNJFOC-20180703429,JOHNSON AND JOHNSON,,66.0,YR,E,M,Y,58.0,KG,20210315.0,,HP,FR,FR,2021,Q1,Elderly
151215119,15121511,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,UNKNOWN,,2021,Q1,Peritonitis,,2021,Q1,9,F,201805.0,20210305.0,20180709,20210315,EXP,FR-AFSSAPS-NY20181156,FR-JNJFOC-20180703429,JOHNSON AND JOHNSON,,66.0,YR,E,M,Y,58.0,KG,20210315.0,,HP,FR,FR,2021,Q1,Elderly
151215119,15121511,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,UNKNOWN,,2021,Q1,Portal hypertension,,2021,Q1,9,F,201805.0,20210305.0,20180709,20210315,EXP,FR-AFSSAPS-NY20181156,FR-JNJFOC-20180703429,JOHNSON AND JOHNSON,,66.0,YR,E,M,Y,58.0,KG,20210315.0,,HP,FR,FR,2021,Q1,Elderly
151215119,15121511,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,UNKNOWN,,2021,Q1,Product use issue,,2021,Q1,9,F,201805.0,20210305.0,20180709,20210315,EXP,FR-AFSSAPS-NY20181156,FR-JNJFOC-20180703429,JOHNSON AND JOHNSON,,66.0,YR,E,M,Y,58.0,KG,20210315.0,,HP,FR,FR,2021,Q1,Elderly
152141052,15214105,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"55 DURING DAY 65 AT NIGHT, BID",,,,, 8F5258A,,21081.0,,,SOLUTION FOR INJECTION,Q12H,2021,Q1,Inappropriate schedule of product administration,,2021,Q1,2,F,2010.0,20210107.0,20180730,20210111,PER,,US-SA-2018SA195950,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20210111.0,,CN,US,US,2021,Q1,Adult
152141052,15214105,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"55 DURING DAY 65 AT NIGHT, BID",,,,, 8F5258A,,21081.0,,,SOLUTION FOR INJECTION,Q12H,2021,Q1,Myocardial infarction,,2021,Q1,2,F,2010.0,20210107.0,20180730,20210111,PER,,US-SA-2018SA195950,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20210111.0,,CN,US,US,2021,Q1,Adult
152141052,15214105,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU, BID",,,,,,,21081.0,100.0,IU,SOLUTION FOR INJECTION,Q12H,2021,Q1,Inappropriate schedule of product administration,,2021,Q1,2,F,2010.0,20210107.0,20180730,20210111,PER,,US-SA-2018SA195950,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20210111.0,,CN,US,US,2021,Q1,Adult
152141052,15214105,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU, BID",,,,,,,21081.0,100.0,IU,SOLUTION FOR INJECTION,Q12H,2021,Q1,Myocardial infarction,,2021,Q1,2,F,2010.0,20210107.0,20180730,20210111,PER,,US-SA-2018SA195950,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20210111.0,,CN,US,US,2021,Q1,Adult
152705962,15270596,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,12.0,IU,INJECTION,,2021,Q1,Angina pectoris,,2021,Q1,2,F,20180417.0,20210118.0,20180813,20210119,EXP,,GR-CELGENEUS-GRC-20180600538,CELGENE,,85.0,YR,,F,Y,,,20210119.0,,HP,GR,GR,2021,Q1,Elderly
152705962,15270596,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,12.0,IU,INJECTION,,2021,Q1,Nephropathy,,2021,Q1,2,F,20180417.0,20210118.0,20180813,20210119,EXP,,GR-CELGENEUS-GRC-20180600538,CELGENE,,85.0,YR,,F,Y,,,20210119.0,,HP,GR,GR,2021,Q1,Elderly
1541683711,15416837,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,10 INTERNATIONAL UNIT,,,U,,,,,10.0,IU,INJECTION,,2021,Q1,Death,,2021,Q1,11,F,20180905.0,20210302.0,20180924,20210305,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-085915,BRISTOL MYERS SQUIBB,,79.0,YR,,M,Y,,,20210305.0,,HP,DE,DE,2021,Q1,Elderly
1541683711,15416837,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,10 INTERNATIONAL UNIT,,,U,,,,,10.0,IU,INJECTION,,2021,Q1,Endophthalmitis,,2021,Q1,11,F,20180905.0,20210302.0,20180924,20210305,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-085915,BRISTOL MYERS SQUIBB,,79.0,YR,,M,Y,,,20210305.0,,HP,DE,DE,2021,Q1,Elderly
1541683711,15416837,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,10 INTERNATIONAL UNIT,,,U,,,,,10.0,IU,INJECTION,,2021,Q1,Hypophysitis,,2021,Q1,11,F,20180905.0,20210302.0,20180924,20210305,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-085915,BRISTOL MYERS SQUIBB,,79.0,YR,,M,Y,,,20210305.0,,HP,DE,DE,2021,Q1,Elderly
1541683711,15416837,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,10 INTERNATIONAL UNIT,,,U,,,,,10.0,IU,INJECTION,,2021,Q1,Pancytopenia,,2021,Q1,11,F,20180905.0,20210302.0,20180924,20210305,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-085915,BRISTOL MYERS SQUIBB,,79.0,YR,,M,Y,,,20210305.0,,HP,DE,DE,2021,Q1,Elderly
1541683711,15416837,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,10 INTERNATIONAL UNIT,,,U,,,,,10.0,IU,INJECTION,,2021,Q1,Staphylococcal infection,,2021,Q1,11,F,20180905.0,20210302.0,20180924,20210305,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-085915,BRISTOL MYERS SQUIBB,,79.0,YR,,M,Y,,,20210305.0,,HP,DE,DE,2021,Q1,Elderly
1541683711,15416837,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,10 INTERNATIONAL UNIT,,,U,,,,,10.0,IU,INJECTION,,2021,Q1,Type 3 diabetes mellitus,,2021,Q1,11,F,20180905.0,20210302.0,20180924,20210305,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-085915,BRISTOL MYERS SQUIBB,,79.0,YR,,M,Y,,,20210305.0,,HP,DE,DE,2021,Q1,Elderly
154194643,15419464,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,,,,,21081.0,16.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Depressed level of consciousness,,2021,Q1,3,F,20180203.0,20210127.0,20180924,20210211,EXP,IT-MINISAL02-497583,IT-SA-2018SA257799,SANOFI AVENTIS,,72.0,YR,E,M,Y,,,20210211.0,,MD,IT,IT,2021,Q1,Elderly
154194643,15419464,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,,,,,21081.0,16.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Dizziness,,2021,Q1,3,F,20180203.0,20210127.0,20180924,20210211,EXP,IT-MINISAL02-497583,IT-SA-2018SA257799,SANOFI AVENTIS,,72.0,YR,E,M,Y,,,20210211.0,,MD,IT,IT,2021,Q1,Elderly
154194643,15419464,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,,,,,21081.0,16.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Hypoglycaemia,,2021,Q1,3,F,20180203.0,20210127.0,20180924,20210211,EXP,IT-MINISAL02-497583,IT-SA-2018SA257799,SANOFI AVENTIS,,72.0,YR,E,M,Y,,,20210211.0,,MD,IT,IT,2021,Q1,Elderly
154194643,15419464,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,,,,,21081.0,16.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Malaise,,2021,Q1,3,F,20180203.0,20210127.0,20180924,20210211,EXP,IT-MINISAL02-497583,IT-SA-2018SA257799,SANOFI AVENTIS,,72.0,YR,E,M,Y,,,20210211.0,,MD,IT,IT,2021,Q1,Elderly
154194643,15419464,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,,,,,21081.0,16.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Neurological symptom,,2021,Q1,3,F,20180203.0,20210127.0,20180924,20210211,EXP,IT-MINISAL02-497583,IT-SA-2018SA257799,SANOFI AVENTIS,,72.0,YR,E,M,Y,,,20210211.0,,MD,IT,IT,2021,Q1,Elderly
155007202,15500720,6,C,INSULIN GLARGINE BS                /01483501/,,2,Subcutaneous,"12 IU, DAILY",,,,,,,,12.0,IU,INJECTION,QD,2021,Q1,Cardiac failure acute,,2021,Q1,2,F,20170912.0,20201228.0,20181015,20210107,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201810002553,ELI LILLY AND CO,,68.0,YR,,M,Y,81.0,KG,20210107.0,,MD,JP,JP,2021,Q1,Elderly
155007202,15500720,6,C,INSULIN GLARGINE BS                /01483501/,,2,Subcutaneous,"12 IU, DAILY",,,,,,,,12.0,IU,INJECTION,QD,2021,Q1,Cholecystitis acute,,2021,Q1,2,F,20170912.0,20201228.0,20181015,20210107,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201810002553,ELI LILLY AND CO,,68.0,YR,,M,Y,81.0,KG,20210107.0,,MD,JP,JP,2021,Q1,Elderly
155007202,15500720,6,C,INSULIN GLARGINE BS                /01483501/,,2,Subcutaneous,"12 IU, DAILY",,,,,,,,12.0,IU,INJECTION,QD,2021,Q1,Myocardial ischaemia,,2021,Q1,2,F,20170912.0,20201228.0,20181015,20210107,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201810002553,ELI LILLY AND CO,,68.0,YR,,M,Y,81.0,KG,20210107.0,,MD,JP,JP,2021,Q1,Elderly
155007202,15500720,6,C,INSULIN GLARGINE BS                /01483501/,,2,Subcutaneous,"12 IU, DAILY",,,,,,,,12.0,IU,INJECTION,QD,2021,Q1,Pancreatitis acute,,2021,Q1,2,F,20170912.0,20201228.0,20181015,20210107,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201810002553,ELI LILLY AND CO,,68.0,YR,,M,Y,81.0,KG,20210107.0,,MD,JP,JP,2021,Q1,Elderly
1564727210,15647272,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Cholangitis,,2021,Q1,10,F,20181112.0,20210216.0,20181122,20210219,EXP,,JP-ROCHE-2215138,ROCHE,,74.0,YR,,M,Y,69.8,KG,20210219.0,,MD,JP,JP,2021,Q1,Elderly
1564727210,15647272,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Cholangitis,,2021,Q1,10,F,20181112.0,20210216.0,20181122,20210219,EXP,,JP-ROCHE-2215138,ROCHE,,74.0,YR,,M,Y,69.8,KG,20210219.0,,MD,JP,JP,2021,Q1,Elderly
1564727210,15647272,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Cholangitis,,2021,Q1,10,F,20181112.0,20210216.0,20181122,20210219,EXP,,JP-ROCHE-2215138,ROCHE,,74.0,YR,,M,Y,69.8,KG,20210219.0,,MD,JP,JP,2021,Q1,Elderly
157106832,15710683,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DF, QD",,,Y,,,,206538.0,1.0,DF,SOLUTION FOR INJECTION,QD,2021,Q1,Confusional state,,2021,Q1,2,F,20180422.0,20210127.0,20181211,20210209,EXP,IT-MINISAL02-512458,IT-SAKK-2018SA327674AA,SANOFI AVENTIS,,84.0,YR,E,M,Y,,,20210209.0,,MD,IT,IT,2021,Q1,Elderly
157106832,15710683,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DF, QD",,,Y,,,,206538.0,1.0,DF,SOLUTION FOR INJECTION,QD,2021,Q1,Hypoglycaemia,,2021,Q1,2,F,20180422.0,20210127.0,20181211,20210209,EXP,IT-MINISAL02-512458,IT-SAKK-2018SA327674AA,SANOFI AVENTIS,,84.0,YR,E,M,Y,,,20210209.0,,MD,IT,IT,2021,Q1,Elderly
157186252,15718625,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,,,,,,20.0,IU,,QD,2021,Q1,Blood glucose increased,,2021,Q1,2,F,20180703.0,20210217.0,20181213,20210302,EXP,,GT-SAKK-2018SA335101AA,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20210302.0,,CN,GT,GT,2021,Q1,Elderly
157186252,15718625,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,,,,,,20.0,IU,,QD,2021,Q1,Seizure,,2021,Q1,2,F,20180703.0,20210217.0,20181213,20210302,EXP,,GT-SAKK-2018SA335101AA,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20210302.0,,CN,GT,GT,2021,Q1,Elderly
157186252,15718625,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"35 IU, QD",,,,,,,,35.0,IU,,QD,2021,Q1,Blood glucose increased,,2021,Q1,2,F,20180703.0,20210217.0,20181213,20210302,EXP,,GT-SAKK-2018SA335101AA,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20210302.0,,CN,GT,GT,2021,Q1,Elderly
157186252,15718625,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"35 IU, QD",,,,,,,,35.0,IU,,QD,2021,Q1,Seizure,,2021,Q1,2,F,20180703.0,20210217.0,20181213,20210302,EXP,,GT-SAKK-2018SA335101AA,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20210302.0,,CN,GT,GT,2021,Q1,Elderly
157186252,15718625,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU TO 38 IU, QD",,,,,,,,,,,QD,2021,Q1,Blood glucose increased,,2021,Q1,2,F,20180703.0,20210217.0,20181213,20210302,EXP,,GT-SAKK-2018SA335101AA,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20210302.0,,CN,GT,GT,2021,Q1,Elderly
157186252,15718625,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU TO 38 IU, QD",,,,,,,,,,,QD,2021,Q1,Seizure,,2021,Q1,2,F,20180703.0,20210217.0,20181213,20210302,EXP,,GT-SAKK-2018SA335101AA,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20210302.0,,CN,GT,GT,2021,Q1,Elderly
158893783,15889378,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2021,Q1,Acute kidney injury,,2021,Q1,3,F,20181212.0,20210308.0,20190130,20210325,EXP,,JP-EISAI MEDICAL RESEARCH-EC-2019-051223,EISAI,,72.0,YR,E,F,Y,48.0,KG,20210325.0,,MD,JP,JP,2021,Q1,Elderly
158893783,15889378,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2021,Q1,Disseminated intravascular coagulation,,2021,Q1,3,F,20181212.0,20210308.0,20190130,20210325,EXP,,JP-EISAI MEDICAL RESEARCH-EC-2019-051223,EISAI,,72.0,YR,E,F,Y,48.0,KG,20210325.0,,MD,JP,JP,2021,Q1,Elderly
159937323,15993732,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU, BID (60 UNITS IN THE MORNING AND 60 UNITS AT NIGHT )",,,,, 8F984A,,206538.0,60.0,IU,SOLUTION FOR INJECTION,Q12H,2021,Q1,Blood glucose increased,,2021,Q1,3,F,2017.0,20210211.0,20190222,20210224,EXP,,US-SA-2019SA046433,SANOFI AVENTIS,,72.0,YR,E,M,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
159937323,15993732,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU, BID (60 UNITS IN THE MORNING AND 60 UNITS AT NIGHT )",,,,, 8F984A,,206538.0,60.0,IU,SOLUTION FOR INJECTION,Q12H,2021,Q1,Confusional state,,2021,Q1,3,F,2017.0,20210211.0,20190222,20210224,EXP,,US-SA-2019SA046433,SANOFI AVENTIS,,72.0,YR,E,M,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
159937323,15993732,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU, BID (60 UNITS IN THE MORNING AND 60 UNITS AT NIGHT )",,,,, 8F984A,,206538.0,60.0,IU,SOLUTION FOR INJECTION,Q12H,2021,Q1,Inappropriate schedule of product administration,,2021,Q1,3,F,2017.0,20210211.0,20190222,20210224,EXP,,US-SA-2019SA046433,SANOFI AVENTIS,,72.0,YR,E,M,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
159937323,15993732,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU, BID (60 UNITS IN THE MORNING AND 60 UNITS AT NIGHT )",,,,, 8F984A,,206538.0,60.0,IU,SOLUTION FOR INJECTION,Q12H,2021,Q1,Stent placement,,2021,Q1,3,F,2017.0,20210211.0,20190222,20210224,EXP,,US-SA-2019SA046433,SANOFI AVENTIS,,72.0,YR,E,M,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
159937323,15993732,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU, BID (60 UNITS IN THE MORNING AND 60 UNITS AT NIGHT )",,,,, 8F984A,,206538.0,60.0,IU,SOLUTION FOR INJECTION,Q12H,2021,Q1,Unevaluable event,,2021,Q1,3,F,2017.0,20210211.0,20190222,20210224,EXP,,US-SA-2019SA046433,SANOFI AVENTIS,,72.0,YR,E,M,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
160407453,16040745,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Acute kidney injury,,2021,Q1,3,F,,20210124.0,20190306,20210201,EXP,,US-PFIZER INC-2019095067,PFIZER,"SUBEDI, P.. CLINDAMYCIN: AN UNUSUAL CAUSE OF ACUTE KIDNEY INJURY. AMERICAN JOURNAL OF CASE REPORTS. 2019?20:248?251",52.0,YR,,M,Y,,,20210201.0,,HP,US,US,2021,Q1,Adult
160407453,16040745,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Decreased appetite,,2021,Q1,3,F,,20210124.0,20190306,20210201,EXP,,US-PFIZER INC-2019095067,PFIZER,"SUBEDI, P.. CLINDAMYCIN: AN UNUSUAL CAUSE OF ACUTE KIDNEY INJURY. AMERICAN JOURNAL OF CASE REPORTS. 2019?20:248?251",52.0,YR,,M,Y,,,20210201.0,,HP,US,US,2021,Q1,Adult
160407453,16040745,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Nausea,,2021,Q1,3,F,,20210124.0,20190306,20210201,EXP,,US-PFIZER INC-2019095067,PFIZER,"SUBEDI, P.. CLINDAMYCIN: AN UNUSUAL CAUSE OF ACUTE KIDNEY INJURY. AMERICAN JOURNAL OF CASE REPORTS. 2019?20:248?251",52.0,YR,,M,Y,,,20210201.0,,HP,US,US,2021,Q1,Adult
160748355,16074835,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"12 UNK, UNKNOWN",,,,,,,,,,,,2021,Q1,Acute coronary syndrome,,2021,Q1,5,F,20171110.0,20210215.0,20190314,20210222,EXP,,PHHY2019CA055398,NOVARTIS,,65.0,YR,,F,Y,119.1,KG,20210222.0,,MD,CA,CA,2021,Q1,Elderly
160748355,16074835,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"12 UNK, UNKNOWN",,,,,,,,,,,,2021,Q1,Acute myocardial infarction,,2021,Q1,5,F,20171110.0,20210215.0,20190314,20210222,EXP,,PHHY2019CA055398,NOVARTIS,,65.0,YR,,F,Y,119.1,KG,20210222.0,,MD,CA,CA,2021,Q1,Elderly
160748355,16074835,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"12 UNK, UNKNOWN",,,,,,,,,,,,2021,Q1,Chest pain,,2021,Q1,5,F,20171110.0,20210215.0,20190314,20210222,EXP,,PHHY2019CA055398,NOVARTIS,,65.0,YR,,F,Y,119.1,KG,20210222.0,,MD,CA,CA,2021,Q1,Elderly
160748355,16074835,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"12 UNK, UNKNOWN",,,,,,,,,,,,2021,Q1,Gastrointestinal haemorrhage,,2021,Q1,5,F,20171110.0,20210215.0,20190314,20210222,EXP,,PHHY2019CA055398,NOVARTIS,,65.0,YR,,F,Y,119.1,KG,20210222.0,,MD,CA,CA,2021,Q1,Elderly
160748355,16074835,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"12 UNK, UNKNOWN",,,,,,,,,,,,2021,Q1,Renal impairment,,2021,Q1,5,F,20171110.0,20210215.0,20190314,20210222,EXP,,PHHY2019CA055398,NOVARTIS,,65.0,YR,,F,Y,119.1,KG,20210222.0,,MD,CA,CA,2021,Q1,Elderly
160748355,16074835,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"12 UNK, UNKNOWN",,,,,,,,,,,,2021,Q1,Syncope,,2021,Q1,5,F,20171110.0,20210215.0,20190314,20210222,EXP,,PHHY2019CA055398,NOVARTIS,,65.0,YR,,F,Y,119.1,KG,20210222.0,,MD,CA,CA,2021,Q1,Elderly
160835556,16083555,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Hepatic encephalopathy,,2021,Q1,6,F,20190311.0,20210127.0,20190318,20210202,PER,,JP-EISAI MEDICAL RESEARCH-EC-2019-053556,EISAI,,60.0,YR,A,M,Y,75.0,KG,20210202.0,,MD,JP,JP,2021,Q1,Adult
160835556,16083555,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Hepatic failure,,2021,Q1,6,F,20190311.0,20210127.0,20190318,20210202,PER,,JP-EISAI MEDICAL RESEARCH-EC-2019-053556,EISAI,,60.0,YR,A,M,Y,75.0,KG,20210202.0,,MD,JP,JP,2021,Q1,Adult
1619976611,16199766,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM: 25 UNIT NO'S,,,U,,,,,1.0,DF,,,2021,Q1,Cutaneous sarcoidosis,,2021,Q1,11,F,20190404.0,20210120.0,20190415,20210126,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036992,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,96.0,KG,20210126.0,,HP,BR,BR,2021,Q1,Elderly
1619976611,16199766,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM: 25 UNIT NO'S,,,U,,,,,1.0,DF,,,2021,Q1,Epiglottic oedema,,2021,Q1,11,F,20190404.0,20210120.0,20190415,20210126,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036992,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,96.0,KG,20210126.0,,HP,BR,BR,2021,Q1,Elderly
1619976611,16199766,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM: 25 UNIT NO'S,,,U,,,,,1.0,DF,,,2021,Q1,Sarcoidosis,,2021,Q1,11,F,20190404.0,20210120.0,20190415,20210126,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036992,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,96.0,KG,20210126.0,,HP,BR,BR,2021,Q1,Elderly
1619976611,16199766,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q1,Cutaneous sarcoidosis,,2021,Q1,11,F,20190404.0,20210120.0,20190415,20210126,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036992,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,96.0,KG,20210126.0,,HP,BR,BR,2021,Q1,Elderly
1619976611,16199766,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q1,Epiglottic oedema,,2021,Q1,11,F,20190404.0,20210120.0,20190415,20210126,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036992,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,96.0,KG,20210126.0,,HP,BR,BR,2021,Q1,Elderly
1619976611,16199766,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q1,Sarcoidosis,,2021,Q1,11,F,20190404.0,20210120.0,20190415,20210126,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036992,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,96.0,KG,20210126.0,,HP,BR,BR,2021,Q1,Elderly
162125002,16212500,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"100 IU, QD",,,,,,,,100.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Cough,,2021,Q1,2,F,20190408.0,20210315.0,20190418,20210326,EXP,,US-SA-2019SA102358,SANOFI AVENTIS,,63.0,YR,A,M,Y,,,20210326.0,,MD,US,US,2021,Q1,Adult
162125002,16212500,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"100 IU, QD",,,,,,,,100.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Malaise,,2021,Q1,2,F,20190408.0,20210315.0,20190418,20210326,EXP,,US-SA-2019SA102358,SANOFI AVENTIS,,63.0,YR,A,M,Y,,,20210326.0,,MD,US,US,2021,Q1,Adult
162125002,16212500,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"100 IU, QD",,,,,,,,100.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Product prescribing issue,,2021,Q1,2,F,20190408.0,20210315.0,20190418,20210326,EXP,,US-SA-2019SA102358,SANOFI AVENTIS,,63.0,YR,A,M,Y,,,20210326.0,,MD,US,US,2021,Q1,Adult
162125002,16212500,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"100 IU, QD",,,,,,,,100.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Sinusitis,,2021,Q1,2,F,20190408.0,20210315.0,20190418,20210326,EXP,,US-SA-2019SA102358,SANOFI AVENTIS,,63.0,YR,A,M,Y,,,20210326.0,,MD,US,US,2021,Q1,Adult
162125002,16212500,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"100 IU, QD",,,,,,,,100.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Upper respiratory tract infection,,2021,Q1,2,F,20190408.0,20210315.0,20190418,20210326,EXP,,US-SA-2019SA102358,SANOFI AVENTIS,,63.0,YR,A,M,Y,,,20210326.0,,MD,US,US,2021,Q1,Adult
162125002,16212500,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"90 IU, Q12H",,,,,,,,90.0,IU,SOLUTION FOR INJECTION,Q12H,2021,Q1,Cough,,2021,Q1,2,F,20190408.0,20210315.0,20190418,20210326,EXP,,US-SA-2019SA102358,SANOFI AVENTIS,,63.0,YR,A,M,Y,,,20210326.0,,MD,US,US,2021,Q1,Adult
162125002,16212500,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"90 IU, Q12H",,,,,,,,90.0,IU,SOLUTION FOR INJECTION,Q12H,2021,Q1,Malaise,,2021,Q1,2,F,20190408.0,20210315.0,20190418,20210326,EXP,,US-SA-2019SA102358,SANOFI AVENTIS,,63.0,YR,A,M,Y,,,20210326.0,,MD,US,US,2021,Q1,Adult
162125002,16212500,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"90 IU, Q12H",,,,,,,,90.0,IU,SOLUTION FOR INJECTION,Q12H,2021,Q1,Product prescribing issue,,2021,Q1,2,F,20190408.0,20210315.0,20190418,20210326,EXP,,US-SA-2019SA102358,SANOFI AVENTIS,,63.0,YR,A,M,Y,,,20210326.0,,MD,US,US,2021,Q1,Adult
162125002,16212500,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"90 IU, Q12H",,,,,,,,90.0,IU,SOLUTION FOR INJECTION,Q12H,2021,Q1,Sinusitis,,2021,Q1,2,F,20190408.0,20210315.0,20190418,20210326,EXP,,US-SA-2019SA102358,SANOFI AVENTIS,,63.0,YR,A,M,Y,,,20210326.0,,MD,US,US,2021,Q1,Adult
162125002,16212500,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"90 IU, Q12H",,,,,,,,90.0,IU,SOLUTION FOR INJECTION,Q12H,2021,Q1,Upper respiratory tract infection,,2021,Q1,2,F,20190408.0,20210315.0,20190418,20210326,EXP,,US-SA-2019SA102358,SANOFI AVENTIS,,63.0,YR,A,M,Y,,,20210326.0,,MD,US,US,2021,Q1,Adult
162732393,16273239,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Hypoglycaemic unconsciousness,,2021,Q1,3,F,,20210315.0,20190506,20210326,EXP,,CA-APOTEX-2019AP012973,APOTEX,,53.0,YR,,F,Y,93.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Adult
163006483,16300648,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,D,,,,,,,UNKNOWN,,2021,Q1,Infusion related reaction,,2021,Q1,3,F,20190301.0,20210105.0,20190510,20210114,EXP,,AU-JNJFOC-20190430771,JOHNSON AND JOHNSON,,71.0,YR,E,F,Y,91.5,KG,20210114.0,,MD,AU,AU,2021,Q1,Elderly
163006483,16300648,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,D,,,,,,,UNKNOWN,,2021,Q1,Respiratory distress,,2021,Q1,3,F,20190301.0,20210105.0,20190510,20210114,EXP,,AU-JNJFOC-20190430771,JOHNSON AND JOHNSON,,71.0,YR,E,F,Y,91.5,KG,20210114.0,,MD,AU,AU,2021,Q1,Elderly
163589242,16358924,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"86 IU, QD (AT NIGHT)",,,,,,,,86.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Blister,,2021,Q1,2,F,20190507.0,20210316.0,20190527,20210320,PER,,US-SA-2019SA129756,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20210320.0,,CN,US,US,2021,Q1,Elderly
163589242,16358924,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"86 IU, QD (AT NIGHT)",,,,,,,,86.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Blood glucose increased,,2021,Q1,2,F,20190507.0,20210316.0,20190527,20210320,PER,,US-SA-2019SA129756,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20210320.0,,CN,US,US,2021,Q1,Elderly
163589242,16358924,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"86 IU, QD (AT NIGHT)",,,,,,,,86.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Constipation,,2021,Q1,2,F,20190507.0,20210316.0,20190527,20210320,PER,,US-SA-2019SA129756,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20210320.0,,CN,US,US,2021,Q1,Elderly
163589242,16358924,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"86 IU, QD (AT NIGHT)",,,,,,,,86.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Dyspnoea,,2021,Q1,2,F,20190507.0,20210316.0,20190527,20210320,PER,,US-SA-2019SA129756,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20210320.0,,CN,US,US,2021,Q1,Elderly
163589242,16358924,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"86 IU, QD (AT NIGHT)",,,,,,,,86.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Fatigue,,2021,Q1,2,F,20190507.0,20210316.0,20190527,20210320,PER,,US-SA-2019SA129756,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20210320.0,,CN,US,US,2021,Q1,Elderly
163589242,16358924,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"86 IU, QD (AT NIGHT)",,,,,,,,86.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Feeling of body temperature change,,2021,Q1,2,F,20190507.0,20210316.0,20190527,20210320,PER,,US-SA-2019SA129756,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20210320.0,,CN,US,US,2021,Q1,Elderly
163589242,16358924,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"86 IU, QD (AT NIGHT)",,,,,,,,86.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Oedema peripheral,,2021,Q1,2,F,20190507.0,20210316.0,20190527,20210320,PER,,US-SA-2019SA129756,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20210320.0,,CN,US,US,2021,Q1,Elderly
163589242,16358924,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"86 IU, QD (AT NIGHT)",,,,,,,,86.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Product prescribing issue,,2021,Q1,2,F,20190507.0,20210316.0,20190527,20210320,PER,,US-SA-2019SA129756,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20210320.0,,CN,US,US,2021,Q1,Elderly
163589242,16358924,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"86 IU, QD (AT NIGHT)",,,,,,,,86.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Wheezing,,2021,Q1,2,F,20190507.0,20210316.0,20190527,20210320,PER,,US-SA-2019SA129756,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20210320.0,,CN,US,US,2021,Q1,Elderly
163589242,16358924,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"45 IU, BID",,,,, 8F5325A,,,45.0,IU,SOLUTION FOR INJECTION,Q12H,2021,Q1,Blister,,2021,Q1,2,F,20190507.0,20210316.0,20190527,20210320,PER,,US-SA-2019SA129756,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20210320.0,,CN,US,US,2021,Q1,Elderly
163589242,16358924,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"45 IU, BID",,,,, 8F5325A,,,45.0,IU,SOLUTION FOR INJECTION,Q12H,2021,Q1,Blood glucose increased,,2021,Q1,2,F,20190507.0,20210316.0,20190527,20210320,PER,,US-SA-2019SA129756,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20210320.0,,CN,US,US,2021,Q1,Elderly
163589242,16358924,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"45 IU, BID",,,,, 8F5325A,,,45.0,IU,SOLUTION FOR INJECTION,Q12H,2021,Q1,Constipation,,2021,Q1,2,F,20190507.0,20210316.0,20190527,20210320,PER,,US-SA-2019SA129756,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20210320.0,,CN,US,US,2021,Q1,Elderly
163589242,16358924,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"45 IU, BID",,,,, 8F5325A,,,45.0,IU,SOLUTION FOR INJECTION,Q12H,2021,Q1,Dyspnoea,,2021,Q1,2,F,20190507.0,20210316.0,20190527,20210320,PER,,US-SA-2019SA129756,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20210320.0,,CN,US,US,2021,Q1,Elderly
163589242,16358924,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"45 IU, BID",,,,, 8F5325A,,,45.0,IU,SOLUTION FOR INJECTION,Q12H,2021,Q1,Fatigue,,2021,Q1,2,F,20190507.0,20210316.0,20190527,20210320,PER,,US-SA-2019SA129756,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20210320.0,,CN,US,US,2021,Q1,Elderly
163589242,16358924,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"45 IU, BID",,,,, 8F5325A,,,45.0,IU,SOLUTION FOR INJECTION,Q12H,2021,Q1,Feeling of body temperature change,,2021,Q1,2,F,20190507.0,20210316.0,20190527,20210320,PER,,US-SA-2019SA129756,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20210320.0,,CN,US,US,2021,Q1,Elderly
163589242,16358924,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"45 IU, BID",,,,, 8F5325A,,,45.0,IU,SOLUTION FOR INJECTION,Q12H,2021,Q1,Oedema peripheral,,2021,Q1,2,F,20190507.0,20210316.0,20190527,20210320,PER,,US-SA-2019SA129756,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20210320.0,,CN,US,US,2021,Q1,Elderly
163589242,16358924,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"45 IU, BID",,,,, 8F5325A,,,45.0,IU,SOLUTION FOR INJECTION,Q12H,2021,Q1,Product prescribing issue,,2021,Q1,2,F,20190507.0,20210316.0,20190527,20210320,PER,,US-SA-2019SA129756,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20210320.0,,CN,US,US,2021,Q1,Elderly
163589242,16358924,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"45 IU, BID",,,,, 8F5325A,,,45.0,IU,SOLUTION FOR INJECTION,Q12H,2021,Q1,Wheezing,,2021,Q1,2,F,20190507.0,20210316.0,20190527,20210320,PER,,US-SA-2019SA129756,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20210320.0,,CN,US,US,2021,Q1,Elderly
163589242,16358924,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60?65 IU, Q12H",,,,,,,,,,SOLUTION FOR INJECTION,Q12H,2021,Q1,Blister,,2021,Q1,2,F,20190507.0,20210316.0,20190527,20210320,PER,,US-SA-2019SA129756,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20210320.0,,CN,US,US,2021,Q1,Elderly
163589242,16358924,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60?65 IU, Q12H",,,,,,,,,,SOLUTION FOR INJECTION,Q12H,2021,Q1,Blood glucose increased,,2021,Q1,2,F,20190507.0,20210316.0,20190527,20210320,PER,,US-SA-2019SA129756,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20210320.0,,CN,US,US,2021,Q1,Elderly
163589242,16358924,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60?65 IU, Q12H",,,,,,,,,,SOLUTION FOR INJECTION,Q12H,2021,Q1,Constipation,,2021,Q1,2,F,20190507.0,20210316.0,20190527,20210320,PER,,US-SA-2019SA129756,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20210320.0,,CN,US,US,2021,Q1,Elderly
163589242,16358924,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60?65 IU, Q12H",,,,,,,,,,SOLUTION FOR INJECTION,Q12H,2021,Q1,Dyspnoea,,2021,Q1,2,F,20190507.0,20210316.0,20190527,20210320,PER,,US-SA-2019SA129756,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20210320.0,,CN,US,US,2021,Q1,Elderly
163589242,16358924,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60?65 IU, Q12H",,,,,,,,,,SOLUTION FOR INJECTION,Q12H,2021,Q1,Fatigue,,2021,Q1,2,F,20190507.0,20210316.0,20190527,20210320,PER,,US-SA-2019SA129756,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20210320.0,,CN,US,US,2021,Q1,Elderly
163589242,16358924,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60?65 IU, Q12H",,,,,,,,,,SOLUTION FOR INJECTION,Q12H,2021,Q1,Feeling of body temperature change,,2021,Q1,2,F,20190507.0,20210316.0,20190527,20210320,PER,,US-SA-2019SA129756,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20210320.0,,CN,US,US,2021,Q1,Elderly
163589242,16358924,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60?65 IU, Q12H",,,,,,,,,,SOLUTION FOR INJECTION,Q12H,2021,Q1,Oedema peripheral,,2021,Q1,2,F,20190507.0,20210316.0,20190527,20210320,PER,,US-SA-2019SA129756,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20210320.0,,CN,US,US,2021,Q1,Elderly
163589242,16358924,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60?65 IU, Q12H",,,,,,,,,,SOLUTION FOR INJECTION,Q12H,2021,Q1,Product prescribing issue,,2021,Q1,2,F,20190507.0,20210316.0,20190527,20210320,PER,,US-SA-2019SA129756,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20210320.0,,CN,US,US,2021,Q1,Elderly
163589242,16358924,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60?65 IU, Q12H",,,,,,,,,,SOLUTION FOR INJECTION,Q12H,2021,Q1,Wheezing,,2021,Q1,2,F,20190507.0,20210316.0,20190527,20210320,PER,,US-SA-2019SA129756,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20210320.0,,CN,US,US,2021,Q1,Elderly
1656848118,16568481,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Anaemia,,2021,Q1,18,F,20190610.0,20210308.0,20190712,20210311,EXP,,PHHY2019FR161521,NOVARTIS,,74.0,YR,,M,Y,88.0,KG,20210311.0,,MD,FR,FR,2021,Q1,Elderly
1656848118,16568481,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Angina pectoris,,2021,Q1,18,F,20190610.0,20210308.0,20190712,20210311,EXP,,PHHY2019FR161521,NOVARTIS,,74.0,YR,,M,Y,88.0,KG,20210311.0,,MD,FR,FR,2021,Q1,Elderly
1656848118,16568481,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Cytomegalovirus test positive,,2021,Q1,18,F,20190610.0,20210308.0,20190712,20210311,EXP,,PHHY2019FR161521,NOVARTIS,,74.0,YR,,M,Y,88.0,KG,20210311.0,,MD,FR,FR,2021,Q1,Elderly
1656848118,16568481,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Endocarditis,,2021,Q1,18,F,20190610.0,20210308.0,20190712,20210311,EXP,,PHHY2019FR161521,NOVARTIS,,74.0,YR,,M,Y,88.0,KG,20210311.0,,MD,FR,FR,2021,Q1,Elderly
1656848118,16568481,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Pyrexia,,2021,Q1,18,F,20190610.0,20210308.0,20190712,20210311,EXP,,PHHY2019FR161521,NOVARTIS,,74.0,YR,,M,Y,88.0,KG,20210311.0,,MD,FR,FR,2021,Q1,Elderly
1656848118,16568481,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Renal impairment,,2021,Q1,18,F,20190610.0,20210308.0,20190712,20210311,EXP,,PHHY2019FR161521,NOVARTIS,,74.0,YR,,M,Y,88.0,KG,20210311.0,,MD,FR,FR,2021,Q1,Elderly
1656848118,16568481,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Skin ulcer,,2021,Q1,18,F,20190610.0,20210308.0,20190712,20210311,EXP,,PHHY2019FR161521,NOVARTIS,,74.0,YR,,M,Y,88.0,KG,20210311.0,,MD,FR,FR,2021,Q1,Elderly
1656848118,16568481,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Tooth abscess,,2021,Q1,18,F,20190610.0,20210308.0,20190712,20210311,EXP,,PHHY2019FR161521,NOVARTIS,,74.0,YR,,M,Y,88.0,KG,20210311.0,,MD,FR,FR,2021,Q1,Elderly
1656848118,16568481,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Urinary tract infection,,2021,Q1,18,F,20190610.0,20210308.0,20190712,20210311,EXP,,PHHY2019FR161521,NOVARTIS,,74.0,YR,,M,Y,88.0,KG,20210311.0,,MD,FR,FR,2021,Q1,Elderly
167840612,16784061,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,21081.0,,,,,2021,Q1,Asthenia,,2021,Q1,2,F,20190829.0,20210211.0,20190909,20210224,EXP,,IL-SA-2019SA246940,SANOFI AVENTIS,,79.0,YR,E,F,Y,,,20210224.0,,CN,IL,IL,2021,Q1,Elderly
167840612,16784061,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,21081.0,,,,,2021,Q1,Blood glucose abnormal,,2021,Q1,2,F,20190829.0,20210211.0,20190909,20210224,EXP,,IL-SA-2019SA246940,SANOFI AVENTIS,,79.0,YR,E,F,Y,,,20210224.0,,CN,IL,IL,2021,Q1,Elderly
167840612,16784061,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,21081.0,,,,,2021,Q1,Urinary tract infection,,2021,Q1,2,F,20190829.0,20210211.0,20190909,20210224,EXP,,IL-SA-2019SA246940,SANOFI AVENTIS,,79.0,YR,E,F,Y,,,20210224.0,,CN,IL,IL,2021,Q1,Elderly
168786953,16878695,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",2320.0,IU,,,,,206538.0,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Decreased appetite,,2021,Q1,3,F,20190301.0,20200324.0,20191002,20210316,EXP,IT-MINISAL02-557219,IT-SA-2019SA170038,SANOFI AVENTIS,,64.0,YR,A,M,Y,72.0,KG,20210316.0,,MD,IT,IT,2021,Q1,Adult
168786953,16878695,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",2320.0,IU,,,,,206538.0,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Diarrhoea,,2021,Q1,3,F,20190301.0,20200324.0,20191002,20210316,EXP,IT-MINISAL02-557219,IT-SA-2019SA170038,SANOFI AVENTIS,,64.0,YR,A,M,Y,72.0,KG,20210316.0,,MD,IT,IT,2021,Q1,Adult
168786953,16878695,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",2320.0,IU,,,,,206538.0,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Nausea,,2021,Q1,3,F,20190301.0,20200324.0,20191002,20210316,EXP,IT-MINISAL02-557219,IT-SA-2019SA170038,SANOFI AVENTIS,,64.0,YR,A,M,Y,72.0,KG,20210316.0,,MD,IT,IT,2021,Q1,Adult
168786953,16878695,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",2320.0,IU,,,,,206538.0,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Pancreatic atrophy,,2021,Q1,3,F,20190301.0,20200324.0,20191002,20210316,EXP,IT-MINISAL02-557219,IT-SA-2019SA170038,SANOFI AVENTIS,,64.0,YR,A,M,Y,72.0,KG,20210316.0,,MD,IT,IT,2021,Q1,Adult
168786953,16878695,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",2320.0,IU,,,,,206538.0,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Pancreatic duct stenosis,,2021,Q1,3,F,20190301.0,20200324.0,20191002,20210316,EXP,IT-MINISAL02-557219,IT-SA-2019SA170038,SANOFI AVENTIS,,64.0,YR,A,M,Y,72.0,KG,20210316.0,,MD,IT,IT,2021,Q1,Adult
168786953,16878695,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",2320.0,IU,,,,,206538.0,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Weight decreased,,2021,Q1,3,F,20190301.0,20200324.0,20191002,20210316,EXP,IT-MINISAL02-557219,IT-SA-2019SA170038,SANOFI AVENTIS,,64.0,YR,A,M,Y,72.0,KG,20210316.0,,MD,IT,IT,2021,Q1,Adult
168825516,16882551,11,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,,,,U,,,,,8.0,IU,,,2021,Q1,Angina pectoris,,2021,Q1,6,F,20181104.0,20201116.0,20191003,20210215,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-104902",BOEHRINGER INGELHEIM,,64.0,YR,A,M,Y,106.7,KG,20210215.0,,MD,JP,JP,2021,Q1,Adult
169324975,16932497,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Leukopenia,,2021,Q1,5,F,20190723.0,20210121.0,20191017,20210122,EXP,,PHHO2019PL007720,NOVARTIS,,63.0,YR,,M,Y,104.0,KG,20210122.0,,MD,PL,PL,2021,Q1,Adult
169324975,16932497,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Neutropenia,,2021,Q1,5,F,20190723.0,20210121.0,20191017,20210122,EXP,,PHHO2019PL007720,NOVARTIS,,63.0,YR,,M,Y,104.0,KG,20210122.0,,MD,PL,PL,2021,Q1,Adult
1696951024,16969510,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,12.0,DF,INJECTION,,2021,Q1,Heart injury,,2021,Q1,24,F,20191021.0,20210220.0,20191029,20210225,EXP,,CN-EISAI MEDICAL RESEARCH-EC-2019-064326,EISAI,,62.0,YR,A,M,Y,69.0,KG,20210225.0,,MD,CN,CN,2021,Q1,Adult
170266994,17026699,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"62 IU, QD (BEDTIME)",,,Y,,,,,62.0,IU,,QD,2021,Q1,Abdominal pain,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"62 IU, QD (BEDTIME)",,,Y,,,,,62.0,IU,,QD,2021,Q1,Abdominal pain upper,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"62 IU, QD (BEDTIME)",,,Y,,,,,62.0,IU,,QD,2021,Q1,Asthenia,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"62 IU, QD (BEDTIME)",,,Y,,,,,62.0,IU,,QD,2021,Q1,Bile output abnormal,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"62 IU, QD (BEDTIME)",,,Y,,,,,62.0,IU,,QD,2021,Q1,Blood lactic acid increased,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"62 IU, QD (BEDTIME)",,,Y,,,,,62.0,IU,,QD,2021,Q1,COVID-19,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"62 IU, QD (BEDTIME)",,,Y,,,,,62.0,IU,,QD,2021,Q1,Cough,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"62 IU, QD (BEDTIME)",,,Y,,,,,62.0,IU,,QD,2021,Q1,Gastritis,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"62 IU, QD (BEDTIME)",,,Y,,,,,62.0,IU,,QD,2021,Q1,Gastrointestinal perforation,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"62 IU, QD (BEDTIME)",,,Y,,,,,62.0,IU,,QD,2021,Q1,Glycosuria,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"62 IU, QD (BEDTIME)",,,Y,,,,,62.0,IU,,QD,2021,Q1,Hepatic cirrhosis,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"62 IU, QD (BEDTIME)",,,Y,,,,,62.0,IU,,QD,2021,Q1,Hepatic steatosis,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"62 IU, QD (BEDTIME)",,,Y,,,,,62.0,IU,,QD,2021,Q1,Malaise,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"62 IU, QD (BEDTIME)",,,Y,,,,,62.0,IU,,QD,2021,Q1,Nausea,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"62 IU, QD (BEDTIME)",,,Y,,,,,62.0,IU,,QD,2021,Q1,Oesophageal candidiasis,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"62 IU, QD (BEDTIME)",,,Y,,,,,62.0,IU,,QD,2021,Q1,Pyrexia,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"62 IU, QD (BEDTIME)",,,Y,,,,,62.0,IU,,QD,2021,Q1,Viral infection,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"62 IU, QD (BEDTIME)",,,Y,,,,,62.0,IU,,QD,2021,Q1,White blood cell count increased,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 48 UNITS QHS",,,Y,,,,,,,,,2021,Q1,Abdominal pain,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 48 UNITS QHS",,,Y,,,,,,,,,2021,Q1,Abdominal pain upper,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 48 UNITS QHS",,,Y,,,,,,,,,2021,Q1,Asthenia,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 48 UNITS QHS",,,Y,,,,,,,,,2021,Q1,Bile output abnormal,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 48 UNITS QHS",,,Y,,,,,,,,,2021,Q1,Blood lactic acid increased,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 48 UNITS QHS",,,Y,,,,,,,,,2021,Q1,COVID-19,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 48 UNITS QHS",,,Y,,,,,,,,,2021,Q1,Cough,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 48 UNITS QHS",,,Y,,,,,,,,,2021,Q1,Gastritis,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 48 UNITS QHS",,,Y,,,,,,,,,2021,Q1,Gastrointestinal perforation,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 48 UNITS QHS",,,Y,,,,,,,,,2021,Q1,Glycosuria,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 48 UNITS QHS",,,Y,,,,,,,,,2021,Q1,Hepatic cirrhosis,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 48 UNITS QHS",,,Y,,,,,,,,,2021,Q1,Hepatic steatosis,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 48 UNITS QHS",,,Y,,,,,,,,,2021,Q1,Malaise,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 48 UNITS QHS",,,Y,,,,,,,,,2021,Q1,Nausea,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 48 UNITS QHS",,,Y,,,,,,,,,2021,Q1,Oesophageal candidiasis,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 48 UNITS QHS",,,Y,,,,,,,,,2021,Q1,Pyrexia,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 48 UNITS QHS",,,Y,,,,,,,,,2021,Q1,Viral infection,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 48 UNITS QHS",,,Y,,,,,,,,,2021,Q1,White blood cell count increased,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170874513,17087451,17,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,5 IU (INTERNATIONAL UNIT)??100 UNIT/ML (U?100),,,,,,,,5.0,IU,SOLUTION,QD,2021,Q1,Basal cell carcinoma,,2021,Q1,3,F,20190917.0,20210106.0,20191128,20210111,EXP,,US-CELGENEUS-USA-20191109152,CELGENE,,85.0,YR,,M,Y,82.54,KG,20210111.0,,MD,US,US,2021,Q1,Elderly
171454232,17145423,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),UNK INFUSION  IV INFUSION OF INSULIN AT 2 UNITS/KG/HOUR. UPON..,,,D,,,,210605.0,,,INJECTION,,2021,Q1,Acute kidney injury,,2021,Q1,2,F,,20210106.0,20191212,20210113,EXP,,GB-MYLANLABS-2019M1121954,MYLAN,"CHAD T, ULLA M, REY VG, GOMEZ C. A LOT OF INSULIN. J?INTENS?CARE?SOC 2020?21 (SUPPL.)(2):201?202 (PLUS ORAL PRESENTATION) ABSTR. 0403.",79.0,YR,,M,Y,80.0,KG,20210113.0,,MD,GB,GB,2021,Q1,Elderly
171454232,17145423,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),UNK INFUSION  IV INFUSION OF INSULIN AT 2 UNITS/KG/HOUR. UPON..,,,D,,,,210605.0,,,INJECTION,,2021,Q1,Cardiogenic shock,,2021,Q1,2,F,,20210106.0,20191212,20210113,EXP,,GB-MYLANLABS-2019M1121954,MYLAN,"CHAD T, ULLA M, REY VG, GOMEZ C. A LOT OF INSULIN. J?INTENS?CARE?SOC 2020?21 (SUPPL.)(2):201?202 (PLUS ORAL PRESENTATION) ABSTR. 0403.",79.0,YR,,M,Y,80.0,KG,20210113.0,,MD,GB,GB,2021,Q1,Elderly
171454232,17145423,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),UNK INFUSION  IV INFUSION OF INSULIN AT 2 UNITS/KG/HOUR. UPON..,,,D,,,,210605.0,,,INJECTION,,2021,Q1,Hypoglycaemia,,2021,Q1,2,F,,20210106.0,20191212,20210113,EXP,,GB-MYLANLABS-2019M1121954,MYLAN,"CHAD T, ULLA M, REY VG, GOMEZ C. A LOT OF INSULIN. J?INTENS?CARE?SOC 2020?21 (SUPPL.)(2):201?202 (PLUS ORAL PRESENTATION) ABSTR. 0403.",79.0,YR,,M,Y,80.0,KG,20210113.0,,MD,GB,GB,2021,Q1,Elderly
171454232,17145423,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),UNK INFUSION  IV INFUSION OF INSULIN AT 2 UNITS/KG/HOUR. UPON..,,,D,,,,210605.0,,,INJECTION,,2021,Q1,Hypokalaemia,,2021,Q1,2,F,,20210106.0,20191212,20210113,EXP,,GB-MYLANLABS-2019M1121954,MYLAN,"CHAD T, ULLA M, REY VG, GOMEZ C. A LOT OF INSULIN. J?INTENS?CARE?SOC 2020?21 (SUPPL.)(2):201?202 (PLUS ORAL PRESENTATION) ABSTR. 0403.",79.0,YR,,M,Y,80.0,KG,20210113.0,,MD,GB,GB,2021,Q1,Elderly
171454232,17145423,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),UNK INFUSION  IV INFUSION OF INSULIN AT 2 UNITS/KG/HOUR. UPON..,,,D,,,,210605.0,,,INJECTION,,2021,Q1,Hypotension,,2021,Q1,2,F,,20210106.0,20191212,20210113,EXP,,GB-MYLANLABS-2019M1121954,MYLAN,"CHAD T, ULLA M, REY VG, GOMEZ C. A LOT OF INSULIN. J?INTENS?CARE?SOC 2020?21 (SUPPL.)(2):201?202 (PLUS ORAL PRESENTATION) ABSTR. 0403.",79.0,YR,,M,Y,80.0,KG,20210113.0,,MD,GB,GB,2021,Q1,Elderly
171454232,17145423,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),UNK INFUSION  IV INFUSION OF INSULIN AT 2 UNITS/KG/HOUR. UPON..,,,D,,,,210605.0,,,INJECTION,,2021,Q1,Intentional overdose,,2021,Q1,2,F,,20210106.0,20191212,20210113,EXP,,GB-MYLANLABS-2019M1121954,MYLAN,"CHAD T, ULLA M, REY VG, GOMEZ C. A LOT OF INSULIN. J?INTENS?CARE?SOC 2020?21 (SUPPL.)(2):201?202 (PLUS ORAL PRESENTATION) ABSTR. 0403.",79.0,YR,,M,Y,80.0,KG,20210113.0,,MD,GB,GB,2021,Q1,Elderly
171454232,17145423,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),UNK INFUSION  IV INFUSION OF INSULIN AT 2 UNITS/KG/HOUR. UPON..,,,D,,,,210605.0,,,INJECTION,,2021,Q1,Off label use,,2021,Q1,2,F,,20210106.0,20191212,20210113,EXP,,GB-MYLANLABS-2019M1121954,MYLAN,"CHAD T, ULLA M, REY VG, GOMEZ C. A LOT OF INSULIN. J?INTENS?CARE?SOC 2020?21 (SUPPL.)(2):201?202 (PLUS ORAL PRESENTATION) ABSTR. 0403.",79.0,YR,,M,Y,80.0,KG,20210113.0,,MD,GB,GB,2021,Q1,Elderly
171454232,17145423,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),UNK INFUSION  IV INFUSION OF INSULIN AT 2 UNITS/KG/HOUR. UPON..,,,D,,,,210605.0,,,INJECTION,,2021,Q1,Shock,,2021,Q1,2,F,,20210106.0,20191212,20210113,EXP,,GB-MYLANLABS-2019M1121954,MYLAN,"CHAD T, ULLA M, REY VG, GOMEZ C. A LOT OF INSULIN. J?INTENS?CARE?SOC 2020?21 (SUPPL.)(2):201?202 (PLUS ORAL PRESENTATION) ABSTR. 0403.",79.0,YR,,M,Y,80.0,KG,20210113.0,,MD,GB,GB,2021,Q1,Elderly
171454232,17145423,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),UNK INFUSION  IV INFUSION OF INSULIN AT 2 UNITS/KG/HOUR. UPON..,,,D,,,,210605.0,,,INJECTION,,2021,Q1,Toxicity to various agents,,2021,Q1,2,F,,20210106.0,20191212,20210113,EXP,,GB-MYLANLABS-2019M1121954,MYLAN,"CHAD T, ULLA M, REY VG, GOMEZ C. A LOT OF INSULIN. J?INTENS?CARE?SOC 2020?21 (SUPPL.)(2):201?202 (PLUS ORAL PRESENTATION) ABSTR. 0403.",79.0,YR,,M,Y,80.0,KG,20210113.0,,MD,GB,GB,2021,Q1,Elderly
171968282,17196828,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Acute kidney injury,,2021,Q1,2,F,20161229.0,20210209.0,20191224,20210217,EXP,,US-ASTRAZENECA-2019SF85032,ASTRAZENECA,,21070.0,DY,,F,Y,86.6,KG,20210217.0,,,US,US,2021,Q1,Elderly
171968282,17196828,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Chronic kidney disease,,2021,Q1,2,F,20161229.0,20210209.0,20191224,20210217,EXP,,US-ASTRAZENECA-2019SF85032,ASTRAZENECA,,21070.0,DY,,F,Y,86.6,KG,20210217.0,,,US,US,2021,Q1,Elderly
171968282,17196828,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Gastric ulcer,,2021,Q1,2,F,20161229.0,20210209.0,20191224,20210217,EXP,,US-ASTRAZENECA-2019SF85032,ASTRAZENECA,,21070.0,DY,,F,Y,86.6,KG,20210217.0,,,US,US,2021,Q1,Elderly
171968282,17196828,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Renal failure,,2021,Q1,2,F,20161229.0,20210209.0,20191224,20210217,EXP,,US-ASTRAZENECA-2019SF85032,ASTRAZENECA,,21070.0,DY,,F,Y,86.6,KG,20210217.0,,,US,US,2021,Q1,Elderly
172933825,17293382,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Blood glucose increased,,2021,Q1,5,F,,20201229.0,20200121,20210108,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,A,M,Y,104.0,KG,20210108.0,,CN,CO,CO,2021,Q1,Adult
172933825,17293382,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Cholelithiasis,,2021,Q1,5,F,,20201229.0,20200121,20210108,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,A,M,Y,104.0,KG,20210108.0,,CN,CO,CO,2021,Q1,Adult
172933825,17293382,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Fatigue,,2021,Q1,5,F,,20201229.0,20200121,20210108,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,A,M,Y,104.0,KG,20210108.0,,CN,CO,CO,2021,Q1,Adult
172933825,17293382,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Food intolerance,,2021,Q1,5,F,,20201229.0,20200121,20210108,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,A,M,Y,104.0,KG,20210108.0,,CN,CO,CO,2021,Q1,Adult
172933825,17293382,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Headache,,2021,Q1,5,F,,20201229.0,20200121,20210108,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,A,M,Y,104.0,KG,20210108.0,,CN,CO,CO,2021,Q1,Adult
172933825,17293382,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Malaise,,2021,Q1,5,F,,20201229.0,20200121,20210108,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,A,M,Y,104.0,KG,20210108.0,,CN,CO,CO,2021,Q1,Adult
172933825,17293382,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Nausea,,2021,Q1,5,F,,20201229.0,20200121,20210108,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,A,M,Y,104.0,KG,20210108.0,,CN,CO,CO,2021,Q1,Adult
172933825,17293382,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Photophobia,,2021,Q1,5,F,,20201229.0,20200121,20210108,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,A,M,Y,104.0,KG,20210108.0,,CN,CO,CO,2021,Q1,Adult
172933825,17293382,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Pituitary enlargement,,2021,Q1,5,F,,20201229.0,20200121,20210108,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,A,M,Y,104.0,KG,20210108.0,,CN,CO,CO,2021,Q1,Adult
172933825,17293382,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Vision blurred,,2021,Q1,5,F,,20201229.0,20200121,20210108,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,A,M,Y,104.0,KG,20210108.0,,CN,CO,CO,2021,Q1,Adult
172933825,17293382,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Vomiting,,2021,Q1,5,F,,20201229.0,20200121,20210108,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,A,M,Y,104.0,KG,20210108.0,,CN,CO,CO,2021,Q1,Adult
173051062,17305106,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,INCREASE 1 IU OF TOUJEO IF THE BASAL GLYCAEMIA GOES ABOVE 130 MG / DL,,,,, 0F768A,,,,,SOLUTION FOR INJECTION,,2021,Q1,Fatigue,,2021,Q1,2,F,2019.0,20210304.0,20200122,20210310,EXP,,ES-AUROBINDO-AUR-APL-2020-003168,AUROBINDO,,72.0,YR,,F,Y,70.0,KG,20210311.0,,CN,ES,ES,2021,Q1,Elderly
173051062,17305106,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,INCREASE 1 IU OF TOUJEO IF THE BASAL GLYCAEMIA GOES ABOVE 130 MG / DL,,,,, 0F768A,,,,,SOLUTION FOR INJECTION,,2021,Q1,Flatulence,,2021,Q1,2,F,2019.0,20210304.0,20200122,20210310,EXP,,ES-AUROBINDO-AUR-APL-2020-003168,AUROBINDO,,72.0,YR,,F,Y,70.0,KG,20210311.0,,CN,ES,ES,2021,Q1,Elderly
173051062,17305106,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,INCREASE 1 IU OF TOUJEO IF THE BASAL GLYCAEMIA GOES ABOVE 130 MG / DL,,,,, 0F768A,,,,,SOLUTION FOR INJECTION,,2021,Q1,Glycosylated haemoglobin increased,,2021,Q1,2,F,2019.0,20210304.0,20200122,20210310,EXP,,ES-AUROBINDO-AUR-APL-2020-003168,AUROBINDO,,72.0,YR,,F,Y,70.0,KG,20210311.0,,CN,ES,ES,2021,Q1,Elderly
173051062,17305106,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,26 INTERNATIONAL UNIT,,,,, 0F768A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Fatigue,,2021,Q1,2,F,2019.0,20210304.0,20200122,20210310,EXP,,ES-AUROBINDO-AUR-APL-2020-003168,AUROBINDO,,72.0,YR,,F,Y,70.0,KG,20210311.0,,CN,ES,ES,2021,Q1,Elderly
173051062,17305106,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,26 INTERNATIONAL UNIT,,,,, 0F768A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Flatulence,,2021,Q1,2,F,2019.0,20210304.0,20200122,20210310,EXP,,ES-AUROBINDO-AUR-APL-2020-003168,AUROBINDO,,72.0,YR,,F,Y,70.0,KG,20210311.0,,CN,ES,ES,2021,Q1,Elderly
173051062,17305106,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,26 INTERNATIONAL UNIT,,,,, 0F768A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Glycosylated haemoglobin increased,,2021,Q1,2,F,2019.0,20210304.0,20200122,20210310,EXP,,ES-AUROBINDO-AUR-APL-2020-003168,AUROBINDO,,72.0,YR,,F,Y,70.0,KG,20210311.0,,CN,ES,ES,2021,Q1,Elderly
173078132,17307813,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,INCREASE 1 IU OF TOUJEO IF THE BASAL GLYCAEMIA GOES ABOVE 130 MG / DL,,,,," 0F768A,0F768A",,,,,SOLUTION FOR INJECTION,,2021,Q1,Fatigue,,2021,Q1,2,F,2019.0,20210305.0,20200123,20210318,EXP,,ES-BAUSCH-BL-2020-001358,BAUSCH AND LOMB,,71.0,YR,,F,Y,70.0,KG,20210318.0,,CN,ES,ES,2021,Q1,Elderly
173078132,17307813,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,INCREASE 1 IU OF TOUJEO IF THE BASAL GLYCAEMIA GOES ABOVE 130 MG / DL,,,,," 0F768A,0F768A",,,,,SOLUTION FOR INJECTION,,2021,Q1,Flatulence,,2021,Q1,2,F,2019.0,20210305.0,20200123,20210318,EXP,,ES-BAUSCH-BL-2020-001358,BAUSCH AND LOMB,,71.0,YR,,F,Y,70.0,KG,20210318.0,,CN,ES,ES,2021,Q1,Elderly
173078132,17307813,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,INCREASE 1 IU OF TOUJEO IF THE BASAL GLYCAEMIA GOES ABOVE 130 MG / DL,,,,," 0F768A,0F768A",,,,,SOLUTION FOR INJECTION,,2021,Q1,Glycosylated haemoglobin increased,,2021,Q1,2,F,2019.0,20210305.0,20200123,20210318,EXP,,ES-BAUSCH-BL-2020-001358,BAUSCH AND LOMB,,71.0,YR,,F,Y,70.0,KG,20210318.0,,CN,ES,ES,2021,Q1,Elderly
173078132,17307813,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,," 0F768A,0F768A",,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Fatigue,,2021,Q1,2,F,2019.0,20210305.0,20200123,20210318,EXP,,ES-BAUSCH-BL-2020-001358,BAUSCH AND LOMB,,71.0,YR,,F,Y,70.0,KG,20210318.0,,CN,ES,ES,2021,Q1,Elderly
173078132,17307813,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,," 0F768A,0F768A",,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Flatulence,,2021,Q1,2,F,2019.0,20210305.0,20200123,20210318,EXP,,ES-BAUSCH-BL-2020-001358,BAUSCH AND LOMB,,71.0,YR,,F,Y,70.0,KG,20210318.0,,CN,ES,ES,2021,Q1,Elderly
173078132,17307813,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,," 0F768A,0F768A",,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Glycosylated haemoglobin increased,,2021,Q1,2,F,2019.0,20210305.0,20200123,20210318,EXP,,ES-BAUSCH-BL-2020-001358,BAUSCH AND LOMB,,71.0,YR,,F,Y,70.0,KG,20210318.0,,CN,ES,ES,2021,Q1,Elderly
173890767,17389076,35,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 UNITS, QD",,,,,,,,,,,QD,2021,Q1,Hyponatraemia,,2021,Q1,7,F,20190805.0,20210304.0,20200206,20210309,EXP,,US-DSJP-DSU-2019-130820,DAIICHI,,51.0,YR,,F,Y,94.5,KG,20210309.0,,MD,US,US,2021,Q1,Adult
173890767,17389076,35,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 UNITS, QD",,,,,,,,,,,QD,2021,Q1,Hypotension,,2021,Q1,7,F,20190805.0,20210304.0,20200206,20210309,EXP,,US-DSJP-DSU-2019-130820,DAIICHI,,51.0,YR,,F,Y,94.5,KG,20210309.0,,MD,US,US,2021,Q1,Adult
174050303,17405030,4,C,INSULIN GLARGINE(GENETICAL RECOMBINATION),INSULIN GLARGINE,1,Unknown,,,,,,,,,24.0,IU,,,2021,Q1,Euglycaemic diabetic ketoacidosis,,2021,Q1,3,F,,20210107.0,20200212,20210112,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-007047",BOEHRINGER INGELHEIM,"UCHIDA J, TAKAHASHI H, SONODA K, A CASE OF EUGLYCAEMIC DIABETIC KETOACIDOSIS TRIGGERED BY POSTOPERATIVE ORAL ADMINISTRATION OF SGLT2 INHIBITOR. THE 658TH KANTO REGIONAL MEETING OF THE JAPANESE SOCIETY OF INTERNAL MEDICINE. 2020 MAR 14?",7.0,DEC,E,F,Y,,,20210112.0,,MD,JP,JP,2021,Q1,Child
174050303,17405030,4,C,INSULIN GLARGINE(GENETICAL RECOMBINATION),INSULIN GLARGINE,1,Unknown,,,,,,,,,24.0,IU,,,2021,Q1,Lumbar spinal stenosis,,2021,Q1,3,F,,20210107.0,20200212,20210112,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-007047",BOEHRINGER INGELHEIM,"UCHIDA J, TAKAHASHI H, SONODA K, A CASE OF EUGLYCAEMIC DIABETIC KETOACIDOSIS TRIGGERED BY POSTOPERATIVE ORAL ADMINISTRATION OF SGLT2 INHIBITOR. THE 658TH KANTO REGIONAL MEETING OF THE JAPANESE SOCIETY OF INTERNAL MEDICINE. 2020 MAR 14?",7.0,DEC,E,F,Y,,,20210112.0,,MD,JP,JP,2021,Q1,Child
174050303,17405030,5,C,INSULIN GLARGINE(GENETICAL RECOMBINATION),INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q1,Euglycaemic diabetic ketoacidosis,,2021,Q1,3,F,,20210107.0,20200212,20210112,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-007047",BOEHRINGER INGELHEIM,"UCHIDA J, TAKAHASHI H, SONODA K, A CASE OF EUGLYCAEMIC DIABETIC KETOACIDOSIS TRIGGERED BY POSTOPERATIVE ORAL ADMINISTRATION OF SGLT2 INHIBITOR. THE 658TH KANTO REGIONAL MEETING OF THE JAPANESE SOCIETY OF INTERNAL MEDICINE. 2020 MAR 14?",7.0,DEC,E,F,Y,,,20210112.0,,MD,JP,JP,2021,Q1,Child
174050303,17405030,5,C,INSULIN GLARGINE(GENETICAL RECOMBINATION),INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q1,Lumbar spinal stenosis,,2021,Q1,3,F,,20210107.0,20200212,20210112,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-007047",BOEHRINGER INGELHEIM,"UCHIDA J, TAKAHASHI H, SONODA K, A CASE OF EUGLYCAEMIC DIABETIC KETOACIDOSIS TRIGGERED BY POSTOPERATIVE ORAL ADMINISTRATION OF SGLT2 INHIBITOR. THE 658TH KANTO REGIONAL MEETING OF THE JAPANESE SOCIETY OF INTERNAL MEDICINE. 2020 MAR 14?",7.0,DEC,E,F,Y,,,20210112.0,,MD,JP,JP,2021,Q1,Child
176888332,17688833,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,,, 0F768A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Fatigue,,2021,Q1,2,F,2019.0,20210305.0,20200421,20210312,EXP,,NVSC2020ES105522,NOVARTIS,,71.0,YR,,F,Y,70.0,KG,20210312.0,,HP,ES,ES,2021,Q1,Elderly
176888332,17688833,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,,, 0F768A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Flatulence,,2021,Q1,2,F,2019.0,20210305.0,20200421,20210312,EXP,,NVSC2020ES105522,NOVARTIS,,71.0,YR,,F,Y,70.0,KG,20210312.0,,HP,ES,ES,2021,Q1,Elderly
176888332,17688833,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,,, 0F768A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Glycosylated haemoglobin increased,,2021,Q1,2,F,2019.0,20210305.0,20200421,20210312,EXP,,NVSC2020ES105522,NOVARTIS,,71.0,YR,,F,Y,70.0,KG,20210312.0,,HP,ES,ES,2021,Q1,Elderly
176888332,17688833,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,INCREASE 1 IU OF TOUJEO IF THE BASAL GLYCAEMIA GOES ABOVE 130 MG / DL,,,,, 0F768A,,,,,SOLUTION FOR INJECTION,,2021,Q1,Fatigue,,2021,Q1,2,F,2019.0,20210305.0,20200421,20210312,EXP,,NVSC2020ES105522,NOVARTIS,,71.0,YR,,F,Y,70.0,KG,20210312.0,,HP,ES,ES,2021,Q1,Elderly
176888332,17688833,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,INCREASE 1 IU OF TOUJEO IF THE BASAL GLYCAEMIA GOES ABOVE 130 MG / DL,,,,, 0F768A,,,,,SOLUTION FOR INJECTION,,2021,Q1,Flatulence,,2021,Q1,2,F,2019.0,20210305.0,20200421,20210312,EXP,,NVSC2020ES105522,NOVARTIS,,71.0,YR,,F,Y,70.0,KG,20210312.0,,HP,ES,ES,2021,Q1,Elderly
176888332,17688833,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,INCREASE 1 IU OF TOUJEO IF THE BASAL GLYCAEMIA GOES ABOVE 130 MG / DL,,,,, 0F768A,,,,,SOLUTION FOR INJECTION,,2021,Q1,Glycosylated haemoglobin increased,,2021,Q1,2,F,2019.0,20210305.0,20200421,20210312,EXP,,NVSC2020ES105522,NOVARTIS,,71.0,YR,,F,Y,70.0,KG,20210312.0,,HP,ES,ES,2021,Q1,Elderly
177488645,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Abdominal pain,,2021,Q1,5,F,20191117.0,20210112.0,20200506,20210118,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210118.0,,CN,NL,NL,2021,Q1,Adult
177488645,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Confusional state,,2021,Q1,5,F,20191117.0,20210112.0,20200506,20210118,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210118.0,,CN,NL,NL,2021,Q1,Adult
177488645,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Crying,,2021,Q1,5,F,20191117.0,20210112.0,20200506,20210118,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210118.0,,CN,NL,NL,2021,Q1,Adult
177488645,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Depressed mood,,2021,Q1,5,F,20191117.0,20210112.0,20200506,20210118,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210118.0,,CN,NL,NL,2021,Q1,Adult
177488645,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Diarrhoea,,2021,Q1,5,F,20191117.0,20210112.0,20200506,20210118,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210118.0,,CN,NL,NL,2021,Q1,Adult
177488645,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Dyskinesia,,2021,Q1,5,F,20191117.0,20210112.0,20200506,20210118,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210118.0,,CN,NL,NL,2021,Q1,Adult
177488645,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Fall,,2021,Q1,5,F,20191117.0,20210112.0,20200506,20210118,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210118.0,,CN,NL,NL,2021,Q1,Adult
177488645,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Gait disturbance,,2021,Q1,5,F,20191117.0,20210112.0,20200506,20210118,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210118.0,,CN,NL,NL,2021,Q1,Adult
177488645,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Impaired gastric emptying,,2021,Q1,5,F,20191117.0,20210112.0,20200506,20210118,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210118.0,,CN,NL,NL,2021,Q1,Adult
177488645,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Impaired quality of life,,2021,Q1,5,F,20191117.0,20210112.0,20200506,20210118,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210118.0,,CN,NL,NL,2021,Q1,Adult
177488645,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Limb discomfort,,2021,Q1,5,F,20191117.0,20210112.0,20200506,20210118,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210118.0,,CN,NL,NL,2021,Q1,Adult
177488645,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Limb operation,,2021,Q1,5,F,20191117.0,20210112.0,20200506,20210118,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210118.0,,CN,NL,NL,2021,Q1,Adult
177488645,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Malaise,,2021,Q1,5,F,20191117.0,20210112.0,20200506,20210118,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210118.0,,CN,NL,NL,2021,Q1,Adult
177488645,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Memory impairment,,2021,Q1,5,F,20191117.0,20210112.0,20200506,20210118,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210118.0,,CN,NL,NL,2021,Q1,Adult
177488645,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Mood altered,,2021,Q1,5,F,20191117.0,20210112.0,20200506,20210118,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210118.0,,CN,NL,NL,2021,Q1,Adult
177488645,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Muscle rigidity,,2021,Q1,5,F,20191117.0,20210112.0,20200506,20210118,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210118.0,,CN,NL,NL,2021,Q1,Adult
177488645,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Muscular weakness,,2021,Q1,5,F,20191117.0,20210112.0,20200506,20210118,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210118.0,,CN,NL,NL,2021,Q1,Adult
177488645,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Nausea,,2021,Q1,5,F,20191117.0,20210112.0,20200506,20210118,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210118.0,,CN,NL,NL,2021,Q1,Adult
177488645,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,On and off phenomenon,,2021,Q1,5,F,20191117.0,20210112.0,20200506,20210118,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210118.0,,CN,NL,NL,2021,Q1,Adult
177488645,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Panic reaction,,2021,Q1,5,F,20191117.0,20210112.0,20200506,20210118,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210118.0,,CN,NL,NL,2021,Q1,Adult
177488645,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Procedural pain,,2021,Q1,5,F,20191117.0,20210112.0,20200506,20210118,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210118.0,,CN,NL,NL,2021,Q1,Adult
177488645,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Protein total increased,,2021,Q1,5,F,20191117.0,20210112.0,20200506,20210118,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210118.0,,CN,NL,NL,2021,Q1,Adult
177488645,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Psychiatric symptom,,2021,Q1,5,F,20191117.0,20210112.0,20200506,20210118,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210118.0,,CN,NL,NL,2021,Q1,Adult
177488645,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Serum ferritin increased,,2021,Q1,5,F,20191117.0,20210112.0,20200506,20210118,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210118.0,,CN,NL,NL,2021,Q1,Adult
177488645,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Sleep disorder due to a general medical condition,,2021,Q1,5,F,20191117.0,20210112.0,20200506,20210118,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210118.0,,CN,NL,NL,2021,Q1,Adult
177488645,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Stoma site erythema,,2021,Q1,5,F,20191117.0,20210112.0,20200506,20210118,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210118.0,,CN,NL,NL,2021,Q1,Adult
177488645,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Stoma site infection,,2021,Q1,5,F,20191117.0,20210112.0,20200506,20210118,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210118.0,,CN,NL,NL,2021,Q1,Adult
177488645,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Stress,,2021,Q1,5,F,20191117.0,20210112.0,20200506,20210118,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210118.0,,CN,NL,NL,2021,Q1,Adult
177488645,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Tension,,2021,Q1,5,F,20191117.0,20210112.0,20200506,20210118,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210118.0,,CN,NL,NL,2021,Q1,Adult
177488645,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Therapeutic response shortened,,2021,Q1,5,F,20191117.0,20210112.0,20200506,20210118,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210118.0,,CN,NL,NL,2021,Q1,Adult
177488645,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Transferrin decreased,,2021,Q1,5,F,20191117.0,20210112.0,20200506,20210118,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210118.0,,CN,NL,NL,2021,Q1,Adult
177488645,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Tremor,,2021,Q1,5,F,20191117.0,20210112.0,20200506,20210118,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210118.0,,CN,NL,NL,2021,Q1,Adult
177488645,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Urinary tract infection,,2021,Q1,5,F,20191117.0,20210112.0,20200506,20210118,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210118.0,,CN,NL,NL,2021,Q1,Adult
177488645,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Vomiting,,2021,Q1,5,F,20191117.0,20210112.0,20200506,20210118,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210118.0,,CN,NL,NL,2021,Q1,Adult
177488645,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Weight decreased,,2021,Q1,5,F,20191117.0,20210112.0,20200506,20210118,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210118.0,,CN,NL,NL,2021,Q1,Adult
178974445,17897444,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, QD",,,,, UNKNOWN,,,22.0,IU,,QD,2021,Q1,Gastric pneumatosis,,2021,Q1,5,F,20200530.0,20210308.0,20200615,20210319,EXP,,JP-NOVOPROD-732754,NOVO NORDISK,,35.0,YR,,M,Y,95.9,KG,20210319.0,,MD,JP,JP,2021,Q1,Adult
178974445,17897444,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, QD",,,,, UNKNOWN,,,22.0,IU,,QD,2021,Q1,Gastric ulcer,,2021,Q1,5,F,20200530.0,20210308.0,20200615,20210319,EXP,,JP-NOVOPROD-732754,NOVO NORDISK,,35.0,YR,,M,Y,95.9,KG,20210319.0,,MD,JP,JP,2021,Q1,Adult
178974445,17897444,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, QD",,,,, UNKNOWN,,,22.0,IU,,QD,2021,Q1,Gastritis,,2021,Q1,5,F,20200530.0,20210308.0,20200615,20210319,EXP,,JP-NOVOPROD-732754,NOVO NORDISK,,35.0,YR,,M,Y,95.9,KG,20210319.0,,MD,JP,JP,2021,Q1,Adult
178974445,17897444,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, QD",,,,, UNKNOWN,,,22.0,IU,,QD,2021,Q1,Gastritis erosive,,2021,Q1,5,F,20200530.0,20210308.0,20200615,20210319,EXP,,JP-NOVOPROD-732754,NOVO NORDISK,,35.0,YR,,M,Y,95.9,KG,20210319.0,,MD,JP,JP,2021,Q1,Adult
178974445,17897444,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, QD",,,,, UNKNOWN,,,22.0,IU,,QD,2021,Q1,Portal venous gas,,2021,Q1,5,F,20200530.0,20210308.0,20200615,20210319,EXP,,JP-NOVOPROD-732754,NOVO NORDISK,,35.0,YR,,M,Y,95.9,KG,20210319.0,,MD,JP,JP,2021,Q1,Adult
179386183,17938618,12,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"300 INTERNATIONAL UNIT,0?0?16?0",,,U,,,,,300.0,IU,,,2021,Q1,Anaemia,,2021,Q1,3,F,,20210125.0,20200625,20210201,EXP,,DE-AUROBINDO-AUR-APL-2020-030160,AUROBINDO,,70.0,YR,,M,Y,78.0,KG,20210201.0,,HP,DE,DE,2021,Q1,Elderly
179386183,17938618,12,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"300 INTERNATIONAL UNIT,0?0?16?0",,,U,,,,,300.0,IU,,,2021,Q1,Electrolyte imbalance,,2021,Q1,3,F,,20210125.0,20200625,20210201,EXP,,DE-AUROBINDO-AUR-APL-2020-030160,AUROBINDO,,70.0,YR,,M,Y,78.0,KG,20210201.0,,HP,DE,DE,2021,Q1,Elderly
179386183,17938618,12,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"300 INTERNATIONAL UNIT,0?0?16?0",,,U,,,,,300.0,IU,,,2021,Q1,Hyperkalaemia,,2021,Q1,3,F,,20210125.0,20200625,20210201,EXP,,DE-AUROBINDO-AUR-APL-2020-030160,AUROBINDO,,70.0,YR,,M,Y,78.0,KG,20210201.0,,HP,DE,DE,2021,Q1,Elderly
179386183,17938618,12,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"300 INTERNATIONAL UNIT,0?0?16?0",,,U,,,,,300.0,IU,,,2021,Q1,Labelled drug-drug interaction medication error,,2021,Q1,3,F,,20210125.0,20200625,20210201,EXP,,DE-AUROBINDO-AUR-APL-2020-030160,AUROBINDO,,70.0,YR,,M,Y,78.0,KG,20210201.0,,HP,DE,DE,2021,Q1,Elderly
179386183,17938618,12,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"300 INTERNATIONAL UNIT,0?0?16?0",,,U,,,,,300.0,IU,,,2021,Q1,Product monitoring error,,2021,Q1,3,F,,20210125.0,20200625,20210201,EXP,,DE-AUROBINDO-AUR-APL-2020-030160,AUROBINDO,,70.0,YR,,M,Y,78.0,KG,20210201.0,,HP,DE,DE,2021,Q1,Elderly
179386183,17938618,12,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"300 INTERNATIONAL UNIT,0?0?16?0",,,U,,,,,300.0,IU,,,2021,Q1,Renal impairment,,2021,Q1,3,F,,20210125.0,20200625,20210201,EXP,,DE-AUROBINDO-AUR-APL-2020-030160,AUROBINDO,,70.0,YR,,M,Y,78.0,KG,20210201.0,,HP,DE,DE,2021,Q1,Elderly
179407995,17940799,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 IU, 0?0?16?0",,,U,,,,,300.0,IU,,,2021,Q1,Anaemia,,2021,Q1,5,F,,20210128.0,20200625,20210204,EXP,,DE-SA-2020SA160936,SANOFI AVENTIS,,70.0,YR,E,M,Y,78.0,KG,20210204.0,,PH,DE,DE,2021,Q1,Elderly
179407995,17940799,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 IU, 0?0?16?0",,,U,,,,,300.0,IU,,,2021,Q1,Electrolyte imbalance,,2021,Q1,5,F,,20210128.0,20200625,20210204,EXP,,DE-SA-2020SA160936,SANOFI AVENTIS,,70.0,YR,E,M,Y,78.0,KG,20210204.0,,PH,DE,DE,2021,Q1,Elderly
179407995,17940799,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 IU, 0?0?16?0",,,U,,,,,300.0,IU,,,2021,Q1,Hyperkalaemia,,2021,Q1,5,F,,20210128.0,20200625,20210204,EXP,,DE-SA-2020SA160936,SANOFI AVENTIS,,70.0,YR,E,M,Y,78.0,KG,20210204.0,,PH,DE,DE,2021,Q1,Elderly
179407995,17940799,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 IU, 0?0?16?0",,,U,,,,,300.0,IU,,,2021,Q1,Labelled drug-drug interaction medication error,,2021,Q1,5,F,,20210128.0,20200625,20210204,EXP,,DE-SA-2020SA160936,SANOFI AVENTIS,,70.0,YR,E,M,Y,78.0,KG,20210204.0,,PH,DE,DE,2021,Q1,Elderly
179407995,17940799,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 IU, 0?0?16?0",,,U,,,,,300.0,IU,,,2021,Q1,Product monitoring error,,2021,Q1,5,F,,20210128.0,20200625,20210204,EXP,,DE-SA-2020SA160936,SANOFI AVENTIS,,70.0,YR,E,M,Y,78.0,KG,20210204.0,,PH,DE,DE,2021,Q1,Elderly
179407995,17940799,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 IU, 0?0?16?0",,,U,,,,,300.0,IU,,,2021,Q1,Renal impairment,,2021,Q1,5,F,,20210128.0,20200625,20210204,EXP,,DE-SA-2020SA160936,SANOFI AVENTIS,,70.0,YR,E,M,Y,78.0,KG,20210204.0,,PH,DE,DE,2021,Q1,Elderly
179445482,17944548,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,INFUSION,,,D,,,,210605.0,,,INJECTION,,2021,Q1,Drug ineffective,,2021,Q1,2,F,,20210106.0,20200625,20210113,EXP,,AU-MYLANLABS-2020M1058456,MYLAN,"ABDULLAH A, HAKEEM R, ALAHAKOON TI, GIRGIS C, KIM A, CARTER A. SEVERE HYPERTRIGLYCERIDEMIA IN PREGNANCYAND PLASMAPHERESIS: A CASE REPORT. OBSTET?MED 2019?12 (SUPPL.)(2):3.",19.0,YR,,F,Y,,,20210113.0,,HP,AU,AU,2021,Q1,Youth
179445482,17944548,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,INFUSION,,,D,,,,210605.0,,,INJECTION,,2021,Q1,Maternal exposure during pregnancy,,2021,Q1,2,F,,20210106.0,20200625,20210113,EXP,,AU-MYLANLABS-2020M1058456,MYLAN,"ABDULLAH A, HAKEEM R, ALAHAKOON TI, GIRGIS C, KIM A, CARTER A. SEVERE HYPERTRIGLYCERIDEMIA IN PREGNANCYAND PLASMAPHERESIS: A CASE REPORT. OBSTET?MED 2019?12 (SUPPL.)(2):3.",19.0,YR,,F,Y,,,20210113.0,,HP,AU,AU,2021,Q1,Youth
179445482,17944548,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,INFUSION,,,D,,,,210605.0,,,INJECTION,,2021,Q1,Normal newborn,,2021,Q1,2,F,,20210106.0,20200625,20210113,EXP,,AU-MYLANLABS-2020M1058456,MYLAN,"ABDULLAH A, HAKEEM R, ALAHAKOON TI, GIRGIS C, KIM A, CARTER A. SEVERE HYPERTRIGLYCERIDEMIA IN PREGNANCYAND PLASMAPHERESIS: A CASE REPORT. OBSTET?MED 2019?12 (SUPPL.)(2):3.",19.0,YR,,F,Y,,,20210113.0,,HP,AU,AU,2021,Q1,Youth
179445482,17944548,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,210605.0,,,INJECTION,,2021,Q1,Drug ineffective,,2021,Q1,2,F,,20210106.0,20200625,20210113,EXP,,AU-MYLANLABS-2020M1058456,MYLAN,"ABDULLAH A, HAKEEM R, ALAHAKOON TI, GIRGIS C, KIM A, CARTER A. SEVERE HYPERTRIGLYCERIDEMIA IN PREGNANCYAND PLASMAPHERESIS: A CASE REPORT. OBSTET?MED 2019?12 (SUPPL.)(2):3.",19.0,YR,,F,Y,,,20210113.0,,HP,AU,AU,2021,Q1,Youth
179445482,17944548,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,210605.0,,,INJECTION,,2021,Q1,Maternal exposure during pregnancy,,2021,Q1,2,F,,20210106.0,20200625,20210113,EXP,,AU-MYLANLABS-2020M1058456,MYLAN,"ABDULLAH A, HAKEEM R, ALAHAKOON TI, GIRGIS C, KIM A, CARTER A. SEVERE HYPERTRIGLYCERIDEMIA IN PREGNANCYAND PLASMAPHERESIS: A CASE REPORT. OBSTET?MED 2019?12 (SUPPL.)(2):3.",19.0,YR,,F,Y,,,20210113.0,,HP,AU,AU,2021,Q1,Youth
179445482,17944548,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,210605.0,,,INJECTION,,2021,Q1,Normal newborn,,2021,Q1,2,F,,20210106.0,20200625,20210113,EXP,,AU-MYLANLABS-2020M1058456,MYLAN,"ABDULLAH A, HAKEEM R, ALAHAKOON TI, GIRGIS C, KIM A, CARTER A. SEVERE HYPERTRIGLYCERIDEMIA IN PREGNANCYAND PLASMAPHERESIS: A CASE REPORT. OBSTET?MED 2019?12 (SUPPL.)(2):3.",19.0,YR,,F,Y,,,20210113.0,,HP,AU,AU,2021,Q1,Youth
179445482,17944548,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,D,,,,210605.0,,,INJECTION,,2021,Q1,Drug ineffective,,2021,Q1,2,F,,20210106.0,20200625,20210113,EXP,,AU-MYLANLABS-2020M1058456,MYLAN,"ABDULLAH A, HAKEEM R, ALAHAKOON TI, GIRGIS C, KIM A, CARTER A. SEVERE HYPERTRIGLYCERIDEMIA IN PREGNANCYAND PLASMAPHERESIS: A CASE REPORT. OBSTET?MED 2019?12 (SUPPL.)(2):3.",19.0,YR,,F,Y,,,20210113.0,,HP,AU,AU,2021,Q1,Youth
179445482,17944548,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,D,,,,210605.0,,,INJECTION,,2021,Q1,Maternal exposure during pregnancy,,2021,Q1,2,F,,20210106.0,20200625,20210113,EXP,,AU-MYLANLABS-2020M1058456,MYLAN,"ABDULLAH A, HAKEEM R, ALAHAKOON TI, GIRGIS C, KIM A, CARTER A. SEVERE HYPERTRIGLYCERIDEMIA IN PREGNANCYAND PLASMAPHERESIS: A CASE REPORT. OBSTET?MED 2019?12 (SUPPL.)(2):3.",19.0,YR,,F,Y,,,20210113.0,,HP,AU,AU,2021,Q1,Youth
179445482,17944548,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,D,,,,210605.0,,,INJECTION,,2021,Q1,Normal newborn,,2021,Q1,2,F,,20210106.0,20200625,20210113,EXP,,AU-MYLANLABS-2020M1058456,MYLAN,"ABDULLAH A, HAKEEM R, ALAHAKOON TI, GIRGIS C, KIM A, CARTER A. SEVERE HYPERTRIGLYCERIDEMIA IN PREGNANCYAND PLASMAPHERESIS: A CASE REPORT. OBSTET?MED 2019?12 (SUPPL.)(2):3.",19.0,YR,,F,Y,,,20210113.0,,HP,AU,AU,2021,Q1,Youth
179842645,17984264,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Acute respiratory distress syndrome,,2021,Q1,5,F,20200325.0,20210203.0,20200706,20210208,EXP,,DE-ABBVIE-20K-062-3470530-00,ABBVIE,,53.0,YR,,F,Y,,,20210208.0,,MD,DE,DE,2021,Q1,Adult
179842645,17984264,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,COVID-19,,2021,Q1,5,F,20200325.0,20210203.0,20200706,20210208,EXP,,DE-ABBVIE-20K-062-3470530-00,ABBVIE,,53.0,YR,,F,Y,,,20210208.0,,MD,DE,DE,2021,Q1,Adult
179842645,17984264,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Cough,,2021,Q1,5,F,20200325.0,20210203.0,20200706,20210208,EXP,,DE-ABBVIE-20K-062-3470530-00,ABBVIE,,53.0,YR,,F,Y,,,20210208.0,,MD,DE,DE,2021,Q1,Adult
179842645,17984264,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Dyspnoea,,2021,Q1,5,F,20200325.0,20210203.0,20200706,20210208,EXP,,DE-ABBVIE-20K-062-3470530-00,ABBVIE,,53.0,YR,,F,Y,,,20210208.0,,MD,DE,DE,2021,Q1,Adult
179842645,17984264,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Headache,,2021,Q1,5,F,20200325.0,20210203.0,20200706,20210208,EXP,,DE-ABBVIE-20K-062-3470530-00,ABBVIE,,53.0,YR,,F,Y,,,20210208.0,,MD,DE,DE,2021,Q1,Adult
179842645,17984264,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Pneumonia viral,,2021,Q1,5,F,20200325.0,20210203.0,20200706,20210208,EXP,,DE-ABBVIE-20K-062-3470530-00,ABBVIE,,53.0,YR,,F,Y,,,20210208.0,,MD,DE,DE,2021,Q1,Adult
179842645,17984264,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Pyrexia,,2021,Q1,5,F,20200325.0,20210203.0,20200706,20210208,EXP,,DE-ABBVIE-20K-062-3470530-00,ABBVIE,,53.0,YR,,F,Y,,,20210208.0,,MD,DE,DE,2021,Q1,Adult
179976468,17997646,105,C,Insuline glargine,INSULIN GLARGINE,1,Unknown,5 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Cholecystitis acute,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
179976468,17997646,105,C,Insuline glargine,INSULIN GLARGINE,1,Unknown,5 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Peripheral ischaemia,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
179976468,17997646,105,C,Insuline glargine,INSULIN GLARGINE,1,Unknown,5 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Sepsis,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
179976468,17997646,106,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,10 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Cholecystitis acute,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
179976468,17997646,106,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,10 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Peripheral ischaemia,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
179976468,17997646,106,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,10 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Sepsis,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
179976468,17997646,107,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,12 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Cholecystitis acute,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
179976468,17997646,107,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,12 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Peripheral ischaemia,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
179976468,17997646,107,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,12 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Sepsis,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
179976468,17997646,108,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,16 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Cholecystitis acute,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
179976468,17997646,108,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,16 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Peripheral ischaemia,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
179976468,17997646,108,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,16 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Sepsis,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
179976468,17997646,109,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,18 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Cholecystitis acute,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
179976468,17997646,109,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,18 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Peripheral ischaemia,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
179976468,17997646,109,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,18 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Sepsis,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
179976468,17997646,110,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,18 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Cholecystitis acute,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
179976468,17997646,110,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,18 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Peripheral ischaemia,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
179976468,17997646,110,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,18 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Sepsis,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
180094755,18009475,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Abdominal discomfort,,2021,Q1,5,F,202008.0,20201230.0,20200710,20210106,EXP,,CO-BAYER-2019-233236,BAYER,,85.0,YR,E,F,Y,,,20210106.0,,HP,CO,CO,2021,Q1,Elderly
180094755,18009475,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Abdominal pain upper,,2021,Q1,5,F,202008.0,20201230.0,20200710,20210106,EXP,,CO-BAYER-2019-233236,BAYER,,85.0,YR,E,F,Y,,,20210106.0,,HP,CO,CO,2021,Q1,Elderly
180094755,18009475,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Blood pressure abnormal,,2021,Q1,5,F,202008.0,20201230.0,20200710,20210106,EXP,,CO-BAYER-2019-233236,BAYER,,85.0,YR,E,F,Y,,,20210106.0,,HP,CO,CO,2021,Q1,Elderly
180094755,18009475,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Chills,,2021,Q1,5,F,202008.0,20201230.0,20200710,20210106,EXP,,CO-BAYER-2019-233236,BAYER,,85.0,YR,E,F,Y,,,20210106.0,,HP,CO,CO,2021,Q1,Elderly
180094755,18009475,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Choking,,2021,Q1,5,F,202008.0,20201230.0,20200710,20210106,EXP,,CO-BAYER-2019-233236,BAYER,,85.0,YR,E,F,Y,,,20210106.0,,HP,CO,CO,2021,Q1,Elderly
180094755,18009475,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Hypertension,,2021,Q1,5,F,202008.0,20201230.0,20200710,20210106,EXP,,CO-BAYER-2019-233236,BAYER,,85.0,YR,E,F,Y,,,20210106.0,,HP,CO,CO,2021,Q1,Elderly
180094755,18009475,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Inappropriate schedule of product administration,,2021,Q1,5,F,202008.0,20201230.0,20200710,20210106,EXP,,CO-BAYER-2019-233236,BAYER,,85.0,YR,E,F,Y,,,20210106.0,,HP,CO,CO,2021,Q1,Elderly
180094755,18009475,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Incorrect product administration duration,,2021,Q1,5,F,202008.0,20201230.0,20200710,20210106,EXP,,CO-BAYER-2019-233236,BAYER,,85.0,YR,E,F,Y,,,20210106.0,,HP,CO,CO,2021,Q1,Elderly
180094755,18009475,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Peripheral swelling,,2021,Q1,5,F,202008.0,20201230.0,20200710,20210106,EXP,,CO-BAYER-2019-233236,BAYER,,85.0,YR,E,F,Y,,,20210106.0,,HP,CO,CO,2021,Q1,Elderly
180094755,18009475,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Product administration error,,2021,Q1,5,F,202008.0,20201230.0,20200710,20210106,EXP,,CO-BAYER-2019-233236,BAYER,,85.0,YR,E,F,Y,,,20210106.0,,HP,CO,CO,2021,Q1,Elderly
180094755,18009475,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Product dose omission issue,,2021,Q1,5,F,202008.0,20201230.0,20200710,20210106,EXP,,CO-BAYER-2019-233236,BAYER,,85.0,YR,E,F,Y,,,20210106.0,,HP,CO,CO,2021,Q1,Elderly
180401412,18040141,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Confusional state,,2021,Q1,2,F,,20210322.0,20200717,20210329,EXP,,US-BAUSCH-BL-2020-020194,BAUSCH AND LOMB,,70.0,YR,,M,Y,89.6,KG,20210329.0,,CN,US,US,2021,Q1,Elderly
180401412,18040141,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Dialysis,,2021,Q1,2,F,,20210322.0,20200717,20210329,EXP,,US-BAUSCH-BL-2020-020194,BAUSCH AND LOMB,,70.0,YR,,M,Y,89.6,KG,20210329.0,,CN,US,US,2021,Q1,Elderly
180401412,18040141,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Disturbance in attention,,2021,Q1,2,F,,20210322.0,20200717,20210329,EXP,,US-BAUSCH-BL-2020-020194,BAUSCH AND LOMB,,70.0,YR,,M,Y,89.6,KG,20210329.0,,CN,US,US,2021,Q1,Elderly
180401412,18040141,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Inability to afford medication,,2021,Q1,2,F,,20210322.0,20200717,20210329,EXP,,US-BAUSCH-BL-2020-020194,BAUSCH AND LOMB,,70.0,YR,,M,Y,89.6,KG,20210329.0,,CN,US,US,2021,Q1,Elderly
180401412,18040141,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Liver dialysis,,2021,Q1,2,F,,20210322.0,20200717,20210329,EXP,,US-BAUSCH-BL-2020-020194,BAUSCH AND LOMB,,70.0,YR,,M,Y,89.6,KG,20210329.0,,CN,US,US,2021,Q1,Elderly
180511203,18051120,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,18 INTERNATIONAL UNIT,,,,, 0F527A,,,18.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Blood glucose fluctuation,,2021,Q1,3,F,2020.0,20210218.0,20200721,20210222,EXP,,ES-MYLANLABS-2020M1064631,MYLAN,,62.0,YR,,M,Y,93.0,KG,20210222.0,,CN,ES,ES,2021,Q1,Adult
180511203,18051120,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,18 INTERNATIONAL UNIT,,,,, 0F527A,,,18.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,3,F,2020.0,20210218.0,20200721,20210222,EXP,,ES-MYLANLABS-2020M1064631,MYLAN,,62.0,YR,,M,Y,93.0,KG,20210222.0,,CN,ES,ES,2021,Q1,Adult
180511203,18051120,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,18 INTERNATIONAL UNIT,,,,, 0F527A,,,18.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Cardiac disorder,,2021,Q1,3,F,2020.0,20210218.0,20200721,20210222,EXP,,ES-MYLANLABS-2020M1064631,MYLAN,,62.0,YR,,M,Y,93.0,KG,20210222.0,,CN,ES,ES,2021,Q1,Adult
180511203,18051120,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,18 INTERNATIONAL UNIT,,,,, 0F527A,,,18.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Injection site bruising,,2021,Q1,3,F,2020.0,20210218.0,20200721,20210222,EXP,,ES-MYLANLABS-2020M1064631,MYLAN,,62.0,YR,,M,Y,93.0,KG,20210222.0,,CN,ES,ES,2021,Q1,Adult
180511203,18051120,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,18 INTERNATIONAL UNIT,,,,, 0F527A,,,18.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Osteoarthritis,,2021,Q1,3,F,2020.0,20210218.0,20200721,20210222,EXP,,ES-MYLANLABS-2020M1064631,MYLAN,,62.0,YR,,M,Y,93.0,KG,20210222.0,,CN,ES,ES,2021,Q1,Adult
180511203,18051120,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,18 INTERNATIONAL UNIT,,,,, 0F527A,,,18.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Urinary incontinence,,2021,Q1,3,F,2020.0,20210218.0,20200721,20210222,EXP,,ES-MYLANLABS-2020M1064631,MYLAN,,62.0,YR,,M,Y,93.0,KG,20210222.0,,CN,ES,ES,2021,Q1,Adult
180511203,18051120,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,18 INTERNATIONAL UNIT,,,,, 0F527A,,,18.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Vascular stent occlusion,,2021,Q1,3,F,2020.0,20210218.0,20200721,20210222,EXP,,ES-MYLANLABS-2020M1064631,MYLAN,,62.0,YR,,M,Y,93.0,KG,20210222.0,,CN,ES,ES,2021,Q1,Adult
180511203,18051120,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Blood glucose fluctuation,,2021,Q1,3,F,2020.0,20210218.0,20200721,20210222,EXP,,ES-MYLANLABS-2020M1064631,MYLAN,,62.0,YR,,M,Y,93.0,KG,20210222.0,,CN,ES,ES,2021,Q1,Adult
180511203,18051120,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,3,F,2020.0,20210218.0,20200721,20210222,EXP,,ES-MYLANLABS-2020M1064631,MYLAN,,62.0,YR,,M,Y,93.0,KG,20210222.0,,CN,ES,ES,2021,Q1,Adult
180511203,18051120,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Cardiac disorder,,2021,Q1,3,F,2020.0,20210218.0,20200721,20210222,EXP,,ES-MYLANLABS-2020M1064631,MYLAN,,62.0,YR,,M,Y,93.0,KG,20210222.0,,CN,ES,ES,2021,Q1,Adult
180511203,18051120,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Injection site bruising,,2021,Q1,3,F,2020.0,20210218.0,20200721,20210222,EXP,,ES-MYLANLABS-2020M1064631,MYLAN,,62.0,YR,,M,Y,93.0,KG,20210222.0,,CN,ES,ES,2021,Q1,Adult
180511203,18051120,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Osteoarthritis,,2021,Q1,3,F,2020.0,20210218.0,20200721,20210222,EXP,,ES-MYLANLABS-2020M1064631,MYLAN,,62.0,YR,,M,Y,93.0,KG,20210222.0,,CN,ES,ES,2021,Q1,Adult
180511203,18051120,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Urinary incontinence,,2021,Q1,3,F,2020.0,20210218.0,20200721,20210222,EXP,,ES-MYLANLABS-2020M1064631,MYLAN,,62.0,YR,,M,Y,93.0,KG,20210222.0,,CN,ES,ES,2021,Q1,Adult
180511203,18051120,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Vascular stent occlusion,,2021,Q1,3,F,2020.0,20210218.0,20200721,20210222,EXP,,ES-MYLANLABS-2020M1064631,MYLAN,,62.0,YR,,M,Y,93.0,KG,20210222.0,,CN,ES,ES,2021,Q1,Adult
180658652,18065865,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Death,,2021,Q1,2,F,20191206.0,20210122.0,20200724,20210126,EXP,,US-ROCHE-2502743,ROCHE,,66.0,YR,,F,Y,81.3,KG,20210126.0,,MD,US,US,2021,Q1,Elderly
180658652,18065865,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Hypoxia,,2021,Q1,2,F,20191206.0,20210122.0,20200724,20210126,EXP,,US-ROCHE-2502743,ROCHE,,66.0,YR,,F,Y,81.3,KG,20210126.0,,MD,US,US,2021,Q1,Elderly
180986319,18098631,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Acute kidney injury,,2021,Q1,9,F,20200226.0,20210121.0,20200731,20210201,EXP,,US-ROCHE-2650965,ROCHE,,66.0,YR,,F,Y,104.0,KG,20210201.0,,MD,US,US,2021,Q1,Elderly
180986319,18098631,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Confusional state,,2021,Q1,9,F,20200226.0,20210121.0,20200731,20210201,EXP,,US-ROCHE-2650965,ROCHE,,66.0,YR,,F,Y,104.0,KG,20210201.0,,MD,US,US,2021,Q1,Elderly
180986319,18098631,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Diarrhoea,,2021,Q1,9,F,20200226.0,20210121.0,20200731,20210201,EXP,,US-ROCHE-2650965,ROCHE,,66.0,YR,,F,Y,104.0,KG,20210201.0,,MD,US,US,2021,Q1,Elderly
180986319,18098631,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Haemorrhage intracranial,,2021,Q1,9,F,20200226.0,20210121.0,20200731,20210201,EXP,,US-ROCHE-2650965,ROCHE,,66.0,YR,,F,Y,104.0,KG,20210201.0,,MD,US,US,2021,Q1,Elderly
180986319,18098631,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Hypoglycaemia,,2021,Q1,9,F,20200226.0,20210121.0,20200731,20210201,EXP,,US-ROCHE-2650965,ROCHE,,66.0,YR,,F,Y,104.0,KG,20210201.0,,MD,US,US,2021,Q1,Elderly
180986319,18098631,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Hypotension,,2021,Q1,9,F,20200226.0,20210121.0,20200731,20210201,EXP,,US-ROCHE-2650965,ROCHE,,66.0,YR,,F,Y,104.0,KG,20210201.0,,MD,US,US,2021,Q1,Elderly
180986319,18098631,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Lethargy,,2021,Q1,9,F,20200226.0,20210121.0,20200731,20210201,EXP,,US-ROCHE-2650965,ROCHE,,66.0,YR,,F,Y,104.0,KG,20210201.0,,MD,US,US,2021,Q1,Elderly
180986319,18098631,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Seizure,,2021,Q1,9,F,20200226.0,20210121.0,20200731,20210201,EXP,,US-ROCHE-2650965,ROCHE,,66.0,YR,,F,Y,104.0,KG,20210201.0,,MD,US,US,2021,Q1,Elderly
180986319,18098631,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Sepsis,,2021,Q1,9,F,20200226.0,20210121.0,20200731,20210201,EXP,,US-ROCHE-2650965,ROCHE,,66.0,YR,,F,Y,104.0,KG,20210201.0,,MD,US,US,2021,Q1,Elderly
180986319,18098631,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Urinary tract infection,,2021,Q1,9,F,20200226.0,20210121.0,20200731,20210201,EXP,,US-ROCHE-2650965,ROCHE,,66.0,YR,,F,Y,104.0,KG,20210201.0,,MD,US,US,2021,Q1,Elderly
181004993,18100499,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,14 UNITS,,,,,,,,,,INJECTION,,2021,Q1,Asthenia,,2021,Q1,3,F,20200718.0,20210302.0,20200731,20210308,EXP,,US-JNJFOC-20200741023,JOHNSON AND JOHNSON,,79.0,YR,E,M,Y,99.5,KG,20210308.0,,HP,US,US,2021,Q1,Elderly
181004993,18100499,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,14 UNITS,,,,,,,,,,INJECTION,,2021,Q1,Cerebrovascular accident,,2021,Q1,3,F,20200718.0,20210302.0,20200731,20210308,EXP,,US-JNJFOC-20200741023,JOHNSON AND JOHNSON,,79.0,YR,E,M,Y,99.5,KG,20210308.0,,HP,US,US,2021,Q1,Elderly
181419334,18141933,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,GENETICAL RECOMBINATION,,,,,,,,,,,,2021,Q1,Chronic kidney disease,,2021,Q1,4,F,20200322.0,20210308.0,20200812,20210310,EXP,,JP-ABBVIE-20K-087-3522495-00,ABBVIE,,69.0,YR,,M,Y,82.0,KG,20210310.0,,MD,JP,JP,2021,Q1,Elderly
181433772,18143377,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"58 UNIT, BID",,,,,,,,,,,BID,2021,Q1,Drug resistance,,2021,Q1,2,F,,20210209.0,20200813,20210220,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-04472,LUPIN,,65.0,YR,,M,Y,,,20210220.0,,HP,US,US,2021,Q1,Elderly
181433772,18143377,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 UNIT, QD",,,,,,,,,,,QD,2021,Q1,Drug resistance,,2021,Q1,2,F,,20210209.0,20200813,20210220,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-04472,LUPIN,,65.0,YR,,M,Y,,,20210220.0,,HP,US,US,2021,Q1,Elderly
181433772,18143377,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"35 UNIT, QD",,,,,,,,,,,QD,2021,Q1,Drug resistance,,2021,Q1,2,F,,20210209.0,20200813,20210220,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-04472,LUPIN,,65.0,YR,,M,Y,,,20210220.0,,HP,US,US,2021,Q1,Elderly
182665334,18266533,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 UNITS, AT BEDTIME (QHS)",,,,,,,,,,FORMULATION UNKNOWN,QD,2021,Q1,Hyperglycaemia,,2021,Q1,4,F,20200907.0,20210323.0,20200915,20210329,EXP,,US-ASTELLAS-2020US030491,ASTELLAS,,72.0,YR,,F,Y,61.0,KG,20210329.0,,CN,US,US,2021,Q1,Elderly
182665334,18266533,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 UNITS, AT BEDTIME (QHS)",,,,,,,,,,FORMULATION UNKNOWN,QD,2021,Q1,Multiple organ dysfunction syndrome,,2021,Q1,4,F,20200907.0,20210323.0,20200915,20210329,EXP,,US-ASTELLAS-2020US030491,ASTELLAS,,72.0,YR,,F,Y,61.0,KG,20210329.0,,CN,US,US,2021,Q1,Elderly
182665334,18266533,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 UNITS, AT BEDTIME (QHS)",,,,,,,,,,FORMULATION UNKNOWN,QD,2021,Q1,Neutropenia,,2021,Q1,4,F,20200907.0,20210323.0,20200915,20210329,EXP,,US-ASTELLAS-2020US030491,ASTELLAS,,72.0,YR,,F,Y,61.0,KG,20210329.0,,CN,US,US,2021,Q1,Elderly
182665334,18266533,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 UNITS, AT BEDTIME (QHS)",,,,,,,,,,FORMULATION UNKNOWN,QD,2021,Q1,Toxic epidermal necrolysis,,2021,Q1,4,F,20200907.0,20210323.0,20200915,20210329,EXP,,US-ASTELLAS-2020US030491,ASTELLAS,,72.0,YR,,F,Y,61.0,KG,20210329.0,,CN,US,US,2021,Q1,Elderly
182665334,18266533,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 UNITS, AT BEDTIME (QHS)",,,,,,,,,,FORMULATION UNKNOWN,QD,2021,Q1,Toxicity to various agents,,2021,Q1,4,F,20200907.0,20210323.0,20200915,20210329,EXP,,US-ASTELLAS-2020US030491,ASTELLAS,,72.0,YR,,F,Y,61.0,KG,20210329.0,,CN,US,US,2021,Q1,Elderly
1827209912,18272099,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,1.0,IU,INJECTION,,2021,Q1,Hypertensive emergency,,2021,Q1,12,F,20200830.0,20210219.0,20200916,20210225,EXP,,US-ASTELLAS-2020US031974,ASTELLAS,,66.0,YR,,M,Y,116.0,KG,20210225.0,,MD,US,US,2021,Q1,Elderly
182829182,18282918,10,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Drug reaction with eosinophilia and systemic symptoms,,2021,Q1,2,F,20200808.0,20210308.0,20200918,20210316,EXP,FR-AFSSAPS-AN20201025,FR-BAYER-2020-201142,BAYER,,79.0,YR,E,F,Y,72.0,KG,20210316.0,,HP,NL,FR,2021,Q1,Elderly
182829182,18282918,10,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Eosinophilia,,2021,Q1,2,F,20200808.0,20210308.0,20200918,20210316,EXP,FR-AFSSAPS-AN20201025,FR-BAYER-2020-201142,BAYER,,79.0,YR,E,F,Y,72.0,KG,20210316.0,,HP,NL,FR,2021,Q1,Elderly
182829182,18282918,10,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Hepatocellular injury,,2021,Q1,2,F,20200808.0,20210308.0,20200918,20210316,EXP,FR-AFSSAPS-AN20201025,FR-BAYER-2020-201142,BAYER,,79.0,YR,E,F,Y,72.0,KG,20210316.0,,HP,NL,FR,2021,Q1,Elderly
182829182,18282918,10,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Hypercreatininaemia,,2021,Q1,2,F,20200808.0,20210308.0,20200918,20210316,EXP,FR-AFSSAPS-AN20201025,FR-BAYER-2020-201142,BAYER,,79.0,YR,E,F,Y,72.0,KG,20210316.0,,HP,NL,FR,2021,Q1,Elderly
182829182,18282918,10,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Rash maculo-papular,,2021,Q1,2,F,20200808.0,20210308.0,20200918,20210316,EXP,FR-AFSSAPS-AN20201025,FR-BAYER-2020-201142,BAYER,,79.0,YR,E,F,Y,72.0,KG,20210316.0,,HP,NL,FR,2021,Q1,Elderly
182853356,18285335,15,C,Insuline Glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Breath sounds,,2021,Q1,6,F,202008.0,20210318.0,20200919,20210324,EXP,,FR-AUROBINDO-AUR-APL-2020-048123,AUROBINDO,,79.0,YR,,F,Y,72.0,KG,20210324.0,,MD,FR,FR,2021,Q1,Elderly
182853356,18285335,15,C,Insuline Glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Cheilitis,,2021,Q1,6,F,202008.0,20210318.0,20200919,20210324,EXP,,FR-AUROBINDO-AUR-APL-2020-048123,AUROBINDO,,79.0,YR,,F,Y,72.0,KG,20210324.0,,MD,FR,FR,2021,Q1,Elderly
182853356,18285335,15,C,Insuline Glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Drug reaction with eosinophilia and systemic symptoms,,2021,Q1,6,F,202008.0,20210318.0,20200919,20210324,EXP,,FR-AUROBINDO-AUR-APL-2020-048123,AUROBINDO,,79.0,YR,,F,Y,72.0,KG,20210324.0,,MD,FR,FR,2021,Q1,Elderly
182853356,18285335,15,C,Insuline Glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Eosinophilia,,2021,Q1,6,F,202008.0,20210318.0,20200919,20210324,EXP,,FR-AUROBINDO-AUR-APL-2020-048123,AUROBINDO,,79.0,YR,,F,Y,72.0,KG,20210324.0,,MD,FR,FR,2021,Q1,Elderly
182853356,18285335,15,C,Insuline Glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Glossitis,,2021,Q1,6,F,202008.0,20210318.0,20200919,20210324,EXP,,FR-AUROBINDO-AUR-APL-2020-048123,AUROBINDO,,79.0,YR,,F,Y,72.0,KG,20210324.0,,MD,FR,FR,2021,Q1,Elderly
182853356,18285335,15,C,Insuline Glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Hepatic cirrhosis,,2021,Q1,6,F,202008.0,20210318.0,20200919,20210324,EXP,,FR-AUROBINDO-AUR-APL-2020-048123,AUROBINDO,,79.0,YR,,F,Y,72.0,KG,20210324.0,,MD,FR,FR,2021,Q1,Elderly
182853356,18285335,15,C,Insuline Glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Hepatocellular injury,,2021,Q1,6,F,202008.0,20210318.0,20200919,20210324,EXP,,FR-AUROBINDO-AUR-APL-2020-048123,AUROBINDO,,79.0,YR,,F,Y,72.0,KG,20210324.0,,MD,FR,FR,2021,Q1,Elderly
182853356,18285335,15,C,Insuline Glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Hypercreatininaemia,,2021,Q1,6,F,202008.0,20210318.0,20200919,20210324,EXP,,FR-AUROBINDO-AUR-APL-2020-048123,AUROBINDO,,79.0,YR,,F,Y,72.0,KG,20210324.0,,MD,FR,FR,2021,Q1,Elderly
182853356,18285335,15,C,Insuline Glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Intra-abdominal fluid collection,,2021,Q1,6,F,202008.0,20210318.0,20200919,20210324,EXP,,FR-AUROBINDO-AUR-APL-2020-048123,AUROBINDO,,79.0,YR,,F,Y,72.0,KG,20210324.0,,MD,FR,FR,2021,Q1,Elderly
182853356,18285335,15,C,Insuline Glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Oedema peripheral,,2021,Q1,6,F,202008.0,20210318.0,20200919,20210324,EXP,,FR-AUROBINDO-AUR-APL-2020-048123,AUROBINDO,,79.0,YR,,F,Y,72.0,KG,20210324.0,,MD,FR,FR,2021,Q1,Elderly
182853356,18285335,15,C,Insuline Glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Rash maculo-papular,,2021,Q1,6,F,202008.0,20210318.0,20200919,20210324,EXP,,FR-AUROBINDO-AUR-APL-2020-048123,AUROBINDO,,79.0,YR,,F,Y,72.0,KG,20210324.0,,MD,FR,FR,2021,Q1,Elderly
182853356,18285335,15,C,Insuline Glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Splenomegaly,,2021,Q1,6,F,202008.0,20210318.0,20200919,20210324,EXP,,FR-AUROBINDO-AUR-APL-2020-048123,AUROBINDO,,79.0,YR,,F,Y,72.0,KG,20210324.0,,MD,FR,FR,2021,Q1,Elderly
182900818,18290081,13,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Breath sounds,,2021,Q1,8,F,202008.0,20210322.0,20200921,20210330,EXP,FR-AFSSAPS-AN20201025,NVSC2020FR252711,NOVARTIS,,79.0,YR,,F,Y,72.0,KG,20210330.0,,HP,FR,FR,2021,Q1,Elderly
182900818,18290081,13,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Cheilitis,,2021,Q1,8,F,202008.0,20210322.0,20200921,20210330,EXP,FR-AFSSAPS-AN20201025,NVSC2020FR252711,NOVARTIS,,79.0,YR,,F,Y,72.0,KG,20210330.0,,HP,FR,FR,2021,Q1,Elderly
182900818,18290081,13,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Drug reaction with eosinophilia and systemic symptoms,,2021,Q1,8,F,202008.0,20210322.0,20200921,20210330,EXP,FR-AFSSAPS-AN20201025,NVSC2020FR252711,NOVARTIS,,79.0,YR,,F,Y,72.0,KG,20210330.0,,HP,FR,FR,2021,Q1,Elderly
182900818,18290081,13,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Eosinophilia,,2021,Q1,8,F,202008.0,20210322.0,20200921,20210330,EXP,FR-AFSSAPS-AN20201025,NVSC2020FR252711,NOVARTIS,,79.0,YR,,F,Y,72.0,KG,20210330.0,,HP,FR,FR,2021,Q1,Elderly
182900818,18290081,13,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Glossitis,,2021,Q1,8,F,202008.0,20210322.0,20200921,20210330,EXP,FR-AFSSAPS-AN20201025,NVSC2020FR252711,NOVARTIS,,79.0,YR,,F,Y,72.0,KG,20210330.0,,HP,FR,FR,2021,Q1,Elderly
182900818,18290081,13,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Hepatic cirrhosis,,2021,Q1,8,F,202008.0,20210322.0,20200921,20210330,EXP,FR-AFSSAPS-AN20201025,NVSC2020FR252711,NOVARTIS,,79.0,YR,,F,Y,72.0,KG,20210330.0,,HP,FR,FR,2021,Q1,Elderly
182900818,18290081,13,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Hepatocellular injury,,2021,Q1,8,F,202008.0,20210322.0,20200921,20210330,EXP,FR-AFSSAPS-AN20201025,NVSC2020FR252711,NOVARTIS,,79.0,YR,,F,Y,72.0,KG,20210330.0,,HP,FR,FR,2021,Q1,Elderly
182900818,18290081,13,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Hypercreatininaemia,,2021,Q1,8,F,202008.0,20210322.0,20200921,20210330,EXP,FR-AFSSAPS-AN20201025,NVSC2020FR252711,NOVARTIS,,79.0,YR,,F,Y,72.0,KG,20210330.0,,HP,FR,FR,2021,Q1,Elderly
182900818,18290081,13,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Intra-abdominal fluid collection,,2021,Q1,8,F,202008.0,20210322.0,20200921,20210330,EXP,FR-AFSSAPS-AN20201025,NVSC2020FR252711,NOVARTIS,,79.0,YR,,F,Y,72.0,KG,20210330.0,,HP,FR,FR,2021,Q1,Elderly
182900818,18290081,13,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Oedema peripheral,,2021,Q1,8,F,202008.0,20210322.0,20200921,20210330,EXP,FR-AFSSAPS-AN20201025,NVSC2020FR252711,NOVARTIS,,79.0,YR,,F,Y,72.0,KG,20210330.0,,HP,FR,FR,2021,Q1,Elderly
182900818,18290081,13,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Rash maculo-papular,,2021,Q1,8,F,202008.0,20210322.0,20200921,20210330,EXP,FR-AFSSAPS-AN20201025,NVSC2020FR252711,NOVARTIS,,79.0,YR,,F,Y,72.0,KG,20210330.0,,HP,FR,FR,2021,Q1,Elderly
182900818,18290081,13,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Splenomegaly,,2021,Q1,8,F,202008.0,20210322.0,20200921,20210330,EXP,FR-AFSSAPS-AN20201025,NVSC2020FR252711,NOVARTIS,,79.0,YR,,F,Y,72.0,KG,20210330.0,,HP,FR,FR,2021,Q1,Elderly
183053953,18305395,11,C,INSULINE GLARGINE ((BACTERIE/ESCHERICHIA COLI)),INSULIN GLARGINE,1,Unknown,INCONNUE (),,,,,,,,,,,,2021,Q1,Drug reaction with eosinophilia and systemic symptoms,,2021,Q1,3,F,20200808.0,20210302.0,20200924,20210317,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-261519,RANBAXY,,79.0,YR,,F,Y,72.0,KG,20210317.0,,HP,NL,FR,2021,Q1,Elderly
183053953,18305395,11,C,INSULINE GLARGINE ((BACTERIE/ESCHERICHIA COLI)),INSULIN GLARGINE,1,Unknown,INCONNUE (),,,,,,,,,,,,2021,Q1,Eosinophilia,,2021,Q1,3,F,20200808.0,20210302.0,20200924,20210317,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-261519,RANBAXY,,79.0,YR,,F,Y,72.0,KG,20210317.0,,HP,NL,FR,2021,Q1,Elderly
183053953,18305395,11,C,INSULINE GLARGINE ((BACTERIE/ESCHERICHIA COLI)),INSULIN GLARGINE,1,Unknown,INCONNUE (),,,,,,,,,,,,2021,Q1,Hepatocellular injury,,2021,Q1,3,F,20200808.0,20210302.0,20200924,20210317,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-261519,RANBAXY,,79.0,YR,,F,Y,72.0,KG,20210317.0,,HP,NL,FR,2021,Q1,Elderly
183053953,18305395,11,C,INSULINE GLARGINE ((BACTERIE/ESCHERICHIA COLI)),INSULIN GLARGINE,1,Unknown,INCONNUE (),,,,,,,,,,,,2021,Q1,Hypercreatininaemia,,2021,Q1,3,F,20200808.0,20210302.0,20200924,20210317,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-261519,RANBAXY,,79.0,YR,,F,Y,72.0,KG,20210317.0,,HP,NL,FR,2021,Q1,Elderly
183053953,18305395,11,C,INSULINE GLARGINE ((BACTERIE/ESCHERICHIA COLI)),INSULIN GLARGINE,1,Unknown,INCONNUE (),,,,,,,,,,,,2021,Q1,Rash maculo-papular,,2021,Q1,3,F,20200808.0,20210302.0,20200924,20210317,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-261519,RANBAXY,,79.0,YR,,F,Y,72.0,KG,20210317.0,,HP,NL,FR,2021,Q1,Elderly
183061292,18306129,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Acute kidney injury,,2021,Q1,2,F,20180918.0,20210315.0,20200924,20210319,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20210319.0,,CN,US,US,2021,Q1,Elderly
183061292,18306129,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Acute respiratory distress syndrome,,2021,Q1,2,F,20180918.0,20210315.0,20200924,20210319,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20210319.0,,CN,US,US,2021,Q1,Elderly
183061292,18306129,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Alanine aminotransferase increased,,2021,Q1,2,F,20180918.0,20210315.0,20200924,20210319,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20210319.0,,CN,US,US,2021,Q1,Elderly
183061292,18306129,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Atrial fibrillation,,2021,Q1,2,F,20180918.0,20210315.0,20200924,20210319,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20210319.0,,CN,US,US,2021,Q1,Elderly
183061292,18306129,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Blood albumin increased,,2021,Q1,2,F,20180918.0,20210315.0,20200924,20210319,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20210319.0,,CN,US,US,2021,Q1,Elderly
183061292,18306129,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Blood bilirubin increased,,2021,Q1,2,F,20180918.0,20210315.0,20200924,20210319,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20210319.0,,CN,US,US,2021,Q1,Elderly
183061292,18306129,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Blood creatinine increased,,2021,Q1,2,F,20180918.0,20210315.0,20200924,20210319,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20210319.0,,CN,US,US,2021,Q1,Elderly
183061292,18306129,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Blood glucose increased,,2021,Q1,2,F,20180918.0,20210315.0,20200924,20210319,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20210319.0,,CN,US,US,2021,Q1,Elderly
183061292,18306129,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Blood urea increased,,2021,Q1,2,F,20180918.0,20210315.0,20200924,20210319,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20210319.0,,CN,US,US,2021,Q1,Elderly
183061292,18306129,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Breast cancer metastatic,,2021,Q1,2,F,20180918.0,20210315.0,20200924,20210319,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20210319.0,,CN,US,US,2021,Q1,Elderly
183061292,18306129,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Cough,,2021,Q1,2,F,20180918.0,20210315.0,20200924,20210319,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20210319.0,,CN,US,US,2021,Q1,Elderly
183061292,18306129,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Decreased appetite,,2021,Q1,2,F,20180918.0,20210315.0,20200924,20210319,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20210319.0,,CN,US,US,2021,Q1,Elderly
183061292,18306129,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Diaphragmatic paralysis,,2021,Q1,2,F,20180918.0,20210315.0,20200924,20210319,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20210319.0,,CN,US,US,2021,Q1,Elderly
183061292,18306129,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Dyspnoea,,2021,Q1,2,F,20180918.0,20210315.0,20200924,20210319,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20210319.0,,CN,US,US,2021,Q1,Elderly
183061292,18306129,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Fatigue,,2021,Q1,2,F,20180918.0,20210315.0,20200924,20210319,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20210319.0,,CN,US,US,2021,Q1,Elderly
183061292,18306129,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Haemoglobin decreased,,2021,Q1,2,F,20180918.0,20210315.0,20200924,20210319,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20210319.0,,CN,US,US,2021,Q1,Elderly
183061292,18306129,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Herpes simplex,,2021,Q1,2,F,20180918.0,20210315.0,20200924,20210319,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20210319.0,,CN,US,US,2021,Q1,Elderly
183061292,18306129,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Illness,,2021,Q1,2,F,20180918.0,20210315.0,20200924,20210319,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20210319.0,,CN,US,US,2021,Q1,Elderly
183061292,18306129,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Infection,,2021,Q1,2,F,20180918.0,20210315.0,20200924,20210319,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20210319.0,,CN,US,US,2021,Q1,Elderly
183061292,18306129,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Malignant neoplasm progression,,2021,Q1,2,F,20180918.0,20210315.0,20200924,20210319,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20210319.0,,CN,US,US,2021,Q1,Elderly
183061292,18306129,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Metastases to central nervous system,,2021,Q1,2,F,20180918.0,20210315.0,20200924,20210319,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20210319.0,,CN,US,US,2021,Q1,Elderly
183061292,18306129,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Mouth ulceration,,2021,Q1,2,F,20180918.0,20210315.0,20200924,20210319,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20210319.0,,CN,US,US,2021,Q1,Elderly
183061292,18306129,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Oral infection,,2021,Q1,2,F,20180918.0,20210315.0,20200924,20210319,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20210319.0,,CN,US,US,2021,Q1,Elderly
183061292,18306129,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Oral pain,,2021,Q1,2,F,20180918.0,20210315.0,20200924,20210319,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20210319.0,,CN,US,US,2021,Q1,Elderly
183061292,18306129,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Oxygen consumption increased,,2021,Q1,2,F,20180918.0,20210315.0,20200924,20210319,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20210319.0,,CN,US,US,2021,Q1,Elderly
183061292,18306129,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Phrenic nerve paralysis,,2021,Q1,2,F,20180918.0,20210315.0,20200924,20210319,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20210319.0,,CN,US,US,2021,Q1,Elderly
183061292,18306129,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Polyuria,,2021,Q1,2,F,20180918.0,20210315.0,20200924,20210319,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20210319.0,,CN,US,US,2021,Q1,Elderly
183061292,18306129,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Renal impairment,,2021,Q1,2,F,20180918.0,20210315.0,20200924,20210319,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20210319.0,,CN,US,US,2021,Q1,Elderly
183061292,18306129,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Respiratory disorder,,2021,Q1,2,F,20180918.0,20210315.0,20200924,20210319,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20210319.0,,CN,US,US,2021,Q1,Elderly
183061292,18306129,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Septic shock,,2021,Q1,2,F,20180918.0,20210315.0,20200924,20210319,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20210319.0,,CN,US,US,2021,Q1,Elderly
183061292,18306129,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Somnolence,,2021,Q1,2,F,20180918.0,20210315.0,20200924,20210319,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20210319.0,,CN,US,US,2021,Q1,Elderly
183061292,18306129,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Tachypnoea,,2021,Q1,2,F,20180918.0,20210315.0,20200924,20210319,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20210319.0,,CN,US,US,2021,Q1,Elderly
183061292,18306129,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Weight decreased,,2021,Q1,2,F,20180918.0,20210315.0,20200924,20210319,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20210319.0,,CN,US,US,2021,Q1,Elderly
183179233,18317923,10,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN FREQ.",,,,, UNK,,,,,FORMULATION UNKNOWN,,2021,Q1,Drug reaction with eosinophilia and systemic symptoms,,2021,Q1,3,F,20200808.0,20210304.0,20200928,20210317,EXP,,FR-ASTELLAS-2020US033375,ASTELLAS,,79.0,YR,,F,Y,,,20210317.0,,CN,GB,FR,2021,Q1,Elderly
183179233,18317923,10,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN FREQ.",,,,, UNK,,,,,FORMULATION UNKNOWN,,2021,Q1,Eosinophilia,,2021,Q1,3,F,20200808.0,20210304.0,20200928,20210317,EXP,,FR-ASTELLAS-2020US033375,ASTELLAS,,79.0,YR,,F,Y,,,20210317.0,,CN,GB,FR,2021,Q1,Elderly
183179233,18317923,10,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN FREQ.",,,,, UNK,,,,,FORMULATION UNKNOWN,,2021,Q1,Hepatocellular injury,,2021,Q1,3,F,20200808.0,20210304.0,20200928,20210317,EXP,,FR-ASTELLAS-2020US033375,ASTELLAS,,79.0,YR,,F,Y,,,20210317.0,,CN,GB,FR,2021,Q1,Elderly
183179233,18317923,10,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN FREQ.",,,,, UNK,,,,,FORMULATION UNKNOWN,,2021,Q1,Hypercreatininaemia,,2021,Q1,3,F,20200808.0,20210304.0,20200928,20210317,EXP,,FR-ASTELLAS-2020US033375,ASTELLAS,,79.0,YR,,F,Y,,,20210317.0,,CN,GB,FR,2021,Q1,Elderly
183179233,18317923,10,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN FREQ.",,,,, UNK,,,,,FORMULATION UNKNOWN,,2021,Q1,Rash maculo-papular,,2021,Q1,3,F,20200808.0,20210304.0,20200928,20210317,EXP,,FR-ASTELLAS-2020US033375,ASTELLAS,,79.0,YR,,F,Y,,,20210317.0,,CN,GB,FR,2021,Q1,Elderly
183242075,18324207,12,C,INSULIN GLARGINE BS[BIOSIMILAR 1],INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,12.0,IU,INJECTION,QD,2021,Q1,Brain herniation,,2021,Q1,5,F,20200921.0,20210212.0,20200928,20210218,EXP,,JP-ASTRAZENECA-2020SF24350,ASTRAZENECA,,16725.0,DY,,M,Y,61.0,KG,20210218.0,,MD,JP,JP,2021,Q1,Elderly
183242075,18324207,12,C,INSULIN GLARGINE BS[BIOSIMILAR 1],INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,12.0,IU,INJECTION,QD,2021,Q1,Dehydration,,2021,Q1,5,F,20200921.0,20210212.0,20200928,20210218,EXP,,JP-ASTRAZENECA-2020SF24350,ASTRAZENECA,,16725.0,DY,,M,Y,61.0,KG,20210218.0,,MD,JP,JP,2021,Q1,Elderly
183242075,18324207,12,C,INSULIN GLARGINE BS[BIOSIMILAR 1],INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,12.0,IU,INJECTION,QD,2021,Q1,Embolic cerebral infarction,,2021,Q1,5,F,20200921.0,20210212.0,20200928,20210218,EXP,,JP-ASTRAZENECA-2020SF24350,ASTRAZENECA,,16725.0,DY,,M,Y,61.0,KG,20210218.0,,MD,JP,JP,2021,Q1,Elderly
183300863,18330086,9,C,INSULINE GLARGINE ((BACTERIE/ESCHERICHIA COLI)),INSULIN GLARGINE,1,,UNKNOWN,,,,, UNKNOWN,,,,,,,2021,Q1,Drug reaction with eosinophilia and systemic symptoms,,2021,Q1,3,F,20200808.0,20210307.0,20200930,20210322,EXP,FR-AFSSAPS-AN20201025,FR-TEVA-2020-FR-1832185,TEVA,,79.0,YR,E,F,Y,72.0,KG,20210322.0,,MD,FR,FR,2021,Q1,Elderly
183303774,18330377,14,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,INCONNUE,,,,,,,,,,,,2021,Q1,Breath sounds,,2021,Q1,4,F,202008.0,20210201.0,20200930,20210204,EXP,FR-AFSSAPS-AN20201025,FR-MYLANLABS-2020M1081955,MYLAN,,79.0,YR,,F,Y,72.0,KG,20210204.0,,MD,FR,FR,2021,Q1,Elderly
183303774,18330377,14,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,INCONNUE,,,,,,,,,,,,2021,Q1,Cheilitis,,2021,Q1,4,F,202008.0,20210201.0,20200930,20210204,EXP,FR-AFSSAPS-AN20201025,FR-MYLANLABS-2020M1081955,MYLAN,,79.0,YR,,F,Y,72.0,KG,20210204.0,,MD,FR,FR,2021,Q1,Elderly
183303774,18330377,14,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,INCONNUE,,,,,,,,,,,,2021,Q1,Eosinophilia,,2021,Q1,4,F,202008.0,20210201.0,20200930,20210204,EXP,FR-AFSSAPS-AN20201025,FR-MYLANLABS-2020M1081955,MYLAN,,79.0,YR,,F,Y,72.0,KG,20210204.0,,MD,FR,FR,2021,Q1,Elderly
183303774,18330377,14,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,INCONNUE,,,,,,,,,,,,2021,Q1,Glossitis,,2021,Q1,4,F,202008.0,20210201.0,20200930,20210204,EXP,FR-AFSSAPS-AN20201025,FR-MYLANLABS-2020M1081955,MYLAN,,79.0,YR,,F,Y,72.0,KG,20210204.0,,MD,FR,FR,2021,Q1,Elderly
183303774,18330377,14,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,INCONNUE,,,,,,,,,,,,2021,Q1,Hepatocellular injury,,2021,Q1,4,F,202008.0,20210201.0,20200930,20210204,EXP,FR-AFSSAPS-AN20201025,FR-MYLANLABS-2020M1081955,MYLAN,,79.0,YR,,F,Y,72.0,KG,20210204.0,,MD,FR,FR,2021,Q1,Elderly
183303774,18330377,14,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,INCONNUE,,,,,,,,,,,,2021,Q1,Hypercreatininaemia,,2021,Q1,4,F,202008.0,20210201.0,20200930,20210204,EXP,FR-AFSSAPS-AN20201025,FR-MYLANLABS-2020M1081955,MYLAN,,79.0,YR,,F,Y,72.0,KG,20210204.0,,MD,FR,FR,2021,Q1,Elderly
183303774,18330377,14,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,INCONNUE,,,,,,,,,,,,2021,Q1,Intra-abdominal fluid collection,,2021,Q1,4,F,202008.0,20210201.0,20200930,20210204,EXP,FR-AFSSAPS-AN20201025,FR-MYLANLABS-2020M1081955,MYLAN,,79.0,YR,,F,Y,72.0,KG,20210204.0,,MD,FR,FR,2021,Q1,Elderly
183303774,18330377,14,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,INCONNUE,,,,,,,,,,,,2021,Q1,Oedema peripheral,,2021,Q1,4,F,202008.0,20210201.0,20200930,20210204,EXP,FR-AFSSAPS-AN20201025,FR-MYLANLABS-2020M1081955,MYLAN,,79.0,YR,,F,Y,72.0,KG,20210204.0,,MD,FR,FR,2021,Q1,Elderly
183303774,18330377,14,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,INCONNUE,,,,,,,,,,,,2021,Q1,Rash maculo-papular,,2021,Q1,4,F,202008.0,20210201.0,20200930,20210204,EXP,FR-AFSSAPS-AN20201025,FR-MYLANLABS-2020M1081955,MYLAN,,79.0,YR,,F,Y,72.0,KG,20210204.0,,MD,FR,FR,2021,Q1,Elderly
183303774,18330377,14,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,INCONNUE,,,,,,,,,,,,2021,Q1,Splenomegaly,,2021,Q1,4,F,202008.0,20210201.0,20200930,20210204,EXP,FR-AFSSAPS-AN20201025,FR-MYLANLABS-2020M1081955,MYLAN,,79.0,YR,,F,Y,72.0,KG,20210204.0,,MD,FR,FR,2021,Q1,Elderly
183353093,18335309,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 IU/ML (INJECT 32 UNITS SUBCUTANEOUSLY AT BEDTIME),,,U,,,,,100.0,IU,,,2021,Q1,Abdominal pain,,2021,Q1,3,F,20170330.0,20210104.0,20201001,20210107,EXP,,PHHY2017CA050720,NOVARTIS,,75.0,YR,,F,Y,,,20210107.0,,,CA,CA,2021,Q1,Elderly
183353093,18335309,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 IU/ML (INJECT 32 UNITS SUBCUTANEOUSLY AT BEDTIME),,,U,,,,,100.0,IU,,,2021,Q1,Anxiety,,2021,Q1,3,F,20170330.0,20210104.0,20201001,20210107,EXP,,PHHY2017CA050720,NOVARTIS,,75.0,YR,,F,Y,,,20210107.0,,,CA,CA,2021,Q1,Elderly
183353093,18335309,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 IU/ML (INJECT 32 UNITS SUBCUTANEOUSLY AT BEDTIME),,,U,,,,,100.0,IU,,,2021,Q1,Blood pressure systolic increased,,2021,Q1,3,F,20170330.0,20210104.0,20201001,20210107,EXP,,PHHY2017CA050720,NOVARTIS,,75.0,YR,,F,Y,,,20210107.0,,,CA,CA,2021,Q1,Elderly
183353093,18335309,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 IU/ML (INJECT 32 UNITS SUBCUTANEOUSLY AT BEDTIME),,,U,,,,,100.0,IU,,,2021,Q1,Body temperature decreased,,2021,Q1,3,F,20170330.0,20210104.0,20201001,20210107,EXP,,PHHY2017CA050720,NOVARTIS,,75.0,YR,,F,Y,,,20210107.0,,,CA,CA,2021,Q1,Elderly
183353093,18335309,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 IU/ML (INJECT 32 UNITS SUBCUTANEOUSLY AT BEDTIME),,,U,,,,,100.0,IU,,,2021,Q1,Body temperature increased,,2021,Q1,3,F,20170330.0,20210104.0,20201001,20210107,EXP,,PHHY2017CA050720,NOVARTIS,,75.0,YR,,F,Y,,,20210107.0,,,CA,CA,2021,Q1,Elderly
183353093,18335309,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 IU/ML (INJECT 32 UNITS SUBCUTANEOUSLY AT BEDTIME),,,U,,,,,100.0,IU,,,2021,Q1,Death,,2021,Q1,3,F,20170330.0,20210104.0,20201001,20210107,EXP,,PHHY2017CA050720,NOVARTIS,,75.0,YR,,F,Y,,,20210107.0,,,CA,CA,2021,Q1,Elderly
183353093,18335309,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 IU/ML (INJECT 32 UNITS SUBCUTANEOUSLY AT BEDTIME),,,U,,,,,100.0,IU,,,2021,Q1,Dementia,,2021,Q1,3,F,20170330.0,20210104.0,20201001,20210107,EXP,,PHHY2017CA050720,NOVARTIS,,75.0,YR,,F,Y,,,20210107.0,,,CA,CA,2021,Q1,Elderly
183353093,18335309,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 IU/ML (INJECT 32 UNITS SUBCUTANEOUSLY AT BEDTIME),,,U,,,,,100.0,IU,,,2021,Q1,Endocrine disorder,,2021,Q1,3,F,20170330.0,20210104.0,20201001,20210107,EXP,,PHHY2017CA050720,NOVARTIS,,75.0,YR,,F,Y,,,20210107.0,,,CA,CA,2021,Q1,Elderly
183353093,18335309,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 IU/ML (INJECT 32 UNITS SUBCUTANEOUSLY AT BEDTIME),,,U,,,,,100.0,IU,,,2021,Q1,Flushing,,2021,Q1,3,F,20170330.0,20210104.0,20201001,20210107,EXP,,PHHY2017CA050720,NOVARTIS,,75.0,YR,,F,Y,,,20210107.0,,,CA,CA,2021,Q1,Elderly
183353093,18335309,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 IU/ML (INJECT 32 UNITS SUBCUTANEOUSLY AT BEDTIME),,,U,,,,,100.0,IU,,,2021,Q1,Heart rate decreased,,2021,Q1,3,F,20170330.0,20210104.0,20201001,20210107,EXP,,PHHY2017CA050720,NOVARTIS,,75.0,YR,,F,Y,,,20210107.0,,,CA,CA,2021,Q1,Elderly
183353093,18335309,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 IU/ML (INJECT 32 UNITS SUBCUTANEOUSLY AT BEDTIME),,,U,,,,,100.0,IU,,,2021,Q1,Hypoacusis,,2021,Q1,3,F,20170330.0,20210104.0,20201001,20210107,EXP,,PHHY2017CA050720,NOVARTIS,,75.0,YR,,F,Y,,,20210107.0,,,CA,CA,2021,Q1,Elderly
183353093,18335309,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 IU/ML (INJECT 32 UNITS SUBCUTANEOUSLY AT BEDTIME),,,U,,,,,100.0,IU,,,2021,Q1,Malaise,,2021,Q1,3,F,20170330.0,20210104.0,20201001,20210107,EXP,,PHHY2017CA050720,NOVARTIS,,75.0,YR,,F,Y,,,20210107.0,,,CA,CA,2021,Q1,Elderly
183353093,18335309,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 IU/ML (INJECT 32 UNITS SUBCUTANEOUSLY AT BEDTIME),,,U,,,,,100.0,IU,,,2021,Q1,Memory impairment,,2021,Q1,3,F,20170330.0,20210104.0,20201001,20210107,EXP,,PHHY2017CA050720,NOVARTIS,,75.0,YR,,F,Y,,,20210107.0,,,CA,CA,2021,Q1,Elderly
183353093,18335309,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 IU/ML (INJECT 32 UNITS SUBCUTANEOUSLY AT BEDTIME),,,U,,,,,100.0,IU,,,2021,Q1,Obesity,,2021,Q1,3,F,20170330.0,20210104.0,20201001,20210107,EXP,,PHHY2017CA050720,NOVARTIS,,75.0,YR,,F,Y,,,20210107.0,,,CA,CA,2021,Q1,Elderly
183353093,18335309,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 IU/ML (INJECT 32 UNITS SUBCUTANEOUSLY AT BEDTIME),,,U,,,,,100.0,IU,,,2021,Q1,Osteoarthritis,,2021,Q1,3,F,20170330.0,20210104.0,20201001,20210107,EXP,,PHHY2017CA050720,NOVARTIS,,75.0,YR,,F,Y,,,20210107.0,,,CA,CA,2021,Q1,Elderly
183353093,18335309,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 IU/ML (INJECT 32 UNITS SUBCUTANEOUSLY AT BEDTIME),,,U,,,,,100.0,IU,,,2021,Q1,Renal failure,,2021,Q1,3,F,20170330.0,20210104.0,20201001,20210107,EXP,,PHHY2017CA050720,NOVARTIS,,75.0,YR,,F,Y,,,20210107.0,,,CA,CA,2021,Q1,Elderly
183409027,18340902,17,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,50 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Acute kidney injury,,2021,Q1,7,F,20200911.0,20210323.0,20201003,20210329,EXP,,US-CELGENEUS-USA-20200907779,CELGENE,,74.0,YR,,M,Y,127.12,KG,20210329.0,,MD,US,US,2021,Q1,Elderly
183409027,18340902,17,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,50 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q1,B-cell lymphoma,,2021,Q1,7,F,20200911.0,20210323.0,20201003,20210329,EXP,,US-CELGENEUS-USA-20200907779,CELGENE,,74.0,YR,,M,Y,127.12,KG,20210329.0,,MD,US,US,2021,Q1,Elderly
183409027,18340902,17,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,50 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Dehydration,,2021,Q1,7,F,20200911.0,20210323.0,20201003,20210329,EXP,,US-CELGENEUS-USA-20200907779,CELGENE,,74.0,YR,,M,Y,127.12,KG,20210329.0,,MD,US,US,2021,Q1,Elderly
183409027,18340902,17,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,50 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Dermatitis atopic,,2021,Q1,7,F,20200911.0,20210323.0,20201003,20210329,EXP,,US-CELGENEUS-USA-20200907779,CELGENE,,74.0,YR,,M,Y,127.12,KG,20210329.0,,MD,US,US,2021,Q1,Elderly
183409027,18340902,17,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,50 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Hypotension,,2021,Q1,7,F,20200911.0,20210323.0,20201003,20210329,EXP,,US-CELGENEUS-USA-20200907779,CELGENE,,74.0,YR,,M,Y,127.12,KG,20210329.0,,MD,US,US,2021,Q1,Elderly
183409027,18340902,17,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,50 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Lactic acidosis,,2021,Q1,7,F,20200911.0,20210323.0,20201003,20210329,EXP,,US-CELGENEUS-USA-20200907779,CELGENE,,74.0,YR,,M,Y,127.12,KG,20210329.0,,MD,US,US,2021,Q1,Elderly
183409027,18340902,17,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,50 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Orthostatic hypotension,,2021,Q1,7,F,20200911.0,20210323.0,20201003,20210329,EXP,,US-CELGENEUS-USA-20200907779,CELGENE,,74.0,YR,,M,Y,127.12,KG,20210329.0,,MD,US,US,2021,Q1,Elderly
183409027,18340902,17,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,50 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Periorbital oedema,,2021,Q1,7,F,20200911.0,20210323.0,20201003,20210329,EXP,,US-CELGENEUS-USA-20200907779,CELGENE,,74.0,YR,,M,Y,127.12,KG,20210329.0,,MD,US,US,2021,Q1,Elderly
183409027,18340902,17,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,50 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Peripheral swelling,,2021,Q1,7,F,20200911.0,20210323.0,20201003,20210329,EXP,,US-CELGENEUS-USA-20200907779,CELGENE,,74.0,YR,,M,Y,127.12,KG,20210329.0,,MD,US,US,2021,Q1,Elderly
183409027,18340902,17,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,50 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Sepsis,,2021,Q1,7,F,20200911.0,20210323.0,20201003,20210329,EXP,,US-CELGENEUS-USA-20200907779,CELGENE,,74.0,YR,,M,Y,127.12,KG,20210329.0,,MD,US,US,2021,Q1,Elderly
183409027,18340902,17,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,50 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Urticaria,,2021,Q1,7,F,20200911.0,20210323.0,20201003,20210329,EXP,,US-CELGENEUS-USA-20200907779,CELGENE,,74.0,YR,,M,Y,127.12,KG,20210329.0,,MD,US,US,2021,Q1,Elderly
183624493,18362449,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q1,Burning sensation,,2021,Q1,3,F,20180301.0,20210126.0,20201008,20210203,EXP,,PHHY2018CO003635,NOVARTIS,,76.0,YR,,M,Y,82.0,KG,20210203.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q1,Elderly
183624493,18362449,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q1,Chromaturia,,2021,Q1,3,F,20180301.0,20210126.0,20201008,20210203,EXP,,PHHY2018CO003635,NOVARTIS,,76.0,YR,,M,Y,82.0,KG,20210203.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q1,Elderly
183624493,18362449,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q1,Decreased appetite,,2021,Q1,3,F,20180301.0,20210126.0,20201008,20210203,EXP,,PHHY2018CO003635,NOVARTIS,,76.0,YR,,M,Y,82.0,KG,20210203.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q1,Elderly
183624493,18362449,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q1,Decreased immune responsiveness,,2021,Q1,3,F,20180301.0,20210126.0,20201008,20210203,EXP,,PHHY2018CO003635,NOVARTIS,,76.0,YR,,M,Y,82.0,KG,20210203.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q1,Elderly
183624493,18362449,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q1,Dizziness,,2021,Q1,3,F,20180301.0,20210126.0,20201008,20210203,EXP,,PHHY2018CO003635,NOVARTIS,,76.0,YR,,M,Y,82.0,KG,20210203.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q1,Elderly
183624493,18362449,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q1,Drug intolerance,,2021,Q1,3,F,20180301.0,20210126.0,20201008,20210203,EXP,,PHHY2018CO003635,NOVARTIS,,76.0,YR,,M,Y,82.0,KG,20210203.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q1,Elderly
183624493,18362449,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q1,Hyperhidrosis,,2021,Q1,3,F,20180301.0,20210126.0,20201008,20210203,EXP,,PHHY2018CO003635,NOVARTIS,,76.0,YR,,M,Y,82.0,KG,20210203.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q1,Elderly
183624493,18362449,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q1,Influenza,,2021,Q1,3,F,20180301.0,20210126.0,20201008,20210203,EXP,,PHHY2018CO003635,NOVARTIS,,76.0,YR,,M,Y,82.0,KG,20210203.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q1,Elderly
183624493,18362449,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q1,Malignant neoplasm progression,,2021,Q1,3,F,20180301.0,20210126.0,20201008,20210203,EXP,,PHHY2018CO003635,NOVARTIS,,76.0,YR,,M,Y,82.0,KG,20210203.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q1,Elderly
183624493,18362449,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q1,Necrosis,,2021,Q1,3,F,20180301.0,20210126.0,20201008,20210203,EXP,,PHHY2018CO003635,NOVARTIS,,76.0,YR,,M,Y,82.0,KG,20210203.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q1,Elderly
183624493,18362449,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q1,Neuroendocrine tumour,,2021,Q1,3,F,20180301.0,20210126.0,20201008,20210203,EXP,,PHHY2018CO003635,NOVARTIS,,76.0,YR,,M,Y,82.0,KG,20210203.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q1,Elderly
183624493,18362449,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q1,Pain,,2021,Q1,3,F,20180301.0,20210126.0,20201008,20210203,EXP,,PHHY2018CO003635,NOVARTIS,,76.0,YR,,M,Y,82.0,KG,20210203.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q1,Elderly
183624493,18362449,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q1,Pruritus,,2021,Q1,3,F,20180301.0,20210126.0,20201008,20210203,EXP,,PHHY2018CO003635,NOVARTIS,,76.0,YR,,M,Y,82.0,KG,20210203.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q1,Elderly
183624493,18362449,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q1,Skin discolouration,,2021,Q1,3,F,20180301.0,20210126.0,20201008,20210203,EXP,,PHHY2018CO003635,NOVARTIS,,76.0,YR,,M,Y,82.0,KG,20210203.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q1,Elderly
183624493,18362449,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q1,Skin necrosis,,2021,Q1,3,F,20180301.0,20210126.0,20201008,20210203,EXP,,PHHY2018CO003635,NOVARTIS,,76.0,YR,,M,Y,82.0,KG,20210203.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q1,Elderly
183624493,18362449,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q1,Skin ulcer,,2021,Q1,3,F,20180301.0,20210126.0,20201008,20210203,EXP,,PHHY2018CO003635,NOVARTIS,,76.0,YR,,M,Y,82.0,KG,20210203.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q1,Elderly
183624493,18362449,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q1,Sleep disorder,,2021,Q1,3,F,20180301.0,20210126.0,20201008,20210203,EXP,,PHHY2018CO003635,NOVARTIS,,76.0,YR,,M,Y,82.0,KG,20210203.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q1,Elderly
183624493,18362449,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q1,Somnolence,,2021,Q1,3,F,20180301.0,20210126.0,20201008,20210203,EXP,,PHHY2018CO003635,NOVARTIS,,76.0,YR,,M,Y,82.0,KG,20210203.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q1,Elderly
183624493,18362449,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q1,Stomatitis,,2021,Q1,3,F,20180301.0,20210126.0,20201008,20210203,EXP,,PHHY2018CO003635,NOVARTIS,,76.0,YR,,M,Y,82.0,KG,20210203.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q1,Elderly
183624493,18362449,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q1,Urticaria,,2021,Q1,3,F,20180301.0,20210126.0,20201008,20210203,EXP,,PHHY2018CO003635,NOVARTIS,,76.0,YR,,M,Y,82.0,KG,20210203.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q1,Elderly
183624493,18362449,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q1,Weight decreased,,2021,Q1,3,F,20180301.0,20210126.0,20201008,20210203,EXP,,PHHY2018CO003635,NOVARTIS,,76.0,YR,,M,Y,82.0,KG,20210203.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q1,Elderly
183969673,18396967,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Crohn's disease,,2021,Q1,3,F,202010.0,20210118.0,20201019,20210128,EXP,,US-UCBSA-2020040475,UCB,,53.0,YR,,F,Y,,,20210128.0,,HP,US,US,2021,Q1,Adult
183969673,18396967,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Diabetes mellitus,,2021,Q1,3,F,202010.0,20210118.0,20201019,20210128,EXP,,US-UCBSA-2020040475,UCB,,53.0,YR,,F,Y,,,20210128.0,,HP,US,US,2021,Q1,Adult
183969673,18396967,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Myocardial infarction,,2021,Q1,3,F,202010.0,20210118.0,20201019,20210128,EXP,,US-UCBSA-2020040475,UCB,,53.0,YR,,F,Y,,,20210128.0,,HP,US,US,2021,Q1,Adult
183969673,18396967,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Psoriatic arthropathy,,2021,Q1,3,F,202010.0,20210118.0,20201019,20210128,EXP,,US-UCBSA-2020040475,UCB,,53.0,YR,,F,Y,,,20210128.0,,HP,US,US,2021,Q1,Adult
184123974,18412397,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 U, QD",,,U,,,,,,,,QD,2021,Q1,Abdominal distension,,2021,Q1,4,F,20200807.0,20210201.0,20201022,20210203,EXP,,JP-SAKK-2020SA291316AA,SANOFI AVENTIS,,68.0,YR,E,M,Y,100.0,KG,20210204.0,,MD,JP,JP,2021,Q1,Elderly
184123974,18412397,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 U, QD",,,U,,,,,,,,QD,2021,Q1,Ascites,,2021,Q1,4,F,20200807.0,20210201.0,20201022,20210203,EXP,,JP-SAKK-2020SA291316AA,SANOFI AVENTIS,,68.0,YR,E,M,Y,100.0,KG,20210204.0,,MD,JP,JP,2021,Q1,Elderly
184123974,18412397,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 U, QD",,,U,,,,,,,,QD,2021,Q1,Condition aggravated,,2021,Q1,4,F,20200807.0,20210201.0,20201022,20210203,EXP,,JP-SAKK-2020SA291316AA,SANOFI AVENTIS,,68.0,YR,E,M,Y,100.0,KG,20210204.0,,MD,JP,JP,2021,Q1,Elderly
184123974,18412397,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 U, QD",,,U,,,,,,,,QD,2021,Q1,Hepatic cirrhosis,,2021,Q1,4,F,20200807.0,20210201.0,20201022,20210203,EXP,,JP-SAKK-2020SA291316AA,SANOFI AVENTIS,,68.0,YR,E,M,Y,100.0,KG,20210204.0,,MD,JP,JP,2021,Q1,Elderly
184123974,18412397,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 U, QD",,,U,,,,,,,,QD,2021,Q1,Hypertension,,2021,Q1,4,F,20200807.0,20210201.0,20201022,20210203,EXP,,JP-SAKK-2020SA291316AA,SANOFI AVENTIS,,68.0,YR,E,M,Y,100.0,KG,20210204.0,,MD,JP,JP,2021,Q1,Elderly
184123974,18412397,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 U, QD",,,U,,,,,,,,QD,2021,Q1,Nephropathy toxic,,2021,Q1,4,F,20200807.0,20210201.0,20201022,20210203,EXP,,JP-SAKK-2020SA291316AA,SANOFI AVENTIS,,68.0,YR,E,M,Y,100.0,KG,20210204.0,,MD,JP,JP,2021,Q1,Elderly
184123974,18412397,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 U, QD",,,U,,,,,,,,QD,2021,Q1,Nephrotic syndrome,,2021,Q1,4,F,20200807.0,20210201.0,20201022,20210203,EXP,,JP-SAKK-2020SA291316AA,SANOFI AVENTIS,,68.0,YR,E,M,Y,100.0,KG,20210204.0,,MD,JP,JP,2021,Q1,Elderly
184123974,18412397,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 U, QD",,,U,,,,,,,,QD,2021,Q1,Oedema peripheral,,2021,Q1,4,F,20200807.0,20210201.0,20201022,20210203,EXP,,JP-SAKK-2020SA291316AA,SANOFI AVENTIS,,68.0,YR,E,M,Y,100.0,KG,20210204.0,,MD,JP,JP,2021,Q1,Elderly
184123974,18412397,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 U, QD",,,U,,,,,,,,QD,2021,Q1,Proteinuria,,2021,Q1,4,F,20200807.0,20210201.0,20201022,20210203,EXP,,JP-SAKK-2020SA291316AA,SANOFI AVENTIS,,68.0,YR,E,M,Y,100.0,KG,20210204.0,,MD,JP,JP,2021,Q1,Elderly
184123974,18412397,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 U, QD",,,U,,,,,,,,QD,2021,Q1,Weight increased,,2021,Q1,4,F,20200807.0,20210201.0,20201022,20210203,EXP,,JP-SAKK-2020SA291316AA,SANOFI AVENTIS,,68.0,YR,E,M,Y,100.0,KG,20210204.0,,MD,JP,JP,2021,Q1,Elderly
184519292,18451929,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,13 INTERNATIONAL UNIT,,,,,,,,13.0,IU,,,2021,Q1,Cutaneous amyloidosis,,2021,Q1,2,F,20190412.0,20210107.0,20201102,20210114,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202010009820,ELI LILLY AND CO,,79.0,YR,,M,Y,58.0,KG,20210114.0,,MD,JP,JP,2021,Q1,Elderly
184519292,18451929,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,13 INTERNATIONAL UNIT,,,,,,,,13.0,IU,,,2021,Q1,Diabetic ketoacidosis,,2021,Q1,2,F,20190412.0,20210107.0,20201102,20210114,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202010009820,ELI LILLY AND CO,,79.0,YR,,M,Y,58.0,KG,20210114.0,,MD,JP,JP,2021,Q1,Elderly
184597285,18459728,13,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,UNKNOWN,,2021,Q1,Cerebral infarction,,2021,Q1,5,F,20200926.0,20210125.0,20201103,20210129,EXP,,JP-CELGENEUS-JPN-20201100119,CELGENE,,77.0,YR,,M,Y,47.08,KG,20210129.0,,PH,JP,JP,2021,Q1,Elderly
184597285,18459728,13,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,UNKNOWN,,2021,Q1,Hypernatraemia,,2021,Q1,5,F,20200926.0,20210125.0,20201103,20210129,EXP,,JP-CELGENEUS-JPN-20201100119,CELGENE,,77.0,YR,,M,Y,47.08,KG,20210129.0,,PH,JP,JP,2021,Q1,Elderly
184597285,18459728,13,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,UNKNOWN,,2021,Q1,Interstitial lung disease,,2021,Q1,5,F,20200926.0,20210125.0,20201103,20210129,EXP,,JP-CELGENEUS-JPN-20201100119,CELGENE,,77.0,YR,,M,Y,47.08,KG,20210129.0,,PH,JP,JP,2021,Q1,Elderly
184597285,18459728,13,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,UNKNOWN,,2021,Q1,Osmotic demyelination syndrome,,2021,Q1,5,F,20200926.0,20210125.0,20201103,20210129,EXP,,JP-CELGENEUS-JPN-20201100119,CELGENE,,77.0,YR,,M,Y,47.08,KG,20210129.0,,PH,JP,JP,2021,Q1,Elderly
184597285,18459728,13,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,UNKNOWN,,2021,Q1,Pneumonia bacterial,,2021,Q1,5,F,20200926.0,20210125.0,20201103,20210129,EXP,,JP-CELGENEUS-JPN-20201100119,CELGENE,,77.0,YR,,M,Y,47.08,KG,20210129.0,,PH,JP,JP,2021,Q1,Elderly
184664598,18466459,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,QD,2021,Q1,Neurotoxicity,,2021,Q1,8,F,20201018.0,20210210.0,20201104,20210215,EXP,,US-ROCHE-2706721,ROCHE,,78.0,YR,,M,Y,100.0,KG,20210215.0,,MD,US,US,2021,Q1,Elderly
184664598,18466459,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,QD,2021,Q1,Septic shock,,2021,Q1,8,F,20201018.0,20210210.0,20201104,20210215,EXP,,US-ROCHE-2706721,ROCHE,,78.0,YR,,M,Y,100.0,KG,20210215.0,,MD,US,US,2021,Q1,Elderly
184686583,18468658,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, UNK",,,,,,,,10.0,IU,,,2021,Q1,COVID-19 treatment,,2021,Q1,3,F,20200922.0,20210104.0,20201105,20210107,EXP,,PT-GILEAD-2020-0496539,GILEAD,,61.0,YR,A,M,Y,101.0,KG,20210107.0,,PH,PT,PT,2021,Q1,Adult
184686583,18468658,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, UNK",,,,,,,,10.0,IU,,,2021,Q1,Hyperkalaemia,,2021,Q1,3,F,20200922.0,20210104.0,20201105,20210107,EXP,,PT-GILEAD-2020-0496539,GILEAD,,61.0,YR,A,M,Y,101.0,KG,20210107.0,,PH,PT,PT,2021,Q1,Adult
184686583,18468658,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, UNK",,,,,,,,10.0,IU,,,2021,Q1,Renal impairment,,2021,Q1,3,F,20200922.0,20210104.0,20201105,20210107,EXP,,PT-GILEAD-2020-0496539,GILEAD,,61.0,YR,A,M,Y,101.0,KG,20210107.0,,PH,PT,PT,2021,Q1,Adult
184765212,18476521,50,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Acute respiratory distress syndrome,,2021,Q1,2,F,2020.0,20210115.0,20201106,20210120,EXP,,US-GILEAD-2020-0466462,GILEAD,,61.0,YR,A,M,Y,81.5,KG,20210120.0,,MD,US,US,2021,Q1,Adult
184765212,18476521,50,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,COVID-19,,2021,Q1,2,F,2020.0,20210115.0,20201106,20210120,EXP,,US-GILEAD-2020-0466462,GILEAD,,61.0,YR,A,M,Y,81.5,KG,20210120.0,,MD,US,US,2021,Q1,Adult
184765212,18476521,50,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Hypercapnia,,2021,Q1,2,F,2020.0,20210115.0,20201106,20210120,EXP,,US-GILEAD-2020-0466462,GILEAD,,61.0,YR,A,M,Y,81.5,KG,20210120.0,,MD,US,US,2021,Q1,Adult
184765212,18476521,50,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Hypoxia,,2021,Q1,2,F,2020.0,20210115.0,20201106,20210120,EXP,,US-GILEAD-2020-0466462,GILEAD,,61.0,YR,A,M,Y,81.5,KG,20210120.0,,MD,US,US,2021,Q1,Adult
184836682,18483668,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Enterobacter bacteraemia,,2021,Q1,2,F,20201023.0,20210118.0,20201109,20210122,EXP,,US-GILEAD-2020-0502183,GILEAD,,60.0,YR,A,M,Y,76.5,KG,20210122.0,,MD,US,US,2021,Q1,Adult
184836682,18483668,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Multiple organ dysfunction syndrome,,2021,Q1,2,F,20201023.0,20210118.0,20201109,20210122,EXP,,US-GILEAD-2020-0502183,GILEAD,,60.0,YR,A,M,Y,76.5,KG,20210122.0,,MD,US,US,2021,Q1,Adult
184879632,18487963,33,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,7 U,,,,,,,,,,INJECTION,,2021,Q1,Bacteraemia,,2021,Q1,2,F,20170824.0,20210305.0,20201111,20210309,EXP,,US-JNJFOC-20170910422,JOHNSON AND JOHNSON,,69.0,YR,E,M,Y,,,20210309.0,,MD,US,US,2021,Q1,Elderly
184879632,18487963,33,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,7 U,,,,,,,,,,INJECTION,,2021,Q1,Gastrointestinal haemorrhage,,2021,Q1,2,F,20170824.0,20210305.0,20201111,20210309,EXP,,US-JNJFOC-20170910422,JOHNSON AND JOHNSON,,69.0,YR,E,M,Y,,,20210309.0,,MD,US,US,2021,Q1,Elderly
184879632,18487963,33,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,7 U,,,,,,,,,,INJECTION,,2021,Q1,Multiple organ dysfunction syndrome,,2021,Q1,2,F,20170824.0,20210305.0,20201111,20210309,EXP,,US-JNJFOC-20170910422,JOHNSON AND JOHNSON,,69.0,YR,E,M,Y,,,20210309.0,,MD,US,US,2021,Q1,Elderly
184917662,18491766,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U, UNKNOWN,,,,,,,2021,Q1,Acute kidney injury,,2021,Q1,2,F,2018.0,20200624.0,20201111,20210131,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20210131.0,,CN,US,US,2021,Q1,Adult
184917662,18491766,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U, UNKNOWN,,,,,,,2021,Q1,Anxiety,,2021,Q1,2,F,2018.0,20200624.0,20201111,20210131,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20210131.0,,CN,US,US,2021,Q1,Adult
184917662,18491766,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U, UNKNOWN,,,,,,,2021,Q1,Asthenia,,2021,Q1,2,F,2018.0,20200624.0,20201111,20210131,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20210131.0,,CN,US,US,2021,Q1,Adult
184917662,18491766,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U, UNKNOWN,,,,,,,2021,Q1,Cardiac arrest,,2021,Q1,2,F,2018.0,20200624.0,20201111,20210131,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20210131.0,,CN,US,US,2021,Q1,Adult
184917662,18491766,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U, UNKNOWN,,,,,,,2021,Q1,Cardiac disorder,,2021,Q1,2,F,2018.0,20200624.0,20201111,20210131,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20210131.0,,CN,US,US,2021,Q1,Adult
184917662,18491766,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U, UNKNOWN,,,,,,,2021,Q1,Cardiac operation,,2021,Q1,2,F,2018.0,20200624.0,20201111,20210131,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20210131.0,,CN,US,US,2021,Q1,Adult
184917662,18491766,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U, UNKNOWN,,,,,,,2021,Q1,Constipation,,2021,Q1,2,F,2018.0,20200624.0,20201111,20210131,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20210131.0,,CN,US,US,2021,Q1,Adult
184917662,18491766,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U, UNKNOWN,,,,,,,2021,Q1,Diabetes mellitus,,2021,Q1,2,F,2018.0,20200624.0,20201111,20210131,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20210131.0,,CN,US,US,2021,Q1,Adult
184917662,18491766,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U, UNKNOWN,,,,,,,2021,Q1,Dizziness,,2021,Q1,2,F,2018.0,20200624.0,20201111,20210131,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20210131.0,,CN,US,US,2021,Q1,Adult
184917662,18491766,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U, UNKNOWN,,,,,,,2021,Q1,Drug dependence,,2021,Q1,2,F,2018.0,20200624.0,20201111,20210131,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20210131.0,,CN,US,US,2021,Q1,Adult
184917662,18491766,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U, UNKNOWN,,,,,,,2021,Q1,End stage renal disease,,2021,Q1,2,F,2018.0,20200624.0,20201111,20210131,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20210131.0,,CN,US,US,2021,Q1,Adult
184917662,18491766,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U, UNKNOWN,,,,,,,2021,Q1,Fluid retention,,2021,Q1,2,F,2018.0,20200624.0,20201111,20210131,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20210131.0,,CN,US,US,2021,Q1,Adult
184917662,18491766,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U, UNKNOWN,,,,,,,2021,Q1,Immobile,,2021,Q1,2,F,2018.0,20200624.0,20201111,20210131,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20210131.0,,CN,US,US,2021,Q1,Adult
184917662,18491766,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U, UNKNOWN,,,,,,,2021,Q1,Insomnia,,2021,Q1,2,F,2018.0,20200624.0,20201111,20210131,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20210131.0,,CN,US,US,2021,Q1,Adult
184917662,18491766,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U, UNKNOWN,,,,,,,2021,Q1,Kidney transplant rejection,,2021,Q1,2,F,2018.0,20200624.0,20201111,20210131,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20210131.0,,CN,US,US,2021,Q1,Adult
184917662,18491766,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U, UNKNOWN,,,,,,,2021,Q1,Nausea,,2021,Q1,2,F,2018.0,20200624.0,20201111,20210131,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20210131.0,,CN,US,US,2021,Q1,Adult
184917662,18491766,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U, UNKNOWN,,,,,,,2021,Q1,Overdose,,2021,Q1,2,F,2018.0,20200624.0,20201111,20210131,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20210131.0,,CN,US,US,2021,Q1,Adult
184917662,18491766,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U, UNKNOWN,,,,,,,2021,Q1,Respiratory disorder,,2021,Q1,2,F,2018.0,20200624.0,20201111,20210131,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20210131.0,,CN,US,US,2021,Q1,Adult
184917662,18491766,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U, UNKNOWN,,,,,,,2021,Q1,Vomiting,,2021,Q1,2,F,2018.0,20200624.0,20201111,20210131,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20210131.0,,CN,US,US,2021,Q1,Adult
185151962,18515196,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q1,Inappropriate antidiuretic hormone secretion,,2021,Q1,2,F,20201102.0,20210126.0,20201118,20210203,EXP,,JP-009507513-2011JPN010507,MERCK,,71.0,YR,,M,Y,,,20210203.0,,PH,JP,JP,2021,Q1,Elderly
185375782,18537578,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,15.0,IU,,,2021,Q1,Serotonin syndrome,,2021,Q1,2,F,20180212.0,20210303.0,20201124,20210315,EXP,,US-DRREDDYS-USA/USA/20/0129193,DR REDDYS,"PANDYA D, TRAN M, VERDUZCO?GUTIERREZ M. CLINICAL RELEVANCE OF PHARMACOGENETICS IN SEROTONIN SYNDROME. CASE REPORTS IN PSYCHIATRY. 2020:ARTICLE NUMBER 8860434. DOI: 10.1155/2020/8860434.",74.0,YR,E,M,Y,75.0,KG,20210315.0,,PH,US,US,2021,Q1,Elderly
185375782,18537578,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,15.0,IU,,,2021,Q1,Toxicity to various agents,,2021,Q1,2,F,20180212.0,20210303.0,20201124,20210315,EXP,,US-DRREDDYS-USA/USA/20/0129193,DR REDDYS,"PANDYA D, TRAN M, VERDUZCO?GUTIERREZ M. CLINICAL RELEVANCE OF PHARMACOGENETICS IN SEROTONIN SYNDROME. CASE REPORTS IN PSYCHIATRY. 2020:ARTICLE NUMBER 8860434. DOI: 10.1155/2020/8860434.",74.0,YR,E,M,Y,75.0,KG,20210315.0,,PH,US,US,2021,Q1,Elderly
185402582,18540258,8,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,PER DAY,,,,,,,,9.0,IU,,,2021,Q1,Delirium,,2021,Q1,2,F,20201115.0,20210121.0,20201124,20210125,EXP,,CO-BAXTER-2020BAX023733,BAXTER,,80.0,YR,,F,Y,50.0,KG,20210125.0,,HP,CO,CO,2021,Q1,Elderly
185526694,18552669,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,INJECT 58 UNIT UNDER SKING EVERY MORNING,,,,,,,,58.0,IU,INJECTION,QD,2021,Q1,Chronic myelomonocytic leukaemia,,2021,Q1,4,F,202001.0,20210121.0,20201127,20210204,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-09308,LUPIN,,61.0,YR,,F,Y,66.5,KG,20210204.0,,HP,US,US,2021,Q1,Adult
185526694,18552669,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,INJECT 58 UNIT UNDER SKING EVERY MORNING,,,,,,,,58.0,IU,INJECTION,QD,2021,Q1,Thyroid mass,,2021,Q1,4,F,202001.0,20210121.0,20201127,20210204,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-09308,LUPIN,,61.0,YR,,F,Y,66.5,KG,20210204.0,,HP,US,US,2021,Q1,Adult
185594092,18559409,14,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,20.0,IU,UNKNOWN,,2021,Q1,Deep vein thrombosis,,2021,Q1,2,F,20201013.0,20210107.0,20201130,20210113,PER,,US-CELGENEUS-USA-20201107146,CELGENE,,86.0,YR,,F,Y,,,20210113.0,,MD,US,US,2021,Q1,Elderly
185726032,18572603,6,C,INSULIN GLARGINE;LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,,,,,,,,,,,,,,2021,Q1,Atypical pneumonia,,2021,Q1,2,F,20201115.0,20210128.0,20201202,20210204,EXP,,US-ELI_LILLY_AND_COMPANY-US202011010153,ELI LILLY AND CO,,58.0,YR,,M,Y,86.2,KG,20210204.0,,PH,US,US,2021,Q1,Adult
185726032,18572603,6,C,INSULIN GLARGINE;LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,,,,,,,,,,,,,,2021,Q1,COVID-19 pneumonia,,2021,Q1,2,F,20201115.0,20210128.0,20201202,20210204,EXP,,US-ELI_LILLY_AND_COMPANY-US202011010153,ELI LILLY AND CO,,58.0,YR,,M,Y,86.2,KG,20210204.0,,PH,US,US,2021,Q1,Adult
185726032,18572603,6,C,INSULIN GLARGINE;LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,,,,,,,,,,,,,,2021,Q1,Hypoxia,,2021,Q1,2,F,20201115.0,20210128.0,20201202,20210204,EXP,,US-ELI_LILLY_AND_COMPANY-US202011010153,ELI LILLY AND CO,,58.0,YR,,M,Y,86.2,KG,20210204.0,,PH,US,US,2021,Q1,Adult
185809852,18580985,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Fatigue,,2021,Q1,2,F,20200909.0,20201127.0,20201204,20210318,EXP,,SE-BAUSCH-BL-2020-035311,BAUSCH AND LOMB,,61.0,YR,,M,Y,101.0,KG,20210318.0,,MD,SE,SE,2021,Q1,Adult
185809852,18580985,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Hypotension,,2021,Q1,2,F,20200909.0,20201127.0,20201204,20210318,EXP,,SE-BAUSCH-BL-2020-035311,BAUSCH AND LOMB,,61.0,YR,,M,Y,101.0,KG,20210318.0,,MD,SE,SE,2021,Q1,Adult
185858852,18585885,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 INTERNATIONAL UNIT, UNKNOWN",,,,, OF662A,,,24.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Blood glucose fluctuation,,2021,Q1,2,F,,20210311.0,20201207,20210323,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20210323.0,,CN,ES,ES,2021,Q1,Elderly
185858852,18585885,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 INTERNATIONAL UNIT, UNKNOWN",,,,, OF662A,,,24.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Dizziness,,2021,Q1,2,F,,20210311.0,20201207,20210323,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20210323.0,,CN,ES,ES,2021,Q1,Elderly
185858852,18585885,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 INTERNATIONAL UNIT, UNKNOWN",,,,, OF662A,,,24.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Hyperglycaemia,,2021,Q1,2,F,,20210311.0,20201207,20210323,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20210323.0,,CN,ES,ES,2021,Q1,Elderly
185858852,18585885,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 INTERNATIONAL UNIT, UNKNOWN",,,,, OF662A,,,24.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Hypoglycaemia,,2021,Q1,2,F,,20210311.0,20201207,20210323,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20210323.0,,CN,ES,ES,2021,Q1,Elderly
185858852,18585885,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 INTERNATIONAL UNIT, UNKNOWN",,,,, OF662A,,,24.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Malaise,,2021,Q1,2,F,,20210311.0,20201207,20210323,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20210323.0,,CN,ES,ES,2021,Q1,Elderly
185858852,18585885,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 INTERNATIONAL UNIT, UNKNOWN",,,,, OF662A,,,24.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Pancreatic disorder,,2021,Q1,2,F,,20210311.0,20201207,20210323,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20210323.0,,CN,ES,ES,2021,Q1,Elderly
185858852,18585885,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 INTERNATIONAL UNIT, UNKNOWN",,,,, OF662A,,,24.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Postprandial hypoglycaemia,,2021,Q1,2,F,,20210311.0,20201207,20210323,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20210323.0,,CN,ES,ES,2021,Q1,Elderly
185858852,18585885,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 INTERNATIONAL UNIT, UNKNOWN",,,,, OF662A,,,25.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Blood glucose fluctuation,,2021,Q1,2,F,,20210311.0,20201207,20210323,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20210323.0,,CN,ES,ES,2021,Q1,Elderly
185858852,18585885,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 INTERNATIONAL UNIT, UNKNOWN",,,,, OF662A,,,25.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Dizziness,,2021,Q1,2,F,,20210311.0,20201207,20210323,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20210323.0,,CN,ES,ES,2021,Q1,Elderly
185858852,18585885,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 INTERNATIONAL UNIT, UNKNOWN",,,,, OF662A,,,25.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Hyperglycaemia,,2021,Q1,2,F,,20210311.0,20201207,20210323,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20210323.0,,CN,ES,ES,2021,Q1,Elderly
185858852,18585885,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 INTERNATIONAL UNIT, UNKNOWN",,,,, OF662A,,,25.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Hypoglycaemia,,2021,Q1,2,F,,20210311.0,20201207,20210323,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20210323.0,,CN,ES,ES,2021,Q1,Elderly
185858852,18585885,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 INTERNATIONAL UNIT, UNKNOWN",,,,, OF662A,,,25.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Malaise,,2021,Q1,2,F,,20210311.0,20201207,20210323,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20210323.0,,CN,ES,ES,2021,Q1,Elderly
185858852,18585885,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 INTERNATIONAL UNIT, UNKNOWN",,,,, OF662A,,,25.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Pancreatic disorder,,2021,Q1,2,F,,20210311.0,20201207,20210323,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20210323.0,,CN,ES,ES,2021,Q1,Elderly
185858852,18585885,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 INTERNATIONAL UNIT, UNKNOWN",,,,, OF662A,,,25.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Postprandial hypoglycaemia,,2021,Q1,2,F,,20210311.0,20201207,20210323,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20210323.0,,CN,ES,ES,2021,Q1,Elderly
185927402,18592740,10,C,Insulin?glargine,INSULIN NOS,1,Unknown,THE MAN RECEIVED 15 UNIT OF INSULIN?GLARGINE,,,U,,,,,,,,,2021,Q1,Serotonin syndrome,,2021,Q1,2,F,20180212.0,20201230.0,20201208,20210109,EXP,,US-TEVA-2020-US-1856262,TEVA,"PANDYA D, TRAN M, VERDUZCO?GUTIERREZ M. CLINICAL RELEVANCE OF PHARMACOGENETICS IN SEROTONIN SYNDROME. CASE?REP?PSYCHIATRY 2020?:.",74.0,YR,E,M,Y,75.0,KG,20210109.0,,HP,US,US,2021,Q1,Elderly
185959645,18595964,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q1,Bacteraemia,,2021,Q1,5,F,20200406.0,20210119.0,20201209,20210122,EXP,,ES-CELGENEUS-ESP-20201104636,CELGENE,,69.0,YR,,M,Y,,,20210122.0,,HP,ES,ES,2021,Q1,Elderly
185959645,18595964,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q1,Escherichia bacteraemia,,2021,Q1,5,F,20200406.0,20210119.0,20201209,20210122,EXP,,ES-CELGENEUS-ESP-20201104636,CELGENE,,69.0,YR,,M,Y,,,20210122.0,,HP,ES,ES,2021,Q1,Elderly
185959645,18595964,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q1,Klebsiella infection,,2021,Q1,5,F,20200406.0,20210119.0,20201209,20210122,EXP,,ES-CELGENEUS-ESP-20201104636,CELGENE,,69.0,YR,,M,Y,,,20210122.0,,HP,ES,ES,2021,Q1,Elderly
186001082,18600108,9,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,INCONNUE,,,,,,,,,,,,2021,Q1,Drug reaction with eosinophilia and systemic symptoms,,2021,Q1,2,F,20200808.0,20210301.0,20201210,20210312,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-102061,BRISTOL MYERS SQUIBB,,79.0,YR,,F,Y,72.0,KG,20210312.0,,MD,FR,FR,2021,Q1,Elderly
186001082,18600108,9,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,INCONNUE,,,,,,,,,,,,2021,Q1,Eosinophilia,,2021,Q1,2,F,20200808.0,20210301.0,20201210,20210312,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-102061,BRISTOL MYERS SQUIBB,,79.0,YR,,F,Y,72.0,KG,20210312.0,,MD,FR,FR,2021,Q1,Elderly
186001082,18600108,9,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,INCONNUE,,,,,,,,,,,,2021,Q1,Hepatocellular injury,,2021,Q1,2,F,20200808.0,20210301.0,20201210,20210312,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-102061,BRISTOL MYERS SQUIBB,,79.0,YR,,F,Y,72.0,KG,20210312.0,,MD,FR,FR,2021,Q1,Elderly
186001082,18600108,9,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,INCONNUE,,,,,,,,,,,,2021,Q1,Hypercreatininaemia,,2021,Q1,2,F,20200808.0,20210301.0,20201210,20210312,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-102061,BRISTOL MYERS SQUIBB,,79.0,YR,,F,Y,72.0,KG,20210312.0,,MD,FR,FR,2021,Q1,Elderly
186001082,18600108,9,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,INCONNUE,,,,,,,,,,,,2021,Q1,Rash maculo-papular,,2021,Q1,2,F,20200808.0,20210301.0,20201210,20210312,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-102061,BRISTOL MYERS SQUIBB,,79.0,YR,,F,Y,72.0,KG,20210312.0,,MD,FR,FR,2021,Q1,Elderly
186118462,18611846,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,15 UNK,,,,,,,,,,,,2021,Q1,Cardiac failure congestive,,2021,Q1,2,F,20201027.0,20210114.0,20201214,20210120,PER,,US-AMGEN-USACT2020200392,AMGEN,,60.0,YR,A,M,Y,106.12,KG,20210120.0,,MD,US,US,2021,Q1,Adult
186300144,18630014,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),,,,,,,,,,,,,2021,Q1,Hepatic cancer metastatic,,2021,Q1,4,F,20200217.0,20201222.0,20201217,20210210,EXP,,CN-GILEAD-2020-0509496,GILEAD,,61.0,YR,A,M,Y,52.0,KG,20210210.0,,HP,CN,CN,2021,Q1,Adult
186324724,18632472,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,14 INTERNATIONAL UNIT,,,,, OF731A,,,14.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Abdominal discomfort,,2021,Q1,4,F,2020.0,20210215.0,20201218,20210217,EXP,,ES-AUROBINDO-AUR-APL-2020-061623,AUROBINDO,,53.0,YR,,F,Y,55.0,KG,20210217.0,,CN,ES,ES,2021,Q1,Adult
186324724,18632472,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,14 INTERNATIONAL UNIT,,,,, OF731A,,,14.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Anxiety,,2021,Q1,4,F,2020.0,20210215.0,20201218,20210217,EXP,,ES-AUROBINDO-AUR-APL-2020-061623,AUROBINDO,,53.0,YR,,F,Y,55.0,KG,20210217.0,,CN,ES,ES,2021,Q1,Adult
186324724,18632472,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,14 INTERNATIONAL UNIT,,,,, OF731A,,,14.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,4,F,2020.0,20210215.0,20201218,20210217,EXP,,ES-AUROBINDO-AUR-APL-2020-061623,AUROBINDO,,53.0,YR,,F,Y,55.0,KG,20210217.0,,CN,ES,ES,2021,Q1,Adult
186324724,18632472,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,14 INTERNATIONAL UNIT,,,,, OF731A,,,14.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Diet noncompliance,,2021,Q1,4,F,2020.0,20210215.0,20201218,20210217,EXP,,ES-AUROBINDO-AUR-APL-2020-061623,AUROBINDO,,53.0,YR,,F,Y,55.0,KG,20210217.0,,CN,ES,ES,2021,Q1,Adult
186324724,18632472,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,14 INTERNATIONAL UNIT,,,,, OF731A,,,14.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Dizziness,,2021,Q1,4,F,2020.0,20210215.0,20201218,20210217,EXP,,ES-AUROBINDO-AUR-APL-2020-061623,AUROBINDO,,53.0,YR,,F,Y,55.0,KG,20210217.0,,CN,ES,ES,2021,Q1,Adult
186324724,18632472,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,DOSE INCREASED,,,,, OF731A,,,,,SOLUTION FOR INJECTION,,2021,Q1,Abdominal discomfort,,2021,Q1,4,F,2020.0,20210215.0,20201218,20210217,EXP,,ES-AUROBINDO-AUR-APL-2020-061623,AUROBINDO,,53.0,YR,,F,Y,55.0,KG,20210217.0,,CN,ES,ES,2021,Q1,Adult
186324724,18632472,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,DOSE INCREASED,,,,, OF731A,,,,,SOLUTION FOR INJECTION,,2021,Q1,Anxiety,,2021,Q1,4,F,2020.0,20210215.0,20201218,20210217,EXP,,ES-AUROBINDO-AUR-APL-2020-061623,AUROBINDO,,53.0,YR,,F,Y,55.0,KG,20210217.0,,CN,ES,ES,2021,Q1,Adult
186324724,18632472,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,DOSE INCREASED,,,,, OF731A,,,,,SOLUTION FOR INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,4,F,2020.0,20210215.0,20201218,20210217,EXP,,ES-AUROBINDO-AUR-APL-2020-061623,AUROBINDO,,53.0,YR,,F,Y,55.0,KG,20210217.0,,CN,ES,ES,2021,Q1,Adult
186324724,18632472,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,DOSE INCREASED,,,,, OF731A,,,,,SOLUTION FOR INJECTION,,2021,Q1,Diet noncompliance,,2021,Q1,4,F,2020.0,20210215.0,20201218,20210217,EXP,,ES-AUROBINDO-AUR-APL-2020-061623,AUROBINDO,,53.0,YR,,F,Y,55.0,KG,20210217.0,,CN,ES,ES,2021,Q1,Adult
186324724,18632472,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,DOSE INCREASED,,,,, OF731A,,,,,SOLUTION FOR INJECTION,,2021,Q1,Dizziness,,2021,Q1,4,F,2020.0,20210215.0,20201218,20210217,EXP,,ES-AUROBINDO-AUR-APL-2020-061623,AUROBINDO,,53.0,YR,,F,Y,55.0,KG,20210217.0,,CN,ES,ES,2021,Q1,Adult
186415352,18641535,9,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Blood glucose abnormal,,2021,Q1,2,F,20200213.0,20210125.0,20201221,20210206,EXP,,US-INTERCEPT-PM2020002566,INTERCEPT PHARMACEUTICALS,,35.0,YR,,F,Y,,,20210206.0,,HP,US,US,2021,Q1,Adult
186415352,18641535,9,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Death,,2021,Q1,2,F,20200213.0,20210125.0,20201221,20210206,EXP,,US-INTERCEPT-PM2020002566,INTERCEPT PHARMACEUTICALS,,35.0,YR,,F,Y,,,20210206.0,,HP,US,US,2021,Q1,Adult
186415352,18641535,9,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Diabetes mellitus inadequate control,,2021,Q1,2,F,20200213.0,20210125.0,20201221,20210206,EXP,,US-INTERCEPT-PM2020002566,INTERCEPT PHARMACEUTICALS,,35.0,YR,,F,Y,,,20210206.0,,HP,US,US,2021,Q1,Adult
186415352,18641535,9,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Ketoacidosis,,2021,Q1,2,F,20200213.0,20210125.0,20201221,20210206,EXP,,US-INTERCEPT-PM2020002566,INTERCEPT PHARMACEUTICALS,,35.0,YR,,F,Y,,,20210206.0,,HP,US,US,2021,Q1,Adult
186531363,18653136,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSAGE IS UNCERTAIN.,,,,,,,,,,,,2021,Q1,Agranulocytosis,,2021,Q1,3,F,20200402.0,20210113.0,20201222,20210118,EXP,,JP-ROCHE-2618085,ROCHE,,79.0,YR,,F,Y,60.0,KG,20210118.0,,MD,JP,JP,2021,Q1,Elderly
186531363,18653136,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSAGE IS UNCERTAIN.,,,,,,,,,,,,2021,Q1,Dyspnoea,,2021,Q1,3,F,20200402.0,20210113.0,20201222,20210118,EXP,,JP-ROCHE-2618085,ROCHE,,79.0,YR,,F,Y,60.0,KG,20210118.0,,MD,JP,JP,2021,Q1,Elderly
186531363,18653136,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSAGE IS UNCERTAIN.,,,,,,,,,,,,2021,Q1,Febrile neutropenia,,2021,Q1,3,F,20200402.0,20210113.0,20201222,20210118,EXP,,JP-ROCHE-2618085,ROCHE,,79.0,YR,,F,Y,60.0,KG,20210118.0,,MD,JP,JP,2021,Q1,Elderly
186531363,18653136,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSAGE IS UNCERTAIN.,,,,,,,,,,,,2021,Q1,Neutrophil count decreased,,2021,Q1,3,F,20200402.0,20210113.0,20201222,20210118,EXP,,JP-ROCHE-2618085,ROCHE,,79.0,YR,,F,Y,60.0,KG,20210118.0,,MD,JP,JP,2021,Q1,Elderly
186544784,18654478,5,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,,TOTAL DAILY DOSE: 12 U,,,,,,,,,,INJECTION,,2021,Q1,Vomiting,,2021,Q1,4,F,20201105.0,20210111.0,20201223,20210121,EXP,,CN-ROCHE-2722963,ROCHE,,61.0,YR,,M,Y,74.0,KG,20210121.0,,MD,CN,CN,2021,Q1,Adult
186586903,18658690,17,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,100 UNITS/ML CRTG 25 UNITS TWICE A DAY,,,,,,,,,,,,2021,Q1,End stage renal disease,,2021,Q1,3,F,20210116.0,20210302.0,20201223,20210311,PER,,US-NEUROCRINE BIOSCIENCES INC.-2020NBI04588,NEUROCRINE BIOSCIENCES,,67.0,YR,E,F,Y,107.14,KG,20210311.0,,MD,US,US,2021,Q1,Elderly
186586903,18658690,17,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,100 UNITS/ML CRTG 25 UNITS TWICE A DAY,,,,,,,,,,,,2021,Q1,Upper respiratory tract infection,,2021,Q1,3,F,20210116.0,20210302.0,20201223,20210311,PER,,US-NEUROCRINE BIOSCIENCES INC.-2020NBI04588,NEUROCRINE BIOSCIENCES,,67.0,YR,E,F,Y,107.14,KG,20210311.0,,MD,US,US,2021,Q1,Elderly
186644412,18664441,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,BASAL?BOLUS,,,,,,,,,,,,2021,Q1,Haemolysis,,2021,Q1,2,F,,20210201.0,20201225,20210212,EXP,,QA-LUPIN PHARMACEUTICALS INC.-2020-10778,LUPIN,,64.0,YR,,M,Y,,,20210212.0,,HP,QA,QA,2021,Q1,Adult
186644412,18664441,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,BASAL?BOLUS,,,,,,,,,,,,2021,Q1,Normochromic normocytic anaemia,,2021,Q1,2,F,,20210201.0,20201225,20210212,EXP,,QA-LUPIN PHARMACEUTICALS INC.-2020-10778,LUPIN,,64.0,YR,,M,Y,,,20210212.0,,HP,QA,QA,2021,Q1,Adult
186644412,18664441,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,BASAL?BOLUS,,,,,,,,,,,,2021,Q1,Off label use,,2021,Q1,2,F,,20210201.0,20201225,20210212,EXP,,QA-LUPIN PHARMACEUTICALS INC.-2020-10778,LUPIN,,64.0,YR,,M,Y,,,20210212.0,,HP,QA,QA,2021,Q1,Adult
186671922,18667192,12,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,INJECT 20 UNITS DAILY WITH LUNCH,,,,,,,,,,INJECTION,QD,2021,Q1,Akathisia,,2021,Q1,2,F,20201008.0,20210129.0,20201228,20210212,PER,,US-NEUROCRINE BIOSCIENCES INC.-2020NBI04651,NEUROCRINE BIOSCIENCES,,51.0,YR,A,F,Y,,,20210212.0,,HP,US,US,2021,Q1,Adult
186671922,18667192,12,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,INJECT 20 UNITS DAILY WITH LUNCH,,,,,,,,,,INJECTION,QD,2021,Q1,Angioedema,,2021,Q1,2,F,20201008.0,20210129.0,20201228,20210212,PER,,US-NEUROCRINE BIOSCIENCES INC.-2020NBI04651,NEUROCRINE BIOSCIENCES,,51.0,YR,A,F,Y,,,20210212.0,,HP,US,US,2021,Q1,Adult
186671922,18667192,12,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,INJECT 20 UNITS DAILY WITH LUNCH,,,,,,,,,,INJECTION,QD,2021,Q1,Anxiety,,2021,Q1,2,F,20201008.0,20210129.0,20201228,20210212,PER,,US-NEUROCRINE BIOSCIENCES INC.-2020NBI04651,NEUROCRINE BIOSCIENCES,,51.0,YR,A,F,Y,,,20210212.0,,HP,US,US,2021,Q1,Adult
186671922,18667192,12,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,INJECT 20 UNITS DAILY WITH LUNCH,,,,,,,,,,INJECTION,QD,2021,Q1,Delusion,,2021,Q1,2,F,20201008.0,20210129.0,20201228,20210212,PER,,US-NEUROCRINE BIOSCIENCES INC.-2020NBI04651,NEUROCRINE BIOSCIENCES,,51.0,YR,A,F,Y,,,20210212.0,,HP,US,US,2021,Q1,Adult
186671922,18667192,12,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,INJECT 20 UNITS DAILY WITH LUNCH,,,,,,,,,,INJECTION,QD,2021,Q1,Depression,,2021,Q1,2,F,20201008.0,20210129.0,20201228,20210212,PER,,US-NEUROCRINE BIOSCIENCES INC.-2020NBI04651,NEUROCRINE BIOSCIENCES,,51.0,YR,A,F,Y,,,20210212.0,,HP,US,US,2021,Q1,Adult
186671922,18667192,12,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,INJECT 20 UNITS DAILY WITH LUNCH,,,,,,,,,,INJECTION,QD,2021,Q1,Dyspepsia,,2021,Q1,2,F,20201008.0,20210129.0,20201228,20210212,PER,,US-NEUROCRINE BIOSCIENCES INC.-2020NBI04651,NEUROCRINE BIOSCIENCES,,51.0,YR,A,F,Y,,,20210212.0,,HP,US,US,2021,Q1,Adult
186671922,18667192,12,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,INJECT 20 UNITS DAILY WITH LUNCH,,,,,,,,,,INJECTION,QD,2021,Q1,Tremor,,2021,Q1,2,F,20201008.0,20210129.0,20201228,20210212,PER,,US-NEUROCRINE BIOSCIENCES INC.-2020NBI04651,NEUROCRINE BIOSCIENCES,,51.0,YR,A,F,Y,,,20210212.0,,HP,US,US,2021,Q1,Adult
186709322,18670932,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,THERAPY START DATE: 2019,,,,,,,,,,,,2021,Q1,Diabetes mellitus inadequate control,,2021,Q1,2,F,2014.0,20201225.0,20201228,20210104,EXP,,RU-EMD SERONO-9207546,EMD SERONO INC,"KHAMNUEVA L, ANDREEVA L, DAVYDOVA A, CHUGUNOVA E, TOKAREVA N, MOLODTSOVA N. THE USE OF FIXED RATIO COMBINATION OF INSULIN GLARGINE AND LIXISENATIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN REAL CLINICAL PRACTICE. OWN CLINICAL EXPERIENCE. OWN CLINICAL EXPERIENCE. 2020 DEC?27(12):107?111. DOI:HTTPS://DX.DOI.ORG/10.18565/PHARMATECA.2020.12.107?111",72.0,YR,E,M,Y,87.0,KG,20210104.0,,MD,RU,RU,2021,Q1,Elderly
186709322,18670932,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,DOSE REDUCED?THERAPY START DATE: MAR 2020,,,,,,,,,,,,2021,Q1,Diabetes mellitus inadequate control,,2021,Q1,2,F,2014.0,20201225.0,20201228,20210104,EXP,,RU-EMD SERONO-9207546,EMD SERONO INC,"KHAMNUEVA L, ANDREEVA L, DAVYDOVA A, CHUGUNOVA E, TOKAREVA N, MOLODTSOVA N. THE USE OF FIXED RATIO COMBINATION OF INSULIN GLARGINE AND LIXISENATIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN REAL CLINICAL PRACTICE. OWN CLINICAL EXPERIENCE. OWN CLINICAL EXPERIENCE. 2020 DEC?27(12):107?111. DOI:HTTPS://DX.DOI.ORG/10.18565/PHARMATECA.2020.12.107?111",72.0,YR,E,M,Y,87.0,KG,20210104.0,,MD,RU,RU,2021,Q1,Elderly
186730602,18673060,5,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Myocardial infarction,,2021,Q1,2,F,20201224.0,20210115.0,20201228,20210125,EXP,,US-EXELIXIS-XL18420036262,EXELIXIS,,79.0,YR,,M,Y,79.0,KG,20210125.0,,MD,US,US,2021,Q1,Elderly
186752412,18675241,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Myocardial infarction,,2021,Q1,2,F,20201224.0,20210125.0,20201229,20210127,EXP,,US-ROCHE-2741111,ROCHE,,79.0,YR,,M,Y,79.0,KG,20210127.0,,MD,US,US,2021,Q1,Elderly
186800892,18680089,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q1,Anaemia,,2021,Q1,2,F,,20210104.0,20201230,20210115,EXP,,US-DRREDDYS-USA/USA/20/0130485,DR REDDYS,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPLANT INFECTIOUS DISEASE. 2020?22(5):ARTICLE NUMBER E13305. DOI: 10.1111/TID.13305.",57.0,YR,A,M,Y,,,20210115.0,,MD,US,US,2021,Q1,Adult
186800892,18680089,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q1,Complications of transplanted kidney,,2021,Q1,2,F,,20210104.0,20201230,20210115,EXP,,US-DRREDDYS-USA/USA/20/0130485,DR REDDYS,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPLANT INFECTIOUS DISEASE. 2020?22(5):ARTICLE NUMBER E13305. DOI: 10.1111/TID.13305.",57.0,YR,A,M,Y,,,20210115.0,,MD,US,US,2021,Q1,Adult
186800892,18680089,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q1,Human ehrlichiosis,,2021,Q1,2,F,,20210104.0,20201230,20210115,EXP,,US-DRREDDYS-USA/USA/20/0130485,DR REDDYS,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPLANT INFECTIOUS DISEASE. 2020?22(5):ARTICLE NUMBER E13305. DOI: 10.1111/TID.13305.",57.0,YR,A,M,Y,,,20210115.0,,MD,US,US,2021,Q1,Adult
186800892,18680089,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q1,Inappropriate antidiuretic hormone secretion,,2021,Q1,2,F,,20210104.0,20201230,20210115,EXP,,US-DRREDDYS-USA/USA/20/0130485,DR REDDYS,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPLANT INFECTIOUS DISEASE. 2020?22(5):ARTICLE NUMBER E13305. DOI: 10.1111/TID.13305.",57.0,YR,A,M,Y,,,20210115.0,,MD,US,US,2021,Q1,Adult
186800892,18680089,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q1,Leukopenia,,2021,Q1,2,F,,20210104.0,20201230,20210115,EXP,,US-DRREDDYS-USA/USA/20/0130485,DR REDDYS,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPLANT INFECTIOUS DISEASE. 2020?22(5):ARTICLE NUMBER E13305. DOI: 10.1111/TID.13305.",57.0,YR,A,M,Y,,,20210115.0,,MD,US,US,2021,Q1,Adult
186800892,18680089,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q1,Renal impairment,,2021,Q1,2,F,,20210104.0,20201230,20210115,EXP,,US-DRREDDYS-USA/USA/20/0130485,DR REDDYS,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPLANT INFECTIOUS DISEASE. 2020?22(5):ARTICLE NUMBER E13305. DOI: 10.1111/TID.13305.",57.0,YR,A,M,Y,,,20210115.0,,MD,US,US,2021,Q1,Adult
186800892,18680089,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q1,Renal tubular necrosis,,2021,Q1,2,F,,20210104.0,20201230,20210115,EXP,,US-DRREDDYS-USA/USA/20/0130485,DR REDDYS,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPLANT INFECTIOUS DISEASE. 2020?22(5):ARTICLE NUMBER E13305. DOI: 10.1111/TID.13305.",57.0,YR,A,M,Y,,,20210115.0,,MD,US,US,2021,Q1,Adult
186800892,18680089,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q1,Thrombocytopenia,,2021,Q1,2,F,,20210104.0,20201230,20210115,EXP,,US-DRREDDYS-USA/USA/20/0130485,DR REDDYS,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPLANT INFECTIOUS DISEASE. 2020?22(5):ARTICLE NUMBER E13305. DOI: 10.1111/TID.13305.",57.0,YR,A,M,Y,,,20210115.0,,MD,US,US,2021,Q1,Adult
186800892,18680089,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q1,Transaminases increased,,2021,Q1,2,F,,20210104.0,20201230,20210115,EXP,,US-DRREDDYS-USA/USA/20/0130485,DR REDDYS,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPLANT INFECTIOUS DISEASE. 2020?22(5):ARTICLE NUMBER E13305. DOI: 10.1111/TID.13305.",57.0,YR,A,M,Y,,,20210115.0,,MD,US,US,2021,Q1,Adult
186800892,18680089,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q1,Transplant rejection,,2021,Q1,2,F,,20210104.0,20201230,20210115,EXP,,US-DRREDDYS-USA/USA/20/0130485,DR REDDYS,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPLANT INFECTIOUS DISEASE. 2020?22(5):ARTICLE NUMBER E13305. DOI: 10.1111/TID.13305.",57.0,YR,A,M,Y,,,20210115.0,,MD,US,US,2021,Q1,Adult
186905461,18690546,8,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Condition aggravated,,2021,Q1,1,I,,20201221.0,20210101,20210101,EXP,,US-AUROBINDO-AUR-APL-2020-063099,AUROBINDO,,57.0,YR,,M,Y,,,20201229.0,,HP,US,US,2021,Q1,Adult
186905461,18690546,8,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Inappropriate antidiuretic hormone secretion,,2021,Q1,1,I,,20201221.0,20210101,20210101,EXP,,US-AUROBINDO-AUR-APL-2020-063099,AUROBINDO,,57.0,YR,,M,Y,,,20201229.0,,HP,US,US,2021,Q1,Adult
186910781,18691078,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Anaemia,,2021,Q1,1,I,,20201221.0,20210101,20210101,EXP,,US-ACCORD-212700,ACCORD,,57.0,YR,,M,Y,,,20210101.0,,MD,US,US,2021,Q1,Adult
186910781,18691078,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Complications of transplanted kidney,,2021,Q1,1,I,,20201221.0,20210101,20210101,EXP,,US-ACCORD-212700,ACCORD,,57.0,YR,,M,Y,,,20210101.0,,MD,US,US,2021,Q1,Adult
186910781,18691078,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Human ehrlichiosis,,2021,Q1,1,I,,20201221.0,20210101,20210101,EXP,,US-ACCORD-212700,ACCORD,,57.0,YR,,M,Y,,,20210101.0,,MD,US,US,2021,Q1,Adult
186910781,18691078,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Inappropriate antidiuretic hormone secretion,,2021,Q1,1,I,,20201221.0,20210101,20210101,EXP,,US-ACCORD-212700,ACCORD,,57.0,YR,,M,Y,,,20210101.0,,MD,US,US,2021,Q1,Adult
186910781,18691078,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Leukopenia,,2021,Q1,1,I,,20201221.0,20210101,20210101,EXP,,US-ACCORD-212700,ACCORD,,57.0,YR,,M,Y,,,20210101.0,,MD,US,US,2021,Q1,Adult
186910781,18691078,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Renal impairment,,2021,Q1,1,I,,20201221.0,20210101,20210101,EXP,,US-ACCORD-212700,ACCORD,,57.0,YR,,M,Y,,,20210101.0,,MD,US,US,2021,Q1,Adult
186910781,18691078,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Renal tubular necrosis,,2021,Q1,1,I,,20201221.0,20210101,20210101,EXP,,US-ACCORD-212700,ACCORD,,57.0,YR,,M,Y,,,20210101.0,,MD,US,US,2021,Q1,Adult
186910781,18691078,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Thrombocytopenia,,2021,Q1,1,I,,20201221.0,20210101,20210101,EXP,,US-ACCORD-212700,ACCORD,,57.0,YR,,M,Y,,,20210101.0,,MD,US,US,2021,Q1,Adult
186910781,18691078,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Transaminases increased,,2021,Q1,1,I,,20201221.0,20210101,20210101,EXP,,US-ACCORD-212700,ACCORD,,57.0,YR,,M,Y,,,20210101.0,,MD,US,US,2021,Q1,Adult
186910781,18691078,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Transplant rejection,,2021,Q1,1,I,,20201221.0,20210101,20210101,EXP,,US-ACCORD-212700,ACCORD,,57.0,YR,,M,Y,,,20210101.0,,MD,US,US,2021,Q1,Adult
186911091,18691109,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNKNOWN,,,U,,,,,,,,,2021,Q1,Condition aggravated,,2021,Q1,1,I,,20201221.0,20210101,20210101,EXP,,US-TORRENT-00010597,TORRENT,,57.0,YR,A,M,Y,,,20210101.0,,MD,US,US,2021,Q1,Adult
186911091,18691109,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNKNOWN,,,U,,,,,,,,,2021,Q1,Inappropriate antidiuretic hormone secretion,,2021,Q1,1,I,,20201221.0,20210101,20210101,EXP,,US-TORRENT-00010597,TORRENT,,57.0,YR,A,M,Y,,,20210101.0,,MD,US,US,2021,Q1,Adult
186923731,18692373,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Anaemia,,2021,Q1,1,I,,20201221.0,20210103,20210103,EXP,,US-GLENMARK PHARMACEUTICALS-2020GMK051105,GLENMARK,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ.. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION.. TRANSPLANT INFECTIOUS DISEASE.. 2020?22 (5)",57.0,YR,,M,Y,,,20210103.0,,MD,US,US,2021,Q1,Adult
186923731,18692373,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Complications of transplanted kidney,,2021,Q1,1,I,,20201221.0,20210103,20210103,EXP,,US-GLENMARK PHARMACEUTICALS-2020GMK051105,GLENMARK,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ.. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION.. TRANSPLANT INFECTIOUS DISEASE.. 2020?22 (5)",57.0,YR,,M,Y,,,20210103.0,,MD,US,US,2021,Q1,Adult
186923731,18692373,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Human ehrlichiosis,,2021,Q1,1,I,,20201221.0,20210103,20210103,EXP,,US-GLENMARK PHARMACEUTICALS-2020GMK051105,GLENMARK,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ.. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION.. TRANSPLANT INFECTIOUS DISEASE.. 2020?22 (5)",57.0,YR,,M,Y,,,20210103.0,,MD,US,US,2021,Q1,Adult
186923731,18692373,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Inappropriate antidiuretic hormone secretion,,2021,Q1,1,I,,20201221.0,20210103,20210103,EXP,,US-GLENMARK PHARMACEUTICALS-2020GMK051105,GLENMARK,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ.. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION.. TRANSPLANT INFECTIOUS DISEASE.. 2020?22 (5)",57.0,YR,,M,Y,,,20210103.0,,MD,US,US,2021,Q1,Adult
186923731,18692373,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Leukopenia,,2021,Q1,1,I,,20201221.0,20210103,20210103,EXP,,US-GLENMARK PHARMACEUTICALS-2020GMK051105,GLENMARK,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ.. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION.. TRANSPLANT INFECTIOUS DISEASE.. 2020?22 (5)",57.0,YR,,M,Y,,,20210103.0,,MD,US,US,2021,Q1,Adult
186923731,18692373,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Renal impairment,,2021,Q1,1,I,,20201221.0,20210103,20210103,EXP,,US-GLENMARK PHARMACEUTICALS-2020GMK051105,GLENMARK,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ.. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION.. TRANSPLANT INFECTIOUS DISEASE.. 2020?22 (5)",57.0,YR,,M,Y,,,20210103.0,,MD,US,US,2021,Q1,Adult
186923731,18692373,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Renal tubular necrosis,,2021,Q1,1,I,,20201221.0,20210103,20210103,EXP,,US-GLENMARK PHARMACEUTICALS-2020GMK051105,GLENMARK,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ.. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION.. TRANSPLANT INFECTIOUS DISEASE.. 2020?22 (5)",57.0,YR,,M,Y,,,20210103.0,,MD,US,US,2021,Q1,Adult
186923731,18692373,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Thrombocytopenia,,2021,Q1,1,I,,20201221.0,20210103,20210103,EXP,,US-GLENMARK PHARMACEUTICALS-2020GMK051105,GLENMARK,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ.. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION.. TRANSPLANT INFECTIOUS DISEASE.. 2020?22 (5)",57.0,YR,,M,Y,,,20210103.0,,MD,US,US,2021,Q1,Adult
186923731,18692373,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Transaminases increased,,2021,Q1,1,I,,20201221.0,20210103,20210103,EXP,,US-GLENMARK PHARMACEUTICALS-2020GMK051105,GLENMARK,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ.. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION.. TRANSPLANT INFECTIOUS DISEASE.. 2020?22 (5)",57.0,YR,,M,Y,,,20210103.0,,MD,US,US,2021,Q1,Adult
186923731,18692373,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Transplant rejection,,2021,Q1,1,I,,20201221.0,20210103,20210103,EXP,,US-GLENMARK PHARMACEUTICALS-2020GMK051105,GLENMARK,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ.. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION.. TRANSPLANT INFECTIOUS DISEASE.. 2020?22 (5)",57.0,YR,,M,Y,,,20210103.0,,MD,US,US,2021,Q1,Adult
186983161,18698316,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,U,,,,,,,UNKNOWN,,2021,Q1,Condition aggravated,,2021,Q1,1,I,,20201221.0,20210105,20210105,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-52963,HIKMA,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPLANT INFECTIOUS DISEASE. 2020?22(5):ARTICLE NUMBER E13305. DOI: 10.1111/TID.13305.",57.0,YR,,M,Y,,,20210105.0,,,COUNTRY NOT SPECIFIED,US,2021,Q1,Adult
186983161,18698316,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,U,,,,,,,UNKNOWN,,2021,Q1,Inappropriate antidiuretic hormone secretion,,2021,Q1,1,I,,20201221.0,20210105,20210105,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-52963,HIKMA,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPLANT INFECTIOUS DISEASE. 2020?22(5):ARTICLE NUMBER E13305. DOI: 10.1111/TID.13305.",57.0,YR,,M,Y,,,20210105.0,,,COUNTRY NOT SPECIFIED,US,2021,Q1,Adult
186990721,18699072,6,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 UNITS, DAILY (AT NIGHT)",,,,,,,,,,,,2021,Q1,BRASH syndrome,,2021,Q1,1,I,,20201221.0,20210105,20210105,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-273952,RANBAXY,"ARIF AW, KHAN MS, MASRI A, MBA B, AYUB MT, DOUKKY R. BRASH SYNDROME WITH HYPERKALEMIA: AN UNDER?RECOGNIZED CLINICAL CONDITION. METHODIST DEBAKEY CARDIOVASC J. 2020?16(3):241?244",55.0,YR,,F,Y,,,20210105.0,,MD,US,US,2021,Q1,Adult
187003651,18700365,13,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,,,,,, UNKNOWN,,,,,,,2021,Q1,Agranulocytosis,,2021,Q1,1,I,20200212.0,20210105.0,20210105,20210105,EXP,FR-AFSSAPS-LM20200784,FR-ROCHE-2743885,ROCHE,,70.0,YR,,M,Y,80.0,KG,20210105.0,,MD,FR,FR,2021,Q1,Elderly
187003651,18700365,13,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,,,,,, UNKNOWN,,,,,,,2021,Q1,Neutropenia,,2021,Q1,1,I,20200212.0,20210105.0,20210105,20210105,EXP,FR-AFSSAPS-LM20200784,FR-ROCHE-2743885,ROCHE,,70.0,YR,,M,Y,80.0,KG,20210105.0,,MD,FR,FR,2021,Q1,Elderly
187012441,18701244,13,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Alanine aminotransferase increased,,2021,Q1,1,I,20210105.0,,20210105,20210105,DIR,,,FDA-CTU,,61.0,YR,,M,N,57.6,KG,20210105.0,N,PH,US,US,2021,Q1,Adult
187012441,18701244,13,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Aspartate aminotransferase increased,,2021,Q1,1,I,20210105.0,,20210105,20210105,DIR,,,FDA-CTU,,61.0,YR,,M,N,57.6,KG,20210105.0,N,PH,US,US,2021,Q1,Adult
187012441,18701244,13,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Intentional product use issue,,2021,Q1,1,I,20210105.0,,20210105,20210105,DIR,,,FDA-CTU,,61.0,YR,,M,N,57.6,KG,20210105.0,N,PH,US,US,2021,Q1,Adult
187044622,18704462,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2021,Q1,Anaemia,,2021,Q1,2,F,,20210105.0,20210106,20210120,EXP,US-SA-2020SA138485,US-ALKEM LABORATORIES LIMITED-US-ALKEM-2020-09272,ALKEM,,57.0,YR,,M,Y,,,20210120.0,,HP,US,US,2021,Q1,Adult
187044622,18704462,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2021,Q1,Complications of transplanted kidney,,2021,Q1,2,F,,20210105.0,20210106,20210120,EXP,US-SA-2020SA138485,US-ALKEM LABORATORIES LIMITED-US-ALKEM-2020-09272,ALKEM,,57.0,YR,,M,Y,,,20210120.0,,HP,US,US,2021,Q1,Adult
187044622,18704462,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2021,Q1,Human ehrlichiosis,,2021,Q1,2,F,,20210105.0,20210106,20210120,EXP,US-SA-2020SA138485,US-ALKEM LABORATORIES LIMITED-US-ALKEM-2020-09272,ALKEM,,57.0,YR,,M,Y,,,20210120.0,,HP,US,US,2021,Q1,Adult
187044622,18704462,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2021,Q1,Inappropriate antidiuretic hormone secretion,,2021,Q1,2,F,,20210105.0,20210106,20210120,EXP,US-SA-2020SA138485,US-ALKEM LABORATORIES LIMITED-US-ALKEM-2020-09272,ALKEM,,57.0,YR,,M,Y,,,20210120.0,,HP,US,US,2021,Q1,Adult
187044622,18704462,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2021,Q1,Leukopenia,,2021,Q1,2,F,,20210105.0,20210106,20210120,EXP,US-SA-2020SA138485,US-ALKEM LABORATORIES LIMITED-US-ALKEM-2020-09272,ALKEM,,57.0,YR,,M,Y,,,20210120.0,,HP,US,US,2021,Q1,Adult
187044622,18704462,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2021,Q1,Renal impairment,,2021,Q1,2,F,,20210105.0,20210106,20210120,EXP,US-SA-2020SA138485,US-ALKEM LABORATORIES LIMITED-US-ALKEM-2020-09272,ALKEM,,57.0,YR,,M,Y,,,20210120.0,,HP,US,US,2021,Q1,Adult
187044622,18704462,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2021,Q1,Renal tubular necrosis,,2021,Q1,2,F,,20210105.0,20210106,20210120,EXP,US-SA-2020SA138485,US-ALKEM LABORATORIES LIMITED-US-ALKEM-2020-09272,ALKEM,,57.0,YR,,M,Y,,,20210120.0,,HP,US,US,2021,Q1,Adult
187044622,18704462,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2021,Q1,Thrombocytopenia,,2021,Q1,2,F,,20210105.0,20210106,20210120,EXP,US-SA-2020SA138485,US-ALKEM LABORATORIES LIMITED-US-ALKEM-2020-09272,ALKEM,,57.0,YR,,M,Y,,,20210120.0,,HP,US,US,2021,Q1,Adult
187044622,18704462,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2021,Q1,Transaminases increased,,2021,Q1,2,F,,20210105.0,20210106,20210120,EXP,US-SA-2020SA138485,US-ALKEM LABORATORIES LIMITED-US-ALKEM-2020-09272,ALKEM,,57.0,YR,,M,Y,,,20210120.0,,HP,US,US,2021,Q1,Adult
187044622,18704462,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2021,Q1,Transplant rejection,,2021,Q1,2,F,,20210105.0,20210106,20210120,EXP,US-SA-2020SA138485,US-ALKEM LABORATORIES LIMITED-US-ALKEM-2020-09272,ALKEM,,57.0,YR,,M,Y,,,20210120.0,,HP,US,US,2021,Q1,Adult
187055051,18705505,13,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Agranulocytosis,,2021,Q1,1,I,20200212.0,20201231.0,20210106,20210106,EXP,,FR-AUROBINDO-AUR-APL-2021-000192,AUROBINDO,,70.0,YR,,M,Y,80.0,KG,20210106.0,,MD,FR,FR,2021,Q1,Elderly
187055051,18705505,13,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Neutropenia,,2021,Q1,1,I,20200212.0,20201231.0,20210106,20210106,EXP,,FR-AUROBINDO-AUR-APL-2021-000192,AUROBINDO,,70.0,YR,,M,Y,80.0,KG,20210106.0,,MD,FR,FR,2021,Q1,Elderly
187070222,18707022,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IU, QD",,,U,,,,21081.0,40.0,IU,,QD,2021,Q1,Asthenia,,2021,Q1,2,F,,20201230.0,20210106,20210113,EXP,,CA-SA-2020SA376667,SANOFI AVENTIS,,57.0,YR,A,M,Y,,,20210113.0,,CN,CA,CA,2021,Q1,Adult
187070222,18707022,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IU, QD",,,U,,,,21081.0,40.0,IU,,QD,2021,Q1,Blood glucose decreased,,2021,Q1,2,F,,20201230.0,20210106,20210113,EXP,,CA-SA-2020SA376667,SANOFI AVENTIS,,57.0,YR,A,M,Y,,,20210113.0,,CN,CA,CA,2021,Q1,Adult
187070222,18707022,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IU, QD",,,U,,,,21081.0,40.0,IU,,QD,2021,Q1,Blood glucose increased,,2021,Q1,2,F,,20201230.0,20210106,20210113,EXP,,CA-SA-2020SA376667,SANOFI AVENTIS,,57.0,YR,A,M,Y,,,20210113.0,,CN,CA,CA,2021,Q1,Adult
187073031,18707303,35,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 U X ONCE,,,,,,,,,,UNKNOWN,,2021,Q1,Encephalopathy,,2021,Q1,1,I,20200830.0,20201231.0,20210106,20210106,EXP,,US-CELGENEUS-USA-20201209414,CELGENE,,67.0,YR,,M,Y,110.0,KG,20210106.0,,MD,US,US,2021,Q1,Elderly
187087291,18708729,7,SS,INSULIN GLARGINE (ER),INSULIN GLARGINE,1,Oral,INGESTION,,,D,,,,,,,,,2021,Q1,Completed suicide,,2021,Q1,1,I,,20201229.0,20210106,20210106,EXP,,US-BAUSCH-BL-2020-039527,BAUSCH AND LOMB,"GUMMIN D, MOWRY J, BEUHLER M, SPYKER D, BROOKS D, DIBERT K, RIVERS L, PHAM N, RYAN M. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2020 DEC 11?58(12):1360?1541. DOI:10.1080/15563650.2020.1834219",61.0,YR,,M,Y,,,20210106.0,,MD,US,US,2021,Q1,Adult
187087291,18708729,8,SS,INSULIN GLARGINE (ER),INSULIN GLARGINE,1,Parenteral,,,,D,,,,,,,,,2021,Q1,Completed suicide,,2021,Q1,1,I,,20201229.0,20210106,20210106,EXP,,US-BAUSCH-BL-2020-039527,BAUSCH AND LOMB,"GUMMIN D, MOWRY J, BEUHLER M, SPYKER D, BROOKS D, DIBERT K, RIVERS L, PHAM N, RYAN M. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2020 DEC 11?58(12):1360?1541. DOI:10.1080/15563650.2020.1834219",61.0,YR,,M,Y,,,20210106.0,,MD,US,US,2021,Q1,Adult
187123831,18712383,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UP TO 10 IU PER KG PER HOUR,,,D,,,,,,,INJECTION,,2021,Q1,Acidosis,,2021,Q1,1,I,,20201230.0,20210107,20210107,EXP,,US-MYLANLABS-2021M1000591,MYLAN,"RAJENDRAN PP, AWAN AA, MAKAWITA S, SHEIKH?HAMAD D. CALCIUM CHANNEL BLOCKER OVERDOSE REVISITED: FROM INSULIN TO METHYLENE BLUE. J?AM?SOC?NEPHROL 2018?29:1154.",53.0,YR,,M,Y,,,20210107.0,,HP,US,US,2021,Q1,Adult
187123831,18712383,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UP TO 10 IU PER KG PER HOUR,,,D,,,,,,,INJECTION,,2021,Q1,Acute kidney injury,,2021,Q1,1,I,,20201230.0,20210107,20210107,EXP,,US-MYLANLABS-2021M1000591,MYLAN,"RAJENDRAN PP, AWAN AA, MAKAWITA S, SHEIKH?HAMAD D. CALCIUM CHANNEL BLOCKER OVERDOSE REVISITED: FROM INSULIN TO METHYLENE BLUE. J?AM?SOC?NEPHROL 2018?29:1154.",53.0,YR,,M,Y,,,20210107.0,,HP,US,US,2021,Q1,Adult
187123831,18712383,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UP TO 10 IU PER KG PER HOUR,,,D,,,,,,,INJECTION,,2021,Q1,Drug ineffective,,2021,Q1,1,I,,20201230.0,20210107,20210107,EXP,,US-MYLANLABS-2021M1000591,MYLAN,"RAJENDRAN PP, AWAN AA, MAKAWITA S, SHEIKH?HAMAD D. CALCIUM CHANNEL BLOCKER OVERDOSE REVISITED: FROM INSULIN TO METHYLENE BLUE. J?AM?SOC?NEPHROL 2018?29:1154.",53.0,YR,,M,Y,,,20210107.0,,HP,US,US,2021,Q1,Adult
187123831,18712383,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UP TO 10 IU PER KG PER HOUR,,,D,,,,,,,INJECTION,,2021,Q1,Hypotension,,2021,Q1,1,I,,20201230.0,20210107,20210107,EXP,,US-MYLANLABS-2021M1000591,MYLAN,"RAJENDRAN PP, AWAN AA, MAKAWITA S, SHEIKH?HAMAD D. CALCIUM CHANNEL BLOCKER OVERDOSE REVISITED: FROM INSULIN TO METHYLENE BLUE. J?AM?SOC?NEPHROL 2018?29:1154.",53.0,YR,,M,Y,,,20210107.0,,HP,US,US,2021,Q1,Adult
187123831,18712383,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UP TO 10 IU PER KG PER HOUR,,,D,,,,,,,INJECTION,,2021,Q1,Hypoxia,,2021,Q1,1,I,,20201230.0,20210107,20210107,EXP,,US-MYLANLABS-2021M1000591,MYLAN,"RAJENDRAN PP, AWAN AA, MAKAWITA S, SHEIKH?HAMAD D. CALCIUM CHANNEL BLOCKER OVERDOSE REVISITED: FROM INSULIN TO METHYLENE BLUE. J?AM?SOC?NEPHROL 2018?29:1154.",53.0,YR,,M,Y,,,20210107.0,,HP,US,US,2021,Q1,Adult
187123831,18712383,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UP TO 10 IU PER KG PER HOUR,,,D,,,,,,,INJECTION,,2021,Q1,Oliguria,,2021,Q1,1,I,,20201230.0,20210107,20210107,EXP,,US-MYLANLABS-2021M1000591,MYLAN,"RAJENDRAN PP, AWAN AA, MAKAWITA S, SHEIKH?HAMAD D. CALCIUM CHANNEL BLOCKER OVERDOSE REVISITED: FROM INSULIN TO METHYLENE BLUE. J?AM?SOC?NEPHROL 2018?29:1154.",53.0,YR,,M,Y,,,20210107.0,,HP,US,US,2021,Q1,Adult
187123831,18712383,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UP TO 10 IU PER KG PER HOUR,,,D,,,,,,,INJECTION,,2021,Q1,Overdose,,2021,Q1,1,I,,20201230.0,20210107,20210107,EXP,,US-MYLANLABS-2021M1000591,MYLAN,"RAJENDRAN PP, AWAN AA, MAKAWITA S, SHEIKH?HAMAD D. CALCIUM CHANNEL BLOCKER OVERDOSE REVISITED: FROM INSULIN TO METHYLENE BLUE. J?AM?SOC?NEPHROL 2018?29:1154.",53.0,YR,,M,Y,,,20210107.0,,HP,US,US,2021,Q1,Adult
187123831,18712383,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UP TO 10 IU PER KG PER HOUR,,,D,,,,,,,INJECTION,,2021,Q1,Pulmonary oedema,,2021,Q1,1,I,,20201230.0,20210107,20210107,EXP,,US-MYLANLABS-2021M1000591,MYLAN,"RAJENDRAN PP, AWAN AA, MAKAWITA S, SHEIKH?HAMAD D. CALCIUM CHANNEL BLOCKER OVERDOSE REVISITED: FROM INSULIN TO METHYLENE BLUE. J?AM?SOC?NEPHROL 2018?29:1154.",53.0,YR,,M,Y,,,20210107.0,,HP,US,US,2021,Q1,Adult
187123831,18712383,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,1000 IU/HR,,,D,,,,,,,INJECTION,,2021,Q1,Acidosis,,2021,Q1,1,I,,20201230.0,20210107,20210107,EXP,,US-MYLANLABS-2021M1000591,MYLAN,"RAJENDRAN PP, AWAN AA, MAKAWITA S, SHEIKH?HAMAD D. CALCIUM CHANNEL BLOCKER OVERDOSE REVISITED: FROM INSULIN TO METHYLENE BLUE. J?AM?SOC?NEPHROL 2018?29:1154.",53.0,YR,,M,Y,,,20210107.0,,HP,US,US,2021,Q1,Adult
187123831,18712383,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,1000 IU/HR,,,D,,,,,,,INJECTION,,2021,Q1,Acute kidney injury,,2021,Q1,1,I,,20201230.0,20210107,20210107,EXP,,US-MYLANLABS-2021M1000591,MYLAN,"RAJENDRAN PP, AWAN AA, MAKAWITA S, SHEIKH?HAMAD D. CALCIUM CHANNEL BLOCKER OVERDOSE REVISITED: FROM INSULIN TO METHYLENE BLUE. J?AM?SOC?NEPHROL 2018?29:1154.",53.0,YR,,M,Y,,,20210107.0,,HP,US,US,2021,Q1,Adult
187123831,18712383,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,1000 IU/HR,,,D,,,,,,,INJECTION,,2021,Q1,Drug ineffective,,2021,Q1,1,I,,20201230.0,20210107,20210107,EXP,,US-MYLANLABS-2021M1000591,MYLAN,"RAJENDRAN PP, AWAN AA, MAKAWITA S, SHEIKH?HAMAD D. CALCIUM CHANNEL BLOCKER OVERDOSE REVISITED: FROM INSULIN TO METHYLENE BLUE. J?AM?SOC?NEPHROL 2018?29:1154.",53.0,YR,,M,Y,,,20210107.0,,HP,US,US,2021,Q1,Adult
187123831,18712383,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,1000 IU/HR,,,D,,,,,,,INJECTION,,2021,Q1,Hypotension,,2021,Q1,1,I,,20201230.0,20210107,20210107,EXP,,US-MYLANLABS-2021M1000591,MYLAN,"RAJENDRAN PP, AWAN AA, MAKAWITA S, SHEIKH?HAMAD D. CALCIUM CHANNEL BLOCKER OVERDOSE REVISITED: FROM INSULIN TO METHYLENE BLUE. J?AM?SOC?NEPHROL 2018?29:1154.",53.0,YR,,M,Y,,,20210107.0,,HP,US,US,2021,Q1,Adult
187123831,18712383,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,1000 IU/HR,,,D,,,,,,,INJECTION,,2021,Q1,Hypoxia,,2021,Q1,1,I,,20201230.0,20210107,20210107,EXP,,US-MYLANLABS-2021M1000591,MYLAN,"RAJENDRAN PP, AWAN AA, MAKAWITA S, SHEIKH?HAMAD D. CALCIUM CHANNEL BLOCKER OVERDOSE REVISITED: FROM INSULIN TO METHYLENE BLUE. J?AM?SOC?NEPHROL 2018?29:1154.",53.0,YR,,M,Y,,,20210107.0,,HP,US,US,2021,Q1,Adult
187123831,18712383,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,1000 IU/HR,,,D,,,,,,,INJECTION,,2021,Q1,Oliguria,,2021,Q1,1,I,,20201230.0,20210107,20210107,EXP,,US-MYLANLABS-2021M1000591,MYLAN,"RAJENDRAN PP, AWAN AA, MAKAWITA S, SHEIKH?HAMAD D. CALCIUM CHANNEL BLOCKER OVERDOSE REVISITED: FROM INSULIN TO METHYLENE BLUE. J?AM?SOC?NEPHROL 2018?29:1154.",53.0,YR,,M,Y,,,20210107.0,,HP,US,US,2021,Q1,Adult
187123831,18712383,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,1000 IU/HR,,,D,,,,,,,INJECTION,,2021,Q1,Overdose,,2021,Q1,1,I,,20201230.0,20210107,20210107,EXP,,US-MYLANLABS-2021M1000591,MYLAN,"RAJENDRAN PP, AWAN AA, MAKAWITA S, SHEIKH?HAMAD D. CALCIUM CHANNEL BLOCKER OVERDOSE REVISITED: FROM INSULIN TO METHYLENE BLUE. J?AM?SOC?NEPHROL 2018?29:1154.",53.0,YR,,M,Y,,,20210107.0,,HP,US,US,2021,Q1,Adult
187123831,18712383,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,1000 IU/HR,,,D,,,,,,,INJECTION,,2021,Q1,Pulmonary oedema,,2021,Q1,1,I,,20201230.0,20210107,20210107,EXP,,US-MYLANLABS-2021M1000591,MYLAN,"RAJENDRAN PP, AWAN AA, MAKAWITA S, SHEIKH?HAMAD D. CALCIUM CHANNEL BLOCKER OVERDOSE REVISITED: FROM INSULIN TO METHYLENE BLUE. J?AM?SOC?NEPHROL 2018?29:1154.",53.0,YR,,M,Y,,,20210107.0,,HP,US,US,2021,Q1,Adult
187133402,18713340,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 INTERNATIONAL UNIT, QD",,,,,,,,10.0,IU,,,2021,Q1,Lactic acidosis,,2021,Q1,2,F,,20210317.0,20210107,20210331,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK051508,GLENMARK,"CERVANTES CE, MENEZ S, MONROY?TRUJILLO JM, HANOUNEH M. CLINICAL APPROACH TO A PATIENT WITH AN ACID?BASE DISTURBANCE. AMERICAN JOURNAL OF KIDNEY DISEASES. 2021?77(2):A9?11",65.0,YR,,F,Y,,,20210331.0,,,COUNTRY NOT SPECIFIED,US,2021,Q1,Elderly
187133402,18713340,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 INTERNATIONAL UNIT, QD",,,,,,,,10.0,IU,,,2021,Q1,Metabolic acidosis,,2021,Q1,2,F,,20210317.0,20210107,20210331,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK051508,GLENMARK,"CERVANTES CE, MENEZ S, MONROY?TRUJILLO JM, HANOUNEH M. CLINICAL APPROACH TO A PATIENT WITH AN ACID?BASE DISTURBANCE. AMERICAN JOURNAL OF KIDNEY DISEASES. 2021?77(2):A9?11",65.0,YR,,F,Y,,,20210331.0,,,COUNTRY NOT SPECIFIED,US,2021,Q1,Elderly
187133402,18713340,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 INTERNATIONAL UNIT, QD",,,,,,,,10.0,IU,,,2021,Q1,Toxicity to various agents,,2021,Q1,2,F,,20210317.0,20210107,20210331,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK051508,GLENMARK,"CERVANTES CE, MENEZ S, MONROY?TRUJILLO JM, HANOUNEH M. CLINICAL APPROACH TO A PATIENT WITH AN ACID?BASE DISTURBANCE. AMERICAN JOURNAL OF KIDNEY DISEASES. 2021?77(2):A9?11",65.0,YR,,F,Y,,,20210331.0,,,COUNTRY NOT SPECIFIED,US,2021,Q1,Elderly
187138802,18713880,7,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,18 UNITS AT NIGHT,,,U,,,,,18.0,IU,,QD,2021,Q1,BRASH syndrome,,2021,Q1,2,F,,20210121.0,20210107,20210205,EXP,,US-TEVA-2020-US-1865189,TEVA,"ARIF AW, KHAN MS, MASRI A, MBA B, TALHA AYUB M, DOUKKY R. BRASH SYNDROME WITH HYPERKALEMIA: AN UNDER?RECOGNIZED CLINICAL CONDITION. METHODIST?DEBAKEY?CARDIOVASC?J 2020?16(3):241?244.",55.0,YR,A,F,Y,,,20210205.0,,MD,US,US,2021,Q1,Adult
187138802,18713880,7,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,18 UNITS AT NIGHT,,,U,,,,,18.0,IU,,QD,2021,Q1,End stage renal disease,,2021,Q1,2,F,,20210121.0,20210107,20210205,EXP,,US-TEVA-2020-US-1865189,TEVA,"ARIF AW, KHAN MS, MASRI A, MBA B, TALHA AYUB M, DOUKKY R. BRASH SYNDROME WITH HYPERKALEMIA: AN UNDER?RECOGNIZED CLINICAL CONDITION. METHODIST?DEBAKEY?CARDIOVASC?J 2020?16(3):241?244.",55.0,YR,A,F,Y,,,20210205.0,,MD,US,US,2021,Q1,Adult
187138802,18713880,7,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,18 UNITS AT NIGHT,,,U,,,,,18.0,IU,,QD,2021,Q1,Pleural effusion,,2021,Q1,2,F,,20210121.0,20210107,20210205,EXP,,US-TEVA-2020-US-1865189,TEVA,"ARIF AW, KHAN MS, MASRI A, MBA B, TALHA AYUB M, DOUKKY R. BRASH SYNDROME WITH HYPERKALEMIA: AN UNDER?RECOGNIZED CLINICAL CONDITION. METHODIST?DEBAKEY?CARDIOVASC?J 2020?16(3):241?244.",55.0,YR,A,F,Y,,,20210205.0,,MD,US,US,2021,Q1,Adult
187138802,18713880,7,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,18 UNITS AT NIGHT,,,U,,,,,18.0,IU,,QD,2021,Q1,Pulmonary congestion,,2021,Q1,2,F,,20210121.0,20210107,20210205,EXP,,US-TEVA-2020-US-1865189,TEVA,"ARIF AW, KHAN MS, MASRI A, MBA B, TALHA AYUB M, DOUKKY R. BRASH SYNDROME WITH HYPERKALEMIA: AN UNDER?RECOGNIZED CLINICAL CONDITION. METHODIST?DEBAKEY?CARDIOVASC?J 2020?16(3):241?244.",55.0,YR,A,F,Y,,,20210205.0,,MD,US,US,2021,Q1,Adult
187142513,18714251,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,D,N,,,,,,,,2021,Q1,Completed suicide,,2021,Q1,3,F,,20210118.0,20210107,20210120,EXP,,US-SA-2021SA004620,SANOFI AVENTIS,"GUMMIN DD. , MOWRY JB., BEUHLER MC., SPYKER DA., BROOKS DE., DIBERT KW. ET AL. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT.. CLINICAL TOXICOLOGY. 2020?58(12):1360?1541",61.0,YR,A,M,Y,,,20210120.0,,MD,US,US,2021,Q1,Adult
187142513,18714251,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,,,,D,N,,,,,,,,2021,Q1,Completed suicide,,2021,Q1,3,F,,20210118.0,20210107,20210120,EXP,,US-SA-2021SA004620,SANOFI AVENTIS,"GUMMIN DD. , MOWRY JB., BEUHLER MC., SPYKER DA., BROOKS DE., DIBERT KW. ET AL. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT.. CLINICAL TOXICOLOGY. 2020?58(12):1360?1541",61.0,YR,A,M,Y,,,20210120.0,,MD,US,US,2021,Q1,Adult
187146352,18714635,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"68 U, DAILY",,,,,,,,68.0,IU,,QD,2021,Q1,Acute kidney injury,,2021,Q1,2,F,20201226.0,20210128.0,20210107,20210203,EXP,,US-ELI_LILLY_AND_COMPANY-US202012013699,ELI LILLY AND CO,,59.0,YR,,M,Y,,,20210203.0,,PH,US,US,2021,Q1,Adult
187146352,18714635,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"68 U, DAILY",,,,,,,,68.0,IU,,QD,2021,Q1,COVID-19 pneumonia,,2021,Q1,2,F,20201226.0,20210128.0,20210107,20210203,EXP,,US-ELI_LILLY_AND_COMPANY-US202012013699,ELI LILLY AND CO,,59.0,YR,,M,Y,,,20210203.0,,PH,US,US,2021,Q1,Adult
187146352,18714635,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"68 U, DAILY",,,,,,,,68.0,IU,,QD,2021,Q1,Epistaxis,,2021,Q1,2,F,20201226.0,20210128.0,20210107,20210203,EXP,,US-ELI_LILLY_AND_COMPANY-US202012013699,ELI LILLY AND CO,,59.0,YR,,M,Y,,,20210203.0,,PH,US,US,2021,Q1,Adult
187146352,18714635,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"68 U, DAILY",,,,,,,,68.0,IU,,QD,2021,Q1,Haemoptysis,,2021,Q1,2,F,20201226.0,20210128.0,20210107,20210203,EXP,,US-ELI_LILLY_AND_COMPANY-US202012013699,ELI LILLY AND CO,,59.0,YR,,M,Y,,,20210203.0,,PH,US,US,2021,Q1,Adult
187146352,18714635,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"68 U, DAILY",,,,,,,,68.0,IU,,QD,2021,Q1,Orthostatic hypotension,,2021,Q1,2,F,20201226.0,20210128.0,20210107,20210203,EXP,,US-ELI_LILLY_AND_COMPANY-US202012013699,ELI LILLY AND CO,,59.0,YR,,M,Y,,,20210203.0,,PH,US,US,2021,Q1,Adult
187146352,18714635,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"68 U, DAILY",,,,,,,,68.0,IU,,QD,2021,Q1,Respiratory failure,,2021,Q1,2,F,20201226.0,20210128.0,20210107,20210203,EXP,,US-ELI_LILLY_AND_COMPANY-US202012013699,ELI LILLY AND CO,,59.0,YR,,M,Y,,,20210203.0,,PH,US,US,2021,Q1,Adult
187165182,18716518,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,Y,,,,21081.0,20.0,IU,,QD,2021,Q1,Suicidal ideation,,2021,Q1,2,F,201612.0,20210210.0,20210108,20210223,EXP,,NZ-SA-2021SA002679,SANOFI AVENTIS,,60.0,YR,A,M,Y,,,20210223.0,,HP,NZ,NZ,2021,Q1,Adult
187174311,18717431,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,D,,,,,,,,,2021,Q1,Completed suicide,Completed suicide,2021,Q1,1,I,,20201225.0,20210108,20210108,EXP,,US-ALVOGEN-2021-ALVOGEN-115734,ALVOGEN,"GUMMIN DD, MOWRY JB, BEUHLER MC, SPYKER DA, BROOKS DE, DIBERT KW, ET AL. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT. CLIN TOXICOL (PHILA). 2020 DEC?58(12):1360?1541.",61.0,YR,,M,Y,,,20210108.0,,MD,US,US,2021,Q1,Adult
187175471,18717547,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q1,Lactic acidosis,,2021,Q1,1,I,,20201231.0,20210108,20210108,EXP,,US-MYLANLABS-2021M1000866,MYLAN,"THURSTON R, IBRAHIM BB, DURR JA, PARK H. A PUZZLING CASE OF METFORMIN (MF) ASSOCIATED LACTIC ACIDOSIS (MALA). J?AM?SOC?NEPHROL 2018?29:576 ABSTR. FR?PO605.",70.0,YR,,F,Y,,,20210108.0,,HP,US,US,2021,Q1,Elderly
187175471,18717547,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q1,Off label use,,2021,Q1,1,I,,20201231.0,20210108,20210108,EXP,,US-MYLANLABS-2021M1000866,MYLAN,"THURSTON R, IBRAHIM BB, DURR JA, PARK H. A PUZZLING CASE OF METFORMIN (MF) ASSOCIATED LACTIC ACIDOSIS (MALA). J?AM?SOC?NEPHROL 2018?29:576 ABSTR. FR?PO605.",70.0,YR,,F,Y,,,20210108.0,,HP,US,US,2021,Q1,Elderly
187175471,18717547,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q1,Toxicity to various agents,,2021,Q1,1,I,,20201231.0,20210108,20210108,EXP,,US-MYLANLABS-2021M1000866,MYLAN,"THURSTON R, IBRAHIM BB, DURR JA, PARK H. A PUZZLING CASE OF METFORMIN (MF) ASSOCIATED LACTIC ACIDOSIS (MALA). J?AM?SOC?NEPHROL 2018?29:576 ABSTR. FR?PO605.",70.0,YR,,F,Y,,,20210108.0,,HP,US,US,2021,Q1,Elderly
187175502,18717550,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2021,Q1,Asthenia,,2021,Q1,2,F,202009.0,20210118.0,20210108,20210128,EXP,,CO-NOVOPROD-778494,NOVO NORDISK,,75.0,YR,,M,Y,,,20210128.0,,CN,CO,CO,2021,Q1,Elderly
187175502,18717550,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2021,Q1,Decreased appetite,,2021,Q1,2,F,202009.0,20210118.0,20210108,20210128,EXP,,CO-NOVOPROD-778494,NOVO NORDISK,,75.0,YR,,M,Y,,,20210128.0,,CN,CO,CO,2021,Q1,Elderly
187175502,18717550,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2021,Q1,Dizziness,,2021,Q1,2,F,202009.0,20210118.0,20210108,20210128,EXP,,CO-NOVOPROD-778494,NOVO NORDISK,,75.0,YR,,M,Y,,,20210128.0,,CN,CO,CO,2021,Q1,Elderly
187175502,18717550,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2021,Q1,Malaise,,2021,Q1,2,F,202009.0,20210118.0,20210108,20210128,EXP,,CO-NOVOPROD-778494,NOVO NORDISK,,75.0,YR,,M,Y,,,20210128.0,,CN,CO,CO,2021,Q1,Elderly
187175502,18717550,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2021,Q1,Metabolic disorder,,2021,Q1,2,F,202009.0,20210118.0,20210108,20210128,EXP,,CO-NOVOPROD-778494,NOVO NORDISK,,75.0,YR,,M,Y,,,20210128.0,,CN,CO,CO,2021,Q1,Elderly
187175502,18717550,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2021,Q1,Paralysis,,2021,Q1,2,F,202009.0,20210118.0,20210108,20210128,EXP,,CO-NOVOPROD-778494,NOVO NORDISK,,75.0,YR,,M,Y,,,20210128.0,,CN,CO,CO,2021,Q1,Elderly
187181373,18718137,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"10 UNITS, DAILY",,,,,,,,,,,,2021,Q1,Lactic acidosis,,2021,Q1,3,F,,20210317.0,20210108,20210330,EXP,,US-PFIZER INC-2020515644,PFIZER,"CERVANTES, C.. CLINICAL APPROACH TO A PATIENT WITH AN ACID?BASE DISTURBANCE.. AMERICAN JOURNAL OF KIDNEY DISEASES. 2021?77(2):A9?A11",65.0,YR,,F,Y,,,20210330.0,,MD,US,US,2021,Q1,Elderly
187181373,18718137,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"10 UNITS, DAILY",,,,,,,,,,,,2021,Q1,Metabolic acidosis,,2021,Q1,3,F,,20210317.0,20210108,20210330,EXP,,US-PFIZER INC-2020515644,PFIZER,"CERVANTES, C.. CLINICAL APPROACH TO A PATIENT WITH AN ACID?BASE DISTURBANCE.. AMERICAN JOURNAL OF KIDNEY DISEASES. 2021?77(2):A9?A11",65.0,YR,,F,Y,,,20210330.0,,MD,US,US,2021,Q1,Elderly
187181373,18718137,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"10 UNITS, DAILY",,,,,,,,,,,,2021,Q1,Off label use,,2021,Q1,3,F,,20210317.0,20210108,20210330,EXP,,US-PFIZER INC-2020515644,PFIZER,"CERVANTES, C.. CLINICAL APPROACH TO A PATIENT WITH AN ACID?BASE DISTURBANCE.. AMERICAN JOURNAL OF KIDNEY DISEASES. 2021?77(2):A9?A11",65.0,YR,,F,Y,,,20210330.0,,MD,US,US,2021,Q1,Elderly
187181373,18718137,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"10 UNITS, DAILY",,,,,,,,,,,,2021,Q1,Toxicity to various agents,,2021,Q1,3,F,,20210317.0,20210108,20210330,EXP,,US-PFIZER INC-2020515644,PFIZER,"CERVANTES, C.. CLINICAL APPROACH TO A PATIENT WITH AN ACID?BASE DISTURBANCE.. AMERICAN JOURNAL OF KIDNEY DISEASES. 2021?77(2):A9?A11",65.0,YR,,F,Y,,,20210330.0,,MD,US,US,2021,Q1,Elderly
187184492,18718449,42,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 U X ONCE,,,,,,,,,,UNKNOWN,,2021,Q1,Encephalopathy,,2021,Q1,2,F,20200924.0,20210208.0,20210108,20210212,EXP,,US-CELGENEUS-USA-20201209424,CELGENE,,67.0,YR,,M,Y,108.0,KG,20210212.0,,MD,US,US,2021,Q1,Elderly
187184492,18718449,43,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 U/ML X 1 X 1 DAYS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Encephalopathy,,2021,Q1,2,F,20200924.0,20210208.0,20210108,20210212,EXP,,US-CELGENEUS-USA-20201209424,CELGENE,,67.0,YR,,M,Y,108.0,KG,20210212.0,,MD,US,US,2021,Q1,Elderly
187184492,18718449,44,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,10 U X 1 X 1 DAYS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Encephalopathy,,2021,Q1,2,F,20200924.0,20210208.0,20210108,20210212,EXP,,US-CELGENEUS-USA-20201209424,CELGENE,,67.0,YR,,M,Y,108.0,KG,20210212.0,,MD,US,US,2021,Q1,Elderly
187186681,18718668,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,Y,U,,,,,,,,2021,Q1,Acute kidney injury,,2021,Q1,1,I,,20201228.0,20210108,20210108,EXP,,PR-AMNEAL PHARMACEUTICALS-2020-AMRX-04153,AMNEAL,"LUGO IDS, BOSCHETTI SA, DE JESUS GG, TORRES JR, MELENDEZ IO. ACUTE KIDNEY INJURY IN METFORMIN USERS, A CONCERNING COMBINATION. ENDOCR. PRACT.. 2020?26(2):151?2",64.0,YR,,M,Y,,,20210108.0,,HP,PR,US,2021,Q1,Adult
187186681,18718668,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,Y,U,,,,,,,,2021,Q1,Lactic acidosis,,2021,Q1,1,I,,20201228.0,20210108,20210108,EXP,,PR-AMNEAL PHARMACEUTICALS-2020-AMRX-04153,AMNEAL,"LUGO IDS, BOSCHETTI SA, DE JESUS GG, TORRES JR, MELENDEZ IO. ACUTE KIDNEY INJURY IN METFORMIN USERS, A CONCERNING COMBINATION. ENDOCR. PRACT.. 2020?26(2):151?2",64.0,YR,,M,Y,,,20210108.0,,HP,PR,US,2021,Q1,Adult
187191511,18719151,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q1,Diabetic ketoacidosis,,2021,Q1,1,I,20201223.0,20201229.0,20210108,20210108,EXP,,US-ELI_LILLY_AND_COMPANY-US202012014077,ELI LILLY AND CO,,67.0,YR,,F,Y,86.7,KG,20210108.0,,PH,US,US,2021,Q1,Elderly
187191511,18719151,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q1,Pulmonary congestion,,2021,Q1,1,I,20201223.0,20201229.0,20210108,20210108,EXP,,US-ELI_LILLY_AND_COMPANY-US202012014077,ELI LILLY AND CO,,67.0,YR,,F,Y,86.7,KG,20210108.0,,PH,US,US,2021,Q1,Elderly
187193571,18719357,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Euglycaemic diabetic ketoacidosis,,2021,Q1,1,I,,20210105.0,20210108,20210108,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-074164",BOEHRINGER INGELHEIM,"HOWARD J, WIEGLEY N, MADAN N, SEVERE EUGLYCEMIC DIABETIC KETOACIDOSIS SECONDARY TO SODIUM?GLUCOSE COTRANSPORTER 2 (SGLT2) INHIBITOR: A DIAGNOSTIC CHALLENGE. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2019? 30 (1): 1198?",46.0,YR,A,,Y,,,20210108.0,,HP,US,US,2021,Q1,Adult
187193571,18719357,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Necrotising soft tissue infection,,2021,Q1,1,I,,20210105.0,20210108,20210108,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-074164",BOEHRINGER INGELHEIM,"HOWARD J, WIEGLEY N, MADAN N, SEVERE EUGLYCEMIC DIABETIC KETOACIDOSIS SECONDARY TO SODIUM?GLUCOSE COTRANSPORTER 2 (SGLT2) INHIBITOR: A DIAGNOSTIC CHALLENGE. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2019? 30 (1): 1198?",46.0,YR,A,,Y,,,20210108.0,,HP,US,US,2021,Q1,Adult
187212832,18721283,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 INTERNATIONAL UNIT, QD",,,,,,,,10.0,IU,,QD,2021,Q1,Lactic acidosis,,2021,Q1,2,F,,20210304.0,20210109,20210318,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-11660,LUPIN,,65.0,YR,,F,Y,,,20210318.0,,HP,US,US,2021,Q1,Elderly
187212832,18721283,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 INTERNATIONAL UNIT, QD",,,,,,,,10.0,IU,,QD,2021,Q1,Metabolic acidosis,,2021,Q1,2,F,,20210304.0,20210109,20210318,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-11660,LUPIN,,65.0,YR,,F,Y,,,20210318.0,,HP,US,US,2021,Q1,Elderly
187212832,18721283,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 INTERNATIONAL UNIT, QD",,,,,,,,10.0,IU,,QD,2021,Q1,Toxicity to various agents,,2021,Q1,2,F,,20210304.0,20210109,20210318,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-11660,LUPIN,,65.0,YR,,F,Y,,,20210318.0,,HP,US,US,2021,Q1,Elderly
187219734,18721973,4,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"10  INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,10.0,IU,,QD,2021,Q1,Lactic acidosis,,2021,Q1,4,F,,20210317.0,20210111,20210329,EXP,,US-AUROBINDO-AUR-APL-2021-000150,AUROBINDO,,65.0,YR,,F,Y,,,20210329.0,,HP,US,US,2021,Q1,Elderly
187219734,18721973,4,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"10  INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,10.0,IU,,QD,2021,Q1,Metabolic acidosis,,2021,Q1,4,F,,20210317.0,20210111,20210329,EXP,,US-AUROBINDO-AUR-APL-2021-000150,AUROBINDO,,65.0,YR,,F,Y,,,20210329.0,,HP,US,US,2021,Q1,Elderly
187219734,18721973,4,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"10  INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,10.0,IU,,QD,2021,Q1,Toxicity to various agents,,2021,Q1,4,F,,20210317.0,20210111,20210329,EXP,,US-AUROBINDO-AUR-APL-2021-000150,AUROBINDO,,65.0,YR,,F,Y,,,20210329.0,,HP,US,US,2021,Q1,Elderly
187255302,18725530,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,UNK,,,D,,,,,,,,,2021,Q1,Completed suicide,,2021,Q1,2,F,2019.0,20210104.0,20210111,20210113,EXP,,US-APOTEX-2021AP000859,APOTEX,"GUMMIN DD, MOWRY JB, BEUHLER MC, SPYKER DA, BROOKS DE, DIBERT KW, RIVERS LJ, PHAM NPT, RYAN ML. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2020?58 (12):1360?1541",46.0,YR,,F,Y,,,20210113.0,,MD,US,US,2021,Q1,Adult
187255302,18725530,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Respiratory (inhalation),UNK,,,D,,,,,,,,,2021,Q1,Completed suicide,,2021,Q1,2,F,2019.0,20210104.0,20210111,20210113,EXP,,US-APOTEX-2021AP000859,APOTEX,"GUMMIN DD, MOWRY JB, BEUHLER MC, SPYKER DA, BROOKS DE, DIBERT KW, RIVERS LJ, PHAM NPT, RYAN ML. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2020?58 (12):1360?1541",46.0,YR,,F,Y,,,20210113.0,,MD,US,US,2021,Q1,Adult
187255302,18725530,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,D,,,,,,,,,2021,Q1,Completed suicide,,2021,Q1,2,F,2019.0,20210104.0,20210111,20210113,EXP,,US-APOTEX-2021AP000859,APOTEX,"GUMMIN DD, MOWRY JB, BEUHLER MC, SPYKER DA, BROOKS DE, DIBERT KW, RIVERS LJ, PHAM NPT, RYAN ML. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2020?58 (12):1360?1541",46.0,YR,,F,Y,,,20210113.0,,MD,US,US,2021,Q1,Adult
187256042,18725604,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 INTERNATIONAL UNIT, QD",,,U,U,,,,10.0,IU,,QD,2021,Q1,Lactic acidosis,,2021,Q1,2,F,,20210304.0,20210111,20210311,EXP,,US-MYLANLABS-2021M1000571,MYLAN,"CERVANTES CE, MENEZ S, MONROY TRUJILLO JM, HANOUNEH M. CLINICAL APPROACH TO A PATIENT WITH AN ACID?BASE DISTURBANCE. AM?J?KIDNEY?DIS 2021?77(2):A9?A11.",65.0,YR,,F,Y,,,20210311.0,,HP,US,US,2021,Q1,Elderly
187256042,18725604,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 INTERNATIONAL UNIT, QD",,,U,U,,,,10.0,IU,,QD,2021,Q1,Metabolic acidosis,,2021,Q1,2,F,,20210304.0,20210111,20210311,EXP,,US-MYLANLABS-2021M1000571,MYLAN,"CERVANTES CE, MENEZ S, MONROY TRUJILLO JM, HANOUNEH M. CLINICAL APPROACH TO A PATIENT WITH AN ACID?BASE DISTURBANCE. AM?J?KIDNEY?DIS 2021?77(2):A9?A11.",65.0,YR,,F,Y,,,20210311.0,,HP,US,US,2021,Q1,Elderly
187256042,18725604,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 INTERNATIONAL UNIT, QD",,,U,U,,,,10.0,IU,,QD,2021,Q1,Toxicity to various agents,,2021,Q1,2,F,,20210304.0,20210111,20210311,EXP,,US-MYLANLABS-2021M1000571,MYLAN,"CERVANTES CE, MENEZ S, MONROY TRUJILLO JM, HANOUNEH M. CLINICAL APPROACH TO A PATIENT WITH AN ACID?BASE DISTURBANCE. AM?J?KIDNEY?DIS 2021?77(2):A9?A11.",65.0,YR,,F,Y,,,20210311.0,,HP,US,US,2021,Q1,Elderly
187259151,18725915,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Acute kidney injury,,2021,Q1,1,I,,20201228.0,20210111,20210111,EXP,,PR-BAUSCH-BL-2020-039188,BAUSCH AND LOMB,"LUGO I, BOSCHETTI S, DE JESUS G, TORRES J, MELENDEZ I. ACUTE KIDNEY INJURY IN METFORMIN USERS, A CONCERNING COMBINATION. ENDOCRINE PRACTICE. 2020 MAY 01?26:SUPPL 2:151?152.",64.0,YR,,M,Y,,,20210111.0,,HP,PR,PR,2021,Q1,Adult
187259151,18725915,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Lactic acidosis,,2021,Q1,1,I,,20201228.0,20210111,20210111,EXP,,PR-BAUSCH-BL-2020-039188,BAUSCH AND LOMB,"LUGO I, BOSCHETTI S, DE JESUS G, TORRES J, MELENDEZ I. ACUTE KIDNEY INJURY IN METFORMIN USERS, A CONCERNING COMBINATION. ENDOCRINE PRACTICE. 2020 MAY 01?26:SUPPL 2:151?152.",64.0,YR,,M,Y,,,20210111.0,,HP,PR,PR,2021,Q1,Adult
187262942,18726294,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 IU, HS",,,,,,,,6.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Blood glucose fluctuation,,2021,Q1,2,F,,20210310.0,20210111,20210329,EXP,,ZA-SA-2021SA006048,SANOFI AVENTIS,,78.0,YR,E,M,Y,,,20210329.0,,MD,ZA,ZA,2021,Q1,Elderly
187262942,18726294,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 IU, HS",,,,,,,,6.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Blood glucose increased,,2021,Q1,2,F,,20210310.0,20210111,20210329,EXP,,ZA-SA-2021SA006048,SANOFI AVENTIS,,78.0,YR,E,M,Y,,,20210329.0,,MD,ZA,ZA,2021,Q1,Elderly
187262942,18726294,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 IU, HS",,,,,,,,6.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Diarrhoea,,2021,Q1,2,F,,20210310.0,20210111,20210329,EXP,,ZA-SA-2021SA006048,SANOFI AVENTIS,,78.0,YR,E,M,Y,,,20210329.0,,MD,ZA,ZA,2021,Q1,Elderly
187269291,18726929,3,SS,INSULIN GLARGINE (ER),INSULIN GLARGINE,1,Oral,INGESTION. EXTENDED RELEASE,,,D,,,,,,,,,2021,Q1,Completed suicide,,2021,Q1,1,I,,20201229.0,20210111,20210111,EXP,,US-BAUSCH-BL-2020-039636,BAUSCH AND LOMB,"GUMMIN D, MOWRY J, BEUHLER M, SPYKER D, BROOKS D, DIBERT K, RIVERS L, PHAM N, RYAN M. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2020 DEC 11?58(12):1360?1541. DOI:10.1080/15563650.2020.1834219",46.0,YR,,F,Y,,,20210111.0,,MD,US,US,2021,Q1,Adult
187269291,18726929,4,SS,INSULIN GLARGINE (ER),INSULIN GLARGINE,1,Other,ASPIRATION (WITH INGESTION),,,D,,,,,,,,,2021,Q1,Completed suicide,,2021,Q1,1,I,,20201229.0,20210111,20210111,EXP,,US-BAUSCH-BL-2020-039636,BAUSCH AND LOMB,"GUMMIN D, MOWRY J, BEUHLER M, SPYKER D, BROOKS D, DIBERT K, RIVERS L, PHAM N, RYAN M. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2020 DEC 11?58(12):1360?1541. DOI:10.1080/15563650.2020.1834219",46.0,YR,,F,Y,,,20210111.0,,MD,US,US,2021,Q1,Adult
187269291,18726929,5,SS,INSULIN GLARGINE (ER),INSULIN GLARGINE,1,Parenteral,,,,D,,,,,,,,,2021,Q1,Completed suicide,,2021,Q1,1,I,,20201229.0,20210111,20210111,EXP,,US-BAUSCH-BL-2020-039636,BAUSCH AND LOMB,"GUMMIN D, MOWRY J, BEUHLER M, SPYKER D, BROOKS D, DIBERT K, RIVERS L, PHAM N, RYAN M. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2020 DEC 11?58(12):1360?1541. DOI:10.1080/15563650.2020.1834219",46.0,YR,,F,Y,,,20210111.0,,MD,US,US,2021,Q1,Adult
187290161,18729016,8,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Acute kidney injury,,2021,Q1,1,I,20210111.0,,20210111,20210111,DIR,,,FDA-CTU,,53.0,YR,,M,N,145.4,KG,20210111.0,N,HP,US,US,2021,Q1,Adult
187290161,18729016,8,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Acute respiratory failure,,2021,Q1,1,I,20210111.0,,20210111,20210111,DIR,,,FDA-CTU,,53.0,YR,,M,N,145.4,KG,20210111.0,N,HP,US,US,2021,Q1,Adult
187290161,18729016,8,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Haemodynamic instability,,2021,Q1,1,I,20210111.0,,20210111,20210111,DIR,,,FDA-CTU,,53.0,YR,,M,N,145.4,KG,20210111.0,N,HP,US,US,2021,Q1,Adult
187290161,18729016,8,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Hypersensitivity,,2021,Q1,1,I,20210111.0,,20210111,20210111,DIR,,,FDA-CTU,,53.0,YR,,M,N,145.4,KG,20210111.0,N,HP,US,US,2021,Q1,Adult
187290161,18729016,8,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Hypotension,,2021,Q1,1,I,20210111.0,,20210111,20210111,DIR,,,FDA-CTU,,53.0,YR,,M,N,145.4,KG,20210111.0,N,HP,US,US,2021,Q1,Adult
187290161,18729016,8,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Infection,,2021,Q1,1,I,20210111.0,,20210111,20210111,DIR,,,FDA-CTU,,53.0,YR,,M,N,145.4,KG,20210111.0,N,HP,US,US,2021,Q1,Adult
187290161,18729016,8,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Multiple organ dysfunction syndrome,,2021,Q1,1,I,20210111.0,,20210111,20210111,DIR,,,FDA-CTU,,53.0,YR,,M,N,145.4,KG,20210111.0,N,HP,US,US,2021,Q1,Adult
187324711,18732471,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,36 INTERNATIONAL UNIT,,,,, OF741A,,,36.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Abdominal abscess,,2021,Q1,1,I,2020.0,20210107.0,20210113,20210113,EXP,,ES-AUROBINDO-AUR-APL-2021-001335,AUROBINDO,,55.0,YR,,F,Y,91.0,KG,20210113.0,,CN,ES,ES,2021,Q1,Adult
187324711,18732471,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,36 INTERNATIONAL UNIT,,,,, OF741A,,,36.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Asymptomatic COVID-19,,2021,Q1,1,I,2020.0,20210107.0,20210113,20210113,EXP,,ES-AUROBINDO-AUR-APL-2021-001335,AUROBINDO,,55.0,YR,,F,Y,91.0,KG,20210113.0,,CN,ES,ES,2021,Q1,Adult
187324711,18732471,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,36 INTERNATIONAL UNIT,,,,, OF741A,,,36.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Dysuria,,2021,Q1,1,I,2020.0,20210107.0,20210113,20210113,EXP,,ES-AUROBINDO-AUR-APL-2021-001335,AUROBINDO,,55.0,YR,,F,Y,91.0,KG,20210113.0,,CN,ES,ES,2021,Q1,Adult
187324711,18732471,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,36 INTERNATIONAL UNIT,,,,, OF741A,,,36.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Hyperglycaemia,,2021,Q1,1,I,2020.0,20210107.0,20210113,20210113,EXP,,ES-AUROBINDO-AUR-APL-2021-001335,AUROBINDO,,55.0,YR,,F,Y,91.0,KG,20210113.0,,CN,ES,ES,2021,Q1,Adult
187324711,18732471,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,36 INTERNATIONAL UNIT,,,,, OF741A,,,36.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Product storage error,,2021,Q1,1,I,2020.0,20210107.0,20210113,20210113,EXP,,ES-AUROBINDO-AUR-APL-2021-001335,AUROBINDO,,55.0,YR,,F,Y,91.0,KG,20210113.0,,CN,ES,ES,2021,Q1,Adult
187324711,18732471,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,36 INTERNATIONAL UNIT,,,,, OF741A,,,36.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Urinary tract infection,,2021,Q1,1,I,2020.0,20210107.0,20210113,20210113,EXP,,ES-AUROBINDO-AUR-APL-2021-001335,AUROBINDO,,55.0,YR,,F,Y,91.0,KG,20210113.0,,CN,ES,ES,2021,Q1,Adult
187326491,18732649,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"4 IU, QD",,,,,,,,4.0,IU,,QD,2021,Q1,Alanine aminotransferase increased,,2021,Q1,1,I,20210105.0,20210106.0,20210112,20210112,EXP,,JP-GILEAD-2021-0511721,GILEAD,,92.0,YR,E,F,Y,,,20210112.0,,PH,JP,JP,2021,Q1,Elderly
187326491,18732649,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"4 IU, QD",,,,,,,,4.0,IU,,QD,2021,Q1,Aspartate aminotransferase increased,,2021,Q1,1,I,20210105.0,20210106.0,20210112,20210112,EXP,,JP-GILEAD-2021-0511721,GILEAD,,92.0,YR,E,F,Y,,,20210112.0,,PH,JP,JP,2021,Q1,Elderly
187326491,18732649,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"8 IU, QD",,,,,,,,8.0,IU,,QD,2021,Q1,Alanine aminotransferase increased,,2021,Q1,1,I,20210105.0,20210106.0,20210112,20210112,EXP,,JP-GILEAD-2021-0511721,GILEAD,,92.0,YR,E,F,Y,,,20210112.0,,PH,JP,JP,2021,Q1,Elderly
187326491,18732649,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"8 IU, QD",,,,,,,,8.0,IU,,QD,2021,Q1,Aspartate aminotransferase increased,,2021,Q1,1,I,20210105.0,20210106.0,20210112,20210112,EXP,,JP-GILEAD-2021-0511721,GILEAD,,92.0,YR,E,F,Y,,,20210112.0,,PH,JP,JP,2021,Q1,Elderly
187330851,18733085,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Anaemia,,2021,Q1,1,I,20201214.0,20201231.0,20210113,20210113,EXP,IT-MINISAL02-650072,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-113015,BRISTOL MYERS SQUIBB,,94.0,YR,,F,Y,,,20210113.0,,MD,IT,IT,2021,Q1,Elderly
187330851,18733085,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Melaena,,2021,Q1,1,I,20201214.0,20201231.0,20210113,20210113,EXP,IT-MINISAL02-650072,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-113015,BRISTOL MYERS SQUIBB,,94.0,YR,,F,Y,,,20210113.0,,MD,IT,IT,2021,Q1,Elderly
187353972,18735397,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q1,Cytokine release syndrome,,2021,Q1,2,F,20210108.0,20210108.0,20210113,20210120,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-001889,BRISTOL MYERS SQUIBB,,70.0,YR,,M,Y,,,20210120.0,,HP,DE,DE,2021,Q1,Elderly
187359122,18735912,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Bleeding time prolonged,,2021,Q1,2,F,,20210121.0,20210113,20210204,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-001568,BRISTOL MYERS SQUIBB,,85.0,YR,,M,Y,,,20210204.0,,CN,FR,FR,2021,Q1,Elderly
187359122,18735912,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Drug interaction,,2021,Q1,2,F,,20210121.0,20210113,20210204,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-001568,BRISTOL MYERS SQUIBB,,85.0,YR,,M,Y,,,20210204.0,,CN,FR,FR,2021,Q1,Elderly
187359122,18735912,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,International normalised ratio increased,,2021,Q1,2,F,,20210121.0,20210113,20210204,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-001568,BRISTOL MYERS SQUIBB,,85.0,YR,,M,Y,,,20210204.0,,CN,FR,FR,2021,Q1,Elderly
187360961,18736096,20,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,,,,D,,,,,,,,,2021,Q1,Completed suicide,,2021,Q1,1,I,2019.0,20210104.0,20210113,20210113,EXP,,US-APOTEX-2021AP000770,APOTEX,"GUMMIN DD, MOWRY JB, BEUHLER MC, SPYKER DA, BROOKS DE, DIBERT KW, RIVERS LJ, PHAM NPT, RYAN ML. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2020?58 (12):1360?1541",61.0,YR,,M,Y,,,20210113.0,,MD,US,US,2021,Q1,Adult
187360961,18736096,21,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,,,,D,,,,,,,,,2021,Q1,Completed suicide,,2021,Q1,1,I,2019.0,20210104.0,20210113,20210113,EXP,,US-APOTEX-2021AP000770,APOTEX,"GUMMIN DD, MOWRY JB, BEUHLER MC, SPYKER DA, BROOKS DE, DIBERT KW, RIVERS LJ, PHAM NPT, RYAN ML. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2020?58 (12):1360?1541",61.0,YR,,M,Y,,,20210113.0,,MD,US,US,2021,Q1,Adult
187367931,18736793,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,210605.0,,,,,2021,Q1,Drug ineffective,,2021,Q1,1,I,,20210106.0,20210113,20210113,EXP,,US-MYLANLABS-2021M1002004,MYLAN,"JAMAL Y, LOPEZ?PADILLA CJ, SCHRIER PB. HEMODIALYSIS ACCESS FAILURE CAUSED BY HYPERVISCOSITY DUE TO SECONDARY POLYCYTHEMIA IN POLYCYSTIC KIDNEY DISEASE. J?AM?SOC?NEPHROL 2019?30:590.",44.0,YR,,M,Y,,,20210113.0,,HP,US,US,2021,Q1,Adult
187370541,18737054,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,,, OF741A,,,36.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Abdominal abscess,,2021,Q1,1,I,2020.0,20210110.0,20210113,20210113,EXP,,NVSC2021ES005008,NOVARTIS,,55.0,YR,,F,Y,91.0,KG,20210113.0,,HP,ES,ES,2021,Q1,Adult
187370541,18737054,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,,, OF741A,,,36.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Asymptomatic COVID-19,,2021,Q1,1,I,2020.0,20210110.0,20210113,20210113,EXP,,NVSC2021ES005008,NOVARTIS,,55.0,YR,,F,Y,91.0,KG,20210113.0,,HP,ES,ES,2021,Q1,Adult
187370541,18737054,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,,, OF741A,,,36.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Dysuria,,2021,Q1,1,I,2020.0,20210110.0,20210113,20210113,EXP,,NVSC2021ES005008,NOVARTIS,,55.0,YR,,F,Y,91.0,KG,20210113.0,,HP,ES,ES,2021,Q1,Adult
187370541,18737054,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,,, OF741A,,,36.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Hyperglycaemia,,2021,Q1,1,I,2020.0,20210110.0,20210113,20210113,EXP,,NVSC2021ES005008,NOVARTIS,,55.0,YR,,F,Y,91.0,KG,20210113.0,,HP,ES,ES,2021,Q1,Adult
187370541,18737054,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,,, OF741A,,,36.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Product storage error,,2021,Q1,1,I,2020.0,20210110.0,20210113,20210113,EXP,,NVSC2021ES005008,NOVARTIS,,55.0,YR,,F,Y,91.0,KG,20210113.0,,HP,ES,ES,2021,Q1,Adult
187370541,18737054,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,,, OF741A,,,36.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Urinary tract infection,,2021,Q1,1,I,2020.0,20210110.0,20210113,20210113,EXP,,NVSC2021ES005008,NOVARTIS,,55.0,YR,,F,Y,91.0,KG,20210113.0,,HP,ES,ES,2021,Q1,Adult
187393531,18739353,6,C,insulin glargine 10 units SC daily,,2,,,,,,,,,,,,,,2021,Q1,Infusion site extravasation,,2021,Q1,1,I,20210112.0,,20210113,20210113,DIR,,,FDA-CTU,,71.0,YR,,F,N,81.6,KG,20210113.0,N,PH,US,US,2021,Q1,Elderly
187394731,18739473,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Drug ineffective,,2021,Q1,1,I,,20210104.0,20210114,20210114,EXP,,US-MYLANLABS-2021M1001540,MYLAN,"TORRICO T, KIAI N, MEZA C, SALAM MT, ABDIJADID S. SUSPECTED ARIPIPRAZOLE?INDUCED NEUTROPENIA IN A GERIATRIC PATIENT: A CASE REPORT. BMC?GERIATR 2020?20:NO. 1.",68.0,YR,,M,Y,,,20210114.0,,HP,US,US,2021,Q1,Elderly
187394731,18739473,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Hypotension,,2021,Q1,1,I,,20210104.0,20210114,20210114,EXP,,US-MYLANLABS-2021M1001540,MYLAN,"TORRICO T, KIAI N, MEZA C, SALAM MT, ABDIJADID S. SUSPECTED ARIPIPRAZOLE?INDUCED NEUTROPENIA IN A GERIATRIC PATIENT: A CASE REPORT. BMC?GERIATR 2020?20:NO. 1.",68.0,YR,,M,Y,,,20210114.0,,HP,US,US,2021,Q1,Elderly
187394731,18739473,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Neutropenia,,2021,Q1,1,I,,20210104.0,20210114,20210114,EXP,,US-MYLANLABS-2021M1001540,MYLAN,"TORRICO T, KIAI N, MEZA C, SALAM MT, ABDIJADID S. SUSPECTED ARIPIPRAZOLE?INDUCED NEUTROPENIA IN A GERIATRIC PATIENT: A CASE REPORT. BMC?GERIATR 2020?20:NO. 1.",68.0,YR,,M,Y,,,20210114.0,,HP,US,US,2021,Q1,Elderly
187402913,18740291,3,C,OPTISULIN [INSULIN GLARGINE],INSULIN GLARGINE,1,,40 IU AT NIGHT,,,,,,,,40.0,IU,,QD,2021,Q1,Burning sensation,,2021,Q1,3,F,20201101.0,20210303.0,20210114,20210325,EXP,,AU-PFIZER INC-2020456015,PFIZER,,75.0,YR,,M,Y,,,20210325.0,,PH,AU,AU,2021,Q1,Elderly
187402913,18740291,3,C,OPTISULIN [INSULIN GLARGINE],INSULIN GLARGINE,1,,40 IU AT NIGHT,,,,,,,,40.0,IU,,QD,2021,Q1,Drug ineffective,,2021,Q1,3,F,20201101.0,20210303.0,20210114,20210325,EXP,,AU-PFIZER INC-2020456015,PFIZER,,75.0,YR,,M,Y,,,20210325.0,,PH,AU,AU,2021,Q1,Elderly
187402913,18740291,3,C,OPTISULIN [INSULIN GLARGINE],INSULIN GLARGINE,1,,40 IU AT NIGHT,,,,,,,,40.0,IU,,QD,2021,Q1,Poor quality product administered,,2021,Q1,3,F,20201101.0,20210303.0,20210114,20210325,EXP,,AU-PFIZER INC-2020456015,PFIZER,,75.0,YR,,M,Y,,,20210325.0,,PH,AU,AU,2021,Q1,Elderly
187402913,18740291,3,C,OPTISULIN [INSULIN GLARGINE],INSULIN GLARGINE,1,,40 IU AT NIGHT,,,,,,,,40.0,IU,,QD,2021,Q1,Product physical issue,,2021,Q1,3,F,20201101.0,20210303.0,20210114,20210325,EXP,,AU-PFIZER INC-2020456015,PFIZER,,75.0,YR,,M,Y,,,20210325.0,,PH,AU,AU,2021,Q1,Elderly
187402913,18740291,3,C,OPTISULIN [INSULIN GLARGINE],INSULIN GLARGINE,1,,40 IU AT NIGHT,,,,,,,,40.0,IU,,QD,2021,Q1,Wrong technique in product usage process,,2021,Q1,3,F,20201101.0,20210303.0,20210114,20210325,EXP,,AU-PFIZER INC-2020456015,PFIZER,,75.0,YR,,M,Y,,,20210325.0,,PH,AU,AU,2021,Q1,Elderly
187406471,18740647,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,"UNK, INGESTION (ER)",,,D,,,,,,,,,2021,Q1,Completed suicide,,2021,Q1,1,I,2019.0,20210108.0,20210114,20210114,EXP,,US-PFIZER INC-2021016417,PFIZER,"GUMMIN, D.. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2020?58 (12):1360?1541",46.0,YR,,F,Y,,,20210114.0,,MD,US,US,2021,Q1,Adult
187406471,18740647,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,UNK,,,D,,,,,,,,,2021,Q1,Completed suicide,,2021,Q1,1,I,2019.0,20210108.0,20210114,20210114,EXP,,US-PFIZER INC-2021016417,PFIZER,"GUMMIN, D.. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2020?58 (12):1360?1541",46.0,YR,,F,Y,,,20210114.0,,MD,US,US,2021,Q1,Adult
187406471,18740647,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Respiratory (inhalation),"UNK, ASPIRATION",,,D,,,,,,,,,2021,Q1,Completed suicide,,2021,Q1,1,I,2019.0,20210108.0,20210114,20210114,EXP,,US-PFIZER INC-2021016417,PFIZER,"GUMMIN, D.. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2020?58 (12):1360?1541",46.0,YR,,F,Y,,,20210114.0,,MD,US,US,2021,Q1,Adult
187407081,18740708,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, DAILY BEFORE SLEEP",,,,,,,,5.0,IU,,QD,2021,Q1,Blood glucose increased,,2021,Q1,1,I,2018.0,20210106.0,20210114,20210114,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202101002779,ELI LILLY AND CO,,56.0,YR,,F,Y,72.0,KG,20210114.0,,CN,CN,CN,2021,Q1,Adult
187408911,18740891,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK (INGEST),,,D,,,,,,,,,2021,Q1,Completed suicide,,2021,Q1,1,I,2019.0,20210108.0,20210114,20210114,EXP,,US-PFIZER INC-2021019776,PFIZER,"GUMMIN, D.. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2020?58 (12):1360?1541",61.0,YR,,M,Y,,,20210114.0,,MD,US,US,2021,Q1,Adult
187423581,18742358,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 IE, 0?0?1?0, INJECTION/INFUSION SOLUTION",,,,,,,,5.0,IU,INJECTION,,2021,Q1,Anuria,,2021,Q1,1,I,,20210111.0,20210114,20210114,EXP,,DE-MYLANLABS-2021M1001917,MYLAN,,68.0,YR,,F,Y,,,20210114.0,,MD,DE,DE,2021,Q1,Elderly
187423581,18742358,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 IE, 0?0?1?0, INJECTION/INFUSION SOLUTION",,,,,,,,5.0,IU,INJECTION,,2021,Q1,Cough,,2021,Q1,1,I,,20210111.0,20210114,20210114,EXP,,DE-MYLANLABS-2021M1001917,MYLAN,,68.0,YR,,F,Y,,,20210114.0,,MD,DE,DE,2021,Q1,Elderly
187423581,18742358,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 IE, 0?0?1?0, INJECTION/INFUSION SOLUTION",,,,,,,,5.0,IU,INJECTION,,2021,Q1,Oedema peripheral,,2021,Q1,1,I,,20210111.0,20210114,20210114,EXP,,DE-MYLANLABS-2021M1001917,MYLAN,,68.0,YR,,F,Y,,,20210114.0,,MD,DE,DE,2021,Q1,Elderly
187423581,18742358,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 IE, 0?0?1?0, INJECTION/INFUSION SOLUTION",,,,,,,,5.0,IU,INJECTION,,2021,Q1,Urinary hesitation,,2021,Q1,1,I,,20210111.0,20210114,20210114,EXP,,DE-MYLANLABS-2021M1001917,MYLAN,,68.0,YR,,F,Y,,,20210114.0,,MD,DE,DE,2021,Q1,Elderly
187426591,18742659,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SUBCUTANEOUS,,,,,,,,,,SOLUTION,,2021,Q1,Carotid artery stenosis,,2021,Q1,1,I,,20210104.0,20210114,20210114,EXP,,CA-BAUSCH-BL-2021-000433,BAUSCH AND LOMB,,73.0,YR,,M,Y,,,20210114.0,,PH,CA,CA,2021,Q1,Elderly
187426591,18742659,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SUBCUTANEOUS,,,,,,,,,,SOLUTION,,2021,Q1,Cerebral infarction,,2021,Q1,1,I,,20210104.0,20210114,20210114,EXP,,CA-BAUSCH-BL-2021-000433,BAUSCH AND LOMB,,73.0,YR,,M,Y,,,20210114.0,,PH,CA,CA,2021,Q1,Elderly
187426591,18742659,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SUBCUTANEOUS,,,,,,,,,,SOLUTION,,2021,Q1,Cerebrovascular accident,,2021,Q1,1,I,,20210104.0,20210114,20210114,EXP,,CA-BAUSCH-BL-2021-000433,BAUSCH AND LOMB,,73.0,YR,,M,Y,,,20210114.0,,PH,CA,CA,2021,Q1,Elderly
187426591,18742659,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SUBCUTANEOUS,,,,,,,,,,SOLUTION,,2021,Q1,Confusional state,,2021,Q1,1,I,,20210104.0,20210114,20210114,EXP,,CA-BAUSCH-BL-2021-000433,BAUSCH AND LOMB,,73.0,YR,,M,Y,,,20210114.0,,PH,CA,CA,2021,Q1,Elderly
187426591,18742659,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SUBCUTANEOUS,,,,,,,,,,SOLUTION,,2021,Q1,Depressed level of consciousness,,2021,Q1,1,I,,20210104.0,20210114,20210114,EXP,,CA-BAUSCH-BL-2021-000433,BAUSCH AND LOMB,,73.0,YR,,M,Y,,,20210114.0,,PH,CA,CA,2021,Q1,Elderly
187426591,18742659,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SUBCUTANEOUS,,,,,,,,,,SOLUTION,,2021,Q1,Fall,,2021,Q1,1,I,,20210104.0,20210114,20210114,EXP,,CA-BAUSCH-BL-2021-000433,BAUSCH AND LOMB,,73.0,YR,,M,Y,,,20210114.0,,PH,CA,CA,2021,Q1,Elderly
187426591,18742659,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SUBCUTANEOUS,,,,,,,,,,SOLUTION,,2021,Q1,Musculoskeletal chest pain,,2021,Q1,1,I,,20210104.0,20210114,20210114,EXP,,CA-BAUSCH-BL-2021-000433,BAUSCH AND LOMB,,73.0,YR,,M,Y,,,20210114.0,,PH,CA,CA,2021,Q1,Elderly
187426591,18742659,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SUBCUTANEOUS,,,,,,,,,,SOLUTION,,2021,Q1,Seizure,,2021,Q1,1,I,,20210104.0,20210114,20210114,EXP,,CA-BAUSCH-BL-2021-000433,BAUSCH AND LOMB,,73.0,YR,,M,Y,,,20210114.0,,PH,CA,CA,2021,Q1,Elderly
187426821,18742682,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,U300,,,,,,,,,,,,2021,Q1,Euglycaemic diabetic ketoacidosis,,2021,Q1,1,I,,20210108.0,20210115,20210115,EXP,,BE-JNJFOC-20210113975,JOHNSON AND JOHNSON,"MENGHOUM N, ORIOT P, HERMANS MP, MARIAGE JL,  [DIABETIC EUGLYCEMIC KETOSIS OR KETOACIDOSIS IN INDIVIDUALS WITH TYPE 2 DIABETES TREATED BY SGLT2 INHIBITORS: A SERIES OF BELGIAN CLINICAL CASES]. REVUE DE MEDECINE INTERNE 2020 41 226?231",74.0,YR,E,M,Y,,,20210115.0,,HP,BE,BE,2021,Q1,Elderly
187426821,18742682,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,U300,,,,,,,,,,,,2021,Q1,Streptococcal sepsis,,2021,Q1,1,I,,20210108.0,20210115,20210115,EXP,,BE-JNJFOC-20210113975,JOHNSON AND JOHNSON,"MENGHOUM N, ORIOT P, HERMANS MP, MARIAGE JL,  [DIABETIC EUGLYCEMIC KETOSIS OR KETOACIDOSIS IN INDIVIDUALS WITH TYPE 2 DIABETES TREATED BY SGLT2 INHIBITORS: A SERIES OF BELGIAN CLINICAL CASES]. REVUE DE MEDECINE INTERNE 2020 41 226?231",74.0,YR,E,M,Y,,,20210115.0,,HP,BE,BE,2021,Q1,Elderly
187438111,18743811,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,22 UNITS NIGHTLY,,,,,,,,22.0,IU,,QD,2021,Q1,COVID-19,,2021,Q1,1,I,,20210111.0,20210114,20210114,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-075498",BOEHRINGER INGELHEIM,"FISHER N, VITALE R, VALTIS Y, MCDONNELL M, PALERMO N, EUGLYCEMIC DIABETIC KETOACIDOSIS WITH COVID?19 INFECTION IN PATIENTS WITH TYPE 2 DIABETES TAKING SGLT2 INHIBITORS. AACE CLINICAL CASE REPORTS. 2020?",53.0,YR,A,F,Y,,,20210115.0,,MD,US,US,2021,Q1,Adult
187438111,18743811,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,22 UNITS NIGHTLY,,,,,,,,22.0,IU,,QD,2021,Q1,Diabetic ketoacidosis,,2021,Q1,1,I,,20210111.0,20210114,20210114,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-075498",BOEHRINGER INGELHEIM,"FISHER N, VITALE R, VALTIS Y, MCDONNELL M, PALERMO N, EUGLYCEMIC DIABETIC KETOACIDOSIS WITH COVID?19 INFECTION IN PATIENTS WITH TYPE 2 DIABETES TAKING SGLT2 INHIBITORS. AACE CLINICAL CASE REPORTS. 2020?",53.0,YR,A,F,Y,,,20210115.0,,MD,US,US,2021,Q1,Adult
187457271,18745727,9,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Intentional product use issue,,2021,Q1,1,I,20210114.0,,20210114,20210114,DIR,,,FDA-CTU,,73.0,YR,,F,N,95.4,KG,20210114.0,N,HP,US,US,2021,Q1,Elderly
187457271,18745727,9,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Pruritus,,2021,Q1,1,I,20210114.0,,20210114,20210114,DIR,,,FDA-CTU,,73.0,YR,,F,N,95.4,KG,20210114.0,N,HP,US,US,2021,Q1,Elderly
187457271,18745727,9,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Rash,,2021,Q1,1,I,20210114.0,,20210114,20210114,DIR,,,FDA-CTU,,73.0,YR,,F,N,95.4,KG,20210114.0,N,HP,US,US,2021,Q1,Elderly
187457271,18745727,9,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Rash erythematous,,2021,Q1,1,I,20210114.0,,20210114,20210114,DIR,,,FDA-CTU,,73.0,YR,,F,N,95.4,KG,20210114.0,N,HP,US,US,2021,Q1,Elderly
187494698,18749469,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,3 MILLILITER,,,,,,,,3.0,ML,,,2021,Q1,Death,,2021,Q1,8,F,20210111.0,20210223.0,20210116,20210227,PER,,US-AMGEN-USACT2021006737,AMGEN,,67.0,YR,E,M,Y,125.91,KG,20210227.0,,MD,US,US,2021,Q1,Elderly
187529161,18752916,3,SS,INSULIN GLARGINE ER,INSULIN GLARGINE,1,Unknown,"UNK UNKNOWN, UNKNOWN",,,D,,,,,,,,,2021,Q1,Completed suicide,,2021,Q1,1,I,2019.0,20210105.0,20210118,20210118,EXP,,US-ENDO PHARMACEUTICALS INC-2021-000445,ENDO,"GUMMIN DD, MOWRY JB, BEUHLER MC, SPYKER DA, BROOKS DE, DIBERT KW., ET AL.. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2020?58(12):1360?1541",46.0,YR,,F,Y,,,20210118.0,,MD,US,US,2021,Q1,Adult
187563341,18756334,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNKNOWN, UNKNOWN",,,D,,,,,,,EXTENDED RELEASE,,2021,Q1,Completed suicide,,2021,Q1,1,I,2019.0,20210105.0,20210119,20210119,EXP,,US-ENDO PHARMACEUTICALS INC-2021-000287,ENDO,"GUMMIN DD, MOWRY JB, BEUHLER MC, SPYKER DA, BROOKS DE, DIBERT KW., ET AL.. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2020?58(12):1360?1541",61.0,YR,,M,Y,,,20210119.0,,MD,US,US,2021,Q1,Adult
187583054,18758305,6,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,100 IU (INTERNATIONAL UNIT),,,,,,,,100.0,IU,UNKNOWN,QD,2021,Q1,Hypotension,,2021,Q1,4,F,20210103.0,20210204.0,20210119,20210210,EXP,,US-CELGENEUS-USA-20210102081,CELGENE,,55.0,YR,,F,Y,60.2,KG,20210210.0,,MD,US,US,2021,Q1,Adult
187583054,18758305,6,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,100 IU (INTERNATIONAL UNIT),,,,,,,,100.0,IU,UNKNOWN,QD,2021,Q1,Respiratory failure,,2021,Q1,4,F,20210103.0,20210204.0,20210119,20210210,EXP,,US-CELGENEUS-USA-20210102081,CELGENE,,55.0,YR,,F,Y,60.2,KG,20210210.0,,MD,US,US,2021,Q1,Adult
187583054,18758305,6,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,100 IU (INTERNATIONAL UNIT),,,,,,,,100.0,IU,UNKNOWN,QD,2021,Q1,Urinary tract infection,,2021,Q1,4,F,20210103.0,20210204.0,20210119,20210210,EXP,,US-CELGENEUS-USA-20210102081,CELGENE,,55.0,YR,,F,Y,60.2,KG,20210210.0,,MD,US,US,2021,Q1,Adult
187604191,18760419,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,,, OF741A,,,36.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Abdominal abscess,,2021,Q1,1,I,2020.0,20210109.0,20210120,20210120,EXP,,ES-BAUSCH-BL-2021-001079,BAUSCH AND LOMB,,55.0,YR,,F,Y,91.0,KG,20210120.0,,CN,ES,ES,2021,Q1,Adult
187604191,18760419,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,,, OF741A,,,36.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Asymptomatic COVID-19,,2021,Q1,1,I,2020.0,20210109.0,20210120,20210120,EXP,,ES-BAUSCH-BL-2021-001079,BAUSCH AND LOMB,,55.0,YR,,F,Y,91.0,KG,20210120.0,,CN,ES,ES,2021,Q1,Adult
187604191,18760419,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,,, OF741A,,,36.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Dysuria,,2021,Q1,1,I,2020.0,20210109.0,20210120,20210120,EXP,,ES-BAUSCH-BL-2021-001079,BAUSCH AND LOMB,,55.0,YR,,F,Y,91.0,KG,20210120.0,,CN,ES,ES,2021,Q1,Adult
187604191,18760419,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,,, OF741A,,,36.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Hyperglycaemia,,2021,Q1,1,I,2020.0,20210109.0,20210120,20210120,EXP,,ES-BAUSCH-BL-2021-001079,BAUSCH AND LOMB,,55.0,YR,,F,Y,91.0,KG,20210120.0,,CN,ES,ES,2021,Q1,Adult
187604191,18760419,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,,, OF741A,,,36.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Product storage error,,2021,Q1,1,I,2020.0,20210109.0,20210120,20210120,EXP,,ES-BAUSCH-BL-2021-001079,BAUSCH AND LOMB,,55.0,YR,,F,Y,91.0,KG,20210120.0,,CN,ES,ES,2021,Q1,Adult
187604191,18760419,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,,, OF741A,,,36.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Urinary tract infection,,2021,Q1,1,I,2020.0,20210109.0,20210120,20210120,EXP,,ES-BAUSCH-BL-2021-001079,BAUSCH AND LOMB,,55.0,YR,,F,Y,91.0,KG,20210120.0,,CN,ES,ES,2021,Q1,Adult
187615391,18761539,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2021,Q1,Drug ineffective,,2021,Q1,1,I,202003.0,20210113.0,20210120,20210120,EXP,,IT-ASTELLAS-2021US002071,ASTELLAS,,73.0,YR,,M,Y,,,20210120.0,,CN,GB,IT,2021,Q1,Elderly
187621631,18762163,1,PS,"INSULIN (INSULIN, GLARGINE, HUMAN 100 UNT/ML INJ)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER DOSE:45 UNITS;?,,,,,,,,45.0,IU,,BID,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,20201216.0,,20210119,20210119,DIR,,,FDA-CTU,,65.0,YR,,M,N,95.0,KG,20210118.0,N,PH,US,US,2021,Q1,Elderly
187621631,18762163,1,PS,"INSULIN (INSULIN, GLARGINE, HUMAN 100 UNT/ML INJ)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER DOSE:45 UNITS;?,,,,,,,,45.0,IU,,BID,2021,Q1,Mental status changes,,2021,Q1,1,I,20201216.0,,20210119,20210119,DIR,,,FDA-CTU,,65.0,YR,,M,N,95.0,KG,20210118.0,N,PH,US,US,2021,Q1,Elderly
187621631,18762163,1,PS,"INSULIN (INSULIN, GLARGINE, HUMAN 100 UNT/ML INJ)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER DOSE:45 UNITS;?,,,,,,,,45.0,IU,,BID,2021,Q1,Unresponsive to stimuli,,2021,Q1,1,I,20201216.0,,20210119,20210119,DIR,,,FDA-CTU,,65.0,YR,,M,N,95.0,KG,20210118.0,N,PH,US,US,2021,Q1,Elderly
187622691,18762269,4,C,INSULIN GLARGINE/LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,26 UNITS EVERY MORNING,,,,,,,,26.0,IU,,QD,2021,Q1,Aggression,,2021,Q1,1,I,2020.0,20201103.0,20210120,20210120,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2020BDSI0672,BIODELIVERY SCIENCES INTERNATIONAL,,62.0,YR,A,F,Y,,,20210120.0,,CN,US,US,2021,Q1,Adult
187622691,18762269,4,C,INSULIN GLARGINE/LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,26 UNITS EVERY MORNING,,,,,,,,26.0,IU,,QD,2021,Q1,Insomnia,,2021,Q1,1,I,2020.0,20201103.0,20210120,20210120,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2020BDSI0672,BIODELIVERY SCIENCES INTERNATIONAL,,62.0,YR,A,F,Y,,,20210120.0,,CN,US,US,2021,Q1,Adult
187628981,18762898,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q1,Human ehrlichiosis,,2021,Q1,1,I,,20210111.0,20210120,20210120,EXP,,US-MYLANLABS-2021M1003094,MYLAN,,57.0,YR,,M,Y,,,20210120.0,,HP,US,US,2021,Q1,Adult
187628981,18762898,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q1,Hyponatraemia,,2021,Q1,1,I,,20210111.0,20210120,20210120,EXP,,US-MYLANLABS-2021M1003094,MYLAN,,57.0,YR,,M,Y,,,20210120.0,,HP,US,US,2021,Q1,Adult
187637082,18763708,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, UNKNOWN,,,12.0,IU,UNKNOWN,,2021,Q1,Keratitis,,2021,Q1,2,F,202006.0,20210202.0,20210120,20210210,EXP,FR-AFSSAPS-AN20210007,FR-FRESENIUS KABI-FK202100635,FRESENIUS KABI,,57.0,YR,,F,Y,50.0,KG,20210210.0,,HP,NL,FR,2021,Q1,Adult
187637082,18763708,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, UNKNOWN,,,12.0,IU,UNKNOWN,,2021,Q1,Visual acuity reduced,,2021,Q1,2,F,202006.0,20210202.0,20210120,20210210,EXP,FR-AFSSAPS-AN20210007,FR-FRESENIUS KABI-FK202100635,FRESENIUS KABI,,57.0,YR,,F,Y,50.0,KG,20210210.0,,HP,NL,FR,2021,Q1,Adult
187644831,18764483,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU/ML, QD",,,Y,, 030719,,,,,,QD,2021,Q1,Hyperglycaemia,,2021,Q1,1,I,20200210.0,20210115.0,20210120,20210120,EXP,,RU-SA-2021SA013323,SANOFI AVENTIS,,16.0,YR,T,M,Y,46.0,KG,20210120.0,,MD,RU,RU,2021,Q1,Youth
187644831,18764483,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU/ML, QD",,,Y,, 030719,,,,,,QD,2021,Q1,Loss of consciousness,,2021,Q1,1,I,20200210.0,20210115.0,20210120,20210120,EXP,,RU-SA-2021SA013323,SANOFI AVENTIS,,16.0,YR,T,M,Y,46.0,KG,20210120.0,,MD,RU,RU,2021,Q1,Youth
187644831,18764483,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU/ML, QD",,,Y,, 030719,,,,,,QD,2021,Q1,Sleep disorder,,2021,Q1,1,I,20200210.0,20210115.0,20210120,20210120,EXP,,RU-SA-2021SA013323,SANOFI AVENTIS,,16.0,YR,T,M,Y,46.0,KG,20210120.0,,MD,RU,RU,2021,Q1,Youth
187644831,18764483,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU/ML, QD",,,Y,, 030719,,,,,,QD,2021,Q1,Vomiting,,2021,Q1,1,I,20200210.0,20210115.0,20210120,20210120,EXP,,RU-SA-2021SA013323,SANOFI AVENTIS,,16.0,YR,T,M,Y,46.0,KG,20210120.0,,MD,RU,RU,2021,Q1,Youth
187651541,18765154,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Chronic gastritis,,2021,Q1,1,I,,20210118.0,20210120,20210120,EXP,,ES-MYLANLABS-2021M1003370,MYLAN,,69.0,YR,,F,Y,,,20210120.0,,MD,ES,ES,2021,Q1,Elderly
187651541,18765154,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Diabetes mellitus inadequate control,,2021,Q1,1,I,,20210118.0,20210120,20210120,EXP,,ES-MYLANLABS-2021M1003370,MYLAN,,69.0,YR,,F,Y,,,20210120.0,,MD,ES,ES,2021,Q1,Elderly
187651541,18765154,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Drug intolerance,,2021,Q1,1,I,,20210118.0,20210120,20210120,EXP,,ES-MYLANLABS-2021M1003370,MYLAN,,69.0,YR,,F,Y,,,20210120.0,,MD,ES,ES,2021,Q1,Elderly
187651541,18765154,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Dyslipidaemia,,2021,Q1,1,I,,20210118.0,20210120,20210120,EXP,,ES-MYLANLABS-2021M1003370,MYLAN,,69.0,YR,,F,Y,,,20210120.0,,MD,ES,ES,2021,Q1,Elderly
187651541,18765154,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Hepatic steatosis,,2021,Q1,1,I,,20210118.0,20210120,20210120,EXP,,ES-MYLANLABS-2021M1003370,MYLAN,,69.0,YR,,F,Y,,,20210120.0,,MD,ES,ES,2021,Q1,Elderly
187651541,18765154,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Hypertension,,2021,Q1,1,I,,20210118.0,20210120,20210120,EXP,,ES-MYLANLABS-2021M1003370,MYLAN,,69.0,YR,,F,Y,,,20210120.0,,MD,ES,ES,2021,Q1,Elderly
187651541,18765154,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Overweight,,2021,Q1,1,I,,20210118.0,20210120,20210120,EXP,,ES-MYLANLABS-2021M1003370,MYLAN,,69.0,YR,,F,Y,,,20210120.0,,MD,ES,ES,2021,Q1,Elderly
187653441,18765344,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNKNOWN, UNKNOWN",,,D,, UNKNOWN,,,,,,,2021,Q1,Exposure to toxic agent,,2021,Q1,1,I,,20210111.0,20210120,20210120,EXP,,US-PERRIGO-21US000481,PERRIGO,,61.0,YR,,M,Y,,,20210120.0,,PH,US,US,2021,Q1,Adult
187667741,18766774,3,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Anaphylactic reaction,,2021,Q1,1,I,20210115.0,,20210120,20210120,DIR,,,FDA-CTU,,56.0,YR,,M,N,146.2,KG,20210120.0,N,HP,US,US,2021,Q1,Adult
187667741,18766774,3,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Diarrhoea,,2021,Q1,1,I,20210115.0,,20210120,20210120,DIR,,,FDA-CTU,,56.0,YR,,M,N,146.2,KG,20210120.0,N,HP,US,US,2021,Q1,Adult
187667741,18766774,3,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Dyspepsia,,2021,Q1,1,I,20210115.0,,20210120,20210120,DIR,,,FDA-CTU,,56.0,YR,,M,N,146.2,KG,20210120.0,N,HP,US,US,2021,Q1,Adult
187667741,18766774,3,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Movement disorder,,2021,Q1,1,I,20210115.0,,20210120,20210120,DIR,,,FDA-CTU,,56.0,YR,,M,N,146.2,KG,20210120.0,N,HP,US,US,2021,Q1,Adult
187679231,18767923,2,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,N,,,,,,,,2021,Q1,Hyponatraemia,,2021,Q1,1,I,,20210120.0,20210121,20210121,EXP,,US-CELLTRION-2021-US-001083,CELLTRION,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ..EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION..TRANSPLANT INFECTIOUS DISEASE.2020?22(5):.",57.0,YR,,M,Y,,,20210121.0,,HP,US,US,2021,Q1,Adult
187679231,18767923,2,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,N,,,,,,,,2021,Q1,Inappropriate antidiuretic hormone secretion,,2021,Q1,1,I,,20210120.0,20210121,20210121,EXP,,US-CELLTRION-2021-US-001083,CELLTRION,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ..EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION..TRANSPLANT INFECTIOUS DISEASE.2020?22(5):.",57.0,YR,,M,Y,,,20210121.0,,HP,US,US,2021,Q1,Adult
187684731,18768473,13,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Death,,2021,Q1,1,I,20200910.0,,20210121,20210121,DIR,,,FDA-CTU,,68.0,YR,,M,N,73.0,KG,20210121.0,N,MD,US,US,2021,Q1,Elderly
187695321,18769532,13,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Agranulocytosis,,2021,Q1,1,I,20200212.0,20210113.0,20210121,20210121,EXP,FR-AFSSAPS-LM20200784,FR-BAYER-2021-022501,BAYER,,70.0,YR,E,M,Y,80.0,KG,20210121.0,,HP,NL,FR,2021,Q1,Elderly
187695321,18769532,13,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Neutropenia,,2021,Q1,1,I,20200212.0,20210113.0,20210121,20210121,EXP,FR-AFSSAPS-LM20200784,FR-BAYER-2021-022501,BAYER,,70.0,YR,E,M,Y,80.0,KG,20210121.0,,HP,NL,FR,2021,Q1,Elderly
187725551,18772555,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,30.0,IU,,QD,2021,Q1,Diabetes mellitus,,2021,Q1,1,I,20200220.0,20200304.0,20210122,20210122,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-012999",BOEHRINGER INGELHEIM,,76.0,YR,E,F,Y,,,20210122.0,,MD,DE,DE,2021,Q1,Elderly
187755101,18775510,2,C,INSULINE GLARGINE ((BACTERIE/ESCHERICHIA COLI)),INSULIN GLARGINE,1,,,,,,, UNKNOWN,,,,,,,2021,Q1,Drug reaction with eosinophilia and systemic symptoms,,2021,Q1,1,I,20200830.0,20210114.0,20210122,20210122,EXP,FR-AFSSAPS-ST20210004,FR-TEVA-2021-FR-1871177,TEVA,,69.0,YR,E,M,Y,90.0,KG,20210122.0,,HP,FR,FR,2021,Q1,Elderly
187759531,18775953,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Oropharyngeal pain,,2021,Q1,1,I,20210107.0,20210112.0,20210122,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202101005817,ELI LILLY AND CO,,81.0,YR,,M,Y,73.92,KG,20210122.0,,MD,US,US,2021,Q1,Elderly
187759531,18775953,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Oxygen saturation decreased,,2021,Q1,1,I,20210107.0,20210112.0,20210122,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202101005817,ELI LILLY AND CO,,81.0,YR,,M,Y,73.92,KG,20210122.0,,MD,US,US,2021,Q1,Elderly
187760231,18776023,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Intestinal ischaemia,,2021,Q1,1,I,20181213.0,20210119.0,20210122,20210122,EXP,,US-ASTRAZENECA-2021A010814,ASTRAZENECA,,22288.0,DY,,F,Y,,,20210122.0,,,US,US,2021,Q1,Elderly
187760231,18776023,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Necrotising fasciitis,,2021,Q1,1,I,20181213.0,20210119.0,20210122,20210122,EXP,,US-ASTRAZENECA-2021A010814,ASTRAZENECA,,22288.0,DY,,F,Y,,,20210122.0,,,US,US,2021,Q1,Elderly
187760231,18776023,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Perforation,,2021,Q1,1,I,20181213.0,20210119.0,20210122,20210122,EXP,,US-ASTRAZENECA-2021A010814,ASTRAZENECA,,22288.0,DY,,F,Y,,,20210122.0,,,US,US,2021,Q1,Elderly
187760231,18776023,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Sepsis,,2021,Q1,1,I,20181213.0,20210119.0,20210122,20210122,EXP,,US-ASTRAZENECA-2021A010814,ASTRAZENECA,,22288.0,DY,,F,Y,,,20210122.0,,,US,US,2021,Q1,Elderly
187760231,18776023,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Septic shock,,2021,Q1,1,I,20181213.0,20210119.0,20210122,20210122,EXP,,US-ASTRAZENECA-2021A010814,ASTRAZENECA,,22288.0,DY,,F,Y,,,20210122.0,,,US,US,2021,Q1,Elderly
187760231,18776023,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Subcutaneous abscess,,2021,Q1,1,I,20181213.0,20210119.0,20210122,20210122,EXP,,US-ASTRAZENECA-2021A010814,ASTRAZENECA,,22288.0,DY,,F,Y,,,20210122.0,,,US,US,2021,Q1,Elderly
187772271,18777227,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Cyanosis,,2021,Q1,1,I,20200823.0,20201202.0,20210123,20210123,EXP,,ES-TAKEDA-2020TUS055483,TAKEDA,,75.0,YR,,M,Y,86.4,KG,20210123.0,,MD,ES,ES,2021,Q1,Elderly
187772271,18777227,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Hypokalaemia,,2021,Q1,1,I,20200823.0,20201202.0,20210123,20210123,EXP,,ES-TAKEDA-2020TUS055483,TAKEDA,,75.0,YR,,M,Y,86.4,KG,20210123.0,,MD,ES,ES,2021,Q1,Elderly
187772271,18777227,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Hyponatraemia,,2021,Q1,1,I,20200823.0,20201202.0,20210123,20210123,EXP,,ES-TAKEDA-2020TUS055483,TAKEDA,,75.0,YR,,M,Y,86.4,KG,20210123.0,,MD,ES,ES,2021,Q1,Elderly
187772271,18777227,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Hypoxia,,2021,Q1,1,I,20200823.0,20201202.0,20210123,20210123,EXP,,ES-TAKEDA-2020TUS055483,TAKEDA,,75.0,YR,,M,Y,86.4,KG,20210123.0,,MD,ES,ES,2021,Q1,Elderly
187772271,18777227,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Klebsiella infection,,2021,Q1,1,I,20200823.0,20201202.0,20210123,20210123,EXP,,ES-TAKEDA-2020TUS055483,TAKEDA,,75.0,YR,,M,Y,86.4,KG,20210123.0,,MD,ES,ES,2021,Q1,Elderly
187784751,18778475,4,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q1,Drug ineffective,,2021,Q1,1,I,,20210111.0,20210123,20210123,EXP,,US-TEVA-2021-US-1869964,TEVA,"TORRICO T, KIAI N, MEZA C, SALAM MT, ABDIJADID S. SUSPECTED ARIPIPRAZOLE?INDUCED NEUTROPENIA IN A GERIATRIC PATIENT: A CASE REPORT. BMC?GERIATR 2020?20:NO. 1.",68.0,YR,E,M,Y,,,20210123.0,,HP,US,US,2021,Q1,Elderly
187784751,18778475,4,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q1,Hypotension,,2021,Q1,1,I,,20210111.0,20210123,20210123,EXP,,US-TEVA-2021-US-1869964,TEVA,"TORRICO T, KIAI N, MEZA C, SALAM MT, ABDIJADID S. SUSPECTED ARIPIPRAZOLE?INDUCED NEUTROPENIA IN A GERIATRIC PATIENT: A CASE REPORT. BMC?GERIATR 2020?20:NO. 1.",68.0,YR,E,M,Y,,,20210123.0,,HP,US,US,2021,Q1,Elderly
187784751,18778475,4,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q1,Neutropenia,,2021,Q1,1,I,,20210111.0,20210123,20210123,EXP,,US-TEVA-2021-US-1869964,TEVA,"TORRICO T, KIAI N, MEZA C, SALAM MT, ABDIJADID S. SUSPECTED ARIPIPRAZOLE?INDUCED NEUTROPENIA IN A GERIATRIC PATIENT: A CASE REPORT. BMC?GERIATR 2020?20:NO. 1.",68.0,YR,E,M,Y,,,20210123.0,,HP,US,US,2021,Q1,Elderly
187810571,18781057,1,PS,"INSULIN (INSULIN, GLARGINE, HUMAN 300 UNIT/ML INJ, SOLOSTAR, 3ML)",INSULIN GLARGINE,1,Subcutaneous,,,,D,N,,,,45.0,DF,,QD,2021,Q1,Diabetic ketoacidosis,,2021,Q1,1,I,20200715.0,,20210124,20210124,DIR,,,FDA-CTU,,63.0,YR,,M,N,72.12,KG,20201021.0,N,PH,US,US,2021,Q1,Adult
187810571,18781057,1,PS,"INSULIN (INSULIN, GLARGINE, HUMAN 300 UNIT/ML INJ, SOLOSTAR, 3ML)",INSULIN GLARGINE,1,Subcutaneous,,,,D,N,,,,45.0,DF,,QD,2021,Q1,Intentional dose omission,,2021,Q1,1,I,20200715.0,,20210124,20210124,DIR,,,FDA-CTU,,63.0,YR,,M,N,72.12,KG,20201021.0,N,PH,US,US,2021,Q1,Adult
187852542,18785254,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Off label use,,2021,Q1,2,F,20190723.0,20210217.0,20210125,20210223,EXP,,CA-TAKEDA-2021TUS004224,TAKEDA,,74.0,YR,,F,Y,,,20210223.0,,CN,CA,CA,2021,Q1,Elderly
187852542,18785254,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Pneumonia,,2021,Q1,2,F,20190723.0,20210217.0,20210125,20210223,EXP,,CA-TAKEDA-2021TUS004224,TAKEDA,,74.0,YR,,F,Y,,,20210223.0,,CN,CA,CA,2021,Q1,Elderly
187891382,18789138,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,, D253709A,,205692.0,,,INJECTION,,2021,Q1,Asthma,,2021,Q1,2,F,20210119.0,20210212.0,20210125,20210310,PER,,US-ELI_LILLY_AND_COMPANY-US202101009832,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20210310.0,,CN,US,US,2021,Q1,Adult
187891382,18789138,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,, D253709A,,205692.0,,,INJECTION,,2021,Q1,Blood glucose decreased,,2021,Q1,2,F,20210119.0,20210212.0,20210125,20210310,PER,,US-ELI_LILLY_AND_COMPANY-US202101009832,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20210310.0,,CN,US,US,2021,Q1,Adult
187891382,18789138,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,, D253709A,,205692.0,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,2,F,20210119.0,20210212.0,20210125,20210310,PER,,US-ELI_LILLY_AND_COMPANY-US202101009832,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20210310.0,,CN,US,US,2021,Q1,Adult
187891382,18789138,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,, D253709A,,205692.0,,,INJECTION,,2021,Q1,Chest discomfort,,2021,Q1,2,F,20210119.0,20210212.0,20210125,20210310,PER,,US-ELI_LILLY_AND_COMPANY-US202101009832,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20210310.0,,CN,US,US,2021,Q1,Adult
187891382,18789138,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,, D253709A,,205692.0,,,INJECTION,,2021,Q1,Chest pain,,2021,Q1,2,F,20210119.0,20210212.0,20210125,20210310,PER,,US-ELI_LILLY_AND_COMPANY-US202101009832,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20210310.0,,CN,US,US,2021,Q1,Adult
187891382,18789138,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,, D253709A,,205692.0,,,INJECTION,,2021,Q1,Malaise,,2021,Q1,2,F,20210119.0,20210212.0,20210125,20210310,PER,,US-ELI_LILLY_AND_COMPANY-US202101009832,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20210310.0,,CN,US,US,2021,Q1,Adult
187891382,18789138,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,, D253709A,,205692.0,,,INJECTION,,2021,Q1,Product dose omission issue,,2021,Q1,2,F,20210119.0,20210212.0,20210125,20210310,PER,,US-ELI_LILLY_AND_COMPANY-US202101009832,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20210310.0,,CN,US,US,2021,Q1,Adult
187927911,18792791,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Off label use,,2021,Q1,1,I,,20210114.0,20210127,20210127,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-00605,LUPIN,,69.0,YR,,F,Y,,,20210127.0,,PH,US,US,2021,Q1,Elderly
187976261,18797626,14,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Anaemia,,2021,Q1,1,I,,20210118.0,20210127,20210127,EXP,,US-AUROBINDO-AUR-APL-2021-002725,AUROBINDO,,57.0,YR,,M,Y,,,20210128.0,,HP,US,US,2021,Q1,Adult
187976261,18797626,14,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Human ehrlichiosis,,2021,Q1,1,I,,20210118.0,20210127,20210127,EXP,,US-AUROBINDO-AUR-APL-2021-002725,AUROBINDO,,57.0,YR,,M,Y,,,20210128.0,,HP,US,US,2021,Q1,Adult
187976261,18797626,14,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Hyponatraemia,,2021,Q1,1,I,,20210118.0,20210127,20210127,EXP,,US-AUROBINDO-AUR-APL-2021-002725,AUROBINDO,,57.0,YR,,M,Y,,,20210128.0,,HP,US,US,2021,Q1,Adult
187976261,18797626,14,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Mental status changes,,2021,Q1,1,I,,20210118.0,20210127,20210127,EXP,,US-AUROBINDO-AUR-APL-2021-002725,AUROBINDO,,57.0,YR,,M,Y,,,20210128.0,,HP,US,US,2021,Q1,Adult
187976261,18797626,14,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Pyrexia,,2021,Q1,1,I,,20210118.0,20210127,20210127,EXP,,US-AUROBINDO-AUR-APL-2021-002725,AUROBINDO,,57.0,YR,,M,Y,,,20210128.0,,HP,US,US,2021,Q1,Adult
187976261,18797626,14,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Renal impairment,,2021,Q1,1,I,,20210118.0,20210127,20210127,EXP,,US-AUROBINDO-AUR-APL-2021-002725,AUROBINDO,,57.0,YR,,M,Y,,,20210128.0,,HP,US,US,2021,Q1,Adult
187976261,18797626,14,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Thrombocytopenia,,2021,Q1,1,I,,20210118.0,20210127,20210127,EXP,,US-AUROBINDO-AUR-APL-2021-002725,AUROBINDO,,57.0,YR,,M,Y,,,20210128.0,,HP,US,US,2021,Q1,Adult
187976261,18797626,14,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Transaminases increased,,2021,Q1,1,I,,20210118.0,20210127,20210127,EXP,,US-AUROBINDO-AUR-APL-2021-002725,AUROBINDO,,57.0,YR,,M,Y,,,20210128.0,,HP,US,US,2021,Q1,Adult
188021751,18802175,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,Y,U,,,210605.0,,,,,2021,Q1,Diabetes mellitus inadequate control,,2021,Q1,1,I,2015.0,20210125.0,20210128,20210128,EXP,,DE-MYLANLABS-2021M1005063,MYLAN,,40.0,YR,,F,Y,,,20210128.0,,CN,DE,DE,2021,Q1,Adult
188021751,18802175,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,Y,U,,,210605.0,,,,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,2015.0,20210125.0,20210128,20210128,EXP,,DE-MYLANLABS-2021M1005063,MYLAN,,40.0,YR,,F,Y,,,20210128.0,,CN,DE,DE,2021,Q1,Adult
188028011,18802801,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,,20210126.0,20210129,20210129,EXP,,JP-009507513-2101JPN011960,MERCK,TANAKA H.. UTILITY OF METFORMIN AND ITS PROPER USE,48.0,YR,,M,Y,,,20210129.0,,MD,JP,JP,2021,Q1,Adult
188028011,18802801,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q1,Intentional self-injury,,2021,Q1,1,I,,20210126.0,20210129,20210129,EXP,,JP-009507513-2101JPN011960,MERCK,TANAKA H.. UTILITY OF METFORMIN AND ITS PROPER USE,48.0,YR,,M,Y,,,20210129.0,,MD,JP,JP,2021,Q1,Adult
188028011,18802801,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q1,Lactic acidosis,,2021,Q1,1,I,,20210126.0,20210129,20210129,EXP,,JP-009507513-2101JPN011960,MERCK,TANAKA H.. UTILITY OF METFORMIN AND ITS PROPER USE,48.0,YR,,M,Y,,,20210129.0,,MD,JP,JP,2021,Q1,Adult
188028011,18802801,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q1,Overdose,,2021,Q1,1,I,,20210126.0,20210129,20210129,EXP,,JP-009507513-2101JPN011960,MERCK,TANAKA H.. UTILITY OF METFORMIN AND ITS PROPER USE,48.0,YR,,M,Y,,,20210129.0,,MD,JP,JP,2021,Q1,Adult
188028011,18802801,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q1,Pneumonia aspiration,,2021,Q1,1,I,,20210126.0,20210129,20210129,EXP,,JP-009507513-2101JPN011960,MERCK,TANAKA H.. UTILITY OF METFORMIN AND ITS PROPER USE,48.0,YR,,M,Y,,,20210129.0,,MD,JP,JP,2021,Q1,Adult
188028011,18802801,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q1,Vomiting,,2021,Q1,1,I,,20210126.0,20210129,20210129,EXP,,JP-009507513-2101JPN011960,MERCK,TANAKA H.. UTILITY OF METFORMIN AND ITS PROPER USE,48.0,YR,,M,Y,,,20210129.0,,MD,JP,JP,2021,Q1,Adult
188061861,18806186,5,C,insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q1,Cardio-respiratory arrest,,2021,Q1,1,I,20201231.0,20210121.0,20210129,20210129,EXP,,CO-BAXTER-2021BAX001574,BAXTER,,38.0,YR,,F,Y,50.0,KG,20210129.0,,HP,CO,CO,2021,Q1,Adult
188061861,18806186,5,C,insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q1,Gastric infection,,2021,Q1,1,I,20201231.0,20210121.0,20210129,20210129,EXP,,CO-BAXTER-2021BAX001574,BAXTER,,38.0,YR,,F,Y,50.0,KG,20210129.0,,HP,CO,CO,2021,Q1,Adult
188061861,18806186,5,C,insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q1,Pneumothorax,,2021,Q1,1,I,20201231.0,20210121.0,20210129,20210129,EXP,,CO-BAXTER-2021BAX001574,BAXTER,,38.0,YR,,F,Y,50.0,KG,20210129.0,,HP,CO,CO,2021,Q1,Adult
188061861,18806186,5,C,insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q1,Pulmonary oedema,,2021,Q1,1,I,20201231.0,20210121.0,20210129,20210129,EXP,,CO-BAXTER-2021BAX001574,BAXTER,,38.0,YR,,F,Y,50.0,KG,20210129.0,,HP,CO,CO,2021,Q1,Adult
188062731,18806273,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, ONCE A DAY",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Blood glucose increased,,2021,Q1,1,I,,20210125.0,20210129,20210129,EXP,,ES-AUROBINDO-AUR-APL-2021-003717,AUROBINDO,,60.0,YR,,F,Y,,,20210129.0,,HP,ES,ES,2021,Q1,Adult
188062731,18806273,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, ONCE A DAY",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Pancreatic disorder,,2021,Q1,1,I,,20210125.0,20210129,20210129,EXP,,ES-AUROBINDO-AUR-APL-2021-003717,AUROBINDO,,60.0,YR,,F,Y,,,20210129.0,,HP,ES,ES,2021,Q1,Adult
188079404,18807940,18,C,INSULIN GLARGINE BS INJECTION,,2,,"3 IU, QD, BEFORE BEDTIME",,,,,,,,3.0,IU,,QD,2021,Q1,Affective disorder,,2021,Q1,4,F,202005.0,20210322.0,20210129,20210329,EXP,,JP-GLAXOSMITHKLINE-JP2021JPN017196,GLAXOSMITHKLINE,,63.0,YR,,F,Y,48.0,KG,20210329.0,,CN,JP,JP,2021,Q1,Adult
188079404,18807940,18,C,INSULIN GLARGINE BS INJECTION,,2,,"3 IU, QD, BEFORE BEDTIME",,,,,,,,3.0,IU,,QD,2021,Q1,Constipation,,2021,Q1,4,F,202005.0,20210322.0,20210129,20210329,EXP,,JP-GLAXOSMITHKLINE-JP2021JPN017196,GLAXOSMITHKLINE,,63.0,YR,,F,Y,48.0,KG,20210329.0,,CN,JP,JP,2021,Q1,Adult
188079404,18807940,18,C,INSULIN GLARGINE BS INJECTION,,2,,"3 IU, QD, BEFORE BEDTIME",,,,,,,,3.0,IU,,QD,2021,Q1,Depressed mood,,2021,Q1,4,F,202005.0,20210322.0,20210129,20210329,EXP,,JP-GLAXOSMITHKLINE-JP2021JPN017196,GLAXOSMITHKLINE,,63.0,YR,,F,Y,48.0,KG,20210329.0,,CN,JP,JP,2021,Q1,Adult
188079404,18807940,18,C,INSULIN GLARGINE BS INJECTION,,2,,"3 IU, QD, BEFORE BEDTIME",,,,,,,,3.0,IU,,QD,2021,Q1,Diverticulum intestinal haemorrhagic,,2021,Q1,4,F,202005.0,20210322.0,20210129,20210329,EXP,,JP-GLAXOSMITHKLINE-JP2021JPN017196,GLAXOSMITHKLINE,,63.0,YR,,F,Y,48.0,KG,20210329.0,,CN,JP,JP,2021,Q1,Adult
188079404,18807940,18,C,INSULIN GLARGINE BS INJECTION,,2,,"3 IU, QD, BEFORE BEDTIME",,,,,,,,3.0,IU,,QD,2021,Q1,"Hallucination, visual",,2021,Q1,4,F,202005.0,20210322.0,20210129,20210329,EXP,,JP-GLAXOSMITHKLINE-JP2021JPN017196,GLAXOSMITHKLINE,,63.0,YR,,F,Y,48.0,KG,20210329.0,,CN,JP,JP,2021,Q1,Adult
188089651,18808965,15,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q1,Diarrhoea,,2021,Q1,1,I,20210121.0,20210121.0,20210129,20210129,PER,,US-CELGENEUS-USA-20210105433,CELGENE,,79.0,YR,,F,Y,77.63,KG,20210129.0,,PH,US,US,2021,Q1,Elderly
188102381,18810238,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"40 UNIT, QD (AT BEDTIME)",,,,,,,,,,,QD,2021,Q1,Off label use,,2021,Q1,1,I,,20210118.0,20210129,20210129,EXP,,IT-LUPIN PHARMACEUTICALS INC.-2021-00928,LUPIN,,73.0,YR,,M,Y,,,20210129.0,,HP,IT,IT,2021,Q1,Elderly
188113031,18811303,14,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q1,Human ehrlichiosis,,2021,Q1,1,I,,20210118.0,20210129,20210129,EXP,,US-TEVA-2021-US-1872171,TEVA,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPL?INFECT?DIS 2020?22:NO. 5.",57.0,YR,A,M,Y,,,20210129.0,,HP,US,US,2021,Q1,Adult
188113031,18811303,14,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q1,Hyponatraemia,,2021,Q1,1,I,,20210118.0,20210129,20210129,EXP,,US-TEVA-2021-US-1872171,TEVA,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPL?INFECT?DIS 2020?22:NO. 5.",57.0,YR,A,M,Y,,,20210129.0,,HP,US,US,2021,Q1,Adult
188124071,18812407,15,C,INSULIN GLARGINE BIOSIMILAR 1,,2,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Decreased appetite,,2021,Q1,1,I,20191008.0,20191010.0,20210130,20210130,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-098429,BRISTOL MYERS SQUIBB,,73.0,YR,,F,Y,93.8,KG,20210130.0,,PH,JP,JP,2021,Q1,Elderly
188124071,18812407,15,C,INSULIN GLARGINE BIOSIMILAR 1,,2,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Interstitial lung disease,,2021,Q1,1,I,20191008.0,20191010.0,20210130,20210130,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-098429,BRISTOL MYERS SQUIBB,,73.0,YR,,F,Y,93.8,KG,20210130.0,,PH,JP,JP,2021,Q1,Elderly
188124071,18812407,15,C,INSULIN GLARGINE BIOSIMILAR 1,,2,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Myasthenia gravis,,2021,Q1,1,I,20191008.0,20191010.0,20210130,20210130,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-098429,BRISTOL MYERS SQUIBB,,73.0,YR,,F,Y,93.8,KG,20210130.0,,PH,JP,JP,2021,Q1,Elderly
188124071,18812407,15,C,INSULIN GLARGINE BIOSIMILAR 1,,2,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Myocarditis,,2021,Q1,1,I,20191008.0,20191010.0,20210130,20210130,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-098429,BRISTOL MYERS SQUIBB,,73.0,YR,,F,Y,93.8,KG,20210130.0,,PH,JP,JP,2021,Q1,Elderly
188124071,18812407,15,C,INSULIN GLARGINE BIOSIMILAR 1,,2,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Myositis,,2021,Q1,1,I,20191008.0,20191010.0,20210130,20210130,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-098429,BRISTOL MYERS SQUIBB,,73.0,YR,,F,Y,93.8,KG,20210130.0,,PH,JP,JP,2021,Q1,Elderly
188125781,18812578,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Atrial flutter,,2021,Q1,1,I,202009.0,20210116.0,20210130,20210130,EXP,,NVSC2021HR011826,NOVARTIS,,73.0,YR,,M,Y,,,20210130.0,,MD,HR,HR,2021,Q1,Elderly
188144551,18814455,16,C,insulin glargine,INSULIN GLARGINE,1,Unknown,"40 UNIT, DAILY",,,U,,,,,,,,,2021,Q1,Drug ineffective,,2021,Q1,1,I,,20210118.0,20210201,20210201,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-278420,RANBAXY,"ANTINORI S, RECH R, GALIMBERTI L, CASTELLI A, ANGELI E, FOSSALI T, ET AL. INVASIVE PULMONARY ASPERGILLOSIS COMPLICATING SARS?COV?2 PNEUMONIA: A DIAGNOSTIC CHALLENGE. TRAVEL MED INFECT DIS. 2020?38:101752",73.0,YR,,M,Y,,,20210201.0,,HP,IT,IT,2021,Q1,Elderly
188144551,18814455,16,C,insulin glargine,INSULIN GLARGINE,1,Unknown,"40 UNIT, DAILY",,,U,,,,,,,,,2021,Q1,Off label use,,2021,Q1,1,I,,20210118.0,20210201,20210201,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-278420,RANBAXY,"ANTINORI S, RECH R, GALIMBERTI L, CASTELLI A, ANGELI E, FOSSALI T, ET AL. INVASIVE PULMONARY ASPERGILLOSIS COMPLICATING SARS?COV?2 PNEUMONIA: A DIAGNOSTIC CHALLENGE. TRAVEL MED INFECT DIS. 2020?38:101752",73.0,YR,,M,Y,,,20210201.0,,HP,IT,IT,2021,Q1,Elderly
188165701,18816570,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q1,Angioedema,,2021,Q1,1,I,,20210120.0,20210201,20210201,EXP,,US-MYLANLABS-2021M1005475,MYLAN,"BATARSEH E, KERSTEN BP, PINELO AC, NADLER JN, SCHWARTZ SA. ANGIOEDEMA IN AFRICAN AMERICAN PATIENTS HOSPITALIZED FOR COVID?19. AM?J?RESPIR?CRIT?CARE?MED 2020?202(11):1581?1583.",69.0,YR,,F,Y,,,20210201.0,,MD,US,US,2021,Q1,Elderly
188165701,18816570,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q1,Drug ineffective,,2021,Q1,1,I,,20210120.0,20210201,20210201,EXP,,US-MYLANLABS-2021M1005475,MYLAN,"BATARSEH E, KERSTEN BP, PINELO AC, NADLER JN, SCHWARTZ SA. ANGIOEDEMA IN AFRICAN AMERICAN PATIENTS HOSPITALIZED FOR COVID?19. AM?J?RESPIR?CRIT?CARE?MED 2020?202(11):1581?1583.",69.0,YR,,F,Y,,,20210201.0,,MD,US,US,2021,Q1,Elderly
188165701,18816570,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q1,Off label use,,2021,Q1,1,I,,20210120.0,20210201,20210201,EXP,,US-MYLANLABS-2021M1005475,MYLAN,"BATARSEH E, KERSTEN BP, PINELO AC, NADLER JN, SCHWARTZ SA. ANGIOEDEMA IN AFRICAN AMERICAN PATIENTS HOSPITALIZED FOR COVID?19. AM?J?RESPIR?CRIT?CARE?MED 2020?202(11):1581?1583.",69.0,YR,,F,Y,,,20210201.0,,MD,US,US,2021,Q1,Elderly
188172981,18817298,2,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, QD",250.0,IU,,, 122006041,,,22.0,IU,,QD,2021,Q1,Drug interaction,,2021,Q1,1,I,20200121.0,20210130.0,20210201,20210201,EXP,,CN-BAYER-2021-048267,BAYER,,83.0,YR,E,M,Y,,,20210201.0,,HP,CN,CN,2021,Q1,Elderly
188172981,18817298,2,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, QD",250.0,IU,,, 122006041,,,22.0,IU,,QD,2021,Q1,Hyperhidrosis,,2021,Q1,1,I,20200121.0,20210130.0,20210201,20210201,EXP,,CN-BAYER-2021-048267,BAYER,,83.0,YR,E,M,Y,,,20210201.0,,HP,CN,CN,2021,Q1,Elderly
188172981,18817298,2,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, QD",250.0,IU,,, 122006041,,,22.0,IU,,QD,2021,Q1,Hypoglycaemic coma,,2021,Q1,1,I,20200121.0,20210130.0,20210201,20210201,EXP,,CN-BAYER-2021-048267,BAYER,,83.0,YR,E,M,Y,,,20210201.0,,HP,CN,CN,2021,Q1,Elderly
188172981,18817298,2,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, QD",250.0,IU,,, 122006041,,,22.0,IU,,QD,2021,Q1,Slow response to stimuli,,2021,Q1,1,I,20200121.0,20210130.0,20210201,20210201,EXP,,CN-BAYER-2021-048267,BAYER,,83.0,YR,E,M,Y,,,20210201.0,,HP,CN,CN,2021,Q1,Elderly
188172981,18817298,2,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, QD",250.0,IU,,, 122006041,,,22.0,IU,,QD,2021,Q1,Unresponsive to stimuli,,2021,Q1,1,I,20200121.0,20210130.0,20210201,20210201,EXP,,CN-BAYER-2021-048267,BAYER,,83.0,YR,E,M,Y,,,20210201.0,,HP,CN,CN,2021,Q1,Elderly
188172981,18817298,3,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",250.0,IU,,, 122006041,,,16.0,IU,,QD,2021,Q1,Drug interaction,,2021,Q1,1,I,20200121.0,20210130.0,20210201,20210201,EXP,,CN-BAYER-2021-048267,BAYER,,83.0,YR,E,M,Y,,,20210201.0,,HP,CN,CN,2021,Q1,Elderly
188172981,18817298,3,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",250.0,IU,,, 122006041,,,16.0,IU,,QD,2021,Q1,Hyperhidrosis,,2021,Q1,1,I,20200121.0,20210130.0,20210201,20210201,EXP,,CN-BAYER-2021-048267,BAYER,,83.0,YR,E,M,Y,,,20210201.0,,HP,CN,CN,2021,Q1,Elderly
188172981,18817298,3,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",250.0,IU,,, 122006041,,,16.0,IU,,QD,2021,Q1,Hypoglycaemic coma,,2021,Q1,1,I,20200121.0,20210130.0,20210201,20210201,EXP,,CN-BAYER-2021-048267,BAYER,,83.0,YR,E,M,Y,,,20210201.0,,HP,CN,CN,2021,Q1,Elderly
188172981,18817298,3,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",250.0,IU,,, 122006041,,,16.0,IU,,QD,2021,Q1,Slow response to stimuli,,2021,Q1,1,I,20200121.0,20210130.0,20210201,20210201,EXP,,CN-BAYER-2021-048267,BAYER,,83.0,YR,E,M,Y,,,20210201.0,,HP,CN,CN,2021,Q1,Elderly
188172981,18817298,3,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",250.0,IU,,, 122006041,,,16.0,IU,,QD,2021,Q1,Unresponsive to stimuli,,2021,Q1,1,I,20200121.0,20210130.0,20210201,20210201,EXP,,CN-BAYER-2021-048267,BAYER,,83.0,YR,E,M,Y,,,20210201.0,,HP,CN,CN,2021,Q1,Elderly
188172981,18817298,4,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, QD",250.0,IU,,, 122006041,,,22.0,IU,,QD,2021,Q1,Drug interaction,,2021,Q1,1,I,20200121.0,20210130.0,20210201,20210201,EXP,,CN-BAYER-2021-048267,BAYER,,83.0,YR,E,M,Y,,,20210201.0,,HP,CN,CN,2021,Q1,Elderly
188172981,18817298,4,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, QD",250.0,IU,,, 122006041,,,22.0,IU,,QD,2021,Q1,Hyperhidrosis,,2021,Q1,1,I,20200121.0,20210130.0,20210201,20210201,EXP,,CN-BAYER-2021-048267,BAYER,,83.0,YR,E,M,Y,,,20210201.0,,HP,CN,CN,2021,Q1,Elderly
188172981,18817298,4,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, QD",250.0,IU,,, 122006041,,,22.0,IU,,QD,2021,Q1,Hypoglycaemic coma,,2021,Q1,1,I,20200121.0,20210130.0,20210201,20210201,EXP,,CN-BAYER-2021-048267,BAYER,,83.0,YR,E,M,Y,,,20210201.0,,HP,CN,CN,2021,Q1,Elderly
188172981,18817298,4,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, QD",250.0,IU,,, 122006041,,,22.0,IU,,QD,2021,Q1,Slow response to stimuli,,2021,Q1,1,I,20200121.0,20210130.0,20210201,20210201,EXP,,CN-BAYER-2021-048267,BAYER,,83.0,YR,E,M,Y,,,20210201.0,,HP,CN,CN,2021,Q1,Elderly
188172981,18817298,4,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, QD",250.0,IU,,, 122006041,,,22.0,IU,,QD,2021,Q1,Unresponsive to stimuli,,2021,Q1,1,I,20200121.0,20210130.0,20210201,20210201,EXP,,CN-BAYER-2021-048267,BAYER,,83.0,YR,E,M,Y,,,20210201.0,,HP,CN,CN,2021,Q1,Elderly
188176031,18817603,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"40 IU, Q12H",,,,, 0F7294A,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2021,Q1,Blood glucose increased,,2021,Q1,1,I,,20210122.0,20210201,20210201,PER,,US-SA-2021SA028706,SANOFI AVENTIS,,63.0,YR,A,M,Y,,,20210201.0,,CN,US,US,2021,Q1,Adult
188176031,18817603,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"40 IU, Q12H",,,,, 0F7294A,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2021,Q1,Device issue,,2021,Q1,1,I,,20210122.0,20210201,20210201,PER,,US-SA-2021SA028706,SANOFI AVENTIS,,63.0,YR,A,M,Y,,,20210201.0,,CN,US,US,2021,Q1,Adult
188176031,18817603,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"40 IU, Q12H",,,,, 0F7294A,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2021,Q1,Inappropriate schedule of product administration,,2021,Q1,1,I,,20210122.0,20210201,20210201,PER,,US-SA-2021SA028706,SANOFI AVENTIS,,63.0,YR,A,M,Y,,,20210201.0,,CN,US,US,2021,Q1,Adult
188176031,18817603,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"40 IU, Q12H",,,,, 0F7294A,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2021,Q1,Incorrect dose administered by device,,2021,Q1,1,I,,20210122.0,20210201,20210201,PER,,US-SA-2021SA028706,SANOFI AVENTIS,,63.0,YR,A,M,Y,,,20210201.0,,CN,US,US,2021,Q1,Adult
188176822,18817682,4,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,26 IU (INTERNATIONAL UNIT),,,,,,,,26.0,IU,UNKNOWN,QD,2021,Q1,Cholangitis,,2021,Q1,2,F,20210121.0,20210205.0,20210201,20210212,EXP,,US-CELGENEUS-USA-20210105633,CELGENE,,73.0,YR,,M,Y,95.2,KG,20210212.0,,HP,US,US,2021,Q1,Elderly
188176822,18817682,4,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,26 IU (INTERNATIONAL UNIT),,,,,,,,26.0,IU,UNKNOWN,QD,2021,Q1,Liver abscess,,2021,Q1,2,F,20210121.0,20210205.0,20210201,20210212,EXP,,US-CELGENEUS-USA-20210105633,CELGENE,,73.0,YR,,M,Y,95.2,KG,20210212.0,,HP,US,US,2021,Q1,Elderly
188176822,18817682,4,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,26 IU (INTERNATIONAL UNIT),,,,,,,,26.0,IU,UNKNOWN,QD,2021,Q1,Septic shock,,2021,Q1,2,F,20210121.0,20210205.0,20210201,20210212,EXP,,US-CELGENEUS-USA-20210105633,CELGENE,,73.0,YR,,M,Y,95.2,KG,20210212.0,,HP,US,US,2021,Q1,Elderly
188176822,18817682,4,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,26 IU (INTERNATIONAL UNIT),,,,,,,,26.0,IU,UNKNOWN,QD,2021,Q1,Stent malfunction,,2021,Q1,2,F,20210121.0,20210205.0,20210201,20210212,EXP,,US-CELGENEUS-USA-20210105633,CELGENE,,73.0,YR,,M,Y,95.2,KG,20210212.0,,HP,US,US,2021,Q1,Elderly
188177751,18817775,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, QD ( BEFORE SLEEP)",30.0,IU,Y,, ABJA014,,206538.0,10.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,20201225.0,20210122.0,20210201,20210201,EXP,,CN-SA-2021SA028569,SANOFI AVENTIS,,50.0,YR,A,M,Y,,,20210201.0,,HP,CN,CN,2021,Q1,Adult
188177751,18817775,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, QD ( BEFORE SLEEP)",30.0,IU,Y,, ABJA014,,206538.0,10.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Polydipsia,,2021,Q1,1,I,20201225.0,20210122.0,20210201,20210201,EXP,,CN-SA-2021SA028569,SANOFI AVENTIS,,50.0,YR,A,M,Y,,,20210201.0,,HP,CN,CN,2021,Q1,Adult
188177751,18817775,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, QD ( BEFORE SLEEP)",30.0,IU,Y,, ABJA014,,206538.0,10.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Polyuria,,2021,Q1,1,I,20201225.0,20210122.0,20210201,20210201,EXP,,CN-SA-2021SA028569,SANOFI AVENTIS,,50.0,YR,A,M,Y,,,20210201.0,,HP,CN,CN,2021,Q1,Adult
188177751,18817775,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, QD ( BEFORE SLEEP)",30.0,IU,Y,, ABJA014,,206538.0,10.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Weight decreased,,2021,Q1,1,I,20201225.0,20210122.0,20210201,20210201,EXP,,CN-SA-2021SA028569,SANOFI AVENTIS,,50.0,YR,A,M,Y,,,20210201.0,,HP,CN,CN,2021,Q1,Adult
188184941,18818494,1,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2021,Q1,Gastritis,,2021,Q1,1,I,20200608.0,20210121.0,20210201,20210201,EXP,NL-LRB-00431198,NL-NOVOPROD-782499,NOVO NORDISK,,54.0,YR,,M,Y,84.0,KG,20210201.0,,MD,NL,NL,2021,Q1,Adult
188184941,18818494,1,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2021,Q1,Idiopathic interstitial pneumonia,,2021,Q1,1,I,20200608.0,20210121.0,20210201,20210201,EXP,NL-LRB-00431198,NL-NOVOPROD-782499,NOVO NORDISK,,54.0,YR,,M,Y,84.0,KG,20210201.0,,MD,NL,NL,2021,Q1,Adult
188184941,18818494,1,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2021,Q1,Intestinal ischaemia,,2021,Q1,1,I,20200608.0,20210121.0,20210201,20210201,EXP,NL-LRB-00431198,NL-NOVOPROD-782499,NOVO NORDISK,,54.0,YR,,M,Y,84.0,KG,20210201.0,,MD,NL,NL,2021,Q1,Adult
188184941,18818494,1,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2021,Q1,Undifferentiated connective tissue disease,,2021,Q1,1,I,20200608.0,20210121.0,20210201,20210201,EXP,NL-LRB-00431198,NL-NOVOPROD-782499,NOVO NORDISK,,54.0,YR,,M,Y,84.0,KG,20210201.0,,MD,NL,NL,2021,Q1,Adult
188194941,18819494,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Anal incontinence,,2021,Q1,1,I,20190107.0,20210129.0,20210201,20210201,EXP,,CN-BAYER-2021-048337,BAYER,,74.0,YR,E,F,Y,66.0,KG,20210201.0,,HP,CN,CN,2021,Q1,Elderly
188194941,18819494,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Asthenia,,2021,Q1,1,I,20190107.0,20210129.0,20210201,20210201,EXP,,CN-BAYER-2021-048337,BAYER,,74.0,YR,E,F,Y,66.0,KG,20210201.0,,HP,CN,CN,2021,Q1,Elderly
188194941,18819494,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Dizziness,,2021,Q1,1,I,20190107.0,20210129.0,20210201,20210201,EXP,,CN-BAYER-2021-048337,BAYER,,74.0,YR,E,F,Y,66.0,KG,20210201.0,,HP,CN,CN,2021,Q1,Elderly
188194941,18819494,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Muscular weakness,,2021,Q1,1,I,20190107.0,20210129.0,20210201,20210201,EXP,,CN-BAYER-2021-048337,BAYER,,74.0,YR,E,F,Y,66.0,KG,20210201.0,,HP,CN,CN,2021,Q1,Elderly
188194941,18819494,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Nausea,,2021,Q1,1,I,20190107.0,20210129.0,20210201,20210201,EXP,,CN-BAYER-2021-048337,BAYER,,74.0,YR,E,F,Y,66.0,KG,20210201.0,,HP,CN,CN,2021,Q1,Elderly
188194941,18819494,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Syncope,,2021,Q1,1,I,20190107.0,20210129.0,20210201,20210201,EXP,,CN-BAYER-2021-048337,BAYER,,74.0,YR,E,F,Y,66.0,KG,20210201.0,,HP,CN,CN,2021,Q1,Elderly
188194941,18819494,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Vomiting,,2021,Q1,1,I,20190107.0,20210129.0,20210201,20210201,EXP,,CN-BAYER-2021-048337,BAYER,,74.0,YR,E,F,Y,66.0,KG,20210201.0,,HP,CN,CN,2021,Q1,Elderly
188203061,18820306,29,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Burkholderia test positive,,2021,Q1,1,I,20201011.0,,20210201,20210201,DIR,,,FDA-CTU,,51.0,YR,,M,N,,,20210127.0,N,PH,US,US,2021,Q1,Adult
188203061,18820306,29,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Klebsiella test positive,,2021,Q1,1,I,20201011.0,,20210201,20210201,DIR,,,FDA-CTU,,51.0,YR,,M,N,,,20210127.0,N,PH,US,US,2021,Q1,Adult
188203061,18820306,29,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Mycobacterium test positive,,2021,Q1,1,I,20201011.0,,20210201,20210201,DIR,,,FDA-CTU,,51.0,YR,,M,N,,,20210127.0,N,PH,US,US,2021,Q1,Adult
188203061,18820306,29,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Pneumonia staphylococcal,,2021,Q1,1,I,20201011.0,,20210201,20210201,DIR,,,FDA-CTU,,51.0,YR,,M,N,,,20210127.0,N,PH,US,US,2021,Q1,Adult
188203061,18820306,29,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Pyelonephritis,,2021,Q1,1,I,20201011.0,,20210201,20210201,DIR,,,FDA-CTU,,51.0,YR,,M,N,,,20210127.0,N,PH,US,US,2021,Q1,Adult
188203061,18820306,29,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Renal failure,,2021,Q1,1,I,20201011.0,,20210201,20210201,DIR,,,FDA-CTU,,51.0,YR,,M,N,,,20210127.0,N,PH,US,US,2021,Q1,Adult
188203061,18820306,29,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Stag horn calculus,,2021,Q1,1,I,20201011.0,,20210201,20210201,DIR,,,FDA-CTU,,51.0,YR,,M,N,,,20210127.0,N,PH,US,US,2021,Q1,Adult
188203061,18820306,29,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Suspected transmission of an infectious agent via product,,2021,Q1,1,I,20201011.0,,20210201,20210201,DIR,,,FDA-CTU,,51.0,YR,,M,N,,,20210127.0,N,PH,US,US,2021,Q1,Adult
188203061,18820306,29,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Urosepsis,,2021,Q1,1,I,20201011.0,,20210201,20210201,DIR,,,FDA-CTU,,51.0,YR,,M,N,,,20210127.0,N,PH,US,US,2021,Q1,Adult
188209031,18820903,121,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Burkholderia test positive,,2021,Q1,1,I,20200823.0,,20210201,20210201,DIR,,,FDA-CTU,,61.0,YR,,M,N,,,20210121.0,N,PH,US,US,2021,Q1,Adult
188209031,18820903,121,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,COVID-19,,2021,Q1,1,I,20200823.0,,20210201,20210201,DIR,,,FDA-CTU,,61.0,YR,,M,N,,,20210121.0,N,PH,US,US,2021,Q1,Adult
188209031,18820903,121,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Intentional product use issue,,2021,Q1,1,I,20200823.0,,20210201,20210201,DIR,,,FDA-CTU,,61.0,YR,,M,N,,,20210121.0,N,PH,US,US,2021,Q1,Adult
188209031,18820903,121,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Klebsiella infection,,2021,Q1,1,I,20200823.0,,20210201,20210201,DIR,,,FDA-CTU,,61.0,YR,,M,N,,,20210121.0,N,PH,US,US,2021,Q1,Adult
188209031,18820903,121,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Lacunar infarction,,2021,Q1,1,I,20200823.0,,20210201,20210201,DIR,,,FDA-CTU,,61.0,YR,,M,N,,,20210121.0,N,PH,US,US,2021,Q1,Adult
188209031,18820903,121,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Mental disorder,,2021,Q1,1,I,20200823.0,,20210201,20210201,DIR,,,FDA-CTU,,61.0,YR,,M,N,,,20210121.0,N,PH,US,US,2021,Q1,Adult
188209031,18820903,121,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Product contamination microbial,,2021,Q1,1,I,20200823.0,,20210201,20210201,DIR,,,FDA-CTU,,61.0,YR,,M,N,,,20210121.0,N,PH,US,US,2021,Q1,Adult
188209031,18820903,121,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Respiratory failure,,2021,Q1,1,I,20200823.0,,20210201,20210201,DIR,,,FDA-CTU,,61.0,YR,,M,N,,,20210121.0,N,PH,US,US,2021,Q1,Adult
188217301,18821730,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,14 INTERNATIONAL UNIT,,,,, OF731A,,,14.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Abdominal discomfort,,2021,Q1,1,I,2020.0,20210125.0,20210202,20210202,EXP,ES-SA-2020SA350711,ES-MYLANLABS-2021M1006603,MYLAN,,53.0,YR,,F,Y,55.0,KG,20210202.0,,CN,ES,ES,2021,Q1,Adult
188217301,18821730,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,14 INTERNATIONAL UNIT,,,,, OF731A,,,14.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,2020.0,20210125.0,20210202,20210202,EXP,ES-SA-2020SA350711,ES-MYLANLABS-2021M1006603,MYLAN,,53.0,YR,,F,Y,55.0,KG,20210202.0,,CN,ES,ES,2021,Q1,Adult
188217301,18821730,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,14 INTERNATIONAL UNIT,,,,, OF731A,,,14.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Dizziness,,2021,Q1,1,I,2020.0,20210125.0,20210202,20210202,EXP,ES-SA-2020SA350711,ES-MYLANLABS-2021M1006603,MYLAN,,53.0,YR,,F,Y,55.0,KG,20210202.0,,CN,ES,ES,2021,Q1,Adult
188227182,18822718,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"38 UNITS, AT NIGHT",,,,,,,,,,,,2021,Q1,Amnesia,,2021,Q1,2,F,20201030.0,20210211.0,20210202,20210219,EXP,,NVSC2021CO022425,NOVARTIS,,46.0,YR,,F,Y,57.0,KG,20210219.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q1,Adult
188227182,18822718,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"38 UNITS, AT NIGHT",,,,,,,,,,,,2021,Q1,Dizziness,,2021,Q1,2,F,20201030.0,20210211.0,20210202,20210219,EXP,,NVSC2021CO022425,NOVARTIS,,46.0,YR,,F,Y,57.0,KG,20210219.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q1,Adult
188227182,18822718,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"38 UNITS, AT NIGHT",,,,,,,,,,,,2021,Q1,Fall,,2021,Q1,2,F,20201030.0,20210211.0,20210202,20210219,EXP,,NVSC2021CO022425,NOVARTIS,,46.0,YR,,F,Y,57.0,KG,20210219.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q1,Adult
188227182,18822718,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"38 UNITS, AT NIGHT",,,,,,,,,,,,2021,Q1,Maculopathy,,2021,Q1,2,F,20201030.0,20210211.0,20210202,20210219,EXP,,NVSC2021CO022425,NOVARTIS,,46.0,YR,,F,Y,57.0,KG,20210219.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q1,Adult
188227182,18822718,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 UNITS, BEFORE EVERY MEALS",,,,,,,,,,,,2021,Q1,Amnesia,,2021,Q1,2,F,20201030.0,20210211.0,20210202,20210219,EXP,,NVSC2021CO022425,NOVARTIS,,46.0,YR,,F,Y,57.0,KG,20210219.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q1,Adult
188227182,18822718,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 UNITS, BEFORE EVERY MEALS",,,,,,,,,,,,2021,Q1,Dizziness,,2021,Q1,2,F,20201030.0,20210211.0,20210202,20210219,EXP,,NVSC2021CO022425,NOVARTIS,,46.0,YR,,F,Y,57.0,KG,20210219.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q1,Adult
188227182,18822718,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 UNITS, BEFORE EVERY MEALS",,,,,,,,,,,,2021,Q1,Fall,,2021,Q1,2,F,20201030.0,20210211.0,20210202,20210219,EXP,,NVSC2021CO022425,NOVARTIS,,46.0,YR,,F,Y,57.0,KG,20210219.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q1,Adult
188227182,18822718,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 UNITS, BEFORE EVERY MEALS",,,,,,,,,,,,2021,Q1,Maculopathy,,2021,Q1,2,F,20201030.0,20210211.0,20210202,20210219,EXP,,NVSC2021CO022425,NOVARTIS,,46.0,YR,,F,Y,57.0,KG,20210219.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q1,Adult
188241911,18824191,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 IU,,,Y,,,,,12.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Disorientation,,2021,Q1,1,I,20171121.0,20210127.0,20210202,20210202,EXP,IT-MINISAL02-450031,IT-SA-2021SA029749,SANOFI AVENTIS,,78.0,YR,E,F,Y,,,20210202.0,,MD,IT,IT,2021,Q1,Elderly
188241911,18824191,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 IU,,,Y,,,,,12.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,20171121.0,20210127.0,20210202,20210202,EXP,IT-MINISAL02-450031,IT-SA-2021SA029749,SANOFI AVENTIS,,78.0,YR,E,F,Y,,,20210202.0,,MD,IT,IT,2021,Q1,Elderly
188327501,18832750,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Atypical femur fracture,,2021,Q1,1,I,2010.0,20210121.0,20210203,20210203,EXP,,PH-ROCHE-2757726,ROCHE,"PAYUMO E, CUDAL B AND CRISOSTOMO T. OSTEONECROSIS OF THE JAW AND BILATERAL ATYPICAL FEMORAL FRACTURE BOTH OCCURRING DURING TREATMENT FOR OSTEOPOROSIS: A CASE REPORT. JOURNAL OF THE ASEAN FEDERATION OF ENDOCRINE SOCIETIES 2018 NOV?33 (2):194?8.",81.0,YR,,F,Y,,,20210203.0,,MD,PH,PH,2021,Q1,Elderly
188327501,18832750,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Osteonecrosis of jaw,,2021,Q1,1,I,2010.0,20210121.0,20210203,20210203,EXP,,PH-ROCHE-2757726,ROCHE,"PAYUMO E, CUDAL B AND CRISOSTOMO T. OSTEONECROSIS OF THE JAW AND BILATERAL ATYPICAL FEMORAL FRACTURE BOTH OCCURRING DURING TREATMENT FOR OSTEOPOROSIS: A CASE REPORT. JOURNAL OF THE ASEAN FEDERATION OF ENDOCRINE SOCIETIES 2018 NOV?33 (2):194?8.",81.0,YR,,F,Y,,,20210203.0,,MD,PH,PH,2021,Q1,Elderly
188339031,18833903,8,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Aspartate aminotransferase increased,,2021,Q1,1,I,20210203.0,,20210203,20210203,DIR,,,FDA-CTU,,58.0,YR,,F,N,92.1,KG,20210203.0,N,PH,US,US,2021,Q1,Adult
188449131,18844913,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"1 INTERNATIONAL UNIT/KILOGRAM, QH  CONTINUOUS INFUSION",,,,,,,,1.0,IU/KG,INJECTION,/hr,2021,Q1,Acidosis,,2021,Q1,1,I,,20210129.0,20210204,20210204,EXP,,US-MYLANLABS-2021M1007191,MYLAN,"SADLER WD, HUNT N, NELSON K, ADELMANN E, MAZUREK P, BASSIN BS. CALCIUM CHANNEL BLOCKER INTOXICATION: A CRITICAL CARE TRANSPORT PERSPECTIVE. AIR?MED?J 2021?40(1):69?72.",20.0,YR,,F,Y,,,20210204.0,,HP,US,US,2021,Q1,Youth
188449131,18844913,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"1 INTERNATIONAL UNIT/KILOGRAM, QH  CONTINUOUS INFUSION",,,,,,,,1.0,IU/KG,INJECTION,/hr,2021,Q1,Acute kidney injury,,2021,Q1,1,I,,20210129.0,20210204,20210204,EXP,,US-MYLANLABS-2021M1007191,MYLAN,"SADLER WD, HUNT N, NELSON K, ADELMANN E, MAZUREK P, BASSIN BS. CALCIUM CHANNEL BLOCKER INTOXICATION: A CRITICAL CARE TRANSPORT PERSPECTIVE. AIR?MED?J 2021?40(1):69?72.",20.0,YR,,F,Y,,,20210204.0,,HP,US,US,2021,Q1,Youth
188449131,18844913,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"1 INTERNATIONAL UNIT/KILOGRAM, QH  CONTINUOUS INFUSION",,,,,,,,1.0,IU/KG,INJECTION,/hr,2021,Q1,Atrioventricular block first degree,,2021,Q1,1,I,,20210129.0,20210204,20210204,EXP,,US-MYLANLABS-2021M1007191,MYLAN,"SADLER WD, HUNT N, NELSON K, ADELMANN E, MAZUREK P, BASSIN BS. CALCIUM CHANNEL BLOCKER INTOXICATION: A CRITICAL CARE TRANSPORT PERSPECTIVE. AIR?MED?J 2021?40(1):69?72.",20.0,YR,,F,Y,,,20210204.0,,HP,US,US,2021,Q1,Youth
188449131,18844913,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"1 INTERNATIONAL UNIT/KILOGRAM, QH  CONTINUOUS INFUSION",,,,,,,,1.0,IU/KG,INJECTION,/hr,2021,Q1,Cardiogenic shock,,2021,Q1,1,I,,20210129.0,20210204,20210204,EXP,,US-MYLANLABS-2021M1007191,MYLAN,"SADLER WD, HUNT N, NELSON K, ADELMANN E, MAZUREK P, BASSIN BS. CALCIUM CHANNEL BLOCKER INTOXICATION: A CRITICAL CARE TRANSPORT PERSPECTIVE. AIR?MED?J 2021?40(1):69?72.",20.0,YR,,F,Y,,,20210204.0,,HP,US,US,2021,Q1,Youth
188449131,18844913,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"1 INTERNATIONAL UNIT/KILOGRAM, QH  CONTINUOUS INFUSION",,,,,,,,1.0,IU/KG,INJECTION,/hr,2021,Q1,Depressed level of consciousness,,2021,Q1,1,I,,20210129.0,20210204,20210204,EXP,,US-MYLANLABS-2021M1007191,MYLAN,"SADLER WD, HUNT N, NELSON K, ADELMANN E, MAZUREK P, BASSIN BS. CALCIUM CHANNEL BLOCKER INTOXICATION: A CRITICAL CARE TRANSPORT PERSPECTIVE. AIR?MED?J 2021?40(1):69?72.",20.0,YR,,F,Y,,,20210204.0,,HP,US,US,2021,Q1,Youth
188449131,18844913,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"1 INTERNATIONAL UNIT/KILOGRAM, QH  CONTINUOUS INFUSION",,,,,,,,1.0,IU/KG,INJECTION,/hr,2021,Q1,Drug ineffective,,2021,Q1,1,I,,20210129.0,20210204,20210204,EXP,,US-MYLANLABS-2021M1007191,MYLAN,"SADLER WD, HUNT N, NELSON K, ADELMANN E, MAZUREK P, BASSIN BS. CALCIUM CHANNEL BLOCKER INTOXICATION: A CRITICAL CARE TRANSPORT PERSPECTIVE. AIR?MED?J 2021?40(1):69?72.",20.0,YR,,F,Y,,,20210204.0,,HP,US,US,2021,Q1,Youth
188449131,18844913,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"1 INTERNATIONAL UNIT/KILOGRAM, QH  CONTINUOUS INFUSION",,,,,,,,1.0,IU/KG,INJECTION,/hr,2021,Q1,Hypokalaemia,,2021,Q1,1,I,,20210129.0,20210204,20210204,EXP,,US-MYLANLABS-2021M1007191,MYLAN,"SADLER WD, HUNT N, NELSON K, ADELMANN E, MAZUREK P, BASSIN BS. CALCIUM CHANNEL BLOCKER INTOXICATION: A CRITICAL CARE TRANSPORT PERSPECTIVE. AIR?MED?J 2021?40(1):69?72.",20.0,YR,,F,Y,,,20210204.0,,HP,US,US,2021,Q1,Youth
188449131,18844913,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"1 INTERNATIONAL UNIT/KILOGRAM, QH  CONTINUOUS INFUSION",,,,,,,,1.0,IU/KG,INJECTION,/hr,2021,Q1,Hypotension,,2021,Q1,1,I,,20210129.0,20210204,20210204,EXP,,US-MYLANLABS-2021M1007191,MYLAN,"SADLER WD, HUNT N, NELSON K, ADELMANN E, MAZUREK P, BASSIN BS. CALCIUM CHANNEL BLOCKER INTOXICATION: A CRITICAL CARE TRANSPORT PERSPECTIVE. AIR?MED?J 2021?40(1):69?72.",20.0,YR,,F,Y,,,20210204.0,,HP,US,US,2021,Q1,Youth
188449131,18844913,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"1 INTERNATIONAL UNIT/KILOGRAM, QH  CONTINUOUS INFUSION",,,,,,,,1.0,IU/KG,INJECTION,/hr,2021,Q1,Intentional overdose,,2021,Q1,1,I,,20210129.0,20210204,20210204,EXP,,US-MYLANLABS-2021M1007191,MYLAN,"SADLER WD, HUNT N, NELSON K, ADELMANN E, MAZUREK P, BASSIN BS. CALCIUM CHANNEL BLOCKER INTOXICATION: A CRITICAL CARE TRANSPORT PERSPECTIVE. AIR?MED?J 2021?40(1):69?72.",20.0,YR,,F,Y,,,20210204.0,,HP,US,US,2021,Q1,Youth
188449131,18844913,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"1 INTERNATIONAL UNIT/KILOGRAM, QH  CONTINUOUS INFUSION",,,,,,,,1.0,IU/KG,INJECTION,/hr,2021,Q1,Mental impairment,,2021,Q1,1,I,,20210129.0,20210204,20210204,EXP,,US-MYLANLABS-2021M1007191,MYLAN,"SADLER WD, HUNT N, NELSON K, ADELMANN E, MAZUREK P, BASSIN BS. CALCIUM CHANNEL BLOCKER INTOXICATION: A CRITICAL CARE TRANSPORT PERSPECTIVE. AIR?MED?J 2021?40(1):69?72.",20.0,YR,,F,Y,,,20210204.0,,HP,US,US,2021,Q1,Youth
188449131,18844913,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"1 INTERNATIONAL UNIT/KILOGRAM, QH  CONTINUOUS INFUSION",,,,,,,,1.0,IU/KG,INJECTION,/hr,2021,Q1,Mental status changes,,2021,Q1,1,I,,20210129.0,20210204,20210204,EXP,,US-MYLANLABS-2021M1007191,MYLAN,"SADLER WD, HUNT N, NELSON K, ADELMANN E, MAZUREK P, BASSIN BS. CALCIUM CHANNEL BLOCKER INTOXICATION: A CRITICAL CARE TRANSPORT PERSPECTIVE. AIR?MED?J 2021?40(1):69?72.",20.0,YR,,F,Y,,,20210204.0,,HP,US,US,2021,Q1,Youth
188449131,18844913,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"1 INTERNATIONAL UNIT/KILOGRAM, QH  CONTINUOUS INFUSION",,,,,,,,1.0,IU/KG,INJECTION,/hr,2021,Q1,Pneumonia aspiration,,2021,Q1,1,I,,20210129.0,20210204,20210204,EXP,,US-MYLANLABS-2021M1007191,MYLAN,"SADLER WD, HUNT N, NELSON K, ADELMANN E, MAZUREK P, BASSIN BS. CALCIUM CHANNEL BLOCKER INTOXICATION: A CRITICAL CARE TRANSPORT PERSPECTIVE. AIR?MED?J 2021?40(1):69?72.",20.0,YR,,F,Y,,,20210204.0,,HP,US,US,2021,Q1,Youth
188449131,18844913,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"1 INTERNATIONAL UNIT/KILOGRAM, QH  CONTINUOUS INFUSION",,,,,,,,1.0,IU/KG,INJECTION,/hr,2021,Q1,Renal tubular necrosis,,2021,Q1,1,I,,20210129.0,20210204,20210204,EXP,,US-MYLANLABS-2021M1007191,MYLAN,"SADLER WD, HUNT N, NELSON K, ADELMANN E, MAZUREK P, BASSIN BS. CALCIUM CHANNEL BLOCKER INTOXICATION: A CRITICAL CARE TRANSPORT PERSPECTIVE. AIR?MED?J 2021?40(1):69?72.",20.0,YR,,F,Y,,,20210204.0,,HP,US,US,2021,Q1,Youth
188449131,18844913,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"1 INTERNATIONAL UNIT/KILOGRAM, QH  CONTINUOUS INFUSION",,,,,,,,1.0,IU/KG,INJECTION,/hr,2021,Q1,Sinus bradycardia,,2021,Q1,1,I,,20210129.0,20210204,20210204,EXP,,US-MYLANLABS-2021M1007191,MYLAN,"SADLER WD, HUNT N, NELSON K, ADELMANN E, MAZUREK P, BASSIN BS. CALCIUM CHANNEL BLOCKER INTOXICATION: A CRITICAL CARE TRANSPORT PERSPECTIVE. AIR?MED?J 2021?40(1):69?72.",20.0,YR,,F,Y,,,20210204.0,,HP,US,US,2021,Q1,Youth
188449131,18844913,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"1 INTERNATIONAL UNIT/KILOGRAM, QH  CONTINUOUS INFUSION",,,,,,,,1.0,IU/KG,INJECTION,/hr,2021,Q1,Thrombosis,,2021,Q1,1,I,,20210129.0,20210204,20210204,EXP,,US-MYLANLABS-2021M1007191,MYLAN,"SADLER WD, HUNT N, NELSON K, ADELMANN E, MAZUREK P, BASSIN BS. CALCIUM CHANNEL BLOCKER INTOXICATION: A CRITICAL CARE TRANSPORT PERSPECTIVE. AIR?MED?J 2021?40(1):69?72.",20.0,YR,,F,Y,,,20210204.0,,HP,US,US,2021,Q1,Youth
188449131,18844913,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"1 INTERNATIONAL UNIT/KILOGRAM, QH  CONTINUOUS INFUSION",,,,,,,,1.0,IU/KG,INJECTION,/hr,2021,Q1,Toxicity to various agents,,2021,Q1,1,I,,20210129.0,20210204,20210204,EXP,,US-MYLANLABS-2021M1007191,MYLAN,"SADLER WD, HUNT N, NELSON K, ADELMANN E, MAZUREK P, BASSIN BS. CALCIUM CHANNEL BLOCKER INTOXICATION: A CRITICAL CARE TRANSPORT PERSPECTIVE. AIR?MED?J 2021?40(1):69?72.",20.0,YR,,F,Y,,,20210204.0,,HP,US,US,2021,Q1,Youth
188449131,18844913,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"1 INTERNATIONAL UNIT/KILOGRAM, QH  CONTINUOUS INFUSION",,,,,,,,1.0,IU/KG,INJECTION,/hr,2021,Q1,Tricuspid valve disease,,2021,Q1,1,I,,20210129.0,20210204,20210204,EXP,,US-MYLANLABS-2021M1007191,MYLAN,"SADLER WD, HUNT N, NELSON K, ADELMANN E, MAZUREK P, BASSIN BS. CALCIUM CHANNEL BLOCKER INTOXICATION: A CRITICAL CARE TRANSPORT PERSPECTIVE. AIR?MED?J 2021?40(1):69?72.",20.0,YR,,F,Y,,,20210204.0,,HP,US,US,2021,Q1,Youth
188449131,18844913,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"1 INTERNATIONAL UNIT/KILOGRAM, QH  CONTINUOUS INFUSION",,,,,,,,1.0,IU/KG,INJECTION,/hr,2021,Q1,Vomiting,,2021,Q1,1,I,,20210129.0,20210204,20210204,EXP,,US-MYLANLABS-2021M1007191,MYLAN,"SADLER WD, HUNT N, NELSON K, ADELMANN E, MAZUREK P, BASSIN BS. CALCIUM CHANNEL BLOCKER INTOXICATION: A CRITICAL CARE TRANSPORT PERSPECTIVE. AIR?MED?J 2021?40(1):69?72.",20.0,YR,,F,Y,,,20210204.0,,HP,US,US,2021,Q1,Youth
188453942,18845394,6,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,CONTINUOUS INFUSION,,,U,U,,,210605.0,,,INJECTION,,2021,Q1,Drug ineffective,,2021,Q1,2,F,,20210305.0,20210204,20210312,EXP,,US-MYLANLABS-2021M1007206,MYLAN,"KIMBRELL BE, HICKS F, FOSTER CB, KISHK OA, QUINTEROS?FERNANDEZ SA, NIKITA ME, ET AL. GROWTH HORMONE AS A RESCUE TREATMENT IN MAPLE SYRUP URINE DISEASE WITH LESSONS FROM PEDIATRIC BURN LITERATURE, CASE REPORT AND BRIEF LITERATURE REVIEW. MOL?GENET?METAB?REP 2020?25:100685.",11.0,YR,,M,Y,,,20210312.0,,HP,US,US,2021,Q1,Child
188453942,18845394,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,U,,,210605.0,,,INJECTION,,2021,Q1,Drug ineffective,,2021,Q1,2,F,,20210305.0,20210204,20210312,EXP,,US-MYLANLABS-2021M1007206,MYLAN,"KIMBRELL BE, HICKS F, FOSTER CB, KISHK OA, QUINTEROS?FERNANDEZ SA, NIKITA ME, ET AL. GROWTH HORMONE AS A RESCUE TREATMENT IN MAPLE SYRUP URINE DISEASE WITH LESSONS FROM PEDIATRIC BURN LITERATURE, CASE REPORT AND BRIEF LITERATURE REVIEW. MOL?GENET?METAB?REP 2020?25:100685.",11.0,YR,,M,Y,,,20210312.0,,HP,US,US,2021,Q1,Child
188472201,18847220,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Coronary artery disease,,2021,Q1,1,I,,20210111.0,20210204,20210204,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202101004311,ELI LILLY AND CO,,72.0,YR,,M,Y,70.0,KG,20210204.0,,CN,CN,CN,2021,Q1,Elderly
188472201,18847220,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Mobility decreased,,2021,Q1,1,I,,20210111.0,20210204,20210204,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202101004311,ELI LILLY AND CO,,72.0,YR,,M,Y,70.0,KG,20210204.0,,CN,CN,CN,2021,Q1,Elderly
188485261,18848526,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Diabetes mellitus inadequate control,,2021,Q1,1,I,,20210201.0,20210204,20210204,EXP,,ES-MYLANLABS-2021M1006887,MYLAN,,72.0,YR,,M,Y,,,20210204.0,,CN,ES,ES,2021,Q1,Elderly
188485261,18848526,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Drug abuse,,2021,Q1,1,I,,20210201.0,20210204,20210204,EXP,,ES-MYLANLABS-2021M1006887,MYLAN,,72.0,YR,,M,Y,,,20210204.0,,CN,ES,ES,2021,Q1,Elderly
188485261,18848526,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Intentional product misuse,,2021,Q1,1,I,,20210201.0,20210204,20210204,EXP,,ES-MYLANLABS-2021M1006887,MYLAN,,72.0,YR,,M,Y,,,20210204.0,,CN,ES,ES,2021,Q1,Elderly
188485261,18848526,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Intentional product use issue,,2021,Q1,1,I,,20210201.0,20210204,20210204,EXP,,ES-MYLANLABS-2021M1006887,MYLAN,,72.0,YR,,M,Y,,,20210204.0,,CN,ES,ES,2021,Q1,Elderly
188485261,18848526,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Lung neoplasm,,2021,Q1,1,I,,20210201.0,20210204,20210204,EXP,,ES-MYLANLABS-2021M1006887,MYLAN,,72.0,YR,,M,Y,,,20210204.0,,CN,ES,ES,2021,Q1,Elderly
188485261,18848526,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Trigger finger,,2021,Q1,1,I,,20210201.0,20210204,20210204,EXP,,ES-MYLANLABS-2021M1006887,MYLAN,,72.0,YR,,M,Y,,,20210204.0,,CN,ES,ES,2021,Q1,Elderly
188491313,18849131,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2021,Q1,Anaemia,,2021,Q1,3,F,2020.0,20210302.0,20210204,20210311,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20210311.0,,MD,CA,CA,2021,Q1,Adult
188491313,18849131,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2021,Q1,Condition aggravated,,2021,Q1,3,F,2020.0,20210302.0,20210204,20210311,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20210311.0,,MD,CA,CA,2021,Q1,Adult
188491313,18849131,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2021,Q1,Dyspnoea,,2021,Q1,3,F,2020.0,20210302.0,20210204,20210311,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20210311.0,,MD,CA,CA,2021,Q1,Adult
188491313,18849131,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2021,Q1,Gout,,2021,Q1,3,F,2020.0,20210302.0,20210204,20210311,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20210311.0,,MD,CA,CA,2021,Q1,Adult
188491313,18849131,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2021,Q1,Hypoxia,,2021,Q1,3,F,2020.0,20210302.0,20210204,20210311,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20210311.0,,MD,CA,CA,2021,Q1,Adult
188491313,18849131,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2021,Q1,Off label use,,2021,Q1,3,F,2020.0,20210302.0,20210204,20210311,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20210311.0,,MD,CA,CA,2021,Q1,Adult
188491313,18849131,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2021,Q1,Oxygen consumption increased,,2021,Q1,3,F,2020.0,20210302.0,20210204,20210311,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20210311.0,,MD,CA,CA,2021,Q1,Adult
188491313,18849131,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2021,Q1,Oxygen saturation decreased,,2021,Q1,3,F,2020.0,20210302.0,20210204,20210311,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20210311.0,,MD,CA,CA,2021,Q1,Adult
188491313,18849131,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2021,Q1,Product use in unapproved indication,,2021,Q1,3,F,2020.0,20210302.0,20210204,20210311,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20210311.0,,MD,CA,CA,2021,Q1,Adult
188491313,18849131,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2021,Q1,Pulmonary arterial hypertension,,2021,Q1,3,F,2020.0,20210302.0,20210204,20210311,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20210311.0,,MD,CA,CA,2021,Q1,Adult
188491313,18849131,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2021,Q1,Pulmonary oedema,,2021,Q1,3,F,2020.0,20210302.0,20210204,20210311,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20210311.0,,MD,CA,CA,2021,Q1,Adult
188491313,18849131,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2021,Q1,Pulmonary veno-occlusive disease,,2021,Q1,3,F,2020.0,20210302.0,20210204,20210311,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20210311.0,,MD,CA,CA,2021,Q1,Adult
188491313,18849131,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2021,Q1,Right ventricular failure,,2021,Q1,3,F,2020.0,20210302.0,20210204,20210311,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20210311.0,,MD,CA,CA,2021,Q1,Adult
188491313,18849131,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2021,Q1,Right-to-left cardiac shunt,,2021,Q1,3,F,2020.0,20210302.0,20210204,20210311,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20210311.0,,MD,CA,CA,2021,Q1,Adult
188491313,18849131,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2021,Q1,Ulcer haemorrhage,,2021,Q1,3,F,2020.0,20210302.0,20210204,20210311,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20210311.0,,MD,CA,CA,2021,Q1,Adult
188498242,18849824,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,34 UNITS AT BEDTIME,,,,,,,,34.0,IU,,QD,2021,Q1,Cerebrovascular accident,,2021,Q1,2,F,20200124.0,20210209.0,20210205,20210216,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-079784",BOEHRINGER INGELHEIM,,77.0,YR,E,F,Y,,,20210216.0,,CN,US,US,2021,Q1,Elderly
188498712,18849871,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Rhabdomyolysis,,2021,Q1,2,F,20210116.0,20210202.0,20210204,20210210,EXP,,US-GILEAD-2021-0515836,GILEAD,,53.0,YR,A,F,Y,108.2,KG,20210210.0,,MD,US,US,2021,Q1,Adult
188511812,18851181,12,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,28 INTERNATIONAL UNIT,,,U,,,,,28.0,IU,,,2021,Q1,Crying,,2021,Q1,2,F,,20210205.0,20210205,20210208,EXP,,ES-AUROBINDO-AUR-APL-2017-21970,AUROBINDO,,68.0,YR,,F,Y,,,20210208.0,,HP,ES,ES,2021,Q1,Elderly
188511812,18851181,12,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,28 INTERNATIONAL UNIT,,,U,,,,,28.0,IU,,,2021,Q1,Drug interaction,,2021,Q1,2,F,,20210205.0,20210205,20210208,EXP,,ES-AUROBINDO-AUR-APL-2017-21970,AUROBINDO,,68.0,YR,,F,Y,,,20210208.0,,HP,ES,ES,2021,Q1,Elderly
188511812,18851181,12,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,28 INTERNATIONAL UNIT,,,U,,,,,28.0,IU,,,2021,Q1,Hyperreflexia,,2021,Q1,2,F,,20210205.0,20210205,20210208,EXP,,ES-AUROBINDO-AUR-APL-2017-21970,AUROBINDO,,68.0,YR,,F,Y,,,20210208.0,,HP,ES,ES,2021,Q1,Elderly
188511812,18851181,12,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,28 INTERNATIONAL UNIT,,,U,,,,,28.0,IU,,,2021,Q1,Musculoskeletal stiffness,,2021,Q1,2,F,,20210205.0,20210205,20210208,EXP,,ES-AUROBINDO-AUR-APL-2017-21970,AUROBINDO,,68.0,YR,,F,Y,,,20210208.0,,HP,ES,ES,2021,Q1,Elderly
188511812,18851181,12,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,28 INTERNATIONAL UNIT,,,U,,,,,28.0,IU,,,2021,Q1,Serotonin syndrome,,2021,Q1,2,F,,20210205.0,20210205,20210208,EXP,,ES-AUROBINDO-AUR-APL-2017-21970,AUROBINDO,,68.0,YR,,F,Y,,,20210208.0,,HP,ES,ES,2021,Q1,Elderly
188511812,18851181,12,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,28 INTERNATIONAL UNIT,,,U,,,,,28.0,IU,,,2021,Q1,Withdrawal syndrome,,2021,Q1,2,F,,20210205.0,20210205,20210208,EXP,,ES-AUROBINDO-AUR-APL-2017-21970,AUROBINDO,,68.0,YR,,F,Y,,,20210208.0,,HP,ES,ES,2021,Q1,Elderly
188513301,18851330,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IE/ML, 0?0?0?20",,,,,,,,,,,,2021,Q1,Accidental overdose,,2021,Q1,1,I,,20210203.0,20210205,20210205,EXP,,DE-009507513-2102DEU001742,MERCK,,77.0,YR,,M,Y,,,20210205.0,,PH,DE,DE,2021,Q1,Elderly
188513301,18851330,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IE/ML, 0?0?0?20",,,,,,,,,,,,2021,Q1,Depressed level of consciousness,,2021,Q1,1,I,,20210203.0,20210205,20210205,EXP,,DE-009507513-2102DEU001742,MERCK,,77.0,YR,,M,Y,,,20210205.0,,PH,DE,DE,2021,Q1,Elderly
188513301,18851330,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IE/ML, 0?0?0?20",,,,,,,,,,,,2021,Q1,Hemiparesis,,2021,Q1,1,I,,20210203.0,20210205,20210205,EXP,,DE-009507513-2102DEU001742,MERCK,,77.0,YR,,M,Y,,,20210205.0,,PH,DE,DE,2021,Q1,Elderly
188513301,18851330,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IE/ML, 0?0?0?20",,,,,,,,,,,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,,20210203.0,20210205,20210205,EXP,,DE-009507513-2102DEU001742,MERCK,,77.0,YR,,M,Y,,,20210205.0,,PH,DE,DE,2021,Q1,Elderly
188513301,18851330,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IE/ML, 0?0?0?20",,,,,,,,,,,,2021,Q1,Seizure,,2021,Q1,1,I,,20210203.0,20210205,20210205,EXP,,DE-009507513-2102DEU001742,MERCK,,77.0,YR,,M,Y,,,20210205.0,,PH,DE,DE,2021,Q1,Elderly
188528483,18852848,2,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"5 U, EACH MORNING",,,,,,,,5.0,IU,INJECTION,QD,2021,Q1,Hypoglycaemia,,2021,Q1,3,F,20210119.0,20210301.0,20210205,20210308,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202102000549,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20210308.0,,MD,JP,JP,2021,Q1,Elderly
188528483,18852848,2,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"5 U, EACH MORNING",,,,,,,,5.0,IU,INJECTION,QD,2021,Q1,Pneumatosis intestinalis,,2021,Q1,3,F,20210119.0,20210301.0,20210205,20210308,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202102000549,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20210308.0,,MD,JP,JP,2021,Q1,Elderly
188528483,18852848,2,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"5 U, EACH MORNING",,,,,,,,5.0,IU,INJECTION,QD,2021,Q1,Retinopathy,,2021,Q1,3,F,20210119.0,20210301.0,20210205,20210308,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202102000549,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20210308.0,,MD,JP,JP,2021,Q1,Elderly
188531831,18853183,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,Y,,,210605.0,,,INJECTION,,2021,Q1,Administration site pain,,2021,Q1,1,I,,20210201.0,20210205,20210205,EXP,,AU-MYLANLABS-2021M1007683,MYLAN,"CLARKE B, LOUDOVARIS T, RADFORD T, DROGEMULLER C, COATES PT, TORPY D. AMBULATORY INTRAVENOUS INSULIN AND ISLET CELL TRANSPLANTATION TO TREAT SEVERE TYPE III INSULIN HYPERSENSITIVITY IN A PATIENT WITH TYPE 1 DIABETES MELLITUS. CLIN?CASE?REP 2020?8(12):2759?2762.",30.0,YR,,F,Y,,,20210205.0,,HP,AU,AU,2021,Q1,Young Adult
188531831,18853183,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,Y,,,210605.0,,,INJECTION,,2021,Q1,Drug ineffective,,2021,Q1,1,I,,20210201.0,20210205,20210205,EXP,,AU-MYLANLABS-2021M1007683,MYLAN,"CLARKE B, LOUDOVARIS T, RADFORD T, DROGEMULLER C, COATES PT, TORPY D. AMBULATORY INTRAVENOUS INSULIN AND ISLET CELL TRANSPLANTATION TO TREAT SEVERE TYPE III INSULIN HYPERSENSITIVITY IN A PATIENT WITH TYPE 1 DIABETES MELLITUS. CLIN?CASE?REP 2020?8(12):2759?2762.",30.0,YR,,F,Y,,,20210205.0,,HP,AU,AU,2021,Q1,Young Adult
188531831,18853183,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,Y,,,210605.0,,,INJECTION,,2021,Q1,Infusion related hypersensitivity reaction,Infusion related hypersensitivity reaction,2021,Q1,1,I,,20210201.0,20210205,20210205,EXP,,AU-MYLANLABS-2021M1007683,MYLAN,"CLARKE B, LOUDOVARIS T, RADFORD T, DROGEMULLER C, COATES PT, TORPY D. AMBULATORY INTRAVENOUS INSULIN AND ISLET CELL TRANSPLANTATION TO TREAT SEVERE TYPE III INSULIN HYPERSENSITIVITY IN A PATIENT WITH TYPE 1 DIABETES MELLITUS. CLIN?CASE?REP 2020?8(12):2759?2762.",30.0,YR,,F,Y,,,20210205.0,,HP,AU,AU,2021,Q1,Young Adult
188531831,18853183,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,Y,,,210605.0,,,INJECTION,,2021,Q1,Myalgia,,2021,Q1,1,I,,20210201.0,20210205,20210205,EXP,,AU-MYLANLABS-2021M1007683,MYLAN,"CLARKE B, LOUDOVARIS T, RADFORD T, DROGEMULLER C, COATES PT, TORPY D. AMBULATORY INTRAVENOUS INSULIN AND ISLET CELL TRANSPLANTATION TO TREAT SEVERE TYPE III INSULIN HYPERSENSITIVITY IN A PATIENT WITH TYPE 1 DIABETES MELLITUS. CLIN?CASE?REP 2020?8(12):2759?2762.",30.0,YR,,F,Y,,,20210205.0,,HP,AU,AU,2021,Q1,Young Adult
188531831,18853183,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,Y,,,210605.0,,,INJECTION,,2021,Q1,Type III immune complex mediated reaction,Type III immune complex mediated reaction,2021,Q1,1,I,,20210201.0,20210205,20210205,EXP,,AU-MYLANLABS-2021M1007683,MYLAN,"CLARKE B, LOUDOVARIS T, RADFORD T, DROGEMULLER C, COATES PT, TORPY D. AMBULATORY INTRAVENOUS INSULIN AND ISLET CELL TRANSPLANTATION TO TREAT SEVERE TYPE III INSULIN HYPERSENSITIVITY IN A PATIENT WITH TYPE 1 DIABETES MELLITUS. CLIN?CASE?REP 2020?8(12):2759?2762.",30.0,YR,,F,Y,,,20210205.0,,HP,AU,AU,2021,Q1,Young Adult
188531831,18853183,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intramuscular,UNK,,,U,U,,,210605.0,,,INJECTION,,2021,Q1,Administration site pain,,2021,Q1,1,I,,20210201.0,20210205,20210205,EXP,,AU-MYLANLABS-2021M1007683,MYLAN,"CLARKE B, LOUDOVARIS T, RADFORD T, DROGEMULLER C, COATES PT, TORPY D. AMBULATORY INTRAVENOUS INSULIN AND ISLET CELL TRANSPLANTATION TO TREAT SEVERE TYPE III INSULIN HYPERSENSITIVITY IN A PATIENT WITH TYPE 1 DIABETES MELLITUS. CLIN?CASE?REP 2020?8(12):2759?2762.",30.0,YR,,F,Y,,,20210205.0,,HP,AU,AU,2021,Q1,Young Adult
188531831,18853183,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intramuscular,UNK,,,U,U,,,210605.0,,,INJECTION,,2021,Q1,Drug ineffective,,2021,Q1,1,I,,20210201.0,20210205,20210205,EXP,,AU-MYLANLABS-2021M1007683,MYLAN,"CLARKE B, LOUDOVARIS T, RADFORD T, DROGEMULLER C, COATES PT, TORPY D. AMBULATORY INTRAVENOUS INSULIN AND ISLET CELL TRANSPLANTATION TO TREAT SEVERE TYPE III INSULIN HYPERSENSITIVITY IN A PATIENT WITH TYPE 1 DIABETES MELLITUS. CLIN?CASE?REP 2020?8(12):2759?2762.",30.0,YR,,F,Y,,,20210205.0,,HP,AU,AU,2021,Q1,Young Adult
188531831,18853183,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intramuscular,UNK,,,U,U,,,210605.0,,,INJECTION,,2021,Q1,Infusion related hypersensitivity reaction,Infusion related hypersensitivity reaction,2021,Q1,1,I,,20210201.0,20210205,20210205,EXP,,AU-MYLANLABS-2021M1007683,MYLAN,"CLARKE B, LOUDOVARIS T, RADFORD T, DROGEMULLER C, COATES PT, TORPY D. AMBULATORY INTRAVENOUS INSULIN AND ISLET CELL TRANSPLANTATION TO TREAT SEVERE TYPE III INSULIN HYPERSENSITIVITY IN A PATIENT WITH TYPE 1 DIABETES MELLITUS. CLIN?CASE?REP 2020?8(12):2759?2762.",30.0,YR,,F,Y,,,20210205.0,,HP,AU,AU,2021,Q1,Young Adult
188531831,18853183,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intramuscular,UNK,,,U,U,,,210605.0,,,INJECTION,,2021,Q1,Myalgia,,2021,Q1,1,I,,20210201.0,20210205,20210205,EXP,,AU-MYLANLABS-2021M1007683,MYLAN,"CLARKE B, LOUDOVARIS T, RADFORD T, DROGEMULLER C, COATES PT, TORPY D. AMBULATORY INTRAVENOUS INSULIN AND ISLET CELL TRANSPLANTATION TO TREAT SEVERE TYPE III INSULIN HYPERSENSITIVITY IN A PATIENT WITH TYPE 1 DIABETES MELLITUS. CLIN?CASE?REP 2020?8(12):2759?2762.",30.0,YR,,F,Y,,,20210205.0,,HP,AU,AU,2021,Q1,Young Adult
188531831,18853183,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intramuscular,UNK,,,U,U,,,210605.0,,,INJECTION,,2021,Q1,Type III immune complex mediated reaction,Type III immune complex mediated reaction,2021,Q1,1,I,,20210201.0,20210205,20210205,EXP,,AU-MYLANLABS-2021M1007683,MYLAN,"CLARKE B, LOUDOVARIS T, RADFORD T, DROGEMULLER C, COATES PT, TORPY D. AMBULATORY INTRAVENOUS INSULIN AND ISLET CELL TRANSPLANTATION TO TREAT SEVERE TYPE III INSULIN HYPERSENSITIVITY IN A PATIENT WITH TYPE 1 DIABETES MELLITUS. CLIN?CASE?REP 2020?8(12):2759?2762.",30.0,YR,,F,Y,,,20210205.0,,HP,AU,AU,2021,Q1,Young Adult
188547332,18854733,1,PS,INSULIN GLARGINE/LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Subcutaneous,45 IU,,,U,, OF259A,,208673.0,45.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,2,F,202012.0,20210128.0,20210205,20210210,PER,,US-SA-2021SA034341,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20210210.0,,CN,US,US,2021,Q1,Adult
188547332,18854733,1,PS,INSULIN GLARGINE/LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Subcutaneous,45 IU,,,U,, OF259A,,208673.0,45.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Palpitations,,2021,Q1,2,F,202012.0,20210128.0,20210205,20210210,PER,,US-SA-2021SA034341,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20210210.0,,CN,US,US,2021,Q1,Adult
188548681,18854868,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Spinal compression fracture,,2021,Q1,1,I,,20210126.0,20210205,20210205,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202101011152,ELI LILLY AND CO,,91.0,YR,,M,Y,75.0,KG,20210205.0,,CN,CN,CN,2021,Q1,Elderly
188548681,18854868,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Urinary tract infection,,2021,Q1,1,I,,20210126.0,20210205,20210205,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202101011152,ELI LILLY AND CO,,91.0,YR,,M,Y,75.0,KG,20210205.0,,CN,CN,CN,2021,Q1,Elderly
188577181,18857718,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"120 UNITS, BID",,,,,,,,,,,BID,2021,Q1,Hospitalisation,,2021,Q1,1,I,20200812.0,20201022.0,20210208,20210208,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005001,AEGERION,,45.0,YR,,F,Y,,,20210208.0,,MD,US,US,2021,Q1,Adult
188577181,18857718,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"120 UNITS, BID",,,,,,,,,,,BID,2021,Q1,Laboratory test abnormal,,2021,Q1,1,I,20200812.0,20201022.0,20210208,20210208,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005001,AEGERION,,45.0,YR,,F,Y,,,20210208.0,,MD,US,US,2021,Q1,Adult
188577181,18857718,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"120 UNITS, BID",,,,,,,,,,,BID,2021,Q1,Nausea,,2021,Q1,1,I,20200812.0,20201022.0,20210208,20210208,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005001,AEGERION,,45.0,YR,,F,Y,,,20210208.0,,MD,US,US,2021,Q1,Adult
188577181,18857718,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"120 UNITS, BID",,,,,,,,,,,BID,2021,Q1,Pancreatitis acute,,2021,Q1,1,I,20200812.0,20201022.0,20210208,20210208,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005001,AEGERION,,45.0,YR,,F,Y,,,20210208.0,,MD,US,US,2021,Q1,Adult
188577181,18857718,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"120 UNITS, BID",,,,,,,,,,,BID,2021,Q1,Vomiting,,2021,Q1,1,I,20200812.0,20201022.0,20210208,20210208,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005001,AEGERION,,45.0,YR,,F,Y,,,20210208.0,,MD,US,US,2021,Q1,Adult
188580281,18858028,4,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Asthenia,,2021,Q1,1,I,20210118.0,,20210205,20210205,DIR,,,FDA-CTU,,80.0,YR,,M,N,107.5,KG,20210205.0,Y,PH,US,US,2021,Q1,Elderly
188580281,18858028,4,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Blood pressure systolic increased,,2021,Q1,1,I,20210118.0,,20210205,20210205,DIR,,,FDA-CTU,,80.0,YR,,M,N,107.5,KG,20210205.0,Y,PH,US,US,2021,Q1,Elderly
188580281,18858028,4,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Heart rate decreased,,2021,Q1,1,I,20210118.0,,20210205,20210205,DIR,,,FDA-CTU,,80.0,YR,,M,N,107.5,KG,20210205.0,Y,PH,US,US,2021,Q1,Elderly
188580281,18858028,4,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Oxygen saturation decreased,,2021,Q1,1,I,20210118.0,,20210205,20210205,DIR,,,FDA-CTU,,80.0,YR,,M,N,107.5,KG,20210205.0,Y,PH,US,US,2021,Q1,Elderly
188580281,18858028,4,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Respiratory rate increased,,2021,Q1,1,I,20210118.0,,20210205,20210205,DIR,,,FDA-CTU,,80.0,YR,,M,N,107.5,KG,20210205.0,Y,PH,US,US,2021,Q1,Elderly
188580931,18858093,8,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Angioedema,,2021,Q1,1,I,20210205.0,,20210205,20210205,DIR,,,FDA-CTU,,64.0,YR,,M,N,113.0,KG,20210205.0,N,PH,US,US,2021,Q1,Adult
188583733,18858373,8,C,Insulin Glargine,INSULIN GLARGINE,1,Intravenous drip,190 MILLIGRAM,,,,,,,,95.0,MG,UNKNOWN,BID,2021,Q1,COVID-19,,2021,Q1,3,F,20201220.0,20210211.0,20210208,20210218,EXP,,US-CELGENEUS-USA-20210200936,CELGENE,,70.0,YR,,M,Y,,,20210218.0,,MD,US,US,2021,Q1,Elderly
188632272,18863227,13,C,GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,DF,,QD,2021,Q1,Cytomegalovirus infection,,2021,Q1,2,F,20201221.0,20210217.0,20210208,20210225,EXP,,AU-JNJFOC-20201241564,JOHNSON AND JOHNSON,,51.0,YR,A,M,Y,75.8,KG,20210225.0,,MD,AU,AU,2021,Q1,Adult
188632272,18863227,13,C,GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,DF,,QD,2021,Q1,Distributive shock,,2021,Q1,2,F,20201221.0,20210217.0,20210208,20210225,EXP,,AU-JNJFOC-20201241564,JOHNSON AND JOHNSON,,51.0,YR,A,M,Y,75.8,KG,20210225.0,,MD,AU,AU,2021,Q1,Adult
188632272,18863227,13,C,GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,DF,,QD,2021,Q1,Hyperglycaemia,,2021,Q1,2,F,20201221.0,20210217.0,20210208,20210225,EXP,,AU-JNJFOC-20201241564,JOHNSON AND JOHNSON,,51.0,YR,A,M,Y,75.8,KG,20210225.0,,MD,AU,AU,2021,Q1,Adult
188632272,18863227,14,C,GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,20.0,DF,,QID,2021,Q1,Cytomegalovirus infection,,2021,Q1,2,F,20201221.0,20210217.0,20210208,20210225,EXP,,AU-JNJFOC-20201241564,JOHNSON AND JOHNSON,,51.0,YR,A,M,Y,75.8,KG,20210225.0,,MD,AU,AU,2021,Q1,Adult
188632272,18863227,14,C,GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,20.0,DF,,QID,2021,Q1,Distributive shock,,2021,Q1,2,F,20201221.0,20210217.0,20210208,20210225,EXP,,AU-JNJFOC-20201241564,JOHNSON AND JOHNSON,,51.0,YR,A,M,Y,75.8,KG,20210225.0,,MD,AU,AU,2021,Q1,Adult
188632272,18863227,14,C,GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,20.0,DF,,QID,2021,Q1,Hyperglycaemia,,2021,Q1,2,F,20201221.0,20210217.0,20210208,20210225,EXP,,AU-JNJFOC-20201241564,JOHNSON AND JOHNSON,,51.0,YR,A,M,Y,75.8,KG,20210225.0,,MD,AU,AU,2021,Q1,Adult
188635113,18863511,9,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,12 DOSAGE FORM ONCE A DAY,,,U,,,,,12.0,DF,SOLUTION FOR INJECTION,QD,2021,Q1,Anaemia,,2021,Q1,3,F,20210129.0,20210219.0,20210209,20210301,EXP,,IT-AUROBINDO-AUR-APL-2021-005299,AUROBINDO,,82.0,YR,,M,Y,,,20210301.0,,MD,IT,IT,2021,Q1,Elderly
188635113,18863511,9,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,12 DOSAGE FORM ONCE A DAY,,,U,,,,,12.0,DF,SOLUTION FOR INJECTION,QD,2021,Q1,Drug interaction,,2021,Q1,3,F,20210129.0,20210219.0,20210209,20210301,EXP,,IT-AUROBINDO-AUR-APL-2021-005299,AUROBINDO,,82.0,YR,,M,Y,,,20210301.0,,MD,IT,IT,2021,Q1,Elderly
188641151,18864115,12,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Drug ineffective,,2021,Q1,1,I,,20210201.0,20210209,20210209,EXP,,US-AUROBINDO-AUR-APL-2021-005121,AUROBINDO,,69.0,YR,,F,Y,,,20210209.0,,MD,US,US,2021,Q1,Elderly
188644921,18864492,13,C,Insulin Glargine 60 units,,2,,,,,,,,,,,,,,2021,Q1,Acute myocardial infarction,,2021,Q1,1,I,20210127.0,,20210208,20210208,DIR,,,FDA-CTU,,83.0,YR,,M,N,106.9,KG,20210208.0,N,PH,US,US,2021,Q1,Elderly
188644921,18864492,13,C,Insulin Glargine 60 units,,2,,,,,,,,,,,,,,2021,Q1,Cardiac arrest,,2021,Q1,1,I,20210127.0,,20210208,20210208,DIR,,,FDA-CTU,,83.0,YR,,M,N,106.9,KG,20210208.0,N,PH,US,US,2021,Q1,Elderly
188663633,18866363,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"40 DF, ONCE DAILY (AT BEDTIME)",,,,,,,,40.0,DF,INJECTION,QD,2021,Q1,Atrioventricular block complete,,2021,Q1,3,F,20200615.0,20210222.0,20210209,20210226,EXP,,US-ASTELLAS-2021US004462,ASTELLAS,,65.0,YR,,M,Y,,,20210226.0,,HP,US,US,2021,Q1,Elderly
188663633,18866363,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"40 DF, ONCE DAILY (AT BEDTIME)",,,,,,,,40.0,DF,INJECTION,QD,2021,Q1,Nodal rhythm,,2021,Q1,3,F,20200615.0,20210222.0,20210209,20210226,EXP,,US-ASTELLAS-2021US004462,ASTELLAS,,65.0,YR,,M,Y,,,20210226.0,,HP,US,US,2021,Q1,Elderly
188692092,18869209,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 IU, QD",,,U,,,,,24.0,IU,,QD,2021,Q1,Conjunctival hyperaemia,,2021,Q1,2,F,,20210215.0,20210209,20210217,EXP,,NVSC2021FR028065,NOVARTIS,,48.0,YR,,M,Y,,,20210217.0,,HP,FR,FR,2021,Q1,Adult
188692092,18869209,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 IU, QD",,,U,,,,,24.0,IU,,QD,2021,Q1,Eye pruritus,,2021,Q1,2,F,,20210215.0,20210209,20210217,EXP,,NVSC2021FR028065,NOVARTIS,,48.0,YR,,M,Y,,,20210217.0,,HP,FR,FR,2021,Q1,Adult
188692092,18869209,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 IU, QD",,,U,,,,,24.0,IU,,QD,2021,Q1,Flushing,,2021,Q1,2,F,,20210215.0,20210209,20210217,EXP,,NVSC2021FR028065,NOVARTIS,,48.0,YR,,M,Y,,,20210217.0,,HP,FR,FR,2021,Q1,Adult
188692092,18869209,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 IU, QD",,,U,,,,,24.0,IU,,QD,2021,Q1,Incorrect route of product administration,,2021,Q1,2,F,,20210215.0,20210209,20210217,EXP,,NVSC2021FR028065,NOVARTIS,,48.0,YR,,M,Y,,,20210217.0,,HP,FR,FR,2021,Q1,Adult
188692092,18869209,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 IU, QD",,,U,,,,,24.0,IU,,QD,2021,Q1,Malaise,,2021,Q1,2,F,,20210215.0,20210209,20210217,EXP,,NVSC2021FR028065,NOVARTIS,,48.0,YR,,M,Y,,,20210217.0,,HP,FR,FR,2021,Q1,Adult
188692092,18869209,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 IU, QD",,,U,,,,,24.0,IU,,QD,2021,Q1,Mydriasis,,2021,Q1,2,F,,20210215.0,20210209,20210217,EXP,,NVSC2021FR028065,NOVARTIS,,48.0,YR,,M,Y,,,20210217.0,,HP,FR,FR,2021,Q1,Adult
188692092,18869209,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 IU, QD",,,U,,,,,24.0,IU,,QD,2021,Q1,Off label use,,2021,Q1,2,F,,20210215.0,20210209,20210217,EXP,,NVSC2021FR028065,NOVARTIS,,48.0,YR,,M,Y,,,20210217.0,,HP,FR,FR,2021,Q1,Adult
188692092,18869209,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 IU, QD",,,U,,,,,24.0,IU,,QD,2021,Q1,Overdose,,2021,Q1,2,F,,20210215.0,20210209,20210217,EXP,,NVSC2021FR028065,NOVARTIS,,48.0,YR,,M,Y,,,20210217.0,,HP,FR,FR,2021,Q1,Adult
188692092,18869209,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 IU, QD",,,U,,,,,24.0,IU,,QD,2021,Q1,Toxicity to various agents,,2021,Q1,2,F,,20210215.0,20210209,20210217,EXP,,NVSC2021FR028065,NOVARTIS,,48.0,YR,,M,Y,,,20210217.0,,HP,FR,FR,2021,Q1,Adult
188692092,18869209,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 IU, QD",,,U,,,,,24.0,IU,,QD,2021,Q1,Vision blurred,,2021,Q1,2,F,,20210215.0,20210209,20210217,EXP,,NVSC2021FR028065,NOVARTIS,,48.0,YR,,M,Y,,,20210217.0,,HP,FR,FR,2021,Q1,Adult
188708271,18870827,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,D,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Administration site discomfort,,2021,Q1,1,I,20210115.0,20210201.0,20210210,20210210,EXP,,ES-AUROBINDO-AUR-APL-2021-005224,AUROBINDO,,50.0,YR,,M,Y,96.0,KG,20210210.0,,CN,ES,ES,2021,Q1,Adult
188708271,18870827,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,D,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Fatigue,,2021,Q1,1,I,20210115.0,20210201.0,20210210,20210210,EXP,,ES-AUROBINDO-AUR-APL-2021-005224,AUROBINDO,,50.0,YR,,M,Y,96.0,KG,20210210.0,,CN,ES,ES,2021,Q1,Adult
188708271,18870827,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,D,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,20210115.0,20210201.0,20210210,20210210,EXP,,ES-AUROBINDO-AUR-APL-2021-005224,AUROBINDO,,50.0,YR,,M,Y,96.0,KG,20210210.0,,CN,ES,ES,2021,Q1,Adult
188708271,18870827,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,D,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Inappropriate schedule of product administration,,2021,Q1,1,I,20210115.0,20210201.0,20210210,20210210,EXP,,ES-AUROBINDO-AUR-APL-2021-005224,AUROBINDO,,50.0,YR,,M,Y,96.0,KG,20210210.0,,CN,ES,ES,2021,Q1,Adult
188708271,18870827,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,D,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Injection site pruritus,,2021,Q1,1,I,20210115.0,20210201.0,20210210,20210210,EXP,,ES-AUROBINDO-AUR-APL-2021-005224,AUROBINDO,,50.0,YR,,M,Y,96.0,KG,20210210.0,,CN,ES,ES,2021,Q1,Adult
188708271,18870827,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,D,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Limb discomfort,,2021,Q1,1,I,20210115.0,20210201.0,20210210,20210210,EXP,,ES-AUROBINDO-AUR-APL-2021-005224,AUROBINDO,,50.0,YR,,M,Y,96.0,KG,20210210.0,,CN,ES,ES,2021,Q1,Adult
188708271,18870827,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,D,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Multiple use of single-use product,,2021,Q1,1,I,20210115.0,20210201.0,20210210,20210210,EXP,,ES-AUROBINDO-AUR-APL-2021-005224,AUROBINDO,,50.0,YR,,M,Y,96.0,KG,20210210.0,,CN,ES,ES,2021,Q1,Adult
188708271,18870827,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,D,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Administration site discomfort,,2021,Q1,1,I,20210115.0,20210201.0,20210210,20210210,EXP,,ES-AUROBINDO-AUR-APL-2021-005224,AUROBINDO,,50.0,YR,,M,Y,96.0,KG,20210210.0,,CN,ES,ES,2021,Q1,Adult
188708271,18870827,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,D,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Fatigue,,2021,Q1,1,I,20210115.0,20210201.0,20210210,20210210,EXP,,ES-AUROBINDO-AUR-APL-2021-005224,AUROBINDO,,50.0,YR,,M,Y,96.0,KG,20210210.0,,CN,ES,ES,2021,Q1,Adult
188708271,18870827,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,D,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,20210115.0,20210201.0,20210210,20210210,EXP,,ES-AUROBINDO-AUR-APL-2021-005224,AUROBINDO,,50.0,YR,,M,Y,96.0,KG,20210210.0,,CN,ES,ES,2021,Q1,Adult
188708271,18870827,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,D,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Inappropriate schedule of product administration,,2021,Q1,1,I,20210115.0,20210201.0,20210210,20210210,EXP,,ES-AUROBINDO-AUR-APL-2021-005224,AUROBINDO,,50.0,YR,,M,Y,96.0,KG,20210210.0,,CN,ES,ES,2021,Q1,Adult
188708271,18870827,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,D,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Injection site pruritus,,2021,Q1,1,I,20210115.0,20210201.0,20210210,20210210,EXP,,ES-AUROBINDO-AUR-APL-2021-005224,AUROBINDO,,50.0,YR,,M,Y,96.0,KG,20210210.0,,CN,ES,ES,2021,Q1,Adult
188708271,18870827,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,D,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Limb discomfort,,2021,Q1,1,I,20210115.0,20210201.0,20210210,20210210,EXP,,ES-AUROBINDO-AUR-APL-2021-005224,AUROBINDO,,50.0,YR,,M,Y,96.0,KG,20210210.0,,CN,ES,ES,2021,Q1,Adult
188708271,18870827,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,D,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Multiple use of single-use product,,2021,Q1,1,I,20210115.0,20210201.0,20210210,20210210,EXP,,ES-AUROBINDO-AUR-APL-2021-005224,AUROBINDO,,50.0,YR,,M,Y,96.0,KG,20210210.0,,CN,ES,ES,2021,Q1,Adult
188738281,18873828,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 (UNIT), QD",,,Y,,,,,,,INJECTION,QD,2021,Q1,Generalised oedema,,2021,Q1,1,I,20210113.0,20210202.0,20210210,20210210,EXP,,NVSC2021CN028102,NOVARTIS,,70.0,YR,,F,Y,56.0,KG,20210210.0,,HP,CN,CN,2021,Q1,Elderly
188770471,18877047,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,Y,U,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Administration site discomfort,,2021,Q1,1,I,20210115.0,20210202.0,20210210,20210210,EXP,,ES-AUROBINDO-AUR-APL-2021-005173,AUROBINDO,,50.0,YR,,M,Y,96.0,KG,20210211.0,,CN,ES,ES,2021,Q1,Adult
188770471,18877047,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,Y,U,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Fatigue,,2021,Q1,1,I,20210115.0,20210202.0,20210210,20210210,EXP,,ES-AUROBINDO-AUR-APL-2021-005173,AUROBINDO,,50.0,YR,,M,Y,96.0,KG,20210211.0,,CN,ES,ES,2021,Q1,Adult
188770471,18877047,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,Y,U,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,20210115.0,20210202.0,20210210,20210210,EXP,,ES-AUROBINDO-AUR-APL-2021-005173,AUROBINDO,,50.0,YR,,M,Y,96.0,KG,20210211.0,,CN,ES,ES,2021,Q1,Adult
188770471,18877047,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,Y,U,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Inappropriate schedule of product administration,,2021,Q1,1,I,20210115.0,20210202.0,20210210,20210210,EXP,,ES-AUROBINDO-AUR-APL-2021-005173,AUROBINDO,,50.0,YR,,M,Y,96.0,KG,20210211.0,,CN,ES,ES,2021,Q1,Adult
188770471,18877047,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,Y,U,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Injection site pruritus,,2021,Q1,1,I,20210115.0,20210202.0,20210210,20210210,EXP,,ES-AUROBINDO-AUR-APL-2021-005173,AUROBINDO,,50.0,YR,,M,Y,96.0,KG,20210211.0,,CN,ES,ES,2021,Q1,Adult
188770471,18877047,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,Y,U,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Limb discomfort,,2021,Q1,1,I,20210115.0,20210202.0,20210210,20210210,EXP,,ES-AUROBINDO-AUR-APL-2021-005173,AUROBINDO,,50.0,YR,,M,Y,96.0,KG,20210211.0,,CN,ES,ES,2021,Q1,Adult
188770471,18877047,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,Y,U,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Multiple use of single-use product,,2021,Q1,1,I,20210115.0,20210202.0,20210210,20210210,EXP,,ES-AUROBINDO-AUR-APL-2021-005173,AUROBINDO,,50.0,YR,,M,Y,96.0,KG,20210211.0,,CN,ES,ES,2021,Q1,Adult
188770471,18877047,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,Y,U,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Administration site discomfort,,2021,Q1,1,I,20210115.0,20210202.0,20210210,20210210,EXP,,ES-AUROBINDO-AUR-APL-2021-005173,AUROBINDO,,50.0,YR,,M,Y,96.0,KG,20210211.0,,CN,ES,ES,2021,Q1,Adult
188770471,18877047,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,Y,U,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Fatigue,,2021,Q1,1,I,20210115.0,20210202.0,20210210,20210210,EXP,,ES-AUROBINDO-AUR-APL-2021-005173,AUROBINDO,,50.0,YR,,M,Y,96.0,KG,20210211.0,,CN,ES,ES,2021,Q1,Adult
188770471,18877047,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,Y,U,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,20210115.0,20210202.0,20210210,20210210,EXP,,ES-AUROBINDO-AUR-APL-2021-005173,AUROBINDO,,50.0,YR,,M,Y,96.0,KG,20210211.0,,CN,ES,ES,2021,Q1,Adult
188770471,18877047,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,Y,U,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Inappropriate schedule of product administration,,2021,Q1,1,I,20210115.0,20210202.0,20210210,20210210,EXP,,ES-AUROBINDO-AUR-APL-2021-005173,AUROBINDO,,50.0,YR,,M,Y,96.0,KG,20210211.0,,CN,ES,ES,2021,Q1,Adult
188770471,18877047,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,Y,U,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Injection site pruritus,,2021,Q1,1,I,20210115.0,20210202.0,20210210,20210210,EXP,,ES-AUROBINDO-AUR-APL-2021-005173,AUROBINDO,,50.0,YR,,M,Y,96.0,KG,20210211.0,,CN,ES,ES,2021,Q1,Adult
188770471,18877047,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,Y,U,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Limb discomfort,,2021,Q1,1,I,20210115.0,20210202.0,20210210,20210210,EXP,,ES-AUROBINDO-AUR-APL-2021-005173,AUROBINDO,,50.0,YR,,M,Y,96.0,KG,20210211.0,,CN,ES,ES,2021,Q1,Adult
188770471,18877047,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,Y,U,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Multiple use of single-use product,,2021,Q1,1,I,20210115.0,20210202.0,20210210,20210210,EXP,,ES-AUROBINDO-AUR-APL-2021-005173,AUROBINDO,,50.0,YR,,M,Y,96.0,KG,20210211.0,,CN,ES,ES,2021,Q1,Adult
188782841,18878284,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Abdominal pain,,2021,Q1,1,I,,20200504.0,20210211,20210211,EXP,,CA-BAYER-2020-085910,BAYER,,72.0,YR,E,M,Y,,,20210211.0,,HP,NL,CA,2021,Q1,Elderly
188782841,18878284,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Anal fistula,,2021,Q1,1,I,,20200504.0,20210211,20210211,EXP,,CA-BAYER-2020-085910,BAYER,,72.0,YR,E,M,Y,,,20210211.0,,HP,NL,CA,2021,Q1,Elderly
188782841,18878284,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Diarrhoea,,2021,Q1,1,I,,20200504.0,20210211,20210211,EXP,,CA-BAYER-2020-085910,BAYER,,72.0,YR,E,M,Y,,,20210211.0,,HP,NL,CA,2021,Q1,Elderly
188782841,18878284,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Fournier's gangrene,,2021,Q1,1,I,,20200504.0,20210211,20210211,EXP,,CA-BAYER-2020-085910,BAYER,,72.0,YR,E,M,Y,,,20210211.0,,HP,NL,CA,2021,Q1,Elderly
188782841,18878284,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Nausea,,2021,Q1,1,I,,20200504.0,20210211,20210211,EXP,,CA-BAYER-2020-085910,BAYER,,72.0,YR,E,M,Y,,,20210211.0,,HP,NL,CA,2021,Q1,Elderly
188782841,18878284,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Prostatitis,,2021,Q1,1,I,,20200504.0,20210211,20210211,EXP,,CA-BAYER-2020-085910,BAYER,,72.0,YR,E,M,Y,,,20210211.0,,HP,NL,CA,2021,Q1,Elderly
188782841,18878284,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Rectal abscess,,2021,Q1,1,I,,20200504.0,20210211,20210211,EXP,,CA-BAYER-2020-085910,BAYER,,72.0,YR,E,M,Y,,,20210211.0,,HP,NL,CA,2021,Q1,Elderly
188784711,18878471,6,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,COVID-19 pneumonia,,2021,Q1,1,I,20210210.0,,20210211,20210211,DIR,,,FDA-CTU,,65.0,YR,,M,N,110.7,KG,20210211.0,Y,CN,US,US,2021,Q1,Elderly
188790601,18879060,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2021,Q1,Blood glucose fluctuation,,2021,Q1,1,I,20201229.0,20210201.0,20210211,20210211,EXP,GB-MHRA-EYC 00239252,GB-ASTELLAS-2021US003942,ASTELLAS,,75.0,YR,,M,Y,,,20210211.0,,CN,GB,GB,2021,Q1,Elderly
188815451,18881545,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Administration site discomfort,,2021,Q1,1,I,20210115.0,20210203.0,20210211,20210211,EXP,,NVSC2021ES026751,NOVARTIS,,50.0,YR,,M,Y,96.0,KG,20210211.0,,HP,ES,ES,2021,Q1,Adult
188815451,18881545,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Fatigue,,2021,Q1,1,I,20210115.0,20210203.0,20210211,20210211,EXP,,NVSC2021ES026751,NOVARTIS,,50.0,YR,,M,Y,96.0,KG,20210211.0,,HP,ES,ES,2021,Q1,Adult
188815451,18881545,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,20210115.0,20210203.0,20210211,20210211,EXP,,NVSC2021ES026751,NOVARTIS,,50.0,YR,,M,Y,96.0,KG,20210211.0,,HP,ES,ES,2021,Q1,Adult
188815451,18881545,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Inappropriate schedule of product administration,,2021,Q1,1,I,20210115.0,20210203.0,20210211,20210211,EXP,,NVSC2021ES026751,NOVARTIS,,50.0,YR,,M,Y,96.0,KG,20210211.0,,HP,ES,ES,2021,Q1,Adult
188815451,18881545,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Injection site pruritus,,2021,Q1,1,I,20210115.0,20210203.0,20210211,20210211,EXP,,NVSC2021ES026751,NOVARTIS,,50.0,YR,,M,Y,96.0,KG,20210211.0,,HP,ES,ES,2021,Q1,Adult
188815451,18881545,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Limb discomfort,,2021,Q1,1,I,20210115.0,20210203.0,20210211,20210211,EXP,,NVSC2021ES026751,NOVARTIS,,50.0,YR,,M,Y,96.0,KG,20210211.0,,HP,ES,ES,2021,Q1,Adult
188815451,18881545,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Multiple use of single-use product,,2021,Q1,1,I,20210115.0,20210203.0,20210211,20210211,EXP,,NVSC2021ES026751,NOVARTIS,,50.0,YR,,M,Y,96.0,KG,20210211.0,,HP,ES,ES,2021,Q1,Adult
188815451,18881545,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Administration site discomfort,,2021,Q1,1,I,20210115.0,20210203.0,20210211,20210211,EXP,,NVSC2021ES026751,NOVARTIS,,50.0,YR,,M,Y,96.0,KG,20210211.0,,HP,ES,ES,2021,Q1,Adult
188815451,18881545,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Fatigue,,2021,Q1,1,I,20210115.0,20210203.0,20210211,20210211,EXP,,NVSC2021ES026751,NOVARTIS,,50.0,YR,,M,Y,96.0,KG,20210211.0,,HP,ES,ES,2021,Q1,Adult
188815451,18881545,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,20210115.0,20210203.0,20210211,20210211,EXP,,NVSC2021ES026751,NOVARTIS,,50.0,YR,,M,Y,96.0,KG,20210211.0,,HP,ES,ES,2021,Q1,Adult
188815451,18881545,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Inappropriate schedule of product administration,,2021,Q1,1,I,20210115.0,20210203.0,20210211,20210211,EXP,,NVSC2021ES026751,NOVARTIS,,50.0,YR,,M,Y,96.0,KG,20210211.0,,HP,ES,ES,2021,Q1,Adult
188815451,18881545,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Injection site pruritus,,2021,Q1,1,I,20210115.0,20210203.0,20210211,20210211,EXP,,NVSC2021ES026751,NOVARTIS,,50.0,YR,,M,Y,96.0,KG,20210211.0,,HP,ES,ES,2021,Q1,Adult
188815451,18881545,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Limb discomfort,,2021,Q1,1,I,20210115.0,20210203.0,20210211,20210211,EXP,,NVSC2021ES026751,NOVARTIS,,50.0,YR,,M,Y,96.0,KG,20210211.0,,HP,ES,ES,2021,Q1,Adult
188815451,18881545,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Multiple use of single-use product,,2021,Q1,1,I,20210115.0,20210203.0,20210211,20210211,EXP,,NVSC2021ES026751,NOVARTIS,,50.0,YR,,M,Y,96.0,KG,20210211.0,,HP,ES,ES,2021,Q1,Adult
188863291,18886329,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,UNKNOWN,,2021,Q1,Hyponatraemia,,2021,Q1,1,I,,20210128.0,20210212,20210212,EXP,,US-SCIEGEN-2021SCILIT00087,SCIEGEN,,57.0,YR,A,M,Y,,,20210212.0,,HP,US,US,2021,Q1,Adult
188863291,18886329,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,UNKNOWN,,2021,Q1,Inappropriate antidiuretic hormone secretion,,2021,Q1,1,I,,20210128.0,20210212,20210212,EXP,,US-SCIEGEN-2021SCILIT00087,SCIEGEN,,57.0,YR,A,M,Y,,,20210212.0,,HP,US,US,2021,Q1,Adult
188863291,18886329,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,UNKNOWN,,2021,Q1,Mental status changes,,2021,Q1,1,I,,20210128.0,20210212,20210212,EXP,,US-SCIEGEN-2021SCILIT00087,SCIEGEN,,57.0,YR,A,M,Y,,,20210212.0,,HP,US,US,2021,Q1,Adult
188864081,18886408,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"BEFORE LOCKDOWN WAS 5 UNITS/DAY (0,10 UNITS/KG/DAY)",,,,,,,,,,,,2021,Q1,Abdominal pain,,2021,Q1,1,I,2020.0,20210203.0,20210212,20210212,EXP,,IT-VERTEX PHARMACEUTICALS-2021-002401,VERTEX,,17.0,YR,,M,Y,,,20210212.0,,HP,IT,IT,2021,Q1,Youth
188864081,18886408,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"BEFORE LOCKDOWN WAS 5 UNITS/DAY (0,10 UNITS/KG/DAY)",,,,,,,,,,,,2021,Q1,Agitation,,2021,Q1,1,I,2020.0,20210203.0,20210212,20210212,EXP,,IT-VERTEX PHARMACEUTICALS-2021-002401,VERTEX,,17.0,YR,,M,Y,,,20210212.0,,HP,IT,IT,2021,Q1,Youth
188864081,18886408,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"BEFORE LOCKDOWN WAS 5 UNITS/DAY (0,10 UNITS/KG/DAY)",,,,,,,,,,,,2021,Q1,Blood glucose fluctuation,,2021,Q1,1,I,2020.0,20210203.0,20210212,20210212,EXP,,IT-VERTEX PHARMACEUTICALS-2021-002401,VERTEX,,17.0,YR,,M,Y,,,20210212.0,,HP,IT,IT,2021,Q1,Youth
188864081,18886408,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"BEFORE LOCKDOWN WAS 5 UNITS/DAY (0,10 UNITS/KG/DAY)",,,,,,,,,,,,2021,Q1,C-reactive protein increased,,2021,Q1,1,I,2020.0,20210203.0,20210212,20210212,EXP,,IT-VERTEX PHARMACEUTICALS-2021-002401,VERTEX,,17.0,YR,,M,Y,,,20210212.0,,HP,IT,IT,2021,Q1,Youth
188864081,18886408,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"BEFORE LOCKDOWN WAS 5 UNITS/DAY (0,10 UNITS/KG/DAY)",,,,,,,,,,,,2021,Q1,Dehydration,,2021,Q1,1,I,2020.0,20210203.0,20210212,20210212,EXP,,IT-VERTEX PHARMACEUTICALS-2021-002401,VERTEX,,17.0,YR,,M,Y,,,20210212.0,,HP,IT,IT,2021,Q1,Youth
188864081,18886408,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"BEFORE LOCKDOWN WAS 5 UNITS/DAY (0,10 UNITS/KG/DAY)",,,,,,,,,,,,2021,Q1,Headache,,2021,Q1,1,I,2020.0,20210203.0,20210212,20210212,EXP,,IT-VERTEX PHARMACEUTICALS-2021-002401,VERTEX,,17.0,YR,,M,Y,,,20210212.0,,HP,IT,IT,2021,Q1,Youth
188864081,18886408,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"BEFORE LOCKDOWN WAS 5 UNITS/DAY (0,10 UNITS/KG/DAY)",,,,,,,,,,,,2021,Q1,Infective pulmonary exacerbation of cystic fibrosis,,2021,Q1,1,I,2020.0,20210203.0,20210212,20210212,EXP,,IT-VERTEX PHARMACEUTICALS-2021-002401,VERTEX,,17.0,YR,,M,Y,,,20210212.0,,HP,IT,IT,2021,Q1,Youth
188864081,18886408,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"BEFORE LOCKDOWN WAS 5 UNITS/DAY (0,10 UNITS/KG/DAY)",,,,,,,,,,,,2021,Q1,Polydipsia,,2021,Q1,1,I,2020.0,20210203.0,20210212,20210212,EXP,,IT-VERTEX PHARMACEUTICALS-2021-002401,VERTEX,,17.0,YR,,M,Y,,,20210212.0,,HP,IT,IT,2021,Q1,Youth
188864081,18886408,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"BEFORE LOCKDOWN WAS 5 UNITS/DAY (0,10 UNITS/KG/DAY)",,,,,,,,,,,,2021,Q1,Polyuria,,2021,Q1,1,I,2020.0,20210203.0,20210212,20210212,EXP,,IT-VERTEX PHARMACEUTICALS-2021-002401,VERTEX,,17.0,YR,,M,Y,,,20210212.0,,HP,IT,IT,2021,Q1,Youth
188864081,18886408,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"BEFORE LOCKDOWN WAS 5 UNITS/DAY (0,10 UNITS/KG/DAY)",,,,,,,,,,,,2021,Q1,Weight decreased,,2021,Q1,1,I,2020.0,20210203.0,20210212,20210212,EXP,,IT-VERTEX PHARMACEUTICALS-2021-002401,VERTEX,,17.0,YR,,M,Y,,,20210212.0,,HP,IT,IT,2021,Q1,Youth
188865601,18886560,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Angina unstable,,2021,Q1,1,I,20210127.0,20210202.0,20210212,20210212,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202102002312,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20210212.0,,HP,CN,CN,2021,Q1,Elderly
188865601,18886560,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Arteriosclerosis,,2021,Q1,1,I,20210127.0,20210202.0,20210212,20210212,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202102002312,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20210212.0,,HP,CN,CN,2021,Q1,Elderly
188865601,18886560,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Cardiac dysfunction,,2021,Q1,1,I,20210127.0,20210202.0,20210212,20210212,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202102002312,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20210212.0,,HP,CN,CN,2021,Q1,Elderly
188865601,18886560,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Coronary artery disease,,2021,Q1,1,I,20210127.0,20210202.0,20210212,20210212,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202102002312,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20210212.0,,HP,CN,CN,2021,Q1,Elderly
188865601,18886560,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Diabetic retinopathy,,2021,Q1,1,I,20210127.0,20210202.0,20210212,20210212,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202102002312,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20210212.0,,HP,CN,CN,2021,Q1,Elderly
188865601,18886560,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Glaucoma,,2021,Q1,1,I,20210127.0,20210202.0,20210212,20210212,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202102002312,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20210212.0,,HP,CN,CN,2021,Q1,Elderly
188865601,18886560,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Hypertension,,2021,Q1,1,I,20210127.0,20210202.0,20210212,20210212,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202102002312,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20210212.0,,HP,CN,CN,2021,Q1,Elderly
188865601,18886560,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,20210127.0,20210202.0,20210212,20210212,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202102002312,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20210212.0,,HP,CN,CN,2021,Q1,Elderly
188865601,18886560,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Left atrial enlargement,,2021,Q1,1,I,20210127.0,20210202.0,20210212,20210212,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202102002312,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20210212.0,,HP,CN,CN,2021,Q1,Elderly
188865601,18886560,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Pneumonia,,2021,Q1,1,I,20210127.0,20210202.0,20210212,20210212,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202102002312,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20210212.0,,HP,CN,CN,2021,Q1,Elderly
188865601,18886560,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Respiratory failure,,2021,Q1,1,I,20210127.0,20210202.0,20210212,20210212,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202102002312,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20210212.0,,HP,CN,CN,2021,Q1,Elderly
188865601,18886560,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Sinus rhythm,,2021,Q1,1,I,20210127.0,20210202.0,20210212,20210212,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202102002312,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20210212.0,,HP,CN,CN,2021,Q1,Elderly
188865601,18886560,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Type 2 diabetes mellitus,,2021,Q1,1,I,20210127.0,20210202.0,20210212,20210212,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202102002312,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20210212.0,,HP,CN,CN,2021,Q1,Elderly
188866061,18886606,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,,2021,Q1,Altered state of consciousness,,2021,Q1,1,I,,20210208.0,20210212,20210212,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-013000,BRISTOL MYERS SQUIBB,,59.0,YR,,F,Y,,,20210212.0,,HP,CA,CA,2021,Q1,Adult
188866061,18886606,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,,2021,Q1,Aphasia,,2021,Q1,1,I,,20210208.0,20210212,20210212,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-013000,BRISTOL MYERS SQUIBB,,59.0,YR,,F,Y,,,20210212.0,,HP,CA,CA,2021,Q1,Adult
188866061,18886606,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,,2021,Q1,Confusional state,,2021,Q1,1,I,,20210208.0,20210212,20210212,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-013000,BRISTOL MYERS SQUIBB,,59.0,YR,,F,Y,,,20210212.0,,HP,CA,CA,2021,Q1,Adult
188866061,18886606,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,,2021,Q1,Fall,,2021,Q1,1,I,,20210208.0,20210212,20210212,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-013000,BRISTOL MYERS SQUIBB,,59.0,YR,,F,Y,,,20210212.0,,HP,CA,CA,2021,Q1,Adult
188866061,18886606,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,,2021,Q1,Subdural haematoma,,2021,Q1,1,I,,20210208.0,20210212,20210212,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-013000,BRISTOL MYERS SQUIBB,,59.0,YR,,F,Y,,,20210212.0,,HP,CA,CA,2021,Q1,Adult
188869011,18886901,12,C,Insulin?glargine,INSULIN NOS,1,Unknown,,,,U,,,,,,,,,2021,Q1,Angioedema,,2021,Q1,1,I,,20210201.0,20210212,20210212,EXP,,US-TEVA-2021-US-1877185,TEVA,"BATARSEH E, KERSTEN BP, PINELO AC, NADLER JN, SCHWARTZ SA. ANGIOEDEMA IN AFRICAN AMERICAN PATIENTS HOSPITALIZED FOR COVID?19. AM?J?RESPIR?CRIT?CARE?MED 2020?202(11):1581?1583.",69.0,YR,E,F,Y,,,20210212.0,,MD,US,US,2021,Q1,Elderly
188869011,18886901,12,C,Insulin?glargine,INSULIN NOS,1,Unknown,,,,U,,,,,,,,,2021,Q1,Drug ineffective,,2021,Q1,1,I,,20210201.0,20210212,20210212,EXP,,US-TEVA-2021-US-1877185,TEVA,"BATARSEH E, KERSTEN BP, PINELO AC, NADLER JN, SCHWARTZ SA. ANGIOEDEMA IN AFRICAN AMERICAN PATIENTS HOSPITALIZED FOR COVID?19. AM?J?RESPIR?CRIT?CARE?MED 2020?202(11):1581?1583.",69.0,YR,E,F,Y,,,20210212.0,,MD,US,US,2021,Q1,Elderly
188869011,18886901,12,C,Insulin?glargine,INSULIN NOS,1,Unknown,,,,U,,,,,,,,,2021,Q1,Off label use,,2021,Q1,1,I,,20210201.0,20210212,20210212,EXP,,US-TEVA-2021-US-1877185,TEVA,"BATARSEH E, KERSTEN BP, PINELO AC, NADLER JN, SCHWARTZ SA. ANGIOEDEMA IN AFRICAN AMERICAN PATIENTS HOSPITALIZED FOR COVID?19. AM?J?RESPIR?CRIT?CARE?MED 2020?202(11):1581?1583.",69.0,YR,E,F,Y,,,20210212.0,,MD,US,US,2021,Q1,Elderly
188876032,18887603,10,C,INSULIN GLARGINE BIOSIMILAR 1,,2,Subcutaneous,"9UNITS, QD",,,,,,,,,,,QD,2021,Q1,COVID-19,,2021,Q1,2,F,20210205.0,20210302.0,20210212,20210304,EXP,,JP-GILEAD-2021-0516319,GILEAD,,74.0,YR,E,F,Y,75.0,KG,20210304.0,,MD,JP,JP,2021,Q1,Elderly
188880211,18888021,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD (18 IU, 1 IN 1 D)",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Blood glucose decreased,,2021,Q1,1,I,20210113.0,20210210.0,20210212,20210212,EXP,,ES-AMERICAN REGENT INC-2021000380,AMERICAN REGENT,,78.0,YR,,F,Y,,,20210212.0,,CN,ES,ES,2021,Q1,Elderly
188880211,18888021,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD (18 IU, 1 IN 1 D)",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,20210113.0,20210210.0,20210212,20210212,EXP,,ES-AMERICAN REGENT INC-2021000380,AMERICAN REGENT,,78.0,YR,,F,Y,,,20210212.0,,CN,ES,ES,2021,Q1,Elderly
188880211,18888021,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD (18 IU, 1 IN 1 D)",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Blood iron abnormal,,2021,Q1,1,I,20210113.0,20210210.0,20210212,20210212,EXP,,ES-AMERICAN REGENT INC-2021000380,AMERICAN REGENT,,78.0,YR,,F,Y,,,20210212.0,,CN,ES,ES,2021,Q1,Elderly
188880211,18888021,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD (18 IU, 1 IN 1 D)",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Decreased appetite,,2021,Q1,1,I,20210113.0,20210210.0,20210212,20210212,EXP,,ES-AMERICAN REGENT INC-2021000380,AMERICAN REGENT,,78.0,YR,,F,Y,,,20210212.0,,CN,ES,ES,2021,Q1,Elderly
188880211,18888021,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD (18 IU, 1 IN 1 D)",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Discomfort,,2021,Q1,1,I,20210113.0,20210210.0,20210212,20210212,EXP,,ES-AMERICAN REGENT INC-2021000380,AMERICAN REGENT,,78.0,YR,,F,Y,,,20210212.0,,CN,ES,ES,2021,Q1,Elderly
188880211,18888021,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD (18 IU, 1 IN 1 D)",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Dizziness,,2021,Q1,1,I,20210113.0,20210210.0,20210212,20210212,EXP,,ES-AMERICAN REGENT INC-2021000380,AMERICAN REGENT,,78.0,YR,,F,Y,,,20210212.0,,CN,ES,ES,2021,Q1,Elderly
188880211,18888021,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD (18 IU, 1 IN 1 D)",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Fear,,2021,Q1,1,I,20210113.0,20210210.0,20210212,20210212,EXP,,ES-AMERICAN REGENT INC-2021000380,AMERICAN REGENT,,78.0,YR,,F,Y,,,20210212.0,,CN,ES,ES,2021,Q1,Elderly
188880211,18888021,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD (18 IU, 1 IN 1 D)",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Hot flush,,2021,Q1,1,I,20210113.0,20210210.0,20210212,20210212,EXP,,ES-AMERICAN REGENT INC-2021000380,AMERICAN REGENT,,78.0,YR,,F,Y,,,20210212.0,,CN,ES,ES,2021,Q1,Elderly
188880211,18888021,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD (18 IU, 1 IN 1 D)",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Hyperglycaemia,,2021,Q1,1,I,20210113.0,20210210.0,20210212,20210212,EXP,,ES-AMERICAN REGENT INC-2021000380,AMERICAN REGENT,,78.0,YR,,F,Y,,,20210212.0,,CN,ES,ES,2021,Q1,Elderly
188880211,18888021,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD (18 IU, 1 IN 1 D)",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Hypertension,,2021,Q1,1,I,20210113.0,20210210.0,20210212,20210212,EXP,,ES-AMERICAN REGENT INC-2021000380,AMERICAN REGENT,,78.0,YR,,F,Y,,,20210212.0,,CN,ES,ES,2021,Q1,Elderly
188880211,18888021,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD (18 IU, 1 IN 1 D)",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Intentional dose omission,,2021,Q1,1,I,20210113.0,20210210.0,20210212,20210212,EXP,,ES-AMERICAN REGENT INC-2021000380,AMERICAN REGENT,,78.0,YR,,F,Y,,,20210212.0,,CN,ES,ES,2021,Q1,Elderly
188880211,18888021,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD (18 IU, 1 IN 1 D)",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Intestinal infarction,,2021,Q1,1,I,20210113.0,20210210.0,20210212,20210212,EXP,,ES-AMERICAN REGENT INC-2021000380,AMERICAN REGENT,,78.0,YR,,F,Y,,,20210212.0,,CN,ES,ES,2021,Q1,Elderly
188880211,18888021,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD (18 IU, 1 IN 1 D)",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Shoulder operation,,2021,Q1,1,I,20210113.0,20210210.0,20210212,20210212,EXP,,ES-AMERICAN REGENT INC-2021000380,AMERICAN REGENT,,78.0,YR,,F,Y,,,20210212.0,,CN,ES,ES,2021,Q1,Elderly
188880211,18888021,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Blood glucose decreased,,2021,Q1,1,I,20210113.0,20210210.0,20210212,20210212,EXP,,ES-AMERICAN REGENT INC-2021000380,AMERICAN REGENT,,78.0,YR,,F,Y,,,20210212.0,,CN,ES,ES,2021,Q1,Elderly
188880211,18888021,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,20210113.0,20210210.0,20210212,20210212,EXP,,ES-AMERICAN REGENT INC-2021000380,AMERICAN REGENT,,78.0,YR,,F,Y,,,20210212.0,,CN,ES,ES,2021,Q1,Elderly
188880211,18888021,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Blood iron abnormal,,2021,Q1,1,I,20210113.0,20210210.0,20210212,20210212,EXP,,ES-AMERICAN REGENT INC-2021000380,AMERICAN REGENT,,78.0,YR,,F,Y,,,20210212.0,,CN,ES,ES,2021,Q1,Elderly
188880211,18888021,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Decreased appetite,,2021,Q1,1,I,20210113.0,20210210.0,20210212,20210212,EXP,,ES-AMERICAN REGENT INC-2021000380,AMERICAN REGENT,,78.0,YR,,F,Y,,,20210212.0,,CN,ES,ES,2021,Q1,Elderly
188880211,18888021,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Discomfort,,2021,Q1,1,I,20210113.0,20210210.0,20210212,20210212,EXP,,ES-AMERICAN REGENT INC-2021000380,AMERICAN REGENT,,78.0,YR,,F,Y,,,20210212.0,,CN,ES,ES,2021,Q1,Elderly
188880211,18888021,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Dizziness,,2021,Q1,1,I,20210113.0,20210210.0,20210212,20210212,EXP,,ES-AMERICAN REGENT INC-2021000380,AMERICAN REGENT,,78.0,YR,,F,Y,,,20210212.0,,CN,ES,ES,2021,Q1,Elderly
188880211,18888021,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Fear,,2021,Q1,1,I,20210113.0,20210210.0,20210212,20210212,EXP,,ES-AMERICAN REGENT INC-2021000380,AMERICAN REGENT,,78.0,YR,,F,Y,,,20210212.0,,CN,ES,ES,2021,Q1,Elderly
188880211,18888021,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Hot flush,,2021,Q1,1,I,20210113.0,20210210.0,20210212,20210212,EXP,,ES-AMERICAN REGENT INC-2021000380,AMERICAN REGENT,,78.0,YR,,F,Y,,,20210212.0,,CN,ES,ES,2021,Q1,Elderly
188880211,18888021,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Hyperglycaemia,,2021,Q1,1,I,20210113.0,20210210.0,20210212,20210212,EXP,,ES-AMERICAN REGENT INC-2021000380,AMERICAN REGENT,,78.0,YR,,F,Y,,,20210212.0,,CN,ES,ES,2021,Q1,Elderly
188880211,18888021,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Hypertension,,2021,Q1,1,I,20210113.0,20210210.0,20210212,20210212,EXP,,ES-AMERICAN REGENT INC-2021000380,AMERICAN REGENT,,78.0,YR,,F,Y,,,20210212.0,,CN,ES,ES,2021,Q1,Elderly
188880211,18888021,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Intentional dose omission,,2021,Q1,1,I,20210113.0,20210210.0,20210212,20210212,EXP,,ES-AMERICAN REGENT INC-2021000380,AMERICAN REGENT,,78.0,YR,,F,Y,,,20210212.0,,CN,ES,ES,2021,Q1,Elderly
188880211,18888021,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Intestinal infarction,,2021,Q1,1,I,20210113.0,20210210.0,20210212,20210212,EXP,,ES-AMERICAN REGENT INC-2021000380,AMERICAN REGENT,,78.0,YR,,F,Y,,,20210212.0,,CN,ES,ES,2021,Q1,Elderly
188880211,18888021,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Shoulder operation,,2021,Q1,1,I,20210113.0,20210210.0,20210212,20210212,EXP,,ES-AMERICAN REGENT INC-2021000380,AMERICAN REGENT,,78.0,YR,,F,Y,,,20210212.0,,CN,ES,ES,2021,Q1,Elderly
188884221,18888422,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,28 IU,,,,, UNKNOWN,,,28.0,IU,,,2021,Q1,Drug interaction,,2021,Q1,1,I,,20210205.0,20210212,20210212,EXP,,ES-PFIZER INC-2021119995,PFIZER,"ALBI?ANA PEREZ, MS. POSIBLE SINDROME SEROTONIERGICO RELACIONADO CON LA ADMINISTRACION DE VENLAFAXINA Y TRAMADOL [POSSIBLE SEROTONIN SYNDROME ASSOCIATED WITH ADMINISTRATION OF VENLAFAXINE AND TRAMADOL]. FARM HOSP. 2012?NOV?DEC 36(6):548",68.0,YR,,F,Y,,,20210212.0,,MD,ES,ES,2021,Q1,Elderly
188884221,18888422,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,28 IU,,,,, UNKNOWN,,,28.0,IU,,,2021,Q1,Hyperreflexia,,2021,Q1,1,I,,20210205.0,20210212,20210212,EXP,,ES-PFIZER INC-2021119995,PFIZER,"ALBI?ANA PEREZ, MS. POSIBLE SINDROME SEROTONIERGICO RELACIONADO CON LA ADMINISTRACION DE VENLAFAXINA Y TRAMADOL [POSSIBLE SEROTONIN SYNDROME ASSOCIATED WITH ADMINISTRATION OF VENLAFAXINE AND TRAMADOL]. FARM HOSP. 2012?NOV?DEC 36(6):548",68.0,YR,,F,Y,,,20210212.0,,MD,ES,ES,2021,Q1,Elderly
188884221,18888422,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,28 IU,,,,, UNKNOWN,,,28.0,IU,,,2021,Q1,Musculoskeletal stiffness,,2021,Q1,1,I,,20210205.0,20210212,20210212,EXP,,ES-PFIZER INC-2021119995,PFIZER,"ALBI?ANA PEREZ, MS. POSIBLE SINDROME SEROTONIERGICO RELACIONADO CON LA ADMINISTRACION DE VENLAFAXINA Y TRAMADOL [POSSIBLE SEROTONIN SYNDROME ASSOCIATED WITH ADMINISTRATION OF VENLAFAXINE AND TRAMADOL]. FARM HOSP. 2012?NOV?DEC 36(6):548",68.0,YR,,F,Y,,,20210212.0,,MD,ES,ES,2021,Q1,Elderly
188884221,18888422,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,28 IU,,,,, UNKNOWN,,,28.0,IU,,,2021,Q1,Serotonin syndrome,,2021,Q1,1,I,,20210205.0,20210212,20210212,EXP,,ES-PFIZER INC-2021119995,PFIZER,"ALBI?ANA PEREZ, MS. POSIBLE SINDROME SEROTONIERGICO RELACIONADO CON LA ADMINISTRACION DE VENLAFAXINA Y TRAMADOL [POSSIBLE SEROTONIN SYNDROME ASSOCIATED WITH ADMINISTRATION OF VENLAFAXINE AND TRAMADOL]. FARM HOSP. 2012?NOV?DEC 36(6):548",68.0,YR,,F,Y,,,20210212.0,,MD,ES,ES,2021,Q1,Elderly
188892592,18889259,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Drug ineffective,,2021,Q1,2,F,,20210223.0,20210213,20210302,EXP,,US-JNJFOC-20210223265,JOHNSON AND JOHNSON,"ROBINSON ZS, ARVIN JP, MADDING KL. RIVAROXABAN FAILURE IN A PATIENT TAKING OXACARBAZEPINE. ANNALS OF PHARMACOTHERAPY. 2021",28.0,YR,A,M,Y,146.0,KG,20210302.0,,HP,US,US,2021,Q1,Young Adult
188892592,18889259,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Drug interaction,,2021,Q1,2,F,,20210223.0,20210213,20210302,EXP,,US-JNJFOC-20210223265,JOHNSON AND JOHNSON,"ROBINSON ZS, ARVIN JP, MADDING KL. RIVAROXABAN FAILURE IN A PATIENT TAKING OXACARBAZEPINE. ANNALS OF PHARMACOTHERAPY. 2021",28.0,YR,A,M,Y,146.0,KG,20210302.0,,HP,US,US,2021,Q1,Young Adult
188892592,18889259,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Drug level decreased,,2021,Q1,2,F,,20210223.0,20210213,20210302,EXP,,US-JNJFOC-20210223265,JOHNSON AND JOHNSON,"ROBINSON ZS, ARVIN JP, MADDING KL. RIVAROXABAN FAILURE IN A PATIENT TAKING OXACARBAZEPINE. ANNALS OF PHARMACOTHERAPY. 2021",28.0,YR,A,M,Y,146.0,KG,20210302.0,,HP,US,US,2021,Q1,Young Adult
188892592,18889259,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Loss of consciousness,,2021,Q1,2,F,,20210223.0,20210213,20210302,EXP,,US-JNJFOC-20210223265,JOHNSON AND JOHNSON,"ROBINSON ZS, ARVIN JP, MADDING KL. RIVAROXABAN FAILURE IN A PATIENT TAKING OXACARBAZEPINE. ANNALS OF PHARMACOTHERAPY. 2021",28.0,YR,A,M,Y,146.0,KG,20210302.0,,HP,US,US,2021,Q1,Young Adult
188892592,18889259,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Pulmonary embolism,,2021,Q1,2,F,,20210223.0,20210213,20210302,EXP,,US-JNJFOC-20210223265,JOHNSON AND JOHNSON,"ROBINSON ZS, ARVIN JP, MADDING KL. RIVAROXABAN FAILURE IN A PATIENT TAKING OXACARBAZEPINE. ANNALS OF PHARMACOTHERAPY. 2021",28.0,YR,A,M,Y,146.0,KG,20210302.0,,HP,US,US,2021,Q1,Young Adult
188971151,18897115,6,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Acute respiratory distress syndrome,,2021,Q1,1,I,20210120.0,,20210212,20210212,DIR,,,FDA-CTU,,69.0,YR,,F,N,144.4,KG,20210212.0,Y,PH,US,US,2021,Q1,Elderly
188971151,18897115,6,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Dyspnoea,,2021,Q1,1,I,20210120.0,,20210212,20210212,DIR,,,FDA-CTU,,69.0,YR,,F,N,144.4,KG,20210212.0,Y,PH,US,US,2021,Q1,Elderly
188971151,18897115,6,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Hypoxia,,2021,Q1,1,I,20210120.0,,20210212,20210212,DIR,,,FDA-CTU,,69.0,YR,,F,N,144.4,KG,20210212.0,Y,PH,US,US,2021,Q1,Elderly
188971151,18897115,6,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Oxygen saturation decreased,,2021,Q1,1,I,20210120.0,,20210212,20210212,DIR,,,FDA-CTU,,69.0,YR,,F,N,144.4,KG,20210212.0,Y,PH,US,US,2021,Q1,Elderly
188971151,18897115,6,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Respiratory distress,,2021,Q1,1,I,20210120.0,,20210212,20210212,DIR,,,FDA-CTU,,69.0,YR,,F,N,144.4,KG,20210212.0,Y,PH,US,US,2021,Q1,Elderly
188971151,18897115,6,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Respiratory failure,,2021,Q1,1,I,20210120.0,,20210212,20210212,DIR,,,FDA-CTU,,69.0,YR,,F,N,144.4,KG,20210212.0,Y,PH,US,US,2021,Q1,Elderly
188971151,18897115,6,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Stridor,,2021,Q1,1,I,20210120.0,,20210212,20210212,DIR,,,FDA-CTU,,69.0,YR,,F,N,144.4,KG,20210212.0,Y,PH,US,US,2021,Q1,Elderly
188971151,18897115,6,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Thyroid mass,,2021,Q1,1,I,20210120.0,,20210212,20210212,DIR,,,FDA-CTU,,69.0,YR,,F,N,144.4,KG,20210212.0,Y,PH,US,US,2021,Q1,Elderly
188973122,18897312,18,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,1 DF,,,,,,,,1.0,DF,INJECTION,,2021,Q1,Diabetic nephropathy,,2021,Q1,2,F,20160125.0,20210219.0,20210215,20210302,PER,,JP-AMGEN-JPNSP2021023685,AMGEN,,70.0,YR,E,F,Y,,,20210302.0,,HP,JP,JP,2021,Q1,Elderly
188973122,18897312,18,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,1 DF,,,,,,,,1.0,DF,INJECTION,,2021,Q1,Gastrointestinal haemorrhage,,2021,Q1,2,F,20160125.0,20210219.0,20210215,20210302,PER,,JP-AMGEN-JPNSP2021023685,AMGEN,,70.0,YR,E,F,Y,,,20210302.0,,HP,JP,JP,2021,Q1,Elderly
188973122,18897312,18,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,1 DF,,,,,,,,1.0,DF,INJECTION,,2021,Q1,Haemodialysis,,2021,Q1,2,F,20160125.0,20210219.0,20210215,20210302,PER,,JP-AMGEN-JPNSP2021023685,AMGEN,,70.0,YR,E,F,Y,,,20210302.0,,HP,JP,JP,2021,Q1,Elderly
188973122,18897312,18,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,1 DF,,,,,,,,1.0,DF,INJECTION,,2021,Q1,Hypovitaminosis,,2021,Q1,2,F,20160125.0,20210219.0,20210215,20210302,PER,,JP-AMGEN-JPNSP2021023685,AMGEN,,70.0,YR,E,F,Y,,,20210302.0,,HP,JP,JP,2021,Q1,Elderly
188973122,18897312,18,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,1 DF,,,,,,,,1.0,DF,INJECTION,,2021,Q1,Influenza,,2021,Q1,2,F,20160125.0,20210219.0,20210215,20210302,PER,,JP-AMGEN-JPNSP2021023685,AMGEN,,70.0,YR,E,F,Y,,,20210302.0,,HP,JP,JP,2021,Q1,Elderly
188973122,18897312,18,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,1 DF,,,,,,,,1.0,DF,INJECTION,,2021,Q1,Nasopharyngitis,,2021,Q1,2,F,20160125.0,20210219.0,20210215,20210302,PER,,JP-AMGEN-JPNSP2021023685,AMGEN,,70.0,YR,E,F,Y,,,20210302.0,,HP,JP,JP,2021,Q1,Elderly
188973122,18897312,18,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,1 DF,,,,,,,,1.0,DF,INJECTION,,2021,Q1,Pharyngitis,,2021,Q1,2,F,20160125.0,20210219.0,20210215,20210302,PER,,JP-AMGEN-JPNSP2021023685,AMGEN,,70.0,YR,E,F,Y,,,20210302.0,,HP,JP,JP,2021,Q1,Elderly
188973122,18897312,18,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,1 DF,,,,,,,,1.0,DF,INJECTION,,2021,Q1,Pyrexia,,2021,Q1,2,F,20160125.0,20210219.0,20210215,20210302,PER,,JP-AMGEN-JPNSP2021023685,AMGEN,,70.0,YR,E,F,Y,,,20210302.0,,HP,JP,JP,2021,Q1,Elderly
188973122,18897312,18,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,1 DF,,,,,,,,1.0,DF,INJECTION,,2021,Q1,Upper gastrointestinal haemorrhage,,2021,Q1,2,F,20160125.0,20210219.0,20210215,20210302,PER,,JP-AMGEN-JPNSP2021023685,AMGEN,,70.0,YR,E,F,Y,,,20210302.0,,HP,JP,JP,2021,Q1,Elderly
188973122,18897312,18,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,1 DF,,,,,,,,1.0,DF,INJECTION,,2021,Q1,Upper respiratory tract inflammation,,2021,Q1,2,F,20160125.0,20210219.0,20210215,20210302,PER,,JP-AMGEN-JPNSP2021023685,AMGEN,,70.0,YR,E,F,Y,,,20210302.0,,HP,JP,JP,2021,Q1,Elderly
188973122,18897312,19,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,3 DF,,,,,,,,3.0,DF,INJECTION,,2021,Q1,Diabetic nephropathy,,2021,Q1,2,F,20160125.0,20210219.0,20210215,20210302,PER,,JP-AMGEN-JPNSP2021023685,AMGEN,,70.0,YR,E,F,Y,,,20210302.0,,HP,JP,JP,2021,Q1,Elderly
188973122,18897312,19,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,3 DF,,,,,,,,3.0,DF,INJECTION,,2021,Q1,Gastrointestinal haemorrhage,,2021,Q1,2,F,20160125.0,20210219.0,20210215,20210302,PER,,JP-AMGEN-JPNSP2021023685,AMGEN,,70.0,YR,E,F,Y,,,20210302.0,,HP,JP,JP,2021,Q1,Elderly
188973122,18897312,19,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,3 DF,,,,,,,,3.0,DF,INJECTION,,2021,Q1,Haemodialysis,,2021,Q1,2,F,20160125.0,20210219.0,20210215,20210302,PER,,JP-AMGEN-JPNSP2021023685,AMGEN,,70.0,YR,E,F,Y,,,20210302.0,,HP,JP,JP,2021,Q1,Elderly
188973122,18897312,19,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,3 DF,,,,,,,,3.0,DF,INJECTION,,2021,Q1,Hypovitaminosis,,2021,Q1,2,F,20160125.0,20210219.0,20210215,20210302,PER,,JP-AMGEN-JPNSP2021023685,AMGEN,,70.0,YR,E,F,Y,,,20210302.0,,HP,JP,JP,2021,Q1,Elderly
188973122,18897312,19,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,3 DF,,,,,,,,3.0,DF,INJECTION,,2021,Q1,Influenza,,2021,Q1,2,F,20160125.0,20210219.0,20210215,20210302,PER,,JP-AMGEN-JPNSP2021023685,AMGEN,,70.0,YR,E,F,Y,,,20210302.0,,HP,JP,JP,2021,Q1,Elderly
188973122,18897312,19,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,3 DF,,,,,,,,3.0,DF,INJECTION,,2021,Q1,Nasopharyngitis,,2021,Q1,2,F,20160125.0,20210219.0,20210215,20210302,PER,,JP-AMGEN-JPNSP2021023685,AMGEN,,70.0,YR,E,F,Y,,,20210302.0,,HP,JP,JP,2021,Q1,Elderly
188973122,18897312,19,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,3 DF,,,,,,,,3.0,DF,INJECTION,,2021,Q1,Pharyngitis,,2021,Q1,2,F,20160125.0,20210219.0,20210215,20210302,PER,,JP-AMGEN-JPNSP2021023685,AMGEN,,70.0,YR,E,F,Y,,,20210302.0,,HP,JP,JP,2021,Q1,Elderly
188973122,18897312,19,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,3 DF,,,,,,,,3.0,DF,INJECTION,,2021,Q1,Pyrexia,,2021,Q1,2,F,20160125.0,20210219.0,20210215,20210302,PER,,JP-AMGEN-JPNSP2021023685,AMGEN,,70.0,YR,E,F,Y,,,20210302.0,,HP,JP,JP,2021,Q1,Elderly
188973122,18897312,19,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,3 DF,,,,,,,,3.0,DF,INJECTION,,2021,Q1,Upper gastrointestinal haemorrhage,,2021,Q1,2,F,20160125.0,20210219.0,20210215,20210302,PER,,JP-AMGEN-JPNSP2021023685,AMGEN,,70.0,YR,E,F,Y,,,20210302.0,,HP,JP,JP,2021,Q1,Elderly
188973122,18897312,19,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,3 DF,,,,,,,,3.0,DF,INJECTION,,2021,Q1,Upper respiratory tract inflammation,,2021,Q1,2,F,20160125.0,20210219.0,20210215,20210302,PER,,JP-AMGEN-JPNSP2021023685,AMGEN,,70.0,YR,E,F,Y,,,20210302.0,,HP,JP,JP,2021,Q1,Elderly
188973122,18897312,20,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,2 DF,,,,,,,,2.0,DF,INJECTION,,2021,Q1,Diabetic nephropathy,,2021,Q1,2,F,20160125.0,20210219.0,20210215,20210302,PER,,JP-AMGEN-JPNSP2021023685,AMGEN,,70.0,YR,E,F,Y,,,20210302.0,,HP,JP,JP,2021,Q1,Elderly
188973122,18897312,20,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,2 DF,,,,,,,,2.0,DF,INJECTION,,2021,Q1,Gastrointestinal haemorrhage,,2021,Q1,2,F,20160125.0,20210219.0,20210215,20210302,PER,,JP-AMGEN-JPNSP2021023685,AMGEN,,70.0,YR,E,F,Y,,,20210302.0,,HP,JP,JP,2021,Q1,Elderly
188973122,18897312,20,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,2 DF,,,,,,,,2.0,DF,INJECTION,,2021,Q1,Haemodialysis,,2021,Q1,2,F,20160125.0,20210219.0,20210215,20210302,PER,,JP-AMGEN-JPNSP2021023685,AMGEN,,70.0,YR,E,F,Y,,,20210302.0,,HP,JP,JP,2021,Q1,Elderly
188973122,18897312,20,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,2 DF,,,,,,,,2.0,DF,INJECTION,,2021,Q1,Hypovitaminosis,,2021,Q1,2,F,20160125.0,20210219.0,20210215,20210302,PER,,JP-AMGEN-JPNSP2021023685,AMGEN,,70.0,YR,E,F,Y,,,20210302.0,,HP,JP,JP,2021,Q1,Elderly
188973122,18897312,20,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,2 DF,,,,,,,,2.0,DF,INJECTION,,2021,Q1,Influenza,,2021,Q1,2,F,20160125.0,20210219.0,20210215,20210302,PER,,JP-AMGEN-JPNSP2021023685,AMGEN,,70.0,YR,E,F,Y,,,20210302.0,,HP,JP,JP,2021,Q1,Elderly
188973122,18897312,20,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,2 DF,,,,,,,,2.0,DF,INJECTION,,2021,Q1,Nasopharyngitis,,2021,Q1,2,F,20160125.0,20210219.0,20210215,20210302,PER,,JP-AMGEN-JPNSP2021023685,AMGEN,,70.0,YR,E,F,Y,,,20210302.0,,HP,JP,JP,2021,Q1,Elderly
188973122,18897312,20,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,2 DF,,,,,,,,2.0,DF,INJECTION,,2021,Q1,Pharyngitis,,2021,Q1,2,F,20160125.0,20210219.0,20210215,20210302,PER,,JP-AMGEN-JPNSP2021023685,AMGEN,,70.0,YR,E,F,Y,,,20210302.0,,HP,JP,JP,2021,Q1,Elderly
188973122,18897312,20,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,2 DF,,,,,,,,2.0,DF,INJECTION,,2021,Q1,Pyrexia,,2021,Q1,2,F,20160125.0,20210219.0,20210215,20210302,PER,,JP-AMGEN-JPNSP2021023685,AMGEN,,70.0,YR,E,F,Y,,,20210302.0,,HP,JP,JP,2021,Q1,Elderly
188973122,18897312,20,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,2 DF,,,,,,,,2.0,DF,INJECTION,,2021,Q1,Upper gastrointestinal haemorrhage,,2021,Q1,2,F,20160125.0,20210219.0,20210215,20210302,PER,,JP-AMGEN-JPNSP2021023685,AMGEN,,70.0,YR,E,F,Y,,,20210302.0,,HP,JP,JP,2021,Q1,Elderly
188973122,18897312,20,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,2 DF,,,,,,,,2.0,DF,INJECTION,,2021,Q1,Upper respiratory tract inflammation,,2021,Q1,2,F,20160125.0,20210219.0,20210215,20210302,PER,,JP-AMGEN-JPNSP2021023685,AMGEN,,70.0,YR,E,F,Y,,,20210302.0,,HP,JP,JP,2021,Q1,Elderly
188973122,18897312,21,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,4 DF,,,,,,,,4.0,DF,INJECTION,,2021,Q1,Diabetic nephropathy,,2021,Q1,2,F,20160125.0,20210219.0,20210215,20210302,PER,,JP-AMGEN-JPNSP2021023685,AMGEN,,70.0,YR,E,F,Y,,,20210302.0,,HP,JP,JP,2021,Q1,Elderly
188973122,18897312,21,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,4 DF,,,,,,,,4.0,DF,INJECTION,,2021,Q1,Gastrointestinal haemorrhage,,2021,Q1,2,F,20160125.0,20210219.0,20210215,20210302,PER,,JP-AMGEN-JPNSP2021023685,AMGEN,,70.0,YR,E,F,Y,,,20210302.0,,HP,JP,JP,2021,Q1,Elderly
188973122,18897312,21,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,4 DF,,,,,,,,4.0,DF,INJECTION,,2021,Q1,Haemodialysis,,2021,Q1,2,F,20160125.0,20210219.0,20210215,20210302,PER,,JP-AMGEN-JPNSP2021023685,AMGEN,,70.0,YR,E,F,Y,,,20210302.0,,HP,JP,JP,2021,Q1,Elderly
188973122,18897312,21,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,4 DF,,,,,,,,4.0,DF,INJECTION,,2021,Q1,Hypovitaminosis,,2021,Q1,2,F,20160125.0,20210219.0,20210215,20210302,PER,,JP-AMGEN-JPNSP2021023685,AMGEN,,70.0,YR,E,F,Y,,,20210302.0,,HP,JP,JP,2021,Q1,Elderly
188973122,18897312,21,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,4 DF,,,,,,,,4.0,DF,INJECTION,,2021,Q1,Influenza,,2021,Q1,2,F,20160125.0,20210219.0,20210215,20210302,PER,,JP-AMGEN-JPNSP2021023685,AMGEN,,70.0,YR,E,F,Y,,,20210302.0,,HP,JP,JP,2021,Q1,Elderly
188973122,18897312,21,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,4 DF,,,,,,,,4.0,DF,INJECTION,,2021,Q1,Nasopharyngitis,,2021,Q1,2,F,20160125.0,20210219.0,20210215,20210302,PER,,JP-AMGEN-JPNSP2021023685,AMGEN,,70.0,YR,E,F,Y,,,20210302.0,,HP,JP,JP,2021,Q1,Elderly
188973122,18897312,21,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,4 DF,,,,,,,,4.0,DF,INJECTION,,2021,Q1,Pharyngitis,,2021,Q1,2,F,20160125.0,20210219.0,20210215,20210302,PER,,JP-AMGEN-JPNSP2021023685,AMGEN,,70.0,YR,E,F,Y,,,20210302.0,,HP,JP,JP,2021,Q1,Elderly
188973122,18897312,21,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,4 DF,,,,,,,,4.0,DF,INJECTION,,2021,Q1,Pyrexia,,2021,Q1,2,F,20160125.0,20210219.0,20210215,20210302,PER,,JP-AMGEN-JPNSP2021023685,AMGEN,,70.0,YR,E,F,Y,,,20210302.0,,HP,JP,JP,2021,Q1,Elderly
188973122,18897312,21,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,4 DF,,,,,,,,4.0,DF,INJECTION,,2021,Q1,Upper gastrointestinal haemorrhage,,2021,Q1,2,F,20160125.0,20210219.0,20210215,20210302,PER,,JP-AMGEN-JPNSP2021023685,AMGEN,,70.0,YR,E,F,Y,,,20210302.0,,HP,JP,JP,2021,Q1,Elderly
188973122,18897312,21,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,4 DF,,,,,,,,4.0,DF,INJECTION,,2021,Q1,Upper respiratory tract inflammation,,2021,Q1,2,F,20160125.0,20210219.0,20210215,20210302,PER,,JP-AMGEN-JPNSP2021023685,AMGEN,,70.0,YR,E,F,Y,,,20210302.0,,HP,JP,JP,2021,Q1,Elderly
188985181,18898518,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 DF,,,,,,,,12.0,DF,SOLUTION FOR INJECTION,,2021,Q1,Anaemia,,2021,Q1,1,I,20210129.0,20210216.0,20210216,20210216,EXP,IT-MINISAL02-665233,IT-JNJFOC-20210227274,JOHNSON AND JOHNSON,,82.0,YR,E,M,Y,,,20210216.0,,MD,IT,IT,2021,Q1,Elderly
188985181,18898518,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 DF,,,,,,,,12.0,DF,SOLUTION FOR INJECTION,,2021,Q1,Drug interaction,,2021,Q1,1,I,20210129.0,20210216.0,20210216,20210216,EXP,IT-MINISAL02-665233,IT-JNJFOC-20210227274,JOHNSON AND JOHNSON,,82.0,YR,E,M,Y,,,20210216.0,,MD,IT,IT,2021,Q1,Elderly
188999001,18899900,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,206538.0,,,SOLUTION FOR INJECTION,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,20200912.0,20210210.0,20210216,20210216,PER,,US-SA-2021SA052757,SANOFI AVENTIS,,55.0,YR,A,F,Y,,,20210216.0,,MD,US,US,2021,Q1,Adult
188999001,18899900,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,206538.0,,,SOLUTION FOR INJECTION,,2021,Q1,Weight increased,,2021,Q1,1,I,20200912.0,20210210.0,20210216,20210216,PER,,US-SA-2021SA052757,SANOFI AVENTIS,,55.0,YR,A,F,Y,,,20210216.0,,MD,US,US,2021,Q1,Adult
189025832,18902583,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q1,Hyperglycaemia,,2021,Q1,2,F,,20210222.0,20210216,20210301,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-083139",BOEHRINGER INGELHEIM,,57.0,YR,A,F,Y,67.0,KG,20210301.0,,PH,JP,JP,2021,Q1,Adult
189025832,18902583,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q1,Lung opacity,,2021,Q1,2,F,,20210222.0,20210216,20210301,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-083139",BOEHRINGER INGELHEIM,,57.0,YR,A,F,Y,67.0,KG,20210301.0,,PH,JP,JP,2021,Q1,Adult
189042301,18904230,1,PS,"INSULIN, GLARGINE, HUMAN 110 UNT/ML INJ",INSULIN GLARGINE,1,Subcutaneous,?          OTHER FREQUENCY:BEDTIME;?,,,D,D,,,,5.0,IU,,HS,2021,Q1,Hyperglycaemia,,2021,Q1,1,I,20201023.0,,20210217,20210217,DIR,,,FDA-CTU,,61.0,YR,,F,N,50.35,KG,20210212.0,N,PH,US,US,2021,Q1,Adult
189042301,18904230,1,PS,"INSULIN, GLARGINE, HUMAN 110 UNT/ML INJ",INSULIN GLARGINE,1,Subcutaneous,?          OTHER FREQUENCY:BEDTIME;?,,,D,D,,,,5.0,IU,,HS,2021,Q1,Impaired self-care,,2021,Q1,1,I,20201023.0,,20210217,20210217,DIR,,,FDA-CTU,,61.0,YR,,F,N,50.35,KG,20210212.0,N,PH,US,US,2021,Q1,Adult
189042301,18904230,1,PS,"INSULIN, GLARGINE, HUMAN 110 UNT/ML INJ",INSULIN GLARGINE,1,Subcutaneous,?          OTHER FREQUENCY:BEDTIME;?,,,D,D,,,,5.0,IU,,HS,2021,Q1,Treatment noncompliance,,2021,Q1,1,I,20201023.0,,20210217,20210217,DIR,,,FDA-CTU,,61.0,YR,,F,N,50.35,KG,20210212.0,N,PH,US,US,2021,Q1,Adult
189088421,18908842,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 IU, QD",16.0,IU,,, ABJA016,,,8.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Pruritus,,2021,Q1,1,I,20210124.0,20210208.0,20210218,20210218,EXP,,CN-SA-2021SA050480,SANOFI AVENTIS,,66.0,YR,E,M,Y,65.0,KG,20210218.0,,HP,CN,CN,2021,Q1,Elderly
189088421,18908842,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 IU, QD",16.0,IU,,, ABJA016,,,8.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Rash erythematous,,2021,Q1,1,I,20210124.0,20210208.0,20210218,20210218,EXP,,CN-SA-2021SA050480,SANOFI AVENTIS,,66.0,YR,E,M,Y,65.0,KG,20210218.0,,HP,CN,CN,2021,Q1,Elderly
189113261,18911326,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2021,Q1,Vomiting,,2021,Q1,1,I,,20210216.0,20210218,20210218,PER,,US-009507513-2102USA006328,MERCK,"DHARMARPANDI J, KAMAT A, MUBEEN F, SULIMAN A. A CASE OF REFRACTORY NAUSEA AND VOMITING. JOURNAL OF GENERAL INTERNAL MEDICINE. 2020?35 (1):S347?8",46.0,YR,,M,Y,,,20210218.0,,HP,US,US,2021,Q1,Adult
189115941,18911594,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SOLUTION,,,U,,,,,,,,,2021,Q1,Acute kidney injury,,2021,Q1,1,I,,20210209.0,20210218,20210218,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-013538,BRISTOL MYERS SQUIBB,,80.0,YR,,M,Y,,,20210218.0,,PH,CA,CA,2021,Q1,Elderly
189115941,18911594,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SOLUTION,,,U,,,,,,,,,2021,Q1,Diarrhoea,,2021,Q1,1,I,,20210209.0,20210218,20210218,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-013538,BRISTOL MYERS SQUIBB,,80.0,YR,,M,Y,,,20210218.0,,PH,CA,CA,2021,Q1,Elderly
189117142,18911714,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QDAY",,,,,,,,20.0,IU,,QD,2021,Q1,Failure to thrive,,2021,Q1,2,F,20210204.0,20210226.0,20210218,20210310,EXP,,US-PFIZER INC-2021124257,PFIZER,,57.0,YR,,M,Y,99.0,KG,20210310.0,,HP,US,US,2021,Q1,Adult
189122271,18912227,19,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,SOLUTION,,2021,Q1,Balance disorder,,2021,Q1,1,I,,20210210.0,20210219,20210219,EXP,,CA-AUROBINDO-AUR-APL-2021-006740,AUROBINDO,,51.0,YR,,M,Y,,,20210219.0,,PH,CA,CA,2021,Q1,Adult
189122271,18912227,19,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,SOLUTION,,2021,Q1,Cogwheel rigidity,,2021,Q1,1,I,,20210210.0,20210219,20210219,EXP,,CA-AUROBINDO-AUR-APL-2021-006740,AUROBINDO,,51.0,YR,,M,Y,,,20210219.0,,PH,CA,CA,2021,Q1,Adult
189122271,18912227,19,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,SOLUTION,,2021,Q1,Fall,,2021,Q1,1,I,,20210210.0,20210219,20210219,EXP,,CA-AUROBINDO-AUR-APL-2021-006740,AUROBINDO,,51.0,YR,,M,Y,,,20210219.0,,PH,CA,CA,2021,Q1,Adult
189122271,18912227,19,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,SOLUTION,,2021,Q1,Gait disturbance,,2021,Q1,1,I,,20210210.0,20210219,20210219,EXP,,CA-AUROBINDO-AUR-APL-2021-006740,AUROBINDO,,51.0,YR,,M,Y,,,20210219.0,,PH,CA,CA,2021,Q1,Adult
189122271,18912227,19,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,SOLUTION,,2021,Q1,Hypertonia,,2021,Q1,1,I,,20210210.0,20210219,20210219,EXP,,CA-AUROBINDO-AUR-APL-2021-006740,AUROBINDO,,51.0,YR,,M,Y,,,20210219.0,,PH,CA,CA,2021,Q1,Adult
189122271,18912227,19,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,SOLUTION,,2021,Q1,Myocarditis,,2021,Q1,1,I,,20210210.0,20210219,20210219,EXP,,CA-AUROBINDO-AUR-APL-2021-006740,AUROBINDO,,51.0,YR,,M,Y,,,20210219.0,,PH,CA,CA,2021,Q1,Adult
189122271,18912227,19,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,SOLUTION,,2021,Q1,Neuroleptic malignant syndrome,,2021,Q1,1,I,,20210210.0,20210219,20210219,EXP,,CA-AUROBINDO-AUR-APL-2021-006740,AUROBINDO,,51.0,YR,,M,Y,,,20210219.0,,PH,CA,CA,2021,Q1,Adult
189122271,18912227,19,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,SOLUTION,,2021,Q1,Nystagmus,,2021,Q1,1,I,,20210210.0,20210219,20210219,EXP,,CA-AUROBINDO-AUR-APL-2021-006740,AUROBINDO,,51.0,YR,,M,Y,,,20210219.0,,PH,CA,CA,2021,Q1,Adult
189122271,18912227,19,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,SOLUTION,,2021,Q1,Somnolence,,2021,Q1,1,I,,20210210.0,20210219,20210219,EXP,,CA-AUROBINDO-AUR-APL-2021-006740,AUROBINDO,,51.0,YR,,M,Y,,,20210219.0,,PH,CA,CA,2021,Q1,Adult
189130851,18913085,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,18 U? S. Q Q D,,,,,,,,,,,,2021,Q1,Drug ineffective,,2021,Q1,1,I,,20210212.0,20210218,20210218,EXP,,GR-MYLANLABS-2021M1010466,MYLAN,"KARAKOSTA P, ASLANIDIS TH, FLIONI E.N AND AGALIADOU? DIORITOU U.. ACQUIRED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSISIN A CRITICALLY ILL PATIENT WITH INVASIVE PULMONARY ASPERGILLOSIS AND TURICELLA OTITIDIS BACTERAEMIA: A CASE REPORT. THE GREEK E?JOURNAL OF PERIOPERATIVE MEDICINE. 2021?20(A):61?66",68.0,YR,,F,Y,,,20210218.0,,MD,GR,GR,2021,Q1,Elderly
189133505,18913350,7,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,,"4 INTERNATIONAL UNIT, DAILY",,,,,,,,,,,,2021,Q1,Dry skin,,2021,Q1,5,F,20201124.0,20210316.0,20210218,20210323,EXP,,JP-ASTRAZENECA-2020SF61672,ASTRAZENECA,,72.0,YR,,M,Y,65.0,KG,20210323.0,,MD,JP,JP,2021,Q1,Elderly
189133505,18913350,7,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,,"4 INTERNATIONAL UNIT, DAILY",,,,,,,,,,,,2021,Q1,Lung disorder,,2021,Q1,5,F,20201124.0,20210316.0,20210218,20210323,EXP,,JP-ASTRAZENECA-2020SF61672,ASTRAZENECA,,72.0,YR,,M,Y,65.0,KG,20210323.0,,MD,JP,JP,2021,Q1,Elderly
189133505,18913350,7,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,,"4 INTERNATIONAL UNIT, DAILY",,,,,,,,,,,,2021,Q1,Off label use,,2021,Q1,5,F,20201124.0,20210316.0,20210218,20210323,EXP,,JP-ASTRAZENECA-2020SF61672,ASTRAZENECA,,72.0,YR,,M,Y,65.0,KG,20210323.0,,MD,JP,JP,2021,Q1,Elderly
189146741,18914674,4,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,206538.0,,,SOLUTION FOR INJECTION,,2021,Q1,Bradycardia,,2021,Q1,1,I,20201030.0,20201204.0,20210218,20210218,EXP,IT-MINISAL02-645559,IT-SA-2020SA351213,SANOFI AVENTIS,,91.0,YR,E,F,Y,,,20210219.0,,PH,IT,IT,2021,Q1,Elderly
189164061,18916406,5,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Acute kidney injury,,2021,Q1,1,I,20210211.0,,20210219,20210219,DIR,,,FDA-CTU,,56.0,YR,,F,N,104.1,KG,20210219.0,N,PH,US,US,2021,Q1,Adult
189164061,18916406,5,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Anaemia,,2021,Q1,1,I,20210211.0,,20210219,20210219,DIR,,,FDA-CTU,,56.0,YR,,F,N,104.1,KG,20210219.0,N,PH,US,US,2021,Q1,Adult
189164061,18916406,5,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Cardiac arrest,,2021,Q1,1,I,20210211.0,,20210219,20210219,DIR,,,FDA-CTU,,56.0,YR,,F,N,104.1,KG,20210219.0,N,PH,US,US,2021,Q1,Adult
189164061,18916406,5,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Coagulopathy,,2021,Q1,1,I,20210211.0,,20210219,20210219,DIR,,,FDA-CTU,,56.0,YR,,F,N,104.1,KG,20210219.0,N,PH,US,US,2021,Q1,Adult
189164061,18916406,5,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Faecaloma,,2021,Q1,1,I,20210211.0,,20210219,20210219,DIR,,,FDA-CTU,,56.0,YR,,F,N,104.1,KG,20210219.0,N,PH,US,US,2021,Q1,Adult
189164061,18916406,5,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Intestinal ischaemia,,2021,Q1,1,I,20210211.0,,20210219,20210219,DIR,,,FDA-CTU,,56.0,YR,,F,N,104.1,KG,20210219.0,N,PH,US,US,2021,Q1,Adult
189164061,18916406,5,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Septic shock,,2021,Q1,1,I,20210211.0,,20210219,20210219,DIR,,,FDA-CTU,,56.0,YR,,F,N,104.1,KG,20210219.0,N,PH,US,US,2021,Q1,Adult
189180173,18918017,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Blood glucose fluctuation,,2021,Q1,3,F,201912.0,20210219.0,20210219,20210304,EXP,,US-SA-2021SA057436,SANOFI AVENTIS,,55.0,YR,A,M,Y,,,20210304.0,,CN,US,US,2021,Q1,Adult
189180173,18918017,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Blood glucose increased,,2021,Q1,3,F,201912.0,20210219.0,20210219,20210304,EXP,,US-SA-2021SA057436,SANOFI AVENTIS,,55.0,YR,A,M,Y,,,20210304.0,,CN,US,US,2021,Q1,Adult
189180173,18918017,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Device operational issue,,2021,Q1,3,F,201912.0,20210219.0,20210219,20210304,EXP,,US-SA-2021SA057436,SANOFI AVENTIS,,55.0,YR,A,M,Y,,,20210304.0,,CN,US,US,2021,Q1,Adult
189180173,18918017,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Dupuytren's contracture,,2021,Q1,3,F,201912.0,20210219.0,20210219,20210304,EXP,,US-SA-2021SA057436,SANOFI AVENTIS,,55.0,YR,A,M,Y,,,20210304.0,,CN,US,US,2021,Q1,Adult
189180173,18918017,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Loss of consciousness,,2021,Q1,3,F,201912.0,20210219.0,20210219,20210304,EXP,,US-SA-2021SA057436,SANOFI AVENTIS,,55.0,YR,A,M,Y,,,20210304.0,,CN,US,US,2021,Q1,Adult
189180173,18918017,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Neoplasm malignant,,2021,Q1,3,F,201912.0,20210219.0,20210219,20210304,EXP,,US-SA-2021SA057436,SANOFI AVENTIS,,55.0,YR,A,M,Y,,,20210304.0,,CN,US,US,2021,Q1,Adult
189180173,18918017,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Weight decreased,,2021,Q1,3,F,201912.0,20210219.0,20210219,20210304,EXP,,US-SA-2021SA057436,SANOFI AVENTIS,,55.0,YR,A,M,Y,,,20210304.0,,CN,US,US,2021,Q1,Adult
189180173,18918017,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Wrong technique in product usage process,,2021,Q1,3,F,201912.0,20210219.0,20210219,20210304,EXP,,US-SA-2021SA057436,SANOFI AVENTIS,,55.0,YR,A,M,Y,,,20210304.0,,CN,US,US,2021,Q1,Adult
189186801,18918680,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, Q4HR",,,,,,,,,,,Q4H,2021,Q1,SARS-CoV-2 test positive,,2021,Q1,1,I,20210217.0,20210217.0,20210220,20210220,EXP,,CO-TAKEDA-2021TUS011090,TAKEDA,,77.0,YR,,M,Y,77.0,KG,20210220.0,,HP,CO,CO,2021,Q1,Elderly
189200441,18920044,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 DOSAGE FORMS,,,,, UNKNOWN,,,12.0,DF,SOLUTION FOR INJECTION,,2021,Q1,Anaemia,,2021,Q1,1,I,20210129.0,20210210.0,20210222,20210222,EXP,IT-MINISAL02-665233,IT-TEVA-2021-IT-1880667,TEVA,,82.0,YR,E,M,Y,,,20210220.0,,MD,IT,IT,2021,Q1,Elderly
189200441,18920044,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 DOSAGE FORMS,,,,, UNKNOWN,,,12.0,DF,SOLUTION FOR INJECTION,,2021,Q1,Drug interaction,,2021,Q1,1,I,20210129.0,20210210.0,20210222,20210222,EXP,IT-MINISAL02-665233,IT-TEVA-2021-IT-1880667,TEVA,,82.0,YR,E,M,Y,,,20210220.0,,MD,IT,IT,2021,Q1,Elderly
189206881,18920688,8,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"24 INTERNATIONAL UNIT, ONCE A DAY",,,U,U,,,,24.0,IU,,QD,2021,Q1,Conjunctival hyperaemia,,2021,Q1,1,I,,20210215.0,20210222,20210222,EXP,,FR-AUROBINDO-AUR-APL-2021-007468,AUROBINDO,,48.0,YR,,M,Y,,,20210222.0,,HP,FR,FR,2021,Q1,Adult
189206881,18920688,8,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"24 INTERNATIONAL UNIT, ONCE A DAY",,,U,U,,,,24.0,IU,,QD,2021,Q1,Eye pruritus,,2021,Q1,1,I,,20210215.0,20210222,20210222,EXP,,FR-AUROBINDO-AUR-APL-2021-007468,AUROBINDO,,48.0,YR,,M,Y,,,20210222.0,,HP,FR,FR,2021,Q1,Adult
189206881,18920688,8,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"24 INTERNATIONAL UNIT, ONCE A DAY",,,U,U,,,,24.0,IU,,QD,2021,Q1,Flushing,,2021,Q1,1,I,,20210215.0,20210222,20210222,EXP,,FR-AUROBINDO-AUR-APL-2021-007468,AUROBINDO,,48.0,YR,,M,Y,,,20210222.0,,HP,FR,FR,2021,Q1,Adult
189206881,18920688,8,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"24 INTERNATIONAL UNIT, ONCE A DAY",,,U,U,,,,24.0,IU,,QD,2021,Q1,Incorrect route of product administration,,2021,Q1,1,I,,20210215.0,20210222,20210222,EXP,,FR-AUROBINDO-AUR-APL-2021-007468,AUROBINDO,,48.0,YR,,M,Y,,,20210222.0,,HP,FR,FR,2021,Q1,Adult
189206881,18920688,8,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"24 INTERNATIONAL UNIT, ONCE A DAY",,,U,U,,,,24.0,IU,,QD,2021,Q1,Malaise,,2021,Q1,1,I,,20210215.0,20210222,20210222,EXP,,FR-AUROBINDO-AUR-APL-2021-007468,AUROBINDO,,48.0,YR,,M,Y,,,20210222.0,,HP,FR,FR,2021,Q1,Adult
189206881,18920688,8,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"24 INTERNATIONAL UNIT, ONCE A DAY",,,U,U,,,,24.0,IU,,QD,2021,Q1,Mydriasis,,2021,Q1,1,I,,20210215.0,20210222,20210222,EXP,,FR-AUROBINDO-AUR-APL-2021-007468,AUROBINDO,,48.0,YR,,M,Y,,,20210222.0,,HP,FR,FR,2021,Q1,Adult
189206881,18920688,8,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"24 INTERNATIONAL UNIT, ONCE A DAY",,,U,U,,,,24.0,IU,,QD,2021,Q1,Off label use,,2021,Q1,1,I,,20210215.0,20210222,20210222,EXP,,FR-AUROBINDO-AUR-APL-2021-007468,AUROBINDO,,48.0,YR,,M,Y,,,20210222.0,,HP,FR,FR,2021,Q1,Adult
189206881,18920688,8,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"24 INTERNATIONAL UNIT, ONCE A DAY",,,U,U,,,,24.0,IU,,QD,2021,Q1,Overdose,,2021,Q1,1,I,,20210215.0,20210222,20210222,EXP,,FR-AUROBINDO-AUR-APL-2021-007468,AUROBINDO,,48.0,YR,,M,Y,,,20210222.0,,HP,FR,FR,2021,Q1,Adult
189206881,18920688,8,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"24 INTERNATIONAL UNIT, ONCE A DAY",,,U,U,,,,24.0,IU,,QD,2021,Q1,Toxicity to various agents,,2021,Q1,1,I,,20210215.0,20210222,20210222,EXP,,FR-AUROBINDO-AUR-APL-2021-007468,AUROBINDO,,48.0,YR,,M,Y,,,20210222.0,,HP,FR,FR,2021,Q1,Adult
189206881,18920688,8,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"24 INTERNATIONAL UNIT, ONCE A DAY",,,U,U,,,,24.0,IU,,QD,2021,Q1,Vision blurred,,2021,Q1,1,I,,20210215.0,20210222,20210222,EXP,,FR-AUROBINDO-AUR-APL-2021-007468,AUROBINDO,,48.0,YR,,M,Y,,,20210222.0,,HP,FR,FR,2021,Q1,Adult
189212414,18921241,30,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SLIDING SCALE U X 1 X 1 DAYS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Fungal sepsis,,2021,Q1,4,F,20210216.0,20210302.0,20210222,20210308,EXP,,US-CELGENEUS-USA-20210204648,CELGENE,,68.0,YR,,F,Y,46.0,KG,20210308.0,,MD,US,US,2021,Q1,Elderly
189224682,18922468,1,PS,INSULIN GLARGINE MYLAN,INSULIN GLARGINE,1,Subcutaneous,10?10.8 UNIT,,,,U,,,210605.0,,,,,2021,Q1,Device defective,,2021,Q1,2,F,,20210217.0,20210222,20210225,EXP,,IN-MYLANLABS-2021M1010588,MYLAN,,71.0,YR,,F,Y,,,20210225.0,,CN,IN,IN,2021,Q1,Elderly
189224682,18922468,1,PS,INSULIN GLARGINE MYLAN,INSULIN GLARGINE,1,Subcutaneous,10?10.8 UNIT,,,,U,,,210605.0,,,,,2021,Q1,Diabetic ketoacidosis,,2021,Q1,2,F,,20210217.0,20210222,20210225,EXP,,IN-MYLANLABS-2021M1010588,MYLAN,,71.0,YR,,F,Y,,,20210225.0,,CN,IN,IN,2021,Q1,Elderly
189224682,18922468,1,PS,INSULIN GLARGINE MYLAN,INSULIN GLARGINE,1,Subcutaneous,10?10.8 UNIT,,,,U,,,210605.0,,,,,2021,Q1,Drug ineffective,,2021,Q1,2,F,,20210217.0,20210222,20210225,EXP,,IN-MYLANLABS-2021M1010588,MYLAN,,71.0,YR,,F,Y,,,20210225.0,,CN,IN,IN,2021,Q1,Elderly
189229261,18922926,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q1,COVID-19 pneumonia,,2021,Q1,1,I,20210210.0,20210211.0,20210222,20210222,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006653,ELI LILLY AND CO,,65.0,YR,,M,Y,111.57,KG,20210222.0,,CN,US,US,2021,Q1,Elderly
189229461,18922946,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,DOSAGE FORM: SOLUTIONSUBCUTANEOUS,,,U,,,,,,,,,2021,Q1,Fournier's gangrene,,2021,Q1,1,I,,20210216.0,20210222,20210222,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-083953",BOEHRINGER INGELHEIM,,52.0,YR,A,F,Y,,,20210222.0,,HP,CA,CA,2021,Q1,Adult
189240131,18924013,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Blood creatine phosphokinase increased,,2021,Q1,1,I,,20210216.0,20210222,20210222,EXP,,GR-MYLANLABS-2021M1010480,MYLAN,"IOANNIS PAPAIOANNOU1,GEORGIA PANTAZIDOU2, STAMATIA CHATZIPERI1, ANDREAS BAIKOUSIS1, PANAGIOTIS KOROVESSIS1. GLUTEAL  COMPARTMENT  SYNDROME?  INTOXICATION?  DRUG?INDUCED  RHABDOMYOLYSIS?  HEMODIALYSIS?  FASCIOTOMY?  DELAYED DIAGNOSIS,. SURGICAL CHRONICLES. 2020?25(4)",47.0,YR,,F,Y,,,20210222.0,,MD,GR,GR,2021,Q1,Adult
189240131,18924013,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Communication disorder,,2021,Q1,1,I,,20210216.0,20210222,20210222,EXP,,GR-MYLANLABS-2021M1010480,MYLAN,"IOANNIS PAPAIOANNOU1,GEORGIA PANTAZIDOU2, STAMATIA CHATZIPERI1, ANDREAS BAIKOUSIS1, PANAGIOTIS KOROVESSIS1. GLUTEAL  COMPARTMENT  SYNDROME?  INTOXICATION?  DRUG?INDUCED  RHABDOMYOLYSIS?  HEMODIALYSIS?  FASCIOTOMY?  DELAYED DIAGNOSIS,. SURGICAL CHRONICLES. 2020?25(4)",47.0,YR,,F,Y,,,20210222.0,,MD,GR,GR,2021,Q1,Adult
189240131,18924013,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,General physical condition abnormal,,2021,Q1,1,I,,20210216.0,20210222,20210222,EXP,,GR-MYLANLABS-2021M1010480,MYLAN,"IOANNIS PAPAIOANNOU1,GEORGIA PANTAZIDOU2, STAMATIA CHATZIPERI1, ANDREAS BAIKOUSIS1, PANAGIOTIS KOROVESSIS1. GLUTEAL  COMPARTMENT  SYNDROME?  INTOXICATION?  DRUG?INDUCED  RHABDOMYOLYSIS?  HEMODIALYSIS?  FASCIOTOMY?  DELAYED DIAGNOSIS,. SURGICAL CHRONICLES. 2020?25(4)",47.0,YR,,F,Y,,,20210222.0,,MD,GR,GR,2021,Q1,Adult
189240131,18924013,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Hepatic function abnormal,,2021,Q1,1,I,,20210216.0,20210222,20210222,EXP,,GR-MYLANLABS-2021M1010480,MYLAN,"IOANNIS PAPAIOANNOU1,GEORGIA PANTAZIDOU2, STAMATIA CHATZIPERI1, ANDREAS BAIKOUSIS1, PANAGIOTIS KOROVESSIS1. GLUTEAL  COMPARTMENT  SYNDROME?  INTOXICATION?  DRUG?INDUCED  RHABDOMYOLYSIS?  HEMODIALYSIS?  FASCIOTOMY?  DELAYED DIAGNOSIS,. SURGICAL CHRONICLES. 2020?25(4)",47.0,YR,,F,Y,,,20210222.0,,MD,GR,GR,2021,Q1,Adult
189240131,18924013,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Labelled drug-food interaction issue,,2021,Q1,1,I,,20210216.0,20210222,20210222,EXP,,GR-MYLANLABS-2021M1010480,MYLAN,"IOANNIS PAPAIOANNOU1,GEORGIA PANTAZIDOU2, STAMATIA CHATZIPERI1, ANDREAS BAIKOUSIS1, PANAGIOTIS KOROVESSIS1. GLUTEAL  COMPARTMENT  SYNDROME?  INTOXICATION?  DRUG?INDUCED  RHABDOMYOLYSIS?  HEMODIALYSIS?  FASCIOTOMY?  DELAYED DIAGNOSIS,. SURGICAL CHRONICLES. 2020?25(4)",47.0,YR,,F,Y,,,20210222.0,,MD,GR,GR,2021,Q1,Adult
189240131,18924013,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Muscle injury,,2021,Q1,1,I,,20210216.0,20210222,20210222,EXP,,GR-MYLANLABS-2021M1010480,MYLAN,"IOANNIS PAPAIOANNOU1,GEORGIA PANTAZIDOU2, STAMATIA CHATZIPERI1, ANDREAS BAIKOUSIS1, PANAGIOTIS KOROVESSIS1. GLUTEAL  COMPARTMENT  SYNDROME?  INTOXICATION?  DRUG?INDUCED  RHABDOMYOLYSIS?  HEMODIALYSIS?  FASCIOTOMY?  DELAYED DIAGNOSIS,. SURGICAL CHRONICLES. 2020?25(4)",47.0,YR,,F,Y,,,20210222.0,,MD,GR,GR,2021,Q1,Adult
189240131,18924013,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Neurological decompensation,,2021,Q1,1,I,,20210216.0,20210222,20210222,EXP,,GR-MYLANLABS-2021M1010480,MYLAN,"IOANNIS PAPAIOANNOU1,GEORGIA PANTAZIDOU2, STAMATIA CHATZIPERI1, ANDREAS BAIKOUSIS1, PANAGIOTIS KOROVESSIS1. GLUTEAL  COMPARTMENT  SYNDROME?  INTOXICATION?  DRUG?INDUCED  RHABDOMYOLYSIS?  HEMODIALYSIS?  FASCIOTOMY?  DELAYED DIAGNOSIS,. SURGICAL CHRONICLES. 2020?25(4)",47.0,YR,,F,Y,,,20210222.0,,MD,GR,GR,2021,Q1,Adult
189240131,18924013,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Renal impairment,,2021,Q1,1,I,,20210216.0,20210222,20210222,EXP,,GR-MYLANLABS-2021M1010480,MYLAN,"IOANNIS PAPAIOANNOU1,GEORGIA PANTAZIDOU2, STAMATIA CHATZIPERI1, ANDREAS BAIKOUSIS1, PANAGIOTIS KOROVESSIS1. GLUTEAL  COMPARTMENT  SYNDROME?  INTOXICATION?  DRUG?INDUCED  RHABDOMYOLYSIS?  HEMODIALYSIS?  FASCIOTOMY?  DELAYED DIAGNOSIS,. SURGICAL CHRONICLES. 2020?25(4)",47.0,YR,,F,Y,,,20210222.0,,MD,GR,GR,2021,Q1,Adult
189240131,18924013,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Rhabdomyolysis,,2021,Q1,1,I,,20210216.0,20210222,20210222,EXP,,GR-MYLANLABS-2021M1010480,MYLAN,"IOANNIS PAPAIOANNOU1,GEORGIA PANTAZIDOU2, STAMATIA CHATZIPERI1, ANDREAS BAIKOUSIS1, PANAGIOTIS KOROVESSIS1. GLUTEAL  COMPARTMENT  SYNDROME?  INTOXICATION?  DRUG?INDUCED  RHABDOMYOLYSIS?  HEMODIALYSIS?  FASCIOTOMY?  DELAYED DIAGNOSIS,. SURGICAL CHRONICLES. 2020?25(4)",47.0,YR,,F,Y,,,20210222.0,,MD,GR,GR,2021,Q1,Adult
189240131,18924013,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Weight bearing difficulty,,2021,Q1,1,I,,20210216.0,20210222,20210222,EXP,,GR-MYLANLABS-2021M1010480,MYLAN,"IOANNIS PAPAIOANNOU1,GEORGIA PANTAZIDOU2, STAMATIA CHATZIPERI1, ANDREAS BAIKOUSIS1, PANAGIOTIS KOROVESSIS1. GLUTEAL  COMPARTMENT  SYNDROME?  INTOXICATION?  DRUG?INDUCED  RHABDOMYOLYSIS?  HEMODIALYSIS?  FASCIOTOMY?  DELAYED DIAGNOSIS,. SURGICAL CHRONICLES. 2020?25(4)",47.0,YR,,F,Y,,,20210222.0,,MD,GR,GR,2021,Q1,Adult
189284151,18928415,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,Y,U,,,210605.0,,,,,2021,Q1,Drug ineffective,,2021,Q1,1,I,,20210217.0,20210223,20210223,EXP,,US-MYLANLABS-2021M1011371,MYLAN,"KARRICK M, ALJAMAL AO, HEIDEMANN DL. INSULIN INDUCED EDEMA: A RARE EFFECT OF A COMMON MEDICATION. J?GEN?INTERN?MED 2020?35 (SUPPL. 1):S492.",75.0,YR,,F,Y,,,20210223.0,,HP,US,US,2021,Q1,Elderly
189284151,18928415,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,Y,U,,,210605.0,,,,,2021,Q1,Generalised oedema,,2021,Q1,1,I,,20210217.0,20210223,20210223,EXP,,US-MYLANLABS-2021M1011371,MYLAN,"KARRICK M, ALJAMAL AO, HEIDEMANN DL. INSULIN INDUCED EDEMA: A RARE EFFECT OF A COMMON MEDICATION. J?GEN?INTERN?MED 2020?35 (SUPPL. 1):S492.",75.0,YR,,F,Y,,,20210223.0,,HP,US,US,2021,Q1,Elderly
189284151,18928415,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,Y,U,,,210605.0,,,,,2021,Q1,Weight increased,,2021,Q1,1,I,,20210217.0,20210223,20210223,EXP,,US-MYLANLABS-2021M1011371,MYLAN,"KARRICK M, ALJAMAL AO, HEIDEMANN DL. INSULIN INDUCED EDEMA: A RARE EFFECT OF A COMMON MEDICATION. J?GEN?INTERN?MED 2020?35 (SUPPL. 1):S492.",75.0,YR,,F,Y,,,20210223.0,,HP,US,US,2021,Q1,Elderly
189305473,18930547,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,,QD,2021,Q1,Fungal sepsis,,2021,Q1,3,F,20210216.0,20210222.0,20210223,20210302,EXP,,US-ABBVIE-21P-163-3785222-00,ABBVIE,,68.0,YR,,F,Y,,,20210302.0,,MD,US,US,2021,Q1,Elderly
189331471,18933147,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Burning sensation,,2021,Q1,1,I,20200129.0,20200131.0,20210224,20210224,PER,,US-LANTHEUS-LMI-2020-00071,LANTHEUS MEDICAL IMAGING,,40.0,YR,,M,Y,124.0,KG,20210211.0,,CN,US,US,2021,Q1,Adult
189331471,18933147,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Drug hypersensitivity,,2021,Q1,1,I,20200129.0,20200131.0,20210224,20210224,PER,,US-LANTHEUS-LMI-2020-00071,LANTHEUS MEDICAL IMAGING,,40.0,YR,,M,Y,124.0,KG,20210211.0,,CN,US,US,2021,Q1,Adult
189331471,18933147,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Hypoaesthesia,,2021,Q1,1,I,20200129.0,20200131.0,20210224,20210224,PER,,US-LANTHEUS-LMI-2020-00071,LANTHEUS MEDICAL IMAGING,,40.0,YR,,M,Y,124.0,KG,20210211.0,,CN,US,US,2021,Q1,Adult
189331471,18933147,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Injection site extravasation,,2021,Q1,1,I,20200129.0,20200131.0,20210224,20210224,PER,,US-LANTHEUS-LMI-2020-00071,LANTHEUS MEDICAL IMAGING,,40.0,YR,,M,Y,124.0,KG,20210211.0,,CN,US,US,2021,Q1,Adult
189331471,18933147,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Paraesthesia,,2021,Q1,1,I,20200129.0,20200131.0,20210224,20210224,PER,,US-LANTHEUS-LMI-2020-00071,LANTHEUS MEDICAL IMAGING,,40.0,YR,,M,Y,124.0,KG,20210211.0,,CN,US,US,2021,Q1,Adult
189331471,18933147,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Petechiae,,2021,Q1,1,I,20200129.0,20200131.0,20210224,20210224,PER,,US-LANTHEUS-LMI-2020-00071,LANTHEUS MEDICAL IMAGING,,40.0,YR,,M,Y,124.0,KG,20210211.0,,CN,US,US,2021,Q1,Adult
189335841,18933584,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 IU,,,,, 0F571A,,,38.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Blood creatine increased,,2021,Q1,1,I,2020.0,20210212.0,20210224,20210224,EXP,,NVSC2021ES034505,NOVARTIS,,70.0,YR,,M,Y,88.0,KG,20210224.0,,HP,ES,ES,2021,Q1,Elderly
189335841,18933584,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 IU,,,,, 0F571A,,,38.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,2020.0,20210212.0,20210224,20210224,EXP,,NVSC2021ES034505,NOVARTIS,,70.0,YR,,M,Y,88.0,KG,20210224.0,,HP,ES,ES,2021,Q1,Elderly
189335841,18933584,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 IU,,,,, 0F571A,,,38.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Feeling abnormal,,2021,Q1,1,I,2020.0,20210212.0,20210224,20210224,EXP,,NVSC2021ES034505,NOVARTIS,,70.0,YR,,M,Y,88.0,KG,20210224.0,,HP,ES,ES,2021,Q1,Elderly
189335841,18933584,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 IU,,,,, 0F571A,,,38.0,IU,SOLUTION FOR INJECTION,,2021,Q1,General physical health deterioration,,2021,Q1,1,I,2020.0,20210212.0,20210224,20210224,EXP,,NVSC2021ES034505,NOVARTIS,,70.0,YR,,M,Y,88.0,KG,20210224.0,,HP,ES,ES,2021,Q1,Elderly
189335841,18933584,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 IU,,,,, 0F571A,,,38.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Hyperglycaemia,,2021,Q1,1,I,2020.0,20210212.0,20210224,20210224,EXP,,NVSC2021ES034505,NOVARTIS,,70.0,YR,,M,Y,88.0,KG,20210224.0,,HP,ES,ES,2021,Q1,Elderly
189335841,18933584,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 IU,,,,, 0F571A,,,38.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,2020.0,20210212.0,20210224,20210224,EXP,,NVSC2021ES034505,NOVARTIS,,70.0,YR,,M,Y,88.0,KG,20210224.0,,HP,ES,ES,2021,Q1,Elderly
189335841,18933584,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 IU,,,,, 0F571A,,,38.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Pollakiuria,,2021,Q1,1,I,2020.0,20210212.0,20210224,20210224,EXP,,NVSC2021ES034505,NOVARTIS,,70.0,YR,,M,Y,88.0,KG,20210224.0,,HP,ES,ES,2021,Q1,Elderly
189335841,18933584,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK (DOSE INCREASED),,,,, 0F571A,,,,,SOLUTION FOR INJECTION,,2021,Q1,Blood creatine increased,,2021,Q1,1,I,2020.0,20210212.0,20210224,20210224,EXP,,NVSC2021ES034505,NOVARTIS,,70.0,YR,,M,Y,88.0,KG,20210224.0,,HP,ES,ES,2021,Q1,Elderly
189335841,18933584,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK (DOSE INCREASED),,,,, 0F571A,,,,,SOLUTION FOR INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,2020.0,20210212.0,20210224,20210224,EXP,,NVSC2021ES034505,NOVARTIS,,70.0,YR,,M,Y,88.0,KG,20210224.0,,HP,ES,ES,2021,Q1,Elderly
189335841,18933584,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK (DOSE INCREASED),,,,, 0F571A,,,,,SOLUTION FOR INJECTION,,2021,Q1,Feeling abnormal,,2021,Q1,1,I,2020.0,20210212.0,20210224,20210224,EXP,,NVSC2021ES034505,NOVARTIS,,70.0,YR,,M,Y,88.0,KG,20210224.0,,HP,ES,ES,2021,Q1,Elderly
189335841,18933584,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK (DOSE INCREASED),,,,, 0F571A,,,,,SOLUTION FOR INJECTION,,2021,Q1,General physical health deterioration,,2021,Q1,1,I,2020.0,20210212.0,20210224,20210224,EXP,,NVSC2021ES034505,NOVARTIS,,70.0,YR,,M,Y,88.0,KG,20210224.0,,HP,ES,ES,2021,Q1,Elderly
189335841,18933584,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK (DOSE INCREASED),,,,, 0F571A,,,,,SOLUTION FOR INJECTION,,2021,Q1,Hyperglycaemia,,2021,Q1,1,I,2020.0,20210212.0,20210224,20210224,EXP,,NVSC2021ES034505,NOVARTIS,,70.0,YR,,M,Y,88.0,KG,20210224.0,,HP,ES,ES,2021,Q1,Elderly
189335841,18933584,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK (DOSE INCREASED),,,,, 0F571A,,,,,SOLUTION FOR INJECTION,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,2020.0,20210212.0,20210224,20210224,EXP,,NVSC2021ES034505,NOVARTIS,,70.0,YR,,M,Y,88.0,KG,20210224.0,,HP,ES,ES,2021,Q1,Elderly
189335841,18933584,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK (DOSE INCREASED),,,,, 0F571A,,,,,SOLUTION FOR INJECTION,,2021,Q1,Pollakiuria,,2021,Q1,1,I,2020.0,20210212.0,20210224,20210224,EXP,,NVSC2021ES034505,NOVARTIS,,70.0,YR,,M,Y,88.0,KG,20210224.0,,HP,ES,ES,2021,Q1,Elderly
189350871,18935087,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, BASAL",,,,,,,,,,,,2021,Q1,Acute respiratory distress syndrome,,2021,Q1,1,I,,20210215.0,20210224,20210224,EXP,,US-STRIDES ARCOLAB LIMITED-2021SP002322,STRIDES,"FEIN LEVY C, PRESSWALA LS, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES IN PATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATR?BLOOD?CANCER. 2021?68(2)",23.0,YR,,M,Y,,,20210224.0,,HP,US,US,2021,Q1,Youth
189350871,18935087,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, BASAL",,,,,,,,,,,,2021,Q1,Pneumonia,,2021,Q1,1,I,,20210215.0,20210224,20210224,EXP,,US-STRIDES ARCOLAB LIMITED-2021SP002322,STRIDES,"FEIN LEVY C, PRESSWALA LS, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES IN PATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATR?BLOOD?CANCER. 2021?68(2)",23.0,YR,,M,Y,,,20210224.0,,HP,US,US,2021,Q1,Youth
189350871,18935087,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, BASAL",,,,,,,,,,,,2021,Q1,Septic shock,,2021,Q1,1,I,,20210215.0,20210224,20210224,EXP,,US-STRIDES ARCOLAB LIMITED-2021SP002322,STRIDES,"FEIN LEVY C, PRESSWALA LS, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES IN PATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATR?BLOOD?CANCER. 2021?68(2)",23.0,YR,,M,Y,,,20210224.0,,HP,US,US,2021,Q1,Youth
189350921,18935092,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 IU, QD",,,,,,,21081.0,4.0,IU,,QD,2021,Q1,Cough,,2021,Q1,1,I,20150601.0,20160613.0,20210224,20210224,EXP,,NZ-SA-2016SA111809,SANOFI AVENTIS,,78.0,YR,E,F,Y,,,20210224.0,,HP,NZ,NZ,2021,Q1,Elderly
189350921,18935092,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 IU, QD",,,,,,,21081.0,4.0,IU,,QD,2021,Q1,Throat tightness,,2021,Q1,1,I,20150601.0,20160613.0,20210224,20210224,EXP,,NZ-SA-2016SA111809,SANOFI AVENTIS,,78.0,YR,E,F,Y,,,20210224.0,,HP,NZ,NZ,2021,Q1,Elderly
189350921,18935092,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 IU, QD",,,,,,,21081.0,4.0,IU,,QD,2021,Q1,Cough,,2021,Q1,1,I,20150601.0,20160613.0,20210224,20210224,EXP,,NZ-SA-2016SA111809,SANOFI AVENTIS,,78.0,YR,E,F,Y,,,20210224.0,,HP,NZ,NZ,2021,Q1,Elderly
189350921,18935092,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 IU, QD",,,,,,,21081.0,4.0,IU,,QD,2021,Q1,Throat tightness,,2021,Q1,1,I,20150601.0,20160613.0,20210224,20210224,EXP,,NZ-SA-2016SA111809,SANOFI AVENTIS,,78.0,YR,E,F,Y,,,20210224.0,,HP,NZ,NZ,2021,Q1,Elderly
189352871,18935287,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,BASAL INSULIN GLARGINE,,,,,,,,,,UNKNOWN,,2021,Q1,Exfoliative rash,,2021,Q1,1,I,,20210215.0,20210224,20210224,EXP,,US-FRESENIUS KABI-FK202101712,FRESENIUS KABI,"FEIN LEVY C, PRESSWALA L, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES INPATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATRIC BLOOD AND CANCER. 2021 FEB?68 (2):.",23.0,YR,,M,Y,,,20210224.0,,HP,US,US,2021,Q1,Youth
189352871,18935287,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,BASAL INSULIN GLARGINE,,,,,,,,,,UNKNOWN,,2021,Q1,Febrile neutropenia,,2021,Q1,1,I,,20210215.0,20210224,20210224,EXP,,US-FRESENIUS KABI-FK202101712,FRESENIUS KABI,"FEIN LEVY C, PRESSWALA L, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES INPATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATRIC BLOOD AND CANCER. 2021 FEB?68 (2):.",23.0,YR,,M,Y,,,20210224.0,,HP,US,US,2021,Q1,Youth
189352871,18935287,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,BASAL INSULIN GLARGINE,,,,,,,,,,UNKNOWN,,2021,Q1,Mucosal inflammation,,2021,Q1,1,I,,20210215.0,20210224,20210224,EXP,,US-FRESENIUS KABI-FK202101712,FRESENIUS KABI,"FEIN LEVY C, PRESSWALA L, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES INPATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATRIC BLOOD AND CANCER. 2021 FEB?68 (2):.",23.0,YR,,M,Y,,,20210224.0,,HP,US,US,2021,Q1,Youth
189352871,18935287,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,BASAL INSULIN GLARGINE,,,,,,,,,,UNKNOWN,,2021,Q1,Pulmonary oedema,,2021,Q1,1,I,,20210215.0,20210224,20210224,EXP,,US-FRESENIUS KABI-FK202101712,FRESENIUS KABI,"FEIN LEVY C, PRESSWALA L, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES INPATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATRIC BLOOD AND CANCER. 2021 FEB?68 (2):.",23.0,YR,,M,Y,,,20210224.0,,HP,US,US,2021,Q1,Youth
189419892,18941989,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intramuscular,"12 UNIT, QD",,,U,,,,,12.0,DF,,QD,2021,Q1,Fatigue,,2021,Q1,2,F,20201111.0,20210226.0,20210225,20210302,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-097416,BRISTOL MYERS SQUIBB,,68.0,YR,,M,Y,,,20210302.0,,HP,CN,CN,2021,Q1,Elderly
189419892,18941989,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intramuscular,"12 UNIT, QD",,,U,,,,,12.0,DF,,QD,2021,Q1,Hypothyroidism,,2021,Q1,2,F,20201111.0,20210226.0,20210225,20210302,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-097416,BRISTOL MYERS SQUIBB,,68.0,YR,,M,Y,,,20210302.0,,HP,CN,CN,2021,Q1,Elderly
189419892,18941989,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intramuscular,"12 UNIT, QD",,,U,,,,,12.0,DF,,QD,2021,Q1,Hypovolaemic shock,,2021,Q1,2,F,20201111.0,20210226.0,20210225,20210302,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-097416,BRISTOL MYERS SQUIBB,,68.0,YR,,M,Y,,,20210302.0,,HP,CN,CN,2021,Q1,Elderly
189419892,18941989,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intramuscular,"12 UNIT, QD",,,U,,,,,12.0,DF,,QD,2021,Q1,Ketoacidosis,,2021,Q1,2,F,20201111.0,20210226.0,20210225,20210302,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-097416,BRISTOL MYERS SQUIBB,,68.0,YR,,M,Y,,,20210302.0,,HP,CN,CN,2021,Q1,Elderly
189419892,18941989,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intramuscular,"12 UNIT, QD",,,U,,,,,12.0,DF,,QD,2021,Q1,Multiple organ dysfunction syndrome,,2021,Q1,2,F,20201111.0,20210226.0,20210225,20210302,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-097416,BRISTOL MYERS SQUIBB,,68.0,YR,,M,Y,,,20210302.0,,HP,CN,CN,2021,Q1,Elderly
189438301,18943830,5,SS,Glargine (ER),INSULIN GLARGINE,1,,UNK,,,D,, UNK,,,,,,,2021,Q1,Suspected suicide,,2021,Q1,1,I,,20210217.0,20210226,20210226,EXP,,US-NOVAST LABORATORIES LTD.-2021NOV000191,NOVAST,,61.0,YR,,M,Y,,,20210226.0,,MD,US,US,2021,Q1,Adult
189445211,18944521,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Diplopia,,2021,Q1,1,I,,20210217.0,20210226,20210226,EXP,,CA-TEVA-2021-CA-1882740,TEVA,,71.0,YR,E,F,Y,,,20210226.0,,PH,CA,CA,2021,Q1,Elderly
189445211,18944521,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Dysphonia,,2021,Q1,1,I,,20210217.0,20210226,20210226,EXP,,CA-TEVA-2021-CA-1882740,TEVA,,71.0,YR,E,F,Y,,,20210226.0,,PH,CA,CA,2021,Q1,Elderly
189445211,18944521,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Dyspnoea,,2021,Q1,1,I,,20210217.0,20210226,20210226,EXP,,CA-TEVA-2021-CA-1882740,TEVA,,71.0,YR,E,F,Y,,,20210226.0,,PH,CA,CA,2021,Q1,Elderly
189445211,18944521,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Eyelid ptosis,,2021,Q1,1,I,,20210217.0,20210226,20210226,EXP,,CA-TEVA-2021-CA-1882740,TEVA,,71.0,YR,E,F,Y,,,20210226.0,,PH,CA,CA,2021,Q1,Elderly
189480012,18948001,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,6 TO 10 UNITS WITH MEALS,,,U,N,,,,,,,,2021,Q1,Ankle fracture,,2021,Q1,2,F,201602.0,20210222.0,20210226,20210303,EXP,,DE-ANIPHARMA-2021-DE-000027,ANI,,73.0,YR,,M,Y,87.0,KG,20210303.0,,MD,DE,DE,2021,Q1,Elderly
189480012,18948001,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,6 TO 10 UNITS WITH MEALS,,,U,N,,,,,,,,2021,Q1,Atrial fibrillation,,2021,Q1,2,F,201602.0,20210222.0,20210226,20210303,EXP,,DE-ANIPHARMA-2021-DE-000027,ANI,,73.0,YR,,M,Y,87.0,KG,20210303.0,,MD,DE,DE,2021,Q1,Elderly
189480012,18948001,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,6 TO 10 UNITS WITH MEALS,,,U,N,,,,,,,,2021,Q1,Coronary artery disease,,2021,Q1,2,F,201602.0,20210222.0,20210226,20210303,EXP,,DE-ANIPHARMA-2021-DE-000027,ANI,,73.0,YR,,M,Y,87.0,KG,20210303.0,,MD,DE,DE,2021,Q1,Elderly
189480012,18948001,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,6 TO 10 UNITS WITH MEALS,,,U,N,,,,,,,,2021,Q1,Hypercholesterolaemia,,2021,Q1,2,F,201602.0,20210222.0,20210226,20210303,EXP,,DE-ANIPHARMA-2021-DE-000027,ANI,,73.0,YR,,M,Y,87.0,KG,20210303.0,,MD,DE,DE,2021,Q1,Elderly
189480012,18948001,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,6 TO 10 UNITS WITH MEALS,,,U,N,,,,,,,,2021,Q1,Hypertension,,2021,Q1,2,F,201602.0,20210222.0,20210226,20210303,EXP,,DE-ANIPHARMA-2021-DE-000027,ANI,,73.0,YR,,M,Y,87.0,KG,20210303.0,,MD,DE,DE,2021,Q1,Elderly
189480012,18948001,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,6 TO 10 UNITS WITH MEALS,,,U,N,,,,,,,,2021,Q1,Lower limb fracture,,2021,Q1,2,F,201602.0,20210222.0,20210226,20210303,EXP,,DE-ANIPHARMA-2021-DE-000027,ANI,,73.0,YR,,M,Y,87.0,KG,20210303.0,,MD,DE,DE,2021,Q1,Elderly
189480012,18948001,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,6 TO 10 UNITS WITH MEALS,,,U,N,,,,,,,,2021,Q1,Myocardial infarction,,2021,Q1,2,F,201602.0,20210222.0,20210226,20210303,EXP,,DE-ANIPHARMA-2021-DE-000027,ANI,,73.0,YR,,M,Y,87.0,KG,20210303.0,,MD,DE,DE,2021,Q1,Elderly
189480012,18948001,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,6 TO 10 UNITS WITH MEALS,,,U,N,,,,,,,,2021,Q1,Obesity,,2021,Q1,2,F,201602.0,20210222.0,20210226,20210303,EXP,,DE-ANIPHARMA-2021-DE-000027,ANI,,73.0,YR,,M,Y,87.0,KG,20210303.0,,MD,DE,DE,2021,Q1,Elderly
189480012,18948001,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,6 TO 10 UNITS WITH MEALS,,,U,N,,,,,,,,2021,Q1,Peripheral arterial occlusive disease,,2021,Q1,2,F,201602.0,20210222.0,20210226,20210303,EXP,,DE-ANIPHARMA-2021-DE-000027,ANI,,73.0,YR,,M,Y,87.0,KG,20210303.0,,MD,DE,DE,2021,Q1,Elderly
189496691,18949669,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,64 IU,,,,, 0F557A,,,64.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Mobility decreased,,2021,Q1,1,I,2020.0,20210219.0,20210227,20210227,EXP,,NVSC2021ES040051,NOVARTIS,,65.0,YR,,F,Y,,,20210227.0,,HP,ES,ES,2021,Q1,Elderly
189496691,18949669,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,64 IU,,,,, 0F557A,,,64.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Renal colic,,2021,Q1,1,I,2020.0,20210219.0,20210227,20210227,EXP,,NVSC2021ES040051,NOVARTIS,,65.0,YR,,F,Y,,,20210227.0,,HP,ES,ES,2021,Q1,Elderly
189496691,18949669,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,64 IU,,,,, 0F557A,,,64.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Renal pain,,2021,Q1,1,I,2020.0,20210219.0,20210227,20210227,EXP,,NVSC2021ES040051,NOVARTIS,,65.0,YR,,F,Y,,,20210227.0,,HP,ES,ES,2021,Q1,Elderly
189496691,18949669,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,64 IU,,,,, 0F557A,,,64.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Urinary tract infection,,2021,Q1,1,I,2020.0,20210219.0,20210227,20210227,EXP,,NVSC2021ES040051,NOVARTIS,,65.0,YR,,F,Y,,,20210227.0,,HP,ES,ES,2021,Q1,Elderly
189496691,18949669,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,64 IU,,,,, 0F557A,,,64.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Visual impairment,,2021,Q1,1,I,2020.0,20210219.0,20210227,20210227,EXP,,NVSC2021ES040051,NOVARTIS,,65.0,YR,,F,Y,,,20210227.0,,HP,ES,ES,2021,Q1,Elderly
189496691,18949669,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,64 IU,,,,, 0F557A,,,64.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Weight increased,,2021,Q1,1,I,2020.0,20210219.0,20210227,20210227,EXP,,NVSC2021ES040051,NOVARTIS,,65.0,YR,,F,Y,,,20210227.0,,HP,ES,ES,2021,Q1,Elderly
189515331,18951533,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,64 INTERNATIONAL UNIT,,,,, 0F557A,,,64.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Mobility decreased,,2021,Q1,1,I,2020.0,20210217.0,20210301,20210301,EXP,,ES-AUROBINDO-AUR-APL-2021-007918,AUROBINDO,,65.0,YR,,F,Y,,,20210301.0,,CN,ES,ES,2021,Q1,Elderly
189515331,18951533,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,64 INTERNATIONAL UNIT,,,,, 0F557A,,,64.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Renal colic,,2021,Q1,1,I,2020.0,20210217.0,20210301,20210301,EXP,,ES-AUROBINDO-AUR-APL-2021-007918,AUROBINDO,,65.0,YR,,F,Y,,,20210301.0,,CN,ES,ES,2021,Q1,Elderly
189515331,18951533,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,64 INTERNATIONAL UNIT,,,,, 0F557A,,,64.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Renal pain,,2021,Q1,1,I,2020.0,20210217.0,20210301,20210301,EXP,,ES-AUROBINDO-AUR-APL-2021-007918,AUROBINDO,,65.0,YR,,F,Y,,,20210301.0,,CN,ES,ES,2021,Q1,Elderly
189515331,18951533,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,64 INTERNATIONAL UNIT,,,,, 0F557A,,,64.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Urinary tract infection,,2021,Q1,1,I,2020.0,20210217.0,20210301,20210301,EXP,,ES-AUROBINDO-AUR-APL-2021-007918,AUROBINDO,,65.0,YR,,F,Y,,,20210301.0,,CN,ES,ES,2021,Q1,Elderly
189515331,18951533,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,64 INTERNATIONAL UNIT,,,,, 0F557A,,,64.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Visual impairment,,2021,Q1,1,I,2020.0,20210217.0,20210301,20210301,EXP,,ES-AUROBINDO-AUR-APL-2021-007918,AUROBINDO,,65.0,YR,,F,Y,,,20210301.0,,CN,ES,ES,2021,Q1,Elderly
189515331,18951533,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,64 INTERNATIONAL UNIT,,,,, 0F557A,,,64.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Weight increased,,2021,Q1,1,I,2020.0,20210217.0,20210301,20210301,EXP,,ES-AUROBINDO-AUR-APL-2021-007918,AUROBINDO,,65.0,YR,,F,Y,,,20210301.0,,CN,ES,ES,2021,Q1,Elderly
189525571,18952557,2,SS,Glargine,INSULIN GLARGINE,1,,UNK,,,D,, UNK,,,,,,,2021,Q1,Suspected suicide,,2021,Q1,1,I,,20210217.0,20210301,20210301,EXP,,US-NOVAST LABORATORIES LTD.-2021NOV000136,NOVAST,,46.0,YR,,F,Y,,,20210301.0,,MD,US,US,2021,Q1,Adult
189533751,18953375,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Blood pressure decreased,,2021,Q1,1,I,2017.0,20210218.0,20210301,20210301,EXP,,JP-MYLANLABS-2021M1011241,MYLAN,,58.0,YR,,M,Y,72.0,KG,20210301.0,,HP,JP,JP,2021,Q1,Adult
189533751,18953375,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Bradycardia,,2021,Q1,1,I,2017.0,20210218.0,20210301,20210301,EXP,,JP-MYLANLABS-2021M1011241,MYLAN,,58.0,YR,,M,Y,72.0,KG,20210301.0,,HP,JP,JP,2021,Q1,Adult
189533751,18953375,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Cardiac arrest,,2021,Q1,1,I,2017.0,20210218.0,20210301,20210301,EXP,,JP-MYLANLABS-2021M1011241,MYLAN,,58.0,YR,,M,Y,72.0,KG,20210301.0,,HP,JP,JP,2021,Q1,Adult
189533751,18953375,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Cardiac valve rupture,,2021,Q1,1,I,2017.0,20210218.0,20210301,20210301,EXP,,JP-MYLANLABS-2021M1011241,MYLAN,,58.0,YR,,M,Y,72.0,KG,20210301.0,,HP,JP,JP,2021,Q1,Adult
189533751,18953375,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Condition aggravated,,2021,Q1,1,I,2017.0,20210218.0,20210301,20210301,EXP,,JP-MYLANLABS-2021M1011241,MYLAN,,58.0,YR,,M,Y,72.0,KG,20210301.0,,HP,JP,JP,2021,Q1,Adult
189533751,18953375,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Feeling abnormal,,2021,Q1,1,I,2017.0,20210218.0,20210301,20210301,EXP,,JP-MYLANLABS-2021M1011241,MYLAN,,58.0,YR,,M,Y,72.0,KG,20210301.0,,HP,JP,JP,2021,Q1,Adult
189533751,18953375,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Hepatic function abnormal,,2021,Q1,1,I,2017.0,20210218.0,20210301,20210301,EXP,,JP-MYLANLABS-2021M1011241,MYLAN,,58.0,YR,,M,Y,72.0,KG,20210301.0,,HP,JP,JP,2021,Q1,Adult
189533751,18953375,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Hyperkalaemia,,2021,Q1,1,I,2017.0,20210218.0,20210301,20210301,EXP,,JP-MYLANLABS-2021M1011241,MYLAN,,58.0,YR,,M,Y,72.0,KG,20210301.0,,HP,JP,JP,2021,Q1,Adult
189533751,18953375,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Hypersensitivity,,2021,Q1,1,I,2017.0,20210218.0,20210301,20210301,EXP,,JP-MYLANLABS-2021M1011241,MYLAN,,58.0,YR,,M,Y,72.0,KG,20210301.0,,HP,JP,JP,2021,Q1,Adult
189533751,18953375,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Hypoxic-ischaemic encephalopathy,,2021,Q1,1,I,2017.0,20210218.0,20210301,20210301,EXP,,JP-MYLANLABS-2021M1011241,MYLAN,,58.0,YR,,M,Y,72.0,KG,20210301.0,,HP,JP,JP,2021,Q1,Adult
189533751,18953375,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Renal impairment,,2021,Q1,1,I,2017.0,20210218.0,20210301,20210301,EXP,,JP-MYLANLABS-2021M1011241,MYLAN,,58.0,YR,,M,Y,72.0,KG,20210301.0,,HP,JP,JP,2021,Q1,Adult
189533751,18953375,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Respiratory arrest,,2021,Q1,1,I,2017.0,20210218.0,20210301,20210301,EXP,,JP-MYLANLABS-2021M1011241,MYLAN,,58.0,YR,,M,Y,72.0,KG,20210301.0,,HP,JP,JP,2021,Q1,Adult
189553571,18955357,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,D,,,,21081.0,,,,,2021,Q1,Product dispensing error,,2021,Q1,1,I,20201117.0,20210215.0,20210301,20210301,PER,,US-SA-2021SA056995,SANOFI AVENTIS,,17.0,YR,T,M,Y,,,20210301.0,,CN,US,US,2021,Q1,Youth
189568072,18956807,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Gastrointestinal haemorrhage,,2021,Q1,2,F,20210208.0,20210309.0,20210301,20210312,EXP,,US-UNITED THERAPEUTICS-UNT-2021-002488,UNITED THERAPEUTICS,,67.0,YR,,M,Y,81.18,KG,20210312.0,,HP,US,US,2021,Q1,Elderly
189568072,18956807,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Off label use,,2021,Q1,2,F,20210208.0,20210309.0,20210301,20210312,EXP,,US-UNITED THERAPEUTICS-UNT-2021-002488,UNITED THERAPEUTICS,,67.0,YR,,M,Y,81.18,KG,20210312.0,,HP,US,US,2021,Q1,Elderly
189596552,18959655,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q1,Compartment syndrome,,2021,Q1,2,F,,20210301.0,20210302,20210304,EXP,,GR-ASTRAZENECA-2021A087709,ASTRAZENECA,,47.0,YR,,F,Y,,,20210304.0,,,GR,GR,2021,Q1,Adult
189596552,18959655,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q1,Drug abuse,,2021,Q1,2,F,,20210301.0,20210302,20210304,EXP,,GR-ASTRAZENECA-2021A087709,ASTRAZENECA,,47.0,YR,,F,Y,,,20210304.0,,,GR,GR,2021,Q1,Adult
189596552,18959655,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q1,Immobilisation prolonged,,2021,Q1,2,F,,20210301.0,20210302,20210304,EXP,,GR-ASTRAZENECA-2021A087709,ASTRAZENECA,,47.0,YR,,F,Y,,,20210304.0,,,GR,GR,2021,Q1,Adult
189596552,18959655,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q1,Poisoning,,2021,Q1,2,F,,20210301.0,20210302,20210304,EXP,,GR-ASTRAZENECA-2021A087709,ASTRAZENECA,,47.0,YR,,F,Y,,,20210304.0,,,GR,GR,2021,Q1,Adult
189596552,18959655,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q1,Rhabdomyolysis,,2021,Q1,2,F,,20210301.0,20210302,20210304,EXP,,GR-ASTRAZENECA-2021A087709,ASTRAZENECA,,47.0,YR,,F,Y,,,20210304.0,,,GR,GR,2021,Q1,Adult
189602351,18960235,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Atrial fibrillation,,2021,Q1,1,I,,20210226.0,20210303,20210303,EXP,,SI-JNJFOC-20210302773,JOHNSON AND JOHNSON,,78.0,YR,E,M,Y,,,20210303.0,,HP,SI,SI,2021,Q1,Elderly
189614791,18961479,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,, UNKNOWN,,,,,,,2021,Q1,Drug abuse,,2021,Q1,1,I,,20210301.0,20210303,20210303,EXP,,GR-ROCHE-2779763,ROCHE,"PAPAIOANNOU I, PANTAZIDOU G, CHATZIPERI S, BAIKOUSIS A, KOROVESSIS P. GLUTEAL COMPARTMENT SYNDROME? THE MISSING DIAGNOSIS.. CASE PRESENTATION AND BRIEF LITERATURE REVIEW. SURG CHRON. 2020?25(4):378?380.",47.0,YR,,F,Y,,,20210303.0,,MD,GR,GR,2021,Q1,Adult
189614791,18961479,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,, UNKNOWN,,,,,,,2021,Q1,Rhabdomyolysis,,2021,Q1,1,I,,20210301.0,20210303,20210303,EXP,,GR-ROCHE-2779763,ROCHE,"PAPAIOANNOU I, PANTAZIDOU G, CHATZIPERI S, BAIKOUSIS A, KOROVESSIS P. GLUTEAL COMPARTMENT SYNDROME? THE MISSING DIAGNOSIS.. CASE PRESENTATION AND BRIEF LITERATURE REVIEW. SURG CHRON. 2020?25(4):378?380.",47.0,YR,,F,Y,,,20210303.0,,MD,GR,GR,2021,Q1,Adult
189629191,18962919,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Blood creatine phosphokinase increased,,2021,Q1,1,I,,20210301.0,20210303,20210303,EXP,,GR-ROCHE-2779769,ROCHE,"IOANNIS P, GEORGIA PANTAZIDOU2, STAMATIA CHATZIPERI1, ANDREAS BAIKOUSIS1, PANAGIOTIS KOROVESSIS1. GLUTEAL COMPARTMENT SYNDROME? INTOXICATION? DRUG?INDUCED RHABDOMYOLYSIS? HEMODIALYSIS? FASCIOTOMY? DELAYED DIAGNOSIS,.. SURGICAL CHRONICLES 2020?25(4):?.",47.0,YR,,F,Y,,,20210303.0,,MD,GR,GR,2021,Q1,Adult
189629191,18962919,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Communication disorder,,2021,Q1,1,I,,20210301.0,20210303,20210303,EXP,,GR-ROCHE-2779769,ROCHE,"IOANNIS P, GEORGIA PANTAZIDOU2, STAMATIA CHATZIPERI1, ANDREAS BAIKOUSIS1, PANAGIOTIS KOROVESSIS1. GLUTEAL COMPARTMENT SYNDROME? INTOXICATION? DRUG?INDUCED RHABDOMYOLYSIS? HEMODIALYSIS? FASCIOTOMY? DELAYED DIAGNOSIS,.. SURGICAL CHRONICLES 2020?25(4):?.",47.0,YR,,F,Y,,,20210303.0,,MD,GR,GR,2021,Q1,Adult
189629191,18962919,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,General physical condition abnormal,,2021,Q1,1,I,,20210301.0,20210303,20210303,EXP,,GR-ROCHE-2779769,ROCHE,"IOANNIS P, GEORGIA PANTAZIDOU2, STAMATIA CHATZIPERI1, ANDREAS BAIKOUSIS1, PANAGIOTIS KOROVESSIS1. GLUTEAL COMPARTMENT SYNDROME? INTOXICATION? DRUG?INDUCED RHABDOMYOLYSIS? HEMODIALYSIS? FASCIOTOMY? DELAYED DIAGNOSIS,.. SURGICAL CHRONICLES 2020?25(4):?.",47.0,YR,,F,Y,,,20210303.0,,MD,GR,GR,2021,Q1,Adult
189629191,18962919,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Hepatic function abnormal,,2021,Q1,1,I,,20210301.0,20210303,20210303,EXP,,GR-ROCHE-2779769,ROCHE,"IOANNIS P, GEORGIA PANTAZIDOU2, STAMATIA CHATZIPERI1, ANDREAS BAIKOUSIS1, PANAGIOTIS KOROVESSIS1. GLUTEAL COMPARTMENT SYNDROME? INTOXICATION? DRUG?INDUCED RHABDOMYOLYSIS? HEMODIALYSIS? FASCIOTOMY? DELAYED DIAGNOSIS,.. SURGICAL CHRONICLES 2020?25(4):?.",47.0,YR,,F,Y,,,20210303.0,,MD,GR,GR,2021,Q1,Adult
189629191,18962919,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Labelled drug-food interaction issue,,2021,Q1,1,I,,20210301.0,20210303,20210303,EXP,,GR-ROCHE-2779769,ROCHE,"IOANNIS P, GEORGIA PANTAZIDOU2, STAMATIA CHATZIPERI1, ANDREAS BAIKOUSIS1, PANAGIOTIS KOROVESSIS1. GLUTEAL COMPARTMENT SYNDROME? INTOXICATION? DRUG?INDUCED RHABDOMYOLYSIS? HEMODIALYSIS? FASCIOTOMY? DELAYED DIAGNOSIS,.. SURGICAL CHRONICLES 2020?25(4):?.",47.0,YR,,F,Y,,,20210303.0,,MD,GR,GR,2021,Q1,Adult
189629191,18962919,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Muscle injury,,2021,Q1,1,I,,20210301.0,20210303,20210303,EXP,,GR-ROCHE-2779769,ROCHE,"IOANNIS P, GEORGIA PANTAZIDOU2, STAMATIA CHATZIPERI1, ANDREAS BAIKOUSIS1, PANAGIOTIS KOROVESSIS1. GLUTEAL COMPARTMENT SYNDROME? INTOXICATION? DRUG?INDUCED RHABDOMYOLYSIS? HEMODIALYSIS? FASCIOTOMY? DELAYED DIAGNOSIS,.. SURGICAL CHRONICLES 2020?25(4):?.",47.0,YR,,F,Y,,,20210303.0,,MD,GR,GR,2021,Q1,Adult
189629191,18962919,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Neurological decompensation,,2021,Q1,1,I,,20210301.0,20210303,20210303,EXP,,GR-ROCHE-2779769,ROCHE,"IOANNIS P, GEORGIA PANTAZIDOU2, STAMATIA CHATZIPERI1, ANDREAS BAIKOUSIS1, PANAGIOTIS KOROVESSIS1. GLUTEAL COMPARTMENT SYNDROME? INTOXICATION? DRUG?INDUCED RHABDOMYOLYSIS? HEMODIALYSIS? FASCIOTOMY? DELAYED DIAGNOSIS,.. SURGICAL CHRONICLES 2020?25(4):?.",47.0,YR,,F,Y,,,20210303.0,,MD,GR,GR,2021,Q1,Adult
189629191,18962919,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Renal impairment,,2021,Q1,1,I,,20210301.0,20210303,20210303,EXP,,GR-ROCHE-2779769,ROCHE,"IOANNIS P, GEORGIA PANTAZIDOU2, STAMATIA CHATZIPERI1, ANDREAS BAIKOUSIS1, PANAGIOTIS KOROVESSIS1. GLUTEAL COMPARTMENT SYNDROME? INTOXICATION? DRUG?INDUCED RHABDOMYOLYSIS? HEMODIALYSIS? FASCIOTOMY? DELAYED DIAGNOSIS,.. SURGICAL CHRONICLES 2020?25(4):?.",47.0,YR,,F,Y,,,20210303.0,,MD,GR,GR,2021,Q1,Adult
189629191,18962919,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Rhabdomyolysis,,2021,Q1,1,I,,20210301.0,20210303,20210303,EXP,,GR-ROCHE-2779769,ROCHE,"IOANNIS P, GEORGIA PANTAZIDOU2, STAMATIA CHATZIPERI1, ANDREAS BAIKOUSIS1, PANAGIOTIS KOROVESSIS1. GLUTEAL COMPARTMENT SYNDROME? INTOXICATION? DRUG?INDUCED RHABDOMYOLYSIS? HEMODIALYSIS? FASCIOTOMY? DELAYED DIAGNOSIS,.. SURGICAL CHRONICLES 2020?25(4):?.",47.0,YR,,F,Y,,,20210303.0,,MD,GR,GR,2021,Q1,Adult
189629191,18962919,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Weight bearing difficulty,,2021,Q1,1,I,,20210301.0,20210303,20210303,EXP,,GR-ROCHE-2779769,ROCHE,"IOANNIS P, GEORGIA PANTAZIDOU2, STAMATIA CHATZIPERI1, ANDREAS BAIKOUSIS1, PANAGIOTIS KOROVESSIS1. GLUTEAL COMPARTMENT SYNDROME? INTOXICATION? DRUG?INDUCED RHABDOMYOLYSIS? HEMODIALYSIS? FASCIOTOMY? DELAYED DIAGNOSIS,.. SURGICAL CHRONICLES 2020?25(4):?.",47.0,YR,,F,Y,,,20210303.0,,MD,GR,GR,2021,Q1,Adult
189634421,18963442,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),IV INFUSION OF INSULIN AT A RATE OF 90 UNITS PER HOUR TO ACHIEVE NORMOGLYCAEMIA,,,,,,,,,,INJECTION,,2021,Q1,Drug ineffective,,2021,Q1,1,I,,20210225.0,20210303,20210303,EXP,,AU-MYLANLABS-2021M1013429,MYLAN,"WONG VW, PAPE AV. EXTREME INSULIN RESISTANCE IN A PATIENT WITH PRE?EXISTING DIABETES DURING PREGNANCY: ROLE OF U?500 INSULIN. MED?J?AUST 2009?190(11):650?651.",38.0,YR,,F,Y,,,20210303.0,,HP,AU,AU,2021,Q1,Adult
189634421,18963442,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),IV INFUSION OF INSULIN AT A RATE OF 90 UNITS PER HOUR TO ACHIEVE NORMOGLYCAEMIA,,,,,,,,,,INJECTION,,2021,Q1,Maternal exposure during pregnancy,,2021,Q1,1,I,,20210225.0,20210303,20210303,EXP,,AU-MYLANLABS-2021M1013429,MYLAN,"WONG VW, PAPE AV. EXTREME INSULIN RESISTANCE IN A PATIENT WITH PRE?EXISTING DIABETES DURING PREGNANCY: ROLE OF U?500 INSULIN. MED?J?AUST 2009?190(11):650?651.",38.0,YR,,F,Y,,,20210303.0,,HP,AU,AU,2021,Q1,Adult
189634421,18963442,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"AT 35 WEEKS OF GESTATION, HER DAILY INSULIN REQUIREMENT HAD REACHED 1455 UNITS",,,,,,,,,,INJECTION,,2021,Q1,Drug ineffective,,2021,Q1,1,I,,20210225.0,20210303,20210303,EXP,,AU-MYLANLABS-2021M1013429,MYLAN,"WONG VW, PAPE AV. EXTREME INSULIN RESISTANCE IN A PATIENT WITH PRE?EXISTING DIABETES DURING PREGNANCY: ROLE OF U?500 INSULIN. MED?J?AUST 2009?190(11):650?651.",38.0,YR,,F,Y,,,20210303.0,,HP,AU,AU,2021,Q1,Adult
189634421,18963442,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"AT 35 WEEKS OF GESTATION, HER DAILY INSULIN REQUIREMENT HAD REACHED 1455 UNITS",,,,,,,,,,INJECTION,,2021,Q1,Maternal exposure during pregnancy,,2021,Q1,1,I,,20210225.0,20210303,20210303,EXP,,AU-MYLANLABS-2021M1013429,MYLAN,"WONG VW, PAPE AV. EXTREME INSULIN RESISTANCE IN A PATIENT WITH PRE?EXISTING DIABETES DURING PREGNANCY: ROLE OF U?500 INSULIN. MED?J?AUST 2009?190(11):650?651.",38.0,YR,,F,Y,,,20210303.0,,HP,AU,AU,2021,Q1,Adult
189638331,18963833,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,UNKNOWN,,2021,Q1,Arthralgia,,2021,Q1,1,I,,20210301.0,20210303,20210303,EXP,,DE-JNJFOC-20210300763,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,64.0,KG,20210303.0,,PH,DE,DE,2021,Q1,Elderly
189638331,18963833,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,UNKNOWN,,2021,Q1,Contraindicated product administered,,2021,Q1,1,I,,20210301.0,20210303,20210303,EXP,,DE-JNJFOC-20210300763,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,64.0,KG,20210303.0,,PH,DE,DE,2021,Q1,Elderly
189638331,18963833,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,UNKNOWN,,2021,Q1,Pain,,2021,Q1,1,I,,20210301.0,20210303,20210303,EXP,,DE-JNJFOC-20210300763,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,64.0,KG,20210303.0,,PH,DE,DE,2021,Q1,Elderly
189672481,18967248,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q1,Acute myocardial infarction,,2021,Q1,1,I,20210130.0,20210228.0,20210304,20210304,EXP,GB-MHRA-EYC 00241967,GB-JNJFOC-20210301483,JOHNSON AND JOHNSON,,86.0,YR,E,F,Y,77.0,KG,20210304.0,,MD,GB,GB,2021,Q1,Elderly
189684161,18968416,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F557A,,,64.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Mobility decreased,,2021,Q1,1,I,2020.0,20210219.0,20210304,20210304,EXP,,ES-BAUSCH-BL-2021-006373,BAUSCH AND LOMB,,65.0,YR,,F,Y,,,20210304.0,,CN,ES,ES,2021,Q1,Elderly
189684161,18968416,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F557A,,,64.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Renal colic,,2021,Q1,1,I,2020.0,20210219.0,20210304,20210304,EXP,,ES-BAUSCH-BL-2021-006373,BAUSCH AND LOMB,,65.0,YR,,F,Y,,,20210304.0,,CN,ES,ES,2021,Q1,Elderly
189684161,18968416,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F557A,,,64.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Renal pain,,2021,Q1,1,I,2020.0,20210219.0,20210304,20210304,EXP,,ES-BAUSCH-BL-2021-006373,BAUSCH AND LOMB,,65.0,YR,,F,Y,,,20210304.0,,CN,ES,ES,2021,Q1,Elderly
189684161,18968416,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F557A,,,64.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Urinary tract infection,,2021,Q1,1,I,2020.0,20210219.0,20210304,20210304,EXP,,ES-BAUSCH-BL-2021-006373,BAUSCH AND LOMB,,65.0,YR,,F,Y,,,20210304.0,,CN,ES,ES,2021,Q1,Elderly
189684161,18968416,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F557A,,,64.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Visual impairment,,2021,Q1,1,I,2020.0,20210219.0,20210304,20210304,EXP,,ES-BAUSCH-BL-2021-006373,BAUSCH AND LOMB,,65.0,YR,,F,Y,,,20210304.0,,CN,ES,ES,2021,Q1,Elderly
189684161,18968416,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F557A,,,64.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Weight increased,,2021,Q1,1,I,2020.0,20210219.0,20210304,20210304,EXP,,ES-BAUSCH-BL-2021-006373,BAUSCH AND LOMB,,65.0,YR,,F,Y,,,20210304.0,,CN,ES,ES,2021,Q1,Elderly
189703281,18970328,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,20 IU AT NIGHT,,,,, UNKNOWN,,,,,,,2021,Q1,Hypoaesthesia,,2021,Q1,1,I,201906.0,20201022.0,20210304,20210304,EXP,,BR-NOVOPROD-790228,NOVO NORDISK,,43.0,YR,,M,Y,69.3,KG,20210304.0,,MD,BR,BR,2021,Q1,Adult
189703281,18970328,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,20 IU AT NIGHT,,,,, UNKNOWN,,,,,,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,201906.0,20201022.0,20210304,20210304,EXP,,BR-NOVOPROD-790228,NOVO NORDISK,,43.0,YR,,M,Y,69.3,KG,20210304.0,,MD,BR,BR,2021,Q1,Adult
189703281,18970328,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,20 IU AT NIGHT,,,,, UNKNOWN,,,,,,,2021,Q1,Pneumonia,,2021,Q1,1,I,201906.0,20201022.0,20210304,20210304,EXP,,BR-NOVOPROD-790228,NOVO NORDISK,,43.0,YR,,M,Y,69.3,KG,20210304.0,,MD,BR,BR,2021,Q1,Adult
189706072,18970607,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Muscular weakness,,2021,Q1,2,F,20210216.0,20210302.0,20210304,20210317,PER,,ES-JAZZ-2021-ES-003694,JAZZ,,66.0,YR,,M,Y,96.5,KG,20210317.0,,MD,ES,ES,2021,Q1,Elderly
189712551,18971255,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Balance disorder,,2021,Q1,1,I,,20210222.0,20210305,20210305,EXP,,CA-BAUSCH-BL-2021-006675,BAUSCH AND LOMB,,51.0,YR,,M,Y,94.0,KG,20210305.0,,PH,CA,CA,2021,Q1,Adult
189712551,18971255,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Cogwheel rigidity,,2021,Q1,1,I,,20210222.0,20210305,20210305,EXP,,CA-BAUSCH-BL-2021-006675,BAUSCH AND LOMB,,51.0,YR,,M,Y,94.0,KG,20210305.0,,PH,CA,CA,2021,Q1,Adult
189712551,18971255,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Fall,,2021,Q1,1,I,,20210222.0,20210305,20210305,EXP,,CA-BAUSCH-BL-2021-006675,BAUSCH AND LOMB,,51.0,YR,,M,Y,94.0,KG,20210305.0,,PH,CA,CA,2021,Q1,Adult
189712551,18971255,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Gait disturbance,,2021,Q1,1,I,,20210222.0,20210305,20210305,EXP,,CA-BAUSCH-BL-2021-006675,BAUSCH AND LOMB,,51.0,YR,,M,Y,94.0,KG,20210305.0,,PH,CA,CA,2021,Q1,Adult
189712551,18971255,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Hypertonia,,2021,Q1,1,I,,20210222.0,20210305,20210305,EXP,,CA-BAUSCH-BL-2021-006675,BAUSCH AND LOMB,,51.0,YR,,M,Y,94.0,KG,20210305.0,,PH,CA,CA,2021,Q1,Adult
189712551,18971255,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Myocarditis,,2021,Q1,1,I,,20210222.0,20210305,20210305,EXP,,CA-BAUSCH-BL-2021-006675,BAUSCH AND LOMB,,51.0,YR,,M,Y,94.0,KG,20210305.0,,PH,CA,CA,2021,Q1,Adult
189712551,18971255,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Neuroleptic malignant syndrome,,2021,Q1,1,I,,20210222.0,20210305,20210305,EXP,,CA-BAUSCH-BL-2021-006675,BAUSCH AND LOMB,,51.0,YR,,M,Y,94.0,KG,20210305.0,,PH,CA,CA,2021,Q1,Adult
189712551,18971255,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Nystagmus,,2021,Q1,1,I,,20210222.0,20210305,20210305,EXP,,CA-BAUSCH-BL-2021-006675,BAUSCH AND LOMB,,51.0,YR,,M,Y,94.0,KG,20210305.0,,PH,CA,CA,2021,Q1,Adult
189712551,18971255,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Somnolence,,2021,Q1,1,I,,20210222.0,20210305,20210305,EXP,,CA-BAUSCH-BL-2021-006675,BAUSCH AND LOMB,,51.0,YR,,M,Y,94.0,KG,20210305.0,,PH,CA,CA,2021,Q1,Adult
189714482,18971448,5,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,, UNK,,,,,,,2021,Q1,Cerebrovascular accident,,2021,Q1,2,F,20210209.0,20210315.0,20210305,20210324,EXP,,US-EXELIXIS-XL18421038013,EXELIXIS,,57.0,YR,,M,Y,130.0,KG,20210324.0,,MD,US,US,2021,Q1,Adult
189714482,18971448,5,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,, UNK,,,,,,,2021,Q1,Hypophysitis,,2021,Q1,2,F,20210209.0,20210315.0,20210305,20210324,EXP,,US-EXELIXIS-XL18421038013,EXELIXIS,,57.0,YR,,M,Y,130.0,KG,20210324.0,,MD,US,US,2021,Q1,Adult
189729581,18972958,3,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q1,Arthralgia,,2021,Q1,1,I,,20210225.0,20210305,20210305,EXP,,DE-AUROBINDO-AUR-APL-2021-008949,AUROBINDO,,74.0,YR,,M,Y,64.0,KG,20210305.0,,PH,DE,DE,2021,Q1,Elderly
189729581,18972958,3,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q1,Contraindicated product administered,,2021,Q1,1,I,,20210225.0,20210305,20210305,EXP,,DE-AUROBINDO-AUR-APL-2021-008949,AUROBINDO,,74.0,YR,,M,Y,64.0,KG,20210305.0,,PH,DE,DE,2021,Q1,Elderly
189729581,18972958,3,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q1,Pain,,2021,Q1,1,I,,20210225.0,20210305,20210305,EXP,,DE-AUROBINDO-AUR-APL-2021-008949,AUROBINDO,,74.0,YR,,M,Y,64.0,KG,20210305.0,,PH,DE,DE,2021,Q1,Elderly
189738041,18973804,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,U,, UNKNOWN,,,,,UNKNOWN,,2021,Q1,Drug interaction,,2021,Q1,1,I,,20210223.0,20210305,20210305,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-21-53788,HIKMA,"ROBINSON ZS, ARVIN JP, MADDING KL. RIVAROXABAN FAILURE IN A PATIENT TAKING OXCARBAZEPINE. ANNALS OF PHARMACOTHERAPY. 2021:1?2. DOI: 10.1177/1060028021990374.",28.0,YR,,M,Y,146.0,KG,20210305.0,,,COUNTRY NOT SPECIFIED,US,2021,Q1,Young Adult
189738041,18973804,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,U,, UNKNOWN,,,,,UNKNOWN,,2021,Q1,Loss of consciousness,,2021,Q1,1,I,,20210223.0,20210305,20210305,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-21-53788,HIKMA,"ROBINSON ZS, ARVIN JP, MADDING KL. RIVAROXABAN FAILURE IN A PATIENT TAKING OXCARBAZEPINE. ANNALS OF PHARMACOTHERAPY. 2021:1?2. DOI: 10.1177/1060028021990374.",28.0,YR,,M,Y,146.0,KG,20210305.0,,,COUNTRY NOT SPECIFIED,US,2021,Q1,Young Adult
189738041,18973804,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,U,, UNKNOWN,,,,,UNKNOWN,,2021,Q1,Pulmonary embolism,,2021,Q1,1,I,,20210223.0,20210305,20210305,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-21-53788,HIKMA,"ROBINSON ZS, ARVIN JP, MADDING KL. RIVAROXABAN FAILURE IN A PATIENT TAKING OXCARBAZEPINE. ANNALS OF PHARMACOTHERAPY. 2021:1?2. DOI: 10.1177/1060028021990374.",28.0,YR,,M,Y,146.0,KG,20210305.0,,,COUNTRY NOT SPECIFIED,US,2021,Q1,Young Adult
189755151,18975515,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"U300, 24IU",,,U,U, UNKNOWN,,,,,,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,2018.0,20201027.0,20210305,20210305,EXP,,BR-NOVOPROD-790451,NOVO NORDISK,,71.0,YR,,F,Y,99.0,KG,20210305.0,,MD,BR,BR,2021,Q1,Elderly
189755151,18975515,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"U300, 24IU",,,U,U, UNKNOWN,,,,,,,2021,Q1,Cholecystitis,,2021,Q1,1,I,2018.0,20201027.0,20210305,20210305,EXP,,BR-NOVOPROD-790451,NOVO NORDISK,,71.0,YR,,F,Y,99.0,KG,20210305.0,,MD,BR,BR,2021,Q1,Elderly
189755151,18975515,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"U300, 24IU",,,U,U, UNKNOWN,,,,,,,2021,Q1,Depression,,2021,Q1,1,I,2018.0,20201027.0,20210305,20210305,EXP,,BR-NOVOPROD-790451,NOVO NORDISK,,71.0,YR,,F,Y,99.0,KG,20210305.0,,MD,BR,BR,2021,Q1,Elderly
189755151,18975515,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"U300, 24IU",,,U,U, UNKNOWN,,,,,,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,2018.0,20201027.0,20210305,20210305,EXP,,BR-NOVOPROD-790451,NOVO NORDISK,,71.0,YR,,F,Y,99.0,KG,20210305.0,,MD,BR,BR,2021,Q1,Elderly
189755151,18975515,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"U300, 24IU",,,U,U, UNKNOWN,,,,,,,2021,Q1,Knee arthroplasty,,2021,Q1,1,I,2018.0,20201027.0,20210305,20210305,EXP,,BR-NOVOPROD-790451,NOVO NORDISK,,71.0,YR,,F,Y,99.0,KG,20210305.0,,MD,BR,BR,2021,Q1,Elderly
189755151,18975515,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,U300 FOR 22IU,,,U,U, UNKNOWN,,,,,,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,2018.0,20201027.0,20210305,20210305,EXP,,BR-NOVOPROD-790451,NOVO NORDISK,,71.0,YR,,F,Y,99.0,KG,20210305.0,,MD,BR,BR,2021,Q1,Elderly
189755151,18975515,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,U300 FOR 22IU,,,U,U, UNKNOWN,,,,,,,2021,Q1,Cholecystitis,,2021,Q1,1,I,2018.0,20201027.0,20210305,20210305,EXP,,BR-NOVOPROD-790451,NOVO NORDISK,,71.0,YR,,F,Y,99.0,KG,20210305.0,,MD,BR,BR,2021,Q1,Elderly
189755151,18975515,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,U300 FOR 22IU,,,U,U, UNKNOWN,,,,,,,2021,Q1,Depression,,2021,Q1,1,I,2018.0,20201027.0,20210305,20210305,EXP,,BR-NOVOPROD-790451,NOVO NORDISK,,71.0,YR,,F,Y,99.0,KG,20210305.0,,MD,BR,BR,2021,Q1,Elderly
189755151,18975515,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,U300 FOR 22IU,,,U,U, UNKNOWN,,,,,,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,2018.0,20201027.0,20210305,20210305,EXP,,BR-NOVOPROD-790451,NOVO NORDISK,,71.0,YR,,F,Y,99.0,KG,20210305.0,,MD,BR,BR,2021,Q1,Elderly
189755151,18975515,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,U300 FOR 22IU,,,U,U, UNKNOWN,,,,,,,2021,Q1,Knee arthroplasty,,2021,Q1,1,I,2018.0,20201027.0,20210305,20210305,EXP,,BR-NOVOPROD-790451,NOVO NORDISK,,71.0,YR,,F,Y,99.0,KG,20210305.0,,MD,BR,BR,2021,Q1,Elderly
189755151,18975515,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,U300 TO 10IU PER DAY,,,U,U, UNKNOWN,,,,,,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,2018.0,20201027.0,20210305,20210305,EXP,,BR-NOVOPROD-790451,NOVO NORDISK,,71.0,YR,,F,Y,99.0,KG,20210305.0,,MD,BR,BR,2021,Q1,Elderly
189755151,18975515,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,U300 TO 10IU PER DAY,,,U,U, UNKNOWN,,,,,,,2021,Q1,Cholecystitis,,2021,Q1,1,I,2018.0,20201027.0,20210305,20210305,EXP,,BR-NOVOPROD-790451,NOVO NORDISK,,71.0,YR,,F,Y,99.0,KG,20210305.0,,MD,BR,BR,2021,Q1,Elderly
189755151,18975515,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,U300 TO 10IU PER DAY,,,U,U, UNKNOWN,,,,,,,2021,Q1,Depression,,2021,Q1,1,I,2018.0,20201027.0,20210305,20210305,EXP,,BR-NOVOPROD-790451,NOVO NORDISK,,71.0,YR,,F,Y,99.0,KG,20210305.0,,MD,BR,BR,2021,Q1,Elderly
189755151,18975515,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,U300 TO 10IU PER DAY,,,U,U, UNKNOWN,,,,,,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,2018.0,20201027.0,20210305,20210305,EXP,,BR-NOVOPROD-790451,NOVO NORDISK,,71.0,YR,,F,Y,99.0,KG,20210305.0,,MD,BR,BR,2021,Q1,Elderly
189755151,18975515,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,U300 TO 10IU PER DAY,,,U,U, UNKNOWN,,,,,,,2021,Q1,Knee arthroplasty,,2021,Q1,1,I,2018.0,20201027.0,20210305,20210305,EXP,,BR-NOVOPROD-790451,NOVO NORDISK,,71.0,YR,,F,Y,99.0,KG,20210305.0,,MD,BR,BR,2021,Q1,Elderly
189755151,18975515,27,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,2 DOSES OF GLARGINE/DAILY,,,U,U, UNKNOWN,,,,,,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,2018.0,20201027.0,20210305,20210305,EXP,,BR-NOVOPROD-790451,NOVO NORDISK,,71.0,YR,,F,Y,99.0,KG,20210305.0,,MD,BR,BR,2021,Q1,Elderly
189755151,18975515,27,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,2 DOSES OF GLARGINE/DAILY,,,U,U, UNKNOWN,,,,,,,2021,Q1,Cholecystitis,,2021,Q1,1,I,2018.0,20201027.0,20210305,20210305,EXP,,BR-NOVOPROD-790451,NOVO NORDISK,,71.0,YR,,F,Y,99.0,KG,20210305.0,,MD,BR,BR,2021,Q1,Elderly
189755151,18975515,27,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,2 DOSES OF GLARGINE/DAILY,,,U,U, UNKNOWN,,,,,,,2021,Q1,Depression,,2021,Q1,1,I,2018.0,20201027.0,20210305,20210305,EXP,,BR-NOVOPROD-790451,NOVO NORDISK,,71.0,YR,,F,Y,99.0,KG,20210305.0,,MD,BR,BR,2021,Q1,Elderly
189755151,18975515,27,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,2 DOSES OF GLARGINE/DAILY,,,U,U, UNKNOWN,,,,,,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,2018.0,20201027.0,20210305,20210305,EXP,,BR-NOVOPROD-790451,NOVO NORDISK,,71.0,YR,,F,Y,99.0,KG,20210305.0,,MD,BR,BR,2021,Q1,Elderly
189755151,18975515,27,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,2 DOSES OF GLARGINE/DAILY,,,U,U, UNKNOWN,,,,,,,2021,Q1,Knee arthroplasty,,2021,Q1,1,I,2018.0,20201027.0,20210305,20210305,EXP,,BR-NOVOPROD-790451,NOVO NORDISK,,71.0,YR,,F,Y,99.0,KG,20210305.0,,MD,BR,BR,2021,Q1,Elderly
189759312,18975931,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,21081.0,,,SOLUTION FOR INJECTION,,2021,Q1,Product prescribing issue,,2021,Q1,2,F,20210223.0,20210310.0,20210306,20210320,PER,,US-SA-2021SA066801,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20210320.0,,MD,US,US,2021,Q1,Elderly
189759312,18975931,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,21081.0,,,SOLUTION FOR INJECTION,,2021,Q1,Product storage error,,2021,Q1,2,F,20210223.0,20210310.0,20210306,20210320,PER,,US-SA-2021SA066801,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20210320.0,,MD,US,US,2021,Q1,Elderly
189759312,18975931,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"58 IU, Q12H",,,D,, 0F062C,,21081.0,58.0,IU,SOLUTION FOR INJECTION,Q12H,2021,Q1,Product prescribing issue,,2021,Q1,2,F,20210223.0,20210310.0,20210306,20210320,PER,,US-SA-2021SA066801,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20210320.0,,MD,US,US,2021,Q1,Elderly
189759312,18975931,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"58 IU, Q12H",,,D,, 0F062C,,21081.0,58.0,IU,SOLUTION FOR INJECTION,Q12H,2021,Q1,Product storage error,,2021,Q1,2,F,20210223.0,20210310.0,20210306,20210320,PER,,US-SA-2021SA066801,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20210320.0,,MD,US,US,2021,Q1,Elderly
189774971,18977497,9,SS,insulin glargine,INSULIN GLARGINE,1,,UNKNOWN,,,D,,,,,,,,,2021,Q1,Completed suicide,,2021,Q1,1,I,,20210224.0,20210306,20210306,EXP,,US-TORRENT-00010910,TORRENT,,61.0,YR,A,M,Y,,,20210306.0,,MD,US,US,2021,Q1,Adult
189774971,18977497,9,SS,insulin glargine,INSULIN GLARGINE,1,,UNKNOWN,,,D,,,,,,,,,2021,Q1,Toxicity to various agents,,2021,Q1,1,I,,20210224.0,20210306,20210306,EXP,,US-TORRENT-00010910,TORRENT,,61.0,YR,A,M,Y,,,20210306.0,,MD,US,US,2021,Q1,Adult
189787811,18978781,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,12.0,IU,,QD,2021,Q1,Carotid endarterectomy,,2021,Q1,1,I,202010.0,20210223.0,20210308,20210308,EXP,,DE-ROCHE-2777863,ROCHE,,63.0,YR,,M,Y,84.0,KG,20210308.0,,MD,DE,DE,2021,Q1,Adult
189787811,18978781,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,12.0,IU,,QD,2021,Q1,Gastrointestinal stromal tumour,,2021,Q1,1,I,202010.0,20210223.0,20210308,20210308,EXP,,DE-ROCHE-2777863,ROCHE,,63.0,YR,,M,Y,84.0,KG,20210308.0,,MD,DE,DE,2021,Q1,Adult
189798951,18979895,9,C,Insulin glargine 45 units daily,,2,,,,,,,,,,,,,,2021,Q1,Asthenia,,2021,Q1,1,I,20201118.0,,20210305,20210305,DIR,,,FDA-CTU,,68.0,YR,,F,N,77.5,KG,20210305.0,N,PH,US,US,2021,Q1,Elderly
189798951,18979895,9,C,Insulin glargine 45 units daily,,2,,,,,,,,,,,,,,2021,Q1,Fluid overload,,2021,Q1,1,I,20201118.0,,20210305,20210305,DIR,,,FDA-CTU,,68.0,YR,,F,N,77.5,KG,20210305.0,N,PH,US,US,2021,Q1,Elderly
189798951,18979895,9,C,Insulin glargine 45 units daily,,2,,,,,,,,,,,,,,2021,Q1,Hepatic cirrhosis,,2021,Q1,1,I,20201118.0,,20210305,20210305,DIR,,,FDA-CTU,,68.0,YR,,F,N,77.5,KG,20210305.0,N,PH,US,US,2021,Q1,Elderly
189798951,18979895,9,C,Insulin glargine 45 units daily,,2,,,,,,,,,,,,,,2021,Q1,Pain in extremity,,2021,Q1,1,I,20201118.0,,20210305,20210305,DIR,,,FDA-CTU,,68.0,YR,,F,N,77.5,KG,20210305.0,N,PH,US,US,2021,Q1,Elderly
189798951,18979895,9,C,Insulin glargine 45 units daily,,2,,,,,,,,,,,,,,2021,Q1,Peripheral swelling,,2021,Q1,1,I,20201118.0,,20210305,20210305,DIR,,,FDA-CTU,,68.0,YR,,F,N,77.5,KG,20210305.0,N,PH,US,US,2021,Q1,Elderly
189799481,18979948,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Drug abuse,,2021,Q1,1,I,,20210216.0,20210308,20210308,EXP,,GR-ACCORD-219334,ACCORD,"PAPAIOANNOU I, PANTAZIDOU G, CHATZIPERI S, BAIKOUSIS A, KOROVESSIS P. GLUTEAL COMPARTMENT SYNDROME? THE MISSING DIAGNOSIS. CASE PRESENTATION AND BRIEF LITERATURE REVIEW. SURGICAL CHRONICLES. 2020? 25(4): 378?380.",47.0,YR,A,F,Y,,,20210308.0,,MD,GR,GR,2021,Q1,Adult
189799481,18979948,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Labelled drug-food interaction issue,,2021,Q1,1,I,,20210216.0,20210308,20210308,EXP,,GR-ACCORD-219334,ACCORD,"PAPAIOANNOU I, PANTAZIDOU G, CHATZIPERI S, BAIKOUSIS A, KOROVESSIS P. GLUTEAL COMPARTMENT SYNDROME? THE MISSING DIAGNOSIS. CASE PRESENTATION AND BRIEF LITERATURE REVIEW. SURGICAL CHRONICLES. 2020? 25(4): 378?380.",47.0,YR,A,F,Y,,,20210308.0,,MD,GR,GR,2021,Q1,Adult
189799481,18979948,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Rhabdomyolysis,,2021,Q1,1,I,,20210216.0,20210308,20210308,EXP,,GR-ACCORD-219334,ACCORD,"PAPAIOANNOU I, PANTAZIDOU G, CHATZIPERI S, BAIKOUSIS A, KOROVESSIS P. GLUTEAL COMPARTMENT SYNDROME? THE MISSING DIAGNOSIS. CASE PRESENTATION AND BRIEF LITERATURE REVIEW. SURGICAL CHRONICLES. 2020? 25(4): 378?380.",47.0,YR,A,F,Y,,,20210308.0,,MD,GR,GR,2021,Q1,Adult
189803001,18980300,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Drug interaction,,2021,Q1,1,I,,20210223.0,20210308,20210308,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK052514,GLENMARK,"ROBINSON ZS, ARVIN JP, MADDING KL.. RIVAROXABAN FAILURE IN A PATIENT TAKING OXCARBAZEPINE.. ANNALS OF PHARMACOTHERAPY.. 2021?1?2",28.0,YR,,M,Y,146.0,KG,20210308.0,,PH,US,US,2021,Q1,Young Adult
189803001,18980300,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Drug level decreased,,2021,Q1,1,I,,20210223.0,20210308,20210308,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK052514,GLENMARK,"ROBINSON ZS, ARVIN JP, MADDING KL.. RIVAROXABAN FAILURE IN A PATIENT TAKING OXCARBAZEPINE.. ANNALS OF PHARMACOTHERAPY.. 2021?1?2",28.0,YR,,M,Y,146.0,KG,20210308.0,,PH,US,US,2021,Q1,Young Adult
189803001,18980300,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Loss of consciousness,,2021,Q1,1,I,,20210223.0,20210308,20210308,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK052514,GLENMARK,"ROBINSON ZS, ARVIN JP, MADDING KL.. RIVAROXABAN FAILURE IN A PATIENT TAKING OXCARBAZEPINE.. ANNALS OF PHARMACOTHERAPY.. 2021?1?2",28.0,YR,,M,Y,146.0,KG,20210308.0,,PH,US,US,2021,Q1,Young Adult
189803001,18980300,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Pulmonary embolism,,2021,Q1,1,I,,20210223.0,20210308,20210308,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK052514,GLENMARK,"ROBINSON ZS, ARVIN JP, MADDING KL.. RIVAROXABAN FAILURE IN A PATIENT TAKING OXCARBAZEPINE.. ANNALS OF PHARMACOTHERAPY.. 2021?1?2",28.0,YR,,M,Y,146.0,KG,20210308.0,,PH,US,US,2021,Q1,Young Adult
189803001,18980300,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Treatment failure,,2021,Q1,1,I,,20210223.0,20210308,20210308,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK052514,GLENMARK,"ROBINSON ZS, ARVIN JP, MADDING KL.. RIVAROXABAN FAILURE IN A PATIENT TAKING OXCARBAZEPINE.. ANNALS OF PHARMACOTHERAPY.. 2021?1?2",28.0,YR,,M,Y,146.0,KG,20210308.0,,PH,US,US,2021,Q1,Young Adult
189819271,18981927,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q1,Alcohol abuse,,2021,Q1,1,I,,20210224.0,20210308,20210308,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202102013190,ELI LILLY AND CO,"PAPAIOANNOU I, PANTAZIDOU G, CHATZIPERI S, BAIKOUSIS A, KOROVESSIS P.GLUTEAL COMPARTMENT SYNDROME? THE MISSING DIAGNOSIS. CASE PRESENTATION AND BRIEF LITERATURE REVIE.SURG CHRON 2020?25(4):378?380.",47.0,YR,,F,Y,,,20210308.0,,MD,GR,GR,2021,Q1,Adult
189819271,18981927,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q1,Communication disorder,,2021,Q1,1,I,,20210224.0,20210308,20210308,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202102013190,ELI LILLY AND CO,"PAPAIOANNOU I, PANTAZIDOU G, CHATZIPERI S, BAIKOUSIS A, KOROVESSIS P.GLUTEAL COMPARTMENT SYNDROME? THE MISSING DIAGNOSIS. CASE PRESENTATION AND BRIEF LITERATURE REVIE.SURG CHRON 2020?25(4):378?380.",47.0,YR,,F,Y,,,20210308.0,,MD,GR,GR,2021,Q1,Adult
189819271,18981927,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q1,Compartment syndrome,,2021,Q1,1,I,,20210224.0,20210308,20210308,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202102013190,ELI LILLY AND CO,"PAPAIOANNOU I, PANTAZIDOU G, CHATZIPERI S, BAIKOUSIS A, KOROVESSIS P.GLUTEAL COMPARTMENT SYNDROME? THE MISSING DIAGNOSIS. CASE PRESENTATION AND BRIEF LITERATURE REVIE.SURG CHRON 2020?25(4):378?380.",47.0,YR,,F,Y,,,20210308.0,,MD,GR,GR,2021,Q1,Adult
189819271,18981927,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q1,Drug abuse,,2021,Q1,1,I,,20210224.0,20210308,20210308,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202102013190,ELI LILLY AND CO,"PAPAIOANNOU I, PANTAZIDOU G, CHATZIPERI S, BAIKOUSIS A, KOROVESSIS P.GLUTEAL COMPARTMENT SYNDROME? THE MISSING DIAGNOSIS. CASE PRESENTATION AND BRIEF LITERATURE REVIE.SURG CHRON 2020?25(4):378?380.",47.0,YR,,F,Y,,,20210308.0,,MD,GR,GR,2021,Q1,Adult
189819271,18981927,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q1,Heart rate increased,,2021,Q1,1,I,,20210224.0,20210308,20210308,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202102013190,ELI LILLY AND CO,"PAPAIOANNOU I, PANTAZIDOU G, CHATZIPERI S, BAIKOUSIS A, KOROVESSIS P.GLUTEAL COMPARTMENT SYNDROME? THE MISSING DIAGNOSIS. CASE PRESENTATION AND BRIEF LITERATURE REVIE.SURG CHRON 2020?25(4):378?380.",47.0,YR,,F,Y,,,20210308.0,,MD,GR,GR,2021,Q1,Adult
189819271,18981927,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q1,Hypotension,,2021,Q1,1,I,,20210224.0,20210308,20210308,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202102013190,ELI LILLY AND CO,"PAPAIOANNOU I, PANTAZIDOU G, CHATZIPERI S, BAIKOUSIS A, KOROVESSIS P.GLUTEAL COMPARTMENT SYNDROME? THE MISSING DIAGNOSIS. CASE PRESENTATION AND BRIEF LITERATURE REVIE.SURG CHRON 2020?25(4):378?380.",47.0,YR,,F,Y,,,20210308.0,,MD,GR,GR,2021,Q1,Adult
189819271,18981927,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q1,Liver disorder,,2021,Q1,1,I,,20210224.0,20210308,20210308,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202102013190,ELI LILLY AND CO,"PAPAIOANNOU I, PANTAZIDOU G, CHATZIPERI S, BAIKOUSIS A, KOROVESSIS P.GLUTEAL COMPARTMENT SYNDROME? THE MISSING DIAGNOSIS. CASE PRESENTATION AND BRIEF LITERATURE REVIE.SURG CHRON 2020?25(4):378?380.",47.0,YR,,F,Y,,,20210308.0,,MD,GR,GR,2021,Q1,Adult
189819271,18981927,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q1,Loss of consciousness,,2021,Q1,1,I,,20210224.0,20210308,20210308,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202102013190,ELI LILLY AND CO,"PAPAIOANNOU I, PANTAZIDOU G, CHATZIPERI S, BAIKOUSIS A, KOROVESSIS P.GLUTEAL COMPARTMENT SYNDROME? THE MISSING DIAGNOSIS. CASE PRESENTATION AND BRIEF LITERATURE REVIE.SURG CHRON 2020?25(4):378?380.",47.0,YR,,F,Y,,,20210308.0,,MD,GR,GR,2021,Q1,Adult
189819271,18981927,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q1,Oxygen saturation decreased,,2021,Q1,1,I,,20210224.0,20210308,20210308,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202102013190,ELI LILLY AND CO,"PAPAIOANNOU I, PANTAZIDOU G, CHATZIPERI S, BAIKOUSIS A, KOROVESSIS P.GLUTEAL COMPARTMENT SYNDROME? THE MISSING DIAGNOSIS. CASE PRESENTATION AND BRIEF LITERATURE REVIE.SURG CHRON 2020?25(4):378?380.",47.0,YR,,F,Y,,,20210308.0,,MD,GR,GR,2021,Q1,Adult
189819271,18981927,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q1,Renal impairment,,2021,Q1,1,I,,20210224.0,20210308,20210308,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202102013190,ELI LILLY AND CO,"PAPAIOANNOU I, PANTAZIDOU G, CHATZIPERI S, BAIKOUSIS A, KOROVESSIS P.GLUTEAL COMPARTMENT SYNDROME? THE MISSING DIAGNOSIS. CASE PRESENTATION AND BRIEF LITERATURE REVIE.SURG CHRON 2020?25(4):378?380.",47.0,YR,,F,Y,,,20210308.0,,MD,GR,GR,2021,Q1,Adult
189819271,18981927,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q1,Respiratory rate increased,,2021,Q1,1,I,,20210224.0,20210308,20210308,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202102013190,ELI LILLY AND CO,"PAPAIOANNOU I, PANTAZIDOU G, CHATZIPERI S, BAIKOUSIS A, KOROVESSIS P.GLUTEAL COMPARTMENT SYNDROME? THE MISSING DIAGNOSIS. CASE PRESENTATION AND BRIEF LITERATURE REVIE.SURG CHRON 2020?25(4):378?380.",47.0,YR,,F,Y,,,20210308.0,,MD,GR,GR,2021,Q1,Adult
189819271,18981927,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q1,Rhabdomyolysis,,2021,Q1,1,I,,20210224.0,20210308,20210308,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202102013190,ELI LILLY AND CO,"PAPAIOANNOU I, PANTAZIDOU G, CHATZIPERI S, BAIKOUSIS A, KOROVESSIS P.GLUTEAL COMPARTMENT SYNDROME? THE MISSING DIAGNOSIS. CASE PRESENTATION AND BRIEF LITERATURE REVIE.SURG CHRON 2020?25(4):378?380.",47.0,YR,,F,Y,,,20210308.0,,MD,GR,GR,2021,Q1,Adult
189819271,18981927,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q1,Toxicity to various agents,,2021,Q1,1,I,,20210224.0,20210308,20210308,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202102013190,ELI LILLY AND CO,"PAPAIOANNOU I, PANTAZIDOU G, CHATZIPERI S, BAIKOUSIS A, KOROVESSIS P.GLUTEAL COMPARTMENT SYNDROME? THE MISSING DIAGNOSIS. CASE PRESENTATION AND BRIEF LITERATURE REVIE.SURG CHRON 2020?25(4):378?380.",47.0,YR,,F,Y,,,20210308.0,,MD,GR,GR,2021,Q1,Adult
189820421,18982042,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD (26 IE, 0?0?0?1, AMPOULE)",,,U,,,,,26.0,IU,,QD,2021,Q1,Abdominal pain,,2021,Q1,1,I,,20210301.0,20210308,20210308,EXP,,DE-GLAXOSMITHKLINE-DECH2021010081,GLAXOSMITHKLINE,,70.0,YR,,F,Y,,,20210308.0,,PH,DE,DE,2021,Q1,Elderly
189820421,18982042,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD (26 IE, 0?0?0?1, AMPOULE)",,,U,,,,,26.0,IU,,QD,2021,Q1,Anaemia,,2021,Q1,1,I,,20210301.0,20210308,20210308,EXP,,DE-GLAXOSMITHKLINE-DECH2021010081,GLAXOSMITHKLINE,,70.0,YR,,F,Y,,,20210308.0,,PH,DE,DE,2021,Q1,Elderly
189820421,18982042,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD (26 IE, 0?0?0?1, AMPOULE)",,,U,,,,,26.0,IU,,QD,2021,Q1,Fatigue,,2021,Q1,1,I,,20210301.0,20210308,20210308,EXP,,DE-GLAXOSMITHKLINE-DECH2021010081,GLAXOSMITHKLINE,,70.0,YR,,F,Y,,,20210308.0,,PH,DE,DE,2021,Q1,Elderly
189820421,18982042,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD (26 IE, 0?0?0?1, AMPOULE)",,,U,,,,,26.0,IU,,QD,2021,Q1,General physical health deterioration,,2021,Q1,1,I,,20210301.0,20210308,20210308,EXP,,DE-GLAXOSMITHKLINE-DECH2021010081,GLAXOSMITHKLINE,,70.0,YR,,F,Y,,,20210308.0,,PH,DE,DE,2021,Q1,Elderly
189820421,18982042,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD (26 IE, 0?0?0?1, AMPOULE)",,,U,,,,,26.0,IU,,QD,2021,Q1,Musculoskeletal pain,,2021,Q1,1,I,,20210301.0,20210308,20210308,EXP,,DE-GLAXOSMITHKLINE-DECH2021010081,GLAXOSMITHKLINE,,70.0,YR,,F,Y,,,20210308.0,,PH,DE,DE,2021,Q1,Elderly
189820421,18982042,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD (26 IE, 0?0?0?1, AMPOULE)",,,U,,,,,26.0,IU,,QD,2021,Q1,Pallor,,2021,Q1,1,I,,20210301.0,20210308,20210308,EXP,,DE-GLAXOSMITHKLINE-DECH2021010081,GLAXOSMITHKLINE,,70.0,YR,,F,Y,,,20210308.0,,PH,DE,DE,2021,Q1,Elderly
189820471,18982047,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q1,Arthralgia,,2021,Q1,1,I,,20210301.0,20210308,20210308,EXP,,DE-GLAXOSMITHKLINE-DECH2021010082,GLAXOSMITHKLINE,,74.0,YR,,M,Y,64.0,KG,20210308.0,,PH,DE,DE,2021,Q1,Elderly
189820471,18982047,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q1,Contraindicated product administered,,2021,Q1,1,I,,20210301.0,20210308,20210308,EXP,,DE-GLAXOSMITHKLINE-DECH2021010082,GLAXOSMITHKLINE,,74.0,YR,,M,Y,64.0,KG,20210308.0,,PH,DE,DE,2021,Q1,Elderly
189820471,18982047,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q1,Pain,,2021,Q1,1,I,,20210301.0,20210308,20210308,EXP,,DE-GLAXOSMITHKLINE-DECH2021010082,GLAXOSMITHKLINE,,74.0,YR,,M,Y,64.0,KG,20210308.0,,PH,DE,DE,2021,Q1,Elderly
189823272,18982327,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD",,,U,,,,,26.0,IU,,QD,2021,Q1,Abdominal pain,,2021,Q1,2,F,,20210301.0,20210308,20210313,EXP,DE-ADRED-05916-01,NVSC2021DE047191,NOVARTIS,,70.0,YR,,F,Y,,,20210313.0,,CN,GB,DE,2021,Q1,Elderly
189823272,18982327,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD",,,U,,,,,26.0,IU,,QD,2021,Q1,Anaemia,,2021,Q1,2,F,,20210301.0,20210308,20210313,EXP,DE-ADRED-05916-01,NVSC2021DE047191,NOVARTIS,,70.0,YR,,F,Y,,,20210313.0,,CN,GB,DE,2021,Q1,Elderly
189823272,18982327,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD",,,U,,,,,26.0,IU,,QD,2021,Q1,Fatigue,,2021,Q1,2,F,,20210301.0,20210308,20210313,EXP,DE-ADRED-05916-01,NVSC2021DE047191,NOVARTIS,,70.0,YR,,F,Y,,,20210313.0,,CN,GB,DE,2021,Q1,Elderly
189823272,18982327,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD",,,U,,,,,26.0,IU,,QD,2021,Q1,General physical health deterioration,,2021,Q1,2,F,,20210301.0,20210308,20210313,EXP,DE-ADRED-05916-01,NVSC2021DE047191,NOVARTIS,,70.0,YR,,F,Y,,,20210313.0,,CN,GB,DE,2021,Q1,Elderly
189823272,18982327,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD",,,U,,,,,26.0,IU,,QD,2021,Q1,Musculoskeletal pain,,2021,Q1,2,F,,20210301.0,20210308,20210313,EXP,DE-ADRED-05916-01,NVSC2021DE047191,NOVARTIS,,70.0,YR,,F,Y,,,20210313.0,,CN,GB,DE,2021,Q1,Elderly
189823272,18982327,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD",,,U,,,,,26.0,IU,,QD,2021,Q1,Pallor,,2021,Q1,2,F,,20210301.0,20210308,20210313,EXP,DE-ADRED-05916-01,NVSC2021DE047191,NOVARTIS,,70.0,YR,,F,Y,,,20210313.0,,CN,GB,DE,2021,Q1,Elderly
189835412,18983541,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Cerebrovascular accident,,2021,Q1,2,F,,20210310.0,20210308,20210315,EXP,,GB-009507513-2103GBR001709,MERCK,,72.0,YR,,M,Y,,,20210315.0,,HP,GB,GB,2021,Q1,Elderly
189835412,18983541,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Dysphagia,,2021,Q1,2,F,,20210310.0,20210308,20210315,EXP,,GB-009507513-2103GBR001709,MERCK,,72.0,YR,,M,Y,,,20210315.0,,HP,GB,GB,2021,Q1,Elderly
189837133,18983713,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,46 IU,,,,, 0F784A,,,46.0,IU,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,3,F,20210209.0,20210319.0,20210308,20210330,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20210330.0,,CN,ES,ES,2021,Q1,Adult
189837133,18983713,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,46 IU,,,,, 0F784A,,,46.0,IU,INJECTION,,2021,Q1,Drug ineffective,,2021,Q1,3,F,20210209.0,20210319.0,20210308,20210330,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20210330.0,,CN,ES,ES,2021,Q1,Adult
189837133,18983713,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,46 IU,,,,, 0F784A,,,46.0,IU,INJECTION,,2021,Q1,Fear,,2021,Q1,3,F,20210209.0,20210319.0,20210308,20210330,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20210330.0,,CN,ES,ES,2021,Q1,Adult
189837133,18983713,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,46 IU,,,,, 0F784A,,,46.0,IU,INJECTION,,2021,Q1,Hyperglycaemia,,2021,Q1,3,F,20210209.0,20210319.0,20210308,20210330,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20210330.0,,CN,ES,ES,2021,Q1,Adult
189837133,18983713,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,46 IU,,,,, 0F784A,,,46.0,IU,INJECTION,,2021,Q1,Hypoglycaemia,,2021,Q1,3,F,20210209.0,20210319.0,20210308,20210330,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20210330.0,,CN,ES,ES,2021,Q1,Adult
189837133,18983713,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,46 IU,,,,, 0F784A,,,46.0,IU,INJECTION,,2021,Q1,Malaise,,2021,Q1,3,F,20210209.0,20210319.0,20210308,20210330,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20210330.0,,CN,ES,ES,2021,Q1,Adult
189837133,18983713,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,46 IU,,,,, 0F784A,,,46.0,IU,INJECTION,,2021,Q1,Unhealthy diet,,2021,Q1,3,F,20210209.0,20210319.0,20210308,20210330,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20210330.0,,CN,ES,ES,2021,Q1,Adult
189837133,18983713,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, 0F784A,,,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,3,F,20210209.0,20210319.0,20210308,20210330,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20210330.0,,CN,ES,ES,2021,Q1,Adult
189837133,18983713,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, 0F784A,,,,,INJECTION,,2021,Q1,Drug ineffective,,2021,Q1,3,F,20210209.0,20210319.0,20210308,20210330,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20210330.0,,CN,ES,ES,2021,Q1,Adult
189837133,18983713,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, 0F784A,,,,,INJECTION,,2021,Q1,Fear,,2021,Q1,3,F,20210209.0,20210319.0,20210308,20210330,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20210330.0,,CN,ES,ES,2021,Q1,Adult
189837133,18983713,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, 0F784A,,,,,INJECTION,,2021,Q1,Hyperglycaemia,,2021,Q1,3,F,20210209.0,20210319.0,20210308,20210330,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20210330.0,,CN,ES,ES,2021,Q1,Adult
189837133,18983713,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, 0F784A,,,,,INJECTION,,2021,Q1,Hypoglycaemia,,2021,Q1,3,F,20210209.0,20210319.0,20210308,20210330,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20210330.0,,CN,ES,ES,2021,Q1,Adult
189837133,18983713,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, 0F784A,,,,,INJECTION,,2021,Q1,Malaise,,2021,Q1,3,F,20210209.0,20210319.0,20210308,20210330,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20210330.0,,CN,ES,ES,2021,Q1,Adult
189837133,18983713,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, 0F784A,,,,,INJECTION,,2021,Q1,Unhealthy diet,,2021,Q1,3,F,20210209.0,20210319.0,20210308,20210330,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20210330.0,,CN,ES,ES,2021,Q1,Adult
189866211,18986621,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,54 IU,,,,, DF743A,,,54.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Abdominal discomfort,,2021,Q1,1,I,,20210301.0,20210309,20210309,EXP,,NVSC2021ES047920,NOVARTIS,,70.0,YR,,F,Y,78.0,KG,20210309.0,,HP,ES,ES,2021,Q1,Elderly
189866211,18986621,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,54 IU,,,,, DF743A,,,54.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Arthralgia,,2021,Q1,1,I,,20210301.0,20210309,20210309,EXP,,NVSC2021ES047920,NOVARTIS,,70.0,YR,,F,Y,78.0,KG,20210309.0,,HP,ES,ES,2021,Q1,Elderly
189866211,18986621,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,54 IU,,,,, DF743A,,,54.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,,20210301.0,20210309,20210309,EXP,,NVSC2021ES047920,NOVARTIS,,70.0,YR,,F,Y,78.0,KG,20210309.0,,HP,ES,ES,2021,Q1,Elderly
189866211,18986621,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,54 IU,,,,, DF743A,,,54.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Food craving,,2021,Q1,1,I,,20210301.0,20210309,20210309,EXP,,NVSC2021ES047920,NOVARTIS,,70.0,YR,,F,Y,78.0,KG,20210309.0,,HP,ES,ES,2021,Q1,Elderly
189866211,18986621,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,54 IU,,,,, DF743A,,,54.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Glycosylated haemoglobin increased,,2021,Q1,1,I,,20210301.0,20210309,20210309,EXP,,NVSC2021ES047920,NOVARTIS,,70.0,YR,,F,Y,78.0,KG,20210309.0,,HP,ES,ES,2021,Q1,Elderly
189866211,18986621,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,54 IU,,,,, DF743A,,,54.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Hyperglycaemia,,2021,Q1,1,I,,20210301.0,20210309,20210309,EXP,,NVSC2021ES047920,NOVARTIS,,70.0,YR,,F,Y,78.0,KG,20210309.0,,HP,ES,ES,2021,Q1,Elderly
189866211,18986621,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,54 IU,,,,, DF743A,,,54.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Joint effusion,,2021,Q1,1,I,,20210301.0,20210309,20210309,EXP,,NVSC2021ES047920,NOVARTIS,,70.0,YR,,F,Y,78.0,KG,20210309.0,,HP,ES,ES,2021,Q1,Elderly
189866211,18986621,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,54 IU,,,,, DF743A,,,54.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Osteoarthritis,,2021,Q1,1,I,,20210301.0,20210309,20210309,EXP,,NVSC2021ES047920,NOVARTIS,,70.0,YR,,F,Y,78.0,KG,20210309.0,,HP,ES,ES,2021,Q1,Elderly
189866211,18986621,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,54 IU,,,,, DF743A,,,54.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Unevaluable event,,2021,Q1,1,I,,20210301.0,20210309,20210309,EXP,,NVSC2021ES047920,NOVARTIS,,70.0,YR,,F,Y,78.0,KG,20210309.0,,HP,ES,ES,2021,Q1,Elderly
189866211,18986621,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE INCREASED,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Abdominal discomfort,,2021,Q1,1,I,,20210301.0,20210309,20210309,EXP,,NVSC2021ES047920,NOVARTIS,,70.0,YR,,F,Y,78.0,KG,20210309.0,,HP,ES,ES,2021,Q1,Elderly
189866211,18986621,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE INCREASED,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Arthralgia,,2021,Q1,1,I,,20210301.0,20210309,20210309,EXP,,NVSC2021ES047920,NOVARTIS,,70.0,YR,,F,Y,78.0,KG,20210309.0,,HP,ES,ES,2021,Q1,Elderly
189866211,18986621,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE INCREASED,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,,20210301.0,20210309,20210309,EXP,,NVSC2021ES047920,NOVARTIS,,70.0,YR,,F,Y,78.0,KG,20210309.0,,HP,ES,ES,2021,Q1,Elderly
189866211,18986621,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE INCREASED,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Food craving,,2021,Q1,1,I,,20210301.0,20210309,20210309,EXP,,NVSC2021ES047920,NOVARTIS,,70.0,YR,,F,Y,78.0,KG,20210309.0,,HP,ES,ES,2021,Q1,Elderly
189866211,18986621,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE INCREASED,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Glycosylated haemoglobin increased,,2021,Q1,1,I,,20210301.0,20210309,20210309,EXP,,NVSC2021ES047920,NOVARTIS,,70.0,YR,,F,Y,78.0,KG,20210309.0,,HP,ES,ES,2021,Q1,Elderly
189866211,18986621,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE INCREASED,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Hyperglycaemia,,2021,Q1,1,I,,20210301.0,20210309,20210309,EXP,,NVSC2021ES047920,NOVARTIS,,70.0,YR,,F,Y,78.0,KG,20210309.0,,HP,ES,ES,2021,Q1,Elderly
189866211,18986621,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE INCREASED,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Joint effusion,,2021,Q1,1,I,,20210301.0,20210309,20210309,EXP,,NVSC2021ES047920,NOVARTIS,,70.0,YR,,F,Y,78.0,KG,20210309.0,,HP,ES,ES,2021,Q1,Elderly
189866211,18986621,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE INCREASED,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Osteoarthritis,,2021,Q1,1,I,,20210301.0,20210309,20210309,EXP,,NVSC2021ES047920,NOVARTIS,,70.0,YR,,F,Y,78.0,KG,20210309.0,,HP,ES,ES,2021,Q1,Elderly
189866211,18986621,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE INCREASED,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Unevaluable event,,2021,Q1,1,I,,20210301.0,20210309,20210309,EXP,,NVSC2021ES047920,NOVARTIS,,70.0,YR,,F,Y,78.0,KG,20210309.0,,HP,ES,ES,2021,Q1,Elderly
189875411,18987541,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q1,Hepatosplenic candidiasis,,2021,Q1,1,I,20190109.0,20210301.0,20210309,20210309,EXP,,FR-FRESENIUS KABI-FK202102129,FRESENIUS KABI,,66.0,YR,,F,Y,,,20210309.0,,HP,NL,FR,2021,Q1,Elderly
189931381,18993138,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q1,Arthralgia,,2021,Q1,1,I,,20210301.0,20210310,20210310,EXP,DE-ADRED-04179-01,NVSC2021DE047148,NOVARTIS,,74.0,YR,,M,Y,64.0,KG,20210310.0,,HP,DE,DE,2021,Q1,Elderly
189931381,18993138,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q1,Contraindicated product administered,,2021,Q1,1,I,,20210301.0,20210310,20210310,EXP,DE-ADRED-04179-01,NVSC2021DE047148,NOVARTIS,,74.0,YR,,M,Y,64.0,KG,20210310.0,,HP,DE,DE,2021,Q1,Elderly
189931381,18993138,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q1,Pain,,2021,Q1,1,I,,20210301.0,20210310,20210310,EXP,DE-ADRED-04179-01,NVSC2021DE047148,NOVARTIS,,74.0,YR,,M,Y,64.0,KG,20210310.0,,HP,DE,DE,2021,Q1,Elderly
189932191,18993219,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,20210127.0,20210224.0,20210310,20210310,EXP,GB-MHRA-EYC 00241587,GB-TEVA-2021-GB-1885966,TEVA,,63.0,YR,A,M,Y,65.0,KG,20210310.0,,HP,GB,GB,2021,Q1,Adult
189932191,18993219,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Cognitive disorder,,2021,Q1,1,I,20210127.0,20210224.0,20210310,20210310,EXP,GB-MHRA-EYC 00241587,GB-TEVA-2021-GB-1885966,TEVA,,63.0,YR,A,M,Y,65.0,KG,20210310.0,,HP,GB,GB,2021,Q1,Adult
189932191,18993219,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Dyspnoea,,2021,Q1,1,I,20210127.0,20210224.0,20210310,20210310,EXP,GB-MHRA-EYC 00241587,GB-TEVA-2021-GB-1885966,TEVA,,63.0,YR,A,M,Y,65.0,KG,20210310.0,,HP,GB,GB,2021,Q1,Adult
189932191,18993219,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Oxygen saturation decreased,,2021,Q1,1,I,20210127.0,20210224.0,20210310,20210310,EXP,GB-MHRA-EYC 00241587,GB-TEVA-2021-GB-1885966,TEVA,,63.0,YR,A,M,Y,65.0,KG,20210310.0,,HP,GB,GB,2021,Q1,Adult
189933161,18993316,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,54 IU,,,,, DF743A,,,54.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Abdominal discomfort,,2021,Q1,1,I,,20210301.0,20210310,20210310,EXP,,ES-BAUSCH-BL-2021-007279,BAUSCH AND LOMB,,70.0,YR,,F,Y,78.0,KG,20210310.0,,CN,ES,ES,2021,Q1,Elderly
189933161,18993316,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,54 IU,,,,, DF743A,,,54.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Arthralgia,,2021,Q1,1,I,,20210301.0,20210310,20210310,EXP,,ES-BAUSCH-BL-2021-007279,BAUSCH AND LOMB,,70.0,YR,,F,Y,78.0,KG,20210310.0,,CN,ES,ES,2021,Q1,Elderly
189933161,18993316,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,54 IU,,,,, DF743A,,,54.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,,20210301.0,20210310,20210310,EXP,,ES-BAUSCH-BL-2021-007279,BAUSCH AND LOMB,,70.0,YR,,F,Y,78.0,KG,20210310.0,,CN,ES,ES,2021,Q1,Elderly
189933161,18993316,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,54 IU,,,,, DF743A,,,54.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Food craving,,2021,Q1,1,I,,20210301.0,20210310,20210310,EXP,,ES-BAUSCH-BL-2021-007279,BAUSCH AND LOMB,,70.0,YR,,F,Y,78.0,KG,20210310.0,,CN,ES,ES,2021,Q1,Elderly
189933161,18993316,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,54 IU,,,,, DF743A,,,54.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Glycosylated haemoglobin increased,,2021,Q1,1,I,,20210301.0,20210310,20210310,EXP,,ES-BAUSCH-BL-2021-007279,BAUSCH AND LOMB,,70.0,YR,,F,Y,78.0,KG,20210310.0,,CN,ES,ES,2021,Q1,Elderly
189933161,18993316,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,54 IU,,,,, DF743A,,,54.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Hyperglycaemia,,2021,Q1,1,I,,20210301.0,20210310,20210310,EXP,,ES-BAUSCH-BL-2021-007279,BAUSCH AND LOMB,,70.0,YR,,F,Y,78.0,KG,20210310.0,,CN,ES,ES,2021,Q1,Elderly
189933161,18993316,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,54 IU,,,,, DF743A,,,54.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Joint effusion,,2021,Q1,1,I,,20210301.0,20210310,20210310,EXP,,ES-BAUSCH-BL-2021-007279,BAUSCH AND LOMB,,70.0,YR,,F,Y,78.0,KG,20210310.0,,CN,ES,ES,2021,Q1,Elderly
189933161,18993316,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,54 IU,,,,, DF743A,,,54.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Osteoarthritis,,2021,Q1,1,I,,20210301.0,20210310,20210310,EXP,,ES-BAUSCH-BL-2021-007279,BAUSCH AND LOMB,,70.0,YR,,F,Y,78.0,KG,20210310.0,,CN,ES,ES,2021,Q1,Elderly
189933161,18993316,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,54 IU,,,,, DF743A,,,54.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Unevaluable event,,2021,Q1,1,I,,20210301.0,20210310,20210310,EXP,,ES-BAUSCH-BL-2021-007279,BAUSCH AND LOMB,,70.0,YR,,F,Y,78.0,KG,20210310.0,,CN,ES,ES,2021,Q1,Elderly
189933161,18993316,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,DOSE INCREASED,,,,, DF743A,,,,,SOLUTION FOR INJECTION,,2021,Q1,Abdominal discomfort,,2021,Q1,1,I,,20210301.0,20210310,20210310,EXP,,ES-BAUSCH-BL-2021-007279,BAUSCH AND LOMB,,70.0,YR,,F,Y,78.0,KG,20210310.0,,CN,ES,ES,2021,Q1,Elderly
189933161,18993316,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,DOSE INCREASED,,,,, DF743A,,,,,SOLUTION FOR INJECTION,,2021,Q1,Arthralgia,,2021,Q1,1,I,,20210301.0,20210310,20210310,EXP,,ES-BAUSCH-BL-2021-007279,BAUSCH AND LOMB,,70.0,YR,,F,Y,78.0,KG,20210310.0,,CN,ES,ES,2021,Q1,Elderly
189933161,18993316,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,DOSE INCREASED,,,,, DF743A,,,,,SOLUTION FOR INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,,20210301.0,20210310,20210310,EXP,,ES-BAUSCH-BL-2021-007279,BAUSCH AND LOMB,,70.0,YR,,F,Y,78.0,KG,20210310.0,,CN,ES,ES,2021,Q1,Elderly
189933161,18993316,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,DOSE INCREASED,,,,, DF743A,,,,,SOLUTION FOR INJECTION,,2021,Q1,Food craving,,2021,Q1,1,I,,20210301.0,20210310,20210310,EXP,,ES-BAUSCH-BL-2021-007279,BAUSCH AND LOMB,,70.0,YR,,F,Y,78.0,KG,20210310.0,,CN,ES,ES,2021,Q1,Elderly
189933161,18993316,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,DOSE INCREASED,,,,, DF743A,,,,,SOLUTION FOR INJECTION,,2021,Q1,Glycosylated haemoglobin increased,,2021,Q1,1,I,,20210301.0,20210310,20210310,EXP,,ES-BAUSCH-BL-2021-007279,BAUSCH AND LOMB,,70.0,YR,,F,Y,78.0,KG,20210310.0,,CN,ES,ES,2021,Q1,Elderly
189933161,18993316,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,DOSE INCREASED,,,,, DF743A,,,,,SOLUTION FOR INJECTION,,2021,Q1,Hyperglycaemia,,2021,Q1,1,I,,20210301.0,20210310,20210310,EXP,,ES-BAUSCH-BL-2021-007279,BAUSCH AND LOMB,,70.0,YR,,F,Y,78.0,KG,20210310.0,,CN,ES,ES,2021,Q1,Elderly
189933161,18993316,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,DOSE INCREASED,,,,, DF743A,,,,,SOLUTION FOR INJECTION,,2021,Q1,Joint effusion,,2021,Q1,1,I,,20210301.0,20210310,20210310,EXP,,ES-BAUSCH-BL-2021-007279,BAUSCH AND LOMB,,70.0,YR,,F,Y,78.0,KG,20210310.0,,CN,ES,ES,2021,Q1,Elderly
189933161,18993316,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,DOSE INCREASED,,,,, DF743A,,,,,SOLUTION FOR INJECTION,,2021,Q1,Osteoarthritis,,2021,Q1,1,I,,20210301.0,20210310,20210310,EXP,,ES-BAUSCH-BL-2021-007279,BAUSCH AND LOMB,,70.0,YR,,F,Y,78.0,KG,20210310.0,,CN,ES,ES,2021,Q1,Elderly
189933161,18993316,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,DOSE INCREASED,,,,, DF743A,,,,,SOLUTION FOR INJECTION,,2021,Q1,Unevaluable event,,2021,Q1,1,I,,20210301.0,20210310,20210310,EXP,,ES-BAUSCH-BL-2021-007279,BAUSCH AND LOMB,,70.0,YR,,F,Y,78.0,KG,20210310.0,,CN,ES,ES,2021,Q1,Elderly
189960221,18996022,4,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Acute respiratory failure,,2021,Q1,1,I,,20210301.0,20210311,20210311,EXP,,DE-BAXTER-2021BAX004053,BAXTER,,73.0,YR,,F,Y,,,20210311.0,,PH,DE,DE,2021,Q1,Elderly
189960221,18996022,4,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Condition aggravated,,2021,Q1,1,I,,20210301.0,20210311,20210311,EXP,,DE-BAXTER-2021BAX004053,BAXTER,,73.0,YR,,F,Y,,,20210311.0,,PH,DE,DE,2021,Q1,Elderly
189960221,18996022,4,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Dyspnoea,,2021,Q1,1,I,,20210301.0,20210311,20210311,EXP,,DE-BAXTER-2021BAX004053,BAXTER,,73.0,YR,,F,Y,,,20210311.0,,PH,DE,DE,2021,Q1,Elderly
189960221,18996022,4,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Fatigue,,2021,Q1,1,I,,20210301.0,20210311,20210311,EXP,,DE-BAXTER-2021BAX004053,BAXTER,,73.0,YR,,F,Y,,,20210311.0,,PH,DE,DE,2021,Q1,Elderly
189960221,18996022,4,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,General physical health deterioration,,2021,Q1,1,I,,20210301.0,20210311,20210311,EXP,,DE-BAXTER-2021BAX004053,BAXTER,,73.0,YR,,F,Y,,,20210311.0,,PH,DE,DE,2021,Q1,Elderly
189960221,18996022,4,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Tachycardia,,2021,Q1,1,I,,20210301.0,20210311,20210311,EXP,,DE-BAXTER-2021BAX004053,BAXTER,,73.0,YR,,F,Y,,,20210311.0,,PH,DE,DE,2021,Q1,Elderly
189960221,18996022,4,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Wheezing,,2021,Q1,1,I,,20210301.0,20210311,20210311,EXP,,DE-BAXTER-2021BAX004053,BAXTER,,73.0,YR,,F,Y,,,20210311.0,,PH,DE,DE,2021,Q1,Elderly
189966071,18996607,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Abdominal pain,,2021,Q1,1,I,,20210226.0,20210311,20210311,EXP,,CL-LUPIN PHARMACEUTICALS INC.-2021-03041,LUPIN,,42.0,YR,,M,Y,,,20210311.0,,HP,CL,CL,2021,Q1,Adult
189966071,18996607,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Blood triglycerides increased,,2021,Q1,1,I,,20210226.0,20210311,20210311,EXP,,CL-LUPIN PHARMACEUTICALS INC.-2021-03041,LUPIN,,42.0,YR,,M,Y,,,20210311.0,,HP,CL,CL,2021,Q1,Adult
189966071,18996607,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Rebound effect,,2021,Q1,1,I,,20210226.0,20210311,20210311,EXP,,CL-LUPIN PHARMACEUTICALS INC.-2021-03041,LUPIN,,42.0,YR,,M,Y,,,20210311.0,,HP,CL,CL,2021,Q1,Adult
189974043,18997404,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,12.0,DF,SOLUTION FOR INJECTION,,2021,Q1,Anaemia,,2021,Q1,3,F,20210129.0,20210315.0,20210311,20210327,EXP,IT-MINISAL02-665233,IT-ACCORD-219275,ACCORD,,82.0,YR,,M,Y,,,20210327.0,,MD,IT,IT,2021,Q1,Elderly
189974043,18997404,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,12.0,DF,SOLUTION FOR INJECTION,,2021,Q1,Drug interaction,,2021,Q1,3,F,20210129.0,20210315.0,20210311,20210327,EXP,IT-MINISAL02-665233,IT-ACCORD-219275,ACCORD,,82.0,YR,,M,Y,,,20210327.0,,MD,IT,IT,2021,Q1,Elderly
189992741,18999274,13,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Drug interaction,,2021,Q1,1,I,,20210225.0,20210312,20210312,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-285453,RANBAXY,"ROBINSON ZS, ARVIN JP, MADDING KL. RIVAROXABAN FAILURE IN A PATIENT TAKING OXCARBAZEPINE. ANN PHARMACOTHER. 2021?1?2",28.0,YR,,M,Y,146.0,KG,20210312.0,,HP,US,US,2021,Q1,Young Adult
189992741,18999274,13,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Treatment failure,,2021,Q1,1,I,,20210225.0,20210312,20210312,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-285453,RANBAXY,"ROBINSON ZS, ARVIN JP, MADDING KL. RIVAROXABAN FAILURE IN A PATIENT TAKING OXCARBAZEPINE. ANN PHARMACOTHER. 2021?1?2",28.0,YR,,M,Y,146.0,KG,20210312.0,,HP,US,US,2021,Q1,Young Adult
190007011,19000701,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,,,,,,2021,Q1,Alopecia,,2021,Q1,1,I,,20210310.0,20210311,20210311,EXP,,CA-FRESENIUS KABI-FK202102352,FRESENIUS KABI,,73.0,YR,,M,Y,,,20210311.0,,CN,CA,CA,2021,Q1,Elderly
190007011,19000701,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,,,,,,2021,Q1,Blood creatinine abnormal,,2021,Q1,1,I,,20210310.0,20210311,20210311,EXP,,CA-FRESENIUS KABI-FK202102352,FRESENIUS KABI,,73.0,YR,,M,Y,,,20210311.0,,CN,CA,CA,2021,Q1,Elderly
190007011,19000701,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,,,,,,2021,Q1,Condition aggravated,,2021,Q1,1,I,,20210310.0,20210311,20210311,EXP,,CA-FRESENIUS KABI-FK202102352,FRESENIUS KABI,,73.0,YR,,M,Y,,,20210311.0,,CN,CA,CA,2021,Q1,Elderly
190007011,19000701,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,,,,,,2021,Q1,Constipation,,2021,Q1,1,I,,20210310.0,20210311,20210311,EXP,,CA-FRESENIUS KABI-FK202102352,FRESENIUS KABI,,73.0,YR,,M,Y,,,20210311.0,,CN,CA,CA,2021,Q1,Elderly
190007011,19000701,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,,,,,,2021,Q1,Drug interaction,,2021,Q1,1,I,,20210310.0,20210311,20210311,EXP,,CA-FRESENIUS KABI-FK202102352,FRESENIUS KABI,,73.0,YR,,M,Y,,,20210311.0,,CN,CA,CA,2021,Q1,Elderly
190007011,19000701,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,,,,,,2021,Q1,Dysphonia,,2021,Q1,1,I,,20210310.0,20210311,20210311,EXP,,CA-FRESENIUS KABI-FK202102352,FRESENIUS KABI,,73.0,YR,,M,Y,,,20210311.0,,CN,CA,CA,2021,Q1,Elderly
190007011,19000701,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,,,,,,2021,Q1,Fall,,2021,Q1,1,I,,20210310.0,20210311,20210311,EXP,,CA-FRESENIUS KABI-FK202102352,FRESENIUS KABI,,73.0,YR,,M,Y,,,20210311.0,,CN,CA,CA,2021,Q1,Elderly
190007011,19000701,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,,,,,,2021,Q1,Fatigue,,2021,Q1,1,I,,20210310.0,20210311,20210311,EXP,,CA-FRESENIUS KABI-FK202102352,FRESENIUS KABI,,73.0,YR,,M,Y,,,20210311.0,,CN,CA,CA,2021,Q1,Elderly
190007011,19000701,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,,,,,,2021,Q1,Headache,,2021,Q1,1,I,,20210310.0,20210311,20210311,EXP,,CA-FRESENIUS KABI-FK202102352,FRESENIUS KABI,,73.0,YR,,M,Y,,,20210311.0,,CN,CA,CA,2021,Q1,Elderly
190007011,19000701,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,,,,,,2021,Q1,Malaise,,2021,Q1,1,I,,20210310.0,20210311,20210311,EXP,,CA-FRESENIUS KABI-FK202102352,FRESENIUS KABI,,73.0,YR,,M,Y,,,20210311.0,,CN,CA,CA,2021,Q1,Elderly
190007011,19000701,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,,,,,,2021,Q1,Muscular weakness,,2021,Q1,1,I,,20210310.0,20210311,20210311,EXP,,CA-FRESENIUS KABI-FK202102352,FRESENIUS KABI,,73.0,YR,,M,Y,,,20210311.0,,CN,CA,CA,2021,Q1,Elderly
190007011,19000701,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,,,,,,2021,Q1,Nausea,,2021,Q1,1,I,,20210310.0,20210311,20210311,EXP,,CA-FRESENIUS KABI-FK202102352,FRESENIUS KABI,,73.0,YR,,M,Y,,,20210311.0,,CN,CA,CA,2021,Q1,Elderly
190007011,19000701,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,,,,,,2021,Q1,Renal impairment,,2021,Q1,1,I,,20210310.0,20210311,20210311,EXP,,CA-FRESENIUS KABI-FK202102352,FRESENIUS KABI,,73.0,YR,,M,Y,,,20210311.0,,CN,CA,CA,2021,Q1,Elderly
190007011,19000701,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,,,,,,2021,Q1,Retching,,2021,Q1,1,I,,20210310.0,20210311,20210311,EXP,,CA-FRESENIUS KABI-FK202102352,FRESENIUS KABI,,73.0,YR,,M,Y,,,20210311.0,,CN,CA,CA,2021,Q1,Elderly
190007011,19000701,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,,,,,,2021,Q1,Tremor,,2021,Q1,1,I,,20210310.0,20210311,20210311,EXP,,CA-FRESENIUS KABI-FK202102352,FRESENIUS KABI,,73.0,YR,,M,Y,,,20210311.0,,CN,CA,CA,2021,Q1,Elderly
190007011,19000701,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,,,,,,2021,Q1,Weight decreased,,2021,Q1,1,I,,20210310.0,20210311,20210311,EXP,,CA-FRESENIUS KABI-FK202102352,FRESENIUS KABI,,73.0,YR,,M,Y,,,20210311.0,,CN,CA,CA,2021,Q1,Elderly
190020601,19002060,7,C,INSULIN GLARGINE(GENETICAL RECOMBINATION),INSULIN GLARGINE,1,Unknown,18 CREDITS AT A TIME,,,U,,,,,,,,,2021,Q1,Diabetes mellitus inadequate control,,2021,Q1,1,I,2013.0,20210304.0,20210312,20210312,EXP,,JP-009507513-2103JPN000457J,MERCK,"TAKADA A, YOSHIDA R, TERAWAKI Y, NAGAISHI A, MURASE K, TANABE M, ET AL.. A CASE OF PRADER?WILLI SYNDROME WITH DIABETES MELLITUS ATTEMPTED TO BE TREATED WITH INCRETIN PREPARATIONS. CLINICAL AND EXPERIMENTAL MEDICINE. 2015?92(1):122?7",17.0,YR,,F,Y,76.0,KG,20210312.0,,MD,JP,JP,2021,Q1,Youth
190020601,19002060,7,C,INSULIN GLARGINE(GENETICAL RECOMBINATION),INSULIN GLARGINE,1,Unknown,18 CREDITS AT A TIME,,,U,,,,,,,,,2021,Q1,Drug ineffective,,2021,Q1,1,I,2013.0,20210304.0,20210312,20210312,EXP,,JP-009507513-2103JPN000457J,MERCK,"TAKADA A, YOSHIDA R, TERAWAKI Y, NAGAISHI A, MURASE K, TANABE M, ET AL.. A CASE OF PRADER?WILLI SYNDROME WITH DIABETES MELLITUS ATTEMPTED TO BE TREATED WITH INCRETIN PREPARATIONS. CLINICAL AND EXPERIMENTAL MEDICINE. 2015?92(1):122?7",17.0,YR,,F,Y,76.0,KG,20210312.0,,MD,JP,JP,2021,Q1,Youth
190020601,19002060,8,C,INSULIN GLARGINE(GENETICAL RECOMBINATION),INSULIN GLARGINE,1,Unknown,INCREASED TO 22?24 UNITS / DAY,,,U,,,,,,,,,2021,Q1,Diabetes mellitus inadequate control,,2021,Q1,1,I,2013.0,20210304.0,20210312,20210312,EXP,,JP-009507513-2103JPN000457J,MERCK,"TAKADA A, YOSHIDA R, TERAWAKI Y, NAGAISHI A, MURASE K, TANABE M, ET AL.. A CASE OF PRADER?WILLI SYNDROME WITH DIABETES MELLITUS ATTEMPTED TO BE TREATED WITH INCRETIN PREPARATIONS. CLINICAL AND EXPERIMENTAL MEDICINE. 2015?92(1):122?7",17.0,YR,,F,Y,76.0,KG,20210312.0,,MD,JP,JP,2021,Q1,Youth
190020601,19002060,8,C,INSULIN GLARGINE(GENETICAL RECOMBINATION),INSULIN GLARGINE,1,Unknown,INCREASED TO 22?24 UNITS / DAY,,,U,,,,,,,,,2021,Q1,Drug ineffective,,2021,Q1,1,I,2013.0,20210304.0,20210312,20210312,EXP,,JP-009507513-2103JPN000457J,MERCK,"TAKADA A, YOSHIDA R, TERAWAKI Y, NAGAISHI A, MURASE K, TANABE M, ET AL.. A CASE OF PRADER?WILLI SYNDROME WITH DIABETES MELLITUS ATTEMPTED TO BE TREATED WITH INCRETIN PREPARATIONS. CLINICAL AND EXPERIMENTAL MEDICINE. 2015?92(1):122?7",17.0,YR,,F,Y,76.0,KG,20210312.0,,MD,JP,JP,2021,Q1,Youth
190020601,19002060,9,C,INSULIN GLARGINE(GENETICAL RECOMBINATION),INSULIN GLARGINE,1,Unknown,30 CREDITS OR MORE / DAY,,,U,,,,,,,,,2021,Q1,Diabetes mellitus inadequate control,,2021,Q1,1,I,2013.0,20210304.0,20210312,20210312,EXP,,JP-009507513-2103JPN000457J,MERCK,"TAKADA A, YOSHIDA R, TERAWAKI Y, NAGAISHI A, MURASE K, TANABE M, ET AL.. A CASE OF PRADER?WILLI SYNDROME WITH DIABETES MELLITUS ATTEMPTED TO BE TREATED WITH INCRETIN PREPARATIONS. CLINICAL AND EXPERIMENTAL MEDICINE. 2015?92(1):122?7",17.0,YR,,F,Y,76.0,KG,20210312.0,,MD,JP,JP,2021,Q1,Youth
190020601,19002060,9,C,INSULIN GLARGINE(GENETICAL RECOMBINATION),INSULIN GLARGINE,1,Unknown,30 CREDITS OR MORE / DAY,,,U,,,,,,,,,2021,Q1,Drug ineffective,,2021,Q1,1,I,2013.0,20210304.0,20210312,20210312,EXP,,JP-009507513-2103JPN000457J,MERCK,"TAKADA A, YOSHIDA R, TERAWAKI Y, NAGAISHI A, MURASE K, TANABE M, ET AL.. A CASE OF PRADER?WILLI SYNDROME WITH DIABETES MELLITUS ATTEMPTED TO BE TREATED WITH INCRETIN PREPARATIONS. CLINICAL AND EXPERIMENTAL MEDICINE. 2015?92(1):122?7",17.0,YR,,F,Y,76.0,KG,20210312.0,,MD,JP,JP,2021,Q1,Youth
190020601,19002060,10,C,INSULIN GLARGINE(GENETICAL RECOMBINATION),INSULIN GLARGINE,1,Unknown,34 CREDITS / DAY,,,U,,,,,,,,,2021,Q1,Diabetes mellitus inadequate control,,2021,Q1,1,I,2013.0,20210304.0,20210312,20210312,EXP,,JP-009507513-2103JPN000457J,MERCK,"TAKADA A, YOSHIDA R, TERAWAKI Y, NAGAISHI A, MURASE K, TANABE M, ET AL.. A CASE OF PRADER?WILLI SYNDROME WITH DIABETES MELLITUS ATTEMPTED TO BE TREATED WITH INCRETIN PREPARATIONS. CLINICAL AND EXPERIMENTAL MEDICINE. 2015?92(1):122?7",17.0,YR,,F,Y,76.0,KG,20210312.0,,MD,JP,JP,2021,Q1,Youth
190020601,19002060,10,C,INSULIN GLARGINE(GENETICAL RECOMBINATION),INSULIN GLARGINE,1,Unknown,34 CREDITS / DAY,,,U,,,,,,,,,2021,Q1,Drug ineffective,,2021,Q1,1,I,2013.0,20210304.0,20210312,20210312,EXP,,JP-009507513-2103JPN000457J,MERCK,"TAKADA A, YOSHIDA R, TERAWAKI Y, NAGAISHI A, MURASE K, TANABE M, ET AL.. A CASE OF PRADER?WILLI SYNDROME WITH DIABETES MELLITUS ATTEMPTED TO BE TREATED WITH INCRETIN PREPARATIONS. CLINICAL AND EXPERIMENTAL MEDICINE. 2015?92(1):122?7",17.0,YR,,F,Y,76.0,KG,20210312.0,,MD,JP,JP,2021,Q1,Youth
190027931,19002793,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q1,Acute respiratory failure,,2021,Q1,1,I,,20210301.0,20210312,20210312,EXP,DE-ADRED-05972-01,DE-PFIZER INC-2021227888,PFIZER,,73.0,YR,,F,Y,,,20210312.0,,PH,DE,DE,2021,Q1,Elderly
190027931,19002793,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q1,Condition aggravated,,2021,Q1,1,I,,20210301.0,20210312,20210312,EXP,DE-ADRED-05972-01,DE-PFIZER INC-2021227888,PFIZER,,73.0,YR,,F,Y,,,20210312.0,,PH,DE,DE,2021,Q1,Elderly
190027931,19002793,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q1,Dyspnoea,,2021,Q1,1,I,,20210301.0,20210312,20210312,EXP,DE-ADRED-05972-01,DE-PFIZER INC-2021227888,PFIZER,,73.0,YR,,F,Y,,,20210312.0,,PH,DE,DE,2021,Q1,Elderly
190027931,19002793,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q1,Fatigue,,2021,Q1,1,I,,20210301.0,20210312,20210312,EXP,DE-ADRED-05972-01,DE-PFIZER INC-2021227888,PFIZER,,73.0,YR,,F,Y,,,20210312.0,,PH,DE,DE,2021,Q1,Elderly
190027931,19002793,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q1,General physical health deterioration,,2021,Q1,1,I,,20210301.0,20210312,20210312,EXP,DE-ADRED-05972-01,DE-PFIZER INC-2021227888,PFIZER,,73.0,YR,,F,Y,,,20210312.0,,PH,DE,DE,2021,Q1,Elderly
190027931,19002793,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q1,Tachycardia,,2021,Q1,1,I,,20210301.0,20210312,20210312,EXP,DE-ADRED-05972-01,DE-PFIZER INC-2021227888,PFIZER,,73.0,YR,,F,Y,,,20210312.0,,PH,DE,DE,2021,Q1,Elderly
190027931,19002793,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q1,Wheezing,,2021,Q1,1,I,,20210301.0,20210312,20210312,EXP,DE-ADRED-05972-01,DE-PFIZER INC-2021227888,PFIZER,,73.0,YR,,F,Y,,,20210312.0,,PH,DE,DE,2021,Q1,Elderly
190037961,19003796,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,25.0,IU,,,2021,Q1,Diabetic hyperosmolar coma,,2021,Q1,1,I,20201209.0,20210305.0,20210312,20210312,EXP,,DE-ASTRAZENECA-2021A106876,ASTRAZENECA,,79.0,YR,,F,Y,,,20210312.0,,,DE,DE,2021,Q1,Elderly
190037961,19003796,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,25.0,IU,,,2021,Q1,Ketoacidosis,,2021,Q1,1,I,20201209.0,20210305.0,20210312,20210312,EXP,,DE-ASTRAZENECA-2021A106876,ASTRAZENECA,,79.0,YR,,F,Y,,,20210312.0,,,DE,DE,2021,Q1,Elderly
190046821,19004682,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"10 U, DAILY",,,,, D214960F,,205692.0,10.0,IU,INJECTION,QD,2021,Q1,Amnesia,,2021,Q1,1,I,,20210301.0,20210312,20210312,EXP,,US-ELI_LILLY_AND_COMPANY-US202103001311,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20210312.0,,CN,US,US,2021,Q1,Elderly
190046821,19004682,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"10 U, DAILY",,,,, D214960F,,205692.0,10.0,IU,INJECTION,QD,2021,Q1,Blood glucose increased,,2021,Q1,1,I,,20210301.0,20210312,20210312,EXP,,US-ELI_LILLY_AND_COMPANY-US202103001311,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20210312.0,,CN,US,US,2021,Q1,Elderly
190046821,19004682,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"10 U, DAILY",,,,, D214960F,,205692.0,10.0,IU,INJECTION,QD,2021,Q1,Drug ineffective,,2021,Q1,1,I,,20210301.0,20210312,20210312,EXP,,US-ELI_LILLY_AND_COMPANY-US202103001311,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20210312.0,,CN,US,US,2021,Q1,Elderly
190046821,19004682,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"10 U, DAILY",,,,, D214960F,,205692.0,10.0,IU,INJECTION,QD,2021,Q1,Incorrect dose administered,,2021,Q1,1,I,,20210301.0,20210312,20210312,EXP,,US-ELI_LILLY_AND_COMPANY-US202103001311,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20210312.0,,CN,US,US,2021,Q1,Elderly
190063451,19006345,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION,,2021,Q1,Chronic kidney disease,,2021,Q1,1,I,,20210308.0,20210315,20210315,EXP,,CA-JNJFOC-20210320466,JOHNSON AND JOHNSON,,82.0,YR,E,F,Y,,,20210315.0,,PH,CA,CA,2021,Q1,Elderly
190063451,19006345,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION,,2021,Q1,Haemodialysis,,2021,Q1,1,I,,20210308.0,20210315,20210315,EXP,,CA-JNJFOC-20210320466,JOHNSON AND JOHNSON,,82.0,YR,E,F,Y,,,20210315.0,,PH,CA,CA,2021,Q1,Elderly
190063451,19006345,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION,,2021,Q1,Metabolic acidosis,,2021,Q1,1,I,,20210308.0,20210315,20210315,EXP,,CA-JNJFOC-20210320466,JOHNSON AND JOHNSON,,82.0,YR,E,F,Y,,,20210315.0,,PH,CA,CA,2021,Q1,Elderly
190100781,19010078,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,16 IU,,,U,,,,,16.0,IU,INJECTION,,2021,Q1,Bradycardia,,2021,Q1,1,I,,20210312.0,20210315,20210315,EXP,DE-ADRED-06274-01,NVSC2021DE058715,NOVARTIS,,71.0,YR,,F,Y,,,20210315.0,,HP,DE,DE,2021,Q1,Elderly
190100781,19010078,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,16 IU,,,U,,,,,16.0,IU,INJECTION,,2021,Q1,Dizziness,,2021,Q1,1,I,,20210312.0,20210315,20210315,EXP,DE-ADRED-06274-01,NVSC2021DE058715,NOVARTIS,,71.0,YR,,F,Y,,,20210315.0,,HP,DE,DE,2021,Q1,Elderly
190100781,19010078,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,16 IU,,,U,,,,,16.0,IU,INJECTION,,2021,Q1,Dyspnoea,,2021,Q1,1,I,,20210312.0,20210315,20210315,EXP,DE-ADRED-06274-01,NVSC2021DE058715,NOVARTIS,,71.0,YR,,F,Y,,,20210315.0,,HP,DE,DE,2021,Q1,Elderly
190100781,19010078,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,16 IU,,,U,,,,,16.0,IU,INJECTION,,2021,Q1,General physical health deterioration,,2021,Q1,1,I,,20210312.0,20210315,20210315,EXP,DE-ADRED-06274-01,NVSC2021DE058715,NOVARTIS,,71.0,YR,,F,Y,,,20210315.0,,HP,DE,DE,2021,Q1,Elderly
190100781,19010078,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,16 IU,,,U,,,,,16.0,IU,INJECTION,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,,20210312.0,20210315,20210315,EXP,DE-ADRED-06274-01,NVSC2021DE058715,NOVARTIS,,71.0,YR,,F,Y,,,20210315.0,,HP,DE,DE,2021,Q1,Elderly
190109571,19010957,1,PS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"4 INTERNATIONAL UNIT, DAILY",,,,,,,205692.0,4.0,IU,INJECTION,QD,2021,Q1,Blood glucose decreased,,2021,Q1,1,I,2020.0,20210308.0,20210316,20210316,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202103004123,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210316.0,,CN,JP,JP,2021,Q1,Adult
190109571,19010957,1,PS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"4 INTERNATIONAL UNIT, DAILY",,,,,,,205692.0,4.0,IU,INJECTION,QD,2021,Q1,Diabetes mellitus inadequate control,,2021,Q1,1,I,2020.0,20210308.0,20210316,20210316,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202103004123,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210316.0,,CN,JP,JP,2021,Q1,Adult
190109571,19010957,1,PS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"4 INTERNATIONAL UNIT, DAILY",,,,,,,205692.0,4.0,IU,INJECTION,QD,2021,Q1,Hepatic function abnormal,,2021,Q1,1,I,2020.0,20210308.0,20210316,20210316,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202103004123,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210316.0,,CN,JP,JP,2021,Q1,Adult
190109571,19010957,1,PS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"4 INTERNATIONAL UNIT, DAILY",,,,,,,205692.0,4.0,IU,INJECTION,QD,2021,Q1,Intentional product misuse,,2021,Q1,1,I,2020.0,20210308.0,20210316,20210316,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202103004123,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210316.0,,CN,JP,JP,2021,Q1,Adult
190109571,19010957,1,PS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"4 INTERNATIONAL UNIT, DAILY",,,,,,,205692.0,4.0,IU,INJECTION,QD,2021,Q1,Product dose omission issue,,2021,Q1,1,I,2020.0,20210308.0,20210316,20210316,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202103004123,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210316.0,,CN,JP,JP,2021,Q1,Adult
190109571,19010957,1,PS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"4 INTERNATIONAL UNIT, DAILY",,,,,,,205692.0,4.0,IU,INJECTION,QD,2021,Q1,Waist circumference increased,,2021,Q1,1,I,2020.0,20210308.0,20210316,20210316,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202103004123,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210316.0,,CN,JP,JP,2021,Q1,Adult
190109571,19010957,2,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"8 INTERNATIONAL UNIT, DAILY",,,,,,,205692.0,8.0,IU,INJECTION,QD,2021,Q1,Blood glucose decreased,,2021,Q1,1,I,2020.0,20210308.0,20210316,20210316,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202103004123,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210316.0,,CN,JP,JP,2021,Q1,Adult
190109571,19010957,2,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"8 INTERNATIONAL UNIT, DAILY",,,,,,,205692.0,8.0,IU,INJECTION,QD,2021,Q1,Diabetes mellitus inadequate control,,2021,Q1,1,I,2020.0,20210308.0,20210316,20210316,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202103004123,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210316.0,,CN,JP,JP,2021,Q1,Adult
190109571,19010957,2,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"8 INTERNATIONAL UNIT, DAILY",,,,,,,205692.0,8.0,IU,INJECTION,QD,2021,Q1,Hepatic function abnormal,,2021,Q1,1,I,2020.0,20210308.0,20210316,20210316,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202103004123,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210316.0,,CN,JP,JP,2021,Q1,Adult
190109571,19010957,2,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"8 INTERNATIONAL UNIT, DAILY",,,,,,,205692.0,8.0,IU,INJECTION,QD,2021,Q1,Intentional product misuse,,2021,Q1,1,I,2020.0,20210308.0,20210316,20210316,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202103004123,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210316.0,,CN,JP,JP,2021,Q1,Adult
190109571,19010957,2,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"8 INTERNATIONAL UNIT, DAILY",,,,,,,205692.0,8.0,IU,INJECTION,QD,2021,Q1,Product dose omission issue,,2021,Q1,1,I,2020.0,20210308.0,20210316,20210316,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202103004123,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210316.0,,CN,JP,JP,2021,Q1,Adult
190109571,19010957,2,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"8 INTERNATIONAL UNIT, DAILY",,,,,,,205692.0,8.0,IU,INJECTION,QD,2021,Q1,Waist circumference increased,,2021,Q1,1,I,2020.0,20210308.0,20210316,20210316,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202103004123,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210316.0,,CN,JP,JP,2021,Q1,Adult
190109571,19010957,3,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"12 INTERNATIONAL UNIT, DAILY",,,,,,,205692.0,12.0,IU,INJECTION,QD,2021,Q1,Blood glucose decreased,,2021,Q1,1,I,2020.0,20210308.0,20210316,20210316,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202103004123,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210316.0,,CN,JP,JP,2021,Q1,Adult
190109571,19010957,3,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"12 INTERNATIONAL UNIT, DAILY",,,,,,,205692.0,12.0,IU,INJECTION,QD,2021,Q1,Diabetes mellitus inadequate control,,2021,Q1,1,I,2020.0,20210308.0,20210316,20210316,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202103004123,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210316.0,,CN,JP,JP,2021,Q1,Adult
190109571,19010957,3,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"12 INTERNATIONAL UNIT, DAILY",,,,,,,205692.0,12.0,IU,INJECTION,QD,2021,Q1,Hepatic function abnormal,,2021,Q1,1,I,2020.0,20210308.0,20210316,20210316,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202103004123,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210316.0,,CN,JP,JP,2021,Q1,Adult
190109571,19010957,3,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"12 INTERNATIONAL UNIT, DAILY",,,,,,,205692.0,12.0,IU,INJECTION,QD,2021,Q1,Intentional product misuse,,2021,Q1,1,I,2020.0,20210308.0,20210316,20210316,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202103004123,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210316.0,,CN,JP,JP,2021,Q1,Adult
190109571,19010957,3,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"12 INTERNATIONAL UNIT, DAILY",,,,,,,205692.0,12.0,IU,INJECTION,QD,2021,Q1,Product dose omission issue,,2021,Q1,1,I,2020.0,20210308.0,20210316,20210316,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202103004123,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210316.0,,CN,JP,JP,2021,Q1,Adult
190109571,19010957,3,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"12 INTERNATIONAL UNIT, DAILY",,,,,,,205692.0,12.0,IU,INJECTION,QD,2021,Q1,Waist circumference increased,,2021,Q1,1,I,2020.0,20210308.0,20210316,20210316,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202103004123,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210316.0,,CN,JP,JP,2021,Q1,Adult
190109571,19010957,4,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"20 INTERNATIONAL UNIT, DAILY",,,,,,,205692.0,20.0,IU,INJECTION,QD,2021,Q1,Blood glucose decreased,,2021,Q1,1,I,2020.0,20210308.0,20210316,20210316,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202103004123,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210316.0,,CN,JP,JP,2021,Q1,Adult
190109571,19010957,4,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"20 INTERNATIONAL UNIT, DAILY",,,,,,,205692.0,20.0,IU,INJECTION,QD,2021,Q1,Diabetes mellitus inadequate control,,2021,Q1,1,I,2020.0,20210308.0,20210316,20210316,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202103004123,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210316.0,,CN,JP,JP,2021,Q1,Adult
190109571,19010957,4,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"20 INTERNATIONAL UNIT, DAILY",,,,,,,205692.0,20.0,IU,INJECTION,QD,2021,Q1,Hepatic function abnormal,,2021,Q1,1,I,2020.0,20210308.0,20210316,20210316,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202103004123,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210316.0,,CN,JP,JP,2021,Q1,Adult
190109571,19010957,4,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"20 INTERNATIONAL UNIT, DAILY",,,,,,,205692.0,20.0,IU,INJECTION,QD,2021,Q1,Intentional product misuse,,2021,Q1,1,I,2020.0,20210308.0,20210316,20210316,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202103004123,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210316.0,,CN,JP,JP,2021,Q1,Adult
190109571,19010957,4,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"20 INTERNATIONAL UNIT, DAILY",,,,,,,205692.0,20.0,IU,INJECTION,QD,2021,Q1,Product dose omission issue,,2021,Q1,1,I,2020.0,20210308.0,20210316,20210316,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202103004123,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210316.0,,CN,JP,JP,2021,Q1,Adult
190109571,19010957,4,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"20 INTERNATIONAL UNIT, DAILY",,,,,,,205692.0,20.0,IU,INJECTION,QD,2021,Q1,Waist circumference increased,,2021,Q1,1,I,2020.0,20210308.0,20210316,20210316,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202103004123,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210316.0,,CN,JP,JP,2021,Q1,Adult
190118672,19011867,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD",,,U,,,,,26.0,IU,,QD,2021,Q1,Abdominal pain,,2021,Q1,2,F,,20210301.0,20210315,20210318,EXP,DE-ADRED-05916-01,DE-GLAXOSMITHKLINE-DECH2021013279,GLAXOSMITHKLINE,,70.0,YR,,F,Y,,,20210318.0,,HP,DE,DE,2021,Q1,Elderly
190118672,19011867,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD",,,U,,,,,26.0,IU,,QD,2021,Q1,Anaemia,,2021,Q1,2,F,,20210301.0,20210315,20210318,EXP,DE-ADRED-05916-01,DE-GLAXOSMITHKLINE-DECH2021013279,GLAXOSMITHKLINE,,70.0,YR,,F,Y,,,20210318.0,,HP,DE,DE,2021,Q1,Elderly
190118672,19011867,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD",,,U,,,,,26.0,IU,,QD,2021,Q1,Fatigue,,2021,Q1,2,F,,20210301.0,20210315,20210318,EXP,DE-ADRED-05916-01,DE-GLAXOSMITHKLINE-DECH2021013279,GLAXOSMITHKLINE,,70.0,YR,,F,Y,,,20210318.0,,HP,DE,DE,2021,Q1,Elderly
190118672,19011867,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD",,,U,,,,,26.0,IU,,QD,2021,Q1,General physical health deterioration,,2021,Q1,2,F,,20210301.0,20210315,20210318,EXP,DE-ADRED-05916-01,DE-GLAXOSMITHKLINE-DECH2021013279,GLAXOSMITHKLINE,,70.0,YR,,F,Y,,,20210318.0,,HP,DE,DE,2021,Q1,Elderly
190118672,19011867,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD",,,U,,,,,26.0,IU,,QD,2021,Q1,Musculoskeletal pain,,2021,Q1,2,F,,20210301.0,20210315,20210318,EXP,DE-ADRED-05916-01,DE-GLAXOSMITHKLINE-DECH2021013279,GLAXOSMITHKLINE,,70.0,YR,,F,Y,,,20210318.0,,HP,DE,DE,2021,Q1,Elderly
190118672,19011867,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD",,,U,,,,,26.0,IU,,QD,2021,Q1,Pallor,,2021,Q1,2,F,,20210301.0,20210315,20210318,EXP,DE-ADRED-05916-01,DE-GLAXOSMITHKLINE-DECH2021013279,GLAXOSMITHKLINE,,70.0,YR,,F,Y,,,20210318.0,,HP,DE,DE,2021,Q1,Elderly
190118701,19011870,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,54 IU,,,,, DF743A,,,54.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Abdominal discomfort,,2021,Q1,1,I,,20210301.0,20210315,20210315,EXP,,ES-GLAXOSMITHKLINE-ESCH2021012059,GLAXOSMITHKLINE,,70.0,YR,,F,Y,,,20210315.0,,CN,ES,ES,2021,Q1,Elderly
190118701,19011870,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,54 IU,,,,, DF743A,,,54.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Arthralgia,,2021,Q1,1,I,,20210301.0,20210315,20210315,EXP,,ES-GLAXOSMITHKLINE-ESCH2021012059,GLAXOSMITHKLINE,,70.0,YR,,F,Y,,,20210315.0,,CN,ES,ES,2021,Q1,Elderly
190118701,19011870,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,54 IU,,,,, DF743A,,,54.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,,20210301.0,20210315,20210315,EXP,,ES-GLAXOSMITHKLINE-ESCH2021012059,GLAXOSMITHKLINE,,70.0,YR,,F,Y,,,20210315.0,,CN,ES,ES,2021,Q1,Elderly
190118701,19011870,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,54 IU,,,,, DF743A,,,54.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Food craving,,2021,Q1,1,I,,20210301.0,20210315,20210315,EXP,,ES-GLAXOSMITHKLINE-ESCH2021012059,GLAXOSMITHKLINE,,70.0,YR,,F,Y,,,20210315.0,,CN,ES,ES,2021,Q1,Elderly
190118701,19011870,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,54 IU,,,,, DF743A,,,54.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Glycosylated haemoglobin increased,,2021,Q1,1,I,,20210301.0,20210315,20210315,EXP,,ES-GLAXOSMITHKLINE-ESCH2021012059,GLAXOSMITHKLINE,,70.0,YR,,F,Y,,,20210315.0,,CN,ES,ES,2021,Q1,Elderly
190118701,19011870,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,54 IU,,,,, DF743A,,,54.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Hyperglycaemia,,2021,Q1,1,I,,20210301.0,20210315,20210315,EXP,,ES-GLAXOSMITHKLINE-ESCH2021012059,GLAXOSMITHKLINE,,70.0,YR,,F,Y,,,20210315.0,,CN,ES,ES,2021,Q1,Elderly
190118701,19011870,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,54 IU,,,,, DF743A,,,54.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Joint effusion,,2021,Q1,1,I,,20210301.0,20210315,20210315,EXP,,ES-GLAXOSMITHKLINE-ESCH2021012059,GLAXOSMITHKLINE,,70.0,YR,,F,Y,,,20210315.0,,CN,ES,ES,2021,Q1,Elderly
190118701,19011870,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,54 IU,,,,, DF743A,,,54.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Osteoarthritis,,2021,Q1,1,I,,20210301.0,20210315,20210315,EXP,,ES-GLAXOSMITHKLINE-ESCH2021012059,GLAXOSMITHKLINE,,70.0,YR,,F,Y,,,20210315.0,,CN,ES,ES,2021,Q1,Elderly
190118701,19011870,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,54 IU,,,,, DF743A,,,54.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Unevaluable event,,2021,Q1,1,I,,20210301.0,20210315,20210315,EXP,,ES-GLAXOSMITHKLINE-ESCH2021012059,GLAXOSMITHKLINE,,70.0,YR,,F,Y,,,20210315.0,,CN,ES,ES,2021,Q1,Elderly
190118701,19011870,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE INCREASED,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Abdominal discomfort,,2021,Q1,1,I,,20210301.0,20210315,20210315,EXP,,ES-GLAXOSMITHKLINE-ESCH2021012059,GLAXOSMITHKLINE,,70.0,YR,,F,Y,,,20210315.0,,CN,ES,ES,2021,Q1,Elderly
190118701,19011870,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE INCREASED,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Arthralgia,,2021,Q1,1,I,,20210301.0,20210315,20210315,EXP,,ES-GLAXOSMITHKLINE-ESCH2021012059,GLAXOSMITHKLINE,,70.0,YR,,F,Y,,,20210315.0,,CN,ES,ES,2021,Q1,Elderly
190118701,19011870,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE INCREASED,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,,20210301.0,20210315,20210315,EXP,,ES-GLAXOSMITHKLINE-ESCH2021012059,GLAXOSMITHKLINE,,70.0,YR,,F,Y,,,20210315.0,,CN,ES,ES,2021,Q1,Elderly
190118701,19011870,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE INCREASED,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Food craving,,2021,Q1,1,I,,20210301.0,20210315,20210315,EXP,,ES-GLAXOSMITHKLINE-ESCH2021012059,GLAXOSMITHKLINE,,70.0,YR,,F,Y,,,20210315.0,,CN,ES,ES,2021,Q1,Elderly
190118701,19011870,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE INCREASED,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Glycosylated haemoglobin increased,,2021,Q1,1,I,,20210301.0,20210315,20210315,EXP,,ES-GLAXOSMITHKLINE-ESCH2021012059,GLAXOSMITHKLINE,,70.0,YR,,F,Y,,,20210315.0,,CN,ES,ES,2021,Q1,Elderly
190118701,19011870,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE INCREASED,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Hyperglycaemia,,2021,Q1,1,I,,20210301.0,20210315,20210315,EXP,,ES-GLAXOSMITHKLINE-ESCH2021012059,GLAXOSMITHKLINE,,70.0,YR,,F,Y,,,20210315.0,,CN,ES,ES,2021,Q1,Elderly
190118701,19011870,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE INCREASED,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Joint effusion,,2021,Q1,1,I,,20210301.0,20210315,20210315,EXP,,ES-GLAXOSMITHKLINE-ESCH2021012059,GLAXOSMITHKLINE,,70.0,YR,,F,Y,,,20210315.0,,CN,ES,ES,2021,Q1,Elderly
190118701,19011870,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE INCREASED,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Osteoarthritis,,2021,Q1,1,I,,20210301.0,20210315,20210315,EXP,,ES-GLAXOSMITHKLINE-ESCH2021012059,GLAXOSMITHKLINE,,70.0,YR,,F,Y,,,20210315.0,,CN,ES,ES,2021,Q1,Elderly
190118701,19011870,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE INCREASED,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Unevaluable event,,2021,Q1,1,I,,20210301.0,20210315,20210315,EXP,,ES-GLAXOSMITHKLINE-ESCH2021012059,GLAXOSMITHKLINE,,70.0,YR,,F,Y,,,20210315.0,,CN,ES,ES,2021,Q1,Elderly
190129861,19012986,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Hyperkalaemia,,2021,Q1,1,I,20210309.0,20210310.0,20210316,20210316,EXP,,US-GLAXOSMITHKLINE-US2021GSK060835,GLAXOSMITHKLINE,,70.0,YR,,M,Y,82.09,KG,20210316.0,,MD,US,US,2021,Q1,Elderly
190129861,19012986,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Hyponatraemia,,2021,Q1,1,I,20210309.0,20210310.0,20210316,20210316,EXP,,US-GLAXOSMITHKLINE-US2021GSK060835,GLAXOSMITHKLINE,,70.0,YR,,M,Y,82.09,KG,20210316.0,,MD,US,US,2021,Q1,Elderly
190130051,19013005,7,C,Insulin glargine 30 units SQ daily,,2,,,,,,,,,,,,,,2021,Q1,Alanine aminotransferase increased,,2021,Q1,1,I,20210211.0,,20210316,20210316,DIR,,,FDA-CTU,,81.0,YR,,M,N,92.3,KG,20210316.0,N,PH,US,US,2021,Q1,Elderly
190140151,19014015,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Blood pressure immeasurable,,2021,Q1,1,I,,20210310.0,20210316,20210316,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202103005270,ELI LILLY AND CO,,72.0,YR,,M,Y,81.0,KG,20210316.0,,PH,CA,CA,2021,Q1,Elderly
190140151,19014015,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Pulse abnormal,,2021,Q1,1,I,,20210310.0,20210316,20210316,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202103005270,ELI LILLY AND CO,,72.0,YR,,M,Y,81.0,KG,20210316.0,,PH,CA,CA,2021,Q1,Elderly
190140151,19014015,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Unresponsive to stimuli,,2021,Q1,1,I,,20210310.0,20210316,20210316,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202103005270,ELI LILLY AND CO,,72.0,YR,,M,Y,81.0,KG,20210316.0,,PH,CA,CA,2021,Q1,Elderly
190154021,19015402,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,202011.0,20210308.0,20210316,20210316,EXP,,CN-ASTRAZENECA-2021A135770,ASTRAZENECA,,55.0,YR,,F,Y,,,20210316.0,,,CN,CN,2021,Q1,Adult
190154021,19015402,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Nausea,,2021,Q1,1,I,202011.0,20210308.0,20210316,20210316,EXP,,CN-ASTRAZENECA-2021A135770,ASTRAZENECA,,55.0,YR,,F,Y,,,20210316.0,,,CN,CN,2021,Q1,Adult
190154021,19015402,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Pyrexia,,2021,Q1,1,I,202011.0,20210308.0,20210316,20210316,EXP,,CN-ASTRAZENECA-2021A135770,ASTRAZENECA,,55.0,YR,,F,Y,,,20210316.0,,,CN,CN,2021,Q1,Adult
190154021,19015402,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Vomiting,,2021,Q1,1,I,202011.0,20210308.0,20210316,20210316,EXP,,CN-ASTRAZENECA-2021A135770,ASTRAZENECA,,55.0,YR,,F,Y,,,20210316.0,,,CN,CN,2021,Q1,Adult
190169862,19016986,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,/month,2021,Q1,COVID-19,,2021,Q1,2,F,20201021.0,20210313.0,20210316,20210322,EXP,,ES-ROCHE-2790416,ROCHE,,35.0,YR,,F,Y,52.0,KG,20210322.0,,MD,ES,ES,2021,Q1,Adult
190190831,19019083,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"16 IE, NACH PLAN, INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,16.0,IU,,,2021,Q1,Bradycardia,,2021,Q1,1,I,,20210310.0,20210316,20210316,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202103005528,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210316.0,,MD,DE,DE,2021,Q1,Elderly
190190831,19019083,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"16 IE, NACH PLAN, INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,16.0,IU,,,2021,Q1,Dizziness,,2021,Q1,1,I,,20210310.0,20210316,20210316,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202103005528,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210316.0,,MD,DE,DE,2021,Q1,Elderly
190190831,19019083,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"16 IE, NACH PLAN, INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,16.0,IU,,,2021,Q1,Dyspnoea,,2021,Q1,1,I,,20210310.0,20210316,20210316,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202103005528,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210316.0,,MD,DE,DE,2021,Q1,Elderly
190190831,19019083,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"16 IE, NACH PLAN, INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,16.0,IU,,,2021,Q1,General physical health deterioration,,2021,Q1,1,I,,20210310.0,20210316,20210316,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202103005528,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210316.0,,MD,DE,DE,2021,Q1,Elderly
190190831,19019083,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"16 IE, NACH PLAN, INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,16.0,IU,,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,,20210310.0,20210316,20210316,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202103005528,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210316.0,,MD,DE,DE,2021,Q1,Elderly
190193161,19019316,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Renal impairment,,2021,Q1,1,I,20190328.0,20190419.0,20210316,20210316,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201904011808,ELI LILLY AND CO,,90.0,YR,,M,Y,,,20210316.0,,MD,JP,JP,2021,Q1,Elderly
190199921,19019992,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNKNOWN,,,,,,,,,,UNKNOWN,,2021,Q1,Acute respiratory failure,,2021,Q1,1,I,,20210303.0,20210317,20210317,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-21-53831,HIKMA,,73.0,YR,,F,Y,,,20210317.0,,PH,DE,DE,2021,Q1,Elderly
190199921,19019992,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNKNOWN,,,,,,,,,,UNKNOWN,,2021,Q1,Condition aggravated,,2021,Q1,1,I,,20210303.0,20210317,20210317,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-21-53831,HIKMA,,73.0,YR,,F,Y,,,20210317.0,,PH,DE,DE,2021,Q1,Elderly
190199921,19019992,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNKNOWN,,,,,,,,,,UNKNOWN,,2021,Q1,Dyspnoea,,2021,Q1,1,I,,20210303.0,20210317,20210317,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-21-53831,HIKMA,,73.0,YR,,F,Y,,,20210317.0,,PH,DE,DE,2021,Q1,Elderly
190199921,19019992,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNKNOWN,,,,,,,,,,UNKNOWN,,2021,Q1,Fatigue,,2021,Q1,1,I,,20210303.0,20210317,20210317,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-21-53831,HIKMA,,73.0,YR,,F,Y,,,20210317.0,,PH,DE,DE,2021,Q1,Elderly
190199921,19019992,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNKNOWN,,,,,,,,,,UNKNOWN,,2021,Q1,General physical health deterioration,,2021,Q1,1,I,,20210303.0,20210317,20210317,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-21-53831,HIKMA,,73.0,YR,,F,Y,,,20210317.0,,PH,DE,DE,2021,Q1,Elderly
190199921,19019992,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNKNOWN,,,,,,,,,,UNKNOWN,,2021,Q1,Tachycardia,,2021,Q1,1,I,,20210303.0,20210317,20210317,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-21-53831,HIKMA,,73.0,YR,,F,Y,,,20210317.0,,PH,DE,DE,2021,Q1,Elderly
190199921,19019992,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNKNOWN,,,,,,,,,,UNKNOWN,,2021,Q1,Wheezing,,2021,Q1,1,I,,20210303.0,20210317,20210317,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-21-53831,HIKMA,,73.0,YR,,F,Y,,,20210317.0,,PH,DE,DE,2021,Q1,Elderly
190201791,19020179,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 UNITS/ML, QDAY, 20 UNIT",,,,,,,,,,SOLUTION,,2021,Q1,Failure to thrive,,2021,Q1,1,I,20210204.0,20210304.0,20210317,20210317,EXP,,US-ACCORD-219593,ACCORD,,57.0,YR,,M,Y,99.0,KG,20210317.0,,HP,US,US,2021,Q1,Adult
190205541,19020554,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"VARIABLE, EVENING",,,,,,,,,,,,2021,Q1,Cryptococcosis,,2021,Q1,1,I,20210206.0,20210308.0,20210317,20210317,EXP,,AU-JNJFOC-20210329775,JOHNSON AND JOHNSON,,52.0,YR,A,M,Y,76.9,KG,20210317.0,,MD,AU,AU,2021,Q1,Adult
190205541,19020554,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"VARIABLE, EVENING",,,,,,,,,,,,2021,Q1,Cytomegalovirus infection,,2021,Q1,1,I,20210206.0,20210308.0,20210317,20210317,EXP,,AU-JNJFOC-20210329775,JOHNSON AND JOHNSON,,52.0,YR,A,M,Y,76.9,KG,20210317.0,,MD,AU,AU,2021,Q1,Adult
190205541,19020554,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,36.0,IU,,QD,2021,Q1,Cryptococcosis,,2021,Q1,1,I,20210206.0,20210308.0,20210317,20210317,EXP,,AU-JNJFOC-20210329775,JOHNSON AND JOHNSON,,52.0,YR,A,M,Y,76.9,KG,20210317.0,,MD,AU,AU,2021,Q1,Adult
190205541,19020554,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,36.0,IU,,QD,2021,Q1,Cytomegalovirus infection,,2021,Q1,1,I,20210206.0,20210308.0,20210317,20210317,EXP,,AU-JNJFOC-20210329775,JOHNSON AND JOHNSON,,52.0,YR,A,M,Y,76.9,KG,20210317.0,,MD,AU,AU,2021,Q1,Adult
190205541,19020554,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,50.0,IU,,QD,2021,Q1,Cryptococcosis,,2021,Q1,1,I,20210206.0,20210308.0,20210317,20210317,EXP,,AU-JNJFOC-20210329775,JOHNSON AND JOHNSON,,52.0,YR,A,M,Y,76.9,KG,20210317.0,,MD,AU,AU,2021,Q1,Adult
190205541,19020554,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,50.0,IU,,QD,2021,Q1,Cytomegalovirus infection,,2021,Q1,1,I,20210206.0,20210308.0,20210317,20210317,EXP,,AU-JNJFOC-20210329775,JOHNSON AND JOHNSON,,52.0,YR,A,M,Y,76.9,KG,20210317.0,,MD,AU,AU,2021,Q1,Adult
190205541,19020554,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,20.0,IU,,QD,2021,Q1,Cryptococcosis,,2021,Q1,1,I,20210206.0,20210308.0,20210317,20210317,EXP,,AU-JNJFOC-20210329775,JOHNSON AND JOHNSON,,52.0,YR,A,M,Y,76.9,KG,20210317.0,,MD,AU,AU,2021,Q1,Adult
190205541,19020554,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,20.0,IU,,QD,2021,Q1,Cytomegalovirus infection,,2021,Q1,1,I,20210206.0,20210308.0,20210317,20210317,EXP,,AU-JNJFOC-20210329775,JOHNSON AND JOHNSON,,52.0,YR,A,M,Y,76.9,KG,20210317.0,,MD,AU,AU,2021,Q1,Adult
190219051,19021905,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Diabetes mellitus inadequate control,,2021,Q1,1,I,201905.0,20210309.0,20210318,20210318,EXP,,PT-EMD SERONO-9225620,EMD SERONO INC,,52.0,YR,A,M,Y,,,20210318.0,,MD,PT,PT,2021,Q1,Adult
190224561,19022456,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 INTERNATIONAL UNIT, ONCE A DAY",,,,,,,,26.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Abdominal pain,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,ES-AUROBINDO-AUR-APL-2021-010542,AUROBINDO,,38.0,YR,,M,Y,,,20210318.0,,CN,ES,ES,2021,Q1,Adult
190224561,19022456,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 INTERNATIONAL UNIT, ONCE A DAY",,,,,,,,26.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Blood glucose increased,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,ES-AUROBINDO-AUR-APL-2021-010542,AUROBINDO,,38.0,YR,,M,Y,,,20210318.0,,CN,ES,ES,2021,Q1,Adult
190224561,19022456,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 INTERNATIONAL UNIT, ONCE A DAY",,,,,,,,26.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Diarrhoea,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,ES-AUROBINDO-AUR-APL-2021-010542,AUROBINDO,,38.0,YR,,M,Y,,,20210318.0,,CN,ES,ES,2021,Q1,Adult
190224561,19022456,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 INTERNATIONAL UNIT, ONCE A DAY",,,,,,,,26.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Haematochezia,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,ES-AUROBINDO-AUR-APL-2021-010542,AUROBINDO,,38.0,YR,,M,Y,,,20210318.0,,CN,ES,ES,2021,Q1,Adult
190224561,19022456,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 INTERNATIONAL UNIT, ONCE A DAY",,,,,,,,26.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Illness,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,ES-AUROBINDO-AUR-APL-2021-010542,AUROBINDO,,38.0,YR,,M,Y,,,20210318.0,,CN,ES,ES,2021,Q1,Adult
190224561,19022456,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 INTERNATIONAL UNIT, ONCE A DAY",,,,,,,,26.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Influenza,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,ES-AUROBINDO-AUR-APL-2021-010542,AUROBINDO,,38.0,YR,,M,Y,,,20210318.0,,CN,ES,ES,2021,Q1,Adult
190224561,19022456,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 INTERNATIONAL UNIT, ONCE A DAY",,,,,,,,26.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Limb discomfort,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,ES-AUROBINDO-AUR-APL-2021-010542,AUROBINDO,,38.0,YR,,M,Y,,,20210318.0,,CN,ES,ES,2021,Q1,Adult
190224561,19022456,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 INTERNATIONAL UNIT, ONCE A DAY",,,,,,,,26.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Weight decreased,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,ES-AUROBINDO-AUR-APL-2021-010542,AUROBINDO,,38.0,YR,,M,Y,,,20210318.0,,CN,ES,ES,2021,Q1,Adult
190233631,19023363,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q1,Abdominal pain,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,CL-TEVA-2021-CL-1890653,TEVA,"JURE B C, SAPIAIN P L, GONZALEZ F S. REFRACTORY SEVERE HYPERTRIGLYCERIDEMIA TREATED WITH APHERESIS. REPORT OF ONE CASE. REV?MED?CHIL 2020?148(9):1362?1367.",42.0,YR,A,M,Y,,,20210318.0,,HP,CL,CL,2021,Q1,Adult
190233631,19023363,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q1,Blood triglycerides increased,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,CL-TEVA-2021-CL-1890653,TEVA,"JURE B C, SAPIAIN P L, GONZALEZ F S. REFRACTORY SEVERE HYPERTRIGLYCERIDEMIA TREATED WITH APHERESIS. REPORT OF ONE CASE. REV?MED?CHIL 2020?148(9):1362?1367.",42.0,YR,A,M,Y,,,20210318.0,,HP,CL,CL,2021,Q1,Adult
190233631,19023363,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q1,Rebound effect,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,CL-TEVA-2021-CL-1890653,TEVA,"JURE B C, SAPIAIN P L, GONZALEZ F S. REFRACTORY SEVERE HYPERTRIGLYCERIDEMIA TREATED WITH APHERESIS. REPORT OF ONE CASE. REV?MED?CHIL 2020?148(9):1362?1367.",42.0,YR,A,M,Y,,,20210318.0,,HP,CL,CL,2021,Q1,Adult
190248231,19024823,3,C,Glargine Insulin,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Blood glucose fluctuation,,2021,Q1,1,I,20201229.0,20210201.0,20210318,20210318,EXP,GB-MHRA-EYC 00239252,GB-TEVA-2021-GB-1876934,TEVA,,75.0,YR,E,M,Y,71.0,KG,20210318.0,,CN,GB,GB,2021,Q1,Elderly
190267811,19026781,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"20 INTERNATIONAL UNIT, DAILY",,,,,,,,20.0,IU,,QD,2021,Q1,Cholecystitis infective,,2021,Q1,1,I,,20210307.0,20210318,20210318,EXP,,US-ELI_LILLY_AND_COMPANY-US202103007875,ELI LILLY AND CO,"BUTLER, J., BJURSTROM, M., MARCEAU, A..POSSIBLE DULAGLUTIDE?ASSOCIATED CHOLECYSTITIS WITH SAFE CONTINUATION POST CHOLECYSTECTOMY.AM J HEALTH?SYST PHARM 2021?:.DOI:10.1093/AJHP/ZXAB045",72.0,YR,,M,Y,111.3,KG,20210318.0,,PH,US,US,2021,Q1,Elderly
190270431,19027043,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"16 IU, ACCORDING TO SCHEDULE,",,,U,,,,,16.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Bradycardia,,2021,Q1,1,I,,20210315.0,20210318,20210318,EXP,DE-BFARM-21002569,DE-SA-2021SA091608,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20210318.0,,MD,DE,DE,2021,Q1,Elderly
190270431,19027043,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"16 IU, ACCORDING TO SCHEDULE,",,,U,,,,,16.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Dizziness,,2021,Q1,1,I,,20210315.0,20210318,20210318,EXP,DE-BFARM-21002569,DE-SA-2021SA091608,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20210318.0,,MD,DE,DE,2021,Q1,Elderly
190270431,19027043,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"16 IU, ACCORDING TO SCHEDULE,",,,U,,,,,16.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Dyspnoea,,2021,Q1,1,I,,20210315.0,20210318,20210318,EXP,DE-BFARM-21002569,DE-SA-2021SA091608,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20210318.0,,MD,DE,DE,2021,Q1,Elderly
190270431,19027043,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"16 IU, ACCORDING TO SCHEDULE,",,,U,,,,,16.0,IU,SOLUTION FOR INJECTION,,2021,Q1,General physical health deterioration,,2021,Q1,1,I,,20210315.0,20210318,20210318,EXP,DE-BFARM-21002569,DE-SA-2021SA091608,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20210318.0,,MD,DE,DE,2021,Q1,Elderly
190270431,19027043,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"16 IU, ACCORDING TO SCHEDULE,",,,U,,,,,16.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,,20210315.0,20210318,20210318,EXP,DE-BFARM-21002569,DE-SA-2021SA091608,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20210318.0,,MD,DE,DE,2021,Q1,Elderly
190292361,19029236,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, UNKNOWN",,,,,,,,18.0,IU,,,2021,Q1,Agitation,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202103004337,ELI LILLY AND CO,,55.0,YR,,M,Y,78.0,KG,20210318.0,,CN,ES,ES,2021,Q1,Adult
190292361,19029236,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, UNKNOWN",,,,,,,,18.0,IU,,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202103004337,ELI LILLY AND CO,,55.0,YR,,M,Y,78.0,KG,20210318.0,,CN,ES,ES,2021,Q1,Adult
190292361,19029236,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, UNKNOWN",,,,,,,,18.0,IU,,,2021,Q1,Cerebrovascular accident,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202103004337,ELI LILLY AND CO,,55.0,YR,,M,Y,78.0,KG,20210318.0,,CN,ES,ES,2021,Q1,Adult
190292361,19029236,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, UNKNOWN",,,,,,,,18.0,IU,,,2021,Q1,Depressed level of consciousness,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202103004337,ELI LILLY AND CO,,55.0,YR,,M,Y,78.0,KG,20210318.0,,CN,ES,ES,2021,Q1,Adult
190292361,19029236,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, UNKNOWN",,,,,,,,18.0,IU,,,2021,Q1,Depressed mood,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202103004337,ELI LILLY AND CO,,55.0,YR,,M,Y,78.0,KG,20210318.0,,CN,ES,ES,2021,Q1,Adult
190292361,19029236,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, UNKNOWN",,,,,,,,18.0,IU,,,2021,Q1,Diabetes mellitus inadequate control,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202103004337,ELI LILLY AND CO,,55.0,YR,,M,Y,78.0,KG,20210318.0,,CN,ES,ES,2021,Q1,Adult
190292361,19029236,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, UNKNOWN",,,,,,,,18.0,IU,,,2021,Q1,Diet noncompliance,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202103004337,ELI LILLY AND CO,,55.0,YR,,M,Y,78.0,KG,20210318.0,,CN,ES,ES,2021,Q1,Adult
190292361,19029236,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, UNKNOWN",,,,,,,,18.0,IU,,,2021,Q1,Dizziness,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202103004337,ELI LILLY AND CO,,55.0,YR,,M,Y,78.0,KG,20210318.0,,CN,ES,ES,2021,Q1,Adult
190292361,19029236,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, UNKNOWN",,,,,,,,18.0,IU,,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202103004337,ELI LILLY AND CO,,55.0,YR,,M,Y,78.0,KG,20210318.0,,CN,ES,ES,2021,Q1,Adult
190292361,19029236,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, UNKNOWN",,,,,,,,18.0,IU,,,2021,Q1,Incorrect dose administered,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202103004337,ELI LILLY AND CO,,55.0,YR,,M,Y,78.0,KG,20210318.0,,CN,ES,ES,2021,Q1,Adult
190292361,19029236,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, UNKNOWN",,,,,,,,18.0,IU,,,2021,Q1,Memory impairment,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202103004337,ELI LILLY AND CO,,55.0,YR,,M,Y,78.0,KG,20210318.0,,CN,ES,ES,2021,Q1,Adult
190292361,19029236,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, UNKNOWN",,,,,,,,18.0,IU,,,2021,Q1,Thrombosis,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202103004337,ELI LILLY AND CO,,55.0,YR,,M,Y,78.0,KG,20210318.0,,CN,ES,ES,2021,Q1,Adult
190292361,19029236,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"24 INTERNATIONAL UNIT, UNKNOWN",,,,, OF784A,,,24.0,IU,,,2021,Q1,Agitation,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202103004337,ELI LILLY AND CO,,55.0,YR,,M,Y,78.0,KG,20210318.0,,CN,ES,ES,2021,Q1,Adult
190292361,19029236,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"24 INTERNATIONAL UNIT, UNKNOWN",,,,, OF784A,,,24.0,IU,,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202103004337,ELI LILLY AND CO,,55.0,YR,,M,Y,78.0,KG,20210318.0,,CN,ES,ES,2021,Q1,Adult
190292361,19029236,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"24 INTERNATIONAL UNIT, UNKNOWN",,,,, OF784A,,,24.0,IU,,,2021,Q1,Cerebrovascular accident,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202103004337,ELI LILLY AND CO,,55.0,YR,,M,Y,78.0,KG,20210318.0,,CN,ES,ES,2021,Q1,Adult
190292361,19029236,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"24 INTERNATIONAL UNIT, UNKNOWN",,,,, OF784A,,,24.0,IU,,,2021,Q1,Depressed level of consciousness,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202103004337,ELI LILLY AND CO,,55.0,YR,,M,Y,78.0,KG,20210318.0,,CN,ES,ES,2021,Q1,Adult
190292361,19029236,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"24 INTERNATIONAL UNIT, UNKNOWN",,,,, OF784A,,,24.0,IU,,,2021,Q1,Depressed mood,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202103004337,ELI LILLY AND CO,,55.0,YR,,M,Y,78.0,KG,20210318.0,,CN,ES,ES,2021,Q1,Adult
190292361,19029236,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"24 INTERNATIONAL UNIT, UNKNOWN",,,,, OF784A,,,24.0,IU,,,2021,Q1,Diabetes mellitus inadequate control,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202103004337,ELI LILLY AND CO,,55.0,YR,,M,Y,78.0,KG,20210318.0,,CN,ES,ES,2021,Q1,Adult
190292361,19029236,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"24 INTERNATIONAL UNIT, UNKNOWN",,,,, OF784A,,,24.0,IU,,,2021,Q1,Diet noncompliance,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202103004337,ELI LILLY AND CO,,55.0,YR,,M,Y,78.0,KG,20210318.0,,CN,ES,ES,2021,Q1,Adult
190292361,19029236,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"24 INTERNATIONAL UNIT, UNKNOWN",,,,, OF784A,,,24.0,IU,,,2021,Q1,Dizziness,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202103004337,ELI LILLY AND CO,,55.0,YR,,M,Y,78.0,KG,20210318.0,,CN,ES,ES,2021,Q1,Adult
190292361,19029236,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"24 INTERNATIONAL UNIT, UNKNOWN",,,,, OF784A,,,24.0,IU,,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202103004337,ELI LILLY AND CO,,55.0,YR,,M,Y,78.0,KG,20210318.0,,CN,ES,ES,2021,Q1,Adult
190292361,19029236,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"24 INTERNATIONAL UNIT, UNKNOWN",,,,, OF784A,,,24.0,IU,,,2021,Q1,Incorrect dose administered,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202103004337,ELI LILLY AND CO,,55.0,YR,,M,Y,78.0,KG,20210318.0,,CN,ES,ES,2021,Q1,Adult
190292361,19029236,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"24 INTERNATIONAL UNIT, UNKNOWN",,,,, OF784A,,,24.0,IU,,,2021,Q1,Memory impairment,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202103004337,ELI LILLY AND CO,,55.0,YR,,M,Y,78.0,KG,20210318.0,,CN,ES,ES,2021,Q1,Adult
190292361,19029236,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"24 INTERNATIONAL UNIT, UNKNOWN",,,,, OF784A,,,24.0,IU,,,2021,Q1,Thrombosis,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202103004337,ELI LILLY AND CO,,55.0,YR,,M,Y,78.0,KG,20210318.0,,CN,ES,ES,2021,Q1,Adult
190311171,19031117,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,HIGH DOSE: 10 UNITS/KG/HR,,,U,U,,,,,,,,2021,Q1,Cardiogenic shock,,2021,Q1,1,I,,20210312.0,20210319,20210319,EXP,,US-MYLANLABS-2021M1016769,MYLAN,"WALTER N, JONES K, HERR D, KACZOROWSKI D, KIM H. CLINICAL CHARACTERISTICS IN CARDIOTOXIC AGENT OVERDOSE NECESSITATING VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION: A CASE SERIES. CLIN?TOXICOL?(PHILA) 2020?58(11):1254?1256 ABSTR. 301.",24.0,YR,,M,Y,,,20210319.0,,HP,US,US,2021,Q1,Young Adult
190311171,19031117,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,HIGH DOSE: 10 UNITS/KG/HR,,,U,U,,,,,,,,2021,Q1,Cardiotoxicity,,2021,Q1,1,I,,20210312.0,20210319,20210319,EXP,,US-MYLANLABS-2021M1016769,MYLAN,"WALTER N, JONES K, HERR D, KACZOROWSKI D, KIM H. CLINICAL CHARACTERISTICS IN CARDIOTOXIC AGENT OVERDOSE NECESSITATING VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION: A CASE SERIES. CLIN?TOXICOL?(PHILA) 2020?58(11):1254?1256 ABSTR. 301.",24.0,YR,,M,Y,,,20210319.0,,HP,US,US,2021,Q1,Young Adult
190311171,19031117,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,HIGH DOSE: 10 UNITS/KG/HR,,,U,U,,,,,,,,2021,Q1,Drug ineffective,,2021,Q1,1,I,,20210312.0,20210319,20210319,EXP,,US-MYLANLABS-2021M1016769,MYLAN,"WALTER N, JONES K, HERR D, KACZOROWSKI D, KIM H. CLINICAL CHARACTERISTICS IN CARDIOTOXIC AGENT OVERDOSE NECESSITATING VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION: A CASE SERIES. CLIN?TOXICOL?(PHILA) 2020?58(11):1254?1256 ABSTR. 301.",24.0,YR,,M,Y,,,20210319.0,,HP,US,US,2021,Q1,Young Adult
190311171,19031117,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,HIGH DOSE: 10 UNITS/KG/HR,,,U,U,,,,,,,,2021,Q1,Overdose,,2021,Q1,1,I,,20210312.0,20210319,20210319,EXP,,US-MYLANLABS-2021M1016769,MYLAN,"WALTER N, JONES K, HERR D, KACZOROWSKI D, KIM H. CLINICAL CHARACTERISTICS IN CARDIOTOXIC AGENT OVERDOSE NECESSITATING VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION: A CASE SERIES. CLIN?TOXICOL?(PHILA) 2020?58(11):1254?1256 ABSTR. 301.",24.0,YR,,M,Y,,,20210319.0,,HP,US,US,2021,Q1,Young Adult
190311171,19031117,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,U,U,,,,,,,,2021,Q1,Cardiogenic shock,,2021,Q1,1,I,,20210312.0,20210319,20210319,EXP,,US-MYLANLABS-2021M1016769,MYLAN,"WALTER N, JONES K, HERR D, KACZOROWSKI D, KIM H. CLINICAL CHARACTERISTICS IN CARDIOTOXIC AGENT OVERDOSE NECESSITATING VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION: A CASE SERIES. CLIN?TOXICOL?(PHILA) 2020?58(11):1254?1256 ABSTR. 301.",24.0,YR,,M,Y,,,20210319.0,,HP,US,US,2021,Q1,Young Adult
190311171,19031117,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,U,U,,,,,,,,2021,Q1,Cardiotoxicity,,2021,Q1,1,I,,20210312.0,20210319,20210319,EXP,,US-MYLANLABS-2021M1016769,MYLAN,"WALTER N, JONES K, HERR D, KACZOROWSKI D, KIM H. CLINICAL CHARACTERISTICS IN CARDIOTOXIC AGENT OVERDOSE NECESSITATING VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION: A CASE SERIES. CLIN?TOXICOL?(PHILA) 2020?58(11):1254?1256 ABSTR. 301.",24.0,YR,,M,Y,,,20210319.0,,HP,US,US,2021,Q1,Young Adult
190311171,19031117,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,U,U,,,,,,,,2021,Q1,Drug ineffective,,2021,Q1,1,I,,20210312.0,20210319,20210319,EXP,,US-MYLANLABS-2021M1016769,MYLAN,"WALTER N, JONES K, HERR D, KACZOROWSKI D, KIM H. CLINICAL CHARACTERISTICS IN CARDIOTOXIC AGENT OVERDOSE NECESSITATING VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION: A CASE SERIES. CLIN?TOXICOL?(PHILA) 2020?58(11):1254?1256 ABSTR. 301.",24.0,YR,,M,Y,,,20210319.0,,HP,US,US,2021,Q1,Young Adult
190311171,19031117,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,U,U,,,,,,,,2021,Q1,Overdose,,2021,Q1,1,I,,20210312.0,20210319,20210319,EXP,,US-MYLANLABS-2021M1016769,MYLAN,"WALTER N, JONES K, HERR D, KACZOROWSKI D, KIM H. CLINICAL CHARACTERISTICS IN CARDIOTOXIC AGENT OVERDOSE NECESSITATING VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION: A CASE SERIES. CLIN?TOXICOL?(PHILA) 2020?58(11):1254?1256 ABSTR. 301.",24.0,YR,,M,Y,,,20210319.0,,HP,US,US,2021,Q1,Young Adult
190311201,19031120,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,HIGH DOSE: 10 UNITS/KG/HR,,,U,U,,,,,,,,2021,Q1,Acute kidney injury,,2021,Q1,1,I,,20210312.0,20210319,20210319,EXP,,US-MYLANLABS-2021M1016768,MYLAN,"WALTER N, JONES K, HERR D, KACZOROWSKI D, KIM H. CLINICAL CHARACTERISTICS IN CARDIOTOXIC AGENT OVERDOSE NECESSITATING VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION: A CASE SERIES. CLIN?TOXICOL?(PHILA) 2020?58(11):1254?1256 ABSTR. 301.",36.0,YR,,M,Y,,,20210319.0,,HP,US,US,2021,Q1,Adult
190311201,19031120,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,HIGH DOSE: 10 UNITS/KG/HR,,,U,U,,,,,,,,2021,Q1,Cardiogenic shock,,2021,Q1,1,I,,20210312.0,20210319,20210319,EXP,,US-MYLANLABS-2021M1016768,MYLAN,"WALTER N, JONES K, HERR D, KACZOROWSKI D, KIM H. CLINICAL CHARACTERISTICS IN CARDIOTOXIC AGENT OVERDOSE NECESSITATING VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION: A CASE SERIES. CLIN?TOXICOL?(PHILA) 2020?58(11):1254?1256 ABSTR. 301.",36.0,YR,,M,Y,,,20210319.0,,HP,US,US,2021,Q1,Adult
190311201,19031120,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,HIGH DOSE: 10 UNITS/KG/HR,,,U,U,,,,,,,,2021,Q1,Cardiotoxicity,,2021,Q1,1,I,,20210312.0,20210319,20210319,EXP,,US-MYLANLABS-2021M1016768,MYLAN,"WALTER N, JONES K, HERR D, KACZOROWSKI D, KIM H. CLINICAL CHARACTERISTICS IN CARDIOTOXIC AGENT OVERDOSE NECESSITATING VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION: A CASE SERIES. CLIN?TOXICOL?(PHILA) 2020?58(11):1254?1256 ABSTR. 301.",36.0,YR,,M,Y,,,20210319.0,,HP,US,US,2021,Q1,Adult
190311201,19031120,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,HIGH DOSE: 10 UNITS/KG/HR,,,U,U,,,,,,,,2021,Q1,Drug ineffective,,2021,Q1,1,I,,20210312.0,20210319,20210319,EXP,,US-MYLANLABS-2021M1016768,MYLAN,"WALTER N, JONES K, HERR D, KACZOROWSKI D, KIM H. CLINICAL CHARACTERISTICS IN CARDIOTOXIC AGENT OVERDOSE NECESSITATING VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION: A CASE SERIES. CLIN?TOXICOL?(PHILA) 2020?58(11):1254?1256 ABSTR. 301.",36.0,YR,,M,Y,,,20210319.0,,HP,US,US,2021,Q1,Adult
190311201,19031120,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,HIGH DOSE: 10 UNITS/KG/HR,,,U,U,,,,,,,,2021,Q1,Overdose,,2021,Q1,1,I,,20210312.0,20210319,20210319,EXP,,US-MYLANLABS-2021M1016768,MYLAN,"WALTER N, JONES K, HERR D, KACZOROWSKI D, KIM H. CLINICAL CHARACTERISTICS IN CARDIOTOXIC AGENT OVERDOSE NECESSITATING VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION: A CASE SERIES. CLIN?TOXICOL?(PHILA) 2020?58(11):1254?1256 ABSTR. 301.",36.0,YR,,M,Y,,,20210319.0,,HP,US,US,2021,Q1,Adult
190311731,19031173,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,HIGH DOSE: 10 UNITS/KG/HR,,,U,U,,,,,,,,2021,Q1,Cardiogenic shock,,2021,Q1,1,I,,20210312.0,20210319,20210319,EXP,,US-MYLANLABS-2021M1016764,MYLAN,"WALTER N, JONES K, HERR D, KACZOROWSKI D, KIM H. CLINICAL CHARACTERISTICS IN CARDIOTOXIC AGENT OVERDOSE NECESSITATING VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION: A CASE SERIES. CLIN?TOXICOL?(PHILA) 2020?58(11):1254?1256 ABSTR. 301.",54.0,YR,,M,Y,,,20210319.0,,HP,US,US,2021,Q1,Adult
190311731,19031173,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,HIGH DOSE: 10 UNITS/KG/HR,,,U,U,,,,,,,,2021,Q1,Cardiotoxicity,,2021,Q1,1,I,,20210312.0,20210319,20210319,EXP,,US-MYLANLABS-2021M1016764,MYLAN,"WALTER N, JONES K, HERR D, KACZOROWSKI D, KIM H. CLINICAL CHARACTERISTICS IN CARDIOTOXIC AGENT OVERDOSE NECESSITATING VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION: A CASE SERIES. CLIN?TOXICOL?(PHILA) 2020?58(11):1254?1256 ABSTR. 301.",54.0,YR,,M,Y,,,20210319.0,,HP,US,US,2021,Q1,Adult
190311731,19031173,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,HIGH DOSE: 10 UNITS/KG/HR,,,U,U,,,,,,,,2021,Q1,Drug ineffective,,2021,Q1,1,I,,20210312.0,20210319,20210319,EXP,,US-MYLANLABS-2021M1016764,MYLAN,"WALTER N, JONES K, HERR D, KACZOROWSKI D, KIM H. CLINICAL CHARACTERISTICS IN CARDIOTOXIC AGENT OVERDOSE NECESSITATING VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION: A CASE SERIES. CLIN?TOXICOL?(PHILA) 2020?58(11):1254?1256 ABSTR. 301.",54.0,YR,,M,Y,,,20210319.0,,HP,US,US,2021,Q1,Adult
190311731,19031173,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,HIGH DOSE: 10 UNITS/KG/HR,,,U,U,,,,,,,,2021,Q1,Overdose,,2021,Q1,1,I,,20210312.0,20210319,20210319,EXP,,US-MYLANLABS-2021M1016764,MYLAN,"WALTER N, JONES K, HERR D, KACZOROWSKI D, KIM H. CLINICAL CHARACTERISTICS IN CARDIOTOXIC AGENT OVERDOSE NECESSITATING VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION: A CASE SERIES. CLIN?TOXICOL?(PHILA) 2020?58(11):1254?1256 ABSTR. 301.",54.0,YR,,M,Y,,,20210319.0,,HP,US,US,2021,Q1,Adult
190311831,19031183,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,HIGH DOSE: 4 UNITS/KG/HR,,,U,U,,,,,,,,2021,Q1,Cardiogenic shock,,2021,Q1,1,I,,20210312.0,20210319,20210319,EXP,,US-MYLANLABS-2021M1016778,MYLAN,"WALTER N, JONES K, HERR D, KACZOROWSKI D, KIM H. CLINICAL CHARACTERISTICS IN CARDIOTOXIC AGENT OVERDOSE NECESSITATING VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION: A CASE SERIES. CLIN?TOXICOL?(PHILA) 2020?58(11):1254?1256 ABSTR. 301.",55.0,YR,,M,Y,,,20210319.0,,HP,US,US,2021,Q1,Adult
190311831,19031183,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,HIGH DOSE: 4 UNITS/KG/HR,,,U,U,,,,,,,,2021,Q1,Cardiotoxicity,,2021,Q1,1,I,,20210312.0,20210319,20210319,EXP,,US-MYLANLABS-2021M1016778,MYLAN,"WALTER N, JONES K, HERR D, KACZOROWSKI D, KIM H. CLINICAL CHARACTERISTICS IN CARDIOTOXIC AGENT OVERDOSE NECESSITATING VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION: A CASE SERIES. CLIN?TOXICOL?(PHILA) 2020?58(11):1254?1256 ABSTR. 301.",55.0,YR,,M,Y,,,20210319.0,,HP,US,US,2021,Q1,Adult
190311831,19031183,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,HIGH DOSE: 4 UNITS/KG/HR,,,U,U,,,,,,,,2021,Q1,Drug ineffective,,2021,Q1,1,I,,20210312.0,20210319,20210319,EXP,,US-MYLANLABS-2021M1016778,MYLAN,"WALTER N, JONES K, HERR D, KACZOROWSKI D, KIM H. CLINICAL CHARACTERISTICS IN CARDIOTOXIC AGENT OVERDOSE NECESSITATING VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION: A CASE SERIES. CLIN?TOXICOL?(PHILA) 2020?58(11):1254?1256 ABSTR. 301.",55.0,YR,,M,Y,,,20210319.0,,HP,US,US,2021,Q1,Adult
190311831,19031183,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,HIGH DOSE: 4 UNITS/KG/HR,,,U,U,,,,,,,,2021,Q1,Overdose,,2021,Q1,1,I,,20210312.0,20210319,20210319,EXP,,US-MYLANLABS-2021M1016778,MYLAN,"WALTER N, JONES K, HERR D, KACZOROWSKI D, KIM H. CLINICAL CHARACTERISTICS IN CARDIOTOXIC AGENT OVERDOSE NECESSITATING VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION: A CASE SERIES. CLIN?TOXICOL?(PHILA) 2020?58(11):1254?1256 ABSTR. 301.",55.0,YR,,M,Y,,,20210319.0,,HP,US,US,2021,Q1,Adult
190345491,19034549,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 U,,,,, G12020060102,,,,,INJECTION,,2021,Q1,Drug-induced liver injury,,2021,Q1,1,I,20210214.0,20210314.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A151167,ASTRAZENECA,,10967.0,DY,,M,Y,46.5,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190345491,19034549,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 U,,,,, G12020060102,,,,,INJECTION,,2021,Q1,Transaminases increased,,2021,Q1,1,I,20210214.0,20210314.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A151167,ASTRAZENECA,,10967.0,DY,,M,Y,46.5,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190349321,19034932,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD",,,,,,,,26.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Abdominal pain,,2021,Q1,1,I,,20210310.0,20210320,20210320,EXP,,NVSC2021ES055654,NOVARTIS,,38.0,YR,,M,Y,,,20210320.0,,HP,ES,ES,2021,Q1,Adult
190349321,19034932,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD",,,,,,,,26.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Blood glucose increased,,2021,Q1,1,I,,20210310.0,20210320,20210320,EXP,,NVSC2021ES055654,NOVARTIS,,38.0,YR,,M,Y,,,20210320.0,,HP,ES,ES,2021,Q1,Adult
190349321,19034932,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD",,,,,,,,26.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Diarrhoea,,2021,Q1,1,I,,20210310.0,20210320,20210320,EXP,,NVSC2021ES055654,NOVARTIS,,38.0,YR,,M,Y,,,20210320.0,,HP,ES,ES,2021,Q1,Adult
190349321,19034932,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD",,,,,,,,26.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Haematochezia,,2021,Q1,1,I,,20210310.0,20210320,20210320,EXP,,NVSC2021ES055654,NOVARTIS,,38.0,YR,,M,Y,,,20210320.0,,HP,ES,ES,2021,Q1,Adult
190349321,19034932,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD",,,,,,,,26.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Illness,,2021,Q1,1,I,,20210310.0,20210320,20210320,EXP,,NVSC2021ES055654,NOVARTIS,,38.0,YR,,M,Y,,,20210320.0,,HP,ES,ES,2021,Q1,Adult
190349321,19034932,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD",,,,,,,,26.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Influenza,,2021,Q1,1,I,,20210310.0,20210320,20210320,EXP,,NVSC2021ES055654,NOVARTIS,,38.0,YR,,M,Y,,,20210320.0,,HP,ES,ES,2021,Q1,Adult
190349321,19034932,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD",,,,,,,,26.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Limb discomfort,,2021,Q1,1,I,,20210310.0,20210320,20210320,EXP,,NVSC2021ES055654,NOVARTIS,,38.0,YR,,M,Y,,,20210320.0,,HP,ES,ES,2021,Q1,Adult
190349321,19034932,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD",,,,,,,,26.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Weight decreased,,2021,Q1,1,I,,20210310.0,20210320,20210320,EXP,,NVSC2021ES055654,NOVARTIS,,38.0,YR,,M,Y,,,20210320.0,,HP,ES,ES,2021,Q1,Adult
190363861,19036386,4,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Bladder cancer,,2021,Q1,1,I,20210302.0,,20210319,20210319,DIR,,,FDA-CTU,,67.0,YR,,M,N,142.0,KG,20210319.0,N,PH,US,US,2021,Q1,Elderly
190366001,19036600,3,SS,INSULIN GLARGINE HUMAN,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,30.0,IU,,HS,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,20210316.0,,20210319,20210319,DIR,,,FDA-CTU,,68.0,YR,,M,N,,,20210319.0,N,PH,US,US,2021,Q1,Elderly
190366001,19036600,3,SS,INSULIN GLARGINE HUMAN,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,30.0,IU,,HS,2021,Q1,Seizure,,2021,Q1,1,I,20210316.0,,20210319,20210319,DIR,,,FDA-CTU,,68.0,YR,,M,N,,,20210319.0,N,PH,US,US,2021,Q1,Elderly
190366101,19036610,8,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Bradycardia,,2021,Q1,1,I,,,20210322,20210322,DIR,,,FDA-CTU,,76.0,YR,,M,N,,,,N,MD,US,US,2021,Q1,Elderly
190366101,19036610,8,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Hypoxia,,2021,Q1,1,I,,,20210322,20210322,DIR,,,FDA-CTU,,76.0,YR,,M,N,,,,N,MD,US,US,2021,Q1,Elderly
190366101,19036610,8,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Tachycardia,,2021,Q1,1,I,,,20210322,20210322,DIR,,,FDA-CTU,,76.0,YR,,M,N,,,,N,MD,US,US,2021,Q1,Elderly
190367201,19036720,3,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Bradycardia,,2021,Q1,1,I,,,20210322,20210322,DIR,,,FDA-CTU,,79.0,YR,,M,N,,,,N,MD,US,US,2021,Q1,Elderly
190392331,19039233,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 UNITS,,,,,,,,,,,QD,2021,Q1,Dehydration,,2021,Q1,1,I,20210223.0,20210310.0,20210322,20210322,EXP,,US-ROCHE-2787925,ROCHE,,67.0,YR,,M,Y,108.0,KG,20210322.0,,MD,US,US,2021,Q1,Elderly
190393731,19039373,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,,,,,,,,,QD,2021,Q1,Cryptococcosis,,2021,Q1,1,I,20210206.0,20210308.0,20210322,20210322,EXP,,AU-TAKEDA-2021TUS017414,TAKEDA,,52.0,YR,,M,Y,76.9,KG,20210322.0,,MD,AU,AU,2021,Q1,Adult
190393731,19039373,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,,,,,,,,,QD,2021,Q1,Cytomegalovirus infection,,2021,Q1,1,I,20210206.0,20210308.0,20210322,20210322,EXP,,AU-TAKEDA-2021TUS017414,TAKEDA,,52.0,YR,,M,Y,76.9,KG,20210322.0,,MD,AU,AU,2021,Q1,Adult
190393731,19039373,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 INTERNATIONAL UNIT, QD",,,,,,,,36.0,IU,,QD,2021,Q1,Cryptococcosis,,2021,Q1,1,I,20210206.0,20210308.0,20210322,20210322,EXP,,AU-TAKEDA-2021TUS017414,TAKEDA,,52.0,YR,,M,Y,76.9,KG,20210322.0,,MD,AU,AU,2021,Q1,Adult
190393731,19039373,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 INTERNATIONAL UNIT, QD",,,,,,,,36.0,IU,,QD,2021,Q1,Cytomegalovirus infection,,2021,Q1,1,I,20210206.0,20210308.0,20210322,20210322,EXP,,AU-TAKEDA-2021TUS017414,TAKEDA,,52.0,YR,,M,Y,76.9,KG,20210322.0,,MD,AU,AU,2021,Q1,Adult
190393731,19039373,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 INTERNATIONAL UNIT, QD",,,,,,,,50.0,IU,,QD,2021,Q1,Cryptococcosis,,2021,Q1,1,I,20210206.0,20210308.0,20210322,20210322,EXP,,AU-TAKEDA-2021TUS017414,TAKEDA,,52.0,YR,,M,Y,76.9,KG,20210322.0,,MD,AU,AU,2021,Q1,Adult
190393731,19039373,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 INTERNATIONAL UNIT, QD",,,,,,,,50.0,IU,,QD,2021,Q1,Cytomegalovirus infection,,2021,Q1,1,I,20210206.0,20210308.0,20210322,20210322,EXP,,AU-TAKEDA-2021TUS017414,TAKEDA,,52.0,YR,,M,Y,76.9,KG,20210322.0,,MD,AU,AU,2021,Q1,Adult
190393731,19039373,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 INTERNATIONAL UNIT, QD",,,,,,,,20.0,IU,,QD,2021,Q1,Cryptococcosis,,2021,Q1,1,I,20210206.0,20210308.0,20210322,20210322,EXP,,AU-TAKEDA-2021TUS017414,TAKEDA,,52.0,YR,,M,Y,76.9,KG,20210322.0,,MD,AU,AU,2021,Q1,Adult
190393731,19039373,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 INTERNATIONAL UNIT, QD",,,,,,,,20.0,IU,,QD,2021,Q1,Cytomegalovirus infection,,2021,Q1,1,I,20210206.0,20210308.0,20210322,20210322,EXP,,AU-TAKEDA-2021TUS017414,TAKEDA,,52.0,YR,,M,Y,76.9,KG,20210322.0,,MD,AU,AU,2021,Q1,Adult
190406632,19040663,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,IN THE EVENING,,,,,,,,38.0,IU,,,2021,Q1,Coma,,2021,Q1,2,F,20210124.0,20210319.0,20210323,20210325,EXP,FR-AFSSAPS-LL20210873,FR-EMD SERONO-E2B_90082830,EMD SERONO INC,,49.0,YR,A,M,Y,,,20210325.0,,MD,FR,FR,2021,Q1,Adult
190406632,19040663,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,IN THE EVENING,,,,,,,,38.0,IU,,,2021,Q1,Hepatic encephalopathy,,2021,Q1,2,F,20210124.0,20210319.0,20210323,20210325,EXP,FR-AFSSAPS-LL20210873,FR-EMD SERONO-E2B_90082830,EMD SERONO INC,,49.0,YR,A,M,Y,,,20210325.0,,MD,FR,FR,2021,Q1,Adult
190406632,19040663,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,IN THE EVENING,,,,,,,,38.0,IU,,,2021,Q1,Lactic acidosis,,2021,Q1,2,F,20210124.0,20210319.0,20210323,20210325,EXP,FR-AFSSAPS-LL20210873,FR-EMD SERONO-E2B_90082830,EMD SERONO INC,,49.0,YR,A,M,Y,,,20210325.0,,MD,FR,FR,2021,Q1,Adult
190417321,19041732,9,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Diabetes mellitus,,2021,Q1,1,I,20200210.0,20210316.0,20210322,20210322,EXP,,NL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-026560,BRISTOL MYERS SQUIBB,,72.0,YR,,F,Y,60.0,KG,20210322.0,,CN,NL,NL,2021,Q1,Elderly
190417321,19041732,9,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Diplopia,,2021,Q1,1,I,20200210.0,20210316.0,20210322,20210322,EXP,,NL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-026560,BRISTOL MYERS SQUIBB,,72.0,YR,,F,Y,60.0,KG,20210322.0,,CN,NL,NL,2021,Q1,Elderly
190417321,19041732,9,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Hepatitis,,2021,Q1,1,I,20200210.0,20210316.0,20210322,20210322,EXP,,NL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-026560,BRISTOL MYERS SQUIBB,,72.0,YR,,F,Y,60.0,KG,20210322.0,,CN,NL,NL,2021,Q1,Elderly
190417321,19041732,9,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Myocarditis,,2021,Q1,1,I,20200210.0,20210316.0,20210322,20210322,EXP,,NL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-026560,BRISTOL MYERS SQUIBB,,72.0,YR,,F,Y,60.0,KG,20210322.0,,CN,NL,NL,2021,Q1,Elderly
190417321,19041732,9,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Myositis,,2021,Q1,1,I,20200210.0,20210316.0,20210322,20210322,EXP,,NL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-026560,BRISTOL MYERS SQUIBB,,72.0,YR,,F,Y,60.0,KG,20210322.0,,CN,NL,NL,2021,Q1,Elderly
190417321,19041732,9,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Thyroiditis,,2021,Q1,1,I,20200210.0,20210316.0,20210322,20210322,EXP,,NL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-026560,BRISTOL MYERS SQUIBB,,72.0,YR,,F,Y,60.0,KG,20210322.0,,CN,NL,NL,2021,Q1,Elderly
190418263,19041826,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 U, QD",200.0,IU,,, G12020060102,,,20.0,IU,,QD,2021,Q1,Drug-induced liver injury,,2021,Q1,3,F,20210214.0,20210325.0,20210322,20210325,EXP,,CN-BAYER-2021-104981,BAYER,,30.0,YR,A,M,Y,46.5,KG,20210325.0,,HP,CN,CN,2021,Q1,Young Adult
190418263,19041826,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 U, QD",200.0,IU,,, G12020060102,,,20.0,IU,,QD,2021,Q1,Transaminases increased,,2021,Q1,3,F,20210214.0,20210325.0,20210322,20210325,EXP,,CN-BAYER-2021-104981,BAYER,,30.0,YR,A,M,Y,46.5,KG,20210325.0,,HP,CN,CN,2021,Q1,Young Adult
190418263,19041826,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 U, TID",200.0,IU,,, G12020060102,,,20.0,IU,,TID,2021,Q1,Drug-induced liver injury,,2021,Q1,3,F,20210214.0,20210325.0,20210322,20210325,EXP,,CN-BAYER-2021-104981,BAYER,,30.0,YR,A,M,Y,46.5,KG,20210325.0,,HP,CN,CN,2021,Q1,Young Adult
190418263,19041826,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 U, TID",200.0,IU,,, G12020060102,,,20.0,IU,,TID,2021,Q1,Transaminases increased,,2021,Q1,3,F,20210214.0,20210325.0,20210322,20210325,EXP,,CN-BAYER-2021-104981,BAYER,,30.0,YR,A,M,Y,46.5,KG,20210325.0,,HP,CN,CN,2021,Q1,Young Adult
190418263,19041826,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 U, TID",200.0,IU,,, G12020060102,,,16.0,IU,,TID,2021,Q1,Drug-induced liver injury,,2021,Q1,3,F,20210214.0,20210325.0,20210322,20210325,EXP,,CN-BAYER-2021-104981,BAYER,,30.0,YR,A,M,Y,46.5,KG,20210325.0,,HP,CN,CN,2021,Q1,Young Adult
190418263,19041826,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 U, TID",200.0,IU,,, G12020060102,,,16.0,IU,,TID,2021,Q1,Transaminases increased,,2021,Q1,3,F,20210214.0,20210325.0,20210322,20210325,EXP,,CN-BAYER-2021-104981,BAYER,,30.0,YR,A,M,Y,46.5,KG,20210325.0,,HP,CN,CN,2021,Q1,Young Adult
190418263,19041826,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 U, TID",200.0,IU,,, G12020060102,,,20.0,IU,,TID,2021,Q1,Drug-induced liver injury,,2021,Q1,3,F,20210214.0,20210325.0,20210322,20210325,EXP,,CN-BAYER-2021-104981,BAYER,,30.0,YR,A,M,Y,46.5,KG,20210325.0,,HP,CN,CN,2021,Q1,Young Adult
190418263,19041826,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 U, TID",200.0,IU,,, G12020060102,,,20.0,IU,,TID,2021,Q1,Transaminases increased,,2021,Q1,3,F,20210214.0,20210325.0,20210322,20210325,EXP,,CN-BAYER-2021-104981,BAYER,,30.0,YR,A,M,Y,46.5,KG,20210325.0,,HP,CN,CN,2021,Q1,Young Adult
190429421,19042942,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2021,Q1,Cardiogenic shock,,2021,Q1,1,I,,20210312.0,20210323,20210323,EXP,,US-STRIDES ARCOLAB LIMITED-2021SP003392,STRIDES,"WALTER N, JONES K, HERR D, KACZOROWSKI D, KIM H.. CLINICAL CHARACTERISTICS IN CARDIOTOXIC AGENT OVERDOSE NECESSITATING VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION: A CASE SERIES. CLIN?TOXICOL?(PHILA). 2020?58(11):1254?1256",24.0,YR,,M,Y,,,20210323.0,,HP,US,US,2021,Q1,Young Adult
190429421,19042942,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2021,Q1,Cardiotoxicity,,2021,Q1,1,I,,20210312.0,20210323,20210323,EXP,,US-STRIDES ARCOLAB LIMITED-2021SP003392,STRIDES,"WALTER N, JONES K, HERR D, KACZOROWSKI D, KIM H.. CLINICAL CHARACTERISTICS IN CARDIOTOXIC AGENT OVERDOSE NECESSITATING VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION: A CASE SERIES. CLIN?TOXICOL?(PHILA). 2020?58(11):1254?1256",24.0,YR,,M,Y,,,20210323.0,,HP,US,US,2021,Q1,Young Adult
190429421,19042942,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2021,Q1,Overdose,,2021,Q1,1,I,,20210312.0,20210323,20210323,EXP,,US-STRIDES ARCOLAB LIMITED-2021SP003392,STRIDES,"WALTER N, JONES K, HERR D, KACZOROWSKI D, KIM H.. CLINICAL CHARACTERISTICS IN CARDIOTOXIC AGENT OVERDOSE NECESSITATING VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION: A CASE SERIES. CLIN?TOXICOL?(PHILA). 2020?58(11):1254?1256",24.0,YR,,M,Y,,,20210323.0,,HP,US,US,2021,Q1,Young Adult
190435641,19043564,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU, QD",,,,,,,21081.0,60.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Scrotal infection,,2021,Q1,1,I,20190511.0,20191105.0,20210323,20210323,EXP,,US-SA-2019SA310719,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20210323.0,,CN,US,US,2021,Q1,Adult
190436141,19043614,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,U300,,,U,,,,,,,,,2021,Q1,Hypothyroidism,,2021,Q1,1,I,,20210317.0,20210322,20210322,EXP,,NVSC2021TR065420,NOVARTIS,"ELBASAN O, YAVUZ DG. REFRACTORY HYPOTHYROIDISM TO LEVOTHYROXINE TREATMENT: FIVE CASES OF PSEUDOMALABSORPTION. ACTA ENDOCRINOLOGICA (BUC). 2020?16(3):339?45",53.0,YR,,F,Y,,,20210322.0,,HP,TR,TR,2021,Q1,Adult
190443401,19044340,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,D,,,,,,,INJECTION,,2021,Q1,Electrocardiogram QT prolonged,,2021,Q1,1,I,,20210315.0,20210323,20210323,EXP,,US-MYLANLABS-2021M1017627,MYLAN,,34.0,YR,,F,Y,,,20210323.0,,MD,US,US,2021,Q1,Young Adult
190443401,19044340,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,D,,,,,,,INJECTION,,2021,Q1,Hyperglycaemia,,2021,Q1,1,I,,20210315.0,20210323,20210323,EXP,,US-MYLANLABS-2021M1017627,MYLAN,,34.0,YR,,F,Y,,,20210323.0,,MD,US,US,2021,Q1,Young Adult
190443401,19044340,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,D,,,,,,,INJECTION,,2021,Q1,Maternal exposure during pregnancy,,2021,Q1,1,I,,20210315.0,20210323,20210323,EXP,,US-MYLANLABS-2021M1017627,MYLAN,,34.0,YR,,F,Y,,,20210323.0,,MD,US,US,2021,Q1,Young Adult
190443401,19044340,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,D,,,,,,,INJECTION,,2021,Q1,Off label use,,2021,Q1,1,I,,20210315.0,20210323,20210323,EXP,,US-MYLANLABS-2021M1017627,MYLAN,,34.0,YR,,F,Y,,,20210323.0,,MD,US,US,2021,Q1,Young Adult
190474751,19047475,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU INTERNATIONAL UNIT(S), QD",,,,,,,,,,,QD,2021,Q1,Abscess jaw,,2021,Q1,1,I,2019.0,20210315.0,20210323,20210323,PER,,US-AMGEN-USASP2021040981,AMGEN,,70.0,YR,E,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190474751,19047475,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU INTERNATIONAL UNIT(S), QD",,,,,,,,,,,QD,2021,Q1,Thyroid cancer,,2021,Q1,1,I,2019.0,20210315.0,20210323,20210323,PER,,US-AMGEN-USASP2021040981,AMGEN,,70.0,YR,E,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190474751,19047475,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Abscess jaw,,2021,Q1,1,I,2019.0,20210315.0,20210323,20210323,PER,,US-AMGEN-USASP2021040981,AMGEN,,70.0,YR,E,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190474751,19047475,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Thyroid cancer,,2021,Q1,1,I,2019.0,20210315.0,20210323,20210323,PER,,US-AMGEN-USASP2021040981,AMGEN,,70.0,YR,E,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483181,19048318,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,26.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Abdominal pain,,2021,Q1,1,I,,20210310.0,20210324,20210324,EXP,,ES-BAUSCH-BL-2021-008719,BAUSCH AND LOMB,,38.0,YR,,M,Y,,,20210324.0,,CN,ES,ES,2021,Q1,Adult
190483181,19048318,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,26.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Blood glucose increased,,2021,Q1,1,I,,20210310.0,20210324,20210324,EXP,,ES-BAUSCH-BL-2021-008719,BAUSCH AND LOMB,,38.0,YR,,M,Y,,,20210324.0,,CN,ES,ES,2021,Q1,Adult
190483181,19048318,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,26.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Diarrhoea,,2021,Q1,1,I,,20210310.0,20210324,20210324,EXP,,ES-BAUSCH-BL-2021-008719,BAUSCH AND LOMB,,38.0,YR,,M,Y,,,20210324.0,,CN,ES,ES,2021,Q1,Adult
190483181,19048318,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,26.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Haematochezia,,2021,Q1,1,I,,20210310.0,20210324,20210324,EXP,,ES-BAUSCH-BL-2021-008719,BAUSCH AND LOMB,,38.0,YR,,M,Y,,,20210324.0,,CN,ES,ES,2021,Q1,Adult
190483181,19048318,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,26.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Illness,,2021,Q1,1,I,,20210310.0,20210324,20210324,EXP,,ES-BAUSCH-BL-2021-008719,BAUSCH AND LOMB,,38.0,YR,,M,Y,,,20210324.0,,CN,ES,ES,2021,Q1,Adult
190483181,19048318,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,26.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Influenza,,2021,Q1,1,I,,20210310.0,20210324,20210324,EXP,,ES-BAUSCH-BL-2021-008719,BAUSCH AND LOMB,,38.0,YR,,M,Y,,,20210324.0,,CN,ES,ES,2021,Q1,Adult
190483181,19048318,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,26.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Limb discomfort,,2021,Q1,1,I,,20210310.0,20210324,20210324,EXP,,ES-BAUSCH-BL-2021-008719,BAUSCH AND LOMB,,38.0,YR,,M,Y,,,20210324.0,,CN,ES,ES,2021,Q1,Adult
190483181,19048318,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,26.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Weight decreased,,2021,Q1,1,I,,20210310.0,20210324,20210324,EXP,,ES-BAUSCH-BL-2021-008719,BAUSCH AND LOMB,,38.0,YR,,M,Y,,,20210324.0,,CN,ES,ES,2021,Q1,Adult
190513891,19051389,4,SS,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Cardiogenic shock,,2021,Q1,1,I,,20210309.0,20210324,20210324,EXP,,"US-COEPTIS PHARMACEUTICALS, INC.-COE-2021-000035",COEPTIS PHARMACEUTICALS,"WALTER N, JONES K, HERR D, KACZOROWSKI D, KIM H. CLINICAL CHARACTERISTICS IN CARDIOTOXIC AGENT OVERDOSE NECESSITATING VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION: A CASE SERIES. CLIN. TOXICOL.. 2020?58 (11):1254?1256. DOI:10.1080/15563650.2020.1804238",24.0,YR,A,M,Y,,,20210318.0,,,COUNTRY NOT SPECIFIED,US,2021,Q1,Young Adult
190513891,19051389,4,SS,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Cardiotoxicity,,2021,Q1,1,I,,20210309.0,20210324,20210324,EXP,,"US-COEPTIS PHARMACEUTICALS, INC.-COE-2021-000035",COEPTIS PHARMACEUTICALS,"WALTER N, JONES K, HERR D, KACZOROWSKI D, KIM H. CLINICAL CHARACTERISTICS IN CARDIOTOXIC AGENT OVERDOSE NECESSITATING VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION: A CASE SERIES. CLIN. TOXICOL.. 2020?58 (11):1254?1256. DOI:10.1080/15563650.2020.1804238",24.0,YR,A,M,Y,,,20210318.0,,,COUNTRY NOT SPECIFIED,US,2021,Q1,Young Adult
190513891,19051389,4,SS,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Overdose,,2021,Q1,1,I,,20210309.0,20210324,20210324,EXP,,"US-COEPTIS PHARMACEUTICALS, INC.-COE-2021-000035",COEPTIS PHARMACEUTICALS,"WALTER N, JONES K, HERR D, KACZOROWSKI D, KIM H. CLINICAL CHARACTERISTICS IN CARDIOTOXIC AGENT OVERDOSE NECESSITATING VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION: A CASE SERIES. CLIN. TOXICOL.. 2020?58 (11):1254?1256. DOI:10.1080/15563650.2020.1804238",24.0,YR,A,M,Y,,,20210318.0,,,COUNTRY NOT SPECIFIED,US,2021,Q1,Young Adult
190524311,19052431,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Hypoglycaemia unawareness,Hypoglycaemia unawareness,2021,Q1,1,I,20140330.0,20210309.0,20210324,20210324,EXP,,ES-ALVOGEN-2021-ALVOGEN-116775,ALVOGEN,,34.0,YR,,F,Y,,,20210324.0,,HP,ES,ES,2021,Q1,Young Adult
190535821,19053582,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,,,,U,,,,,,,,,2021,Q1,Cardiogenic shock,,2021,Q1,1,I,,20210310.0,20210324,20210324,EXP,,"US-AZURITY PHARMACEUTICALS, INC.-2021AZY00028",AZURITY PHARMACEUTICALS,"WALTER N, JONES K, HERR D, KACZOROWSKI D, KIM H.. CLINICAL CHARACTERISTICS IN CARDIOTOXIC AGENT OVERDOSE NECESSITATING VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION: A CASE SERIES.. CLIN TOXICOL.. 2020?58(11):1254?1256",24.0,YR,,M,Y,,,20210324.0,,HP,US,US,2021,Q1,Young Adult
190535821,19053582,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,,,,U,,,,,,,,,2021,Q1,Overdose,,2021,Q1,1,I,,20210310.0,20210324,20210324,EXP,,"US-AZURITY PHARMACEUTICALS, INC.-2021AZY00028",AZURITY PHARMACEUTICALS,"WALTER N, JONES K, HERR D, KACZOROWSKI D, KIM H.. CLINICAL CHARACTERISTICS IN CARDIOTOXIC AGENT OVERDOSE NECESSITATING VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION: A CASE SERIES.. CLIN TOXICOL.. 2020?58(11):1254?1256",24.0,YR,,M,Y,,,20210324.0,,HP,US,US,2021,Q1,Young Adult
190535821,19053582,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,,,,U,,,,,,,,,2021,Q1,Toxicity to various agents,,2021,Q1,1,I,,20210310.0,20210324,20210324,EXP,,"US-AZURITY PHARMACEUTICALS, INC.-2021AZY00028",AZURITY PHARMACEUTICALS,"WALTER N, JONES K, HERR D, KACZOROWSKI D, KIM H.. CLINICAL CHARACTERISTICS IN CARDIOTOXIC AGENT OVERDOSE NECESSITATING VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION: A CASE SERIES.. CLIN TOXICOL.. 2020?58(11):1254?1256",24.0,YR,,M,Y,,,20210324.0,,HP,US,US,2021,Q1,Young Adult
190539471,19053947,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q1,Condition aggravated,,2021,Q1,1,I,,20210318.0,20210324,20210324,EXP,,CN-FRESENIUS KABI-FK202102942,FRESENIUS KABI,"ZHU Y, ZHAO Z, DONG C, JIANG H. CRYPTOCOCCAL MENINGITIS PRESENTED ASSUDDEN HEARING LOSS: A CASE STUDY. JOURNAL DE MYCOLOGIE MEDICALE. 2021 MAR?31 (1):.",52.0,YR,,M,Y,,,20210324.0,,HP,CN,CN,2021,Q1,Adult
190539471,19053947,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q1,Meningitis cryptococcal,,2021,Q1,1,I,,20210318.0,20210324,20210324,EXP,,CN-FRESENIUS KABI-FK202102942,FRESENIUS KABI,"ZHU Y, ZHAO Z, DONG C, JIANG H. CRYPTOCOCCAL MENINGITIS PRESENTED ASSUDDEN HEARING LOSS: A CASE STUDY. JOURNAL DE MYCOLOGIE MEDICALE. 2021 MAR?31 (1):.",52.0,YR,,M,Y,,,20210324.0,,HP,CN,CN,2021,Q1,Adult
190540031,19054003,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE AND FREQUENCY UNKNOWN,,,,,,,,,,SOLUTION,,2021,Q1,Blood pressure increased,,2021,Q1,1,I,,20210317.0,20210324,20210324,EXP,,CA-EISAI MEDICAL RESEARCH-EC-2021-089775,EISAI,,63.0,YR,A,M,Y,,,20210324.0,,HP,CA,CA,2021,Q1,Adult
190540031,19054003,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE AND FREQUENCY UNKNOWN,,,,,,,,,,SOLUTION,,2021,Q1,Confusional state,,2021,Q1,1,I,,20210317.0,20210324,20210324,EXP,,CA-EISAI MEDICAL RESEARCH-EC-2021-089775,EISAI,,63.0,YR,A,M,Y,,,20210324.0,,HP,CA,CA,2021,Q1,Adult
190540031,19054003,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE AND FREQUENCY UNKNOWN,,,,,,,,,,SOLUTION,,2021,Q1,Delirium,,2021,Q1,1,I,,20210317.0,20210324,20210324,EXP,,CA-EISAI MEDICAL RESEARCH-EC-2021-089775,EISAI,,63.0,YR,A,M,Y,,,20210324.0,,HP,CA,CA,2021,Q1,Adult
190540031,19054003,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE AND FREQUENCY UNKNOWN,,,,,,,,,,SOLUTION,,2021,Q1,Hypertensive encephalopathy,,2021,Q1,1,I,,20210317.0,20210324,20210324,EXP,,CA-EISAI MEDICAL RESEARCH-EC-2021-089775,EISAI,,63.0,YR,A,M,Y,,,20210324.0,,HP,CA,CA,2021,Q1,Adult
190540031,19054003,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE AND FREQUENCY UNKNOWN,,,,,,,,,,SOLUTION,,2021,Q1,Loss of consciousness,,2021,Q1,1,I,,20210317.0,20210324,20210324,EXP,,CA-EISAI MEDICAL RESEARCH-EC-2021-089775,EISAI,,63.0,YR,A,M,Y,,,20210324.0,,HP,CA,CA,2021,Q1,Adult
190540031,19054003,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE AND FREQUENCY UNKNOWN,,,,,,,,,,SOLUTION,,2021,Q1,Myoclonus,,2021,Q1,1,I,,20210317.0,20210324,20210324,EXP,,CA-EISAI MEDICAL RESEARCH-EC-2021-089775,EISAI,,63.0,YR,A,M,Y,,,20210324.0,,HP,CA,CA,2021,Q1,Adult
190540031,19054003,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE AND FREQUENCY UNKNOWN,,,,,,,,,,SOLUTION,,2021,Q1,White matter lesion,,2021,Q1,1,I,,20210317.0,20210324,20210324,EXP,,CA-EISAI MEDICAL RESEARCH-EC-2021-089775,EISAI,,63.0,YR,A,M,Y,,,20210324.0,,HP,CA,CA,2021,Q1,Adult
190551901,19055190,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,D,, UNKNOWN,,,,,,,2021,Q1,Cardiogenic shock,,2021,Q1,1,I,,20210312.0,20210325,20210325,EXP,,US-DRREDDYS-USA/USA/21/0133368,DR REDDYS,"WALTER N, JONES K, HERR D, KACZOROWSKI D, KIM H. CLINICAL CHARACTERISTICS IN CARDIOTOXIC AGENT OVERDOSE NECESSITATING VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION: A CASE SERIES. CLINICAL TOXICOLOGY. 2020?58 (11):1254?1256. DOI:10.1080/15563650.2020.1804238",24.0,YR,A,M,Y,,,20210325.0,,HP,US,US,2021,Q1,Young Adult
190551901,19055190,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,D,, UNKNOWN,,,,,,,2021,Q1,Overdose,,2021,Q1,1,I,,20210312.0,20210325,20210325,EXP,,US-DRREDDYS-USA/USA/21/0133368,DR REDDYS,"WALTER N, JONES K, HERR D, KACZOROWSKI D, KIM H. CLINICAL CHARACTERISTICS IN CARDIOTOXIC AGENT OVERDOSE NECESSITATING VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION: A CASE SERIES. CLINICAL TOXICOLOGY. 2020?58 (11):1254?1256. DOI:10.1080/15563650.2020.1804238",24.0,YR,A,M,Y,,,20210325.0,,HP,US,US,2021,Q1,Young Adult
190560901,19056090,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Cardiogenic shock,,2021,Q1,1,I,,20210312.0,20210325,20210325,EXP,,US-APOTEX-2021AP006884,APOTEX,"WALTER N, JONES K, HERR D, KACZOROWSKI D, KIM H.. CLINICAL CHARACTERISTICS IN CARDIOTOXIC AGENT OVERDOSE NECESSITATING VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION: A CASE SERIES. CLINICAL TOXICOLOGY. 2020?58(11):1254?1256",24.0,YR,,M,Y,,,20210325.0,,HP,US,US,2021,Q1,Young Adult
190560901,19056090,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Cardiotoxicity,,2021,Q1,1,I,,20210312.0,20210325,20210325,EXP,,US-APOTEX-2021AP006884,APOTEX,"WALTER N, JONES K, HERR D, KACZOROWSKI D, KIM H.. CLINICAL CHARACTERISTICS IN CARDIOTOXIC AGENT OVERDOSE NECESSITATING VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION: A CASE SERIES. CLINICAL TOXICOLOGY. 2020?58(11):1254?1256",24.0,YR,,M,Y,,,20210325.0,,HP,US,US,2021,Q1,Young Adult
190560901,19056090,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Overdose,,2021,Q1,1,I,,20210312.0,20210325,20210325,EXP,,US-APOTEX-2021AP006884,APOTEX,"WALTER N, JONES K, HERR D, KACZOROWSKI D, KIM H.. CLINICAL CHARACTERISTICS IN CARDIOTOXIC AGENT OVERDOSE NECESSITATING VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION: A CASE SERIES. CLINICAL TOXICOLOGY. 2020?58(11):1254?1256",24.0,YR,,M,Y,,,20210325.0,,HP,US,US,2021,Q1,Young Adult
190560901,19056090,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Toxicity to various agents,,2021,Q1,1,I,,20210312.0,20210325,20210325,EXP,,US-APOTEX-2021AP006884,APOTEX,"WALTER N, JONES K, HERR D, KACZOROWSKI D, KIM H.. CLINICAL CHARACTERISTICS IN CARDIOTOXIC AGENT OVERDOSE NECESSITATING VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION: A CASE SERIES. CLINICAL TOXICOLOGY. 2020?58(11):1254?1256",24.0,YR,,M,Y,,,20210325.0,,HP,US,US,2021,Q1,Young Adult
190578101,19057810,3,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,N,,,,,,,,2021,Q1,Drug interaction,,2021,Q1,1,I,,20210323.0,20210324,20210324,EXP,,US-ANIPHARMA-2021-US-004683,ANI,"ROBINSON ZS, ARVIN JP, MADDING KL.RIVAROXABAN FAILURE IN A PATIENT TAKING OXCARBAZEPINE..ANNALS OF PHARMACOTHERAPY.2021?.",28.0,YR,,M,Y,146.0,KG,20210324.0,,PH,US,US,2021,Q1,Young Adult
190578101,19057810,3,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,N,,,,,,,,2021,Q1,Pulmonary embolism,,2021,Q1,1,I,,20210323.0,20210324,20210324,EXP,,US-ANIPHARMA-2021-US-004683,ANI,"ROBINSON ZS, ARVIN JP, MADDING KL.RIVAROXABAN FAILURE IN A PATIENT TAKING OXCARBAZEPINE..ANNALS OF PHARMACOTHERAPY.2021?.",28.0,YR,,M,Y,146.0,KG,20210324.0,,PH,US,US,2021,Q1,Young Adult
190578421,19057842,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,40 UNITS,,,,, UNKNOWN,,,,,,,2021,Q1,Abortion spontaneous,,2021,Q1,1,I,,20210315.0,20210325,20210325,EXP,,JP-NOVOPROD-796704,NOVO NORDISK,"HONOKI, H., YAGI, K., TSUDA, S. ET AL.. TYPE 1 DIABETES WOMAN WITH REPEATED MISCARRIAGES SUCCESSFULLY GAVE BIRTH AFTERINTRODUCING AN INSULIN PUMP WITH A PREDICTIVELOW GLUCOSE SUSPEND FEATURE. DIABETOLOGY INTERNATIONAL. 2021",20.0,YR,,F,Y,,,20210325.0,,MD,JP,JP,2021,Q1,Youth
190578421,19057842,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,40 UNITS,,,,, UNKNOWN,,,,,,,2021,Q1,Blood glucose fluctuation,,2021,Q1,1,I,,20210315.0,20210325,20210325,EXP,,JP-NOVOPROD-796704,NOVO NORDISK,"HONOKI, H., YAGI, K., TSUDA, S. ET AL.. TYPE 1 DIABETES WOMAN WITH REPEATED MISCARRIAGES SUCCESSFULLY GAVE BIRTH AFTERINTRODUCING AN INSULIN PUMP WITH A PREDICTIVELOW GLUCOSE SUSPEND FEATURE. DIABETOLOGY INTERNATIONAL. 2021",20.0,YR,,F,Y,,,20210325.0,,MD,JP,JP,2021,Q1,Youth
190578421,19057842,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,40 UNITS,,,,, UNKNOWN,,,,,,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,,20210315.0,20210325,20210325,EXP,,JP-NOVOPROD-796704,NOVO NORDISK,"HONOKI, H., YAGI, K., TSUDA, S. ET AL.. TYPE 1 DIABETES WOMAN WITH REPEATED MISCARRIAGES SUCCESSFULLY GAVE BIRTH AFTERINTRODUCING AN INSULIN PUMP WITH A PREDICTIVELOW GLUCOSE SUSPEND FEATURE. DIABETOLOGY INTERNATIONAL. 2021",20.0,YR,,F,Y,,,20210325.0,,MD,JP,JP,2021,Q1,Youth
190578421,19057842,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,40 UNITS,,,,, UNKNOWN,,,,,,,2021,Q1,Maternal exposure during pregnancy,,2021,Q1,1,I,,20210315.0,20210325,20210325,EXP,,JP-NOVOPROD-796704,NOVO NORDISK,"HONOKI, H., YAGI, K., TSUDA, S. ET AL.. TYPE 1 DIABETES WOMAN WITH REPEATED MISCARRIAGES SUCCESSFULLY GAVE BIRTH AFTERINTRODUCING AN INSULIN PUMP WITH A PREDICTIVELOW GLUCOSE SUSPEND FEATURE. DIABETOLOGY INTERNATIONAL. 2021",20.0,YR,,F,Y,,,20210325.0,,MD,JP,JP,2021,Q1,Youth
190579671,19057967,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q1,Inappropriate antidiuretic hormone secretion,,2021,Q1,1,I,20201102.0,20201113.0,20210325,20210325,EXP,,JP-ORGANON-2011JPN010507,ORGANON,,71.0,YR,,M,Y,,,20210325.0,,PH,JP,JP,2021,Q1,Elderly
190580861,19058086,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q1,Medication error,,2021,Q1,1,I,20200723.0,20200724.0,20210324,20210324,EXP,,PT-GILEAD-2020-0487041,GILEAD,,64.0,YR,,F,Y,85.0,KG,20210324.0,,PH,PT,PT,2021,Q1,Adult
190580861,19058086,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q1,Seroma,,2021,Q1,1,I,20200723.0,20200724.0,20210324,20210324,EXP,,PT-GILEAD-2020-0487041,GILEAD,,64.0,YR,,F,Y,85.0,KG,20210324.0,,PH,PT,PT,2021,Q1,Adult
190584401,19058440,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, UNKNOWN,,,,,,,2021,Q1,Drug reaction with eosinophilia and systemic symptoms,,2021,Q1,1,I,20201130.0,20210322.0,20210325,20210325,EXP,FR-AFSSAPS-TO20211517,FR-FRESENIUS KABI-FK202103007,FRESENIUS KABI,,69.0,YR,,M,Y,88.0,KG,20210325.0,,HP,NL,FR,2021,Q1,Elderly
190584401,19058440,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, UNKNOWN,,,,,,,2021,Q1,Eosinophilia,,2021,Q1,1,I,20201130.0,20210322.0,20210325,20210325,EXP,FR-AFSSAPS-TO20211517,FR-FRESENIUS KABI-FK202103007,FRESENIUS KABI,,69.0,YR,,M,Y,88.0,KG,20210325.0,,HP,NL,FR,2021,Q1,Elderly
190584401,19058440,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, UNKNOWN,,,,,,,2021,Q1,Jaundice,,2021,Q1,1,I,20201130.0,20210322.0,20210325,20210325,EXP,FR-AFSSAPS-TO20211517,FR-FRESENIUS KABI-FK202103007,FRESENIUS KABI,,69.0,YR,,M,Y,88.0,KG,20210325.0,,HP,NL,FR,2021,Q1,Elderly
190584401,19058440,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, UNKNOWN,,,,,,,2021,Q1,Pruritus,,2021,Q1,1,I,20201130.0,20210322.0,20210325,20210325,EXP,FR-AFSSAPS-TO20211517,FR-FRESENIUS KABI-FK202103007,FRESENIUS KABI,,69.0,YR,,M,Y,88.0,KG,20210325.0,,HP,NL,FR,2021,Q1,Elderly
190584401,19058440,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, UNKNOWN,,,,,,,2021,Q1,Renal failure,,2021,Q1,1,I,20201130.0,20210322.0,20210325,20210325,EXP,FR-AFSSAPS-TO20211517,FR-FRESENIUS KABI-FK202103007,FRESENIUS KABI,,69.0,YR,,M,Y,88.0,KG,20210325.0,,HP,NL,FR,2021,Q1,Elderly
190600511,19060051,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2021,Q1,Cardiogenic shock,,2021,Q1,1,I,,20210312.0,20210326,20210326,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-03728,LUPIN,,24.0,YR,,M,Y,,,20210326.0,,HP,US,US,2021,Q1,Young Adult
190600511,19060051,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2021,Q1,Cardiotoxicity,,2021,Q1,1,I,,20210312.0,20210326,20210326,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-03728,LUPIN,,24.0,YR,,M,Y,,,20210326.0,,HP,US,US,2021,Q1,Young Adult
190600511,19060051,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2021,Q1,Overdose,,2021,Q1,1,I,,20210312.0,20210326,20210326,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-03728,LUPIN,,24.0,YR,,M,Y,,,20210326.0,,HP,US,US,2021,Q1,Young Adult
190658481,19065848,11,C,Insuline Glargine,INSULIN GLARGINE,1,Subcutaneous,100UNITS/ML,,,,,,,,,,INJECTION,,2021,Q1,Rash pruritic,,2021,Q1,1,I,202103.0,20210316.0,20210327,20210327,PER,,US-CELGENEUS-USA-20210305011,CELGENE,,57.0,YR,,M,Y,107.6,KG,20210327.0,,PH,US,US,2021,Q1,Adult
190658481,19065848,11,C,Insuline Glargine,INSULIN GLARGINE,1,Subcutaneous,100UNITS/ML,,,,,,,,,,INJECTION,,2021,Q1,Skin burning sensation,,2021,Q1,1,I,202103.0,20210316.0,20210327,20210327,PER,,US-CELGENEUS-USA-20210305011,CELGENE,,57.0,YR,,M,Y,107.6,KG,20210327.0,,PH,US,US,2021,Q1,Adult
190670461,19067046,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Anaemia,,2021,Q1,1,I,20201124.0,20210318.0,20210329,20210329,EXP,FR-AFSSAPS-RE20210616,FR-JNJFOC-20210336954,JOHNSON AND JOHNSON,,75.0,YR,E,M,Y,80.0,KG,20210329.0,,MD,FR,FR,2021,Q1,Elderly
190670461,19067046,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Condition aggravated,,2021,Q1,1,I,20201124.0,20210318.0,20210329,20210329,EXP,FR-AFSSAPS-RE20210616,FR-JNJFOC-20210336954,JOHNSON AND JOHNSON,,75.0,YR,E,M,Y,80.0,KG,20210329.0,,MD,FR,FR,2021,Q1,Elderly
190670461,19067046,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Epistaxis,,2021,Q1,1,I,20201124.0,20210318.0,20210329,20210329,EXP,FR-AFSSAPS-RE20210616,FR-JNJFOC-20210336954,JOHNSON AND JOHNSON,,75.0,YR,E,M,Y,80.0,KG,20210329.0,,MD,FR,FR,2021,Q1,Elderly
190670461,19067046,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Haematuria,,2021,Q1,1,I,20201124.0,20210318.0,20210329,20210329,EXP,FR-AFSSAPS-RE20210616,FR-JNJFOC-20210336954,JOHNSON AND JOHNSON,,75.0,YR,E,M,Y,80.0,KG,20210329.0,,MD,FR,FR,2021,Q1,Elderly
190670461,19067046,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Rectal haemorrhage,,2021,Q1,1,I,20201124.0,20210318.0,20210329,20210329,EXP,FR-AFSSAPS-RE20210616,FR-JNJFOC-20210336954,JOHNSON AND JOHNSON,,75.0,YR,E,M,Y,80.0,KG,20210329.0,,MD,FR,FR,2021,Q1,Elderly
190709201,19070920,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Blood potassium decreased,,2021,Q1,1,I,,20210323.0,20210330,20210330,EXP,,CA-ROCHE-2796181,ROCHE,,65.0,YR,,F,Y,98.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Elderly
190709201,19070920,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Cardiac dysfunction,,2021,Q1,1,I,,20210323.0,20210330,20210330,EXP,,CA-ROCHE-2796181,ROCHE,,65.0,YR,,F,Y,98.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Elderly
190709201,19070920,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Cough,,2021,Q1,1,I,,20210323.0,20210330,20210330,EXP,,CA-ROCHE-2796181,ROCHE,,65.0,YR,,F,Y,98.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Elderly
190709201,19070920,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Drug interaction,,2021,Q1,1,I,,20210323.0,20210330,20210330,EXP,,CA-ROCHE-2796181,ROCHE,,65.0,YR,,F,Y,98.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Elderly
190709201,19070920,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Dyspnoea,,2021,Q1,1,I,,20210323.0,20210330,20210330,EXP,,CA-ROCHE-2796181,ROCHE,,65.0,YR,,F,Y,98.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Elderly
190709201,19070920,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Fatigue,,2021,Q1,1,I,,20210323.0,20210330,20210330,EXP,,CA-ROCHE-2796181,ROCHE,,65.0,YR,,F,Y,98.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Elderly
190709201,19070920,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Myocardial infarction,,2021,Q1,1,I,,20210323.0,20210330,20210330,EXP,,CA-ROCHE-2796181,ROCHE,,65.0,YR,,F,Y,98.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Elderly
190715601,19071560,12,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Pancytopenia,,2021,Q1,1,I,20210312.0,20210321.0,20210330,20210330,EXP,,GB-AUROBINDO-AUR-APL-2021-012710,AUROBINDO,,58.0,YR,,F,Y,,,20210330.0,,PH,GB,GB,2021,Q1,Adult
190717401,19071740,4,SS,Glargine,INSULIN GLARGINE,1,Unknown,40 UNITS,,,,,,,,,,,,2021,Q1,Euglycaemic diabetic ketoacidosis,,2021,Q1,1,I,,20210315.0,20210330,20210330,EXP,,PK-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-287904,RANBAXY,"RASHID O, FAROOQ S, KIRAN Z, ISLAM N. EUGLYCAEMIC DIABETIC KETOACIDOSIS IN A PATIENT WITH TYPE 2 DIABETES STARTED ON EMPAGLIFLOZIN. BMJ CASE REP. 2016?MAY 1",42.0,YR,,M,Y,,,20210330.0,,HP,PK,US,2021,Q1,Adult
190717401,19071740,5,SS,Glargine,INSULIN GLARGINE,1,Unknown,20 UNITS,,,,,,,,,,,,2021,Q1,Euglycaemic diabetic ketoacidosis,,2021,Q1,1,I,,20210315.0,20210330,20210330,EXP,,PK-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-287904,RANBAXY,"RASHID O, FAROOQ S, KIRAN Z, ISLAM N. EUGLYCAEMIC DIABETIC KETOACIDOSIS IN A PATIENT WITH TYPE 2 DIABETES STARTED ON EMPAGLIFLOZIN. BMJ CASE REP. 2016?MAY 1",42.0,YR,,M,Y,,,20210330.0,,HP,PK,US,2021,Q1,Adult
190729501,19072950,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Neuropathic arthropathy,,2021,Q1,1,I,20200608.0,20210315.0,20210330,20210330,EXP,,AU-ASTRAZENECA-2021A204308,ASTRAZENECA,,54.0,YR,,M,Y,,,20210330.0,,,DE,AU,2021,Q1,Adult
190729501,19072950,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Syncope,,2021,Q1,1,I,20200608.0,20210315.0,20210330,20210330,EXP,,AU-ASTRAZENECA-2021A204308,ASTRAZENECA,,54.0,YR,,M,Y,,,20210330.0,,,DE,AU,2021,Q1,Adult
190736411,19073641,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,Y,,,,21081.0,,,,,2021,Q1,Renal disorder,,2021,Q1,1,I,,20210317.0,20210330,20210330,EXP,,HN-SA-2021SA095862,SANOFI AVENTIS,,52.0,YR,A,M,Y,,,20210330.0,,CN,HN,HN,2021,Q1,Adult
190742051,19074205,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q1,Pancytopenia,,2021,Q1,1,I,20210312.0,20210321.0,20210330,20210330,EXP,GB-MHRA-EYC 00244580,GB-PFIZER INC-2021306962,PFIZER,,58.0,YR,,F,Y,,,20210330.0,,PH,GB,GB,2021,Q1,Adult
190756531,19075653,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Diabetic ketoacidosis,,2021,Q1,1,I,202103.0,20210318.0,20210330,20210330,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202103009583,ELI LILLY AND CO,,79.0,YR,,M,Y,,,20210330.0,,MD,CN,CN,2021,Q1,Elderly
190756531,19075653,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q1,Diarrhoea,,2021,Q1,1,I,202103.0,20210318.0,20210330,20210330,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202103009583,ELI LILLY AND CO,,79.0,YR,,M,Y,,,20210330.0,,MD,CN,CN,2021,Q1,Elderly
190785621,19078562,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,20?30 UNITS,,,,,,,,,,,,2021,Q1,Treatment failure,,2021,Q1,1,I,,20210317.0,20210331,20210331,PER,,GR-LUPIN PHARMACEUTICALS INC.-2021-03983,LUPIN,,57.0,YR,,M,Y,,,20210331.0,,HP,GR,GR,2021,Q1,Adult
190801391,19080139,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 UNITS, QD",,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Diabetic foot,,2021,Q1,1,I,,20190102.0,20210331,20210331,EXP,,GR-VALIDUS PHARMACEUTICALS LLC-GR-2021VAL000696,VALIDUS,,53.0,YR,,F,Y,,,20210331.0,,CN,GR,GR,2021,Q1,Adult
190801391,19080139,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 UNITS, QD",,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Diabetic nephropathy,,2021,Q1,1,I,,20190102.0,20210331,20210331,EXP,,GR-VALIDUS PHARMACEUTICALS LLC-GR-2021VAL000696,VALIDUS,,53.0,YR,,F,Y,,,20210331.0,,CN,GR,GR,2021,Q1,Adult
190801391,19080139,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 UNITS, QD",,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Epilepsy,,2021,Q1,1,I,,20190102.0,20210331,20210331,EXP,,GR-VALIDUS PHARMACEUTICALS LLC-GR-2021VAL000696,VALIDUS,,53.0,YR,,F,Y,,,20210331.0,,CN,GR,GR,2021,Q1,Adult
190801391,19080139,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 UNITS, QD",,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,,20190102.0,20210331,20210331,EXP,,GR-VALIDUS PHARMACEUTICALS LLC-GR-2021VAL000696,VALIDUS,,53.0,YR,,F,Y,,,20210331.0,,CN,GR,GR,2021,Q1,Adult
190801391,19080139,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 UNITS, QD",,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Pain in extremity,,2021,Q1,1,I,,20190102.0,20210331,20210331,EXP,,GR-VALIDUS PHARMACEUTICALS LLC-GR-2021VAL000696,VALIDUS,,53.0,YR,,F,Y,,,20210331.0,,CN,GR,GR,2021,Q1,Adult
190805741,19080574,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q1,Peripheral motor neuropathy,,2021,Q1,1,I,20210309.0,20210319.0,20210331,20210331,EXP,,US-CELGENEUS-USA-20210305956,CELGENE,,50.0,YR,,F,Y,95.3,KG,20210331.0,,HP,US,US,2021,Q1,Adult
95555105,9555510,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,,,,,21081.0,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Abdominal discomfort,,2021,Q1,5,F,,20210112.0,20130926,20210114,EXP,,US-SANOFI-AVENTIS-2013SA093122,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20210114.0,,CN,US,US,2021,Q1,Elderly
95555105,9555510,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,,,,,21081.0,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,General physical health deterioration,,2021,Q1,5,F,,20210112.0,20130926,20210114,EXP,,US-SANOFI-AVENTIS-2013SA093122,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20210114.0,,CN,US,US,2021,Q1,Elderly
95555105,9555510,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,,,,,21081.0,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Hyperkeratosis,,2021,Q1,5,F,,20210112.0,20130926,20210114,EXP,,US-SANOFI-AVENTIS-2013SA093122,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20210114.0,,CN,US,US,2021,Q1,Elderly
95555105,9555510,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,,,,,21081.0,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Illness,,2021,Q1,5,F,,20210112.0,20130926,20210114,EXP,,US-SANOFI-AVENTIS-2013SA093122,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20210114.0,,CN,US,US,2021,Q1,Elderly
95555105,9555510,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,,,,,21081.0,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Muscular weakness,,2021,Q1,5,F,,20210112.0,20130926,20210114,EXP,,US-SANOFI-AVENTIS-2013SA093122,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20210114.0,,CN,US,US,2021,Q1,Elderly
95555105,9555510,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,,,,,21081.0,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Neuropathy peripheral,,2021,Q1,5,F,,20210112.0,20130926,20210114,EXP,,US-SANOFI-AVENTIS-2013SA093122,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20210114.0,,CN,US,US,2021,Q1,Elderly
95555105,9555510,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,,,,,21081.0,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Sinusitis,,2021,Q1,5,F,,20210112.0,20130926,20210114,EXP,,US-SANOFI-AVENTIS-2013SA093122,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20210114.0,,CN,US,US,2021,Q1,Elderly
95555105,9555510,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,,,,,21081.0,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Tooth abscess,,2021,Q1,5,F,,20210112.0,20130926,20210114,EXP,,US-SANOFI-AVENTIS-2013SA093122,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20210114.0,,CN,US,US,2021,Q1,Elderly
95555105,9555510,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,,,,,21081.0,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Urinary tract infection,,2021,Q1,5,F,,20210112.0,20130926,20210114,EXP,,US-SANOFI-AVENTIS-2013SA093122,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20210114.0,,CN,US,US,2021,Q1,Elderly
95555105,9555510,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,,,,,21081.0,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Wound infection,,2021,Q1,5,F,,20210112.0,20130926,20210114,EXP,,US-SANOFI-AVENTIS-2013SA093122,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20210114.0,,CN,US,US,2021,Q1,Elderly
124024503,12402450,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24?27 IU, QD(AT NIGHT )",,,,, 5F2089A,,21081.0,,,SOLUTION FOR INJECTION,QD,2021,Q2,Blood glucose decreased,,2021,Q2,3,F,,20210420.0,20160525,20210504,EXP,,US-SA-2016SA041704,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20210504.0,,CN,US,US,2021,Q2,Elderly
124024503,12402450,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24?27 IU, QD(AT NIGHT )",,,,, 5F2089A,,21081.0,,,SOLUTION FOR INJECTION,QD,2021,Q2,Blood glucose increased,,2021,Q2,3,F,,20210420.0,20160525,20210504,EXP,,US-SA-2016SA041704,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20210504.0,,CN,US,US,2021,Q2,Elderly
124024503,12402450,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24?27 IU, QD(AT NIGHT )",,,,, 5F2089A,,21081.0,,,SOLUTION FOR INJECTION,QD,2021,Q2,Decreased appetite,,2021,Q2,3,F,,20210420.0,20160525,20210504,EXP,,US-SA-2016SA041704,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20210504.0,,CN,US,US,2021,Q2,Elderly
124024503,12402450,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24?27 IU, QD(AT NIGHT )",,,,, 5F2089A,,21081.0,,,SOLUTION FOR INJECTION,QD,2021,Q2,Hyperhidrosis,,2021,Q2,3,F,,20210420.0,20160525,20210504,EXP,,US-SA-2016SA041704,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20210504.0,,CN,US,US,2021,Q2,Elderly
124024503,12402450,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24?27 IU, QD(AT NIGHT )",,,,, 5F2089A,,21081.0,,,SOLUTION FOR INJECTION,QD,2021,Q2,Tremor,,2021,Q2,3,F,,20210420.0,20160525,20210504,EXP,,US-SA-2016SA041704,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20210504.0,,CN,US,US,2021,Q2,Elderly
124024503,12402450,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24?27 IU, QD(AT NIGHT )",,,,, 5F2089A,,21081.0,,,SOLUTION FOR INJECTION,QD,2021,Q2,Unevaluable event,,2021,Q2,3,F,,20210420.0,20160525,20210504,EXP,,US-SA-2016SA041704,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20210504.0,,CN,US,US,2021,Q2,Elderly
124024503,12402450,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24IU , QD(AT NIGHT )",,,,,,,21081.0,24.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Blood glucose decreased,,2021,Q2,3,F,,20210420.0,20160525,20210504,EXP,,US-SA-2016SA041704,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20210504.0,,CN,US,US,2021,Q2,Elderly
124024503,12402450,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24IU , QD(AT NIGHT )",,,,,,,21081.0,24.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Blood glucose increased,,2021,Q2,3,F,,20210420.0,20160525,20210504,EXP,,US-SA-2016SA041704,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20210504.0,,CN,US,US,2021,Q2,Elderly
124024503,12402450,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24IU , QD(AT NIGHT )",,,,,,,21081.0,24.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Decreased appetite,,2021,Q2,3,F,,20210420.0,20160525,20210504,EXP,,US-SA-2016SA041704,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20210504.0,,CN,US,US,2021,Q2,Elderly
124024503,12402450,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24IU , QD(AT NIGHT )",,,,,,,21081.0,24.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Hyperhidrosis,,2021,Q2,3,F,,20210420.0,20160525,20210504,EXP,,US-SA-2016SA041704,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20210504.0,,CN,US,US,2021,Q2,Elderly
124024503,12402450,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24IU , QD(AT NIGHT )",,,,,,,21081.0,24.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Tremor,,2021,Q2,3,F,,20210420.0,20160525,20210504,EXP,,US-SA-2016SA041704,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20210504.0,,CN,US,US,2021,Q2,Elderly
124024503,12402450,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24IU , QD(AT NIGHT )",,,,,,,21081.0,24.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Unevaluable event,,2021,Q2,3,F,,20210420.0,20160525,20210504,EXP,,US-SA-2016SA041704,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20210504.0,,CN,US,US,2021,Q2,Elderly
127094679,12709467,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, UNK",,,,,,,,16.0,IU,,,2021,Q2,Blister,,2021,Q2,9,F,20010704.0,20210603.0,20160902,20210616,EXP,,DE-BAYER-2016-164660,BAYER,,73.0,YR,E,F,Y,69.0,KG,20210616.0,,CN,US,DE,2021,Q2,Elderly
127094679,12709467,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, UNK",,,,,,,,16.0,IU,,,2021,Q2,Cholecystitis,,2021,Q2,9,F,20010704.0,20210603.0,20160902,20210616,EXP,,DE-BAYER-2016-164660,BAYER,,73.0,YR,E,F,Y,69.0,KG,20210616.0,,CN,US,DE,2021,Q2,Elderly
127094679,12709467,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, UNK",,,,,,,,16.0,IU,,,2021,Q2,Cholelithiasis,,2021,Q2,9,F,20010704.0,20210603.0,20160902,20210616,EXP,,DE-BAYER-2016-164660,BAYER,,73.0,YR,E,F,Y,69.0,KG,20210616.0,,CN,US,DE,2021,Q2,Elderly
127094679,12709467,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, UNK",,,,,,,,16.0,IU,,,2021,Q2,Dermatitis exfoliative,,2021,Q2,9,F,20010704.0,20210603.0,20160902,20210616,EXP,,DE-BAYER-2016-164660,BAYER,,73.0,YR,E,F,Y,69.0,KG,20210616.0,,CN,US,DE,2021,Q2,Elderly
127094679,12709467,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, UNK",,,,,,,,16.0,IU,,,2021,Q2,Diarrhoea,,2021,Q2,9,F,20010704.0,20210603.0,20160902,20210616,EXP,,DE-BAYER-2016-164660,BAYER,,73.0,YR,E,F,Y,69.0,KG,20210616.0,,CN,US,DE,2021,Q2,Elderly
127094679,12709467,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, UNK",,,,,,,,16.0,IU,,,2021,Q2,Electrolyte imbalance,,2021,Q2,9,F,20010704.0,20210603.0,20160902,20210616,EXP,,DE-BAYER-2016-164660,BAYER,,73.0,YR,E,F,Y,69.0,KG,20210616.0,,CN,US,DE,2021,Q2,Elderly
127094679,12709467,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, UNK",,,,,,,,16.0,IU,,,2021,Q2,Erythema,,2021,Q2,9,F,20010704.0,20210603.0,20160902,20210616,EXP,,DE-BAYER-2016-164660,BAYER,,73.0,YR,E,F,Y,69.0,KG,20210616.0,,CN,US,DE,2021,Q2,Elderly
127094679,12709467,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, UNK",,,,,,,,16.0,IU,,,2021,Q2,Hyperthyroidism,,2021,Q2,9,F,20010704.0,20210603.0,20160902,20210616,EXP,,DE-BAYER-2016-164660,BAYER,,73.0,YR,E,F,Y,69.0,KG,20210616.0,,CN,US,DE,2021,Q2,Elderly
127094679,12709467,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, UNK",,,,,,,,16.0,IU,,,2021,Q2,Multiple organ dysfunction syndrome,,2021,Q2,9,F,20010704.0,20210603.0,20160902,20210616,EXP,,DE-BAYER-2016-164660,BAYER,,73.0,YR,E,F,Y,69.0,KG,20210616.0,,CN,US,DE,2021,Q2,Elderly
127094679,12709467,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, UNK",,,,,,,,16.0,IU,,,2021,Q2,Nausea,,2021,Q2,9,F,20010704.0,20210603.0,20160902,20210616,EXP,,DE-BAYER-2016-164660,BAYER,,73.0,YR,E,F,Y,69.0,KG,20210616.0,,CN,US,DE,2021,Q2,Elderly
127094679,12709467,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, UNK",,,,,,,,16.0,IU,,,2021,Q2,Respiratory disorder,,2021,Q2,9,F,20010704.0,20210603.0,20160902,20210616,EXP,,DE-BAYER-2016-164660,BAYER,,73.0,YR,E,F,Y,69.0,KG,20210616.0,,CN,US,DE,2021,Q2,Elderly
127094679,12709467,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, UNK",,,,,,,,16.0,IU,,,2021,Q2,Restlessness,,2021,Q2,9,F,20010704.0,20210603.0,20160902,20210616,EXP,,DE-BAYER-2016-164660,BAYER,,73.0,YR,E,F,Y,69.0,KG,20210616.0,,CN,US,DE,2021,Q2,Elderly
127094679,12709467,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, UNK",,,,,,,,16.0,IU,,,2021,Q2,Toxic epidermal necrolysis,,2021,Q2,9,F,20010704.0,20210603.0,20160902,20210616,EXP,,DE-BAYER-2016-164660,BAYER,,73.0,YR,E,F,Y,69.0,KG,20210616.0,,CN,US,DE,2021,Q2,Elderly
1354294412,13542944,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Asthenia,,2021,Q2,12,F,20170508.0,20190420.0,20170513,20210519,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-041774,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,71.66,KG,20210519.0,,CN,US,US,2021,Q2,Elderly
1354294412,13542944,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Cough,,2021,Q2,12,F,20170508.0,20190420.0,20170513,20210519,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-041774,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,71.66,KG,20210519.0,,CN,US,US,2021,Q2,Elderly
1354294412,13542944,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Fatigue,,2021,Q2,12,F,20170508.0,20190420.0,20170513,20210519,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-041774,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,71.66,KG,20210519.0,,CN,US,US,2021,Q2,Elderly
1354294412,13542944,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Feeling abnormal,,2021,Q2,12,F,20170508.0,20190420.0,20170513,20210519,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-041774,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,71.66,KG,20210519.0,,CN,US,US,2021,Q2,Elderly
1354294412,13542944,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Fungal infection,,2021,Q2,12,F,20170508.0,20190420.0,20170513,20210519,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-041774,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,71.66,KG,20210519.0,,CN,US,US,2021,Q2,Elderly
1354294412,13542944,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Gait inability,,2021,Q2,12,F,20170508.0,20190420.0,20170513,20210519,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-041774,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,71.66,KG,20210519.0,,CN,US,US,2021,Q2,Elderly
1354294412,13542944,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Headache,,2021,Q2,12,F,20170508.0,20190420.0,20170513,20210519,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-041774,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,71.66,KG,20210519.0,,CN,US,US,2021,Q2,Elderly
1354294412,13542944,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Herpes zoster,,2021,Q2,12,F,20170508.0,20190420.0,20170513,20210519,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-041774,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,71.66,KG,20210519.0,,CN,US,US,2021,Q2,Elderly
1354294412,13542944,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Hypersensitivity,,2021,Q2,12,F,20170508.0,20190420.0,20170513,20210519,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-041774,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,71.66,KG,20210519.0,,CN,US,US,2021,Q2,Elderly
1354294412,13542944,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Influenza,,2021,Q2,12,F,20170508.0,20190420.0,20170513,20210519,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-041774,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,71.66,KG,20210519.0,,CN,US,US,2021,Q2,Elderly
1354294412,13542944,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Knee deformity,,2021,Q2,12,F,20170508.0,20190420.0,20170513,20210519,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-041774,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,71.66,KG,20210519.0,,CN,US,US,2021,Q2,Elderly
1354294412,13542944,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Lethargy,,2021,Q2,12,F,20170508.0,20190420.0,20170513,20210519,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-041774,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,71.66,KG,20210519.0,,CN,US,US,2021,Q2,Elderly
1354294412,13542944,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Limb deformity,,2021,Q2,12,F,20170508.0,20190420.0,20170513,20210519,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-041774,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,71.66,KG,20210519.0,,CN,US,US,2021,Q2,Elderly
1354294412,13542944,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Malaise,,2021,Q2,12,F,20170508.0,20190420.0,20170513,20210519,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-041774,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,71.66,KG,20210519.0,,CN,US,US,2021,Q2,Elderly
1354294412,13542944,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Meniscus injury,,2021,Q2,12,F,20170508.0,20190420.0,20170513,20210519,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-041774,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,71.66,KG,20210519.0,,CN,US,US,2021,Q2,Elderly
1354294412,13542944,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Oral candidiasis,,2021,Q2,12,F,20170508.0,20190420.0,20170513,20210519,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-041774,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,71.66,KG,20210519.0,,CN,US,US,2021,Q2,Elderly
1354294412,13542944,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Pain,,2021,Q2,12,F,20170508.0,20190420.0,20170513,20210519,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-041774,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,71.66,KG,20210519.0,,CN,US,US,2021,Q2,Elderly
1354294412,13542944,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Peripheral swelling,,2021,Q2,12,F,20170508.0,20190420.0,20170513,20210519,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-041774,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,71.66,KG,20210519.0,,CN,US,US,2021,Q2,Elderly
1354294412,13542944,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Pneumonia,,2021,Q2,12,F,20170508.0,20190420.0,20170513,20210519,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-041774,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,71.66,KG,20210519.0,,CN,US,US,2021,Q2,Elderly
1354294412,13542944,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Product administration error,,2021,Q2,12,F,20170508.0,20190420.0,20170513,20210519,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-041774,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,71.66,KG,20210519.0,,CN,US,US,2021,Q2,Elderly
1354294412,13542944,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Rash,,2021,Q2,12,F,20170508.0,20190420.0,20170513,20210519,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-041774,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,71.66,KG,20210519.0,,CN,US,US,2021,Q2,Elderly
1354294412,13542944,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Renal impairment,,2021,Q2,12,F,20170508.0,20190420.0,20170513,20210519,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-041774,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,71.66,KG,20210519.0,,CN,US,US,2021,Q2,Elderly
1354294412,13542944,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Tongue coated,,2021,Q2,12,F,20170508.0,20190420.0,20170513,20210519,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-041774,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,71.66,KG,20210519.0,,CN,US,US,2021,Q2,Elderly
1354294412,13542944,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Tooth disorder,,2021,Q2,12,F,20170508.0,20190420.0,20170513,20210519,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-041774,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,71.66,KG,20210519.0,,CN,US,US,2021,Q2,Elderly
1354294412,13542944,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Urinary tract infection,,2021,Q2,12,F,20170508.0,20190420.0,20170513,20210519,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-041774,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,71.66,KG,20210519.0,,CN,US,US,2021,Q2,Elderly
1367540218,13675402,14,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Adverse drug reaction,,2021,Q2,18,F,,20210322.0,20170621,20210405,EXP,,CA-APOTEX-2017AP012984,APOTEX,,42.0,YR,,F,Y,,,20210405.0,,CN,CA,CA,2021,Q2,Adult
1367540218,13675402,14,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Arthralgia,,2021,Q2,18,F,,20210322.0,20170621,20210405,EXP,,CA-APOTEX-2017AP012984,APOTEX,,42.0,YR,,F,Y,,,20210405.0,,CN,CA,CA,2021,Q2,Adult
1367540218,13675402,14,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Condition aggravated,,2021,Q2,18,F,,20210322.0,20170621,20210405,EXP,,CA-APOTEX-2017AP012984,APOTEX,,42.0,YR,,F,Y,,,20210405.0,,CN,CA,CA,2021,Q2,Adult
1367540218,13675402,14,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Drug ineffective,,2021,Q2,18,F,,20210322.0,20170621,20210405,EXP,,CA-APOTEX-2017AP012984,APOTEX,,42.0,YR,,F,Y,,,20210405.0,,CN,CA,CA,2021,Q2,Adult
1367540218,13675402,14,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Gait inability,,2021,Q2,18,F,,20210322.0,20170621,20210405,EXP,,CA-APOTEX-2017AP012984,APOTEX,,42.0,YR,,F,Y,,,20210405.0,,CN,CA,CA,2021,Q2,Adult
1367540218,13675402,14,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Headache,,2021,Q2,18,F,,20210322.0,20170621,20210405,EXP,,CA-APOTEX-2017AP012984,APOTEX,,42.0,YR,,F,Y,,,20210405.0,,CN,CA,CA,2021,Q2,Adult
1367540218,13675402,14,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Hypoaesthesia,,2021,Q2,18,F,,20210322.0,20170621,20210405,EXP,,CA-APOTEX-2017AP012984,APOTEX,,42.0,YR,,F,Y,,,20210405.0,,CN,CA,CA,2021,Q2,Adult
1367540218,13675402,14,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Lower respiratory tract infection,,2021,Q2,18,F,,20210322.0,20170621,20210405,EXP,,CA-APOTEX-2017AP012984,APOTEX,,42.0,YR,,F,Y,,,20210405.0,,CN,CA,CA,2021,Q2,Adult
1367540218,13675402,14,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Pharyngitis,,2021,Q2,18,F,,20210322.0,20170621,20210405,EXP,,CA-APOTEX-2017AP012984,APOTEX,,42.0,YR,,F,Y,,,20210405.0,,CN,CA,CA,2021,Q2,Adult
1367540218,13675402,14,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Toothache,,2021,Q2,18,F,,20210322.0,20170621,20210405,EXP,,CA-APOTEX-2017AP012984,APOTEX,,42.0,YR,,F,Y,,,20210405.0,,CN,CA,CA,2021,Q2,Adult
1367540218,13675402,15,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Adverse drug reaction,,2021,Q2,18,F,,20210322.0,20170621,20210405,EXP,,CA-APOTEX-2017AP012984,APOTEX,,42.0,YR,,F,Y,,,20210405.0,,CN,CA,CA,2021,Q2,Adult
1367540218,13675402,15,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Arthralgia,,2021,Q2,18,F,,20210322.0,20170621,20210405,EXP,,CA-APOTEX-2017AP012984,APOTEX,,42.0,YR,,F,Y,,,20210405.0,,CN,CA,CA,2021,Q2,Adult
1367540218,13675402,15,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Condition aggravated,,2021,Q2,18,F,,20210322.0,20170621,20210405,EXP,,CA-APOTEX-2017AP012984,APOTEX,,42.0,YR,,F,Y,,,20210405.0,,CN,CA,CA,2021,Q2,Adult
1367540218,13675402,15,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Drug ineffective,,2021,Q2,18,F,,20210322.0,20170621,20210405,EXP,,CA-APOTEX-2017AP012984,APOTEX,,42.0,YR,,F,Y,,,20210405.0,,CN,CA,CA,2021,Q2,Adult
1367540218,13675402,15,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Gait inability,,2021,Q2,18,F,,20210322.0,20170621,20210405,EXP,,CA-APOTEX-2017AP012984,APOTEX,,42.0,YR,,F,Y,,,20210405.0,,CN,CA,CA,2021,Q2,Adult
1367540218,13675402,15,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Headache,,2021,Q2,18,F,,20210322.0,20170621,20210405,EXP,,CA-APOTEX-2017AP012984,APOTEX,,42.0,YR,,F,Y,,,20210405.0,,CN,CA,CA,2021,Q2,Adult
1367540218,13675402,15,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Hypoaesthesia,,2021,Q2,18,F,,20210322.0,20170621,20210405,EXP,,CA-APOTEX-2017AP012984,APOTEX,,42.0,YR,,F,Y,,,20210405.0,,CN,CA,CA,2021,Q2,Adult
1367540218,13675402,15,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Lower respiratory tract infection,,2021,Q2,18,F,,20210322.0,20170621,20210405,EXP,,CA-APOTEX-2017AP012984,APOTEX,,42.0,YR,,F,Y,,,20210405.0,,CN,CA,CA,2021,Q2,Adult
1367540218,13675402,15,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Pharyngitis,,2021,Q2,18,F,,20210322.0,20170621,20210405,EXP,,CA-APOTEX-2017AP012984,APOTEX,,42.0,YR,,F,Y,,,20210405.0,,CN,CA,CA,2021,Q2,Adult
1367540218,13675402,15,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Toothache,,2021,Q2,18,F,,20210322.0,20170621,20210405,EXP,,CA-APOTEX-2017AP012984,APOTEX,,42.0,YR,,F,Y,,,20210405.0,,CN,CA,CA,2021,Q2,Adult
1431063811,14310638,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Aphasia,,2021,Q2,11,F,20171211.0,20210511.0,20171220,20210512,EXP,,JP-BEH-2017085987,CSL BEHRING,,73.0,YR,E,M,Y,58.9,KG,20210512.0,,MD,JP,JP,2021,Q2,Elderly
1431063811,14310638,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Atrial thrombosis,,2021,Q2,11,F,20171211.0,20210511.0,20171220,20210512,EXP,,JP-BEH-2017085987,CSL BEHRING,,73.0,YR,E,M,Y,58.9,KG,20210512.0,,MD,JP,JP,2021,Q2,Elderly
1431063811,14310638,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,C-reactive protein increased,,2021,Q2,11,F,20171211.0,20210511.0,20171220,20210512,EXP,,JP-BEH-2017085987,CSL BEHRING,,73.0,YR,E,M,Y,58.9,KG,20210512.0,,MD,JP,JP,2021,Q2,Elderly
1431063811,14310638,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Carotid arterial embolus,,2021,Q2,11,F,20171211.0,20210511.0,20171220,20210512,EXP,,JP-BEH-2017085987,CSL BEHRING,,73.0,YR,E,M,Y,58.9,KG,20210512.0,,MD,JP,JP,2021,Q2,Elderly
1431063811,14310638,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Cerebral infarction,,2021,Q2,11,F,20171211.0,20210511.0,20171220,20210512,EXP,,JP-BEH-2017085987,CSL BEHRING,,73.0,YR,E,M,Y,58.9,KG,20210512.0,,MD,JP,JP,2021,Q2,Elderly
1431063811,14310638,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Embolic stroke,,2021,Q2,11,F,20171211.0,20210511.0,20171220,20210512,EXP,,JP-BEH-2017085987,CSL BEHRING,,73.0,YR,E,M,Y,58.9,KG,20210512.0,,MD,JP,JP,2021,Q2,Elderly
1431063811,14310638,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Escherichia test positive,,2021,Q2,11,F,20171211.0,20210511.0,20171220,20210512,EXP,,JP-BEH-2017085987,CSL BEHRING,,73.0,YR,E,M,Y,58.9,KG,20210512.0,,MD,JP,JP,2021,Q2,Elderly
1431063811,14310638,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Hemiplegia,,2021,Q2,11,F,20171211.0,20210511.0,20171220,20210512,EXP,,JP-BEH-2017085987,CSL BEHRING,,73.0,YR,E,M,Y,58.9,KG,20210512.0,,MD,JP,JP,2021,Q2,Elderly
1431063811,14310638,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Pain in extremity,,2021,Q2,11,F,20171211.0,20210511.0,20171220,20210512,EXP,,JP-BEH-2017085987,CSL BEHRING,,73.0,YR,E,M,Y,58.9,KG,20210512.0,,MD,JP,JP,2021,Q2,Elderly
1431063811,14310638,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Peripheral artery occlusion,,2021,Q2,11,F,20171211.0,20210511.0,20171220,20210512,EXP,,JP-BEH-2017085987,CSL BEHRING,,73.0,YR,E,M,Y,58.9,KG,20210512.0,,MD,JP,JP,2021,Q2,Elderly
1431063811,14310638,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Pneumonia aspiration,,2021,Q2,11,F,20171211.0,20210511.0,20171220,20210512,EXP,,JP-BEH-2017085987,CSL BEHRING,,73.0,YR,E,M,Y,58.9,KG,20210512.0,,MD,JP,JP,2021,Q2,Elderly
1431063811,14310638,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Pyrexia,,2021,Q2,11,F,20171211.0,20210511.0,20171220,20210512,EXP,,JP-BEH-2017085987,CSL BEHRING,,73.0,YR,E,M,Y,58.9,KG,20210512.0,,MD,JP,JP,2021,Q2,Elderly
1431063811,14310638,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Urinary tract infection,,2021,Q2,11,F,20171211.0,20210511.0,20171220,20210512,EXP,,JP-BEH-2017085987,CSL BEHRING,,73.0,YR,E,M,Y,58.9,KG,20210512.0,,MD,JP,JP,2021,Q2,Elderly
1431063811,14310638,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Urine abnormality,,2021,Q2,11,F,20171211.0,20210511.0,20171220,20210512,EXP,,JP-BEH-2017085987,CSL BEHRING,,73.0,YR,E,M,Y,58.9,KG,20210512.0,,MD,JP,JP,2021,Q2,Elderly
1486216712,14862167,64,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,,,2021,Q2,Blister,,2021,Q2,12,F,20010704.0,20190107.0,20180508,20210407,EXP,DE-BRISTOL-MYERS SQUIBB COMPANY-12380408,DE-VALIDUS PHARMACEUTICALS LLC-DE-2018VAL000738,VALIDUS,,73.0,YR,,F,Y,69.0,KG,20210407.0,,HP,DE,DE,2021,Q2,Elderly
1486216712,14862167,64,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,,,2021,Q2,Cholecystitis,,2021,Q2,12,F,20010704.0,20190107.0,20180508,20210407,EXP,DE-BRISTOL-MYERS SQUIBB COMPANY-12380408,DE-VALIDUS PHARMACEUTICALS LLC-DE-2018VAL000738,VALIDUS,,73.0,YR,,F,Y,69.0,KG,20210407.0,,HP,DE,DE,2021,Q2,Elderly
1486216712,14862167,64,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,,,2021,Q2,Cholelithiasis,,2021,Q2,12,F,20010704.0,20190107.0,20180508,20210407,EXP,DE-BRISTOL-MYERS SQUIBB COMPANY-12380408,DE-VALIDUS PHARMACEUTICALS LLC-DE-2018VAL000738,VALIDUS,,73.0,YR,,F,Y,69.0,KG,20210407.0,,HP,DE,DE,2021,Q2,Elderly
1486216712,14862167,64,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,,,2021,Q2,Condition aggravated,,2021,Q2,12,F,20010704.0,20190107.0,20180508,20210407,EXP,DE-BRISTOL-MYERS SQUIBB COMPANY-12380408,DE-VALIDUS PHARMACEUTICALS LLC-DE-2018VAL000738,VALIDUS,,73.0,YR,,F,Y,69.0,KG,20210407.0,,HP,DE,DE,2021,Q2,Elderly
1486216712,14862167,64,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,,,2021,Q2,Dermatitis exfoliative,,2021,Q2,12,F,20010704.0,20190107.0,20180508,20210407,EXP,DE-BRISTOL-MYERS SQUIBB COMPANY-12380408,DE-VALIDUS PHARMACEUTICALS LLC-DE-2018VAL000738,VALIDUS,,73.0,YR,,F,Y,69.0,KG,20210407.0,,HP,DE,DE,2021,Q2,Elderly
1486216712,14862167,64,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,,,2021,Q2,Diarrhoea,,2021,Q2,12,F,20010704.0,20190107.0,20180508,20210407,EXP,DE-BRISTOL-MYERS SQUIBB COMPANY-12380408,DE-VALIDUS PHARMACEUTICALS LLC-DE-2018VAL000738,VALIDUS,,73.0,YR,,F,Y,69.0,KG,20210407.0,,HP,DE,DE,2021,Q2,Elderly
1486216712,14862167,64,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,,,2021,Q2,Electrolyte imbalance,,2021,Q2,12,F,20010704.0,20190107.0,20180508,20210407,EXP,DE-BRISTOL-MYERS SQUIBB COMPANY-12380408,DE-VALIDUS PHARMACEUTICALS LLC-DE-2018VAL000738,VALIDUS,,73.0,YR,,F,Y,69.0,KG,20210407.0,,HP,DE,DE,2021,Q2,Elderly
1486216712,14862167,64,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,,,2021,Q2,Erythema,,2021,Q2,12,F,20010704.0,20190107.0,20180508,20210407,EXP,DE-BRISTOL-MYERS SQUIBB COMPANY-12380408,DE-VALIDUS PHARMACEUTICALS LLC-DE-2018VAL000738,VALIDUS,,73.0,YR,,F,Y,69.0,KG,20210407.0,,HP,DE,DE,2021,Q2,Elderly
1486216712,14862167,64,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,,,2021,Q2,Hyperthyroidism,,2021,Q2,12,F,20010704.0,20190107.0,20180508,20210407,EXP,DE-BRISTOL-MYERS SQUIBB COMPANY-12380408,DE-VALIDUS PHARMACEUTICALS LLC-DE-2018VAL000738,VALIDUS,,73.0,YR,,F,Y,69.0,KG,20210407.0,,HP,DE,DE,2021,Q2,Elderly
1486216712,14862167,64,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,,,2021,Q2,Multiple organ dysfunction syndrome,,2021,Q2,12,F,20010704.0,20190107.0,20180508,20210407,EXP,DE-BRISTOL-MYERS SQUIBB COMPANY-12380408,DE-VALIDUS PHARMACEUTICALS LLC-DE-2018VAL000738,VALIDUS,,73.0,YR,,F,Y,69.0,KG,20210407.0,,HP,DE,DE,2021,Q2,Elderly
1486216712,14862167,64,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,,,2021,Q2,Nausea,,2021,Q2,12,F,20010704.0,20190107.0,20180508,20210407,EXP,DE-BRISTOL-MYERS SQUIBB COMPANY-12380408,DE-VALIDUS PHARMACEUTICALS LLC-DE-2018VAL000738,VALIDUS,,73.0,YR,,F,Y,69.0,KG,20210407.0,,HP,DE,DE,2021,Q2,Elderly
1486216712,14862167,64,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,,,2021,Q2,Respiratory disorder,,2021,Q2,12,F,20010704.0,20190107.0,20180508,20210407,EXP,DE-BRISTOL-MYERS SQUIBB COMPANY-12380408,DE-VALIDUS PHARMACEUTICALS LLC-DE-2018VAL000738,VALIDUS,,73.0,YR,,F,Y,69.0,KG,20210407.0,,HP,DE,DE,2021,Q2,Elderly
1486216712,14862167,64,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,,,2021,Q2,Restlessness,,2021,Q2,12,F,20010704.0,20190107.0,20180508,20210407,EXP,DE-BRISTOL-MYERS SQUIBB COMPANY-12380408,DE-VALIDUS PHARMACEUTICALS LLC-DE-2018VAL000738,VALIDUS,,73.0,YR,,F,Y,69.0,KG,20210407.0,,HP,DE,DE,2021,Q2,Elderly
1486216712,14862167,64,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,,,2021,Q2,Toxic epidermal necrolysis,,2021,Q2,12,F,20010704.0,20190107.0,20180508,20210407,EXP,DE-BRISTOL-MYERS SQUIBB COMPANY-12380408,DE-VALIDUS PHARMACEUTICALS LLC-DE-2018VAL000738,VALIDUS,,73.0,YR,,F,Y,69.0,KG,20210407.0,,HP,DE,DE,2021,Q2,Elderly
1495401923,14954019,69,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, 1X/DAY",224.0,IU,,,,,,16.0,IU,ORAL SUSPENSION,QD,2021,Q2,Blister,,2021,Q2,23,F,20010629.0,20210618.0,20180530,20210630,EXP,,US-PFIZER INC-2003041703,PFIZER,,73.0,YR,,F,Y,60.0,KG,20210630.0,,HP,DE,DE,2021,Q2,Elderly
1495401923,14954019,69,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, 1X/DAY",224.0,IU,,,,,,16.0,IU,ORAL SUSPENSION,QD,2021,Q2,Cholecystitis,,2021,Q2,23,F,20010629.0,20210618.0,20180530,20210630,EXP,,US-PFIZER INC-2003041703,PFIZER,,73.0,YR,,F,Y,60.0,KG,20210630.0,,HP,DE,DE,2021,Q2,Elderly
1495401923,14954019,69,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, 1X/DAY",224.0,IU,,,,,,16.0,IU,ORAL SUSPENSION,QD,2021,Q2,Cholelithiasis,,2021,Q2,23,F,20010629.0,20210618.0,20180530,20210630,EXP,,US-PFIZER INC-2003041703,PFIZER,,73.0,YR,,F,Y,60.0,KG,20210630.0,,HP,DE,DE,2021,Q2,Elderly
1495401923,14954019,69,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, 1X/DAY",224.0,IU,,,,,,16.0,IU,ORAL SUSPENSION,QD,2021,Q2,Condition aggravated,,2021,Q2,23,F,20010629.0,20210618.0,20180530,20210630,EXP,,US-PFIZER INC-2003041703,PFIZER,,73.0,YR,,F,Y,60.0,KG,20210630.0,,HP,DE,DE,2021,Q2,Elderly
1495401923,14954019,69,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, 1X/DAY",224.0,IU,,,,,,16.0,IU,ORAL SUSPENSION,QD,2021,Q2,Coronary artery disease,,2021,Q2,23,F,20010629.0,20210618.0,20180530,20210630,EXP,,US-PFIZER INC-2003041703,PFIZER,,73.0,YR,,F,Y,60.0,KG,20210630.0,,HP,DE,DE,2021,Q2,Elderly
1495401923,14954019,69,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, 1X/DAY",224.0,IU,,,,,,16.0,IU,ORAL SUSPENSION,QD,2021,Q2,Dermatitis exfoliative,,2021,Q2,23,F,20010629.0,20210618.0,20180530,20210630,EXP,,US-PFIZER INC-2003041703,PFIZER,,73.0,YR,,F,Y,60.0,KG,20210630.0,,HP,DE,DE,2021,Q2,Elderly
1495401923,14954019,69,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, 1X/DAY",224.0,IU,,,,,,16.0,IU,ORAL SUSPENSION,QD,2021,Q2,Diarrhoea,,2021,Q2,23,F,20010629.0,20210618.0,20180530,20210630,EXP,,US-PFIZER INC-2003041703,PFIZER,,73.0,YR,,F,Y,60.0,KG,20210630.0,,HP,DE,DE,2021,Q2,Elderly
1495401923,14954019,69,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, 1X/DAY",224.0,IU,,,,,,16.0,IU,ORAL SUSPENSION,QD,2021,Q2,Dyspnoea,,2021,Q2,23,F,20010629.0,20210618.0,20180530,20210630,EXP,,US-PFIZER INC-2003041703,PFIZER,,73.0,YR,,F,Y,60.0,KG,20210630.0,,HP,DE,DE,2021,Q2,Elderly
1495401923,14954019,69,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, 1X/DAY",224.0,IU,,,,,,16.0,IU,ORAL SUSPENSION,QD,2021,Q2,Electrolyte imbalance,,2021,Q2,23,F,20010629.0,20210618.0,20180530,20210630,EXP,,US-PFIZER INC-2003041703,PFIZER,,73.0,YR,,F,Y,60.0,KG,20210630.0,,HP,DE,DE,2021,Q2,Elderly
1495401923,14954019,69,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, 1X/DAY",224.0,IU,,,,,,16.0,IU,ORAL SUSPENSION,QD,2021,Q2,Erythema,,2021,Q2,23,F,20010629.0,20210618.0,20180530,20210630,EXP,,US-PFIZER INC-2003041703,PFIZER,,73.0,YR,,F,Y,60.0,KG,20210630.0,,HP,DE,DE,2021,Q2,Elderly
1495401923,14954019,69,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, 1X/DAY",224.0,IU,,,,,,16.0,IU,ORAL SUSPENSION,QD,2021,Q2,Hypertension,,2021,Q2,23,F,20010629.0,20210618.0,20180530,20210630,EXP,,US-PFIZER INC-2003041703,PFIZER,,73.0,YR,,F,Y,60.0,KG,20210630.0,,HP,DE,DE,2021,Q2,Elderly
1495401923,14954019,69,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, 1X/DAY",224.0,IU,,,,,,16.0,IU,ORAL SUSPENSION,QD,2021,Q2,Hyperthyroidism,,2021,Q2,23,F,20010629.0,20210618.0,20180530,20210630,EXP,,US-PFIZER INC-2003041703,PFIZER,,73.0,YR,,F,Y,60.0,KG,20210630.0,,HP,DE,DE,2021,Q2,Elderly
1495401923,14954019,69,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, 1X/DAY",224.0,IU,,,,,,16.0,IU,ORAL SUSPENSION,QD,2021,Q2,Lung disorder,,2021,Q2,23,F,20010629.0,20210618.0,20180530,20210630,EXP,,US-PFIZER INC-2003041703,PFIZER,,73.0,YR,,F,Y,60.0,KG,20210630.0,,HP,DE,DE,2021,Q2,Elderly
1495401923,14954019,69,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, 1X/DAY",224.0,IU,,,,,,16.0,IU,ORAL SUSPENSION,QD,2021,Q2,Multiple organ dysfunction syndrome,,2021,Q2,23,F,20010629.0,20210618.0,20180530,20210630,EXP,,US-PFIZER INC-2003041703,PFIZER,,73.0,YR,,F,Y,60.0,KG,20210630.0,,HP,DE,DE,2021,Q2,Elderly
1495401923,14954019,69,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, 1X/DAY",224.0,IU,,,,,,16.0,IU,ORAL SUSPENSION,QD,2021,Q2,Nausea,,2021,Q2,23,F,20010629.0,20210618.0,20180530,20210630,EXP,,US-PFIZER INC-2003041703,PFIZER,,73.0,YR,,F,Y,60.0,KG,20210630.0,,HP,DE,DE,2021,Q2,Elderly
1495401923,14954019,69,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, 1X/DAY",224.0,IU,,,,,,16.0,IU,ORAL SUSPENSION,QD,2021,Q2,Pain,,2021,Q2,23,F,20010629.0,20210618.0,20180530,20210630,EXP,,US-PFIZER INC-2003041703,PFIZER,,73.0,YR,,F,Y,60.0,KG,20210630.0,,HP,DE,DE,2021,Q2,Elderly
1495401923,14954019,69,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, 1X/DAY",224.0,IU,,,,,,16.0,IU,ORAL SUSPENSION,QD,2021,Q2,Pyrexia,,2021,Q2,23,F,20010629.0,20210618.0,20180530,20210630,EXP,,US-PFIZER INC-2003041703,PFIZER,,73.0,YR,,F,Y,60.0,KG,20210630.0,,HP,DE,DE,2021,Q2,Elderly
1495401923,14954019,69,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, 1X/DAY",224.0,IU,,,,,,16.0,IU,ORAL SUSPENSION,QD,2021,Q2,Respiratory disorder,,2021,Q2,23,F,20010629.0,20210618.0,20180530,20210630,EXP,,US-PFIZER INC-2003041703,PFIZER,,73.0,YR,,F,Y,60.0,KG,20210630.0,,HP,DE,DE,2021,Q2,Elderly
1495401923,14954019,69,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, 1X/DAY",224.0,IU,,,,,,16.0,IU,ORAL SUSPENSION,QD,2021,Q2,Restlessness,,2021,Q2,23,F,20010629.0,20210618.0,20180530,20210630,EXP,,US-PFIZER INC-2003041703,PFIZER,,73.0,YR,,F,Y,60.0,KG,20210630.0,,HP,DE,DE,2021,Q2,Elderly
1495401923,14954019,69,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, 1X/DAY",224.0,IU,,,,,,16.0,IU,ORAL SUSPENSION,QD,2021,Q2,Toxic epidermal necrolysis,,2021,Q2,23,F,20010629.0,20210618.0,20180530,20210630,EXP,,US-PFIZER INC-2003041703,PFIZER,,73.0,YR,,F,Y,60.0,KG,20210630.0,,HP,DE,DE,2021,Q2,Elderly
151158867,15115886,54,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,,QD,2021,Q2,Blister,,2021,Q2,7,F,,20210525.0,20180706,20210528,EXP,,PHHY2003DE006001,NOVARTIS,,73.0,YR,,F,Y,60.0,KG,20210528.0,,HP,DE,DE,2021,Q2,Elderly
151158867,15115886,54,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,,QD,2021,Q2,Cholecystitis,,2021,Q2,7,F,,20210525.0,20180706,20210528,EXP,,PHHY2003DE006001,NOVARTIS,,73.0,YR,,F,Y,60.0,KG,20210528.0,,HP,DE,DE,2021,Q2,Elderly
151158867,15115886,54,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,,QD,2021,Q2,Cholelithiasis,,2021,Q2,7,F,,20210525.0,20180706,20210528,EXP,,PHHY2003DE006001,NOVARTIS,,73.0,YR,,F,Y,60.0,KG,20210528.0,,HP,DE,DE,2021,Q2,Elderly
151158867,15115886,54,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,,QD,2021,Q2,Condition aggravated,,2021,Q2,7,F,,20210525.0,20180706,20210528,EXP,,PHHY2003DE006001,NOVARTIS,,73.0,YR,,F,Y,60.0,KG,20210528.0,,HP,DE,DE,2021,Q2,Elderly
151158867,15115886,54,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,,QD,2021,Q2,Dermatitis exfoliative,,2021,Q2,7,F,,20210525.0,20180706,20210528,EXP,,PHHY2003DE006001,NOVARTIS,,73.0,YR,,F,Y,60.0,KG,20210528.0,,HP,DE,DE,2021,Q2,Elderly
151158867,15115886,54,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,,QD,2021,Q2,Diarrhoea,,2021,Q2,7,F,,20210525.0,20180706,20210528,EXP,,PHHY2003DE006001,NOVARTIS,,73.0,YR,,F,Y,60.0,KG,20210528.0,,HP,DE,DE,2021,Q2,Elderly
151158867,15115886,54,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,,QD,2021,Q2,Electrolyte imbalance,,2021,Q2,7,F,,20210525.0,20180706,20210528,EXP,,PHHY2003DE006001,NOVARTIS,,73.0,YR,,F,Y,60.0,KG,20210528.0,,HP,DE,DE,2021,Q2,Elderly
151158867,15115886,54,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,,QD,2021,Q2,Erythema,,2021,Q2,7,F,,20210525.0,20180706,20210528,EXP,,PHHY2003DE006001,NOVARTIS,,73.0,YR,,F,Y,60.0,KG,20210528.0,,HP,DE,DE,2021,Q2,Elderly
151158867,15115886,54,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,,QD,2021,Q2,Hyperthyroidism,,2021,Q2,7,F,,20210525.0,20180706,20210528,EXP,,PHHY2003DE006001,NOVARTIS,,73.0,YR,,F,Y,60.0,KG,20210528.0,,HP,DE,DE,2021,Q2,Elderly
151158867,15115886,54,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,,QD,2021,Q2,Multiple organ dysfunction syndrome,,2021,Q2,7,F,,20210525.0,20180706,20210528,EXP,,PHHY2003DE006001,NOVARTIS,,73.0,YR,,F,Y,60.0,KG,20210528.0,,HP,DE,DE,2021,Q2,Elderly
151158867,15115886,54,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,,QD,2021,Q2,Nausea,,2021,Q2,7,F,,20210525.0,20180706,20210528,EXP,,PHHY2003DE006001,NOVARTIS,,73.0,YR,,F,Y,60.0,KG,20210528.0,,HP,DE,DE,2021,Q2,Elderly
151158867,15115886,54,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,,QD,2021,Q2,Respiratory disorder,,2021,Q2,7,F,,20210525.0,20180706,20210528,EXP,,PHHY2003DE006001,NOVARTIS,,73.0,YR,,F,Y,60.0,KG,20210528.0,,HP,DE,DE,2021,Q2,Elderly
151158867,15115886,54,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,,QD,2021,Q2,Restlessness,,2021,Q2,7,F,,20210525.0,20180706,20210528,EXP,,PHHY2003DE006001,NOVARTIS,,73.0,YR,,F,Y,60.0,KG,20210528.0,,HP,DE,DE,2021,Q2,Elderly
151158867,15115886,54,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,,QD,2021,Q2,Toxic epidermal necrolysis,,2021,Q2,7,F,,20210525.0,20180706,20210528,EXP,,PHHY2003DE006001,NOVARTIS,,73.0,YR,,F,Y,60.0,KG,20210528.0,,HP,DE,DE,2021,Q2,Elderly
152145348,15214534,53,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"16 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,16.0,IU,,QD,2021,Q2,Blister,,2021,Q2,8,F,20010703.0,20210621.0,20180730,20210630,EXP,,GB-AUROBINDO-AUR-APL-2018-022707,AUROBINDO,,73.0,YR,,F,Y,69.0,KG,20210630.0,,CN,DE,DE,2021,Q2,Elderly
152145348,15214534,53,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"16 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,16.0,IU,,QD,2021,Q2,Cholecystitis,,2021,Q2,8,F,20010703.0,20210621.0,20180730,20210630,EXP,,GB-AUROBINDO-AUR-APL-2018-022707,AUROBINDO,,73.0,YR,,F,Y,69.0,KG,20210630.0,,CN,DE,DE,2021,Q2,Elderly
152145348,15214534,53,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"16 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,16.0,IU,,QD,2021,Q2,Cholelithiasis,,2021,Q2,8,F,20010703.0,20210621.0,20180730,20210630,EXP,,GB-AUROBINDO-AUR-APL-2018-022707,AUROBINDO,,73.0,YR,,F,Y,69.0,KG,20210630.0,,CN,DE,DE,2021,Q2,Elderly
152145348,15214534,53,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"16 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,16.0,IU,,QD,2021,Q2,Condition aggravated,,2021,Q2,8,F,20010703.0,20210621.0,20180730,20210630,EXP,,GB-AUROBINDO-AUR-APL-2018-022707,AUROBINDO,,73.0,YR,,F,Y,69.0,KG,20210630.0,,CN,DE,DE,2021,Q2,Elderly
152145348,15214534,53,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"16 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,16.0,IU,,QD,2021,Q2,Dermatitis exfoliative,,2021,Q2,8,F,20010703.0,20210621.0,20180730,20210630,EXP,,GB-AUROBINDO-AUR-APL-2018-022707,AUROBINDO,,73.0,YR,,F,Y,69.0,KG,20210630.0,,CN,DE,DE,2021,Q2,Elderly
152145348,15214534,53,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"16 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,16.0,IU,,QD,2021,Q2,Diarrhoea,,2021,Q2,8,F,20010703.0,20210621.0,20180730,20210630,EXP,,GB-AUROBINDO-AUR-APL-2018-022707,AUROBINDO,,73.0,YR,,F,Y,69.0,KG,20210630.0,,CN,DE,DE,2021,Q2,Elderly
152145348,15214534,53,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"16 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,16.0,IU,,QD,2021,Q2,Electrolyte imbalance,,2021,Q2,8,F,20010703.0,20210621.0,20180730,20210630,EXP,,GB-AUROBINDO-AUR-APL-2018-022707,AUROBINDO,,73.0,YR,,F,Y,69.0,KG,20210630.0,,CN,DE,DE,2021,Q2,Elderly
152145348,15214534,53,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"16 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,16.0,IU,,QD,2021,Q2,Erythema,,2021,Q2,8,F,20010703.0,20210621.0,20180730,20210630,EXP,,GB-AUROBINDO-AUR-APL-2018-022707,AUROBINDO,,73.0,YR,,F,Y,69.0,KG,20210630.0,,CN,DE,DE,2021,Q2,Elderly
152145348,15214534,53,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"16 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,16.0,IU,,QD,2021,Q2,Hyperthyroidism,,2021,Q2,8,F,20010703.0,20210621.0,20180730,20210630,EXP,,GB-AUROBINDO-AUR-APL-2018-022707,AUROBINDO,,73.0,YR,,F,Y,69.0,KG,20210630.0,,CN,DE,DE,2021,Q2,Elderly
152145348,15214534,53,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"16 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,16.0,IU,,QD,2021,Q2,Multiple organ dysfunction syndrome,,2021,Q2,8,F,20010703.0,20210621.0,20180730,20210630,EXP,,GB-AUROBINDO-AUR-APL-2018-022707,AUROBINDO,,73.0,YR,,F,Y,69.0,KG,20210630.0,,CN,DE,DE,2021,Q2,Elderly
152145348,15214534,53,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"16 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,16.0,IU,,QD,2021,Q2,Nausea,,2021,Q2,8,F,20010703.0,20210621.0,20180730,20210630,EXP,,GB-AUROBINDO-AUR-APL-2018-022707,AUROBINDO,,73.0,YR,,F,Y,69.0,KG,20210630.0,,CN,DE,DE,2021,Q2,Elderly
152145348,15214534,53,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"16 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,16.0,IU,,QD,2021,Q2,Respiratory disorder,,2021,Q2,8,F,20010703.0,20210621.0,20180730,20210630,EXP,,GB-AUROBINDO-AUR-APL-2018-022707,AUROBINDO,,73.0,YR,,F,Y,69.0,KG,20210630.0,,CN,DE,DE,2021,Q2,Elderly
152145348,15214534,53,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"16 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,16.0,IU,,QD,2021,Q2,Restlessness,,2021,Q2,8,F,20010703.0,20210621.0,20180730,20210630,EXP,,GB-AUROBINDO-AUR-APL-2018-022707,AUROBINDO,,73.0,YR,,F,Y,69.0,KG,20210630.0,,CN,DE,DE,2021,Q2,Elderly
152145348,15214534,53,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"16 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,16.0,IU,,QD,2021,Q2,Toxic epidermal necrolysis,,2021,Q2,8,F,20010703.0,20210621.0,20180730,20210630,EXP,,GB-AUROBINDO-AUR-APL-2018-022707,AUROBINDO,,73.0,YR,,F,Y,69.0,KG,20210630.0,,CN,DE,DE,2021,Q2,Elderly
152282563,15228256,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,13USP UNITS DAILY,,,,,,,,,,,,2021,Q2,Blood electrolytes decreased,,2021,Q2,3,F,2012.0,20210622.0,20180801,20210630,EXP,,CA-ASTRAZENECA-2018SE95997,ASTRAZENECA,,59.0,YR,,M,Y,54.0,KG,20210630.0,,,CA,CA,2021,Q2,Adult
152282563,15228256,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,13USP UNITS DAILY,,,,,,,,,,,,2021,Q2,Blood iron decreased,,2021,Q2,3,F,2012.0,20210622.0,20180801,20210630,EXP,,CA-ASTRAZENECA-2018SE95997,ASTRAZENECA,,59.0,YR,,M,Y,54.0,KG,20210630.0,,,CA,CA,2021,Q2,Adult
152282563,15228256,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,13USP UNITS DAILY,,,,,,,,,,,,2021,Q2,Cardiac valve disease,,2021,Q2,3,F,2012.0,20210622.0,20180801,20210630,EXP,,CA-ASTRAZENECA-2018SE95997,ASTRAZENECA,,59.0,YR,,M,Y,54.0,KG,20210630.0,,,CA,CA,2021,Q2,Adult
152282563,15228256,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,13USP UNITS DAILY,,,,,,,,,,,,2021,Q2,Coeliac disease,,2021,Q2,3,F,2012.0,20210622.0,20180801,20210630,EXP,,CA-ASTRAZENECA-2018SE95997,ASTRAZENECA,,59.0,YR,,M,Y,54.0,KG,20210630.0,,,CA,CA,2021,Q2,Adult
152282563,15228256,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,13USP UNITS DAILY,,,,,,,,,,,,2021,Q2,Drug ineffective,,2021,Q2,3,F,2012.0,20210622.0,20180801,20210630,EXP,,CA-ASTRAZENECA-2018SE95997,ASTRAZENECA,,59.0,YR,,M,Y,54.0,KG,20210630.0,,,CA,CA,2021,Q2,Adult
152282563,15228256,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,13USP UNITS DAILY,,,,,,,,,,,,2021,Q2,Dyspnoea,,2021,Q2,3,F,2012.0,20210622.0,20180801,20210630,EXP,,CA-ASTRAZENECA-2018SE95997,ASTRAZENECA,,59.0,YR,,M,Y,54.0,KG,20210630.0,,,CA,CA,2021,Q2,Adult
152282563,15228256,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,13USP UNITS DAILY,,,,,,,,,,,,2021,Q2,Incorrect dose administered,,2021,Q2,3,F,2012.0,20210622.0,20180801,20210630,EXP,,CA-ASTRAZENECA-2018SE95997,ASTRAZENECA,,59.0,YR,,M,Y,54.0,KG,20210630.0,,,CA,CA,2021,Q2,Adult
152282563,15228256,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,13USP UNITS DAILY,,,,,,,,,,,,2021,Q2,Product use issue,,2021,Q2,3,F,2012.0,20210622.0,20180801,20210630,EXP,,CA-ASTRAZENECA-2018SE95997,ASTRAZENECA,,59.0,YR,,M,Y,54.0,KG,20210630.0,,,CA,CA,2021,Q2,Adult
152282563,15228256,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,13USP UNITS DAILY,,,,,,,,,,,,2021,Q2,Somnolence,,2021,Q2,3,F,2012.0,20210622.0,20180801,20210630,EXP,,CA-ASTRAZENECA-2018SE95997,ASTRAZENECA,,59.0,YR,,M,Y,54.0,KG,20210630.0,,,CA,CA,2021,Q2,Adult
152282563,15228256,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,13USP UNITS DAILY,,,,,,,,,,,,2021,Q2,Underdose,,2021,Q2,3,F,2012.0,20210622.0,20180801,20210630,EXP,,CA-ASTRAZENECA-2018SE95997,ASTRAZENECA,,59.0,YR,,M,Y,54.0,KG,20210630.0,,,CA,CA,2021,Q2,Adult
152282563,15228256,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,13USP UNITS DAILY,,,,,,,,,,,,2021,Q2,Weight decreased,,2021,Q2,3,F,2012.0,20210622.0,20180801,20210630,EXP,,CA-ASTRAZENECA-2018SE95997,ASTRAZENECA,,59.0,YR,,M,Y,54.0,KG,20210630.0,,,CA,CA,2021,Q2,Adult
1524542418,15245424,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,18.0,IU,,QD,2021,Q2,Anaemia,,2021,Q2,18,F,20180605.0,20210413.0,20180806,20210421,EXP,,PL-ABBVIE-18P-129-2407306-00,ABBVIE,,67.0,YR,,M,Y,100.8,KG,20210421.0,,MD,PL,PL,2021,Q2,Elderly
1524542418,15245424,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,18.0,IU,,QD,2021,Q2,Febrile neutropenia,,2021,Q2,18,F,20180605.0,20210413.0,20180806,20210421,EXP,,PL-ABBVIE-18P-129-2407306-00,ABBVIE,,67.0,YR,,M,Y,100.8,KG,20210421.0,,MD,PL,PL,2021,Q2,Elderly
1524542418,15245424,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,18.0,IU,,QD,2021,Q2,Neutropenia,,2021,Q2,18,F,20180605.0,20210413.0,20180806,20210421,EXP,,PL-ABBVIE-18P-129-2407306-00,ABBVIE,,67.0,YR,,M,Y,100.8,KG,20210421.0,,MD,PL,PL,2021,Q2,Elderly
1524542418,15245424,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,18.0,IU,,QD,2021,Q2,Thrombocytopenia,,2021,Q2,18,F,20180605.0,20210413.0,20180806,20210421,EXP,,PL-ABBVIE-18P-129-2407306-00,ABBVIE,,67.0,YR,,M,Y,100.8,KG,20210421.0,,MD,PL,PL,2021,Q2,Elderly
154992758,15499275,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"25 IU, DAILY (AT NIGHT)",,,,, ASKU,,,25.0,IU,INJECTION,QD,2021,Q2,Blindness,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"25 IU, DAILY (AT NIGHT)",,,,, ASKU,,,25.0,IU,INJECTION,QD,2021,Q2,Blood glucose decreased,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"25 IU, DAILY (AT NIGHT)",,,,, ASKU,,,25.0,IU,INJECTION,QD,2021,Q2,Blood glucose increased,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"25 IU, DAILY (AT NIGHT)",,,,, ASKU,,,25.0,IU,INJECTION,QD,2021,Q2,Blood pressure increased,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"25 IU, DAILY (AT NIGHT)",,,,, ASKU,,,25.0,IU,INJECTION,QD,2021,Q2,COVID-19,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"25 IU, DAILY (AT NIGHT)",,,,, ASKU,,,25.0,IU,INJECTION,QD,2021,Q2,Diplopia,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"25 IU, DAILY (AT NIGHT)",,,,, ASKU,,,25.0,IU,INJECTION,QD,2021,Q2,Eye haemorrhage,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"25 IU, DAILY (AT NIGHT)",,,,, ASKU,,,25.0,IU,INJECTION,QD,2021,Q2,Eye pain,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"25 IU, DAILY (AT NIGHT)",,,,, ASKU,,,25.0,IU,INJECTION,QD,2021,Q2,Glycosylated haemoglobin increased,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"25 IU, DAILY (AT NIGHT)",,,,, ASKU,,,25.0,IU,INJECTION,QD,2021,Q2,Hyperhidrosis,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"25 IU, DAILY (AT NIGHT)",,,,, ASKU,,,25.0,IU,INJECTION,QD,2021,Q2,Hypoacusis,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"25 IU, DAILY (AT NIGHT)",,,,, ASKU,,,25.0,IU,INJECTION,QD,2021,Q2,Impaired healing,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"25 IU, DAILY (AT NIGHT)",,,,, ASKU,,,25.0,IU,INJECTION,QD,2021,Q2,Muscular weakness,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"25 IU, DAILY (AT NIGHT)",,,,, ASKU,,,25.0,IU,INJECTION,QD,2021,Q2,Pain in extremity,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"25 IU, DAILY (AT NIGHT)",,,,, ASKU,,,25.0,IU,INJECTION,QD,2021,Q2,Pneumonia,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"25 IU, DAILY (AT NIGHT)",,,,, ASKU,,,25.0,IU,INJECTION,QD,2021,Q2,Retinal detachment,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"25 IU, DAILY (AT NIGHT)",,,,, ASKU,,,25.0,IU,INJECTION,QD,2021,Q2,Sepsis,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"25 IU, DAILY (AT NIGHT)",,,,, ASKU,,,25.0,IU,INJECTION,QD,2021,Q2,Thinking abnormal,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"25 IU, DAILY (AT NIGHT)",,,,, ASKU,,,25.0,IU,INJECTION,QD,2021,Q2,Tremor,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"25 IU, DAILY (AT NIGHT)",,,,, ASKU,,,25.0,IU,INJECTION,QD,2021,Q2,Visual impairment,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"25 IU, DAILY (AT NIGHT)",,,,, ASKU,,,25.0,IU,INJECTION,QD,2021,Q2,Wrong patient received product,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"25 IU, DAILY (AT NIGHT)",,,,, ASKU,,,25.0,IU,INJECTION,QD,2021,Q2,Wrong product administered,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"5 IU, TID",,,,,,,,5.0,IU,INJECTION,TID,2021,Q2,Blindness,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"5 IU, TID",,,,,,,,5.0,IU,INJECTION,TID,2021,Q2,Blood glucose decreased,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"5 IU, TID",,,,,,,,5.0,IU,INJECTION,TID,2021,Q2,Blood glucose increased,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"5 IU, TID",,,,,,,,5.0,IU,INJECTION,TID,2021,Q2,Blood pressure increased,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"5 IU, TID",,,,,,,,5.0,IU,INJECTION,TID,2021,Q2,COVID-19,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"5 IU, TID",,,,,,,,5.0,IU,INJECTION,TID,2021,Q2,Diplopia,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"5 IU, TID",,,,,,,,5.0,IU,INJECTION,TID,2021,Q2,Eye haemorrhage,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"5 IU, TID",,,,,,,,5.0,IU,INJECTION,TID,2021,Q2,Eye pain,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"5 IU, TID",,,,,,,,5.0,IU,INJECTION,TID,2021,Q2,Glycosylated haemoglobin increased,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"5 IU, TID",,,,,,,,5.0,IU,INJECTION,TID,2021,Q2,Hyperhidrosis,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"5 IU, TID",,,,,,,,5.0,IU,INJECTION,TID,2021,Q2,Hypoacusis,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"5 IU, TID",,,,,,,,5.0,IU,INJECTION,TID,2021,Q2,Impaired healing,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"5 IU, TID",,,,,,,,5.0,IU,INJECTION,TID,2021,Q2,Muscular weakness,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"5 IU, TID",,,,,,,,5.0,IU,INJECTION,TID,2021,Q2,Pain in extremity,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"5 IU, TID",,,,,,,,5.0,IU,INJECTION,TID,2021,Q2,Pneumonia,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"5 IU, TID",,,,,,,,5.0,IU,INJECTION,TID,2021,Q2,Retinal detachment,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"5 IU, TID",,,,,,,,5.0,IU,INJECTION,TID,2021,Q2,Sepsis,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"5 IU, TID",,,,,,,,5.0,IU,INJECTION,TID,2021,Q2,Thinking abnormal,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"5 IU, TID",,,,,,,,5.0,IU,INJECTION,TID,2021,Q2,Tremor,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"5 IU, TID",,,,,,,,5.0,IU,INJECTION,TID,2021,Q2,Visual impairment,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"5 IU, TID",,,,,,,,5.0,IU,INJECTION,TID,2021,Q2,Wrong patient received product,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"5 IU, TID",,,,,,,,5.0,IU,INJECTION,TID,2021,Q2,Wrong product administered,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 U, DAILY",,,,,,,,26.0,IU,INJECTION,QD,2021,Q2,Blindness,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 U, DAILY",,,,,,,,26.0,IU,INJECTION,QD,2021,Q2,Blood glucose decreased,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 U, DAILY",,,,,,,,26.0,IU,INJECTION,QD,2021,Q2,Blood glucose increased,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 U, DAILY",,,,,,,,26.0,IU,INJECTION,QD,2021,Q2,Blood pressure increased,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 U, DAILY",,,,,,,,26.0,IU,INJECTION,QD,2021,Q2,COVID-19,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 U, DAILY",,,,,,,,26.0,IU,INJECTION,QD,2021,Q2,Diplopia,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 U, DAILY",,,,,,,,26.0,IU,INJECTION,QD,2021,Q2,Eye haemorrhage,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 U, DAILY",,,,,,,,26.0,IU,INJECTION,QD,2021,Q2,Eye pain,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 U, DAILY",,,,,,,,26.0,IU,INJECTION,QD,2021,Q2,Glycosylated haemoglobin increased,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 U, DAILY",,,,,,,,26.0,IU,INJECTION,QD,2021,Q2,Hyperhidrosis,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 U, DAILY",,,,,,,,26.0,IU,INJECTION,QD,2021,Q2,Hypoacusis,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 U, DAILY",,,,,,,,26.0,IU,INJECTION,QD,2021,Q2,Impaired healing,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 U, DAILY",,,,,,,,26.0,IU,INJECTION,QD,2021,Q2,Muscular weakness,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 U, DAILY",,,,,,,,26.0,IU,INJECTION,QD,2021,Q2,Pain in extremity,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 U, DAILY",,,,,,,,26.0,IU,INJECTION,QD,2021,Q2,Pneumonia,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 U, DAILY",,,,,,,,26.0,IU,INJECTION,QD,2021,Q2,Retinal detachment,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 U, DAILY",,,,,,,,26.0,IU,INJECTION,QD,2021,Q2,Sepsis,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 U, DAILY",,,,,,,,26.0,IU,INJECTION,QD,2021,Q2,Thinking abnormal,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 U, DAILY",,,,,,,,26.0,IU,INJECTION,QD,2021,Q2,Tremor,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 U, DAILY",,,,,,,,26.0,IU,INJECTION,QD,2021,Q2,Visual impairment,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 U, DAILY",,,,,,,,26.0,IU,INJECTION,QD,2021,Q2,Wrong patient received product,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
154992758,15499275,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 U, DAILY",,,,,,,,26.0,IU,INJECTION,QD,2021,Q2,Wrong product administered,,2021,Q2,8,F,201809.0,20210601.0,20181015,20210610,EXP,,US-ELI_LILLY_AND_COMPANY-US201810003082,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210610.0,,CN,US,US,2021,Q2,Elderly
155496604,15549660,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,,,,,,,,,2021,Q2,Altered state of consciousness,,2021,Q2,4,F,,20210421.0,20181025,20210503,EXP,,PT-AUROBINDO-AUR-APL-2018-051110,AUROBINDO,,73.0,YR,,F,Y,,,20210503.0,,HP,PT,PT,2021,Q2,Elderly
155496604,15549660,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,,,,,,,,,2021,Q2,Anaphylactic reaction,,2021,Q2,4,F,,20210421.0,20181025,20210503,EXP,,PT-AUROBINDO-AUR-APL-2018-051110,AUROBINDO,,73.0,YR,,F,Y,,,20210503.0,,HP,PT,PT,2021,Q2,Elderly
155496604,15549660,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,,,,,,,,,2021,Q2,Anaphylactic shock,,2021,Q2,4,F,,20210421.0,20181025,20210503,EXP,,PT-AUROBINDO-AUR-APL-2018-051110,AUROBINDO,,73.0,YR,,F,Y,,,20210503.0,,HP,PT,PT,2021,Q2,Elderly
155496604,15549660,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,,,,,,,,,2021,Q2,Arteriosclerosis,,2021,Q2,4,F,,20210421.0,20181025,20210503,EXP,,PT-AUROBINDO-AUR-APL-2018-051110,AUROBINDO,,73.0,YR,,F,Y,,,20210503.0,,HP,PT,PT,2021,Q2,Elderly
155496604,15549660,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,,,,,,,,,2021,Q2,Cardio-respiratory arrest,,2021,Q2,4,F,,20210421.0,20181025,20210503,EXP,,PT-AUROBINDO-AUR-APL-2018-051110,AUROBINDO,,73.0,YR,,F,Y,,,20210503.0,,HP,PT,PT,2021,Q2,Elderly
155496604,15549660,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,,,,,,,,,2021,Q2,Electrocardiogram ST segment elevation,,2021,Q2,4,F,,20210421.0,20181025,20210503,EXP,,PT-AUROBINDO-AUR-APL-2018-051110,AUROBINDO,,73.0,YR,,F,Y,,,20210503.0,,HP,PT,PT,2021,Q2,Elderly
155496604,15549660,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,,,,,,,,,2021,Q2,Kounis syndrome,,2021,Q2,4,F,,20210421.0,20181025,20210503,EXP,,PT-AUROBINDO-AUR-APL-2018-051110,AUROBINDO,,73.0,YR,,F,Y,,,20210503.0,,HP,PT,PT,2021,Q2,Elderly
155496604,15549660,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,,,,,,,,,2021,Q2,Rash,,2021,Q2,4,F,,20210421.0,20181025,20210503,EXP,,PT-AUROBINDO-AUR-APL-2018-051110,AUROBINDO,,73.0,YR,,F,Y,,,20210503.0,,HP,PT,PT,2021,Q2,Elderly
155496604,15549660,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,,,,,,,,,2021,Q2,Respiratory arrest,,2021,Q2,4,F,,20210421.0,20181025,20210503,EXP,,PT-AUROBINDO-AUR-APL-2018-051110,AUROBINDO,,73.0,YR,,F,Y,,,20210503.0,,HP,PT,PT,2021,Q2,Elderly
155496604,15549660,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,,,,,,,,,2021,Q2,Shock,,2021,Q2,4,F,,20210421.0,20181025,20210503,EXP,,PT-AUROBINDO-AUR-APL-2018-051110,AUROBINDO,,73.0,YR,,F,Y,,,20210503.0,,HP,PT,PT,2021,Q2,Elderly
157010792,15701079,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30U AM (AT MORNING) 15U PM (AT NIGHT),,,,,,,206538.0,,,SOLUTION FOR INJECTION,Q12H,2021,Q2,Asthenia,,2021,Q2,2,F,2013.0,20210322.0,20181207,20210405,EXP,,US-SA-2018SA328875,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20210405.0,,MD,US,US,2021,Q2,Elderly
157010792,15701079,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30U AM (AT MORNING) 15U PM (AT NIGHT),,,,,,,206538.0,,,SOLUTION FOR INJECTION,Q12H,2021,Q2,Blood glucose decreased,,2021,Q2,2,F,2013.0,20210322.0,20181207,20210405,EXP,,US-SA-2018SA328875,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20210405.0,,MD,US,US,2021,Q2,Elderly
157010792,15701079,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30U AM (AT MORNING) 15U PM (AT NIGHT),,,,,,,206538.0,,,SOLUTION FOR INJECTION,Q12H,2021,Q2,Cardiac failure congestive,,2021,Q2,2,F,2013.0,20210322.0,20181207,20210405,EXP,,US-SA-2018SA328875,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20210405.0,,MD,US,US,2021,Q2,Elderly
157010792,15701079,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30U AM (AT MORNING) 15U PM (AT NIGHT),,,,,,,206538.0,,,SOLUTION FOR INJECTION,Q12H,2021,Q2,Escherichia infection,,2021,Q2,2,F,2013.0,20210322.0,20181207,20210405,EXP,,US-SA-2018SA328875,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20210405.0,,MD,US,US,2021,Q2,Elderly
157010792,15701079,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30U AM (AT MORNING) 15U PM (AT NIGHT),,,,,,,206538.0,,,SOLUTION FOR INJECTION,Q12H,2021,Q2,Nasopharyngitis,,2021,Q2,2,F,2013.0,20210322.0,20181207,20210405,EXP,,US-SA-2018SA328875,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20210405.0,,MD,US,US,2021,Q2,Elderly
157010792,15701079,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30U AM (AT MORNING) 15U PM (AT NIGHT),,,,,,,206538.0,,,SOLUTION FOR INJECTION,Q12H,2021,Q2,Neoplasm malignant,,2021,Q2,2,F,2013.0,20210322.0,20181207,20210405,EXP,,US-SA-2018SA328875,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20210405.0,,MD,US,US,2021,Q2,Elderly
157010792,15701079,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30U AM (AT MORNING) 15U PM (AT NIGHT),,,,,,,206538.0,,,SOLUTION FOR INJECTION,Q12H,2021,Q2,Nephrolithiasis,,2021,Q2,2,F,2013.0,20210322.0,20181207,20210405,EXP,,US-SA-2018SA328875,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20210405.0,,MD,US,US,2021,Q2,Elderly
157010792,15701079,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30U AM (AT MORNING) 15U PM (AT NIGHT),,,,,,,206538.0,,,SOLUTION FOR INJECTION,Q12H,2021,Q2,Peripheral swelling,,2021,Q2,2,F,2013.0,20210322.0,20181207,20210405,EXP,,US-SA-2018SA328875,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20210405.0,,MD,US,US,2021,Q2,Elderly
157010792,15701079,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30U AM (AT MORNING) 15U PM (AT NIGHT),,,,,,,206538.0,,,SOLUTION FOR INJECTION,Q12H,2021,Q2,Pneumonia,,2021,Q2,2,F,2013.0,20210322.0,20181207,20210405,EXP,,US-SA-2018SA328875,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20210405.0,,MD,US,US,2021,Q2,Elderly
157010792,15701079,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30U AM (AT MORNING) 15U PM (AT NIGHT),,,,,,,206538.0,,,SOLUTION FOR INJECTION,Q12H,2021,Q2,Product prescribing issue,,2021,Q2,2,F,2013.0,20210322.0,20181207,20210405,EXP,,US-SA-2018SA328875,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20210405.0,,MD,US,US,2021,Q2,Elderly
157010792,15701079,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30U AM (AT MORNING) 15U PM (AT NIGHT),,,,,,,206538.0,,,SOLUTION FOR INJECTION,Q12H,2021,Q2,Sepsis,,2021,Q2,2,F,2013.0,20210322.0,20181207,20210405,EXP,,US-SA-2018SA328875,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20210405.0,,MD,US,US,2021,Q2,Elderly
157010792,15701079,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30U AM (AT MORNING) 15U PM (AT NIGHT),,,,,,,206538.0,,,SOLUTION FOR INJECTION,Q12H,2021,Q2,Urinary tract infection,,2021,Q2,2,F,2013.0,20210322.0,20181207,20210405,EXP,,US-SA-2018SA328875,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20210405.0,,MD,US,US,2021,Q2,Elderly
1575153110,15751531,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,D,,,,,30.0,IU,,QD,2021,Q2,Cerebral haemorrhage,,2021,Q2,10,F,20180115.0,20210628.0,20181221,20210629,EXP,,PHHY2018DE189162,NOVARTIS,,73.0,YR,,M,Y,117.0,KG,20210629.0,,HP,DE,DE,2021,Q2,Elderly
1575153110,15751531,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,D,,,,,30.0,IU,,QD,2021,Q2,Gamma-glutamyltransferase increased,,2021,Q2,10,F,20180115.0,20210628.0,20181221,20210629,EXP,,PHHY2018DE189162,NOVARTIS,,73.0,YR,,M,Y,117.0,KG,20210629.0,,HP,DE,DE,2021,Q2,Elderly
1575153110,15751531,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,D,,,,,30.0,IU,,QD,2021,Q2,Malignant neoplasm progression,,2021,Q2,10,F,20180115.0,20210628.0,20181221,20210629,EXP,,PHHY2018DE189162,NOVARTIS,,73.0,YR,,M,Y,117.0,KG,20210629.0,,HP,DE,DE,2021,Q2,Elderly
1575153110,15751531,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,D,,,,,30.0,IU,,QD,2021,Q2,Metastases to central nervous system,,2021,Q2,10,F,20180115.0,20210628.0,20181221,20210629,EXP,,PHHY2018DE189162,NOVARTIS,,73.0,YR,,M,Y,117.0,KG,20210629.0,,HP,DE,DE,2021,Q2,Elderly
1575153110,15751531,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,D,,,,,30.0,IU,,QD,2021,Q2,Metastatic malignant melanoma,,2021,Q2,10,F,20180115.0,20210628.0,20181221,20210629,EXP,,PHHY2018DE189162,NOVARTIS,,73.0,YR,,M,Y,117.0,KG,20210629.0,,HP,DE,DE,2021,Q2,Elderly
1575153110,15751531,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,D,,,,,30.0,IU,,QD,2021,Q2,Partial seizures,,2021,Q2,10,F,20180115.0,20210628.0,20181221,20210629,EXP,,PHHY2018DE189162,NOVARTIS,,73.0,YR,,M,Y,117.0,KG,20210629.0,,HP,DE,DE,2021,Q2,Elderly
1575153110,15751531,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,D,,,,,30.0,IU,,QD,2021,Q2,Renal failure,,2021,Q2,10,F,20180115.0,20210628.0,20181221,20210629,EXP,,PHHY2018DE189162,NOVARTIS,,73.0,YR,,M,Y,117.0,KG,20210629.0,,HP,DE,DE,2021,Q2,Elderly
1575153110,15751531,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,D,,,,,30.0,IU,,QD,2021,Q2,Urinary tract infection,,2021,Q2,10,F,20180115.0,20210628.0,20181221,20210629,EXP,,PHHY2018DE189162,NOVARTIS,,73.0,YR,,M,Y,117.0,KG,20210629.0,,HP,DE,DE,2021,Q2,Elderly
163699748,16369974,68,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2021,Q2,Mucosal inflammation,,2021,Q2,8,F,20190517.0,20210521.0,20190530,20210524,EXP,,IT-ROCHE-2326430,ROCHE,,56.0,YR,,F,Y,67.0,KG,20210524.0,,MD,IT,IT,2021,Q2,Adult
1637836111,16378361,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,Q8H,2021,Q2,Asthenia,,2021,Q2,11,F,20140221.0,20210427.0,20190531,20210505,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,51.0,YR,,M,Y,47.0,KG,20210505.0,,CN,CO,CO,2021,Q2,Adult
1637836111,16378361,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,Q8H,2021,Q2,Cellulitis,,2021,Q2,11,F,20140221.0,20210427.0,20190531,20210505,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,51.0,YR,,M,Y,47.0,KG,20210505.0,,CN,CO,CO,2021,Q2,Adult
1637836111,16378361,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,Q8H,2021,Q2,Erythema,,2021,Q2,11,F,20140221.0,20210427.0,20190531,20210505,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,51.0,YR,,M,Y,47.0,KG,20210505.0,,CN,CO,CO,2021,Q2,Adult
1637836111,16378361,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,Q8H,2021,Q2,Fatigue,,2021,Q2,11,F,20140221.0,20210427.0,20190531,20210505,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,51.0,YR,,M,Y,47.0,KG,20210505.0,,CN,CO,CO,2021,Q2,Adult
1637836111,16378361,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,Q8H,2021,Q2,General physical health deterioration,,2021,Q2,11,F,20140221.0,20210427.0,20190531,20210505,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,51.0,YR,,M,Y,47.0,KG,20210505.0,,CN,CO,CO,2021,Q2,Adult
1637836111,16378361,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,Q8H,2021,Q2,Hepatitis,,2021,Q2,11,F,20140221.0,20210427.0,20190531,20210505,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,51.0,YR,,M,Y,47.0,KG,20210505.0,,CN,CO,CO,2021,Q2,Adult
1637836111,16378361,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,Q8H,2021,Q2,Inflammation,,2021,Q2,11,F,20140221.0,20210427.0,20190531,20210505,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,51.0,YR,,M,Y,47.0,KG,20210505.0,,CN,CO,CO,2021,Q2,Adult
1637836111,16378361,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,Q8H,2021,Q2,Oedema peripheral,,2021,Q2,11,F,20140221.0,20210427.0,20190531,20210505,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,51.0,YR,,M,Y,47.0,KG,20210505.0,,CN,CO,CO,2021,Q2,Adult
1637836111,16378361,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,Q8H,2021,Q2,Pain in extremity,,2021,Q2,11,F,20140221.0,20210427.0,20190531,20210505,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,51.0,YR,,M,Y,47.0,KG,20210505.0,,CN,CO,CO,2021,Q2,Adult
1637836111,16378361,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,Q8H,2021,Q2,Portal vein phlebitis,,2021,Q2,11,F,20140221.0,20210427.0,20190531,20210505,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,51.0,YR,,M,Y,47.0,KG,20210505.0,,CN,CO,CO,2021,Q2,Adult
1637836111,16378361,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,Q8H,2021,Q2,Product availability issue,,2021,Q2,11,F,20140221.0,20210427.0,20190531,20210505,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,51.0,YR,,M,Y,47.0,KG,20210505.0,,CN,CO,CO,2021,Q2,Adult
1637836111,16378361,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,Q8H,2021,Q2,Product packaging quantity issue,,2021,Q2,11,F,20140221.0,20210427.0,20190531,20210505,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,51.0,YR,,M,Y,47.0,KG,20210505.0,,CN,CO,CO,2021,Q2,Adult
1637836111,16378361,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,Q8H,2021,Q2,Product use in unapproved indication,,2021,Q2,11,F,20140221.0,20210427.0,20190531,20210505,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,51.0,YR,,M,Y,47.0,KG,20210505.0,,CN,CO,CO,2021,Q2,Adult
1637836111,16378361,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,Q8H,2021,Q2,Splenitis,,2021,Q2,11,F,20140221.0,20210427.0,20190531,20210505,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,51.0,YR,,M,Y,47.0,KG,20210505.0,,CN,CO,CO,2021,Q2,Adult
1637836111,16378361,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,Q8H,2021,Q2,Urinary tract infection,,2021,Q2,11,F,20140221.0,20210427.0,20190531,20210505,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,51.0,YR,,M,Y,47.0,KG,20210505.0,,CN,CO,CO,2021,Q2,Adult
1637836111,16378361,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,Q8H,2021,Q2,Weight decreased,,2021,Q2,11,F,20140221.0,20210427.0,20190531,20210505,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,51.0,YR,,M,Y,47.0,KG,20210505.0,,CN,CO,CO,2021,Q2,Adult
163879563,16387956,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML,,,,,,,,,,,,2021,Q2,Abdominal distension,,2021,Q2,3,F,20190401.0,20210623.0,20190604,20210630,EXP,,US-BAUSCH-BL-2019-016082,BAUSCH AND LOMB,,72.0,YR,,M,Y,,,20210630.0,,CN,US,US,2021,Q2,Elderly
163879563,16387956,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML,,,,,,,,,,,,2021,Q2,Adverse event,,2021,Q2,3,F,20190401.0,20210623.0,20190604,20210630,EXP,,US-BAUSCH-BL-2019-016082,BAUSCH AND LOMB,,72.0,YR,,M,Y,,,20210630.0,,CN,US,US,2021,Q2,Elderly
163879563,16387956,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML,,,,,,,,,,,,2021,Q2,Agitation,,2021,Q2,3,F,20190401.0,20210623.0,20190604,20210630,EXP,,US-BAUSCH-BL-2019-016082,BAUSCH AND LOMB,,72.0,YR,,M,Y,,,20210630.0,,CN,US,US,2021,Q2,Elderly
163879563,16387956,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML,,,,,,,,,,,,2021,Q2,Confusional state,,2021,Q2,3,F,20190401.0,20210623.0,20190604,20210630,EXP,,US-BAUSCH-BL-2019-016082,BAUSCH AND LOMB,,72.0,YR,,M,Y,,,20210630.0,,CN,US,US,2021,Q2,Elderly
163879563,16387956,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML,,,,,,,,,,,,2021,Q2,Hospitalisation,,2021,Q2,3,F,20190401.0,20210623.0,20190604,20210630,EXP,,US-BAUSCH-BL-2019-016082,BAUSCH AND LOMB,,72.0,YR,,M,Y,,,20210630.0,,CN,US,US,2021,Q2,Elderly
163879563,16387956,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML,,,,,,,,,,,,2021,Q2,Inability to afford medication,,2021,Q2,3,F,20190401.0,20210623.0,20190604,20210630,EXP,,US-BAUSCH-BL-2019-016082,BAUSCH AND LOMB,,72.0,YR,,M,Y,,,20210630.0,,CN,US,US,2021,Q2,Elderly
163879563,16387956,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML,,,,,,,,,,,,2021,Q2,Jaundice,,2021,Q2,3,F,20190401.0,20210623.0,20190604,20210630,EXP,,US-BAUSCH-BL-2019-016082,BAUSCH AND LOMB,,72.0,YR,,M,Y,,,20210630.0,,CN,US,US,2021,Q2,Elderly
164137692,16413769,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,60 U IN AM AND 70 U IN PM,,,,, A8161,,206538.0,,,SOLUTION FOR INJECTION,Q12H,2021,Q2,Cholecystectomy,,2021,Q2,2,F,19970311.0,20210409.0,20190611,20210416,EXP,,US-SA-2019SA154719,SANOFI AVENTIS,,70.0,YR,E,M,Y,,,20210416.0,,CN,US,US,2021,Q2,Elderly
164137692,16413769,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,60 U IN AM AND 70 U IN PM,,,,, A8161,,206538.0,,,SOLUTION FOR INJECTION,Q12H,2021,Q2,Eye operation,,2021,Q2,2,F,19970311.0,20210409.0,20190611,20210416,EXP,,US-SA-2019SA154719,SANOFI AVENTIS,,70.0,YR,E,M,Y,,,20210416.0,,CN,US,US,2021,Q2,Elderly
164137692,16413769,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,60 U IN AM AND 70 U IN PM,,,,, A8161,,206538.0,,,SOLUTION FOR INJECTION,Q12H,2021,Q2,Glycosylated haemoglobin increased,,2021,Q2,2,F,19970311.0,20210409.0,20190611,20210416,EXP,,US-SA-2019SA154719,SANOFI AVENTIS,,70.0,YR,E,M,Y,,,20210416.0,,CN,US,US,2021,Q2,Elderly
164137692,16413769,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,60 U IN AM AND 70 U IN PM,,,,, A8161,,206538.0,,,SOLUTION FOR INJECTION,Q12H,2021,Q2,Inappropriate schedule of product administration,,2021,Q2,2,F,19970311.0,20210409.0,20190611,20210416,EXP,,US-SA-2019SA154719,SANOFI AVENTIS,,70.0,YR,E,M,Y,,,20210416.0,,CN,US,US,2021,Q2,Elderly
164137692,16413769,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,60 U IN AM AND 70 U IN PM,,,,, A8161,,206538.0,,,SOLUTION FOR INJECTION,Q12H,2021,Q2,Myocardial infarction,,2021,Q2,2,F,19970311.0,20210409.0,20190611,20210416,EXP,,US-SA-2019SA154719,SANOFI AVENTIS,,70.0,YR,E,M,Y,,,20210416.0,,CN,US,US,2021,Q2,Elderly
164137692,16413769,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,60 U IN AM AND 70 U IN PM,,,,, A8161,,206538.0,,,SOLUTION FOR INJECTION,Q12H,2021,Q2,Product dose omission issue,,2021,Q2,2,F,19970311.0,20210409.0,20190611,20210416,EXP,,US-SA-2019SA154719,SANOFI AVENTIS,,70.0,YR,E,M,Y,,,20210416.0,,CN,US,US,2021,Q2,Elderly
164648343,16464834,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Blood cholesterol increased,,2021,Q2,3,F,,20210129.0,20190621,20210421,EXP,,ES-SYNTHON BV-IN51PV19_48906,SYNTHON,,72.0,YR,,M,Y,,,20210421.0,,PH,ES,ES,2021,Q2,Elderly
164648343,16464834,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Blood triglycerides increased,,2021,Q2,3,F,,20210129.0,20190621,20210421,EXP,,ES-SYNTHON BV-IN51PV19_48906,SYNTHON,,72.0,YR,,M,Y,,,20210421.0,,PH,ES,ES,2021,Q2,Elderly
164648343,16464834,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Fatigue,,2021,Q2,3,F,,20210129.0,20190621,20210421,EXP,,ES-SYNTHON BV-IN51PV19_48906,SYNTHON,,72.0,YR,,M,Y,,,20210421.0,,PH,ES,ES,2021,Q2,Elderly
164648343,16464834,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Hyperglycaemia,,2021,Q2,3,F,,20210129.0,20190621,20210421,EXP,,ES-SYNTHON BV-IN51PV19_48906,SYNTHON,,72.0,YR,,M,Y,,,20210421.0,,PH,ES,ES,2021,Q2,Elderly
164648343,16464834,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Hypertension,,2021,Q2,3,F,,20210129.0,20190621,20210421,EXP,,ES-SYNTHON BV-IN51PV19_48906,SYNTHON,,72.0,YR,,M,Y,,,20210421.0,,PH,ES,ES,2021,Q2,Elderly
164648343,16464834,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Overdose,,2021,Q2,3,F,,20210129.0,20190621,20210421,EXP,,ES-SYNTHON BV-IN51PV19_48906,SYNTHON,,72.0,YR,,M,Y,,,20210421.0,,PH,ES,ES,2021,Q2,Elderly
164648343,16464834,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Treatment noncompliance,,2021,Q2,3,F,,20210129.0,20190621,20210421,EXP,,ES-SYNTHON BV-IN51PV19_48906,SYNTHON,,72.0,YR,,M,Y,,,20210421.0,,PH,ES,ES,2021,Q2,Elderly
1656848119,16568481,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Anaemia,,2021,Q2,19,F,20190610.0,20210608.0,20190712,20210611,EXP,,PHHY2019FR161521,NOVARTIS,,74.0,YR,,M,Y,88.0,KG,20210611.0,,MD,FR,FR,2021,Q2,Elderly
1656848119,16568481,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Angina pectoris,,2021,Q2,19,F,20190610.0,20210608.0,20190712,20210611,EXP,,PHHY2019FR161521,NOVARTIS,,74.0,YR,,M,Y,88.0,KG,20210611.0,,MD,FR,FR,2021,Q2,Elderly
1656848119,16568481,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Cytomegalovirus test positive,,2021,Q2,19,F,20190610.0,20210608.0,20190712,20210611,EXP,,PHHY2019FR161521,NOVARTIS,,74.0,YR,,M,Y,88.0,KG,20210611.0,,MD,FR,FR,2021,Q2,Elderly
1656848119,16568481,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Endocarditis,,2021,Q2,19,F,20190610.0,20210608.0,20190712,20210611,EXP,,PHHY2019FR161521,NOVARTIS,,74.0,YR,,M,Y,88.0,KG,20210611.0,,MD,FR,FR,2021,Q2,Elderly
1656848119,16568481,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Pyrexia,,2021,Q2,19,F,20190610.0,20210608.0,20190712,20210611,EXP,,PHHY2019FR161521,NOVARTIS,,74.0,YR,,M,Y,88.0,KG,20210611.0,,MD,FR,FR,2021,Q2,Elderly
1656848119,16568481,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Renal impairment,,2021,Q2,19,F,20190610.0,20210608.0,20190712,20210611,EXP,,PHHY2019FR161521,NOVARTIS,,74.0,YR,,M,Y,88.0,KG,20210611.0,,MD,FR,FR,2021,Q2,Elderly
1656848119,16568481,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Skin ulcer,,2021,Q2,19,F,20190610.0,20210608.0,20190712,20210611,EXP,,PHHY2019FR161521,NOVARTIS,,74.0,YR,,M,Y,88.0,KG,20210611.0,,MD,FR,FR,2021,Q2,Elderly
1656848119,16568481,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Tooth abscess,,2021,Q2,19,F,20190610.0,20210608.0,20190712,20210611,EXP,,PHHY2019FR161521,NOVARTIS,,74.0,YR,,M,Y,88.0,KG,20210611.0,,MD,FR,FR,2021,Q2,Elderly
1656848119,16568481,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Urinary tract infection,,2021,Q2,19,F,20190610.0,20210608.0,20190712,20210611,EXP,,PHHY2019FR161521,NOVARTIS,,74.0,YR,,M,Y,88.0,KG,20210611.0,,MD,FR,FR,2021,Q2,Elderly
166864032,16686403,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Hepatocellular carcinoma,,2021,Q2,2,F,20180531.0,20210505.0,20190809,20210517,EXP,FR-AFSSAPS-NY20191247,FR-ACCORD-150691,ACCORD,,66.0,YR,,M,Y,58.0,KG,20210517.0,,HP,FR,FR,2021,Q2,Elderly
173607195,17360719,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 IN THE EVENING,,,Y,,,,,,,INJECTION,,2021,Q2,Diabetic ketoacidosis,,2021,Q2,5,F,20200113.0,20210601.0,20200203,20210607,EXP,,JP-ASTRAZENECA-2020SE13889,ASTRAZENECA,,16464.0,DY,,F,Y,42.0,KG,20210607.0,,,JP,JP,2021,Q2,Elderly
173607195,17360719,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 IN THE EVENING,,,Y,,,,,,,INJECTION,,2021,Q2,Influenza,,2021,Q2,5,F,20200113.0,20210601.0,20200203,20210607,EXP,,JP-ASTRAZENECA-2020SE13889,ASTRAZENECA,,16464.0,DY,,F,Y,42.0,KG,20210607.0,,,JP,JP,2021,Q2,Elderly
173607195,17360719,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,10 UNITS IN THE EVENING,,,Y,,,,,,,INJECTION,,2021,Q2,Diabetic ketoacidosis,,2021,Q2,5,F,20200113.0,20210601.0,20200203,20210607,EXP,,JP-ASTRAZENECA-2020SE13889,ASTRAZENECA,,16464.0,DY,,F,Y,42.0,KG,20210607.0,,,JP,JP,2021,Q2,Elderly
173607195,17360719,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,10 UNITS IN THE EVENING,,,Y,,,,,,,INJECTION,,2021,Q2,Influenza,,2021,Q2,5,F,20200113.0,20210601.0,20200203,20210607,EXP,,JP-ASTRAZENECA-2020SE13889,ASTRAZENECA,,16464.0,DY,,F,Y,42.0,KG,20210607.0,,,JP,JP,2021,Q2,Elderly
174008458,17400845,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML (3ML) INSULIN PEN INTO THE SKIN NIGHTLY FOR 90 DAYS,,,,,,,,20.0,IU,,,2021,Q2,Death,,2021,Q2,8,F,2020.0,20210329.0,20200211,20210402,EXP,,US-ABBVIE-20K-163-3269659-00,ABBVIE,,71.0,YR,,M,Y,118.04,KG,20210402.0,,HP,US,US,2021,Q2,Elderly
174008458,17400845,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML (3ML) INSULIN PEN INTO THE SKIN NIGHTLY FOR 90 DAYS,,,,,,,,20.0,IU,,,2021,Q2,Dyspnoea,,2021,Q2,8,F,2020.0,20210329.0,20200211,20210402,EXP,,US-ABBVIE-20K-163-3269659-00,ABBVIE,,71.0,YR,,M,Y,118.04,KG,20210402.0,,HP,US,US,2021,Q2,Elderly
174008458,17400845,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML (3ML) INSULIN PEN INTO THE SKIN NIGHTLY FOR 90 DAYS,,,,,,,,20.0,IU,,,2021,Q2,Ear haemorrhage,,2021,Q2,8,F,2020.0,20210329.0,20200211,20210402,EXP,,US-ABBVIE-20K-163-3269659-00,ABBVIE,,71.0,YR,,M,Y,118.04,KG,20210402.0,,HP,US,US,2021,Q2,Elderly
174008458,17400845,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML (3ML) INSULIN PEN INTO THE SKIN NIGHTLY FOR 90 DAYS,,,,,,,,20.0,IU,,,2021,Q2,Enzyme level increased,,2021,Q2,8,F,2020.0,20210329.0,20200211,20210402,EXP,,US-ABBVIE-20K-163-3269659-00,ABBVIE,,71.0,YR,,M,Y,118.04,KG,20210402.0,,HP,US,US,2021,Q2,Elderly
174008458,17400845,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML (3ML) INSULIN PEN INTO THE SKIN NIGHTLY FOR 90 DAYS,,,,,,,,20.0,IU,,,2021,Q2,Off label use,,2021,Q2,8,F,2020.0,20210329.0,20200211,20210402,EXP,,US-ABBVIE-20K-163-3269659-00,ABBVIE,,71.0,YR,,M,Y,118.04,KG,20210402.0,,HP,US,US,2021,Q2,Elderly
174008458,17400845,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML (3ML) INSULIN PEN INTO THE SKIN NIGHTLY FOR 90 DAYS,,,,,,,,20.0,IU,,,2021,Q2,Product dispensing error,,2021,Q2,8,F,2020.0,20210329.0,20200211,20210402,EXP,,US-ABBVIE-20K-163-3269659-00,ABBVIE,,71.0,YR,,M,Y,118.04,KG,20210402.0,,HP,US,US,2021,Q2,Elderly
175539606,17553960,23,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Blood pressure increased,,2021,Q2,6,F,20191119.0,20210426.0,20200317,20210430,EXP,,JP-BEH-2020114465,CSL BEHRING,,36.0,YR,A,M,Y,95.6,KG,20210430.0,,MD,JP,JP,2021,Q2,Adult
175539606,17553960,23,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Diabetic nephropathy,,2021,Q2,6,F,20191119.0,20210426.0,20200317,20210430,EXP,,JP-BEH-2020114465,CSL BEHRING,,36.0,YR,A,M,Y,95.6,KG,20210430.0,,MD,JP,JP,2021,Q2,Adult
175539606,17553960,23,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Hypertension,,2021,Q2,6,F,20191119.0,20210426.0,20200317,20210430,EXP,,JP-BEH-2020114465,CSL BEHRING,,36.0,YR,A,M,Y,95.6,KG,20210430.0,,MD,JP,JP,2021,Q2,Adult
175539606,17553960,23,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Oedema,,2021,Q2,6,F,20191119.0,20210426.0,20200317,20210430,EXP,,JP-BEH-2020114465,CSL BEHRING,,36.0,YR,A,M,Y,95.6,KG,20210430.0,,MD,JP,JP,2021,Q2,Adult
175539606,17553960,23,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Oedema peripheral,,2021,Q2,6,F,20191119.0,20210426.0,20200317,20210430,EXP,,JP-BEH-2020114465,CSL BEHRING,,36.0,YR,A,M,Y,95.6,KG,20210430.0,,MD,JP,JP,2021,Q2,Adult
175539606,17553960,23,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Protein urine present,,2021,Q2,6,F,20191119.0,20210426.0,20200317,20210430,EXP,,JP-BEH-2020114465,CSL BEHRING,,36.0,YR,A,M,Y,95.6,KG,20210430.0,,MD,JP,JP,2021,Q2,Adult
175539606,17553960,23,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Renal impairment,,2021,Q2,6,F,20191119.0,20210426.0,20200317,20210430,EXP,,JP-BEH-2020114465,CSL BEHRING,,36.0,YR,A,M,Y,95.6,KG,20210430.0,,MD,JP,JP,2021,Q2,Adult
175608634,17560863,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,4,F,,20210426.0,20200319,20210428,EXP,,PT-MYLANLABS-2020M1028430,MYLAN,,61.0,YR,,M,Y,,,20210428.0,,HP,PT,PT,2021,Q2,Adult
175608634,17560863,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,INJECTION,,2021,Q2,Drug ineffective,,2021,Q2,4,F,,20210426.0,20200319,20210428,EXP,,PT-MYLANLABS-2020M1028430,MYLAN,,61.0,YR,,M,Y,,,20210428.0,,HP,PT,PT,2021,Q2,Adult
175608634,17560863,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,INJECTION,,2021,Q2,Gastrointestinal disorder,,2021,Q2,4,F,,20210426.0,20200319,20210428,EXP,,PT-MYLANLABS-2020M1028430,MYLAN,,61.0,YR,,M,Y,,,20210428.0,,HP,PT,PT,2021,Q2,Adult
175608634,17560863,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,INJECTION,,2021,Q2,Product administration error,,2021,Q2,4,F,,20210426.0,20200319,20210428,EXP,,PT-MYLANLABS-2020M1028430,MYLAN,,61.0,YR,,M,Y,,,20210428.0,,HP,PT,PT,2021,Q2,Adult
175608634,17560863,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,INJECTION,,2021,Q2,Urinary tract disorder,,2021,Q2,4,F,,20210426.0,20200319,20210428,EXP,,PT-MYLANLABS-2020M1028430,MYLAN,,61.0,YR,,M,Y,,,20210428.0,,HP,PT,PT,2021,Q2,Adult
175848756,17584875,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Infection in an immunocompromised host,,2021,Q2,6,F,2020.0,20210517.0,20200326,20210526,EXP,,US-VERTEX PHARMACEUTICALS-2020-006304,VERTEX,,16.0,YR,,M,Y,54.0,KG,20210526.0,,HP,US,US,2021,Q2,Youth
175848756,17584875,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Liver transplant rejection,,2021,Q2,6,F,2020.0,20210517.0,20200326,20210526,EXP,,US-VERTEX PHARMACEUTICALS-2020-006304,VERTEX,,16.0,YR,,M,Y,54.0,KG,20210526.0,,HP,US,US,2021,Q2,Youth
175848756,17584875,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Postoperative adhesion,,2021,Q2,6,F,2020.0,20210517.0,20200326,20210526,EXP,,US-VERTEX PHARMACEUTICALS-2020-006304,VERTEX,,16.0,YR,,M,Y,54.0,KG,20210526.0,,HP,US,US,2021,Q2,Youth
175848756,17584875,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Volvulus,,2021,Q2,6,F,2020.0,20210517.0,20200326,20210526,EXP,,US-VERTEX PHARMACEUTICALS-2020-006304,VERTEX,,16.0,YR,,M,Y,54.0,KG,20210526.0,,HP,US,US,2021,Q2,Youth
175848756,17584875,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Weight decreased,,2021,Q2,6,F,2020.0,20210517.0,20200326,20210526,EXP,,US-VERTEX PHARMACEUTICALS-2020-006304,VERTEX,,16.0,YR,,M,Y,54.0,KG,20210526.0,,HP,US,US,2021,Q2,Youth
176562983,17656298,5,C,GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,12.0,IU,INJECTION,QD,2021,Q2,Diabetic ketosis,,2021,Q2,3,F,20180820.0,20191002.0,20200410,20210626,EXP,,CN-ASTRAZENECA-2020SE49165,ASTRAZENECA,,8605.0,DY,,M,Y,,,20210626.0,,MD,CN,CN,2021,Q2,Elderly
176890087,17689008,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Depressed mood,,2021,Q2,7,F,202006.0,20210525.0,20200421,20210601,PER,,US-VERTEX PHARMACEUTICALS-2020-004716,VERTEX,,33.0,YR,,F,Y,57.0,KG,20210601.0,,CN,US,US,2021,Q2,Young Adult
176890087,17689008,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Fatigue,,2021,Q2,7,F,202006.0,20210525.0,20200421,20210601,PER,,US-VERTEX PHARMACEUTICALS-2020-004716,VERTEX,,33.0,YR,,F,Y,57.0,KG,20210601.0,,CN,US,US,2021,Q2,Young Adult
176890087,17689008,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Weight increased,,2021,Q2,7,F,202006.0,20210525.0,20200421,20210601,PER,,US-VERTEX PHARMACEUTICALS-2020-004716,VERTEX,,33.0,YR,,F,Y,57.0,KG,20210601.0,,CN,US,US,2021,Q2,Young Adult
177034583,17703458,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Acute kidney injury,,2021,Q2,3,F,2014.0,20210408.0,20200424,20210413,EXP,,US-ASTRAZENECA-2020SE53993,ASTRAZENECA,,57.0,YR,,M,Y,119.7,KG,20210413.0,,,US,US,2021,Q2,Adult
177034583,17703458,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Chronic kidney disease,,2021,Q2,3,F,2014.0,20210408.0,20200424,20210413,EXP,,US-ASTRAZENECA-2020SE53993,ASTRAZENECA,,57.0,YR,,M,Y,119.7,KG,20210413.0,,,US,US,2021,Q2,Adult
177034583,17703458,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Chronic kidney disease-mineral and bone disorder,,2021,Q2,3,F,2014.0,20210408.0,20200424,20210413,EXP,,US-ASTRAZENECA-2020SE53993,ASTRAZENECA,,57.0,YR,,M,Y,119.7,KG,20210413.0,,,US,US,2021,Q2,Adult
177034583,17703458,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Death,,2021,Q2,3,F,2014.0,20210408.0,20200424,20210413,EXP,,US-ASTRAZENECA-2020SE53993,ASTRAZENECA,,57.0,YR,,M,Y,119.7,KG,20210413.0,,,US,US,2021,Q2,Adult
177034583,17703458,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,End stage renal disease,,2021,Q2,3,F,2014.0,20210408.0,20200424,20210413,EXP,,US-ASTRAZENECA-2020SE53993,ASTRAZENECA,,57.0,YR,,M,Y,119.7,KG,20210413.0,,,US,US,2021,Q2,Adult
177034583,17703458,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Nephrogenic anaemia,,2021,Q2,3,F,2014.0,20210408.0,20200424,20210413,EXP,,US-ASTRAZENECA-2020SE53993,ASTRAZENECA,,57.0,YR,,M,Y,119.7,KG,20210413.0,,,US,US,2021,Q2,Adult
177034583,17703458,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Renal failure,,2021,Q2,3,F,2014.0,20210408.0,20200424,20210413,EXP,,US-ASTRAZENECA-2020SE53993,ASTRAZENECA,,57.0,YR,,M,Y,119.7,KG,20210413.0,,,US,US,2021,Q2,Adult
177488646,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Abdominal pain,,2021,Q2,6,F,20191117.0,20210609.0,20200506,20210615,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210615.0,,CN,NL,NL,2021,Q2,Adult
177488646,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Confusional state,,2021,Q2,6,F,20191117.0,20210609.0,20200506,20210615,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210615.0,,CN,NL,NL,2021,Q2,Adult
177488646,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Crying,,2021,Q2,6,F,20191117.0,20210609.0,20200506,20210615,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210615.0,,CN,NL,NL,2021,Q2,Adult
177488646,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Depressed mood,,2021,Q2,6,F,20191117.0,20210609.0,20200506,20210615,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210615.0,,CN,NL,NL,2021,Q2,Adult
177488646,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Diarrhoea,,2021,Q2,6,F,20191117.0,20210609.0,20200506,20210615,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210615.0,,CN,NL,NL,2021,Q2,Adult
177488646,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Dyskinesia,,2021,Q2,6,F,20191117.0,20210609.0,20200506,20210615,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210615.0,,CN,NL,NL,2021,Q2,Adult
177488646,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Fall,,2021,Q2,6,F,20191117.0,20210609.0,20200506,20210615,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210615.0,,CN,NL,NL,2021,Q2,Adult
177488646,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Gait disturbance,,2021,Q2,6,F,20191117.0,20210609.0,20200506,20210615,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210615.0,,CN,NL,NL,2021,Q2,Adult
177488646,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Impaired gastric emptying,,2021,Q2,6,F,20191117.0,20210609.0,20200506,20210615,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210615.0,,CN,NL,NL,2021,Q2,Adult
177488646,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Impaired quality of life,,2021,Q2,6,F,20191117.0,20210609.0,20200506,20210615,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210615.0,,CN,NL,NL,2021,Q2,Adult
177488646,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Limb discomfort,,2021,Q2,6,F,20191117.0,20210609.0,20200506,20210615,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210615.0,,CN,NL,NL,2021,Q2,Adult
177488646,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Limb operation,,2021,Q2,6,F,20191117.0,20210609.0,20200506,20210615,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210615.0,,CN,NL,NL,2021,Q2,Adult
177488646,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Malaise,,2021,Q2,6,F,20191117.0,20210609.0,20200506,20210615,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210615.0,,CN,NL,NL,2021,Q2,Adult
177488646,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Memory impairment,,2021,Q2,6,F,20191117.0,20210609.0,20200506,20210615,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210615.0,,CN,NL,NL,2021,Q2,Adult
177488646,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Mood altered,,2021,Q2,6,F,20191117.0,20210609.0,20200506,20210615,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210615.0,,CN,NL,NL,2021,Q2,Adult
177488646,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Muscle rigidity,,2021,Q2,6,F,20191117.0,20210609.0,20200506,20210615,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210615.0,,CN,NL,NL,2021,Q2,Adult
177488646,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Muscular weakness,,2021,Q2,6,F,20191117.0,20210609.0,20200506,20210615,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210615.0,,CN,NL,NL,2021,Q2,Adult
177488646,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Nausea,,2021,Q2,6,F,20191117.0,20210609.0,20200506,20210615,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210615.0,,CN,NL,NL,2021,Q2,Adult
177488646,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,On and off phenomenon,,2021,Q2,6,F,20191117.0,20210609.0,20200506,20210615,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210615.0,,CN,NL,NL,2021,Q2,Adult
177488646,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Panic reaction,,2021,Q2,6,F,20191117.0,20210609.0,20200506,20210615,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210615.0,,CN,NL,NL,2021,Q2,Adult
177488646,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Procedural pain,,2021,Q2,6,F,20191117.0,20210609.0,20200506,20210615,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210615.0,,CN,NL,NL,2021,Q2,Adult
177488646,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Protein total increased,,2021,Q2,6,F,20191117.0,20210609.0,20200506,20210615,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210615.0,,CN,NL,NL,2021,Q2,Adult
177488646,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Psychiatric symptom,,2021,Q2,6,F,20191117.0,20210609.0,20200506,20210615,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210615.0,,CN,NL,NL,2021,Q2,Adult
177488646,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Serum ferritin increased,,2021,Q2,6,F,20191117.0,20210609.0,20200506,20210615,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210615.0,,CN,NL,NL,2021,Q2,Adult
177488646,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Sleep disorder due to a general medical condition,,2021,Q2,6,F,20191117.0,20210609.0,20200506,20210615,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210615.0,,CN,NL,NL,2021,Q2,Adult
177488646,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Stoma site erythema,,2021,Q2,6,F,20191117.0,20210609.0,20200506,20210615,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210615.0,,CN,NL,NL,2021,Q2,Adult
177488646,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Stoma site infection,,2021,Q2,6,F,20191117.0,20210609.0,20200506,20210615,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210615.0,,CN,NL,NL,2021,Q2,Adult
177488646,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Stress,,2021,Q2,6,F,20191117.0,20210609.0,20200506,20210615,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210615.0,,CN,NL,NL,2021,Q2,Adult
177488646,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Tension,,2021,Q2,6,F,20191117.0,20210609.0,20200506,20210615,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210615.0,,CN,NL,NL,2021,Q2,Adult
177488646,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Therapeutic response shortened,,2021,Q2,6,F,20191117.0,20210609.0,20200506,20210615,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210615.0,,CN,NL,NL,2021,Q2,Adult
177488646,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Transferrin decreased,,2021,Q2,6,F,20191117.0,20210609.0,20200506,20210615,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210615.0,,CN,NL,NL,2021,Q2,Adult
177488646,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Tremor,,2021,Q2,6,F,20191117.0,20210609.0,20200506,20210615,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210615.0,,CN,NL,NL,2021,Q2,Adult
177488646,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Urinary tract infection,,2021,Q2,6,F,20191117.0,20210609.0,20200506,20210615,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210615.0,,CN,NL,NL,2021,Q2,Adult
177488646,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Vomiting,,2021,Q2,6,F,20191117.0,20210609.0,20200506,20210615,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210615.0,,CN,NL,NL,2021,Q2,Adult
177488646,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Weight decreased,,2021,Q2,6,F,20191117.0,20210609.0,20200506,20210615,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210615.0,,CN,NL,NL,2021,Q2,Adult
178338252,17833825,4,C,INSULIN GLARGINE BIOSIMILAR 1,,2,Subcutaneous,,,,U,,,,,,,,,2021,Q2,Jaundice,,2021,Q2,2,F,20200415.0,20210414.0,20200528,20210420,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-024254",BOEHRINGER INGELHEIM,,74.0,YR,E,M,Y,,,20210420.0,,MD,JP,JP,2021,Q2,Elderly
178338252,17833825,4,C,INSULIN GLARGINE BIOSIMILAR 1,,2,Subcutaneous,,,,U,,,,,,,,,2021,Q2,Lymphadenopathy,,2021,Q2,2,F,20200415.0,20210414.0,20200528,20210420,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-024254",BOEHRINGER INGELHEIM,,74.0,YR,E,M,Y,,,20210420.0,,MD,JP,JP,2021,Q2,Elderly
178338252,17833825,4,C,INSULIN GLARGINE BIOSIMILAR 1,,2,Subcutaneous,,,,U,,,,,,,,,2021,Q2,Metastases to peritoneum,,2021,Q2,2,F,20200415.0,20210414.0,20200528,20210420,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-024254",BOEHRINGER INGELHEIM,,74.0,YR,E,M,Y,,,20210420.0,,MD,JP,JP,2021,Q2,Elderly
178338252,17833825,4,C,INSULIN GLARGINE BIOSIMILAR 1,,2,Subcutaneous,,,,U,,,,,,,,,2021,Q2,Pancreatitis acute,,2021,Q2,2,F,20200415.0,20210414.0,20200528,20210420,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-024254",BOEHRINGER INGELHEIM,,74.0,YR,E,M,Y,,,20210420.0,,MD,JP,JP,2021,Q2,Elderly
178338252,17833825,5,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,,2021,Q2,Jaundice,,2021,Q2,2,F,20200415.0,20210414.0,20200528,20210420,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-024254",BOEHRINGER INGELHEIM,,74.0,YR,E,M,Y,,,20210420.0,,MD,JP,JP,2021,Q2,Elderly
178338252,17833825,5,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,,2021,Q2,Lymphadenopathy,,2021,Q2,2,F,20200415.0,20210414.0,20200528,20210420,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-024254",BOEHRINGER INGELHEIM,,74.0,YR,E,M,Y,,,20210420.0,,MD,JP,JP,2021,Q2,Elderly
178338252,17833825,5,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,,2021,Q2,Metastases to peritoneum,,2021,Q2,2,F,20200415.0,20210414.0,20200528,20210420,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-024254",BOEHRINGER INGELHEIM,,74.0,YR,E,M,Y,,,20210420.0,,MD,JP,JP,2021,Q2,Elderly
178338252,17833825,5,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,,2021,Q2,Pancreatitis acute,,2021,Q2,2,F,20200415.0,20210414.0,20200528,20210420,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-024254",BOEHRINGER INGELHEIM,,74.0,YR,E,M,Y,,,20210420.0,,MD,JP,JP,2021,Q2,Elderly
178341136,17834113,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED,,,Y,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Anal incontinence,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178341136,17834113,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED,,,Y,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Asthenia,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178341136,17834113,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED,,,Y,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178341136,17834113,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED,,,Y,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Boredom,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178341136,17834113,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED,,,Y,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Diabetes mellitus inadequate control,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178341136,17834113,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED,,,Y,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Diarrhoea,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178341136,17834113,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED,,,Y,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Drug ineffective,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178341136,17834113,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED,,,Y,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Feeling abnormal,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178341136,17834113,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED,,,Y,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Hypoglycaemia,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178341136,17834113,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED,,,Y,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Injection site pain,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178341136,17834113,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED,,,Y,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Malaise,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178341136,17834113,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED,,,Y,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Multiple use of single-use product,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178341136,17834113,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED,,,Y,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Product storage error,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178341136,17834113,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED,,,Y,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Psychiatric symptom,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178341136,17834113,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED,,,Y,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Tremor,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178341136,17834113,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Anal incontinence,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178341136,17834113,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Asthenia,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178341136,17834113,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178341136,17834113,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Boredom,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178341136,17834113,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Diabetes mellitus inadequate control,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178341136,17834113,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Diarrhoea,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178341136,17834113,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Drug ineffective,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178341136,17834113,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Feeling abnormal,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178341136,17834113,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Hypoglycaemia,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178341136,17834113,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Injection site pain,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178341136,17834113,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Malaise,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178341136,17834113,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Multiple use of single-use product,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178341136,17834113,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Product storage error,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178341136,17834113,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Psychiatric symptom,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178341136,17834113,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Tremor,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178341136,17834113,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Anal incontinence,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178341136,17834113,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Asthenia,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178341136,17834113,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178341136,17834113,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Boredom,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178341136,17834113,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Diabetes mellitus inadequate control,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178341136,17834113,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Diarrhoea,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178341136,17834113,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Drug ineffective,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178341136,17834113,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Feeling abnormal,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178341136,17834113,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Hypoglycaemia,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178341136,17834113,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Injection site pain,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178341136,17834113,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Malaise,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178341136,17834113,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Multiple use of single-use product,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178341136,17834113,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Product storage error,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178341136,17834113,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Psychiatric symptom,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178341136,17834113,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Tremor,,2021,Q2,6,F,2020.0,20210614.0,20200528,20210628,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20210628.0,,HP,ES,ES,2021,Q2,Elderly
178759017,17875901,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 U,,,,,,,,,,,QD,2021,Q2,Blood creatinine increased,,2021,Q2,7,F,20200603.0,20210406.0,20200609,20210409,EXP,,ES-ROCHE-2616155,ROCHE,,71.0,YR,,M,Y,93.2,KG,20210409.0,,MD,ES,ES,2021,Q2,Elderly
178868342,17886834,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Hypoxia,,2021,Q2,2,F,20200531.0,20210526.0,20200611,20210526,EXP,,US-ROCHE-2615271,ROCHE,,71.0,YR,,F,Y,47.3,KG,20210526.0,,HP,US,US,2021,Q2,Elderly
178955712,17895571,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Febrile neutropenia,,2021,Q2,2,F,20200528.0,20210526.0,20200615,20210531,EXP,,US-ROCHE-2617940,ROCHE,,71.0,YR,,F,Y,47.3,KG,20210531.0,,HP,US,US,2021,Q2,Elderly
178955712,17895571,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Neutrophil count decreased,,2021,Q2,2,F,20200528.0,20210526.0,20200615,20210531,EXP,,US-ROCHE-2617940,ROCHE,,71.0,YR,,F,Y,47.3,KG,20210531.0,,HP,US,US,2021,Q2,Elderly
178955712,17895571,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Pancytopenia,,2021,Q2,2,F,20200528.0,20210526.0,20200615,20210531,EXP,,US-ROCHE-2617940,ROCHE,,71.0,YR,,F,Y,47.3,KG,20210531.0,,HP,US,US,2021,Q2,Elderly
178955712,17895571,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,White blood cell count decreased,,2021,Q2,2,F,20200528.0,20210526.0,20200615,20210531,EXP,,US-ROCHE-2617940,ROCHE,,71.0,YR,,F,Y,47.3,KG,20210531.0,,HP,US,US,2021,Q2,Elderly
179109465,17910946,23,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 IU, QD",,,,,,,,15.0,IU,INJECTION,QD,2021,Q2,Drug interaction,,2021,Q2,5,F,201808.0,20210426.0,20200618,20210429,EXP,,NVSC2020DE169310,NOVARTIS,,69.0,YR,,M,Y,77.0,KG,20210429.0,,MD,DE,DE,2021,Q2,Elderly
179109465,17910946,23,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 IU, QD",,,,,,,,15.0,IU,INJECTION,QD,2021,Q2,Eye movement disorder,,2021,Q2,5,F,201808.0,20210426.0,20200618,20210429,EXP,,NVSC2020DE169310,NOVARTIS,,69.0,YR,,M,Y,77.0,KG,20210429.0,,MD,DE,DE,2021,Q2,Elderly
179109465,17910946,23,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 IU, QD",,,,,,,,15.0,IU,INJECTION,QD,2021,Q2,Movement disorder,,2021,Q2,5,F,201808.0,20210426.0,20200618,20210429,EXP,,NVSC2020DE169310,NOVARTIS,,69.0,YR,,M,Y,77.0,KG,20210429.0,,MD,DE,DE,2021,Q2,Elderly
179109465,17910946,23,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 IU, QD",,,,,,,,15.0,IU,INJECTION,QD,2021,Q2,Muscle spasms,,2021,Q2,5,F,201808.0,20210426.0,20200618,20210429,EXP,,NVSC2020DE169310,NOVARTIS,,69.0,YR,,M,Y,77.0,KG,20210429.0,,MD,DE,DE,2021,Q2,Elderly
179109465,17910946,23,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 IU, QD",,,,,,,,15.0,IU,INJECTION,QD,2021,Q2,Oculogyric crisis,,2021,Q2,5,F,201808.0,20210426.0,20200618,20210429,EXP,,NVSC2020DE169310,NOVARTIS,,69.0,YR,,M,Y,77.0,KG,20210429.0,,MD,DE,DE,2021,Q2,Elderly
179109465,17910946,23,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 IU, QD",,,,,,,,15.0,IU,INJECTION,QD,2021,Q2,Off label use,,2021,Q2,5,F,201808.0,20210426.0,20200618,20210429,EXP,,NVSC2020DE169310,NOVARTIS,,69.0,YR,,M,Y,77.0,KG,20210429.0,,MD,DE,DE,2021,Q2,Elderly
179109465,17910946,23,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 IU, QD",,,,,,,,15.0,IU,INJECTION,QD,2021,Q2,Product use issue,,2021,Q2,5,F,201808.0,20210426.0,20200618,20210429,EXP,,NVSC2020DE169310,NOVARTIS,,69.0,YR,,M,Y,77.0,KG,20210429.0,,MD,DE,DE,2021,Q2,Elderly
179109465,17910946,23,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 IU, QD",,,,,,,,15.0,IU,INJECTION,QD,2021,Q2,Seizure,,2021,Q2,5,F,201808.0,20210426.0,20200618,20210429,EXP,,NVSC2020DE169310,NOVARTIS,,69.0,YR,,M,Y,77.0,KG,20210429.0,,MD,DE,DE,2021,Q2,Elderly
179109465,17910946,23,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 IU, QD",,,,,,,,15.0,IU,INJECTION,QD,2021,Q2,Status epilepticus,,2021,Q2,5,F,201808.0,20210426.0,20200618,20210429,EXP,,NVSC2020DE169310,NOVARTIS,,69.0,YR,,M,Y,77.0,KG,20210429.0,,MD,DE,DE,2021,Q2,Elderly
179401015,17940101,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"8 IU, QD (AT NIGHT)",,,U,,,,,8.0,IU,,QD,2021,Q2,Arrhythmia,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179401015,17940101,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"8 IU, QD (AT NIGHT)",,,U,,,,,8.0,IU,,QD,2021,Q2,Aura,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179401015,17940101,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"8 IU, QD (AT NIGHT)",,,U,,,,,8.0,IU,,QD,2021,Q2,Confusional state,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179401015,17940101,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"8 IU, QD (AT NIGHT)",,,U,,,,,8.0,IU,,QD,2021,Q2,Disinhibition,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179401015,17940101,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"8 IU, QD (AT NIGHT)",,,U,,,,,8.0,IU,,QD,2021,Q2,Disorientation,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179401015,17940101,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"8 IU, QD (AT NIGHT)",,,U,,,,,8.0,IU,,QD,2021,Q2,Encephalitis,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179401015,17940101,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"8 IU, QD (AT NIGHT)",,,U,,,,,8.0,IU,,QD,2021,Q2,Epilepsy,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179401015,17940101,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"8 IU, QD (AT NIGHT)",,,U,,,,,8.0,IU,,QD,2021,Q2,Headache,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179401015,17940101,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"8 IU, QD (AT NIGHT)",,,U,,,,,8.0,IU,,QD,2021,Q2,Intracranial pressure increased,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179401015,17940101,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"8 IU, QD (AT NIGHT)",,,U,,,,,8.0,IU,,QD,2021,Q2,Meningoencephalitis herpetic,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179401015,17940101,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"8 IU, QD (AT NIGHT)",,,U,,,,,8.0,IU,,QD,2021,Q2,Postictal state,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179401015,17940101,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"8 IU, QD (AT NIGHT)",,,U,,,,,8.0,IU,,QD,2021,Q2,Syncope,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179401015,17940101,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"8 IU, QD (AT NIGHT)",,,U,,,,,8.0,IU,,QD,2021,Q2,Therapeutic response unexpected,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179401015,17940101,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"8 IU, QD (AT NIGHT)",,,U,,,,,8.0,IU,,QD,2021,Q2,Tonic clonic movements,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179401015,17940101,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"8 IU, QD (AT NIGHT)",,,U,,,,,8.0,IU,,QD,2021,Q2,Ventricular extrasystoles,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179401015,17940101,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"10 IU, QD",,,U,,,,,10.0,IU,,QD,2021,Q2,Arrhythmia,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179401015,17940101,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"10 IU, QD",,,U,,,,,10.0,IU,,QD,2021,Q2,Aura,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179401015,17940101,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"10 IU, QD",,,U,,,,,10.0,IU,,QD,2021,Q2,Confusional state,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179401015,17940101,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"10 IU, QD",,,U,,,,,10.0,IU,,QD,2021,Q2,Disinhibition,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179401015,17940101,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"10 IU, QD",,,U,,,,,10.0,IU,,QD,2021,Q2,Disorientation,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179401015,17940101,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"10 IU, QD",,,U,,,,,10.0,IU,,QD,2021,Q2,Encephalitis,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179401015,17940101,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"10 IU, QD",,,U,,,,,10.0,IU,,QD,2021,Q2,Epilepsy,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179401015,17940101,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"10 IU, QD",,,U,,,,,10.0,IU,,QD,2021,Q2,Headache,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179401015,17940101,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"10 IU, QD",,,U,,,,,10.0,IU,,QD,2021,Q2,Intracranial pressure increased,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179401015,17940101,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"10 IU, QD",,,U,,,,,10.0,IU,,QD,2021,Q2,Meningoencephalitis herpetic,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179401015,17940101,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"10 IU, QD",,,U,,,,,10.0,IU,,QD,2021,Q2,Postictal state,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179401015,17940101,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"10 IU, QD",,,U,,,,,10.0,IU,,QD,2021,Q2,Syncope,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179401015,17940101,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"10 IU, QD",,,U,,,,,10.0,IU,,QD,2021,Q2,Therapeutic response unexpected,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179401015,17940101,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"10 IU, QD",,,U,,,,,10.0,IU,,QD,2021,Q2,Tonic clonic movements,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179401015,17940101,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"10 IU, QD",,,U,,,,,10.0,IU,,QD,2021,Q2,Ventricular extrasystoles,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179589605,17958960,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,,,,,,,,UNKNOWN,,2021,Q2,Exposure during pregnancy,,2021,Q2,5,F,20200620.0,20210524.0,20200629,20210528,EXP,,US-FRESENIUS KABI-FK202006367,FRESENIUS KABI,,33.0,YR,,F,Y,,,20210528.0,,HP,US,US,2021,Q2,Young Adult
179589605,17958960,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,,,,,,,,UNKNOWN,,2021,Q2,Hypotension,,2021,Q2,5,F,20200620.0,20210524.0,20200629,20210528,EXP,,US-FRESENIUS KABI-FK202006367,FRESENIUS KABI,,33.0,YR,,F,Y,,,20210528.0,,HP,US,US,2021,Q2,Young Adult
179589605,17958960,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,,,,,,,,UNKNOWN,,2021,Q2,Product use issue,,2021,Q2,5,F,20200620.0,20210524.0,20200629,20210528,EXP,,US-FRESENIUS KABI-FK202006367,FRESENIUS KABI,,33.0,YR,,F,Y,,,20210528.0,,HP,US,US,2021,Q2,Young Adult
179976469,17997646,108,C,Insuline glargine,INSULIN GLARGINE,1,Unknown,5 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q2,Cholecystitis acute,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
179976469,17997646,108,C,Insuline glargine,INSULIN GLARGINE,1,Unknown,5 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q2,Peripheral ischaemia,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
179976469,17997646,108,C,Insuline glargine,INSULIN GLARGINE,1,Unknown,5 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q2,Sepsis,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
179976469,17997646,109,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,10 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q2,Cholecystitis acute,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
179976469,17997646,109,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,10 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q2,Peripheral ischaemia,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
179976469,17997646,109,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,10 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q2,Sepsis,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
179976469,17997646,110,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,12 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q2,Cholecystitis acute,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
179976469,17997646,110,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,12 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q2,Peripheral ischaemia,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
179976469,17997646,110,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,12 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q2,Sepsis,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
179976469,17997646,111,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,16 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q2,Cholecystitis acute,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
179976469,17997646,111,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,16 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q2,Peripheral ischaemia,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
179976469,17997646,111,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,16 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q2,Sepsis,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
179976469,17997646,112,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,18 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q2,Cholecystitis acute,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
179976469,17997646,112,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,18 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q2,Peripheral ischaemia,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
179976469,17997646,112,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,18 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q2,Sepsis,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
179976469,17997646,113,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,18 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q2,Cholecystitis acute,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
179976469,17997646,113,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,18 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q2,Peripheral ischaemia,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
179976469,17997646,113,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,18 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q2,Sepsis,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
180401535,18040153,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,8 UNITS,,,,,,,,,,,,2021,Q2,Acute myocardial infarction,,2021,Q2,5,F,202007.0,20200820.0,20200717,20210511,EXP,,US-GILEAD-2020-0483271,GILEAD,,90.0,YR,E,M,Y,95.0,KG,20210511.0,,PH,US,US,2021,Q2,Elderly
180401535,18040153,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,8 UNITS,,,,,,,,,,,,2021,Q2,Bradycardia,,2021,Q2,5,F,202007.0,20200820.0,20200717,20210511,EXP,,US-GILEAD-2020-0483271,GILEAD,,90.0,YR,E,M,Y,95.0,KG,20210511.0,,PH,US,US,2021,Q2,Elderly
180401535,18040153,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,8 UNITS,,,,,,,,,,,,2021,Q2,Respiratory failure,,2021,Q2,5,F,202007.0,20200820.0,20200717,20210511,EXP,,US-GILEAD-2020-0483271,GILEAD,,90.0,YR,E,M,Y,95.0,KG,20210511.0,,PH,US,US,2021,Q2,Elderly
1809863110,18098631,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Acute kidney injury,,2021,Q2,10,F,20200226.0,20210503.0,20200731,20210512,EXP,,US-ROCHE-2650965,ROCHE,,66.0,YR,,F,Y,104.0,KG,20210512.0,,MD,US,US,2021,Q2,Elderly
1809863110,18098631,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Confusional state,,2021,Q2,10,F,20200226.0,20210503.0,20200731,20210512,EXP,,US-ROCHE-2650965,ROCHE,,66.0,YR,,F,Y,104.0,KG,20210512.0,,MD,US,US,2021,Q2,Elderly
1809863110,18098631,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Diarrhoea,,2021,Q2,10,F,20200226.0,20210503.0,20200731,20210512,EXP,,US-ROCHE-2650965,ROCHE,,66.0,YR,,F,Y,104.0,KG,20210512.0,,MD,US,US,2021,Q2,Elderly
1809863110,18098631,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Encephalitis,,2021,Q2,10,F,20200226.0,20210503.0,20200731,20210512,EXP,,US-ROCHE-2650965,ROCHE,,66.0,YR,,F,Y,104.0,KG,20210512.0,,MD,US,US,2021,Q2,Elderly
1809863110,18098631,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Haemorrhage intracranial,,2021,Q2,10,F,20200226.0,20210503.0,20200731,20210512,EXP,,US-ROCHE-2650965,ROCHE,,66.0,YR,,F,Y,104.0,KG,20210512.0,,MD,US,US,2021,Q2,Elderly
1809863110,18098631,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Hypoglycaemia,,2021,Q2,10,F,20200226.0,20210503.0,20200731,20210512,EXP,,US-ROCHE-2650965,ROCHE,,66.0,YR,,F,Y,104.0,KG,20210512.0,,MD,US,US,2021,Q2,Elderly
1809863110,18098631,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Hypotension,,2021,Q2,10,F,20200226.0,20210503.0,20200731,20210512,EXP,,US-ROCHE-2650965,ROCHE,,66.0,YR,,F,Y,104.0,KG,20210512.0,,MD,US,US,2021,Q2,Elderly
1809863110,18098631,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Lethargy,,2021,Q2,10,F,20200226.0,20210503.0,20200731,20210512,EXP,,US-ROCHE-2650965,ROCHE,,66.0,YR,,F,Y,104.0,KG,20210512.0,,MD,US,US,2021,Q2,Elderly
1809863110,18098631,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Seizure,,2021,Q2,10,F,20200226.0,20210503.0,20200731,20210512,EXP,,US-ROCHE-2650965,ROCHE,,66.0,YR,,F,Y,104.0,KG,20210512.0,,MD,US,US,2021,Q2,Elderly
1809863110,18098631,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Sepsis,,2021,Q2,10,F,20200226.0,20210503.0,20200731,20210512,EXP,,US-ROCHE-2650965,ROCHE,,66.0,YR,,F,Y,104.0,KG,20210512.0,,MD,US,US,2021,Q2,Elderly
1809863110,18098631,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Urinary tract infection,,2021,Q2,10,F,20200226.0,20210503.0,20200731,20210512,EXP,,US-ROCHE-2650965,ROCHE,,66.0,YR,,F,Y,104.0,KG,20210512.0,,MD,US,US,2021,Q2,Elderly
181126093,18112609,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2021,Q2,Anaemia,,2021,Q2,3,F,2019.0,20210520.0,20200805,20210528,EXP,,CO-EMD SERONO-9178316,EMD SERONO INC,,76.0,YR,E,F,Y,52.0,KG,20210528.0,,CN,CO,CO,2021,Q2,Elderly
181126093,18112609,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2021,Q2,Anxiety,,2021,Q2,3,F,2019.0,20210520.0,20200805,20210528,EXP,,CO-EMD SERONO-9178316,EMD SERONO INC,,76.0,YR,E,F,Y,52.0,KG,20210528.0,,CN,CO,CO,2021,Q2,Elderly
181126093,18112609,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2021,Q2,Arrhythmia,,2021,Q2,3,F,2019.0,20210520.0,20200805,20210528,EXP,,CO-EMD SERONO-9178316,EMD SERONO INC,,76.0,YR,E,F,Y,52.0,KG,20210528.0,,CN,CO,CO,2021,Q2,Elderly
181126093,18112609,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2021,Q2,Blood iron decreased,,2021,Q2,3,F,2019.0,20210520.0,20200805,20210528,EXP,,CO-EMD SERONO-9178316,EMD SERONO INC,,76.0,YR,E,F,Y,52.0,KG,20210528.0,,CN,CO,CO,2021,Q2,Elderly
181126093,18112609,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2021,Q2,Blood potassium decreased,,2021,Q2,3,F,2019.0,20210520.0,20200805,20210528,EXP,,CO-EMD SERONO-9178316,EMD SERONO INC,,76.0,YR,E,F,Y,52.0,KG,20210528.0,,CN,CO,CO,2021,Q2,Elderly
181126093,18112609,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2021,Q2,Blood sodium decreased,,2021,Q2,3,F,2019.0,20210520.0,20200805,20210528,EXP,,CO-EMD SERONO-9178316,EMD SERONO INC,,76.0,YR,E,F,Y,52.0,KG,20210528.0,,CN,CO,CO,2021,Q2,Elderly
181126093,18112609,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2021,Q2,Bronchitis,,2021,Q2,3,F,2019.0,20210520.0,20200805,20210528,EXP,,CO-EMD SERONO-9178316,EMD SERONO INC,,76.0,YR,E,F,Y,52.0,KG,20210528.0,,CN,CO,CO,2021,Q2,Elderly
181126093,18112609,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2021,Q2,Hypertension,,2021,Q2,3,F,2019.0,20210520.0,20200805,20210528,EXP,,CO-EMD SERONO-9178316,EMD SERONO INC,,76.0,YR,E,F,Y,52.0,KG,20210528.0,,CN,CO,CO,2021,Q2,Elderly
181126093,18112609,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2021,Q2,Poor quality sleep,,2021,Q2,3,F,2019.0,20210520.0,20200805,20210528,EXP,,CO-EMD SERONO-9178316,EMD SERONO INC,,76.0,YR,E,F,Y,52.0,KG,20210528.0,,CN,CO,CO,2021,Q2,Elderly
181126093,18112609,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2021,Q2,Pulmonary valve incompetence,,2021,Q2,3,F,2019.0,20210520.0,20200805,20210528,EXP,,CO-EMD SERONO-9178316,EMD SERONO INC,,76.0,YR,E,F,Y,52.0,KG,20210528.0,,CN,CO,CO,2021,Q2,Elderly
181126093,18112609,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2021,Q2,Vomiting,,2021,Q2,3,F,2019.0,20210520.0,20200805,20210528,EXP,,CO-EMD SERONO-9178316,EMD SERONO INC,,76.0,YR,E,F,Y,52.0,KG,20210528.0,,CN,CO,CO,2021,Q2,Elderly
181126093,18112609,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2021,Q2,White blood cell count decreased,,2021,Q2,3,F,2019.0,20210520.0,20200805,20210528,EXP,,CO-EMD SERONO-9178316,EMD SERONO INC,,76.0,YR,E,F,Y,52.0,KG,20210528.0,,CN,CO,CO,2021,Q2,Elderly
181228363,18122836,10,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,"8 IU/DAY, UNKNOWN FREQ.",,,,,,,,8.0,IU,INJECTION,,2021,Q2,Bacteraemia,,2021,Q2,3,F,20190828.0,20210331.0,20200807,20210405,EXP,,JP-ASTELLAS-2019JP018774,ASTELLAS,,76.0,YR,,F,Y,47.0,KG,20210405.0,,MD,JP,JP,2021,Q2,Elderly
181228363,18122836,10,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,"8 IU/DAY, UNKNOWN FREQ.",,,,,,,,8.0,IU,INJECTION,,2021,Q2,Cerebral haemorrhage,,2021,Q2,3,F,20190828.0,20210331.0,20200807,20210405,EXP,,JP-ASTELLAS-2019JP018774,ASTELLAS,,76.0,YR,,F,Y,47.0,KG,20210405.0,,MD,JP,JP,2021,Q2,Elderly
181228363,18122836,10,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,"8 IU/DAY, UNKNOWN FREQ.",,,,,,,,8.0,IU,INJECTION,,2021,Q2,Drug eruption,,2021,Q2,3,F,20190828.0,20210331.0,20200807,20210405,EXP,,JP-ASTELLAS-2019JP018774,ASTELLAS,,76.0,YR,,F,Y,47.0,KG,20210405.0,,MD,JP,JP,2021,Q2,Elderly
181228363,18122836,10,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,"8 IU/DAY, UNKNOWN FREQ.",,,,,,,,8.0,IU,INJECTION,,2021,Q2,Electrocardiogram QT prolonged,,2021,Q2,3,F,20190828.0,20210331.0,20200807,20210405,EXP,,JP-ASTELLAS-2019JP018774,ASTELLAS,,76.0,YR,,F,Y,47.0,KG,20210405.0,,MD,JP,JP,2021,Q2,Elderly
181228363,18122836,10,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,"8 IU/DAY, UNKNOWN FREQ.",,,,,,,,8.0,IU,INJECTION,,2021,Q2,Liver disorder,,2021,Q2,3,F,20190828.0,20210331.0,20200807,20210405,EXP,,JP-ASTELLAS-2019JP018774,ASTELLAS,,76.0,YR,,F,Y,47.0,KG,20210405.0,,MD,JP,JP,2021,Q2,Elderly
181228363,18122836,10,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,"8 IU/DAY, UNKNOWN FREQ.",,,,,,,,8.0,IU,INJECTION,,2021,Q2,Pyrexia,,2021,Q2,3,F,20190828.0,20210331.0,20200807,20210405,EXP,,JP-ASTELLAS-2019JP018774,ASTELLAS,,76.0,YR,,F,Y,47.0,KG,20210405.0,,MD,JP,JP,2021,Q2,Elderly
182731313,18273131,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 IU, QD",,,,,,,,4.0,IU,INJECTION,QD,2021,Q2,Diarrhoea,,2021,Q2,3,F,20200702.0,20210608.0,20200916,20210610,EXP,,JP-DSJP-DSJ-2020-120903,DAIICHI,,78.0,YR,,F,Y,39.0,KG,20210610.0,,MD,JP,JP,2021,Q2,Elderly
182731313,18273131,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 IU, QD",,,,,,,,4.0,IU,INJECTION,QD,2021,Q2,Disease progression,,2021,Q2,3,F,20200702.0,20210608.0,20200916,20210610,EXP,,JP-DSJP-DSJ-2020-120903,DAIICHI,,78.0,YR,,F,Y,39.0,KG,20210610.0,,MD,JP,JP,2021,Q2,Elderly
182731313,18273131,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 IU, QD",,,,,,,,4.0,IU,INJECTION,QD,2021,Q2,Gastroenteritis,,2021,Q2,3,F,20200702.0,20210608.0,20200916,20210610,EXP,,JP-DSJP-DSJ-2020-120903,DAIICHI,,78.0,YR,,F,Y,39.0,KG,20210610.0,,MD,JP,JP,2021,Q2,Elderly
182731313,18273131,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 IU, QD",,,,,,,,4.0,IU,INJECTION,QD,2021,Q2,Nausea,,2021,Q2,3,F,20200702.0,20210608.0,20200916,20210610,EXP,,JP-DSJP-DSJ-2020-120903,DAIICHI,,78.0,YR,,F,Y,39.0,KG,20210610.0,,MD,JP,JP,2021,Q2,Elderly
182900819,18290081,13,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Breath sounds,,2021,Q2,9,F,202008.0,20210412.0,20200921,20210419,EXP,FR-AFSSAPS-AN20201025,NVSC2020FR252711,NOVARTIS,,79.0,YR,,F,Y,72.0,KG,20210419.0,,HP,FR,FR,2021,Q2,Elderly
182900819,18290081,13,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Cheilitis,,2021,Q2,9,F,202008.0,20210412.0,20200921,20210419,EXP,FR-AFSSAPS-AN20201025,NVSC2020FR252711,NOVARTIS,,79.0,YR,,F,Y,72.0,KG,20210419.0,,HP,FR,FR,2021,Q2,Elderly
182900819,18290081,13,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Drug reaction with eosinophilia and systemic symptoms,,2021,Q2,9,F,202008.0,20210412.0,20200921,20210419,EXP,FR-AFSSAPS-AN20201025,NVSC2020FR252711,NOVARTIS,,79.0,YR,,F,Y,72.0,KG,20210419.0,,HP,FR,FR,2021,Q2,Elderly
182900819,18290081,13,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Eosinophilia,,2021,Q2,9,F,202008.0,20210412.0,20200921,20210419,EXP,FR-AFSSAPS-AN20201025,NVSC2020FR252711,NOVARTIS,,79.0,YR,,F,Y,72.0,KG,20210419.0,,HP,FR,FR,2021,Q2,Elderly
182900819,18290081,13,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Glossitis,,2021,Q2,9,F,202008.0,20210412.0,20200921,20210419,EXP,FR-AFSSAPS-AN20201025,NVSC2020FR252711,NOVARTIS,,79.0,YR,,F,Y,72.0,KG,20210419.0,,HP,FR,FR,2021,Q2,Elderly
182900819,18290081,13,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Hepatic cirrhosis,,2021,Q2,9,F,202008.0,20210412.0,20200921,20210419,EXP,FR-AFSSAPS-AN20201025,NVSC2020FR252711,NOVARTIS,,79.0,YR,,F,Y,72.0,KG,20210419.0,,HP,FR,FR,2021,Q2,Elderly
182900819,18290081,13,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Hepatic cytolysis,,2021,Q2,9,F,202008.0,20210412.0,20200921,20210419,EXP,FR-AFSSAPS-AN20201025,NVSC2020FR252711,NOVARTIS,,79.0,YR,,F,Y,72.0,KG,20210419.0,,HP,FR,FR,2021,Q2,Elderly
182900819,18290081,13,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Hypercreatininaemia,,2021,Q2,9,F,202008.0,20210412.0,20200921,20210419,EXP,FR-AFSSAPS-AN20201025,NVSC2020FR252711,NOVARTIS,,79.0,YR,,F,Y,72.0,KG,20210419.0,,HP,FR,FR,2021,Q2,Elderly
182900819,18290081,13,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Intra-abdominal fluid collection,,2021,Q2,9,F,202008.0,20210412.0,20200921,20210419,EXP,FR-AFSSAPS-AN20201025,NVSC2020FR252711,NOVARTIS,,79.0,YR,,F,Y,72.0,KG,20210419.0,,HP,FR,FR,2021,Q2,Elderly
182900819,18290081,13,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Oedema peripheral,,2021,Q2,9,F,202008.0,20210412.0,20200921,20210419,EXP,FR-AFSSAPS-AN20201025,NVSC2020FR252711,NOVARTIS,,79.0,YR,,F,Y,72.0,KG,20210419.0,,HP,FR,FR,2021,Q2,Elderly
182900819,18290081,13,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Rash maculo-papular,,2021,Q2,9,F,202008.0,20210412.0,20200921,20210419,EXP,FR-AFSSAPS-AN20201025,NVSC2020FR252711,NOVARTIS,,79.0,YR,,F,Y,72.0,KG,20210419.0,,HP,FR,FR,2021,Q2,Elderly
182900819,18290081,13,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Splenomegaly,,2021,Q2,9,F,202008.0,20210412.0,20200921,20210419,EXP,FR-AFSSAPS-AN20201025,NVSC2020FR252711,NOVARTIS,,79.0,YR,,F,Y,72.0,KG,20210419.0,,HP,FR,FR,2021,Q2,Elderly
182995585,18299558,49,C,INSULIN GLARGINE BS INJECTION,,2,,"BEFORE BEDTIME 30 IU, QD",,,,,,,,30.0,IU,,QD,2021,Q2,Angina unstable,,2021,Q2,5,F,20200411.0,20210625.0,20200923,20210629,EXP,,JP-GLAXOSMITHKLINE-JP2020JPN188231,GLAXOSMITHKLINE,,47.0,YR,,M,Y,85.0,KG,20210629.0,,CN,JP,JP,2021,Q2,Adult
182995585,18299558,49,C,INSULIN GLARGINE BS INJECTION,,2,,"BEFORE BEDTIME 30 IU, QD",,,,,,,,30.0,IU,,QD,2021,Q2,Gastroenteritis,,2021,Q2,5,F,20200411.0,20210625.0,20200923,20210629,EXP,,JP-GLAXOSMITHKLINE-JP2020JPN188231,GLAXOSMITHKLINE,,47.0,YR,,M,Y,85.0,KG,20210629.0,,CN,JP,JP,2021,Q2,Adult
182995585,18299558,49,C,INSULIN GLARGINE BS INJECTION,,2,,"BEFORE BEDTIME 30 IU, QD",,,,,,,,30.0,IU,,QD,2021,Q2,Off label use,,2021,Q2,5,F,20200411.0,20210625.0,20200923,20210629,EXP,,JP-GLAXOSMITHKLINE-JP2020JPN188231,GLAXOSMITHKLINE,,47.0,YR,,M,Y,85.0,KG,20210629.0,,CN,JP,JP,2021,Q2,Adult
182995585,18299558,49,C,INSULIN GLARGINE BS INJECTION,,2,,"BEFORE BEDTIME 30 IU, QD",,,,,,,,30.0,IU,,QD,2021,Q2,Pancreatitis acute,,2021,Q2,5,F,20200411.0,20210625.0,20200923,20210629,EXP,,JP-GLAXOSMITHKLINE-JP2020JPN188231,GLAXOSMITHKLINE,,47.0,YR,,M,Y,85.0,KG,20210629.0,,CN,JP,JP,2021,Q2,Adult
182995585,18299558,49,C,INSULIN GLARGINE BS INJECTION,,2,,"BEFORE BEDTIME 30 IU, QD",,,,,,,,30.0,IU,,QD,2021,Q2,Prescribed underdose,,2021,Q2,5,F,20200411.0,20210625.0,20200923,20210629,EXP,,JP-GLAXOSMITHKLINE-JP2020JPN188231,GLAXOSMITHKLINE,,47.0,YR,,M,Y,85.0,KG,20210629.0,,CN,JP,JP,2021,Q2,Adult
183024175,18302417,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,INCONNUE,,,,,,,,,,,,2021,Q2,Breath sounds,,2021,Q2,5,F,202008.0,20210322.0,20200923,20210401,EXP,FR-AFSSAPS-AN20201025,FR-JNJFOC-20200924658,JOHNSON AND JOHNSON,,79.0,YR,E,F,Y,72.0,KG,20210401.0,,MD,FR,FR,2021,Q2,Elderly
183024175,18302417,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,INCONNUE,,,,,,,,,,,,2021,Q2,Cheilitis,,2021,Q2,5,F,202008.0,20210322.0,20200923,20210401,EXP,FR-AFSSAPS-AN20201025,FR-JNJFOC-20200924658,JOHNSON AND JOHNSON,,79.0,YR,E,F,Y,72.0,KG,20210401.0,,MD,FR,FR,2021,Q2,Elderly
183024175,18302417,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,INCONNUE,,,,,,,,,,,,2021,Q2,Drug reaction with eosinophilia and systemic symptoms,,2021,Q2,5,F,202008.0,20210322.0,20200923,20210401,EXP,FR-AFSSAPS-AN20201025,FR-JNJFOC-20200924658,JOHNSON AND JOHNSON,,79.0,YR,E,F,Y,72.0,KG,20210401.0,,MD,FR,FR,2021,Q2,Elderly
183024175,18302417,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,INCONNUE,,,,,,,,,,,,2021,Q2,Eosinophilia,,2021,Q2,5,F,202008.0,20210322.0,20200923,20210401,EXP,FR-AFSSAPS-AN20201025,FR-JNJFOC-20200924658,JOHNSON AND JOHNSON,,79.0,YR,E,F,Y,72.0,KG,20210401.0,,MD,FR,FR,2021,Q2,Elderly
183024175,18302417,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,INCONNUE,,,,,,,,,,,,2021,Q2,Glossitis,,2021,Q2,5,F,202008.0,20210322.0,20200923,20210401,EXP,FR-AFSSAPS-AN20201025,FR-JNJFOC-20200924658,JOHNSON AND JOHNSON,,79.0,YR,E,F,Y,72.0,KG,20210401.0,,MD,FR,FR,2021,Q2,Elderly
183024175,18302417,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,INCONNUE,,,,,,,,,,,,2021,Q2,Hepatic cirrhosis,,2021,Q2,5,F,202008.0,20210322.0,20200923,20210401,EXP,FR-AFSSAPS-AN20201025,FR-JNJFOC-20200924658,JOHNSON AND JOHNSON,,79.0,YR,E,F,Y,72.0,KG,20210401.0,,MD,FR,FR,2021,Q2,Elderly
183024175,18302417,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,INCONNUE,,,,,,,,,,,,2021,Q2,Hepatic cytolysis,,2021,Q2,5,F,202008.0,20210322.0,20200923,20210401,EXP,FR-AFSSAPS-AN20201025,FR-JNJFOC-20200924658,JOHNSON AND JOHNSON,,79.0,YR,E,F,Y,72.0,KG,20210401.0,,MD,FR,FR,2021,Q2,Elderly
183024175,18302417,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,INCONNUE,,,,,,,,,,,,2021,Q2,Hypercreatininaemia,,2021,Q2,5,F,202008.0,20210322.0,20200923,20210401,EXP,FR-AFSSAPS-AN20201025,FR-JNJFOC-20200924658,JOHNSON AND JOHNSON,,79.0,YR,E,F,Y,72.0,KG,20210401.0,,MD,FR,FR,2021,Q2,Elderly
183024175,18302417,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,INCONNUE,,,,,,,,,,,,2021,Q2,Intra-abdominal fluid collection,,2021,Q2,5,F,202008.0,20210322.0,20200923,20210401,EXP,FR-AFSSAPS-AN20201025,FR-JNJFOC-20200924658,JOHNSON AND JOHNSON,,79.0,YR,E,F,Y,72.0,KG,20210401.0,,MD,FR,FR,2021,Q2,Elderly
183024175,18302417,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,INCONNUE,,,,,,,,,,,,2021,Q2,Oedema peripheral,,2021,Q2,5,F,202008.0,20210322.0,20200923,20210401,EXP,FR-AFSSAPS-AN20201025,FR-JNJFOC-20200924658,JOHNSON AND JOHNSON,,79.0,YR,E,F,Y,72.0,KG,20210401.0,,MD,FR,FR,2021,Q2,Elderly
183024175,18302417,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,INCONNUE,,,,,,,,,,,,2021,Q2,Rash maculo-papular,,2021,Q2,5,F,202008.0,20210322.0,20200923,20210401,EXP,FR-AFSSAPS-AN20201025,FR-JNJFOC-20200924658,JOHNSON AND JOHNSON,,79.0,YR,E,F,Y,72.0,KG,20210401.0,,MD,FR,FR,2021,Q2,Elderly
183024175,18302417,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,INCONNUE,,,,,,,,,,,,2021,Q2,Splenomegaly,,2021,Q2,5,F,202008.0,20210322.0,20200923,20210401,EXP,FR-AFSSAPS-AN20201025,FR-JNJFOC-20200924658,JOHNSON AND JOHNSON,,79.0,YR,E,F,Y,72.0,KG,20210401.0,,MD,FR,FR,2021,Q2,Elderly
183300864,18330086,7,C,INSULINE GLARGINE ((BACTERIE/ESCHERICHIA COLI)),INSULIN GLARGINE,1,,UNKNOWN,,,,, UNKNOWN,,,,,,,2021,Q2,Drug reaction with eosinophilia and systemic symptoms,,2021,Q2,4,F,20200808.0,20210414.0,20200930,20210422,EXP,FR-AFSSAPS-AN20201025,FR-TEVA-2020-FR-1832185,TEVA,,79.0,YR,E,F,Y,72.0,KG,20210422.0,,MD,FR,FR,2021,Q2,Elderly
1837317711,18373177,33,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"4 UNITS, ONCE DAILY EVERY MORNING",,,,,,,,,,FORMULATION UNKNOWN,QD,2021,Q2,Acute kidney injury,,2021,Q2,11,F,20200928.0,20210617.0,20201012,20210618,EXP,,US-ASTELLAS-2020US034378,ASTELLAS,,73.0,YR,,M,Y,,,20210618.0,,MD,US,US,2021,Q2,Elderly
1837317711,18373177,33,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"4 UNITS, ONCE DAILY EVERY MORNING",,,,,,,,,,FORMULATION UNKNOWN,QD,2021,Q2,Septic shock,,2021,Q2,11,F,20200928.0,20210617.0,20201012,20210618,EXP,,US-ASTELLAS-2020US034378,ASTELLAS,,73.0,YR,,M,Y,,,20210618.0,,MD,US,US,2021,Q2,Elderly
1837317711,18373177,33,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"4 UNITS, ONCE DAILY EVERY MORNING",,,,,,,,,,FORMULATION UNKNOWN,QD,2021,Q2,Stevens-Johnson syndrome,,2021,Q2,11,F,20200928.0,20210617.0,20201012,20210618,EXP,,US-ASTELLAS-2020US034378,ASTELLAS,,73.0,YR,,M,Y,,,20210618.0,,MD,US,US,2021,Q2,Elderly
183817152,18381715,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Acute kidney injury,,2021,Q2,2,F,20200814.0,20210429.0,20201014,20210506,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-082920,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,,,20210506.0,,MD,DE,DE,2021,Q2,Elderly
183817152,18381715,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Dehydration,,2021,Q2,2,F,20200814.0,20210429.0,20201014,20210506,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-082920,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,,,20210506.0,,MD,DE,DE,2021,Q2,Elderly
183817152,18381715,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Escherichia urinary tract infection,,2021,Q2,2,F,20200814.0,20210429.0,20201014,20210506,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-082920,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,,,20210506.0,,MD,DE,DE,2021,Q2,Elderly
183817152,18381715,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Syncope,,2021,Q2,2,F,20200814.0,20210429.0,20201014,20210506,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-082920,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,,,20210506.0,,MD,DE,DE,2021,Q2,Elderly
184145165,18414516,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ., 1 BOTTLE, INJECTION",,,,,,,,,,INJECTION,,2021,Q2,Colitis ischaemic,,2021,Q2,5,F,20190220.0,20210428.0,20201022,20210504,EXP,,JP-ASTELLAS-2020JP015707,ASTELLAS,"IMANAKA T, UEDA H, FUJIMURA K, SAITO T, NAGATA O, TAKAYA R, ET AL.. A CASE OF CONCOMITANT USE OF GILTERITINIB AND CHEMOTHERAPY FOR FLT?ITD MUTATION POSITIVE ACUTE MYELOID LEUKEMIA. THE 59TH CHUGOKU?SHIKOKU REGINAL MEETING OF JAPANESE SOCIETY OF HEMATOLOGY PROGR. 2020?37",82.0,YR,,F,Y,51.0,KG,20210504.0,,MD,JP,JP,2021,Q2,Elderly
184145165,18414516,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ., 1 BOTTLE, INJECTION",,,,,,,,,,INJECTION,,2021,Q2,Constipation,,2021,Q2,5,F,20190220.0,20210428.0,20201022,20210504,EXP,,JP-ASTELLAS-2020JP015707,ASTELLAS,"IMANAKA T, UEDA H, FUJIMURA K, SAITO T, NAGATA O, TAKAYA R, ET AL.. A CASE OF CONCOMITANT USE OF GILTERITINIB AND CHEMOTHERAPY FOR FLT?ITD MUTATION POSITIVE ACUTE MYELOID LEUKEMIA. THE 59TH CHUGOKU?SHIKOKU REGINAL MEETING OF JAPANESE SOCIETY OF HEMATOLOGY PROGR. 2020?37",82.0,YR,,F,Y,51.0,KG,20210504.0,,MD,JP,JP,2021,Q2,Elderly
184145165,18414516,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ., 1 BOTTLE, INJECTION",,,,,,,,,,INJECTION,,2021,Q2,Dysuria,,2021,Q2,5,F,20190220.0,20210428.0,20201022,20210504,EXP,,JP-ASTELLAS-2020JP015707,ASTELLAS,"IMANAKA T, UEDA H, FUJIMURA K, SAITO T, NAGATA O, TAKAYA R, ET AL.. A CASE OF CONCOMITANT USE OF GILTERITINIB AND CHEMOTHERAPY FOR FLT?ITD MUTATION POSITIVE ACUTE MYELOID LEUKEMIA. THE 59TH CHUGOKU?SHIKOKU REGINAL MEETING OF JAPANESE SOCIETY OF HEMATOLOGY PROGR. 2020?37",82.0,YR,,F,Y,51.0,KG,20210504.0,,MD,JP,JP,2021,Q2,Elderly
184145165,18414516,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ., 1 BOTTLE, INJECTION",,,,,,,,,,INJECTION,,2021,Q2,Eczema asteatotic,,2021,Q2,5,F,20190220.0,20210428.0,20201022,20210504,EXP,,JP-ASTELLAS-2020JP015707,ASTELLAS,"IMANAKA T, UEDA H, FUJIMURA K, SAITO T, NAGATA O, TAKAYA R, ET AL.. A CASE OF CONCOMITANT USE OF GILTERITINIB AND CHEMOTHERAPY FOR FLT?ITD MUTATION POSITIVE ACUTE MYELOID LEUKEMIA. THE 59TH CHUGOKU?SHIKOKU REGINAL MEETING OF JAPANESE SOCIETY OF HEMATOLOGY PROGR. 2020?37",82.0,YR,,F,Y,51.0,KG,20210504.0,,MD,JP,JP,2021,Q2,Elderly
184145165,18414516,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ., 1 BOTTLE, INJECTION",,,,,,,,,,INJECTION,,2021,Q2,Enterocolitis haemorrhagic,,2021,Q2,5,F,20190220.0,20210428.0,20201022,20210504,EXP,,JP-ASTELLAS-2020JP015707,ASTELLAS,"IMANAKA T, UEDA H, FUJIMURA K, SAITO T, NAGATA O, TAKAYA R, ET AL.. A CASE OF CONCOMITANT USE OF GILTERITINIB AND CHEMOTHERAPY FOR FLT?ITD MUTATION POSITIVE ACUTE MYELOID LEUKEMIA. THE 59TH CHUGOKU?SHIKOKU REGINAL MEETING OF JAPANESE SOCIETY OF HEMATOLOGY PROGR. 2020?37",82.0,YR,,F,Y,51.0,KG,20210504.0,,MD,JP,JP,2021,Q2,Elderly
184145165,18414516,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ., 1 BOTTLE, INJECTION",,,,,,,,,,INJECTION,,2021,Q2,Hepatic function abnormal,,2021,Q2,5,F,20190220.0,20210428.0,20201022,20210504,EXP,,JP-ASTELLAS-2020JP015707,ASTELLAS,"IMANAKA T, UEDA H, FUJIMURA K, SAITO T, NAGATA O, TAKAYA R, ET AL.. A CASE OF CONCOMITANT USE OF GILTERITINIB AND CHEMOTHERAPY FOR FLT?ITD MUTATION POSITIVE ACUTE MYELOID LEUKEMIA. THE 59TH CHUGOKU?SHIKOKU REGINAL MEETING OF JAPANESE SOCIETY OF HEMATOLOGY PROGR. 2020?37",82.0,YR,,F,Y,51.0,KG,20210504.0,,MD,JP,JP,2021,Q2,Elderly
184145165,18414516,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ., 1 BOTTLE, INJECTION",,,,,,,,,,INJECTION,,2021,Q2,Hyperkalaemia,,2021,Q2,5,F,20190220.0,20210428.0,20201022,20210504,EXP,,JP-ASTELLAS-2020JP015707,ASTELLAS,"IMANAKA T, UEDA H, FUJIMURA K, SAITO T, NAGATA O, TAKAYA R, ET AL.. A CASE OF CONCOMITANT USE OF GILTERITINIB AND CHEMOTHERAPY FOR FLT?ITD MUTATION POSITIVE ACUTE MYELOID LEUKEMIA. THE 59TH CHUGOKU?SHIKOKU REGINAL MEETING OF JAPANESE SOCIETY OF HEMATOLOGY PROGR. 2020?37",82.0,YR,,F,Y,51.0,KG,20210504.0,,MD,JP,JP,2021,Q2,Elderly
184145165,18414516,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ., 1 BOTTLE, INJECTION",,,,,,,,,,INJECTION,,2021,Q2,Neutrophil count decreased,,2021,Q2,5,F,20190220.0,20210428.0,20201022,20210504,EXP,,JP-ASTELLAS-2020JP015707,ASTELLAS,"IMANAKA T, UEDA H, FUJIMURA K, SAITO T, NAGATA O, TAKAYA R, ET AL.. A CASE OF CONCOMITANT USE OF GILTERITINIB AND CHEMOTHERAPY FOR FLT?ITD MUTATION POSITIVE ACUTE MYELOID LEUKEMIA. THE 59TH CHUGOKU?SHIKOKU REGINAL MEETING OF JAPANESE SOCIETY OF HEMATOLOGY PROGR. 2020?37",82.0,YR,,F,Y,51.0,KG,20210504.0,,MD,JP,JP,2021,Q2,Elderly
184145165,18414516,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ., 1 BOTTLE, INJECTION",,,,,,,,,,INJECTION,,2021,Q2,Oedema peripheral,,2021,Q2,5,F,20190220.0,20210428.0,20201022,20210504,EXP,,JP-ASTELLAS-2020JP015707,ASTELLAS,"IMANAKA T, UEDA H, FUJIMURA K, SAITO T, NAGATA O, TAKAYA R, ET AL.. A CASE OF CONCOMITANT USE OF GILTERITINIB AND CHEMOTHERAPY FOR FLT?ITD MUTATION POSITIVE ACUTE MYELOID LEUKEMIA. THE 59TH CHUGOKU?SHIKOKU REGINAL MEETING OF JAPANESE SOCIETY OF HEMATOLOGY PROGR. 2020?37",82.0,YR,,F,Y,51.0,KG,20210504.0,,MD,JP,JP,2021,Q2,Elderly
184145165,18414516,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ., 1 BOTTLE, INJECTION",,,,,,,,,,INJECTION,,2021,Q2,Oral herpes,,2021,Q2,5,F,20190220.0,20210428.0,20201022,20210504,EXP,,JP-ASTELLAS-2020JP015707,ASTELLAS,"IMANAKA T, UEDA H, FUJIMURA K, SAITO T, NAGATA O, TAKAYA R, ET AL.. A CASE OF CONCOMITANT USE OF GILTERITINIB AND CHEMOTHERAPY FOR FLT?ITD MUTATION POSITIVE ACUTE MYELOID LEUKEMIA. THE 59TH CHUGOKU?SHIKOKU REGINAL MEETING OF JAPANESE SOCIETY OF HEMATOLOGY PROGR. 2020?37",82.0,YR,,F,Y,51.0,KG,20210504.0,,MD,JP,JP,2021,Q2,Elderly
184145165,18414516,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ., 1 BOTTLE, INJECTION",,,,,,,,,,INJECTION,,2021,Q2,Pyrexia,,2021,Q2,5,F,20190220.0,20210428.0,20201022,20210504,EXP,,JP-ASTELLAS-2020JP015707,ASTELLAS,"IMANAKA T, UEDA H, FUJIMURA K, SAITO T, NAGATA O, TAKAYA R, ET AL.. A CASE OF CONCOMITANT USE OF GILTERITINIB AND CHEMOTHERAPY FOR FLT?ITD MUTATION POSITIVE ACUTE MYELOID LEUKEMIA. THE 59TH CHUGOKU?SHIKOKU REGINAL MEETING OF JAPANESE SOCIETY OF HEMATOLOGY PROGR. 2020?37",82.0,YR,,F,Y,51.0,KG,20210504.0,,MD,JP,JP,2021,Q2,Elderly
184292523,18429252,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, UNKNOWN",,,U,,,,,10.0,IU,INJECTION,,2021,Q2,Cardiac ventricular thrombosis,,2021,Q2,3,F,20200828.0,20210329.0,20201026,20210408,EXP,,NVSC2020CN285955,NOVARTIS,,57.0,YR,,M,Y,,,20210408.0,,MD,CN,CN,2021,Q2,Adult
184292523,18429252,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, UNKNOWN",,,U,,,,,10.0,IU,INJECTION,,2021,Q2,Ventricular arrhythmia,,2021,Q2,3,F,20200828.0,20210329.0,20201026,20210408,EXP,,NVSC2020CN285955,NOVARTIS,,57.0,YR,,M,Y,,,20210408.0,,MD,CN,CN,2021,Q2,Adult
184292523,18429252,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, UNKNOWN",,,U,,,,,14.0,IU,INJECTION,,2021,Q2,Cardiac ventricular thrombosis,,2021,Q2,3,F,20200828.0,20210329.0,20201026,20210408,EXP,,NVSC2020CN285955,NOVARTIS,,57.0,YR,,M,Y,,,20210408.0,,MD,CN,CN,2021,Q2,Adult
184292523,18429252,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, UNKNOWN",,,U,,,,,14.0,IU,INJECTION,,2021,Q2,Ventricular arrhythmia,,2021,Q2,3,F,20200828.0,20210329.0,20201026,20210408,EXP,,NVSC2020CN285955,NOVARTIS,,57.0,YR,,M,Y,,,20210408.0,,MD,CN,CN,2021,Q2,Adult
184293762,18429376,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Acute kidney injury,,2021,Q2,2,F,20200814.0,20210510.0,20201026,20210520,EXP,,NVSC2020DE281452,NOVARTIS,,80.0,YR,,F,Y,,,20210520.0,,HP,DE,DE,2021,Q2,Elderly
184293762,18429376,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Dehydration,,2021,Q2,2,F,20200814.0,20210510.0,20201026,20210520,EXP,,NVSC2020DE281452,NOVARTIS,,80.0,YR,,F,Y,,,20210520.0,,HP,DE,DE,2021,Q2,Elderly
184293762,18429376,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Escherichia urinary tract infection,,2021,Q2,2,F,20200814.0,20210510.0,20201026,20210520,EXP,,NVSC2020DE281452,NOVARTIS,,80.0,YR,,F,Y,,,20210520.0,,HP,DE,DE,2021,Q2,Elderly
184293762,18429376,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Syncope,,2021,Q2,2,F,20200814.0,20210510.0,20201026,20210520,EXP,,NVSC2020DE281452,NOVARTIS,,80.0,YR,,F,Y,,,20210520.0,,HP,DE,DE,2021,Q2,Elderly
184317732,18431773,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Acute kidney injury,,2021,Q2,2,F,20200814.0,20210510.0,20201027,20210519,EXP,,DE-PFIZER INC-2020410735,PFIZER,,80.0,YR,,F,Y,,,20210519.0,,MD,DE,DE,2021,Q2,Elderly
184317732,18431773,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Dehydration,,2021,Q2,2,F,20200814.0,20210510.0,20201027,20210519,EXP,,DE-PFIZER INC-2020410735,PFIZER,,80.0,YR,,F,Y,,,20210519.0,,MD,DE,DE,2021,Q2,Elderly
184317732,18431773,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Escherichia urinary tract infection,,2021,Q2,2,F,20200814.0,20210510.0,20201027,20210519,EXP,,DE-PFIZER INC-2020410735,PFIZER,,80.0,YR,,F,Y,,,20210519.0,,MD,DE,DE,2021,Q2,Elderly
184317732,18431773,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Syncope,,2021,Q2,2,F,20200814.0,20210510.0,20201027,20210519,EXP,,DE-PFIZER INC-2020410735,PFIZER,,80.0,YR,,F,Y,,,20210519.0,,MD,DE,DE,2021,Q2,Elderly
184762115,18476211,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,10 U,,,,,,,,,,,,2021,Q2,Bradycardia,,2021,Q2,5,F,20201024.0,20210402.0,20201106,20210407,EXP,,PT-GILEAD-2020-0502547,GILEAD,,71.0,YR,E,M,Y,,,20210407.0,,PH,PT,PT,2021,Q2,Elderly
186013679,18601367,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,INJECTION,,2021,Q2,Blood creatinine increased,,2021,Q2,9,F,20201103.0,20210506.0,20201210,20210507,EXP,,NVSC2020CN326492,NOVARTIS,,65.0,YR,,F,Y,56.0,KG,20210507.0,,HP,CN,CN,2021,Q2,Elderly
186386472,18638647,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,AT NIGHT,,,U,, UNKNOWN,,,18.0,IU,,,2021,Q2,BRASH syndrome,,2021,Q2,2,F,,20210414.0,20201219,20210420,EXP,,US-DRREDDYS-USA/USA/20/0130084,DR REDDYS,"ARIF AW, KHAN MS, MASRI A, MBA B, TALHA AYUB M, DOUKKY R. BRASH SYNDROME WITH HYPERKALEMIA: AN UNDER?RECOGNIZED CLINICAL CONDITION. METHODIST DEBAKEY CARDIOVASCULAR JOURNAL. 2020?16(3):241?4. DOI:10.14797/MDCJ?16?3?241.",55.0,YR,A,F,Y,,,20210420.0,,MD,US,US,2021,Q2,Adult
186412288,18641228,21,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,QD,2021,Q2,Abdominal pain,,2021,Q2,8,F,20180201.0,20210517.0,20201221,20210525,EXP,,US-BLUEPRINT MEDICINES CORPORATION-SP-US-2020-001322,BLUEPRINT MEDICINES,,63.0,YR,A,M,Y,85.2,KG,20210525.0,,CN,US,US,2021,Q2,Adult
186412288,18641228,21,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,QD,2021,Q2,Agitation,,2021,Q2,8,F,20180201.0,20210517.0,20201221,20210525,EXP,,US-BLUEPRINT MEDICINES CORPORATION-SP-US-2020-001322,BLUEPRINT MEDICINES,,63.0,YR,A,M,Y,85.2,KG,20210525.0,,CN,US,US,2021,Q2,Adult
186412288,18641228,21,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,QD,2021,Q2,Cerebrovascular accident,,2021,Q2,8,F,20180201.0,20210517.0,20201221,20210525,EXP,,US-BLUEPRINT MEDICINES CORPORATION-SP-US-2020-001322,BLUEPRINT MEDICINES,,63.0,YR,A,M,Y,85.2,KG,20210525.0,,CN,US,US,2021,Q2,Adult
186412288,18641228,21,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,QD,2021,Q2,Confusional state,,2021,Q2,8,F,20180201.0,20210517.0,20201221,20210525,EXP,,US-BLUEPRINT MEDICINES CORPORATION-SP-US-2020-001322,BLUEPRINT MEDICINES,,63.0,YR,A,M,Y,85.2,KG,20210525.0,,CN,US,US,2021,Q2,Adult
186412288,18641228,21,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,QD,2021,Q2,Constipation,,2021,Q2,8,F,20180201.0,20210517.0,20201221,20210525,EXP,,US-BLUEPRINT MEDICINES CORPORATION-SP-US-2020-001322,BLUEPRINT MEDICINES,,63.0,YR,A,M,Y,85.2,KG,20210525.0,,CN,US,US,2021,Q2,Adult
186412288,18641228,21,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,QD,2021,Q2,Diverticulum intestinal,,2021,Q2,8,F,20180201.0,20210517.0,20201221,20210525,EXP,,US-BLUEPRINT MEDICINES CORPORATION-SP-US-2020-001322,BLUEPRINT MEDICINES,,63.0,YR,A,M,Y,85.2,KG,20210525.0,,CN,US,US,2021,Q2,Adult
186412288,18641228,21,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,QD,2021,Q2,Dizziness,,2021,Q2,8,F,20180201.0,20210517.0,20201221,20210525,EXP,,US-BLUEPRINT MEDICINES CORPORATION-SP-US-2020-001322,BLUEPRINT MEDICINES,,63.0,YR,A,M,Y,85.2,KG,20210525.0,,CN,US,US,2021,Q2,Adult
186412288,18641228,21,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,QD,2021,Q2,Dyspnoea,,2021,Q2,8,F,20180201.0,20210517.0,20201221,20210525,EXP,,US-BLUEPRINT MEDICINES CORPORATION-SP-US-2020-001322,BLUEPRINT MEDICINES,,63.0,YR,A,M,Y,85.2,KG,20210525.0,,CN,US,US,2021,Q2,Adult
186412288,18641228,21,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,QD,2021,Q2,Fatigue,,2021,Q2,8,F,20180201.0,20210517.0,20201221,20210525,EXP,,US-BLUEPRINT MEDICINES CORPORATION-SP-US-2020-001322,BLUEPRINT MEDICINES,,63.0,YR,A,M,Y,85.2,KG,20210525.0,,CN,US,US,2021,Q2,Adult
186412288,18641228,21,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,QD,2021,Q2,Hyperthyroidism,,2021,Q2,8,F,20180201.0,20210517.0,20201221,20210525,EXP,,US-BLUEPRINT MEDICINES CORPORATION-SP-US-2020-001322,BLUEPRINT MEDICINES,,63.0,YR,A,M,Y,85.2,KG,20210525.0,,CN,US,US,2021,Q2,Adult
186412288,18641228,21,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,QD,2021,Q2,Memory impairment,,2021,Q2,8,F,20180201.0,20210517.0,20201221,20210525,EXP,,US-BLUEPRINT MEDICINES CORPORATION-SP-US-2020-001322,BLUEPRINT MEDICINES,,63.0,YR,A,M,Y,85.2,KG,20210525.0,,CN,US,US,2021,Q2,Adult
186412288,18641228,21,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,QD,2021,Q2,Mood altered,,2021,Q2,8,F,20180201.0,20210517.0,20201221,20210525,EXP,,US-BLUEPRINT MEDICINES CORPORATION-SP-US-2020-001322,BLUEPRINT MEDICINES,,63.0,YR,A,M,Y,85.2,KG,20210525.0,,CN,US,US,2021,Q2,Adult
186412288,18641228,21,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,QD,2021,Q2,Musculoskeletal chest pain,,2021,Q2,8,F,20180201.0,20210517.0,20201221,20210525,EXP,,US-BLUEPRINT MEDICINES CORPORATION-SP-US-2020-001322,BLUEPRINT MEDICINES,,63.0,YR,A,M,Y,85.2,KG,20210525.0,,CN,US,US,2021,Q2,Adult
186412288,18641228,21,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,QD,2021,Q2,Nausea,,2021,Q2,8,F,20180201.0,20210517.0,20201221,20210525,EXP,,US-BLUEPRINT MEDICINES CORPORATION-SP-US-2020-001322,BLUEPRINT MEDICINES,,63.0,YR,A,M,Y,85.2,KG,20210525.0,,CN,US,US,2021,Q2,Adult
186412288,18641228,21,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,QD,2021,Q2,Neoplasm recurrence,,2021,Q2,8,F,20180201.0,20210517.0,20201221,20210525,EXP,,US-BLUEPRINT MEDICINES CORPORATION-SP-US-2020-001322,BLUEPRINT MEDICINES,,63.0,YR,A,M,Y,85.2,KG,20210525.0,,CN,US,US,2021,Q2,Adult
186412288,18641228,21,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,QD,2021,Q2,Neuropathy peripheral,,2021,Q2,8,F,20180201.0,20210517.0,20201221,20210525,EXP,,US-BLUEPRINT MEDICINES CORPORATION-SP-US-2020-001322,BLUEPRINT MEDICINES,,63.0,YR,A,M,Y,85.2,KG,20210525.0,,CN,US,US,2021,Q2,Adult
186412288,18641228,21,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,QD,2021,Q2,Off label use,,2021,Q2,8,F,20180201.0,20210517.0,20201221,20210525,EXP,,US-BLUEPRINT MEDICINES CORPORATION-SP-US-2020-001322,BLUEPRINT MEDICINES,,63.0,YR,A,M,Y,85.2,KG,20210525.0,,CN,US,US,2021,Q2,Adult
186412288,18641228,21,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,QD,2021,Q2,Pain,,2021,Q2,8,F,20180201.0,20210517.0,20201221,20210525,EXP,,US-BLUEPRINT MEDICINES CORPORATION-SP-US-2020-001322,BLUEPRINT MEDICINES,,63.0,YR,A,M,Y,85.2,KG,20210525.0,,CN,US,US,2021,Q2,Adult
186412288,18641228,21,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,QD,2021,Q2,Pleural effusion,,2021,Q2,8,F,20180201.0,20210517.0,20201221,20210525,EXP,,US-BLUEPRINT MEDICINES CORPORATION-SP-US-2020-001322,BLUEPRINT MEDICINES,,63.0,YR,A,M,Y,85.2,KG,20210525.0,,CN,US,US,2021,Q2,Adult
186412288,18641228,21,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,QD,2021,Q2,Pleural mass,,2021,Q2,8,F,20180201.0,20210517.0,20201221,20210525,EXP,,US-BLUEPRINT MEDICINES CORPORATION-SP-US-2020-001322,BLUEPRINT MEDICINES,,63.0,YR,A,M,Y,85.2,KG,20210525.0,,CN,US,US,2021,Q2,Adult
186412288,18641228,21,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,QD,2021,Q2,Somnolence,,2021,Q2,8,F,20180201.0,20210517.0,20201221,20210525,EXP,,US-BLUEPRINT MEDICINES CORPORATION-SP-US-2020-001322,BLUEPRINT MEDICINES,,63.0,YR,A,M,Y,85.2,KG,20210525.0,,CN,US,US,2021,Q2,Adult
186412288,18641228,21,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,QD,2021,Q2,Status epilepticus,,2021,Q2,8,F,20180201.0,20210517.0,20201221,20210525,EXP,,US-BLUEPRINT MEDICINES CORPORATION-SP-US-2020-001322,BLUEPRINT MEDICINES,,63.0,YR,A,M,Y,85.2,KG,20210525.0,,CN,US,US,2021,Q2,Adult
186587386,18658738,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q2,Acute respiratory failure,,2021,Q2,6,F,20201218.0,20210504.0,20201223,20210510,EXP,,US-ELI_LILLY_AND_COMPANY-US202012011173,ELI LILLY AND CO,,65.0,YR,,F,Y,83.7,KG,20210510.0,,PH,US,US,2021,Q2,Elderly
186587386,18658738,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q2,COVID-19 pneumonia,,2021,Q2,6,F,20201218.0,20210504.0,20201223,20210510,EXP,,US-ELI_LILLY_AND_COMPANY-US202012011173,ELI LILLY AND CO,,65.0,YR,,F,Y,83.7,KG,20210510.0,,PH,US,US,2021,Q2,Elderly
186587386,18658738,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q2,Death,,2021,Q2,6,F,20201218.0,20210504.0,20201223,20210510,EXP,,US-ELI_LILLY_AND_COMPANY-US202012011173,ELI LILLY AND CO,,65.0,YR,,F,Y,83.7,KG,20210510.0,,PH,US,US,2021,Q2,Elderly
186587386,18658738,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q2,Deep vein thrombosis,,2021,Q2,6,F,20201218.0,20210504.0,20201223,20210510,EXP,,US-ELI_LILLY_AND_COMPANY-US202012011173,ELI LILLY AND CO,,65.0,YR,,F,Y,83.7,KG,20210510.0,,PH,US,US,2021,Q2,Elderly
186587386,18658738,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q2,Enterococcus test positive,,2021,Q2,6,F,20201218.0,20210504.0,20201223,20210510,EXP,,US-ELI_LILLY_AND_COMPANY-US202012011173,ELI LILLY AND CO,,65.0,YR,,F,Y,83.7,KG,20210510.0,,PH,US,US,2021,Q2,Elderly
186587386,18658738,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q2,Pneumonia,,2021,Q2,6,F,20201218.0,20210504.0,20201223,20210510,EXP,,US-ELI_LILLY_AND_COMPANY-US202012011173,ELI LILLY AND CO,,65.0,YR,,F,Y,83.7,KG,20210510.0,,PH,US,US,2021,Q2,Elderly
186632348,18663234,4,C,Insulin Glargine,INSULIN GLARGINE,1,Oral,,,,,,,,,,,TABLETS,,2021,Q2,Cataract,,2021,Q2,8,F,20201207.0,20210610.0,20201224,20210615,EXP,,CN-CELGENEUS-CHN-20201205574,CELGENE,,77.0,YR,,M,Y,,,20210615.0,,HP,CN,CN,2021,Q2,Elderly
186632348,18663234,4,C,Insulin Glargine,INSULIN GLARGINE,1,Oral,,,,,,,,,,,TABLETS,,2021,Q2,Glaucoma,,2021,Q2,8,F,20201207.0,20210610.0,20201224,20210615,EXP,,CN-CELGENEUS-CHN-20201205574,CELGENE,,77.0,YR,,M,Y,,,20210615.0,,HP,CN,CN,2021,Q2,Elderly
186800893,18680089,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q2,Anaemia,,2021,Q2,3,F,,20210412.0,20201230,20210420,EXP,,US-DRREDDYS-USA/USA/20/0130485,DR REDDYS,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPLANT INFECTIOUS DISEASE. 2020?22(5):ARTICLE NUMBER E13305. DOI: 10.1111/TID.13305.",57.0,YR,A,M,Y,,,20210420.0,,MD,US,US,2021,Q2,Adult
186800893,18680089,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q2,Complications of transplanted kidney,,2021,Q2,3,F,,20210412.0,20201230,20210420,EXP,,US-DRREDDYS-USA/USA/20/0130485,DR REDDYS,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPLANT INFECTIOUS DISEASE. 2020?22(5):ARTICLE NUMBER E13305. DOI: 10.1111/TID.13305.",57.0,YR,A,M,Y,,,20210420.0,,MD,US,US,2021,Q2,Adult
186800893,18680089,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q2,Human ehrlichiosis,,2021,Q2,3,F,,20210412.0,20201230,20210420,EXP,,US-DRREDDYS-USA/USA/20/0130485,DR REDDYS,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPLANT INFECTIOUS DISEASE. 2020?22(5):ARTICLE NUMBER E13305. DOI: 10.1111/TID.13305.",57.0,YR,A,M,Y,,,20210420.0,,MD,US,US,2021,Q2,Adult
186800893,18680089,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q2,Inappropriate antidiuretic hormone secretion,,2021,Q2,3,F,,20210412.0,20201230,20210420,EXP,,US-DRREDDYS-USA/USA/20/0130485,DR REDDYS,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPLANT INFECTIOUS DISEASE. 2020?22(5):ARTICLE NUMBER E13305. DOI: 10.1111/TID.13305.",57.0,YR,A,M,Y,,,20210420.0,,MD,US,US,2021,Q2,Adult
186800893,18680089,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q2,Leukopenia,,2021,Q2,3,F,,20210412.0,20201230,20210420,EXP,,US-DRREDDYS-USA/USA/20/0130485,DR REDDYS,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPLANT INFECTIOUS DISEASE. 2020?22(5):ARTICLE NUMBER E13305. DOI: 10.1111/TID.13305.",57.0,YR,A,M,Y,,,20210420.0,,MD,US,US,2021,Q2,Adult
186800893,18680089,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q2,Renal impairment,,2021,Q2,3,F,,20210412.0,20201230,20210420,EXP,,US-DRREDDYS-USA/USA/20/0130485,DR REDDYS,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPLANT INFECTIOUS DISEASE. 2020?22(5):ARTICLE NUMBER E13305. DOI: 10.1111/TID.13305.",57.0,YR,A,M,Y,,,20210420.0,,MD,US,US,2021,Q2,Adult
186800893,18680089,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q2,Renal tubular necrosis,,2021,Q2,3,F,,20210412.0,20201230,20210420,EXP,,US-DRREDDYS-USA/USA/20/0130485,DR REDDYS,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPLANT INFECTIOUS DISEASE. 2020?22(5):ARTICLE NUMBER E13305. DOI: 10.1111/TID.13305.",57.0,YR,A,M,Y,,,20210420.0,,MD,US,US,2021,Q2,Adult
186800893,18680089,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q2,Thrombocytopenia,,2021,Q2,3,F,,20210412.0,20201230,20210420,EXP,,US-DRREDDYS-USA/USA/20/0130485,DR REDDYS,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPLANT INFECTIOUS DISEASE. 2020?22(5):ARTICLE NUMBER E13305. DOI: 10.1111/TID.13305.",57.0,YR,A,M,Y,,,20210420.0,,MD,US,US,2021,Q2,Adult
186800893,18680089,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q2,Transaminases increased,,2021,Q2,3,F,,20210412.0,20201230,20210420,EXP,,US-DRREDDYS-USA/USA/20/0130485,DR REDDYS,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPLANT INFECTIOUS DISEASE. 2020?22(5):ARTICLE NUMBER E13305. DOI: 10.1111/TID.13305.",57.0,YR,A,M,Y,,,20210420.0,,MD,US,US,2021,Q2,Adult
186800893,18680089,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q2,Transplant rejection,,2021,Q2,3,F,,20210412.0,20201230,20210420,EXP,,US-DRREDDYS-USA/USA/20/0130485,DR REDDYS,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPLANT INFECTIOUS DISEASE. 2020?22(5):ARTICLE NUMBER E13305. DOI: 10.1111/TID.13305.",57.0,YR,A,M,Y,,,20210420.0,,MD,US,US,2021,Q2,Adult
186827402,18682740,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,, UNKNOWN,,,,,,,2021,Q2,Condition aggravated,,2021,Q2,2,F,,20210412.0,20201229,20210420,EXP,,US-DRREDDYS-USA/USA/20/0130487,DR REDDYS,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPLANT INFECTIOUS DISEASE. 2020?22(5):ARTICLE NUMBER E13305. DOI: 10.1111/TID.13305.",57.0,YR,A,M,Y,,,20210420.0,,MD,US,US,2021,Q2,Adult
186827402,18682740,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,, UNKNOWN,,,,,,,2021,Q2,Inappropriate antidiuretic hormone secretion,,2021,Q2,2,F,,20210412.0,20201229,20210420,EXP,,US-DRREDDYS-USA/USA/20/0130487,DR REDDYS,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPLANT INFECTIOUS DISEASE. 2020?22(5):ARTICLE NUMBER E13305. DOI: 10.1111/TID.13305.",57.0,YR,A,M,Y,,,20210420.0,,MD,US,US,2021,Q2,Adult
187055872,18705587,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,INJECTION,,2021,Q2,Femur fracture,,2021,Q2,2,F,202011.0,20210330.0,20210106,20210412,EXP,,NVSJ2020JP014558,NOVARTIS,,84.0,YR,,F,Y,,,20210412.0,,PH,JP,JP,2021,Q2,Elderly
187055872,18705587,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,INJECTION,,2021,Q2,Incorrect dose administered,,2021,Q2,2,F,202011.0,20210330.0,20210106,20210412,EXP,,NVSJ2020JP014558,NOVARTIS,,84.0,YR,,F,Y,,,20210412.0,,PH,JP,JP,2021,Q2,Elderly
187133403,18713340,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 INTERNATIONAL UNIT, QD",,,,,,,,10.0,IU,,,2021,Q2,Lactic acidosis,,2021,Q2,3,F,,20210430.0,20210107,20210507,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK051508,GLENMARK,"CERVANTES CE, MENEZ S, MONROY?TRUJILLO JM, HANOUNEH M. CLINICAL APPROACH TO A PATIENT WITH AN ACID?BASE DISTURBANCE. AMERICAN JOURNAL OF KIDNEY DISEASES. 2021?77(2):A9?11",65.0,YR,,F,Y,,,20210507.0,,,COUNTRY NOT SPECIFIED,US,2021,Q2,Elderly
187133403,18713340,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 INTERNATIONAL UNIT, QD",,,,,,,,10.0,IU,,,2021,Q2,Metabolic acidosis,,2021,Q2,3,F,,20210430.0,20210107,20210507,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK051508,GLENMARK,"CERVANTES CE, MENEZ S, MONROY?TRUJILLO JM, HANOUNEH M. CLINICAL APPROACH TO A PATIENT WITH AN ACID?BASE DISTURBANCE. AMERICAN JOURNAL OF KIDNEY DISEASES. 2021?77(2):A9?11",65.0,YR,,F,Y,,,20210507.0,,,COUNTRY NOT SPECIFIED,US,2021,Q2,Elderly
187133403,18713340,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 INTERNATIONAL UNIT, QD",,,,,,,,10.0,IU,,,2021,Q2,Toxicity to various agents,,2021,Q2,3,F,,20210430.0,20210107,20210507,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK051508,GLENMARK,"CERVANTES CE, MENEZ S, MONROY?TRUJILLO JM, HANOUNEH M. CLINICAL APPROACH TO A PATIENT WITH AN ACID?BASE DISTURBANCE. AMERICAN JOURNAL OF KIDNEY DISEASES. 2021?77(2):A9?11",65.0,YR,,F,Y,,,20210507.0,,,COUNTRY NOT SPECIFIED,US,2021,Q2,Elderly
187416173,18741617,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q2,Lactic acidosis,,2021,Q2,3,F,,20210602.0,20210114,20210611,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-21-53302,HIKMA,"CERVANTES C, MENEZ S, MONROY TRUJILLO J, HANOUNEH M. CLINICAL APPROACH TO A PATIENT WITH AN ACID?BASE DISTURBANCE. AMERICAN JOURNAL OF KIDNEY DISEASES. 2021?77 (2):9?11. DOI:10.1053/J.AJKD.2020.06.022",65.0,YR,,F,Y,,,20210610.0,,,COUNTRY NOT SPECIFIED,US,2021,Q2,Elderly
187416173,18741617,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q2,Metabolic acidosis,,2021,Q2,3,F,,20210602.0,20210114,20210611,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-21-53302,HIKMA,"CERVANTES C, MENEZ S, MONROY TRUJILLO J, HANOUNEH M. CLINICAL APPROACH TO A PATIENT WITH AN ACID?BASE DISTURBANCE. AMERICAN JOURNAL OF KIDNEY DISEASES. 2021?77 (2):9?11. DOI:10.1053/J.AJKD.2020.06.022",65.0,YR,,F,Y,,,20210610.0,,,COUNTRY NOT SPECIFIED,US,2021,Q2,Elderly
187416173,18741617,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q2,Toxicity to various agents,,2021,Q2,3,F,,20210602.0,20210114,20210611,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-21-53302,HIKMA,"CERVANTES C, MENEZ S, MONROY TRUJILLO J, HANOUNEH M. CLINICAL APPROACH TO A PATIENT WITH AN ACID?BASE DISTURBANCE. AMERICAN JOURNAL OF KIDNEY DISEASES. 2021?77 (2):9?11. DOI:10.1053/J.AJKD.2020.06.022",65.0,YR,,F,Y,,,20210610.0,,,COUNTRY NOT SPECIFIED,US,2021,Q2,Elderly
187533072,18753307,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28?0?0,,,U,,,,,,,INJECTION,,2021,Q2,Arrhythmia,,2021,Q2,2,F,20210110.0,20210413.0,20210118,20210422,EXP,,JP-ASTRAZENECA-2021A006828,ASTRAZENECA,,59.0,YR,,M,Y,83.0,KG,20210421.0,,MD,JP,JP,2021,Q2,Adult
187533072,18753307,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28?0?0,,,U,,,,,,,INJECTION,,2021,Q2,Diabetic ketoacidosis,,2021,Q2,2,F,20210110.0,20210413.0,20210118,20210422,EXP,,JP-ASTRAZENECA-2021A006828,ASTRAZENECA,,59.0,YR,,M,Y,83.0,KG,20210421.0,,MD,JP,JP,2021,Q2,Adult
187533072,18753307,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 UNIT,,,U,,,,,,,INJECTION,,2021,Q2,Arrhythmia,,2021,Q2,2,F,20210110.0,20210413.0,20210118,20210422,EXP,,JP-ASTRAZENECA-2021A006828,ASTRAZENECA,,59.0,YR,,M,Y,83.0,KG,20210421.0,,MD,JP,JP,2021,Q2,Adult
187533072,18753307,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 UNIT,,,U,,,,,,,INJECTION,,2021,Q2,Diabetic ketoacidosis,,2021,Q2,2,F,20210110.0,20210413.0,20210118,20210422,EXP,,JP-ASTRAZENECA-2021A006828,ASTRAZENECA,,59.0,YR,,M,Y,83.0,KG,20210421.0,,MD,JP,JP,2021,Q2,Adult
187583055,18758305,6,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,100 IU (INTERNATIONAL UNIT),,,,,,,,100.0,IU,UNKNOWN,QD,2021,Q2,Hypotension,,2021,Q2,5,F,20210103.0,20210519.0,20210119,20210524,EXP,,US-CELGENEUS-USA-20210102081,CELGENE,,55.0,YR,,F,Y,60.2,KG,20210524.0,,MD,US,US,2021,Q2,Adult
187583055,18758305,6,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,100 IU (INTERNATIONAL UNIT),,,,,,,,100.0,IU,UNKNOWN,QD,2021,Q2,Respiratory failure,,2021,Q2,5,F,20210103.0,20210519.0,20210119,20210524,EXP,,US-CELGENEUS-USA-20210102081,CELGENE,,55.0,YR,,F,Y,60.2,KG,20210524.0,,MD,US,US,2021,Q2,Adult
187583055,18758305,6,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,100 IU (INTERNATIONAL UNIT),,,,,,,,100.0,IU,UNKNOWN,QD,2021,Q2,Urinary tract infection enterococcal,,2021,Q2,5,F,20210103.0,20210519.0,20210119,20210524,EXP,,US-CELGENEUS-USA-20210102081,CELGENE,,55.0,YR,,F,Y,60.2,KG,20210524.0,,MD,US,US,2021,Q2,Adult
187637083,18763708,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, UNKNOWN,,,12.0,IU,UNKNOWN,,2021,Q2,Keratitis,,2021,Q2,3,F,202006.0,20210503.0,20210120,20210513,EXP,FR-AFSSAPS-AN20210007,FR-FRESENIUS KABI-FK202100635,FRESENIUS KABI,,57.0,YR,,F,Y,50.0,KG,20210513.0,,HP,NL,FR,2021,Q2,Adult
187637083,18763708,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, UNKNOWN,,,12.0,IU,UNKNOWN,,2021,Q2,Visual acuity reduced,,2021,Q2,3,F,202006.0,20210503.0,20210120,20210513,EXP,FR-AFSSAPS-AN20210007,FR-FRESENIUS KABI-FK202100635,FRESENIUS KABI,,57.0,YR,,F,Y,50.0,KG,20210513.0,,HP,NL,FR,2021,Q2,Adult
188079405,18807940,18,C,INSULIN GLARGINE BS INJECTION,,2,,"3 IU, QD, BEFORE BEDTIME",,,,,,,,3.0,IU,,QD,2021,Q2,Affective disorder,,2021,Q2,5,F,202002.0,20210511.0,20210129,20210517,EXP,,JP-GLAXOSMITHKLINE-JP2021JPN017196,GLAXOSMITHKLINE,,63.0,YR,,F,Y,48.0,KG,20210517.0,,CN,JP,JP,2021,Q2,Adult
188079405,18807940,18,C,INSULIN GLARGINE BS INJECTION,,2,,"3 IU, QD, BEFORE BEDTIME",,,,,,,,3.0,IU,,QD,2021,Q2,Constipation,,2021,Q2,5,F,202002.0,20210511.0,20210129,20210517,EXP,,JP-GLAXOSMITHKLINE-JP2021JPN017196,GLAXOSMITHKLINE,,63.0,YR,,F,Y,48.0,KG,20210517.0,,CN,JP,JP,2021,Q2,Adult
188079405,18807940,18,C,INSULIN GLARGINE BS INJECTION,,2,,"3 IU, QD, BEFORE BEDTIME",,,,,,,,3.0,IU,,QD,2021,Q2,Depressed mood,,2021,Q2,5,F,202002.0,20210511.0,20210129,20210517,EXP,,JP-GLAXOSMITHKLINE-JP2021JPN017196,GLAXOSMITHKLINE,,63.0,YR,,F,Y,48.0,KG,20210517.0,,CN,JP,JP,2021,Q2,Adult
188079405,18807940,18,C,INSULIN GLARGINE BS INJECTION,,2,,"3 IU, QD, BEFORE BEDTIME",,,,,,,,3.0,IU,,QD,2021,Q2,Diverticulum intestinal haemorrhagic,,2021,Q2,5,F,202002.0,20210511.0,20210129,20210517,EXP,,JP-GLAXOSMITHKLINE-JP2021JPN017196,GLAXOSMITHKLINE,,63.0,YR,,F,Y,48.0,KG,20210517.0,,CN,JP,JP,2021,Q2,Adult
188079405,18807940,18,C,INSULIN GLARGINE BS INJECTION,,2,,"3 IU, QD, BEFORE BEDTIME",,,,,,,,3.0,IU,,QD,2021,Q2,"Hallucination, visual",,2021,Q2,5,F,202002.0,20210511.0,20210129,20210517,EXP,,JP-GLAXOSMITHKLINE-JP2021JPN017196,GLAXOSMITHKLINE,,63.0,YR,,F,Y,48.0,KG,20210517.0,,CN,JP,JP,2021,Q2,Adult
188113032,18811303,14,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Human ehrlichiosis,,2021,Q2,2,F,,20210625.0,20210129,20210629,EXP,,US-TEVA-2021-US-1872171,TEVA,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPL?INFECT?DIS 2020?22:NO. 5.",57.0,YR,A,M,Y,,,20210629.0,,HP,US,US,2021,Q2,Adult
188113032,18811303,14,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Hyponatraemia,,2021,Q2,2,F,,20210625.0,20210129,20210629,EXP,,US-TEVA-2021-US-1872171,TEVA,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPL?INFECT?DIS 2020?22:NO. 5.",57.0,YR,A,M,Y,,,20210629.0,,HP,US,US,2021,Q2,Adult
188203272,18820327,19,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Adenocarcinoma,,2021,Q2,2,F,20191116.0,20210601.0,20210202,20210604,EXP,,NVSC2020DE326484,NOVARTIS,,61.0,YR,,M,Y,,,20210604.0,,MD,DE,DE,2021,Q2,Adult
188203272,18820327,19,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Asthenia,,2021,Q2,2,F,20191116.0,20210601.0,20210202,20210604,EXP,,NVSC2020DE326484,NOVARTIS,,61.0,YR,,M,Y,,,20210604.0,,MD,DE,DE,2021,Q2,Adult
188203272,18820327,19,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Decreased appetite,,2021,Q2,2,F,20191116.0,20210601.0,20210202,20210604,EXP,,NVSC2020DE326484,NOVARTIS,,61.0,YR,,M,Y,,,20210604.0,,MD,DE,DE,2021,Q2,Adult
188203272,18820327,19,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Drug ineffective,,2021,Q2,2,F,20191116.0,20210601.0,20210202,20210604,EXP,,NVSC2020DE326484,NOVARTIS,,61.0,YR,,M,Y,,,20210604.0,,MD,DE,DE,2021,Q2,Adult
188203272,18820327,19,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Dyspnoea,,2021,Q2,2,F,20191116.0,20210601.0,20210202,20210604,EXP,,NVSC2020DE326484,NOVARTIS,,61.0,YR,,M,Y,,,20210604.0,,MD,DE,DE,2021,Q2,Adult
188203272,18820327,19,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Fatigue,,2021,Q2,2,F,20191116.0,20210601.0,20210202,20210604,EXP,,NVSC2020DE326484,NOVARTIS,,61.0,YR,,M,Y,,,20210604.0,,MD,DE,DE,2021,Q2,Adult
188203272,18820327,19,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,General physical health deterioration,,2021,Q2,2,F,20191116.0,20210601.0,20210202,20210604,EXP,,NVSC2020DE326484,NOVARTIS,,61.0,YR,,M,Y,,,20210604.0,,MD,DE,DE,2021,Q2,Adult
188203272,18820327,19,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Hyperkalaemia,,2021,Q2,2,F,20191116.0,20210601.0,20210202,20210604,EXP,,NVSC2020DE326484,NOVARTIS,,61.0,YR,,M,Y,,,20210604.0,,MD,DE,DE,2021,Q2,Adult
188203272,18820327,19,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Hyponatraemia,,2021,Q2,2,F,20191116.0,20210601.0,20210202,20210604,EXP,,NVSC2020DE326484,NOVARTIS,,61.0,YR,,M,Y,,,20210604.0,,MD,DE,DE,2021,Q2,Adult
188203272,18820327,19,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Lumbar vertebral fracture,,2021,Q2,2,F,20191116.0,20210601.0,20210202,20210604,EXP,,NVSC2020DE326484,NOVARTIS,,61.0,YR,,M,Y,,,20210604.0,,MD,DE,DE,2021,Q2,Adult
188203272,18820327,19,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Malignant neoplasm of pleura,,2021,Q2,2,F,20191116.0,20210601.0,20210202,20210604,EXP,,NVSC2020DE326484,NOVARTIS,,61.0,YR,,M,Y,,,20210604.0,,MD,DE,DE,2021,Q2,Adult
188203272,18820327,19,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Metastases to adrenals,,2021,Q2,2,F,20191116.0,20210601.0,20210202,20210604,EXP,,NVSC2020DE326484,NOVARTIS,,61.0,YR,,M,Y,,,20210604.0,,MD,DE,DE,2021,Q2,Adult
188203272,18820327,19,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Metastases to bone,,2021,Q2,2,F,20191116.0,20210601.0,20210202,20210604,EXP,,NVSC2020DE326484,NOVARTIS,,61.0,YR,,M,Y,,,20210604.0,,MD,DE,DE,2021,Q2,Adult
188203272,18820327,19,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Metastases to liver,,2021,Q2,2,F,20191116.0,20210601.0,20210202,20210604,EXP,,NVSC2020DE326484,NOVARTIS,,61.0,YR,,M,Y,,,20210604.0,,MD,DE,DE,2021,Q2,Adult
188203272,18820327,19,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Neoplasm progression,,2021,Q2,2,F,20191116.0,20210601.0,20210202,20210604,EXP,,NVSC2020DE326484,NOVARTIS,,61.0,YR,,M,Y,,,20210604.0,,MD,DE,DE,2021,Q2,Adult
188203272,18820327,19,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Oedema peripheral,,2021,Q2,2,F,20191116.0,20210601.0,20210202,20210604,EXP,,NVSC2020DE326484,NOVARTIS,,61.0,YR,,M,Y,,,20210604.0,,MD,DE,DE,2021,Q2,Adult
188203272,18820327,19,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Weight increased,,2021,Q2,2,F,20191116.0,20210601.0,20210202,20210604,EXP,,NVSC2020DE326484,NOVARTIS,,61.0,YR,,M,Y,,,20210604.0,,MD,DE,DE,2021,Q2,Adult
188556525,18855652,5,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,12.0,IU,INJECTION,,2021,Q2,Ascites,,2021,Q2,5,F,20210120.0,20210401.0,20210205,20210408,EXP,,JP-EISAI MEDICAL RESEARCH-EC-2021-087415,EISAI,,58.0,YR,A,M,Y,75.0,KG,20210408.0,,MD,JP,JP,2021,Q2,Adult
188556525,18855652,5,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,12.0,IU,INJECTION,,2021,Q2,Interstitial lung disease,,2021,Q2,5,F,20210120.0,20210401.0,20210205,20210408,EXP,,JP-EISAI MEDICAL RESEARCH-EC-2021-087415,EISAI,,58.0,YR,A,M,Y,75.0,KG,20210408.0,,MD,JP,JP,2021,Q2,Adult
188556525,18855652,6,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,2.0,IU,INJECTION,,2021,Q2,Ascites,,2021,Q2,5,F,20210120.0,20210401.0,20210205,20210408,EXP,,JP-EISAI MEDICAL RESEARCH-EC-2021-087415,EISAI,,58.0,YR,A,M,Y,75.0,KG,20210408.0,,MD,JP,JP,2021,Q2,Adult
188556525,18855652,6,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,2.0,IU,INJECTION,,2021,Q2,Interstitial lung disease,,2021,Q2,5,F,20210120.0,20210401.0,20210205,20210408,EXP,,JP-EISAI MEDICAL RESEARCH-EC-2021-087415,EISAI,,58.0,YR,A,M,Y,75.0,KG,20210408.0,,MD,JP,JP,2021,Q2,Adult
188577183,18857718,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"120 UNITS, BID",,,,,,,,,,,BID,2021,Q2,Cerebrovascular accident,,2021,Q2,3,F,20200812.0,20210614.0,20210208,20210628,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005001,AEGERION,,45.0,YR,,F,Y,,,20210628.0,,CN,US,US,2021,Q2,Adult
188577183,18857718,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"120 UNITS, BID",,,,,,,,,,,BID,2021,Q2,Hospitalisation,,2021,Q2,3,F,20200812.0,20210614.0,20210208,20210628,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005001,AEGERION,,45.0,YR,,F,Y,,,20210628.0,,CN,US,US,2021,Q2,Adult
188577183,18857718,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"120 UNITS, BID",,,,,,,,,,,BID,2021,Q2,Laboratory test abnormal,,2021,Q2,3,F,20200812.0,20210614.0,20210208,20210628,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005001,AEGERION,,45.0,YR,,F,Y,,,20210628.0,,CN,US,US,2021,Q2,Adult
188577183,18857718,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"120 UNITS, BID",,,,,,,,,,,BID,2021,Q2,Memory impairment,,2021,Q2,3,F,20200812.0,20210614.0,20210208,20210628,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005001,AEGERION,,45.0,YR,,F,Y,,,20210628.0,,CN,US,US,2021,Q2,Adult
188577183,18857718,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"120 UNITS, BID",,,,,,,,,,,BID,2021,Q2,Nausea,,2021,Q2,3,F,20200812.0,20210614.0,20210208,20210628,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005001,AEGERION,,45.0,YR,,F,Y,,,20210628.0,,CN,US,US,2021,Q2,Adult
188577183,18857718,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"120 UNITS, BID",,,,,,,,,,,BID,2021,Q2,Pancreatitis acute,,2021,Q2,3,F,20200812.0,20210614.0,20210208,20210628,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005001,AEGERION,,45.0,YR,,F,Y,,,20210628.0,,CN,US,US,2021,Q2,Adult
188577183,18857718,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"120 UNITS, BID",,,,,,,,,,,BID,2021,Q2,Road traffic accident,,2021,Q2,3,F,20200812.0,20210614.0,20210208,20210628,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005001,AEGERION,,45.0,YR,,F,Y,,,20210628.0,,CN,US,US,2021,Q2,Adult
188577183,18857718,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"120 UNITS, BID",,,,,,,,,,,BID,2021,Q2,Vomiting,,2021,Q2,3,F,20200812.0,20210614.0,20210208,20210628,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005001,AEGERION,,45.0,YR,,F,Y,,,20210628.0,,CN,US,US,2021,Q2,Adult
188864082,18886408,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"BEFORE LOCKDOWN WAS 5 UNITS/DAY (0,10 UNITS/KG/DAY)",,,,,,,,,,,,2021,Q2,Abdominal pain,,2021,Q2,2,F,2020.0,20210614.0,20210212,20210621,EXP,,IT-VERTEX PHARMACEUTICALS-2021-002401,VERTEX,,17.0,YR,,M,Y,,,20210621.0,,HP,IT,IT,2021,Q2,Youth
188864082,18886408,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"BEFORE LOCKDOWN WAS 5 UNITS/DAY (0,10 UNITS/KG/DAY)",,,,,,,,,,,,2021,Q2,Agitation,,2021,Q2,2,F,2020.0,20210614.0,20210212,20210621,EXP,,IT-VERTEX PHARMACEUTICALS-2021-002401,VERTEX,,17.0,YR,,M,Y,,,20210621.0,,HP,IT,IT,2021,Q2,Youth
188864082,18886408,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"BEFORE LOCKDOWN WAS 5 UNITS/DAY (0,10 UNITS/KG/DAY)",,,,,,,,,,,,2021,Q2,Blood glucose fluctuation,,2021,Q2,2,F,2020.0,20210614.0,20210212,20210621,EXP,,IT-VERTEX PHARMACEUTICALS-2021-002401,VERTEX,,17.0,YR,,M,Y,,,20210621.0,,HP,IT,IT,2021,Q2,Youth
188864082,18886408,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"BEFORE LOCKDOWN WAS 5 UNITS/DAY (0,10 UNITS/KG/DAY)",,,,,,,,,,,,2021,Q2,C-reactive protein increased,,2021,Q2,2,F,2020.0,20210614.0,20210212,20210621,EXP,,IT-VERTEX PHARMACEUTICALS-2021-002401,VERTEX,,17.0,YR,,M,Y,,,20210621.0,,HP,IT,IT,2021,Q2,Youth
188864082,18886408,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"BEFORE LOCKDOWN WAS 5 UNITS/DAY (0,10 UNITS/KG/DAY)",,,,,,,,,,,,2021,Q2,Dehydration,,2021,Q2,2,F,2020.0,20210614.0,20210212,20210621,EXP,,IT-VERTEX PHARMACEUTICALS-2021-002401,VERTEX,,17.0,YR,,M,Y,,,20210621.0,,HP,IT,IT,2021,Q2,Youth
188864082,18886408,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"BEFORE LOCKDOWN WAS 5 UNITS/DAY (0,10 UNITS/KG/DAY)",,,,,,,,,,,,2021,Q2,Headache,,2021,Q2,2,F,2020.0,20210614.0,20210212,20210621,EXP,,IT-VERTEX PHARMACEUTICALS-2021-002401,VERTEX,,17.0,YR,,M,Y,,,20210621.0,,HP,IT,IT,2021,Q2,Youth
188864082,18886408,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"BEFORE LOCKDOWN WAS 5 UNITS/DAY (0,10 UNITS/KG/DAY)",,,,,,,,,,,,2021,Q2,Infective pulmonary exacerbation of cystic fibrosis,,2021,Q2,2,F,2020.0,20210614.0,20210212,20210621,EXP,,IT-VERTEX PHARMACEUTICALS-2021-002401,VERTEX,,17.0,YR,,M,Y,,,20210621.0,,HP,IT,IT,2021,Q2,Youth
188864082,18886408,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"BEFORE LOCKDOWN WAS 5 UNITS/DAY (0,10 UNITS/KG/DAY)",,,,,,,,,,,,2021,Q2,Polydipsia,,2021,Q2,2,F,2020.0,20210614.0,20210212,20210621,EXP,,IT-VERTEX PHARMACEUTICALS-2021-002401,VERTEX,,17.0,YR,,M,Y,,,20210621.0,,HP,IT,IT,2021,Q2,Youth
188864082,18886408,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"BEFORE LOCKDOWN WAS 5 UNITS/DAY (0,10 UNITS/KG/DAY)",,,,,,,,,,,,2021,Q2,Polyuria,,2021,Q2,2,F,2020.0,20210614.0,20210212,20210621,EXP,,IT-VERTEX PHARMACEUTICALS-2021-002401,VERTEX,,17.0,YR,,M,Y,,,20210621.0,,HP,IT,IT,2021,Q2,Youth
188864082,18886408,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"BEFORE LOCKDOWN WAS 5 UNITS/DAY (0,10 UNITS/KG/DAY)",,,,,,,,,,,,2021,Q2,Weight decreased,,2021,Q2,2,F,2020.0,20210614.0,20210212,20210621,EXP,,IT-VERTEX PHARMACEUTICALS-2021-002401,VERTEX,,17.0,YR,,M,Y,,,20210621.0,,HP,IT,IT,2021,Q2,Youth
189063652,18906365,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Asthenia,,2021,Q2,2,F,20210118.0,20210329.0,20210217,20210405,PER,,US-ELI_LILLY_AND_COMPANY-US202102004802,ELI LILLY AND CO,,80.0,YR,,M,Y,107.5,KG,20210405.0,,PH,US,US,2021,Q2,Elderly
189063652,18906365,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Fatigue,,2021,Q2,2,F,20210118.0,20210329.0,20210217,20210405,PER,,US-ELI_LILLY_AND_COMPANY-US202102004802,ELI LILLY AND CO,,80.0,YR,,M,Y,107.5,KG,20210405.0,,PH,US,US,2021,Q2,Elderly
189063652,18906365,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Hypersomnia,,2021,Q2,2,F,20210118.0,20210329.0,20210217,20210405,PER,,US-ELI_LILLY_AND_COMPANY-US202102004802,ELI LILLY AND CO,,80.0,YR,,M,Y,107.5,KG,20210405.0,,PH,US,US,2021,Q2,Elderly
189087012,18908701,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q2,Acute respiratory distress syndrome,,2021,Q2,2,F,202101.0,20210329.0,20210218,20210402,EXP,,US-ELI_LILLY_AND_COMPANY-US202102007873,ELI LILLY AND CO,,69.0,YR,,F,Y,144.4,KG,20210402.0,,PH,US,US,2021,Q2,Elderly
189087012,18908701,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q2,Respiratory failure,,2021,Q2,2,F,202101.0,20210329.0,20210218,20210402,EXP,,US-ELI_LILLY_AND_COMPANY-US202102007873,ELI LILLY AND CO,,69.0,YR,,F,Y,144.4,KG,20210402.0,,PH,US,US,2021,Q2,Elderly
189087012,18908701,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q2,Supraventricular extrasystoles,,2021,Q2,2,F,202101.0,20210329.0,20210218,20210402,EXP,,US-ELI_LILLY_AND_COMPANY-US202102007873,ELI LILLY AND CO,,69.0,YR,,F,Y,144.4,KG,20210402.0,,PH,US,US,2021,Q2,Elderly
189087012,18908701,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q2,Thyroid cyst,,2021,Q2,2,F,202101.0,20210329.0,20210218,20210402,EXP,,US-ELI_LILLY_AND_COMPANY-US202102007873,ELI LILLY AND CO,,69.0,YR,,F,Y,144.4,KG,20210402.0,,PH,US,US,2021,Q2,Elderly
189180174,18918017,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Blood glucose abnormal,,2021,Q2,4,F,201912.0,20210608.0,20210219,20210617,EXP,,US-SA-2021SA057436,SANOFI AVENTIS,,55.0,YR,A,M,Y,,,20210617.0,,CN,US,US,2021,Q2,Adult
189180174,18918017,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Blood glucose fluctuation,,2021,Q2,4,F,201912.0,20210608.0,20210219,20210617,EXP,,US-SA-2021SA057436,SANOFI AVENTIS,,55.0,YR,A,M,Y,,,20210617.0,,CN,US,US,2021,Q2,Adult
189180174,18918017,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Device operational issue,,2021,Q2,4,F,201912.0,20210608.0,20210219,20210617,EXP,,US-SA-2021SA057436,SANOFI AVENTIS,,55.0,YR,A,M,Y,,,20210617.0,,CN,US,US,2021,Q2,Adult
189180174,18918017,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Dupuytren's contracture,,2021,Q2,4,F,201912.0,20210608.0,20210219,20210617,EXP,,US-SA-2021SA057436,SANOFI AVENTIS,,55.0,YR,A,M,Y,,,20210617.0,,CN,US,US,2021,Q2,Adult
189180174,18918017,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Loss of consciousness,,2021,Q2,4,F,201912.0,20210608.0,20210219,20210617,EXP,,US-SA-2021SA057436,SANOFI AVENTIS,,55.0,YR,A,M,Y,,,20210617.0,,CN,US,US,2021,Q2,Adult
189180174,18918017,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Neoplasm malignant,,2021,Q2,4,F,201912.0,20210608.0,20210219,20210617,EXP,,US-SA-2021SA057436,SANOFI AVENTIS,,55.0,YR,A,M,Y,,,20210617.0,,CN,US,US,2021,Q2,Adult
189180174,18918017,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Weight decreased,,2021,Q2,4,F,201912.0,20210608.0,20210219,20210617,EXP,,US-SA-2021SA057436,SANOFI AVENTIS,,55.0,YR,A,M,Y,,,20210617.0,,CN,US,US,2021,Q2,Adult
189180174,18918017,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Wrong technique in product usage process,,2021,Q2,4,F,201912.0,20210608.0,20210219,20210617,EXP,,US-SA-2021SA057436,SANOFI AVENTIS,,55.0,YR,A,M,Y,,,20210617.0,,CN,US,US,2021,Q2,Adult
189182927,18918292,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Abscess,,2021,Q2,7,F,20210216.0,20210503.0,20210219,20210505,EXP,,US-GILEAD-2021-0518037,GILEAD,,72.0,YR,E,M,Y,121.09,KG,20210505.0,,HP,US,US,2021,Q2,Elderly
189212418,18921241,30,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SLIDING SCALE U X 1 X 1 DAYS,,,,,,,,,,UNKNOWN,QD,2021,Q2,Fungal sepsis,,2021,Q2,8,F,20210216.0,20210608.0,20210222,20210611,EXP,,US-CELGENEUS-USA-20210204648,CELGENE,,68.0,YR,,F,Y,46.0,KG,20210611.0,,MD,US,US,2021,Q2,Elderly
189305476,18930547,31,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,,QD,2021,Q2,Fungal sepsis,,2021,Q2,6,F,20210216.0,20210608.0,20210223,20210615,EXP,,US-ABBVIE-21P-163-3785222-00,ABBVIE,,68.0,YR,,F,Y,46.0,KG,20210615.0,,MD,US,US,2021,Q2,Elderly
189322913,18932291,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),24 UNK,,,,,,,,,,,,2021,Q2,Peripheral arterial occlusive disease,,2021,Q2,3,F,20191115.0,20210622.0,20210224,20210628,PER,,RU-AMGEN-RUSNI2021026942,AMGEN,,49.0,YR,A,M,Y,77.5,KG,20210628.0,,MD,RU,RU,2021,Q2,Adult
189454552,18945455,2,C,OPTISULIN [INSULIN GLARGINE],INSULIN GLARGINE,1,Unknown,UNK,,,,, UNK,,,,,,,2021,Q2,Toe amputation,,2021,Q2,2,F,,20210406.0,20210226,20210416,EXP,,AU-NOVOPROD-789792,NOVO NORDISK,,91.0,YR,,M,Y,80.0,KG,20210416.0,,PH,AU,AU,2021,Q2,Elderly
189787813,18978781,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, UNKNOWN,,,12.0,IU,,QD,2021,Q2,Carotid artery stenosis,,2021,Q2,3,F,20201020.0,20210512.0,20210308,20210525,EXP,,DE-ROCHE-2777863,ROCHE,,63.0,YR,,M,Y,84.0,KG,20210525.0,,MD,DE,DE,2021,Q2,Adult
189787813,18978781,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, UNKNOWN,,,12.0,IU,,QD,2021,Q2,Carotid endarterectomy,,2021,Q2,3,F,20201020.0,20210512.0,20210308,20210525,EXP,,DE-ROCHE-2777863,ROCHE,,63.0,YR,,M,Y,84.0,KG,20210525.0,,MD,DE,DE,2021,Q2,Adult
189791956,18979195,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q2,COVID-19,,2021,Q2,6,F,20210227.0,20210415.0,20210308,20210416,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-021589,BRISTOL MYERS SQUIBB,,69.0,YR,,M,Y,107.04,KG,20210416.0,,HP,US,US,2021,Q2,Elderly
189791956,18979195,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Staphylococcal sepsis,,2021,Q2,6,F,20210227.0,20210415.0,20210308,20210416,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-021589,BRISTOL MYERS SQUIBB,,69.0,YR,,M,Y,107.04,KG,20210416.0,,HP,US,US,2021,Q2,Elderly
189799482,18979948,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Drug abuse,,2021,Q2,2,F,,20210301.0,20210308,20210629,EXP,,GR-ACCORD-219334,ACCORD,"PAPAIOANNOU I, PANTAZIDOU G, CHATZIPERI S, BAIKOUSIS A, KOROVESSIS P. GLUTEAL COMPARTMENT SYNDROME? THE MISSING DIAGNOSIS. CASE PRESENTATION AND BRIEF LITERATURE REVIEW. SURGICAL CHRONICLES. 2020? 25(4): 378?380.",47.0,YR,,F,Y,,,20210629.0,,MD,GR,GR,2021,Q2,Adult
189799482,18979948,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Labelled drug-food interaction issue,,2021,Q2,2,F,,20210301.0,20210308,20210629,EXP,,GR-ACCORD-219334,ACCORD,"PAPAIOANNOU I, PANTAZIDOU G, CHATZIPERI S, BAIKOUSIS A, KOROVESSIS P. GLUTEAL COMPARTMENT SYNDROME? THE MISSING DIAGNOSIS. CASE PRESENTATION AND BRIEF LITERATURE REVIEW. SURGICAL CHRONICLES. 2020? 25(4): 378?380.",47.0,YR,,F,Y,,,20210629.0,,MD,GR,GR,2021,Q2,Adult
189799482,18979948,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Rhabdomyolysis,,2021,Q2,2,F,,20210301.0,20210308,20210629,EXP,,GR-ACCORD-219334,ACCORD,"PAPAIOANNOU I, PANTAZIDOU G, CHATZIPERI S, BAIKOUSIS A, KOROVESSIS P. GLUTEAL COMPARTMENT SYNDROME? THE MISSING DIAGNOSIS. CASE PRESENTATION AND BRIEF LITERATURE REVIEW. SURGICAL CHRONICLES. 2020? 25(4): 378?380.",47.0,YR,,F,Y,,,20210629.0,,MD,GR,GR,2021,Q2,Adult
189875412,18987541,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q2,Hepatosplenic candidiasis,,2021,Q2,2,F,20190109.0,20210517.0,20210309,20210525,EXP,,FR-FRESENIUS KABI-FK202102129,FRESENIUS KABI,,66.0,YR,,F,Y,,,20210525.0,,HP,NL,FR,2021,Q2,Elderly
189962212,18996221,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"32.00 IU, QD",,,,, UNKNOWN,,,32.0,IU,,QD,2021,Q2,Cardiac arrest,,2021,Q2,2,F,202011.0,20210325.0,20210311,20210402,EXP,,CO-NOVOPROD-792877,NOVO NORDISK,,76.0,YR,,M,Y,62.0,KG,20210402.0,,CN,CO,CO,2021,Q2,Elderly
189962212,18996221,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"32.00 IU, QD",,,,, UNKNOWN,,,32.0,IU,,QD,2021,Q2,Decreased appetite,,2021,Q2,2,F,202011.0,20210325.0,20210311,20210402,EXP,,CO-NOVOPROD-792877,NOVO NORDISK,,76.0,YR,,M,Y,62.0,KG,20210402.0,,CN,CO,CO,2021,Q2,Elderly
189962212,18996221,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"32.00 IU, QD",,,,, UNKNOWN,,,32.0,IU,,QD,2021,Q2,Gastric ulcer perforation,,2021,Q2,2,F,202011.0,20210325.0,20210311,20210402,EXP,,CO-NOVOPROD-792877,NOVO NORDISK,,76.0,YR,,M,Y,62.0,KG,20210402.0,,CN,CO,CO,2021,Q2,Elderly
189962212,18996221,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"32.00 IU, QD",,,,, UNKNOWN,,,32.0,IU,,QD,2021,Q2,Haematemesis,,2021,Q2,2,F,202011.0,20210325.0,20210311,20210402,EXP,,CO-NOVOPROD-792877,NOVO NORDISK,,76.0,YR,,M,Y,62.0,KG,20210402.0,,CN,CO,CO,2021,Q2,Elderly
189962212,18996221,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"32.00 IU, QD",,,,, UNKNOWN,,,32.0,IU,,QD,2021,Q2,Limb injury,,2021,Q2,2,F,202011.0,20210325.0,20210311,20210402,EXP,,CO-NOVOPROD-792877,NOVO NORDISK,,76.0,YR,,M,Y,62.0,KG,20210402.0,,CN,CO,CO,2021,Q2,Elderly
189962212,18996221,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"32.00 IU, QD",,,,, UNKNOWN,,,32.0,IU,,QD,2021,Q2,Venous occlusion,,2021,Q2,2,F,202011.0,20210325.0,20210311,20210402,EXP,,CO-NOVOPROD-792877,NOVO NORDISK,,76.0,YR,,M,Y,62.0,KG,20210402.0,,CN,CO,CO,2021,Q2,Elderly
190113684,19011368,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,22 U,,,,,,,,,,,QD,2021,Q2,Cytokine release syndrome,,2021,Q2,4,F,20201212.0,20210514.0,20210316,20210520,EXP,,US-ROCHE-2734786,ROCHE,,72.0,YR,,M,Y,82.5,KG,20210520.0,,MD,US,US,2021,Q2,Elderly
190129864,19012986,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Hyperkalaemia,,2021,Q2,4,F,20210309.0,20210528.0,20210316,20210531,EXP,,US-GLAXOSMITHKLINE-US2021GSK060835,GLAXOSMITHKLINE,,70.0,YR,,M,Y,81.63,KG,20210531.0,,MD,US,US,2021,Q2,Elderly
190129864,19012986,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Hyponatraemia,,2021,Q2,4,F,20210309.0,20210528.0,20210316,20210531,EXP,,US-GLAXOSMITHKLINE-US2021GSK060835,GLAXOSMITHKLINE,,70.0,YR,,M,Y,81.63,KG,20210531.0,,MD,US,US,2021,Q2,Elderly
190169863,19016986,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,/month,2021,Q2,COVID-19,,2021,Q2,3,F,20201021.0,20210524.0,20210316,20210525,EXP,,ES-ROCHE-2790416,ROCHE,,35.0,YR,,F,Y,52.0,KG,20210525.0,,MD,ES,ES,2021,Q2,Adult
190205542,19020554,15,C,GLARGINE,INSULIN GLARGINE,1,Subcutaneous,VARIABLE,,,,,,,,,,,QD,2021,Q2,Cytomegalovirus infection,,2021,Q2,2,F,20210206.0,20210513.0,20210317,20210524,EXP,,AU-JNJFOC-20210329775,JOHNSON AND JOHNSON,,52.0,YR,A,M,Y,76.9,KG,20210524.0,,MD,AU,AU,2021,Q2,Adult
190205542,19020554,15,C,GLARGINE,INSULIN GLARGINE,1,Subcutaneous,VARIABLE,,,,,,,,,,,QD,2021,Q2,Disseminated cryptococcosis,,2021,Q2,2,F,20210206.0,20210513.0,20210317,20210524,EXP,,AU-JNJFOC-20210329775,JOHNSON AND JOHNSON,,52.0,YR,A,M,Y,76.9,KG,20210524.0,,MD,AU,AU,2021,Q2,Adult
190325292,19032529,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2021,Q2,Blood glucose decreased,,2021,Q2,2,F,20210204.0,20210430.0,20210319,20210512,EXP,,US-JNJFOC-20210219816,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,93.52,KG,20210512.0,,CN,US,US,2021,Q2,Elderly
190325292,19032529,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2021,Q2,Bradycardia,,2021,Q2,2,F,20210204.0,20210430.0,20210319,20210512,EXP,,US-JNJFOC-20210219816,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,93.52,KG,20210512.0,,CN,US,US,2021,Q2,Elderly
190325292,19032529,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2021,Q2,Cardiac failure,,2021,Q2,2,F,20210204.0,20210430.0,20210319,20210512,EXP,,US-JNJFOC-20210219816,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,93.52,KG,20210512.0,,CN,US,US,2021,Q2,Elderly
190325292,19032529,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2021,Q2,Fall,,2021,Q2,2,F,20210204.0,20210430.0,20210319,20210512,EXP,,US-JNJFOC-20210219816,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,93.52,KG,20210512.0,,CN,US,US,2021,Q2,Elderly
190325292,19032529,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2021,Q2,Haemoglobin decreased,,2021,Q2,2,F,20210204.0,20210430.0,20210319,20210512,EXP,,US-JNJFOC-20210219816,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,93.52,KG,20210512.0,,CN,US,US,2021,Q2,Elderly
190325292,19032529,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2021,Q2,Iron deficiency anaemia,,2021,Q2,2,F,20210204.0,20210430.0,20210319,20210512,EXP,,US-JNJFOC-20210219816,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,93.52,KG,20210512.0,,CN,US,US,2021,Q2,Elderly
190385732,19038573,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q2,Haematocrit decreased,,2021,Q2,2,F,20210304.0,20210407.0,20210322,20210413,EXP,,US-MYLANLABS-2021M1016088,MYLAN,,65.0,YR,,F,Y,,,20210413.0,,HP,US,US,2021,Q2,Elderly
190385732,19038573,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q2,Haemoglobin decreased,,2021,Q2,2,F,20210304.0,20210407.0,20210322,20210413,EXP,,US-MYLANLABS-2021M1016088,MYLAN,,65.0,YR,,F,Y,,,20210413.0,,HP,US,US,2021,Q2,Elderly
190385732,19038573,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q2,Lymphocyte count increased,,2021,Q2,2,F,20210304.0,20210407.0,20210322,20210413,EXP,,US-MYLANLABS-2021M1016088,MYLAN,,65.0,YR,,F,Y,,,20210413.0,,HP,US,US,2021,Q2,Elderly
190385732,19038573,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q2,Lymphocyte morphology abnormal,,2021,Q2,2,F,20210304.0,20210407.0,20210322,20210413,EXP,,US-MYLANLABS-2021M1016088,MYLAN,,65.0,YR,,F,Y,,,20210413.0,,HP,US,US,2021,Q2,Elderly
190385732,19038573,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q2,Mean cell haemoglobin concentration decreased,,2021,Q2,2,F,20210304.0,20210407.0,20210322,20210413,EXP,,US-MYLANLABS-2021M1016088,MYLAN,,65.0,YR,,F,Y,,,20210413.0,,HP,US,US,2021,Q2,Elderly
190385732,19038573,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q2,Mean platelet volume increased,,2021,Q2,2,F,20210304.0,20210407.0,20210322,20210413,EXP,,US-MYLANLABS-2021M1016088,MYLAN,,65.0,YR,,F,Y,,,20210413.0,,HP,US,US,2021,Q2,Elderly
190385732,19038573,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q2,Neutropenia,,2021,Q2,2,F,20210304.0,20210407.0,20210322,20210413,EXP,,US-MYLANLABS-2021M1016088,MYLAN,,65.0,YR,,F,Y,,,20210413.0,,HP,US,US,2021,Q2,Elderly
190385732,19038573,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q2,Off label use,,2021,Q2,2,F,20210304.0,20210407.0,20210322,20210413,EXP,,US-MYLANLABS-2021M1016088,MYLAN,,65.0,YR,,F,Y,,,20210413.0,,HP,US,US,2021,Q2,Elderly
190385732,19038573,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q2,Platelet count decreased,,2021,Q2,2,F,20210304.0,20210407.0,20210322,20210413,EXP,,US-MYLANLABS-2021M1016088,MYLAN,,65.0,YR,,F,Y,,,20210413.0,,HP,US,US,2021,Q2,Elderly
190385732,19038573,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q2,Red blood cell count decreased,,2021,Q2,2,F,20210304.0,20210407.0,20210322,20210413,EXP,,US-MYLANLABS-2021M1016088,MYLAN,,65.0,YR,,F,Y,,,20210413.0,,HP,US,US,2021,Q2,Elderly
190385732,19038573,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q2,Red cell distribution width increased,,2021,Q2,2,F,20210304.0,20210407.0,20210322,20210413,EXP,,US-MYLANLABS-2021M1016088,MYLAN,,65.0,YR,,F,Y,,,20210413.0,,HP,US,US,2021,Q2,Elderly
190385732,19038573,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q2,Respiratory distress,,2021,Q2,2,F,20210304.0,20210407.0,20210322,20210413,EXP,,US-MYLANLABS-2021M1016088,MYLAN,,65.0,YR,,F,Y,,,20210413.0,,HP,US,US,2021,Q2,Elderly
190385732,19038573,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q2,White blood cell count decreased,,2021,Q2,2,F,20210304.0,20210407.0,20210322,20210413,EXP,,US-MYLANLABS-2021M1016088,MYLAN,,65.0,YR,,F,Y,,,20210413.0,,HP,US,US,2021,Q2,Elderly
190390432,19039043,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Dyspnoea,,2021,Q2,2,F,20200817.0,20210330.0,20210322,20210412,EXP,,GB-PFIZER INC-2021267315,PFIZER,,66.0,YR,,M,Y,83.9,KG,20210412.0,,MD,GB,GB,2021,Q2,Elderly
190390432,19039043,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Left ventricular failure,,2021,Q2,2,F,20200817.0,20210330.0,20210322,20210412,EXP,,GB-PFIZER INC-2021267315,PFIZER,,66.0,YR,,M,Y,83.9,KG,20210412.0,,MD,GB,GB,2021,Q2,Elderly
190390432,19039043,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Oedema peripheral,,2021,Q2,2,F,20200817.0,20210330.0,20210322,20210412,EXP,,GB-PFIZER INC-2021267315,PFIZER,,66.0,YR,,M,Y,83.9,KG,20210412.0,,MD,GB,GB,2021,Q2,Elderly
190390432,19039043,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Pulmonary oedema,,2021,Q2,2,F,20200817.0,20210330.0,20210322,20210412,EXP,,GB-PFIZER INC-2021267315,PFIZER,,66.0,YR,,M,Y,83.9,KG,20210412.0,,MD,GB,GB,2021,Q2,Elderly
190393732,19039373,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,,,,,,,,,QD,2021,Q2,Cytomegalovirus infection,,2021,Q2,2,F,20210206.0,20210513.0,20210322,20210526,EXP,,AU-TAKEDA-2021TUS017414,TAKEDA,,52.0,YR,,M,Y,76.9,KG,20210526.0,,MD,AU,AU,2021,Q2,Adult
190393732,19039373,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,,,,,,,,,QD,2021,Q2,Disseminated cryptococcosis,,2021,Q2,2,F,20210206.0,20210513.0,20210322,20210526,EXP,,AU-TAKEDA-2021TUS017414,TAKEDA,,52.0,YR,,M,Y,76.9,KG,20210526.0,,MD,AU,AU,2021,Q2,Adult
190462932,19046293,3,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"16 U, EACH MORNING",,,,,,,,16.0,IU,,QD,2021,Q2,Blood glucose increased,,2021,Q2,2,F,,20210331.0,20210323,20210412,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202103007296,ELI LILLY AND CO,,73.0,YR,,F,Y,81.0,KG,20210412.0,,MD,JP,JP,2021,Q2,Elderly
190462932,19046293,3,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"16 U, EACH MORNING",,,,,,,,16.0,IU,,QD,2021,Q2,Type 1 diabetes mellitus,,2021,Q2,2,F,,20210331.0,20210323,20210412,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202103007296,ELI LILLY AND CO,,73.0,YR,,F,Y,81.0,KG,20210412.0,,MD,JP,JP,2021,Q2,Elderly
190462932,19046293,4,SS,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Blood glucose increased,,2021,Q2,2,F,,20210331.0,20210323,20210412,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202103007296,ELI LILLY AND CO,,73.0,YR,,F,Y,81.0,KG,20210412.0,,MD,JP,JP,2021,Q2,Elderly
190462932,19046293,4,SS,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Type 1 diabetes mellitus,,2021,Q2,2,F,,20210331.0,20210323,20210412,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202103007296,ELI LILLY AND CO,,73.0,YR,,F,Y,81.0,KG,20210412.0,,MD,JP,JP,2021,Q2,Elderly
190648562,19064856,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Anaemia,,2021,Q2,2,F,20200418.0,20210330.0,20210326,20210405,EXP,,US-GILEAD-2020-0467816,GILEAD,,77.0,YR,E,M,Y,89.7,KG,20210405.0,,MD,US,US,2021,Q2,Elderly
190648562,19064856,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Blood urea increased,,2021,Q2,2,F,20200418.0,20210330.0,20210326,20210405,EXP,,US-GILEAD-2020-0467816,GILEAD,,77.0,YR,E,M,Y,89.7,KG,20210405.0,,MD,US,US,2021,Q2,Elderly
190648562,19064856,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Hypernatraemia,,2021,Q2,2,F,20200418.0,20210330.0,20210326,20210405,EXP,,US-GILEAD-2020-0467816,GILEAD,,77.0,YR,E,M,Y,89.7,KG,20210405.0,,MD,US,US,2021,Q2,Elderly
190648562,19064856,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Hyperphosphataemia,,2021,Q2,2,F,20200418.0,20210330.0,20210326,20210405,EXP,,US-GILEAD-2020-0467816,GILEAD,,77.0,YR,E,M,Y,89.7,KG,20210405.0,,MD,US,US,2021,Q2,Elderly
190648562,19064856,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Leukocytosis,,2021,Q2,2,F,20200418.0,20210330.0,20210326,20210405,EXP,,US-GILEAD-2020-0467816,GILEAD,,77.0,YR,E,M,Y,89.7,KG,20210405.0,,MD,US,US,2021,Q2,Elderly
190648562,19064856,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Multi-organ disorder,,2021,Q2,2,F,20200418.0,20210330.0,20210326,20210405,EXP,,US-GILEAD-2020-0467816,GILEAD,,77.0,YR,E,M,Y,89.7,KG,20210405.0,,MD,US,US,2021,Q2,Elderly
190648562,19064856,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Respiratory failure,,2021,Q2,2,F,20200418.0,20210330.0,20210326,20210405,EXP,,US-GILEAD-2020-0467816,GILEAD,,77.0,YR,E,M,Y,89.7,KG,20210405.0,,MD,US,US,2021,Q2,Elderly
190648562,19064856,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Sepsis,,2021,Q2,2,F,20200418.0,20210330.0,20210326,20210405,EXP,,US-GILEAD-2020-0467816,GILEAD,,77.0,YR,E,M,Y,89.7,KG,20210405.0,,MD,US,US,2021,Q2,Elderly
190805744,19080574,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q2,Peripheral motor neuropathy,,2021,Q2,4,F,20210309.0,20210603.0,20210331,20210609,EXP,,US-CELGENEUS-USA-20210305956,CELGENE,,50.0,YR,,F,Y,95.3,KG,20210609.0,,HP,US,US,2021,Q2,Adult
190830921,19083092,8,C,insulin glargine 5 U Daily,,2,,,,,,,,,,,,,,2021,Q2,Acidosis,,2021,Q2,1,I,20210118.0,,20210401,20210401,DIR,,,FDA-CTU,,62.0,YR,,M,N,100.0,KG,20210401.0,Y,HP,US,US,2021,Q2,Adult
190830921,19083092,8,C,insulin glargine 5 U Daily,,2,,,,,,,,,,,,,,2021,Q2,Acute kidney injury,,2021,Q2,1,I,20210118.0,,20210401,20210401,DIR,,,FDA-CTU,,62.0,YR,,M,N,100.0,KG,20210401.0,Y,HP,US,US,2021,Q2,Adult
190830921,19083092,8,C,insulin glargine 5 U Daily,,2,,,,,,,,,,,,,,2021,Q2,Agitation,,2021,Q2,1,I,20210118.0,,20210401,20210401,DIR,,,FDA-CTU,,62.0,YR,,M,N,100.0,KG,20210401.0,Y,HP,US,US,2021,Q2,Adult
190830921,19083092,8,C,insulin glargine 5 U Daily,,2,,,,,,,,,,,,,,2021,Q2,Atelectasis,,2021,Q2,1,I,20210118.0,,20210401,20210401,DIR,,,FDA-CTU,,62.0,YR,,M,N,100.0,KG,20210401.0,Y,HP,US,US,2021,Q2,Adult
190830921,19083092,8,C,insulin glargine 5 U Daily,,2,,,,,,,,,,,,,,2021,Q2,Bradycardia,,2021,Q2,1,I,20210118.0,,20210401,20210401,DIR,,,FDA-CTU,,62.0,YR,,M,N,100.0,KG,20210401.0,Y,HP,US,US,2021,Q2,Adult
190830921,19083092,8,C,insulin glargine 5 U Daily,,2,,,,,,,,,,,,,,2021,Q2,Colitis ischaemic,,2021,Q2,1,I,20210118.0,,20210401,20210401,DIR,,,FDA-CTU,,62.0,YR,,M,N,100.0,KG,20210401.0,Y,HP,US,US,2021,Q2,Adult
190830921,19083092,8,C,insulin glargine 5 U Daily,,2,,,,,,,,,,,,,,2021,Q2,Cytomegalovirus viraemia,,2021,Q2,1,I,20210118.0,,20210401,20210401,DIR,,,FDA-CTU,,62.0,YR,,M,N,100.0,KG,20210401.0,Y,HP,US,US,2021,Q2,Adult
190830921,19083092,8,C,insulin glargine 5 U Daily,,2,,,,,,,,,,,,,,2021,Q2,Dehydration,,2021,Q2,1,I,20210118.0,,20210401,20210401,DIR,,,FDA-CTU,,62.0,YR,,M,N,100.0,KG,20210401.0,Y,HP,US,US,2021,Q2,Adult
190830921,19083092,8,C,insulin glargine 5 U Daily,,2,,,,,,,,,,,,,,2021,Q2,Diarrhoea,,2021,Q2,1,I,20210118.0,,20210401,20210401,DIR,,,FDA-CTU,,62.0,YR,,M,N,100.0,KG,20210401.0,Y,HP,US,US,2021,Q2,Adult
190830921,19083092,8,C,insulin glargine 5 U Daily,,2,,,,,,,,,,,,,,2021,Q2,Dyspnoea,,2021,Q2,1,I,20210118.0,,20210401,20210401,DIR,,,FDA-CTU,,62.0,YR,,M,N,100.0,KG,20210401.0,Y,HP,US,US,2021,Q2,Adult
190830921,19083092,8,C,insulin glargine 5 U Daily,,2,,,,,,,,,,,,,,2021,Q2,Gastrointestinal haemorrhage,,2021,Q2,1,I,20210118.0,,20210401,20210401,DIR,,,FDA-CTU,,62.0,YR,,M,N,100.0,KG,20210401.0,Y,HP,US,US,2021,Q2,Adult
190830921,19083092,8,C,insulin glargine 5 U Daily,,2,,,,,,,,,,,,,,2021,Q2,General physical health deterioration,,2021,Q2,1,I,20210118.0,,20210401,20210401,DIR,,,FDA-CTU,,62.0,YR,,M,N,100.0,KG,20210401.0,Y,HP,US,US,2021,Q2,Adult
190830921,19083092,8,C,insulin glargine 5 U Daily,,2,,,,,,,,,,,,,,2021,Q2,Haematemesis,,2021,Q2,1,I,20210118.0,,20210401,20210401,DIR,,,FDA-CTU,,62.0,YR,,M,N,100.0,KG,20210401.0,Y,HP,US,US,2021,Q2,Adult
190830921,19083092,8,C,insulin glargine 5 U Daily,,2,,,,,,,,,,,,,,2021,Q2,Hypotension,,2021,Q2,1,I,20210118.0,,20210401,20210401,DIR,,,FDA-CTU,,62.0,YR,,M,N,100.0,KG,20210401.0,Y,HP,US,US,2021,Q2,Adult
190830921,19083092,8,C,insulin glargine 5 U Daily,,2,,,,,,,,,,,,,,2021,Q2,Nausea,,2021,Q2,1,I,20210118.0,,20210401,20210401,DIR,,,FDA-CTU,,62.0,YR,,M,N,100.0,KG,20210401.0,Y,HP,US,US,2021,Q2,Adult
190830921,19083092,8,C,insulin glargine 5 U Daily,,2,,,,,,,,,,,,,,2021,Q2,Pneumatosis,,2021,Q2,1,I,20210118.0,,20210401,20210401,DIR,,,FDA-CTU,,62.0,YR,,M,N,100.0,KG,20210401.0,Y,HP,US,US,2021,Q2,Adult
190830921,19083092,8,C,insulin glargine 5 U Daily,,2,,,,,,,,,,,,,,2021,Q2,Pyrexia,,2021,Q2,1,I,20210118.0,,20210401,20210401,DIR,,,FDA-CTU,,62.0,YR,,M,N,100.0,KG,20210401.0,Y,HP,US,US,2021,Q2,Adult
190830921,19083092,8,C,insulin glargine 5 U Daily,,2,,,,,,,,,,,,,,2021,Q2,Respiratory failure,,2021,Q2,1,I,20210118.0,,20210401,20210401,DIR,,,FDA-CTU,,62.0,YR,,M,N,100.0,KG,20210401.0,Y,HP,US,US,2021,Q2,Adult
190830921,19083092,8,C,insulin glargine 5 U Daily,,2,,,,,,,,,,,,,,2021,Q2,Shock haemorrhagic,,2021,Q2,1,I,20210118.0,,20210401,20210401,DIR,,,FDA-CTU,,62.0,YR,,M,N,100.0,KG,20210401.0,Y,HP,US,US,2021,Q2,Adult
190830921,19083092,8,C,insulin glargine 5 U Daily,,2,,,,,,,,,,,,,,2021,Q2,Splenic infarction,,2021,Q2,1,I,20210118.0,,20210401,20210401,DIR,,,FDA-CTU,,62.0,YR,,M,N,100.0,KG,20210401.0,Y,HP,US,US,2021,Q2,Adult
190830921,19083092,8,C,insulin glargine 5 U Daily,,2,,,,,,,,,,,,,,2021,Q2,Thrombocytopenia,,2021,Q2,1,I,20210118.0,,20210401,20210401,DIR,,,FDA-CTU,,62.0,YR,,M,N,100.0,KG,20210401.0,Y,HP,US,US,2021,Q2,Adult
190830921,19083092,8,C,insulin glargine 5 U Daily,,2,,,,,,,,,,,,,,2021,Q2,Vomiting,,2021,Q2,1,I,20210118.0,,20210401,20210401,DIR,,,FDA-CTU,,62.0,YR,,M,N,100.0,KG,20210401.0,Y,HP,US,US,2021,Q2,Adult
190841371,19084137,4,C,Insulin glargine,INSULIN GLARGINE,1,Oral,UNK,,,U,,,,,,,,,2021,Q2,Blood pressure decreased,,2021,Q2,1,I,,20210322.0,20210401,20210401,EXP,,US-AUROBINDO-AUR-APL-2021-013542,AUROBINDO,,24.0,YR,,M,Y,,,20210401.0,,HP,US,US,2021,Q2,Young Adult
190841371,19084137,4,C,Insulin glargine,INSULIN GLARGINE,1,Oral,UNK,,,U,,,,,,,,,2021,Q2,Cardiogenic shock,,2021,Q2,1,I,,20210322.0,20210401,20210401,EXP,,US-AUROBINDO-AUR-APL-2021-013542,AUROBINDO,,24.0,YR,,M,Y,,,20210401.0,,HP,US,US,2021,Q2,Young Adult
190841371,19084137,4,C,Insulin glargine,INSULIN GLARGINE,1,Oral,UNK,,,U,,,,,,,,,2021,Q2,Mean arterial pressure decreased,,2021,Q2,1,I,,20210322.0,20210401,20210401,EXP,,US-AUROBINDO-AUR-APL-2021-013542,AUROBINDO,,24.0,YR,,M,Y,,,20210401.0,,HP,US,US,2021,Q2,Young Adult
190841371,19084137,4,C,Insulin glargine,INSULIN GLARGINE,1,Oral,UNK,,,U,,,,,,,,,2021,Q2,Overdose,,2021,Q2,1,I,,20210322.0,20210401,20210401,EXP,,US-AUROBINDO-AUR-APL-2021-013542,AUROBINDO,,24.0,YR,,M,Y,,,20210401.0,,HP,US,US,2021,Q2,Young Adult
190862252,19086225,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Atrial flutter,,2021,Q2,2,F,202010.0,20210409.0,20210402,20210419,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202103012317AA,ELI LILLY AND CO,,78.0,YR,,F,Y,47.0,KG,20210419.0,,MD,JP,JP,2021,Q2,Elderly
190862252,19086225,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Cardiac failure,,2021,Q2,2,F,202010.0,20210409.0,20210402,20210419,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202103012317AA,ELI LILLY AND CO,,78.0,YR,,F,Y,47.0,KG,20210419.0,,MD,JP,JP,2021,Q2,Elderly
190862252,19086225,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Drug ineffective,,2021,Q2,2,F,202010.0,20210409.0,20210402,20210419,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202103012317AA,ELI LILLY AND CO,,78.0,YR,,F,Y,47.0,KG,20210419.0,,MD,JP,JP,2021,Q2,Elderly
190862252,19086225,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Hypoalbuminaemia,,2021,Q2,2,F,202010.0,20210409.0,20210402,20210419,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202103012317AA,ELI LILLY AND CO,,78.0,YR,,F,Y,47.0,KG,20210419.0,,MD,JP,JP,2021,Q2,Elderly
190862252,19086225,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Supraventricular tachycardia,,2021,Q2,2,F,202010.0,20210409.0,20210402,20210419,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202103012317AA,ELI LILLY AND CO,,78.0,YR,,F,Y,47.0,KG,20210419.0,,MD,JP,JP,2021,Q2,Elderly
190874552,19087455,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,55.0,ML,,QD,2021,Q2,Acute kidney injury,,2021,Q2,2,F,20210212.0,20210420.0,20210402,20210426,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-086461",BOEHRINGER INGELHEIM,,74.0,YR,E,F,Y,89.0,KG,20210426.0,,MD,US,US,2021,Q2,Elderly
190874552,19087455,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,55.0,ML,,QD,2021,Q2,Colitis ischaemic,,2021,Q2,2,F,20210212.0,20210420.0,20210402,20210426,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-086461",BOEHRINGER INGELHEIM,,74.0,YR,E,F,Y,89.0,KG,20210426.0,,MD,US,US,2021,Q2,Elderly
190874552,19087455,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,55.0,ML,,QD,2021,Q2,Renal impairment,,2021,Q2,2,F,20210212.0,20210420.0,20210402,20210426,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-086461",BOEHRINGER INGELHEIM,,74.0,YR,E,F,Y,89.0,KG,20210426.0,,MD,US,US,2021,Q2,Elderly
190885591,19088559,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Hypertension,,2021,Q2,1,I,20180927.0,20181018.0,20210402,20210402,EXP,IT-MINISAL02-502630,IT-VALIDUS PHARMACEUTICALS LLC-IT-2021VAL000532,VALIDUS,,82.0,YR,,F,Y,,,20210402.0,,PH,IT,IT,2021,Q2,Elderly
190885591,19088559,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,20180927.0,20181018.0,20210402,20210402,EXP,IT-MINISAL02-502630,IT-VALIDUS PHARMACEUTICALS LLC-IT-2021VAL000532,VALIDUS,,82.0,YR,,F,Y,,,20210402.0,,PH,IT,IT,2021,Q2,Elderly
190885591,19088559,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Overdose,,2021,Q2,1,I,20180927.0,20181018.0,20210402,20210402,EXP,IT-MINISAL02-502630,IT-VALIDUS PHARMACEUTICALS LLC-IT-2021VAL000532,VALIDUS,,82.0,YR,,F,Y,,,20210402.0,,PH,IT,IT,2021,Q2,Elderly
190890731,19089073,6,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,40 INTERNATIONAL UNIT,,,D,, UNKNOWN,,,40.0,IU,,,2021,Q2,Drug ineffective,,2021,Q2,1,I,,20210322.0,20210403,20210403,EXP,,TR-LUPIN PHARMACEUTICALS INC.-2021-04219,LUPIN,,53.0,YR,,F,Y,,,20210403.0,,HP,TR,TR,2021,Q2,Adult
190890731,19089073,6,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,40 INTERNATIONAL UNIT,,,D,, UNKNOWN,,,40.0,IU,,,2021,Q2,Drug interaction,,2021,Q2,1,I,,20210322.0,20210403,20210403,EXP,,TR-LUPIN PHARMACEUTICALS INC.-2021-04219,LUPIN,,53.0,YR,,F,Y,,,20210403.0,,HP,TR,TR,2021,Q2,Adult
190900401,19090040,10,C,Insulin glargine,INSULIN GLARGINE,1,Oral,,,,U,,,,,,,,,2021,Q2,Cardiogenic shock,,2021,Q2,1,I,,20210322.0,20210404,20210404,EXP,,US-TEVA-2021-US-1895773,TEVA,"WALTER N, JONES K, HERR D, KACZOROWSKI D, KIM H. CLINICAL CHARACTERISTICS IN CARDIOTOXIC AGENT OVERDOSE NECESSITATING VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION: A CASE SERIES. CLIN?TOXICOL?(PHILA) 2020?58(11):1254?1256 ABSTR. 301.",24.0,YR,A,M,Y,,,20210404.0,,HP,US,US,2021,Q2,Young Adult
190900401,19090040,10,C,Insulin glargine,INSULIN GLARGINE,1,Oral,,,,U,,,,,,,,,2021,Q2,Cardiotoxicity,,2021,Q2,1,I,,20210322.0,20210404,20210404,EXP,,US-TEVA-2021-US-1895773,TEVA,"WALTER N, JONES K, HERR D, KACZOROWSKI D, KIM H. CLINICAL CHARACTERISTICS IN CARDIOTOXIC AGENT OVERDOSE NECESSITATING VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION: A CASE SERIES. CLIN?TOXICOL?(PHILA) 2020?58(11):1254?1256 ABSTR. 301.",24.0,YR,A,M,Y,,,20210404.0,,HP,US,US,2021,Q2,Young Adult
190900401,19090040,10,C,Insulin glargine,INSULIN GLARGINE,1,Oral,,,,U,,,,,,,,,2021,Q2,Drug ineffective,,2021,Q2,1,I,,20210322.0,20210404,20210404,EXP,,US-TEVA-2021-US-1895773,TEVA,"WALTER N, JONES K, HERR D, KACZOROWSKI D, KIM H. CLINICAL CHARACTERISTICS IN CARDIOTOXIC AGENT OVERDOSE NECESSITATING VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION: A CASE SERIES. CLIN?TOXICOL?(PHILA) 2020?58(11):1254?1256 ABSTR. 301.",24.0,YR,A,M,Y,,,20210404.0,,HP,US,US,2021,Q2,Young Adult
190900401,19090040,10,C,Insulin glargine,INSULIN GLARGINE,1,Oral,,,,U,,,,,,,,,2021,Q2,Overdose,,2021,Q2,1,I,,20210322.0,20210404,20210404,EXP,,US-TEVA-2021-US-1895773,TEVA,"WALTER N, JONES K, HERR D, KACZOROWSKI D, KIM H. CLINICAL CHARACTERISTICS IN CARDIOTOXIC AGENT OVERDOSE NECESSITATING VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION: A CASE SERIES. CLIN?TOXICOL?(PHILA) 2020?58(11):1254?1256 ABSTR. 301.",24.0,YR,A,M,Y,,,20210404.0,,HP,US,US,2021,Q2,Young Adult
190911051,19091105,11,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,,,,,, UNKNOWN,,,,,,,2021,Q2,Anaphylactic shock,,2021,Q2,1,I,20210320.0,20210326.0,20210405,20210405,EXP,NL-LRB-00482002,NL-ROCHE-2799460,ROCHE,,57.0,YR,,M,Y,82.0,KG,20210405.0,,MD,NL,NL,2021,Q2,Adult
190919041,19091904,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Hepatic enzyme increased,,2021,Q2,1,I,20210402.0,,20210402,20210402,DIR,,,FDA-CTU,,77.0,YR,,M,N,99.7,KG,20210402.0,N,PH,US,US,2021,Q2,Elderly
190923481,19092348,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"22 IU, 1X/DAY (EVENING)",,,,,,,,22.0,IU,,QD,2021,Q2,Nervous system disorder,,2021,Q2,1,I,201703.0,20210318.0,20210405,20210405,EXP,,FR-PFIZER INC-2021304683,PFIZER,"DURAND, A.. NEUROLOGICAL IMPAIRMENT WITH DAPTOMYCIN IN A RESUSCITATION PATIENT: ADVERSE DRUG REACTION OR MISUSE? A CASE REPORT. PHARMACIEN HOSPITALIER ET CLINICIEN. 2021?56 (1):87?90",67.0,YR,,M,Y,,,20210405.0,,HP,FR,FR,2021,Q2,Elderly
190923481,19092348,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"22 IU, 1X/DAY (EVENING)",,,,,,,,22.0,IU,,QD,2021,Q2,Seizure,,2021,Q2,1,I,201703.0,20210318.0,20210405,20210405,EXP,,FR-PFIZER INC-2021304683,PFIZER,"DURAND, A.. NEUROLOGICAL IMPAIRMENT WITH DAPTOMYCIN IN A RESUSCITATION PATIENT: ADVERSE DRUG REACTION OR MISUSE? A CASE REPORT. PHARMACIEN HOSPITALIER ET CLINICIEN. 2021?56 (1):87?90",67.0,YR,,M,Y,,,20210405.0,,HP,FR,FR,2021,Q2,Elderly
190923481,19092348,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"22 IU, 1X/DAY (EVENING)",,,,,,,,22.0,IU,,QD,2021,Q2,Toxicity to various agents,,2021,Q2,1,I,201703.0,20210318.0,20210405,20210405,EXP,,FR-PFIZER INC-2021304683,PFIZER,"DURAND, A.. NEUROLOGICAL IMPAIRMENT WITH DAPTOMYCIN IN A RESUSCITATION PATIENT: ADVERSE DRUG REACTION OR MISUSE? A CASE REPORT. PHARMACIEN HOSPITALIER ET CLINICIEN. 2021?56 (1):87?90",67.0,YR,,M,Y,,,20210405.0,,HP,FR,FR,2021,Q2,Elderly
190923621,19092362,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,24?30U IN THE MORNING,,,,U,,,210605.0,,,INJECTION,,2021,Q2,Drug dependence,,2021,Q2,1,I,,20210326.0,20210405,20210405,EXP,,PT-MYLANLABS-2021M1019386,MYLAN,"FERNANDES LN, SILVA D.. THE IMPORTANCE OF QUESTIONING THE DIAGNOSIS OF DIABETES MELLITUS TYPE 2: A CASE OF LADA. PORTUGUESE CONGRESS OF ENDOCRINOLOGY /72ND SPEDM ANNUAL MEETING? REVISTA PORTUGU. 2021?16 SUPPLEMENT:53",65.0,YR,,F,Y,,,20210405.0,,MD,PT,PT,2021,Q2,Elderly
190923621,19092362,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,24?30U IN THE MORNING,,,,U,,,210605.0,,,INJECTION,,2021,Q2,Vomiting,,2021,Q2,1,I,,20210326.0,20210405,20210405,EXP,,PT-MYLANLABS-2021M1019386,MYLAN,"FERNANDES LN, SILVA D.. THE IMPORTANCE OF QUESTIONING THE DIAGNOSIS OF DIABETES MELLITUS TYPE 2: A CASE OF LADA. PORTUGUESE CONGRESS OF ENDOCRINOLOGY /72ND SPEDM ANNUAL MEETING? REVISTA PORTUGU. 2021?16 SUPPLEMENT:53",65.0,YR,,F,Y,,,20210405.0,,MD,PT,PT,2021,Q2,Elderly
190923621,19092362,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,24?30U IN THE MORNING,,,,U,,,210605.0,,,INJECTION,,2021,Q2,Weight increased,,2021,Q2,1,I,,20210326.0,20210405,20210405,EXP,,PT-MYLANLABS-2021M1019386,MYLAN,"FERNANDES LN, SILVA D.. THE IMPORTANCE OF QUESTIONING THE DIAGNOSIS OF DIABETES MELLITUS TYPE 2: A CASE OF LADA. PORTUGUESE CONGRESS OF ENDOCRINOLOGY /72ND SPEDM ANNUAL MEETING? REVISTA PORTUGU. 2021?16 SUPPLEMENT:53",65.0,YR,,F,Y,,,20210405.0,,MD,PT,PT,2021,Q2,Elderly
190924911,19092491,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Arthralgia,,2021,Q2,1,I,,20210323.0,20210405,20210405,EXP,DE-BFARM-21001932,DE-ACCORD-221973,ACCORD,,74.0,YR,E,M,Y,64.0,KG,20210405.0,,PH,DE,DE,2021,Q2,Elderly
190924911,19092491,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Contraindicated product administered,,2021,Q2,1,I,,20210323.0,20210405,20210405,EXP,DE-BFARM-21001932,DE-ACCORD-221973,ACCORD,,74.0,YR,E,M,Y,64.0,KG,20210405.0,,PH,DE,DE,2021,Q2,Elderly
190924911,19092491,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Medication error,,2021,Q2,1,I,,20210323.0,20210405,20210405,EXP,DE-BFARM-21001932,DE-ACCORD-221973,ACCORD,,74.0,YR,E,M,Y,64.0,KG,20210405.0,,PH,DE,DE,2021,Q2,Elderly
190924911,19092491,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Pain,,2021,Q2,1,I,,20210323.0,20210405,20210405,EXP,DE-BFARM-21001932,DE-ACCORD-221973,ACCORD,,74.0,YR,E,M,Y,64.0,KG,20210405.0,,PH,DE,DE,2021,Q2,Elderly
190940951,19094095,6,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,40 IU (INTERNATIONAL UNIT),,,,,,,,40.0,IU,UNKNOWN,QD,2021,Q2,Basal cell carcinoma,,2021,Q2,1,I,20210325.0,20210329.0,20210405,20210405,EXP,,US-CELGENEUS-USA-20210307983,CELGENE,,71.0,YR,,M,Y,87.17,KG,20210405.0,,MD,US,US,2021,Q2,Elderly
190940951,19094095,6,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,40 IU (INTERNATIONAL UNIT),,,,,,,,40.0,IU,UNKNOWN,QD,2021,Q2,Squamous cell carcinoma,,2021,Q2,1,I,20210325.0,20210329.0,20210405,20210405,EXP,,US-CELGENEUS-USA-20210307983,CELGENE,,71.0,YR,,M,Y,87.17,KG,20210405.0,,MD,US,US,2021,Q2,Elderly
190953451,19095345,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Intestinal ischaemia,,2021,Q2,1,I,20200717.0,20200914.0,20210406,20210406,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-075505,BRISTOL MYERS SQUIBB,,61.0,YR,,M,Y,60.3,KG,20210406.0,,HP,US,US,2021,Q2,Adult
190953451,19095345,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Ischaemic hepatitis,,2021,Q2,1,I,20200717.0,20200914.0,20210406,20210406,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-075505,BRISTOL MYERS SQUIBB,,61.0,YR,,M,Y,60.3,KG,20210406.0,,HP,US,US,2021,Q2,Adult
190953451,19095345,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Sepsis,,2021,Q2,1,I,20200717.0,20200914.0,20210406,20210406,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-075505,BRISTOL MYERS SQUIBB,,61.0,YR,,M,Y,60.3,KG,20210406.0,,HP,US,US,2021,Q2,Adult
190953741,19095374,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 INTERNATIONAL UNIT, QD",,,,,,,,16.0,IU,INJECTION,QD,2021,Q2,Anaemia,,2021,Q2,1,I,20181220.0,20190304.0,20210406,20210406,EXP,,JP-TAKEDA-2019TJP004931,TAKEDA,,61.0,YR,,M,Y,74.8,KG,20210406.0,,MD,JP,JP,2021,Q2,Adult
190953741,19095374,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 INTERNATIONAL UNIT, QD",,,,,,,,16.0,IU,INJECTION,QD,2021,Q2,Bronchitis,,2021,Q2,1,I,20181220.0,20190304.0,20210406,20210406,EXP,,JP-TAKEDA-2019TJP004931,TAKEDA,,61.0,YR,,M,Y,74.8,KG,20210406.0,,MD,JP,JP,2021,Q2,Adult
190953741,19095374,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 INTERNATIONAL UNIT, QD",,,,,,,,16.0,IU,INJECTION,QD,2021,Q2,Diabetes mellitus,,2021,Q2,1,I,20181220.0,20190304.0,20210406,20210406,EXP,,JP-TAKEDA-2019TJP004931,TAKEDA,,61.0,YR,,M,Y,74.8,KG,20210406.0,,MD,JP,JP,2021,Q2,Adult
190953741,19095374,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 INTERNATIONAL UNIT, QD",,,,,,,,16.0,IU,INJECTION,QD,2021,Q2,Diarrhoea,,2021,Q2,1,I,20181220.0,20190304.0,20210406,20210406,EXP,,JP-TAKEDA-2019TJP004931,TAKEDA,,61.0,YR,,M,Y,74.8,KG,20210406.0,,MD,JP,JP,2021,Q2,Adult
190953741,19095374,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 INTERNATIONAL UNIT, QD",,,,,,,,16.0,IU,INJECTION,QD,2021,Q2,Herpes zoster,,2021,Q2,1,I,20181220.0,20190304.0,20210406,20210406,EXP,,JP-TAKEDA-2019TJP004931,TAKEDA,,61.0,YR,,M,Y,74.8,KG,20210406.0,,MD,JP,JP,2021,Q2,Adult
190953741,19095374,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 INTERNATIONAL UNIT, QD",,,,,,,,16.0,IU,INJECTION,QD,2021,Q2,Neutrophil count decreased,,2021,Q2,1,I,20181220.0,20190304.0,20210406,20210406,EXP,,JP-TAKEDA-2019TJP004931,TAKEDA,,61.0,YR,,M,Y,74.8,KG,20210406.0,,MD,JP,JP,2021,Q2,Adult
190953741,19095374,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 INTERNATIONAL UNIT, QD",,,,,,,,16.0,IU,INJECTION,QD,2021,Q2,Platelet count decreased,,2021,Q2,1,I,20181220.0,20190304.0,20210406,20210406,EXP,,JP-TAKEDA-2019TJP004931,TAKEDA,,61.0,YR,,M,Y,74.8,KG,20210406.0,,MD,JP,JP,2021,Q2,Adult
190953741,19095374,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 INTERNATIONAL UNIT, QD",,,,,,,,16.0,IU,INJECTION,QD,2021,Q2,Taste disorder,,2021,Q2,1,I,20181220.0,20190304.0,20210406,20210406,EXP,,JP-TAKEDA-2019TJP004931,TAKEDA,,61.0,YR,,M,Y,74.8,KG,20210406.0,,MD,JP,JP,2021,Q2,Adult
190953741,19095374,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 INTERNATIONAL UNIT, QD",,,,,,,,16.0,IU,INJECTION,QD,2021,Q2,Vomiting,,2021,Q2,1,I,20181220.0,20190304.0,20210406,20210406,EXP,,JP-TAKEDA-2019TJP004931,TAKEDA,,61.0,YR,,M,Y,74.8,KG,20210406.0,,MD,JP,JP,2021,Q2,Adult
190953741,19095374,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 INTERNATIONAL UNIT, QD",,,,,,,,16.0,IU,INJECTION,QD,2021,Q2,White blood cell count decreased,,2021,Q2,1,I,20181220.0,20190304.0,20210406,20210406,EXP,,JP-TAKEDA-2019TJP004931,TAKEDA,,61.0,YR,,M,Y,74.8,KG,20210406.0,,MD,JP,JP,2021,Q2,Adult
190985662,19098566,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Asthma,,2021,Q2,2,F,2015.0,20210407.0,20210406,20210412,PER,,US-ORGANON-O2104USA000274,ORGANON,,79.0,YR,,M,Y,,,20210412.0,,MD,US,US,2021,Q2,Elderly
190985662,19098566,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Device malfunction,,2021,Q2,2,F,2015.0,20210407.0,20210406,20210412,PER,,US-ORGANON-O2104USA000274,ORGANON,,79.0,YR,,M,Y,,,20210412.0,,MD,US,US,2021,Q2,Elderly
190985662,19098566,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Hypermetropia,,2021,Q2,2,F,2015.0,20210407.0,20210406,20210412,PER,,US-ORGANON-O2104USA000274,ORGANON,,79.0,YR,,M,Y,,,20210412.0,,MD,US,US,2021,Q2,Elderly
190985662,19098566,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Poor quality device used,,2021,Q2,2,F,2015.0,20210407.0,20210406,20210412,PER,,US-ORGANON-O2104USA000274,ORGANON,,79.0,YR,,M,Y,,,20210412.0,,MD,US,US,2021,Q2,Elderly
190985662,19098566,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Visual impairment,,2021,Q2,2,F,2015.0,20210407.0,20210406,20210412,PER,,US-ORGANON-O2104USA000274,ORGANON,,79.0,YR,,M,Y,,,20210412.0,,MD,US,US,2021,Q2,Elderly
190985662,19098566,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Wrong technique in device usage process,,2021,Q2,2,F,2015.0,20210407.0,20210406,20210412,PER,,US-ORGANON-O2104USA000274,ORGANON,,79.0,YR,,M,Y,,,20210412.0,,MD,US,US,2021,Q2,Elderly
191027181,19102718,7,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Acute kidney injury,,2021,Q2,1,I,20210403.0,,20210407,20210407,DIR,,,FDA-CTU,,55.0,YR,,M,N,135.45,KG,20210407.0,N,PH,US,US,2021,Q2,Adult
191027181,19102718,7,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Rhabdomyolysis,,2021,Q2,1,I,20210403.0,,20210407,20210407,DIR,,,FDA-CTU,,55.0,YR,,M,N,135.45,KG,20210407.0,N,PH,US,US,2021,Q2,Adult
191027181,19102718,7,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Transaminases increased,,2021,Q2,1,I,20210403.0,,20210407,20210407,DIR,,,FDA-CTU,,55.0,YR,,M,N,135.45,KG,20210407.0,N,PH,US,US,2021,Q2,Adult
191043241,19104324,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 U, QD",,,,, 8F879A,,,,,SOLUTION FOR INJECTION,,2021,Q2,Atrial fibrillation,,2021,Q2,1,I,,20190323.0,20210407,20210407,EXP,,GR-VALIDUS PHARMACEUTICALS LLC-GR-2021VAL000426,VALIDUS,,82.0,YR,,M,Y,,,20210407.0,,CN,GR,GR,2021,Q2,Elderly
191043241,19104324,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 U, QD",,,,, 8F879A,,,,,SOLUTION FOR INJECTION,,2021,Q2,Cardiac failure,,2021,Q2,1,I,,20190323.0,20210407,20210407,EXP,,GR-VALIDUS PHARMACEUTICALS LLC-GR-2021VAL000426,VALIDUS,,82.0,YR,,M,Y,,,20210407.0,,CN,GR,GR,2021,Q2,Elderly
191043241,19104324,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 U, QD",,,,, 8F879A,,,,,SOLUTION FOR INJECTION,,2021,Q2,Device use error,,2021,Q2,1,I,,20190323.0,20210407,20210407,EXP,,GR-VALIDUS PHARMACEUTICALS LLC-GR-2021VAL000426,VALIDUS,,82.0,YR,,M,Y,,,20210407.0,,CN,GR,GR,2021,Q2,Elderly
191043241,19104324,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 U, QD",,,,, 8F879A,,,,,SOLUTION FOR INJECTION,,2021,Q2,Drug ineffective,,2021,Q2,1,I,,20190323.0,20210407,20210407,EXP,,GR-VALIDUS PHARMACEUTICALS LLC-GR-2021VAL000426,VALIDUS,,82.0,YR,,M,Y,,,20210407.0,,CN,GR,GR,2021,Q2,Elderly
191043241,19104324,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 U, QD",,,,, 8F879A,,,,,SOLUTION FOR INJECTION,,2021,Q2,Macular degeneration,,2021,Q2,1,I,,20190323.0,20210407,20210407,EXP,,GR-VALIDUS PHARMACEUTICALS LLC-GR-2021VAL000426,VALIDUS,,82.0,YR,,M,Y,,,20210407.0,,CN,GR,GR,2021,Q2,Elderly
191043241,19104324,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 U, QD",,,,, 8F879A,,,,,SOLUTION FOR INJECTION,,2021,Q2,Product storage error,,2021,Q2,1,I,,20190323.0,20210407,20210407,EXP,,GR-VALIDUS PHARMACEUTICALS LLC-GR-2021VAL000426,VALIDUS,,82.0,YR,,M,Y,,,20210407.0,,CN,GR,GR,2021,Q2,Elderly
191055542,19105554,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Inappropriate schedule of product administration,,2021,Q2,2,F,20210211.0,20210525.0,20210408,20210601,PER,,US-JNJFOC-20210356288,JOHNSON AND JOHNSON,,74.0,YR,E,,Y,,,20210602.0,,HP,US,US,2021,Q2,Elderly
191066671,19106667,9,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Blood pressure decreased,,2021,Q2,1,I,2021.0,20210401.0,20210407,20210407,EXP,,US-ABBVIE-21K-163-3843005-00,ABBVIE,,70.0,YR,,F,Y,,,20210407.0,,CN,US,US,2021,Q2,Elderly
191066671,19106667,9,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Colitis,,2021,Q2,1,I,2021.0,20210401.0,20210407,20210407,EXP,,US-ABBVIE-21K-163-3843005-00,ABBVIE,,70.0,YR,,F,Y,,,20210407.0,,CN,US,US,2021,Q2,Elderly
191066671,19106667,9,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Nephrolithiasis,,2021,Q2,1,I,2021.0,20210401.0,20210407,20210407,EXP,,US-ABBVIE-21K-163-3843005-00,ABBVIE,,70.0,YR,,F,Y,,,20210407.0,,CN,US,US,2021,Q2,Elderly
191066671,19106667,9,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Sepsis,,2021,Q2,1,I,2021.0,20210401.0,20210407,20210407,EXP,,US-ABBVIE-21K-163-3843005-00,ABBVIE,,70.0,YR,,F,Y,,,20210407.0,,CN,US,US,2021,Q2,Elderly
191066671,19106667,9,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Urinary tract infection,,2021,Q2,1,I,2021.0,20210401.0,20210407,20210407,EXP,,US-ABBVIE-21K-163-3843005-00,ABBVIE,,70.0,YR,,F,Y,,,20210407.0,,CN,US,US,2021,Q2,Elderly
191103101,19110310,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Blood glucose fluctuation,,2021,Q2,1,I,,20210330.0,20210408,20210408,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202103015292,ELI LILLY AND CO,,69.0,YR,,M,Y,65.0,KG,20210408.0,,CN,CN,CN,2021,Q2,Elderly
191103101,19110310,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Eye disorder,,2021,Q2,1,I,,20210330.0,20210408,20210408,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202103015292,ELI LILLY AND CO,,69.0,YR,,M,Y,65.0,KG,20210408.0,,CN,CN,CN,2021,Q2,Elderly
191151191,19115119,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, QD",,,N,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Blood glucose abnormal,,2021,Q2,1,I,,20181010.0,20210408,20210408,EXP,,GR-VALIDUS PHARMACEUTICALS LLC-GR-2021VAL000723,VALIDUS,,74.0,YR,,M,Y,,,20210408.0,,CN,GR,GR,2021,Q2,Elderly
191151191,19115119,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, QD",,,N,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Diarrhoea,,2021,Q2,1,I,,20181010.0,20210408,20210408,EXP,,GR-VALIDUS PHARMACEUTICALS LLC-GR-2021VAL000723,VALIDUS,,74.0,YR,,M,Y,,,20210408.0,,CN,GR,GR,2021,Q2,Elderly
191151191,19115119,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, QD",,,N,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Dyspnoea,,2021,Q2,1,I,,20181010.0,20210408,20210408,EXP,,GR-VALIDUS PHARMACEUTICALS LLC-GR-2021VAL000723,VALIDUS,,74.0,YR,,M,Y,,,20210408.0,,CN,GR,GR,2021,Q2,Elderly
191151191,19115119,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, QD",,,N,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Gastroenteritis,,2021,Q2,1,I,,20181010.0,20210408,20210408,EXP,,GR-VALIDUS PHARMACEUTICALS LLC-GR-2021VAL000723,VALIDUS,,74.0,YR,,M,Y,,,20210408.0,,CN,GR,GR,2021,Q2,Elderly
191151191,19115119,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,N,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Blood glucose abnormal,,2021,Q2,1,I,,20181010.0,20210408,20210408,EXP,,GR-VALIDUS PHARMACEUTICALS LLC-GR-2021VAL000723,VALIDUS,,74.0,YR,,M,Y,,,20210408.0,,CN,GR,GR,2021,Q2,Elderly
191151191,19115119,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,N,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Diarrhoea,,2021,Q2,1,I,,20181010.0,20210408,20210408,EXP,,GR-VALIDUS PHARMACEUTICALS LLC-GR-2021VAL000723,VALIDUS,,74.0,YR,,M,Y,,,20210408.0,,CN,GR,GR,2021,Q2,Elderly
191151191,19115119,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,N,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Dyspnoea,,2021,Q2,1,I,,20181010.0,20210408,20210408,EXP,,GR-VALIDUS PHARMACEUTICALS LLC-GR-2021VAL000723,VALIDUS,,74.0,YR,,M,Y,,,20210408.0,,CN,GR,GR,2021,Q2,Elderly
191151191,19115119,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,N,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Gastroenteritis,,2021,Q2,1,I,,20181010.0,20210408,20210408,EXP,,GR-VALIDUS PHARMACEUTICALS LLC-GR-2021VAL000723,VALIDUS,,74.0,YR,,M,Y,,,20210408.0,,CN,GR,GR,2021,Q2,Elderly
191176961,19117696,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Necrotising fasciitis,,2021,Q2,1,I,20180813.0,20210402.0,20210409,20210409,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-095867",BOEHRINGER INGELHEIM,,42.0,YR,A,M,Y,,,20210409.0,,MD,US,US,2021,Q2,Adult
1911844913,19118449,5,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2021,Q2,Platelet count decreased,,2021,Q2,13,F,20210317.0,20210621.0,20210409,20210625,EXP,,CN-ROCHE-2803858,ROCHE,,53.0,YR,,F,Y,56.0,KG,20210625.0,,MD,CN,CN,2021,Q2,Adult
1911844913,19118449,5,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2021,Q2,Pneumonia,,2021,Q2,13,F,20210317.0,20210621.0,20210409,20210625,EXP,,CN-ROCHE-2803858,ROCHE,,53.0,YR,,F,Y,56.0,KG,20210625.0,,MD,CN,CN,2021,Q2,Adult
191249481,19124948,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,206538.0,,,SOLUTION FOR INJECTION,,2021,Q2,Blindness,,2021,Q2,1,I,,20210331.0,20210412,20210412,EXP,,MX-SA-2021SA115235,SANOFI AVENTIS,,32.0,YR,A,M,Y,,,20210412.0,,CN,MX,MX,2021,Q2,Young Adult
191270151,19127015,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Off label use,,2021,Q2,1,I,,20210407.0,20210412,20210412,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-034211,BRISTOL MYERS SQUIBB,,69.0,YR,,F,Y,60.32,KG,20210412.0,,CN,US,US,2021,Q2,Elderly
191270151,19127015,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Weight increased,,2021,Q2,1,I,,20210407.0,20210412,20210412,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-034211,BRISTOL MYERS SQUIBB,,69.0,YR,,F,Y,60.32,KG,20210412.0,,CN,US,US,2021,Q2,Elderly
191294502,19129450,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Disease progression,,2021,Q2,2,F,20210202.0,20210430.0,20210413,20210507,EXP,,US-ROCHE-2762839,ROCHE,,74.0,YR,,M,Y,,,20210507.0,,MD,US,US,2021,Q2,Elderly
191294502,19129450,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Hypernatraemia,,2021,Q2,2,F,20210202.0,20210430.0,20210413,20210507,EXP,,US-ROCHE-2762839,ROCHE,,74.0,YR,,M,Y,,,20210507.0,,MD,US,US,2021,Q2,Elderly
191298211,19129821,3,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Sunconjunctival,"12 IU, QD (SOLUTION FOR INJECTION IN PRE?FILLED PEN)",,,U,,,,206538.0,12.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Cardiac failure,,2021,Q2,1,I,20210208.0,20210407.0,20210413,20210413,EXP,FR-AFSSAPS-AN20211021,FR-SA-2021SA118942,SANOFI AVENTIS,,70.0,YR,E,M,Y,59.2,KG,20210413.0,,MD,FR,FR,2021,Q2,Elderly
191318381,19131838,18,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, 1X/DAY",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2021,Q2,Asthma,,2021,Q2,1,I,,20210405.0,20210413,20210413,EXP,,CA-PFIZER INC-2021390135,PFIZER,,65.0,YR,,M,Y,,,20210413.0,,CN,CA,CA,2021,Q2,Elderly
191318381,19131838,18,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, 1X/DAY",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2021,Q2,Condition aggravated,,2021,Q2,1,I,,20210405.0,20210413,20210413,EXP,,CA-PFIZER INC-2021390135,PFIZER,,65.0,YR,,M,Y,,,20210413.0,,CN,CA,CA,2021,Q2,Elderly
191318381,19131838,18,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, 1X/DAY",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2021,Q2,Dyspnoea,,2021,Q2,1,I,,20210405.0,20210413,20210413,EXP,,CA-PFIZER INC-2021390135,PFIZER,,65.0,YR,,M,Y,,,20210413.0,,CN,CA,CA,2021,Q2,Elderly
191318381,19131838,18,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, 1X/DAY",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2021,Q2,Haemoptysis,,2021,Q2,1,I,,20210405.0,20210413,20210413,EXP,,CA-PFIZER INC-2021390135,PFIZER,,65.0,YR,,M,Y,,,20210413.0,,CN,CA,CA,2021,Q2,Elderly
191318381,19131838,18,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, 1X/DAY",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2021,Q2,Loss of personal independence in daily activities,,2021,Q2,1,I,,20210405.0,20210413,20210413,EXP,,CA-PFIZER INC-2021390135,PFIZER,,65.0,YR,,M,Y,,,20210413.0,,CN,CA,CA,2021,Q2,Elderly
191318381,19131838,18,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, 1X/DAY",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2021,Q2,Lung disorder,,2021,Q2,1,I,,20210405.0,20210413,20210413,EXP,,CA-PFIZER INC-2021390135,PFIZER,,65.0,YR,,M,Y,,,20210413.0,,CN,CA,CA,2021,Q2,Elderly
191318381,19131838,18,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, 1X/DAY",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2021,Q2,Neuritis,,2021,Q2,1,I,,20210405.0,20210413,20210413,EXP,,CA-PFIZER INC-2021390135,PFIZER,,65.0,YR,,M,Y,,,20210413.0,,CN,CA,CA,2021,Q2,Elderly
191318381,19131838,18,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, 1X/DAY",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2021,Q2,Neurological symptom,,2021,Q2,1,I,,20210405.0,20210413,20210413,EXP,,CA-PFIZER INC-2021390135,PFIZER,,65.0,YR,,M,Y,,,20210413.0,,CN,CA,CA,2021,Q2,Elderly
191318381,19131838,18,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, 1X/DAY",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2021,Q2,Obstructive airways disorder,,2021,Q2,1,I,,20210405.0,20210413,20210413,EXP,,CA-PFIZER INC-2021390135,PFIZER,,65.0,YR,,M,Y,,,20210413.0,,CN,CA,CA,2021,Q2,Elderly
191318381,19131838,18,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, 1X/DAY",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2021,Q2,Pain in extremity,,2021,Q2,1,I,,20210405.0,20210413,20210413,EXP,,CA-PFIZER INC-2021390135,PFIZER,,65.0,YR,,M,Y,,,20210413.0,,CN,CA,CA,2021,Q2,Elderly
191318381,19131838,18,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, 1X/DAY",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2021,Q2,Pulmonary alveolar haemorrhage,,2021,Q2,1,I,,20210405.0,20210413,20210413,EXP,,CA-PFIZER INC-2021390135,PFIZER,,65.0,YR,,M,Y,,,20210413.0,,CN,CA,CA,2021,Q2,Elderly
191318381,19131838,18,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, 1X/DAY",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2021,Q2,Pulmonary fibrosis,,2021,Q2,1,I,,20210405.0,20210413,20210413,EXP,,CA-PFIZER INC-2021390135,PFIZER,,65.0,YR,,M,Y,,,20210413.0,,CN,CA,CA,2021,Q2,Elderly
191318381,19131838,18,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, 1X/DAY",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2021,Q2,Pulmonary vasculitis,,2021,Q2,1,I,,20210405.0,20210413,20210413,EXP,,CA-PFIZER INC-2021390135,PFIZER,,65.0,YR,,M,Y,,,20210413.0,,CN,CA,CA,2021,Q2,Elderly
191318381,19131838,18,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, 1X/DAY",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2021,Q2,Respiratory symptom,,2021,Q2,1,I,,20210405.0,20210413,20210413,EXP,,CA-PFIZER INC-2021390135,PFIZER,,65.0,YR,,M,Y,,,20210413.0,,CN,CA,CA,2021,Q2,Elderly
191318381,19131838,18,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, 1X/DAY",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2021,Q2,Sleep disorder due to a general medical condition,,2021,Q2,1,I,,20210405.0,20210413,20210413,EXP,,CA-PFIZER INC-2021390135,PFIZER,,65.0,YR,,M,Y,,,20210413.0,,CN,CA,CA,2021,Q2,Elderly
191318381,19131838,18,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, 1X/DAY",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2021,Q2,Therapeutic product effect incomplete,,2021,Q2,1,I,,20210405.0,20210413,20210413,EXP,,CA-PFIZER INC-2021390135,PFIZER,,65.0,YR,,M,Y,,,20210413.0,,CN,CA,CA,2021,Q2,Elderly
191318381,19131838,18,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, 1X/DAY",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2021,Q2,Vasculitis,,2021,Q2,1,I,,20210405.0,20210413,20210413,EXP,,CA-PFIZER INC-2021390135,PFIZER,,65.0,YR,,M,Y,,,20210413.0,,CN,CA,CA,2021,Q2,Elderly
191318381,19131838,18,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, 1X/DAY",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2021,Q2,Wheezing,,2021,Q2,1,I,,20210405.0,20210413,20210413,EXP,,CA-PFIZER INC-2021390135,PFIZER,,65.0,YR,,M,Y,,,20210413.0,,CN,CA,CA,2021,Q2,Elderly
191328721,19132872,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Diabetes mellitus inadequate control,,2021,Q2,1,I,20210317.0,20210322.0,20210414,20210414,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202103010957,ELI LILLY AND CO,,47.0,YR,,F,Y,75.0,KG,20210414.0,,CN,CN,CN,2021,Q2,Adult
191328721,19132872,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Drug hypersensitivity,,2021,Q2,1,I,20210317.0,20210322.0,20210414,20210414,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202103010957,ELI LILLY AND CO,,47.0,YR,,F,Y,75.0,KG,20210414.0,,CN,CN,CN,2021,Q2,Adult
191328721,19132872,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Headache,,2021,Q2,1,I,20210317.0,20210322.0,20210414,20210414,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202103010957,ELI LILLY AND CO,,47.0,YR,,F,Y,75.0,KG,20210414.0,,CN,CN,CN,2021,Q2,Adult
191328771,19132877,8,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2021,Q2,Arrhythmia supraventricular,,2021,Q2,1,I,20210401.0,20210406.0,20210414,20210414,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202104004219,ELI LILLY AND CO,,78.0,YR,,F,Y,55.0,KG,20210414.0,,MD,CN,CN,2021,Q2,Elderly
191328771,19132877,8,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2021,Q2,Supraventricular tachycardia,,2021,Q2,1,I,20210401.0,20210406.0,20210414,20210414,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202104004219,ELI LILLY AND CO,,78.0,YR,,F,Y,55.0,KG,20210414.0,,MD,CN,CN,2021,Q2,Elderly
191387382,19138738,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"30 INTERNATIONAL UNIT, ONCE A DAY",,,,, 1F935A,,,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Blood glucose increased,,2021,Q2,2,F,202103.0,20210526.0,20210415,20210529,EXP,,ES-AUROBINDO-AUR-APL-2021-015538,AUROBINDO,,79.0,YR,,F,Y,52.6,KG,20210529.0,,CN,ES,ES,2021,Q2,Elderly
191387382,19138738,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"30 INTERNATIONAL UNIT, ONCE A DAY",,,,, 1F935A,,,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Extremity contracture,,2021,Q2,2,F,202103.0,20210526.0,20210415,20210529,EXP,,ES-AUROBINDO-AUR-APL-2021-015538,AUROBINDO,,79.0,YR,,F,Y,52.6,KG,20210529.0,,CN,ES,ES,2021,Q2,Elderly
191387382,19138738,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"30 INTERNATIONAL UNIT, ONCE A DAY",,,,, 1F935A,,,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Gait disturbance,,2021,Q2,2,F,202103.0,20210526.0,20210415,20210529,EXP,,ES-AUROBINDO-AUR-APL-2021-015538,AUROBINDO,,79.0,YR,,F,Y,52.6,KG,20210529.0,,CN,ES,ES,2021,Q2,Elderly
191387382,19138738,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"30 INTERNATIONAL UNIT, ONCE A DAY",,,,, 1F935A,,,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Hyperglycaemia,,2021,Q2,2,F,202103.0,20210526.0,20210415,20210529,EXP,,ES-AUROBINDO-AUR-APL-2021-015538,AUROBINDO,,79.0,YR,,F,Y,52.6,KG,20210529.0,,CN,ES,ES,2021,Q2,Elderly
191387382,19138738,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"30 INTERNATIONAL UNIT, ONCE A DAY",,,,, 1F935A,,,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Limb discomfort,,2021,Q2,2,F,202103.0,20210526.0,20210415,20210529,EXP,,ES-AUROBINDO-AUR-APL-2021-015538,AUROBINDO,,79.0,YR,,F,Y,52.6,KG,20210529.0,,CN,ES,ES,2021,Q2,Elderly
191387382,19138738,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"30 INTERNATIONAL UNIT, ONCE A DAY",,,,, 1F935A,,,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Listless,,2021,Q2,2,F,202103.0,20210526.0,20210415,20210529,EXP,,ES-AUROBINDO-AUR-APL-2021-015538,AUROBINDO,,79.0,YR,,F,Y,52.6,KG,20210529.0,,CN,ES,ES,2021,Q2,Elderly
191387382,19138738,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"30 INTERNATIONAL UNIT, ONCE A DAY",,,,, 1F935A,,,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Pain in extremity,,2021,Q2,2,F,202103.0,20210526.0,20210415,20210529,EXP,,ES-AUROBINDO-AUR-APL-2021-015538,AUROBINDO,,79.0,YR,,F,Y,52.6,KG,20210529.0,,CN,ES,ES,2021,Q2,Elderly
191387382,19138738,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"30 INTERNATIONAL UNIT, ONCE A DAY",,,,, 1F935A,,,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Poor quality sleep,,2021,Q2,2,F,202103.0,20210526.0,20210415,20210529,EXP,,ES-AUROBINDO-AUR-APL-2021-015538,AUROBINDO,,79.0,YR,,F,Y,52.6,KG,20210529.0,,CN,ES,ES,2021,Q2,Elderly
191387382,19138738,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"30 INTERNATIONAL UNIT, ONCE A DAY",,,,, 1F935A,,,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Sciatica,,2021,Q2,2,F,202103.0,20210526.0,20210415,20210529,EXP,,ES-AUROBINDO-AUR-APL-2021-015538,AUROBINDO,,79.0,YR,,F,Y,52.6,KG,20210529.0,,CN,ES,ES,2021,Q2,Elderly
191396801,19139680,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"INJECT 15 UNITS DAILY AT BEDTIME OR AS DIRECTED BY DIABETES CLINIC, 100 UNIT/ML",,,,,,,,,,SOLUTION,,2021,Q2,Change of bowel habit,,2021,Q2,1,I,,20210330.0,20210415,20210415,EXP,,US-BAUSCH-BL-2021-011270,BAUSCH AND LOMB,,74.0,YR,,F,Y,100.79,KG,20210415.0,,MD,US,US,2021,Q2,Elderly
191396801,19139680,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"INJECT 15 UNITS DAILY AT BEDTIME OR AS DIRECTED BY DIABETES CLINIC, 100 UNIT/ML",,,,,,,,,,SOLUTION,,2021,Q2,Condition aggravated,,2021,Q2,1,I,,20210330.0,20210415,20210415,EXP,,US-BAUSCH-BL-2021-011270,BAUSCH AND LOMB,,74.0,YR,,F,Y,100.79,KG,20210415.0,,MD,US,US,2021,Q2,Elderly
191396801,19139680,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"INJECT 15 UNITS DAILY AT BEDTIME OR AS DIRECTED BY DIABETES CLINIC, 100 UNIT/ML",,,,,,,,,,SOLUTION,,2021,Q2,Confusional state,,2021,Q2,1,I,,20210330.0,20210415,20210415,EXP,,US-BAUSCH-BL-2021-011270,BAUSCH AND LOMB,,74.0,YR,,F,Y,100.79,KG,20210415.0,,MD,US,US,2021,Q2,Elderly
191396801,19139680,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"INJECT 15 UNITS DAILY AT BEDTIME OR AS DIRECTED BY DIABETES CLINIC, 100 UNIT/ML",,,,,,,,,,SOLUTION,,2021,Q2,Hepatic encephalopathy,,2021,Q2,1,I,,20210330.0,20210415,20210415,EXP,,US-BAUSCH-BL-2021-011270,BAUSCH AND LOMB,,74.0,YR,,F,Y,100.79,KG,20210415.0,,MD,US,US,2021,Q2,Elderly
191396801,19139680,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"INJECT 15 UNITS DAILY AT BEDTIME OR AS DIRECTED BY DIABETES CLINIC, 100 UNIT/ML",,,,,,,,,,SOLUTION,,2021,Q2,Lethargy,,2021,Q2,1,I,,20210330.0,20210415,20210415,EXP,,US-BAUSCH-BL-2021-011270,BAUSCH AND LOMB,,74.0,YR,,F,Y,100.79,KG,20210415.0,,MD,US,US,2021,Q2,Elderly
191396801,19139680,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"INJECT 15 UNITS DAILY AT BEDTIME OR AS DIRECTED BY DIABETES CLINIC, 100 UNIT/ML",,,,,,,,,,SOLUTION,,2021,Q2,Renal impairment,,2021,Q2,1,I,,20210330.0,20210415,20210415,EXP,,US-BAUSCH-BL-2021-011270,BAUSCH AND LOMB,,74.0,YR,,F,Y,100.79,KG,20210415.0,,MD,US,US,2021,Q2,Elderly
191400442,19140044,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,8 UNITS,,,,,,,,,,,QD,2021,Q2,Chest discomfort,,2021,Q2,2,F,,20210416.0,20210415,20210427,PER,,US-VERTEX PHARMACEUTICALS-2021-005948,VERTEX,,32.0,YR,,F,Y,61.0,KG,20210427.0,,PH,US,US,2021,Q2,Young Adult
191400442,19140044,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,8 UNITS,,,,,,,,,,,QD,2021,Q2,Cough,,2021,Q2,2,F,,20210416.0,20210415,20210427,PER,,US-VERTEX PHARMACEUTICALS-2021-005948,VERTEX,,32.0,YR,,F,Y,61.0,KG,20210427.0,,PH,US,US,2021,Q2,Young Adult
191400442,19140044,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,8 UNITS,,,,,,,,,,,QD,2021,Q2,Peak expiratory flow rate decreased,,2021,Q2,2,F,,20210416.0,20210415,20210427,PER,,US-VERTEX PHARMACEUTICALS-2021-005948,VERTEX,,32.0,YR,,F,Y,61.0,KG,20210427.0,,PH,US,US,2021,Q2,Young Adult
191402061,19140206,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Death,,2021,Q2,1,I,20210112.0,,20210415,20210415,DIR,,,FDA-CTU,,81.0,YR,,M,N,87.75,KG,20210415.0,Y,CN,US,US,2021,Q2,Elderly
191428921,19142892,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 INTERNATIONAL UNIT, ONCE",20.0,IU,Y,,,,,20.0,IU,SOLUTION FOR INJECTION IN PRE-FILLED PEN,1X,2021,Q2,Coma,,2021,Q2,1,I,202102.0,20210407.0,20210416,20210416,EXP,FR-AFSSAPS-AN20210805,FR-JNJFOC-20210428302,JOHNSON AND JOHNSON,,86.0,YR,E,M,Y,100.0,KG,20210416.0,,PH,FR,FR,2021,Q2,Elderly
191428921,19142892,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 INTERNATIONAL UNIT, ONCE",20.0,IU,Y,,,,,20.0,IU,SOLUTION FOR INJECTION IN PRE-FILLED PEN,1X,2021,Q2,Dependence on oxygen therapy,,2021,Q2,1,I,202102.0,20210407.0,20210416,20210416,EXP,FR-AFSSAPS-AN20210805,FR-JNJFOC-20210428302,JOHNSON AND JOHNSON,,86.0,YR,E,M,Y,100.0,KG,20210416.0,,PH,FR,FR,2021,Q2,Elderly
191428921,19142892,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 INTERNATIONAL UNIT, ONCE",20.0,IU,Y,,,,,20.0,IU,SOLUTION FOR INJECTION IN PRE-FILLED PEN,1X,2021,Q2,Drug interaction,,2021,Q2,1,I,202102.0,20210407.0,20210416,20210416,EXP,FR-AFSSAPS-AN20210805,FR-JNJFOC-20210428302,JOHNSON AND JOHNSON,,86.0,YR,E,M,Y,100.0,KG,20210416.0,,PH,FR,FR,2021,Q2,Elderly
191431801,19143180,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,40.0,,UNK,,2021,Q2,Hypothyroidism,,2021,Q2,1,I,,20210407.0,20210416,20210416,EXP,,TR-GRANULES-TR-2021GRALIT00244,GRANULES INDIA,,53.0,YR,A,F,Y,,,20210416.0,,HP,TR,TR,2021,Q2,Adult
191431801,19143180,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,40.0,,UNK,,2021,Q2,Malabsorption,,2021,Q2,1,I,,20210407.0,20210416,20210416,EXP,,TR-GRANULES-TR-2021GRALIT00244,GRANULES INDIA,,53.0,YR,A,F,Y,,,20210416.0,,HP,TR,TR,2021,Q2,Adult
191435311,19143531,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Off label use,,2021,Q2,1,I,2020.0,20210406.0,20210415,20210415,EXP,,AT-LUPIN PHARMACEUTICALS INC.-2021-04811,LUPIN,,70.0,YR,,M,Y,,,20210416.0,,HP,AT,AT,2021,Q2,Elderly
191453622,19145362,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,8 UNITS,,,,,,,,,,,QD,2021,Q2,Neonatal hypoacusis,,2021,Q2,2,F,20210401.0,20210416.0,20210416,20210423,EXP,,US-VERTEX PHARMACEUTICALS-2021-005619,VERTEX,,1.0,MON,,M,Y,3.0,KG,20210423.0,,HP,US,US,2021,Q2,Child
191456821,19145682,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,24?30U IN THE MORNING,,,,U, UNKNOWN,,,,,INJECTION,,2021,Q2,Drug dependence,,2021,Q2,1,I,,20210408.0,20210416,20210416,EXP,,"PT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-096139",BOEHRINGER INGELHEIM,"FERNANDES LN, SILVA D.. THE IMPORTANCE OF QUESTIONING THE DIAGNOSIS OF DIABETES MELLITUS TYPE 2: A CASE OF LADA. PORTUGUESE CONGRESS OF ENDOCRINOLOGY /72ND SPEDM ANNUAL MEETING? REVISTA PORTUGU. 2021?16 SUPPLEMENT:53",65.0,YR,A,F,Y,,,20210416.0,,CN,PT,PT,2021,Q2,Elderly
191456821,19145682,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,24?30U IN THE MORNING,,,,U, UNKNOWN,,,,,INJECTION,,2021,Q2,Vomiting,,2021,Q2,1,I,,20210408.0,20210416,20210416,EXP,,"PT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-096139",BOEHRINGER INGELHEIM,"FERNANDES LN, SILVA D.. THE IMPORTANCE OF QUESTIONING THE DIAGNOSIS OF DIABETES MELLITUS TYPE 2: A CASE OF LADA. PORTUGUESE CONGRESS OF ENDOCRINOLOGY /72ND SPEDM ANNUAL MEETING? REVISTA PORTUGU. 2021?16 SUPPLEMENT:53",65.0,YR,A,F,Y,,,20210416.0,,CN,PT,PT,2021,Q2,Elderly
191456821,19145682,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,24?30U IN THE MORNING,,,,U, UNKNOWN,,,,,INJECTION,,2021,Q2,Weight increased,,2021,Q2,1,I,,20210408.0,20210416,20210416,EXP,,"PT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-096139",BOEHRINGER INGELHEIM,"FERNANDES LN, SILVA D.. THE IMPORTANCE OF QUESTIONING THE DIAGNOSIS OF DIABETES MELLITUS TYPE 2: A CASE OF LADA. PORTUGUESE CONGRESS OF ENDOCRINOLOGY /72ND SPEDM ANNUAL MEETING? REVISTA PORTUGU. 2021?16 SUPPLEMENT:53",65.0,YR,A,F,Y,,,20210416.0,,CN,PT,PT,2021,Q2,Elderly
191488021,19148802,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNKNOWN DOSE EVERY DAY,,,U,N,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q2,Asthma,,2021,Q2,1,I,,20210409.0,20210416,20210416,EXP,,CA-ANIPHARMA-2021-CA-000457,ANI,,65.0,YR,,M,Y,,,20210416.0,,CN,CA,CA,2021,Q2,Elderly
191488021,19148802,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNKNOWN DOSE EVERY DAY,,,U,N,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q2,Condition aggravated,,2021,Q2,1,I,,20210409.0,20210416,20210416,EXP,,CA-ANIPHARMA-2021-CA-000457,ANI,,65.0,YR,,M,Y,,,20210416.0,,CN,CA,CA,2021,Q2,Elderly
191488021,19148802,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNKNOWN DOSE EVERY DAY,,,U,N,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q2,Dyspnoea,,2021,Q2,1,I,,20210409.0,20210416,20210416,EXP,,CA-ANIPHARMA-2021-CA-000457,ANI,,65.0,YR,,M,Y,,,20210416.0,,CN,CA,CA,2021,Q2,Elderly
191488021,19148802,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNKNOWN DOSE EVERY DAY,,,U,N,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q2,Haemoptysis,,2021,Q2,1,I,,20210409.0,20210416,20210416,EXP,,CA-ANIPHARMA-2021-CA-000457,ANI,,65.0,YR,,M,Y,,,20210416.0,,CN,CA,CA,2021,Q2,Elderly
191488021,19148802,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNKNOWN DOSE EVERY DAY,,,U,N,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q2,Loss of personal independence in daily activities,,2021,Q2,1,I,,20210409.0,20210416,20210416,EXP,,CA-ANIPHARMA-2021-CA-000457,ANI,,65.0,YR,,M,Y,,,20210416.0,,CN,CA,CA,2021,Q2,Elderly
191488021,19148802,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNKNOWN DOSE EVERY DAY,,,U,N,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q2,Lung disorder,,2021,Q2,1,I,,20210409.0,20210416,20210416,EXP,,CA-ANIPHARMA-2021-CA-000457,ANI,,65.0,YR,,M,Y,,,20210416.0,,CN,CA,CA,2021,Q2,Elderly
191488021,19148802,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNKNOWN DOSE EVERY DAY,,,U,N,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q2,Neuritis,,2021,Q2,1,I,,20210409.0,20210416,20210416,EXP,,CA-ANIPHARMA-2021-CA-000457,ANI,,65.0,YR,,M,Y,,,20210416.0,,CN,CA,CA,2021,Q2,Elderly
191488021,19148802,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNKNOWN DOSE EVERY DAY,,,U,N,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q2,Neurological symptom,,2021,Q2,1,I,,20210409.0,20210416,20210416,EXP,,CA-ANIPHARMA-2021-CA-000457,ANI,,65.0,YR,,M,Y,,,20210416.0,,CN,CA,CA,2021,Q2,Elderly
191488021,19148802,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNKNOWN DOSE EVERY DAY,,,U,N,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q2,Obstructive airways disorder,,2021,Q2,1,I,,20210409.0,20210416,20210416,EXP,,CA-ANIPHARMA-2021-CA-000457,ANI,,65.0,YR,,M,Y,,,20210416.0,,CN,CA,CA,2021,Q2,Elderly
191488021,19148802,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNKNOWN DOSE EVERY DAY,,,U,N,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q2,Pain in extremity,,2021,Q2,1,I,,20210409.0,20210416,20210416,EXP,,CA-ANIPHARMA-2021-CA-000457,ANI,,65.0,YR,,M,Y,,,20210416.0,,CN,CA,CA,2021,Q2,Elderly
191488021,19148802,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNKNOWN DOSE EVERY DAY,,,U,N,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q2,Pulmonary alveolar haemorrhage,,2021,Q2,1,I,,20210409.0,20210416,20210416,EXP,,CA-ANIPHARMA-2021-CA-000457,ANI,,65.0,YR,,M,Y,,,20210416.0,,CN,CA,CA,2021,Q2,Elderly
191488021,19148802,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNKNOWN DOSE EVERY DAY,,,U,N,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q2,Pulmonary fibrosis,,2021,Q2,1,I,,20210409.0,20210416,20210416,EXP,,CA-ANIPHARMA-2021-CA-000457,ANI,,65.0,YR,,M,Y,,,20210416.0,,CN,CA,CA,2021,Q2,Elderly
191488021,19148802,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNKNOWN DOSE EVERY DAY,,,U,N,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q2,Pulmonary vasculitis,,2021,Q2,1,I,,20210409.0,20210416,20210416,EXP,,CA-ANIPHARMA-2021-CA-000457,ANI,,65.0,YR,,M,Y,,,20210416.0,,CN,CA,CA,2021,Q2,Elderly
191488021,19148802,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNKNOWN DOSE EVERY DAY,,,U,N,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q2,Respiratory symptom,,2021,Q2,1,I,,20210409.0,20210416,20210416,EXP,,CA-ANIPHARMA-2021-CA-000457,ANI,,65.0,YR,,M,Y,,,20210416.0,,CN,CA,CA,2021,Q2,Elderly
191488021,19148802,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNKNOWN DOSE EVERY DAY,,,U,N,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q2,Sleep disorder due to a general medical condition,,2021,Q2,1,I,,20210409.0,20210416,20210416,EXP,,CA-ANIPHARMA-2021-CA-000457,ANI,,65.0,YR,,M,Y,,,20210416.0,,CN,CA,CA,2021,Q2,Elderly
191488021,19148802,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNKNOWN DOSE EVERY DAY,,,U,N,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q2,Therapeutic product effect incomplete,,2021,Q2,1,I,,20210409.0,20210416,20210416,EXP,,CA-ANIPHARMA-2021-CA-000457,ANI,,65.0,YR,,M,Y,,,20210416.0,,CN,CA,CA,2021,Q2,Elderly
191488021,19148802,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNKNOWN DOSE EVERY DAY,,,U,N,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q2,Vasculitis,,2021,Q2,1,I,,20210409.0,20210416,20210416,EXP,,CA-ANIPHARMA-2021-CA-000457,ANI,,65.0,YR,,M,Y,,,20210416.0,,CN,CA,CA,2021,Q2,Elderly
191488021,19148802,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNKNOWN DOSE EVERY DAY,,,U,N,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q2,Wheezing,,2021,Q2,1,I,,20210409.0,20210416,20210416,EXP,,CA-ANIPHARMA-2021-CA-000457,ANI,,65.0,YR,,M,Y,,,20210416.0,,CN,CA,CA,2021,Q2,Elderly
191518931,19151893,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,, UNKNOWN,,,40.0,,,,2021,Q2,Malabsorption,,2021,Q2,1,I,,20210408.0,20210419,20210419,EXP,,TR-SCIEGEN-2021SCILIT00366,SCIEGEN,,53.0,YR,A,F,Y,,,20210419.0,,HP,TR,TR,2021,Q2,Adult
191519831,19151983,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,40U,,,U,, UNKNOWN,,,,,,,2021,Q2,Hypothyroidism,,2021,Q2,1,I,,20210405.0,20210419,20210419,EXP,,TR-EPICPHARMA-TR-2021EPCLIT00421,EPIC PHARM,,53.0,YR,A,F,Y,,,20210419.0,,HP,TR,TR,2021,Q2,Adult
191519831,19151983,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,40U,,,U,, UNKNOWN,,,,,,,2021,Q2,Malabsorption,,2021,Q2,1,I,,20210405.0,20210419,20210419,EXP,,TR-EPICPHARMA-TR-2021EPCLIT00421,EPIC PHARM,,53.0,YR,A,F,Y,,,20210419.0,,HP,TR,TR,2021,Q2,Adult
191547342,19154734,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,10 IU,,,,, OF741A,,,10.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Diarrhoea,,2021,Q2,2,F,2020.0,20210519.0,20210419,20210524,EXP,,ES-MYLANLABS-2021M1022602,MYLAN,,52.0,YR,,M,Y,97.0,KG,20210524.0,,HP,ES,ES,2021,Q2,Adult
191547342,19154734,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,10 IU,,,,, OF741A,,,10.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Product storage error,,2021,Q2,2,F,2020.0,20210519.0,20210419,20210524,EXP,,ES-MYLANLABS-2021M1022602,MYLAN,,52.0,YR,,M,Y,97.0,KG,20210524.0,,HP,ES,ES,2021,Q2,Adult
191549732,19154973,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Extravasation,,2021,Q2,2,F,20210416.0,20210507.0,20210419,20210511,PER,,US-GILEAD-2021-0525823,GILEAD,,68.0,YR,E,F,Y,86.0,KG,20210511.0,,PH,US,US,2021,Q2,Elderly
191554332,19155433,7,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q2,Interstitial lung disease,,2021,Q2,2,F,20200318.0,20210519.0,20210419,20210531,EXP,,JP-BAUSCH-BL-2021-012463,BAUSCH AND LOMB,,80.0,YR,,M,Y,,,20210531.0,,PH,JP,JP,2021,Q2,Elderly
191557133,19155713,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,Y,,,,21081.0,,,,,2021,Q2,Abdominal distension,,2021,Q2,3,F,,20210408.0,20210419,20210422,PER,,US-SA-2021SA115871,SANOFI AVENTIS,,72.0,YR,E,M,Y,,,20210423.0,,CN,US,US,2021,Q2,Elderly
191557133,19155713,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,Y,,,,21081.0,,,,,2021,Q2,Abdominal pain upper,,2021,Q2,3,F,,20210408.0,20210419,20210422,PER,,US-SA-2021SA115871,SANOFI AVENTIS,,72.0,YR,E,M,Y,,,20210423.0,,CN,US,US,2021,Q2,Elderly
191557133,19155713,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,Y,,,,21081.0,,,,,2021,Q2,Diarrhoea,,2021,Q2,3,F,,20210408.0,20210419,20210422,PER,,US-SA-2021SA115871,SANOFI AVENTIS,,72.0,YR,E,M,Y,,,20210423.0,,CN,US,US,2021,Q2,Elderly
191557133,19155713,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,Y,,,,21081.0,,,,,2021,Q2,Endocrine pancreatic disorder,,2021,Q2,3,F,,20210408.0,20210419,20210422,PER,,US-SA-2021SA115871,SANOFI AVENTIS,,72.0,YR,E,M,Y,,,20210423.0,,CN,US,US,2021,Q2,Elderly
191557133,19155713,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,Y,,,,21081.0,,,,,2021,Q2,Flatulence,,2021,Q2,3,F,,20210408.0,20210419,20210422,PER,,US-SA-2021SA115871,SANOFI AVENTIS,,72.0,YR,E,M,Y,,,20210423.0,,CN,US,US,2021,Q2,Elderly
191574541,19157454,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Encephalopathy,,2021,Q2,1,I,201710.0,20210408.0,20210420,20210420,EXP,,HU-ELI_LILLY_AND_COMPANY-HU202104004731,ELI LILLY AND CO,,49.0,YR,,F,Y,160.0,KG,20210420.0,,MD,HU,HU,2021,Q2,Adult
191574541,19157454,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Gastritis,,2021,Q2,1,I,201710.0,20210408.0,20210420,20210420,EXP,,HU-ELI_LILLY_AND_COMPANY-HU202104004731,ELI LILLY AND CO,,49.0,YR,,F,Y,160.0,KG,20210420.0,,MD,HU,HU,2021,Q2,Adult
191574541,19157454,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Gastrointestinal hypomotility,,2021,Q2,1,I,201710.0,20210408.0,20210420,20210420,EXP,,HU-ELI_LILLY_AND_COMPANY-HU202104004731,ELI LILLY AND CO,,49.0,YR,,F,Y,160.0,KG,20210420.0,,MD,HU,HU,2021,Q2,Adult
191574541,19157454,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Nausea,,2021,Q2,1,I,201710.0,20210408.0,20210420,20210420,EXP,,HU-ELI_LILLY_AND_COMPANY-HU202104004731,ELI LILLY AND CO,,49.0,YR,,F,Y,160.0,KG,20210420.0,,MD,HU,HU,2021,Q2,Adult
191574541,19157454,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Polyneuropathy,,2021,Q2,1,I,201710.0,20210408.0,20210420,20210420,EXP,,HU-ELI_LILLY_AND_COMPANY-HU202104004731,ELI LILLY AND CO,,49.0,YR,,F,Y,160.0,KG,20210420.0,,MD,HU,HU,2021,Q2,Adult
191581211,19158121,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNITES AT NIGHT,,,Y,U,,,,,,,,2021,Q2,Lymphocyte count increased,,2021,Q2,1,I,2021.0,20210303.0,20210420,20210420,EXP,,AU-MYLANLABS-2021M1013775,MYLAN,,20.0,YR,,M,Y,,,20210420.0,,HP,AU,AU,2021,Q2,Youth
191581211,19158121,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNITES AT NIGHT,,,Y,U,,,,,,,,2021,Q2,Mean cell haemoglobin decreased,,2021,Q2,1,I,2021.0,20210303.0,20210420,20210420,EXP,,AU-MYLANLABS-2021M1013775,MYLAN,,20.0,YR,,M,Y,,,20210420.0,,HP,AU,AU,2021,Q2,Youth
191581211,19158121,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNITES AT NIGHT,,,Y,U,,,,,,,,2021,Q2,Mean cell volume decreased,,2021,Q2,1,I,2021.0,20210303.0,20210420,20210420,EXP,,AU-MYLANLABS-2021M1013775,MYLAN,,20.0,YR,,M,Y,,,20210420.0,,HP,AU,AU,2021,Q2,Youth
191581211,19158121,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNITES AT NIGHT,,,Y,U,,,,,,,,2021,Q2,Myocarditis,,2021,Q2,1,I,2021.0,20210303.0,20210420,20210420,EXP,,AU-MYLANLABS-2021M1013775,MYLAN,,20.0,YR,,M,Y,,,20210420.0,,HP,AU,AU,2021,Q2,Youth
191581211,19158121,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,6 UNITES AT NIGHT,,,Y,U,,,,,,,,2021,Q2,Lymphocyte count increased,,2021,Q2,1,I,2021.0,20210303.0,20210420,20210420,EXP,,AU-MYLANLABS-2021M1013775,MYLAN,,20.0,YR,,M,Y,,,20210420.0,,HP,AU,AU,2021,Q2,Youth
191581211,19158121,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,6 UNITES AT NIGHT,,,Y,U,,,,,,,,2021,Q2,Mean cell haemoglobin decreased,,2021,Q2,1,I,2021.0,20210303.0,20210420,20210420,EXP,,AU-MYLANLABS-2021M1013775,MYLAN,,20.0,YR,,M,Y,,,20210420.0,,HP,AU,AU,2021,Q2,Youth
191581211,19158121,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,6 UNITES AT NIGHT,,,Y,U,,,,,,,,2021,Q2,Mean cell volume decreased,,2021,Q2,1,I,2021.0,20210303.0,20210420,20210420,EXP,,AU-MYLANLABS-2021M1013775,MYLAN,,20.0,YR,,M,Y,,,20210420.0,,HP,AU,AU,2021,Q2,Youth
191581211,19158121,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,6 UNITES AT NIGHT,,,Y,U,,,,,,,,2021,Q2,Myocarditis,,2021,Q2,1,I,2021.0,20210303.0,20210420,20210420,EXP,,AU-MYLANLABS-2021M1013775,MYLAN,,20.0,YR,,M,Y,,,20210420.0,,HP,AU,AU,2021,Q2,Youth
191637272,19163727,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,,, 1F935A,,,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Blood glucose increased,,2021,Q2,2,F,202103.0,20210528.0,20210421,20210604,EXP,,NVSC2021ES084456,NOVARTIS,,79.0,YR,,F,Y,52.6,KG,20210604.0,,HP,ES,ES,2021,Q2,Elderly
191637272,19163727,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,,, 1F935A,,,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Extremity contracture,,2021,Q2,2,F,202103.0,20210528.0,20210421,20210604,EXP,,NVSC2021ES084456,NOVARTIS,,79.0,YR,,F,Y,52.6,KG,20210604.0,,HP,ES,ES,2021,Q2,Elderly
191637272,19163727,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,,, 1F935A,,,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Gait disturbance,,2021,Q2,2,F,202103.0,20210528.0,20210421,20210604,EXP,,NVSC2021ES084456,NOVARTIS,,79.0,YR,,F,Y,52.6,KG,20210604.0,,HP,ES,ES,2021,Q2,Elderly
191637272,19163727,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,,, 1F935A,,,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Hyperglycaemia,,2021,Q2,2,F,202103.0,20210528.0,20210421,20210604,EXP,,NVSC2021ES084456,NOVARTIS,,79.0,YR,,F,Y,52.6,KG,20210604.0,,HP,ES,ES,2021,Q2,Elderly
191637272,19163727,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,,, 1F935A,,,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Limb discomfort,,2021,Q2,2,F,202103.0,20210528.0,20210421,20210604,EXP,,NVSC2021ES084456,NOVARTIS,,79.0,YR,,F,Y,52.6,KG,20210604.0,,HP,ES,ES,2021,Q2,Elderly
191637272,19163727,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,,, 1F935A,,,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Listless,,2021,Q2,2,F,202103.0,20210528.0,20210421,20210604,EXP,,NVSC2021ES084456,NOVARTIS,,79.0,YR,,F,Y,52.6,KG,20210604.0,,HP,ES,ES,2021,Q2,Elderly
191637272,19163727,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,,, 1F935A,,,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Pain in extremity,,2021,Q2,2,F,202103.0,20210528.0,20210421,20210604,EXP,,NVSC2021ES084456,NOVARTIS,,79.0,YR,,F,Y,52.6,KG,20210604.0,,HP,ES,ES,2021,Q2,Elderly
191637272,19163727,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,,, 1F935A,,,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Poor quality sleep,,2021,Q2,2,F,202103.0,20210528.0,20210421,20210604,EXP,,NVSC2021ES084456,NOVARTIS,,79.0,YR,,F,Y,52.6,KG,20210604.0,,HP,ES,ES,2021,Q2,Elderly
191637272,19163727,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,,, 1F935A,,,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Sciatica,,2021,Q2,2,F,202103.0,20210528.0,20210421,20210604,EXP,,NVSC2021ES084456,NOVARTIS,,79.0,YR,,F,Y,52.6,KG,20210604.0,,HP,ES,ES,2021,Q2,Elderly
191643881,19164388,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"BASAGLAR KWIKPEN 100 UNITS/ML SUBCUTANEOUS SOLUTION, SUBSTITUTION ALLOWED",,,,, UNKNOWN,,,,,SOLUTION,,2021,Q2,Infection,,2021,Q2,1,I,20210326.0,20210412.0,20210421,20210421,EXP,,US-FRESENIUS KABI-FK202103970,FRESENIUS KABI,,76.0,YR,,F,Y,70.9,KG,20210421.0,,MD,US,US,2021,Q2,Elderly
191682962,19168296,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"85 INTERNATIONAL UNIT, QD",,,D,,,,,85.0,IU,,QD,2021,Q2,Haemorrhagic stroke,,2021,Q2,2,F,20210309.0,20210415.0,20210422,20210423,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-037668,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,,,20210423.0,,CN,US,US,2021,Q2,Elderly
191706484,19170648,14,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,Subcutaneous,"3 IE/ML, PRN",,,,,,,,,,,/yr,2021,Q2,Respiratory failure,,2021,Q2,4,F,20210417.0,20210526.0,20210422,20210528,EXP,,"DE-PORTOLA PHARMACEUTICALS, INC.-A202104684",ALEXION,,82.0,YR,,M,Y,,,20210528.0,,HP,DE,DE,2021,Q2,Elderly
191718401,19171840,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,,,2021,Q2,Chest discomfort,,2021,Q2,1,I,,20210412.0,20210423,20210423,EXP,,AU-NOVOPROD-803836,NOVO NORDISK,K. M. ROTHACKER AND J. KAYE. INSULIN OEDEMA AND TREATMENT?INDUCED NEUROPATHY OCCURRING IN A 20?YEAR?OLD PATIENT WITH TYPE 1 DIABETES COMMENCED ON AN INSULIN PUMP. DIABETIC MEDICINE. 2014?31:E6?E10,20.0,YR,,M,Y,,,20210423.0,,HP,AU,AU,2021,Q2,Youth
191718401,19171840,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,,,2021,Q2,Epigastric discomfort,,2021,Q2,1,I,,20210412.0,20210423,20210423,EXP,,AU-NOVOPROD-803836,NOVO NORDISK,K. M. ROTHACKER AND J. KAYE. INSULIN OEDEMA AND TREATMENT?INDUCED NEUROPATHY OCCURRING IN A 20?YEAR?OLD PATIENT WITH TYPE 1 DIABETES COMMENCED ON AN INSULIN PUMP. DIABETIC MEDICINE. 2014?31:E6?E10,20.0,YR,,M,Y,,,20210423.0,,HP,AU,AU,2021,Q2,Youth
191718401,19171840,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,,,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,,20210412.0,20210423,20210423,EXP,,AU-NOVOPROD-803836,NOVO NORDISK,K. M. ROTHACKER AND J. KAYE. INSULIN OEDEMA AND TREATMENT?INDUCED NEUROPATHY OCCURRING IN A 20?YEAR?OLD PATIENT WITH TYPE 1 DIABETES COMMENCED ON AN INSULIN PUMP. DIABETIC MEDICINE. 2014?31:E6?E10,20.0,YR,,M,Y,,,20210423.0,,HP,AU,AU,2021,Q2,Youth
191718401,19171840,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,,,2021,Q2,Oedema,,2021,Q2,1,I,,20210412.0,20210423,20210423,EXP,,AU-NOVOPROD-803836,NOVO NORDISK,K. M. ROTHACKER AND J. KAYE. INSULIN OEDEMA AND TREATMENT?INDUCED NEUROPATHY OCCURRING IN A 20?YEAR?OLD PATIENT WITH TYPE 1 DIABETES COMMENCED ON AN INSULIN PUMP. DIABETIC MEDICINE. 2014?31:E6?E10,20.0,YR,,M,Y,,,20210423.0,,HP,AU,AU,2021,Q2,Youth
191738812,19173881,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Acute kidney injury,,2021,Q2,2,F,,20210426.0,20210423,20210428,EXP,,US-009507513-2104USA003854,MERCK,,48.0,YR,,F,Y,,,20210428.0,,HP,US,US,2021,Q2,Adult
191738812,19173881,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Drug interaction,,2021,Q2,2,F,,20210426.0,20210423,20210428,EXP,,US-009507513-2104USA003854,MERCK,,48.0,YR,,F,Y,,,20210428.0,,HP,US,US,2021,Q2,Adult
191738812,19173881,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Hyponatraemia,,2021,Q2,2,F,,20210426.0,20210423,20210428,EXP,,US-009507513-2104USA003854,MERCK,,48.0,YR,,F,Y,,,20210428.0,,HP,US,US,2021,Q2,Adult
191738812,19173881,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Hypovolaemia,,2021,Q2,2,F,,20210426.0,20210423,20210428,EXP,,US-009507513-2104USA003854,MERCK,,48.0,YR,,F,Y,,,20210428.0,,HP,US,US,2021,Q2,Adult
191738812,19173881,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Labelled drug-drug interaction medication error,,2021,Q2,2,F,,20210426.0,20210423,20210428,EXP,,US-009507513-2104USA003854,MERCK,,48.0,YR,,F,Y,,,20210428.0,,HP,US,US,2021,Q2,Adult
191738812,19173881,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Toxicity to various agents,,2021,Q2,2,F,,20210426.0,20210423,20210428,EXP,,US-009507513-2104USA003854,MERCK,,48.0,YR,,F,Y,,,20210428.0,,HP,US,US,2021,Q2,Adult
191747771,19174777,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,26 IU AGAIN IN THE MORNING,,,,,,,,,,,,2021,Q2,Aptyalism,,2021,Q2,1,I,,20210419.0,20210423,20210423,EXP,,MX-ASTRAZENECA-2021A343928,ASTRAZENECA,,47.0,YR,,F,Y,65.0,KG,20210423.0,,,MX,MX,2021,Q2,Adult
191747771,19174777,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,26 IU AGAIN IN THE MORNING,,,,,,,,,,,,2021,Q2,Decreased activity,,2021,Q2,1,I,,20210419.0,20210423,20210423,EXP,,MX-ASTRAZENECA-2021A343928,ASTRAZENECA,,47.0,YR,,F,Y,65.0,KG,20210423.0,,,MX,MX,2021,Q2,Adult
191747771,19174777,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,26 IU AGAIN IN THE MORNING,,,,,,,,,,,,2021,Q2,Decreased appetite,,2021,Q2,1,I,,20210419.0,20210423,20210423,EXP,,MX-ASTRAZENECA-2021A343928,ASTRAZENECA,,47.0,YR,,F,Y,65.0,KG,20210423.0,,,MX,MX,2021,Q2,Adult
191747771,19174777,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,26 IU AGAIN IN THE MORNING,,,,,,,,,,,,2021,Q2,Disturbance in attention,,2021,Q2,1,I,,20210419.0,20210423,20210423,EXP,,MX-ASTRAZENECA-2021A343928,ASTRAZENECA,,47.0,YR,,F,Y,65.0,KG,20210423.0,,,MX,MX,2021,Q2,Adult
191747771,19174777,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,26 IU AGAIN IN THE MORNING,,,,,,,,,,,,2021,Q2,Dizziness,,2021,Q2,1,I,,20210419.0,20210423,20210423,EXP,,MX-ASTRAZENECA-2021A343928,ASTRAZENECA,,47.0,YR,,F,Y,65.0,KG,20210423.0,,,MX,MX,2021,Q2,Adult
191747771,19174777,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,26 IU AGAIN IN THE MORNING,,,,,,,,,,,,2021,Q2,Fatigue,,2021,Q2,1,I,,20210419.0,20210423,20210423,EXP,,MX-ASTRAZENECA-2021A343928,ASTRAZENECA,,47.0,YR,,F,Y,65.0,KG,20210423.0,,,MX,MX,2021,Q2,Adult
191747771,19174777,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,26 IU AGAIN IN THE MORNING,,,,,,,,,,,,2021,Q2,Hot flush,,2021,Q2,1,I,,20210419.0,20210423,20210423,EXP,,MX-ASTRAZENECA-2021A343928,ASTRAZENECA,,47.0,YR,,F,Y,65.0,KG,20210423.0,,,MX,MX,2021,Q2,Adult
191747771,19174777,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,26 IU AGAIN IN THE MORNING,,,,,,,,,,,,2021,Q2,Impaired work ability,,2021,Q2,1,I,,20210419.0,20210423,20210423,EXP,,MX-ASTRAZENECA-2021A343928,ASTRAZENECA,,47.0,YR,,F,Y,65.0,KG,20210423.0,,,MX,MX,2021,Q2,Adult
191747771,19174777,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,26 IU AGAIN IN THE MORNING,,,,,,,,,,,,2021,Q2,Inflammation,,2021,Q2,1,I,,20210419.0,20210423,20210423,EXP,,MX-ASTRAZENECA-2021A343928,ASTRAZENECA,,47.0,YR,,F,Y,65.0,KG,20210423.0,,,MX,MX,2021,Q2,Adult
191747771,19174777,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,26 IU AGAIN IN THE MORNING,,,,,,,,,,,,2021,Q2,Irritability,,2021,Q2,1,I,,20210419.0,20210423,20210423,EXP,,MX-ASTRAZENECA-2021A343928,ASTRAZENECA,,47.0,YR,,F,Y,65.0,KG,20210423.0,,,MX,MX,2021,Q2,Adult
191747771,19174777,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,26 IU AGAIN IN THE MORNING,,,,,,,,,,,,2021,Q2,Nausea,,2021,Q2,1,I,,20210419.0,20210423,20210423,EXP,,MX-ASTRAZENECA-2021A343928,ASTRAZENECA,,47.0,YR,,F,Y,65.0,KG,20210423.0,,,MX,MX,2021,Q2,Adult
191747771,19174777,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,26 IU AGAIN IN THE MORNING,,,,,,,,,,,,2021,Q2,Parosmia,,2021,Q2,1,I,,20210419.0,20210423,20210423,EXP,,MX-ASTRAZENECA-2021A343928,ASTRAZENECA,,47.0,YR,,F,Y,65.0,KG,20210423.0,,,MX,MX,2021,Q2,Adult
191747771,19174777,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,26 IU AGAIN IN THE MORNING,,,,,,,,,,,,2021,Q2,Sensory loss,,2021,Q2,1,I,,20210419.0,20210423,20210423,EXP,,MX-ASTRAZENECA-2021A343928,ASTRAZENECA,,47.0,YR,,F,Y,65.0,KG,20210423.0,,,MX,MX,2021,Q2,Adult
191819711,19181971,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Penile swelling,,2021,Q2,1,I,2021.0,20210413.0,20210426,20210426,PER,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-097748",BOEHRINGER INGELHEIM,,67.0,YR,E,M,Y,,,20210426.0,,CN,US,US,2021,Q2,Elderly
191832591,19183259,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Alopecia,,2021,Q2,1,I,,20210414.0,20210427,20210427,EXP,,CA-APOTEX-2021AP009958,APOTEX,,73.0,YR,,M,Y,,,20210427.0,,CN,CA,CA,2021,Q2,Elderly
191832591,19183259,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Blood creatinine abnormal,,2021,Q2,1,I,,20210414.0,20210427,20210427,EXP,,CA-APOTEX-2021AP009958,APOTEX,,73.0,YR,,M,Y,,,20210427.0,,CN,CA,CA,2021,Q2,Elderly
191832591,19183259,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Condition aggravated,,2021,Q2,1,I,,20210414.0,20210427,20210427,EXP,,CA-APOTEX-2021AP009958,APOTEX,,73.0,YR,,M,Y,,,20210427.0,,CN,CA,CA,2021,Q2,Elderly
191832591,19183259,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Constipation,,2021,Q2,1,I,,20210414.0,20210427,20210427,EXP,,CA-APOTEX-2021AP009958,APOTEX,,73.0,YR,,M,Y,,,20210427.0,,CN,CA,CA,2021,Q2,Elderly
191832591,19183259,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Drug interaction,,2021,Q2,1,I,,20210414.0,20210427,20210427,EXP,,CA-APOTEX-2021AP009958,APOTEX,,73.0,YR,,M,Y,,,20210427.0,,CN,CA,CA,2021,Q2,Elderly
191832591,19183259,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Dysphonia,,2021,Q2,1,I,,20210414.0,20210427,20210427,EXP,,CA-APOTEX-2021AP009958,APOTEX,,73.0,YR,,M,Y,,,20210427.0,,CN,CA,CA,2021,Q2,Elderly
191832591,19183259,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Fall,,2021,Q2,1,I,,20210414.0,20210427,20210427,EXP,,CA-APOTEX-2021AP009958,APOTEX,,73.0,YR,,M,Y,,,20210427.0,,CN,CA,CA,2021,Q2,Elderly
191832591,19183259,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Fatigue,,2021,Q2,1,I,,20210414.0,20210427,20210427,EXP,,CA-APOTEX-2021AP009958,APOTEX,,73.0,YR,,M,Y,,,20210427.0,,CN,CA,CA,2021,Q2,Elderly
191832591,19183259,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Headache,,2021,Q2,1,I,,20210414.0,20210427,20210427,EXP,,CA-APOTEX-2021AP009958,APOTEX,,73.0,YR,,M,Y,,,20210427.0,,CN,CA,CA,2021,Q2,Elderly
191832591,19183259,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Malaise,,2021,Q2,1,I,,20210414.0,20210427,20210427,EXP,,CA-APOTEX-2021AP009958,APOTEX,,73.0,YR,,M,Y,,,20210427.0,,CN,CA,CA,2021,Q2,Elderly
191832591,19183259,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Muscular weakness,,2021,Q2,1,I,,20210414.0,20210427,20210427,EXP,,CA-APOTEX-2021AP009958,APOTEX,,73.0,YR,,M,Y,,,20210427.0,,CN,CA,CA,2021,Q2,Elderly
191832591,19183259,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Nausea,,2021,Q2,1,I,,20210414.0,20210427,20210427,EXP,,CA-APOTEX-2021AP009958,APOTEX,,73.0,YR,,M,Y,,,20210427.0,,CN,CA,CA,2021,Q2,Elderly
191832591,19183259,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Renal impairment,,2021,Q2,1,I,,20210414.0,20210427,20210427,EXP,,CA-APOTEX-2021AP009958,APOTEX,,73.0,YR,,M,Y,,,20210427.0,,CN,CA,CA,2021,Q2,Elderly
191832591,19183259,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Retching,,2021,Q2,1,I,,20210414.0,20210427,20210427,EXP,,CA-APOTEX-2021AP009958,APOTEX,,73.0,YR,,M,Y,,,20210427.0,,CN,CA,CA,2021,Q2,Elderly
191832591,19183259,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Tremor,,2021,Q2,1,I,,20210414.0,20210427,20210427,EXP,,CA-APOTEX-2021AP009958,APOTEX,,73.0,YR,,M,Y,,,20210427.0,,CN,CA,CA,2021,Q2,Elderly
191832591,19183259,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Weight decreased,,2021,Q2,1,I,,20210414.0,20210427,20210427,EXP,,CA-APOTEX-2021AP009958,APOTEX,,73.0,YR,,M,Y,,,20210427.0,,CN,CA,CA,2021,Q2,Elderly
191849881,19184988,4,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Blood bicarbonate decreased,,2021,Q2,1,I,20210404.0,,20210426,20210426,DIR,,,FDA-CTU,,31.0,YR,,M,N,,,20210426.0,N,,US,US,2021,Q2,Young Adult
191849881,19184988,4,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Blood creatinine increased,,2021,Q2,1,I,20210404.0,,20210426,20210426,DIR,,,FDA-CTU,,31.0,YR,,M,N,,,20210426.0,N,,US,US,2021,Q2,Young Adult
191849881,19184988,4,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,20210404.0,,20210426,20210426,DIR,,,FDA-CTU,,31.0,YR,,M,N,,,20210426.0,N,,US,US,2021,Q2,Young Adult
191849881,19184988,4,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Blood urea decreased,,2021,Q2,1,I,20210404.0,,20210426,20210426,DIR,,,FDA-CTU,,31.0,YR,,M,N,,,20210426.0,N,,US,US,2021,Q2,Young Adult
191849881,19184988,4,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Cardiac failure,,2021,Q2,1,I,20210404.0,,20210426,20210426,DIR,,,FDA-CTU,,31.0,YR,,M,N,,,20210426.0,N,,US,US,2021,Q2,Young Adult
191849881,19184988,4,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Cardiomyopathy,,2021,Q2,1,I,20210404.0,,20210426,20210426,DIR,,,FDA-CTU,,31.0,YR,,M,N,,,20210426.0,N,,US,US,2021,Q2,Young Adult
191849881,19184988,4,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Gait inability,,2021,Q2,1,I,20210404.0,,20210426,20210426,DIR,,,FDA-CTU,,31.0,YR,,M,N,,,20210426.0,N,,US,US,2021,Q2,Young Adult
191849881,19184988,4,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Guillain-Barre syndrome,,2021,Q2,1,I,20210404.0,,20210426,20210426,DIR,,,FDA-CTU,,31.0,YR,,M,N,,,20210426.0,N,,US,US,2021,Q2,Young Adult
191849881,19184988,4,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Haemoglobin decreased,,2021,Q2,1,I,20210404.0,,20210426,20210426,DIR,,,FDA-CTU,,31.0,YR,,M,N,,,20210426.0,N,,US,US,2021,Q2,Young Adult
191849881,19184988,4,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Hyponatraemia,,2021,Q2,1,I,20210404.0,,20210426,20210426,DIR,,,FDA-CTU,,31.0,YR,,M,N,,,20210426.0,N,,US,US,2021,Q2,Young Adult
191849881,19184988,4,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Hypoxia,,2021,Q2,1,I,20210404.0,,20210426,20210426,DIR,,,FDA-CTU,,31.0,YR,,M,N,,,20210426.0,N,,US,US,2021,Q2,Young Adult
191849881,19184988,4,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Muscular weakness,,2021,Q2,1,I,20210404.0,,20210426,20210426,DIR,,,FDA-CTU,,31.0,YR,,M,N,,,20210426.0,N,,US,US,2021,Q2,Young Adult
191849881,19184988,4,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Myocarditis,,2021,Q2,1,I,20210404.0,,20210426,20210426,DIR,,,FDA-CTU,,31.0,YR,,M,N,,,20210426.0,N,,US,US,2021,Q2,Young Adult
191849881,19184988,4,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Pulmonary oedema,,2021,Q2,1,I,20210404.0,,20210426,20210426,DIR,,,FDA-CTU,,31.0,YR,,M,N,,,20210426.0,N,,US,US,2021,Q2,Young Adult
191849881,19184988,4,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Syringomyelia,,2021,Q2,1,I,20210404.0,,20210426,20210426,DIR,,,FDA-CTU,,31.0,YR,,M,N,,,20210426.0,N,,US,US,2021,Q2,Young Adult
191858311,19185831,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Hepatic function abnormal,,2021,Q2,1,I,20210418.0,20210422.0,20210427,20210427,EXP,,JP-GILEAD-2021-0526359,GILEAD,,63.0,YR,A,M,Y,74.0,KG,20210427.0,,MD,JP,JP,2021,Q2,Adult
191860051,19186005,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Aphthous ulcer,,2021,Q2,1,I,,20210418.0,20210427,20210427,EXP,,NVSC2021CA090088,NOVARTIS,,84.0,YR,,M,Y,58.0,KG,20210427.0,,HP,CA,CA,2021,Q2,Elderly
191860051,19186005,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,General physical health deterioration,,2021,Q2,1,I,,20210418.0,20210427,20210427,EXP,,NVSC2021CA090088,NOVARTIS,,84.0,YR,,M,Y,58.0,KG,20210427.0,,HP,CA,CA,2021,Q2,Elderly
191860051,19186005,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Herpes simplex test negative,,2021,Q2,1,I,,20210418.0,20210427,20210427,EXP,,NVSC2021CA090088,NOVARTIS,,84.0,YR,,M,Y,58.0,KG,20210427.0,,HP,CA,CA,2021,Q2,Elderly
191860051,19186005,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Hypophagia,,2021,Q2,1,I,,20210418.0,20210427,20210427,EXP,,NVSC2021CA090088,NOVARTIS,,84.0,YR,,M,Y,58.0,KG,20210427.0,,HP,CA,CA,2021,Q2,Elderly
191860051,19186005,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Oral pain,,2021,Q2,1,I,,20210418.0,20210427,20210427,EXP,,NVSC2021CA090088,NOVARTIS,,84.0,YR,,M,Y,58.0,KG,20210427.0,,HP,CA,CA,2021,Q2,Elderly
191860051,19186005,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Oropharyngeal plaque,,2021,Q2,1,I,,20210418.0,20210427,20210427,EXP,,NVSC2021CA090088,NOVARTIS,,84.0,YR,,M,Y,58.0,KG,20210427.0,,HP,CA,CA,2021,Q2,Elderly
191860051,19186005,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Saliva altered,,2021,Q2,1,I,,20210418.0,20210427,20210427,EXP,,NVSC2021CA090088,NOVARTIS,,84.0,YR,,M,Y,58.0,KG,20210427.0,,HP,CA,CA,2021,Q2,Elderly
191945281,19194528,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"HIGH DOSE, MAXIMUM DOSE OF 9 UNITS/KG/H",,,U,U,,,,,,INJECTION,,2021,Q2,Acute kidney injury,,2021,Q2,1,I,,20210421.0,20210429,20210429,EXP,,US-MYLANLABS-2021M1025247,MYLAN,"SALLAM M, PARSRIJA D, PHALTAS R, KOSHEL C, KORUMILLI R, PROUT A, ET AL. HIGH?DOSE INSULIN FOR CALCIUM CHANNEL BLOCKER OVERDOSE IN A PEDIATRIC PATIENT. CRIT?CARE?MED 2021?49 (SUPPL.)(1):193 ABSTR. 408.",15.0,YR,,,Y,,,20210429.0,,HP,US,US,2021,Q2,Youth
191945281,19194528,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"HIGH DOSE, MAXIMUM DOSE OF 9 UNITS/KG/H",,,U,U,,,,,,INJECTION,,2021,Q2,Acute respiratory distress syndrome,,2021,Q2,1,I,,20210421.0,20210429,20210429,EXP,,US-MYLANLABS-2021M1025247,MYLAN,"SALLAM M, PARSRIJA D, PHALTAS R, KOSHEL C, KORUMILLI R, PROUT A, ET AL. HIGH?DOSE INSULIN FOR CALCIUM CHANNEL BLOCKER OVERDOSE IN A PEDIATRIC PATIENT. CRIT?CARE?MED 2021?49 (SUPPL.)(1):193 ABSTR. 408.",15.0,YR,,,Y,,,20210429.0,,HP,US,US,2021,Q2,Youth
191945281,19194528,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"HIGH DOSE, MAXIMUM DOSE OF 9 UNITS/KG/H",,,U,U,,,,,,INJECTION,,2021,Q2,Fluid overload,,2021,Q2,1,I,,20210421.0,20210429,20210429,EXP,,US-MYLANLABS-2021M1025247,MYLAN,"SALLAM M, PARSRIJA D, PHALTAS R, KOSHEL C, KORUMILLI R, PROUT A, ET AL. HIGH?DOSE INSULIN FOR CALCIUM CHANNEL BLOCKER OVERDOSE IN A PEDIATRIC PATIENT. CRIT?CARE?MED 2021?49 (SUPPL.)(1):193 ABSTR. 408.",15.0,YR,,,Y,,,20210429.0,,HP,US,US,2021,Q2,Youth
191945281,19194528,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"HIGH DOSE, MAXIMUM DOSE OF 9 UNITS/KG/H",,,U,U,,,,,,INJECTION,,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,,20210421.0,20210429,20210429,EXP,,US-MYLANLABS-2021M1025247,MYLAN,"SALLAM M, PARSRIJA D, PHALTAS R, KOSHEL C, KORUMILLI R, PROUT A, ET AL. HIGH?DOSE INSULIN FOR CALCIUM CHANNEL BLOCKER OVERDOSE IN A PEDIATRIC PATIENT. CRIT?CARE?MED 2021?49 (SUPPL.)(1):193 ABSTR. 408.",15.0,YR,,,Y,,,20210429.0,,HP,US,US,2021,Q2,Youth
191945281,19194528,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"HIGH DOSE, MAXIMUM DOSE OF 9 UNITS/KG/H",,,U,U,,,,,,INJECTION,,2021,Q2,Metabolic acidosis,,2021,Q2,1,I,,20210421.0,20210429,20210429,EXP,,US-MYLANLABS-2021M1025247,MYLAN,"SALLAM M, PARSRIJA D, PHALTAS R, KOSHEL C, KORUMILLI R, PROUT A, ET AL. HIGH?DOSE INSULIN FOR CALCIUM CHANNEL BLOCKER OVERDOSE IN A PEDIATRIC PATIENT. CRIT?CARE?MED 2021?49 (SUPPL.)(1):193 ABSTR. 408.",15.0,YR,,,Y,,,20210429.0,,HP,US,US,2021,Q2,Youth
191945281,19194528,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"HIGH DOSE, MAXIMUM DOSE OF 9 UNITS/KG/H",,,U,U,,,,,,INJECTION,,2021,Q2,Off label use,,2021,Q2,1,I,,20210421.0,20210429,20210429,EXP,,US-MYLANLABS-2021M1025247,MYLAN,"SALLAM M, PARSRIJA D, PHALTAS R, KOSHEL C, KORUMILLI R, PROUT A, ET AL. HIGH?DOSE INSULIN FOR CALCIUM CHANNEL BLOCKER OVERDOSE IN A PEDIATRIC PATIENT. CRIT?CARE?MED 2021?49 (SUPPL.)(1):193 ABSTR. 408.",15.0,YR,,,Y,,,20210429.0,,HP,US,US,2021,Q2,Youth
191945281,19194528,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"HIGH DOSE, MAXIMUM DOSE OF 9 UNITS/KG/H",,,U,U,,,,,,INJECTION,,2021,Q2,Overdose,,2021,Q2,1,I,,20210421.0,20210429,20210429,EXP,,US-MYLANLABS-2021M1025247,MYLAN,"SALLAM M, PARSRIJA D, PHALTAS R, KOSHEL C, KORUMILLI R, PROUT A, ET AL. HIGH?DOSE INSULIN FOR CALCIUM CHANNEL BLOCKER OVERDOSE IN A PEDIATRIC PATIENT. CRIT?CARE?MED 2021?49 (SUPPL.)(1):193 ABSTR. 408.",15.0,YR,,,Y,,,20210429.0,,HP,US,US,2021,Q2,Youth
191945281,19194528,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"HIGH DOSE, MAXIMUM DOSE OF 9 UNITS/KG/H",,,U,U,,,,,,INJECTION,,2021,Q2,Shock,,2021,Q2,1,I,,20210421.0,20210429,20210429,EXP,,US-MYLANLABS-2021M1025247,MYLAN,"SALLAM M, PARSRIJA D, PHALTAS R, KOSHEL C, KORUMILLI R, PROUT A, ET AL. HIGH?DOSE INSULIN FOR CALCIUM CHANNEL BLOCKER OVERDOSE IN A PEDIATRIC PATIENT. CRIT?CARE?MED 2021?49 (SUPPL.)(1):193 ABSTR. 408.",15.0,YR,,,Y,,,20210429.0,,HP,US,US,2021,Q2,Youth
191945281,19194528,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"HIGH DOSE, MAXIMUM DOSE OF 9 UNITS/KG/H",,,U,U,,,,,,INJECTION,,2021,Q2,Toxicity to various agents,,2021,Q2,1,I,,20210421.0,20210429,20210429,EXP,,US-MYLANLABS-2021M1025247,MYLAN,"SALLAM M, PARSRIJA D, PHALTAS R, KOSHEL C, KORUMILLI R, PROUT A, ET AL. HIGH?DOSE INSULIN FOR CALCIUM CHANNEL BLOCKER OVERDOSE IN A PEDIATRIC PATIENT. CRIT?CARE?MED 2021?49 (SUPPL.)(1):193 ABSTR. 408.",15.0,YR,,,Y,,,20210429.0,,HP,US,US,2021,Q2,Youth
191951682,19195168,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,30 UNITS,,,,,,,,,,,,2021,Q2,Cerebrovascular accident,,2021,Q2,2,F,20210404.0,20210524.0,20210429,20210604,EXP,,AE-UCBSA-2021018271,UCB,,45.0,YR,,F,Y,79.0,KG,20210604.0,,MD,AE,AE,2021,Q2,Adult
191951682,19195168,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,30 UNITS,,,,,,,,,,,,2021,Q2,SARS-CoV-2 test negative,,2021,Q2,2,F,20210404.0,20210524.0,20210429,20210604,EXP,,AE-UCBSA-2021018271,UCB,,45.0,YR,,F,Y,79.0,KG,20210604.0,,MD,AE,AE,2021,Q2,Adult
191975692,19197569,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Asthenia,,2021,Q2,2,F,20201227.0,20210526.0,20210430,20210602,EXP,,US-ABBVIE-21K-163-3864692-00,ABBVIE,,72.0,YR,,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
191975692,19197569,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Brain injury,,2021,Q2,2,F,20201227.0,20210526.0,20210430,20210602,EXP,,US-ABBVIE-21K-163-3864692-00,ABBVIE,,72.0,YR,,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
191975692,19197569,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,COVID-19,,2021,Q2,2,F,20201227.0,20210526.0,20210430,20210602,EXP,,US-ABBVIE-21K-163-3864692-00,ABBVIE,,72.0,YR,,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
191975692,19197569,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Gait disturbance,,2021,Q2,2,F,20201227.0,20210526.0,20210430,20210602,EXP,,US-ABBVIE-21K-163-3864692-00,ABBVIE,,72.0,YR,,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
191975692,19197569,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Infection,,2021,Q2,2,F,20201227.0,20210526.0,20210430,20210602,EXP,,US-ABBVIE-21K-163-3864692-00,ABBVIE,,72.0,YR,,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
191975692,19197569,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Oxygen saturation abnormal,,2021,Q2,2,F,20201227.0,20210526.0,20210430,20210602,EXP,,US-ABBVIE-21K-163-3864692-00,ABBVIE,,72.0,YR,,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
191975692,19197569,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Psoriatic arthropathy,,2021,Q2,2,F,20201227.0,20210526.0,20210430,20210602,EXP,,US-ABBVIE-21K-163-3864692-00,ABBVIE,,72.0,YR,,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
192011752,19201175,4,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,"INJECTION FLUID, 300 UNITS/ML (UNITS PERMILLILITERS)",,,,,,,,,,,,2021,Q2,Acute leukaemia,,2021,Q2,2,F,20210413.0,20210611.0,20210430,20210616,EXP,,NL-ASTRAZENECA-2021A363495,ASTRAZENECA,,61.0,YR,,F,Y,70.0,KG,20210616.0,,MD,NL,NL,2021,Q2,Adult
192011752,19201175,4,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,"INJECTION FLUID, 300 UNITS/ML (UNITS PERMILLILITERS)",,,,,,,,,,,,2021,Q2,Myelodysplastic syndrome,,2021,Q2,2,F,20210413.0,20210611.0,20210430,20210616,EXP,,NL-ASTRAZENECA-2021A363495,ASTRAZENECA,,61.0,YR,,F,Y,70.0,KG,20210616.0,,MD,NL,NL,2021,Q2,Adult
192040982,19204098,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),,,,U,,,,,,,,,2021,Q2,Asthenia,,2021,Q2,2,F,,20210520.0,20210503,20210524,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-100447",BOEHRINGER INGELHEIM,,8.0,DEC,E,M,Y,62.4,KG,20210524.0,,MD,JP,JP,2021,Q2,Child
192040982,19204098,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),,,,U,,,,,,,,,2021,Q2,Pyrexia,,2021,Q2,2,F,,20210520.0,20210503,20210524,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-100447",BOEHRINGER INGELHEIM,,8.0,DEC,E,M,Y,62.4,KG,20210524.0,,MD,JP,JP,2021,Q2,Child
192040982,19204098,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),,,,U,,,,,,,,,2021,Q2,Sepsis,,2021,Q2,2,F,,20210520.0,20210503,20210524,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-100447",BOEHRINGER INGELHEIM,,8.0,DEC,E,M,Y,62.4,KG,20210524.0,,MD,JP,JP,2021,Q2,Child
192040982,19204098,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),,,,U,,,,,,,,,2021,Q2,Urinary retention,,2021,Q2,2,F,,20210520.0,20210503,20210524,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-100447",BOEHRINGER INGELHEIM,,8.0,DEC,E,M,Y,62.4,KG,20210524.0,,MD,JP,JP,2021,Q2,Child
192062732,19206273,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Blood glucose increased,,2021,Q2,2,F,202102.0,20210507.0,20210503,20210518,EXP,,ES-AUROBINDO-AUR-APL-2021-017535,AUROBINDO,,71.0,YR,,F,Y,92.0,KG,20210518.0,,CN,ES,ES,2021,Q2,Elderly
192062732,19206273,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Cardiovascular disorder,,2021,Q2,2,F,202102.0,20210507.0,20210503,20210518,EXP,,ES-AUROBINDO-AUR-APL-2021-017535,AUROBINDO,,71.0,YR,,F,Y,92.0,KG,20210518.0,,CN,ES,ES,2021,Q2,Elderly
192062732,19206273,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Decreased appetite,,2021,Q2,2,F,202102.0,20210507.0,20210503,20210518,EXP,,ES-AUROBINDO-AUR-APL-2021-017535,AUROBINDO,,71.0,YR,,F,Y,92.0,KG,20210518.0,,CN,ES,ES,2021,Q2,Elderly
192062732,19206273,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Discomfort,,2021,Q2,2,F,202102.0,20210507.0,20210503,20210518,EXP,,ES-AUROBINDO-AUR-APL-2021-017535,AUROBINDO,,71.0,YR,,F,Y,92.0,KG,20210518.0,,CN,ES,ES,2021,Q2,Elderly
192062732,19206273,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Dizziness,,2021,Q2,2,F,202102.0,20210507.0,20210503,20210518,EXP,,ES-AUROBINDO-AUR-APL-2021-017535,AUROBINDO,,71.0,YR,,F,Y,92.0,KG,20210518.0,,CN,ES,ES,2021,Q2,Elderly
192062732,19206273,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Flatulence,,2021,Q2,2,F,202102.0,20210507.0,20210503,20210518,EXP,,ES-AUROBINDO-AUR-APL-2021-017535,AUROBINDO,,71.0,YR,,F,Y,92.0,KG,20210518.0,,CN,ES,ES,2021,Q2,Elderly
192062732,19206273,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Illness,,2021,Q2,2,F,202102.0,20210507.0,20210503,20210518,EXP,,ES-AUROBINDO-AUR-APL-2021-017535,AUROBINDO,,71.0,YR,,F,Y,92.0,KG,20210518.0,,CN,ES,ES,2021,Q2,Elderly
192062732,19206273,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Inappropriate schedule of product administration,,2021,Q2,2,F,202102.0,20210507.0,20210503,20210518,EXP,,ES-AUROBINDO-AUR-APL-2021-017535,AUROBINDO,,71.0,YR,,F,Y,92.0,KG,20210518.0,,CN,ES,ES,2021,Q2,Elderly
192062732,19206273,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Nausea,,2021,Q2,2,F,202102.0,20210507.0,20210503,20210518,EXP,,ES-AUROBINDO-AUR-APL-2021-017535,AUROBINDO,,71.0,YR,,F,Y,92.0,KG,20210518.0,,CN,ES,ES,2021,Q2,Elderly
192062732,19206273,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Osteoporosis,,2021,Q2,2,F,202102.0,20210507.0,20210503,20210518,EXP,,ES-AUROBINDO-AUR-APL-2021-017535,AUROBINDO,,71.0,YR,,F,Y,92.0,KG,20210518.0,,CN,ES,ES,2021,Q2,Elderly
192062732,19206273,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Paraesthesia,,2021,Q2,2,F,202102.0,20210507.0,20210503,20210518,EXP,,ES-AUROBINDO-AUR-APL-2021-017535,AUROBINDO,,71.0,YR,,F,Y,92.0,KG,20210518.0,,CN,ES,ES,2021,Q2,Elderly
192062732,19206273,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Urinary tract infection,,2021,Q2,2,F,202102.0,20210507.0,20210503,20210518,EXP,,ES-AUROBINDO-AUR-APL-2021-017535,AUROBINDO,,71.0,YR,,F,Y,92.0,KG,20210518.0,,CN,ES,ES,2021,Q2,Elderly
192062732,19206273,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Weight decreased,,2021,Q2,2,F,202102.0,20210507.0,20210503,20210518,EXP,,ES-AUROBINDO-AUR-APL-2021-017535,AUROBINDO,,71.0,YR,,F,Y,92.0,KG,20210518.0,,CN,ES,ES,2021,Q2,Elderly
192062732,19206273,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, ONCE A DAY(DOSE INCREASED )",,,D,, DF784A,,,,,SOLUTION FOR INJECTION,QD,2021,Q2,Blood glucose increased,,2021,Q2,2,F,202102.0,20210507.0,20210503,20210518,EXP,,ES-AUROBINDO-AUR-APL-2021-017535,AUROBINDO,,71.0,YR,,F,Y,92.0,KG,20210518.0,,CN,ES,ES,2021,Q2,Elderly
192062732,19206273,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, ONCE A DAY(DOSE INCREASED )",,,D,, DF784A,,,,,SOLUTION FOR INJECTION,QD,2021,Q2,Cardiovascular disorder,,2021,Q2,2,F,202102.0,20210507.0,20210503,20210518,EXP,,ES-AUROBINDO-AUR-APL-2021-017535,AUROBINDO,,71.0,YR,,F,Y,92.0,KG,20210518.0,,CN,ES,ES,2021,Q2,Elderly
192062732,19206273,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, ONCE A DAY(DOSE INCREASED )",,,D,, DF784A,,,,,SOLUTION FOR INJECTION,QD,2021,Q2,Decreased appetite,,2021,Q2,2,F,202102.0,20210507.0,20210503,20210518,EXP,,ES-AUROBINDO-AUR-APL-2021-017535,AUROBINDO,,71.0,YR,,F,Y,92.0,KG,20210518.0,,CN,ES,ES,2021,Q2,Elderly
192062732,19206273,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, ONCE A DAY(DOSE INCREASED )",,,D,, DF784A,,,,,SOLUTION FOR INJECTION,QD,2021,Q2,Discomfort,,2021,Q2,2,F,202102.0,20210507.0,20210503,20210518,EXP,,ES-AUROBINDO-AUR-APL-2021-017535,AUROBINDO,,71.0,YR,,F,Y,92.0,KG,20210518.0,,CN,ES,ES,2021,Q2,Elderly
192062732,19206273,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, ONCE A DAY(DOSE INCREASED )",,,D,, DF784A,,,,,SOLUTION FOR INJECTION,QD,2021,Q2,Dizziness,,2021,Q2,2,F,202102.0,20210507.0,20210503,20210518,EXP,,ES-AUROBINDO-AUR-APL-2021-017535,AUROBINDO,,71.0,YR,,F,Y,92.0,KG,20210518.0,,CN,ES,ES,2021,Q2,Elderly
192062732,19206273,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, ONCE A DAY(DOSE INCREASED )",,,D,, DF784A,,,,,SOLUTION FOR INJECTION,QD,2021,Q2,Flatulence,,2021,Q2,2,F,202102.0,20210507.0,20210503,20210518,EXP,,ES-AUROBINDO-AUR-APL-2021-017535,AUROBINDO,,71.0,YR,,F,Y,92.0,KG,20210518.0,,CN,ES,ES,2021,Q2,Elderly
192062732,19206273,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, ONCE A DAY(DOSE INCREASED )",,,D,, DF784A,,,,,SOLUTION FOR INJECTION,QD,2021,Q2,Illness,,2021,Q2,2,F,202102.0,20210507.0,20210503,20210518,EXP,,ES-AUROBINDO-AUR-APL-2021-017535,AUROBINDO,,71.0,YR,,F,Y,92.0,KG,20210518.0,,CN,ES,ES,2021,Q2,Elderly
192062732,19206273,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, ONCE A DAY(DOSE INCREASED )",,,D,, DF784A,,,,,SOLUTION FOR INJECTION,QD,2021,Q2,Inappropriate schedule of product administration,,2021,Q2,2,F,202102.0,20210507.0,20210503,20210518,EXP,,ES-AUROBINDO-AUR-APL-2021-017535,AUROBINDO,,71.0,YR,,F,Y,92.0,KG,20210518.0,,CN,ES,ES,2021,Q2,Elderly
192062732,19206273,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, ONCE A DAY(DOSE INCREASED )",,,D,, DF784A,,,,,SOLUTION FOR INJECTION,QD,2021,Q2,Nausea,,2021,Q2,2,F,202102.0,20210507.0,20210503,20210518,EXP,,ES-AUROBINDO-AUR-APL-2021-017535,AUROBINDO,,71.0,YR,,F,Y,92.0,KG,20210518.0,,CN,ES,ES,2021,Q2,Elderly
192062732,19206273,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, ONCE A DAY(DOSE INCREASED )",,,D,, DF784A,,,,,SOLUTION FOR INJECTION,QD,2021,Q2,Osteoporosis,,2021,Q2,2,F,202102.0,20210507.0,20210503,20210518,EXP,,ES-AUROBINDO-AUR-APL-2021-017535,AUROBINDO,,71.0,YR,,F,Y,92.0,KG,20210518.0,,CN,ES,ES,2021,Q2,Elderly
192062732,19206273,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, ONCE A DAY(DOSE INCREASED )",,,D,, DF784A,,,,,SOLUTION FOR INJECTION,QD,2021,Q2,Paraesthesia,,2021,Q2,2,F,202102.0,20210507.0,20210503,20210518,EXP,,ES-AUROBINDO-AUR-APL-2021-017535,AUROBINDO,,71.0,YR,,F,Y,92.0,KG,20210518.0,,CN,ES,ES,2021,Q2,Elderly
192062732,19206273,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, ONCE A DAY(DOSE INCREASED )",,,D,, DF784A,,,,,SOLUTION FOR INJECTION,QD,2021,Q2,Urinary tract infection,,2021,Q2,2,F,202102.0,20210507.0,20210503,20210518,EXP,,ES-AUROBINDO-AUR-APL-2021-017535,AUROBINDO,,71.0,YR,,F,Y,92.0,KG,20210518.0,,CN,ES,ES,2021,Q2,Elderly
192062732,19206273,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, ONCE A DAY(DOSE INCREASED )",,,D,, DF784A,,,,,SOLUTION FOR INJECTION,QD,2021,Q2,Weight decreased,,2021,Q2,2,F,202102.0,20210507.0,20210503,20210518,EXP,,ES-AUROBINDO-AUR-APL-2021-017535,AUROBINDO,,71.0,YR,,F,Y,92.0,KG,20210518.0,,CN,ES,ES,2021,Q2,Elderly
192066681,19206668,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Bradycardia,,2021,Q2,1,I,20200426.0,20200428.0,20210430,20210430,EXP,,US-GILEAD-2020-0463184,GILEAD,,64.0,YR,,M,Y,94.8,KG,20210430.0,,HP,US,US,2021,Q2,Adult
192066681,19206668,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,COVID-19,,2021,Q2,1,I,20200426.0,20200428.0,20210430,20210430,EXP,,US-GILEAD-2020-0463184,GILEAD,,64.0,YR,,M,Y,94.8,KG,20210430.0,,HP,US,US,2021,Q2,Adult
192066681,19206668,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Cardiac arrest,,2021,Q2,1,I,20200426.0,20200428.0,20210430,20210430,EXP,,US-GILEAD-2020-0463184,GILEAD,,64.0,YR,,M,Y,94.8,KG,20210430.0,,HP,US,US,2021,Q2,Adult
192066681,19206668,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Hypertension,,2021,Q2,1,I,20200426.0,20200428.0,20210430,20210430,EXP,,US-GILEAD-2020-0463184,GILEAD,,64.0,YR,,M,Y,94.8,KG,20210430.0,,HP,US,US,2021,Q2,Adult
192066681,19206668,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Tachycardia,,2021,Q2,1,I,20200426.0,20200428.0,20210430,20210430,EXP,,US-GILEAD-2020-0463184,GILEAD,,64.0,YR,,M,Y,94.8,KG,20210430.0,,HP,US,US,2021,Q2,Adult
192066681,19206668,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Tremor,,2021,Q2,1,I,20200426.0,20200428.0,20210430,20210430,EXP,,US-GILEAD-2020-0463184,GILEAD,,64.0,YR,,M,Y,94.8,KG,20210430.0,,HP,US,US,2021,Q2,Adult
192066681,19206668,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,20 UNITS Q AM,,,,,,,,,,,,2021,Q2,Bradycardia,,2021,Q2,1,I,20200426.0,20200428.0,20210430,20210430,EXP,,US-GILEAD-2020-0463184,GILEAD,,64.0,YR,,M,Y,94.8,KG,20210430.0,,HP,US,US,2021,Q2,Adult
192066681,19206668,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,20 UNITS Q AM,,,,,,,,,,,,2021,Q2,COVID-19,,2021,Q2,1,I,20200426.0,20200428.0,20210430,20210430,EXP,,US-GILEAD-2020-0463184,GILEAD,,64.0,YR,,M,Y,94.8,KG,20210430.0,,HP,US,US,2021,Q2,Adult
192066681,19206668,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,20 UNITS Q AM,,,,,,,,,,,,2021,Q2,Cardiac arrest,,2021,Q2,1,I,20200426.0,20200428.0,20210430,20210430,EXP,,US-GILEAD-2020-0463184,GILEAD,,64.0,YR,,M,Y,94.8,KG,20210430.0,,HP,US,US,2021,Q2,Adult
192066681,19206668,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,20 UNITS Q AM,,,,,,,,,,,,2021,Q2,Hypertension,,2021,Q2,1,I,20200426.0,20200428.0,20210430,20210430,EXP,,US-GILEAD-2020-0463184,GILEAD,,64.0,YR,,M,Y,94.8,KG,20210430.0,,HP,US,US,2021,Q2,Adult
192066681,19206668,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,20 UNITS Q AM,,,,,,,,,,,,2021,Q2,Tachycardia,,2021,Q2,1,I,20200426.0,20200428.0,20210430,20210430,EXP,,US-GILEAD-2020-0463184,GILEAD,,64.0,YR,,M,Y,94.8,KG,20210430.0,,HP,US,US,2021,Q2,Adult
192066681,19206668,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,20 UNITS Q AM,,,,,,,,,,,,2021,Q2,Tremor,,2021,Q2,1,I,20200426.0,20200428.0,20210430,20210430,EXP,,US-GILEAD-2020-0463184,GILEAD,,64.0,YR,,M,Y,94.8,KG,20210430.0,,HP,US,US,2021,Q2,Adult
192066681,19206668,27,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML,,,,,,,,,,,,2021,Q2,Bradycardia,,2021,Q2,1,I,20200426.0,20200428.0,20210430,20210430,EXP,,US-GILEAD-2020-0463184,GILEAD,,64.0,YR,,M,Y,94.8,KG,20210430.0,,HP,US,US,2021,Q2,Adult
192066681,19206668,27,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML,,,,,,,,,,,,2021,Q2,COVID-19,,2021,Q2,1,I,20200426.0,20200428.0,20210430,20210430,EXP,,US-GILEAD-2020-0463184,GILEAD,,64.0,YR,,M,Y,94.8,KG,20210430.0,,HP,US,US,2021,Q2,Adult
192066681,19206668,27,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML,,,,,,,,,,,,2021,Q2,Cardiac arrest,,2021,Q2,1,I,20200426.0,20200428.0,20210430,20210430,EXP,,US-GILEAD-2020-0463184,GILEAD,,64.0,YR,,M,Y,94.8,KG,20210430.0,,HP,US,US,2021,Q2,Adult
192066681,19206668,27,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML,,,,,,,,,,,,2021,Q2,Hypertension,,2021,Q2,1,I,20200426.0,20200428.0,20210430,20210430,EXP,,US-GILEAD-2020-0463184,GILEAD,,64.0,YR,,M,Y,94.8,KG,20210430.0,,HP,US,US,2021,Q2,Adult
192066681,19206668,27,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML,,,,,,,,,,,,2021,Q2,Tachycardia,,2021,Q2,1,I,20200426.0,20200428.0,20210430,20210430,EXP,,US-GILEAD-2020-0463184,GILEAD,,64.0,YR,,M,Y,94.8,KG,20210430.0,,HP,US,US,2021,Q2,Adult
192066681,19206668,27,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML,,,,,,,,,,,,2021,Q2,Tremor,,2021,Q2,1,I,20200426.0,20200428.0,20210430,20210430,EXP,,US-GILEAD-2020-0463184,GILEAD,,64.0,YR,,M,Y,94.8,KG,20210430.0,,HP,US,US,2021,Q2,Adult
192066681,19206668,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q2,Bradycardia,,2021,Q2,1,I,20200426.0,20200428.0,20210430,20210430,EXP,,US-GILEAD-2020-0463184,GILEAD,,64.0,YR,,M,Y,94.8,KG,20210430.0,,HP,US,US,2021,Q2,Adult
192066681,19206668,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q2,COVID-19,,2021,Q2,1,I,20200426.0,20200428.0,20210430,20210430,EXP,,US-GILEAD-2020-0463184,GILEAD,,64.0,YR,,M,Y,94.8,KG,20210430.0,,HP,US,US,2021,Q2,Adult
192066681,19206668,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q2,Cardiac arrest,,2021,Q2,1,I,20200426.0,20200428.0,20210430,20210430,EXP,,US-GILEAD-2020-0463184,GILEAD,,64.0,YR,,M,Y,94.8,KG,20210430.0,,HP,US,US,2021,Q2,Adult
192066681,19206668,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q2,Hypertension,,2021,Q2,1,I,20200426.0,20200428.0,20210430,20210430,EXP,,US-GILEAD-2020-0463184,GILEAD,,64.0,YR,,M,Y,94.8,KG,20210430.0,,HP,US,US,2021,Q2,Adult
192066681,19206668,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q2,Tachycardia,,2021,Q2,1,I,20200426.0,20200428.0,20210430,20210430,EXP,,US-GILEAD-2020-0463184,GILEAD,,64.0,YR,,M,Y,94.8,KG,20210430.0,,HP,US,US,2021,Q2,Adult
192066681,19206668,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q2,Tremor,,2021,Q2,1,I,20200426.0,20200428.0,20210430,20210430,EXP,,US-GILEAD-2020-0463184,GILEAD,,64.0,YR,,M,Y,94.8,KG,20210430.0,,HP,US,US,2021,Q2,Adult
192093412,19209341,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, DAILY",,,U,,,,,18.0,IU,,QD,2021,Q2,Blood glucose increased,,2021,Q2,2,F,202102.0,20210507.0,20210503,20210518,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104009832,ELI LILLY AND CO,,71.0,YR,,F,Y,92.0,KG,20210518.0,,CN,ES,ES,2021,Q2,Elderly
192093412,19209341,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, DAILY",,,U,,,,,18.0,IU,,QD,2021,Q2,Cardiovascular disorder,,2021,Q2,2,F,202102.0,20210507.0,20210503,20210518,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104009832,ELI LILLY AND CO,,71.0,YR,,F,Y,92.0,KG,20210518.0,,CN,ES,ES,2021,Q2,Elderly
192093412,19209341,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, DAILY",,,U,,,,,18.0,IU,,QD,2021,Q2,Decreased appetite,,2021,Q2,2,F,202102.0,20210507.0,20210503,20210518,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104009832,ELI LILLY AND CO,,71.0,YR,,F,Y,92.0,KG,20210518.0,,CN,ES,ES,2021,Q2,Elderly
192093412,19209341,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, DAILY",,,U,,,,,18.0,IU,,QD,2021,Q2,Discomfort,,2021,Q2,2,F,202102.0,20210507.0,20210503,20210518,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104009832,ELI LILLY AND CO,,71.0,YR,,F,Y,92.0,KG,20210518.0,,CN,ES,ES,2021,Q2,Elderly
192093412,19209341,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, DAILY",,,U,,,,,18.0,IU,,QD,2021,Q2,Dizziness,,2021,Q2,2,F,202102.0,20210507.0,20210503,20210518,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104009832,ELI LILLY AND CO,,71.0,YR,,F,Y,92.0,KG,20210518.0,,CN,ES,ES,2021,Q2,Elderly
192093412,19209341,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, DAILY",,,U,,,,,18.0,IU,,QD,2021,Q2,Flatulence,,2021,Q2,2,F,202102.0,20210507.0,20210503,20210518,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104009832,ELI LILLY AND CO,,71.0,YR,,F,Y,92.0,KG,20210518.0,,CN,ES,ES,2021,Q2,Elderly
192093412,19209341,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, DAILY",,,U,,,,,18.0,IU,,QD,2021,Q2,Illness,,2021,Q2,2,F,202102.0,20210507.0,20210503,20210518,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104009832,ELI LILLY AND CO,,71.0,YR,,F,Y,92.0,KG,20210518.0,,CN,ES,ES,2021,Q2,Elderly
192093412,19209341,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, DAILY",,,U,,,,,18.0,IU,,QD,2021,Q2,Inappropriate schedule of product administration,,2021,Q2,2,F,202102.0,20210507.0,20210503,20210518,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104009832,ELI LILLY AND CO,,71.0,YR,,F,Y,92.0,KG,20210518.0,,CN,ES,ES,2021,Q2,Elderly
192093412,19209341,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, DAILY",,,U,,,,,18.0,IU,,QD,2021,Q2,Nausea,,2021,Q2,2,F,202102.0,20210507.0,20210503,20210518,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104009832,ELI LILLY AND CO,,71.0,YR,,F,Y,92.0,KG,20210518.0,,CN,ES,ES,2021,Q2,Elderly
192093412,19209341,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, DAILY",,,U,,,,,18.0,IU,,QD,2021,Q2,Osteoporosis,,2021,Q2,2,F,202102.0,20210507.0,20210503,20210518,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104009832,ELI LILLY AND CO,,71.0,YR,,F,Y,92.0,KG,20210518.0,,CN,ES,ES,2021,Q2,Elderly
192093412,19209341,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, DAILY",,,U,,,,,18.0,IU,,QD,2021,Q2,Paraesthesia,,2021,Q2,2,F,202102.0,20210507.0,20210503,20210518,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104009832,ELI LILLY AND CO,,71.0,YR,,F,Y,92.0,KG,20210518.0,,CN,ES,ES,2021,Q2,Elderly
192093412,19209341,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, DAILY",,,U,,,,,18.0,IU,,QD,2021,Q2,Urinary tract infection,,2021,Q2,2,F,202102.0,20210507.0,20210503,20210518,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104009832,ELI LILLY AND CO,,71.0,YR,,F,Y,92.0,KG,20210518.0,,CN,ES,ES,2021,Q2,Elderly
192093412,19209341,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, DAILY",,,U,,,,,18.0,IU,,QD,2021,Q2,Weight decreased,,2021,Q2,2,F,202102.0,20210507.0,20210503,20210518,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104009832,ELI LILLY AND CO,,71.0,YR,,F,Y,92.0,KG,20210518.0,,CN,ES,ES,2021,Q2,Elderly
192117941,19211794,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 IE, 1?0?0?0",,,,,,,,,,,,2021,Q2,Decreased appetite,,2021,Q2,1,I,,20210422.0,20210504,20210504,EXP,DE-BFARM-21002300,DE-ACCORD-224153,ACCORD,,90.0,YR,E,M,Y,,,20210504.0,,MD,DE,DE,2021,Q2,Elderly
192117941,19211794,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 IE, 1?0?0?0",,,,,,,,,,,,2021,Q2,Diarrhoea,,2021,Q2,1,I,,20210422.0,20210504,20210504,EXP,DE-BFARM-21002300,DE-ACCORD-224153,ACCORD,,90.0,YR,E,M,Y,,,20210504.0,,MD,DE,DE,2021,Q2,Elderly
192117941,19211794,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 IE, 1?0?0?0",,,,,,,,,,,,2021,Q2,Dizziness,,2021,Q2,1,I,,20210422.0,20210504,20210504,EXP,DE-BFARM-21002300,DE-ACCORD-224153,ACCORD,,90.0,YR,E,M,Y,,,20210504.0,,MD,DE,DE,2021,Q2,Elderly
192165231,19216523,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Acute myocardial infarction,,2021,Q2,1,I,20210417.0,20210503.0,20210505,20210505,EXP,GB-MHRA-EYC 00249358,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-101554",BOEHRINGER INGELHEIM,,56.0,YR,A,F,Y,63.5,KG,20210505.0,,PH,GB,GB,2021,Q2,Adult
192165231,19216523,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,COVID-19,,2021,Q2,1,I,20210417.0,20210503.0,20210505,20210505,EXP,GB-MHRA-EYC 00249358,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-101554",BOEHRINGER INGELHEIM,,56.0,YR,A,F,Y,63.5,KG,20210505.0,,PH,GB,GB,2021,Q2,Adult
192165231,19216523,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Diabetic ketoacidosis,,2021,Q2,1,I,20210417.0,20210503.0,20210505,20210505,EXP,GB-MHRA-EYC 00249358,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-101554",BOEHRINGER INGELHEIM,,56.0,YR,A,F,Y,63.5,KG,20210505.0,,PH,GB,GB,2021,Q2,Adult
192165231,19216523,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Pulmonary embolism,,2021,Q2,1,I,20210417.0,20210503.0,20210505,20210505,EXP,GB-MHRA-EYC 00249358,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-101554",BOEHRINGER INGELHEIM,,56.0,YR,A,F,Y,63.5,KG,20210505.0,,PH,GB,GB,2021,Q2,Adult
192165231,19216523,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Respiratory failure,,2021,Q2,1,I,20210417.0,20210503.0,20210505,20210505,EXP,GB-MHRA-EYC 00249358,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-101554",BOEHRINGER INGELHEIM,,56.0,YR,A,F,Y,63.5,KG,20210505.0,,PH,GB,GB,2021,Q2,Adult
192165231,19216523,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Sepsis,,2021,Q2,1,I,20210417.0,20210503.0,20210505,20210505,EXP,GB-MHRA-EYC 00249358,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-101554",BOEHRINGER INGELHEIM,,56.0,YR,A,F,Y,63.5,KG,20210505.0,,PH,GB,GB,2021,Q2,Adult
192174231,19217423,18,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,50 UNITS INTO THE SKIN NIGHTLY,,,,,,,,,,PEN,QD,2021,Q2,Arthralgia,,2021,Q2,1,I,20210226.0,20210302.0,20210505,20210505,PER,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-21-01058,HIKMA,,65.0,YR,,F,Y,,,20210505.0,,CN,US,US,2021,Q2,Elderly
192174231,19217423,18,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,50 UNITS INTO THE SKIN NIGHTLY,,,,,,,,,,PEN,QD,2021,Q2,Gait inability,,2021,Q2,1,I,20210226.0,20210302.0,20210505,20210505,PER,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-21-01058,HIKMA,,65.0,YR,,F,Y,,,20210505.0,,CN,US,US,2021,Q2,Elderly
192184141,19218414,10,C,INSULIN GLARGINE BS [BIOSIMILAR 1],,2,Subcutaneous,DOSE AND FREQUENCY UNKNOWN,,,,,,,,,,INJECTION,,2021,Q2,Back pain,,2021,Q2,1,I,20210422.0,20210427.0,20210505,20210505,PER,,JP-EISAI MEDICAL RESEARCH-EC-2021-092107,EISAI,,68.0,YR,E,M,Y,78.0,KG,20210505.0,,PH,JP,JP,2021,Q2,Elderly
192184141,19218414,10,C,INSULIN GLARGINE BS [BIOSIMILAR 1],,2,Subcutaneous,DOSE AND FREQUENCY UNKNOWN,,,,,,,,,,INJECTION,,2021,Q2,Glomerular filtration rate decreased,,2021,Q2,1,I,20210422.0,20210427.0,20210505,20210505,PER,,JP-EISAI MEDICAL RESEARCH-EC-2021-092107,EISAI,,68.0,YR,E,M,Y,78.0,KG,20210505.0,,PH,JP,JP,2021,Q2,Elderly
192184141,19218414,10,C,INSULIN GLARGINE BS [BIOSIMILAR 1],,2,Subcutaneous,DOSE AND FREQUENCY UNKNOWN,,,,,,,,,,INJECTION,,2021,Q2,Pain in extremity,,2021,Q2,1,I,20210422.0,20210427.0,20210505,20210505,PER,,JP-EISAI MEDICAL RESEARCH-EC-2021-092107,EISAI,,68.0,YR,E,M,Y,78.0,KG,20210505.0,,PH,JP,JP,2021,Q2,Elderly
192185561,19218556,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"420 U, QD",,,D,,,,21081.0,,,,QD,2021,Q2,Diabetic hyperosmolar coma,,2021,Q2,1,I,,20210419.0,20210505,20210505,EXP,,TR-SA-2021SA135183,SANOFI AVENTIS,MEHMET EMRE ATABEK AND OZGUR PIRGON. SOME EFFECT OF METFORMIN ON INSULIN RESISTANCE IN AN INFANT WITH LEPRECHAUNISM. JOURNAL OF PEDIATRIC ENDOCRINOLOGY + METABOLISM. 2006?19:1257?1261,30.0,DY,I,M,Y,,,20210505.0,,HP,TR,TR,2021,Q2,Young Adult
192185561,19218556,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"420 U, QD",,,D,,,,21081.0,,,,QD,2021,Q2,Drug ineffective,,2021,Q2,1,I,,20210419.0,20210505,20210505,EXP,,TR-SA-2021SA135183,SANOFI AVENTIS,MEHMET EMRE ATABEK AND OZGUR PIRGON. SOME EFFECT OF METFORMIN ON INSULIN RESISTANCE IN AN INFANT WITH LEPRECHAUNISM. JOURNAL OF PEDIATRIC ENDOCRINOLOGY + METABOLISM. 2006?19:1257?1261,30.0,DY,I,M,Y,,,20210505.0,,HP,TR,TR,2021,Q2,Young Adult
192185561,19218556,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"420 U, QD",,,D,,,,21081.0,,,,QD,2021,Q2,Hyperglycaemia,,2021,Q2,1,I,,20210419.0,20210505,20210505,EXP,,TR-SA-2021SA135183,SANOFI AVENTIS,MEHMET EMRE ATABEK AND OZGUR PIRGON. SOME EFFECT OF METFORMIN ON INSULIN RESISTANCE IN AN INFANT WITH LEPRECHAUNISM. JOURNAL OF PEDIATRIC ENDOCRINOLOGY + METABOLISM. 2006?19:1257?1261,30.0,DY,I,M,Y,,,20210505.0,,HP,TR,TR,2021,Q2,Young Adult
192185561,19218556,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,10 IU/KG,,,D,,,,21081.0,10.0,IU/KG,,,2021,Q2,Diabetic hyperosmolar coma,,2021,Q2,1,I,,20210419.0,20210505,20210505,EXP,,TR-SA-2021SA135183,SANOFI AVENTIS,MEHMET EMRE ATABEK AND OZGUR PIRGON. SOME EFFECT OF METFORMIN ON INSULIN RESISTANCE IN AN INFANT WITH LEPRECHAUNISM. JOURNAL OF PEDIATRIC ENDOCRINOLOGY + METABOLISM. 2006?19:1257?1261,30.0,DY,I,M,Y,,,20210505.0,,HP,TR,TR,2021,Q2,Young Adult
192185561,19218556,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,10 IU/KG,,,D,,,,21081.0,10.0,IU/KG,,,2021,Q2,Drug ineffective,,2021,Q2,1,I,,20210419.0,20210505,20210505,EXP,,TR-SA-2021SA135183,SANOFI AVENTIS,MEHMET EMRE ATABEK AND OZGUR PIRGON. SOME EFFECT OF METFORMIN ON INSULIN RESISTANCE IN AN INFANT WITH LEPRECHAUNISM. JOURNAL OF PEDIATRIC ENDOCRINOLOGY + METABOLISM. 2006?19:1257?1261,30.0,DY,I,M,Y,,,20210505.0,,HP,TR,TR,2021,Q2,Young Adult
192185561,19218556,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,10 IU/KG,,,D,,,,21081.0,10.0,IU/KG,,,2021,Q2,Hyperglycaemia,,2021,Q2,1,I,,20210419.0,20210505,20210505,EXP,,TR-SA-2021SA135183,SANOFI AVENTIS,MEHMET EMRE ATABEK AND OZGUR PIRGON. SOME EFFECT OF METFORMIN ON INSULIN RESISTANCE IN AN INFANT WITH LEPRECHAUNISM. JOURNAL OF PEDIATRIC ENDOCRINOLOGY + METABOLISM. 2006?19:1257?1261,30.0,DY,I,M,Y,,,20210505.0,,HP,TR,TR,2021,Q2,Young Adult
192213732,19221373,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Blood glucose increased,,2021,Q2,2,F,202102.0,20210509.0,20210505,20210520,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210520.0,,HP,ES,ES,2021,Q2,Elderly
192213732,19221373,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Cardiovascular disorder,,2021,Q2,2,F,202102.0,20210509.0,20210505,20210520,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210520.0,,HP,ES,ES,2021,Q2,Elderly
192213732,19221373,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Decreased appetite,,2021,Q2,2,F,202102.0,20210509.0,20210505,20210520,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210520.0,,HP,ES,ES,2021,Q2,Elderly
192213732,19221373,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Discomfort,,2021,Q2,2,F,202102.0,20210509.0,20210505,20210520,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210520.0,,HP,ES,ES,2021,Q2,Elderly
192213732,19221373,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Dizziness,,2021,Q2,2,F,202102.0,20210509.0,20210505,20210520,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210520.0,,HP,ES,ES,2021,Q2,Elderly
192213732,19221373,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Flatulence,,2021,Q2,2,F,202102.0,20210509.0,20210505,20210520,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210520.0,,HP,ES,ES,2021,Q2,Elderly
192213732,19221373,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Illness,,2021,Q2,2,F,202102.0,20210509.0,20210505,20210520,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210520.0,,HP,ES,ES,2021,Q2,Elderly
192213732,19221373,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Inappropriate schedule of product administration,,2021,Q2,2,F,202102.0,20210509.0,20210505,20210520,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210520.0,,HP,ES,ES,2021,Q2,Elderly
192213732,19221373,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Nausea,,2021,Q2,2,F,202102.0,20210509.0,20210505,20210520,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210520.0,,HP,ES,ES,2021,Q2,Elderly
192213732,19221373,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Osteoporosis,,2021,Q2,2,F,202102.0,20210509.0,20210505,20210520,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210520.0,,HP,ES,ES,2021,Q2,Elderly
192213732,19221373,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Paraesthesia,,2021,Q2,2,F,202102.0,20210509.0,20210505,20210520,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210520.0,,HP,ES,ES,2021,Q2,Elderly
192213732,19221373,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Urinary tract infection,,2021,Q2,2,F,202102.0,20210509.0,20210505,20210520,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210520.0,,HP,ES,ES,2021,Q2,Elderly
192213732,19221373,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Weight decreased,,2021,Q2,2,F,202102.0,20210509.0,20210505,20210520,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210520.0,,HP,ES,ES,2021,Q2,Elderly
192213732,19221373,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, DF784A,,,,,SOLUTION FOR INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,2,F,202102.0,20210509.0,20210505,20210520,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210520.0,,HP,ES,ES,2021,Q2,Elderly
192213732,19221373,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, DF784A,,,,,SOLUTION FOR INJECTION,,2021,Q2,Cardiovascular disorder,,2021,Q2,2,F,202102.0,20210509.0,20210505,20210520,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210520.0,,HP,ES,ES,2021,Q2,Elderly
192213732,19221373,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, DF784A,,,,,SOLUTION FOR INJECTION,,2021,Q2,Decreased appetite,,2021,Q2,2,F,202102.0,20210509.0,20210505,20210520,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210520.0,,HP,ES,ES,2021,Q2,Elderly
192213732,19221373,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, DF784A,,,,,SOLUTION FOR INJECTION,,2021,Q2,Discomfort,,2021,Q2,2,F,202102.0,20210509.0,20210505,20210520,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210520.0,,HP,ES,ES,2021,Q2,Elderly
192213732,19221373,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, DF784A,,,,,SOLUTION FOR INJECTION,,2021,Q2,Dizziness,,2021,Q2,2,F,202102.0,20210509.0,20210505,20210520,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210520.0,,HP,ES,ES,2021,Q2,Elderly
192213732,19221373,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, DF784A,,,,,SOLUTION FOR INJECTION,,2021,Q2,Flatulence,,2021,Q2,2,F,202102.0,20210509.0,20210505,20210520,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210520.0,,HP,ES,ES,2021,Q2,Elderly
192213732,19221373,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, DF784A,,,,,SOLUTION FOR INJECTION,,2021,Q2,Illness,,2021,Q2,2,F,202102.0,20210509.0,20210505,20210520,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210520.0,,HP,ES,ES,2021,Q2,Elderly
192213732,19221373,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, DF784A,,,,,SOLUTION FOR INJECTION,,2021,Q2,Inappropriate schedule of product administration,,2021,Q2,2,F,202102.0,20210509.0,20210505,20210520,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210520.0,,HP,ES,ES,2021,Q2,Elderly
192213732,19221373,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, DF784A,,,,,SOLUTION FOR INJECTION,,2021,Q2,Nausea,,2021,Q2,2,F,202102.0,20210509.0,20210505,20210520,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210520.0,,HP,ES,ES,2021,Q2,Elderly
192213732,19221373,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, DF784A,,,,,SOLUTION FOR INJECTION,,2021,Q2,Osteoporosis,,2021,Q2,2,F,202102.0,20210509.0,20210505,20210520,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210520.0,,HP,ES,ES,2021,Q2,Elderly
192213732,19221373,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, DF784A,,,,,SOLUTION FOR INJECTION,,2021,Q2,Paraesthesia,,2021,Q2,2,F,202102.0,20210509.0,20210505,20210520,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210520.0,,HP,ES,ES,2021,Q2,Elderly
192213732,19221373,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, DF784A,,,,,SOLUTION FOR INJECTION,,2021,Q2,Urinary tract infection,,2021,Q2,2,F,202102.0,20210509.0,20210505,20210520,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210520.0,,HP,ES,ES,2021,Q2,Elderly
192213732,19221373,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, DF784A,,,,,SOLUTION FOR INJECTION,,2021,Q2,Weight decreased,,2021,Q2,2,F,202102.0,20210509.0,20210505,20210520,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210520.0,,HP,ES,ES,2021,Q2,Elderly
192225431,19222543,10,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Acute kidney injury,,2021,Q2,1,I,20210428.0,,20210506,20210506,DIR,,,FDA-CTU,,75.0,YR,,M,N,91.1,KG,20210506.0,N,PH,US,US,2021,Q2,Elderly
192225431,19222543,10,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Blood culture positive,,2021,Q2,1,I,20210428.0,,20210506,20210506,DIR,,,FDA-CTU,,75.0,YR,,M,N,91.1,KG,20210506.0,N,PH,US,US,2021,Q2,Elderly
192225431,19222543,10,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Cryptococcosis,,2021,Q2,1,I,20210428.0,,20210506,20210506,DIR,,,FDA-CTU,,75.0,YR,,M,N,91.1,KG,20210506.0,N,PH,US,US,2021,Q2,Elderly
192225431,19222543,10,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,General physical health deterioration,,2021,Q2,1,I,20210428.0,,20210506,20210506,DIR,,,FDA-CTU,,75.0,YR,,M,N,91.1,KG,20210506.0,N,PH,US,US,2021,Q2,Elderly
192225431,19222543,10,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Hypotension,,2021,Q2,1,I,20210428.0,,20210506,20210506,DIR,,,FDA-CTU,,75.0,YR,,M,N,91.1,KG,20210506.0,N,PH,US,US,2021,Q2,Elderly
192225431,19222543,10,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Hypothermia,,2021,Q2,1,I,20210428.0,,20210506,20210506,DIR,,,FDA-CTU,,75.0,YR,,M,N,91.1,KG,20210506.0,N,PH,US,US,2021,Q2,Elderly
192225431,19222543,10,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Lethargy,,2021,Q2,1,I,20210428.0,,20210506,20210506,DIR,,,FDA-CTU,,75.0,YR,,M,N,91.1,KG,20210506.0,N,PH,US,US,2021,Q2,Elderly
192225431,19222543,10,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Respiratory failure,,2021,Q2,1,I,20210428.0,,20210506,20210506,DIR,,,FDA-CTU,,75.0,YR,,M,N,91.1,KG,20210506.0,N,PH,US,US,2021,Q2,Elderly
192225431,19222543,10,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Urine output decreased,,2021,Q2,1,I,20210428.0,,20210506,20210506,DIR,,,FDA-CTU,,75.0,YR,,M,N,91.1,KG,20210506.0,N,PH,US,US,2021,Q2,Elderly
192227701,19222770,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,30 U,,,,, UNKNOWN,,,,,,,2021,Q2,Erysipelas,,2021,Q2,1,I,2021.0,20210426.0,20210506,20210506,EXP,,BR-NOVOPROD-809097,NOVO NORDISK,,55.0,YR,,F,Y,82.0,KG,20210506.0,,MD,BR,BR,2021,Q2,Adult
192227701,19222770,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,30 U?0?0?10U,,,,, UNKNOWN,,,,,,,2021,Q2,Erysipelas,,2021,Q2,1,I,2021.0,20210426.0,20210506,20210506,EXP,,BR-NOVOPROD-809097,NOVO NORDISK,,55.0,YR,,F,Y,82.0,KG,20210506.0,,MD,BR,BR,2021,Q2,Adult
192252602,19225260,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"30 INTERNATIONAL UNIT, DAILY",,,Y,, 0F784A,,,30.0,IU,,QD,2021,Q2,Asthenia,,2021,Q2,2,F,20210330.0,20210614.0,20210505,20210628,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104012469,ELI LILLY AND CO,,89.0,YR,,M,Y,70.0,KG,20210628.0,,CN,ES,ES,2021,Q2,Elderly
192252602,19225260,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"30 INTERNATIONAL UNIT, DAILY",,,Y,, 0F784A,,,30.0,IU,,QD,2021,Q2,Blood glucose decreased,,2021,Q2,2,F,20210330.0,20210614.0,20210505,20210628,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104012469,ELI LILLY AND CO,,89.0,YR,,M,Y,70.0,KG,20210628.0,,CN,ES,ES,2021,Q2,Elderly
192252602,19225260,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"30 INTERNATIONAL UNIT, DAILY",,,Y,, 0F784A,,,30.0,IU,,QD,2021,Q2,Blood glucose increased,,2021,Q2,2,F,20210330.0,20210614.0,20210505,20210628,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104012469,ELI LILLY AND CO,,89.0,YR,,M,Y,70.0,KG,20210628.0,,CN,ES,ES,2021,Q2,Elderly
192252602,19225260,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"30 INTERNATIONAL UNIT, DAILY",,,Y,, 0F784A,,,30.0,IU,,QD,2021,Q2,Cardiac valve disease,,2021,Q2,2,F,20210330.0,20210614.0,20210505,20210628,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104012469,ELI LILLY AND CO,,89.0,YR,,M,Y,70.0,KG,20210628.0,,CN,ES,ES,2021,Q2,Elderly
192252602,19225260,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"30 INTERNATIONAL UNIT, DAILY",,,Y,, 0F784A,,,30.0,IU,,QD,2021,Q2,Choking,,2021,Q2,2,F,20210330.0,20210614.0,20210505,20210628,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104012469,ELI LILLY AND CO,,89.0,YR,,M,Y,70.0,KG,20210628.0,,CN,ES,ES,2021,Q2,Elderly
192252602,19225260,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"30 INTERNATIONAL UNIT, DAILY",,,Y,, 0F784A,,,30.0,IU,,QD,2021,Q2,Hypoglycaemia,,2021,Q2,2,F,20210330.0,20210614.0,20210505,20210628,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104012469,ELI LILLY AND CO,,89.0,YR,,M,Y,70.0,KG,20210628.0,,CN,ES,ES,2021,Q2,Elderly
192252602,19225260,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"30 INTERNATIONAL UNIT, DAILY",,,Y,, 0F784A,,,30.0,IU,,QD,2021,Q2,Poor quality sleep,,2021,Q2,2,F,20210330.0,20210614.0,20210505,20210628,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104012469,ELI LILLY AND CO,,89.0,YR,,M,Y,70.0,KG,20210628.0,,CN,ES,ES,2021,Q2,Elderly
192252602,19225260,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"30 INTERNATIONAL UNIT, DAILY",,,Y,, 0F784A,,,30.0,IU,,QD,2021,Q2,Weight decreased,,2021,Q2,2,F,20210330.0,20210614.0,20210505,20210628,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104012469,ELI LILLY AND CO,,89.0,YR,,M,Y,70.0,KG,20210628.0,,CN,ES,ES,2021,Q2,Elderly
192252602,19225260,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"24 INTERNATIONAL UNIT, DAILY",,,Y,, 0F784A,,,24.0,IU,,QD,2021,Q2,Asthenia,,2021,Q2,2,F,20210330.0,20210614.0,20210505,20210628,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104012469,ELI LILLY AND CO,,89.0,YR,,M,Y,70.0,KG,20210628.0,,CN,ES,ES,2021,Q2,Elderly
192252602,19225260,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"24 INTERNATIONAL UNIT, DAILY",,,Y,, 0F784A,,,24.0,IU,,QD,2021,Q2,Blood glucose decreased,,2021,Q2,2,F,20210330.0,20210614.0,20210505,20210628,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104012469,ELI LILLY AND CO,,89.0,YR,,M,Y,70.0,KG,20210628.0,,CN,ES,ES,2021,Q2,Elderly
192252602,19225260,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"24 INTERNATIONAL UNIT, DAILY",,,Y,, 0F784A,,,24.0,IU,,QD,2021,Q2,Blood glucose increased,,2021,Q2,2,F,20210330.0,20210614.0,20210505,20210628,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104012469,ELI LILLY AND CO,,89.0,YR,,M,Y,70.0,KG,20210628.0,,CN,ES,ES,2021,Q2,Elderly
192252602,19225260,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"24 INTERNATIONAL UNIT, DAILY",,,Y,, 0F784A,,,24.0,IU,,QD,2021,Q2,Cardiac valve disease,,2021,Q2,2,F,20210330.0,20210614.0,20210505,20210628,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104012469,ELI LILLY AND CO,,89.0,YR,,M,Y,70.0,KG,20210628.0,,CN,ES,ES,2021,Q2,Elderly
192252602,19225260,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"24 INTERNATIONAL UNIT, DAILY",,,Y,, 0F784A,,,24.0,IU,,QD,2021,Q2,Choking,,2021,Q2,2,F,20210330.0,20210614.0,20210505,20210628,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104012469,ELI LILLY AND CO,,89.0,YR,,M,Y,70.0,KG,20210628.0,,CN,ES,ES,2021,Q2,Elderly
192252602,19225260,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"24 INTERNATIONAL UNIT, DAILY",,,Y,, 0F784A,,,24.0,IU,,QD,2021,Q2,Hypoglycaemia,,2021,Q2,2,F,20210330.0,20210614.0,20210505,20210628,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104012469,ELI LILLY AND CO,,89.0,YR,,M,Y,70.0,KG,20210628.0,,CN,ES,ES,2021,Q2,Elderly
192252602,19225260,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"24 INTERNATIONAL UNIT, DAILY",,,Y,, 0F784A,,,24.0,IU,,QD,2021,Q2,Poor quality sleep,,2021,Q2,2,F,20210330.0,20210614.0,20210505,20210628,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104012469,ELI LILLY AND CO,,89.0,YR,,M,Y,70.0,KG,20210628.0,,CN,ES,ES,2021,Q2,Elderly
192252602,19225260,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"24 INTERNATIONAL UNIT, DAILY",,,Y,, 0F784A,,,24.0,IU,,QD,2021,Q2,Weight decreased,,2021,Q2,2,F,20210330.0,20210614.0,20210505,20210628,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104012469,ELI LILLY AND CO,,89.0,YR,,M,Y,70.0,KG,20210628.0,,CN,ES,ES,2021,Q2,Elderly
192252602,19225260,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"30 INTERNATIONAL UNIT, DAILY",,,Y,, 0F784A,,,30.0,IU,,QD,2021,Q2,Asthenia,,2021,Q2,2,F,20210330.0,20210614.0,20210505,20210628,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104012469,ELI LILLY AND CO,,89.0,YR,,M,Y,70.0,KG,20210628.0,,CN,ES,ES,2021,Q2,Elderly
192252602,19225260,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"30 INTERNATIONAL UNIT, DAILY",,,Y,, 0F784A,,,30.0,IU,,QD,2021,Q2,Blood glucose decreased,,2021,Q2,2,F,20210330.0,20210614.0,20210505,20210628,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104012469,ELI LILLY AND CO,,89.0,YR,,M,Y,70.0,KG,20210628.0,,CN,ES,ES,2021,Q2,Elderly
192252602,19225260,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"30 INTERNATIONAL UNIT, DAILY",,,Y,, 0F784A,,,30.0,IU,,QD,2021,Q2,Blood glucose increased,,2021,Q2,2,F,20210330.0,20210614.0,20210505,20210628,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104012469,ELI LILLY AND CO,,89.0,YR,,M,Y,70.0,KG,20210628.0,,CN,ES,ES,2021,Q2,Elderly
192252602,19225260,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"30 INTERNATIONAL UNIT, DAILY",,,Y,, 0F784A,,,30.0,IU,,QD,2021,Q2,Cardiac valve disease,,2021,Q2,2,F,20210330.0,20210614.0,20210505,20210628,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104012469,ELI LILLY AND CO,,89.0,YR,,M,Y,70.0,KG,20210628.0,,CN,ES,ES,2021,Q2,Elderly
192252602,19225260,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"30 INTERNATIONAL UNIT, DAILY",,,Y,, 0F784A,,,30.0,IU,,QD,2021,Q2,Choking,,2021,Q2,2,F,20210330.0,20210614.0,20210505,20210628,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104012469,ELI LILLY AND CO,,89.0,YR,,M,Y,70.0,KG,20210628.0,,CN,ES,ES,2021,Q2,Elderly
192252602,19225260,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"30 INTERNATIONAL UNIT, DAILY",,,Y,, 0F784A,,,30.0,IU,,QD,2021,Q2,Hypoglycaemia,,2021,Q2,2,F,20210330.0,20210614.0,20210505,20210628,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104012469,ELI LILLY AND CO,,89.0,YR,,M,Y,70.0,KG,20210628.0,,CN,ES,ES,2021,Q2,Elderly
192252602,19225260,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"30 INTERNATIONAL UNIT, DAILY",,,Y,, 0F784A,,,30.0,IU,,QD,2021,Q2,Poor quality sleep,,2021,Q2,2,F,20210330.0,20210614.0,20210505,20210628,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104012469,ELI LILLY AND CO,,89.0,YR,,M,Y,70.0,KG,20210628.0,,CN,ES,ES,2021,Q2,Elderly
192252602,19225260,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"30 INTERNATIONAL UNIT, DAILY",,,Y,, 0F784A,,,30.0,IU,,QD,2021,Q2,Weight decreased,,2021,Q2,2,F,20210330.0,20210614.0,20210505,20210628,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104012469,ELI LILLY AND CO,,89.0,YR,,M,Y,70.0,KG,20210628.0,,CN,ES,ES,2021,Q2,Elderly
192275161,19227516,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Syncope,,2021,Q2,1,I,20210101.0,20210209.0,20210506,20210506,EXP,,US-ABBVIE-21P-163-3767329-00,ABBVIE,,56.0,YR,,F,Y,76.2,KG,20210506.0,,MD,US,US,2021,Q2,Adult
192276041,19227604,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,52 INTERNATIONAL UNIT,,,,,,,,52.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Dehydration,,2021,Q2,1,I,202011.0,20210428.0,20210507,20210507,EXP,,ES-AUROBINDO-AUR-APL-2021-018478,AUROBINDO,,69.0,YR,,M,Y,,,20210507.0,,CN,ES,ES,2021,Q2,Elderly
192276041,19227604,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,52 INTERNATIONAL UNIT,,,,,,,,52.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Diabetes mellitus inadequate control,,2021,Q2,1,I,202011.0,20210428.0,20210507,20210507,EXP,,ES-AUROBINDO-AUR-APL-2021-018478,AUROBINDO,,69.0,YR,,M,Y,,,20210507.0,,CN,ES,ES,2021,Q2,Elderly
192276041,19227604,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,52 INTERNATIONAL UNIT,,,,,,,,52.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Diabetic nephropathy,,2021,Q2,1,I,202011.0,20210428.0,20210507,20210507,EXP,,ES-AUROBINDO-AUR-APL-2021-018478,AUROBINDO,,69.0,YR,,M,Y,,,20210507.0,,CN,ES,ES,2021,Q2,Elderly
192276041,19227604,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,52 INTERNATIONAL UNIT,,,,,,,,52.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Diarrhoea,,2021,Q2,1,I,202011.0,20210428.0,20210507,20210507,EXP,,ES-AUROBINDO-AUR-APL-2021-018478,AUROBINDO,,69.0,YR,,M,Y,,,20210507.0,,CN,ES,ES,2021,Q2,Elderly
192276041,19227604,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,52 INTERNATIONAL UNIT,,,,,,,,52.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Nervousness,,2021,Q2,1,I,202011.0,20210428.0,20210507,20210507,EXP,,ES-AUROBINDO-AUR-APL-2021-018478,AUROBINDO,,69.0,YR,,M,Y,,,20210507.0,,CN,ES,ES,2021,Q2,Elderly
192276041,19227604,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,52 INTERNATIONAL UNIT,,,,,,,,52.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Weight decreased,,2021,Q2,1,I,202011.0,20210428.0,20210507,20210507,EXP,,ES-AUROBINDO-AUR-APL-2021-018478,AUROBINDO,,69.0,YR,,M,Y,,,20210507.0,,CN,ES,ES,2021,Q2,Elderly
192306301,19230630,8,C,LANTUS SOLOSTAR GLARGINE,,2,,,,,,,,,,,,,,2021,Q2,Product distribution issue,,2021,Q2,1,I,20210422.0,,20210506,20210506,DIR,,,FDA-CTU,,70.0,YR,,F,N,48.6,KG,20210506.0,Y,CN,US,US,2021,Q2,Elderly
192306301,19230630,8,C,LANTUS SOLOSTAR GLARGINE,,2,,,,,,,,,,,,,,2021,Q2,Product storage error,,2021,Q2,1,I,20210422.0,,20210506,20210506,DIR,,,FDA-CTU,,70.0,YR,,F,N,48.6,KG,20210506.0,Y,CN,US,US,2021,Q2,Elderly
192306301,19230630,8,C,LANTUS SOLOSTAR GLARGINE,,2,,,,,,,,,,,,,,2021,Q2,Therapy interrupted,,2021,Q2,1,I,20210422.0,,20210506,20210506,DIR,,,FDA-CTU,,70.0,YR,,F,N,48.6,KG,20210506.0,Y,CN,US,US,2021,Q2,Elderly
192307351,19230735,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Arthralgia,,2021,Q2,1,I,20210505.0,,20210507,20210507,DIR,,,FDA-CTU,,65.0,YR,,M,N,83.25,KG,20210507.0,N,CN,US,US,2021,Q2,Elderly
192307351,19230735,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Disturbance in attention,,2021,Q2,1,I,20210505.0,,20210507,20210507,DIR,,,FDA-CTU,,65.0,YR,,M,N,83.25,KG,20210507.0,N,CN,US,US,2021,Q2,Elderly
192307351,19230735,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Erythema,,2021,Q2,1,I,20210505.0,,20210507,20210507,DIR,,,FDA-CTU,,65.0,YR,,M,N,83.25,KG,20210507.0,N,CN,US,US,2021,Q2,Elderly
192307351,19230735,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Headache,,2021,Q2,1,I,20210505.0,,20210507,20210507,DIR,,,FDA-CTU,,65.0,YR,,M,N,83.25,KG,20210507.0,N,CN,US,US,2021,Q2,Elderly
192307351,19230735,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Musculoskeletal stiffness,,2021,Q2,1,I,20210505.0,,20210507,20210507,DIR,,,FDA-CTU,,65.0,YR,,M,N,83.25,KG,20210507.0,N,CN,US,US,2021,Q2,Elderly
192307351,19230735,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Myalgia,,2021,Q2,1,I,20210505.0,,20210507,20210507,DIR,,,FDA-CTU,,65.0,YR,,M,N,83.25,KG,20210507.0,N,CN,US,US,2021,Q2,Elderly
192307351,19230735,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Neck pain,,2021,Q2,1,I,20210505.0,,20210507,20210507,DIR,,,FDA-CTU,,65.0,YR,,M,N,83.25,KG,20210507.0,N,CN,US,US,2021,Q2,Elderly
192307351,19230735,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Pain in extremity,,2021,Q2,1,I,20210505.0,,20210507,20210507,DIR,,,FDA-CTU,,65.0,YR,,M,N,83.25,KG,20210507.0,N,CN,US,US,2021,Q2,Elderly
192307351,19230735,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Peripheral swelling,,2021,Q2,1,I,20210505.0,,20210507,20210507,DIR,,,FDA-CTU,,65.0,YR,,M,N,83.25,KG,20210507.0,N,CN,US,US,2021,Q2,Elderly
192307351,19230735,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Pruritus,,2021,Q2,1,I,20210505.0,,20210507,20210507,DIR,,,FDA-CTU,,65.0,YR,,M,N,83.25,KG,20210507.0,N,CN,US,US,2021,Q2,Elderly
192307351,19230735,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Vision blurred,,2021,Q2,1,I,20210505.0,,20210507,20210507,DIR,,,FDA-CTU,,65.0,YR,,M,N,83.25,KG,20210507.0,N,CN,US,US,2021,Q2,Elderly
192315941,19231594,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Gangrene,,2021,Q2,1,I,,20210430.0,20210507,20210507,EXP,,CA-ASTRAZENECA-2021A382742,ASTRAZENECA,,71.0,YR,,M,Y,,,20210507.0,,HP,CA,CA,2021,Q2,Elderly
192315941,19231594,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Necrotising fasciitis,,2021,Q2,1,I,,20210430.0,20210507,20210507,EXP,,CA-ASTRAZENECA-2021A382742,ASTRAZENECA,,71.0,YR,,M,Y,,,20210507.0,,HP,CA,CA,2021,Q2,Elderly
192317831,19231783,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,52 IU,,,,,,,,52.0,IU,,,2021,Q2,Dehydration,,2021,Q2,1,I,202011.0,20210428.0,20210507,20210507,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104013106,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20210507.0,,CN,ES,ES,2021,Q2,Elderly
192317831,19231783,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,52 IU,,,,,,,,52.0,IU,,,2021,Q2,Diabetes mellitus inadequate control,,2021,Q2,1,I,202011.0,20210428.0,20210507,20210507,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104013106,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20210507.0,,CN,ES,ES,2021,Q2,Elderly
192317831,19231783,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,52 IU,,,,,,,,52.0,IU,,,2021,Q2,Diabetic nephropathy,,2021,Q2,1,I,202011.0,20210428.0,20210507,20210507,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104013106,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20210507.0,,CN,ES,ES,2021,Q2,Elderly
192317831,19231783,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,52 IU,,,,,,,,52.0,IU,,,2021,Q2,Diarrhoea,,2021,Q2,1,I,202011.0,20210428.0,20210507,20210507,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104013106,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20210507.0,,CN,ES,ES,2021,Q2,Elderly
192317831,19231783,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,52 IU,,,,,,,,52.0,IU,,,2021,Q2,Nervousness,,2021,Q2,1,I,202011.0,20210428.0,20210507,20210507,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104013106,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20210507.0,,CN,ES,ES,2021,Q2,Elderly
192317831,19231783,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,52 IU,,,,,,,,52.0,IU,,,2021,Q2,Weight decreased,,2021,Q2,1,I,202011.0,20210428.0,20210507,20210507,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104013106,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20210507.0,,CN,ES,ES,2021,Q2,Elderly
192321591,19232159,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 IU,,,,,,,,50.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Asthenia,,2021,Q2,1,I,,20210428.0,20210507,20210507,EXP,,ES-PFIZER INC-2021472629,PFIZER,,69.0,YR,,M,Y,,,20210507.0,,CN,ES,ES,2021,Q2,Elderly
192321591,19232159,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 IU,,,,,,,,50.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Drug ineffective,,2021,Q2,1,I,,20210428.0,20210507,20210507,EXP,,ES-PFIZER INC-2021472629,PFIZER,,69.0,YR,,M,Y,,,20210507.0,,CN,ES,ES,2021,Q2,Elderly
192321591,19232159,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 IU,,,,,,,,50.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Penile haemorrhage,,2021,Q2,1,I,,20210428.0,20210507,20210507,EXP,,ES-PFIZER INC-2021472629,PFIZER,,69.0,YR,,M,Y,,,20210507.0,,CN,ES,ES,2021,Q2,Elderly
192321591,19232159,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 IU,,,,,,,,50.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Penis injury,,2021,Q2,1,I,,20210428.0,20210507,20210507,EXP,,ES-PFIZER INC-2021472629,PFIZER,,69.0,YR,,M,Y,,,20210507.0,,CN,ES,ES,2021,Q2,Elderly
192321591,19232159,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 IU,,,,,,,,50.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Skin fissures,,2021,Q2,1,I,,20210428.0,20210507,20210507,EXP,,ES-PFIZER INC-2021472629,PFIZER,,69.0,YR,,M,Y,,,20210507.0,,CN,ES,ES,2021,Q2,Elderly
192385611,19238561,1,PS,INSULIN GLARGINE MYLAN,INSULIN GLARGINE,1,Subcutaneous,10 UI/DAY,,,,U,,,210605.0,,,INJECTION,QD,2021,Q2,Facial paralysis,,2021,Q2,1,I,20210418.0,20210425.0,20210510,20210510,EXP,,DZ-MYLANLABS-2021M1027508,MYLAN,,46.0,YR,,F,Y,,,20210510.0,,MD,DZ,DZ,2021,Q2,Adult
192400651,19240065,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,52 IU,,,,,,,,52.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Dehydration,,2021,Q2,1,I,202011.0,20210430.0,20210510,20210510,EXP,,ES-PFIZER INC-2021483340,PFIZER,,69.0,YR,,M,Y,,,20210510.0,,CN,ES,ES,2021,Q2,Elderly
192400651,19240065,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,52 IU,,,,,,,,52.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Diabetes mellitus inadequate control,,2021,Q2,1,I,202011.0,20210430.0,20210510,20210510,EXP,,ES-PFIZER INC-2021483340,PFIZER,,69.0,YR,,M,Y,,,20210510.0,,CN,ES,ES,2021,Q2,Elderly
192400651,19240065,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,52 IU,,,,,,,,52.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Diabetic nephropathy,,2021,Q2,1,I,202011.0,20210430.0,20210510,20210510,EXP,,ES-PFIZER INC-2021483340,PFIZER,,69.0,YR,,M,Y,,,20210510.0,,CN,ES,ES,2021,Q2,Elderly
192400651,19240065,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,52 IU,,,,,,,,52.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Diarrhoea,,2021,Q2,1,I,202011.0,20210430.0,20210510,20210510,EXP,,ES-PFIZER INC-2021483340,PFIZER,,69.0,YR,,M,Y,,,20210510.0,,CN,ES,ES,2021,Q2,Elderly
192400651,19240065,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,52 IU,,,,,,,,52.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Nervousness,,2021,Q2,1,I,202011.0,20210430.0,20210510,20210510,EXP,,ES-PFIZER INC-2021483340,PFIZER,,69.0,YR,,M,Y,,,20210510.0,,CN,ES,ES,2021,Q2,Elderly
192400651,19240065,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,52 IU,,,,,,,,52.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Weight decreased,,2021,Q2,1,I,202011.0,20210430.0,20210510,20210510,EXP,,ES-PFIZER INC-2021483340,PFIZER,,69.0,YR,,M,Y,,,20210510.0,,CN,ES,ES,2021,Q2,Elderly
192401342,19240134,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 UNITS SUBCUTANEOUS, QHS",,,,,,,,,,,QD,2021,Q2,Fall,,2021,Q2,2,F,20210501.0,20210610.0,20210510,20210617,EXP,,US-JNJFOC-20210505725,JOHNSON AND JOHNSON,,70.0,YR,E,M,Y,124.4,KG,20210617.0,,HP,US,US,2021,Q2,Elderly
192401342,19240134,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 UNITS SUBCUTANEOUS, QHS",,,,,,,,,,,QD,2021,Q2,Rib fracture,,2021,Q2,2,F,20210501.0,20210610.0,20210510,20210617,EXP,,US-JNJFOC-20210505725,JOHNSON AND JOHNSON,,70.0,YR,E,M,Y,124.4,KG,20210617.0,,HP,US,US,2021,Q2,Elderly
192409911,19240991,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,,, UNKNOWN,,,18.0,IU,,QD,2021,Q2,Intestinal obstruction,,2021,Q2,1,I,20210504.0,20210504.0,20210511,20210511,EXP,,CN-NOVOPROD-810325,NOVO NORDISK,,54.0,YR,,F,Y,,,20210511.0,,MD,CN,CN,2021,Q2,Adult
192409911,19240991,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,,, UNKNOWN,,,18.0,IU,,QD,2021,Q2,Loss of consciousness,,2021,Q2,1,I,20210504.0,20210504.0,20210511,20210511,EXP,,CN-NOVOPROD-810325,NOVO NORDISK,,54.0,YR,,F,Y,,,20210511.0,,MD,CN,CN,2021,Q2,Adult
192409911,19240991,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,,, UNKNOWN,,,18.0,IU,,QD,2021,Q2,Multiple organ dysfunction syndrome,,2021,Q2,1,I,20210504.0,20210504.0,20210511,20210511,EXP,,CN-NOVOPROD-810325,NOVO NORDISK,,54.0,YR,,F,Y,,,20210511.0,,MD,CN,CN,2021,Q2,Adult
192429111,19242911,17,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,,QD,2021,Q2,Asthma,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-015009,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429111,19242911,17,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,,QD,2021,Q2,Condition aggravated,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-015009,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429111,19242911,17,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,,QD,2021,Q2,Dyspnoea,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-015009,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429111,19242911,17,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,,QD,2021,Q2,Haemoptysis,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-015009,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429111,19242911,17,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,,QD,2021,Q2,Loss of personal independence in daily activities,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-015009,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429111,19242911,17,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,,QD,2021,Q2,Lung disorder,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-015009,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429111,19242911,17,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,,QD,2021,Q2,Neuritis,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-015009,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429111,19242911,17,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,,QD,2021,Q2,Neurological symptom,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-015009,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429111,19242911,17,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,,QD,2021,Q2,Obstructive airways disorder,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-015009,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429111,19242911,17,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,,QD,2021,Q2,Pain in extremity,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-015009,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429111,19242911,17,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,,QD,2021,Q2,Pulmonary alveolar haemorrhage,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-015009,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429111,19242911,17,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,,QD,2021,Q2,Pulmonary fibrosis,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-015009,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429111,19242911,17,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,,QD,2021,Q2,Pulmonary vasculitis,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-015009,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429111,19242911,17,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,,QD,2021,Q2,Respiratory symptom,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-015009,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429111,19242911,17,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,,QD,2021,Q2,Sleep disorder due to a general medical condition,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-015009,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429111,19242911,17,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,,QD,2021,Q2,Therapeutic product effect incomplete,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-015009,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429111,19242911,17,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,,QD,2021,Q2,Vasculitis,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-015009,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429111,19242911,17,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,,QD,2021,Q2,Wheezing,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-015009,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192479171,19247917,9,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,,,,,,,,UNKNOWN,,2021,Q2,Loss of consciousness,,2021,Q2,1,I,20210125.0,20210128.0,20210512,20210512,EXP,,JP-CELGENEUS-JPN-20210106929,CELGENE,,74.0,YR,,M,Y,,,20210512.0,,MD,JP,JP,2021,Q2,Elderly
192517121,19251712,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 IU, BEFORE SLEEP",,,,, UNKNOWN,,,,,,,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,202104.0,20210430.0,20210513,20210513,EXP,CN-NMPA-3417011515249202100059,CN-NOVOPROD-809237,NOVO NORDISK,,66.0,YR,,F,Y,46.0,KG,20210513.0,,HP,CN,CN,2021,Q2,Elderly
192517121,19251712,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 IU, BEFORE SLEEP",,,,, UNKNOWN,,,,,,,2021,Q2,Pain,,2021,Q2,1,I,202104.0,20210430.0,20210513,20210513,EXP,CN-NMPA-3417011515249202100059,CN-NOVOPROD-809237,NOVO NORDISK,,66.0,YR,,F,Y,46.0,KG,20210513.0,,HP,CN,CN,2021,Q2,Elderly
192555323,19255532,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 TO 6 UNITS/ONCE?DAILY,,,,,,,,,,,,2021,Q2,Acute kidney injury,,2021,Q2,3,F,20150729.0,20210520.0,20210513,20210526,PER,,TR-AMGEN-TURSP2021068379,AMGEN,TOPRAK O.? BOZYEL E. A.? ALP B.. DISCONTINUING HEMODIALYSIS WITH PATIENT CARE AND A SUCCESSFUL 9?YEAR FOLLOW?UP IN A PATIENT PRESUMED TO HAVE END?STAGE KIDNEY DISEASE SCHEDULED TO LIFELONG HEMODIALYSIS: A CASE REPORT. CLINICS AND PRACTICE. 2021?11 (1):131?142,71.0,YR,E,F,Y,,,20210526.0,,HP,TR,TR,2021,Q2,Elderly
192555323,19255532,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 TO 6 UNITS/ONCE?DAILY,,,,,,,,,,,,2021,Q2,Glomerular filtration rate increased,,2021,Q2,3,F,20150729.0,20210520.0,20210513,20210526,PER,,TR-AMGEN-TURSP2021068379,AMGEN,TOPRAK O.? BOZYEL E. A.? ALP B.. DISCONTINUING HEMODIALYSIS WITH PATIENT CARE AND A SUCCESSFUL 9?YEAR FOLLOW?UP IN A PATIENT PRESUMED TO HAVE END?STAGE KIDNEY DISEASE SCHEDULED TO LIFELONG HEMODIALYSIS: A CASE REPORT. CLINICS AND PRACTICE. 2021?11 (1):131?142,71.0,YR,E,F,Y,,,20210526.0,,HP,TR,TR,2021,Q2,Elderly
192555323,19255532,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 TO 6 UNITS/ONCE?DAILY,,,,,,,,,,,,2021,Q2,Hyponatraemia,,2021,Q2,3,F,20150729.0,20210520.0,20210513,20210526,PER,,TR-AMGEN-TURSP2021068379,AMGEN,TOPRAK O.? BOZYEL E. A.? ALP B.. DISCONTINUING HEMODIALYSIS WITH PATIENT CARE AND A SUCCESSFUL 9?YEAR FOLLOW?UP IN A PATIENT PRESUMED TO HAVE END?STAGE KIDNEY DISEASE SCHEDULED TO LIFELONG HEMODIALYSIS: A CASE REPORT. CLINICS AND PRACTICE. 2021?11 (1):131?142,71.0,YR,E,F,Y,,,20210526.0,,HP,TR,TR,2021,Q2,Elderly
192555323,19255532,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 TO 6 UNITS/ONCE?DAILY,,,,,,,,,,,,2021,Q2,Pneumonia,,2021,Q2,3,F,20150729.0,20210520.0,20210513,20210526,PER,,TR-AMGEN-TURSP2021068379,AMGEN,TOPRAK O.? BOZYEL E. A.? ALP B.. DISCONTINUING HEMODIALYSIS WITH PATIENT CARE AND A SUCCESSFUL 9?YEAR FOLLOW?UP IN A PATIENT PRESUMED TO HAVE END?STAGE KIDNEY DISEASE SCHEDULED TO LIFELONG HEMODIALYSIS: A CASE REPORT. CLINICS AND PRACTICE. 2021?11 (1):131?142,71.0,YR,E,F,Y,,,20210526.0,,HP,TR,TR,2021,Q2,Elderly
192555323,19255532,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 TO 6 UNITS/ONCE?DAILY,,,,,,,,,,,,2021,Q2,Urinary tract infection,,2021,Q2,3,F,20150729.0,20210520.0,20210513,20210526,PER,,TR-AMGEN-TURSP2021068379,AMGEN,TOPRAK O.? BOZYEL E. A.? ALP B.. DISCONTINUING HEMODIALYSIS WITH PATIENT CARE AND A SUCCESSFUL 9?YEAR FOLLOW?UP IN A PATIENT PRESUMED TO HAVE END?STAGE KIDNEY DISEASE SCHEDULED TO LIFELONG HEMODIALYSIS: A CASE REPORT. CLINICS AND PRACTICE. 2021?11 (1):131?142,71.0,YR,E,F,Y,,,20210526.0,,HP,TR,TR,2021,Q2,Elderly
192588251,19258825,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"8 U, DAILY",,,U,,,,205692.0,8.0,IU,,QD,2021,Q2,Adrenocortical insufficiency acute,,2021,Q2,1,I,20151224.0,20210510.0,20210514,20210514,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202105005089,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20210514.0,,MD,DE,DE,2021,Q2,Adult
192588321,19258832,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"8 INTERNATIONAL UNIT, DAILY",,,,,,,205692.0,8.0,IU,,QD,2021,Q2,Adrenocortical insufficiency acute,,2021,Q2,1,I,20151129.0,20210510.0,20210514,20210514,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202105005094,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20210514.0,,MD,DE,DE,2021,Q2,Adult
192619891,19261989,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Erectile dysfunction,,2021,Q2,1,I,,20210505.0,20210516,20210516,EXP,,US-AUROBINDO-AUR-APL-2021-019145,AUROBINDO,,52.0,YR,,M,Y,,,20210516.0,,MD,US,US,2021,Q2,Adult
192619891,19261989,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Priapism,,2021,Q2,1,I,,20210505.0,20210516,20210516,EXP,,US-AUROBINDO-AUR-APL-2021-019145,AUROBINDO,,52.0,YR,,M,Y,,,20210516.0,,MD,US,US,2021,Q2,Adult
192623081,19262308,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,, UNKNOWN,,,,,,,2021,Q2,Product use in unapproved indication,,2021,Q2,1,I,,20210506.0,20210516,20210516,EXP,,US-DRREDDYS-USA/USA/21/0135515,DR REDDYS,"LEWIS P, THARP J. BREAKTHROUGH VENOUS THROMBOEMBOLIC EVENTS IN FIVE PATIENTS WITH COVID?19 ON DIRECT ORAL ANTICOAGULANTS. J CLIN PHARM THER. 2021?46(2):516?523. DOI:10.1111/JCPT.13311",70.0,YR,E,M,Y,,,20210517.0,,HP,US,US,2021,Q2,Elderly
192629141,19262914,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,35 IU SC IN THE MORNING AND 15 IU SC AT DINNER,,,,, UNKNOWN,,,,,,,2021,Q2,Asthenia,,2021,Q2,1,I,202102.0,20210505.0,20210517,20210517,EXP,,BR-NOVOPROD-811158,NOVO NORDISK,,74.0,YR,,F,Y,,,20210517.0,,MD,BR,BR,2021,Q2,Elderly
192629141,19262914,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,35 IU SC IN THE MORNING AND 15 IU SC AT DINNER,,,,, UNKNOWN,,,,,,,2021,Q2,Nocturia,,2021,Q2,1,I,202102.0,20210505.0,20210517,20210517,EXP,,BR-NOVOPROD-811158,NOVO NORDISK,,74.0,YR,,F,Y,,,20210517.0,,MD,BR,BR,2021,Q2,Elderly
192629141,19262914,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,35 IU SC IN THE MORNING AND 15 IU SC AT DINNER,,,,, UNKNOWN,,,,,,,2021,Q2,Urinary tract infection,,2021,Q2,1,I,202102.0,20210505.0,20210517,20210517,EXP,,BR-NOVOPROD-811158,NOVO NORDISK,,74.0,YR,,F,Y,,,20210517.0,,MD,BR,BR,2021,Q2,Elderly
192629141,19262914,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,35 IU SC IN THE MORNING AND 15 IU SC AT DINNER,,,,, UNKNOWN,,,,,,,2021,Q2,Vision blurred,,2021,Q2,1,I,202102.0,20210505.0,20210517,20210517,EXP,,BR-NOVOPROD-811158,NOVO NORDISK,,74.0,YR,,F,Y,,,20210517.0,,MD,BR,BR,2021,Q2,Elderly
192629141,19262914,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,35 IU SC IN THE MORNING AND 15 IU SC AT DINNER,,,,, UNKNOWN,,,,,,,2021,Q2,Weight decreased,,2021,Q2,1,I,202102.0,20210505.0,20210517,20210517,EXP,,BR-NOVOPROD-811158,NOVO NORDISK,,74.0,YR,,F,Y,,,20210517.0,,MD,BR,BR,2021,Q2,Elderly
192688901,19268890,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,SARS-CoV-2 test positive,,2021,Q2,1,I,,20210503.0,20210517,20210517,EXP,,CA-PFIZER INC-2021493241,PFIZER,,70.0,YR,,F,Y,,,20210517.0,,HP,CA,CA,2021,Q2,Elderly
192689954,19268995,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Disseminated varicella zoster virus infection,,2021,Q2,4,F,20210430.0,20210525.0,20210518,20210602,EXP,,NVSC2021US103274,NOVARTIS,,66.0,YR,,M,Y,62.1,KG,20210602.0,,HP,US,US,2021,Q2,Elderly
192692451,19269245,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Administration site extravasation,,2021,Q2,1,I,20210426.0,20210426.0,20210517,20210517,PER,,US-GILEAD-2021-0527011,GILEAD,,81.0,YR,E,M,Y,82.1,KG,20210517.0,,PH,US,US,2021,Q2,Elderly
192692451,19269245,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Infusion site swelling,,2021,Q2,1,I,20210426.0,20210426.0,20210517,20210517,PER,,US-GILEAD-2021-0527011,GILEAD,,81.0,YR,E,M,Y,82.1,KG,20210517.0,,PH,US,US,2021,Q2,Elderly
192722511,19272251,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2021,Q2,Cystitis haemorrhagic,,2021,Q2,1,I,,20210509.0,20210519,20210519,EXP,,ES-NOVOPROD-812516,NOVO NORDISK,,73.0,YR,,F,Y,59.0,KG,20210519.0,,MD,ES,ES,2021,Q2,Elderly
192722651,19272265,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"25 IU, QD",,,,, UNKNOWN,,,25.0,IU,,QD,2021,Q2,Acute myocardial infarction,,2021,Q2,1,I,201810.0,20210508.0,20210519,20210519,EXP,,BR-NOVOPROD-812497,NOVO NORDISK,,72.0,YR,,M,Y,82.0,KG,20210519.0,,MD,BR,BR,2021,Q2,Elderly
192738401,19273840,4,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Death,,2021,Q2,1,I,20210518.0,,20210518,20210518,DIR,,,FDA-CTU,,75.0,YR,,M,N,,,20210518.0,N,MD,US,US,2021,Q2,Elderly
192752401,19275240,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,1 DF,,,U,,,,,1.0,DF,,,2021,Q2,Asthma,,2021,Q2,1,I,,20210510.0,20210519,20210519,EXP,,CA-SA-2021SA164671,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210519.0,,CN,CA,CA,2021,Q2,Elderly
192752401,19275240,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,1 DF,,,U,,,,,1.0,DF,,,2021,Q2,Condition aggravated,,2021,Q2,1,I,,20210510.0,20210519,20210519,EXP,,CA-SA-2021SA164671,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210519.0,,CN,CA,CA,2021,Q2,Elderly
192752401,19275240,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,1 DF,,,U,,,,,1.0,DF,,,2021,Q2,Dyspnoea,,2021,Q2,1,I,,20210510.0,20210519,20210519,EXP,,CA-SA-2021SA164671,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210519.0,,CN,CA,CA,2021,Q2,Elderly
192752401,19275240,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,1 DF,,,U,,,,,1.0,DF,,,2021,Q2,Haemoptysis,,2021,Q2,1,I,,20210510.0,20210519,20210519,EXP,,CA-SA-2021SA164671,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210519.0,,CN,CA,CA,2021,Q2,Elderly
192752401,19275240,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,1 DF,,,U,,,,,1.0,DF,,,2021,Q2,Loss of personal independence in daily activities,,2021,Q2,1,I,,20210510.0,20210519,20210519,EXP,,CA-SA-2021SA164671,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210519.0,,CN,CA,CA,2021,Q2,Elderly
192752401,19275240,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,1 DF,,,U,,,,,1.0,DF,,,2021,Q2,Lung disorder,,2021,Q2,1,I,,20210510.0,20210519,20210519,EXP,,CA-SA-2021SA164671,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210519.0,,CN,CA,CA,2021,Q2,Elderly
192752401,19275240,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,1 DF,,,U,,,,,1.0,DF,,,2021,Q2,Neuritis,,2021,Q2,1,I,,20210510.0,20210519,20210519,EXP,,CA-SA-2021SA164671,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210519.0,,CN,CA,CA,2021,Q2,Elderly
192752401,19275240,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,1 DF,,,U,,,,,1.0,DF,,,2021,Q2,Neurological symptom,,2021,Q2,1,I,,20210510.0,20210519,20210519,EXP,,CA-SA-2021SA164671,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210519.0,,CN,CA,CA,2021,Q2,Elderly
192752401,19275240,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,1 DF,,,U,,,,,1.0,DF,,,2021,Q2,Obstructive airways disorder,,2021,Q2,1,I,,20210510.0,20210519,20210519,EXP,,CA-SA-2021SA164671,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210519.0,,CN,CA,CA,2021,Q2,Elderly
192752401,19275240,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,1 DF,,,U,,,,,1.0,DF,,,2021,Q2,Pain in extremity,,2021,Q2,1,I,,20210510.0,20210519,20210519,EXP,,CA-SA-2021SA164671,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210519.0,,CN,CA,CA,2021,Q2,Elderly
192752401,19275240,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,1 DF,,,U,,,,,1.0,DF,,,2021,Q2,Pulmonary alveolar haemorrhage,,2021,Q2,1,I,,20210510.0,20210519,20210519,EXP,,CA-SA-2021SA164671,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210519.0,,CN,CA,CA,2021,Q2,Elderly
192752401,19275240,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,1 DF,,,U,,,,,1.0,DF,,,2021,Q2,Pulmonary fibrosis,,2021,Q2,1,I,,20210510.0,20210519,20210519,EXP,,CA-SA-2021SA164671,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210519.0,,CN,CA,CA,2021,Q2,Elderly
192752401,19275240,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,1 DF,,,U,,,,,1.0,DF,,,2021,Q2,Pulmonary vasculitis,,2021,Q2,1,I,,20210510.0,20210519,20210519,EXP,,CA-SA-2021SA164671,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210519.0,,CN,CA,CA,2021,Q2,Elderly
192752401,19275240,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,1 DF,,,U,,,,,1.0,DF,,,2021,Q2,Respiratory symptom,,2021,Q2,1,I,,20210510.0,20210519,20210519,EXP,,CA-SA-2021SA164671,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210519.0,,CN,CA,CA,2021,Q2,Elderly
192752401,19275240,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,1 DF,,,U,,,,,1.0,DF,,,2021,Q2,Sleep disorder due to a general medical condition,,2021,Q2,1,I,,20210510.0,20210519,20210519,EXP,,CA-SA-2021SA164671,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210519.0,,CN,CA,CA,2021,Q2,Elderly
192752401,19275240,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,1 DF,,,U,,,,,1.0,DF,,,2021,Q2,Therapeutic product effect incomplete,,2021,Q2,1,I,,20210510.0,20210519,20210519,EXP,,CA-SA-2021SA164671,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210519.0,,CN,CA,CA,2021,Q2,Elderly
192752401,19275240,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,1 DF,,,U,,,,,1.0,DF,,,2021,Q2,Vasculitis,,2021,Q2,1,I,,20210510.0,20210519,20210519,EXP,,CA-SA-2021SA164671,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210519.0,,CN,CA,CA,2021,Q2,Elderly
192752401,19275240,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,1 DF,,,U,,,,,1.0,DF,,,2021,Q2,Wheezing,,2021,Q2,1,I,,20210510.0,20210519,20210519,EXP,,CA-SA-2021SA164671,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210519.0,,CN,CA,CA,2021,Q2,Elderly
192761341,19276134,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Arrhythmia,,2021,Q2,1,I,,20210512.0,20210520,20210520,EXP,,CA-ASTRAZENECA-2021A421819,ASTRAZENECA,,63.0,YR,,M,Y,,,20210519.0,,HP,CA,CA,2021,Q2,Adult
192761341,19276134,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Ventricular extrasystoles,,2021,Q2,1,I,,20210512.0,20210520,20210520,EXP,,CA-ASTRAZENECA-2021A421819,ASTRAZENECA,,63.0,YR,,M,Y,,,20210519.0,,HP,CA,CA,2021,Q2,Adult
192763311,19276331,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,100.0,DF,,QD,2021,Q2,Hypotension,,2021,Q2,1,I,20210103.0,20210104.0,20210519,20210519,EXP,,US-ABBVIE-21P-163-3717189-00,ABBVIE,,55.0,YR,,F,Y,60.2,KG,20210519.0,,MD,US,US,2021,Q2,Adult
192763311,19276331,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,100.0,DF,,QD,2021,Q2,Respiratory failure,,2021,Q2,1,I,20210103.0,20210104.0,20210519,20210519,EXP,,US-ABBVIE-21P-163-3717189-00,ABBVIE,,55.0,YR,,F,Y,60.2,KG,20210519.0,,MD,US,US,2021,Q2,Adult
192763311,19276331,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,100.0,DF,,QD,2021,Q2,Urinary tract infection enterococcal,,2021,Q2,1,I,20210103.0,20210104.0,20210519,20210519,EXP,,US-ABBVIE-21P-163-3717189-00,ABBVIE,,55.0,YR,,F,Y,60.2,KG,20210519.0,,MD,US,US,2021,Q2,Adult
192799231,19279923,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,EVERY NIGHT,,,,,,,,,,INJECTION,,2021,Q2,Diabetic ketoacidosis,,2021,Q2,1,I,,20210511.0,20210520,20210520,EXP,,CN-ASTRAZENECA-2021A427450,ASTRAZENECA,,50.0,YR,,F,Y,,,20210520.0,,MD,CN,CN,2021,Q2,Adult
192807791,19280779,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intramuscular,"12 IU, QD",,,Y,, ABJA018,,21081.0,12.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Tachycardia,,2021,Q2,1,I,20210502.0,20210507.0,20210521,20210521,EXP,,CN-SA-2021SA157266,SANOFI AVENTIS,,83.0,YR,E,M,Y,,,20210521.0,,HP,CN,CN,2021,Q2,Elderly
192822552,19282255,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,40.0,DF,,QD,2021,Q2,Anaemia,,2021,Q2,2,F,20201103.0,20210608.0,20210521,20210615,EXP,,US-JNJFOC-20201110900,JOHNSON AND JOHNSON,,71.0,YR,E,F,Y,61.29,KG,20210616.0,,HP,US,US,2021,Q2,Elderly
192822552,19282255,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,40.0,DF,,QD,2021,Q2,Cardiac failure congestive,,2021,Q2,2,F,20201103.0,20210608.0,20210521,20210615,EXP,,US-JNJFOC-20201110900,JOHNSON AND JOHNSON,,71.0,YR,E,F,Y,61.29,KG,20210616.0,,HP,US,US,2021,Q2,Elderly
192822552,19282255,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,40.0,DF,,QD,2021,Q2,Device related sepsis,,2021,Q2,2,F,20201103.0,20210608.0,20210521,20210615,EXP,,US-JNJFOC-20201110900,JOHNSON AND JOHNSON,,71.0,YR,E,F,Y,61.29,KG,20210616.0,,HP,US,US,2021,Q2,Elderly
192822552,19282255,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,40.0,DF,,QD,2021,Q2,Infusion site phlebitis,,2021,Q2,2,F,20201103.0,20210608.0,20210521,20210615,EXP,,US-JNJFOC-20201110900,JOHNSON AND JOHNSON,,71.0,YR,E,F,Y,61.29,KG,20210616.0,,HP,US,US,2021,Q2,Elderly
192822552,19282255,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,40.0,DF,,QD,2021,Q2,Myalgia,,2021,Q2,2,F,20201103.0,20210608.0,20210521,20210615,EXP,,US-JNJFOC-20201110900,JOHNSON AND JOHNSON,,71.0,YR,E,F,Y,61.29,KG,20210616.0,,HP,US,US,2021,Q2,Elderly
192822552,19282255,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,TAKE IN PM,,,,,,,,20.0,DF,,QD,2021,Q2,Anaemia,,2021,Q2,2,F,20201103.0,20210608.0,20210521,20210615,EXP,,US-JNJFOC-20201110900,JOHNSON AND JOHNSON,,71.0,YR,E,F,Y,61.29,KG,20210616.0,,HP,US,US,2021,Q2,Elderly
192822552,19282255,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,TAKE IN PM,,,,,,,,20.0,DF,,QD,2021,Q2,Cardiac failure congestive,,2021,Q2,2,F,20201103.0,20210608.0,20210521,20210615,EXP,,US-JNJFOC-20201110900,JOHNSON AND JOHNSON,,71.0,YR,E,F,Y,61.29,KG,20210616.0,,HP,US,US,2021,Q2,Elderly
192822552,19282255,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,TAKE IN PM,,,,,,,,20.0,DF,,QD,2021,Q2,Device related sepsis,,2021,Q2,2,F,20201103.0,20210608.0,20210521,20210615,EXP,,US-JNJFOC-20201110900,JOHNSON AND JOHNSON,,71.0,YR,E,F,Y,61.29,KG,20210616.0,,HP,US,US,2021,Q2,Elderly
192822552,19282255,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,TAKE IN PM,,,,,,,,20.0,DF,,QD,2021,Q2,Infusion site phlebitis,,2021,Q2,2,F,20201103.0,20210608.0,20210521,20210615,EXP,,US-JNJFOC-20201110900,JOHNSON AND JOHNSON,,71.0,YR,E,F,Y,61.29,KG,20210616.0,,HP,US,US,2021,Q2,Elderly
192822552,19282255,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,TAKE IN PM,,,,,,,,20.0,DF,,QD,2021,Q2,Myalgia,,2021,Q2,2,F,20201103.0,20210608.0,20210521,20210615,EXP,,US-JNJFOC-20201110900,JOHNSON AND JOHNSON,,71.0,YR,E,F,Y,61.29,KG,20210616.0,,HP,US,US,2021,Q2,Elderly
192839571,19283957,4,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q2,Unevaluable event,,2021,Q2,1,I,20180301.0,20210505.0,20210521,20210521,EXP,,US-CELGENEUS-USA-20210501469,CELGENE,,67.0,YR,,M,Y,,,20210521.0,,PH,US,US,2021,Q2,Elderly
192852601,19285260,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Myopathy,,2021,Q2,1,I,,20210511.0,20210521,20210521,PER,,US-APOTEX-2021AP012171,APOTEX,IRVINE NJ.. ANTI?HMGCR MYOPATHY: A RARE AND SERIOUS SIDE EFFECT OF STATINS. J AM BOARD FAM MED. 2020?33(5):785?788,54.0,YR,,F,Y,,,20210521.0,,MD,US,US,2021,Q2,Adult
192881851,19288185,4,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Parosmia,,2021,Q2,1,I,,20210421.0,20210522,20210522,EXP,,US-AUROBINDO-AUR-APL-2021-017094,AUROBINDO,,57.0,YR,,F,Y,,,20210522.0,,MD,US,US,2021,Q2,Adult
192881851,19288185,4,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Selective eating disorder,,2021,Q2,1,I,,20210421.0,20210522,20210522,EXP,,US-AUROBINDO-AUR-APL-2021-017094,AUROBINDO,,57.0,YR,,F,Y,,,20210522.0,,MD,US,US,2021,Q2,Adult
192881851,19288185,4,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Weight decreased,,2021,Q2,1,I,,20210421.0,20210522,20210522,EXP,,US-AUROBINDO-AUR-APL-2021-017094,AUROBINDO,,57.0,YR,,F,Y,,,20210522.0,,MD,US,US,2021,Q2,Adult
192894832,19289483,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,50 IU / 24H,,,,,,,,50.0,IU,,QD,2021,Q2,Acute kidney injury,,2021,Q2,2,F,2019.0,20210518.0,20210521,20210526,EXP,,ES-009507513-2105ESP004931,MERCK,,67.0,YR,,M,Y,,,20210526.0,,MD,ES,ES,2021,Q2,Elderly
192894832,19289483,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,50 IU / 24H,,,,,,,,50.0,IU,,QD,2021,Q2,Aortic valve incompetence,,2021,Q2,2,F,2019.0,20210518.0,20210521,20210526,EXP,,ES-009507513-2105ESP004931,MERCK,,67.0,YR,,M,Y,,,20210526.0,,MD,ES,ES,2021,Q2,Elderly
192894832,19289483,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,50 IU / 24H,,,,,,,,50.0,IU,,QD,2021,Q2,Hypertensive cardiomyopathy,,2021,Q2,2,F,2019.0,20210518.0,20210521,20210526,EXP,,ES-009507513-2105ESP004931,MERCK,,67.0,YR,,M,Y,,,20210526.0,,MD,ES,ES,2021,Q2,Elderly
192894832,19289483,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,50 IU / 24H,,,,,,,,50.0,IU,,QD,2021,Q2,Ischaemic cardiomyopathy,,2021,Q2,2,F,2019.0,20210518.0,20210521,20210526,EXP,,ES-009507513-2105ESP004931,MERCK,,67.0,YR,,M,Y,,,20210526.0,,MD,ES,ES,2021,Q2,Elderly
192894832,19289483,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,50 IU / 24H,,,,,,,,50.0,IU,,QD,2021,Q2,Pain,,2021,Q2,2,F,2019.0,20210518.0,20210521,20210526,EXP,,ES-009507513-2105ESP004931,MERCK,,67.0,YR,,M,Y,,,20210526.0,,MD,ES,ES,2021,Q2,Elderly
192894832,19289483,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,50 IU / 24H,,,,,,,,50.0,IU,,QD,2021,Q2,Post infection glomerulonephritis,,2021,Q2,2,F,2019.0,20210518.0,20210521,20210526,EXP,,ES-009507513-2105ESP004931,MERCK,,67.0,YR,,M,Y,,,20210526.0,,MD,ES,ES,2021,Q2,Elderly
192894832,19289483,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,50 IU / 24H,,,,,,,,50.0,IU,,QD,2021,Q2,Rehabilitation therapy,,2021,Q2,2,F,2019.0,20210518.0,20210521,20210526,EXP,,ES-009507513-2105ESP004931,MERCK,,67.0,YR,,M,Y,,,20210526.0,,MD,ES,ES,2021,Q2,Elderly
192894832,19289483,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,50 IU / 24H,,,,,,,,50.0,IU,,QD,2021,Q2,Tubulointerstitial nephritis,,2021,Q2,2,F,2019.0,20210518.0,20210521,20210526,EXP,,ES-009507513-2105ESP004931,MERCK,,67.0,YR,,M,Y,,,20210526.0,,MD,ES,ES,2021,Q2,Elderly
192894832,19289483,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,50 IU / 24H,,,,,,,,50.0,IU,,QD,2021,Q2,Weight decreased,,2021,Q2,2,F,2019.0,20210518.0,20210521,20210526,EXP,,ES-009507513-2105ESP004931,MERCK,,67.0,YR,,M,Y,,,20210526.0,,MD,ES,ES,2021,Q2,Elderly
192922672,19292267,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, QD (STARTED 5 YEARS AGO)",,,D,,,,,15.0,IU,,QD,2021,Q2,Inappropriate schedule of product administration,,2021,Q2,2,F,20210319.0,20210525.0,20210524,20210529,EXP,,NVSC2021MX115422,NOVARTIS,,56.0,YR,,M,Y,72.0,KG,20210529.0,,CN,COUNTRY NOT SPECIFIED,MX,2021,Q2,Adult
192922672,19292267,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, QD (STARTED 5 YEARS AGO)",,,D,,,,,15.0,IU,,QD,2021,Q2,Myocardial infarction,,2021,Q2,2,F,20210319.0,20210525.0,20210524,20210529,EXP,,NVSC2021MX115422,NOVARTIS,,56.0,YR,,M,Y,72.0,KG,20210529.0,,CN,COUNTRY NOT SPECIFIED,MX,2021,Q2,Adult
192922672,19292267,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, QD (STARTED 5 YEARS AGO)",,,D,,,,,15.0,IU,,QD,2021,Q2,Product use in unapproved indication,,2021,Q2,2,F,20210319.0,20210525.0,20210524,20210529,EXP,,NVSC2021MX115422,NOVARTIS,,56.0,YR,,M,Y,72.0,KG,20210529.0,,CN,COUNTRY NOT SPECIFIED,MX,2021,Q2,Adult
192947702,19294770,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,INJECTION,,2021,Q2,Immune-mediated myositis,,2021,Q2,2,F,,20210527.0,20210524,20210609,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-07577,LUPIN,,54.0,YR,,F,Y,,,20210609.0,,CN,NL,US,2021,Q2,Adult
192947702,19294770,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,INJECTION,,2021,Q2,Myopathy,,2021,Q2,2,F,,20210527.0,20210524,20210609,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-07577,LUPIN,,54.0,YR,,F,Y,,,20210609.0,,CN,NL,US,2021,Q2,Adult
192948601,19294860,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,24 INTERNATIONAL UNIT (24 IU),,,Y,,,,210605.0,24.0,IU,INJECTION,,2021,Q2,Amnesia,,2021,Q2,1,I,,20210517.0,20210524,20210524,EXP,,ES-MYLANLABS-2021M1029228,MYLAN,,79.0,YR,,F,Y,,,20210524.0,,CN,ES,ES,2021,Q2,Elderly
192948601,19294860,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,24 INTERNATIONAL UNIT (24 IU),,,Y,,,,210605.0,24.0,IU,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,,20210517.0,20210524,20210524,EXP,,ES-MYLANLABS-2021M1029228,MYLAN,,79.0,YR,,F,Y,,,20210524.0,,CN,ES,ES,2021,Q2,Elderly
192948601,19294860,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,24 INTERNATIONAL UNIT (24 IU),,,Y,,,,210605.0,24.0,IU,INJECTION,,2021,Q2,Disorganised speech,,2021,Q2,1,I,,20210517.0,20210524,20210524,EXP,,ES-MYLANLABS-2021M1029228,MYLAN,,79.0,YR,,F,Y,,,20210524.0,,CN,ES,ES,2021,Q2,Elderly
192948601,19294860,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,24 INTERNATIONAL UNIT (24 IU),,,Y,,,,210605.0,24.0,IU,INJECTION,,2021,Q2,Swelling face,,2021,Q2,1,I,,20210517.0,20210524,20210524,EXP,,ES-MYLANLABS-2021M1029228,MYLAN,,79.0,YR,,F,Y,,,20210524.0,,CN,ES,ES,2021,Q2,Elderly
192948601,19294860,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,22 INTERNATIONAL UNIT/ (22 IU (DOSE REDUCED)),,,Y,,,,210605.0,22.0,IU,INJECTION,,2021,Q2,Amnesia,,2021,Q2,1,I,,20210517.0,20210524,20210524,EXP,,ES-MYLANLABS-2021M1029228,MYLAN,,79.0,YR,,F,Y,,,20210524.0,,CN,ES,ES,2021,Q2,Elderly
192948601,19294860,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,22 INTERNATIONAL UNIT/ (22 IU (DOSE REDUCED)),,,Y,,,,210605.0,22.0,IU,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,,20210517.0,20210524,20210524,EXP,,ES-MYLANLABS-2021M1029228,MYLAN,,79.0,YR,,F,Y,,,20210524.0,,CN,ES,ES,2021,Q2,Elderly
192948601,19294860,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,22 INTERNATIONAL UNIT/ (22 IU (DOSE REDUCED)),,,Y,,,,210605.0,22.0,IU,INJECTION,,2021,Q2,Disorganised speech,,2021,Q2,1,I,,20210517.0,20210524,20210524,EXP,,ES-MYLANLABS-2021M1029228,MYLAN,,79.0,YR,,F,Y,,,20210524.0,,CN,ES,ES,2021,Q2,Elderly
192948601,19294860,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,22 INTERNATIONAL UNIT/ (22 IU (DOSE REDUCED)),,,Y,,,,210605.0,22.0,IU,INJECTION,,2021,Q2,Swelling face,,2021,Q2,1,I,,20210517.0,20210524,20210524,EXP,,ES-MYLANLABS-2021M1029228,MYLAN,,79.0,YR,,F,Y,,,20210524.0,,CN,ES,ES,2021,Q2,Elderly
192949241,19294924,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"8 U, 1X/DAY:QD, DAILY",,,D,,,,,,,,QD,2021,Q2,Adrenocortical insufficiency acute,,2021,Q2,1,I,20151224.0,20210512.0,20210524,20210524,EXP,,DE-BAUSCH-BL-2021-017376,BAUSCH AND LOMB,,64.0,YR,,F,Y,,,20210524.0,,MD,DE,DE,2021,Q2,Adult
193008001,19300800,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 IU, 1X/DAY:QD",,,,,,,,8.0,IU,,QD,2021,Q2,Adrenocortical insufficiency acute,,2021,Q2,1,I,20151129.0,20210512.0,20210524,20210524,EXP,,DE-BAUSCH-BL-2021-017378,BAUSCH AND LOMB,,64.0,YR,,F,Y,,,20210524.0,,MD,DE,DE,2021,Q2,Adult
193008681,19300868,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12UNITS,,,,,,,,,,INJECTION,,2021,Q2,Blood glucose decreased,,2021,Q2,1,I,202104.0,20210518.0,20210524,20210524,PER,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-105229",BOEHRINGER INGELHEIM,,77.0,YR,E,F,Y,,,20210524.0,,CN,US,US,2021,Q2,Elderly
193008681,19300868,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12UNITS,,,,,,,,,,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,202104.0,20210518.0,20210524,20210524,PER,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-105229",BOEHRINGER INGELHEIM,,77.0,YR,E,F,Y,,,20210524.0,,CN,US,US,2021,Q2,Elderly
193008681,19300868,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12UNITS,,,,,,,,,,INJECTION,,2021,Q2,Urinary tract infection,,2021,Q2,1,I,202104.0,20210518.0,20210524,20210524,PER,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-105229",BOEHRINGER INGELHEIM,,77.0,YR,E,F,Y,,,20210524.0,,CN,US,US,2021,Q2,Elderly
193033233,19303323,11,C,Insulin Glargine BS,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,UNKNOWN,,2021,Q2,Interstitial lung disease,,2021,Q2,3,F,20201216.0,20210525.0,20210525,20210602,EXP,,JP-CELGENEUS-JPN-20210505440,CELGENE,,80.0,YR,,F,Y,,,20210602.0,,PH,JP,JP,2021,Q2,Elderly
193060021,19306002,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q2,Asthma,,2021,Q2,1,I,,20210517.0,20210526,20210526,EXP,CA- HEALTHCANVIG- E2B_03692076,CA-NOVOPROD-814010,NOVO NORDISK,,65.0,YR,,M,Y,,,20210526.0,,CN,CA,CA,2021,Q2,Elderly
193060021,19306002,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q2,Condition aggravated,,2021,Q2,1,I,,20210517.0,20210526,20210526,EXP,CA- HEALTHCANVIG- E2B_03692076,CA-NOVOPROD-814010,NOVO NORDISK,,65.0,YR,,M,Y,,,20210526.0,,CN,CA,CA,2021,Q2,Elderly
193060021,19306002,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q2,Dyspnoea,,2021,Q2,1,I,,20210517.0,20210526,20210526,EXP,CA- HEALTHCANVIG- E2B_03692076,CA-NOVOPROD-814010,NOVO NORDISK,,65.0,YR,,M,Y,,,20210526.0,,CN,CA,CA,2021,Q2,Elderly
193060021,19306002,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q2,Haemoptysis,,2021,Q2,1,I,,20210517.0,20210526,20210526,EXP,CA- HEALTHCANVIG- E2B_03692076,CA-NOVOPROD-814010,NOVO NORDISK,,65.0,YR,,M,Y,,,20210526.0,,CN,CA,CA,2021,Q2,Elderly
193060021,19306002,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q2,Loss of personal independence in daily activities,,2021,Q2,1,I,,20210517.0,20210526,20210526,EXP,CA- HEALTHCANVIG- E2B_03692076,CA-NOVOPROD-814010,NOVO NORDISK,,65.0,YR,,M,Y,,,20210526.0,,CN,CA,CA,2021,Q2,Elderly
193060021,19306002,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q2,Lung disorder,,2021,Q2,1,I,,20210517.0,20210526,20210526,EXP,CA- HEALTHCANVIG- E2B_03692076,CA-NOVOPROD-814010,NOVO NORDISK,,65.0,YR,,M,Y,,,20210526.0,,CN,CA,CA,2021,Q2,Elderly
193060021,19306002,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q2,Neuritis,,2021,Q2,1,I,,20210517.0,20210526,20210526,EXP,CA- HEALTHCANVIG- E2B_03692076,CA-NOVOPROD-814010,NOVO NORDISK,,65.0,YR,,M,Y,,,20210526.0,,CN,CA,CA,2021,Q2,Elderly
193060021,19306002,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q2,Neurological symptom,,2021,Q2,1,I,,20210517.0,20210526,20210526,EXP,CA- HEALTHCANVIG- E2B_03692076,CA-NOVOPROD-814010,NOVO NORDISK,,65.0,YR,,M,Y,,,20210526.0,,CN,CA,CA,2021,Q2,Elderly
193060021,19306002,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q2,Obstructive airways disorder,,2021,Q2,1,I,,20210517.0,20210526,20210526,EXP,CA- HEALTHCANVIG- E2B_03692076,CA-NOVOPROD-814010,NOVO NORDISK,,65.0,YR,,M,Y,,,20210526.0,,CN,CA,CA,2021,Q2,Elderly
193060021,19306002,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q2,Pain in extremity,,2021,Q2,1,I,,20210517.0,20210526,20210526,EXP,CA- HEALTHCANVIG- E2B_03692076,CA-NOVOPROD-814010,NOVO NORDISK,,65.0,YR,,M,Y,,,20210526.0,,CN,CA,CA,2021,Q2,Elderly
193060021,19306002,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q2,Pulmonary alveolar haemorrhage,,2021,Q2,1,I,,20210517.0,20210526,20210526,EXP,CA- HEALTHCANVIG- E2B_03692076,CA-NOVOPROD-814010,NOVO NORDISK,,65.0,YR,,M,Y,,,20210526.0,,CN,CA,CA,2021,Q2,Elderly
193060021,19306002,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q2,Pulmonary fibrosis,,2021,Q2,1,I,,20210517.0,20210526,20210526,EXP,CA- HEALTHCANVIG- E2B_03692076,CA-NOVOPROD-814010,NOVO NORDISK,,65.0,YR,,M,Y,,,20210526.0,,CN,CA,CA,2021,Q2,Elderly
193060021,19306002,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q2,Pulmonary vasculitis,,2021,Q2,1,I,,20210517.0,20210526,20210526,EXP,CA- HEALTHCANVIG- E2B_03692076,CA-NOVOPROD-814010,NOVO NORDISK,,65.0,YR,,M,Y,,,20210526.0,,CN,CA,CA,2021,Q2,Elderly
193060021,19306002,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q2,Respiratory symptom,,2021,Q2,1,I,,20210517.0,20210526,20210526,EXP,CA- HEALTHCANVIG- E2B_03692076,CA-NOVOPROD-814010,NOVO NORDISK,,65.0,YR,,M,Y,,,20210526.0,,CN,CA,CA,2021,Q2,Elderly
193060021,19306002,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q2,Sleep disorder due to a general medical condition,,2021,Q2,1,I,,20210517.0,20210526,20210526,EXP,CA- HEALTHCANVIG- E2B_03692076,CA-NOVOPROD-814010,NOVO NORDISK,,65.0,YR,,M,Y,,,20210526.0,,CN,CA,CA,2021,Q2,Elderly
193060021,19306002,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q2,Therapeutic product effect incomplete,,2021,Q2,1,I,,20210517.0,20210526,20210526,EXP,CA- HEALTHCANVIG- E2B_03692076,CA-NOVOPROD-814010,NOVO NORDISK,,65.0,YR,,M,Y,,,20210526.0,,CN,CA,CA,2021,Q2,Elderly
193060021,19306002,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q2,Vasculitis,,2021,Q2,1,I,,20210517.0,20210526,20210526,EXP,CA- HEALTHCANVIG- E2B_03692076,CA-NOVOPROD-814010,NOVO NORDISK,,65.0,YR,,M,Y,,,20210526.0,,CN,CA,CA,2021,Q2,Elderly
193060021,19306002,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q2,Wheezing,,2021,Q2,1,I,,20210517.0,20210526,20210526,EXP,CA- HEALTHCANVIG- E2B_03692076,CA-NOVOPROD-814010,NOVO NORDISK,,65.0,YR,,M,Y,,,20210526.0,,CN,CA,CA,2021,Q2,Elderly
193077942,19307794,52,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Peritonitis bacterial,,2021,Q2,2,F,20210520.0,20210602.0,20210526,20210604,EXP,,NVSC2021US115927,NOVARTIS,,58.0,YR,,M,Y,72.6,KG,20210604.0,,HP,US,US,2021,Q2,Adult
193077942,19307794,53,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Peritonitis bacterial,,2021,Q2,2,F,20210520.0,20210602.0,20210526,20210604,EXP,,NVSC2021US115927,NOVARTIS,,58.0,YR,,M,Y,72.6,KG,20210604.0,,HP,US,US,2021,Q2,Adult
193077942,19307794,54,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Peritonitis bacterial,,2021,Q2,2,F,20210520.0,20210602.0,20210526,20210604,EXP,,NVSC2021US115927,NOVARTIS,,58.0,YR,,M,Y,72.6,KG,20210604.0,,HP,US,US,2021,Q2,Adult
193127401,19312740,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,C-reactive protein increased,,2021,Q2,1,I,,20210517.0,20210527,20210527,EXP,,CA-APOTEX-2021AP012366,APOTEX,,49.0,YR,,F,Y,,,20210527.0,,CN,CA,CA,2021,Q2,Adult
193127401,19312740,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Dactylitis,,2021,Q2,1,I,,20210517.0,20210527,20210527,EXP,,CA-APOTEX-2021AP012366,APOTEX,,49.0,YR,,F,Y,,,20210527.0,,CN,CA,CA,2021,Q2,Adult
193127401,19312740,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Drug ineffective,,2021,Q2,1,I,,20210517.0,20210527,20210527,EXP,,CA-APOTEX-2021AP012366,APOTEX,,49.0,YR,,F,Y,,,20210527.0,,CN,CA,CA,2021,Q2,Adult
193127401,19312740,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Herpes zoster,,2021,Q2,1,I,,20210517.0,20210527,20210527,EXP,,CA-APOTEX-2021AP012366,APOTEX,,49.0,YR,,F,Y,,,20210527.0,,CN,CA,CA,2021,Q2,Adult
193127401,19312740,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Psoriasis,,2021,Q2,1,I,,20210517.0,20210527,20210527,EXP,,CA-APOTEX-2021AP012366,APOTEX,,49.0,YR,,F,Y,,,20210527.0,,CN,CA,CA,2021,Q2,Adult
193127401,19312740,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Psoriatic arthropathy,,2021,Q2,1,I,,20210517.0,20210527,20210527,EXP,,CA-APOTEX-2021AP012366,APOTEX,,49.0,YR,,F,Y,,,20210527.0,,CN,CA,CA,2021,Q2,Adult
193127401,19312740,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Rash,,2021,Q2,1,I,,20210517.0,20210527,20210527,EXP,,CA-APOTEX-2021AP012366,APOTEX,,49.0,YR,,F,Y,,,20210527.0,,CN,CA,CA,2021,Q2,Adult
193134211,19313421,1,PS,"INSULIN (INSULIN, GLARGINE , HUMAN 100 UNT/ML/INJ)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER STRENGTH:100 UNT/ML;?,,,D,D,,,,5.0,DF,,HS,2021,Q2,Hyperglycaemia,,2021,Q2,1,I,20201023.0,,20210526,20210526,DIR,,,FDA-CTU,,61.0,YR,,F,N,50.35,KG,20210212.0,N,PH,US,US,2021,Q2,Adult
193136901,19313690,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q2,Diabetic ketoacidosis,,2021,Q2,1,I,20210513.0,20210520.0,20210527,20210527,EXP,GB-MHRA-EYC 00251058,GB-JNJFOC-20210541988,JOHNSON AND JOHNSON,,65.0,YR,E,M,Y,70.0,KG,20210527.0,,PH,GB,GB,2021,Q2,Elderly
193136901,19313690,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q2,Medication error,,2021,Q2,1,I,20210513.0,20210520.0,20210527,20210527,EXP,GB-MHRA-EYC 00251058,GB-JNJFOC-20210541988,JOHNSON AND JOHNSON,,65.0,YR,E,M,Y,70.0,KG,20210527.0,,PH,GB,GB,2021,Q2,Elderly
193136901,19313690,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q2,Toe amputation,,2021,Q2,1,I,20210513.0,20210520.0,20210527,20210527,EXP,GB-MHRA-EYC 00251058,GB-JNJFOC-20210541988,JOHNSON AND JOHNSON,,65.0,YR,E,M,Y,70.0,KG,20210527.0,,PH,GB,GB,2021,Q2,Elderly
193139343,19313934,2,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,900 U,,,U,,,,,900.0,IU,,,2021,Q2,Hypoglycaemia,,2021,Q2,3,F,20000519.0,20210609.0,20210527,20210616,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202105009177,ELI LILLY AND CO,"HARI Y, ET AL..TWO CASES OF PROLONGED HYPOGLYCAEMIA DUE TO ADMINISTRATION OF HIGH DOSE INSULIN FOR SUICIDE ATTEMPT.THE JAPAN DIABETIC SOCIETY 2021?:37?6.",40.0,YR,,F,Y,,,20210616.0,,MD,JP,JP,2021,Q2,Adult
193139343,19313934,2,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,900 U,,,U,,,,,900.0,IU,,,2021,Q2,Intentional overdose,,2021,Q2,3,F,20000519.0,20210609.0,20210527,20210616,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202105009177,ELI LILLY AND CO,"HARI Y, ET AL..TWO CASES OF PROLONGED HYPOGLYCAEMIA DUE TO ADMINISTRATION OF HIGH DOSE INSULIN FOR SUICIDE ATTEMPT.THE JAPAN DIABETIC SOCIETY 2021?:37?6.",40.0,YR,,F,Y,,,20210616.0,,MD,JP,JP,2021,Q2,Adult
193139343,19313934,2,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,900 U,,,U,,,,,900.0,IU,,,2021,Q2,Suicide attempt,,2021,Q2,3,F,20000519.0,20210609.0,20210527,20210616,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202105009177,ELI LILLY AND CO,"HARI Y, ET AL..TWO CASES OF PROLONGED HYPOGLYCAEMIA DUE TO ADMINISTRATION OF HIGH DOSE INSULIN FOR SUICIDE ATTEMPT.THE JAPAN DIABETIC SOCIETY 2021?:37?6.",40.0,YR,,F,Y,,,20210616.0,,MD,JP,JP,2021,Q2,Adult
193166511,19316651,12,C,INSULINE GLARGINE 100E/ML INJVLST / LANTUS INJ 100E/ML PATROON 3ML,,2,,100 UNITS / ML (UNITS PER MILLILITER)THERAPY START DATE :THERAPY END DATE :ASKU,,,,, UNKNOWN,,,,,SOLUTION FOR INJECTION,,2021,Q2,Haemoglobin decreased,,2021,Q2,1,I,20210420.0,20210520.0,20210527,20210527,EXP,NL-LRB-00532172,NL-TEVA-2021-NL-1916149,TEVA,,76.0,YR,E,M,Y,72.9,KG,20210527.0,,PH,NL,NL,2021,Q2,Elderly
193166511,19316651,12,C,INSULINE GLARGINE 100E/ML INJVLST / LANTUS INJ 100E/ML PATROON 3ML,,2,,100 UNITS / ML (UNITS PER MILLILITER)THERAPY START DATE :THERAPY END DATE :ASKU,,,,, UNKNOWN,,,,,SOLUTION FOR INJECTION,,2021,Q2,Lymphopenia,,2021,Q2,1,I,20210420.0,20210520.0,20210527,20210527,EXP,NL-LRB-00532172,NL-TEVA-2021-NL-1916149,TEVA,,76.0,YR,E,M,Y,72.9,KG,20210527.0,,PH,NL,NL,2021,Q2,Elderly
193166511,19316651,12,C,INSULINE GLARGINE 100E/ML INJVLST / LANTUS INJ 100E/ML PATROON 3ML,,2,,100 UNITS / ML (UNITS PER MILLILITER)THERAPY START DATE :THERAPY END DATE :ASKU,,,,, UNKNOWN,,,,,SOLUTION FOR INJECTION,,2021,Q2,Thrombocytopenia,,2021,Q2,1,I,20210420.0,20210520.0,20210527,20210527,EXP,NL-LRB-00532172,NL-TEVA-2021-NL-1916149,TEVA,,76.0,YR,E,M,Y,72.9,KG,20210527.0,,PH,NL,NL,2021,Q2,Elderly
193169431,19316943,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Euglycaemic diabetic ketoacidosis,,2021,Q2,1,I,,20210423.0,20210527,20210527,EXP,,AE-ASTRAZENECA-2021A467286,ASTRAZENECA,,65.0,YR,,F,Y,,,20210527.0,,HP,AE,AE,2021,Q2,Elderly
193207991,19320799,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Cardiac failure congestive,,2021,Q2,1,I,20200930.0,20200930.0,20210527,20210527,EXP,,NVSC2020US266135,NOVARTIS,,56.0,YR,,F,Y,50.0,KG,20210527.0,,HP,US,US,2021,Q2,Adult
193212781,19321278,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,,20210524.0,20210527,20210527,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202105011357,ELI LILLY AND CO,,13.0,YR,,,Y,51.0,KG,20210527.0,,CN,CN,CN,2021,Q2,Child
193212781,19321278,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Infusion site haemorrhage,,2021,Q2,1,I,,20210524.0,20210527,20210527,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202105011357,ELI LILLY AND CO,,13.0,YR,,,Y,51.0,KG,20210527.0,,CN,CN,CN,2021,Q2,Child
193212781,19321278,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Infusion site hypersensitivity,,2021,Q2,1,I,,20210524.0,20210527,20210527,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202105011357,ELI LILLY AND CO,,13.0,YR,,,Y,51.0,KG,20210527.0,,CN,CN,CN,2021,Q2,Child
193212781,19321278,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Infusion site injury,,2021,Q2,1,I,,20210524.0,20210527,20210527,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202105011357,ELI LILLY AND CO,,13.0,YR,,,Y,51.0,KG,20210527.0,,CN,CN,CN,2021,Q2,Child
193232851,19323285,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Acute kidney injury,,2021,Q2,1,I,,20210518.0,20210528,20210528,EXP,,US-APOTEX-2021AP012636,APOTEX,,48.0,YR,,F,Y,,,20210528.0,,HP,US,US,2021,Q2,Adult
193232851,19323285,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Antipsychotic drug level increased,,2021,Q2,1,I,,20210518.0,20210528,20210528,EXP,,US-APOTEX-2021AP012636,APOTEX,,48.0,YR,,F,Y,,,20210528.0,,HP,US,US,2021,Q2,Adult
193232851,19323285,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Balance disorder,,2021,Q2,1,I,,20210518.0,20210528,20210528,EXP,,US-APOTEX-2021AP012636,APOTEX,,48.0,YR,,F,Y,,,20210528.0,,HP,US,US,2021,Q2,Adult
193232851,19323285,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Confusional state,,2021,Q2,1,I,,20210518.0,20210528,20210528,EXP,,US-APOTEX-2021AP012636,APOTEX,,48.0,YR,,F,Y,,,20210528.0,,HP,US,US,2021,Q2,Adult
193232851,19323285,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Dizziness,,2021,Q2,1,I,,20210518.0,20210528,20210528,EXP,,US-APOTEX-2021AP012636,APOTEX,,48.0,YR,,F,Y,,,20210528.0,,HP,US,US,2021,Q2,Adult
193232851,19323285,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Drug interaction,,2021,Q2,1,I,,20210518.0,20210528,20210528,EXP,,US-APOTEX-2021AP012636,APOTEX,,48.0,YR,,F,Y,,,20210528.0,,HP,US,US,2021,Q2,Adult
193232851,19323285,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Fall,,2021,Q2,1,I,,20210518.0,20210528,20210528,EXP,,US-APOTEX-2021AP012636,APOTEX,,48.0,YR,,F,Y,,,20210528.0,,HP,US,US,2021,Q2,Adult
193232851,19323285,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Grip strength decreased,,2021,Q2,1,I,,20210518.0,20210528,20210528,EXP,,US-APOTEX-2021AP012636,APOTEX,,48.0,YR,,F,Y,,,20210528.0,,HP,US,US,2021,Q2,Adult
193232851,19323285,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Hyponatraemia,,2021,Q2,1,I,,20210518.0,20210528,20210528,EXP,,US-APOTEX-2021AP012636,APOTEX,,48.0,YR,,F,Y,,,20210528.0,,HP,US,US,2021,Q2,Adult
193232851,19323285,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Hypovolaemia,,2021,Q2,1,I,,20210518.0,20210528,20210528,EXP,,US-APOTEX-2021AP012636,APOTEX,,48.0,YR,,F,Y,,,20210528.0,,HP,US,US,2021,Q2,Adult
193232851,19323285,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Limb discomfort,,2021,Q2,1,I,,20210518.0,20210528,20210528,EXP,,US-APOTEX-2021AP012636,APOTEX,,48.0,YR,,F,Y,,,20210528.0,,HP,US,US,2021,Q2,Adult
193232851,19323285,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Movement disorder,,2021,Q2,1,I,,20210518.0,20210528,20210528,EXP,,US-APOTEX-2021AP012636,APOTEX,,48.0,YR,,F,Y,,,20210528.0,,HP,US,US,2021,Q2,Adult
193232851,19323285,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Mucosal dryness,,2021,Q2,1,I,,20210518.0,20210528,20210528,EXP,,US-APOTEX-2021AP012636,APOTEX,,48.0,YR,,F,Y,,,20210528.0,,HP,US,US,2021,Q2,Adult
193232851,19323285,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Nausea,,2021,Q2,1,I,,20210518.0,20210528,20210528,EXP,,US-APOTEX-2021AP012636,APOTEX,,48.0,YR,,F,Y,,,20210528.0,,HP,US,US,2021,Q2,Adult
193232851,19323285,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Toxicity to various agents,,2021,Q2,1,I,,20210518.0,20210528,20210528,EXP,,US-APOTEX-2021AP012636,APOTEX,,48.0,YR,,F,Y,,,20210528.0,,HP,US,US,2021,Q2,Adult
193232851,19323285,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Tremor,,2021,Q2,1,I,,20210518.0,20210528,20210528,EXP,,US-APOTEX-2021AP012636,APOTEX,,48.0,YR,,F,Y,,,20210528.0,,HP,US,US,2021,Q2,Adult
193232851,19323285,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Vomiting,,2021,Q2,1,I,,20210518.0,20210528,20210528,EXP,,US-APOTEX-2021AP012636,APOTEX,,48.0,YR,,F,Y,,,20210528.0,,HP,US,US,2021,Q2,Adult
193239231,19323923,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,LONGSTANDING MEDICATION,,,U,U,,,,,,,,2021,Q2,Acute kidney injury,,2021,Q2,1,I,,20210518.0,20210528,20210528,EXP,,US-MYLANLABS-2021M1030685,MYLAN,,48.0,YR,,F,Y,,,20210528.0,,HP,US,US,2021,Q2,Adult
193239231,19323923,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,LONGSTANDING MEDICATION,,,U,U,,,,,,,,2021,Q2,Brugada syndrome,,2021,Q2,1,I,,20210518.0,20210528,20210528,EXP,,US-MYLANLABS-2021M1030685,MYLAN,,48.0,YR,,F,Y,,,20210528.0,,HP,US,US,2021,Q2,Adult
193239231,19323923,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,LONGSTANDING MEDICATION,,,U,U,,,,,,,,2021,Q2,Drug interaction,,2021,Q2,1,I,,20210518.0,20210528,20210528,EXP,,US-MYLANLABS-2021M1030685,MYLAN,,48.0,YR,,F,Y,,,20210528.0,,HP,US,US,2021,Q2,Adult
193239231,19323923,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,LONGSTANDING MEDICATION,,,U,U,,,,,,,,2021,Q2,Hyponatraemia,,2021,Q2,1,I,,20210518.0,20210528,20210528,EXP,,US-MYLANLABS-2021M1030685,MYLAN,,48.0,YR,,F,Y,,,20210528.0,,HP,US,US,2021,Q2,Adult
193239231,19323923,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,LONGSTANDING MEDICATION,,,U,U,,,,,,,,2021,Q2,Hypovolaemia,,2021,Q2,1,I,,20210518.0,20210528,20210528,EXP,,US-MYLANLABS-2021M1030685,MYLAN,,48.0,YR,,F,Y,,,20210528.0,,HP,US,US,2021,Q2,Adult
193239231,19323923,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,LONGSTANDING MEDICATION,,,U,U,,,,,,,,2021,Q2,Toxicity to various agents,,2021,Q2,1,I,,20210518.0,20210528,20210528,EXP,,US-MYLANLABS-2021M1030685,MYLAN,,48.0,YR,,F,Y,,,20210528.0,,HP,US,US,2021,Q2,Adult
193239231,19323923,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,LONGSTANDING MEDICATION,,,U,U,,,,,,,,2021,Q2,Unmasking of previously unidentified disease,,2021,Q2,1,I,,20210518.0,20210528,20210528,EXP,,US-MYLANLABS-2021M1030685,MYLAN,,48.0,YR,,F,Y,,,20210528.0,,HP,US,US,2021,Q2,Adult
193257861,19325786,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Arthralgia,,2021,Q2,1,I,,20210517.0,20210528,20210528,EXP,,CA-APOTEX-2021AP012333,APOTEX,,14.0,YR,,F,Y,41.0,KG,20210528.0,,CN,CA,CA,2021,Q2,Youth
193257861,19325786,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Joint swelling,,2021,Q2,1,I,,20210517.0,20210528,20210528,EXP,,CA-APOTEX-2021AP012333,APOTEX,,14.0,YR,,F,Y,41.0,KG,20210528.0,,CN,CA,CA,2021,Q2,Youth
193257861,19325786,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Pain,,2021,Q2,1,I,,20210517.0,20210528,20210528,EXP,,CA-APOTEX-2021AP012333,APOTEX,,14.0,YR,,F,Y,41.0,KG,20210528.0,,CN,CA,CA,2021,Q2,Youth
193257861,19325786,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Rash macular,,2021,Q2,1,I,,20210517.0,20210528,20210528,EXP,,CA-APOTEX-2021AP012333,APOTEX,,14.0,YR,,F,Y,41.0,KG,20210528.0,,CN,CA,CA,2021,Q2,Youth
193271241,19327124,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,60 IU,,,Y,,,,21081.0,60.0,IU,,,2021,Q2,Interstitial lung disease,,2021,Q2,1,I,20210403.0,20210517.0,20210528,20210528,EXP,FR-AFSSAPS-PV20210970,FR-SA-2021SA163771,SANOFI AVENTIS,,50.0,YR,A,M,Y,81.0,KG,20210528.0,,MD,FR,FR,2021,Q2,Adult
193277932,19327793,18,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Acute kidney injury,,2021,Q2,2,F,20201113.0,20210620.0,20210528,20210625,EXP,,JP-GILEAD-2021-0532329,GILEAD,,67.0,YR,E,M,Y,,,20210625.0,,MD,JP,JP,2021,Q2,Elderly
193277932,19327793,18,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Metabolic acidosis,,2021,Q2,2,F,20201113.0,20210620.0,20210528,20210625,EXP,,JP-GILEAD-2021-0532329,GILEAD,,67.0,YR,E,M,Y,,,20210625.0,,MD,JP,JP,2021,Q2,Elderly
193278441,19327844,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Treatment failure,,2021,Q2,1,I,,20210518.0,20210528,20210528,EXP,,US-MICRO LABS LIMITED-ML2021-01666,MICRO LABS,"LEWIS P, THARP J. BREAKTHROUGH VENOUS THROMBOEMBOLIC EVENTS IN FIVE PATIENTS WITH COVID?19 ON DIRECT ORAL ANTICOAGULANTS.. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS. 2021?46 (2):519?523.",70.0,YR,,M,Y,,,20210528.0,,HP,US,US,2021,Q2,Elderly
193283091,19328309,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Autoimmune haemolytic anaemia,,2021,Q2,1,I,,20210514.0,20210529,20210529,EXP,,FR-AUROBINDO-AUR-APL-2021-020700,AUROBINDO,,43.0,YR,,F,Y,,,20210529.0,,HP,FR,FR,2021,Q2,Adult
193283091,19328309,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Dyspnoea,,2021,Q2,1,I,,20210514.0,20210529,20210529,EXP,,FR-AUROBINDO-AUR-APL-2021-020700,AUROBINDO,,43.0,YR,,F,Y,,,20210529.0,,HP,FR,FR,2021,Q2,Adult
193284232,19328423,1,PS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,205692.0,,,INJECTION,,2021,Q2,Autoimmune hepatitis,,2021,Q2,2,F,,20210601.0,20210528,20210611,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202105008673,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20210611.0,,MD,JP,JP,2021,Q2,Elderly
193284232,19328423,1,PS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,205692.0,,,INJECTION,,2021,Q2,Hepatic function abnormal,,2021,Q2,2,F,,20210601.0,20210528,20210611,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202105008673,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20210611.0,,MD,JP,JP,2021,Q2,Elderly
193291381,19329138,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Insulin autoimmune syndrome,,2021,Q2,1,I,,20210523.0,20210528,20210528,EXP,,US-ASTRAZENECA-2021A472939,ASTRAZENECA,,63.0,YR,,M,Y,,,20210528.0,,MD,US,US,2021,Q2,Adult
193291381,19329138,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Type 1 diabetes mellitus,,2021,Q2,1,I,,20210523.0,20210528,20210528,EXP,,US-ASTRAZENECA-2021A472939,ASTRAZENECA,,63.0,YR,,M,Y,,,20210528.0,,MD,US,US,2021,Q2,Adult
193494951,19349495,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,10 IU INTERNATIONAL UNIT(S) PER DAY NIGHTLY,,,,,,,,,,,,2021,Q2,Off label use,,2021,Q2,1,I,,20200515.0,20210531,20210531,PER,US-MLMSERVICE-20200508-2294334-1,US-STRIDES ARCOLAB LIMITED-2020SP006002,STRIDES,,69.0,YR,,M,Y,,,20210531.0,,,NL,US,2021,Q2,Elderly
193499131,19349913,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,, UNKNOWN,,,,,,,2021,Q2,Parosmia,,2021,Q2,1,I,,20210517.0,20210531,20210531,PER,,US-DRREDDYS-USA/USA/21/0135740,DR REDDYS,"MALATY J, ROUSSEAU C. DYSOSMIA AND DRUG TOLERANCE WITH USE OF VENLAFAXINE. BMJ CASE REP. 2021?14(4):1?3. DOI:10.1136/BCR?2020?240547",57.0,YR,A,F,Y,,,20210529.0,,MD,US,US,2021,Q2,Adult
193499131,19349913,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,, UNKNOWN,,,,,,,2021,Q2,Selective eating disorder,,2021,Q2,1,I,,20210517.0,20210531,20210531,PER,,US-DRREDDYS-USA/USA/21/0135740,DR REDDYS,"MALATY J, ROUSSEAU C. DYSOSMIA AND DRUG TOLERANCE WITH USE OF VENLAFAXINE. BMJ CASE REP. 2021?14(4):1?3. DOI:10.1136/BCR?2020?240547",57.0,YR,A,F,Y,,,20210529.0,,MD,US,US,2021,Q2,Adult
193499131,19349913,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,, UNKNOWN,,,,,,,2021,Q2,Weight decreased,,2021,Q2,1,I,,20210517.0,20210531,20210531,PER,,US-DRREDDYS-USA/USA/21/0135740,DR REDDYS,"MALATY J, ROUSSEAU C. DYSOSMIA AND DRUG TOLERANCE WITH USE OF VENLAFAXINE. BMJ CASE REP. 2021?14(4):1?3. DOI:10.1136/BCR?2020?240547",57.0,YR,A,F,Y,,,20210529.0,,MD,US,US,2021,Q2,Adult
193499491,19349949,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK,LONGSTANDING MEDICATION",,,,,,,,,,,,2021,Q2,Acute kidney injury,,2021,Q2,1,I,,20210518.0,20210531,20210531,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-08140,LUPIN,,48.0,YR,,F,Y,,,20210531.0,,HP,US,US,2021,Q2,Adult
193499491,19349949,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK,LONGSTANDING MEDICATION",,,,,,,,,,,,2021,Q2,Brugada syndrome,,2021,Q2,1,I,,20210518.0,20210531,20210531,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-08140,LUPIN,,48.0,YR,,F,Y,,,20210531.0,,HP,US,US,2021,Q2,Adult
193499491,19349949,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK,LONGSTANDING MEDICATION",,,,,,,,,,,,2021,Q2,Drug interaction,,2021,Q2,1,I,,20210518.0,20210531,20210531,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-08140,LUPIN,,48.0,YR,,F,Y,,,20210531.0,,HP,US,US,2021,Q2,Adult
193499491,19349949,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK,LONGSTANDING MEDICATION",,,,,,,,,,,,2021,Q2,Hyponatraemia,,2021,Q2,1,I,,20210518.0,20210531,20210531,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-08140,LUPIN,,48.0,YR,,F,Y,,,20210531.0,,HP,US,US,2021,Q2,Adult
193499491,19349949,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK,LONGSTANDING MEDICATION",,,,,,,,,,,,2021,Q2,Hypovolaemia,,2021,Q2,1,I,,20210518.0,20210531,20210531,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-08140,LUPIN,,48.0,YR,,F,Y,,,20210531.0,,HP,US,US,2021,Q2,Adult
193499491,19349949,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK,LONGSTANDING MEDICATION",,,,,,,,,,,,2021,Q2,Unmasking of previously unidentified disease,,2021,Q2,1,I,,20210518.0,20210531,20210531,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-08140,LUPIN,,48.0,YR,,F,Y,,,20210531.0,,HP,US,US,2021,Q2,Adult
193524572,19352457,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,21081.0,,,,,2021,Q2,Inappropriate schedule of product administration,,2021,Q2,2,F,202003.0,20210518.0,20210601,20210603,PER,,US-SA-2021SA170180,SANOFI AVENTIS,,61.0,YR,A,F,Y,,,20210603.0,,CN,US,US,2021,Q2,Adult
193524572,19352457,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,21081.0,,,,,2021,Q2,Injection site mass,,2021,Q2,2,F,202003.0,20210518.0,20210601,20210603,PER,,US-SA-2021SA170180,SANOFI AVENTIS,,61.0,YR,A,F,Y,,,20210603.0,,CN,US,US,2021,Q2,Adult
193524572,19352457,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,21081.0,,,,,2021,Q2,Injection site pain,,2021,Q2,2,F,202003.0,20210518.0,20210601,20210603,PER,,US-SA-2021SA170180,SANOFI AVENTIS,,61.0,YR,A,F,Y,,,20210603.0,,CN,US,US,2021,Q2,Adult
193525061,19352506,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"30 IU, QD",,,,, UNKNOWN,,,30.0,IU,,QD,2021,Q2,Anal candidiasis,,2021,Q2,1,I,2019.0,20210518.0,20210601,20210601,EXP,,BR-NOVOPROD-815360,NOVO NORDISK,,46.0,YR,,F,Y,60.0,KG,20210601.0,,MD,BR,BR,2021,Q2,Adult
193525061,19352506,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"30 IU, QD",,,,, UNKNOWN,,,30.0,IU,,QD,2021,Q2,Diabetic ketoacidosis,,2021,Q2,1,I,2019.0,20210518.0,20210601,20210601,EXP,,BR-NOVOPROD-815360,NOVO NORDISK,,46.0,YR,,F,Y,60.0,KG,20210601.0,,MD,BR,BR,2021,Q2,Adult
193525061,19352506,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"30 IU, QD",,,,, UNKNOWN,,,30.0,IU,,QD,2021,Q2,Paraesthesia,,2021,Q2,1,I,2019.0,20210518.0,20210601,20210601,EXP,,BR-NOVOPROD-815360,NOVO NORDISK,,46.0,YR,,F,Y,60.0,KG,20210601.0,,MD,BR,BR,2021,Q2,Adult
193525061,19352506,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"30 IU, QD",,,,, UNKNOWN,,,30.0,IU,,QD,2021,Q2,Treatment noncompliance,,2021,Q2,1,I,2019.0,20210518.0,20210601,20210601,EXP,,BR-NOVOPROD-815360,NOVO NORDISK,,46.0,YR,,F,Y,60.0,KG,20210601.0,,MD,BR,BR,2021,Q2,Adult
193554081,19355408,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UP TO 3,300 UNITS",,,D,,,,,,,,,2021,Q2,Heart rate decreased,,2021,Q2,1,I,,20130902.0,20210602,20210602,EXP,,US-AUROBINDO-AUR-APL-2013-07456,AUROBINDO,INSULIN GLARGINE/MULTIPLE OTHER DRUGS OVERDOSE: HYPOGLYCAEMIA TREATED WITH OCTREOTIDE: CASE REPORT. REACTIONS WEEKLY. 2013?1467:21 ?,56.0,YR,,M,Y,,,20210602.0,,PH,US,US,2021,Q2,Adult
193554081,19355408,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UP TO 3,300 UNITS",,,D,,,,,,,,,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,,20130902.0,20210602,20210602,EXP,,US-AUROBINDO-AUR-APL-2013-07456,AUROBINDO,INSULIN GLARGINE/MULTIPLE OTHER DRUGS OVERDOSE: HYPOGLYCAEMIA TREATED WITH OCTREOTIDE: CASE REPORT. REACTIONS WEEKLY. 2013?1467:21 ?,56.0,YR,,M,Y,,,20210602.0,,PH,US,US,2021,Q2,Adult
193554081,19355408,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UP TO 3,300 UNITS",,,D,,,,,,,,,2021,Q2,Hypotension,,2021,Q2,1,I,,20130902.0,20210602,20210602,EXP,,US-AUROBINDO-AUR-APL-2013-07456,AUROBINDO,INSULIN GLARGINE/MULTIPLE OTHER DRUGS OVERDOSE: HYPOGLYCAEMIA TREATED WITH OCTREOTIDE: CASE REPORT. REACTIONS WEEKLY. 2013?1467:21 ?,56.0,YR,,M,Y,,,20210602.0,,PH,US,US,2021,Q2,Adult
193554081,19355408,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UP TO 3,300 UNITS",,,D,,,,,,,,,2021,Q2,Overdose,,2021,Q2,1,I,,20130902.0,20210602,20210602,EXP,,US-AUROBINDO-AUR-APL-2013-07456,AUROBINDO,INSULIN GLARGINE/MULTIPLE OTHER DRUGS OVERDOSE: HYPOGLYCAEMIA TREATED WITH OCTREOTIDE: CASE REPORT. REACTIONS WEEKLY. 2013?1467:21 ?,56.0,YR,,M,Y,,,20210602.0,,PH,US,US,2021,Q2,Adult
193554081,19355408,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UP TO 3,300 UNITS",,,D,,,,,,,,,2021,Q2,Somnolence,,2021,Q2,1,I,,20130902.0,20210602,20210602,EXP,,US-AUROBINDO-AUR-APL-2013-07456,AUROBINDO,INSULIN GLARGINE/MULTIPLE OTHER DRUGS OVERDOSE: HYPOGLYCAEMIA TREATED WITH OCTREOTIDE: CASE REPORT. REACTIONS WEEKLY. 2013?1467:21 ?,56.0,YR,,M,Y,,,20210602.0,,PH,US,US,2021,Q2,Adult
193554081,19355408,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UP TO 3,300 UNITS",,,D,,,,,,,,,2021,Q2,Suicide attempt,,2021,Q2,1,I,,20130902.0,20210602,20210602,EXP,,US-AUROBINDO-AUR-APL-2013-07456,AUROBINDO,INSULIN GLARGINE/MULTIPLE OTHER DRUGS OVERDOSE: HYPOGLYCAEMIA TREATED WITH OCTREOTIDE: CASE REPORT. REACTIONS WEEKLY. 2013?1467:21 ?,56.0,YR,,M,Y,,,20210602.0,,PH,US,US,2021,Q2,Adult
193582131,19358213,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"45 DOSAGE FORM, HS",,,,,,,,45.0,DF,,QD,2021,Q2,Contraindicated product administered,,2021,Q2,1,I,,20210513.0,20210602,20210602,PER,,US-009507513-2105USA004232,MERCK,"KUHADIYA ND, ISRAA M. EFFECTS OF CONCOMITANT COMBINATION OF SGLT?2 INHIBITOR AND GLP?1 RECEPTOR AGONIST ON RENAL OUTCOMES IN T2D WITH EGFR BELOW 30 AND MACROALBUMINURIA: A CASE SERIES. CLINICAL CASE REPORTS. 2021?9(9):2310?6",62.0,YR,,M,Y,87.1,KG,20210602.0,,HP,US,US,2021,Q2,Adult
193582131,19358213,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"60 DOSAGE FORM, HS",,,,,,,,60.0,DF,,QD,2021,Q2,Contraindicated product administered,,2021,Q2,1,I,,20210513.0,20210602,20210602,PER,,US-009507513-2105USA004232,MERCK,"KUHADIYA ND, ISRAA M. EFFECTS OF CONCOMITANT COMBINATION OF SGLT?2 INHIBITOR AND GLP?1 RECEPTOR AGONIST ON RENAL OUTCOMES IN T2D WITH EGFR BELOW 30 AND MACROALBUMINURIA: A CASE SERIES. CLINICAL CASE REPORTS. 2021?9(9):2310?6",62.0,YR,,M,Y,87.1,KG,20210602.0,,HP,US,US,2021,Q2,Adult
193582131,19358213,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 DOSAGE FORM, HS",,,,,,,,20.0,DF,,QD,2021,Q2,Contraindicated product administered,,2021,Q2,1,I,,20210513.0,20210602,20210602,PER,,US-009507513-2105USA004232,MERCK,"KUHADIYA ND, ISRAA M. EFFECTS OF CONCOMITANT COMBINATION OF SGLT?2 INHIBITOR AND GLP?1 RECEPTOR AGONIST ON RENAL OUTCOMES IN T2D WITH EGFR BELOW 30 AND MACROALBUMINURIA: A CASE SERIES. CLINICAL CASE REPORTS. 2021?9(9):2310?6",62.0,YR,,M,Y,87.1,KG,20210602.0,,HP,US,US,2021,Q2,Adult
193584051,19358405,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"16 IU, QD",,,,,,,,16.0,IU,,QD,2021,Q2,Acute myocardial infarction,,2021,Q2,1,I,2020.0,20210523.0,20210602,20210602,EXP,,BR-NOVOPROD-816357,NOVO NORDISK,,82.0,YR,,F,Y,43.0,KG,20210602.0,,MD,BR,BR,2021,Q2,Elderly
193584051,19358405,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"16 IU, QD",,,,,,,,16.0,IU,,QD,2021,Q2,Gastrointestinal carcinoma,,2021,Q2,1,I,2020.0,20210523.0,20210602,20210602,EXP,,BR-NOVOPROD-816357,NOVO NORDISK,,82.0,YR,,F,Y,43.0,KG,20210602.0,,MD,BR,BR,2021,Q2,Elderly
193584051,19358405,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"16 IU, QD",,,,,,,,16.0,IU,,QD,2021,Q2,Hypothyroidism,,2021,Q2,1,I,2020.0,20210523.0,20210602,20210602,EXP,,BR-NOVOPROD-816357,NOVO NORDISK,,82.0,YR,,F,Y,43.0,KG,20210602.0,,MD,BR,BR,2021,Q2,Elderly
193584051,19358405,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"16 IU, QD",,,,,,,,16.0,IU,,QD,2021,Q2,Weight decreased,,2021,Q2,1,I,2020.0,20210523.0,20210602,20210602,EXP,,BR-NOVOPROD-816357,NOVO NORDISK,,82.0,YR,,F,Y,43.0,KG,20210602.0,,MD,BR,BR,2021,Q2,Elderly
193601001,19360100,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Balance disorder,,2021,Q2,1,I,,20210520.0,20210601,20210601,EXP,,CA-APOTEX-2021AP012733,APOTEX,,51.0,YR,,M,Y,94.0,KG,20210601.0,,CN,CA,CA,2021,Q2,Adult
193601001,19360100,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Blood creatine phosphokinase increased,,2021,Q2,1,I,,20210520.0,20210601,20210601,EXP,,CA-APOTEX-2021AP012733,APOTEX,,51.0,YR,,M,Y,94.0,KG,20210601.0,,CN,CA,CA,2021,Q2,Adult
193601001,19360100,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Cogwheel rigidity,,2021,Q2,1,I,,20210520.0,20210601,20210601,EXP,,CA-APOTEX-2021AP012733,APOTEX,,51.0,YR,,M,Y,94.0,KG,20210601.0,,CN,CA,CA,2021,Q2,Adult
193601001,19360100,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Fall,,2021,Q2,1,I,,20210520.0,20210601,20210601,EXP,,CA-APOTEX-2021AP012733,APOTEX,,51.0,YR,,M,Y,94.0,KG,20210601.0,,CN,CA,CA,2021,Q2,Adult
193601001,19360100,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Gait disturbance,,2021,Q2,1,I,,20210520.0,20210601,20210601,EXP,,CA-APOTEX-2021AP012733,APOTEX,,51.0,YR,,M,Y,94.0,KG,20210601.0,,CN,CA,CA,2021,Q2,Adult
193601001,19360100,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Hypertonia,,2021,Q2,1,I,,20210520.0,20210601,20210601,EXP,,CA-APOTEX-2021AP012733,APOTEX,,51.0,YR,,M,Y,94.0,KG,20210601.0,,CN,CA,CA,2021,Q2,Adult
193601001,19360100,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Lactic acidosis,,2021,Q2,1,I,,20210520.0,20210601,20210601,EXP,,CA-APOTEX-2021AP012733,APOTEX,,51.0,YR,,M,Y,94.0,KG,20210601.0,,CN,CA,CA,2021,Q2,Adult
193601001,19360100,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Myocarditis,,2021,Q2,1,I,,20210520.0,20210601,20210601,EXP,,CA-APOTEX-2021AP012733,APOTEX,,51.0,YR,,M,Y,94.0,KG,20210601.0,,CN,CA,CA,2021,Q2,Adult
193601001,19360100,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Neuroleptic malignant syndrome,,2021,Q2,1,I,,20210520.0,20210601,20210601,EXP,,CA-APOTEX-2021AP012733,APOTEX,,51.0,YR,,M,Y,94.0,KG,20210601.0,,CN,CA,CA,2021,Q2,Adult
193601001,19360100,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Nystagmus,,2021,Q2,1,I,,20210520.0,20210601,20210601,EXP,,CA-APOTEX-2021AP012733,APOTEX,,51.0,YR,,M,Y,94.0,KG,20210601.0,,CN,CA,CA,2021,Q2,Adult
193601001,19360100,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Pyrexia,,2021,Q2,1,I,,20210520.0,20210601,20210601,EXP,,CA-APOTEX-2021AP012733,APOTEX,,51.0,YR,,M,Y,94.0,KG,20210601.0,,CN,CA,CA,2021,Q2,Adult
193601001,19360100,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Somnolence,,2021,Q2,1,I,,20210520.0,20210601,20210601,EXP,,CA-APOTEX-2021AP012733,APOTEX,,51.0,YR,,M,Y,94.0,KG,20210601.0,,CN,CA,CA,2021,Q2,Adult
193601001,19360100,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Tachycardia,,2021,Q2,1,I,,20210520.0,20210601,20210601,EXP,,CA-APOTEX-2021AP012733,APOTEX,,51.0,YR,,M,Y,94.0,KG,20210601.0,,CN,CA,CA,2021,Q2,Adult
193620792,19362079,3,SS,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,Subcutaneous,"19 IU, QD",,,,U,,,,19.0,IU,,QD,2021,Q2,Anti-insulin antibody positive,,2021,Q2,2,F,,20210602.0,20210603,20210614,EXP,,JP-NOVOPROD-816736,NOVO NORDISK,YUI IMATAKI ET.AL. A CASE WITH ANTI?INSULIN ANTIBODY POSITIVE TYPE 1 DIABETES MELLITUS WHO DEVELOPED KETOACIDOSIS OVER THE COURSE OF HOSPITALIZATION. THE 243RD TOKAI BRANCH MEETING OF THE JAPANESE SOCIETY OF INTERNAL MEDICINE. 2021?46,58.0,YR,,F,Y,,,20210614.0,,MD,JP,JP,2021,Q2,Adult
193620792,19362079,3,SS,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,Subcutaneous,"19 IU, QD",,,,U,,,,19.0,IU,,QD,2021,Q2,Blood glucose fluctuation,,2021,Q2,2,F,,20210602.0,20210603,20210614,EXP,,JP-NOVOPROD-816736,NOVO NORDISK,YUI IMATAKI ET.AL. A CASE WITH ANTI?INSULIN ANTIBODY POSITIVE TYPE 1 DIABETES MELLITUS WHO DEVELOPED KETOACIDOSIS OVER THE COURSE OF HOSPITALIZATION. THE 243RD TOKAI BRANCH MEETING OF THE JAPANESE SOCIETY OF INTERNAL MEDICINE. 2021?46,58.0,YR,,F,Y,,,20210614.0,,MD,JP,JP,2021,Q2,Adult
193620792,19362079,3,SS,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,Subcutaneous,"19 IU, QD",,,,U,,,,19.0,IU,,QD,2021,Q2,Diabetic ketoacidosis,,2021,Q2,2,F,,20210602.0,20210603,20210614,EXP,,JP-NOVOPROD-816736,NOVO NORDISK,YUI IMATAKI ET.AL. A CASE WITH ANTI?INSULIN ANTIBODY POSITIVE TYPE 1 DIABETES MELLITUS WHO DEVELOPED KETOACIDOSIS OVER THE COURSE OF HOSPITALIZATION. THE 243RD TOKAI BRANCH MEETING OF THE JAPANESE SOCIETY OF INTERNAL MEDICINE. 2021?46,58.0,YR,,F,Y,,,20210614.0,,MD,JP,JP,2021,Q2,Adult
193643062,19364306,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,LONGSTANDING MEDICATION,,,U,,,,,,,,,2021,Q2,Acute kidney injury,,2021,Q2,2,F,,20210611.0,20210603,20210616,EXP,,US-TEVA-2021-US-1917625,TEVA,"SCHNEIR A, MASOM CP. LITHIUM TOXICITY FROM THE ADDITION OF AN ACE INHIBITOR WITH AN UNEXPECTED TYPE I BRUGADA PATTERN ECG: CASE FILES OF THE MEDICAL TOXICOLOGY FELLOWSHIP AT THE UNIVERSITY OF CALIFORNIA, SAN DIEGO. J?MED?TOXICOL 2020?16(3):321?328.",48.0,YR,A,F,Y,,,20210616.0,,HP,US,US,2021,Q2,Adult
193643062,19364306,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,LONGSTANDING MEDICATION,,,U,,,,,,,,,2021,Q2,Brugada syndrome,,2021,Q2,2,F,,20210611.0,20210603,20210616,EXP,,US-TEVA-2021-US-1917625,TEVA,"SCHNEIR A, MASOM CP. LITHIUM TOXICITY FROM THE ADDITION OF AN ACE INHIBITOR WITH AN UNEXPECTED TYPE I BRUGADA PATTERN ECG: CASE FILES OF THE MEDICAL TOXICOLOGY FELLOWSHIP AT THE UNIVERSITY OF CALIFORNIA, SAN DIEGO. J?MED?TOXICOL 2020?16(3):321?328.",48.0,YR,A,F,Y,,,20210616.0,,HP,US,US,2021,Q2,Adult
193643062,19364306,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,LONGSTANDING MEDICATION,,,U,,,,,,,,,2021,Q2,Drug interaction,,2021,Q2,2,F,,20210611.0,20210603,20210616,EXP,,US-TEVA-2021-US-1917625,TEVA,"SCHNEIR A, MASOM CP. LITHIUM TOXICITY FROM THE ADDITION OF AN ACE INHIBITOR WITH AN UNEXPECTED TYPE I BRUGADA PATTERN ECG: CASE FILES OF THE MEDICAL TOXICOLOGY FELLOWSHIP AT THE UNIVERSITY OF CALIFORNIA, SAN DIEGO. J?MED?TOXICOL 2020?16(3):321?328.",48.0,YR,A,F,Y,,,20210616.0,,HP,US,US,2021,Q2,Adult
193643062,19364306,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,LONGSTANDING MEDICATION,,,U,,,,,,,,,2021,Q2,Hyponatraemia,,2021,Q2,2,F,,20210611.0,20210603,20210616,EXP,,US-TEVA-2021-US-1917625,TEVA,"SCHNEIR A, MASOM CP. LITHIUM TOXICITY FROM THE ADDITION OF AN ACE INHIBITOR WITH AN UNEXPECTED TYPE I BRUGADA PATTERN ECG: CASE FILES OF THE MEDICAL TOXICOLOGY FELLOWSHIP AT THE UNIVERSITY OF CALIFORNIA, SAN DIEGO. J?MED?TOXICOL 2020?16(3):321?328.",48.0,YR,A,F,Y,,,20210616.0,,HP,US,US,2021,Q2,Adult
193643062,19364306,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,LONGSTANDING MEDICATION,,,U,,,,,,,,,2021,Q2,Hypovolaemia,,2021,Q2,2,F,,20210611.0,20210603,20210616,EXP,,US-TEVA-2021-US-1917625,TEVA,"SCHNEIR A, MASOM CP. LITHIUM TOXICITY FROM THE ADDITION OF AN ACE INHIBITOR WITH AN UNEXPECTED TYPE I BRUGADA PATTERN ECG: CASE FILES OF THE MEDICAL TOXICOLOGY FELLOWSHIP AT THE UNIVERSITY OF CALIFORNIA, SAN DIEGO. J?MED?TOXICOL 2020?16(3):321?328.",48.0,YR,A,F,Y,,,20210616.0,,HP,US,US,2021,Q2,Adult
193643062,19364306,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,LONGSTANDING MEDICATION,,,U,,,,,,,,,2021,Q2,Toxicity to various agents,,2021,Q2,2,F,,20210611.0,20210603,20210616,EXP,,US-TEVA-2021-US-1917625,TEVA,"SCHNEIR A, MASOM CP. LITHIUM TOXICITY FROM THE ADDITION OF AN ACE INHIBITOR WITH AN UNEXPECTED TYPE I BRUGADA PATTERN ECG: CASE FILES OF THE MEDICAL TOXICOLOGY FELLOWSHIP AT THE UNIVERSITY OF CALIFORNIA, SAN DIEGO. J?MED?TOXICOL 2020?16(3):321?328.",48.0,YR,A,F,Y,,,20210616.0,,HP,US,US,2021,Q2,Adult
193643062,19364306,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,LONGSTANDING MEDICATION,,,U,,,,,,,,,2021,Q2,Unmasking of previously unidentified disease,,2021,Q2,2,F,,20210611.0,20210603,20210616,EXP,,US-TEVA-2021-US-1917625,TEVA,"SCHNEIR A, MASOM CP. LITHIUM TOXICITY FROM THE ADDITION OF AN ACE INHIBITOR WITH AN UNEXPECTED TYPE I BRUGADA PATTERN ECG: CASE FILES OF THE MEDICAL TOXICOLOGY FELLOWSHIP AT THE UNIVERSITY OF CALIFORNIA, SAN DIEGO. J?MED?TOXICOL 2020?16(3):321?328.",48.0,YR,A,F,Y,,,20210616.0,,HP,US,US,2021,Q2,Adult
193646141,19364614,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Atrial fibrillation,,2021,Q2,1,I,,20210525.0,20210603,20210603,EXP,,US-JNJFOC-20210552052,JOHNSON AND JOHNSON,"SCHNEIDER R, LIZER M. APPARENT SEIZURE AND ATRIAL FIBRILLATION ASSOCIATED WITH PALIPERIDONE. AM J HEALTH SYST PHARM. 2008 NOV 15?65 (22):2122?2125.",46.0,YR,A,M,Y,,,20210603.0,,HP,US,US,2021,Q2,Adult
193646141,19364614,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Seizure,,2021,Q2,1,I,,20210525.0,20210603,20210603,EXP,,US-JNJFOC-20210552052,JOHNSON AND JOHNSON,"SCHNEIDER R, LIZER M. APPARENT SEIZURE AND ATRIAL FIBRILLATION ASSOCIATED WITH PALIPERIDONE. AM J HEALTH SYST PHARM. 2008 NOV 15?65 (22):2122?2125.",46.0,YR,A,M,Y,,,20210603.0,,HP,US,US,2021,Q2,Adult
193648011,19364801,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,, UNKNOWN,,,,,INJECTION,,2021,Q2,Immune-mediated myositis,,2021,Q2,1,I,,20210527.0,20210603,20210603,EXP,,US-DRREDDYS-USA/USA/21/0136176,DR REDDYS,IRVINE NJ. ANTI?HMGCR MYOPATHY: A RARE AND SERIOUS SIDE EFFECT OF STATINS. JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE. 2020?33(5):785?8. DOI: 10.3122/JABFM.2020.05.190450,54.0,YR,A,F,Y,,,20210603.0,,MD,US,US,2021,Q2,Adult
193648011,19364801,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,, UNKNOWN,,,,,INJECTION,,2021,Q2,Myopathy,,2021,Q2,1,I,,20210527.0,20210603,20210603,EXP,,US-DRREDDYS-USA/USA/21/0136176,DR REDDYS,IRVINE NJ. ANTI?HMGCR MYOPATHY: A RARE AND SERIOUS SIDE EFFECT OF STATINS. JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE. 2020?33(5):785?8. DOI: 10.3122/JABFM.2020.05.190450,54.0,YR,A,F,Y,,,20210603.0,,MD,US,US,2021,Q2,Adult
193696792,19369679,13,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q2,Death,,2021,Q2,2,F,20200303.0,20210615.0,20210603,20210618,EXP,,ES-CELGENEUS-ESP-20210600473,CELGENE,,79.0,YR,,M,Y,,,20210618.0,,HP,ES,ES,2021,Q2,Elderly
193711782,19371178,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Alanine aminotransferase increased,,2021,Q2,2,F,20130618.0,20210521.0,20210604,20210618,PER,,KR-AMGEN-KORCT2021084256,AMGEN,,68.0,YR,E,M,Y,,,20210618.0,,MD,KR,KR,2021,Q2,Elderly
193711782,19371178,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Aspartate aminotransferase increased,,2021,Q2,2,F,20130618.0,20210521.0,20210604,20210618,PER,,KR-AMGEN-KORCT2021084256,AMGEN,,68.0,YR,E,M,Y,,,20210618.0,,MD,KR,KR,2021,Q2,Elderly
193711782,19371178,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Blood bilirubin increased,,2021,Q2,2,F,20130618.0,20210521.0,20210604,20210618,PER,,KR-AMGEN-KORCT2021084256,AMGEN,,68.0,YR,E,M,Y,,,20210618.0,,MD,KR,KR,2021,Q2,Elderly
193711782,19371178,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Constipation,,2021,Q2,2,F,20130618.0,20210521.0,20210604,20210618,PER,,KR-AMGEN-KORCT2021084256,AMGEN,,68.0,YR,E,M,Y,,,20210618.0,,MD,KR,KR,2021,Q2,Elderly
193711782,19371178,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Cough,,2021,Q2,2,F,20130618.0,20210521.0,20210604,20210618,PER,,KR-AMGEN-KORCT2021084256,AMGEN,,68.0,YR,E,M,Y,,,20210618.0,,MD,KR,KR,2021,Q2,Elderly
193711782,19371178,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Decreased appetite,,2021,Q2,2,F,20130618.0,20210521.0,20210604,20210618,PER,,KR-AMGEN-KORCT2021084256,AMGEN,,68.0,YR,E,M,Y,,,20210618.0,,MD,KR,KR,2021,Q2,Elderly
193711782,19371178,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Epigastric discomfort,,2021,Q2,2,F,20130618.0,20210521.0,20210604,20210618,PER,,KR-AMGEN-KORCT2021084256,AMGEN,,68.0,YR,E,M,Y,,,20210618.0,,MD,KR,KR,2021,Q2,Elderly
193711782,19371178,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Febrile neutropenia,,2021,Q2,2,F,20130618.0,20210521.0,20210604,20210618,PER,,KR-AMGEN-KORCT2021084256,AMGEN,,68.0,YR,E,M,Y,,,20210618.0,,MD,KR,KR,2021,Q2,Elderly
193711782,19371178,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Haematoma,,2021,Q2,2,F,20130618.0,20210521.0,20210604,20210618,PER,,KR-AMGEN-KORCT2021084256,AMGEN,,68.0,YR,E,M,Y,,,20210618.0,,MD,KR,KR,2021,Q2,Elderly
193711782,19371178,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Injection site haemorrhage,,2021,Q2,2,F,20130618.0,20210521.0,20210604,20210618,PER,,KR-AMGEN-KORCT2021084256,AMGEN,,68.0,YR,E,M,Y,,,20210618.0,,MD,KR,KR,2021,Q2,Elderly
193711782,19371178,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Injection site pain,,2021,Q2,2,F,20130618.0,20210521.0,20210604,20210618,PER,,KR-AMGEN-KORCT2021084256,AMGEN,,68.0,YR,E,M,Y,,,20210618.0,,MD,KR,KR,2021,Q2,Elderly
193711782,19371178,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Iron metabolism disorder,,2021,Q2,2,F,20130618.0,20210521.0,20210604,20210618,PER,,KR-AMGEN-KORCT2021084256,AMGEN,,68.0,YR,E,M,Y,,,20210618.0,,MD,KR,KR,2021,Q2,Elderly
193711782,19371178,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Nausea,,2021,Q2,2,F,20130618.0,20210521.0,20210604,20210618,PER,,KR-AMGEN-KORCT2021084256,AMGEN,,68.0,YR,E,M,Y,,,20210618.0,,MD,KR,KR,2021,Q2,Elderly
193711782,19371178,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Neutropenia,,2021,Q2,2,F,20130618.0,20210521.0,20210604,20210618,PER,,KR-AMGEN-KORCT2021084256,AMGEN,,68.0,YR,E,M,Y,,,20210618.0,,MD,KR,KR,2021,Q2,Elderly
193711782,19371178,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Pulmonary oedema,,2021,Q2,2,F,20130618.0,20210521.0,20210604,20210618,PER,,KR-AMGEN-KORCT2021084256,AMGEN,,68.0,YR,E,M,Y,,,20210618.0,,MD,KR,KR,2021,Q2,Elderly
193711782,19371178,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Pyrexia,,2021,Q2,2,F,20130618.0,20210521.0,20210604,20210618,PER,,KR-AMGEN-KORCT2021084256,AMGEN,,68.0,YR,E,M,Y,,,20210618.0,,MD,KR,KR,2021,Q2,Elderly
193711782,19371178,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Radiculopathy,,2021,Q2,2,F,20130618.0,20210521.0,20210604,20210618,PER,,KR-AMGEN-KORCT2021084256,AMGEN,,68.0,YR,E,M,Y,,,20210618.0,,MD,KR,KR,2021,Q2,Elderly
193711782,19371178,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Urticaria,,2021,Q2,2,F,20130618.0,20210521.0,20210604,20210618,PER,,KR-AMGEN-KORCT2021084256,AMGEN,,68.0,YR,E,M,Y,,,20210618.0,,MD,KR,KR,2021,Q2,Elderly
193712641,19371264,2,SS,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,Subcutaneous,"22 INTERNATIONAL UNIT, DAILY",,,Y,, 122010101,,,22.0,IU,,QD,2021,Q2,Diabetic complication,,2021,Q2,1,I,20210520.0,20210522.0,20210603,20210603,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202105010948,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20210603.0,,HP,CN,CN,2021,Q2,Elderly
193712641,19371264,2,SS,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,Subcutaneous,"22 INTERNATIONAL UNIT, DAILY",,,Y,, 122010101,,,22.0,IU,,QD,2021,Q2,Hypoglycaemic coma,,2021,Q2,1,I,20210520.0,20210522.0,20210603,20210603,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202105010948,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20210603.0,,HP,CN,CN,2021,Q2,Elderly
193713321,19371332,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"30 IU, QD AT NIGHT",,,,, UNKNOWN,,,30.0,IU,,QD,2021,Q2,Chronic kidney disease,,2021,Q2,1,I,,20201026.0,20210603,20210603,EXP,,BR-NOVOPROD-806662,NOVO NORDISK,,75.0,YR,,M,Y,83.1,KG,20210603.0,,MD,BR,BR,2021,Q2,Elderly
193713321,19371332,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"30 IU, QD AT NIGHT",,,,, UNKNOWN,,,30.0,IU,,QD,2021,Q2,Chronic lymphocytic leukaemia,,2021,Q2,1,I,,20201026.0,20210603,20210603,EXP,,BR-NOVOPROD-806662,NOVO NORDISK,,75.0,YR,,M,Y,83.1,KG,20210603.0,,MD,BR,BR,2021,Q2,Elderly
193713321,19371332,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"30 IU, QD AT NIGHT",,,,, UNKNOWN,,,30.0,IU,,QD,2021,Q2,Diabetes mellitus inadequate control,,2021,Q2,1,I,,20201026.0,20210603,20210603,EXP,,BR-NOVOPROD-806662,NOVO NORDISK,,75.0,YR,,M,Y,83.1,KG,20210603.0,,MD,BR,BR,2021,Q2,Elderly
193713321,19371332,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"30 IU, QD AT NIGHT",,,,, UNKNOWN,,,30.0,IU,,QD,2021,Q2,Retinopathy proliferative,,2021,Q2,1,I,,20201026.0,20210603,20210603,EXP,,BR-NOVOPROD-806662,NOVO NORDISK,,75.0,YR,,M,Y,83.1,KG,20210603.0,,MD,BR,BR,2021,Q2,Elderly
193713321,19371332,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U,,,,, UNKNOWN,,,,,,,2021,Q2,Chronic kidney disease,,2021,Q2,1,I,,20201026.0,20210603,20210603,EXP,,BR-NOVOPROD-806662,NOVO NORDISK,,75.0,YR,,M,Y,83.1,KG,20210603.0,,MD,BR,BR,2021,Q2,Elderly
193713321,19371332,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U,,,,, UNKNOWN,,,,,,,2021,Q2,Chronic lymphocytic leukaemia,,2021,Q2,1,I,,20201026.0,20210603,20210603,EXP,,BR-NOVOPROD-806662,NOVO NORDISK,,75.0,YR,,M,Y,83.1,KG,20210603.0,,MD,BR,BR,2021,Q2,Elderly
193713321,19371332,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U,,,,, UNKNOWN,,,,,,,2021,Q2,Diabetes mellitus inadequate control,,2021,Q2,1,I,,20201026.0,20210603,20210603,EXP,,BR-NOVOPROD-806662,NOVO NORDISK,,75.0,YR,,M,Y,83.1,KG,20210603.0,,MD,BR,BR,2021,Q2,Elderly
193713321,19371332,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U,,,,, UNKNOWN,,,,,,,2021,Q2,Retinopathy proliferative,,2021,Q2,1,I,,20201026.0,20210603,20210603,EXP,,BR-NOVOPROD-806662,NOVO NORDISK,,75.0,YR,,M,Y,83.1,KG,20210603.0,,MD,BR,BR,2021,Q2,Elderly
193716331,19371633,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,35 IU,,,,,,,,35.0,IU,,QD,2021,Q2,Appendicectomy,,2021,Q2,1,I,2018.0,20210525.0,20210604,20210604,EXP,,BR-NOVOPROD-817173,NOVO NORDISK,,42.0,YR,,F,Y,83.7,KG,20210604.0,,MD,BR,BR,2021,Q2,Adult
193716331,19371633,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,35 IU,,,,,,,,35.0,IU,,QD,2021,Q2,Hyperglycaemia,,2021,Q2,1,I,2018.0,20210525.0,20210604,20210604,EXP,,BR-NOVOPROD-817173,NOVO NORDISK,,42.0,YR,,F,Y,83.7,KG,20210604.0,,MD,BR,BR,2021,Q2,Adult
193716331,19371633,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,35 IU,,,,,,,,35.0,IU,,QD,2021,Q2,Hypertension,,2021,Q2,1,I,2018.0,20210525.0,20210604,20210604,EXP,,BR-NOVOPROD-817173,NOVO NORDISK,,42.0,YR,,F,Y,83.7,KG,20210604.0,,MD,BR,BR,2021,Q2,Adult
193716331,19371633,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,35 IU,,,,,,,,35.0,IU,,QD,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,2018.0,20210525.0,20210604,20210604,EXP,,BR-NOVOPROD-817173,NOVO NORDISK,,42.0,YR,,F,Y,83.7,KG,20210604.0,,MD,BR,BR,2021,Q2,Adult
193720391,19372039,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Alopecia,,2021,Q2,1,I,,20210526.0,20210604,20210604,EXP,,CA-TEVA-2021-CA-1917159,TEVA,,73.0,YR,E,M,Y,,,20210604.0,,CN,CA,CA,2021,Q2,Elderly
193720391,19372039,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Blood creatinine abnormal,,2021,Q2,1,I,,20210526.0,20210604,20210604,EXP,,CA-TEVA-2021-CA-1917159,TEVA,,73.0,YR,E,M,Y,,,20210604.0,,CN,CA,CA,2021,Q2,Elderly
193720391,19372039,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Condition aggravated,,2021,Q2,1,I,,20210526.0,20210604,20210604,EXP,,CA-TEVA-2021-CA-1917159,TEVA,,73.0,YR,E,M,Y,,,20210604.0,,CN,CA,CA,2021,Q2,Elderly
193720391,19372039,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Constipation,,2021,Q2,1,I,,20210526.0,20210604,20210604,EXP,,CA-TEVA-2021-CA-1917159,TEVA,,73.0,YR,E,M,Y,,,20210604.0,,CN,CA,CA,2021,Q2,Elderly
193720391,19372039,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Drug interaction,,2021,Q2,1,I,,20210526.0,20210604,20210604,EXP,,CA-TEVA-2021-CA-1917159,TEVA,,73.0,YR,E,M,Y,,,20210604.0,,CN,CA,CA,2021,Q2,Elderly
193720391,19372039,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Dysphonia,,2021,Q2,1,I,,20210526.0,20210604,20210604,EXP,,CA-TEVA-2021-CA-1917159,TEVA,,73.0,YR,E,M,Y,,,20210604.0,,CN,CA,CA,2021,Q2,Elderly
193720391,19372039,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Fall,,2021,Q2,1,I,,20210526.0,20210604,20210604,EXP,,CA-TEVA-2021-CA-1917159,TEVA,,73.0,YR,E,M,Y,,,20210604.0,,CN,CA,CA,2021,Q2,Elderly
193720391,19372039,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Fatigue,,2021,Q2,1,I,,20210526.0,20210604,20210604,EXP,,CA-TEVA-2021-CA-1917159,TEVA,,73.0,YR,E,M,Y,,,20210604.0,,CN,CA,CA,2021,Q2,Elderly
193720391,19372039,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Headache,,2021,Q2,1,I,,20210526.0,20210604,20210604,EXP,,CA-TEVA-2021-CA-1917159,TEVA,,73.0,YR,E,M,Y,,,20210604.0,,CN,CA,CA,2021,Q2,Elderly
193720391,19372039,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Malaise,,2021,Q2,1,I,,20210526.0,20210604,20210604,EXP,,CA-TEVA-2021-CA-1917159,TEVA,,73.0,YR,E,M,Y,,,20210604.0,,CN,CA,CA,2021,Q2,Elderly
193720391,19372039,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Muscular weakness,,2021,Q2,1,I,,20210526.0,20210604,20210604,EXP,,CA-TEVA-2021-CA-1917159,TEVA,,73.0,YR,E,M,Y,,,20210604.0,,CN,CA,CA,2021,Q2,Elderly
193720391,19372039,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Nausea,,2021,Q2,1,I,,20210526.0,20210604,20210604,EXP,,CA-TEVA-2021-CA-1917159,TEVA,,73.0,YR,E,M,Y,,,20210604.0,,CN,CA,CA,2021,Q2,Elderly
193720391,19372039,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Renal impairment,,2021,Q2,1,I,,20210526.0,20210604,20210604,EXP,,CA-TEVA-2021-CA-1917159,TEVA,,73.0,YR,E,M,Y,,,20210604.0,,CN,CA,CA,2021,Q2,Elderly
193720391,19372039,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Retching,,2021,Q2,1,I,,20210526.0,20210604,20210604,EXP,,CA-TEVA-2021-CA-1917159,TEVA,,73.0,YR,E,M,Y,,,20210604.0,,CN,CA,CA,2021,Q2,Elderly
193720391,19372039,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Tremor,,2021,Q2,1,I,,20210526.0,20210604,20210604,EXP,,CA-TEVA-2021-CA-1917159,TEVA,,73.0,YR,E,M,Y,,,20210604.0,,CN,CA,CA,2021,Q2,Elderly
193720391,19372039,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Weight decreased,,2021,Q2,1,I,,20210526.0,20210604,20210604,EXP,,CA-TEVA-2021-CA-1917159,TEVA,,73.0,YR,E,M,Y,,,20210604.0,,CN,CA,CA,2021,Q2,Elderly
193724561,19372456,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,206538.0,,,SOLUTION FOR INJECTION,,2021,Q2,Blood glucose decreased,,2021,Q2,1,I,,20210524.0,20210604,20210604,EXP,,US-SA-2021SA173732,SANOFI AVENTIS,,56.0,YR,A,F,Y,,,20210604.0,,HP,US,US,2021,Q2,Adult
193724561,19372456,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,206538.0,,,SOLUTION FOR INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,,20210524.0,20210604,20210604,EXP,,US-SA-2021SA173732,SANOFI AVENTIS,,56.0,YR,A,F,Y,,,20210604.0,,HP,US,US,2021,Q2,Adult
193724561,19372456,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,206538.0,,,SOLUTION FOR INJECTION,,2021,Q2,Drug hypersensitivity,,2021,Q2,1,I,,20210524.0,20210604,20210604,EXP,,US-SA-2021SA173732,SANOFI AVENTIS,,56.0,YR,A,F,Y,,,20210604.0,,HP,US,US,2021,Q2,Adult
193724561,19372456,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,206538.0,,,SOLUTION FOR INJECTION,,2021,Q2,Drug ineffective,,2021,Q2,1,I,,20210524.0,20210604,20210604,EXP,,US-SA-2021SA173732,SANOFI AVENTIS,,56.0,YR,A,F,Y,,,20210604.0,,HP,US,US,2021,Q2,Adult
193724561,19372456,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,206538.0,,,SOLUTION FOR INJECTION,,2021,Q2,Myocardial infarction,,2021,Q2,1,I,,20210524.0,20210604,20210604,EXP,,US-SA-2021SA173732,SANOFI AVENTIS,,56.0,YR,A,F,Y,,,20210604.0,,HP,US,US,2021,Q2,Adult
193724561,19372456,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,206538.0,,,SOLUTION FOR INJECTION,,2021,Q2,Starvation,,2021,Q2,1,I,,20210524.0,20210604,20210604,EXP,,US-SA-2021SA173732,SANOFI AVENTIS,,56.0,YR,A,F,Y,,,20210604.0,,HP,US,US,2021,Q2,Adult
193724561,19372456,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,206538.0,,,SOLUTION FOR INJECTION,,2021,Q2,Weight decreased,,2021,Q2,1,I,,20210524.0,20210604,20210604,EXP,,US-SA-2021SA173732,SANOFI AVENTIS,,56.0,YR,A,F,Y,,,20210604.0,,HP,US,US,2021,Q2,Adult
193765621,19376562,2,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,10 ME PER DAY,,,,,,,,10.0,DF,,QD,2021,Q2,Diabetes mellitus inadequate control,,2021,Q2,1,I,20210114.0,20210531.0,20210604,20210604,EXP,,RU-009507513-2106RUS000920,MERCK,,54.0,YR,,M,Y,,,20210604.0,,CN,RU,RU,2021,Q2,Adult
193765621,19376562,2,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,10 ME PER DAY,,,,,,,,10.0,DF,,QD,2021,Q2,Product use issue,,2021,Q2,1,I,20210114.0,20210531.0,20210604,20210604,EXP,,RU-009507513-2106RUS000920,MERCK,,54.0,YR,,M,Y,,,20210604.0,,CN,RU,RU,2021,Q2,Adult
193769381,19376938,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q2,Electrocardiogram abnormal,,2021,Q2,1,I,,20210526.0,20210604,20210604,EXP,,US-MYLANLABS-2021M1032574,MYLAN,"PEPIN LC, MATSLER N, CAMARENA?MICHEL A, ZUCKERMAN M. SUSTAINED RELEASE POTASSIUM OVERDOSE REQUIRING PROLONGED HEMODIALYSIS. J?MED?TOXICOL 2021?17:112 ABSTR. 056.",72.0,YR,,F,Y,,,20210604.0,,HP,US,US,2021,Q2,Elderly
193769381,19376938,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q2,Haemodynamic instability,,2021,Q2,1,I,,20210526.0,20210604,20210604,EXP,,US-MYLANLABS-2021M1032574,MYLAN,"PEPIN LC, MATSLER N, CAMARENA?MICHEL A, ZUCKERMAN M. SUSTAINED RELEASE POTASSIUM OVERDOSE REQUIRING PROLONGED HEMODIALYSIS. J?MED?TOXICOL 2021?17:112 ABSTR. 056.",72.0,YR,,F,Y,,,20210604.0,,HP,US,US,2021,Q2,Elderly
193769381,19376938,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q2,Hyperkalaemia,,2021,Q2,1,I,,20210526.0,20210604,20210604,EXP,,US-MYLANLABS-2021M1032574,MYLAN,"PEPIN LC, MATSLER N, CAMARENA?MICHEL A, ZUCKERMAN M. SUSTAINED RELEASE POTASSIUM OVERDOSE REQUIRING PROLONGED HEMODIALYSIS. J?MED?TOXICOL 2021?17:112 ABSTR. 056.",72.0,YR,,F,Y,,,20210604.0,,HP,US,US,2021,Q2,Elderly
193769381,19376938,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q2,Ileus,,2021,Q2,1,I,,20210526.0,20210604,20210604,EXP,,US-MYLANLABS-2021M1032574,MYLAN,"PEPIN LC, MATSLER N, CAMARENA?MICHEL A, ZUCKERMAN M. SUSTAINED RELEASE POTASSIUM OVERDOSE REQUIRING PROLONGED HEMODIALYSIS. J?MED?TOXICOL 2021?17:112 ABSTR. 056.",72.0,YR,,F,Y,,,20210604.0,,HP,US,US,2021,Q2,Elderly
193769381,19376938,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q2,Intentional overdose,,2021,Q2,1,I,,20210526.0,20210604,20210604,EXP,,US-MYLANLABS-2021M1032574,MYLAN,"PEPIN LC, MATSLER N, CAMARENA?MICHEL A, ZUCKERMAN M. SUSTAINED RELEASE POTASSIUM OVERDOSE REQUIRING PROLONGED HEMODIALYSIS. J?MED?TOXICOL 2021?17:112 ABSTR. 056.",72.0,YR,,F,Y,,,20210604.0,,HP,US,US,2021,Q2,Elderly
193769381,19376938,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q2,Therapy non-responder,,2021,Q2,1,I,,20210526.0,20210604,20210604,EXP,,US-MYLANLABS-2021M1032574,MYLAN,"PEPIN LC, MATSLER N, CAMARENA?MICHEL A, ZUCKERMAN M. SUSTAINED RELEASE POTASSIUM OVERDOSE REQUIRING PROLONGED HEMODIALYSIS. J?MED?TOXICOL 2021?17:112 ABSTR. 056.",72.0,YR,,F,Y,,,20210604.0,,HP,US,US,2021,Q2,Elderly
193780331,19378033,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Diabetes mellitus,,2021,Q2,1,I,20150618.0,20210521.0,20210605,20210605,PER,,KR-AMGEN INC.-KORCT2021081897,AMGEN,,57.0,YR,A,F,Y,,,20210605.0,,MD,KR,KR,2021,Q2,Adult
193780331,19378033,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Metastatic neoplasm,,2021,Q2,1,I,20150618.0,20210521.0,20210605,20210605,PER,,KR-AMGEN INC.-KORCT2021081897,AMGEN,,57.0,YR,A,F,Y,,,20210605.0,,MD,KR,KR,2021,Q2,Adult
193780331,19378033,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Neurogenic bladder,,2021,Q2,1,I,20150618.0,20210521.0,20210605,20210605,PER,,KR-AMGEN INC.-KORCT2021081897,AMGEN,,57.0,YR,A,F,Y,,,20210605.0,,MD,KR,KR,2021,Q2,Adult
193780331,19378033,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Neutrophil count decreased,,2021,Q2,1,I,20150618.0,20210521.0,20210605,20210605,PER,,KR-AMGEN INC.-KORCT2021081897,AMGEN,,57.0,YR,A,F,Y,,,20210605.0,,MD,KR,KR,2021,Q2,Adult
193795421,19379542,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, QD",,,,,,,,50.0,IU,,QD,2021,Q2,Atrial fibrillation,,2021,Q2,1,I,20200930.0,20210531.0,20210607,20210607,EXP,,EE-JNJFOC-20210609329,JOHNSON AND JOHNSON,,77.0,YR,E,F,Y,,,20210607.0,,CN,EE,EE,2021,Q2,Elderly
193795421,19379542,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, QD",,,,,,,,50.0,IU,,QD,2021,Q2,Respiratory failure,,2021,Q2,1,I,20200930.0,20210531.0,20210607,20210607,EXP,,EE-JNJFOC-20210609329,JOHNSON AND JOHNSON,,77.0,YR,E,F,Y,,,20210607.0,,CN,EE,EE,2021,Q2,Elderly
193795421,19379542,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, QD",,,,,,,,50.0,IU,,QD,2021,Q2,Subcutaneous haematoma,,2021,Q2,1,I,20200930.0,20210531.0,20210607,20210607,EXP,,EE-JNJFOC-20210609329,JOHNSON AND JOHNSON,,77.0,YR,E,F,Y,,,20210607.0,,CN,EE,EE,2021,Q2,Elderly
193801251,19380125,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Acute kidney injury,,2021,Q2,1,I,,20210524.0,20210607,20210607,EXP,,US-AUROBINDO-AUR-APL-2021-022790,AUROBINDO,,48.0,YR,,F,Y,,,20210607.0,,HP,US,US,2021,Q2,Adult
193801251,19380125,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Brugada syndrome,,2021,Q2,1,I,,20210524.0,20210607,20210607,EXP,,US-AUROBINDO-AUR-APL-2021-022790,AUROBINDO,,48.0,YR,,F,Y,,,20210607.0,,HP,US,US,2021,Q2,Adult
193801251,19380125,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Confusional state,,2021,Q2,1,I,,20210524.0,20210607,20210607,EXP,,US-AUROBINDO-AUR-APL-2021-022790,AUROBINDO,,48.0,YR,,F,Y,,,20210607.0,,HP,US,US,2021,Q2,Adult
193801251,19380125,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Dizziness,,2021,Q2,1,I,,20210524.0,20210607,20210607,EXP,,US-AUROBINDO-AUR-APL-2021-022790,AUROBINDO,,48.0,YR,,F,Y,,,20210607.0,,HP,US,US,2021,Q2,Adult
193801251,19380125,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Drug interaction,,2021,Q2,1,I,,20210524.0,20210607,20210607,EXP,,US-AUROBINDO-AUR-APL-2021-022790,AUROBINDO,,48.0,YR,,F,Y,,,20210607.0,,HP,US,US,2021,Q2,Adult
193801251,19380125,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Gait disturbance,,2021,Q2,1,I,,20210524.0,20210607,20210607,EXP,,US-AUROBINDO-AUR-APL-2021-022790,AUROBINDO,,48.0,YR,,F,Y,,,20210607.0,,HP,US,US,2021,Q2,Adult
193801251,19380125,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Hyponatraemia,,2021,Q2,1,I,,20210524.0,20210607,20210607,EXP,,US-AUROBINDO-AUR-APL-2021-022790,AUROBINDO,,48.0,YR,,F,Y,,,20210607.0,,HP,US,US,2021,Q2,Adult
193801251,19380125,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Mucosal dryness,,2021,Q2,1,I,,20210524.0,20210607,20210607,EXP,,US-AUROBINDO-AUR-APL-2021-022790,AUROBINDO,,48.0,YR,,F,Y,,,20210607.0,,HP,US,US,2021,Q2,Adult
193801251,19380125,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Nausea,,2021,Q2,1,I,,20210524.0,20210607,20210607,EXP,,US-AUROBINDO-AUR-APL-2021-022790,AUROBINDO,,48.0,YR,,F,Y,,,20210607.0,,HP,US,US,2021,Q2,Adult
193801251,19380125,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Toxicity to various agents,,2021,Q2,1,I,,20210524.0,20210607,20210607,EXP,,US-AUROBINDO-AUR-APL-2021-022790,AUROBINDO,,48.0,YR,,F,Y,,,20210607.0,,HP,US,US,2021,Q2,Adult
193801251,19380125,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Tremor,,2021,Q2,1,I,,20210524.0,20210607,20210607,EXP,,US-AUROBINDO-AUR-APL-2021-022790,AUROBINDO,,48.0,YR,,F,Y,,,20210607.0,,HP,US,US,2021,Q2,Adult
193801251,19380125,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Vomiting,,2021,Q2,1,I,,20210524.0,20210607,20210607,EXP,,US-AUROBINDO-AUR-APL-2021-022790,AUROBINDO,,48.0,YR,,F,Y,,,20210607.0,,HP,US,US,2021,Q2,Adult
193801311,19380131,6,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q2,Serotonin syndrome,,2021,Q2,1,I,,20101030.0,20210607,20210607,EXP,,US-AUROBINDO-AUR-APL-2019-100698,AUROBINDO,,46.0,YR,,F,Y,,,20210607.0,,MD,US,US,2021,Q2,Adult
193802001,19380200,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK (ACCORDING TO THE SCHEME, INJECTION / INFUSION SOLUTION)",,,U,U,,,,,,,,2021,Q2,Acute respiratory failure,,2021,Q2,1,I,,20210527.0,20210607,20210607,EXP,,DE-AUROBINDO-AUR-APL-2021-022874,AUROBINDO,,79.0,YR,,M,Y,,,20210607.0,,PH,DE,DE,2021,Q2,Elderly
193802001,19380200,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK (ACCORDING TO THE SCHEME, INJECTION / INFUSION SOLUTION)",,,U,U,,,,,,,,2021,Q2,Somnolence,,2021,Q2,1,I,,20210527.0,20210607,20210607,EXP,,DE-AUROBINDO-AUR-APL-2021-022874,AUROBINDO,,79.0,YR,,M,Y,,,20210607.0,,PH,DE,DE,2021,Q2,Elderly
193805691,19380569,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,,,2021,Q2,Confusional state,,2021,Q2,1,I,,20210527.0,20210607,20210607,EXP,DE-BFARM-21005204,DE-NOVOPROD-817228,NOVO NORDISK,,85.0,YR,,M,Y,,,20210607.0,,PH,DE,DE,2021,Q2,Elderly
193805691,19380569,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,,,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,,20210527.0,20210607,20210607,EXP,DE-BFARM-21005204,DE-NOVOPROD-817228,NOVO NORDISK,,85.0,YR,,M,Y,,,20210607.0,,PH,DE,DE,2021,Q2,Elderly
193805691,19380569,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,,,2021,Q2,Product administration error,,2021,Q2,1,I,,20210527.0,20210607,20210607,EXP,DE-BFARM-21005204,DE-NOVOPROD-817228,NOVO NORDISK,,85.0,YR,,M,Y,,,20210607.0,,PH,DE,DE,2021,Q2,Elderly
193815091,19381509,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"10 UNITS, DAILY",,,,,,,,,,,,2021,Q2,Anaemia,,2021,Q2,1,I,,20210526.0,20210607,20210607,EXP,,US-BAYER-2021-151813,BAYER,"CERVANTES CE, MENEZ S, MONROY TRUJILLO JM, HANOUNEH M. CLINICAL APPROACH TO A PATIENT WITH AN ACID?BASE DISTURBANCE. AMERICAN JOURNAL OF KIDNEY DISEASES. 2021?77:2:A9?A11",65.0,YR,E,F,Y,,,20210607.0,,MD,US,US,2021,Q2,Elderly
193815091,19381509,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"10 UNITS, DAILY",,,,,,,,,,,,2021,Q2,Haematemesis,,2021,Q2,1,I,,20210526.0,20210607,20210607,EXP,,US-BAYER-2021-151813,BAYER,"CERVANTES CE, MENEZ S, MONROY TRUJILLO JM, HANOUNEH M. CLINICAL APPROACH TO A PATIENT WITH AN ACID?BASE DISTURBANCE. AMERICAN JOURNAL OF KIDNEY DISEASES. 2021?77:2:A9?A11",65.0,YR,E,F,Y,,,20210607.0,,MD,US,US,2021,Q2,Elderly
193817811,19381781,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (16 IE, 0?0?0?1, INJEKTIONS?/INFUSIONSL?SUNG)",,,U,,,,,,,,,2021,Q2,Condition aggravated,,2021,Q2,1,I,,20210531.0,20210607,20210607,EXP,DE-ADRED-06388-01,NVSC2021DE123308,NOVARTIS,,56.0,YR,,F,Y,103.0,KG,20210607.0,,HP,DE,DE,2021,Q2,Adult
193817811,19381781,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (16 IE, 0?0?0?1, INJEKTIONS?/INFUSIONSL?SUNG)",,,U,,,,,,,,,2021,Q2,Renal impairment,,2021,Q2,1,I,,20210531.0,20210607,20210607,EXP,DE-ADRED-06388-01,NVSC2021DE123308,NOVARTIS,,56.0,YR,,F,Y,103.0,KG,20210607.0,,HP,DE,DE,2021,Q2,Adult
193817811,19381781,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (16 IE, 0?0?0?1, INJEKTIONS?/INFUSIONSL?SUNG)",,,U,,,,,,,,,2021,Q2,Weight increased,,2021,Q2,1,I,,20210531.0,20210607,20210607,EXP,DE-ADRED-06388-01,NVSC2021DE123308,NOVARTIS,,56.0,YR,,F,Y,103.0,KG,20210607.0,,HP,DE,DE,2021,Q2,Adult
193826251,19382625,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"NACH SCHEMA, INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,,,,,2021,Q2,Acute respiratory failure,,2021,Q2,1,I,,20210531.0,20210607,20210607,EXP,DE-ADRED-05982-01,NVSC2021DE123215,NOVARTIS,,79.0,YR,,M,Y,,,20210607.0,,HP,DE,DE,2021,Q2,Elderly
193826251,19382625,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"NACH SCHEMA, INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,,,,,2021,Q2,Somnolence,,2021,Q2,1,I,,20210531.0,20210607,20210607,EXP,DE-ADRED-05982-01,NVSC2021DE123215,NOVARTIS,,79.0,YR,,M,Y,,,20210607.0,,HP,DE,DE,2021,Q2,Elderly
193893382,19389338,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q2,Neurotoxicity,,2021,Q2,2,F,,20210609.0,20210608,20210615,EXP,,CH-MYLANLABS-2021M1033455,MYLAN,,86.0,YR,,F,Y,,,20210615.0,,HP,CH,CH,2021,Q2,Elderly
193894591,19389459,9,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Drug interaction,,2021,Q2,1,I,,20210531.0,20210608,20210608,EXP,,IT-MYLANLABS-2021M1033584,MYLAN,,93.0,YR,,M,Y,,,20210608.0,,HP,IT,IT,2021,Q2,Elderly
193894591,19389459,9,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Electrocardiogram QT prolonged,,2021,Q2,1,I,,20210531.0,20210608,20210608,EXP,,IT-MYLANLABS-2021M1033584,MYLAN,,93.0,YR,,M,Y,,,20210608.0,,HP,IT,IT,2021,Q2,Elderly
193894591,19389459,9,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Off label use,,2021,Q2,1,I,,20210531.0,20210608,20210608,EXP,,IT-MYLANLABS-2021M1033584,MYLAN,,93.0,YR,,M,Y,,,20210608.0,,HP,IT,IT,2021,Q2,Elderly
193916491,19391649,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 U, QN, IH",,,,, UNKNOWN,,,,,,,2021,Q2,Atrioventricular block,,2021,Q2,1,I,20210409.0,20210529.0,20210609,20210609,EXP,CN-NMPA-8201011028531202100983,CN-NOVOPROD-817664,NOVO NORDISK,,65.0,YR,,M,Y,76.0,KG,20210609.0,,HP,CN,CN,2021,Q2,Elderly
193916491,19391649,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 U, QN, IH",,,,, UNKNOWN,,,,,,,2021,Q2,Bradycardia,,2021,Q2,1,I,20210409.0,20210529.0,20210609,20210609,EXP,CN-NMPA-8201011028531202100983,CN-NOVOPROD-817664,NOVO NORDISK,,65.0,YR,,M,Y,76.0,KG,20210609.0,,HP,CN,CN,2021,Q2,Elderly
193925151,19392515,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, ACCORDING TO THE SCHEME",,,U,,,,,,,,,2021,Q2,Acute respiratory failure,,2021,Q2,1,I,,20210527.0,20210608,20210608,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202105013025,ELI LILLY AND CO,,79.0,YR,,M,Y,,,20210608.0,,PH,DE,DE,2021,Q2,Elderly
193925151,19392515,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, ACCORDING TO THE SCHEME",,,U,,,,,,,,,2021,Q2,Somnolence,,2021,Q2,1,I,,20210527.0,20210608,20210608,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202105013025,ELI LILLY AND CO,,79.0,YR,,M,Y,,,20210608.0,,PH,DE,DE,2021,Q2,Elderly
193925271,19392527,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, ACCORDING TO THE SCHEME",,,U,,,,205692.0,,,,,2021,Q2,Confusional state,,2021,Q2,1,I,,20210527.0,20210608,20210608,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202105013030,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210608.0,,PH,DE,DE,2021,Q2,Elderly
193925271,19392527,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, ACCORDING TO THE SCHEME",,,U,,,,205692.0,,,,,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,,20210527.0,20210608,20210608,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202105013030,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210608.0,,PH,DE,DE,2021,Q2,Elderly
193925271,19392527,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, ACCORDING TO THE SCHEME",,,U,,,,205692.0,,,,,2021,Q2,Product administration error,,2021,Q2,1,I,,20210527.0,20210608,20210608,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202105013030,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210608.0,,PH,DE,DE,2021,Q2,Elderly
193956151,19395615,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 UNITS,,,,, UNKNOWN,,,,,UNKNOWN,QD,2021,Q2,Bronchopulmonary aspergillosis,,2021,Q2,1,I,,20210603.0,20210609,20210609,EXP,,US-FRESENIUS KABI-FK202105811,FRESENIUS KABI,"JOHNSON A, GHAZARIAN Z, CENDROWSKI K, PERSICHINO J. PULMONARY ASPERGILLOSIS AND MUCORMYCOSIS IN A PATIENT WITH COVID?19. MEDICAL MYCOLOGY CASE REPORTS. 2021 JUN?32:64?67.",79.0,YR,,M,Y,,,20210609.0,,HP,US,US,2021,Q2,Elderly
193956151,19395615,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 UNITS,,,,, UNKNOWN,,,,,UNKNOWN,QD,2021,Q2,Encephalopathy,,2021,Q2,1,I,,20210603.0,20210609,20210609,EXP,,US-FRESENIUS KABI-FK202105811,FRESENIUS KABI,"JOHNSON A, GHAZARIAN Z, CENDROWSKI K, PERSICHINO J. PULMONARY ASPERGILLOSIS AND MUCORMYCOSIS IN A PATIENT WITH COVID?19. MEDICAL MYCOLOGY CASE REPORTS. 2021 JUN?32:64?67.",79.0,YR,,M,Y,,,20210609.0,,HP,US,US,2021,Q2,Elderly
193956151,19395615,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 UNITS,,,,, UNKNOWN,,,,,UNKNOWN,QD,2021,Q2,Klebsiella infection,,2021,Q2,1,I,,20210603.0,20210609,20210609,EXP,,US-FRESENIUS KABI-FK202105811,FRESENIUS KABI,"JOHNSON A, GHAZARIAN Z, CENDROWSKI K, PERSICHINO J. PULMONARY ASPERGILLOSIS AND MUCORMYCOSIS IN A PATIENT WITH COVID?19. MEDICAL MYCOLOGY CASE REPORTS. 2021 JUN?32:64?67.",79.0,YR,,M,Y,,,20210609.0,,HP,US,US,2021,Q2,Elderly
193956151,19395615,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 UNITS,,,,, UNKNOWN,,,,,UNKNOWN,QD,2021,Q2,Pneumonia,,2021,Q2,1,I,,20210603.0,20210609,20210609,EXP,,US-FRESENIUS KABI-FK202105811,FRESENIUS KABI,"JOHNSON A, GHAZARIAN Z, CENDROWSKI K, PERSICHINO J. PULMONARY ASPERGILLOSIS AND MUCORMYCOSIS IN A PATIENT WITH COVID?19. MEDICAL MYCOLOGY CASE REPORTS. 2021 JUN?32:64?67.",79.0,YR,,M,Y,,,20210609.0,,HP,US,US,2021,Q2,Elderly
193956151,19395615,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 UNITS,,,,, UNKNOWN,,,,,UNKNOWN,QD,2021,Q2,Pulmonary mucormycosis,,2021,Q2,1,I,,20210603.0,20210609,20210609,EXP,,US-FRESENIUS KABI-FK202105811,FRESENIUS KABI,"JOHNSON A, GHAZARIAN Z, CENDROWSKI K, PERSICHINO J. PULMONARY ASPERGILLOSIS AND MUCORMYCOSIS IN A PATIENT WITH COVID?19. MEDICAL MYCOLOGY CASE REPORTS. 2021 JUN?32:64?67.",79.0,YR,,M,Y,,,20210609.0,,HP,US,US,2021,Q2,Elderly
193956151,19395615,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 UNITS,,,,, UNKNOWN,,,,,UNKNOWN,QD,2021,Q2,Respiratory failure,,2021,Q2,1,I,,20210603.0,20210609,20210609,EXP,,US-FRESENIUS KABI-FK202105811,FRESENIUS KABI,"JOHNSON A, GHAZARIAN Z, CENDROWSKI K, PERSICHINO J. PULMONARY ASPERGILLOSIS AND MUCORMYCOSIS IN A PATIENT WITH COVID?19. MEDICAL MYCOLOGY CASE REPORTS. 2021 JUN?32:64?67.",79.0,YR,,M,Y,,,20210609.0,,HP,US,US,2021,Q2,Elderly
193956151,19395615,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 UNITS,,,,, UNKNOWN,,,,,UNKNOWN,QD,2021,Q2,Staphylococcal infection,,2021,Q2,1,I,,20210603.0,20210609,20210609,EXP,,US-FRESENIUS KABI-FK202105811,FRESENIUS KABI,"JOHNSON A, GHAZARIAN Z, CENDROWSKI K, PERSICHINO J. PULMONARY ASPERGILLOSIS AND MUCORMYCOSIS IN A PATIENT WITH COVID?19. MEDICAL MYCOLOGY CASE REPORTS. 2021 JUN?32:64?67.",79.0,YR,,M,Y,,,20210609.0,,HP,US,US,2021,Q2,Elderly
193956151,19395615,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,, UNKNOWN,,,,,,,2021,Q2,Bronchopulmonary aspergillosis,,2021,Q2,1,I,,20210603.0,20210609,20210609,EXP,,US-FRESENIUS KABI-FK202105811,FRESENIUS KABI,"JOHNSON A, GHAZARIAN Z, CENDROWSKI K, PERSICHINO J. PULMONARY ASPERGILLOSIS AND MUCORMYCOSIS IN A PATIENT WITH COVID?19. MEDICAL MYCOLOGY CASE REPORTS. 2021 JUN?32:64?67.",79.0,YR,,M,Y,,,20210609.0,,HP,US,US,2021,Q2,Elderly
193956151,19395615,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,, UNKNOWN,,,,,,,2021,Q2,Encephalopathy,,2021,Q2,1,I,,20210603.0,20210609,20210609,EXP,,US-FRESENIUS KABI-FK202105811,FRESENIUS KABI,"JOHNSON A, GHAZARIAN Z, CENDROWSKI K, PERSICHINO J. PULMONARY ASPERGILLOSIS AND MUCORMYCOSIS IN A PATIENT WITH COVID?19. MEDICAL MYCOLOGY CASE REPORTS. 2021 JUN?32:64?67.",79.0,YR,,M,Y,,,20210609.0,,HP,US,US,2021,Q2,Elderly
193956151,19395615,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,, UNKNOWN,,,,,,,2021,Q2,Klebsiella infection,,2021,Q2,1,I,,20210603.0,20210609,20210609,EXP,,US-FRESENIUS KABI-FK202105811,FRESENIUS KABI,"JOHNSON A, GHAZARIAN Z, CENDROWSKI K, PERSICHINO J. PULMONARY ASPERGILLOSIS AND MUCORMYCOSIS IN A PATIENT WITH COVID?19. MEDICAL MYCOLOGY CASE REPORTS. 2021 JUN?32:64?67.",79.0,YR,,M,Y,,,20210609.0,,HP,US,US,2021,Q2,Elderly
193956151,19395615,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,, UNKNOWN,,,,,,,2021,Q2,Pneumonia,,2021,Q2,1,I,,20210603.0,20210609,20210609,EXP,,US-FRESENIUS KABI-FK202105811,FRESENIUS KABI,"JOHNSON A, GHAZARIAN Z, CENDROWSKI K, PERSICHINO J. PULMONARY ASPERGILLOSIS AND MUCORMYCOSIS IN A PATIENT WITH COVID?19. MEDICAL MYCOLOGY CASE REPORTS. 2021 JUN?32:64?67.",79.0,YR,,M,Y,,,20210609.0,,HP,US,US,2021,Q2,Elderly
193956151,19395615,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,, UNKNOWN,,,,,,,2021,Q2,Pulmonary mucormycosis,,2021,Q2,1,I,,20210603.0,20210609,20210609,EXP,,US-FRESENIUS KABI-FK202105811,FRESENIUS KABI,"JOHNSON A, GHAZARIAN Z, CENDROWSKI K, PERSICHINO J. PULMONARY ASPERGILLOSIS AND MUCORMYCOSIS IN A PATIENT WITH COVID?19. MEDICAL MYCOLOGY CASE REPORTS. 2021 JUN?32:64?67.",79.0,YR,,M,Y,,,20210609.0,,HP,US,US,2021,Q2,Elderly
193956151,19395615,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,, UNKNOWN,,,,,,,2021,Q2,Respiratory failure,,2021,Q2,1,I,,20210603.0,20210609,20210609,EXP,,US-FRESENIUS KABI-FK202105811,FRESENIUS KABI,"JOHNSON A, GHAZARIAN Z, CENDROWSKI K, PERSICHINO J. PULMONARY ASPERGILLOSIS AND MUCORMYCOSIS IN A PATIENT WITH COVID?19. MEDICAL MYCOLOGY CASE REPORTS. 2021 JUN?32:64?67.",79.0,YR,,M,Y,,,20210609.0,,HP,US,US,2021,Q2,Elderly
193956151,19395615,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,, UNKNOWN,,,,,,,2021,Q2,Staphylococcal infection,,2021,Q2,1,I,,20210603.0,20210609,20210609,EXP,,US-FRESENIUS KABI-FK202105811,FRESENIUS KABI,"JOHNSON A, GHAZARIAN Z, CENDROWSKI K, PERSICHINO J. PULMONARY ASPERGILLOSIS AND MUCORMYCOSIS IN A PATIENT WITH COVID?19. MEDICAL MYCOLOGY CASE REPORTS. 2021 JUN?32:64?67.",79.0,YR,,M,Y,,,20210609.0,,HP,US,US,2021,Q2,Elderly
193989801,19398980,5,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Osteomyelitis,,2021,Q2,1,I,20210601.0,,20210610,20210610,DIR,,,FDA-CTU,,72.0,YR,,M,N,97.2,KG,20210610.0,N,MD,US,US,2021,Q2,Elderly
193989801,19398980,5,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Skin discolouration,,2021,Q2,1,I,20210601.0,,20210610,20210610,DIR,,,FDA-CTU,,72.0,YR,,M,N,97.2,KG,20210610.0,N,MD,US,US,2021,Q2,Elderly
193989801,19398980,5,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Toe amputation,,2021,Q2,1,I,20210601.0,,20210610,20210610,DIR,,,FDA-CTU,,72.0,YR,,M,N,97.2,KG,20210610.0,N,MD,US,US,2021,Q2,Elderly
193992371,19399237,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, OF731A,,,,,,,2021,Q2,Abdominal discomfort,,2021,Q2,1,I,2020.0,20210607.0,20210610,20210610,EXP,,ES-MYLANLABS-2021M1033564,MYLAN,,53.0,YR,,F,Y,55.0,KG,20210610.0,,CN,ES,ES,2021,Q2,Adult
193992371,19399237,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, OF731A,,,,,,,2021,Q2,Anxiety,,2021,Q2,1,I,2020.0,20210607.0,20210610,20210610,EXP,,ES-MYLANLABS-2021M1033564,MYLAN,,53.0,YR,,F,Y,55.0,KG,20210610.0,,CN,ES,ES,2021,Q2,Adult
193992371,19399237,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, OF731A,,,,,,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,2020.0,20210607.0,20210610,20210610,EXP,,ES-MYLANLABS-2021M1033564,MYLAN,,53.0,YR,,F,Y,55.0,KG,20210610.0,,CN,ES,ES,2021,Q2,Adult
193992371,19399237,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, OF731A,,,,,,,2021,Q2,Dizziness,,2021,Q2,1,I,2020.0,20210607.0,20210610,20210610,EXP,,ES-MYLANLABS-2021M1033564,MYLAN,,53.0,YR,,F,Y,55.0,KG,20210610.0,,CN,ES,ES,2021,Q2,Adult
193992371,19399237,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,14 IU,,,,, OF731A,,,14.0,IU,,,2021,Q2,Abdominal discomfort,,2021,Q2,1,I,2020.0,20210607.0,20210610,20210610,EXP,,ES-MYLANLABS-2021M1033564,MYLAN,,53.0,YR,,F,Y,55.0,KG,20210610.0,,CN,ES,ES,2021,Q2,Adult
193992371,19399237,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,14 IU,,,,, OF731A,,,14.0,IU,,,2021,Q2,Anxiety,,2021,Q2,1,I,2020.0,20210607.0,20210610,20210610,EXP,,ES-MYLANLABS-2021M1033564,MYLAN,,53.0,YR,,F,Y,55.0,KG,20210610.0,,CN,ES,ES,2021,Q2,Adult
193992371,19399237,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,14 IU,,,,, OF731A,,,14.0,IU,,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,2020.0,20210607.0,20210610,20210610,EXP,,ES-MYLANLABS-2021M1033564,MYLAN,,53.0,YR,,F,Y,55.0,KG,20210610.0,,CN,ES,ES,2021,Q2,Adult
193992371,19399237,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,14 IU,,,,, OF731A,,,14.0,IU,,,2021,Q2,Dizziness,,2021,Q2,1,I,2020.0,20210607.0,20210610,20210610,EXP,,ES-MYLANLABS-2021M1033564,MYLAN,,53.0,YR,,F,Y,55.0,KG,20210610.0,,CN,ES,ES,2021,Q2,Adult
194006111,19400611,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"ACCORDING TO THE SCHEDULE, INJECTION SOLUTION/ INFUSION SOLUTION",,,U,,,,,,,INJECTION,,2021,Q2,Acute respiratory failure,,2021,Q2,1,I,,20210601.0,20210610,20210610,EXP,,DE-EMD SERONO-E2B_90083781,EMD SERONO INC,,79.0,YR,E,M,Y,,,20210610.0,,PH,DE,DE,2021,Q2,Elderly
194006111,19400611,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"ACCORDING TO THE SCHEDULE, INJECTION SOLUTION/ INFUSION SOLUTION",,,U,,,,,,,INJECTION,,2021,Q2,Somnolence,,2021,Q2,1,I,,20210601.0,20210610,20210610,EXP,,DE-EMD SERONO-E2B_90083781,EMD SERONO INC,,79.0,YR,E,M,Y,,,20210610.0,,PH,DE,DE,2021,Q2,Elderly
194018422,19401842,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,6 U,,,,,,,,6.0,IU,,,2021,Q2,Cardiac failure,,2021,Q2,2,F,202104.0,20210607.0,20210611,20210616,EXP,,HR-JNJFOC-20210621719,JOHNSON AND JOHNSON,,75.0,YR,E,,Y,,,20210617.0,,MD,HR,HR,2021,Q2,Elderly
194018422,19401842,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,6 U,,,,,,,,6.0,IU,,,2021,Q2,Urinary tract infection,,2021,Q2,2,F,202104.0,20210607.0,20210611,20210616,EXP,,HR-JNJFOC-20210621719,JOHNSON AND JOHNSON,,75.0,YR,E,,Y,,,20210617.0,,MD,HR,HR,2021,Q2,Elderly
194023901,19402390,4,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Subcutaneous,"100 UG, 1X/DAY",,,,,,,,100.0,UG,INJECTION,QD,2021,Q2,Cystitis,,2021,Q2,1,I,20200709.0,20201228.0,20210610,20210610,EXP,,JP-PFIZER INC-2020515146,PFIZER,,67.0,YR,,M,Y,57.0,KG,20210610.0,,PH,JP,JP,2021,Q2,Elderly
194023901,19402390,4,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Subcutaneous,"100 UG, 1X/DAY",,,,,,,,100.0,UG,INJECTION,QD,2021,Q2,Dermatitis acneiform,,2021,Q2,1,I,20200709.0,20201228.0,20210610,20210610,EXP,,JP-PFIZER INC-2020515146,PFIZER,,67.0,YR,,M,Y,57.0,KG,20210610.0,,PH,JP,JP,2021,Q2,Elderly
194023901,19402390,4,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Subcutaneous,"100 UG, 1X/DAY",,,,,,,,100.0,UG,INJECTION,QD,2021,Q2,Diarrhoea,,2021,Q2,1,I,20200709.0,20201228.0,20210610,20210610,EXP,,JP-PFIZER INC-2020515146,PFIZER,,67.0,YR,,M,Y,57.0,KG,20210610.0,,PH,JP,JP,2021,Q2,Elderly
194023901,19402390,4,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Subcutaneous,"100 UG, 1X/DAY",,,,,,,,100.0,UG,INJECTION,QD,2021,Q2,Interstitial lung disease,,2021,Q2,1,I,20200709.0,20201228.0,20210610,20210610,EXP,,JP-PFIZER INC-2020515146,PFIZER,,67.0,YR,,M,Y,57.0,KG,20210610.0,,PH,JP,JP,2021,Q2,Elderly
194023901,19402390,4,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Subcutaneous,"100 UG, 1X/DAY",,,,,,,,100.0,UG,INJECTION,QD,2021,Q2,Pneumocystis jirovecii pneumonia,,2021,Q2,1,I,20200709.0,20201228.0,20210610,20210610,EXP,,JP-PFIZER INC-2020515146,PFIZER,,67.0,YR,,M,Y,57.0,KG,20210610.0,,PH,JP,JP,2021,Q2,Elderly
194029001,19402900,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"ACCORDING TO THE SCHEME, INJECTION / INFUSION SOLUTION",,,U,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q2,Acute respiratory failure,,2021,Q2,1,I,,20210529.0,20210610,20210610,EXP,DE-ADRED-05982-01,DE-BAUSCH-BL-2021-019408,BAUSCH AND LOMB,,79.0,YR,,M,Y,,,20210610.0,,PH,DE,DE,2021,Q2,Elderly
194029001,19402900,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"ACCORDING TO THE SCHEME, INJECTION / INFUSION SOLUTION",,,U,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q2,Somnolence,,2021,Q2,1,I,,20210529.0,20210610,20210610,EXP,DE-ADRED-05982-01,DE-BAUSCH-BL-2021-019408,BAUSCH AND LOMB,,79.0,YR,,M,Y,,,20210610.0,,PH,DE,DE,2021,Q2,Elderly
194049061,19404906,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Administration site pain,,2021,Q2,1,I,,20210601.0,20210611,20210611,EXP,,AU-BAUSCH-BL-2021-019583,BAUSCH AND LOMB,,30.0,YR,,F,Y,,,20210611.0,,CN,AU,AU,2021,Q2,Young Adult
194049061,19404906,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Drug ineffective,,2021,Q2,1,I,,20210601.0,20210611,20210611,EXP,,AU-BAUSCH-BL-2021-019583,BAUSCH AND LOMB,,30.0,YR,,F,Y,,,20210611.0,,CN,AU,AU,2021,Q2,Young Adult
194049061,19404906,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Infusion related hypersensitivity reaction,,2021,Q2,1,I,,20210601.0,20210611,20210611,EXP,,AU-BAUSCH-BL-2021-019583,BAUSCH AND LOMB,,30.0,YR,,F,Y,,,20210611.0,,CN,AU,AU,2021,Q2,Young Adult
194049061,19404906,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Myalgia,,2021,Q2,1,I,,20210601.0,20210611,20210611,EXP,,AU-BAUSCH-BL-2021-019583,BAUSCH AND LOMB,,30.0,YR,,F,Y,,,20210611.0,,CN,AU,AU,2021,Q2,Young Adult
194049061,19404906,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Type III immune complex mediated reaction,,2021,Q2,1,I,,20210601.0,20210611,20210611,EXP,,AU-BAUSCH-BL-2021-019583,BAUSCH AND LOMB,,30.0,YR,,F,Y,,,20210611.0,,CN,AU,AU,2021,Q2,Young Adult
194050401,19405040,15,C,Insulin?glargine,INSULIN NOS,1,Unknown,,,,U,,,,,,,,,2021,Q2,Neurotoxicity,,2021,Q2,1,I,,20210607.0,20210611,20210611,EXP,,CH-TEVA-2021-CH-1922292,TEVA,"ZIMMERMANN P, CAMENZIND D, BEER JH, TARNUTZER AA. NEGATIVE MYOCLONUS AS THE LEADING SYMPTOM IN ACUTE CEFEPIME NEUROTOXICITY. BMJ?CASE?REP 2021?14:NO. 4.",86.0,YR,E,F,Y,,,20210611.0,,HP,CH,CH,2021,Q2,Elderly
194050401,19405040,15,C,Insulin?glargine,INSULIN NOS,1,Unknown,,,,U,,,,,,,,,2021,Q2,Toxicity to various agents,,2021,Q2,1,I,,20210607.0,20210611,20210611,EXP,,CH-TEVA-2021-CH-1922292,TEVA,"ZIMMERMANN P, CAMENZIND D, BEER JH, TARNUTZER AA. NEGATIVE MYOCLONUS AS THE LEADING SYMPTOM IN ACUTE CEFEPIME NEUROTOXICITY. BMJ?CASE?REP 2021?14:NO. 4.",86.0,YR,E,F,Y,,,20210611.0,,HP,CH,CH,2021,Q2,Elderly
194065791,19406579,2,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"ACCORDING TO THE SCHEME, INJECTION / INFUSION SOLUTION",,,U,,,,21081.0,,,,,2021,Q2,Confusional state,,2021,Q2,1,I,,20210601.0,20210611,20210611,EXP,,DE-SA-2021SA183750,SANOFI AVENTIS,,85.0,YR,E,M,Y,,,20210611.0,,PH,DE,DE,2021,Q2,Elderly
194065791,19406579,2,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"ACCORDING TO THE SCHEME, INJECTION / INFUSION SOLUTION",,,U,,,,21081.0,,,,,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,,20210601.0,20210611,20210611,EXP,,DE-SA-2021SA183750,SANOFI AVENTIS,,85.0,YR,E,M,Y,,,20210611.0,,PH,DE,DE,2021,Q2,Elderly
194065791,19406579,2,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"ACCORDING TO THE SCHEME, INJECTION / INFUSION SOLUTION",,,U,,,,21081.0,,,,,2021,Q2,Product administration error,,2021,Q2,1,I,,20210601.0,20210611,20210611,EXP,,DE-SA-2021SA183750,SANOFI AVENTIS,,85.0,YR,E,M,Y,,,20210611.0,,PH,DE,DE,2021,Q2,Elderly
194066945,19406694,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Angina unstable,,2021,Q2,5,F,,20210625.0,20210611,20210630,EXP,,NVSC2021PL110207,NOVARTIS,,39.0,YR,,M,Y,,,20210630.0,,HP,PL,PL,2021,Q2,Adult
194066945,19406694,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Drug ineffective,,2021,Q2,5,F,,20210625.0,20210611,20210630,EXP,,NVSC2021PL110207,NOVARTIS,,39.0,YR,,M,Y,,,20210630.0,,HP,PL,PL,2021,Q2,Adult
194066945,19406694,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,ECG signs of myocardial ischaemia,,2021,Q2,5,F,,20210625.0,20210611,20210630,EXP,,NVSC2021PL110207,NOVARTIS,,39.0,YR,,M,Y,,,20210630.0,,HP,PL,PL,2021,Q2,Adult
194066945,19406694,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Product use in unapproved indication,,2021,Q2,5,F,,20210625.0,20210611,20210630,EXP,,NVSC2021PL110207,NOVARTIS,,39.0,YR,,M,Y,,,20210630.0,,HP,PL,PL,2021,Q2,Adult
194066945,19406694,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Treatment failure,,2021,Q2,5,F,,20210625.0,20210611,20210630,EXP,,NVSC2021PL110207,NOVARTIS,,39.0,YR,,M,Y,,,20210630.0,,HP,PL,PL,2021,Q2,Adult
194069241,19406924,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",3568.0,IU,Y,U, ABJA020,,,16.0,IU,,QD,2021,Q2,Diabetic foot infection,,2021,Q2,1,I,20210512.0,20210528.0,20210611,20210611,EXP,CN-NMPA-4403061004832202100127,CN-NOVOPROD-817829,NOVO NORDISK,,44.0,YR,,M,Y,59.0,KG,20210611.0,,HP,CN,CN,2021,Q2,Adult
194069241,19406924,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",3568.0,IU,Y,U, ABJA020,,,16.0,IU,,QD,2021,Q2,Hypoglycaemic coma,,2021,Q2,1,I,20210512.0,20210528.0,20210611,20210611,EXP,CN-NMPA-4403061004832202100127,CN-NOVOPROD-817829,NOVO NORDISK,,44.0,YR,,M,Y,59.0,KG,20210611.0,,HP,CN,CN,2021,Q2,Adult
194082591,19408259,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 UNITS ONE TIME PER DAY,,,,,,,,,,,,2021,Q2,Hypomagnesaemia,,2021,Q2,1,I,20210302.0,20210330.0,20210611,20210611,EXP,,US-AMERICAN REGENT INC-2021000822,AMERICAN REGENT,,85.0,YR,,M,Y,66.12,KG,20210611.0,,CN,US,US,2021,Q2,Elderly
194082591,19408259,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 UNITS ONE TIME PER DAY,,,,,,,,,,,,2021,Q2,Hypophosphataemia,,2021,Q2,1,I,20210302.0,20210330.0,20210611,20210611,EXP,,US-AMERICAN REGENT INC-2021000822,AMERICAN REGENT,,85.0,YR,,M,Y,66.12,KG,20210611.0,,CN,US,US,2021,Q2,Elderly
194112341,19411234,1,PS,insulin glargine,INSULIN GLARGINE,1,,,,,,Y,,,,,,,,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,20210614.0,,20210614,20210614,DIR,,,FDA-CTU,,80.0,YR,,F,N,,,20210614.0,N,PH,US,US,2021,Q2,Elderly
194112341,19411234,1,PS,insulin glargine,INSULIN GLARGINE,1,,,,,,Y,,,,,,,,2021,Q2,Therapy change,,2021,Q2,1,I,20210614.0,,20210614,20210614,DIR,,,FDA-CTU,,80.0,YR,,F,N,,,20210614.0,N,PH,US,US,2021,Q2,Elderly
194113411,19411341,7,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Confusional state,,2021,Q2,1,I,20210614.0,,20210614,20210614,DIR,,,FDA-CTU,,77.0,YR,,M,N,85.5,KG,20210614.0,N,CN,US,US,2021,Q2,Elderly
194123691,19412369,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"ACCORDING TO THE SCHEME, INJECTION / INFUSION SOLUTION",,,U,,,,21081.0,,,,,2021,Q2,Acute respiratory failure,,2021,Q2,1,I,,20210601.0,20210614,20210614,EXP,,DE-SA-2021SA184197,SANOFI AVENTIS,,79.0,YR,E,M,Y,,,20210614.0,,PH,DE,DE,2021,Q2,Elderly
194123691,19412369,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"ACCORDING TO THE SCHEME, INJECTION / INFUSION SOLUTION",,,U,,,,21081.0,,,,,2021,Q2,Somnolence,,2021,Q2,1,I,,20210601.0,20210614,20210614,EXP,,DE-SA-2021SA184197,SANOFI AVENTIS,,79.0,YR,E,M,Y,,,20210614.0,,PH,DE,DE,2021,Q2,Elderly
194126731,19412673,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION,,2021,Q2,Acute kidney injury,,2021,Q2,1,I,,20210607.0,20210614,20210614,EXP,CA-MHPD-000928543,CA-ACCORD-228224,ACCORD,,62.0,YR,,F,Y,107.0,KG,20210614.0,,HP,CA,CA,2021,Q2,Adult
194126731,19412673,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION,,2021,Q2,Diarrhoea,,2021,Q2,1,I,,20210607.0,20210614,20210614,EXP,CA-MHPD-000928543,CA-ACCORD-228224,ACCORD,,62.0,YR,,F,Y,107.0,KG,20210614.0,,HP,CA,CA,2021,Q2,Adult
194126731,19412673,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION,,2021,Q2,Febrile neutropenia,,2021,Q2,1,I,,20210607.0,20210614,20210614,EXP,CA-MHPD-000928543,CA-ACCORD-228224,ACCORD,,62.0,YR,,F,Y,107.0,KG,20210614.0,,HP,CA,CA,2021,Q2,Adult
194126731,19412673,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION,,2021,Q2,Hypotension,,2021,Q2,1,I,,20210607.0,20210614,20210614,EXP,CA-MHPD-000928543,CA-ACCORD-228224,ACCORD,,62.0,YR,,F,Y,107.0,KG,20210614.0,,HP,CA,CA,2021,Q2,Adult
194126731,19412673,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION,,2021,Q2,Mucosal inflammation,,2021,Q2,1,I,,20210607.0,20210614,20210614,EXP,CA-MHPD-000928543,CA-ACCORD-228224,ACCORD,,62.0,YR,,F,Y,107.0,KG,20210614.0,,HP,CA,CA,2021,Q2,Adult
194128161,19412816,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 UNITS DAILY,,,U,,,,,,,INJECTION,,2021,Q2,Aspergillus infection,,2021,Q2,1,I,,20210603.0,20210614,20210614,EXP,,US-MYLANLABS-2021M1033984,MYLAN,,79.0,YR,,M,Y,,,20210614.0,,HP,US,US,2021,Q2,Elderly
194128161,19412816,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 UNITS DAILY,,,U,,,,,,,INJECTION,,2021,Q2,Bronchopulmonary aspergillosis,,2021,Q2,1,I,,20210603.0,20210614,20210614,EXP,,US-MYLANLABS-2021M1033984,MYLAN,,79.0,YR,,M,Y,,,20210614.0,,HP,US,US,2021,Q2,Elderly
194128161,19412816,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 UNITS DAILY,,,U,,,,,,,INJECTION,,2021,Q2,Encephalopathy,,2021,Q2,1,I,,20210603.0,20210614,20210614,EXP,,US-MYLANLABS-2021M1033984,MYLAN,,79.0,YR,,M,Y,,,20210614.0,,HP,US,US,2021,Q2,Elderly
194128161,19412816,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 UNITS DAILY,,,U,,,,,,,INJECTION,,2021,Q2,Mucormycosis,,2021,Q2,1,I,,20210603.0,20210614,20210614,EXP,,US-MYLANLABS-2021M1033984,MYLAN,,79.0,YR,,M,Y,,,20210614.0,,HP,US,US,2021,Q2,Elderly
194128161,19412816,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 UNITS DAILY,,,U,,,,,,,INJECTION,,2021,Q2,Off label use,,2021,Q2,1,I,,20210603.0,20210614,20210614,EXP,,US-MYLANLABS-2021M1033984,MYLAN,,79.0,YR,,M,Y,,,20210614.0,,HP,US,US,2021,Q2,Elderly
194128161,19412816,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 UNITS DAILY,,,U,,,,,,,INJECTION,,2021,Q2,Pulmonary mucormycosis,,2021,Q2,1,I,,20210603.0,20210614,20210614,EXP,,US-MYLANLABS-2021M1033984,MYLAN,,79.0,YR,,M,Y,,,20210614.0,,HP,US,US,2021,Q2,Elderly
194128161,19412816,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 UNITS DAILY,,,U,,,,,,,INJECTION,,2021,Q2,Respiratory failure,,2021,Q2,1,I,,20210603.0,20210614,20210614,EXP,,US-MYLANLABS-2021M1033984,MYLAN,,79.0,YR,,M,Y,,,20210614.0,,HP,US,US,2021,Q2,Elderly
194143671,19414367,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"48 IU, QD (30?0?18)",,,,, UNKNOWN,,,48.0,IU,,QD,2021,Q2,COVID-19,,2021,Q2,1,I,20200920.0,20210604.0,20210615,20210615,EXP,,BR-NOVOPROD-820000,NOVO NORDISK,,24.0,YR,,F,Y,57.0,KG,20210615.0,,MD,BR,BR,2021,Q2,Young Adult
194143671,19414367,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"48 IU, QD (30?0?18)",,,,, UNKNOWN,,,48.0,IU,,QD,2021,Q2,Hyperglycaemia,,2021,Q2,1,I,20200920.0,20210604.0,20210615,20210615,EXP,,BR-NOVOPROD-820000,NOVO NORDISK,,24.0,YR,,F,Y,57.0,KG,20210615.0,,MD,BR,BR,2021,Q2,Young Adult
194143671,19414367,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"48 IU, QD (30?0?18)",,,,, UNKNOWN,,,48.0,IU,,QD,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,20200920.0,20210604.0,20210615,20210615,EXP,,BR-NOVOPROD-820000,NOVO NORDISK,,24.0,YR,,F,Y,57.0,KG,20210615.0,,MD,BR,BR,2021,Q2,Young Adult
194143671,19414367,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"48 IU, QD (30?0?18)",,,,, UNKNOWN,,,48.0,IU,,QD,2021,Q2,Injection site atrophy,,2021,Q2,1,I,20200920.0,20210604.0,20210615,20210615,EXP,,BR-NOVOPROD-820000,NOVO NORDISK,,24.0,YR,,F,Y,57.0,KG,20210615.0,,MD,BR,BR,2021,Q2,Young Adult
194146001,19414600,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, 0?0?1?0, SOLUTION FOR INJECTION / INFUSION",,,,,,,,,,,,2021,Q2,General physical health deterioration,,2021,Q2,1,I,,20210531.0,20210615,20210615,EXP,DE-BFARM-21003846,DE-ACCORD-227726,ACCORD,,71.0,YR,E,F,Y,,,20210615.0,,MD,DE,DE,2021,Q2,Elderly
194146001,19414600,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, 0?0?1?0, SOLUTION FOR INJECTION / INFUSION",,,,,,,,,,,,2021,Q2,Haematemesis,,2021,Q2,1,I,,20210531.0,20210615,20210615,EXP,DE-BFARM-21003846,DE-ACCORD-227726,ACCORD,,71.0,YR,E,F,Y,,,20210615.0,,MD,DE,DE,2021,Q2,Elderly
194146001,19414600,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, 0?0?1?0, SOLUTION FOR INJECTION / INFUSION",,,,,,,,,,,,2021,Q2,Labelled drug-drug interaction medication error,,2021,Q2,1,I,,20210531.0,20210615,20210615,EXP,DE-BFARM-21003846,DE-ACCORD-227726,ACCORD,,71.0,YR,E,F,Y,,,20210615.0,,MD,DE,DE,2021,Q2,Elderly
194146001,19414600,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, 0?0?1?0, SOLUTION FOR INJECTION / INFUSION",,,,,,,,,,,,2021,Q2,Renal impairment,,2021,Q2,1,I,,20210531.0,20210615,20210615,EXP,DE-BFARM-21003846,DE-ACCORD-227726,ACCORD,,71.0,YR,E,F,Y,,,20210615.0,,MD,DE,DE,2021,Q2,Elderly
194166541,19416654,1,PS,"INSULIN (INSULIN, GLARGINE, HUMAN 100 UNT/ML INJ)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER DOSE:15 UNITS;?,,,Y,D,,,,,,,QD,2021,Q2,Hypoglycaemic coma,,2021,Q2,1,I,20170715.0,,20210614,20210614,DIR,,,FDA-CTU,,70.0,YR,,M,N,97.07,KG,20171122.0,N,PH,US,US,2021,Q2,Elderly
194177641,19417764,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Neurotoxicity,,2021,Q2,1,I,,20210531.0,20210615,20210615,EXP,,CH-PFIZER INC-2021681859,PFIZER,"ZIMMERMANN, P.. NEGATIVE MYOCLONUS AS THE LEADING SYMPTOM IN ACUTE CEFEPIME NEUROTOXICITY.. BMJ CASE REP. 2021?14:1?5",86.0,YR,,F,Y,,,20210615.0,,HP,CH,CH,2021,Q2,Elderly
194233081,19423308,8,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD, 50 UNITS",,,,,,,,,,,QD,2021,Q2,Off label use,,2021,Q2,1,I,,20210603.0,20210616,20210616,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-09529,LUPIN,,79.0,YR,,M,Y,,,20210616.0,,HP,US,US,2021,Q2,Elderly
194239461,19423946,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q2,Catheter site haemorrhage,,2021,Q2,1,I,,20210608.0,20210616,20210616,EXP,,US-MYLANLABS-2021M1034735,MYLAN,"TORRES R, GUL F, AZMAIPARASHVILI Z, PATARROYO?APONTE G. BI?ATRIAL THROMBOSIS IN A PATIENT WITH SARS?COV?2 INFECTION: A CASE REPORT. EUR?HEART?J?CASE?REP 2020?4:NO. 6.",68.0,YR,,F,Y,,,20210616.0,,HP,US,US,2021,Q2,Elderly
194239461,19423946,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q2,Off label use,,2021,Q2,1,I,,20210608.0,20210616,20210616,EXP,,US-MYLANLABS-2021M1034735,MYLAN,"TORRES R, GUL F, AZMAIPARASHVILI Z, PATARROYO?APONTE G. BI?ATRIAL THROMBOSIS IN A PATIENT WITH SARS?COV?2 INFECTION: A CASE REPORT. EUR?HEART?J?CASE?REP 2020?4:NO. 6.",68.0,YR,,F,Y,,,20210616.0,,HP,US,US,2021,Q2,Elderly
194239981,19423998,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,40 UI EARLY AND 10 UI AT NIGHT,,,U,U,,,,,,,,2021,Q2,Coronary artery disease,,2021,Q2,1,I,2018.0,20201008.0,20210616,20210616,EXP,,BR-NOVOPROD-813915,NOVO NORDISK,,26.0,YR,,M,Y,72.0,KG,20210616.0,,MD,BR,BR,2021,Q2,Young Adult
194239981,19423998,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,40 UI EARLY AND 10 UI AT NIGHT,,,U,U,,,,,,,,2021,Q2,Hypoglycaemic seizure,,2021,Q2,1,I,2018.0,20201008.0,20210616,20210616,EXP,,BR-NOVOPROD-813915,NOVO NORDISK,,26.0,YR,,M,Y,72.0,KG,20210616.0,,MD,BR,BR,2021,Q2,Young Adult
194239981,19423998,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,40 UI EARLY AND 10 UI AT NIGHT,,,U,U,,,,,,,,2021,Q2,Hypoglycaemic unconsciousness,,2021,Q2,1,I,2018.0,20201008.0,20210616,20210616,EXP,,BR-NOVOPROD-813915,NOVO NORDISK,,26.0,YR,,M,Y,72.0,KG,20210616.0,,MD,BR,BR,2021,Q2,Young Adult
194239981,19423998,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,40 UI EARLY AND 10 UI AT NIGHT,,,U,U,,,,,,,,2021,Q2,Obsessive-compulsive disorder,,2021,Q2,1,I,2018.0,20201008.0,20210616,20210616,EXP,,BR-NOVOPROD-813915,NOVO NORDISK,,26.0,YR,,M,Y,72.0,KG,20210616.0,,MD,BR,BR,2021,Q2,Young Adult
194239981,19423998,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,40 UI EARLY AND 10 UI AT NIGHT,,,U,U,,,,,,,,2021,Q2,Treatment noncompliance,,2021,Q2,1,I,2018.0,20201008.0,20210616,20210616,EXP,,BR-NOVOPROD-813915,NOVO NORDISK,,26.0,YR,,M,Y,72.0,KG,20210616.0,,MD,BR,BR,2021,Q2,Young Adult
194275291,19427529,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,D,,,,,,,INJECTION,,2021,Q2,Drug interaction,,2021,Q2,1,I,20210505.0,20210604.0,20210616,20210616,EXP,ES-AEMPS-893522,ES-ELI_LILLY_AND_COMPANY-ES202106002905,ELI LILLY AND CO,,80.0,YR,,M,Y,,,20210616.0,,PH,ES,ES,2021,Q2,Elderly
194275291,19427529,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,D,,,,,,,INJECTION,,2021,Q2,Hyperglycaemia,,2021,Q2,1,I,20210505.0,20210604.0,20210616,20210616,EXP,ES-AEMPS-893522,ES-ELI_LILLY_AND_COMPANY-ES202106002905,ELI LILLY AND CO,,80.0,YR,,M,Y,,,20210616.0,,PH,ES,ES,2021,Q2,Elderly
194275291,19427529,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,D,,,,,,,INJECTION,,2021,Q2,Product administration error,,2021,Q2,1,I,20210505.0,20210604.0,20210616,20210616,EXP,ES-AEMPS-893522,ES-ELI_LILLY_AND_COMPANY-ES202106002905,ELI LILLY AND CO,,80.0,YR,,M,Y,,,20210616.0,,PH,ES,ES,2021,Q2,Elderly
194275311,19427531,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"100 IU/ML, UNKNOWN",,,U,U,,,205692.0,100.0,,,,2021,Q2,Flushing,,2021,Q2,1,I,20210528.0,20210604.0,20210616,20210616,EXP,GB-MHRA-TPP41703771C126133YC1622621048824,GB-ELI_LILLY_AND_COMPANY-GB202106002947,ELI LILLY AND CO,,62.0,YR,,F,Y,100.0,KG,20210616.0,,MD,GB,GB,2021,Q2,Adult
194275311,19427531,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"100 IU/ML, UNKNOWN",,,U,U,,,205692.0,100.0,,,,2021,Q2,Swelling face,,2021,Q2,1,I,20210528.0,20210604.0,20210616,20210616,EXP,GB-MHRA-TPP41703771C126133YC1622621048824,GB-ELI_LILLY_AND_COMPANY-GB202106002947,ELI LILLY AND CO,,62.0,YR,,F,Y,100.0,KG,20210616.0,,MD,GB,GB,2021,Q2,Adult
194275311,19427531,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"100 IU/ML, UNKNOWN",,,U,U,,,205692.0,100.0,,,,2021,Q2,Syncope,,2021,Q2,1,I,20210528.0,20210604.0,20210616,20210616,EXP,GB-MHRA-TPP41703771C126133YC1622621048824,GB-ELI_LILLY_AND_COMPANY-GB202106002947,ELI LILLY AND CO,,62.0,YR,,F,Y,100.0,KG,20210616.0,,MD,GB,GB,2021,Q2,Adult
194299361,19429936,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,34?0?0?0,,,,,,,,,,,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,,20201125.0,20210617,20210617,EXP,,BR-NOVOPROD-814094,NOVO NORDISK,,21.0,YR,,,Y,66.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Youth
194299361,19429936,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,34?0?0?0,,,,,,,,,,,,2021,Q2,Diabetic ketoacidosis,,2021,Q2,1,I,,20201125.0,20210617,20210617,EXP,,BR-NOVOPROD-814094,NOVO NORDISK,,21.0,YR,,,Y,66.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Youth
194299361,19429936,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,34?0?0?0,,,,,,,,,,,,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,,20201125.0,20210617,20210617,EXP,,BR-NOVOPROD-814094,NOVO NORDISK,,21.0,YR,,,Y,66.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Youth
194299361,19429936,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,34?0?0?0,,,,,,,,,,,,2021,Q2,Respiratory tract infection,,2021,Q2,1,I,,20201125.0,20210617,20210617,EXP,,BR-NOVOPROD-814094,NOVO NORDISK,,21.0,YR,,,Y,66.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Youth
194299361,19429936,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,34?0?0?0,,,,,,,,,,,,2021,Q2,Weight increased,,2021,Q2,1,I,,20201125.0,20210617,20210617,EXP,,BR-NOVOPROD-814094,NOVO NORDISK,,21.0,YR,,,Y,66.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Youth
194299361,19429936,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,28?0?0?0,,,,,,,,,,,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,,20201125.0,20210617,20210617,EXP,,BR-NOVOPROD-814094,NOVO NORDISK,,21.0,YR,,,Y,66.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Youth
194299361,19429936,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,28?0?0?0,,,,,,,,,,,,2021,Q2,Diabetic ketoacidosis,,2021,Q2,1,I,,20201125.0,20210617,20210617,EXP,,BR-NOVOPROD-814094,NOVO NORDISK,,21.0,YR,,,Y,66.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Youth
194299361,19429936,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,28?0?0?0,,,,,,,,,,,,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,,20201125.0,20210617,20210617,EXP,,BR-NOVOPROD-814094,NOVO NORDISK,,21.0,YR,,,Y,66.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Youth
194299361,19429936,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,28?0?0?0,,,,,,,,,,,,2021,Q2,Respiratory tract infection,,2021,Q2,1,I,,20201125.0,20210617,20210617,EXP,,BR-NOVOPROD-814094,NOVO NORDISK,,21.0,YR,,,Y,66.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Youth
194299361,19429936,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,28?0?0?0,,,,,,,,,,,,2021,Q2,Weight increased,,2021,Q2,1,I,,20201125.0,20210617,20210617,EXP,,BR-NOVOPROD-814094,NOVO NORDISK,,21.0,YR,,,Y,66.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Youth
194299361,19429936,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,36?0?0?0,,,,,,,,,,,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,,20201125.0,20210617,20210617,EXP,,BR-NOVOPROD-814094,NOVO NORDISK,,21.0,YR,,,Y,66.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Youth
194299361,19429936,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,36?0?0?0,,,,,,,,,,,,2021,Q2,Diabetic ketoacidosis,,2021,Q2,1,I,,20201125.0,20210617,20210617,EXP,,BR-NOVOPROD-814094,NOVO NORDISK,,21.0,YR,,,Y,66.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Youth
194299361,19429936,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,36?0?0?0,,,,,,,,,,,,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,,20201125.0,20210617,20210617,EXP,,BR-NOVOPROD-814094,NOVO NORDISK,,21.0,YR,,,Y,66.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Youth
194299361,19429936,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,36?0?0?0,,,,,,,,,,,,2021,Q2,Respiratory tract infection,,2021,Q2,1,I,,20201125.0,20210617,20210617,EXP,,BR-NOVOPROD-814094,NOVO NORDISK,,21.0,YR,,,Y,66.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Youth
194299361,19429936,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,36?0?0?0,,,,,,,,,,,,2021,Q2,Weight increased,,2021,Q2,1,I,,20201125.0,20210617,20210617,EXP,,BR-NOVOPROD-814094,NOVO NORDISK,,21.0,YR,,,Y,66.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Youth
194299361,19429936,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,28?0?0?0,,,,,,,,,,,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,,20201125.0,20210617,20210617,EXP,,BR-NOVOPROD-814094,NOVO NORDISK,,21.0,YR,,,Y,66.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Youth
194299361,19429936,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,28?0?0?0,,,,,,,,,,,,2021,Q2,Diabetic ketoacidosis,,2021,Q2,1,I,,20201125.0,20210617,20210617,EXP,,BR-NOVOPROD-814094,NOVO NORDISK,,21.0,YR,,,Y,66.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Youth
194299361,19429936,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,28?0?0?0,,,,,,,,,,,,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,,20201125.0,20210617,20210617,EXP,,BR-NOVOPROD-814094,NOVO NORDISK,,21.0,YR,,,Y,66.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Youth
194299361,19429936,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,28?0?0?0,,,,,,,,,,,,2021,Q2,Respiratory tract infection,,2021,Q2,1,I,,20201125.0,20210617,20210617,EXP,,BR-NOVOPROD-814094,NOVO NORDISK,,21.0,YR,,,Y,66.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Youth
194299361,19429936,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,28?0?0?0,,,,,,,,,,,,2021,Q2,Weight increased,,2021,Q2,1,I,,20201125.0,20210617,20210617,EXP,,BR-NOVOPROD-814094,NOVO NORDISK,,21.0,YR,,,Y,66.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Youth
194299361,19429936,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,38?0?0?0,,,,,,,,,,,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,,20201125.0,20210617,20210617,EXP,,BR-NOVOPROD-814094,NOVO NORDISK,,21.0,YR,,,Y,66.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Youth
194299361,19429936,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,38?0?0?0,,,,,,,,,,,,2021,Q2,Diabetic ketoacidosis,,2021,Q2,1,I,,20201125.0,20210617,20210617,EXP,,BR-NOVOPROD-814094,NOVO NORDISK,,21.0,YR,,,Y,66.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Youth
194299361,19429936,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,38?0?0?0,,,,,,,,,,,,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,,20201125.0,20210617,20210617,EXP,,BR-NOVOPROD-814094,NOVO NORDISK,,21.0,YR,,,Y,66.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Youth
194299361,19429936,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,38?0?0?0,,,,,,,,,,,,2021,Q2,Respiratory tract infection,,2021,Q2,1,I,,20201125.0,20210617,20210617,EXP,,BR-NOVOPROD-814094,NOVO NORDISK,,21.0,YR,,,Y,66.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Youth
194299361,19429936,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,38?0?0?0,,,,,,,,,,,,2021,Q2,Weight increased,,2021,Q2,1,I,,20201125.0,20210617,20210617,EXP,,BR-NOVOPROD-814094,NOVO NORDISK,,21.0,YR,,,Y,66.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Youth
194303381,19430338,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU, QD",,,,,,,,100.0,IU,,QD,2021,Q2,Appendicectomy,,2021,Q2,1,I,201111.0,20201210.0,20210617,20210617,EXP,,BR-NOVOPROD-814133,NOVO NORDISK,,38.0,YR,,M,Y,75.5,KG,20210617.0,,CN,BR,BR,2021,Q2,Adult
194303381,19430338,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU, QD",,,,,,,,100.0,IU,,QD,2021,Q2,Hyperglycaemic seizure,,2021,Q2,1,I,201111.0,20201210.0,20210617,20210617,EXP,,BR-NOVOPROD-814133,NOVO NORDISK,,38.0,YR,,M,Y,75.5,KG,20210617.0,,CN,BR,BR,2021,Q2,Adult
194303381,19430338,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU, QD",,,,,,,,100.0,IU,,QD,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,201111.0,20201210.0,20210617,20210617,EXP,,BR-NOVOPROD-814133,NOVO NORDISK,,38.0,YR,,M,Y,75.5,KG,20210617.0,,CN,BR,BR,2021,Q2,Adult
194303381,19430338,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU, QD",,,,,,,,100.0,IU,,QD,2021,Q2,Insomnia,,2021,Q2,1,I,201111.0,20201210.0,20210617,20210617,EXP,,BR-NOVOPROD-814133,NOVO NORDISK,,38.0,YR,,M,Y,75.5,KG,20210617.0,,CN,BR,BR,2021,Q2,Adult
194303381,19430338,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 UNK,,,,,,,,12.0,IU,,QD,2021,Q2,Appendicectomy,,2021,Q2,1,I,201111.0,20201210.0,20210617,20210617,EXP,,BR-NOVOPROD-814133,NOVO NORDISK,,38.0,YR,,M,Y,75.5,KG,20210617.0,,CN,BR,BR,2021,Q2,Adult
194303381,19430338,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 UNK,,,,,,,,12.0,IU,,QD,2021,Q2,Hyperglycaemic seizure,,2021,Q2,1,I,201111.0,20201210.0,20210617,20210617,EXP,,BR-NOVOPROD-814133,NOVO NORDISK,,38.0,YR,,M,Y,75.5,KG,20210617.0,,CN,BR,BR,2021,Q2,Adult
194303381,19430338,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 UNK,,,,,,,,12.0,IU,,QD,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,201111.0,20201210.0,20210617,20210617,EXP,,BR-NOVOPROD-814133,NOVO NORDISK,,38.0,YR,,M,Y,75.5,KG,20210617.0,,CN,BR,BR,2021,Q2,Adult
194303381,19430338,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 UNK,,,,,,,,12.0,IU,,QD,2021,Q2,Insomnia,,2021,Q2,1,I,201111.0,20201210.0,20210617,20210617,EXP,,BR-NOVOPROD-814133,NOVO NORDISK,,38.0,YR,,M,Y,75.5,KG,20210617.0,,CN,BR,BR,2021,Q2,Adult
194303381,19430338,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, QD",,,,,,,,14.0,IU,,QD,2021,Q2,Appendicectomy,,2021,Q2,1,I,201111.0,20201210.0,20210617,20210617,EXP,,BR-NOVOPROD-814133,NOVO NORDISK,,38.0,YR,,M,Y,75.5,KG,20210617.0,,CN,BR,BR,2021,Q2,Adult
194303381,19430338,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, QD",,,,,,,,14.0,IU,,QD,2021,Q2,Hyperglycaemic seizure,,2021,Q2,1,I,201111.0,20201210.0,20210617,20210617,EXP,,BR-NOVOPROD-814133,NOVO NORDISK,,38.0,YR,,M,Y,75.5,KG,20210617.0,,CN,BR,BR,2021,Q2,Adult
194303381,19430338,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, QD",,,,,,,,14.0,IU,,QD,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,201111.0,20201210.0,20210617,20210617,EXP,,BR-NOVOPROD-814133,NOVO NORDISK,,38.0,YR,,M,Y,75.5,KG,20210617.0,,CN,BR,BR,2021,Q2,Adult
194303381,19430338,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, QD",,,,,,,,14.0,IU,,QD,2021,Q2,Insomnia,,2021,Q2,1,I,201111.0,20201210.0,20210617,20210617,EXP,,BR-NOVOPROD-814133,NOVO NORDISK,,38.0,YR,,M,Y,75.5,KG,20210617.0,,CN,BR,BR,2021,Q2,Adult
194303531,19430353,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"22 IU, QD (IN THE MORNING)",,,,,,,,22.0,IU,,QD,2021,Q2,Blood glucose fluctuation,,2021,Q2,1,I,20180715.0,20201215.0,20210617,20210617,EXP,,BR-NOVOPROD-814139,NOVO NORDISK,,24.0,YR,,F,Y,68.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Young Adult
194303531,19430353,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"22 IU, QD (IN THE MORNING)",,,,,,,,22.0,IU,,QD,2021,Q2,Diabetes mellitus inadequate control,,2021,Q2,1,I,20180715.0,20201215.0,20210617,20210617,EXP,,BR-NOVOPROD-814139,NOVO NORDISK,,24.0,YR,,F,Y,68.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Young Adult
194303531,19430353,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"22 IU, QD (IN THE MORNING)",,,,,,,,22.0,IU,,QD,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,20180715.0,20201215.0,20210617,20210617,EXP,,BR-NOVOPROD-814139,NOVO NORDISK,,24.0,YR,,F,Y,68.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Young Adult
194303531,19430353,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"22 IU, QD (IN THE MORNING)",,,,,,,,22.0,IU,,QD,2021,Q2,Nephrolithiasis,,2021,Q2,1,I,20180715.0,20201215.0,20210617,20210617,EXP,,BR-NOVOPROD-814139,NOVO NORDISK,,24.0,YR,,F,Y,68.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Young Adult
194303531,19430353,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"22 IU, QD (IN THE MORNING)",,,,,,,,22.0,IU,,QD,2021,Q2,Pyelonephritis,,2021,Q2,1,I,20180715.0,20201215.0,20210617,20210617,EXP,,BR-NOVOPROD-814139,NOVO NORDISK,,24.0,YR,,F,Y,68.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Young Adult
194303531,19430353,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"22 IU, QD (IN THE MORNING)",,,,,,,,22.0,IU,,QD,2021,Q2,Urinary tract infection,,2021,Q2,1,I,20180715.0,20201215.0,20210617,20210617,EXP,,BR-NOVOPROD-814139,NOVO NORDISK,,24.0,YR,,F,Y,68.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Young Adult
194307841,19430784,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,38 IU,,,U,U,,,,,,,,2021,Q2,Coronary artery disease,,2021,Q2,1,I,202005.0,20201009.0,20210617,20210617,EXP,,BR-NOVOPROD-819005,NOVO NORDISK,,40.0,YR,,M,Y,85.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Adult
194307841,19430784,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,38 IU,,,U,U,,,,,,,,2021,Q2,Hyperglycaemia,,2021,Q2,1,I,202005.0,20201009.0,20210617,20210617,EXP,,BR-NOVOPROD-819005,NOVO NORDISK,,40.0,YR,,M,Y,85.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Adult
194307841,19430784,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,38 IU,,,U,U,,,,,,,,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,202005.0,20201009.0,20210617,20210617,EXP,,BR-NOVOPROD-819005,NOVO NORDISK,,40.0,YR,,M,Y,85.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Adult
194307841,19430784,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,38 IU,,,U,U,,,,,,,,2021,Q2,Inappropriate schedule of product administration,,2021,Q2,1,I,202005.0,20201009.0,20210617,20210617,EXP,,BR-NOVOPROD-819005,NOVO NORDISK,,40.0,YR,,M,Y,85.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Adult
194307841,19430784,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,38 IU,,,U,U,,,,,,,,2021,Q2,Weight increased,,2021,Q2,1,I,202005.0,20201009.0,20210617,20210617,EXP,,BR-NOVOPROD-819005,NOVO NORDISK,,40.0,YR,,M,Y,85.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Adult
194307841,19430784,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,32 IU,,,U,U,,,,,,,,2021,Q2,Coronary artery disease,,2021,Q2,1,I,202005.0,20201009.0,20210617,20210617,EXP,,BR-NOVOPROD-819005,NOVO NORDISK,,40.0,YR,,M,Y,85.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Adult
194307841,19430784,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,32 IU,,,U,U,,,,,,,,2021,Q2,Hyperglycaemia,,2021,Q2,1,I,202005.0,20201009.0,20210617,20210617,EXP,,BR-NOVOPROD-819005,NOVO NORDISK,,40.0,YR,,M,Y,85.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Adult
194307841,19430784,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,32 IU,,,U,U,,,,,,,,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,202005.0,20201009.0,20210617,20210617,EXP,,BR-NOVOPROD-819005,NOVO NORDISK,,40.0,YR,,M,Y,85.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Adult
194307841,19430784,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,32 IU,,,U,U,,,,,,,,2021,Q2,Inappropriate schedule of product administration,,2021,Q2,1,I,202005.0,20201009.0,20210617,20210617,EXP,,BR-NOVOPROD-819005,NOVO NORDISK,,40.0,YR,,M,Y,85.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Adult
194307841,19430784,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,32 IU,,,U,U,,,,,,,,2021,Q2,Weight increased,,2021,Q2,1,I,202005.0,20201009.0,20210617,20210617,EXP,,BR-NOVOPROD-819005,NOVO NORDISK,,40.0,YR,,M,Y,85.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Adult
194308091,19430809,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,8 UI AT 9PM,,,,,,,,,,,,2021,Q2,Diabetic ketoacidosis,,2021,Q2,1,I,,20201130.0,20210617,20210617,EXP,,BR-NOVOPROD-814111,NOVO NORDISK,,5.0,YR,,M,Y,16.7,KG,20210617.0,,MD,BR,BR,2021,Q2,Child
194308091,19430809,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,8 UI AT 9PM,,,,,,,,,,,,2021,Q2,Hyperglycaemia,,2021,Q2,1,I,,20201130.0,20210617,20210617,EXP,,BR-NOVOPROD-814111,NOVO NORDISK,,5.0,YR,,M,Y,16.7,KG,20210617.0,,MD,BR,BR,2021,Q2,Child
194308091,19430809,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,8 UI AT 9PM,,,,,,,,,,,,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,,20201130.0,20210617,20210617,EXP,,BR-NOVOPROD-814111,NOVO NORDISK,,5.0,YR,,M,Y,16.7,KG,20210617.0,,MD,BR,BR,2021,Q2,Child
194308091,19430809,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,8 UI AT 9PM,,,,,,,,,,,,2021,Q2,Lipodystrophy acquired,,2021,Q2,1,I,,20201130.0,20210617,20210617,EXP,,BR-NOVOPROD-814111,NOVO NORDISK,,5.0,YR,,M,Y,16.7,KG,20210617.0,,MD,BR,BR,2021,Q2,Child
194333951,19433395,10,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Arteriosclerosis coronary artery,,2021,Q2,1,I,,20210607.0,20210618,20210618,EXP,,CA-AUROBINDO-AUR-APL-2021-024806,AUROBINDO,,71.0,YR,,M,Y,,,20210618.0,,CN,CA,CA,2021,Q2,Elderly
194333951,19433395,10,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Chest pain,,2021,Q2,1,I,,20210607.0,20210618,20210618,EXP,,CA-AUROBINDO-AUR-APL-2021-024806,AUROBINDO,,71.0,YR,,M,Y,,,20210618.0,,CN,CA,CA,2021,Q2,Elderly
194333951,19433395,10,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Dyspnoea exertional,,2021,Q2,1,I,,20210607.0,20210618,20210618,EXP,,CA-AUROBINDO-AUR-APL-2021-024806,AUROBINDO,,71.0,YR,,M,Y,,,20210618.0,,CN,CA,CA,2021,Q2,Elderly
194333951,19433395,10,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Pneumonia,,2021,Q2,1,I,,20210607.0,20210618,20210618,EXP,,CA-AUROBINDO-AUR-APL-2021-024806,AUROBINDO,,71.0,YR,,M,Y,,,20210618.0,,CN,CA,CA,2021,Q2,Elderly
194333951,19433395,11,C,Insulin glargine,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q2,Arteriosclerosis coronary artery,,2021,Q2,1,I,,20210607.0,20210618,20210618,EXP,,CA-AUROBINDO-AUR-APL-2021-024806,AUROBINDO,,71.0,YR,,M,Y,,,20210618.0,,CN,CA,CA,2021,Q2,Elderly
194333951,19433395,11,C,Insulin glargine,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q2,Chest pain,,2021,Q2,1,I,,20210607.0,20210618,20210618,EXP,,CA-AUROBINDO-AUR-APL-2021-024806,AUROBINDO,,71.0,YR,,M,Y,,,20210618.0,,CN,CA,CA,2021,Q2,Elderly
194333951,19433395,11,C,Insulin glargine,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q2,Dyspnoea exertional,,2021,Q2,1,I,,20210607.0,20210618,20210618,EXP,,CA-AUROBINDO-AUR-APL-2021-024806,AUROBINDO,,71.0,YR,,M,Y,,,20210618.0,,CN,CA,CA,2021,Q2,Elderly
194333951,19433395,11,C,Insulin glargine,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q2,Pneumonia,,2021,Q2,1,I,,20210607.0,20210618,20210618,EXP,,CA-AUROBINDO-AUR-APL-2021-024806,AUROBINDO,,71.0,YR,,M,Y,,,20210618.0,,CN,CA,CA,2021,Q2,Elderly
194335601,19433560,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"21 IU, QD",,,D,,,,,21.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Acute respiratory distress syndrome,,2021,Q2,1,I,20210603.0,20210612.0,20210617,20210617,EXP,,ID-SA-2021SA200708,SANOFI AVENTIS,,34.0,YR,A,F,Y,,,20210618.0,,MD,ID,ID,2021,Q2,Young Adult
194335601,19433560,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"21 IU, QD",,,D,,,,,21.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Apnoea,,2021,Q2,1,I,20210603.0,20210612.0,20210617,20210617,EXP,,ID-SA-2021SA200708,SANOFI AVENTIS,,34.0,YR,A,F,Y,,,20210618.0,,MD,ID,ID,2021,Q2,Young Adult
194335601,19433560,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"21 IU, QD",,,D,,,,,21.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Blood glucose increased,,2021,Q2,1,I,20210603.0,20210612.0,20210617,20210617,EXP,,ID-SA-2021SA200708,SANOFI AVENTIS,,34.0,YR,A,F,Y,,,20210618.0,,MD,ID,ID,2021,Q2,Young Adult
194345181,19434518,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,30.0,IU,INJECTION,QD,2021,Q2,Herpes zoster,,2021,Q2,1,I,,20200814.0,20210617,20210617,EXP,,US-ROCHE-2661469,ROCHE,,76.0,YR,,F,Y,,,20210618.0,,CN,US,US,2021,Q2,Elderly
194345181,19434518,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,30.0,IU,INJECTION,QD,2021,Q2,Off label use,,2021,Q2,1,I,,20200814.0,20210617,20210617,EXP,,US-ROCHE-2661469,ROCHE,,76.0,YR,,F,Y,,,20210618.0,,CN,US,US,2021,Q2,Elderly
194345181,19434518,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,30.0,IU,INJECTION,QD,2021,Q2,Product use in unapproved indication,,2021,Q2,1,I,,20200814.0,20210617,20210617,EXP,,US-ROCHE-2661469,ROCHE,,76.0,YR,,F,Y,,,20210618.0,,CN,US,US,2021,Q2,Elderly
194371931,19437193,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 INTERNATIONAL UNIT,,,,, OF741A,,,36.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Abdominal abscess,,2021,Q2,1,I,2020.0,20210614.0,20210618,20210618,EXP,,ES-MYLANLABS-2021M1035652,MYLAN,,55.0,YR,,F,Y,91.0,KG,20210618.0,,CN,ES,ES,2021,Q2,Adult
194371931,19437193,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 INTERNATIONAL UNIT,,,,, OF741A,,,36.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Asymptomatic COVID-19,,2021,Q2,1,I,2020.0,20210614.0,20210618,20210618,EXP,,ES-MYLANLABS-2021M1035652,MYLAN,,55.0,YR,,F,Y,91.0,KG,20210618.0,,CN,ES,ES,2021,Q2,Adult
194371931,19437193,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 INTERNATIONAL UNIT,,,,, OF741A,,,36.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Dysuria,,2021,Q2,1,I,2020.0,20210614.0,20210618,20210618,EXP,,ES-MYLANLABS-2021M1035652,MYLAN,,55.0,YR,,F,Y,91.0,KG,20210618.0,,CN,ES,ES,2021,Q2,Adult
194371931,19437193,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 INTERNATIONAL UNIT,,,,, OF741A,,,36.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Hyperglycaemia,,2021,Q2,1,I,2020.0,20210614.0,20210618,20210618,EXP,,ES-MYLANLABS-2021M1035652,MYLAN,,55.0,YR,,F,Y,91.0,KG,20210618.0,,CN,ES,ES,2021,Q2,Adult
194371931,19437193,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 INTERNATIONAL UNIT,,,,, OF741A,,,36.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Intentional product misuse,,2021,Q2,1,I,2020.0,20210614.0,20210618,20210618,EXP,,ES-MYLANLABS-2021M1035652,MYLAN,,55.0,YR,,F,Y,91.0,KG,20210618.0,,CN,ES,ES,2021,Q2,Adult
194371931,19437193,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 INTERNATIONAL UNIT,,,,, OF741A,,,36.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Medication error,,2021,Q2,1,I,2020.0,20210614.0,20210618,20210618,EXP,,ES-MYLANLABS-2021M1035652,MYLAN,,55.0,YR,,F,Y,91.0,KG,20210618.0,,CN,ES,ES,2021,Q2,Adult
194371931,19437193,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 INTERNATIONAL UNIT,,,,, OF741A,,,36.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Product storage error,,2021,Q2,1,I,2020.0,20210614.0,20210618,20210618,EXP,,ES-MYLANLABS-2021M1035652,MYLAN,,55.0,YR,,F,Y,91.0,KG,20210618.0,,CN,ES,ES,2021,Q2,Adult
194371931,19437193,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 INTERNATIONAL UNIT,,,,, OF741A,,,36.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Urinary tract infection,,2021,Q2,1,I,2020.0,20210614.0,20210618,20210618,EXP,,ES-MYLANLABS-2021M1035652,MYLAN,,55.0,YR,,F,Y,91.0,KG,20210618.0,,CN,ES,ES,2021,Q2,Adult
194436321,19443632,2,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Atrial flutter,,2021,Q2,1,I,,,20210621,20210621,DIR,,,FDA-CTU,,53.0,YR,,M,N,,,,N,MD,US,US,2021,Q2,Adult
194436321,19443632,2,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Bradycardia,,2021,Q2,1,I,,,20210621,20210621,DIR,,,FDA-CTU,,53.0,YR,,M,N,,,,N,MD,US,US,2021,Q2,Adult
194436321,19443632,2,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Bundle branch block left,,2021,Q2,1,I,,,20210621,20210621,DIR,,,FDA-CTU,,53.0,YR,,M,N,,,,N,MD,US,US,2021,Q2,Adult
194436321,19443632,2,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Bundle branch block right,,2021,Q2,1,I,,,20210621,20210621,DIR,,,FDA-CTU,,53.0,YR,,M,N,,,,N,MD,US,US,2021,Q2,Adult
194436321,19443632,2,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Cardiac arrest,,2021,Q2,1,I,,,20210621,20210621,DIR,,,FDA-CTU,,53.0,YR,,M,N,,,,N,MD,US,US,2021,Q2,Adult
194436321,19443632,2,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Hypoxia,,2021,Q2,1,I,,,20210621,20210621,DIR,,,FDA-CTU,,53.0,YR,,M,N,,,,N,MD,US,US,2021,Q2,Adult
194436321,19443632,2,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Pulseless electrical activity,,2021,Q2,1,I,,,20210621,20210621,DIR,,,FDA-CTU,,53.0,YR,,M,N,,,,N,MD,US,US,2021,Q2,Adult
194436391,19443639,8,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Atrioventricular block second degree,,2021,Q2,1,I,,,20210621,20210621,DIR,,,FDA-CTU,,67.0,YR,,M,N,,,,N,MD,US,US,2021,Q2,Elderly
194436391,19443639,8,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Electrocardiogram QRS complex prolonged,,2021,Q2,1,I,,,20210621,20210621,DIR,,,FDA-CTU,,67.0,YR,,M,N,,,,N,MD,US,US,2021,Q2,Elderly
194436391,19443639,8,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Heart rate irregular,,2021,Q2,1,I,,,20210621,20210621,DIR,,,FDA-CTU,,67.0,YR,,M,N,,,,N,MD,US,US,2021,Q2,Elderly
194436391,19443639,8,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Sinus bradycardia,,2021,Q2,1,I,,,20210621,20210621,DIR,,,FDA-CTU,,67.0,YR,,M,N,,,,N,MD,US,US,2021,Q2,Elderly
194439832,19443983,5,C,Insuline glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Acute kidney injury,,2021,Q2,2,F,,20210625.0,20210621,20210629,EXP,,GR-TEVA-2021-GR-1923803,TEVA,"PAPAIOANNOU I. GLUTEAL COMPARTMENT SYNDROME ? THE MISSING DIAGNOSIS. CASE PRESENTATION AND BRIEF LITERATURE REVIEW. SURGICAL CHRONICLES, 2020, VOL. 25, ISSUE 4 (OCT?DEC). 378?380.",47.0,YR,A,F,Y,,,20210629.0,,MD,GR,GR,2021,Q2,Adult
194439832,19443983,5,C,Insuline glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Compartment syndrome,,2021,Q2,2,F,,20210625.0,20210621,20210629,EXP,,GR-TEVA-2021-GR-1923803,TEVA,"PAPAIOANNOU I. GLUTEAL COMPARTMENT SYNDROME ? THE MISSING DIAGNOSIS. CASE PRESENTATION AND BRIEF LITERATURE REVIEW. SURGICAL CHRONICLES, 2020, VOL. 25, ISSUE 4 (OCT?DEC). 378?380.",47.0,YR,A,F,Y,,,20210629.0,,MD,GR,GR,2021,Q2,Adult
194439832,19443983,5,C,Insuline glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Drug abuse,,2021,Q2,2,F,,20210625.0,20210621,20210629,EXP,,GR-TEVA-2021-GR-1923803,TEVA,"PAPAIOANNOU I. GLUTEAL COMPARTMENT SYNDROME ? THE MISSING DIAGNOSIS. CASE PRESENTATION AND BRIEF LITERATURE REVIEW. SURGICAL CHRONICLES, 2020, VOL. 25, ISSUE 4 (OCT?DEC). 378?380.",47.0,YR,A,F,Y,,,20210629.0,,MD,GR,GR,2021,Q2,Adult
194439832,19443983,5,C,Insuline glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Haemodynamic instability,,2021,Q2,2,F,,20210625.0,20210621,20210629,EXP,,GR-TEVA-2021-GR-1923803,TEVA,"PAPAIOANNOU I. GLUTEAL COMPARTMENT SYNDROME ? THE MISSING DIAGNOSIS. CASE PRESENTATION AND BRIEF LITERATURE REVIEW. SURGICAL CHRONICLES, 2020, VOL. 25, ISSUE 4 (OCT?DEC). 378?380.",47.0,YR,A,F,Y,,,20210629.0,,MD,GR,GR,2021,Q2,Adult
194439832,19443983,5,C,Insuline glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Hepatic function abnormal,,2021,Q2,2,F,,20210625.0,20210621,20210629,EXP,,GR-TEVA-2021-GR-1923803,TEVA,"PAPAIOANNOU I. GLUTEAL COMPARTMENT SYNDROME ? THE MISSING DIAGNOSIS. CASE PRESENTATION AND BRIEF LITERATURE REVIEW. SURGICAL CHRONICLES, 2020, VOL. 25, ISSUE 4 (OCT?DEC). 378?380.",47.0,YR,A,F,Y,,,20210629.0,,MD,GR,GR,2021,Q2,Adult
194439832,19443983,5,C,Insuline glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Immobilisation prolonged,,2021,Q2,2,F,,20210625.0,20210621,20210629,EXP,,GR-TEVA-2021-GR-1923803,TEVA,"PAPAIOANNOU I. GLUTEAL COMPARTMENT SYNDROME ? THE MISSING DIAGNOSIS. CASE PRESENTATION AND BRIEF LITERATURE REVIEW. SURGICAL CHRONICLES, 2020, VOL. 25, ISSUE 4 (OCT?DEC). 378?380.",47.0,YR,A,F,Y,,,20210629.0,,MD,GR,GR,2021,Q2,Adult
194439832,19443983,5,C,Insuline glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Rhabdomyolysis,,2021,Q2,2,F,,20210625.0,20210621,20210629,EXP,,GR-TEVA-2021-GR-1923803,TEVA,"PAPAIOANNOU I. GLUTEAL COMPARTMENT SYNDROME ? THE MISSING DIAGNOSIS. CASE PRESENTATION AND BRIEF LITERATURE REVIEW. SURGICAL CHRONICLES, 2020, VOL. 25, ISSUE 4 (OCT?DEC). 378?380.",47.0,YR,A,F,Y,,,20210629.0,,MD,GR,GR,2021,Q2,Adult
194439832,19443983,5,C,Insuline glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Toxicity to various agents,,2021,Q2,2,F,,20210625.0,20210621,20210629,EXP,,GR-TEVA-2021-GR-1923803,TEVA,"PAPAIOANNOU I. GLUTEAL COMPARTMENT SYNDROME ? THE MISSING DIAGNOSIS. CASE PRESENTATION AND BRIEF LITERATURE REVIEW. SURGICAL CHRONICLES, 2020, VOL. 25, ISSUE 4 (OCT?DEC). 378?380.",47.0,YR,A,F,Y,,,20210629.0,,MD,GR,GR,2021,Q2,Adult
194443171,19444317,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,FORM OF ADMIN.: SOLUTIONSUBCUTANEOUS,,,,,,,,,,,,2021,Q2,Emphysematous pyelonephritis,,2021,Q2,1,I,,20210610.0,20210621,20210621,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-110414",BOEHRINGER INGELHEIM,,57.0,YR,A,F,Y,,,20210621.0,,PH,CA,CA,2021,Q2,Adult
194443171,19444317,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,FORM OF ADMIN.: SOLUTIONSUBCUTANEOUS,,,,,,,,,,,,2021,Q2,Escherichia bacteraemia,,2021,Q2,1,I,,20210610.0,20210621,20210621,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-110414",BOEHRINGER INGELHEIM,,57.0,YR,A,F,Y,,,20210621.0,,PH,CA,CA,2021,Q2,Adult
194443171,19444317,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,FORM OF ADMIN.: SOLUTIONSUBCUTANEOUS,,,,,,,,,,,,2021,Q2,Nephrostomy,,2021,Q2,1,I,,20210610.0,20210621,20210621,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-110414",BOEHRINGER INGELHEIM,,57.0,YR,A,F,Y,,,20210621.0,,PH,CA,CA,2021,Q2,Adult
194443171,19444317,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,FORM OF ADMIN.: SOLUTIONSUBCUTANEOUS,,,,,,,,,,,,2021,Q2,Septic shock,,2021,Q2,1,I,,20210610.0,20210621,20210621,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-110414",BOEHRINGER INGELHEIM,,57.0,YR,A,F,Y,,,20210621.0,,PH,CA,CA,2021,Q2,Adult
194500181,19450018,4,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q2,Neutropenic sepsis,,2021,Q2,1,I,20210605.0,20210615.0,20210622,20210622,EXP,,US-CELGENEUS-USA-20210604338,CELGENE,,64.0,YR,,M,Y,,,20210622.0,,HP,US,US,2021,Q2,Adult
194537671,19453767,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Glucocorticoid deficiency,,2021,Q2,1,I,20210617.0,20210619.0,20210623,20210623,EXP,GB-MHRA-EYC 00253560,GB-GLAXOSMITHKLINE-GB2021134584,GLAXOSMITHKLINE,,89.0,YR,,M,Y,89.0,KG,20210623.0,,PH,GB,GB,2021,Q2,Elderly
194537671,19453767,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Medication error,,2021,Q2,1,I,20210617.0,20210619.0,20210623,20210623,EXP,GB-MHRA-EYC 00253560,GB-GLAXOSMITHKLINE-GB2021134584,GLAXOSMITHKLINE,,89.0,YR,,M,Y,89.0,KG,20210623.0,,PH,GB,GB,2021,Q2,Elderly
194549711,19454971,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,,,2021,Q2,Balance disorder,,2021,Q2,1,I,,20210609.0,20210623,20210623,PER,,CA-HLS-202107682,HLS THERAPEUTICS,,51.0,YR,A,M,Y,94.0,KG,20210623.0,,MD,CA,CA,2021,Q2,Adult
194549711,19454971,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,,,2021,Q2,Blood creatine phosphokinase increased,,2021,Q2,1,I,,20210609.0,20210623,20210623,PER,,CA-HLS-202107682,HLS THERAPEUTICS,,51.0,YR,A,M,Y,94.0,KG,20210623.0,,MD,CA,CA,2021,Q2,Adult
194549711,19454971,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,,,2021,Q2,Cogwheel rigidity,,2021,Q2,1,I,,20210609.0,20210623,20210623,PER,,CA-HLS-202107682,HLS THERAPEUTICS,,51.0,YR,A,M,Y,94.0,KG,20210623.0,,MD,CA,CA,2021,Q2,Adult
194549711,19454971,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,,,2021,Q2,Fall,,2021,Q2,1,I,,20210609.0,20210623,20210623,PER,,CA-HLS-202107682,HLS THERAPEUTICS,,51.0,YR,A,M,Y,94.0,KG,20210623.0,,MD,CA,CA,2021,Q2,Adult
194549711,19454971,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,,,2021,Q2,Gait disturbance,,2021,Q2,1,I,,20210609.0,20210623,20210623,PER,,CA-HLS-202107682,HLS THERAPEUTICS,,51.0,YR,A,M,Y,94.0,KG,20210623.0,,MD,CA,CA,2021,Q2,Adult
194549711,19454971,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,,,2021,Q2,Hypertonia,,2021,Q2,1,I,,20210609.0,20210623,20210623,PER,,CA-HLS-202107682,HLS THERAPEUTICS,,51.0,YR,A,M,Y,94.0,KG,20210623.0,,MD,CA,CA,2021,Q2,Adult
194549711,19454971,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,,,2021,Q2,Lactic acidosis,,2021,Q2,1,I,,20210609.0,20210623,20210623,PER,,CA-HLS-202107682,HLS THERAPEUTICS,,51.0,YR,A,M,Y,94.0,KG,20210623.0,,MD,CA,CA,2021,Q2,Adult
194549711,19454971,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,,,2021,Q2,Myocarditis,,2021,Q2,1,I,,20210609.0,20210623,20210623,PER,,CA-HLS-202107682,HLS THERAPEUTICS,,51.0,YR,A,M,Y,94.0,KG,20210623.0,,MD,CA,CA,2021,Q2,Adult
194549711,19454971,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,,,2021,Q2,Neuroleptic malignant syndrome,,2021,Q2,1,I,,20210609.0,20210623,20210623,PER,,CA-HLS-202107682,HLS THERAPEUTICS,,51.0,YR,A,M,Y,94.0,KG,20210623.0,,MD,CA,CA,2021,Q2,Adult
194549711,19454971,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,,,2021,Q2,Nystagmus,,2021,Q2,1,I,,20210609.0,20210623,20210623,PER,,CA-HLS-202107682,HLS THERAPEUTICS,,51.0,YR,A,M,Y,94.0,KG,20210623.0,,MD,CA,CA,2021,Q2,Adult
194549711,19454971,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,,,2021,Q2,Pyrexia,,2021,Q2,1,I,,20210609.0,20210623,20210623,PER,,CA-HLS-202107682,HLS THERAPEUTICS,,51.0,YR,A,M,Y,94.0,KG,20210623.0,,MD,CA,CA,2021,Q2,Adult
194549711,19454971,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,,,2021,Q2,Somnolence,,2021,Q2,1,I,,20210609.0,20210623,20210623,PER,,CA-HLS-202107682,HLS THERAPEUTICS,,51.0,YR,A,M,Y,94.0,KG,20210623.0,,MD,CA,CA,2021,Q2,Adult
194549711,19454971,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,,,2021,Q2,Tachycardia,,2021,Q2,1,I,,20210609.0,20210623,20210623,PER,,CA-HLS-202107682,HLS THERAPEUTICS,,51.0,YR,A,M,Y,94.0,KG,20210623.0,,MD,CA,CA,2021,Q2,Adult
194558721,19455872,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Hepatitis viral,,2021,Q2,1,I,20210512.0,20210617.0,20210624,20210624,EXP,,US-GILEAD-2021-0537322,GILEAD,,71.0,YR,E,M,Y,,,20210623.0,,MD,US,US,2021,Q2,Elderly
194574691,19457469,8,C,INSULIN GLARGINE BS[BIOSIMILAR 1],INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,INJECTION,,2021,Q2,Diabetes mellitus,,2021,Q2,1,I,20210415.0,20210602.0,20210624,20210624,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-055098,BRISTOL MYERS SQUIBB,,70.0,YR,,M,Y,54.8,KG,20210624.0,,PH,JP,JP,2021,Q2,Elderly
194574691,19457469,8,C,INSULIN GLARGINE BS[BIOSIMILAR 1],INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,INJECTION,,2021,Q2,Myositis,,2021,Q2,1,I,20210415.0,20210602.0,20210624,20210624,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-055098,BRISTOL MYERS SQUIBB,,70.0,YR,,M,Y,54.8,KG,20210624.0,,PH,JP,JP,2021,Q2,Elderly
194585781,19458578,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"0.1 INTERNATIONAL UNIT/KILOGRAM, QH, CONTINUOUS INTRAVENOUS REGULAR INSULIN..",,,Y,U,,,210605.0,0.1,IU/KG,INJECTION,/hr,2021,Q2,Condition aggravated,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,TH-MYLANLABS-2021M1036942,MYLAN,,9.0,YR,,M,Y,,,20210624.0,,HP,TH,TH,2021,Q2,Child
194585781,19458578,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"0.1 INTERNATIONAL UNIT/KILOGRAM, QH, CONTINUOUS INTRAVENOUS REGULAR INSULIN..",,,Y,U,,,210605.0,0.1,IU/KG,INJECTION,/hr,2021,Q2,Diabetic ketoacidosis,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,TH-MYLANLABS-2021M1036942,MYLAN,,9.0,YR,,M,Y,,,20210624.0,,HP,TH,TH,2021,Q2,Child
194585781,19458578,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"0.1 INTERNATIONAL UNIT/KILOGRAM, QH, CONTINUOUS INTRAVENOUS REGULAR INSULIN..",,,Y,U,,,210605.0,0.1,IU/KG,INJECTION,/hr,2021,Q2,Drug interaction,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,TH-MYLANLABS-2021M1036942,MYLAN,,9.0,YR,,M,Y,,,20210624.0,,HP,TH,TH,2021,Q2,Child
194585781,19458578,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"0.1 INTERNATIONAL UNIT/KILOGRAM, QH, CONTINUOUS INTRAVENOUS REGULAR INSULIN..",,,Y,U,,,210605.0,0.1,IU/KG,INJECTION,/hr,2021,Q2,Hypotension,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,TH-MYLANLABS-2021M1036942,MYLAN,,9.0,YR,,M,Y,,,20210624.0,,HP,TH,TH,2021,Q2,Child
194631991,19463199,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"36 IU, QD",,,U,U,,,,36.0,IU,,QD,2021,Q2,Acute kidney injury,,2021,Q2,1,I,202009.0,20201125.0,20210625,20210625,EXP,,BR-NOVOPROD-814048,NOVO NORDISK,,66.0,YR,,M,Y,76.0,KG,20210625.0,,MD,BR,BR,2021,Q2,Elderly
194631991,19463199,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"36 IU, QD",,,U,U,,,,36.0,IU,,QD,2021,Q2,COVID-19 pneumonia,,2021,Q2,1,I,202009.0,20201125.0,20210625,20210625,EXP,,BR-NOVOPROD-814048,NOVO NORDISK,,66.0,YR,,M,Y,76.0,KG,20210625.0,,MD,BR,BR,2021,Q2,Elderly
194631991,19463199,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"36 IU, QD",,,U,U,,,,36.0,IU,,QD,2021,Q2,Fungal balanitis,,2021,Q2,1,I,202009.0,20201125.0,20210625,20210625,EXP,,BR-NOVOPROD-814048,NOVO NORDISK,,66.0,YR,,M,Y,76.0,KG,20210625.0,,MD,BR,BR,2021,Q2,Elderly
194631991,19463199,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"36 IU, QD",,,U,U,,,,36.0,IU,,QD,2021,Q2,Hyperglycaemia,,2021,Q2,1,I,202009.0,20201125.0,20210625,20210625,EXP,,BR-NOVOPROD-814048,NOVO NORDISK,,66.0,YR,,M,Y,76.0,KG,20210625.0,,MD,BR,BR,2021,Q2,Elderly
194631991,19463199,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"36 IU, QD",,,U,U,,,,36.0,IU,,QD,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,202009.0,20201125.0,20210625,20210625,EXP,,BR-NOVOPROD-814048,NOVO NORDISK,,66.0,YR,,M,Y,76.0,KG,20210625.0,,MD,BR,BR,2021,Q2,Elderly
194693441,19469344,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IE, 0?0?0?1",,,U,U,,,,,,,QD,2021,Q2,Diarrhoea,,2021,Q2,1,I,,20210622.0,20210629,20210629,PER,DE-ADRED-06496-01,DE-SHILPA MEDICARE LIMITED-SML-DE-2021-00833,SHILPA MEDICARE,,78.0,YR,E,M,Y,88.4,KG,20210629.0,,MD,DE,DE,2021,Q2,Elderly
194693441,19469344,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IE, 0?0?0?1",,,U,U,,,,,,,QD,2021,Q2,Fatigue,,2021,Q2,1,I,,20210622.0,20210629,20210629,PER,DE-ADRED-06496-01,DE-SHILPA MEDICARE LIMITED-SML-DE-2021-00833,SHILPA MEDICARE,,78.0,YR,E,M,Y,88.4,KG,20210629.0,,MD,DE,DE,2021,Q2,Elderly
194693441,19469344,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IE, 0?0?0?1",,,U,U,,,,,,,QD,2021,Q2,General physical health deterioration,,2021,Q2,1,I,,20210622.0,20210629,20210629,PER,DE-ADRED-06496-01,DE-SHILPA MEDICARE LIMITED-SML-DE-2021-00833,SHILPA MEDICARE,,78.0,YR,E,M,Y,88.4,KG,20210629.0,,MD,DE,DE,2021,Q2,Elderly
194693441,19469344,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IE, 0?0?0?1",,,U,U,,,,,,,QD,2021,Q2,Medication error,,2021,Q2,1,I,,20210622.0,20210629,20210629,PER,DE-ADRED-06496-01,DE-SHILPA MEDICARE LIMITED-SML-DE-2021-00833,SHILPA MEDICARE,,78.0,YR,E,M,Y,88.4,KG,20210629.0,,MD,DE,DE,2021,Q2,Elderly
194693441,19469344,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IE, 0?0?0?1",,,U,U,,,,,,,QD,2021,Q2,Night sweats,,2021,Q2,1,I,,20210622.0,20210629,20210629,PER,DE-ADRED-06496-01,DE-SHILPA MEDICARE LIMITED-SML-DE-2021-00833,SHILPA MEDICARE,,78.0,YR,E,M,Y,88.4,KG,20210629.0,,MD,DE,DE,2021,Q2,Elderly
194696161,19469616,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, QD (11 UNITS/DAY) (FOR MORE THAN 1 YEAR)",,,U,,,,,,,,QD,2021,Q2,Neuroleptic malignant syndrome,,2021,Q2,1,I,,20210621.0,20210628,20210628,EXP,,NVSC2021TR143401,NOVARTIS,"EROGLU EO, YILDIZ MI, YAZICI MK. ATYPICAL NEUROLEPTIC MALIGNANT SYNDROME INDUCED BY LOW DOSE QUETIAPINE IN A PATIENT TREATED WITH DONEPEZIL. ARCH NEUROPSYCHIATRY. 2021?58:166?8",84.0,YR,,M,Y,,,20210628.0,,HP,TR,TR,2021,Q2,Elderly
194696161,19469616,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, QD (11 UNITS/DAY) (FOR MORE THAN 1 YEAR)",,,U,,,,,,,,QD,2021,Q2,Product use in unapproved indication,,2021,Q2,1,I,,20210621.0,20210628,20210628,EXP,,NVSC2021TR143401,NOVARTIS,"EROGLU EO, YILDIZ MI, YAZICI MK. ATYPICAL NEUROLEPTIC MALIGNANT SYNDROME INDUCED BY LOW DOSE QUETIAPINE IN A PATIENT TREATED WITH DONEPEZIL. ARCH NEUROPSYCHIATRY. 2021?58:166?8",84.0,YR,,M,Y,,,20210628.0,,HP,TR,TR,2021,Q2,Elderly
194698701,19469870,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 INTERNATIONAL UNIT, QD",,,,,,,210605.0,26.0,IU,INJECTION,QD,2021,Q2,Nervousness,,2021,Q2,1,I,,20210621.0,20210628,20210628,EXP,,ES-MYLANLABS-2021M1036725,MYLAN,,76.0,YR,,F,Y,,,20210628.0,,CN,ES,ES,2021,Q2,Elderly
194698741,19469874,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 INTERNATIONAL UNIT, QD",,,,,,,210605.0,16.0,IU,INJECTION,QD,2021,Q2,Diabetes mellitus inadequate control,,2021,Q2,1,I,2020.0,20210621.0,20210628,20210628,EXP,,ES-MYLANLABS-2021M1036735,MYLAN,,75.0,YR,,M,Y,,,20210628.0,,CN,ES,ES,2021,Q2,Elderly
194702291,19470229,8,C,Insulin?glargine,INSULIN NOS,1,Unknown,,,,D,U,,,,,,,,2021,Q2,Condition aggravated,,2021,Q2,1,I,,20210614.0,20210629,20210629,EXP,,CH-COREPHARMA LLC-2113239,COREPHARMA,"ZIMMERMANN P. NEGATIVE MYOCLONUS AS THE LEADING SYMPTOM IN ACUTE CEFEPIME NEUROTOXICITY. BMJ CASE REPORTS 14: NO. 4, 8 APR 2021.HTTP://DOI.ORG/10.1136/BCR?2020?239744.",86.0,YR,,F,Y,,,20210629.0,,HP,CH,CH,2021,Q2,Elderly
194702291,19470229,8,C,Insulin?glargine,INSULIN NOS,1,Unknown,,,,D,U,,,,,,,,2021,Q2,Renal injury,,2021,Q2,1,I,,20210614.0,20210629,20210629,EXP,,CH-COREPHARMA LLC-2113239,COREPHARMA,"ZIMMERMANN P. NEGATIVE MYOCLONUS AS THE LEADING SYMPTOM IN ACUTE CEFEPIME NEUROTOXICITY. BMJ CASE REPORTS 14: NO. 4, 8 APR 2021.HTTP://DOI.ORG/10.1136/BCR?2020?239744.",86.0,YR,,F,Y,,,20210629.0,,HP,CH,CH,2021,Q2,Elderly
194706051,19470605,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IU, UNK",,,U,,,,21081.0,10.0,IU,,,2021,Q2,Cardio-respiratory arrest,,2021,Q2,1,I,,20210624.0,20210629,20210629,EXP,HR-HALMED-300048412,HR-SA-2021SA211098,SANOFI AVENTIS,,69.0,YR,E,M,Y,90.0,KG,20210629.0,,CN,HR,HR,2021,Q2,Elderly
194706051,19470605,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IU, UNK",,,U,,,,21081.0,10.0,IU,,,2021,Q2,Resuscitation,,2021,Q2,1,I,,20210624.0,20210629,20210629,EXP,HR-HALMED-300048412,HR-SA-2021SA211098,SANOFI AVENTIS,,69.0,YR,E,M,Y,90.0,KG,20210629.0,,CN,HR,HR,2021,Q2,Elderly
194710231,19471023,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Visual impairment,,2021,Q2,1,I,20210616.0,20210621.0,20210628,20210628,EXP,,PE-ELI_LILLY_AND_COMPANY-PE202106011276,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20210628.0,,CN,PE,PE,2021,Q2,Adult
194710542,19471054,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"58 INTERNATIONAL UNIT, DAILY",,,U,, 1F915A,,,58.0,IU,,QD,2021,Q2,Anxiety,,2021,Q2,2,F,2019.0,20210615.0,20210628,20210628,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202106007928,ELI LILLY AND CO,,54.0,YR,,M,Y,90.0,KG,20210628.0,,CN,ES,ES,2021,Q2,Adult
194710542,19471054,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"58 INTERNATIONAL UNIT, DAILY",,,U,, 1F915A,,,58.0,IU,,QD,2021,Q2,Fluid retention,,2021,Q2,2,F,2019.0,20210615.0,20210628,20210628,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202106007928,ELI LILLY AND CO,,54.0,YR,,M,Y,90.0,KG,20210628.0,,CN,ES,ES,2021,Q2,Adult
194710542,19471054,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"58 INTERNATIONAL UNIT, DAILY",,,U,, 1F915A,,,58.0,IU,,QD,2021,Q2,Hyperglycaemia,,2021,Q2,2,F,2019.0,20210615.0,20210628,20210628,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202106007928,ELI LILLY AND CO,,54.0,YR,,M,Y,90.0,KG,20210628.0,,CN,ES,ES,2021,Q2,Adult
194710542,19471054,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"58 INTERNATIONAL UNIT, DAILY",,,U,, 1F915A,,,58.0,IU,,QD,2021,Q2,Injection site pain,,2021,Q2,2,F,2019.0,20210615.0,20210628,20210628,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202106007928,ELI LILLY AND CO,,54.0,YR,,M,Y,90.0,KG,20210628.0,,CN,ES,ES,2021,Q2,Adult
194710542,19471054,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"58 INTERNATIONAL UNIT, DAILY",,,U,, 1F915A,,,58.0,IU,,QD,2021,Q2,Peripheral swelling,,2021,Q2,2,F,2019.0,20210615.0,20210628,20210628,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202106007928,ELI LILLY AND CO,,54.0,YR,,M,Y,90.0,KG,20210628.0,,CN,ES,ES,2021,Q2,Adult
194710542,19471054,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"58 INTERNATIONAL UNIT, DAILY",,,U,, 1F915A,,,58.0,IU,,QD,2021,Q2,Pneumonia,,2021,Q2,2,F,2019.0,20210615.0,20210628,20210628,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202106007928,ELI LILLY AND CO,,54.0,YR,,M,Y,90.0,KG,20210628.0,,CN,ES,ES,2021,Q2,Adult
194710542,19471054,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"56 INTERNATIONAL UNIT, DAILY",,,U,, 1F915A,,,56.0,IU,,QD,2021,Q2,Anxiety,,2021,Q2,2,F,2019.0,20210615.0,20210628,20210628,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202106007928,ELI LILLY AND CO,,54.0,YR,,M,Y,90.0,KG,20210628.0,,CN,ES,ES,2021,Q2,Adult
194710542,19471054,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"56 INTERNATIONAL UNIT, DAILY",,,U,, 1F915A,,,56.0,IU,,QD,2021,Q2,Fluid retention,,2021,Q2,2,F,2019.0,20210615.0,20210628,20210628,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202106007928,ELI LILLY AND CO,,54.0,YR,,M,Y,90.0,KG,20210628.0,,CN,ES,ES,2021,Q2,Adult
194710542,19471054,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"56 INTERNATIONAL UNIT, DAILY",,,U,, 1F915A,,,56.0,IU,,QD,2021,Q2,Hyperglycaemia,,2021,Q2,2,F,2019.0,20210615.0,20210628,20210628,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202106007928,ELI LILLY AND CO,,54.0,YR,,M,Y,90.0,KG,20210628.0,,CN,ES,ES,2021,Q2,Adult
194710542,19471054,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"56 INTERNATIONAL UNIT, DAILY",,,U,, 1F915A,,,56.0,IU,,QD,2021,Q2,Injection site pain,,2021,Q2,2,F,2019.0,20210615.0,20210628,20210628,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202106007928,ELI LILLY AND CO,,54.0,YR,,M,Y,90.0,KG,20210628.0,,CN,ES,ES,2021,Q2,Adult
194710542,19471054,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"56 INTERNATIONAL UNIT, DAILY",,,U,, 1F915A,,,56.0,IU,,QD,2021,Q2,Peripheral swelling,,2021,Q2,2,F,2019.0,20210615.0,20210628,20210628,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202106007928,ELI LILLY AND CO,,54.0,YR,,M,Y,90.0,KG,20210628.0,,CN,ES,ES,2021,Q2,Adult
194710542,19471054,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"56 INTERNATIONAL UNIT, DAILY",,,U,, 1F915A,,,56.0,IU,,QD,2021,Q2,Pneumonia,,2021,Q2,2,F,2019.0,20210615.0,20210628,20210628,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202106007928,ELI LILLY AND CO,,54.0,YR,,M,Y,90.0,KG,20210628.0,,CN,ES,ES,2021,Q2,Adult
194710791,19471079,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, DAILY",,,U,,,,,,,,QD,2021,Q2,Arthralgia,,2021,Q2,1,I,,20210615.0,20210628,20210628,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202106009241,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210628.0,,HP,CA,CA,2021,Q2,Adult
194710791,19471079,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, DAILY",,,U,,,,,,,,QD,2021,Q2,Drug ineffective,,2021,Q2,1,I,,20210615.0,20210628,20210628,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202106009241,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210628.0,,HP,CA,CA,2021,Q2,Adult
194710791,19471079,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, DAILY",,,U,,,,,,,,QD,2021,Q2,Gait inability,,2021,Q2,1,I,,20210615.0,20210628,20210628,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202106009241,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210628.0,,HP,CA,CA,2021,Q2,Adult
194710791,19471079,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, DAILY",,,U,,,,,,,,QD,2021,Q2,Headache,,2021,Q2,1,I,,20210615.0,20210628,20210628,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202106009241,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210628.0,,HP,CA,CA,2021,Q2,Adult
194710791,19471079,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, DAILY",,,U,,,,,,,,QD,2021,Q2,Hypoaesthesia,,2021,Q2,1,I,,20210615.0,20210628,20210628,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202106009241,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210628.0,,HP,CA,CA,2021,Q2,Adult
194710791,19471079,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, DAILY",,,U,,,,,,,,QD,2021,Q2,Lower respiratory tract infection,,2021,Q2,1,I,,20210615.0,20210628,20210628,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202106009241,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210628.0,,HP,CA,CA,2021,Q2,Adult
194710791,19471079,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, DAILY",,,U,,,,,,,,QD,2021,Q2,Pharyngitis,,2021,Q2,1,I,,20210615.0,20210628,20210628,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202106009241,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210628.0,,HP,CA,CA,2021,Q2,Adult
194710791,19471079,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, DAILY",,,U,,,,,,,,QD,2021,Q2,Toothache,,2021,Q2,1,I,,20210615.0,20210628,20210628,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202106009241,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210628.0,,HP,CA,CA,2021,Q2,Adult
194711201,19471120,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"10 INTERNATIONAL UNIT, DAILY",,,U,,,,205692.0,10.0,IU,,QD,2021,Q2,Cardio-respiratory arrest,,2021,Q2,1,I,20210323.0,20210621.0,20210628,20210628,EXP,HR-HALMED-300048412,HR-ELI_LILLY_AND_COMPANY-HR202106010694,ELI LILLY AND CO,,69.0,YR,,M,Y,90.0,KG,20210628.0,,CN,HR,HR,2021,Q2,Elderly
194720971,19472097,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"49 INTERNATIONAL UNIT, ONCE A DAY",,,,, 0F731A,,,49.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Blood glucose abnormal,,2021,Q2,1,I,2021.0,20210621.0,20210629,20210629,EXP,,ES-AUROBINDO-AUR-APL-2021-027007,AUROBINDO,,77.0,YR,,F,Y,66.0,KG,20210629.0,,CN,ES,ES,2021,Q2,Elderly
194720971,19472097,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"49 INTERNATIONAL UNIT, ONCE A DAY",,,,, 0F731A,,,49.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Cardiac disorder,,2021,Q2,1,I,2021.0,20210621.0,20210629,20210629,EXP,,ES-AUROBINDO-AUR-APL-2021-027007,AUROBINDO,,77.0,YR,,F,Y,66.0,KG,20210629.0,,CN,ES,ES,2021,Q2,Elderly
194720971,19472097,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"49 INTERNATIONAL UNIT, ONCE A DAY",,,,, 0F731A,,,49.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Decreased appetite,,2021,Q2,1,I,2021.0,20210621.0,20210629,20210629,EXP,,ES-AUROBINDO-AUR-APL-2021-027007,AUROBINDO,,77.0,YR,,F,Y,66.0,KG,20210629.0,,CN,ES,ES,2021,Q2,Elderly
194720971,19472097,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"49 INTERNATIONAL UNIT, ONCE A DAY",,,,, 0F731A,,,49.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Depressed mood,,2021,Q2,1,I,2021.0,20210621.0,20210629,20210629,EXP,,ES-AUROBINDO-AUR-APL-2021-027007,AUROBINDO,,77.0,YR,,F,Y,66.0,KG,20210629.0,,CN,ES,ES,2021,Q2,Elderly
194720971,19472097,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"49 INTERNATIONAL UNIT, ONCE A DAY",,,,, 0F731A,,,49.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Renal disorder,,2021,Q2,1,I,2021.0,20210621.0,20210629,20210629,EXP,,ES-AUROBINDO-AUR-APL-2021-027007,AUROBINDO,,77.0,YR,,F,Y,66.0,KG,20210629.0,,CN,ES,ES,2021,Q2,Elderly
194720971,19472097,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"49 INTERNATIONAL UNIT, ONCE A DAY",,,,, 0F731A,,,49.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Weight decreased,,2021,Q2,1,I,2021.0,20210621.0,20210629,20210629,EXP,,ES-AUROBINDO-AUR-APL-2021-027007,AUROBINDO,,77.0,YR,,F,Y,66.0,KG,20210629.0,,CN,ES,ES,2021,Q2,Elderly
194720971,19472097,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,DOSE INCREASED,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Blood glucose abnormal,,2021,Q2,1,I,2021.0,20210621.0,20210629,20210629,EXP,,ES-AUROBINDO-AUR-APL-2021-027007,AUROBINDO,,77.0,YR,,F,Y,66.0,KG,20210629.0,,CN,ES,ES,2021,Q2,Elderly
194720971,19472097,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,DOSE INCREASED,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Cardiac disorder,,2021,Q2,1,I,2021.0,20210621.0,20210629,20210629,EXP,,ES-AUROBINDO-AUR-APL-2021-027007,AUROBINDO,,77.0,YR,,F,Y,66.0,KG,20210629.0,,CN,ES,ES,2021,Q2,Elderly
194720971,19472097,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,DOSE INCREASED,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Decreased appetite,,2021,Q2,1,I,2021.0,20210621.0,20210629,20210629,EXP,,ES-AUROBINDO-AUR-APL-2021-027007,AUROBINDO,,77.0,YR,,F,Y,66.0,KG,20210629.0,,CN,ES,ES,2021,Q2,Elderly
194720971,19472097,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,DOSE INCREASED,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Depressed mood,,2021,Q2,1,I,2021.0,20210621.0,20210629,20210629,EXP,,ES-AUROBINDO-AUR-APL-2021-027007,AUROBINDO,,77.0,YR,,F,Y,66.0,KG,20210629.0,,CN,ES,ES,2021,Q2,Elderly
194720971,19472097,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,DOSE INCREASED,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Renal disorder,,2021,Q2,1,I,2021.0,20210621.0,20210629,20210629,EXP,,ES-AUROBINDO-AUR-APL-2021-027007,AUROBINDO,,77.0,YR,,F,Y,66.0,KG,20210629.0,,CN,ES,ES,2021,Q2,Elderly
194720971,19472097,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,DOSE INCREASED,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Weight decreased,,2021,Q2,1,I,2021.0,20210621.0,20210629,20210629,EXP,,ES-AUROBINDO-AUR-APL-2021-027007,AUROBINDO,,77.0,YR,,F,Y,66.0,KG,20210629.0,,CN,ES,ES,2021,Q2,Elderly
194725841,19472584,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Anaemia,,2021,Q2,1,I,201811.0,20210615.0,20210629,20210629,EXP,FR-AFSSAPS-2021042833,FR-ACCORD-229643,ACCORD,,72.0,YR,A,M,Y,141.0,KG,20210629.0,,PH,FR,FR,2021,Q2,Elderly
194725841,19472584,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Rectal haemorrhage,,2021,Q2,1,I,201811.0,20210615.0,20210629,20210629,EXP,FR-AFSSAPS-2021042833,FR-ACCORD-229643,ACCORD,,72.0,YR,A,M,Y,141.0,KG,20210629.0,,PH,FR,FR,2021,Q2,Elderly
194726971,19472697,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 IU, QD",,,,, 0F8994,,,75.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Asymptomatic COVID-19,,2021,Q2,1,I,2021.0,20210621.0,20210629,20210629,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-110653",BOEHRINGER INGELHEIM,,56.0,YR,A,F,Y,112.0,KG,20210629.0,,HP,ES,ES,2021,Q2,Adult
194726971,19472697,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 IU, QD",,,,, 0F8994,,,75.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Blood glucose increased,,2021,Q2,1,I,2021.0,20210621.0,20210629,20210629,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-110653",BOEHRINGER INGELHEIM,,56.0,YR,A,F,Y,112.0,KG,20210629.0,,HP,ES,ES,2021,Q2,Adult
194726971,19472697,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 IU, QD",,,,, 0F8994,,,75.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Diarrhoea,,2021,Q2,1,I,2021.0,20210621.0,20210629,20210629,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-110653",BOEHRINGER INGELHEIM,,56.0,YR,A,F,Y,112.0,KG,20210629.0,,HP,ES,ES,2021,Q2,Adult
194726971,19472697,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 IU, QD",,,,, 0F8994,,,75.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Dysgeusia,,2021,Q2,1,I,2021.0,20210621.0,20210629,20210629,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-110653",BOEHRINGER INGELHEIM,,56.0,YR,A,F,Y,112.0,KG,20210629.0,,HP,ES,ES,2021,Q2,Adult
194726971,19472697,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 IU, QD",,,,, 0F8994,,,75.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Ear infection,,2021,Q2,1,I,2021.0,20210621.0,20210629,20210629,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-110653",BOEHRINGER INGELHEIM,,56.0,YR,A,F,Y,112.0,KG,20210629.0,,HP,ES,ES,2021,Q2,Adult
194726971,19472697,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 IU, QD",,,,, 0F8994,,,75.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Eructation,,2021,Q2,1,I,2021.0,20210621.0,20210629,20210629,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-110653",BOEHRINGER INGELHEIM,,56.0,YR,A,F,Y,112.0,KG,20210629.0,,HP,ES,ES,2021,Q2,Adult
194726971,19472697,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 IU, QD",,,,, 0F8994,,,75.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Faeces soft,,2021,Q2,1,I,2021.0,20210621.0,20210629,20210629,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-110653",BOEHRINGER INGELHEIM,,56.0,YR,A,F,Y,112.0,KG,20210629.0,,HP,ES,ES,2021,Q2,Adult
194726971,19472697,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 IU, QD",,,,, 0F8994,,,75.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Flatulence,,2021,Q2,1,I,2021.0,20210621.0,20210629,20210629,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-110653",BOEHRINGER INGELHEIM,,56.0,YR,A,F,Y,112.0,KG,20210629.0,,HP,ES,ES,2021,Q2,Adult
194726971,19472697,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 IU, QD",,,,, 0F8994,,,75.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Lacrimation increased,,2021,Q2,1,I,2021.0,20210621.0,20210629,20210629,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-110653",BOEHRINGER INGELHEIM,,56.0,YR,A,F,Y,112.0,KG,20210629.0,,HP,ES,ES,2021,Q2,Adult
194726971,19472697,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 IU, QD",,,,, 0F8994,,,75.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Nasopharyngitis,,2021,Q2,1,I,2021.0,20210621.0,20210629,20210629,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-110653",BOEHRINGER INGELHEIM,,56.0,YR,A,F,Y,112.0,KG,20210629.0,,HP,ES,ES,2021,Q2,Adult
194726971,19472697,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 IU, QD",,,,, 0F8994,,,75.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Weight decreased,,2021,Q2,1,I,2021.0,20210621.0,20210629,20210629,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-110653",BOEHRINGER INGELHEIM,,56.0,YR,A,F,Y,112.0,KG,20210629.0,,HP,ES,ES,2021,Q2,Adult
194726991,19472699,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Asthenia,,2021,Q2,1,I,202106.0,20210609.0,20210629,20210629,EXP,,US-EISAI MEDICAL RESEARCH-EC-2021-094247,EISAI,,77.0,YR,E,M,Y,86.0,KG,20210629.0,,CN,US,US,2021,Q2,Elderly
194726991,19472699,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Confusional state,,2021,Q2,1,I,202106.0,20210609.0,20210629,20210629,EXP,,US-EISAI MEDICAL RESEARCH-EC-2021-094247,EISAI,,77.0,YR,E,M,Y,86.0,KG,20210629.0,,CN,US,US,2021,Q2,Elderly
194726991,19472699,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Decreased appetite,,2021,Q2,1,I,202106.0,20210609.0,20210629,20210629,EXP,,US-EISAI MEDICAL RESEARCH-EC-2021-094247,EISAI,,77.0,YR,E,M,Y,86.0,KG,20210629.0,,CN,US,US,2021,Q2,Elderly
194726991,19472699,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Diarrhoea,,2021,Q2,1,I,202106.0,20210609.0,20210629,20210629,EXP,,US-EISAI MEDICAL RESEARCH-EC-2021-094247,EISAI,,77.0,YR,E,M,Y,86.0,KG,20210629.0,,CN,US,US,2021,Q2,Elderly
194726991,19472699,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Nausea,,2021,Q2,1,I,202106.0,20210609.0,20210629,20210629,EXP,,US-EISAI MEDICAL RESEARCH-EC-2021-094247,EISAI,,77.0,YR,E,M,Y,86.0,KG,20210629.0,,CN,US,US,2021,Q2,Elderly
194734571,19473457,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q2,Neutropenia,,2021,Q2,1,I,201812.0,20201013.0,20210629,20210629,EXP,,JP-GILEAD-2020-0499087,GILEAD,,43.0,YR,A,M,Y,,,20210629.0,,MD,JP,JP,2021,Q2,Adult
194758861,19475886,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 INTERNATIONAL UNIT, DAILY",,,,,,,,4.0,IU,,,2021,Q2,Conjunctivitis,,2021,Q2,1,I,20210315.0,20210615.0,20210630,20210630,EXP,,ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-302447,RANBAXY,,91.0,YR,,F,Y,,,20210630.0,,MD,ES,ES,2021,Q2,Elderly
194758861,19475886,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 INTERNATIONAL UNIT, DAILY",,,,,,,,4.0,IU,,,2021,Q2,Fatigue,,2021,Q2,1,I,20210315.0,20210615.0,20210630,20210630,EXP,,ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-302447,RANBAXY,,91.0,YR,,F,Y,,,20210630.0,,MD,ES,ES,2021,Q2,Elderly
194758861,19475886,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 INTERNATIONAL UNIT, DAILY",,,,,,,,4.0,IU,,,2021,Q2,Muscle spasms,,2021,Q2,1,I,20210315.0,20210615.0,20210630,20210630,EXP,,ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-302447,RANBAXY,,91.0,YR,,F,Y,,,20210630.0,,MD,ES,ES,2021,Q2,Elderly
194761451,19476145,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, 0?0?0?1, INJECTION / INFUSION SOLUTION",,,,,,,,,,INFUSION,,2021,Q2,Condition aggravated,,2021,Q2,1,I,,20210617.0,20210630,20210630,EXP,DE-BFARM-21005115,DE-ACCORD-229976,ACCORD,,56.0,YR,A,F,Y,103.0,KG,20210630.0,,MD,DE,DE,2021,Q2,Adult
194761451,19476145,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, 0?0?0?1, INJECTION / INFUSION SOLUTION",,,,,,,,,,INFUSION,,2021,Q2,Renal impairment,,2021,Q2,1,I,,20210617.0,20210630,20210630,EXP,DE-BFARM-21005115,DE-ACCORD-229976,ACCORD,,56.0,YR,A,F,Y,103.0,KG,20210630.0,,MD,DE,DE,2021,Q2,Adult
194761451,19476145,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, 0?0?0?1, INJECTION / INFUSION SOLUTION",,,,,,,,,,INFUSION,,2021,Q2,Weight increased,,2021,Q2,1,I,,20210617.0,20210630,20210630,EXP,DE-BFARM-21005115,DE-ACCORD-229976,ACCORD,,56.0,YR,A,F,Y,103.0,KG,20210630.0,,MD,DE,DE,2021,Q2,Adult
194768541,19476854,2,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Urticaria,,2021,Q2,1,I,20210621.0,,20210629,20210629,DIR,,,FDA-CTU,,15.0,YR,,M,N,49.55,KG,20210629.0,Y,HP,US,US,2021,Q2,Youth
194768541,19476854,2,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q2,Urticaria papular,,2021,Q2,1,I,20210621.0,,20210629,20210629,DIR,,,FDA-CTU,,15.0,YR,,M,N,49.55,KG,20210629.0,Y,HP,US,US,2021,Q2,Youth
194776431,19477643,1,PS,"INSULIN (INSULIN, GLARGINE, HUMAN 100 UNT/ML INJ)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER FREQUENCY:AT BEDTIME ;?,,,,,,,,40.0,IU,,HS,2021,Q2,Intentional overdose,,2021,Q2,1,I,20210406.0,,20210630,20210630,DIR,,,FDA-CTU,,93.0,YR,,M,N,164.0,KG,20210504.0,N,PH,US,US,2021,Q2,Elderly
194776431,19477643,1,PS,"INSULIN (INSULIN, GLARGINE, HUMAN 100 UNT/ML INJ)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER FREQUENCY:AT BEDTIME ;?,,,,,,,,40.0,IU,,HS,2021,Q2,Suicide attempt,,2021,Q2,1,I,20210406.0,,20210630,20210630,DIR,,,FDA-CTU,,93.0,YR,,M,N,164.0,KG,20210504.0,N,PH,US,US,2021,Q2,Elderly
194789041,19478904,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, QD(BEFORE SLEEPING)",,,Y,, 122010171,,,10.0,IU,,QD,2021,Q2,Hypoglycaemic coma,,2021,Q2,1,I,20210615.0,20210619.0,20210630,20210630,EXP,CN-NMPA-3306861056562202100066,CN-NOVOPROD-823251,NOVO NORDISK,,62.0,YR,,M,Y,70.0,KG,20210630.0,,HP,CN,CN,2021,Q2,Adult
194789041,19478904,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, QD(BEFORE SLEEPING)",,,Y,, 122010171,,,10.0,IU,,QD,2021,Q2,Vomiting,,2021,Q2,1,I,20210615.0,20210619.0,20210630,20210630,EXP,CN-NMPA-3306861056562202100066,CN-NOVOPROD-823251,NOVO NORDISK,,62.0,YR,,M,Y,70.0,KG,20210630.0,,HP,CN,CN,2021,Q2,Adult
194789041,19478904,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 IU, QD(BEFORE SLEEPING)",,,Y,, 122010171,,,8.0,IU,,QD,2021,Q2,Hypoglycaemic coma,,2021,Q2,1,I,20210615.0,20210619.0,20210630,20210630,EXP,CN-NMPA-3306861056562202100066,CN-NOVOPROD-823251,NOVO NORDISK,,62.0,YR,,M,Y,70.0,KG,20210630.0,,HP,CN,CN,2021,Q2,Adult
194789041,19478904,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 IU, QD(BEFORE SLEEPING)",,,Y,, 122010171,,,8.0,IU,,QD,2021,Q2,Vomiting,,2021,Q2,1,I,20210615.0,20210619.0,20210630,20210630,EXP,CN-NMPA-3306861056562202100066,CN-NOVOPROD-823251,NOVO NORDISK,,62.0,YR,,M,Y,70.0,KG,20210630.0,,HP,CN,CN,2021,Q2,Adult
194789871,19478987,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, QD",,,U,,,,21081.0,50.0,IU,,QD,2021,Q2,Cough,,2021,Q2,1,I,,20210625.0,20210630,20210630,EXP,,CA-SA-2021SA214978,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20210630.0,,CN,CA,CA,2021,Q2,Elderly
194789871,19478987,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, QD",,,U,,,,21081.0,50.0,IU,,QD,2021,Q2,Feeling abnormal,,2021,Q2,1,I,,20210625.0,20210630,20210630,EXP,,CA-SA-2021SA214978,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20210630.0,,CN,CA,CA,2021,Q2,Elderly
194789871,19478987,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, QD",,,U,,,,21081.0,50.0,IU,,QD,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,,20210625.0,20210630,20210630,EXP,,CA-SA-2021SA214978,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20210630.0,,CN,CA,CA,2021,Q2,Elderly
194793451,19479345,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,,,,,,2021,Q2,Diarrhoea,,2021,Q2,1,I,,20210622.0,20210630,20210630,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202106011375,ELI LILLY AND CO,,78.0,YR,,M,Y,88.4,KG,20210630.0,,MD,DE,DE,2021,Q2,Elderly
194793451,19479345,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,,,,,,2021,Q2,Fatigue,,2021,Q2,1,I,,20210622.0,20210630,20210630,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202106011375,ELI LILLY AND CO,,78.0,YR,,M,Y,88.4,KG,20210630.0,,MD,DE,DE,2021,Q2,Elderly
194793451,19479345,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,,,,,,2021,Q2,General physical health deterioration,,2021,Q2,1,I,,20210622.0,20210630,20210630,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202106011375,ELI LILLY AND CO,,78.0,YR,,M,Y,88.4,KG,20210630.0,,MD,DE,DE,2021,Q2,Elderly
194793451,19479345,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,,,,,,2021,Q2,Medication error,,2021,Q2,1,I,,20210622.0,20210630,20210630,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202106011375,ELI LILLY AND CO,,78.0,YR,,M,Y,88.4,KG,20210630.0,,MD,DE,DE,2021,Q2,Elderly
194793451,19479345,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,,,,,,2021,Q2,Night sweats,,2021,Q2,1,I,,20210622.0,20210630,20210630,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202106011375,ELI LILLY AND CO,,78.0,YR,,M,Y,88.4,KG,20210630.0,,MD,DE,DE,2021,Q2,Elderly
194799861,19479986,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"75 IU, QD",,,,, 0F8994,,,75.0,IU,,QD,2021,Q2,Asymptomatic COVID-19,,2021,Q2,1,I,2021.0,20210618.0,20210630,20210630,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202106009862,ELI LILLY AND CO,,56.0,YR,,F,Y,112.0,KG,20210630.0,,CN,ES,ES,2021,Q2,Adult
194799861,19479986,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"75 IU, QD",,,,, 0F8994,,,75.0,IU,,QD,2021,Q2,Blood glucose increased,,2021,Q2,1,I,2021.0,20210618.0,20210630,20210630,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202106009862,ELI LILLY AND CO,,56.0,YR,,F,Y,112.0,KG,20210630.0,,CN,ES,ES,2021,Q2,Adult
194799861,19479986,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"75 IU, QD",,,,, 0F8994,,,75.0,IU,,QD,2021,Q2,Diarrhoea,,2021,Q2,1,I,2021.0,20210618.0,20210630,20210630,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202106009862,ELI LILLY AND CO,,56.0,YR,,F,Y,112.0,KG,20210630.0,,CN,ES,ES,2021,Q2,Adult
194799861,19479986,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"75 IU, QD",,,,, 0F8994,,,75.0,IU,,QD,2021,Q2,Dysgeusia,,2021,Q2,1,I,2021.0,20210618.0,20210630,20210630,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202106009862,ELI LILLY AND CO,,56.0,YR,,F,Y,112.0,KG,20210630.0,,CN,ES,ES,2021,Q2,Adult
194799861,19479986,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"75 IU, QD",,,,, 0F8994,,,75.0,IU,,QD,2021,Q2,Ear infection,,2021,Q2,1,I,2021.0,20210618.0,20210630,20210630,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202106009862,ELI LILLY AND CO,,56.0,YR,,F,Y,112.0,KG,20210630.0,,CN,ES,ES,2021,Q2,Adult
194799861,19479986,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"75 IU, QD",,,,, 0F8994,,,75.0,IU,,QD,2021,Q2,Eructation,,2021,Q2,1,I,2021.0,20210618.0,20210630,20210630,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202106009862,ELI LILLY AND CO,,56.0,YR,,F,Y,112.0,KG,20210630.0,,CN,ES,ES,2021,Q2,Adult
194799861,19479986,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"75 IU, QD",,,,, 0F8994,,,75.0,IU,,QD,2021,Q2,Faeces soft,,2021,Q2,1,I,2021.0,20210618.0,20210630,20210630,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202106009862,ELI LILLY AND CO,,56.0,YR,,F,Y,112.0,KG,20210630.0,,CN,ES,ES,2021,Q2,Adult
194799861,19479986,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"75 IU, QD",,,,, 0F8994,,,75.0,IU,,QD,2021,Q2,Flatulence,,2021,Q2,1,I,2021.0,20210618.0,20210630,20210630,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202106009862,ELI LILLY AND CO,,56.0,YR,,F,Y,112.0,KG,20210630.0,,CN,ES,ES,2021,Q2,Adult
194799861,19479986,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"75 IU, QD",,,,, 0F8994,,,75.0,IU,,QD,2021,Q2,Lacrimation increased,,2021,Q2,1,I,2021.0,20210618.0,20210630,20210630,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202106009862,ELI LILLY AND CO,,56.0,YR,,F,Y,112.0,KG,20210630.0,,CN,ES,ES,2021,Q2,Adult
194799861,19479986,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"75 IU, QD",,,,, 0F8994,,,75.0,IU,,QD,2021,Q2,Nasopharyngitis,,2021,Q2,1,I,2021.0,20210618.0,20210630,20210630,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202106009862,ELI LILLY AND CO,,56.0,YR,,F,Y,112.0,KG,20210630.0,,CN,ES,ES,2021,Q2,Adult
194799861,19479986,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"75 IU, QD",,,,, 0F8994,,,75.0,IU,,QD,2021,Q2,Weight decreased,,2021,Q2,1,I,2021.0,20210618.0,20210630,20210630,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202106009862,ELI LILLY AND CO,,56.0,YR,,F,Y,112.0,KG,20210630.0,,CN,ES,ES,2021,Q2,Adult
194799961,19479996,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q2,Hypoacusis,,2021,Q2,1,I,,20210611.0,20210630,20210630,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202106007061,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20210630.0,,CN,CN,CN,2021,Q2,Adult
105270879,10527087,6,SS,Insulin glargine,INSULIN GLARGINE,1,Intracardiac,"500 MG,3 TIMES A DAY,",,,,,,,,500.0,MG,,TID,2021,Q3,Alanine aminotransferase increased,,2021,Q3,9,F,2013.0,20210805.0,20141020,20210820,EXP,,DE-AUROBINDO-AUR-APL-2014-03804,AUROBINDO,,41.0,YR,,M,Y,,,20210820.0,,HP,DE,DE,2021,Q3,Adult
105270879,10527087,6,SS,Insulin glargine,INSULIN GLARGINE,1,Intracardiac,"500 MG,3 TIMES A DAY,",,,,,,,,500.0,MG,,TID,2021,Q3,Aspartate aminotransferase increased,,2021,Q3,9,F,2013.0,20210805.0,20141020,20210820,EXP,,DE-AUROBINDO-AUR-APL-2014-03804,AUROBINDO,,41.0,YR,,M,Y,,,20210820.0,,HP,DE,DE,2021,Q3,Adult
105270879,10527087,6,SS,Insulin glargine,INSULIN GLARGINE,1,Intracardiac,"500 MG,3 TIMES A DAY,",,,,,,,,500.0,MG,,TID,2021,Q3,Blood alkaline phosphatase increased,,2021,Q3,9,F,2013.0,20210805.0,20141020,20210820,EXP,,DE-AUROBINDO-AUR-APL-2014-03804,AUROBINDO,,41.0,YR,,M,Y,,,20210820.0,,HP,DE,DE,2021,Q3,Adult
105270879,10527087,6,SS,Insulin glargine,INSULIN GLARGINE,1,Intracardiac,"500 MG,3 TIMES A DAY,",,,,,,,,500.0,MG,,TID,2021,Q3,Blood bilirubin increased,,2021,Q3,9,F,2013.0,20210805.0,20141020,20210820,EXP,,DE-AUROBINDO-AUR-APL-2014-03804,AUROBINDO,,41.0,YR,,M,Y,,,20210820.0,,HP,DE,DE,2021,Q3,Adult
105270879,10527087,6,SS,Insulin glargine,INSULIN GLARGINE,1,Intracardiac,"500 MG,3 TIMES A DAY,",,,,,,,,500.0,MG,,TID,2021,Q3,Chromaturia,,2021,Q3,9,F,2013.0,20210805.0,20141020,20210820,EXP,,DE-AUROBINDO-AUR-APL-2014-03804,AUROBINDO,,41.0,YR,,M,Y,,,20210820.0,,HP,DE,DE,2021,Q3,Adult
105270879,10527087,6,SS,Insulin glargine,INSULIN GLARGINE,1,Intracardiac,"500 MG,3 TIMES A DAY,",,,,,,,,500.0,MG,,TID,2021,Q3,Drug-induced liver injury,,2021,Q3,9,F,2013.0,20210805.0,20141020,20210820,EXP,,DE-AUROBINDO-AUR-APL-2014-03804,AUROBINDO,,41.0,YR,,M,Y,,,20210820.0,,HP,DE,DE,2021,Q3,Adult
105270879,10527087,6,SS,Insulin glargine,INSULIN GLARGINE,1,Intracardiac,"500 MG,3 TIMES A DAY,",,,,,,,,500.0,MG,,TID,2021,Q3,Eosinophilia,,2021,Q3,9,F,2013.0,20210805.0,20141020,20210820,EXP,,DE-AUROBINDO-AUR-APL-2014-03804,AUROBINDO,,41.0,YR,,M,Y,,,20210820.0,,HP,DE,DE,2021,Q3,Adult
105270879,10527087,6,SS,Insulin glargine,INSULIN GLARGINE,1,Intracardiac,"500 MG,3 TIMES A DAY,",,,,,,,,500.0,MG,,TID,2021,Q3,Faeces discoloured,,2021,Q3,9,F,2013.0,20210805.0,20141020,20210820,EXP,,DE-AUROBINDO-AUR-APL-2014-03804,AUROBINDO,,41.0,YR,,M,Y,,,20210820.0,,HP,DE,DE,2021,Q3,Adult
105270879,10527087,6,SS,Insulin glargine,INSULIN GLARGINE,1,Intracardiac,"500 MG,3 TIMES A DAY,",,,,,,,,500.0,MG,,TID,2021,Q3,Fatigue,,2021,Q3,9,F,2013.0,20210805.0,20141020,20210820,EXP,,DE-AUROBINDO-AUR-APL-2014-03804,AUROBINDO,,41.0,YR,,M,Y,,,20210820.0,,HP,DE,DE,2021,Q3,Adult
105270879,10527087,6,SS,Insulin glargine,INSULIN GLARGINE,1,Intracardiac,"500 MG,3 TIMES A DAY,",,,,,,,,500.0,MG,,TID,2021,Q3,Gamma-glutamyltransferase increased,,2021,Q3,9,F,2013.0,20210805.0,20141020,20210820,EXP,,DE-AUROBINDO-AUR-APL-2014-03804,AUROBINDO,,41.0,YR,,M,Y,,,20210820.0,,HP,DE,DE,2021,Q3,Adult
105270879,10527087,6,SS,Insulin glargine,INSULIN GLARGINE,1,Intracardiac,"500 MG,3 TIMES A DAY,",,,,,,,,500.0,MG,,TID,2021,Q3,Hepatic steatosis,,2021,Q3,9,F,2013.0,20210805.0,20141020,20210820,EXP,,DE-AUROBINDO-AUR-APL-2014-03804,AUROBINDO,,41.0,YR,,M,Y,,,20210820.0,,HP,DE,DE,2021,Q3,Adult
105270879,10527087,6,SS,Insulin glargine,INSULIN GLARGINE,1,Intracardiac,"500 MG,3 TIMES A DAY,",,,,,,,,500.0,MG,,TID,2021,Q3,Hepatitis,,2021,Q3,9,F,2013.0,20210805.0,20141020,20210820,EXP,,DE-AUROBINDO-AUR-APL-2014-03804,AUROBINDO,,41.0,YR,,M,Y,,,20210820.0,,HP,DE,DE,2021,Q3,Adult
105270879,10527087,6,SS,Insulin glargine,INSULIN GLARGINE,1,Intracardiac,"500 MG,3 TIMES A DAY,",,,,,,,,500.0,MG,,TID,2021,Q3,Hepatitis cholestatic,,2021,Q3,9,F,2013.0,20210805.0,20141020,20210820,EXP,,DE-AUROBINDO-AUR-APL-2014-03804,AUROBINDO,,41.0,YR,,M,Y,,,20210820.0,,HP,DE,DE,2021,Q3,Adult
105270879,10527087,6,SS,Insulin glargine,INSULIN GLARGINE,1,Intracardiac,"500 MG,3 TIMES A DAY,",,,,,,,,500.0,MG,,TID,2021,Q3,Idiosyncratic drug reaction,,2021,Q3,9,F,2013.0,20210805.0,20141020,20210820,EXP,,DE-AUROBINDO-AUR-APL-2014-03804,AUROBINDO,,41.0,YR,,M,Y,,,20210820.0,,HP,DE,DE,2021,Q3,Adult
105270879,10527087,6,SS,Insulin glargine,INSULIN GLARGINE,1,Intracardiac,"500 MG,3 TIMES A DAY,",,,,,,,,500.0,MG,,TID,2021,Q3,Jaundice,,2021,Q3,9,F,2013.0,20210805.0,20141020,20210820,EXP,,DE-AUROBINDO-AUR-APL-2014-03804,AUROBINDO,,41.0,YR,,M,Y,,,20210820.0,,HP,DE,DE,2021,Q3,Adult
105270879,10527087,6,SS,Insulin glargine,INSULIN GLARGINE,1,Intracardiac,"500 MG,3 TIMES A DAY,",,,,,,,,500.0,MG,,TID,2021,Q3,Pruritus,,2021,Q3,9,F,2013.0,20210805.0,20141020,20210820,EXP,,DE-AUROBINDO-AUR-APL-2014-03804,AUROBINDO,,41.0,YR,,M,Y,,,20210820.0,,HP,DE,DE,2021,Q3,Adult
105270879,10527087,6,SS,Insulin glargine,INSULIN GLARGINE,1,Intracardiac,"500 MG,3 TIMES A DAY,",,,,,,,,500.0,MG,,TID,2021,Q3,Rash,,2021,Q3,9,F,2013.0,20210805.0,20141020,20210820,EXP,,DE-AUROBINDO-AUR-APL-2014-03804,AUROBINDO,,41.0,YR,,M,Y,,,20210820.0,,HP,DE,DE,2021,Q3,Adult
105270879,10527087,6,SS,Insulin glargine,INSULIN GLARGINE,1,Intracardiac,"500 MG,3 TIMES A DAY,",,,,,,,,500.0,MG,,TID,2021,Q3,Scleral discolouration,,2021,Q3,9,F,2013.0,20210805.0,20141020,20210820,EXP,,DE-AUROBINDO-AUR-APL-2014-03804,AUROBINDO,,41.0,YR,,M,Y,,,20210820.0,,HP,DE,DE,2021,Q3,Adult
105270879,10527087,7,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Alanine aminotransferase increased,,2021,Q3,9,F,2013.0,20210805.0,20141020,20210820,EXP,,DE-AUROBINDO-AUR-APL-2014-03804,AUROBINDO,,41.0,YR,,M,Y,,,20210820.0,,HP,DE,DE,2021,Q3,Adult
105270879,10527087,7,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Aspartate aminotransferase increased,,2021,Q3,9,F,2013.0,20210805.0,20141020,20210820,EXP,,DE-AUROBINDO-AUR-APL-2014-03804,AUROBINDO,,41.0,YR,,M,Y,,,20210820.0,,HP,DE,DE,2021,Q3,Adult
105270879,10527087,7,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Blood alkaline phosphatase increased,,2021,Q3,9,F,2013.0,20210805.0,20141020,20210820,EXP,,DE-AUROBINDO-AUR-APL-2014-03804,AUROBINDO,,41.0,YR,,M,Y,,,20210820.0,,HP,DE,DE,2021,Q3,Adult
105270879,10527087,7,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Blood bilirubin increased,,2021,Q3,9,F,2013.0,20210805.0,20141020,20210820,EXP,,DE-AUROBINDO-AUR-APL-2014-03804,AUROBINDO,,41.0,YR,,M,Y,,,20210820.0,,HP,DE,DE,2021,Q3,Adult
105270879,10527087,7,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Chromaturia,,2021,Q3,9,F,2013.0,20210805.0,20141020,20210820,EXP,,DE-AUROBINDO-AUR-APL-2014-03804,AUROBINDO,,41.0,YR,,M,Y,,,20210820.0,,HP,DE,DE,2021,Q3,Adult
105270879,10527087,7,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Drug-induced liver injury,,2021,Q3,9,F,2013.0,20210805.0,20141020,20210820,EXP,,DE-AUROBINDO-AUR-APL-2014-03804,AUROBINDO,,41.0,YR,,M,Y,,,20210820.0,,HP,DE,DE,2021,Q3,Adult
105270879,10527087,7,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Eosinophilia,,2021,Q3,9,F,2013.0,20210805.0,20141020,20210820,EXP,,DE-AUROBINDO-AUR-APL-2014-03804,AUROBINDO,,41.0,YR,,M,Y,,,20210820.0,,HP,DE,DE,2021,Q3,Adult
105270879,10527087,7,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Faeces discoloured,,2021,Q3,9,F,2013.0,20210805.0,20141020,20210820,EXP,,DE-AUROBINDO-AUR-APL-2014-03804,AUROBINDO,,41.0,YR,,M,Y,,,20210820.0,,HP,DE,DE,2021,Q3,Adult
105270879,10527087,7,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Fatigue,,2021,Q3,9,F,2013.0,20210805.0,20141020,20210820,EXP,,DE-AUROBINDO-AUR-APL-2014-03804,AUROBINDO,,41.0,YR,,M,Y,,,20210820.0,,HP,DE,DE,2021,Q3,Adult
105270879,10527087,7,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Gamma-glutamyltransferase increased,,2021,Q3,9,F,2013.0,20210805.0,20141020,20210820,EXP,,DE-AUROBINDO-AUR-APL-2014-03804,AUROBINDO,,41.0,YR,,M,Y,,,20210820.0,,HP,DE,DE,2021,Q3,Adult
105270879,10527087,7,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Hepatic steatosis,,2021,Q3,9,F,2013.0,20210805.0,20141020,20210820,EXP,,DE-AUROBINDO-AUR-APL-2014-03804,AUROBINDO,,41.0,YR,,M,Y,,,20210820.0,,HP,DE,DE,2021,Q3,Adult
105270879,10527087,7,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Hepatitis,,2021,Q3,9,F,2013.0,20210805.0,20141020,20210820,EXP,,DE-AUROBINDO-AUR-APL-2014-03804,AUROBINDO,,41.0,YR,,M,Y,,,20210820.0,,HP,DE,DE,2021,Q3,Adult
105270879,10527087,7,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Hepatitis cholestatic,,2021,Q3,9,F,2013.0,20210805.0,20141020,20210820,EXP,,DE-AUROBINDO-AUR-APL-2014-03804,AUROBINDO,,41.0,YR,,M,Y,,,20210820.0,,HP,DE,DE,2021,Q3,Adult
105270879,10527087,7,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Idiosyncratic drug reaction,,2021,Q3,9,F,2013.0,20210805.0,20141020,20210820,EXP,,DE-AUROBINDO-AUR-APL-2014-03804,AUROBINDO,,41.0,YR,,M,Y,,,20210820.0,,HP,DE,DE,2021,Q3,Adult
105270879,10527087,7,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Jaundice,,2021,Q3,9,F,2013.0,20210805.0,20141020,20210820,EXP,,DE-AUROBINDO-AUR-APL-2014-03804,AUROBINDO,,41.0,YR,,M,Y,,,20210820.0,,HP,DE,DE,2021,Q3,Adult
105270879,10527087,7,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Pruritus,,2021,Q3,9,F,2013.0,20210805.0,20141020,20210820,EXP,,DE-AUROBINDO-AUR-APL-2014-03804,AUROBINDO,,41.0,YR,,M,Y,,,20210820.0,,HP,DE,DE,2021,Q3,Adult
105270879,10527087,7,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Rash,,2021,Q3,9,F,2013.0,20210805.0,20141020,20210820,EXP,,DE-AUROBINDO-AUR-APL-2014-03804,AUROBINDO,,41.0,YR,,M,Y,,,20210820.0,,HP,DE,DE,2021,Q3,Adult
105270879,10527087,7,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Scleral discolouration,,2021,Q3,9,F,2013.0,20210805.0,20141020,20210820,EXP,,DE-AUROBINDO-AUR-APL-2014-03804,AUROBINDO,,41.0,YR,,M,Y,,,20210820.0,,HP,DE,DE,2021,Q3,Adult
109068763,10906876,32,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,10 UNITS,,,U,,,,,,,,BID,2021,Q3,Hyperkalaemia,,2021,Q3,3,F,,20210920.0,20150312,20210930,EXP,,US-AUROBINDO-AUR-APL-2015-01992,AUROBINDO,,69.0,YR,,M,Y,68.0,KG,20210930.0,,PH,US,US,2021,Q3,Elderly
109068763,10906876,33,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,15 UNITS,,,U,,,,,,,,BID,2021,Q3,Hyperkalaemia,,2021,Q3,3,F,,20210920.0,20150312,20210930,EXP,,US-AUROBINDO-AUR-APL-2015-01992,AUROBINDO,,69.0,YR,,M,Y,68.0,KG,20210930.0,,PH,US,US,2021,Q3,Elderly
109068763,10906876,34,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,18 UNITS,,,U,,,,,,,,BID,2021,Q3,Hyperkalaemia,,2021,Q3,3,F,,20210920.0,20150312,20210930,EXP,,US-AUROBINDO-AUR-APL-2015-01992,AUROBINDO,,69.0,YR,,M,Y,68.0,KG,20210930.0,,PH,US,US,2021,Q3,Elderly
127502434,12750243,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"24 DF,QD",,,,, 6F2926A,,,24.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,4,F,20171031.0,20210706.0,20160916,20210720,EXP,,US-SA-2016SA168430,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20210720.0,,CN,US,US,2021,Q3,Elderly
127502434,12750243,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"24 DF,QD",,,,, 6F2926A,,,24.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Device leakage,,2021,Q3,4,F,20171031.0,20210706.0,20160916,20210720,EXP,,US-SA-2016SA168430,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20210720.0,,CN,US,US,2021,Q3,Elderly
127502434,12750243,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"24 DF,QD",,,,, 6F2926A,,,24.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Incorrect dose administered by device,,2021,Q3,4,F,20171031.0,20210706.0,20160916,20210720,EXP,,US-SA-2016SA168430,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20210720.0,,CN,US,US,2021,Q3,Elderly
127502434,12750243,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"24 DF,QD",,,,, 6F2926A,,,24.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Malaise,,2021,Q3,4,F,20171031.0,20210706.0,20160916,20210720,EXP,,US-SA-2016SA168430,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20210720.0,,CN,US,US,2021,Q3,Elderly
127502434,12750243,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"24 DF,QD",,,,, 7F4542A,,,24.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,4,F,20171031.0,20210706.0,20160916,20210720,EXP,,US-SA-2016SA168430,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20210720.0,,CN,US,US,2021,Q3,Elderly
127502434,12750243,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"24 DF,QD",,,,, 7F4542A,,,24.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Device leakage,,2021,Q3,4,F,20171031.0,20210706.0,20160916,20210720,EXP,,US-SA-2016SA168430,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20210720.0,,CN,US,US,2021,Q3,Elderly
127502434,12750243,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"24 DF,QD",,,,, 7F4542A,,,24.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Incorrect dose administered by device,,2021,Q3,4,F,20171031.0,20210706.0,20160916,20210720,EXP,,US-SA-2016SA168430,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20210720.0,,CN,US,US,2021,Q3,Elderly
127502434,12750243,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"24 DF,QD",,,,, 7F4542A,,,24.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Malaise,,2021,Q3,4,F,20171031.0,20210706.0,20160916,20210720,EXP,,US-SA-2016SA168430,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20210720.0,,CN,US,US,2021,Q3,Elderly
1327014121,13270141,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2021,Q3,Anaemia,,2021,Q3,21,F,2015.0,20210629.0,20170224,20210708,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20210708.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q3,Elderly
1327014121,13270141,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2021,Q3,Blood pressure systolic increased,,2021,Q3,21,F,2015.0,20210629.0,20170224,20210708,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20210708.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q3,Elderly
1327014121,13270141,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2021,Q3,Body temperature decreased,,2021,Q3,21,F,2015.0,20210629.0,20170224,20210708,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20210708.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q3,Elderly
1327014121,13270141,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2021,Q3,Diarrhoea,,2021,Q3,21,F,2015.0,20210629.0,20170224,20210708,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20210708.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q3,Elderly
1327014121,13270141,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2021,Q3,Fall,,2021,Q3,21,F,2015.0,20210629.0,20170224,20210708,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20210708.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q3,Elderly
1327014121,13270141,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2021,Q3,Hyperglycaemia,,2021,Q3,21,F,2015.0,20210629.0,20170224,20210708,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20210708.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q3,Elderly
1327014121,13270141,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2021,Q3,Hypoglycaemia,,2021,Q3,21,F,2015.0,20210629.0,20170224,20210708,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20210708.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q3,Elderly
1327014121,13270141,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2021,Q3,Hypotension,,2021,Q3,21,F,2015.0,20210629.0,20170224,20210708,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20210708.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q3,Elderly
1327014121,13270141,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2021,Q3,Injection site mass,,2021,Q3,21,F,2015.0,20210629.0,20170224,20210708,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20210708.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q3,Elderly
1327014121,13270141,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2021,Q3,Injection site pain,,2021,Q3,21,F,2015.0,20210629.0,20170224,20210708,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20210708.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q3,Elderly
1327014121,13270141,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2021,Q3,Metastases to liver,,2021,Q3,21,F,2015.0,20210629.0,20170224,20210708,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20210708.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q3,Elderly
1327014121,13270141,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2021,Q3,Nausea,,2021,Q3,21,F,2015.0,20210629.0,20170224,20210708,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20210708.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q3,Elderly
1327014121,13270141,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2021,Q3,Pneumonia,,2021,Q3,21,F,2015.0,20210629.0,20170224,20210708,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20210708.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q3,Elderly
1327014121,13270141,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2021,Q3,Renal failure,,2021,Q3,21,F,2015.0,20210629.0,20170224,20210708,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20210708.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q3,Elderly
1327014121,13270141,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2021,Q3,Skin lesion,,2021,Q3,21,F,2015.0,20210629.0,20170224,20210708,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20210708.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q3,Elderly
1327014121,13270141,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2021,Q3,Urinary tract infection,,2021,Q3,21,F,2015.0,20210629.0,20170224,20210708,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20210708.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q3,Elderly
136165012,13616501,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"21 DF, QD",,,,, A5922,,21081.0,21.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,2,F,,20210908.0,20170606,20210914,EXP,,US-SA-2016SA084489,SANOFI AVENTIS,,55.0,YR,A,F,Y,,,20210914.0,,CN,US,US,2021,Q3,Adult
136165012,13616501,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"21 DF, QD",,,,, A5922,,21081.0,21.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Dysstasia,,2021,Q3,2,F,,20210908.0,20170606,20210914,EXP,,US-SA-2016SA084489,SANOFI AVENTIS,,55.0,YR,A,F,Y,,,20210914.0,,CN,US,US,2021,Q3,Adult
136165012,13616501,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"21 DF, QD",,,,, A5922,,21081.0,21.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Gait disturbance,,2021,Q3,2,F,,20210908.0,20170606,20210914,EXP,,US-SA-2016SA084489,SANOFI AVENTIS,,55.0,YR,A,F,Y,,,20210914.0,,CN,US,US,2021,Q3,Adult
136165012,13616501,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"21 DF, QD",,,,, A5922,,21081.0,21.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Impaired driving ability,,2021,Q3,2,F,,20210908.0,20170606,20210914,EXP,,US-SA-2016SA084489,SANOFI AVENTIS,,55.0,YR,A,F,Y,,,20210914.0,,CN,US,US,2021,Q3,Adult
136165012,13616501,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"21 DF, QD",,,,, A5922,,21081.0,21.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Limb discomfort,,2021,Q3,2,F,,20210908.0,20170606,20210914,EXP,,US-SA-2016SA084489,SANOFI AVENTIS,,55.0,YR,A,F,Y,,,20210914.0,,CN,US,US,2021,Q3,Adult
136165012,13616501,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU DAILY,,,,,,,21081.0,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,2,F,,20210908.0,20170606,20210914,EXP,,US-SA-2016SA084489,SANOFI AVENTIS,,55.0,YR,A,F,Y,,,20210914.0,,CN,US,US,2021,Q3,Adult
136165012,13616501,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU DAILY,,,,,,,21081.0,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Dysstasia,,2021,Q3,2,F,,20210908.0,20170606,20210914,EXP,,US-SA-2016SA084489,SANOFI AVENTIS,,55.0,YR,A,F,Y,,,20210914.0,,CN,US,US,2021,Q3,Adult
136165012,13616501,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU DAILY,,,,,,,21081.0,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Gait disturbance,,2021,Q3,2,F,,20210908.0,20170606,20210914,EXP,,US-SA-2016SA084489,SANOFI AVENTIS,,55.0,YR,A,F,Y,,,20210914.0,,CN,US,US,2021,Q3,Adult
136165012,13616501,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU DAILY,,,,,,,21081.0,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Impaired driving ability,,2021,Q3,2,F,,20210908.0,20170606,20210914,EXP,,US-SA-2016SA084489,SANOFI AVENTIS,,55.0,YR,A,F,Y,,,20210914.0,,CN,US,US,2021,Q3,Adult
136165012,13616501,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU DAILY,,,,,,,21081.0,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Limb discomfort,,2021,Q3,2,F,,20210908.0,20170606,20210914,EXP,,US-SA-2016SA084489,SANOFI AVENTIS,,55.0,YR,A,F,Y,,,20210914.0,,CN,US,US,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,Anxiety,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,Arthralgia,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,Asthenia,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,Back pain,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,Blindness unilateral,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,Blood glucose decreased,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,Blood pressure decreased,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,Blood triglycerides increased,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,Carpal tunnel syndrome,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,Cataract,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,Chest pain,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,Contusion,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,Cough,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,Dehydration,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,Depressed mood,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,Depression,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,Diabetic coma,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,Dizziness,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,Dyspnoea,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,Epistaxis,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,Fall,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,Fatigue,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,Fear,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,Feeling abnormal,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,General physical health deterioration,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,Haemorrhage,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,Headache,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,Hypoaesthesia,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,Influenza like illness,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,Malaise,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,Muscle spasms,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,Nausea,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,Pain,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,Pain in extremity,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,Paraesthesia,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,Platelet count decreased,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,Pneumonia,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,Poor quality sleep,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,Product supply issue,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,Somnolence,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,Syncope,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,Thrombocytopenia,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,Vertigo,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,Vision blurred,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1381731520,13817315,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 U, UNK",,,U,,,,,,,INJECTION,,2021,Q3,Visual impairment,,2021,Q3,20,F,2016.0,20210830.0,20170731,20210906,EXP,,PHHY2016CO148527,NOVARTIS,,47.0,YR,,F,Y,64.0,KG,20210906.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
1382394014,13823940,51,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE: 10 UNIT,,,,,,,,,,,,2021,Q3,Encephalitis autoimmune,,2021,Q3,14,F,20170712.0,20210811.0,20170802,20210816,EXP,,US-ROCHE-1970955,ROCHE,,64.0,YR,,M,Y,82.4,KG,20210816.0,,MD,US,US,2021,Q3,Adult
1382394014,13823940,51,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE: 10 UNIT,,,,,,,,,,,,2021,Q3,Mental status changes,,2021,Q3,14,F,20170712.0,20210811.0,20170802,20210816,EXP,,US-ROCHE-1970955,ROCHE,,64.0,YR,,M,Y,82.4,KG,20210816.0,,MD,US,US,2021,Q3,Adult
1382394014,13823940,52,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE: 15 UNIT,,,,,,,,,,,QD,2021,Q3,Encephalitis autoimmune,,2021,Q3,14,F,20170712.0,20210811.0,20170802,20210816,EXP,,US-ROCHE-1970955,ROCHE,,64.0,YR,,M,Y,82.4,KG,20210816.0,,MD,US,US,2021,Q3,Adult
1382394014,13823940,52,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE: 15 UNIT,,,,,,,,,,,QD,2021,Q3,Mental status changes,,2021,Q3,14,F,20170712.0,20210811.0,20170802,20210816,EXP,,US-ROCHE-1970955,ROCHE,,64.0,YR,,M,Y,82.4,KG,20210816.0,,MD,US,US,2021,Q3,Adult
138325923,13832592,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 IU, DAILY",,,U,, UNKNOWN,,,18.0,IU,,QD,2021,Q3,Carotid arteriosclerosis,,2021,Q3,3,F,20170709.0,20210909.0,20170804,20210915,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201708000087,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20210915.0,,MD,IT,IT,2021,Q3,Elderly
138325923,13832592,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 IU, DAILY",,,U,, UNKNOWN,,,18.0,IU,,QD,2021,Q3,Chronic lymphocytic leukaemia,,2021,Q3,3,F,20170709.0,20210909.0,20170804,20210915,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201708000087,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20210915.0,,MD,IT,IT,2021,Q3,Elderly
138325923,13832592,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 IU, DAILY",,,U,, UNKNOWN,,,18.0,IU,,QD,2021,Q3,Craniocerebral injury,,2021,Q3,3,F,20170709.0,20210909.0,20170804,20210915,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201708000087,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20210915.0,,MD,IT,IT,2021,Q3,Elderly
138325923,13832592,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 IU, DAILY",,,U,, UNKNOWN,,,18.0,IU,,QD,2021,Q3,Fall,,2021,Q3,3,F,20170709.0,20210909.0,20170804,20210915,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201708000087,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20210915.0,,MD,IT,IT,2021,Q3,Elderly
138325923,13832592,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 IU, DAILY",,,U,, UNKNOWN,,,18.0,IU,,QD,2021,Q3,Hypoglycaemic coma,,2021,Q3,3,F,20170709.0,20210909.0,20170804,20210915,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201708000087,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20210915.0,,MD,IT,IT,2021,Q3,Elderly
138325923,13832592,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 IU, DAILY",,,U,, UNKNOWN,,,18.0,IU,,QD,2021,Q3,Inguinal hernia,,2021,Q3,3,F,20170709.0,20210909.0,20170804,20210915,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201708000087,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20210915.0,,MD,IT,IT,2021,Q3,Elderly
138325923,13832592,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 IU, DAILY",,,U,, UNKNOWN,,,18.0,IU,,QD,2021,Q3,Polyneuropathy,,2021,Q3,3,F,20170709.0,20210909.0,20170804,20210915,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201708000087,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20210915.0,,MD,IT,IT,2021,Q3,Elderly
142618345,14261834,48,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Anaphylactic reaction,,2021,Q3,5,F,,20201028.0,20171208,20210729,EXP,,CA-APOTEX-2017AP022094,APOTEX,,70.0,YR,,F,Y,,,20210729.0,,CN,CA,CA,2021,Q3,Elderly
142618345,14261834,48,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Drug intolerance,,2021,Q3,5,F,,20201028.0,20171208,20210729,EXP,,CA-APOTEX-2017AP022094,APOTEX,,70.0,YR,,F,Y,,,20210729.0,,CN,CA,CA,2021,Q3,Elderly
143788262,14378826,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"24 IU, DAILY MORNINGS",,,Y,U,,,,24.0,IU,,,2021,Q3,Blood glucose increased,,2021,Q3,2,F,20130920.0,20210805.0,20180112,20210814,EXP,,DE-AUROBINDO-AUR-APL-2018-001625,AUROBINDO,,65.0,YR,,F,Y,90.0,KG,20210814.0,,HP,DE,DE,2021,Q3,Elderly
143788262,14378826,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"24 IU, DAILY MORNINGS",,,Y,U,,,,24.0,IU,,,2021,Q3,Decreased appetite,,2021,Q3,2,F,20130920.0,20210805.0,20180112,20210814,EXP,,DE-AUROBINDO-AUR-APL-2018-001625,AUROBINDO,,65.0,YR,,F,Y,90.0,KG,20210814.0,,HP,DE,DE,2021,Q3,Elderly
143788262,14378826,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"24 IU, DAILY MORNINGS",,,Y,U,,,,24.0,IU,,,2021,Q3,Fatigue,,2021,Q3,2,F,20130920.0,20210805.0,20180112,20210814,EXP,,DE-AUROBINDO-AUR-APL-2018-001625,AUROBINDO,,65.0,YR,,F,Y,90.0,KG,20210814.0,,HP,DE,DE,2021,Q3,Elderly
143788262,14378826,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"24 IU, DAILY MORNINGS",,,Y,U,,,,24.0,IU,,,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,2,F,20130920.0,20210805.0,20180112,20210814,EXP,,DE-AUROBINDO-AUR-APL-2018-001625,AUROBINDO,,65.0,YR,,F,Y,90.0,KG,20210814.0,,HP,DE,DE,2021,Q3,Elderly
143788262,14378826,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"24 IU, DAILY MORNINGS",,,Y,U,,,,24.0,IU,,,2021,Q3,Hypoaesthesia,,2021,Q3,2,F,20130920.0,20210805.0,20180112,20210814,EXP,,DE-AUROBINDO-AUR-APL-2018-001625,AUROBINDO,,65.0,YR,,F,Y,90.0,KG,20210814.0,,HP,DE,DE,2021,Q3,Elderly
143788262,14378826,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"24 IU, DAILY MORNINGS",,,Y,U,,,,24.0,IU,,,2021,Q3,Weight decreased,,2021,Q3,2,F,20130920.0,20210805.0,20180112,20210814,EXP,,DE-AUROBINDO-AUR-APL-2018-001625,AUROBINDO,,65.0,YR,,F,Y,90.0,KG,20210814.0,,HP,DE,DE,2021,Q3,Elderly
1440127219,14401272,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, OTHER",,,U,,,,,,,,,2021,Q3,Abdominal pain,,2021,Q3,19,F,20171114.0,20210924.0,20180117,20210930,EXP,,PHHY2017CA170126,NOVARTIS,,71.0,YR,,M,Y,,,20210930.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q3,Elderly
1440127219,14401272,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, OTHER",,,U,,,,,,,,,2021,Q3,Asthenia,,2021,Q3,19,F,20171114.0,20210924.0,20180117,20210930,EXP,,PHHY2017CA170126,NOVARTIS,,71.0,YR,,M,Y,,,20210930.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q3,Elderly
1440127219,14401272,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, OTHER",,,U,,,,,,,,,2021,Q3,Blood glucose abnormal,,2021,Q3,19,F,20171114.0,20210924.0,20180117,20210930,EXP,,PHHY2017CA170126,NOVARTIS,,71.0,YR,,M,Y,,,20210930.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q3,Elderly
1440127219,14401272,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, OTHER",,,U,,,,,,,,,2021,Q3,Blood pressure increased,,2021,Q3,19,F,20171114.0,20210924.0,20180117,20210930,EXP,,PHHY2017CA170126,NOVARTIS,,71.0,YR,,M,Y,,,20210930.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q3,Elderly
1440127219,14401272,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, OTHER",,,U,,,,,,,,,2021,Q3,Blood pressure systolic increased,,2021,Q3,19,F,20171114.0,20210924.0,20180117,20210930,EXP,,PHHY2017CA170126,NOVARTIS,,71.0,YR,,M,Y,,,20210930.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q3,Elderly
1440127219,14401272,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, OTHER",,,U,,,,,,,,,2021,Q3,Carcinoid tumour,,2021,Q3,19,F,20171114.0,20210924.0,20180117,20210930,EXP,,PHHY2017CA170126,NOVARTIS,,71.0,YR,,M,Y,,,20210930.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q3,Elderly
1440127219,14401272,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, OTHER",,,U,,,,,,,,,2021,Q3,Decreased appetite,,2021,Q3,19,F,20171114.0,20210924.0,20180117,20210930,EXP,,PHHY2017CA170126,NOVARTIS,,71.0,YR,,M,Y,,,20210930.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q3,Elderly
1440127219,14401272,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, OTHER",,,U,,,,,,,,,2021,Q3,Fatigue,,2021,Q3,19,F,20171114.0,20210924.0,20180117,20210930,EXP,,PHHY2017CA170126,NOVARTIS,,71.0,YR,,M,Y,,,20210930.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q3,Elderly
1440127219,14401272,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, OTHER",,,U,,,,,,,,,2021,Q3,Loss of personal independence in daily activities,,2021,Q3,19,F,20171114.0,20210924.0,20180117,20210930,EXP,,PHHY2017CA170126,NOVARTIS,,71.0,YR,,M,Y,,,20210930.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q3,Elderly
1440127219,14401272,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, OTHER",,,U,,,,,,,,,2021,Q3,Malignant neoplasm progression,,2021,Q3,19,F,20171114.0,20210924.0,20180117,20210930,EXP,,PHHY2017CA170126,NOVARTIS,,71.0,YR,,M,Y,,,20210930.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q3,Elderly
1440127219,14401272,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, OTHER",,,U,,,,,,,,,2021,Q3,Pruritus,,2021,Q3,19,F,20171114.0,20210924.0,20180117,20210930,EXP,,PHHY2017CA170126,NOVARTIS,,71.0,YR,,M,Y,,,20210930.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q3,Elderly
1440127219,14401272,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, OTHER",,,U,,,,,,,,,2021,Q3,Transfusion-related circulatory overload,,2021,Q3,19,F,20171114.0,20210924.0,20180117,20210930,EXP,,PHHY2017CA170126,NOVARTIS,,71.0,YR,,M,Y,,,20210930.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q3,Elderly
146027664,14602766,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,,,,,,,,QD,2021,Q3,Abdominal pain,,2021,Q3,4,F,2002.0,20210727.0,20180306,20210809,EXP,,PHHY2016CO109800,NOVARTIS,,41.0,YR,,F,Y,67.0,KG,20210810.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
146027664,14602766,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,,,,,,,,QD,2021,Q3,Blood growth hormone increased,,2021,Q3,4,F,2002.0,20210727.0,20180306,20210809,EXP,,PHHY2016CO109800,NOVARTIS,,41.0,YR,,F,Y,67.0,KG,20210810.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
146027664,14602766,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,,,,,,,,QD,2021,Q3,Bone pain,,2021,Q3,4,F,2002.0,20210727.0,20180306,20210809,EXP,,PHHY2016CO109800,NOVARTIS,,41.0,YR,,F,Y,67.0,KG,20210810.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
146027664,14602766,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,,,,,,,,QD,2021,Q3,Depression,,2021,Q3,4,F,2002.0,20210727.0,20180306,20210809,EXP,,PHHY2016CO109800,NOVARTIS,,41.0,YR,,F,Y,67.0,KG,20210810.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
146027664,14602766,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,,,,,,,,QD,2021,Q3,Dizziness,,2021,Q3,4,F,2002.0,20210727.0,20180306,20210809,EXP,,PHHY2016CO109800,NOVARTIS,,41.0,YR,,F,Y,67.0,KG,20210810.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
146027664,14602766,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,,,,,,,,QD,2021,Q3,Dysuria,,2021,Q3,4,F,2002.0,20210727.0,20180306,20210809,EXP,,PHHY2016CO109800,NOVARTIS,,41.0,YR,,F,Y,67.0,KG,20210810.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
146027664,14602766,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,,,,,,,,QD,2021,Q3,Headache,,2021,Q3,4,F,2002.0,20210727.0,20180306,20210809,EXP,,PHHY2016CO109800,NOVARTIS,,41.0,YR,,F,Y,67.0,KG,20210810.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
146027664,14602766,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,,,,,,,,QD,2021,Q3,Hypertension,,2021,Q3,4,F,2002.0,20210727.0,20180306,20210809,EXP,,PHHY2016CO109800,NOVARTIS,,41.0,YR,,F,Y,67.0,KG,20210810.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
146027664,14602766,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,,,,,,,,QD,2021,Q3,Hypotension,,2021,Q3,4,F,2002.0,20210727.0,20180306,20210809,EXP,,PHHY2016CO109800,NOVARTIS,,41.0,YR,,F,Y,67.0,KG,20210810.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
146027664,14602766,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,,,,,,,,QD,2021,Q3,Illness,,2021,Q3,4,F,2002.0,20210727.0,20180306,20210809,EXP,,PHHY2016CO109800,NOVARTIS,,41.0,YR,,F,Y,67.0,KG,20210810.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
146027664,14602766,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,,,,,,,,QD,2021,Q3,Malaise,,2021,Q3,4,F,2002.0,20210727.0,20180306,20210809,EXP,,PHHY2016CO109800,NOVARTIS,,41.0,YR,,F,Y,67.0,KG,20210810.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
146027664,14602766,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,,,,,,,,QD,2021,Q3,Neoplasm progression,,2021,Q3,4,F,2002.0,20210727.0,20180306,20210809,EXP,,PHHY2016CO109800,NOVARTIS,,41.0,YR,,F,Y,67.0,KG,20210810.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
146027664,14602766,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,,,,,,,,QD,2021,Q3,Pain,,2021,Q3,4,F,2002.0,20210727.0,20180306,20210809,EXP,,PHHY2016CO109800,NOVARTIS,,41.0,YR,,F,Y,67.0,KG,20210810.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
146027664,14602766,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,,,,,,,,QD,2021,Q3,Product prescribing error,,2021,Q3,4,F,2002.0,20210727.0,20180306,20210809,EXP,,PHHY2016CO109800,NOVARTIS,,41.0,YR,,F,Y,67.0,KG,20210810.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
146027664,14602766,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,,,,,,,,QD,2021,Q3,Thyroid disorder,,2021,Q3,4,F,2002.0,20210727.0,20180306,20210809,EXP,,PHHY2016CO109800,NOVARTIS,,41.0,YR,,F,Y,67.0,KG,20210810.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
146810433,14681043,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"36 IU, DAILY",,,U,,,,,36.0,IU,,QD,2021,Q3,Fall,,2021,Q3,3,F,20180306.0,20210909.0,20180326,20210922,EXP,IT-MINISAL02-462085,IT-ELI_LILLY_AND_COMPANY-IT201803006684,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20210922.0,,MD,IT,IT,2021,Q3,Adult
146810433,14681043,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"36 IU, DAILY",,,U,,,,,36.0,IU,,QD,2021,Q3,Head injury,,2021,Q3,3,F,20180306.0,20210909.0,20180326,20210922,EXP,IT-MINISAL02-462085,IT-ELI_LILLY_AND_COMPANY-IT201803006684,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20210922.0,,MD,IT,IT,2021,Q3,Adult
146810433,14681043,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"36 IU, DAILY",,,U,,,,,36.0,IU,,QD,2021,Q3,Hyperglycaemia,,2021,Q3,3,F,20180306.0,20210909.0,20180326,20210922,EXP,IT-MINISAL02-462085,IT-ELI_LILLY_AND_COMPANY-IT201803006684,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20210922.0,,MD,IT,IT,2021,Q3,Adult
146810433,14681043,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"36 IU, DAILY",,,U,,,,,36.0,IU,,QD,2021,Q3,Sopor,,2021,Q3,3,F,20180306.0,20210909.0,20180326,20210922,EXP,IT-MINISAL02-462085,IT-ELI_LILLY_AND_COMPANY-IT201803006684,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20210922.0,,MD,IT,IT,2021,Q3,Adult
1472727812,14727278,56,C,INSULIN GLARGINE (GENETICAL RECOMBINATION),INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Cellulitis,,2021,Q3,12,F,2018.0,20210922.0,20180406,20210927,EXP,,JP-GLAXOSMITHKLINE-JP2018JPN056741,GLAXOSMITHKLINE,,46.0,YR,,M,Y,95.0,KG,20210927.0,,CN,JP,JP,2021,Q3,Adult
1472727812,14727278,56,C,INSULIN GLARGINE (GENETICAL RECOMBINATION),INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Cytomegalovirus infection,,2021,Q3,12,F,2018.0,20210922.0,20180406,20210927,EXP,,JP-GLAXOSMITHKLINE-JP2018JPN056741,GLAXOSMITHKLINE,,46.0,YR,,M,Y,95.0,KG,20210927.0,,CN,JP,JP,2021,Q3,Adult
1472727812,14727278,56,C,INSULIN GLARGINE (GENETICAL RECOMBINATION),INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Neutrophil count decreased,,2021,Q3,12,F,2018.0,20210922.0,20180406,20210927,EXP,,JP-GLAXOSMITHKLINE-JP2018JPN056741,GLAXOSMITHKLINE,,46.0,YR,,M,Y,95.0,KG,20210927.0,,CN,JP,JP,2021,Q3,Adult
1472727812,14727278,56,C,INSULIN GLARGINE (GENETICAL RECOMBINATION),INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Pancreatitis acute,,2021,Q3,12,F,2018.0,20210922.0,20180406,20210927,EXP,,JP-GLAXOSMITHKLINE-JP2018JPN056741,GLAXOSMITHKLINE,,46.0,YR,,M,Y,95.0,KG,20210927.0,,CN,JP,JP,2021,Q3,Adult
1472727812,14727278,56,C,INSULIN GLARGINE (GENETICAL RECOMBINATION),INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Pneumocystis jirovecii pneumonia,,2021,Q3,12,F,2018.0,20210922.0,20180406,20210927,EXP,,JP-GLAXOSMITHKLINE-JP2018JPN056741,GLAXOSMITHKLINE,,46.0,YR,,M,Y,95.0,KG,20210927.0,,CN,JP,JP,2021,Q3,Adult
1472727812,14727278,56,C,INSULIN GLARGINE (GENETICAL RECOMBINATION),INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,White blood cell count decreased,,2021,Q3,12,F,2018.0,20210922.0,20180406,20210927,EXP,,JP-GLAXOSMITHKLINE-JP2018JPN056741,GLAXOSMITHKLINE,,46.0,YR,,M,Y,95.0,KG,20210927.0,,CN,JP,JP,2021,Q3,Adult
147300736,14730073,59,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML,,,,,,,,,,,,2021,Q3,Acute kidney injury,,2021,Q3,6,F,20151024.0,20210716.0,20180406,20210730,EXP,,US-PFIZER INC-2018136913,PFIZER,,29.0,YR,,F,Y,,,20210730.0,,CN,US,US,2021,Q3,Young Adult
147300736,14730073,59,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML,,,,,,,,,,,,2021,Q3,Chronic kidney disease,,2021,Q3,6,F,20151024.0,20210716.0,20180406,20210730,EXP,,US-PFIZER INC-2018136913,PFIZER,,29.0,YR,,F,Y,,,20210730.0,,CN,US,US,2021,Q3,Young Adult
147300736,14730073,59,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML,,,,,,,,,,,,2021,Q3,End stage renal disease,,2021,Q3,6,F,20151024.0,20210716.0,20180406,20210730,EXP,,US-PFIZER INC-2018136913,PFIZER,,29.0,YR,,F,Y,,,20210730.0,,CN,US,US,2021,Q3,Young Adult
147300736,14730073,59,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML,,,,,,,,,,,,2021,Q3,Gastrooesophageal reflux disease,,2021,Q3,6,F,20151024.0,20210716.0,20180406,20210730,EXP,,US-PFIZER INC-2018136913,PFIZER,,29.0,YR,,F,Y,,,20210730.0,,CN,US,US,2021,Q3,Young Adult
147300736,14730073,59,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML,,,,,,,,,,,,2021,Q3,Nephrogenic anaemia,,2021,Q3,6,F,20151024.0,20210716.0,20180406,20210730,EXP,,US-PFIZER INC-2018136913,PFIZER,,29.0,YR,,F,Y,,,20210730.0,,CN,US,US,2021,Q3,Young Adult
147300736,14730073,59,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML,,,,,,,,,,,,2021,Q3,Renal failure,,2021,Q3,6,F,20151024.0,20210716.0,20180406,20210730,EXP,,US-PFIZER INC-2018136913,PFIZER,,29.0,YR,,F,Y,,,20210730.0,,CN,US,US,2021,Q3,Young Adult
1483934021,14839340,64,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q3,Blister,,2021,Q3,21,F,20010704.0,20210620.0,20180502,20210705,EXP,,DE-BAUSCH-BL-2018-012079,BAUSCH AND LOMB,,73.0,YR,,F,Y,69.0,KG,20210705.0,,HP,FR,DE,2021,Q3,Elderly
1483934021,14839340,64,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q3,Cholecystitis,,2021,Q3,21,F,20010704.0,20210620.0,20180502,20210705,EXP,,DE-BAUSCH-BL-2018-012079,BAUSCH AND LOMB,,73.0,YR,,F,Y,69.0,KG,20210705.0,,HP,FR,DE,2021,Q3,Elderly
1483934021,14839340,64,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q3,Cholelithiasis,,2021,Q3,21,F,20010704.0,20210620.0,20180502,20210705,EXP,,DE-BAUSCH-BL-2018-012079,BAUSCH AND LOMB,,73.0,YR,,F,Y,69.0,KG,20210705.0,,HP,FR,DE,2021,Q3,Elderly
1483934021,14839340,64,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q3,Condition aggravated,,2021,Q3,21,F,20010704.0,20210620.0,20180502,20210705,EXP,,DE-BAUSCH-BL-2018-012079,BAUSCH AND LOMB,,73.0,YR,,F,Y,69.0,KG,20210705.0,,HP,FR,DE,2021,Q3,Elderly
1483934021,14839340,64,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q3,Dermatitis exfoliative,,2021,Q3,21,F,20010704.0,20210620.0,20180502,20210705,EXP,,DE-BAUSCH-BL-2018-012079,BAUSCH AND LOMB,,73.0,YR,,F,Y,69.0,KG,20210705.0,,HP,FR,DE,2021,Q3,Elderly
1483934021,14839340,64,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q3,Diarrhoea,,2021,Q3,21,F,20010704.0,20210620.0,20180502,20210705,EXP,,DE-BAUSCH-BL-2018-012079,BAUSCH AND LOMB,,73.0,YR,,F,Y,69.0,KG,20210705.0,,HP,FR,DE,2021,Q3,Elderly
1483934021,14839340,64,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q3,Electrolyte imbalance,,2021,Q3,21,F,20010704.0,20210620.0,20180502,20210705,EXP,,DE-BAUSCH-BL-2018-012079,BAUSCH AND LOMB,,73.0,YR,,F,Y,69.0,KG,20210705.0,,HP,FR,DE,2021,Q3,Elderly
1483934021,14839340,64,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q3,Erythema,,2021,Q3,21,F,20010704.0,20210620.0,20180502,20210705,EXP,,DE-BAUSCH-BL-2018-012079,BAUSCH AND LOMB,,73.0,YR,,F,Y,69.0,KG,20210705.0,,HP,FR,DE,2021,Q3,Elderly
1483934021,14839340,64,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q3,Hyperthyroidism,,2021,Q3,21,F,20010704.0,20210620.0,20180502,20210705,EXP,,DE-BAUSCH-BL-2018-012079,BAUSCH AND LOMB,,73.0,YR,,F,Y,69.0,KG,20210705.0,,HP,FR,DE,2021,Q3,Elderly
1483934021,14839340,64,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q3,Multiple organ dysfunction syndrome,,2021,Q3,21,F,20010704.0,20210620.0,20180502,20210705,EXP,,DE-BAUSCH-BL-2018-012079,BAUSCH AND LOMB,,73.0,YR,,F,Y,69.0,KG,20210705.0,,HP,FR,DE,2021,Q3,Elderly
1483934021,14839340,64,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q3,Nausea,,2021,Q3,21,F,20010704.0,20210620.0,20180502,20210705,EXP,,DE-BAUSCH-BL-2018-012079,BAUSCH AND LOMB,,73.0,YR,,F,Y,69.0,KG,20210705.0,,HP,FR,DE,2021,Q3,Elderly
1483934021,14839340,64,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q3,Respiratory disorder,,2021,Q3,21,F,20010704.0,20210620.0,20180502,20210705,EXP,,DE-BAUSCH-BL-2018-012079,BAUSCH AND LOMB,,73.0,YR,,F,Y,69.0,KG,20210705.0,,HP,FR,DE,2021,Q3,Elderly
1483934021,14839340,64,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q3,Restlessness,,2021,Q3,21,F,20010704.0,20210620.0,20180502,20210705,EXP,,DE-BAUSCH-BL-2018-012079,BAUSCH AND LOMB,,73.0,YR,,F,Y,69.0,KG,20210705.0,,HP,FR,DE,2021,Q3,Elderly
1483934021,14839340,64,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q3,Toxic epidermal necrolysis,,2021,Q3,21,F,20010704.0,20210620.0,20180502,20210705,EXP,,DE-BAUSCH-BL-2018-012079,BAUSCH AND LOMB,,73.0,YR,,F,Y,69.0,KG,20210705.0,,HP,FR,DE,2021,Q3,Elderly
148714662,14871466,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, HS",,,,,,,21081.0,70.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,2,F,,20210706.0,20180509,20210719,EXP,,US-SA-2018SA130385,SANOFI AVENTIS,,58.0,YR,A,M,Y,,,20210720.0,,HP,US,US,2021,Q3,Adult
148714662,14871466,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, HS",,,,,,,21081.0,70.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Nephrolithiasis,,2021,Q3,2,F,,20210706.0,20180509,20210719,EXP,,US-SA-2018SA130385,SANOFI AVENTIS,,58.0,YR,A,M,Y,,,20210720.0,,HP,US,US,2021,Q3,Adult
148714662,14871466,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, HS",,,,,,,21081.0,70.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Nervous system disorder,,2021,Q3,2,F,,20210706.0,20180509,20210719,EXP,,US-SA-2018SA130385,SANOFI AVENTIS,,58.0,YR,A,M,Y,,,20210720.0,,HP,US,US,2021,Q3,Adult
148714662,14871466,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, HS",,,,,,,21081.0,70.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Product dose omission issue,,2021,Q3,2,F,,20210706.0,20180509,20210719,EXP,,US-SA-2018SA130385,SANOFI AVENTIS,,58.0,YR,A,M,Y,,,20210720.0,,HP,US,US,2021,Q3,Adult
148714662,14871466,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"80 IU, HS",,,,,,,21081.0,80.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,2,F,,20210706.0,20180509,20210719,EXP,,US-SA-2018SA130385,SANOFI AVENTIS,,58.0,YR,A,M,Y,,,20210720.0,,HP,US,US,2021,Q3,Adult
148714662,14871466,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"80 IU, HS",,,,,,,21081.0,80.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Nephrolithiasis,,2021,Q3,2,F,,20210706.0,20180509,20210719,EXP,,US-SA-2018SA130385,SANOFI AVENTIS,,58.0,YR,A,M,Y,,,20210720.0,,HP,US,US,2021,Q3,Adult
148714662,14871466,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"80 IU, HS",,,,,,,21081.0,80.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Nervous system disorder,,2021,Q3,2,F,,20210706.0,20180509,20210719,EXP,,US-SA-2018SA130385,SANOFI AVENTIS,,58.0,YR,A,M,Y,,,20210720.0,,HP,US,US,2021,Q3,Adult
148714662,14871466,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"80 IU, HS",,,,,,,21081.0,80.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Product dose omission issue,,2021,Q3,2,F,,20210706.0,20180509,20210719,EXP,,US-SA-2018SA130385,SANOFI AVENTIS,,58.0,YR,A,M,Y,,,20210720.0,,HP,US,US,2021,Q3,Adult
151158868,15115886,54,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,,QD,2021,Q3,Blister,,2021,Q3,8,F,,20210525.0,20180706,20210722,EXP,,PHHY2003DE006001,NOVARTIS,,73.0,YR,,F,Y,60.0,KG,20210722.0,,HP,DE,DE,2021,Q3,Elderly
151158868,15115886,54,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,,QD,2021,Q3,Cholecystitis,,2021,Q3,8,F,,20210525.0,20180706,20210722,EXP,,PHHY2003DE006001,NOVARTIS,,73.0,YR,,F,Y,60.0,KG,20210722.0,,HP,DE,DE,2021,Q3,Elderly
151158868,15115886,54,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,,QD,2021,Q3,Cholelithiasis,,2021,Q3,8,F,,20210525.0,20180706,20210722,EXP,,PHHY2003DE006001,NOVARTIS,,73.0,YR,,F,Y,60.0,KG,20210722.0,,HP,DE,DE,2021,Q3,Elderly
151158868,15115886,54,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,,QD,2021,Q3,Condition aggravated,,2021,Q3,8,F,,20210525.0,20180706,20210722,EXP,,PHHY2003DE006001,NOVARTIS,,73.0,YR,,F,Y,60.0,KG,20210722.0,,HP,DE,DE,2021,Q3,Elderly
151158868,15115886,54,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,,QD,2021,Q3,Dermatitis exfoliative,,2021,Q3,8,F,,20210525.0,20180706,20210722,EXP,,PHHY2003DE006001,NOVARTIS,,73.0,YR,,F,Y,60.0,KG,20210722.0,,HP,DE,DE,2021,Q3,Elderly
151158868,15115886,54,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,,QD,2021,Q3,Diarrhoea,,2021,Q3,8,F,,20210525.0,20180706,20210722,EXP,,PHHY2003DE006001,NOVARTIS,,73.0,YR,,F,Y,60.0,KG,20210722.0,,HP,DE,DE,2021,Q3,Elderly
151158868,15115886,54,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,,QD,2021,Q3,Electrolyte imbalance,,2021,Q3,8,F,,20210525.0,20180706,20210722,EXP,,PHHY2003DE006001,NOVARTIS,,73.0,YR,,F,Y,60.0,KG,20210722.0,,HP,DE,DE,2021,Q3,Elderly
151158868,15115886,54,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,,QD,2021,Q3,Erythema,,2021,Q3,8,F,,20210525.0,20180706,20210722,EXP,,PHHY2003DE006001,NOVARTIS,,73.0,YR,,F,Y,60.0,KG,20210722.0,,HP,DE,DE,2021,Q3,Elderly
151158868,15115886,54,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,,QD,2021,Q3,Hyperthyroidism,,2021,Q3,8,F,,20210525.0,20180706,20210722,EXP,,PHHY2003DE006001,NOVARTIS,,73.0,YR,,F,Y,60.0,KG,20210722.0,,HP,DE,DE,2021,Q3,Elderly
151158868,15115886,54,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,,QD,2021,Q3,Multiple organ dysfunction syndrome,,2021,Q3,8,F,,20210525.0,20180706,20210722,EXP,,PHHY2003DE006001,NOVARTIS,,73.0,YR,,F,Y,60.0,KG,20210722.0,,HP,DE,DE,2021,Q3,Elderly
151158868,15115886,54,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,,QD,2021,Q3,Nausea,,2021,Q3,8,F,,20210525.0,20180706,20210722,EXP,,PHHY2003DE006001,NOVARTIS,,73.0,YR,,F,Y,60.0,KG,20210722.0,,HP,DE,DE,2021,Q3,Elderly
151158868,15115886,54,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,,QD,2021,Q3,Respiratory disorder,,2021,Q3,8,F,,20210525.0,20180706,20210722,EXP,,PHHY2003DE006001,NOVARTIS,,73.0,YR,,F,Y,60.0,KG,20210722.0,,HP,DE,DE,2021,Q3,Elderly
151158868,15115886,54,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,,QD,2021,Q3,Restlessness,,2021,Q3,8,F,,20210525.0,20180706,20210722,EXP,,PHHY2003DE006001,NOVARTIS,,73.0,YR,,F,Y,60.0,KG,20210722.0,,HP,DE,DE,2021,Q3,Elderly
151158868,15115886,54,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,,QD,2021,Q3,Toxic epidermal necrolysis,,2021,Q3,8,F,,20210525.0,20180706,20210722,EXP,,PHHY2003DE006001,NOVARTIS,,73.0,YR,,F,Y,60.0,KG,20210722.0,,HP,DE,DE,2021,Q3,Elderly
152282564,15228256,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,13USP UNITS DAILY,,,,,,,,,,,,2021,Q3,Blood electrolytes decreased,,2021,Q3,4,F,2012.0,20210622.0,20180801,20210923,EXP,,CA-ASTRAZENECA-2018SE95997,ASTRAZENECA,,59.0,YR,,M,Y,54.0,KG,20210923.0,,,CA,CA,2021,Q3,Adult
152282564,15228256,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,13USP UNITS DAILY,,,,,,,,,,,,2021,Q3,Blood iron decreased,,2021,Q3,4,F,2012.0,20210622.0,20180801,20210923,EXP,,CA-ASTRAZENECA-2018SE95997,ASTRAZENECA,,59.0,YR,,M,Y,54.0,KG,20210923.0,,,CA,CA,2021,Q3,Adult
152282564,15228256,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,13USP UNITS DAILY,,,,,,,,,,,,2021,Q3,Cardiac valve disease,,2021,Q3,4,F,2012.0,20210622.0,20180801,20210923,EXP,,CA-ASTRAZENECA-2018SE95997,ASTRAZENECA,,59.0,YR,,M,Y,54.0,KG,20210923.0,,,CA,CA,2021,Q3,Adult
152282564,15228256,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,13USP UNITS DAILY,,,,,,,,,,,,2021,Q3,Coeliac disease,,2021,Q3,4,F,2012.0,20210622.0,20180801,20210923,EXP,,CA-ASTRAZENECA-2018SE95997,ASTRAZENECA,,59.0,YR,,M,Y,54.0,KG,20210923.0,,,CA,CA,2021,Q3,Adult
152282564,15228256,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,13USP UNITS DAILY,,,,,,,,,,,,2021,Q3,Drug ineffective,,2021,Q3,4,F,2012.0,20210622.0,20180801,20210923,EXP,,CA-ASTRAZENECA-2018SE95997,ASTRAZENECA,,59.0,YR,,M,Y,54.0,KG,20210923.0,,,CA,CA,2021,Q3,Adult
152282564,15228256,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,13USP UNITS DAILY,,,,,,,,,,,,2021,Q3,Dyspnoea,,2021,Q3,4,F,2012.0,20210622.0,20180801,20210923,EXP,,CA-ASTRAZENECA-2018SE95997,ASTRAZENECA,,59.0,YR,,M,Y,54.0,KG,20210923.0,,,CA,CA,2021,Q3,Adult
152282564,15228256,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,13USP UNITS DAILY,,,,,,,,,,,,2021,Q3,Incorrect dose administered,,2021,Q3,4,F,2012.0,20210622.0,20180801,20210923,EXP,,CA-ASTRAZENECA-2018SE95997,ASTRAZENECA,,59.0,YR,,M,Y,54.0,KG,20210923.0,,,CA,CA,2021,Q3,Adult
152282564,15228256,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,13USP UNITS DAILY,,,,,,,,,,,,2021,Q3,Product use issue,,2021,Q3,4,F,2012.0,20210622.0,20180801,20210923,EXP,,CA-ASTRAZENECA-2018SE95997,ASTRAZENECA,,59.0,YR,,M,Y,54.0,KG,20210923.0,,,CA,CA,2021,Q3,Adult
152282564,15228256,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,13USP UNITS DAILY,,,,,,,,,,,,2021,Q3,Somnolence,,2021,Q3,4,F,2012.0,20210622.0,20180801,20210923,EXP,,CA-ASTRAZENECA-2018SE95997,ASTRAZENECA,,59.0,YR,,M,Y,54.0,KG,20210923.0,,,CA,CA,2021,Q3,Adult
152282564,15228256,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,13USP UNITS DAILY,,,,,,,,,,,,2021,Q3,Underdose,,2021,Q3,4,F,2012.0,20210622.0,20180801,20210923,EXP,,CA-ASTRAZENECA-2018SE95997,ASTRAZENECA,,59.0,YR,,M,Y,54.0,KG,20210923.0,,,CA,CA,2021,Q3,Adult
152282564,15228256,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,13USP UNITS DAILY,,,,,,,,,,,,2021,Q3,Weight decreased,,2021,Q3,4,F,2012.0,20210622.0,20180801,20210923,EXP,,CA-ASTRAZENECA-2018SE95997,ASTRAZENECA,,59.0,YR,,M,Y,54.0,KG,20210923.0,,,CA,CA,2021,Q3,Adult
1543145622,15431456,24,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Transplacental,UNK,4060.0,MG,D,,,,,,,,,2021,Q3,Foetal disorder,,2021,Q3,22,F,20170914.0,20210807.0,20180926,20210812,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20210812.0,,CN,FR,FR,2021,Q3,Child
1543145622,15431456,24,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Transplacental,UNK,4060.0,MG,D,,,,,,,,,2021,Q3,Foetal exposure during pregnancy,,2021,Q3,22,F,20170914.0,20210807.0,20180926,20210812,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20210812.0,,CN,FR,FR,2021,Q3,Child
1543145622,15431456,24,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Transplacental,UNK,4060.0,MG,D,,,,,,,,,2021,Q3,Low birth weight baby,,2021,Q3,22,F,20170914.0,20210807.0,20180926,20210812,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20210812.0,,CN,FR,FR,2021,Q3,Child
1543145622,15431456,24,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Transplacental,UNK,4060.0,MG,D,,,,,,,,,2021,Q3,Neutropenia neonatal,,2021,Q3,22,F,20170914.0,20210807.0,20180926,20210812,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20210812.0,,CN,FR,FR,2021,Q3,Child
1543145622,15431456,24,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Transplacental,UNK,4060.0,MG,D,,,,,,,,,2021,Q3,Premature baby,,2021,Q3,22,F,20170914.0,20210807.0,20180926,20210812,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20210812.0,,CN,FR,FR,2021,Q3,Child
1543145622,15431456,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Transplacental,"20 MILLIGRAM, QD",4060.0,MG,D,,,,,20.0,MG,,QD,2021,Q3,Foetal disorder,,2021,Q3,22,F,20170914.0,20210807.0,20180926,20210812,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20210812.0,,CN,FR,FR,2021,Q3,Child
1543145622,15431456,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Transplacental,"20 MILLIGRAM, QD",4060.0,MG,D,,,,,20.0,MG,,QD,2021,Q3,Foetal exposure during pregnancy,,2021,Q3,22,F,20170914.0,20210807.0,20180926,20210812,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20210812.0,,CN,FR,FR,2021,Q3,Child
1543145622,15431456,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Transplacental,"20 MILLIGRAM, QD",4060.0,MG,D,,,,,20.0,MG,,QD,2021,Q3,Low birth weight baby,,2021,Q3,22,F,20170914.0,20210807.0,20180926,20210812,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20210812.0,,CN,FR,FR,2021,Q3,Child
1543145622,15431456,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Transplacental,"20 MILLIGRAM, QD",4060.0,MG,D,,,,,20.0,MG,,QD,2021,Q3,Neutropenia neonatal,,2021,Q3,22,F,20170914.0,20210807.0,20180926,20210812,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20210812.0,,CN,FR,FR,2021,Q3,Child
1543145622,15431456,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Transplacental,"20 MILLIGRAM, QD",4060.0,MG,D,,,,,20.0,MG,,QD,2021,Q3,Premature baby,,2021,Q3,22,F,20170914.0,20210807.0,20180926,20210812,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20210812.0,,CN,FR,FR,2021,Q3,Child
156335013,15633501,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK UNK, UNK",,,U,,,,,,,,,2021,Q3,Alopecia,,2021,Q3,3,F,20080821.0,20210723.0,20181119,20210730,PER,,US-SA-2018SA314151,SANOFI AVENTIS,,50.0,YR,A,F,Y,154.2,KG,20210730.0,,LW,US,US,2021,Q3,Adult
156335013,15633501,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK UNK, UNK",,,U,,,,,,,,,2021,Q3,Psychological trauma,,2021,Q3,3,F,20080821.0,20210723.0,20181119,20210730,PER,,US-SA-2018SA314151,SANOFI AVENTIS,,50.0,YR,A,F,Y,154.2,KG,20210730.0,,LW,US,US,2021,Q3,Adult
1564727212,15647272,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Cholangitis,,2021,Q3,12,F,20181112.0,20210719.0,20181122,20210722,EXP,,JP-ROCHE-2215138,ROCHE,,74.0,YR,,M,Y,69.8,KG,20210722.0,,MD,JP,JP,2021,Q3,Elderly
1564727212,15647272,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Cholangitis,,2021,Q3,12,F,20181112.0,20210719.0,20181122,20210722,EXP,,JP-ROCHE-2215138,ROCHE,,74.0,YR,,M,Y,69.8,KG,20210722.0,,MD,JP,JP,2021,Q3,Elderly
1564727212,15647272,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Cholangitis,,2021,Q3,12,F,20181112.0,20210719.0,20181122,20210722,EXP,,JP-ROCHE-2215138,ROCHE,,74.0,YR,,M,Y,69.8,KG,20210722.0,,MD,JP,JP,2021,Q3,Elderly
156622212,15662221,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75?90 IU, QD",,,,, 8F8678,,,,,SOLUTION FOR INJECTION,QD,2021,Q3,Balance disorder,,2021,Q3,2,F,,20210720.0,20181127,20210803,EXP,,US-SAKK-2018SA320180AA,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20210803.0,,CN,US,US,2021,Q3,Elderly
156622212,15662221,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75?90 IU, QD",,,,, 8F8678,,,,,SOLUTION FOR INJECTION,QD,2021,Q3,Blood disorder,,2021,Q3,2,F,,20210720.0,20181127,20210803,EXP,,US-SAKK-2018SA320180AA,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20210803.0,,CN,US,US,2021,Q3,Elderly
156622212,15662221,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75?90 IU, QD",,,,, 8F8678,,,,,SOLUTION FOR INJECTION,QD,2021,Q3,Chronic obstructive pulmonary disease,,2021,Q3,2,F,,20210720.0,20181127,20210803,EXP,,US-SAKK-2018SA320180AA,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20210803.0,,CN,US,US,2021,Q3,Elderly
156622212,15662221,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75?90 IU, QD",,,,, 8F8678,,,,,SOLUTION FOR INJECTION,QD,2021,Q3,Dizziness,,2021,Q3,2,F,,20210720.0,20181127,20210803,EXP,,US-SAKK-2018SA320180AA,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20210803.0,,CN,US,US,2021,Q3,Elderly
156622212,15662221,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75?90 IU, QD",,,,, 8F8678,,,,,SOLUTION FOR INJECTION,QD,2021,Q3,Gait disturbance,,2021,Q3,2,F,,20210720.0,20181127,20210803,EXP,,US-SAKK-2018SA320180AA,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20210803.0,,CN,US,US,2021,Q3,Elderly
156622212,15662221,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75?90 IU, QD",,,,, 8F8678,,,,,SOLUTION FOR INJECTION,QD,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,2,F,,20210720.0,20181127,20210803,EXP,,US-SAKK-2018SA320180AA,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20210803.0,,CN,US,US,2021,Q3,Elderly
156622212,15662221,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75?90 IU, QD",,,,, 8F8678,,,,,SOLUTION FOR INJECTION,QD,2021,Q3,Hypoacusis,,2021,Q3,2,F,,20210720.0,20181127,20210803,EXP,,US-SAKK-2018SA320180AA,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20210803.0,,CN,US,US,2021,Q3,Elderly
156622212,15662221,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75?90 IU, QD",,,,, 8F8678,,,,,SOLUTION FOR INJECTION,QD,2021,Q3,Limb discomfort,,2021,Q3,2,F,,20210720.0,20181127,20210803,EXP,,US-SAKK-2018SA320180AA,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20210803.0,,CN,US,US,2021,Q3,Elderly
156622212,15662221,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75?90 IU, QD",,,,, 8F8678,,,,,SOLUTION FOR INJECTION,QD,2021,Q3,Musculoskeletal discomfort,,2021,Q3,2,F,,20210720.0,20181127,20210803,EXP,,US-SAKK-2018SA320180AA,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20210803.0,,CN,US,US,2021,Q3,Elderly
156622212,15662221,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75?90 IU, QD",,,,, 8F8678,,,,,SOLUTION FOR INJECTION,QD,2021,Q3,Nervous system disorder,,2021,Q3,2,F,,20210720.0,20181127,20210803,EXP,,US-SAKK-2018SA320180AA,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20210803.0,,CN,US,US,2021,Q3,Elderly
156622212,15662221,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75?90 IU, QD",,,,, 8F8678,,,,,SOLUTION FOR INJECTION,QD,2021,Q3,Road traffic accident,,2021,Q3,2,F,,20210720.0,20181127,20210803,EXP,,US-SAKK-2018SA320180AA,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20210803.0,,CN,US,US,2021,Q3,Elderly
156622212,15662221,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75?90 IU, QD",,,,, 8F8678,,,,,SOLUTION FOR INJECTION,QD,2021,Q3,Sternal fracture,,2021,Q3,2,F,,20210720.0,20181127,20210803,EXP,,US-SAKK-2018SA320180AA,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20210803.0,,CN,US,US,2021,Q3,Elderly
156622212,15662221,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75?90 IU, QD",,,,, 8F8678,,,,,SOLUTION FOR INJECTION,QD,2021,Q3,Vertigo,,2021,Q3,2,F,,20210720.0,20181127,20210803,EXP,,US-SAKK-2018SA320180AA,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20210803.0,,CN,US,US,2021,Q3,Elderly
156622212,15662221,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75?90 IU, QD",,,,, 8F8678,,,,,SOLUTION FOR INJECTION,QD,2021,Q3,Visual impairment,,2021,Q3,2,F,,20210720.0,20181127,20210803,EXP,,US-SAKK-2018SA320180AA,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20210803.0,,CN,US,US,2021,Q3,Elderly
156622212,15662221,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75?90 IU, QD",,,,, 8F8678,,,,,SOLUTION FOR INJECTION,QD,2021,Q3,Wrist fracture,,2021,Q3,2,F,,20210720.0,20181127,20210803,EXP,,US-SAKK-2018SA320180AA,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20210803.0,,CN,US,US,2021,Q3,Elderly
156622212,15662221,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU, QD",,,,, 1F885A,,,60.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Balance disorder,,2021,Q3,2,F,,20210720.0,20181127,20210803,EXP,,US-SAKK-2018SA320180AA,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20210803.0,,CN,US,US,2021,Q3,Elderly
156622212,15662221,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU, QD",,,,, 1F885A,,,60.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood disorder,,2021,Q3,2,F,,20210720.0,20181127,20210803,EXP,,US-SAKK-2018SA320180AA,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20210803.0,,CN,US,US,2021,Q3,Elderly
156622212,15662221,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU, QD",,,,, 1F885A,,,60.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Chronic obstructive pulmonary disease,,2021,Q3,2,F,,20210720.0,20181127,20210803,EXP,,US-SAKK-2018SA320180AA,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20210803.0,,CN,US,US,2021,Q3,Elderly
156622212,15662221,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU, QD",,,,, 1F885A,,,60.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Dizziness,,2021,Q3,2,F,,20210720.0,20181127,20210803,EXP,,US-SAKK-2018SA320180AA,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20210803.0,,CN,US,US,2021,Q3,Elderly
156622212,15662221,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU, QD",,,,, 1F885A,,,60.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Gait disturbance,,2021,Q3,2,F,,20210720.0,20181127,20210803,EXP,,US-SAKK-2018SA320180AA,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20210803.0,,CN,US,US,2021,Q3,Elderly
156622212,15662221,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU, QD",,,,, 1F885A,,,60.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,2,F,,20210720.0,20181127,20210803,EXP,,US-SAKK-2018SA320180AA,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20210803.0,,CN,US,US,2021,Q3,Elderly
156622212,15662221,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU, QD",,,,, 1F885A,,,60.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hypoacusis,,2021,Q3,2,F,,20210720.0,20181127,20210803,EXP,,US-SAKK-2018SA320180AA,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20210803.0,,CN,US,US,2021,Q3,Elderly
156622212,15662221,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU, QD",,,,, 1F885A,,,60.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Limb discomfort,,2021,Q3,2,F,,20210720.0,20181127,20210803,EXP,,US-SAKK-2018SA320180AA,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20210803.0,,CN,US,US,2021,Q3,Elderly
156622212,15662221,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU, QD",,,,, 1F885A,,,60.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Musculoskeletal discomfort,,2021,Q3,2,F,,20210720.0,20181127,20210803,EXP,,US-SAKK-2018SA320180AA,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20210803.0,,CN,US,US,2021,Q3,Elderly
156622212,15662221,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU, QD",,,,, 1F885A,,,60.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Nervous system disorder,,2021,Q3,2,F,,20210720.0,20181127,20210803,EXP,,US-SAKK-2018SA320180AA,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20210803.0,,CN,US,US,2021,Q3,Elderly
156622212,15662221,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU, QD",,,,, 1F885A,,,60.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Road traffic accident,,2021,Q3,2,F,,20210720.0,20181127,20210803,EXP,,US-SAKK-2018SA320180AA,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20210803.0,,CN,US,US,2021,Q3,Elderly
156622212,15662221,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU, QD",,,,, 1F885A,,,60.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Sternal fracture,,2021,Q3,2,F,,20210720.0,20181127,20210803,EXP,,US-SAKK-2018SA320180AA,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20210803.0,,CN,US,US,2021,Q3,Elderly
156622212,15662221,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU, QD",,,,, 1F885A,,,60.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Vertigo,,2021,Q3,2,F,,20210720.0,20181127,20210803,EXP,,US-SAKK-2018SA320180AA,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20210803.0,,CN,US,US,2021,Q3,Elderly
156622212,15662221,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU, QD",,,,, 1F885A,,,60.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Visual impairment,,2021,Q3,2,F,,20210720.0,20181127,20210803,EXP,,US-SAKK-2018SA320180AA,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20210803.0,,CN,US,US,2021,Q3,Elderly
156622212,15662221,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU, QD",,,,, 1F885A,,,60.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Wrist fracture,,2021,Q3,2,F,,20210720.0,20181127,20210803,EXP,,US-SAKK-2018SA320180AA,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20210803.0,,CN,US,US,2021,Q3,Elderly
157010832,15701083,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 U, BID",,,,,,,,,,SOLUTION FOR INJECTION,Q12H,2021,Q3,Inappropriate schedule of product administration,,2021,Q3,2,F,202103.0,20210812.0,20181207,20210823,EXP,,US-SA-2018SA328849,SANOFI AVENTIS,,57.0,YR,A,M,Y,,,20210823.0,,CN,US,US,2021,Q3,Adult
157010832,15701083,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 U, BID",,,,,,,,,,SOLUTION FOR INJECTION,Q12H,2021,Q3,Neoplasm malignant,,2021,Q3,2,F,202103.0,20210812.0,20181207,20210823,EXP,,US-SA-2018SA328849,SANOFI AVENTIS,,57.0,YR,A,M,Y,,,20210823.0,,CN,US,US,2021,Q3,Adult
157010832,15701083,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 U, BID",,,,,,,,,,SOLUTION FOR INJECTION,Q12H,2021,Q3,Prostatic operation,,2021,Q3,2,F,202103.0,20210812.0,20181207,20210823,EXP,,US-SA-2018SA328849,SANOFI AVENTIS,,57.0,YR,A,M,Y,,,20210823.0,,CN,US,US,2021,Q3,Adult
157010832,15701083,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 IU,,,,,,,,50.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Inappropriate schedule of product administration,,2021,Q3,2,F,202103.0,20210812.0,20181207,20210823,EXP,,US-SA-2018SA328849,SANOFI AVENTIS,,57.0,YR,A,M,Y,,,20210823.0,,CN,US,US,2021,Q3,Adult
157010832,15701083,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 IU,,,,,,,,50.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Neoplasm malignant,,2021,Q3,2,F,202103.0,20210812.0,20181207,20210823,EXP,,US-SA-2018SA328849,SANOFI AVENTIS,,57.0,YR,A,M,Y,,,20210823.0,,CN,US,US,2021,Q3,Adult
157010832,15701083,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 IU,,,,,,,,50.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Prostatic operation,,2021,Q3,2,F,202103.0,20210812.0,20181207,20210823,EXP,,US-SA-2018SA328849,SANOFI AVENTIS,,57.0,YR,A,M,Y,,,20210823.0,,CN,US,US,2021,Q3,Adult
157811112,15781111,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"30 IU,QD",,,Y,U, UNK,,21081.0,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,2,F,20180321.0,20180510.0,20190102,20210928,EXP,,EG-SA-2018SA109440,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20210928.0,,CN,EG,EG,2021,Q3,Elderly
157811112,15781111,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"30 IU,QD",,,Y,U, UNK,,21081.0,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Cardiovascular disorder,,2021,Q3,2,F,20180321.0,20180510.0,20190102,20210928,EXP,,EG-SA-2018SA109440,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20210928.0,,CN,EG,EG,2021,Q3,Elderly
157811112,15781111,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"30 IU,QD",,,Y,U, UNK,,21081.0,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Fluid retention,,2021,Q3,2,F,20180321.0,20180510.0,20190102,20210928,EXP,,EG-SA-2018SA109440,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20210928.0,,CN,EG,EG,2021,Q3,Elderly
157811112,15781111,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"30 IU,QD",,,Y,U, UNK,,21081.0,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hyperglycaemia,,2021,Q3,2,F,20180321.0,20180510.0,20190102,20210928,EXP,,EG-SA-2018SA109440,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20210928.0,,CN,EG,EG,2021,Q3,Elderly
157811112,15781111,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"30 IU,QD",,,Y,U, U,,21081.0,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,2,F,20180321.0,20180510.0,20190102,20210928,EXP,,EG-SA-2018SA109440,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20210928.0,,CN,EG,EG,2021,Q3,Elderly
157811112,15781111,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"30 IU,QD",,,Y,U, U,,21081.0,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Cardiovascular disorder,,2021,Q3,2,F,20180321.0,20180510.0,20190102,20210928,EXP,,EG-SA-2018SA109440,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20210928.0,,CN,EG,EG,2021,Q3,Elderly
157811112,15781111,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"30 IU,QD",,,Y,U, U,,21081.0,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Fluid retention,,2021,Q3,2,F,20180321.0,20180510.0,20190102,20210928,EXP,,EG-SA-2018SA109440,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20210928.0,,CN,EG,EG,2021,Q3,Elderly
157811112,15781111,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"30 IU,QD",,,Y,U, U,,21081.0,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hyperglycaemia,,2021,Q3,2,F,20180321.0,20180510.0,20190102,20210928,EXP,,EG-SA-2018SA109440,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20210928.0,,CN,EG,EG,2021,Q3,Elderly
159407515,15940751,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q3,Acute kidney injury,,2021,Q3,5,F,2012.0,20210714.0,20190208,20210726,EXP,,US-ASTRAZENECA-2018SF34722,ASTRAZENECA,,51.0,YR,,M,Y,71.2,KG,20210726.0,,,US,US,2021,Q3,Adult
159407515,15940751,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q3,Chronic kidney disease,,2021,Q3,5,F,2012.0,20210714.0,20190208,20210726,EXP,,US-ASTRAZENECA-2018SF34722,ASTRAZENECA,,51.0,YR,,M,Y,71.2,KG,20210726.0,,,US,US,2021,Q3,Adult
159407515,15940751,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q3,End stage renal disease,,2021,Q3,5,F,2012.0,20210714.0,20190208,20210726,EXP,,US-ASTRAZENECA-2018SF34722,ASTRAZENECA,,51.0,YR,,M,Y,71.2,KG,20210726.0,,,US,US,2021,Q3,Adult
159407515,15940751,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q3,Gastrooesophageal reflux disease,,2021,Q3,5,F,2012.0,20210714.0,20190208,20210726,EXP,,US-ASTRAZENECA-2018SF34722,ASTRAZENECA,,51.0,YR,,M,Y,71.2,KG,20210726.0,,,US,US,2021,Q3,Adult
159407515,15940751,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q3,Nephrogenic anaemia,,2021,Q3,5,F,2012.0,20210714.0,20190208,20210726,EXP,,US-ASTRAZENECA-2018SF34722,ASTRAZENECA,,51.0,YR,,M,Y,71.2,KG,20210726.0,,,US,US,2021,Q3,Adult
159407515,15940751,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q3,Nephropathy,,2021,Q3,5,F,2012.0,20210714.0,20190208,20210726,EXP,,US-ASTRAZENECA-2018SF34722,ASTRAZENECA,,51.0,YR,,M,Y,71.2,KG,20210726.0,,,US,US,2021,Q3,Adult
159407515,15940751,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q3,Renal failure,,2021,Q3,5,F,2012.0,20210714.0,20190208,20210726,EXP,,US-ASTRAZENECA-2018SF34722,ASTRAZENECA,,51.0,YR,,M,Y,71.2,KG,20210726.0,,,US,US,2021,Q3,Adult
159407515,15940751,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q3,Renal injury,,2021,Q3,5,F,2012.0,20210714.0,20190208,20210726,EXP,,US-ASTRAZENECA-2018SF34722,ASTRAZENECA,,51.0,YR,,M,Y,71.2,KG,20210726.0,,,US,US,2021,Q3,Adult
159407515,15940751,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q3,Acute kidney injury,,2021,Q3,5,F,2012.0,20210714.0,20190208,20210726,EXP,,US-ASTRAZENECA-2018SF34722,ASTRAZENECA,,51.0,YR,,M,Y,71.2,KG,20210726.0,,,US,US,2021,Q3,Adult
159407515,15940751,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q3,Chronic kidney disease,,2021,Q3,5,F,2012.0,20210714.0,20190208,20210726,EXP,,US-ASTRAZENECA-2018SF34722,ASTRAZENECA,,51.0,YR,,M,Y,71.2,KG,20210726.0,,,US,US,2021,Q3,Adult
159407515,15940751,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q3,End stage renal disease,,2021,Q3,5,F,2012.0,20210714.0,20190208,20210726,EXP,,US-ASTRAZENECA-2018SF34722,ASTRAZENECA,,51.0,YR,,M,Y,71.2,KG,20210726.0,,,US,US,2021,Q3,Adult
159407515,15940751,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q3,Gastrooesophageal reflux disease,,2021,Q3,5,F,2012.0,20210714.0,20190208,20210726,EXP,,US-ASTRAZENECA-2018SF34722,ASTRAZENECA,,51.0,YR,,M,Y,71.2,KG,20210726.0,,,US,US,2021,Q3,Adult
159407515,15940751,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q3,Nephrogenic anaemia,,2021,Q3,5,F,2012.0,20210714.0,20190208,20210726,EXP,,US-ASTRAZENECA-2018SF34722,ASTRAZENECA,,51.0,YR,,M,Y,71.2,KG,20210726.0,,,US,US,2021,Q3,Adult
159407515,15940751,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q3,Nephropathy,,2021,Q3,5,F,2012.0,20210714.0,20190208,20210726,EXP,,US-ASTRAZENECA-2018SF34722,ASTRAZENECA,,51.0,YR,,M,Y,71.2,KG,20210726.0,,,US,US,2021,Q3,Adult
159407515,15940751,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q3,Renal failure,,2021,Q3,5,F,2012.0,20210714.0,20190208,20210726,EXP,,US-ASTRAZENECA-2018SF34722,ASTRAZENECA,,51.0,YR,,M,Y,71.2,KG,20210726.0,,,US,US,2021,Q3,Adult
159407515,15940751,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q3,Renal injury,,2021,Q3,5,F,2012.0,20210714.0,20190208,20210726,EXP,,US-ASTRAZENECA-2018SF34722,ASTRAZENECA,,51.0,YR,,M,Y,71.2,KG,20210726.0,,,US,US,2021,Q3,Adult
1637836112,16378361,22,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,,2021,Q3,Asthenia,,2021,Q3,12,F,20140221.0,20210809.0,20190531,20210817,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,57.0,YR,,M,Y,47.0,KG,20210817.0,,CN,CO,CO,2021,Q3,Adult
1637836112,16378361,22,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,,2021,Q3,Cellulitis,,2021,Q3,12,F,20140221.0,20210809.0,20190531,20210817,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,57.0,YR,,M,Y,47.0,KG,20210817.0,,CN,CO,CO,2021,Q3,Adult
1637836112,16378361,22,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,,2021,Q3,Erythema,,2021,Q3,12,F,20140221.0,20210809.0,20190531,20210817,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,57.0,YR,,M,Y,47.0,KG,20210817.0,,CN,CO,CO,2021,Q3,Adult
1637836112,16378361,22,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,,2021,Q3,Fatigue,,2021,Q3,12,F,20140221.0,20210809.0,20190531,20210817,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,57.0,YR,,M,Y,47.0,KG,20210817.0,,CN,CO,CO,2021,Q3,Adult
1637836112,16378361,22,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,,2021,Q3,General physical health deterioration,,2021,Q3,12,F,20140221.0,20210809.0,20190531,20210817,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,57.0,YR,,M,Y,47.0,KG,20210817.0,,CN,CO,CO,2021,Q3,Adult
1637836112,16378361,22,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,,2021,Q3,Hepatitis,,2021,Q3,12,F,20140221.0,20210809.0,20190531,20210817,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,57.0,YR,,M,Y,47.0,KG,20210817.0,,CN,CO,CO,2021,Q3,Adult
1637836112,16378361,22,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,,2021,Q3,Inflammation,,2021,Q3,12,F,20140221.0,20210809.0,20190531,20210817,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,57.0,YR,,M,Y,47.0,KG,20210817.0,,CN,CO,CO,2021,Q3,Adult
1637836112,16378361,22,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,,2021,Q3,Oedema peripheral,,2021,Q3,12,F,20140221.0,20210809.0,20190531,20210817,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,57.0,YR,,M,Y,47.0,KG,20210817.0,,CN,CO,CO,2021,Q3,Adult
1637836112,16378361,22,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,,2021,Q3,Pain in extremity,,2021,Q3,12,F,20140221.0,20210809.0,20190531,20210817,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,57.0,YR,,M,Y,47.0,KG,20210817.0,,CN,CO,CO,2021,Q3,Adult
1637836112,16378361,22,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,,2021,Q3,Portal vein phlebitis,,2021,Q3,12,F,20140221.0,20210809.0,20190531,20210817,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,57.0,YR,,M,Y,47.0,KG,20210817.0,,CN,CO,CO,2021,Q3,Adult
1637836112,16378361,22,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,,2021,Q3,Product availability issue,,2021,Q3,12,F,20140221.0,20210809.0,20190531,20210817,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,57.0,YR,,M,Y,47.0,KG,20210817.0,,CN,CO,CO,2021,Q3,Adult
1637836112,16378361,22,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,,2021,Q3,Product packaging quantity issue,,2021,Q3,12,F,20140221.0,20210809.0,20190531,20210817,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,57.0,YR,,M,Y,47.0,KG,20210817.0,,CN,CO,CO,2021,Q3,Adult
1637836112,16378361,22,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,,2021,Q3,Product use in unapproved indication,,2021,Q3,12,F,20140221.0,20210809.0,20190531,20210817,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,57.0,YR,,M,Y,47.0,KG,20210817.0,,CN,CO,CO,2021,Q3,Adult
1637836112,16378361,22,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,,2021,Q3,Splenitis,,2021,Q3,12,F,20140221.0,20210809.0,20190531,20210817,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,57.0,YR,,M,Y,47.0,KG,20210817.0,,CN,CO,CO,2021,Q3,Adult
1637836112,16378361,22,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,,2021,Q3,Transplantation complication,,2021,Q3,12,F,20140221.0,20210809.0,20190531,20210817,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,57.0,YR,,M,Y,47.0,KG,20210817.0,,CN,CO,CO,2021,Q3,Adult
1637836112,16378361,22,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,,2021,Q3,Urinary tract infection,,2021,Q3,12,F,20140221.0,20210809.0,20190531,20210817,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,57.0,YR,,M,Y,47.0,KG,20210817.0,,CN,CO,CO,2021,Q3,Adult
1637836112,16378361,22,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,,2021,Q3,Weight decreased,,2021,Q3,12,F,20140221.0,20210809.0,20190531,20210817,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,57.0,YR,,M,Y,47.0,KG,20210817.0,,CN,CO,CO,2021,Q3,Adult
168225665,16822566,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, 1X/DAY, (AT BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,QD,2021,Q3,Depression,,2021,Q3,5,F,,20210829.0,20190918,20210902,PER,,US-PFIZER INC-2015330930,PFIZER,,45.0,YR,,F,Y,61.22,KG,20210902.0,,HP,US,US,2021,Q3,Adult
168225665,16822566,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, 1X/DAY, (AT BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,QD,2021,Q3,Off label use,,2021,Q3,5,F,,20210829.0,20190918,20210902,PER,,US-PFIZER INC-2015330930,PFIZER,,45.0,YR,,F,Y,61.22,KG,20210902.0,,HP,US,US,2021,Q3,Adult
169324976,16932497,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Leukopenia,,2021,Q3,6,F,20190723.0,20210701.0,20191017,20210706,EXP,,PHHO2019PL007720,NOVARTIS,,63.0,YR,,M,Y,104.0,KG,20210706.0,,MD,PL,PL,2021,Q3,Adult
169324976,16932497,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Neutropenia,,2021,Q3,6,F,20190723.0,20210701.0,20191017,20210706,EXP,,PHHO2019PL007720,NOVARTIS,,63.0,YR,,M,Y,104.0,KG,20210706.0,,MD,PL,PL,2021,Q3,Adult
170996266,17099626,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,INJECTION,,2021,Q3,Pleural effusion,,2021,Q3,6,F,20191112.0,20210802.0,20191202,20210809,EXP,,NVSC2019CN041826,NOVARTIS,,50.0,YR,,F,Y,53.0,KG,20210809.0,,MD,CN,CN,2021,Q3,Adult
171829483,17182948,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 U X 1 X 1 DAYS,,,,,,,,,,UNKNOWN,QD,2021,Q3,Vitamin B1 decreased,,2021,Q3,3,F,20191016.0,20200114.0,20191220,20210714,EXP,,US-CELGENEUS-USA-20191205924,CELGENE,,78.0,YR,,M,Y,90.0,KG,20210714.0,,MD,US,US,2021,Q3,Elderly
172933826,17293382,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Blood glucose increased,,2021,Q3,6,F,,20210730.0,20200121,20210805,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,A,M,Y,104.0,KG,20210805.0,,CN,CO,CO,2021,Q3,Adult
172933826,17293382,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Cholelithiasis,,2021,Q3,6,F,,20210730.0,20200121,20210805,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,A,M,Y,104.0,KG,20210805.0,,CN,CO,CO,2021,Q3,Adult
172933826,17293382,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Fatigue,,2021,Q3,6,F,,20210730.0,20200121,20210805,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,A,M,Y,104.0,KG,20210805.0,,CN,CO,CO,2021,Q3,Adult
172933826,17293382,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Food intolerance,,2021,Q3,6,F,,20210730.0,20200121,20210805,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,A,M,Y,104.0,KG,20210805.0,,CN,CO,CO,2021,Q3,Adult
172933826,17293382,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Headache,,2021,Q3,6,F,,20210730.0,20200121,20210805,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,A,M,Y,104.0,KG,20210805.0,,CN,CO,CO,2021,Q3,Adult
172933826,17293382,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Malaise,,2021,Q3,6,F,,20210730.0,20200121,20210805,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,A,M,Y,104.0,KG,20210805.0,,CN,CO,CO,2021,Q3,Adult
172933826,17293382,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Nausea,,2021,Q3,6,F,,20210730.0,20200121,20210805,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,A,M,Y,104.0,KG,20210805.0,,CN,CO,CO,2021,Q3,Adult
172933826,17293382,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Photophobia,,2021,Q3,6,F,,20210730.0,20200121,20210805,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,A,M,Y,104.0,KG,20210805.0,,CN,CO,CO,2021,Q3,Adult
172933826,17293382,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Pituitary enlargement,,2021,Q3,6,F,,20210730.0,20200121,20210805,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,A,M,Y,104.0,KG,20210805.0,,CN,CO,CO,2021,Q3,Adult
172933826,17293382,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Vision blurred,,2021,Q3,6,F,,20210730.0,20200121,20210805,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,A,M,Y,104.0,KG,20210805.0,,CN,CO,CO,2021,Q3,Adult
172933826,17293382,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Vomiting,,2021,Q3,6,F,,20210730.0,20200121,20210805,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,A,M,Y,104.0,KG,20210805.0,,CN,CO,CO,2021,Q3,Adult
174050304,17405030,3,C,INSULIN GLARGINE(GENETICAL RECOMBINATION),INSULIN GLARGINE,1,Unknown,,,,,,,,,24.0,IU,,,2021,Q3,Euglycaemic diabetic ketoacidosis,,2021,Q3,4,F,,20210706.0,20200212,20210709,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-007047",BOEHRINGER INGELHEIM,A CASE OF SGLT2 INHIBITOR?ASSOCIATED EUGLYCEMIC DIABETIC KETOACIDOSIS ON POSTOPERATIVE DAY 3. THE 669TH KANTO REGIONAL MEETING OF THE JAPANESE SOCIETY OF INTERNAL MEDICINE [COMPLETELY WEB?BASED]. 2021 JUN 12?,7.0,DEC,E,F,Y,,,20210709.0,,,COUNTRY NOT SPECIFIED,JP,2021,Q3,Child
174050304,17405030,3,C,INSULIN GLARGINE(GENETICAL RECOMBINATION),INSULIN GLARGINE,1,Unknown,,,,,,,,,24.0,IU,,,2021,Q3,Lumbar spinal stenosis,,2021,Q3,4,F,,20210706.0,20200212,20210709,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-007047",BOEHRINGER INGELHEIM,A CASE OF SGLT2 INHIBITOR?ASSOCIATED EUGLYCEMIC DIABETIC KETOACIDOSIS ON POSTOPERATIVE DAY 3. THE 669TH KANTO REGIONAL MEETING OF THE JAPANESE SOCIETY OF INTERNAL MEDICINE [COMPLETELY WEB?BASED]. 2021 JUN 12?,7.0,DEC,E,F,Y,,,20210709.0,,,COUNTRY NOT SPECIFIED,JP,2021,Q3,Child
174194273,17419427,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,12.0,IU,,,2021,Q3,Abdominal pain,,2021,Q3,3,F,2002.0,20210810.0,20200214,20210817,EXP,,CO-EMD SERONO-9144845,EMD SERONO INC,,46.0,YR,A,F,Y,67.0,KG,20210818.0,,CN,CO,CO,2021,Q3,Adult
174194273,17419427,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,12.0,IU,,,2021,Q3,Blood growth hormone increased,,2021,Q3,3,F,2002.0,20210810.0,20200214,20210817,EXP,,CO-EMD SERONO-9144845,EMD SERONO INC,,46.0,YR,A,F,Y,67.0,KG,20210818.0,,CN,CO,CO,2021,Q3,Adult
174194273,17419427,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,12.0,IU,,,2021,Q3,Bone pain,,2021,Q3,3,F,2002.0,20210810.0,20200214,20210817,EXP,,CO-EMD SERONO-9144845,EMD SERONO INC,,46.0,YR,A,F,Y,67.0,KG,20210818.0,,CN,CO,CO,2021,Q3,Adult
174194273,17419427,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,12.0,IU,,,2021,Q3,Depression,,2021,Q3,3,F,2002.0,20210810.0,20200214,20210817,EXP,,CO-EMD SERONO-9144845,EMD SERONO INC,,46.0,YR,A,F,Y,67.0,KG,20210818.0,,CN,CO,CO,2021,Q3,Adult
174194273,17419427,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,12.0,IU,,,2021,Q3,Dizziness,,2021,Q3,3,F,2002.0,20210810.0,20200214,20210817,EXP,,CO-EMD SERONO-9144845,EMD SERONO INC,,46.0,YR,A,F,Y,67.0,KG,20210818.0,,CN,CO,CO,2021,Q3,Adult
174194273,17419427,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,12.0,IU,,,2021,Q3,Dysuria,,2021,Q3,3,F,2002.0,20210810.0,20200214,20210817,EXP,,CO-EMD SERONO-9144845,EMD SERONO INC,,46.0,YR,A,F,Y,67.0,KG,20210818.0,,CN,CO,CO,2021,Q3,Adult
174194273,17419427,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,12.0,IU,,,2021,Q3,Headache,,2021,Q3,3,F,2002.0,20210810.0,20200214,20210817,EXP,,CO-EMD SERONO-9144845,EMD SERONO INC,,46.0,YR,A,F,Y,67.0,KG,20210818.0,,CN,CO,CO,2021,Q3,Adult
174194273,17419427,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,12.0,IU,,,2021,Q3,Hypertension,,2021,Q3,3,F,2002.0,20210810.0,20200214,20210817,EXP,,CO-EMD SERONO-9144845,EMD SERONO INC,,46.0,YR,A,F,Y,67.0,KG,20210818.0,,CN,CO,CO,2021,Q3,Adult
174194273,17419427,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,12.0,IU,,,2021,Q3,Hypotension,,2021,Q3,3,F,2002.0,20210810.0,20200214,20210817,EXP,,CO-EMD SERONO-9144845,EMD SERONO INC,,46.0,YR,A,F,Y,67.0,KG,20210818.0,,CN,CO,CO,2021,Q3,Adult
174194273,17419427,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,12.0,IU,,,2021,Q3,Illness,,2021,Q3,3,F,2002.0,20210810.0,20200214,20210817,EXP,,CO-EMD SERONO-9144845,EMD SERONO INC,,46.0,YR,A,F,Y,67.0,KG,20210818.0,,CN,CO,CO,2021,Q3,Adult
174194273,17419427,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,12.0,IU,,,2021,Q3,Malaise,,2021,Q3,3,F,2002.0,20210810.0,20200214,20210817,EXP,,CO-EMD SERONO-9144845,EMD SERONO INC,,46.0,YR,A,F,Y,67.0,KG,20210818.0,,CN,CO,CO,2021,Q3,Adult
174194273,17419427,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,12.0,IU,,,2021,Q3,Neoplasm progression,,2021,Q3,3,F,2002.0,20210810.0,20200214,20210817,EXP,,CO-EMD SERONO-9144845,EMD SERONO INC,,46.0,YR,A,F,Y,67.0,KG,20210818.0,,CN,CO,CO,2021,Q3,Adult
174194273,17419427,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,12.0,IU,,,2021,Q3,Off label use,,2021,Q3,3,F,2002.0,20210810.0,20200214,20210817,EXP,,CO-EMD SERONO-9144845,EMD SERONO INC,,46.0,YR,A,F,Y,67.0,KG,20210818.0,,CN,CO,CO,2021,Q3,Adult
174194273,17419427,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,12.0,IU,,,2021,Q3,Pelvic pain,,2021,Q3,3,F,2002.0,20210810.0,20200214,20210817,EXP,,CO-EMD SERONO-9144845,EMD SERONO INC,,46.0,YR,A,F,Y,67.0,KG,20210818.0,,CN,CO,CO,2021,Q3,Adult
174194273,17419427,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,12.0,IU,,,2021,Q3,Thyroid disorder,,2021,Q3,3,F,2002.0,20210810.0,20200214,20210817,EXP,,CO-EMD SERONO-9144845,EMD SERONO INC,,46.0,YR,A,F,Y,67.0,KG,20210818.0,,CN,CO,CO,2021,Q3,Adult
174212864,17421286,14,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,15 UNITS IN NIGHT,,,,,,,,,,FORMULATION UNKNOWN,,2021,Q3,Amnesia,,2021,Q3,4,F,2015.0,20210819.0,20200214,20210827,EXP,,CO-ASTELLAS-2019US024573,ASTELLAS,,65.0,YR,,F,Y,,,20210827.0,,CN,CO,CO,2021,Q3,Elderly
174212864,17421286,14,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,15 UNITS IN NIGHT,,,,,,,,,,FORMULATION UNKNOWN,,2021,Q3,Anaemia,,2021,Q3,4,F,2015.0,20210819.0,20200214,20210827,EXP,,CO-ASTELLAS-2019US024573,ASTELLAS,,65.0,YR,,F,Y,,,20210827.0,,CN,CO,CO,2021,Q3,Elderly
174212864,17421286,14,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,15 UNITS IN NIGHT,,,,,,,,,,FORMULATION UNKNOWN,,2021,Q3,Blood creatinine increased,,2021,Q3,4,F,2015.0,20210819.0,20200214,20210827,EXP,,CO-ASTELLAS-2019US024573,ASTELLAS,,65.0,YR,,F,Y,,,20210827.0,,CN,CO,CO,2021,Q3,Elderly
174212864,17421286,14,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,15 UNITS IN NIGHT,,,,,,,,,,FORMULATION UNKNOWN,,2021,Q3,Blood glucose increased,,2021,Q3,4,F,2015.0,20210819.0,20200214,20210827,EXP,,CO-ASTELLAS-2019US024573,ASTELLAS,,65.0,YR,,F,Y,,,20210827.0,,CN,CO,CO,2021,Q3,Elderly
174212864,17421286,14,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,15 UNITS IN NIGHT,,,,,,,,,,FORMULATION UNKNOWN,,2021,Q3,Complications of transplanted kidney,,2021,Q3,4,F,2015.0,20210819.0,20200214,20210827,EXP,,CO-ASTELLAS-2019US024573,ASTELLAS,,65.0,YR,,F,Y,,,20210827.0,,CN,CO,CO,2021,Q3,Elderly
174212864,17421286,14,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,15 UNITS IN NIGHT,,,,,,,,,,FORMULATION UNKNOWN,,2021,Q3,Delirium,,2021,Q3,4,F,2015.0,20210819.0,20200214,20210827,EXP,,CO-ASTELLAS-2019US024573,ASTELLAS,,65.0,YR,,F,Y,,,20210827.0,,CN,CO,CO,2021,Q3,Elderly
174212864,17421286,14,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,15 UNITS IN NIGHT,,,,,,,,,,FORMULATION UNKNOWN,,2021,Q3,Diarrhoea,,2021,Q3,4,F,2015.0,20210819.0,20200214,20210827,EXP,,CO-ASTELLAS-2019US024573,ASTELLAS,,65.0,YR,,F,Y,,,20210827.0,,CN,CO,CO,2021,Q3,Elderly
174212864,17421286,14,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,15 UNITS IN NIGHT,,,,,,,,,,FORMULATION UNKNOWN,,2021,Q3,Drug ineffective,,2021,Q3,4,F,2015.0,20210819.0,20200214,20210827,EXP,,CO-ASTELLAS-2019US024573,ASTELLAS,,65.0,YR,,F,Y,,,20210827.0,,CN,CO,CO,2021,Q3,Elderly
174212864,17421286,14,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,15 UNITS IN NIGHT,,,,,,,,,,FORMULATION UNKNOWN,,2021,Q3,Hemiplegia,,2021,Q3,4,F,2015.0,20210819.0,20200214,20210827,EXP,,CO-ASTELLAS-2019US024573,ASTELLAS,,65.0,YR,,F,Y,,,20210827.0,,CN,CO,CO,2021,Q3,Elderly
174212864,17421286,14,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,15 UNITS IN NIGHT,,,,,,,,,,FORMULATION UNKNOWN,,2021,Q3,Human polyomavirus infection,,2021,Q3,4,F,2015.0,20210819.0,20200214,20210827,EXP,,CO-ASTELLAS-2019US024573,ASTELLAS,,65.0,YR,,F,Y,,,20210827.0,,CN,CO,CO,2021,Q3,Elderly
174212864,17421286,14,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,15 UNITS IN NIGHT,,,,,,,,,,FORMULATION UNKNOWN,,2021,Q3,Hypoacusis,,2021,Q3,4,F,2015.0,20210819.0,20200214,20210827,EXP,,CO-ASTELLAS-2019US024573,ASTELLAS,,65.0,YR,,F,Y,,,20210827.0,,CN,CO,CO,2021,Q3,Elderly
174212864,17421286,14,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,15 UNITS IN NIGHT,,,,,,,,,,FORMULATION UNKNOWN,,2021,Q3,Hypoaesthesia,,2021,Q3,4,F,2015.0,20210819.0,20200214,20210827,EXP,,CO-ASTELLAS-2019US024573,ASTELLAS,,65.0,YR,,F,Y,,,20210827.0,,CN,CO,CO,2021,Q3,Elderly
174212864,17421286,14,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,15 UNITS IN NIGHT,,,,,,,,,,FORMULATION UNKNOWN,,2021,Q3,Inflammation,,2021,Q3,4,F,2015.0,20210819.0,20200214,20210827,EXP,,CO-ASTELLAS-2019US024573,ASTELLAS,,65.0,YR,,F,Y,,,20210827.0,,CN,CO,CO,2021,Q3,Elderly
174212864,17421286,14,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,15 UNITS IN NIGHT,,,,,,,,,,FORMULATION UNKNOWN,,2021,Q3,Malnutrition,,2021,Q3,4,F,2015.0,20210819.0,20200214,20210827,EXP,,CO-ASTELLAS-2019US024573,ASTELLAS,,65.0,YR,,F,Y,,,20210827.0,,CN,CO,CO,2021,Q3,Elderly
174212864,17421286,14,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,15 UNITS IN NIGHT,,,,,,,,,,FORMULATION UNKNOWN,,2021,Q3,Mental impairment,,2021,Q3,4,F,2015.0,20210819.0,20200214,20210827,EXP,,CO-ASTELLAS-2019US024573,ASTELLAS,,65.0,YR,,F,Y,,,20210827.0,,CN,CO,CO,2021,Q3,Elderly
174212864,17421286,14,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,15 UNITS IN NIGHT,,,,,,,,,,FORMULATION UNKNOWN,,2021,Q3,Monoplegia,,2021,Q3,4,F,2015.0,20210819.0,20200214,20210827,EXP,,CO-ASTELLAS-2019US024573,ASTELLAS,,65.0,YR,,F,Y,,,20210827.0,,CN,CO,CO,2021,Q3,Elderly
174212864,17421286,14,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,15 UNITS IN NIGHT,,,,,,,,,,FORMULATION UNKNOWN,,2021,Q3,Pain,,2021,Q3,4,F,2015.0,20210819.0,20200214,20210827,EXP,,CO-ASTELLAS-2019US024573,ASTELLAS,,65.0,YR,,F,Y,,,20210827.0,,CN,CO,CO,2021,Q3,Elderly
174212864,17421286,14,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,15 UNITS IN NIGHT,,,,,,,,,,FORMULATION UNKNOWN,,2021,Q3,Renal disorder,,2021,Q3,4,F,2015.0,20210819.0,20200214,20210827,EXP,,CO-ASTELLAS-2019US024573,ASTELLAS,,65.0,YR,,F,Y,,,20210827.0,,CN,CO,CO,2021,Q3,Elderly
174212864,17421286,14,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,15 UNITS IN NIGHT,,,,,,,,,,FORMULATION UNKNOWN,,2021,Q3,Tremor,,2021,Q3,4,F,2015.0,20210819.0,20200214,20210827,EXP,,CO-ASTELLAS-2019US024573,ASTELLAS,,65.0,YR,,F,Y,,,20210827.0,,CN,CO,CO,2021,Q3,Elderly
174212864,17421286,14,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,15 UNITS IN NIGHT,,,,,,,,,,FORMULATION UNKNOWN,,2021,Q3,Viral infection,,2021,Q3,4,F,2015.0,20210819.0,20200214,20210827,EXP,,CO-ASTELLAS-2019US024573,ASTELLAS,,65.0,YR,,F,Y,,,20210827.0,,CN,CO,CO,2021,Q3,Elderly
174212864,17421286,14,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,15 UNITS IN NIGHT,,,,,,,,,,FORMULATION UNKNOWN,,2021,Q3,Vomiting,,2021,Q3,4,F,2015.0,20210819.0,20200214,20210827,EXP,,CO-ASTELLAS-2019US024573,ASTELLAS,,65.0,YR,,F,Y,,,20210827.0,,CN,CO,CO,2021,Q3,Elderly
174212864,17421286,14,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,15 UNITS IN NIGHT,,,,,,,,,,FORMULATION UNKNOWN,,2021,Q3,Weight increased,,2021,Q3,4,F,2015.0,20210819.0,20200214,20210827,EXP,,CO-ASTELLAS-2019US024573,ASTELLAS,,65.0,YR,,F,Y,,,20210827.0,,CN,CO,CO,2021,Q3,Elderly
1754535310,17545353,13,C,Insuline Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q3,Differentiation syndrome,,2021,Q3,10,F,20200216.0,20210709.0,20200316,20210713,EXP,,ES-CELGENEUS-ESP-20200301108,CELGENE,,80.0,YR,,F,Y,66.0,KG,20210713.0,,MD,ES,ES,2021,Q3,Elderly
1754535310,17545353,13,C,Insuline Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q3,Pneumonia,,2021,Q3,10,F,20200216.0,20210709.0,20200316,20210713,EXP,,ES-CELGENEUS-ESP-20200301108,CELGENE,,80.0,YR,,F,Y,66.0,KG,20210713.0,,MD,ES,ES,2021,Q3,Elderly
1754535310,17545353,13,C,Insuline Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q3,Renal failure,,2021,Q3,10,F,20200216.0,20210709.0,20200316,20210713,EXP,,ES-CELGENEUS-ESP-20200301108,CELGENE,,80.0,YR,,F,Y,66.0,KG,20210713.0,,MD,ES,ES,2021,Q3,Elderly
175852437,17585243,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Neutrophil count decreased,,2021,Q3,7,F,20200319.0,20210819.0,20200326,20210827,EXP,,NVSC2020DE080769,NOVARTIS,,66.0,YR,,M,Y,,,20210827.0,,HP,DE,DE,2021,Q3,Elderly
175852437,17585243,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,White blood cell count decreased,,2021,Q3,7,F,20200319.0,20210819.0,20200326,20210827,EXP,,NVSC2020DE080769,NOVARTIS,,66.0,YR,,M,Y,,,20210827.0,,HP,DE,DE,2021,Q3,Elderly
177002133,17700213,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,43 IU,,,Y,, 9F404A,,,43.0,IU,,,2021,Q3,Aphonia,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,43 IU,,,Y,, 9F404A,,,43.0,IU,,,2021,Q3,Blood glucose decreased,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,43 IU,,,Y,, 9F404A,,,43.0,IU,,,2021,Q3,Blood glucose increased,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,43 IU,,,Y,, 9F404A,,,43.0,IU,,,2021,Q3,Dizziness,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,43 IU,,,Y,, 9F404A,,,43.0,IU,,,2021,Q3,Drug ineffective,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,43 IU,,,Y,, 9F404A,,,43.0,IU,,,2021,Q3,Frequent bowel movements,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,43 IU,,,Y,, 9F404A,,,43.0,IU,,,2021,Q3,Gastrooesophageal reflux disease,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,43 IU,,,Y,, 9F404A,,,43.0,IU,,,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,43 IU,,,Y,, 9F404A,,,43.0,IU,,,2021,Q3,Hypoglycaemia,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,43 IU,,,Y,, 9F404A,,,43.0,IU,,,2021,Q3,Insomnia,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,43 IU,,,Y,, 9F404A,,,43.0,IU,,,2021,Q3,Insulin resistance,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,Y,, 0F517A,,,40.0,IU,,,2021,Q3,Aphonia,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,Y,, 0F517A,,,40.0,IU,,,2021,Q3,Blood glucose decreased,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,Y,, 0F517A,,,40.0,IU,,,2021,Q3,Blood glucose increased,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,Y,, 0F517A,,,40.0,IU,,,2021,Q3,Dizziness,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,Y,, 0F517A,,,40.0,IU,,,2021,Q3,Drug ineffective,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,Y,, 0F517A,,,40.0,IU,,,2021,Q3,Frequent bowel movements,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,Y,, 0F517A,,,40.0,IU,,,2021,Q3,Gastrooesophageal reflux disease,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,Y,, 0F517A,,,40.0,IU,,,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,Y,, 0F517A,,,40.0,IU,,,2021,Q3,Hypoglycaemia,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,Y,, 0F517A,,,40.0,IU,,,2021,Q3,Insomnia,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,Y,, 0F517A,,,40.0,IU,,,2021,Q3,Insulin resistance,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"38 INTERNATIONAL UNIT, DAILY",,,Y,,,,,38.0,IU,,QD,2021,Q3,Aphonia,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"38 INTERNATIONAL UNIT, DAILY",,,Y,,,,,38.0,IU,,QD,2021,Q3,Blood glucose decreased,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"38 INTERNATIONAL UNIT, DAILY",,,Y,,,,,38.0,IU,,QD,2021,Q3,Blood glucose increased,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"38 INTERNATIONAL UNIT, DAILY",,,Y,,,,,38.0,IU,,QD,2021,Q3,Dizziness,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"38 INTERNATIONAL UNIT, DAILY",,,Y,,,,,38.0,IU,,QD,2021,Q3,Drug ineffective,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"38 INTERNATIONAL UNIT, DAILY",,,Y,,,,,38.0,IU,,QD,2021,Q3,Frequent bowel movements,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"38 INTERNATIONAL UNIT, DAILY",,,Y,,,,,38.0,IU,,QD,2021,Q3,Gastrooesophageal reflux disease,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"38 INTERNATIONAL UNIT, DAILY",,,Y,,,,,38.0,IU,,QD,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"38 INTERNATIONAL UNIT, DAILY",,,Y,,,,,38.0,IU,,QD,2021,Q3,Hypoglycaemia,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"38 INTERNATIONAL UNIT, DAILY",,,Y,,,,,38.0,IU,,QD,2021,Q3,Insomnia,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"38 INTERNATIONAL UNIT, DAILY",,,Y,,,,,38.0,IU,,QD,2021,Q3,Insulin resistance,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 INTERNATIONAL UNIT, DAILY",,,Y,,,,,36.0,IU,,QD,2021,Q3,Aphonia,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 INTERNATIONAL UNIT, DAILY",,,Y,,,,,36.0,IU,,QD,2021,Q3,Blood glucose decreased,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 INTERNATIONAL UNIT, DAILY",,,Y,,,,,36.0,IU,,QD,2021,Q3,Blood glucose increased,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 INTERNATIONAL UNIT, DAILY",,,Y,,,,,36.0,IU,,QD,2021,Q3,Dizziness,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 INTERNATIONAL UNIT, DAILY",,,Y,,,,,36.0,IU,,QD,2021,Q3,Drug ineffective,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 INTERNATIONAL UNIT, DAILY",,,Y,,,,,36.0,IU,,QD,2021,Q3,Frequent bowel movements,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 INTERNATIONAL UNIT, DAILY",,,Y,,,,,36.0,IU,,QD,2021,Q3,Gastrooesophageal reflux disease,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 INTERNATIONAL UNIT, DAILY",,,Y,,,,,36.0,IU,,QD,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 INTERNATIONAL UNIT, DAILY",,,Y,,,,,36.0,IU,,QD,2021,Q3,Hypoglycaemia,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 INTERNATIONAL UNIT, DAILY",,,Y,,,,,36.0,IU,,QD,2021,Q3,Insomnia,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 INTERNATIONAL UNIT, DAILY",,,Y,,,,,36.0,IU,,QD,2021,Q3,Insulin resistance,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177488647,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Abdominal pain,,2021,Q3,7,F,20191117.0,20210715.0,20200506,20210722,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210722.0,,CN,NL,NL,2021,Q3,Adult
177488647,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Confusional state,,2021,Q3,7,F,20191117.0,20210715.0,20200506,20210722,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210722.0,,CN,NL,NL,2021,Q3,Adult
177488647,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Crying,,2021,Q3,7,F,20191117.0,20210715.0,20200506,20210722,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210722.0,,CN,NL,NL,2021,Q3,Adult
177488647,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Depressed mood,,2021,Q3,7,F,20191117.0,20210715.0,20200506,20210722,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210722.0,,CN,NL,NL,2021,Q3,Adult
177488647,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Diarrhoea,,2021,Q3,7,F,20191117.0,20210715.0,20200506,20210722,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210722.0,,CN,NL,NL,2021,Q3,Adult
177488647,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Dyskinesia,,2021,Q3,7,F,20191117.0,20210715.0,20200506,20210722,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210722.0,,CN,NL,NL,2021,Q3,Adult
177488647,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Fall,,2021,Q3,7,F,20191117.0,20210715.0,20200506,20210722,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210722.0,,CN,NL,NL,2021,Q3,Adult
177488647,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Gait disturbance,,2021,Q3,7,F,20191117.0,20210715.0,20200506,20210722,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210722.0,,CN,NL,NL,2021,Q3,Adult
177488647,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Impaired gastric emptying,,2021,Q3,7,F,20191117.0,20210715.0,20200506,20210722,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210722.0,,CN,NL,NL,2021,Q3,Adult
177488647,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Impaired quality of life,,2021,Q3,7,F,20191117.0,20210715.0,20200506,20210722,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210722.0,,CN,NL,NL,2021,Q3,Adult
177488647,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Limb discomfort,,2021,Q3,7,F,20191117.0,20210715.0,20200506,20210722,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210722.0,,CN,NL,NL,2021,Q3,Adult
177488647,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Limb operation,,2021,Q3,7,F,20191117.0,20210715.0,20200506,20210722,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210722.0,,CN,NL,NL,2021,Q3,Adult
177488647,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Living in residential institution,,2021,Q3,7,F,20191117.0,20210715.0,20200506,20210722,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210722.0,,CN,NL,NL,2021,Q3,Adult
177488647,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Malaise,,2021,Q3,7,F,20191117.0,20210715.0,20200506,20210722,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210722.0,,CN,NL,NL,2021,Q3,Adult
177488647,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Memory impairment,,2021,Q3,7,F,20191117.0,20210715.0,20200506,20210722,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210722.0,,CN,NL,NL,2021,Q3,Adult
177488647,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Mood altered,,2021,Q3,7,F,20191117.0,20210715.0,20200506,20210722,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210722.0,,CN,NL,NL,2021,Q3,Adult
177488647,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Muscle rigidity,,2021,Q3,7,F,20191117.0,20210715.0,20200506,20210722,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210722.0,,CN,NL,NL,2021,Q3,Adult
177488647,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Muscular weakness,,2021,Q3,7,F,20191117.0,20210715.0,20200506,20210722,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210722.0,,CN,NL,NL,2021,Q3,Adult
177488647,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Nausea,,2021,Q3,7,F,20191117.0,20210715.0,20200506,20210722,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210722.0,,CN,NL,NL,2021,Q3,Adult
177488647,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,On and off phenomenon,,2021,Q3,7,F,20191117.0,20210715.0,20200506,20210722,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210722.0,,CN,NL,NL,2021,Q3,Adult
177488647,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Pallor,,2021,Q3,7,F,20191117.0,20210715.0,20200506,20210722,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210722.0,,CN,NL,NL,2021,Q3,Adult
177488647,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Panic reaction,,2021,Q3,7,F,20191117.0,20210715.0,20200506,20210722,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210722.0,,CN,NL,NL,2021,Q3,Adult
177488647,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Procedural pain,,2021,Q3,7,F,20191117.0,20210715.0,20200506,20210722,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210722.0,,CN,NL,NL,2021,Q3,Adult
177488647,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Protein total increased,,2021,Q3,7,F,20191117.0,20210715.0,20200506,20210722,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210722.0,,CN,NL,NL,2021,Q3,Adult
177488647,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Psychiatric symptom,,2021,Q3,7,F,20191117.0,20210715.0,20200506,20210722,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210722.0,,CN,NL,NL,2021,Q3,Adult
177488647,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Serum ferritin increased,,2021,Q3,7,F,20191117.0,20210715.0,20200506,20210722,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210722.0,,CN,NL,NL,2021,Q3,Adult
177488647,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Sleep disorder due to a general medical condition,,2021,Q3,7,F,20191117.0,20210715.0,20200506,20210722,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210722.0,,CN,NL,NL,2021,Q3,Adult
177488647,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Stoma site erythema,,2021,Q3,7,F,20191117.0,20210715.0,20200506,20210722,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210722.0,,CN,NL,NL,2021,Q3,Adult
177488647,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Stoma site infection,,2021,Q3,7,F,20191117.0,20210715.0,20200506,20210722,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210722.0,,CN,NL,NL,2021,Q3,Adult
177488647,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Stress,,2021,Q3,7,F,20191117.0,20210715.0,20200506,20210722,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210722.0,,CN,NL,NL,2021,Q3,Adult
177488647,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Tension,,2021,Q3,7,F,20191117.0,20210715.0,20200506,20210722,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210722.0,,CN,NL,NL,2021,Q3,Adult
177488647,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Therapeutic response shortened,,2021,Q3,7,F,20191117.0,20210715.0,20200506,20210722,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210722.0,,CN,NL,NL,2021,Q3,Adult
177488647,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Transferrin decreased,,2021,Q3,7,F,20191117.0,20210715.0,20200506,20210722,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210722.0,,CN,NL,NL,2021,Q3,Adult
177488647,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Tremor,,2021,Q3,7,F,20191117.0,20210715.0,20200506,20210722,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210722.0,,CN,NL,NL,2021,Q3,Adult
177488647,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Urinary tract infection,,2021,Q3,7,F,20191117.0,20210715.0,20200506,20210722,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210722.0,,CN,NL,NL,2021,Q3,Adult
177488647,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Vomiting,,2021,Q3,7,F,20191117.0,20210715.0,20200506,20210722,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210722.0,,CN,NL,NL,2021,Q3,Adult
177488647,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Weight decreased,,2021,Q3,7,F,20191117.0,20210715.0,20200506,20210722,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20210722.0,,CN,NL,NL,2021,Q3,Adult
177688652,17768865,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q3,Acute kidney injury,,2021,Q3,2,F,,20210820.0,20200512,20210826,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02196,HIKMA,"SCHNEIR A, MASOM C. LITHIUM TOXICITY FROM THE ADDITION OF AN ACE INHIBITOR WITH AN UNEXPECTED TYPE I BRUGADA PATTERN ECG: CASE FILES OF THE MEDICAL TOXICOLOGY FELLOWSHIP AT THE UNIVERSITY OF CALIFORNIA, SAN DIEGO. JOURNAL OF MEDICAL TOXICOLOGY? DOI: 10.1007/S13181?020?00773?9. 2020?16(3):321?328. DOI:10.1007/S13181?020?00773?9",48.0,YR,,F,Y,,,20210826.0,,,COUNTRY NOT SPECIFIED,US,2021,Q3,Adult
177688652,17768865,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q3,Brugada syndrome,,2021,Q3,2,F,,20210820.0,20200512,20210826,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02196,HIKMA,"SCHNEIR A, MASOM C. LITHIUM TOXICITY FROM THE ADDITION OF AN ACE INHIBITOR WITH AN UNEXPECTED TYPE I BRUGADA PATTERN ECG: CASE FILES OF THE MEDICAL TOXICOLOGY FELLOWSHIP AT THE UNIVERSITY OF CALIFORNIA, SAN DIEGO. JOURNAL OF MEDICAL TOXICOLOGY? DOI: 10.1007/S13181?020?00773?9. 2020?16(3):321?328. DOI:10.1007/S13181?020?00773?9",48.0,YR,,F,Y,,,20210826.0,,,COUNTRY NOT SPECIFIED,US,2021,Q3,Adult
177688652,17768865,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q3,Confusional state,,2021,Q3,2,F,,20210820.0,20200512,20210826,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02196,HIKMA,"SCHNEIR A, MASOM C. LITHIUM TOXICITY FROM THE ADDITION OF AN ACE INHIBITOR WITH AN UNEXPECTED TYPE I BRUGADA PATTERN ECG: CASE FILES OF THE MEDICAL TOXICOLOGY FELLOWSHIP AT THE UNIVERSITY OF CALIFORNIA, SAN DIEGO. JOURNAL OF MEDICAL TOXICOLOGY? DOI: 10.1007/S13181?020?00773?9. 2020?16(3):321?328. DOI:10.1007/S13181?020?00773?9",48.0,YR,,F,Y,,,20210826.0,,,COUNTRY NOT SPECIFIED,US,2021,Q3,Adult
177688652,17768865,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q3,Coordination abnormal,,2021,Q3,2,F,,20210820.0,20200512,20210826,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02196,HIKMA,"SCHNEIR A, MASOM C. LITHIUM TOXICITY FROM THE ADDITION OF AN ACE INHIBITOR WITH AN UNEXPECTED TYPE I BRUGADA PATTERN ECG: CASE FILES OF THE MEDICAL TOXICOLOGY FELLOWSHIP AT THE UNIVERSITY OF CALIFORNIA, SAN DIEGO. JOURNAL OF MEDICAL TOXICOLOGY? DOI: 10.1007/S13181?020?00773?9. 2020?16(3):321?328. DOI:10.1007/S13181?020?00773?9",48.0,YR,,F,Y,,,20210826.0,,,COUNTRY NOT SPECIFIED,US,2021,Q3,Adult
177688652,17768865,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q3,Dizziness postural,,2021,Q3,2,F,,20210820.0,20200512,20210826,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02196,HIKMA,"SCHNEIR A, MASOM C. LITHIUM TOXICITY FROM THE ADDITION OF AN ACE INHIBITOR WITH AN UNEXPECTED TYPE I BRUGADA PATTERN ECG: CASE FILES OF THE MEDICAL TOXICOLOGY FELLOWSHIP AT THE UNIVERSITY OF CALIFORNIA, SAN DIEGO. JOURNAL OF MEDICAL TOXICOLOGY? DOI: 10.1007/S13181?020?00773?9. 2020?16(3):321?328. DOI:10.1007/S13181?020?00773?9",48.0,YR,,F,Y,,,20210826.0,,,COUNTRY NOT SPECIFIED,US,2021,Q3,Adult
177688652,17768865,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q3,Drug interaction,,2021,Q3,2,F,,20210820.0,20200512,20210826,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02196,HIKMA,"SCHNEIR A, MASOM C. LITHIUM TOXICITY FROM THE ADDITION OF AN ACE INHIBITOR WITH AN UNEXPECTED TYPE I BRUGADA PATTERN ECG: CASE FILES OF THE MEDICAL TOXICOLOGY FELLOWSHIP AT THE UNIVERSITY OF CALIFORNIA, SAN DIEGO. JOURNAL OF MEDICAL TOXICOLOGY? DOI: 10.1007/S13181?020?00773?9. 2020?16(3):321?328. DOI:10.1007/S13181?020?00773?9",48.0,YR,,F,Y,,,20210826.0,,,COUNTRY NOT SPECIFIED,US,2021,Q3,Adult
177688652,17768865,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q3,Fall,,2021,Q3,2,F,,20210820.0,20200512,20210826,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02196,HIKMA,"SCHNEIR A, MASOM C. LITHIUM TOXICITY FROM THE ADDITION OF AN ACE INHIBITOR WITH AN UNEXPECTED TYPE I BRUGADA PATTERN ECG: CASE FILES OF THE MEDICAL TOXICOLOGY FELLOWSHIP AT THE UNIVERSITY OF CALIFORNIA, SAN DIEGO. JOURNAL OF MEDICAL TOXICOLOGY? DOI: 10.1007/S13181?020?00773?9. 2020?16(3):321?328. DOI:10.1007/S13181?020?00773?9",48.0,YR,,F,Y,,,20210826.0,,,COUNTRY NOT SPECIFIED,US,2021,Q3,Adult
177688652,17768865,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q3,Hypovolaemia,,2021,Q3,2,F,,20210820.0,20200512,20210826,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02196,HIKMA,"SCHNEIR A, MASOM C. LITHIUM TOXICITY FROM THE ADDITION OF AN ACE INHIBITOR WITH AN UNEXPECTED TYPE I BRUGADA PATTERN ECG: CASE FILES OF THE MEDICAL TOXICOLOGY FELLOWSHIP AT THE UNIVERSITY OF CALIFORNIA, SAN DIEGO. JOURNAL OF MEDICAL TOXICOLOGY? DOI: 10.1007/S13181?020?00773?9. 2020?16(3):321?328. DOI:10.1007/S13181?020?00773?9",48.0,YR,,F,Y,,,20210826.0,,,COUNTRY NOT SPECIFIED,US,2021,Q3,Adult
177688652,17768865,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q3,Nausea,,2021,Q3,2,F,,20210820.0,20200512,20210826,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02196,HIKMA,"SCHNEIR A, MASOM C. LITHIUM TOXICITY FROM THE ADDITION OF AN ACE INHIBITOR WITH AN UNEXPECTED TYPE I BRUGADA PATTERN ECG: CASE FILES OF THE MEDICAL TOXICOLOGY FELLOWSHIP AT THE UNIVERSITY OF CALIFORNIA, SAN DIEGO. JOURNAL OF MEDICAL TOXICOLOGY? DOI: 10.1007/S13181?020?00773?9. 2020?16(3):321?328. DOI:10.1007/S13181?020?00773?9",48.0,YR,,F,Y,,,20210826.0,,,COUNTRY NOT SPECIFIED,US,2021,Q3,Adult
177688652,17768865,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q3,Toxicity to various agents,,2021,Q3,2,F,,20210820.0,20200512,20210826,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02196,HIKMA,"SCHNEIR A, MASOM C. LITHIUM TOXICITY FROM THE ADDITION OF AN ACE INHIBITOR WITH AN UNEXPECTED TYPE I BRUGADA PATTERN ECG: CASE FILES OF THE MEDICAL TOXICOLOGY FELLOWSHIP AT THE UNIVERSITY OF CALIFORNIA, SAN DIEGO. JOURNAL OF MEDICAL TOXICOLOGY? DOI: 10.1007/S13181?020?00773?9. 2020?16(3):321?328. DOI:10.1007/S13181?020?00773?9",48.0,YR,,F,Y,,,20210826.0,,,COUNTRY NOT SPECIFIED,US,2021,Q3,Adult
177688652,17768865,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q3,Tremor,,2021,Q3,2,F,,20210820.0,20200512,20210826,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02196,HIKMA,"SCHNEIR A, MASOM C. LITHIUM TOXICITY FROM THE ADDITION OF AN ACE INHIBITOR WITH AN UNEXPECTED TYPE I BRUGADA PATTERN ECG: CASE FILES OF THE MEDICAL TOXICOLOGY FELLOWSHIP AT THE UNIVERSITY OF CALIFORNIA, SAN DIEGO. JOURNAL OF MEDICAL TOXICOLOGY? DOI: 10.1007/S13181?020?00773?9. 2020?16(3):321?328. DOI:10.1007/S13181?020?00773?9",48.0,YR,,F,Y,,,20210826.0,,,COUNTRY NOT SPECIFIED,US,2021,Q3,Adult
177688652,17768865,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q3,Vomiting,,2021,Q3,2,F,,20210820.0,20200512,20210826,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02196,HIKMA,"SCHNEIR A, MASOM C. LITHIUM TOXICITY FROM THE ADDITION OF AN ACE INHIBITOR WITH AN UNEXPECTED TYPE I BRUGADA PATTERN ECG: CASE FILES OF THE MEDICAL TOXICOLOGY FELLOWSHIP AT THE UNIVERSITY OF CALIFORNIA, SAN DIEGO. JOURNAL OF MEDICAL TOXICOLOGY? DOI: 10.1007/S13181?020?00773?9. 2020?16(3):321?328. DOI:10.1007/S13181?020?00773?9",48.0,YR,,F,Y,,,20210826.0,,,COUNTRY NOT SPECIFIED,US,2021,Q3,Adult
179842646,17984264,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Acute respiratory distress syndrome,,2021,Q3,6,F,20200325.0,20210902.0,20200706,20210905,EXP,,DE-ABBVIE-20K-062-3470530-00,ABBVIE,,53.0,YR,,F,Y,,,20210905.0,,MD,DE,DE,2021,Q3,Adult
179842646,17984264,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,COVID-19 pneumonia,,2021,Q3,6,F,20200325.0,20210902.0,20200706,20210905,EXP,,DE-ABBVIE-20K-062-3470530-00,ABBVIE,,53.0,YR,,F,Y,,,20210905.0,,MD,DE,DE,2021,Q3,Adult
1799764612,17997646,120,C,Insuline glargine,INSULIN GLARGINE,1,Unknown,5 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q3,Cholecystitis acute,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
1799764612,17997646,120,C,Insuline glargine,INSULIN GLARGINE,1,Unknown,5 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q3,Peripheral ischaemia,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
1799764612,17997646,120,C,Insuline glargine,INSULIN GLARGINE,1,Unknown,5 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q3,Sepsis,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
1799764612,17997646,121,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,10 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q3,Cholecystitis acute,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
1799764612,17997646,121,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,10 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q3,Peripheral ischaemia,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
1799764612,17997646,121,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,10 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q3,Sepsis,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
1799764612,17997646,122,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,12 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q3,Cholecystitis acute,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
1799764612,17997646,122,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,12 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q3,Peripheral ischaemia,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
1799764612,17997646,122,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,12 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q3,Sepsis,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
1799764612,17997646,123,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,16 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q3,Cholecystitis acute,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
1799764612,17997646,123,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,16 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q3,Peripheral ischaemia,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
1799764612,17997646,123,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,16 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q3,Sepsis,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
1799764612,17997646,124,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,18 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q3,Cholecystitis acute,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
1799764612,17997646,124,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,18 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q3,Peripheral ischaemia,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
1799764612,17997646,124,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,18 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q3,Sepsis,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
1799764612,17997646,125,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,18 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q3,Cholecystitis acute,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
1799764612,17997646,125,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,18 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q3,Peripheral ischaemia,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
1799764612,17997646,125,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,18 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q3,Sepsis,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
180401413,18040141,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Confusional state,,2021,Q3,3,F,20210813.0,20210817.0,20200717,20210823,EXP,,US-BAUSCH-BL-2020-020194,BAUSCH AND LOMB,,70.0,YR,,M,Y,89.6,KG,20210823.0,,CN,US,US,2021,Q3,Elderly
180401413,18040141,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Dialysis,,2021,Q3,3,F,20210813.0,20210817.0,20200717,20210823,EXP,,US-BAUSCH-BL-2020-020194,BAUSCH AND LOMB,,70.0,YR,,M,Y,89.6,KG,20210823.0,,CN,US,US,2021,Q3,Elderly
180401413,18040141,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Disturbance in attention,,2021,Q3,3,F,20210813.0,20210817.0,20200717,20210823,EXP,,US-BAUSCH-BL-2020-020194,BAUSCH AND LOMB,,70.0,YR,,M,Y,89.6,KG,20210823.0,,CN,US,US,2021,Q3,Elderly
180401413,18040141,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Inability to afford medication,,2021,Q3,3,F,20210813.0,20210817.0,20200717,20210823,EXP,,US-BAUSCH-BL-2020-020194,BAUSCH AND LOMB,,70.0,YR,,M,Y,89.6,KG,20210823.0,,CN,US,US,2021,Q3,Elderly
180401413,18040141,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Liver dialysis,,2021,Q3,3,F,20210813.0,20210817.0,20200717,20210823,EXP,,US-BAUSCH-BL-2020-020194,BAUSCH AND LOMB,,70.0,YR,,M,Y,89.6,KG,20210823.0,,CN,US,US,2021,Q3,Elderly
180401413,18040141,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Therapy interrupted,,2021,Q3,3,F,20210813.0,20210817.0,20200717,20210823,EXP,,US-BAUSCH-BL-2020-020194,BAUSCH AND LOMB,,70.0,YR,,M,Y,89.6,KG,20210823.0,,CN,US,US,2021,Q3,Elderly
180666572,18066657,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (DOSE INCREASED),,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Blood creatine increased,,2021,Q3,2,F,2020.0,20210802.0,20200724,20210806,EXP,,ES-MYLANLABS-2020M1066083,MYLAN,,70.0,YR,,M,Y,88.0,KG,20210806.0,,CN,ES,ES,2021,Q3,Elderly
180666572,18066657,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (DOSE INCREASED),,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,2,F,2020.0,20210802.0,20200724,20210806,EXP,,ES-MYLANLABS-2020M1066083,MYLAN,,70.0,YR,,M,Y,88.0,KG,20210806.0,,CN,ES,ES,2021,Q3,Elderly
180666572,18066657,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (DOSE INCREASED),,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Feeling abnormal,,2021,Q3,2,F,2020.0,20210802.0,20200724,20210806,EXP,,ES-MYLANLABS-2020M1066083,MYLAN,,70.0,YR,,M,Y,88.0,KG,20210806.0,,CN,ES,ES,2021,Q3,Elderly
180666572,18066657,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (DOSE INCREASED),,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,General physical health deterioration,,2021,Q3,2,F,2020.0,20210802.0,20200724,20210806,EXP,,ES-MYLANLABS-2020M1066083,MYLAN,,70.0,YR,,M,Y,88.0,KG,20210806.0,,CN,ES,ES,2021,Q3,Elderly
180666572,18066657,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (DOSE INCREASED),,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Hyperglycaemia,,2021,Q3,2,F,2020.0,20210802.0,20200724,20210806,EXP,,ES-MYLANLABS-2020M1066083,MYLAN,,70.0,YR,,M,Y,88.0,KG,20210806.0,,CN,ES,ES,2021,Q3,Elderly
180666572,18066657,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (DOSE INCREASED),,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Hypoglycaemia,,2021,Q3,2,F,2020.0,20210802.0,20200724,20210806,EXP,,ES-MYLANLABS-2020M1066083,MYLAN,,70.0,YR,,M,Y,88.0,KG,20210806.0,,CN,ES,ES,2021,Q3,Elderly
180666572,18066657,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (DOSE INCREASED),,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Pollakiuria,,2021,Q3,2,F,2020.0,20210802.0,20200724,20210806,EXP,,ES-MYLANLABS-2020M1066083,MYLAN,,70.0,YR,,M,Y,88.0,KG,20210806.0,,CN,ES,ES,2021,Q3,Elderly
180666572,18066657,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 IU,,,,, 0F571A,,,38.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Blood creatine increased,,2021,Q3,2,F,2020.0,20210802.0,20200724,20210806,EXP,,ES-MYLANLABS-2020M1066083,MYLAN,,70.0,YR,,M,Y,88.0,KG,20210806.0,,CN,ES,ES,2021,Q3,Elderly
180666572,18066657,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 IU,,,,, 0F571A,,,38.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,2,F,2020.0,20210802.0,20200724,20210806,EXP,,ES-MYLANLABS-2020M1066083,MYLAN,,70.0,YR,,M,Y,88.0,KG,20210806.0,,CN,ES,ES,2021,Q3,Elderly
180666572,18066657,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 IU,,,,, 0F571A,,,38.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Feeling abnormal,,2021,Q3,2,F,2020.0,20210802.0,20200724,20210806,EXP,,ES-MYLANLABS-2020M1066083,MYLAN,,70.0,YR,,M,Y,88.0,KG,20210806.0,,CN,ES,ES,2021,Q3,Elderly
180666572,18066657,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 IU,,,,, 0F571A,,,38.0,IU,SOLUTION FOR INJECTION,,2021,Q3,General physical health deterioration,,2021,Q3,2,F,2020.0,20210802.0,20200724,20210806,EXP,,ES-MYLANLABS-2020M1066083,MYLAN,,70.0,YR,,M,Y,88.0,KG,20210806.0,,CN,ES,ES,2021,Q3,Elderly
180666572,18066657,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 IU,,,,, 0F571A,,,38.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hyperglycaemia,,2021,Q3,2,F,2020.0,20210802.0,20200724,20210806,EXP,,ES-MYLANLABS-2020M1066083,MYLAN,,70.0,YR,,M,Y,88.0,KG,20210806.0,,CN,ES,ES,2021,Q3,Elderly
180666572,18066657,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 IU,,,,, 0F571A,,,38.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hypoglycaemia,,2021,Q3,2,F,2020.0,20210802.0,20200724,20210806,EXP,,ES-MYLANLABS-2020M1066083,MYLAN,,70.0,YR,,M,Y,88.0,KG,20210806.0,,CN,ES,ES,2021,Q3,Elderly
180666572,18066657,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 IU,,,,, 0F571A,,,38.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Pollakiuria,,2021,Q3,2,F,2020.0,20210802.0,20200724,20210806,EXP,,ES-MYLANLABS-2020M1066083,MYLAN,,70.0,YR,,M,Y,88.0,KG,20210806.0,,CN,ES,ES,2021,Q3,Elderly
180666572,18066657,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, 0F571A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Blood creatine increased,,2021,Q3,2,F,2020.0,20210802.0,20200724,20210806,EXP,,ES-MYLANLABS-2020M1066083,MYLAN,,70.0,YR,,M,Y,88.0,KG,20210806.0,,CN,ES,ES,2021,Q3,Elderly
180666572,18066657,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, 0F571A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,2,F,2020.0,20210802.0,20200724,20210806,EXP,,ES-MYLANLABS-2020M1066083,MYLAN,,70.0,YR,,M,Y,88.0,KG,20210806.0,,CN,ES,ES,2021,Q3,Elderly
180666572,18066657,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, 0F571A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Feeling abnormal,,2021,Q3,2,F,2020.0,20210802.0,20200724,20210806,EXP,,ES-MYLANLABS-2020M1066083,MYLAN,,70.0,YR,,M,Y,88.0,KG,20210806.0,,CN,ES,ES,2021,Q3,Elderly
180666572,18066657,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, 0F571A,,,,,SOLUTION FOR INJECTION,,2021,Q3,General physical health deterioration,,2021,Q3,2,F,2020.0,20210802.0,20200724,20210806,EXP,,ES-MYLANLABS-2020M1066083,MYLAN,,70.0,YR,,M,Y,88.0,KG,20210806.0,,CN,ES,ES,2021,Q3,Elderly
180666572,18066657,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, 0F571A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Hyperglycaemia,,2021,Q3,2,F,2020.0,20210802.0,20200724,20210806,EXP,,ES-MYLANLABS-2020M1066083,MYLAN,,70.0,YR,,M,Y,88.0,KG,20210806.0,,CN,ES,ES,2021,Q3,Elderly
180666572,18066657,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, 0F571A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Hypoglycaemia,,2021,Q3,2,F,2020.0,20210802.0,20200724,20210806,EXP,,ES-MYLANLABS-2020M1066083,MYLAN,,70.0,YR,,M,Y,88.0,KG,20210806.0,,CN,ES,ES,2021,Q3,Elderly
180666572,18066657,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, 0F571A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Pollakiuria,,2021,Q3,2,F,2020.0,20210802.0,20200724,20210806,EXP,,ES-MYLANLABS-2020M1066083,MYLAN,,70.0,YR,,M,Y,88.0,KG,20210806.0,,CN,ES,ES,2021,Q3,Elderly
1809863111,18098631,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Acute kidney injury,,2021,Q3,11,F,20200226.0,20210802.0,20200731,20210809,EXP,,US-ROCHE-2650965,ROCHE,,66.0,YR,,F,Y,104.0,KG,20210809.0,,MD,US,US,2021,Q3,Elderly
1809863111,18098631,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Confusional state,,2021,Q3,11,F,20200226.0,20210802.0,20200731,20210809,EXP,,US-ROCHE-2650965,ROCHE,,66.0,YR,,F,Y,104.0,KG,20210809.0,,MD,US,US,2021,Q3,Elderly
1809863111,18098631,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Diarrhoea,,2021,Q3,11,F,20200226.0,20210802.0,20200731,20210809,EXP,,US-ROCHE-2650965,ROCHE,,66.0,YR,,F,Y,104.0,KG,20210809.0,,MD,US,US,2021,Q3,Elderly
1809863111,18098631,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Encephalitis,,2021,Q3,11,F,20200226.0,20210802.0,20200731,20210809,EXP,,US-ROCHE-2650965,ROCHE,,66.0,YR,,F,Y,104.0,KG,20210809.0,,MD,US,US,2021,Q3,Elderly
1809863111,18098631,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Haemorrhage intracranial,,2021,Q3,11,F,20200226.0,20210802.0,20200731,20210809,EXP,,US-ROCHE-2650965,ROCHE,,66.0,YR,,F,Y,104.0,KG,20210809.0,,MD,US,US,2021,Q3,Elderly
1809863111,18098631,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Hypoglycaemia,,2021,Q3,11,F,20200226.0,20210802.0,20200731,20210809,EXP,,US-ROCHE-2650965,ROCHE,,66.0,YR,,F,Y,104.0,KG,20210809.0,,MD,US,US,2021,Q3,Elderly
1809863111,18098631,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Hypotension,,2021,Q3,11,F,20200226.0,20210802.0,20200731,20210809,EXP,,US-ROCHE-2650965,ROCHE,,66.0,YR,,F,Y,104.0,KG,20210809.0,,MD,US,US,2021,Q3,Elderly
1809863111,18098631,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Lethargy,,2021,Q3,11,F,20200226.0,20210802.0,20200731,20210809,EXP,,US-ROCHE-2650965,ROCHE,,66.0,YR,,F,Y,104.0,KG,20210809.0,,MD,US,US,2021,Q3,Elderly
1809863111,18098631,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Seizure,,2021,Q3,11,F,20200226.0,20210802.0,20200731,20210809,EXP,,US-ROCHE-2650965,ROCHE,,66.0,YR,,F,Y,104.0,KG,20210809.0,,MD,US,US,2021,Q3,Elderly
1809863111,18098631,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Sepsis,,2021,Q3,11,F,20200226.0,20210802.0,20200731,20210809,EXP,,US-ROCHE-2650965,ROCHE,,66.0,YR,,F,Y,104.0,KG,20210809.0,,MD,US,US,2021,Q3,Elderly
1809863111,18098631,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Urinary tract infection,,2021,Q3,11,F,20200226.0,20210802.0,20200731,20210809,EXP,,US-ROCHE-2650965,ROCHE,,66.0,YR,,F,Y,104.0,KG,20210809.0,,MD,US,US,2021,Q3,Elderly
182008736,18200873,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q3,Diarrhoea,,2021,Q3,6,F,,20210714.0,20200827,20210722,EXP,,DE-AUROBINDO-AUR-APL-2020-044564,AUROBINDO,,26.0,YR,,M,Y,,,20210722.0,,HP,DE,DE,2021,Q3,Young Adult
182008736,18200873,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q3,Drug ineffective,,2021,Q3,6,F,,20210714.0,20200827,20210722,EXP,,DE-AUROBINDO-AUR-APL-2020-044564,AUROBINDO,,26.0,YR,,M,Y,,,20210722.0,,HP,DE,DE,2021,Q3,Young Adult
182008736,18200873,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q3,Gastrointestinal disorder,,2021,Q3,6,F,,20210714.0,20200827,20210722,EXP,,DE-AUROBINDO-AUR-APL-2020-044564,AUROBINDO,,26.0,YR,,M,Y,,,20210722.0,,HP,DE,DE,2021,Q3,Young Adult
182008736,18200873,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q3,Lymphoma,,2021,Q3,6,F,,20210714.0,20200827,20210722,EXP,,DE-AUROBINDO-AUR-APL-2020-044564,AUROBINDO,,26.0,YR,,M,Y,,,20210722.0,,HP,DE,DE,2021,Q3,Young Adult
182008736,18200873,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q3,Therapy non-responder,,2021,Q3,6,F,,20210714.0,20200827,20210722,EXP,,DE-AUROBINDO-AUR-APL-2020-044564,AUROBINDO,,26.0,YR,,M,Y,,,20210722.0,,HP,DE,DE,2021,Q3,Young Adult
182305572,18230557,9,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,28.0,IU,FORMULATION UNKNOWN,QD,2021,Q3,Asthenia,,2021,Q3,2,F,20170608.0,20210804.0,20200904,20210811,EXP,,ES-ASTELLAS-2020US030349,ASTELLAS,"BORRELL C R, BUENO V C, ALVAREZ R, HERRANZ A, SANJURJO M. ACUTE PANCREATITIS IN A PATIENT TREATED WITH IMATINIB AND GEFITINIB. JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2020",48.0,YR,,F,Y,,,20210811.0,,HP,ES,ES,2021,Q3,Adult
182305572,18230557,9,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,28.0,IU,FORMULATION UNKNOWN,QD,2021,Q3,Drug interaction,,2021,Q3,2,F,20170608.0,20210804.0,20200904,20210811,EXP,,ES-ASTELLAS-2020US030349,ASTELLAS,"BORRELL C R, BUENO V C, ALVAREZ R, HERRANZ A, SANJURJO M. ACUTE PANCREATITIS IN A PATIENT TREATED WITH IMATINIB AND GEFITINIB. JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2020",48.0,YR,,F,Y,,,20210811.0,,HP,ES,ES,2021,Q3,Adult
182305572,18230557,9,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,28.0,IU,FORMULATION UNKNOWN,QD,2021,Q3,Gastrointestinal toxicity,,2021,Q3,2,F,20170608.0,20210804.0,20200904,20210811,EXP,,ES-ASTELLAS-2020US030349,ASTELLAS,"BORRELL C R, BUENO V C, ALVAREZ R, HERRANZ A, SANJURJO M. ACUTE PANCREATITIS IN A PATIENT TREATED WITH IMATINIB AND GEFITINIB. JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2020",48.0,YR,,F,Y,,,20210811.0,,HP,ES,ES,2021,Q3,Adult
182305572,18230557,9,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,28.0,IU,FORMULATION UNKNOWN,QD,2021,Q3,Neoplasm progression,,2021,Q3,2,F,20170608.0,20210804.0,20200904,20210811,EXP,,ES-ASTELLAS-2020US030349,ASTELLAS,"BORRELL C R, BUENO V C, ALVAREZ R, HERRANZ A, SANJURJO M. ACUTE PANCREATITIS IN A PATIENT TREATED WITH IMATINIB AND GEFITINIB. JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2020",48.0,YR,,F,Y,,,20210811.0,,HP,ES,ES,2021,Q3,Adult
182305572,18230557,9,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,28.0,IU,FORMULATION UNKNOWN,QD,2021,Q3,Off label use,,2021,Q3,2,F,20170608.0,20210804.0,20200904,20210811,EXP,,ES-ASTELLAS-2020US030349,ASTELLAS,"BORRELL C R, BUENO V C, ALVAREZ R, HERRANZ A, SANJURJO M. ACUTE PANCREATITIS IN A PATIENT TREATED WITH IMATINIB AND GEFITINIB. JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2020",48.0,YR,,F,Y,,,20210811.0,,HP,ES,ES,2021,Q3,Adult
182305572,18230557,9,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,28.0,IU,FORMULATION UNKNOWN,QD,2021,Q3,Pancreatitis,,2021,Q3,2,F,20170608.0,20210804.0,20200904,20210811,EXP,,ES-ASTELLAS-2020US030349,ASTELLAS,"BORRELL C R, BUENO V C, ALVAREZ R, HERRANZ A, SANJURJO M. ACUTE PANCREATITIS IN A PATIENT TREATED WITH IMATINIB AND GEFITINIB. JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2020",48.0,YR,,F,Y,,,20210811.0,,HP,ES,ES,2021,Q3,Adult
182305572,18230557,9,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,28.0,IU,FORMULATION UNKNOWN,QD,2021,Q3,Pancreatitis acute,,2021,Q3,2,F,20170608.0,20210804.0,20200904,20210811,EXP,,ES-ASTELLAS-2020US030349,ASTELLAS,"BORRELL C R, BUENO V C, ALVAREZ R, HERRANZ A, SANJURJO M. ACUTE PANCREATITIS IN A PATIENT TREATED WITH IMATINIB AND GEFITINIB. JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2020",48.0,YR,,F,Y,,,20210811.0,,HP,ES,ES,2021,Q3,Adult
1823883613,18238836,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,28 IU (INTERNATIONAL UNIT) DAILY,,,D,,,,,28.0,IU,,QD,2021,Q3,Asthenia,,2021,Q3,13,F,20170608.0,20210920.0,20200907,20210923,EXP,,NVSC2020ES230163,NOVARTIS,,48.0,YR,,F,Y,,,20210924.0,,HP,ES,ES,2021,Q3,Adult
1823883613,18238836,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,28 IU (INTERNATIONAL UNIT) DAILY,,,D,,,,,28.0,IU,,QD,2021,Q3,Drug interaction,,2021,Q3,13,F,20170608.0,20210920.0,20200907,20210923,EXP,,NVSC2020ES230163,NOVARTIS,,48.0,YR,,F,Y,,,20210924.0,,HP,ES,ES,2021,Q3,Adult
1823883613,18238836,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,28 IU (INTERNATIONAL UNIT) DAILY,,,D,,,,,28.0,IU,,QD,2021,Q3,Gastrointestinal toxicity,,2021,Q3,13,F,20170608.0,20210920.0,20200907,20210923,EXP,,NVSC2020ES230163,NOVARTIS,,48.0,YR,,F,Y,,,20210924.0,,HP,ES,ES,2021,Q3,Adult
1823883613,18238836,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,28 IU (INTERNATIONAL UNIT) DAILY,,,D,,,,,28.0,IU,,QD,2021,Q3,Malignant neoplasm progression,,2021,Q3,13,F,20170608.0,20210920.0,20200907,20210923,EXP,,NVSC2020ES230163,NOVARTIS,,48.0,YR,,F,Y,,,20210924.0,,HP,ES,ES,2021,Q3,Adult
1823883613,18238836,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,28 IU (INTERNATIONAL UNIT) DAILY,,,D,,,,,28.0,IU,,QD,2021,Q3,Neoplasm progression,,2021,Q3,13,F,20170608.0,20210920.0,20200907,20210923,EXP,,NVSC2020ES230163,NOVARTIS,,48.0,YR,,F,Y,,,20210924.0,,HP,ES,ES,2021,Q3,Adult
1823883613,18238836,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,28 IU (INTERNATIONAL UNIT) DAILY,,,D,,,,,28.0,IU,,QD,2021,Q3,Pancreatitis,,2021,Q3,13,F,20170608.0,20210920.0,20200907,20210923,EXP,,NVSC2020ES230163,NOVARTIS,,48.0,YR,,F,Y,,,20210924.0,,HP,ES,ES,2021,Q3,Adult
1823883613,18238836,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,28 IU (INTERNATIONAL UNIT) DAILY,,,D,,,,,28.0,IU,,QD,2021,Q3,Pancreatitis acute,,2021,Q3,13,F,20170608.0,20210920.0,20200907,20210923,EXP,,NVSC2020ES230163,NOVARTIS,,48.0,YR,,F,Y,,,20210924.0,,HP,ES,ES,2021,Q3,Adult
182499184,18249918,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 IU, QD",,,U,,,,,28.0,IU,,QD,2021,Q3,Drug interaction,,2021,Q3,4,F,,20210802.0,20200910,20210804,EXP,,NVSC2020ES244286,NOVARTIS,"ESCUDERO?VILAPLANA V, COLLADO?BORRELL R, VILLANUEVA?BUENO C, ROSA A, HERRANZ A, SANJURJO M. ACUTE PANCREATITIS IN A PATIENT TREATED WITH IMATINIB AND GEFITINIB. J ONCOL PHARM PRACT. 2021?27(4):980?3",48.0,YR,,F,Y,,,20210804.0,,HP,ES,ES,2021,Q3,Adult
182499184,18249918,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 IU, QD",,,U,,,,,28.0,IU,,QD,2021,Q3,Pancreatitis acute,,2021,Q3,4,F,,20210802.0,20200910,20210804,EXP,,NVSC2020ES244286,NOVARTIS,"ESCUDERO?VILAPLANA V, COLLADO?BORRELL R, VILLANUEVA?BUENO C, ROSA A, HERRANZ A, SANJURJO M. ACUTE PANCREATITIS IN A PATIENT TREATED WITH IMATINIB AND GEFITINIB. J ONCOL PHARM PRACT. 2021?27(4):980?3",48.0,YR,,F,Y,,,20210804.0,,HP,ES,ES,2021,Q3,Adult
1827209913,18272099,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,1.0,IU,INJECTION,,2021,Q3,Hypertensive emergency,,2021,Q3,13,F,20200830.0,20210922.0,20200916,20210928,EXP,,US-ASTELLAS-2020US031974,ASTELLAS,,66.0,YR,,M,Y,116.0,KG,20210928.0,,MD,US,US,2021,Q3,Elderly
182843815,18284381,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q3,Diabetes mellitus inadequate control,,2021,Q3,5,F,,20210715.0,20200918,20210716,EXP,,NVSC2020DE247971,NOVARTIS,,26.0,YR,,M,Y,,,20210716.0,,HP,DE,DE,2021,Q3,Young Adult
182843815,18284381,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q3,Diarrhoea,,2021,Q3,5,F,,20210715.0,20200918,20210716,EXP,,NVSC2020DE247971,NOVARTIS,,26.0,YR,,M,Y,,,20210716.0,,HP,DE,DE,2021,Q3,Young Adult
182843815,18284381,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q3,Drug ineffective,,2021,Q3,5,F,,20210715.0,20200918,20210716,EXP,,NVSC2020DE247971,NOVARTIS,,26.0,YR,,M,Y,,,20210716.0,,HP,DE,DE,2021,Q3,Young Adult
182843815,18284381,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q3,Gastrointestinal disorder,,2021,Q3,5,F,,20210715.0,20200918,20210716,EXP,,NVSC2020DE247971,NOVARTIS,,26.0,YR,,M,Y,,,20210716.0,,HP,DE,DE,2021,Q3,Young Adult
182843815,18284381,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q3,Lymphoma,,2021,Q3,5,F,,20210715.0,20200918,20210716,EXP,,NVSC2020DE247971,NOVARTIS,,26.0,YR,,M,Y,,,20210716.0,,HP,DE,DE,2021,Q3,Young Adult
182843815,18284381,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q3,Therapy non-responder,,2021,Q3,5,F,,20210715.0,20200918,20210716,EXP,,NVSC2020DE247971,NOVARTIS,,26.0,YR,,M,Y,,,20210716.0,,HP,DE,DE,2021,Q3,Young Adult
182967233,18296723,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"24 IU, 1X/DAY 0?1?0?0 INJECTION / INFUSION SOLUTION",,,,,,,,24.0,IU,,QD,2021,Q3,Abdominal pain upper,,2021,Q3,3,F,,20210628.0,20200922,20210709,EXP,DE-ADRED-04739-03,DE-PFIZER INC-2020362521,PFIZER,,64.0,YR,,F,Y,,,20210709.0,,MD,DE,DE,2021,Q3,Adult
182967233,18296723,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"24 IU, 1X/DAY 0?1?0?0 INJECTION / INFUSION SOLUTION",,,,,,,,24.0,IU,,QD,2021,Q3,Anaemia macrocytic,,2021,Q3,3,F,,20210628.0,20200922,20210709,EXP,DE-ADRED-04739-03,DE-PFIZER INC-2020362521,PFIZER,,64.0,YR,,F,Y,,,20210709.0,,MD,DE,DE,2021,Q3,Adult
182967233,18296723,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"24 IU, 1X/DAY 0?1?0?0 INJECTION / INFUSION SOLUTION",,,,,,,,24.0,IU,,QD,2021,Q3,Circulatory collapse,,2021,Q3,3,F,,20210628.0,20200922,20210709,EXP,DE-ADRED-04739-03,DE-PFIZER INC-2020362521,PFIZER,,64.0,YR,,F,Y,,,20210709.0,,MD,DE,DE,2021,Q3,Adult
182967233,18296723,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"24 IU, 1X/DAY 0?1?0?0 INJECTION / INFUSION SOLUTION",,,,,,,,24.0,IU,,QD,2021,Q3,Contusion,,2021,Q3,3,F,,20210628.0,20200922,20210709,EXP,DE-ADRED-04739-03,DE-PFIZER INC-2020362521,PFIZER,,64.0,YR,,F,Y,,,20210709.0,,MD,DE,DE,2021,Q3,Adult
182967233,18296723,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"24 IU, 1X/DAY 0?1?0?0 INJECTION / INFUSION SOLUTION",,,,,,,,24.0,IU,,QD,2021,Q3,Dizziness,,2021,Q3,3,F,,20210628.0,20200922,20210709,EXP,DE-ADRED-04739-03,DE-PFIZER INC-2020362521,PFIZER,,64.0,YR,,F,Y,,,20210709.0,,MD,DE,DE,2021,Q3,Adult
182967233,18296723,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"24 IU, 1X/DAY 0?1?0?0 INJECTION / INFUSION SOLUTION",,,,,,,,24.0,IU,,QD,2021,Q3,Hepatic failure,,2021,Q3,3,F,,20210628.0,20200922,20210709,EXP,DE-ADRED-04739-03,DE-PFIZER INC-2020362521,PFIZER,,64.0,YR,,F,Y,,,20210709.0,,MD,DE,DE,2021,Q3,Adult
182967233,18296723,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"24 IU, 1X/DAY 0?1?0?0 INJECTION / INFUSION SOLUTION",,,,,,,,24.0,IU,,QD,2021,Q3,Liver function test increased,,2021,Q3,3,F,,20210628.0,20200922,20210709,EXP,DE-ADRED-04739-03,DE-PFIZER INC-2020362521,PFIZER,,64.0,YR,,F,Y,,,20210709.0,,MD,DE,DE,2021,Q3,Adult
182967233,18296723,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"24 IU, 1X/DAY 0?1?0?0 INJECTION / INFUSION SOLUTION",,,,,,,,24.0,IU,,QD,2021,Q3,Medication error,,2021,Q3,3,F,,20210628.0,20200922,20210709,EXP,DE-ADRED-04739-03,DE-PFIZER INC-2020362521,PFIZER,,64.0,YR,,F,Y,,,20210709.0,,MD,DE,DE,2021,Q3,Adult
182967233,18296723,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"24 IU, 1X/DAY 0?1?0?0 INJECTION / INFUSION SOLUTION",,,,,,,,24.0,IU,,QD,2021,Q3,White blood cell count decreased,,2021,Q3,3,F,,20210628.0,20200922,20210709,EXP,DE-ADRED-04739-03,DE-PFIZER INC-2020362521,PFIZER,,64.0,YR,,F,Y,,,20210709.0,,MD,DE,DE,2021,Q3,Adult
182995586,18299558,49,C,INSULIN GLARGINE BS INJECTION,,2,,"BEFORE BEDTIME 30 IU, QD",,,,,,,,30.0,IU,,QD,2021,Q3,Angina unstable,,2021,Q3,6,F,20200411.0,20210922.0,20200923,20210927,EXP,,JP-GLAXOSMITHKLINE-JP2020JPN188231,GLAXOSMITHKLINE,,47.0,YR,,M,Y,85.0,KG,20210927.0,,CN,JP,JP,2021,Q3,Adult
182995586,18299558,49,C,INSULIN GLARGINE BS INJECTION,,2,,"BEFORE BEDTIME 30 IU, QD",,,,,,,,30.0,IU,,QD,2021,Q3,Gastroenteritis,,2021,Q3,6,F,20200411.0,20210922.0,20200923,20210927,EXP,,JP-GLAXOSMITHKLINE-JP2020JPN188231,GLAXOSMITHKLINE,,47.0,YR,,M,Y,85.0,KG,20210927.0,,CN,JP,JP,2021,Q3,Adult
182995586,18299558,49,C,INSULIN GLARGINE BS INJECTION,,2,,"BEFORE BEDTIME 30 IU, QD",,,,,,,,30.0,IU,,QD,2021,Q3,Off label use,,2021,Q3,6,F,20200411.0,20210922.0,20200923,20210927,EXP,,JP-GLAXOSMITHKLINE-JP2020JPN188231,GLAXOSMITHKLINE,,47.0,YR,,M,Y,85.0,KG,20210927.0,,CN,JP,JP,2021,Q3,Adult
182995586,18299558,49,C,INSULIN GLARGINE BS INJECTION,,2,,"BEFORE BEDTIME 30 IU, QD",,,,,,,,30.0,IU,,QD,2021,Q3,Prescribed underdose,,2021,Q3,6,F,20200411.0,20210922.0,20200923,20210927,EXP,,JP-GLAXOSMITHKLINE-JP2020JPN188231,GLAXOSMITHKLINE,,47.0,YR,,M,Y,85.0,KG,20210927.0,,CN,JP,JP,2021,Q3,Adult
183009493,18300949,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 IU, QD (0?1?0?0), INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,24.0,IU,,QD,2021,Q3,Abdominal pain upper,,2021,Q3,3,F,,20210628.0,20200923,20210712,EXP,,NVSC2020DE253542,NOVARTIS,,64.0,YR,,F,Y,,,20210712.0,,HP,DE,DE,2021,Q3,Adult
183009493,18300949,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 IU, QD (0?1?0?0), INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,24.0,IU,,QD,2021,Q3,Anaemia macrocytic,,2021,Q3,3,F,,20210628.0,20200923,20210712,EXP,,NVSC2020DE253542,NOVARTIS,,64.0,YR,,F,Y,,,20210712.0,,HP,DE,DE,2021,Q3,Adult
183009493,18300949,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 IU, QD (0?1?0?0), INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,24.0,IU,,QD,2021,Q3,Circulatory collapse,,2021,Q3,3,F,,20210628.0,20200923,20210712,EXP,,NVSC2020DE253542,NOVARTIS,,64.0,YR,,F,Y,,,20210712.0,,HP,DE,DE,2021,Q3,Adult
183009493,18300949,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 IU, QD (0?1?0?0), INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,24.0,IU,,QD,2021,Q3,Contusion,,2021,Q3,3,F,,20210628.0,20200923,20210712,EXP,,NVSC2020DE253542,NOVARTIS,,64.0,YR,,F,Y,,,20210712.0,,HP,DE,DE,2021,Q3,Adult
183009493,18300949,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 IU, QD (0?1?0?0), INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,24.0,IU,,QD,2021,Q3,Dizziness,,2021,Q3,3,F,,20210628.0,20200923,20210712,EXP,,NVSC2020DE253542,NOVARTIS,,64.0,YR,,F,Y,,,20210712.0,,HP,DE,DE,2021,Q3,Adult
183009493,18300949,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 IU, QD (0?1?0?0), INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,24.0,IU,,QD,2021,Q3,Hepatic failure,,2021,Q3,3,F,,20210628.0,20200923,20210712,EXP,,NVSC2020DE253542,NOVARTIS,,64.0,YR,,F,Y,,,20210712.0,,HP,DE,DE,2021,Q3,Adult
183009493,18300949,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 IU, QD (0?1?0?0), INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,24.0,IU,,QD,2021,Q3,Liver function test increased,,2021,Q3,3,F,,20210628.0,20200923,20210712,EXP,,NVSC2020DE253542,NOVARTIS,,64.0,YR,,F,Y,,,20210712.0,,HP,DE,DE,2021,Q3,Adult
183009493,18300949,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 IU, QD (0?1?0?0), INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,24.0,IU,,QD,2021,Q3,Medication error,,2021,Q3,3,F,,20210628.0,20200923,20210712,EXP,,NVSC2020DE253542,NOVARTIS,,64.0,YR,,F,Y,,,20210712.0,,HP,DE,DE,2021,Q3,Adult
183009493,18300949,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 IU, QD (0?1?0?0), INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,24.0,IU,,QD,2021,Q3,White blood cell count decreased,,2021,Q3,3,F,,20210628.0,20200923,20210712,EXP,,NVSC2020DE253542,NOVARTIS,,64.0,YR,,F,Y,,,20210712.0,,HP,DE,DE,2021,Q3,Adult
183105173,18310517,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 UNK, QD(14 UNITS QN)",,,U,,,,,,,INJECTION,QD,2021,Q3,Cardiac dysfunction,,2021,Q3,3,F,20200729.0,20210630.0,20200924,20210706,EXP,,NVSC2020CN259632,NOVARTIS,,48.0,YR,,M,Y,72.0,KG,20210707.0,,MD,CN,CN,2021,Q3,Adult
183105173,18310517,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 UNK, QD(14 UNITS QN)",,,U,,,,,,,INJECTION,QD,2021,Q3,Chest discomfort,,2021,Q3,3,F,20200729.0,20210630.0,20200924,20210706,EXP,,NVSC2020CN259632,NOVARTIS,,48.0,YR,,M,Y,72.0,KG,20210707.0,,MD,CN,CN,2021,Q3,Adult
183105173,18310517,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 UNK, QD(14 UNITS QN)",,,U,,,,,,,INJECTION,QD,2021,Q3,Coronary artery disease,,2021,Q3,3,F,20200729.0,20210630.0,20200924,20210706,EXP,,NVSC2020CN259632,NOVARTIS,,48.0,YR,,M,Y,72.0,KG,20210707.0,,MD,CN,CN,2021,Q3,Adult
183105173,18310517,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 UNK, QD(14 UNITS QN)",,,U,,,,,,,INJECTION,QD,2021,Q3,Death,,2021,Q3,3,F,20200729.0,20210630.0,20200924,20210706,EXP,,NVSC2020CN259632,NOVARTIS,,48.0,YR,,M,Y,72.0,KG,20210707.0,,MD,CN,CN,2021,Q3,Adult
183105173,18310517,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 UNK, QD(14 UNITS QN)",,,U,,,,,,,INJECTION,QD,2021,Q3,Discomfort,,2021,Q3,3,F,20200729.0,20210630.0,20200924,20210706,EXP,,NVSC2020CN259632,NOVARTIS,,48.0,YR,,M,Y,72.0,KG,20210707.0,,MD,CN,CN,2021,Q3,Adult
183105173,18310517,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 UNK, QD(14 UNITS QN)",,,U,,,,,,,INJECTION,QD,2021,Q3,Myocardial infarction,,2021,Q3,3,F,20200729.0,20210630.0,20200924,20210706,EXP,,NVSC2020CN259632,NOVARTIS,,48.0,YR,,M,Y,72.0,KG,20210707.0,,MD,CN,CN,2021,Q3,Adult
183112513,18311251,6,C,insulin glargine,INSULIN GLARGINE,1,Unknown,"28 U, DAILY",,,,,,,,,,,,2021,Q3,Drug interaction,,2021,Q3,3,F,,20210723.0,20200925,20210806,EXP,,ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-261402,RANBAXY,"ESCUDERO?VILAPLANA V, COLLADO?BORRELL R, VILLANUEVA?BUENO C, ROSA A, HERRANZ A, SANJURJO M. ACUTE PANCREATITIS IN A PATIENT TREATED WITH IMATINIB AND GEFITINIB. J ONCOL PHARM PRACT. 2020?AUG 16:NO PAGINATION",48.0,YR,,F,Y,,,20210806.0,,HP,ES,ES,2021,Q3,Adult
183112513,18311251,6,C,insulin glargine,INSULIN GLARGINE,1,Unknown,"28 U, DAILY",,,,,,,,,,,,2021,Q3,Pancreatitis acute,,2021,Q3,3,F,,20210723.0,20200925,20210806,EXP,,ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-261402,RANBAXY,"ESCUDERO?VILAPLANA V, COLLADO?BORRELL R, VILLANUEVA?BUENO C, ROSA A, HERRANZ A, SANJURJO M. ACUTE PANCREATITIS IN A PATIENT TREATED WITH IMATINIB AND GEFITINIB. J ONCOL PHARM PRACT. 2020?AUG 16:NO PAGINATION",48.0,YR,,F,Y,,,20210806.0,,HP,ES,ES,2021,Q3,Adult
183303776,18330377,16,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,INCONNUE,,,,,,,,,,,,2021,Q3,Breath sounds,,2021,Q3,6,F,202008.0,20210823.0,20200930,20210827,EXP,FR-AFSSAPS-AN20201025,FR-MYLANLABS-2020M1081955,MYLAN,,79.0,YR,,F,Y,72.0,KG,20210827.0,,MD,FR,FR,2021,Q3,Elderly
183303776,18330377,16,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,INCONNUE,,,,,,,,,,,,2021,Q3,Cheilitis,,2021,Q3,6,F,202008.0,20210823.0,20200930,20210827,EXP,FR-AFSSAPS-AN20201025,FR-MYLANLABS-2020M1081955,MYLAN,,79.0,YR,,F,Y,72.0,KG,20210827.0,,MD,FR,FR,2021,Q3,Elderly
183303776,18330377,16,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,INCONNUE,,,,,,,,,,,,2021,Q3,Drug reaction with eosinophilia and systemic symptoms,,2021,Q3,6,F,202008.0,20210823.0,20200930,20210827,EXP,FR-AFSSAPS-AN20201025,FR-MYLANLABS-2020M1081955,MYLAN,,79.0,YR,,F,Y,72.0,KG,20210827.0,,MD,FR,FR,2021,Q3,Elderly
183303776,18330377,16,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,INCONNUE,,,,,,,,,,,,2021,Q3,Eosinophilia,,2021,Q3,6,F,202008.0,20210823.0,20200930,20210827,EXP,FR-AFSSAPS-AN20201025,FR-MYLANLABS-2020M1081955,MYLAN,,79.0,YR,,F,Y,72.0,KG,20210827.0,,MD,FR,FR,2021,Q3,Elderly
183303776,18330377,16,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,INCONNUE,,,,,,,,,,,,2021,Q3,Glossitis,,2021,Q3,6,F,202008.0,20210823.0,20200930,20210827,EXP,FR-AFSSAPS-AN20201025,FR-MYLANLABS-2020M1081955,MYLAN,,79.0,YR,,F,Y,72.0,KG,20210827.0,,MD,FR,FR,2021,Q3,Elderly
183303776,18330377,16,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,INCONNUE,,,,,,,,,,,,2021,Q3,Hepatic cirrhosis,,2021,Q3,6,F,202008.0,20210823.0,20200930,20210827,EXP,FR-AFSSAPS-AN20201025,FR-MYLANLABS-2020M1081955,MYLAN,,79.0,YR,,F,Y,72.0,KG,20210827.0,,MD,FR,FR,2021,Q3,Elderly
183303776,18330377,16,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,INCONNUE,,,,,,,,,,,,2021,Q3,Hepatic cytolysis,,2021,Q3,6,F,202008.0,20210823.0,20200930,20210827,EXP,FR-AFSSAPS-AN20201025,FR-MYLANLABS-2020M1081955,MYLAN,,79.0,YR,,F,Y,72.0,KG,20210827.0,,MD,FR,FR,2021,Q3,Elderly
183303776,18330377,16,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,INCONNUE,,,,,,,,,,,,2021,Q3,Hypercreatininaemia,,2021,Q3,6,F,202008.0,20210823.0,20200930,20210827,EXP,FR-AFSSAPS-AN20201025,FR-MYLANLABS-2020M1081955,MYLAN,,79.0,YR,,F,Y,72.0,KG,20210827.0,,MD,FR,FR,2021,Q3,Elderly
183303776,18330377,16,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,INCONNUE,,,,,,,,,,,,2021,Q3,Intra-abdominal fluid collection,,2021,Q3,6,F,202008.0,20210823.0,20200930,20210827,EXP,FR-AFSSAPS-AN20201025,FR-MYLANLABS-2020M1081955,MYLAN,,79.0,YR,,F,Y,72.0,KG,20210827.0,,MD,FR,FR,2021,Q3,Elderly
183303776,18330377,16,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,INCONNUE,,,,,,,,,,,,2021,Q3,Oedema peripheral,,2021,Q3,6,F,202008.0,20210823.0,20200930,20210827,EXP,FR-AFSSAPS-AN20201025,FR-MYLANLABS-2020M1081955,MYLAN,,79.0,YR,,F,Y,72.0,KG,20210827.0,,MD,FR,FR,2021,Q3,Elderly
183303776,18330377,16,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,INCONNUE,,,,,,,,,,,,2021,Q3,Rash maculo-papular,,2021,Q3,6,F,202008.0,20210823.0,20200930,20210827,EXP,FR-AFSSAPS-AN20201025,FR-MYLANLABS-2020M1081955,MYLAN,,79.0,YR,,F,Y,72.0,KG,20210827.0,,MD,FR,FR,2021,Q3,Elderly
183303776,18330377,16,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,INCONNUE,,,,,,,,,,,,2021,Q3,Splenomegaly,,2021,Q3,6,F,202008.0,20210823.0,20200930,20210827,EXP,FR-AFSSAPS-AN20201025,FR-MYLANLABS-2020M1081955,MYLAN,,79.0,YR,,F,Y,72.0,KG,20210827.0,,MD,FR,FR,2021,Q3,Elderly
183364823,18336482,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q3,Drug ineffective,,2021,Q3,3,F,,20210716.0,20201001,20210726,EXP,DE-EMA-DD-20200915-PRABHAKAR_D-181703,DE-EMD SERONO-E2B_90080394,EMD SERONO INC,"DONATH H, HESS U, KIESLICH M, THEIS M, OHLENSCHLAGER U, SCHUBERT R, WOELKE S, ZIELEN S. DIABETES IN PATIENTS WITH ATAXIA TELANGIECTASIA: A NATIONAL COHORT STUDY. FRONT PEDIATR. 2020?8:317. DOI:10.3389/FPED.2020.00317.",26.0,YR,A,M,Y,,,20210726.0,,MD,DE,DE,2021,Q3,Young Adult
183364823,18336482,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q3,Gastrointestinal disorder,,2021,Q3,3,F,,20210716.0,20201001,20210726,EXP,DE-EMA-DD-20200915-PRABHAKAR_D-181703,DE-EMD SERONO-E2B_90080394,EMD SERONO INC,"DONATH H, HESS U, KIESLICH M, THEIS M, OHLENSCHLAGER U, SCHUBERT R, WOELKE S, ZIELEN S. DIABETES IN PATIENTS WITH ATAXIA TELANGIECTASIA: A NATIONAL COHORT STUDY. FRONT PEDIATR. 2020?8:317. DOI:10.3389/FPED.2020.00317.",26.0,YR,A,M,Y,,,20210726.0,,MD,DE,DE,2021,Q3,Young Adult
183364823,18336482,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q3,Lymphoma,,2021,Q3,3,F,,20210716.0,20201001,20210726,EXP,DE-EMA-DD-20200915-PRABHAKAR_D-181703,DE-EMD SERONO-E2B_90080394,EMD SERONO INC,"DONATH H, HESS U, KIESLICH M, THEIS M, OHLENSCHLAGER U, SCHUBERT R, WOELKE S, ZIELEN S. DIABETES IN PATIENTS WITH ATAXIA TELANGIECTASIA: A NATIONAL COHORT STUDY. FRONT PEDIATR. 2020?8:317. DOI:10.3389/FPED.2020.00317.",26.0,YR,A,M,Y,,,20210726.0,,MD,DE,DE,2021,Q3,Young Adult
183364823,18336482,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q3,Therapy non-responder,,2021,Q3,3,F,,20210716.0,20201001,20210726,EXP,DE-EMA-DD-20200915-PRABHAKAR_D-181703,DE-EMD SERONO-E2B_90080394,EMD SERONO INC,"DONATH H, HESS U, KIESLICH M, THEIS M, OHLENSCHLAGER U, SCHUBERT R, WOELKE S, ZIELEN S. DIABETES IN PATIENTS WITH ATAXIA TELANGIECTASIA: A NATIONAL COHORT STUDY. FRONT PEDIATR. 2020?8:317. DOI:10.3389/FPED.2020.00317.",26.0,YR,A,M,Y,,,20210726.0,,MD,DE,DE,2021,Q3,Young Adult
183373904,18337390,51,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Abscess limb,,2021,Q3,4,F,20171222.0,20210629.0,20201002,20210705,EXP,,US-ASTRAZENECA-2020SF25300,ASTRAZENECA,,18493.0,DY,,F,Y,93.4,KG,20210705.0,,,US,US,2021,Q3,Elderly
183373904,18337390,51,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Erythema,,2021,Q3,4,F,20171222.0,20210629.0,20201002,20210705,EXP,,US-ASTRAZENECA-2020SF25300,ASTRAZENECA,,18493.0,DY,,F,Y,93.4,KG,20210705.0,,,US,US,2021,Q3,Elderly
183373904,18337390,51,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Fournier's gangrene,,2021,Q3,4,F,20171222.0,20210629.0,20201002,20210705,EXP,,US-ASTRAZENECA-2020SF25300,ASTRAZENECA,,18493.0,DY,,F,Y,93.4,KG,20210705.0,,,US,US,2021,Q3,Elderly
183373904,18337390,51,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Groin abscess,,2021,Q3,4,F,20171222.0,20210629.0,20201002,20210705,EXP,,US-ASTRAZENECA-2020SF25300,ASTRAZENECA,,18493.0,DY,,F,Y,93.4,KG,20210705.0,,,US,US,2021,Q3,Elderly
183373904,18337390,51,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Necrotising soft tissue infection,,2021,Q3,4,F,20171222.0,20210629.0,20201002,20210705,EXP,,US-ASTRAZENECA-2020SF25300,ASTRAZENECA,,18493.0,DY,,F,Y,93.4,KG,20210705.0,,,US,US,2021,Q3,Elderly
183373904,18337390,51,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Sepsis,,2021,Q3,4,F,20171222.0,20210629.0,20201002,20210705,EXP,,US-ASTRAZENECA-2020SF25300,ASTRAZENECA,,18493.0,DY,,F,Y,93.4,KG,20210705.0,,,US,US,2021,Q3,Elderly
183373904,18337390,51,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Septic shock,,2021,Q3,4,F,20171222.0,20210629.0,20201002,20210705,EXP,,US-ASTRAZENECA-2020SF25300,ASTRAZENECA,,18493.0,DY,,F,Y,93.4,KG,20210705.0,,,US,US,2021,Q3,Elderly
183373904,18337390,51,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Urinary tract infection,,2021,Q3,4,F,20171222.0,20210629.0,20201002,20210705,EXP,,US-ASTRAZENECA-2020SF25300,ASTRAZENECA,,18493.0,DY,,F,Y,93.4,KG,20210705.0,,,US,US,2021,Q3,Elderly
183740515,18374051,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM,,,U,,,,,1.0,DF,,,2021,Q3,Acute kidney injury,,2021,Q3,5,F,20201005.0,20210729.0,20201012,20210804,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-082607,BRISTOL MYERS SQUIBB,,69.0,YR,,M,Y,110.0,KG,20210804.0,,HP,DE,DE,2021,Q3,Elderly
183817153,18381715,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Acute kidney injury,,2021,Q3,3,F,20200814.0,20210910.0,20201014,20210920,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-082920,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,,,20210920.0,,MD,DE,DE,2021,Q3,Elderly
183817153,18381715,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Dehydration,,2021,Q3,3,F,20200814.0,20210910.0,20201014,20210920,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-082920,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,,,20210920.0,,MD,DE,DE,2021,Q3,Elderly
183817153,18381715,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Escherichia urinary tract infection,,2021,Q3,3,F,20200814.0,20210910.0,20201014,20210920,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-082920,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,,,20210920.0,,MD,DE,DE,2021,Q3,Elderly
183817153,18381715,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Intracranial aneurysm,,2021,Q3,3,F,20200814.0,20210910.0,20201014,20210920,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-082920,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,,,20210920.0,,MD,DE,DE,2021,Q3,Elderly
183817153,18381715,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Mesenteric arterial occlusion,,2021,Q3,3,F,20200814.0,20210910.0,20201014,20210920,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-082920,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,,,20210920.0,,MD,DE,DE,2021,Q3,Elderly
183817153,18381715,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Syncope,,2021,Q3,3,F,20200814.0,20210910.0,20201014,20210920,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-082920,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,,,20210920.0,,MD,DE,DE,2021,Q3,Elderly
184292524,18429252,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, UNKNOWN",,,U,,,,,10.0,IU,INJECTION,,2021,Q3,Cardiac ventricular thrombosis,,2021,Q3,4,F,20200828.0,20210906.0,20201026,20210909,EXP,,NVSC2020CN285955,NOVARTIS,,57.0,YR,,M,Y,,,20210909.0,,MD,CN,CN,2021,Q3,Adult
184292524,18429252,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, UNKNOWN",,,U,,,,,10.0,IU,INJECTION,,2021,Q3,Ventricular arrhythmia,,2021,Q3,4,F,20200828.0,20210906.0,20201026,20210909,EXP,,NVSC2020CN285955,NOVARTIS,,57.0,YR,,M,Y,,,20210909.0,,MD,CN,CN,2021,Q3,Adult
184292524,18429252,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, UNKNOWN",,,U,,,,,14.0,IU,INJECTION,,2021,Q3,Cardiac ventricular thrombosis,,2021,Q3,4,F,20200828.0,20210906.0,20201026,20210909,EXP,,NVSC2020CN285955,NOVARTIS,,57.0,YR,,M,Y,,,20210909.0,,MD,CN,CN,2021,Q3,Adult
184292524,18429252,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, UNKNOWN",,,U,,,,,14.0,IU,INJECTION,,2021,Q3,Ventricular arrhythmia,,2021,Q3,4,F,20200828.0,20210906.0,20201026,20210909,EXP,,NVSC2020CN285955,NOVARTIS,,57.0,YR,,M,Y,,,20210909.0,,MD,CN,CN,2021,Q3,Adult
184293763,18429376,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Acute kidney injury,,2021,Q3,3,F,20200814.0,20210923.0,20201026,20210928,EXP,,NVSC2020DE281452,NOVARTIS,,80.0,YR,,F,Y,,,20210928.0,,HP,DE,DE,2021,Q3,Elderly
184293763,18429376,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Dehydration,,2021,Q3,3,F,20200814.0,20210923.0,20201026,20210928,EXP,,NVSC2020DE281452,NOVARTIS,,80.0,YR,,F,Y,,,20210928.0,,HP,DE,DE,2021,Q3,Elderly
184293763,18429376,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Escherichia urinary tract infection,,2021,Q3,3,F,20200814.0,20210923.0,20201026,20210928,EXP,,NVSC2020DE281452,NOVARTIS,,80.0,YR,,F,Y,,,20210928.0,,HP,DE,DE,2021,Q3,Elderly
184293763,18429376,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Intracranial aneurysm,,2021,Q3,3,F,20200814.0,20210923.0,20201026,20210928,EXP,,NVSC2020DE281452,NOVARTIS,,80.0,YR,,F,Y,,,20210928.0,,HP,DE,DE,2021,Q3,Elderly
184293763,18429376,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Mesenteric arterial occlusion,,2021,Q3,3,F,20200814.0,20210923.0,20201026,20210928,EXP,,NVSC2020DE281452,NOVARTIS,,80.0,YR,,F,Y,,,20210928.0,,HP,DE,DE,2021,Q3,Elderly
184293763,18429376,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Syncope,,2021,Q3,3,F,20200814.0,20210923.0,20201026,20210928,EXP,,NVSC2020DE281452,NOVARTIS,,80.0,YR,,F,Y,,,20210928.0,,HP,DE,DE,2021,Q3,Elderly
184317733,18431773,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Acute kidney injury,,2021,Q3,3,F,20200814.0,20210923.0,20201027,20210928,EXP,,DE-PFIZER INC-2020410735,PFIZER,,80.0,YR,,F,Y,,,20210928.0,,MD,DE,DE,2021,Q3,Elderly
184317733,18431773,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Carotid artery aneurysm,,2021,Q3,3,F,20200814.0,20210923.0,20201027,20210928,EXP,,DE-PFIZER INC-2020410735,PFIZER,,80.0,YR,,F,Y,,,20210928.0,,MD,DE,DE,2021,Q3,Elderly
184317733,18431773,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Carotid artery thrombosis,,2021,Q3,3,F,20200814.0,20210923.0,20201027,20210928,EXP,,DE-PFIZER INC-2020410735,PFIZER,,80.0,YR,,F,Y,,,20210928.0,,MD,DE,DE,2021,Q3,Elderly
184317733,18431773,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Dehydration,,2021,Q3,3,F,20200814.0,20210923.0,20201027,20210928,EXP,,DE-PFIZER INC-2020410735,PFIZER,,80.0,YR,,F,Y,,,20210928.0,,MD,DE,DE,2021,Q3,Elderly
184317733,18431773,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Escherichia urinary tract infection,,2021,Q3,3,F,20200814.0,20210923.0,20201027,20210928,EXP,,DE-PFIZER INC-2020410735,PFIZER,,80.0,YR,,F,Y,,,20210928.0,,MD,DE,DE,2021,Q3,Elderly
184317733,18431773,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Mesenteric arterial occlusion,,2021,Q3,3,F,20200814.0,20210923.0,20201027,20210928,EXP,,DE-PFIZER INC-2020410735,PFIZER,,80.0,YR,,F,Y,,,20210928.0,,MD,DE,DE,2021,Q3,Elderly
184317733,18431773,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Syncope,,2021,Q3,3,F,20200814.0,20210923.0,20201027,20210928,EXP,,DE-PFIZER INC-2020410735,PFIZER,,80.0,YR,,F,Y,,,20210928.0,,MD,DE,DE,2021,Q3,Elderly
184544252,18454425,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,U,,,,,,,,2021,Q3,Acute kidney injury,,2021,Q3,2,F,20200814.0,20210917.0,20201102,20210921,EXP,,DE-MYLANLABS-2020M1090594,MYLAN,,80.0,YR,,F,Y,,,20210921.0,,MD,DE,DE,2021,Q3,Elderly
184544252,18454425,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,U,,,,,,,,2021,Q3,Dehydration,,2021,Q3,2,F,20200814.0,20210917.0,20201102,20210921,EXP,,DE-MYLANLABS-2020M1090594,MYLAN,,80.0,YR,,F,Y,,,20210921.0,,MD,DE,DE,2021,Q3,Elderly
184544252,18454425,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,U,,,,,,,,2021,Q3,Escherichia urinary tract infection,,2021,Q3,2,F,20200814.0,20210917.0,20201102,20210921,EXP,,DE-MYLANLABS-2020M1090594,MYLAN,,80.0,YR,,F,Y,,,20210921.0,,MD,DE,DE,2021,Q3,Elderly
184544252,18454425,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,U,,,,,,,,2021,Q3,Syncope,,2021,Q3,2,F,20200814.0,20210917.0,20201102,20210921,EXP,,DE-MYLANLABS-2020M1090594,MYLAN,,80.0,YR,,F,Y,,,20210921.0,,MD,DE,DE,2021,Q3,Elderly
184793152,18479315,7,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"10 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,10.0,IU,AMPOULES,QD,2021,Q3,Abdominal pain,,2021,Q3,2,F,,20201027.0,20201109,20210825,EXP,,DE-AUROBINDO-AUR-APL-2020-054924,AUROBINDO,,64.0,YR,,F,Y,,,20210825.0,,MD,DE,DE,2021,Q3,Adult
184793152,18479315,7,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"10 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,10.0,IU,AMPOULES,QD,2021,Q3,General physical health deterioration,,2021,Q3,2,F,,20201027.0,20201109,20210825,EXP,,DE-AUROBINDO-AUR-APL-2020-054924,AUROBINDO,,64.0,YR,,F,Y,,,20210825.0,,MD,DE,DE,2021,Q3,Adult
184793152,18479315,7,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"10 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,10.0,IU,AMPOULES,QD,2021,Q3,Nausea,,2021,Q3,2,F,,20201027.0,20201109,20210825,EXP,,DE-AUROBINDO-AUR-APL-2020-054924,AUROBINDO,,64.0,YR,,F,Y,,,20210825.0,,MD,DE,DE,2021,Q3,Adult
184793152,18479315,7,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"10 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,10.0,IU,AMPOULES,QD,2021,Q3,Product prescribing error,,2021,Q3,2,F,,20201027.0,20201109,20210825,EXP,,DE-AUROBINDO-AUR-APL-2020-054924,AUROBINDO,,64.0,YR,,F,Y,,,20210825.0,,MD,DE,DE,2021,Q3,Adult
184793152,18479315,7,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"10 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,10.0,IU,AMPOULES,QD,2021,Q3,Vomiting,,2021,Q3,2,F,,20201027.0,20201109,20210825,EXP,,DE-AUROBINDO-AUR-APL-2020-054924,AUROBINDO,,64.0,YR,,F,Y,,,20210825.0,,MD,DE,DE,2021,Q3,Adult
185556992,18555699,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,,,,,21081.0,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Aphasia,,2021,Q3,2,F,2019.0,20210921.0,20201127,20210928,EXP,,GT-SA-2020SA336182,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20210928.0,,CN,GT,GT,2021,Q3,Elderly
185556992,18555699,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,,,,,21081.0,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Cerebrovascular accident,,2021,Q3,2,F,2019.0,20210921.0,20201127,20210928,EXP,,GT-SA-2020SA336182,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20210928.0,,CN,GT,GT,2021,Q3,Elderly
185556992,18555699,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,,,,,21081.0,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Inappropriate schedule of product administration,,2021,Q3,2,F,2019.0,20210921.0,20201127,20210928,EXP,,GT-SA-2020SA336182,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20210928.0,,CN,GT,GT,2021,Q3,Elderly
185556992,18555699,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, Q12H (MORNING AND EVENING )",,,,,,,21081.0,30.0,IU,SOLUTION FOR INJECTION,Q12H,2021,Q3,Aphasia,,2021,Q3,2,F,2019.0,20210921.0,20201127,20210928,EXP,,GT-SA-2020SA336182,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20210928.0,,CN,GT,GT,2021,Q3,Elderly
185556992,18555699,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, Q12H (MORNING AND EVENING )",,,,,,,21081.0,30.0,IU,SOLUTION FOR INJECTION,Q12H,2021,Q3,Cerebrovascular accident,,2021,Q3,2,F,2019.0,20210921.0,20201127,20210928,EXP,,GT-SA-2020SA336182,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20210928.0,,CN,GT,GT,2021,Q3,Elderly
185556992,18555699,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, Q12H (MORNING AND EVENING )",,,,,,,21081.0,30.0,IU,SOLUTION FOR INJECTION,Q12H,2021,Q3,Inappropriate schedule of product administration,,2021,Q3,2,F,2019.0,20210921.0,20201127,20210928,EXP,,GT-SA-2020SA336182,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20210928.0,,CN,GT,GT,2021,Q3,Elderly
1866018510,18660185,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q3,Cerebral infarction,,2021,Q3,10,F,20201218.0,20210701.0,20201223,20210712,EXP,,CN-AGIOS-2012CN02369,AGIOS PHARMACEUTICALS,,67.0,YR,,F,Y,83.0,KG,20210712.0,,MD,CN,CN,2021,Q3,Elderly
1868266210,18682662,8,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q3,Cerebral infarction,,2021,Q3,10,F,20201218.0,20210708.0,20201230,20210714,EXP,,CN-CELGENEUS-CHN-20201207658,CELGENE,,67.0,YR,,F,Y,83.0,KG,20210714.0,,MD,CN,CN,2021,Q3,Elderly
187784752,18778475,4,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q3,Drug ineffective,,2021,Q3,2,F,,20210703.0,20210123,20210713,EXP,,US-TEVA-2021-US-1869964,TEVA,"TORRICO T, KIAI N, MEZA C, SALAM MT, ABDIJADID S. SUSPECTED ARIPIPRAZOLE?INDUCED NEUTROPENIA IN A GERIATRIC PATIENT: A CASE REPORT. BMC?GERIATR 2020?20:NO. 1.",68.0,YR,E,M,Y,,,20210713.0,,HP,US,US,2021,Q3,Elderly
187784752,18778475,4,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q3,Hypotension,,2021,Q3,2,F,,20210703.0,20210123,20210713,EXP,,US-TEVA-2021-US-1869964,TEVA,"TORRICO T, KIAI N, MEZA C, SALAM MT, ABDIJADID S. SUSPECTED ARIPIPRAZOLE?INDUCED NEUTROPENIA IN A GERIATRIC PATIENT: A CASE REPORT. BMC?GERIATR 2020?20:NO. 1.",68.0,YR,E,M,Y,,,20210713.0,,HP,US,US,2021,Q3,Elderly
187784752,18778475,4,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q3,Neutropenia,,2021,Q3,2,F,,20210703.0,20210123,20210713,EXP,,US-TEVA-2021-US-1869964,TEVA,"TORRICO T, KIAI N, MEZA C, SALAM MT, ABDIJADID S. SUSPECTED ARIPIPRAZOLE?INDUCED NEUTROPENIA IN A GERIATRIC PATIENT: A CASE REPORT. BMC?GERIATR 2020?20:NO. 1.",68.0,YR,E,M,Y,,,20210713.0,,HP,US,US,2021,Q3,Elderly
187849454,18784945,8,C,Insulin Glargine,INSULIN GLARGINE,1,,20 INTERNATIONAL UNIT,,,,,,,,20.0,IU,,,2021,Q3,Abdominal pain,,2021,Q3,4,F,20210112.0,20210813.0,20210125,20210819,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20210819.0,,CN,CO,CO,2021,Q3,Adult
187849454,18784945,8,C,Insulin Glargine,INSULIN GLARGINE,1,,20 INTERNATIONAL UNIT,,,,,,,,20.0,IU,,,2021,Q3,Colitis ulcerative,,2021,Q3,4,F,20210112.0,20210813.0,20210125,20210819,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20210819.0,,CN,CO,CO,2021,Q3,Adult
187849454,18784945,8,C,Insulin Glargine,INSULIN GLARGINE,1,,20 INTERNATIONAL UNIT,,,,,,,,20.0,IU,,,2021,Q3,Haematochezia,,2021,Q3,4,F,20210112.0,20210813.0,20210125,20210819,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20210819.0,,CN,CO,CO,2021,Q3,Adult
187849454,18784945,8,C,Insulin Glargine,INSULIN GLARGINE,1,,20 INTERNATIONAL UNIT,,,,,,,,20.0,IU,,,2021,Q3,Latent tuberculosis,,2021,Q3,4,F,20210112.0,20210813.0,20210125,20210819,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20210819.0,,CN,CO,CO,2021,Q3,Adult
187849454,18784945,8,C,Insulin Glargine,INSULIN GLARGINE,1,,20 INTERNATIONAL UNIT,,,,,,,,20.0,IU,,,2021,Q3,Type 2 diabetes mellitus,,2021,Q3,4,F,20210112.0,20210813.0,20210125,20210819,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20210819.0,,CN,CO,CO,2021,Q3,Adult
187849454,18784945,8,C,Insulin Glargine,INSULIN GLARGINE,1,,20 INTERNATIONAL UNIT,,,,,,,,20.0,IU,,,2021,Q3,Weight increased,,2021,Q3,4,F,20210112.0,20210813.0,20210125,20210819,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20210819.0,,CN,CO,CO,2021,Q3,Adult
187975992,18797599,11,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,40 UNITS ONCE A DAY,,,U,,,,,,,,QD,2021,Q3,Acute kidney injury,,2021,Q3,2,F,,20210802.0,20210128,20210816,EXP,,US-AUROBINDO-AUR-APL-2021-002754,AUROBINDO,,35.0,YR,,F,Y,,,20210816.0,,HP,US,US,2021,Q3,Adult
187975992,18797599,11,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,40 UNITS ONCE A DAY,,,U,,,,,,,,QD,2021,Q3,Hypokalaemia,,2021,Q3,2,F,,20210802.0,20210128,20210816,EXP,,US-AUROBINDO-AUR-APL-2021-002754,AUROBINDO,,35.0,YR,,F,Y,,,20210816.0,,HP,US,US,2021,Q3,Adult
187975992,18797599,11,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,40 UNITS ONCE A DAY,,,U,,,,,,,,QD,2021,Q3,Hypomagnesaemia,,2021,Q3,2,F,,20210802.0,20210128,20210816,EXP,,US-AUROBINDO-AUR-APL-2021-002754,AUROBINDO,,35.0,YR,,F,Y,,,20210816.0,,HP,US,US,2021,Q3,Adult
187975992,18797599,11,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,40 UNITS ONCE A DAY,,,U,,,,,,,,QD,2021,Q3,Hypotension,,2021,Q3,2,F,,20210802.0,20210128,20210816,EXP,,US-AUROBINDO-AUR-APL-2021-002754,AUROBINDO,,35.0,YR,,F,Y,,,20210816.0,,HP,US,US,2021,Q3,Adult
187975992,18797599,11,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,40 UNITS ONCE A DAY,,,U,,,,,,,,QD,2021,Q3,Maternal exposure during pregnancy,,2021,Q3,2,F,,20210802.0,20210128,20210816,EXP,,US-AUROBINDO-AUR-APL-2021-002754,AUROBINDO,,35.0,YR,,F,Y,,,20210816.0,,HP,US,US,2021,Q3,Adult
187975992,18797599,11,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,40 UNITS ONCE A DAY,,,U,,,,,,,,QD,2021,Q3,Pseudohyperphosphataemia,,2021,Q3,2,F,,20210802.0,20210128,20210816,EXP,,US-AUROBINDO-AUR-APL-2021-002754,AUROBINDO,,35.0,YR,,F,Y,,,20210816.0,,HP,US,US,2021,Q3,Adult
187975992,18797599,11,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,40 UNITS ONCE A DAY,,,U,,,,,,,,QD,2021,Q3,Tubulointerstitial nephritis,,2021,Q3,2,F,,20210802.0,20210128,20210816,EXP,,US-AUROBINDO-AUR-APL-2021-002754,AUROBINDO,,35.0,YR,,F,Y,,,20210816.0,,HP,US,US,2021,Q3,Adult
188056454,18805645,13,SS,Insulin?glargine,INSULIN NOS,1,Unknown,40UNITS,,,U,,,,,,,,,2021,Q3,Acute kidney injury,,2021,Q3,4,F,,20210813.0,20210128,20210817,EXP,,US-TEVA-2021-US-1872160,TEVA,PHAM P. SEVERE HYPERPHOSPHATEMIA IN A PATIENT WITH MILD ACUTE KIDNEY INJURY.. CASE?REP?MED. 2021?.,35.0,YR,A,F,Y,,,20210817.0,,HP,US,US,2021,Q3,Adult
188056454,18805645,13,SS,Insulin?glargine,INSULIN NOS,1,Unknown,40UNITS,,,U,,,,,,,,,2021,Q3,Hypoalbuminaemia,,2021,Q3,4,F,,20210813.0,20210128,20210817,EXP,,US-TEVA-2021-US-1872160,TEVA,PHAM P. SEVERE HYPERPHOSPHATEMIA IN A PATIENT WITH MILD ACUTE KIDNEY INJURY.. CASE?REP?MED. 2021?.,35.0,YR,A,F,Y,,,20210817.0,,HP,US,US,2021,Q3,Adult
188056454,18805645,13,SS,Insulin?glargine,INSULIN NOS,1,Unknown,40UNITS,,,U,,,,,,,,,2021,Q3,Hypokalaemia,,2021,Q3,4,F,,20210813.0,20210128,20210817,EXP,,US-TEVA-2021-US-1872160,TEVA,PHAM P. SEVERE HYPERPHOSPHATEMIA IN A PATIENT WITH MILD ACUTE KIDNEY INJURY.. CASE?REP?MED. 2021?.,35.0,YR,A,F,Y,,,20210817.0,,HP,US,US,2021,Q3,Adult
188056454,18805645,13,SS,Insulin?glargine,INSULIN NOS,1,Unknown,40UNITS,,,U,,,,,,,,,2021,Q3,Hypomagnesaemia,,2021,Q3,4,F,,20210813.0,20210128,20210817,EXP,,US-TEVA-2021-US-1872160,TEVA,PHAM P. SEVERE HYPERPHOSPHATEMIA IN A PATIENT WITH MILD ACUTE KIDNEY INJURY.. CASE?REP?MED. 2021?.,35.0,YR,A,F,Y,,,20210817.0,,HP,US,US,2021,Q3,Adult
188056454,18805645,13,SS,Insulin?glargine,INSULIN NOS,1,Unknown,40UNITS,,,U,,,,,,,,,2021,Q3,Hypotension,,2021,Q3,4,F,,20210813.0,20210128,20210817,EXP,,US-TEVA-2021-US-1872160,TEVA,PHAM P. SEVERE HYPERPHOSPHATEMIA IN A PATIENT WITH MILD ACUTE KIDNEY INJURY.. CASE?REP?MED. 2021?.,35.0,YR,A,F,Y,,,20210817.0,,HP,US,US,2021,Q3,Adult
188056454,18805645,13,SS,Insulin?glargine,INSULIN NOS,1,Unknown,40UNITS,,,U,,,,,,,,,2021,Q3,Maternal exposure during pregnancy,,2021,Q3,4,F,,20210813.0,20210128,20210817,EXP,,US-TEVA-2021-US-1872160,TEVA,PHAM P. SEVERE HYPERPHOSPHATEMIA IN A PATIENT WITH MILD ACUTE KIDNEY INJURY.. CASE?REP?MED. 2021?.,35.0,YR,A,F,Y,,,20210817.0,,HP,US,US,2021,Q3,Adult
188056454,18805645,13,SS,Insulin?glargine,INSULIN NOS,1,Unknown,40UNITS,,,U,,,,,,,,,2021,Q3,Metabolic acidosis,,2021,Q3,4,F,,20210813.0,20210128,20210817,EXP,,US-TEVA-2021-US-1872160,TEVA,PHAM P. SEVERE HYPERPHOSPHATEMIA IN A PATIENT WITH MILD ACUTE KIDNEY INJURY.. CASE?REP?MED. 2021?.,35.0,YR,A,F,Y,,,20210817.0,,HP,US,US,2021,Q3,Adult
188056454,18805645,13,SS,Insulin?glargine,INSULIN NOS,1,Unknown,40UNITS,,,U,,,,,,,,,2021,Q3,Pseudohyperphosphataemia,,2021,Q3,4,F,,20210813.0,20210128,20210817,EXP,,US-TEVA-2021-US-1872160,TEVA,PHAM P. SEVERE HYPERPHOSPHATEMIA IN A PATIENT WITH MILD ACUTE KIDNEY INJURY.. CASE?REP?MED. 2021?.,35.0,YR,A,F,Y,,,20210817.0,,HP,US,US,2021,Q3,Adult
188056454,18805645,13,SS,Insulin?glargine,INSULIN NOS,1,Unknown,40UNITS,,,U,,,,,,,,,2021,Q3,Respiratory alkalosis,,2021,Q3,4,F,,20210813.0,20210128,20210817,EXP,,US-TEVA-2021-US-1872160,TEVA,PHAM P. SEVERE HYPERPHOSPHATEMIA IN A PATIENT WITH MILD ACUTE KIDNEY INJURY.. CASE?REP?MED. 2021?.,35.0,YR,A,F,Y,,,20210817.0,,HP,US,US,2021,Q3,Adult
188124072,18812407,15,C,INSULIN GLARGINE BIOSIMILAR 1,,2,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Decreased appetite,,2021,Q3,2,F,20191008.0,20210719.0,20210130,20210727,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-098429,BRISTOL MYERS SQUIBB,,73.0,YR,,F,Y,93.8,KG,20210727.0,,PH,JP,JP,2021,Q3,Elderly
188124072,18812407,15,C,INSULIN GLARGINE BIOSIMILAR 1,,2,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Interstitial lung disease,,2021,Q3,2,F,20191008.0,20210719.0,20210130,20210727,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-098429,BRISTOL MYERS SQUIBB,,73.0,YR,,F,Y,93.8,KG,20210727.0,,PH,JP,JP,2021,Q3,Elderly
188124072,18812407,15,C,INSULIN GLARGINE BIOSIMILAR 1,,2,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Myasthenia gravis,,2021,Q3,2,F,20191008.0,20210719.0,20210130,20210727,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-098429,BRISTOL MYERS SQUIBB,,73.0,YR,,F,Y,93.8,KG,20210727.0,,PH,JP,JP,2021,Q3,Elderly
188124072,18812407,15,C,INSULIN GLARGINE BIOSIMILAR 1,,2,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Myocarditis,,2021,Q3,2,F,20191008.0,20210719.0,20210130,20210727,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-098429,BRISTOL MYERS SQUIBB,,73.0,YR,,F,Y,93.8,KG,20210727.0,,PH,JP,JP,2021,Q3,Elderly
188124072,18812407,15,C,INSULIN GLARGINE BIOSIMILAR 1,,2,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Myositis,,2021,Q3,2,F,20191008.0,20210719.0,20210130,20210727,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-098429,BRISTOL MYERS SQUIBB,,73.0,YR,,F,Y,93.8,KG,20210727.0,,PH,JP,JP,2021,Q3,Elderly
188227183,18822718,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"38 UNITS, AT NIGHT",,,,,,,,,,,,2021,Q3,Amnesia,,2021,Q3,3,F,20201030.0,20210211.0,20210202,20210809,EXP,,NVSC2021CO022425,NOVARTIS,,46.0,YR,,F,Y,57.0,KG,20210807.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
188227183,18822718,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"38 UNITS, AT NIGHT",,,,,,,,,,,,2021,Q3,Dizziness,,2021,Q3,3,F,20201030.0,20210211.0,20210202,20210809,EXP,,NVSC2021CO022425,NOVARTIS,,46.0,YR,,F,Y,57.0,KG,20210807.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
188227183,18822718,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"38 UNITS, AT NIGHT",,,,,,,,,,,,2021,Q3,Fall,,2021,Q3,3,F,20201030.0,20210211.0,20210202,20210809,EXP,,NVSC2021CO022425,NOVARTIS,,46.0,YR,,F,Y,57.0,KG,20210807.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
188227183,18822718,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"38 UNITS, AT NIGHT",,,,,,,,,,,,2021,Q3,Maculopathy,,2021,Q3,3,F,20201030.0,20210211.0,20210202,20210809,EXP,,NVSC2021CO022425,NOVARTIS,,46.0,YR,,F,Y,57.0,KG,20210807.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
188227183,18822718,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 UNITS, BEFORE EVERY MEALS",,,,,,,,,,,,2021,Q3,Amnesia,,2021,Q3,3,F,20201030.0,20210211.0,20210202,20210809,EXP,,NVSC2021CO022425,NOVARTIS,,46.0,YR,,F,Y,57.0,KG,20210807.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
188227183,18822718,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 UNITS, BEFORE EVERY MEALS",,,,,,,,,,,,2021,Q3,Dizziness,,2021,Q3,3,F,20201030.0,20210211.0,20210202,20210809,EXP,,NVSC2021CO022425,NOVARTIS,,46.0,YR,,F,Y,57.0,KG,20210807.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
188227183,18822718,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 UNITS, BEFORE EVERY MEALS",,,,,,,,,,,,2021,Q3,Fall,,2021,Q3,3,F,20201030.0,20210211.0,20210202,20210809,EXP,,NVSC2021CO022425,NOVARTIS,,46.0,YR,,F,Y,57.0,KG,20210807.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
188227183,18822718,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 UNITS, BEFORE EVERY MEALS",,,,,,,,,,,,2021,Q3,Maculopathy,,2021,Q3,3,F,20201030.0,20210211.0,20210202,20210809,EXP,,NVSC2021CO022425,NOVARTIS,,46.0,YR,,F,Y,57.0,KG,20210807.0,,CN,COUNTRY NOT SPECIFIED,CO,2021,Q3,Adult
189212419,18921241,30,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SLIDING SCALE U X 1 X 1 DAYS,,,,,,,,,,UNKNOWN,QD,2021,Q3,Fungal sepsis,,2021,Q3,9,F,20210216.0,20210721.0,20210222,20210727,EXP,,US-CELGENEUS-USA-20210204648,CELGENE,,68.0,YR,,F,Y,46.0,KG,20210727.0,,MD,US,US,2021,Q3,Elderly
189629194,18962919,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Acute kidney injury,,2021,Q3,4,F,,20210818.0,20210303,20210823,EXP,,GR-ROCHE-2779769,ROCHE,"IOANNIS P, GEORGIA PANTAZIDOU2, STAMATIA CHATZIPERI1, ANDREAS BAIKOUSIS1, PANAGIOTIS KOROVESSIS1. GLUTEAL COMPARTMENT SYNDROME? INTOXICATION? DRUG?INDUCED RHABDOMYOLYSIS? HEMODIALYSIS? FASCIOTOMY? DELAYED DIAGNOSIS,.. SURGICAL CHRONICLES 2020?25(4):378?380.",47.0,YR,,F,Y,,,20210823.0,,MD,GR,GR,2021,Q3,Adult
189629194,18962919,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Blood creatine phosphokinase increased,,2021,Q3,4,F,,20210818.0,20210303,20210823,EXP,,GR-ROCHE-2779769,ROCHE,"IOANNIS P, GEORGIA PANTAZIDOU2, STAMATIA CHATZIPERI1, ANDREAS BAIKOUSIS1, PANAGIOTIS KOROVESSIS1. GLUTEAL COMPARTMENT SYNDROME? INTOXICATION? DRUG?INDUCED RHABDOMYOLYSIS? HEMODIALYSIS? FASCIOTOMY? DELAYED DIAGNOSIS,.. SURGICAL CHRONICLES 2020?25(4):378?380.",47.0,YR,,F,Y,,,20210823.0,,MD,GR,GR,2021,Q3,Adult
189629194,18962919,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Communication disorder,,2021,Q3,4,F,,20210818.0,20210303,20210823,EXP,,GR-ROCHE-2779769,ROCHE,"IOANNIS P, GEORGIA PANTAZIDOU2, STAMATIA CHATZIPERI1, ANDREAS BAIKOUSIS1, PANAGIOTIS KOROVESSIS1. GLUTEAL COMPARTMENT SYNDROME? INTOXICATION? DRUG?INDUCED RHABDOMYOLYSIS? HEMODIALYSIS? FASCIOTOMY? DELAYED DIAGNOSIS,.. SURGICAL CHRONICLES 2020?25(4):378?380.",47.0,YR,,F,Y,,,20210823.0,,MD,GR,GR,2021,Q3,Adult
189629194,18962919,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Compartment syndrome,,2021,Q3,4,F,,20210818.0,20210303,20210823,EXP,,GR-ROCHE-2779769,ROCHE,"IOANNIS P, GEORGIA PANTAZIDOU2, STAMATIA CHATZIPERI1, ANDREAS BAIKOUSIS1, PANAGIOTIS KOROVESSIS1. GLUTEAL COMPARTMENT SYNDROME? INTOXICATION? DRUG?INDUCED RHABDOMYOLYSIS? HEMODIALYSIS? FASCIOTOMY? DELAYED DIAGNOSIS,.. SURGICAL CHRONICLES 2020?25(4):378?380.",47.0,YR,,F,Y,,,20210823.0,,MD,GR,GR,2021,Q3,Adult
189629194,18962919,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Drug abuse,,2021,Q3,4,F,,20210818.0,20210303,20210823,EXP,,GR-ROCHE-2779769,ROCHE,"IOANNIS P, GEORGIA PANTAZIDOU2, STAMATIA CHATZIPERI1, ANDREAS BAIKOUSIS1, PANAGIOTIS KOROVESSIS1. GLUTEAL COMPARTMENT SYNDROME? INTOXICATION? DRUG?INDUCED RHABDOMYOLYSIS? HEMODIALYSIS? FASCIOTOMY? DELAYED DIAGNOSIS,.. SURGICAL CHRONICLES 2020?25(4):378?380.",47.0,YR,,F,Y,,,20210823.0,,MD,GR,GR,2021,Q3,Adult
189629194,18962919,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,General physical condition abnormal,,2021,Q3,4,F,,20210818.0,20210303,20210823,EXP,,GR-ROCHE-2779769,ROCHE,"IOANNIS P, GEORGIA PANTAZIDOU2, STAMATIA CHATZIPERI1, ANDREAS BAIKOUSIS1, PANAGIOTIS KOROVESSIS1. GLUTEAL COMPARTMENT SYNDROME? INTOXICATION? DRUG?INDUCED RHABDOMYOLYSIS? HEMODIALYSIS? FASCIOTOMY? DELAYED DIAGNOSIS,.. SURGICAL CHRONICLES 2020?25(4):378?380.",47.0,YR,,F,Y,,,20210823.0,,MD,GR,GR,2021,Q3,Adult
189629194,18962919,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Haemodynamic instability,,2021,Q3,4,F,,20210818.0,20210303,20210823,EXP,,GR-ROCHE-2779769,ROCHE,"IOANNIS P, GEORGIA PANTAZIDOU2, STAMATIA CHATZIPERI1, ANDREAS BAIKOUSIS1, PANAGIOTIS KOROVESSIS1. GLUTEAL COMPARTMENT SYNDROME? INTOXICATION? DRUG?INDUCED RHABDOMYOLYSIS? HEMODIALYSIS? FASCIOTOMY? DELAYED DIAGNOSIS,.. SURGICAL CHRONICLES 2020?25(4):378?380.",47.0,YR,,F,Y,,,20210823.0,,MD,GR,GR,2021,Q3,Adult
189629194,18962919,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Hepatic function abnormal,,2021,Q3,4,F,,20210818.0,20210303,20210823,EXP,,GR-ROCHE-2779769,ROCHE,"IOANNIS P, GEORGIA PANTAZIDOU2, STAMATIA CHATZIPERI1, ANDREAS BAIKOUSIS1, PANAGIOTIS KOROVESSIS1. GLUTEAL COMPARTMENT SYNDROME? INTOXICATION? DRUG?INDUCED RHABDOMYOLYSIS? HEMODIALYSIS? FASCIOTOMY? DELAYED DIAGNOSIS,.. SURGICAL CHRONICLES 2020?25(4):378?380.",47.0,YR,,F,Y,,,20210823.0,,MD,GR,GR,2021,Q3,Adult
189629194,18962919,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Immobilisation prolonged,,2021,Q3,4,F,,20210818.0,20210303,20210823,EXP,,GR-ROCHE-2779769,ROCHE,"IOANNIS P, GEORGIA PANTAZIDOU2, STAMATIA CHATZIPERI1, ANDREAS BAIKOUSIS1, PANAGIOTIS KOROVESSIS1. GLUTEAL COMPARTMENT SYNDROME? INTOXICATION? DRUG?INDUCED RHABDOMYOLYSIS? HEMODIALYSIS? FASCIOTOMY? DELAYED DIAGNOSIS,.. SURGICAL CHRONICLES 2020?25(4):378?380.",47.0,YR,,F,Y,,,20210823.0,,MD,GR,GR,2021,Q3,Adult
189629194,18962919,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Labelled drug-food interaction issue,,2021,Q3,4,F,,20210818.0,20210303,20210823,EXP,,GR-ROCHE-2779769,ROCHE,"IOANNIS P, GEORGIA PANTAZIDOU2, STAMATIA CHATZIPERI1, ANDREAS BAIKOUSIS1, PANAGIOTIS KOROVESSIS1. GLUTEAL COMPARTMENT SYNDROME? INTOXICATION? DRUG?INDUCED RHABDOMYOLYSIS? HEMODIALYSIS? FASCIOTOMY? DELAYED DIAGNOSIS,.. SURGICAL CHRONICLES 2020?25(4):378?380.",47.0,YR,,F,Y,,,20210823.0,,MD,GR,GR,2021,Q3,Adult
189629194,18962919,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Muscle injury,,2021,Q3,4,F,,20210818.0,20210303,20210823,EXP,,GR-ROCHE-2779769,ROCHE,"IOANNIS P, GEORGIA PANTAZIDOU2, STAMATIA CHATZIPERI1, ANDREAS BAIKOUSIS1, PANAGIOTIS KOROVESSIS1. GLUTEAL COMPARTMENT SYNDROME? INTOXICATION? DRUG?INDUCED RHABDOMYOLYSIS? HEMODIALYSIS? FASCIOTOMY? DELAYED DIAGNOSIS,.. SURGICAL CHRONICLES 2020?25(4):378?380.",47.0,YR,,F,Y,,,20210823.0,,MD,GR,GR,2021,Q3,Adult
189629194,18962919,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Neurological decompensation,,2021,Q3,4,F,,20210818.0,20210303,20210823,EXP,,GR-ROCHE-2779769,ROCHE,"IOANNIS P, GEORGIA PANTAZIDOU2, STAMATIA CHATZIPERI1, ANDREAS BAIKOUSIS1, PANAGIOTIS KOROVESSIS1. GLUTEAL COMPARTMENT SYNDROME? INTOXICATION? DRUG?INDUCED RHABDOMYOLYSIS? HEMODIALYSIS? FASCIOTOMY? DELAYED DIAGNOSIS,.. SURGICAL CHRONICLES 2020?25(4):378?380.",47.0,YR,,F,Y,,,20210823.0,,MD,GR,GR,2021,Q3,Adult
189629194,18962919,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Poisoning,,2021,Q3,4,F,,20210818.0,20210303,20210823,EXP,,GR-ROCHE-2779769,ROCHE,"IOANNIS P, GEORGIA PANTAZIDOU2, STAMATIA CHATZIPERI1, ANDREAS BAIKOUSIS1, PANAGIOTIS KOROVESSIS1. GLUTEAL COMPARTMENT SYNDROME? INTOXICATION? DRUG?INDUCED RHABDOMYOLYSIS? HEMODIALYSIS? FASCIOTOMY? DELAYED DIAGNOSIS,.. SURGICAL CHRONICLES 2020?25(4):378?380.",47.0,YR,,F,Y,,,20210823.0,,MD,GR,GR,2021,Q3,Adult
189629194,18962919,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Renal impairment,,2021,Q3,4,F,,20210818.0,20210303,20210823,EXP,,GR-ROCHE-2779769,ROCHE,"IOANNIS P, GEORGIA PANTAZIDOU2, STAMATIA CHATZIPERI1, ANDREAS BAIKOUSIS1, PANAGIOTIS KOROVESSIS1. GLUTEAL COMPARTMENT SYNDROME? INTOXICATION? DRUG?INDUCED RHABDOMYOLYSIS? HEMODIALYSIS? FASCIOTOMY? DELAYED DIAGNOSIS,.. SURGICAL CHRONICLES 2020?25(4):378?380.",47.0,YR,,F,Y,,,20210823.0,,MD,GR,GR,2021,Q3,Adult
189629194,18962919,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Rhabdomyolysis,,2021,Q3,4,F,,20210818.0,20210303,20210823,EXP,,GR-ROCHE-2779769,ROCHE,"IOANNIS P, GEORGIA PANTAZIDOU2, STAMATIA CHATZIPERI1, ANDREAS BAIKOUSIS1, PANAGIOTIS KOROVESSIS1. GLUTEAL COMPARTMENT SYNDROME? INTOXICATION? DRUG?INDUCED RHABDOMYOLYSIS? HEMODIALYSIS? FASCIOTOMY? DELAYED DIAGNOSIS,.. SURGICAL CHRONICLES 2020?25(4):378?380.",47.0,YR,,F,Y,,,20210823.0,,MD,GR,GR,2021,Q3,Adult
189629194,18962919,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Weight bearing difficulty,,2021,Q3,4,F,,20210818.0,20210303,20210823,EXP,,GR-ROCHE-2779769,ROCHE,"IOANNIS P, GEORGIA PANTAZIDOU2, STAMATIA CHATZIPERI1, ANDREAS BAIKOUSIS1, PANAGIOTIS KOROVESSIS1. GLUTEAL COMPARTMENT SYNDROME? INTOXICATION? DRUG?INDUCED RHABDOMYOLYSIS? HEMODIALYSIS? FASCIOTOMY? DELAYED DIAGNOSIS,.. SURGICAL CHRONICLES 2020?25(4):378?380.",47.0,YR,,F,Y,,,20210823.0,,MD,GR,GR,2021,Q3,Adult
189799483,18979948,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Drug abuse,,2021,Q3,3,F,,20210817.0,20210308,20210825,EXP,,GR-ACCORD-219334,ACCORD,"PAPAIOANNOU I, PANTAZIDOU G, CHATZIPERI S, BAIKOUSIS A, KOROVESSIS P. GLUTEAL COMPARTMENT SYNDROME? THE MISSING DIAGNOSIS. CASE PRESENTATION AND BRIEF LITERATURE REVIEW. SURGICAL CHRONICLES. 2020? 25(4): 378?380.",47.0,YR,,F,Y,,,20210825.0,,MD,GR,GR,2021,Q3,Adult
189799483,18979948,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Labelled drug-food interaction issue,,2021,Q3,3,F,,20210817.0,20210308,20210825,EXP,,GR-ACCORD-219334,ACCORD,"PAPAIOANNOU I, PANTAZIDOU G, CHATZIPERI S, BAIKOUSIS A, KOROVESSIS P. GLUTEAL COMPARTMENT SYNDROME? THE MISSING DIAGNOSIS. CASE PRESENTATION AND BRIEF LITERATURE REVIEW. SURGICAL CHRONICLES. 2020? 25(4): 378?380.",47.0,YR,,F,Y,,,20210825.0,,MD,GR,GR,2021,Q3,Adult
189799483,18979948,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Rhabdomyolysis,,2021,Q3,3,F,,20210817.0,20210308,20210825,EXP,,GR-ACCORD-219334,ACCORD,"PAPAIOANNOU I, PANTAZIDOU G, CHATZIPERI S, BAIKOUSIS A, KOROVESSIS P. GLUTEAL COMPARTMENT SYNDROME? THE MISSING DIAGNOSIS. CASE PRESENTATION AND BRIEF LITERATURE REVIEW. SURGICAL CHRONICLES. 2020? 25(4): 378?380.",47.0,YR,,F,Y,,,20210825.0,,MD,GR,GR,2021,Q3,Adult
189803002,18980300,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Drug interaction,,2021,Q3,2,F,,20210905.0,20210308,20210916,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK052514,GLENMARK,"ROBINSON ZS, ARVIN JP, MADDING KL.. RIVAROXABAN FAILURE IN A PATIENT TAKING OXCARBAZEPINE.. ANNALS OF PHARMACOTHERAPY.. 2021?55 (10):1302?1303",28.0,YR,,M,Y,146.0,KG,20210916.0,,HP,US,US,2021,Q3,Young Adult
189803002,18980300,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Drug level decreased,,2021,Q3,2,F,,20210905.0,20210308,20210916,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK052514,GLENMARK,"ROBINSON ZS, ARVIN JP, MADDING KL.. RIVAROXABAN FAILURE IN A PATIENT TAKING OXCARBAZEPINE.. ANNALS OF PHARMACOTHERAPY.. 2021?55 (10):1302?1303",28.0,YR,,M,Y,146.0,KG,20210916.0,,HP,US,US,2021,Q3,Young Adult
189803002,18980300,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Loss of consciousness,,2021,Q3,2,F,,20210905.0,20210308,20210916,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK052514,GLENMARK,"ROBINSON ZS, ARVIN JP, MADDING KL.. RIVAROXABAN FAILURE IN A PATIENT TAKING OXCARBAZEPINE.. ANNALS OF PHARMACOTHERAPY.. 2021?55 (10):1302?1303",28.0,YR,,M,Y,146.0,KG,20210916.0,,HP,US,US,2021,Q3,Young Adult
189803002,18980300,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Pulmonary embolism,,2021,Q3,2,F,,20210905.0,20210308,20210916,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK052514,GLENMARK,"ROBINSON ZS, ARVIN JP, MADDING KL.. RIVAROXABAN FAILURE IN A PATIENT TAKING OXCARBAZEPINE.. ANNALS OF PHARMACOTHERAPY.. 2021?55 (10):1302?1303",28.0,YR,,M,Y,146.0,KG,20210916.0,,HP,US,US,2021,Q3,Young Adult
189803002,18980300,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Treatment failure,,2021,Q3,2,F,,20210905.0,20210308,20210916,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK052514,GLENMARK,"ROBINSON ZS, ARVIN JP, MADDING KL.. RIVAROXABAN FAILURE IN A PATIENT TAKING OXCARBAZEPINE.. ANNALS OF PHARMACOTHERAPY.. 2021?55 (10):1302?1303",28.0,YR,,M,Y,146.0,KG,20210916.0,,HP,US,US,2021,Q3,Young Adult
189850362,18985036,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Acute kidney injury,,2021,Q3,2,F,2009.0,20210922.0,20210308,20210930,EXP,,US-ASTRAZENECA-2021A096052,ASTRAZENECA,,48.0,YR,,M,Y,94.3,KG,20210930.0,,,US,US,2021,Q3,Adult
189850362,18985036,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Chronic kidney disease,,2021,Q3,2,F,2009.0,20210922.0,20210308,20210930,EXP,,US-ASTRAZENECA-2021A096052,ASTRAZENECA,,48.0,YR,,M,Y,94.3,KG,20210930.0,,,US,US,2021,Q3,Adult
189850362,18985036,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Chronic kidney disease-mineral and bone disorder,,2021,Q3,2,F,2009.0,20210922.0,20210308,20210930,EXP,,US-ASTRAZENECA-2021A096052,ASTRAZENECA,,48.0,YR,,M,Y,94.3,KG,20210930.0,,,US,US,2021,Q3,Adult
189850362,18985036,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,End stage renal disease,,2021,Q3,2,F,2009.0,20210922.0,20210308,20210930,EXP,,US-ASTRAZENECA-2021A096052,ASTRAZENECA,,48.0,YR,,M,Y,94.3,KG,20210930.0,,,US,US,2021,Q3,Adult
189850362,18985036,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Gastrooesophageal reflux disease,,2021,Q3,2,F,2009.0,20210922.0,20210308,20210930,EXP,,US-ASTRAZENECA-2021A096052,ASTRAZENECA,,48.0,YR,,M,Y,94.3,KG,20210930.0,,,US,US,2021,Q3,Adult
189850362,18985036,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Nephrogenic anaemia,,2021,Q3,2,F,2009.0,20210922.0,20210308,20210930,EXP,,US-ASTRAZENECA-2021A096052,ASTRAZENECA,,48.0,YR,,M,Y,94.3,KG,20210930.0,,,US,US,2021,Q3,Adult
189850362,18985036,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Renal failure,,2021,Q3,2,F,2009.0,20210922.0,20210308,20210930,EXP,,US-ASTRAZENECA-2021A096052,ASTRAZENECA,,48.0,YR,,M,Y,94.3,KG,20210930.0,,,US,US,2021,Q3,Adult
189850362,18985036,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Renal injury,,2021,Q3,2,F,2009.0,20210922.0,20210308,20210930,EXP,,US-ASTRAZENECA-2021A096052,ASTRAZENECA,,48.0,YR,,M,Y,94.3,KG,20210930.0,,,US,US,2021,Q3,Adult
190225083,19022508,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,,,,,,,,,26.0,IU,UNKNOWN,QD,2021,Q3,Embolism,,2021,Q3,3,F,20210215.0,20210715.0,20210318,20210722,EXP,,ES-JNJFOC-20210328823,JOHNSON AND JOHNSON,,68.0,YR,E,M,Y,73.0,KG,20210722.0,,HP,ES,ES,2021,Q3,Elderly
190392333,19039233,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 UNITS,,,,,,,,,,,QD,2021,Q3,Acute kidney injury,,2021,Q3,3,F,20210223.0,20210728.0,20210322,20210806,EXP,,US-ROCHE-2787925,ROCHE,,67.0,YR,,M,Y,110.0,KG,20210806.0,,MD,US,US,2021,Q3,Elderly
190392333,19039233,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 UNITS,,,,,,,,,,,QD,2021,Q3,Dehydration,,2021,Q3,3,F,20210223.0,20210728.0,20210322,20210806,EXP,,US-ROCHE-2787925,ROCHE,,67.0,YR,,M,Y,110.0,KG,20210806.0,,MD,US,US,2021,Q3,Elderly
190392333,19039233,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 UNITS,,,,,,,,,,,QD,2021,Q3,Tumour lysis syndrome,,2021,Q3,3,F,20210223.0,20210728.0,20210322,20210806,EXP,,US-ROCHE-2787925,ROCHE,,67.0,YR,,M,Y,110.0,KG,20210806.0,,MD,US,US,2021,Q3,Elderly
190516232,19051623,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 IU,,,,,,,,10.0,IU,,,2021,Q3,Anxiety,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 IU,,,,,,,,10.0,IU,,,2021,Q3,Beta haemolytic streptococcal infection,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 IU,,,,,,,,10.0,IU,,,2021,Q3,Cellulitis,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 IU,,,,,,,,10.0,IU,,,2021,Q3,Cellulitis orbital,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 IU,,,,,,,,10.0,IU,,,2021,Q3,Constipation,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 IU,,,,,,,,10.0,IU,,,2021,Q3,Crying,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 IU,,,,,,,,10.0,IU,,,2021,Q3,Diarrhoea,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 IU,,,,,,,,10.0,IU,,,2021,Q3,Drug hypersensitivity,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 IU,,,,,,,,10.0,IU,,,2021,Q3,Empty sella syndrome,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 IU,,,,,,,,10.0,IU,,,2021,Q3,Erythema,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 IU,,,,,,,,10.0,IU,,,2021,Q3,Hemianopia,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 IU,,,,,,,,10.0,IU,,,2021,Q3,Hyperglycaemia,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 IU,,,,,,,,10.0,IU,,,2021,Q3,Hypokalaemia,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 IU,,,,,,,,10.0,IU,,,2021,Q3,Insomnia,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 IU,,,,,,,,10.0,IU,,,2021,Q3,Nausea,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 IU,,,,,,,,10.0,IU,,,2021,Q3,Nervousness,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 IU,,,,,,,,10.0,IU,,,2021,Q3,Neuropathy peripheral,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 IU,,,,,,,,10.0,IU,,,2021,Q3,Osteoarthritis,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 IU,,,,,,,,10.0,IU,,,2021,Q3,Pollakiuria,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 IU,,,,,,,,10.0,IU,,,2021,Q3,Presyncope,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 IU,,,,,,,,10.0,IU,,,2021,Q3,Rhinorrhoea,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 IU,,,,,,,,10.0,IU,,,2021,Q3,Throat tightness,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 IU,,,,,,,,10.0,IU,,,2021,Q3,Tooth disorder,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 IU,,,,,,,,10.0,IU,,,2021,Q3,Tremor,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 IU,,,,,,,,10.0,IU,,,2021,Q3,Vision blurred,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 IU,,,,,,,,10.0,IU,,,2021,Q3,Vomiting,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 IU,,,,,,,,10.0,IU,,,2021,Q3,White blood cell count increased,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190620272,19062027,4,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Cardiogenic shock,,2021,Q3,2,F,,20210902.0,20210326,20210903,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-288038,RANBAXY,"WALTER N, JONES K, HERR D, KACZOROWSKI D, KIM H. CLINICAL CHARACTERISTICS IN CARDIOTOXIC AGENT OVERDOSE NECESSITATING VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION: A CASE SERIES. CLIN TOXICOL (PHILA). 2020?58(11):1254?1256 (301)",24.0,YR,,M,Y,,,20210903.0,,MD,US,US,2021,Q3,Young Adult
190620272,19062027,4,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Overdose,,2021,Q3,2,F,,20210902.0,20210326,20210903,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-288038,RANBAXY,"WALTER N, JONES K, HERR D, KACZOROWSKI D, KIM H. CLINICAL CHARACTERISTICS IN CARDIOTOXIC AGENT OVERDOSE NECESSITATING VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION: A CASE SERIES. CLIN TOXICOL (PHILA). 2020?58(11):1254?1256 (301)",24.0,YR,,M,Y,,,20210903.0,,MD,US,US,2021,Q3,Young Adult
190722943,19072294,19,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Sunconjunctival,,,,,,,,,12.0,IU,,,2021,Q3,Cardiac failure,,2021,Q3,3,F,20210208.0,20210817.0,20210330,20210826,EXP,FR-AFSSAPS-AN20211021,FR-ABBVIE-21K-056-3831732-00,ABBVIE,,70.0,YR,,M,Y,59.2,KG,20210826.0,,MD,FR,FR,2021,Q3,Elderly
190805745,19080574,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q3,Peripheral motor neuropathy,,2021,Q3,5,F,20210309.0,20210823.0,20210331,20210831,EXP,,US-CELGENEUS-USA-20210305956,CELGENE,,50.0,YR,,F,Y,95.3,KG,20210831.0,,HP,US,US,2021,Q3,Adult
190984787,19098478,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,45 UNIT,,,U,,,,,45.0,DF,,,2021,Q3,Anaemia,,2021,Q3,7,F,20210324.0,20210921.0,20210406,20210927,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-031764,BRISTOL MYERS SQUIBB,,73.0,YR,,F,Y,,,20210927.0,,HP,US,US,2021,Q3,Elderly
190984787,19098478,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,45 UNIT,,,U,,,,,45.0,DF,,,2021,Q3,Diabetes mellitus,,2021,Q3,7,F,20210324.0,20210921.0,20210406,20210927,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-031764,BRISTOL MYERS SQUIBB,,73.0,YR,,F,Y,,,20210927.0,,HP,US,US,2021,Q3,Elderly
190984787,19098478,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,45 UNIT,,,U,,,,,45.0,DF,,,2021,Q3,Diarrhoea,,2021,Q3,7,F,20210324.0,20210921.0,20210406,20210927,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-031764,BRISTOL MYERS SQUIBB,,73.0,YR,,F,Y,,,20210927.0,,HP,US,US,2021,Q3,Elderly
190984787,19098478,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,45 UNIT,,,U,,,,,45.0,DF,,,2021,Q3,Dizziness,,2021,Q3,7,F,20210324.0,20210921.0,20210406,20210927,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-031764,BRISTOL MYERS SQUIBB,,73.0,YR,,F,Y,,,20210927.0,,HP,US,US,2021,Q3,Elderly
190984787,19098478,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,45 UNIT,,,U,,,,,45.0,DF,,,2021,Q3,Heart rate increased,,2021,Q3,7,F,20210324.0,20210921.0,20210406,20210927,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-031764,BRISTOL MYERS SQUIBB,,73.0,YR,,F,Y,,,20210927.0,,HP,US,US,2021,Q3,Elderly
190984787,19098478,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,45 UNIT,,,U,,,,,45.0,DF,,,2021,Q3,Hypotension,,2021,Q3,7,F,20210324.0,20210921.0,20210406,20210927,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-031764,BRISTOL MYERS SQUIBB,,73.0,YR,,F,Y,,,20210927.0,,HP,US,US,2021,Q3,Elderly
190984787,19098478,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,45 UNIT,,,U,,,,,45.0,DF,,,2021,Q3,Palpitations,,2021,Q3,7,F,20210324.0,20210921.0,20210406,20210927,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-031764,BRISTOL MYERS SQUIBB,,73.0,YR,,F,Y,,,20210927.0,,HP,US,US,2021,Q3,Elderly
190984787,19098478,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,45 UNIT,,,U,,,,,45.0,DF,,,2021,Q3,Swelling of eyelid,,2021,Q3,7,F,20210324.0,20210921.0,20210406,20210927,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-031764,BRISTOL MYERS SQUIBB,,73.0,YR,,F,Y,,,20210927.0,,HP,US,US,2021,Q3,Elderly
190984787,19098478,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,45 UNIT,,,U,,,,,45.0,DF,,,2021,Q3,Syncope,,2021,Q3,7,F,20210324.0,20210921.0,20210406,20210927,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-031764,BRISTOL MYERS SQUIBB,,73.0,YR,,F,Y,,,20210927.0,,HP,US,US,2021,Q3,Elderly
1911844915,19118449,5,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2021,Q3,Platelet count decreased,,2021,Q3,15,F,20210317.0,20210809.0,20210409,20210816,EXP,,CN-ROCHE-2803858,ROCHE,,53.0,YR,,F,Y,56.0,KG,20210816.0,,MD,CN,CN,2021,Q3,Adult
1911844915,19118449,5,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2021,Q3,Pneumonia,,2021,Q3,15,F,20210317.0,20210809.0,20210409,20210816,EXP,,CN-ROCHE-2803858,ROCHE,,53.0,YR,,F,Y,56.0,KG,20210816.0,,MD,CN,CN,2021,Q3,Adult
191456822,19145682,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,24?30U IN THE MORNING,,,,, UNKNOWN,,,,,INJECTION,QD,2021,Q3,Drug dependence,,2021,Q3,2,F,,20210914.0,20210416,20210921,EXP,,"PT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-096139",BOEHRINGER INGELHEIM,"FERNANDES LN, SILVA D.. THE IMPORTANCE OF QUESTIONING THE DIAGNOSIS OF DIABETES MELLITUS TYPE 2: A CASE OF LADA. PORTUGUESE CONGRESS OF ENDOCRINOLOGY /72ND SPEDM ANNUAL MEETING? REVISTA PORTUGU. 2021?16 SUPPLEMENT:53",65.0,YR,E,F,Y,,,20210921.0,,,COUNTRY NOT SPECIFIED,PT,2021,Q3,Elderly
191456822,19145682,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,24?30U IN THE MORNING,,,,, UNKNOWN,,,,,INJECTION,QD,2021,Q3,Vomiting,,2021,Q3,2,F,,20210914.0,20210416,20210921,EXP,,"PT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-096139",BOEHRINGER INGELHEIM,"FERNANDES LN, SILVA D.. THE IMPORTANCE OF QUESTIONING THE DIAGNOSIS OF DIABETES MELLITUS TYPE 2: A CASE OF LADA. PORTUGUESE CONGRESS OF ENDOCRINOLOGY /72ND SPEDM ANNUAL MEETING? REVISTA PORTUGU. 2021?16 SUPPLEMENT:53",65.0,YR,E,F,Y,,,20210921.0,,,COUNTRY NOT SPECIFIED,PT,2021,Q3,Elderly
191456822,19145682,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,24?30U IN THE MORNING,,,,, UNKNOWN,,,,,INJECTION,QD,2021,Q3,Weight increased,,2021,Q3,2,F,,20210914.0,20210416,20210921,EXP,,"PT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-096139",BOEHRINGER INGELHEIM,"FERNANDES LN, SILVA D.. THE IMPORTANCE OF QUESTIONING THE DIAGNOSIS OF DIABETES MELLITUS TYPE 2: A CASE OF LADA. PORTUGUESE CONGRESS OF ENDOCRINOLOGY /72ND SPEDM ANNUAL MEETING? REVISTA PORTUGU. 2021?16 SUPPLEMENT:53",65.0,YR,E,F,Y,,,20210921.0,,,COUNTRY NOT SPECIFIED,PT,2021,Q3,Elderly
191599903,19159990,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, AS DIRECTED",,,,,,,,30.0,IU,,,2021,Q3,Drug hypersensitivity,,2021,Q3,3,F,20210317.0,20210706.0,20210420,20210713,EXP,,US-AMERICAN REGENT INC-2021000982,AMERICAN REGENT,,46.0,YR,,F,Y,81.2,KG,20210713.0,,HP,CH,US,2021,Q3,Adult
191682963,19168296,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"85 INTERNATIONAL UNIT, QD",,,D,,,,,85.0,IU,,QD,2021,Q3,Haemorrhagic stroke,,2021,Q3,3,F,20210309.0,20210903.0,20210422,20210909,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-037668,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,,,20210909.0,,CN,US,US,2021,Q3,Elderly
191743802,19174380,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 IE, 0?0?1?0, BATCH / LOT NR.: REPORTED AS {UNKNOWN}",,,,, UNK,,,18.0,IU,UNKNOWN,QD,2021,Q3,Asthenia,,2021,Q3,2,F,2021.0,20210705.0,20210423,20210713,EXP,,DE-FRESENIUS KABI-FK202103797,FRESENIUS KABI,,79.0,YR,,M,Y,,,20210713.0,,HP,NL,DE,2021,Q3,Elderly
191743802,19174380,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 IE, 0?0?1?0, BATCH / LOT NR.: REPORTED AS {UNKNOWN}",,,,, UNK,,,18.0,IU,UNKNOWN,QD,2021,Q3,General physical health deterioration,,2021,Q3,2,F,2021.0,20210705.0,20210423,20210713,EXP,,DE-FRESENIUS KABI-FK202103797,FRESENIUS KABI,,79.0,YR,,M,Y,,,20210713.0,,HP,NL,DE,2021,Q3,Elderly
191743802,19174380,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 IE, 0?0?1?0, BATCH / LOT NR.: REPORTED AS {UNKNOWN}",,,,, UNK,,,18.0,IU,UNKNOWN,QD,2021,Q3,Immobile,,2021,Q3,2,F,2021.0,20210705.0,20210423,20210713,EXP,,DE-FRESENIUS KABI-FK202103797,FRESENIUS KABI,,79.0,YR,,M,Y,,,20210713.0,,HP,NL,DE,2021,Q3,Elderly
191743802,19174380,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 IE, 0?0?1?0, BATCH / LOT NR.: REPORTED AS {UNKNOWN}",,,,, UNK,,,18.0,IU,UNKNOWN,QD,2021,Q3,Jaundice,,2021,Q3,2,F,2021.0,20210705.0,20210423,20210713,EXP,,DE-FRESENIUS KABI-FK202103797,FRESENIUS KABI,,79.0,YR,,M,Y,,,20210713.0,,HP,NL,DE,2021,Q3,Elderly
191743802,19174380,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 IE, 0?0?1?0, BATCH / LOT NR.: REPORTED AS {UNKNOWN}",,,,, UNK,,,18.0,IU,UNKNOWN,QD,2021,Q3,Pyrexia,,2021,Q3,2,F,2021.0,20210705.0,20210423,20210713,EXP,,DE-FRESENIUS KABI-FK202103797,FRESENIUS KABI,,79.0,YR,,M,Y,,,20210713.0,,HP,NL,DE,2021,Q3,Elderly
191873432,19187343,1,PS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,Unknown,UNK,,,,, BF2000583,,210605.0,,,INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,2,F,,20210902.0,20210427,20210909,30DAY,,DK-MYLANLABS-2021M1023884,MYLAN,,60.0,YR,,M,Y,,,20210909.0,,PH,DK,DK,2021,Q3,Adult
191873432,19187343,1,PS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,Unknown,UNK,,,,, BF2000583,,210605.0,,,INJECTION,,2021,Q3,Device malfunction,,2021,Q3,2,F,,20210902.0,20210427,20210909,30DAY,,DK-MYLANLABS-2021M1023884,MYLAN,,60.0,YR,,M,Y,,,20210909.0,,PH,DK,DK,2021,Q3,Adult
191873432,19187343,1,PS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,Unknown,UNK,,,,, BF2000583,,210605.0,,,INJECTION,,2021,Q3,Drug ineffective,,2021,Q3,2,F,,20210902.0,20210427,20210909,30DAY,,DK-MYLANLABS-2021M1023884,MYLAN,,60.0,YR,,M,Y,,,20210909.0,,PH,DK,DK,2021,Q3,Adult
191879782,19187978,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q3,Flatulence,,2021,Q3,2,F,20201203.0,20210719.0,20210427,20210802,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202104007221,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210802.0,,MD,DE,DE,2021,Q3,Elderly
191879782,19187978,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q3,Ketoacidosis,,2021,Q3,2,F,20201203.0,20210719.0,20210427,20210802,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202104007221,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210802.0,,MD,DE,DE,2021,Q3,Elderly
192093413,19209341,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, DAILY",,,,,,,,18.0,IU,,QD,2021,Q3,Blood glucose increased,,2021,Q3,3,F,2021.0,20210715.0,20210503,20210727,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104009832,ELI LILLY AND CO,,71.0,YR,,F,Y,92.0,KG,20210727.0,,CN,ES,ES,2021,Q3,Elderly
192093413,19209341,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, DAILY",,,,,,,,18.0,IU,,QD,2021,Q3,Cardiovascular disorder,,2021,Q3,3,F,2021.0,20210715.0,20210503,20210727,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104009832,ELI LILLY AND CO,,71.0,YR,,F,Y,92.0,KG,20210727.0,,CN,ES,ES,2021,Q3,Elderly
192093413,19209341,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, DAILY",,,,,,,,18.0,IU,,QD,2021,Q3,Decreased appetite,,2021,Q3,3,F,2021.0,20210715.0,20210503,20210727,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104009832,ELI LILLY AND CO,,71.0,YR,,F,Y,92.0,KG,20210727.0,,CN,ES,ES,2021,Q3,Elderly
192093413,19209341,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, DAILY",,,,,,,,18.0,IU,,QD,2021,Q3,Discomfort,,2021,Q3,3,F,2021.0,20210715.0,20210503,20210727,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104009832,ELI LILLY AND CO,,71.0,YR,,F,Y,92.0,KG,20210727.0,,CN,ES,ES,2021,Q3,Elderly
192093413,19209341,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, DAILY",,,,,,,,18.0,IU,,QD,2021,Q3,Dizziness,,2021,Q3,3,F,2021.0,20210715.0,20210503,20210727,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104009832,ELI LILLY AND CO,,71.0,YR,,F,Y,92.0,KG,20210727.0,,CN,ES,ES,2021,Q3,Elderly
192093413,19209341,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, DAILY",,,,,,,,18.0,IU,,QD,2021,Q3,Flatulence,,2021,Q3,3,F,2021.0,20210715.0,20210503,20210727,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104009832,ELI LILLY AND CO,,71.0,YR,,F,Y,92.0,KG,20210727.0,,CN,ES,ES,2021,Q3,Elderly
192093413,19209341,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, DAILY",,,,,,,,18.0,IU,,QD,2021,Q3,Illness,,2021,Q3,3,F,2021.0,20210715.0,20210503,20210727,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104009832,ELI LILLY AND CO,,71.0,YR,,F,Y,92.0,KG,20210727.0,,CN,ES,ES,2021,Q3,Elderly
192093413,19209341,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, DAILY",,,,,,,,18.0,IU,,QD,2021,Q3,Inappropriate schedule of product administration,,2021,Q3,3,F,2021.0,20210715.0,20210503,20210727,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104009832,ELI LILLY AND CO,,71.0,YR,,F,Y,92.0,KG,20210727.0,,CN,ES,ES,2021,Q3,Elderly
192093413,19209341,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, DAILY",,,,,,,,18.0,IU,,QD,2021,Q3,Nausea,,2021,Q3,3,F,2021.0,20210715.0,20210503,20210727,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104009832,ELI LILLY AND CO,,71.0,YR,,F,Y,92.0,KG,20210727.0,,CN,ES,ES,2021,Q3,Elderly
192093413,19209341,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, DAILY",,,,,,,,18.0,IU,,QD,2021,Q3,Osteoporosis,,2021,Q3,3,F,2021.0,20210715.0,20210503,20210727,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104009832,ELI LILLY AND CO,,71.0,YR,,F,Y,92.0,KG,20210727.0,,CN,ES,ES,2021,Q3,Elderly
192093413,19209341,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, DAILY",,,,,,,,18.0,IU,,QD,2021,Q3,Paraesthesia,,2021,Q3,3,F,2021.0,20210715.0,20210503,20210727,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104009832,ELI LILLY AND CO,,71.0,YR,,F,Y,92.0,KG,20210727.0,,CN,ES,ES,2021,Q3,Elderly
192093413,19209341,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, DAILY",,,,,,,,18.0,IU,,QD,2021,Q3,Urinary tract infection,,2021,Q3,3,F,2021.0,20210715.0,20210503,20210727,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104009832,ELI LILLY AND CO,,71.0,YR,,F,Y,92.0,KG,20210727.0,,CN,ES,ES,2021,Q3,Elderly
192093413,19209341,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, DAILY",,,,,,,,18.0,IU,,QD,2021,Q3,Weight decreased,,2021,Q3,3,F,2021.0,20210715.0,20210503,20210727,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104009832,ELI LILLY AND CO,,71.0,YR,,F,Y,92.0,KG,20210727.0,,CN,ES,ES,2021,Q3,Elderly
192093413,19209341,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, DF784A,,,,,,,2021,Q3,Blood glucose increased,,2021,Q3,3,F,2021.0,20210715.0,20210503,20210727,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104009832,ELI LILLY AND CO,,71.0,YR,,F,Y,92.0,KG,20210727.0,,CN,ES,ES,2021,Q3,Elderly
192093413,19209341,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, DF784A,,,,,,,2021,Q3,Cardiovascular disorder,,2021,Q3,3,F,2021.0,20210715.0,20210503,20210727,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104009832,ELI LILLY AND CO,,71.0,YR,,F,Y,92.0,KG,20210727.0,,CN,ES,ES,2021,Q3,Elderly
192093413,19209341,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, DF784A,,,,,,,2021,Q3,Decreased appetite,,2021,Q3,3,F,2021.0,20210715.0,20210503,20210727,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104009832,ELI LILLY AND CO,,71.0,YR,,F,Y,92.0,KG,20210727.0,,CN,ES,ES,2021,Q3,Elderly
192093413,19209341,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, DF784A,,,,,,,2021,Q3,Discomfort,,2021,Q3,3,F,2021.0,20210715.0,20210503,20210727,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104009832,ELI LILLY AND CO,,71.0,YR,,F,Y,92.0,KG,20210727.0,,CN,ES,ES,2021,Q3,Elderly
192093413,19209341,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, DF784A,,,,,,,2021,Q3,Dizziness,,2021,Q3,3,F,2021.0,20210715.0,20210503,20210727,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104009832,ELI LILLY AND CO,,71.0,YR,,F,Y,92.0,KG,20210727.0,,CN,ES,ES,2021,Q3,Elderly
192093413,19209341,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, DF784A,,,,,,,2021,Q3,Flatulence,,2021,Q3,3,F,2021.0,20210715.0,20210503,20210727,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104009832,ELI LILLY AND CO,,71.0,YR,,F,Y,92.0,KG,20210727.0,,CN,ES,ES,2021,Q3,Elderly
192093413,19209341,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, DF784A,,,,,,,2021,Q3,Illness,,2021,Q3,3,F,2021.0,20210715.0,20210503,20210727,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104009832,ELI LILLY AND CO,,71.0,YR,,F,Y,92.0,KG,20210727.0,,CN,ES,ES,2021,Q3,Elderly
192093413,19209341,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, DF784A,,,,,,,2021,Q3,Inappropriate schedule of product administration,,2021,Q3,3,F,2021.0,20210715.0,20210503,20210727,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104009832,ELI LILLY AND CO,,71.0,YR,,F,Y,92.0,KG,20210727.0,,CN,ES,ES,2021,Q3,Elderly
192093413,19209341,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, DF784A,,,,,,,2021,Q3,Nausea,,2021,Q3,3,F,2021.0,20210715.0,20210503,20210727,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104009832,ELI LILLY AND CO,,71.0,YR,,F,Y,92.0,KG,20210727.0,,CN,ES,ES,2021,Q3,Elderly
192093413,19209341,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, DF784A,,,,,,,2021,Q3,Osteoporosis,,2021,Q3,3,F,2021.0,20210715.0,20210503,20210727,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104009832,ELI LILLY AND CO,,71.0,YR,,F,Y,92.0,KG,20210727.0,,CN,ES,ES,2021,Q3,Elderly
192093413,19209341,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, DF784A,,,,,,,2021,Q3,Paraesthesia,,2021,Q3,3,F,2021.0,20210715.0,20210503,20210727,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104009832,ELI LILLY AND CO,,71.0,YR,,F,Y,92.0,KG,20210727.0,,CN,ES,ES,2021,Q3,Elderly
192093413,19209341,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, DF784A,,,,,,,2021,Q3,Urinary tract infection,,2021,Q3,3,F,2021.0,20210715.0,20210503,20210727,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104009832,ELI LILLY AND CO,,71.0,YR,,F,Y,92.0,KG,20210727.0,,CN,ES,ES,2021,Q3,Elderly
192093413,19209341,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, DF784A,,,,,,,2021,Q3,Weight decreased,,2021,Q3,3,F,2021.0,20210715.0,20210503,20210727,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104009832,ELI LILLY AND CO,,71.0,YR,,F,Y,92.0,KG,20210727.0,,CN,ES,ES,2021,Q3,Elderly
192213733,19221373,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD (DOSE INCREASED)",,,,, DF784A,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,3,F,2021.0,20210719.0,20210505,20210730,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210731.0,,HP,ES,ES,2021,Q3,Elderly
192213733,19221373,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD (DOSE INCREASED)",,,,, DF784A,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Cardiovascular disorder,,2021,Q3,3,F,2021.0,20210719.0,20210505,20210730,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210731.0,,HP,ES,ES,2021,Q3,Elderly
192213733,19221373,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD (DOSE INCREASED)",,,,, DF784A,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Decreased appetite,,2021,Q3,3,F,2021.0,20210719.0,20210505,20210730,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210731.0,,HP,ES,ES,2021,Q3,Elderly
192213733,19221373,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD (DOSE INCREASED)",,,,, DF784A,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Discomfort,,2021,Q3,3,F,2021.0,20210719.0,20210505,20210730,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210731.0,,HP,ES,ES,2021,Q3,Elderly
192213733,19221373,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD (DOSE INCREASED)",,,,, DF784A,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Dizziness,,2021,Q3,3,F,2021.0,20210719.0,20210505,20210730,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210731.0,,HP,ES,ES,2021,Q3,Elderly
192213733,19221373,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD (DOSE INCREASED)",,,,, DF784A,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Flatulence,,2021,Q3,3,F,2021.0,20210719.0,20210505,20210730,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210731.0,,HP,ES,ES,2021,Q3,Elderly
192213733,19221373,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD (DOSE INCREASED)",,,,, DF784A,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Illness,,2021,Q3,3,F,2021.0,20210719.0,20210505,20210730,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210731.0,,HP,ES,ES,2021,Q3,Elderly
192213733,19221373,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD (DOSE INCREASED)",,,,, DF784A,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Inappropriate schedule of product administration,,2021,Q3,3,F,2021.0,20210719.0,20210505,20210730,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210731.0,,HP,ES,ES,2021,Q3,Elderly
192213733,19221373,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD (DOSE INCREASED)",,,,, DF784A,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Nausea,,2021,Q3,3,F,2021.0,20210719.0,20210505,20210730,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210731.0,,HP,ES,ES,2021,Q3,Elderly
192213733,19221373,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD (DOSE INCREASED)",,,,, DF784A,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Osteoporosis,,2021,Q3,3,F,2021.0,20210719.0,20210505,20210730,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210731.0,,HP,ES,ES,2021,Q3,Elderly
192213733,19221373,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD (DOSE INCREASED)",,,,, DF784A,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Paraesthesia,,2021,Q3,3,F,2021.0,20210719.0,20210505,20210730,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210731.0,,HP,ES,ES,2021,Q3,Elderly
192213733,19221373,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD (DOSE INCREASED)",,,,, DF784A,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Urinary tract infection,,2021,Q3,3,F,2021.0,20210719.0,20210505,20210730,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210731.0,,HP,ES,ES,2021,Q3,Elderly
192213733,19221373,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD (DOSE INCREASED)",,,,, DF784A,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Weight decreased,,2021,Q3,3,F,2021.0,20210719.0,20210505,20210730,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210731.0,,HP,ES,ES,2021,Q3,Elderly
192213733,19221373,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, DF784A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,3,F,2021.0,20210719.0,20210505,20210730,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210731.0,,HP,ES,ES,2021,Q3,Elderly
192213733,19221373,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, DF784A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Cardiovascular disorder,,2021,Q3,3,F,2021.0,20210719.0,20210505,20210730,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210731.0,,HP,ES,ES,2021,Q3,Elderly
192213733,19221373,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, DF784A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Decreased appetite,,2021,Q3,3,F,2021.0,20210719.0,20210505,20210730,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210731.0,,HP,ES,ES,2021,Q3,Elderly
192213733,19221373,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, DF784A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Discomfort,,2021,Q3,3,F,2021.0,20210719.0,20210505,20210730,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210731.0,,HP,ES,ES,2021,Q3,Elderly
192213733,19221373,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, DF784A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Dizziness,,2021,Q3,3,F,2021.0,20210719.0,20210505,20210730,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210731.0,,HP,ES,ES,2021,Q3,Elderly
192213733,19221373,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, DF784A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Flatulence,,2021,Q3,3,F,2021.0,20210719.0,20210505,20210730,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210731.0,,HP,ES,ES,2021,Q3,Elderly
192213733,19221373,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, DF784A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Illness,,2021,Q3,3,F,2021.0,20210719.0,20210505,20210730,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210731.0,,HP,ES,ES,2021,Q3,Elderly
192213733,19221373,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, DF784A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Inappropriate schedule of product administration,,2021,Q3,3,F,2021.0,20210719.0,20210505,20210730,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210731.0,,HP,ES,ES,2021,Q3,Elderly
192213733,19221373,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, DF784A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Nausea,,2021,Q3,3,F,2021.0,20210719.0,20210505,20210730,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210731.0,,HP,ES,ES,2021,Q3,Elderly
192213733,19221373,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, DF784A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Osteoporosis,,2021,Q3,3,F,2021.0,20210719.0,20210505,20210730,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210731.0,,HP,ES,ES,2021,Q3,Elderly
192213733,19221373,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, DF784A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Paraesthesia,,2021,Q3,3,F,2021.0,20210719.0,20210505,20210730,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210731.0,,HP,ES,ES,2021,Q3,Elderly
192213733,19221373,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, DF784A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Urinary tract infection,,2021,Q3,3,F,2021.0,20210719.0,20210505,20210730,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210731.0,,HP,ES,ES,2021,Q3,Elderly
192213733,19221373,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, DF784A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Weight decreased,,2021,Q3,3,F,2021.0,20210719.0,20210505,20210730,EXP,,NVSC2021ES092182,NOVARTIS,,71.0,YR,,F,Y,92.0,KG,20210731.0,,HP,ES,ES,2021,Q3,Elderly
192664982,19266498,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"32.0,U,",,,,,,,,,,,,2021,Q3,Intentional overdose,,2021,Q3,2,F,20210505.0,20210628.0,20210518,20210708,EXP,,BE-NOVOPROD-810668,NOVO NORDISK,,68.0,YR,,F,Y,74.0,KG,20210708.0,,MD,BE,BE,2021,Q3,Elderly
192689957,19268995,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Disseminated varicella zoster virus infection,,2021,Q3,7,F,20210430.0,20210924.0,20210518,20210928,EXP,,NVSC2021US103274,NOVARTIS,,66.0,YR,,M,Y,62.1,KG,20210928.0,,HP,US,US,2021,Q3,Elderly
192841693,19284169,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,INJECTION,,2021,Q3,Cerebral infarction,,2021,Q3,3,F,20210511.0,20210629.0,20210521,20210701,EXP,,NVSC2021CN107829,NOVARTIS,,61.0,YR,,F,Y,56.6,KG,20210701.0,,HP,CN,CN,2021,Q3,Adult
192967363,19296736,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,INJECTION,,2021,Q3,Inappropriate antidiuretic hormone secretion,,2021,Q3,3,F,,20210713.0,20210524,20210720,EXP,,JP-TAKEDA-2021TJP025448,TAKEDA,,83.0,YR,,F,Y,,,20210721.0,,HP,JP,JP,2021,Q3,Elderly
193040482,19304048,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),UNK,,,,,,,,,,,,2021,Q3,Liver disorder,,2021,Q3,2,F,20200524.0,20210707.0,20210525,20210713,EXP,,JP-GILEAD-2020-0468611,GILEAD,,74.0,YR,E,M,Y,61.0,KG,20210713.0,,MD,JP,JP,2021,Q3,Elderly
193040482,19304048,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),UNK,,,,,,,,,,,,2021,Q3,Renal disorder,,2021,Q3,2,F,20200524.0,20210707.0,20210525,20210713,EXP,,JP-GILEAD-2020-0468611,GILEAD,,74.0,YR,E,M,Y,61.0,KG,20210713.0,,MD,JP,JP,2021,Q3,Elderly
193499492,19349949,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK,LONGSTANDING MEDICATION",,,,,,,,,,,,2021,Q3,Acute kidney injury,,2021,Q3,2,F,,20210820.0,20210531,20210903,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-08140,LUPIN,,48.0,YR,,F,Y,,,20210903.0,,CN,NL,US,2021,Q3,Adult
193499492,19349949,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK,LONGSTANDING MEDICATION",,,,,,,,,,,,2021,Q3,Brugada syndrome,,2021,Q3,2,F,,20210820.0,20210531,20210903,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-08140,LUPIN,,48.0,YR,,F,Y,,,20210903.0,,CN,NL,US,2021,Q3,Adult
193499492,19349949,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK,LONGSTANDING MEDICATION",,,,,,,,,,,,2021,Q3,Confusional state,,2021,Q3,2,F,,20210820.0,20210531,20210903,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-08140,LUPIN,,48.0,YR,,F,Y,,,20210903.0,,CN,NL,US,2021,Q3,Adult
193499492,19349949,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK,LONGSTANDING MEDICATION",,,,,,,,,,,,2021,Q3,Dizziness,,2021,Q3,2,F,,20210820.0,20210531,20210903,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-08140,LUPIN,,48.0,YR,,F,Y,,,20210903.0,,CN,NL,US,2021,Q3,Adult
193499492,19349949,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK,LONGSTANDING MEDICATION",,,,,,,,,,,,2021,Q3,Drug interaction,,2021,Q3,2,F,,20210820.0,20210531,20210903,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-08140,LUPIN,,48.0,YR,,F,Y,,,20210903.0,,CN,NL,US,2021,Q3,Adult
193499492,19349949,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK,LONGSTANDING MEDICATION",,,,,,,,,,,,2021,Q3,Fall,,2021,Q3,2,F,,20210820.0,20210531,20210903,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-08140,LUPIN,,48.0,YR,,F,Y,,,20210903.0,,CN,NL,US,2021,Q3,Adult
193499492,19349949,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK,LONGSTANDING MEDICATION",,,,,,,,,,,,2021,Q3,Hyponatraemia,,2021,Q3,2,F,,20210820.0,20210531,20210903,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-08140,LUPIN,,48.0,YR,,F,Y,,,20210903.0,,CN,NL,US,2021,Q3,Adult
193499492,19349949,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK,LONGSTANDING MEDICATION",,,,,,,,,,,,2021,Q3,Hypovolaemia,,2021,Q3,2,F,,20210820.0,20210531,20210903,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-08140,LUPIN,,48.0,YR,,F,Y,,,20210903.0,,CN,NL,US,2021,Q3,Adult
193499492,19349949,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK,LONGSTANDING MEDICATION",,,,,,,,,,,,2021,Q3,Nausea,,2021,Q3,2,F,,20210820.0,20210531,20210903,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-08140,LUPIN,,48.0,YR,,F,Y,,,20210903.0,,CN,NL,US,2021,Q3,Adult
193499492,19349949,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK,LONGSTANDING MEDICATION",,,,,,,,,,,,2021,Q3,Toxicity to various agents,,2021,Q3,2,F,,20210820.0,20210531,20210903,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-08140,LUPIN,,48.0,YR,,F,Y,,,20210903.0,,CN,NL,US,2021,Q3,Adult
193499492,19349949,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK,LONGSTANDING MEDICATION",,,,,,,,,,,,2021,Q3,Tremor,,2021,Q3,2,F,,20210820.0,20210531,20210903,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-08140,LUPIN,,48.0,YR,,F,Y,,,20210903.0,,CN,NL,US,2021,Q3,Adult
193499492,19349949,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK,LONGSTANDING MEDICATION",,,,,,,,,,,,2021,Q3,Unmasking of previously unidentified disease,,2021,Q3,2,F,,20210820.0,20210531,20210903,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-08140,LUPIN,,48.0,YR,,F,Y,,,20210903.0,,CN,NL,US,2021,Q3,Adult
193499492,19349949,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK,LONGSTANDING MEDICATION",,,,,,,,,,,,2021,Q3,Vomiting,,2021,Q3,2,F,,20210820.0,20210531,20210903,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-08140,LUPIN,,48.0,YR,,F,Y,,,20210903.0,,CN,NL,US,2021,Q3,Adult
193639013,19363901,2,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"20 INTERNATIONAL UNIT, DAILY",,,U,,,,,20.0,IU,,QD,2021,Q3,COVID-19,,2021,Q3,3,F,,20210709.0,20210602,20210716,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202105010794,ELI LILLY AND CO,YUASA AET AL..CURRENT STATUS AND SEVERITY OF GLYCEMIC CONTROL IN HOSPITALIZED PATIENTS WITH SARS?COV?2 INFECTION COMPLICATED BY DIABETES MELLITUS.OPEN CALL PROJECT OF THE 64TH ANNUAL MEETING OF THE JAPAN DIABETES SOCIETY ?:.,65.0,YR,,M,Y,,,20210716.0,,MD,JP,JP,2021,Q3,Elderly
193801252,19380125,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Acute kidney injury,,2021,Q3,2,F,,20210820.0,20210607,20210901,EXP,,US-AUROBINDO-AUR-APL-2021-022790,AUROBINDO,,48.0,YR,,F,Y,,,20210901.0,,HP,US,US,2021,Q3,Adult
193801252,19380125,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Brugada syndrome,,2021,Q3,2,F,,20210820.0,20210607,20210901,EXP,,US-AUROBINDO-AUR-APL-2021-022790,AUROBINDO,,48.0,YR,,F,Y,,,20210901.0,,HP,US,US,2021,Q3,Adult
193801252,19380125,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Confusional state,,2021,Q3,2,F,,20210820.0,20210607,20210901,EXP,,US-AUROBINDO-AUR-APL-2021-022790,AUROBINDO,,48.0,YR,,F,Y,,,20210901.0,,HP,US,US,2021,Q3,Adult
193801252,19380125,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Dizziness,,2021,Q3,2,F,,20210820.0,20210607,20210901,EXP,,US-AUROBINDO-AUR-APL-2021-022790,AUROBINDO,,48.0,YR,,F,Y,,,20210901.0,,HP,US,US,2021,Q3,Adult
193801252,19380125,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Drug interaction,,2021,Q3,2,F,,20210820.0,20210607,20210901,EXP,,US-AUROBINDO-AUR-APL-2021-022790,AUROBINDO,,48.0,YR,,F,Y,,,20210901.0,,HP,US,US,2021,Q3,Adult
193801252,19380125,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Fall,,2021,Q3,2,F,,20210820.0,20210607,20210901,EXP,,US-AUROBINDO-AUR-APL-2021-022790,AUROBINDO,,48.0,YR,,F,Y,,,20210901.0,,HP,US,US,2021,Q3,Adult
193801252,19380125,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Gait disturbance,,2021,Q3,2,F,,20210820.0,20210607,20210901,EXP,,US-AUROBINDO-AUR-APL-2021-022790,AUROBINDO,,48.0,YR,,F,Y,,,20210901.0,,HP,US,US,2021,Q3,Adult
193801252,19380125,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Hyponatraemia,,2021,Q3,2,F,,20210820.0,20210607,20210901,EXP,,US-AUROBINDO-AUR-APL-2021-022790,AUROBINDO,,48.0,YR,,F,Y,,,20210901.0,,HP,US,US,2021,Q3,Adult
193801252,19380125,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Hypovolaemia,,2021,Q3,2,F,,20210820.0,20210607,20210901,EXP,,US-AUROBINDO-AUR-APL-2021-022790,AUROBINDO,,48.0,YR,,F,Y,,,20210901.0,,HP,US,US,2021,Q3,Adult
193801252,19380125,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Mucosal dryness,,2021,Q3,2,F,,20210820.0,20210607,20210901,EXP,,US-AUROBINDO-AUR-APL-2021-022790,AUROBINDO,,48.0,YR,,F,Y,,,20210901.0,,HP,US,US,2021,Q3,Adult
193801252,19380125,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Nausea,,2021,Q3,2,F,,20210820.0,20210607,20210901,EXP,,US-AUROBINDO-AUR-APL-2021-022790,AUROBINDO,,48.0,YR,,F,Y,,,20210901.0,,HP,US,US,2021,Q3,Adult
193801252,19380125,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Toxicity to various agents,,2021,Q3,2,F,,20210820.0,20210607,20210901,EXP,,US-AUROBINDO-AUR-APL-2021-022790,AUROBINDO,,48.0,YR,,F,Y,,,20210901.0,,HP,US,US,2021,Q3,Adult
193801252,19380125,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Tremor,,2021,Q3,2,F,,20210820.0,20210607,20210901,EXP,,US-AUROBINDO-AUR-APL-2021-022790,AUROBINDO,,48.0,YR,,F,Y,,,20210901.0,,HP,US,US,2021,Q3,Adult
193801252,19380125,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Vomiting,,2021,Q3,2,F,,20210820.0,20210607,20210901,EXP,,US-AUROBINDO-AUR-APL-2021-022790,AUROBINDO,,48.0,YR,,F,Y,,,20210901.0,,HP,US,US,2021,Q3,Adult
193851042,19385104,9,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, INSULIN GLARGINE 15U AT 09.00 P.M.",,,D,, UNKNOWN,,,,,,,2021,Q3,Hypertensive crisis,,2021,Q3,2,F,,20210721.0,20210608,20210803,EXP,,IT-LUPIN PHARMACEUTICALS INC.-2021-08770,LUPIN,,33.0,YR,,F,Y,,,20210803.0,,HP,IT,IT,2021,Q3,Young Adult
193851042,19385104,9,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, INSULIN GLARGINE 15U AT 09.00 P.M.",,,D,, UNKNOWN,,,,,,,2021,Q3,Maternal exposure during pregnancy,,2021,Q3,2,F,,20210721.0,20210608,20210803,EXP,,IT-LUPIN PHARMACEUTICALS INC.-2021-08770,LUPIN,,33.0,YR,,F,Y,,,20210803.0,,HP,IT,IT,2021,Q3,Young Adult
193851042,19385104,9,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, INSULIN GLARGINE 15U AT 09.00 P.M.",,,D,, UNKNOWN,,,,,,,2021,Q3,Off label use,,2021,Q3,2,F,,20210721.0,20210608,20210803,EXP,,IT-LUPIN PHARMACEUTICALS INC.-2021-08770,LUPIN,,33.0,YR,,F,Y,,,20210803.0,,HP,IT,IT,2021,Q3,Young Adult
193851042,19385104,9,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, INSULIN GLARGINE 15U AT 09.00 P.M.",,,D,, UNKNOWN,,,,,,,2021,Q3,Phaeochromocytoma,,2021,Q3,2,F,,20210721.0,20210608,20210803,EXP,,IT-LUPIN PHARMACEUTICALS INC.-2021-08770,LUPIN,,33.0,YR,,F,Y,,,20210803.0,,HP,IT,IT,2021,Q3,Young Adult
193851042,19385104,9,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, INSULIN GLARGINE 15U AT 09.00 P.M.",,,D,, UNKNOWN,,,,,,,2021,Q3,Premature delivery,,2021,Q3,2,F,,20210721.0,20210608,20210803,EXP,,IT-LUPIN PHARMACEUTICALS INC.-2021-08770,LUPIN,,33.0,YR,,F,Y,,,20210803.0,,HP,IT,IT,2021,Q3,Young Adult
193872792,19387279,6,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK (ACCORDING TO THE SCHEME, INJECTION / INFUSION SOLUTION)",,,,,,,,,,,,2021,Q3,Abdominal pain upper,,2021,Q3,2,F,,20210628.0,20210608,20210708,EXP,,DE-AUROBINDO-AUR-APL-2021-023488,AUROBINDO,,70.0,YR,,F,Y,,,20210708.0,,MD,DE,DE,2021,Q3,Elderly
193872792,19387279,6,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK (ACCORDING TO THE SCHEME, INJECTION / INFUSION SOLUTION)",,,,,,,,,,,,2021,Q3,Dyspnoea,,2021,Q3,2,F,,20210628.0,20210608,20210708,EXP,,DE-AUROBINDO-AUR-APL-2021-023488,AUROBINDO,,70.0,YR,,F,Y,,,20210708.0,,MD,DE,DE,2021,Q3,Elderly
193872792,19387279,6,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK (ACCORDING TO THE SCHEME, INJECTION / INFUSION SOLUTION)",,,,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,2,F,,20210628.0,20210608,20210708,EXP,,DE-AUROBINDO-AUR-APL-2021-023488,AUROBINDO,,70.0,YR,,F,Y,,,20210708.0,,MD,DE,DE,2021,Q3,Elderly
193872792,19387279,6,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK (ACCORDING TO THE SCHEME, INJECTION / INFUSION SOLUTION)",,,,,,,,,,,,2021,Q3,Product prescribing error,,2021,Q3,2,F,,20210628.0,20210608,20210708,EXP,,DE-AUROBINDO-AUR-APL-2021-023488,AUROBINDO,,70.0,YR,,F,Y,,,20210708.0,,MD,DE,DE,2021,Q3,Elderly
193929083,19392908,32,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, ONCE A DAY",,,U,U,,,,,,SOLUTION,QD,2021,Q3,Asthma,,2021,Q3,3,F,,20210914.0,20210609,20210922,EXP,,CA-AUROBINDO-AUR-APL-2021-022535,AUROBINDO,,65.0,YR,,M,Y,,,20210922.0,,CN,CA,CA,2021,Q3,Elderly
193929083,19392908,32,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, ONCE A DAY",,,U,U,,,,,,SOLUTION,QD,2021,Q3,Condition aggravated,,2021,Q3,3,F,,20210914.0,20210609,20210922,EXP,,CA-AUROBINDO-AUR-APL-2021-022535,AUROBINDO,,65.0,YR,,M,Y,,,20210922.0,,CN,CA,CA,2021,Q3,Elderly
193929083,19392908,32,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, ONCE A DAY",,,U,U,,,,,,SOLUTION,QD,2021,Q3,Dyspnoea,,2021,Q3,3,F,,20210914.0,20210609,20210922,EXP,,CA-AUROBINDO-AUR-APL-2021-022535,AUROBINDO,,65.0,YR,,M,Y,,,20210922.0,,CN,CA,CA,2021,Q3,Elderly
193929083,19392908,32,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, ONCE A DAY",,,U,U,,,,,,SOLUTION,QD,2021,Q3,Haemoptysis,,2021,Q3,3,F,,20210914.0,20210609,20210922,EXP,,CA-AUROBINDO-AUR-APL-2021-022535,AUROBINDO,,65.0,YR,,M,Y,,,20210922.0,,CN,CA,CA,2021,Q3,Elderly
193929083,19392908,32,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, ONCE A DAY",,,U,U,,,,,,SOLUTION,QD,2021,Q3,Loss of personal independence in daily activities,,2021,Q3,3,F,,20210914.0,20210609,20210922,EXP,,CA-AUROBINDO-AUR-APL-2021-022535,AUROBINDO,,65.0,YR,,M,Y,,,20210922.0,,CN,CA,CA,2021,Q3,Elderly
193929083,19392908,32,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, ONCE A DAY",,,U,U,,,,,,SOLUTION,QD,2021,Q3,Lung disorder,,2021,Q3,3,F,,20210914.0,20210609,20210922,EXP,,CA-AUROBINDO-AUR-APL-2021-022535,AUROBINDO,,65.0,YR,,M,Y,,,20210922.0,,CN,CA,CA,2021,Q3,Elderly
193929083,19392908,32,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, ONCE A DAY",,,U,U,,,,,,SOLUTION,QD,2021,Q3,Neuritis,,2021,Q3,3,F,,20210914.0,20210609,20210922,EXP,,CA-AUROBINDO-AUR-APL-2021-022535,AUROBINDO,,65.0,YR,,M,Y,,,20210922.0,,CN,CA,CA,2021,Q3,Elderly
193929083,19392908,32,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, ONCE A DAY",,,U,U,,,,,,SOLUTION,QD,2021,Q3,Neurological symptom,,2021,Q3,3,F,,20210914.0,20210609,20210922,EXP,,CA-AUROBINDO-AUR-APL-2021-022535,AUROBINDO,,65.0,YR,,M,Y,,,20210922.0,,CN,CA,CA,2021,Q3,Elderly
193929083,19392908,32,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, ONCE A DAY",,,U,U,,,,,,SOLUTION,QD,2021,Q3,Obstructive airways disorder,,2021,Q3,3,F,,20210914.0,20210609,20210922,EXP,,CA-AUROBINDO-AUR-APL-2021-022535,AUROBINDO,,65.0,YR,,M,Y,,,20210922.0,,CN,CA,CA,2021,Q3,Elderly
193929083,19392908,32,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, ONCE A DAY",,,U,U,,,,,,SOLUTION,QD,2021,Q3,Pain in extremity,,2021,Q3,3,F,,20210914.0,20210609,20210922,EXP,,CA-AUROBINDO-AUR-APL-2021-022535,AUROBINDO,,65.0,YR,,M,Y,,,20210922.0,,CN,CA,CA,2021,Q3,Elderly
193929083,19392908,32,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, ONCE A DAY",,,U,U,,,,,,SOLUTION,QD,2021,Q3,Pulmonary alveolar haemorrhage,,2021,Q3,3,F,,20210914.0,20210609,20210922,EXP,,CA-AUROBINDO-AUR-APL-2021-022535,AUROBINDO,,65.0,YR,,M,Y,,,20210922.0,,CN,CA,CA,2021,Q3,Elderly
193929083,19392908,32,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, ONCE A DAY",,,U,U,,,,,,SOLUTION,QD,2021,Q3,Pulmonary fibrosis,,2021,Q3,3,F,,20210914.0,20210609,20210922,EXP,,CA-AUROBINDO-AUR-APL-2021-022535,AUROBINDO,,65.0,YR,,M,Y,,,20210922.0,,CN,CA,CA,2021,Q3,Elderly
193929083,19392908,32,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, ONCE A DAY",,,U,U,,,,,,SOLUTION,QD,2021,Q3,Pulmonary vasculitis,,2021,Q3,3,F,,20210914.0,20210609,20210922,EXP,,CA-AUROBINDO-AUR-APL-2021-022535,AUROBINDO,,65.0,YR,,M,Y,,,20210922.0,,CN,CA,CA,2021,Q3,Elderly
193929083,19392908,32,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, ONCE A DAY",,,U,U,,,,,,SOLUTION,QD,2021,Q3,Respiratory symptom,,2021,Q3,3,F,,20210914.0,20210609,20210922,EXP,,CA-AUROBINDO-AUR-APL-2021-022535,AUROBINDO,,65.0,YR,,M,Y,,,20210922.0,,CN,CA,CA,2021,Q3,Elderly
193929083,19392908,32,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, ONCE A DAY",,,U,U,,,,,,SOLUTION,QD,2021,Q3,Sleep disorder due to a general medical condition,,2021,Q3,3,F,,20210914.0,20210609,20210922,EXP,,CA-AUROBINDO-AUR-APL-2021-022535,AUROBINDO,,65.0,YR,,M,Y,,,20210922.0,,CN,CA,CA,2021,Q3,Elderly
193929083,19392908,32,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, ONCE A DAY",,,U,U,,,,,,SOLUTION,QD,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,3,F,,20210914.0,20210609,20210922,EXP,,CA-AUROBINDO-AUR-APL-2021-022535,AUROBINDO,,65.0,YR,,M,Y,,,20210922.0,,CN,CA,CA,2021,Q3,Elderly
193929083,19392908,32,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, ONCE A DAY",,,U,U,,,,,,SOLUTION,QD,2021,Q3,Vasculitis,,2021,Q3,3,F,,20210914.0,20210609,20210922,EXP,,CA-AUROBINDO-AUR-APL-2021-022535,AUROBINDO,,65.0,YR,,M,Y,,,20210922.0,,CN,CA,CA,2021,Q3,Elderly
193929083,19392908,32,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, ONCE A DAY",,,U,U,,,,,,SOLUTION,QD,2021,Q3,Wheezing,,2021,Q3,3,F,,20210914.0,20210609,20210922,EXP,,CA-AUROBINDO-AUR-APL-2021-022535,AUROBINDO,,65.0,YR,,M,Y,,,20210922.0,,CN,CA,CA,2021,Q3,Elderly
193929182,19392918,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,26 INTERNATIONAL UNIT,,,,, 1F915A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Diabetes mellitus inadequate control,,2021,Q3,2,F,20210517.0,20210701.0,20210609,20210712,EXP,,ES-AUROBINDO-AUR-APL-2021-023359,AUROBINDO,,68.0,YR,,M,Y,168.0,KG,20210712.0,,CN,ES,ES,2021,Q3,Elderly
193929182,19392918,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,26 INTERNATIONAL UNIT,,,,, 1F915A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Intentional product misuse,,2021,Q3,2,F,20210517.0,20210701.0,20210609,20210712,EXP,,ES-AUROBINDO-AUR-APL-2021-023359,AUROBINDO,,68.0,YR,,M,Y,168.0,KG,20210712.0,,CN,ES,ES,2021,Q3,Elderly
193929182,19392918,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, DOSE INCREASED ABOVE THE MEDICAL TARGET",,,,, 1F915A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Diabetes mellitus inadequate control,,2021,Q3,2,F,20210517.0,20210701.0,20210609,20210712,EXP,,ES-AUROBINDO-AUR-APL-2021-023359,AUROBINDO,,68.0,YR,,M,Y,168.0,KG,20210712.0,,CN,ES,ES,2021,Q3,Elderly
193929182,19392918,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, DOSE INCREASED ABOVE THE MEDICAL TARGET",,,,, 1F915A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Intentional product misuse,,2021,Q3,2,F,20210517.0,20210701.0,20210609,20210712,EXP,,ES-AUROBINDO-AUR-APL-2021-023359,AUROBINDO,,68.0,YR,,M,Y,168.0,KG,20210712.0,,CN,ES,ES,2021,Q3,Elderly
193992373,19399237,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, OF731A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Abdominal discomfort,,2021,Q3,3,F,2020.0,20210802.0,20210610,20210809,EXP,,ES-MYLANLABS-2021M1033564,MYLAN,,53.0,YR,,F,Y,55.0,KG,20210809.0,,CN,ES,ES,2021,Q3,Adult
193992373,19399237,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, OF731A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Anxiety,,2021,Q3,3,F,2020.0,20210802.0,20210610,20210809,EXP,,ES-MYLANLABS-2021M1033564,MYLAN,,53.0,YR,,F,Y,55.0,KG,20210809.0,,CN,ES,ES,2021,Q3,Adult
193992373,19399237,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, OF731A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,3,F,2020.0,20210802.0,20210610,20210809,EXP,,ES-MYLANLABS-2021M1033564,MYLAN,,53.0,YR,,F,Y,55.0,KG,20210809.0,,CN,ES,ES,2021,Q3,Adult
193992373,19399237,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, OF731A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Diet noncompliance,,2021,Q3,3,F,2020.0,20210802.0,20210610,20210809,EXP,,ES-MYLANLABS-2021M1033564,MYLAN,,53.0,YR,,F,Y,55.0,KG,20210809.0,,CN,ES,ES,2021,Q3,Adult
193992373,19399237,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, OF731A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Dizziness,,2021,Q3,3,F,2020.0,20210802.0,20210610,20210809,EXP,,ES-MYLANLABS-2021M1033564,MYLAN,,53.0,YR,,F,Y,55.0,KG,20210809.0,,CN,ES,ES,2021,Q3,Adult
193992373,19399237,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,14 INTERNATIONAL UNIT,,,,, OF731A,,,14.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Abdominal discomfort,,2021,Q3,3,F,2020.0,20210802.0,20210610,20210809,EXP,,ES-MYLANLABS-2021M1033564,MYLAN,,53.0,YR,,F,Y,55.0,KG,20210809.0,,CN,ES,ES,2021,Q3,Adult
193992373,19399237,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,14 INTERNATIONAL UNIT,,,,, OF731A,,,14.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Anxiety,,2021,Q3,3,F,2020.0,20210802.0,20210610,20210809,EXP,,ES-MYLANLABS-2021M1033564,MYLAN,,53.0,YR,,F,Y,55.0,KG,20210809.0,,CN,ES,ES,2021,Q3,Adult
193992373,19399237,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,14 INTERNATIONAL UNIT,,,,, OF731A,,,14.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,3,F,2020.0,20210802.0,20210610,20210809,EXP,,ES-MYLANLABS-2021M1033564,MYLAN,,53.0,YR,,F,Y,55.0,KG,20210809.0,,CN,ES,ES,2021,Q3,Adult
193992373,19399237,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,14 INTERNATIONAL UNIT,,,,, OF731A,,,14.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Diet noncompliance,,2021,Q3,3,F,2020.0,20210802.0,20210610,20210809,EXP,,ES-MYLANLABS-2021M1033564,MYLAN,,53.0,YR,,F,Y,55.0,KG,20210809.0,,CN,ES,ES,2021,Q3,Adult
193992373,19399237,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,14 INTERNATIONAL UNIT,,,,, OF731A,,,14.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Dizziness,,2021,Q3,3,F,2020.0,20210802.0,20210610,20210809,EXP,,ES-MYLANLABS-2021M1033564,MYLAN,,53.0,YR,,F,Y,55.0,KG,20210809.0,,CN,ES,ES,2021,Q3,Adult
194023902,19402390,4,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Subcutaneous,"100 UG, 1X/DAY",,,,,,,,100.0,UG,INJECTION,QD,2021,Q3,Cystitis,,2021,Q3,2,F,20200709.0,20210715.0,20210610,20210729,EXP,,JP-PFIZER INC-2020515146,PFIZER,,67.0,YR,,M,Y,57.0,KG,20210729.0,,PH,JP,JP,2021,Q3,Elderly
194023902,19402390,4,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Subcutaneous,"100 UG, 1X/DAY",,,,,,,,100.0,UG,INJECTION,QD,2021,Q3,Dermatitis acneiform,,2021,Q3,2,F,20200709.0,20210715.0,20210610,20210729,EXP,,JP-PFIZER INC-2020515146,PFIZER,,67.0,YR,,M,Y,57.0,KG,20210729.0,,PH,JP,JP,2021,Q3,Elderly
194023902,19402390,4,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Subcutaneous,"100 UG, 1X/DAY",,,,,,,,100.0,UG,INJECTION,QD,2021,Q3,Diarrhoea,,2021,Q3,2,F,20200709.0,20210715.0,20210610,20210729,EXP,,JP-PFIZER INC-2020515146,PFIZER,,67.0,YR,,M,Y,57.0,KG,20210729.0,,PH,JP,JP,2021,Q3,Elderly
194023902,19402390,4,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Subcutaneous,"100 UG, 1X/DAY",,,,,,,,100.0,UG,INJECTION,QD,2021,Q3,Interstitial lung disease,,2021,Q3,2,F,20200709.0,20210715.0,20210610,20210729,EXP,,JP-PFIZER INC-2020515146,PFIZER,,67.0,YR,,M,Y,57.0,KG,20210729.0,,PH,JP,JP,2021,Q3,Elderly
194053052,19405305,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"ACCORDING TO SCHEME, INJECTION/INFUSION SOLUTION, LONG?ACTING INSULIN ANALOGUE",,,,,,,,,,SOLUTION,,2021,Q3,Abdominal pain upper,,2021,Q3,2,F,,20210629.0,20210611,20210707,EXP,,DE-JNJFOC-20210607360,JOHNSON AND JOHNSON,,70.0,YR,E,F,Y,,,20210707.0,,MD,DE,DE,2021,Q3,Elderly
194053052,19405305,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"ACCORDING TO SCHEME, INJECTION/INFUSION SOLUTION, LONG?ACTING INSULIN ANALOGUE",,,,,,,,,,SOLUTION,,2021,Q3,Dyspnoea,,2021,Q3,2,F,,20210629.0,20210611,20210707,EXP,,DE-JNJFOC-20210607360,JOHNSON AND JOHNSON,,70.0,YR,E,F,Y,,,20210707.0,,MD,DE,DE,2021,Q3,Elderly
194053052,19405305,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"ACCORDING TO SCHEME, INJECTION/INFUSION SOLUTION, LONG?ACTING INSULIN ANALOGUE",,,,,,,,,,SOLUTION,,2021,Q3,General physical health deterioration,,2021,Q3,2,F,,20210629.0,20210611,20210707,EXP,,DE-JNJFOC-20210607360,JOHNSON AND JOHNSON,,70.0,YR,E,F,Y,,,20210707.0,,MD,DE,DE,2021,Q3,Elderly
194066946,19406694,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Angina pectoris,,2021,Q3,6,F,,20210729.0,20210611,20210806,EXP,,NVSC2021PL110207,NOVARTIS,,39.0,YR,,M,Y,,,20210806.0,,HP,PL,PL,2021,Q3,Adult
194066946,19406694,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Angina unstable,,2021,Q3,6,F,,20210729.0,20210611,20210806,EXP,,NVSC2021PL110207,NOVARTIS,,39.0,YR,,M,Y,,,20210806.0,,HP,PL,PL,2021,Q3,Adult
194066946,19406694,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Blood triglycerides increased,,2021,Q3,6,F,,20210729.0,20210611,20210806,EXP,,NVSC2021PL110207,NOVARTIS,,39.0,YR,,M,Y,,,20210806.0,,HP,PL,PL,2021,Q3,Adult
194066946,19406694,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Drug ineffective,,2021,Q3,6,F,,20210729.0,20210611,20210806,EXP,,NVSC2021PL110207,NOVARTIS,,39.0,YR,,M,Y,,,20210806.0,,HP,PL,PL,2021,Q3,Adult
194066946,19406694,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,ECG signs of myocardial ischaemia,,2021,Q3,6,F,,20210729.0,20210611,20210806,EXP,,NVSC2021PL110207,NOVARTIS,,39.0,YR,,M,Y,,,20210806.0,,HP,PL,PL,2021,Q3,Adult
194066946,19406694,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Low density lipoprotein increased,,2021,Q3,6,F,,20210729.0,20210611,20210806,EXP,,NVSC2021PL110207,NOVARTIS,,39.0,YR,,M,Y,,,20210806.0,,HP,PL,PL,2021,Q3,Adult
194066946,19406694,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Product use in unapproved indication,,2021,Q3,6,F,,20210729.0,20210611,20210806,EXP,,NVSC2021PL110207,NOVARTIS,,39.0,YR,,M,Y,,,20210806.0,,HP,PL,PL,2021,Q3,Adult
194066946,19406694,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Treatment failure,,2021,Q3,6,F,,20210729.0,20210611,20210806,EXP,,NVSC2021PL110207,NOVARTIS,,39.0,YR,,M,Y,,,20210806.0,,HP,PL,PL,2021,Q3,Adult
194075102,19407510,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 1F915A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Diabetes mellitus inadequate control,,2021,Q3,2,F,20210517.0,20210705.0,20210611,20210714,EXP,,NVSC2021ES125324,NOVARTIS,,68.0,YR,,M,Y,168.0,KG,20210714.0,,HP,ES,ES,2021,Q3,Elderly
194075102,19407510,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 1F915A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Intentional product misuse,,2021,Q3,2,F,20210517.0,20210705.0,20210611,20210714,EXP,,NVSC2021ES125324,NOVARTIS,,68.0,YR,,M,Y,168.0,KG,20210714.0,,HP,ES,ES,2021,Q3,Elderly
194075102,19407510,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, DOSE INCREASED ABOVE THE MEDICAL TARGET",,,Y,, 1F915A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Diabetes mellitus inadequate control,,2021,Q3,2,F,20210517.0,20210705.0,20210611,20210714,EXP,,NVSC2021ES125324,NOVARTIS,,68.0,YR,,M,Y,168.0,KG,20210714.0,,HP,ES,ES,2021,Q3,Elderly
194075102,19407510,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, DOSE INCREASED ABOVE THE MEDICAL TARGET",,,Y,, 1F915A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Intentional product misuse,,2021,Q3,2,F,20210517.0,20210705.0,20210611,20210714,EXP,,NVSC2021ES125324,NOVARTIS,,68.0,YR,,M,Y,168.0,KG,20210714.0,,HP,ES,ES,2021,Q3,Elderly
194075102,19407510,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,24 IU,,,Y,, 1F415A,,,24.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Diabetes mellitus inadequate control,,2021,Q3,2,F,20210517.0,20210705.0,20210611,20210714,EXP,,NVSC2021ES125324,NOVARTIS,,68.0,YR,,M,Y,168.0,KG,20210714.0,,HP,ES,ES,2021,Q3,Elderly
194075102,19407510,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,24 IU,,,Y,, 1F415A,,,24.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Intentional product misuse,,2021,Q3,2,F,20210517.0,20210705.0,20210611,20210714,EXP,,NVSC2021ES125324,NOVARTIS,,68.0,YR,,M,Y,168.0,KG,20210714.0,,HP,ES,ES,2021,Q3,Elderly
194075102,19407510,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Diabetes mellitus inadequate control,,2021,Q3,2,F,20210517.0,20210705.0,20210611,20210714,EXP,,NVSC2021ES125324,NOVARTIS,,68.0,YR,,M,Y,168.0,KG,20210714.0,,HP,ES,ES,2021,Q3,Elderly
194075102,19407510,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Intentional product misuse,,2021,Q3,2,F,20210517.0,20210705.0,20210611,20210714,EXP,,NVSC2021ES125324,NOVARTIS,,68.0,YR,,M,Y,168.0,KG,20210714.0,,HP,ES,ES,2021,Q3,Elderly
194099532,19409953,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Cytokine release syndrome,,2021,Q3,2,F,20210511.0,20210813.0,20210614,20210827,EXP,,FR-AUROBINDO-AUR-APL-2021-024507,AUROBINDO,,55.0,YR,,M,Y,93.0,KG,20210827.0,,HP,FR,FR,2021,Q3,Adult
194099532,19409953,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Off label use,,2021,Q3,2,F,20210511.0,20210813.0,20210614,20210827,EXP,,FR-AUROBINDO-AUR-APL-2021-024507,AUROBINDO,,55.0,YR,,M,Y,93.0,KG,20210827.0,,HP,FR,FR,2021,Q3,Adult
194099532,19409953,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Sepsis,,2021,Q3,2,F,20210511.0,20210813.0,20210614,20210827,EXP,,FR-AUROBINDO-AUR-APL-2021-024507,AUROBINDO,,55.0,YR,,M,Y,93.0,KG,20210827.0,,HP,FR,FR,2021,Q3,Adult
194123394,19412339,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"3 ML, QHS, SQ",,,,,,,,3.0,ML,,,2021,Q3,Influenza like illness,,2021,Q3,4,F,20210606.0,20210721.0,20210614,20210728,EXP,,NVSC2021US131276,NOVARTIS,,49.0,YR,,M,Y,69.0,KG,20210728.0,,MD,US,US,2021,Q3,Adult
194158442,19415844,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE INCREASED ABOVE THE MEDICAL TARGET,,,Y,," 1F915A,1F915A,1F915A",,,,,SOLUTION FOR INJECTION,,2021,Q3,Diabetes mellitus inadequate control,,2021,Q3,2,F,2021.0,20210703.0,20210614,20210716,EXP,ES-SA-2021SA171737,ES-BAUSCH-BL-2021-020293,BAUSCH AND LOMB,,68.0,YR,,M,Y,168.0,KG,20210716.0,,CN,ES,ES,2021,Q3,Elderly
194158442,19415844,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE INCREASED ABOVE THE MEDICAL TARGET,,,Y,," 1F915A,1F915A,1F915A",,,,,SOLUTION FOR INJECTION,,2021,Q3,Intentional product misuse,,2021,Q3,2,F,2021.0,20210703.0,20210614,20210716,EXP,ES-SA-2021SA171737,ES-BAUSCH-BL-2021-020293,BAUSCH AND LOMB,,68.0,YR,,M,Y,168.0,KG,20210716.0,,CN,ES,ES,2021,Q3,Elderly
194158442,19415844,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,," 1F915A,1F915A,1F915A",,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Diabetes mellitus inadequate control,,2021,Q3,2,F,2021.0,20210703.0,20210614,20210716,EXP,ES-SA-2021SA171737,ES-BAUSCH-BL-2021-020293,BAUSCH AND LOMB,,68.0,YR,,M,Y,168.0,KG,20210716.0,,CN,ES,ES,2021,Q3,Elderly
194158442,19415844,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,," 1F915A,1F915A,1F915A",,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Intentional product misuse,,2021,Q3,2,F,2021.0,20210703.0,20210614,20210716,EXP,ES-SA-2021SA171737,ES-BAUSCH-BL-2021-020293,BAUSCH AND LOMB,,68.0,YR,,M,Y,168.0,KG,20210716.0,,CN,ES,ES,2021,Q3,Elderly
194158442,19415844,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,," 1F915A,1F915A,1F915A",,,24.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Diabetes mellitus inadequate control,,2021,Q3,2,F,2021.0,20210703.0,20210614,20210716,EXP,ES-SA-2021SA171737,ES-BAUSCH-BL-2021-020293,BAUSCH AND LOMB,,68.0,YR,,M,Y,168.0,KG,20210716.0,,CN,ES,ES,2021,Q3,Elderly
194158442,19415844,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,," 1F915A,1F915A,1F915A",,,24.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Intentional product misuse,,2021,Q3,2,F,2021.0,20210703.0,20210614,20210716,EXP,ES-SA-2021SA171737,ES-BAUSCH-BL-2021-020293,BAUSCH AND LOMB,,68.0,YR,,M,Y,168.0,KG,20210716.0,,CN,ES,ES,2021,Q3,Elderly
194169373,19416937,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"NACH SCHEMA, INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,,,INJECTION,,2021,Q3,Abdominal pain upper,,2021,Q3,3,F,,20210628.0,20210614,20210710,EXP,DE-ADRED-06412-01,NVSC2021DE125188,NOVARTIS,,70.0,YR,,F,Y,,,20210710.0,,HP,DE,DE,2021,Q3,Elderly
194169373,19416937,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"NACH SCHEMA, INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,,,INJECTION,,2021,Q3,Dyspnoea,,2021,Q3,3,F,,20210628.0,20210614,20210710,EXP,DE-ADRED-06412-01,NVSC2021DE125188,NOVARTIS,,70.0,YR,,F,Y,,,20210710.0,,HP,DE,DE,2021,Q3,Elderly
194169373,19416937,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"NACH SCHEMA, INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,,,INJECTION,,2021,Q3,General physical health deterioration,,2021,Q3,3,F,,20210628.0,20210614,20210710,EXP,DE-ADRED-06412-01,NVSC2021DE125188,NOVARTIS,,70.0,YR,,F,Y,,,20210710.0,,HP,DE,DE,2021,Q3,Elderly
194169373,19416937,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"NACH SCHEMA, INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,,,INJECTION,,2021,Q3,Product prescribing error,,2021,Q3,3,F,,20210628.0,20210614,20210710,EXP,DE-ADRED-06412-01,NVSC2021DE125188,NOVARTIS,,70.0,YR,,F,Y,,,20210710.0,,HP,DE,DE,2021,Q3,Elderly
194233082,19423308,8,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD, 50 UNITS",,,,,,,,,,,QD,2021,Q3,Off label use,,2021,Q3,2,F,,20210820.0,20210616,20210902,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-09529,LUPIN,,79.0,YR,,M,Y,,,20210902.0,,HP,US,US,2021,Q3,Elderly
194234872,19423487,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q3,Cytokine release syndrome,,2021,Q3,2,F,20210511.0,20210818.0,20210616,20210826,EXP,,FR-FRESENIUS KABI-FK202105850,FRESENIUS KABI,,55.0,YR,,M,Y,93.0,KG,20210826.0,,HP,NL,FR,2021,Q3,Adult
194234872,19423487,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q3,Off label use,,2021,Q3,2,F,20210511.0,20210818.0,20210616,20210826,EXP,,FR-FRESENIUS KABI-FK202105850,FRESENIUS KABI,,55.0,YR,,M,Y,93.0,KG,20210826.0,,HP,NL,FR,2021,Q3,Adult
194234872,19423487,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q3,Sepsis,,2021,Q3,2,F,20210511.0,20210818.0,20210616,20210826,EXP,,FR-FRESENIUS KABI-FK202105850,FRESENIUS KABI,,55.0,YR,,M,Y,93.0,KG,20210826.0,,HP,NL,FR,2021,Q3,Adult
194300782,19430078,32,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2021,Q3,Cytokine release syndrome,,2021,Q3,2,F,20210511.0,20210813.0,20210617,20210819,EXP,,FR-ELI_LILLY_AND_COMPANY-FR202106002258,ELI LILLY AND CO,,55.0,YR,,M,Y,93.0,KG,20210819.0,,HP,FR,FR,2021,Q3,Adult
194300782,19430078,32,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2021,Q3,Off label use,,2021,Q3,2,F,20210511.0,20210813.0,20210617,20210819,EXP,,FR-ELI_LILLY_AND_COMPANY-FR202106002258,ELI LILLY AND CO,,55.0,YR,,M,Y,93.0,KG,20210819.0,,HP,FR,FR,2021,Q3,Adult
194300782,19430078,32,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2021,Q3,Sepsis,,2021,Q3,2,F,20210511.0,20210813.0,20210617,20210819,EXP,,FR-ELI_LILLY_AND_COMPANY-FR202106002258,ELI LILLY AND CO,,55.0,YR,,M,Y,93.0,KG,20210819.0,,HP,FR,FR,2021,Q3,Adult
194363123,19436312,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"40 IU, 1X/DAY",,,,,,,,40.0,IU,,QD,2021,Q3,Maternal exposure during pregnancy,,2021,Q3,3,F,,20210618.0,20210618,20210709,EXP,,US-PFIZER INC-2021690668,PFIZER,"PHAM, P.. SEVERE HYPERPHOSPHATEMIA IN A PATIENT WITH MILD ACUTE KIDNEY INJURY. CASE REPORTS IN MEDICINE. 2021?1?5",35.0,YR,,F,Y,,,20210709.0,,HP,US,US,2021,Q3,Adult
194363123,19436312,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"40 IU, 1X/DAY",,,,,,,,40.0,IU,,QD,2021,Q3,Tubulointerstitial nephritis,,2021,Q3,3,F,,20210618.0,20210618,20210709,EXP,,US-PFIZER INC-2021690668,PFIZER,"PHAM, P.. SEVERE HYPERPHOSPHATEMIA IN A PATIENT WITH MILD ACUTE KIDNEY INJURY. CASE REPORTS IN MEDICINE. 2021?1?5",35.0,YR,,F,Y,,,20210709.0,,HP,US,US,2021,Q3,Adult
194431822,19443182,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Blood creatine increased,,2021,Q3,2,F,20210511.0,20210817.0,20210621,20210901,EXP,,FR-PFIZER INC-2021660909,PFIZER,,55.0,YR,,M,Y,93.0,KG,20210901.0,,HP,FR,FR,2021,Q3,Adult
194431822,19443182,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,C-reactive protein increased,,2021,Q3,2,F,20210511.0,20210817.0,20210621,20210901,EXP,,FR-PFIZER INC-2021660909,PFIZER,,55.0,YR,,M,Y,93.0,KG,20210901.0,,HP,FR,FR,2021,Q3,Adult
194431822,19443182,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Cytokine release syndrome,,2021,Q3,2,F,20210511.0,20210817.0,20210621,20210901,EXP,,FR-PFIZER INC-2021660909,PFIZER,,55.0,YR,,M,Y,93.0,KG,20210901.0,,HP,FR,FR,2021,Q3,Adult
194431822,19443182,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Haemoglobin decreased,,2021,Q3,2,F,20210511.0,20210817.0,20210621,20210901,EXP,,FR-PFIZER INC-2021660909,PFIZER,,55.0,YR,,M,Y,93.0,KG,20210901.0,,HP,FR,FR,2021,Q3,Adult
194431822,19443182,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Neutrophil count decreased,,2021,Q3,2,F,20210511.0,20210817.0,20210621,20210901,EXP,,FR-PFIZER INC-2021660909,PFIZER,,55.0,YR,,M,Y,93.0,KG,20210901.0,,HP,FR,FR,2021,Q3,Adult
194431822,19443182,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Off label use,,2021,Q3,2,F,20210511.0,20210817.0,20210621,20210901,EXP,,FR-PFIZER INC-2021660909,PFIZER,,55.0,YR,,M,Y,93.0,KG,20210901.0,,HP,FR,FR,2021,Q3,Adult
194431822,19443182,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Platelet count decreased,,2021,Q3,2,F,20210511.0,20210817.0,20210621,20210901,EXP,,FR-PFIZER INC-2021660909,PFIZER,,55.0,YR,,M,Y,93.0,KG,20210901.0,,HP,FR,FR,2021,Q3,Adult
194431822,19443182,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Procalcitonin increased,,2021,Q3,2,F,20210511.0,20210817.0,20210621,20210901,EXP,,FR-PFIZER INC-2021660909,PFIZER,,55.0,YR,,M,Y,93.0,KG,20210901.0,,HP,FR,FR,2021,Q3,Adult
194431822,19443182,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Sepsis,,2021,Q3,2,F,20210511.0,20210817.0,20210621,20210901,EXP,,FR-PFIZER INC-2021660909,PFIZER,,55.0,YR,,M,Y,93.0,KG,20210901.0,,HP,FR,FR,2021,Q3,Adult
194431822,19443182,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,White blood cell count decreased,,2021,Q3,2,F,20210511.0,20210817.0,20210621,20210901,EXP,,FR-PFIZER INC-2021660909,PFIZER,,55.0,YR,,M,Y,93.0,KG,20210901.0,,HP,FR,FR,2021,Q3,Adult
194443852,19444385,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Chronic obstructive pulmonary disease,,2021,Q3,2,F,20210607.0,20210620.0,20210621,20210701,EXP,,US-ABBVIE-21K-163-3957921-00,ABBVIE,,54.0,YR,,F,Y,113.5,KG,20210701.0,,CN,US,US,2021,Q3,Adult
194443852,19444385,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Dyspnoea,,2021,Q3,2,F,20210607.0,20210620.0,20210621,20210701,EXP,,US-ABBVIE-21K-163-3957921-00,ABBVIE,,54.0,YR,,F,Y,113.5,KG,20210701.0,,CN,US,US,2021,Q3,Adult
194443852,19444385,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Pancreatitis necrotising,,2021,Q3,2,F,20210607.0,20210620.0,20210621,20210701,EXP,,US-ABBVIE-21K-163-3957921-00,ABBVIE,,54.0,YR,,F,Y,113.5,KG,20210701.0,,CN,US,US,2021,Q3,Adult
194443852,19444385,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Pneumonia,,2021,Q3,2,F,20210607.0,20210620.0,20210621,20210701,EXP,,US-ABBVIE-21K-163-3957921-00,ABBVIE,,54.0,YR,,F,Y,113.5,KG,20210701.0,,CN,US,US,2021,Q3,Adult
194500182,19450018,4,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q3,Neutropenic sepsis,,2021,Q3,2,F,20210605.0,20210802.0,20210622,20210810,EXP,,US-CELGENEUS-USA-20210604338,CELGENE,,64.0,YR,,M,Y,,,20210810.0,,HP,US,US,2021,Q3,Adult
194558722,19455872,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Hepatitis viral,,2021,Q3,2,F,20210512.0,20210806.0,20210624,20210811,EXP,,US-GILEAD-2021-0537322,GILEAD,,71.0,YR,E,M,Y,,,20210811.0,,MD,US,US,2021,Q3,Elderly
194595309,19459530,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),30 UNITS,,,,,,,,,,,,2021,Q3,Eye oedema,,2021,Q3,9,F,202107.0,20210909.0,20210624,20210914,PER,,US-DSJP-DSU-2021-118873,DAIICHI,,71.0,YR,,M,Y,,,20210914.0,,HP,US,US,2021,Q3,Elderly
194595309,19459530,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),30 UNITS,,,,,,,,,,,,2021,Q3,Hypoaesthesia,,2021,Q3,9,F,202107.0,20210909.0,20210624,20210914,PER,,US-DSJP-DSU-2021-118873,DAIICHI,,71.0,YR,,M,Y,,,20210914.0,,HP,US,US,2021,Q3,Elderly
194595309,19459530,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),30 UNITS,,,,,,,,,,,,2021,Q3,Incontinence,,2021,Q3,9,F,202107.0,20210909.0,20210624,20210914,PER,,US-DSJP-DSU-2021-118873,DAIICHI,,71.0,YR,,M,Y,,,20210914.0,,HP,US,US,2021,Q3,Elderly
194595309,19459530,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),30 UNITS,,,,,,,,,,,,2021,Q3,Incorrect dose administered,,2021,Q3,9,F,202107.0,20210909.0,20210624,20210914,PER,,US-DSJP-DSU-2021-118873,DAIICHI,,71.0,YR,,M,Y,,,20210914.0,,HP,US,US,2021,Q3,Elderly
194595309,19459530,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),30 UNITS,,,,,,,,,,,,2021,Q3,Off label use,,2021,Q3,9,F,202107.0,20210909.0,20210624,20210914,PER,,US-DSJP-DSU-2021-118873,DAIICHI,,71.0,YR,,M,Y,,,20210914.0,,HP,US,US,2021,Q3,Elderly
194595309,19459530,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),30 UNITS,,,,,,,,,,,,2021,Q3,Pain in extremity,,2021,Q3,9,F,202107.0,20210909.0,20210624,20210914,PER,,US-DSJP-DSU-2021-118873,DAIICHI,,71.0,YR,,M,Y,,,20210914.0,,HP,US,US,2021,Q3,Elderly
194595309,19459530,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),30 UNITS,,,,,,,,,,,,2021,Q3,Periorbital swelling,,2021,Q3,9,F,202107.0,20210909.0,20210624,20210914,PER,,US-DSJP-DSU-2021-118873,DAIICHI,,71.0,YR,,M,Y,,,20210914.0,,HP,US,US,2021,Q3,Elderly
194595309,19459530,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),30 UNITS,,,,,,,,,,,,2021,Q3,Peripheral swelling,,2021,Q3,9,F,202107.0,20210909.0,20210624,20210914,PER,,US-DSJP-DSU-2021-118873,DAIICHI,,71.0,YR,,M,Y,,,20210914.0,,HP,US,US,2021,Q3,Elderly
194595309,19459530,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),30 UNITS,,,,,,,,,,,,2021,Q3,Rash,,2021,Q3,9,F,202107.0,20210909.0,20210624,20210914,PER,,US-DSJP-DSU-2021-118873,DAIICHI,,71.0,YR,,M,Y,,,20210914.0,,HP,US,US,2021,Q3,Elderly
194595309,19459530,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),30 UNITS,,,,,,,,,,,,2021,Q3,Rash macular,,2021,Q3,9,F,202107.0,20210909.0,20210624,20210914,PER,,US-DSJP-DSU-2021-118873,DAIICHI,,71.0,YR,,M,Y,,,20210914.0,,HP,US,US,2021,Q3,Elderly
194595309,19459530,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),30 UNITS,,,,,,,,,,,,2021,Q3,Renal pain,,2021,Q3,9,F,202107.0,20210909.0,20210624,20210914,PER,,US-DSJP-DSU-2021-118873,DAIICHI,,71.0,YR,,M,Y,,,20210914.0,,HP,US,US,2021,Q3,Elderly
194677872,19467787,1,PS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,Subcutaneous,"30 INTERNATIONAL UNIT, HS",,,,,,,210605.0,30.0,IU,INJECTION,QD,2021,Q3,Device issue,,2021,Q3,2,F,20210607.0,20210608.0,20210628,20210702,PER,,US-MYLANLABS-2021M1033859,MYLAN,,60.0,YR,,F,Y,,,20210702.0,,CN,US,US,2021,Q3,Adult
194677872,19467787,1,PS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,Subcutaneous,"30 INTERNATIONAL UNIT, HS",,,,,,,210605.0,30.0,IU,INJECTION,QD,2021,Q3,Product preparation error,,2021,Q3,2,F,20210607.0,20210608.0,20210628,20210702,PER,,US-MYLANLABS-2021M1033859,MYLAN,,60.0,YR,,F,Y,,,20210702.0,,CN,US,US,2021,Q3,Adult
194677872,19467787,1,PS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,Subcutaneous,"30 INTERNATIONAL UNIT, HS",,,,,,,210605.0,30.0,IU,INJECTION,QD,2021,Q3,Wrong technique in product usage process,,2021,Q3,2,F,20210607.0,20210608.0,20210628,20210702,PER,,US-MYLANLABS-2021M1033859,MYLAN,,60.0,YR,,F,Y,,,20210702.0,,CN,US,US,2021,Q3,Adult
194696162,19469616,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, QD (11 UNITS/DAY) (FOR MORE THAN 1 YEAR)",,,U,,,,,,,,QD,2021,Q3,Neuroleptic malignant syndrome,,2021,Q3,2,F,,20210831.0,20210628,20210903,EXP,,NVSC2021TR143401,NOVARTIS,"EROGLU EO, YILDIZ MI, YAZICI MK. ATYPICAL NEUROLEPTIC MALIGNANT SYNDROME INDUCED BY LOW DOSE QUETIAPINE IN A PATIENT TREATED WITH DONEPEZIL. ARCH NEUROPSYCHIATRY. 2021?58:166?8",84.0,YR,,M,Y,,,20210903.0,,HP,TR,TR,2021,Q3,Elderly
194696162,19469616,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, QD (11 UNITS/DAY) (FOR MORE THAN 1 YEAR)",,,U,,,,,,,,QD,2021,Q3,Product use in unapproved indication,,2021,Q3,2,F,,20210831.0,20210628,20210903,EXP,,NVSC2021TR143401,NOVARTIS,"EROGLU EO, YILDIZ MI, YAZICI MK. ATYPICAL NEUROLEPTIC MALIGNANT SYNDROME INDUCED BY LOW DOSE QUETIAPINE IN A PATIENT TREATED WITH DONEPEZIL. ARCH NEUROPSYCHIATRY. 2021?58:166?8",84.0,YR,,M,Y,,,20210903.0,,HP,TR,TR,2021,Q3,Elderly
194698742,19469874,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 INTERNATIONAL UNIT, QD",,,,, 0F768A,,,16.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Diabetes mellitus inadequate control,,2021,Q3,2,F,2020.0,20210729.0,20210628,20210809,EXP,,ES-MYLANLABS-2021M1036735,MYLAN,,75.0,YR,,M,Y,,,20210809.0,,CN,ES,ES,2021,Q3,Elderly
194758863,19475886,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 INTERNATIONAL UNIT, DAILY",,,,,,,,4.0,IU,,,2021,Q3,Conjunctivitis,,2021,Q3,3,F,20210315.0,20210714.0,20210630,20210729,EXP,,ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-302447,RANBAXY,,91.0,YR,,F,Y,,,20210729.0,,MD,ES,ES,2021,Q3,Elderly
194758863,19475886,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 INTERNATIONAL UNIT, DAILY",,,,,,,,4.0,IU,,,2021,Q3,Fatigue,,2021,Q3,3,F,20210315.0,20210714.0,20210630,20210729,EXP,,ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-302447,RANBAXY,,91.0,YR,,F,Y,,,20210729.0,,MD,ES,ES,2021,Q3,Elderly
194758863,19475886,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 INTERNATIONAL UNIT, DAILY",,,,,,,,4.0,IU,,,2021,Q3,Muscle spasms,,2021,Q3,3,F,20210315.0,20210714.0,20210630,20210729,EXP,,ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-302447,RANBAXY,,91.0,YR,,F,Y,,,20210729.0,,MD,ES,ES,2021,Q3,Elderly
194766182,19476618,2,C,INSULIN GLARGINE;LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Subcutaneous,,,,,,,,,150.0,UG,,QD,2021,Q3,Euglycaemic diabetic ketoacidosis,,2021,Q3,2,F,20200928.0,20210714.0,20210630,20210716,EXP,,"MY-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-112227",BOEHRINGER INGELHEIM,,41.0,YR,A,F,Y,,,20210716.0,,MD,MY,MY,2021,Q3,Adult
194766182,19476618,3,C,INSULIN GLARGINE;LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,,100/50 MCG BD,,,,,,,,,,,QD,2021,Q3,Euglycaemic diabetic ketoacidosis,,2021,Q3,2,F,20200928.0,20210714.0,20210630,20210716,EXP,,"MY-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-112227",BOEHRINGER INGELHEIM,,41.0,YR,A,F,Y,,,20210716.0,,MD,MY,MY,2021,Q3,Adult
194810402,19481040,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q3,Diabetic ketoacidosis,,2021,Q3,2,F,,20210712.0,20210630,20210715,EXP,,"GR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-111533",BOEHRINGER INGELHEIM,"VIOLATZI P, AVRAMMIDOU D, ZIKOUDI D, MOURSELOGLOU A, METAXA E, PARTSALIDIS A. ET AL. ACUTE NECROTIZING ESOPHAGITIS FOLLOWING DIABETIC KETOACIDOSIS IN A PATIENT WITH T2DM AND OVERCONSUMPTION OF COLA SOFT DRINKS.. 19TH PANHELLENIC DIABETOLOGICAL CONFERENCE, 2?5 JUNE 2021. 2021 JUN?",47.0,YR,A,M,Y,,,20210715.0,,CN,GR,GR,2021,Q3,Adult
194810402,19481040,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q3,Necrotising oesophagitis,,2021,Q3,2,F,,20210712.0,20210630,20210715,EXP,,"GR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-111533",BOEHRINGER INGELHEIM,"VIOLATZI P, AVRAMMIDOU D, ZIKOUDI D, MOURSELOGLOU A, METAXA E, PARTSALIDIS A. ET AL. ACUTE NECROTIZING ESOPHAGITIS FOLLOWING DIABETIC KETOACIDOSIS IN A PATIENT WITH T2DM AND OVERCONSUMPTION OF COLA SOFT DRINKS.. 19TH PANHELLENIC DIABETOLOGICAL CONFERENCE, 2?5 JUNE 2021. 2021 JUN?",47.0,YR,A,M,Y,,,20210715.0,,CN,GR,GR,2021,Q3,Adult
194816491,19481649,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,60.0,UG,,QD,2021,Q3,Conjunctival haemorrhage,,2021,Q3,1,I,20210622.0,20210622.0,20210701,20210701,EXP,,MX-ROCHE-2860718,ROCHE,,55.0,YR,,F,Y,,,20210701.0,,MD,MX,MX,2021,Q3,Adult
194816491,19481649,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,60.0,UG,,QD,2021,Q3,Off label use,,2021,Q3,1,I,20210622.0,20210622.0,20210701,20210701,EXP,,MX-ROCHE-2860718,ROCHE,,55.0,YR,,F,Y,,,20210701.0,,MD,MX,MX,2021,Q3,Adult
194822351,19482235,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"49 IU, QD",,,,, 0F731A,,,49.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose abnormal,,2021,Q3,1,I,202103.0,20210621.0,20210701,20210701,EXP,,NVSC2021ES140761,NOVARTIS,,77.0,YR,,F,Y,66.0,KG,20210701.0,,HP,ES,ES,2021,Q3,Elderly
194822351,19482235,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"49 IU, QD",,,,, 0F731A,,,49.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Cardiac disorder,,2021,Q3,1,I,202103.0,20210621.0,20210701,20210701,EXP,,NVSC2021ES140761,NOVARTIS,,77.0,YR,,F,Y,66.0,KG,20210701.0,,HP,ES,ES,2021,Q3,Elderly
194822351,19482235,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"49 IU, QD",,,,, 0F731A,,,49.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Decreased appetite,,2021,Q3,1,I,202103.0,20210621.0,20210701,20210701,EXP,,NVSC2021ES140761,NOVARTIS,,77.0,YR,,F,Y,66.0,KG,20210701.0,,HP,ES,ES,2021,Q3,Elderly
194822351,19482235,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"49 IU, QD",,,,, 0F731A,,,49.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Depressed mood,,2021,Q3,1,I,202103.0,20210621.0,20210701,20210701,EXP,,NVSC2021ES140761,NOVARTIS,,77.0,YR,,F,Y,66.0,KG,20210701.0,,HP,ES,ES,2021,Q3,Elderly
194822351,19482235,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"49 IU, QD",,,,, 0F731A,,,49.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Renal disorder,,2021,Q3,1,I,202103.0,20210621.0,20210701,20210701,EXP,,NVSC2021ES140761,NOVARTIS,,77.0,YR,,F,Y,66.0,KG,20210701.0,,HP,ES,ES,2021,Q3,Elderly
194822351,19482235,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"49 IU, QD",,,,, 0F731A,,,49.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Weight decreased,,2021,Q3,1,I,202103.0,20210621.0,20210701,20210701,EXP,,NVSC2021ES140761,NOVARTIS,,77.0,YR,,F,Y,66.0,KG,20210701.0,,HP,ES,ES,2021,Q3,Elderly
194822351,19482235,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DF, QD (DOSE INCREASED)",,,,,,,,1.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose abnormal,,2021,Q3,1,I,202103.0,20210621.0,20210701,20210701,EXP,,NVSC2021ES140761,NOVARTIS,,77.0,YR,,F,Y,66.0,KG,20210701.0,,HP,ES,ES,2021,Q3,Elderly
194822351,19482235,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DF, QD (DOSE INCREASED)",,,,,,,,1.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Cardiac disorder,,2021,Q3,1,I,202103.0,20210621.0,20210701,20210701,EXP,,NVSC2021ES140761,NOVARTIS,,77.0,YR,,F,Y,66.0,KG,20210701.0,,HP,ES,ES,2021,Q3,Elderly
194822351,19482235,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DF, QD (DOSE INCREASED)",,,,,,,,1.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Decreased appetite,,2021,Q3,1,I,202103.0,20210621.0,20210701,20210701,EXP,,NVSC2021ES140761,NOVARTIS,,77.0,YR,,F,Y,66.0,KG,20210701.0,,HP,ES,ES,2021,Q3,Elderly
194822351,19482235,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DF, QD (DOSE INCREASED)",,,,,,,,1.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Depressed mood,,2021,Q3,1,I,202103.0,20210621.0,20210701,20210701,EXP,,NVSC2021ES140761,NOVARTIS,,77.0,YR,,F,Y,66.0,KG,20210701.0,,HP,ES,ES,2021,Q3,Elderly
194822351,19482235,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DF, QD (DOSE INCREASED)",,,,,,,,1.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Renal disorder,,2021,Q3,1,I,202103.0,20210621.0,20210701,20210701,EXP,,NVSC2021ES140761,NOVARTIS,,77.0,YR,,F,Y,66.0,KG,20210701.0,,HP,ES,ES,2021,Q3,Elderly
194822351,19482235,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DF, QD (DOSE INCREASED)",,,,,,,,1.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Weight decreased,,2021,Q3,1,I,202103.0,20210621.0,20210701,20210701,EXP,,NVSC2021ES140761,NOVARTIS,,77.0,YR,,F,Y,66.0,KG,20210701.0,,HP,ES,ES,2021,Q3,Elderly
194826461,19482646,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, QD",,,,,,,,10.0,IU,,QD,2021,Q3,Abdominal pain,,2021,Q3,1,I,,20210625.0,20210701,20210701,EXP,DE-ADRED-05369-02,DE-DSJP-DSE-2021-119634,DAIICHI,,77.0,YR,,F,Y,56.0,KG,20210701.0,,MD,DE,DE,2021,Q3,Elderly
194826461,19482646,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, QD",,,,,,,,10.0,IU,,QD,2021,Q3,Decreased appetite,,2021,Q3,1,I,,20210625.0,20210701,20210701,EXP,DE-ADRED-05369-02,DE-DSJP-DSE-2021-119634,DAIICHI,,77.0,YR,,F,Y,56.0,KG,20210701.0,,MD,DE,DE,2021,Q3,Elderly
194826461,19482646,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, QD",,,,,,,,10.0,IU,,QD,2021,Q3,Dizziness,,2021,Q3,1,I,,20210625.0,20210701,20210701,EXP,DE-ADRED-05369-02,DE-DSJP-DSE-2021-119634,DAIICHI,,77.0,YR,,F,Y,56.0,KG,20210701.0,,MD,DE,DE,2021,Q3,Elderly
194826461,19482646,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, QD",,,,,,,,10.0,IU,,QD,2021,Q3,Fatigue,,2021,Q3,1,I,,20210625.0,20210701,20210701,EXP,DE-ADRED-05369-02,DE-DSJP-DSE-2021-119634,DAIICHI,,77.0,YR,,F,Y,56.0,KG,20210701.0,,MD,DE,DE,2021,Q3,Elderly
194826461,19482646,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, QD",,,,,,,,10.0,IU,,QD,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210625.0,20210701,20210701,EXP,DE-ADRED-05369-02,DE-DSJP-DSE-2021-119634,DAIICHI,,77.0,YR,,F,Y,56.0,KG,20210701.0,,MD,DE,DE,2021,Q3,Elderly
194826461,19482646,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, QD",,,,,,,,10.0,IU,,QD,2021,Q3,Haematochezia,,2021,Q3,1,I,,20210625.0,20210701,20210701,EXP,DE-ADRED-05369-02,DE-DSJP-DSE-2021-119634,DAIICHI,,77.0,YR,,F,Y,56.0,KG,20210701.0,,MD,DE,DE,2021,Q3,Elderly
194826461,19482646,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, QD",,,,,,,,10.0,IU,,QD,2021,Q3,Headache,,2021,Q3,1,I,,20210625.0,20210701,20210701,EXP,DE-ADRED-05369-02,DE-DSJP-DSE-2021-119634,DAIICHI,,77.0,YR,,F,Y,56.0,KG,20210701.0,,MD,DE,DE,2021,Q3,Elderly
194826461,19482646,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, QD",,,,,,,,10.0,IU,,QD,2021,Q3,Nausea,,2021,Q3,1,I,,20210625.0,20210701,20210701,EXP,DE-ADRED-05369-02,DE-DSJP-DSE-2021-119634,DAIICHI,,77.0,YR,,F,Y,56.0,KG,20210701.0,,MD,DE,DE,2021,Q3,Elderly
194826461,19482646,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, QD",,,,,,,,10.0,IU,,QD,2021,Q3,Syncope,,2021,Q3,1,I,,20210625.0,20210701,20210701,EXP,DE-ADRED-05369-02,DE-DSJP-DSE-2021-119634,DAIICHI,,77.0,YR,,F,Y,56.0,KG,20210701.0,,MD,DE,DE,2021,Q3,Elderly
194829941,19482994,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 INTERNATIONAL UNIT, DAILY",,,,,,,,14.0,IU,,QD,2021,Q3,Incorrect dose administered,,2021,Q3,1,I,,20210601.0,20210701,20210701,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202106001750,ELI LILLY AND CO,"TOKUMARU M, ET AL..A CASE OF LACTIC ACIDOSIS IN OVERDOSE OF METFORMIN AND INSULIN FOR SUICIDE ATTEMPT..DIABETES 2021?64 (S):.",28.0,YR,,F,Y,,,20210701.0,,MD,JP,JP,2021,Q3,Young Adult
194829941,19482994,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 INTERNATIONAL UNIT, DAILY",,,,,,,,14.0,IU,,QD,2021,Q3,Lactic acidosis,,2021,Q3,1,I,,20210601.0,20210701,20210701,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202106001750,ELI LILLY AND CO,"TOKUMARU M, ET AL..A CASE OF LACTIC ACIDOSIS IN OVERDOSE OF METFORMIN AND INSULIN FOR SUICIDE ATTEMPT..DIABETES 2021?64 (S):.",28.0,YR,,F,Y,,,20210701.0,,MD,JP,JP,2021,Q3,Young Adult
194829941,19482994,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 INTERNATIONAL UNIT, DAILY",,,,,,,,14.0,IU,,QD,2021,Q3,Suicide attempt,,2021,Q3,1,I,,20210601.0,20210701,20210701,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202106001750,ELI LILLY AND CO,"TOKUMARU M, ET AL..A CASE OF LACTIC ACIDOSIS IN OVERDOSE OF METFORMIN AND INSULIN FOR SUICIDE ATTEMPT..DIABETES 2021?64 (S):.",28.0,YR,,F,Y,,,20210701.0,,MD,JP,JP,2021,Q3,Young Adult
194829941,19482994,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,450 INTERNATIONAL UNIT,,,,,,,,450.0,IU,,,2021,Q3,Incorrect dose administered,,2021,Q3,1,I,,20210601.0,20210701,20210701,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202106001750,ELI LILLY AND CO,"TOKUMARU M, ET AL..A CASE OF LACTIC ACIDOSIS IN OVERDOSE OF METFORMIN AND INSULIN FOR SUICIDE ATTEMPT..DIABETES 2021?64 (S):.",28.0,YR,,F,Y,,,20210701.0,,MD,JP,JP,2021,Q3,Young Adult
194829941,19482994,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,450 INTERNATIONAL UNIT,,,,,,,,450.0,IU,,,2021,Q3,Lactic acidosis,,2021,Q3,1,I,,20210601.0,20210701,20210701,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202106001750,ELI LILLY AND CO,"TOKUMARU M, ET AL..A CASE OF LACTIC ACIDOSIS IN OVERDOSE OF METFORMIN AND INSULIN FOR SUICIDE ATTEMPT..DIABETES 2021?64 (S):.",28.0,YR,,F,Y,,,20210701.0,,MD,JP,JP,2021,Q3,Young Adult
194829941,19482994,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,450 INTERNATIONAL UNIT,,,,,,,,450.0,IU,,,2021,Q3,Suicide attempt,,2021,Q3,1,I,,20210601.0,20210701,20210701,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202106001750,ELI LILLY AND CO,"TOKUMARU M, ET AL..A CASE OF LACTIC ACIDOSIS IN OVERDOSE OF METFORMIN AND INSULIN FOR SUICIDE ATTEMPT..DIABETES 2021?64 (S):.",28.0,YR,,F,Y,,,20210701.0,,MD,JP,JP,2021,Q3,Young Adult
194842581,19484258,10,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"14 INTERNATIONAL UNIT (0?0?0?1, SOLUTION FOR INJECTION/INFUSION)",,,,,,,,14.0,IU,,,2021,Q3,Abdominal distension,,2021,Q3,1,I,,20210622.0,20210702,20210702,EXP,,DE-AUROBINDO-AUR-APL-2021-027368,AUROBINDO,,71.0,YR,,M,Y,90.5,KG,20210702.0,,PH,DE,DE,2021,Q3,Elderly
194842581,19484258,10,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"14 INTERNATIONAL UNIT (0?0?0?1, SOLUTION FOR INJECTION/INFUSION)",,,,,,,,14.0,IU,,,2021,Q3,Chills,,2021,Q3,1,I,,20210622.0,20210702,20210702,EXP,,DE-AUROBINDO-AUR-APL-2021-027368,AUROBINDO,,71.0,YR,,M,Y,90.5,KG,20210702.0,,PH,DE,DE,2021,Q3,Elderly
194842581,19484258,10,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"14 INTERNATIONAL UNIT (0?0?0?1, SOLUTION FOR INJECTION/INFUSION)",,,,,,,,14.0,IU,,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210622.0,20210702,20210702,EXP,,DE-AUROBINDO-AUR-APL-2021-027368,AUROBINDO,,71.0,YR,,M,Y,90.5,KG,20210702.0,,PH,DE,DE,2021,Q3,Elderly
194850492,19485049,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"40 INTERNATIONAL UNIT, ONCE A DAY",,,,, 0F784A,,,40.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose fluctuation,,2021,Q3,2,F,202104.0,20210825.0,20210702,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-028019,AUROBINDO,,75.0,YR,,M,Y,69.5,KG,20210907.0,,CN,ES,ES,2021,Q3,Elderly
194850492,19485049,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"40 INTERNATIONAL UNIT, ONCE A DAY",,,,, 0F784A,,,40.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,2,F,202104.0,20210825.0,20210702,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-028019,AUROBINDO,,75.0,YR,,M,Y,69.5,KG,20210907.0,,CN,ES,ES,2021,Q3,Elderly
194850492,19485049,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"40 INTERNATIONAL UNIT, ONCE A DAY",,,,, 0F784A,,,40.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Drug ineffective,,2021,Q3,2,F,202104.0,20210825.0,20210702,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-028019,AUROBINDO,,75.0,YR,,M,Y,69.5,KG,20210907.0,,CN,ES,ES,2021,Q3,Elderly
194850492,19485049,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"40 INTERNATIONAL UNIT, ONCE A DAY",,,,, 0F784A,,,40.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Intentional product misuse,,2021,Q3,2,F,202104.0,20210825.0,20210702,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-028019,AUROBINDO,,75.0,YR,,M,Y,69.5,KG,20210907.0,,CN,ES,ES,2021,Q3,Elderly
194850492,19485049,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"40 INTERNATIONAL UNIT, ONCE A DAY",,,,, 0F784A,,,40.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Stress,,2021,Q3,2,F,202104.0,20210825.0,20210702,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-028019,AUROBINDO,,75.0,YR,,M,Y,69.5,KG,20210907.0,,CN,ES,ES,2021,Q3,Elderly
194850492,19485049,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"42 INTERNATIONAL UNIT, ONCE A DAY",,,,, 0F784A,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose fluctuation,,2021,Q3,2,F,202104.0,20210825.0,20210702,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-028019,AUROBINDO,,75.0,YR,,M,Y,69.5,KG,20210907.0,,CN,ES,ES,2021,Q3,Elderly
194850492,19485049,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"42 INTERNATIONAL UNIT, ONCE A DAY",,,,, 0F784A,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,2,F,202104.0,20210825.0,20210702,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-028019,AUROBINDO,,75.0,YR,,M,Y,69.5,KG,20210907.0,,CN,ES,ES,2021,Q3,Elderly
194850492,19485049,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"42 INTERNATIONAL UNIT, ONCE A DAY",,,,, 0F784A,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Drug ineffective,,2021,Q3,2,F,202104.0,20210825.0,20210702,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-028019,AUROBINDO,,75.0,YR,,M,Y,69.5,KG,20210907.0,,CN,ES,ES,2021,Q3,Elderly
194850492,19485049,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"42 INTERNATIONAL UNIT, ONCE A DAY",,,,, 0F784A,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Intentional product misuse,,2021,Q3,2,F,202104.0,20210825.0,20210702,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-028019,AUROBINDO,,75.0,YR,,M,Y,69.5,KG,20210907.0,,CN,ES,ES,2021,Q3,Elderly
194850492,19485049,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"42 INTERNATIONAL UNIT, ONCE A DAY",,,,, 0F784A,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Stress,,2021,Q3,2,F,202104.0,20210825.0,20210702,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-028019,AUROBINDO,,75.0,YR,,M,Y,69.5,KG,20210907.0,,CN,ES,ES,2021,Q3,Elderly
194859231,19485923,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,,,,,2021,Q3,Neurotoxicity,,2021,Q3,1,I,,20210617.0,20210702,20210702,EXP,,CH-SCIEGENPHARMA-2021SCILIT00539,SCIEGEN,ZIMMERMANN P.NEGATIVE MYOCLONUS AS THE LEADING SYMPTOM IN ACUTE CEFEPIME NEUROTOXICITY.BMJ CASE REPORTS.08?APR?2021?14,86.0,YR,E,F,Y,,,20210702.0,,HP,CH,CH,2021,Q3,Elderly
194872961,19487296,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,29.0,IU,INJECTION,,2021,Q3,Diabetic metabolic decompensation,,2021,Q3,1,I,201605.0,20210622.0,20210702,20210702,EXP,,SK-EMD SERONO-9247559,EMD SERONO INC,UNKNOWN. PRACTICAL EXPERIENCE CONFIRMS THE RESULTS OF THE RCT AND RWE STUDIES WITH EMPAGLIFLOSIN: CASE REPORTS. FORUM DIABETOLOGICUM. 2021?10(1):53?61.,53.0,YR,A,M,Y,,,20210702.0,,MD,SK,SK,2021,Q3,Adult
194872961,19487296,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,29.0,IU,INJECTION,,2021,Q3,Drug ineffective,,2021,Q3,1,I,201605.0,20210622.0,20210702,20210702,EXP,,SK-EMD SERONO-9247559,EMD SERONO INC,UNKNOWN. PRACTICAL EXPERIENCE CONFIRMS THE RESULTS OF THE RCT AND RWE STUDIES WITH EMPAGLIFLOSIN: CASE REPORTS. FORUM DIABETOLOGICUM. 2021?10(1):53?61.,53.0,YR,A,M,Y,,,20210702.0,,MD,SK,SK,2021,Q3,Adult
194872961,19487296,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,29.0,IU,INJECTION,,2021,Q3,Weight increased,,2021,Q3,1,I,201605.0,20210622.0,20210702,20210702,EXP,,SK-EMD SERONO-9247559,EMD SERONO INC,UNKNOWN. PRACTICAL EXPERIENCE CONFIRMS THE RESULTS OF THE RCT AND RWE STUDIES WITH EMPAGLIFLOSIN: CASE REPORTS. FORUM DIABETOLOGICUM. 2021?10(1):53?61.,53.0,YR,A,M,Y,,,20210702.0,,MD,SK,SK,2021,Q3,Adult
194872961,19487296,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,TOTAL DAILY INSULIN DOSE WAS 80 UNITS/DAY (INSULIN LISPRO PLUS GLARGINE),,,,,,,,,,INJECTION,,2021,Q3,Diabetic metabolic decompensation,,2021,Q3,1,I,201605.0,20210622.0,20210702,20210702,EXP,,SK-EMD SERONO-9247559,EMD SERONO INC,UNKNOWN. PRACTICAL EXPERIENCE CONFIRMS THE RESULTS OF THE RCT AND RWE STUDIES WITH EMPAGLIFLOSIN: CASE REPORTS. FORUM DIABETOLOGICUM. 2021?10(1):53?61.,53.0,YR,A,M,Y,,,20210702.0,,MD,SK,SK,2021,Q3,Adult
194872961,19487296,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,TOTAL DAILY INSULIN DOSE WAS 80 UNITS/DAY (INSULIN LISPRO PLUS GLARGINE),,,,,,,,,,INJECTION,,2021,Q3,Drug ineffective,,2021,Q3,1,I,201605.0,20210622.0,20210702,20210702,EXP,,SK-EMD SERONO-9247559,EMD SERONO INC,UNKNOWN. PRACTICAL EXPERIENCE CONFIRMS THE RESULTS OF THE RCT AND RWE STUDIES WITH EMPAGLIFLOSIN: CASE REPORTS. FORUM DIABETOLOGICUM. 2021?10(1):53?61.,53.0,YR,A,M,Y,,,20210702.0,,MD,SK,SK,2021,Q3,Adult
194872961,19487296,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,TOTAL DAILY INSULIN DOSE WAS 80 UNITS/DAY (INSULIN LISPRO PLUS GLARGINE),,,,,,,,,,INJECTION,,2021,Q3,Weight increased,,2021,Q3,1,I,201605.0,20210622.0,20210702,20210702,EXP,,SK-EMD SERONO-9247559,EMD SERONO INC,UNKNOWN. PRACTICAL EXPERIENCE CONFIRMS THE RESULTS OF THE RCT AND RWE STUDIES WITH EMPAGLIFLOSIN: CASE REPORTS. FORUM DIABETOLOGICUM. 2021?10(1):53?61.,53.0,YR,A,M,Y,,,20210702.0,,MD,SK,SK,2021,Q3,Adult
194872961,19487296,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,DOSE REDUCED,,,,,,,,12.0,IU,INJECTION,QD,2021,Q3,Diabetic metabolic decompensation,,2021,Q3,1,I,201605.0,20210622.0,20210702,20210702,EXP,,SK-EMD SERONO-9247559,EMD SERONO INC,UNKNOWN. PRACTICAL EXPERIENCE CONFIRMS THE RESULTS OF THE RCT AND RWE STUDIES WITH EMPAGLIFLOSIN: CASE REPORTS. FORUM DIABETOLOGICUM. 2021?10(1):53?61.,53.0,YR,A,M,Y,,,20210702.0,,MD,SK,SK,2021,Q3,Adult
194872961,19487296,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,DOSE REDUCED,,,,,,,,12.0,IU,INJECTION,QD,2021,Q3,Drug ineffective,,2021,Q3,1,I,201605.0,20210622.0,20210702,20210702,EXP,,SK-EMD SERONO-9247559,EMD SERONO INC,UNKNOWN. PRACTICAL EXPERIENCE CONFIRMS THE RESULTS OF THE RCT AND RWE STUDIES WITH EMPAGLIFLOSIN: CASE REPORTS. FORUM DIABETOLOGICUM. 2021?10(1):53?61.,53.0,YR,A,M,Y,,,20210702.0,,MD,SK,SK,2021,Q3,Adult
194872961,19487296,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,DOSE REDUCED,,,,,,,,12.0,IU,INJECTION,QD,2021,Q3,Weight increased,,2021,Q3,1,I,201605.0,20210622.0,20210702,20210702,EXP,,SK-EMD SERONO-9247559,EMD SERONO INC,UNKNOWN. PRACTICAL EXPERIENCE CONFIRMS THE RESULTS OF THE RCT AND RWE STUDIES WITH EMPAGLIFLOSIN: CASE REPORTS. FORUM DIABETOLOGICUM. 2021?10(1):53?61.,53.0,YR,A,M,Y,,,20210702.0,,MD,SK,SK,2021,Q3,Adult
194875731,19487573,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,INJECTION,,2021,Q3,Drug ineffective,,2021,Q3,1,I,,20210624.0,20210702,20210702,EXP,,US-MYLANLABS-2021M1039334,MYLAN,"TARIQ F, PAU D. SEVERE HYPERTRIGLYCERIDEMIA IN CRITICALLY ILL PATIENTS WITH COVID?19. AM?J?RESPIR?CRIT?CARE?MED 2021?203: (PLUS POSTER) ABSTR. TP100.",73.0,YR,,M,Y,,,20210702.0,,HP,US,US,2021,Q3,Elderly
194875731,19487573,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,INJECTION,,2021,Q3,Drug ineffective for unapproved indication,,2021,Q3,1,I,,20210624.0,20210702,20210702,EXP,,US-MYLANLABS-2021M1039334,MYLAN,"TARIQ F, PAU D. SEVERE HYPERTRIGLYCERIDEMIA IN CRITICALLY ILL PATIENTS WITH COVID?19. AM?J?RESPIR?CRIT?CARE?MED 2021?203: (PLUS POSTER) ABSTR. TP100.",73.0,YR,,M,Y,,,20210702.0,,HP,US,US,2021,Q3,Elderly
194875731,19487573,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,INJECTION,,2021,Q3,Off label use,,2021,Q3,1,I,,20210624.0,20210702,20210702,EXP,,US-MYLANLABS-2021M1039334,MYLAN,"TARIQ F, PAU D. SEVERE HYPERTRIGLYCERIDEMIA IN CRITICALLY ILL PATIENTS WITH COVID?19. AM?J?RESPIR?CRIT?CARE?MED 2021?203: (PLUS POSTER) ABSTR. TP100.",73.0,YR,,M,Y,,,20210702.0,,HP,US,US,2021,Q3,Elderly
194880686,19488068,12,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q3,Acute kidney injury,,2021,Q3,6,F,20210626.0,20210907.0,20210702,20210908,EXP,,US-CELGENEUS-USA-20210700150,CELGENE,,69.0,YR,,M,Y,,,20210908.0,,HP,US,US,2021,Q3,Elderly
194880686,19488068,12,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q3,Pneumonia fungal,,2021,Q3,6,F,20210626.0,20210907.0,20210702,20210908,EXP,,US-CELGENEUS-USA-20210700150,CELGENE,,69.0,YR,,M,Y,,,20210908.0,,HP,US,US,2021,Q3,Elderly
194881301,19488130,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"1000 UNITS PER ML INJECTION, 50 UNITS",,,,,,,,50.0,IU,INJECTION,QD,2021,Q3,Decreased activity,,2021,Q3,1,I,20210222.0,20210224.0,20210702,20210702,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2021BDSI0086,BIODELIVERY SCIENCES INTERNATIONAL,,42.0,YR,A,F,Y,118.04,KG,20210702.0,,CN,US,US,2021,Q3,Adult
194881301,19488130,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"1000 UNITS PER ML INJECTION, 50 UNITS",,,,,,,,50.0,IU,INJECTION,QD,2021,Q3,Disturbance in attention,,2021,Q3,1,I,20210222.0,20210224.0,20210702,20210702,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2021BDSI0086,BIODELIVERY SCIENCES INTERNATIONAL,,42.0,YR,A,F,Y,118.04,KG,20210702.0,,CN,US,US,2021,Q3,Adult
194881301,19488130,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"1000 UNITS PER ML INJECTION, 50 UNITS",,,,,,,,50.0,IU,INJECTION,QD,2021,Q3,Dizziness,,2021,Q3,1,I,20210222.0,20210224.0,20210702,20210702,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2021BDSI0086,BIODELIVERY SCIENCES INTERNATIONAL,,42.0,YR,A,F,Y,118.04,KG,20210702.0,,CN,US,US,2021,Q3,Adult
194881301,19488130,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"1000 UNITS PER ML INJECTION, 50 UNITS",,,,,,,,50.0,IU,INJECTION,QD,2021,Q3,Lethargy,,2021,Q3,1,I,20210222.0,20210224.0,20210702,20210702,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2021BDSI0086,BIODELIVERY SCIENCES INTERNATIONAL,,42.0,YR,A,F,Y,118.04,KG,20210702.0,,CN,US,US,2021,Q3,Adult
194881301,19488130,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"1000 UNITS PER ML INJECTION, 50 UNITS",,,,,,,,50.0,IU,INJECTION,QD,2021,Q3,Malaise,,2021,Q3,1,I,20210222.0,20210224.0,20210702,20210702,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2021BDSI0086,BIODELIVERY SCIENCES INTERNATIONAL,,42.0,YR,A,F,Y,118.04,KG,20210702.0,,CN,US,US,2021,Q3,Adult
194881301,19488130,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"1000 UNITS PER ML INJECTION, 50 UNITS",,,,,,,,50.0,IU,INJECTION,QD,2021,Q3,Nausea,,2021,Q3,1,I,20210222.0,20210224.0,20210702,20210702,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2021BDSI0086,BIODELIVERY SCIENCES INTERNATIONAL,,42.0,YR,A,F,Y,118.04,KG,20210702.0,,CN,US,US,2021,Q3,Adult
194881301,19488130,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"1000 UNITS PER ML INJECTION, 50 UNITS",,,,,,,,50.0,IU,INJECTION,QD,2021,Q3,Oral administration complication,,2021,Q3,1,I,20210222.0,20210224.0,20210702,20210702,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2021BDSI0086,BIODELIVERY SCIENCES INTERNATIONAL,,42.0,YR,A,F,Y,118.04,KG,20210702.0,,CN,US,US,2021,Q3,Adult
194881301,19488130,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"1000 UNITS PER ML INJECTION, 50 UNITS",,,,,,,,50.0,IU,INJECTION,QD,2021,Q3,Product adhesion issue,,2021,Q3,1,I,20210222.0,20210224.0,20210702,20210702,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2021BDSI0086,BIODELIVERY SCIENCES INTERNATIONAL,,42.0,YR,A,F,Y,118.04,KG,20210702.0,,CN,US,US,2021,Q3,Adult
194883621,19488362,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IE, 0?0?0?1, INJEKTIONS?/INFUSIONSLOSUNG",,,U,, UNK,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q3,Abdominal distension,,2021,Q3,1,I,,20210624.0,20210702,20210702,EXP,,NVSC2021DE142851,NOVARTIS,,71.0,YR,,M,Y,90.5,KG,20210702.0,,HP,DE,DE,2021,Q3,Elderly
194883621,19488362,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IE, 0?0?0?1, INJEKTIONS?/INFUSIONSLOSUNG",,,U,, UNK,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q3,Chills,,2021,Q3,1,I,,20210624.0,20210702,20210702,EXP,,NVSC2021DE142851,NOVARTIS,,71.0,YR,,M,Y,90.5,KG,20210702.0,,HP,DE,DE,2021,Q3,Elderly
194883621,19488362,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IE, 0?0?0?1, INJEKTIONS?/INFUSIONSLOSUNG",,,U,, UNK,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210624.0,20210702,20210702,EXP,,NVSC2021DE142851,NOVARTIS,,71.0,YR,,M,Y,90.5,KG,20210702.0,,HP,DE,DE,2021,Q3,Elderly
194899252,19489925,13,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,"2 UNITES,BEFORE SLEEP",,,U,,,,,,,,,2021,Q3,Cerebral infarction,,2021,Q3,2,F,20210601.0,20210729.0,20210704,20210802,EXP,,NVSJ2021JP009906,NOVARTIS,,67.0,YR,,F,Y,,,20210803.0,,MD,JP,JP,2021,Q3,Elderly
194899252,19489925,13,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,"2 UNITES,BEFORE SLEEP",,,U,,,,,,,,,2021,Q3,Wrong technique in product usage process,,2021,Q3,2,F,20210601.0,20210729.0,20210704,20210802,EXP,,NVSJ2021JP009906,NOVARTIS,,67.0,YR,,F,Y,,,20210803.0,,MD,JP,JP,2021,Q3,Elderly
194904511,19490451,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, QD",,,D,,,,21081.0,10.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Impaired healing,,2021,Q3,1,I,20200813.0,20210625.0,20210705,20210705,EXP,,DE-SA-2021SA213249,SANOFI AVENTIS,,59.0,YR,A,M,Y,114.0,KG,20210705.0,,PH,DE,DE,2021,Q3,Adult
194904511,19490451,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, QD",,,D,,,,21081.0,10.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Product monitoring error,,2021,Q3,1,I,20200813.0,20210625.0,20210705,20210705,EXP,,DE-SA-2021SA213249,SANOFI AVENTIS,,59.0,YR,A,M,Y,114.0,KG,20210705.0,,PH,DE,DE,2021,Q3,Adult
194904511,19490451,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, QD",,,D,,,,21081.0,10.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Product prescribing error,,2021,Q3,1,I,20200813.0,20210625.0,20210705,20210705,EXP,,DE-SA-2021SA213249,SANOFI AVENTIS,,59.0,YR,A,M,Y,114.0,KG,20210705.0,,PH,DE,DE,2021,Q3,Adult
194908981,19490898,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IU, HS",,,D,,,,206538.0,24.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210625.0,20210705,20210705,EXP,,DE-SA-2021SA213229,SANOFI AVENTIS,,78.0,YR,E,M,Y,88.4,KG,20210705.0,,MD,DE,DE,2021,Q3,Elderly
194908981,19490898,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IU, HS",,,D,,,,206538.0,24.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Fatigue,,2021,Q3,1,I,,20210625.0,20210705,20210705,EXP,,DE-SA-2021SA213229,SANOFI AVENTIS,,78.0,YR,E,M,Y,88.4,KG,20210705.0,,MD,DE,DE,2021,Q3,Elderly
194908981,19490898,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IU, HS",,,D,,,,206538.0,24.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210625.0,20210705,20210705,EXP,,DE-SA-2021SA213229,SANOFI AVENTIS,,78.0,YR,E,M,Y,88.4,KG,20210705.0,,MD,DE,DE,2021,Q3,Elderly
194908981,19490898,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IU, HS",,,D,,,,206538.0,24.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Medication error,,2021,Q3,1,I,,20210625.0,20210705,20210705,EXP,,DE-SA-2021SA213229,SANOFI AVENTIS,,78.0,YR,E,M,Y,88.4,KG,20210705.0,,MD,DE,DE,2021,Q3,Elderly
194908981,19490898,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IU, HS",,,D,,,,206538.0,24.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Night sweats,,2021,Q3,1,I,,20210625.0,20210705,20210705,EXP,,DE-SA-2021SA213229,SANOFI AVENTIS,,78.0,YR,E,M,Y,88.4,KG,20210705.0,,MD,DE,DE,2021,Q3,Elderly
194909731,19490973,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (10 IE, 0?0?1?0, INJEKTIONS?/INFUSIONSLOSUNG)",,,U,,,,,,,INJECTION,,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210624.0,20210705,20210705,EXP,DE-ADRED-06001-01,NVSC2021DE142807,NOVARTIS,,69.0,YR,,M,Y,105.0,KG,20210705.0,,HP,DE,DE,2021,Q3,Elderly
194909731,19490973,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (10 IE, 0?0?1?0, INJEKTIONS?/INFUSIONSLOSUNG)",,,U,,,,,,,INJECTION,,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20210624.0,20210705,20210705,EXP,DE-ADRED-06001-01,NVSC2021DE142807,NOVARTIS,,69.0,YR,,M,Y,105.0,KG,20210705.0,,HP,DE,DE,2021,Q3,Elderly
194909731,19490973,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (10 IE, 0?0?1?0, INJEKTIONS?/INFUSIONSLOSUNG)",,,U,,,,,,,INJECTION,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210624.0,20210705,20210705,EXP,DE-ADRED-06001-01,NVSC2021DE142807,NOVARTIS,,69.0,YR,,M,Y,105.0,KG,20210705.0,,HP,DE,DE,2021,Q3,Elderly
194909731,19490973,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (10 IE, 0?0?1?0, INJEKTIONS?/INFUSIONSLOSUNG)",,,U,,,,,,,INJECTION,,2021,Q3,Restlessness,,2021,Q3,1,I,,20210624.0,20210705,20210705,EXP,DE-ADRED-06001-01,NVSC2021DE142807,NOVARTIS,,69.0,YR,,M,Y,105.0,KG,20210705.0,,HP,DE,DE,2021,Q3,Elderly
194930841,19493084,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IU, QD (12?0?0?0, FERTIGSPRITZEN)",,,U,,,,,1.0,IU,,QD,2021,Q3,Dysuria,,2021,Q3,1,I,,20210628.0,20210705,20210705,EXP,DE-ADRED-06713-01,NVSC2021DE146683,NOVARTIS,,72.0,YR,,M,Y,80.0,KG,20210705.0,,HP,DE,DE,2021,Q3,Elderly
194930841,19493084,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IU, QD (12?0?0?0, FERTIGSPRITZEN)",,,U,,,,,1.0,IU,,QD,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210628.0,20210705,20210705,EXP,DE-ADRED-06713-01,NVSC2021DE146683,NOVARTIS,,72.0,YR,,M,Y,80.0,KG,20210705.0,,HP,DE,DE,2021,Q3,Elderly
194930841,19493084,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IU, QD (12?0?0?0, FERTIGSPRITZEN)",,,U,,,,,1.0,IU,,QD,2021,Q3,Oliguria,,2021,Q3,1,I,,20210628.0,20210705,20210705,EXP,DE-ADRED-06713-01,NVSC2021DE146683,NOVARTIS,,72.0,YR,,M,Y,80.0,KG,20210705.0,,HP,DE,DE,2021,Q3,Elderly
194930841,19493084,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IU, QD (12?0?0?0, FERTIGSPRITZEN)",,,U,,,,,1.0,IU,,QD,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210628.0,20210705,20210705,EXP,DE-ADRED-06713-01,NVSC2021DE146683,NOVARTIS,,72.0,YR,,M,Y,80.0,KG,20210705.0,,HP,DE,DE,2021,Q3,Elderly
194941971,19494197,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, QD",,,,,,,,14.0,IU,,QD,2021,Q3,Asthenia,,2021,Q3,1,I,,20210701.0,20210706,20210706,EXP,,DE-JNJFOC-20210710231,JOHNSON AND JOHNSON,,79.0,YR,E,F,Y,,,20210706.0,,MD,DE,DE,2021,Q3,Elderly
194941971,19494197,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, QD",,,,,,,,14.0,IU,,QD,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210701.0,20210706,20210706,EXP,,DE-JNJFOC-20210710231,JOHNSON AND JOHNSON,,79.0,YR,E,F,Y,,,20210706.0,,MD,DE,DE,2021,Q3,Elderly
194941971,19494197,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, QD",,,,,,,,14.0,IU,,QD,2021,Q3,Hypotension,,2021,Q3,1,I,,20210701.0,20210706,20210706,EXP,,DE-JNJFOC-20210710231,JOHNSON AND JOHNSON,,79.0,YR,E,F,Y,,,20210706.0,,MD,DE,DE,2021,Q3,Elderly
194949831,19494983,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"60 IU, QD",,,,,,,,60.0,IU,,QD,2021,Q3,Anaemia,,2021,Q3,1,I,,20210701.0,20210705,20210705,EXP,,DE-JNJFOC-20210710144,JOHNSON AND JOHNSON,,82.0,YR,E,M,Y,,,20210706.0,,PH,DE,DE,2021,Q3,Elderly
194949831,19494983,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"60 IU, QD",,,,,,,,60.0,IU,,QD,2021,Q3,Atrial fibrillation,,2021,Q3,1,I,,20210701.0,20210705,20210705,EXP,,DE-JNJFOC-20210710144,JOHNSON AND JOHNSON,,82.0,YR,E,M,Y,,,20210706.0,,PH,DE,DE,2021,Q3,Elderly
194949831,19494983,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"60 IU, QD",,,,,,,,60.0,IU,,QD,2021,Q3,Bladder transitional cell carcinoma,,2021,Q3,1,I,,20210701.0,20210705,20210705,EXP,,DE-JNJFOC-20210710144,JOHNSON AND JOHNSON,,82.0,YR,E,M,Y,,,20210706.0,,PH,DE,DE,2021,Q3,Elderly
194949831,19494983,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"60 IU, QD",,,,,,,,60.0,IU,,QD,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210701.0,20210705,20210705,EXP,,DE-JNJFOC-20210710144,JOHNSON AND JOHNSON,,82.0,YR,E,M,Y,,,20210706.0,,PH,DE,DE,2021,Q3,Elderly
194949831,19494983,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"60 IU, QD",,,,,,,,60.0,IU,,QD,2021,Q3,Renal impairment,,2021,Q3,1,I,,20210701.0,20210705,20210705,EXP,,DE-JNJFOC-20210710144,JOHNSON AND JOHNSON,,82.0,YR,E,M,Y,,,20210706.0,,PH,DE,DE,2021,Q3,Elderly
194949831,19494983,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"60 IU, QD",,,,,,,,60.0,IU,,QD,2021,Q3,Urogenital haemorrhage,,2021,Q3,1,I,,20210701.0,20210705,20210705,EXP,,DE-JNJFOC-20210710144,JOHNSON AND JOHNSON,,82.0,YR,E,M,Y,,,20210706.0,,PH,DE,DE,2021,Q3,Elderly
194949831,19494983,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"60 IU, QD",,,,,,,,60.0,IU,,QD,2021,Q3,Weight increased,,2021,Q3,1,I,,20210701.0,20210705,20210705,EXP,,DE-JNJFOC-20210710144,JOHNSON AND JOHNSON,,82.0,YR,E,M,Y,,,20210706.0,,PH,DE,DE,2021,Q3,Elderly
194955151,19495515,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IU, 0?0?1?0, SOLUTION FOR INJECTION / INFUSION",,,,,,,,40.0,IU,,QD,2021,Q3,Dyschezia,,2021,Q3,1,I,,20210701.0,20210706,20210706,EXP,,DE-ORGANON-O2107DEU000103,ORGANON,,80.0,YR,,M,Y,73.0,KG,20210706.0,,PH,DE,DE,2021,Q3,Elderly
194955151,19495515,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IU, 0?0?1?0, SOLUTION FOR INJECTION / INFUSION",,,,,,,,40.0,IU,,QD,2021,Q3,Dysuria,,2021,Q3,1,I,,20210701.0,20210706,20210706,EXP,,DE-ORGANON-O2107DEU000103,ORGANON,,80.0,YR,,M,Y,73.0,KG,20210706.0,,PH,DE,DE,2021,Q3,Elderly
194955151,19495515,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IU, 0?0?1?0, SOLUTION FOR INJECTION / INFUSION",,,,,,,,40.0,IU,,QD,2021,Q3,Weight decreased,,2021,Q3,1,I,,20210701.0,20210706,20210706,EXP,,DE-ORGANON-O2107DEU000103,ORGANON,,80.0,YR,,M,Y,73.0,KG,20210706.0,,PH,DE,DE,2021,Q3,Elderly
194959042,19495904,5,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,,,,,, UNKNOWN,,,,,,,2021,Q3,Acute kidney injury,,2021,Q3,2,F,,20210708.0,20210706,20210712,EXP,,GR-ROCHE-2859249,ROCHE,"PAPAIOANNOU I. GLUTEAL COMPARTMENT SYNDROME ? THE MISSING DIAGNOSIS.. CASE PRESENTATION AND BRIEF LITERATURE REVIEW. SURGICAL CHRONICLES, 2020?25:378?380.",47.0,YR,,F,Y,,,20210713.0,,MD,GR,GR,2021,Q3,Adult
194959042,19495904,5,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,,,,,, UNKNOWN,,,,,,,2021,Q3,Compartment syndrome,,2021,Q3,2,F,,20210708.0,20210706,20210712,EXP,,GR-ROCHE-2859249,ROCHE,"PAPAIOANNOU I. GLUTEAL COMPARTMENT SYNDROME ? THE MISSING DIAGNOSIS.. CASE PRESENTATION AND BRIEF LITERATURE REVIEW. SURGICAL CHRONICLES, 2020?25:378?380.",47.0,YR,,F,Y,,,20210713.0,,MD,GR,GR,2021,Q3,Adult
194959042,19495904,5,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,,,,,, UNKNOWN,,,,,,,2021,Q3,Drug abuse,,2021,Q3,2,F,,20210708.0,20210706,20210712,EXP,,GR-ROCHE-2859249,ROCHE,"PAPAIOANNOU I. GLUTEAL COMPARTMENT SYNDROME ? THE MISSING DIAGNOSIS.. CASE PRESENTATION AND BRIEF LITERATURE REVIEW. SURGICAL CHRONICLES, 2020?25:378?380.",47.0,YR,,F,Y,,,20210713.0,,MD,GR,GR,2021,Q3,Adult
194959042,19495904,5,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,,,,,, UNKNOWN,,,,,,,2021,Q3,Haemodynamic instability,,2021,Q3,2,F,,20210708.0,20210706,20210712,EXP,,GR-ROCHE-2859249,ROCHE,"PAPAIOANNOU I. GLUTEAL COMPARTMENT SYNDROME ? THE MISSING DIAGNOSIS.. CASE PRESENTATION AND BRIEF LITERATURE REVIEW. SURGICAL CHRONICLES, 2020?25:378?380.",47.0,YR,,F,Y,,,20210713.0,,MD,GR,GR,2021,Q3,Adult
194959042,19495904,5,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,,,,,, UNKNOWN,,,,,,,2021,Q3,Hepatic function abnormal,,2021,Q3,2,F,,20210708.0,20210706,20210712,EXP,,GR-ROCHE-2859249,ROCHE,"PAPAIOANNOU I. GLUTEAL COMPARTMENT SYNDROME ? THE MISSING DIAGNOSIS.. CASE PRESENTATION AND BRIEF LITERATURE REVIEW. SURGICAL CHRONICLES, 2020?25:378?380.",47.0,YR,,F,Y,,,20210713.0,,MD,GR,GR,2021,Q3,Adult
194959042,19495904,5,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,,,,,, UNKNOWN,,,,,,,2021,Q3,Immobilisation prolonged,,2021,Q3,2,F,,20210708.0,20210706,20210712,EXP,,GR-ROCHE-2859249,ROCHE,"PAPAIOANNOU I. GLUTEAL COMPARTMENT SYNDROME ? THE MISSING DIAGNOSIS.. CASE PRESENTATION AND BRIEF LITERATURE REVIEW. SURGICAL CHRONICLES, 2020?25:378?380.",47.0,YR,,F,Y,,,20210713.0,,MD,GR,GR,2021,Q3,Adult
194959042,19495904,5,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,,,,,, UNKNOWN,,,,,,,2021,Q3,Rhabdomyolysis,,2021,Q3,2,F,,20210708.0,20210706,20210712,EXP,,GR-ROCHE-2859249,ROCHE,"PAPAIOANNOU I. GLUTEAL COMPARTMENT SYNDROME ? THE MISSING DIAGNOSIS.. CASE PRESENTATION AND BRIEF LITERATURE REVIEW. SURGICAL CHRONICLES, 2020?25:378?380.",47.0,YR,,F,Y,,,20210713.0,,MD,GR,GR,2021,Q3,Adult
194959042,19495904,5,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,,,,,, UNKNOWN,,,,,,,2021,Q3,Toxicity to various agents,,2021,Q3,2,F,,20210708.0,20210706,20210712,EXP,,GR-ROCHE-2859249,ROCHE,"PAPAIOANNOU I. GLUTEAL COMPARTMENT SYNDROME ? THE MISSING DIAGNOSIS.. CASE PRESENTATION AND BRIEF LITERATURE REVIEW. SURGICAL CHRONICLES, 2020?25:378?380.",47.0,YR,,F,Y,,,20210713.0,,MD,GR,GR,2021,Q3,Adult
194974261,19497426,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, 0?0?0?1",,,D,,,,21081.0,,,,,2021,Q3,Foot amputation,,2021,Q3,1,I,20200922.0,20210625.0,20210706,20210706,EXP,,DE-SA-2021SA212380,SANOFI AVENTIS,,71.0,YR,E,M,Y,93.0,KG,20210706.0,,PH,DE,DE,2021,Q3,Elderly
194974261,19497426,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, 0?0?0?1",,,D,,,,21081.0,,,,,2021,Q3,Wound dehiscence,,2021,Q3,1,I,20200922.0,20210625.0,20210706,20210706,EXP,,DE-SA-2021SA212380,SANOFI AVENTIS,,71.0,YR,E,M,Y,93.0,KG,20210706.0,,PH,DE,DE,2021,Q3,Elderly
194976781,19497678,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 IU, QD",,,D,, 0F815A,,,34.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blister,,2021,Q3,1,I,2021.0,20210702.0,20210706,20210706,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-113027",BOEHRINGER INGELHEIM,,63.0,YR,A,M,Y,70.0,KG,20210706.0,,CN,ES,ES,2021,Q3,Adult
194976781,19497678,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 IU, QD",,,D,, 0F815A,,,34.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Drug hypersensitivity,,2021,Q3,1,I,2021.0,20210702.0,20210706,20210706,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-113027",BOEHRINGER INGELHEIM,,63.0,YR,A,M,Y,70.0,KG,20210706.0,,CN,ES,ES,2021,Q3,Adult
194976781,19497678,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 IU, QD",,,D,, 0F815A,,,34.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Multiple use of single-use product,,2021,Q3,1,I,2021.0,20210702.0,20210706,20210706,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-113027",BOEHRINGER INGELHEIM,,63.0,YR,A,M,Y,70.0,KG,20210706.0,,CN,ES,ES,2021,Q3,Adult
194976781,19497678,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 IU, QD",,,D,, 0F815A,,,34.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Product preparation error,,2021,Q3,1,I,2021.0,20210702.0,20210706,20210706,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-113027",BOEHRINGER INGELHEIM,,63.0,YR,A,M,Y,70.0,KG,20210706.0,,CN,ES,ES,2021,Q3,Adult
194978721,19497872,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNKNOWN,,,U,,,,21081.0,,,,,2021,Q3,Diabetic ketoacidosis,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA213634,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20210706.0,,PH,CA,CA,2021,Q3,Adult
194986983,19498698,5,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q3,Febrile neutropenia,,2021,Q3,3,F,20210618.0,20210730.0,20210706,20210804,PER,,US-CELGENEUS-USA-20210607882,CELGENE,,69.0,YR,,M,Y,,,20210804.0,,MD,US,US,2021,Q3,Elderly
194992971,19499297,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"10 INTERNATIONAL UNIT,  0?0?0?1",,,U,,,,,10.0,IU,INJECTION,,2021,Q3,Foot amputation,,2021,Q3,1,I,20200922.0,20210622.0,20210706,20210706,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202106011393,ELI LILLY AND CO,,71.0,YR,,M,Y,93.0,KG,20210706.0,,PH,DE,DE,2021,Q3,Elderly
194992971,19499297,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"10 INTERNATIONAL UNIT,  0?0?0?1",,,U,,,,,10.0,IU,INJECTION,,2021,Q3,Wound dehiscence,,2021,Q3,1,I,20200922.0,20210622.0,20210706,20210706,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202106011393,ELI LILLY AND CO,,71.0,YR,,M,Y,93.0,KG,20210706.0,,PH,DE,DE,2021,Q3,Elderly
194993071,19499307,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"100 IE/ML, 0?0?0?10",,,U,,,,205692.0,,,,,2021,Q3,Product monitoring error,,2021,Q3,1,I,20200813.0,20210622.0,20210706,20210706,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202106011370,ELI LILLY AND CO,,59.0,YR,,M,Y,114.0,KG,20210706.0,,PH,DE,DE,2021,Q3,Adult
194993071,19499307,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"100 IE/ML, 0?0?0?10",,,U,,,,205692.0,,,,,2021,Q3,Product prescribing error,,2021,Q3,1,I,20200813.0,20210622.0,20210706,20210706,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202106011370,ELI LILLY AND CO,,59.0,YR,,M,Y,114.0,KG,20210706.0,,PH,DE,DE,2021,Q3,Adult
194993071,19499307,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"100 IE/ML, 0?0?0?10",,,U,,,,205692.0,,,,,2021,Q3,Wound,,2021,Q3,1,I,20200813.0,20210622.0,20210706,20210706,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202106011370,ELI LILLY AND CO,,59.0,YR,,M,Y,114.0,KG,20210706.0,,PH,DE,DE,2021,Q3,Adult
194998361,19499836,9,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"40 INTERNATIONAL UNIT, ONCE A DAY (0?0?1?0)",,,U,,,,,40.0,IU,SOLUTION FOR INJECTION/INFUSION,QD,2021,Q3,Dyschezia,,2021,Q3,1,I,,20210628.0,20210707,20210707,EXP,,DE-AUROBINDO-AUR-APL-2021-028058,AUROBINDO,,80.0,YR,,M,Y,73.0,KG,20210707.0,,PH,DE,DE,2021,Q3,Elderly
194998361,19499836,9,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"40 INTERNATIONAL UNIT, ONCE A DAY (0?0?1?0)",,,U,,,,,40.0,IU,SOLUTION FOR INJECTION/INFUSION,QD,2021,Q3,Dysuria,,2021,Q3,1,I,,20210628.0,20210707,20210707,EXP,,DE-AUROBINDO-AUR-APL-2021-028058,AUROBINDO,,80.0,YR,,M,Y,73.0,KG,20210707.0,,PH,DE,DE,2021,Q3,Elderly
194998361,19499836,9,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"40 INTERNATIONAL UNIT, ONCE A DAY (0?0?1?0)",,,U,,,,,40.0,IU,SOLUTION FOR INJECTION/INFUSION,QD,2021,Q3,Weight decreased,,2021,Q3,1,I,,20210628.0,20210707,20210707,EXP,,DE-AUROBINDO-AUR-APL-2021-028058,AUROBINDO,,80.0,YR,,M,Y,73.0,KG,20210707.0,,PH,DE,DE,2021,Q3,Elderly
194999851,19499985,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, QD",135.0,IU,Y,Y, ABJL017,,,15.0,IU,,QD,2021,Q3,Hyperhidrosis,,2021,Q3,1,I,20210506.0,20210626.0,20210707,20210707,EXP,CN-NMPA-3303011655707202100242,CN-NOVOPROD-825176,NOVO NORDISK,,60.0,YR,,F,Y,60.0,KG,20210707.0,,HP,CN,CN,2021,Q3,Adult
194999851,19499985,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, QD",135.0,IU,Y,Y, ABJL017,,,15.0,IU,,QD,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,20210506.0,20210626.0,20210707,20210707,EXP,CN-NMPA-3303011655707202100242,CN-NOVOPROD-825176,NOVO NORDISK,,60.0,YR,,F,Y,60.0,KG,20210707.0,,HP,CN,CN,2021,Q3,Adult
194999851,19499985,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, QD",135.0,IU,Y,Y, ABJL017,,,15.0,IU,,QD,2021,Q3,Palpitations,,2021,Q3,1,I,20210506.0,20210626.0,20210707,20210707,EXP,CN-NMPA-3303011655707202100242,CN-NOVOPROD-825176,NOVO NORDISK,,60.0,YR,,F,Y,60.0,KG,20210707.0,,HP,CN,CN,2021,Q3,Adult
194999851,19499985,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,135.0,IU,Y,Y, ABJL017,,,,,,,2021,Q3,Hyperhidrosis,,2021,Q3,1,I,20210506.0,20210626.0,20210707,20210707,EXP,CN-NMPA-3303011655707202100242,CN-NOVOPROD-825176,NOVO NORDISK,,60.0,YR,,F,Y,60.0,KG,20210707.0,,HP,CN,CN,2021,Q3,Adult
194999851,19499985,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,135.0,IU,Y,Y, ABJL017,,,,,,,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,20210506.0,20210626.0,20210707,20210707,EXP,CN-NMPA-3303011655707202100242,CN-NOVOPROD-825176,NOVO NORDISK,,60.0,YR,,F,Y,60.0,KG,20210707.0,,HP,CN,CN,2021,Q3,Adult
194999851,19499985,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,135.0,IU,Y,Y, ABJL017,,,,,,,2021,Q3,Palpitations,,2021,Q3,1,I,20210506.0,20210626.0,20210707,20210707,EXP,CN-NMPA-3303011655707202100242,CN-NOVOPROD-825176,NOVO NORDISK,,60.0,YR,,F,Y,60.0,KG,20210707.0,,HP,CN,CN,2021,Q3,Adult
195009654,19500965,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 UNIT/MVL VIAL,,,U,,,,,,,,,2021,Q3,Encephalopathy,,2021,Q3,4,F,20210620.0,20210721.0,20210707,20210727,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-061237,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,52.5,KG,20210727.0,,HP,US,US,2021,Q3,Elderly
195009654,19500965,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 UNIT/MVL VIAL,,,U,,,,,,,,,2021,Q3,Multiple organ dysfunction syndrome,,2021,Q3,4,F,20210620.0,20210721.0,20210707,20210727,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-061237,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,52.5,KG,20210727.0,,HP,US,US,2021,Q3,Elderly
195009654,19500965,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 UNIT/MVL VIAL,,,U,,,,,,,,,2021,Q3,Pneumonia,,2021,Q3,4,F,20210620.0,20210721.0,20210707,20210727,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-061237,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,52.5,KG,20210727.0,,HP,US,US,2021,Q3,Elderly
195009654,19500965,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 UNIT/MVL VIAL,,,U,,,,,,,,,2021,Q3,Pneumonitis,,2021,Q3,4,F,20210620.0,20210721.0,20210707,20210727,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-061237,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,52.5,KG,20210727.0,,HP,US,US,2021,Q3,Elderly
195009654,19500965,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 UNIT/MVL VIAL,,,U,,,,,,,,,2021,Q3,Respiratory failure,,2021,Q3,4,F,20210620.0,20210721.0,20210707,20210727,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-061237,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,52.5,KG,20210727.0,,HP,US,US,2021,Q3,Elderly
195009654,19500965,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 UNIT/MVL VIAL,,,U,,,,,,,,,2021,Q3,Sepsis,,2021,Q3,4,F,20210620.0,20210721.0,20210707,20210727,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-061237,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,52.5,KG,20210727.0,,HP,US,US,2021,Q3,Elderly
195035191,19503519,1,PS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,Intramuscular,"UNK UNK, QD (25UNITS ONCE DAILY)",,,D,, BF20003631,,210605.0,,,INJECTION,QD,2021,Q3,Device issue,,2021,Q3,1,I,20210604.0,20210604.0,20210707,20210707,EXP,,GB-MYLANLABS-2021M1034471,MYLAN,,63.0,YR,,,Y,,,20210707.0,,HP,GB,GB,2021,Q3,Adult
195035191,19503519,1,PS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,Intramuscular,"UNK UNK, QD (25UNITS ONCE DAILY)",,,D,, BF20003631,,210605.0,,,INJECTION,QD,2021,Q3,Incorrect dose administered by device,,2021,Q3,1,I,20210604.0,20210604.0,20210707,20210707,EXP,,GB-MYLANLABS-2021M1034471,MYLAN,,63.0,YR,,,Y,,,20210707.0,,HP,GB,GB,2021,Q3,Adult
195035962,19503596,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2021,Q3,Diarrhoea,,2021,Q3,2,F,20210623.0,20210709.0,20210707,20210721,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202106013523,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20210721.0,,CN,CN,CN,2021,Q3,Adult
195035962,19503596,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2021,Q3,Small intestinal obstruction,,2021,Q3,2,F,20210623.0,20210709.0,20210707,20210721,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202106013523,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20210721.0,,CN,CN,CN,2021,Q3,Adult
195037021,19503702,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Candida infection,,2021,Q3,1,I,,20210702.0,20210707,20210707,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-113308",BOEHRINGER INGELHEIM,"WOLOSHUK A, LEE M, ASSMUS M, AGARWAL D, KRAMBECK A, LARGE T. ET AL. A CASE OF URETHRAL FUNGAL MASS REMOVAL IN A PATIENT TAKING EMPAGLIFLOZIN. CEN CASE REPORTS. 2021?",67.0,YR,E,F,Y,,,20210707.0,,HP,US,US,2021,Q3,Elderly
195037021,19503702,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Pyelitis,,2021,Q3,1,I,,20210702.0,20210707,20210707,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-113308",BOEHRINGER INGELHEIM,"WOLOSHUK A, LEE M, ASSMUS M, AGARWAL D, KRAMBECK A, LARGE T. ET AL. A CASE OF URETHRAL FUNGAL MASS REMOVAL IN A PATIENT TAKING EMPAGLIFLOZIN. CEN CASE REPORTS. 2021?",67.0,YR,E,F,Y,,,20210707.0,,HP,US,US,2021,Q3,Elderly
195042661,19504266,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,14 IE,,,,, UNKNOWN,,,,,INJECTION,,2021,Q3,Abdominal distension,,2021,Q3,1,I,,20210628.0,20210708,20210708,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-21-54784,HIKMA,,71.0,YR,,M,Y,90.5,KG,20210708.0,,PH,DE,DE,2021,Q3,Elderly
195042661,19504266,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,14 IE,,,,, UNKNOWN,,,,,INJECTION,,2021,Q3,Chills,,2021,Q3,1,I,,20210628.0,20210708,20210708,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-21-54784,HIKMA,,71.0,YR,,M,Y,90.5,KG,20210708.0,,PH,DE,DE,2021,Q3,Elderly
195042661,19504266,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,14 IE,,,,, UNKNOWN,,,,,INJECTION,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210628.0,20210708,20210708,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-21-54784,HIKMA,,71.0,YR,,M,Y,90.5,KG,20210708.0,,PH,DE,DE,2021,Q3,Elderly
195062861,19506286,10,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Alopecia,,2021,Q3,1,I,20210701.0,,20210708,20210708,DIR,,,FDA-CTU,,59.0,YR,,F,N,101.0,KG,20210708.0,N,PH,US,US,2021,Q3,Adult
195072321,19507232,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IE, 0?0?0?1, SOLUTION FOR INJECTION/INFUSION",,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210628.0,20210708,20210708,EXP,,DE-FRESENIUS KABI-FK202106883,FRESENIUS KABI,,78.0,YR,,M,Y,88.4,KG,20210708.0,,HP,NL,DE,2021,Q3,Elderly
195072321,19507232,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IE, 0?0?0?1, SOLUTION FOR INJECTION/INFUSION",,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q3,Fatigue,,2021,Q3,1,I,,20210628.0,20210708,20210708,EXP,,DE-FRESENIUS KABI-FK202106883,FRESENIUS KABI,,78.0,YR,,M,Y,88.4,KG,20210708.0,,HP,NL,DE,2021,Q3,Elderly
195072321,19507232,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IE, 0?0?0?1, SOLUTION FOR INJECTION/INFUSION",,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210628.0,20210708,20210708,EXP,,DE-FRESENIUS KABI-FK202106883,FRESENIUS KABI,,78.0,YR,,M,Y,88.4,KG,20210708.0,,HP,NL,DE,2021,Q3,Elderly
195072321,19507232,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IE, 0?0?0?1, SOLUTION FOR INJECTION/INFUSION",,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q3,Medication error,,2021,Q3,1,I,,20210628.0,20210708,20210708,EXP,,DE-FRESENIUS KABI-FK202106883,FRESENIUS KABI,,78.0,YR,,M,Y,88.4,KG,20210708.0,,HP,NL,DE,2021,Q3,Elderly
195072321,19507232,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IE, 0?0?0?1, SOLUTION FOR INJECTION/INFUSION",,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q3,Night sweats,,2021,Q3,1,I,,20210628.0,20210708,20210708,EXP,,DE-FRESENIUS KABI-FK202106883,FRESENIUS KABI,,78.0,YR,,M,Y,88.4,KG,20210708.0,,HP,NL,DE,2021,Q3,Elderly
195072851,19507285,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IE, 0?0?0?1, SOLUTION FOR INJECTION/INFUSION",,,,,,,,,,UNKNOWN,,2021,Q3,Abdominal distension,,2021,Q3,1,I,,20210628.0,20210708,20210708,EXP,,DE-FRESENIUS KABI-FK202106884,FRESENIUS KABI,,71.0,YR,,M,Y,90.5,KG,20210708.0,,HP,NL,DE,2021,Q3,Elderly
195072851,19507285,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IE, 0?0?0?1, SOLUTION FOR INJECTION/INFUSION",,,,,,,,,,UNKNOWN,,2021,Q3,Chills,,2021,Q3,1,I,,20210628.0,20210708,20210708,EXP,,DE-FRESENIUS KABI-FK202106884,FRESENIUS KABI,,71.0,YR,,M,Y,90.5,KG,20210708.0,,HP,NL,DE,2021,Q3,Elderly
195072851,19507285,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IE, 0?0?0?1, SOLUTION FOR INJECTION/INFUSION",,,,,,,,,,UNKNOWN,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210628.0,20210708,20210708,EXP,,DE-FRESENIUS KABI-FK202106884,FRESENIUS KABI,,71.0,YR,,M,Y,90.5,KG,20210708.0,,HP,NL,DE,2021,Q3,Elderly
195086741,19508674,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, 0?0?0?1, SOLUTION FOR INJECTION / INFUSION",,,,,,,,16.0,IU,,QD,2021,Q3,Acute kidney injury,,2021,Q3,1,I,,20210624.0,20210708,20210708,EXP,DE-ADRED-06282-01,DE-PFIZER INC-2021770582,PFIZER,,74.0,YR,,M,Y,,,20210708.0,,MD,DE,DE,2021,Q3,Elderly
195086741,19508674,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, 0?0?0?1, SOLUTION FOR INJECTION / INFUSION",,,,,,,,16.0,IU,,QD,2021,Q3,Dehydration,,2021,Q3,1,I,,20210624.0,20210708,20210708,EXP,DE-ADRED-06282-01,DE-PFIZER INC-2021770582,PFIZER,,74.0,YR,,M,Y,,,20210708.0,,MD,DE,DE,2021,Q3,Elderly
195086741,19508674,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, 0?0?0?1, SOLUTION FOR INJECTION / INFUSION",,,,,,,,16.0,IU,,QD,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210624.0,20210708,20210708,EXP,DE-ADRED-06282-01,DE-PFIZER INC-2021770582,PFIZER,,74.0,YR,,M,Y,,,20210708.0,,MD,DE,DE,2021,Q3,Elderly
195086741,19508674,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, 0?0?0?1, SOLUTION FOR INJECTION / INFUSION",,,,,,,,16.0,IU,,QD,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210624.0,20210708,20210708,EXP,DE-ADRED-06282-01,DE-PFIZER INC-2021770582,PFIZER,,74.0,YR,,M,Y,,,20210708.0,,MD,DE,DE,2021,Q3,Elderly
195086741,19508674,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, 0?0?0?1, SOLUTION FOR INJECTION / INFUSION",,,,,,,,16.0,IU,,QD,2021,Q3,Haematochezia,,2021,Q3,1,I,,20210624.0,20210708,20210708,EXP,DE-ADRED-06282-01,DE-PFIZER INC-2021770582,PFIZER,,74.0,YR,,M,Y,,,20210708.0,,MD,DE,DE,2021,Q3,Elderly
195098332,19509833,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"1 DOSAGE FORM, QD",,,U,,,,,1.0,DF,SOLUTION FOR INJECTION,,2021,Q3,Asthma,,2021,Q3,2,F,,20210914.0,20210709,20210923,EXP,,CA-APOTEX-2021AP015690,APOTEX,,65.0,YR,,M,Y,,,20210923.0,,CN,CA,CA,2021,Q3,Elderly
195098332,19509833,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"1 DOSAGE FORM, QD",,,U,,,,,1.0,DF,SOLUTION FOR INJECTION,,2021,Q3,Condition aggravated,,2021,Q3,2,F,,20210914.0,20210709,20210923,EXP,,CA-APOTEX-2021AP015690,APOTEX,,65.0,YR,,M,Y,,,20210923.0,,CN,CA,CA,2021,Q3,Elderly
195098332,19509833,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"1 DOSAGE FORM, QD",,,U,,,,,1.0,DF,SOLUTION FOR INJECTION,,2021,Q3,Dyspnoea,,2021,Q3,2,F,,20210914.0,20210709,20210923,EXP,,CA-APOTEX-2021AP015690,APOTEX,,65.0,YR,,M,Y,,,20210923.0,,CN,CA,CA,2021,Q3,Elderly
195098332,19509833,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"1 DOSAGE FORM, QD",,,U,,,,,1.0,DF,SOLUTION FOR INJECTION,,2021,Q3,Haemoptysis,,2021,Q3,2,F,,20210914.0,20210709,20210923,EXP,,CA-APOTEX-2021AP015690,APOTEX,,65.0,YR,,M,Y,,,20210923.0,,CN,CA,CA,2021,Q3,Elderly
195098332,19509833,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"1 DOSAGE FORM, QD",,,U,,,,,1.0,DF,SOLUTION FOR INJECTION,,2021,Q3,Loss of personal independence in daily activities,,2021,Q3,2,F,,20210914.0,20210709,20210923,EXP,,CA-APOTEX-2021AP015690,APOTEX,,65.0,YR,,M,Y,,,20210923.0,,CN,CA,CA,2021,Q3,Elderly
195098332,19509833,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"1 DOSAGE FORM, QD",,,U,,,,,1.0,DF,SOLUTION FOR INJECTION,,2021,Q3,Lung disorder,,2021,Q3,2,F,,20210914.0,20210709,20210923,EXP,,CA-APOTEX-2021AP015690,APOTEX,,65.0,YR,,M,Y,,,20210923.0,,CN,CA,CA,2021,Q3,Elderly
195098332,19509833,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"1 DOSAGE FORM, QD",,,U,,,,,1.0,DF,SOLUTION FOR INJECTION,,2021,Q3,Neuritis,,2021,Q3,2,F,,20210914.0,20210709,20210923,EXP,,CA-APOTEX-2021AP015690,APOTEX,,65.0,YR,,M,Y,,,20210923.0,,CN,CA,CA,2021,Q3,Elderly
195098332,19509833,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"1 DOSAGE FORM, QD",,,U,,,,,1.0,DF,SOLUTION FOR INJECTION,,2021,Q3,Neurological symptom,,2021,Q3,2,F,,20210914.0,20210709,20210923,EXP,,CA-APOTEX-2021AP015690,APOTEX,,65.0,YR,,M,Y,,,20210923.0,,CN,CA,CA,2021,Q3,Elderly
195098332,19509833,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"1 DOSAGE FORM, QD",,,U,,,,,1.0,DF,SOLUTION FOR INJECTION,,2021,Q3,Obstructive airways disorder,,2021,Q3,2,F,,20210914.0,20210709,20210923,EXP,,CA-APOTEX-2021AP015690,APOTEX,,65.0,YR,,M,Y,,,20210923.0,,CN,CA,CA,2021,Q3,Elderly
195098332,19509833,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"1 DOSAGE FORM, QD",,,U,,,,,1.0,DF,SOLUTION FOR INJECTION,,2021,Q3,Pain in extremity,,2021,Q3,2,F,,20210914.0,20210709,20210923,EXP,,CA-APOTEX-2021AP015690,APOTEX,,65.0,YR,,M,Y,,,20210923.0,,CN,CA,CA,2021,Q3,Elderly
195098332,19509833,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"1 DOSAGE FORM, QD",,,U,,,,,1.0,DF,SOLUTION FOR INJECTION,,2021,Q3,Pulmonary alveolar haemorrhage,,2021,Q3,2,F,,20210914.0,20210709,20210923,EXP,,CA-APOTEX-2021AP015690,APOTEX,,65.0,YR,,M,Y,,,20210923.0,,CN,CA,CA,2021,Q3,Elderly
195098332,19509833,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"1 DOSAGE FORM, QD",,,U,,,,,1.0,DF,SOLUTION FOR INJECTION,,2021,Q3,Pulmonary fibrosis,,2021,Q3,2,F,,20210914.0,20210709,20210923,EXP,,CA-APOTEX-2021AP015690,APOTEX,,65.0,YR,,M,Y,,,20210923.0,,CN,CA,CA,2021,Q3,Elderly
195098332,19509833,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"1 DOSAGE FORM, QD",,,U,,,,,1.0,DF,SOLUTION FOR INJECTION,,2021,Q3,Pulmonary vasculitis,,2021,Q3,2,F,,20210914.0,20210709,20210923,EXP,,CA-APOTEX-2021AP015690,APOTEX,,65.0,YR,,M,Y,,,20210923.0,,CN,CA,CA,2021,Q3,Elderly
195098332,19509833,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"1 DOSAGE FORM, QD",,,U,,,,,1.0,DF,SOLUTION FOR INJECTION,,2021,Q3,Respiratory symptom,,2021,Q3,2,F,,20210914.0,20210709,20210923,EXP,,CA-APOTEX-2021AP015690,APOTEX,,65.0,YR,,M,Y,,,20210923.0,,CN,CA,CA,2021,Q3,Elderly
195098332,19509833,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"1 DOSAGE FORM, QD",,,U,,,,,1.0,DF,SOLUTION FOR INJECTION,,2021,Q3,Sleep disorder due to a general medical condition,,2021,Q3,2,F,,20210914.0,20210709,20210923,EXP,,CA-APOTEX-2021AP015690,APOTEX,,65.0,YR,,M,Y,,,20210923.0,,CN,CA,CA,2021,Q3,Elderly
195098332,19509833,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"1 DOSAGE FORM, QD",,,U,,,,,1.0,DF,SOLUTION FOR INJECTION,,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,2,F,,20210914.0,20210709,20210923,EXP,,CA-APOTEX-2021AP015690,APOTEX,,65.0,YR,,M,Y,,,20210923.0,,CN,CA,CA,2021,Q3,Elderly
195098332,19509833,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"1 DOSAGE FORM, QD",,,U,,,,,1.0,DF,SOLUTION FOR INJECTION,,2021,Q3,Vasculitis,,2021,Q3,2,F,,20210914.0,20210709,20210923,EXP,,CA-APOTEX-2021AP015690,APOTEX,,65.0,YR,,M,Y,,,20210923.0,,CN,CA,CA,2021,Q3,Elderly
195098332,19509833,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"1 DOSAGE FORM, QD",,,U,,,,,1.0,DF,SOLUTION FOR INJECTION,,2021,Q3,Wheezing,,2021,Q3,2,F,,20210914.0,20210709,20210923,EXP,,CA-APOTEX-2021AP015690,APOTEX,,65.0,YR,,M,Y,,,20210923.0,,CN,CA,CA,2021,Q3,Elderly
195098332,19509833,26,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Asthma,,2021,Q3,2,F,,20210914.0,20210709,20210923,EXP,,CA-APOTEX-2021AP015690,APOTEX,,65.0,YR,,M,Y,,,20210923.0,,CN,CA,CA,2021,Q3,Elderly
195098332,19509833,26,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Condition aggravated,,2021,Q3,2,F,,20210914.0,20210709,20210923,EXP,,CA-APOTEX-2021AP015690,APOTEX,,65.0,YR,,M,Y,,,20210923.0,,CN,CA,CA,2021,Q3,Elderly
195098332,19509833,26,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Dyspnoea,,2021,Q3,2,F,,20210914.0,20210709,20210923,EXP,,CA-APOTEX-2021AP015690,APOTEX,,65.0,YR,,M,Y,,,20210923.0,,CN,CA,CA,2021,Q3,Elderly
195098332,19509833,26,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Haemoptysis,,2021,Q3,2,F,,20210914.0,20210709,20210923,EXP,,CA-APOTEX-2021AP015690,APOTEX,,65.0,YR,,M,Y,,,20210923.0,,CN,CA,CA,2021,Q3,Elderly
195098332,19509833,26,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Loss of personal independence in daily activities,,2021,Q3,2,F,,20210914.0,20210709,20210923,EXP,,CA-APOTEX-2021AP015690,APOTEX,,65.0,YR,,M,Y,,,20210923.0,,CN,CA,CA,2021,Q3,Elderly
195098332,19509833,26,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Lung disorder,,2021,Q3,2,F,,20210914.0,20210709,20210923,EXP,,CA-APOTEX-2021AP015690,APOTEX,,65.0,YR,,M,Y,,,20210923.0,,CN,CA,CA,2021,Q3,Elderly
195098332,19509833,26,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Neuritis,,2021,Q3,2,F,,20210914.0,20210709,20210923,EXP,,CA-APOTEX-2021AP015690,APOTEX,,65.0,YR,,M,Y,,,20210923.0,,CN,CA,CA,2021,Q3,Elderly
195098332,19509833,26,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Neurological symptom,,2021,Q3,2,F,,20210914.0,20210709,20210923,EXP,,CA-APOTEX-2021AP015690,APOTEX,,65.0,YR,,M,Y,,,20210923.0,,CN,CA,CA,2021,Q3,Elderly
195098332,19509833,26,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Obstructive airways disorder,,2021,Q3,2,F,,20210914.0,20210709,20210923,EXP,,CA-APOTEX-2021AP015690,APOTEX,,65.0,YR,,M,Y,,,20210923.0,,CN,CA,CA,2021,Q3,Elderly
195098332,19509833,26,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Pain in extremity,,2021,Q3,2,F,,20210914.0,20210709,20210923,EXP,,CA-APOTEX-2021AP015690,APOTEX,,65.0,YR,,M,Y,,,20210923.0,,CN,CA,CA,2021,Q3,Elderly
195098332,19509833,26,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Pulmonary alveolar haemorrhage,,2021,Q3,2,F,,20210914.0,20210709,20210923,EXP,,CA-APOTEX-2021AP015690,APOTEX,,65.0,YR,,M,Y,,,20210923.0,,CN,CA,CA,2021,Q3,Elderly
195098332,19509833,26,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Pulmonary fibrosis,,2021,Q3,2,F,,20210914.0,20210709,20210923,EXP,,CA-APOTEX-2021AP015690,APOTEX,,65.0,YR,,M,Y,,,20210923.0,,CN,CA,CA,2021,Q3,Elderly
195098332,19509833,26,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Pulmonary vasculitis,,2021,Q3,2,F,,20210914.0,20210709,20210923,EXP,,CA-APOTEX-2021AP015690,APOTEX,,65.0,YR,,M,Y,,,20210923.0,,CN,CA,CA,2021,Q3,Elderly
195098332,19509833,26,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Respiratory symptom,,2021,Q3,2,F,,20210914.0,20210709,20210923,EXP,,CA-APOTEX-2021AP015690,APOTEX,,65.0,YR,,M,Y,,,20210923.0,,CN,CA,CA,2021,Q3,Elderly
195098332,19509833,26,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Sleep disorder due to a general medical condition,,2021,Q3,2,F,,20210914.0,20210709,20210923,EXP,,CA-APOTEX-2021AP015690,APOTEX,,65.0,YR,,M,Y,,,20210923.0,,CN,CA,CA,2021,Q3,Elderly
195098332,19509833,26,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,2,F,,20210914.0,20210709,20210923,EXP,,CA-APOTEX-2021AP015690,APOTEX,,65.0,YR,,M,Y,,,20210923.0,,CN,CA,CA,2021,Q3,Elderly
195098332,19509833,26,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Vasculitis,,2021,Q3,2,F,,20210914.0,20210709,20210923,EXP,,CA-APOTEX-2021AP015690,APOTEX,,65.0,YR,,M,Y,,,20210923.0,,CN,CA,CA,2021,Q3,Elderly
195098332,19509833,26,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Wheezing,,2021,Q3,2,F,,20210914.0,20210709,20210923,EXP,,CA-APOTEX-2021AP015690,APOTEX,,65.0,YR,,M,Y,,,20210923.0,,CN,CA,CA,2021,Q3,Elderly
195108251,19510825,8,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"14 INTERNATIONAL UNIT (0?0?1?0, PRE?FILLED SYRINGES)",,,,,,,,14.0,IU,,,2021,Q3,Asthenia,,2021,Q3,1,I,,20210628.0,20210709,20210709,EXP,,DE-AUROBINDO-AUR-APL-2021-028052,AUROBINDO,,79.0,YR,,F,Y,,,20210709.0,,MD,DE,DE,2021,Q3,Elderly
195108251,19510825,8,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"14 INTERNATIONAL UNIT (0?0?1?0, PRE?FILLED SYRINGES)",,,,,,,,14.0,IU,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210628.0,20210709,20210709,EXP,,DE-AUROBINDO-AUR-APL-2021-028052,AUROBINDO,,79.0,YR,,F,Y,,,20210709.0,,MD,DE,DE,2021,Q3,Elderly
195108251,19510825,8,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"14 INTERNATIONAL UNIT (0?0?1?0, PRE?FILLED SYRINGES)",,,,,,,,14.0,IU,,,2021,Q3,Hypotension,,2021,Q3,1,I,,20210628.0,20210709,20210709,EXP,,DE-AUROBINDO-AUR-APL-2021-028052,AUROBINDO,,79.0,YR,,F,Y,,,20210709.0,,MD,DE,DE,2021,Q3,Elderly
195133901,19513390,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,14 IU UNK,,,U,N,,,,,,,,2021,Q3,Asthenia,,2021,Q3,1,I,,20210706.0,20210709,20210709,EXP,,DE-ANIPHARMA-2021-DE-000145,ANI,,79.0,YR,,F,Y,,,20210709.0,,MD,DE,DE,2021,Q3,Elderly
195133901,19513390,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,14 IU UNK,,,U,N,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210706.0,20210709,20210709,EXP,,DE-ANIPHARMA-2021-DE-000145,ANI,,79.0,YR,,F,Y,,,20210709.0,,MD,DE,DE,2021,Q3,Elderly
195133901,19513390,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,14 IU UNK,,,U,N,,,,,,,,2021,Q3,Hypotension,,2021,Q3,1,I,,20210706.0,20210709,20210709,EXP,,DE-ANIPHARMA-2021-DE-000145,ANI,,79.0,YR,,F,Y,,,20210709.0,,MD,DE,DE,2021,Q3,Elderly
195144881,19514488,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IE, 0?0?1?0, FERTIGSPRITZEN",,,U,, UNK,,,,,,QD,2021,Q3,Asthenia,,2021,Q3,1,I,,20210628.0,20210709,20210709,EXP,DE-ADRED-06171-01,NVSC2021DE146669,NOVARTIS,,79.0,YR,,F,Y,,,20210709.0,,HP,DE,DE,2021,Q3,Elderly
195144881,19514488,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IE, 0?0?1?0, FERTIGSPRITZEN",,,U,, UNK,,,,,,QD,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210628.0,20210709,20210709,EXP,DE-ADRED-06171-01,NVSC2021DE146669,NOVARTIS,,79.0,YR,,F,Y,,,20210709.0,,HP,DE,DE,2021,Q3,Elderly
195144881,19514488,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IE, 0?0?1?0, FERTIGSPRITZEN",,,U,, UNK,,,,,,QD,2021,Q3,Hypotension,,2021,Q3,1,I,,20210628.0,20210709,20210709,EXP,DE-ADRED-06171-01,NVSC2021DE146669,NOVARTIS,,79.0,YR,,F,Y,,,20210709.0,,HP,DE,DE,2021,Q3,Elderly
195153041,19515304,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,25.0,IU,UNKNOWN,QD,2021,Q3,Arthralgia,,2021,Q3,1,I,20210625.0,20210706.0,20210709,20210709,EXP,,US-FRESENIUS KABI-FK202106988,FRESENIUS KABI,,80.0,YR,,M,Y,97.5,KG,20210709.0,,CN,US,US,2021,Q3,Elderly
195153041,19515304,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,25.0,IU,UNKNOWN,QD,2021,Q3,Contraindicated product administered,,2021,Q3,1,I,20210625.0,20210706.0,20210709,20210709,EXP,,US-FRESENIUS KABI-FK202106988,FRESENIUS KABI,,80.0,YR,,M,Y,97.5,KG,20210709.0,,CN,US,US,2021,Q3,Elderly
195170721,19517072,7,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,"INJECTIEVLOEISTOF, 300 EENHEDEN/ML (EENHEDEN PER MILLILITER)",,,,,,,,300.0,MG,,,2021,Q3,Demyelinating polyneuropathy,,2021,Q3,1,I,20200416.0,20210708.0,20210712,20210712,EXP,NL-LRB-00608465,NL-ABBVIE-21K-114-3983081-00,ABBVIE,,49.0,YR,,F,Y,47.0,KG,20210711.0,,MD,NL,NL,2021,Q3,Adult
195207361,19520736,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IE, DONNERSTAGS, INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,,,,,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20210628.0,20210712,20210712,EXP,,NVSC2021DE148852,NOVARTIS,,79.0,YR,,F,Y,,,20210712.0,,HP,DE,DE,2021,Q3,Elderly
195207361,19520736,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IE, DONNERSTAGS, INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210628.0,20210712,20210712,EXP,,NVSC2021DE148852,NOVARTIS,,79.0,YR,,F,Y,,,20210712.0,,HP,DE,DE,2021,Q3,Elderly
195207361,19520736,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IE, DONNERSTAGS, INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,,,,,2021,Q3,Pallor,,2021,Q3,1,I,,20210628.0,20210712,20210712,EXP,,NVSC2021DE148852,NOVARTIS,,79.0,YR,,F,Y,,,20210712.0,,HP,DE,DE,2021,Q3,Elderly
195211031,19521103,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, QD",,,U,,,,,14.0,IU,,QD,2021,Q3,Abdominal pain,,2021,Q3,1,I,,20210630.0,20210712,20210712,EXP,,DE-SA-2021SA217950,SANOFI AVENTIS,,79.0,YR,E,F,Y,54.0,KG,20210712.0,,PH,DE,DE,2021,Q3,Elderly
195211031,19521103,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, QD",,,U,,,,,14.0,IU,,QD,2021,Q3,Bile duct stone,,2021,Q3,1,I,,20210630.0,20210712,20210712,EXP,,DE-SA-2021SA217950,SANOFI AVENTIS,,79.0,YR,E,F,Y,54.0,KG,20210712.0,,PH,DE,DE,2021,Q3,Elderly
195211031,19521103,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, QD",,,U,,,,,14.0,IU,,QD,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210630.0,20210712,20210712,EXP,,DE-SA-2021SA217950,SANOFI AVENTIS,,79.0,YR,E,F,Y,54.0,KG,20210712.0,,PH,DE,DE,2021,Q3,Elderly
195211031,19521103,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, QD",,,U,,,,,14.0,IU,,QD,2021,Q3,Liver function test abnormal,,2021,Q3,1,I,,20210630.0,20210712,20210712,EXP,,DE-SA-2021SA217950,SANOFI AVENTIS,,79.0,YR,E,F,Y,54.0,KG,20210712.0,,PH,DE,DE,2021,Q3,Elderly
195211031,19521103,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, QD",,,U,,,,,14.0,IU,,QD,2021,Q3,Vomiting,,2021,Q3,1,I,,20210630.0,20210712,20210712,EXP,,DE-SA-2021SA217950,SANOFI AVENTIS,,79.0,YR,E,F,Y,54.0,KG,20210712.0,,PH,DE,DE,2021,Q3,Elderly
195213821,19521382,31,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,Y,,,,,,,,,2021,Q3,Cytomegalovirus infection reactivation,,2021,Q3,1,I,20190809.0,20201028.0,20210712,20210712,EXP,,ES-ROCHE-2704334,ROCHE,,73.0,YR,,M,Y,73.0,KG,20210712.0,,MD,ES,ES,2021,Q3,Elderly
195213821,19521382,31,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,Y,,,,,,,,,2021,Q3,Fluid retention,,2021,Q3,1,I,20190809.0,20201028.0,20210712,20210712,EXP,,ES-ROCHE-2704334,ROCHE,,73.0,YR,,M,Y,73.0,KG,20210712.0,,MD,ES,ES,2021,Q3,Elderly
195213821,19521382,31,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,Y,,,,,,,,,2021,Q3,Tremor,,2021,Q3,1,I,20190809.0,20201028.0,20210712,20210712,EXP,,ES-ROCHE-2704334,ROCHE,,73.0,YR,,M,Y,73.0,KG,20210712.0,,MD,ES,ES,2021,Q3,Elderly
195222101,19522210,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"30 INTERNATIONAL UNIT, ONCE A DAY",,,Y,, 1F935A,,,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose fluctuation,,2021,Q3,1,I,202103.0,20210701.0,20210713,20210713,EXP,,ES-AUROBINDO-AUR-APL-2021-028879,AUROBINDO,,49.0,YR,,M,Y,75.0,KG,20210713.0,,HP,ES,ES,2021,Q3,Adult
195222101,19522210,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"30 INTERNATIONAL UNIT, ONCE A DAY",,,Y,, 1F935A,,,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Gait disturbance,,2021,Q3,1,I,202103.0,20210701.0,20210713,20210713,EXP,,ES-AUROBINDO-AUR-APL-2021-028879,AUROBINDO,,49.0,YR,,M,Y,75.0,KG,20210713.0,,HP,ES,ES,2021,Q3,Adult
195222101,19522210,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"30 INTERNATIONAL UNIT, ONCE A DAY",,,Y,, 1F935A,,,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Nervousness,,2021,Q3,1,I,202103.0,20210701.0,20210713,20210713,EXP,,ES-AUROBINDO-AUR-APL-2021-028879,AUROBINDO,,49.0,YR,,M,Y,75.0,KG,20210713.0,,HP,ES,ES,2021,Q3,Adult
195222101,19522210,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"30 INTERNATIONAL UNIT, ONCE A DAY",,,Y,, 1F935A,,,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Weight decreased,,2021,Q3,1,I,202103.0,20210701.0,20210713,20210713,EXP,,ES-AUROBINDO-AUR-APL-2021-028879,AUROBINDO,,49.0,YR,,M,Y,75.0,KG,20210713.0,,HP,ES,ES,2021,Q3,Adult
195222101,19522210,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"20 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose fluctuation,,2021,Q3,1,I,202103.0,20210701.0,20210713,20210713,EXP,,ES-AUROBINDO-AUR-APL-2021-028879,AUROBINDO,,49.0,YR,,M,Y,75.0,KG,20210713.0,,HP,ES,ES,2021,Q3,Adult
195222101,19522210,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"20 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Gait disturbance,,2021,Q3,1,I,202103.0,20210701.0,20210713,20210713,EXP,,ES-AUROBINDO-AUR-APL-2021-028879,AUROBINDO,,49.0,YR,,M,Y,75.0,KG,20210713.0,,HP,ES,ES,2021,Q3,Adult
195222101,19522210,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"20 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Nervousness,,2021,Q3,1,I,202103.0,20210701.0,20210713,20210713,EXP,,ES-AUROBINDO-AUR-APL-2021-028879,AUROBINDO,,49.0,YR,,M,Y,75.0,KG,20210713.0,,HP,ES,ES,2021,Q3,Adult
195222101,19522210,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"20 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Weight decreased,,2021,Q3,1,I,202103.0,20210701.0,20210713,20210713,EXP,,ES-AUROBINDO-AUR-APL-2021-028879,AUROBINDO,,49.0,YR,,M,Y,75.0,KG,20210713.0,,HP,ES,ES,2021,Q3,Adult
195229431,19522943,1,PS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,Unknown,"UNK UNK, PM",,,,, BF20001997,,210605.0,,,INJECTION,QD,2021,Q3,Device issue,,2021,Q3,1,I,2021.0,20210702.0,20210712,20210712,PER,,US-MYLANLABS-2021M1040238,MYLAN,,40.0,YR,,F,Y,118.39,KG,20210712.0,,CN,US,US,2021,Q3,Adult
195229431,19522943,1,PS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,Unknown,"UNK UNK, PM",,,,, BF20001997,,210605.0,,,INJECTION,QD,2021,Q3,Injection site pain,,2021,Q3,1,I,2021.0,20210702.0,20210712,20210712,PER,,US-MYLANLABS-2021M1040238,MYLAN,,40.0,YR,,F,Y,118.39,KG,20210712.0,,CN,US,US,2021,Q3,Adult
195229431,19522943,1,PS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,Unknown,"UNK UNK, PM",,,,, BF20001997,,210605.0,,,INJECTION,QD,2021,Q3,Product dose omission issue,,2021,Q3,1,I,2021.0,20210702.0,20210712,20210712,PER,,US-MYLANLABS-2021M1040238,MYLAN,,40.0,YR,,F,Y,118.39,KG,20210712.0,,CN,US,US,2021,Q3,Adult
195229431,19522943,1,PS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,Unknown,"UNK UNK, PM",,,,, BF20001997,,210605.0,,,INJECTION,QD,2021,Q3,Product label issue,,2021,Q3,1,I,2021.0,20210702.0,20210712,20210712,PER,,US-MYLANLABS-2021M1040238,MYLAN,,40.0,YR,,F,Y,118.39,KG,20210712.0,,CN,US,US,2021,Q3,Adult
195229431,19522943,1,PS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,Unknown,"UNK UNK, PM",,,,, BF20001997,,210605.0,,,INJECTION,QD,2021,Q3,Weight decreased,,2021,Q3,1,I,2021.0,20210702.0,20210712,20210712,PER,,US-MYLANLABS-2021M1040238,MYLAN,,40.0,YR,,F,Y,118.39,KG,20210712.0,,CN,US,US,2021,Q3,Adult
195229431,19522943,2,SS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,Unknown,UNK,,,,, BF20002483,,210605.0,,,INJECTION,,2021,Q3,Device issue,,2021,Q3,1,I,2021.0,20210702.0,20210712,20210712,PER,,US-MYLANLABS-2021M1040238,MYLAN,,40.0,YR,,F,Y,118.39,KG,20210712.0,,CN,US,US,2021,Q3,Adult
195229431,19522943,2,SS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,Unknown,UNK,,,,, BF20002483,,210605.0,,,INJECTION,,2021,Q3,Injection site pain,,2021,Q3,1,I,2021.0,20210702.0,20210712,20210712,PER,,US-MYLANLABS-2021M1040238,MYLAN,,40.0,YR,,F,Y,118.39,KG,20210712.0,,CN,US,US,2021,Q3,Adult
195229431,19522943,2,SS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,Unknown,UNK,,,,, BF20002483,,210605.0,,,INJECTION,,2021,Q3,Product dose omission issue,,2021,Q3,1,I,2021.0,20210702.0,20210712,20210712,PER,,US-MYLANLABS-2021M1040238,MYLAN,,40.0,YR,,F,Y,118.39,KG,20210712.0,,CN,US,US,2021,Q3,Adult
195229431,19522943,2,SS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,Unknown,UNK,,,,, BF20002483,,210605.0,,,INJECTION,,2021,Q3,Product label issue,,2021,Q3,1,I,2021.0,20210702.0,20210712,20210712,PER,,US-MYLANLABS-2021M1040238,MYLAN,,40.0,YR,,F,Y,118.39,KG,20210712.0,,CN,US,US,2021,Q3,Adult
195229431,19522943,2,SS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,Unknown,UNK,,,,, BF20002483,,210605.0,,,INJECTION,,2021,Q3,Weight decreased,,2021,Q3,1,I,2021.0,20210702.0,20210712,20210712,PER,,US-MYLANLABS-2021M1040238,MYLAN,,40.0,YR,,F,Y,118.39,KG,20210712.0,,CN,US,US,2021,Q3,Adult
195275161,19527516,43,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,Y,,,,,,,,,2021,Q3,Cytomegalovirus infection reactivation,,2021,Q3,1,I,20190809.0,20201026.0,20210713,20210713,EXP,,NVSC2020ES289258,NOVARTIS,,73.0,YR,,M,Y,73.0,KG,20210713.0,,HP,ES,ES,2021,Q3,Elderly
195275161,19527516,43,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,Y,,,,,,,,,2021,Q3,Fluid retention,,2021,Q3,1,I,20190809.0,20201026.0,20210713,20210713,EXP,,NVSC2020ES289258,NOVARTIS,,73.0,YR,,M,Y,73.0,KG,20210713.0,,HP,ES,ES,2021,Q3,Elderly
195275161,19527516,43,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,Y,,,,,,,,,2021,Q3,Tremor,,2021,Q3,1,I,20190809.0,20201026.0,20210713,20210713,EXP,,NVSC2020ES289258,NOVARTIS,,73.0,YR,,M,Y,73.0,KG,20210713.0,,HP,ES,ES,2021,Q3,Elderly
195375721,19537572,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q3,Drug ineffective,,2021,Q3,1,I,,20210705.0,20210713,20210713,EXP,,GR-MYLANLABS-2021M1041654,MYLAN,"LIATSOS GD, TSIRIGA A, DOURAKIS SP. FATAL STREPTOCOCCUS PSEUDOPORCINUS DISSEMINATED INFECTION IN DECOMPENSATED LIVER CIRRHOSIS: A CASE REPORT. J?MED?CASE?REP 2021?15:NO. 1.",55.0,YR,,M,Y,,,20210713.0,,HP,GR,GR,2021,Q3,Adult
195456124,19545612,24,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,5 UNIT,,,,,,,,,,UNKNOWN,QD,2021,Q3,Hypotension,,2021,Q3,4,F,20210628.0,20210810.0,20210714,20210816,PER,,US-CELGENEUS-USA-20210702095,CELGENE,,78.0,YR,,F,Y,70.3,KG,20210816.0,,HP,US,US,2021,Q3,Elderly
195582821,19558282,1,PS,INSULIN GLARGINE MYLAN,INSULIN GLARGINE,1,Subcutaneous,"12 INTERNATIONAL UNIT, QD",,,Y,,,,210605.0,12.0,IU,INJECTION,QD,2021,Q3,Disorientation,,2021,Q3,1,I,20171121.0,20210708.0,20210714,20210714,EXP,IT-MINISAL02-450031,IT-MYLANLABS-2021M1041455,MYLAN,,78.0,YR,,F,Y,,,20210714.0,,MD,IT,IT,2021,Q3,Elderly
195582821,19558282,1,PS,INSULIN GLARGINE MYLAN,INSULIN GLARGINE,1,Subcutaneous,"12 INTERNATIONAL UNIT, QD",,,Y,,,,210605.0,12.0,IU,INJECTION,QD,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,20171121.0,20210708.0,20210714,20210714,EXP,IT-MINISAL02-450031,IT-MYLANLABS-2021M1041455,MYLAN,,78.0,YR,,F,Y,,,20210714.0,,MD,IT,IT,2021,Q3,Elderly
195582821,19558282,1,PS,INSULIN GLARGINE MYLAN,INSULIN GLARGINE,1,Subcutaneous,"12 INTERNATIONAL UNIT, QD",,,Y,,,,210605.0,12.0,IU,INJECTION,QD,2021,Q3,Medication error,,2021,Q3,1,I,20171121.0,20210708.0,20210714,20210714,EXP,IT-MINISAL02-450031,IT-MYLANLABS-2021M1041455,MYLAN,,78.0,YR,,F,Y,,,20210714.0,,MD,IT,IT,2021,Q3,Elderly
195652732,19565273,1,PS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"40 INTERNATIONAL UNIT, EACH MORNING",,,Y,,,,205692.0,40.0,IU,,QD,2021,Q3,Abortion spontaneous,,2021,Q3,2,F,,20210729.0,20210716,20210810,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202107002986,ELI LILLY AND CO,"HONOKI H,ET AL..TYPE 1 DIABETES WOMAN WITH REPEATED MISCARRIAGES SUCCESSFULLY GAVE BIRTH AFTER INTRODUCING AN INSULIN PUMP WITH A PREDICTIVE LOW GLUCOSE SUSPEND FEATURE.DIABETOLOGY INTERNATIONAL 2021?12 (3):324?329.",20.0,YR,,F,Y,,,20210810.0,,MD,JP,JP,2021,Q3,Youth
195652732,19565273,1,PS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"40 INTERNATIONAL UNIT, EACH MORNING",,,Y,,,,205692.0,40.0,IU,,QD,2021,Q3,Blood glucose fluctuation,,2021,Q3,2,F,,20210729.0,20210716,20210810,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202107002986,ELI LILLY AND CO,"HONOKI H,ET AL..TYPE 1 DIABETES WOMAN WITH REPEATED MISCARRIAGES SUCCESSFULLY GAVE BIRTH AFTER INTRODUCING AN INSULIN PUMP WITH A PREDICTIVE LOW GLUCOSE SUSPEND FEATURE.DIABETOLOGY INTERNATIONAL 2021?12 (3):324?329.",20.0,YR,,F,Y,,,20210810.0,,MD,JP,JP,2021,Q3,Youth
195652732,19565273,1,PS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"40 INTERNATIONAL UNIT, EACH MORNING",,,Y,,,,205692.0,40.0,IU,,QD,2021,Q3,Hypoglycaemia,,2021,Q3,2,F,,20210729.0,20210716,20210810,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202107002986,ELI LILLY AND CO,"HONOKI H,ET AL..TYPE 1 DIABETES WOMAN WITH REPEATED MISCARRIAGES SUCCESSFULLY GAVE BIRTH AFTER INTRODUCING AN INSULIN PUMP WITH A PREDICTIVE LOW GLUCOSE SUSPEND FEATURE.DIABETOLOGY INTERNATIONAL 2021?12 (3):324?329.",20.0,YR,,F,Y,,,20210810.0,,MD,JP,JP,2021,Q3,Youth
195652732,19565273,1,PS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"40 INTERNATIONAL UNIT, EACH MORNING",,,Y,,,,205692.0,40.0,IU,,QD,2021,Q3,Maternal exposure during pregnancy,,2021,Q3,2,F,,20210729.0,20210716,20210810,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202107002986,ELI LILLY AND CO,"HONOKI H,ET AL..TYPE 1 DIABETES WOMAN WITH REPEATED MISCARRIAGES SUCCESSFULLY GAVE BIRTH AFTER INTRODUCING AN INSULIN PUMP WITH A PREDICTIVE LOW GLUCOSE SUSPEND FEATURE.DIABETOLOGY INTERNATIONAL 2021?12 (3):324?329.",20.0,YR,,F,Y,,,20210810.0,,MD,JP,JP,2021,Q3,Youth
195653971,19565397,5,C,INSULIN GLARGINE(GENETICAL RECOMBINATION) [BIOSIMILAR 1],,2,Unknown,UNK,,,U,,,,,,,INJECTION,,2021,Q3,Liver disorder,,2021,Q3,1,I,,20210707.0,20210714,20210714,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-068731,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,,,20210714.0,,MD,JP,JP,2021,Q3,Elderly
195653971,19565397,5,C,INSULIN GLARGINE(GENETICAL RECOMBINATION) [BIOSIMILAR 1],,2,Unknown,UNK,,,U,,,,,,,INJECTION,,2021,Q3,Malignant neoplasm progression,,2021,Q3,1,I,,20210707.0,20210714,20210714,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-068731,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,,,20210714.0,,MD,JP,JP,2021,Q3,Elderly
195682851,19568285,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q3,Heart rate decreased,,2021,Q3,1,I,20210427.0,20210506.0,20210714,20210714,PER,,US-NOVOPROD-812179,NOVO NORDISK,,70.0,YR,,M,Y,,,20210714.0,,HP,US,US,2021,Q3,Elderly
195697031,19569703,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),0.07 UNITS/KG/HOUR,,,Y,N,,,210605.0,,,INJECTION,,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,,20210709.0,20210716,20210716,EXP,,US-MYLANLABS-2021M1043233,MYLAN,"REED JM, HOGAN BM, NASSER?GHODSI N, LOFTUS CG. MANAGEMENT OF HYPERTRIGLYCERIDEMIA?INDUCED ACUTE PANCREATITIS IN A NONDIABETIC PATIENT. MAYO?CLIN?PROC?INNOV?QUAL?OUTCOMES 2021?5(1):230?235.",34.0,YR,,F,Y,,,20210716.0,,PH,US,US,2021,Q3,Young Adult
195697031,19569703,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),0.07 UNITS/KG/HOUR,,,Y,N,,,210605.0,,,INJECTION,,2021,Q3,Off label use,,2021,Q3,1,I,,20210709.0,20210716,20210716,EXP,,US-MYLANLABS-2021M1043233,MYLAN,"REED JM, HOGAN BM, NASSER?GHODSI N, LOFTUS CG. MANAGEMENT OF HYPERTRIGLYCERIDEMIA?INDUCED ACUTE PANCREATITIS IN A NONDIABETIC PATIENT. MAYO?CLIN?PROC?INNOV?QUAL?OUTCOMES 2021?5(1):230?235.",34.0,YR,,F,Y,,,20210716.0,,PH,US,US,2021,Q3,Young Adult
195699932,19569993,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,TOTAL DAILY INSULIN DOSE WAS 80 UNITS/DAY (INSULIN LISPRO PLUS GLARGINE),,,,,,,,,,INJECTION,,2021,Q3,Diabetic metabolic decompensation,,2021,Q3,2,F,201605.0,20210713.0,20210715,20210721,EXP,,SK-ASTRAZENECA-2021A601970,ASTRAZENECA,,53.0,YR,,M,Y,,,20210721.0,,HP,SK,SK,2021,Q3,Adult
195699932,19569993,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,TOTAL DAILY INSULIN DOSE WAS 80 UNITS/DAY (INSULIN LISPRO PLUS GLARGINE),,,,,,,,,,INJECTION,,2021,Q3,Drug ineffective,,2021,Q3,2,F,201605.0,20210713.0,20210715,20210721,EXP,,SK-ASTRAZENECA-2021A601970,ASTRAZENECA,,53.0,YR,,M,Y,,,20210721.0,,HP,SK,SK,2021,Q3,Adult
195699932,19569993,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,TOTAL DAILY INSULIN DOSE WAS 80 UNITS/DAY (INSULIN LISPRO PLUS GLARGINE),,,,,,,,,,INJECTION,,2021,Q3,Injection site nodule,,2021,Q3,2,F,201605.0,20210713.0,20210715,20210721,EXP,,SK-ASTRAZENECA-2021A601970,ASTRAZENECA,,53.0,YR,,M,Y,,,20210721.0,,HP,SK,SK,2021,Q3,Adult
195699932,19569993,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,29.0IU UNKNOWN,,,,,,,,29.0,IU,INJECTION,,2021,Q3,Diabetic metabolic decompensation,,2021,Q3,2,F,201605.0,20210713.0,20210715,20210721,EXP,,SK-ASTRAZENECA-2021A601970,ASTRAZENECA,,53.0,YR,,M,Y,,,20210721.0,,HP,SK,SK,2021,Q3,Adult
195699932,19569993,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,29.0IU UNKNOWN,,,,,,,,29.0,IU,INJECTION,,2021,Q3,Drug ineffective,,2021,Q3,2,F,201605.0,20210713.0,20210715,20210721,EXP,,SK-ASTRAZENECA-2021A601970,ASTRAZENECA,,53.0,YR,,M,Y,,,20210721.0,,HP,SK,SK,2021,Q3,Adult
195699932,19569993,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,29.0IU UNKNOWN,,,,,,,,29.0,IU,INJECTION,,2021,Q3,Injection site nodule,,2021,Q3,2,F,201605.0,20210713.0,20210715,20210721,EXP,,SK-ASTRAZENECA-2021A601970,ASTRAZENECA,,53.0,YR,,M,Y,,,20210721.0,,HP,SK,SK,2021,Q3,Adult
195699932,19569993,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE REDUCED12.0IU UNKNOWN,,,,,,,,12.0,IU,INJECTION,QD,2021,Q3,Diabetic metabolic decompensation,,2021,Q3,2,F,201605.0,20210713.0,20210715,20210721,EXP,,SK-ASTRAZENECA-2021A601970,ASTRAZENECA,,53.0,YR,,M,Y,,,20210721.0,,HP,SK,SK,2021,Q3,Adult
195699932,19569993,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE REDUCED12.0IU UNKNOWN,,,,,,,,12.0,IU,INJECTION,QD,2021,Q3,Drug ineffective,,2021,Q3,2,F,201605.0,20210713.0,20210715,20210721,EXP,,SK-ASTRAZENECA-2021A601970,ASTRAZENECA,,53.0,YR,,M,Y,,,20210721.0,,HP,SK,SK,2021,Q3,Adult
195699932,19569993,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE REDUCED12.0IU UNKNOWN,,,,,,,,12.0,IU,INJECTION,QD,2021,Q3,Injection site nodule,,2021,Q3,2,F,201605.0,20210713.0,20210715,20210721,EXP,,SK-ASTRAZENECA-2021A601970,ASTRAZENECA,,53.0,YR,,M,Y,,,20210721.0,,HP,SK,SK,2021,Q3,Adult
195701081,19570108,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Back pain,,2021,Q3,1,I,2021.0,20210701.0,20210715,20210715,EXP,,ES-BAUSCH-BL-2021-023139,BAUSCH AND LOMB,,80.0,YR,,F,Y,65.0,KG,20210715.0,,CN,ES,ES,2021,Q3,Elderly
195701081,19570108,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose decreased,,2021,Q3,1,I,2021.0,20210701.0,20210715,20210715,EXP,,ES-BAUSCH-BL-2021-023139,BAUSCH AND LOMB,,80.0,YR,,F,Y,65.0,KG,20210715.0,,CN,ES,ES,2021,Q3,Elderly
195701081,19570108,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,1,I,2021.0,20210701.0,20210715,20210715,EXP,,ES-BAUSCH-BL-2021-023139,BAUSCH AND LOMB,,80.0,YR,,F,Y,65.0,KG,20210715.0,,CN,ES,ES,2021,Q3,Elderly
195701081,19570108,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Diabetes mellitus inadequate control,,2021,Q3,1,I,2021.0,20210701.0,20210715,20210715,EXP,,ES-BAUSCH-BL-2021-023139,BAUSCH AND LOMB,,80.0,YR,,F,Y,65.0,KG,20210715.0,,CN,ES,ES,2021,Q3,Elderly
195701081,19570108,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Eating disorder,,2021,Q3,1,I,2021.0,20210701.0,20210715,20210715,EXP,,ES-BAUSCH-BL-2021-023139,BAUSCH AND LOMB,,80.0,YR,,F,Y,65.0,KG,20210715.0,,CN,ES,ES,2021,Q3,Elderly
195701081,19570108,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Intentional product use issue,,2021,Q3,1,I,2021.0,20210701.0,20210715,20210715,EXP,,ES-BAUSCH-BL-2021-023139,BAUSCH AND LOMB,,80.0,YR,,F,Y,65.0,KG,20210715.0,,CN,ES,ES,2021,Q3,Elderly
195701081,19570108,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Mobility decreased,,2021,Q3,1,I,2021.0,20210701.0,20210715,20210715,EXP,,ES-BAUSCH-BL-2021-023139,BAUSCH AND LOMB,,80.0,YR,,F,Y,65.0,KG,20210715.0,,CN,ES,ES,2021,Q3,Elderly
195701081,19570108,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Tooth injury,,2021,Q3,1,I,2021.0,20210701.0,20210715,20210715,EXP,,ES-BAUSCH-BL-2021-023139,BAUSCH AND LOMB,,80.0,YR,,F,Y,65.0,KG,20210715.0,,CN,ES,ES,2021,Q3,Elderly
195712961,19571296,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,, 1F935A,,,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose fluctuation,,2021,Q3,1,I,202103.0,20210703.0,20210716,20210716,EXP,,ES-BAUSCH-BL-2021-023618,BAUSCH AND LOMB,,49.0,YR,,M,Y,75.0,KG,20210716.0,,HP,ES,ES,2021,Q3,Adult
195712961,19571296,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,, 1F935A,,,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Gait disturbance,,2021,Q3,1,I,202103.0,20210703.0,20210716,20210716,EXP,,ES-BAUSCH-BL-2021-023618,BAUSCH AND LOMB,,49.0,YR,,M,Y,75.0,KG,20210716.0,,HP,ES,ES,2021,Q3,Adult
195712961,19571296,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,, 1F935A,,,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Nervousness,,2021,Q3,1,I,202103.0,20210703.0,20210716,20210716,EXP,,ES-BAUSCH-BL-2021-023618,BAUSCH AND LOMB,,49.0,YR,,M,Y,75.0,KG,20210716.0,,HP,ES,ES,2021,Q3,Adult
195712961,19571296,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,, 1F935A,,,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Weight decreased,,2021,Q3,1,I,202103.0,20210703.0,20210716,20210716,EXP,,ES-BAUSCH-BL-2021-023618,BAUSCH AND LOMB,,49.0,YR,,M,Y,75.0,KG,20210716.0,,HP,ES,ES,2021,Q3,Adult
195712961,19571296,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,REDUCED DOSE,,,Y,, 1F935A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose fluctuation,,2021,Q3,1,I,202103.0,20210703.0,20210716,20210716,EXP,,ES-BAUSCH-BL-2021-023618,BAUSCH AND LOMB,,49.0,YR,,M,Y,75.0,KG,20210716.0,,HP,ES,ES,2021,Q3,Adult
195712961,19571296,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,REDUCED DOSE,,,Y,, 1F935A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Gait disturbance,,2021,Q3,1,I,202103.0,20210703.0,20210716,20210716,EXP,,ES-BAUSCH-BL-2021-023618,BAUSCH AND LOMB,,49.0,YR,,M,Y,75.0,KG,20210716.0,,HP,ES,ES,2021,Q3,Adult
195712961,19571296,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,REDUCED DOSE,,,Y,, 1F935A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Nervousness,,2021,Q3,1,I,202103.0,20210703.0,20210716,20210716,EXP,,ES-BAUSCH-BL-2021-023618,BAUSCH AND LOMB,,49.0,YR,,M,Y,75.0,KG,20210716.0,,HP,ES,ES,2021,Q3,Adult
195712961,19571296,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,REDUCED DOSE,,,Y,, 1F935A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Weight decreased,,2021,Q3,1,I,202103.0,20210703.0,20210716,20210716,EXP,,ES-BAUSCH-BL-2021-023618,BAUSCH AND LOMB,,49.0,YR,,M,Y,75.0,KG,20210716.0,,HP,ES,ES,2021,Q3,Adult
195725181,19572518,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,Y,, 1F935A,,,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose fluctuation,,2021,Q3,1,I,202103.0,20210705.0,20210716,20210716,EXP,,NVSC2021ES151302,NOVARTIS,,49.0,YR,,M,Y,75.0,KG,20210716.0,,HP,ES,ES,2021,Q3,Adult
195725181,19572518,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,Y,, 1F935A,,,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Gait disturbance,,2021,Q3,1,I,202103.0,20210705.0,20210716,20210716,EXP,,NVSC2021ES151302,NOVARTIS,,49.0,YR,,M,Y,75.0,KG,20210716.0,,HP,ES,ES,2021,Q3,Adult
195725181,19572518,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,Y,, 1F935A,,,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Nervousness,,2021,Q3,1,I,202103.0,20210705.0,20210716,20210716,EXP,,NVSC2021ES151302,NOVARTIS,,49.0,YR,,M,Y,75.0,KG,20210716.0,,HP,ES,ES,2021,Q3,Adult
195725181,19572518,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,Y,, 1F935A,,,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Weight decreased,,2021,Q3,1,I,202103.0,20210705.0,20210716,20210716,EXP,,NVSC2021ES151302,NOVARTIS,,49.0,YR,,M,Y,75.0,KG,20210716.0,,HP,ES,ES,2021,Q3,Adult
195725181,19572518,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,Y,,,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose fluctuation,,2021,Q3,1,I,202103.0,20210705.0,20210716,20210716,EXP,,NVSC2021ES151302,NOVARTIS,,49.0,YR,,M,Y,75.0,KG,20210716.0,,HP,ES,ES,2021,Q3,Adult
195725181,19572518,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,Y,,,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Gait disturbance,,2021,Q3,1,I,202103.0,20210705.0,20210716,20210716,EXP,,NVSC2021ES151302,NOVARTIS,,49.0,YR,,M,Y,75.0,KG,20210716.0,,HP,ES,ES,2021,Q3,Adult
195725181,19572518,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,Y,,,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Nervousness,,2021,Q3,1,I,202103.0,20210705.0,20210716,20210716,EXP,,NVSC2021ES151302,NOVARTIS,,49.0,YR,,M,Y,75.0,KG,20210716.0,,HP,ES,ES,2021,Q3,Adult
195725181,19572518,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,Y,,,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Weight decreased,,2021,Q3,1,I,202103.0,20210705.0,20210716,20210716,EXP,,NVSC2021ES151302,NOVARTIS,,49.0,YR,,M,Y,75.0,KG,20210716.0,,HP,ES,ES,2021,Q3,Adult
195746951,19574695,9,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Bradycardia,,2021,Q3,1,I,,20210705.0,20210719,20210719,EXP,,GR-LUPIN PHARMACEUTICALS INC.-2021-11997,LUPIN,,55.0,YR,,M,Y,,,20210719.0,,HP,GR,GR,2021,Q3,Adult
195746951,19574695,9,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Drug ineffective,,2021,Q3,1,I,,20210705.0,20210719,20210719,EXP,,GR-LUPIN PHARMACEUTICALS INC.-2021-11997,LUPIN,,55.0,YR,,M,Y,,,20210719.0,,HP,GR,GR,2021,Q3,Adult
195754982,19575498,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,Y,, 0F7798,,,36.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,2,F,2021.0,20210809.0,20210719,20210816,EXP,,NVSC2021ES152376,NOVARTIS,,79.0,YR,,M,Y,80.0,KG,20210816.0,,HP,ES,ES,2021,Q3,Elderly
195754982,19575498,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,Y,, 0F7798,,,36.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hypoglycaemia,,2021,Q3,2,F,2021.0,20210809.0,20210719,20210816,EXP,,NVSC2021ES152376,NOVARTIS,,79.0,YR,,M,Y,80.0,KG,20210816.0,,HP,ES,ES,2021,Q3,Elderly
195754982,19575498,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,Y,, 0F7798,,,36.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hypotension,,2021,Q3,2,F,2021.0,20210809.0,20210719,20210816,EXP,,NVSC2021ES152376,NOVARTIS,,79.0,YR,,M,Y,80.0,KG,20210816.0,,HP,ES,ES,2021,Q3,Elderly
195754982,19575498,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,44 IU,,,Y,, 0F7798,,,44.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,2,F,2021.0,20210809.0,20210719,20210816,EXP,,NVSC2021ES152376,NOVARTIS,,79.0,YR,,M,Y,80.0,KG,20210816.0,,HP,ES,ES,2021,Q3,Elderly
195754982,19575498,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,44 IU,,,Y,, 0F7798,,,44.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hypoglycaemia,,2021,Q3,2,F,2021.0,20210809.0,20210719,20210816,EXP,,NVSC2021ES152376,NOVARTIS,,79.0,YR,,M,Y,80.0,KG,20210816.0,,HP,ES,ES,2021,Q3,Elderly
195754982,19575498,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,44 IU,,,Y,, 0F7798,,,44.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hypotension,,2021,Q3,2,F,2021.0,20210809.0,20210719,20210816,EXP,,NVSC2021ES152376,NOVARTIS,,79.0,YR,,M,Y,80.0,KG,20210816.0,,HP,ES,ES,2021,Q3,Elderly
195772782,19577278,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,14.0,IU,INJECTION,QD,2021,Q3,Ketoacidosis,,2021,Q3,2,F,20210702.0,20210910.0,20210719,20210917,EXP,,JP-ASTRAZENECA-2021A616289,ASTRAZENECA,,12540.0,DY,,F,Y,53.0,KG,20210917.0,,,JP,JP,2021,Q3,Elderly
195781981,19578198,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15U S.C. AT 09.00 P.M,,,U,,,,,15.0,IU,,,2021,Q3,Exposure during pregnancy,Exposure during pregnancy,2021,Q3,1,I,,20210706.0,20210719,20210719,EXP,,IT-INVATECH-000118,INVATECH PHARMA SOLUTIONS,,33.0,YR,A,F,Y,,,20210714.0,,HP,IT,IT,2021,Q3,Young Adult
195781981,19578198,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15U S.C. AT 09.00 P.M,,,U,,,,,15.0,IU,,,2021,Q3,Hypertension,Hypertension,2021,Q3,1,I,,20210706.0,20210719,20210719,EXP,,IT-INVATECH-000118,INVATECH PHARMA SOLUTIONS,,33.0,YR,A,F,Y,,,20210714.0,,HP,IT,IT,2021,Q3,Young Adult
195781981,19578198,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15U S.C. AT 09.00 P.M,,,U,,,,,15.0,IU,,,2021,Q3,Phaeochromocytoma,Phaeochromocytoma,2021,Q3,1,I,,20210706.0,20210719,20210719,EXP,,IT-INVATECH-000118,INVATECH PHARMA SOLUTIONS,,33.0,YR,A,F,Y,,,20210714.0,,HP,IT,IT,2021,Q3,Young Adult
195798151,19579815,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q3,Hypoglycaemic unconsciousness,,2021,Q3,1,I,20210118.0,20210125.0,20210719,20210719,PER,,US-NOVOPROD-782974,NOVO NORDISK,,71.0,YR,,M,Y,,,20210719.0,,CN,US,US,2021,Q3,Elderly
195805171,19580517,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,U,, D070627D,,205692.0,,,INJECTION,,2021,Q3,Cataract,,2021,Q3,1,I,202106.0,20200610.0,20210719,20210719,EXP,,US-ELI_LILLY_AND_COMPANY-US202006005426,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20210719.0,,CN,US,US,2021,Q3,Adult
195805171,19580517,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,U,, D070627D,,205692.0,,,INJECTION,,2021,Q3,Fall,,2021,Q3,1,I,202106.0,20200610.0,20210719,20210719,EXP,,US-ELI_LILLY_AND_COMPANY-US202006005426,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20210719.0,,CN,US,US,2021,Q3,Adult
195805171,19580517,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,U,, D070627D,,205692.0,,,INJECTION,,2021,Q3,Skull fracture,,2021,Q3,1,I,202106.0,20200610.0,20210719,20210719,EXP,,US-ELI_LILLY_AND_COMPANY-US202006005426,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20210719.0,,CN,US,US,2021,Q3,Adult
195827551,19582755,2,SS,"INSULIN (INSULIN, GLARGINE, HUMAN 100 UNT/ML INJ)",INSULIN GLARGINE,1,,?          OTHER STRENGTH:100 UNT/ML;OTHER DOSE:30 UNITS;?,,,D,D,,,,,,,,2021,Q3,Delirium,,2021,Q3,1,I,20210111.0,,20210720,20210720,DIR,,,FDA-CTU,,72.0,YR,,M,N,,,20210113.0,N,PH,US,US,2021,Q3,Elderly
195827551,19582755,2,SS,"INSULIN (INSULIN, GLARGINE, HUMAN 100 UNT/ML INJ)",INSULIN GLARGINE,1,,?          OTHER STRENGTH:100 UNT/ML;OTHER DOSE:30 UNITS;?,,,D,D,,,,,,,,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,20210111.0,,20210720,20210720,DIR,,,FDA-CTU,,72.0,YR,,M,N,,,20210113.0,N,PH,US,US,2021,Q3,Elderly
195827551,19582755,2,SS,"INSULIN (INSULIN, GLARGINE, HUMAN 100 UNT/ML INJ)",INSULIN GLARGINE,1,,?          OTHER STRENGTH:100 UNT/ML;OTHER DOSE:30 UNITS;?,,,D,D,,,,,,,,2021,Q3,Pyrexia,,2021,Q3,1,I,20210111.0,,20210720,20210720,DIR,,,FDA-CTU,,72.0,YR,,M,N,,,20210113.0,N,PH,US,US,2021,Q3,Elderly
195833011,19583301,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,1,I,,20210712.0,20210720,20210720,EXP,,ES-MYLANLABS-2021M1042311,MYLAN,,60.0,YR,,F,Y,,,20210720.0,,HP,ES,ES,2021,Q3,Adult
195833011,19583301,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Pancreatic disorder,,2021,Q3,1,I,,20210712.0,20210720,20210720,EXP,,ES-MYLANLABS-2021M1042311,MYLAN,,60.0,YR,,F,Y,,,20210720.0,,HP,ES,ES,2021,Q3,Adult
195848272,19584827,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,TOTAL DAILY INSULIN DOSE WAS 80 UNITS/DAY (INSULIN LISPRO PLUS GLARGINE),,,D,,,,,,,,,2021,Q3,Diabetes mellitus inadequate control,,2021,Q3,2,F,201605.0,20210910.0,20210720,20210923,EXP,,SK-BAUSCH-BL-2021-023831,BAUSCH AND LOMB,"MARTINKA E, KOLLAROVA D, URBANOVA M. SKUSENOSTI Z PRAXE POTVRDZUJU VYSLEDKY STUDII RCT A RWE S EMPAGLIFLOZINOM: KAZUISTIKY. FORUM DIABETOLOGICUM. 2021?10(1):53?61.",53.0,YR,,M,Y,,,20210923.0,,MD,SK,SK,2021,Q3,Adult
195848272,19584827,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,28 UNITS,,,D,,,,,,,,,2021,Q3,Diabetes mellitus inadequate control,,2021,Q3,2,F,201605.0,20210910.0,20210720,20210923,EXP,,SK-BAUSCH-BL-2021-023831,BAUSCH AND LOMB,"MARTINKA E, KOLLAROVA D, URBANOVA M. SKUSENOSTI Z PRAXE POTVRDZUJU VYSLEDKY STUDII RCT A RWE S EMPAGLIFLOZINOM: KAZUISTIKY. FORUM DIABETOLOGICUM. 2021?10(1):53?61.",53.0,YR,,M,Y,,,20210923.0,,MD,SK,SK,2021,Q3,Adult
195848272,19584827,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 UNITS PER DAY (REDUCTION OF THE GLARGINE DOSE UNTIL IT IS DISCONTINUED FROM TREATMENT),,,D,,,,,,,,,2021,Q3,Diabetes mellitus inadequate control,,2021,Q3,2,F,201605.0,20210910.0,20210720,20210923,EXP,,SK-BAUSCH-BL-2021-023831,BAUSCH AND LOMB,"MARTINKA E, KOLLAROVA D, URBANOVA M. SKUSENOSTI Z PRAXE POTVRDZUJU VYSLEDKY STUDII RCT A RWE S EMPAGLIFLOZINOM: KAZUISTIKY. FORUM DIABETOLOGICUM. 2021?10(1):53?61.",53.0,YR,,M,Y,,,20210923.0,,MD,SK,SK,2021,Q3,Adult
195849262,19584926,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,U,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Administration site discomfort,,2021,Q3,2,F,20210115.0,20210719.0,20210720,20210802,EXP,,ES-MYLANLABS-2021M1044318,MYLAN,,50.0,YR,,M,Y,96.0,KG,20210802.0,,HP,ES,ES,2021,Q3,Adult
195849262,19584926,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,U,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Fatigue,,2021,Q3,2,F,20210115.0,20210719.0,20210720,20210802,EXP,,ES-MYLANLABS-2021M1044318,MYLAN,,50.0,YR,,M,Y,96.0,KG,20210802.0,,HP,ES,ES,2021,Q3,Adult
195849262,19584926,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,U,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hypoglycaemia,,2021,Q3,2,F,20210115.0,20210719.0,20210720,20210802,EXP,,ES-MYLANLABS-2021M1044318,MYLAN,,50.0,YR,,M,Y,96.0,KG,20210802.0,,HP,ES,ES,2021,Q3,Adult
195849262,19584926,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,U,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Inappropriate schedule of product administration,,2021,Q3,2,F,20210115.0,20210719.0,20210720,20210802,EXP,,ES-MYLANLABS-2021M1044318,MYLAN,,50.0,YR,,M,Y,96.0,KG,20210802.0,,HP,ES,ES,2021,Q3,Adult
195849262,19584926,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,U,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Injection site pruritus,,2021,Q3,2,F,20210115.0,20210719.0,20210720,20210802,EXP,,ES-MYLANLABS-2021M1044318,MYLAN,,50.0,YR,,M,Y,96.0,KG,20210802.0,,HP,ES,ES,2021,Q3,Adult
195849262,19584926,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,U,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Limb discomfort,,2021,Q3,2,F,20210115.0,20210719.0,20210720,20210802,EXP,,ES-MYLANLABS-2021M1044318,MYLAN,,50.0,YR,,M,Y,96.0,KG,20210802.0,,HP,ES,ES,2021,Q3,Adult
195849262,19584926,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,U,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Multiple use of single-use product,,2021,Q3,2,F,20210115.0,20210719.0,20210720,20210802,EXP,,ES-MYLANLABS-2021M1044318,MYLAN,,50.0,YR,,M,Y,96.0,KG,20210802.0,,HP,ES,ES,2021,Q3,Adult
195849262,19584926,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,U,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Administration site discomfort,,2021,Q3,2,F,20210115.0,20210719.0,20210720,20210802,EXP,,ES-MYLANLABS-2021M1044318,MYLAN,,50.0,YR,,M,Y,96.0,KG,20210802.0,,HP,ES,ES,2021,Q3,Adult
195849262,19584926,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,U,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Fatigue,,2021,Q3,2,F,20210115.0,20210719.0,20210720,20210802,EXP,,ES-MYLANLABS-2021M1044318,MYLAN,,50.0,YR,,M,Y,96.0,KG,20210802.0,,HP,ES,ES,2021,Q3,Adult
195849262,19584926,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,U,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hypoglycaemia,,2021,Q3,2,F,20210115.0,20210719.0,20210720,20210802,EXP,,ES-MYLANLABS-2021M1044318,MYLAN,,50.0,YR,,M,Y,96.0,KG,20210802.0,,HP,ES,ES,2021,Q3,Adult
195849262,19584926,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,U,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Inappropriate schedule of product administration,,2021,Q3,2,F,20210115.0,20210719.0,20210720,20210802,EXP,,ES-MYLANLABS-2021M1044318,MYLAN,,50.0,YR,,M,Y,96.0,KG,20210802.0,,HP,ES,ES,2021,Q3,Adult
195849262,19584926,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,U,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Injection site pruritus,,2021,Q3,2,F,20210115.0,20210719.0,20210720,20210802,EXP,,ES-MYLANLABS-2021M1044318,MYLAN,,50.0,YR,,M,Y,96.0,KG,20210802.0,,HP,ES,ES,2021,Q3,Adult
195849262,19584926,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,U,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Limb discomfort,,2021,Q3,2,F,20210115.0,20210719.0,20210720,20210802,EXP,,ES-MYLANLABS-2021M1044318,MYLAN,,50.0,YR,,M,Y,96.0,KG,20210802.0,,HP,ES,ES,2021,Q3,Adult
195849262,19584926,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,U,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Multiple use of single-use product,,2021,Q3,2,F,20210115.0,20210719.0,20210720,20210802,EXP,,ES-MYLANLABS-2021M1044318,MYLAN,,50.0,YR,,M,Y,96.0,KG,20210802.0,,HP,ES,ES,2021,Q3,Adult
195851692,19585169,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 UNITS, QD",,,,,,,,,,,,2021,Q3,Pneumonia,,2021,Q3,2,F,20210520.0,20210921.0,20210720,20210929,EXP,,US-GLAXOSMITHKLINE-US2021GSK111808,GLAXOSMITHKLINE,,74.0,YR,,M,Y,,,20210929.0,,MD,US,US,2021,Q3,Elderly
195861562,19586156,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,21081.0,,,,,2021,Q3,Blister,,2021,Q3,2,F,20210704.0,20210725.0,20210720,20210728,EXP,GB-MHRA-WEBRADR-20210711153344,GB-SA-2021SA229013,SANOFI AVENTIS,,63.0,YR,A,F,Y,75.0,KG,20210729.0,,MD,GB,GB,2021,Q3,Adult
195861562,19586156,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,21081.0,,,,,2021,Q3,Rash erythematous,,2021,Q3,2,F,20210704.0,20210725.0,20210720,20210728,EXP,GB-MHRA-WEBRADR-20210711153344,GB-SA-2021SA229013,SANOFI AVENTIS,,63.0,YR,A,F,Y,75.0,KG,20210729.0,,MD,GB,GB,2021,Q3,Adult
195861562,19586156,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,21081.0,,,,,2021,Q3,Skin discolouration,,2021,Q3,2,F,20210704.0,20210725.0,20210720,20210728,EXP,GB-MHRA-WEBRADR-20210711153344,GB-SA-2021SA229013,SANOFI AVENTIS,,63.0,YR,A,F,Y,75.0,KG,20210729.0,,MD,GB,GB,2021,Q3,Adult
195872951,19587295,2,SS,"INSULIN (INSULIN, GLARGINE, HUMAN 100 UNT/ML INJ)",INSULIN GLARGINE,1,Subcutaneous,,,,N,N,,,,60.0,IU,,QD,2021,Q3,Weight increased,,2021,Q3,1,I,20190101.0,,20210720,20210720,DIR,,,FDA-CTU,,63.0,YR,,M,N,100.11,KG,20190225.0,N,PH,US,US,2021,Q3,Adult
195879511,19587951,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IU, 0?0?0?1, SOLUTION FOR INJECTION/INFUSION",,,U,,,,,,,,,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210709.0,20210721,20210721,EXP,DE-BFARM-21005977,DE-ACCORD-232288,ACCORD,,78.0,YR,E,M,Y,88.4,KG,20210721.0,,MD,DE,DE,2021,Q3,Elderly
195879511,19587951,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IU, 0?0?0?1, SOLUTION FOR INJECTION/INFUSION",,,U,,,,,,,,,2021,Q3,Fatigue,,2021,Q3,1,I,,20210709.0,20210721,20210721,EXP,DE-BFARM-21005977,DE-ACCORD-232288,ACCORD,,78.0,YR,E,M,Y,88.4,KG,20210721.0,,MD,DE,DE,2021,Q3,Elderly
195879511,19587951,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IU, 0?0?0?1, SOLUTION FOR INJECTION/INFUSION",,,U,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210709.0,20210721,20210721,EXP,DE-BFARM-21005977,DE-ACCORD-232288,ACCORD,,78.0,YR,E,M,Y,88.4,KG,20210721.0,,MD,DE,DE,2021,Q3,Elderly
195879511,19587951,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IU, 0?0?0?1, SOLUTION FOR INJECTION/INFUSION",,,U,,,,,,,,,2021,Q3,Medication error,,2021,Q3,1,I,,20210709.0,20210721,20210721,EXP,DE-BFARM-21005977,DE-ACCORD-232288,ACCORD,,78.0,YR,E,M,Y,88.4,KG,20210721.0,,MD,DE,DE,2021,Q3,Elderly
195879511,19587951,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IU, 0?0?0?1, SOLUTION FOR INJECTION/INFUSION",,,U,,,,,,,,,2021,Q3,Night sweats,,2021,Q3,1,I,,20210709.0,20210721,20210721,EXP,DE-BFARM-21005977,DE-ACCORD-232288,ACCORD,,78.0,YR,E,M,Y,88.4,KG,20210721.0,,MD,DE,DE,2021,Q3,Elderly
195885171,19588517,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Asphyxia,Asphyxia,2021,Q3,1,I,,20210712.0,20210721,20210721,EXP,,FR-ALS-000331,ALIGNSCIENCE PHARMA,,57.0,YR,A,M,Y,,,20210721.0,,HP,FR,FR,2021,Q3,Adult
195885171,19588517,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Cyanosis,Cyanosis,2021,Q3,1,I,,20210712.0,20210721,20210721,EXP,,FR-ALS-000331,ALIGNSCIENCE PHARMA,,57.0,YR,A,M,Y,,,20210721.0,,HP,FR,FR,2021,Q3,Adult
195885171,19588517,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Overdose,Overdose,2021,Q3,1,I,,20210712.0,20210721,20210721,EXP,,FR-ALS-000331,ALIGNSCIENCE PHARMA,,57.0,YR,A,M,Y,,,20210721.0,,HP,FR,FR,2021,Q3,Adult
195885171,19588517,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Toxicity to various agents,Toxicity to various agents,2021,Q3,1,I,,20210712.0,20210721,20210721,EXP,,FR-ALS-000331,ALIGNSCIENCE PHARMA,,57.0,YR,A,M,Y,,,20210721.0,,HP,FR,FR,2021,Q3,Adult
195896831,19589683,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, ER",,,D,,,,,,,,,2021,Q3,Completed suicide,,2021,Q3,1,I,2019.0,20210713.0,20210721,20210721,EXP,,US-AMERICAN REGENT INC-2021001892,AMERICAN REGENT,,61.0,YR,,M,Y,,,20210721.0,,PH,US,US,2021,Q3,Adult
195899741,19589974,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,,,,,21081.0,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hypoglycaemic unconsciousness,,2021,Q3,1,I,20191107.0,20210708.0,20210721,20210721,PER,,US-SA-2021SA235684,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20210721.0,,HP,US,US,2021,Q3,Adult
195909902,19590990,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, HS AT 09.00 P.M",,,D,,,,,15.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Anxiety,,2021,Q3,2,F,,20210715.0,20210721,20210726,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL.. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE.. J HYPERTENS.. 2021?39 SUPPL 1:E342",33.0,YR,A,F,Y,,,20210726.0,,MD,IT,IT,2021,Q3,Young Adult
195909902,19590990,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, HS AT 09.00 P.M",,,D,,,,,15.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Asthenia,,2021,Q3,2,F,,20210715.0,20210721,20210726,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL.. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE.. J HYPERTENS.. 2021?39 SUPPL 1:E342",33.0,YR,A,F,Y,,,20210726.0,,MD,IT,IT,2021,Q3,Young Adult
195909902,19590990,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, HS AT 09.00 P.M",,,D,,,,,15.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Condition aggravated,,2021,Q3,2,F,,20210715.0,20210721,20210726,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL.. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE.. J HYPERTENS.. 2021?39 SUPPL 1:E342",33.0,YR,A,F,Y,,,20210726.0,,MD,IT,IT,2021,Q3,Young Adult
195909902,19590990,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, HS AT 09.00 P.M",,,D,,,,,15.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Exposure during pregnancy,,2021,Q3,2,F,,20210715.0,20210721,20210726,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL.. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE.. J HYPERTENS.. 2021?39 SUPPL 1:E342",33.0,YR,A,F,Y,,,20210726.0,,MD,IT,IT,2021,Q3,Young Adult
195909902,19590990,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, HS AT 09.00 P.M",,,D,,,,,15.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Headache,,2021,Q3,2,F,,20210715.0,20210721,20210726,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL.. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE.. J HYPERTENS.. 2021?39 SUPPL 1:E342",33.0,YR,A,F,Y,,,20210726.0,,MD,IT,IT,2021,Q3,Young Adult
195909902,19590990,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, HS AT 09.00 P.M",,,D,,,,,15.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hypertensive crisis,,2021,Q3,2,F,,20210715.0,20210721,20210726,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL.. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE.. J HYPERTENS.. 2021?39 SUPPL 1:E342",33.0,YR,A,F,Y,,,20210726.0,,MD,IT,IT,2021,Q3,Young Adult
195909902,19590990,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, HS AT 09.00 P.M",,,D,,,,,15.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hypokalaemia,,2021,Q3,2,F,,20210715.0,20210721,20210726,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL.. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE.. J HYPERTENS.. 2021?39 SUPPL 1:E342",33.0,YR,A,F,Y,,,20210726.0,,MD,IT,IT,2021,Q3,Young Adult
195909902,19590990,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, HS AT 09.00 P.M",,,D,,,,,15.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Irritability,,2021,Q3,2,F,,20210715.0,20210721,20210726,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL.. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE.. J HYPERTENS.. 2021?39 SUPPL 1:E342",33.0,YR,A,F,Y,,,20210726.0,,MD,IT,IT,2021,Q3,Young Adult
195909902,19590990,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, HS AT 09.00 P.M",,,D,,,,,15.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Phaeochromocytoma crisis,,2021,Q3,2,F,,20210715.0,20210721,20210726,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL.. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE.. J HYPERTENS.. 2021?39 SUPPL 1:E342",33.0,YR,A,F,Y,,,20210726.0,,MD,IT,IT,2021,Q3,Young Adult
195909902,19590990,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, HS AT 09.00 P.M",,,D,,,,,15.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Proteinuria,,2021,Q3,2,F,,20210715.0,20210721,20210726,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL.. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE.. J HYPERTENS.. 2021?39 SUPPL 1:E342",33.0,YR,A,F,Y,,,20210726.0,,MD,IT,IT,2021,Q3,Young Adult
195909902,19590990,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, HS AT 09.00 P.M",,,D,,,,,15.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Tachycardia,,2021,Q3,2,F,,20210715.0,20210721,20210726,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL.. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE.. J HYPERTENS.. 2021?39 SUPPL 1:E342",33.0,YR,A,F,Y,,,20210726.0,,MD,IT,IT,2021,Q3,Young Adult
195911962,19591196,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,206538.0,,,SOLUTION FOR INJECTION,,2021,Q3,No adverse event,,2021,Q3,2,F,,20210722.0,20210721,20210802,EXP,,MX-SA-2021SA231643,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20210802.0,,CN,MX,MX,2021,Q3,Elderly
195913821,19591382,11,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Clostridium difficile colitis,,2021,Q3,1,I,,20210713.0,20210722,20210722,EXP,,CA-AUROBINDO-AUR-APL-2021-031409,AUROBINDO,,77.0,YR,,F,Y,102.0,KG,20210722.0,,HP,CA,CA,2021,Q3,Elderly
195978041,19597804,7,C,INSULIN GLARGINE BS[BIOSIMILAR 1],INSULIN GLARGINE,1,Unknown,,,,,,,,,,,INJECTION,,2021,Q3,Bile duct stone,,2021,Q3,1,I,20200804.0,20210714.0,20210722,20210722,EXP,,JP-ASTRAZENECA-2021A626973,ASTRAZENECA,,79.0,YR,,M,Y,52.0,KG,20210722.0,,,JP,JP,2021,Q3,Elderly
195978041,19597804,7,C,INSULIN GLARGINE BS[BIOSIMILAR 1],INSULIN GLARGINE,1,Unknown,,,,,,,,,,,INJECTION,,2021,Q3,Hepatic enzyme increased,,2021,Q3,1,I,20200804.0,20210714.0,20210722,20210722,EXP,,JP-ASTRAZENECA-2021A626973,ASTRAZENECA,,79.0,YR,,M,Y,52.0,KG,20210722.0,,,JP,JP,2021,Q3,Elderly
195978041,19597804,7,C,INSULIN GLARGINE BS[BIOSIMILAR 1],INSULIN GLARGINE,1,Unknown,,,,,,,,,,,INJECTION,,2021,Q3,Hepatic function abnormal,,2021,Q3,1,I,20200804.0,20210714.0,20210722,20210722,EXP,,JP-ASTRAZENECA-2021A626973,ASTRAZENECA,,79.0,YR,,M,Y,52.0,KG,20210722.0,,,JP,JP,2021,Q3,Elderly
195997141,19599714,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Abdominal pain,,2021,Q3,1,I,20201225.0,,20210723,20210723,DIR,,,FDA-CTU,,54.0,YR,,M,N,127.7,KG,20210723.0,N,PH,US,US,2021,Q3,Adult
195997141,19599714,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,20201225.0,,20210723,20210723,DIR,,,FDA-CTU,,54.0,YR,,M,N,127.7,KG,20210723.0,N,PH,US,US,2021,Q3,Adult
195997141,19599714,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Nausea,,2021,Q3,1,I,20201225.0,,20210723,20210723,DIR,,,FDA-CTU,,54.0,YR,,M,N,127.7,KG,20210723.0,N,PH,US,US,2021,Q3,Adult
195997141,19599714,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Pancreatitis,,2021,Q3,1,I,20201225.0,,20210723,20210723,DIR,,,FDA-CTU,,54.0,YR,,M,N,127.7,KG,20210723.0,N,PH,US,US,2021,Q3,Adult
195997141,19599714,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Treatment noncompliance,,2021,Q3,1,I,20201225.0,,20210723,20210723,DIR,,,FDA-CTU,,54.0,YR,,M,N,127.7,KG,20210723.0,N,PH,US,US,2021,Q3,Adult
195997141,19599714,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Vomiting,,2021,Q3,1,I,20201225.0,,20210723,20210723,DIR,,,FDA-CTU,,54.0,YR,,M,N,127.7,KG,20210723.0,N,PH,US,US,2021,Q3,Adult
196015681,19601568,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,D,U,,,205692.0,,,,,2021,Q3,Blister,,2021,Q3,1,I,20210704.0,20210712.0,20210723,20210723,EXP,GB-MHRA-WEBRADR-20210711153344,GB-ELI_LILLY_AND_COMPANY-GB202107004752,ELI LILLY AND CO,,63.0,YR,,F,Y,75.0,KG,20210723.0,,MD,GB,GB,2021,Q3,Adult
196015681,19601568,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,D,U,,,205692.0,,,,,2021,Q3,Rash erythematous,,2021,Q3,1,I,20210704.0,20210712.0,20210723,20210723,EXP,GB-MHRA-WEBRADR-20210711153344,GB-ELI_LILLY_AND_COMPANY-GB202107004752,ELI LILLY AND CO,,63.0,YR,,F,Y,75.0,KG,20210723.0,,MD,GB,GB,2021,Q3,Adult
196015681,19601568,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,D,U,,,205692.0,,,,,2021,Q3,Skin discolouration,,2021,Q3,1,I,20210704.0,20210712.0,20210723,20210723,EXP,GB-MHRA-WEBRADR-20210711153344,GB-ELI_LILLY_AND_COMPANY-GB202107004752,ELI LILLY AND CO,,63.0,YR,,F,Y,75.0,KG,20210723.0,,MD,GB,GB,2021,Q3,Adult
196017791,19601779,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, 0?0?0?1",,,,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q3,Abdominal distension,,2021,Q3,1,I,,20210709.0,20210723,20210723,EXP,DE-BFARM-21005993,DE-ACCORD-232332,ACCORD,,71.0,YR,E,M,Y,90.5,KG,20210723.0,,PH,DE,DE,2021,Q3,Elderly
196017791,19601779,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, 0?0?0?1",,,,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q3,Chills,,2021,Q3,1,I,,20210709.0,20210723,20210723,EXP,DE-BFARM-21005993,DE-ACCORD-232332,ACCORD,,71.0,YR,E,M,Y,90.5,KG,20210723.0,,PH,DE,DE,2021,Q3,Elderly
196017791,19601779,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, 0?0?0?1",,,,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210709.0,20210723,20210723,EXP,DE-BFARM-21005993,DE-ACCORD-232332,ACCORD,,71.0,YR,E,M,Y,90.5,KG,20210723.0,,PH,DE,DE,2021,Q3,Elderly
196018491,19601849,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IU, 0?0?1?0, SOLUTION FOR INJECTION / INFUSION",,,,,,,,40.0,IU,,,2021,Q3,Dyschezia,,2021,Q3,1,I,,20210713.0,20210723,20210723,EXP,DE-BFARM-21006320,DE-ACCORD-232715,ACCORD,,80.0,YR,E,M,Y,73.0,KG,20210723.0,,PH,DE,DE,2021,Q3,Elderly
196018491,19601849,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IU, 0?0?1?0, SOLUTION FOR INJECTION / INFUSION",,,,,,,,40.0,IU,,,2021,Q3,Dysuria,,2021,Q3,1,I,,20210713.0,20210723,20210723,EXP,DE-BFARM-21006320,DE-ACCORD-232715,ACCORD,,80.0,YR,E,M,Y,73.0,KG,20210723.0,,PH,DE,DE,2021,Q3,Elderly
196018491,19601849,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IU, 0?0?1?0, SOLUTION FOR INJECTION / INFUSION",,,,,,,,40.0,IU,,,2021,Q3,Weight decreased,,2021,Q3,1,I,,20210713.0,20210723,20210723,EXP,DE-BFARM-21006320,DE-ACCORD-232715,ACCORD,,80.0,YR,E,M,Y,73.0,KG,20210723.0,,PH,DE,DE,2021,Q3,Elderly
196060041,19606004,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,28 UNITS,,,Y,,,,,,,,,2021,Q3,Diabetes mellitus inadequate control,,2021,Q3,1,I,,20210714.0,20210723,20210723,EXP,,SK-SA-2021SA233415,SANOFI AVENTIS,"MARTINKA E, KOLLAROVA D, URBANOVA M.. PRACTICAL EXPERIENCE CONFIRMS THE RESULTS OF THE RCT AND RWE STUDIES WITH EMPAGLIFLOSIN: CASE REPORTS. FORUM DIABETOLOGICUM. 2021?10(1):53?61",53.0,YR,A,M,Y,,,20210724.0,,HP,SK,SK,2021,Q3,Adult
196060041,19606004,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,28 UNITS,,,Y,,,,,,,,,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,,20210714.0,20210723,20210723,EXP,,SK-SA-2021SA233415,SANOFI AVENTIS,"MARTINKA E, KOLLAROVA D, URBANOVA M.. PRACTICAL EXPERIENCE CONFIRMS THE RESULTS OF THE RCT AND RWE STUDIES WITH EMPAGLIFLOSIN: CASE REPORTS. FORUM DIABETOLOGICUM. 2021?10(1):53?61",53.0,YR,A,M,Y,,,20210724.0,,HP,SK,SK,2021,Q3,Adult
196060041,19606004,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,28 UNITS,,,Y,,,,,,,,,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,1,I,,20210714.0,20210723,20210723,EXP,,SK-SA-2021SA233415,SANOFI AVENTIS,"MARTINKA E, KOLLAROVA D, URBANOVA M.. PRACTICAL EXPERIENCE CONFIRMS THE RESULTS OF THE RCT AND RWE STUDIES WITH EMPAGLIFLOSIN: CASE REPORTS. FORUM DIABETOLOGICUM. 2021?10(1):53?61",53.0,YR,A,M,Y,,,20210724.0,,HP,SK,SK,2021,Q3,Adult
196060041,19606004,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,28 UNITS,,,Y,,,,,,,,,2021,Q3,Weight increased,,2021,Q3,1,I,,20210714.0,20210723,20210723,EXP,,SK-SA-2021SA233415,SANOFI AVENTIS,"MARTINKA E, KOLLAROVA D, URBANOVA M.. PRACTICAL EXPERIENCE CONFIRMS THE RESULTS OF THE RCT AND RWE STUDIES WITH EMPAGLIFLOSIN: CASE REPORTS. FORUM DIABETOLOGICUM. 2021?10(1):53?61",53.0,YR,A,M,Y,,,20210724.0,,HP,SK,SK,2021,Q3,Adult
196071811,19607181,17,SS,Insulin glargine,INSULIN GLARGINE,1,Oral,UNK,,,D,,,,,,,,,2021,Q3,Completed suicide,,2021,Q3,1,I,,20210712.0,20210726,20210726,EXP,,US-AUROBINDO-AUR-APL-2021-031103,AUROBINDO,,61.0,YR,,M,Y,,,20210726.0,,HP,US,US,2021,Q3,Adult
196071811,19607181,18,SS,Insulin glargine,INSULIN GLARGINE,1,Parenteral,UNK,,,D,,,,,,,,,2021,Q3,Completed suicide,,2021,Q3,1,I,,20210712.0,20210726,20210726,EXP,,US-AUROBINDO-AUR-APL-2021-031103,AUROBINDO,,61.0,YR,,M,Y,,,20210726.0,,HP,US,US,2021,Q3,Adult
196078591,19607859,7,SS,Insulin glargine,INSULIN GLARGINE,1,Oral,UNK,,,D,,,,,,,,,2021,Q3,Completed suicide,,2021,Q3,1,I,,20210712.0,20210726,20210726,EXP,,US-AUROBINDO-AUR-APL-2021-031206,AUROBINDO,,46.0,YR,,F,Y,,,20210726.0,,MD,US,US,2021,Q3,Adult
196078591,19607859,8,SS,Insulin glargine,INSULIN GLARGINE,1,Respiratory (inhalation),UNK,,,D,,,,,,,,,2021,Q3,Completed suicide,,2021,Q3,1,I,,20210712.0,20210726,20210726,EXP,,US-AUROBINDO-AUR-APL-2021-031206,AUROBINDO,,46.0,YR,,F,Y,,,20210726.0,,MD,US,US,2021,Q3,Adult
196078591,19607859,9,SS,Insulin glargine,INSULIN GLARGINE,1,Parenteral,UNK,,,D,,,,,,,,,2021,Q3,Completed suicide,,2021,Q3,1,I,,20210712.0,20210726,20210726,EXP,,US-AUROBINDO-AUR-APL-2021-031206,AUROBINDO,,46.0,YR,,F,Y,,,20210726.0,,MD,US,US,2021,Q3,Adult
196083015,19608301,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"40.0,U,",,,,,,,,,,,,2021,Q3,Cholecystitis,,2021,Q3,5,F,20210708.0,20210823.0,20210726,20210830,EXP,,IL-NOVOPROD-828509,NOVO NORDISK,,47.0,YR,,M,Y,86.0,KG,20210830.0,,MD,IL,IL,2021,Q3,Adult
196083015,19608301,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"40.0,U,",,,,,,,,,,,,2021,Q3,Cholelithiasis,,2021,Q3,5,F,20210708.0,20210823.0,20210726,20210830,EXP,,IL-NOVOPROD-828509,NOVO NORDISK,,47.0,YR,,M,Y,86.0,KG,20210830.0,,MD,IL,IL,2021,Q3,Adult
196092221,19609222,3,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Atrioventricular block first degree,,2021,Q3,1,I,20210719.0,,20210726,20210726,DIR,,,FDA-CTU,,80.0,YR,,F,N,84.7,KG,20210726.0,N,PH,US,US,2021,Q3,Elderly
196092221,19609222,3,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Heart rate decreased,,2021,Q3,1,I,20210719.0,,20210726,20210726,DIR,,,FDA-CTU,,80.0,YR,,F,N,84.7,KG,20210726.0,N,PH,US,US,2021,Q3,Elderly
196092221,19609222,3,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Sinus bradycardia,,2021,Q3,1,I,20210719.0,,20210726,20210726,DIR,,,FDA-CTU,,80.0,YR,,F,N,84.7,KG,20210726.0,N,PH,US,US,2021,Q3,Elderly
196094351,19609435,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IU, 14?0?0?0, PRE?FILLED SYRINGES",,,,,,,,,,,,2021,Q3,Abdominal pain,,2021,Q3,1,I,,20210713.0,20210726,20210726,EXP,DE-BFARM-21006326,DE-ACCORD-232783,ACCORD,,79.0,YR,E,F,Y,54.0,KG,20210726.0,,PH,DE,DE,2021,Q3,Elderly
196094351,19609435,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IU, 14?0?0?0, PRE?FILLED SYRINGES",,,,,,,,,,,,2021,Q3,Bile duct stone,,2021,Q3,1,I,,20210713.0,20210726,20210726,EXP,DE-BFARM-21006326,DE-ACCORD-232783,ACCORD,,79.0,YR,E,F,Y,54.0,KG,20210726.0,,PH,DE,DE,2021,Q3,Elderly
196094351,19609435,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IU, 14?0?0?0, PRE?FILLED SYRINGES",,,,,,,,,,,,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210713.0,20210726,20210726,EXP,DE-BFARM-21006326,DE-ACCORD-232783,ACCORD,,79.0,YR,E,F,Y,54.0,KG,20210726.0,,PH,DE,DE,2021,Q3,Elderly
196094351,19609435,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IU, 14?0?0?0, PRE?FILLED SYRINGES",,,,,,,,,,,,2021,Q3,Liver function test abnormal,,2021,Q3,1,I,,20210713.0,20210726,20210726,EXP,DE-BFARM-21006326,DE-ACCORD-232783,ACCORD,,79.0,YR,E,F,Y,54.0,KG,20210726.0,,PH,DE,DE,2021,Q3,Elderly
196094351,19609435,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IU, 14?0?0?0, PRE?FILLED SYRINGES",,,,,,,,,,,,2021,Q3,Vomiting,,2021,Q3,1,I,,20210713.0,20210726,20210726,EXP,DE-BFARM-21006326,DE-ACCORD-232783,ACCORD,,79.0,YR,E,F,Y,54.0,KG,20210726.0,,PH,DE,DE,2021,Q3,Elderly
196109134,19610913,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Dizziness,,2021,Q3,4,F,20210716.0,20210901.0,20210726,20210910,EXP,,TR-JNJFOC-20210738141,JOHNSON AND JOHNSON,,57.0,YR,A,F,Y,80.0,KG,20210910.0,,MD,TR,TR,2021,Q3,Adult
196128781,19612878,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15U AT 09.00 P.M,,,U,,,,,15.0,IU,,,2021,Q3,Condition aggravated,,2021,Q3,1,I,,20210601.0,20210727,20210727,EXP,,IT-ACCORD-227448,ACCORD,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE. JOURNAL OF HYPERTENSION. 2021?39(1):E342.",33.0,YR,,F,Y,,,20210727.0,,MD,IT,IT,2021,Q3,Young Adult
196128781,19612878,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15U AT 09.00 P.M,,,U,,,,,15.0,IU,,,2021,Q3,Hypertension,,2021,Q3,1,I,,20210601.0,20210727,20210727,EXP,,IT-ACCORD-227448,ACCORD,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE. JOURNAL OF HYPERTENSION. 2021?39(1):E342.",33.0,YR,,F,Y,,,20210727.0,,MD,IT,IT,2021,Q3,Young Adult
196128781,19612878,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15U AT 09.00 P.M,,,U,,,,,15.0,IU,,,2021,Q3,Maternal exposure during pregnancy,,2021,Q3,1,I,,20210601.0,20210727,20210727,EXP,,IT-ACCORD-227448,ACCORD,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE. JOURNAL OF HYPERTENSION. 2021?39(1):E342.",33.0,YR,,F,Y,,,20210727.0,,MD,IT,IT,2021,Q3,Young Adult
196128781,19612878,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15U AT 09.00 P.M,,,U,,,,,15.0,IU,,,2021,Q3,Phaeochromocytoma,,2021,Q3,1,I,,20210601.0,20210727,20210727,EXP,,IT-ACCORD-227448,ACCORD,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE. JOURNAL OF HYPERTENSION. 2021?39(1):E342.",33.0,YR,,F,Y,,,20210727.0,,MD,IT,IT,2021,Q3,Young Adult
196128781,19612878,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15U AT 09.00 P.M,,,U,,,,,15.0,IU,,,2021,Q3,Unmasking of previously unidentified disease,,2021,Q3,1,I,,20210601.0,20210727,20210727,EXP,,IT-ACCORD-227448,ACCORD,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE. JOURNAL OF HYPERTENSION. 2021?39(1):E342.",33.0,YR,,F,Y,,,20210727.0,,MD,IT,IT,2021,Q3,Young Adult
196143912,19614391,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,40.0,IU,UNKNOWN,QD,2021,Q3,Acute kidney injury,,2021,Q3,2,F,,20210727.0,20210727,20210802,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-21-03417,HIKMA,"PHAM P, VENTAKARAM R, PHAM J, SIDHU H, BADER N, PHAM P, PHAM P. SEVERE HYPERPHOSPHATEMIA IN A PATIENT WITH MILD ACUTE KIDNEY INJURY. CASE REPORTS IN MEDICINE. 2021?. DOI:HTTPS://DOI.ORG/10.1155/2021/9962624",35.0,YR,,F,Y,,,20210802.0,,,COUNTRY NOT SPECIFIED,US,2021,Q3,Adult
196143912,19614391,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,40.0,IU,UNKNOWN,QD,2021,Q3,Maternal exposure during pregnancy,,2021,Q3,2,F,,20210727.0,20210727,20210802,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-21-03417,HIKMA,"PHAM P, VENTAKARAM R, PHAM J, SIDHU H, BADER N, PHAM P, PHAM P. SEVERE HYPERPHOSPHATEMIA IN A PATIENT WITH MILD ACUTE KIDNEY INJURY. CASE REPORTS IN MEDICINE. 2021?. DOI:HTTPS://DOI.ORG/10.1155/2021/9962624",35.0,YR,,F,Y,,,20210802.0,,,COUNTRY NOT SPECIFIED,US,2021,Q3,Adult
196147461,19614746,5,C,Insulin?glargine,INSULIN NOS,1,,,,,,, UNKNOWN,,,,,,,2021,Q3,Asthenia,,2021,Q3,1,I,,20210714.0,20210727,20210727,EXP,,ES-DRREDDYS-LIT/SPN/21/0138125,DR REDDYS,"ESCUDERO?VILAPLANA V, COLLADO?BORRELL R, VILLANUEVA?BUENO C, ALVAREZ R, HERRANZ A, SANJURJO M. ACUTE PANCREATITIS IN A PATIENT TREATED WITH IMATINIB AND GEFITINIB. J. ONCOL. PHARM. PRACT.. 2021?27(4):980?3. DOI:10.1177/1078155220949639",48.0,YR,A,F,Y,,,20210727.0,,HP,ES,ES,2021,Q3,Adult
196147461,19614746,5,C,Insulin?glargine,INSULIN NOS,1,,,,,,, UNKNOWN,,,,,,,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210714.0,20210727,20210727,EXP,,ES-DRREDDYS-LIT/SPN/21/0138125,DR REDDYS,"ESCUDERO?VILAPLANA V, COLLADO?BORRELL R, VILLANUEVA?BUENO C, ALVAREZ R, HERRANZ A, SANJURJO M. ACUTE PANCREATITIS IN A PATIENT TREATED WITH IMATINIB AND GEFITINIB. J. ONCOL. PHARM. PRACT.. 2021?27(4):980?3. DOI:10.1177/1078155220949639",48.0,YR,A,F,Y,,,20210727.0,,HP,ES,ES,2021,Q3,Adult
196147461,19614746,5,C,Insulin?glargine,INSULIN NOS,1,,,,,,, UNKNOWN,,,,,,,2021,Q3,Drug interaction,,2021,Q3,1,I,,20210714.0,20210727,20210727,EXP,,ES-DRREDDYS-LIT/SPN/21/0138125,DR REDDYS,"ESCUDERO?VILAPLANA V, COLLADO?BORRELL R, VILLANUEVA?BUENO C, ALVAREZ R, HERRANZ A, SANJURJO M. ACUTE PANCREATITIS IN A PATIENT TREATED WITH IMATINIB AND GEFITINIB. J. ONCOL. PHARM. PRACT.. 2021?27(4):980?3. DOI:10.1177/1078155220949639",48.0,YR,A,F,Y,,,20210727.0,,HP,ES,ES,2021,Q3,Adult
196147461,19614746,5,C,Insulin?glargine,INSULIN NOS,1,,,,,,, UNKNOWN,,,,,,,2021,Q3,Nausea,,2021,Q3,1,I,,20210714.0,20210727,20210727,EXP,,ES-DRREDDYS-LIT/SPN/21/0138125,DR REDDYS,"ESCUDERO?VILAPLANA V, COLLADO?BORRELL R, VILLANUEVA?BUENO C, ALVAREZ R, HERRANZ A, SANJURJO M. ACUTE PANCREATITIS IN A PATIENT TREATED WITH IMATINIB AND GEFITINIB. J. ONCOL. PHARM. PRACT.. 2021?27(4):980?3. DOI:10.1177/1078155220949639",48.0,YR,A,F,Y,,,20210727.0,,HP,ES,ES,2021,Q3,Adult
196147461,19614746,5,C,Insulin?glargine,INSULIN NOS,1,,,,,,, UNKNOWN,,,,,,,2021,Q3,Pancreatitis acute,,2021,Q3,1,I,,20210714.0,20210727,20210727,EXP,,ES-DRREDDYS-LIT/SPN/21/0138125,DR REDDYS,"ESCUDERO?VILAPLANA V, COLLADO?BORRELL R, VILLANUEVA?BUENO C, ALVAREZ R, HERRANZ A, SANJURJO M. ACUTE PANCREATITIS IN A PATIENT TREATED WITH IMATINIB AND GEFITINIB. J. ONCOL. PHARM. PRACT.. 2021?27(4):980?3. DOI:10.1177/1078155220949639",48.0,YR,A,F,Y,,,20210727.0,,HP,ES,ES,2021,Q3,Adult
196147461,19614746,5,C,Insulin?glargine,INSULIN NOS,1,,,,,,, UNKNOWN,,,,,,,2021,Q3,Vomiting,,2021,Q3,1,I,,20210714.0,20210727,20210727,EXP,,ES-DRREDDYS-LIT/SPN/21/0138125,DR REDDYS,"ESCUDERO?VILAPLANA V, COLLADO?BORRELL R, VILLANUEVA?BUENO C, ALVAREZ R, HERRANZ A, SANJURJO M. ACUTE PANCREATITIS IN A PATIENT TREATED WITH IMATINIB AND GEFITINIB. J. ONCOL. PHARM. PRACT.. 2021?27(4):980?3. DOI:10.1177/1078155220949639",48.0,YR,A,F,Y,,,20210727.0,,HP,ES,ES,2021,Q3,Adult
196174824,19617482,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK (DOSE INCREASED),,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose decreased,,2021,Q3,4,F,20210818.0,20210907.0,20210728,20210916,EXP,,ES-AUROBINDO-AUR-APL-2021-031996,AUROBINDO,,72.0,YR,,F,Y,80.0,KG,20210916.0,,CN,ES,ES,2021,Q3,Elderly
196174824,19617482,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK (DOSE INCREASED),,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,4,F,20210818.0,20210907.0,20210728,20210916,EXP,,ES-AUROBINDO-AUR-APL-2021-031996,AUROBINDO,,72.0,YR,,F,Y,80.0,KG,20210916.0,,CN,ES,ES,2021,Q3,Elderly
196174824,19617482,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK (DOSE INCREASED),,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Confusional state,,2021,Q3,4,F,20210818.0,20210907.0,20210728,20210916,EXP,,ES-AUROBINDO-AUR-APL-2021-031996,AUROBINDO,,72.0,YR,,F,Y,80.0,KG,20210916.0,,CN,ES,ES,2021,Q3,Elderly
196174824,19617482,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK (DOSE INCREASED),,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Fear,,2021,Q3,4,F,20210818.0,20210907.0,20210728,20210916,EXP,,ES-AUROBINDO-AUR-APL-2021-031996,AUROBINDO,,72.0,YR,,F,Y,80.0,KG,20210916.0,,CN,ES,ES,2021,Q3,Elderly
196174824,19617482,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK (DOSE INCREASED),,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Head discomfort,,2021,Q3,4,F,20210818.0,20210907.0,20210728,20210916,EXP,,ES-AUROBINDO-AUR-APL-2021-031996,AUROBINDO,,72.0,YR,,F,Y,80.0,KG,20210916.0,,CN,ES,ES,2021,Q3,Elderly
196174824,19617482,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK (DOSE INCREASED),,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Hyperglycaemia,,2021,Q3,4,F,20210818.0,20210907.0,20210728,20210916,EXP,,ES-AUROBINDO-AUR-APL-2021-031996,AUROBINDO,,72.0,YR,,F,Y,80.0,KG,20210916.0,,CN,ES,ES,2021,Q3,Elderly
196174824,19617482,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK (DOSE INCREASED),,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Hyperhidrosis,,2021,Q3,4,F,20210818.0,20210907.0,20210728,20210916,EXP,,ES-AUROBINDO-AUR-APL-2021-031996,AUROBINDO,,72.0,YR,,F,Y,80.0,KG,20210916.0,,CN,ES,ES,2021,Q3,Elderly
196174824,19617482,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK (DOSE INCREASED),,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Hypoglycaemia,,2021,Q3,4,F,20210818.0,20210907.0,20210728,20210916,EXP,,ES-AUROBINDO-AUR-APL-2021-031996,AUROBINDO,,72.0,YR,,F,Y,80.0,KG,20210916.0,,CN,ES,ES,2021,Q3,Elderly
196174824,19617482,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK (DOSE INCREASED),,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Product storage error,,2021,Q3,4,F,20210818.0,20210907.0,20210728,20210916,EXP,,ES-AUROBINDO-AUR-APL-2021-031996,AUROBINDO,,72.0,YR,,F,Y,80.0,KG,20210916.0,,CN,ES,ES,2021,Q3,Elderly
196174824,19617482,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK (DOSE INCREASED),,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Tremor,,2021,Q3,4,F,20210818.0,20210907.0,20210728,20210916,EXP,,ES-AUROBINDO-AUR-APL-2021-031996,AUROBINDO,,72.0,YR,,F,Y,80.0,KG,20210916.0,,CN,ES,ES,2021,Q3,Elderly
196174824,19617482,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK (DOSE INCREASED),,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Weight fluctuation,,2021,Q3,4,F,20210818.0,20210907.0,20210728,20210916,EXP,,ES-AUROBINDO-AUR-APL-2021-031996,AUROBINDO,,72.0,YR,,F,Y,80.0,KG,20210916.0,,CN,ES,ES,2021,Q3,Elderly
196174824,19617482,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"20 INTERNATIONAL UNIT, ONCE A DAY",,,,, 1F939A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose decreased,,2021,Q3,4,F,20210818.0,20210907.0,20210728,20210916,EXP,,ES-AUROBINDO-AUR-APL-2021-031996,AUROBINDO,,72.0,YR,,F,Y,80.0,KG,20210916.0,,CN,ES,ES,2021,Q3,Elderly
196174824,19617482,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"20 INTERNATIONAL UNIT, ONCE A DAY",,,,, 1F939A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,4,F,20210818.0,20210907.0,20210728,20210916,EXP,,ES-AUROBINDO-AUR-APL-2021-031996,AUROBINDO,,72.0,YR,,F,Y,80.0,KG,20210916.0,,CN,ES,ES,2021,Q3,Elderly
196174824,19617482,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"20 INTERNATIONAL UNIT, ONCE A DAY",,,,, 1F939A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Confusional state,,2021,Q3,4,F,20210818.0,20210907.0,20210728,20210916,EXP,,ES-AUROBINDO-AUR-APL-2021-031996,AUROBINDO,,72.0,YR,,F,Y,80.0,KG,20210916.0,,CN,ES,ES,2021,Q3,Elderly
196174824,19617482,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"20 INTERNATIONAL UNIT, ONCE A DAY",,,,, 1F939A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Fear,,2021,Q3,4,F,20210818.0,20210907.0,20210728,20210916,EXP,,ES-AUROBINDO-AUR-APL-2021-031996,AUROBINDO,,72.0,YR,,F,Y,80.0,KG,20210916.0,,CN,ES,ES,2021,Q3,Elderly
196174824,19617482,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"20 INTERNATIONAL UNIT, ONCE A DAY",,,,, 1F939A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Head discomfort,,2021,Q3,4,F,20210818.0,20210907.0,20210728,20210916,EXP,,ES-AUROBINDO-AUR-APL-2021-031996,AUROBINDO,,72.0,YR,,F,Y,80.0,KG,20210916.0,,CN,ES,ES,2021,Q3,Elderly
196174824,19617482,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"20 INTERNATIONAL UNIT, ONCE A DAY",,,,, 1F939A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hyperglycaemia,,2021,Q3,4,F,20210818.0,20210907.0,20210728,20210916,EXP,,ES-AUROBINDO-AUR-APL-2021-031996,AUROBINDO,,72.0,YR,,F,Y,80.0,KG,20210916.0,,CN,ES,ES,2021,Q3,Elderly
196174824,19617482,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"20 INTERNATIONAL UNIT, ONCE A DAY",,,,, 1F939A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hyperhidrosis,,2021,Q3,4,F,20210818.0,20210907.0,20210728,20210916,EXP,,ES-AUROBINDO-AUR-APL-2021-031996,AUROBINDO,,72.0,YR,,F,Y,80.0,KG,20210916.0,,CN,ES,ES,2021,Q3,Elderly
196174824,19617482,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"20 INTERNATIONAL UNIT, ONCE A DAY",,,,, 1F939A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hypoglycaemia,,2021,Q3,4,F,20210818.0,20210907.0,20210728,20210916,EXP,,ES-AUROBINDO-AUR-APL-2021-031996,AUROBINDO,,72.0,YR,,F,Y,80.0,KG,20210916.0,,CN,ES,ES,2021,Q3,Elderly
196174824,19617482,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"20 INTERNATIONAL UNIT, ONCE A DAY",,,,, 1F939A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Product storage error,,2021,Q3,4,F,20210818.0,20210907.0,20210728,20210916,EXP,,ES-AUROBINDO-AUR-APL-2021-031996,AUROBINDO,,72.0,YR,,F,Y,80.0,KG,20210916.0,,CN,ES,ES,2021,Q3,Elderly
196174824,19617482,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"20 INTERNATIONAL UNIT, ONCE A DAY",,,,, 1F939A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Tremor,,2021,Q3,4,F,20210818.0,20210907.0,20210728,20210916,EXP,,ES-AUROBINDO-AUR-APL-2021-031996,AUROBINDO,,72.0,YR,,F,Y,80.0,KG,20210916.0,,CN,ES,ES,2021,Q3,Elderly
196174824,19617482,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"20 INTERNATIONAL UNIT, ONCE A DAY",,,,, 1F939A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Weight fluctuation,,2021,Q3,4,F,20210818.0,20210907.0,20210728,20210916,EXP,,ES-AUROBINDO-AUR-APL-2021-031996,AUROBINDO,,72.0,YR,,F,Y,80.0,KG,20210916.0,,CN,ES,ES,2021,Q3,Elderly
196177692,19617769,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,AT 9:00 P.M.,,,D,,,,,15.0,IU,,,2021,Q3,Maternal exposure during pregnancy,,2021,Q3,2,F,,20210712.0,20210727,20210825,EXP,,IT-BAUSCH-BL-2021-025030,BAUSCH AND LOMB,"NEGRO A, VERZICCO I, TEDESCHI S, SANTI R, PALLADINI B, CALVI A, GIUNTA A, CUNZI D, COGHI P, VOLPI R, CABASSI A. UNRECOGNISED PHEOCHROMOCYTOMA IN PREGNANCY DISCOVERED THROUGH METOCLOPRAMIDE?TRIGGERED HYPERTENSIVE EMERGENCY. BLOOD PRESSURE. 2021?1?5. DOI:10.1080/08037051.2021.1945428",33.0,YR,,F,Y,,,20210825.0,,HP,IT,IT,2021,Q3,Young Adult
196177692,19617769,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,AT 9:00 P.M.,,,D,,,,,15.0,IU,,,2021,Q3,Phaeochromocytoma crisis,,2021,Q3,2,F,,20210712.0,20210727,20210825,EXP,,IT-BAUSCH-BL-2021-025030,BAUSCH AND LOMB,"NEGRO A, VERZICCO I, TEDESCHI S, SANTI R, PALLADINI B, CALVI A, GIUNTA A, CUNZI D, COGHI P, VOLPI R, CABASSI A. UNRECOGNISED PHEOCHROMOCYTOMA IN PREGNANCY DISCOVERED THROUGH METOCLOPRAMIDE?TRIGGERED HYPERTENSIVE EMERGENCY. BLOOD PRESSURE. 2021?1?5. DOI:10.1080/08037051.2021.1945428",33.0,YR,,F,Y,,,20210825.0,,HP,IT,IT,2021,Q3,Young Adult
196216191,19621619,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,40 UNITS QD,,,U,,,,,,,,,2021,Q3,Contraindicated product administered,,2021,Q3,1,I,,20210722.0,20210728,20210728,EXP,,NVSC2021US166735,NOVARTIS,"PHAM PC, VENTAKARAM RK, PHAM J, SIDHU H, BADER N, PHAM PM ET AL.. SEVERE HYPERPHOSPHATEMIA IN A PATIENT WITH MILD ACUTE KIDNEY INJURY. CASE REPORTS IN MEDICINE. 2021?1?5",35.0,YR,,F,Y,,,20210728.0,,HP,US,US,2021,Q3,Adult
196216191,19621619,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,40 UNITS QD,,,U,,,,,,,,,2021,Q3,Maternal exposure during pregnancy,,2021,Q3,1,I,,20210722.0,20210728,20210728,EXP,,NVSC2021US166735,NOVARTIS,"PHAM PC, VENTAKARAM RK, PHAM J, SIDHU H, BADER N, PHAM PM ET AL.. SEVERE HYPERPHOSPHATEMIA IN A PATIENT WITH MILD ACUTE KIDNEY INJURY. CASE REPORTS IN MEDICINE. 2021?1?5",35.0,YR,,F,Y,,,20210728.0,,HP,US,US,2021,Q3,Adult
196216191,19621619,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,40 UNITS QD,,,U,,,,,,,,,2021,Q3,Tubulointerstitial nephritis,,2021,Q3,1,I,,20210722.0,20210728,20210728,EXP,,NVSC2021US166735,NOVARTIS,"PHAM PC, VENTAKARAM RK, PHAM J, SIDHU H, BADER N, PHAM PM ET AL.. SEVERE HYPERPHOSPHATEMIA IN A PATIENT WITH MILD ACUTE KIDNEY INJURY. CASE REPORTS IN MEDICINE. 2021?1?5",35.0,YR,,F,Y,,,20210728.0,,HP,US,US,2021,Q3,Adult
196231331,19623133,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"40 UNITS, ONCE A DAY",,,D,,,,,,,,QD,2021,Q3,Acute kidney injury,,2021,Q3,1,I,,20210721.0,20210728,20210728,EXP,,US-MYLANLABS-2021M1046392,MYLAN,"PHAM PC, KONANUR VENTAKARAM R, PHAM J, SIDHU H, BADER N, PHAM PM, ET AL. SEVERE HYPERPHOSPHATEMIA IN A PATIENT WITH MILD ACUTE KIDNEY INJURY. CASE?REP?MED 2021?NULL:NULL.",35.0,YR,,F,Y,,,20210728.0,,HP,US,US,2021,Q3,Adult
196231331,19623133,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"40 UNITS, ONCE A DAY",,,D,,,,,,,,QD,2021,Q3,Hypotension,,2021,Q3,1,I,,20210721.0,20210728,20210728,EXP,,US-MYLANLABS-2021M1046392,MYLAN,"PHAM PC, KONANUR VENTAKARAM R, PHAM J, SIDHU H, BADER N, PHAM PM, ET AL. SEVERE HYPERPHOSPHATEMIA IN A PATIENT WITH MILD ACUTE KIDNEY INJURY. CASE?REP?MED 2021?NULL:NULL.",35.0,YR,,F,Y,,,20210728.0,,HP,US,US,2021,Q3,Adult
196231331,19623133,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"40 UNITS, ONCE A DAY",,,D,,,,,,,,QD,2021,Q3,Maternal exposure during pregnancy,,2021,Q3,1,I,,20210721.0,20210728,20210728,EXP,,US-MYLANLABS-2021M1046392,MYLAN,"PHAM PC, KONANUR VENTAKARAM R, PHAM J, SIDHU H, BADER N, PHAM PM, ET AL. SEVERE HYPERPHOSPHATEMIA IN A PATIENT WITH MILD ACUTE KIDNEY INJURY. CASE?REP?MED 2021?NULL:NULL.",35.0,YR,,F,Y,,,20210728.0,,HP,US,US,2021,Q3,Adult
196231331,19623133,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"40 UNITS, ONCE A DAY",,,D,,,,,,,,QD,2021,Q3,Metabolic acidosis,,2021,Q3,1,I,,20210721.0,20210728,20210728,EXP,,US-MYLANLABS-2021M1046392,MYLAN,"PHAM PC, KONANUR VENTAKARAM R, PHAM J, SIDHU H, BADER N, PHAM PM, ET AL. SEVERE HYPERPHOSPHATEMIA IN A PATIENT WITH MILD ACUTE KIDNEY INJURY. CASE?REP?MED 2021?NULL:NULL.",35.0,YR,,F,Y,,,20210728.0,,HP,US,US,2021,Q3,Adult
196249111,19624911,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Facial paresis,,2021,Q3,1,I,20210304.0,20210720.0,20210729,20210729,PER,DE-CELGENE-DEU-20210701799,DE-SHILPA MEDICARE LIMITED-SML-DE-2021-00923,SHILPA MEDICARE,,70.0,YR,E,F,Y,,,20210729.0,,HP,COUNTRY NOT SPECIFIED,DE,2021,Q3,Elderly
196251961,19625196,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,210605.0,,,,,2021,Q3,Blister,,2021,Q3,1,I,20210704.0,20210720.0,20210728,20210728,EXP,GB-MHRA-WEBRADR-20210711153344,GB-MYLANLABS-2021M1045240,MYLAN,,63.0,YR,,F,Y,75.0,KG,20210728.0,,CN,GB,GB,2021,Q3,Adult
196251961,19625196,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,210605.0,,,,,2021,Q3,Rash erythematous,,2021,Q3,1,I,20210704.0,20210720.0,20210728,20210728,EXP,GB-MHRA-WEBRADR-20210711153344,GB-MYLANLABS-2021M1045240,MYLAN,,63.0,YR,,F,Y,75.0,KG,20210728.0,,CN,GB,GB,2021,Q3,Adult
196251961,19625196,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,210605.0,,,,,2021,Q3,Skin discolouration,,2021,Q3,1,I,20210704.0,20210720.0,20210728,20210728,EXP,GB-MHRA-WEBRADR-20210711153344,GB-MYLANLABS-2021M1045240,MYLAN,,63.0,YR,,F,Y,75.0,KG,20210728.0,,CN,GB,GB,2021,Q3,Adult
196263041,19626304,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,18 IU/D,,,,,,,,18.0,IU,UNKNOWN,QD,2021,Q3,Asthenia,,2021,Q3,1,I,2021.0,20210719.0,20210728,20210728,EXP,,DE-FRESENIUS KABI-FK202107594,FRESENIUS KABI,,79.0,YR,,M,Y,,,20210728.0,,HP,NL,DE,2021,Q3,Elderly
196263041,19626304,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,18 IU/D,,,,,,,,18.0,IU,UNKNOWN,QD,2021,Q3,General physical health deterioration,,2021,Q3,1,I,2021.0,20210719.0,20210728,20210728,EXP,,DE-FRESENIUS KABI-FK202107594,FRESENIUS KABI,,79.0,YR,,M,Y,,,20210728.0,,HP,NL,DE,2021,Q3,Elderly
196263041,19626304,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,18 IU/D,,,,,,,,18.0,IU,UNKNOWN,QD,2021,Q3,Immobile,,2021,Q3,1,I,2021.0,20210719.0,20210728,20210728,EXP,,DE-FRESENIUS KABI-FK202107594,FRESENIUS KABI,,79.0,YR,,M,Y,,,20210728.0,,HP,NL,DE,2021,Q3,Elderly
196263041,19626304,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,18 IU/D,,,,,,,,18.0,IU,UNKNOWN,QD,2021,Q3,Jaundice,,2021,Q3,1,I,2021.0,20210719.0,20210728,20210728,EXP,,DE-FRESENIUS KABI-FK202107594,FRESENIUS KABI,,79.0,YR,,M,Y,,,20210728.0,,HP,NL,DE,2021,Q3,Elderly
196263041,19626304,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,18 IU/D,,,,,,,,18.0,IU,UNKNOWN,QD,2021,Q3,Pyrexia,,2021,Q3,1,I,2021.0,20210719.0,20210728,20210728,EXP,,DE-FRESENIUS KABI-FK202107594,FRESENIUS KABI,,79.0,YR,,M,Y,,,20210728.0,,HP,NL,DE,2021,Q3,Elderly
196269621,19626962,5,C,Insulin?glargine,INSULIN NOS,1,Unknown,28 IU (INTERNATIONAL UNIT) DAILY;,,,,,,,,28.0,IU,,QD,2021,Q3,Drug interaction,,2021,Q3,1,I,,20210726.0,20210729,20210729,EXP,,ES-TEVA-2021-ES-1938038,TEVA,"ESCUDERO?VILAPLANA V, COLLADO?BORRELL R, VILLANUEVA?BUENO C, ALVAREZ R, HERRANZ A, SANJURJO M. ACUTE PANCREATITIS IN A PATIENT TREATED WITH IMATINIB AND GEFITINIB. J?ONCOL?PHARM?PRACT 2021?27(4):980?983.",48.0,YR,A,F,Y,,,20210729.0,,HP,ES,ES,2021,Q3,Adult
196269621,19626962,5,C,Insulin?glargine,INSULIN NOS,1,Unknown,28 IU (INTERNATIONAL UNIT) DAILY;,,,,,,,,28.0,IU,,QD,2021,Q3,Pancreatitis acute,,2021,Q3,1,I,,20210726.0,20210729,20210729,EXP,,ES-TEVA-2021-ES-1938038,TEVA,"ESCUDERO?VILAPLANA V, COLLADO?BORRELL R, VILLANUEVA?BUENO C, ALVAREZ R, HERRANZ A, SANJURJO M. ACUTE PANCREATITIS IN A PATIENT TREATED WITH IMATINIB AND GEFITINIB. J?ONCOL?PHARM?PRACT 2021?27(4):980?983.",48.0,YR,A,F,Y,,,20210729.0,,HP,ES,ES,2021,Q3,Adult
196308082,19630808,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 UNITS IN THE MORNING AND 40 UNITS IN THE EVENING50 UNITS IN THE MORNING AND 40 UNITS IN THE EVENI,,,D,, 0F7341A,,21081.0,,,SOLUTION FOR INJECTION,Q12H,2021,Q3,Inappropriate schedule of product administration,,2021,Q3,2,F,,20210723.0,20210728,20210803,PER,,US-SA-2021SA244007,SANOFI AVENTIS,,45.0,YR,A,F,Y,,,20210803.0,,CN,US,US,2021,Q3,Adult
196308082,19630808,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 UNITS IN THE MORNING AND 40 UNITS IN THE EVENING50 UNITS IN THE MORNING AND 40 UNITS IN THE EVENI,,,D,, 0F7341A,,21081.0,,,SOLUTION FOR INJECTION,Q12H,2021,Q3,Product prescribing issue,,2021,Q3,2,F,,20210723.0,20210728,20210803,PER,,US-SA-2021SA244007,SANOFI AVENTIS,,45.0,YR,A,F,Y,,,20210803.0,,CN,US,US,2021,Q3,Adult
196308082,19630808,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 UNITS IN THE MORNING AND 40 UNITS IN THE EVENING50 UNITS IN THE MORNING AND 40 UNITS IN THE EVENI,,,D,, 0F7341A,,21081.0,,,SOLUTION FOR INJECTION,Q12H,2021,Q3,Product storage error,,2021,Q3,2,F,,20210723.0,20210728,20210803,PER,,US-SA-2021SA244007,SANOFI AVENTIS,,45.0,YR,A,F,Y,,,20210803.0,,CN,US,US,2021,Q3,Adult
196308082,19630808,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,55U BID,,,D,,,,21081.0,55.0,IU,SOLUTION FOR INJECTION,Q12H,2021,Q3,Inappropriate schedule of product administration,,2021,Q3,2,F,,20210723.0,20210728,20210803,PER,,US-SA-2021SA244007,SANOFI AVENTIS,,45.0,YR,A,F,Y,,,20210803.0,,CN,US,US,2021,Q3,Adult
196308082,19630808,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,55U BID,,,D,,,,21081.0,55.0,IU,SOLUTION FOR INJECTION,Q12H,2021,Q3,Product prescribing issue,,2021,Q3,2,F,,20210723.0,20210728,20210803,PER,,US-SA-2021SA244007,SANOFI AVENTIS,,45.0,YR,A,F,Y,,,20210803.0,,CN,US,US,2021,Q3,Adult
196308082,19630808,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,55U BID,,,D,,,,21081.0,55.0,IU,SOLUTION FOR INJECTION,Q12H,2021,Q3,Product storage error,,2021,Q3,2,F,,20210723.0,20210728,20210803,PER,,US-SA-2021SA244007,SANOFI AVENTIS,,45.0,YR,A,F,Y,,,20210803.0,,CN,US,US,2021,Q3,Adult
196337492,19633749,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,12.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hyperlactacidaemia,,2021,Q3,2,F,20210716.0,20210811.0,20210730,20210816,EXP,IT-MINISAL02-759266,IT-JNJFOC-20210752546,JOHNSON AND JOHNSON,,76.0,YR,E,M,Y,70.0,KG,20210816.0,,MD,IT,IT,2021,Q3,Elderly
196337492,19633749,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,12.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Metabolic acidosis,,2021,Q3,2,F,20210716.0,20210811.0,20210730,20210816,EXP,IT-MINISAL02-759266,IT-JNJFOC-20210752546,JOHNSON AND JOHNSON,,76.0,YR,E,M,Y,70.0,KG,20210816.0,,MD,IT,IT,2021,Q3,Elderly
196337492,19633749,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,12.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Respiratory distress,,2021,Q3,2,F,20210716.0,20210811.0,20210730,20210816,EXP,IT-MINISAL02-759266,IT-JNJFOC-20210752546,JOHNSON AND JOHNSON,,76.0,YR,E,M,Y,70.0,KG,20210816.0,,MD,IT,IT,2021,Q3,Elderly
196355323,19635532,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,,, 1F939A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose decreased,,2021,Q3,3,F,20210818.0,20210830.0,20210730,20210906,EXP,,NVSC2021ES165189,NOVARTIS,,72.0,YR,,F,Y,80.0,KG,20210906.0,,HP,ES,ES,2021,Q3,Elderly
196355323,19635532,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,,, 1F939A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,3,F,20210818.0,20210830.0,20210730,20210906,EXP,,NVSC2021ES165189,NOVARTIS,,72.0,YR,,F,Y,80.0,KG,20210906.0,,HP,ES,ES,2021,Q3,Elderly
196355323,19635532,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,,, 1F939A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Confusional state,,2021,Q3,3,F,20210818.0,20210830.0,20210730,20210906,EXP,,NVSC2021ES165189,NOVARTIS,,72.0,YR,,F,Y,80.0,KG,20210906.0,,HP,ES,ES,2021,Q3,Elderly
196355323,19635532,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,,, 1F939A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Fear,,2021,Q3,3,F,20210818.0,20210830.0,20210730,20210906,EXP,,NVSC2021ES165189,NOVARTIS,,72.0,YR,,F,Y,80.0,KG,20210906.0,,HP,ES,ES,2021,Q3,Elderly
196355323,19635532,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,,, 1F939A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Head discomfort,,2021,Q3,3,F,20210818.0,20210830.0,20210730,20210906,EXP,,NVSC2021ES165189,NOVARTIS,,72.0,YR,,F,Y,80.0,KG,20210906.0,,HP,ES,ES,2021,Q3,Elderly
196355323,19635532,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,,, 1F939A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hyperglycaemia,,2021,Q3,3,F,20210818.0,20210830.0,20210730,20210906,EXP,,NVSC2021ES165189,NOVARTIS,,72.0,YR,,F,Y,80.0,KG,20210906.0,,HP,ES,ES,2021,Q3,Elderly
196355323,19635532,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,,, 1F939A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hyperhidrosis,,2021,Q3,3,F,20210818.0,20210830.0,20210730,20210906,EXP,,NVSC2021ES165189,NOVARTIS,,72.0,YR,,F,Y,80.0,KG,20210906.0,,HP,ES,ES,2021,Q3,Elderly
196355323,19635532,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,,, 1F939A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hypoglycaemia,,2021,Q3,3,F,20210818.0,20210830.0,20210730,20210906,EXP,,NVSC2021ES165189,NOVARTIS,,72.0,YR,,F,Y,80.0,KG,20210906.0,,HP,ES,ES,2021,Q3,Elderly
196355323,19635532,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,,, 1F939A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Product storage error,,2021,Q3,3,F,20210818.0,20210830.0,20210730,20210906,EXP,,NVSC2021ES165189,NOVARTIS,,72.0,YR,,F,Y,80.0,KG,20210906.0,,HP,ES,ES,2021,Q3,Elderly
196355323,19635532,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,,, 1F939A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Tremor,,2021,Q3,3,F,20210818.0,20210830.0,20210730,20210906,EXP,,NVSC2021ES165189,NOVARTIS,,72.0,YR,,F,Y,80.0,KG,20210906.0,,HP,ES,ES,2021,Q3,Elderly
196355323,19635532,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,,, 1F939A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Weight fluctuation,,2021,Q3,3,F,20210818.0,20210830.0,20210730,20210906,EXP,,NVSC2021ES165189,NOVARTIS,,72.0,YR,,F,Y,80.0,KG,20210906.0,,HP,ES,ES,2021,Q3,Elderly
196357781,19635778,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,40 UNITS PER DAY,,,D,,,,,,,,,2021,Q3,Maternal exposure during pregnancy,,2021,Q3,1,I,,20210721.0,20210730,20210730,EXP,,US-STRIDES ARCOLAB LIMITED-2021SP025588,STRIDES,"PHAM PC, KONANUR VENTAKARAM R, PHAM J, SIDHU H, BADER N, PHAM PM, ET AL.. SEVERE HYPERPHOSPHATEMIA IN A PATIENT WITH MILD ACUTE KIDNEY INJURY. CASE?REP?MED. 2021",35.0,YR,,F,Y,,,20210730.0,,HP,US,US,2021,Q3,Adult
196357781,19635778,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,40 UNITS PER DAY,,,D,,,,,,,,,2021,Q3,Tubulointerstitial nephritis,,2021,Q3,1,I,,20210721.0,20210730,20210730,EXP,,US-STRIDES ARCOLAB LIMITED-2021SP025588,STRIDES,"PHAM PC, KONANUR VENTAKARAM R, PHAM J, SIDHU H, BADER N, PHAM PM, ET AL.. SEVERE HYPERPHOSPHATEMIA IN A PATIENT WITH MILD ACUTE KIDNEY INJURY. CASE?REP?MED. 2021",35.0,YR,,F,Y,,,20210730.0,,HP,US,US,2021,Q3,Adult
196357941,19635794,7,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q3,Diabetic ketoacidosis,,2021,Q3,1,I,20210712.0,20210719.0,20210730,20210730,EXP,,US-CELGENEUS-USA-20210705041,CELGENE,,56.0,YR,,M,Y,,,20210730.0,,PH,US,US,2021,Q3,Adult
196361673,19636167,20,C,INSULIN GLARGINE INJECTION,,2,Intravenous (not otherwise specified),,,,,,,,,,,,,2021,Q3,Asthma,,2021,Q3,3,F,20200702.0,20210908.0,20210730,20210913,EXP,,JP-GLAXOSMITHKLINE-JP2021162434,GLAXOSMITHKLINE,,49.0,YR,,M,Y,,,20210913.0,,CN,JP,JP,2021,Q3,Adult
196361673,19636167,20,C,INSULIN GLARGINE INJECTION,,2,Intravenous (not otherwise specified),,,,,,,,,,,,,2021,Q3,Drug ineffective,,2021,Q3,3,F,20200702.0,20210908.0,20210730,20210913,EXP,,JP-GLAXOSMITHKLINE-JP2021162434,GLAXOSMITHKLINE,,49.0,YR,,M,Y,,,20210913.0,,CN,JP,JP,2021,Q3,Adult
196361673,19636167,20,C,INSULIN GLARGINE INJECTION,,2,Intravenous (not otherwise specified),,,,,,,,,,,,,2021,Q3,Folliculitis,,2021,Q3,3,F,20200702.0,20210908.0,20210730,20210913,EXP,,JP-GLAXOSMITHKLINE-JP2021162434,GLAXOSMITHKLINE,,49.0,YR,,M,Y,,,20210913.0,,CN,JP,JP,2021,Q3,Adult
196361673,19636167,20,C,INSULIN GLARGINE INJECTION,,2,Intravenous (not otherwise specified),,,,,,,,,,,,,2021,Q3,Inappropriate schedule of product administration,,2021,Q3,3,F,20200702.0,20210908.0,20210730,20210913,EXP,,JP-GLAXOSMITHKLINE-JP2021162434,GLAXOSMITHKLINE,,49.0,YR,,M,Y,,,20210913.0,,CN,JP,JP,2021,Q3,Adult
196361673,19636167,20,C,INSULIN GLARGINE INJECTION,,2,Intravenous (not otherwise specified),,,,,,,,,,,,,2021,Q3,Pneumonia bacterial,,2021,Q3,3,F,20200702.0,20210908.0,20210730,20210913,EXP,,JP-GLAXOSMITHKLINE-JP2021162434,GLAXOSMITHKLINE,,49.0,YR,,M,Y,,,20210913.0,,CN,JP,JP,2021,Q3,Adult
196363841,19636384,10,SS,INSULIN GLARGINE MYLAN,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q3,Drug ineffective,,2021,Q3,1,I,,20210719.0,20210730,20210730,EXP,,US-MYLANLABS-2021M1046072,MYLAN,"SCOTT NS, THOMAS SS, YEH DD, FOX AS, SMITH RN. CASE 2?2021: A 26?YEAR?OLD PREGNANT WOMAN WITH VENTRICULAR TACHYCARDIA AND SHOCK. N?ENGL?J?MED 2021?384(3):272?282.",26.0,YR,,F,Y,,,20210730.0,,MD,US,US,2021,Q3,Young Adult
196363841,19636384,10,SS,INSULIN GLARGINE MYLAN,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q3,Maternal exposure during pregnancy,,2021,Q3,1,I,,20210719.0,20210730,20210730,EXP,,US-MYLANLABS-2021M1046072,MYLAN,"SCOTT NS, THOMAS SS, YEH DD, FOX AS, SMITH RN. CASE 2?2021: A 26?YEAR?OLD PREGNANT WOMAN WITH VENTRICULAR TACHYCARDIA AND SHOCK. N?ENGL?J?MED 2021?384(3):272?282.",26.0,YR,,F,Y,,,20210730.0,,MD,US,US,2021,Q3,Young Adult
196363841,19636384,10,SS,INSULIN GLARGINE MYLAN,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q3,Normal newborn,,2021,Q3,1,I,,20210719.0,20210730,20210730,EXP,,US-MYLANLABS-2021M1046072,MYLAN,"SCOTT NS, THOMAS SS, YEH DD, FOX AS, SMITH RN. CASE 2?2021: A 26?YEAR?OLD PREGNANT WOMAN WITH VENTRICULAR TACHYCARDIA AND SHOCK. N?ENGL?J?MED 2021?384(3):272?282.",26.0,YR,,F,Y,,,20210730.0,,MD,US,US,2021,Q3,Young Adult
196367971,19636797,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,36 IU,,,U,,,,,,,,,2021,Q3,Condition aggravated,,2021,Q3,1,I,,20210721.0,20210730,20210730,EXP,,DE-ACCORD-233183,ACCORD,"BERNSDORF S, GRUN MP, LUDEMANN C, THEVISSEN J, STRASSBURG C, JAEHDE U. MEDICATION ANALYSIS FOR A PATIENT WITH LIVER CIRRHOSIS. MEDIZINISCHE MONATSSCHRIFT FUR PHARMAZEUTEN. 2020?43(11):439?44.",61.0,YR,,M,Y,,,20210730.0,,PH,DE,DE,2021,Q3,Adult
196367971,19636797,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,36 IU,,,U,,,,,,,,,2021,Q3,Renal impairment,,2021,Q3,1,I,,20210721.0,20210730,20210730,EXP,,DE-ACCORD-233183,ACCORD,"BERNSDORF S, GRUN MP, LUDEMANN C, THEVISSEN J, STRASSBURG C, JAEHDE U. MEDICATION ANALYSIS FOR A PATIENT WITH LIVER CIRRHOSIS. MEDIZINISCHE MONATSSCHRIFT FUR PHARMAZEUTEN. 2020?43(11):439?44.",61.0,YR,,M,Y,,,20210730.0,,PH,DE,DE,2021,Q3,Adult
196378771,19637877,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2021,Q3,COVID-19 pneumonia,,2021,Q3,1,I,,20210728.0,20210729,20210729,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-118240",BOEHRINGER INGELHEIM,,72.0,YR,E,M,Y,,,20210729.0,,HP,CA,CA,2021,Q3,Elderly
196378771,19637877,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2021,Q3,Diabetic ketoacidosis,,2021,Q3,1,I,,20210728.0,20210729,20210729,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-118240",BOEHRINGER INGELHEIM,,72.0,YR,E,M,Y,,,20210729.0,,HP,CA,CA,2021,Q3,Elderly
196402841,19640284,2,C,GLARGINE INSULIN,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Ketoacidosis,,2021,Q3,1,I,20210706.0,20210721.0,20210730,20210730,EXP,,CN-ASTRAZENECA-2021A637332,ASTRAZENECA,,49.0,YR,,M,Y,55.0,KG,20210730.0,,HP,CN,CN,2021,Q3,Adult
196473583,19647358,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"3 DF, QD",,,,,,,,3.0,DF,,QD,2021,Q3,Pneumonia,,2021,Q3,3,F,20210721.0,20210921.0,20210802,20210928,EXP,,US-GLAXOSMITHKLINE-US2021GSK159888,GLAXOSMITHKLINE,,75.0,YR,,M,Y,,,20210928.0,,MD,US,US,2021,Q3,Elderly
196473583,19647358,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"3 DF, QD",,,,,,,,3.0,DF,,QD,2021,Q3,Pulmonary oedema,,2021,Q3,3,F,20210721.0,20210921.0,20210802,20210928,EXP,,US-GLAXOSMITHKLINE-US2021GSK159888,GLAXOSMITHKLINE,,75.0,YR,,M,Y,,,20210928.0,,MD,US,US,2021,Q3,Elderly
196483661,19648366,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q3,C-reactive protein increased,,2021,Q3,1,I,,20210725.0,20210802,20210802,EXP,,CA-SA-2021SA251922,SANOFI AVENTIS,,49.0,YR,A,F,Y,,,20210802.0,,HP,CA,CA,2021,Q3,Adult
196483661,19648366,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q3,Dactylitis,,2021,Q3,1,I,,20210725.0,20210802,20210802,EXP,,CA-SA-2021SA251922,SANOFI AVENTIS,,49.0,YR,A,F,Y,,,20210802.0,,HP,CA,CA,2021,Q3,Adult
196483661,19648366,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q3,Drug ineffective,,2021,Q3,1,I,,20210725.0,20210802,20210802,EXP,,CA-SA-2021SA251922,SANOFI AVENTIS,,49.0,YR,A,F,Y,,,20210802.0,,HP,CA,CA,2021,Q3,Adult
196483661,19648366,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q3,Herpes zoster,,2021,Q3,1,I,,20210725.0,20210802,20210802,EXP,,CA-SA-2021SA251922,SANOFI AVENTIS,,49.0,YR,A,F,Y,,,20210802.0,,HP,CA,CA,2021,Q3,Adult
196483661,19648366,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q3,Psoriasis,,2021,Q3,1,I,,20210725.0,20210802,20210802,EXP,,CA-SA-2021SA251922,SANOFI AVENTIS,,49.0,YR,A,F,Y,,,20210802.0,,HP,CA,CA,2021,Q3,Adult
196483661,19648366,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q3,Psoriatic arthropathy,,2021,Q3,1,I,,20210725.0,20210802,20210802,EXP,,CA-SA-2021SA251922,SANOFI AVENTIS,,49.0,YR,A,F,Y,,,20210802.0,,HP,CA,CA,2021,Q3,Adult
196483661,19648366,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q3,Rash,,2021,Q3,1,I,,20210725.0,20210802,20210802,EXP,,CA-SA-2021SA251922,SANOFI AVENTIS,,49.0,YR,A,F,Y,,,20210802.0,,HP,CA,CA,2021,Q3,Adult
196490591,19649059,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 DOSAGE FORM, QD",,,,,,,,12.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Anaemia,,2021,Q3,1,I,20210129.0,20210728.0,20210802,20210802,EXP,IT-MINISAL02-665233,IT-MYLANLABS-2021M1046988,MYLAN,,82.0,YR,,M,Y,,,20210802.0,,MD,IT,IT,2021,Q3,Elderly
196490591,19649059,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 DOSAGE FORM, QD",,,,,,,,12.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Drug interaction,,2021,Q3,1,I,20210129.0,20210728.0,20210802,20210802,EXP,IT-MINISAL02-665233,IT-MYLANLABS-2021M1046988,MYLAN,,82.0,YR,,M,Y,,,20210802.0,,MD,IT,IT,2021,Q3,Elderly
196513891,19651389,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,RECEIVED BASAL BOLUS INSULIN REGIMEN; 32U IN THE MORNING,,,U,U,,,,,,INJECTION,,2021,Q3,Diabetic neuropathy,,2021,Q3,1,I,,20210726.0,20210803,20210803,EXP,,PT-MYLANLABS-2021M1047946,MYLAN,"FERREIRA M, CAMOES G, GOMES JFF, FERREIRA DM. TREATMENT?INDUCED DIABETES NEUROPATHY: REMINDER OF AN IMPORTANT CLINICAL LESSON. BMJ?CASE?REP 2021?14(5):1?3.",32.0,YR,,M,Y,72.0,KG,20210803.0,,MD,PT,PT,2021,Q3,Young Adult
196513891,19651389,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,RECEIVED BASAL BOLUS INSULIN REGIMEN; 32U IN THE MORNING,,,U,U,,,,,,INJECTION,,2021,Q3,Drug ineffective,,2021,Q3,1,I,,20210726.0,20210803,20210803,EXP,,PT-MYLANLABS-2021M1047946,MYLAN,"FERREIRA M, CAMOES G, GOMES JFF, FERREIRA DM. TREATMENT?INDUCED DIABETES NEUROPATHY: REMINDER OF AN IMPORTANT CLINICAL LESSON. BMJ?CASE?REP 2021?14(5):1?3.",32.0,YR,,M,Y,72.0,KG,20210803.0,,MD,PT,PT,2021,Q3,Young Adult
196513891,19651389,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,RECEIVED BASAL BOLUS INSULIN REGIMEN; 32U IN THE MORNING,,,U,U,,,,,,INJECTION,,2021,Q3,Intentional product misuse,,2021,Q3,1,I,,20210726.0,20210803,20210803,EXP,,PT-MYLANLABS-2021M1047946,MYLAN,"FERREIRA M, CAMOES G, GOMES JFF, FERREIRA DM. TREATMENT?INDUCED DIABETES NEUROPATHY: REMINDER OF AN IMPORTANT CLINICAL LESSON. BMJ?CASE?REP 2021?14(5):1?3.",32.0,YR,,M,Y,72.0,KG,20210803.0,,MD,PT,PT,2021,Q3,Young Adult
196519133,19651913,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,,, 1F939A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose decreased,,2021,Q3,3,F,20210818.0,20210830.0,20210803,20210910,EXP,,ES-BAUSCH-BL-2021-025662,BAUSCH AND LOMB,,72.0,YR,,F,Y,80.0,KG,20210910.0,,CN,ES,ES,2021,Q3,Elderly
196519133,19651913,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,,, 1F939A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,3,F,20210818.0,20210830.0,20210803,20210910,EXP,,ES-BAUSCH-BL-2021-025662,BAUSCH AND LOMB,,72.0,YR,,F,Y,80.0,KG,20210910.0,,CN,ES,ES,2021,Q3,Elderly
196519133,19651913,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,,, 1F939A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Confusional state,,2021,Q3,3,F,20210818.0,20210830.0,20210803,20210910,EXP,,ES-BAUSCH-BL-2021-025662,BAUSCH AND LOMB,,72.0,YR,,F,Y,80.0,KG,20210910.0,,CN,ES,ES,2021,Q3,Elderly
196519133,19651913,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,,, 1F939A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Fear,,2021,Q3,3,F,20210818.0,20210830.0,20210803,20210910,EXP,,ES-BAUSCH-BL-2021-025662,BAUSCH AND LOMB,,72.0,YR,,F,Y,80.0,KG,20210910.0,,CN,ES,ES,2021,Q3,Elderly
196519133,19651913,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,,, 1F939A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Head discomfort,,2021,Q3,3,F,20210818.0,20210830.0,20210803,20210910,EXP,,ES-BAUSCH-BL-2021-025662,BAUSCH AND LOMB,,72.0,YR,,F,Y,80.0,KG,20210910.0,,CN,ES,ES,2021,Q3,Elderly
196519133,19651913,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,,, 1F939A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hyperglycaemia,,2021,Q3,3,F,20210818.0,20210830.0,20210803,20210910,EXP,,ES-BAUSCH-BL-2021-025662,BAUSCH AND LOMB,,72.0,YR,,F,Y,80.0,KG,20210910.0,,CN,ES,ES,2021,Q3,Elderly
196519133,19651913,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,,, 1F939A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hyperhidrosis,,2021,Q3,3,F,20210818.0,20210830.0,20210803,20210910,EXP,,ES-BAUSCH-BL-2021-025662,BAUSCH AND LOMB,,72.0,YR,,F,Y,80.0,KG,20210910.0,,CN,ES,ES,2021,Q3,Elderly
196519133,19651913,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,,, 1F939A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hypoglycaemia,,2021,Q3,3,F,20210818.0,20210830.0,20210803,20210910,EXP,,ES-BAUSCH-BL-2021-025662,BAUSCH AND LOMB,,72.0,YR,,F,Y,80.0,KG,20210910.0,,CN,ES,ES,2021,Q3,Elderly
196519133,19651913,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,,, 1F939A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Product storage error,,2021,Q3,3,F,20210818.0,20210830.0,20210803,20210910,EXP,,ES-BAUSCH-BL-2021-025662,BAUSCH AND LOMB,,72.0,YR,,F,Y,80.0,KG,20210910.0,,CN,ES,ES,2021,Q3,Elderly
196519133,19651913,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,,, 1F939A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Tremor,,2021,Q3,3,F,20210818.0,20210830.0,20210803,20210910,EXP,,ES-BAUSCH-BL-2021-025662,BAUSCH AND LOMB,,72.0,YR,,F,Y,80.0,KG,20210910.0,,CN,ES,ES,2021,Q3,Elderly
196519133,19651913,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,,, 1F939A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Weight fluctuation,,2021,Q3,3,F,20210818.0,20210830.0,20210803,20210910,EXP,,ES-BAUSCH-BL-2021-025662,BAUSCH AND LOMB,,72.0,YR,,F,Y,80.0,KG,20210910.0,,CN,ES,ES,2021,Q3,Elderly
196519133,19651913,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE INCREASED,,,,, 1F939A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose decreased,,2021,Q3,3,F,20210818.0,20210830.0,20210803,20210910,EXP,,ES-BAUSCH-BL-2021-025662,BAUSCH AND LOMB,,72.0,YR,,F,Y,80.0,KG,20210910.0,,CN,ES,ES,2021,Q3,Elderly
196519133,19651913,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE INCREASED,,,,, 1F939A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,3,F,20210818.0,20210830.0,20210803,20210910,EXP,,ES-BAUSCH-BL-2021-025662,BAUSCH AND LOMB,,72.0,YR,,F,Y,80.0,KG,20210910.0,,CN,ES,ES,2021,Q3,Elderly
196519133,19651913,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE INCREASED,,,,, 1F939A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Confusional state,,2021,Q3,3,F,20210818.0,20210830.0,20210803,20210910,EXP,,ES-BAUSCH-BL-2021-025662,BAUSCH AND LOMB,,72.0,YR,,F,Y,80.0,KG,20210910.0,,CN,ES,ES,2021,Q3,Elderly
196519133,19651913,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE INCREASED,,,,, 1F939A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Fear,,2021,Q3,3,F,20210818.0,20210830.0,20210803,20210910,EXP,,ES-BAUSCH-BL-2021-025662,BAUSCH AND LOMB,,72.0,YR,,F,Y,80.0,KG,20210910.0,,CN,ES,ES,2021,Q3,Elderly
196519133,19651913,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE INCREASED,,,,, 1F939A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Head discomfort,,2021,Q3,3,F,20210818.0,20210830.0,20210803,20210910,EXP,,ES-BAUSCH-BL-2021-025662,BAUSCH AND LOMB,,72.0,YR,,F,Y,80.0,KG,20210910.0,,CN,ES,ES,2021,Q3,Elderly
196519133,19651913,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE INCREASED,,,,, 1F939A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Hyperglycaemia,,2021,Q3,3,F,20210818.0,20210830.0,20210803,20210910,EXP,,ES-BAUSCH-BL-2021-025662,BAUSCH AND LOMB,,72.0,YR,,F,Y,80.0,KG,20210910.0,,CN,ES,ES,2021,Q3,Elderly
196519133,19651913,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE INCREASED,,,,, 1F939A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Hyperhidrosis,,2021,Q3,3,F,20210818.0,20210830.0,20210803,20210910,EXP,,ES-BAUSCH-BL-2021-025662,BAUSCH AND LOMB,,72.0,YR,,F,Y,80.0,KG,20210910.0,,CN,ES,ES,2021,Q3,Elderly
196519133,19651913,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE INCREASED,,,,, 1F939A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Hypoglycaemia,,2021,Q3,3,F,20210818.0,20210830.0,20210803,20210910,EXP,,ES-BAUSCH-BL-2021-025662,BAUSCH AND LOMB,,72.0,YR,,F,Y,80.0,KG,20210910.0,,CN,ES,ES,2021,Q3,Elderly
196519133,19651913,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE INCREASED,,,,, 1F939A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Product storage error,,2021,Q3,3,F,20210818.0,20210830.0,20210803,20210910,EXP,,ES-BAUSCH-BL-2021-025662,BAUSCH AND LOMB,,72.0,YR,,F,Y,80.0,KG,20210910.0,,CN,ES,ES,2021,Q3,Elderly
196519133,19651913,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE INCREASED,,,,, 1F939A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Tremor,,2021,Q3,3,F,20210818.0,20210830.0,20210803,20210910,EXP,,ES-BAUSCH-BL-2021-025662,BAUSCH AND LOMB,,72.0,YR,,F,Y,80.0,KG,20210910.0,,CN,ES,ES,2021,Q3,Elderly
196519133,19651913,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE INCREASED,,,,, 1F939A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Weight fluctuation,,2021,Q3,3,F,20210818.0,20210830.0,20210803,20210910,EXP,,ES-BAUSCH-BL-2021-025662,BAUSCH AND LOMB,,72.0,YR,,F,Y,80.0,KG,20210910.0,,CN,ES,ES,2021,Q3,Elderly
196523231,19652323,16,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, QD (40 UNITS)",,,D,, UNKNOWN,,,,,,QD,2021,Q3,Acute kidney injury,,2021,Q3,1,I,,20210721.0,20210803,20210803,PER,,US-LUPIN PHARMACEUTICALS INC.-2021-13587,LUPIN,,35.0,YR,,F,Y,,,20210803.0,,HP,US,US,2021,Q3,Adult
196523231,19652323,16,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, QD (40 UNITS)",,,D,, UNKNOWN,,,,,,QD,2021,Q3,Exposure during pregnancy,,2021,Q3,1,I,,20210721.0,20210803,20210803,PER,,US-LUPIN PHARMACEUTICALS INC.-2021-13587,LUPIN,,35.0,YR,,F,Y,,,20210803.0,,HP,US,US,2021,Q3,Adult
196541021,19654102,13,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,25 INTERNATIONAL UNIT DAILY,,,,,,,,25.0,IU,,,2021,Q3,Calciphylaxis,,2021,Q3,1,I,,20210727.0,20210804,20210804,EXP,,US-STRIDES ARCOLAB LIMITED-2021SP025870,STRIDES,"ADAPA S, NARAMALA S, GAYAM V, KODURI NM, DAGGUBATI SR, PATEL P, ET AL. CALCIPHYLAXIS IN A PATIENT ON HOME HEMODIALYSIS. J?INVESTIG?MED?HIGH?IMPACT?CASE?REP. 2020",51.0,YR,,F,Y,,,20210804.0,,MD,US,US,2021,Q3,Adult
196541021,19654102,13,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,25 INTERNATIONAL UNIT DAILY,,,,,,,,25.0,IU,,,2021,Q3,Off label use,,2021,Q3,1,I,,20210727.0,20210804,20210804,EXP,,US-STRIDES ARCOLAB LIMITED-2021SP025870,STRIDES,"ADAPA S, NARAMALA S, GAYAM V, KODURI NM, DAGGUBATI SR, PATEL P, ET AL. CALCIPHYLAXIS IN A PATIENT ON HOME HEMODIALYSIS. J?INVESTIG?MED?HIGH?IMPACT?CASE?REP. 2020",51.0,YR,,F,Y,,,20210804.0,,MD,US,US,2021,Q3,Adult
196543701,19654370,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"148 IU, QD (120 IU EARLY AND 28 IU AT 10 PM)",,,,, UNKNOWN,,,148.0,IU,,QD,2021,Q3,Amaurosis,,2021,Q3,1,I,,20210726.0,20210804,20210804,EXP,,BR-NOVOPROD-833828,NOVO NORDISK,,81.0,YR,,M,Y,85.0,KG,20210804.0,,MD,BR,BR,2021,Q3,Elderly
196546091,19654609,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,1,I,,20210729.0,20210804,20210804,EXP,,ES-AUROBINDO-AUR-APL-2021-033501,AUROBINDO,,77.0,YR,,M,Y,67.0,KG,20210804.0,,CN,ES,ES,2021,Q3,Elderly
196546091,19654609,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Drug ineffective,,2021,Q3,1,I,,20210729.0,20210804,20210804,EXP,,ES-AUROBINDO-AUR-APL-2021-033501,AUROBINDO,,77.0,YR,,M,Y,67.0,KG,20210804.0,,CN,ES,ES,2021,Q3,Elderly
196546091,19654609,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Renal injury,,2021,Q3,1,I,,20210729.0,20210804,20210804,EXP,,ES-AUROBINDO-AUR-APL-2021-033501,AUROBINDO,,77.0,YR,,M,Y,67.0,KG,20210804.0,,CN,ES,ES,2021,Q3,Elderly
196546091,19654609,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"36 INTERNATIONAL UNIT, ONCE A DAY",,,,, 1F850A,,,36.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,1,I,,20210729.0,20210804,20210804,EXP,,ES-AUROBINDO-AUR-APL-2021-033501,AUROBINDO,,77.0,YR,,M,Y,67.0,KG,20210804.0,,CN,ES,ES,2021,Q3,Elderly
196546091,19654609,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"36 INTERNATIONAL UNIT, ONCE A DAY",,,,, 1F850A,,,36.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Drug ineffective,,2021,Q3,1,I,,20210729.0,20210804,20210804,EXP,,ES-AUROBINDO-AUR-APL-2021-033501,AUROBINDO,,77.0,YR,,M,Y,67.0,KG,20210804.0,,CN,ES,ES,2021,Q3,Elderly
196546091,19654609,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"36 INTERNATIONAL UNIT, ONCE A DAY",,,,, 1F850A,,,36.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Renal injury,,2021,Q3,1,I,,20210729.0,20210804,20210804,EXP,,ES-AUROBINDO-AUR-APL-2021-033501,AUROBINDO,,77.0,YR,,M,Y,67.0,KG,20210804.0,,CN,ES,ES,2021,Q3,Elderly
196566951,19656695,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q3,Loss of consciousness,,2021,Q3,1,I,,20210726.0,20210804,20210804,EXP,,DE-ACCORD-233792,ACCORD,"HECK J, GROH A, STICHTENOTH DO, BLEICH S, KRAUSE O. LOOK?ALIKES, SOUND?ALIKES: THREE CASES OF INSIDIOUS MEDICATION ERRORS. CLINICAL CASE REPORTS. 2020?8(12):3284?7. DOI: 10.1002/CCR3.3409",80.0,YR,,F,Y,,,20210804.0,,HP,DE,DE,2021,Q3,Elderly
196566951,19656695,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q3,Procalcitonin increased,,2021,Q3,1,I,,20210726.0,20210804,20210804,EXP,,DE-ACCORD-233792,ACCORD,"HECK J, GROH A, STICHTENOTH DO, BLEICH S, KRAUSE O. LOOK?ALIKES, SOUND?ALIKES: THREE CASES OF INSIDIOUS MEDICATION ERRORS. CLINICAL CASE REPORTS. 2020?8(12):3284?7. DOI: 10.1002/CCR3.3409",80.0,YR,,F,Y,,,20210804.0,,HP,DE,DE,2021,Q3,Elderly
196566951,19656695,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q3,Product dispensing error,,2021,Q3,1,I,,20210726.0,20210804,20210804,EXP,,DE-ACCORD-233792,ACCORD,"HECK J, GROH A, STICHTENOTH DO, BLEICH S, KRAUSE O. LOOK?ALIKES, SOUND?ALIKES: THREE CASES OF INSIDIOUS MEDICATION ERRORS. CLINICAL CASE REPORTS. 2020?8(12):3284?7. DOI: 10.1002/CCR3.3409",80.0,YR,,F,Y,,,20210804.0,,HP,DE,DE,2021,Q3,Elderly
196571621,19657162,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q3,Facial paresis,,2021,Q3,1,I,20210304.0,20210726.0,20210804,20210804,EXP,,DE-FRESENIUS KABI-FK202107976,FRESENIUS KABI,,70.0,YR,,F,Y,,,20210804.0,,HP,NL,DE,2021,Q3,Elderly
196598632,19659863,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"32 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Anxiety,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"32 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Asthenia,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"32 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose fluctuation,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"32 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"32 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Cerebrovascular accident,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"32 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Chest discomfort,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"32 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Dizziness,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"32 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Dry mouth,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"32 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Headache,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"32 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hemiparesis,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"32 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hyperglycaemia,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"32 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hypoglycaemia,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"32 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Intentional product use issue,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"32 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Intracardiac thrombus,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"32 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Multiple use of single-use product,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"32 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Neck pain,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"32 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Nervousness,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"32 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Pain,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"32 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Product storage error,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"32 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Psychiatric symptom,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"32 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Rash macular,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"32 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Self-injurious ideation,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"32 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Speech disorder,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"32 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Visual acuity reduced,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"42 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Anxiety,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"42 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Asthenia,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"42 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose fluctuation,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"42 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"42 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Cerebrovascular accident,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"42 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Chest discomfort,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"42 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Dizziness,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"42 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Dry mouth,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"42 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Headache,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"42 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hemiparesis,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"42 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hyperglycaemia,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"42 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hypoglycaemia,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"42 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Intentional product use issue,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"42 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Intracardiac thrombus,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"42 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Multiple use of single-use product,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"42 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Neck pain,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"42 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Nervousness,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"42 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Pain,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"42 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Product storage error,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"42 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Psychiatric symptom,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"42 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Rash macular,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"42 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Self-injurious ideation,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"42 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Speech disorder,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"42 INTERNATIONAL UNIT, ONCE A DAY",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Visual acuity reduced,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Anxiety,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Asthenia,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose fluctuation,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Cerebrovascular accident,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Chest discomfort,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Dizziness,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Dry mouth,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Headache,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hemiparesis,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hyperglycaemia,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hypoglycaemia,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Intentional product use issue,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Intracardiac thrombus,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Multiple use of single-use product,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Neck pain,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Nervousness,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Pain,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Product storage error,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Psychiatric symptom,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Rash macular,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Self-injurious ideation,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Speech disorder,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Visual acuity reduced,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,26 INTERNATIONAL UNIT,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Anxiety,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,26 INTERNATIONAL UNIT,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Asthenia,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,26 INTERNATIONAL UNIT,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose fluctuation,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,26 INTERNATIONAL UNIT,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,26 INTERNATIONAL UNIT,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Cerebrovascular accident,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,26 INTERNATIONAL UNIT,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Chest discomfort,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,26 INTERNATIONAL UNIT,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Dizziness,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,26 INTERNATIONAL UNIT,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Dry mouth,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,26 INTERNATIONAL UNIT,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Headache,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,26 INTERNATIONAL UNIT,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hemiparesis,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,26 INTERNATIONAL UNIT,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hyperglycaemia,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,26 INTERNATIONAL UNIT,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hypoglycaemia,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,26 INTERNATIONAL UNIT,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Intentional product use issue,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,26 INTERNATIONAL UNIT,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Intracardiac thrombus,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,26 INTERNATIONAL UNIT,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Multiple use of single-use product,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,26 INTERNATIONAL UNIT,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Neck pain,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,26 INTERNATIONAL UNIT,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Nervousness,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,26 INTERNATIONAL UNIT,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Pain,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,26 INTERNATIONAL UNIT,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Product storage error,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,26 INTERNATIONAL UNIT,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Psychiatric symptom,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,26 INTERNATIONAL UNIT,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Rash macular,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,26 INTERNATIONAL UNIT,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Self-injurious ideation,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,26 INTERNATIONAL UNIT,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Speech disorder,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,26 INTERNATIONAL UNIT,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Visual acuity reduced,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"46 INTERNATIONAL UNIT, ONCE A DAY",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Anxiety,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"46 INTERNATIONAL UNIT, ONCE A DAY",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Asthenia,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"46 INTERNATIONAL UNIT, ONCE A DAY",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose fluctuation,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"46 INTERNATIONAL UNIT, ONCE A DAY",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"46 INTERNATIONAL UNIT, ONCE A DAY",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Cerebrovascular accident,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"46 INTERNATIONAL UNIT, ONCE A DAY",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Chest discomfort,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"46 INTERNATIONAL UNIT, ONCE A DAY",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Dizziness,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"46 INTERNATIONAL UNIT, ONCE A DAY",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Dry mouth,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"46 INTERNATIONAL UNIT, ONCE A DAY",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Headache,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"46 INTERNATIONAL UNIT, ONCE A DAY",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hemiparesis,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"46 INTERNATIONAL UNIT, ONCE A DAY",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hyperglycaemia,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"46 INTERNATIONAL UNIT, ONCE A DAY",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hypoglycaemia,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"46 INTERNATIONAL UNIT, ONCE A DAY",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Intentional product use issue,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"46 INTERNATIONAL UNIT, ONCE A DAY",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Intracardiac thrombus,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"46 INTERNATIONAL UNIT, ONCE A DAY",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Multiple use of single-use product,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"46 INTERNATIONAL UNIT, ONCE A DAY",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Neck pain,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"46 INTERNATIONAL UNIT, ONCE A DAY",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Nervousness,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"46 INTERNATIONAL UNIT, ONCE A DAY",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Pain,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"46 INTERNATIONAL UNIT, ONCE A DAY",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Product storage error,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"46 INTERNATIONAL UNIT, ONCE A DAY",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Psychiatric symptom,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"46 INTERNATIONAL UNIT, ONCE A DAY",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Rash macular,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"46 INTERNATIONAL UNIT, ONCE A DAY",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Self-injurious ideation,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"46 INTERNATIONAL UNIT, ONCE A DAY",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Speech disorder,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196598632,19659863,7,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"46 INTERNATIONAL UNIT, ONCE A DAY",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Visual acuity reduced,,2021,Q3,2,F,20210815.0,20210827.0,20210805,20210907,EXP,,ES-AUROBINDO-AUR-APL-2021-032926,AUROBINDO,,48.0,YR,,F,Y,67.8,KG,20210907.0,,HP,ES,ES,2021,Q3,Adult
196603161,19660316,11,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, QD; 25 UNITS",,,U,U,,,,,,,QD,2021,Q3,Calciphylaxis,,2021,Q3,1,I,,20210727.0,20210805,20210805,EXP,,US-MYLANLABS-2021M1048022,MYLAN,"ADAPA S, NARAMALA S, GAYAM V, KODURI NM, DAGGUBATI SR, PATEL P, ET AL. CALCIPHYLAXIS IN A PATIENT ON HOME HEMODIALYSIS. J?INVESTIG?MED?HIGH?IMPACT?CASE?REP 2020?NULL:NULL.",51.0,YR,,F,Y,,,20210805.0,,MD,US,US,2021,Q3,Adult
196603161,19660316,11,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, QD; 25 UNITS",,,U,U,,,,,,,QD,2021,Q3,Emotional distress,,2021,Q3,1,I,,20210727.0,20210805,20210805,EXP,,US-MYLANLABS-2021M1048022,MYLAN,"ADAPA S, NARAMALA S, GAYAM V, KODURI NM, DAGGUBATI SR, PATEL P, ET AL. CALCIPHYLAXIS IN A PATIENT ON HOME HEMODIALYSIS. J?INVESTIG?MED?HIGH?IMPACT?CASE?REP 2020?NULL:NULL.",51.0,YR,,F,Y,,,20210805.0,,MD,US,US,2021,Q3,Adult
196610731,19661073,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,BASAL INSULIN GLARGINE,,,U,,,,,,,,,2021,Q3,Drug eruption,,2021,Q3,1,I,,20210729.0,20210805,20210805,EXP,,US-SA-2021SA253128,SANOFI AVENTIS,"FEIN LC, PRESSWALA LS, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R.. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES IN PATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATR BLOOD CANCER.. 2021?68(2):1?5",23.0,YR,A,M,Y,,,20210805.0,,HP,US,US,2021,Q3,Youth
196610731,19661073,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,BASAL INSULIN GLARGINE,,,U,,,,,,,,,2021,Q3,Pancytopenia,,2021,Q3,1,I,,20210729.0,20210805,20210805,EXP,,US-SA-2021SA253128,SANOFI AVENTIS,"FEIN LC, PRESSWALA LS, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R.. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES IN PATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATR BLOOD CANCER.. 2021?68(2):1?5",23.0,YR,A,M,Y,,,20210805.0,,HP,US,US,2021,Q3,Youth
196610731,19661073,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,BASAL INSULIN GLARGINE,,,U,,,,,,,,,2021,Q3,Pulmonary oedema,,2021,Q3,1,I,,20210729.0,20210805,20210805,EXP,,US-SA-2021SA253128,SANOFI AVENTIS,"FEIN LC, PRESSWALA LS, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R.. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES IN PATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATR BLOOD CANCER.. 2021?68(2):1?5",23.0,YR,A,M,Y,,,20210805.0,,HP,US,US,2021,Q3,Youth
196610731,19661073,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,BASAL INSULIN GLARGINE,,,U,,,,,,,,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210729.0,20210805,20210805,EXP,,US-SA-2021SA253128,SANOFI AVENTIS,"FEIN LC, PRESSWALA LS, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R.. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES IN PATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATR BLOOD CANCER.. 2021?68(2):1?5",23.0,YR,A,M,Y,,,20210805.0,,HP,US,US,2021,Q3,Youth
196612911,19661291,25,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Cardiac failure congestive,,2021,Q3,1,I,202105.0,,20210805,20210805,DIR,,,FDA-CTU,,61.0,YR,,F,N,,,20210804.0,Y,CN,US,US,2021,Q3,Adult
196612911,19661291,25,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Myocardial infarction,,2021,Q3,1,I,202105.0,,20210805,20210805,DIR,,,FDA-CTU,,61.0,YR,,F,N,,,20210804.0,Y,CN,US,US,2021,Q3,Adult
196629071,19662907,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q3,Acute kidney injury,Acute kidney injury,2021,Q3,1,I,,20210801.0,20210806,20210806,EXP,,US-PHARMGEN-000010,PHARMGEN,,48.0,YR,A,F,Y,,,20210805.0,,HP,US,US,2021,Q3,Adult
196629071,19662907,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q3,Brugada syndrome,Brugada syndrome,2021,Q3,1,I,,20210801.0,20210806,20210806,EXP,,US-PHARMGEN-000010,PHARMGEN,,48.0,YR,A,F,Y,,,20210805.0,,HP,US,US,2021,Q3,Adult
196629071,19662907,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q3,Drug interaction,Drug interaction,2021,Q3,1,I,,20210801.0,20210806,20210806,EXP,,US-PHARMGEN-000010,PHARMGEN,,48.0,YR,A,F,Y,,,20210805.0,,HP,US,US,2021,Q3,Adult
196629071,19662907,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q3,Toxicity to various agents,Toxicity to various agents,2021,Q3,1,I,,20210801.0,20210806,20210806,EXP,,US-PHARMGEN-000010,PHARMGEN,,48.0,YR,A,F,Y,,,20210805.0,,HP,US,US,2021,Q3,Adult
196643401,19664340,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"1 INTERNATIONAL UNIT, UNKNOWN",,,U,,,,,1.0,IU,,,2021,Q3,Acute respiratory failure,,2021,Q3,1,I,,20210730.0,20210805,20210805,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202107013221,ELI LILLY AND CO,,56.0,YR,,F,Y,105.0,KG,20210805.0,,PH,DE,DE,2021,Q3,Adult
196643401,19664340,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"1 INTERNATIONAL UNIT, UNKNOWN",,,U,,,,,1.0,IU,,,2021,Q3,Condition aggravated,,2021,Q3,1,I,,20210730.0,20210805,20210805,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202107013221,ELI LILLY AND CO,,56.0,YR,,F,Y,105.0,KG,20210805.0,,PH,DE,DE,2021,Q3,Adult
196643401,19664340,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"1 INTERNATIONAL UNIT, UNKNOWN",,,U,,,,,1.0,IU,,,2021,Q3,Cough,,2021,Q3,1,I,,20210730.0,20210805,20210805,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202107013221,ELI LILLY AND CO,,56.0,YR,,F,Y,105.0,KG,20210805.0,,PH,DE,DE,2021,Q3,Adult
196643401,19664340,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"1 INTERNATIONAL UNIT, UNKNOWN",,,U,,,,,1.0,IU,,,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20210730.0,20210805,20210805,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202107013221,ELI LILLY AND CO,,56.0,YR,,F,Y,105.0,KG,20210805.0,,PH,DE,DE,2021,Q3,Adult
196643401,19664340,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"1 INTERNATIONAL UNIT, UNKNOWN",,,U,,,,,1.0,IU,,,2021,Q3,Hypoxia,,2021,Q3,1,I,,20210730.0,20210805,20210805,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202107013221,ELI LILLY AND CO,,56.0,YR,,F,Y,105.0,KG,20210805.0,,PH,DE,DE,2021,Q3,Adult
196643401,19664340,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"1 INTERNATIONAL UNIT, UNKNOWN",,,U,,,,,1.0,IU,,,2021,Q3,Product administration error,,2021,Q3,1,I,,20210730.0,20210805,20210805,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202107013221,ELI LILLY AND CO,,56.0,YR,,F,Y,105.0,KG,20210805.0,,PH,DE,DE,2021,Q3,Adult
196658861,19665886,5,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"11 INTERNATIONAL UNIT, DAILY, FOR MORE THAN 1 YEAR",,,,,,,,11.0,IU,,QD,2021,Q3,Neuroleptic malignant syndrome,,2021,Q3,1,I,,20210726.0,20210806,20210806,PER,,TR-LUPIN PHARMACEUTICALS INC.-2021-13730,LUPIN,,84.0,YR,,M,Y,,,20210806.0,,HP,TR,TR,2021,Q3,Elderly
196662011,19666201,10,C,INSULIN GLARGINE;LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Brain natriuretic peptide increased,,2021,Q3,1,I,20200619.0,20210729.0,20210806,20210806,EXP,,US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2021-000257,VALIDUS,,65.0,YR,,M,Y,,,20210806.0,,CN,CH,US,2021,Q3,Elderly
196662011,19666201,10,C,INSULIN GLARGINE;LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Cardiac failure chronic,,2021,Q3,1,I,20200619.0,20210729.0,20210806,20210806,EXP,,US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2021-000257,VALIDUS,,65.0,YR,,M,Y,,,20210806.0,,CN,CH,US,2021,Q3,Elderly
196667661,19666766,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,11 UNITS/DAY,,,,,,,,,,,,2021,Q3,Drug interaction,,2021,Q3,1,I,,20210728.0,20210806,20210806,EXP,,TR-STRIDES ARCOLAB LIMITED-2021SP025884,STRIDES,"OZCELIK EROGLU E, YILDIZ MI, YAZICI MK. ATYPICAL NEUROLEPTIC MALIGNANT SYNDROME INDUCED BY LOW DOSE QUETIAPINE IN A PATIENT TREATED WITH DONEPEZIL. NOROPSIKIYATRI?ARSIVI. 2021?58(2):166?168",84.0,YR,,M,Y,,,20210806.0,,HP,TR,TR,2021,Q3,Elderly
196667661,19666766,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,11 UNITS/DAY,,,,,,,,,,,,2021,Q3,Neuroleptic malignant syndrome,,2021,Q3,1,I,,20210728.0,20210806,20210806,EXP,,TR-STRIDES ARCOLAB LIMITED-2021SP025884,STRIDES,"OZCELIK EROGLU E, YILDIZ MI, YAZICI MK. ATYPICAL NEUROLEPTIC MALIGNANT SYNDROME INDUCED BY LOW DOSE QUETIAPINE IN A PATIENT TREATED WITH DONEPEZIL. NOROPSIKIYATRI?ARSIVI. 2021?58(2):166?168",84.0,YR,,M,Y,,,20210806.0,,HP,TR,TR,2021,Q3,Elderly
196688262,19668826,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,, UNKNOWN,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Anxiety,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,, UNKNOWN,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Asthenia,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,, UNKNOWN,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose fluctuation,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,, UNKNOWN,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,, UNKNOWN,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Cerebrovascular accident,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,, UNKNOWN,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Chest discomfort,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,, UNKNOWN,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Dizziness,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,, UNKNOWN,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Dry mouth,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,, UNKNOWN,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Headache,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,, UNKNOWN,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hemiparesis,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,, UNKNOWN,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hyperglycaemia,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,, UNKNOWN,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hypoglycaemia,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,, UNKNOWN,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Intentional product use issue,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,, UNKNOWN,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Intracardiac thrombus,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,, UNKNOWN,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Multiple use of single-use product,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,, UNKNOWN,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Neck pain,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,, UNKNOWN,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Nervousness,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,, UNKNOWN,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Pain,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,, UNKNOWN,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Product storage error,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,, UNKNOWN,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Psychiatric symptom,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,, UNKNOWN,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Rash macular,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,, UNKNOWN,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Self-injurious ideation,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,, UNKNOWN,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Speech disorder,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,, UNKNOWN,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Visual acuity reduced,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Anxiety,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Asthenia,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose fluctuation,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Cerebrovascular accident,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Chest discomfort,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Dizziness,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Dry mouth,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Headache,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hemiparesis,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hyperglycaemia,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hypoglycaemia,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Intentional product use issue,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Intracardiac thrombus,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Multiple use of single-use product,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Neck pain,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Nervousness,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Pain,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Product storage error,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Psychiatric symptom,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Rash macular,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Self-injurious ideation,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Speech disorder,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Visual acuity reduced,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,, UNKNOWN,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Anxiety,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,, UNKNOWN,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Asthenia,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,, UNKNOWN,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose fluctuation,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,, UNKNOWN,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,, UNKNOWN,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Cerebrovascular accident,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,, UNKNOWN,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Chest discomfort,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,, UNKNOWN,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Dizziness,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,, UNKNOWN,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Dry mouth,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,, UNKNOWN,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Headache,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,, UNKNOWN,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hemiparesis,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,, UNKNOWN,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hyperglycaemia,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,, UNKNOWN,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hypoglycaemia,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,, UNKNOWN,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Intentional product use issue,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,, UNKNOWN,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Intracardiac thrombus,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,, UNKNOWN,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Multiple use of single-use product,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,, UNKNOWN,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Neck pain,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,, UNKNOWN,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Nervousness,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,, UNKNOWN,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Pain,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,, UNKNOWN,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Product storage error,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,, UNKNOWN,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Psychiatric symptom,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,, UNKNOWN,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Rash macular,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,, UNKNOWN,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Self-injurious ideation,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,, UNKNOWN,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Speech disorder,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,, UNKNOWN,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Visual acuity reduced,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Anxiety,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Asthenia,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose fluctuation,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Cerebrovascular accident,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Chest discomfort,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Dizziness,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Dry mouth,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Headache,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hemiparesis,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hyperglycaemia,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hypoglycaemia,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Intentional product use issue,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Intracardiac thrombus,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Multiple use of single-use product,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Neck pain,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Nervousness,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Pain,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Product storage error,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Psychiatric symptom,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Rash macular,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Self-injurious ideation,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Speech disorder,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Visual acuity reduced,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Anxiety,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Asthenia,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose fluctuation,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Cerebrovascular accident,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Chest discomfort,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Dizziness,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Dry mouth,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Headache,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hemiparesis,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hyperglycaemia,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hypoglycaemia,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Intentional product use issue,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Intracardiac thrombus,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Multiple use of single-use product,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Neck pain,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Nervousness,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Pain,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Product storage error,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Psychiatric symptom,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Rash macular,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Self-injurious ideation,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Speech disorder,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196688262,19668826,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Visual acuity reduced,,2021,Q3,2,F,2021.0,20210830.0,20210806,20210909,EXP,,ES-PFIZER INC-202100946861,PFIZER,,48.0,YR,,F,Y,67.8,KG,20210909.0,,HP,ES,ES,2021,Q3,Adult
196692491,19669249,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 IU,,,D,,,,21081.0,1.0,IU,,,2021,Q3,Acute respiratory failure,,2021,Q3,1,I,,20210804.0,20210806,20210806,EXP,,DE-SA-2021SA260866,SANOFI AVENTIS,,56.0,YR,A,F,Y,105.0,KG,20210806.0,,PH,DE,DE,2021,Q3,Adult
196692491,19669249,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 IU,,,D,,,,21081.0,1.0,IU,,,2021,Q3,Condition aggravated,,2021,Q3,1,I,,20210804.0,20210806,20210806,EXP,,DE-SA-2021SA260866,SANOFI AVENTIS,,56.0,YR,A,F,Y,105.0,KG,20210806.0,,PH,DE,DE,2021,Q3,Adult
196692491,19669249,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 IU,,,D,,,,21081.0,1.0,IU,,,2021,Q3,Cough,,2021,Q3,1,I,,20210804.0,20210806,20210806,EXP,,DE-SA-2021SA260866,SANOFI AVENTIS,,56.0,YR,A,F,Y,105.0,KG,20210806.0,,PH,DE,DE,2021,Q3,Adult
196692491,19669249,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 IU,,,D,,,,21081.0,1.0,IU,,,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20210804.0,20210806,20210806,EXP,,DE-SA-2021SA260866,SANOFI AVENTIS,,56.0,YR,A,F,Y,105.0,KG,20210806.0,,PH,DE,DE,2021,Q3,Adult
196692491,19669249,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 IU,,,D,,,,21081.0,1.0,IU,,,2021,Q3,Hypoxia,,2021,Q3,1,I,,20210804.0,20210806,20210806,EXP,,DE-SA-2021SA260866,SANOFI AVENTIS,,56.0,YR,A,F,Y,105.0,KG,20210806.0,,PH,DE,DE,2021,Q3,Adult
196692491,19669249,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 IU,,,D,,,,21081.0,1.0,IU,,,2021,Q3,Product administration error,,2021,Q3,1,I,,20210804.0,20210806,20210806,EXP,,DE-SA-2021SA260866,SANOFI AVENTIS,,56.0,YR,A,F,Y,105.0,KG,20210806.0,,PH,DE,DE,2021,Q3,Adult
196729042,19672904,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Anxiety,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Asthenia,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose fluctuation,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Cerebrovascular accident,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Chest discomfort,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Dizziness,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Dry mouth,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Headache,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hemiparesis,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hyperglycaemia,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hypoglycaemia,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Intentional product use issue,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Intracardiac thrombus,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Neck pain,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Nervousness,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Pain,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Product storage error,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Psychiatric symptom,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Rash macular,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Self-injurious ideation,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Speech disorder,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 IU, QD",,,Y,, 0F141,,,46.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Visual acuity reduced,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Anxiety,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Asthenia,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose fluctuation,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Cerebrovascular accident,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Chest discomfort,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Dizziness,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Dry mouth,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Headache,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hemiparesis,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hyperglycaemia,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hypoglycaemia,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Intentional product use issue,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Intracardiac thrombus,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Neck pain,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Nervousness,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Pain,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Product storage error,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Psychiatric symptom,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Rash macular,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Self-injurious ideation,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Speech disorder,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 IU, QD",,,Y,,,,,42.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Visual acuity reduced,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Anxiety,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Asthenia,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose fluctuation,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Cerebrovascular accident,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Chest discomfort,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Dizziness,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Dry mouth,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Headache,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hemiparesis,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hyperglycaemia,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hypoglycaemia,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Intentional product use issue,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Intracardiac thrombus,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Neck pain,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Nervousness,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Pain,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Product storage error,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Psychiatric symptom,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Rash macular,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Self-injurious ideation,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Speech disorder,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, QD",,,Y,,,,,32.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Visual acuity reduced,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Anxiety,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Asthenia,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose fluctuation,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Cerebrovascular accident,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Chest discomfort,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Dizziness,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Dry mouth,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Headache,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hemiparesis,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hyperglycaemia,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hypoglycaemia,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Intentional product use issue,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Intracardiac thrombus,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Neck pain,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Nervousness,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Pain,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Product storage error,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Psychiatric symptom,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Rash macular,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Self-injurious ideation,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Speech disorder,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,Y,, 0F731A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Visual acuity reduced,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Anxiety,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Asthenia,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose fluctuation,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Cerebrovascular accident,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Chest discomfort,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Dizziness,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Dry mouth,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Headache,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hemiparesis,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hyperglycaemia,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hypoglycaemia,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Intentional product use issue,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Intracardiac thrombus,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Neck pain,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Nervousness,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Pain,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Product storage error,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Psychiatric symptom,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Rash macular,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Self-injurious ideation,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Speech disorder,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196729042,19672904,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,Y,, 1F899A,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Visual acuity reduced,,2021,Q3,2,F,2021.0,20210830.0,20210809,20210910,EXP,ES-SA-SAC20210429001339,NVSC2021ES168222,NOVARTIS,,48.0,YR,,F,Y,67.8,KG,20210910.0,,HP,ES,ES,2021,Q3,Adult
196732211,19673221,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q3,Loss of consciousness,,2021,Q3,1,I,,20210726.0,20210809,20210809,EXP,,DE-AUROBINDO-AUR-APL-2021-032916,AUROBINDO,,80.0,YR,,F,Y,,,20210809.0,,HP,DE,DE,2021,Q3,Elderly
196732211,19673221,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q3,Procalcitonin increased,,2021,Q3,1,I,,20210726.0,20210809,20210809,EXP,,DE-AUROBINDO-AUR-APL-2021-032916,AUROBINDO,,80.0,YR,,F,Y,,,20210809.0,,HP,DE,DE,2021,Q3,Elderly
196732211,19673221,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q3,Product dispensing error,,2021,Q3,1,I,,20210726.0,20210809,20210809,EXP,,DE-AUROBINDO-AUR-APL-2021-032916,AUROBINDO,,80.0,YR,,F,Y,,,20210809.0,,HP,DE,DE,2021,Q3,Elderly
196737461,19673746,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Alopecia,,2021,Q3,1,I,20151123.0,20191220.0,20210809,20210809,EXP,,US-ACCORD-167492,ACCORD,,61.0,YR,,F,Y,,,20210807.0,,LW,US,US,2021,Q3,Adult
196749321,19674932,9,C,insulin glargine (Lantus) injection,,2,,,,,,,,,,,,,,2021,Q3,Cognitive disorder,,2021,Q3,1,I,20210528.0,,20210809,20210809,DIR,,,FDA-CTU,,66.0,YR,,M,N,107.0,KG,20210809.0,N,HP,US,US,2021,Q3,Elderly
196749321,19674932,9,C,insulin glargine (Lantus) injection,,2,,,,,,,,,,,,,,2021,Q3,Cytokine release syndrome,,2021,Q3,1,I,20210528.0,,20210809,20210809,DIR,,,FDA-CTU,,66.0,YR,,M,N,107.0,KG,20210809.0,N,HP,US,US,2021,Q3,Elderly
196749321,19674932,9,C,insulin glargine (Lantus) injection,,2,,,,,,,,,,,,,,2021,Q3,Cytomegalovirus viraemia,,2021,Q3,1,I,20210528.0,,20210809,20210809,DIR,,,FDA-CTU,,66.0,YR,,M,N,107.0,KG,20210809.0,N,HP,US,US,2021,Q3,Elderly
196749321,19674932,9,C,insulin glargine (Lantus) injection,,2,,,,,,,,,,,,,,2021,Q3,Dementia,,2021,Q3,1,I,20210528.0,,20210809,20210809,DIR,,,FDA-CTU,,66.0,YR,,M,N,107.0,KG,20210809.0,N,HP,US,US,2021,Q3,Elderly
196749321,19674932,9,C,insulin glargine (Lantus) injection,,2,,,,,,,,,,,,,,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,20210528.0,,20210809,20210809,DIR,,,FDA-CTU,,66.0,YR,,M,N,107.0,KG,20210809.0,N,HP,US,US,2021,Q3,Elderly
196749321,19674932,9,C,insulin glargine (Lantus) injection,,2,,,,,,,,,,,,,,2021,Q3,Immune effector cell-associated neurotoxicity syndrome,,2021,Q3,1,I,20210528.0,,20210809,20210809,DIR,,,FDA-CTU,,66.0,YR,,M,N,107.0,KG,20210809.0,N,HP,US,US,2021,Q3,Elderly
196749321,19674932,9,C,insulin glargine (Lantus) injection,,2,,,,,,,,,,,,,,2021,Q3,Urinary tract infection,,2021,Q3,1,I,20210528.0,,20210809,20210809,DIR,,,FDA-CTU,,66.0,YR,,M,N,107.0,KG,20210809.0,N,HP,US,US,2021,Q3,Elderly
196754751,19675475,14,C,Insuline Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Appendicitis perforated,,2021,Q3,1,I,20210429.0,20210802.0,20210809,20210809,EXP,,US-EXELIXIS-XL18421042981,EXELIXIS,,58.0,YR,,M,Y,112.0,KG,20210809.0,,MD,US,US,2021,Q3,Adult
196783078,19678307,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),,,,,,,,,100.0,IU,,,2021,Q3,Liver function test abnormal,,2021,Q3,8,F,20210727.0,20210916.0,20210809,20210922,EXP,,TR-ROCHE-2882466,ROCHE,,72.0,YR,,M,Y,67.5,KG,20210922.0,,MD,TR,TR,2021,Q3,Elderly
196783561,19678356,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Bronchitis,,2021,Q3,1,I,201901.0,20201230.0,20210810,20210810,EXP,,US-ABBVIE-20K-163-3713377-00,ABBVIE,,61.0,YR,,F,Y,64.47,KG,20210810.0,,CN,US,US,2021,Q3,Adult
196783561,19678356,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Knee arthroplasty,,2021,Q3,1,I,201901.0,20201230.0,20210810,20210810,EXP,,US-ABBVIE-20K-163-3713377-00,ABBVIE,,61.0,YR,,F,Y,64.47,KG,20210810.0,,CN,US,US,2021,Q3,Adult
196783561,19678356,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Nasopharyngitis,,2021,Q3,1,I,201901.0,20201230.0,20210810,20210810,EXP,,US-ABBVIE-20K-163-3713377-00,ABBVIE,,61.0,YR,,F,Y,64.47,KG,20210810.0,,CN,US,US,2021,Q3,Adult
196783561,19678356,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Post procedural swelling,,2021,Q3,1,I,201901.0,20201230.0,20210810,20210810,EXP,,US-ABBVIE-20K-163-3713377-00,ABBVIE,,61.0,YR,,F,Y,64.47,KG,20210810.0,,CN,US,US,2021,Q3,Adult
196783561,19678356,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Procedural pain,,2021,Q3,1,I,201901.0,20201230.0,20210810,20210810,EXP,,US-ABBVIE-20K-163-3713377-00,ABBVIE,,61.0,YR,,F,Y,64.47,KG,20210810.0,,CN,US,US,2021,Q3,Adult
196783561,19678356,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Stomatitis,,2021,Q3,1,I,201901.0,20201230.0,20210810,20210810,EXP,,US-ABBVIE-20K-163-3713377-00,ABBVIE,,61.0,YR,,F,Y,64.47,KG,20210810.0,,CN,US,US,2021,Q3,Adult
196786911,19678691,2,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Back pain,,2021,Q3,1,I,20210622.0,,20210809,20210809,DIR,,,FDA-CTU,,44.0,YR,,F,N,83.0,KG,20210809.0,N,PH,US,US,2021,Q3,Adult
196786911,19678691,2,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Chromaturia,,2021,Q3,1,I,20210622.0,,20210809,20210809,DIR,,,FDA-CTU,,44.0,YR,,F,N,83.0,KG,20210809.0,N,PH,US,US,2021,Q3,Adult
196786911,19678691,2,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Euglycaemic diabetic ketoacidosis,,2021,Q3,1,I,20210622.0,,20210809,20210809,DIR,,,FDA-CTU,,44.0,YR,,F,N,83.0,KG,20210809.0,N,PH,US,US,2021,Q3,Adult
196786911,19678691,2,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Pneumonia,,2021,Q3,1,I,20210622.0,,20210809,20210809,DIR,,,FDA-CTU,,44.0,YR,,F,N,83.0,KG,20210809.0,N,PH,US,US,2021,Q3,Adult
196786911,19678691,2,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Sepsis,,2021,Q3,1,I,20210622.0,,20210809,20210809,DIR,,,FDA-CTU,,44.0,YR,,F,N,83.0,KG,20210809.0,N,PH,US,US,2021,Q3,Adult
196786911,19678691,2,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Urine odour abnormal,,2021,Q3,1,I,20210622.0,,20210809,20210809,DIR,,,FDA-CTU,,44.0,YR,,F,N,83.0,KG,20210809.0,N,PH,US,US,2021,Q3,Adult
196791111,19679111,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,16.0,IU,,QD,2021,Q3,Diabetic metabolic decompensation,,2021,Q3,1,I,,20210726.0,20210809,20210809,EXP,,IT-EMD SERONO-9255225,EMD SERONO INC,"CIARDULLO S, PERSEGHIN G. STEATOSI EPATICA NON ALCOLICA: NON SEMPRE UNA CONDIZIONE BENIGNA.. ILDIA.. 2021 JUL?33(2):.",47.0,YR,A,F,Y,115.0,KG,20210809.0,,MD,IT,IT,2021,Q3,Adult
196791111,19679111,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,16.0,IU,,QD,2021,Q3,Hypothyroidism,,2021,Q3,1,I,,20210726.0,20210809,20210809,EXP,,IT-EMD SERONO-9255225,EMD SERONO INC,"CIARDULLO S, PERSEGHIN G. STEATOSI EPATICA NON ALCOLICA: NON SEMPRE UNA CONDIZIONE BENIGNA.. ILDIA.. 2021 JUL?33(2):.",47.0,YR,A,F,Y,115.0,KG,20210809.0,,MD,IT,IT,2021,Q3,Adult
196791111,19679111,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,16.0,IU,,QD,2021,Q3,Therapy partial responder,,2021,Q3,1,I,,20210726.0,20210809,20210809,EXP,,IT-EMD SERONO-9255225,EMD SERONO INC,"CIARDULLO S, PERSEGHIN G. STEATOSI EPATICA NON ALCOLICA: NON SEMPRE UNA CONDIZIONE BENIGNA.. ILDIA.. 2021 JUL?33(2):.",47.0,YR,A,F,Y,115.0,KG,20210809.0,,MD,IT,IT,2021,Q3,Adult
196827361,19682736,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Acute kidney injury,Acute kidney injury,2021,Q3,1,I,,20210727.0,20210811,20210811,EXP,,US-ALVOGEN-2021-ALVOGEN-117292,ALVOGEN,,48.0,YR,,F,Y,,,20210811.0,,HP,US,US,2021,Q3,Adult
196827361,19682736,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Drug interaction,Drug interaction,2021,Q3,1,I,,20210727.0,20210811,20210811,EXP,,US-ALVOGEN-2021-ALVOGEN-117292,ALVOGEN,,48.0,YR,,F,Y,,,20210811.0,,HP,US,US,2021,Q3,Adult
196827361,19682736,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Toxicity to various agents,Toxicity to various agents,2021,Q3,1,I,,20210727.0,20210811,20210811,EXP,,US-ALVOGEN-2021-ALVOGEN-117292,ALVOGEN,,48.0,YR,,F,Y,,,20210811.0,,HP,US,US,2021,Q3,Adult
196830901,19683090,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"10 INTERNATIONAL UNIT, ONCE A DAY",,,U,U, 1F975A,,,10.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Appetite disorder,,2021,Q3,1,I,2021.0,20210730.0,20210811,20210811,EXP,,ES-AUROBINDO-AUR-APL-2021-034011,AUROBINDO,,51.0,YR,,M,Y,110.0,KG,20210811.0,,CN,ES,ES,2021,Q3,Adult
196830901,19683090,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"10 INTERNATIONAL UNIT, ONCE A DAY",,,U,U, 1F975A,,,10.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose decreased,,2021,Q3,1,I,2021.0,20210730.0,20210811,20210811,EXP,,ES-AUROBINDO-AUR-APL-2021-034011,AUROBINDO,,51.0,YR,,M,Y,110.0,KG,20210811.0,,CN,ES,ES,2021,Q3,Adult
196830901,19683090,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"10 INTERNATIONAL UNIT, ONCE A DAY",,,U,U, 1F975A,,,10.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose fluctuation,,2021,Q3,1,I,2021.0,20210730.0,20210811,20210811,EXP,,ES-AUROBINDO-AUR-APL-2021-034011,AUROBINDO,,51.0,YR,,M,Y,110.0,KG,20210811.0,,CN,ES,ES,2021,Q3,Adult
196830901,19683090,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"10 INTERNATIONAL UNIT, ONCE A DAY",,,U,U, 1F975A,,,10.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Cold sweat,,2021,Q3,1,I,2021.0,20210730.0,20210811,20210811,EXP,,ES-AUROBINDO-AUR-APL-2021-034011,AUROBINDO,,51.0,YR,,M,Y,110.0,KG,20210811.0,,CN,ES,ES,2021,Q3,Adult
196830901,19683090,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"10 INTERNATIONAL UNIT, ONCE A DAY",,,U,U, 1F975A,,,10.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Colitis,,2021,Q3,1,I,2021.0,20210730.0,20210811,20210811,EXP,,ES-AUROBINDO-AUR-APL-2021-034011,AUROBINDO,,51.0,YR,,M,Y,110.0,KG,20210811.0,,CN,ES,ES,2021,Q3,Adult
196830901,19683090,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"10 INTERNATIONAL UNIT, ONCE A DAY",,,U,U, 1F975A,,,10.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Flatulence,,2021,Q3,1,I,2021.0,20210730.0,20210811,20210811,EXP,,ES-AUROBINDO-AUR-APL-2021-034011,AUROBINDO,,51.0,YR,,M,Y,110.0,KG,20210811.0,,CN,ES,ES,2021,Q3,Adult
196830901,19683090,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"10 INTERNATIONAL UNIT, ONCE A DAY",,,U,U, 1F975A,,,10.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Gastrointestinal injury,,2021,Q3,1,I,2021.0,20210730.0,20210811,20210811,EXP,,ES-AUROBINDO-AUR-APL-2021-034011,AUROBINDO,,51.0,YR,,M,Y,110.0,KG,20210811.0,,CN,ES,ES,2021,Q3,Adult
196830901,19683090,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"10 INTERNATIONAL UNIT, ONCE A DAY",,,U,U, 1F975A,,,10.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Headache,,2021,Q3,1,I,2021.0,20210730.0,20210811,20210811,EXP,,ES-AUROBINDO-AUR-APL-2021-034011,AUROBINDO,,51.0,YR,,M,Y,110.0,KG,20210811.0,,CN,ES,ES,2021,Q3,Adult
196830901,19683090,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"10 INTERNATIONAL UNIT, ONCE A DAY",,,U,U, 1F975A,,,10.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hunger,,2021,Q3,1,I,2021.0,20210730.0,20210811,20210811,EXP,,ES-AUROBINDO-AUR-APL-2021-034011,AUROBINDO,,51.0,YR,,M,Y,110.0,KG,20210811.0,,CN,ES,ES,2021,Q3,Adult
196830901,19683090,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"10 INTERNATIONAL UNIT, ONCE A DAY",,,U,U, 1F975A,,,10.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Nausea,,2021,Q3,1,I,2021.0,20210730.0,20210811,20210811,EXP,,ES-AUROBINDO-AUR-APL-2021-034011,AUROBINDO,,51.0,YR,,M,Y,110.0,KG,20210811.0,,CN,ES,ES,2021,Q3,Adult
196830901,19683090,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"10 INTERNATIONAL UNIT, ONCE A DAY",,,U,U, 1F975A,,,10.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Somnolence,,2021,Q3,1,I,2021.0,20210730.0,20210811,20210811,EXP,,ES-AUROBINDO-AUR-APL-2021-034011,AUROBINDO,,51.0,YR,,M,Y,110.0,KG,20210811.0,,CN,ES,ES,2021,Q3,Adult
196830901,19683090,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"10 INTERNATIONAL UNIT, ONCE A DAY",,,U,U, 1F975A,,,10.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Thirst,,2021,Q3,1,I,2021.0,20210730.0,20210811,20210811,EXP,,ES-AUROBINDO-AUR-APL-2021-034011,AUROBINDO,,51.0,YR,,M,Y,110.0,KG,20210811.0,,CN,ES,ES,2021,Q3,Adult
196830901,19683090,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"10 INTERNATIONAL UNIT, ONCE A DAY",,,U,U, 1F975A,,,10.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Weight decreased,,2021,Q3,1,I,2021.0,20210730.0,20210811,20210811,EXP,,ES-AUROBINDO-AUR-APL-2021-034011,AUROBINDO,,51.0,YR,,M,Y,110.0,KG,20210811.0,,CN,ES,ES,2021,Q3,Adult
196842511,19684251,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 IE, 28?0?0?0",,,,,,,,,,,,2021,Q3,Dizziness,,2021,Q3,1,I,,20210805.0,20210811,20210811,EXP,DE-ADRED-07001-01,NVSC2021DE177801,NOVARTIS,,77.0,YR,,M,Y,82.0,KG,20210811.0,,HP,DE,DE,2021,Q3,Elderly
196842511,19684251,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 IE, 28?0?0?0",,,,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210805.0,20210811,20210811,EXP,DE-ADRED-07001-01,NVSC2021DE177801,NOVARTIS,,77.0,YR,,M,Y,82.0,KG,20210811.0,,HP,DE,DE,2021,Q3,Elderly
196842511,19684251,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 IE, 28?0?0?0",,,,,,,,,,,,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,,20210805.0,20210811,20210811,EXP,DE-ADRED-07001-01,NVSC2021DE177801,NOVARTIS,,77.0,YR,,M,Y,82.0,KG,20210811.0,,HP,DE,DE,2021,Q3,Elderly
196842511,19684251,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 IE, 28?0?0?0",,,,,,,,,,,,2021,Q3,Hypotension,,2021,Q3,1,I,,20210805.0,20210811,20210811,EXP,DE-ADRED-07001-01,NVSC2021DE177801,NOVARTIS,,77.0,YR,,M,Y,82.0,KG,20210811.0,,HP,DE,DE,2021,Q3,Elderly
196842511,19684251,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 IE, 28?0?0?0",,,,,,,,,,,,2021,Q3,Renal impairment,,2021,Q3,1,I,,20210805.0,20210811,20210811,EXP,DE-ADRED-07001-01,NVSC2021DE177801,NOVARTIS,,77.0,YR,,M,Y,82.0,KG,20210811.0,,HP,DE,DE,2021,Q3,Elderly
196850501,19685050,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 IU, QD",,,U,U,,,,24.0,IU,,QD,2021,Q3,Conjunctival hyperaemia,,2021,Q3,1,I,,20210802.0,20210811,20210811,EXP,,FR-MYLANLABS-2021M1048687,MYLAN,"MICHELON, HUGUES? LARABI, ISLAM AMINE? LEMOINE, JEROME? ALVAREZ, JEAN?CLAUDE? GENEVEE, ANNE. LILLO?LELOUET, AGNES? AZOUVI, PHILIPPE? LEFEVRE?DOGNIN, CL?MENCE? PAQUEREAU, JULIE. ATROPINE?INDUCED TOXICITY AFTER OFF?LABEL SUBLINGUAL ADMINISTRATION OF EYEDROP FOR SIALORRHEA TREATMENT IN NEUROLOGICAL DISABLED PATIENTS.. BR. J. CLIN. PHARMACOL.. 2021",48.0,YR,,M,Y,,,20210811.0,,HP,FR,FR,2021,Q3,Adult
196850501,19685050,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 IU, QD",,,U,U,,,,24.0,IU,,QD,2021,Q3,Eye pruritus,,2021,Q3,1,I,,20210802.0,20210811,20210811,EXP,,FR-MYLANLABS-2021M1048687,MYLAN,"MICHELON, HUGUES? LARABI, ISLAM AMINE? LEMOINE, JEROME? ALVAREZ, JEAN?CLAUDE? GENEVEE, ANNE. LILLO?LELOUET, AGNES? AZOUVI, PHILIPPE? LEFEVRE?DOGNIN, CL?MENCE? PAQUEREAU, JULIE. ATROPINE?INDUCED TOXICITY AFTER OFF?LABEL SUBLINGUAL ADMINISTRATION OF EYEDROP FOR SIALORRHEA TREATMENT IN NEUROLOGICAL DISABLED PATIENTS.. BR. J. CLIN. PHARMACOL.. 2021",48.0,YR,,M,Y,,,20210811.0,,HP,FR,FR,2021,Q3,Adult
196850501,19685050,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 IU, QD",,,U,U,,,,24.0,IU,,QD,2021,Q3,Flushing,,2021,Q3,1,I,,20210802.0,20210811,20210811,EXP,,FR-MYLANLABS-2021M1048687,MYLAN,"MICHELON, HUGUES? LARABI, ISLAM AMINE? LEMOINE, JEROME? ALVAREZ, JEAN?CLAUDE? GENEVEE, ANNE. LILLO?LELOUET, AGNES? AZOUVI, PHILIPPE? LEFEVRE?DOGNIN, CL?MENCE? PAQUEREAU, JULIE. ATROPINE?INDUCED TOXICITY AFTER OFF?LABEL SUBLINGUAL ADMINISTRATION OF EYEDROP FOR SIALORRHEA TREATMENT IN NEUROLOGICAL DISABLED PATIENTS.. BR. J. CLIN. PHARMACOL.. 2021",48.0,YR,,M,Y,,,20210811.0,,HP,FR,FR,2021,Q3,Adult
196850501,19685050,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 IU, QD",,,U,U,,,,24.0,IU,,QD,2021,Q3,Incorrect route of product administration,,2021,Q3,1,I,,20210802.0,20210811,20210811,EXP,,FR-MYLANLABS-2021M1048687,MYLAN,"MICHELON, HUGUES? LARABI, ISLAM AMINE? LEMOINE, JEROME? ALVAREZ, JEAN?CLAUDE? GENEVEE, ANNE. LILLO?LELOUET, AGNES? AZOUVI, PHILIPPE? LEFEVRE?DOGNIN, CL?MENCE? PAQUEREAU, JULIE. ATROPINE?INDUCED TOXICITY AFTER OFF?LABEL SUBLINGUAL ADMINISTRATION OF EYEDROP FOR SIALORRHEA TREATMENT IN NEUROLOGICAL DISABLED PATIENTS.. BR. J. CLIN. PHARMACOL.. 2021",48.0,YR,,M,Y,,,20210811.0,,HP,FR,FR,2021,Q3,Adult
196850501,19685050,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 IU, QD",,,U,U,,,,24.0,IU,,QD,2021,Q3,Malaise,,2021,Q3,1,I,,20210802.0,20210811,20210811,EXP,,FR-MYLANLABS-2021M1048687,MYLAN,"MICHELON, HUGUES? LARABI, ISLAM AMINE? LEMOINE, JEROME? ALVAREZ, JEAN?CLAUDE? GENEVEE, ANNE. LILLO?LELOUET, AGNES? AZOUVI, PHILIPPE? LEFEVRE?DOGNIN, CL?MENCE? PAQUEREAU, JULIE. ATROPINE?INDUCED TOXICITY AFTER OFF?LABEL SUBLINGUAL ADMINISTRATION OF EYEDROP FOR SIALORRHEA TREATMENT IN NEUROLOGICAL DISABLED PATIENTS.. BR. J. CLIN. PHARMACOL.. 2021",48.0,YR,,M,Y,,,20210811.0,,HP,FR,FR,2021,Q3,Adult
196850501,19685050,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 IU, QD",,,U,U,,,,24.0,IU,,QD,2021,Q3,Mydriasis,,2021,Q3,1,I,,20210802.0,20210811,20210811,EXP,,FR-MYLANLABS-2021M1048687,MYLAN,"MICHELON, HUGUES? LARABI, ISLAM AMINE? LEMOINE, JEROME? ALVAREZ, JEAN?CLAUDE? GENEVEE, ANNE. LILLO?LELOUET, AGNES? AZOUVI, PHILIPPE? LEFEVRE?DOGNIN, CL?MENCE? PAQUEREAU, JULIE. ATROPINE?INDUCED TOXICITY AFTER OFF?LABEL SUBLINGUAL ADMINISTRATION OF EYEDROP FOR SIALORRHEA TREATMENT IN NEUROLOGICAL DISABLED PATIENTS.. BR. J. CLIN. PHARMACOL.. 2021",48.0,YR,,M,Y,,,20210811.0,,HP,FR,FR,2021,Q3,Adult
196850501,19685050,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 IU, QD",,,U,U,,,,24.0,IU,,QD,2021,Q3,Off label use,,2021,Q3,1,I,,20210802.0,20210811,20210811,EXP,,FR-MYLANLABS-2021M1048687,MYLAN,"MICHELON, HUGUES? LARABI, ISLAM AMINE? LEMOINE, JEROME? ALVAREZ, JEAN?CLAUDE? GENEVEE, ANNE. LILLO?LELOUET, AGNES? AZOUVI, PHILIPPE? LEFEVRE?DOGNIN, CL?MENCE? PAQUEREAU, JULIE. ATROPINE?INDUCED TOXICITY AFTER OFF?LABEL SUBLINGUAL ADMINISTRATION OF EYEDROP FOR SIALORRHEA TREATMENT IN NEUROLOGICAL DISABLED PATIENTS.. BR. J. CLIN. PHARMACOL.. 2021",48.0,YR,,M,Y,,,20210811.0,,HP,FR,FR,2021,Q3,Adult
196850501,19685050,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 IU, QD",,,U,U,,,,24.0,IU,,QD,2021,Q3,Overdose,,2021,Q3,1,I,,20210802.0,20210811,20210811,EXP,,FR-MYLANLABS-2021M1048687,MYLAN,"MICHELON, HUGUES? LARABI, ISLAM AMINE? LEMOINE, JEROME? ALVAREZ, JEAN?CLAUDE? GENEVEE, ANNE. LILLO?LELOUET, AGNES? AZOUVI, PHILIPPE? LEFEVRE?DOGNIN, CL?MENCE? PAQUEREAU, JULIE. ATROPINE?INDUCED TOXICITY AFTER OFF?LABEL SUBLINGUAL ADMINISTRATION OF EYEDROP FOR SIALORRHEA TREATMENT IN NEUROLOGICAL DISABLED PATIENTS.. BR. J. CLIN. PHARMACOL.. 2021",48.0,YR,,M,Y,,,20210811.0,,HP,FR,FR,2021,Q3,Adult
196850501,19685050,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 IU, QD",,,U,U,,,,24.0,IU,,QD,2021,Q3,Toxicity to various agents,,2021,Q3,1,I,,20210802.0,20210811,20210811,EXP,,FR-MYLANLABS-2021M1048687,MYLAN,"MICHELON, HUGUES? LARABI, ISLAM AMINE? LEMOINE, JEROME? ALVAREZ, JEAN?CLAUDE? GENEVEE, ANNE. LILLO?LELOUET, AGNES? AZOUVI, PHILIPPE? LEFEVRE?DOGNIN, CL?MENCE? PAQUEREAU, JULIE. ATROPINE?INDUCED TOXICITY AFTER OFF?LABEL SUBLINGUAL ADMINISTRATION OF EYEDROP FOR SIALORRHEA TREATMENT IN NEUROLOGICAL DISABLED PATIENTS.. BR. J. CLIN. PHARMACOL.. 2021",48.0,YR,,M,Y,,,20210811.0,,HP,FR,FR,2021,Q3,Adult
196850501,19685050,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 IU, QD",,,U,U,,,,24.0,IU,,QD,2021,Q3,Vision blurred,,2021,Q3,1,I,,20210802.0,20210811,20210811,EXP,,FR-MYLANLABS-2021M1048687,MYLAN,"MICHELON, HUGUES? LARABI, ISLAM AMINE? LEMOINE, JEROME? ALVAREZ, JEAN?CLAUDE? GENEVEE, ANNE. LILLO?LELOUET, AGNES? AZOUVI, PHILIPPE? LEFEVRE?DOGNIN, CL?MENCE? PAQUEREAU, JULIE. ATROPINE?INDUCED TOXICITY AFTER OFF?LABEL SUBLINGUAL ADMINISTRATION OF EYEDROP FOR SIALORRHEA TREATMENT IN NEUROLOGICAL DISABLED PATIENTS.. BR. J. CLIN. PHARMACOL.. 2021",48.0,YR,,M,Y,,,20210811.0,,HP,FR,FR,2021,Q3,Adult
196922811,19692281,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 IE, 28?0?0?0",,,U,,,,21081.0,,,,,2021,Q3,Dizziness,,2021,Q3,1,I,,20210806.0,20210812,20210812,EXP,,DE-SA-2021SA263679,SANOFI AVENTIS,,77.0,YR,E,M,Y,82.0,KG,20210812.0,,PH,DE,DE,2021,Q3,Elderly
196922811,19692281,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 IE, 28?0?0?0",,,U,,,,21081.0,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210806.0,20210812,20210812,EXP,,DE-SA-2021SA263679,SANOFI AVENTIS,,77.0,YR,E,M,Y,82.0,KG,20210812.0,,PH,DE,DE,2021,Q3,Elderly
196922811,19692281,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 IE, 28?0?0?0",,,U,,,,21081.0,,,,,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,,20210806.0,20210812,20210812,EXP,,DE-SA-2021SA263679,SANOFI AVENTIS,,77.0,YR,E,M,Y,82.0,KG,20210812.0,,PH,DE,DE,2021,Q3,Elderly
196922811,19692281,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 IE, 28?0?0?0",,,U,,,,21081.0,,,,,2021,Q3,Hypotension,,2021,Q3,1,I,,20210806.0,20210812,20210812,EXP,,DE-SA-2021SA263679,SANOFI AVENTIS,,77.0,YR,E,M,Y,82.0,KG,20210812.0,,PH,DE,DE,2021,Q3,Elderly
196922811,19692281,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 IE, 28?0?0?0",,,U,,,,21081.0,,,,,2021,Q3,Renal impairment,,2021,Q3,1,I,,20210806.0,20210812,20210812,EXP,,DE-SA-2021SA263679,SANOFI AVENTIS,,77.0,YR,E,M,Y,82.0,KG,20210812.0,,PH,DE,DE,2021,Q3,Elderly
196930762,19693076,11,C,Insuline glargine,INSULIN GLARGINE,1,Unknown,25 UNITS,,,U,,,,,,,,,2021,Q3,Calciphylaxis,,2021,Q3,2,F,,20210813.0,20210812,20210817,EXP,,US-TEVA-2021-US-1940291,TEVA,"ADAPA S, NARAMALA S, GAYAM V, KODURI NM, DAGGUBATI SR, PATEL P, ET AL. CALCIPHYLAXIS IN A PATIENT ON HOME HEMODIALYSIS. J?INVESTIG?MED?HIGH?IMPACT?CASE?REP 2020?:.",51.0,YR,A,F,Y,,,20210817.0,,MD,US,US,2021,Q3,Adult
196930762,19693076,11,C,Insuline glargine,INSULIN GLARGINE,1,Unknown,25 UNITS,,,U,,,,,,,,,2021,Q3,Emotional distress,,2021,Q3,2,F,,20210813.0,20210812,20210817,EXP,,US-TEVA-2021-US-1940291,TEVA,"ADAPA S, NARAMALA S, GAYAM V, KODURI NM, DAGGUBATI SR, PATEL P, ET AL. CALCIPHYLAXIS IN A PATIENT ON HOME HEMODIALYSIS. J?INVESTIG?MED?HIGH?IMPACT?CASE?REP 2020?:.",51.0,YR,A,F,Y,,,20210817.0,,MD,US,US,2021,Q3,Adult
196941691,19694169,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,20 IU,,,,,,,,,,,,2021,Q3,Diastolic dysfunction,,2021,Q3,1,I,,20210803.0,20210813,20210813,EXP,,BR-NOVOPROD-836696,NOVO NORDISK,,41.0,YR,,M,Y,82.0,KG,20210813.0,,MD,BR,BR,2021,Q3,Adult
196941691,19694169,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,20 IU,,,,,,,,,,,,2021,Q3,Fatigue,,2021,Q3,1,I,,20210803.0,20210813,20210813,EXP,,BR-NOVOPROD-836696,NOVO NORDISK,,41.0,YR,,M,Y,82.0,KG,20210813.0,,MD,BR,BR,2021,Q3,Adult
196941691,19694169,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,20 IU,,,,,,,,,,,,2021,Q3,Hyperhidrosis,,2021,Q3,1,I,,20210803.0,20210813,20210813,EXP,,BR-NOVOPROD-836696,NOVO NORDISK,,41.0,YR,,M,Y,82.0,KG,20210813.0,,MD,BR,BR,2021,Q3,Adult
196941691,19694169,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,20 IU,,,,,,,,,,,,2021,Q3,Left atrial enlargement,,2021,Q3,1,I,,20210803.0,20210813,20210813,EXP,,BR-NOVOPROD-836696,NOVO NORDISK,,41.0,YR,,M,Y,82.0,KG,20210813.0,,MD,BR,BR,2021,Q3,Adult
196947281,19694728,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Limb discomfort,,2021,Q3,1,I,,20210803.0,20210813,20210813,EXP,,CA-TEVA-2021-CA-1939901,TEVA,,64.0,YR,A,F,Y,,,20210813.0,,HP,CA,CA,2021,Q3,Adult
196947281,19694728,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Pain in extremity,,2021,Q3,1,I,,20210803.0,20210813,20210813,EXP,,CA-TEVA-2021-CA-1939901,TEVA,,64.0,YR,A,F,Y,,,20210813.0,,HP,CA,CA,2021,Q3,Adult
196947281,19694728,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Paraesthesia,,2021,Q3,1,I,,20210803.0,20210813,20210813,EXP,,CA-TEVA-2021-CA-1939901,TEVA,,64.0,YR,A,F,Y,,,20210813.0,,HP,CA,CA,2021,Q3,Adult
196949512,19694951,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Acute kidney injury,,2021,Q3,2,F,,20210820.0,20210813,20210901,EXP,,US-ACCORD-235166,ACCORD,,48.0,YR,,F,Y,,,20210901.0,,HP,US,US,2021,Q3,Adult
196949512,19694951,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Brugada syndrome,,2021,Q3,2,F,,20210820.0,20210813,20210901,EXP,,US-ACCORD-235166,ACCORD,,48.0,YR,,F,Y,,,20210901.0,,HP,US,US,2021,Q3,Adult
196949512,19694951,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Confusional state,,2021,Q3,2,F,,20210820.0,20210813,20210901,EXP,,US-ACCORD-235166,ACCORD,,48.0,YR,,F,Y,,,20210901.0,,HP,US,US,2021,Q3,Adult
196949512,19694951,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Dizziness,,2021,Q3,2,F,,20210820.0,20210813,20210901,EXP,,US-ACCORD-235166,ACCORD,,48.0,YR,,F,Y,,,20210901.0,,HP,US,US,2021,Q3,Adult
196949512,19694951,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Drug interaction,,2021,Q3,2,F,,20210820.0,20210813,20210901,EXP,,US-ACCORD-235166,ACCORD,,48.0,YR,,F,Y,,,20210901.0,,HP,US,US,2021,Q3,Adult
196949512,19694951,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Fall,,2021,Q3,2,F,,20210820.0,20210813,20210901,EXP,,US-ACCORD-235166,ACCORD,,48.0,YR,,F,Y,,,20210901.0,,HP,US,US,2021,Q3,Adult
196949512,19694951,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Nausea,,2021,Q3,2,F,,20210820.0,20210813,20210901,EXP,,US-ACCORD-235166,ACCORD,,48.0,YR,,F,Y,,,20210901.0,,HP,US,US,2021,Q3,Adult
196949512,19694951,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Tremor,,2021,Q3,2,F,,20210820.0,20210813,20210901,EXP,,US-ACCORD-235166,ACCORD,,48.0,YR,,F,Y,,,20210901.0,,HP,US,US,2021,Q3,Adult
196949512,19694951,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Vomiting,,2021,Q3,2,F,,20210820.0,20210813,20210901,EXP,,US-ACCORD-235166,ACCORD,,48.0,YR,,F,Y,,,20210901.0,,HP,US,US,2021,Q3,Adult
196982631,19698263,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,64 INTERNATIONAL UNIT,,,,, 0F557A,,,64.0,IU,,,2021,Q3,Mobility decreased,,2021,Q3,1,I,2020.0,20210804.0,20210813,20210813,EXP,,ES-MYLANLABS-2021M1049466,MYLAN,,65.0,YR,,F,Y,,,20210813.0,,CN,ES,ES,2021,Q3,Elderly
196982631,19698263,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,64 INTERNATIONAL UNIT,,,,, 0F557A,,,64.0,IU,,,2021,Q3,Renal colic,,2021,Q3,1,I,2020.0,20210804.0,20210813,20210813,EXP,,ES-MYLANLABS-2021M1049466,MYLAN,,65.0,YR,,F,Y,,,20210813.0,,CN,ES,ES,2021,Q3,Elderly
196982631,19698263,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,64 INTERNATIONAL UNIT,,,,, 0F557A,,,64.0,IU,,,2021,Q3,Renal pain,,2021,Q3,1,I,2020.0,20210804.0,20210813,20210813,EXP,,ES-MYLANLABS-2021M1049466,MYLAN,,65.0,YR,,F,Y,,,20210813.0,,CN,ES,ES,2021,Q3,Elderly
196982631,19698263,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,64 INTERNATIONAL UNIT,,,,, 0F557A,,,64.0,IU,,,2021,Q3,Urinary tract infection,,2021,Q3,1,I,2020.0,20210804.0,20210813,20210813,EXP,,ES-MYLANLABS-2021M1049466,MYLAN,,65.0,YR,,F,Y,,,20210813.0,,CN,ES,ES,2021,Q3,Elderly
196982631,19698263,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,64 INTERNATIONAL UNIT,,,,, 0F557A,,,64.0,IU,,,2021,Q3,Visual impairment,,2021,Q3,1,I,2020.0,20210804.0,20210813,20210813,EXP,,ES-MYLANLABS-2021M1049466,MYLAN,,65.0,YR,,F,Y,,,20210813.0,,CN,ES,ES,2021,Q3,Elderly
196982631,19698263,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,64 INTERNATIONAL UNIT,,,,, 0F557A,,,64.0,IU,,,2021,Q3,Weight increased,,2021,Q3,1,I,2020.0,20210804.0,20210813,20210813,EXP,,ES-MYLANLABS-2021M1049466,MYLAN,,65.0,YR,,F,Y,,,20210813.0,,CN,ES,ES,2021,Q3,Elderly
197009371,19700937,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 IE, 28?0?0?0",,,U,,,,,,,,,2021,Q3,Anaemia,,2021,Q3,1,I,,20210802.0,20210813,20210813,EXP,DE-ADRED-06895-01,NVSC2021DE176274,NOVARTIS,,73.0,YR,,M,Y,,,20210813.0,,HP,DE,DE,2021,Q3,Elderly
197009371,19700937,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 IE, 28?0?0?0",,,U,,,,,,,,,2021,Q3,Aortic aneurysm,,2021,Q3,1,I,,20210802.0,20210813,20210813,EXP,DE-ADRED-06895-01,NVSC2021DE176274,NOVARTIS,,73.0,YR,,M,Y,,,20210813.0,,HP,DE,DE,2021,Q3,Elderly
197009371,19700937,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 IE, 28?0?0?0",,,U,,,,,,,,,2021,Q3,Asthenia,,2021,Q3,1,I,,20210802.0,20210813,20210813,EXP,DE-ADRED-06895-01,NVSC2021DE176274,NOVARTIS,,73.0,YR,,M,Y,,,20210813.0,,HP,DE,DE,2021,Q3,Elderly
197009371,19700937,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 IE, 28?0?0?0",,,U,,,,,,,,,2021,Q3,Atrial fibrillation,,2021,Q3,1,I,,20210802.0,20210813,20210813,EXP,DE-ADRED-06895-01,NVSC2021DE176274,NOVARTIS,,73.0,YR,,M,Y,,,20210813.0,,HP,DE,DE,2021,Q3,Elderly
197009371,19700937,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 IE, 28?0?0?0",,,U,,,,,,,,,2021,Q3,Bite,,2021,Q3,1,I,,20210802.0,20210813,20210813,EXP,DE-ADRED-06895-01,NVSC2021DE176274,NOVARTIS,,73.0,YR,,M,Y,,,20210813.0,,HP,DE,DE,2021,Q3,Elderly
197009371,19700937,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 IE, 28?0?0?0",,,U,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210802.0,20210813,20210813,EXP,DE-ADRED-06895-01,NVSC2021DE176274,NOVARTIS,,73.0,YR,,M,Y,,,20210813.0,,HP,DE,DE,2021,Q3,Elderly
197009371,19700937,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 IE, 28?0?0?0",,,U,,,,,,,,,2021,Q3,Hemiparesis,,2021,Q3,1,I,,20210802.0,20210813,20210813,EXP,DE-ADRED-06895-01,NVSC2021DE176274,NOVARTIS,,73.0,YR,,M,Y,,,20210813.0,,HP,DE,DE,2021,Q3,Elderly
197009371,19700937,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 IE, 28?0?0?0",,,U,,,,,,,,,2021,Q3,Language disorder,,2021,Q3,1,I,,20210802.0,20210813,20210813,EXP,DE-ADRED-06895-01,NVSC2021DE176274,NOVARTIS,,73.0,YR,,M,Y,,,20210813.0,,HP,DE,DE,2021,Q3,Elderly
197009371,19700937,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 IE, 28?0?0?0",,,U,,,,,,,,,2021,Q3,Renal impairment,,2021,Q3,1,I,,20210802.0,20210813,20210813,EXP,DE-ADRED-06895-01,NVSC2021DE176274,NOVARTIS,,73.0,YR,,M,Y,,,20210813.0,,HP,DE,DE,2021,Q3,Elderly
197014111,19701411,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, OTHER, 28 IE, 28?0?0?0",,,U,,,,205692.0,,,,,2021,Q3,Dizziness,,2021,Q3,1,I,,20210803.0,20210813,20210813,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202108001176,ELI LILLY AND CO,,77.0,YR,,M,Y,82.0,KG,20210813.0,,PH,DE,DE,2021,Q3,Elderly
197014111,19701411,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, OTHER, 28 IE, 28?0?0?0",,,U,,,,205692.0,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210803.0,20210813,20210813,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202108001176,ELI LILLY AND CO,,77.0,YR,,M,Y,82.0,KG,20210813.0,,PH,DE,DE,2021,Q3,Elderly
197014111,19701411,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, OTHER, 28 IE, 28?0?0?0",,,U,,,,205692.0,,,,,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,,20210803.0,20210813,20210813,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202108001176,ELI LILLY AND CO,,77.0,YR,,M,Y,82.0,KG,20210813.0,,PH,DE,DE,2021,Q3,Elderly
197014111,19701411,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, OTHER, 28 IE, 28?0?0?0",,,U,,,,205692.0,,,,,2021,Q3,Hypotension,,2021,Q3,1,I,,20210803.0,20210813,20210813,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202108001176,ELI LILLY AND CO,,77.0,YR,,M,Y,82.0,KG,20210813.0,,PH,DE,DE,2021,Q3,Elderly
197014111,19701411,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, OTHER, 28 IE, 28?0?0?0",,,U,,,,205692.0,,,,,2021,Q3,Renal impairment,,2021,Q3,1,I,,20210803.0,20210813,20210813,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202108001176,ELI LILLY AND CO,,77.0,YR,,M,Y,82.0,KG,20210813.0,,PH,DE,DE,2021,Q3,Elderly
197014591,19701459,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q3,Arthralgia,,2021,Q3,1,I,,20210805.0,20210814,20210814,EXP,,CA-TEVA-2021-CA-1941041,TEVA,,14.0,YR,T,F,Y,41.0,KG,20210814.0,,PH,CA,CA,2021,Q3,Youth
197014591,19701459,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q3,Joint swelling,,2021,Q3,1,I,,20210805.0,20210814,20210814,EXP,,CA-TEVA-2021-CA-1941041,TEVA,,14.0,YR,T,F,Y,41.0,KG,20210814.0,,PH,CA,CA,2021,Q3,Youth
197014591,19701459,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q3,Pain,,2021,Q3,1,I,,20210805.0,20210814,20210814,EXP,,CA-TEVA-2021-CA-1941041,TEVA,,14.0,YR,T,F,Y,41.0,KG,20210814.0,,PH,CA,CA,2021,Q3,Youth
197014591,19701459,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q3,Rash macular,,2021,Q3,1,I,,20210805.0,20210814,20210814,EXP,,CA-TEVA-2021-CA-1941041,TEVA,,14.0,YR,T,F,Y,41.0,KG,20210814.0,,PH,CA,CA,2021,Q3,Youth
197017231,19701723,7,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q3,Rash,,2021,Q3,1,I,20210808.0,20210809.0,20210813,20210813,PER,,US-CELGENEUS-USA-20210802436,CELGENE,,78.0,YR,,M,Y,95.61,KG,20210813.0,,HP,US,US,2021,Q3,Elderly
197017231,19701723,7,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q3,Skin exfoliation,,2021,Q3,1,I,20210808.0,20210809.0,20210813,20210813,PER,,US-CELGENEUS-USA-20210802436,CELGENE,,78.0,YR,,M,Y,95.61,KG,20210813.0,,HP,US,US,2021,Q3,Elderly
197017231,19701723,7,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q3,Swelling,,2021,Q3,1,I,20210808.0,20210809.0,20210813,20210813,PER,,US-CELGENEUS-USA-20210802436,CELGENE,,78.0,YR,,M,Y,95.61,KG,20210813.0,,HP,US,US,2021,Q3,Elderly
197033051,19703305,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"28 IE, 28?0?0?0",,,,,,,,,,,,2021,Q3,Dizziness,,2021,Q3,1,I,,20210804.0,20210816,20210816,EXP,,DE-AUROBINDO-AUR-APL-2021-034373,AUROBINDO,,77.0,YR,,M,Y,82.0,KG,20210816.0,,PH,DE,DE,2021,Q3,Elderly
197033051,19703305,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"28 IE, 28?0?0?0",,,,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210804.0,20210816,20210816,EXP,,DE-AUROBINDO-AUR-APL-2021-034373,AUROBINDO,,77.0,YR,,M,Y,82.0,KG,20210816.0,,PH,DE,DE,2021,Q3,Elderly
197033051,19703305,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"28 IE, 28?0?0?0",,,,,,,,,,,,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,,20210804.0,20210816,20210816,EXP,,DE-AUROBINDO-AUR-APL-2021-034373,AUROBINDO,,77.0,YR,,M,Y,82.0,KG,20210816.0,,PH,DE,DE,2021,Q3,Elderly
197033051,19703305,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"28 IE, 28?0?0?0",,,,,,,,,,,,2021,Q3,Hypotension,,2021,Q3,1,I,,20210804.0,20210816,20210816,EXP,,DE-AUROBINDO-AUR-APL-2021-034373,AUROBINDO,,77.0,YR,,M,Y,82.0,KG,20210816.0,,PH,DE,DE,2021,Q3,Elderly
197033051,19703305,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"28 IE, 28?0?0?0",,,,,,,,,,,,2021,Q3,Renal impairment,,2021,Q3,1,I,,20210804.0,20210816,20210816,EXP,,DE-AUROBINDO-AUR-APL-2021-034373,AUROBINDO,,77.0,YR,,M,Y,82.0,KG,20210816.0,,PH,DE,DE,2021,Q3,Elderly
197035271,19703527,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, 1F975A,,,10.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Appetite disorder,,2021,Q3,1,I,2021.0,20210801.0,20210816,20210816,EXP,,ES-BAUSCH-BL-2021-026873,BAUSCH AND LOMB,,51.0,YR,,M,Y,110.0,KG,20210816.0,,CN,ES,ES,2021,Q3,Adult
197035271,19703527,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, 1F975A,,,10.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose decreased,,2021,Q3,1,I,2021.0,20210801.0,20210816,20210816,EXP,,ES-BAUSCH-BL-2021-026873,BAUSCH AND LOMB,,51.0,YR,,M,Y,110.0,KG,20210816.0,,CN,ES,ES,2021,Q3,Adult
197035271,19703527,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, 1F975A,,,10.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose fluctuation,,2021,Q3,1,I,2021.0,20210801.0,20210816,20210816,EXP,,ES-BAUSCH-BL-2021-026873,BAUSCH AND LOMB,,51.0,YR,,M,Y,110.0,KG,20210816.0,,CN,ES,ES,2021,Q3,Adult
197035271,19703527,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, 1F975A,,,10.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Cold sweat,,2021,Q3,1,I,2021.0,20210801.0,20210816,20210816,EXP,,ES-BAUSCH-BL-2021-026873,BAUSCH AND LOMB,,51.0,YR,,M,Y,110.0,KG,20210816.0,,CN,ES,ES,2021,Q3,Adult
197035271,19703527,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, 1F975A,,,10.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Colitis,,2021,Q3,1,I,2021.0,20210801.0,20210816,20210816,EXP,,ES-BAUSCH-BL-2021-026873,BAUSCH AND LOMB,,51.0,YR,,M,Y,110.0,KG,20210816.0,,CN,ES,ES,2021,Q3,Adult
197035271,19703527,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, 1F975A,,,10.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Flatulence,,2021,Q3,1,I,2021.0,20210801.0,20210816,20210816,EXP,,ES-BAUSCH-BL-2021-026873,BAUSCH AND LOMB,,51.0,YR,,M,Y,110.0,KG,20210816.0,,CN,ES,ES,2021,Q3,Adult
197035271,19703527,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, 1F975A,,,10.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Gastrointestinal injury,,2021,Q3,1,I,2021.0,20210801.0,20210816,20210816,EXP,,ES-BAUSCH-BL-2021-026873,BAUSCH AND LOMB,,51.0,YR,,M,Y,110.0,KG,20210816.0,,CN,ES,ES,2021,Q3,Adult
197035271,19703527,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, 1F975A,,,10.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Headache,,2021,Q3,1,I,2021.0,20210801.0,20210816,20210816,EXP,,ES-BAUSCH-BL-2021-026873,BAUSCH AND LOMB,,51.0,YR,,M,Y,110.0,KG,20210816.0,,CN,ES,ES,2021,Q3,Adult
197035271,19703527,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, 1F975A,,,10.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hunger,,2021,Q3,1,I,2021.0,20210801.0,20210816,20210816,EXP,,ES-BAUSCH-BL-2021-026873,BAUSCH AND LOMB,,51.0,YR,,M,Y,110.0,KG,20210816.0,,CN,ES,ES,2021,Q3,Adult
197035271,19703527,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, 1F975A,,,10.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Nausea,,2021,Q3,1,I,2021.0,20210801.0,20210816,20210816,EXP,,ES-BAUSCH-BL-2021-026873,BAUSCH AND LOMB,,51.0,YR,,M,Y,110.0,KG,20210816.0,,CN,ES,ES,2021,Q3,Adult
197035271,19703527,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, 1F975A,,,10.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Somnolence,,2021,Q3,1,I,2021.0,20210801.0,20210816,20210816,EXP,,ES-BAUSCH-BL-2021-026873,BAUSCH AND LOMB,,51.0,YR,,M,Y,110.0,KG,20210816.0,,CN,ES,ES,2021,Q3,Adult
197035271,19703527,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, 1F975A,,,10.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Thirst,,2021,Q3,1,I,2021.0,20210801.0,20210816,20210816,EXP,,ES-BAUSCH-BL-2021-026873,BAUSCH AND LOMB,,51.0,YR,,M,Y,110.0,KG,20210816.0,,CN,ES,ES,2021,Q3,Adult
197035271,19703527,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, 1F975A,,,10.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Weight decreased,,2021,Q3,1,I,2021.0,20210801.0,20210816,20210816,EXP,,ES-BAUSCH-BL-2021-026873,BAUSCH AND LOMB,,51.0,YR,,M,Y,110.0,KG,20210816.0,,CN,ES,ES,2021,Q3,Adult
197045132,19704513,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q3,Acute respiratory failure,,2021,Q3,2,F,,20210811.0,20210816,20210819,EXP,,DE-MYLANLABS-2021M1051556,MYLAN,,73.0,YR,,F,Y,,,20210819.0,,PH,DE,DE,2021,Q3,Elderly
197045132,19704513,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q3,Condition aggravated,,2021,Q3,2,F,,20210811.0,20210816,20210819,EXP,,DE-MYLANLABS-2021M1051556,MYLAN,,73.0,YR,,F,Y,,,20210819.0,,PH,DE,DE,2021,Q3,Elderly
197045132,19704513,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q3,Dyspnoea,,2021,Q3,2,F,,20210811.0,20210816,20210819,EXP,,DE-MYLANLABS-2021M1051556,MYLAN,,73.0,YR,,F,Y,,,20210819.0,,PH,DE,DE,2021,Q3,Elderly
197045132,19704513,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q3,Fatigue,,2021,Q3,2,F,,20210811.0,20210816,20210819,EXP,,DE-MYLANLABS-2021M1051556,MYLAN,,73.0,YR,,F,Y,,,20210819.0,,PH,DE,DE,2021,Q3,Elderly
197045132,19704513,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,2,F,,20210811.0,20210816,20210819,EXP,,DE-MYLANLABS-2021M1051556,MYLAN,,73.0,YR,,F,Y,,,20210819.0,,PH,DE,DE,2021,Q3,Elderly
197045132,19704513,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q3,Tachycardia,,2021,Q3,2,F,,20210811.0,20210816,20210819,EXP,,DE-MYLANLABS-2021M1051556,MYLAN,,73.0,YR,,F,Y,,,20210819.0,,PH,DE,DE,2021,Q3,Elderly
197045132,19704513,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q3,Wheezing,,2021,Q3,2,F,,20210811.0,20210816,20210819,EXP,,DE-MYLANLABS-2021M1051556,MYLAN,,73.0,YR,,F,Y,,,20210819.0,,PH,DE,DE,2021,Q3,Elderly
197058491,19705849,14,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,18 INTERNATIONAL UNIT,,,,,,,,18.0,IU,,,2021,Q3,Off label use,,2021,Q3,1,I,,20210803.0,20210817,20210817,PER,,TR-LUPIN PHARMACEUTICALS INC.-2021-14840,LUPIN,,50.0,YR,,M,Y,,,20210817.0,,HP,TR,TR,2021,Q3,Adult
197069521,19706952,19,C,"insulin glargine (LANTUS, BASAGLAR) injection 100 units/mL pen",,2,,,,,,,,,,,,,,2021,Q3,Hypotension,,2021,Q3,1,I,20210610.0,,20210816,20210816,DIR,,,FDA-CTU,,76.0,YR,,M,N,93.6,KG,20210816.0,N,,US,US,2021,Q3,Elderly
197069521,19706952,19,C,"insulin glargine (LANTUS, BASAGLAR) injection 100 units/mL pen",,2,,,,,,,,,,,,,,2021,Q3,Rash erythematous,,2021,Q3,1,I,20210610.0,,20210816,20210816,DIR,,,FDA-CTU,,76.0,YR,,M,N,93.6,KG,20210816.0,N,,US,US,2021,Q3,Elderly
197069521,19706952,19,C,"insulin glargine (LANTUS, BASAGLAR) injection 100 units/mL pen",,2,,,,,,,,,,,,,,2021,Q3,Staphylococcal bacteraemia,,2021,Q3,1,I,20210610.0,,20210816,20210816,DIR,,,FDA-CTU,,76.0,YR,,M,N,93.6,KG,20210816.0,N,,US,US,2021,Q3,Elderly
197069521,19706952,19,C,"insulin glargine (LANTUS, BASAGLAR) injection 100 units/mL pen",,2,,,,,,,,,,,,,,2021,Q3,Stevens-Johnson syndrome,,2021,Q3,1,I,20210610.0,,20210816,20210816,DIR,,,FDA-CTU,,76.0,YR,,M,N,93.6,KG,20210816.0,N,,US,US,2021,Q3,Elderly
197069521,19706952,19,C,"insulin glargine (LANTUS, BASAGLAR) injection 100 units/mL pen",,2,,,,,,,,,,,,,,2021,Q3,Toxic epidermal necrolysis,,2021,Q3,1,I,20210610.0,,20210816,20210816,DIR,,,FDA-CTU,,76.0,YR,,M,N,93.6,KG,20210816.0,N,,US,US,2021,Q3,Elderly
197100252,19710025,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Acute kidney injury,,2021,Q3,2,F,20210225.0,20210921.0,20210816,20210924,EXP,,US-GILEAD-2021-0520462,GILEAD,,69.0,YR,E,M,Y,,,20210924.0,,HP,US,US,2021,Q3,Elderly
197100252,19710025,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Respiratory failure,,2021,Q3,2,F,20210225.0,20210921.0,20210816,20210924,EXP,,US-GILEAD-2021-0520462,GILEAD,,69.0,YR,E,M,Y,,,20210924.0,,HP,US,US,2021,Q3,Elderly
197100252,19710025,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Staphylococcal sepsis,,2021,Q3,2,F,20210225.0,20210921.0,20210816,20210924,EXP,,US-GILEAD-2021-0520462,GILEAD,,69.0,YR,E,M,Y,,,20210924.0,,HP,US,US,2021,Q3,Elderly
197146661,19714666,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Haematemesis,,2021,Q3,1,I,20210730.0,20210814.0,20210818,20210818,EXP,,CN-JNJFOC-20210830641,JOHNSON AND JOHNSON,,73.0,YR,E,F,Y,50.0,KG,20210818.0,,HP,CN,CN,2021,Q3,Elderly
197146661,19714666,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Nausea,,2021,Q3,1,I,20210730.0,20210814.0,20210818,20210818,EXP,,CN-JNJFOC-20210830641,JOHNSON AND JOHNSON,,73.0,YR,E,F,Y,50.0,KG,20210818.0,,HP,CN,CN,2021,Q3,Elderly
197146661,19714666,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Upper gastrointestinal haemorrhage,,2021,Q3,1,I,20210730.0,20210814.0,20210818,20210818,EXP,,CN-JNJFOC-20210830641,JOHNSON AND JOHNSON,,73.0,YR,E,F,Y,50.0,KG,20210818.0,,HP,CN,CN,2021,Q3,Elderly
197163051,19716305,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q3,Arthralgia,,2021,Q3,1,I,,20210811.0,20210818,20210818,EXP,,DE-MYLANLABS-2021M1051742,MYLAN,,74.0,YR,,M,Y,64.0,KG,20210818.0,,PH,DE,DE,2021,Q3,Elderly
197163051,19716305,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q3,Contraindicated product administered,,2021,Q3,1,I,,20210811.0,20210818,20210818,EXP,,DE-MYLANLABS-2021M1051742,MYLAN,,74.0,YR,,M,Y,64.0,KG,20210818.0,,PH,DE,DE,2021,Q3,Elderly
197163051,19716305,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q3,Pain,,2021,Q3,1,I,,20210811.0,20210818,20210818,EXP,,DE-MYLANLABS-2021M1051742,MYLAN,,74.0,YR,,M,Y,64.0,KG,20210818.0,,PH,DE,DE,2021,Q3,Elderly
197163181,19716318,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 INTERNATIONAL UNIT, QD, 0?0?0?1, AMPULLEN",,,,,,,,26.0,IU,,QD,2021,Q3,Abdominal pain,,2021,Q3,1,I,,20210811.0,20210818,20210818,EXP,,DE-MYLANLABS-2021M1051750,MYLAN,,70.0,YR,,F,Y,,,20210818.0,,PH,DE,DE,2021,Q3,Elderly
197163181,19716318,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 INTERNATIONAL UNIT, QD, 0?0?0?1, AMPULLEN",,,,,,,,26.0,IU,,QD,2021,Q3,Anaemia,,2021,Q3,1,I,,20210811.0,20210818,20210818,EXP,,DE-MYLANLABS-2021M1051750,MYLAN,,70.0,YR,,F,Y,,,20210818.0,,PH,DE,DE,2021,Q3,Elderly
197163181,19716318,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 INTERNATIONAL UNIT, QD, 0?0?0?1, AMPULLEN",,,,,,,,26.0,IU,,QD,2021,Q3,Fatigue,,2021,Q3,1,I,,20210811.0,20210818,20210818,EXP,,DE-MYLANLABS-2021M1051750,MYLAN,,70.0,YR,,F,Y,,,20210818.0,,PH,DE,DE,2021,Q3,Elderly
197163181,19716318,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 INTERNATIONAL UNIT, QD, 0?0?0?1, AMPULLEN",,,,,,,,26.0,IU,,QD,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210811.0,20210818,20210818,EXP,,DE-MYLANLABS-2021M1051750,MYLAN,,70.0,YR,,F,Y,,,20210818.0,,PH,DE,DE,2021,Q3,Elderly
197163181,19716318,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 INTERNATIONAL UNIT, QD, 0?0?0?1, AMPULLEN",,,,,,,,26.0,IU,,QD,2021,Q3,Musculoskeletal pain,,2021,Q3,1,I,,20210811.0,20210818,20210818,EXP,,DE-MYLANLABS-2021M1051750,MYLAN,,70.0,YR,,F,Y,,,20210818.0,,PH,DE,DE,2021,Q3,Elderly
197163181,19716318,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 INTERNATIONAL UNIT, QD, 0?0?0?1, AMPULLEN",,,,,,,,26.0,IU,,QD,2021,Q3,Pallor,,2021,Q3,1,I,,20210811.0,20210818,20210818,EXP,,DE-MYLANLABS-2021M1051750,MYLAN,,70.0,YR,,F,Y,,,20210818.0,,PH,DE,DE,2021,Q3,Elderly
197186811,19718681,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK(15U S.C. AT 09.00 P.M.),,,U,U,,,,,,,,2021,Q3,Anxiety,,2021,Q3,1,I,,20210804.0,20210818,20210818,EXP,,IT-AUROBINDO-AUR-APL-2021-034480,AUROBINDO,,33.0,YR,,F,Y,,,20210818.0,,HP,IT,IT,2021,Q3,Young Adult
197186811,19718681,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK(15U S.C. AT 09.00 P.M.),,,U,U,,,,,,,,2021,Q3,Asthenia,,2021,Q3,1,I,,20210804.0,20210818,20210818,EXP,,IT-AUROBINDO-AUR-APL-2021-034480,AUROBINDO,,33.0,YR,,F,Y,,,20210818.0,,HP,IT,IT,2021,Q3,Young Adult
197186811,19718681,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK(15U S.C. AT 09.00 P.M.),,,U,U,,,,,,,,2021,Q3,Blood catecholamines abnormal,,2021,Q3,1,I,,20210804.0,20210818,20210818,EXP,,IT-AUROBINDO-AUR-APL-2021-034480,AUROBINDO,,33.0,YR,,F,Y,,,20210818.0,,HP,IT,IT,2021,Q3,Young Adult
197186811,19718681,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK(15U S.C. AT 09.00 P.M.),,,U,U,,,,,,,,2021,Q3,Exposure during pregnancy,,2021,Q3,1,I,,20210804.0,20210818,20210818,EXP,,IT-AUROBINDO-AUR-APL-2021-034480,AUROBINDO,,33.0,YR,,F,Y,,,20210818.0,,HP,IT,IT,2021,Q3,Young Adult
197186811,19718681,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK(15U S.C. AT 09.00 P.M.),,,U,U,,,,,,,,2021,Q3,Headache,,2021,Q3,1,I,,20210804.0,20210818,20210818,EXP,,IT-AUROBINDO-AUR-APL-2021-034480,AUROBINDO,,33.0,YR,,F,Y,,,20210818.0,,HP,IT,IT,2021,Q3,Young Adult
197186811,19718681,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK(15U S.C. AT 09.00 P.M.),,,U,U,,,,,,,,2021,Q3,Hypertension,,2021,Q3,1,I,,20210804.0,20210818,20210818,EXP,,IT-AUROBINDO-AUR-APL-2021-034480,AUROBINDO,,33.0,YR,,F,Y,,,20210818.0,,HP,IT,IT,2021,Q3,Young Adult
197186811,19718681,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK(15U S.C. AT 09.00 P.M.),,,U,U,,,,,,,,2021,Q3,Hypokalaemia,,2021,Q3,1,I,,20210804.0,20210818,20210818,EXP,,IT-AUROBINDO-AUR-APL-2021-034480,AUROBINDO,,33.0,YR,,F,Y,,,20210818.0,,HP,IT,IT,2021,Q3,Young Adult
197186811,19718681,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK(15U S.C. AT 09.00 P.M.),,,U,U,,,,,,,,2021,Q3,Illness,,2021,Q3,1,I,,20210804.0,20210818,20210818,EXP,,IT-AUROBINDO-AUR-APL-2021-034480,AUROBINDO,,33.0,YR,,F,Y,,,20210818.0,,HP,IT,IT,2021,Q3,Young Adult
197186811,19718681,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK(15U S.C. AT 09.00 P.M.),,,U,U,,,,,,,,2021,Q3,Irritability,,2021,Q3,1,I,,20210804.0,20210818,20210818,EXP,,IT-AUROBINDO-AUR-APL-2021-034480,AUROBINDO,,33.0,YR,,F,Y,,,20210818.0,,HP,IT,IT,2021,Q3,Young Adult
197186811,19718681,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK(15U S.C. AT 09.00 P.M.),,,U,U,,,,,,,,2021,Q3,Live birth,,2021,Q3,1,I,,20210804.0,20210818,20210818,EXP,,IT-AUROBINDO-AUR-APL-2021-034480,AUROBINDO,,33.0,YR,,F,Y,,,20210818.0,,HP,IT,IT,2021,Q3,Young Adult
197186811,19718681,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK(15U S.C. AT 09.00 P.M.),,,U,U,,,,,,,,2021,Q3,Myalgia,,2021,Q3,1,I,,20210804.0,20210818,20210818,EXP,,IT-AUROBINDO-AUR-APL-2021-034480,AUROBINDO,,33.0,YR,,F,Y,,,20210818.0,,HP,IT,IT,2021,Q3,Young Adult
197186811,19718681,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK(15U S.C. AT 09.00 P.M.),,,U,U,,,,,,,,2021,Q3,Palpitations,,2021,Q3,1,I,,20210804.0,20210818,20210818,EXP,,IT-AUROBINDO-AUR-APL-2021-034480,AUROBINDO,,33.0,YR,,F,Y,,,20210818.0,,HP,IT,IT,2021,Q3,Young Adult
197186811,19718681,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK(15U S.C. AT 09.00 P.M.),,,U,U,,,,,,,,2021,Q3,Phaeochromocytoma,,2021,Q3,1,I,,20210804.0,20210818,20210818,EXP,,IT-AUROBINDO-AUR-APL-2021-034480,AUROBINDO,,33.0,YR,,F,Y,,,20210818.0,,HP,IT,IT,2021,Q3,Young Adult
197186811,19718681,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK(15U S.C. AT 09.00 P.M.),,,U,U,,,,,,,,2021,Q3,Phaeochromocytoma crisis,,2021,Q3,1,I,,20210804.0,20210818,20210818,EXP,,IT-AUROBINDO-AUR-APL-2021-034480,AUROBINDO,,33.0,YR,,F,Y,,,20210818.0,,HP,IT,IT,2021,Q3,Young Adult
197186811,19718681,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK(15U S.C. AT 09.00 P.M.),,,U,U,,,,,,,,2021,Q3,Premature labour,,2021,Q3,1,I,,20210804.0,20210818,20210818,EXP,,IT-AUROBINDO-AUR-APL-2021-034480,AUROBINDO,,33.0,YR,,F,Y,,,20210818.0,,HP,IT,IT,2021,Q3,Young Adult
197186811,19718681,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK(15U S.C. AT 09.00 P.M.),,,U,U,,,,,,,,2021,Q3,Product selection error,,2021,Q3,1,I,,20210804.0,20210818,20210818,EXP,,IT-AUROBINDO-AUR-APL-2021-034480,AUROBINDO,,33.0,YR,,F,Y,,,20210818.0,,HP,IT,IT,2021,Q3,Young Adult
197186811,19718681,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK(15U S.C. AT 09.00 P.M.),,,U,U,,,,,,,,2021,Q3,Proteinuria,,2021,Q3,1,I,,20210804.0,20210818,20210818,EXP,,IT-AUROBINDO-AUR-APL-2021-034480,AUROBINDO,,33.0,YR,,F,Y,,,20210818.0,,HP,IT,IT,2021,Q3,Young Adult
197186811,19718681,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK(15U S.C. AT 09.00 P.M.),,,U,U,,,,,,,,2021,Q3,Renal disorder,,2021,Q3,1,I,,20210804.0,20210818,20210818,EXP,,IT-AUROBINDO-AUR-APL-2021-034480,AUROBINDO,,33.0,YR,,F,Y,,,20210818.0,,HP,IT,IT,2021,Q3,Young Adult
197186811,19718681,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK(15U S.C. AT 09.00 P.M.),,,U,U,,,,,,,,2021,Q3,Skin striae,,2021,Q3,1,I,,20210804.0,20210818,20210818,EXP,,IT-AUROBINDO-AUR-APL-2021-034480,AUROBINDO,,33.0,YR,,F,Y,,,20210818.0,,HP,IT,IT,2021,Q3,Young Adult
197186811,19718681,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK(15U S.C. AT 09.00 P.M.),,,U,U,,,,,,,,2021,Q3,Tachycardia,,2021,Q3,1,I,,20210804.0,20210818,20210818,EXP,,IT-AUROBINDO-AUR-APL-2021-034480,AUROBINDO,,33.0,YR,,F,Y,,,20210818.0,,HP,IT,IT,2021,Q3,Young Adult
197211361,19721136,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,16 INTERNATIONAL UNIT,,,U,,,,,16.0,IU,,,2021,Q3,Diabetic metabolic decompensation,,2021,Q3,1,I,,20210813.0,20210818,20210818,EXP,,IT-TAKEDA-2021TEU007057,TAKEDA,"CIARDULLO S, PERSEGHIN G.. STEATOSI EPATICA NON ALCOLICA: NON SEMPRE UNA CONDIZIONE BENIGNA.. ILDIA. 2021?33(2)",47.0,YR,,F,Y,115.0,KG,20210818.0,,HP,IT,IT,2021,Q3,Adult
197211361,19721136,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,16 INTERNATIONAL UNIT,,,U,,,,,16.0,IU,,,2021,Q3,Hypothyroidism,,2021,Q3,1,I,,20210813.0,20210818,20210818,EXP,,IT-TAKEDA-2021TEU007057,TAKEDA,"CIARDULLO S, PERSEGHIN G.. STEATOSI EPATICA NON ALCOLICA: NON SEMPRE UNA CONDIZIONE BENIGNA.. ILDIA. 2021?33(2)",47.0,YR,,F,Y,115.0,KG,20210818.0,,HP,IT,IT,2021,Q3,Adult
197211361,19721136,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,16 INTERNATIONAL UNIT,,,U,,,,,16.0,IU,,,2021,Q3,Therapy partial responder,,2021,Q3,1,I,,20210813.0,20210818,20210818,EXP,,IT-TAKEDA-2021TEU007057,TAKEDA,"CIARDULLO S, PERSEGHIN G.. STEATOSI EPATICA NON ALCOLICA: NON SEMPRE UNA CONDIZIONE BENIGNA.. ILDIA. 2021?33(2)",47.0,YR,,F,Y,115.0,KG,20210818.0,,HP,IT,IT,2021,Q3,Adult
197222841,19722284,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 INTERNATIONAL UNIT,,,,, 0F768A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Fatigue,,2021,Q3,1,I,2019.0,20210812.0,20210819,20210819,EXP,,ES-MYLANLABS-2021M1052174,MYLAN,,71.0,YR,,F,Y,70.0,KG,20210819.0,,CN,ES,ES,2021,Q3,Elderly
197222841,19722284,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 INTERNATIONAL UNIT,,,,, 0F768A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Flatulence,,2021,Q3,1,I,2019.0,20210812.0,20210819,20210819,EXP,,ES-MYLANLABS-2021M1052174,MYLAN,,71.0,YR,,F,Y,70.0,KG,20210819.0,,CN,ES,ES,2021,Q3,Elderly
197222841,19722284,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 INTERNATIONAL UNIT,,,,, 0F768A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,1,I,2019.0,20210812.0,20210819,20210819,EXP,,ES-MYLANLABS-2021M1052174,MYLAN,,71.0,YR,,F,Y,70.0,KG,20210819.0,,CN,ES,ES,2021,Q3,Elderly
197222841,19722284,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,INCREASE 1 IU OF TOUJEO IF THE BASAL GLYCAEMIA GOES ABOVE 130 MG / DL,,,,, 0F768A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Fatigue,,2021,Q3,1,I,2019.0,20210812.0,20210819,20210819,EXP,,ES-MYLANLABS-2021M1052174,MYLAN,,71.0,YR,,F,Y,70.0,KG,20210819.0,,CN,ES,ES,2021,Q3,Elderly
197222841,19722284,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,INCREASE 1 IU OF TOUJEO IF THE BASAL GLYCAEMIA GOES ABOVE 130 MG / DL,,,,, 0F768A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Flatulence,,2021,Q3,1,I,2019.0,20210812.0,20210819,20210819,EXP,,ES-MYLANLABS-2021M1052174,MYLAN,,71.0,YR,,F,Y,70.0,KG,20210819.0,,CN,ES,ES,2021,Q3,Elderly
197222841,19722284,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,INCREASE 1 IU OF TOUJEO IF THE BASAL GLYCAEMIA GOES ABOVE 130 MG / DL,,,,, 0F768A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,1,I,2019.0,20210812.0,20210819,20210819,EXP,,ES-MYLANLABS-2021M1052174,MYLAN,,71.0,YR,,F,Y,70.0,KG,20210819.0,,CN,ES,ES,2021,Q3,Elderly
197278081,19727808,7,C,insulin glargine/insulin lispro,,2,,,,,,,,,,,,,,2021,Q3,Atrial fibrillation,,2021,Q3,1,I,20210816.0,,20210820,20210820,DIR,,,FDA-CTU,,68.0,YR,,M,N,100.0,KG,20210820.0,N,PH,US,US,2021,Q3,Elderly
197278081,19727808,7,C,insulin glargine/insulin lispro,,2,,,,,,,,,,,,,,2021,Q3,Bradycardia,,2021,Q3,1,I,20210816.0,,20210820,20210820,DIR,,,FDA-CTU,,68.0,YR,,M,N,100.0,KG,20210820.0,N,PH,US,US,2021,Q3,Elderly
197278081,19727808,7,C,insulin glargine/insulin lispro,,2,,,,,,,,,,,,,,2021,Q3,Rhythm idioventricular,,2021,Q3,1,I,20210816.0,,20210820,20210820,DIR,,,FDA-CTU,,68.0,YR,,M,N,100.0,KG,20210820.0,N,PH,US,US,2021,Q3,Elderly
197298611,19729861,1,PS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,,UNK,,,,, BF20002483,,210605.0,,,INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,1,I,202106.0,20210701.0,20210820,20210820,PER,,US-MYLANLABS-2021M1040840,MYLAN,,40.0,YR,,F,Y,118.3,KG,20210820.0,,CN,US,US,2021,Q3,Adult
197298611,19729861,1,PS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,,UNK,,,,, BF20002483,,210605.0,,,INJECTION,,2021,Q3,Device issue,,2021,Q3,1,I,202106.0,20210701.0,20210820,20210820,PER,,US-MYLANLABS-2021M1040840,MYLAN,,40.0,YR,,F,Y,118.3,KG,20210820.0,,CN,US,US,2021,Q3,Adult
197298611,19729861,1,PS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,,UNK,,,,, BF20002483,,210605.0,,,INJECTION,,2021,Q3,Glycosylated haemoglobin decreased,,2021,Q3,1,I,202106.0,20210701.0,20210820,20210820,PER,,US-MYLANLABS-2021M1040840,MYLAN,,40.0,YR,,F,Y,118.3,KG,20210820.0,,CN,US,US,2021,Q3,Adult
197298611,19729861,1,PS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,,UNK,,,,, BF20002483,,210605.0,,,INJECTION,,2021,Q3,Injection site pain,,2021,Q3,1,I,202106.0,20210701.0,20210820,20210820,PER,,US-MYLANLABS-2021M1040840,MYLAN,,40.0,YR,,F,Y,118.3,KG,20210820.0,,CN,US,US,2021,Q3,Adult
197298611,19729861,1,PS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,,UNK,,,,, BF20002483,,210605.0,,,INJECTION,,2021,Q3,Product dose omission issue,,2021,Q3,1,I,202106.0,20210701.0,20210820,20210820,PER,,US-MYLANLABS-2021M1040840,MYLAN,,40.0,YR,,F,Y,118.3,KG,20210820.0,,CN,US,US,2021,Q3,Adult
197298611,19729861,1,PS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,,UNK,,,,, BF20002483,,210605.0,,,INJECTION,,2021,Q3,Vision blurred,,2021,Q3,1,I,202106.0,20210701.0,20210820,20210820,PER,,US-MYLANLABS-2021M1040840,MYLAN,,40.0,YR,,F,Y,118.3,KG,20210820.0,,CN,US,US,2021,Q3,Adult
197298611,19729861,1,PS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,,UNK,,,,, BF20002483,,210605.0,,,INJECTION,,2021,Q3,Weight decreased,,2021,Q3,1,I,202106.0,20210701.0,20210820,20210820,PER,,US-MYLANLABS-2021M1040840,MYLAN,,40.0,YR,,F,Y,118.3,KG,20210820.0,,CN,US,US,2021,Q3,Adult
197298611,19729861,2,SS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,,"100 UNITS/ MILLILITER, 65 UNITS",,,,, BF20001997,,210605.0,,,INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,1,I,202106.0,20210701.0,20210820,20210820,PER,,US-MYLANLABS-2021M1040840,MYLAN,,40.0,YR,,F,Y,118.3,KG,20210820.0,,CN,US,US,2021,Q3,Adult
197298611,19729861,2,SS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,,"100 UNITS/ MILLILITER, 65 UNITS",,,,, BF20001997,,210605.0,,,INJECTION,,2021,Q3,Device issue,,2021,Q3,1,I,202106.0,20210701.0,20210820,20210820,PER,,US-MYLANLABS-2021M1040840,MYLAN,,40.0,YR,,F,Y,118.3,KG,20210820.0,,CN,US,US,2021,Q3,Adult
197298611,19729861,2,SS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,,"100 UNITS/ MILLILITER, 65 UNITS",,,,, BF20001997,,210605.0,,,INJECTION,,2021,Q3,Glycosylated haemoglobin decreased,,2021,Q3,1,I,202106.0,20210701.0,20210820,20210820,PER,,US-MYLANLABS-2021M1040840,MYLAN,,40.0,YR,,F,Y,118.3,KG,20210820.0,,CN,US,US,2021,Q3,Adult
197298611,19729861,2,SS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,,"100 UNITS/ MILLILITER, 65 UNITS",,,,, BF20001997,,210605.0,,,INJECTION,,2021,Q3,Injection site pain,,2021,Q3,1,I,202106.0,20210701.0,20210820,20210820,PER,,US-MYLANLABS-2021M1040840,MYLAN,,40.0,YR,,F,Y,118.3,KG,20210820.0,,CN,US,US,2021,Q3,Adult
197298611,19729861,2,SS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,,"100 UNITS/ MILLILITER, 65 UNITS",,,,, BF20001997,,210605.0,,,INJECTION,,2021,Q3,Product dose omission issue,,2021,Q3,1,I,202106.0,20210701.0,20210820,20210820,PER,,US-MYLANLABS-2021M1040840,MYLAN,,40.0,YR,,F,Y,118.3,KG,20210820.0,,CN,US,US,2021,Q3,Adult
197298611,19729861,2,SS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,,"100 UNITS/ MILLILITER, 65 UNITS",,,,, BF20001997,,210605.0,,,INJECTION,,2021,Q3,Vision blurred,,2021,Q3,1,I,202106.0,20210701.0,20210820,20210820,PER,,US-MYLANLABS-2021M1040840,MYLAN,,40.0,YR,,F,Y,118.3,KG,20210820.0,,CN,US,US,2021,Q3,Adult
197298611,19729861,2,SS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,,"100 UNITS/ MILLILITER, 65 UNITS",,,,, BF20001997,,210605.0,,,INJECTION,,2021,Q3,Weight decreased,,2021,Q3,1,I,202106.0,20210701.0,20210820,20210820,PER,,US-MYLANLABS-2021M1040840,MYLAN,,40.0,YR,,F,Y,118.3,KG,20210820.0,,CN,US,US,2021,Q3,Adult
197314611,19731461,1,PS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,Subcutaneous,"35 INTERNATIONAL UNIT PER MILLILITRE, QD (35 UNITS A DAY)",,,,, BF20001998,,210605.0,,,INJECTION,QD,2021,Q3,Device issue,,2021,Q3,1,I,20210709.0,20210714.0,20210820,20210820,PER,,US-MYLANLABS-2021M1043238,MYLAN,,61.0,YR,,M,Y,,,20210820.0,,CN,US,US,2021,Q3,Adult
197314611,19731461,1,PS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,Subcutaneous,"35 INTERNATIONAL UNIT PER MILLILITRE, QD (35 UNITS A DAY)",,,,, BF20001998,,210605.0,,,INJECTION,QD,2021,Q3,Product dose omission issue,,2021,Q3,1,I,20210709.0,20210714.0,20210820,20210820,PER,,US-MYLANLABS-2021M1043238,MYLAN,,61.0,YR,,M,Y,,,20210820.0,,CN,US,US,2021,Q3,Adult
197316521,19731652,1,PS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,Subcutaneous,"UNK, PRN (TAKE 22 UNITS AT NIGHT)",,,,, BF20001609,,210605.0,,,INJECTION,,2021,Q3,Device issue,,2021,Q3,1,I,20210720.0,20210720.0,20210820,20210820,PER,,US-MYLANLABS-2021M1044787,MYLAN,,57.0,YR,,F,Y,78.0,KG,20210820.0,,CN,US,US,2021,Q3,Adult
197316521,19731652,1,PS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,Subcutaneous,"UNK, PRN (TAKE 22 UNITS AT NIGHT)",,,,, BF20001609,,210605.0,,,INJECTION,,2021,Q3,Wrong technique in device usage process,,2021,Q3,1,I,20210720.0,20210720.0,20210820,20210820,PER,,US-MYLANLABS-2021M1044787,MYLAN,,57.0,YR,,F,Y,78.0,KG,20210820.0,,CN,US,US,2021,Q3,Adult
197350201,19735020,1,PS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,205692.0,,,,,2021,Q3,Acute myocardial infarction,,2021,Q3,1,I,,20210811.0,20210823,20210823,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202108005914,ELI LILLY AND CO,"MINEOKA Y,ET AL..A CASE OF TYPE 2 DIABETES MICHIOCARDIAL INFARCTION DURING PERIOPERATIVE GLYCEMIC CONTROL.MUNICIPAL OTSU MUNICIPAL HOSPITAL MAGAZINE 2021?21:31?34.",75.0,YR,,M,Y,61.0,KG,20210823.0,,MD,JP,JP,2021,Q3,Elderly
197360571,19736057,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 IE, 1?0?0?0",,,,,,,,,,,,2021,Q3,Decreased appetite,,2021,Q3,1,I,,20210816.0,20210823,20210823,EXP,,DE-MYLANLABS-2021M1053404,MYLAN,,90.0,YR,,M,Y,,,20210823.0,,MD,DE,DE,2021,Q3,Elderly
197360571,19736057,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 IE, 1?0?0?0",,,,,,,,,,,,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210816.0,20210823,20210823,EXP,,DE-MYLANLABS-2021M1053404,MYLAN,,90.0,YR,,M,Y,,,20210823.0,,MD,DE,DE,2021,Q3,Elderly
197360571,19736057,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 IE, 1?0?0?0",,,,,,,,,,,,2021,Q3,Dizziness,,2021,Q3,1,I,,20210816.0,20210823,20210823,EXP,,DE-MYLANLABS-2021M1053404,MYLAN,,90.0,YR,,M,Y,,,20210823.0,,MD,DE,DE,2021,Q3,Elderly
197373151,19737315,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 U, DAILY (NIGHT)",,,,,,,,8.0,IU,,QD,2021,Q3,Blood glucose increased,,2021,Q3,1,I,,20210811.0,20210823,20210823,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202108005386,ELI LILLY AND CO,,40.0,YR,,M,Y,57.0,KG,20210823.0,,CN,CN,CN,2021,Q3,Adult
197373151,19737315,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 U, DAILY (NIGHT)",,,,,,,,8.0,IU,,QD,2021,Q3,Weight decreased,,2021,Q3,1,I,,20210811.0,20210823,20210823,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202108005386,ELI LILLY AND CO,,40.0,YR,,M,Y,57.0,KG,20210823.0,,CN,CN,CN,2021,Q3,Adult
197376102,19737610,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Cardiac failure congestive,,2021,Q3,2,F,20210619.0,20210826.0,20210824,20210827,EXP,,NVSC2021US141256,NOVARTIS,,41.0,YR,,F,Y,92.6,KG,20210827.0,,HP,US,US,2021,Q3,Adult
197376102,19737610,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Diabetic ketoacidosis,,2021,Q3,2,F,20210619.0,20210826.0,20210824,20210827,EXP,,NVSC2021US141256,NOVARTIS,,41.0,YR,,F,Y,92.6,KG,20210827.0,,HP,US,US,2021,Q3,Adult
197379961,19737996,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 INTERNATIONAL UNIT, QD",,,,,,,,26.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Abdominal pain,,2021,Q3,1,I,,20210817.0,20210823,20210823,EXP,,ES-MYLANLABS-2021M1053455,MYLAN,,38.0,YR,,M,Y,,,20210823.0,,CN,ES,ES,2021,Q3,Adult
197379961,19737996,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 INTERNATIONAL UNIT, QD",,,,,,,,26.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,1,I,,20210817.0,20210823,20210823,EXP,,ES-MYLANLABS-2021M1053455,MYLAN,,38.0,YR,,M,Y,,,20210823.0,,CN,ES,ES,2021,Q3,Adult
197379961,19737996,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 INTERNATIONAL UNIT, QD",,,,,,,,26.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210817.0,20210823,20210823,EXP,,ES-MYLANLABS-2021M1053455,MYLAN,,38.0,YR,,M,Y,,,20210823.0,,CN,ES,ES,2021,Q3,Adult
197379961,19737996,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 INTERNATIONAL UNIT, QD",,,,,,,,26.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Haematochezia,,2021,Q3,1,I,,20210817.0,20210823,20210823,EXP,,ES-MYLANLABS-2021M1053455,MYLAN,,38.0,YR,,M,Y,,,20210823.0,,CN,ES,ES,2021,Q3,Adult
197379961,19737996,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 INTERNATIONAL UNIT, QD",,,,,,,,26.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Illness,,2021,Q3,1,I,,20210817.0,20210823,20210823,EXP,,ES-MYLANLABS-2021M1053455,MYLAN,,38.0,YR,,M,Y,,,20210823.0,,CN,ES,ES,2021,Q3,Adult
197379961,19737996,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 INTERNATIONAL UNIT, QD",,,,,,,,26.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Influenza,,2021,Q3,1,I,,20210817.0,20210823,20210823,EXP,,ES-MYLANLABS-2021M1053455,MYLAN,,38.0,YR,,M,Y,,,20210823.0,,CN,ES,ES,2021,Q3,Adult
197379961,19737996,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 INTERNATIONAL UNIT, QD",,,,,,,,26.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Limb discomfort,,2021,Q3,1,I,,20210817.0,20210823,20210823,EXP,,ES-MYLANLABS-2021M1053455,MYLAN,,38.0,YR,,M,Y,,,20210823.0,,CN,ES,ES,2021,Q3,Adult
197379961,19737996,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 INTERNATIONAL UNIT, QD",,,,,,,,26.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Weight decreased,,2021,Q3,1,I,,20210817.0,20210823,20210823,EXP,,ES-MYLANLABS-2021M1053455,MYLAN,,38.0,YR,,M,Y,,,20210823.0,,CN,ES,ES,2021,Q3,Adult
197392592,19739259,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,Y,U, 1F013A,,,16.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,2,F,2021.0,20210921.0,20210824,20210928,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-121599",BOEHRINGER INGELHEIM,,77.0,YR,E,F,Y,58.6,KG,20210928.0,,HP,ES,ES,2021,Q3,Elderly
197392592,19739259,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,Y,U, 1F013A,,,16.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Depressed mood,,2021,Q3,2,F,2021.0,20210921.0,20210824,20210928,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-121599",BOEHRINGER INGELHEIM,,77.0,YR,E,F,Y,58.6,KG,20210928.0,,HP,ES,ES,2021,Q3,Elderly
197392592,19739259,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,Y,U, 1F013A,,,16.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hypoglycaemia,,2021,Q3,2,F,2021.0,20210921.0,20210824,20210928,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-121599",BOEHRINGER INGELHEIM,,77.0,YR,E,F,Y,58.6,KG,20210928.0,,HP,ES,ES,2021,Q3,Elderly
197392592,19739259,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,Y,U, 1F013A,,,16.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Listless,,2021,Q3,2,F,2021.0,20210921.0,20210824,20210928,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-121599",BOEHRINGER INGELHEIM,,77.0,YR,E,F,Y,58.6,KG,20210928.0,,HP,ES,ES,2021,Q3,Elderly
197392592,19739259,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD",,,Y,U, 1F975A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,2,F,2021.0,20210921.0,20210824,20210928,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-121599",BOEHRINGER INGELHEIM,,77.0,YR,E,F,Y,58.6,KG,20210928.0,,HP,ES,ES,2021,Q3,Elderly
197392592,19739259,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD",,,Y,U, 1F975A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Depressed mood,,2021,Q3,2,F,2021.0,20210921.0,20210824,20210928,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-121599",BOEHRINGER INGELHEIM,,77.0,YR,E,F,Y,58.6,KG,20210928.0,,HP,ES,ES,2021,Q3,Elderly
197392592,19739259,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD",,,Y,U, 1F975A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hypoglycaemia,,2021,Q3,2,F,2021.0,20210921.0,20210824,20210928,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-121599",BOEHRINGER INGELHEIM,,77.0,YR,E,F,Y,58.6,KG,20210928.0,,HP,ES,ES,2021,Q3,Elderly
197392592,19739259,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD",,,Y,U, 1F975A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Listless,,2021,Q3,2,F,2021.0,20210921.0,20210824,20210928,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-121599",BOEHRINGER INGELHEIM,,77.0,YR,E,F,Y,58.6,KG,20210928.0,,HP,ES,ES,2021,Q3,Elderly
197393063,19739306,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Colitis,,2021,Q3,3,F,20210811.0,20210924.0,20210824,20210928,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-083340,BRISTOL MYERS SQUIBB,,73.0,YR,,F,Y,69.0,KG,20210928.0,,HP,ES,ES,2021,Q3,Elderly
197393063,19739306,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Sepsis,,2021,Q3,3,F,20210811.0,20210924.0,20210824,20210928,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-083340,BRISTOL MYERS SQUIBB,,73.0,YR,,F,Y,69.0,KG,20210928.0,,HP,ES,ES,2021,Q3,Elderly
197408341,19740834,4,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,16 INTERNATIONAL UNIT,,,U,U,,,,16.0,IU,,,2021,Q3,Diabetic metabolic decompensation,,2021,Q3,1,I,,20210810.0,20210825,20210825,EXP,,IT-AUROBINDO-AUR-APL-2021-035533,AUROBINDO,,47.0,YR,,F,Y,115.0,KG,20210825.0,,HP,IT,IT,2021,Q3,Adult
197408341,19740834,4,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,16 INTERNATIONAL UNIT,,,U,U,,,,16.0,IU,,,2021,Q3,Hypothyroidism,,2021,Q3,1,I,,20210810.0,20210825,20210825,EXP,,IT-AUROBINDO-AUR-APL-2021-035533,AUROBINDO,,47.0,YR,,F,Y,115.0,KG,20210825.0,,HP,IT,IT,2021,Q3,Adult
197408341,19740834,4,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,16 INTERNATIONAL UNIT,,,U,U,,,,16.0,IU,,,2021,Q3,Therapy partial responder,,2021,Q3,1,I,,20210810.0,20210825,20210825,EXP,,IT-AUROBINDO-AUR-APL-2021-035533,AUROBINDO,,47.0,YR,,F,Y,115.0,KG,20210825.0,,HP,IT,IT,2021,Q3,Adult
197433804,19743380,36,C,GLARGINE BS,,2,Subcutaneous,28 UNITS,,,D,,,,,,,,QD,2021,Q3,Cerebral haemorrhage,,2021,Q3,4,F,20210813.0,20210914.0,20210824,20210921,EXP,,JP-ABBVIE-21P-087-4046479-00,ABBVIE,,23.0,YR,,F,Y,64.1,KG,20210921.0,,MD,JP,JP,2021,Q3,Youth
197433804,19743380,36,C,GLARGINE BS,,2,Subcutaneous,28 UNITS,,,D,,,,,,,,QD,2021,Q3,Sepsis,,2021,Q3,4,F,20210813.0,20210914.0,20210824,20210921,EXP,,JP-ABBVIE-21P-087-4046479-00,ABBVIE,,23.0,YR,,F,Y,64.1,KG,20210921.0,,MD,JP,JP,2021,Q3,Youth
197442521,19744252,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"16 IU, ACCORDING TO PLAN, SOLUTION FOR INJECTION / INFUSION",,,U,U,,,,16.0,IU,,,2021,Q3,Bradycardia,,2021,Q3,1,I,,20210817.0,20210825,20210825,EXP,,DE-MYLANLABS-2021M1053684,MYLAN,,71.0,YR,,F,Y,,,20210825.0,,MD,DE,DE,2021,Q3,Elderly
197442521,19744252,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"16 IU, ACCORDING TO PLAN, SOLUTION FOR INJECTION / INFUSION",,,U,U,,,,16.0,IU,,,2021,Q3,Dizziness,,2021,Q3,1,I,,20210817.0,20210825,20210825,EXP,,DE-MYLANLABS-2021M1053684,MYLAN,,71.0,YR,,F,Y,,,20210825.0,,MD,DE,DE,2021,Q3,Elderly
197442521,19744252,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"16 IU, ACCORDING TO PLAN, SOLUTION FOR INJECTION / INFUSION",,,U,U,,,,16.0,IU,,,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20210817.0,20210825,20210825,EXP,,DE-MYLANLABS-2021M1053684,MYLAN,,71.0,YR,,F,Y,,,20210825.0,,MD,DE,DE,2021,Q3,Elderly
197442521,19744252,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"16 IU, ACCORDING TO PLAN, SOLUTION FOR INJECTION / INFUSION",,,U,U,,,,16.0,IU,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210817.0,20210825,20210825,EXP,,DE-MYLANLABS-2021M1053684,MYLAN,,71.0,YR,,F,Y,,,20210825.0,,MD,DE,DE,2021,Q3,Elderly
197442521,19744252,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"16 IU, ACCORDING TO PLAN, SOLUTION FOR INJECTION / INFUSION",,,U,U,,,,16.0,IU,,,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,,20210817.0,20210825,20210825,EXP,,DE-MYLANLABS-2021M1053684,MYLAN,,71.0,YR,,F,Y,,,20210825.0,,MD,DE,DE,2021,Q3,Elderly
197446661,19744666,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q3,Arteriosclerosis coronary artery,,2021,Q3,1,I,,20210816.0,20210825,20210825,EXP,,CA-APOTEX-2021AP035906,APOTEX,,71.0,YR,,M,Y,,,20210825.0,,CN,CA,CA,2021,Q3,Elderly
197446661,19744666,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q3,Chest pain,,2021,Q3,1,I,,20210816.0,20210825,20210825,EXP,,CA-APOTEX-2021AP035906,APOTEX,,71.0,YR,,M,Y,,,20210825.0,,CN,CA,CA,2021,Q3,Elderly
197446661,19744666,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q3,Dyspnoea exertional,,2021,Q3,1,I,,20210816.0,20210825,20210825,EXP,,CA-APOTEX-2021AP035906,APOTEX,,71.0,YR,,M,Y,,,20210825.0,,CN,CA,CA,2021,Q3,Elderly
197446661,19744666,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q3,Pneumonia,,2021,Q3,1,I,,20210816.0,20210825,20210825,EXP,,CA-APOTEX-2021AP035906,APOTEX,,71.0,YR,,M,Y,,,20210825.0,,CN,CA,CA,2021,Q3,Elderly
197446661,19744666,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,D,,,,,,,,,2021,Q3,Arteriosclerosis coronary artery,,2021,Q3,1,I,,20210816.0,20210825,20210825,EXP,,CA-APOTEX-2021AP035906,APOTEX,,71.0,YR,,M,Y,,,20210825.0,,CN,CA,CA,2021,Q3,Elderly
197446661,19744666,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,D,,,,,,,,,2021,Q3,Chest pain,,2021,Q3,1,I,,20210816.0,20210825,20210825,EXP,,CA-APOTEX-2021AP035906,APOTEX,,71.0,YR,,M,Y,,,20210825.0,,CN,CA,CA,2021,Q3,Elderly
197446661,19744666,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,D,,,,,,,,,2021,Q3,Dyspnoea exertional,,2021,Q3,1,I,,20210816.0,20210825,20210825,EXP,,CA-APOTEX-2021AP035906,APOTEX,,71.0,YR,,M,Y,,,20210825.0,,CN,CA,CA,2021,Q3,Elderly
197446661,19744666,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,D,,,,,,,,,2021,Q3,Pneumonia,,2021,Q3,1,I,,20210816.0,20210825,20210825,EXP,,CA-APOTEX-2021AP035906,APOTEX,,71.0,YR,,M,Y,,,20210825.0,,CN,CA,CA,2021,Q3,Elderly
197454701,19745470,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,6 TO 10 UNITS WITH MEALS,,,,,,,,,,,,2021,Q3,Ankle fracture,,2021,Q3,1,I,201602.0,20210819.0,20210825,20210825,EXP,,DE-MYLANLABS-2021M1054589,MYLAN,,73.0,YR,,M,Y,87.0,KG,20210825.0,,MD,DE,DE,2021,Q3,Elderly
197454701,19745470,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,6 TO 10 UNITS WITH MEALS,,,,,,,,,,,,2021,Q3,Atrial fibrillation,,2021,Q3,1,I,201602.0,20210819.0,20210825,20210825,EXP,,DE-MYLANLABS-2021M1054589,MYLAN,,73.0,YR,,M,Y,87.0,KG,20210825.0,,MD,DE,DE,2021,Q3,Elderly
197454701,19745470,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,6 TO 10 UNITS WITH MEALS,,,,,,,,,,,,2021,Q3,Coronary artery disease,,2021,Q3,1,I,201602.0,20210819.0,20210825,20210825,EXP,,DE-MYLANLABS-2021M1054589,MYLAN,,73.0,YR,,M,Y,87.0,KG,20210825.0,,MD,DE,DE,2021,Q3,Elderly
197454701,19745470,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,6 TO 10 UNITS WITH MEALS,,,,,,,,,,,,2021,Q3,Hypercholesterolaemia,,2021,Q3,1,I,201602.0,20210819.0,20210825,20210825,EXP,,DE-MYLANLABS-2021M1054589,MYLAN,,73.0,YR,,M,Y,87.0,KG,20210825.0,,MD,DE,DE,2021,Q3,Elderly
197454701,19745470,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,6 TO 10 UNITS WITH MEALS,,,,,,,,,,,,2021,Q3,Hypertension,,2021,Q3,1,I,201602.0,20210819.0,20210825,20210825,EXP,,DE-MYLANLABS-2021M1054589,MYLAN,,73.0,YR,,M,Y,87.0,KG,20210825.0,,MD,DE,DE,2021,Q3,Elderly
197454701,19745470,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,6 TO 10 UNITS WITH MEALS,,,,,,,,,,,,2021,Q3,Lower limb fracture,,2021,Q3,1,I,201602.0,20210819.0,20210825,20210825,EXP,,DE-MYLANLABS-2021M1054589,MYLAN,,73.0,YR,,M,Y,87.0,KG,20210825.0,,MD,DE,DE,2021,Q3,Elderly
197454701,19745470,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,6 TO 10 UNITS WITH MEALS,,,,,,,,,,,,2021,Q3,Myocardial infarction,,2021,Q3,1,I,201602.0,20210819.0,20210825,20210825,EXP,,DE-MYLANLABS-2021M1054589,MYLAN,,73.0,YR,,M,Y,87.0,KG,20210825.0,,MD,DE,DE,2021,Q3,Elderly
197454701,19745470,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,6 TO 10 UNITS WITH MEALS,,,,,,,,,,,,2021,Q3,Obesity,,2021,Q3,1,I,201602.0,20210819.0,20210825,20210825,EXP,,DE-MYLANLABS-2021M1054589,MYLAN,,73.0,YR,,M,Y,87.0,KG,20210825.0,,MD,DE,DE,2021,Q3,Elderly
197454701,19745470,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,6 TO 10 UNITS WITH MEALS,,,,,,,,,,,,2021,Q3,Peripheral arterial occlusive disease,,2021,Q3,1,I,201602.0,20210819.0,20210825,20210825,EXP,,DE-MYLANLABS-2021M1054589,MYLAN,,73.0,YR,,M,Y,87.0,KG,20210825.0,,MD,DE,DE,2021,Q3,Elderly
197460702,19746070,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,16 LU,,,U,,,,,16.0,IU,,,2021,Q3,Diabetic metabolic decompensation,,2021,Q3,2,F,,20210902.0,20210825,20210916,EXP,,IT-BAUSCH-BL-2021-027975,BAUSCH AND LOMB,"CIARDULLO S, PERSEGHIN G. STEATOSI EPATICA NON ALCOLICA: NON SEMPRE UNA CONDIZIONE BENIGNA. AGGIORNAMEN TO CLINICO. 2021 JUL?33(2):173?178. DOI:10.30682/ILDIA2102G",47.0,YR,,F,Y,115.0,KG,20210916.0,,HP,IT,IT,2021,Q3,Adult
197460702,19746070,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,16 LU,,,U,,,,,16.0,IU,,,2021,Q3,Hypothyroidism,,2021,Q3,2,F,,20210902.0,20210825,20210916,EXP,,IT-BAUSCH-BL-2021-027975,BAUSCH AND LOMB,"CIARDULLO S, PERSEGHIN G. STEATOSI EPATICA NON ALCOLICA: NON SEMPRE UNA CONDIZIONE BENIGNA. AGGIORNAMEN TO CLINICO. 2021 JUL?33(2):173?178. DOI:10.30682/ILDIA2102G",47.0,YR,,F,Y,115.0,KG,20210916.0,,HP,IT,IT,2021,Q3,Adult
197460702,19746070,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,16 LU,,,U,,,,,16.0,IU,,,2021,Q3,Therapy partial responder,,2021,Q3,2,F,,20210902.0,20210825,20210916,EXP,,IT-BAUSCH-BL-2021-027975,BAUSCH AND LOMB,"CIARDULLO S, PERSEGHIN G. STEATOSI EPATICA NON ALCOLICA: NON SEMPRE UNA CONDIZIONE BENIGNA. AGGIORNAMEN TO CLINICO. 2021 JUL?33(2):173?178. DOI:10.30682/ILDIA2102G",47.0,YR,,F,Y,115.0,KG,20210916.0,,HP,IT,IT,2021,Q3,Adult
197470283,19747028,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2021,Q3,Drug eruption,,2021,Q3,3,F,20190523.0,20210825.0,20210826,20210907,EXP,,"US-MELINTA THERAPEUTICS, LLC-US-MLNT-20-00085",MELINTA THERAPEUTICS,"RYBAK M, ALOSAIMY S, JORGENSEN S, LAGNF A, MELVIN S, MYNATT R, CARLSON T, GAREY K, DAVID A, VENUGOPALAN V, VEVE M, ATHANS V, SAW S, YOST C, SUSAN D. REAL?WORLD MULTICENTER ANALYSIS OF CLINICAL OUTCOMES AND SAFETY OF MEROPENEM?VABORBACTAM IN PATIENTS TREATED FOR SERIOUS GRAM?NEGATIVE BACTERIAL INFECTIONS. OXFORD UNIVERSITY PRESS. 2020?1?15.",62.0,YR,,F,Y,83.9,KG,20210907.0,,,COUNTRY NOT SPECIFIED,US,2021,Q3,Adult
197470283,19747028,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2021,Q3,Stevens-Johnson syndrome,,2021,Q3,3,F,20190523.0,20210825.0,20210826,20210907,EXP,,"US-MELINTA THERAPEUTICS, LLC-US-MLNT-20-00085",MELINTA THERAPEUTICS,"RYBAK M, ALOSAIMY S, JORGENSEN S, LAGNF A, MELVIN S, MYNATT R, CARLSON T, GAREY K, DAVID A, VENUGOPALAN V, VEVE M, ATHANS V, SAW S, YOST C, SUSAN D. REAL?WORLD MULTICENTER ANALYSIS OF CLINICAL OUTCOMES AND SAFETY OF MEROPENEM?VABORBACTAM IN PATIENTS TREATED FOR SERIOUS GRAM?NEGATIVE BACTERIAL INFECTIONS. OXFORD UNIVERSITY PRESS. 2020?1?15.",62.0,YR,,F,Y,83.9,KG,20210907.0,,,COUNTRY NOT SPECIFIED,US,2021,Q3,Adult
197470283,19747028,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2021,Q3,Toxic epidermal necrolysis,,2021,Q3,3,F,20190523.0,20210825.0,20210826,20210907,EXP,,"US-MELINTA THERAPEUTICS, LLC-US-MLNT-20-00085",MELINTA THERAPEUTICS,"RYBAK M, ALOSAIMY S, JORGENSEN S, LAGNF A, MELVIN S, MYNATT R, CARLSON T, GAREY K, DAVID A, VENUGOPALAN V, VEVE M, ATHANS V, SAW S, YOST C, SUSAN D. REAL?WORLD MULTICENTER ANALYSIS OF CLINICAL OUTCOMES AND SAFETY OF MEROPENEM?VABORBACTAM IN PATIENTS TREATED FOR SERIOUS GRAM?NEGATIVE BACTERIAL INFECTIONS. OXFORD UNIVERSITY PRESS. 2020?1?15.",62.0,YR,,F,Y,83.9,KG,20210907.0,,,COUNTRY NOT SPECIFIED,US,2021,Q3,Adult
197491081,19749108,6,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Peripheral artery thrombosis,,2021,Q3,1,I,20210824.0,,20210825,20210825,DIR,,,FDA-CTU,,73.0,YR,,M,N,86.5,KG,20210825.0,N,PH,US,US,2021,Q3,Elderly
197491081,19749108,6,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Thrombosis,,2021,Q3,1,I,20210824.0,,20210825,20210825,DIR,,,FDA-CTU,,73.0,YR,,M,N,86.5,KG,20210825.0,N,PH,US,US,2021,Q3,Elderly
197495171,19749517,11,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Death,,2021,Q3,1,I,20210715.0,,20210824,20210824,DIR,,,FDA-CTU,,74.0,YR,,F,N,,,20210824.0,Y,PH,US,US,2021,Q3,Elderly
197511301,19751130,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Acute kidney injury,,2021,Q3,1,I,20210528.0,20210816.0,20210826,20210826,EXP,,US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2021-000365,VALIDUS,,77.0,YR,,F,Y,87.7,KG,20210826.0,,CN,US,US,2021,Q3,Elderly
197511301,19751130,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Blood creatine increased,,2021,Q3,1,I,20210528.0,20210816.0,20210826,20210826,EXP,,US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2021-000365,VALIDUS,,77.0,YR,,F,Y,87.7,KG,20210826.0,,CN,US,US,2021,Q3,Elderly
197547432,19754743,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,, UNK,,,,,,,2021,Q3,Acute kidney injury,,2021,Q3,2,F,,20210820.0,20210827,20210831,EXP,,US-EMCURE PHARMACEUTICALS LTD-2021-EPL-002753,EMCURE,"SCHNEIR A, MASOM CP. LITHIUM TOXICITY FROM THE ADDITION OF AN ACE INHIBITOR WITH AN UNEXPECTED TYPE I BRUGADA PATTERN ECG: CASE FILES OF THE MEDICAL TOXICOLOGY FELLOWSHIP AT THE UNIVERSITY OF CALIFORNIA, SAN DIEGO. JOURNAL OF MEDICAL TOXICOLOGY. 2020?16(3)::321?8",48.0,YR,,F,Y,,,20210826.0,,HP,US,US,2021,Q3,Adult
197547432,19754743,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,, UNK,,,,,,,2021,Q3,Confusional state,,2021,Q3,2,F,,20210820.0,20210827,20210831,EXP,,US-EMCURE PHARMACEUTICALS LTD-2021-EPL-002753,EMCURE,"SCHNEIR A, MASOM CP. LITHIUM TOXICITY FROM THE ADDITION OF AN ACE INHIBITOR WITH AN UNEXPECTED TYPE I BRUGADA PATTERN ECG: CASE FILES OF THE MEDICAL TOXICOLOGY FELLOWSHIP AT THE UNIVERSITY OF CALIFORNIA, SAN DIEGO. JOURNAL OF MEDICAL TOXICOLOGY. 2020?16(3)::321?8",48.0,YR,,F,Y,,,20210826.0,,HP,US,US,2021,Q3,Adult
197547432,19754743,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,, UNK,,,,,,,2021,Q3,Dizziness,,2021,Q3,2,F,,20210820.0,20210827,20210831,EXP,,US-EMCURE PHARMACEUTICALS LTD-2021-EPL-002753,EMCURE,"SCHNEIR A, MASOM CP. LITHIUM TOXICITY FROM THE ADDITION OF AN ACE INHIBITOR WITH AN UNEXPECTED TYPE I BRUGADA PATTERN ECG: CASE FILES OF THE MEDICAL TOXICOLOGY FELLOWSHIP AT THE UNIVERSITY OF CALIFORNIA, SAN DIEGO. JOURNAL OF MEDICAL TOXICOLOGY. 2020?16(3)::321?8",48.0,YR,,F,Y,,,20210826.0,,HP,US,US,2021,Q3,Adult
197547432,19754743,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,, UNK,,,,,,,2021,Q3,Drug interaction,,2021,Q3,2,F,,20210820.0,20210827,20210831,EXP,,US-EMCURE PHARMACEUTICALS LTD-2021-EPL-002753,EMCURE,"SCHNEIR A, MASOM CP. LITHIUM TOXICITY FROM THE ADDITION OF AN ACE INHIBITOR WITH AN UNEXPECTED TYPE I BRUGADA PATTERN ECG: CASE FILES OF THE MEDICAL TOXICOLOGY FELLOWSHIP AT THE UNIVERSITY OF CALIFORNIA, SAN DIEGO. JOURNAL OF MEDICAL TOXICOLOGY. 2020?16(3)::321?8",48.0,YR,,F,Y,,,20210826.0,,HP,US,US,2021,Q3,Adult
197547432,19754743,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,, UNK,,,,,,,2021,Q3,Electrocardiogram abnormal,,2021,Q3,2,F,,20210820.0,20210827,20210831,EXP,,US-EMCURE PHARMACEUTICALS LTD-2021-EPL-002753,EMCURE,"SCHNEIR A, MASOM CP. LITHIUM TOXICITY FROM THE ADDITION OF AN ACE INHIBITOR WITH AN UNEXPECTED TYPE I BRUGADA PATTERN ECG: CASE FILES OF THE MEDICAL TOXICOLOGY FELLOWSHIP AT THE UNIVERSITY OF CALIFORNIA, SAN DIEGO. JOURNAL OF MEDICAL TOXICOLOGY. 2020?16(3)::321?8",48.0,YR,,F,Y,,,20210826.0,,HP,US,US,2021,Q3,Adult
197547432,19754743,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,, UNK,,,,,,,2021,Q3,Fall,,2021,Q3,2,F,,20210820.0,20210827,20210831,EXP,,US-EMCURE PHARMACEUTICALS LTD-2021-EPL-002753,EMCURE,"SCHNEIR A, MASOM CP. LITHIUM TOXICITY FROM THE ADDITION OF AN ACE INHIBITOR WITH AN UNEXPECTED TYPE I BRUGADA PATTERN ECG: CASE FILES OF THE MEDICAL TOXICOLOGY FELLOWSHIP AT THE UNIVERSITY OF CALIFORNIA, SAN DIEGO. JOURNAL OF MEDICAL TOXICOLOGY. 2020?16(3)::321?8",48.0,YR,,F,Y,,,20210826.0,,HP,US,US,2021,Q3,Adult
197547432,19754743,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,, UNK,,,,,,,2021,Q3,Hypovolaemia,,2021,Q3,2,F,,20210820.0,20210827,20210831,EXP,,US-EMCURE PHARMACEUTICALS LTD-2021-EPL-002753,EMCURE,"SCHNEIR A, MASOM CP. LITHIUM TOXICITY FROM THE ADDITION OF AN ACE INHIBITOR WITH AN UNEXPECTED TYPE I BRUGADA PATTERN ECG: CASE FILES OF THE MEDICAL TOXICOLOGY FELLOWSHIP AT THE UNIVERSITY OF CALIFORNIA, SAN DIEGO. JOURNAL OF MEDICAL TOXICOLOGY. 2020?16(3)::321?8",48.0,YR,,F,Y,,,20210826.0,,HP,US,US,2021,Q3,Adult
197547432,19754743,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,, UNK,,,,,,,2021,Q3,Nausea,,2021,Q3,2,F,,20210820.0,20210827,20210831,EXP,,US-EMCURE PHARMACEUTICALS LTD-2021-EPL-002753,EMCURE,"SCHNEIR A, MASOM CP. LITHIUM TOXICITY FROM THE ADDITION OF AN ACE INHIBITOR WITH AN UNEXPECTED TYPE I BRUGADA PATTERN ECG: CASE FILES OF THE MEDICAL TOXICOLOGY FELLOWSHIP AT THE UNIVERSITY OF CALIFORNIA, SAN DIEGO. JOURNAL OF MEDICAL TOXICOLOGY. 2020?16(3)::321?8",48.0,YR,,F,Y,,,20210826.0,,HP,US,US,2021,Q3,Adult
197547432,19754743,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,, UNK,,,,,,,2021,Q3,Toxicity to various agents,,2021,Q3,2,F,,20210820.0,20210827,20210831,EXP,,US-EMCURE PHARMACEUTICALS LTD-2021-EPL-002753,EMCURE,"SCHNEIR A, MASOM CP. LITHIUM TOXICITY FROM THE ADDITION OF AN ACE INHIBITOR WITH AN UNEXPECTED TYPE I BRUGADA PATTERN ECG: CASE FILES OF THE MEDICAL TOXICOLOGY FELLOWSHIP AT THE UNIVERSITY OF CALIFORNIA, SAN DIEGO. JOURNAL OF MEDICAL TOXICOLOGY. 2020?16(3)::321?8",48.0,YR,,F,Y,,,20210826.0,,HP,US,US,2021,Q3,Adult
197547432,19754743,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,, UNK,,,,,,,2021,Q3,Tremor,,2021,Q3,2,F,,20210820.0,20210827,20210831,EXP,,US-EMCURE PHARMACEUTICALS LTD-2021-EPL-002753,EMCURE,"SCHNEIR A, MASOM CP. LITHIUM TOXICITY FROM THE ADDITION OF AN ACE INHIBITOR WITH AN UNEXPECTED TYPE I BRUGADA PATTERN ECG: CASE FILES OF THE MEDICAL TOXICOLOGY FELLOWSHIP AT THE UNIVERSITY OF CALIFORNIA, SAN DIEGO. JOURNAL OF MEDICAL TOXICOLOGY. 2020?16(3)::321?8",48.0,YR,,F,Y,,,20210826.0,,HP,US,US,2021,Q3,Adult
197547432,19754743,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,, UNK,,,,,,,2021,Q3,Vomiting,,2021,Q3,2,F,,20210820.0,20210827,20210831,EXP,,US-EMCURE PHARMACEUTICALS LTD-2021-EPL-002753,EMCURE,"SCHNEIR A, MASOM CP. LITHIUM TOXICITY FROM THE ADDITION OF AN ACE INHIBITOR WITH AN UNEXPECTED TYPE I BRUGADA PATTERN ECG: CASE FILES OF THE MEDICAL TOXICOLOGY FELLOWSHIP AT THE UNIVERSITY OF CALIFORNIA, SAN DIEGO. JOURNAL OF MEDICAL TOXICOLOGY. 2020?16(3)::321?8",48.0,YR,,F,Y,,,20210826.0,,HP,US,US,2021,Q3,Adult
197585341,19758534,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q3,Asthenia,,2021,Q3,1,I,,20210817.0,20210828,20210828,EXP,,NVSC2021CA190095,NOVARTIS,,54.0,YR,,F,Y,,,20210829.0,,HP,CA,CA,2021,Q3,Adult
197585341,19758534,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q3,Fall,,2021,Q3,1,I,,20210817.0,20210828,20210828,EXP,,NVSC2021CA190095,NOVARTIS,,54.0,YR,,F,Y,,,20210829.0,,HP,CA,CA,2021,Q3,Adult
197585341,19758534,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q3,Gait disturbance,,2021,Q3,1,I,,20210817.0,20210828,20210828,EXP,,NVSC2021CA190095,NOVARTIS,,54.0,YR,,F,Y,,,20210829.0,,HP,CA,CA,2021,Q3,Adult
197585341,19758534,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q3,Oral pain,,2021,Q3,1,I,,20210817.0,20210828,20210828,EXP,,NVSC2021CA190095,NOVARTIS,,54.0,YR,,F,Y,,,20210829.0,,HP,CA,CA,2021,Q3,Adult
197585341,19758534,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q3,Oxygen saturation decreased,,2021,Q3,1,I,,20210817.0,20210828,20210828,EXP,,NVSC2021CA190095,NOVARTIS,,54.0,YR,,F,Y,,,20210829.0,,HP,CA,CA,2021,Q3,Adult
197585341,19758534,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q3,Pneumonitis,,2021,Q3,1,I,,20210817.0,20210828,20210828,EXP,,NVSC2021CA190095,NOVARTIS,,54.0,YR,,F,Y,,,20210829.0,,HP,CA,CA,2021,Q3,Adult
197585341,19758534,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q3,Respiratory failure,,2021,Q3,1,I,,20210817.0,20210828,20210828,EXP,,NVSC2021CA190095,NOVARTIS,,54.0,YR,,F,Y,,,20210829.0,,HP,CA,CA,2021,Q3,Adult
197588911,19758891,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,,,2021,Q3,Balance disorder,,2021,Q3,1,I,,20210816.0,20210829,20210829,EXP,CA-MHPD-E2B_03412917,CA-ACCORD-236026,ACCORD,,51.0,YR,,M,Y,94.0,KG,20210828.0,,MD,CA,CA,2021,Q3,Adult
197588911,19758891,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,,,2021,Q3,Blood creatine phosphokinase increased,,2021,Q3,1,I,,20210816.0,20210829,20210829,EXP,CA-MHPD-E2B_03412917,CA-ACCORD-236026,ACCORD,,51.0,YR,,M,Y,94.0,KG,20210828.0,,MD,CA,CA,2021,Q3,Adult
197588911,19758891,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,,,2021,Q3,Cogwheel rigidity,,2021,Q3,1,I,,20210816.0,20210829,20210829,EXP,CA-MHPD-E2B_03412917,CA-ACCORD-236026,ACCORD,,51.0,YR,,M,Y,94.0,KG,20210828.0,,MD,CA,CA,2021,Q3,Adult
197588911,19758891,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,,,2021,Q3,Fall,,2021,Q3,1,I,,20210816.0,20210829,20210829,EXP,CA-MHPD-E2B_03412917,CA-ACCORD-236026,ACCORD,,51.0,YR,,M,Y,94.0,KG,20210828.0,,MD,CA,CA,2021,Q3,Adult
197588911,19758891,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,,,2021,Q3,Gait disturbance,,2021,Q3,1,I,,20210816.0,20210829,20210829,EXP,CA-MHPD-E2B_03412917,CA-ACCORD-236026,ACCORD,,51.0,YR,,M,Y,94.0,KG,20210828.0,,MD,CA,CA,2021,Q3,Adult
197588911,19758891,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,,,2021,Q3,Hypertonia,,2021,Q3,1,I,,20210816.0,20210829,20210829,EXP,CA-MHPD-E2B_03412917,CA-ACCORD-236026,ACCORD,,51.0,YR,,M,Y,94.0,KG,20210828.0,,MD,CA,CA,2021,Q3,Adult
197588911,19758891,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,,,2021,Q3,Lactic acidosis,,2021,Q3,1,I,,20210816.0,20210829,20210829,EXP,CA-MHPD-E2B_03412917,CA-ACCORD-236026,ACCORD,,51.0,YR,,M,Y,94.0,KG,20210828.0,,MD,CA,CA,2021,Q3,Adult
197588911,19758891,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,,,2021,Q3,Myocarditis,,2021,Q3,1,I,,20210816.0,20210829,20210829,EXP,CA-MHPD-E2B_03412917,CA-ACCORD-236026,ACCORD,,51.0,YR,,M,Y,94.0,KG,20210828.0,,MD,CA,CA,2021,Q3,Adult
197588911,19758891,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,,,2021,Q3,Neuroleptic malignant syndrome,,2021,Q3,1,I,,20210816.0,20210829,20210829,EXP,CA-MHPD-E2B_03412917,CA-ACCORD-236026,ACCORD,,51.0,YR,,M,Y,94.0,KG,20210828.0,,MD,CA,CA,2021,Q3,Adult
197588911,19758891,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,,,2021,Q3,Nystagmus,,2021,Q3,1,I,,20210816.0,20210829,20210829,EXP,CA-MHPD-E2B_03412917,CA-ACCORD-236026,ACCORD,,51.0,YR,,M,Y,94.0,KG,20210828.0,,MD,CA,CA,2021,Q3,Adult
197588911,19758891,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210816.0,20210829,20210829,EXP,CA-MHPD-E2B_03412917,CA-ACCORD-236026,ACCORD,,51.0,YR,,M,Y,94.0,KG,20210828.0,,MD,CA,CA,2021,Q3,Adult
197588911,19758891,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,,,2021,Q3,Somnolence,,2021,Q3,1,I,,20210816.0,20210829,20210829,EXP,CA-MHPD-E2B_03412917,CA-ACCORD-236026,ACCORD,,51.0,YR,,M,Y,94.0,KG,20210828.0,,MD,CA,CA,2021,Q3,Adult
197588911,19758891,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,,,2021,Q3,Tachycardia,,2021,Q3,1,I,,20210816.0,20210829,20210829,EXP,CA-MHPD-E2B_03412917,CA-ACCORD-236026,ACCORD,,51.0,YR,,M,Y,94.0,KG,20210828.0,,MD,CA,CA,2021,Q3,Adult
197657361,19765736,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD (IN THE MORNING)",,,,, UNKNOWN,,,20.0,IU,,QD,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,,20210821.0,20210831,20210831,EXP,,BR-NOVOPROD-841796,NOVO NORDISK,,35.0,YR,,F,Y,52.0,KG,20210831.0,,MD,BR,BR,2021,Q3,Adult
197657361,19765736,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD (IN THE MORNING)",,,,, UNKNOWN,,,20.0,IU,,QD,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,,20210821.0,20210831,20210831,EXP,,BR-NOVOPROD-841796,NOVO NORDISK,,35.0,YR,,F,Y,52.0,KG,20210831.0,,MD,BR,BR,2021,Q3,Adult
197657361,19765736,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD (IN THE MORNING)",,,,, UNKNOWN,,,20.0,IU,,QD,2021,Q3,Road traffic accident,,2021,Q3,1,I,,20210821.0,20210831,20210831,EXP,,BR-NOVOPROD-841796,NOVO NORDISK,,35.0,YR,,F,Y,52.0,KG,20210831.0,,MD,BR,BR,2021,Q3,Adult
197657513,19765751,1,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"28.0,U,ONCE DAILY",,,,,,,,,,,,2021,Q3,Hypoglycaemia,,2021,Q3,3,F,20210805.0,20210908.0,20210831,20210920,EXP,,JP-NOVOPROD-841098,NOVO NORDISK,,66.0,YR,,M,Y,80.0,KG,20210921.0,,MD,JP,JP,2021,Q3,Elderly
197658543,19765854,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,42.0,IU,,QD,2021,Q3,Diabetic ketoacidosis,,2021,Q3,3,F,20210827.0,20210924.0,20210830,20210928,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-124107",BOEHRINGER INGELHEIM,,17.0,YR,T,M,Y,114.0,KG,20210928.0,,MD,US,US,2021,Q3,Youth
197664701,19766470,6,C,INSULIN GLARGINE/LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,,"450 IE, 0?0?24?0",,,,,,,,24.0,IU,,,2021,Q3,Dehydration,,2021,Q3,1,I,,20210816.0,20210831,20210831,EXP,DE-BFARM-21007550,DE-ACCORD-236583,ACCORD,,77.0,YR,E,F,Y,64.0,KG,20210831.0,,PH,DE,DE,2021,Q3,Elderly
197664701,19766470,6,C,INSULIN GLARGINE/LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,,"450 IE, 0?0?24?0",,,,,,,,24.0,IU,,,2021,Q3,Hyponatraemia,,2021,Q3,1,I,,20210816.0,20210831,20210831,EXP,DE-BFARM-21007550,DE-ACCORD-236583,ACCORD,,77.0,YR,E,F,Y,64.0,KG,20210831.0,,PH,DE,DE,2021,Q3,Elderly
197664701,19766470,6,C,INSULIN GLARGINE/LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,,"450 IE, 0?0?24?0",,,,,,,,24.0,IU,,,2021,Q3,Syncope,,2021,Q3,1,I,,20210816.0,20210831,20210831,EXP,DE-BFARM-21007550,DE-ACCORD-236583,ACCORD,,77.0,YR,E,F,Y,64.0,KG,20210831.0,,PH,DE,DE,2021,Q3,Elderly
197668961,19766896,3,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,,,20210830,20210830,DIR,,,FDA-CTU,,64.0,YR,,M,N,192.3,KG,20210830.0,N,PH,US,US,2021,Q3,Adult
197668961,19766896,3,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Incorrect dose administered,,2021,Q3,1,I,,,20210830,20210830,DIR,,,FDA-CTU,,64.0,YR,,M,N,192.3,KG,20210830.0,N,PH,US,US,2021,Q3,Adult
197668961,19766896,3,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Product label issue,,2021,Q3,1,I,,,20210830,20210830,DIR,,,FDA-CTU,,64.0,YR,,M,N,192.3,KG,20210830.0,N,PH,US,US,2021,Q3,Adult
197668961,19766896,3,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Product quality issue,,2021,Q3,1,I,,,20210830,20210830,DIR,,,FDA-CTU,,64.0,YR,,M,N,192.3,KG,20210830.0,N,PH,US,US,2021,Q3,Adult
197668961,19766896,3,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Recalled product administered,,2021,Q3,1,I,,,20210830,20210830,DIR,,,FDA-CTU,,64.0,YR,,M,N,192.3,KG,20210830.0,N,PH,US,US,2021,Q3,Adult
197704243,19770424,1,PS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,205692.0,,,INJECTION,,2021,Q3,Death,,2021,Q3,3,F,,20210909.0,20210831,20210915,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202108011265,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20210915.0,,PH,JP,JP,2021,Q3,Elderly
197707251,19770725,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,FOUR DOSES OF BASAL BOLUS THERAPY,,,D,,,,210605.0,,,INJECTION,,2021,Q3,Drug ineffective,,2021,Q3,1,I,,20210824.0,20210901,20210901,EXP,,MK-MYLANLABS-2021M1057514,MYLAN,"TRAJKOVSKA I, ILIEVSKA DB, HASAN T. TYPE 2 DIABETES IN YOUNG ADULTS, CAN WE DO MORE FOR THEM? ? CASE PRESENTATION. ROMAN?J?DIABET?NUTRIT?METAB?DIS 2021?28(1):116?120.",19.0,YR,,M,Y,,,20210901.0,,HP,MK,MK,2021,Q3,Youth
197749961,19774996,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),UNK,,,D,,,,,,,INJECTION,,2021,Q3,Drug abuse,,2021,Q3,1,I,,20210825.0,20210901,20210901,EXP,,AU-MYLANLABS-2021M1057861,MYLAN,"GRIFFITHS A, MILNE N, ONG B, WATKINS T. 2,4?DINITROPHENOL OVERDOSE ? EVERYTHING OLD IS NEW AGAIN. J?FORENS?LEGAL?MED 2021?NULL:NULL.",23.0,YR,,M,Y,,,20210901.0,,HP,AU,AU,2021,Q3,Youth
197749961,19774996,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),UNK,,,D,,,,,,,INJECTION,,2021,Q3,Drug ineffective,,2021,Q3,1,I,,20210825.0,20210901,20210901,EXP,,AU-MYLANLABS-2021M1057861,MYLAN,"GRIFFITHS A, MILNE N, ONG B, WATKINS T. 2,4?DINITROPHENOL OVERDOSE ? EVERYTHING OLD IS NEW AGAIN. J?FORENS?LEGAL?MED 2021?NULL:NULL.",23.0,YR,,M,Y,,,20210901.0,,HP,AU,AU,2021,Q3,Youth
197749961,19774996,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,D,,,,,,,INJECTION,,2021,Q3,Drug abuse,,2021,Q3,1,I,,20210825.0,20210901,20210901,EXP,,AU-MYLANLABS-2021M1057861,MYLAN,"GRIFFITHS A, MILNE N, ONG B, WATKINS T. 2,4?DINITROPHENOL OVERDOSE ? EVERYTHING OLD IS NEW AGAIN. J?FORENS?LEGAL?MED 2021?NULL:NULL.",23.0,YR,,M,Y,,,20210901.0,,HP,AU,AU,2021,Q3,Youth
197749961,19774996,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,D,,,,,,,INJECTION,,2021,Q3,Drug ineffective,,2021,Q3,1,I,,20210825.0,20210901,20210901,EXP,,AU-MYLANLABS-2021M1057861,MYLAN,"GRIFFITHS A, MILNE N, ONG B, WATKINS T. 2,4?DINITROPHENOL OVERDOSE ? EVERYTHING OLD IS NEW AGAIN. J?FORENS?LEGAL?MED 2021?NULL:NULL.",23.0,YR,,M,Y,,,20210901.0,,HP,AU,AU,2021,Q3,Youth
197755591,19775559,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Acute kidney injury,,2021,Q3,1,I,,20210820.0,20210902,20210902,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK067505,GLENMARK,,48.0,YR,,F,Y,,,20210902.0,,HP,US,US,2021,Q3,Adult
197755591,19775559,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Confusional state,,2021,Q3,1,I,,20210820.0,20210902,20210902,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK067505,GLENMARK,,48.0,YR,,F,Y,,,20210902.0,,HP,US,US,2021,Q3,Adult
197755591,19775559,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Dizziness,,2021,Q3,1,I,,20210820.0,20210902,20210902,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK067505,GLENMARK,,48.0,YR,,F,Y,,,20210902.0,,HP,US,US,2021,Q3,Adult
197755591,19775559,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Drug interaction,,2021,Q3,1,I,,20210820.0,20210902,20210902,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK067505,GLENMARK,,48.0,YR,,F,Y,,,20210902.0,,HP,US,US,2021,Q3,Adult
197755591,19775559,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Electrocardiogram abnormal,,2021,Q3,1,I,,20210820.0,20210902,20210902,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK067505,GLENMARK,,48.0,YR,,F,Y,,,20210902.0,,HP,US,US,2021,Q3,Adult
197755591,19775559,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Fall,,2021,Q3,1,I,,20210820.0,20210902,20210902,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK067505,GLENMARK,,48.0,YR,,F,Y,,,20210902.0,,HP,US,US,2021,Q3,Adult
197755591,19775559,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Hypovolaemia,,2021,Q3,1,I,,20210820.0,20210902,20210902,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK067505,GLENMARK,,48.0,YR,,F,Y,,,20210902.0,,HP,US,US,2021,Q3,Adult
197755591,19775559,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Nausea,,2021,Q3,1,I,,20210820.0,20210902,20210902,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK067505,GLENMARK,,48.0,YR,,F,Y,,,20210902.0,,HP,US,US,2021,Q3,Adult
197755591,19775559,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Toxicity to various agents,,2021,Q3,1,I,,20210820.0,20210902,20210902,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK067505,GLENMARK,,48.0,YR,,F,Y,,,20210902.0,,HP,US,US,2021,Q3,Adult
197755591,19775559,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Tremor,,2021,Q3,1,I,,20210820.0,20210902,20210902,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK067505,GLENMARK,,48.0,YR,,F,Y,,,20210902.0,,HP,US,US,2021,Q3,Adult
197755591,19775559,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Vomiting,,2021,Q3,1,I,,20210820.0,20210902,20210902,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK067505,GLENMARK,,48.0,YR,,F,Y,,,20210902.0,,HP,US,US,2021,Q3,Adult
197788301,19778830,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,INJECTION,,2021,Q3,Adrenocortical carcinoma,Adrenocortical carcinoma,2021,Q3,1,I,,20210823.0,20210902,20210902,EXP,,CN-ALS-000387,ALIGNSCIENCE PHARMA,,57.0,YR,A,M,Y,,,20210902.0,,HP,CN,CN,2021,Q3,Adult
197788301,19778830,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,INJECTION,,2021,Q3,Disseminated intravascular coagulation,Disseminated intravascular coagulation,2021,Q3,1,I,,20210823.0,20210902,20210902,EXP,,CN-ALS-000387,ALIGNSCIENCE PHARMA,,57.0,YR,A,M,Y,,,20210902.0,,HP,CN,CN,2021,Q3,Adult
197788301,19778830,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,INJECTION,,2021,Q3,Haemangioma,Haemangioma,2021,Q3,1,I,,20210823.0,20210902,20210902,EXP,,CN-ALS-000387,ALIGNSCIENCE PHARMA,,57.0,YR,A,M,Y,,,20210902.0,,HP,CN,CN,2021,Q3,Adult
197788301,19778830,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,INJECTION,,2021,Q3,Haemorrhagic infarction,Haemorrhagic infarction,2021,Q3,1,I,,20210823.0,20210902,20210902,EXP,,CN-ALS-000387,ALIGNSCIENCE PHARMA,,57.0,YR,A,M,Y,,,20210902.0,,HP,CN,CN,2021,Q3,Adult
197803792,19780379,1,PS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,Subcutaneous,"140 INTERNATIONAL UNIT PER MILLILITRE, QD",,,,, BF20002212,,210605.0,,,INJECTION,QD,2021,Q3,Device issue,,2021,Q3,2,F,20210820.0,20210916.0,20210902,20210924,PER,,US-MYLANLABS-2021M1054938,MYLAN,,56.0,YR,,M,Y,128.0,KG,20210924.0,,CN,US,US,2021,Q3,Adult
197803792,19780379,1,PS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,Subcutaneous,"140 INTERNATIONAL UNIT PER MILLILITRE, QD",,,,, BF20002212,,210605.0,,,INJECTION,QD,2021,Q3,Incorrect dose administered,,2021,Q3,2,F,20210820.0,20210916.0,20210902,20210924,PER,,US-MYLANLABS-2021M1054938,MYLAN,,56.0,YR,,M,Y,128.0,KG,20210924.0,,CN,US,US,2021,Q3,Adult
197803792,19780379,2,SS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, BF20002498,,210605.0,,,INJECTION,,2021,Q3,Device issue,,2021,Q3,2,F,20210820.0,20210916.0,20210902,20210924,PER,,US-MYLANLABS-2021M1054938,MYLAN,,56.0,YR,,M,Y,128.0,KG,20210924.0,,CN,US,US,2021,Q3,Adult
197803792,19780379,2,SS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, BF20002498,,210605.0,,,INJECTION,,2021,Q3,Incorrect dose administered,,2021,Q3,2,F,20210820.0,20210916.0,20210902,20210924,PER,,US-MYLANLABS-2021M1054938,MYLAN,,56.0,YR,,M,Y,128.0,KG,20210924.0,,CN,US,US,2021,Q3,Adult
197828281,19782828,6,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 U/ML,,,U,,,,206538.0,,,SOLUTION FOR INJECTION,,2021,Q3,Abdominal pain,,2021,Q3,1,I,20210522.0,20210826.0,20210902,20210902,EXP,,FR-SA-2021SA285494,SANOFI AVENTIS,,59.0,YR,A,M,Y,64.0,KG,20210902.0,,HP,FR,FR,2021,Q3,Adult
197828281,19782828,6,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 U/ML,,,U,,,,206538.0,,,SOLUTION FOR INJECTION,,2021,Q3,Arthralgia,,2021,Q3,1,I,20210522.0,20210826.0,20210902,20210902,EXP,,FR-SA-2021SA285494,SANOFI AVENTIS,,59.0,YR,A,M,Y,64.0,KG,20210902.0,,HP,FR,FR,2021,Q3,Adult
197828281,19782828,6,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 U/ML,,,U,,,,206538.0,,,SOLUTION FOR INJECTION,,2021,Q3,Haematoma muscle,,2021,Q3,1,I,20210522.0,20210826.0,20210902,20210902,EXP,,FR-SA-2021SA285494,SANOFI AVENTIS,,59.0,YR,A,M,Y,64.0,KG,20210902.0,,HP,FR,FR,2021,Q3,Adult
197828281,19782828,6,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 U/ML,,,U,,,,206538.0,,,SOLUTION FOR INJECTION,,2021,Q3,Muscular weakness,,2021,Q3,1,I,20210522.0,20210826.0,20210902,20210902,EXP,,FR-SA-2021SA285494,SANOFI AVENTIS,,59.0,YR,A,M,Y,64.0,KG,20210902.0,,HP,FR,FR,2021,Q3,Adult
197828281,19782828,6,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 U/ML,,,U,,,,206538.0,,,SOLUTION FOR INJECTION,,2021,Q3,Pain in extremity,,2021,Q3,1,I,20210522.0,20210826.0,20210902,20210902,EXP,,FR-SA-2021SA285494,SANOFI AVENTIS,,59.0,YR,A,M,Y,64.0,KG,20210902.0,,HP,FR,FR,2021,Q3,Adult
197828281,19782828,6,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 U/ML,,,U,,,,206538.0,,,SOLUTION FOR INJECTION,,2021,Q3,Pyelocaliectasis,,2021,Q3,1,I,20210522.0,20210826.0,20210902,20210902,EXP,,FR-SA-2021SA285494,SANOFI AVENTIS,,59.0,YR,A,M,Y,64.0,KG,20210902.0,,HP,FR,FR,2021,Q3,Adult
197828281,19782828,6,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 U/ML,,,U,,,,206538.0,,,SOLUTION FOR INJECTION,,2021,Q3,Ureteric compression,,2021,Q3,1,I,20210522.0,20210826.0,20210902,20210902,EXP,,FR-SA-2021SA285494,SANOFI AVENTIS,,59.0,YR,A,M,Y,64.0,KG,20210902.0,,HP,FR,FR,2021,Q3,Adult
197847192,19784719,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,COVID-19 pneumonia,,2021,Q3,2,F,20210218.0,20210908.0,20210903,20210914,EXP,,US-ROCHE-2903641,ROCHE,,72.0,YR,,F,Y,91.9,KG,20210914.0,,MD,US,US,2021,Q3,Elderly
197847192,19784719,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Off label use,,2021,Q3,2,F,20210218.0,20210908.0,20210903,20210914,EXP,,US-ROCHE-2903641,ROCHE,,72.0,YR,,F,Y,91.9,KG,20210914.0,,MD,US,US,2021,Q3,Elderly
197851601,19785160,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,210605.0,,,,,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,2014.0,20210831.0,20210903,20210903,EXP,,PL-MYLANLABS-2021M1057907,MYLAN,,40.0,YR,,F,Y,,,20210903.0,,CN,PL,PL,2021,Q3,Adult
197851601,19785160,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,210605.0,,,,,2021,Q3,Insomnia,,2021,Q3,1,I,2014.0,20210831.0,20210903,20210903,EXP,,PL-MYLANLABS-2021M1057907,MYLAN,,40.0,YR,,F,Y,,,20210903.0,,CN,PL,PL,2021,Q3,Adult
197851601,19785160,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,210605.0,,,,,2021,Q3,Product dose omission issue,,2021,Q3,1,I,2014.0,20210831.0,20210903,20210903,EXP,,PL-MYLANLABS-2021M1057907,MYLAN,,40.0,YR,,F,Y,,,20210903.0,,CN,PL,PL,2021,Q3,Adult
197851601,19785160,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,210605.0,,,,,2021,Q3,Thyroid disorder,,2021,Q3,1,I,2014.0,20210831.0,20210903,20210903,EXP,,PL-MYLANLABS-2021M1057907,MYLAN,,40.0,YR,,F,Y,,,20210903.0,,CN,PL,PL,2021,Q3,Adult
197851601,19785160,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,210605.0,,,,,2021,Q3,Weight increased,,2021,Q3,1,I,2014.0,20210831.0,20210903,20210903,EXP,,PL-MYLANLABS-2021M1057907,MYLAN,,40.0,YR,,F,Y,,,20210903.0,,CN,PL,PL,2021,Q3,Adult
197853211,19785321,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"8 DF, QD",10000.0,DF,U,,,,21081.0,8.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,20170625.0,20180314.0,20210903,20210903,EXP,IT-MINISAL02-462291,IT-SA-2018SA078656,SANOFI AVENTIS,,73.0,YR,E,M,Y,,,20210903.0,,MD,IT,IT,2021,Q3,Elderly
197853211,19785321,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"8 DF, QD",10000.0,DF,U,,,,21081.0,8.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Presyncope,,2021,Q3,1,I,20170625.0,20180314.0,20210903,20210903,EXP,IT-MINISAL02-462291,IT-SA-2018SA078656,SANOFI AVENTIS,,73.0,YR,E,M,Y,,,20210903.0,,MD,IT,IT,2021,Q3,Elderly
197883301,19788330,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Acute kidney injury,,2021,Q3,1,I,,20210825.0,20210903,20210903,EXP,,CA-TEVA-2021-CA-1947369,TEVA,,62.0,YR,A,F,Y,107.0,KG,20210903.0,,HP,CA,CA,2021,Q3,Adult
197883301,19788330,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210825.0,20210903,20210903,EXP,,CA-TEVA-2021-CA-1947369,TEVA,,62.0,YR,A,F,Y,107.0,KG,20210903.0,,HP,CA,CA,2021,Q3,Adult
197883301,19788330,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Febrile neutropenia,,2021,Q3,1,I,,20210825.0,20210903,20210903,EXP,,CA-TEVA-2021-CA-1947369,TEVA,,62.0,YR,A,F,Y,107.0,KG,20210903.0,,HP,CA,CA,2021,Q3,Adult
197883301,19788330,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Hypotension,,2021,Q3,1,I,,20210825.0,20210903,20210903,EXP,,CA-TEVA-2021-CA-1947369,TEVA,,62.0,YR,A,F,Y,107.0,KG,20210903.0,,HP,CA,CA,2021,Q3,Adult
197883301,19788330,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Mucosal inflammation,,2021,Q3,1,I,,20210825.0,20210903,20210903,EXP,,CA-TEVA-2021-CA-1947369,TEVA,,62.0,YR,A,F,Y,107.0,KG,20210903.0,,HP,CA,CA,2021,Q3,Adult
197903441,19790344,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,30 UNITS EVERY MORNING,,,,,,,,,,,,2021,Q3,Diabetic ketoacidosis,,2021,Q3,1,I,,20210830.0,20210906,20210906,EXP,,US-ROCHE-2904271,ROCHE,"CLONTZ R, DANG D, HIEGER M AND BECKER B. ATEZOLIZUMAB?INDUCED AUTOIMMUNE DIABETES IN A PATIENT WITH METASTATIC BREAST CANCER: A CASE REPORT. CLINICAL PRACTICE AND CASES IN EMERGENCY MEDICINE 2021 MAY?5 (2):190?3.",74.0,YR,,F,Y,,,20210906.0,,MD,US,US,2021,Q3,Elderly
197903441,19790344,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,30 UNITS EVERY MORNING,,,,,,,,,,,,2021,Q3,Neuropathy peripheral,,2021,Q3,1,I,,20210830.0,20210906,20210906,EXP,,US-ROCHE-2904271,ROCHE,"CLONTZ R, DANG D, HIEGER M AND BECKER B. ATEZOLIZUMAB?INDUCED AUTOIMMUNE DIABETES IN A PATIENT WITH METASTATIC BREAST CANCER: A CASE REPORT. CLINICAL PRACTICE AND CASES IN EMERGENCY MEDICINE 2021 MAY?5 (2):190?3.",74.0,YR,,F,Y,,,20210906.0,,MD,US,US,2021,Q3,Elderly
197906291,19790629,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 INTERNATIONAL UNIT, DAILY",,,U,,,,,14.0,IU,,QD,2021,Q3,Incorrect dose administered,,2021,Q3,1,I,,20210901.0,20210906,20210906,EXP,,JP-SA-2021SA292383,SANOFI AVENTIS,TOKUMARU M.. A CASE OF LACTIC ACIDOSIS IN OVERDOSE OF METFORMIN AND INSULIN FOR SUICIDE ATTEMPT. DIABETES. 2021?64(S):UNK,28.0,YR,A,F,Y,,,20210906.0,,MD,JP,JP,2021,Q3,Young Adult
197906291,19790629,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 INTERNATIONAL UNIT, DAILY",,,U,,,,,14.0,IU,,QD,2021,Q3,Lactic acidosis,,2021,Q3,1,I,,20210901.0,20210906,20210906,EXP,,JP-SA-2021SA292383,SANOFI AVENTIS,TOKUMARU M.. A CASE OF LACTIC ACIDOSIS IN OVERDOSE OF METFORMIN AND INSULIN FOR SUICIDE ATTEMPT. DIABETES. 2021?64(S):UNK,28.0,YR,A,F,Y,,,20210906.0,,MD,JP,JP,2021,Q3,Young Adult
197906291,19790629,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 INTERNATIONAL UNIT, DAILY",,,U,,,,,14.0,IU,,QD,2021,Q3,Suicide attempt,,2021,Q3,1,I,,20210901.0,20210906,20210906,EXP,,JP-SA-2021SA292383,SANOFI AVENTIS,TOKUMARU M.. A CASE OF LACTIC ACIDOSIS IN OVERDOSE OF METFORMIN AND INSULIN FOR SUICIDE ATTEMPT. DIABETES. 2021?64(S):UNK,28.0,YR,A,F,Y,,,20210906.0,,MD,JP,JP,2021,Q3,Young Adult
197906291,19790629,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,450 INTERNATIONAL UNIT,,,U,,,,,450.0,IU,,,2021,Q3,Incorrect dose administered,,2021,Q3,1,I,,20210901.0,20210906,20210906,EXP,,JP-SA-2021SA292383,SANOFI AVENTIS,TOKUMARU M.. A CASE OF LACTIC ACIDOSIS IN OVERDOSE OF METFORMIN AND INSULIN FOR SUICIDE ATTEMPT. DIABETES. 2021?64(S):UNK,28.0,YR,A,F,Y,,,20210906.0,,MD,JP,JP,2021,Q3,Young Adult
197906291,19790629,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,450 INTERNATIONAL UNIT,,,U,,,,,450.0,IU,,,2021,Q3,Lactic acidosis,,2021,Q3,1,I,,20210901.0,20210906,20210906,EXP,,JP-SA-2021SA292383,SANOFI AVENTIS,TOKUMARU M.. A CASE OF LACTIC ACIDOSIS IN OVERDOSE OF METFORMIN AND INSULIN FOR SUICIDE ATTEMPT. DIABETES. 2021?64(S):UNK,28.0,YR,A,F,Y,,,20210906.0,,MD,JP,JP,2021,Q3,Young Adult
197906291,19790629,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,450 INTERNATIONAL UNIT,,,U,,,,,450.0,IU,,,2021,Q3,Suicide attempt,,2021,Q3,1,I,,20210901.0,20210906,20210906,EXP,,JP-SA-2021SA292383,SANOFI AVENTIS,TOKUMARU M.. A CASE OF LACTIC ACIDOSIS IN OVERDOSE OF METFORMIN AND INSULIN FOR SUICIDE ATTEMPT. DIABETES. 2021?64(S):UNK,28.0,YR,A,F,Y,,,20210906.0,,MD,JP,JP,2021,Q3,Young Adult
197910151,19791015,16,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,SOLUTION,QD,2021,Q3,Asthma,,2021,Q3,1,I,,20210830.0,20210906,20210906,EXP,,CA-BAUSCH-BL-2021-029744,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210906.0,,CN,CA,CA,2021,Q3,Elderly
197910151,19791015,16,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,SOLUTION,QD,2021,Q3,Condition aggravated,,2021,Q3,1,I,,20210830.0,20210906,20210906,EXP,,CA-BAUSCH-BL-2021-029744,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210906.0,,CN,CA,CA,2021,Q3,Elderly
197910151,19791015,16,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,SOLUTION,QD,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20210830.0,20210906,20210906,EXP,,CA-BAUSCH-BL-2021-029744,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210906.0,,CN,CA,CA,2021,Q3,Elderly
197910151,19791015,16,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,SOLUTION,QD,2021,Q3,Haemoptysis,,2021,Q3,1,I,,20210830.0,20210906,20210906,EXP,,CA-BAUSCH-BL-2021-029744,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210906.0,,CN,CA,CA,2021,Q3,Elderly
197910151,19791015,16,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,SOLUTION,QD,2021,Q3,Loss of personal independence in daily activities,,2021,Q3,1,I,,20210830.0,20210906,20210906,EXP,,CA-BAUSCH-BL-2021-029744,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210906.0,,CN,CA,CA,2021,Q3,Elderly
197910151,19791015,16,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,SOLUTION,QD,2021,Q3,Lung disorder,,2021,Q3,1,I,,20210830.0,20210906,20210906,EXP,,CA-BAUSCH-BL-2021-029744,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210906.0,,CN,CA,CA,2021,Q3,Elderly
197910151,19791015,16,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,SOLUTION,QD,2021,Q3,Neuritis,,2021,Q3,1,I,,20210830.0,20210906,20210906,EXP,,CA-BAUSCH-BL-2021-029744,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210906.0,,CN,CA,CA,2021,Q3,Elderly
197910151,19791015,16,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,SOLUTION,QD,2021,Q3,Neurological symptom,,2021,Q3,1,I,,20210830.0,20210906,20210906,EXP,,CA-BAUSCH-BL-2021-029744,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210906.0,,CN,CA,CA,2021,Q3,Elderly
197910151,19791015,16,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,SOLUTION,QD,2021,Q3,Obstructive airways disorder,,2021,Q3,1,I,,20210830.0,20210906,20210906,EXP,,CA-BAUSCH-BL-2021-029744,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210906.0,,CN,CA,CA,2021,Q3,Elderly
197910151,19791015,16,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,SOLUTION,QD,2021,Q3,Pain in extremity,,2021,Q3,1,I,,20210830.0,20210906,20210906,EXP,,CA-BAUSCH-BL-2021-029744,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210906.0,,CN,CA,CA,2021,Q3,Elderly
197910151,19791015,16,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,SOLUTION,QD,2021,Q3,Pulmonary alveolar haemorrhage,,2021,Q3,1,I,,20210830.0,20210906,20210906,EXP,,CA-BAUSCH-BL-2021-029744,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210906.0,,CN,CA,CA,2021,Q3,Elderly
197910151,19791015,16,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,SOLUTION,QD,2021,Q3,Pulmonary fibrosis,,2021,Q3,1,I,,20210830.0,20210906,20210906,EXP,,CA-BAUSCH-BL-2021-029744,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210906.0,,CN,CA,CA,2021,Q3,Elderly
197910151,19791015,16,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,SOLUTION,QD,2021,Q3,Pulmonary vasculitis,,2021,Q3,1,I,,20210830.0,20210906,20210906,EXP,,CA-BAUSCH-BL-2021-029744,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210906.0,,CN,CA,CA,2021,Q3,Elderly
197910151,19791015,16,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,SOLUTION,QD,2021,Q3,Respiratory symptom,,2021,Q3,1,I,,20210830.0,20210906,20210906,EXP,,CA-BAUSCH-BL-2021-029744,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210906.0,,CN,CA,CA,2021,Q3,Elderly
197910151,19791015,16,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,SOLUTION,QD,2021,Q3,Sleep disorder due to a general medical condition,,2021,Q3,1,I,,20210830.0,20210906,20210906,EXP,,CA-BAUSCH-BL-2021-029744,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210906.0,,CN,CA,CA,2021,Q3,Elderly
197910151,19791015,16,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,SOLUTION,QD,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,1,I,,20210830.0,20210906,20210906,EXP,,CA-BAUSCH-BL-2021-029744,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210906.0,,CN,CA,CA,2021,Q3,Elderly
197910151,19791015,16,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,SOLUTION,QD,2021,Q3,Vasculitis,,2021,Q3,1,I,,20210830.0,20210906,20210906,EXP,,CA-BAUSCH-BL-2021-029744,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210906.0,,CN,CA,CA,2021,Q3,Elderly
197910151,19791015,16,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,SOLUTION,QD,2021,Q3,Wheezing,,2021,Q3,1,I,,20210830.0,20210906,20210906,EXP,,CA-BAUSCH-BL-2021-029744,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210906.0,,CN,CA,CA,2021,Q3,Elderly
197933511,19793351,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 IU, QD",,,D,,,,,48.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blindness unilateral,,2021,Q3,1,I,,20210901.0,20210906,20210906,EXP,,NVSC2021ES198152,NOVARTIS,,67.0,YR,,F,Y,94.2,KG,20210906.0,,HP,COUNTRY NOT SPECIFIED,ES,2021,Q3,Elderly
197933511,19793351,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 IU, QD",,,D,,,,,48.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,1,I,,20210901.0,20210906,20210906,EXP,,NVSC2021ES198152,NOVARTIS,,67.0,YR,,F,Y,94.2,KG,20210906.0,,HP,COUNTRY NOT SPECIFIED,ES,2021,Q3,Elderly
197933511,19793351,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 IU, QD",,,D,,,,,48.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Cataract diabetic,,2021,Q3,1,I,,20210901.0,20210906,20210906,EXP,,NVSC2021ES198152,NOVARTIS,,67.0,YR,,F,Y,94.2,KG,20210906.0,,HP,COUNTRY NOT SPECIFIED,ES,2021,Q3,Elderly
197933511,19793351,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 IU, QD",,,D,,,,,48.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210901.0,20210906,20210906,EXP,,NVSC2021ES198152,NOVARTIS,,67.0,YR,,F,Y,94.2,KG,20210906.0,,HP,COUNTRY NOT SPECIFIED,ES,2021,Q3,Elderly
197933511,19793351,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 IU, QD",,,D,,,,,48.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Gait inability,,2021,Q3,1,I,,20210901.0,20210906,20210906,EXP,,NVSC2021ES198152,NOVARTIS,,67.0,YR,,F,Y,94.2,KG,20210906.0,,HP,COUNTRY NOT SPECIFIED,ES,2021,Q3,Elderly
197933511,19793351,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 IU, QD",,,D,,,,,48.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Multiple use of single-use product,,2021,Q3,1,I,,20210901.0,20210906,20210906,EXP,,NVSC2021ES198152,NOVARTIS,,67.0,YR,,F,Y,94.2,KG,20210906.0,,HP,COUNTRY NOT SPECIFIED,ES,2021,Q3,Elderly
197933511,19793351,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 IU, QD",,,D,,,,,48.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Post procedural complication,,2021,Q3,1,I,,20210901.0,20210906,20210906,EXP,,NVSC2021ES198152,NOVARTIS,,67.0,YR,,F,Y,94.2,KG,20210906.0,,HP,COUNTRY NOT SPECIFIED,ES,2021,Q3,Elderly
197933511,19793351,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 IU, QD",,,D,,,,,48.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Retinal injury,,2021,Q3,1,I,,20210901.0,20210906,20210906,EXP,,NVSC2021ES198152,NOVARTIS,,67.0,YR,,F,Y,94.2,KG,20210906.0,,HP,COUNTRY NOT SPECIFIED,ES,2021,Q3,Elderly
197933511,19793351,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, QD",,,D,,,,,50.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blindness unilateral,,2021,Q3,1,I,,20210901.0,20210906,20210906,EXP,,NVSC2021ES198152,NOVARTIS,,67.0,YR,,F,Y,94.2,KG,20210906.0,,HP,COUNTRY NOT SPECIFIED,ES,2021,Q3,Elderly
197933511,19793351,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, QD",,,D,,,,,50.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,1,I,,20210901.0,20210906,20210906,EXP,,NVSC2021ES198152,NOVARTIS,,67.0,YR,,F,Y,94.2,KG,20210906.0,,HP,COUNTRY NOT SPECIFIED,ES,2021,Q3,Elderly
197933511,19793351,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, QD",,,D,,,,,50.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Cataract diabetic,,2021,Q3,1,I,,20210901.0,20210906,20210906,EXP,,NVSC2021ES198152,NOVARTIS,,67.0,YR,,F,Y,94.2,KG,20210906.0,,HP,COUNTRY NOT SPECIFIED,ES,2021,Q3,Elderly
197933511,19793351,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, QD",,,D,,,,,50.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210901.0,20210906,20210906,EXP,,NVSC2021ES198152,NOVARTIS,,67.0,YR,,F,Y,94.2,KG,20210906.0,,HP,COUNTRY NOT SPECIFIED,ES,2021,Q3,Elderly
197933511,19793351,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, QD",,,D,,,,,50.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Gait inability,,2021,Q3,1,I,,20210901.0,20210906,20210906,EXP,,NVSC2021ES198152,NOVARTIS,,67.0,YR,,F,Y,94.2,KG,20210906.0,,HP,COUNTRY NOT SPECIFIED,ES,2021,Q3,Elderly
197933511,19793351,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, QD",,,D,,,,,50.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Multiple use of single-use product,,2021,Q3,1,I,,20210901.0,20210906,20210906,EXP,,NVSC2021ES198152,NOVARTIS,,67.0,YR,,F,Y,94.2,KG,20210906.0,,HP,COUNTRY NOT SPECIFIED,ES,2021,Q3,Elderly
197933511,19793351,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, QD",,,D,,,,,50.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Post procedural complication,,2021,Q3,1,I,,20210901.0,20210906,20210906,EXP,,NVSC2021ES198152,NOVARTIS,,67.0,YR,,F,Y,94.2,KG,20210906.0,,HP,COUNTRY NOT SPECIFIED,ES,2021,Q3,Elderly
197933511,19793351,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, QD",,,D,,,,,50.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Retinal injury,,2021,Q3,1,I,,20210901.0,20210906,20210906,EXP,,NVSC2021ES198152,NOVARTIS,,67.0,YR,,F,Y,94.2,KG,20210906.0,,HP,COUNTRY NOT SPECIFIED,ES,2021,Q3,Elderly
197933511,19793351,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"52 IU, QD",,,D,, 1F939A,,,52.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blindness unilateral,,2021,Q3,1,I,,20210901.0,20210906,20210906,EXP,,NVSC2021ES198152,NOVARTIS,,67.0,YR,,F,Y,94.2,KG,20210906.0,,HP,COUNTRY NOT SPECIFIED,ES,2021,Q3,Elderly
197933511,19793351,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"52 IU, QD",,,D,, 1F939A,,,52.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,1,I,,20210901.0,20210906,20210906,EXP,,NVSC2021ES198152,NOVARTIS,,67.0,YR,,F,Y,94.2,KG,20210906.0,,HP,COUNTRY NOT SPECIFIED,ES,2021,Q3,Elderly
197933511,19793351,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"52 IU, QD",,,D,, 1F939A,,,52.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Cataract diabetic,,2021,Q3,1,I,,20210901.0,20210906,20210906,EXP,,NVSC2021ES198152,NOVARTIS,,67.0,YR,,F,Y,94.2,KG,20210906.0,,HP,COUNTRY NOT SPECIFIED,ES,2021,Q3,Elderly
197933511,19793351,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"52 IU, QD",,,D,, 1F939A,,,52.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210901.0,20210906,20210906,EXP,,NVSC2021ES198152,NOVARTIS,,67.0,YR,,F,Y,94.2,KG,20210906.0,,HP,COUNTRY NOT SPECIFIED,ES,2021,Q3,Elderly
197933511,19793351,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"52 IU, QD",,,D,, 1F939A,,,52.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Gait inability,,2021,Q3,1,I,,20210901.0,20210906,20210906,EXP,,NVSC2021ES198152,NOVARTIS,,67.0,YR,,F,Y,94.2,KG,20210906.0,,HP,COUNTRY NOT SPECIFIED,ES,2021,Q3,Elderly
197933511,19793351,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"52 IU, QD",,,D,, 1F939A,,,52.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Multiple use of single-use product,,2021,Q3,1,I,,20210901.0,20210906,20210906,EXP,,NVSC2021ES198152,NOVARTIS,,67.0,YR,,F,Y,94.2,KG,20210906.0,,HP,COUNTRY NOT SPECIFIED,ES,2021,Q3,Elderly
197933511,19793351,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"52 IU, QD",,,D,, 1F939A,,,52.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Post procedural complication,,2021,Q3,1,I,,20210901.0,20210906,20210906,EXP,,NVSC2021ES198152,NOVARTIS,,67.0,YR,,F,Y,94.2,KG,20210906.0,,HP,COUNTRY NOT SPECIFIED,ES,2021,Q3,Elderly
197933511,19793351,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"52 IU, QD",,,D,, 1F939A,,,52.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Retinal injury,,2021,Q3,1,I,,20210901.0,20210906,20210906,EXP,,NVSC2021ES198152,NOVARTIS,,67.0,YR,,F,Y,94.2,KG,20210906.0,,HP,COUNTRY NOT SPECIFIED,ES,2021,Q3,Elderly
197943912,19794391,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,,, 0F741A,,,36.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Anxiety,,2021,Q3,2,F,2021.0,20210913.0,20210906,20210920,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-117499",BOEHRINGER INGELHEIM,,67.0,YR,E,M,Y,93.8,KG,20210920.0,,CN,ES,ES,2021,Q3,Elderly
197943912,19794391,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,,, 0F741A,,,36.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Arthralgia,,2021,Q3,2,F,2021.0,20210913.0,20210906,20210920,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-117499",BOEHRINGER INGELHEIM,,67.0,YR,E,M,Y,93.8,KG,20210920.0,,CN,ES,ES,2021,Q3,Elderly
197943912,19794391,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,,, 0F741A,,,36.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Back pain,,2021,Q3,2,F,2021.0,20210913.0,20210906,20210920,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-117499",BOEHRINGER INGELHEIM,,67.0,YR,E,M,Y,93.8,KG,20210920.0,,CN,ES,ES,2021,Q3,Elderly
197943912,19794391,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,,, 0F741A,,,36.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose decreased,,2021,Q3,2,F,2021.0,20210913.0,20210906,20210920,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-117499",BOEHRINGER INGELHEIM,,67.0,YR,E,M,Y,93.8,KG,20210920.0,,CN,ES,ES,2021,Q3,Elderly
197943912,19794391,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,,, 0F741A,,,36.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose fluctuation,,2021,Q3,2,F,2021.0,20210913.0,20210906,20210920,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-117499",BOEHRINGER INGELHEIM,,67.0,YR,E,M,Y,93.8,KG,20210920.0,,CN,ES,ES,2021,Q3,Elderly
197943912,19794391,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,,, 0F741A,,,36.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,2,F,2021.0,20210913.0,20210906,20210920,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-117499",BOEHRINGER INGELHEIM,,67.0,YR,E,M,Y,93.8,KG,20210920.0,,CN,ES,ES,2021,Q3,Elderly
197943912,19794391,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,,, 0F741A,,,36.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Condition aggravated,,2021,Q3,2,F,2021.0,20210913.0,20210906,20210920,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-117499",BOEHRINGER INGELHEIM,,67.0,YR,E,M,Y,93.8,KG,20210920.0,,CN,ES,ES,2021,Q3,Elderly
197943912,19794391,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,,, 0F741A,,,36.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Decreased appetite,,2021,Q3,2,F,2021.0,20210913.0,20210906,20210920,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-117499",BOEHRINGER INGELHEIM,,67.0,YR,E,M,Y,93.8,KG,20210920.0,,CN,ES,ES,2021,Q3,Elderly
197943912,19794391,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,,, 0F741A,,,36.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Depression,,2021,Q3,2,F,2021.0,20210913.0,20210906,20210920,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-117499",BOEHRINGER INGELHEIM,,67.0,YR,E,M,Y,93.8,KG,20210920.0,,CN,ES,ES,2021,Q3,Elderly
197943912,19794391,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,,, 0F741A,,,36.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Diabetes mellitus inadequate control,,2021,Q3,2,F,2021.0,20210913.0,20210906,20210920,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-117499",BOEHRINGER INGELHEIM,,67.0,YR,E,M,Y,93.8,KG,20210920.0,,CN,ES,ES,2021,Q3,Elderly
197943912,19794391,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,,, 0F741A,,,36.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Fatigue,,2021,Q3,2,F,2021.0,20210913.0,20210906,20210920,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-117499",BOEHRINGER INGELHEIM,,67.0,YR,E,M,Y,93.8,KG,20210920.0,,CN,ES,ES,2021,Q3,Elderly
197943912,19794391,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,,, 0F741A,,,36.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hunger,,2021,Q3,2,F,2021.0,20210913.0,20210906,20210920,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-117499",BOEHRINGER INGELHEIM,,67.0,YR,E,M,Y,93.8,KG,20210920.0,,CN,ES,ES,2021,Q3,Elderly
197943912,19794391,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,,, 0F741A,,,36.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hypersomnia,,2021,Q3,2,F,2021.0,20210913.0,20210906,20210920,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-117499",BOEHRINGER INGELHEIM,,67.0,YR,E,M,Y,93.8,KG,20210920.0,,CN,ES,ES,2021,Q3,Elderly
197943912,19794391,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,,, 0F741A,,,36.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hypoglycaemia,,2021,Q3,2,F,2021.0,20210913.0,20210906,20210920,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-117499",BOEHRINGER INGELHEIM,,67.0,YR,E,M,Y,93.8,KG,20210920.0,,CN,ES,ES,2021,Q3,Elderly
197943912,19794391,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,,, 0F741A,,,36.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Intervertebral disc protrusion,,2021,Q3,2,F,2021.0,20210913.0,20210906,20210920,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-117499",BOEHRINGER INGELHEIM,,67.0,YR,E,M,Y,93.8,KG,20210920.0,,CN,ES,ES,2021,Q3,Elderly
197943912,19794391,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,,, 0F741A,,,36.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Oral herpes,,2021,Q3,2,F,2021.0,20210913.0,20210906,20210920,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-117499",BOEHRINGER INGELHEIM,,67.0,YR,E,M,Y,93.8,KG,20210920.0,,CN,ES,ES,2021,Q3,Elderly
197943912,19794391,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,,, 0F741A,,,36.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Pollakiuria,,2021,Q3,2,F,2021.0,20210913.0,20210906,20210920,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-117499",BOEHRINGER INGELHEIM,,67.0,YR,E,M,Y,93.8,KG,20210920.0,,CN,ES,ES,2021,Q3,Elderly
197943912,19794391,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,,, 0F741A,,,36.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Product dose omission issue,,2021,Q3,2,F,2021.0,20210913.0,20210906,20210920,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-117499",BOEHRINGER INGELHEIM,,67.0,YR,E,M,Y,93.8,KG,20210920.0,,CN,ES,ES,2021,Q3,Elderly
197943912,19794391,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,,, 0F741A,,,36.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Spinal disorder,,2021,Q3,2,F,2021.0,20210913.0,20210906,20210920,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-117499",BOEHRINGER INGELHEIM,,67.0,YR,E,M,Y,93.8,KG,20210920.0,,CN,ES,ES,2021,Q3,Elderly
197943912,19794391,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,,, 0F741A,,,36.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Thirst,,2021,Q3,2,F,2021.0,20210913.0,20210906,20210920,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-117499",BOEHRINGER INGELHEIM,,67.0,YR,E,M,Y,93.8,KG,20210920.0,,CN,ES,ES,2021,Q3,Elderly
197943912,19794391,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 IU, QD",,,,, 0F527A,,,34.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Anxiety,,2021,Q3,2,F,2021.0,20210913.0,20210906,20210920,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-117499",BOEHRINGER INGELHEIM,,67.0,YR,E,M,Y,93.8,KG,20210920.0,,CN,ES,ES,2021,Q3,Elderly
197943912,19794391,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 IU, QD",,,,, 0F527A,,,34.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Arthralgia,,2021,Q3,2,F,2021.0,20210913.0,20210906,20210920,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-117499",BOEHRINGER INGELHEIM,,67.0,YR,E,M,Y,93.8,KG,20210920.0,,CN,ES,ES,2021,Q3,Elderly
197943912,19794391,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 IU, QD",,,,, 0F527A,,,34.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Back pain,,2021,Q3,2,F,2021.0,20210913.0,20210906,20210920,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-117499",BOEHRINGER INGELHEIM,,67.0,YR,E,M,Y,93.8,KG,20210920.0,,CN,ES,ES,2021,Q3,Elderly
197943912,19794391,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 IU, QD",,,,, 0F527A,,,34.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose decreased,,2021,Q3,2,F,2021.0,20210913.0,20210906,20210920,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-117499",BOEHRINGER INGELHEIM,,67.0,YR,E,M,Y,93.8,KG,20210920.0,,CN,ES,ES,2021,Q3,Elderly
197943912,19794391,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 IU, QD",,,,, 0F527A,,,34.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose fluctuation,,2021,Q3,2,F,2021.0,20210913.0,20210906,20210920,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-117499",BOEHRINGER INGELHEIM,,67.0,YR,E,M,Y,93.8,KG,20210920.0,,CN,ES,ES,2021,Q3,Elderly
197943912,19794391,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 IU, QD",,,,, 0F527A,,,34.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,2,F,2021.0,20210913.0,20210906,20210920,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-117499",BOEHRINGER INGELHEIM,,67.0,YR,E,M,Y,93.8,KG,20210920.0,,CN,ES,ES,2021,Q3,Elderly
197943912,19794391,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 IU, QD",,,,, 0F527A,,,34.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Condition aggravated,,2021,Q3,2,F,2021.0,20210913.0,20210906,20210920,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-117499",BOEHRINGER INGELHEIM,,67.0,YR,E,M,Y,93.8,KG,20210920.0,,CN,ES,ES,2021,Q3,Elderly
197943912,19794391,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 IU, QD",,,,, 0F527A,,,34.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Decreased appetite,,2021,Q3,2,F,2021.0,20210913.0,20210906,20210920,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-117499",BOEHRINGER INGELHEIM,,67.0,YR,E,M,Y,93.8,KG,20210920.0,,CN,ES,ES,2021,Q3,Elderly
197943912,19794391,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 IU, QD",,,,, 0F527A,,,34.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Depression,,2021,Q3,2,F,2021.0,20210913.0,20210906,20210920,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-117499",BOEHRINGER INGELHEIM,,67.0,YR,E,M,Y,93.8,KG,20210920.0,,CN,ES,ES,2021,Q3,Elderly
197943912,19794391,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 IU, QD",,,,, 0F527A,,,34.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Diabetes mellitus inadequate control,,2021,Q3,2,F,2021.0,20210913.0,20210906,20210920,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-117499",BOEHRINGER INGELHEIM,,67.0,YR,E,M,Y,93.8,KG,20210920.0,,CN,ES,ES,2021,Q3,Elderly
197943912,19794391,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 IU, QD",,,,, 0F527A,,,34.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Fatigue,,2021,Q3,2,F,2021.0,20210913.0,20210906,20210920,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-117499",BOEHRINGER INGELHEIM,,67.0,YR,E,M,Y,93.8,KG,20210920.0,,CN,ES,ES,2021,Q3,Elderly
197943912,19794391,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 IU, QD",,,,, 0F527A,,,34.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hunger,,2021,Q3,2,F,2021.0,20210913.0,20210906,20210920,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-117499",BOEHRINGER INGELHEIM,,67.0,YR,E,M,Y,93.8,KG,20210920.0,,CN,ES,ES,2021,Q3,Elderly
197943912,19794391,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 IU, QD",,,,, 0F527A,,,34.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hypersomnia,,2021,Q3,2,F,2021.0,20210913.0,20210906,20210920,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-117499",BOEHRINGER INGELHEIM,,67.0,YR,E,M,Y,93.8,KG,20210920.0,,CN,ES,ES,2021,Q3,Elderly
197943912,19794391,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 IU, QD",,,,, 0F527A,,,34.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hypoglycaemia,,2021,Q3,2,F,2021.0,20210913.0,20210906,20210920,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-117499",BOEHRINGER INGELHEIM,,67.0,YR,E,M,Y,93.8,KG,20210920.0,,CN,ES,ES,2021,Q3,Elderly
197943912,19794391,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 IU, QD",,,,, 0F527A,,,34.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Intervertebral disc protrusion,,2021,Q3,2,F,2021.0,20210913.0,20210906,20210920,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-117499",BOEHRINGER INGELHEIM,,67.0,YR,E,M,Y,93.8,KG,20210920.0,,CN,ES,ES,2021,Q3,Elderly
197943912,19794391,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 IU, QD",,,,, 0F527A,,,34.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Oral herpes,,2021,Q3,2,F,2021.0,20210913.0,20210906,20210920,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-117499",BOEHRINGER INGELHEIM,,67.0,YR,E,M,Y,93.8,KG,20210920.0,,CN,ES,ES,2021,Q3,Elderly
197943912,19794391,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 IU, QD",,,,, 0F527A,,,34.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Pollakiuria,,2021,Q3,2,F,2021.0,20210913.0,20210906,20210920,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-117499",BOEHRINGER INGELHEIM,,67.0,YR,E,M,Y,93.8,KG,20210920.0,,CN,ES,ES,2021,Q3,Elderly
197943912,19794391,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 IU, QD",,,,, 0F527A,,,34.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Product dose omission issue,,2021,Q3,2,F,2021.0,20210913.0,20210906,20210920,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-117499",BOEHRINGER INGELHEIM,,67.0,YR,E,M,Y,93.8,KG,20210920.0,,CN,ES,ES,2021,Q3,Elderly
197943912,19794391,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 IU, QD",,,,, 0F527A,,,34.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Spinal disorder,,2021,Q3,2,F,2021.0,20210913.0,20210906,20210920,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-117499",BOEHRINGER INGELHEIM,,67.0,YR,E,M,Y,93.8,KG,20210920.0,,CN,ES,ES,2021,Q3,Elderly
197943912,19794391,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 IU, QD",,,,, 0F527A,,,34.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Thirst,,2021,Q3,2,F,2021.0,20210913.0,20210906,20210920,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-117499",BOEHRINGER INGELHEIM,,67.0,YR,E,M,Y,93.8,KG,20210920.0,,CN,ES,ES,2021,Q3,Elderly
197950691,19795069,14,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Pneumonia,,2021,Q3,1,I,20210829.0,,20210903,20210903,DIR,,,FDA-CTU,,62.0,YR,,F,N,75.8,KG,20210903.0,N,PH,US,US,2021,Q3,Adult
197950691,19795069,14,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Sputum culture positive,,2021,Q3,1,I,20210829.0,,20210903,20210903,DIR,,,FDA-CTU,,62.0,YR,,F,N,75.8,KG,20210903.0,N,PH,US,US,2021,Q3,Adult
197950691,19795069,14,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Staphylococcal infection,,2021,Q3,1,I,20210829.0,,20210903,20210903,DIR,,,FDA-CTU,,62.0,YR,,F,N,75.8,KG,20210903.0,N,PH,US,US,2021,Q3,Adult
197994131,19799413,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Anaemia,,2021,Q3,1,I,,20210902.0,20210907,20210907,EXP,,NVSC2021DE199715,NOVARTIS,,75.0,YR,,M,Y,111.0,KG,20210907.0,,HP,DE,DE,2021,Q3,Elderly
197994131,19799413,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20210902.0,20210907,20210907,EXP,,NVSC2021DE199715,NOVARTIS,,75.0,YR,,M,Y,111.0,KG,20210907.0,,HP,DE,DE,2021,Q3,Elderly
197994131,19799413,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Electrocardiogram abnormal,,2021,Q3,1,I,,20210902.0,20210907,20210907,EXP,,NVSC2021DE199715,NOVARTIS,,75.0,YR,,M,Y,111.0,KG,20210907.0,,HP,DE,DE,2021,Q3,Elderly
197994131,19799413,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210902.0,20210907,20210907,EXP,,NVSC2021DE199715,NOVARTIS,,75.0,YR,,M,Y,111.0,KG,20210907.0,,HP,DE,DE,2021,Q3,Elderly
197994131,19799413,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,,20210902.0,20210907,20210907,EXP,,NVSC2021DE199715,NOVARTIS,,75.0,YR,,M,Y,111.0,KG,20210907.0,,HP,DE,DE,2021,Q3,Elderly
197994131,19799413,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Jaundice,,2021,Q3,1,I,,20210902.0,20210907,20210907,EXP,,NVSC2021DE199715,NOVARTIS,,75.0,YR,,M,Y,111.0,KG,20210907.0,,HP,DE,DE,2021,Q3,Elderly
197994131,19799413,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Oedema peripheral,,2021,Q3,1,I,,20210902.0,20210907,20210907,EXP,,NVSC2021DE199715,NOVARTIS,,75.0,YR,,M,Y,111.0,KG,20210907.0,,HP,DE,DE,2021,Q3,Elderly
197994131,19799413,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210902.0,20210907,20210907,EXP,,NVSC2021DE199715,NOVARTIS,,75.0,YR,,M,Y,111.0,KG,20210907.0,,HP,DE,DE,2021,Q3,Elderly
197994131,19799413,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Renal impairment,,2021,Q3,1,I,,20210902.0,20210907,20210907,EXP,,NVSC2021DE199715,NOVARTIS,,75.0,YR,,M,Y,111.0,KG,20210907.0,,HP,DE,DE,2021,Q3,Elderly
197994131,19799413,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Systemic infection,,2021,Q3,1,I,,20210902.0,20210907,20210907,EXP,,NVSC2021DE199715,NOVARTIS,,75.0,YR,,M,Y,111.0,KG,20210907.0,,HP,DE,DE,2021,Q3,Elderly
197994131,19799413,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Tachypnoea,,2021,Q3,1,I,,20210902.0,20210907,20210907,EXP,,NVSC2021DE199715,NOVARTIS,,75.0,YR,,M,Y,111.0,KG,20210907.0,,HP,DE,DE,2021,Q3,Elderly
197994131,19799413,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Weight increased,,2021,Q3,1,I,,20210902.0,20210907,20210907,EXP,,NVSC2021DE199715,NOVARTIS,,75.0,YR,,M,Y,111.0,KG,20210907.0,,HP,DE,DE,2021,Q3,Elderly
197994131,19799413,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Wheezing,,2021,Q3,1,I,,20210902.0,20210907,20210907,EXP,,NVSC2021DE199715,NOVARTIS,,75.0,YR,,M,Y,111.0,KG,20210907.0,,HP,DE,DE,2021,Q3,Elderly
198011122,19801112,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Feeling abnormal,,2021,Q3,2,F,202106.0,20210830.0,20210907,20210909,EXP,,US-ELI_LILLY_AND_COMPANY-US202108011803,ELI LILLY AND CO,,34.0,YR,,F,Y,,,20210909.0,,HP,US,US,2021,Q3,Young Adult
198011122,19801112,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Pain,,2021,Q3,2,F,202106.0,20210830.0,20210907,20210909,EXP,,US-ELI_LILLY_AND_COMPANY-US202108011803,ELI LILLY AND CO,,34.0,YR,,F,Y,,,20210909.0,,HP,US,US,2021,Q3,Young Adult
198011122,19801112,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Superior mesenteric artery syndrome,,2021,Q3,2,F,202106.0,20210830.0,20210907,20210909,EXP,,US-ELI_LILLY_AND_COMPANY-US202108011803,ELI LILLY AND CO,,34.0,YR,,F,Y,,,20210909.0,,HP,US,US,2021,Q3,Young Adult
198026331,19802633,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Anuria,,2021,Q3,1,I,20201125.0,20210903.0,20210908,20210908,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-125125",BOEHRINGER INGELHEIM,,76.0,YR,E,M,Y,,,20210908.0,,PH,DE,DE,2021,Q3,Elderly
198026331,19802633,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Apnoea,,2021,Q3,1,I,20201125.0,20210903.0,20210908,20210908,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-125125",BOEHRINGER INGELHEIM,,76.0,YR,E,M,Y,,,20210908.0,,PH,DE,DE,2021,Q3,Elderly
198026331,19802633,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Bradypnoea,,2021,Q3,1,I,20201125.0,20210903.0,20210908,20210908,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-125125",BOEHRINGER INGELHEIM,,76.0,YR,E,M,Y,,,20210908.0,,PH,DE,DE,2021,Q3,Elderly
198026331,19802633,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Condition aggravated,,2021,Q3,1,I,20201125.0,20210903.0,20210908,20210908,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-125125",BOEHRINGER INGELHEIM,,76.0,YR,E,M,Y,,,20210908.0,,PH,DE,DE,2021,Q3,Elderly
198026331,19802633,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Cyanosis,,2021,Q3,1,I,20201125.0,20210903.0,20210908,20210908,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-125125",BOEHRINGER INGELHEIM,,76.0,YR,E,M,Y,,,20210908.0,,PH,DE,DE,2021,Q3,Elderly
198026331,19802633,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Death,,2021,Q3,1,I,20201125.0,20210903.0,20210908,20210908,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-125125",BOEHRINGER INGELHEIM,,76.0,YR,E,M,Y,,,20210908.0,,PH,DE,DE,2021,Q3,Elderly
198026331,19802633,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Decubitus ulcer,,2021,Q3,1,I,20201125.0,20210903.0,20210908,20210908,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-125125",BOEHRINGER INGELHEIM,,76.0,YR,E,M,Y,,,20210908.0,,PH,DE,DE,2021,Q3,Elderly
198026331,19802633,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Dehydration,,2021,Q3,1,I,20201125.0,20210903.0,20210908,20210908,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-125125",BOEHRINGER INGELHEIM,,76.0,YR,E,M,Y,,,20210908.0,,PH,DE,DE,2021,Q3,Elderly
198026331,19802633,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Disorientation,,2021,Q3,1,I,20201125.0,20210903.0,20210908,20210908,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-125125",BOEHRINGER INGELHEIM,,76.0,YR,E,M,Y,,,20210908.0,,PH,DE,DE,2021,Q3,Elderly
198026331,19802633,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Dyspnoea,,2021,Q3,1,I,20201125.0,20210903.0,20210908,20210908,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-125125",BOEHRINGER INGELHEIM,,76.0,YR,E,M,Y,,,20210908.0,,PH,DE,DE,2021,Q3,Elderly
198026331,19802633,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Electrocardiogram abnormal,,2021,Q3,1,I,20201125.0,20210903.0,20210908,20210908,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-125125",BOEHRINGER INGELHEIM,,76.0,YR,E,M,Y,,,20210908.0,,PH,DE,DE,2021,Q3,Elderly
198026331,19802633,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Electrolyte imbalance,,2021,Q3,1,I,20201125.0,20210903.0,20210908,20210908,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-125125",BOEHRINGER INGELHEIM,,76.0,YR,E,M,Y,,,20210908.0,,PH,DE,DE,2021,Q3,Elderly
198026331,19802633,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,20201125.0,20210903.0,20210908,20210908,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-125125",BOEHRINGER INGELHEIM,,76.0,YR,E,M,Y,,,20210908.0,,PH,DE,DE,2021,Q3,Elderly
198026331,19802633,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,20201125.0,20210903.0,20210908,20210908,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-125125",BOEHRINGER INGELHEIM,,76.0,YR,E,M,Y,,,20210908.0,,PH,DE,DE,2021,Q3,Elderly
198026331,19802633,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Hypotension,,2021,Q3,1,I,20201125.0,20210903.0,20210908,20210908,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-125125",BOEHRINGER INGELHEIM,,76.0,YR,E,M,Y,,,20210908.0,,PH,DE,DE,2021,Q3,Elderly
198026331,19802633,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Hypotonia,,2021,Q3,1,I,20201125.0,20210903.0,20210908,20210908,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-125125",BOEHRINGER INGELHEIM,,76.0,YR,E,M,Y,,,20210908.0,,PH,DE,DE,2021,Q3,Elderly
198026331,19802633,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Loss of consciousness,,2021,Q3,1,I,20201125.0,20210903.0,20210908,20210908,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-125125",BOEHRINGER INGELHEIM,,76.0,YR,E,M,Y,,,20210908.0,,PH,DE,DE,2021,Q3,Elderly
198026331,19802633,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Nuchal rigidity,,2021,Q3,1,I,20201125.0,20210903.0,20210908,20210908,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-125125",BOEHRINGER INGELHEIM,,76.0,YR,E,M,Y,,,20210908.0,,PH,DE,DE,2021,Q3,Elderly
198026331,19802633,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Oedema peripheral,,2021,Q3,1,I,20201125.0,20210903.0,20210908,20210908,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-125125",BOEHRINGER INGELHEIM,,76.0,YR,E,M,Y,,,20210908.0,,PH,DE,DE,2021,Q3,Elderly
198026331,19802633,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Pupils unequal,,2021,Q3,1,I,20201125.0,20210903.0,20210908,20210908,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-125125",BOEHRINGER INGELHEIM,,76.0,YR,E,M,Y,,,20210908.0,,PH,DE,DE,2021,Q3,Elderly
198026331,19802633,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Renal impairment,,2021,Q3,1,I,20201125.0,20210903.0,20210908,20210908,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-125125",BOEHRINGER INGELHEIM,,76.0,YR,E,M,Y,,,20210908.0,,PH,DE,DE,2021,Q3,Elderly
198026331,19802633,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Skin irritation,,2021,Q3,1,I,20201125.0,20210903.0,20210908,20210908,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-125125",BOEHRINGER INGELHEIM,,76.0,YR,E,M,Y,,,20210908.0,,PH,DE,DE,2021,Q3,Elderly
198026331,19802633,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Skin pressure mark,,2021,Q3,1,I,20201125.0,20210903.0,20210908,20210908,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-125125",BOEHRINGER INGELHEIM,,76.0,YR,E,M,Y,,,20210908.0,,PH,DE,DE,2021,Q3,Elderly
198026331,19802633,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Systemic infection,,2021,Q3,1,I,20201125.0,20210903.0,20210908,20210908,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-125125",BOEHRINGER INGELHEIM,,76.0,YR,E,M,Y,,,20210908.0,,PH,DE,DE,2021,Q3,Elderly
198026331,19802633,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Tachycardia,,2021,Q3,1,I,20201125.0,20210903.0,20210908,20210908,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-125125",BOEHRINGER INGELHEIM,,76.0,YR,E,M,Y,,,20210908.0,,PH,DE,DE,2021,Q3,Elderly
198026331,19802633,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Tachypnoea,,2021,Q3,1,I,20201125.0,20210903.0,20210908,20210908,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-125125",BOEHRINGER INGELHEIM,,76.0,YR,E,M,Y,,,20210908.0,,PH,DE,DE,2021,Q3,Elderly
198029822,19802982,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 IU,,,,,,,,12.0,IU,INJECTION,,2021,Q3,Renal impairment,,2021,Q3,2,F,20210708.0,20210924.0,20210908,20210928,EXP,,NVSJ2021JP013333,NOVARTIS,,95.0,YR,,F,Y,,,20210928.0,,PH,JP,JP,2021,Q3,Elderly
198037922,19803792,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,18 UNITS AT BEDTIME,,,,,,,,,,,,2021,Q3,Euglycaemic diabetic ketoacidosis,,2021,Q3,2,F,,20210909.0,20210908,20210914,EXP,,PK-ASTRAZENECA-2021A709408,ASTRAZENECA,,55.0,YR,,F,Y,,,20210914.0,,HP,PK,PK,2021,Q3,Adult
198039271,19803927,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM,,,U,,,,,1.0,DF,,,2021,Q3,Cerebral haemorrhage,,2021,Q3,1,I,,20210901.0,20210908,20210908,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-088022,BRISTOL MYERS SQUIBB,,77.0,YR,,M,Y,85.0,KG,20210908.0,,PH,DE,DE,2021,Q3,Elderly
198039271,19803927,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM,,,U,,,,,1.0,DF,,,2021,Q3,Dysarthria,,2021,Q3,1,I,,20210901.0,20210908,20210908,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-088022,BRISTOL MYERS SQUIBB,,77.0,YR,,M,Y,85.0,KG,20210908.0,,PH,DE,DE,2021,Q3,Elderly
198039271,19803927,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM,,,U,,,,,1.0,DF,,,2021,Q3,Fatigue,,2021,Q3,1,I,,20210901.0,20210908,20210908,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-088022,BRISTOL MYERS SQUIBB,,77.0,YR,,M,Y,85.0,KG,20210908.0,,PH,DE,DE,2021,Q3,Elderly
198039271,19803927,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM,,,U,,,,,1.0,DF,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210901.0,20210908,20210908,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-088022,BRISTOL MYERS SQUIBB,,77.0,YR,,M,Y,85.0,KG,20210908.0,,PH,DE,DE,2021,Q3,Elderly
198039271,19803927,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM,,,U,,,,,1.0,DF,,,2021,Q3,Muscular weakness,,2021,Q3,1,I,,20210901.0,20210908,20210908,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-088022,BRISTOL MYERS SQUIBB,,77.0,YR,,M,Y,85.0,KG,20210908.0,,PH,DE,DE,2021,Q3,Elderly
198061181,19806118,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK (SCHEME),,,,,,,,,,,,2021,Q3,Anaemia,,2021,Q3,1,I,,20210831.0,20210909,20210909,EXP,,DE-AUROBINDO-AUR-APL-2021-038122,AUROBINDO,,75.0,YR,,M,Y,111.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198061181,19806118,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK (SCHEME),,,,,,,,,,,,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20210831.0,20210909,20210909,EXP,,DE-AUROBINDO-AUR-APL-2021-038122,AUROBINDO,,75.0,YR,,M,Y,111.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198061181,19806118,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK (SCHEME),,,,,,,,,,,,2021,Q3,Electrocardiogram abnormal,,2021,Q3,1,I,,20210831.0,20210909,20210909,EXP,,DE-AUROBINDO-AUR-APL-2021-038122,AUROBINDO,,75.0,YR,,M,Y,111.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198061181,19806118,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK (SCHEME),,,,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210831.0,20210909,20210909,EXP,,DE-AUROBINDO-AUR-APL-2021-038122,AUROBINDO,,75.0,YR,,M,Y,111.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198061181,19806118,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK (SCHEME),,,,,,,,,,,,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,,20210831.0,20210909,20210909,EXP,,DE-AUROBINDO-AUR-APL-2021-038122,AUROBINDO,,75.0,YR,,M,Y,111.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198061181,19806118,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK (SCHEME),,,,,,,,,,,,2021,Q3,Jaundice,,2021,Q3,1,I,,20210831.0,20210909,20210909,EXP,,DE-AUROBINDO-AUR-APL-2021-038122,AUROBINDO,,75.0,YR,,M,Y,111.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198061181,19806118,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK (SCHEME),,,,,,,,,,,,2021,Q3,Oedema peripheral,,2021,Q3,1,I,,20210831.0,20210909,20210909,EXP,,DE-AUROBINDO-AUR-APL-2021-038122,AUROBINDO,,75.0,YR,,M,Y,111.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198061181,19806118,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK (SCHEME),,,,,,,,,,,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210831.0,20210909,20210909,EXP,,DE-AUROBINDO-AUR-APL-2021-038122,AUROBINDO,,75.0,YR,,M,Y,111.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198061181,19806118,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK (SCHEME),,,,,,,,,,,,2021,Q3,Renal impairment,,2021,Q3,1,I,,20210831.0,20210909,20210909,EXP,,DE-AUROBINDO-AUR-APL-2021-038122,AUROBINDO,,75.0,YR,,M,Y,111.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198061181,19806118,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK (SCHEME),,,,,,,,,,,,2021,Q3,Systemic infection,,2021,Q3,1,I,,20210831.0,20210909,20210909,EXP,,DE-AUROBINDO-AUR-APL-2021-038122,AUROBINDO,,75.0,YR,,M,Y,111.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198061181,19806118,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK (SCHEME),,,,,,,,,,,,2021,Q3,Tachypnoea,,2021,Q3,1,I,,20210831.0,20210909,20210909,EXP,,DE-AUROBINDO-AUR-APL-2021-038122,AUROBINDO,,75.0,YR,,M,Y,111.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198061181,19806118,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK (SCHEME),,,,,,,,,,,,2021,Q3,Weight increased,,2021,Q3,1,I,,20210831.0,20210909,20210909,EXP,,DE-AUROBINDO-AUR-APL-2021-038122,AUROBINDO,,75.0,YR,,M,Y,111.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198061181,19806118,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK (SCHEME),,,,,,,,,,,,2021,Q3,Wheezing,,2021,Q3,1,I,,20210831.0,20210909,20210909,EXP,,DE-AUROBINDO-AUR-APL-2021-038122,AUROBINDO,,75.0,YR,,M,Y,111.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198063321,19806332,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"48 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,48.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blindness unilateral,,2021,Q3,1,I,,20210830.0,20210909,20210909,EXP,,ES-AUROBINDO-AUR-APL-2021-037814,AUROBINDO,,67.0,YR,,F,Y,94.2,KG,20210909.0,,CN,ES,ES,2021,Q3,Elderly
198063321,19806332,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"48 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,48.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,1,I,,20210830.0,20210909,20210909,EXP,,ES-AUROBINDO-AUR-APL-2021-037814,AUROBINDO,,67.0,YR,,F,Y,94.2,KG,20210909.0,,CN,ES,ES,2021,Q3,Elderly
198063321,19806332,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"48 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,48.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Cataract diabetic,,2021,Q3,1,I,,20210830.0,20210909,20210909,EXP,,ES-AUROBINDO-AUR-APL-2021-037814,AUROBINDO,,67.0,YR,,F,Y,94.2,KG,20210909.0,,CN,ES,ES,2021,Q3,Elderly
198063321,19806332,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"48 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,48.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210830.0,20210909,20210909,EXP,,ES-AUROBINDO-AUR-APL-2021-037814,AUROBINDO,,67.0,YR,,F,Y,94.2,KG,20210909.0,,CN,ES,ES,2021,Q3,Elderly
198063321,19806332,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"48 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,48.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Disability,,2021,Q3,1,I,,20210830.0,20210909,20210909,EXP,,ES-AUROBINDO-AUR-APL-2021-037814,AUROBINDO,,67.0,YR,,F,Y,94.2,KG,20210909.0,,CN,ES,ES,2021,Q3,Elderly
198063321,19806332,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"48 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,48.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Exercise lack of,,2021,Q3,1,I,,20210830.0,20210909,20210909,EXP,,ES-AUROBINDO-AUR-APL-2021-037814,AUROBINDO,,67.0,YR,,F,Y,94.2,KG,20210909.0,,CN,ES,ES,2021,Q3,Elderly
198063321,19806332,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"48 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,48.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Gait inability,,2021,Q3,1,I,,20210830.0,20210909,20210909,EXP,,ES-AUROBINDO-AUR-APL-2021-037814,AUROBINDO,,67.0,YR,,F,Y,94.2,KG,20210909.0,,CN,ES,ES,2021,Q3,Elderly
198063321,19806332,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"48 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,48.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Multiple use of single-use product,,2021,Q3,1,I,,20210830.0,20210909,20210909,EXP,,ES-AUROBINDO-AUR-APL-2021-037814,AUROBINDO,,67.0,YR,,F,Y,94.2,KG,20210909.0,,CN,ES,ES,2021,Q3,Elderly
198063321,19806332,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"48 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,48.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Post procedural complication,,2021,Q3,1,I,,20210830.0,20210909,20210909,EXP,,ES-AUROBINDO-AUR-APL-2021-037814,AUROBINDO,,67.0,YR,,F,Y,94.2,KG,20210909.0,,CN,ES,ES,2021,Q3,Elderly
198063321,19806332,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"48 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,48.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Retinal injury,,2021,Q3,1,I,,20210830.0,20210909,20210909,EXP,,ES-AUROBINDO-AUR-APL-2021-037814,AUROBINDO,,67.0,YR,,F,Y,94.2,KG,20210909.0,,CN,ES,ES,2021,Q3,Elderly
198063321,19806332,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"48 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,48.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Uterine operation,,2021,Q3,1,I,,20210830.0,20210909,20210909,EXP,,ES-AUROBINDO-AUR-APL-2021-037814,AUROBINDO,,67.0,YR,,F,Y,94.2,KG,20210909.0,,CN,ES,ES,2021,Q3,Elderly
198063321,19806332,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"50 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,50.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blindness unilateral,,2021,Q3,1,I,,20210830.0,20210909,20210909,EXP,,ES-AUROBINDO-AUR-APL-2021-037814,AUROBINDO,,67.0,YR,,F,Y,94.2,KG,20210909.0,,CN,ES,ES,2021,Q3,Elderly
198063321,19806332,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"50 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,50.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,1,I,,20210830.0,20210909,20210909,EXP,,ES-AUROBINDO-AUR-APL-2021-037814,AUROBINDO,,67.0,YR,,F,Y,94.2,KG,20210909.0,,CN,ES,ES,2021,Q3,Elderly
198063321,19806332,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"50 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,50.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Cataract diabetic,,2021,Q3,1,I,,20210830.0,20210909,20210909,EXP,,ES-AUROBINDO-AUR-APL-2021-037814,AUROBINDO,,67.0,YR,,F,Y,94.2,KG,20210909.0,,CN,ES,ES,2021,Q3,Elderly
198063321,19806332,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"50 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,50.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210830.0,20210909,20210909,EXP,,ES-AUROBINDO-AUR-APL-2021-037814,AUROBINDO,,67.0,YR,,F,Y,94.2,KG,20210909.0,,CN,ES,ES,2021,Q3,Elderly
198063321,19806332,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"50 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,50.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Disability,,2021,Q3,1,I,,20210830.0,20210909,20210909,EXP,,ES-AUROBINDO-AUR-APL-2021-037814,AUROBINDO,,67.0,YR,,F,Y,94.2,KG,20210909.0,,CN,ES,ES,2021,Q3,Elderly
198063321,19806332,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"50 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,50.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Exercise lack of,,2021,Q3,1,I,,20210830.0,20210909,20210909,EXP,,ES-AUROBINDO-AUR-APL-2021-037814,AUROBINDO,,67.0,YR,,F,Y,94.2,KG,20210909.0,,CN,ES,ES,2021,Q3,Elderly
198063321,19806332,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"50 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,50.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Gait inability,,2021,Q3,1,I,,20210830.0,20210909,20210909,EXP,,ES-AUROBINDO-AUR-APL-2021-037814,AUROBINDO,,67.0,YR,,F,Y,94.2,KG,20210909.0,,CN,ES,ES,2021,Q3,Elderly
198063321,19806332,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"50 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,50.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Multiple use of single-use product,,2021,Q3,1,I,,20210830.0,20210909,20210909,EXP,,ES-AUROBINDO-AUR-APL-2021-037814,AUROBINDO,,67.0,YR,,F,Y,94.2,KG,20210909.0,,CN,ES,ES,2021,Q3,Elderly
198063321,19806332,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"50 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,50.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Post procedural complication,,2021,Q3,1,I,,20210830.0,20210909,20210909,EXP,,ES-AUROBINDO-AUR-APL-2021-037814,AUROBINDO,,67.0,YR,,F,Y,94.2,KG,20210909.0,,CN,ES,ES,2021,Q3,Elderly
198063321,19806332,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"50 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,50.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Retinal injury,,2021,Q3,1,I,,20210830.0,20210909,20210909,EXP,,ES-AUROBINDO-AUR-APL-2021-037814,AUROBINDO,,67.0,YR,,F,Y,94.2,KG,20210909.0,,CN,ES,ES,2021,Q3,Elderly
198063321,19806332,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"50 INTERNATIONAL UNIT, ONCE A DAY",,,D,,,,,50.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Uterine operation,,2021,Q3,1,I,,20210830.0,20210909,20210909,EXP,,ES-AUROBINDO-AUR-APL-2021-037814,AUROBINDO,,67.0,YR,,F,Y,94.2,KG,20210909.0,,CN,ES,ES,2021,Q3,Elderly
198063321,19806332,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"52 INTERNATIONAL UNIT, ONCE A DAY",,,D,, 1F939A,,,52.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blindness unilateral,,2021,Q3,1,I,,20210830.0,20210909,20210909,EXP,,ES-AUROBINDO-AUR-APL-2021-037814,AUROBINDO,,67.0,YR,,F,Y,94.2,KG,20210909.0,,CN,ES,ES,2021,Q3,Elderly
198063321,19806332,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"52 INTERNATIONAL UNIT, ONCE A DAY",,,D,, 1F939A,,,52.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,1,I,,20210830.0,20210909,20210909,EXP,,ES-AUROBINDO-AUR-APL-2021-037814,AUROBINDO,,67.0,YR,,F,Y,94.2,KG,20210909.0,,CN,ES,ES,2021,Q3,Elderly
198063321,19806332,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"52 INTERNATIONAL UNIT, ONCE A DAY",,,D,, 1F939A,,,52.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Cataract diabetic,,2021,Q3,1,I,,20210830.0,20210909,20210909,EXP,,ES-AUROBINDO-AUR-APL-2021-037814,AUROBINDO,,67.0,YR,,F,Y,94.2,KG,20210909.0,,CN,ES,ES,2021,Q3,Elderly
198063321,19806332,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"52 INTERNATIONAL UNIT, ONCE A DAY",,,D,, 1F939A,,,52.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210830.0,20210909,20210909,EXP,,ES-AUROBINDO-AUR-APL-2021-037814,AUROBINDO,,67.0,YR,,F,Y,94.2,KG,20210909.0,,CN,ES,ES,2021,Q3,Elderly
198063321,19806332,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"52 INTERNATIONAL UNIT, ONCE A DAY",,,D,, 1F939A,,,52.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Disability,,2021,Q3,1,I,,20210830.0,20210909,20210909,EXP,,ES-AUROBINDO-AUR-APL-2021-037814,AUROBINDO,,67.0,YR,,F,Y,94.2,KG,20210909.0,,CN,ES,ES,2021,Q3,Elderly
198063321,19806332,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"52 INTERNATIONAL UNIT, ONCE A DAY",,,D,, 1F939A,,,52.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Exercise lack of,,2021,Q3,1,I,,20210830.0,20210909,20210909,EXP,,ES-AUROBINDO-AUR-APL-2021-037814,AUROBINDO,,67.0,YR,,F,Y,94.2,KG,20210909.0,,CN,ES,ES,2021,Q3,Elderly
198063321,19806332,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"52 INTERNATIONAL UNIT, ONCE A DAY",,,D,, 1F939A,,,52.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Gait inability,,2021,Q3,1,I,,20210830.0,20210909,20210909,EXP,,ES-AUROBINDO-AUR-APL-2021-037814,AUROBINDO,,67.0,YR,,F,Y,94.2,KG,20210909.0,,CN,ES,ES,2021,Q3,Elderly
198063321,19806332,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"52 INTERNATIONAL UNIT, ONCE A DAY",,,D,, 1F939A,,,52.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Multiple use of single-use product,,2021,Q3,1,I,,20210830.0,20210909,20210909,EXP,,ES-AUROBINDO-AUR-APL-2021-037814,AUROBINDO,,67.0,YR,,F,Y,94.2,KG,20210909.0,,CN,ES,ES,2021,Q3,Elderly
198063321,19806332,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"52 INTERNATIONAL UNIT, ONCE A DAY",,,D,, 1F939A,,,52.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Post procedural complication,,2021,Q3,1,I,,20210830.0,20210909,20210909,EXP,,ES-AUROBINDO-AUR-APL-2021-037814,AUROBINDO,,67.0,YR,,F,Y,94.2,KG,20210909.0,,CN,ES,ES,2021,Q3,Elderly
198063321,19806332,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"52 INTERNATIONAL UNIT, ONCE A DAY",,,D,, 1F939A,,,52.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Retinal injury,,2021,Q3,1,I,,20210830.0,20210909,20210909,EXP,,ES-AUROBINDO-AUR-APL-2021-037814,AUROBINDO,,67.0,YR,,F,Y,94.2,KG,20210909.0,,CN,ES,ES,2021,Q3,Elderly
198063321,19806332,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"52 INTERNATIONAL UNIT, ONCE A DAY",,,D,, 1F939A,,,52.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Uterine operation,,2021,Q3,1,I,,20210830.0,20210909,20210909,EXP,,ES-AUROBINDO-AUR-APL-2021-037814,AUROBINDO,,67.0,YR,,F,Y,94.2,KG,20210909.0,,CN,ES,ES,2021,Q3,Elderly
198067071,19806707,4,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK (450 U / 1.5ML, 0?0?0?6, PRE?FILLED SYRINGES)",,,,,,,,,,,,2021,Q3,Decreased appetite,,2021,Q3,1,I,,20210831.0,20210909,20210909,EXP,,DE-AUROBINDO-AUR-APL-2021-038318,AUROBINDO,,69.0,YR,,M,Y,61.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198067071,19806707,4,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK (450 U / 1.5ML, 0?0?0?6, PRE?FILLED SYRINGES)",,,,,,,,,,,,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210831.0,20210909,20210909,EXP,,DE-AUROBINDO-AUR-APL-2021-038318,AUROBINDO,,69.0,YR,,M,Y,61.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198067071,19806707,4,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK (450 U / 1.5ML, 0?0?0?6, PRE?FILLED SYRINGES)",,,,,,,,,,,,2021,Q3,Fine motor skill dysfunction,,2021,Q3,1,I,,20210831.0,20210909,20210909,EXP,,DE-AUROBINDO-AUR-APL-2021-038318,AUROBINDO,,69.0,YR,,M,Y,61.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198067071,19806707,4,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK (450 U / 1.5ML, 0?0?0?6, PRE?FILLED SYRINGES)",,,,,,,,,,,,2021,Q3,Fluid intake reduced,,2021,Q3,1,I,,20210831.0,20210909,20210909,EXP,,DE-AUROBINDO-AUR-APL-2021-038318,AUROBINDO,,69.0,YR,,M,Y,61.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198067071,19806707,4,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK (450 U / 1.5ML, 0?0?0?6, PRE?FILLED SYRINGES)",,,,,,,,,,,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210831.0,20210909,20210909,EXP,,DE-AUROBINDO-AUR-APL-2021-038318,AUROBINDO,,69.0,YR,,M,Y,61.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198084311,19808431,7,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,U,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Abdominal pain,,2021,Q3,1,I,20210522.0,20210904.0,20210909,20210909,EXP,,FR-AUROBINDO-AUR-APL-2021-038517,AUROBINDO,,59.0,YR,,M,Y,64.0,KG,20210909.0,,HP,FR,FR,2021,Q3,Adult
198084311,19808431,7,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,U,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Arthralgia,,2021,Q3,1,I,20210522.0,20210904.0,20210909,20210909,EXP,,FR-AUROBINDO-AUR-APL-2021-038517,AUROBINDO,,59.0,YR,,M,Y,64.0,KG,20210909.0,,HP,FR,FR,2021,Q3,Adult
198084311,19808431,7,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,U,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Haematoma muscle,,2021,Q3,1,I,20210522.0,20210904.0,20210909,20210909,EXP,,FR-AUROBINDO-AUR-APL-2021-038517,AUROBINDO,,59.0,YR,,M,Y,64.0,KG,20210909.0,,HP,FR,FR,2021,Q3,Adult
198084311,19808431,7,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,U,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Muscular weakness,,2021,Q3,1,I,20210522.0,20210904.0,20210909,20210909,EXP,,FR-AUROBINDO-AUR-APL-2021-038517,AUROBINDO,,59.0,YR,,M,Y,64.0,KG,20210909.0,,HP,FR,FR,2021,Q3,Adult
198084311,19808431,7,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,U,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Pain in extremity,,2021,Q3,1,I,20210522.0,20210904.0,20210909,20210909,EXP,,FR-AUROBINDO-AUR-APL-2021-038517,AUROBINDO,,59.0,YR,,M,Y,64.0,KG,20210909.0,,HP,FR,FR,2021,Q3,Adult
198084311,19808431,7,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,U,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Pyelocaliectasis,,2021,Q3,1,I,20210522.0,20210904.0,20210909,20210909,EXP,,FR-AUROBINDO-AUR-APL-2021-038517,AUROBINDO,,59.0,YR,,M,Y,64.0,KG,20210909.0,,HP,FR,FR,2021,Q3,Adult
198084311,19808431,7,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,U,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Ureteric compression,,2021,Q3,1,I,20210522.0,20210904.0,20210909,20210909,EXP,,FR-AUROBINDO-AUR-APL-2021-038517,AUROBINDO,,59.0,YR,,M,Y,64.0,KG,20210909.0,,HP,FR,FR,2021,Q3,Adult
198084381,19808438,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Anuria,,2021,Q3,1,I,,20210831.0,20210909,20210909,EXP,,DE-AUROBINDO-AUR-APL-2021-038117,AUROBINDO,,76.0,YR,,M,Y,,,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198084381,19808438,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Apnoea,,2021,Q3,1,I,,20210831.0,20210909,20210909,EXP,,DE-AUROBINDO-AUR-APL-2021-038117,AUROBINDO,,76.0,YR,,M,Y,,,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198084381,19808438,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Bradypnoea,,2021,Q3,1,I,,20210831.0,20210909,20210909,EXP,,DE-AUROBINDO-AUR-APL-2021-038117,AUROBINDO,,76.0,YR,,M,Y,,,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198084381,19808438,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Condition aggravated,,2021,Q3,1,I,,20210831.0,20210909,20210909,EXP,,DE-AUROBINDO-AUR-APL-2021-038117,AUROBINDO,,76.0,YR,,M,Y,,,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198084381,19808438,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Cyanosis,,2021,Q3,1,I,,20210831.0,20210909,20210909,EXP,,DE-AUROBINDO-AUR-APL-2021-038117,AUROBINDO,,76.0,YR,,M,Y,,,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198084381,19808438,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Decubitus ulcer,,2021,Q3,1,I,,20210831.0,20210909,20210909,EXP,,DE-AUROBINDO-AUR-APL-2021-038117,AUROBINDO,,76.0,YR,,M,Y,,,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198084381,19808438,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Dehydration,,2021,Q3,1,I,,20210831.0,20210909,20210909,EXP,,DE-AUROBINDO-AUR-APL-2021-038117,AUROBINDO,,76.0,YR,,M,Y,,,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198084381,19808438,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Disorientation,,2021,Q3,1,I,,20210831.0,20210909,20210909,EXP,,DE-AUROBINDO-AUR-APL-2021-038117,AUROBINDO,,76.0,YR,,M,Y,,,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198084381,19808438,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20210831.0,20210909,20210909,EXP,,DE-AUROBINDO-AUR-APL-2021-038117,AUROBINDO,,76.0,YR,,M,Y,,,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198084381,19808438,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Electrocardiogram abnormal,,2021,Q3,1,I,,20210831.0,20210909,20210909,EXP,,DE-AUROBINDO-AUR-APL-2021-038117,AUROBINDO,,76.0,YR,,M,Y,,,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198084381,19808438,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Electrolyte imbalance,,2021,Q3,1,I,,20210831.0,20210909,20210909,EXP,,DE-AUROBINDO-AUR-APL-2021-038117,AUROBINDO,,76.0,YR,,M,Y,,,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198084381,19808438,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210831.0,20210909,20210909,EXP,,DE-AUROBINDO-AUR-APL-2021-038117,AUROBINDO,,76.0,YR,,M,Y,,,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198084381,19808438,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,,20210831.0,20210909,20210909,EXP,,DE-AUROBINDO-AUR-APL-2021-038117,AUROBINDO,,76.0,YR,,M,Y,,,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198084381,19808438,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Hypotension,,2021,Q3,1,I,,20210831.0,20210909,20210909,EXP,,DE-AUROBINDO-AUR-APL-2021-038117,AUROBINDO,,76.0,YR,,M,Y,,,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198084381,19808438,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Hypotonia,,2021,Q3,1,I,,20210831.0,20210909,20210909,EXP,,DE-AUROBINDO-AUR-APL-2021-038117,AUROBINDO,,76.0,YR,,M,Y,,,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198084381,19808438,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Loss of consciousness,,2021,Q3,1,I,,20210831.0,20210909,20210909,EXP,,DE-AUROBINDO-AUR-APL-2021-038117,AUROBINDO,,76.0,YR,,M,Y,,,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198084381,19808438,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Nuchal rigidity,,2021,Q3,1,I,,20210831.0,20210909,20210909,EXP,,DE-AUROBINDO-AUR-APL-2021-038117,AUROBINDO,,76.0,YR,,M,Y,,,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198084381,19808438,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Oedema peripheral,,2021,Q3,1,I,,20210831.0,20210909,20210909,EXP,,DE-AUROBINDO-AUR-APL-2021-038117,AUROBINDO,,76.0,YR,,M,Y,,,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198084381,19808438,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Pupils unequal,,2021,Q3,1,I,,20210831.0,20210909,20210909,EXP,,DE-AUROBINDO-AUR-APL-2021-038117,AUROBINDO,,76.0,YR,,M,Y,,,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198084381,19808438,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Renal impairment,,2021,Q3,1,I,,20210831.0,20210909,20210909,EXP,,DE-AUROBINDO-AUR-APL-2021-038117,AUROBINDO,,76.0,YR,,M,Y,,,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198084381,19808438,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Skin irritation,,2021,Q3,1,I,,20210831.0,20210909,20210909,EXP,,DE-AUROBINDO-AUR-APL-2021-038117,AUROBINDO,,76.0,YR,,M,Y,,,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198084381,19808438,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Skin pressure mark,,2021,Q3,1,I,,20210831.0,20210909,20210909,EXP,,DE-AUROBINDO-AUR-APL-2021-038117,AUROBINDO,,76.0,YR,,M,Y,,,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198084381,19808438,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Systemic infection,,2021,Q3,1,I,,20210831.0,20210909,20210909,EXP,,DE-AUROBINDO-AUR-APL-2021-038117,AUROBINDO,,76.0,YR,,M,Y,,,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198084381,19808438,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Tachycardia,,2021,Q3,1,I,,20210831.0,20210909,20210909,EXP,,DE-AUROBINDO-AUR-APL-2021-038117,AUROBINDO,,76.0,YR,,M,Y,,,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198084381,19808438,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Tachypnoea,,2021,Q3,1,I,,20210831.0,20210909,20210909,EXP,,DE-AUROBINDO-AUR-APL-2021-038117,AUROBINDO,,76.0,YR,,M,Y,,,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198086941,19808694,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, QD",,,U,,,,,22.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Arthralgia,,2021,Q3,1,I,202108.0,20210906.0,20210909,20210909,EXP,,NVSC2021ES202355,NOVARTIS,,84.0,YR,,F,Y,65.0,KG,20210909.0,,HP,COUNTRY NOT SPECIFIED,ES,2021,Q3,Elderly
198086941,19808694,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, QD",,,U,,,,,22.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,1,I,202108.0,20210906.0,20210909,20210909,EXP,,NVSC2021ES202355,NOVARTIS,,84.0,YR,,F,Y,65.0,KG,20210909.0,,HP,COUNTRY NOT SPECIFIED,ES,2021,Q3,Elderly
198086941,19808694,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, QD",,,U,,,,,22.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Dizziness,,2021,Q3,1,I,202108.0,20210906.0,20210909,20210909,EXP,,NVSC2021ES202355,NOVARTIS,,84.0,YR,,F,Y,65.0,KG,20210909.0,,HP,COUNTRY NOT SPECIFIED,ES,2021,Q3,Elderly
198086941,19808694,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, QD",,,U,,,,,22.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Fall,,2021,Q3,1,I,202108.0,20210906.0,20210909,20210909,EXP,,NVSC2021ES202355,NOVARTIS,,84.0,YR,,F,Y,65.0,KG,20210909.0,,HP,COUNTRY NOT SPECIFIED,ES,2021,Q3,Elderly
198086941,19808694,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, QD",,,U,,,,,22.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hip fracture,,2021,Q3,1,I,202108.0,20210906.0,20210909,20210909,EXP,,NVSC2021ES202355,NOVARTIS,,84.0,YR,,F,Y,65.0,KG,20210909.0,,HP,COUNTRY NOT SPECIFIED,ES,2021,Q3,Elderly
198089401,19808940,7,C,insulin (regular ??} glargine and lispro),,2,,,,,,,,,,,,,,2021,Q3,Deep vein thrombosis,,2021,Q3,1,I,20210905.0,,20210909,20210909,DIR,,,FDA-CTU,,32.0,YR,,M,N,161.2,KG,20210909.0,N,PH,US,US,2021,Q3,Young Adult
198089401,19808940,7,C,insulin (regular ??} glargine and lispro),,2,,,,,,,,,,,,,,2021,Q3,Hypoxia,,2021,Q3,1,I,20210905.0,,20210909,20210909,DIR,,,FDA-CTU,,32.0,YR,,M,N,161.2,KG,20210909.0,N,PH,US,US,2021,Q3,Young Adult
198089401,19808940,7,C,insulin (regular ??} glargine and lispro),,2,,,,,,,,,,,,,,2021,Q3,Pulmonary embolism,,2021,Q3,1,I,20210905.0,,20210909,20210909,DIR,,,FDA-CTU,,32.0,YR,,M,N,161.2,KG,20210909.0,N,PH,US,US,2021,Q3,Young Adult
198089401,19808940,7,C,insulin (regular ??} glargine and lispro),,2,,,,,,,,,,,,,,2021,Q3,Supraventricular tachycardia,,2021,Q3,1,I,20210905.0,,20210909,20210909,DIR,,,FDA-CTU,,32.0,YR,,M,N,161.2,KG,20210909.0,N,PH,US,US,2021,Q3,Young Adult
198093441,19809344,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (1 IE, 0?0?0?12, ZYLINDERAMPULLEN)",,,U,,,,,,,,,2021,Q3,Acute kidney injury,,2021,Q3,1,I,,20210903.0,20210909,20210909,EXP,DE-ADRED-07171-01,NVSC2021DE200937,NOVARTIS,,55.0,YR,,F,Y,62.0,KG,20210909.0,,HP,DE,DE,2021,Q3,Adult
198093441,19809344,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (1 IE, 0?0?0?12, ZYLINDERAMPULLEN)",,,U,,,,,,,,,2021,Q3,Decreased appetite,,2021,Q3,1,I,,20210903.0,20210909,20210909,EXP,DE-ADRED-07171-01,NVSC2021DE200937,NOVARTIS,,55.0,YR,,F,Y,62.0,KG,20210909.0,,HP,DE,DE,2021,Q3,Adult
198093441,19809344,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (1 IE, 0?0?0?12, ZYLINDERAMPULLEN)",,,U,,,,,,,,,2021,Q3,Fatigue,,2021,Q3,1,I,,20210903.0,20210909,20210909,EXP,DE-ADRED-07171-01,NVSC2021DE200937,NOVARTIS,,55.0,YR,,F,Y,62.0,KG,20210909.0,,HP,DE,DE,2021,Q3,Adult
198093441,19809344,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (1 IE, 0?0?0?12, ZYLINDERAMPULLEN)",,,U,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210903.0,20210909,20210909,EXP,DE-ADRED-07171-01,NVSC2021DE200937,NOVARTIS,,55.0,YR,,F,Y,62.0,KG,20210909.0,,HP,DE,DE,2021,Q3,Adult
198093441,19809344,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (1 IE, 0?0?0?12, ZYLINDERAMPULLEN)",,,U,,,,,,,,,2021,Q3,Headache,,2021,Q3,1,I,,20210903.0,20210909,20210909,EXP,DE-ADRED-07171-01,NVSC2021DE200937,NOVARTIS,,55.0,YR,,F,Y,62.0,KG,20210909.0,,HP,DE,DE,2021,Q3,Adult
198093441,19809344,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (1 IE, 0?0?0?12, ZYLINDERAMPULLEN)",,,U,,,,,,,,,2021,Q3,Jaundice,,2021,Q3,1,I,,20210903.0,20210909,20210909,EXP,DE-ADRED-07171-01,NVSC2021DE200937,NOVARTIS,,55.0,YR,,F,Y,62.0,KG,20210909.0,,HP,DE,DE,2021,Q3,Adult
198093441,19809344,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (1 IE, 0?0?0?12, ZYLINDERAMPULLEN)",,,U,,,,,,,,,2021,Q3,Nausea,,2021,Q3,1,I,,20210903.0,20210909,20210909,EXP,DE-ADRED-07171-01,NVSC2021DE200937,NOVARTIS,,55.0,YR,,F,Y,62.0,KG,20210909.0,,HP,DE,DE,2021,Q3,Adult
198093511,19809351,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK (10 U),,,U,,,,,,,,,2021,Q3,Abdominal pain,,2021,Q3,1,I,,20210901.0,20210909,20210909,EXP,,NVSC2021TH199489,NOVARTIS,,63.0,YR,,M,Y,,,20210909.0,,MD,TH,TH,2021,Q3,Adult
198093511,19809351,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK (10 U),,,U,,,,,,,,,2021,Q3,Asthenia,,2021,Q3,1,I,,20210901.0,20210909,20210909,EXP,,NVSC2021TH199489,NOVARTIS,,63.0,YR,,M,Y,,,20210909.0,,MD,TH,TH,2021,Q3,Adult
198093511,19809351,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK (10 U),,,U,,,,,,,,,2021,Q3,BK virus infection,,2021,Q3,1,I,,20210901.0,20210909,20210909,EXP,,NVSC2021TH199489,NOVARTIS,,63.0,YR,,M,Y,,,20210909.0,,MD,TH,TH,2021,Q3,Adult
198093511,19809351,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK (10 U),,,U,,,,,,,,,2021,Q3,Blood creatinine increased,,2021,Q3,1,I,,20210901.0,20210909,20210909,EXP,,NVSC2021TH199489,NOVARTIS,,63.0,YR,,M,Y,,,20210909.0,,MD,TH,TH,2021,Q3,Adult
198093511,19809351,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK (10 U),,,U,,,,,,,,,2021,Q3,Blood urea abnormal,,2021,Q3,1,I,,20210901.0,20210909,20210909,EXP,,NVSC2021TH199489,NOVARTIS,,63.0,YR,,M,Y,,,20210909.0,,MD,TH,TH,2021,Q3,Adult
198093511,19809351,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK (10 U),,,U,,,,,,,,,2021,Q3,Cough,,2021,Q3,1,I,,20210901.0,20210909,20210909,EXP,,NVSC2021TH199489,NOVARTIS,,63.0,YR,,M,Y,,,20210909.0,,MD,TH,TH,2021,Q3,Adult
198093511,19809351,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK (10 U),,,U,,,,,,,,,2021,Q3,Cytomegalovirus infection,,2021,Q3,1,I,,20210901.0,20210909,20210909,EXP,,NVSC2021TH199489,NOVARTIS,,63.0,YR,,M,Y,,,20210909.0,,MD,TH,TH,2021,Q3,Adult
198093511,19809351,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK (10 U),,,U,,,,,,,,,2021,Q3,Decreased appetite,,2021,Q3,1,I,,20210901.0,20210909,20210909,EXP,,NVSC2021TH199489,NOVARTIS,,63.0,YR,,M,Y,,,20210909.0,,MD,TH,TH,2021,Q3,Adult
198093511,19809351,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK (10 U),,,U,,,,,,,,,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210901.0,20210909,20210909,EXP,,NVSC2021TH199489,NOVARTIS,,63.0,YR,,M,Y,,,20210909.0,,MD,TH,TH,2021,Q3,Adult
198093511,19809351,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK (10 U),,,U,,,,,,,,,2021,Q3,Fatigue,,2021,Q3,1,I,,20210901.0,20210909,20210909,EXP,,NVSC2021TH199489,NOVARTIS,,63.0,YR,,M,Y,,,20210909.0,,MD,TH,TH,2021,Q3,Adult
198093511,19809351,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK (10 U),,,U,,,,,,,,,2021,Q3,Feeling cold,,2021,Q3,1,I,,20210901.0,20210909,20210909,EXP,,NVSC2021TH199489,NOVARTIS,,63.0,YR,,M,Y,,,20210909.0,,MD,TH,TH,2021,Q3,Adult
198093511,19809351,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK (10 U),,,U,,,,,,,,,2021,Q3,New onset diabetes after transplantation,,2021,Q3,1,I,,20210901.0,20210909,20210909,EXP,,NVSC2021TH199489,NOVARTIS,,63.0,YR,,M,Y,,,20210909.0,,MD,TH,TH,2021,Q3,Adult
198093511,19809351,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK (10 U),,,U,,,,,,,,,2021,Q3,Pain,,2021,Q3,1,I,,20210901.0,20210909,20210909,EXP,,NVSC2021TH199489,NOVARTIS,,63.0,YR,,M,Y,,,20210909.0,,MD,TH,TH,2021,Q3,Adult
198093511,19809351,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK (10 U),,,U,,,,,,,,,2021,Q3,Polyomavirus-associated nephropathy,,2021,Q3,1,I,,20210901.0,20210909,20210909,EXP,,NVSC2021TH199489,NOVARTIS,,63.0,YR,,M,Y,,,20210909.0,,MD,TH,TH,2021,Q3,Adult
198093511,19809351,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK (10 U),,,U,,,,,,,,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210901.0,20210909,20210909,EXP,,NVSC2021TH199489,NOVARTIS,,63.0,YR,,M,Y,,,20210909.0,,MD,TH,TH,2021,Q3,Adult
198093511,19809351,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK (10 U),,,U,,,,,,,,,2021,Q3,Weight decreased,,2021,Q3,1,I,,20210901.0,20210909,20210909,EXP,,NVSC2021TH199489,NOVARTIS,,63.0,YR,,M,Y,,,20210909.0,,MD,TH,TH,2021,Q3,Adult
198098201,19809820,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Anaemia,,2021,Q3,1,I,,20210903.0,20210909,20210909,PER,,DE-AMGEN-DEUSP2021137135,AMGEN,,69.0,YR,E,F,Y,91.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198098201,19809820,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Chills,,2021,Q3,1,I,,20210903.0,20210909,20210909,PER,,DE-AMGEN-DEUSP2021137135,AMGEN,,69.0,YR,E,F,Y,91.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198098201,19809820,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Condition aggravated,,2021,Q3,1,I,,20210903.0,20210909,20210909,PER,,DE-AMGEN-DEUSP2021137135,AMGEN,,69.0,YR,E,F,Y,91.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198098201,19809820,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Constipation,,2021,Q3,1,I,,20210903.0,20210909,20210909,PER,,DE-AMGEN-DEUSP2021137135,AMGEN,,69.0,YR,E,F,Y,91.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198098201,19809820,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210903.0,20210909,20210909,PER,,DE-AMGEN-DEUSP2021137135,AMGEN,,69.0,YR,E,F,Y,91.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198098201,19809820,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,,20210903.0,20210909,20210909,PER,,DE-AMGEN-DEUSP2021137135,AMGEN,,69.0,YR,E,F,Y,91.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198098201,19809820,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210903.0,20210909,20210909,PER,,DE-AMGEN-DEUSP2021137135,AMGEN,,69.0,YR,E,F,Y,91.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198098201,19809820,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Renal impairment,,2021,Q3,1,I,,20210903.0,20210909,20210909,PER,,DE-AMGEN-DEUSP2021137135,AMGEN,,69.0,YR,E,F,Y,91.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198098201,19809820,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Sepsis,,2021,Q3,1,I,,20210903.0,20210909,20210909,PER,,DE-AMGEN-DEUSP2021137135,AMGEN,,69.0,YR,E,F,Y,91.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198098201,19809820,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Systemic infection,,2021,Q3,1,I,,20210903.0,20210909,20210909,PER,,DE-AMGEN-DEUSP2021137135,AMGEN,,69.0,YR,E,F,Y,91.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198098201,19809820,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Tachycardia,,2021,Q3,1,I,,20210903.0,20210909,20210909,PER,,DE-AMGEN-DEUSP2021137135,AMGEN,,69.0,YR,E,F,Y,91.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198098201,19809820,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Tachypnoea,,2021,Q3,1,I,,20210903.0,20210909,20210909,PER,,DE-AMGEN-DEUSP2021137135,AMGEN,,69.0,YR,E,F,Y,91.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198098201,19809820,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Weight increased,,2021,Q3,1,I,,20210903.0,20210909,20210909,PER,,DE-AMGEN-DEUSP2021137135,AMGEN,,69.0,YR,E,F,Y,91.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198108951,19810895,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IU, QD (0?0?20?0)",,,U,,,,,1.0,IU,SOLUTION FOR INJECTION/INFUSION,QD,2021,Q3,Acute kidney injury,,2021,Q3,1,I,,20210903.0,20210909,20210909,EXP,,NVSC2021DE200658,NOVARTIS,,78.0,YR,,M,Y,80.0,KG,20210909.0,,HP,DE,DE,2021,Q3,Elderly
198108951,19810895,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IU, QD (0?0?20?0)",,,U,,,,,1.0,IU,SOLUTION FOR INJECTION/INFUSION,QD,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210903.0,20210909,20210909,EXP,,NVSC2021DE200658,NOVARTIS,,78.0,YR,,M,Y,80.0,KG,20210909.0,,HP,DE,DE,2021,Q3,Elderly
198108951,19810895,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IU, QD (0?0?20?0)",,,U,,,,,1.0,IU,SOLUTION FOR INJECTION/INFUSION,QD,2021,Q3,Duodenal ulcer haemorrhage,,2021,Q3,1,I,,20210903.0,20210909,20210909,EXP,,NVSC2021DE200658,NOVARTIS,,78.0,YR,,M,Y,80.0,KG,20210909.0,,HP,DE,DE,2021,Q3,Elderly
198108951,19810895,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IU, QD (0?0?20?0)",,,U,,,,,1.0,IU,SOLUTION FOR INJECTION/INFUSION,QD,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20210903.0,20210909,20210909,EXP,,NVSC2021DE200658,NOVARTIS,,78.0,YR,,M,Y,80.0,KG,20210909.0,,HP,DE,DE,2021,Q3,Elderly
198108951,19810895,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IU, QD (0?0?20?0)",,,U,,,,,1.0,IU,SOLUTION FOR INJECTION/INFUSION,QD,2021,Q3,Haematochezia,,2021,Q3,1,I,,20210903.0,20210909,20210909,EXP,,NVSC2021DE200658,NOVARTIS,,78.0,YR,,M,Y,80.0,KG,20210909.0,,HP,DE,DE,2021,Q3,Elderly
198108951,19810895,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IU, QD (0?0?20?0)",,,U,,,,,1.0,IU,SOLUTION FOR INJECTION/INFUSION,QD,2021,Q3,Oedema peripheral,,2021,Q3,1,I,,20210903.0,20210909,20210909,EXP,,NVSC2021DE200658,NOVARTIS,,78.0,YR,,M,Y,80.0,KG,20210909.0,,HP,DE,DE,2021,Q3,Elderly
198118062,19811806,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,QD,2021,Q3,Infusion related reaction,,2021,Q3,2,F,20210831.0,20210910.0,20210909,20210916,EXP,,GB-ROCHE-2905434,ROCHE,,65.0,YR,,M,Y,69.7,KG,20210916.0,,MD,GB,GB,2021,Q3,Elderly
198141662,19814166,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,,, 1F935A,,,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,2,F,202103.0,20210924.0,20210909,20210930,EXP,,ES-MYLANLABS-2021M1059263,MYLAN,,79.0,YR,,F,Y,52.6,KG,20210930.0,,CN,ES,ES,2021,Q3,Elderly
198141662,19814166,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,,, 1F935A,,,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Extremity contracture,,2021,Q3,2,F,202103.0,20210924.0,20210909,20210930,EXP,,ES-MYLANLABS-2021M1059263,MYLAN,,79.0,YR,,F,Y,52.6,KG,20210930.0,,CN,ES,ES,2021,Q3,Elderly
198141662,19814166,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,,, 1F935A,,,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Gait disturbance,,2021,Q3,2,F,202103.0,20210924.0,20210909,20210930,EXP,,ES-MYLANLABS-2021M1059263,MYLAN,,79.0,YR,,F,Y,52.6,KG,20210930.0,,CN,ES,ES,2021,Q3,Elderly
198141662,19814166,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,,, 1F935A,,,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hyperglycaemia,,2021,Q3,2,F,202103.0,20210924.0,20210909,20210930,EXP,,ES-MYLANLABS-2021M1059263,MYLAN,,79.0,YR,,F,Y,52.6,KG,20210930.0,,CN,ES,ES,2021,Q3,Elderly
198141662,19814166,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,,, 1F935A,,,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Limb discomfort,,2021,Q3,2,F,202103.0,20210924.0,20210909,20210930,EXP,,ES-MYLANLABS-2021M1059263,MYLAN,,79.0,YR,,F,Y,52.6,KG,20210930.0,,CN,ES,ES,2021,Q3,Elderly
198141662,19814166,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,,, 1F935A,,,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Listless,,2021,Q3,2,F,202103.0,20210924.0,20210909,20210930,EXP,,ES-MYLANLABS-2021M1059263,MYLAN,,79.0,YR,,F,Y,52.6,KG,20210930.0,,CN,ES,ES,2021,Q3,Elderly
198141662,19814166,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,,, 1F935A,,,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Pain in extremity,,2021,Q3,2,F,202103.0,20210924.0,20210909,20210930,EXP,,ES-MYLANLABS-2021M1059263,MYLAN,,79.0,YR,,F,Y,52.6,KG,20210930.0,,CN,ES,ES,2021,Q3,Elderly
198141662,19814166,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,,, 1F935A,,,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Poor quality sleep,,2021,Q3,2,F,202103.0,20210924.0,20210909,20210930,EXP,,ES-MYLANLABS-2021M1059263,MYLAN,,79.0,YR,,F,Y,52.6,KG,20210930.0,,CN,ES,ES,2021,Q3,Elderly
198141662,19814166,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,,, 1F935A,,,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Sciatica,,2021,Q3,2,F,202103.0,20210924.0,20210909,20210930,EXP,,ES-MYLANLABS-2021M1059263,MYLAN,,79.0,YR,,F,Y,52.6,KG,20210930.0,,CN,ES,ES,2021,Q3,Elderly
198144162,19814416,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Anuria,,2021,Q3,2,F,,20210902.0,20210909,20210915,EXP,DE-ADRED-07036-02,NVSC2021DE199737,NOVARTIS,,76.0,YR,,M,Y,,,20210915.0,,HP,DE,DE,2021,Q3,Elderly
198144162,19814416,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Apnoea,,2021,Q3,2,F,,20210902.0,20210909,20210915,EXP,DE-ADRED-07036-02,NVSC2021DE199737,NOVARTIS,,76.0,YR,,M,Y,,,20210915.0,,HP,DE,DE,2021,Q3,Elderly
198144162,19814416,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Bradypnoea,,2021,Q3,2,F,,20210902.0,20210909,20210915,EXP,DE-ADRED-07036-02,NVSC2021DE199737,NOVARTIS,,76.0,YR,,M,Y,,,20210915.0,,HP,DE,DE,2021,Q3,Elderly
198144162,19814416,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Condition aggravated,,2021,Q3,2,F,,20210902.0,20210909,20210915,EXP,DE-ADRED-07036-02,NVSC2021DE199737,NOVARTIS,,76.0,YR,,M,Y,,,20210915.0,,HP,DE,DE,2021,Q3,Elderly
198144162,19814416,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Cyanosis,,2021,Q3,2,F,,20210902.0,20210909,20210915,EXP,DE-ADRED-07036-02,NVSC2021DE199737,NOVARTIS,,76.0,YR,,M,Y,,,20210915.0,,HP,DE,DE,2021,Q3,Elderly
198144162,19814416,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Decubitus ulcer,,2021,Q3,2,F,,20210902.0,20210909,20210915,EXP,DE-ADRED-07036-02,NVSC2021DE199737,NOVARTIS,,76.0,YR,,M,Y,,,20210915.0,,HP,DE,DE,2021,Q3,Elderly
198144162,19814416,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Dehydration,,2021,Q3,2,F,,20210902.0,20210909,20210915,EXP,DE-ADRED-07036-02,NVSC2021DE199737,NOVARTIS,,76.0,YR,,M,Y,,,20210915.0,,HP,DE,DE,2021,Q3,Elderly
198144162,19814416,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Disorientation,,2021,Q3,2,F,,20210902.0,20210909,20210915,EXP,DE-ADRED-07036-02,NVSC2021DE199737,NOVARTIS,,76.0,YR,,M,Y,,,20210915.0,,HP,DE,DE,2021,Q3,Elderly
198144162,19814416,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Dyspnoea,,2021,Q3,2,F,,20210902.0,20210909,20210915,EXP,DE-ADRED-07036-02,NVSC2021DE199737,NOVARTIS,,76.0,YR,,M,Y,,,20210915.0,,HP,DE,DE,2021,Q3,Elderly
198144162,19814416,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Electrocardiogram abnormal,,2021,Q3,2,F,,20210902.0,20210909,20210915,EXP,DE-ADRED-07036-02,NVSC2021DE199737,NOVARTIS,,76.0,YR,,M,Y,,,20210915.0,,HP,DE,DE,2021,Q3,Elderly
198144162,19814416,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Electrolyte imbalance,,2021,Q3,2,F,,20210902.0,20210909,20210915,EXP,DE-ADRED-07036-02,NVSC2021DE199737,NOVARTIS,,76.0,YR,,M,Y,,,20210915.0,,HP,DE,DE,2021,Q3,Elderly
198144162,19814416,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,2,F,,20210902.0,20210909,20210915,EXP,DE-ADRED-07036-02,NVSC2021DE199737,NOVARTIS,,76.0,YR,,M,Y,,,20210915.0,,HP,DE,DE,2021,Q3,Elderly
198144162,19814416,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Hyperglycaemia,,2021,Q3,2,F,,20210902.0,20210909,20210915,EXP,DE-ADRED-07036-02,NVSC2021DE199737,NOVARTIS,,76.0,YR,,M,Y,,,20210915.0,,HP,DE,DE,2021,Q3,Elderly
198144162,19814416,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Hypotension,,2021,Q3,2,F,,20210902.0,20210909,20210915,EXP,DE-ADRED-07036-02,NVSC2021DE199737,NOVARTIS,,76.0,YR,,M,Y,,,20210915.0,,HP,DE,DE,2021,Q3,Elderly
198144162,19814416,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Hypotonia,,2021,Q3,2,F,,20210902.0,20210909,20210915,EXP,DE-ADRED-07036-02,NVSC2021DE199737,NOVARTIS,,76.0,YR,,M,Y,,,20210915.0,,HP,DE,DE,2021,Q3,Elderly
198144162,19814416,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Loss of consciousness,,2021,Q3,2,F,,20210902.0,20210909,20210915,EXP,DE-ADRED-07036-02,NVSC2021DE199737,NOVARTIS,,76.0,YR,,M,Y,,,20210915.0,,HP,DE,DE,2021,Q3,Elderly
198144162,19814416,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Nuchal rigidity,,2021,Q3,2,F,,20210902.0,20210909,20210915,EXP,DE-ADRED-07036-02,NVSC2021DE199737,NOVARTIS,,76.0,YR,,M,Y,,,20210915.0,,HP,DE,DE,2021,Q3,Elderly
198144162,19814416,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Oedema peripheral,,2021,Q3,2,F,,20210902.0,20210909,20210915,EXP,DE-ADRED-07036-02,NVSC2021DE199737,NOVARTIS,,76.0,YR,,M,Y,,,20210915.0,,HP,DE,DE,2021,Q3,Elderly
198144162,19814416,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Pupils unequal,,2021,Q3,2,F,,20210902.0,20210909,20210915,EXP,DE-ADRED-07036-02,NVSC2021DE199737,NOVARTIS,,76.0,YR,,M,Y,,,20210915.0,,HP,DE,DE,2021,Q3,Elderly
198144162,19814416,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Renal impairment,,2021,Q3,2,F,,20210902.0,20210909,20210915,EXP,DE-ADRED-07036-02,NVSC2021DE199737,NOVARTIS,,76.0,YR,,M,Y,,,20210915.0,,HP,DE,DE,2021,Q3,Elderly
198144162,19814416,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Skin irritation,,2021,Q3,2,F,,20210902.0,20210909,20210915,EXP,DE-ADRED-07036-02,NVSC2021DE199737,NOVARTIS,,76.0,YR,,M,Y,,,20210915.0,,HP,DE,DE,2021,Q3,Elderly
198144162,19814416,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Skin pressure mark,,2021,Q3,2,F,,20210902.0,20210909,20210915,EXP,DE-ADRED-07036-02,NVSC2021DE199737,NOVARTIS,,76.0,YR,,M,Y,,,20210915.0,,HP,DE,DE,2021,Q3,Elderly
198144162,19814416,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Systemic infection,,2021,Q3,2,F,,20210902.0,20210909,20210915,EXP,DE-ADRED-07036-02,NVSC2021DE199737,NOVARTIS,,76.0,YR,,M,Y,,,20210915.0,,HP,DE,DE,2021,Q3,Elderly
198144162,19814416,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Tachycardia,,2021,Q3,2,F,,20210902.0,20210909,20210915,EXP,DE-ADRED-07036-02,NVSC2021DE199737,NOVARTIS,,76.0,YR,,M,Y,,,20210915.0,,HP,DE,DE,2021,Q3,Elderly
198144162,19814416,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Tachypnoea,,2021,Q3,2,F,,20210902.0,20210909,20210915,EXP,DE-ADRED-07036-02,NVSC2021DE199737,NOVARTIS,,76.0,YR,,M,Y,,,20210915.0,,HP,DE,DE,2021,Q3,Elderly
198163112,19816311,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Anaemia,,2021,Q3,2,F,20210126.0,20210916.0,20210909,20210920,EXP,,DE-GILEAD-2021-0547844,GILEAD,,80.0,YR,E,M,Y,63.0,KG,20210920.0,,PH,DE,DE,2021,Q3,Elderly
198163112,19816311,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Condition aggravated,,2021,Q3,2,F,20210126.0,20210916.0,20210909,20210920,EXP,,DE-GILEAD-2021-0547844,GILEAD,,80.0,YR,E,M,Y,63.0,KG,20210920.0,,PH,DE,DE,2021,Q3,Elderly
198163112,19816311,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Cough,,2021,Q3,2,F,20210126.0,20210916.0,20210909,20210920,EXP,,DE-GILEAD-2021-0547844,GILEAD,,80.0,YR,E,M,Y,63.0,KG,20210920.0,,PH,DE,DE,2021,Q3,Elderly
198163112,19816311,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Death,,2021,Q3,2,F,20210126.0,20210916.0,20210909,20210920,EXP,,DE-GILEAD-2021-0547844,GILEAD,,80.0,YR,E,M,Y,63.0,KG,20210920.0,,PH,DE,DE,2021,Q3,Elderly
198163112,19816311,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Dyspnoea,,2021,Q3,2,F,20210126.0,20210916.0,20210909,20210920,EXP,,DE-GILEAD-2021-0547844,GILEAD,,80.0,YR,E,M,Y,63.0,KG,20210920.0,,PH,DE,DE,2021,Q3,Elderly
198163112,19816311,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Electrocardiogram abnormal,,2021,Q3,2,F,20210126.0,20210916.0,20210909,20210920,EXP,,DE-GILEAD-2021-0547844,GILEAD,,80.0,YR,E,M,Y,63.0,KG,20210920.0,,PH,DE,DE,2021,Q3,Elderly
198163112,19816311,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Erythema,,2021,Q3,2,F,20210126.0,20210916.0,20210909,20210920,EXP,,DE-GILEAD-2021-0547844,GILEAD,,80.0,YR,E,M,Y,63.0,KG,20210920.0,,PH,DE,DE,2021,Q3,Elderly
198163112,19816311,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Feeling hot,,2021,Q3,2,F,20210126.0,20210916.0,20210909,20210920,EXP,,DE-GILEAD-2021-0547844,GILEAD,,80.0,YR,E,M,Y,63.0,KG,20210920.0,,PH,DE,DE,2021,Q3,Elderly
198163112,19816311,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,2,F,20210126.0,20210916.0,20210909,20210920,EXP,,DE-GILEAD-2021-0547844,GILEAD,,80.0,YR,E,M,Y,63.0,KG,20210920.0,,PH,DE,DE,2021,Q3,Elderly
198163112,19816311,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Hyperglycaemia,,2021,Q3,2,F,20210126.0,20210916.0,20210909,20210920,EXP,,DE-GILEAD-2021-0547844,GILEAD,,80.0,YR,E,M,Y,63.0,KG,20210920.0,,PH,DE,DE,2021,Q3,Elderly
198163112,19816311,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Pneumonia,,2021,Q3,2,F,20210126.0,20210916.0,20210909,20210920,EXP,,DE-GILEAD-2021-0547844,GILEAD,,80.0,YR,E,M,Y,63.0,KG,20210920.0,,PH,DE,DE,2021,Q3,Elderly
198163112,19816311,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Skin hyperpigmentation,,2021,Q3,2,F,20210126.0,20210916.0,20210909,20210920,EXP,,DE-GILEAD-2021-0547844,GILEAD,,80.0,YR,E,M,Y,63.0,KG,20210920.0,,PH,DE,DE,2021,Q3,Elderly
198163112,19816311,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Systemic infection,,2021,Q3,2,F,20210126.0,20210916.0,20210909,20210920,EXP,,DE-GILEAD-2021-0547844,GILEAD,,80.0,YR,E,M,Y,63.0,KG,20210920.0,,PH,DE,DE,2021,Q3,Elderly
198163112,19816311,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Tachypnoea,,2021,Q3,2,F,20210126.0,20210916.0,20210909,20210920,EXP,,DE-GILEAD-2021-0547844,GILEAD,,80.0,YR,E,M,Y,63.0,KG,20210920.0,,PH,DE,DE,2021,Q3,Elderly
198163112,19816311,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Wound,,2021,Q3,2,F,20210126.0,20210916.0,20210909,20210920,EXP,,DE-GILEAD-2021-0547844,GILEAD,,80.0,YR,E,M,Y,63.0,KG,20210920.0,,PH,DE,DE,2021,Q3,Elderly
198184651,19818465,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Abdominal distension,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,,NVSC2021DE202703,NOVARTIS,,69.0,YR,,F,Y,93.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184651,19818465,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Abdominal pain,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,,NVSC2021DE202703,NOVARTIS,,69.0,YR,,F,Y,93.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184651,19818465,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Anaemia,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,,NVSC2021DE202703,NOVARTIS,,69.0,YR,,F,Y,93.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184651,19818465,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Condition aggravated,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,,NVSC2021DE202703,NOVARTIS,,69.0,YR,,F,Y,93.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184651,19818465,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,,NVSC2021DE202703,NOVARTIS,,69.0,YR,,F,Y,93.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184651,19818465,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Dysuria,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,,NVSC2021DE202703,NOVARTIS,,69.0,YR,,F,Y,93.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184651,19818465,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,,NVSC2021DE202703,NOVARTIS,,69.0,YR,,F,Y,93.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184651,19818465,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Hypotension,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,,NVSC2021DE202703,NOVARTIS,,69.0,YR,,F,Y,93.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184651,19818465,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,,NVSC2021DE202703,NOVARTIS,,69.0,YR,,F,Y,93.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184651,19818465,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Renal impairment,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,,NVSC2021DE202703,NOVARTIS,,69.0,YR,,F,Y,93.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184651,19818465,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Sepsis,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,,NVSC2021DE202703,NOVARTIS,,69.0,YR,,F,Y,93.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184651,19818465,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Systemic infection,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,,NVSC2021DE202703,NOVARTIS,,69.0,YR,,F,Y,93.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184651,19818465,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Tachycardia,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,,NVSC2021DE202703,NOVARTIS,,69.0,YR,,F,Y,93.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184651,19818465,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Vomiting,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,,NVSC2021DE202703,NOVARTIS,,69.0,YR,,F,Y,93.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184651,19818465,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Weight increased,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,,NVSC2021DE202703,NOVARTIS,,69.0,YR,,F,Y,93.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184671,19818467,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Anaemia,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,DE-ADRED-07164-01,NVSC2021DE200928,NOVARTIS,,75.0,YR,,M,Y,90.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184671,19818467,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Condition aggravated,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,DE-ADRED-07164-01,NVSC2021DE200928,NOVARTIS,,75.0,YR,,M,Y,90.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184671,19818467,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Disorientation,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,DE-ADRED-07164-01,NVSC2021DE200928,NOVARTIS,,75.0,YR,,M,Y,90.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184671,19818467,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Electrocardiogram abnormal,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,DE-ADRED-07164-01,NVSC2021DE200928,NOVARTIS,,75.0,YR,,M,Y,90.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184671,19818467,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,DE-ADRED-07164-01,NVSC2021DE200928,NOVARTIS,,75.0,YR,,M,Y,90.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184671,19818467,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,DE-ADRED-07164-01,NVSC2021DE200928,NOVARTIS,,75.0,YR,,M,Y,90.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184671,19818467,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Hypertension,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,DE-ADRED-07164-01,NVSC2021DE200928,NOVARTIS,,75.0,YR,,M,Y,90.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184671,19818467,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Oedema peripheral,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,DE-ADRED-07164-01,NVSC2021DE200928,NOVARTIS,,75.0,YR,,M,Y,90.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184671,19818467,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,DE-ADRED-07164-01,NVSC2021DE200928,NOVARTIS,,75.0,YR,,M,Y,90.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184671,19818467,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Renal impairment,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,DE-ADRED-07164-01,NVSC2021DE200928,NOVARTIS,,75.0,YR,,M,Y,90.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184671,19818467,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Systemic infection,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,DE-ADRED-07164-01,NVSC2021DE200928,NOVARTIS,,75.0,YR,,M,Y,90.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184671,19818467,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Tachycardia,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,DE-ADRED-07164-01,NVSC2021DE200928,NOVARTIS,,75.0,YR,,M,Y,90.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184671,19818467,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Tachypnoea,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,DE-ADRED-07164-01,NVSC2021DE200928,NOVARTIS,,75.0,YR,,M,Y,90.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198188791,19818879,11,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0?0?0?12, ZYLINDERAMPULLEN",,,U,,,,,,,,,2021,Q3,Acute kidney injury,,2021,Q3,1,I,,20210901.0,20210912,20210912,EXP,,DE-AUROBINDO-AUR-APL-2021-038201,AUROBINDO,,55.0,YR,,F,Y,62.0,KG,20210913.0,,PH,DE,DE,2021,Q3,Adult
198188791,19818879,11,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0?0?0?12, ZYLINDERAMPULLEN",,,U,,,,,,,,,2021,Q3,Decreased appetite,,2021,Q3,1,I,,20210901.0,20210912,20210912,EXP,,DE-AUROBINDO-AUR-APL-2021-038201,AUROBINDO,,55.0,YR,,F,Y,62.0,KG,20210913.0,,PH,DE,DE,2021,Q3,Adult
198188791,19818879,11,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0?0?0?12, ZYLINDERAMPULLEN",,,U,,,,,,,,,2021,Q3,Fatigue,,2021,Q3,1,I,,20210901.0,20210912,20210912,EXP,,DE-AUROBINDO-AUR-APL-2021-038201,AUROBINDO,,55.0,YR,,F,Y,62.0,KG,20210913.0,,PH,DE,DE,2021,Q3,Adult
198188791,19818879,11,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0?0?0?12, ZYLINDERAMPULLEN",,,U,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210901.0,20210912,20210912,EXP,,DE-AUROBINDO-AUR-APL-2021-038201,AUROBINDO,,55.0,YR,,F,Y,62.0,KG,20210913.0,,PH,DE,DE,2021,Q3,Adult
198188791,19818879,11,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0?0?0?12, ZYLINDERAMPULLEN",,,U,,,,,,,,,2021,Q3,Headache,,2021,Q3,1,I,,20210901.0,20210912,20210912,EXP,,DE-AUROBINDO-AUR-APL-2021-038201,AUROBINDO,,55.0,YR,,F,Y,62.0,KG,20210913.0,,PH,DE,DE,2021,Q3,Adult
198188791,19818879,11,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0?0?0?12, ZYLINDERAMPULLEN",,,U,,,,,,,,,2021,Q3,Jaundice,,2021,Q3,1,I,,20210901.0,20210912,20210912,EXP,,DE-AUROBINDO-AUR-APL-2021-038201,AUROBINDO,,55.0,YR,,F,Y,62.0,KG,20210913.0,,PH,DE,DE,2021,Q3,Adult
198188791,19818879,11,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0?0?0?12, ZYLINDERAMPULLEN",,,U,,,,,,,,,2021,Q3,Nausea,,2021,Q3,1,I,,20210901.0,20210912,20210912,EXP,,DE-AUROBINDO-AUR-APL-2021-038201,AUROBINDO,,55.0,YR,,F,Y,62.0,KG,20210913.0,,PH,DE,DE,2021,Q3,Adult
198192521,19819252,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Anaemia,,2021,Q3,1,I,20210119.0,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021137133,AMGEN,,70.0,YR,E,F,Y,,,20210912.0,,PH,DE,DE,2021,Q3,Elderly
198192521,19819252,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Condition aggravated,,2021,Q3,1,I,20210119.0,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021137133,AMGEN,,70.0,YR,E,F,Y,,,20210912.0,,PH,DE,DE,2021,Q3,Elderly
198192521,19819252,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Death,,2021,Q3,1,I,20210119.0,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021137133,AMGEN,,70.0,YR,E,F,Y,,,20210912.0,,PH,DE,DE,2021,Q3,Elderly
198192521,19819252,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Electrocardiogram abnormal,,2021,Q3,1,I,20210119.0,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021137133,AMGEN,,70.0,YR,E,F,Y,,,20210912.0,,PH,DE,DE,2021,Q3,Elderly
198192521,19819252,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,20210119.0,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021137133,AMGEN,,70.0,YR,E,F,Y,,,20210912.0,,PH,DE,DE,2021,Q3,Elderly
198192521,19819252,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,20210119.0,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021137133,AMGEN,,70.0,YR,E,F,Y,,,20210912.0,,PH,DE,DE,2021,Q3,Elderly
198192521,19819252,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Musculoskeletal pain,,2021,Q3,1,I,20210119.0,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021137133,AMGEN,,70.0,YR,E,F,Y,,,20210912.0,,PH,DE,DE,2021,Q3,Elderly
198192521,19819252,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Oedema peripheral,,2021,Q3,1,I,20210119.0,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021137133,AMGEN,,70.0,YR,E,F,Y,,,20210912.0,,PH,DE,DE,2021,Q3,Elderly
198192521,19819252,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Pyrexia,,2021,Q3,1,I,20210119.0,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021137133,AMGEN,,70.0,YR,E,F,Y,,,20210912.0,,PH,DE,DE,2021,Q3,Elderly
198192521,19819252,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Renal impairment,,2021,Q3,1,I,20210119.0,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021137133,AMGEN,,70.0,YR,E,F,Y,,,20210912.0,,PH,DE,DE,2021,Q3,Elderly
198192521,19819252,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Sepsis,,2021,Q3,1,I,20210119.0,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021137133,AMGEN,,70.0,YR,E,F,Y,,,20210912.0,,PH,DE,DE,2021,Q3,Elderly
198192521,19819252,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Systemic infection,,2021,Q3,1,I,20210119.0,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021137133,AMGEN,,70.0,YR,E,F,Y,,,20210912.0,,PH,DE,DE,2021,Q3,Elderly
198192521,19819252,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Tachycardia,,2021,Q3,1,I,20210119.0,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021137133,AMGEN,,70.0,YR,E,F,Y,,,20210912.0,,PH,DE,DE,2021,Q3,Elderly
198192521,19819252,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Tachypnoea,,2021,Q3,1,I,20210119.0,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021137133,AMGEN,,70.0,YR,E,F,Y,,,20210912.0,,PH,DE,DE,2021,Q3,Elderly
198192521,19819252,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Weight increased,,2021,Q3,1,I,20210119.0,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021137133,AMGEN,,70.0,YR,E,F,Y,,,20210912.0,,PH,DE,DE,2021,Q3,Elderly
198193071,19819307,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"450 E/1.5ML, 0?0?0?6",,,,,,,,,,UNKNOWN,,2021,Q3,Decreased appetite,,2021,Q3,1,I,,20210906.0,20210913,20210913,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-21-55384,HIKMA,,69.0,YR,,M,Y,61.0,KG,20210913.0,,PH,DE,DE,2021,Q3,Elderly
198193071,19819307,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"450 E/1.5ML, 0?0?0?6",,,,,,,,,,UNKNOWN,,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210906.0,20210913,20210913,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-21-55384,HIKMA,,69.0,YR,,M,Y,61.0,KG,20210913.0,,PH,DE,DE,2021,Q3,Elderly
198193071,19819307,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"450 E/1.5ML, 0?0?0?6",,,,,,,,,,UNKNOWN,,2021,Q3,Fine motor skill dysfunction,,2021,Q3,1,I,,20210906.0,20210913,20210913,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-21-55384,HIKMA,,69.0,YR,,M,Y,61.0,KG,20210913.0,,PH,DE,DE,2021,Q3,Elderly
198193071,19819307,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"450 E/1.5ML, 0?0?0?6",,,,,,,,,,UNKNOWN,,2021,Q3,Fluid intake reduced,,2021,Q3,1,I,,20210906.0,20210913,20210913,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-21-55384,HIKMA,,69.0,YR,,M,Y,61.0,KG,20210913.0,,PH,DE,DE,2021,Q3,Elderly
198193071,19819307,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"450 E/1.5ML, 0?0?0?6",,,,,,,,,,UNKNOWN,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210906.0,20210913,20210913,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-21-55384,HIKMA,,69.0,YR,,M,Y,61.0,KG,20210913.0,,PH,DE,DE,2021,Q3,Elderly
198197061,19819706,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ML,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Abdominal pain,,2021,Q3,1,I,20210522.0,20210908.0,20210913,20210913,PER,,FR-AMGEN-FRASP2021139643,AMGEN,,59.0,YR,A,M,Y,64.0,KG,20210913.0,,HP,FR,FR,2021,Q3,Adult
198197061,19819706,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ML,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Arthralgia,,2021,Q3,1,I,20210522.0,20210908.0,20210913,20210913,PER,,FR-AMGEN-FRASP2021139643,AMGEN,,59.0,YR,A,M,Y,64.0,KG,20210913.0,,HP,FR,FR,2021,Q3,Adult
198197061,19819706,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ML,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Haematoma muscle,,2021,Q3,1,I,20210522.0,20210908.0,20210913,20210913,PER,,FR-AMGEN-FRASP2021139643,AMGEN,,59.0,YR,A,M,Y,64.0,KG,20210913.0,,HP,FR,FR,2021,Q3,Adult
198197061,19819706,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ML,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Muscular weakness,,2021,Q3,1,I,20210522.0,20210908.0,20210913,20210913,PER,,FR-AMGEN-FRASP2021139643,AMGEN,,59.0,YR,A,M,Y,64.0,KG,20210913.0,,HP,FR,FR,2021,Q3,Adult
198197061,19819706,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ML,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Pain in extremity,,2021,Q3,1,I,20210522.0,20210908.0,20210913,20210913,PER,,FR-AMGEN-FRASP2021139643,AMGEN,,59.0,YR,A,M,Y,64.0,KG,20210913.0,,HP,FR,FR,2021,Q3,Adult
198197061,19819706,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ML,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Pyelocaliectasis,,2021,Q3,1,I,20210522.0,20210908.0,20210913,20210913,PER,,FR-AMGEN-FRASP2021139643,AMGEN,,59.0,YR,A,M,Y,64.0,KG,20210913.0,,HP,FR,FR,2021,Q3,Adult
198197061,19819706,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ML,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Ureteric compression,,2021,Q3,1,I,20210522.0,20210908.0,20210913,20210913,PER,,FR-AMGEN-FRASP2021139643,AMGEN,,59.0,YR,A,M,Y,64.0,KG,20210913.0,,HP,FR,FR,2021,Q3,Adult
198200451,19820045,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Death,,2021,Q3,1,I,20210828.0,20210907.0,20210913,20210913,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-091307,BRISTOL MYERS SQUIBB,,79.0,YR,,M,Y,,,20210913.0,,HP,US,US,2021,Q3,Elderly
198203551,19820355,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Abdominal distension,,2021,Q3,1,I,,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021138408,AMGEN,,69.0,YR,E,F,Y,93.0,KG,20210913.0,,HP,DE,DE,2021,Q3,Elderly
198203551,19820355,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Abdominal pain,,2021,Q3,1,I,,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021138408,AMGEN,,69.0,YR,E,F,Y,93.0,KG,20210913.0,,HP,DE,DE,2021,Q3,Elderly
198203551,19820355,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Anaemia,,2021,Q3,1,I,,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021138408,AMGEN,,69.0,YR,E,F,Y,93.0,KG,20210913.0,,HP,DE,DE,2021,Q3,Elderly
198203551,19820355,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Condition aggravated,,2021,Q3,1,I,,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021138408,AMGEN,,69.0,YR,E,F,Y,93.0,KG,20210913.0,,HP,DE,DE,2021,Q3,Elderly
198203551,19820355,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021138408,AMGEN,,69.0,YR,E,F,Y,93.0,KG,20210913.0,,HP,DE,DE,2021,Q3,Elderly
198203551,19820355,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Dysuria,,2021,Q3,1,I,,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021138408,AMGEN,,69.0,YR,E,F,Y,93.0,KG,20210913.0,,HP,DE,DE,2021,Q3,Elderly
198203551,19820355,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021138408,AMGEN,,69.0,YR,E,F,Y,93.0,KG,20210913.0,,HP,DE,DE,2021,Q3,Elderly
198203551,19820355,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Hypotension,,2021,Q3,1,I,,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021138408,AMGEN,,69.0,YR,E,F,Y,93.0,KG,20210913.0,,HP,DE,DE,2021,Q3,Elderly
198203551,19820355,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021138408,AMGEN,,69.0,YR,E,F,Y,93.0,KG,20210913.0,,HP,DE,DE,2021,Q3,Elderly
198203551,19820355,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Renal impairment,,2021,Q3,1,I,,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021138408,AMGEN,,69.0,YR,E,F,Y,93.0,KG,20210913.0,,HP,DE,DE,2021,Q3,Elderly
198203551,19820355,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Sepsis,,2021,Q3,1,I,,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021138408,AMGEN,,69.0,YR,E,F,Y,93.0,KG,20210913.0,,HP,DE,DE,2021,Q3,Elderly
198203551,19820355,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Systemic infection,,2021,Q3,1,I,,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021138408,AMGEN,,69.0,YR,E,F,Y,93.0,KG,20210913.0,,HP,DE,DE,2021,Q3,Elderly
198203551,19820355,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Tachycardia,,2021,Q3,1,I,,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021138408,AMGEN,,69.0,YR,E,F,Y,93.0,KG,20210913.0,,HP,DE,DE,2021,Q3,Elderly
198203551,19820355,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Vomiting,,2021,Q3,1,I,,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021138408,AMGEN,,69.0,YR,E,F,Y,93.0,KG,20210913.0,,HP,DE,DE,2021,Q3,Elderly
198203551,19820355,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Weight increased,,2021,Q3,1,I,,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021138408,AMGEN,,69.0,YR,E,F,Y,93.0,KG,20210913.0,,HP,DE,DE,2021,Q3,Elderly
198204081,19820408,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"22 INTERNATIONAL UNIT, ONCE A DAY",,,U,U,,,,22.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Arthralgia,,2021,Q3,1,I,202108.0,20210902.0,20210913,20210913,EXP,,ES-AUROBINDO-AUR-APL-2021-038480,AUROBINDO,,84.0,YR,,F,Y,65.0,KG,20210913.0,,CN,ES,ES,2021,Q3,Elderly
198204081,19820408,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"22 INTERNATIONAL UNIT, ONCE A DAY",,,U,U,,,,22.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,1,I,202108.0,20210902.0,20210913,20210913,EXP,,ES-AUROBINDO-AUR-APL-2021-038480,AUROBINDO,,84.0,YR,,F,Y,65.0,KG,20210913.0,,CN,ES,ES,2021,Q3,Elderly
198204081,19820408,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"22 INTERNATIONAL UNIT, ONCE A DAY",,,U,U,,,,22.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Dizziness,,2021,Q3,1,I,202108.0,20210902.0,20210913,20210913,EXP,,ES-AUROBINDO-AUR-APL-2021-038480,AUROBINDO,,84.0,YR,,F,Y,65.0,KG,20210913.0,,CN,ES,ES,2021,Q3,Elderly
198204081,19820408,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"22 INTERNATIONAL UNIT, ONCE A DAY",,,U,U,,,,22.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Fall,,2021,Q3,1,I,202108.0,20210902.0,20210913,20210913,EXP,,ES-AUROBINDO-AUR-APL-2021-038480,AUROBINDO,,84.0,YR,,F,Y,65.0,KG,20210913.0,,CN,ES,ES,2021,Q3,Elderly
198204081,19820408,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"22 INTERNATIONAL UNIT, ONCE A DAY",,,U,U,,,,22.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hip fracture,,2021,Q3,1,I,202108.0,20210902.0,20210913,20210913,EXP,,ES-AUROBINDO-AUR-APL-2021-038480,AUROBINDO,,84.0,YR,,F,Y,65.0,KG,20210913.0,,CN,ES,ES,2021,Q3,Elderly
198205281,19820528,17,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,1 DF,,,U,,,,,1.0,DF,,,2021,Q3,Asthma,,2021,Q3,1,I,,20210907.0,20210913,20210913,EXP,,CA-GLAXOSMITHKLINE-CA2021AMR192415,GLAXOSMITHKLINE,,65.0,YR,,M,Y,,,20210913.0,,CN,CA,CA,2021,Q3,Elderly
198205281,19820528,17,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,1 DF,,,U,,,,,1.0,DF,,,2021,Q3,Condition aggravated,,2021,Q3,1,I,,20210907.0,20210913,20210913,EXP,,CA-GLAXOSMITHKLINE-CA2021AMR192415,GLAXOSMITHKLINE,,65.0,YR,,M,Y,,,20210913.0,,CN,CA,CA,2021,Q3,Elderly
198205281,19820528,17,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,1 DF,,,U,,,,,1.0,DF,,,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20210907.0,20210913,20210913,EXP,,CA-GLAXOSMITHKLINE-CA2021AMR192415,GLAXOSMITHKLINE,,65.0,YR,,M,Y,,,20210913.0,,CN,CA,CA,2021,Q3,Elderly
198205281,19820528,17,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,1 DF,,,U,,,,,1.0,DF,,,2021,Q3,Haemoptysis,,2021,Q3,1,I,,20210907.0,20210913,20210913,EXP,,CA-GLAXOSMITHKLINE-CA2021AMR192415,GLAXOSMITHKLINE,,65.0,YR,,M,Y,,,20210913.0,,CN,CA,CA,2021,Q3,Elderly
198205281,19820528,17,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,1 DF,,,U,,,,,1.0,DF,,,2021,Q3,Loss of personal independence in daily activities,,2021,Q3,1,I,,20210907.0,20210913,20210913,EXP,,CA-GLAXOSMITHKLINE-CA2021AMR192415,GLAXOSMITHKLINE,,65.0,YR,,M,Y,,,20210913.0,,CN,CA,CA,2021,Q3,Elderly
198205281,19820528,17,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,1 DF,,,U,,,,,1.0,DF,,,2021,Q3,Lung disorder,,2021,Q3,1,I,,20210907.0,20210913,20210913,EXP,,CA-GLAXOSMITHKLINE-CA2021AMR192415,GLAXOSMITHKLINE,,65.0,YR,,M,Y,,,20210913.0,,CN,CA,CA,2021,Q3,Elderly
198205281,19820528,17,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,1 DF,,,U,,,,,1.0,DF,,,2021,Q3,Neuritis,,2021,Q3,1,I,,20210907.0,20210913,20210913,EXP,,CA-GLAXOSMITHKLINE-CA2021AMR192415,GLAXOSMITHKLINE,,65.0,YR,,M,Y,,,20210913.0,,CN,CA,CA,2021,Q3,Elderly
198205281,19820528,17,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,1 DF,,,U,,,,,1.0,DF,,,2021,Q3,Neurological symptom,,2021,Q3,1,I,,20210907.0,20210913,20210913,EXP,,CA-GLAXOSMITHKLINE-CA2021AMR192415,GLAXOSMITHKLINE,,65.0,YR,,M,Y,,,20210913.0,,CN,CA,CA,2021,Q3,Elderly
198205281,19820528,17,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,1 DF,,,U,,,,,1.0,DF,,,2021,Q3,Obstructive airways disorder,,2021,Q3,1,I,,20210907.0,20210913,20210913,EXP,,CA-GLAXOSMITHKLINE-CA2021AMR192415,GLAXOSMITHKLINE,,65.0,YR,,M,Y,,,20210913.0,,CN,CA,CA,2021,Q3,Elderly
198205281,19820528,17,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,1 DF,,,U,,,,,1.0,DF,,,2021,Q3,Pain in extremity,,2021,Q3,1,I,,20210907.0,20210913,20210913,EXP,,CA-GLAXOSMITHKLINE-CA2021AMR192415,GLAXOSMITHKLINE,,65.0,YR,,M,Y,,,20210913.0,,CN,CA,CA,2021,Q3,Elderly
198205281,19820528,17,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,1 DF,,,U,,,,,1.0,DF,,,2021,Q3,Pulmonary alveolar haemorrhage,,2021,Q3,1,I,,20210907.0,20210913,20210913,EXP,,CA-GLAXOSMITHKLINE-CA2021AMR192415,GLAXOSMITHKLINE,,65.0,YR,,M,Y,,,20210913.0,,CN,CA,CA,2021,Q3,Elderly
198205281,19820528,17,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,1 DF,,,U,,,,,1.0,DF,,,2021,Q3,Pulmonary fibrosis,,2021,Q3,1,I,,20210907.0,20210913,20210913,EXP,,CA-GLAXOSMITHKLINE-CA2021AMR192415,GLAXOSMITHKLINE,,65.0,YR,,M,Y,,,20210913.0,,CN,CA,CA,2021,Q3,Elderly
198205281,19820528,17,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,1 DF,,,U,,,,,1.0,DF,,,2021,Q3,Pulmonary vasculitis,,2021,Q3,1,I,,20210907.0,20210913,20210913,EXP,,CA-GLAXOSMITHKLINE-CA2021AMR192415,GLAXOSMITHKLINE,,65.0,YR,,M,Y,,,20210913.0,,CN,CA,CA,2021,Q3,Elderly
198205281,19820528,17,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,1 DF,,,U,,,,,1.0,DF,,,2021,Q3,Respiratory symptom,,2021,Q3,1,I,,20210907.0,20210913,20210913,EXP,,CA-GLAXOSMITHKLINE-CA2021AMR192415,GLAXOSMITHKLINE,,65.0,YR,,M,Y,,,20210913.0,,CN,CA,CA,2021,Q3,Elderly
198205281,19820528,17,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,1 DF,,,U,,,,,1.0,DF,,,2021,Q3,Sleep disorder due to a general medical condition,,2021,Q3,1,I,,20210907.0,20210913,20210913,EXP,,CA-GLAXOSMITHKLINE-CA2021AMR192415,GLAXOSMITHKLINE,,65.0,YR,,M,Y,,,20210913.0,,CN,CA,CA,2021,Q3,Elderly
198205281,19820528,17,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,1 DF,,,U,,,,,1.0,DF,,,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,1,I,,20210907.0,20210913,20210913,EXP,,CA-GLAXOSMITHKLINE-CA2021AMR192415,GLAXOSMITHKLINE,,65.0,YR,,M,Y,,,20210913.0,,CN,CA,CA,2021,Q3,Elderly
198205281,19820528,17,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,1 DF,,,U,,,,,1.0,DF,,,2021,Q3,Vasculitis,,2021,Q3,1,I,,20210907.0,20210913,20210913,EXP,,CA-GLAXOSMITHKLINE-CA2021AMR192415,GLAXOSMITHKLINE,,65.0,YR,,M,Y,,,20210913.0,,CN,CA,CA,2021,Q3,Elderly
198205281,19820528,17,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,1 DF,,,U,,,,,1.0,DF,,,2021,Q3,Wheezing,,2021,Q3,1,I,,20210907.0,20210913,20210913,EXP,,CA-GLAXOSMITHKLINE-CA2021AMR192415,GLAXOSMITHKLINE,,65.0,YR,,M,Y,,,20210913.0,,CN,CA,CA,2021,Q3,Elderly
198212261,19821226,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (1 IU, 0?0?0?12, CYLINDRICAL AMPOULES)",,,U,,,,,,,,,2021,Q3,Acute kidney injury,,2021,Q3,1,I,,20210903.0,20210913,20210913,EXP,DE-ADRED-07171-01,DE-GLAXOSMITHKLINE-DECH2021061542,GLAXOSMITHKLINE,,55.0,YR,,F,Y,,,20210913.0,,HP,DE,DE,2021,Q3,Adult
198212261,19821226,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (1 IU, 0?0?0?12, CYLINDRICAL AMPOULES)",,,U,,,,,,,,,2021,Q3,Decreased appetite,,2021,Q3,1,I,,20210903.0,20210913,20210913,EXP,DE-ADRED-07171-01,DE-GLAXOSMITHKLINE-DECH2021061542,GLAXOSMITHKLINE,,55.0,YR,,F,Y,,,20210913.0,,HP,DE,DE,2021,Q3,Adult
198212261,19821226,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (1 IU, 0?0?0?12, CYLINDRICAL AMPOULES)",,,U,,,,,,,,,2021,Q3,Fatigue,,2021,Q3,1,I,,20210903.0,20210913,20210913,EXP,DE-ADRED-07171-01,DE-GLAXOSMITHKLINE-DECH2021061542,GLAXOSMITHKLINE,,55.0,YR,,F,Y,,,20210913.0,,HP,DE,DE,2021,Q3,Adult
198212261,19821226,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (1 IU, 0?0?0?12, CYLINDRICAL AMPOULES)",,,U,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210903.0,20210913,20210913,EXP,DE-ADRED-07171-01,DE-GLAXOSMITHKLINE-DECH2021061542,GLAXOSMITHKLINE,,55.0,YR,,F,Y,,,20210913.0,,HP,DE,DE,2021,Q3,Adult
198212261,19821226,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (1 IU, 0?0?0?12, CYLINDRICAL AMPOULES)",,,U,,,,,,,,,2021,Q3,Headache,,2021,Q3,1,I,,20210903.0,20210913,20210913,EXP,DE-ADRED-07171-01,DE-GLAXOSMITHKLINE-DECH2021061542,GLAXOSMITHKLINE,,55.0,YR,,F,Y,,,20210913.0,,HP,DE,DE,2021,Q3,Adult
198212261,19821226,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (1 IU, 0?0?0?12, CYLINDRICAL AMPOULES)",,,U,,,,,,,,,2021,Q3,Jaundice,,2021,Q3,1,I,,20210903.0,20210913,20210913,EXP,DE-ADRED-07171-01,DE-GLAXOSMITHKLINE-DECH2021061542,GLAXOSMITHKLINE,,55.0,YR,,F,Y,,,20210913.0,,HP,DE,DE,2021,Q3,Adult
198212261,19821226,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (1 IU, 0?0?0?12, CYLINDRICAL AMPOULES)",,,U,,,,,,,,,2021,Q3,Nausea,,2021,Q3,1,I,,20210903.0,20210913,20210913,EXP,DE-ADRED-07171-01,DE-GLAXOSMITHKLINE-DECH2021061542,GLAXOSMITHKLINE,,55.0,YR,,F,Y,,,20210913.0,,HP,DE,DE,2021,Q3,Adult
198231181,19823118,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 IU, QD",,,U,, 1F975A,,,6.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose decreased,,2021,Q3,1,I,,20210906.0,20210913,20210913,EXP,,NVSC2021ES202752,NOVARTIS,,78.0,YR,,F,Y,37.0,KG,20210913.0,,HP,ES,ES,2021,Q3,Elderly
198231181,19823118,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 IU, QD",,,U,, 1F975A,,,6.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Decreased appetite,,2021,Q3,1,I,,20210906.0,20210913,20210913,EXP,,NVSC2021ES202752,NOVARTIS,,78.0,YR,,F,Y,37.0,KG,20210913.0,,HP,ES,ES,2021,Q3,Elderly
198231181,19823118,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 IU, QD",,,U,, 1F975A,,,6.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Depressed level of consciousness,,2021,Q3,1,I,,20210906.0,20210913,20210913,EXP,,NVSC2021ES202752,NOVARTIS,,78.0,YR,,F,Y,37.0,KG,20210913.0,,HP,ES,ES,2021,Q3,Elderly
198231181,19823118,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 IU, QD",,,U,, 1F975A,,,6.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210906.0,20210913,20210913,EXP,,NVSC2021ES202752,NOVARTIS,,78.0,YR,,F,Y,37.0,KG,20210913.0,,HP,ES,ES,2021,Q3,Elderly
198231181,19823118,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 IU, QD",,,U,, 1F975A,,,6.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Feeling abnormal,,2021,Q3,1,I,,20210906.0,20210913,20210913,EXP,,NVSC2021ES202752,NOVARTIS,,78.0,YR,,F,Y,37.0,KG,20210913.0,,HP,ES,ES,2021,Q3,Elderly
198231181,19823118,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 IU, QD",,,U,, 1F975A,,,6.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,,20210906.0,20210913,20210913,EXP,,NVSC2021ES202752,NOVARTIS,,78.0,YR,,F,Y,37.0,KG,20210913.0,,HP,ES,ES,2021,Q3,Elderly
198239162,19823916,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,,,,,,26.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,2,F,202103.0,20210917.0,20210913,20210922,EXP,,ES-MYLANLABS-2021M1060845,MYLAN,,75.0,YR,,F,Y,74.8,KG,20210922.0,,CN,ES,ES,2021,Q3,Elderly
198239162,19823916,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,,,,,,26.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,COVID-19,,2021,Q3,2,F,202103.0,20210917.0,20210913,20210922,EXP,,ES-MYLANLABS-2021M1060845,MYLAN,,75.0,YR,,F,Y,74.8,KG,20210922.0,,CN,ES,ES,2021,Q3,Elderly
198239162,19823916,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 IU,,,,,,,,26.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Renal colic,,2021,Q3,2,F,202103.0,20210917.0,20210913,20210922,EXP,,ES-MYLANLABS-2021M1060845,MYLAN,,75.0,YR,,F,Y,74.8,KG,20210922.0,,CN,ES,ES,2021,Q3,Elderly
198242162,19824216,35,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32?UNITS NOT SPECIFIED,,,,,,,,,,,,2021,Q3,Prostatic haemorrhage,,2021,Q3,2,F,202010.0,20210920.0,20210913,20210923,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-113758,BRISTOL MYERS SQUIBB,,77.0,YR,,M,Y,87.0,KG,20210923.0,,HP,US,US,2021,Q3,Elderly
198242162,19824216,35,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32?UNITS NOT SPECIFIED,,,,,,,,,,,,2021,Q3,Urinary tract infection,,2021,Q3,2,F,202010.0,20210920.0,20210913,20210923,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-113758,BRISTOL MYERS SQUIBB,,77.0,YR,,M,Y,87.0,KG,20210923.0,,HP,US,US,2021,Q3,Elderly
198242351,19824235,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"450 IU, 0?0?0?26",,,U,,,,,,,,QD,2021,Q3,Abdominal pain upper,,2021,Q3,1,I,20210111.0,20210907.0,20210913,20210913,EXP,,DE-SA-2021SA297063,SANOFI AVENTIS,,73.0,YR,E,M,Y,74.0,KG,20210913.0,,PH,DE,DE,2021,Q3,Elderly
198242351,19824235,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"450 IU, 0?0?0?26",,,U,,,,,,,,QD,2021,Q3,Blood glucose increased,,2021,Q3,1,I,20210111.0,20210907.0,20210913,20210913,EXP,,DE-SA-2021SA297063,SANOFI AVENTIS,,73.0,YR,E,M,Y,74.0,KG,20210913.0,,PH,DE,DE,2021,Q3,Elderly
198242351,19824235,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"450 IU, 0?0?0?26",,,U,,,,,,,,QD,2021,Q3,Fatigue,,2021,Q3,1,I,20210111.0,20210907.0,20210913,20210913,EXP,,DE-SA-2021SA297063,SANOFI AVENTIS,,73.0,YR,E,M,Y,74.0,KG,20210913.0,,PH,DE,DE,2021,Q3,Elderly
198242351,19824235,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"450 IU, 0?0?0?26",,,U,,,,,,,,QD,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,20210111.0,20210907.0,20210913,20210913,EXP,,DE-SA-2021SA297063,SANOFI AVENTIS,,73.0,YR,E,M,Y,74.0,KG,20210913.0,,PH,DE,DE,2021,Q3,Elderly
198242351,19824235,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"450 IU, 0?0?0?26",,,U,,,,,,,,QD,2021,Q3,Lack of application site rotation,,2021,Q3,1,I,20210111.0,20210907.0,20210913,20210913,EXP,,DE-SA-2021SA297063,SANOFI AVENTIS,,73.0,YR,E,M,Y,74.0,KG,20210913.0,,PH,DE,DE,2021,Q3,Elderly
198244731,19824473,3,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,22U,,,,,,,,,,,,2021,Q3,Diabetic ketoacidosis,,2021,Q3,1,I,,20210831.0,20210913,20210913,EXP,,CN-ASTRAZENECA-2021A711188,ASTRAZENECA,,43.0,YR,,M,Y,,,20210913.0,,HP,CN,CN,2021,Q3,Adult
198254611,19825461,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, QD(BEFORE SLEEPING)",,,,, BBJA005,,,22.0,IU,,QD,2021,Q3,Dizziness,,2021,Q3,1,I,20210725.0,20210903.0,20210914,20210914,EXP,CN-NMPA-4403061004846202100178,CN-NOVOPROD-844669,NOVO NORDISK,,30.0,YR,,F,Y,46.0,KG,20210914.0,,HP,CN,CN,2021,Q3,Young Adult
198254611,19825461,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, QD(BEFORE SLEEPING)",,,,, BBJA005,,,22.0,IU,,QD,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,20210725.0,20210903.0,20210914,20210914,EXP,CN-NMPA-4403061004846202100178,CN-NOVOPROD-844669,NOVO NORDISK,,30.0,YR,,F,Y,46.0,KG,20210914.0,,HP,CN,CN,2021,Q3,Young Adult
198254611,19825461,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, QD(BEFORE SLEEPING)",,,,, BBJA005,,,22.0,IU,,QD,2021,Q3,Palpitations,,2021,Q3,1,I,20210725.0,20210903.0,20210914,20210914,EXP,CN-NMPA-4403061004846202100178,CN-NOVOPROD-844669,NOVO NORDISK,,30.0,YR,,F,Y,46.0,KG,20210914.0,,HP,CN,CN,2021,Q3,Young Adult
198254611,19825461,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, QD",,,,, BBJA005,,,14.0,IU,,QD,2021,Q3,Dizziness,,2021,Q3,1,I,20210725.0,20210903.0,20210914,20210914,EXP,CN-NMPA-4403061004846202100178,CN-NOVOPROD-844669,NOVO NORDISK,,30.0,YR,,F,Y,46.0,KG,20210914.0,,HP,CN,CN,2021,Q3,Young Adult
198254611,19825461,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, QD",,,,, BBJA005,,,14.0,IU,,QD,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,20210725.0,20210903.0,20210914,20210914,EXP,CN-NMPA-4403061004846202100178,CN-NOVOPROD-844669,NOVO NORDISK,,30.0,YR,,F,Y,46.0,KG,20210914.0,,HP,CN,CN,2021,Q3,Young Adult
198254611,19825461,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, QD",,,,, BBJA005,,,14.0,IU,,QD,2021,Q3,Palpitations,,2021,Q3,1,I,20210725.0,20210903.0,20210914,20210914,EXP,CN-NMPA-4403061004846202100178,CN-NOVOPROD-844669,NOVO NORDISK,,30.0,YR,,F,Y,46.0,KG,20210914.0,,HP,CN,CN,2021,Q3,Young Adult
198254611,19825461,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD(BEFORE SLEEPING)",,,,, BBJA005,,,18.0,IU,,QD,2021,Q3,Dizziness,,2021,Q3,1,I,20210725.0,20210903.0,20210914,20210914,EXP,CN-NMPA-4403061004846202100178,CN-NOVOPROD-844669,NOVO NORDISK,,30.0,YR,,F,Y,46.0,KG,20210914.0,,HP,CN,CN,2021,Q3,Young Adult
198254611,19825461,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD(BEFORE SLEEPING)",,,,, BBJA005,,,18.0,IU,,QD,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,20210725.0,20210903.0,20210914,20210914,EXP,CN-NMPA-4403061004846202100178,CN-NOVOPROD-844669,NOVO NORDISK,,30.0,YR,,F,Y,46.0,KG,20210914.0,,HP,CN,CN,2021,Q3,Young Adult
198254611,19825461,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD(BEFORE SLEEPING)",,,,, BBJA005,,,18.0,IU,,QD,2021,Q3,Palpitations,,2021,Q3,1,I,20210725.0,20210903.0,20210914,20210914,EXP,CN-NMPA-4403061004846202100178,CN-NOVOPROD-844669,NOVO NORDISK,,30.0,YR,,F,Y,46.0,KG,20210914.0,,HP,CN,CN,2021,Q3,Young Adult
198254611,19825461,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD(BEFORE SLEEPING)",,,,, BBJA005,,,20.0,IU,,QD,2021,Q3,Dizziness,,2021,Q3,1,I,20210725.0,20210903.0,20210914,20210914,EXP,CN-NMPA-4403061004846202100178,CN-NOVOPROD-844669,NOVO NORDISK,,30.0,YR,,F,Y,46.0,KG,20210914.0,,HP,CN,CN,2021,Q3,Young Adult
198254611,19825461,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD(BEFORE SLEEPING)",,,,, BBJA005,,,20.0,IU,,QD,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,20210725.0,20210903.0,20210914,20210914,EXP,CN-NMPA-4403061004846202100178,CN-NOVOPROD-844669,NOVO NORDISK,,30.0,YR,,F,Y,46.0,KG,20210914.0,,HP,CN,CN,2021,Q3,Young Adult
198254611,19825461,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD(BEFORE SLEEPING)",,,,, BBJA005,,,20.0,IU,,QD,2021,Q3,Palpitations,,2021,Q3,1,I,20210725.0,20210903.0,20210914,20210914,EXP,CN-NMPA-4403061004846202100178,CN-NOVOPROD-844669,NOVO NORDISK,,30.0,YR,,F,Y,46.0,KG,20210914.0,,HP,CN,CN,2021,Q3,Young Adult
198269521,19826952,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Anaemia,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE201784,NOVARTIS,,69.0,YR,,F,Y,91.0,KG,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198269521,19826952,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Chills,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE201784,NOVARTIS,,69.0,YR,,F,Y,91.0,KG,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198269521,19826952,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Condition aggravated,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE201784,NOVARTIS,,69.0,YR,,F,Y,91.0,KG,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198269521,19826952,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Constipation,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE201784,NOVARTIS,,69.0,YR,,F,Y,91.0,KG,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198269521,19826952,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE201784,NOVARTIS,,69.0,YR,,F,Y,91.0,KG,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198269521,19826952,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE201784,NOVARTIS,,69.0,YR,,F,Y,91.0,KG,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198269521,19826952,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE201784,NOVARTIS,,69.0,YR,,F,Y,91.0,KG,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198269521,19826952,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Renal impairment,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE201784,NOVARTIS,,69.0,YR,,F,Y,91.0,KG,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198269521,19826952,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Sepsis,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE201784,NOVARTIS,,69.0,YR,,F,Y,91.0,KG,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198269521,19826952,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Systemic infection,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE201784,NOVARTIS,,69.0,YR,,F,Y,91.0,KG,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198269521,19826952,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Tachycardia,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE201784,NOVARTIS,,69.0,YR,,F,Y,91.0,KG,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198269521,19826952,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Tachypnoea,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE201784,NOVARTIS,,69.0,YR,,F,Y,91.0,KG,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198269521,19826952,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Weight increased,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE201784,NOVARTIS,,69.0,YR,,F,Y,91.0,KG,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198276411,19827641,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Anaemia,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE202906,NOVARTIS,,70.0,YR,,F,Y,,,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198276411,19827641,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Condition aggravated,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE202906,NOVARTIS,,70.0,YR,,F,Y,,,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198276411,19827641,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Electrocardiogram abnormal,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE202906,NOVARTIS,,70.0,YR,,F,Y,,,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198276411,19827641,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE202906,NOVARTIS,,70.0,YR,,F,Y,,,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198276411,19827641,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE202906,NOVARTIS,,70.0,YR,,F,Y,,,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198276411,19827641,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Musculoskeletal pain,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE202906,NOVARTIS,,70.0,YR,,F,Y,,,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198276411,19827641,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Oedema peripheral,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE202906,NOVARTIS,,70.0,YR,,F,Y,,,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198276411,19827641,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE202906,NOVARTIS,,70.0,YR,,F,Y,,,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198276411,19827641,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Renal impairment,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE202906,NOVARTIS,,70.0,YR,,F,Y,,,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198276411,19827641,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Sepsis,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE202906,NOVARTIS,,70.0,YR,,F,Y,,,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198276411,19827641,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Systemic infection,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE202906,NOVARTIS,,70.0,YR,,F,Y,,,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198276411,19827641,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Tachycardia,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE202906,NOVARTIS,,70.0,YR,,F,Y,,,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198276411,19827641,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Tachypnoea,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE202906,NOVARTIS,,70.0,YR,,F,Y,,,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198276411,19827641,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Weight increased,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE202906,NOVARTIS,,70.0,YR,,F,Y,,,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198283191,19828319,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, QD (EVERY NIGHT)",,,Y,, BBJA004,,21081.0,22.0,IU,,QD,2021,Q3,Abdominal pain,,2021,Q3,1,I,20210817.0,20210907.0,20210914,20210914,EXP,,CN-SA-2021SA299739,SANOFI AVENTIS,,63.0,YR,A,M,Y,60.0,KG,20210914.0,,HP,CN,CN,2021,Q3,Adult
198285141,19828514,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,," UNKNOWN,ASKED BUT UNKNOWN",,,,,,,2021,Q3,Acute respiratory distress syndrome,,2021,Q3,1,I,20200325.0,20210215.0,20210914,20210914,EXP,,DE-ROCHE-2770019,ROCHE,,53.0,YR,,F,Y,,,20210914.0,,CN,DE,DE,2021,Q3,Adult
198285141,19828514,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,," UNKNOWN,ASKED BUT UNKNOWN",,,,,,,2021,Q3,COVID-19 pneumonia,,2021,Q3,1,I,20200325.0,20210215.0,20210914,20210914,EXP,,DE-ROCHE-2770019,ROCHE,,53.0,YR,,F,Y,,,20210914.0,,CN,DE,DE,2021,Q3,Adult
198286882,19828688,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,2,F,2021.0,20210917.0,20210914,20210922,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20210922.0,,CN,ES,ES,2021,Q3,Elderly
198286882,19828688,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Cardiovascular disorder,,2021,Q3,2,F,2021.0,20210917.0,20210914,20210922,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20210922.0,,CN,ES,ES,2021,Q3,Elderly
198286882,19828688,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Decreased appetite,,2021,Q3,2,F,2021.0,20210917.0,20210914,20210922,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20210922.0,,CN,ES,ES,2021,Q3,Elderly
198286882,19828688,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Discomfort,,2021,Q3,2,F,2021.0,20210917.0,20210914,20210922,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20210922.0,,CN,ES,ES,2021,Q3,Elderly
198286882,19828688,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Dizziness,,2021,Q3,2,F,2021.0,20210917.0,20210914,20210922,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20210922.0,,CN,ES,ES,2021,Q3,Elderly
198286882,19828688,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Flatulence,,2021,Q3,2,F,2021.0,20210917.0,20210914,20210922,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20210922.0,,CN,ES,ES,2021,Q3,Elderly
198286882,19828688,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Illness,,2021,Q3,2,F,2021.0,20210917.0,20210914,20210922,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20210922.0,,CN,ES,ES,2021,Q3,Elderly
198286882,19828688,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Inappropriate schedule of product administration,,2021,Q3,2,F,2021.0,20210917.0,20210914,20210922,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20210922.0,,CN,ES,ES,2021,Q3,Elderly
198286882,19828688,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Nausea,,2021,Q3,2,F,2021.0,20210917.0,20210914,20210922,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20210922.0,,CN,ES,ES,2021,Q3,Elderly
198286882,19828688,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Osteoporosis,,2021,Q3,2,F,2021.0,20210917.0,20210914,20210922,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20210922.0,,CN,ES,ES,2021,Q3,Elderly
198286882,19828688,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Paraesthesia,,2021,Q3,2,F,2021.0,20210917.0,20210914,20210922,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20210922.0,,CN,ES,ES,2021,Q3,Elderly
198286882,19828688,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Urinary tract infection,,2021,Q3,2,F,2021.0,20210917.0,20210914,20210922,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20210922.0,,CN,ES,ES,2021,Q3,Elderly
198286882,19828688,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Weight decreased,,2021,Q3,2,F,2021.0,20210917.0,20210914,20210922,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20210922.0,,CN,ES,ES,2021,Q3,Elderly
198286882,19828688,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,,,,,,,,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,2,F,2021.0,20210917.0,20210914,20210922,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20210922.0,,CN,ES,ES,2021,Q3,Elderly
198286882,19828688,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,,,,,,,,SOLUTION FOR INJECTION,QD,2021,Q3,Cardiovascular disorder,,2021,Q3,2,F,2021.0,20210917.0,20210914,20210922,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20210922.0,,CN,ES,ES,2021,Q3,Elderly
198286882,19828688,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,,,,,,,,SOLUTION FOR INJECTION,QD,2021,Q3,Decreased appetite,,2021,Q3,2,F,2021.0,20210917.0,20210914,20210922,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20210922.0,,CN,ES,ES,2021,Q3,Elderly
198286882,19828688,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,,,,,,,,SOLUTION FOR INJECTION,QD,2021,Q3,Discomfort,,2021,Q3,2,F,2021.0,20210917.0,20210914,20210922,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20210922.0,,CN,ES,ES,2021,Q3,Elderly
198286882,19828688,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,,,,,,,,SOLUTION FOR INJECTION,QD,2021,Q3,Dizziness,,2021,Q3,2,F,2021.0,20210917.0,20210914,20210922,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20210922.0,,CN,ES,ES,2021,Q3,Elderly
198286882,19828688,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,,,,,,,,SOLUTION FOR INJECTION,QD,2021,Q3,Flatulence,,2021,Q3,2,F,2021.0,20210917.0,20210914,20210922,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20210922.0,,CN,ES,ES,2021,Q3,Elderly
198286882,19828688,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,,,,,,,,SOLUTION FOR INJECTION,QD,2021,Q3,Illness,,2021,Q3,2,F,2021.0,20210917.0,20210914,20210922,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20210922.0,,CN,ES,ES,2021,Q3,Elderly
198286882,19828688,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,,,,,,,,SOLUTION FOR INJECTION,QD,2021,Q3,Inappropriate schedule of product administration,,2021,Q3,2,F,2021.0,20210917.0,20210914,20210922,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20210922.0,,CN,ES,ES,2021,Q3,Elderly
198286882,19828688,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,,,,,,,,SOLUTION FOR INJECTION,QD,2021,Q3,Nausea,,2021,Q3,2,F,2021.0,20210917.0,20210914,20210922,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20210922.0,,CN,ES,ES,2021,Q3,Elderly
198286882,19828688,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,,,,,,,,SOLUTION FOR INJECTION,QD,2021,Q3,Osteoporosis,,2021,Q3,2,F,2021.0,20210917.0,20210914,20210922,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20210922.0,,CN,ES,ES,2021,Q3,Elderly
198286882,19828688,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,,,,,,,,SOLUTION FOR INJECTION,QD,2021,Q3,Paraesthesia,,2021,Q3,2,F,2021.0,20210917.0,20210914,20210922,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20210922.0,,CN,ES,ES,2021,Q3,Elderly
198286882,19828688,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,,,,,,,,SOLUTION FOR INJECTION,QD,2021,Q3,Urinary tract infection,,2021,Q3,2,F,2021.0,20210917.0,20210914,20210922,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20210922.0,,CN,ES,ES,2021,Q3,Elderly
198286882,19828688,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,,,,,,,,SOLUTION FOR INJECTION,QD,2021,Q3,Weight decreased,,2021,Q3,2,F,2021.0,20210917.0,20210914,20210922,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20210922.0,,CN,ES,ES,2021,Q3,Elderly
198301431,19830143,18,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, UNKNOWN,,,0.5,ML,,QD,2021,Q3,Hyperkalaemia,,2021,Q3,1,I,20140307.0,20140309.0,20210915,20210915,EXP,,US-ROCHE-1363158,ROCHE,,78.0,YR,,M,Y,,,20210915.0,,MD,US,US,2021,Q3,Elderly
198301431,19830143,18,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, UNKNOWN,,,0.5,ML,,QD,2021,Q3,Pneumonia,,2021,Q3,1,I,20140307.0,20140309.0,20210915,20210915,EXP,,US-ROCHE-1363158,ROCHE,,78.0,YR,,M,Y,,,20210915.0,,MD,US,US,2021,Q3,Elderly
198301431,19830143,18,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, UNKNOWN,,,0.5,ML,,QD,2021,Q3,Pneumonia staphylococcal,,2021,Q3,1,I,20140307.0,20140309.0,20210915,20210915,EXP,,US-ROCHE-1363158,ROCHE,,78.0,YR,,M,Y,,,20210915.0,,MD,US,US,2021,Q3,Elderly
198301431,19830143,18,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, UNKNOWN,,,0.5,ML,,QD,2021,Q3,Pneumonia streptococcal,,2021,Q3,1,I,20140307.0,20140309.0,20210915,20210915,EXP,,US-ROCHE-1363158,ROCHE,,78.0,YR,,M,Y,,,20210915.0,,MD,US,US,2021,Q3,Elderly
198301431,19830143,18,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, UNKNOWN,,,0.5,ML,,QD,2021,Q3,Pseudomonas infection,,2021,Q3,1,I,20140307.0,20140309.0,20210915,20210915,EXP,,US-ROCHE-1363158,ROCHE,,78.0,YR,,M,Y,,,20210915.0,,MD,US,US,2021,Q3,Elderly
198304581,19830458,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,48.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blindness unilateral,,2021,Q3,1,I,,20210901.0,20210915,20210915,EXP,,ES-BAUSCH-BL-2021-029857,BAUSCH AND LOMB,,67.0,YR,,F,Y,94.2,KG,20210915.0,,CN,ES,ES,2021,Q3,Elderly
198304581,19830458,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,48.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,1,I,,20210901.0,20210915,20210915,EXP,,ES-BAUSCH-BL-2021-029857,BAUSCH AND LOMB,,67.0,YR,,F,Y,94.2,KG,20210915.0,,CN,ES,ES,2021,Q3,Elderly
198304581,19830458,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,48.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Cataract diabetic,,2021,Q3,1,I,,20210901.0,20210915,20210915,EXP,,ES-BAUSCH-BL-2021-029857,BAUSCH AND LOMB,,67.0,YR,,F,Y,94.2,KG,20210915.0,,CN,ES,ES,2021,Q3,Elderly
198304581,19830458,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,48.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210901.0,20210915,20210915,EXP,,ES-BAUSCH-BL-2021-029857,BAUSCH AND LOMB,,67.0,YR,,F,Y,94.2,KG,20210915.0,,CN,ES,ES,2021,Q3,Elderly
198304581,19830458,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,48.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Disability,,2021,Q3,1,I,,20210901.0,20210915,20210915,EXP,,ES-BAUSCH-BL-2021-029857,BAUSCH AND LOMB,,67.0,YR,,F,Y,94.2,KG,20210915.0,,CN,ES,ES,2021,Q3,Elderly
198304581,19830458,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,48.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Exercise lack of,,2021,Q3,1,I,,20210901.0,20210915,20210915,EXP,,ES-BAUSCH-BL-2021-029857,BAUSCH AND LOMB,,67.0,YR,,F,Y,94.2,KG,20210915.0,,CN,ES,ES,2021,Q3,Elderly
198304581,19830458,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,48.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Gait inability,,2021,Q3,1,I,,20210901.0,20210915,20210915,EXP,,ES-BAUSCH-BL-2021-029857,BAUSCH AND LOMB,,67.0,YR,,F,Y,94.2,KG,20210915.0,,CN,ES,ES,2021,Q3,Elderly
198304581,19830458,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,48.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Multiple use of single-use product,,2021,Q3,1,I,,20210901.0,20210915,20210915,EXP,,ES-BAUSCH-BL-2021-029857,BAUSCH AND LOMB,,67.0,YR,,F,Y,94.2,KG,20210915.0,,CN,ES,ES,2021,Q3,Elderly
198304581,19830458,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,48.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Post procedural complication,,2021,Q3,1,I,,20210901.0,20210915,20210915,EXP,,ES-BAUSCH-BL-2021-029857,BAUSCH AND LOMB,,67.0,YR,,F,Y,94.2,KG,20210915.0,,CN,ES,ES,2021,Q3,Elderly
198304581,19830458,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,48.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Retinal injury,,2021,Q3,1,I,,20210901.0,20210915,20210915,EXP,,ES-BAUSCH-BL-2021-029857,BAUSCH AND LOMB,,67.0,YR,,F,Y,94.2,KG,20210915.0,,CN,ES,ES,2021,Q3,Elderly
198304581,19830458,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,48.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Uterine operation,,2021,Q3,1,I,,20210901.0,20210915,20210915,EXP,,ES-BAUSCH-BL-2021-029857,BAUSCH AND LOMB,,67.0,YR,,F,Y,94.2,KG,20210915.0,,CN,ES,ES,2021,Q3,Elderly
198304581,19830458,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,50.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blindness unilateral,,2021,Q3,1,I,,20210901.0,20210915,20210915,EXP,,ES-BAUSCH-BL-2021-029857,BAUSCH AND LOMB,,67.0,YR,,F,Y,94.2,KG,20210915.0,,CN,ES,ES,2021,Q3,Elderly
198304581,19830458,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,50.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,1,I,,20210901.0,20210915,20210915,EXP,,ES-BAUSCH-BL-2021-029857,BAUSCH AND LOMB,,67.0,YR,,F,Y,94.2,KG,20210915.0,,CN,ES,ES,2021,Q3,Elderly
198304581,19830458,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,50.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Cataract diabetic,,2021,Q3,1,I,,20210901.0,20210915,20210915,EXP,,ES-BAUSCH-BL-2021-029857,BAUSCH AND LOMB,,67.0,YR,,F,Y,94.2,KG,20210915.0,,CN,ES,ES,2021,Q3,Elderly
198304581,19830458,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,50.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210901.0,20210915,20210915,EXP,,ES-BAUSCH-BL-2021-029857,BAUSCH AND LOMB,,67.0,YR,,F,Y,94.2,KG,20210915.0,,CN,ES,ES,2021,Q3,Elderly
198304581,19830458,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,50.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Disability,,2021,Q3,1,I,,20210901.0,20210915,20210915,EXP,,ES-BAUSCH-BL-2021-029857,BAUSCH AND LOMB,,67.0,YR,,F,Y,94.2,KG,20210915.0,,CN,ES,ES,2021,Q3,Elderly
198304581,19830458,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,50.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Exercise lack of,,2021,Q3,1,I,,20210901.0,20210915,20210915,EXP,,ES-BAUSCH-BL-2021-029857,BAUSCH AND LOMB,,67.0,YR,,F,Y,94.2,KG,20210915.0,,CN,ES,ES,2021,Q3,Elderly
198304581,19830458,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,50.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Gait inability,,2021,Q3,1,I,,20210901.0,20210915,20210915,EXP,,ES-BAUSCH-BL-2021-029857,BAUSCH AND LOMB,,67.0,YR,,F,Y,94.2,KG,20210915.0,,CN,ES,ES,2021,Q3,Elderly
198304581,19830458,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,50.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Multiple use of single-use product,,2021,Q3,1,I,,20210901.0,20210915,20210915,EXP,,ES-BAUSCH-BL-2021-029857,BAUSCH AND LOMB,,67.0,YR,,F,Y,94.2,KG,20210915.0,,CN,ES,ES,2021,Q3,Elderly
198304581,19830458,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,50.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Post procedural complication,,2021,Q3,1,I,,20210901.0,20210915,20210915,EXP,,ES-BAUSCH-BL-2021-029857,BAUSCH AND LOMB,,67.0,YR,,F,Y,94.2,KG,20210915.0,,CN,ES,ES,2021,Q3,Elderly
198304581,19830458,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,50.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Retinal injury,,2021,Q3,1,I,,20210901.0,20210915,20210915,EXP,,ES-BAUSCH-BL-2021-029857,BAUSCH AND LOMB,,67.0,YR,,F,Y,94.2,KG,20210915.0,,CN,ES,ES,2021,Q3,Elderly
198304581,19830458,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,50.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Uterine operation,,2021,Q3,1,I,,20210901.0,20210915,20210915,EXP,,ES-BAUSCH-BL-2021-029857,BAUSCH AND LOMB,,67.0,YR,,F,Y,94.2,KG,20210915.0,,CN,ES,ES,2021,Q3,Elderly
198304581,19830458,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,52.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blindness unilateral,,2021,Q3,1,I,,20210901.0,20210915,20210915,EXP,,ES-BAUSCH-BL-2021-029857,BAUSCH AND LOMB,,67.0,YR,,F,Y,94.2,KG,20210915.0,,CN,ES,ES,2021,Q3,Elderly
198304581,19830458,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,52.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,1,I,,20210901.0,20210915,20210915,EXP,,ES-BAUSCH-BL-2021-029857,BAUSCH AND LOMB,,67.0,YR,,F,Y,94.2,KG,20210915.0,,CN,ES,ES,2021,Q3,Elderly
198304581,19830458,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,52.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Cataract diabetic,,2021,Q3,1,I,,20210901.0,20210915,20210915,EXP,,ES-BAUSCH-BL-2021-029857,BAUSCH AND LOMB,,67.0,YR,,F,Y,94.2,KG,20210915.0,,CN,ES,ES,2021,Q3,Elderly
198304581,19830458,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,52.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210901.0,20210915,20210915,EXP,,ES-BAUSCH-BL-2021-029857,BAUSCH AND LOMB,,67.0,YR,,F,Y,94.2,KG,20210915.0,,CN,ES,ES,2021,Q3,Elderly
198304581,19830458,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,52.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Disability,,2021,Q3,1,I,,20210901.0,20210915,20210915,EXP,,ES-BAUSCH-BL-2021-029857,BAUSCH AND LOMB,,67.0,YR,,F,Y,94.2,KG,20210915.0,,CN,ES,ES,2021,Q3,Elderly
198304581,19830458,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,52.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Exercise lack of,,2021,Q3,1,I,,20210901.0,20210915,20210915,EXP,,ES-BAUSCH-BL-2021-029857,BAUSCH AND LOMB,,67.0,YR,,F,Y,94.2,KG,20210915.0,,CN,ES,ES,2021,Q3,Elderly
198304581,19830458,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,52.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Gait inability,,2021,Q3,1,I,,20210901.0,20210915,20210915,EXP,,ES-BAUSCH-BL-2021-029857,BAUSCH AND LOMB,,67.0,YR,,F,Y,94.2,KG,20210915.0,,CN,ES,ES,2021,Q3,Elderly
198304581,19830458,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,52.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Multiple use of single-use product,,2021,Q3,1,I,,20210901.0,20210915,20210915,EXP,,ES-BAUSCH-BL-2021-029857,BAUSCH AND LOMB,,67.0,YR,,F,Y,94.2,KG,20210915.0,,CN,ES,ES,2021,Q3,Elderly
198304581,19830458,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,52.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Post procedural complication,,2021,Q3,1,I,,20210901.0,20210915,20210915,EXP,,ES-BAUSCH-BL-2021-029857,BAUSCH AND LOMB,,67.0,YR,,F,Y,94.2,KG,20210915.0,,CN,ES,ES,2021,Q3,Elderly
198304581,19830458,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,52.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Retinal injury,,2021,Q3,1,I,,20210901.0,20210915,20210915,EXP,,ES-BAUSCH-BL-2021-029857,BAUSCH AND LOMB,,67.0,YR,,F,Y,94.2,KG,20210915.0,,CN,ES,ES,2021,Q3,Elderly
198304581,19830458,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,52.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Uterine operation,,2021,Q3,1,I,,20210901.0,20210915,20210915,EXP,,ES-BAUSCH-BL-2021-029857,BAUSCH AND LOMB,,67.0,YR,,F,Y,94.2,KG,20210915.0,,CN,ES,ES,2021,Q3,Elderly
198312951,19831295,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"6 INTERNATIONAL UNIT, ONCE A DAY(6 IU, QD)",,,U,U, 1F975A,,,6.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Blood glucose decreased,,2021,Q3,1,I,,20210904.0,20210915,20210915,EXP,,ES-AUROBINDO-AUR-APL-2021-038724,AUROBINDO,,78.0,YR,,F,Y,37.0,KG,20210915.0,,CN,ES,ES,2021,Q3,Elderly
198312951,19831295,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"6 INTERNATIONAL UNIT, ONCE A DAY(6 IU, QD)",,,U,U, 1F975A,,,6.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Decreased appetite,,2021,Q3,1,I,,20210904.0,20210915,20210915,EXP,,ES-AUROBINDO-AUR-APL-2021-038724,AUROBINDO,,78.0,YR,,F,Y,37.0,KG,20210915.0,,CN,ES,ES,2021,Q3,Elderly
198312951,19831295,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"6 INTERNATIONAL UNIT, ONCE A DAY(6 IU, QD)",,,U,U, 1F975A,,,6.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Depressed level of consciousness,,2021,Q3,1,I,,20210904.0,20210915,20210915,EXP,,ES-AUROBINDO-AUR-APL-2021-038724,AUROBINDO,,78.0,YR,,F,Y,37.0,KG,20210915.0,,CN,ES,ES,2021,Q3,Elderly
198312951,19831295,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"6 INTERNATIONAL UNIT, ONCE A DAY(6 IU, QD)",,,U,U, 1F975A,,,6.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210904.0,20210915,20210915,EXP,,ES-AUROBINDO-AUR-APL-2021-038724,AUROBINDO,,78.0,YR,,F,Y,37.0,KG,20210915.0,,CN,ES,ES,2021,Q3,Elderly
198312951,19831295,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"6 INTERNATIONAL UNIT, ONCE A DAY(6 IU, QD)",,,U,U, 1F975A,,,6.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Feeling abnormal,,2021,Q3,1,I,,20210904.0,20210915,20210915,EXP,,ES-AUROBINDO-AUR-APL-2021-038724,AUROBINDO,,78.0,YR,,F,Y,37.0,KG,20210915.0,,CN,ES,ES,2021,Q3,Elderly
198312951,19831295,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"6 INTERNATIONAL UNIT, ONCE A DAY(6 IU, QD)",,,U,U, 1F975A,,,6.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,,20210904.0,20210915,20210915,EXP,,ES-AUROBINDO-AUR-APL-2021-038724,AUROBINDO,,78.0,YR,,F,Y,37.0,KG,20210915.0,,CN,ES,ES,2021,Q3,Elderly
198326171,19832617,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"450 IE, 0?0?0?26, FERTIGSPRITZEN",,,U,,,,,,,,,2021,Q3,Abdominal pain upper,,2021,Q3,1,I,20210111.0,20210902.0,20210914,20210914,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202109001407,ELI LILLY AND CO,,73.0,YR,,M,Y,74.0,KG,20210914.0,,PH,DE,DE,2021,Q3,Elderly
198326171,19832617,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"450 IE, 0?0?0?26, FERTIGSPRITZEN",,,U,,,,,,,,,2021,Q3,Blood glucose increased,,2021,Q3,1,I,20210111.0,20210902.0,20210914,20210914,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202109001407,ELI LILLY AND CO,,73.0,YR,,M,Y,74.0,KG,20210914.0,,PH,DE,DE,2021,Q3,Elderly
198326171,19832617,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"450 IE, 0?0?0?26, FERTIGSPRITZEN",,,U,,,,,,,,,2021,Q3,Fatigue,,2021,Q3,1,I,20210111.0,20210902.0,20210914,20210914,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202109001407,ELI LILLY AND CO,,73.0,YR,,M,Y,74.0,KG,20210914.0,,PH,DE,DE,2021,Q3,Elderly
198326171,19832617,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"450 IE, 0?0?0?26, FERTIGSPRITZEN",,,U,,,,,,,,,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,20210111.0,20210902.0,20210914,20210914,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202109001407,ELI LILLY AND CO,,73.0,YR,,M,Y,74.0,KG,20210914.0,,PH,DE,DE,2021,Q3,Elderly
198326171,19832617,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"450 IE, 0?0?0?26, FERTIGSPRITZEN",,,U,,,,,,,,,2021,Q3,Lack of application site rotation,,2021,Q3,1,I,20210111.0,20210902.0,20210914,20210914,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202109001407,ELI LILLY AND CO,,73.0,YR,,M,Y,74.0,KG,20210914.0,,PH,DE,DE,2021,Q3,Elderly
198343931,19834393,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ML UNKNOWN,,,U,,,,,,,,,2021,Q3,Abdominal pain,,2021,Q3,1,I,20210522.0,20210908.0,20210915,20210915,EXP,,FR-ASTRAZENECA-2021A718519,ASTRAZENECA,,59.0,YR,,M,Y,64.0,KG,20210915.0,,HP,FR,FR,2021,Q3,Adult
198343931,19834393,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ML UNKNOWN,,,U,,,,,,,,,2021,Q3,Arthralgia,,2021,Q3,1,I,20210522.0,20210908.0,20210915,20210915,EXP,,FR-ASTRAZENECA-2021A718519,ASTRAZENECA,,59.0,YR,,M,Y,64.0,KG,20210915.0,,HP,FR,FR,2021,Q3,Adult
198343931,19834393,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ML UNKNOWN,,,U,,,,,,,,,2021,Q3,Haematoma muscle,,2021,Q3,1,I,20210522.0,20210908.0,20210915,20210915,EXP,,FR-ASTRAZENECA-2021A718519,ASTRAZENECA,,59.0,YR,,M,Y,64.0,KG,20210915.0,,HP,FR,FR,2021,Q3,Adult
198343931,19834393,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ML UNKNOWN,,,U,,,,,,,,,2021,Q3,Muscular weakness,,2021,Q3,1,I,20210522.0,20210908.0,20210915,20210915,EXP,,FR-ASTRAZENECA-2021A718519,ASTRAZENECA,,59.0,YR,,M,Y,64.0,KG,20210915.0,,HP,FR,FR,2021,Q3,Adult
198343931,19834393,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ML UNKNOWN,,,U,,,,,,,,,2021,Q3,Pain in extremity,,2021,Q3,1,I,20210522.0,20210908.0,20210915,20210915,EXP,,FR-ASTRAZENECA-2021A718519,ASTRAZENECA,,59.0,YR,,M,Y,64.0,KG,20210915.0,,HP,FR,FR,2021,Q3,Adult
198343931,19834393,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ML UNKNOWN,,,U,,,,,,,,,2021,Q3,Pyelocaliectasis,,2021,Q3,1,I,20210522.0,20210908.0,20210915,20210915,EXP,,FR-ASTRAZENECA-2021A718519,ASTRAZENECA,,59.0,YR,,M,Y,64.0,KG,20210915.0,,HP,FR,FR,2021,Q3,Adult
198343931,19834393,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ML UNKNOWN,,,U,,,,,,,,,2021,Q3,Ureteric compression,,2021,Q3,1,I,20210522.0,20210908.0,20210915,20210915,EXP,,FR-ASTRAZENECA-2021A718519,ASTRAZENECA,,59.0,YR,,M,Y,64.0,KG,20210915.0,,HP,FR,FR,2021,Q3,Adult
198353311,19835331,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"450 E/1.5ML, 0?0?0?6, PRE?FILLED SYRINGES",,,,,,,,,,,,2021,Q3,Decreased appetite,,2021,Q3,1,I,,20210903.0,20210915,20210915,EXP,DE-BFARM-21008338,DE-ACCORD-238374,ACCORD,,69.0,YR,E,M,Y,61.0,KG,20210915.0,,PH,DE,DE,2021,Q3,Elderly
198353311,19835331,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"450 E/1.5ML, 0?0?0?6, PRE?FILLED SYRINGES",,,,,,,,,,,,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210903.0,20210915,20210915,EXP,DE-BFARM-21008338,DE-ACCORD-238374,ACCORD,,69.0,YR,E,M,Y,61.0,KG,20210915.0,,PH,DE,DE,2021,Q3,Elderly
198353311,19835331,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"450 E/1.5ML, 0?0?0?6, PRE?FILLED SYRINGES",,,,,,,,,,,,2021,Q3,Fine motor skill dysfunction,,2021,Q3,1,I,,20210903.0,20210915,20210915,EXP,DE-BFARM-21008338,DE-ACCORD-238374,ACCORD,,69.0,YR,E,M,Y,61.0,KG,20210915.0,,PH,DE,DE,2021,Q3,Elderly
198353311,19835331,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"450 E/1.5ML, 0?0?0?6, PRE?FILLED SYRINGES",,,,,,,,,,,,2021,Q3,Fluid intake reduced,,2021,Q3,1,I,,20210903.0,20210915,20210915,EXP,DE-BFARM-21008338,DE-ACCORD-238374,ACCORD,,69.0,YR,E,M,Y,61.0,KG,20210915.0,,PH,DE,DE,2021,Q3,Elderly
198353311,19835331,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"450 E/1.5ML, 0?0?0?6, PRE?FILLED SYRINGES",,,,,,,,,,,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210903.0,20210915,20210915,EXP,DE-BFARM-21008338,DE-ACCORD-238374,ACCORD,,69.0,YR,E,M,Y,61.0,KG,20210915.0,,PH,DE,DE,2021,Q3,Elderly
198354693,19835469,6,C,Insuline Glargine,INSULIN GLARGINE,1,Subcutaneous,100 IU (INTERNATIONAL UNIT),,,,,,,,100.0,IU,INJECTION,QD,2021,Q3,Embolism,,2021,Q3,3,F,20210906.0,20210920.0,20210914,20210928,EXP,,GB-CELGENEUS-GBR-20210901902,CELGENE,,70.0,YR,,M,Y,65.5,KG,20210928.0,,MD,GB,GB,2021,Q3,Elderly
198405671,19840567,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Acute kidney injury,,2021,Q3,1,I,,20210902.0,20210915,20210915,EXP,,CA-PFIZER INC-202101144756,PFIZER,,62.0,YR,,F,Y,107.0,KG,20210915.0,,HP,CA,CA,2021,Q3,Adult
198405671,19840567,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210902.0,20210915,20210915,EXP,,CA-PFIZER INC-202101144756,PFIZER,,62.0,YR,,F,Y,107.0,KG,20210915.0,,HP,CA,CA,2021,Q3,Adult
198405671,19840567,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Febrile neutropenia,,2021,Q3,1,I,,20210902.0,20210915,20210915,EXP,,CA-PFIZER INC-202101144756,PFIZER,,62.0,YR,,F,Y,107.0,KG,20210915.0,,HP,CA,CA,2021,Q3,Adult
198405671,19840567,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Hypotension,,2021,Q3,1,I,,20210902.0,20210915,20210915,EXP,,CA-PFIZER INC-202101144756,PFIZER,,62.0,YR,,F,Y,107.0,KG,20210915.0,,HP,CA,CA,2021,Q3,Adult
198405671,19840567,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Mucosal inflammation,,2021,Q3,1,I,,20210902.0,20210915,20210915,EXP,,CA-PFIZER INC-202101144756,PFIZER,,62.0,YR,,F,Y,107.0,KG,20210915.0,,HP,CA,CA,2021,Q3,Adult
198412631,19841263,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,,,,,,,,,2021,Q3,Abdominal pain,,2021,Q3,1,I,20210522.0,20210906.0,20210915,20210915,EXP,,NVSC2021FR202918,NOVARTIS,,59.0,YR,,M,Y,64.0,KG,20210915.0,,HP,FR,FR,2021,Q3,Adult
198412631,19841263,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,,,,,,,,,2021,Q3,Arthralgia,,2021,Q3,1,I,20210522.0,20210906.0,20210915,20210915,EXP,,NVSC2021FR202918,NOVARTIS,,59.0,YR,,M,Y,64.0,KG,20210915.0,,HP,FR,FR,2021,Q3,Adult
198412631,19841263,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,,,,,,,,,2021,Q3,Haematoma muscle,,2021,Q3,1,I,20210522.0,20210906.0,20210915,20210915,EXP,,NVSC2021FR202918,NOVARTIS,,59.0,YR,,M,Y,64.0,KG,20210915.0,,HP,FR,FR,2021,Q3,Adult
198412631,19841263,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,,,,,,,,,2021,Q3,Muscular weakness,,2021,Q3,1,I,20210522.0,20210906.0,20210915,20210915,EXP,,NVSC2021FR202918,NOVARTIS,,59.0,YR,,M,Y,64.0,KG,20210915.0,,HP,FR,FR,2021,Q3,Adult
198412631,19841263,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,,,,,,,,,2021,Q3,Pain in extremity,,2021,Q3,1,I,20210522.0,20210906.0,20210915,20210915,EXP,,NVSC2021FR202918,NOVARTIS,,59.0,YR,,M,Y,64.0,KG,20210915.0,,HP,FR,FR,2021,Q3,Adult
198412631,19841263,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,,,,,,,,,2021,Q3,Pyelocaliectasis,,2021,Q3,1,I,20210522.0,20210906.0,20210915,20210915,EXP,,NVSC2021FR202918,NOVARTIS,,59.0,YR,,M,Y,64.0,KG,20210915.0,,HP,FR,FR,2021,Q3,Adult
198412631,19841263,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,,,,,,,,,2021,Q3,Ureteric compression,,2021,Q3,1,I,20210522.0,20210906.0,20210915,20210915,EXP,,NVSC2021FR202918,NOVARTIS,,59.0,YR,,M,Y,64.0,KG,20210915.0,,HP,FR,FR,2021,Q3,Adult
198438851,19843885,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"450 E/1.5ML, 0?0?0?6, PREFILLED SYRINGES",,,,, UNKNOWN,,,,,,,2021,Q3,Decreased appetite,,2021,Q3,1,I,,20210906.0,20210916,20210916,EXP,,DE-FRESENIUS KABI-FK202109646,FRESENIUS KABI,,69.0,YR,,M,Y,61.0,KG,20210916.0,,HP,NL,DE,2021,Q3,Elderly
198438851,19843885,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"450 E/1.5ML, 0?0?0?6, PREFILLED SYRINGES",,,,, UNKNOWN,,,,,,,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210906.0,20210916,20210916,EXP,,DE-FRESENIUS KABI-FK202109646,FRESENIUS KABI,,69.0,YR,,M,Y,61.0,KG,20210916.0,,HP,NL,DE,2021,Q3,Elderly
198438851,19843885,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"450 E/1.5ML, 0?0?0?6, PREFILLED SYRINGES",,,,, UNKNOWN,,,,,,,2021,Q3,Fine motor skill dysfunction,,2021,Q3,1,I,,20210906.0,20210916,20210916,EXP,,DE-FRESENIUS KABI-FK202109646,FRESENIUS KABI,,69.0,YR,,M,Y,61.0,KG,20210916.0,,HP,NL,DE,2021,Q3,Elderly
198438851,19843885,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"450 E/1.5ML, 0?0?0?6, PREFILLED SYRINGES",,,,, UNKNOWN,,,,,,,2021,Q3,Fluid intake reduced,,2021,Q3,1,I,,20210906.0,20210916,20210916,EXP,,DE-FRESENIUS KABI-FK202109646,FRESENIUS KABI,,69.0,YR,,M,Y,61.0,KG,20210916.0,,HP,NL,DE,2021,Q3,Elderly
198438851,19843885,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"450 E/1.5ML, 0?0?0?6, PREFILLED SYRINGES",,,,, UNKNOWN,,,,,,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210906.0,20210916,20210916,EXP,,DE-FRESENIUS KABI-FK202109646,FRESENIUS KABI,,69.0,YR,,M,Y,61.0,KG,20210916.0,,HP,NL,DE,2021,Q3,Elderly
198448221,19844822,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,INJECTION,,2021,Q3,Type I hypersensitivity,,2021,Q3,1,I,,20210817.0,20210916,20210916,EXP,,RO-ASTRAZENECA-2021A685925,ASTRAZENECA,,49.0,YR,,F,Y,,,20210916.0,,HP,RO,RO,2021,Q3,Adult
198448221,19844822,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"START DOSE FOR DESENSITIZATION PROTOCOL WAS 0.000001U, DOSES WERE ESCALATED EVERY 30 MINUTES.",,,U,,,,,,,,,2021,Q3,Type I hypersensitivity,,2021,Q3,1,I,,20210817.0,20210916,20210916,EXP,,RO-ASTRAZENECA-2021A685925,ASTRAZENECA,,49.0,YR,,F,Y,,,20210916.0,,HP,RO,RO,2021,Q3,Adult
198449461,19844946,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Abdominal pain,,2021,Q3,1,I,20210522.0,20210906.0,20210917,20210917,EXP,,FR-BAUSCH-BL-2021-031008,BAUSCH AND LOMB,,59.0,YR,,M,Y,64.0,KG,20210917.0,,HP,FR,FR,2021,Q3,Adult
198449461,19844946,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Arthralgia,,2021,Q3,1,I,20210522.0,20210906.0,20210917,20210917,EXP,,FR-BAUSCH-BL-2021-031008,BAUSCH AND LOMB,,59.0,YR,,M,Y,64.0,KG,20210917.0,,HP,FR,FR,2021,Q3,Adult
198449461,19844946,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Haematoma muscle,,2021,Q3,1,I,20210522.0,20210906.0,20210917,20210917,EXP,,FR-BAUSCH-BL-2021-031008,BAUSCH AND LOMB,,59.0,YR,,M,Y,64.0,KG,20210917.0,,HP,FR,FR,2021,Q3,Adult
198449461,19844946,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Muscular weakness,,2021,Q3,1,I,20210522.0,20210906.0,20210917,20210917,EXP,,FR-BAUSCH-BL-2021-031008,BAUSCH AND LOMB,,59.0,YR,,M,Y,64.0,KG,20210917.0,,HP,FR,FR,2021,Q3,Adult
198449461,19844946,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Pain in extremity,,2021,Q3,1,I,20210522.0,20210906.0,20210917,20210917,EXP,,FR-BAUSCH-BL-2021-031008,BAUSCH AND LOMB,,59.0,YR,,M,Y,64.0,KG,20210917.0,,HP,FR,FR,2021,Q3,Adult
198449461,19844946,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Pyelocaliectasis,,2021,Q3,1,I,20210522.0,20210906.0,20210917,20210917,EXP,,FR-BAUSCH-BL-2021-031008,BAUSCH AND LOMB,,59.0,YR,,M,Y,64.0,KG,20210917.0,,HP,FR,FR,2021,Q3,Adult
198449461,19844946,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Ureteric compression,,2021,Q3,1,I,20210522.0,20210906.0,20210917,20210917,EXP,,FR-BAUSCH-BL-2021-031008,BAUSCH AND LOMB,,59.0,YR,,M,Y,64.0,KG,20210917.0,,HP,FR,FR,2021,Q3,Adult
198466931,19846693,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0?0?0?22,  PRE?FILLED SYRINGES",,,,,,,,,,,,2021,Q3,Atrial fibrillation,,2021,Q3,1,I,,20210906.0,20210917,20210917,EXP,DE-BFARM-21008457,DE-ACCORD-238783,ACCORD,,77.0,YR,E,F,Y,79.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198466931,19846693,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0?0?0?22,  PRE?FILLED SYRINGES",,,,,,,,,,,,2021,Q3,Dehydration,,2021,Q3,1,I,,20210906.0,20210917,20210917,EXP,DE-BFARM-21008457,DE-ACCORD-238783,ACCORD,,77.0,YR,E,F,Y,79.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198466931,19846693,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0?0?0?22,  PRE?FILLED SYRINGES",,,,,,,,,,,,2021,Q3,Fall,,2021,Q3,1,I,,20210906.0,20210917,20210917,EXP,DE-BFARM-21008457,DE-ACCORD-238783,ACCORD,,77.0,YR,E,F,Y,79.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198466931,19846693,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0?0?0?22,  PRE?FILLED SYRINGES",,,,,,,,,,,,2021,Q3,Fatigue,,2021,Q3,1,I,,20210906.0,20210917,20210917,EXP,DE-BFARM-21008457,DE-ACCORD-238783,ACCORD,,77.0,YR,E,F,Y,79.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198466931,19846693,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0?0?0?22,  PRE?FILLED SYRINGES",,,,,,,,,,,,2021,Q3,Insomnia,,2021,Q3,1,I,,20210906.0,20210917,20210917,EXP,DE-BFARM-21008457,DE-ACCORD-238783,ACCORD,,77.0,YR,E,F,Y,79.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198466931,19846693,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0?0?0?22,  PRE?FILLED SYRINGES",,,,,,,,,,,,2021,Q3,Tachycardia,,2021,Q3,1,I,,20210906.0,20210917,20210917,EXP,DE-BFARM-21008457,DE-ACCORD-238783,ACCORD,,77.0,YR,E,F,Y,79.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198470951,19847095,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, 9F6516A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Abdominal distension,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, 9F6516A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Benign pancreatic neoplasm,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, 9F6516A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Blood disorder,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, 9F6516A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose abnormal,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, 9F6516A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose fluctuation,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, 9F6516A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Blood pressure abnormal,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, 9F6516A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Blood sodium decreased,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, 9F6516A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Cyanosis,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, 9F6516A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Diabetes mellitus inadequate control,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, 9F6516A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Fatigue,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, 9F6516A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Fluid retention,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, 9F6516A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Hepatic cyst,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, 9F6516A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Hepatic neoplasm,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, 9F6516A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, 9F6516A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Intentional product misuse,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, 9F6516A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Loss of consciousness,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, 9F6516A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Nocturia,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, 9F6516A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Pancreatic cyst,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, 9F6516A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Renal disorder,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, 9F6516A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Urine analysis abnormal,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, 9F6516A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Visual impairment,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, 9F6516A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Weight decreased,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, 9F6516A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Weight increased,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED TO 26 IU,,,Y,, 9F6516A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Abdominal distension,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED TO 26 IU,,,Y,, 9F6516A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Benign pancreatic neoplasm,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED TO 26 IU,,,Y,, 9F6516A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Blood disorder,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED TO 26 IU,,,Y,, 9F6516A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose abnormal,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED TO 26 IU,,,Y,, 9F6516A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose fluctuation,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED TO 26 IU,,,Y,, 9F6516A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Blood pressure abnormal,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED TO 26 IU,,,Y,, 9F6516A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Blood sodium decreased,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED TO 26 IU,,,Y,, 9F6516A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Cyanosis,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED TO 26 IU,,,Y,, 9F6516A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Diabetes mellitus inadequate control,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED TO 26 IU,,,Y,, 9F6516A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Fatigue,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED TO 26 IU,,,Y,, 9F6516A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Fluid retention,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED TO 26 IU,,,Y,, 9F6516A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hepatic cyst,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED TO 26 IU,,,Y,, 9F6516A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hepatic neoplasm,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED TO 26 IU,,,Y,, 9F6516A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED TO 26 IU,,,Y,, 9F6516A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Intentional product misuse,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED TO 26 IU,,,Y,, 9F6516A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Loss of consciousness,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED TO 26 IU,,,Y,, 9F6516A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Nocturia,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED TO 26 IU,,,Y,, 9F6516A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Pancreatic cyst,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED TO 26 IU,,,Y,, 9F6516A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Renal disorder,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED TO 26 IU,,,Y,, 9F6516A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Urine analysis abnormal,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED TO 26 IU,,,Y,, 9F6516A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Visual impairment,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED TO 26 IU,,,Y,, 9F6516A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Weight decreased,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED TO 26 IU,,,Y,, 9F6516A,,,26.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Weight increased,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU,,,Y,, 0F7275A,,,28.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Abdominal distension,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU,,,Y,, 0F7275A,,,28.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Benign pancreatic neoplasm,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU,,,Y,, 0F7275A,,,28.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Blood disorder,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU,,,Y,, 0F7275A,,,28.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose abnormal,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU,,,Y,, 0F7275A,,,28.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose fluctuation,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU,,,Y,, 0F7275A,,,28.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Blood pressure abnormal,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU,,,Y,, 0F7275A,,,28.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Blood sodium decreased,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU,,,Y,, 0F7275A,,,28.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Cyanosis,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU,,,Y,, 0F7275A,,,28.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Diabetes mellitus inadequate control,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU,,,Y,, 0F7275A,,,28.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Fatigue,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU,,,Y,, 0F7275A,,,28.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Fluid retention,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU,,,Y,, 0F7275A,,,28.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hepatic cyst,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU,,,Y,, 0F7275A,,,28.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hepatic neoplasm,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU,,,Y,, 0F7275A,,,28.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU,,,Y,, 0F7275A,,,28.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Intentional product misuse,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU,,,Y,, 0F7275A,,,28.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Loss of consciousness,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU,,,Y,, 0F7275A,,,28.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Nocturia,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU,,,Y,, 0F7275A,,,28.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Pancreatic cyst,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU,,,Y,, 0F7275A,,,28.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Renal disorder,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU,,,Y,, 0F7275A,,,28.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Urine analysis abnormal,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU,,,Y,, 0F7275A,,,28.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Visual impairment,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU,,,Y,, 0F7275A,,,28.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Weight decreased,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU,,,Y,, 0F7275A,,,28.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Weight increased,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 IU,,,Y,, 0F7275A,,,30.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Abdominal distension,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 IU,,,Y,, 0F7275A,,,30.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Benign pancreatic neoplasm,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 IU,,,Y,, 0F7275A,,,30.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Blood disorder,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 IU,,,Y,, 0F7275A,,,30.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose abnormal,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 IU,,,Y,, 0F7275A,,,30.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose fluctuation,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 IU,,,Y,, 0F7275A,,,30.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Blood pressure abnormal,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 IU,,,Y,, 0F7275A,,,30.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Blood sodium decreased,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 IU,,,Y,, 0F7275A,,,30.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Cyanosis,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 IU,,,Y,, 0F7275A,,,30.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Diabetes mellitus inadequate control,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 IU,,,Y,, 0F7275A,,,30.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Fatigue,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 IU,,,Y,, 0F7275A,,,30.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Fluid retention,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 IU,,,Y,, 0F7275A,,,30.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hepatic cyst,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 IU,,,Y,, 0F7275A,,,30.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hepatic neoplasm,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 IU,,,Y,, 0F7275A,,,30.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 IU,,,Y,, 0F7275A,,,30.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Intentional product misuse,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 IU,,,Y,, 0F7275A,,,30.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Loss of consciousness,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 IU,,,Y,, 0F7275A,,,30.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Nocturia,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 IU,,,Y,, 0F7275A,,,30.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Pancreatic cyst,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 IU,,,Y,, 0F7275A,,,30.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Renal disorder,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 IU,,,Y,, 0F7275A,,,30.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Urine analysis abnormal,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 IU,,,Y,, 0F7275A,,,30.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Visual impairment,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 IU,,,Y,, 0F7275A,,,30.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Weight decreased,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 IU,,,Y,, 0F7275A,,,30.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Weight increased,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 IU,,,Y,, 0F7275A,,,32.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Abdominal distension,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 IU,,,Y,, 0F7275A,,,32.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Benign pancreatic neoplasm,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 IU,,,Y,, 0F7275A,,,32.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Blood disorder,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 IU,,,Y,, 0F7275A,,,32.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose abnormal,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 IU,,,Y,, 0F7275A,,,32.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose fluctuation,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 IU,,,Y,, 0F7275A,,,32.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Blood pressure abnormal,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 IU,,,Y,, 0F7275A,,,32.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Blood sodium decreased,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 IU,,,Y,, 0F7275A,,,32.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Cyanosis,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 IU,,,Y,, 0F7275A,,,32.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Diabetes mellitus inadequate control,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 IU,,,Y,, 0F7275A,,,32.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Fatigue,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 IU,,,Y,, 0F7275A,,,32.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Fluid retention,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 IU,,,Y,, 0F7275A,,,32.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hepatic cyst,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 IU,,,Y,, 0F7275A,,,32.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hepatic neoplasm,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 IU,,,Y,, 0F7275A,,,32.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 IU,,,Y,, 0F7275A,,,32.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Intentional product misuse,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 IU,,,Y,, 0F7275A,,,32.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Loss of consciousness,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 IU,,,Y,, 0F7275A,,,32.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Nocturia,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 IU,,,Y,, 0F7275A,,,32.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Pancreatic cyst,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 IU,,,Y,, 0F7275A,,,32.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Renal disorder,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 IU,,,Y,, 0F7275A,,,32.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Urine analysis abnormal,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 IU,,,Y,, 0F7275A,,,32.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Visual impairment,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 IU,,,Y,, 0F7275A,,,32.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Weight decreased,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198470951,19847095,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 IU,,,Y,, 0F7275A,,,32.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Weight increased,,2021,Q3,1,I,20200130.0,20210902.0,20210917,20210917,EXP,,ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2021-001652,VALIDUS,,83.0,YR,,M,Y,68.0,KG,20210917.0,,CN,US,ES,2021,Q3,Elderly
198471711,19847171,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,End stage renal disease,,2021,Q3,1,I,20210111.0,20210816.0,20210917,20210917,EXP,,JP-GILEAD-2021-0544694,GILEAD,,49.0,YR,A,F,Y,79.1,KG,20210917.0,,PH,JP,JP,2021,Q3,Adult
198471711,19847171,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q3,Renal impairment,,2021,Q3,1,I,20210111.0,20210816.0,20210917,20210917,EXP,,JP-GILEAD-2021-0544694,GILEAD,,49.0,YR,A,F,Y,79.1,KG,20210917.0,,PH,JP,JP,2021,Q3,Adult
198496321,19849632,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEME,,,,,,,,,,,,2021,Q3,Anaemia,,2021,Q3,1,I,,20210903.0,20210917,20210917,EXP,DE-ADRED-07152-03,DE-PFIZER INC-202101149149,PFIZER,,69.0,YR,,F,Y,91.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198496321,19849632,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEME,,,,,,,,,,,,2021,Q3,Chills,,2021,Q3,1,I,,20210903.0,20210917,20210917,EXP,DE-ADRED-07152-03,DE-PFIZER INC-202101149149,PFIZER,,69.0,YR,,F,Y,91.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198496321,19849632,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEME,,,,,,,,,,,,2021,Q3,Condition aggravated,,2021,Q3,1,I,,20210903.0,20210917,20210917,EXP,DE-ADRED-07152-03,DE-PFIZER INC-202101149149,PFIZER,,69.0,YR,,F,Y,91.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198496321,19849632,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEME,,,,,,,,,,,,2021,Q3,Constipation,,2021,Q3,1,I,,20210903.0,20210917,20210917,EXP,DE-ADRED-07152-03,DE-PFIZER INC-202101149149,PFIZER,,69.0,YR,,F,Y,91.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198496321,19849632,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEME,,,,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210903.0,20210917,20210917,EXP,DE-ADRED-07152-03,DE-PFIZER INC-202101149149,PFIZER,,69.0,YR,,F,Y,91.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198496321,19849632,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEME,,,,,,,,,,,,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,,20210903.0,20210917,20210917,EXP,DE-ADRED-07152-03,DE-PFIZER INC-202101149149,PFIZER,,69.0,YR,,F,Y,91.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198496321,19849632,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEME,,,,,,,,,,,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210903.0,20210917,20210917,EXP,DE-ADRED-07152-03,DE-PFIZER INC-202101149149,PFIZER,,69.0,YR,,F,Y,91.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198496321,19849632,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEME,,,,,,,,,,,,2021,Q3,Renal impairment,,2021,Q3,1,I,,20210903.0,20210917,20210917,EXP,DE-ADRED-07152-03,DE-PFIZER INC-202101149149,PFIZER,,69.0,YR,,F,Y,91.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198496321,19849632,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEME,,,,,,,,,,,,2021,Q3,Sepsis,,2021,Q3,1,I,,20210903.0,20210917,20210917,EXP,DE-ADRED-07152-03,DE-PFIZER INC-202101149149,PFIZER,,69.0,YR,,F,Y,91.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198496321,19849632,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEME,,,,,,,,,,,,2021,Q3,Systemic infection,,2021,Q3,1,I,,20210903.0,20210917,20210917,EXP,DE-ADRED-07152-03,DE-PFIZER INC-202101149149,PFIZER,,69.0,YR,,F,Y,91.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198496321,19849632,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEME,,,,,,,,,,,,2021,Q3,Tachycardia,,2021,Q3,1,I,,20210903.0,20210917,20210917,EXP,DE-ADRED-07152-03,DE-PFIZER INC-202101149149,PFIZER,,69.0,YR,,F,Y,91.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198496321,19849632,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEME,,,,,,,,,,,,2021,Q3,Tachypnoea,,2021,Q3,1,I,,20210903.0,20210917,20210917,EXP,DE-ADRED-07152-03,DE-PFIZER INC-202101149149,PFIZER,,69.0,YR,,F,Y,91.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198496321,19849632,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SCHEME,,,,,,,,,,,,2021,Q3,Weight increased,,2021,Q3,1,I,,20210903.0,20210917,20210917,EXP,DE-ADRED-07152-03,DE-PFIZER INC-202101149149,PFIZER,,69.0,YR,,F,Y,91.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198546911,19854691,6,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Electrocardiogram QT prolonged,,2021,Q3,1,I,20210918.0,,20210919,20210919,DIR,,,FDA-CTU,,79.0,YR,,F,N,61.5,KG,20210919.0,N,PH,US,US,2021,Q3,Elderly
198553531,19855353,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,, ASKED BUT UNKNOWN,,,,,SOLUTION FOR INJECTION,,2021,Q3,Abdominal pain,,2021,Q3,1,I,20210522.0,20210909.0,20210920,20210920,EXP,,FR-ROCHE-2907964,ROCHE,,59.0,YR,,M,Y,64.0,KG,20210920.0,,HP,FR,FR,2021,Q3,Adult
198553531,19855353,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,, ASKED BUT UNKNOWN,,,,,SOLUTION FOR INJECTION,,2021,Q3,Arthralgia,,2021,Q3,1,I,20210522.0,20210909.0,20210920,20210920,EXP,,FR-ROCHE-2907964,ROCHE,,59.0,YR,,M,Y,64.0,KG,20210920.0,,HP,FR,FR,2021,Q3,Adult
198553531,19855353,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,, ASKED BUT UNKNOWN,,,,,SOLUTION FOR INJECTION,,2021,Q3,Haematoma muscle,,2021,Q3,1,I,20210522.0,20210909.0,20210920,20210920,EXP,,FR-ROCHE-2907964,ROCHE,,59.0,YR,,M,Y,64.0,KG,20210920.0,,HP,FR,FR,2021,Q3,Adult
198553531,19855353,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,, ASKED BUT UNKNOWN,,,,,SOLUTION FOR INJECTION,,2021,Q3,Muscular weakness,,2021,Q3,1,I,20210522.0,20210909.0,20210920,20210920,EXP,,FR-ROCHE-2907964,ROCHE,,59.0,YR,,M,Y,64.0,KG,20210920.0,,HP,FR,FR,2021,Q3,Adult
198553531,19855353,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,, ASKED BUT UNKNOWN,,,,,SOLUTION FOR INJECTION,,2021,Q3,Pain in extremity,,2021,Q3,1,I,20210522.0,20210909.0,20210920,20210920,EXP,,FR-ROCHE-2907964,ROCHE,,59.0,YR,,M,Y,64.0,KG,20210920.0,,HP,FR,FR,2021,Q3,Adult
198553531,19855353,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,, ASKED BUT UNKNOWN,,,,,SOLUTION FOR INJECTION,,2021,Q3,Pyelocaliectasis,,2021,Q3,1,I,20210522.0,20210909.0,20210920,20210920,EXP,,FR-ROCHE-2907964,ROCHE,,59.0,YR,,M,Y,64.0,KG,20210920.0,,HP,FR,FR,2021,Q3,Adult
198553531,19855353,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,, ASKED BUT UNKNOWN,,,,,SOLUTION FOR INJECTION,,2021,Q3,Ureteric compression,,2021,Q3,1,I,20210522.0,20210909.0,20210920,20210920,EXP,,FR-ROCHE-2907964,ROCHE,,59.0,YR,,M,Y,64.0,KG,20210920.0,,HP,FR,FR,2021,Q3,Adult
198557611,19855761,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 100 INTERNATIONAL UNIT PER MILLILITRE",,,U,U,,,,,,INJECTION,,2021,Q3,Abdominal pain,,2021,Q3,1,I,20210522.0,20210908.0,20210920,20210920,EXP,,FR-MYLANLABS-2021M1063205,MYLAN,,59.0,YR,,M,Y,64.0,KG,20210920.0,,HP,FR,FR,2021,Q3,Adult
198557611,19855761,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 100 INTERNATIONAL UNIT PER MILLILITRE",,,U,U,,,,,,INJECTION,,2021,Q3,Arthralgia,,2021,Q3,1,I,20210522.0,20210908.0,20210920,20210920,EXP,,FR-MYLANLABS-2021M1063205,MYLAN,,59.0,YR,,M,Y,64.0,KG,20210920.0,,HP,FR,FR,2021,Q3,Adult
198557611,19855761,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 100 INTERNATIONAL UNIT PER MILLILITRE",,,U,U,,,,,,INJECTION,,2021,Q3,Haematoma muscle,,2021,Q3,1,I,20210522.0,20210908.0,20210920,20210920,EXP,,FR-MYLANLABS-2021M1063205,MYLAN,,59.0,YR,,M,Y,64.0,KG,20210920.0,,HP,FR,FR,2021,Q3,Adult
198557611,19855761,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 100 INTERNATIONAL UNIT PER MILLILITRE",,,U,U,,,,,,INJECTION,,2021,Q3,Muscular weakness,,2021,Q3,1,I,20210522.0,20210908.0,20210920,20210920,EXP,,FR-MYLANLABS-2021M1063205,MYLAN,,59.0,YR,,M,Y,64.0,KG,20210920.0,,HP,FR,FR,2021,Q3,Adult
198557611,19855761,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 100 INTERNATIONAL UNIT PER MILLILITRE",,,U,U,,,,,,INJECTION,,2021,Q3,Pain in extremity,,2021,Q3,1,I,20210522.0,20210908.0,20210920,20210920,EXP,,FR-MYLANLABS-2021M1063205,MYLAN,,59.0,YR,,M,Y,64.0,KG,20210920.0,,HP,FR,FR,2021,Q3,Adult
198557611,19855761,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 100 INTERNATIONAL UNIT PER MILLILITRE",,,U,U,,,,,,INJECTION,,2021,Q3,Pyelocaliectasis,,2021,Q3,1,I,20210522.0,20210908.0,20210920,20210920,EXP,,FR-MYLANLABS-2021M1063205,MYLAN,,59.0,YR,,M,Y,64.0,KG,20210920.0,,HP,FR,FR,2021,Q3,Adult
198557611,19855761,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 100 INTERNATIONAL UNIT PER MILLILITRE",,,U,U,,,,,,INJECTION,,2021,Q3,Ureteric compression,,2021,Q3,1,I,20210522.0,20210908.0,20210920,20210920,EXP,,FR-MYLANLABS-2021M1063205,MYLAN,,59.0,YR,,M,Y,64.0,KG,20210920.0,,HP,FR,FR,2021,Q3,Adult
198614351,19861435,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 IU/ML,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Abdominal pain,,2021,Q3,1,I,20210522.0,20210907.0,20210920,20210920,EXP,,FR-PFIZER INC-202101165126,PFIZER,,59.0,YR,,M,Y,64.0,KG,20210920.0,,HP,FR,FR,2021,Q3,Adult
198614351,19861435,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 IU/ML,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Arthralgia,,2021,Q3,1,I,20210522.0,20210907.0,20210920,20210920,EXP,,FR-PFIZER INC-202101165126,PFIZER,,59.0,YR,,M,Y,64.0,KG,20210920.0,,HP,FR,FR,2021,Q3,Adult
198614351,19861435,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 IU/ML,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Haematoma muscle,,2021,Q3,1,I,20210522.0,20210907.0,20210920,20210920,EXP,,FR-PFIZER INC-202101165126,PFIZER,,59.0,YR,,M,Y,64.0,KG,20210920.0,,HP,FR,FR,2021,Q3,Adult
198614351,19861435,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 IU/ML,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Muscular weakness,,2021,Q3,1,I,20210522.0,20210907.0,20210920,20210920,EXP,,FR-PFIZER INC-202101165126,PFIZER,,59.0,YR,,M,Y,64.0,KG,20210920.0,,HP,FR,FR,2021,Q3,Adult
198614351,19861435,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 IU/ML,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Pain in extremity,,2021,Q3,1,I,20210522.0,20210907.0,20210920,20210920,EXP,,FR-PFIZER INC-202101165126,PFIZER,,59.0,YR,,M,Y,64.0,KG,20210920.0,,HP,FR,FR,2021,Q3,Adult
198614351,19861435,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 IU/ML,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Pyelocaliectasis,,2021,Q3,1,I,20210522.0,20210907.0,20210920,20210920,EXP,,FR-PFIZER INC-202101165126,PFIZER,,59.0,YR,,M,Y,64.0,KG,20210920.0,,HP,FR,FR,2021,Q3,Adult
198614351,19861435,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 IU/ML,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Ureteric compression,,2021,Q3,1,I,20210522.0,20210907.0,20210920,20210920,EXP,,FR-PFIZER INC-202101165126,PFIZER,,59.0,YR,,M,Y,64.0,KG,20210920.0,,HP,FR,FR,2021,Q3,Adult
198647341,19864734,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UI CADA 24 HORAS,,,,,,,,,,,,2021,Q3,Atrioventricular block,Atrioventricular block,2021,Q3,1,I,20210117.0,20210906.0,20210921,20210921,EXP,ES-AEMPS-985120,ES-ALVOGEN-2021-ALVOGEN-117524,ALVOGEN,,79.0,YR,,M,Y,,,20210921.0,,MD,ES,ES,2021,Q3,Elderly
198647341,19864734,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UI CADA 24 HORAS,,,,,,,,,,,,2021,Q3,Syncope,Syncope,2021,Q3,1,I,20210117.0,20210906.0,20210921,20210921,EXP,ES-AEMPS-985120,ES-ALVOGEN-2021-ALVOGEN-117524,ALVOGEN,,79.0,YR,,M,Y,,,20210921.0,,MD,ES,ES,2021,Q3,Elderly
198650922,19865092,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"8 U, QD",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2021,Q3,Altered state of consciousness,,2021,Q3,2,F,,20210927.0,20210921,20210930,EXP,,JP-SA-2021SA309843,SANOFI AVENTIS,"SUGITO E, TSUJIMOTO T, ARAI N, BOUCHI R, OHSUGI M, TANABE A ET AL.. LEFT HEMIPLEGIA POSSIBLY DUE TO GLUCOSE REPERFUSION INJURY AFTER RECOVERY OF SEVERE HYPOGLYCEMIA IN A WOMAN WITH TYPE 2 DIABETES MELLITUS.. INTERNAL MEDICINE (TOKYO, JAPAN). 2021?UNKNOWN:UNKNOWN",79.0,YR,E,F,Y,,,20210930.0,,HP,JP,JP,2021,Q3,Elderly
198650922,19865092,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"8 U, QD",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2021,Q3,Eye movement disorder,,2021,Q3,2,F,,20210927.0,20210921,20210930,EXP,,JP-SA-2021SA309843,SANOFI AVENTIS,"SUGITO E, TSUJIMOTO T, ARAI N, BOUCHI R, OHSUGI M, TANABE A ET AL.. LEFT HEMIPLEGIA POSSIBLY DUE TO GLUCOSE REPERFUSION INJURY AFTER RECOVERY OF SEVERE HYPOGLYCEMIA IN A WOMAN WITH TYPE 2 DIABETES MELLITUS.. INTERNAL MEDICINE (TOKYO, JAPAN). 2021?UNKNOWN:UNKNOWN",79.0,YR,E,F,Y,,,20210930.0,,HP,JP,JP,2021,Q3,Elderly
198650922,19865092,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"8 U, QD",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2021,Q3,Hemiplegia,,2021,Q3,2,F,,20210927.0,20210921,20210930,EXP,,JP-SA-2021SA309843,SANOFI AVENTIS,"SUGITO E, TSUJIMOTO T, ARAI N, BOUCHI R, OHSUGI M, TANABE A ET AL.. LEFT HEMIPLEGIA POSSIBLY DUE TO GLUCOSE REPERFUSION INJURY AFTER RECOVERY OF SEVERE HYPOGLYCEMIA IN A WOMAN WITH TYPE 2 DIABETES MELLITUS.. INTERNAL MEDICINE (TOKYO, JAPAN). 2021?UNKNOWN:UNKNOWN",79.0,YR,E,F,Y,,,20210930.0,,HP,JP,JP,2021,Q3,Elderly
198650922,19865092,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"8 U, QD",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2021,Q3,Hypoglycaemic encephalopathy,,2021,Q3,2,F,,20210927.0,20210921,20210930,EXP,,JP-SA-2021SA309843,SANOFI AVENTIS,"SUGITO E, TSUJIMOTO T, ARAI N, BOUCHI R, OHSUGI M, TANABE A ET AL.. LEFT HEMIPLEGIA POSSIBLY DUE TO GLUCOSE REPERFUSION INJURY AFTER RECOVERY OF SEVERE HYPOGLYCEMIA IN A WOMAN WITH TYPE 2 DIABETES MELLITUS.. INTERNAL MEDICINE (TOKYO, JAPAN). 2021?UNKNOWN:UNKNOWN",79.0,YR,E,F,Y,,,20210930.0,,HP,JP,JP,2021,Q3,Elderly
198650922,19865092,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"8 U, QD",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2021,Q3,Reperfusion injury,,2021,Q3,2,F,,20210927.0,20210921,20210930,EXP,,JP-SA-2021SA309843,SANOFI AVENTIS,"SUGITO E, TSUJIMOTO T, ARAI N, BOUCHI R, OHSUGI M, TANABE A ET AL.. LEFT HEMIPLEGIA POSSIBLY DUE TO GLUCOSE REPERFUSION INJURY AFTER RECOVERY OF SEVERE HYPOGLYCEMIA IN A WOMAN WITH TYPE 2 DIABETES MELLITUS.. INTERNAL MEDICINE (TOKYO, JAPAN). 2021?UNKNOWN:UNKNOWN",79.0,YR,E,F,Y,,,20210930.0,,HP,JP,JP,2021,Q3,Elderly
198650922,19865092,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"8 U, QD",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2021,Q3,Unresponsive to stimuli,,2021,Q3,2,F,,20210927.0,20210921,20210930,EXP,,JP-SA-2021SA309843,SANOFI AVENTIS,"SUGITO E, TSUJIMOTO T, ARAI N, BOUCHI R, OHSUGI M, TANABE A ET AL.. LEFT HEMIPLEGIA POSSIBLY DUE TO GLUCOSE REPERFUSION INJURY AFTER RECOVERY OF SEVERE HYPOGLYCEMIA IN A WOMAN WITH TYPE 2 DIABETES MELLITUS.. INTERNAL MEDICINE (TOKYO, JAPAN). 2021?UNKNOWN:UNKNOWN",79.0,YR,E,F,Y,,,20210930.0,,HP,JP,JP,2021,Q3,Elderly
198656411,19865641,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,IU  DAILY,,,,, UNKNOWN,,,,,,,2021,Q3,Urinary tract infection,,2021,Q3,1,I,20190815.0,20210913.0,20210921,20210921,EXP,,DE-FRESENIUS KABI-FK202109984,FRESENIUS KABI,,74.0,YR,,F,Y,,,20210921.0,,HP,NL,DE,2021,Q3,Elderly
198684821,19868482,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Exposure via body fluid,,2021,Q3,1,I,20210617.0,20210211.0,20210921,20210921,EXP,,AU-GILEAD-2021-0517396,GILEAD,,30.0,YR,A,F,Y,51.9,KG,20210921.0,,PH,AU,AU,2021,Q3,Young Adult
198684821,19868482,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Foetal distress syndrome,,2021,Q3,1,I,20210617.0,20210211.0,20210921,20210921,EXP,,AU-GILEAD-2021-0517396,GILEAD,,30.0,YR,A,F,Y,51.9,KG,20210921.0,,PH,AU,AU,2021,Q3,Young Adult
198684821,19868482,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Maternal exposure during pregnancy,,2021,Q3,1,I,20210617.0,20210211.0,20210921,20210921,EXP,,AU-GILEAD-2021-0517396,GILEAD,,30.0,YR,A,F,Y,51.9,KG,20210921.0,,PH,AU,AU,2021,Q3,Young Adult
198684821,19868482,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Placental disorder,,2021,Q3,1,I,20210617.0,20210211.0,20210921,20210921,EXP,,AU-GILEAD-2021-0517396,GILEAD,,30.0,YR,A,F,Y,51.9,KG,20210921.0,,PH,AU,AU,2021,Q3,Young Adult
198684821,19868482,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Premature labour,,2021,Q3,1,I,20210617.0,20210211.0,20210921,20210921,EXP,,AU-GILEAD-2021-0517396,GILEAD,,30.0,YR,A,F,Y,51.9,KG,20210921.0,,PH,AU,AU,2021,Q3,Young Adult
198727181,19872718,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,21081.0,,,,QD,2021,Q3,Asthma,,2021,Q3,1,I,,20210920.0,20210922,20210922,EXP,,CA-SA-2021SA312571,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210922.0,,CN,CA,CA,2021,Q3,Elderly
198727181,19872718,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,21081.0,,,,QD,2021,Q3,Condition aggravated,,2021,Q3,1,I,,20210920.0,20210922,20210922,EXP,,CA-SA-2021SA312571,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210922.0,,CN,CA,CA,2021,Q3,Elderly
198727181,19872718,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,21081.0,,,,QD,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20210920.0,20210922,20210922,EXP,,CA-SA-2021SA312571,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210922.0,,CN,CA,CA,2021,Q3,Elderly
198727181,19872718,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,21081.0,,,,QD,2021,Q3,Haemoptysis,,2021,Q3,1,I,,20210920.0,20210922,20210922,EXP,,CA-SA-2021SA312571,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210922.0,,CN,CA,CA,2021,Q3,Elderly
198727181,19872718,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,21081.0,,,,QD,2021,Q3,Loss of personal independence in daily activities,,2021,Q3,1,I,,20210920.0,20210922,20210922,EXP,,CA-SA-2021SA312571,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210922.0,,CN,CA,CA,2021,Q3,Elderly
198727181,19872718,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,21081.0,,,,QD,2021,Q3,Lung disorder,,2021,Q3,1,I,,20210920.0,20210922,20210922,EXP,,CA-SA-2021SA312571,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210922.0,,CN,CA,CA,2021,Q3,Elderly
198727181,19872718,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,21081.0,,,,QD,2021,Q3,Neuritis,,2021,Q3,1,I,,20210920.0,20210922,20210922,EXP,,CA-SA-2021SA312571,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210922.0,,CN,CA,CA,2021,Q3,Elderly
198727181,19872718,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,21081.0,,,,QD,2021,Q3,Neurological symptom,,2021,Q3,1,I,,20210920.0,20210922,20210922,EXP,,CA-SA-2021SA312571,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210922.0,,CN,CA,CA,2021,Q3,Elderly
198727181,19872718,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,21081.0,,,,QD,2021,Q3,Obstructive airways disorder,,2021,Q3,1,I,,20210920.0,20210922,20210922,EXP,,CA-SA-2021SA312571,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210922.0,,CN,CA,CA,2021,Q3,Elderly
198727181,19872718,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,21081.0,,,,QD,2021,Q3,Pain in extremity,,2021,Q3,1,I,,20210920.0,20210922,20210922,EXP,,CA-SA-2021SA312571,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210922.0,,CN,CA,CA,2021,Q3,Elderly
198727181,19872718,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,21081.0,,,,QD,2021,Q3,Pulmonary alveolar haemorrhage,,2021,Q3,1,I,,20210920.0,20210922,20210922,EXP,,CA-SA-2021SA312571,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210922.0,,CN,CA,CA,2021,Q3,Elderly
198727181,19872718,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,21081.0,,,,QD,2021,Q3,Pulmonary fibrosis,,2021,Q3,1,I,,20210920.0,20210922,20210922,EXP,,CA-SA-2021SA312571,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210922.0,,CN,CA,CA,2021,Q3,Elderly
198727181,19872718,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,21081.0,,,,QD,2021,Q3,Pulmonary vasculitis,,2021,Q3,1,I,,20210920.0,20210922,20210922,EXP,,CA-SA-2021SA312571,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210922.0,,CN,CA,CA,2021,Q3,Elderly
198727181,19872718,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,21081.0,,,,QD,2021,Q3,Respiratory symptom,,2021,Q3,1,I,,20210920.0,20210922,20210922,EXP,,CA-SA-2021SA312571,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210922.0,,CN,CA,CA,2021,Q3,Elderly
198727181,19872718,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,21081.0,,,,QD,2021,Q3,Sleep disorder due to a general medical condition,,2021,Q3,1,I,,20210920.0,20210922,20210922,EXP,,CA-SA-2021SA312571,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210922.0,,CN,CA,CA,2021,Q3,Elderly
198727181,19872718,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,21081.0,,,,QD,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,1,I,,20210920.0,20210922,20210922,EXP,,CA-SA-2021SA312571,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210922.0,,CN,CA,CA,2021,Q3,Elderly
198727181,19872718,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,21081.0,,,,QD,2021,Q3,Vasculitis,,2021,Q3,1,I,,20210920.0,20210922,20210922,EXP,,CA-SA-2021SA312571,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210922.0,,CN,CA,CA,2021,Q3,Elderly
198727181,19872718,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,U,,,,21081.0,,,,QD,2021,Q3,Wheezing,,2021,Q3,1,I,,20210920.0,20210922,20210922,EXP,,CA-SA-2021SA312571,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210922.0,,CN,CA,CA,2021,Q3,Elderly
198755781,19875578,10,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Abdominal pain,,2021,Q3,1,I,,20210914.0,20210924,20210924,EXP,,CA-AUROBINDO-AUR-APL-2021-039611,AUROBINDO,,78.0,YR,,M,Y,86.0,KG,20210924.0,,PH,CA,CA,2021,Q3,Elderly
198755781,19875578,10,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Clostridium test positive,,2021,Q3,1,I,,20210914.0,20210924,20210924,EXP,,CA-AUROBINDO-AUR-APL-2021-039611,AUROBINDO,,78.0,YR,,M,Y,86.0,KG,20210924.0,,PH,CA,CA,2021,Q3,Elderly
198755781,19875578,10,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Decreased appetite,,2021,Q3,1,I,,20210914.0,20210924,20210924,EXP,,CA-AUROBINDO-AUR-APL-2021-039611,AUROBINDO,,78.0,YR,,M,Y,86.0,KG,20210924.0,,PH,CA,CA,2021,Q3,Elderly
198755781,19875578,10,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210914.0,20210924,20210924,EXP,,CA-AUROBINDO-AUR-APL-2021-039611,AUROBINDO,,78.0,YR,,M,Y,86.0,KG,20210924.0,,PH,CA,CA,2021,Q3,Elderly
198755781,19875578,10,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Frequent bowel movements,,2021,Q3,1,I,,20210914.0,20210924,20210924,EXP,,CA-AUROBINDO-AUR-APL-2021-039611,AUROBINDO,,78.0,YR,,M,Y,86.0,KG,20210924.0,,PH,CA,CA,2021,Q3,Elderly
198781001,19878100,15,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,1 DOSAGE FORM,,,U,U,,,,1.0,DF,,,2021,Q3,Asthma,,2021,Q3,1,I,,20210914.0,20210924,20210924,EXP,,CA-AUROBINDO-AUR-APL-2021-039563,AUROBINDO,,65.0,YR,,M,Y,,,20210924.0,,CN,CA,CA,2021,Q3,Elderly
198781001,19878100,15,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,1 DOSAGE FORM,,,U,U,,,,1.0,DF,,,2021,Q3,Condition aggravated,,2021,Q3,1,I,,20210914.0,20210924,20210924,EXP,,CA-AUROBINDO-AUR-APL-2021-039563,AUROBINDO,,65.0,YR,,M,Y,,,20210924.0,,CN,CA,CA,2021,Q3,Elderly
198781001,19878100,15,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,1 DOSAGE FORM,,,U,U,,,,1.0,DF,,,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20210914.0,20210924,20210924,EXP,,CA-AUROBINDO-AUR-APL-2021-039563,AUROBINDO,,65.0,YR,,M,Y,,,20210924.0,,CN,CA,CA,2021,Q3,Elderly
198781001,19878100,15,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,1 DOSAGE FORM,,,U,U,,,,1.0,DF,,,2021,Q3,Haemoptysis,,2021,Q3,1,I,,20210914.0,20210924,20210924,EXP,,CA-AUROBINDO-AUR-APL-2021-039563,AUROBINDO,,65.0,YR,,M,Y,,,20210924.0,,CN,CA,CA,2021,Q3,Elderly
198781001,19878100,15,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,1 DOSAGE FORM,,,U,U,,,,1.0,DF,,,2021,Q3,Loss of personal independence in daily activities,,2021,Q3,1,I,,20210914.0,20210924,20210924,EXP,,CA-AUROBINDO-AUR-APL-2021-039563,AUROBINDO,,65.0,YR,,M,Y,,,20210924.0,,CN,CA,CA,2021,Q3,Elderly
198781001,19878100,15,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,1 DOSAGE FORM,,,U,U,,,,1.0,DF,,,2021,Q3,Lung disorder,,2021,Q3,1,I,,20210914.0,20210924,20210924,EXP,,CA-AUROBINDO-AUR-APL-2021-039563,AUROBINDO,,65.0,YR,,M,Y,,,20210924.0,,CN,CA,CA,2021,Q3,Elderly
198781001,19878100,15,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,1 DOSAGE FORM,,,U,U,,,,1.0,DF,,,2021,Q3,Neuritis,,2021,Q3,1,I,,20210914.0,20210924,20210924,EXP,,CA-AUROBINDO-AUR-APL-2021-039563,AUROBINDO,,65.0,YR,,M,Y,,,20210924.0,,CN,CA,CA,2021,Q3,Elderly
198781001,19878100,15,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,1 DOSAGE FORM,,,U,U,,,,1.0,DF,,,2021,Q3,Neurological symptom,,2021,Q3,1,I,,20210914.0,20210924,20210924,EXP,,CA-AUROBINDO-AUR-APL-2021-039563,AUROBINDO,,65.0,YR,,M,Y,,,20210924.0,,CN,CA,CA,2021,Q3,Elderly
198781001,19878100,15,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,1 DOSAGE FORM,,,U,U,,,,1.0,DF,,,2021,Q3,Obstructive airways disorder,,2021,Q3,1,I,,20210914.0,20210924,20210924,EXP,,CA-AUROBINDO-AUR-APL-2021-039563,AUROBINDO,,65.0,YR,,M,Y,,,20210924.0,,CN,CA,CA,2021,Q3,Elderly
198781001,19878100,15,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,1 DOSAGE FORM,,,U,U,,,,1.0,DF,,,2021,Q3,Pain in extremity,,2021,Q3,1,I,,20210914.0,20210924,20210924,EXP,,CA-AUROBINDO-AUR-APL-2021-039563,AUROBINDO,,65.0,YR,,M,Y,,,20210924.0,,CN,CA,CA,2021,Q3,Elderly
198781001,19878100,15,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,1 DOSAGE FORM,,,U,U,,,,1.0,DF,,,2021,Q3,Pulmonary alveolar haemorrhage,,2021,Q3,1,I,,20210914.0,20210924,20210924,EXP,,CA-AUROBINDO-AUR-APL-2021-039563,AUROBINDO,,65.0,YR,,M,Y,,,20210924.0,,CN,CA,CA,2021,Q3,Elderly
198781001,19878100,15,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,1 DOSAGE FORM,,,U,U,,,,1.0,DF,,,2021,Q3,Pulmonary fibrosis,,2021,Q3,1,I,,20210914.0,20210924,20210924,EXP,,CA-AUROBINDO-AUR-APL-2021-039563,AUROBINDO,,65.0,YR,,M,Y,,,20210924.0,,CN,CA,CA,2021,Q3,Elderly
198781001,19878100,15,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,1 DOSAGE FORM,,,U,U,,,,1.0,DF,,,2021,Q3,Pulmonary vasculitis,,2021,Q3,1,I,,20210914.0,20210924,20210924,EXP,,CA-AUROBINDO-AUR-APL-2021-039563,AUROBINDO,,65.0,YR,,M,Y,,,20210924.0,,CN,CA,CA,2021,Q3,Elderly
198781001,19878100,15,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,1 DOSAGE FORM,,,U,U,,,,1.0,DF,,,2021,Q3,Respiratory symptom,,2021,Q3,1,I,,20210914.0,20210924,20210924,EXP,,CA-AUROBINDO-AUR-APL-2021-039563,AUROBINDO,,65.0,YR,,M,Y,,,20210924.0,,CN,CA,CA,2021,Q3,Elderly
198781001,19878100,15,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,1 DOSAGE FORM,,,U,U,,,,1.0,DF,,,2021,Q3,Sleep disorder due to a general medical condition,,2021,Q3,1,I,,20210914.0,20210924,20210924,EXP,,CA-AUROBINDO-AUR-APL-2021-039563,AUROBINDO,,65.0,YR,,M,Y,,,20210924.0,,CN,CA,CA,2021,Q3,Elderly
198781001,19878100,15,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,1 DOSAGE FORM,,,U,U,,,,1.0,DF,,,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,1,I,,20210914.0,20210924,20210924,EXP,,CA-AUROBINDO-AUR-APL-2021-039563,AUROBINDO,,65.0,YR,,M,Y,,,20210924.0,,CN,CA,CA,2021,Q3,Elderly
198781001,19878100,15,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,1 DOSAGE FORM,,,U,U,,,,1.0,DF,,,2021,Q3,Vasculitis,,2021,Q3,1,I,,20210914.0,20210924,20210924,EXP,,CA-AUROBINDO-AUR-APL-2021-039563,AUROBINDO,,65.0,YR,,M,Y,,,20210924.0,,CN,CA,CA,2021,Q3,Elderly
198781001,19878100,15,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,1 DOSAGE FORM,,,U,U,,,,1.0,DF,,,2021,Q3,Wheezing,,2021,Q3,1,I,,20210914.0,20210924,20210924,EXP,,CA-AUROBINDO-AUR-APL-2021-039563,AUROBINDO,,65.0,YR,,M,Y,,,20210924.0,,CN,CA,CA,2021,Q3,Elderly
198783181,19878318,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, 0?0?0?1, PRE?FILLED SYRINGES",,,U,,,,,,,,,2021,Q3,Foot amputation,,2021,Q3,1,I,20200922.0,20210916.0,20210924,20210924,EXP,,DE-009507513-2109DEU004147,MERCK,,71.0,YR,,M,Y,93.0,KG,20210924.0,,PH,DE,DE,2021,Q3,Elderly
198783181,19878318,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, 0?0?0?1, PRE?FILLED SYRINGES",,,U,,,,,,,,,2021,Q3,Wound dehiscence,,2021,Q3,1,I,20200922.0,20210916.0,20210924,20210924,EXP,,DE-009507513-2109DEU004147,MERCK,,71.0,YR,,M,Y,93.0,KG,20210924.0,,PH,DE,DE,2021,Q3,Elderly
198805301,19880530,6,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"12 INTERNATIONAL UNIT, QD",,,,,,,,12.0,IU,,QD,2021,Q3,Febrile neutropenia,,2021,Q3,1,I,20210904.0,20210915.0,20210924,20210924,EXP,,US-TAKEDA-2021TUS057379,TAKEDA,,67.0,YR,,M,Y,97.6,KG,20210924.0,,MD,US,US,2021,Q3,Elderly
198811021,19881102,1,PS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,Subcutaneous,"30 INTERNATIONAL UNIT, BID",,,,, BF20002498,,210605.0,30.0,IU,INJECTION,BID,2021,Q3,Device breakage,,2021,Q3,1,I,20210829.0,20210831.0,20210924,20210924,PER,,US-MYLANLABS-2021M1058041,MYLAN,,43.0,YR,,M,Y,,,20210924.0,,CN,US,US,2021,Q3,Adult
198811021,19881102,1,PS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,Subcutaneous,"30 INTERNATIONAL UNIT, BID",,,,, BF20002498,,210605.0,30.0,IU,INJECTION,BID,2021,Q3,Off label use,,2021,Q3,1,I,20210829.0,20210831.0,20210924,20210924,PER,,US-MYLANLABS-2021M1058041,MYLAN,,43.0,YR,,M,Y,,,20210924.0,,CN,US,US,2021,Q3,Adult
198811021,19881102,1,PS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,Subcutaneous,"30 INTERNATIONAL UNIT, BID",,,,, BF20002498,,210605.0,30.0,IU,INJECTION,BID,2021,Q3,Product storage error,,2021,Q3,1,I,20210829.0,20210831.0,20210924,20210924,PER,,US-MYLANLABS-2021M1058041,MYLAN,,43.0,YR,,M,Y,,,20210924.0,,CN,US,US,2021,Q3,Adult
198832401,19883240,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Arteriosclerosis,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Arthralgia,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Ataxia,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Back pain,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Bladder dilatation,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Blood glucose abnormal,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Carotid artery stenosis,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Cholelithiasis,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Cough,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Cystitis,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Diarrhoea,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Disturbance in attention,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Dizziness,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Dysphagia,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Fall,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Fatigue,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Insomnia,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Ischaemic stroke,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Joint effusion,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Leukocytosis,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Mastoiditis,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Nephrolithiasis,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Orthostatic hypotension,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Pain,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Pain in extremity,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Rehabilitation therapy,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Renal cyst,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Renal hamartoma,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Renal mass,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Restless legs syndrome,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Sinusitis,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Therapy interrupted,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Urinary tract infection,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Vascular calcification,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN EVERY MORNING,,,,,,,,,,INJECTION,,2021,Q3,Arteriosclerosis,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN EVERY MORNING,,,,,,,,,,INJECTION,,2021,Q3,Arthralgia,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN EVERY MORNING,,,,,,,,,,INJECTION,,2021,Q3,Ataxia,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN EVERY MORNING,,,,,,,,,,INJECTION,,2021,Q3,Back pain,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN EVERY MORNING,,,,,,,,,,INJECTION,,2021,Q3,Bladder dilatation,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN EVERY MORNING,,,,,,,,,,INJECTION,,2021,Q3,Blood glucose abnormal,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN EVERY MORNING,,,,,,,,,,INJECTION,,2021,Q3,Carotid artery stenosis,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN EVERY MORNING,,,,,,,,,,INJECTION,,2021,Q3,Cholelithiasis,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN EVERY MORNING,,,,,,,,,,INJECTION,,2021,Q3,Cough,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN EVERY MORNING,,,,,,,,,,INJECTION,,2021,Q3,Cystitis,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN EVERY MORNING,,,,,,,,,,INJECTION,,2021,Q3,Diarrhoea,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN EVERY MORNING,,,,,,,,,,INJECTION,,2021,Q3,Disturbance in attention,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN EVERY MORNING,,,,,,,,,,INJECTION,,2021,Q3,Dizziness,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN EVERY MORNING,,,,,,,,,,INJECTION,,2021,Q3,Dysphagia,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN EVERY MORNING,,,,,,,,,,INJECTION,,2021,Q3,Fall,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN EVERY MORNING,,,,,,,,,,INJECTION,,2021,Q3,Fatigue,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN EVERY MORNING,,,,,,,,,,INJECTION,,2021,Q3,Insomnia,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN EVERY MORNING,,,,,,,,,,INJECTION,,2021,Q3,Ischaemic stroke,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN EVERY MORNING,,,,,,,,,,INJECTION,,2021,Q3,Joint effusion,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN EVERY MORNING,,,,,,,,,,INJECTION,,2021,Q3,Leukocytosis,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN EVERY MORNING,,,,,,,,,,INJECTION,,2021,Q3,Mastoiditis,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN EVERY MORNING,,,,,,,,,,INJECTION,,2021,Q3,Nephrolithiasis,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN EVERY MORNING,,,,,,,,,,INJECTION,,2021,Q3,Orthostatic hypotension,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN EVERY MORNING,,,,,,,,,,INJECTION,,2021,Q3,Pain,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN EVERY MORNING,,,,,,,,,,INJECTION,,2021,Q3,Pain in extremity,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN EVERY MORNING,,,,,,,,,,INJECTION,,2021,Q3,Rehabilitation therapy,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN EVERY MORNING,,,,,,,,,,INJECTION,,2021,Q3,Renal cyst,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN EVERY MORNING,,,,,,,,,,INJECTION,,2021,Q3,Renal hamartoma,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN EVERY MORNING,,,,,,,,,,INJECTION,,2021,Q3,Renal mass,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN EVERY MORNING,,,,,,,,,,INJECTION,,2021,Q3,Restless legs syndrome,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN EVERY MORNING,,,,,,,,,,INJECTION,,2021,Q3,Sinusitis,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN EVERY MORNING,,,,,,,,,,INJECTION,,2021,Q3,Therapy interrupted,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN EVERY MORNING,,,,,,,,,,INJECTION,,2021,Q3,Urinary tract infection,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 22 UNITS INTO THE SKIN EVERY MORNING,,,,,,,,,,INJECTION,,2021,Q3,Vascular calcification,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 24 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Arteriosclerosis,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 24 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Arthralgia,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 24 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Ataxia,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 24 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Back pain,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 24 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Bladder dilatation,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 24 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Blood glucose abnormal,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 24 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Carotid artery stenosis,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 24 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Cholelithiasis,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 24 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Cough,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 24 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Cystitis,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 24 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Diarrhoea,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 24 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Disturbance in attention,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 24 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Dizziness,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 24 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Dysphagia,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 24 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Fall,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 24 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Fatigue,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 24 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Insomnia,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 24 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Ischaemic stroke,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 24 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Joint effusion,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 24 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Leukocytosis,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 24 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Mastoiditis,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 24 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Nephrolithiasis,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 24 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Orthostatic hypotension,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 24 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Pain,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 24 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Pain in extremity,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 24 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Rehabilitation therapy,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 24 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Renal cyst,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 24 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Renal hamartoma,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 24 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Renal mass,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 24 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Restless legs syndrome,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 24 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Sinusitis,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 24 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Therapy interrupted,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 24 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Urinary tract infection,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198832401,19883240,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,INJECT 24 UNITS INTO THE SKIN NIGHTLY AT BEDTIME,,,,,,,,,,INJECTION,,2021,Q3,Vascular calcification,,2021,Q3,1,I,2021.0,20210827.0,20210926,20210926,EXP,,US-INTERCEPT-PM2021002654,INTERCEPT PHARMACEUTICALS,,60.0,YR,,F,Y,53.6,KG,20210926.0,,HP,US,US,2021,Q3,Adult
198844021,19884402,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,1.0,DF,,,2021,Q3,Drug ineffective for unapproved indication,,2021,Q3,1,I,,20210921.0,20210927,20210927,EXP,,CA-ROCHE-2918049,ROCHE,,68.0,YR,,M,Y,,,20210927.0,,HP,CA,CA,2021,Q3,Elderly
198844021,19884402,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,1.0,DF,,,2021,Q3,End stage renal disease,,2021,Q3,1,I,,20210921.0,20210927,20210927,EXP,,CA-ROCHE-2918049,ROCHE,,68.0,YR,,M,Y,,,20210927.0,,HP,CA,CA,2021,Q3,Elderly
198853211,19885321,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Adverse event,,2021,Q3,1,I,,20210921.0,20210927,20210927,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-096854,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,,,20210927.0,,CN,US,US,2021,Q3,Elderly
198853211,19885321,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Intentional product use issue,,2021,Q3,1,I,,20210921.0,20210927,20210927,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-096854,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,,,20210927.0,,CN,US,US,2021,Q3,Elderly
198859311,19885931,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,8.0,IU,,,2021,Q3,Hemiplegia,,2021,Q3,1,I,,20210917.0,20210927,20210927,EXP,,JP-ACCORD-239469,ACCORD,"SUGITO E, TSUJIMOTO T, ARAI N, BOUCHI R, OHSUGI M, TANABE A ET AL. LEFT HEMIPLEGIA POSSIBLY DUE TO GLUCOSE REPERFUSION INJURY AFTER RECOVERY OF SEVERE HYPOGLYCEMIA IN A WOMAN WITH TYPE 2 DIABETES MELLITUS. INTERNAL MEDICINE (TOKYO, JAPAN). 2021. DOI:10.2169/INTERNALMEDICINE.7202?21",79.0,YR,,F,Y,,,20210927.0,,MD,JP,JP,2021,Q3,Elderly
198859311,19885931,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,8.0,IU,,,2021,Q3,Hypoglycaemic encephalopathy,,2021,Q3,1,I,,20210917.0,20210927,20210927,EXP,,JP-ACCORD-239469,ACCORD,"SUGITO E, TSUJIMOTO T, ARAI N, BOUCHI R, OHSUGI M, TANABE A ET AL. LEFT HEMIPLEGIA POSSIBLY DUE TO GLUCOSE REPERFUSION INJURY AFTER RECOVERY OF SEVERE HYPOGLYCEMIA IN A WOMAN WITH TYPE 2 DIABETES MELLITUS. INTERNAL MEDICINE (TOKYO, JAPAN). 2021. DOI:10.2169/INTERNALMEDICINE.7202?21",79.0,YR,,F,Y,,,20210927.0,,MD,JP,JP,2021,Q3,Elderly
198859311,19885931,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,8.0,IU,,,2021,Q3,Reperfusion injury,,2021,Q3,1,I,,20210917.0,20210927,20210927,EXP,,JP-ACCORD-239469,ACCORD,"SUGITO E, TSUJIMOTO T, ARAI N, BOUCHI R, OHSUGI M, TANABE A ET AL. LEFT HEMIPLEGIA POSSIBLY DUE TO GLUCOSE REPERFUSION INJURY AFTER RECOVERY OF SEVERE HYPOGLYCEMIA IN A WOMAN WITH TYPE 2 DIABETES MELLITUS. INTERNAL MEDICINE (TOKYO, JAPAN). 2021. DOI:10.2169/INTERNALMEDICINE.7202?21",79.0,YR,,F,Y,,,20210927.0,,MD,JP,JP,2021,Q3,Elderly
198859311,19885931,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,8.0,IU,,,2021,Q3,Unresponsive to stimuli,,2021,Q3,1,I,,20210917.0,20210927,20210927,EXP,,JP-ACCORD-239469,ACCORD,"SUGITO E, TSUJIMOTO T, ARAI N, BOUCHI R, OHSUGI M, TANABE A ET AL. LEFT HEMIPLEGIA POSSIBLY DUE TO GLUCOSE REPERFUSION INJURY AFTER RECOVERY OF SEVERE HYPOGLYCEMIA IN A WOMAN WITH TYPE 2 DIABETES MELLITUS. INTERNAL MEDICINE (TOKYO, JAPAN). 2021. DOI:10.2169/INTERNALMEDICINE.7202?21",79.0,YR,,F,Y,,,20210927.0,,MD,JP,JP,2021,Q3,Elderly
198872211,19887221,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,21081.0,,,,,2021,Q3,Renal disorder,,2021,Q3,1,I,,20210920.0,20210928,20210928,EXP,,CA-SA-2021SA311449,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20210928.0,,PH,CA,CA,2021,Q3,Adult
198878971,19887897,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,21081.0,,,,,2021,Q3,Abdominal pain upper,,2021,Q3,1,I,,20210920.0,20210928,20210928,EXP,,CA-SA-2021SA312580,SANOFI AVENTIS,,13.0,YR,T,F,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Child
198878971,19887897,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,21081.0,,,,,2021,Q3,Blood glucose increased,,2021,Q3,1,I,,20210920.0,20210928,20210928,EXP,,CA-SA-2021SA312580,SANOFI AVENTIS,,13.0,YR,T,F,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Child
198878971,19887897,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,21081.0,,,,,2021,Q3,Dizziness,,2021,Q3,1,I,,20210920.0,20210928,20210928,EXP,,CA-SA-2021SA312580,SANOFI AVENTIS,,13.0,YR,T,F,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Child
198878971,19887897,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,21081.0,,,,,2021,Q3,Drug ineffective,,2021,Q3,1,I,,20210920.0,20210928,20210928,EXP,,CA-SA-2021SA312580,SANOFI AVENTIS,,13.0,YR,T,F,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Child
198878971,19887897,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,21081.0,,,,,2021,Q3,Feeling hot,,2021,Q3,1,I,,20210920.0,20210928,20210928,EXP,,CA-SA-2021SA312580,SANOFI AVENTIS,,13.0,YR,T,F,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Child
198878971,19887897,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,21081.0,,,,,2021,Q3,Nausea,,2021,Q3,1,I,,20210920.0,20210928,20210928,EXP,,CA-SA-2021SA312580,SANOFI AVENTIS,,13.0,YR,T,F,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Child
198878971,19887897,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,21081.0,,,,,2021,Q3,Pollakiuria,,2021,Q3,1,I,,20210920.0,20210928,20210928,EXP,,CA-SA-2021SA312580,SANOFI AVENTIS,,13.0,YR,T,F,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Child
198878971,19887897,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,21081.0,,,,,2021,Q3,Syncope,,2021,Q3,1,I,,20210920.0,20210928,20210928,EXP,,CA-SA-2021SA312580,SANOFI AVENTIS,,13.0,YR,T,F,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Child
198885471,19888547,2,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Back pain,,2021,Q3,1,I,20210919.0,,20210927,20210927,DIR,,,FDA-CTU,,46.0,YR,,M,N,128.25,KG,20210927.0,Y,HP,US,US,2021,Q3,Adult
198885471,19888547,2,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Cough,,2021,Q3,1,I,20210919.0,,20210927,20210927,DIR,,,FDA-CTU,,46.0,YR,,M,N,128.25,KG,20210927.0,Y,HP,US,US,2021,Q3,Adult
198885471,19888547,2,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Headache,,2021,Q3,1,I,20210919.0,,20210927,20210927,DIR,,,FDA-CTU,,46.0,YR,,M,N,128.25,KG,20210927.0,Y,HP,US,US,2021,Q3,Adult
198885471,19888547,2,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Paranasal sinus discomfort,,2021,Q3,1,I,20210919.0,,20210927,20210927,DIR,,,FDA-CTU,,46.0,YR,,M,N,128.25,KG,20210927.0,Y,HP,US,US,2021,Q3,Adult
198900191,19890019,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,52 IU,,,U,,,,206538.0,52.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,1,I,,20210920.0,20210928,20210928,EXP,,CA-SA-2021SA312350,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Elderly
198900191,19890019,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,52 IU,,,U,,,,206538.0,52.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Loss of consciousness,,2021,Q3,1,I,,20210920.0,20210928,20210928,EXP,,CA-SA-2021SA312350,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Elderly
198900191,19890019,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,52 IU,,,U,,,,206538.0,52.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Memory impairment,,2021,Q3,1,I,,20210920.0,20210928,20210928,EXP,,CA-SA-2021SA312350,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Elderly
198907031,19890703,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,205692.0,,,,,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,20210715.0,20210915.0,20210928,20210928,EXP,IT-MINISAL02-785491,IT-ELI_LILLY_AND_COMPANY-IT202109006113,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210928.0,,PH,IT,IT,2021,Q3,Elderly
198907041,19890704,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, UNKNOWN",,,U,,,,205692.0,,,,,2021,Q3,Asthma,,2021,Q3,1,I,,20210921.0,20210928,20210928,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109008337,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Elderly
198907041,19890704,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, UNKNOWN",,,U,,,,205692.0,,,,,2021,Q3,Condition aggravated,,2021,Q3,1,I,,20210921.0,20210928,20210928,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109008337,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Elderly
198907041,19890704,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, UNKNOWN",,,U,,,,205692.0,,,,,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20210921.0,20210928,20210928,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109008337,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Elderly
198907041,19890704,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, UNKNOWN",,,U,,,,205692.0,,,,,2021,Q3,Haemoptysis,,2021,Q3,1,I,,20210921.0,20210928,20210928,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109008337,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Elderly
198907041,19890704,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, UNKNOWN",,,U,,,,205692.0,,,,,2021,Q3,Loss of personal independence in daily activities,,2021,Q3,1,I,,20210921.0,20210928,20210928,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109008337,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Elderly
198907041,19890704,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, UNKNOWN",,,U,,,,205692.0,,,,,2021,Q3,Lung disorder,,2021,Q3,1,I,,20210921.0,20210928,20210928,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109008337,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Elderly
198907041,19890704,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, UNKNOWN",,,U,,,,205692.0,,,,,2021,Q3,Neuritis,,2021,Q3,1,I,,20210921.0,20210928,20210928,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109008337,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Elderly
198907041,19890704,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, UNKNOWN",,,U,,,,205692.0,,,,,2021,Q3,Neurological symptom,,2021,Q3,1,I,,20210921.0,20210928,20210928,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109008337,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Elderly
198907041,19890704,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, UNKNOWN",,,U,,,,205692.0,,,,,2021,Q3,Obstructive airways disorder,,2021,Q3,1,I,,20210921.0,20210928,20210928,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109008337,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Elderly
198907041,19890704,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, UNKNOWN",,,U,,,,205692.0,,,,,2021,Q3,Pain in extremity,,2021,Q3,1,I,,20210921.0,20210928,20210928,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109008337,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Elderly
198907041,19890704,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, UNKNOWN",,,U,,,,205692.0,,,,,2021,Q3,Pulmonary alveolar haemorrhage,,2021,Q3,1,I,,20210921.0,20210928,20210928,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109008337,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Elderly
198907041,19890704,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, UNKNOWN",,,U,,,,205692.0,,,,,2021,Q3,Pulmonary fibrosis,,2021,Q3,1,I,,20210921.0,20210928,20210928,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109008337,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Elderly
198907041,19890704,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, UNKNOWN",,,U,,,,205692.0,,,,,2021,Q3,Pulmonary vasculitis,,2021,Q3,1,I,,20210921.0,20210928,20210928,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109008337,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Elderly
198907041,19890704,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, UNKNOWN",,,U,,,,205692.0,,,,,2021,Q3,Respiratory symptom,,2021,Q3,1,I,,20210921.0,20210928,20210928,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109008337,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Elderly
198907041,19890704,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, UNKNOWN",,,U,,,,205692.0,,,,,2021,Q3,Sleep disorder due to a general medical condition,,2021,Q3,1,I,,20210921.0,20210928,20210928,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109008337,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Elderly
198907041,19890704,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, UNKNOWN",,,U,,,,205692.0,,,,,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,1,I,,20210921.0,20210928,20210928,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109008337,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Elderly
198907041,19890704,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, UNKNOWN",,,U,,,,205692.0,,,,,2021,Q3,Vasculitis,,2021,Q3,1,I,,20210921.0,20210928,20210928,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109008337,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Elderly
198907041,19890704,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, UNKNOWN",,,U,,,,205692.0,,,,,2021,Q3,Wheezing,,2021,Q3,1,I,,20210921.0,20210928,20210928,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109008337,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Elderly
198907061,19890706,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, DAILY",,,U,,,,205692.0,,,,QD,2021,Q3,Asthma,,2021,Q3,1,I,,20210921.0,20210928,20210928,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109008390,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Elderly
198907061,19890706,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, DAILY",,,U,,,,205692.0,,,,QD,2021,Q3,Condition aggravated,,2021,Q3,1,I,,20210921.0,20210928,20210928,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109008390,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Elderly
198907061,19890706,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, DAILY",,,U,,,,205692.0,,,,QD,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20210921.0,20210928,20210928,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109008390,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Elderly
198907061,19890706,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, DAILY",,,U,,,,205692.0,,,,QD,2021,Q3,Haemoptysis,,2021,Q3,1,I,,20210921.0,20210928,20210928,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109008390,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Elderly
198907061,19890706,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, DAILY",,,U,,,,205692.0,,,,QD,2021,Q3,Loss of personal independence in daily activities,,2021,Q3,1,I,,20210921.0,20210928,20210928,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109008390,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Elderly
198907061,19890706,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, DAILY",,,U,,,,205692.0,,,,QD,2021,Q3,Lung disorder,,2021,Q3,1,I,,20210921.0,20210928,20210928,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109008390,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Elderly
198907061,19890706,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, DAILY",,,U,,,,205692.0,,,,QD,2021,Q3,Neuritis,,2021,Q3,1,I,,20210921.0,20210928,20210928,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109008390,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Elderly
198907061,19890706,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, DAILY",,,U,,,,205692.0,,,,QD,2021,Q3,Neurological symptom,,2021,Q3,1,I,,20210921.0,20210928,20210928,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109008390,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Elderly
198907061,19890706,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, DAILY",,,U,,,,205692.0,,,,QD,2021,Q3,Obstructive airways disorder,,2021,Q3,1,I,,20210921.0,20210928,20210928,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109008390,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Elderly
198907061,19890706,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, DAILY",,,U,,,,205692.0,,,,QD,2021,Q3,Pain in extremity,,2021,Q3,1,I,,20210921.0,20210928,20210928,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109008390,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Elderly
198907061,19890706,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, DAILY",,,U,,,,205692.0,,,,QD,2021,Q3,Pulmonary alveolar haemorrhage,,2021,Q3,1,I,,20210921.0,20210928,20210928,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109008390,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Elderly
198907061,19890706,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, DAILY",,,U,,,,205692.0,,,,QD,2021,Q3,Pulmonary fibrosis,,2021,Q3,1,I,,20210921.0,20210928,20210928,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109008390,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Elderly
198907061,19890706,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, DAILY",,,U,,,,205692.0,,,,QD,2021,Q3,Pulmonary vasculitis,,2021,Q3,1,I,,20210921.0,20210928,20210928,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109008390,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Elderly
198907061,19890706,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, DAILY",,,U,,,,205692.0,,,,QD,2021,Q3,Respiratory symptom,,2021,Q3,1,I,,20210921.0,20210928,20210928,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109008390,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Elderly
198907061,19890706,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, DAILY",,,U,,,,205692.0,,,,QD,2021,Q3,Sleep disorder due to a general medical condition,,2021,Q3,1,I,,20210921.0,20210928,20210928,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109008390,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Elderly
198907061,19890706,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, DAILY",,,U,,,,205692.0,,,,QD,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,1,I,,20210921.0,20210928,20210928,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109008390,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Elderly
198907061,19890706,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, DAILY",,,U,,,,205692.0,,,,QD,2021,Q3,Vasculitis,,2021,Q3,1,I,,20210921.0,20210928,20210928,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109008390,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Elderly
198907061,19890706,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, DAILY",,,U,,,,205692.0,,,,QD,2021,Q3,Wheezing,,2021,Q3,1,I,,20210921.0,20210928,20210928,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109008390,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Elderly
198911461,19891146,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"10 IU, QD AT BEDTIME",,,,,,,,10.0,IU,,QD,2021,Q3,Abdominal pain,,2021,Q3,1,I,2021.0,20210920.0,20210927,20210927,EXP,,US-NOVOPROD-848913,NOVO NORDISK,,41.0,YR,,F,Y,,,20210927.0,,HP,US,US,2021,Q3,Adult
198911461,19891146,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"10 IU, QD AT BEDTIME",,,,,,,,10.0,IU,,QD,2021,Q3,Diarrhoea,,2021,Q3,1,I,2021.0,20210920.0,20210927,20210927,EXP,,US-NOVOPROD-848913,NOVO NORDISK,,41.0,YR,,F,Y,,,20210927.0,,HP,US,US,2021,Q3,Adult
198911461,19891146,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"10 IU, QD AT BEDTIME",,,,,,,,10.0,IU,,QD,2021,Q3,Dizziness,,2021,Q3,1,I,2021.0,20210920.0,20210927,20210927,EXP,,US-NOVOPROD-848913,NOVO NORDISK,,41.0,YR,,F,Y,,,20210927.0,,HP,US,US,2021,Q3,Adult
198911461,19891146,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"10 IU, QD AT BEDTIME",,,,,,,,10.0,IU,,QD,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,1,I,2021.0,20210920.0,20210927,20210927,EXP,,US-NOVOPROD-848913,NOVO NORDISK,,41.0,YR,,F,Y,,,20210927.0,,HP,US,US,2021,Q3,Adult
198911461,19891146,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"10 IU, QD AT BEDTIME",,,,,,,,10.0,IU,,QD,2021,Q3,Nausea,,2021,Q3,1,I,2021.0,20210920.0,20210927,20210927,EXP,,US-NOVOPROD-848913,NOVO NORDISK,,41.0,YR,,F,Y,,,20210927.0,,HP,US,US,2021,Q3,Adult
198911461,19891146,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"10 IU, QD AT BEDTIME",,,,,,,,10.0,IU,,QD,2021,Q3,Visual impairment,,2021,Q3,1,I,2021.0,20210920.0,20210927,20210927,EXP,,US-NOVOPROD-848913,NOVO NORDISK,,41.0,YR,,F,Y,,,20210927.0,,HP,US,US,2021,Q3,Adult
198911461,19891146,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"10 IU, QD AT BEDTIME",,,,,,,,10.0,IU,,QD,2021,Q3,Vomiting,,2021,Q3,1,I,2021.0,20210920.0,20210927,20210927,EXP,,US-NOVOPROD-848913,NOVO NORDISK,,41.0,YR,,F,Y,,,20210927.0,,HP,US,US,2021,Q3,Adult
198934771,19893477,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,21081.0,,,,,2021,Q3,Blood pressure increased,,2021,Q3,1,I,,20210920.0,20210928,20210928,EXP,,CA-SA-2021SA312588,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Adult
198934771,19893477,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,21081.0,,,,,2021,Q3,Cardiovascular disorder,,2021,Q3,1,I,,20210920.0,20210928,20210928,EXP,,CA-SA-2021SA312588,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Adult
198934771,19893477,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,21081.0,,,,,2021,Q3,Dysstasia,,2021,Q3,1,I,,20210920.0,20210928,20210928,EXP,,CA-SA-2021SA312588,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Adult
198934771,19893477,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,21081.0,,,,,2021,Q3,Dysuria,,2021,Q3,1,I,,20210920.0,20210928,20210928,EXP,,CA-SA-2021SA312588,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Adult
198934771,19893477,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,21081.0,,,,,2021,Q3,Fall,,2021,Q3,1,I,,20210920.0,20210928,20210928,EXP,,CA-SA-2021SA312588,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Adult
198934771,19893477,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,21081.0,,,,,2021,Q3,Fatigue,,2021,Q3,1,I,,20210920.0,20210928,20210928,EXP,,CA-SA-2021SA312588,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Adult
198934771,19893477,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,21081.0,,,,,2021,Q3,Headache,,2021,Q3,1,I,,20210920.0,20210928,20210928,EXP,,CA-SA-2021SA312588,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Adult
198934771,19893477,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,21081.0,,,,,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,,20210920.0,20210928,20210928,EXP,,CA-SA-2021SA312588,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Adult
198934771,19893477,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,21081.0,,,,,2021,Q3,Lung disorder,,2021,Q3,1,I,,20210920.0,20210928,20210928,EXP,,CA-SA-2021SA312588,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Adult
198934771,19893477,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,21081.0,,,,,2021,Q3,Respiratory disorder,,2021,Q3,1,I,,20210920.0,20210928,20210928,EXP,,CA-SA-2021SA312588,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20210928.0,,CN,CA,CA,2021,Q3,Adult
198954621,19895462,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU QD, (28 DV, ONCE IN THE EVENING)",,,,,,,210605.0,28.0,IU,INJECTION,QD,2021,Q3,Diabetic hepatopathy,,2021,Q3,1,I,20200906.0,20210922.0,20210929,20210929,EXP,,LV-MYLANLABS-2021M1066521,MYLAN,"N. SENTERJAKOVA, A. STAKA. POORLY COMPENSATED TYPE 1 DIABETES ? LIVER DAMAGE AS A CONSEQUENCE. DOCTUS. 2021?9 (246):39?42",22.0,YR,,F,Y,58.0,KG,20210929.0,,HP,LV,LV,2021,Q3,Youth
198954621,19895462,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU QD, (28 DV, ONCE IN THE EVENING)",,,,,,,210605.0,28.0,IU,INJECTION,QD,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,20200906.0,20210922.0,20210929,20210929,EXP,,LV-MYLANLABS-2021M1066521,MYLAN,"N. SENTERJAKOVA, A. STAKA. POORLY COMPENSATED TYPE 1 DIABETES ? LIVER DAMAGE AS A CONSEQUENCE. DOCTUS. 2021?9 (246):39?42",22.0,YR,,F,Y,58.0,KG,20210929.0,,HP,LV,LV,2021,Q3,Youth
198954621,19895462,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU QD, (28 DV, ONCE IN THE EVENING)",,,,,,,210605.0,28.0,IU,INJECTION,QD,2021,Q3,Non-alcoholic steatohepatitis,,2021,Q3,1,I,20200906.0,20210922.0,20210929,20210929,EXP,,LV-MYLANLABS-2021M1066521,MYLAN,"N. SENTERJAKOVA, A. STAKA. POORLY COMPENSATED TYPE 1 DIABETES ? LIVER DAMAGE AS A CONSEQUENCE. DOCTUS. 2021?9 (246):39?42",22.0,YR,,F,Y,58.0,KG,20210929.0,,HP,LV,LV,2021,Q3,Youth
198954621,19895462,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU QD, (28 DV, ONCE IN THE EVENING)",,,,,,,210605.0,28.0,IU,INJECTION,QD,2021,Q3,Pyoderma,,2021,Q3,1,I,20200906.0,20210922.0,20210929,20210929,EXP,,LV-MYLANLABS-2021M1066521,MYLAN,"N. SENTERJAKOVA, A. STAKA. POORLY COMPENSATED TYPE 1 DIABETES ? LIVER DAMAGE AS A CONSEQUENCE. DOCTUS. 2021?9 (246):39?42",22.0,YR,,F,Y,58.0,KG,20210929.0,,HP,LV,LV,2021,Q3,Youth
198957861,19895786,1,PS,"INSULIN (INSULIN, GLARGINE , HUMAN 100 UNIT/ML INJ, SOLOSTAR,3ML)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER DOSE:15 UNITS;?,,,Y,D,,,,15.0,IU,,QD,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,20210723.0,,20210929,20210929,DIR,,,FDA-CTU,,65.0,YR,,M,N,90.26,KG,20210922.0,N,PH,US,US,2021,Q3,Elderly
198957861,19895786,1,PS,"INSULIN (INSULIN, GLARGINE , HUMAN 100 UNIT/ML INJ, SOLOSTAR,3ML)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER DOSE:15 UNITS;?,,,Y,D,,,,15.0,IU,,QD,2021,Q3,Hypersensitivity,,2021,Q3,1,I,20210723.0,,20210929,20210929,DIR,,,FDA-CTU,,65.0,YR,,M,N,90.26,KG,20210922.0,N,PH,US,US,2021,Q3,Elderly
198965061,19896506,5,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q3,Rash,,2021,Q3,1,I,20210916.0,20210916.0,20210929,20210929,PER,,US-CELGENEUS-USA-20210905570,CELGENE,,77.0,YR,,M,Y,82.67,KG,20210929.0,,PH,US,US,2021,Q3,Elderly
198974971,19897497,8,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, ONCE A DAY",,,U,,,,,,,,QD,2021,Q3,Diabetes mellitus,,2021,Q3,1,I,,20210921.0,20210930,20210930,EXP,,CA-AUROBINDO-AUR-APL-2021-040570,AUROBINDO,,35.0,YR,,F,Y,,,20210930.0,,HP,CA,CA,2021,Q3,Adult
198974971,19897497,8,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, ONCE A DAY",,,U,,,,,,,,QD,2021,Q3,Rheumatoid arthritis,,2021,Q3,1,I,,20210921.0,20210930,20210930,EXP,,CA-AUROBINDO-AUR-APL-2021-040570,AUROBINDO,,35.0,YR,,F,Y,,,20210930.0,,HP,CA,CA,2021,Q3,Adult
198985731,19898573,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, ACCORDING TO SCHEME, INJECTION/INFUSION SOLUTION",,,U,U,,,,,,,,2021,Q3,Acute respiratory failure,,2021,Q3,1,I,,20210924.0,20210929,20210929,EXP,,DE-MYLANLABS-2021M1066601,MYLAN,,79.0,YR,,M,Y,,,20210929.0,,PH,DE,DE,2021,Q3,Elderly
198985731,19898573,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, ACCORDING TO SCHEME, INJECTION/INFUSION SOLUTION",,,U,U,,,,,,,,2021,Q3,Somnolence,,2021,Q3,1,I,,20210924.0,20210929,20210929,EXP,,DE-MYLANLABS-2021M1066601,MYLAN,,79.0,YR,,M,Y,,,20210929.0,,PH,DE,DE,2021,Q3,Elderly
198986181,19898618,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Clostridium difficile infection,,2021,Q3,1,I,,20210922.0,20210929,20210929,EXP,,NVSC2021CA219208,NOVARTIS,,76.0,YR,,F,Y,90.0,KG,20210929.0,,HP,CA,CA,2021,Q3,Elderly
198986181,19898618,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Diabetic foot infection,,2021,Q3,1,I,,20210922.0,20210929,20210929,EXP,,NVSC2021CA219208,NOVARTIS,,76.0,YR,,F,Y,90.0,KG,20210929.0,,HP,CA,CA,2021,Q3,Elderly
198986181,19898618,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Osteomyelitis,,2021,Q3,1,I,,20210922.0,20210929,20210929,EXP,,NVSC2021CA219208,NOVARTIS,,76.0,YR,,F,Y,90.0,KG,20210929.0,,HP,CA,CA,2021,Q3,Elderly
198986181,19898618,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Sepsis,,2021,Q3,1,I,,20210922.0,20210929,20210929,EXP,,NVSC2021CA219208,NOVARTIS,,76.0,YR,,F,Y,90.0,KG,20210929.0,,HP,CA,CA,2021,Q3,Elderly
198998231,19899823,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IE, 0?0?0?1, INJEKTIONS?/INFUSIONSL?SUNG",,,,,,,,16.0,IU,,QD,2021,Q3,Condition aggravated,,2021,Q3,1,I,,20210924.0,20210929,20210929,EXP,,DE-MYLANLABS-2021M1066555,MYLAN,,56.0,YR,,F,Y,103.0,KG,20210929.0,,MD,DE,DE,2021,Q3,Adult
198998231,19899823,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IE, 0?0?0?1, INJEKTIONS?/INFUSIONSL?SUNG",,,,,,,,16.0,IU,,QD,2021,Q3,Renal impairment,,2021,Q3,1,I,,20210924.0,20210929,20210929,EXP,,DE-MYLANLABS-2021M1066555,MYLAN,,56.0,YR,,F,Y,103.0,KG,20210929.0,,MD,DE,DE,2021,Q3,Adult
198998231,19899823,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IE, 0?0?0?1, INJEKTIONS?/INFUSIONSL?SUNG",,,,,,,,16.0,IU,,QD,2021,Q3,Weight increased,,2021,Q3,1,I,,20210924.0,20210929,20210929,EXP,,DE-MYLANLABS-2021M1066555,MYLAN,,56.0,YR,,F,Y,103.0,KG,20210929.0,,MD,DE,DE,2021,Q3,Adult
199021221,19902122,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, ACCORDING TO THE SCHEME, SOLUTION FOR INJECTION / INFUSION",,,D,,,,210605.0,,,INJECTION,,2021,Q3,Confusional state,,2021,Q3,1,I,,20210924.0,20210930,20210930,EXP,,DE-MYLANLABS-2021M1066462,MYLAN,,85.0,YR,,M,Y,,,20210930.0,,PH,DE,DE,2021,Q3,Elderly
199021221,19902122,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, ACCORDING TO THE SCHEME, SOLUTION FOR INJECTION / INFUSION",,,D,,,,210605.0,,,INJECTION,,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,,20210924.0,20210930,20210930,EXP,,DE-MYLANLABS-2021M1066462,MYLAN,,85.0,YR,,M,Y,,,20210930.0,,PH,DE,DE,2021,Q3,Elderly
199021221,19902122,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, ACCORDING TO THE SCHEME, SOLUTION FOR INJECTION / INFUSION",,,D,,,,210605.0,,,INJECTION,,2021,Q3,Product administration error,,2021,Q3,1,I,,20210924.0,20210930,20210930,EXP,,DE-MYLANLABS-2021M1066462,MYLAN,,85.0,YR,,M,Y,,,20210930.0,,PH,DE,DE,2021,Q3,Elderly
199072401,19907240,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU ONCE DAILY IN THE EVENING,,,U,,,,21081.0,28.0,IU,,QD,2021,Q3,Abdominal pain,,2021,Q3,1,I,20200906.0,20210922.0,20210930,20210930,EXP,,LV-SA-2021SA315255,SANOFI AVENTIS,"?ENTERJAKOVA N, ST?KA A. POORLY COMPENSATED TYPE 1 DIABETES ? LIVER DAMAGE AS A CONSEQUENCE. DOCTUS. 2021?9(246):39?42",22.0,YR,A,F,Y,58.0,KG,20210930.0,,HP,LV,LV,2021,Q3,Youth
199072401,19907240,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU ONCE DAILY IN THE EVENING,,,U,,,,21081.0,28.0,IU,,QD,2021,Q3,Asthenia,,2021,Q3,1,I,20200906.0,20210922.0,20210930,20210930,EXP,,LV-SA-2021SA315255,SANOFI AVENTIS,"?ENTERJAKOVA N, ST?KA A. POORLY COMPENSATED TYPE 1 DIABETES ? LIVER DAMAGE AS A CONSEQUENCE. DOCTUS. 2021?9(246):39?42",22.0,YR,A,F,Y,58.0,KG,20210930.0,,HP,LV,LV,2021,Q3,Youth
199072401,19907240,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU ONCE DAILY IN THE EVENING,,,U,,,,21081.0,28.0,IU,,QD,2021,Q3,Decreased appetite,,2021,Q3,1,I,20200906.0,20210922.0,20210930,20210930,EXP,,LV-SA-2021SA315255,SANOFI AVENTIS,"?ENTERJAKOVA N, ST?KA A. POORLY COMPENSATED TYPE 1 DIABETES ? LIVER DAMAGE AS A CONSEQUENCE. DOCTUS. 2021?9(246):39?42",22.0,YR,A,F,Y,58.0,KG,20210930.0,,HP,LV,LV,2021,Q3,Youth
199072401,19907240,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU ONCE DAILY IN THE EVENING,,,U,,,,21081.0,28.0,IU,,QD,2021,Q3,Diabetes mellitus inadequate control,,2021,Q3,1,I,20200906.0,20210922.0,20210930,20210930,EXP,,LV-SA-2021SA315255,SANOFI AVENTIS,"?ENTERJAKOVA N, ST?KA A. POORLY COMPENSATED TYPE 1 DIABETES ? LIVER DAMAGE AS A CONSEQUENCE. DOCTUS. 2021?9(246):39?42",22.0,YR,A,F,Y,58.0,KG,20210930.0,,HP,LV,LV,2021,Q3,Youth
199072401,19907240,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU ONCE DAILY IN THE EVENING,,,U,,,,21081.0,28.0,IU,,QD,2021,Q3,Diabetic hepatopathy,,2021,Q3,1,I,20200906.0,20210922.0,20210930,20210930,EXP,,LV-SA-2021SA315255,SANOFI AVENTIS,"?ENTERJAKOVA N, ST?KA A. POORLY COMPENSATED TYPE 1 DIABETES ? LIVER DAMAGE AS A CONSEQUENCE. DOCTUS. 2021?9(246):39?42",22.0,YR,A,F,Y,58.0,KG,20210930.0,,HP,LV,LV,2021,Q3,Youth
199072401,19907240,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU ONCE DAILY IN THE EVENING,,,U,,,,21081.0,28.0,IU,,QD,2021,Q3,Erythema,,2021,Q3,1,I,20200906.0,20210922.0,20210930,20210930,EXP,,LV-SA-2021SA315255,SANOFI AVENTIS,"?ENTERJAKOVA N, ST?KA A. POORLY COMPENSATED TYPE 1 DIABETES ? LIVER DAMAGE AS A CONSEQUENCE. DOCTUS. 2021?9(246):39?42",22.0,YR,A,F,Y,58.0,KG,20210930.0,,HP,LV,LV,2021,Q3,Youth
199072401,19907240,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU ONCE DAILY IN THE EVENING,,,U,,,,21081.0,28.0,IU,,QD,2021,Q3,Hepatic cytolysis,,2021,Q3,1,I,20200906.0,20210922.0,20210930,20210930,EXP,,LV-SA-2021SA315255,SANOFI AVENTIS,"?ENTERJAKOVA N, ST?KA A. POORLY COMPENSATED TYPE 1 DIABETES ? LIVER DAMAGE AS A CONSEQUENCE. DOCTUS. 2021?9(246):39?42",22.0,YR,A,F,Y,58.0,KG,20210930.0,,HP,LV,LV,2021,Q3,Youth
199072401,19907240,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU ONCE DAILY IN THE EVENING,,,U,,,,21081.0,28.0,IU,,QD,2021,Q3,Hepatic function abnormal,,2021,Q3,1,I,20200906.0,20210922.0,20210930,20210930,EXP,,LV-SA-2021SA315255,SANOFI AVENTIS,"?ENTERJAKOVA N, ST?KA A. POORLY COMPENSATED TYPE 1 DIABETES ? LIVER DAMAGE AS A CONSEQUENCE. DOCTUS. 2021?9(246):39?42",22.0,YR,A,F,Y,58.0,KG,20210930.0,,HP,LV,LV,2021,Q3,Youth
199072401,19907240,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU ONCE DAILY IN THE EVENING,,,U,,,,21081.0,28.0,IU,,QD,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,20200906.0,20210922.0,20210930,20210930,EXP,,LV-SA-2021SA315255,SANOFI AVENTIS,"?ENTERJAKOVA N, ST?KA A. POORLY COMPENSATED TYPE 1 DIABETES ? LIVER DAMAGE AS A CONSEQUENCE. DOCTUS. 2021?9(246):39?42",22.0,YR,A,F,Y,58.0,KG,20210930.0,,HP,LV,LV,2021,Q3,Youth
199072401,19907240,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU ONCE DAILY IN THE EVENING,,,U,,,,21081.0,28.0,IU,,QD,2021,Q3,Liver injury,,2021,Q3,1,I,20200906.0,20210922.0,20210930,20210930,EXP,,LV-SA-2021SA315255,SANOFI AVENTIS,"?ENTERJAKOVA N, ST?KA A. POORLY COMPENSATED TYPE 1 DIABETES ? LIVER DAMAGE AS A CONSEQUENCE. DOCTUS. 2021?9(246):39?42",22.0,YR,A,F,Y,58.0,KG,20210930.0,,HP,LV,LV,2021,Q3,Youth
199072401,19907240,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU ONCE DAILY IN THE EVENING,,,U,,,,21081.0,28.0,IU,,QD,2021,Q3,Nausea,,2021,Q3,1,I,20200906.0,20210922.0,20210930,20210930,EXP,,LV-SA-2021SA315255,SANOFI AVENTIS,"?ENTERJAKOVA N, ST?KA A. POORLY COMPENSATED TYPE 1 DIABETES ? LIVER DAMAGE AS A CONSEQUENCE. DOCTUS. 2021?9(246):39?42",22.0,YR,A,F,Y,58.0,KG,20210930.0,,HP,LV,LV,2021,Q3,Youth
199072401,19907240,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU ONCE DAILY IN THE EVENING,,,U,,,,21081.0,28.0,IU,,QD,2021,Q3,Non-alcoholic steatohepatitis,,2021,Q3,1,I,20200906.0,20210922.0,20210930,20210930,EXP,,LV-SA-2021SA315255,SANOFI AVENTIS,"?ENTERJAKOVA N, ST?KA A. POORLY COMPENSATED TYPE 1 DIABETES ? LIVER DAMAGE AS A CONSEQUENCE. DOCTUS. 2021?9(246):39?42",22.0,YR,A,F,Y,58.0,KG,20210930.0,,HP,LV,LV,2021,Q3,Youth
199072401,19907240,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU ONCE DAILY IN THE EVENING,,,U,,,,21081.0,28.0,IU,,QD,2021,Q3,Purulent discharge,,2021,Q3,1,I,20200906.0,20210922.0,20210930,20210930,EXP,,LV-SA-2021SA315255,SANOFI AVENTIS,"?ENTERJAKOVA N, ST?KA A. POORLY COMPENSATED TYPE 1 DIABETES ? LIVER DAMAGE AS A CONSEQUENCE. DOCTUS. 2021?9(246):39?42",22.0,YR,A,F,Y,58.0,KG,20210930.0,,HP,LV,LV,2021,Q3,Youth
199072401,19907240,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU ONCE DAILY IN THE EVENING,,,U,,,,21081.0,28.0,IU,,QD,2021,Q3,Pyoderma,,2021,Q3,1,I,20200906.0,20210922.0,20210930,20210930,EXP,,LV-SA-2021SA315255,SANOFI AVENTIS,"?ENTERJAKOVA N, ST?KA A. POORLY COMPENSATED TYPE 1 DIABETES ? LIVER DAMAGE AS A CONSEQUENCE. DOCTUS. 2021?9(246):39?42",22.0,YR,A,F,Y,58.0,KG,20210930.0,,HP,LV,LV,2021,Q3,Youth
199072401,19907240,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU ONCE DAILY IN THE EVENING,,,U,,,,21081.0,28.0,IU,,QD,2021,Q3,Rash,,2021,Q3,1,I,20200906.0,20210922.0,20210930,20210930,EXP,,LV-SA-2021SA315255,SANOFI AVENTIS,"?ENTERJAKOVA N, ST?KA A. POORLY COMPENSATED TYPE 1 DIABETES ? LIVER DAMAGE AS A CONSEQUENCE. DOCTUS. 2021?9(246):39?42",22.0,YR,A,F,Y,58.0,KG,20210930.0,,HP,LV,LV,2021,Q3,Youth
199072401,19907240,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU ONCE DAILY IN THE EVENING,,,U,,,,21081.0,28.0,IU,,QD,2021,Q3,Scab,,2021,Q3,1,I,20200906.0,20210922.0,20210930,20210930,EXP,,LV-SA-2021SA315255,SANOFI AVENTIS,"?ENTERJAKOVA N, ST?KA A. POORLY COMPENSATED TYPE 1 DIABETES ? LIVER DAMAGE AS A CONSEQUENCE. DOCTUS. 2021?9(246):39?42",22.0,YR,A,F,Y,58.0,KG,20210930.0,,HP,LV,LV,2021,Q3,Youth
199072401,19907240,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU ONCE DAILY IN THE EVENING,,,U,,,,21081.0,28.0,IU,,QD,2021,Q3,Secretion discharge,,2021,Q3,1,I,20200906.0,20210922.0,20210930,20210930,EXP,,LV-SA-2021SA315255,SANOFI AVENTIS,"?ENTERJAKOVA N, ST?KA A. POORLY COMPENSATED TYPE 1 DIABETES ? LIVER DAMAGE AS A CONSEQUENCE. DOCTUS. 2021?9(246):39?42",22.0,YR,A,F,Y,58.0,KG,20210930.0,,HP,LV,LV,2021,Q3,Youth
199072401,19907240,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU ONCE DAILY IN THE EVENING,,,U,,,,21081.0,28.0,IU,,QD,2021,Q3,Skin disorder,,2021,Q3,1,I,20200906.0,20210922.0,20210930,20210930,EXP,,LV-SA-2021SA315255,SANOFI AVENTIS,"?ENTERJAKOVA N, ST?KA A. POORLY COMPENSATED TYPE 1 DIABETES ? LIVER DAMAGE AS A CONSEQUENCE. DOCTUS. 2021?9(246):39?42",22.0,YR,A,F,Y,58.0,KG,20210930.0,,HP,LV,LV,2021,Q3,Youth
199072401,19907240,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU ONCE DAILY IN THE EVENING,,,U,,,,21081.0,28.0,IU,,QD,2021,Q3,Vomiting,,2021,Q3,1,I,20200906.0,20210922.0,20210930,20210930,EXP,,LV-SA-2021SA315255,SANOFI AVENTIS,"?ENTERJAKOVA N, ST?KA A. POORLY COMPENSATED TYPE 1 DIABETES ? LIVER DAMAGE AS A CONSEQUENCE. DOCTUS. 2021?9(246):39?42",22.0,YR,A,F,Y,58.0,KG,20210930.0,,HP,LV,LV,2021,Q3,Youth
89001552,8900155,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q3,Breast cancer,,2021,Q3,2,F,,20210913.0,20121109,20210919,EXP,,PHHY2012ES102419,NOVARTIS,,72.0,YR,,F,Y,,,20210920.0,,HP,ES,ES,2021,Q3,Elderly
89001552,8900155,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q3,Femoral neck fracture,,2021,Q3,2,F,,20210913.0,20121109,20210919,EXP,,PHHY2012ES102419,NOVARTIS,,72.0,YR,,F,Y,,,20210920.0,,HP,ES,ES,2021,Q3,Elderly
89001552,8900155,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q3,Femur fracture,,2021,Q3,2,F,,20210913.0,20121109,20210919,EXP,,PHHY2012ES102419,NOVARTIS,,72.0,YR,,F,Y,,,20210920.0,,HP,ES,ES,2021,Q3,Elderly
89001552,8900155,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q3,Spinal fracture,,2021,Q3,2,F,,20210913.0,20121109,20210919,EXP,,PHHY2012ES102419,NOVARTIS,,72.0,YR,,F,Y,,,20210920.0,,HP,ES,ES,2021,Q3,Elderly
99891527,9989152,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Syncope,,2021,Q3,7,F,20140305.0,20210712.0,20140310,20210715,EXP,,JP-ROCHE-1360598,ROCHE,,83.0,YR,,F,Y,50.9,KG,20210715.0,,MD,JP,JP,2021,Q3,Elderly
99891527,9989152,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q3,Syncope,,2021,Q3,7,F,20140305.0,20210712.0,20140310,20210715,EXP,,JP-ROCHE-1360598,ROCHE,,83.0,YR,,F,Y,50.9,KG,20210715.0,,MD,JP,JP,2021,Q3,Elderly
109982199,10998219,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (300 unit/ ml (1.5 ml) insulin pen),,,,,,,,,,,,2021,Q4,Blindness,,2021,Q4,9,F,20050414.0,20210930.0,20150408,20211008,EXP,,US-PFIZER INC-2015119344,PFIZER,,44.0,YR,,M,Y,75.0,KG,20211008.0,,CN,US,US,2021,Q4,Adult
109982199,10998219,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (300 unit/ ml (1.5 ml) insulin pen),,,,,,,,,,,,2021,Q4,Diabetic coma,,2021,Q4,9,F,20050414.0,20210930.0,20150408,20211008,EXP,,US-PFIZER INC-2015119344,PFIZER,,44.0,YR,,M,Y,75.0,KG,20211008.0,,CN,US,US,2021,Q4,Adult
109982199,10998219,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (300 unit/ ml (1.5 ml) insulin pen),,,,,,,,,,,,2021,Q4,Myocardial infarction,,2021,Q4,9,F,20050414.0,20210930.0,20150408,20211008,EXP,,US-PFIZER INC-2015119344,PFIZER,,44.0,YR,,M,Y,75.0,KG,20211008.0,,CN,US,US,2021,Q4,Adult
109982199,10998219,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (300 unit/ ml (1.5 ml) insulin pen),,,,,,,,,,,,2021,Q4,Steroid diabetes,,2021,Q4,9,F,20050414.0,20210930.0,20150408,20211008,EXP,,US-PFIZER INC-2015119344,PFIZER,,44.0,YR,,M,Y,75.0,KG,20211008.0,,CN,US,US,2021,Q4,Adult
109982199,10998219,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (300 unit/ ml (1.5 ml) insulin pen),,,,,,,,,,,,2021,Q4,Off label use,,2021,Q4,9,F,20050414.0,20210930.0,20150408,20211008,EXP,,US-PFIZER INC-2015119344,PFIZER,,44.0,YR,,M,Y,75.0,KG,20211008.0,,CN,US,US,2021,Q4,Adult
109982199,10998219,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (300 unit/ ml (1.5 ml) insulin pen),,,,,,,,,,,,2021,Q4,Product dispensing error,,2021,Q4,9,F,20050414.0,20210930.0,20150408,20211008,EXP,,US-PFIZER INC-2015119344,PFIZER,,44.0,YR,,M,Y,75.0,KG,20211008.0,,CN,US,US,2021,Q4,Adult
127862184,12786218,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Drug ineffective for unapproved indication,,2021,Q4,4,F,20160725.0,20210122.0,20160927,20211020,PER,,US-FRI-1000085911,ALLERGAN,,68.0,YR,,M,Y,86.17,KG,20211020.0,,CN,US,US,2021,Q4,Elderly
127862184,12786218,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Abdominal pain lower,,2021,Q4,4,F,20160725.0,20210122.0,20160927,20211020,PER,,US-FRI-1000085911,ALLERGAN,,68.0,YR,,M,Y,86.17,KG,20211020.0,,CN,US,US,2021,Q4,Elderly
127862184,12786218,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,4,F,20160725.0,20210122.0,20160927,20211020,PER,,US-FRI-1000085911,ALLERGAN,,68.0,YR,,M,Y,86.17,KG,20211020.0,,CN,US,US,2021,Q4,Elderly
127862184,12786218,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Product storage error,,2021,Q4,4,F,20160725.0,20210122.0,20160927,20211020,PER,,US-FRI-1000085911,ALLERGAN,,68.0,YR,,M,Y,86.17,KG,20211020.0,,CN,US,US,2021,Q4,Elderly
127862184,12786218,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Off label use,,2021,Q4,4,F,20160725.0,20210122.0,20160927,20211020,PER,,US-FRI-1000085911,ALLERGAN,,68.0,YR,,M,Y,86.17,KG,20211020.0,,CN,US,US,2021,Q4,Elderly
127862184,12786218,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Abnormal faeces,,2021,Q4,4,F,20160725.0,20210122.0,20160927,20211020,PER,,US-FRI-1000085911,ALLERGAN,,68.0,YR,,M,Y,86.17,KG,20211020.0,,CN,US,US,2021,Q4,Elderly
127862184,12786218,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Abdominal discomfort,,2021,Q4,4,F,20160725.0,20210122.0,20160927,20211020,PER,,US-FRI-1000085911,ALLERGAN,,68.0,YR,,M,Y,86.17,KG,20211020.0,,CN,US,US,2021,Q4,Elderly
127862184,12786218,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Abdominal pain upper,,2021,Q4,4,F,20160725.0,20210122.0,20160927,20211020,PER,,US-FRI-1000085911,ALLERGAN,,68.0,YR,,M,Y,86.17,KG,20211020.0,,CN,US,US,2021,Q4,Elderly
129566613,12956661,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2021,Q4,Gastrointestinal oedema,,2021,Q4,3,F,,20211123.0,20161118,20211126,EXP,,US-SA-2016SA206897,SANOFI AVENTIS,"Desai M, Khov N, Yang Z, Reiprich AJ, Mathew A, Levenick JM.. Crystal-associated colitis with ulceration leading to hematochezia and abdominal pain.. Am J Gastroenterol.. 2015;110 Suppl 1:S121",45.0,YR,A,F,Y,,,20211126.0,,,COUNTRY NOT SPECIFIED,US,2021,Q4,Adult
129566613,12956661,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2021,Q4,Abdominal pain,,2021,Q4,3,F,,20211123.0,20161118,20211126,EXP,,US-SA-2016SA206897,SANOFI AVENTIS,"Desai M, Khov N, Yang Z, Reiprich AJ, Mathew A, Levenick JM.. Crystal-associated colitis with ulceration leading to hematochezia and abdominal pain.. Am J Gastroenterol.. 2015;110 Suppl 1:S121",45.0,YR,A,F,Y,,,20211126.0,,,COUNTRY NOT SPECIFIED,US,2021,Q4,Adult
129566613,12956661,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2021,Q4,Abdominal pain,,2021,Q4,3,F,,20211123.0,20161118,20211126,EXP,,US-SA-2016SA206897,SANOFI AVENTIS,"Desai M, Khov N, Yang Z, Reiprich AJ, Mathew A, Levenick JM.. Crystal-associated colitis with ulceration leading to hematochezia and abdominal pain.. Am J Gastroenterol.. 2015;110 Suppl 1:S121",45.0,YR,A,F,Y,,,20211126.0,,,COUNTRY NOT SPECIFIED,US,2021,Q4,Adult
129566613,12956661,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2021,Q4,Hypotension,,2021,Q4,3,F,,20211123.0,20161118,20211126,EXP,,US-SA-2016SA206897,SANOFI AVENTIS,"Desai M, Khov N, Yang Z, Reiprich AJ, Mathew A, Levenick JM.. Crystal-associated colitis with ulceration leading to hematochezia and abdominal pain.. Am J Gastroenterol.. 2015;110 Suppl 1:S121",45.0,YR,A,F,Y,,,20211126.0,,,COUNTRY NOT SPECIFIED,US,2021,Q4,Adult
129566613,12956661,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2021,Q4,Colitis,,2021,Q4,3,F,,20211123.0,20161118,20211126,EXP,,US-SA-2016SA206897,SANOFI AVENTIS,"Desai M, Khov N, Yang Z, Reiprich AJ, Mathew A, Levenick JM.. Crystal-associated colitis with ulceration leading to hematochezia and abdominal pain.. Am J Gastroenterol.. 2015;110 Suppl 1:S121",45.0,YR,A,F,Y,,,20211126.0,,,COUNTRY NOT SPECIFIED,US,2021,Q4,Adult
129566613,12956661,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2021,Q4,Haematochezia,,2021,Q4,3,F,,20211123.0,20161118,20211126,EXP,,US-SA-2016SA206897,SANOFI AVENTIS,"Desai M, Khov N, Yang Z, Reiprich AJ, Mathew A, Levenick JM.. Crystal-associated colitis with ulceration leading to hematochezia and abdominal pain.. Am J Gastroenterol.. 2015;110 Suppl 1:S121",45.0,YR,A,F,Y,,,20211126.0,,,COUNTRY NOT SPECIFIED,US,2021,Q4,Adult
129566613,12956661,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2021,Q4,Haemoglobin decreased,,2021,Q4,3,F,,20211123.0,20161118,20211126,EXP,,US-SA-2016SA206897,SANOFI AVENTIS,"Desai M, Khov N, Yang Z, Reiprich AJ, Mathew A, Levenick JM.. Crystal-associated colitis with ulceration leading to hematochezia and abdominal pain.. Am J Gastroenterol.. 2015;110 Suppl 1:S121",45.0,YR,A,F,Y,,,20211126.0,,,COUNTRY NOT SPECIFIED,US,2021,Q4,Adult
129566613,12956661,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2021,Q4,Large intestinal ulcer,,2021,Q4,3,F,,20211123.0,20161118,20211126,EXP,,US-SA-2016SA206897,SANOFI AVENTIS,"Desai M, Khov N, Yang Z, Reiprich AJ, Mathew A, Levenick JM.. Crystal-associated colitis with ulceration leading to hematochezia and abdominal pain.. Am J Gastroenterol.. 2015;110 Suppl 1:S121",45.0,YR,A,F,Y,,,20211126.0,,,COUNTRY NOT SPECIFIED,US,2021,Q4,Adult
129566613,12956661,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2021,Q4,Crystal deposit intestine,,2021,Q4,3,F,,20211123.0,20161118,20211126,EXP,,US-SA-2016SA206897,SANOFI AVENTIS,"Desai M, Khov N, Yang Z, Reiprich AJ, Mathew A, Levenick JM.. Crystal-associated colitis with ulceration leading to hematochezia and abdominal pain.. Am J Gastroenterol.. 2015;110 Suppl 1:S121",45.0,YR,A,F,Y,,,20211126.0,,,COUNTRY NOT SPECIFIED,US,2021,Q4,Adult
151355882,15135588,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 iU, QD",,,D,,,,21081.0,16.0,IU,Solution for injection,QD,2021,Q4,Death,,2021,Q4,2,F,20180623.0,20180623.0,20180712,20211215,EXP,,IN-SA-2018SA170522,SANOFI AVENTIS,,71.0,YR,E,M,Y,80.0,KG,20211215.0,,CN,IN,IN,2021,Q4,Elderly
1518334321,15183343,131,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Blister,,2021,Q4,21,F,20010703.0,20211005.0,20180723,20211008,EXP,,GB-MYLANLABS-2018M1053534,MYLAN,,73.0,YR,,F,Y,69.0,KG,20211008.0,,MD,DE,DE,2021,Q4,Elderly
1518334321,15183343,131,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Erythema,,2021,Q4,21,F,20010703.0,20211005.0,20180723,20211008,EXP,,GB-MYLANLABS-2018M1053534,MYLAN,,73.0,YR,,F,Y,69.0,KG,20211008.0,,MD,DE,DE,2021,Q4,Elderly
1518334321,15183343,131,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Multiple organ dysfunction syndrome,,2021,Q4,21,F,20010703.0,20211005.0,20180723,20211008,EXP,,GB-MYLANLABS-2018M1053534,MYLAN,,73.0,YR,,F,Y,69.0,KG,20211008.0,,MD,DE,DE,2021,Q4,Elderly
1518334321,15183343,131,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Toxic epidermal necrolysis,,2021,Q4,21,F,20010703.0,20211005.0,20180723,20211008,EXP,,GB-MYLANLABS-2018M1053534,MYLAN,,73.0,YR,,F,Y,69.0,KG,20211008.0,,MD,DE,DE,2021,Q4,Elderly
1518334321,15183343,131,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Respiratory disorder,,2021,Q4,21,F,20010703.0,20211005.0,20180723,20211008,EXP,,GB-MYLANLABS-2018M1053534,MYLAN,,73.0,YR,,F,Y,69.0,KG,20211008.0,,MD,DE,DE,2021,Q4,Elderly
1518334321,15183343,131,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Cholelithiasis,,2021,Q4,21,F,20010703.0,20211005.0,20180723,20211008,EXP,,GB-MYLANLABS-2018M1053534,MYLAN,,73.0,YR,,F,Y,69.0,KG,20211008.0,,MD,DE,DE,2021,Q4,Elderly
1518334321,15183343,131,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Restlessness,,2021,Q4,21,F,20010703.0,20211005.0,20180723,20211008,EXP,,GB-MYLANLABS-2018M1053534,MYLAN,,73.0,YR,,F,Y,69.0,KG,20211008.0,,MD,DE,DE,2021,Q4,Elderly
1518334321,15183343,131,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Dermatitis exfoliative,,2021,Q4,21,F,20010703.0,20211005.0,20180723,20211008,EXP,,GB-MYLANLABS-2018M1053534,MYLAN,,73.0,YR,,F,Y,69.0,KG,20211008.0,,MD,DE,DE,2021,Q4,Elderly
1518334321,15183343,131,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Nausea,,2021,Q4,21,F,20010703.0,20211005.0,20180723,20211008,EXP,,GB-MYLANLABS-2018M1053534,MYLAN,,73.0,YR,,F,Y,69.0,KG,20211008.0,,MD,DE,DE,2021,Q4,Elderly
1518334321,15183343,131,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,21,F,20010703.0,20211005.0,20180723,20211008,EXP,,GB-MYLANLABS-2018M1053534,MYLAN,,73.0,YR,,F,Y,69.0,KG,20211008.0,,MD,DE,DE,2021,Q4,Elderly
1518334321,15183343,131,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Hyperthyroidism,,2021,Q4,21,F,20010703.0,20211005.0,20180723,20211008,EXP,,GB-MYLANLABS-2018M1053534,MYLAN,,73.0,YR,,F,Y,69.0,KG,20211008.0,,MD,DE,DE,2021,Q4,Elderly
1518334321,15183343,131,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Electrolyte imbalance,,2021,Q4,21,F,20010703.0,20211005.0,20180723,20211008,EXP,,GB-MYLANLABS-2018M1053534,MYLAN,,73.0,YR,,F,Y,69.0,KG,20211008.0,,MD,DE,DE,2021,Q4,Elderly
1518334321,15183343,131,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Condition aggravated,,2021,Q4,21,F,20010703.0,20211005.0,20180723,20211008,EXP,,GB-MYLANLABS-2018M1053534,MYLAN,,73.0,YR,,F,Y,69.0,KG,20211008.0,,MD,DE,DE,2021,Q4,Elderly
1518334321,15183343,131,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Cholecystitis,,2021,Q4,21,F,20010703.0,20211005.0,20180723,20211008,EXP,,GB-MYLANLABS-2018M1053534,MYLAN,,73.0,YR,,F,Y,69.0,KG,20211008.0,,MD,DE,DE,2021,Q4,Elderly
1518334321,15183343,132,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,16 international unit,,,,,,,,16.0,IU,,,2021,Q4,Blister,,2021,Q4,21,F,20010703.0,20211005.0,20180723,20211008,EXP,,GB-MYLANLABS-2018M1053534,MYLAN,,73.0,YR,,F,Y,69.0,KG,20211008.0,,MD,DE,DE,2021,Q4,Elderly
1518334321,15183343,132,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,16 international unit,,,,,,,,16.0,IU,,,2021,Q4,Erythema,,2021,Q4,21,F,20010703.0,20211005.0,20180723,20211008,EXP,,GB-MYLANLABS-2018M1053534,MYLAN,,73.0,YR,,F,Y,69.0,KG,20211008.0,,MD,DE,DE,2021,Q4,Elderly
1518334321,15183343,132,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,16 international unit,,,,,,,,16.0,IU,,,2021,Q4,Multiple organ dysfunction syndrome,,2021,Q4,21,F,20010703.0,20211005.0,20180723,20211008,EXP,,GB-MYLANLABS-2018M1053534,MYLAN,,73.0,YR,,F,Y,69.0,KG,20211008.0,,MD,DE,DE,2021,Q4,Elderly
1518334321,15183343,132,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,16 international unit,,,,,,,,16.0,IU,,,2021,Q4,Toxic epidermal necrolysis,,2021,Q4,21,F,20010703.0,20211005.0,20180723,20211008,EXP,,GB-MYLANLABS-2018M1053534,MYLAN,,73.0,YR,,F,Y,69.0,KG,20211008.0,,MD,DE,DE,2021,Q4,Elderly
1518334321,15183343,132,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,16 international unit,,,,,,,,16.0,IU,,,2021,Q4,Respiratory disorder,,2021,Q4,21,F,20010703.0,20211005.0,20180723,20211008,EXP,,GB-MYLANLABS-2018M1053534,MYLAN,,73.0,YR,,F,Y,69.0,KG,20211008.0,,MD,DE,DE,2021,Q4,Elderly
1518334321,15183343,132,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,16 international unit,,,,,,,,16.0,IU,,,2021,Q4,Cholelithiasis,,2021,Q4,21,F,20010703.0,20211005.0,20180723,20211008,EXP,,GB-MYLANLABS-2018M1053534,MYLAN,,73.0,YR,,F,Y,69.0,KG,20211008.0,,MD,DE,DE,2021,Q4,Elderly
1518334321,15183343,132,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,16 international unit,,,,,,,,16.0,IU,,,2021,Q4,Restlessness,,2021,Q4,21,F,20010703.0,20211005.0,20180723,20211008,EXP,,GB-MYLANLABS-2018M1053534,MYLAN,,73.0,YR,,F,Y,69.0,KG,20211008.0,,MD,DE,DE,2021,Q4,Elderly
1518334321,15183343,132,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,16 international unit,,,,,,,,16.0,IU,,,2021,Q4,Dermatitis exfoliative,,2021,Q4,21,F,20010703.0,20211005.0,20180723,20211008,EXP,,GB-MYLANLABS-2018M1053534,MYLAN,,73.0,YR,,F,Y,69.0,KG,20211008.0,,MD,DE,DE,2021,Q4,Elderly
1518334321,15183343,132,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,16 international unit,,,,,,,,16.0,IU,,,2021,Q4,Nausea,,2021,Q4,21,F,20010703.0,20211005.0,20180723,20211008,EXP,,GB-MYLANLABS-2018M1053534,MYLAN,,73.0,YR,,F,Y,69.0,KG,20211008.0,,MD,DE,DE,2021,Q4,Elderly
1518334321,15183343,132,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,16 international unit,,,,,,,,16.0,IU,,,2021,Q4,Diarrhoea,,2021,Q4,21,F,20010703.0,20211005.0,20180723,20211008,EXP,,GB-MYLANLABS-2018M1053534,MYLAN,,73.0,YR,,F,Y,69.0,KG,20211008.0,,MD,DE,DE,2021,Q4,Elderly
1518334321,15183343,132,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,16 international unit,,,,,,,,16.0,IU,,,2021,Q4,Hyperthyroidism,,2021,Q4,21,F,20010703.0,20211005.0,20180723,20211008,EXP,,GB-MYLANLABS-2018M1053534,MYLAN,,73.0,YR,,F,Y,69.0,KG,20211008.0,,MD,DE,DE,2021,Q4,Elderly
1518334321,15183343,132,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,16 international unit,,,,,,,,16.0,IU,,,2021,Q4,Electrolyte imbalance,,2021,Q4,21,F,20010703.0,20211005.0,20180723,20211008,EXP,,GB-MYLANLABS-2018M1053534,MYLAN,,73.0,YR,,F,Y,69.0,KG,20211008.0,,MD,DE,DE,2021,Q4,Elderly
1518334321,15183343,132,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,16 international unit,,,,,,,,16.0,IU,,,2021,Q4,Condition aggravated,,2021,Q4,21,F,20010703.0,20211005.0,20180723,20211008,EXP,,GB-MYLANLABS-2018M1053534,MYLAN,,73.0,YR,,F,Y,69.0,KG,20211008.0,,MD,DE,DE,2021,Q4,Elderly
1518334321,15183343,132,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,16 international unit,,,,,,,,16.0,IU,,,2021,Q4,Cholecystitis,,2021,Q4,21,F,20010703.0,20211005.0,20180723,20211008,EXP,,GB-MYLANLABS-2018M1053534,MYLAN,,73.0,YR,,F,Y,69.0,KG,20211008.0,,MD,DE,DE,2021,Q4,Elderly
152008112,15200811,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"23 iU,QD",,,D,,,,,23.0,IU,Solution for injection,QD,2021,Q4,Condition aggravated,,2021,Q4,2,F,20170101.0,20211217.0,20180726,20211222,EXP,ES-EMA-DD-20171204-KUMARNVEVHP-115719,ES-SA-2017SA196930,SANOFI AVENTIS,,83.0,YR,E,M,Y,,,20211222.0,,CN,ES,ES,2021,Q4,Elderly
152008112,15200811,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"23 iU,QD",,,D,,,,,23.0,IU,Solution for injection,QD,2021,Q4,Bedridden,,2021,Q4,2,F,20170101.0,20211217.0,20180726,20211222,EXP,ES-EMA-DD-20171204-KUMARNVEVHP-115719,ES-SA-2017SA196930,SANOFI AVENTIS,,83.0,YR,E,M,Y,,,20211222.0,,CN,ES,ES,2021,Q4,Elderly
152008112,15200811,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"23 iU,QD",,,D,,,,,23.0,IU,Solution for injection,QD,2021,Q4,Respiratory failure,,2021,Q4,2,F,20170101.0,20211217.0,20180726,20211222,EXP,ES-EMA-DD-20171204-KUMARNVEVHP-115719,ES-SA-2017SA196930,SANOFI AVENTIS,,83.0,YR,E,M,Y,,,20211222.0,,CN,ES,ES,2021,Q4,Elderly
152008112,15200811,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"23 iU,QD",,,D,,,,,23.0,IU,Solution for injection,QD,2021,Q4,Decreased appetite,,2021,Q4,2,F,20170101.0,20211217.0,20180726,20211222,EXP,ES-EMA-DD-20171204-KUMARNVEVHP-115719,ES-SA-2017SA196930,SANOFI AVENTIS,,83.0,YR,E,M,Y,,,20211222.0,,CN,ES,ES,2021,Q4,Elderly
154818752,15481875,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Vomiting,,2021,Q4,2,F,20180502.0,20211013.0,20181010,20211018,PER,,US-AMGEN-USACT2018140585,AMGEN,,53.0,YR,A,M,Y,99.7,KG,20211018.0,,MD,US,US,2021,Q4,Adult
154818752,15481875,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Mental disorder,,2021,Q4,2,F,20180502.0,20211013.0,20181010,20211018,PER,,US-AMGEN-USACT2018140585,AMGEN,,53.0,YR,A,M,Y,99.7,KG,20211018.0,,MD,US,US,2021,Q4,Adult
154818752,15481875,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Pancreatitis,,2021,Q4,2,F,20180502.0,20211013.0,20181010,20211018,PER,,US-AMGEN-USACT2018140585,AMGEN,,53.0,YR,A,M,Y,99.7,KG,20211018.0,,MD,US,US,2021,Q4,Adult
154818752,15481875,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Hypertriglyceridaemia,,2021,Q4,2,F,20180502.0,20211013.0,20181010,20211018,PER,,US-AMGEN-USACT2018140585,AMGEN,,53.0,YR,A,M,Y,99.7,KG,20211018.0,,MD,US,US,2021,Q4,Adult
154818752,15481875,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Metabolic disorder,,2021,Q4,2,F,20180502.0,20211013.0,20181010,20211018,PER,,US-AMGEN-USACT2018140585,AMGEN,,53.0,YR,A,M,Y,99.7,KG,20211018.0,,MD,US,US,2021,Q4,Adult
1572525113,15725251,50,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, Once a Day (daily at bed time)",,,U,,,,,,,Solution,QD,2021,Q4,Drug ineffective,,2021,Q4,13,F,,20211028.0,20181215,20211112,EXP,,CA-AUROBINDO-AUR-APL-2018-059432,AUROBINDO,"Yang A, Brown J, Mak E. Persistent diarrhea after celiac plexus block in a pancreatic cancer patient: Case report and literature review. Journal of Palliative Medicine. 2016;19(1):83-6",70.0,YR,,F,Y,,,20211112.0,,MD,CA,CA,2021,Q4,Elderly
1572525113,15725251,50,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, Once a Day (daily at bed time)",,,U,,,,,,,Solution,QD,2021,Q4,Anaphylactic reaction,,2021,Q4,13,F,,20211028.0,20181215,20211112,EXP,,CA-AUROBINDO-AUR-APL-2018-059432,AUROBINDO,"Yang A, Brown J, Mak E. Persistent diarrhea after celiac plexus block in a pancreatic cancer patient: Case report and literature review. Journal of Palliative Medicine. 2016;19(1):83-6",70.0,YR,,F,Y,,,20211112.0,,MD,CA,CA,2021,Q4,Elderly
1572525113,15725251,50,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, Once a Day (daily at bed time)",,,U,,,,,,,Solution,QD,2021,Q4,Drug intolerance,,2021,Q4,13,F,,20211028.0,20181215,20211112,EXP,,CA-AUROBINDO-AUR-APL-2018-059432,AUROBINDO,"Yang A, Brown J, Mak E. Persistent diarrhea after celiac plexus block in a pancreatic cancer patient: Case report and literature review. Journal of Palliative Medicine. 2016;19(1):83-6",70.0,YR,,F,Y,,,20211112.0,,MD,CA,CA,2021,Q4,Elderly
161236889,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 international unit, qd",,,D,,,,,26.0,IU,,QD,2021,Q4,Pulmonary congestion,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 international unit, qd",,,D,,,,,26.0,IU,,QD,2021,Q4,Atrial fibrillation,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 international unit, qd",,,D,,,,,26.0,IU,,QD,2021,Q4,Skin disorder,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 international unit, qd",,,D,,,,,26.0,IU,,QD,2021,Q4,Arrhythmia,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 international unit, qd",,,D,,,,,26.0,IU,,QD,2021,Q4,Presyncope,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 international unit, qd",,,D,,,,,26.0,IU,,QD,2021,Q4,Drug interaction,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 international unit, qd",,,D,,,,,26.0,IU,,QD,2021,Q4,Dizziness,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 international unit, qd",,,D,,,,,26.0,IU,,QD,2021,Q4,Dehydration,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 international unit, qd",,,D,,,,,26.0,IU,,QD,2021,Q4,Acute kidney injury,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 international unit, qd",,,D,,,,,26.0,IU,,QD,2021,Q4,Renal disorder,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 international unit, qd",,,D,,,,,26.0,IU,,QD,2021,Q4,Heart rate irregular,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 international unit, qd",,,D,,,,,26.0,IU,,QD,2021,Q4,Mucosal dryness,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 international unit, qd",,,D,,,,,26.0,IU,,QD,2021,Q4,Hypovolaemia,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 international unit, qd",,,D,,,,,26.0,IU,,QD,2021,Q4,Syncope,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 international unit, qd",,,D,,,,,26.0,IU,,QD,2021,Q4,Haematocrit increased,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 international unit, qd",,,D,,,,,26.0,IU,,QD,2021,Q4,Haemoglobin increased,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 international unit, qd",,,D,,,,,26.0,IU,,QD,2021,Q4,Left atrial dilatation,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 international unit, qd",,,D,,,,,26.0,IU,,QD,2021,Q4,Hypotension,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 international unit, qd",,,D,,,,,26.0,IU,,QD,2021,Q4,Oedema peripheral,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 international unit, qd",,,D,,,,,26.0,IU,,QD,2021,Q4,Bradycardia,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Pulmonary congestion,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Atrial fibrillation,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Skin disorder,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Arrhythmia,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Presyncope,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Drug interaction,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Dizziness,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Dehydration,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Acute kidney injury,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Renal disorder,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Heart rate irregular,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Mucosal dryness,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Hypovolaemia,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Syncope,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Haematocrit increased,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Haemoglobin increased,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Left atrial dilatation,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Hypotension,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Oedema peripheral,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Bradycardia,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
164503743,16450374,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Neutropenia,,2021,Q4,3,F,20181201.0,20210927.0,20190619,20211001,EXP,,JP-GILEAD-2019-0413528,GILEAD,,44.0,YR,A,M,Y,,,20211001.0,,MD,JP,JP,2021,Q4,Adult
165219739,16521973,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Serum sickness,,2021,Q4,9,F,20181122.0,20211025.0,20190702,20211101,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,69.0,YR,,F,Y,83.3,KG,20211101.0,,MD,FR,FR,2021,Q4,Elderly
165219739,16521973,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Pyelonephritis,,2021,Q4,9,F,20181122.0,20211025.0,20190702,20211101,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,69.0,YR,,F,Y,83.3,KG,20211101.0,,MD,FR,FR,2021,Q4,Elderly
165219739,16521973,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Underdose,,2021,Q4,9,F,20181122.0,20211025.0,20190702,20211101,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,69.0,YR,,F,Y,83.3,KG,20211101.0,,MD,FR,FR,2021,Q4,Elderly
165219739,16521973,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Hypervolaemia,,2021,Q4,9,F,20181122.0,20211025.0,20190702,20211101,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,69.0,YR,,F,Y,83.3,KG,20211101.0,,MD,FR,FR,2021,Q4,Elderly
165219739,16521973,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Acidosis,,2021,Q4,9,F,20181122.0,20211025.0,20190702,20211101,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,69.0,YR,,F,Y,83.3,KG,20211101.0,,MD,FR,FR,2021,Q4,Elderly
165219739,16521973,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Blood creatine increased,,2021,Q4,9,F,20181122.0,20211025.0,20190702,20211101,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,69.0,YR,,F,Y,83.3,KG,20211101.0,,MD,FR,FR,2021,Q4,Elderly
165219739,16521973,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Hypertension,,2021,Q4,9,F,20181122.0,20211025.0,20190702,20211101,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,69.0,YR,,F,Y,83.3,KG,20211101.0,,MD,FR,FR,2021,Q4,Elderly
165219739,16521973,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Hypomagnesaemia,,2021,Q4,9,F,20181122.0,20211025.0,20190702,20211101,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,69.0,YR,,F,Y,83.3,KG,20211101.0,,MD,FR,FR,2021,Q4,Elderly
165219739,16521973,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Hyperkalaemia,,2021,Q4,9,F,20181122.0,20211025.0,20190702,20211101,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,69.0,YR,,F,Y,83.3,KG,20211101.0,,MD,FR,FR,2021,Q4,Elderly
165219739,16521973,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Haematuria,,2021,Q4,9,F,20181122.0,20211025.0,20190702,20211101,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,69.0,YR,,F,Y,83.3,KG,20211101.0,,MD,FR,FR,2021,Q4,Elderly
165219739,16521973,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Overdose,,2021,Q4,9,F,20181122.0,20211025.0,20190702,20211101,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,69.0,YR,,F,Y,83.3,KG,20211101.0,,MD,FR,FR,2021,Q4,Elderly
165219739,16521973,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Cardiac disorder,,2021,Q4,9,F,20181122.0,20211025.0,20190702,20211101,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,69.0,YR,,F,Y,83.3,KG,20211101.0,,MD,FR,FR,2021,Q4,Elderly
165219739,16521973,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Carotid artery stenosis,,2021,Q4,9,F,20181122.0,20211025.0,20190702,20211101,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,69.0,YR,,F,Y,83.3,KG,20211101.0,,MD,FR,FR,2021,Q4,Elderly
165219739,16521973,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Nausea,,2021,Q4,9,F,20181122.0,20211025.0,20190702,20211101,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,69.0,YR,,F,Y,83.3,KG,20211101.0,,MD,FR,FR,2021,Q4,Elderly
165219739,16521973,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Renal impairment,,2021,Q4,9,F,20181122.0,20211025.0,20190702,20211101,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,69.0,YR,,F,Y,83.3,KG,20211101.0,,MD,FR,FR,2021,Q4,Elderly
165219739,16521973,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,9,F,20181122.0,20211025.0,20190702,20211101,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,69.0,YR,,F,Y,83.3,KG,20211101.0,,MD,FR,FR,2021,Q4,Elderly
167281036,16728103,44,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2021,Q4,Drug intolerance,,2021,Q4,6,F,,20211028.0,20190822,20211111,EXP,,CA-AUROBINDO-AUR-APL-2019-054279,AUROBINDO,,70.0,YR,,F,Y,,,20211111.0,,MD,CA,CA,2021,Q4,Elderly
167281036,16728103,44,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2021,Q4,Anaphylactic reaction,,2021,Q4,6,F,,20211028.0,20190822,20211111,EXP,,CA-AUROBINDO-AUR-APL-2019-054279,AUROBINDO,,70.0,YR,,F,Y,,,20211111.0,,MD,CA,CA,2021,Q4,Elderly
1696951025,16969510,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,Injection,,2021,Q4,Myocardial injury,,2021,Q4,25,F,20191021.0,20211030.0,20191029,20211105,EXP,,CN-Eisai Medical Research-EC-2019-064326,EISAI,,62.0,YR,A,M,Y,69.0,KG,20211105.0,,MD,CN,,2021,Q4,Adult
170853522,17085352,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, Once a Day",,,U,,,,,,,,QD,2021,Q4,Blood pressure decreased,,2021,Q4,2,F,,20211022.0,20191128,20211030,EXP,,CA-AUROBINDO-AUR-APL-2019-074702,AUROBINDO,,64.0,YR,,M,Y,,,20211030.0,,CN,CA,CA,2021,Q4,Adult
170853522,17085352,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, Once a Day",,,U,,,,,,,,QD,2021,Q4,Hypersensitivity,,2021,Q4,2,F,,20211022.0,20191128,20211030,EXP,,CA-AUROBINDO-AUR-APL-2019-074702,AUROBINDO,,64.0,YR,,M,Y,,,20211030.0,,CN,CA,CA,2021,Q4,Adult
172074814,17207481,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Transdermal,UNK,,,U,,,,,,,Injection,,2021,Q4,Erythema,,2021,Q4,4,F,20191210.0,20211007.0,20191227,20211014,EXP,,NVSJ2019JP006136,NOVARTIS,,81.0,YR,,M,Y,58.4,KG,20211014.0,,MD,JP,JP,2021,Q4,Elderly
172074814,17207481,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Transdermal,UNK,,,U,,,,,,,Injection,,2021,Q4,Cellulitis,,2021,Q4,4,F,20191210.0,20211007.0,20191227,20211014,EXP,,NVSJ2019JP006136,NOVARTIS,,81.0,YR,,M,Y,58.4,KG,20211014.0,,MD,JP,JP,2021,Q4,Elderly
172074814,17207481,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Transdermal,UNK,,,U,,,,,,,Injection,,2021,Q4,Pyrexia,,2021,Q4,4,F,20191210.0,20211007.0,20191227,20211014,EXP,,NVSJ2019JP006136,NOVARTIS,,81.0,YR,,M,Y,58.4,KG,20211014.0,,MD,JP,JP,2021,Q4,Elderly
172074814,17207481,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Transdermal,UNK,,,U,,,,,,,Injection,,2021,Q4,Blood pressure decreased,,2021,Q4,4,F,20191210.0,20211007.0,20191227,20211014,EXP,,NVSJ2019JP006136,NOVARTIS,,81.0,YR,,M,Y,58.4,KG,20211014.0,,MD,JP,JP,2021,Q4,Elderly
172074814,17207481,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Transdermal,UNK,,,U,,,,,,,Injection,,2021,Q4,Blood calcium increased,,2021,Q4,4,F,20191210.0,20211007.0,20191227,20211014,EXP,,NVSJ2019JP006136,NOVARTIS,,81.0,YR,,M,Y,58.4,KG,20211014.0,,MD,JP,JP,2021,Q4,Elderly
172074814,17207481,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Transdermal,UNK,,,U,,,,,,,Injection,,2021,Q4,Abscess limb,,2021,Q4,4,F,20191210.0,20211007.0,20191227,20211014,EXP,,NVSJ2019JP006136,NOVARTIS,,81.0,YR,,M,Y,58.4,KG,20211014.0,,MD,JP,JP,2021,Q4,Elderly
172074814,17207481,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Transdermal,UNK,,,U,,,,,,,Injection,,2021,Q4,Cerebral infarction,,2021,Q4,4,F,20191210.0,20211007.0,20191227,20211014,EXP,,NVSJ2019JP006136,NOVARTIS,,81.0,YR,,M,Y,58.4,KG,20211014.0,,MD,JP,JP,2021,Q4,Elderly
172074814,17207481,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Transdermal,UNK,,,U,,,,,,,Injection,,2021,Q4,Immobilisation syndrome,,2021,Q4,4,F,20191210.0,20211007.0,20191227,20211014,EXP,,NVSJ2019JP006136,NOVARTIS,,81.0,YR,,M,Y,58.4,KG,20211014.0,,MD,JP,JP,2021,Q4,Elderly
172074814,17207481,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Transdermal,UNK,,,U,,,,,,,Injection,,2021,Q4,Pain,,2021,Q4,4,F,20191210.0,20211007.0,20191227,20211014,EXP,,NVSJ2019JP006136,NOVARTIS,,81.0,YR,,M,Y,58.4,KG,20211014.0,,MD,JP,JP,2021,Q4,Elderly
175149062,17514906,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"85 iU, Q12H",,,,,9F050A,,21081.0,85.0,IU,Solution for injection,Q12H,2021,Q4,Blindness unilateral,,2021,Q4,2,F,,20211013.0,20200309,20211019,EXP,,US-SA-2020SA055264,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20211019.0,,CN,US,US,2021,Q4,Elderly
175149062,17514906,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"85 iU, Q12H",,,,,9F050A,,21081.0,85.0,IU,Solution for injection,Q12H,2021,Q4,Visual impairment,,2021,Q4,2,F,,20211013.0,20200309,20211019,EXP,,US-SA-2020SA055264,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20211019.0,,CN,US,US,2021,Q4,Elderly
175149062,17514906,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"85 iU, Q12H",,,,,9F050A,,21081.0,85.0,IU,Solution for injection,Q12H,2021,Q4,Product storage error,,2021,Q4,2,F,,20211013.0,20200309,20211019,EXP,,US-SA-2020SA055264,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20211019.0,,CN,US,US,2021,Q4,Elderly
175149062,17514906,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"85 iU, Q12H",,,,,9F050A,,21081.0,85.0,IU,Solution for injection,Q12H,2021,Q4,Inappropriate schedule of product administration,,2021,Q4,2,F,,20211013.0,20200309,20211019,EXP,,US-SA-2020SA055264,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20211019.0,,CN,US,US,2021,Q4,Elderly
175246226,17524622,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 international unit, qd (20 iU, per day)",,,U,U,,,210605.0,20.0,IU,Injection,QD,2021,Q4,Toxic skin eruption,,2021,Q4,6,F,20190610.0,20211125.0,20200310,20211201,EXP,,ES-MYLANLABS-2020M1025374,MYLAN,"Gonzalez-Estriegana S, del Rio-Lechuga A, Oneto-Otero J. Fever and skin lesions: does it have to do with the heart. Rev Esp Casos Clin Med Intern. 2019;4(3):134-136",73.0,YR,,F,Y,,,20211201.0,,MD,ES,ES,2021,Q4,Elderly
175246226,17524622,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 international unit, qd (20 iU, per day)",,,U,U,,,210605.0,20.0,IU,Injection,QD,2021,Q4,Erythema multiforme,,2021,Q4,6,F,20190610.0,20211125.0,20200310,20211201,EXP,,ES-MYLANLABS-2020M1025374,MYLAN,"Gonzalez-Estriegana S, del Rio-Lechuga A, Oneto-Otero J. Fever and skin lesions: does it have to do with the heart. Rev Esp Casos Clin Med Intern. 2019;4(3):134-136",73.0,YR,,F,Y,,,20211201.0,,MD,ES,ES,2021,Q4,Elderly
175246226,17524622,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 international unit, qd (20 iU, per day)",,,U,U,,,210605.0,20.0,IU,Injection,QD,2021,Q4,Pyrexia,,2021,Q4,6,F,20190610.0,20211125.0,20200310,20211201,EXP,,ES-MYLANLABS-2020M1025374,MYLAN,"Gonzalez-Estriegana S, del Rio-Lechuga A, Oneto-Otero J. Fever and skin lesions: does it have to do with the heart. Rev Esp Casos Clin Med Intern. 2019;4(3):134-136",73.0,YR,,F,Y,,,20211201.0,,MD,ES,ES,2021,Q4,Elderly
175539607,17553960,19,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Blood pressure increased,,2021,Q4,7,F,20191119.0,20211119.0,20200317,20211129,EXP,,JP-BEH-2020114465,CSL BEHRING,,36.0,YR,A,M,Y,95.6,KG,20211129.0,,MD,JP,JP,2021,Q4,Adult
175539607,17553960,19,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Oedema peripheral,,2021,Q4,7,F,20191119.0,20211119.0,20200317,20211129,EXP,,JP-BEH-2020114465,CSL BEHRING,,36.0,YR,A,M,Y,95.6,KG,20211129.0,,MD,JP,JP,2021,Q4,Adult
175539607,17553960,19,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Hypertension,,2021,Q4,7,F,20191119.0,20211119.0,20200317,20211129,EXP,,JP-BEH-2020114465,CSL BEHRING,,36.0,YR,A,M,Y,95.6,KG,20211129.0,,MD,JP,JP,2021,Q4,Adult
175539607,17553960,19,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Renal impairment,,2021,Q4,7,F,20191119.0,20211119.0,20200317,20211129,EXP,,JP-BEH-2020114465,CSL BEHRING,,36.0,YR,A,M,Y,95.6,KG,20211129.0,,MD,JP,JP,2021,Q4,Adult
175539607,17553960,19,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Protein urine present,,2021,Q4,7,F,20191119.0,20211119.0,20200317,20211129,EXP,,JP-BEH-2020114465,CSL BEHRING,,36.0,YR,A,M,Y,95.6,KG,20211129.0,,MD,JP,JP,2021,Q4,Adult
175539607,17553960,19,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Diabetic nephropathy,,2021,Q4,7,F,20191119.0,20211119.0,20200317,20211129,EXP,,JP-BEH-2020114465,CSL BEHRING,,36.0,YR,A,M,Y,95.6,KG,20211129.0,,MD,JP,JP,2021,Q4,Adult
175539607,17553960,19,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Oedema,,2021,Q4,7,F,20191119.0,20211119.0,20200317,20211129,EXP,,JP-BEH-2020114465,CSL BEHRING,,36.0,YR,A,M,Y,95.6,KG,20211129.0,,MD,JP,JP,2021,Q4,Adult
175699477,17569947,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Liver transplant,,2021,Q4,7,F,20200218.0,20211116.0,20200323,20211118,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-023877,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,86.0,KG,20211118.0,,HP,DE,DE,2021,Q4,Elderly
175699477,17569947,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Cholangitis,,2021,Q4,7,F,20200218.0,20211116.0,20200323,20211118,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-023877,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,86.0,KG,20211118.0,,HP,DE,DE,2021,Q4,Elderly
175699477,17569947,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Liver transplant rejection,,2021,Q4,7,F,20200218.0,20211116.0,20200323,20211118,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-023877,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,86.0,KG,20211118.0,,HP,DE,DE,2021,Q4,Elderly
175730324,17573032,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Febrile neutropenia,,2021,Q4,4,F,20191029.0,20211108.0,20200323,20211121,EXP,,DE-009507513-2003DEU005886,MERCK,,70.0,YR,,M,Y,98.6,KG,20211121.0,,MD,DE,DE,2021,Q4,Elderly
175730324,17573032,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Myocardial ischaemia,,2021,Q4,4,F,20191029.0,20211108.0,20200323,20211121,EXP,,DE-009507513-2003DEU005886,MERCK,,70.0,YR,,M,Y,98.6,KG,20211121.0,,MD,DE,DE,2021,Q4,Elderly
175730324,17573032,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Blood lactate dehydrogenase increased,,2021,Q4,4,F,20191029.0,20211108.0,20200323,20211121,EXP,,DE-009507513-2003DEU005886,MERCK,,70.0,YR,,M,Y,98.6,KG,20211121.0,,MD,DE,DE,2021,Q4,Elderly
177337353,17733735,40,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Chronic kidney disease,,2021,Q4,3,F,20040101.0,20211122.0,20200501,20211129,EXP,,US-AstraZeneca-2020SE56744,ASTRAZENECA,,46.0,YR,,F,Y,78.5,KG,20211130.0,,LW,US,,2021,Q4,Adult
177337353,17733735,40,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Gastrooesophageal reflux disease,,2021,Q4,3,F,20040101.0,20211122.0,20200501,20211129,EXP,,US-AstraZeneca-2020SE56744,ASTRAZENECA,,46.0,YR,,F,Y,78.5,KG,20211130.0,,LW,US,,2021,Q4,Adult
177337353,17733735,40,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Renal tubular necrosis,,2021,Q4,3,F,20040101.0,20211122.0,20200501,20211129,EXP,,US-AstraZeneca-2020SE56744,ASTRAZENECA,,46.0,YR,,F,Y,78.5,KG,20211130.0,,LW,US,,2021,Q4,Adult
177337353,17733735,40,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Acute kidney injury,,2021,Q4,3,F,20040101.0,20211122.0,20200501,20211129,EXP,,US-AstraZeneca-2020SE56744,ASTRAZENECA,,46.0,YR,,F,Y,78.5,KG,20211130.0,,LW,US,,2021,Q4,Adult
177337353,17733735,40,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Renal failure,,2021,Q4,3,F,20040101.0,20211122.0,20200501,20211129,EXP,,US-AstraZeneca-2020SE56744,ASTRAZENECA,,46.0,YR,,F,Y,78.5,KG,20211130.0,,LW,US,,2021,Q4,Adult
177337353,17733735,40,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,End stage renal disease,,2021,Q4,3,F,20040101.0,20211122.0,20200501,20211129,EXP,,US-AstraZeneca-2020SE56744,ASTRAZENECA,,46.0,YR,,F,Y,78.5,KG,20211130.0,,LW,US,,2021,Q4,Adult
177411815,17741181,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,U,,,,,20.0,IU,,QD,2021,Q4,Pyrexia,,2021,Q4,5,F,20190610.0,20211013.0,20200504,20211019,EXP,,NVSC2020ES115050,NOVARTIS,"Gonzaaez-Estriegana S, Rio-Lechuga A, Oneto-Otero J. Fever and skin lesions: does it have to do with the heart?. REV ESP CASOS CLIN MED INTERN. 2019;4(3):134-6",73.0,YR,,F,Y,,,20211019.0,,HP,ES,ES,2021,Q4,Elderly
177411815,17741181,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,U,,,,,20.0,IU,,QD,2021,Q4,Toxic skin eruption,,2021,Q4,5,F,20190610.0,20211013.0,20200504,20211019,EXP,,NVSC2020ES115050,NOVARTIS,"Gonzaaez-Estriegana S, Rio-Lechuga A, Oneto-Otero J. Fever and skin lesions: does it have to do with the heart?. REV ESP CASOS CLIN MED INTERN. 2019;4(3):134-6",73.0,YR,,F,Y,,,20211019.0,,HP,ES,ES,2021,Q4,Elderly
177411815,17741181,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,U,,,,,20.0,IU,,QD,2021,Q4,Erythema multiforme,,2021,Q4,5,F,20190610.0,20211013.0,20200504,20211019,EXP,,NVSC2020ES115050,NOVARTIS,"Gonzaaez-Estriegana S, Rio-Lechuga A, Oneto-Otero J. Fever and skin lesions: does it have to do with the heart?. REV ESP CASOS CLIN MED INTERN. 2019;4(3):134-6",73.0,YR,,F,Y,,,20211019.0,,HP,ES,ES,2021,Q4,Elderly
177488648,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Vomiting,,2021,Q4,8,F,20191117.0,20211116.0,20200506,20211123,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20211123.0,,HP,COUNTRY NOT SPECIFIED,NL,2021,Q4,Adult
177488648,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Panic reaction,,2021,Q4,8,F,20191117.0,20211116.0,20200506,20211123,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20211123.0,,HP,COUNTRY NOT SPECIFIED,NL,2021,Q4,Adult
177488648,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Abdominal pain,,2021,Q4,8,F,20191117.0,20211116.0,20200506,20211123,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20211123.0,,HP,COUNTRY NOT SPECIFIED,NL,2021,Q4,Adult
177488648,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Depressed mood,,2021,Q4,8,F,20191117.0,20211116.0,20200506,20211123,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20211123.0,,HP,COUNTRY NOT SPECIFIED,NL,2021,Q4,Adult
177488648,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Abdominal pain,,2021,Q4,8,F,20191117.0,20211116.0,20200506,20211123,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20211123.0,,HP,COUNTRY NOT SPECIFIED,NL,2021,Q4,Adult
177488648,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Tremor,,2021,Q4,8,F,20191117.0,20211116.0,20200506,20211123,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20211123.0,,HP,COUNTRY NOT SPECIFIED,NL,2021,Q4,Adult
177488648,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Impaired gastric emptying,,2021,Q4,8,F,20191117.0,20211116.0,20200506,20211123,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20211123.0,,HP,COUNTRY NOT SPECIFIED,NL,2021,Q4,Adult
177488648,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Limb operation,,2021,Q4,8,F,20191117.0,20211116.0,20200506,20211123,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20211123.0,,HP,COUNTRY NOT SPECIFIED,NL,2021,Q4,Adult
177488648,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Limb discomfort,,2021,Q4,8,F,20191117.0,20211116.0,20200506,20211123,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20211123.0,,HP,COUNTRY NOT SPECIFIED,NL,2021,Q4,Adult
177488648,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Living in residential institution,,2021,Q4,8,F,20191117.0,20211116.0,20200506,20211123,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20211123.0,,HP,COUNTRY NOT SPECIFIED,NL,2021,Q4,Adult
177488648,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Stress,,2021,Q4,8,F,20191117.0,20211116.0,20200506,20211123,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20211123.0,,HP,COUNTRY NOT SPECIFIED,NL,2021,Q4,Adult
177488648,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Weight decreased,,2021,Q4,8,F,20191117.0,20211116.0,20200506,20211123,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20211123.0,,HP,COUNTRY NOT SPECIFIED,NL,2021,Q4,Adult
177488648,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Sleep disorder due to a general medical condition,,2021,Q4,8,F,20191117.0,20211116.0,20200506,20211123,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20211123.0,,HP,COUNTRY NOT SPECIFIED,NL,2021,Q4,Adult
177488648,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Impaired quality of life,,2021,Q4,8,F,20191117.0,20211116.0,20200506,20211123,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20211123.0,,HP,COUNTRY NOT SPECIFIED,NL,2021,Q4,Adult
177488648,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Depressed mood,,2021,Q4,8,F,20191117.0,20211116.0,20200506,20211123,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20211123.0,,HP,COUNTRY NOT SPECIFIED,NL,2021,Q4,Adult
177488648,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Muscular weakness,,2021,Q4,8,F,20191117.0,20211116.0,20200506,20211123,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20211123.0,,HP,COUNTRY NOT SPECIFIED,NL,2021,Q4,Adult
177488648,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Psychiatric symptom,,2021,Q4,8,F,20191117.0,20211116.0,20200506,20211123,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20211123.0,,HP,COUNTRY NOT SPECIFIED,NL,2021,Q4,Adult
177488648,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Protein total increased,,2021,Q4,8,F,20191117.0,20211116.0,20200506,20211123,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20211123.0,,HP,COUNTRY NOT SPECIFIED,NL,2021,Q4,Adult
177488648,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Dyskinesia,,2021,Q4,8,F,20191117.0,20211116.0,20200506,20211123,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20211123.0,,HP,COUNTRY NOT SPECIFIED,NL,2021,Q4,Adult
177488648,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Mood altered,,2021,Q4,8,F,20191117.0,20211116.0,20200506,20211123,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20211123.0,,HP,COUNTRY NOT SPECIFIED,NL,2021,Q4,Adult
177488648,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Nausea,,2021,Q4,8,F,20191117.0,20211116.0,20200506,20211123,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20211123.0,,HP,COUNTRY NOT SPECIFIED,NL,2021,Q4,Adult
177488648,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Abdominal pain,,2021,Q4,8,F,20191117.0,20211116.0,20200506,20211123,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20211123.0,,HP,COUNTRY NOT SPECIFIED,NL,2021,Q4,Adult
177488648,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Crying,,2021,Q4,8,F,20191117.0,20211116.0,20200506,20211123,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20211123.0,,HP,COUNTRY NOT SPECIFIED,NL,2021,Q4,Adult
177488648,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Stoma site erythema,,2021,Q4,8,F,20191117.0,20211116.0,20200506,20211123,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20211123.0,,HP,COUNTRY NOT SPECIFIED,NL,2021,Q4,Adult
177488648,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Transferrin decreased,,2021,Q4,8,F,20191117.0,20211116.0,20200506,20211123,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20211123.0,,HP,COUNTRY NOT SPECIFIED,NL,2021,Q4,Adult
177488648,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Muscle rigidity,,2021,Q4,8,F,20191117.0,20211116.0,20200506,20211123,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20211123.0,,HP,COUNTRY NOT SPECIFIED,NL,2021,Q4,Adult
177488648,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Fall,,2021,Q4,8,F,20191117.0,20211116.0,20200506,20211123,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20211123.0,,HP,COUNTRY NOT SPECIFIED,NL,2021,Q4,Adult
177488648,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Depressed mood,,2021,Q4,8,F,20191117.0,20211116.0,20200506,20211123,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20211123.0,,HP,COUNTRY NOT SPECIFIED,NL,2021,Q4,Adult
177488648,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Malaise,,2021,Q4,8,F,20191117.0,20211116.0,20200506,20211123,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20211123.0,,HP,COUNTRY NOT SPECIFIED,NL,2021,Q4,Adult
177488648,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Pallor,,2021,Q4,8,F,20191117.0,20211116.0,20200506,20211123,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20211123.0,,HP,COUNTRY NOT SPECIFIED,NL,2021,Q4,Adult
177488648,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Serum ferritin increased,,2021,Q4,8,F,20191117.0,20211116.0,20200506,20211123,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20211123.0,,HP,COUNTRY NOT SPECIFIED,NL,2021,Q4,Adult
177488648,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Procedural pain,,2021,Q4,8,F,20191117.0,20211116.0,20200506,20211123,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20211123.0,,HP,COUNTRY NOT SPECIFIED,NL,2021,Q4,Adult
177488648,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Memory impairment,,2021,Q4,8,F,20191117.0,20211116.0,20200506,20211123,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20211123.0,,HP,COUNTRY NOT SPECIFIED,NL,2021,Q4,Adult
177488648,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Confusional state,,2021,Q4,8,F,20191117.0,20211116.0,20200506,20211123,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20211123.0,,HP,COUNTRY NOT SPECIFIED,NL,2021,Q4,Adult
177488648,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Therapeutic response shortened,,2021,Q4,8,F,20191117.0,20211116.0,20200506,20211123,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20211123.0,,HP,COUNTRY NOT SPECIFIED,NL,2021,Q4,Adult
177488648,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Gait disturbance,,2021,Q4,8,F,20191117.0,20211116.0,20200506,20211123,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20211123.0,,HP,COUNTRY NOT SPECIFIED,NL,2021,Q4,Adult
177488648,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,8,F,20191117.0,20211116.0,20200506,20211123,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20211123.0,,HP,COUNTRY NOT SPECIFIED,NL,2021,Q4,Adult
177488648,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Urinary tract infection,,2021,Q4,8,F,20191117.0,20211116.0,20200506,20211123,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20211123.0,,HP,COUNTRY NOT SPECIFIED,NL,2021,Q4,Adult
177488648,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,On and off phenomenon,,2021,Q4,8,F,20191117.0,20211116.0,20200506,20211123,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20211123.0,,HP,COUNTRY NOT SPECIFIED,NL,2021,Q4,Adult
177488648,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Nausea,,2021,Q4,8,F,20191117.0,20211116.0,20200506,20211123,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20211123.0,,HP,COUNTRY NOT SPECIFIED,NL,2021,Q4,Adult
177488648,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Tension,,2021,Q4,8,F,20191117.0,20211116.0,20200506,20211123,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20211123.0,,HP,COUNTRY NOT SPECIFIED,NL,2021,Q4,Adult
177488648,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Dyskinesia,,2021,Q4,8,F,20191117.0,20211116.0,20200506,20211123,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20211123.0,,HP,COUNTRY NOT SPECIFIED,NL,2021,Q4,Adult
177488648,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Stoma site infection,,2021,Q4,8,F,20191117.0,20211116.0,20200506,20211123,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20211123.0,,HP,COUNTRY NOT SPECIFIED,NL,2021,Q4,Adult
177488648,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Therapeutic response shortened,,2021,Q4,8,F,20191117.0,20211116.0,20200506,20211123,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20211123.0,,HP,COUNTRY NOT SPECIFIED,NL,2021,Q4,Adult
178463275,17846327,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, dose reduced",,,Y,,,,,,,Solution for injection,,2021,Q4,Tremor,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, dose reduced",,,Y,,,,,,,Solution for injection,,2021,Q4,Intentional product misuse,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, dose reduced",,,Y,,,,,,,Solution for injection,,2021,Q4,Drug ineffective,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, dose reduced",,,Y,,,,,,,Solution for injection,,2021,Q4,Depressed mood,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, dose reduced",,,Y,,,,,,,Solution for injection,,2021,Q4,Pseudohypoglycaemia,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, dose reduced",,,Y,,,,,,,Solution for injection,,2021,Q4,Diarrhoea,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, dose reduced",,,Y,,,,,,,Solution for injection,,2021,Q4,Malaise,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, dose reduced",,,Y,,,,,,,Solution for injection,,2021,Q4,Boredom,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, dose reduced",,,Y,,,,,,,Solution for injection,,2021,Q4,Feeling abnormal,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, dose reduced",,,Y,,,,,,,Solution for injection,,2021,Q4,Blood glucose increased,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, dose reduced",,,Y,,,,,,,Solution for injection,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, dose reduced",,,Y,,,,,,,Solution for injection,,2021,Q4,Anal incontinence,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, dose reduced",,,Y,,,,,,,Solution for injection,,2021,Q4,Psychiatric symptom,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, dose reduced",,,Y,,,,,,,Solution for injection,,2021,Q4,Product storage error,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, dose reduced",,,Y,,,,,,,Solution for injection,,2021,Q4,Multiple use of single-use product,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, dose reduced",,,Y,,,,,,,Solution for injection,,2021,Q4,Hypoglycaemia,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, dose reduced",,,Y,,,,,,,Solution for injection,,2021,Q4,Asthenia,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, dose reduced",,,Y,,,,,,,Solution for injection,,2021,Q4,Injection site pain,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 iU,,,Y,,,,,36.0,IU,Solution for injection,,2021,Q4,Tremor,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 iU,,,Y,,,,,36.0,IU,Solution for injection,,2021,Q4,Intentional product misuse,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 iU,,,Y,,,,,36.0,IU,Solution for injection,,2021,Q4,Drug ineffective,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 iU,,,Y,,,,,36.0,IU,Solution for injection,,2021,Q4,Depressed mood,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 iU,,,Y,,,,,36.0,IU,Solution for injection,,2021,Q4,Pseudohypoglycaemia,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 iU,,,Y,,,,,36.0,IU,Solution for injection,,2021,Q4,Diarrhoea,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 iU,,,Y,,,,,36.0,IU,Solution for injection,,2021,Q4,Malaise,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 iU,,,Y,,,,,36.0,IU,Solution for injection,,2021,Q4,Boredom,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 iU,,,Y,,,,,36.0,IU,Solution for injection,,2021,Q4,Feeling abnormal,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 iU,,,Y,,,,,36.0,IU,Solution for injection,,2021,Q4,Blood glucose increased,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 iU,,,Y,,,,,36.0,IU,Solution for injection,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 iU,,,Y,,,,,36.0,IU,Solution for injection,,2021,Q4,Anal incontinence,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 iU,,,Y,,,,,36.0,IU,Solution for injection,,2021,Q4,Psychiatric symptom,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 iU,,,Y,,,,,36.0,IU,Solution for injection,,2021,Q4,Product storage error,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 iU,,,Y,,,,,36.0,IU,Solution for injection,,2021,Q4,Multiple use of single-use product,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 iU,,,Y,,,,,36.0,IU,Solution for injection,,2021,Q4,Hypoglycaemia,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 iU,,,Y,,,,,36.0,IU,Solution for injection,,2021,Q4,Asthenia,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 iU,,,Y,,,,,36.0,IU,Solution for injection,,2021,Q4,Injection site pain,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 international unit,,,Y,,,,,38.0,IU,Solution for injection,,2021,Q4,Tremor,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 international unit,,,Y,,,,,38.0,IU,Solution for injection,,2021,Q4,Intentional product misuse,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 international unit,,,Y,,,,,38.0,IU,Solution for injection,,2021,Q4,Drug ineffective,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 international unit,,,Y,,,,,38.0,IU,Solution for injection,,2021,Q4,Depressed mood,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 international unit,,,Y,,,,,38.0,IU,Solution for injection,,2021,Q4,Pseudohypoglycaemia,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 international unit,,,Y,,,,,38.0,IU,Solution for injection,,2021,Q4,Diarrhoea,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 international unit,,,Y,,,,,38.0,IU,Solution for injection,,2021,Q4,Malaise,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 international unit,,,Y,,,,,38.0,IU,Solution for injection,,2021,Q4,Boredom,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 international unit,,,Y,,,,,38.0,IU,Solution for injection,,2021,Q4,Feeling abnormal,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 international unit,,,Y,,,,,38.0,IU,Solution for injection,,2021,Q4,Blood glucose increased,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 international unit,,,Y,,,,,38.0,IU,Solution for injection,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 international unit,,,Y,,,,,38.0,IU,Solution for injection,,2021,Q4,Anal incontinence,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 international unit,,,Y,,,,,38.0,IU,Solution for injection,,2021,Q4,Psychiatric symptom,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 international unit,,,Y,,,,,38.0,IU,Solution for injection,,2021,Q4,Product storage error,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 international unit,,,Y,,,,,38.0,IU,Solution for injection,,2021,Q4,Multiple use of single-use product,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 international unit,,,Y,,,,,38.0,IU,Solution for injection,,2021,Q4,Hypoglycaemia,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 international unit,,,Y,,,,,38.0,IU,Solution for injection,,2021,Q4,Asthenia,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
178463275,17846327,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 international unit,,,Y,,,,,38.0,IU,Solution for injection,,2021,Q4,Injection site pain,,2021,Q4,5,F,20200101.0,20211004.0,20200601,20211011,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
179592632,17959263,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 U, HS (22 units SC @ hs)",,,U,,,,,,,,QD,2021,Q4,Mobility decreased,,2021,Q4,2,F,20190405.0,20211025.0,20200629,20211101,EXP,,CA-SA-2020SA163392,SANOFI AVENTIS,,34.0,YR,A,F,Y,,,20211101.0,,PH,CA,CA,2021,Q4,Young Adult
179592632,17959263,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 U, HS (22 units SC @ hs)",,,U,,,,,,,,QD,2021,Q4,Rhabdomyolysis,,2021,Q4,2,F,20190405.0,20211025.0,20200629,20211101,EXP,,CA-SA-2020SA163392,SANOFI AVENTIS,,34.0,YR,A,F,Y,,,20211101.0,,PH,CA,CA,2021,Q4,Young Adult
179592632,17959263,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 U, HS (22 units SC @ hs)",,,U,,,,,,,,QD,2021,Q4,Blood creatine phosphokinase increased,,2021,Q4,2,F,20190405.0,20211025.0,20200629,20211101,EXP,,CA-SA-2020SA163392,SANOFI AVENTIS,,34.0,YR,A,F,Y,,,20211101.0,,PH,CA,CA,2021,Q4,Young Adult
179592632,17959263,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 U, HS (22 units SC @ hs)",,,U,,,,,,,,QD,2021,Q4,Blood creatinine increased,,2021,Q4,2,F,20190405.0,20211025.0,20200629,20211101,EXP,,CA-SA-2020SA163392,SANOFI AVENTIS,,34.0,YR,A,F,Y,,,20211101.0,,PH,CA,CA,2021,Q4,Young Adult
179592632,17959263,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 U, HS (22 units SC @ hs)",,,U,,,,,,,,QD,2021,Q4,Pain,,2021,Q4,2,F,20190405.0,20211025.0,20200629,20211101,EXP,,CA-SA-2020SA163392,SANOFI AVENTIS,,34.0,YR,A,F,Y,,,20211101.0,,PH,CA,CA,2021,Q4,Young Adult
179592632,17959263,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 U, HS (22 units SC @ hs)",,,U,,,,,,,,QD,2021,Q4,Arthralgia,,2021,Q4,2,F,20190405.0,20211025.0,20200629,20211101,EXP,,CA-SA-2020SA163392,SANOFI AVENTIS,,34.0,YR,A,F,Y,,,20211101.0,,PH,CA,CA,2021,Q4,Young Adult
179592632,17959263,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 U, HS (22 units SC @ hs)",,,U,,,,,,,,QD,2021,Q4,Grip strength decreased,,2021,Q4,2,F,20190405.0,20211025.0,20200629,20211101,EXP,,CA-SA-2020SA163392,SANOFI AVENTIS,,34.0,YR,A,F,Y,,,20211101.0,,PH,CA,CA,2021,Q4,Young Adult
179592632,17959263,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 U, HS (22 units SC @ hs)",,,U,,,,,,,,QD,2021,Q4,Myalgia,,2021,Q4,2,F,20190405.0,20211025.0,20200629,20211101,EXP,,CA-SA-2020SA163392,SANOFI AVENTIS,,34.0,YR,A,F,Y,,,20211101.0,,PH,CA,CA,2021,Q4,Young Adult
179592632,17959263,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 U, HS (22 units SC @ hs)",,,U,,,,,,,,QD,2021,Q4,Myositis,,2021,Q4,2,F,20190405.0,20211025.0,20200629,20211101,EXP,,CA-SA-2020SA163392,SANOFI AVENTIS,,34.0,YR,A,F,Y,,,20211101.0,,PH,CA,CA,2021,Q4,Young Adult
182097125,18209712,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Thrombotic microangiopathy,,2021,Q4,5,F,20200818.0,20211011.0,20200828,20211119,EXP,,JP-009507513-2008JPN014013,MERCK,"Kamiya C, et al. A case of multiple myeloma complicated with thrombotic microangiopathy induced by carfilzomib. The 83rd Annual Meeting of the Japanese Society of Hematology. 2021;40-9",71.0,YR,,F,Y,,,20211119.0,,MD,JP,JP,2021,Q4,Elderly
1826359711,18263597,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 international unit, qd",,,,,,,,28.0,IU,,QD,2021,Q4,Asthenia,,2021,Q4,11,F,20170608.0,20211116.0,20200914,20211122,EXP,,ES-MYLANLABS-2020M1077486,MYLAN,"Escudero-Vilaplana V, Collado-Borrell R, Villanueva-Bueno C, Rosa A, Herranz A, Sanjurjo M et al. Acute pancreatitis in a patient treated with imatinib and gefitinib.. J Oncol Pharm Pract. 2020;27(4):980-3",57.0,YR,,F,Y,,,20211122.0,,HP,ES,ES,2021,Q4,Adult
1826359711,18263597,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 international unit, qd",,,,,,,,28.0,IU,,QD,2021,Q4,Off label use,,2021,Q4,11,F,20170608.0,20211116.0,20200914,20211122,EXP,,ES-MYLANLABS-2020M1077486,MYLAN,"Escudero-Vilaplana V, Collado-Borrell R, Villanueva-Bueno C, Rosa A, Herranz A, Sanjurjo M et al. Acute pancreatitis in a patient treated with imatinib and gefitinib.. J Oncol Pharm Pract. 2020;27(4):980-3",57.0,YR,,F,Y,,,20211122.0,,HP,ES,ES,2021,Q4,Adult
1826359711,18263597,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 international unit, qd",,,,,,,,28.0,IU,,QD,2021,Q4,Diarrhoea,,2021,Q4,11,F,20170608.0,20211116.0,20200914,20211122,EXP,,ES-MYLANLABS-2020M1077486,MYLAN,"Escudero-Vilaplana V, Collado-Borrell R, Villanueva-Bueno C, Rosa A, Herranz A, Sanjurjo M et al. Acute pancreatitis in a patient treated with imatinib and gefitinib.. J Oncol Pharm Pract. 2020;27(4):980-3",57.0,YR,,F,Y,,,20211122.0,,HP,ES,ES,2021,Q4,Adult
1826359711,18263597,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 international unit, qd",,,,,,,,28.0,IU,,QD,2021,Q4,Malignant neoplasm progression,,2021,Q4,11,F,20170608.0,20211116.0,20200914,20211122,EXP,,ES-MYLANLABS-2020M1077486,MYLAN,"Escudero-Vilaplana V, Collado-Borrell R, Villanueva-Bueno C, Rosa A, Herranz A, Sanjurjo M et al. Acute pancreatitis in a patient treated with imatinib and gefitinib.. J Oncol Pharm Pract. 2020;27(4):980-3",57.0,YR,,F,Y,,,20211122.0,,HP,ES,ES,2021,Q4,Adult
1826359711,18263597,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 international unit, qd",,,,,,,,28.0,IU,,QD,2021,Q4,Product use in unapproved indication,,2021,Q4,11,F,20170608.0,20211116.0,20200914,20211122,EXP,,ES-MYLANLABS-2020M1077486,MYLAN,"Escudero-Vilaplana V, Collado-Borrell R, Villanueva-Bueno C, Rosa A, Herranz A, Sanjurjo M et al. Acute pancreatitis in a patient treated with imatinib and gefitinib.. J Oncol Pharm Pract. 2020;27(4):980-3",57.0,YR,,F,Y,,,20211122.0,,HP,ES,ES,2021,Q4,Adult
1826359711,18263597,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 international unit, qd",,,,,,,,28.0,IU,,QD,2021,Q4,Nausea,,2021,Q4,11,F,20170608.0,20211116.0,20200914,20211122,EXP,,ES-MYLANLABS-2020M1077486,MYLAN,"Escudero-Vilaplana V, Collado-Borrell R, Villanueva-Bueno C, Rosa A, Herranz A, Sanjurjo M et al. Acute pancreatitis in a patient treated with imatinib and gefitinib.. J Oncol Pharm Pract. 2020;27(4):980-3",57.0,YR,,F,Y,,,20211122.0,,HP,ES,ES,2021,Q4,Adult
1826359711,18263597,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 international unit, qd",,,,,,,,28.0,IU,,QD,2021,Q4,Pancreatic toxicity,,2021,Q4,11,F,20170608.0,20211116.0,20200914,20211122,EXP,,ES-MYLANLABS-2020M1077486,MYLAN,"Escudero-Vilaplana V, Collado-Borrell R, Villanueva-Bueno C, Rosa A, Herranz A, Sanjurjo M et al. Acute pancreatitis in a patient treated with imatinib and gefitinib.. J Oncol Pharm Pract. 2020;27(4):980-3",57.0,YR,,F,Y,,,20211122.0,,HP,ES,ES,2021,Q4,Adult
1826359711,18263597,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 international unit, qd",,,,,,,,28.0,IU,,QD,2021,Q4,Gastrointestinal toxicity,,2021,Q4,11,F,20170608.0,20211116.0,20200914,20211122,EXP,,ES-MYLANLABS-2020M1077486,MYLAN,"Escudero-Vilaplana V, Collado-Borrell R, Villanueva-Bueno C, Rosa A, Herranz A, Sanjurjo M et al. Acute pancreatitis in a patient treated with imatinib and gefitinib.. J Oncol Pharm Pract. 2020;27(4):980-3",57.0,YR,,F,Y,,,20211122.0,,HP,ES,ES,2021,Q4,Adult
1826359711,18263597,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 international unit, qd",,,,,,,,28.0,IU,,QD,2021,Q4,Drug interaction,,2021,Q4,11,F,20170608.0,20211116.0,20200914,20211122,EXP,,ES-MYLANLABS-2020M1077486,MYLAN,"Escudero-Vilaplana V, Collado-Borrell R, Villanueva-Bueno C, Rosa A, Herranz A, Sanjurjo M et al. Acute pancreatitis in a patient treated with imatinib and gefitinib.. J Oncol Pharm Pract. 2020;27(4):980-3",57.0,YR,,F,Y,,,20211122.0,,HP,ES,ES,2021,Q4,Adult
1826359711,18263597,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 international unit, qd",,,,,,,,28.0,IU,,QD,2021,Q4,Vomiting,,2021,Q4,11,F,20170608.0,20211116.0,20200914,20211122,EXP,,ES-MYLANLABS-2020M1077486,MYLAN,"Escudero-Vilaplana V, Collado-Borrell R, Villanueva-Bueno C, Rosa A, Herranz A, Sanjurjo M et al. Acute pancreatitis in a patient treated with imatinib and gefitinib.. J Oncol Pharm Pract. 2020;27(4):980-3",57.0,YR,,F,Y,,,20211122.0,,HP,ES,ES,2021,Q4,Adult
1826359711,18263597,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 international unit, qd",,,,,,,,28.0,IU,,QD,2021,Q4,Pancreatitis acute,,2021,Q4,11,F,20170608.0,20211116.0,20200914,20211122,EXP,,ES-MYLANLABS-2020M1077486,MYLAN,"Escudero-Vilaplana V, Collado-Borrell R, Villanueva-Bueno C, Rosa A, Herranz A, Sanjurjo M et al. Acute pancreatitis in a patient treated with imatinib and gefitinib.. J Oncol Pharm Pract. 2020;27(4):980-3",57.0,YR,,F,Y,,,20211122.0,,HP,ES,ES,2021,Q4,Adult
183105174,18310517,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 UNK, QD(14 units qn)",,,D,,,,,,,Injection,QD,2021,Q4,Myocardial infarction,,2021,Q4,4,F,20200729.0,20211028.0,20200924,20211030,EXP,,NVSC2020CN259632,NOVARTIS,,48.0,YR,,M,Y,72.0,KG,20211030.0,,MD,CN,CN,2021,Q4,Adult
183105174,18310517,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 UNK, QD(14 units qn)",,,D,,,,,,,Injection,QD,2021,Q4,Chest discomfort,,2021,Q4,4,F,20200729.0,20211028.0,20200924,20211030,EXP,,NVSC2020CN259632,NOVARTIS,,48.0,YR,,M,Y,72.0,KG,20211030.0,,MD,CN,CN,2021,Q4,Adult
183105174,18310517,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 UNK, QD(14 units qn)",,,D,,,,,,,Injection,QD,2021,Q4,Cardiac failure chronic,,2021,Q4,4,F,20200729.0,20211028.0,20200924,20211030,EXP,,NVSC2020CN259632,NOVARTIS,,48.0,YR,,M,Y,72.0,KG,20211030.0,,MD,CN,CN,2021,Q4,Adult
183105174,18310517,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 UNK, QD(14 units qn)",,,D,,,,,,,Injection,QD,2021,Q4,Cardiac dysfunction,,2021,Q4,4,F,20200729.0,20211028.0,20200924,20211030,EXP,,NVSC2020CN259632,NOVARTIS,,48.0,YR,,M,Y,72.0,KG,20211030.0,,MD,CN,CN,2021,Q4,Adult
183105174,18310517,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 UNK, QD(14 units qn)",,,D,,,,,,,Injection,QD,2021,Q4,Coronary artery disease,,2021,Q4,4,F,20200729.0,20211028.0,20200924,20211030,EXP,,NVSC2020CN259632,NOVARTIS,,48.0,YR,,M,Y,72.0,KG,20211030.0,,MD,CN,CN,2021,Q4,Adult
183105174,18310517,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 UNK, QD(14 units qn)",,,D,,,,,,,Injection,QD,2021,Q4,Discomfort,,2021,Q4,4,F,20200729.0,20211028.0,20200924,20211030,EXP,,NVSC2020CN259632,NOVARTIS,,48.0,YR,,M,Y,72.0,KG,20211030.0,,MD,CN,CN,2021,Q4,Adult
183817154,18381715,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Escherichia urinary tract infection,,2021,Q4,4,F,20200814.0,20211227.0,20201014,20211228,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-082920,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,,,20211228.0,,MD,DE,DE,2021,Q4,Elderly
183817154,18381715,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Syncope,,2021,Q4,4,F,20200814.0,20211227.0,20201014,20211228,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-082920,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,,,20211228.0,,MD,DE,DE,2021,Q4,Elderly
183817154,18381715,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Acute kidney injury,,2021,Q4,4,F,20200814.0,20211227.0,20201014,20211228,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-082920,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,,,20211228.0,,MD,DE,DE,2021,Q4,Elderly
183817154,18381715,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Intracranial aneurysm,,2021,Q4,4,F,20200814.0,20211227.0,20201014,20211228,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-082920,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,,,20211228.0,,MD,DE,DE,2021,Q4,Elderly
183817154,18381715,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Mesenteric arterial occlusion,,2021,Q4,4,F,20200814.0,20211227.0,20201014,20211228,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-082920,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,,,20211228.0,,MD,DE,DE,2021,Q4,Elderly
183817154,18381715,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Dehydration,,2021,Q4,4,F,20200814.0,20211227.0,20201014,20211228,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-082920,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,,,20211228.0,,MD,DE,DE,2021,Q4,Elderly
184590473,18459047,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 international unit, qd",,,U,U,,,,20.0,IU,Injection,QD,2021,Q4,Drug interaction,,2021,Q4,3,F,,20211009.0,20201103,20211014,EXP,,FR-MYLANLABS-2020M1090981,MYLAN,,53.0,YR,,M,Y,82.0,KG,20211014.0,,MD,FR,FR,2021,Q4,Adult
184590473,18459047,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 international unit, qd",,,U,U,,,,20.0,IU,Injection,QD,2021,Q4,Hypokalaemia,,2021,Q4,3,F,,20211009.0,20201103,20211014,EXP,,FR-MYLANLABS-2020M1090981,MYLAN,,53.0,YR,,M,Y,82.0,KG,20211014.0,,MD,FR,FR,2021,Q4,Adult
184590473,18459047,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 international unit, qd",,,U,U,,,,20.0,IU,Injection,QD,2021,Q4,Acute kidney injury,,2021,Q4,3,F,,20211009.0,20201103,20211014,EXP,,FR-MYLANLABS-2020M1090981,MYLAN,,53.0,YR,,M,Y,82.0,KG,20211014.0,,MD,FR,FR,2021,Q4,Adult
184590473,18459047,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 international unit, qd",,,U,U,,,,20.0,IU,Injection,QD,2021,Q4,Hyperkalaemia,,2021,Q4,3,F,,20211009.0,20201103,20211014,EXP,,FR-MYLANLABS-2020M1090981,MYLAN,,53.0,YR,,M,Y,82.0,KG,20211014.0,,MD,FR,FR,2021,Q4,Adult
184590473,18459047,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 international unit, qd",,,U,U,,,,20.0,IU,Injection,QD,2021,Q4,Drug ineffective,,2021,Q4,3,F,,20211009.0,20201103,20211014,EXP,,FR-MYLANLABS-2020M1090981,MYLAN,,53.0,YR,,M,Y,82.0,KG,20211014.0,,MD,FR,FR,2021,Q4,Adult
184590473,18459047,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 international unit, qd",,,U,U,,,,20.0,IU,Injection,QD,2021,Q4,Labelled drug-drug interaction medication error,,2021,Q4,3,F,,20211009.0,20201103,20211014,EXP,,FR-MYLANLABS-2020M1090981,MYLAN,,53.0,YR,,M,Y,82.0,KG,20211014.0,,MD,FR,FR,2021,Q4,Adult
185380444,18538044,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Muscular weakness,,2021,Q4,4,F,20191008.0,20211216.0,20201123,20211221,EXP,,US-GILEAD-2019-0432608,GILEAD,,81.0,YR,E,M,Y,94.0,KG,20211221.0,,MD,US,US,2021,Q4,Elderly
185380444,18538044,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Toxic encephalopathy,,2021,Q4,4,F,20191008.0,20211216.0,20201123,20211221,EXP,,US-GILEAD-2019-0432608,GILEAD,,81.0,YR,E,M,Y,94.0,KG,20211221.0,,MD,US,US,2021,Q4,Elderly
185953593,18595359,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,,,2021,Q4,Hyperhidrosis,,2021,Q4,3,F,,20211029.0,20201209,20211103,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202011013750,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20211103.0,,CN,GR,GR,2021,Q4,Elderly
185953593,18595359,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,,,2021,Q4,Confusional state,,2021,Q4,3,F,,20211029.0,20201209,20211103,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202011013750,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20211103.0,,CN,GR,GR,2021,Q4,Elderly
185953593,18595359,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,,,2021,Q4,Hypoglycaemia,,2021,Q4,3,F,,20211029.0,20201209,20211103,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202011013750,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20211103.0,,CN,GR,GR,2021,Q4,Elderly
185953593,18595359,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,,,2021,Q4,Aggression,,2021,Q4,3,F,,20211029.0,20201209,20211103,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202011013750,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20211103.0,,CN,GR,GR,2021,Q4,Elderly
185953593,18595359,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,,,2021,Q4,Agitation,,2021,Q4,3,F,,20211029.0,20201209,20211103,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202011013750,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20211103.0,,CN,GR,GR,2021,Q4,Elderly
185953593,18595359,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,,,2021,Q4,Communication disorder,,2021,Q4,3,F,,20211029.0,20201209,20211103,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202011013750,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20211103.0,,CN,GR,GR,2021,Q4,Elderly
185953593,18595359,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,,,2021,Q4,Mental disorder,,2021,Q4,3,F,,20211029.0,20201209,20211103,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202011013750,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20211103.0,,CN,GR,GR,2021,Q4,Elderly
185953593,18595359,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,,,2021,Q4,Disorientation,,2021,Q4,3,F,,20211029.0,20201209,20211103,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202011013750,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20211103.0,,CN,GR,GR,2021,Q4,Elderly
186253535,18625353,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Oesophageal ulcer,,2021,Q4,5,F,,20210927.0,20201217,20211121,EXP,,JP-009507513-1909JPN002962J,MERCK,"Shimamoto Y, Kinoshita Y, Kawata Y, Moriguchi A, Kitada S, Minamino H, et al.. 46 A case of oesophageal ulcer during administration of pembrolizumab.. The 229th Annual Meeting of the Japanese Society of Internal Medicine, Kinki",78.0,YR,,M,Y,,,20211121.0,,MD,JP,JP,2021,Q4,Elderly
186455492,18645549,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 international unit, daily",,,,,,,,16.0,IU,,QD,2021,Q4,Vitamin B12 deficiency,,2021,Q4,2,F,20201105.0,20211207.0,20201221,20211216,EXP,FR-AFSSAPS-AM20201369,FR-ELI_LILLY_AND_COMPANY-FR202012007494,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20211216.0,,CN,FR,FR,2021,Q4,Elderly
186455492,18645549,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, unknown",,,,,,,,,,,,2021,Q4,Vitamin B12 deficiency,,2021,Q4,2,F,20201105.0,20211207.0,20201221,20211216,EXP,FR-AFSSAPS-AM20201369,FR-ELI_LILLY_AND_COMPANY-FR202012007494,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20211216.0,,CN,FR,FR,2021,Q4,Elderly
186489772,18648977,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 international unit, qd",,,,,,,,8.0,IU,Injection,QD,2021,Q4,Hyponatraemia,,2021,Q4,2,F,20201101.0,20211029.0,20201222,20211104,EXP,FR-AFSSAPS-RE20201113,FR-MYLANLABS-2020M1103363,MYLAN,,44.0,YR,,F,Y,64.0,KG,20211104.0,,MD,FR,FR,2021,Q4,Adult
186489772,18648977,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 international unit, qd",,,,,,,,8.0,IU,Injection,QD,2021,Q4,Thrombocytopenia,,2021,Q4,2,F,20201101.0,20211029.0,20201222,20211104,EXP,FR-AFSSAPS-RE20201113,FR-MYLANLABS-2020M1103363,MYLAN,,44.0,YR,,F,Y,64.0,KG,20211104.0,,MD,FR,FR,2021,Q4,Adult
186489772,18648977,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 international unit, qd",,,,,,,,8.0,IU,Injection,QD,2021,Q4,Epistaxis,,2021,Q4,2,F,20201101.0,20211029.0,20201222,20211104,EXP,FR-AFSSAPS-RE20201113,FR-MYLANLABS-2020M1103363,MYLAN,,44.0,YR,,F,Y,64.0,KG,20211104.0,,MD,FR,FR,2021,Q4,Adult
186600542,18660054,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,,,,,,16.0,IU,,QD,2021,Q4,Vitamin B12 deficiency,,2021,Q4,2,F,20201105.0,20211209.0,20201224,20211216,EXP,FR-AFSSAPS-AM20201369,NVSC2020FR335104,NOVARTIS,,70.0,YR,,F,Y,,,20211216.0,,MD,FR,FR,2021,Q4,Elderly
187070223,18707022,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 iU, QD",,,,,,,21081.0,40.0,IU,,QD,2021,Q4,Blood glucose decreased,,2021,Q4,3,F,20200323.0,20211102.0,20210106,20211109,EXP,,CA-SA-2020SA376667,SANOFI AVENTIS,,57.0,YR,A,M,Y,,,20211109.0,,CN,CA,CA,2021,Q4,Adult
187070223,18707022,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 iU, QD",,,,,,,21081.0,40.0,IU,,QD,2021,Q4,Blood glucose increased,,2021,Q4,3,F,20200323.0,20211102.0,20210106,20211109,EXP,,CA-SA-2020SA376667,SANOFI AVENTIS,,57.0,YR,A,M,Y,,,20211109.0,,CN,CA,CA,2021,Q4,Adult
187070223,18707022,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 iU, QD",,,,,,,21081.0,40.0,IU,,QD,2021,Q4,Asthenia,,2021,Q4,3,F,20200323.0,20211102.0,20210106,20211109,EXP,,CA-SA-2020SA376667,SANOFI AVENTIS,,57.0,YR,A,M,Y,,,20211109.0,,CN,CA,CA,2021,Q4,Adult
187077312,18707731,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 iU, QD (1 every 1 Days)",,,,,D042883E,,206538.0,14.0,IU,Solution for injection,QD,2021,Q4,Breast cancer,,2021,Q4,2,F,20191101.0,20211102.0,20210106,20211109,EXP,,CA-SA-2020SA376691,SANOFI AVENTIS,,90.0,YR,E,F,Y,,,20211109.0,,CN,CA,CA,2021,Q4,Elderly
187533073,18753307,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28-0-0,,,,,,,,,,Injection,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,3,F,20210110.0,20211130.0,20210118,20211203,EXP,,JP-AstraZeneca-2021A006828,ASTRAZENECA,,59.0,YR,,M,Y,83.0,KG,20211203.0,,MD,JP,,2021,Q4,Adult
187533073,18753307,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 unit,,,,,,,,,,Injection,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,3,F,20210110.0,20211130.0,20210118,20211203,EXP,,JP-AstraZeneca-2021A006828,ASTRAZENECA,,59.0,YR,,M,Y,83.0,KG,20211203.0,,MD,JP,,2021,Q4,Adult
187852543,18785254,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Abnormal behaviour,,2021,Q4,3,F,20190723.0,20211027.0,20210125,20211101,EXP,,CA-TAKEDA-2021TUS004224,TAKEDA,,74.0,YR,,F,Y,,,20211101.0,,MD,CA,CA,2021,Q4,Elderly
187852543,18785254,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Malaise,,2021,Q4,3,F,20190723.0,20211027.0,20210125,20211101,EXP,,CA-TAKEDA-2021TUS004224,TAKEDA,,74.0,YR,,F,Y,,,20211101.0,,MD,CA,CA,2021,Q4,Elderly
187852543,18785254,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Off label use,,2021,Q4,3,F,20190723.0,20211027.0,20210125,20211101,EXP,,CA-TAKEDA-2021TUS004224,TAKEDA,,74.0,YR,,F,Y,,,20211101.0,,MD,CA,CA,2021,Q4,Elderly
187852543,18785254,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Pneumonia,,2021,Q4,3,F,20190723.0,20211027.0,20210125,20211101,EXP,,CA-TAKEDA-2021TUS004224,TAKEDA,,74.0,YR,,F,Y,,,20211101.0,,MD,CA,CA,2021,Q4,Elderly
188213844,18821384,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 units, 1x/day",,,,,,,,,,Injection,QD,2021,Q4,Off label use,,2021,Q4,4,F,20200925.0,20211217.0,20210201,20211229,EXP,,JP-PFIZER INC-2021072881,PFIZER,,45.0,YR,,M,Y,50.5,KG,20211229.0,,PH,JP,JP,2021,Q4,Adult
188213844,18821384,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 units, 1x/day",,,,,,,,,,Injection,QD,2021,Q4,Optic neuritis,,2021,Q4,4,F,20200925.0,20211217.0,20210201,20211229,EXP,,JP-PFIZER INC-2021072881,PFIZER,,45.0,YR,,M,Y,50.5,KG,20211229.0,,PH,JP,JP,2021,Q4,Adult
188491314,18849131,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2021,Q4,Oxygen saturation decreased,,2021,Q4,4,F,20200101.0,20211109.0,20210204,20211119,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20211119.0,,MD,CA,CA,2021,Q4,Adult
188491314,18849131,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2021,Q4,Condition aggravated,,2021,Q4,4,F,20200101.0,20211109.0,20210204,20211119,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20211119.0,,MD,CA,CA,2021,Q4,Adult
188491314,18849131,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2021,Q4,Right ventricular failure,,2021,Q4,4,F,20200101.0,20211109.0,20210204,20211119,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20211119.0,,MD,CA,CA,2021,Q4,Adult
188491314,18849131,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2021,Q4,Pulmonary veno-occlusive disease,,2021,Q4,4,F,20200101.0,20211109.0,20210204,20211119,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20211119.0,,MD,CA,CA,2021,Q4,Adult
188491314,18849131,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2021,Q4,Ulcer haemorrhage,,2021,Q4,4,F,20200101.0,20211109.0,20210204,20211119,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20211119.0,,MD,CA,CA,2021,Q4,Adult
188491314,18849131,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2021,Q4,Gout,,2021,Q4,4,F,20200101.0,20211109.0,20210204,20211119,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20211119.0,,MD,CA,CA,2021,Q4,Adult
188491314,18849131,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,4,F,20200101.0,20211109.0,20210204,20211119,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20211119.0,,MD,CA,CA,2021,Q4,Adult
188491314,18849131,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2021,Q4,Oxygen consumption increased,,2021,Q4,4,F,20200101.0,20211109.0,20210204,20211119,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20211119.0,,MD,CA,CA,2021,Q4,Adult
188491314,18849131,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2021,Q4,Pulmonary arterial hypertension,,2021,Q4,4,F,20200101.0,20211109.0,20210204,20211119,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20211119.0,,MD,CA,CA,2021,Q4,Adult
188491314,18849131,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2021,Q4,Anaemia,,2021,Q4,4,F,20200101.0,20211109.0,20210204,20211119,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20211119.0,,MD,CA,CA,2021,Q4,Adult
188491314,18849131,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2021,Q4,Pulmonary oedema,,2021,Q4,4,F,20200101.0,20211109.0,20210204,20211119,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20211119.0,,MD,CA,CA,2021,Q4,Adult
188491314,18849131,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2021,Q4,Off label use,,2021,Q4,4,F,20200101.0,20211109.0,20210204,20211119,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20211119.0,,MD,CA,CA,2021,Q4,Adult
188491314,18849131,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2021,Q4,Product use in unapproved indication,,2021,Q4,4,F,20200101.0,20211109.0,20210204,20211119,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20211119.0,,MD,CA,CA,2021,Q4,Adult
188491314,18849131,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2021,Q4,Hypoxia,,2021,Q4,4,F,20200101.0,20211109.0,20210204,20211119,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20211119.0,,MD,CA,CA,2021,Q4,Adult
188491314,18849131,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2021,Q4,Right-to-left cardiac shunt,,2021,Q4,4,F,20200101.0,20211109.0,20210204,20211119,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20211119.0,,MD,CA,CA,2021,Q4,Adult
189441573,18944157,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,22 units/day,,,U,,,,,,,Injection,,2021,Q4,Cholelithiasis,,2021,Q4,3,F,20200801.0,20210408.0,20210226,20211215,EXP,,NVSJ2021JP002954,NOVARTIS,,56.0,YR,,M,Y,73.5,KG,20211215.0,,MD,JP,JP,2021,Q4,Adult
189441573,18944157,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,22 units/day,,,U,,,,,,,Injection,,2021,Q4,Renal cyst,,2021,Q4,3,F,20200801.0,20210408.0,20210226,20211215,EXP,,NVSJ2021JP002954,NOVARTIS,,56.0,YR,,M,Y,73.5,KG,20211215.0,,MD,JP,JP,2021,Q4,Adult
189441573,18944157,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,22 units/day,,,U,,,,,,,Injection,,2021,Q4,Pancreatic neuroendocrine tumour,,2021,Q4,3,F,20200801.0,20210408.0,20210226,20211215,EXP,,NVSJ2021JP002954,NOVARTIS,,56.0,YR,,M,Y,73.5,KG,20211215.0,,MD,JP,JP,2021,Q4,Adult
189700412,18970041,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q4,Malignant neoplasm progression,,2021,Q4,2,F,20180101.0,20211013.0,20210304,20211109,EXP,,NVSC2021DE047241,NOVARTIS,,73.0,YR,,M,Y,96.0,KG,20211109.0,,MD,DE,DE,2021,Q4,Elderly
189700412,18970041,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q4,Pyrexia,,2021,Q4,2,F,20180101.0,20211013.0,20210304,20211109,EXP,,NVSC2021DE047241,NOVARTIS,,73.0,YR,,M,Y,96.0,KG,20211109.0,,MD,DE,DE,2021,Q4,Elderly
189700412,18970041,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q4,Cytokine release syndrome,,2021,Q4,2,F,20180101.0,20211013.0,20210304,20211109,EXP,,NVSC2021DE047241,NOVARTIS,,73.0,YR,,M,Y,96.0,KG,20211109.0,,MD,DE,DE,2021,Q4,Elderly
189700412,18970041,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q4,Acute lymphocytic leukaemia,,2021,Q4,2,F,20180101.0,20211013.0,20210304,20211109,EXP,,NVSC2021DE047241,NOVARTIS,,73.0,YR,,M,Y,96.0,KG,20211109.0,,MD,DE,DE,2021,Q4,Elderly
189700412,18970041,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q4,Lactose intolerance,,2021,Q4,2,F,20180101.0,20211013.0,20210304,20211109,EXP,,NVSC2021DE047241,NOVARTIS,,73.0,YR,,M,Y,96.0,KG,20211109.0,,MD,DE,DE,2021,Q4,Elderly
189700412,18970041,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q4,Hypotension,,2021,Q4,2,F,20180101.0,20211013.0,20210304,20211109,EXP,,NVSC2021DE047241,NOVARTIS,,73.0,YR,,M,Y,96.0,KG,20211109.0,,MD,DE,DE,2021,Q4,Elderly
189700412,18970041,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q4,Gastritis,,2021,Q4,2,F,20180101.0,20211013.0,20210304,20211109,EXP,,NVSC2021DE047241,NOVARTIS,,73.0,YR,,M,Y,96.0,KG,20211109.0,,MD,DE,DE,2021,Q4,Elderly
189700412,18970041,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q4,Escherichia urinary tract infection,,2021,Q4,2,F,20180101.0,20211013.0,20210304,20211109,EXP,,NVSC2021DE047241,NOVARTIS,,73.0,YR,,M,Y,96.0,KG,20211109.0,,MD,DE,DE,2021,Q4,Elderly
189700412,18970041,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q4,Blood chloride increased,,2021,Q4,2,F,20180101.0,20211013.0,20210304,20211109,EXP,,NVSC2021DE047241,NOVARTIS,,73.0,YR,,M,Y,96.0,KG,20211109.0,,MD,DE,DE,2021,Q4,Elderly
189700412,18970041,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q4,Gamma-glutamyltransferase increased,,2021,Q4,2,F,20180101.0,20211013.0,20210304,20211109,EXP,,NVSC2021DE047241,NOVARTIS,,73.0,YR,,M,Y,96.0,KG,20211109.0,,MD,DE,DE,2021,Q4,Elderly
189700412,18970041,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q4,Enterococcal infection,,2021,Q4,2,F,20180101.0,20211013.0,20210304,20211109,EXP,,NVSC2021DE047241,NOVARTIS,,73.0,YR,,M,Y,96.0,KG,20211109.0,,MD,DE,DE,2021,Q4,Elderly
189700412,18970041,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q4,Myelocyte count increased,,2021,Q4,2,F,20180101.0,20211013.0,20210304,20211109,EXP,,NVSC2021DE047241,NOVARTIS,,73.0,YR,,M,Y,96.0,KG,20211109.0,,MD,DE,DE,2021,Q4,Elderly
189700412,18970041,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q4,Hepatic calcification,,2021,Q4,2,F,20180101.0,20211013.0,20210304,20211109,EXP,,NVSC2021DE047241,NOVARTIS,,73.0,YR,,M,Y,96.0,KG,20211109.0,,MD,DE,DE,2021,Q4,Elderly
189700412,18970041,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q4,Lymphadenopathy,,2021,Q4,2,F,20180101.0,20211013.0,20210304,20211109,EXP,,NVSC2021DE047241,NOVARTIS,,73.0,YR,,M,Y,96.0,KG,20211109.0,,MD,DE,DE,2021,Q4,Elderly
189700412,18970041,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q4,Neutrophil count decreased,,2021,Q4,2,F,20180101.0,20211013.0,20210304,20211109,EXP,,NVSC2021DE047241,NOVARTIS,,73.0,YR,,M,Y,96.0,KG,20211109.0,,MD,DE,DE,2021,Q4,Elderly
189700412,18970041,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q4,Lymphocyte count decreased,,2021,Q4,2,F,20180101.0,20211013.0,20210304,20211109,EXP,,NVSC2021DE047241,NOVARTIS,,73.0,YR,,M,Y,96.0,KG,20211109.0,,MD,DE,DE,2021,Q4,Elderly
189700412,18970041,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q4,Red cell distribution width increased,,2021,Q4,2,F,20180101.0,20211013.0,20210304,20211109,EXP,,NVSC2021DE047241,NOVARTIS,,73.0,YR,,M,Y,96.0,KG,20211109.0,,MD,DE,DE,2021,Q4,Elderly
189700412,18970041,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q4,Platelet count decreased,,2021,Q4,2,F,20180101.0,20211013.0,20210304,20211109,EXP,,NVSC2021DE047241,NOVARTIS,,73.0,YR,,M,Y,96.0,KG,20211109.0,,MD,DE,DE,2021,Q4,Elderly
189700412,18970041,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q4,Blood calcium increased,,2021,Q4,2,F,20180101.0,20211013.0,20210304,20211109,EXP,,NVSC2021DE047241,NOVARTIS,,73.0,YR,,M,Y,96.0,KG,20211109.0,,MD,DE,DE,2021,Q4,Elderly
189700412,18970041,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q4,Blast cells present,,2021,Q4,2,F,20180101.0,20211013.0,20210304,20211109,EXP,,NVSC2021DE047241,NOVARTIS,,73.0,YR,,M,Y,96.0,KG,20211109.0,,MD,DE,DE,2021,Q4,Elderly
189700412,18970041,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q4,Diaphragmatic disorder,,2021,Q4,2,F,20180101.0,20211013.0,20210304,20211109,EXP,,NVSC2021DE047241,NOVARTIS,,73.0,YR,,M,Y,96.0,KG,20211109.0,,MD,DE,DE,2021,Q4,Elderly
189700412,18970041,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q4,White blood cell count increased,,2021,Q4,2,F,20180101.0,20211013.0,20210304,20211109,EXP,,NVSC2021DE047241,NOVARTIS,,73.0,YR,,M,Y,96.0,KG,20211109.0,,MD,DE,DE,2021,Q4,Elderly
189700412,18970041,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q4,Haemangioma,,2021,Q4,2,F,20180101.0,20211013.0,20210304,20211109,EXP,,NVSC2021DE047241,NOVARTIS,,73.0,YR,,M,Y,96.0,KG,20211109.0,,MD,DE,DE,2021,Q4,Elderly
189700412,18970041,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q4,Weight decreased,,2021,Q4,2,F,20180101.0,20211013.0,20210304,20211109,EXP,,NVSC2021DE047241,NOVARTIS,,73.0,YR,,M,Y,96.0,KG,20211109.0,,MD,DE,DE,2021,Q4,Elderly
189700412,18970041,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q4,Blood lactate dehydrogenase increased,,2021,Q4,2,F,20180101.0,20211013.0,20210304,20211109,EXP,,NVSC2021DE047241,NOVARTIS,,73.0,YR,,M,Y,96.0,KG,20211109.0,,MD,DE,DE,2021,Q4,Elderly
189700412,18970041,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q4,Arteriosclerosis coronary artery,,2021,Q4,2,F,20180101.0,20211013.0,20210304,20211109,EXP,,NVSC2021DE047241,NOVARTIS,,73.0,YR,,M,Y,96.0,KG,20211109.0,,MD,DE,DE,2021,Q4,Elderly
189700412,18970041,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q4,Blood bilirubin increased,,2021,Q4,2,F,20180101.0,20211013.0,20210304,20211109,EXP,,NVSC2021DE047241,NOVARTIS,,73.0,YR,,M,Y,96.0,KG,20211109.0,,MD,DE,DE,2021,Q4,Elderly
189700412,18970041,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q4,Monocyte count decreased,,2021,Q4,2,F,20180101.0,20211013.0,20210304,20211109,EXP,,NVSC2021DE047241,NOVARTIS,,73.0,YR,,M,Y,96.0,KG,20211109.0,,MD,DE,DE,2021,Q4,Elderly
189700412,18970041,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q4,Febrile infection,,2021,Q4,2,F,20180101.0,20211013.0,20210304,20211109,EXP,,NVSC2021DE047241,NOVARTIS,,73.0,YR,,M,Y,96.0,KG,20211109.0,,MD,DE,DE,2021,Q4,Elderly
189700412,18970041,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q4,Pancreatitis chronic,,2021,Q4,2,F,20180101.0,20211013.0,20210304,20211109,EXP,,NVSC2021DE047241,NOVARTIS,,73.0,YR,,M,Y,96.0,KG,20211109.0,,MD,DE,DE,2021,Q4,Elderly
189700412,18970041,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q4,Costal cartilage fracture,,2021,Q4,2,F,20180101.0,20211013.0,20210304,20211109,EXP,,NVSC2021DE047241,NOVARTIS,,73.0,YR,,M,Y,96.0,KG,20211109.0,,MD,DE,DE,2021,Q4,Elderly
189700412,18970041,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q4,Neutropenia,,2021,Q4,2,F,20180101.0,20211013.0,20210304,20211109,EXP,,NVSC2021DE047241,NOVARTIS,,73.0,YR,,M,Y,96.0,KG,20211109.0,,MD,DE,DE,2021,Q4,Elderly
189700412,18970041,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q4,Metamyelocyte count increased,,2021,Q4,2,F,20180101.0,20211013.0,20210304,20211109,EXP,,NVSC2021DE047241,NOVARTIS,,73.0,YR,,M,Y,96.0,KG,20211109.0,,MD,DE,DE,2021,Q4,Elderly
189700412,18970041,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q4,Activated partial thromboplastin time prolonged,,2021,Q4,2,F,20180101.0,20211013.0,20210304,20211109,EXP,,NVSC2021DE047241,NOVARTIS,,73.0,YR,,M,Y,96.0,KG,20211109.0,,MD,DE,DE,2021,Q4,Elderly
189700412,18970041,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q4,Euphoric mood,,2021,Q4,2,F,20180101.0,20211013.0,20210304,20211109,EXP,,NVSC2021DE047241,NOVARTIS,,73.0,YR,,M,Y,96.0,KG,20211109.0,,MD,DE,DE,2021,Q4,Elderly
189700412,18970041,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q4,Herpes simplex,,2021,Q4,2,F,20180101.0,20211013.0,20210304,20211109,EXP,,NVSC2021DE047241,NOVARTIS,,73.0,YR,,M,Y,96.0,KG,20211109.0,,MD,DE,DE,2021,Q4,Elderly
189700412,18970041,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q4,C-reactive protein increased,,2021,Q4,2,F,20180101.0,20211013.0,20210304,20211109,EXP,,NVSC2021DE047241,NOVARTIS,,73.0,YR,,M,Y,96.0,KG,20211109.0,,MD,DE,DE,2021,Q4,Elderly
189700412,18970041,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q4,Procalcitonin increased,,2021,Q4,2,F,20180101.0,20211013.0,20210304,20211109,EXP,,NVSC2021DE047241,NOVARTIS,,73.0,YR,,M,Y,96.0,KG,20211109.0,,MD,DE,DE,2021,Q4,Elderly
189700412,18970041,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q4,Adrenomegaly,,2021,Q4,2,F,20180101.0,20211013.0,20210304,20211109,EXP,,NVSC2021DE047241,NOVARTIS,,73.0,YR,,M,Y,96.0,KG,20211109.0,,MD,DE,DE,2021,Q4,Elderly
189700412,18970041,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q4,Acute lymphocytic leukaemia recurrent,,2021,Q4,2,F,20180101.0,20211013.0,20210304,20211109,EXP,,NVSC2021DE047241,NOVARTIS,,73.0,YR,,M,Y,96.0,KG,20211109.0,,MD,DE,DE,2021,Q4,Elderly
189700412,18970041,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q4,Prothrombin time prolonged,,2021,Q4,2,F,20180101.0,20211013.0,20210304,20211109,EXP,,NVSC2021DE047241,NOVARTIS,,73.0,YR,,M,Y,96.0,KG,20211109.0,,MD,DE,DE,2021,Q4,Elderly
189700412,18970041,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q4,Serum ferritin increased,,2021,Q4,2,F,20180101.0,20211013.0,20210304,20211109,EXP,,NVSC2021DE047241,NOVARTIS,,73.0,YR,,M,Y,96.0,KG,20211109.0,,MD,DE,DE,2021,Q4,Elderly
189700412,18970041,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q4,Blood glucose increased,,2021,Q4,2,F,20180101.0,20211013.0,20210304,20211109,EXP,,NVSC2021DE047241,NOVARTIS,,73.0,YR,,M,Y,96.0,KG,20211109.0,,MD,DE,DE,2021,Q4,Elderly
189837134,18983713,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,46 iU,,,,,0F784A,,,46.0,IU,Injection,,2021,Q4,Drug ineffective,,2021,Q4,4,F,20210209.0,20211022.0,20210308,20211104,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20211104.0,,CN,US,ES,2021,Q4,Adult
189837134,18983713,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,46 iU,,,,,0F784A,,,46.0,IU,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20210209.0,20211022.0,20210308,20211104,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20211104.0,,CN,US,ES,2021,Q4,Adult
189837134,18983713,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,46 iU,,,,,0F784A,,,46.0,IU,Injection,,2021,Q4,Malaise,,2021,Q4,4,F,20210209.0,20211022.0,20210308,20211104,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20211104.0,,CN,US,ES,2021,Q4,Adult
189837134,18983713,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,46 iU,,,,,0F784A,,,46.0,IU,Injection,,2021,Q4,Hypoglycaemia,,2021,Q4,4,F,20210209.0,20211022.0,20210308,20211104,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20211104.0,,CN,US,ES,2021,Q4,Adult
189837134,18983713,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,46 iU,,,,,0F784A,,,46.0,IU,Injection,,2021,Q4,Fear,,2021,Q4,4,F,20210209.0,20211022.0,20210308,20211104,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20211104.0,,CN,US,ES,2021,Q4,Adult
189837134,18983713,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,46 iU,,,,,0F784A,,,46.0,IU,Injection,,2021,Q4,Malaise,,2021,Q4,4,F,20210209.0,20211022.0,20210308,20211104,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20211104.0,,CN,US,ES,2021,Q4,Adult
189837134,18983713,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,46 iU,,,,,0F784A,,,46.0,IU,Injection,,2021,Q4,Hyperglycaemia,,2021,Q4,4,F,20210209.0,20211022.0,20210308,20211104,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20211104.0,,CN,US,ES,2021,Q4,Adult
189837134,18983713,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,46 iU,,,,,0F784A,,,46.0,IU,Injection,,2021,Q4,Unhealthy diet,,2021,Q4,4,F,20210209.0,20211022.0,20210308,20211104,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20211104.0,,CN,US,ES,2021,Q4,Adult
189837134,18983713,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,46 iU,,,,,0F784A,,,46.0,IU,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20210209.0,20211022.0,20210308,20211104,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20211104.0,,CN,US,ES,2021,Q4,Adult
189837134,18983713,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, unknown",,,,,0F784A,,,,,Injection,,2021,Q4,Drug ineffective,,2021,Q4,4,F,20210209.0,20211022.0,20210308,20211104,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20211104.0,,CN,US,ES,2021,Q4,Adult
189837134,18983713,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, unknown",,,,,0F784A,,,,,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20210209.0,20211022.0,20210308,20211104,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20211104.0,,CN,US,ES,2021,Q4,Adult
189837134,18983713,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, unknown",,,,,0F784A,,,,,Injection,,2021,Q4,Malaise,,2021,Q4,4,F,20210209.0,20211022.0,20210308,20211104,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20211104.0,,CN,US,ES,2021,Q4,Adult
189837134,18983713,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, unknown",,,,,0F784A,,,,,Injection,,2021,Q4,Hypoglycaemia,,2021,Q4,4,F,20210209.0,20211022.0,20210308,20211104,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20211104.0,,CN,US,ES,2021,Q4,Adult
189837134,18983713,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, unknown",,,,,0F784A,,,,,Injection,,2021,Q4,Fear,,2021,Q4,4,F,20210209.0,20211022.0,20210308,20211104,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20211104.0,,CN,US,ES,2021,Q4,Adult
189837134,18983713,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, unknown",,,,,0F784A,,,,,Injection,,2021,Q4,Malaise,,2021,Q4,4,F,20210209.0,20211022.0,20210308,20211104,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20211104.0,,CN,US,ES,2021,Q4,Adult
189837134,18983713,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, unknown",,,,,0F784A,,,,,Injection,,2021,Q4,Hyperglycaemia,,2021,Q4,4,F,20210209.0,20211022.0,20210308,20211104,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20211104.0,,CN,US,ES,2021,Q4,Adult
189837134,18983713,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, unknown",,,,,0F784A,,,,,Injection,,2021,Q4,Unhealthy diet,,2021,Q4,4,F,20210209.0,20211022.0,20210308,20211104,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20211104.0,,CN,US,ES,2021,Q4,Adult
189837134,18983713,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, unknown",,,,,0F784A,,,,,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20210209.0,20211022.0,20210308,20211104,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20211104.0,,CN,US,ES,2021,Q4,Adult
189837134,18983713,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"56 international unit, daily",,,,,1F143A,,,56.0,IU,Injection,QD,2021,Q4,Drug ineffective,,2021,Q4,4,F,20210209.0,20211022.0,20210308,20211104,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20211104.0,,CN,US,ES,2021,Q4,Adult
189837134,18983713,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"56 international unit, daily",,,,,1F143A,,,56.0,IU,Injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20210209.0,20211022.0,20210308,20211104,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20211104.0,,CN,US,ES,2021,Q4,Adult
189837134,18983713,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"56 international unit, daily",,,,,1F143A,,,56.0,IU,Injection,QD,2021,Q4,Malaise,,2021,Q4,4,F,20210209.0,20211022.0,20210308,20211104,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20211104.0,,CN,US,ES,2021,Q4,Adult
189837134,18983713,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"56 international unit, daily",,,,,1F143A,,,56.0,IU,Injection,QD,2021,Q4,Hypoglycaemia,,2021,Q4,4,F,20210209.0,20211022.0,20210308,20211104,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20211104.0,,CN,US,ES,2021,Q4,Adult
189837134,18983713,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"56 international unit, daily",,,,,1F143A,,,56.0,IU,Injection,QD,2021,Q4,Fear,,2021,Q4,4,F,20210209.0,20211022.0,20210308,20211104,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20211104.0,,CN,US,ES,2021,Q4,Adult
189837134,18983713,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"56 international unit, daily",,,,,1F143A,,,56.0,IU,Injection,QD,2021,Q4,Malaise,,2021,Q4,4,F,20210209.0,20211022.0,20210308,20211104,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20211104.0,,CN,US,ES,2021,Q4,Adult
189837134,18983713,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"56 international unit, daily",,,,,1F143A,,,56.0,IU,Injection,QD,2021,Q4,Hyperglycaemia,,2021,Q4,4,F,20210209.0,20211022.0,20210308,20211104,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20211104.0,,CN,US,ES,2021,Q4,Adult
189837134,18983713,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"56 international unit, daily",,,,,1F143A,,,56.0,IU,Injection,QD,2021,Q4,Unhealthy diet,,2021,Q4,4,F,20210209.0,20211022.0,20210308,20211104,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20211104.0,,CN,US,ES,2021,Q4,Adult
189837134,18983713,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"56 international unit, daily",,,,,1F143A,,,56.0,IU,Injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20210209.0,20211022.0,20210308,20211104,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20211104.0,,CN,US,ES,2021,Q4,Adult
190298442,19029844,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Monocyte count decreased,,2021,Q4,2,F,20180101.0,20211113.0,20210318,20211119,EXP,,DE-BAUSCH-BL-2021-008178,BAUSCH AND LOMB,,73.0,YR,,M,Y,96.0,KG,20211119.0,,MD,DE,DE,2021,Q4,Elderly
190298442,19029844,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Herpes simplex,,2021,Q4,2,F,20180101.0,20211113.0,20210318,20211119,EXP,,DE-BAUSCH-BL-2021-008178,BAUSCH AND LOMB,,73.0,YR,,M,Y,96.0,KG,20211119.0,,MD,DE,DE,2021,Q4,Elderly
190298442,19029844,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Weight decreased,,2021,Q4,2,F,20180101.0,20211113.0,20210318,20211119,EXP,,DE-BAUSCH-BL-2021-008178,BAUSCH AND LOMB,,73.0,YR,,M,Y,96.0,KG,20211119.0,,MD,DE,DE,2021,Q4,Elderly
190298442,19029844,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Diaphragmatic disorder,,2021,Q4,2,F,20180101.0,20211113.0,20210318,20211119,EXP,,DE-BAUSCH-BL-2021-008178,BAUSCH AND LOMB,,73.0,YR,,M,Y,96.0,KG,20211119.0,,MD,DE,DE,2021,Q4,Elderly
190298442,19029844,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Lymphocyte count decreased,,2021,Q4,2,F,20180101.0,20211113.0,20210318,20211119,EXP,,DE-BAUSCH-BL-2021-008178,BAUSCH AND LOMB,,73.0,YR,,M,Y,96.0,KG,20211119.0,,MD,DE,DE,2021,Q4,Elderly
190298442,19029844,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Adrenomegaly,,2021,Q4,2,F,20180101.0,20211113.0,20210318,20211119,EXP,,DE-BAUSCH-BL-2021-008178,BAUSCH AND LOMB,,73.0,YR,,M,Y,96.0,KG,20211119.0,,MD,DE,DE,2021,Q4,Elderly
190298442,19029844,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,White blood cell count increased,,2021,Q4,2,F,20180101.0,20211113.0,20210318,20211119,EXP,,DE-BAUSCH-BL-2021-008178,BAUSCH AND LOMB,,73.0,YR,,M,Y,96.0,KG,20211119.0,,MD,DE,DE,2021,Q4,Elderly
190298442,19029844,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Malignant neoplasm progression,,2021,Q4,2,F,20180101.0,20211113.0,20210318,20211119,EXP,,DE-BAUSCH-BL-2021-008178,BAUSCH AND LOMB,,73.0,YR,,M,Y,96.0,KG,20211119.0,,MD,DE,DE,2021,Q4,Elderly
190298442,19029844,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Febrile infection,,2021,Q4,2,F,20180101.0,20211113.0,20210318,20211119,EXP,,DE-BAUSCH-BL-2021-008178,BAUSCH AND LOMB,,73.0,YR,,M,Y,96.0,KG,20211119.0,,MD,DE,DE,2021,Q4,Elderly
190298442,19029844,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Blast cells present,,2021,Q4,2,F,20180101.0,20211113.0,20210318,20211119,EXP,,DE-BAUSCH-BL-2021-008178,BAUSCH AND LOMB,,73.0,YR,,M,Y,96.0,KG,20211119.0,,MD,DE,DE,2021,Q4,Elderly
190298442,19029844,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Costal cartilage fracture,,2021,Q4,2,F,20180101.0,20211113.0,20210318,20211119,EXP,,DE-BAUSCH-BL-2021-008178,BAUSCH AND LOMB,,73.0,YR,,M,Y,96.0,KG,20211119.0,,MD,DE,DE,2021,Q4,Elderly
190298442,19029844,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Hypotension,,2021,Q4,2,F,20180101.0,20211113.0,20210318,20211119,EXP,,DE-BAUSCH-BL-2021-008178,BAUSCH AND LOMB,,73.0,YR,,M,Y,96.0,KG,20211119.0,,MD,DE,DE,2021,Q4,Elderly
190298442,19029844,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Blood glucose increased,,2021,Q4,2,F,20180101.0,20211113.0,20210318,20211119,EXP,,DE-BAUSCH-BL-2021-008178,BAUSCH AND LOMB,,73.0,YR,,M,Y,96.0,KG,20211119.0,,MD,DE,DE,2021,Q4,Elderly
190298442,19029844,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Serum ferritin increased,,2021,Q4,2,F,20180101.0,20211113.0,20210318,20211119,EXP,,DE-BAUSCH-BL-2021-008178,BAUSCH AND LOMB,,73.0,YR,,M,Y,96.0,KG,20211119.0,,MD,DE,DE,2021,Q4,Elderly
190298442,19029844,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Enterococcal infection,,2021,Q4,2,F,20180101.0,20211113.0,20210318,20211119,EXP,,DE-BAUSCH-BL-2021-008178,BAUSCH AND LOMB,,73.0,YR,,M,Y,96.0,KG,20211119.0,,MD,DE,DE,2021,Q4,Elderly
190298442,19029844,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Prothrombin time prolonged,,2021,Q4,2,F,20180101.0,20211113.0,20210318,20211119,EXP,,DE-BAUSCH-BL-2021-008178,BAUSCH AND LOMB,,73.0,YR,,M,Y,96.0,KG,20211119.0,,MD,DE,DE,2021,Q4,Elderly
190298442,19029844,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Euphoric mood,,2021,Q4,2,F,20180101.0,20211113.0,20210318,20211119,EXP,,DE-BAUSCH-BL-2021-008178,BAUSCH AND LOMB,,73.0,YR,,M,Y,96.0,KG,20211119.0,,MD,DE,DE,2021,Q4,Elderly
190298442,19029844,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Blood calcium increased,,2021,Q4,2,F,20180101.0,20211113.0,20210318,20211119,EXP,,DE-BAUSCH-BL-2021-008178,BAUSCH AND LOMB,,73.0,YR,,M,Y,96.0,KG,20211119.0,,MD,DE,DE,2021,Q4,Elderly
190298442,19029844,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Activated partial thromboplastin time prolonged,,2021,Q4,2,F,20180101.0,20211113.0,20210318,20211119,EXP,,DE-BAUSCH-BL-2021-008178,BAUSCH AND LOMB,,73.0,YR,,M,Y,96.0,KG,20211119.0,,MD,DE,DE,2021,Q4,Elderly
190298442,19029844,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,C-reactive protein increased,,2021,Q4,2,F,20180101.0,20211113.0,20210318,20211119,EXP,,DE-BAUSCH-BL-2021-008178,BAUSCH AND LOMB,,73.0,YR,,M,Y,96.0,KG,20211119.0,,MD,DE,DE,2021,Q4,Elderly
190298442,19029844,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Neutropenia,,2021,Q4,2,F,20180101.0,20211113.0,20210318,20211119,EXP,,DE-BAUSCH-BL-2021-008178,BAUSCH AND LOMB,,73.0,YR,,M,Y,96.0,KG,20211119.0,,MD,DE,DE,2021,Q4,Elderly
190298442,19029844,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Gastritis,,2021,Q4,2,F,20180101.0,20211113.0,20210318,20211119,EXP,,DE-BAUSCH-BL-2021-008178,BAUSCH AND LOMB,,73.0,YR,,M,Y,96.0,KG,20211119.0,,MD,DE,DE,2021,Q4,Elderly
190298442,19029844,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Acute lymphocytic leukaemia recurrent,,2021,Q4,2,F,20180101.0,20211113.0,20210318,20211119,EXP,,DE-BAUSCH-BL-2021-008178,BAUSCH AND LOMB,,73.0,YR,,M,Y,96.0,KG,20211119.0,,MD,DE,DE,2021,Q4,Elderly
190298442,19029844,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Platelet count decreased,,2021,Q4,2,F,20180101.0,20211113.0,20210318,20211119,EXP,,DE-BAUSCH-BL-2021-008178,BAUSCH AND LOMB,,73.0,YR,,M,Y,96.0,KG,20211119.0,,MD,DE,DE,2021,Q4,Elderly
190298442,19029844,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Pyrexia,,2021,Q4,2,F,20180101.0,20211113.0,20210318,20211119,EXP,,DE-BAUSCH-BL-2021-008178,BAUSCH AND LOMB,,73.0,YR,,M,Y,96.0,KG,20211119.0,,MD,DE,DE,2021,Q4,Elderly
190298442,19029844,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Escherichia urinary tract infection,,2021,Q4,2,F,20180101.0,20211113.0,20210318,20211119,EXP,,DE-BAUSCH-BL-2021-008178,BAUSCH AND LOMB,,73.0,YR,,M,Y,96.0,KG,20211119.0,,MD,DE,DE,2021,Q4,Elderly
190298442,19029844,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Blood bilirubin increased,,2021,Q4,2,F,20180101.0,20211113.0,20210318,20211119,EXP,,DE-BAUSCH-BL-2021-008178,BAUSCH AND LOMB,,73.0,YR,,M,Y,96.0,KG,20211119.0,,MD,DE,DE,2021,Q4,Elderly
190298442,19029844,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Acute lymphocytic leukaemia,,2021,Q4,2,F,20180101.0,20211113.0,20210318,20211119,EXP,,DE-BAUSCH-BL-2021-008178,BAUSCH AND LOMB,,73.0,YR,,M,Y,96.0,KG,20211119.0,,MD,DE,DE,2021,Q4,Elderly
190298442,19029844,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Procalcitonin increased,,2021,Q4,2,F,20180101.0,20211113.0,20210318,20211119,EXP,,DE-BAUSCH-BL-2021-008178,BAUSCH AND LOMB,,73.0,YR,,M,Y,96.0,KG,20211119.0,,MD,DE,DE,2021,Q4,Elderly
190298442,19029844,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Haemangioma,,2021,Q4,2,F,20180101.0,20211113.0,20210318,20211119,EXP,,DE-BAUSCH-BL-2021-008178,BAUSCH AND LOMB,,73.0,YR,,M,Y,96.0,KG,20211119.0,,MD,DE,DE,2021,Q4,Elderly
190298442,19029844,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Cytokine release syndrome,,2021,Q4,2,F,20180101.0,20211113.0,20210318,20211119,EXP,,DE-BAUSCH-BL-2021-008178,BAUSCH AND LOMB,,73.0,YR,,M,Y,96.0,KG,20211119.0,,MD,DE,DE,2021,Q4,Elderly
190298442,19029844,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Blood chloride increased,,2021,Q4,2,F,20180101.0,20211113.0,20210318,20211119,EXP,,DE-BAUSCH-BL-2021-008178,BAUSCH AND LOMB,,73.0,YR,,M,Y,96.0,KG,20211119.0,,MD,DE,DE,2021,Q4,Elderly
190298442,19029844,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Neutrophil count decreased,,2021,Q4,2,F,20180101.0,20211113.0,20210318,20211119,EXP,,DE-BAUSCH-BL-2021-008178,BAUSCH AND LOMB,,73.0,YR,,M,Y,96.0,KG,20211119.0,,MD,DE,DE,2021,Q4,Elderly
190298442,19029844,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Lactose intolerance,,2021,Q4,2,F,20180101.0,20211113.0,20210318,20211119,EXP,,DE-BAUSCH-BL-2021-008178,BAUSCH AND LOMB,,73.0,YR,,M,Y,96.0,KG,20211119.0,,MD,DE,DE,2021,Q4,Elderly
190298442,19029844,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Arteriosclerosis coronary artery,,2021,Q4,2,F,20180101.0,20211113.0,20210318,20211119,EXP,,DE-BAUSCH-BL-2021-008178,BAUSCH AND LOMB,,73.0,YR,,M,Y,96.0,KG,20211119.0,,MD,DE,DE,2021,Q4,Elderly
190298442,19029844,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Hepatic calcification,,2021,Q4,2,F,20180101.0,20211113.0,20210318,20211119,EXP,,DE-BAUSCH-BL-2021-008178,BAUSCH AND LOMB,,73.0,YR,,M,Y,96.0,KG,20211119.0,,MD,DE,DE,2021,Q4,Elderly
190298442,19029844,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Blood lactate dehydrogenase increased,,2021,Q4,2,F,20180101.0,20211113.0,20210318,20211119,EXP,,DE-BAUSCH-BL-2021-008178,BAUSCH AND LOMB,,73.0,YR,,M,Y,96.0,KG,20211119.0,,MD,DE,DE,2021,Q4,Elderly
190298442,19029844,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Myelocyte count increased,,2021,Q4,2,F,20180101.0,20211113.0,20210318,20211119,EXP,,DE-BAUSCH-BL-2021-008178,BAUSCH AND LOMB,,73.0,YR,,M,Y,96.0,KG,20211119.0,,MD,DE,DE,2021,Q4,Elderly
190298442,19029844,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Metamyelocyte count increased,,2021,Q4,2,F,20180101.0,20211113.0,20210318,20211119,EXP,,DE-BAUSCH-BL-2021-008178,BAUSCH AND LOMB,,73.0,YR,,M,Y,96.0,KG,20211119.0,,MD,DE,DE,2021,Q4,Elderly
190298442,19029844,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Lymphadenopathy,,2021,Q4,2,F,20180101.0,20211113.0,20210318,20211119,EXP,,DE-BAUSCH-BL-2021-008178,BAUSCH AND LOMB,,73.0,YR,,M,Y,96.0,KG,20211119.0,,MD,DE,DE,2021,Q4,Elderly
190298442,19029844,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Pancreatitis chronic,,2021,Q4,2,F,20180101.0,20211113.0,20210318,20211119,EXP,,DE-BAUSCH-BL-2021-008178,BAUSCH AND LOMB,,73.0,YR,,M,Y,96.0,KG,20211119.0,,MD,DE,DE,2021,Q4,Elderly
190298442,19029844,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Gamma-glutamyltransferase increased,,2021,Q4,2,F,20180101.0,20211113.0,20210318,20211119,EXP,,DE-BAUSCH-BL-2021-008178,BAUSCH AND LOMB,,73.0,YR,,M,Y,96.0,KG,20211119.0,,MD,DE,DE,2021,Q4,Elderly
190298442,19029844,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Red cell distribution width increased,,2021,Q4,2,F,20180101.0,20211113.0,20210318,20211119,EXP,,DE-BAUSCH-BL-2021-008178,BAUSCH AND LOMB,,73.0,YR,,M,Y,96.0,KG,20211119.0,,MD,DE,DE,2021,Q4,Elderly
190392334,19039233,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 Units,,,,,,,,,,,QD,2021,Q4,Tumour lysis syndrome,,2021,Q4,4,F,20210223.0,20211021.0,20210322,20211029,EXP,,US-ROCHE-2787925,ROCHE,,67.0,YR,,M,Y,110.0,KG,20211029.0,,MD,US,US,2021,Q4,Elderly
190392334,19039233,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 Units,,,,,,,,,,,QD,2021,Q4,Dehydration,,2021,Q4,4,F,20210223.0,20211021.0,20210322,20211029,EXP,,US-ROCHE-2787925,ROCHE,,67.0,YR,,M,Y,110.0,KG,20211029.0,,MD,US,US,2021,Q4,Elderly
190392334,19039233,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 Units,,,,,,,,,,,QD,2021,Q4,Acute kidney injury,,2021,Q4,4,F,20210223.0,20211021.0,20210322,20211029,EXP,,US-ROCHE-2787925,ROCHE,,67.0,YR,,M,Y,110.0,KG,20211029.0,,MD,US,US,2021,Q4,Elderly
190984788,19098478,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,45 unit,,,U,,,,,,,,,2021,Q4,Dizziness,,2021,Q4,8,F,20210324.0,20211228.0,20210406,20211228,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-031764,BRISTOL MYERS SQUIBB,,73.0,YR,,F,Y,,,20211228.0,,CN,US,US,2021,Q4,Elderly
190984788,19098478,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,45 unit,,,U,,,,,,,,,2021,Q4,Hypotension,,2021,Q4,8,F,20210324.0,20211228.0,20210406,20211228,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-031764,BRISTOL MYERS SQUIBB,,73.0,YR,,F,Y,,,20211228.0,,CN,US,US,2021,Q4,Elderly
190984788,19098478,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,45 unit,,,U,,,,,,,,,2021,Q4,Anaemia,,2021,Q4,8,F,20210324.0,20211228.0,20210406,20211228,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-031764,BRISTOL MYERS SQUIBB,,73.0,YR,,F,Y,,,20211228.0,,CN,US,US,2021,Q4,Elderly
190984788,19098478,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,45 unit,,,U,,,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,8,F,20210324.0,20211228.0,20210406,20211228,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-031764,BRISTOL MYERS SQUIBB,,73.0,YR,,F,Y,,,20211228.0,,CN,US,US,2021,Q4,Elderly
190984788,19098478,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,45 unit,,,U,,,,,,,,,2021,Q4,Palpitations,,2021,Q4,8,F,20210324.0,20211228.0,20210406,20211228,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-031764,BRISTOL MYERS SQUIBB,,73.0,YR,,F,Y,,,20211228.0,,CN,US,US,2021,Q4,Elderly
190984788,19098478,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,45 unit,,,U,,,,,,,,,2021,Q4,Diabetes mellitus,,2021,Q4,8,F,20210324.0,20211228.0,20210406,20211228,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-031764,BRISTOL MYERS SQUIBB,,73.0,YR,,F,Y,,,20211228.0,,CN,US,US,2021,Q4,Elderly
190984788,19098478,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,45 unit,,,U,,,,,,,,,2021,Q4,Syncope,,2021,Q4,8,F,20210324.0,20211228.0,20210406,20211228,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-031764,BRISTOL MYERS SQUIBB,,73.0,YR,,F,Y,,,20211228.0,,CN,US,US,2021,Q4,Elderly
190984788,19098478,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,45 unit,,,U,,,,,,,,,2021,Q4,Heart rate increased,,2021,Q4,8,F,20210324.0,20211228.0,20210406,20211228,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-031764,BRISTOL MYERS SQUIBB,,73.0,YR,,F,Y,,,20211228.0,,CN,US,US,2021,Q4,Elderly
190984788,19098478,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,45 unit,,,U,,,,,,,,,2021,Q4,Swelling of eyelid,,2021,Q4,8,F,20210324.0,20211228.0,20210406,20211228,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-031764,BRISTOL MYERS SQUIBB,,73.0,YR,,F,Y,,,20211228.0,,CN,US,US,2021,Q4,Elderly
191387383,19138738,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 international unit, Once a Day",,,,,1F935A,,,30.0,IU,Solution for injection,QD,2021,Q4,Listless,,2021,Q4,3,F,20210301.0,20211101.0,20210415,20211115,EXP,,ES-AUROBINDO-AUR-APL-2021-015538,AUROBINDO,,79.0,YR,,F,Y,52.6,KG,20211115.0,,CN,ES,ES,2021,Q4,Elderly
191387383,19138738,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 international unit, Once a Day",,,,,1F935A,,,30.0,IU,Solution for injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,3,F,20210301.0,20211101.0,20210415,20211115,EXP,,ES-AUROBINDO-AUR-APL-2021-015538,AUROBINDO,,79.0,YR,,F,Y,52.6,KG,20211115.0,,CN,ES,ES,2021,Q4,Elderly
191387383,19138738,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 international unit, Once a Day",,,,,1F935A,,,30.0,IU,Solution for injection,QD,2021,Q4,Gait disturbance,,2021,Q4,3,F,20210301.0,20211101.0,20210415,20211115,EXP,,ES-AUROBINDO-AUR-APL-2021-015538,AUROBINDO,,79.0,YR,,F,Y,52.6,KG,20211115.0,,CN,ES,ES,2021,Q4,Elderly
191387383,19138738,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 international unit, Once a Day",,,,,1F935A,,,30.0,IU,Solution for injection,QD,2021,Q4,Hyperglycaemia,,2021,Q4,3,F,20210301.0,20211101.0,20210415,20211115,EXP,,ES-AUROBINDO-AUR-APL-2021-015538,AUROBINDO,,79.0,YR,,F,Y,52.6,KG,20211115.0,,CN,ES,ES,2021,Q4,Elderly
191387383,19138738,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 international unit, Once a Day",,,,,1F935A,,,30.0,IU,Solution for injection,QD,2021,Q4,Poor quality sleep,,2021,Q4,3,F,20210301.0,20211101.0,20210415,20211115,EXP,,ES-AUROBINDO-AUR-APL-2021-015538,AUROBINDO,,79.0,YR,,F,Y,52.6,KG,20211115.0,,CN,ES,ES,2021,Q4,Elderly
191387383,19138738,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 international unit, Once a Day",,,,,1F935A,,,30.0,IU,Solution for injection,QD,2021,Q4,Sciatica,,2021,Q4,3,F,20210301.0,20211101.0,20210415,20211115,EXP,,ES-AUROBINDO-AUR-APL-2021-015538,AUROBINDO,,79.0,YR,,F,Y,52.6,KG,20211115.0,,CN,ES,ES,2021,Q4,Elderly
191387383,19138738,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 international unit, Once a Day",,,,,1F935A,,,30.0,IU,Solution for injection,QD,2021,Q4,Extremity contracture,,2021,Q4,3,F,20210301.0,20211101.0,20210415,20211115,EXP,,ES-AUROBINDO-AUR-APL-2021-015538,AUROBINDO,,79.0,YR,,F,Y,52.6,KG,20211115.0,,CN,ES,ES,2021,Q4,Elderly
191387383,19138738,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 international unit, Once a Day",,,,,1F935A,,,30.0,IU,Solution for injection,QD,2021,Q4,Pain in extremity,,2021,Q4,3,F,20210301.0,20211101.0,20210415,20211115,EXP,,ES-AUROBINDO-AUR-APL-2021-015538,AUROBINDO,,79.0,YR,,F,Y,52.6,KG,20211115.0,,CN,ES,ES,2021,Q4,Elderly
191387383,19138738,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 international unit, Once a Day",,,,,1F935A,,,30.0,IU,Solution for injection,QD,2021,Q4,Limb discomfort,,2021,Q4,3,F,20210301.0,20211101.0,20210415,20211115,EXP,,ES-AUROBINDO-AUR-APL-2021-015538,AUROBINDO,,79.0,YR,,F,Y,52.6,KG,20211115.0,,CN,ES,ES,2021,Q4,Elderly
191488028,19148802,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DF DAILY,,,U,N,,,,,,Solution for injection/infusion,,2021,Q4,Neurological symptom,,2021,Q4,8,F,,20211006.0,20210416,20211013,EXP,,CA-ANIPHARMA-2021-CA-000457,ANI,,65.0,YR,,M,Y,,,20211013.0,,CN,CA,CA,2021,Q4,Elderly
191488028,19148802,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DF DAILY,,,U,N,,,,,,Solution for injection/infusion,,2021,Q4,Obstructive airways disorder,,2021,Q4,8,F,,20211006.0,20210416,20211013,EXP,,CA-ANIPHARMA-2021-CA-000457,ANI,,65.0,YR,,M,Y,,,20211013.0,,CN,CA,CA,2021,Q4,Elderly
191488028,19148802,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DF DAILY,,,U,N,,,,,,Solution for injection/infusion,,2021,Q4,Pulmonary vasculitis,,2021,Q4,8,F,,20211006.0,20210416,20211013,EXP,,CA-ANIPHARMA-2021-CA-000457,ANI,,65.0,YR,,M,Y,,,20211013.0,,CN,CA,CA,2021,Q4,Elderly
191488028,19148802,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DF DAILY,,,U,N,,,,,,Solution for injection/infusion,,2021,Q4,Asthma,,2021,Q4,8,F,,20211006.0,20210416,20211013,EXP,,CA-ANIPHARMA-2021-CA-000457,ANI,,65.0,YR,,M,Y,,,20211013.0,,CN,CA,CA,2021,Q4,Elderly
191488028,19148802,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DF DAILY,,,U,N,,,,,,Solution for injection/infusion,,2021,Q4,Pain in extremity,,2021,Q4,8,F,,20211006.0,20210416,20211013,EXP,,CA-ANIPHARMA-2021-CA-000457,ANI,,65.0,YR,,M,Y,,,20211013.0,,CN,CA,CA,2021,Q4,Elderly
191488028,19148802,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DF DAILY,,,U,N,,,,,,Solution for injection/infusion,,2021,Q4,Pulmonary alveolar haemorrhage,,2021,Q4,8,F,,20211006.0,20210416,20211013,EXP,,CA-ANIPHARMA-2021-CA-000457,ANI,,65.0,YR,,M,Y,,,20211013.0,,CN,CA,CA,2021,Q4,Elderly
191488028,19148802,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DF DAILY,,,U,N,,,,,,Solution for injection/infusion,,2021,Q4,Pulmonary fibrosis,,2021,Q4,8,F,,20211006.0,20210416,20211013,EXP,,CA-ANIPHARMA-2021-CA-000457,ANI,,65.0,YR,,M,Y,,,20211013.0,,CN,CA,CA,2021,Q4,Elderly
191488028,19148802,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DF DAILY,,,U,N,,,,,,Solution for injection/infusion,,2021,Q4,Respiratory symptom,,2021,Q4,8,F,,20211006.0,20210416,20211013,EXP,,CA-ANIPHARMA-2021-CA-000457,ANI,,65.0,YR,,M,Y,,,20211013.0,,CN,CA,CA,2021,Q4,Elderly
191488028,19148802,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DF DAILY,,,U,N,,,,,,Solution for injection/infusion,,2021,Q4,Sleep disorder due to a general medical condition,,2021,Q4,8,F,,20211006.0,20210416,20211013,EXP,,CA-ANIPHARMA-2021-CA-000457,ANI,,65.0,YR,,M,Y,,,20211013.0,,CN,CA,CA,2021,Q4,Elderly
191488028,19148802,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DF DAILY,,,U,N,,,,,,Solution for injection/infusion,,2021,Q4,Neuritis,,2021,Q4,8,F,,20211006.0,20210416,20211013,EXP,,CA-ANIPHARMA-2021-CA-000457,ANI,,65.0,YR,,M,Y,,,20211013.0,,CN,CA,CA,2021,Q4,Elderly
191488028,19148802,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DF DAILY,,,U,N,,,,,,Solution for injection/infusion,,2021,Q4,Lung disorder,,2021,Q4,8,F,,20211006.0,20210416,20211013,EXP,,CA-ANIPHARMA-2021-CA-000457,ANI,,65.0,YR,,M,Y,,,20211013.0,,CN,CA,CA,2021,Q4,Elderly
191488028,19148802,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DF DAILY,,,U,N,,,,,,Solution for injection/infusion,,2021,Q4,Loss of personal independence in daily activities,,2021,Q4,8,F,,20211006.0,20210416,20211013,EXP,,CA-ANIPHARMA-2021-CA-000457,ANI,,65.0,YR,,M,Y,,,20211013.0,,CN,CA,CA,2021,Q4,Elderly
191488028,19148802,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DF DAILY,,,U,N,,,,,,Solution for injection/infusion,,2021,Q4,Haemoptysis,,2021,Q4,8,F,,20211006.0,20210416,20211013,EXP,,CA-ANIPHARMA-2021-CA-000457,ANI,,65.0,YR,,M,Y,,,20211013.0,,CN,CA,CA,2021,Q4,Elderly
191488028,19148802,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DF DAILY,,,U,N,,,,,,Solution for injection/infusion,,2021,Q4,Dyspnoea,,2021,Q4,8,F,,20211006.0,20210416,20211013,EXP,,CA-ANIPHARMA-2021-CA-000457,ANI,,65.0,YR,,M,Y,,,20211013.0,,CN,CA,CA,2021,Q4,Elderly
191488028,19148802,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DF DAILY,,,U,N,,,,,,Solution for injection/infusion,,2021,Q4,Vasculitis,,2021,Q4,8,F,,20211006.0,20210416,20211013,EXP,,CA-ANIPHARMA-2021-CA-000457,ANI,,65.0,YR,,M,Y,,,20211013.0,,CN,CA,CA,2021,Q4,Elderly
191488028,19148802,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DF DAILY,,,U,N,,,,,,Solution for injection/infusion,,2021,Q4,Wheezing,,2021,Q4,8,F,,20211006.0,20210416,20211013,EXP,,CA-ANIPHARMA-2021-CA-000457,ANI,,65.0,YR,,M,Y,,,20211013.0,,CN,CA,CA,2021,Q4,Elderly
191488028,19148802,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DF DAILY,,,U,N,,,,,,Solution for injection/infusion,,2021,Q4,Condition aggravated,,2021,Q4,8,F,,20211006.0,20210416,20211013,EXP,,CA-ANIPHARMA-2021-CA-000457,ANI,,65.0,YR,,M,Y,,,20211013.0,,CN,CA,CA,2021,Q4,Elderly
192663534,19266353,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Exercise lack of,,2021,Q4,4,F,20210101.0,20211110.0,20210517,20211118,EXP,,PE-BAYER-2021-127548,BAYER,,56.0,YR,A,M,Y,,,20211118.0,,CN,PE,PE,2021,Q4,Adult
192663534,19266353,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Leg amputation,,2021,Q4,4,F,20210101.0,20211110.0,20210517,20211118,EXP,,PE-BAYER-2021-127548,BAYER,,56.0,YR,A,M,Y,,,20211118.0,,CN,PE,PE,2021,Q4,Adult
192663534,19266353,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Gait disturbance,,2021,Q4,4,F,20210101.0,20211110.0,20210517,20211118,EXP,,PE-BAYER-2021-127548,BAYER,,56.0,YR,A,M,Y,,,20211118.0,,CN,PE,PE,2021,Q4,Adult
192663534,19266353,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Skin wound,,2021,Q4,4,F,20210101.0,20211110.0,20210517,20211118,EXP,,PE-BAYER-2021-127548,BAYER,,56.0,YR,A,M,Y,,,20211118.0,,CN,PE,PE,2021,Q4,Adult
192663534,19266353,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Mobility decreased,,2021,Q4,4,F,20210101.0,20211110.0,20210517,20211118,EXP,,PE-BAYER-2021-127548,BAYER,,56.0,YR,A,M,Y,,,20211118.0,,CN,PE,PE,2021,Q4,Adult
192663534,19266353,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Adverse reaction,,2021,Q4,4,F,20210101.0,20211110.0,20210517,20211118,EXP,,PE-BAYER-2021-127548,BAYER,,56.0,YR,A,M,Y,,,20211118.0,,CN,PE,PE,2021,Q4,Adult
192663534,19266353,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Pain,,2021,Q4,4,F,20210101.0,20211110.0,20210517,20211118,EXP,,PE-BAYER-2021-127548,BAYER,,56.0,YR,A,M,Y,,,20211118.0,,CN,PE,PE,2021,Q4,Adult
192663534,19266353,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Limb injury,,2021,Q4,4,F,20210101.0,20211110.0,20210517,20211118,EXP,,PE-BAYER-2021-127548,BAYER,,56.0,YR,A,M,Y,,,20211118.0,,CN,PE,PE,2021,Q4,Adult
192663534,19266353,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Blister infected,,2021,Q4,4,F,20210101.0,20211110.0,20210517,20211118,EXP,,PE-BAYER-2021-127548,BAYER,,56.0,YR,A,M,Y,,,20211118.0,,CN,PE,PE,2021,Q4,Adult
192689958,19268995,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Herpes zoster disseminated,,2021,Q4,8,F,20210430.0,20211210.0,20210518,20211215,EXP,,NVSC2021US103274,NOVARTIS,,66.0,YR,,M,Y,76.3,KG,20211215.0,,MD,US,US,2021,Q4,Elderly
192924452,19292445,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intramuscular,"20 IU, qd (night)",,,,,unk,,,20.0,IU,,QD,2021,Q4,Death,,2021,Q4,2,F,,20210903.0,20210524,20211215,EXP,,AU-NOVOPROD-813822,NOVO NORDISK,,75.0,YR,,M,Y,72.0,KG,20211215.0,,HP,AU,AU,2021,Q4,Elderly
192924452,19292445,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intramuscular,"20 IU, qd (night)",,,,,unk,,,20.0,IU,,QD,2021,Q4,Hypoglycaemic unconsciousness,,2021,Q4,2,F,,20210903.0,20210524,20211215,EXP,,AU-NOVOPROD-813822,NOVO NORDISK,,75.0,YR,,M,Y,72.0,KG,20211215.0,,HP,AU,AU,2021,Q4,Elderly
192924452,19292445,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intramuscular,"20 IU, qd (night)",,,,,unk,,,20.0,IU,,QD,2021,Q4,Hypoglycaemia,,2021,Q4,2,F,,20210903.0,20210524,20211215,EXP,,AU-NOVOPROD-813822,NOVO NORDISK,,75.0,YR,,M,Y,72.0,KG,20211215.0,,HP,AU,AU,2021,Q4,Elderly
193621653,19362165,76,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 UNK,,,,,,,,,,,,2021,Q4,Blood bilirubin increased,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,76,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 UNK,,,,,,,,,,,,2021,Q4,Anaemia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,76,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 UNK,,,,,,,,,,,,2021,Q4,Sputum increased,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,76,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 UNK,,,,,,,,,,,,2021,Q4,Constipation,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,76,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 UNK,,,,,,,,,,,,2021,Q4,Agitation,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,76,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 UNK,,,,,,,,,,,,2021,Q4,Aspergillus infection,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,76,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 UNK,,,,,,,,,,,,2021,Q4,Neutropenia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,76,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 UNK,,,,,,,,,,,,2021,Q4,Chills,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,76,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 UNK,,,,,,,,,,,,2021,Q4,Blood pressure decreased,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,76,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 UNK,,,,,,,,,,,,2021,Q4,Haemoptysis,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,76,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 UNK,,,,,,,,,,,,2021,Q4,Hypokalaemia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,76,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 UNK,,,,,,,,,,,,2021,Q4,Hyperglycaemia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,76,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 UNK,,,,,,,,,,,,2021,Q4,Epistaxis,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,76,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 UNK,,,,,,,,,,,,2021,Q4,Arthralgia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,76,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 UNK,,,,,,,,,,,,2021,Q4,Anaemia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,76,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 UNK,,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,76,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 UNK,,,,,,,,,,,,2021,Q4,Pleural effusion,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,76,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 UNK,,,,,,,,,,,,2021,Q4,Purpura,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,76,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 UNK,,,,,,,,,,,,2021,Q4,Pleuritic pain,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,76,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 UNK,,,,,,,,,,,,2021,Q4,Hypoacusis,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,76,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 UNK,,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,76,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 UNK,,,,,,,,,,,,2021,Q4,Pleuritic pain,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,76,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 UNK,,,,,,,,,,,,2021,Q4,Hypotension,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,76,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 UNK,,,,,,,,,,,,2021,Q4,Platelet count decreased,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,76,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 UNK,,,,,,,,,,,,2021,Q4,Cough,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,76,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 UNK,,,,,,,,,,,,2021,Q4,Atypical pneumonia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,76,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 UNK,,,,,,,,,,,,2021,Q4,Cough,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,76,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 UNK,,,,,,,,,,,,2021,Q4,Blood pressure decreased,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,76,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 UNK,,,,,,,,,,,,2021,Q4,Mouth ulceration,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,76,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 UNK,,,,,,,,,,,,2021,Q4,Gait inability,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,76,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 UNK,,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,76,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 UNK,,,,,,,,,,,,2021,Q4,Hyperglycaemia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,76,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 UNK,,,,,,,,,,,,2021,Q4,Pyrexia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,76,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 UNK,,,,,,,,,,,,2021,Q4,Blood bilirubin increased,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,76,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 UNK,,,,,,,,,,,,2021,Q4,Dizziness,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,76,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 UNK,,,,,,,,,,,,2021,Q4,Scrotal irritation,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,76,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 UNK,,,,,,,,,,,,2021,Q4,Chest pain,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,77,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Blood bilirubin increased,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,77,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Anaemia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,77,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Sputum increased,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,77,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Constipation,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,77,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Agitation,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,77,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Aspergillus infection,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,77,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Neutropenia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,77,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Chills,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,77,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Blood pressure decreased,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,77,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Haemoptysis,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,77,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Hypokalaemia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,77,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Hyperglycaemia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,77,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Epistaxis,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,77,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Arthralgia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,77,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Anaemia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,77,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,77,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Pleural effusion,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,77,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Purpura,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,77,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Pleuritic pain,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,77,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Hypoacusis,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,77,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,77,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Pleuritic pain,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,77,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Hypotension,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,77,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Platelet count decreased,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,77,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Cough,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,77,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Atypical pneumonia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,77,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Cough,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,77,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Blood pressure decreased,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,77,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Mouth ulceration,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,77,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Gait inability,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,77,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,77,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Hyperglycaemia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,77,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Pyrexia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,77,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Blood bilirubin increased,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,77,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Dizziness,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,77,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Scrotal irritation,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,77,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Chest pain,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,78,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Blood bilirubin increased,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,78,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Anaemia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,78,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Sputum increased,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,78,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Constipation,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,78,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Agitation,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,78,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Aspergillus infection,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,78,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Neutropenia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,78,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Chills,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,78,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Blood pressure decreased,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,78,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Haemoptysis,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,78,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Hypokalaemia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,78,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Hyperglycaemia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,78,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Epistaxis,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,78,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Arthralgia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,78,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Anaemia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,78,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,78,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Pleural effusion,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,78,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Purpura,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,78,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Pleuritic pain,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,78,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Hypoacusis,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,78,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,78,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Pleuritic pain,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,78,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Hypotension,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,78,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Platelet count decreased,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,78,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Cough,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,78,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Atypical pneumonia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,78,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Cough,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,78,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Blood pressure decreased,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,78,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Mouth ulceration,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,78,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Gait inability,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,78,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,78,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Hyperglycaemia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,78,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Pyrexia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,78,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Blood bilirubin increased,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,78,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Dizziness,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,78,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Scrotal irritation,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,78,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,14 UNK,,,,,,,,,,,,2021,Q4,Chest pain,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,79,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Blood bilirubin increased,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,79,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Anaemia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,79,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Sputum increased,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,79,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Constipation,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,79,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Agitation,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,79,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Aspergillus infection,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,79,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Neutropenia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,79,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Chills,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,79,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Blood pressure decreased,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,79,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Haemoptysis,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,79,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Hypokalaemia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,79,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Hyperglycaemia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,79,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Epistaxis,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,79,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Arthralgia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,79,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Anaemia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,79,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,79,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Pleural effusion,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,79,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Purpura,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,79,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Pleuritic pain,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,79,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Hypoacusis,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,79,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,79,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Pleuritic pain,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,79,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Hypotension,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,79,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Platelet count decreased,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,79,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Cough,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,79,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Atypical pneumonia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,79,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Cough,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,79,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Blood pressure decreased,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,79,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Mouth ulceration,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,79,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Gait inability,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,79,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,79,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Hyperglycaemia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,79,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Pyrexia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,79,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Blood bilirubin increased,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,79,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Dizziness,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,79,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Scrotal irritation,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,79,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Chest pain,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,80,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Blood bilirubin increased,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,80,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Anaemia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,80,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Sputum increased,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,80,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Constipation,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,80,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Agitation,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,80,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Aspergillus infection,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,80,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Neutropenia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,80,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Chills,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,80,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Blood pressure decreased,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,80,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Haemoptysis,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,80,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Hypokalaemia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,80,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Hyperglycaemia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,80,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Epistaxis,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,80,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Arthralgia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,80,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Anaemia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,80,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,80,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Pleural effusion,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,80,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Purpura,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,80,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Pleuritic pain,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,80,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Hypoacusis,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,80,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,80,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Pleuritic pain,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,80,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Hypotension,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,80,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Platelet count decreased,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,80,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Cough,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,80,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Atypical pneumonia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,80,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Cough,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,80,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Blood pressure decreased,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,80,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Mouth ulceration,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,80,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Gait inability,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,80,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,80,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Hyperglycaemia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,80,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Pyrexia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,80,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Blood bilirubin increased,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,80,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Dizziness,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,80,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Scrotal irritation,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,80,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Chest pain,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,81,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Blood bilirubin increased,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,81,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Anaemia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,81,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Sputum increased,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,81,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Constipation,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,81,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Agitation,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,81,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Aspergillus infection,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,81,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Neutropenia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,81,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Chills,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,81,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Blood pressure decreased,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,81,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Haemoptysis,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,81,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Hypokalaemia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,81,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Hyperglycaemia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,81,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Epistaxis,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,81,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Arthralgia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,81,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Anaemia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,81,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,81,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Pleural effusion,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,81,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Purpura,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,81,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Pleuritic pain,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,81,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Hypoacusis,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,81,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,81,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Pleuritic pain,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,81,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Hypotension,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,81,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Platelet count decreased,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,81,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Cough,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,81,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Atypical pneumonia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,81,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Cough,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,81,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Blood pressure decreased,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,81,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Mouth ulceration,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,81,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Gait inability,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,81,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,81,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Hyperglycaemia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,81,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Pyrexia,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,81,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Blood bilirubin increased,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,81,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Dizziness,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,81,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Scrotal irritation,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193621653,19362165,81,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 UNK,,,,,,,,,,,,2021,Q4,Chest pain,,2021,Q4,3,F,20110214.0,20210521.0,20210603,20211117,PER,,KR-AMGEN-KORCT2021084119,AMGEN,,55.0,YR,A,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Adult
193711783,19371178,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Neutropenia,,2021,Q4,3,F,20130605.0,20210521.0,20210604,20211117,PER,,KR-AMGEN-KORCT2021084256,AMGEN,,68.0,YR,E,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Elderly
193711783,19371178,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Cough,,2021,Q4,3,F,20130605.0,20210521.0,20210604,20211117,PER,,KR-AMGEN-KORCT2021084256,AMGEN,,68.0,YR,E,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Elderly
193711783,19371178,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Radiculopathy,,2021,Q4,3,F,20130605.0,20210521.0,20210604,20211117,PER,,KR-AMGEN-KORCT2021084256,AMGEN,,68.0,YR,E,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Elderly
193711783,19371178,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Blood bilirubin increased,,2021,Q4,3,F,20130605.0,20210521.0,20210604,20211117,PER,,KR-AMGEN-KORCT2021084256,AMGEN,,68.0,YR,E,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Elderly
193711783,19371178,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Urticaria,,2021,Q4,3,F,20130605.0,20210521.0,20210604,20211117,PER,,KR-AMGEN-KORCT2021084256,AMGEN,,68.0,YR,E,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Elderly
193711783,19371178,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Pulmonary oedema,,2021,Q4,3,F,20130605.0,20210521.0,20210604,20211117,PER,,KR-AMGEN-KORCT2021084256,AMGEN,,68.0,YR,E,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Elderly
193711783,19371178,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Epigastric discomfort,,2021,Q4,3,F,20130605.0,20210521.0,20210604,20211117,PER,,KR-AMGEN-KORCT2021084256,AMGEN,,68.0,YR,E,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Elderly
193711783,19371178,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Injection site haemorrhage,,2021,Q4,3,F,20130605.0,20210521.0,20210604,20211117,PER,,KR-AMGEN-KORCT2021084256,AMGEN,,68.0,YR,E,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Elderly
193711783,19371178,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Blood bilirubin increased,,2021,Q4,3,F,20130605.0,20210521.0,20210604,20211117,PER,,KR-AMGEN-KORCT2021084256,AMGEN,,68.0,YR,E,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Elderly
193711783,19371178,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Febrile neutropenia,,2021,Q4,3,F,20130605.0,20210521.0,20210604,20211117,PER,,KR-AMGEN-KORCT2021084256,AMGEN,,68.0,YR,E,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Elderly
193711783,19371178,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Aspartate aminotransferase increased,,2021,Q4,3,F,20130605.0,20210521.0,20210604,20211117,PER,,KR-AMGEN-KORCT2021084256,AMGEN,,68.0,YR,E,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Elderly
193711783,19371178,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Pyrexia,,2021,Q4,3,F,20130605.0,20210521.0,20210604,20211117,PER,,KR-AMGEN-KORCT2021084256,AMGEN,,68.0,YR,E,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Elderly
193711783,19371178,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Neutropenia,,2021,Q4,3,F,20130605.0,20210521.0,20210604,20211117,PER,,KR-AMGEN-KORCT2021084256,AMGEN,,68.0,YR,E,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Elderly
193711783,19371178,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Nausea,,2021,Q4,3,F,20130605.0,20210521.0,20210604,20211117,PER,,KR-AMGEN-KORCT2021084256,AMGEN,,68.0,YR,E,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Elderly
193711783,19371178,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Alanine aminotransferase increased,,2021,Q4,3,F,20130605.0,20210521.0,20210604,20211117,PER,,KR-AMGEN-KORCT2021084256,AMGEN,,68.0,YR,E,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Elderly
193711783,19371178,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Decreased appetite,,2021,Q4,3,F,20130605.0,20210521.0,20210604,20211117,PER,,KR-AMGEN-KORCT2021084256,AMGEN,,68.0,YR,E,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Elderly
193711783,19371178,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Injection site pain,,2021,Q4,3,F,20130605.0,20210521.0,20210604,20211117,PER,,KR-AMGEN-KORCT2021084256,AMGEN,,68.0,YR,E,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Elderly
193711783,19371178,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Iron metabolism disorder,,2021,Q4,3,F,20130605.0,20210521.0,20210604,20211117,PER,,KR-AMGEN-KORCT2021084256,AMGEN,,68.0,YR,E,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Elderly
193711783,19371178,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Blood bilirubin increased,,2021,Q4,3,F,20130605.0,20210521.0,20210604,20211117,PER,,KR-AMGEN-KORCT2021084256,AMGEN,,68.0,YR,E,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Elderly
193711783,19371178,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Haematoma,,2021,Q4,3,F,20130605.0,20210521.0,20210604,20211117,PER,,KR-AMGEN-KORCT2021084256,AMGEN,,68.0,YR,E,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Elderly
193711783,19371178,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Constipation,,2021,Q4,3,F,20130605.0,20210521.0,20210604,20211117,PER,,KR-AMGEN-KORCT2021084256,AMGEN,,68.0,YR,E,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Elderly
193711783,19371178,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Haematoma,,2021,Q4,3,F,20130605.0,20210521.0,20210604,20211117,PER,,KR-AMGEN-KORCT2021084256,AMGEN,,68.0,YR,E,M,Y,,,20211117.0,,MD,KR,KR,2021,Q4,Elderly
193929085,19392908,34,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, Once a Day",,,U,U,,,,,,Solution,QD,2021,Q4,Dyspnoea,,2021,Q4,5,F,,20211124.0,20210609,20211205,EXP,,CA-AUROBINDO-AUR-APL-2021-022535,AUROBINDO,,65.0,YR,,M,Y,,,20211206.0,,HP,CA,CA,2021,Q4,Elderly
193929085,19392908,34,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, Once a Day",,,U,U,,,,,,Solution,QD,2021,Q4,Respiratory symptom,,2021,Q4,5,F,,20211124.0,20210609,20211205,EXP,,CA-AUROBINDO-AUR-APL-2021-022535,AUROBINDO,,65.0,YR,,M,Y,,,20211206.0,,HP,CA,CA,2021,Q4,Elderly
193929085,19392908,34,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, Once a Day",,,U,U,,,,,,Solution,QD,2021,Q4,Asthma,,2021,Q4,5,F,,20211124.0,20210609,20211205,EXP,,CA-AUROBINDO-AUR-APL-2021-022535,AUROBINDO,,65.0,YR,,M,Y,,,20211206.0,,HP,CA,CA,2021,Q4,Elderly
193929085,19392908,34,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, Once a Day",,,U,U,,,,,,Solution,QD,2021,Q4,Obstructive airways disorder,,2021,Q4,5,F,,20211124.0,20210609,20211205,EXP,,CA-AUROBINDO-AUR-APL-2021-022535,AUROBINDO,,65.0,YR,,M,Y,,,20211206.0,,HP,CA,CA,2021,Q4,Elderly
193929085,19392908,34,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, Once a Day",,,U,U,,,,,,Solution,QD,2021,Q4,Therapeutic product effect incomplete,,2021,Q4,5,F,,20211124.0,20210609,20211205,EXP,,CA-AUROBINDO-AUR-APL-2021-022535,AUROBINDO,,65.0,YR,,M,Y,,,20211206.0,,HP,CA,CA,2021,Q4,Elderly
193929085,19392908,34,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, Once a Day",,,U,U,,,,,,Solution,QD,2021,Q4,Haemoptysis,,2021,Q4,5,F,,20211124.0,20210609,20211205,EXP,,CA-AUROBINDO-AUR-APL-2021-022535,AUROBINDO,,65.0,YR,,M,Y,,,20211206.0,,HP,CA,CA,2021,Q4,Elderly
193929085,19392908,34,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, Once a Day",,,U,U,,,,,,Solution,QD,2021,Q4,Pulmonary alveolar haemorrhage,,2021,Q4,5,F,,20211124.0,20210609,20211205,EXP,,CA-AUROBINDO-AUR-APL-2021-022535,AUROBINDO,,65.0,YR,,M,Y,,,20211206.0,,HP,CA,CA,2021,Q4,Elderly
193929085,19392908,34,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, Once a Day",,,U,U,,,,,,Solution,QD,2021,Q4,Neuritis,,2021,Q4,5,F,,20211124.0,20210609,20211205,EXP,,CA-AUROBINDO-AUR-APL-2021-022535,AUROBINDO,,65.0,YR,,M,Y,,,20211206.0,,HP,CA,CA,2021,Q4,Elderly
193929085,19392908,34,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, Once a Day",,,U,U,,,,,,Solution,QD,2021,Q4,Pulmonary vasculitis,,2021,Q4,5,F,,20211124.0,20210609,20211205,EXP,,CA-AUROBINDO-AUR-APL-2021-022535,AUROBINDO,,65.0,YR,,M,Y,,,20211206.0,,HP,CA,CA,2021,Q4,Elderly
193929085,19392908,34,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, Once a Day",,,U,U,,,,,,Solution,QD,2021,Q4,Pain in extremity,,2021,Q4,5,F,,20211124.0,20210609,20211205,EXP,,CA-AUROBINDO-AUR-APL-2021-022535,AUROBINDO,,65.0,YR,,M,Y,,,20211206.0,,HP,CA,CA,2021,Q4,Elderly
193929085,19392908,34,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, Once a Day",,,U,U,,,,,,Solution,QD,2021,Q4,Condition aggravated,,2021,Q4,5,F,,20211124.0,20210609,20211205,EXP,,CA-AUROBINDO-AUR-APL-2021-022535,AUROBINDO,,65.0,YR,,M,Y,,,20211206.0,,HP,CA,CA,2021,Q4,Elderly
193929085,19392908,34,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, Once a Day",,,U,U,,,,,,Solution,QD,2021,Q4,Sleep disorder due to a general medical condition,,2021,Q4,5,F,,20211124.0,20210609,20211205,EXP,,CA-AUROBINDO-AUR-APL-2021-022535,AUROBINDO,,65.0,YR,,M,Y,,,20211206.0,,HP,CA,CA,2021,Q4,Elderly
193929085,19392908,34,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, Once a Day",,,U,U,,,,,,Solution,QD,2021,Q4,Wheezing,,2021,Q4,5,F,,20211124.0,20210609,20211205,EXP,,CA-AUROBINDO-AUR-APL-2021-022535,AUROBINDO,,65.0,YR,,M,Y,,,20211206.0,,HP,CA,CA,2021,Q4,Elderly
193929085,19392908,34,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, Once a Day",,,U,U,,,,,,Solution,QD,2021,Q4,Neurological symptom,,2021,Q4,5,F,,20211124.0,20210609,20211205,EXP,,CA-AUROBINDO-AUR-APL-2021-022535,AUROBINDO,,65.0,YR,,M,Y,,,20211206.0,,HP,CA,CA,2021,Q4,Elderly
193929085,19392908,34,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, Once a Day",,,U,U,,,,,,Solution,QD,2021,Q4,Lung disorder,,2021,Q4,5,F,,20211124.0,20210609,20211205,EXP,,CA-AUROBINDO-AUR-APL-2021-022535,AUROBINDO,,65.0,YR,,M,Y,,,20211206.0,,HP,CA,CA,2021,Q4,Elderly
193929085,19392908,34,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, Once a Day",,,U,U,,,,,,Solution,QD,2021,Q4,Pulmonary fibrosis,,2021,Q4,5,F,,20211124.0,20210609,20211205,EXP,,CA-AUROBINDO-AUR-APL-2021-022535,AUROBINDO,,65.0,YR,,M,Y,,,20211206.0,,HP,CA,CA,2021,Q4,Elderly
193929085,19392908,34,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, Once a Day",,,U,U,,,,,,Solution,QD,2021,Q4,Loss of personal independence in daily activities,,2021,Q4,5,F,,20211124.0,20210609,20211205,EXP,,CA-AUROBINDO-AUR-APL-2021-022535,AUROBINDO,,65.0,YR,,M,Y,,,20211206.0,,HP,CA,CA,2021,Q4,Elderly
193929085,19392908,34,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, Once a Day",,,U,U,,,,,,Solution,QD,2021,Q4,Vasculitis,,2021,Q4,5,F,,20211124.0,20210609,20211205,EXP,,CA-AUROBINDO-AUR-APL-2021-022535,AUROBINDO,,65.0,YR,,M,Y,,,20211206.0,,HP,CA,CA,2021,Q4,Elderly
194079102,19407910,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Nephrotic syndrome,,2021,Q4,2,F,20210305.0,20210924.0,20210611,20211005,EXP,,FR-ROCHE-2798644,ROCHE,,70.0,YR,,M,Y,76.0,KG,20211005.0,,MD,FR,FR,2021,Q4,Elderly
194484164,19448416,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 iU, QD",,,,,,,,10.0,IU,,QD,2021,Q4,Neutropenia,,2021,Q4,4,F,20210610.0,20211014.0,20210622,20211027,EXP,,"IT-KARYOPHARM THERAPEUTICS, INC.-2021KPT000801",KARYOPHARM THERAPEUTICS,,77.0,YR,,M,Y,90.0,KG,20211027.0,,MD,IT,IT,2021,Q4,Elderly
194484164,19448416,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 iU, QD",,,,,,,,10.0,IU,,QD,2021,Q4,Thrombocytopenia,,2021,Q4,4,F,20210610.0,20211014.0,20210622,20211027,EXP,,"IT-KARYOPHARM THERAPEUTICS, INC.-2021KPT000801",KARYOPHARM THERAPEUTICS,,77.0,YR,,M,Y,90.0,KG,20211027.0,,MD,IT,IT,2021,Q4,Elderly
194789872,19478987,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 iU, QD",,,N,,D042881G,,21081.0,50.0,IU,,QD,2021,Q4,Cough,,2021,Q4,2,F,,20211125.0,20210630,20211202,EXP,,CA-SA-2021SA214978,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20211202.0,,CN,CA,CA,2021,Q4,Elderly
194789872,19478987,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 iU, QD",,,N,,D042881G,,21081.0,50.0,IU,,QD,2021,Q4,Hypoglycaemia,,2021,Q4,2,F,,20211125.0,20210630,20211202,EXP,,CA-SA-2021SA214978,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20211202.0,,CN,CA,CA,2021,Q4,Elderly
194789872,19478987,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 iU, QD",,,N,,D042881G,,21081.0,50.0,IU,,QD,2021,Q4,Feeling abnormal,,2021,Q4,2,F,,20211125.0,20210630,20211202,EXP,,CA-SA-2021SA214978,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20211202.0,,CN,CA,CA,2021,Q4,Elderly
194801537,19480153,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,Injection,,2021,Q4,Hyperglycaemic hyperosmolar nonketotic syndrome,,2021,Q4,7,F,20210501.0,20211004.0,20210701,20211004,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-062379,BRISTOL MYERS SQUIBB,,73.0,YR,,M,Y,56.0,KG,20211004.0,,MD,JP,JP,2021,Q4,Elderly
194801537,19480153,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,Injection,,2021,Q4,Skin disorder,,2021,Q4,7,F,20210501.0,20211004.0,20210701,20211004,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-062379,BRISTOL MYERS SQUIBB,,73.0,YR,,M,Y,56.0,KG,20211004.0,,MD,JP,JP,2021,Q4,Elderly
194801537,19480153,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,Injection,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,7,F,20210501.0,20211004.0,20210701,20211004,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-062379,BRISTOL MYERS SQUIBB,,73.0,YR,,M,Y,56.0,KG,20211004.0,,MD,JP,JP,2021,Q4,Elderly
1948806812,19488068,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,Unknown,,2021,Q4,Pneumonia fungal,,2021,Q4,12,F,20210626.0,20211207.0,20210702,20211209,EXP,,US-CELGENEUS-USA-20210700150,CELGENE,,69.0,YR,,M,Y,,,20211209.0,,HP,US,US,2021,Q4,Elderly
1948806812,19488068,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,Unknown,,2021,Q4,Acute kidney injury,,2021,Q4,12,F,20210626.0,20211207.0,20210702,20211209,EXP,,US-CELGENEUS-USA-20210700150,CELGENE,,69.0,YR,,M,Y,,,20211209.0,,HP,US,US,2021,Q4,Elderly
195212322,19521232,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"8 IU, qd, Before sleep",,,,,,,,8.0,IU,,QD,2021,Q4,Renal impairment,,2021,Q4,2,F,,20210928.0,20210712,20211011,EXP,,JP-DSJP-DSJ-2021-120956AA,DAIICHI,"Yagi I, Fujinaga H, Iima T, Fujisawa K, Kawata A, Okada A, et al.. A Case of Diuretic Resistant Ischemic Heart Failure With 2 Type Diabetes Which Empagliflozin Was Effective. Heart. 2021;53(6):583-590",8.0,DEC,,M,Y,64.0,KG,20211011.0,,MD,JP,JP,2021,Q4,Child
195212322,19521232,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"8 IU, qd, Before sleep",,,,,,,,8.0,IU,,QD,2021,Q4,Pneumonia,,2021,Q4,2,F,,20210928.0,20210712,20211011,EXP,,JP-DSJP-DSJ-2021-120956AA,DAIICHI,"Yagi I, Fujinaga H, Iima T, Fujisawa K, Kawata A, Okada A, et al.. A Case of Diuretic Resistant Ischemic Heart Failure With 2 Type Diabetes Which Empagliflozin Was Effective. Heart. 2021;53(6):583-590",8.0,DEC,,M,Y,64.0,KG,20211011.0,,MD,JP,JP,2021,Q4,Child
195212322,19521232,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"8 IU, qd, Before sleep",,,,,,,,8.0,IU,,QD,2021,Q4,Cardiac failure acute,,2021,Q4,2,F,,20210928.0,20210712,20211011,EXP,,JP-DSJP-DSJ-2021-120956AA,DAIICHI,"Yagi I, Fujinaga H, Iima T, Fujisawa K, Kawata A, Okada A, et al.. A Case of Diuretic Resistant Ischemic Heart Failure With 2 Type Diabetes Which Empagliflozin Was Effective. Heart. 2021;53(6):583-590",8.0,DEC,,M,Y,64.0,KG,20211011.0,,MD,JP,JP,2021,Q4,Child
195582822,19558282,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 international unit, qd",,,Y,,,,210605.0,12.0,IU,Injection,QD,2021,Q4,Disorientation,,2021,Q4,2,F,20171121.0,20211113.0,20210714,20211119,EXP,IT-MINISAL02-450031,IT-MYLANLABS-2021M1041455,MYLAN,,78.0,YR,,F,Y,,,20211119.0,,MD,IT,IT,2021,Q4,Elderly
195582822,19558282,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 international unit, qd",,,Y,,,,210605.0,12.0,IU,Injection,QD,2021,Q4,Medication error,,2021,Q4,2,F,20171121.0,20211113.0,20210714,20211119,EXP,IT-MINISAL02-450031,IT-MYLANLABS-2021M1041455,MYLAN,,78.0,YR,,F,Y,,,20211119.0,,MD,IT,IT,2021,Q4,Elderly
195582822,19558282,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 international unit, qd",,,Y,,,,210605.0,12.0,IU,Injection,QD,2021,Q4,Hypoglycaemia,,2021,Q4,2,F,20171121.0,20211113.0,20210714,20211119,EXP,IT-MINISAL02-450031,IT-MYLANLABS-2021M1041455,MYLAN,,78.0,YR,,F,Y,,,20211119.0,,MD,IT,IT,2021,Q4,Elderly
195582822,19558282,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,,,210605.0,,,Injection,,2021,Q4,Disorientation,,2021,Q4,2,F,20171121.0,20211113.0,20210714,20211119,EXP,IT-MINISAL02-450031,IT-MYLANLABS-2021M1041455,MYLAN,,78.0,YR,,F,Y,,,20211119.0,,MD,IT,IT,2021,Q4,Elderly
195582822,19558282,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,,,210605.0,,,Injection,,2021,Q4,Medication error,,2021,Q4,2,F,20171121.0,20211113.0,20210714,20211119,EXP,IT-MINISAL02-450031,IT-MYLANLABS-2021M1041455,MYLAN,,78.0,YR,,F,Y,,,20211119.0,,MD,IT,IT,2021,Q4,Elderly
195582822,19558282,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,,,210605.0,,,Injection,,2021,Q4,Hypoglycaemia,,2021,Q4,2,F,20171121.0,20211113.0,20210714,20211119,EXP,IT-MINISAL02-450031,IT-MYLANLABS-2021M1041455,MYLAN,,78.0,YR,,F,Y,,,20211119.0,,MD,IT,IT,2021,Q4,Elderly
195809882,19580988,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Decreased appetite,,2021,Q4,2,F,20210227.0,20210426.0,20210719,20211124,PER,,US-NOVOPROD-808987,NOVO NORDISK,,69.0,YR,,F,Y,,,20211124.0,,CN,US,US,2021,Q4,Elderly
195809882,19580988,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Fatigue,,2021,Q4,2,F,20210227.0,20210426.0,20210719,20211124,PER,,US-NOVOPROD-808987,NOVO NORDISK,,69.0,YR,,F,Y,,,20211124.0,,CN,US,US,2021,Q4,Elderly
195809882,19580988,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,2,F,20210227.0,20210426.0,20210719,20211124,PER,,US-NOVOPROD-808987,NOVO NORDISK,,69.0,YR,,F,Y,,,20211124.0,,CN,US,US,2021,Q4,Elderly
195809882,19580988,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Blood glucose increased,,2021,Q4,2,F,20210227.0,20210426.0,20210719,20211124,PER,,US-NOVOPROD-808987,NOVO NORDISK,,69.0,YR,,F,Y,,,20211124.0,,CN,US,US,2021,Q4,Elderly
195809882,19580988,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Nausea,,2021,Q4,2,F,20210227.0,20210426.0,20210719,20211124,PER,,US-NOVOPROD-808987,NOVO NORDISK,,69.0,YR,,F,Y,,,20211124.0,,CN,US,US,2021,Q4,Elderly
195809882,19580988,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Constipation,,2021,Q4,2,F,20210227.0,20210426.0,20210719,20211124,PER,,US-NOVOPROD-808987,NOVO NORDISK,,69.0,YR,,F,Y,,,20211124.0,,CN,US,US,2021,Q4,Elderly
195809882,19580988,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,increased dose,,,,,,,,,,,,2021,Q4,Decreased appetite,,2021,Q4,2,F,20210227.0,20210426.0,20210719,20211124,PER,,US-NOVOPROD-808987,NOVO NORDISK,,69.0,YR,,F,Y,,,20211124.0,,CN,US,US,2021,Q4,Elderly
195809882,19580988,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,increased dose,,,,,,,,,,,,2021,Q4,Fatigue,,2021,Q4,2,F,20210227.0,20210426.0,20210719,20211124,PER,,US-NOVOPROD-808987,NOVO NORDISK,,69.0,YR,,F,Y,,,20211124.0,,CN,US,US,2021,Q4,Elderly
195809882,19580988,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,increased dose,,,,,,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,2,F,20210227.0,20210426.0,20210719,20211124,PER,,US-NOVOPROD-808987,NOVO NORDISK,,69.0,YR,,F,Y,,,20211124.0,,CN,US,US,2021,Q4,Elderly
195809882,19580988,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,increased dose,,,,,,,,,,,,2021,Q4,Blood glucose increased,,2021,Q4,2,F,20210227.0,20210426.0,20210719,20211124,PER,,US-NOVOPROD-808987,NOVO NORDISK,,69.0,YR,,F,Y,,,20211124.0,,CN,US,US,2021,Q4,Elderly
195809882,19580988,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,increased dose,,,,,,,,,,,,2021,Q4,Nausea,,2021,Q4,2,F,20210227.0,20210426.0,20210719,20211124,PER,,US-NOVOPROD-808987,NOVO NORDISK,,69.0,YR,,F,Y,,,20211124.0,,CN,US,US,2021,Q4,Elderly
195809882,19580988,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,increased dose,,,,,,,,,,,,2021,Q4,Constipation,,2021,Q4,2,F,20210227.0,20210426.0,20210719,20211124,PER,,US-NOVOPROD-808987,NOVO NORDISK,,69.0,YR,,F,Y,,,20211124.0,,CN,US,US,2021,Q4,Elderly
195848273,19584827,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,total daily insulin dose was 80 units/day (insulin lispro plus glargine),,,D,,,,,,,,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,3,F,20160501.0,20210910.0,20210720,20211015,EXP,,SK-BAUSCH-BL-2021-023831,BAUSCH AND LOMB,"Martinka E, Kollarova D, Urbanova M. Skusenosti z praxe potvrdzuju vysledky studii RCT a RWE s empagliflozinom: kazuistiky. Forum Diabetologicum. 2021;10(1):53-61.",53.0,YR,,M,Y,,,20211015.0,,MD,SK,SK,2021,Q4,Adult
195848273,19584827,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,28 units,,,D,,,,,,,,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,3,F,20160501.0,20210910.0,20210720,20211015,EXP,,SK-BAUSCH-BL-2021-023831,BAUSCH AND LOMB,"Martinka E, Kollarova D, Urbanova M. Skusenosti z praxe potvrdzuju vysledky studii RCT a RWE s empagliflozinom: kazuistiky. Forum Diabetologicum. 2021;10(1):53-61.",53.0,YR,,M,Y,,,20211015.0,,MD,SK,SK,2021,Q4,Adult
195848273,19584827,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 units per day (reduction of the glargine dose until it is discontinued from treatment),,,D,,,,,,,,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,3,F,20160501.0,20210910.0,20210720,20211015,EXP,,SK-BAUSCH-BL-2021-023831,BAUSCH AND LOMB,"Martinka E, Kollarova D, Urbanova M. Skusenosti z praxe potvrdzuju vysledky studii RCT a RWE s empagliflozinom: kazuistiky. Forum Diabetologicum. 2021;10(1):53-61.",53.0,YR,,M,Y,,,20211015.0,,MD,SK,SK,2021,Q4,Adult
196083017,19608301,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"40.0,U,",,,,,,,,,,,,2021,Q4,Cholelithiasis,,2021,Q4,7,F,20210708.0,20211114.0,20210726,20211119,EXP,,IL-NOVOPROD-828509,NOVO NORDISK,,47.0,YR,,M,Y,86.0,KG,20211119.0,,MD,IL,IL,2021,Q4,Adult
196083017,19608301,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"40.0,U,",,,,,,,,,,,,2021,Q4,Cholecystitis,,2021,Q4,7,F,20210708.0,20211114.0,20210726,20211119,EXP,,IL-NOVOPROD-828509,NOVO NORDISK,,47.0,YR,,M,Y,86.0,KG,20211119.0,,MD,IL,IL,2021,Q4,Adult
196091443,19609144,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,28 units,,,,,,,,,,,,2021,Q4,Type 2 diabetes mellitus,,2021,Q4,3,F,20210720.0,20211013.0,20210726,20211119,EXP,,JP-009507513-2107JPN001874J,MERCK,,60.0,YR,,M,Y,,,20211119.0,,PH,JP,JP,2021,Q4,Adult
196091443,19609144,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,33 units,,,,,,,,,,,,2021,Q4,Type 2 diabetes mellitus,,2021,Q4,3,F,20210720.0,20211013.0,20210726,20211119,EXP,,JP-009507513-2107JPN001874J,MERCK,,60.0,YR,,M,Y,,,20211119.0,,PH,JP,JP,2021,Q4,Adult
196091443,19609144,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,40 units,,,,,,,,,,,,2021,Q4,Type 2 diabetes mellitus,,2021,Q4,3,F,20210720.0,20211013.0,20210726,20211119,EXP,,JP-009507513-2107JPN001874J,MERCK,,60.0,YR,,M,Y,,,20211119.0,,PH,JP,JP,2021,Q4,Adult
196091443,19609144,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,47units,,,,,,,,,,,,2021,Q4,Type 2 diabetes mellitus,,2021,Q4,3,F,20210720.0,20211013.0,20210726,20211119,EXP,,JP-009507513-2107JPN001874J,MERCK,,60.0,YR,,M,Y,,,20211119.0,,PH,JP,JP,2021,Q4,Adult
196109135,19610913,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Dizziness,,2021,Q4,5,F,20210716.0,20211013.0,20210726,20211019,EXP,,TR-JNJFOC-20210738141,JOHNSON AND JOHNSON,,57.0,YR,A,F,Y,80.0,KG,20211019.0,,MD,TR,TR,2021,Q4,Adult
1964310812,19643108,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"3 ml, QHS",,,D,,,,,3.0,ML,,,2021,Q4,Pancreatic carcinoma,,2021,Q4,12,F,20210713.0,20211022.0,20210730,20211029,EXP,,NVSC2021US163698,NOVARTIS,,49.0,YR,,M,Y,64.0,KG,20211029.0,,MD,US,US,2021,Q4,Adult
1964310812,19643108,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"3 ml, QHS",,,D,,,,,3.0,ML,,,2021,Q4,Liver abscess,,2021,Q4,12,F,20210713.0,20211022.0,20210730,20211029,EXP,,NVSC2021US163698,NOVARTIS,,49.0,YR,,M,Y,64.0,KG,20211029.0,,MD,US,US,2021,Q4,Adult
1964310812,19643108,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"3 ml, QHS",,,D,,,,,3.0,ML,,,2021,Q4,Malignant neoplasm progression,,2021,Q4,12,F,20210713.0,20211022.0,20210730,20211029,EXP,,NVSC2021US163698,NOVARTIS,,49.0,YR,,M,Y,64.0,KG,20211029.0,,MD,US,US,2021,Q4,Adult
1964310812,19643108,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"3 ml, QHS",,,D,,,,,3.0,ML,,,2021,Q4,Enterocolitis,,2021,Q4,12,F,20210713.0,20211022.0,20210730,20211029,EXP,,NVSC2021US163698,NOVARTIS,,49.0,YR,,M,Y,64.0,KG,20211029.0,,MD,US,US,2021,Q4,Adult
196483662,19648366,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q4,Rash,,2021,Q4,2,F,,20211119.0,20210802,20211130,EXP,,CA-SA-2021SA251922,SANOFI AVENTIS,,49.0,YR,A,F,Y,,,20211130.0,,HP,CA,CA,2021,Q4,Adult
196483662,19648366,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q4,Rash,,2021,Q4,2,F,,20211119.0,20210802,20211130,EXP,,CA-SA-2021SA251922,SANOFI AVENTIS,,49.0,YR,A,F,Y,,,20211130.0,,HP,CA,CA,2021,Q4,Adult
196483662,19648366,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q4,Psoriatic arthropathy,,2021,Q4,2,F,,20211119.0,20210802,20211130,EXP,,CA-SA-2021SA251922,SANOFI AVENTIS,,49.0,YR,A,F,Y,,,20211130.0,,HP,CA,CA,2021,Q4,Adult
196483662,19648366,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q4,Drug ineffective,,2021,Q4,2,F,,20211119.0,20210802,20211130,EXP,,CA-SA-2021SA251922,SANOFI AVENTIS,,49.0,YR,A,F,Y,,,20211130.0,,HP,CA,CA,2021,Q4,Adult
196483662,19648366,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q4,Herpes zoster,,2021,Q4,2,F,,20211119.0,20210802,20211130,EXP,,CA-SA-2021SA251922,SANOFI AVENTIS,,49.0,YR,A,F,Y,,,20211130.0,,HP,CA,CA,2021,Q4,Adult
196483662,19648366,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q4,C-reactive protein increased,,2021,Q4,2,F,,20211119.0,20210802,20211130,EXP,,CA-SA-2021SA251922,SANOFI AVENTIS,,49.0,YR,A,F,Y,,,20211130.0,,HP,CA,CA,2021,Q4,Adult
196483662,19648366,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q4,Psoriasis,,2021,Q4,2,F,,20211119.0,20210802,20211130,EXP,,CA-SA-2021SA251922,SANOFI AVENTIS,,49.0,YR,A,F,Y,,,20211130.0,,HP,CA,CA,2021,Q4,Adult
196483662,19648366,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q4,Drug ineffective,,2021,Q4,2,F,,20211119.0,20210802,20211130,EXP,,CA-SA-2021SA251922,SANOFI AVENTIS,,49.0,YR,A,F,Y,,,20211130.0,,HP,CA,CA,2021,Q4,Adult
196483662,19648366,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q4,Dactylitis,,2021,Q4,2,F,,20211119.0,20210802,20211130,EXP,,CA-SA-2021SA251922,SANOFI AVENTIS,,49.0,YR,A,F,Y,,,20211130.0,,HP,CA,CA,2021,Q4,Adult
196483662,19648366,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q4,Herpes zoster,,2021,Q4,2,F,,20211119.0,20210802,20211130,EXP,,CA-SA-2021SA251922,SANOFI AVENTIS,,49.0,YR,A,F,Y,,,20211130.0,,HP,CA,CA,2021,Q4,Adult
196483662,19648366,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q4,Rash erythematous,,2021,Q4,2,F,,20211119.0,20210802,20211130,EXP,,CA-SA-2021SA251922,SANOFI AVENTIS,,49.0,YR,A,F,Y,,,20211130.0,,HP,CA,CA,2021,Q4,Adult
196483662,19648366,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q4,Drug intolerance,,2021,Q4,2,F,,20211119.0,20210802,20211130,EXP,,CA-SA-2021SA251922,SANOFI AVENTIS,,49.0,YR,A,F,Y,,,20211130.0,,HP,CA,CA,2021,Q4,Adult
196483662,19648366,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q4,Psoriatic arthropathy,,2021,Q4,2,F,,20211119.0,20210802,20211130,EXP,,CA-SA-2021SA251922,SANOFI AVENTIS,,49.0,YR,A,F,Y,,,20211130.0,,HP,CA,CA,2021,Q4,Adult
196483662,19648366,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q4,C-reactive protein abnormal,,2021,Q4,2,F,,20211119.0,20210802,20211130,EXP,,CA-SA-2021SA251922,SANOFI AVENTIS,,49.0,YR,A,F,Y,,,20211130.0,,HP,CA,CA,2021,Q4,Adult
196543702,19654370,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"148 IU, qd (120 IU early and 28 IU at 10 pm)",,,,,Unknown,,,148.0,IU,,QD,2021,Q4,Amaurosis,,2021,Q4,2,F,,20211110.0,20210804,20211119,EXP,,BR-NOVOPROD-833828,NOVO NORDISK,,81.0,YR,,M,Y,85.0,KG,20211119.0,,MD,BR,BR,2021,Q4,Elderly
196612293,19661229,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Renal impairment,,2021,Q4,3,F,20210208.0,20210927.0,20210805,20211007,EXP,,JP-PFIZER INC-202100958693,PFIZER,,77.0,YR,,M,Y,55.2,KG,20211007.0,,PH,JP,JP,2021,Q4,Elderly
196612293,19661229,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Platelet count decreased,,2021,Q4,3,F,20210208.0,20210927.0,20210805,20211007,EXP,,JP-PFIZER INC-202100958693,PFIZER,,77.0,YR,,M,Y,55.2,KG,20211007.0,,PH,JP,JP,2021,Q4,Elderly
196612293,19661229,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Cardiac failure,,2021,Q4,3,F,20210208.0,20210927.0,20210805,20211007,EXP,,JP-PFIZER INC-202100958693,PFIZER,,77.0,YR,,M,Y,55.2,KG,20211007.0,,PH,JP,JP,2021,Q4,Elderly
196612293,19661229,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Myelosuppression,,2021,Q4,3,F,20210208.0,20210927.0,20210805,20211007,EXP,,JP-PFIZER INC-202100958693,PFIZER,,77.0,YR,,M,Y,55.2,KG,20211007.0,,PH,JP,JP,2021,Q4,Elderly
196732212,19673221,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Product dispensing error,,2021,Q4,2,F,,20211108.0,20210809,20211120,EXP,,DE-AUROBINDO-AUR-APL-2021-032916,AUROBINDO,"Heck J, Groh A, Stichtenoth DO, Bleich S, Krause O.. Look-alikes, sound-alikes: Three cases of insidious medication errors.. Clinical Case Reports.. 2020;8(12):3284-7",80.0,YR,,F,Y,,,20211120.0,,HP,DE,DE,2021,Q4,Elderly
196732212,19673221,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Loss of consciousness,,2021,Q4,2,F,,20211108.0,20210809,20211120,EXP,,DE-AUROBINDO-AUR-APL-2021-032916,AUROBINDO,"Heck J, Groh A, Stichtenoth DO, Bleich S, Krause O.. Look-alikes, sound-alikes: Three cases of insidious medication errors.. Clinical Case Reports.. 2020;8(12):3284-7",80.0,YR,,F,Y,,,20211120.0,,HP,DE,DE,2021,Q4,Elderly
196732212,19673221,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Procalcitonin increased,,2021,Q4,2,F,,20211108.0,20210809,20211120,EXP,,DE-AUROBINDO-AUR-APL-2021-032916,AUROBINDO,"Heck J, Groh A, Stichtenoth DO, Bleich S, Krause O.. Look-alikes, sound-alikes: Three cases of insidious medication errors.. Clinical Case Reports.. 2020;8(12):3284-7",80.0,YR,,F,Y,,,20211120.0,,HP,DE,DE,2021,Q4,Elderly
197017232,19701723,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,Unknown,,2021,Q4,Rash,,2021,Q4,2,F,20210808.0,20211111.0,20210813,20211123,PER,,US-CELGENEUS-USA-20210802436,CELGENE,,78.0,YR,,M,Y,95.4,KG,20211123.0,,MD,US,US,2021,Q4,Elderly
197017232,19701723,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,Unknown,,2021,Q4,Skin exfoliation,,2021,Q4,2,F,20210808.0,20211111.0,20210813,20211123,PER,,US-CELGENEUS-USA-20210802436,CELGENE,,78.0,YR,,M,Y,95.4,KG,20211123.0,,MD,US,US,2021,Q4,Elderly
197017232,19701723,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,Unknown,,2021,Q4,Swelling,,2021,Q4,2,F,20210808.0,20211111.0,20210813,20211123,PER,,US-CELGENEUS-USA-20210802436,CELGENE,,78.0,YR,,M,Y,95.4,KG,20211123.0,,MD,US,US,2021,Q4,Elderly
197069736,19706973,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Proteinuria,,2021,Q4,6,F,20200212.0,20211001.0,20210817,20211006,EXP,,FR-MYLANLABS-2021M1050656,MYLAN,,67.0,YR,,M,Y,82.0,KG,20211006.0,,MD,FR,FR,2021,Q4,Elderly
197069736,19706973,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Vitamin D deficiency,,2021,Q4,6,F,20200212.0,20211001.0,20210817,20211006,EXP,,FR-MYLANLABS-2021M1050656,MYLAN,,67.0,YR,,M,Y,82.0,KG,20211006.0,,MD,FR,FR,2021,Q4,Elderly
197069736,19706973,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Diabetes mellitus,,2021,Q4,6,F,20200212.0,20211001.0,20210817,20211006,EXP,,FR-MYLANLABS-2021M1050656,MYLAN,,67.0,YR,,M,Y,82.0,KG,20211006.0,,MD,FR,FR,2021,Q4,Elderly
197069736,19706973,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,6,F,20200212.0,20211001.0,20210817,20211006,EXP,,FR-MYLANLABS-2021M1050656,MYLAN,,67.0,YR,,M,Y,82.0,KG,20211006.0,,MD,FR,FR,2021,Q4,Elderly
197069736,19706973,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Product use in unapproved indication,,2021,Q4,6,F,20200212.0,20211001.0,20210817,20211006,EXP,,FR-MYLANLABS-2021M1050656,MYLAN,,67.0,YR,,M,Y,82.0,KG,20211006.0,,MD,FR,FR,2021,Q4,Elderly
197069736,19706973,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Serum ferritin increased,,2021,Q4,6,F,20200212.0,20211001.0,20210817,20211006,EXP,,FR-MYLANLABS-2021M1050656,MYLAN,,67.0,YR,,M,Y,82.0,KG,20211006.0,,MD,FR,FR,2021,Q4,Elderly
197069736,19706973,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Blood lactate dehydrogenase increased,,2021,Q4,6,F,20200212.0,20211001.0,20210817,20211006,EXP,,FR-MYLANLABS-2021M1050656,MYLAN,,67.0,YR,,M,Y,82.0,KG,20211006.0,,MD,FR,FR,2021,Q4,Elderly
197069736,19706973,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Transferrin saturation decreased,,2021,Q4,6,F,20200212.0,20211001.0,20210817,20211006,EXP,,FR-MYLANLABS-2021M1050656,MYLAN,,67.0,YR,,M,Y,82.0,KG,20211006.0,,MD,FR,FR,2021,Q4,Elderly
197069736,19706973,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Dyslipidaemia,,2021,Q4,6,F,20200212.0,20211001.0,20210817,20211006,EXP,,FR-MYLANLABS-2021M1050656,MYLAN,,67.0,YR,,M,Y,82.0,KG,20211006.0,,MD,FR,FR,2021,Q4,Elderly
197069736,19706973,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Bone density decreased,,2021,Q4,6,F,20200212.0,20211001.0,20210817,20211006,EXP,,FR-MYLANLABS-2021M1050656,MYLAN,,67.0,YR,,M,Y,82.0,KG,20211006.0,,MD,FR,FR,2021,Q4,Elderly
197069736,19706973,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Abdominal pain upper,,2021,Q4,6,F,20200212.0,20211001.0,20210817,20211006,EXP,,FR-MYLANLABS-2021M1050656,MYLAN,,67.0,YR,,M,Y,82.0,KG,20211006.0,,MD,FR,FR,2021,Q4,Elderly
197069736,19706973,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Hepatic steatosis,,2021,Q4,6,F,20200212.0,20211001.0,20210817,20211006,EXP,,FR-MYLANLABS-2021M1050656,MYLAN,,67.0,YR,,M,Y,82.0,KG,20211006.0,,MD,FR,FR,2021,Q4,Elderly
197069736,19706973,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Hypomagnesaemia,,2021,Q4,6,F,20200212.0,20211001.0,20210817,20211006,EXP,,FR-MYLANLABS-2021M1050656,MYLAN,,67.0,YR,,M,Y,82.0,KG,20211006.0,,MD,FR,FR,2021,Q4,Elderly
197069736,19706973,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Bronchitis,,2021,Q4,6,F,20200212.0,20211001.0,20210817,20211006,EXP,,FR-MYLANLABS-2021M1050656,MYLAN,,67.0,YR,,M,Y,82.0,KG,20211006.0,,MD,FR,FR,2021,Q4,Elderly
197069736,19706973,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Steroid diabetes,,2021,Q4,6,F,20200212.0,20211001.0,20210817,20211006,EXP,,FR-MYLANLABS-2021M1050656,MYLAN,,67.0,YR,,M,Y,82.0,KG,20211006.0,,MD,FR,FR,2021,Q4,Elderly
197100253,19710025,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Acute kidney injury,,2021,Q4,3,F,20210225.0,20211018.0,20210816,20211025,EXP,,US-GILEAD-2021-0520462,GILEAD,,70.0,YR,E,M,Y,,,20211025.0,,HP,US,US,2021,Q4,Elderly
197100253,19710025,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Respiratory failure,,2021,Q4,3,F,20210225.0,20211018.0,20210816,20211025,EXP,,US-GILEAD-2021-0520462,GILEAD,,70.0,YR,E,M,Y,,,20211025.0,,HP,US,US,2021,Q4,Elderly
197100253,19710025,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Staphylococcal sepsis,,2021,Q4,3,F,20210225.0,20211018.0,20210816,20211025,EXP,,US-GILEAD-2021-0520462,GILEAD,,70.0,YR,E,M,Y,,,20211025.0,,HP,US,US,2021,Q4,Elderly
197376104,19737610,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Cardiac failure congestive,,2021,Q4,4,F,20210619.0,20211014.0,20210824,20211018,EXP,,NVSC2021US141256,NOVARTIS,,41.0,YR,,F,Y,92.6,KG,20211018.0,,MD,US,US,2021,Q4,Adult
197376104,19737610,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Cardiac failure congestive,,2021,Q4,4,F,20210619.0,20211014.0,20210824,20211018,EXP,,NVSC2021US141256,NOVARTIS,,41.0,YR,,F,Y,92.6,KG,20211018.0,,MD,US,US,2021,Q4,Adult
197376104,19737610,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,4,F,20210619.0,20211014.0,20210824,20211018,EXP,,NVSC2021US141256,NOVARTIS,,41.0,YR,,F,Y,92.6,KG,20211018.0,,MD,US,US,2021,Q4,Adult
197433805,19743380,36,C,GLARGINE BS,,2,Subcutaneous,28 units,,,D,,,,,,,,QD,2021,Q4,Cerebral haemorrhage,,2021,Q4,5,F,20210813.0,20211021.0,20210824,20211103,EXP,,JP-ABBVIE-21P-087-4046479-00,ABBVIE,,23.0,YR,,F,Y,64.1,KG,20211029.0,,MD,COUNTRY NOT SPECIFIED,JP,2021,Q4,Youth
197433805,19743380,36,C,GLARGINE BS,,2,Subcutaneous,28 units,,,D,,,,,,,,QD,2021,Q4,Sepsis,,2021,Q4,5,F,20210813.0,20211021.0,20210824,20211103,EXP,,JP-ABBVIE-21P-087-4046479-00,ABBVIE,,23.0,YR,,F,Y,64.1,KG,20211029.0,,MD,COUNTRY NOT SPECIFIED,JP,2021,Q4,Youth
197607183,19760718,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Aspartate aminotransferase increased,,2021,Q4,3,F,20210601.0,20211001.0,20210830,20211004,EXP,,JP-GLAXOSMITHKLINE-JP2021172633,GLAXOSMITHKLINE,,74.0,YR,,M,Y,58.8,KG,20211004.0,,MD,JP,JP,2021,Q4,Elderly
197607183,19760718,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Drug-induced liver injury,,2021,Q4,3,F,20210601.0,20211001.0,20210830,20211004,EXP,,JP-GLAXOSMITHKLINE-JP2021172633,GLAXOSMITHKLINE,,74.0,YR,,M,Y,58.8,KG,20211004.0,,MD,JP,JP,2021,Q4,Elderly
197607183,19760718,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Hepatic enzyme increased,,2021,Q4,3,F,20210601.0,20211001.0,20210830,20211004,EXP,,JP-GLAXOSMITHKLINE-JP2021172633,GLAXOSMITHKLINE,,74.0,YR,,M,Y,58.8,KG,20211004.0,,MD,JP,JP,2021,Q4,Elderly
197607183,19760718,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Alanine aminotransferase increased,,2021,Q4,3,F,20210601.0,20211001.0,20210830,20211004,EXP,,JP-GLAXOSMITHKLINE-JP2021172633,GLAXOSMITHKLINE,,74.0,YR,,M,Y,58.8,KG,20211004.0,,MD,JP,JP,2021,Q4,Elderly
197607183,19760718,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Jaundice,,2021,Q4,3,F,20210601.0,20211001.0,20210830,20211004,EXP,,JP-GLAXOSMITHKLINE-JP2021172633,GLAXOSMITHKLINE,,74.0,YR,,M,Y,58.8,KG,20211004.0,,MD,JP,JP,2021,Q4,Elderly
197607183,19760718,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Interstitial lung disease,,2021,Q4,3,F,20210601.0,20211001.0,20210830,20211004,EXP,,JP-GLAXOSMITHKLINE-JP2021172633,GLAXOSMITHKLINE,,74.0,YR,,M,Y,58.8,KG,20211004.0,,MD,JP,JP,2021,Q4,Elderly
197657362,19765736,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, qd (in the morning)",,,,,Unknown,,,20.0,IU,,QD,2021,Q4,Hypoglycaemia,,2021,Q4,2,F,,20210824.0,20210831,20211104,EXP,,BR-NOVOPROD-841796,NOVO NORDISK,,35.0,YR,,F,Y,52.0,KG,20211104.0,,MD,BR,BR,2021,Q4,Adult
197657362,19765736,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, qd (in the morning)",,,,,Unknown,,,20.0,IU,,QD,2021,Q4,Road traffic accident,,2021,Q4,2,F,,20210824.0,20210831,20211104,EXP,,BR-NOVOPROD-841796,NOVO NORDISK,,35.0,YR,,F,Y,52.0,KG,20211104.0,,MD,BR,BR,2021,Q4,Adult
197657362,19765736,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, qd (in the morning)",,,,,Unknown,,,20.0,IU,,QD,2021,Q4,Hyperglycaemia,,2021,Q4,2,F,,20210824.0,20210831,20211104,EXP,,BR-NOVOPROD-841796,NOVO NORDISK,,35.0,YR,,F,Y,52.0,KG,20211104.0,,MD,BR,BR,2021,Q4,Adult
197885063,19788506,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 U, 1X",,,D,,,,,,,,1X,2021,Q4,Cardio-respiratory arrest,,2021,Q4,3,F,,20211116.0,20210903,20211116,EXP,,JP-SA-2021SA292048,SANOFI AVENTIS,Tokimaru.. A case developed lactic acidosis following overdose of metformin and insulin in a suicide attempt. a presentation at YIA. Young investigator award.. unk;unknown:61-65,28.0,YR,A,F,Y,,,20211116.0,,HP,JP,JP,2021,Q4,Young Adult
197885063,19788506,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 U, 1X",,,D,,,,,,,,1X,2021,Q4,Intentional overdose,,2021,Q4,3,F,,20211116.0,20210903,20211116,EXP,,JP-SA-2021SA292048,SANOFI AVENTIS,Tokimaru.. A case developed lactic acidosis following overdose of metformin and insulin in a suicide attempt. a presentation at YIA. Young investigator award.. unk;unknown:61-65,28.0,YR,A,F,Y,,,20211116.0,,HP,JP,JP,2021,Q4,Young Adult
197885063,19788506,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 U, 1X",,,D,,,,,,,,1X,2021,Q4,Lactic acidosis,,2021,Q4,3,F,,20211116.0,20210903,20211116,EXP,,JP-SA-2021SA292048,SANOFI AVENTIS,Tokimaru.. A case developed lactic acidosis following overdose of metformin and insulin in a suicide attempt. a presentation at YIA. Young investigator award.. unk;unknown:61-65,28.0,YR,A,F,Y,,,20211116.0,,HP,JP,JP,2021,Q4,Young Adult
197885063,19788506,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 U, 1X",,,D,,,,,,,,1X,2021,Q4,Altered state of consciousness,,2021,Q4,3,F,,20211116.0,20210903,20211116,EXP,,JP-SA-2021SA292048,SANOFI AVENTIS,Tokimaru.. A case developed lactic acidosis following overdose of metformin and insulin in a suicide attempt. a presentation at YIA. Young investigator award.. unk;unknown:61-65,28.0,YR,A,F,Y,,,20211116.0,,HP,JP,JP,2021,Q4,Young Adult
198084312,19808431,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 u/ML,,,U,,,,,,,Solution for injection,,2021,Q4,Pain in extremity,,2021,Q4,2,F,20210522.0,20211120.0,20210909,20211126,EXP,,FR-AUROBINDO-AUR-APL-2021-038517,AUROBINDO,,59.0,YR,,M,Y,64.0,KG,20211126.0,,HP,FR,FR,2021,Q4,Adult
198084312,19808431,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 u/ML,,,U,,,,,,,Solution for injection,,2021,Q4,Abdominal pain,,2021,Q4,2,F,20210522.0,20211120.0,20210909,20211126,EXP,,FR-AUROBINDO-AUR-APL-2021-038517,AUROBINDO,,59.0,YR,,M,Y,64.0,KG,20211126.0,,HP,FR,FR,2021,Q4,Adult
198084312,19808431,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 u/ML,,,U,,,,,,,Solution for injection,,2021,Q4,Pyelocaliectasis,,2021,Q4,2,F,20210522.0,20211120.0,20210909,20211126,EXP,,FR-AUROBINDO-AUR-APL-2021-038517,AUROBINDO,,59.0,YR,,M,Y,64.0,KG,20211126.0,,HP,FR,FR,2021,Q4,Adult
198084312,19808431,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 u/ML,,,U,,,,,,,Solution for injection,,2021,Q4,Haematoma muscle,,2021,Q4,2,F,20210522.0,20211120.0,20210909,20211126,EXP,,FR-AUROBINDO-AUR-APL-2021-038517,AUROBINDO,,59.0,YR,,M,Y,64.0,KG,20211126.0,,HP,FR,FR,2021,Q4,Adult
198084312,19808431,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 u/ML,,,U,,,,,,,Solution for injection,,2021,Q4,Arthralgia,,2021,Q4,2,F,20210522.0,20211120.0,20210909,20211126,EXP,,FR-AUROBINDO-AUR-APL-2021-038517,AUROBINDO,,59.0,YR,,M,Y,64.0,KG,20211126.0,,HP,FR,FR,2021,Q4,Adult
198084312,19808431,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 u/ML,,,U,,,,,,,Solution for injection,,2021,Q4,Muscular weakness,,2021,Q4,2,F,20210522.0,20211120.0,20210909,20211126,EXP,,FR-AUROBINDO-AUR-APL-2021-038517,AUROBINDO,,59.0,YR,,M,Y,64.0,KG,20211126.0,,HP,FR,FR,2021,Q4,Adult
198084312,19808431,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 u/ML,,,U,,,,,,,Solution for injection,,2021,Q4,Ureteric compression,,2021,Q4,2,F,20210522.0,20211120.0,20210909,20211126,EXP,,FR-AUROBINDO-AUR-APL-2021-038517,AUROBINDO,,59.0,YR,,M,Y,64.0,KG,20211126.0,,HP,FR,FR,2021,Q4,Adult
198086942,19808694,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, QD",,,U,,,,,22.0,IU,Solution for injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,2,F,20210801.0,20211025.0,20210909,20211101,EXP,,NVSC2021ES202355,NOVARTIS,,84.0,YR,,F,Y,65.0,KG,20211101.0,,CN,ES,ES,2021,Q4,Elderly
198086942,19808694,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, QD",,,U,,,,,22.0,IU,Solution for injection,QD,2021,Q4,Arthralgia,,2021,Q4,2,F,20210801.0,20211025.0,20210909,20211101,EXP,,NVSC2021ES202355,NOVARTIS,,84.0,YR,,F,Y,65.0,KG,20211101.0,,CN,ES,ES,2021,Q4,Elderly
198086942,19808694,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, QD",,,U,,,,,22.0,IU,Solution for injection,QD,2021,Q4,Dizziness,,2021,Q4,2,F,20210801.0,20211025.0,20210909,20211101,EXP,,NVSC2021ES202355,NOVARTIS,,84.0,YR,,F,Y,65.0,KG,20211101.0,,CN,ES,ES,2021,Q4,Elderly
198086942,19808694,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, QD",,,U,,,,,22.0,IU,Solution for injection,QD,2021,Q4,Fall,,2021,Q4,2,F,20210801.0,20211025.0,20210909,20211101,EXP,,NVSC2021ES202355,NOVARTIS,,84.0,YR,,F,Y,65.0,KG,20211101.0,,CN,ES,ES,2021,Q4,Elderly
198086942,19808694,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, QD",,,U,,,,,22.0,IU,Solution for injection,QD,2021,Q4,Hip fracture,,2021,Q4,2,F,20210801.0,20211025.0,20210909,20211101,EXP,,NVSC2021ES202355,NOVARTIS,,84.0,YR,,F,Y,65.0,KG,20211101.0,,CN,ES,ES,2021,Q4,Elderly
198086942,19808694,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IU, UNK",,,U,,,,,24.0,IU,Solution for injection,,2021,Q4,Blood glucose increased,,2021,Q4,2,F,20210801.0,20211025.0,20210909,20211101,EXP,,NVSC2021ES202355,NOVARTIS,,84.0,YR,,F,Y,65.0,KG,20211101.0,,CN,ES,ES,2021,Q4,Elderly
198086942,19808694,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IU, UNK",,,U,,,,,24.0,IU,Solution for injection,,2021,Q4,Arthralgia,,2021,Q4,2,F,20210801.0,20211025.0,20210909,20211101,EXP,,NVSC2021ES202355,NOVARTIS,,84.0,YR,,F,Y,65.0,KG,20211101.0,,CN,ES,ES,2021,Q4,Elderly
198086942,19808694,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IU, UNK",,,U,,,,,24.0,IU,Solution for injection,,2021,Q4,Dizziness,,2021,Q4,2,F,20210801.0,20211025.0,20210909,20211101,EXP,,NVSC2021ES202355,NOVARTIS,,84.0,YR,,F,Y,65.0,KG,20211101.0,,CN,ES,ES,2021,Q4,Elderly
198086942,19808694,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IU, UNK",,,U,,,,,24.0,IU,Solution for injection,,2021,Q4,Fall,,2021,Q4,2,F,20210801.0,20211025.0,20210909,20211101,EXP,,NVSC2021ES202355,NOVARTIS,,84.0,YR,,F,Y,65.0,KG,20211101.0,,CN,ES,ES,2021,Q4,Elderly
198086942,19808694,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IU, UNK",,,U,,,,,24.0,IU,Solution for injection,,2021,Q4,Hip fracture,,2021,Q4,2,F,20210801.0,20211025.0,20210909,20211101,EXP,,NVSC2021ES202355,NOVARTIS,,84.0,YR,,F,Y,65.0,KG,20211101.0,,CN,ES,ES,2021,Q4,Elderly
198141663,19814166,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 international unit, qd",,,,,1F935A,,,30.0,IU,Solution for injection,QD,2021,Q4,Hyperglycaemia,,2021,Q4,3,F,20210301.0,20211208.0,20210909,20211214,EXP,,ES-MYLANLABS-2021M1059263,MYLAN,,79.0,YR,,F,Y,52.6,KG,20211214.0,,CN,ES,ES,2021,Q4,Elderly
198141663,19814166,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 international unit, qd",,,,,1F935A,,,30.0,IU,Solution for injection,QD,2021,Q4,Poor quality sleep,,2021,Q4,3,F,20210301.0,20211208.0,20210909,20211214,EXP,,ES-MYLANLABS-2021M1059263,MYLAN,,79.0,YR,,F,Y,52.6,KG,20211214.0,,CN,ES,ES,2021,Q4,Elderly
198141663,19814166,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 international unit, qd",,,,,1F935A,,,30.0,IU,Solution for injection,QD,2021,Q4,Gait disturbance,,2021,Q4,3,F,20210301.0,20211208.0,20210909,20211214,EXP,,ES-MYLANLABS-2021M1059263,MYLAN,,79.0,YR,,F,Y,52.6,KG,20211214.0,,CN,ES,ES,2021,Q4,Elderly
198141663,19814166,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 international unit, qd",,,,,1F935A,,,30.0,IU,Solution for injection,QD,2021,Q4,Limb discomfort,,2021,Q4,3,F,20210301.0,20211208.0,20210909,20211214,EXP,,ES-MYLANLABS-2021M1059263,MYLAN,,79.0,YR,,F,Y,52.6,KG,20211214.0,,CN,ES,ES,2021,Q4,Elderly
198141663,19814166,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 international unit, qd",,,,,1F935A,,,30.0,IU,Solution for injection,QD,2021,Q4,Pain in extremity,,2021,Q4,3,F,20210301.0,20211208.0,20210909,20211214,EXP,,ES-MYLANLABS-2021M1059263,MYLAN,,79.0,YR,,F,Y,52.6,KG,20211214.0,,CN,ES,ES,2021,Q4,Elderly
198141663,19814166,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 international unit, qd",,,,,1F935A,,,30.0,IU,Solution for injection,QD,2021,Q4,Listless,,2021,Q4,3,F,20210301.0,20211208.0,20210909,20211214,EXP,,ES-MYLANLABS-2021M1059263,MYLAN,,79.0,YR,,F,Y,52.6,KG,20211214.0,,CN,ES,ES,2021,Q4,Elderly
198141663,19814166,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 international unit, qd",,,,,1F935A,,,30.0,IU,Solution for injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,3,F,20210301.0,20211208.0,20210909,20211214,EXP,,ES-MYLANLABS-2021M1059263,MYLAN,,79.0,YR,,F,Y,52.6,KG,20211214.0,,CN,ES,ES,2021,Q4,Elderly
198141663,19814166,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 international unit, qd",,,,,1F935A,,,30.0,IU,Solution for injection,QD,2021,Q4,Sciatica,,2021,Q4,3,F,20210301.0,20211208.0,20210909,20211214,EXP,,ES-MYLANLABS-2021M1059263,MYLAN,,79.0,YR,,F,Y,52.6,KG,20211214.0,,CN,ES,ES,2021,Q4,Elderly
198141663,19814166,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 international unit, qd",,,,,1F935A,,,30.0,IU,Solution for injection,QD,2021,Q4,Extremity contracture,,2021,Q4,3,F,20210301.0,20211208.0,20210909,20211214,EXP,,ES-MYLANLABS-2021M1059263,MYLAN,,79.0,YR,,F,Y,52.6,KG,20211214.0,,CN,ES,ES,2021,Q4,Elderly
198147693,19814769,6,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,Subcutaneous,"20 IU, qd",,,,,,,,20.0,IU,,QD,2021,Q4,Diarrhoea,,2021,Q4,3,F,20210701.0,20210927.0,20210910,20211007,EXP,,JP-NOVOPROD-844412,NOVO NORDISK,,61.0,YR,,F,Y,64.0,KG,20211007.0,,MD,JP,JP,2021,Q4,Adult
198147693,19814769,6,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,Subcutaneous,"20 IU, qd",,,,,,,,20.0,IU,,QD,2021,Q4,Acute kidney injury,,2021,Q4,3,F,20210701.0,20210927.0,20210910,20211007,EXP,,JP-NOVOPROD-844412,NOVO NORDISK,,61.0,YR,,F,Y,64.0,KG,20211007.0,,MD,JP,JP,2021,Q4,Adult
198147693,19814769,6,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,Subcutaneous,"20 IU, qd",,,,,,,,20.0,IU,,QD,2021,Q4,Dehydration,,2021,Q4,3,F,20210701.0,20210927.0,20210910,20211007,EXP,,JP-NOVOPROD-844412,NOVO NORDISK,,61.0,YR,,F,Y,64.0,KG,20211007.0,,MD,JP,JP,2021,Q4,Adult
198197062,19819706,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/mL,,,,,,,,,,,,2021,Q4,Abdominal pain,,2021,Q4,2,F,20210522.0,20211124.0,20210913,20211203,PER,,FR-AMGEN-FRASP2021139643,AMGEN,,59.0,YR,A,M,Y,64.0,KG,20211203.0,,HP,FR,FR,2021,Q4,Adult
198197062,19819706,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/mL,,,,,,,,,,,,2021,Q4,Ureteric compression,,2021,Q4,2,F,20210522.0,20211124.0,20210913,20211203,PER,,FR-AMGEN-FRASP2021139643,AMGEN,,59.0,YR,A,M,Y,64.0,KG,20211203.0,,HP,FR,FR,2021,Q4,Adult
198197062,19819706,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/mL,,,,,,,,,,,,2021,Q4,Arthralgia,,2021,Q4,2,F,20210522.0,20211124.0,20210913,20211203,PER,,FR-AMGEN-FRASP2021139643,AMGEN,,59.0,YR,A,M,Y,64.0,KG,20211203.0,,HP,FR,FR,2021,Q4,Adult
198197062,19819706,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/mL,,,,,,,,,,,,2021,Q4,Pain in extremity,,2021,Q4,2,F,20210522.0,20211124.0,20210913,20211203,PER,,FR-AMGEN-FRASP2021139643,AMGEN,,59.0,YR,A,M,Y,64.0,KG,20211203.0,,HP,FR,FR,2021,Q4,Adult
198197062,19819706,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/mL,,,,,,,,,,,,2021,Q4,Muscular weakness,,2021,Q4,2,F,20210522.0,20211124.0,20210913,20211203,PER,,FR-AMGEN-FRASP2021139643,AMGEN,,59.0,YR,A,M,Y,64.0,KG,20211203.0,,HP,FR,FR,2021,Q4,Adult
198197062,19819706,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/mL,,,,,,,,,,,,2021,Q4,Haematoma muscle,,2021,Q4,2,F,20210522.0,20211124.0,20210913,20211203,PER,,FR-AMGEN-FRASP2021139643,AMGEN,,59.0,YR,A,M,Y,64.0,KG,20211203.0,,HP,FR,FR,2021,Q4,Adult
198197062,19819706,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/mL,,,,,,,,,,,,2021,Q4,Pyelocaliectasis,,2021,Q4,2,F,20210522.0,20211124.0,20210913,20211203,PER,,FR-AMGEN-FRASP2021139643,AMGEN,,59.0,YR,A,M,Y,64.0,KG,20211203.0,,HP,FR,FR,2021,Q4,Adult
198204082,19820408,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,24 international unit,,,U,,,,,24.0,IU,Solution for injection,,2021,Q4,Blood glucose increased,,2021,Q4,2,F,20210801.0,20211021.0,20210913,20211105,EXP,,ES-AUROBINDO-AUR-APL-2021-038480,AUROBINDO,,84.0,YR,,F,Y,65.0,KG,20211105.0,,CN,ES,ES,2021,Q4,Elderly
198204082,19820408,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,24 international unit,,,U,,,,,24.0,IU,Solution for injection,,2021,Q4,Dizziness,,2021,Q4,2,F,20210801.0,20211021.0,20210913,20211105,EXP,,ES-AUROBINDO-AUR-APL-2021-038480,AUROBINDO,,84.0,YR,,F,Y,65.0,KG,20211105.0,,CN,ES,ES,2021,Q4,Elderly
198204082,19820408,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,24 international unit,,,U,,,,,24.0,IU,Solution for injection,,2021,Q4,Arthralgia,,2021,Q4,2,F,20210801.0,20211021.0,20210913,20211105,EXP,,ES-AUROBINDO-AUR-APL-2021-038480,AUROBINDO,,84.0,YR,,F,Y,65.0,KG,20211105.0,,CN,ES,ES,2021,Q4,Elderly
198204082,19820408,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,24 international unit,,,U,,,,,24.0,IU,Solution for injection,,2021,Q4,Fall,,2021,Q4,2,F,20210801.0,20211021.0,20210913,20211105,EXP,,ES-AUROBINDO-AUR-APL-2021-038480,AUROBINDO,,84.0,YR,,F,Y,65.0,KG,20211105.0,,CN,ES,ES,2021,Q4,Elderly
198204082,19820408,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,24 international unit,,,U,,,,,24.0,IU,Solution for injection,,2021,Q4,Hip fracture,,2021,Q4,2,F,20210801.0,20211021.0,20210913,20211105,EXP,,ES-AUROBINDO-AUR-APL-2021-038480,AUROBINDO,,84.0,YR,,F,Y,65.0,KG,20211105.0,,CN,ES,ES,2021,Q4,Elderly
198204082,19820408,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 international unit, Once a Day",,,U,,,,,22.0,IU,Solution for injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,2,F,20210801.0,20211021.0,20210913,20211105,EXP,,ES-AUROBINDO-AUR-APL-2021-038480,AUROBINDO,,84.0,YR,,F,Y,65.0,KG,20211105.0,,CN,ES,ES,2021,Q4,Elderly
198204082,19820408,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 international unit, Once a Day",,,U,,,,,22.0,IU,Solution for injection,QD,2021,Q4,Dizziness,,2021,Q4,2,F,20210801.0,20211021.0,20210913,20211105,EXP,,ES-AUROBINDO-AUR-APL-2021-038480,AUROBINDO,,84.0,YR,,F,Y,65.0,KG,20211105.0,,CN,ES,ES,2021,Q4,Elderly
198204082,19820408,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 international unit, Once a Day",,,U,,,,,22.0,IU,Solution for injection,QD,2021,Q4,Arthralgia,,2021,Q4,2,F,20210801.0,20211021.0,20210913,20211105,EXP,,ES-AUROBINDO-AUR-APL-2021-038480,AUROBINDO,,84.0,YR,,F,Y,65.0,KG,20211105.0,,CN,ES,ES,2021,Q4,Elderly
198204082,19820408,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 international unit, Once a Day",,,U,,,,,22.0,IU,Solution for injection,QD,2021,Q4,Fall,,2021,Q4,2,F,20210801.0,20211021.0,20210913,20211105,EXP,,ES-AUROBINDO-AUR-APL-2021-038480,AUROBINDO,,84.0,YR,,F,Y,65.0,KG,20211105.0,,CN,ES,ES,2021,Q4,Elderly
198204082,19820408,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 international unit, Once a Day",,,U,,,,,22.0,IU,Solution for injection,QD,2021,Q4,Hip fracture,,2021,Q4,2,F,20210801.0,20211021.0,20210913,20211105,EXP,,ES-AUROBINDO-AUR-APL-2021-038480,AUROBINDO,,84.0,YR,,F,Y,65.0,KG,20211105.0,,CN,ES,ES,2021,Q4,Elderly
198286883,19828688,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 iU, QD",,,,,,,,18.0,IU,Solution for injection,QD,2021,Q4,Illness,,2021,Q4,3,F,20210409.0,20211018.0,20210914,20211025,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20211025.0,,CN,ES,ES,2021,Q4,Elderly
198286883,19828688,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 iU, QD",,,,,,,,18.0,IU,Solution for injection,QD,2021,Q4,Osteoporosis,,2021,Q4,3,F,20210409.0,20211018.0,20210914,20211025,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20211025.0,,CN,ES,ES,2021,Q4,Elderly
198286883,19828688,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 iU, QD",,,,,,,,18.0,IU,Solution for injection,QD,2021,Q4,Weight decreased,,2021,Q4,3,F,20210409.0,20211018.0,20210914,20211025,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20211025.0,,CN,ES,ES,2021,Q4,Elderly
198286883,19828688,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 iU, QD",,,,,,,,18.0,IU,Solution for injection,QD,2021,Q4,Inappropriate schedule of product administration,,2021,Q4,3,F,20210409.0,20211018.0,20210914,20211025,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20211025.0,,CN,ES,ES,2021,Q4,Elderly
198286883,19828688,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 iU, QD",,,,,,,,18.0,IU,Solution for injection,QD,2021,Q4,Discomfort,,2021,Q4,3,F,20210409.0,20211018.0,20210914,20211025,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20211025.0,,CN,ES,ES,2021,Q4,Elderly
198286883,19828688,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 iU, QD",,,,,,,,18.0,IU,Solution for injection,QD,2021,Q4,Urinary tract infection,,2021,Q4,3,F,20210409.0,20211018.0,20210914,20211025,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20211025.0,,CN,ES,ES,2021,Q4,Elderly
198286883,19828688,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 iU, QD",,,,,,,,18.0,IU,Solution for injection,QD,2021,Q4,Paraesthesia,,2021,Q4,3,F,20210409.0,20211018.0,20210914,20211025,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20211025.0,,CN,ES,ES,2021,Q4,Elderly
198286883,19828688,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 iU, QD",,,,,,,,18.0,IU,Solution for injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,3,F,20210409.0,20211018.0,20210914,20211025,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20211025.0,,CN,ES,ES,2021,Q4,Elderly
198286883,19828688,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 iU, QD",,,,,,,,18.0,IU,Solution for injection,QD,2021,Q4,Flatulence,,2021,Q4,3,F,20210409.0,20211018.0,20210914,20211025,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20211025.0,,CN,ES,ES,2021,Q4,Elderly
198286883,19828688,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 iU, QD",,,,,,,,18.0,IU,Solution for injection,QD,2021,Q4,Dizziness,,2021,Q4,3,F,20210409.0,20211018.0,20210914,20211025,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20211025.0,,CN,ES,ES,2021,Q4,Elderly
198286883,19828688,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 iU, QD",,,,,,,,18.0,IU,Solution for injection,QD,2021,Q4,Nausea,,2021,Q4,3,F,20210409.0,20211018.0,20210914,20211025,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20211025.0,,CN,ES,ES,2021,Q4,Elderly
198286883,19828688,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 iU, QD",,,,,,,,18.0,IU,Solution for injection,QD,2021,Q4,Cardiovascular disorder,,2021,Q4,3,F,20210409.0,20211018.0,20210914,20211025,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20211025.0,,CN,ES,ES,2021,Q4,Elderly
198286883,19828688,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 iU, QD",,,,,,,,18.0,IU,Solution for injection,QD,2021,Q4,Decreased appetite,,2021,Q4,3,F,20210409.0,20211018.0,20210914,20211025,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20211025.0,,CN,ES,ES,2021,Q4,Elderly
198286883,19828688,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, qd",,,,,,,,,,Solution for injection,QD,2021,Q4,Illness,,2021,Q4,3,F,20210409.0,20211018.0,20210914,20211025,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20211025.0,,CN,ES,ES,2021,Q4,Elderly
198286883,19828688,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, qd",,,,,,,,,,Solution for injection,QD,2021,Q4,Osteoporosis,,2021,Q4,3,F,20210409.0,20211018.0,20210914,20211025,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20211025.0,,CN,ES,ES,2021,Q4,Elderly
198286883,19828688,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, qd",,,,,,,,,,Solution for injection,QD,2021,Q4,Weight decreased,,2021,Q4,3,F,20210409.0,20211018.0,20210914,20211025,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20211025.0,,CN,ES,ES,2021,Q4,Elderly
198286883,19828688,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, qd",,,,,,,,,,Solution for injection,QD,2021,Q4,Inappropriate schedule of product administration,,2021,Q4,3,F,20210409.0,20211018.0,20210914,20211025,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20211025.0,,CN,ES,ES,2021,Q4,Elderly
198286883,19828688,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, qd",,,,,,,,,,Solution for injection,QD,2021,Q4,Discomfort,,2021,Q4,3,F,20210409.0,20211018.0,20210914,20211025,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20211025.0,,CN,ES,ES,2021,Q4,Elderly
198286883,19828688,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, qd",,,,,,,,,,Solution for injection,QD,2021,Q4,Urinary tract infection,,2021,Q4,3,F,20210409.0,20211018.0,20210914,20211025,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20211025.0,,CN,ES,ES,2021,Q4,Elderly
198286883,19828688,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, qd",,,,,,,,,,Solution for injection,QD,2021,Q4,Paraesthesia,,2021,Q4,3,F,20210409.0,20211018.0,20210914,20211025,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20211025.0,,CN,ES,ES,2021,Q4,Elderly
198286883,19828688,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, qd",,,,,,,,,,Solution for injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,3,F,20210409.0,20211018.0,20210914,20211025,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20211025.0,,CN,ES,ES,2021,Q4,Elderly
198286883,19828688,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, qd",,,,,,,,,,Solution for injection,QD,2021,Q4,Flatulence,,2021,Q4,3,F,20210409.0,20211018.0,20210914,20211025,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20211025.0,,CN,ES,ES,2021,Q4,Elderly
198286883,19828688,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, qd",,,,,,,,,,Solution for injection,QD,2021,Q4,Dizziness,,2021,Q4,3,F,20210409.0,20211018.0,20210914,20211025,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20211025.0,,CN,ES,ES,2021,Q4,Elderly
198286883,19828688,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, qd",,,,,,,,,,Solution for injection,QD,2021,Q4,Nausea,,2021,Q4,3,F,20210409.0,20211018.0,20210914,20211025,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20211025.0,,CN,ES,ES,2021,Q4,Elderly
198286883,19828688,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, qd",,,,,,,,,,Solution for injection,QD,2021,Q4,Cardiovascular disorder,,2021,Q4,3,F,20210409.0,20211018.0,20210914,20211025,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20211025.0,,CN,ES,ES,2021,Q4,Elderly
198286883,19828688,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, qd",,,,,,,,,,Solution for injection,QD,2021,Q4,Decreased appetite,,2021,Q4,3,F,20210409.0,20211018.0,20210914,20211025,EXP,,ES-MYLANLABS-2021M1061533,MYLAN,,71.0,YR,,F,Y,92.0,KG,20211025.0,,CN,ES,ES,2021,Q4,Elderly
198329098,19832909,54,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous drip,25 Milligram,,,,,,,,25.0,MG,Injection,QD,2021,Q4,Interstitial lung disease,,2021,Q4,8,F,20210902.0,20211207.0,20210915,20211216,EXP,,US-CELGENEUS-USA-20210902235,CELGENE,,73.0,YR,,F,Y,70.37,KG,20211216.0,,HP,US,US,2021,Q4,Elderly
198329098,19832909,54,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous drip,25 Milligram,,,,,,,,25.0,MG,Injection,QD,2021,Q4,Embolism,,2021,Q4,8,F,20210902.0,20211207.0,20210915,20211216,EXP,,US-CELGENEUS-USA-20210902235,CELGENE,,73.0,YR,,F,Y,70.37,KG,20211216.0,,HP,US,US,2021,Q4,Elderly
198329098,19832909,54,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous drip,25 Milligram,,,,,,,,25.0,MG,Injection,QD,2021,Q4,Respiratory disorder,,2021,Q4,8,F,20210902.0,20211207.0,20210915,20211216,EXP,,US-CELGENEUS-USA-20210902235,CELGENE,,73.0,YR,,F,Y,70.37,KG,20211216.0,,HP,US,US,2021,Q4,Elderly
198329098,19832909,54,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous drip,25 Milligram,,,,,,,,25.0,MG,Injection,QD,2021,Q4,Cardiac failure,,2021,Q4,8,F,20210902.0,20211207.0,20210915,20211216,EXP,,US-CELGENEUS-USA-20210902235,CELGENE,,73.0,YR,,F,Y,70.37,KG,20211216.0,,HP,US,US,2021,Q4,Elderly
198329098,19832909,55,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous drip,18 IU (International Unit),,,,,,,,18.0,IU,Injection,QD,2021,Q4,Interstitial lung disease,,2021,Q4,8,F,20210902.0,20211207.0,20210915,20211216,EXP,,US-CELGENEUS-USA-20210902235,CELGENE,,73.0,YR,,F,Y,70.37,KG,20211216.0,,HP,US,US,2021,Q4,Elderly
198329098,19832909,55,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous drip,18 IU (International Unit),,,,,,,,18.0,IU,Injection,QD,2021,Q4,Embolism,,2021,Q4,8,F,20210902.0,20211207.0,20210915,20211216,EXP,,US-CELGENEUS-USA-20210902235,CELGENE,,73.0,YR,,F,Y,70.37,KG,20211216.0,,HP,US,US,2021,Q4,Elderly
198329098,19832909,55,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous drip,18 IU (International Unit),,,,,,,,18.0,IU,Injection,QD,2021,Q4,Respiratory disorder,,2021,Q4,8,F,20210902.0,20211207.0,20210915,20211216,EXP,,US-CELGENEUS-USA-20210902235,CELGENE,,73.0,YR,,F,Y,70.37,KG,20211216.0,,HP,US,US,2021,Q4,Elderly
198329098,19832909,55,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous drip,18 IU (International Unit),,,,,,,,18.0,IU,Injection,QD,2021,Q4,Cardiac failure,,2021,Q4,8,F,20210902.0,20211207.0,20210915,20211216,EXP,,US-CELGENEUS-USA-20210902235,CELGENE,,73.0,YR,,F,Y,70.37,KG,20211216.0,,HP,US,US,2021,Q4,Elderly
198329098,19832909,56,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous drip,14 IU (International Unit),,,,,,,,14.0,IU,Injection,QD,2021,Q4,Interstitial lung disease,,2021,Q4,8,F,20210902.0,20211207.0,20210915,20211216,EXP,,US-CELGENEUS-USA-20210902235,CELGENE,,73.0,YR,,F,Y,70.37,KG,20211216.0,,HP,US,US,2021,Q4,Elderly
198329098,19832909,56,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous drip,14 IU (International Unit),,,,,,,,14.0,IU,Injection,QD,2021,Q4,Embolism,,2021,Q4,8,F,20210902.0,20211207.0,20210915,20211216,EXP,,US-CELGENEUS-USA-20210902235,CELGENE,,73.0,YR,,F,Y,70.37,KG,20211216.0,,HP,US,US,2021,Q4,Elderly
198329098,19832909,56,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous drip,14 IU (International Unit),,,,,,,,14.0,IU,Injection,QD,2021,Q4,Respiratory disorder,,2021,Q4,8,F,20210902.0,20211207.0,20210915,20211216,EXP,,US-CELGENEUS-USA-20210902235,CELGENE,,73.0,YR,,F,Y,70.37,KG,20211216.0,,HP,US,US,2021,Q4,Elderly
198329098,19832909,56,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous drip,14 IU (International Unit),,,,,,,,14.0,IU,Injection,QD,2021,Q4,Cardiac failure,,2021,Q4,8,F,20210902.0,20211207.0,20210915,20211216,EXP,,US-CELGENEUS-USA-20210902235,CELGENE,,73.0,YR,,F,Y,70.37,KG,20211216.0,,HP,US,US,2021,Q4,Elderly
198329098,19832909,57,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous drip,10 IU (International Unit),,,,,,,,10.0,IU,Injection,QD,2021,Q4,Interstitial lung disease,,2021,Q4,8,F,20210902.0,20211207.0,20210915,20211216,EXP,,US-CELGENEUS-USA-20210902235,CELGENE,,73.0,YR,,F,Y,70.37,KG,20211216.0,,HP,US,US,2021,Q4,Elderly
198329098,19832909,57,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous drip,10 IU (International Unit),,,,,,,,10.0,IU,Injection,QD,2021,Q4,Embolism,,2021,Q4,8,F,20210902.0,20211207.0,20210915,20211216,EXP,,US-CELGENEUS-USA-20210902235,CELGENE,,73.0,YR,,F,Y,70.37,KG,20211216.0,,HP,US,US,2021,Q4,Elderly
198329098,19832909,57,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous drip,10 IU (International Unit),,,,,,,,10.0,IU,Injection,QD,2021,Q4,Respiratory disorder,,2021,Q4,8,F,20210902.0,20211207.0,20210915,20211216,EXP,,US-CELGENEUS-USA-20210902235,CELGENE,,73.0,YR,,F,Y,70.37,KG,20211216.0,,HP,US,US,2021,Q4,Elderly
198329098,19832909,57,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous drip,10 IU (International Unit),,,,,,,,10.0,IU,Injection,QD,2021,Q4,Cardiac failure,,2021,Q4,8,F,20210902.0,20211207.0,20210915,20211216,EXP,,US-CELGENEUS-USA-20210902235,CELGENE,,73.0,YR,,F,Y,70.37,KG,20211216.0,,HP,US,US,2021,Q4,Elderly
198343932,19834393,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/mL UNKNOWN,,,U,,,,,,,,,2021,Q4,Ureteric compression,,2021,Q4,2,F,20210522.0,20211125.0,20210915,20211203,EXP,,FR-AstraZeneca-2021A718519,ASTRAZENECA,,59.0,YR,,M,Y,64.0,KG,20211203.0,,MD,FR,,2021,Q4,Adult
198343932,19834393,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/mL UNKNOWN,,,U,,,,,,,,,2021,Q4,Muscular weakness,,2021,Q4,2,F,20210522.0,20211125.0,20210915,20211203,EXP,,FR-AstraZeneca-2021A718519,ASTRAZENECA,,59.0,YR,,M,Y,64.0,KG,20211203.0,,MD,FR,,2021,Q4,Adult
198343932,19834393,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/mL UNKNOWN,,,U,,,,,,,,,2021,Q4,Arthralgia,,2021,Q4,2,F,20210522.0,20211125.0,20210915,20211203,EXP,,FR-AstraZeneca-2021A718519,ASTRAZENECA,,59.0,YR,,M,Y,64.0,KG,20211203.0,,MD,FR,,2021,Q4,Adult
198343932,19834393,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/mL UNKNOWN,,,U,,,,,,,,,2021,Q4,Abdominal pain,,2021,Q4,2,F,20210522.0,20211125.0,20210915,20211203,EXP,,FR-AstraZeneca-2021A718519,ASTRAZENECA,,59.0,YR,,M,Y,64.0,KG,20211203.0,,MD,FR,,2021,Q4,Adult
198343932,19834393,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/mL UNKNOWN,,,U,,,,,,,,,2021,Q4,Haematoma muscle,,2021,Q4,2,F,20210522.0,20211125.0,20210915,20211203,EXP,,FR-AstraZeneca-2021A718519,ASTRAZENECA,,59.0,YR,,M,Y,64.0,KG,20211203.0,,MD,FR,,2021,Q4,Adult
198343932,19834393,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/mL UNKNOWN,,,U,,,,,,,,,2021,Q4,Pain in extremity,,2021,Q4,2,F,20210522.0,20211125.0,20210915,20211203,EXP,,FR-AstraZeneca-2021A718519,ASTRAZENECA,,59.0,YR,,M,Y,64.0,KG,20211203.0,,MD,FR,,2021,Q4,Adult
198343932,19834393,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/mL UNKNOWN,,,U,,,,,,,,,2021,Q4,Pyelocaliectasis,,2021,Q4,2,F,20210522.0,20211125.0,20210915,20211203,EXP,,FR-AstraZeneca-2021A718519,ASTRAZENECA,,59.0,YR,,M,Y,64.0,KG,20211203.0,,MD,FR,,2021,Q4,Adult
198349282,19834928,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,unit/ml,,,,,,,,,,Solution for injection in pre-filled pen,,2021,Q4,Weight decreased,,2021,Q4,2,F,20200401.0,20211102.0,20210915,20211104,EXP,,US-ABBVIE-21K-163-4078240-00,ABBVIE,,79.0,YR,,M,Y,72.64,KG,20211104.0,,MD,COUNTRY NOT SPECIFIED,US,2021,Q4,Elderly
198349282,19834928,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,unit/ml,,,,,,,,,,Solution for injection in pre-filled pen,,2021,Q4,Myasthenia gravis,,2021,Q4,2,F,20200401.0,20211102.0,20210915,20211104,EXP,,US-ABBVIE-21K-163-4078240-00,ABBVIE,,79.0,YR,,M,Y,72.64,KG,20211104.0,,MD,COUNTRY NOT SPECIFIED,US,2021,Q4,Elderly
198349282,19834928,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,unit/ml,,,,,,,,,,Solution for injection in pre-filled pen,,2021,Q4,Haemorrhage intracranial,,2021,Q4,2,F,20200401.0,20211102.0,20210915,20211104,EXP,,US-ABBVIE-21K-163-4078240-00,ABBVIE,,79.0,YR,,M,Y,72.64,KG,20211104.0,,MD,COUNTRY NOT SPECIFIED,US,2021,Q4,Elderly
198349282,19834928,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,unit/ml,,,,,,,,,,Solution for injection in pre-filled pen,,2021,Q4,Anaemia,,2021,Q4,2,F,20200401.0,20211102.0,20210915,20211104,EXP,,US-ABBVIE-21K-163-4078240-00,ABBVIE,,79.0,YR,,M,Y,72.64,KG,20211104.0,,MD,COUNTRY NOT SPECIFIED,US,2021,Q4,Elderly
198349282,19834928,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,unit/ml,,,,,,,,,,Solution for injection in pre-filled pen,,2021,Q4,Death,,2021,Q4,2,F,20200401.0,20211102.0,20210915,20211104,EXP,,US-ABBVIE-21K-163-4078240-00,ABBVIE,,79.0,YR,,M,Y,72.64,KG,20211104.0,,MD,COUNTRY NOT SPECIFIED,US,2021,Q4,Elderly
198349282,19834928,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,unit/ml,,,,,,,,,,Solution for injection in pre-filled pen,,2021,Q4,Acute respiratory failure,,2021,Q4,2,F,20200401.0,20211102.0,20210915,20211104,EXP,,US-ABBVIE-21K-163-4078240-00,ABBVIE,,79.0,YR,,M,Y,72.64,KG,20211104.0,,MD,COUNTRY NOT SPECIFIED,US,2021,Q4,Elderly
198349282,19834928,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,unit/ml,,,,,,,,,,Solution for injection in pre-filled pen,,2021,Q4,Leukopenia,,2021,Q4,2,F,20200401.0,20211102.0,20210915,20211104,EXP,,US-ABBVIE-21K-163-4078240-00,ABBVIE,,79.0,YR,,M,Y,72.64,KG,20211104.0,,MD,COUNTRY NOT SPECIFIED,US,2021,Q4,Elderly
198412633,19841263,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ml,,,U,,,,,100.0,ML,Solution for injection,,2021,Q4,Muscular weakness,,2021,Q4,3,F,20210522.0,20211122.0,20210915,20211203,EXP,FR-NOVARTISPH-NVSC2021FR202918,NVSC2021FR202918,NOVARTIS,,59.0,YR,,M,Y,64.0,KG,20211203.0,,HP,FR,FR,2021,Q4,Adult
198412633,19841263,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ml,,,U,,,,,100.0,ML,Solution for injection,,2021,Q4,Pyelocaliectasis,,2021,Q4,3,F,20210522.0,20211122.0,20210915,20211203,EXP,FR-NOVARTISPH-NVSC2021FR202918,NVSC2021FR202918,NOVARTIS,,59.0,YR,,M,Y,64.0,KG,20211203.0,,HP,FR,FR,2021,Q4,Adult
198412633,19841263,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ml,,,U,,,,,100.0,ML,Solution for injection,,2021,Q4,Arthralgia,,2021,Q4,3,F,20210522.0,20211122.0,20210915,20211203,EXP,FR-NOVARTISPH-NVSC2021FR202918,NVSC2021FR202918,NOVARTIS,,59.0,YR,,M,Y,64.0,KG,20211203.0,,HP,FR,FR,2021,Q4,Adult
198412633,19841263,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ml,,,U,,,,,100.0,ML,Solution for injection,,2021,Q4,Abdominal pain,,2021,Q4,3,F,20210522.0,20211122.0,20210915,20211203,EXP,FR-NOVARTISPH-NVSC2021FR202918,NVSC2021FR202918,NOVARTIS,,59.0,YR,,M,Y,64.0,KG,20211203.0,,HP,FR,FR,2021,Q4,Adult
198412633,19841263,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ml,,,U,,,,,100.0,ML,Solution for injection,,2021,Q4,Pain in extremity,,2021,Q4,3,F,20210522.0,20211122.0,20210915,20211203,EXP,FR-NOVARTISPH-NVSC2021FR202918,NVSC2021FR202918,NOVARTIS,,59.0,YR,,M,Y,64.0,KG,20211203.0,,HP,FR,FR,2021,Q4,Adult
198412633,19841263,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ml,,,U,,,,,100.0,ML,Solution for injection,,2021,Q4,Haematoma muscle,,2021,Q4,3,F,20210522.0,20211122.0,20210915,20211203,EXP,FR-NOVARTISPH-NVSC2021FR202918,NVSC2021FR202918,NOVARTIS,,59.0,YR,,M,Y,64.0,KG,20211203.0,,HP,FR,FR,2021,Q4,Adult
198412633,19841263,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ml,,,U,,,,,100.0,ML,Solution for injection,,2021,Q4,Ureteric compression,,2021,Q4,3,F,20210522.0,20211122.0,20210915,20211203,EXP,FR-NOVARTISPH-NVSC2021FR202918,NVSC2021FR202918,NOVARTIS,,59.0,YR,,M,Y,64.0,KG,20211203.0,,HP,FR,FR,2021,Q4,Adult
198412633,19841263,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 ml,,,U,,,,,100.0,ML,Solution for injection,,2021,Q4,Muscular weakness,,2021,Q4,3,F,20210522.0,20211122.0,20210915,20211203,EXP,FR-NOVARTISPH-NVSC2021FR202918,NVSC2021FR202918,NOVARTIS,,59.0,YR,,M,Y,64.0,KG,20211203.0,,HP,FR,FR,2021,Q4,Adult
198412633,19841263,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 ml,,,U,,,,,100.0,ML,Solution for injection,,2021,Q4,Pyelocaliectasis,,2021,Q4,3,F,20210522.0,20211122.0,20210915,20211203,EXP,FR-NOVARTISPH-NVSC2021FR202918,NVSC2021FR202918,NOVARTIS,,59.0,YR,,M,Y,64.0,KG,20211203.0,,HP,FR,FR,2021,Q4,Adult
198412633,19841263,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 ml,,,U,,,,,100.0,ML,Solution for injection,,2021,Q4,Arthralgia,,2021,Q4,3,F,20210522.0,20211122.0,20210915,20211203,EXP,FR-NOVARTISPH-NVSC2021FR202918,NVSC2021FR202918,NOVARTIS,,59.0,YR,,M,Y,64.0,KG,20211203.0,,HP,FR,FR,2021,Q4,Adult
198412633,19841263,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 ml,,,U,,,,,100.0,ML,Solution for injection,,2021,Q4,Abdominal pain,,2021,Q4,3,F,20210522.0,20211122.0,20210915,20211203,EXP,FR-NOVARTISPH-NVSC2021FR202918,NVSC2021FR202918,NOVARTIS,,59.0,YR,,M,Y,64.0,KG,20211203.0,,HP,FR,FR,2021,Q4,Adult
198412633,19841263,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 ml,,,U,,,,,100.0,ML,Solution for injection,,2021,Q4,Pain in extremity,,2021,Q4,3,F,20210522.0,20211122.0,20210915,20211203,EXP,FR-NOVARTISPH-NVSC2021FR202918,NVSC2021FR202918,NOVARTIS,,59.0,YR,,M,Y,64.0,KG,20211203.0,,HP,FR,FR,2021,Q4,Adult
198412633,19841263,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 ml,,,U,,,,,100.0,ML,Solution for injection,,2021,Q4,Haematoma muscle,,2021,Q4,3,F,20210522.0,20211122.0,20210915,20211203,EXP,FR-NOVARTISPH-NVSC2021FR202918,NVSC2021FR202918,NOVARTIS,,59.0,YR,,M,Y,64.0,KG,20211203.0,,HP,FR,FR,2021,Q4,Adult
198412633,19841263,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 ml,,,U,,,,,100.0,ML,Solution for injection,,2021,Q4,Ureteric compression,,2021,Q4,3,F,20210522.0,20211122.0,20210915,20211203,EXP,FR-NOVARTISPH-NVSC2021FR202918,NVSC2021FR202918,NOVARTIS,,59.0,YR,,M,Y,64.0,KG,20211203.0,,HP,FR,FR,2021,Q4,Adult
198442472,19844247,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,Injection,,2021,Q4,Interstitial lung disease,,2021,Q4,2,F,20210617.0,20210920.0,20210916,20211001,EXP,,JP-PFIZER INC-202101149749,PFIZER,,44.0,YR,,F,Y,,,20211001.0,,PH,JP,JP,2021,Q4,Adult
198471712,19847171,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,End stage renal disease,,2021,Q4,2,F,20210111.0,20210914.0,20210917,20211015,EXP,,JP-GILEAD-2021-0544694,GILEAD,"Yoshida J, Otani K, Tamura T, Shiraishi K, Tanaka M.. Clinical guidelines: Factors including medication to prevent increase in severity of condition of inpatients with COVID-19 - receiver operating characteristic analysis by approximate PaO2/FiO2 ratio. The Japanese Journal of Clinical and Experimental Medicine. 2021;98(7):853-856",49.0,YR,A,F,Y,79.1,KG,20211015.0,,MD,JP,JP,2021,Q4,Adult
198471712,19847171,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Renal impairment,,2021,Q4,2,F,20210111.0,20210914.0,20210917,20211015,EXP,,JP-GILEAD-2021-0544694,GILEAD,"Yoshida J, Otani K, Tamura T, Shiraishi K, Tanaka M.. Clinical guidelines: Factors including medication to prevent increase in severity of condition of inpatients with COVID-19 - receiver operating characteristic analysis by approximate PaO2/FiO2 ratio. The Japanese Journal of Clinical and Experimental Medicine. 2021;98(7):853-856",49.0,YR,A,F,Y,79.1,KG,20211015.0,,MD,JP,JP,2021,Q4,Adult
198492904,19849290,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,22 units (frequency = once daily),,,U,,,,,,,,QD,2021,Q4,Pneumonia,,2021,Q4,4,F,20210909.0,20211019.0,20210917,20211102,EXP,,ES-GLAXOSMITHKLINE-ES2021193346,GLAXOSMITHKLINE,,75.0,YR,,M,Y,64.9,KG,20211102.0,,MD,ES,ES,2021,Q4,Elderly
198546856,19854685,43,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, unknown",,,,,,,,,,,,2021,Q4,Abdominal pain,,2021,Q4,6,F,20210827.0,20211209.0,20210920,20211216,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202109001846,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20211216.0,,CN,CN,CN,2021,Q4,Adult
198546856,19854685,43,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, unknown",,,,,,,,,,,,2021,Q4,Nausea,,2021,Q4,6,F,20210827.0,20211209.0,20210920,20211216,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202109001846,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20211216.0,,CN,CN,CN,2021,Q4,Adult
198546856,19854685,43,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, unknown",,,,,,,,,,,,2021,Q4,Fatigue,,2021,Q4,6,F,20210827.0,20211209.0,20210920,20211216,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202109001846,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20211216.0,,CN,CN,CN,2021,Q4,Adult
198546856,19854685,43,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, unknown",,,,,,,,,,,,2021,Q4,Regurgitation,,2021,Q4,6,F,20210827.0,20211209.0,20210920,20211216,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202109001846,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20211216.0,,CN,CN,CN,2021,Q4,Adult
198651735,19865173,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Encephalopathy,,2021,Q4,5,F,20210812.0,20211116.0,20210921,20211122,EXP,,US-GILEAD-2021-0545614,GILEAD,,70.0,YR,E,M,Y,,,20211122.0,,HP,US,US,2021,Q4,Elderly
198651735,19865173,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Opportunistic infection,,2021,Q4,5,F,20210812.0,20211116.0,20210921,20211122,EXP,,US-GILEAD-2021-0545614,GILEAD,,70.0,YR,E,M,Y,,,20211122.0,,HP,US,US,2021,Q4,Elderly
198651735,19865173,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Cytomegalovirus viraemia,,2021,Q4,5,F,20210812.0,20211116.0,20210921,20211122,EXP,,US-GILEAD-2021-0545614,GILEAD,,70.0,YR,E,M,Y,,,20211122.0,,HP,US,US,2021,Q4,Elderly
198651735,19865173,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Fungaemia,,2021,Q4,5,F,20210812.0,20211116.0,20210921,20211122,EXP,,US-GILEAD-2021-0545614,GILEAD,,70.0,YR,E,M,Y,,,20211122.0,,HP,US,US,2021,Q4,Elderly
198651735,19865173,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Bacteraemia,,2021,Q4,5,F,20210812.0,20211116.0,20210921,20211122,EXP,,US-GILEAD-2021-0545614,GILEAD,,70.0,YR,E,M,Y,,,20211122.0,,HP,US,US,2021,Q4,Elderly
198844022,19884402,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Drug ineffective for unapproved indication,,2021,Q4,2,F,,20211223.0,20210927,20211230,EXP,,CA-ROCHE-2918049,ROCHE,,68.0,YR,,M,Y,,,20211230.0,,HP,CA,,2021,Q4,Elderly
198844022,19884402,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,End stage renal disease,,2021,Q4,2,F,,20211223.0,20210927,20211230,EXP,,CA-ROCHE-2918049,ROCHE,,68.0,YR,,M,Y,,,20211230.0,,HP,CA,,2021,Q4,Elderly
198844022,19884402,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Blood glucose increased,,2021,Q4,2,F,,20211223.0,20210927,20211230,EXP,,CA-ROCHE-2918049,ROCHE,,68.0,YR,,M,Y,,,20211230.0,,HP,CA,,2021,Q4,Elderly
198844022,19884402,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Off label use,,2021,Q4,2,F,,20211223.0,20210927,20211230,EXP,,CA-ROCHE-2918049,ROCHE,,68.0,YR,,M,Y,,,20211230.0,,HP,CA,,2021,Q4,Elderly
198853212,19885321,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Adverse event,,2021,Q4,2,F,,20211229.0,20210927,20211229,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-096854,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Elderly
198853212,19885321,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Intentional product use issue,,2021,Q4,2,F,,20211229.0,20210927,20211229,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-096854,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Elderly
198904882,19890488,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Oesophagitis,,2021,Q4,2,F,20210831.0,20211215.0,20210927,20211222,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-095697,BRISTOL MYERS SQUIBB,,56.0,YR,,M,Y,138.0,KG,20211222.0,,HP,US,US,2021,Q4,Adult
198907032,19890703,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, unknown",,,U,,,,205692.0,,,,,2021,Q4,Hyperglycaemia,,2021,Q4,2,F,20210715.0,20211025.0,20210928,20211103,EXP,IT-MINISAL02-785491,IT-ELI_LILLY_AND_COMPANY-IT202109006113,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20211103.0,,CN,IT,IT,2021,Q4,Elderly
198954622,19895462,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU qd, (28 DV, once in the evening)",,,,,,,210605.0,28.0,IU,Injection,QD,2021,Q4,Hyperglycaemia,,2021,Q4,2,F,20200906.0,20211120.0,20210929,20211129,EXP,,LV-MYLANLABS-2021M1066521,MYLAN,"N. Senterjakova, A. Staka. Poorly compensated type 1 diabetes - liver damage as a consequence. Doctus. 2021;9 (246):39-42",22.0,YR,,F,Y,58.0,KG,20211129.0,,HP,LV,LV,2021,Q4,Youth
198954622,19895462,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU qd, (28 DV, once in the evening)",,,,,,,210605.0,28.0,IU,Injection,QD,2021,Q4,Hepatic function abnormal,,2021,Q4,2,F,20200906.0,20211120.0,20210929,20211129,EXP,,LV-MYLANLABS-2021M1066521,MYLAN,"N. Senterjakova, A. Staka. Poorly compensated type 1 diabetes - liver damage as a consequence. Doctus. 2021;9 (246):39-42",22.0,YR,,F,Y,58.0,KG,20211129.0,,HP,LV,LV,2021,Q4,Youth
198954622,19895462,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU qd, (28 DV, once in the evening)",,,,,,,210605.0,28.0,IU,Injection,QD,2021,Q4,Pancreatitis acute,,2021,Q4,2,F,20200906.0,20211120.0,20210929,20211129,EXP,,LV-MYLANLABS-2021M1066521,MYLAN,"N. Senterjakova, A. Staka. Poorly compensated type 1 diabetes - liver damage as a consequence. Doctus. 2021;9 (246):39-42",22.0,YR,,F,Y,58.0,KG,20211129.0,,HP,LV,LV,2021,Q4,Youth
198954622,19895462,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU qd, (28 DV, once in the evening)",,,,,,,210605.0,28.0,IU,Injection,QD,2021,Q4,Scab,,2021,Q4,2,F,20200906.0,20211120.0,20210929,20211129,EXP,,LV-MYLANLABS-2021M1066521,MYLAN,"N. Senterjakova, A. Staka. Poorly compensated type 1 diabetes - liver damage as a consequence. Doctus. 2021;9 (246):39-42",22.0,YR,,F,Y,58.0,KG,20211129.0,,HP,LV,LV,2021,Q4,Youth
198954622,19895462,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU qd, (28 DV, once in the evening)",,,,,,,210605.0,28.0,IU,Injection,QD,2021,Q4,Abdominal pain,,2021,Q4,2,F,20200906.0,20211120.0,20210929,20211129,EXP,,LV-MYLANLABS-2021M1066521,MYLAN,"N. Senterjakova, A. Staka. Poorly compensated type 1 diabetes - liver damage as a consequence. Doctus. 2021;9 (246):39-42",22.0,YR,,F,Y,58.0,KG,20211129.0,,HP,LV,LV,2021,Q4,Youth
198954622,19895462,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU qd, (28 DV, once in the evening)",,,,,,,210605.0,28.0,IU,Injection,QD,2021,Q4,Secretion discharge,,2021,Q4,2,F,20200906.0,20211120.0,20210929,20211129,EXP,,LV-MYLANLABS-2021M1066521,MYLAN,"N. Senterjakova, A. Staka. Poorly compensated type 1 diabetes - liver damage as a consequence. Doctus. 2021;9 (246):39-42",22.0,YR,,F,Y,58.0,KG,20211129.0,,HP,LV,LV,2021,Q4,Youth
198954622,19895462,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU qd, (28 DV, once in the evening)",,,,,,,210605.0,28.0,IU,Injection,QD,2021,Q4,Rash,,2021,Q4,2,F,20200906.0,20211120.0,20210929,20211129,EXP,,LV-MYLANLABS-2021M1066521,MYLAN,"N. Senterjakova, A. Staka. Poorly compensated type 1 diabetes - liver damage as a consequence. Doctus. 2021;9 (246):39-42",22.0,YR,,F,Y,58.0,KG,20211129.0,,HP,LV,LV,2021,Q4,Youth
198954622,19895462,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU qd, (28 DV, once in the evening)",,,,,,,210605.0,28.0,IU,Injection,QD,2021,Q4,Liver injury,,2021,Q4,2,F,20200906.0,20211120.0,20210929,20211129,EXP,,LV-MYLANLABS-2021M1066521,MYLAN,"N. Senterjakova, A. Staka. Poorly compensated type 1 diabetes - liver damage as a consequence. Doctus. 2021;9 (246):39-42",22.0,YR,,F,Y,58.0,KG,20211129.0,,HP,LV,LV,2021,Q4,Youth
198954622,19895462,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU qd, (28 DV, once in the evening)",,,,,,,210605.0,28.0,IU,Injection,QD,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,2,F,20200906.0,20211120.0,20210929,20211129,EXP,,LV-MYLANLABS-2021M1066521,MYLAN,"N. Senterjakova, A. Staka. Poorly compensated type 1 diabetes - liver damage as a consequence. Doctus. 2021;9 (246):39-42",22.0,YR,,F,Y,58.0,KG,20211129.0,,HP,LV,LV,2021,Q4,Youth
198954622,19895462,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU qd, (28 DV, once in the evening)",,,,,,,210605.0,28.0,IU,Injection,QD,2021,Q4,Diabetic hepatopathy,,2021,Q4,2,F,20200906.0,20211120.0,20210929,20211129,EXP,,LV-MYLANLABS-2021M1066521,MYLAN,"N. Senterjakova, A. Staka. Poorly compensated type 1 diabetes - liver damage as a consequence. Doctus. 2021;9 (246):39-42",22.0,YR,,F,Y,58.0,KG,20211129.0,,HP,LV,LV,2021,Q4,Youth
198954622,19895462,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU qd, (28 DV, once in the evening)",,,,,,,210605.0,28.0,IU,Injection,QD,2021,Q4,Hepatic cytolysis,,2021,Q4,2,F,20200906.0,20211120.0,20210929,20211129,EXP,,LV-MYLANLABS-2021M1066521,MYLAN,"N. Senterjakova, A. Staka. Poorly compensated type 1 diabetes - liver damage as a consequence. Doctus. 2021;9 (246):39-42",22.0,YR,,F,Y,58.0,KG,20211129.0,,HP,LV,LV,2021,Q4,Youth
198954622,19895462,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU qd, (28 DV, once in the evening)",,,,,,,210605.0,28.0,IU,Injection,QD,2021,Q4,Skin disorder,,2021,Q4,2,F,20200906.0,20211120.0,20210929,20211129,EXP,,LV-MYLANLABS-2021M1066521,MYLAN,"N. Senterjakova, A. Staka. Poorly compensated type 1 diabetes - liver damage as a consequence. Doctus. 2021;9 (246):39-42",22.0,YR,,F,Y,58.0,KG,20211129.0,,HP,LV,LV,2021,Q4,Youth
198954622,19895462,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU qd, (28 DV, once in the evening)",,,,,,,210605.0,28.0,IU,Injection,QD,2021,Q4,Asthenia,,2021,Q4,2,F,20200906.0,20211120.0,20210929,20211129,EXP,,LV-MYLANLABS-2021M1066521,MYLAN,"N. Senterjakova, A. Staka. Poorly compensated type 1 diabetes - liver damage as a consequence. Doctus. 2021;9 (246):39-42",22.0,YR,,F,Y,58.0,KG,20211129.0,,HP,LV,LV,2021,Q4,Youth
198954622,19895462,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU qd, (28 DV, once in the evening)",,,,,,,210605.0,28.0,IU,Injection,QD,2021,Q4,Pyoderma,,2021,Q4,2,F,20200906.0,20211120.0,20210929,20211129,EXP,,LV-MYLANLABS-2021M1066521,MYLAN,"N. Senterjakova, A. Staka. Poorly compensated type 1 diabetes - liver damage as a consequence. Doctus. 2021;9 (246):39-42",22.0,YR,,F,Y,58.0,KG,20211129.0,,HP,LV,LV,2021,Q4,Youth
198954622,19895462,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU qd, (28 DV, once in the evening)",,,,,,,210605.0,28.0,IU,Injection,QD,2021,Q4,Vomiting,,2021,Q4,2,F,20200906.0,20211120.0,20210929,20211129,EXP,,LV-MYLANLABS-2021M1066521,MYLAN,"N. Senterjakova, A. Staka. Poorly compensated type 1 diabetes - liver damage as a consequence. Doctus. 2021;9 (246):39-42",22.0,YR,,F,Y,58.0,KG,20211129.0,,HP,LV,LV,2021,Q4,Youth
198954622,19895462,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU qd, (28 DV, once in the evening)",,,,,,,210605.0,28.0,IU,Injection,QD,2021,Q4,Erythema,,2021,Q4,2,F,20200906.0,20211120.0,20210929,20211129,EXP,,LV-MYLANLABS-2021M1066521,MYLAN,"N. Senterjakova, A. Staka. Poorly compensated type 1 diabetes - liver damage as a consequence. Doctus. 2021;9 (246):39-42",22.0,YR,,F,Y,58.0,KG,20211129.0,,HP,LV,LV,2021,Q4,Youth
198954622,19895462,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU qd, (28 DV, once in the evening)",,,,,,,210605.0,28.0,IU,Injection,QD,2021,Q4,Nausea,,2021,Q4,2,F,20200906.0,20211120.0,20210929,20211129,EXP,,LV-MYLANLABS-2021M1066521,MYLAN,"N. Senterjakova, A. Staka. Poorly compensated type 1 diabetes - liver damage as a consequence. Doctus. 2021;9 (246):39-42",22.0,YR,,F,Y,58.0,KG,20211129.0,,HP,LV,LV,2021,Q4,Youth
198954622,19895462,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU qd, (28 DV, once in the evening)",,,,,,,210605.0,28.0,IU,Injection,QD,2021,Q4,Purulent discharge,,2021,Q4,2,F,20200906.0,20211120.0,20210929,20211129,EXP,,LV-MYLANLABS-2021M1066521,MYLAN,"N. Senterjakova, A. Staka. Poorly compensated type 1 diabetes - liver damage as a consequence. Doctus. 2021;9 (246):39-42",22.0,YR,,F,Y,58.0,KG,20211129.0,,HP,LV,LV,2021,Q4,Youth
198954622,19895462,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU qd, (28 DV, once in the evening)",,,,,,,210605.0,28.0,IU,Injection,QD,2021,Q4,Non-alcoholic steatohepatitis,,2021,Q4,2,F,20200906.0,20211120.0,20210929,20211129,EXP,,LV-MYLANLABS-2021M1066521,MYLAN,"N. Senterjakova, A. Staka. Poorly compensated type 1 diabetes - liver damage as a consequence. Doctus. 2021;9 (246):39-42",22.0,YR,,F,Y,58.0,KG,20211129.0,,HP,LV,LV,2021,Q4,Youth
198954622,19895462,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU qd, (28 DV, once in the evening)",,,,,,,210605.0,28.0,IU,Injection,QD,2021,Q4,Decreased appetite,,2021,Q4,2,F,20200906.0,20211120.0,20210929,20211129,EXP,,LV-MYLANLABS-2021M1066521,MYLAN,"N. Senterjakova, A. Staka. Poorly compensated type 1 diabetes - liver damage as a consequence. Doctus. 2021;9 (246):39-42",22.0,YR,,F,Y,58.0,KG,20211129.0,,HP,LV,LV,2021,Q4,Youth
199055432,19905543,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, dose increased above the medical target",,,Y,,1f915a,,,,,Solution for injection,,2021,Q4,Intentional product misuse,,2021,Q4,2,F,20210101.0,20211014.0,20211001,20211019,EXP,,ES-MYLANLABS-2021M1067045,MYLAN,,68.0,YR,,M,Y,168.0,KG,20211019.0,,CN,ES,ES,2021,Q4,Elderly
199055432,19905543,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, dose increased above the medical target",,,Y,,1f915a,,,,,Solution for injection,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,2,F,20210101.0,20211014.0,20211001,20211019,EXP,,ES-MYLANLABS-2021M1067045,MYLAN,,68.0,YR,,M,Y,168.0,KG,20211019.0,,CN,ES,ES,2021,Q4,Elderly
199055432,19905543,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 iU,,,Y,,1f915a,,,26.0,IU,Solution for injection,,2021,Q4,Intentional product misuse,,2021,Q4,2,F,20210101.0,20211014.0,20211001,20211019,EXP,,ES-MYLANLABS-2021M1067045,MYLAN,,68.0,YR,,M,Y,168.0,KG,20211019.0,,CN,ES,ES,2021,Q4,Elderly
199055432,19905543,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 iU,,,Y,,1f915a,,,26.0,IU,Solution for injection,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,2,F,20210101.0,20211014.0,20211001,20211019,EXP,,ES-MYLANLABS-2021M1067045,MYLAN,,68.0,YR,,M,Y,168.0,KG,20211019.0,,CN,ES,ES,2021,Q4,Elderly
199055432,19905543,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,24 international unit,,,Y,,1f415a,,,24.0,IU,Solution for injection,,2021,Q4,Intentional product misuse,,2021,Q4,2,F,20210101.0,20211014.0,20211001,20211019,EXP,,ES-MYLANLABS-2021M1067045,MYLAN,,68.0,YR,,M,Y,168.0,KG,20211019.0,,CN,ES,ES,2021,Q4,Elderly
199055432,19905543,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,24 international unit,,,Y,,1f415a,,,24.0,IU,Solution for injection,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,2,F,20210101.0,20211014.0,20211001,20211019,EXP,,ES-MYLANLABS-2021M1067045,MYLAN,,68.0,YR,,M,Y,168.0,KG,20211019.0,,CN,ES,ES,2021,Q4,Elderly
199062412,19906241,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,Injection,,2021,Q4,Dyspnoea,,2021,Q4,2,F,,20211008.0,20211001,20211014,EXP,,DE-MYLANLABS-2021M1067123,MYLAN,,70.0,YR,,F,Y,,,20211014.0,,MD,DE,DE,2021,Q4,Elderly
199062412,19906241,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,Injection,,2021,Q4,Product prescribing error,,2021,Q4,2,F,,20211008.0,20211001,20211014,EXP,,DE-MYLANLABS-2021M1067123,MYLAN,,70.0,YR,,F,Y,,,20211014.0,,MD,DE,DE,2021,Q4,Elderly
199062412,19906241,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,Injection,,2021,Q4,General physical health deterioration,,2021,Q4,2,F,,20211008.0,20211001,20211014,EXP,,DE-MYLANLABS-2021M1067123,MYLAN,,70.0,YR,,F,Y,,,20211014.0,,MD,DE,DE,2021,Q4,Elderly
199062412,19906241,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,Injection,,2021,Q4,Abdominal pain upper,,2021,Q4,2,F,,20211008.0,20211001,20211014,EXP,,DE-MYLANLABS-2021M1067123,MYLAN,,70.0,YR,,F,Y,,,20211014.0,,MD,DE,DE,2021,Q4,Elderly
199073391,19907339,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,Injection,,2021,Q4,Underdose,,2021,Q4,1,I,20210412.0,20210929.0,20211001,20211001,EXP,,JP-OTSUKA-2021_033959,OTSUKA,,73.0,YR,,F,Y,99.4,KG,20211001.0,,PH,JP,JP,2021,Q4,Elderly
199073391,19907339,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,Injection,,2021,Q4,Liver disorder,,2021,Q4,1,I,20210412.0,20210929.0,20211001,20211001,EXP,,JP-OTSUKA-2021_033959,OTSUKA,,73.0,YR,,F,Y,99.4,KG,20211001.0,,PH,JP,JP,2021,Q4,Elderly
199073391,19907339,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,Injection,,2021,Q4,Condition aggravated,,2021,Q4,1,I,20210412.0,20210929.0,20211001,20211001,EXP,,JP-OTSUKA-2021_033959,OTSUKA,,73.0,YR,,F,Y,99.4,KG,20211001.0,,PH,JP,JP,2021,Q4,Elderly
199073391,19907339,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,Injection,,2021,Q4,Respiratory symptom,,2021,Q4,1,I,20210412.0,20210929.0,20211001,20211001,EXP,,JP-OTSUKA-2021_033959,OTSUKA,,73.0,YR,,F,Y,99.4,KG,20211001.0,,PH,JP,JP,2021,Q4,Elderly
199087261,19908726,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,QD,2021,Q4,Epistaxis,,2021,Q4,1,I,20190210.0,20200801.0,20211001,20211001,PER,,"US-AMARIN PHARMA, INC.-2020AMR000511",AMARIN,,71.0,YR,A,M,Y,104.42,KG,20210930.0,,CN,US,US,2021,Q4,Elderly
199118081,19911808,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"1 dose per 1 D, 18 units",,,,,UNK,,,,,,,2021,Q4,Inappropriate schedule of product administration,,2021,Q4,1,I,,20210921.0,20211004,20211004,EXP,,US-AVET LIFESCIENCES LTD-2021-AVET-000027,EMCURE,"Rupp J, Gillespie A.. A Case of Diabetic Hemichorea Hemiballismus Exacerbated by Hypoglycemia. AACE Clinical Case Reports. 2021;7(5):327-329",62.0,YR,,F,Y,,,20211004.0,,MD,US,US,2021,Q4,Adult
199118081,19911808,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"1 dose per 1 D, 18 units",,,,,UNK,,,,,,,2021,Q4,Pollakiuria,,2021,Q4,1,I,,20210921.0,20211004,20211004,EXP,,US-AVET LIFESCIENCES LTD-2021-AVET-000027,EMCURE,"Rupp J, Gillespie A.. A Case of Diabetic Hemichorea Hemiballismus Exacerbated by Hypoglycemia. AACE Clinical Case Reports. 2021;7(5):327-329",62.0,YR,,F,Y,,,20211004.0,,MD,US,US,2021,Q4,Adult
199118081,19911808,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"1 dose per 1 D, 18 units",,,,,UNK,,,,,,,2021,Q4,Weight decreased,,2021,Q4,1,I,,20210921.0,20211004,20211004,EXP,,US-AVET LIFESCIENCES LTD-2021-AVET-000027,EMCURE,"Rupp J, Gillespie A.. A Case of Diabetic Hemichorea Hemiballismus Exacerbated by Hypoglycemia. AACE Clinical Case Reports. 2021;7(5):327-329",62.0,YR,,F,Y,,,20211004.0,,MD,US,US,2021,Q4,Adult
199118081,19911808,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"1 dose per 1 D, 14 units",,,,,UNK,,,,,,,2021,Q4,Inappropriate schedule of product administration,,2021,Q4,1,I,,20210921.0,20211004,20211004,EXP,,US-AVET LIFESCIENCES LTD-2021-AVET-000027,EMCURE,"Rupp J, Gillespie A.. A Case of Diabetic Hemichorea Hemiballismus Exacerbated by Hypoglycemia. AACE Clinical Case Reports. 2021;7(5):327-329",62.0,YR,,F,Y,,,20211004.0,,MD,US,US,2021,Q4,Adult
199118081,19911808,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"1 dose per 1 D, 14 units",,,,,UNK,,,,,,,2021,Q4,Pollakiuria,,2021,Q4,1,I,,20210921.0,20211004,20211004,EXP,,US-AVET LIFESCIENCES LTD-2021-AVET-000027,EMCURE,"Rupp J, Gillespie A.. A Case of Diabetic Hemichorea Hemiballismus Exacerbated by Hypoglycemia. AACE Clinical Case Reports. 2021;7(5):327-329",62.0,YR,,F,Y,,,20211004.0,,MD,US,US,2021,Q4,Adult
199118081,19911808,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"1 dose per 1 D, 14 units",,,,,UNK,,,,,,,2021,Q4,Weight decreased,,2021,Q4,1,I,,20210921.0,20211004,20211004,EXP,,US-AVET LIFESCIENCES LTD-2021-AVET-000027,EMCURE,"Rupp J, Gillespie A.. A Case of Diabetic Hemichorea Hemiballismus Exacerbated by Hypoglycemia. AACE Clinical Case Reports. 2021;7(5):327-329",62.0,YR,,F,Y,,,20211004.0,,MD,US,US,2021,Q4,Adult
199118081,19911808,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"1 dose per 1 D, 22 units",,,,,UNK,,,,,,,2021,Q4,Inappropriate schedule of product administration,,2021,Q4,1,I,,20210921.0,20211004,20211004,EXP,,US-AVET LIFESCIENCES LTD-2021-AVET-000027,EMCURE,"Rupp J, Gillespie A.. A Case of Diabetic Hemichorea Hemiballismus Exacerbated by Hypoglycemia. AACE Clinical Case Reports. 2021;7(5):327-329",62.0,YR,,F,Y,,,20211004.0,,MD,US,US,2021,Q4,Adult
199118081,19911808,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"1 dose per 1 D, 22 units",,,,,UNK,,,,,,,2021,Q4,Pollakiuria,,2021,Q4,1,I,,20210921.0,20211004,20211004,EXP,,US-AVET LIFESCIENCES LTD-2021-AVET-000027,EMCURE,"Rupp J, Gillespie A.. A Case of Diabetic Hemichorea Hemiballismus Exacerbated by Hypoglycemia. AACE Clinical Case Reports. 2021;7(5):327-329",62.0,YR,,F,Y,,,20211004.0,,MD,US,US,2021,Q4,Adult
199118081,19911808,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"1 dose per 1 D, 22 units",,,,,UNK,,,,,,,2021,Q4,Weight decreased,,2021,Q4,1,I,,20210921.0,20211004,20211004,EXP,,US-AVET LIFESCIENCES LTD-2021-AVET-000027,EMCURE,"Rupp J, Gillespie A.. A Case of Diabetic Hemichorea Hemiballismus Exacerbated by Hypoglycemia. AACE Clinical Case Reports. 2021;7(5):327-329",62.0,YR,,F,Y,,,20211004.0,,MD,US,US,2021,Q4,Adult
199120841,19912084,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q4,Nasal discomfort,,2021,Q4,1,I,,20210201.0,20211004,20211004,EXP,,FR-AKCEA THERAPEUTICS-2021IS001085,AKCEA THERAPEUTICS,,66.0,YR,,M,Y,,,20211004.0,,CN,FR,FR,2021,Q4,Elderly
199120841,19912084,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q4,Skin disorder,,2021,Q4,1,I,,20210201.0,20211004,20211004,EXP,,FR-AKCEA THERAPEUTICS-2021IS001085,AKCEA THERAPEUTICS,,66.0,YR,,M,Y,,,20211004.0,,CN,FR,FR,2021,Q4,Elderly
199120841,19912084,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q4,Rash,,2021,Q4,1,I,,20210201.0,20211004,20211004,EXP,,FR-AKCEA THERAPEUTICS-2021IS001085,AKCEA THERAPEUTICS,,66.0,YR,,M,Y,,,20211004.0,,CN,FR,FR,2021,Q4,Elderly
199120841,19912084,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q4,Peripheral swelling,,2021,Q4,1,I,,20210201.0,20211004,20211004,EXP,,FR-AKCEA THERAPEUTICS-2021IS001085,AKCEA THERAPEUTICS,,66.0,YR,,M,Y,,,20211004.0,,CN,FR,FR,2021,Q4,Elderly
199120841,19912084,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q4,Pruritus,,2021,Q4,1,I,,20210201.0,20211004,20211004,EXP,,FR-AKCEA THERAPEUTICS-2021IS001085,AKCEA THERAPEUTICS,,66.0,YR,,M,Y,,,20211004.0,,CN,FR,FR,2021,Q4,Elderly
199120841,19912084,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q4,Epistaxis,,2021,Q4,1,I,,20210201.0,20211004,20211004,EXP,,FR-AKCEA THERAPEUTICS-2021IS001085,AKCEA THERAPEUTICS,,66.0,YR,,M,Y,,,20211004.0,,CN,FR,FR,2021,Q4,Elderly
199120841,19912084,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q4,Renal failure,,2021,Q4,1,I,,20210201.0,20211004,20211004,EXP,,FR-AKCEA THERAPEUTICS-2021IS001085,AKCEA THERAPEUTICS,,66.0,YR,,M,Y,,,20211004.0,,CN,FR,FR,2021,Q4,Elderly
199120841,19912084,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q4,Cardiac failure,,2021,Q4,1,I,,20210201.0,20211004,20211004,EXP,,FR-AKCEA THERAPEUTICS-2021IS001085,AKCEA THERAPEUTICS,,66.0,YR,,M,Y,,,20211004.0,,CN,FR,FR,2021,Q4,Elderly
199120841,19912084,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q4,Cardiac failure acute,,2021,Q4,1,I,,20210201.0,20211004,20211004,EXP,,FR-AKCEA THERAPEUTICS-2021IS001085,AKCEA THERAPEUTICS,,66.0,YR,,M,Y,,,20211004.0,,CN,FR,FR,2021,Q4,Elderly
199120841,19912084,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q4,Pulmonary oedema,,2021,Q4,1,I,,20210201.0,20211004,20211004,EXP,,FR-AKCEA THERAPEUTICS-2021IS001085,AKCEA THERAPEUTICS,,66.0,YR,,M,Y,,,20211004.0,,CN,FR,FR,2021,Q4,Elderly
199120841,19912084,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q4,Glomerular filtration rate decreased,,2021,Q4,1,I,,20210201.0,20211004,20211004,EXP,,FR-AKCEA THERAPEUTICS-2021IS001085,AKCEA THERAPEUTICS,,66.0,YR,,M,Y,,,20211004.0,,CN,FR,FR,2021,Q4,Elderly
199120841,19912084,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q4,Cardiorenal syndrome,,2021,Q4,1,I,,20210201.0,20211004,20211004,EXP,,FR-AKCEA THERAPEUTICS-2021IS001085,AKCEA THERAPEUTICS,,66.0,YR,,M,Y,,,20211004.0,,CN,FR,FR,2021,Q4,Elderly
199142793,19914279,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,Unknown,,,38.0,IU,Injection,,2021,Q4,Renal impairment,,2021,Q4,3,F,,20211020.0,20211005,20211028,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-129981",BOEHRINGER INGELHEIM,,56.0,YR,A,M,Y,119.2,KG,20211028.0,,MD,JP,JP,2021,Q4,Adult
199142793,19914279,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,Unknown,,,38.0,IU,Injection,,2021,Q4,Dehydration,,2021,Q4,3,F,,20211020.0,20211005,20211028,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-129981",BOEHRINGER INGELHEIM,,56.0,YR,A,M,Y,119.2,KG,20211028.0,,MD,JP,JP,2021,Q4,Adult
199142793,19914279,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,Unknown,,,38.0,IU,Injection,,2021,Q4,Toxicity to various agents,,2021,Q4,3,F,,20211020.0,20211005,20211028,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-129981",BOEHRINGER INGELHEIM,,56.0,YR,A,M,Y,119.2,KG,20211028.0,,MD,JP,JP,2021,Q4,Adult
199155172,19915517,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Hypotension,,2021,Q4,2,F,20200201.0,20211012.0,20211004,20211022,EXP,,HR-PFIZER INC-202101262062,PFIZER,,80.0,YR,,M,Y,82.0,KG,20211022.0,,MD,HR,HR,2021,Q4,Elderly
199155172,19915517,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,N-terminal prohormone brain natriuretic peptide increased,,2021,Q4,2,F,20200201.0,20211012.0,20211004,20211022,EXP,,HR-PFIZER INC-202101262062,PFIZER,,80.0,YR,,M,Y,82.0,KG,20211022.0,,MD,HR,HR,2021,Q4,Elderly
199155172,19915517,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Renal impairment,,2021,Q4,2,F,20200201.0,20211012.0,20211004,20211022,EXP,,HR-PFIZER INC-202101262062,PFIZER,,80.0,YR,,M,Y,82.0,KG,20211022.0,,MD,HR,HR,2021,Q4,Elderly
199155172,19915517,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Hyperkalaemia,,2021,Q4,2,F,20200201.0,20211012.0,20211004,20211022,EXP,,HR-PFIZER INC-202101262062,PFIZER,,80.0,YR,,M,Y,82.0,KG,20211022.0,,MD,HR,HR,2021,Q4,Elderly
199155172,19915517,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Gait disturbance,,2021,Q4,2,F,20200201.0,20211012.0,20211004,20211022,EXP,,HR-PFIZER INC-202101262062,PFIZER,,80.0,YR,,M,Y,82.0,KG,20211022.0,,MD,HR,HR,2021,Q4,Elderly
199155172,19915517,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,2,F,20200201.0,20211012.0,20211004,20211022,EXP,,HR-PFIZER INC-202101262062,PFIZER,,80.0,YR,,M,Y,82.0,KG,20211022.0,,MD,HR,HR,2021,Q4,Elderly
199155172,19915517,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Vertigo,,2021,Q4,2,F,20200201.0,20211012.0,20211004,20211022,EXP,,HR-PFIZER INC-202101262062,PFIZER,,80.0,YR,,M,Y,82.0,KG,20211022.0,,MD,HR,HR,2021,Q4,Elderly
199155172,19915517,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Dizziness,,2021,Q4,2,F,20200201.0,20211012.0,20211004,20211022,EXP,,HR-PFIZER INC-202101262062,PFIZER,,80.0,YR,,M,Y,82.0,KG,20211022.0,,MD,HR,HR,2021,Q4,Elderly
199157952,19915795,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Bacillus infection,,2021,Q4,2,F,20201010.0,20211015.0,20211004,20211020,EXP,,US-PFIZER INC-202101296187,PFIZER,,57.0,YR,,M,Y,140.0,KG,20211020.0,,MD,US,US,2021,Q4,Adult
199157952,19915795,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Bacterial infection,,2021,Q4,2,F,20201010.0,20211015.0,20211004,20211020,EXP,,US-PFIZER INC-202101296187,PFIZER,,57.0,YR,,M,Y,140.0,KG,20211020.0,,MD,US,US,2021,Q4,Adult
199157952,19915795,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Pneumonia aspiration,,2021,Q4,2,F,20201010.0,20211015.0,20211004,20211020,EXP,,US-PFIZER INC-202101296187,PFIZER,,57.0,YR,,M,Y,140.0,KG,20211020.0,,MD,US,US,2021,Q4,Adult
199157952,19915795,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Superficial vein thrombosis,,2021,Q4,2,F,20201010.0,20211015.0,20211004,20211020,EXP,,US-PFIZER INC-202101296187,PFIZER,,57.0,YR,,M,Y,140.0,KG,20211020.0,,MD,US,US,2021,Q4,Adult
199157952,19915795,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Septic shock,,2021,Q4,2,F,20201010.0,20211015.0,20211004,20211020,EXP,,US-PFIZER INC-202101296187,PFIZER,,57.0,YR,,M,Y,140.0,KG,20211020.0,,MD,US,US,2021,Q4,Adult
199160543,19916054,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"12 international unit, Daily",,,,,,,,12.0,IU,,,2021,Q4,Off label use,,2021,Q4,3,F,20190201.0,20211206.0,20211005,20211217,EXP,,PT-AUROBINDO-AUR-APL-2021-036046,AUROBINDO,"Barbosa M, Fernandes V.. Hiperglicemia Induzida Por Clozapina: Quando E Como. Portuguese Journal of Diabetes. 2021;16(1):69-73",45.0,YR,,F,Y,,,20211217.0,,MD,PT,PT,2021,Q4,Adult
199160543,19916054,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"12 international unit, Daily",,,,,,,,12.0,IU,,,2021,Q4,Hyperglycaemia,,2021,Q4,3,F,20190201.0,20211206.0,20211005,20211217,EXP,,PT-AUROBINDO-AUR-APL-2021-036046,AUROBINDO,"Barbosa M, Fernandes V.. Hiperglicemia Induzida Por Clozapina: Quando E Como. Portuguese Journal of Diabetes. 2021;16(1):69-73",45.0,YR,,F,Y,,,20211217.0,,MD,PT,PT,2021,Q4,Adult
199165791,19916579,2,C,insulin glargine 55 units daily,,2,,,,,,,,,,,,,,2021,Q4,Condition aggravated,,2021,Q4,1,I,20210929.0,,20211004,20211004,DIR,585049,,FDA-CTU,,52.0,YR,,F,N,85.05,KG,20211004.0,N,PH,US,US,2021,Q4,Adult
199165791,19916579,2,C,insulin glargine 55 units daily,,2,,,,,,,,,,,,,,2021,Q4,Motion sickness,,2021,Q4,1,I,20210929.0,,20211004,20211004,DIR,585049,,FDA-CTU,,52.0,YR,,F,N,85.05,KG,20211004.0,N,PH,US,US,2021,Q4,Adult
199165791,19916579,2,C,insulin glargine 55 units daily,,2,,,,,,,,,,,,,,2021,Q4,Dizziness,,2021,Q4,1,I,20210929.0,,20211004,20211004,DIR,585049,,FDA-CTU,,52.0,YR,,F,N,85.05,KG,20211004.0,N,PH,US,US,2021,Q4,Adult
199165791,19916579,2,C,insulin glargine 55 units daily,,2,,,,,,,,,,,,,,2021,Q4,Nausea,,2021,Q4,1,I,20210929.0,,20211004,20211004,DIR,585049,,FDA-CTU,,52.0,YR,,F,N,85.05,KG,20211004.0,N,PH,US,US,2021,Q4,Adult
199178851,19917885,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Myoglobin blood increased,,2021,Q4,1,I,,20090406.0,20211005,20211005,EXP,,US-AUROBINDO-09-AUR-09793,AUROBINDO,Rifkin SI. Multiple drug interactions in a renal transplant patient leading to simvastatin-induced rhabdomyolysis: a case report. Medscape Journal of Medicine. 2008;10(11):264,56.0,YR,,M,Y,,,20211005.0,,MD,US,US,2021,Q4,Adult
199178851,19917885,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Rhabdomyolysis,,2021,Q4,1,I,,20090406.0,20211005,20211005,EXP,,US-AUROBINDO-09-AUR-09793,AUROBINDO,Rifkin SI. Multiple drug interactions in a renal transplant patient leading to simvastatin-induced rhabdomyolysis: a case report. Medscape Journal of Medicine. 2008;10(11):264,56.0,YR,,M,Y,,,20211005.0,,MD,US,US,2021,Q4,Adult
199178851,19917885,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Blood creatine phosphokinase increased,,2021,Q4,1,I,,20090406.0,20211005,20211005,EXP,,US-AUROBINDO-09-AUR-09793,AUROBINDO,Rifkin SI. Multiple drug interactions in a renal transplant patient leading to simvastatin-induced rhabdomyolysis: a case report. Medscape Journal of Medicine. 2008;10(11):264,56.0,YR,,M,Y,,,20211005.0,,MD,US,US,2021,Q4,Adult
199178851,19917885,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Aspartate aminotransferase increased,,2021,Q4,1,I,,20090406.0,20211005,20211005,EXP,,US-AUROBINDO-09-AUR-09793,AUROBINDO,Rifkin SI. Multiple drug interactions in a renal transplant patient leading to simvastatin-induced rhabdomyolysis: a case report. Medscape Journal of Medicine. 2008;10(11):264,56.0,YR,,M,Y,,,20211005.0,,MD,US,US,2021,Q4,Adult
199178851,19917885,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Blood creatinine increased,,2021,Q4,1,I,,20090406.0,20211005,20211005,EXP,,US-AUROBINDO-09-AUR-09793,AUROBINDO,Rifkin SI. Multiple drug interactions in a renal transplant patient leading to simvastatin-induced rhabdomyolysis: a case report. Medscape Journal of Medicine. 2008;10(11):264,56.0,YR,,M,Y,,,20211005.0,,MD,US,US,2021,Q4,Adult
199178851,19917885,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Myalgia,,2021,Q4,1,I,,20090406.0,20211005,20211005,EXP,,US-AUROBINDO-09-AUR-09793,AUROBINDO,Rifkin SI. Multiple drug interactions in a renal transplant patient leading to simvastatin-induced rhabdomyolysis: a case report. Medscape Journal of Medicine. 2008;10(11):264,56.0,YR,,M,Y,,,20211005.0,,MD,US,US,2021,Q4,Adult
199178851,19917885,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Asthenia,,2021,Q4,1,I,,20090406.0,20211005,20211005,EXP,,US-AUROBINDO-09-AUR-09793,AUROBINDO,Rifkin SI. Multiple drug interactions in a renal transplant patient leading to simvastatin-induced rhabdomyolysis: a case report. Medscape Journal of Medicine. 2008;10(11):264,56.0,YR,,M,Y,,,20211005.0,,MD,US,US,2021,Q4,Adult
199178851,19917885,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Drug interaction,,2021,Q4,1,I,,20090406.0,20211005,20211005,EXP,,US-AUROBINDO-09-AUR-09793,AUROBINDO,Rifkin SI. Multiple drug interactions in a renal transplant patient leading to simvastatin-induced rhabdomyolysis: a case report. Medscape Journal of Medicine. 2008;10(11):264,56.0,YR,,M,Y,,,20211005.0,,MD,US,US,2021,Q4,Adult
199187771,19918777,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 international unit, daily",,,,,,,,12.0,IU,,QD,2021,Q4,Retinal haemorrhage,,2021,Q4,1,I,20060101.0,20210923.0,20211004,20211004,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202109009852,ELI LILLY AND CO,,69.0,YR,,F,Y,59.0,KG,20211004.0,,CN,CN,CN,2021,Q4,Elderly
199187771,19918777,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 international unit, daily",,,,,,,,12.0,IU,,QD,2021,Q4,Eye haemangioma,,2021,Q4,1,I,20060101.0,20210923.0,20211004,20211004,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202109009852,ELI LILLY AND CO,,69.0,YR,,F,Y,59.0,KG,20211004.0,,CN,CN,CN,2021,Q4,Elderly
199187771,19918777,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 international unit, daily",,,,,,,,12.0,IU,,QD,2021,Q4,Blood glucose abnormal,,2021,Q4,1,I,20060101.0,20210923.0,20211004,20211004,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202109009852,ELI LILLY AND CO,,69.0,YR,,F,Y,59.0,KG,20211004.0,,CN,CN,CN,2021,Q4,Elderly
199187771,19918777,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 international unit, daily",,,,,,,,12.0,IU,,QD,2021,Q4,Cataract,,2021,Q4,1,I,20060101.0,20210923.0,20211004,20211004,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202109009852,ELI LILLY AND CO,,69.0,YR,,F,Y,59.0,KG,20211004.0,,CN,CN,CN,2021,Q4,Elderly
199192161,19919216,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,IU,,QD,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,,20210927.0,20211004,20211004,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-129241",BOEHRINGER INGELHEIM,"Franck A, Hendrickson A, Ye X, Kalra S, Urbine D. Euglycemic Diabetic Ketoacidosis in a Patient Prescribed Empagliflozin and a Ketogenic Diet: A Case of Misdiagnosed Type I Diabetes. Clinical Diabetes. 2021; 39 (1): 121-123.",70.0,YR,E,F,Y,,,20211005.0,,HP,US,US,2021,Q4,Elderly
199192161,19919216,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,IU,,QD,2021,Q4,Off label use,,2021,Q4,1,I,,20210927.0,20211004,20211004,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-129241",BOEHRINGER INGELHEIM,"Franck A, Hendrickson A, Ye X, Kalra S, Urbine D. Euglycemic Diabetic Ketoacidosis in a Patient Prescribed Empagliflozin and a Ketogenic Diet: A Case of Misdiagnosed Type I Diabetes. Clinical Diabetes. 2021; 39 (1): 121-123.",70.0,YR,E,F,Y,,,20211005.0,,HP,US,US,2021,Q4,Elderly
199195423,19919542,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),15 international unit,,,,,,,,15.0,IU,,,2021,Q4,Hospitalisation,,2021,Q4,3,F,20210828.0,20211201.0,20211005,20211215,EXP,,IT-TAKEDA-2021TUS055967,TAKEDA,,75.0,YR,,M,Y,,,20211215.0,,HP,IT,IT,2021,Q4,Elderly
199195423,19919542,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),15 international unit,,,,,,,,15.0,IU,,,2021,Q4,Thalamic infarction,,2021,Q4,3,F,20210828.0,20211201.0,20211005,20211215,EXP,,IT-TAKEDA-2021TUS055967,TAKEDA,,75.0,YR,,M,Y,,,20211215.0,,HP,IT,IT,2021,Q4,Elderly
199195423,19919542,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,20 international unit,,,,,,,,20.0,IU,,,2021,Q4,Hospitalisation,,2021,Q4,3,F,20210828.0,20211201.0,20211005,20211215,EXP,,IT-TAKEDA-2021TUS055967,TAKEDA,,75.0,YR,,M,Y,,,20211215.0,,HP,IT,IT,2021,Q4,Elderly
199195423,19919542,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,20 international unit,,,,,,,,20.0,IU,,,2021,Q4,Thalamic infarction,,2021,Q4,3,F,20210828.0,20211201.0,20211005,20211215,EXP,,IT-TAKEDA-2021TUS055967,TAKEDA,,75.0,YR,,M,Y,,,20211215.0,,HP,IT,IT,2021,Q4,Elderly
199201072,19920107,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Drug-induced liver injury,,2021,Q4,2,F,20210611.0,20211013.0,20211005,20211019,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202109008647AA,ELI LILLY AND CO,,74.0,YR,,M,Y,59.0,KG,20211019.0,,CN,JP,JP,2021,Q4,Elderly
199201072,19920107,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Interstitial lung disease,,2021,Q4,2,F,20210611.0,20211013.0,20211005,20211019,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202109008647AA,ELI LILLY AND CO,,74.0,YR,,M,Y,59.0,KG,20211019.0,,CN,JP,JP,2021,Q4,Elderly
199201072,19920107,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Drug eruption,,2021,Q4,2,F,20210611.0,20211013.0,20211005,20211019,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202109008647AA,ELI LILLY AND CO,,74.0,YR,,M,Y,59.0,KG,20211019.0,,CN,JP,JP,2021,Q4,Elderly
199202852,19920285,31,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Cytokine release syndrome,,2021,Q4,2,F,20210511.0,20211105.0,20211005,20211112,EXP,,FR-MYLANLABS-2021M1068433,MYLAN,,55.0,YR,,M,Y,93.0,KG,20211112.0,,HP,FR,FR,2021,Q4,Adult
199202852,19920285,31,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Off label use,,2021,Q4,2,F,20210511.0,20211105.0,20211005,20211112,EXP,,FR-MYLANLABS-2021M1068433,MYLAN,,55.0,YR,,M,Y,93.0,KG,20211112.0,,HP,FR,FR,2021,Q4,Adult
199202852,19920285,31,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Sepsis,,2021,Q4,2,F,20210511.0,20211105.0,20211005,20211112,EXP,,FR-MYLANLABS-2021M1068433,MYLAN,,55.0,YR,,M,Y,93.0,KG,20211112.0,,HP,FR,FR,2021,Q4,Adult
199206141,19920614,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU, qd , in the evening",,,,,Unknown,,,28.0,IU,,QD,2021,Q4,Pancreatitis acute,,2021,Q4,1,I,20200906.0,20210921.0,20211005,20211005,EXP,,LV-NOVOPROD-853114,NOVO NORDISK,"Staka A., Senterjakova N,. Poorly controlles Type 1 Diabetes resulting in Liver injury. Doctus. 2021;9:246",22.0,YR,,F,Y,58.0,KG,20211005.0,,MD,LV,LV,2021,Q4,Youth
199206141,19920614,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU, qd , in the evening",,,,,Unknown,,,28.0,IU,,QD,2021,Q4,Non-alcoholic steatohepatitis,,2021,Q4,1,I,20200906.0,20210921.0,20211005,20211005,EXP,,LV-NOVOPROD-853114,NOVO NORDISK,"Staka A., Senterjakova N,. Poorly controlles Type 1 Diabetes resulting in Liver injury. Doctus. 2021;9:246",22.0,YR,,F,Y,58.0,KG,20211005.0,,MD,LV,LV,2021,Q4,Youth
199206141,19920614,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU, qd , in the evening",,,,,Unknown,,,28.0,IU,,QD,2021,Q4,Diabetic hepatopathy,,2021,Q4,1,I,20200906.0,20210921.0,20211005,20211005,EXP,,LV-NOVOPROD-853114,NOVO NORDISK,"Staka A., Senterjakova N,. Poorly controlles Type 1 Diabetes resulting in Liver injury. Doctus. 2021;9:246",22.0,YR,,F,Y,58.0,KG,20211005.0,,MD,LV,LV,2021,Q4,Youth
199211001,19921100,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 international unit, qd",,,Y,U,1f899a,,,22.0,IU,Solution for injection,QD,2021,Q4,Product storage error,,2021,Q4,1,I,20210101.0,20211001.0,20211005,20211005,EXP,,ES-MYLANLABS-2021M1068594,MYLAN,,84.0,YR,,M,Y,85.0,KG,20211005.0,,CN,ES,ES,2021,Q4,Elderly
199211001,19921100,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 international unit, qd",,,Y,U,1f899a,,,22.0,IU,Solution for injection,QD,2021,Q4,Vaccination site mass,,2021,Q4,1,I,20210101.0,20211001.0,20211005,20211005,EXP,,ES-MYLANLABS-2021M1068594,MYLAN,,84.0,YR,,M,Y,85.0,KG,20211005.0,,CN,ES,ES,2021,Q4,Elderly
199211001,19921100,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 international unit, qd",,,Y,U,1f899a,,,22.0,IU,Solution for injection,QD,2021,Q4,Multiple use of single-use product,,2021,Q4,1,I,20210101.0,20211001.0,20211005,20211005,EXP,,ES-MYLANLABS-2021M1068594,MYLAN,,84.0,YR,,M,Y,85.0,KG,20211005.0,,CN,ES,ES,2021,Q4,Elderly
199211001,19921100,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 international unit, qd",,,Y,U,1f899a,,,22.0,IU,Solution for injection,QD,2021,Q4,Diarrhoea,,2021,Q4,1,I,20210101.0,20211001.0,20211005,20211005,EXP,,ES-MYLANLABS-2021M1068594,MYLAN,,84.0,YR,,M,Y,85.0,KG,20211005.0,,CN,ES,ES,2021,Q4,Elderly
199211001,19921100,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 international unit, qd",,,Y,U,1f899a,,,22.0,IU,Solution for injection,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20210101.0,20211001.0,20211005,20211005,EXP,,ES-MYLANLABS-2021M1068594,MYLAN,,84.0,YR,,M,Y,85.0,KG,20211005.0,,CN,ES,ES,2021,Q4,Elderly
199211001,19921100,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 international unit, qd",,,Y,U,,,,18.0,IU,Solution for injection,QD,2021,Q4,Product storage error,,2021,Q4,1,I,20210101.0,20211001.0,20211005,20211005,EXP,,ES-MYLANLABS-2021M1068594,MYLAN,,84.0,YR,,M,Y,85.0,KG,20211005.0,,CN,ES,ES,2021,Q4,Elderly
199211001,19921100,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 international unit, qd",,,Y,U,,,,18.0,IU,Solution for injection,QD,2021,Q4,Vaccination site mass,,2021,Q4,1,I,20210101.0,20211001.0,20211005,20211005,EXP,,ES-MYLANLABS-2021M1068594,MYLAN,,84.0,YR,,M,Y,85.0,KG,20211005.0,,CN,ES,ES,2021,Q4,Elderly
199211001,19921100,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 international unit, qd",,,Y,U,,,,18.0,IU,Solution for injection,QD,2021,Q4,Multiple use of single-use product,,2021,Q4,1,I,20210101.0,20211001.0,20211005,20211005,EXP,,ES-MYLANLABS-2021M1068594,MYLAN,,84.0,YR,,M,Y,85.0,KG,20211005.0,,CN,ES,ES,2021,Q4,Elderly
199211001,19921100,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 international unit, qd",,,Y,U,,,,18.0,IU,Solution for injection,QD,2021,Q4,Diarrhoea,,2021,Q4,1,I,20210101.0,20211001.0,20211005,20211005,EXP,,ES-MYLANLABS-2021M1068594,MYLAN,,84.0,YR,,M,Y,85.0,KG,20211005.0,,CN,ES,ES,2021,Q4,Elderly
199211001,19921100,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 international unit, qd",,,Y,U,,,,18.0,IU,Solution for injection,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20210101.0,20211001.0,20211005,20211005,EXP,,ES-MYLANLABS-2021M1068594,MYLAN,,84.0,YR,,M,Y,85.0,KG,20211005.0,,CN,ES,ES,2021,Q4,Elderly
199211442,19921144,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 u, daily",,,U,,,,,18.0,IU,,QD,2021,Q4,Pancreatic carcinoma metastatic,,2021,Q4,2,F,,20211130.0,20211005,20211206,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202109012755,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20211206.0,,CN,JP,JP,2021,Q4,Elderly
199217561,19921756,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,8 units/day,,,U,,,,,,,,,2021,Q4,Reperfusion injury,,2021,Q4,1,I,,20210927.0,20211006,20211006,EXP,,JP-TEVA-2021-JP-1960964,TEVA,"Sugito E, Tsujimoto T, Arai N, Bouchi R, Ohsugi M, Tanabe A, et al. Left Hemiplegia Possibly Due to Glucose Reperfusion Injury after Recovery of Severe Hypoglycemia in a Woman with Type 2 Diabetes Mellitus. Intern-Med 2021;:.",79.0,YR,E,F,Y,,,20211006.0,,HP,JP,JP,2021,Q4,Elderly
199217561,19921756,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,8 units/day,,,U,,,,,,,,,2021,Q4,Hypoglycaemic encephalopathy,,2021,Q4,1,I,,20210927.0,20211006,20211006,EXP,,JP-TEVA-2021-JP-1960964,TEVA,"Sugito E, Tsujimoto T, Arai N, Bouchi R, Ohsugi M, Tanabe A, et al. Left Hemiplegia Possibly Due to Glucose Reperfusion Injury after Recovery of Severe Hypoglycemia in a Woman with Type 2 Diabetes Mellitus. Intern-Med 2021;:.",79.0,YR,E,F,Y,,,20211006.0,,HP,JP,JP,2021,Q4,Elderly
199217561,19921756,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,8 units/day,,,U,,,,,,,,,2021,Q4,Hemiplegia,,2021,Q4,1,I,,20210927.0,20211006,20211006,EXP,,JP-TEVA-2021-JP-1960964,TEVA,"Sugito E, Tsujimoto T, Arai N, Bouchi R, Ohsugi M, Tanabe A, et al. Left Hemiplegia Possibly Due to Glucose Reperfusion Injury after Recovery of Severe Hypoglycemia in a Woman with Type 2 Diabetes Mellitus. Intern-Med 2021;:.",79.0,YR,E,F,Y,,,20211006.0,,HP,JP,JP,2021,Q4,Elderly
199225231,19922523,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"38 IU, qd, Before breakfast",,,,,,,,38.0,IU,Injection,QD,2021,Q4,Toxicity to various agents,,2021,Q4,1,I,,20210928.0,20211005,20211005,EXP,,JP-DSJP-DSJ-2021-131729,DAIICHI,"Tsuji H, Mantani T, Yamamoto Y. A case of severe obesity patient with bipolar affective disorder complicated with acute lithium poisoning during hospitalization for low calorie diet therapy. Journal of Japan Society for the Study of Obesity. 2021;27(2):99-102",56.0,YR,,M,Y,119.0,KG,20211005.0,,MD,JP,JP,2021,Q4,Adult
199225231,19922523,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"38 IU, qd, Before breakfast",,,,,,,,38.0,IU,Injection,QD,2021,Q4,Renal impairment,,2021,Q4,1,I,,20210928.0,20211005,20211005,EXP,,JP-DSJP-DSJ-2021-131729,DAIICHI,"Tsuji H, Mantani T, Yamamoto Y. A case of severe obesity patient with bipolar affective disorder complicated with acute lithium poisoning during hospitalization for low calorie diet therapy. Journal of Japan Society for the Study of Obesity. 2021;27(2):99-102",56.0,YR,,M,Y,119.0,KG,20211005.0,,MD,JP,JP,2021,Q4,Adult
199225231,19922523,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"38 IU, qd, Before breakfast",,,,,,,,38.0,IU,Injection,QD,2021,Q4,Atrial flutter,,2021,Q4,1,I,,20210928.0,20211005,20211005,EXP,,JP-DSJP-DSJ-2021-131729,DAIICHI,"Tsuji H, Mantani T, Yamamoto Y. A case of severe obesity patient with bipolar affective disorder complicated with acute lithium poisoning during hospitalization for low calorie diet therapy. Journal of Japan Society for the Study of Obesity. 2021;27(2):99-102",56.0,YR,,M,Y,119.0,KG,20211005.0,,MD,JP,JP,2021,Q4,Adult
199225231,19922523,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"38 IU, qd, Before breakfast",,,,,,,,38.0,IU,Injection,QD,2021,Q4,Atrial fibrillation,,2021,Q4,1,I,,20210928.0,20211005,20211005,EXP,,JP-DSJP-DSJ-2021-131729,DAIICHI,"Tsuji H, Mantani T, Yamamoto Y. A case of severe obesity patient with bipolar affective disorder complicated with acute lithium poisoning during hospitalization for low calorie diet therapy. Journal of Japan Society for the Study of Obesity. 2021;27(2):99-102",56.0,YR,,M,Y,119.0,KG,20211005.0,,MD,JP,JP,2021,Q4,Adult
199225231,19922523,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"38 IU, qd, Before breakfast",,,,,,,,38.0,IU,Injection,QD,2021,Q4,Blood pressure decreased,,2021,Q4,1,I,,20210928.0,20211005,20211005,EXP,,JP-DSJP-DSJ-2021-131729,DAIICHI,"Tsuji H, Mantani T, Yamamoto Y. A case of severe obesity patient with bipolar affective disorder complicated with acute lithium poisoning during hospitalization for low calorie diet therapy. Journal of Japan Society for the Study of Obesity. 2021;27(2):99-102",56.0,YR,,M,Y,119.0,KG,20211005.0,,MD,JP,JP,2021,Q4,Adult
199225231,19922523,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"38 IU, qd, Before breakfast",,,,,,,,38.0,IU,Injection,QD,2021,Q4,Weight decreased,,2021,Q4,1,I,,20210928.0,20211005,20211005,EXP,,JP-DSJP-DSJ-2021-131729,DAIICHI,"Tsuji H, Mantani T, Yamamoto Y. A case of severe obesity patient with bipolar affective disorder complicated with acute lithium poisoning during hospitalization for low calorie diet therapy. Journal of Japan Society for the Study of Obesity. 2021;27(2):99-102",56.0,YR,,M,Y,119.0,KG,20211005.0,,MD,JP,JP,2021,Q4,Adult
199226511,19922651,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 international unit, daily",,,Y,,0F815A,,,22.0,IU,,QD,2021,Q4,Anxiety,,2021,Q4,1,I,20210911.0,20210923.0,20211005,20211005,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202109009471,ELI LILLY AND CO,,71.0,YR,,M,Y,65.0,KG,20211005.0,,CN,ES,ES,2021,Q4,Elderly
199226511,19922651,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 international unit, daily",,,Y,,0F815A,,,22.0,IU,,QD,2021,Q4,Gait inability,,2021,Q4,1,I,20210911.0,20210923.0,20211005,20211005,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202109009471,ELI LILLY AND CO,,71.0,YR,,M,Y,65.0,KG,20211005.0,,CN,ES,ES,2021,Q4,Elderly
199226511,19922651,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 international unit, daily",,,Y,,0F815A,,,22.0,IU,,QD,2021,Q4,Feeding disorder,,2021,Q4,1,I,20210911.0,20210923.0,20211005,20211005,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202109009471,ELI LILLY AND CO,,71.0,YR,,M,Y,65.0,KG,20211005.0,,CN,ES,ES,2021,Q4,Elderly
199226511,19922651,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 international unit, daily",,,Y,,0F815A,,,22.0,IU,,QD,2021,Q4,Weight increased,,2021,Q4,1,I,20210911.0,20210923.0,20211005,20211005,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202109009471,ELI LILLY AND CO,,71.0,YR,,M,Y,65.0,KG,20211005.0,,CN,ES,ES,2021,Q4,Elderly
199226511,19922651,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 international unit, daily",,,Y,,0F815A,,,22.0,IU,,QD,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,20210911.0,20210923.0,20211005,20211005,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202109009471,ELI LILLY AND CO,,71.0,YR,,M,Y,65.0,KG,20211005.0,,CN,ES,ES,2021,Q4,Elderly
199226511,19922651,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 international unit, daily",,,Y,,0F815A,,,22.0,IU,,QD,2021,Q4,Intentional dose omission,,2021,Q4,1,I,20210911.0,20210923.0,20211005,20211005,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202109009471,ELI LILLY AND CO,,71.0,YR,,M,Y,65.0,KG,20211005.0,,CN,ES,ES,2021,Q4,Elderly
199226511,19922651,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 international unit, daily",,,Y,,0F815A,,,22.0,IU,,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20210911.0,20210923.0,20211005,20211005,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202109009471,ELI LILLY AND CO,,71.0,YR,,M,Y,65.0,KG,20211005.0,,CN,ES,ES,2021,Q4,Elderly
199226511,19922651,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 international unit, daily",,,Y,,1F975A,,,20.0,IU,,QD,2021,Q4,Anxiety,,2021,Q4,1,I,20210911.0,20210923.0,20211005,20211005,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202109009471,ELI LILLY AND CO,,71.0,YR,,M,Y,65.0,KG,20211005.0,,CN,ES,ES,2021,Q4,Elderly
199226511,19922651,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 international unit, daily",,,Y,,1F975A,,,20.0,IU,,QD,2021,Q4,Gait inability,,2021,Q4,1,I,20210911.0,20210923.0,20211005,20211005,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202109009471,ELI LILLY AND CO,,71.0,YR,,M,Y,65.0,KG,20211005.0,,CN,ES,ES,2021,Q4,Elderly
199226511,19922651,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 international unit, daily",,,Y,,1F975A,,,20.0,IU,,QD,2021,Q4,Feeding disorder,,2021,Q4,1,I,20210911.0,20210923.0,20211005,20211005,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202109009471,ELI LILLY AND CO,,71.0,YR,,M,Y,65.0,KG,20211005.0,,CN,ES,ES,2021,Q4,Elderly
199226511,19922651,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 international unit, daily",,,Y,,1F975A,,,20.0,IU,,QD,2021,Q4,Weight increased,,2021,Q4,1,I,20210911.0,20210923.0,20211005,20211005,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202109009471,ELI LILLY AND CO,,71.0,YR,,M,Y,65.0,KG,20211005.0,,CN,ES,ES,2021,Q4,Elderly
199226511,19922651,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 international unit, daily",,,Y,,1F975A,,,20.0,IU,,QD,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,20210911.0,20210923.0,20211005,20211005,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202109009471,ELI LILLY AND CO,,71.0,YR,,M,Y,65.0,KG,20211005.0,,CN,ES,ES,2021,Q4,Elderly
199226511,19922651,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 international unit, daily",,,Y,,1F975A,,,20.0,IU,,QD,2021,Q4,Intentional dose omission,,2021,Q4,1,I,20210911.0,20210923.0,20211005,20211005,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202109009471,ELI LILLY AND CO,,71.0,YR,,M,Y,65.0,KG,20211005.0,,CN,ES,ES,2021,Q4,Elderly
199226511,19922651,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 international unit, daily",,,Y,,1F975A,,,20.0,IU,,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20210911.0,20210923.0,20211005,20211005,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202109009471,ELI LILLY AND CO,,71.0,YR,,M,Y,65.0,KG,20211005.0,,CN,ES,ES,2021,Q4,Elderly
199226531,19922653,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK, unknown",,,,,,,,,,,,2021,Q4,Cardiovascular disorder,,2021,Q4,1,I,20210922.0,20210923.0,20211005,20211005,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202109009658,ELI LILLY AND CO,,45.0,YR,,F,Y,,,20211005.0,,CN,CN,CN,2021,Q4,Adult
199226531,19922653,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK, unknown",,,,,,,,,,,,2021,Q4,Cerebrovascular disorder,,2021,Q4,1,I,20210922.0,20210923.0,20211005,20211005,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202109009658,ELI LILLY AND CO,,45.0,YR,,F,Y,,,20211005.0,,CN,CN,CN,2021,Q4,Adult
199226531,19922653,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK, unknown",,,,,,,,,,,,2021,Q4,Product dose omission issue,,2021,Q4,1,I,20210922.0,20210923.0,20211005,20211005,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202109009658,ELI LILLY AND CO,,45.0,YR,,F,Y,,,20211005.0,,CN,CN,CN,2021,Q4,Adult
199242941,19924294,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 iU, QD",,,Y,U,1f899a,,,22.0,IU,Solution for injection,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20210101.0,20210930.0,20211006,20211006,EXP,ES-SA-SAC20210526000327,ES-MYLANLABS-2021M1067042,MYLAN,,84.0,YR,,M,Y,85.0,KG,20211006.0,,CN,ES,ES,2021,Q4,Elderly
199242941,19924294,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 iU, QD",,,Y,U,1f899a,,,22.0,IU,Solution for injection,QD,2021,Q4,Product storage error,,2021,Q4,1,I,20210101.0,20210930.0,20211006,20211006,EXP,ES-SA-SAC20210526000327,ES-MYLANLABS-2021M1067042,MYLAN,,84.0,YR,,M,Y,85.0,KG,20211006.0,,CN,ES,ES,2021,Q4,Elderly
199242941,19924294,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 iU, QD",,,Y,U,1f899a,,,22.0,IU,Solution for injection,QD,2021,Q4,Multiple use of single-use product,,2021,Q4,1,I,20210101.0,20210930.0,20211006,20211006,EXP,ES-SA-SAC20210526000327,ES-MYLANLABS-2021M1067042,MYLAN,,84.0,YR,,M,Y,85.0,KG,20211006.0,,CN,ES,ES,2021,Q4,Elderly
199242941,19924294,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 iU, QD",,,Y,U,1f899a,,,22.0,IU,Solution for injection,QD,2021,Q4,Injection site mass,,2021,Q4,1,I,20210101.0,20210930.0,20211006,20211006,EXP,ES-SA-SAC20210526000327,ES-MYLANLABS-2021M1067042,MYLAN,,84.0,YR,,M,Y,85.0,KG,20211006.0,,CN,ES,ES,2021,Q4,Elderly
199242941,19924294,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 iU, QD",,,Y,U,1f899a,,,22.0,IU,Solution for injection,QD,2021,Q4,Diarrhoea,,2021,Q4,1,I,20210101.0,20210930.0,20211006,20211006,EXP,ES-SA-SAC20210526000327,ES-MYLANLABS-2021M1067042,MYLAN,,84.0,YR,,M,Y,85.0,KG,20211006.0,,CN,ES,ES,2021,Q4,Elderly
199242941,19924294,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 iU, QD",,,Y,U,,,,18.0,IU,Solution for injection,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20210101.0,20210930.0,20211006,20211006,EXP,ES-SA-SAC20210526000327,ES-MYLANLABS-2021M1067042,MYLAN,,84.0,YR,,M,Y,85.0,KG,20211006.0,,CN,ES,ES,2021,Q4,Elderly
199242941,19924294,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 iU, QD",,,Y,U,,,,18.0,IU,Solution for injection,QD,2021,Q4,Product storage error,,2021,Q4,1,I,20210101.0,20210930.0,20211006,20211006,EXP,ES-SA-SAC20210526000327,ES-MYLANLABS-2021M1067042,MYLAN,,84.0,YR,,M,Y,85.0,KG,20211006.0,,CN,ES,ES,2021,Q4,Elderly
199242941,19924294,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 iU, QD",,,Y,U,,,,18.0,IU,Solution for injection,QD,2021,Q4,Multiple use of single-use product,,2021,Q4,1,I,20210101.0,20210930.0,20211006,20211006,EXP,ES-SA-SAC20210526000327,ES-MYLANLABS-2021M1067042,MYLAN,,84.0,YR,,M,Y,85.0,KG,20211006.0,,CN,ES,ES,2021,Q4,Elderly
199242941,19924294,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 iU, QD",,,Y,U,,,,18.0,IU,Solution for injection,QD,2021,Q4,Injection site mass,,2021,Q4,1,I,20210101.0,20210930.0,20211006,20211006,EXP,ES-SA-SAC20210526000327,ES-MYLANLABS-2021M1067042,MYLAN,,84.0,YR,,M,Y,85.0,KG,20211006.0,,CN,ES,ES,2021,Q4,Elderly
199242941,19924294,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 iU, QD",,,Y,U,,,,18.0,IU,Solution for injection,QD,2021,Q4,Diarrhoea,,2021,Q4,1,I,20210101.0,20210930.0,20211006,20211006,EXP,ES-SA-SAC20210526000327,ES-MYLANLABS-2021M1067042,MYLAN,,84.0,YR,,M,Y,85.0,KG,20211006.0,,CN,ES,ES,2021,Q4,Elderly
199249121,19924912,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, daily",,,,,,,,,,,QD,2021,Q4,Drug intolerance,,2021,Q4,1,I,,20210923.0,20211006,20211006,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109009482,ELI LILLY AND CO,,64.0,YR,,M,Y,140.0,KG,20211006.0,,CN,CA,CA,2021,Q4,Adult
199249121,19924912,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, daily",,,,,,,,,,,QD,2021,Q4,Drug hypersensitivity,,2021,Q4,1,I,,20210923.0,20211006,20211006,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109009482,ELI LILLY AND CO,,64.0,YR,,M,Y,140.0,KG,20211006.0,,CN,CA,CA,2021,Q4,Adult
199249121,19924912,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, daily",,,,,,,,,,,QD,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,,20210923.0,20211006,20211006,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109009482,ELI LILLY AND CO,,64.0,YR,,M,Y,140.0,KG,20211006.0,,CN,CA,CA,2021,Q4,Adult
199249121,19924912,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, daily",,,,,,,,,,,QD,2021,Q4,Condition aggravated,,2021,Q4,1,I,,20210923.0,20211006,20211006,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109009482,ELI LILLY AND CO,,64.0,YR,,M,Y,140.0,KG,20211006.0,,CN,CA,CA,2021,Q4,Adult
199249121,19924912,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, daily",,,,,,,,,,,QD,2021,Q4,Hypertension,,2021,Q4,1,I,,20210923.0,20211006,20211006,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109009482,ELI LILLY AND CO,,64.0,YR,,M,Y,140.0,KG,20211006.0,,CN,CA,CA,2021,Q4,Adult
199249121,19924912,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, daily",,,,,,,,,,,QD,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,1,I,,20210923.0,20211006,20211006,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109009482,ELI LILLY AND CO,,64.0,YR,,M,Y,140.0,KG,20211006.0,,CN,CA,CA,2021,Q4,Adult
199249121,19924912,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, daily",,,,,,,,,,,QD,2021,Q4,Pain,,2021,Q4,1,I,,20210923.0,20211006,20211006,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109009482,ELI LILLY AND CO,,64.0,YR,,M,Y,140.0,KG,20211006.0,,CN,CA,CA,2021,Q4,Adult
199249121,19924912,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, daily",,,,,,,,,,,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20210923.0,20211006,20211006,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109009482,ELI LILLY AND CO,,64.0,YR,,M,Y,140.0,KG,20211006.0,,CN,CA,CA,2021,Q4,Adult
199249121,19924912,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, daily",,,,,,,,,,,QD,2021,Q4,Increased appetite,,2021,Q4,1,I,,20210923.0,20211006,20211006,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109009482,ELI LILLY AND CO,,64.0,YR,,M,Y,140.0,KG,20211006.0,,CN,CA,CA,2021,Q4,Adult
199249121,19924912,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, daily",,,,,,,,,,,QD,2021,Q4,Weight increased,,2021,Q4,1,I,,20210923.0,20211006,20211006,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109009482,ELI LILLY AND CO,,64.0,YR,,M,Y,140.0,KG,20211006.0,,CN,CA,CA,2021,Q4,Adult
199249121,19924912,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, daily",,,,,,,,,,,QD,2021,Q4,Infection,,2021,Q4,1,I,,20210923.0,20211006,20211006,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109009482,ELI LILLY AND CO,,64.0,YR,,M,Y,140.0,KG,20211006.0,,CN,CA,CA,2021,Q4,Adult
199249121,19924912,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, daily",,,,,,,,,,,QD,2021,Q4,Insulin-like growth factor increased,,2021,Q4,1,I,,20210923.0,20211006,20211006,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202109009482,ELI LILLY AND CO,,64.0,YR,,M,Y,140.0,KG,20211006.0,,CN,CA,CA,2021,Q4,Adult
199249194,19924919,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100, 1x/day",,,,,,,,,,Injection,QD,2021,Q4,Respiratory failure,,2021,Q4,4,F,20210926.0,20211102.0,20211006,20211110,EXP,,GB-PFIZER INC-202101293867,PFIZER,,72.0,YR,,M,Y,70.4,KG,20211110.0,,MD,GB,GB,2021,Q4,Elderly
199251342,19925134,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"8 UI, frequency unknown",,,,,,,,,,Unknown,,2021,Q4,Bladder perforation,,2021,Q4,2,F,20210909.0,20211006.0,20211006,20211013,EXP,,ES-EISAI MEDICAL RESEARCH-EC-2021-100560,EISAI,,78.0,YR,E,M,Y,,,20211013.0,,MD,ES,ES,2021,Q4,Elderly
199251342,19925134,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"8 UI, frequency unknown",,,,,,,,,,Unknown,,2021,Q4,Cardiac failure,,2021,Q4,2,F,20210909.0,20211006.0,20211006,20211013,EXP,,ES-EISAI MEDICAL RESEARCH-EC-2021-100560,EISAI,,78.0,YR,E,M,Y,,,20211013.0,,MD,ES,ES,2021,Q4,Elderly
199251342,19925134,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"8 UI, frequency unknown",,,,,,,,,,Unknown,,2021,Q4,Haematuria,,2021,Q4,2,F,20210909.0,20211006.0,20211006,20211013,EXP,,ES-EISAI MEDICAL RESEARCH-EC-2021-100560,EISAI,,78.0,YR,E,M,Y,,,20211013.0,,MD,ES,ES,2021,Q4,Elderly
199251342,19925134,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"8 UI, frequency unknown",,,,,,,,,,Unknown,,2021,Q4,Pneumonia,,2021,Q4,2,F,20210909.0,20211006.0,20211006,20211013,EXP,,ES-EISAI MEDICAL RESEARCH-EC-2021-100560,EISAI,,78.0,YR,E,M,Y,,,20211013.0,,MD,ES,ES,2021,Q4,Elderly
199273752,19927375,15,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,Solution,,2021,Q4,Sleep disorder due to a general medical condition,,2021,Q4,2,F,,20211227.0,20211006,20211231,EXP,,CA-BAUSCH-BL-2021-033092,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20211231.0,,CN,CA,CA,2021,Q4,Elderly
199273752,19927375,15,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,Solution,,2021,Q4,Condition aggravated,,2021,Q4,2,F,,20211227.0,20211006,20211231,EXP,,CA-BAUSCH-BL-2021-033092,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20211231.0,,CN,CA,CA,2021,Q4,Elderly
199273752,19927375,15,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,Solution,,2021,Q4,Respiratory symptom,,2021,Q4,2,F,,20211227.0,20211006,20211231,EXP,,CA-BAUSCH-BL-2021-033092,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20211231.0,,CN,CA,CA,2021,Q4,Elderly
199273752,19927375,15,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,Solution,,2021,Q4,Wheezing,,2021,Q4,2,F,,20211227.0,20211006,20211231,EXP,,CA-BAUSCH-BL-2021-033092,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20211231.0,,CN,CA,CA,2021,Q4,Elderly
199273752,19927375,15,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,Solution,,2021,Q4,Loss of personal independence in daily activities,,2021,Q4,2,F,,20211227.0,20211006,20211231,EXP,,CA-BAUSCH-BL-2021-033092,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20211231.0,,CN,CA,CA,2021,Q4,Elderly
199273752,19927375,15,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,Solution,,2021,Q4,Vasculitis,,2021,Q4,2,F,,20211227.0,20211006,20211231,EXP,,CA-BAUSCH-BL-2021-033092,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20211231.0,,CN,CA,CA,2021,Q4,Elderly
199273752,19927375,15,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,Solution,,2021,Q4,Pulmonary fibrosis,,2021,Q4,2,F,,20211227.0,20211006,20211231,EXP,,CA-BAUSCH-BL-2021-033092,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20211231.0,,CN,CA,CA,2021,Q4,Elderly
199273752,19927375,15,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,Solution,,2021,Q4,Dyspnoea,,2021,Q4,2,F,,20211227.0,20211006,20211231,EXP,,CA-BAUSCH-BL-2021-033092,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20211231.0,,CN,CA,CA,2021,Q4,Elderly
199273752,19927375,15,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,Solution,,2021,Q4,Pulmonary vasculitis,,2021,Q4,2,F,,20211227.0,20211006,20211231,EXP,,CA-BAUSCH-BL-2021-033092,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20211231.0,,CN,CA,CA,2021,Q4,Elderly
199273752,19927375,15,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,Solution,,2021,Q4,Asthma,,2021,Q4,2,F,,20211227.0,20211006,20211231,EXP,,CA-BAUSCH-BL-2021-033092,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20211231.0,,CN,CA,CA,2021,Q4,Elderly
199273752,19927375,15,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,Solution,,2021,Q4,Haemoptysis,,2021,Q4,2,F,,20211227.0,20211006,20211231,EXP,,CA-BAUSCH-BL-2021-033092,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20211231.0,,CN,CA,CA,2021,Q4,Elderly
199273752,19927375,15,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,Solution,,2021,Q4,Lung disorder,,2021,Q4,2,F,,20211227.0,20211006,20211231,EXP,,CA-BAUSCH-BL-2021-033092,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20211231.0,,CN,CA,CA,2021,Q4,Elderly
199273752,19927375,15,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,Solution,,2021,Q4,Therapeutic product effect incomplete,,2021,Q4,2,F,,20211227.0,20211006,20211231,EXP,,CA-BAUSCH-BL-2021-033092,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20211231.0,,CN,CA,CA,2021,Q4,Elderly
199273752,19927375,15,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,Solution,,2021,Q4,Neuritis,,2021,Q4,2,F,,20211227.0,20211006,20211231,EXP,,CA-BAUSCH-BL-2021-033092,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20211231.0,,CN,CA,CA,2021,Q4,Elderly
199273752,19927375,15,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,Solution,,2021,Q4,Pain in extremity,,2021,Q4,2,F,,20211227.0,20211006,20211231,EXP,,CA-BAUSCH-BL-2021-033092,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20211231.0,,CN,CA,CA,2021,Q4,Elderly
199273752,19927375,15,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,Solution,,2021,Q4,Neurological symptom,,2021,Q4,2,F,,20211227.0,20211006,20211231,EXP,,CA-BAUSCH-BL-2021-033092,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20211231.0,,CN,CA,CA,2021,Q4,Elderly
199273752,19927375,15,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,Solution,,2021,Q4,Obstructive airways disorder,,2021,Q4,2,F,,20211227.0,20211006,20211231,EXP,,CA-BAUSCH-BL-2021-033092,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20211231.0,,CN,CA,CA,2021,Q4,Elderly
199273752,19927375,15,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,Solution,,2021,Q4,Pulmonary alveolar haemorrhage,,2021,Q4,2,F,,20211227.0,20211006,20211231,EXP,,CA-BAUSCH-BL-2021-033092,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20211231.0,,CN,CA,CA,2021,Q4,Elderly
199287201,19928720,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,20200601.0,20210928.0,20211007,20211007,EXP,,CN-ASTRAZENECA-2021A754766,ASTRAZENECA,"Linna S, Chengxiang W. Euglycemic diabetic ketoacidosis induced by SGLT??2 inhibitors in a patient with type 2 diabetes mellitus. Chin J Gen Pract 2021;20(9):",24.0,YR,,M,Y,,,20211007.0,,MD,CN,CN,2021,Q4,Young Adult
199311392,19931139,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 international unit, qd",,,,,,,,18.0,IU,Injection,QD,2021,Q4,Diabetes mellitus,,2021,Q4,2,F,20181227.0,20211102.0,20211007,20211109,EXP,,JP-ABBVIE-21P-087-4110725-00,ABBVIE,,66.0,YR,,M,Y,51.0,KG,20211109.0,,MD,COUNTRY NOT SPECIFIED,JP,2021,Q4,Elderly
199313271,19931327,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"27 international unit, qd",,,U,,0F768A,,,27.0,IU,Injection,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,,20210901.0,20211007,20211007,EXP,,ES-MYLANLABS-2021M1058613,MYLAN,,70.0,YR,,F,Y,97.0,KG,20211007.0,,CN,ES,ES,2021,Q4,Elderly
199313271,19931327,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"27 international unit, qd",,,U,,0F768A,,,27.0,IU,Injection,QD,2021,Q4,Discomfort,,2021,Q4,1,I,,20210901.0,20211007,20211007,EXP,,ES-MYLANLABS-2021M1058613,MYLAN,,70.0,YR,,F,Y,97.0,KG,20211007.0,,CN,ES,ES,2021,Q4,Elderly
199313271,19931327,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"27 international unit, qd",,,U,,0F768A,,,27.0,IU,Injection,QD,2021,Q4,Transaminases increased,,2021,Q4,1,I,,20210901.0,20211007,20211007,EXP,,ES-MYLANLABS-2021M1058613,MYLAN,,70.0,YR,,F,Y,97.0,KG,20211007.0,,CN,ES,ES,2021,Q4,Elderly
199313271,19931327,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"27 international unit, qd",,,U,,0F768A,,,27.0,IU,Injection,QD,2021,Q4,Anxiety,,2021,Q4,1,I,,20210901.0,20211007,20211007,EXP,,ES-MYLANLABS-2021M1058613,MYLAN,,70.0,YR,,F,Y,97.0,KG,20211007.0,,CN,ES,ES,2021,Q4,Elderly
199313271,19931327,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"27 international unit, qd",,,U,,0F768A,,,27.0,IU,Injection,QD,2021,Q4,Peripheral swelling,,2021,Q4,1,I,,20210901.0,20211007,20211007,EXP,,ES-MYLANLABS-2021M1058613,MYLAN,,70.0,YR,,F,Y,97.0,KG,20211007.0,,CN,ES,ES,2021,Q4,Elderly
199313271,19931327,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"27 international unit, qd",,,U,,0F768A,,,27.0,IU,Injection,QD,2021,Q4,Hypotension,,2021,Q4,1,I,,20210901.0,20211007,20211007,EXP,,ES-MYLANLABS-2021M1058613,MYLAN,,70.0,YR,,F,Y,97.0,KG,20211007.0,,CN,ES,ES,2021,Q4,Elderly
199313271,19931327,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"27 international unit, qd",,,U,,0F768A,,,27.0,IU,Injection,QD,2021,Q4,Fatigue,,2021,Q4,1,I,,20210901.0,20211007,20211007,EXP,,ES-MYLANLABS-2021M1058613,MYLAN,,70.0,YR,,F,Y,97.0,KG,20211007.0,,CN,ES,ES,2021,Q4,Elderly
199313271,19931327,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"29 international unit, qd",,,U,,,,,29.0,IU,Injection,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,,20210901.0,20211007,20211007,EXP,,ES-MYLANLABS-2021M1058613,MYLAN,,70.0,YR,,F,Y,97.0,KG,20211007.0,,CN,ES,ES,2021,Q4,Elderly
199313271,19931327,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"29 international unit, qd",,,U,,,,,29.0,IU,Injection,QD,2021,Q4,Discomfort,,2021,Q4,1,I,,20210901.0,20211007,20211007,EXP,,ES-MYLANLABS-2021M1058613,MYLAN,,70.0,YR,,F,Y,97.0,KG,20211007.0,,CN,ES,ES,2021,Q4,Elderly
199313271,19931327,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"29 international unit, qd",,,U,,,,,29.0,IU,Injection,QD,2021,Q4,Transaminases increased,,2021,Q4,1,I,,20210901.0,20211007,20211007,EXP,,ES-MYLANLABS-2021M1058613,MYLAN,,70.0,YR,,F,Y,97.0,KG,20211007.0,,CN,ES,ES,2021,Q4,Elderly
199313271,19931327,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"29 international unit, qd",,,U,,,,,29.0,IU,Injection,QD,2021,Q4,Anxiety,,2021,Q4,1,I,,20210901.0,20211007,20211007,EXP,,ES-MYLANLABS-2021M1058613,MYLAN,,70.0,YR,,F,Y,97.0,KG,20211007.0,,CN,ES,ES,2021,Q4,Elderly
199313271,19931327,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"29 international unit, qd",,,U,,,,,29.0,IU,Injection,QD,2021,Q4,Peripheral swelling,,2021,Q4,1,I,,20210901.0,20211007,20211007,EXP,,ES-MYLANLABS-2021M1058613,MYLAN,,70.0,YR,,F,Y,97.0,KG,20211007.0,,CN,ES,ES,2021,Q4,Elderly
199313271,19931327,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"29 international unit, qd",,,U,,,,,29.0,IU,Injection,QD,2021,Q4,Hypotension,,2021,Q4,1,I,,20210901.0,20211007,20211007,EXP,,ES-MYLANLABS-2021M1058613,MYLAN,,70.0,YR,,F,Y,97.0,KG,20211007.0,,CN,ES,ES,2021,Q4,Elderly
199313271,19931327,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"29 international unit, qd",,,U,,,,,29.0,IU,Injection,QD,2021,Q4,Fatigue,,2021,Q4,1,I,,20210901.0,20211007,20211007,EXP,,ES-MYLANLABS-2021M1058613,MYLAN,,70.0,YR,,F,Y,97.0,KG,20211007.0,,CN,ES,ES,2021,Q4,Elderly
199335272,19933527,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 international unit, daily",,,U,,,,205692.0,12.0,IU,,QD,2021,Q4,Blood pressure decreased,,2021,Q4,2,F,,20211019.0,20211008,20211026,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202110000624,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20211026.0,,CN,JP,JP,2021,Q4,Adult
199335272,19933527,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 international unit, daily",,,U,,,,205692.0,12.0,IU,,QD,2021,Q4,Pyrexia,,2021,Q4,2,F,,20211019.0,20211008,20211026,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202110000624,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20211026.0,,CN,JP,JP,2021,Q4,Adult
199335272,19933527,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 international unit, daily",,,U,,,,205692.0,12.0,IU,,QD,2021,Q4,Cardiac failure congestive,,2021,Q4,2,F,,20211019.0,20211008,20211026,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202110000624,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20211026.0,,CN,JP,JP,2021,Q4,Adult
199335272,19933527,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 international unit, daily",,,U,,,,205692.0,12.0,IU,,QD,2021,Q4,Anaemia,,2021,Q4,2,F,,20211019.0,20211008,20211026,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202110000624,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20211026.0,,CN,JP,JP,2021,Q4,Adult
199335272,19933527,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 international unit, daily",,,U,,,,205692.0,12.0,IU,,QD,2021,Q4,Hypoglycaemia,,2021,Q4,2,F,,20211019.0,20211008,20211026,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202110000624,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20211026.0,,CN,JP,JP,2021,Q4,Adult
199341082,19934108,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Death,,2021,Q4,2,F,20211004.0,20211005.0,20211008,20211012,EXP,,DE-PFIZER INC-202101317941,PFIZER,,77.0,YR,,F,Y,72.0,KG,20211012.0,,HP,DE,DE,2021,Q4,Elderly
199346142,19934614,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Joint swelling,,2021,Q4,2,F,20210801.0,20211005.0,20211008,20211018,PER,,US-AMGEN-USASP2021153907,AMGEN,,50.0,YR,A,F,Y,,,20211018.0,,HP,US,US,2021,Q4,Adult
199346142,19934614,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Arthralgia,,2021,Q4,2,F,20210801.0,20211005.0,20211008,20211018,PER,,US-AMGEN-USASP2021153907,AMGEN,,50.0,YR,A,F,Y,,,20211018.0,,HP,US,US,2021,Q4,Adult
199346691,19934669,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,Unknown,,2021,Q4,Diarrhoea,,2021,Q4,1,I,20181022.0,20211006.0,20211008,20211008,EXP,,US-CELGENEUS-USA-20211001520,CELGENE,,66.0,YR,,M,Y,68.1,KG,20211008.0,,MD,US,US,2021,Q4,Elderly
199346691,19934669,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,Unknown,,2021,Q4,Hypotension,,2021,Q4,1,I,20181022.0,20211006.0,20211008,20211008,EXP,,US-CELGENEUS-USA-20211001520,CELGENE,,66.0,YR,,M,Y,68.1,KG,20211008.0,,MD,US,US,2021,Q4,Elderly
199382692,19938269,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,unk,,,,,unk,,,,,,,2021,Q4,Abdominal pain,,2021,Q4,2,F,20210811.0,20211102.0,20211011,20211111,EXP,,CO-NOVOPROD-853866,NOVO NORDISK,,52.0,YR,,F,Y,70.0,KG,20211111.0,,CN,CO,CO,2021,Q4,Adult
199382692,19938269,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,unk,,,,,unk,,,,,,,2021,Q4,Decreased appetite,,2021,Q4,2,F,20210811.0,20211102.0,20211011,20211111,EXP,,CO-NOVOPROD-853866,NOVO NORDISK,,52.0,YR,,F,Y,70.0,KG,20211111.0,,CN,CO,CO,2021,Q4,Adult
199382692,19938269,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,unk,,,,,unk,,,,,,,2021,Q4,Vomiting,,2021,Q4,2,F,20210811.0,20211102.0,20211011,20211111,EXP,,CO-NOVOPROD-853866,NOVO NORDISK,,52.0,YR,,F,Y,70.0,KG,20211111.0,,CN,CO,CO,2021,Q4,Adult
199382692,19938269,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,unk,,,,,unk,,,,,,,2021,Q4,Constipation,,2021,Q4,2,F,20210811.0,20211102.0,20211011,20211111,EXP,,CO-NOVOPROD-853866,NOVO NORDISK,,52.0,YR,,F,Y,70.0,KG,20211111.0,,CN,CO,CO,2021,Q4,Adult
199385391,19938539,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Fatigue,,2021,Q4,1,I,,20211004.0,20211011,20211011,PER,,US-AMGEN-USASP2021152922,AMGEN,Hahn M. Utilization of indirect calorimetry to assist in determining undiagnosed hypothyroidism in a patient on mechanical ventilation. Nutrition in Clinical Practice. 2021;36(4):833-838,52.0,YR,A,M,Y,,,20211011.0,,HP,US,US,2021,Q4,Adult
199385391,19938539,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Trismus,,2021,Q4,1,I,,20211004.0,20211011,20211011,PER,,US-AMGEN-USASP2021152922,AMGEN,Hahn M. Utilization of indirect calorimetry to assist in determining undiagnosed hypothyroidism in a patient on mechanical ventilation. Nutrition in Clinical Practice. 2021;36(4):833-838,52.0,YR,A,M,Y,,,20211011.0,,HP,US,US,2021,Q4,Adult
199385391,19938539,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Pain in jaw,,2021,Q4,1,I,,20211004.0,20211011,20211011,PER,,US-AMGEN-USASP2021152922,AMGEN,Hahn M. Utilization of indirect calorimetry to assist in determining undiagnosed hypothyroidism in a patient on mechanical ventilation. Nutrition in Clinical Practice. 2021;36(4):833-838,52.0,YR,A,M,Y,,,20211011.0,,HP,US,US,2021,Q4,Adult
199385391,19938539,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Swelling,,2021,Q4,1,I,,20211004.0,20211011,20211011,PER,,US-AMGEN-USASP2021152922,AMGEN,Hahn M. Utilization of indirect calorimetry to assist in determining undiagnosed hypothyroidism in a patient on mechanical ventilation. Nutrition in Clinical Practice. 2021;36(4):833-838,52.0,YR,A,M,Y,,,20211011.0,,HP,US,US,2021,Q4,Adult
199385391,19938539,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Adrenal insufficiency,,2021,Q4,1,I,,20211004.0,20211011,20211011,PER,,US-AMGEN-USASP2021152922,AMGEN,Hahn M. Utilization of indirect calorimetry to assist in determining undiagnosed hypothyroidism in a patient on mechanical ventilation. Nutrition in Clinical Practice. 2021;36(4):833-838,52.0,YR,A,M,Y,,,20211011.0,,HP,US,US,2021,Q4,Adult
199385391,19938539,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,,20211004.0,20211011,20211011,PER,,US-AMGEN-USASP2021152922,AMGEN,Hahn M. Utilization of indirect calorimetry to assist in determining undiagnosed hypothyroidism in a patient on mechanical ventilation. Nutrition in Clinical Practice. 2021;36(4):833-838,52.0,YR,A,M,Y,,,20211011.0,,HP,US,US,2021,Q4,Adult
199385391,19938539,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Infection,,2021,Q4,1,I,,20211004.0,20211011,20211011,PER,,US-AMGEN-USASP2021152922,AMGEN,Hahn M. Utilization of indirect calorimetry to assist in determining undiagnosed hypothyroidism in a patient on mechanical ventilation. Nutrition in Clinical Practice. 2021;36(4):833-838,52.0,YR,A,M,Y,,,20211011.0,,HP,US,US,2021,Q4,Adult
199385391,19938539,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Osteitis,,2021,Q4,1,I,,20211004.0,20211011,20211011,PER,,US-AMGEN-USASP2021152922,AMGEN,Hahn M. Utilization of indirect calorimetry to assist in determining undiagnosed hypothyroidism in a patient on mechanical ventilation. Nutrition in Clinical Practice. 2021;36(4):833-838,52.0,YR,A,M,Y,,,20211011.0,,HP,US,US,2021,Q4,Adult
199385391,19938539,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Hypophagia,,2021,Q4,1,I,,20211004.0,20211011,20211011,PER,,US-AMGEN-USASP2021152922,AMGEN,Hahn M. Utilization of indirect calorimetry to assist in determining undiagnosed hypothyroidism in a patient on mechanical ventilation. Nutrition in Clinical Practice. 2021;36(4):833-838,52.0,YR,A,M,Y,,,20211011.0,,HP,US,US,2021,Q4,Adult
199385391,19938539,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Tooth extraction,,2021,Q4,1,I,,20211004.0,20211011,20211011,PER,,US-AMGEN-USASP2021152922,AMGEN,Hahn M. Utilization of indirect calorimetry to assist in determining undiagnosed hypothyroidism in a patient on mechanical ventilation. Nutrition in Clinical Practice. 2021;36(4):833-838,52.0,YR,A,M,Y,,,20211011.0,,HP,US,US,2021,Q4,Adult
199385391,19938539,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Oral disorder,,2021,Q4,1,I,,20211004.0,20211011,20211011,PER,,US-AMGEN-USASP2021152922,AMGEN,Hahn M. Utilization of indirect calorimetry to assist in determining undiagnosed hypothyroidism in a patient on mechanical ventilation. Nutrition in Clinical Practice. 2021;36(4):833-838,52.0,YR,A,M,Y,,,20211011.0,,HP,US,US,2021,Q4,Adult
199385391,19938539,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Mastication disorder,,2021,Q4,1,I,,20211004.0,20211011,20211011,PER,,US-AMGEN-USASP2021152922,AMGEN,Hahn M. Utilization of indirect calorimetry to assist in determining undiagnosed hypothyroidism in a patient on mechanical ventilation. Nutrition in Clinical Practice. 2021;36(4):833-838,52.0,YR,A,M,Y,,,20211011.0,,HP,US,US,2021,Q4,Adult
199385391,19938539,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Face oedema,,2021,Q4,1,I,,20211004.0,20211011,20211011,PER,,US-AMGEN-USASP2021152922,AMGEN,Hahn M. Utilization of indirect calorimetry to assist in determining undiagnosed hypothyroidism in a patient on mechanical ventilation. Nutrition in Clinical Practice. 2021;36(4):833-838,52.0,YR,A,M,Y,,,20211011.0,,HP,US,US,2021,Q4,Adult
199385391,19938539,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Decubitus ulcer,,2021,Q4,1,I,,20211004.0,20211011,20211011,PER,,US-AMGEN-USASP2021152922,AMGEN,Hahn M. Utilization of indirect calorimetry to assist in determining undiagnosed hypothyroidism in a patient on mechanical ventilation. Nutrition in Clinical Practice. 2021;36(4):833-838,52.0,YR,A,M,Y,,,20211011.0,,HP,US,US,2021,Q4,Adult
199385391,19938539,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Muscle atrophy,,2021,Q4,1,I,,20211004.0,20211011,20211011,PER,,US-AMGEN-USASP2021152922,AMGEN,Hahn M. Utilization of indirect calorimetry to assist in determining undiagnosed hypothyroidism in a patient on mechanical ventilation. Nutrition in Clinical Practice. 2021;36(4):833-838,52.0,YR,A,M,Y,,,20211011.0,,HP,US,US,2021,Q4,Adult
199385391,19938539,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Malnutrition,,2021,Q4,1,I,,20211004.0,20211011,20211011,PER,,US-AMGEN-USASP2021152922,AMGEN,Hahn M. Utilization of indirect calorimetry to assist in determining undiagnosed hypothyroidism in a patient on mechanical ventilation. Nutrition in Clinical Practice. 2021;36(4):833-838,52.0,YR,A,M,Y,,,20211011.0,,HP,US,US,2021,Q4,Adult
199385391,19938539,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Electrolyte imbalance,,2021,Q4,1,I,,20211004.0,20211011,20211011,PER,,US-AMGEN-USASP2021152922,AMGEN,Hahn M. Utilization of indirect calorimetry to assist in determining undiagnosed hypothyroidism in a patient on mechanical ventilation. Nutrition in Clinical Practice. 2021;36(4):833-838,52.0,YR,A,M,Y,,,20211011.0,,HP,US,US,2021,Q4,Adult
199385391,19938539,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Adrenal insufficiency,,2021,Q4,1,I,,20211004.0,20211011,20211011,PER,,US-AMGEN-USASP2021152922,AMGEN,Hahn M. Utilization of indirect calorimetry to assist in determining undiagnosed hypothyroidism in a patient on mechanical ventilation. Nutrition in Clinical Practice. 2021;36(4):833-838,52.0,YR,A,M,Y,,,20211011.0,,HP,US,US,2021,Q4,Adult
199385391,19938539,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Mouth swelling,,2021,Q4,1,I,,20211004.0,20211011,20211011,PER,,US-AMGEN-USASP2021152922,AMGEN,Hahn M. Utilization of indirect calorimetry to assist in determining undiagnosed hypothyroidism in a patient on mechanical ventilation. Nutrition in Clinical Practice. 2021;36(4):833-838,52.0,YR,A,M,Y,,,20211011.0,,HP,US,US,2021,Q4,Adult
199385391,19938539,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Refeeding syndrome,,2021,Q4,1,I,,20211004.0,20211011,20211011,PER,,US-AMGEN-USASP2021152922,AMGEN,Hahn M. Utilization of indirect calorimetry to assist in determining undiagnosed hypothyroidism in a patient on mechanical ventilation. Nutrition in Clinical Practice. 2021;36(4):833-838,52.0,YR,A,M,Y,,,20211011.0,,HP,US,US,2021,Q4,Adult
199385391,19938539,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Blood thyroid stimulating hormone increased,,2021,Q4,1,I,,20211004.0,20211011,20211011,PER,,US-AMGEN-USASP2021152922,AMGEN,Hahn M. Utilization of indirect calorimetry to assist in determining undiagnosed hypothyroidism in a patient on mechanical ventilation. Nutrition in Clinical Practice. 2021;36(4):833-838,52.0,YR,A,M,Y,,,20211011.0,,HP,US,US,2021,Q4,Adult
199385391,19938539,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Tri-iodothyronine decreased,,2021,Q4,1,I,,20211004.0,20211011,20211011,PER,,US-AMGEN-USASP2021152922,AMGEN,Hahn M. Utilization of indirect calorimetry to assist in determining undiagnosed hypothyroidism in a patient on mechanical ventilation. Nutrition in Clinical Practice. 2021;36(4):833-838,52.0,YR,A,M,Y,,,20211011.0,,HP,US,US,2021,Q4,Adult
199385391,19938539,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Thyroxine decreased,,2021,Q4,1,I,,20211004.0,20211011,20211011,PER,,US-AMGEN-USASP2021152922,AMGEN,Hahn M. Utilization of indirect calorimetry to assist in determining undiagnosed hypothyroidism in a patient on mechanical ventilation. Nutrition in Clinical Practice. 2021;36(4):833-838,52.0,YR,A,M,Y,,,20211011.0,,HP,US,US,2021,Q4,Adult
199385391,19938539,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Pulseless electrical activity,,2021,Q4,1,I,,20211004.0,20211011,20211011,PER,,US-AMGEN-USASP2021152922,AMGEN,Hahn M. Utilization of indirect calorimetry to assist in determining undiagnosed hypothyroidism in a patient on mechanical ventilation. Nutrition in Clinical Practice. 2021;36(4):833-838,52.0,YR,A,M,Y,,,20211011.0,,HP,US,US,2021,Q4,Adult
199385391,19938539,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Plasma cell myeloma,,2021,Q4,1,I,,20211004.0,20211011,20211011,PER,,US-AMGEN-USASP2021152922,AMGEN,Hahn M. Utilization of indirect calorimetry to assist in determining undiagnosed hypothyroidism in a patient on mechanical ventilation. Nutrition in Clinical Practice. 2021;36(4):833-838,52.0,YR,A,M,Y,,,20211011.0,,HP,US,US,2021,Q4,Adult
199385391,19938539,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Blood phosphorus decreased,,2021,Q4,1,I,,20211004.0,20211011,20211011,PER,,US-AMGEN-USASP2021152922,AMGEN,Hahn M. Utilization of indirect calorimetry to assist in determining undiagnosed hypothyroidism in a patient on mechanical ventilation. Nutrition in Clinical Practice. 2021;36(4):833-838,52.0,YR,A,M,Y,,,20211011.0,,HP,US,US,2021,Q4,Adult
199385391,19938539,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Blood potassium decreased,,2021,Q4,1,I,,20211004.0,20211011,20211011,PER,,US-AMGEN-USASP2021152922,AMGEN,Hahn M. Utilization of indirect calorimetry to assist in determining undiagnosed hypothyroidism in a patient on mechanical ventilation. Nutrition in Clinical Practice. 2021;36(4):833-838,52.0,YR,A,M,Y,,,20211011.0,,HP,US,US,2021,Q4,Adult
199385391,19938539,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Decreased appetite,,2021,Q4,1,I,,20211004.0,20211011,20211011,PER,,US-AMGEN-USASP2021152922,AMGEN,Hahn M. Utilization of indirect calorimetry to assist in determining undiagnosed hypothyroidism in a patient on mechanical ventilation. Nutrition in Clinical Practice. 2021;36(4):833-838,52.0,YR,A,M,Y,,,20211011.0,,HP,US,US,2021,Q4,Adult
199385391,19938539,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Oedema peripheral,,2021,Q4,1,I,,20211004.0,20211011,20211011,PER,,US-AMGEN-USASP2021152922,AMGEN,Hahn M. Utilization of indirect calorimetry to assist in determining undiagnosed hypothyroidism in a patient on mechanical ventilation. Nutrition in Clinical Practice. 2021;36(4):833-838,52.0,YR,A,M,Y,,,20211011.0,,HP,US,US,2021,Q4,Adult
199385391,19938539,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Hyponatraemia,,2021,Q4,1,I,,20211004.0,20211011,20211011,PER,,US-AMGEN-USASP2021152922,AMGEN,Hahn M. Utilization of indirect calorimetry to assist in determining undiagnosed hypothyroidism in a patient on mechanical ventilation. Nutrition in Clinical Practice. 2021;36(4):833-838,52.0,YR,A,M,Y,,,20211011.0,,HP,US,US,2021,Q4,Adult
199385391,19938539,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Hypotension,,2021,Q4,1,I,,20211004.0,20211011,20211011,PER,,US-AMGEN-USASP2021152922,AMGEN,Hahn M. Utilization of indirect calorimetry to assist in determining undiagnosed hypothyroidism in a patient on mechanical ventilation. Nutrition in Clinical Practice. 2021;36(4):833-838,52.0,YR,A,M,Y,,,20211011.0,,HP,US,US,2021,Q4,Adult
199385391,19938539,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Sepsis,,2021,Q4,1,I,,20211004.0,20211011,20211011,PER,,US-AMGEN-USASP2021152922,AMGEN,Hahn M. Utilization of indirect calorimetry to assist in determining undiagnosed hypothyroidism in a patient on mechanical ventilation. Nutrition in Clinical Practice. 2021;36(4):833-838,52.0,YR,A,M,Y,,,20211011.0,,HP,US,US,2021,Q4,Adult
199388434,19938843,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Pneumonia,,2021,Q4,4,F,20210808.0,20211210.0,20211011,20211216,EXP,,NVSC2021US181359,NOVARTIS,,67.0,YR,,M,Y,96.0,KG,20211216.0,,MD,US,US,2021,Q4,Elderly
199392771,19939277,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,UNKNOWN,,,,,,,2021,Q4,Hypoglycaemic encephalopathy,,2021,Q4,1,I,,20210928.0,20211011,20211011,EXP,,JP-MICRO LABS LIMITED-ML2021-02336,MICRO LABS,"Sugito E, Tsujimoto T, Arai N, Bouchi R, Ohsugi M, Tanabe A, et al. Left Hemiplegia Possibly Due to Glucose Reperfusion Injury after Recovery of Severe Hypoglycemia in a Woman with Type 2 Diabetes Mellitus. Internal Medicine Advance Publication 2021.",79.0,YR,,F,Y,,,20211011.0,,MD,JP,JP,2021,Q4,Elderly
199394673,19939467,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,8 units/day,,,U,,,,,8.0,IU,,QD,2021,Q4,Hypoglycaemia,,2021,Q4,3,F,20190807.0,20211108.0,20211011,20211122,EXP,,JP-009507513-2110JPN002373,MERCK,"Sugito E, Tsujimoto T, Arai N, Bouchi R, Ohsugi M, Tanabe A, et al.. Left Hemiplegia Possibly Due to Glucose Reperfusion Injury after Recovery of Severe Hypoglycemia in a Woman with Type 2 Diabetes Mellitus. Internal Medicine. 2021",79.0,YR,,F,Y,,,20211122.0,,MD,JP,JP,2021,Q4,Elderly
199394673,19939467,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,8 units/day,,,U,,,,,8.0,IU,,QD,2021,Q4,Altered state of consciousness,,2021,Q4,3,F,20190807.0,20211108.0,20211011,20211122,EXP,,JP-009507513-2110JPN002373,MERCK,"Sugito E, Tsujimoto T, Arai N, Bouchi R, Ohsugi M, Tanabe A, et al.. Left Hemiplegia Possibly Due to Glucose Reperfusion Injury after Recovery of Severe Hypoglycemia in a Woman with Type 2 Diabetes Mellitus. Internal Medicine. 2021",79.0,YR,,F,Y,,,20211122.0,,MD,JP,JP,2021,Q4,Elderly
199411051,19941105,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Chronic kidney disease,,2021,Q4,1,I,20190318.0,20211004.0,20211011,20211011,EXP,FR-AFSSAPS-AM20211644,FR-MYLANLABS-2021M1069284,MYLAN,,68.0,YR,,M,Y,85.0,KG,20211011.0,,PH,FR,FR,2021,Q4,Elderly
199435611,19943561,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IE, 0-0-0-1, Injektions-/Infusionsl?sung",,,,,,,,,,Injection,,2021,Q4,Diarrhoea,,2021,Q4,1,I,,20211006.0,20211012,20211012,EXP,,DE-MYLANLABS-2021M1070718,MYLAN,,74.0,YR,,M,Y,,,20211012.0,,MD,DE,DE,2021,Q4,Elderly
199435611,19943561,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IE, 0-0-0-1, Injektions-/Infusionsl?sung",,,,,,,,,,Injection,,2021,Q4,Dehydration,,2021,Q4,1,I,,20211006.0,20211012,20211012,EXP,,DE-MYLANLABS-2021M1070718,MYLAN,,74.0,YR,,M,Y,,,20211012.0,,MD,DE,DE,2021,Q4,Elderly
199435611,19943561,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IE, 0-0-0-1, Injektions-/Infusionsl?sung",,,,,,,,,,Injection,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211006.0,20211012,20211012,EXP,,DE-MYLANLABS-2021M1070718,MYLAN,,74.0,YR,,M,Y,,,20211012.0,,MD,DE,DE,2021,Q4,Elderly
199435611,19943561,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IE, 0-0-0-1, Injektions-/Infusionsl?sung",,,,,,,,,,Injection,,2021,Q4,Acute kidney injury,,2021,Q4,1,I,,20211006.0,20211012,20211012,EXP,,DE-MYLANLABS-2021M1070718,MYLAN,,74.0,YR,,M,Y,,,20211012.0,,MD,DE,DE,2021,Q4,Elderly
199435611,19943561,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IE, 0-0-0-1, Injektions-/Infusionsl?sung",,,,,,,,,,Injection,,2021,Q4,Haematochezia,,2021,Q4,1,I,,20211006.0,20211012,20211012,EXP,,DE-MYLANLABS-2021M1070718,MYLAN,,74.0,YR,,M,Y,,,20211012.0,,MD,DE,DE,2021,Q4,Elderly
199435632,19943563,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK (8 IE, 0-0-1-0, Injektions-/Infusionslosung)",,,,,,,,,,,,2021,Q4,Renal impairment,,2021,Q4,2,F,20210224.0,20211006.0,20211012,20211018,EXP,,DE-MYLANLABS-2021M1070958,MYLAN,,80.0,YR,,F,Y,,,20211018.0,,MD,DE,DE,2021,Q4,Elderly
199435641,19943564,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"49 iU, QD",,,,,0f731a,,,49.0,IU,,QD,2021,Q4,Blood glucose abnormal,,2021,Q4,1,I,20210101.0,20211005.0,20211011,20211011,EXP,,ES-MYLANLABS-2021M1069708,MYLAN,,77.0,YR,,F,Y,66.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
199435641,19943564,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"49 iU, QD",,,,,0f731a,,,49.0,IU,,QD,2021,Q4,Weight decreased,,2021,Q4,1,I,20210101.0,20211005.0,20211011,20211011,EXP,,ES-MYLANLABS-2021M1069708,MYLAN,,77.0,YR,,F,Y,66.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
199435641,19943564,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"49 iU, QD",,,,,0f731a,,,49.0,IU,,QD,2021,Q4,Depressed mood,,2021,Q4,1,I,20210101.0,20211005.0,20211011,20211011,EXP,,ES-MYLANLABS-2021M1069708,MYLAN,,77.0,YR,,F,Y,66.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
199435641,19943564,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"49 iU, QD",,,,,0f731a,,,49.0,IU,,QD,2021,Q4,Renal disorder,,2021,Q4,1,I,20210101.0,20211005.0,20211011,20211011,EXP,,ES-MYLANLABS-2021M1069708,MYLAN,,77.0,YR,,F,Y,66.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
199435641,19943564,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"49 iU, QD",,,,,0f731a,,,49.0,IU,,QD,2021,Q4,Cardiac disorder,,2021,Q4,1,I,20210101.0,20211005.0,20211011,20211011,EXP,,ES-MYLANLABS-2021M1069708,MYLAN,,77.0,YR,,F,Y,66.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
199435641,19943564,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"49 iU, QD",,,,,0f731a,,,49.0,IU,,QD,2021,Q4,Decreased appetite,,2021,Q4,1,I,20210101.0,20211005.0,20211011,20211011,EXP,,ES-MYLANLABS-2021M1069708,MYLAN,,77.0,YR,,F,Y,66.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
199435641,19943564,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,dose increased,,,,,,,,,,,,2021,Q4,Blood glucose abnormal,,2021,Q4,1,I,20210101.0,20211005.0,20211011,20211011,EXP,,ES-MYLANLABS-2021M1069708,MYLAN,,77.0,YR,,F,Y,66.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
199435641,19943564,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,dose increased,,,,,,,,,,,,2021,Q4,Weight decreased,,2021,Q4,1,I,20210101.0,20211005.0,20211011,20211011,EXP,,ES-MYLANLABS-2021M1069708,MYLAN,,77.0,YR,,F,Y,66.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
199435641,19943564,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,dose increased,,,,,,,,,,,,2021,Q4,Depressed mood,,2021,Q4,1,I,20210101.0,20211005.0,20211011,20211011,EXP,,ES-MYLANLABS-2021M1069708,MYLAN,,77.0,YR,,F,Y,66.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
199435641,19943564,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,dose increased,,,,,,,,,,,,2021,Q4,Renal disorder,,2021,Q4,1,I,20210101.0,20211005.0,20211011,20211011,EXP,,ES-MYLANLABS-2021M1069708,MYLAN,,77.0,YR,,F,Y,66.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
199435641,19943564,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,dose increased,,,,,,,,,,,,2021,Q4,Cardiac disorder,,2021,Q4,1,I,20210101.0,20211005.0,20211011,20211011,EXP,,ES-MYLANLABS-2021M1069708,MYLAN,,77.0,YR,,F,Y,66.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
199435641,19943564,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,dose increased,,,,,,,,,,,,2021,Q4,Decreased appetite,,2021,Q4,1,I,20210101.0,20211005.0,20211011,20211011,EXP,,ES-MYLANLABS-2021M1069708,MYLAN,,77.0,YR,,F,Y,66.0,KG,20211011.0,,CN,ES,ES,2021,Q4,Elderly
199436012,19943601,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 international unit, qd",,,U,U,,,,24.0,IU,Injection,QD,2021,Q4,Diarrhoea,,2021,Q4,2,F,,20211006.0,20211012,20211014,EXP,,DE-MYLANLABS-2021M1070354,MYLAN,,78.0,YR,,M,Y,88.4,KG,20211014.0,,MD,DE,DE,2021,Q4,Elderly
199436012,19943601,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 international unit, qd",,,U,U,,,,24.0,IU,Injection,QD,2021,Q4,Night sweats,,2021,Q4,2,F,,20211006.0,20211012,20211014,EXP,,DE-MYLANLABS-2021M1070354,MYLAN,,78.0,YR,,M,Y,88.4,KG,20211014.0,,MD,DE,DE,2021,Q4,Elderly
199436012,19943601,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 international unit, qd",,,U,U,,,,24.0,IU,Injection,QD,2021,Q4,General physical health deterioration,,2021,Q4,2,F,,20211006.0,20211012,20211014,EXP,,DE-MYLANLABS-2021M1070354,MYLAN,,78.0,YR,,M,Y,88.4,KG,20211014.0,,MD,DE,DE,2021,Q4,Elderly
199436012,19943601,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 international unit, qd",,,U,U,,,,24.0,IU,Injection,QD,2021,Q4,Fatigue,,2021,Q4,2,F,,20211006.0,20211012,20211014,EXP,,DE-MYLANLABS-2021M1070354,MYLAN,,78.0,YR,,M,Y,88.4,KG,20211014.0,,MD,DE,DE,2021,Q4,Elderly
199436012,19943601,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 international unit, qd",,,U,U,,,,24.0,IU,Injection,QD,2021,Q4,Medication error,,2021,Q4,2,F,,20211006.0,20211012,20211014,EXP,,DE-MYLANLABS-2021M1070354,MYLAN,,78.0,YR,,M,Y,88.4,KG,20211014.0,,MD,DE,DE,2021,Q4,Elderly
199436242,19943624,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (10 IE, 0-0-1-0, ampoules)",,,,,,,,,,,,2021,Q4,Haematochezia,,2021,Q4,2,F,,20211006.0,20211012,20211018,EXP,,DE-MYLANLABS-2021M1070964,MYLAN,,77.0,YR,,F,Y,56.0,KG,20211018.0,,MD,DE,DE,2021,Q4,Elderly
199436242,19943624,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (10 IE, 0-0-1-0, ampoules)",,,,,,,,,,,,2021,Q4,Syncope,,2021,Q4,2,F,,20211006.0,20211012,20211018,EXP,,DE-MYLANLABS-2021M1070964,MYLAN,,77.0,YR,,F,Y,56.0,KG,20211018.0,,MD,DE,DE,2021,Q4,Elderly
199436242,19943624,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (10 IE, 0-0-1-0, ampoules)",,,,,,,,,,,,2021,Q4,Fatigue,,2021,Q4,2,F,,20211006.0,20211012,20211018,EXP,,DE-MYLANLABS-2021M1070964,MYLAN,,77.0,YR,,F,Y,56.0,KG,20211018.0,,MD,DE,DE,2021,Q4,Elderly
199436242,19943624,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (10 IE, 0-0-1-0, ampoules)",,,,,,,,,,,,2021,Q4,Headache,,2021,Q4,2,F,,20211006.0,20211012,20211018,EXP,,DE-MYLANLABS-2021M1070964,MYLAN,,77.0,YR,,F,Y,56.0,KG,20211018.0,,MD,DE,DE,2021,Q4,Elderly
199436242,19943624,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (10 IE, 0-0-1-0, ampoules)",,,,,,,,,,,,2021,Q4,Nausea,,2021,Q4,2,F,,20211006.0,20211012,20211018,EXP,,DE-MYLANLABS-2021M1070964,MYLAN,,77.0,YR,,F,Y,56.0,KG,20211018.0,,MD,DE,DE,2021,Q4,Elderly
199436242,19943624,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (10 IE, 0-0-1-0, ampoules)",,,,,,,,,,,,2021,Q4,Dizziness,,2021,Q4,2,F,,20211006.0,20211012,20211018,EXP,,DE-MYLANLABS-2021M1070964,MYLAN,,77.0,YR,,F,Y,56.0,KG,20211018.0,,MD,DE,DE,2021,Q4,Elderly
199436242,19943624,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (10 IE, 0-0-1-0, ampoules)",,,,,,,,,,,,2021,Q4,Abdominal pain,,2021,Q4,2,F,,20211006.0,20211012,20211018,EXP,,DE-MYLANLABS-2021M1070964,MYLAN,,77.0,YR,,F,Y,56.0,KG,20211018.0,,MD,DE,DE,2021,Q4,Elderly
199436242,19943624,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (10 IE, 0-0-1-0, ampoules)",,,,,,,,,,,,2021,Q4,General physical health deterioration,,2021,Q4,2,F,,20211006.0,20211012,20211018,EXP,,DE-MYLANLABS-2021M1070964,MYLAN,,77.0,YR,,F,Y,56.0,KG,20211018.0,,MD,DE,DE,2021,Q4,Elderly
199436242,19943624,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (10 IE, 0-0-1-0, ampoules)",,,,,,,,,,,,2021,Q4,Decreased appetite,,2021,Q4,2,F,,20211006.0,20211012,20211018,EXP,,DE-MYLANLABS-2021M1070964,MYLAN,,77.0,YR,,F,Y,56.0,KG,20211018.0,,MD,DE,DE,2021,Q4,Elderly
199438451,19943845,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 international unit, qd (14 IE, 0-0-0-1, solution for injection/infusion)",,,,,,,,14.0,IU,Injection,QD,2021,Q4,Abdominal distension,,2021,Q4,1,I,,20211006.0,20211011,20211011,EXP,,DE-MYLANLABS-2021M1070299,MYLAN,,71.0,YR,,M,Y,90.5,KG,20211011.0,,PH,DE,DE,2021,Q4,Elderly
199438451,19943845,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 international unit, qd (14 IE, 0-0-0-1, solution for injection/infusion)",,,,,,,,14.0,IU,Injection,QD,2021,Q4,Pyrexia,,2021,Q4,1,I,,20211006.0,20211011,20211011,EXP,,DE-MYLANLABS-2021M1070299,MYLAN,,71.0,YR,,M,Y,90.5,KG,20211011.0,,PH,DE,DE,2021,Q4,Elderly
199438451,19943845,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 international unit, qd (14 IE, 0-0-0-1, solution for injection/infusion)",,,,,,,,14.0,IU,Injection,QD,2021,Q4,Chills,,2021,Q4,1,I,,20211006.0,20211011,20211011,EXP,,DE-MYLANLABS-2021M1070299,MYLAN,,71.0,YR,,M,Y,90.5,KG,20211011.0,,PH,DE,DE,2021,Q4,Elderly
199439922,19943992,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,26 IU (International Unit),,,,,,,,26.0,IU,Unknown,QD,2021,Q4,Device related infection,,2021,Q4,2,F,20210918.0,20211008.0,20211011,20211014,EXP,,FR-CELGENEUS-FRA-20210905765,CELGENE,,60.0,YR,,F,Y,69.0,KG,20211014.0,,HP,FR,FR,2021,Q4,Adult
199477221,19947722,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (10 IE, 0-0-1-0, Injektions-/Infusionsl?sung)",,,,,,,,,,Injection,,2021,Q4,Restlessness,,2021,Q4,1,I,,20211006.0,20211012,20211012,EXP,,DE-MYLANLABS-2021M1070526,MYLAN,,69.0,YR,,M,Y,105.0,KG,20211012.0,,PH,DE,DE,2021,Q4,Elderly
199477221,19947722,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (10 IE, 0-0-1-0, Injektions-/Infusionsl?sung)",,,,,,,,,,Injection,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211006.0,20211012,20211012,EXP,,DE-MYLANLABS-2021M1070526,MYLAN,,69.0,YR,,M,Y,105.0,KG,20211012.0,,PH,DE,DE,2021,Q4,Elderly
199477221,19947722,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (10 IE, 0-0-1-0, Injektions-/Infusionsl?sung)",,,,,,,,,,Injection,,2021,Q4,Dyspnoea,,2021,Q4,1,I,,20211006.0,20211012,20211012,EXP,,DE-MYLANLABS-2021M1070526,MYLAN,,69.0,YR,,M,Y,105.0,KG,20211012.0,,PH,DE,DE,2021,Q4,Elderly
199477221,19947722,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (10 IE, 0-0-1-0, Injektions-/Infusionsl?sung)",,,,,,,,,,Injection,,2021,Q4,Diarrhoea,,2021,Q4,1,I,,20211006.0,20211012,20211012,EXP,,DE-MYLANLABS-2021M1070526,MYLAN,,69.0,YR,,M,Y,105.0,KG,20211012.0,,PH,DE,DE,2021,Q4,Elderly
199509811,19950981,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,"1F013A,1F013A,1F013A",,,14.0,IU,Solution for injection,QD,2021,Q4,Vomiting,,2021,Q4,1,I,20210101.0,20211003.0,20211014,20211014,EXP,,ES-BAUSCH-BL-2021-033720,BAUSCH AND LOMB,,78.0,YR,,F,Y,53.0,KG,20211014.0,,CN,ES,ES,2021,Q4,Elderly
199509811,19950981,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,"1F013A,1F013A,1F013A",,,14.0,IU,Solution for injection,QD,2021,Q4,Decreased appetite,,2021,Q4,1,I,20210101.0,20211003.0,20211014,20211014,EXP,,ES-BAUSCH-BL-2021-033720,BAUSCH AND LOMB,,78.0,YR,,F,Y,53.0,KG,20211014.0,,CN,ES,ES,2021,Q4,Elderly
199509811,19950981,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,"1F013A,1F013A,1F013A",,,14.0,IU,Solution for injection,QD,2021,Q4,Gait inability,,2021,Q4,1,I,20210101.0,20211003.0,20211014,20211014,EXP,,ES-BAUSCH-BL-2021-033720,BAUSCH AND LOMB,,78.0,YR,,F,Y,53.0,KG,20211014.0,,CN,ES,ES,2021,Q4,Elderly
199509811,19950981,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,"1F013A,1F013A,1F013A",,,14.0,IU,Solution for injection,QD,2021,Q4,Joint swelling,,2021,Q4,1,I,20210101.0,20211003.0,20211014,20211014,EXP,,ES-BAUSCH-BL-2021-033720,BAUSCH AND LOMB,,78.0,YR,,F,Y,53.0,KG,20211014.0,,CN,ES,ES,2021,Q4,Elderly
199509811,19950981,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,"1F013A,1F013A,1F013A",,,14.0,IU,Solution for injection,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20210101.0,20211003.0,20211014,20211014,EXP,,ES-BAUSCH-BL-2021-033720,BAUSCH AND LOMB,,78.0,YR,,F,Y,53.0,KG,20211014.0,,CN,ES,ES,2021,Q4,Elderly
199509811,19950981,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,"1F013A,1F013A,1F013A",,,14.0,IU,Solution for injection,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20210101.0,20211003.0,20211014,20211014,EXP,,ES-BAUSCH-BL-2021-033720,BAUSCH AND LOMB,,78.0,YR,,F,Y,53.0,KG,20211014.0,,CN,ES,ES,2021,Q4,Elderly
199509811,19950981,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,"1F013A,1F013A,1F013A",,,14.0,IU,Solution for injection,QD,2021,Q4,Product storage error,,2021,Q4,1,I,20210101.0,20211003.0,20211014,20211014,EXP,,ES-BAUSCH-BL-2021-033720,BAUSCH AND LOMB,,78.0,YR,,F,Y,53.0,KG,20211014.0,,CN,ES,ES,2021,Q4,Elderly
199509811,19950981,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,"1F013A,1F013A,1F013A",,,14.0,IU,Solution for injection,QD,2021,Q4,Arthropathy,,2021,Q4,1,I,20210101.0,20211003.0,20211014,20211014,EXP,,ES-BAUSCH-BL-2021-033720,BAUSCH AND LOMB,,78.0,YR,,F,Y,53.0,KG,20211014.0,,CN,ES,ES,2021,Q4,Elderly
199509811,19950981,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,"1F013A,1F013A,1F013A",,,14.0,IU,Solution for injection,QD,2021,Q4,Weight decreased,,2021,Q4,1,I,20210101.0,20211003.0,20211014,20211014,EXP,,ES-BAUSCH-BL-2021-033720,BAUSCH AND LOMB,,78.0,YR,,F,Y,53.0,KG,20211014.0,,CN,ES,ES,2021,Q4,Elderly
199509811,19950981,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,"1F013A,1F013A,1F013A",,,14.0,IU,Solution for injection,QD,2021,Q4,Arthralgia,,2021,Q4,1,I,20210101.0,20211003.0,20211014,20211014,EXP,,ES-BAUSCH-BL-2021-033720,BAUSCH AND LOMB,,78.0,YR,,F,Y,53.0,KG,20211014.0,,CN,ES,ES,2021,Q4,Elderly
199509811,19950981,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,"1F013A,1F013A,1F013A",,,14.0,IU,Solution for injection,QD,2021,Q4,Mobility decreased,,2021,Q4,1,I,20210101.0,20211003.0,20211014,20211014,EXP,,ES-BAUSCH-BL-2021-033720,BAUSCH AND LOMB,,78.0,YR,,F,Y,53.0,KG,20211014.0,,CN,ES,ES,2021,Q4,Elderly
199509811,19950981,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 iU, QD (dose reduced by 2iU)",,,Y,,"1F013A,1F013A,1F013A",,,16.0,IU,Solution for injection,QD,2021,Q4,Vomiting,,2021,Q4,1,I,20210101.0,20211003.0,20211014,20211014,EXP,,ES-BAUSCH-BL-2021-033720,BAUSCH AND LOMB,,78.0,YR,,F,Y,53.0,KG,20211014.0,,CN,ES,ES,2021,Q4,Elderly
199509811,19950981,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 iU, QD (dose reduced by 2iU)",,,Y,,"1F013A,1F013A,1F013A",,,16.0,IU,Solution for injection,QD,2021,Q4,Decreased appetite,,2021,Q4,1,I,20210101.0,20211003.0,20211014,20211014,EXP,,ES-BAUSCH-BL-2021-033720,BAUSCH AND LOMB,,78.0,YR,,F,Y,53.0,KG,20211014.0,,CN,ES,ES,2021,Q4,Elderly
199509811,19950981,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 iU, QD (dose reduced by 2iU)",,,Y,,"1F013A,1F013A,1F013A",,,16.0,IU,Solution for injection,QD,2021,Q4,Gait inability,,2021,Q4,1,I,20210101.0,20211003.0,20211014,20211014,EXP,,ES-BAUSCH-BL-2021-033720,BAUSCH AND LOMB,,78.0,YR,,F,Y,53.0,KG,20211014.0,,CN,ES,ES,2021,Q4,Elderly
199509811,19950981,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 iU, QD (dose reduced by 2iU)",,,Y,,"1F013A,1F013A,1F013A",,,16.0,IU,Solution for injection,QD,2021,Q4,Joint swelling,,2021,Q4,1,I,20210101.0,20211003.0,20211014,20211014,EXP,,ES-BAUSCH-BL-2021-033720,BAUSCH AND LOMB,,78.0,YR,,F,Y,53.0,KG,20211014.0,,CN,ES,ES,2021,Q4,Elderly
199509811,19950981,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 iU, QD (dose reduced by 2iU)",,,Y,,"1F013A,1F013A,1F013A",,,16.0,IU,Solution for injection,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20210101.0,20211003.0,20211014,20211014,EXP,,ES-BAUSCH-BL-2021-033720,BAUSCH AND LOMB,,78.0,YR,,F,Y,53.0,KG,20211014.0,,CN,ES,ES,2021,Q4,Elderly
199509811,19950981,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 iU, QD (dose reduced by 2iU)",,,Y,,"1F013A,1F013A,1F013A",,,16.0,IU,Solution for injection,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20210101.0,20211003.0,20211014,20211014,EXP,,ES-BAUSCH-BL-2021-033720,BAUSCH AND LOMB,,78.0,YR,,F,Y,53.0,KG,20211014.0,,CN,ES,ES,2021,Q4,Elderly
199509811,19950981,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 iU, QD (dose reduced by 2iU)",,,Y,,"1F013A,1F013A,1F013A",,,16.0,IU,Solution for injection,QD,2021,Q4,Product storage error,,2021,Q4,1,I,20210101.0,20211003.0,20211014,20211014,EXP,,ES-BAUSCH-BL-2021-033720,BAUSCH AND LOMB,,78.0,YR,,F,Y,53.0,KG,20211014.0,,CN,ES,ES,2021,Q4,Elderly
199509811,19950981,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 iU, QD (dose reduced by 2iU)",,,Y,,"1F013A,1F013A,1F013A",,,16.0,IU,Solution for injection,QD,2021,Q4,Arthropathy,,2021,Q4,1,I,20210101.0,20211003.0,20211014,20211014,EXP,,ES-BAUSCH-BL-2021-033720,BAUSCH AND LOMB,,78.0,YR,,F,Y,53.0,KG,20211014.0,,CN,ES,ES,2021,Q4,Elderly
199509811,19950981,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 iU, QD (dose reduced by 2iU)",,,Y,,"1F013A,1F013A,1F013A",,,16.0,IU,Solution for injection,QD,2021,Q4,Weight decreased,,2021,Q4,1,I,20210101.0,20211003.0,20211014,20211014,EXP,,ES-BAUSCH-BL-2021-033720,BAUSCH AND LOMB,,78.0,YR,,F,Y,53.0,KG,20211014.0,,CN,ES,ES,2021,Q4,Elderly
199509811,19950981,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 iU, QD (dose reduced by 2iU)",,,Y,,"1F013A,1F013A,1F013A",,,16.0,IU,Solution for injection,QD,2021,Q4,Arthralgia,,2021,Q4,1,I,20210101.0,20211003.0,20211014,20211014,EXP,,ES-BAUSCH-BL-2021-033720,BAUSCH AND LOMB,,78.0,YR,,F,Y,53.0,KG,20211014.0,,CN,ES,ES,2021,Q4,Elderly
199509811,19950981,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 iU, QD (dose reduced by 2iU)",,,Y,,"1F013A,1F013A,1F013A",,,16.0,IU,Solution for injection,QD,2021,Q4,Mobility decreased,,2021,Q4,1,I,20210101.0,20211003.0,20211014,20211014,EXP,,ES-BAUSCH-BL-2021-033720,BAUSCH AND LOMB,,78.0,YR,,F,Y,53.0,KG,20211014.0,,CN,ES,ES,2021,Q4,Elderly
199509811,19950981,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 iU, QD",,,Y,,"1F013A,1F013A,1F013A",,,18.0,IU,Solution for injection,QD,2021,Q4,Vomiting,,2021,Q4,1,I,20210101.0,20211003.0,20211014,20211014,EXP,,ES-BAUSCH-BL-2021-033720,BAUSCH AND LOMB,,78.0,YR,,F,Y,53.0,KG,20211014.0,,CN,ES,ES,2021,Q4,Elderly
199509811,19950981,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 iU, QD",,,Y,,"1F013A,1F013A,1F013A",,,18.0,IU,Solution for injection,QD,2021,Q4,Decreased appetite,,2021,Q4,1,I,20210101.0,20211003.0,20211014,20211014,EXP,,ES-BAUSCH-BL-2021-033720,BAUSCH AND LOMB,,78.0,YR,,F,Y,53.0,KG,20211014.0,,CN,ES,ES,2021,Q4,Elderly
199509811,19950981,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 iU, QD",,,Y,,"1F013A,1F013A,1F013A",,,18.0,IU,Solution for injection,QD,2021,Q4,Gait inability,,2021,Q4,1,I,20210101.0,20211003.0,20211014,20211014,EXP,,ES-BAUSCH-BL-2021-033720,BAUSCH AND LOMB,,78.0,YR,,F,Y,53.0,KG,20211014.0,,CN,ES,ES,2021,Q4,Elderly
199509811,19950981,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 iU, QD",,,Y,,"1F013A,1F013A,1F013A",,,18.0,IU,Solution for injection,QD,2021,Q4,Joint swelling,,2021,Q4,1,I,20210101.0,20211003.0,20211014,20211014,EXP,,ES-BAUSCH-BL-2021-033720,BAUSCH AND LOMB,,78.0,YR,,F,Y,53.0,KG,20211014.0,,CN,ES,ES,2021,Q4,Elderly
199509811,19950981,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 iU, QD",,,Y,,"1F013A,1F013A,1F013A",,,18.0,IU,Solution for injection,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20210101.0,20211003.0,20211014,20211014,EXP,,ES-BAUSCH-BL-2021-033720,BAUSCH AND LOMB,,78.0,YR,,F,Y,53.0,KG,20211014.0,,CN,ES,ES,2021,Q4,Elderly
199509811,19950981,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 iU, QD",,,Y,,"1F013A,1F013A,1F013A",,,18.0,IU,Solution for injection,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20210101.0,20211003.0,20211014,20211014,EXP,,ES-BAUSCH-BL-2021-033720,BAUSCH AND LOMB,,78.0,YR,,F,Y,53.0,KG,20211014.0,,CN,ES,ES,2021,Q4,Elderly
199509811,19950981,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 iU, QD",,,Y,,"1F013A,1F013A,1F013A",,,18.0,IU,Solution for injection,QD,2021,Q4,Product storage error,,2021,Q4,1,I,20210101.0,20211003.0,20211014,20211014,EXP,,ES-BAUSCH-BL-2021-033720,BAUSCH AND LOMB,,78.0,YR,,F,Y,53.0,KG,20211014.0,,CN,ES,ES,2021,Q4,Elderly
199509811,19950981,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 iU, QD",,,Y,,"1F013A,1F013A,1F013A",,,18.0,IU,Solution for injection,QD,2021,Q4,Arthropathy,,2021,Q4,1,I,20210101.0,20211003.0,20211014,20211014,EXP,,ES-BAUSCH-BL-2021-033720,BAUSCH AND LOMB,,78.0,YR,,F,Y,53.0,KG,20211014.0,,CN,ES,ES,2021,Q4,Elderly
199509811,19950981,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 iU, QD",,,Y,,"1F013A,1F013A,1F013A",,,18.0,IU,Solution for injection,QD,2021,Q4,Weight decreased,,2021,Q4,1,I,20210101.0,20211003.0,20211014,20211014,EXP,,ES-BAUSCH-BL-2021-033720,BAUSCH AND LOMB,,78.0,YR,,F,Y,53.0,KG,20211014.0,,CN,ES,ES,2021,Q4,Elderly
199509811,19950981,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 iU, QD",,,Y,,"1F013A,1F013A,1F013A",,,18.0,IU,Solution for injection,QD,2021,Q4,Arthralgia,,2021,Q4,1,I,20210101.0,20211003.0,20211014,20211014,EXP,,ES-BAUSCH-BL-2021-033720,BAUSCH AND LOMB,,78.0,YR,,F,Y,53.0,KG,20211014.0,,CN,ES,ES,2021,Q4,Elderly
199509811,19950981,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 iU, QD",,,Y,,"1F013A,1F013A,1F013A",,,18.0,IU,Solution for injection,QD,2021,Q4,Mobility decreased,,2021,Q4,1,I,20210101.0,20211003.0,20211014,20211014,EXP,,ES-BAUSCH-BL-2021-033720,BAUSCH AND LOMB,,78.0,YR,,F,Y,53.0,KG,20211014.0,,CN,ES,ES,2021,Q4,Elderly
199517294,19951729,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),,,,D,,,,,,,,,2021,Q4,Drug ineffective,,2021,Q4,4,F,,20211022.0,20211014,20211028,EXP,,AU-BAUSCH-BL-2021-034102,BAUSCH AND LOMB,"Griffiths A, Milne N, Ong B, Watkins T. 2,4-Dinitrophenol overdose - Everything old is new again. Journal of Forensic and Legal Medicine. 2021 MAR 03;79:1-5. doi:10.1016/j.jflm.2021.102148",23.0,YR,,M,Y,,,20211028.0,,HP,AU,AU,2021,Q4,Youth
199517294,19951729,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),,,,D,,,,,,,,,2021,Q4,Drug abuse,,2021,Q4,4,F,,20211022.0,20211014,20211028,EXP,,AU-BAUSCH-BL-2021-034102,BAUSCH AND LOMB,"Griffiths A, Milne N, Ong B, Watkins T. 2,4-Dinitrophenol overdose - Everything old is new again. Journal of Forensic and Legal Medicine. 2021 MAR 03;79:1-5. doi:10.1016/j.jflm.2021.102148",23.0,YR,,M,Y,,,20211028.0,,HP,AU,AU,2021,Q4,Youth
199517294,19951729,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,D,,,,,,,,,2021,Q4,Drug ineffective,,2021,Q4,4,F,,20211022.0,20211014,20211028,EXP,,AU-BAUSCH-BL-2021-034102,BAUSCH AND LOMB,"Griffiths A, Milne N, Ong B, Watkins T. 2,4-Dinitrophenol overdose - Everything old is new again. Journal of Forensic and Legal Medicine. 2021 MAR 03;79:1-5. doi:10.1016/j.jflm.2021.102148",23.0,YR,,M,Y,,,20211028.0,,HP,AU,AU,2021,Q4,Youth
199517294,19951729,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,D,,,,,,,,,2021,Q4,Drug abuse,,2021,Q4,4,F,,20211022.0,20211014,20211028,EXP,,AU-BAUSCH-BL-2021-034102,BAUSCH AND LOMB,"Griffiths A, Milne N, Ong B, Watkins T. 2,4-Dinitrophenol overdose - Everything old is new again. Journal of Forensic and Legal Medicine. 2021 MAR 03;79:1-5. doi:10.1016/j.jflm.2021.102148",23.0,YR,,M,Y,,,20211028.0,,HP,AU,AU,2021,Q4,Youth
199530561,19953056,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 units,,,U,,,,,20.0,IU,,,2021,Q4,Surgery,Surgery,2021,Q4,1,I,,20211004.0,20211014,20211014,EXP,,US-ALS-000419,ALIGNSCIENCE PHARMA,"Butler J., Bjurstrom M., Marceau A. Possible dulaglutide-associated cholecystitis with safe continuation post cholecystectomy. Am J Health Syst Pharm. 2021;78(8):684-88. DOI: 10.1093/ajhp/zxab045",72.0,YR,E,M,Y,111.3,KG,20211014.0,,HP,US,US,2021,Q4,Elderly
199530561,19953056,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 units,,,U,,,,,20.0,IU,,,2021,Q4,Cholecystectomy,Cholecystectomy,2021,Q4,1,I,,20211004.0,20211014,20211014,EXP,,US-ALS-000419,ALIGNSCIENCE PHARMA,"Butler J., Bjurstrom M., Marceau A. Possible dulaglutide-associated cholecystitis with safe continuation post cholecystectomy. Am J Health Syst Pharm. 2021;78(8):684-88. DOI: 10.1093/ajhp/zxab045",72.0,YR,E,M,Y,111.3,KG,20211014.0,,HP,US,US,2021,Q4,Elderly
199530561,19953056,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 units,,,U,,,,,20.0,IU,,,2021,Q4,Cholecystitis infective,Cholecystitis infective,2021,Q4,1,I,,20211004.0,20211014,20211014,EXP,,US-ALS-000419,ALIGNSCIENCE PHARMA,"Butler J., Bjurstrom M., Marceau A. Possible dulaglutide-associated cholecystitis with safe continuation post cholecystectomy. Am J Health Syst Pharm. 2021;78(8):684-88. DOI: 10.1093/ajhp/zxab045",72.0,YR,E,M,Y,111.3,KG,20211014.0,,HP,US,US,2021,Q4,Elderly
199538161,19953816,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 u, daily",,,Y,,122011132,,,24.0,IU,Injection,QD,2021,Q4,Palpitations,,2021,Q4,1,I,20210928.0,20211001.0,20211013,20211013,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202110001089,ELI LILLY AND CO,,58.0,YR,,F,Y,82.0,KG,20211013.0,,CN,CN,CN,2021,Q4,Adult
199538161,19953816,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 u, daily",,,Y,,122011132,,,24.0,IU,Injection,QD,2021,Q4,Chest discomfort,,2021,Q4,1,I,20210928.0,20211001.0,20211013,20211013,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202110001089,ELI LILLY AND CO,,58.0,YR,,F,Y,82.0,KG,20211013.0,,CN,CN,CN,2021,Q4,Adult
199538161,19953816,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 u, daily",,,Y,,122011132,,,24.0,IU,Injection,QD,2021,Q4,Tremor,,2021,Q4,1,I,20210928.0,20211001.0,20211013,20211013,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202110001089,ELI LILLY AND CO,,58.0,YR,,F,Y,82.0,KG,20211013.0,,CN,CN,CN,2021,Q4,Adult
199538161,19953816,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 u, daily",,,Y,,122011132,,,24.0,IU,Injection,QD,2021,Q4,Discomfort,,2021,Q4,1,I,20210928.0,20211001.0,20211013,20211013,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202110001089,ELI LILLY AND CO,,58.0,YR,,F,Y,82.0,KG,20211013.0,,CN,CN,CN,2021,Q4,Adult
199538161,19953816,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 u, daily",,,Y,,122011132,,,24.0,IU,Injection,QD,2021,Q4,Blood pressure increased,,2021,Q4,1,I,20210928.0,20211001.0,20211013,20211013,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202110001089,ELI LILLY AND CO,,58.0,YR,,F,Y,82.0,KG,20211013.0,,CN,CN,CN,2021,Q4,Adult
199538161,19953816,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 u, daily",,,Y,,122011132,,,24.0,IU,Injection,QD,2021,Q4,Hyperhidrosis,,2021,Q4,1,I,20210928.0,20211001.0,20211013,20211013,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202110001089,ELI LILLY AND CO,,58.0,YR,,F,Y,82.0,KG,20211013.0,,CN,CN,CN,2021,Q4,Adult
199539181,19953918,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 international unit, qd",,,,,,,,15.0,IU,,QD,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211008.0,20211013,20211013,EXP,,DE-MYLANLABS-2021M1071433,MYLAN,,79.0,YR,,F,Y,,,20211013.0,,MD,DE,DE,2021,Q4,Elderly
199539181,19953918,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 international unit, qd",,,,,,,,15.0,IU,,QD,2021,Q4,Asthenia,,2021,Q4,1,I,,20211008.0,20211013,20211013,EXP,,DE-MYLANLABS-2021M1071433,MYLAN,,79.0,YR,,F,Y,,,20211013.0,,MD,DE,DE,2021,Q4,Elderly
199539181,19953918,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 international unit, qd",,,,,,,,15.0,IU,,QD,2021,Q4,Hypotension,,2021,Q4,1,I,,20211008.0,20211013,20211013,EXP,,DE-MYLANLABS-2021M1071433,MYLAN,,79.0,YR,,F,Y,,,20211013.0,,MD,DE,DE,2021,Q4,Elderly
199542221,19954222,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 international unit, qd, 0-0-1-0",,,,,,,,40.0,IU,,QD,2021,Q4,Dysuria,,2021,Q4,1,I,,20211008.0,20211013,20211013,EXP,,DE-MYLANLABS-2021M1071233,MYLAN,,80.0,YR,,M,Y,73.0,KG,20211013.0,,PH,DE,DE,2021,Q4,Elderly
199542221,19954222,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 international unit, qd, 0-0-1-0",,,,,,,,40.0,IU,,QD,2021,Q4,Weight decreased,,2021,Q4,1,I,,20211008.0,20211013,20211013,EXP,,DE-MYLANLABS-2021M1071233,MYLAN,,80.0,YR,,M,Y,73.0,KG,20211013.0,,PH,DE,DE,2021,Q4,Elderly
199542221,19954222,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 international unit, qd, 0-0-1-0",,,,,,,,40.0,IU,,QD,2021,Q4,Dyschezia,,2021,Q4,1,I,,20211008.0,20211013,20211013,EXP,,DE-MYLANLABS-2021M1071233,MYLAN,,80.0,YR,,M,Y,73.0,KG,20211013.0,,PH,DE,DE,2021,Q4,Elderly
199542791,19954279,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 12-0-0-0, Pre-filled syringes",,,,,,,,,,,,2021,Q4,Dysuria,,2021,Q4,1,I,,20211008.0,20211013,20211013,EXP,,DE-MYLANLABS-2021M1071352,MYLAN,,72.0,YR,,M,Y,80.0,KG,20211013.0,,PH,DE,DE,2021,Q4,Elderly
199542791,19954279,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 12-0-0-0, Pre-filled syringes",,,,,,,,,,,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211008.0,20211013,20211013,EXP,,DE-MYLANLABS-2021M1071352,MYLAN,,72.0,YR,,M,Y,80.0,KG,20211013.0,,PH,DE,DE,2021,Q4,Elderly
199542791,19954279,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 12-0-0-0, Pre-filled syringes",,,,,,,,,,,,2021,Q4,Oliguria,,2021,Q4,1,I,,20211008.0,20211013,20211013,EXP,,DE-MYLANLABS-2021M1071352,MYLAN,,72.0,YR,,M,Y,80.0,KG,20211013.0,,PH,DE,DE,2021,Q4,Elderly
199542791,19954279,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 12-0-0-0, Pre-filled syringes",,,,,,,,,,,,2021,Q4,Pyrexia,,2021,Q4,1,I,,20211008.0,20211013,20211013,EXP,,DE-MYLANLABS-2021M1071352,MYLAN,,72.0,YR,,M,Y,80.0,KG,20211013.0,,PH,DE,DE,2021,Q4,Elderly
199546724,19954672,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (15 I.U in the morning),,,,,,,,,,,,2021,Q4,Constipation,,2021,Q4,4,F,20180101.0,20211124.0,20211014,20211130,EXP,,DE-MYLANLABS-2021M1072556,MYLAN,,65.0,YR,,M,Y,95.0,KG,20211130.0,,CN,DE,DE,2021,Q4,Elderly
199546724,19954672,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (15 I.U in the morning),,,,,,,,,,,,2021,Q4,Epigastric discomfort,,2021,Q4,4,F,20180101.0,20211124.0,20211014,20211130,EXP,,DE-MYLANLABS-2021M1072556,MYLAN,,65.0,YR,,M,Y,95.0,KG,20211130.0,,CN,DE,DE,2021,Q4,Elderly
199546724,19954672,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (15 I.U in the morning),,,,,,,,,,,,2021,Q4,Flatulence,,2021,Q4,4,F,20180101.0,20211124.0,20211014,20211130,EXP,,DE-MYLANLABS-2021M1072556,MYLAN,,65.0,YR,,M,Y,95.0,KG,20211130.0,,CN,DE,DE,2021,Q4,Elderly
199546724,19954672,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (15 I.U in the morning),,,,,,,,,,,,2021,Q4,Gastrointestinal candidiasis,,2021,Q4,4,F,20180101.0,20211124.0,20211014,20211130,EXP,,DE-MYLANLABS-2021M1072556,MYLAN,,65.0,YR,,M,Y,95.0,KG,20211130.0,,CN,DE,DE,2021,Q4,Elderly
199556591,19955659,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Not provided,,,,,,,,,,,,2021,Q4,Drug interaction,,2021,Q4,1,I,,20211001.0,20211013,20211013,EXP,,"US-SUPERNUS PHARMACEUTICALS, INC.-SUP202110-002023",SUPERNUS,,28.0,YR,A,M,Y,,,20211012.0,,HP,US,US,2021,Q4,Young Adult
199556591,19955659,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Not provided,,,,,,,,,,,,2021,Q4,Anticoagulation drug level decreased,,2021,Q4,1,I,,20211001.0,20211013,20211013,EXP,,"US-SUPERNUS PHARMACEUTICALS, INC.-SUP202110-002023",SUPERNUS,,28.0,YR,A,M,Y,,,20211012.0,,HP,US,US,2021,Q4,Young Adult
199556591,19955659,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Not provided,,,,,,,,,,,,2021,Q4,Pulmonary embolism,,2021,Q4,1,I,,20211001.0,20211013,20211013,EXP,,"US-SUPERNUS PHARMACEUTICALS, INC.-SUP202110-002023",SUPERNUS,,28.0,YR,A,M,Y,,,20211012.0,,HP,US,US,2021,Q4,Young Adult
199558611,19955861,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,Unknown,,,,,,,2021,Q4,Hypothyroidism,,2021,Q4,1,I,,20210408.0,20211014,20211014,EXP,,TR-SCIEGENPHARMA-2021SCILIT00366,SCIEGEN,"Onur Elbasan.Refractory hypothyroidism to levothyroxine treatment: Five cases of pseudomalabsorption.Acta endocrinologica (Bucharest, Romania).SEP-2020;16: 339-345",53.0,YR,A,F,Y,,,20211014.0,,MD,TR,TR,2021,Q4,Adult
199558611,19955861,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,Unknown,,,,,,,2021,Q4,Malabsorption,,2021,Q4,1,I,,20210408.0,20211014,20211014,EXP,,TR-SCIEGENPHARMA-2021SCILIT00366,SCIEGEN,"Onur Elbasan.Refractory hypothyroidism to levothyroxine treatment: Five cases of pseudomalabsorption.Acta endocrinologica (Bucharest, Romania).SEP-2020;16: 339-345",53.0,YR,A,F,Y,,,20211014.0,,MD,TR,TR,2021,Q4,Adult
199562442,19956244,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 iU, QD",,,,,0f784A,,,40.0,IU,Injection,QD,2021,Q4,Drug ineffective,,2021,Q4,2,F,20210101.0,20211109.0,20211014,20211116,EXP,,ES-MYLANLABS-2021M1071154,MYLAN,,75.0,YR,,M,Y,69.5,KG,20211116.0,,CN,ES,ES,2021,Q4,Elderly
199562442,19956244,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 iU, QD",,,,,0f784A,,,40.0,IU,Injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,2,F,20210101.0,20211109.0,20211014,20211116,EXP,,ES-MYLANLABS-2021M1071154,MYLAN,,75.0,YR,,M,Y,69.5,KG,20211116.0,,CN,ES,ES,2021,Q4,Elderly
199562442,19956244,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 iU, QD",,,,,0f784A,,,40.0,IU,Injection,QD,2021,Q4,Stress,,2021,Q4,2,F,20210101.0,20211109.0,20211014,20211116,EXP,,ES-MYLANLABS-2021M1071154,MYLAN,,75.0,YR,,M,Y,69.5,KG,20211116.0,,CN,ES,ES,2021,Q4,Elderly
199562442,19956244,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 iU, QD",,,,,0f784A,,,40.0,IU,Injection,QD,2021,Q4,Blood glucose fluctuation,,2021,Q4,2,F,20210101.0,20211109.0,20211014,20211116,EXP,,ES-MYLANLABS-2021M1071154,MYLAN,,75.0,YR,,M,Y,69.5,KG,20211116.0,,CN,ES,ES,2021,Q4,Elderly
199562442,19956244,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 iU, QD",,,,,0f784A,,,40.0,IU,Injection,QD,2021,Q4,Intentional product misuse,,2021,Q4,2,F,20210101.0,20211109.0,20211014,20211116,EXP,,ES-MYLANLABS-2021M1071154,MYLAN,,75.0,YR,,M,Y,69.5,KG,20211116.0,,CN,ES,ES,2021,Q4,Elderly
199562442,19956244,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 iU, QD, Dose increase",,,,,0f784A,,,42.0,IU,Injection,QD,2021,Q4,Drug ineffective,,2021,Q4,2,F,20210101.0,20211109.0,20211014,20211116,EXP,,ES-MYLANLABS-2021M1071154,MYLAN,,75.0,YR,,M,Y,69.5,KG,20211116.0,,CN,ES,ES,2021,Q4,Elderly
199562442,19956244,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 iU, QD, Dose increase",,,,,0f784A,,,42.0,IU,Injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,2,F,20210101.0,20211109.0,20211014,20211116,EXP,,ES-MYLANLABS-2021M1071154,MYLAN,,75.0,YR,,M,Y,69.5,KG,20211116.0,,CN,ES,ES,2021,Q4,Elderly
199562442,19956244,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 iU, QD, Dose increase",,,,,0f784A,,,42.0,IU,Injection,QD,2021,Q4,Stress,,2021,Q4,2,F,20210101.0,20211109.0,20211014,20211116,EXP,,ES-MYLANLABS-2021M1071154,MYLAN,,75.0,YR,,M,Y,69.5,KG,20211116.0,,CN,ES,ES,2021,Q4,Elderly
199562442,19956244,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 iU, QD, Dose increase",,,,,0f784A,,,42.0,IU,Injection,QD,2021,Q4,Blood glucose fluctuation,,2021,Q4,2,F,20210101.0,20211109.0,20211014,20211116,EXP,,ES-MYLANLABS-2021M1071154,MYLAN,,75.0,YR,,M,Y,69.5,KG,20211116.0,,CN,ES,ES,2021,Q4,Elderly
199562442,19956244,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 iU, QD, Dose increase",,,,,0f784A,,,42.0,IU,Injection,QD,2021,Q4,Intentional product misuse,,2021,Q4,2,F,20210101.0,20211109.0,20211014,20211116,EXP,,ES-MYLANLABS-2021M1071154,MYLAN,,75.0,YR,,M,Y,69.5,KG,20211116.0,,CN,ES,ES,2021,Q4,Elderly
199566392,19956639,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Infection,,2021,Q4,2,F,20210831.0,20210913.0,20211014,20211210,PER,,"US-Stemline Therapeutics, Inc.-2021ST000055",STEMLINE THERAPEUTICS,,73.0,YR,E,F,Y,85.1,KG,20211209.0,,MD,US,US,2021,Q4,Elderly
199566392,19956639,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Diarrhoea haemorrhagic,,2021,Q4,2,F,20210831.0,20210913.0,20211014,20211210,PER,,"US-Stemline Therapeutics, Inc.-2021ST000055",STEMLINE THERAPEUTICS,,73.0,YR,E,F,Y,85.1,KG,20211209.0,,MD,US,US,2021,Q4,Elderly
199566392,19956639,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Abdominal pain,,2021,Q4,2,F,20210831.0,20210913.0,20211014,20211210,PER,,"US-Stemline Therapeutics, Inc.-2021ST000055",STEMLINE THERAPEUTICS,,73.0,YR,E,F,Y,85.1,KG,20211209.0,,MD,US,US,2021,Q4,Elderly
199566392,19956639,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Product use in unapproved indication,,2021,Q4,2,F,20210831.0,20210913.0,20211014,20211210,PER,,"US-Stemline Therapeutics, Inc.-2021ST000055",STEMLINE THERAPEUTICS,,73.0,YR,E,F,Y,85.1,KG,20211209.0,,MD,US,US,2021,Q4,Elderly
199566392,19956639,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Platelet count decreased,,2021,Q4,2,F,20210831.0,20210913.0,20211014,20211210,PER,,"US-Stemline Therapeutics, Inc.-2021ST000055",STEMLINE THERAPEUTICS,,73.0,YR,E,F,Y,85.1,KG,20211209.0,,MD,US,US,2021,Q4,Elderly
199569931,19956993,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 units subcutaneously at bedtime,,,,,,,,,,,QD,2021,Q4,Acute myocardial infarction,,2021,Q4,1,I,,20211004.0,20211014,20211014,EXP,,US-BAXTER-2021BAX031647,BAXTER,"SAEED M, GIL G, LOPEZ P, VISCO F, PEKLER G, MUSHIYEV S. CHEST PAIN INDUCED BY INTRAVENOUS NITROGLYCERIN. AMERICAN JOURNAL OF THERAPEUTICS. 2020;27(3):E299-E301.",54.0,YR,,M,Y,,,20211014.0,,MD,US,US,2021,Q4,Adult
199572093,19957209,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 dosage form = 62 Units NOS,,,U,,,,,,,,,2021,Q4,Pemphigoid,,2021,Q4,3,F,20211006.0,20211227.0,20211014,20211230,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-105502,BRISTOL MYERS SQUIBB,,71.0,YR,,F,Y,86.0,KG,20211230.0,,HP,FR,FR,2021,Q4,Elderly
199585761,19958576,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 international unit, qd (1 IE, 14-0-0-0, Fertigspritzen)",,,,,,,,14.0,IU,,QD,2021,Q4,Diarrhoea,,2021,Q4,1,I,,20211008.0,20211015,20211015,EXP,,DE-MYLANLABS-2021M1071691,MYLAN,,79.0,YR,,F,Y,54.0,KG,20211015.0,,PH,DE,DE,2021,Q4,Elderly
199585761,19958576,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 international unit, qd (1 IE, 14-0-0-0, Fertigspritzen)",,,,,,,,14.0,IU,,QD,2021,Q4,Bile duct stone,,2021,Q4,1,I,,20211008.0,20211015,20211015,EXP,,DE-MYLANLABS-2021M1071691,MYLAN,,79.0,YR,,F,Y,54.0,KG,20211015.0,,PH,DE,DE,2021,Q4,Elderly
199585761,19958576,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 international unit, qd (1 IE, 14-0-0-0, Fertigspritzen)",,,,,,,,14.0,IU,,QD,2021,Q4,Liver function test abnormal,,2021,Q4,1,I,,20211008.0,20211015,20211015,EXP,,DE-MYLANLABS-2021M1071691,MYLAN,,79.0,YR,,F,Y,54.0,KG,20211015.0,,PH,DE,DE,2021,Q4,Elderly
199585761,19958576,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 international unit, qd (1 IE, 14-0-0-0, Fertigspritzen)",,,,,,,,14.0,IU,,QD,2021,Q4,Vomiting,,2021,Q4,1,I,,20211008.0,20211015,20211015,EXP,,DE-MYLANLABS-2021M1071691,MYLAN,,79.0,YR,,F,Y,54.0,KG,20211015.0,,PH,DE,DE,2021,Q4,Elderly
199585761,19958576,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 international unit, qd (1 IE, 14-0-0-0, Fertigspritzen)",,,,,,,,14.0,IU,,QD,2021,Q4,Abdominal pain,,2021,Q4,1,I,,20211008.0,20211015,20211015,EXP,,DE-MYLANLABS-2021M1071691,MYLAN,,79.0,YR,,F,Y,54.0,KG,20211015.0,,PH,DE,DE,2021,Q4,Elderly
199587321,19958732,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"36 IU, qd",,,,,unk,,,36.0,IU,,QD,2021,Q4,COVID-19 pneumonia,,2021,Q4,1,I,20210601.0,20211005.0,20211015,20211015,EXP,,BR-NOVOPROD-855008,NOVO NORDISK,,82.0,YR,,F,Y,74.4,KG,20211015.0,,MD,BR,BR,2021,Q4,Elderly
199587321,19958732,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"36 IU, qd",,,,,unk,,,36.0,IU,,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20210601.0,20211005.0,20211015,20211015,EXP,,BR-NOVOPROD-855008,NOVO NORDISK,,82.0,YR,,F,Y,74.4,KG,20211015.0,,MD,BR,BR,2021,Q4,Elderly
199587321,19958732,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"36 IU, qd",,,,,unk,,,36.0,IU,,QD,2021,Q4,Blood glucose abnormal,,2021,Q4,1,I,20210601.0,20211005.0,20211015,20211015,EXP,,BR-NOVOPROD-855008,NOVO NORDISK,,82.0,YR,,F,Y,74.4,KG,20211015.0,,MD,BR,BR,2021,Q4,Elderly
199587321,19958732,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"36 IU, qd",,,,,unk,,,36.0,IU,,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20210601.0,20211005.0,20211015,20211015,EXP,,BR-NOVOPROD-855008,NOVO NORDISK,,82.0,YR,,F,Y,74.4,KG,20211015.0,,MD,BR,BR,2021,Q4,Elderly
199587321,19958732,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"36 IU, qd",,,,,unk,,,36.0,IU,,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20210601.0,20211005.0,20211015,20211015,EXP,,BR-NOVOPROD-855008,NOVO NORDISK,,82.0,YR,,F,Y,74.4,KG,20211015.0,,MD,BR,BR,2021,Q4,Elderly
199587321,19958732,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"44 IU, qd",,,,,unk,,,44.0,IU,,QD,2021,Q4,COVID-19 pneumonia,,2021,Q4,1,I,20210601.0,20211005.0,20211015,20211015,EXP,,BR-NOVOPROD-855008,NOVO NORDISK,,82.0,YR,,F,Y,74.4,KG,20211015.0,,MD,BR,BR,2021,Q4,Elderly
199587321,19958732,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"44 IU, qd",,,,,unk,,,44.0,IU,,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20210601.0,20211005.0,20211015,20211015,EXP,,BR-NOVOPROD-855008,NOVO NORDISK,,82.0,YR,,F,Y,74.4,KG,20211015.0,,MD,BR,BR,2021,Q4,Elderly
199587321,19958732,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"44 IU, qd",,,,,unk,,,44.0,IU,,QD,2021,Q4,Blood glucose abnormal,,2021,Q4,1,I,20210601.0,20211005.0,20211015,20211015,EXP,,BR-NOVOPROD-855008,NOVO NORDISK,,82.0,YR,,F,Y,74.4,KG,20211015.0,,MD,BR,BR,2021,Q4,Elderly
199587321,19958732,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"44 IU, qd",,,,,unk,,,44.0,IU,,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20210601.0,20211005.0,20211015,20211015,EXP,,BR-NOVOPROD-855008,NOVO NORDISK,,82.0,YR,,F,Y,74.4,KG,20211015.0,,MD,BR,BR,2021,Q4,Elderly
199587321,19958732,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"44 IU, qd",,,,,unk,,,44.0,IU,,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20210601.0,20211005.0,20211015,20211015,EXP,,BR-NOVOPROD-855008,NOVO NORDISK,,82.0,YR,,F,Y,74.4,KG,20211015.0,,MD,BR,BR,2021,Q4,Elderly
199589371,19958937,1,PS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,Subcutaneous,prn nightly,,,,,BF20001998,,210605.0,,,Injection,,2021,Q4,Incorrect dose administered,,2021,Q4,1,I,20210930.0,20211001.0,20211015,20211015,PER,,US-MYLANLABS-2021M1068937,MYLAN,,63.0,YR,,M,Y,68.0,KG,20211015.0,,CN,US,US,2021,Q4,Adult
199589371,19958937,1,PS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,Subcutaneous,prn nightly,,,,,BF20001998,,210605.0,,,Injection,,2021,Q4,Device issue,,2021,Q4,1,I,20210930.0,20211001.0,20211015,20211015,PER,,US-MYLANLABS-2021M1068937,MYLAN,,63.0,YR,,M,Y,68.0,KG,20211015.0,,CN,US,US,2021,Q4,Adult
199598961,19959896,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"Injectievloeistof, 100 eenheden/ml (eenheden per milliliter) [fluid for injection, 100 units/nl]",,,,,,,,,,,,2021,Q4,Renal impairment,,2021,Q4,1,I,20210927.0,20211015.0,20211015,20211015,EXP,NL-LRB-00698307,"NL-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-132749",BOEHRINGER INGELHEIM,,50.0,YR,A,M,Y,85.0,KG,20211015.0,,PH,NL,NL,2021,Q4,Adult
199598961,19959896,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"Injectievloeistof, 100 eenheden/ml (eenheden per milliliter) [fluid for injection, 100 units/nl]",,,,,,,,,,,,2021,Q4,Abdominal pain,,2021,Q4,1,I,20210927.0,20211015.0,20211015,20211015,EXP,NL-LRB-00698307,"NL-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-132749",BOEHRINGER INGELHEIM,,50.0,YR,A,M,Y,85.0,KG,20211015.0,,PH,NL,NL,2021,Q4,Adult
199598961,19959896,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"Injectievloeistof, 100 eenheden/ml (eenheden per milliliter) [fluid for injection, 100 units/nl]",,,,,,,,,,,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,20210927.0,20211015.0,20211015,20211015,EXP,NL-LRB-00698307,"NL-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-132749",BOEHRINGER INGELHEIM,,50.0,YR,A,M,Y,85.0,KG,20211015.0,,PH,NL,NL,2021,Q4,Adult
199598961,19959896,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"Injectievloeistof, 100 eenheden/ml (eenheden per milliliter) [fluid for injection, 100 units/nl]",,,,,,,,,,,,2021,Q4,Hyperventilation,,2021,Q4,1,I,20210927.0,20211015.0,20211015,20211015,EXP,NL-LRB-00698307,"NL-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-132749",BOEHRINGER INGELHEIM,,50.0,YR,A,M,Y,85.0,KG,20211015.0,,PH,NL,NL,2021,Q4,Adult
199617441,19961744,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,25.0,IU,,QD,2021,Q4,Oesophageal varices haemorrhage,,2021,Q4,1,I,20210919.0,20211012.0,20211018,20211018,EXP,,DE-ABBVIE-21K-062-4121976-00,ABBVIE,,72.0,YR,,M,Y,75.0,KG,20211018.0,,MD,COUNTRY NOT SPECIFIED,DE,2021,Q4,Elderly
199628491,19962849,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 IU, QD",,,,,,,,25.0,IU,,QD,2021,Q4,Sinus bradycardia,,2021,Q4,1,I,20210901.0,20211012.0,20211018,20211018,EXP,FR-AFSSAPS-AN20213915,NVSC2021FR234026,NOVARTIS,,67.0,YR,,M,Y,81.8,KG,20211018.0,,PH,FR,FR,2021,Q4,Elderly
199628491,19962849,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 IU, QD",,,,,,,,25.0,IU,,QD,2021,Q4,Cardioactive drug level increased,,2021,Q4,1,I,20210901.0,20211012.0,20211018,20211018,EXP,FR-AFSSAPS-AN20213915,NVSC2021FR234026,NOVARTIS,,67.0,YR,,M,Y,81.8,KG,20211018.0,,PH,FR,FR,2021,Q4,Elderly
199646621,19964662,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 international unit, qd (30 iU, QD)",,,Y,,1f935a,,,30.0,IU,Solution for injection,QD,2021,Q4,Gait disturbance,,2021,Q4,1,I,20210301.0,20211014.0,20211018,20211018,EXP,,ES-MYLANLABS-2021M1072891,MYLAN,,49.0,YR,,M,Y,75.0,KG,20211018.0,,CN,ES,ES,2021,Q4,Adult
199646621,19964662,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 international unit, qd (30 iU, QD)",,,Y,,1f935a,,,30.0,IU,Solution for injection,QD,2021,Q4,Weight decreased,,2021,Q4,1,I,20210301.0,20211014.0,20211018,20211018,EXP,,ES-MYLANLABS-2021M1072891,MYLAN,,49.0,YR,,M,Y,75.0,KG,20211018.0,,CN,ES,ES,2021,Q4,Adult
199646621,19964662,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 international unit, qd (30 iU, QD)",,,Y,,1f935a,,,30.0,IU,Solution for injection,QD,2021,Q4,Blood glucose fluctuation,,2021,Q4,1,I,20210301.0,20211014.0,20211018,20211018,EXP,,ES-MYLANLABS-2021M1072891,MYLAN,,49.0,YR,,M,Y,75.0,KG,20211018.0,,CN,ES,ES,2021,Q4,Adult
199646621,19964662,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 international unit, qd (30 iU, QD)",,,Y,,1f935a,,,30.0,IU,Solution for injection,QD,2021,Q4,Nervousness,,2021,Q4,1,I,20210301.0,20211014.0,20211018,20211018,EXP,,ES-MYLANLABS-2021M1072891,MYLAN,,49.0,YR,,M,Y,75.0,KG,20211018.0,,CN,ES,ES,2021,Q4,Adult
199646621,19964662,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 international unit, qd (20 iU, QD  )",,,Y,,,,,20.0,IU,Solution for injection,QD,2021,Q4,Gait disturbance,,2021,Q4,1,I,20210301.0,20211014.0,20211018,20211018,EXP,,ES-MYLANLABS-2021M1072891,MYLAN,,49.0,YR,,M,Y,75.0,KG,20211018.0,,CN,ES,ES,2021,Q4,Adult
199646621,19964662,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 international unit, qd (20 iU, QD  )",,,Y,,,,,20.0,IU,Solution for injection,QD,2021,Q4,Weight decreased,,2021,Q4,1,I,20210301.0,20211014.0,20211018,20211018,EXP,,ES-MYLANLABS-2021M1072891,MYLAN,,49.0,YR,,M,Y,75.0,KG,20211018.0,,CN,ES,ES,2021,Q4,Adult
199646621,19964662,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 international unit, qd (20 iU, QD  )",,,Y,,,,,20.0,IU,Solution for injection,QD,2021,Q4,Blood glucose fluctuation,,2021,Q4,1,I,20210301.0,20211014.0,20211018,20211018,EXP,,ES-MYLANLABS-2021M1072891,MYLAN,,49.0,YR,,M,Y,75.0,KG,20211018.0,,CN,ES,ES,2021,Q4,Adult
199646621,19964662,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 international unit, qd (20 iU, QD  )",,,Y,,,,,20.0,IU,Solution for injection,QD,2021,Q4,Nervousness,,2021,Q4,1,I,20210301.0,20211014.0,20211018,20211018,EXP,,ES-MYLANLABS-2021M1072891,MYLAN,,49.0,YR,,M,Y,75.0,KG,20211018.0,,CN,ES,ES,2021,Q4,Adult
199655841,19965584,3,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Subcutaneous,100 IU / 50 ?g before breakfast 20 IU,,,U,,,,,20.0,IU,,QD,2021,Q4,Bile duct stone,,2021,Q4,1,I,,20211011.0,20211018,20211018,EXP,,SK-SA-2021SA338452,SANOFI AVENTIS,,66.0,YR,E,M,Y,93.0,KG,20211018.0,,MD,SK,SK,2021,Q4,Elderly
199655841,19965584,3,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Subcutaneous,100 IU / 50 ?g before breakfast 20 IU,,,U,,,,,20.0,IU,,QD,2021,Q4,Balanoposthitis,,2021,Q4,1,I,,20211011.0,20211018,20211018,EXP,,SK-SA-2021SA338452,SANOFI AVENTIS,,66.0,YR,E,M,Y,93.0,KG,20211018.0,,MD,SK,SK,2021,Q4,Elderly
199655841,19965584,3,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Subcutaneous,100 IU / 50 ?g before breakfast 20 IU,,,U,,,,,20.0,IU,,QD,2021,Q4,Diabetic neuropathy,,2021,Q4,1,I,,20211011.0,20211018,20211018,EXP,,SK-SA-2021SA338452,SANOFI AVENTIS,,66.0,YR,E,M,Y,93.0,KG,20211018.0,,MD,SK,SK,2021,Q4,Elderly
199655841,19965584,3,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Subcutaneous,100 IU / 50 ?g before breakfast 20 IU,,,U,,,,,20.0,IU,,QD,2021,Q4,Diabetic retinopathy,,2021,Q4,1,I,,20211011.0,20211018,20211018,EXP,,SK-SA-2021SA338452,SANOFI AVENTIS,,66.0,YR,E,M,Y,93.0,KG,20211018.0,,MD,SK,SK,2021,Q4,Elderly
199655841,19965584,4,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Subcutaneous,in the morning 26 iu,,,U,,,,,26.0,IU,,QD,2021,Q4,Bile duct stone,,2021,Q4,1,I,,20211011.0,20211018,20211018,EXP,,SK-SA-2021SA338452,SANOFI AVENTIS,,66.0,YR,E,M,Y,93.0,KG,20211018.0,,MD,SK,SK,2021,Q4,Elderly
199655841,19965584,4,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Subcutaneous,in the morning 26 iu,,,U,,,,,26.0,IU,,QD,2021,Q4,Balanoposthitis,,2021,Q4,1,I,,20211011.0,20211018,20211018,EXP,,SK-SA-2021SA338452,SANOFI AVENTIS,,66.0,YR,E,M,Y,93.0,KG,20211018.0,,MD,SK,SK,2021,Q4,Elderly
199655841,19965584,4,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Subcutaneous,in the morning 26 iu,,,U,,,,,26.0,IU,,QD,2021,Q4,Diabetic neuropathy,,2021,Q4,1,I,,20211011.0,20211018,20211018,EXP,,SK-SA-2021SA338452,SANOFI AVENTIS,,66.0,YR,E,M,Y,93.0,KG,20211018.0,,MD,SK,SK,2021,Q4,Elderly
199655841,19965584,4,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Subcutaneous,in the morning 26 iu,,,U,,,,,26.0,IU,,QD,2021,Q4,Diabetic retinopathy,,2021,Q4,1,I,,20211011.0,20211018,20211018,EXP,,SK-SA-2021SA338452,SANOFI AVENTIS,,66.0,YR,E,M,Y,93.0,KG,20211018.0,,MD,SK,SK,2021,Q4,Elderly
199655841,19965584,5,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Subcutaneous,in the morning 28 iu,,,U,,,,,28.0,IU,,QD,2021,Q4,Bile duct stone,,2021,Q4,1,I,,20211011.0,20211018,20211018,EXP,,SK-SA-2021SA338452,SANOFI AVENTIS,,66.0,YR,E,M,Y,93.0,KG,20211018.0,,MD,SK,SK,2021,Q4,Elderly
199655841,19965584,5,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Subcutaneous,in the morning 28 iu,,,U,,,,,28.0,IU,,QD,2021,Q4,Balanoposthitis,,2021,Q4,1,I,,20211011.0,20211018,20211018,EXP,,SK-SA-2021SA338452,SANOFI AVENTIS,,66.0,YR,E,M,Y,93.0,KG,20211018.0,,MD,SK,SK,2021,Q4,Elderly
199655841,19965584,5,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Subcutaneous,in the morning 28 iu,,,U,,,,,28.0,IU,,QD,2021,Q4,Diabetic neuropathy,,2021,Q4,1,I,,20211011.0,20211018,20211018,EXP,,SK-SA-2021SA338452,SANOFI AVENTIS,,66.0,YR,E,M,Y,93.0,KG,20211018.0,,MD,SK,SK,2021,Q4,Elderly
199655841,19965584,5,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Subcutaneous,in the morning 28 iu,,,U,,,,,28.0,IU,,QD,2021,Q4,Diabetic retinopathy,,2021,Q4,1,I,,20211011.0,20211018,20211018,EXP,,SK-SA-2021SA338452,SANOFI AVENTIS,,66.0,YR,E,M,Y,93.0,KG,20211018.0,,MD,SK,SK,2021,Q4,Elderly
199682251,19968225,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 units,,,,,,,,,,Injection,,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20210930.0,20211001.0,20211019,20211019,EXP,,JP-ASTRAZENECA-2021A759841,ASTRAZENECA,,74.0,YR,,M,Y,46.0,KG,20211019.0,,MD,JP,JP,2021,Q4,Elderly
199682251,19968225,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 units,,,,,,,,,,Injection,,2021,Q4,Loss of consciousness,,2021,Q4,1,I,20210930.0,20211001.0,20211019,20211019,EXP,,JP-ASTRAZENECA-2021A759841,ASTRAZENECA,,74.0,YR,,M,Y,46.0,KG,20211019.0,,MD,JP,JP,2021,Q4,Elderly
199682251,19968225,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 units,,,,,,,,,,Injection,,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20210930.0,20211001.0,20211019,20211019,EXP,,JP-ASTRAZENECA-2021A759841,ASTRAZENECA,,74.0,YR,,M,Y,46.0,KG,20211019.0,,MD,JP,JP,2021,Q4,Elderly
199682251,19968225,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 units,,,,,,,,,,Injection,,2021,Q4,Loss of consciousness,,2021,Q4,1,I,20210930.0,20211001.0,20211019,20211019,EXP,,JP-ASTRAZENECA-2021A759841,ASTRAZENECA,,74.0,YR,,M,Y,46.0,KG,20211019.0,,MD,JP,JP,2021,Q4,Elderly
199689102,19968910,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 iU,,,Y,,,,,36.0,IU,Solution for injection,,2021,Q4,Hypotension,,2021,Q4,2,F,20210101.0,20211031.0,20211019,20211105,EXP,,ES-MYLANLABS-2021M1073099,MYLAN,,79.0,YR,,M,Y,80.0,KG,20211105.0,,CN,ES,ES,2021,Q4,Elderly
199689102,19968910,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 iU,,,Y,,,,,36.0,IU,Solution for injection,,2021,Q4,Hypoglycaemia,,2021,Q4,2,F,20210101.0,20211031.0,20211019,20211105,EXP,,ES-MYLANLABS-2021M1073099,MYLAN,,79.0,YR,,M,Y,80.0,KG,20211105.0,,CN,ES,ES,2021,Q4,Elderly
199689102,19968910,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 iU,,,Y,,,,,36.0,IU,Solution for injection,,2021,Q4,Blood glucose increased,,2021,Q4,2,F,20210101.0,20211031.0,20211019,20211105,EXP,,ES-MYLANLABS-2021M1073099,MYLAN,,79.0,YR,,M,Y,80.0,KG,20211105.0,,CN,ES,ES,2021,Q4,Elderly
199689102,19968910,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,44 iU,,,Y,,0F779B,,,44.0,IU,Solution for injection,,2021,Q4,Hypotension,,2021,Q4,2,F,20210101.0,20211031.0,20211019,20211105,EXP,,ES-MYLANLABS-2021M1073099,MYLAN,,79.0,YR,,M,Y,80.0,KG,20211105.0,,CN,ES,ES,2021,Q4,Elderly
199689102,19968910,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,44 iU,,,Y,,0F779B,,,44.0,IU,Solution for injection,,2021,Q4,Hypoglycaemia,,2021,Q4,2,F,20210101.0,20211031.0,20211019,20211105,EXP,,ES-MYLANLABS-2021M1073099,MYLAN,,79.0,YR,,M,Y,80.0,KG,20211105.0,,CN,ES,ES,2021,Q4,Elderly
199689102,19968910,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,44 iU,,,Y,,0F779B,,,44.0,IU,Solution for injection,,2021,Q4,Blood glucose increased,,2021,Q4,2,F,20210101.0,20211031.0,20211019,20211105,EXP,,ES-MYLANLABS-2021M1073099,MYLAN,,79.0,YR,,M,Y,80.0,KG,20211105.0,,CN,ES,ES,2021,Q4,Elderly
199689941,19968994,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Fungal infection,,2021,Q4,1,I,20180101.0,20200804.0,20211019,20211019,EXP,,CZ-MYLANLABS-2020M1070332,MYLAN,"Novakova M, Svobodova K, Hercogova J.. Unusual manifestation of cutaneous mycosis in a patient after heart transplantation.. CESKA DERMATOVENEROLOGIE. 2020;10(2):116-119",65.0,YR,,M,Y,,,20211019.0,,HP,CZ,CZ,2021,Q4,Elderly
199689941,19968994,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Skin haemorrhage,,2021,Q4,1,I,20180101.0,20200804.0,20211019,20211019,EXP,,CZ-MYLANLABS-2020M1070332,MYLAN,"Novakova M, Svobodova K, Hercogova J.. Unusual manifestation of cutaneous mycosis in a patient after heart transplantation.. CESKA DERMATOVENEROLOGIE. 2020;10(2):116-119",65.0,YR,,M,Y,,,20211019.0,,HP,CZ,CZ,2021,Q4,Elderly
199689941,19968994,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Skin ulcer,,2021,Q4,1,I,20180101.0,20200804.0,20211019,20211019,EXP,,CZ-MYLANLABS-2020M1070332,MYLAN,"Novakova M, Svobodova K, Hercogova J.. Unusual manifestation of cutaneous mycosis in a patient after heart transplantation.. CESKA DERMATOVENEROLOGIE. 2020;10(2):116-119",65.0,YR,,M,Y,,,20211019.0,,HP,CZ,CZ,2021,Q4,Elderly
199689941,19968994,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Mass,,2021,Q4,1,I,20180101.0,20200804.0,20211019,20211019,EXP,,CZ-MYLANLABS-2020M1070332,MYLAN,"Novakova M, Svobodova K, Hercogova J.. Unusual manifestation of cutaneous mycosis in a patient after heart transplantation.. CESKA DERMATOVENEROLOGIE. 2020;10(2):116-119",65.0,YR,,M,Y,,,20211019.0,,HP,CZ,CZ,2021,Q4,Elderly
199689941,19968994,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Back pain,,2021,Q4,1,I,20180101.0,20200804.0,20211019,20211019,EXP,,CZ-MYLANLABS-2020M1070332,MYLAN,"Novakova M, Svobodova K, Hercogova J.. Unusual manifestation of cutaneous mycosis in a patient after heart transplantation.. CESKA DERMATOVENEROLOGIE. 2020;10(2):116-119",65.0,YR,,M,Y,,,20211019.0,,HP,CZ,CZ,2021,Q4,Elderly
199689941,19968994,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Trichophytosis,,2021,Q4,1,I,20180101.0,20200804.0,20211019,20211019,EXP,,CZ-MYLANLABS-2020M1070332,MYLAN,"Novakova M, Svobodova K, Hercogova J.. Unusual manifestation of cutaneous mycosis in a patient after heart transplantation.. CESKA DERMATOVENEROLOGIE. 2020;10(2):116-119",65.0,YR,,M,Y,,,20211019.0,,HP,CZ,CZ,2021,Q4,Elderly
199707671,19970767,32,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,Y,U,,,,,,,,2021,Q4,Cytomegalovirus infection reactivation,,2021,Q4,1,I,20190809.0,20211014.0,20211019,20211019,EXP,,ES-MYLANLABS-2021M1073200,MYLAN,,73.0,YR,,M,Y,73.0,KG,20211019.0,,MD,ES,ES,2021,Q4,Elderly
199707671,19970767,32,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,Y,U,,,,,,,,2021,Q4,Fluid retention,,2021,Q4,1,I,20190809.0,20211014.0,20211019,20211019,EXP,,ES-MYLANLABS-2021M1073200,MYLAN,,73.0,YR,,M,Y,73.0,KG,20211019.0,,MD,ES,ES,2021,Q4,Elderly
199707671,19970767,32,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,Y,U,,,,,,,,2021,Q4,Tremor,,2021,Q4,1,I,20190809.0,20211014.0,20211019,20211019,EXP,,ES-MYLANLABS-2021M1073200,MYLAN,,73.0,YR,,M,Y,73.0,KG,20211019.0,,MD,ES,ES,2021,Q4,Elderly
199711861,19971186,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"20 IU, qd (morning)",,,,,UNKNOWN,,,20.0,IU,,QD,2021,Q4,Transient ischaemic attack,,2021,Q4,1,I,20201201.0,20211009.0,20211020,20211020,EXP,,BR-NOVOPROD-856924,NOVO NORDISK,,73.0,YR,,F,Y,62.0,KG,20211020.0,,MD,BR,BR,2021,Q4,Elderly
199711861,19971186,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"20 IU, qd (morning)",,,,,UNKNOWN,,,20.0,IU,,QD,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,20201201.0,20211009.0,20211020,20211020,EXP,,BR-NOVOPROD-856924,NOVO NORDISK,,73.0,YR,,F,Y,62.0,KG,20211020.0,,MD,BR,BR,2021,Q4,Elderly
199711861,19971186,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"20 IU, qd (morning)",,,,,UNKNOWN,,,20.0,IU,,QD,2021,Q4,Renal impairment,,2021,Q4,1,I,20201201.0,20211009.0,20211020,20211020,EXP,,BR-NOVOPROD-856924,NOVO NORDISK,,73.0,YR,,F,Y,62.0,KG,20211020.0,,MD,BR,BR,2021,Q4,Elderly
199726881,19972688,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 international unit, Once a Day(12 iU, QD)",,,U,,1F090A,,,12.0,IU,Solution for injection,QD,2021,Q4,Asthenia,,2021,Q4,1,I,20210901.0,20211008.0,20211020,20211020,EXP,,ES-AUROBINDO-AUR-APL-2021-042864,AUROBINDO,,69.0,YR,,M,Y,69.0,KG,20211020.0,,HP,ES,ES,2021,Q4,Elderly
199726881,19972688,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 international unit, Once a Day(12 iU, QD)",,,U,,1F090A,,,12.0,IU,Solution for injection,QD,2021,Q4,Blood glucose fluctuation,,2021,Q4,1,I,20210901.0,20211008.0,20211020,20211020,EXP,,ES-AUROBINDO-AUR-APL-2021-042864,AUROBINDO,,69.0,YR,,M,Y,69.0,KG,20211020.0,,HP,ES,ES,2021,Q4,Elderly
199762011,19976201,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,30 units at bedtime,,,,,,,,,,Unknown,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,,20211012.0,20211021,20211021,EXP,,CA-JNJFOC-20211035870,JOHNSON AND JOHNSON,,17.0,YR,T,M,Y,,,20211021.0,,MD,CA,CA,2021,Q4,Youth
199762011,19976201,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,30 units at bedtime,,,,,,,,,,Unknown,,2021,Q4,Product use issue,,2021,Q4,1,I,,20211012.0,20211021,20211021,EXP,,CA-JNJFOC-20211035870,JOHNSON AND JOHNSON,,17.0,YR,T,M,Y,,,20211021.0,,MD,CA,CA,2021,Q4,Youth
199762011,19976201,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,30 units at bedtime,,,,,,,,,,Unknown,,2021,Q4,Off label use,,2021,Q4,1,I,,20211012.0,20211021,20211021,EXP,,CA-JNJFOC-20211035870,JOHNSON AND JOHNSON,,17.0,YR,T,M,Y,,,20211021.0,,MD,CA,CA,2021,Q4,Youth
199762691,19976269,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 international unit, Once a Day",,,,,,,,25.0,IU,,QD,2021,Q4,Cardioactive drug level increased,,2021,Q4,1,I,20210901.0,20211008.0,20211021,20211021,EXP,,FR-AUROBINDO-AUR-APL-2021-042879,AUROBINDO,,67.0,YR,,M,Y,81.8,KG,20211021.0,,PH,FR,FR,2021,Q4,Elderly
199762691,19976269,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 international unit, Once a Day",,,,,,,,25.0,IU,,QD,2021,Q4,Sinus bradycardia,,2021,Q4,1,I,20210901.0,20211008.0,20211021,20211021,EXP,,FR-AUROBINDO-AUR-APL-2021-042879,AUROBINDO,,67.0,YR,,M,Y,81.8,KG,20211021.0,,PH,FR,FR,2021,Q4,Elderly
199796141,19979614,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 iU, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,24.0,IU,Solution for injection,QD,2021,Q4,Drug ineffective,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 iU, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,24.0,IU,Solution for injection,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 iU, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,24.0,IU,Solution for injection,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 iU, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,24.0,IU,Solution for injection,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 iU, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,24.0,IU,Solution for injection,QD,2021,Q4,Hyperhidrosis,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 iU, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,24.0,IU,Solution for injection,QD,2021,Q4,Fatigue,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 iU, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,24.0,IU,Solution for injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 iU, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,24.0,IU,Solution for injection,QD,2021,Q4,Product prescribing issue,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 iU, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,24.0,IU,Solution for injection,QD,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 iU, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,24.0,IU,Solution for injection,QD,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,,,Solution for injection,QD,2021,Q4,Drug ineffective,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,,,Solution for injection,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,,,Solution for injection,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,,,Solution for injection,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,,,Solution for injection,QD,2021,Q4,Hyperhidrosis,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,,,Solution for injection,QD,2021,Q4,Fatigue,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,,,Solution for injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,,,Solution for injection,QD,2021,Q4,Product prescribing issue,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,,,Solution for injection,QD,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,,,Solution for injection,QD,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 iU, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,36.0,IU,Solution for injection,QD,2021,Q4,Drug ineffective,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 iU, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,36.0,IU,Solution for injection,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 iU, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,36.0,IU,Solution for injection,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 iU, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,36.0,IU,Solution for injection,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 iU, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,36.0,IU,Solution for injection,QD,2021,Q4,Hyperhidrosis,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 iU, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,36.0,IU,Solution for injection,QD,2021,Q4,Fatigue,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 iU, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,36.0,IU,Solution for injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 iU, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,36.0,IU,Solution for injection,QD,2021,Q4,Product prescribing issue,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 iU, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,36.0,IU,Solution for injection,QD,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 iU, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,36.0,IU,Solution for injection,QD,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 iU, QD (dose reduced)",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,36.0,IU,Solution for injection,QD,2021,Q4,Drug ineffective,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 iU, QD (dose reduced)",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,36.0,IU,Solution for injection,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 iU, QD (dose reduced)",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,36.0,IU,Solution for injection,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 iU, QD (dose reduced)",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,36.0,IU,Solution for injection,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 iU, QD (dose reduced)",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,36.0,IU,Solution for injection,QD,2021,Q4,Hyperhidrosis,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 iU, QD (dose reduced)",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,36.0,IU,Solution for injection,QD,2021,Q4,Fatigue,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 iU, QD (dose reduced)",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,36.0,IU,Solution for injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 iU, QD (dose reduced)",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,36.0,IU,Solution for injection,QD,2021,Q4,Product prescribing issue,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 iU, QD (dose reduced)",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,36.0,IU,Solution for injection,QD,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 iU, QD (dose reduced)",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,36.0,IU,Solution for injection,QD,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 iU, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,40.0,IU,Solution for injection,QD,2021,Q4,Drug ineffective,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 iU, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,40.0,IU,Solution for injection,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 iU, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,40.0,IU,Solution for injection,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 iU, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,40.0,IU,Solution for injection,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 iU, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,40.0,IU,Solution for injection,QD,2021,Q4,Hyperhidrosis,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 iU, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,40.0,IU,Solution for injection,QD,2021,Q4,Fatigue,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 iU, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,40.0,IU,Solution for injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 iU, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,40.0,IU,Solution for injection,QD,2021,Q4,Product prescribing issue,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 iU, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,40.0,IU,Solution for injection,QD,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 iU, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,40.0,IU,Solution for injection,QD,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 iU, QD (dose reduced)",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,34.0,IU,Solution for injection,QD,2021,Q4,Drug ineffective,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 iU, QD (dose reduced)",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,34.0,IU,Solution for injection,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 iU, QD (dose reduced)",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,34.0,IU,Solution for injection,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 iU, QD (dose reduced)",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,34.0,IU,Solution for injection,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 iU, QD (dose reduced)",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,34.0,IU,Solution for injection,QD,2021,Q4,Hyperhidrosis,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 iU, QD (dose reduced)",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,34.0,IU,Solution for injection,QD,2021,Q4,Fatigue,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 iU, QD (dose reduced)",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,34.0,IU,Solution for injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 iU, QD (dose reduced)",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,34.0,IU,Solution for injection,QD,2021,Q4,Product prescribing issue,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 iU, QD (dose reduced)",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,34.0,IU,Solution for injection,QD,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 iU, QD (dose reduced)",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,34.0,IU,Solution for injection,QD,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 iU, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,28.0,IU,Solution for injection,QD,2021,Q4,Drug ineffective,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 iU, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,28.0,IU,Solution for injection,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 iU, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,28.0,IU,Solution for injection,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 iU, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,28.0,IU,Solution for injection,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 iU, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,28.0,IU,Solution for injection,QD,2021,Q4,Hyperhidrosis,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 iU, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,28.0,IU,Solution for injection,QD,2021,Q4,Fatigue,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 iU, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,28.0,IU,Solution for injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 iU, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,28.0,IU,Solution for injection,QD,2021,Q4,Product prescribing issue,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 iU, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,28.0,IU,Solution for injection,QD,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199796141,19979614,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 iU, QD",,,Y,,"1F935A,1F935A,1F040A,1F040A",,,28.0,IU,Solution for injection,QD,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,20200101.0,20211015.0,20211021,20211021,EXP,,ES-BAUSCH-BL-2021-034861,BAUSCH AND LOMB,,68.0,YR,,M,Y,83.0,KG,20211021.0,,CN,ES,ES,2021,Q4,Elderly
199799421,19979942,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 dosage form, qd",,,U,U,,,,,,,QD,2021,Q4,Therapeutic product effect increased,,2021,Q4,1,I,,20211011.0,20211021,20211021,EXP,,US-MYLANLABS-2021M1073825,MYLAN,"Del Toro-Pagan NM, Matos A, Thacker D, Turgeon J, Amin NS, Michaud V. Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report. Medicina-Kaunas 2021;57:No. 9.",66.0,YR,,F,Y,,,20211021.0,,HP,US,US,2021,Q4,Elderly
199799421,19979942,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 dosage form, qd",,,U,U,,,,,,,QD,2021,Q4,Bradycardia,,2021,Q4,1,I,,20211011.0,20211021,20211021,EXP,,US-MYLANLABS-2021M1073825,MYLAN,"Del Toro-Pagan NM, Matos A, Thacker D, Turgeon J, Amin NS, Michaud V. Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report. Medicina-Kaunas 2021;57:No. 9.",66.0,YR,,F,Y,,,20211021.0,,HP,US,US,2021,Q4,Elderly
199799421,19979942,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 dosage form, qd",,,U,U,,,,,,,QD,2021,Q4,CYP2D6 gene status assay,,2021,Q4,1,I,,20211011.0,20211021,20211021,EXP,,US-MYLANLABS-2021M1073825,MYLAN,"Del Toro-Pagan NM, Matos A, Thacker D, Turgeon J, Amin NS, Michaud V. Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report. Medicina-Kaunas 2021;57:No. 9.",66.0,YR,,F,Y,,,20211021.0,,HP,US,US,2021,Q4,Elderly
199799421,19979942,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 dosage form, qd",,,U,U,,,,,,,QD,2021,Q4,Drug interaction,,2021,Q4,1,I,,20211011.0,20211021,20211021,EXP,,US-MYLANLABS-2021M1073825,MYLAN,"Del Toro-Pagan NM, Matos A, Thacker D, Turgeon J, Amin NS, Michaud V. Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report. Medicina-Kaunas 2021;57:No. 9.",66.0,YR,,F,Y,,,20211021.0,,HP,US,US,2021,Q4,Elderly
199799421,19979942,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 dosage form, qd",,,U,U,,,,,,,QD,2021,Q4,Cytogenetic analysis abnormal,,2021,Q4,1,I,,20211011.0,20211021,20211021,EXP,,US-MYLANLABS-2021M1073825,MYLAN,"Del Toro-Pagan NM, Matos A, Thacker D, Turgeon J, Amin NS, Michaud V. Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report. Medicina-Kaunas 2021;57:No. 9.",66.0,YR,,F,Y,,,20211021.0,,HP,US,US,2021,Q4,Elderly
199802371,19980237,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,210605.0,,,,,2021,Q4,Multiple organ dysfunction syndrome,,2021,Q4,1,I,,20211013.0,20211021,20211021,EXP,,US-MYLANLABS-2021M1074514,MYLAN,"Billig V, Lindo P. A CASE OF MALIGNANT HYPERTHERMIA IN A PATIENT WITH HYPEROSMOLAR HYPERGLYCEMIC STATE. Chest 2021;160 (Suppl.)(4):A653.",24.0,YR,,M,Y,,,20211021.0,,HP,US,US,2021,Q4,Young Adult
199802371,19980237,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,210605.0,,,,,2021,Q4,Cardio-respiratory arrest,,2021,Q4,1,I,,20211013.0,20211021,20211021,EXP,,US-MYLANLABS-2021M1074514,MYLAN,"Billig V, Lindo P. A CASE OF MALIGNANT HYPERTHERMIA IN A PATIENT WITH HYPEROSMOLAR HYPERGLYCEMIC STATE. Chest 2021;160 (Suppl.)(4):A653.",24.0,YR,,M,Y,,,20211021.0,,HP,US,US,2021,Q4,Young Adult
199802371,19980237,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,210605.0,,,,,2021,Q4,Hyperthermia malignant,,2021,Q4,1,I,,20211013.0,20211021,20211021,EXP,,US-MYLANLABS-2021M1074514,MYLAN,"Billig V, Lindo P. A CASE OF MALIGNANT HYPERTHERMIA IN A PATIENT WITH HYPEROSMOLAR HYPERGLYCEMIC STATE. Chest 2021;160 (Suppl.)(4):A653.",24.0,YR,,M,Y,,,20211021.0,,HP,US,US,2021,Q4,Young Adult
199802371,19980237,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,210605.0,,,,,2021,Q4,Disseminated intravascular coagulation,,2021,Q4,1,I,,20211013.0,20211021,20211021,EXP,,US-MYLANLABS-2021M1074514,MYLAN,"Billig V, Lindo P. A CASE OF MALIGNANT HYPERTHERMIA IN A PATIENT WITH HYPEROSMOLAR HYPERGLYCEMIC STATE. Chest 2021;160 (Suppl.)(4):A653.",24.0,YR,,M,Y,,,20211021.0,,HP,US,US,2021,Q4,Young Adult
199802371,19980237,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,210605.0,,,,,2021,Q4,Tachyarrhythmia,,2021,Q4,1,I,,20211013.0,20211021,20211021,EXP,,US-MYLANLABS-2021M1074514,MYLAN,"Billig V, Lindo P. A CASE OF MALIGNANT HYPERTHERMIA IN A PATIENT WITH HYPEROSMOLAR HYPERGLYCEMIC STATE. Chest 2021;160 (Suppl.)(4):A653.",24.0,YR,,M,Y,,,20211021.0,,HP,US,US,2021,Q4,Young Adult
199805722,19980572,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 international unit, daily",,,U,,1F080A,,,16.0,IU,,QD,2021,Q4,Hypoglycaemia,,2021,Q4,2,F,20210927.0,20211103.0,20211021,20211110,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202110004586,ELI LILLY AND CO,,77.0,YR,,F,Y,74.4,KG,20211110.0,,CN,ES,ES,2021,Q4,Elderly
199805722,19980572,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 international unit, daily",,,U,,1F080A,,,16.0,IU,,QD,2021,Q4,Feeling hot,,2021,Q4,2,F,20210927.0,20211103.0,20211021,20211110,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202110004586,ELI LILLY AND CO,,77.0,YR,,F,Y,74.4,KG,20211110.0,,CN,ES,ES,2021,Q4,Elderly
199805722,19980572,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 international unit, daily",,,U,,1F080A,,,16.0,IU,,QD,2021,Q4,Asthenia,,2021,Q4,2,F,20210927.0,20211103.0,20211021,20211110,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202110004586,ELI LILLY AND CO,,77.0,YR,,F,Y,74.4,KG,20211110.0,,CN,ES,ES,2021,Q4,Elderly
199805722,19980572,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 international unit, daily",,,U,,1F080A,,,16.0,IU,,QD,2021,Q4,Hyperglycaemia,,2021,Q4,2,F,20210927.0,20211103.0,20211021,20211110,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202110004586,ELI LILLY AND CO,,77.0,YR,,F,Y,74.4,KG,20211110.0,,CN,ES,ES,2021,Q4,Elderly
199805722,19980572,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 international unit, daily",,,U,,1F080A,,,16.0,IU,,QD,2021,Q4,Feeling abnormal,,2021,Q4,2,F,20210927.0,20211103.0,20211021,20211110,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202110004586,ELI LILLY AND CO,,77.0,YR,,F,Y,74.4,KG,20211110.0,,CN,ES,ES,2021,Q4,Elderly
199805722,19980572,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 international unit, daily",,,U,,1F080A,,,16.0,IU,,QD,2021,Q4,Blood glucose increased,,2021,Q4,2,F,20210927.0,20211103.0,20211021,20211110,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202110004586,ELI LILLY AND CO,,77.0,YR,,F,Y,74.4,KG,20211110.0,,CN,ES,ES,2021,Q4,Elderly
199805722,19980572,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 international unit, daily",,,U,,1F080A,,,16.0,IU,,QD,2021,Q4,Cold sweat,,2021,Q4,2,F,20210927.0,20211103.0,20211021,20211110,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202110004586,ELI LILLY AND CO,,77.0,YR,,F,Y,74.4,KG,20211110.0,,CN,ES,ES,2021,Q4,Elderly
199805722,19980572,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 international unit, daily",,,U,,1F080A,,,16.0,IU,,QD,2021,Q4,Nervousness,,2021,Q4,2,F,20210927.0,20211103.0,20211021,20211110,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202110004586,ELI LILLY AND CO,,77.0,YR,,F,Y,74.4,KG,20211110.0,,CN,ES,ES,2021,Q4,Elderly
199805722,19980572,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 international unit, daily",,,U,,1F080A,,,16.0,IU,,QD,2021,Q4,Feeling abnormal,,2021,Q4,2,F,20210927.0,20211103.0,20211021,20211110,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202110004586,ELI LILLY AND CO,,77.0,YR,,F,Y,74.4,KG,20211110.0,,CN,ES,ES,2021,Q4,Elderly
199805722,19980572,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 international unit, daily",,,U,,1F080A,,,16.0,IU,,QD,2021,Q4,Nervousness,,2021,Q4,2,F,20210927.0,20211103.0,20211021,20211110,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202110004586,ELI LILLY AND CO,,77.0,YR,,F,Y,74.4,KG,20211110.0,,CN,ES,ES,2021,Q4,Elderly
199805722,19980572,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 international unit, daily",,,U,,1F080A,,,16.0,IU,,QD,2021,Q4,Hyperhidrosis,,2021,Q4,2,F,20210927.0,20211103.0,20211021,20211110,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202110004586,ELI LILLY AND CO,,77.0,YR,,F,Y,74.4,KG,20211110.0,,CN,ES,ES,2021,Q4,Elderly
199805722,19980572,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 international unit, daily",,,U,,1F080A,,,16.0,IU,,QD,2021,Q4,Hyperhidrosis,,2021,Q4,2,F,20210927.0,20211103.0,20211021,20211110,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202110004586,ELI LILLY AND CO,,77.0,YR,,F,Y,74.4,KG,20211110.0,,CN,ES,ES,2021,Q4,Elderly
199805722,19980572,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 international unit, daily",,,U,,1F080A,,,16.0,IU,,QD,2021,Q4,Hypoglycaemia,,2021,Q4,2,F,20210927.0,20211103.0,20211021,20211110,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202110004586,ELI LILLY AND CO,,77.0,YR,,F,Y,74.4,KG,20211110.0,,CN,ES,ES,2021,Q4,Elderly
199805722,19980572,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 international unit, daily",,,U,,1F080A,,,16.0,IU,,QD,2021,Q4,Abnormal dreams,,2021,Q4,2,F,20210927.0,20211103.0,20211021,20211110,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202110004586,ELI LILLY AND CO,,77.0,YR,,F,Y,74.4,KG,20211110.0,,CN,ES,ES,2021,Q4,Elderly
199817641,19981764,2,SS,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,Subcutaneous,"12 IU, qd",,,U,U,,,,12.0,IU,,QD,2021,Q4,Intentional overdose,,2021,Q4,1,I,,20211011.0,20211022,20211022,EXP,,JP-NOVOPROD-857298,NOVO NORDISK,"Yuka Kaikoi, et al. A case of type 1 diabetes mellitus leading to congestive cardiac failure after factitious hypoglycaemia developed. The 95th Japan Diabetes Society Chubu Chapter Meeting, Program and abstracts. 2021;45",42.0,YR,,F,Y,,,20211022.0,,MD,JP,JP,2021,Q4,Adult
199817641,19981764,2,SS,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,Subcutaneous,"12 IU, qd",,,U,U,,,,12.0,IU,,QD,2021,Q4,Cardiac failure congestive,,2021,Q4,1,I,,20211011.0,20211022,20211022,EXP,,JP-NOVOPROD-857298,NOVO NORDISK,"Yuka Kaikoi, et al. A case of type 1 diabetes mellitus leading to congestive cardiac failure after factitious hypoglycaemia developed. The 95th Japan Diabetes Society Chubu Chapter Meeting, Program and abstracts. 2021;45",42.0,YR,,F,Y,,,20211022.0,,MD,JP,JP,2021,Q4,Adult
199817641,19981764,2,SS,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,Subcutaneous,"12 IU, qd",,,U,U,,,,12.0,IU,,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211011.0,20211022,20211022,EXP,,JP-NOVOPROD-857298,NOVO NORDISK,"Yuka Kaikoi, et al. A case of type 1 diabetes mellitus leading to congestive cardiac failure after factitious hypoglycaemia developed. The 95th Japan Diabetes Society Chubu Chapter Meeting, Program and abstracts. 2021;45",42.0,YR,,F,Y,,,20211022.0,,MD,JP,JP,2021,Q4,Adult
199843941,19984394,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Angioedema,,2021,Q4,1,I,20211003.0,,20211022,20211022,DIR,587641,,FDA-CTU,,58.0,YR,,F,N,137.7,KG,20211022.0,N,PH,US,US,2021,Q4,Adult
199846324,19984632,7,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,Subcutaneous,"6 units, once daily (before sleep)",,,,,,,,,,For solution,QD,2021,Q4,Sepsis,,2021,Q4,4,F,20211017.0,20211122.0,20211022,20211129,EXP,,JP-ASTELLAS-2021JP020149,ASTELLAS,,62.0,YR,,M,Y,64.0,KG,20211129.0,,MD,JP,JP,2021,Q4,Adult
199846324,19984632,7,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,Subcutaneous,"6 units, once daily (before sleep)",,,,,,,,,,For solution,QD,2021,Q4,Acute kidney injury,,2021,Q4,4,F,20211017.0,20211122.0,20211022,20211129,EXP,,JP-ASTELLAS-2021JP020149,ASTELLAS,,62.0,YR,,M,Y,64.0,KG,20211129.0,,MD,JP,JP,2021,Q4,Adult
199846324,19984632,7,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,Subcutaneous,"6 units, once daily (before sleep)",,,,,,,,,,For solution,QD,2021,Q4,Electrocardiogram ST segment elevation,,2021,Q4,4,F,20211017.0,20211122.0,20211022,20211129,EXP,,JP-ASTELLAS-2021JP020149,ASTELLAS,,62.0,YR,,M,Y,64.0,KG,20211129.0,,MD,JP,JP,2021,Q4,Adult
199846324,19984632,7,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,Subcutaneous,"6 units, once daily (before sleep)",,,,,,,,,,For solution,QD,2021,Q4,Mucosal disorder,,2021,Q4,4,F,20211017.0,20211122.0,20211022,20211129,EXP,,JP-ASTELLAS-2021JP020149,ASTELLAS,,62.0,YR,,M,Y,64.0,KG,20211129.0,,MD,JP,JP,2021,Q4,Adult
199846324,19984632,7,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,Subcutaneous,"6 units, once daily (before sleep)",,,,,,,,,,For solution,QD,2021,Q4,Pneumonia,,2021,Q4,4,F,20211017.0,20211122.0,20211022,20211129,EXP,,JP-ASTELLAS-2021JP020149,ASTELLAS,,62.0,YR,,M,Y,64.0,KG,20211129.0,,MD,JP,JP,2021,Q4,Adult
199846324,19984632,7,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,Subcutaneous,"6 units, once daily (before sleep)",,,,,,,,,,For solution,QD,2021,Q4,Hypokalaemia,,2021,Q4,4,F,20211017.0,20211122.0,20211022,20211129,EXP,,JP-ASTELLAS-2021JP020149,ASTELLAS,,62.0,YR,,M,Y,64.0,KG,20211129.0,,MD,JP,JP,2021,Q4,Adult
199847881,19984788,16,C,Insulin glargine sq,,2,,,,,,,,,,,,,,2021,Q4,Abdominal distension,,2021,Q4,1,I,20211017.0,,20211022,20211022,DIR,587660,,FDA-CTU,,54.0,YR,,M,N,90.3,KG,20211022.0,Y,PH,US,US,2021,Q4,Adult
199847881,19984788,16,C,Insulin glargine sq,,2,,,,,,,,,,,,,,2021,Q4,Pneumoperitoneum,,2021,Q4,1,I,20211017.0,,20211022,20211022,DIR,587660,,FDA-CTU,,54.0,YR,,M,N,90.3,KG,20211022.0,Y,PH,US,US,2021,Q4,Adult
199847881,19984788,16,C,Insulin glargine sq,,2,,,,,,,,,,,,,,2021,Q4,Large intestine perforation,,2021,Q4,1,I,20211017.0,,20211022,20211022,DIR,587660,,FDA-CTU,,54.0,YR,,M,N,90.3,KG,20211022.0,Y,PH,US,US,2021,Q4,Adult
199847881,19984788,16,C,Insulin glargine sq,,2,,,,,,,,,,,,,,2021,Q4,Pyrexia,,2021,Q4,1,I,20211017.0,,20211022,20211022,DIR,587660,,FDA-CTU,,54.0,YR,,M,N,90.3,KG,20211022.0,Y,PH,US,US,2021,Q4,Adult
199848342,19984834,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,9F6516A,,21081.0,,,Solution for injection,,2021,Q4,Benign pancreatic neoplasm,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,9F6516A,,21081.0,,,Solution for injection,,2021,Q4,Condition aggravated,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,9F6516A,,21081.0,,,Solution for injection,,2021,Q4,Weight increased,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,9F6516A,,21081.0,,,Solution for injection,,2021,Q4,Urine analysis abnormal,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,9F6516A,,21081.0,,,Solution for injection,,2021,Q4,Blood glucose abnormal,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,9F6516A,,21081.0,,,Solution for injection,,2021,Q4,Visual impairment,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,9F6516A,,21081.0,,,Solution for injection,,2021,Q4,Hepatic neoplasm,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,9F6516A,,21081.0,,,Solution for injection,,2021,Q4,Asthenia,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,9F6516A,,21081.0,,,Solution for injection,,2021,Q4,Fatigue,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,9F6516A,,21081.0,,,Solution for injection,,2021,Q4,Weight decreased,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,9F6516A,,21081.0,,,Solution for injection,,2021,Q4,Pancreatic cyst,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,9F6516A,,21081.0,,,Solution for injection,,2021,Q4,Loss of consciousness,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,9F6516A,,21081.0,,,Solution for injection,,2021,Q4,Blood sodium decreased,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,9F6516A,,21081.0,,,Solution for injection,,2021,Q4,Blood pressure abnormal,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,9F6516A,,21081.0,,,Solution for injection,,2021,Q4,Blood disorder,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,9F6516A,,21081.0,,,Solution for injection,,2021,Q4,Intentional product misuse,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,9F6516A,,21081.0,,,Solution for injection,,2021,Q4,Renal disorder,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,9F6516A,,21081.0,,,Solution for injection,,2021,Q4,Blood glucose fluctuation,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,9F6516A,,21081.0,,,Solution for injection,,2021,Q4,Nocturia,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,9F6516A,,21081.0,,,Solution for injection,,2021,Q4,Cyanosis,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,9F6516A,,21081.0,,,Solution for injection,,2021,Q4,Hepatic cyst,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,9F6516A,,21081.0,,,Solution for injection,,2021,Q4,Hypertension,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,9F6516A,,21081.0,,,Solution for injection,,2021,Q4,Fluid retention,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,9F6516A,,21081.0,,,Solution for injection,,2021,Q4,Abdominal distension,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,9F6516A,,21081.0,,,Solution for injection,,2021,Q4,Hypoglycaemia,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,9F6516A,,21081.0,,,Solution for injection,,2021,Q4,Hypoglycaemia,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,9F6516A,,21081.0,,,Solution for injection,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 iU (dose reduced to 26 iU),,,Y,,9F6516A,,21081.0,26.0,IU,Solution for injection,,2021,Q4,Benign pancreatic neoplasm,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 iU (dose reduced to 26 iU),,,Y,,9F6516A,,21081.0,26.0,IU,Solution for injection,,2021,Q4,Condition aggravated,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 iU (dose reduced to 26 iU),,,Y,,9F6516A,,21081.0,26.0,IU,Solution for injection,,2021,Q4,Weight increased,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 iU (dose reduced to 26 iU),,,Y,,9F6516A,,21081.0,26.0,IU,Solution for injection,,2021,Q4,Urine analysis abnormal,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 iU (dose reduced to 26 iU),,,Y,,9F6516A,,21081.0,26.0,IU,Solution for injection,,2021,Q4,Blood glucose abnormal,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 iU (dose reduced to 26 iU),,,Y,,9F6516A,,21081.0,26.0,IU,Solution for injection,,2021,Q4,Visual impairment,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 iU (dose reduced to 26 iU),,,Y,,9F6516A,,21081.0,26.0,IU,Solution for injection,,2021,Q4,Hepatic neoplasm,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 iU (dose reduced to 26 iU),,,Y,,9F6516A,,21081.0,26.0,IU,Solution for injection,,2021,Q4,Asthenia,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 iU (dose reduced to 26 iU),,,Y,,9F6516A,,21081.0,26.0,IU,Solution for injection,,2021,Q4,Fatigue,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 iU (dose reduced to 26 iU),,,Y,,9F6516A,,21081.0,26.0,IU,Solution for injection,,2021,Q4,Weight decreased,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 iU (dose reduced to 26 iU),,,Y,,9F6516A,,21081.0,26.0,IU,Solution for injection,,2021,Q4,Pancreatic cyst,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 iU (dose reduced to 26 iU),,,Y,,9F6516A,,21081.0,26.0,IU,Solution for injection,,2021,Q4,Loss of consciousness,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 iU (dose reduced to 26 iU),,,Y,,9F6516A,,21081.0,26.0,IU,Solution for injection,,2021,Q4,Blood sodium decreased,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 iU (dose reduced to 26 iU),,,Y,,9F6516A,,21081.0,26.0,IU,Solution for injection,,2021,Q4,Blood pressure abnormal,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 iU (dose reduced to 26 iU),,,Y,,9F6516A,,21081.0,26.0,IU,Solution for injection,,2021,Q4,Blood disorder,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 iU (dose reduced to 26 iU),,,Y,,9F6516A,,21081.0,26.0,IU,Solution for injection,,2021,Q4,Intentional product misuse,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 iU (dose reduced to 26 iU),,,Y,,9F6516A,,21081.0,26.0,IU,Solution for injection,,2021,Q4,Renal disorder,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 iU (dose reduced to 26 iU),,,Y,,9F6516A,,21081.0,26.0,IU,Solution for injection,,2021,Q4,Blood glucose fluctuation,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 iU (dose reduced to 26 iU),,,Y,,9F6516A,,21081.0,26.0,IU,Solution for injection,,2021,Q4,Nocturia,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 iU (dose reduced to 26 iU),,,Y,,9F6516A,,21081.0,26.0,IU,Solution for injection,,2021,Q4,Cyanosis,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 iU (dose reduced to 26 iU),,,Y,,9F6516A,,21081.0,26.0,IU,Solution for injection,,2021,Q4,Hepatic cyst,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 iU (dose reduced to 26 iU),,,Y,,9F6516A,,21081.0,26.0,IU,Solution for injection,,2021,Q4,Hypertension,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 iU (dose reduced to 26 iU),,,Y,,9F6516A,,21081.0,26.0,IU,Solution for injection,,2021,Q4,Fluid retention,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 iU (dose reduced to 26 iU),,,Y,,9F6516A,,21081.0,26.0,IU,Solution for injection,,2021,Q4,Abdominal distension,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 iU (dose reduced to 26 iU),,,Y,,9F6516A,,21081.0,26.0,IU,Solution for injection,,2021,Q4,Hypoglycaemia,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 iU (dose reduced to 26 iU),,,Y,,9F6516A,,21081.0,26.0,IU,Solution for injection,,2021,Q4,Hypoglycaemia,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 iU (dose reduced to 26 iU),,,Y,,9F6516A,,21081.0,26.0,IU,Solution for injection,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 iU,,,Y,,0F7275A,,21081.0,28.0,IU,Solution for injection,,2021,Q4,Benign pancreatic neoplasm,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 iU,,,Y,,0F7275A,,21081.0,28.0,IU,Solution for injection,,2021,Q4,Condition aggravated,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 iU,,,Y,,0F7275A,,21081.0,28.0,IU,Solution for injection,,2021,Q4,Weight increased,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 iU,,,Y,,0F7275A,,21081.0,28.0,IU,Solution for injection,,2021,Q4,Urine analysis abnormal,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 iU,,,Y,,0F7275A,,21081.0,28.0,IU,Solution for injection,,2021,Q4,Blood glucose abnormal,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 iU,,,Y,,0F7275A,,21081.0,28.0,IU,Solution for injection,,2021,Q4,Visual impairment,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 iU,,,Y,,0F7275A,,21081.0,28.0,IU,Solution for injection,,2021,Q4,Hepatic neoplasm,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 iU,,,Y,,0F7275A,,21081.0,28.0,IU,Solution for injection,,2021,Q4,Asthenia,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 iU,,,Y,,0F7275A,,21081.0,28.0,IU,Solution for injection,,2021,Q4,Fatigue,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 iU,,,Y,,0F7275A,,21081.0,28.0,IU,Solution for injection,,2021,Q4,Weight decreased,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 iU,,,Y,,0F7275A,,21081.0,28.0,IU,Solution for injection,,2021,Q4,Pancreatic cyst,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 iU,,,Y,,0F7275A,,21081.0,28.0,IU,Solution for injection,,2021,Q4,Loss of consciousness,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 iU,,,Y,,0F7275A,,21081.0,28.0,IU,Solution for injection,,2021,Q4,Blood sodium decreased,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 iU,,,Y,,0F7275A,,21081.0,28.0,IU,Solution for injection,,2021,Q4,Blood pressure abnormal,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 iU,,,Y,,0F7275A,,21081.0,28.0,IU,Solution for injection,,2021,Q4,Blood disorder,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 iU,,,Y,,0F7275A,,21081.0,28.0,IU,Solution for injection,,2021,Q4,Intentional product misuse,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 iU,,,Y,,0F7275A,,21081.0,28.0,IU,Solution for injection,,2021,Q4,Renal disorder,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 iU,,,Y,,0F7275A,,21081.0,28.0,IU,Solution for injection,,2021,Q4,Blood glucose fluctuation,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 iU,,,Y,,0F7275A,,21081.0,28.0,IU,Solution for injection,,2021,Q4,Nocturia,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 iU,,,Y,,0F7275A,,21081.0,28.0,IU,Solution for injection,,2021,Q4,Cyanosis,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 iU,,,Y,,0F7275A,,21081.0,28.0,IU,Solution for injection,,2021,Q4,Hepatic cyst,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 iU,,,Y,,0F7275A,,21081.0,28.0,IU,Solution for injection,,2021,Q4,Hypertension,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 iU,,,Y,,0F7275A,,21081.0,28.0,IU,Solution for injection,,2021,Q4,Fluid retention,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 iU,,,Y,,0F7275A,,21081.0,28.0,IU,Solution for injection,,2021,Q4,Abdominal distension,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 iU,,,Y,,0F7275A,,21081.0,28.0,IU,Solution for injection,,2021,Q4,Hypoglycaemia,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 iU,,,Y,,0F7275A,,21081.0,28.0,IU,Solution for injection,,2021,Q4,Hypoglycaemia,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 iU,,,Y,,0F7275A,,21081.0,28.0,IU,Solution for injection,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 iU,,,Y,,0F7275A,,21081.0,30.0,IU,Solution for injection,,2021,Q4,Benign pancreatic neoplasm,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 iU,,,Y,,0F7275A,,21081.0,30.0,IU,Solution for injection,,2021,Q4,Condition aggravated,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 iU,,,Y,,0F7275A,,21081.0,30.0,IU,Solution for injection,,2021,Q4,Weight increased,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 iU,,,Y,,0F7275A,,21081.0,30.0,IU,Solution for injection,,2021,Q4,Urine analysis abnormal,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 iU,,,Y,,0F7275A,,21081.0,30.0,IU,Solution for injection,,2021,Q4,Blood glucose abnormal,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 iU,,,Y,,0F7275A,,21081.0,30.0,IU,Solution for injection,,2021,Q4,Visual impairment,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 iU,,,Y,,0F7275A,,21081.0,30.0,IU,Solution for injection,,2021,Q4,Hepatic neoplasm,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 iU,,,Y,,0F7275A,,21081.0,30.0,IU,Solution for injection,,2021,Q4,Asthenia,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 iU,,,Y,,0F7275A,,21081.0,30.0,IU,Solution for injection,,2021,Q4,Fatigue,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 iU,,,Y,,0F7275A,,21081.0,30.0,IU,Solution for injection,,2021,Q4,Weight decreased,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 iU,,,Y,,0F7275A,,21081.0,30.0,IU,Solution for injection,,2021,Q4,Pancreatic cyst,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 iU,,,Y,,0F7275A,,21081.0,30.0,IU,Solution for injection,,2021,Q4,Loss of consciousness,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 iU,,,Y,,0F7275A,,21081.0,30.0,IU,Solution for injection,,2021,Q4,Blood sodium decreased,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 iU,,,Y,,0F7275A,,21081.0,30.0,IU,Solution for injection,,2021,Q4,Blood pressure abnormal,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 iU,,,Y,,0F7275A,,21081.0,30.0,IU,Solution for injection,,2021,Q4,Blood disorder,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 iU,,,Y,,0F7275A,,21081.0,30.0,IU,Solution for injection,,2021,Q4,Intentional product misuse,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 iU,,,Y,,0F7275A,,21081.0,30.0,IU,Solution for injection,,2021,Q4,Renal disorder,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 iU,,,Y,,0F7275A,,21081.0,30.0,IU,Solution for injection,,2021,Q4,Blood glucose fluctuation,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 iU,,,Y,,0F7275A,,21081.0,30.0,IU,Solution for injection,,2021,Q4,Nocturia,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 iU,,,Y,,0F7275A,,21081.0,30.0,IU,Solution for injection,,2021,Q4,Cyanosis,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 iU,,,Y,,0F7275A,,21081.0,30.0,IU,Solution for injection,,2021,Q4,Hepatic cyst,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 iU,,,Y,,0F7275A,,21081.0,30.0,IU,Solution for injection,,2021,Q4,Hypertension,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 iU,,,Y,,0F7275A,,21081.0,30.0,IU,Solution for injection,,2021,Q4,Fluid retention,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 iU,,,Y,,0F7275A,,21081.0,30.0,IU,Solution for injection,,2021,Q4,Abdominal distension,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 iU,,,Y,,0F7275A,,21081.0,30.0,IU,Solution for injection,,2021,Q4,Hypoglycaemia,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 iU,,,Y,,0F7275A,,21081.0,30.0,IU,Solution for injection,,2021,Q4,Hypoglycaemia,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 iU,,,Y,,0F7275A,,21081.0,30.0,IU,Solution for injection,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 iU,,,Y,,0F7275A,,21081.0,32.0,IU,Solution for injection,,2021,Q4,Benign pancreatic neoplasm,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 iU,,,Y,,0F7275A,,21081.0,32.0,IU,Solution for injection,,2021,Q4,Condition aggravated,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 iU,,,Y,,0F7275A,,21081.0,32.0,IU,Solution for injection,,2021,Q4,Weight increased,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 iU,,,Y,,0F7275A,,21081.0,32.0,IU,Solution for injection,,2021,Q4,Urine analysis abnormal,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 iU,,,Y,,0F7275A,,21081.0,32.0,IU,Solution for injection,,2021,Q4,Blood glucose abnormal,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 iU,,,Y,,0F7275A,,21081.0,32.0,IU,Solution for injection,,2021,Q4,Visual impairment,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 iU,,,Y,,0F7275A,,21081.0,32.0,IU,Solution for injection,,2021,Q4,Hepatic neoplasm,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 iU,,,Y,,0F7275A,,21081.0,32.0,IU,Solution for injection,,2021,Q4,Asthenia,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 iU,,,Y,,0F7275A,,21081.0,32.0,IU,Solution for injection,,2021,Q4,Fatigue,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 iU,,,Y,,0F7275A,,21081.0,32.0,IU,Solution for injection,,2021,Q4,Weight decreased,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 iU,,,Y,,0F7275A,,21081.0,32.0,IU,Solution for injection,,2021,Q4,Pancreatic cyst,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 iU,,,Y,,0F7275A,,21081.0,32.0,IU,Solution for injection,,2021,Q4,Loss of consciousness,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 iU,,,Y,,0F7275A,,21081.0,32.0,IU,Solution for injection,,2021,Q4,Blood sodium decreased,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 iU,,,Y,,0F7275A,,21081.0,32.0,IU,Solution for injection,,2021,Q4,Blood pressure abnormal,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 iU,,,Y,,0F7275A,,21081.0,32.0,IU,Solution for injection,,2021,Q4,Blood disorder,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 iU,,,Y,,0F7275A,,21081.0,32.0,IU,Solution for injection,,2021,Q4,Intentional product misuse,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 iU,,,Y,,0F7275A,,21081.0,32.0,IU,Solution for injection,,2021,Q4,Renal disorder,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 iU,,,Y,,0F7275A,,21081.0,32.0,IU,Solution for injection,,2021,Q4,Blood glucose fluctuation,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 iU,,,Y,,0F7275A,,21081.0,32.0,IU,Solution for injection,,2021,Q4,Nocturia,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 iU,,,Y,,0F7275A,,21081.0,32.0,IU,Solution for injection,,2021,Q4,Cyanosis,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 iU,,,Y,,0F7275A,,21081.0,32.0,IU,Solution for injection,,2021,Q4,Hepatic cyst,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 iU,,,Y,,0F7275A,,21081.0,32.0,IU,Solution for injection,,2021,Q4,Hypertension,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 iU,,,Y,,0F7275A,,21081.0,32.0,IU,Solution for injection,,2021,Q4,Fluid retention,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 iU,,,Y,,0F7275A,,21081.0,32.0,IU,Solution for injection,,2021,Q4,Abdominal distension,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 iU,,,Y,,0F7275A,,21081.0,32.0,IU,Solution for injection,,2021,Q4,Hypoglycaemia,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 iU,,,Y,,0F7275A,,21081.0,32.0,IU,Solution for injection,,2021,Q4,Hypoglycaemia,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199848342,19984834,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 iU,,,Y,,0F7275A,,21081.0,32.0,IU,Solution for injection,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,2,F,20200130.0,20211117.0,20211021,20211125,EXP,,ES-SA-2020SA032378,SANOFI AVENTIS,,83.0,YR,E,M,Y,68.0,KG,20211125.0,,CN,ES,ES,2021,Q4,Elderly
199858391,19985839,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q4,Blood creatinine increased,,2021,Q4,1,I,20210917.0,20211012.0,20211021,20211021,EXP,SE-MPA-2021-086470,SE-BAXTER-2021BAX031984,BAXTER,,83.0,YR,,F,Y,,,20211021.0,,MD,SE,SE,2021,Q4,Elderly
199858391,19985839,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q4,Blood test abnormal,,2021,Q4,1,I,20210917.0,20211012.0,20211021,20211021,EXP,SE-MPA-2021-086470,SE-BAXTER-2021BAX031984,BAXTER,,83.0,YR,,F,Y,,,20211021.0,,MD,SE,SE,2021,Q4,Elderly
199858391,19985839,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q4,N-terminal prohormone brain natriuretic peptide increased,,2021,Q4,1,I,20210917.0,20211012.0,20211021,20211021,EXP,SE-MPA-2021-086470,SE-BAXTER-2021BAX031984,BAXTER,,83.0,YR,,F,Y,,,20211021.0,,MD,SE,SE,2021,Q4,Elderly
199858391,19985839,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q4,Renal function test abnormal,,2021,Q4,1,I,20210917.0,20211012.0,20211021,20211021,EXP,SE-MPA-2021-086470,SE-BAXTER-2021BAX031984,BAXTER,,83.0,YR,,F,Y,,,20211021.0,,MD,SE,SE,2021,Q4,Elderly
199858391,19985839,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q4,Fibrin D dimer increased,,2021,Q4,1,I,20210917.0,20211012.0,20211021,20211021,EXP,SE-MPA-2021-086470,SE-BAXTER-2021BAX031984,BAXTER,,83.0,YR,,F,Y,,,20211021.0,,MD,SE,SE,2021,Q4,Elderly
199858391,19985839,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q4,Hepatic enzyme increased,,2021,Q4,1,I,20210917.0,20211012.0,20211021,20211021,EXP,SE-MPA-2021-086470,SE-BAXTER-2021BAX031984,BAXTER,,83.0,YR,,F,Y,,,20211021.0,,MD,SE,SE,2021,Q4,Elderly
199866641,19986664,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 (units) UNK,,,U,,,,,,,,,2021,Q4,Renal impairment,,2021,Q4,1,I,20200201.0,20210912.0,20211022,20211022,EXP,,NVSC2021HR210474,NOVARTIS,,78.0,YR,,M,Y,82.0,KG,20211022.0,,MD,HR,HR,2021,Q4,Elderly
199866641,19986664,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 (units) UNK,,,U,,,,,,,,,2021,Q4,Hyperkalaemia,,2021,Q4,1,I,20200201.0,20210912.0,20211022,20211022,EXP,,NVSC2021HR210474,NOVARTIS,,78.0,YR,,M,Y,82.0,KG,20211022.0,,MD,HR,HR,2021,Q4,Elderly
199866641,19986664,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 (units) UNK,,,U,,,,,,,,,2021,Q4,N-terminal prohormone brain natriuretic peptide increased,,2021,Q4,1,I,20200201.0,20210912.0,20211022,20211022,EXP,,NVSC2021HR210474,NOVARTIS,,78.0,YR,,M,Y,82.0,KG,20211022.0,,MD,HR,HR,2021,Q4,Elderly
199866641,19986664,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 (units) UNK,,,U,,,,,,,,,2021,Q4,Hypotension,,2021,Q4,1,I,20200201.0,20210912.0,20211022,20211022,EXP,,NVSC2021HR210474,NOVARTIS,,78.0,YR,,M,Y,82.0,KG,20211022.0,,MD,HR,HR,2021,Q4,Elderly
199866641,19986664,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 (units) UNK,,,U,,,,,,,,,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,1,I,20200201.0,20210912.0,20211022,20211022,EXP,,NVSC2021HR210474,NOVARTIS,,78.0,YR,,M,Y,82.0,KG,20211022.0,,MD,HR,HR,2021,Q4,Elderly
199866641,19986664,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 (units) UNK,,,U,,,,,,,,,2021,Q4,Vertigo,,2021,Q4,1,I,20200201.0,20210912.0,20211022,20211022,EXP,,NVSC2021HR210474,NOVARTIS,,78.0,YR,,M,Y,82.0,KG,20211022.0,,MD,HR,HR,2021,Q4,Elderly
199866641,19986664,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 (units) UNK,,,U,,,,,,,,,2021,Q4,Dizziness,,2021,Q4,1,I,20200201.0,20210912.0,20211022,20211022,EXP,,NVSC2021HR210474,NOVARTIS,,78.0,YR,,M,Y,82.0,KG,20211022.0,,MD,HR,HR,2021,Q4,Elderly
199866641,19986664,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 (units) UNK,,,U,,,,,,,,,2021,Q4,Gait disturbance,,2021,Q4,1,I,20200201.0,20210912.0,20211022,20211022,EXP,,NVSC2021HR210474,NOVARTIS,,78.0,YR,,M,Y,82.0,KG,20211022.0,,MD,HR,HR,2021,Q4,Elderly
199872331,19987233,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"Therapy Start date :ASKU, 25 IU",,,,,,,,25.0,IU,,,2021,Q4,Cardioactive drug level increased,,2021,Q4,1,I,20210901.0,20211013.0,20211022,20211022,EXP,FR-AFSSAPS-AN20213915,FR-TEVA-2021-FR-1967220,TEVA,,67.0,YR,E,M,Y,81.8,KG,20211022.0,,PH,FR,FR,2021,Q4,Elderly
199872331,19987233,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"Therapy Start date :ASKU, 25 IU",,,,,,,,25.0,IU,,,2021,Q4,Sinus bradycardia,,2021,Q4,1,I,20210901.0,20211013.0,20211022,20211022,EXP,FR-AFSSAPS-AN20213915,FR-TEVA-2021-FR-1967220,TEVA,,67.0,YR,E,M,Y,81.8,KG,20211022.0,,PH,FR,FR,2021,Q4,Elderly
199880501,19988050,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,unk,,,D,,,,,,,,,2021,Q4,Femur fracture,,2021,Q4,1,I,20080801.0,20210909.0,20211022,20211022,EXP,,ES-ROCHE-2933717,ROCHE,"Garcia M, Garcia-Martin A, Reyes-Garcia R, Varsavsky M, Munoz-Torres M. Diagnosis and management of bilateral diaphyseal femoral fracture. Endocrine.. 2012;;42(2):451-452.",72.0,YR,,F,Y,,,20211022.0,,HP,ES,ES,2021,Q4,Elderly
199881281,19988128,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,more than 80 units,,,D,,0F861A,,,,,Solution for injection,,2021,Q4,Product storage error,,2021,Q4,1,I,,20211014.0,20211022,20211022,EXP,,ES-BAUSCH-BL-2021-034758,BAUSCH AND LOMB,,52.0,YR,,M,Y,90.3,KG,20211022.0,,CN,ES,ES,2021,Q4,Adult
199881281,19988128,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,more than 80 units,,,D,,0F861A,,,,,Solution for injection,,2021,Q4,Incorrect dose administered,,2021,Q4,1,I,,20211014.0,20211022,20211022,EXP,,ES-BAUSCH-BL-2021-034758,BAUSCH AND LOMB,,52.0,YR,,M,Y,90.3,KG,20211022.0,,CN,ES,ES,2021,Q4,Adult
199881281,19988128,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,more than 80 units,,,D,,0F861A,,,,,Solution for injection,,2021,Q4,Diarrhoea,,2021,Q4,1,I,,20211014.0,20211022,20211022,EXP,,ES-BAUSCH-BL-2021-034758,BAUSCH AND LOMB,,52.0,YR,,M,Y,90.3,KG,20211022.0,,CN,ES,ES,2021,Q4,Adult
199881281,19988128,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,more than 80 units,,,D,,0F861A,,,,,Solution for injection,,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,,20211014.0,20211022,20211022,EXP,,ES-BAUSCH-BL-2021-034758,BAUSCH AND LOMB,,52.0,YR,,M,Y,90.3,KG,20211022.0,,CN,ES,ES,2021,Q4,Adult
199881281,19988128,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,more than 80 units,,,D,,0F861A,,,,,Solution for injection,,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211014.0,20211022,20211022,EXP,,ES-BAUSCH-BL-2021-034758,BAUSCH AND LOMB,,52.0,YR,,M,Y,90.3,KG,20211022.0,,CN,ES,ES,2021,Q4,Adult
199881281,19988128,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,more than 80 units,,,D,,0F861A,,,,,Solution for injection,,2021,Q4,Illness,,2021,Q4,1,I,,20211014.0,20211022,20211022,EXP,,ES-BAUSCH-BL-2021-034758,BAUSCH AND LOMB,,52.0,YR,,M,Y,90.3,KG,20211022.0,,CN,ES,ES,2021,Q4,Adult
199881281,19988128,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,more than 80 units,,,D,,0F861A,,,,,Solution for injection,,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,,20211014.0,20211022,20211022,EXP,,ES-BAUSCH-BL-2021-034758,BAUSCH AND LOMB,,52.0,YR,,M,Y,90.3,KG,20211022.0,,CN,ES,ES,2021,Q4,Adult
199881281,19988128,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,more than 80 units,,,D,,0F861A,,,,,Solution for injection,,2021,Q4,Confusional state,,2021,Q4,1,I,,20211014.0,20211022,20211022,EXP,,ES-BAUSCH-BL-2021-034758,BAUSCH AND LOMB,,52.0,YR,,M,Y,90.3,KG,20211022.0,,CN,ES,ES,2021,Q4,Adult
199881281,19988128,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,more than 80 units,,,D,,0F861A,,,,,Solution for injection,,2021,Q4,Memory impairment,,2021,Q4,1,I,,20211014.0,20211022,20211022,EXP,,ES-BAUSCH-BL-2021-034758,BAUSCH AND LOMB,,52.0,YR,,M,Y,90.3,KG,20211022.0,,CN,ES,ES,2021,Q4,Adult
199881281,19988128,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,more than 80 units,,,D,,0F861A,,,,,Solution for injection,,2021,Q4,Angiopathy,,2021,Q4,1,I,,20211014.0,20211022,20211022,EXP,,ES-BAUSCH-BL-2021-034758,BAUSCH AND LOMB,,52.0,YR,,M,Y,90.3,KG,20211022.0,,CN,ES,ES,2021,Q4,Adult
199881281,19988128,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,more than 80 units,,,D,,0F861A,,,,,Solution for injection,,2021,Q4,Hospitalisation,,2021,Q4,1,I,,20211014.0,20211022,20211022,EXP,,ES-BAUSCH-BL-2021-034758,BAUSCH AND LOMB,,52.0,YR,,M,Y,90.3,KG,20211022.0,,CN,ES,ES,2021,Q4,Adult
199881281,19988128,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,more than 80 units,,,D,,0F861A,,,,,Solution for injection,,2021,Q4,Cerebrovascular accident,,2021,Q4,1,I,,20211014.0,20211022,20211022,EXP,,ES-BAUSCH-BL-2021-034758,BAUSCH AND LOMB,,52.0,YR,,M,Y,90.3,KG,20211022.0,,CN,ES,ES,2021,Q4,Adult
199881281,19988128,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"68 iU, QD",,,D,,0F861A,,,68.0,IU,Solution for injection,QD,2021,Q4,Product storage error,,2021,Q4,1,I,,20211014.0,20211022,20211022,EXP,,ES-BAUSCH-BL-2021-034758,BAUSCH AND LOMB,,52.0,YR,,M,Y,90.3,KG,20211022.0,,CN,ES,ES,2021,Q4,Adult
199881281,19988128,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"68 iU, QD",,,D,,0F861A,,,68.0,IU,Solution for injection,QD,2021,Q4,Incorrect dose administered,,2021,Q4,1,I,,20211014.0,20211022,20211022,EXP,,ES-BAUSCH-BL-2021-034758,BAUSCH AND LOMB,,52.0,YR,,M,Y,90.3,KG,20211022.0,,CN,ES,ES,2021,Q4,Adult
199881281,19988128,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"68 iU, QD",,,D,,0F861A,,,68.0,IU,Solution for injection,QD,2021,Q4,Diarrhoea,,2021,Q4,1,I,,20211014.0,20211022,20211022,EXP,,ES-BAUSCH-BL-2021-034758,BAUSCH AND LOMB,,52.0,YR,,M,Y,90.3,KG,20211022.0,,CN,ES,ES,2021,Q4,Adult
199881281,19988128,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"68 iU, QD",,,D,,0F861A,,,68.0,IU,Solution for injection,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,,20211014.0,20211022,20211022,EXP,,ES-BAUSCH-BL-2021-034758,BAUSCH AND LOMB,,52.0,YR,,M,Y,90.3,KG,20211022.0,,CN,ES,ES,2021,Q4,Adult
199881281,19988128,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"68 iU, QD",,,D,,0F861A,,,68.0,IU,Solution for injection,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211014.0,20211022,20211022,EXP,,ES-BAUSCH-BL-2021-034758,BAUSCH AND LOMB,,52.0,YR,,M,Y,90.3,KG,20211022.0,,CN,ES,ES,2021,Q4,Adult
199881281,19988128,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"68 iU, QD",,,D,,0F861A,,,68.0,IU,Solution for injection,QD,2021,Q4,Illness,,2021,Q4,1,I,,20211014.0,20211022,20211022,EXP,,ES-BAUSCH-BL-2021-034758,BAUSCH AND LOMB,,52.0,YR,,M,Y,90.3,KG,20211022.0,,CN,ES,ES,2021,Q4,Adult
199881281,19988128,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"68 iU, QD",,,D,,0F861A,,,68.0,IU,Solution for injection,QD,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,,20211014.0,20211022,20211022,EXP,,ES-BAUSCH-BL-2021-034758,BAUSCH AND LOMB,,52.0,YR,,M,Y,90.3,KG,20211022.0,,CN,ES,ES,2021,Q4,Adult
199881281,19988128,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"68 iU, QD",,,D,,0F861A,,,68.0,IU,Solution for injection,QD,2021,Q4,Confusional state,,2021,Q4,1,I,,20211014.0,20211022,20211022,EXP,,ES-BAUSCH-BL-2021-034758,BAUSCH AND LOMB,,52.0,YR,,M,Y,90.3,KG,20211022.0,,CN,ES,ES,2021,Q4,Adult
199881281,19988128,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"68 iU, QD",,,D,,0F861A,,,68.0,IU,Solution for injection,QD,2021,Q4,Memory impairment,,2021,Q4,1,I,,20211014.0,20211022,20211022,EXP,,ES-BAUSCH-BL-2021-034758,BAUSCH AND LOMB,,52.0,YR,,M,Y,90.3,KG,20211022.0,,CN,ES,ES,2021,Q4,Adult
199881281,19988128,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"68 iU, QD",,,D,,0F861A,,,68.0,IU,Solution for injection,QD,2021,Q4,Angiopathy,,2021,Q4,1,I,,20211014.0,20211022,20211022,EXP,,ES-BAUSCH-BL-2021-034758,BAUSCH AND LOMB,,52.0,YR,,M,Y,90.3,KG,20211022.0,,CN,ES,ES,2021,Q4,Adult
199881281,19988128,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"68 iU, QD",,,D,,0F861A,,,68.0,IU,Solution for injection,QD,2021,Q4,Hospitalisation,,2021,Q4,1,I,,20211014.0,20211022,20211022,EXP,,ES-BAUSCH-BL-2021-034758,BAUSCH AND LOMB,,52.0,YR,,M,Y,90.3,KG,20211022.0,,CN,ES,ES,2021,Q4,Adult
199881281,19988128,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"68 iU, QD",,,D,,0F861A,,,68.0,IU,Solution for injection,QD,2021,Q4,Cerebrovascular accident,,2021,Q4,1,I,,20211014.0,20211022,20211022,EXP,,ES-BAUSCH-BL-2021-034758,BAUSCH AND LOMB,,52.0,YR,,M,Y,90.3,KG,20211022.0,,CN,ES,ES,2021,Q4,Adult
199914802,19991480,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,28 units,,,Y,U,,,,,,,,2021,Q4,Weight increased,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,28 units,,,Y,U,,,,,,,,2021,Q4,Therapeutic product effect incomplete,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,28 units,,,Y,U,,,,,,,,2021,Q4,Diabetic metabolic decompensation,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,28 units,,,Y,U,,,,,,,,2021,Q4,Drug ineffective,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,28 units,,,Y,U,,,,,,,,2021,Q4,Hyperglycaemia,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,28 units,,,Y,U,,,,,,,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,total daily insulin dose was 80 units/day (insulin lispro plus glargine),,,,,,,,,,Injection,,2021,Q4,Weight increased,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,total daily insulin dose was 80 units/day (insulin lispro plus glargine),,,,,,,,,,Injection,,2021,Q4,Therapeutic product effect incomplete,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,total daily insulin dose was 80 units/day (insulin lispro plus glargine),,,,,,,,,,Injection,,2021,Q4,Diabetic metabolic decompensation,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,total daily insulin dose was 80 units/day (insulin lispro plus glargine),,,,,,,,,,Injection,,2021,Q4,Drug ineffective,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,total daily insulin dose was 80 units/day (insulin lispro plus glargine),,,,,,,,,,Injection,,2021,Q4,Hyperglycaemia,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,total daily insulin dose was 80 units/day (insulin lispro plus glargine),,,,,,,,,,Injection,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"29 international unit, qd",,,,,,,,29.0,IU,Injection,QD,2021,Q4,Weight increased,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"29 international unit, qd",,,,,,,,29.0,IU,Injection,QD,2021,Q4,Therapeutic product effect incomplete,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"29 international unit, qd",,,,,,,,29.0,IU,Injection,QD,2021,Q4,Diabetic metabolic decompensation,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"29 international unit, qd",,,,,,,,29.0,IU,Injection,QD,2021,Q4,Drug ineffective,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"29 international unit, qd",,,,,,,,29.0,IU,Injection,QD,2021,Q4,Hyperglycaemia,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"29 international unit, qd",,,,,,,,29.0,IU,Injection,QD,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"12 international unit, qd",,,,,,,,12.0,IU,Injection,QD,2021,Q4,Weight increased,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"12 international unit, qd",,,,,,,,12.0,IU,Injection,QD,2021,Q4,Therapeutic product effect incomplete,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"12 international unit, qd",,,,,,,,12.0,IU,Injection,QD,2021,Q4,Diabetic metabolic decompensation,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"12 international unit, qd",,,,,,,,12.0,IU,Injection,QD,2021,Q4,Drug ineffective,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"12 international unit, qd",,,,,,,,12.0,IU,Injection,QD,2021,Q4,Hyperglycaemia,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"12 international unit, qd",,,,,,,,12.0,IU,Injection,QD,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199916243,19991624,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 DF, once daily (300 u/ml injection, 6 units per day)",,,,,,,,,,Formulation unknown,QD,2021,Q4,Pyrexia,,2021,Q4,3,F,20211011.0,20211125.0,20211025,20211201,EXP,,BE-ASTELLAS-2021US040651,ASTELLAS,,73.0,YR,,M,Y,62.0,KG,20211201.0,,MD,BE,BE,2021,Q4,Elderly
199916243,19991624,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 DF, once daily (300 u/ml injection, 6 units per day)",,,,,,,,,,Formulation unknown,QD,2021,Q4,Dyspnoea exertional,,2021,Q4,3,F,20211011.0,20211125.0,20211025,20211201,EXP,,BE-ASTELLAS-2021US040651,ASTELLAS,,73.0,YR,,M,Y,62.0,KG,20211201.0,,MD,BE,BE,2021,Q4,Elderly
199917341,19991734,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 UNIT, tid",,,,,,,,,,,TID,2021,Q4,Drug ineffective,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-20509,LUPIN,"Del Toro-Pagan NM, Matos A, Thacker D, Turgeon J, Amin NS, Michaud V. Pharmacist-led medication evaluation considering pharmacogenomics and drug-induced phenoconversion in the treatment of multiple comorbidities: A case report. Medicina. 2021;57:955:1-10",66.0,YR,,F,Y,,,20211025.0,,HP,US,US,2021,Q4,Elderly
199917341,19991734,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 UNIT, tid",,,,,,,,,,,TID,2021,Q4,CYP2D6 gene status assay,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-20509,LUPIN,"Del Toro-Pagan NM, Matos A, Thacker D, Turgeon J, Amin NS, Michaud V. Pharmacist-led medication evaluation considering pharmacogenomics and drug-induced phenoconversion in the treatment of multiple comorbidities: A case report. Medicina. 2021;57:955:1-10",66.0,YR,,F,Y,,,20211025.0,,HP,US,US,2021,Q4,Elderly
199917341,19991734,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 UNIT, tid",,,,,,,,,,,TID,2021,Q4,Cytogenetic analysis abnormal,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-20509,LUPIN,"Del Toro-Pagan NM, Matos A, Thacker D, Turgeon J, Amin NS, Michaud V. Pharmacist-led medication evaluation considering pharmacogenomics and drug-induced phenoconversion in the treatment of multiple comorbidities: A case report. Medicina. 2021;57:955:1-10",66.0,YR,,F,Y,,,20211025.0,,HP,US,US,2021,Q4,Elderly
199917341,19991734,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 UNIT, tid",,,,,,,,,,,TID,2021,Q4,Therapeutic product effect increased,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-20509,LUPIN,"Del Toro-Pagan NM, Matos A, Thacker D, Turgeon J, Amin NS, Michaud V. Pharmacist-led medication evaluation considering pharmacogenomics and drug-induced phenoconversion in the treatment of multiple comorbidities: A case report. Medicina. 2021;57:955:1-10",66.0,YR,,F,Y,,,20211025.0,,HP,US,US,2021,Q4,Elderly
199917341,19991734,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 UNIT, tid",,,,,,,,,,,TID,2021,Q4,Drug interaction,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-20509,LUPIN,"Del Toro-Pagan NM, Matos A, Thacker D, Turgeon J, Amin NS, Michaud V. Pharmacist-led medication evaluation considering pharmacogenomics and drug-induced phenoconversion in the treatment of multiple comorbidities: A case report. Medicina. 2021;57:955:1-10",66.0,YR,,F,Y,,,20211025.0,,HP,US,US,2021,Q4,Elderly
199922771,19992277,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,more than 80 units,,,D,,,,,,,Solution for injection,,2021,Q4,Confusional state,,2021,Q4,1,I,,20211011.0,20211026,20211026,EXP,,ES-AUROBINDO-AUR-APL-2021-043658,AUROBINDO,,52.0,YR,,M,Y,90.3,KG,20211026.0,,CN,ES,ES,2021,Q4,Adult
199922771,19992277,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,more than 80 units,,,D,,,,,,,Solution for injection,,2021,Q4,Incorrect dose administered,,2021,Q4,1,I,,20211011.0,20211026,20211026,EXP,,ES-AUROBINDO-AUR-APL-2021-043658,AUROBINDO,,52.0,YR,,M,Y,90.3,KG,20211026.0,,CN,ES,ES,2021,Q4,Adult
199922771,19992277,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,more than 80 units,,,D,,,,,,,Solution for injection,,2021,Q4,Cerebrovascular accident,,2021,Q4,1,I,,20211011.0,20211026,20211026,EXP,,ES-AUROBINDO-AUR-APL-2021-043658,AUROBINDO,,52.0,YR,,M,Y,90.3,KG,20211026.0,,CN,ES,ES,2021,Q4,Adult
199922771,19992277,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,more than 80 units,,,D,,,,,,,Solution for injection,,2021,Q4,Angiopathy,,2021,Q4,1,I,,20211011.0,20211026,20211026,EXP,,ES-AUROBINDO-AUR-APL-2021-043658,AUROBINDO,,52.0,YR,,M,Y,90.3,KG,20211026.0,,CN,ES,ES,2021,Q4,Adult
199922771,19992277,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,more than 80 units,,,D,,,,,,,Solution for injection,,2021,Q4,Diarrhoea,,2021,Q4,1,I,,20211011.0,20211026,20211026,EXP,,ES-AUROBINDO-AUR-APL-2021-043658,AUROBINDO,,52.0,YR,,M,Y,90.3,KG,20211026.0,,CN,ES,ES,2021,Q4,Adult
199922771,19992277,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,more than 80 units,,,D,,,,,,,Solution for injection,,2021,Q4,Memory impairment,,2021,Q4,1,I,,20211011.0,20211026,20211026,EXP,,ES-AUROBINDO-AUR-APL-2021-043658,AUROBINDO,,52.0,YR,,M,Y,90.3,KG,20211026.0,,CN,ES,ES,2021,Q4,Adult
199922771,19992277,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,more than 80 units,,,D,,,,,,,Solution for injection,,2021,Q4,Product storage error,,2021,Q4,1,I,,20211011.0,20211026,20211026,EXP,,ES-AUROBINDO-AUR-APL-2021-043658,AUROBINDO,,52.0,YR,,M,Y,90.3,KG,20211026.0,,CN,ES,ES,2021,Q4,Adult
199922771,19992277,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,more than 80 units,,,D,,,,,,,Solution for injection,,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211011.0,20211026,20211026,EXP,,ES-AUROBINDO-AUR-APL-2021-043658,AUROBINDO,,52.0,YR,,M,Y,90.3,KG,20211026.0,,CN,ES,ES,2021,Q4,Adult
199922771,19992277,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,more than 80 units,,,D,,,,,,,Solution for injection,,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,,20211011.0,20211026,20211026,EXP,,ES-AUROBINDO-AUR-APL-2021-043658,AUROBINDO,,52.0,YR,,M,Y,90.3,KG,20211026.0,,CN,ES,ES,2021,Q4,Adult
199922771,19992277,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,more than 80 units,,,D,,,,,,,Solution for injection,,2021,Q4,Illness,,2021,Q4,1,I,,20211011.0,20211026,20211026,EXP,,ES-AUROBINDO-AUR-APL-2021-043658,AUROBINDO,,52.0,YR,,M,Y,90.3,KG,20211026.0,,CN,ES,ES,2021,Q4,Adult
199922771,19992277,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,more than 80 units,,,D,,,,,,,Solution for injection,,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,,20211011.0,20211026,20211026,EXP,,ES-AUROBINDO-AUR-APL-2021-043658,AUROBINDO,,52.0,YR,,M,Y,90.3,KG,20211026.0,,CN,ES,ES,2021,Q4,Adult
199922771,19992277,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"68 international unit, Once a Day",,,D,,0F861A,,,68.0,IU,Solution for injection,QD,2021,Q4,Confusional state,,2021,Q4,1,I,,20211011.0,20211026,20211026,EXP,,ES-AUROBINDO-AUR-APL-2021-043658,AUROBINDO,,52.0,YR,,M,Y,90.3,KG,20211026.0,,CN,ES,ES,2021,Q4,Adult
199922771,19992277,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"68 international unit, Once a Day",,,D,,0F861A,,,68.0,IU,Solution for injection,QD,2021,Q4,Incorrect dose administered,,2021,Q4,1,I,,20211011.0,20211026,20211026,EXP,,ES-AUROBINDO-AUR-APL-2021-043658,AUROBINDO,,52.0,YR,,M,Y,90.3,KG,20211026.0,,CN,ES,ES,2021,Q4,Adult
199922771,19992277,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"68 international unit, Once a Day",,,D,,0F861A,,,68.0,IU,Solution for injection,QD,2021,Q4,Cerebrovascular accident,,2021,Q4,1,I,,20211011.0,20211026,20211026,EXP,,ES-AUROBINDO-AUR-APL-2021-043658,AUROBINDO,,52.0,YR,,M,Y,90.3,KG,20211026.0,,CN,ES,ES,2021,Q4,Adult
199922771,19992277,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"68 international unit, Once a Day",,,D,,0F861A,,,68.0,IU,Solution for injection,QD,2021,Q4,Angiopathy,,2021,Q4,1,I,,20211011.0,20211026,20211026,EXP,,ES-AUROBINDO-AUR-APL-2021-043658,AUROBINDO,,52.0,YR,,M,Y,90.3,KG,20211026.0,,CN,ES,ES,2021,Q4,Adult
199922771,19992277,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"68 international unit, Once a Day",,,D,,0F861A,,,68.0,IU,Solution for injection,QD,2021,Q4,Diarrhoea,,2021,Q4,1,I,,20211011.0,20211026,20211026,EXP,,ES-AUROBINDO-AUR-APL-2021-043658,AUROBINDO,,52.0,YR,,M,Y,90.3,KG,20211026.0,,CN,ES,ES,2021,Q4,Adult
199922771,19992277,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"68 international unit, Once a Day",,,D,,0F861A,,,68.0,IU,Solution for injection,QD,2021,Q4,Memory impairment,,2021,Q4,1,I,,20211011.0,20211026,20211026,EXP,,ES-AUROBINDO-AUR-APL-2021-043658,AUROBINDO,,52.0,YR,,M,Y,90.3,KG,20211026.0,,CN,ES,ES,2021,Q4,Adult
199922771,19992277,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"68 international unit, Once a Day",,,D,,0F861A,,,68.0,IU,Solution for injection,QD,2021,Q4,Product storage error,,2021,Q4,1,I,,20211011.0,20211026,20211026,EXP,,ES-AUROBINDO-AUR-APL-2021-043658,AUROBINDO,,52.0,YR,,M,Y,90.3,KG,20211026.0,,CN,ES,ES,2021,Q4,Adult
199922771,19992277,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"68 international unit, Once a Day",,,D,,0F861A,,,68.0,IU,Solution for injection,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211011.0,20211026,20211026,EXP,,ES-AUROBINDO-AUR-APL-2021-043658,AUROBINDO,,52.0,YR,,M,Y,90.3,KG,20211026.0,,CN,ES,ES,2021,Q4,Adult
199922771,19992277,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"68 international unit, Once a Day",,,D,,0F861A,,,68.0,IU,Solution for injection,QD,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,,20211011.0,20211026,20211026,EXP,,ES-AUROBINDO-AUR-APL-2021-043658,AUROBINDO,,52.0,YR,,M,Y,90.3,KG,20211026.0,,CN,ES,ES,2021,Q4,Adult
199922771,19992277,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"68 international unit, Once a Day",,,D,,0F861A,,,68.0,IU,Solution for injection,QD,2021,Q4,Illness,,2021,Q4,1,I,,20211011.0,20211026,20211026,EXP,,ES-AUROBINDO-AUR-APL-2021-043658,AUROBINDO,,52.0,YR,,M,Y,90.3,KG,20211026.0,,CN,ES,ES,2021,Q4,Adult
199922771,19992277,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"68 international unit, Once a Day",,,D,,0F861A,,,68.0,IU,Solution for injection,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,,20211011.0,20211026,20211026,EXP,,ES-AUROBINDO-AUR-APL-2021-043658,AUROBINDO,,52.0,YR,,M,Y,90.3,KG,20211026.0,,CN,ES,ES,2021,Q4,Adult
199927931,19992793,1,PS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,"38 iU, QD",,,,,,,208673.0,38.0,IU,Solution for injection,QD,2021,Q4,Pancreatitis acute,,2021,Q4,1,I,,20211019.0,20211026,20211026,EXP,,RO-SA-2021SA350231,SANOFI AVENTIS,,62.0,YR,A,,Y,,,20211026.0,,MD,RO,RO,2021,Q4,Adult
199929761,19992976,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 milligram, Daily",,,,,,,,20.0,MG,,,2021,Q4,Drug interaction,,2021,Q4,1,I,,20211011.0,20211026,20211026,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-315078,RANBAXY,"Del Toro-Pagan NM, Matos A, Thacker D, Turgeon J, Amin NS, Michaud V. Pharmacist Led Medication Evaluation Considering Pharmacogenomics and Drug Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report. Medicina Kaunas. 2021;57(9):955",66.0,YR,,F,Y,,,20211026.0,,HP,US,US,2021,Q4,Elderly
199929761,19992976,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 milligram, Daily",,,,,,,,20.0,MG,,,2021,Q4,CYP2D6 polymorphism,,2021,Q4,1,I,,20211011.0,20211026,20211026,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-315078,RANBAXY,"Del Toro-Pagan NM, Matos A, Thacker D, Turgeon J, Amin NS, Michaud V. Pharmacist Led Medication Evaluation Considering Pharmacogenomics and Drug Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report. Medicina Kaunas. 2021;57(9):955",66.0,YR,,F,Y,,,20211026.0,,HP,US,US,2021,Q4,Elderly
199963501,19996350,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, unknown",,,U,,,,205692.0,,,Injection,,2021,Q4,Dialysis related complication,,2021,Q4,1,I,20200101.0,20211014.0,20211026,20211026,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202110005951,ELI LILLY AND CO,,41.0,YR,,F,Y,,,20211026.0,,CN,DE,DE,2021,Q4,Adult
199963501,19996350,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, unknown",,,U,,,,205692.0,,,Injection,,2021,Q4,Pancreatic cyst,,2021,Q4,1,I,20200101.0,20211014.0,20211026,20211026,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202110005951,ELI LILLY AND CO,,41.0,YR,,F,Y,,,20211026.0,,CN,DE,DE,2021,Q4,Adult
199963501,19996350,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, unknown",,,U,,,,205692.0,,,Injection,,2021,Q4,Thrombosis,,2021,Q4,1,I,20200101.0,20211014.0,20211026,20211026,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202110005951,ELI LILLY AND CO,,41.0,YR,,F,Y,,,20211026.0,,CN,DE,DE,2021,Q4,Adult
199963501,19996350,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, unknown",,,U,,,,205692.0,,,Injection,,2021,Q4,Asymptomatic COVID-19,,2021,Q4,1,I,20200101.0,20211014.0,20211026,20211026,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202110005951,ELI LILLY AND CO,,41.0,YR,,F,Y,,,20211026.0,,CN,DE,DE,2021,Q4,Adult
199963501,19996350,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, unknown",,,U,,,,205692.0,,,Injection,,2021,Q4,Thyroid disorder,,2021,Q4,1,I,20200101.0,20211014.0,20211026,20211026,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202110005951,ELI LILLY AND CO,,41.0,YR,,F,Y,,,20211026.0,,CN,DE,DE,2021,Q4,Adult
199966081,19996608,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Fatigue,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101358809,PFIZER,,75.0,YR,,M,Y,80.0,KG,20211025.0,,HP,CA,CA,2021,Q4,Elderly
199966081,19996608,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Swelling,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101358809,PFIZER,,75.0,YR,,M,Y,80.0,KG,20211025.0,,HP,CA,CA,2021,Q4,Elderly
199966081,19996608,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Red blood cell count decreased,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101358809,PFIZER,,75.0,YR,,M,Y,80.0,KG,20211025.0,,HP,CA,CA,2021,Q4,Elderly
199966081,19996608,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Rectal haemorrhage,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101358809,PFIZER,,75.0,YR,,M,Y,80.0,KG,20211025.0,,HP,CA,CA,2021,Q4,Elderly
199966081,19996608,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Taste disorder,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101358809,PFIZER,,75.0,YR,,M,Y,80.0,KG,20211025.0,,HP,CA,CA,2021,Q4,Elderly
199966081,19996608,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Gastrooesophageal reflux disease,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101358809,PFIZER,,75.0,YR,,M,Y,80.0,KG,20211025.0,,HP,CA,CA,2021,Q4,Elderly
199966081,19996608,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Nausea,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101358809,PFIZER,,75.0,YR,,M,Y,80.0,KG,20211025.0,,HP,CA,CA,2021,Q4,Elderly
199966081,19996608,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Pleural effusion,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101358809,PFIZER,,75.0,YR,,M,Y,80.0,KG,20211025.0,,HP,CA,CA,2021,Q4,Elderly
199966081,19996608,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Haematocrit decreased,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101358809,PFIZER,,75.0,YR,,M,Y,80.0,KG,20211025.0,,HP,CA,CA,2021,Q4,Elderly
199966081,19996608,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Haemoglobin decreased,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101358809,PFIZER,,75.0,YR,,M,Y,80.0,KG,20211025.0,,HP,CA,CA,2021,Q4,Elderly
199966081,19996608,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Abdominal discomfort,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101358809,PFIZER,,75.0,YR,,M,Y,80.0,KG,20211025.0,,HP,CA,CA,2021,Q4,Elderly
199966081,19996608,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Cardiac disorder,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101358809,PFIZER,,75.0,YR,,M,Y,80.0,KG,20211025.0,,HP,CA,CA,2021,Q4,Elderly
199966081,19996608,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Carditis,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101358809,PFIZER,,75.0,YR,,M,Y,80.0,KG,20211025.0,,HP,CA,CA,2021,Q4,Elderly
199966081,19996608,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Chest pain,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101358809,PFIZER,,75.0,YR,,M,Y,80.0,KG,20211025.0,,HP,CA,CA,2021,Q4,Elderly
199966081,19996608,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Cough,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101358809,PFIZER,,75.0,YR,,M,Y,80.0,KG,20211025.0,,HP,CA,CA,2021,Q4,Elderly
199966081,19996608,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101358809,PFIZER,,75.0,YR,,M,Y,80.0,KG,20211025.0,,HP,CA,CA,2021,Q4,Elderly
199966081,19996608,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Dry eye,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101358809,PFIZER,,75.0,YR,,M,Y,80.0,KG,20211025.0,,HP,CA,CA,2021,Q4,Elderly
199966081,19996608,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Dry mouth,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101358809,PFIZER,,75.0,YR,,M,Y,80.0,KG,20211025.0,,HP,CA,CA,2021,Q4,Elderly
199966081,19996608,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101358809,PFIZER,,75.0,YR,,M,Y,80.0,KG,20211025.0,,HP,CA,CA,2021,Q4,Elderly
199966081,19996608,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Joint effusion,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101358809,PFIZER,,75.0,YR,,M,Y,80.0,KG,20211025.0,,HP,CA,CA,2021,Q4,Elderly
199970721,19997072,8,C,insulin lispro and glargine,,2,,,,,,,,,,,,,,2021,Q4,Myalgia,,2021,Q4,1,I,20211021.0,,20211026,20211026,DIR,588185,,FDA-CTU,,58.0,YR,,M,N,145.0,KG,20211026.0,N,PH,US,US,2021,Q4,Adult
199970721,19997072,8,C,insulin lispro and glargine,,2,,,,,,,,,,,,,,2021,Q4,Oropharyngeal pain,,2021,Q4,1,I,20211021.0,,20211026,20211026,DIR,588185,,FDA-CTU,,58.0,YR,,M,N,145.0,KG,20211026.0,N,PH,US,US,2021,Q4,Adult
199970721,19997072,8,C,insulin lispro and glargine,,2,,,,,,,,,,,,,,2021,Q4,Headache,,2021,Q4,1,I,20211021.0,,20211026,20211026,DIR,588185,,FDA-CTU,,58.0,YR,,M,N,145.0,KG,20211026.0,N,PH,US,US,2021,Q4,Adult
199970721,19997072,8,C,insulin lispro and glargine,,2,,,,,,,,,,,,,,2021,Q4,Confusional state,,2021,Q4,1,I,20211021.0,,20211026,20211026,DIR,588185,,FDA-CTU,,58.0,YR,,M,N,145.0,KG,20211026.0,N,PH,US,US,2021,Q4,Adult
199970721,19997072,8,C,insulin lispro and glargine,,2,,,,,,,,,,,,,,2021,Q4,Feeling abnormal,,2021,Q4,1,I,20211021.0,,20211026,20211026,DIR,588185,,FDA-CTU,,58.0,YR,,M,N,145.0,KG,20211026.0,N,PH,US,US,2021,Q4,Adult
199970721,19997072,8,C,insulin lispro and glargine,,2,,,,,,,,,,,,,,2021,Q4,COVID-19 pneumonia,,2021,Q4,1,I,20211021.0,,20211026,20211026,DIR,588185,,FDA-CTU,,58.0,YR,,M,N,145.0,KG,20211026.0,N,PH,US,US,2021,Q4,Adult
199970721,19997072,8,C,insulin lispro and glargine,,2,,,,,,,,,,,,,,2021,Q4,Thrombocytopenia,,2021,Q4,1,I,20211021.0,,20211026,20211026,DIR,588185,,FDA-CTU,,58.0,YR,,M,N,145.0,KG,20211026.0,N,PH,US,US,2021,Q4,Adult
199970721,19997072,8,C,insulin lispro and glargine,,2,,,,,,,,,,,,,,2021,Q4,Aspartate aminotransferase increased,,2021,Q4,1,I,20211021.0,,20211026,20211026,DIR,588185,,FDA-CTU,,58.0,YR,,M,N,145.0,KG,20211026.0,N,PH,US,US,2021,Q4,Adult
199970721,19997072,8,C,insulin lispro and glargine,,2,,,,,,,,,,,,,,2021,Q4,Alanine aminotransferase increased,,2021,Q4,1,I,20211021.0,,20211026,20211026,DIR,588185,,FDA-CTU,,58.0,YR,,M,N,145.0,KG,20211026.0,N,PH,US,US,2021,Q4,Adult
199970721,19997072,8,C,insulin lispro and glargine,,2,,,,,,,,,,,,,,2021,Q4,Pain,,2021,Q4,1,I,20211021.0,,20211026,20211026,DIR,588185,,FDA-CTU,,58.0,YR,,M,N,145.0,KG,20211026.0,N,PH,US,US,2021,Q4,Adult
199970721,19997072,8,C,insulin lispro and glargine,,2,,,,,,,,,,,,,,2021,Q4,Fatigue,,2021,Q4,1,I,20211021.0,,20211026,20211026,DIR,588185,,FDA-CTU,,58.0,YR,,M,N,145.0,KG,20211026.0,N,PH,US,US,2021,Q4,Adult
199970721,19997072,8,C,insulin lispro and glargine,,2,,,,,,,,,,,,,,2021,Q4,Dysphonia,,2021,Q4,1,I,20211021.0,,20211026,20211026,DIR,588185,,FDA-CTU,,58.0,YR,,M,N,145.0,KG,20211026.0,N,PH,US,US,2021,Q4,Adult
199970721,19997072,8,C,insulin lispro and glargine,,2,,,,,,,,,,,,,,2021,Q4,Cough,,2021,Q4,1,I,20211021.0,,20211026,20211026,DIR,588185,,FDA-CTU,,58.0,YR,,M,N,145.0,KG,20211026.0,N,PH,US,US,2021,Q4,Adult
199970721,19997072,8,C,insulin lispro and glargine,,2,,,,,,,,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,1,I,20211021.0,,20211026,20211026,DIR,588185,,FDA-CTU,,58.0,YR,,M,N,145.0,KG,20211026.0,N,PH,US,US,2021,Q4,Adult
199970721,19997072,8,C,insulin lispro and glargine,,2,,,,,,,,,,,,,,2021,Q4,Haemoptysis,,2021,Q4,1,I,20211021.0,,20211026,20211026,DIR,588185,,FDA-CTU,,58.0,YR,,M,N,145.0,KG,20211026.0,N,PH,US,US,2021,Q4,Adult
199970721,19997072,8,C,insulin lispro and glargine,,2,,,,,,,,,,,,,,2021,Q4,Chills,,2021,Q4,1,I,20211021.0,,20211026,20211026,DIR,588185,,FDA-CTU,,58.0,YR,,M,N,145.0,KG,20211026.0,N,PH,US,US,2021,Q4,Adult
199970721,19997072,8,C,insulin lispro and glargine,,2,,,,,,,,,,,,,,2021,Q4,Dizziness,,2021,Q4,1,I,20211021.0,,20211026,20211026,DIR,588185,,FDA-CTU,,58.0,YR,,M,N,145.0,KG,20211026.0,N,PH,US,US,2021,Q4,Adult
199975861,19997586,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose,,,U,U,,,,,,,,2021,Q4,Electrocardiogram QRS complex shortened,,2021,Q4,1,I,,20211019.0,20211026,20211026,EXP,,US-MYLANLABS-2021M1075812,MYLAN,"Wu D, Patrick T. METHYLENE BLUE AND POISON-INDUCED CARDIOGENIC SHOCK. Chest 2021;160 (Suppl.)(4):A160.",55.0,YR,,F,Y,,,20211026.0,,HP,US,US,2021,Q4,Adult
199975861,19997586,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose,,,U,U,,,,,,,,2021,Q4,Atrioventricular block first degree,,2021,Q4,1,I,,20211019.0,20211026,20211026,EXP,,US-MYLANLABS-2021M1075812,MYLAN,"Wu D, Patrick T. METHYLENE BLUE AND POISON-INDUCED CARDIOGENIC SHOCK. Chest 2021;160 (Suppl.)(4):A160.",55.0,YR,,F,Y,,,20211026.0,,HP,US,US,2021,Q4,Adult
199975861,19997586,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose,,,U,U,,,,,,,,2021,Q4,Bradycardia,,2021,Q4,1,I,,20211019.0,20211026,20211026,EXP,,US-MYLANLABS-2021M1075812,MYLAN,"Wu D, Patrick T. METHYLENE BLUE AND POISON-INDUCED CARDIOGENIC SHOCK. Chest 2021;160 (Suppl.)(4):A160.",55.0,YR,,F,Y,,,20211026.0,,HP,US,US,2021,Q4,Adult
199975861,19997586,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose,,,U,U,,,,,,,,2021,Q4,Drug ineffective,,2021,Q4,1,I,,20211019.0,20211026,20211026,EXP,,US-MYLANLABS-2021M1075812,MYLAN,"Wu D, Patrick T. METHYLENE BLUE AND POISON-INDUCED CARDIOGENIC SHOCK. Chest 2021;160 (Suppl.)(4):A160.",55.0,YR,,F,Y,,,20211026.0,,HP,US,US,2021,Q4,Adult
199975861,19997586,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose,,,U,U,,,,,,,,2021,Q4,Mental status changes,,2021,Q4,1,I,,20211019.0,20211026,20211026,EXP,,US-MYLANLABS-2021M1075812,MYLAN,"Wu D, Patrick T. METHYLENE BLUE AND POISON-INDUCED CARDIOGENIC SHOCK. Chest 2021;160 (Suppl.)(4):A160.",55.0,YR,,F,Y,,,20211026.0,,HP,US,US,2021,Q4,Adult
199975861,19997586,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose,,,U,U,,,,,,,,2021,Q4,Hypotension,,2021,Q4,1,I,,20211019.0,20211026,20211026,EXP,,US-MYLANLABS-2021M1075812,MYLAN,"Wu D, Patrick T. METHYLENE BLUE AND POISON-INDUCED CARDIOGENIC SHOCK. Chest 2021;160 (Suppl.)(4):A160.",55.0,YR,,F,Y,,,20211026.0,,HP,US,US,2021,Q4,Adult
199975861,19997586,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose,,,U,U,,,,,,,,2021,Q4,Hypocalcaemia,,2021,Q4,1,I,,20211019.0,20211026,20211026,EXP,,US-MYLANLABS-2021M1075812,MYLAN,"Wu D, Patrick T. METHYLENE BLUE AND POISON-INDUCED CARDIOGENIC SHOCK. Chest 2021;160 (Suppl.)(4):A160.",55.0,YR,,F,Y,,,20211026.0,,HP,US,US,2021,Q4,Adult
199975861,19997586,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose,,,U,U,,,,,,,,2021,Q4,Hypoalbuminaemia,,2021,Q4,1,I,,20211019.0,20211026,20211026,EXP,,US-MYLANLABS-2021M1075812,MYLAN,"Wu D, Patrick T. METHYLENE BLUE AND POISON-INDUCED CARDIOGENIC SHOCK. Chest 2021;160 (Suppl.)(4):A160.",55.0,YR,,F,Y,,,20211026.0,,HP,US,US,2021,Q4,Adult
199975861,19997586,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose,,,U,U,,,,,,,,2021,Q4,Lethargy,,2021,Q4,1,I,,20211019.0,20211026,20211026,EXP,,US-MYLANLABS-2021M1075812,MYLAN,"Wu D, Patrick T. METHYLENE BLUE AND POISON-INDUCED CARDIOGENIC SHOCK. Chest 2021;160 (Suppl.)(4):A160.",55.0,YR,,F,Y,,,20211026.0,,HP,US,US,2021,Q4,Adult
199975861,19997586,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose,,,U,U,,,,,,,,2021,Q4,Asthenia,,2021,Q4,1,I,,20211019.0,20211026,20211026,EXP,,US-MYLANLABS-2021M1075812,MYLAN,"Wu D, Patrick T. METHYLENE BLUE AND POISON-INDUCED CARDIOGENIC SHOCK. Chest 2021;160 (Suppl.)(4):A160.",55.0,YR,,F,Y,,,20211026.0,,HP,US,US,2021,Q4,Adult
199975861,19997586,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose,,,U,U,,,,,,,,2021,Q4,Suicide attempt,,2021,Q4,1,I,,20211019.0,20211026,20211026,EXP,,US-MYLANLABS-2021M1075812,MYLAN,"Wu D, Patrick T. METHYLENE BLUE AND POISON-INDUCED CARDIOGENIC SHOCK. Chest 2021;160 (Suppl.)(4):A160.",55.0,YR,,F,Y,,,20211026.0,,HP,US,US,2021,Q4,Adult
199975861,19997586,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose,,,U,U,,,,,,,,2021,Q4,Intentional overdose,,2021,Q4,1,I,,20211019.0,20211026,20211026,EXP,,US-MYLANLABS-2021M1075812,MYLAN,"Wu D, Patrick T. METHYLENE BLUE AND POISON-INDUCED CARDIOGENIC SHOCK. Chest 2021;160 (Suppl.)(4):A160.",55.0,YR,,F,Y,,,20211026.0,,HP,US,US,2021,Q4,Adult
199975861,19997586,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose,,,U,U,,,,,,,,2021,Q4,Toxicity to various agents,,2021,Q4,1,I,,20211019.0,20211026,20211026,EXP,,US-MYLANLABS-2021M1075812,MYLAN,"Wu D, Patrick T. METHYLENE BLUE AND POISON-INDUCED CARDIOGENIC SHOCK. Chest 2021;160 (Suppl.)(4):A160.",55.0,YR,,F,Y,,,20211026.0,,HP,US,US,2021,Q4,Adult
199975861,19997586,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose,,,U,U,,,,,,,,2021,Q4,Cardiogenic shock,,2021,Q4,1,I,,20211019.0,20211026,20211026,EXP,,US-MYLANLABS-2021M1075812,MYLAN,"Wu D, Patrick T. METHYLENE BLUE AND POISON-INDUCED CARDIOGENIC SHOCK. Chest 2021;160 (Suppl.)(4):A160.",55.0,YR,,F,Y,,,20211026.0,,HP,US,US,2021,Q4,Adult
199977623,19997762,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 international unit, qd",,,,,1F939A,,,20.0,IU,Solution for injection,QD,2021,Q4,Tremor,,2021,Q4,3,F,20210818.0,20211112.0,20211026,20211119,EXP,,ES-MYLANLABS-2021M1075282,MYLAN,,72.0,YR,,F,Y,80.0,KG,20211119.0,,CN,ES,ES,2021,Q4,Elderly
199977623,19997762,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 international unit, qd",,,,,1F939A,,,20.0,IU,Solution for injection,QD,2021,Q4,Blood glucose decreased,,2021,Q4,3,F,20210818.0,20211112.0,20211026,20211119,EXP,,ES-MYLANLABS-2021M1075282,MYLAN,,72.0,YR,,F,Y,80.0,KG,20211119.0,,CN,ES,ES,2021,Q4,Elderly
199977623,19997762,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 international unit, qd",,,,,1F939A,,,20.0,IU,Solution for injection,QD,2021,Q4,Hypoglycaemia,,2021,Q4,3,F,20210818.0,20211112.0,20211026,20211119,EXP,,ES-MYLANLABS-2021M1075282,MYLAN,,72.0,YR,,F,Y,80.0,KG,20211119.0,,CN,ES,ES,2021,Q4,Elderly
199977623,19997762,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 international unit, qd",,,,,1F939A,,,20.0,IU,Solution for injection,QD,2021,Q4,Product storage error,,2021,Q4,3,F,20210818.0,20211112.0,20211026,20211119,EXP,,ES-MYLANLABS-2021M1075282,MYLAN,,72.0,YR,,F,Y,80.0,KG,20211119.0,,CN,ES,ES,2021,Q4,Elderly
199977623,19997762,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 international unit, qd",,,,,1F939A,,,20.0,IU,Solution for injection,QD,2021,Q4,Weight fluctuation,,2021,Q4,3,F,20210818.0,20211112.0,20211026,20211119,EXP,,ES-MYLANLABS-2021M1075282,MYLAN,,72.0,YR,,F,Y,80.0,KG,20211119.0,,CN,ES,ES,2021,Q4,Elderly
199977623,19997762,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 international unit, qd",,,,,1F939A,,,20.0,IU,Solution for injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,3,F,20210818.0,20211112.0,20211026,20211119,EXP,,ES-MYLANLABS-2021M1075282,MYLAN,,72.0,YR,,F,Y,80.0,KG,20211119.0,,CN,ES,ES,2021,Q4,Elderly
199977623,19997762,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 international unit, qd",,,,,1F939A,,,20.0,IU,Solution for injection,QD,2021,Q4,Hyperglycaemia,,2021,Q4,3,F,20210818.0,20211112.0,20211026,20211119,EXP,,ES-MYLANLABS-2021M1075282,MYLAN,,72.0,YR,,F,Y,80.0,KG,20211119.0,,CN,ES,ES,2021,Q4,Elderly
199977623,19997762,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 international unit, qd",,,,,1F939A,,,20.0,IU,Solution for injection,QD,2021,Q4,Hyperhidrosis,,2021,Q4,3,F,20210818.0,20211112.0,20211026,20211119,EXP,,ES-MYLANLABS-2021M1075282,MYLAN,,72.0,YR,,F,Y,80.0,KG,20211119.0,,CN,ES,ES,2021,Q4,Elderly
199977623,19997762,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 international unit, qd",,,,,1F939A,,,20.0,IU,Solution for injection,QD,2021,Q4,Fear,,2021,Q4,3,F,20210818.0,20211112.0,20211026,20211119,EXP,,ES-MYLANLABS-2021M1075282,MYLAN,,72.0,YR,,F,Y,80.0,KG,20211119.0,,CN,ES,ES,2021,Q4,Elderly
199977623,19997762,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 international unit, qd",,,,,1F939A,,,20.0,IU,Solution for injection,QD,2021,Q4,Head discomfort,,2021,Q4,3,F,20210818.0,20211112.0,20211026,20211119,EXP,,ES-MYLANLABS-2021M1075282,MYLAN,,72.0,YR,,F,Y,80.0,KG,20211119.0,,CN,ES,ES,2021,Q4,Elderly
199977623,19997762,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 international unit, qd",,,,,1F939A,,,20.0,IU,Solution for injection,QD,2021,Q4,Confusional state,,2021,Q4,3,F,20210818.0,20211112.0,20211026,20211119,EXP,,ES-MYLANLABS-2021M1075282,MYLAN,,72.0,YR,,F,Y,80.0,KG,20211119.0,,CN,ES,ES,2021,Q4,Elderly
200003072,20000307,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 international unit, prn",,,,,,,,12.0,IU,,,2021,Q4,Clostridium difficile infection,,2021,Q4,2,F,20181219.0,20211029.0,20211026,20211102,EXP,,DE-TAKEDA-2021TUS065234,TAKEDA,,70.0,YR,,M,Y,,,20211102.0,,HP,DE,DE,2021,Q4,Elderly
200003072,20000307,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 international unit, prn",,,,,,,,12.0,IU,,,2021,Q4,Hypokalaemia,,2021,Q4,2,F,20181219.0,20211029.0,20211026,20211102,EXP,,DE-TAKEDA-2021TUS065234,TAKEDA,,70.0,YR,,M,Y,,,20211102.0,,HP,DE,DE,2021,Q4,Elderly
200003072,20000307,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2021,Q4,Clostridium difficile infection,,2021,Q4,2,F,20181219.0,20211029.0,20211026,20211102,EXP,,DE-TAKEDA-2021TUS065234,TAKEDA,,70.0,YR,,M,Y,,,20211102.0,,HP,DE,DE,2021,Q4,Elderly
200003072,20000307,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2021,Q4,Hypokalaemia,,2021,Q4,2,F,20181219.0,20211029.0,20211026,20211102,EXP,,DE-TAKEDA-2021TUS065234,TAKEDA,,70.0,YR,,M,Y,,,20211102.0,,HP,DE,DE,2021,Q4,Elderly
200005582,20000558,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,each night,,,D,,,,21081.0,,,,,2021,Q4,Hypoglycaemia,,2021,Q4,2,F,,20211027.0,20211026,20211104,EXP,,US-SA-2021SA348218,SANOFI AVENTIS,,16.0,YR,T,M,Y,,,20211104.0,,MD,US,US,2021,Q4,Youth
200005582,20000558,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,each night,,,D,,,,21081.0,,,,,2021,Q4,Glycogen storage disease type VIII,,2021,Q4,2,F,,20211027.0,20211026,20211104,EXP,,US-SA-2021SA348218,SANOFI AVENTIS,,16.0,YR,T,M,Y,,,20211104.0,,MD,US,US,2021,Q4,Youth
200005582,20000558,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,each night,,,D,,,,21081.0,,,,,2021,Q4,Overdose,,2021,Q4,2,F,,20211027.0,20211026,20211104,EXP,,US-SA-2021SA348218,SANOFI AVENTIS,,16.0,YR,T,M,Y,,,20211104.0,,MD,US,US,2021,Q4,Youth
200005582,20000558,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,each night,,,D,,,,21081.0,,,,,2021,Q4,Abdominal discomfort,,2021,Q4,2,F,,20211027.0,20211026,20211104,EXP,,US-SA-2021SA348218,SANOFI AVENTIS,,16.0,YR,T,M,Y,,,20211104.0,,MD,US,US,2021,Q4,Youth
200005582,20000558,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,each night,,,D,,,,21081.0,,,,,2021,Q4,Hepatitis acute,,2021,Q4,2,F,,20211027.0,20211026,20211104,EXP,,US-SA-2021SA348218,SANOFI AVENTIS,,16.0,YR,T,M,Y,,,20211104.0,,MD,US,US,2021,Q4,Youth
200005582,20000558,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,each night,,,D,,,,21081.0,,,,,2021,Q4,Abdominal tenderness,,2021,Q4,2,F,,20211027.0,20211026,20211104,EXP,,US-SA-2021SA348218,SANOFI AVENTIS,,16.0,YR,T,M,Y,,,20211104.0,,MD,US,US,2021,Q4,Youth
200005582,20000558,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,each night,,,D,,,,21081.0,,,,,2021,Q4,Vomiting,,2021,Q4,2,F,,20211027.0,20211026,20211104,EXP,,US-SA-2021SA348218,SANOFI AVENTIS,,16.0,YR,T,M,Y,,,20211104.0,,MD,US,US,2021,Q4,Youth
200005582,20000558,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,each night,,,D,,,,21081.0,,,,,2021,Q4,Nausea,,2021,Q4,2,F,,20211027.0,20211026,20211104,EXP,,US-SA-2021SA348218,SANOFI AVENTIS,,16.0,YR,T,M,Y,,,20211104.0,,MD,US,US,2021,Q4,Youth
200005582,20000558,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,each night,,,D,,,,21081.0,,,,,2021,Q4,Abdominal pain,,2021,Q4,2,F,,20211027.0,20211026,20211104,EXP,,US-SA-2021SA348218,SANOFI AVENTIS,,16.0,YR,T,M,Y,,,20211104.0,,MD,US,US,2021,Q4,Youth
200022521,20002252,3,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,Subcutaneous,"24 IU, qd",,,U,U,Unknown,,,24.0,IU,,QD,2021,Q4,COVID-19,,2021,Q4,1,I,,20211018.0,20211027,20211027,EXP,,JP-NOVOPROD-859511,NOVO NORDISK,,60.0,YR,,M,Y,,,20211027.0,,MD,JP,JP,2021,Q4,Adult
200022521,20002252,3,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,Subcutaneous,"24 IU, qd",,,U,U,Unknown,,,24.0,IU,,QD,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,,20211018.0,20211027,20211027,EXP,,JP-NOVOPROD-859511,NOVO NORDISK,,60.0,YR,,M,Y,,,20211027.0,,MD,JP,JP,2021,Q4,Adult
200044641,20004464,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,34 international unit (34 iU),,,,,,,,34.0,IU,Solution for injection,,2021,Q4,Contusion,,2021,Q4,1,I,20210101.0,20211021.0,20211027,20211027,EXP,,ES-MYLANLABS-2021M1075794,MYLAN,,83.0,YR,,F,Y,78.0,KG,20211027.0,,CN,ES,ES,2021,Q4,Elderly
200044641,20004464,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,34 international unit (34 iU),,,,,,,,34.0,IU,Solution for injection,,2021,Q4,Decreased appetite,,2021,Q4,1,I,20210101.0,20211021.0,20211027,20211027,EXP,,ES-MYLANLABS-2021M1075794,MYLAN,,83.0,YR,,F,Y,78.0,KG,20211027.0,,CN,ES,ES,2021,Q4,Elderly
200044641,20004464,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,34 international unit (34 iU),,,,,,,,34.0,IU,Solution for injection,,2021,Q4,Limb injury,,2021,Q4,1,I,20210101.0,20211021.0,20211027,20211027,EXP,,ES-MYLANLABS-2021M1075794,MYLAN,,83.0,YR,,F,Y,78.0,KG,20211027.0,,CN,ES,ES,2021,Q4,Elderly
200044641,20004464,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,34 international unit (34 iU),,,,,,,,34.0,IU,Solution for injection,,2021,Q4,Localised infection,,2021,Q4,1,I,20210101.0,20211021.0,20211027,20211027,EXP,,ES-MYLANLABS-2021M1075794,MYLAN,,83.0,YR,,F,Y,78.0,KG,20211027.0,,CN,ES,ES,2021,Q4,Elderly
200044641,20004464,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,34 international unit (34 iU),,,,,,,,34.0,IU,Solution for injection,,2021,Q4,Pain in extremity,,2021,Q4,1,I,20210101.0,20211021.0,20211027,20211027,EXP,,ES-MYLANLABS-2021M1075794,MYLAN,,83.0,YR,,F,Y,78.0,KG,20211027.0,,CN,ES,ES,2021,Q4,Elderly
200044641,20004464,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,34 international unit (34 iU),,,,,,,,34.0,IU,Solution for injection,,2021,Q4,Fatigue,,2021,Q4,1,I,20210101.0,20211021.0,20211027,20211027,EXP,,ES-MYLANLABS-2021M1075794,MYLAN,,83.0,YR,,F,Y,78.0,KG,20211027.0,,CN,ES,ES,2021,Q4,Elderly
200044641,20004464,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,34 international unit (34 iU),,,,,,,,34.0,IU,Solution for injection,,2021,Q4,Depressed mood,,2021,Q4,1,I,20210101.0,20211021.0,20211027,20211027,EXP,,ES-MYLANLABS-2021M1075794,MYLAN,,83.0,YR,,F,Y,78.0,KG,20211027.0,,CN,ES,ES,2021,Q4,Elderly
200044641,20004464,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,34 international unit (34 iU),,,,,,,,34.0,IU,Solution for injection,,2021,Q4,Nervousness,,2021,Q4,1,I,20210101.0,20211021.0,20211027,20211027,EXP,,ES-MYLANLABS-2021M1075794,MYLAN,,83.0,YR,,F,Y,78.0,KG,20211027.0,,CN,ES,ES,2021,Q4,Elderly
200044641,20004464,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,34 international unit (34 iU),,,,,,,,34.0,IU,Solution for injection,,2021,Q4,Blood glucose abnormal,,2021,Q4,1,I,20210101.0,20211021.0,20211027,20211027,EXP,,ES-MYLANLABS-2021M1075794,MYLAN,,83.0,YR,,F,Y,78.0,KG,20211027.0,,CN,ES,ES,2021,Q4,Elderly
200044641,20004464,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,34 international unit (34 iU),,,,,,,,34.0,IU,Solution for injection,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,20210101.0,20211021.0,20211027,20211027,EXP,,ES-MYLANLABS-2021M1075794,MYLAN,,83.0,YR,,F,Y,78.0,KG,20211027.0,,CN,ES,ES,2021,Q4,Elderly
200044641,20004464,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,34 international unit (34 iU),,,,,,,,34.0,IU,Solution for injection,,2021,Q4,Cardiac failure chronic,,2021,Q4,1,I,20210101.0,20211021.0,20211027,20211027,EXP,,ES-MYLANLABS-2021M1075794,MYLAN,,83.0,YR,,F,Y,78.0,KG,20211027.0,,CN,ES,ES,2021,Q4,Elderly
200044641,20004464,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,34 international unit (34 iU),,,,,,,,34.0,IU,Solution for injection,,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20210101.0,20211021.0,20211027,20211027,EXP,,ES-MYLANLABS-2021M1075794,MYLAN,,83.0,YR,,F,Y,78.0,KG,20211027.0,,CN,ES,ES,2021,Q4,Elderly
200044641,20004464,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,34 international unit (34 iU),,,,,,,,34.0,IU,Solution for injection,,2021,Q4,Skin discolouration,,2021,Q4,1,I,20210101.0,20211021.0,20211027,20211027,EXP,,ES-MYLANLABS-2021M1075794,MYLAN,,83.0,YR,,F,Y,78.0,KG,20211027.0,,CN,ES,ES,2021,Q4,Elderly
200044641,20004464,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (dose increased),,,,,,,,,,Solution for injection,,2021,Q4,Contusion,,2021,Q4,1,I,20210101.0,20211021.0,20211027,20211027,EXP,,ES-MYLANLABS-2021M1075794,MYLAN,,83.0,YR,,F,Y,78.0,KG,20211027.0,,CN,ES,ES,2021,Q4,Elderly
200044641,20004464,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (dose increased),,,,,,,,,,Solution for injection,,2021,Q4,Decreased appetite,,2021,Q4,1,I,20210101.0,20211021.0,20211027,20211027,EXP,,ES-MYLANLABS-2021M1075794,MYLAN,,83.0,YR,,F,Y,78.0,KG,20211027.0,,CN,ES,ES,2021,Q4,Elderly
200044641,20004464,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (dose increased),,,,,,,,,,Solution for injection,,2021,Q4,Limb injury,,2021,Q4,1,I,20210101.0,20211021.0,20211027,20211027,EXP,,ES-MYLANLABS-2021M1075794,MYLAN,,83.0,YR,,F,Y,78.0,KG,20211027.0,,CN,ES,ES,2021,Q4,Elderly
200044641,20004464,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (dose increased),,,,,,,,,,Solution for injection,,2021,Q4,Localised infection,,2021,Q4,1,I,20210101.0,20211021.0,20211027,20211027,EXP,,ES-MYLANLABS-2021M1075794,MYLAN,,83.0,YR,,F,Y,78.0,KG,20211027.0,,CN,ES,ES,2021,Q4,Elderly
200044641,20004464,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (dose increased),,,,,,,,,,Solution for injection,,2021,Q4,Pain in extremity,,2021,Q4,1,I,20210101.0,20211021.0,20211027,20211027,EXP,,ES-MYLANLABS-2021M1075794,MYLAN,,83.0,YR,,F,Y,78.0,KG,20211027.0,,CN,ES,ES,2021,Q4,Elderly
200044641,20004464,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (dose increased),,,,,,,,,,Solution for injection,,2021,Q4,Fatigue,,2021,Q4,1,I,20210101.0,20211021.0,20211027,20211027,EXP,,ES-MYLANLABS-2021M1075794,MYLAN,,83.0,YR,,F,Y,78.0,KG,20211027.0,,CN,ES,ES,2021,Q4,Elderly
200044641,20004464,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (dose increased),,,,,,,,,,Solution for injection,,2021,Q4,Depressed mood,,2021,Q4,1,I,20210101.0,20211021.0,20211027,20211027,EXP,,ES-MYLANLABS-2021M1075794,MYLAN,,83.0,YR,,F,Y,78.0,KG,20211027.0,,CN,ES,ES,2021,Q4,Elderly
200044641,20004464,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (dose increased),,,,,,,,,,Solution for injection,,2021,Q4,Nervousness,,2021,Q4,1,I,20210101.0,20211021.0,20211027,20211027,EXP,,ES-MYLANLABS-2021M1075794,MYLAN,,83.0,YR,,F,Y,78.0,KG,20211027.0,,CN,ES,ES,2021,Q4,Elderly
200044641,20004464,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (dose increased),,,,,,,,,,Solution for injection,,2021,Q4,Blood glucose abnormal,,2021,Q4,1,I,20210101.0,20211021.0,20211027,20211027,EXP,,ES-MYLANLABS-2021M1075794,MYLAN,,83.0,YR,,F,Y,78.0,KG,20211027.0,,CN,ES,ES,2021,Q4,Elderly
200044641,20004464,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (dose increased),,,,,,,,,,Solution for injection,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,20210101.0,20211021.0,20211027,20211027,EXP,,ES-MYLANLABS-2021M1075794,MYLAN,,83.0,YR,,F,Y,78.0,KG,20211027.0,,CN,ES,ES,2021,Q4,Elderly
200044641,20004464,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (dose increased),,,,,,,,,,Solution for injection,,2021,Q4,Cardiac failure chronic,,2021,Q4,1,I,20210101.0,20211021.0,20211027,20211027,EXP,,ES-MYLANLABS-2021M1075794,MYLAN,,83.0,YR,,F,Y,78.0,KG,20211027.0,,CN,ES,ES,2021,Q4,Elderly
200044641,20004464,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (dose increased),,,,,,,,,,Solution for injection,,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20210101.0,20211021.0,20211027,20211027,EXP,,ES-MYLANLABS-2021M1075794,MYLAN,,83.0,YR,,F,Y,78.0,KG,20211027.0,,CN,ES,ES,2021,Q4,Elderly
200044641,20004464,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (dose increased),,,,,,,,,,Solution for injection,,2021,Q4,Skin discolouration,,2021,Q4,1,I,20210101.0,20211021.0,20211027,20211027,EXP,,ES-MYLANLABS-2021M1075794,MYLAN,,83.0,YR,,F,Y,78.0,KG,20211027.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, Once a Day",,,Y,,,,,,,Solution for injection,QD,2021,Q4,Product prescribing issue,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, Once a Day",,,Y,,,,,,,Solution for injection,QD,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, Once a Day",,,Y,,,,,,,Solution for injection,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, Once a Day",,,Y,,,,,,,Solution for injection,QD,2021,Q4,Drug ineffective,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, Once a Day",,,Y,,,,,,,Solution for injection,QD,2021,Q4,Fatigue,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, Once a Day",,,Y,,,,,,,Solution for injection,QD,2021,Q4,Hyperhidrosis,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, Once a Day",,,Y,,,,,,,Solution for injection,QD,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, Once a Day",,,Y,,,,,,,Solution for injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, Once a Day",,,Y,,,,,,,Solution for injection,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, Once a Day",,,Y,,,,,,,Solution for injection,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 international unit, Once a Day",,,Y,,1F040A,,,34.0,IU,Solution for injection,QD,2021,Q4,Product prescribing issue,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 international unit, Once a Day",,,Y,,1F040A,,,34.0,IU,Solution for injection,QD,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 international unit, Once a Day",,,Y,,1F040A,,,34.0,IU,Solution for injection,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 international unit, Once a Day",,,Y,,1F040A,,,34.0,IU,Solution for injection,QD,2021,Q4,Drug ineffective,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 international unit, Once a Day",,,Y,,1F040A,,,34.0,IU,Solution for injection,QD,2021,Q4,Fatigue,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 international unit, Once a Day",,,Y,,1F040A,,,34.0,IU,Solution for injection,QD,2021,Q4,Hyperhidrosis,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 international unit, Once a Day",,,Y,,1F040A,,,34.0,IU,Solution for injection,QD,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 international unit, Once a Day",,,Y,,1F040A,,,34.0,IU,Solution for injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 international unit, Once a Day",,,Y,,1F040A,,,34.0,IU,Solution for injection,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 international unit, Once a Day",,,Y,,1F040A,,,34.0,IU,Solution for injection,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 international unit, Once a Day",,,Y,,1F935A,,,24.0,IU,Solution for injection,QD,2021,Q4,Product prescribing issue,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 international unit, Once a Day",,,Y,,1F935A,,,24.0,IU,Solution for injection,QD,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 international unit, Once a Day",,,Y,,1F935A,,,24.0,IU,Solution for injection,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 international unit, Once a Day",,,Y,,1F935A,,,24.0,IU,Solution for injection,QD,2021,Q4,Drug ineffective,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 international unit, Once a Day",,,Y,,1F935A,,,24.0,IU,Solution for injection,QD,2021,Q4,Fatigue,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 international unit, Once a Day",,,Y,,1F935A,,,24.0,IU,Solution for injection,QD,2021,Q4,Hyperhidrosis,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 international unit, Once a Day",,,Y,,1F935A,,,24.0,IU,Solution for injection,QD,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 international unit, Once a Day",,,Y,,1F935A,,,24.0,IU,Solution for injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 international unit, Once a Day",,,Y,,1F935A,,,24.0,IU,Solution for injection,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 international unit, Once a Day",,,Y,,1F935A,,,24.0,IU,Solution for injection,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"36 international unit, Once a Day",,,Y,,1F935A,,,36.0,IU,Solution for injection,QD,2021,Q4,Product prescribing issue,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"36 international unit, Once a Day",,,Y,,1F935A,,,36.0,IU,Solution for injection,QD,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"36 international unit, Once a Day",,,Y,,1F935A,,,36.0,IU,Solution for injection,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"36 international unit, Once a Day",,,Y,,1F935A,,,36.0,IU,Solution for injection,QD,2021,Q4,Drug ineffective,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"36 international unit, Once a Day",,,Y,,1F935A,,,36.0,IU,Solution for injection,QD,2021,Q4,Fatigue,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"36 international unit, Once a Day",,,Y,,1F935A,,,36.0,IU,Solution for injection,QD,2021,Q4,Hyperhidrosis,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"36 international unit, Once a Day",,,Y,,1F935A,,,36.0,IU,Solution for injection,QD,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"36 international unit, Once a Day",,,Y,,1F935A,,,36.0,IU,Solution for injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"36 international unit, Once a Day",,,Y,,1F935A,,,36.0,IU,Solution for injection,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"36 international unit, Once a Day",,,Y,,1F935A,,,36.0,IU,Solution for injection,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 international unit, Once a Day",,,Y,,1F040A,,,36.0,IU,Solution for injection,QD,2021,Q4,Product prescribing issue,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 international unit, Once a Day",,,Y,,1F040A,,,36.0,IU,Solution for injection,QD,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 international unit, Once a Day",,,Y,,1F040A,,,36.0,IU,Solution for injection,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 international unit, Once a Day",,,Y,,1F040A,,,36.0,IU,Solution for injection,QD,2021,Q4,Drug ineffective,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 international unit, Once a Day",,,Y,,1F040A,,,36.0,IU,Solution for injection,QD,2021,Q4,Fatigue,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 international unit, Once a Day",,,Y,,1F040A,,,36.0,IU,Solution for injection,QD,2021,Q4,Hyperhidrosis,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 international unit, Once a Day",,,Y,,1F040A,,,36.0,IU,Solution for injection,QD,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 international unit, Once a Day",,,Y,,1F040A,,,36.0,IU,Solution for injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 international unit, Once a Day",,,Y,,1F040A,,,36.0,IU,Solution for injection,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 international unit, Once a Day",,,Y,,1F040A,,,36.0,IU,Solution for injection,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 international unit, Once a Day",,,Y,,,,,28.0,IU,Solution for injection,QD,2021,Q4,Product prescribing issue,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 international unit, Once a Day",,,Y,,,,,28.0,IU,Solution for injection,QD,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 international unit, Once a Day",,,Y,,,,,28.0,IU,Solution for injection,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 international unit, Once a Day",,,Y,,,,,28.0,IU,Solution for injection,QD,2021,Q4,Drug ineffective,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 international unit, Once a Day",,,Y,,,,,28.0,IU,Solution for injection,QD,2021,Q4,Fatigue,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 international unit, Once a Day",,,Y,,,,,28.0,IU,Solution for injection,QD,2021,Q4,Hyperhidrosis,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 international unit, Once a Day",,,Y,,,,,28.0,IU,Solution for injection,QD,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 international unit, Once a Day",,,Y,,,,,28.0,IU,Solution for injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 international unit, Once a Day",,,Y,,,,,28.0,IU,Solution for injection,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 international unit, Once a Day",,,Y,,,,,28.0,IU,Solution for injection,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 international unit, Once a Day",,,Y,,,,,40.0,IU,Solution for injection,QD,2021,Q4,Product prescribing issue,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 international unit, Once a Day",,,Y,,,,,40.0,IU,Solution for injection,QD,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 international unit, Once a Day",,,Y,,,,,40.0,IU,Solution for injection,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 international unit, Once a Day",,,Y,,,,,40.0,IU,Solution for injection,QD,2021,Q4,Drug ineffective,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 international unit, Once a Day",,,Y,,,,,40.0,IU,Solution for injection,QD,2021,Q4,Fatigue,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 international unit, Once a Day",,,Y,,,,,40.0,IU,Solution for injection,QD,2021,Q4,Hyperhidrosis,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 international unit, Once a Day",,,Y,,,,,40.0,IU,Solution for injection,QD,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 international unit, Once a Day",,,Y,,,,,40.0,IU,Solution for injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 international unit, Once a Day",,,Y,,,,,40.0,IU,Solution for injection,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 international unit, Once a Day",,,Y,,,,,40.0,IU,Solution for injection,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,Y,,,,,,,Solution for injection,,2021,Q4,Product prescribing issue,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,Y,,,,,,,Solution for injection,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,Y,,,,,,,Solution for injection,,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,Y,,,,,,,Solution for injection,,2021,Q4,Drug ineffective,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,Y,,,,,,,Solution for injection,,2021,Q4,Fatigue,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,Y,,,,,,,Solution for injection,,2021,Q4,Hyperhidrosis,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,Y,,,,,,,Solution for injection,,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,Y,,,,,,,Solution for injection,,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,Y,,,,,,,Solution for injection,,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200066231,20006623,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,Y,,,,,,,Solution for injection,,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20200101.0,20211013.0,20211028,20211028,EXP,,ES-AUROBINDO-AUR-APL-2021-043559,AUROBINDO,,68.0,YR,,M,Y,83.0,KG,20211028.0,,CN,ES,ES,2021,Q4,Elderly
200078023,20007802,106,C,INSULIN GLARGINE BIOSIMILAR 1,,1,Unknown,"Unknown, Unknown",,,,,,,,,,,,2021,Q4,Pancytopenia,,2021,Q4,3,F,20210604.0,20211209.0,20211028,20211215,EXP,,JP-BioDelivery Sciences International-E2B_00001343,BIODELIVERY SCIENCES INTERNATIONAL,,78.0,YR,E,M,Y,,,20211215.0,,MD,JP,JP,2021,Q4,Elderly
200105091,20010509,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Vomiting,,2021,Q4,1,I,20190101.0,20211025.0,20211029,20211029,EXP,,PR-ABBVIE-21K-131-4138119-00,ABBVIE,,63.0,YR,,F,Y,86.26,KG,20211029.0,,CN,COUNTRY NOT SPECIFIED,PR,2021,Q4,Adult
200105091,20010509,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Dizziness,,2021,Q4,1,I,20190101.0,20211025.0,20211029,20211029,EXP,,PR-ABBVIE-21K-131-4138119-00,ABBVIE,,63.0,YR,,F,Y,86.26,KG,20211029.0,,CN,COUNTRY NOT SPECIFIED,PR,2021,Q4,Adult
200105091,20010509,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Cataract,,2021,Q4,1,I,20190101.0,20211025.0,20211029,20211029,EXP,,PR-ABBVIE-21K-131-4138119-00,ABBVIE,,63.0,YR,,F,Y,86.26,KG,20211029.0,,CN,COUNTRY NOT SPECIFIED,PR,2021,Q4,Adult
200105091,20010509,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Cataract,,2021,Q4,1,I,20190101.0,20211025.0,20211029,20211029,EXP,,PR-ABBVIE-21K-131-4138119-00,ABBVIE,,63.0,YR,,F,Y,86.26,KG,20211029.0,,CN,COUNTRY NOT SPECIFIED,PR,2021,Q4,Adult
200105091,20010509,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Vertigo,,2021,Q4,1,I,20190101.0,20211025.0,20211029,20211029,EXP,,PR-ABBVIE-21K-131-4138119-00,ABBVIE,,63.0,YR,,F,Y,86.26,KG,20211029.0,,CN,COUNTRY NOT SPECIFIED,PR,2021,Q4,Adult
200105091,20010509,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Eye infarction,,2021,Q4,1,I,20190101.0,20211025.0,20211029,20211029,EXP,,PR-ABBVIE-21K-131-4138119-00,ABBVIE,,63.0,YR,,F,Y,86.26,KG,20211029.0,,CN,COUNTRY NOT SPECIFIED,PR,2021,Q4,Adult
200108132,20010813,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 units,,,U,,,,,,,,,2021,Q4,Therapeutic product effect decreased,,2021,Q4,2,F,,20211029.0,20211028,20211102,EXP,,US-TEVA-2021-US-1968811,TEVA,"Del Toro-Pagan NM, Matos A, Thacker D, Turgeon J, Amin NS, Michaud V. Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report. Medicina-Kaunas 2021;57:No. 9.",66.0,YR,E,F,Y,,,20211102.0,,HP,US,US,2021,Q4,Elderly
200108132,20010813,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 units,,,U,,,,,,,,,2021,Q4,CYP2D6 gene status assay,,2021,Q4,2,F,,20211029.0,20211028,20211102,EXP,,US-TEVA-2021-US-1968811,TEVA,"Del Toro-Pagan NM, Matos A, Thacker D, Turgeon J, Amin NS, Michaud V. Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report. Medicina-Kaunas 2021;57:No. 9.",66.0,YR,E,F,Y,,,20211102.0,,HP,US,US,2021,Q4,Elderly
200108132,20010813,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 units,,,U,,,,,,,,,2021,Q4,Therapeutic product effect increased,,2021,Q4,2,F,,20211029.0,20211028,20211102,EXP,,US-TEVA-2021-US-1968811,TEVA,"Del Toro-Pagan NM, Matos A, Thacker D, Turgeon J, Amin NS, Michaud V. Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report. Medicina-Kaunas 2021;57:No. 9.",66.0,YR,E,F,Y,,,20211102.0,,HP,US,US,2021,Q4,Elderly
200108132,20010813,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 units,,,U,,,,,,,,,2021,Q4,Bradycardia,,2021,Q4,2,F,,20211029.0,20211028,20211102,EXP,,US-TEVA-2021-US-1968811,TEVA,"Del Toro-Pagan NM, Matos A, Thacker D, Turgeon J, Amin NS, Michaud V. Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report. Medicina-Kaunas 2021;57:No. 9.",66.0,YR,E,F,Y,,,20211102.0,,HP,US,US,2021,Q4,Elderly
200108132,20010813,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 units,,,U,,,,,,,,,2021,Q4,Cytogenetic analysis abnormal,,2021,Q4,2,F,,20211029.0,20211028,20211102,EXP,,US-TEVA-2021-US-1968811,TEVA,"Del Toro-Pagan NM, Matos A, Thacker D, Turgeon J, Amin NS, Michaud V. Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report. Medicina-Kaunas 2021;57:No. 9.",66.0,YR,E,F,Y,,,20211102.0,,HP,US,US,2021,Q4,Elderly
200108132,20010813,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 units,,,U,,,,,,,,,2021,Q4,Drug interaction,,2021,Q4,2,F,,20211029.0,20211028,20211102,EXP,,US-TEVA-2021-US-1968811,TEVA,"Del Toro-Pagan NM, Matos A, Thacker D, Turgeon J, Amin NS, Michaud V. Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report. Medicina-Kaunas 2021;57:No. 9.",66.0,YR,E,F,Y,,,20211102.0,,HP,US,US,2021,Q4,Elderly
200109511,20010951,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 u, daily",,,Y,,,,205692.0,8.0,IU,Injection,QD,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,20210816.0,20211018.0,20211029,20211029,EXP,IT-MINISAL02-799459,IT-ELI_LILLY_AND_COMPANY-IT202110007513,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20211029.0,,CN,IT,IT,2021,Q4,Adult
200119413,20011941,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IU, NK [presumably not known], prefilled syringes",,,U,U,,,210605.0,1.0,IU,Injection,,2021,Q4,Acute respiratory failure,,2021,Q4,3,F,,20211025.0,20211029,20211104,EXP,,DE-MYLANLABS-2021M1076678,MYLAN,,56.0,YR,,F,Y,105.0,KG,20211104.0,,PH,DE,DE,2021,Q4,Adult
200119413,20011941,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IU, NK [presumably not known], prefilled syringes",,,U,U,,,210605.0,1.0,IU,Injection,,2021,Q4,Product administration error,,2021,Q4,3,F,,20211025.0,20211029,20211104,EXP,,DE-MYLANLABS-2021M1076678,MYLAN,,56.0,YR,,F,Y,105.0,KG,20211104.0,,PH,DE,DE,2021,Q4,Adult
200119413,20011941,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IU, NK [presumably not known], prefilled syringes",,,U,U,,,210605.0,1.0,IU,Injection,,2021,Q4,Condition aggravated,,2021,Q4,3,F,,20211025.0,20211029,20211104,EXP,,DE-MYLANLABS-2021M1076678,MYLAN,,56.0,YR,,F,Y,105.0,KG,20211104.0,,PH,DE,DE,2021,Q4,Adult
200119413,20011941,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IU, NK [presumably not known], prefilled syringes",,,U,U,,,210605.0,1.0,IU,Injection,,2021,Q4,Cough,,2021,Q4,3,F,,20211025.0,20211029,20211104,EXP,,DE-MYLANLABS-2021M1076678,MYLAN,,56.0,YR,,F,Y,105.0,KG,20211104.0,,PH,DE,DE,2021,Q4,Adult
200119413,20011941,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IU, NK [presumably not known], prefilled syringes",,,U,U,,,210605.0,1.0,IU,Injection,,2021,Q4,Hypoxia,,2021,Q4,3,F,,20211025.0,20211029,20211104,EXP,,DE-MYLANLABS-2021M1076678,MYLAN,,56.0,YR,,F,Y,105.0,KG,20211104.0,,PH,DE,DE,2021,Q4,Adult
200119413,20011941,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IU, NK [presumably not known], prefilled syringes",,,U,U,,,210605.0,1.0,IU,Injection,,2021,Q4,Dyspnoea,,2021,Q4,3,F,,20211025.0,20211029,20211104,EXP,,DE-MYLANLABS-2021M1076678,MYLAN,,56.0,YR,,F,Y,105.0,KG,20211104.0,,PH,DE,DE,2021,Q4,Adult
200127881,20012788,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,25 units daily,,,U,U,,,,,,,QD,2021,Q4,Acute respiratory failure,,2021,Q4,1,I,,20211022.0,20211029,20211029,EXP,,US-MYLANLABS-2021M1079194,MYLAN,"Chetram VK, Ahmad AI, Farid S, Sood T. Acute Kidney Injury Secondary to Rhabdomyolysis and COVID-19: A Case Report and Literature Review. Case-Rep-Nephrol 2021;null:null.",62.0,YR,,M,Y,,,20211029.0,,HP,US,US,2021,Q4,Adult
200127881,20012788,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,25 units daily,,,U,U,,,,,,,QD,2021,Q4,Rhabdomyolysis,,2021,Q4,1,I,,20211022.0,20211029,20211029,EXP,,US-MYLANLABS-2021M1079194,MYLAN,"Chetram VK, Ahmad AI, Farid S, Sood T. Acute Kidney Injury Secondary to Rhabdomyolysis and COVID-19: A Case Report and Literature Review. Case-Rep-Nephrol 2021;null:null.",62.0,YR,,M,Y,,,20211029.0,,HP,US,US,2021,Q4,Adult
200127881,20012788,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,25 units daily,,,U,U,,,,,,,QD,2021,Q4,Acute kidney injury,,2021,Q4,1,I,,20211022.0,20211029,20211029,EXP,,US-MYLANLABS-2021M1079194,MYLAN,"Chetram VK, Ahmad AI, Farid S, Sood T. Acute Kidney Injury Secondary to Rhabdomyolysis and COVID-19: A Case Report and Literature Review. Case-Rep-Nephrol 2021;null:null.",62.0,YR,,M,Y,,,20211029.0,,HP,US,US,2021,Q4,Adult
200127881,20012788,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,25 units daily,,,U,U,,,,,,,QD,2021,Q4,Off label use,,2021,Q4,1,I,,20211022.0,20211029,20211029,EXP,,US-MYLANLABS-2021M1079194,MYLAN,"Chetram VK, Ahmad AI, Farid S, Sood T. Acute Kidney Injury Secondary to Rhabdomyolysis and COVID-19: A Case Report and Literature Review. Case-Rep-Nephrol 2021;null:null.",62.0,YR,,M,Y,,,20211029.0,,HP,US,US,2021,Q4,Adult
200127881,20012788,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,25 units daily,,,U,U,,,,,,,QD,2021,Q4,Metabolic acidosis,,2021,Q4,1,I,,20211022.0,20211029,20211029,EXP,,US-MYLANLABS-2021M1079194,MYLAN,"Chetram VK, Ahmad AI, Farid S, Sood T. Acute Kidney Injury Secondary to Rhabdomyolysis and COVID-19: A Case Report and Literature Review. Case-Rep-Nephrol 2021;null:null.",62.0,YR,,M,Y,,,20211029.0,,HP,US,US,2021,Q4,Adult
200131441,20013144,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Abdominal distension,,2021,Q4,1,I,20211010.0,20211022.0,20211029,20211029,EXP,,US-ROCHE-2944833,ROCHE,,53.0,YR,,M,Y,90.3,KG,20211029.0,,PH,US,US,2021,Q4,Adult
200131441,20013144,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Off label use,,2021,Q4,1,I,20211010.0,20211022.0,20211029,20211029,EXP,,US-ROCHE-2944833,ROCHE,,53.0,YR,,M,Y,90.3,KG,20211029.0,,PH,US,US,2021,Q4,Adult
200174281,20017428,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,8 IU (International Unit) Daily; 8 I.U. per day,,,N,,,,,8.0,IU,,QD,2021,Q4,Appendicitis,,2021,Q4,1,I,20190917.0,20211021.0,20211030,20211030,EXP,,DE-TEVA-2021-DE-1970252,TEVA,,48.0,YR,A,M,Y,,,20211030.0,,MD,DE,DE,2021,Q4,Adult
200207301,20020730,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 international unit, qd",,,U,,1f975a,,,10.0,IU,,QD,2021,Q4,Appetite disorder,,2021,Q4,1,I,20210101.0,20211025.0,20211101,20211101,EXP,,ES-MYLANLABS-2021M1076576,MYLAN,,51.0,YR,,M,Y,110.0,KG,20211101.0,,CN,ES,ES,2021,Q4,Adult
200207301,20020730,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 international unit, qd",,,U,,1f975a,,,10.0,IU,,QD,2021,Q4,Cold sweat,,2021,Q4,1,I,20210101.0,20211025.0,20211101,20211101,EXP,,ES-MYLANLABS-2021M1076576,MYLAN,,51.0,YR,,M,Y,110.0,KG,20211101.0,,CN,ES,ES,2021,Q4,Adult
200207301,20020730,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 international unit, qd",,,U,,1f975a,,,10.0,IU,,QD,2021,Q4,Blood glucose fluctuation,,2021,Q4,1,I,20210101.0,20211025.0,20211101,20211101,EXP,,ES-MYLANLABS-2021M1076576,MYLAN,,51.0,YR,,M,Y,110.0,KG,20211101.0,,CN,ES,ES,2021,Q4,Adult
200207301,20020730,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 international unit, qd",,,U,,1f975a,,,10.0,IU,,QD,2021,Q4,Weight decreased,,2021,Q4,1,I,20210101.0,20211025.0,20211101,20211101,EXP,,ES-MYLANLABS-2021M1076576,MYLAN,,51.0,YR,,M,Y,110.0,KG,20211101.0,,CN,ES,ES,2021,Q4,Adult
200207301,20020730,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 international unit, qd",,,U,,1f975a,,,10.0,IU,,QD,2021,Q4,Colitis,,2021,Q4,1,I,20210101.0,20211025.0,20211101,20211101,EXP,,ES-MYLANLABS-2021M1076576,MYLAN,,51.0,YR,,M,Y,110.0,KG,20211101.0,,CN,ES,ES,2021,Q4,Adult
200207301,20020730,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 international unit, qd",,,U,,1f975a,,,10.0,IU,,QD,2021,Q4,Nausea,,2021,Q4,1,I,20210101.0,20211025.0,20211101,20211101,EXP,,ES-MYLANLABS-2021M1076576,MYLAN,,51.0,YR,,M,Y,110.0,KG,20211101.0,,CN,ES,ES,2021,Q4,Adult
200207301,20020730,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 international unit, qd",,,U,,1f975a,,,10.0,IU,,QD,2021,Q4,Thirst,,2021,Q4,1,I,20210101.0,20211025.0,20211101,20211101,EXP,,ES-MYLANLABS-2021M1076576,MYLAN,,51.0,YR,,M,Y,110.0,KG,20211101.0,,CN,ES,ES,2021,Q4,Adult
200207301,20020730,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 international unit, qd",,,U,,1f975a,,,10.0,IU,,QD,2021,Q4,Flatulence,,2021,Q4,1,I,20210101.0,20211025.0,20211101,20211101,EXP,,ES-MYLANLABS-2021M1076576,MYLAN,,51.0,YR,,M,Y,110.0,KG,20211101.0,,CN,ES,ES,2021,Q4,Adult
200207301,20020730,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 international unit, qd",,,U,,1f975a,,,10.0,IU,,QD,2021,Q4,Headache,,2021,Q4,1,I,20210101.0,20211025.0,20211101,20211101,EXP,,ES-MYLANLABS-2021M1076576,MYLAN,,51.0,YR,,M,Y,110.0,KG,20211101.0,,CN,ES,ES,2021,Q4,Adult
200207301,20020730,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 international unit, qd",,,U,,1f975a,,,10.0,IU,,QD,2021,Q4,Hunger,,2021,Q4,1,I,20210101.0,20211025.0,20211101,20211101,EXP,,ES-MYLANLABS-2021M1076576,MYLAN,,51.0,YR,,M,Y,110.0,KG,20211101.0,,CN,ES,ES,2021,Q4,Adult
200207301,20020730,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 international unit, qd",,,U,,1f975a,,,10.0,IU,,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20210101.0,20211025.0,20211101,20211101,EXP,,ES-MYLANLABS-2021M1076576,MYLAN,,51.0,YR,,M,Y,110.0,KG,20211101.0,,CN,ES,ES,2021,Q4,Adult
200207301,20020730,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 international unit, qd",,,U,,1f975a,,,10.0,IU,,QD,2021,Q4,Gastrointestinal injury,,2021,Q4,1,I,20210101.0,20211025.0,20211101,20211101,EXP,,ES-MYLANLABS-2021M1076576,MYLAN,,51.0,YR,,M,Y,110.0,KG,20211101.0,,CN,ES,ES,2021,Q4,Adult
200207301,20020730,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 international unit, qd",,,U,,1f975a,,,10.0,IU,,QD,2021,Q4,Somnolence,,2021,Q4,1,I,20210101.0,20211025.0,20211101,20211101,EXP,,ES-MYLANLABS-2021M1076576,MYLAN,,51.0,YR,,M,Y,110.0,KG,20211101.0,,CN,ES,ES,2021,Q4,Adult
200207931,20020793,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU / ml / h once in the evening,,,U,,UNKNOWN,,,,,Unknown,,2021,Q4,Pseudomonas infection,,2021,Q4,1,I,20210712.0,20211026.0,20211101,20211101,EXP,FR-AFSSAPS-GR20214204,FR-Fresenius Kabi-FK202111648,FRESENIUS KABI,,77.0,YR,,M,Y,,,20211101.0,,HP,NL,,2021,Q4,Elderly
200207931,20020793,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU / ml / h once in the evening,,,U,,UNKNOWN,,,,,Unknown,,2021,Q4,Poisoning deliberate,,2021,Q4,1,I,20210712.0,20211026.0,20211101,20211101,EXP,FR-AFSSAPS-GR20214204,FR-Fresenius Kabi-FK202111648,FRESENIUS KABI,,77.0,YR,,M,Y,,,20211101.0,,HP,NL,,2021,Q4,Elderly
200207931,20020793,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU / ml / h once in the evening,,,U,,UNKNOWN,,,,,Unknown,,2021,Q4,Bradycardia,,2021,Q4,1,I,20210712.0,20211026.0,20211101,20211101,EXP,FR-AFSSAPS-GR20214204,FR-Fresenius Kabi-FK202111648,FRESENIUS KABI,,77.0,YR,,M,Y,,,20211101.0,,HP,NL,,2021,Q4,Elderly
200207931,20020793,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU / ml / h once in the evening,,,U,,UNKNOWN,,,,,Unknown,,2021,Q4,Hypotension,,2021,Q4,1,I,20210712.0,20211026.0,20211101,20211101,EXP,FR-AFSSAPS-GR20214204,FR-Fresenius Kabi-FK202111648,FRESENIUS KABI,,77.0,YR,,M,Y,,,20211101.0,,HP,NL,,2021,Q4,Elderly
200207931,20020793,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU / ml / h once in the evening,,,U,,UNKNOWN,,,,,Unknown,,2021,Q4,Acute kidney injury,,2021,Q4,1,I,20210712.0,20211026.0,20211101,20211101,EXP,FR-AFSSAPS-GR20214204,FR-Fresenius Kabi-FK202111648,FRESENIUS KABI,,77.0,YR,,M,Y,,,20211101.0,,HP,NL,,2021,Q4,Elderly
200207931,20020793,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU / ml / h once in the evening,,,U,,UNKNOWN,,,,,Unknown,,2021,Q4,Cardiogenic shock,,2021,Q4,1,I,20210712.0,20211026.0,20211101,20211101,EXP,FR-AFSSAPS-GR20214204,FR-Fresenius Kabi-FK202111648,FRESENIUS KABI,,77.0,YR,,M,Y,,,20211101.0,,HP,NL,,2021,Q4,Elderly
200207931,20020793,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU / ml / h once in the evening,,,U,,UNKNOWN,,,,,Unknown,,2021,Q4,Pneumonia aspiration,,2021,Q4,1,I,20210712.0,20211026.0,20211101,20211101,EXP,FR-AFSSAPS-GR20214204,FR-Fresenius Kabi-FK202111648,FRESENIUS KABI,,77.0,YR,,M,Y,,,20211101.0,,HP,NL,,2021,Q4,Elderly
200207931,20020793,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU / ml / h once in the evening,,,U,,UNKNOWN,,,,,Unknown,,2021,Q4,Coma,,2021,Q4,1,I,20210712.0,20211026.0,20211101,20211101,EXP,FR-AFSSAPS-GR20214204,FR-Fresenius Kabi-FK202111648,FRESENIUS KABI,,77.0,YR,,M,Y,,,20211101.0,,HP,NL,,2021,Q4,Elderly
200208031,20020803,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),UNK,,,Y,,,,,,,,,2021,Q4,Rash,,2021,Q4,1,I,20180101.0,20211026.0,20211101,20211101,EXP,,CN-SA-2021SA357938,SANOFI AVENTIS,"Zhuqing Z, Zelin L, Xiaobo L. Insulin pump combined with flash glucose monitoring for insulin desensitization treatment. Chin J Diabetes. 2021;29(10):781-783",67.0,YR,E,M,Y,,,20211101.0,,HP,CN,CN,2021,Q4,Elderly
200208031,20020803,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),UNK,,,Y,,,,,,,,,2021,Q4,Drug hypersensitivity,,2021,Q4,1,I,20180101.0,20211026.0,20211101,20211101,EXP,,CN-SA-2021SA357938,SANOFI AVENTIS,"Zhuqing Z, Zelin L, Xiaobo L. Insulin pump combined with flash glucose monitoring for insulin desensitization treatment. Chin J Diabetes. 2021;29(10):781-783",67.0,YR,E,M,Y,,,20211101.0,,HP,CN,CN,2021,Q4,Elderly
200208031,20020803,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),UNK,,,Y,,,,,,,,,2021,Q4,Urticaria,,2021,Q4,1,I,20180101.0,20211026.0,20211101,20211101,EXP,,CN-SA-2021SA357938,SANOFI AVENTIS,"Zhuqing Z, Zelin L, Xiaobo L. Insulin pump combined with flash glucose monitoring for insulin desensitization treatment. Chin J Diabetes. 2021;29(10):781-783",67.0,YR,E,M,Y,,,20211101.0,,HP,CN,CN,2021,Q4,Elderly
200208031,20020803,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),UNK,,,Y,,,,,,,,,2021,Q4,Therapeutic response decreased,,2021,Q4,1,I,20180101.0,20211026.0,20211101,20211101,EXP,,CN-SA-2021SA357938,SANOFI AVENTIS,"Zhuqing Z, Zelin L, Xiaobo L. Insulin pump combined with flash glucose monitoring for insulin desensitization treatment. Chin J Diabetes. 2021;29(10):781-783",67.0,YR,E,M,Y,,,20211101.0,,HP,CN,CN,2021,Q4,Elderly
200208031,20020803,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),UNK,,,Y,,,,,,,,,2021,Q4,Polyuria,,2021,Q4,1,I,20180101.0,20211026.0,20211101,20211101,EXP,,CN-SA-2021SA357938,SANOFI AVENTIS,"Zhuqing Z, Zelin L, Xiaobo L. Insulin pump combined with flash glucose monitoring for insulin desensitization treatment. Chin J Diabetes. 2021;29(10):781-783",67.0,YR,E,M,Y,,,20211101.0,,HP,CN,CN,2021,Q4,Elderly
200208031,20020803,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),UNK,,,Y,,,,,,,,,2021,Q4,Condition aggravated,,2021,Q4,1,I,20180101.0,20211026.0,20211101,20211101,EXP,,CN-SA-2021SA357938,SANOFI AVENTIS,"Zhuqing Z, Zelin L, Xiaobo L. Insulin pump combined with flash glucose monitoring for insulin desensitization treatment. Chin J Diabetes. 2021;29(10):781-783",67.0,YR,E,M,Y,,,20211101.0,,HP,CN,CN,2021,Q4,Elderly
200208031,20020803,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),UNK,,,Y,,,,,,,,,2021,Q4,Dry mouth,,2021,Q4,1,I,20180101.0,20211026.0,20211101,20211101,EXP,,CN-SA-2021SA357938,SANOFI AVENTIS,"Zhuqing Z, Zelin L, Xiaobo L. Insulin pump combined with flash glucose monitoring for insulin desensitization treatment. Chin J Diabetes. 2021;29(10):781-783",67.0,YR,E,M,Y,,,20211101.0,,HP,CN,CN,2021,Q4,Elderly
200208031,20020803,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),UNK,,,Y,,,,,,,,,2021,Q4,Disease recurrence,,2021,Q4,1,I,20180101.0,20211026.0,20211101,20211101,EXP,,CN-SA-2021SA357938,SANOFI AVENTIS,"Zhuqing Z, Zelin L, Xiaobo L. Insulin pump combined with flash glucose monitoring for insulin desensitization treatment. Chin J Diabetes. 2021;29(10):781-783",67.0,YR,E,M,Y,,,20211101.0,,HP,CN,CN,2021,Q4,Elderly
200208031,20020803,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),UNK,,,Y,,,,,,,,,2021,Q4,Pruritus,,2021,Q4,1,I,20180101.0,20211026.0,20211101,20211101,EXP,,CN-SA-2021SA357938,SANOFI AVENTIS,"Zhuqing Z, Zelin L, Xiaobo L. Insulin pump combined with flash glucose monitoring for insulin desensitization treatment. Chin J Diabetes. 2021;29(10):781-783",67.0,YR,E,M,Y,,,20211101.0,,HP,CN,CN,2021,Q4,Elderly
200208031,20020803,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),UNK,,,Y,,,,,,,,,2021,Q4,Polydipsia,,2021,Q4,1,I,20180101.0,20211026.0,20211101,20211101,EXP,,CN-SA-2021SA357938,SANOFI AVENTIS,"Zhuqing Z, Zelin L, Xiaobo L. Insulin pump combined with flash glucose monitoring for insulin desensitization treatment. Chin J Diabetes. 2021;29(10):781-783",67.0,YR,E,M,Y,,,20211101.0,,HP,CN,CN,2021,Q4,Elderly
200208031,20020803,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),UNK,,,Y,,,,,,,,,2021,Q4,Skin mass,,2021,Q4,1,I,20180101.0,20211026.0,20211101,20211101,EXP,,CN-SA-2021SA357938,SANOFI AVENTIS,"Zhuqing Z, Zelin L, Xiaobo L. Insulin pump combined with flash glucose monitoring for insulin desensitization treatment. Chin J Diabetes. 2021;29(10):781-783",67.0,YR,E,M,Y,,,20211101.0,,HP,CN,CN,2021,Q4,Elderly
200208031,20020803,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),UNK,,,Y,,,,,,,,,2021,Q4,Injection site nodule,,2021,Q4,1,I,20180101.0,20211026.0,20211101,20211101,EXP,,CN-SA-2021SA357938,SANOFI AVENTIS,"Zhuqing Z, Zelin L, Xiaobo L. Insulin pump combined with flash glucose monitoring for insulin desensitization treatment. Chin J Diabetes. 2021;29(10):781-783",67.0,YR,E,M,Y,,,20211101.0,,HP,CN,CN,2021,Q4,Elderly
200209321,20020932,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, Ongoing",,,,,,,,,,,,2021,Q4,Thrombocytopenia,,2021,Q4,1,I,20210220.0,20211025.0,20211101,20211101,EXP,,IT-MYLANLABS-2021M1076635,MYLAN,,74.0,YR,,F,Y,,,20211101.0,,MD,IT,IT,2021,Q4,Elderly
200227252,20022725,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,Dose: 1U,,,,,,,,,,,,2021,Q4,Acute kidney injury,,2021,Q4,2,F,20210304.0,20211103.0,20211102,20211111,EXP,,US-ROCHE-2788394,ROCHE,,56.0,YR,,M,Y,69.0,KG,20211111.0,,MD,US,,2021,Q4,Adult
200227252,20022725,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,Dose: 1U,,,,,,,,,,,,2021,Q4,Device occlusion,,2021,Q4,2,F,20210304.0,20211103.0,20211102,20211111,EXP,,US-ROCHE-2788394,ROCHE,,56.0,YR,,M,Y,69.0,KG,20211111.0,,MD,US,,2021,Q4,Adult
200234501,20023450,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Hypertensive urgency,,2021,Q4,1,I,20190101.0,20201117.0,20211102,20211102,PER,,IN-LUPIN LIMITED-2020-09471,LUPIN,"Shukla R, Khasbage S, Garg M, Singh S. Duloxetine-induced hypertensive urgency in type 2 diabetes mellitus with diabetic neuropathy. Indian journal of pharmacology. 2020;52(3):213-215",62.0,YR,,F,Y,,,20211102.0,,HP,IN,IN,2021,Q4,Adult
200253141,20025314,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Acute lung injury,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080248,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",70.0,YR,,M,Y,,,20211102.0,,HP,US,US,2021,Q4,Elderly
200253141,20025314,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Coma,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080248,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",70.0,YR,,M,Y,,,20211102.0,,HP,US,US,2021,Q4,Elderly
200253141,20025314,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Acute respiratory distress syndrome,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080248,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",70.0,YR,,M,Y,,,20211102.0,,HP,US,US,2021,Q4,Elderly
200253141,20025314,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Hypotension,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080248,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",70.0,YR,,M,Y,,,20211102.0,,HP,US,US,2021,Q4,Elderly
200253141,20025314,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Drug ineffective,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080248,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",70.0,YR,,M,Y,,,20211102.0,,HP,US,US,2021,Q4,Elderly
200253141,20025314,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Delirium,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080248,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",70.0,YR,,M,Y,,,20211102.0,,HP,US,US,2021,Q4,Elderly
200253141,20025314,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Acute kidney injury,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080248,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",70.0,YR,,M,Y,,,20211102.0,,HP,US,US,2021,Q4,Elderly
200253141,20025314,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Toxicity to various agents,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080248,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",70.0,YR,,M,Y,,,20211102.0,,HP,US,US,2021,Q4,Elderly
200254771,20025477,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Anion gap,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080156,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",33.0,YR,,F,Y,,,20211102.0,,HP,US,US,2021,Q4,Young Adult
200254771,20025477,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Metabolic acidosis,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080156,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",33.0,YR,,F,Y,,,20211102.0,,HP,US,US,2021,Q4,Young Adult
200254771,20025477,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Acute kidney injury,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080156,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",33.0,YR,,F,Y,,,20211102.0,,HP,US,US,2021,Q4,Young Adult
200254771,20025477,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Hypotension,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080156,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",33.0,YR,,F,Y,,,20211102.0,,HP,US,US,2021,Q4,Young Adult
200254771,20025477,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Toxicity to various agents,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080156,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",33.0,YR,,F,Y,,,20211102.0,,HP,US,US,2021,Q4,Young Adult
200254771,20025477,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Atrioventricular block,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080156,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",33.0,YR,,F,Y,,,20211102.0,,HP,US,US,2021,Q4,Young Adult
200254771,20025477,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Bradycardia,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080156,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",33.0,YR,,F,Y,,,20211102.0,,HP,US,US,2021,Q4,Young Adult
200254771,20025477,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Asthma,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080156,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",33.0,YR,,F,Y,,,20211102.0,,HP,US,US,2021,Q4,Young Adult
200254771,20025477,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Bronchial hyperreactivity,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080156,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",33.0,YR,,F,Y,,,20211102.0,,HP,US,US,2021,Q4,Young Adult
200254771,20025477,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Coma,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080156,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",33.0,YR,,F,Y,,,20211102.0,,HP,US,US,2021,Q4,Young Adult
200254771,20025477,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Coagulopathy,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080156,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",33.0,YR,,F,Y,,,20211102.0,,HP,US,US,2021,Q4,Young Adult
200254771,20025477,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Drug ineffective,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080156,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",33.0,YR,,F,Y,,,20211102.0,,HP,US,US,2021,Q4,Young Adult
200254851,20025485,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Coma,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080158,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",47.0,YR,,F,Y,,,20211102.0,,HP,US,US,2021,Q4,Adult
200254851,20025485,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Acute lung injury,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080158,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",47.0,YR,,F,Y,,,20211102.0,,HP,US,US,2021,Q4,Adult
200254851,20025485,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Toxicity to various agents,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080158,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",47.0,YR,,F,Y,,,20211102.0,,HP,US,US,2021,Q4,Adult
200254851,20025485,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Atrioventricular block,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080158,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",47.0,YR,,F,Y,,,20211102.0,,HP,US,US,2021,Q4,Adult
200254851,20025485,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Bradycardia,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080158,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",47.0,YR,,F,Y,,,20211102.0,,HP,US,US,2021,Q4,Adult
200254851,20025485,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Hypotension,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080158,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",47.0,YR,,F,Y,,,20211102.0,,HP,US,US,2021,Q4,Adult
200254851,20025485,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Electrocardiogram QT prolonged,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080158,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",47.0,YR,,F,Y,,,20211102.0,,HP,US,US,2021,Q4,Adult
200254851,20025485,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Respiratory depression,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080158,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",47.0,YR,,F,Y,,,20211102.0,,HP,US,US,2021,Q4,Adult
200254851,20025485,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Pneumonitis aspiration,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080158,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",47.0,YR,,F,Y,,,20211102.0,,HP,US,US,2021,Q4,Adult
200254851,20025485,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Metabolic acidosis,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080158,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",47.0,YR,,F,Y,,,20211102.0,,HP,US,US,2021,Q4,Adult
200254851,20025485,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Acute kidney injury,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080158,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",47.0,YR,,F,Y,,,20211102.0,,HP,US,US,2021,Q4,Adult
200254851,20025485,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Electrocardiogram QRS complex prolonged,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080158,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",47.0,YR,,F,Y,,,20211102.0,,HP,US,US,2021,Q4,Adult
200254851,20025485,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Acute respiratory distress syndrome,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080158,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",47.0,YR,,F,Y,,,20211102.0,,HP,US,US,2021,Q4,Adult
200254851,20025485,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Ventricular tachycardia,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080158,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",47.0,YR,,F,Y,,,20211102.0,,HP,US,US,2021,Q4,Adult
200254851,20025485,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Drug ineffective,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080158,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",47.0,YR,,F,Y,,,20211102.0,,HP,US,US,2021,Q4,Adult
200259091,20025909,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Rhabdomyolysis,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080213,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",67.0,YR,,M,Y,,,20211102.0,,HP,US,US,2021,Q4,Elderly
200259091,20025909,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Respiratory depression,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080213,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",67.0,YR,,M,Y,,,20211102.0,,HP,US,US,2021,Q4,Elderly
200259091,20025909,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Bradycardia,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080213,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",67.0,YR,,M,Y,,,20211102.0,,HP,US,US,2021,Q4,Elderly
200259091,20025909,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Anion gap,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080213,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",67.0,YR,,M,Y,,,20211102.0,,HP,US,US,2021,Q4,Elderly
200259091,20025909,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Coma,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080213,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",67.0,YR,,M,Y,,,20211102.0,,HP,US,US,2021,Q4,Elderly
200259091,20025909,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Drug ineffective,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080213,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",67.0,YR,,M,Y,,,20211102.0,,HP,US,US,2021,Q4,Elderly
200259091,20025909,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Toxicity to various agents,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080213,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",67.0,YR,,M,Y,,,20211102.0,,HP,US,US,2021,Q4,Elderly
200259091,20025909,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Electrocardiogram QRS complex prolonged,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080213,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",67.0,YR,,M,Y,,,20211102.0,,HP,US,US,2021,Q4,Elderly
200259091,20025909,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Acute kidney injury,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080213,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",67.0,YR,,M,Y,,,20211102.0,,HP,US,US,2021,Q4,Elderly
200259091,20025909,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Metabolic acidosis,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080213,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",67.0,YR,,M,Y,,,20211102.0,,HP,US,US,2021,Q4,Elderly
200259091,20025909,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Coagulopathy,,2021,Q4,1,I,,20211025.0,20211102,20211102,EXP,,US-MYLANLABS-2021M1080213,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",67.0,YR,,M,Y,,,20211102.0,,HP,US,US,2021,Q4,Elderly
200277501,20027750,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 international unit, qd",,,U,,,,,20.0,IU,,,2021,Q4,Myocardial bridging,,2021,Q4,1,I,,20211025.0,20211103,20211103,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK068624,GLENMARK,"Saeed M, Gil GS, Lopez PD, Visco F, Pekler G, Mushiyev S.. Chest Pain Induced by Intravenous Nitroglycerin... American journal of therapeutics. 2020;27(3):e299-301",54.0,YR,,M,Y,,,20211103.0,,MD,US,US,2021,Q4,Adult
200277501,20027750,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 international unit, qd",,,U,,,,,20.0,IU,,,2021,Q4,Acute myocardial infarction,,2021,Q4,1,I,,20211025.0,20211103,20211103,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK068624,GLENMARK,"Saeed M, Gil GS, Lopez PD, Visco F, Pekler G, Mushiyev S.. Chest Pain Induced by Intravenous Nitroglycerin... American journal of therapeutics. 2020;27(3):e299-301",54.0,YR,,M,Y,,,20211103.0,,MD,US,US,2021,Q4,Adult
200280301,20028030,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,daily dose: 8 Iu international unit(s) every Days,,,,,UNKNOWN,,,8.0,IU,,QD,2021,Q4,Sepsis,,2021,Q4,1,I,20210501.0,20211021.0,20211103,20211103,EXP,,DE-ROCHE-2942400,ROCHE,,72.0,YR,,F,Y,90.0,KG,20211103.0,,MD,DE,DE,2021,Q4,Elderly
200280301,20028030,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,daily dose: 8 Iu international unit(s) every Days,,,,,UNKNOWN,,,8.0,IU,,QD,2021,Q4,Systemic mycosis,,2021,Q4,1,I,20210501.0,20211021.0,20211103,20211103,EXP,,DE-ROCHE-2942400,ROCHE,,72.0,YR,,F,Y,90.0,KG,20211103.0,,MD,DE,DE,2021,Q4,Elderly
200280301,20028030,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,daily dose: 8 Iu international unit(s) every Days,,,,,UNKNOWN,,,8.0,IU,,QD,2021,Q4,Thrombocytopenia,,2021,Q4,1,I,20210501.0,20211021.0,20211103,20211103,EXP,,DE-ROCHE-2942400,ROCHE,,72.0,YR,,F,Y,90.0,KG,20211103.0,,MD,DE,DE,2021,Q4,Elderly
200287681,20028768,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,20.0,IU,,,2021,Q4,Drug ineffective,,2021,Q4,1,I,,20211027.0,20211103,20211103,EXP,,US-TORRENT-00011305,TORRENT,,66.0,YR,E,F,Y,,,20211103.0,,HP,US,US,2021,Q4,Elderly
200287681,20028768,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,20.0,IU,,,2021,Q4,Toxicity to various agents,,2021,Q4,1,I,,20211027.0,20211103,20211103,EXP,,US-TORRENT-00011305,TORRENT,,66.0,YR,E,F,Y,,,20211103.0,,HP,US,US,2021,Q4,Elderly
200287681,20028768,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,20.0,IU,,,2021,Q4,Bradycardia,,2021,Q4,1,I,,20211027.0,20211103,20211103,EXP,,US-TORRENT-00011305,TORRENT,,66.0,YR,E,F,Y,,,20211103.0,,HP,US,US,2021,Q4,Elderly
200287681,20028768,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,20.0,IU,,,2021,Q4,Depression,,2021,Q4,1,I,,20211027.0,20211103,20211103,EXP,,US-TORRENT-00011305,TORRENT,,66.0,YR,E,F,Y,,,20211103.0,,HP,US,US,2021,Q4,Elderly
200287681,20028768,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,20.0,IU,,,2021,Q4,Drug interaction,,2021,Q4,1,I,,20211027.0,20211103,20211103,EXP,,US-TORRENT-00011305,TORRENT,,66.0,YR,E,F,Y,,,20211103.0,,HP,US,US,2021,Q4,Elderly
200302391,20030239,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Hypotension,,2021,Q4,1,I,,20211025.0,20211103,20211103,EXP,,US-MYLANLABS-2021M1080210,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",49.0,YR,,M,Y,,,20211103.0,,HP,US,US,2021,Q4,Adult
200302391,20030239,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Drug ineffective,,2021,Q4,1,I,,20211025.0,20211103,20211103,EXP,,US-MYLANLABS-2021M1080210,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",49.0,YR,,M,Y,,,20211103.0,,HP,US,US,2021,Q4,Adult
200302391,20030239,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Toxicity to various agents,,2021,Q4,1,I,,20211025.0,20211103,20211103,EXP,,US-MYLANLABS-2021M1080210,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",49.0,YR,,M,Y,,,20211103.0,,HP,US,US,2021,Q4,Adult
200302391,20030239,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Acute kidney injury,,2021,Q4,1,I,,20211025.0,20211103,20211103,EXP,,US-MYLANLABS-2021M1080210,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",49.0,YR,,M,Y,,,20211103.0,,HP,US,US,2021,Q4,Adult
200302391,20030239,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Respiratory depression,,2021,Q4,1,I,,20211025.0,20211103,20211103,EXP,,US-MYLANLABS-2021M1080210,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",49.0,YR,,M,Y,,,20211103.0,,HP,US,US,2021,Q4,Adult
200302391,20030239,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Coma,,2021,Q4,1,I,,20211025.0,20211103,20211103,EXP,,US-MYLANLABS-2021M1080210,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",49.0,YR,,M,Y,,,20211103.0,,HP,US,US,2021,Q4,Adult
200302391,20030239,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,High-dose insulin euglycaemic therapy,,,D,,,,,,,,,2021,Q4,Metabolic acidosis,,2021,Q4,1,I,,20211025.0,20211103,20211103,EXP,,US-MYLANLABS-2021M1080210,MYLAN,"Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J-Med-Toxicol 2020;16(4):361-387.",49.0,YR,,M,Y,,,20211103.0,,HP,US,US,2021,Q4,Adult
200310083,20031008,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"7 dosage form, qd",,,,,,,,,,Injection,QD,2021,Q4,Arteriovenous fistula,,2021,Q4,3,F,20201030.0,20211209.0,20211103,20211215,EXP,,JP-MYLANLABS-2021M1077755,MYLAN,,24.0,YR,,F,Y,40.3,KG,20211215.0,,MD,JP,JP,2021,Q4,Young Adult
200310083,20031008,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"7 dosage form, qd",,,,,,,,,,Injection,QD,2021,Q4,Corneal degeneration,,2021,Q4,3,F,20201030.0,20211209.0,20211103,20211215,EXP,,JP-MYLANLABS-2021M1077755,MYLAN,,24.0,YR,,F,Y,40.3,KG,20211215.0,,MD,JP,JP,2021,Q4,Young Adult
200310083,20031008,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 dosage form, qd",,,,,,,,,,Injection,QD,2021,Q4,Arteriovenous fistula,,2021,Q4,3,F,20201030.0,20211209.0,20211103,20211215,EXP,,JP-MYLANLABS-2021M1077755,MYLAN,,24.0,YR,,F,Y,40.3,KG,20211215.0,,MD,JP,JP,2021,Q4,Young Adult
200310083,20031008,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 dosage form, qd",,,,,,,,,,Injection,QD,2021,Q4,Corneal degeneration,,2021,Q4,3,F,20201030.0,20211209.0,20211103,20211215,EXP,,JP-MYLANLABS-2021M1077755,MYLAN,,24.0,YR,,F,Y,40.3,KG,20211215.0,,MD,JP,JP,2021,Q4,Young Adult
200310083,20031008,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 dosage form, qd",,,,,,,,,,Injection,QD,2021,Q4,Arteriovenous fistula,,2021,Q4,3,F,20201030.0,20211209.0,20211103,20211215,EXP,,JP-MYLANLABS-2021M1077755,MYLAN,,24.0,YR,,F,Y,40.3,KG,20211215.0,,MD,JP,JP,2021,Q4,Young Adult
200310083,20031008,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 dosage form, qd",,,,,,,,,,Injection,QD,2021,Q4,Corneal degeneration,,2021,Q4,3,F,20201030.0,20211209.0,20211103,20211215,EXP,,JP-MYLANLABS-2021M1077755,MYLAN,,24.0,YR,,F,Y,40.3,KG,20211215.0,,MD,JP,JP,2021,Q4,Young Adult
200312533,20031253,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,QD,2021,Q4,Streptococcal bacteraemia,,2021,Q4,3,F,20211026.0,20211122.0,20211103,20211129,EXP,,US-ABBVIE-21P-163-4140208-00,ABBVIE,,78.0,YR,,F,Y,67.5,KG,20211129.0,,MD,COUNTRY NOT SPECIFIED,US,2021,Q4,Elderly
200314651,20031465,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Arthralgia,,2021,Q4,1,I,20200701.0,20211019.0,20211103,20211103,EXP,,CO-ABBVIE-20K-036-3619994-00,ABBVIE,,70.0,YR,,F,Y,73.0,KG,20211029.0,,HP,COUNTRY NOT SPECIFIED,CO,2021,Q4,Elderly
200314651,20031465,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Inflammation,,2021,Q4,1,I,20200701.0,20211019.0,20211103,20211103,EXP,,CO-ABBVIE-20K-036-3619994-00,ABBVIE,,70.0,YR,,F,Y,73.0,KG,20211029.0,,HP,COUNTRY NOT SPECIFIED,CO,2021,Q4,Elderly
200314651,20031465,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,1,I,20200701.0,20211019.0,20211103,20211103,EXP,,CO-ABBVIE-20K-036-3619994-00,ABBVIE,,70.0,YR,,F,Y,73.0,KG,20211029.0,,HP,COUNTRY NOT SPECIFIED,CO,2021,Q4,Elderly
200314651,20031465,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Pain in extremity,,2021,Q4,1,I,20200701.0,20211019.0,20211103,20211103,EXP,,CO-ABBVIE-20K-036-3619994-00,ABBVIE,,70.0,YR,,F,Y,73.0,KG,20211029.0,,HP,COUNTRY NOT SPECIFIED,CO,2021,Q4,Elderly
200314651,20031465,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Arthropathy,,2021,Q4,1,I,20200701.0,20211019.0,20211103,20211103,EXP,,CO-ABBVIE-20K-036-3619994-00,ABBVIE,,70.0,YR,,F,Y,73.0,KG,20211029.0,,HP,COUNTRY NOT SPECIFIED,CO,2021,Q4,Elderly
200314651,20031465,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Sciatica,,2021,Q4,1,I,20200701.0,20211019.0,20211103,20211103,EXP,,CO-ABBVIE-20K-036-3619994-00,ABBVIE,,70.0,YR,,F,Y,73.0,KG,20211029.0,,HP,COUNTRY NOT SPECIFIED,CO,2021,Q4,Elderly
200315981,20031598,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Folate deficiency,,2021,Q4,1,I,20190601.0,20211026.0,20211103,20211103,EXP,,FR-ABBVIE-21K-056-4136963-00,ABBVIE,,66.0,YR,,F,Y,,,20211101.0,,MD,FR,FR,2021,Q4,Elderly
200315981,20031598,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Thrombocytopenia,,2021,Q4,1,I,20190601.0,20211026.0,20211103,20211103,EXP,,FR-ABBVIE-21K-056-4136963-00,ABBVIE,,66.0,YR,,F,Y,,,20211101.0,,MD,FR,FR,2021,Q4,Elderly
200325361,20032536,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q4,Platelet count decreased,,2021,Q4,1,I,20210819.0,20211028.0,20211103,20211103,EXP,,US-Taiho Oncology  Inc-EU-2021-02375,TAIHO ONCOLOGY INC,,78.0,YR,,M,Y,,,20211103.0,,CN,US,US,2021,Q4,Elderly
200325361,20032536,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q4,White blood cell count decreased,,2021,Q4,1,I,20210819.0,20211028.0,20211103,20211103,EXP,,US-Taiho Oncology  Inc-EU-2021-02375,TAIHO ONCOLOGY INC,,78.0,YR,,M,Y,,,20211103.0,,CN,US,US,2021,Q4,Elderly
200325361,20032536,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q4,Lung lobectomy,,2021,Q4,1,I,20210819.0,20211028.0,20211103,20211103,EXP,,US-Taiho Oncology  Inc-EU-2021-02375,TAIHO ONCOLOGY INC,,78.0,YR,,M,Y,,,20211103.0,,CN,US,US,2021,Q4,Elderly
200326631,20032663,22,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q4,Respiratory symptom,,2021,Q4,1,I,,20211027.0,20211103,20211103,EXP,,CA-TEVA-2021-CA-1972358,TEVA,,65.0,YR,E,M,Y,,,20211103.0,,CN,CA,CA,2021,Q4,Elderly
200326631,20032663,22,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q4,Vasculitis,,2021,Q4,1,I,,20211027.0,20211103,20211103,EXP,,CA-TEVA-2021-CA-1972358,TEVA,,65.0,YR,E,M,Y,,,20211103.0,,CN,CA,CA,2021,Q4,Elderly
200326631,20032663,22,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q4,Pulmonary vasculitis,,2021,Q4,1,I,,20211027.0,20211103,20211103,EXP,,CA-TEVA-2021-CA-1972358,TEVA,,65.0,YR,E,M,Y,,,20211103.0,,CN,CA,CA,2021,Q4,Elderly
200326631,20032663,22,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q4,Therapeutic product effect incomplete,,2021,Q4,1,I,,20211027.0,20211103,20211103,EXP,,CA-TEVA-2021-CA-1972358,TEVA,,65.0,YR,E,M,Y,,,20211103.0,,CN,CA,CA,2021,Q4,Elderly
200326631,20032663,22,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q4,Lung disorder,,2021,Q4,1,I,,20211027.0,20211103,20211103,EXP,,CA-TEVA-2021-CA-1972358,TEVA,,65.0,YR,E,M,Y,,,20211103.0,,CN,CA,CA,2021,Q4,Elderly
200326631,20032663,22,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q4,Neurological symptom,,2021,Q4,1,I,,20211027.0,20211103,20211103,EXP,,CA-TEVA-2021-CA-1972358,TEVA,,65.0,YR,E,M,Y,,,20211103.0,,CN,CA,CA,2021,Q4,Elderly
200326631,20032663,22,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q4,Condition aggravated,,2021,Q4,1,I,,20211027.0,20211103,20211103,EXP,,CA-TEVA-2021-CA-1972358,TEVA,,65.0,YR,E,M,Y,,,20211103.0,,CN,CA,CA,2021,Q4,Elderly
200326631,20032663,22,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,1,I,,20211027.0,20211103,20211103,EXP,,CA-TEVA-2021-CA-1972358,TEVA,,65.0,YR,E,M,Y,,,20211103.0,,CN,CA,CA,2021,Q4,Elderly
200326631,20032663,22,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q4,Wheezing,,2021,Q4,1,I,,20211027.0,20211103,20211103,EXP,,CA-TEVA-2021-CA-1972358,TEVA,,65.0,YR,E,M,Y,,,20211103.0,,CN,CA,CA,2021,Q4,Elderly
200326631,20032663,22,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q4,Haemoptysis,,2021,Q4,1,I,,20211027.0,20211103,20211103,EXP,,CA-TEVA-2021-CA-1972358,TEVA,,65.0,YR,E,M,Y,,,20211103.0,,CN,CA,CA,2021,Q4,Elderly
200326631,20032663,22,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q4,Pain in extremity,,2021,Q4,1,I,,20211027.0,20211103,20211103,EXP,,CA-TEVA-2021-CA-1972358,TEVA,,65.0,YR,E,M,Y,,,20211103.0,,CN,CA,CA,2021,Q4,Elderly
200326631,20032663,22,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q4,Loss of personal independence in daily activities,,2021,Q4,1,I,,20211027.0,20211103,20211103,EXP,,CA-TEVA-2021-CA-1972358,TEVA,,65.0,YR,E,M,Y,,,20211103.0,,CN,CA,CA,2021,Q4,Elderly
200326631,20032663,22,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q4,Pulmonary alveolar haemorrhage,,2021,Q4,1,I,,20211027.0,20211103,20211103,EXP,,CA-TEVA-2021-CA-1972358,TEVA,,65.0,YR,E,M,Y,,,20211103.0,,CN,CA,CA,2021,Q4,Elderly
200326631,20032663,22,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q4,Pulmonary fibrosis,,2021,Q4,1,I,,20211027.0,20211103,20211103,EXP,,CA-TEVA-2021-CA-1972358,TEVA,,65.0,YR,E,M,Y,,,20211103.0,,CN,CA,CA,2021,Q4,Elderly
200326631,20032663,22,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q4,Obstructive airways disorder,,2021,Q4,1,I,,20211027.0,20211103,20211103,EXP,,CA-TEVA-2021-CA-1972358,TEVA,,65.0,YR,E,M,Y,,,20211103.0,,CN,CA,CA,2021,Q4,Elderly
200326631,20032663,22,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q4,Asthma,,2021,Q4,1,I,,20211027.0,20211103,20211103,EXP,,CA-TEVA-2021-CA-1972358,TEVA,,65.0,YR,E,M,Y,,,20211103.0,,CN,CA,CA,2021,Q4,Elderly
200326631,20032663,22,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q4,Sleep disorder due to a general medical condition,,2021,Q4,1,I,,20211027.0,20211103,20211103,EXP,,CA-TEVA-2021-CA-1972358,TEVA,,65.0,YR,E,M,Y,,,20211103.0,,CN,CA,CA,2021,Q4,Elderly
200326631,20032663,22,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q4,Neuritis,,2021,Q4,1,I,,20211027.0,20211103,20211103,EXP,,CA-TEVA-2021-CA-1972358,TEVA,,65.0,YR,E,M,Y,,,20211103.0,,CN,CA,CA,2021,Q4,Elderly
200326794,20032679,54,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,QD,2021,Q4,Therapeutic product effect incomplete,,2021,Q4,4,F,,20211207.0,20211103,20211217,EXP,,CA-TEVA-2021-CA-1972981,TEVA,,65.0,YR,E,M,Y,,,20211217.0,,CN,CA,CA,2021,Q4,Elderly
200326794,20032679,54,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,QD,2021,Q4,Neuritis,,2021,Q4,4,F,,20211207.0,20211103,20211217,EXP,,CA-TEVA-2021-CA-1972981,TEVA,,65.0,YR,E,M,Y,,,20211217.0,,CN,CA,CA,2021,Q4,Elderly
200326794,20032679,54,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,QD,2021,Q4,Pulmonary fibrosis,,2021,Q4,4,F,,20211207.0,20211103,20211217,EXP,,CA-TEVA-2021-CA-1972981,TEVA,,65.0,YR,E,M,Y,,,20211217.0,,CN,CA,CA,2021,Q4,Elderly
200326794,20032679,54,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,QD,2021,Q4,Haemoptysis,,2021,Q4,4,F,,20211207.0,20211103,20211217,EXP,,CA-TEVA-2021-CA-1972981,TEVA,,65.0,YR,E,M,Y,,,20211217.0,,CN,CA,CA,2021,Q4,Elderly
200326794,20032679,54,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,QD,2021,Q4,Neurological symptom,,2021,Q4,4,F,,20211207.0,20211103,20211217,EXP,,CA-TEVA-2021-CA-1972981,TEVA,,65.0,YR,E,M,Y,,,20211217.0,,CN,CA,CA,2021,Q4,Elderly
200326794,20032679,54,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,QD,2021,Q4,Dyspnoea,,2021,Q4,4,F,,20211207.0,20211103,20211217,EXP,,CA-TEVA-2021-CA-1972981,TEVA,,65.0,YR,E,M,Y,,,20211217.0,,CN,CA,CA,2021,Q4,Elderly
200326794,20032679,54,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,QD,2021,Q4,Respiratory symptom,,2021,Q4,4,F,,20211207.0,20211103,20211217,EXP,,CA-TEVA-2021-CA-1972981,TEVA,,65.0,YR,E,M,Y,,,20211217.0,,CN,CA,CA,2021,Q4,Elderly
200326794,20032679,54,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,QD,2021,Q4,Pulmonary vasculitis,,2021,Q4,4,F,,20211207.0,20211103,20211217,EXP,,CA-TEVA-2021-CA-1972981,TEVA,,65.0,YR,E,M,Y,,,20211217.0,,CN,CA,CA,2021,Q4,Elderly
200326794,20032679,54,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,QD,2021,Q4,Pain in extremity,,2021,Q4,4,F,,20211207.0,20211103,20211217,EXP,,CA-TEVA-2021-CA-1972981,TEVA,,65.0,YR,E,M,Y,,,20211217.0,,CN,CA,CA,2021,Q4,Elderly
200326794,20032679,54,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,QD,2021,Q4,Asthma,,2021,Q4,4,F,,20211207.0,20211103,20211217,EXP,,CA-TEVA-2021-CA-1972981,TEVA,,65.0,YR,E,M,Y,,,20211217.0,,CN,CA,CA,2021,Q4,Elderly
200326794,20032679,54,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,QD,2021,Q4,Obstructive airways disorder,,2021,Q4,4,F,,20211207.0,20211103,20211217,EXP,,CA-TEVA-2021-CA-1972981,TEVA,,65.0,YR,E,M,Y,,,20211217.0,,CN,CA,CA,2021,Q4,Elderly
200326794,20032679,54,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,QD,2021,Q4,Loss of personal independence in daily activities,,2021,Q4,4,F,,20211207.0,20211103,20211217,EXP,,CA-TEVA-2021-CA-1972981,TEVA,,65.0,YR,E,M,Y,,,20211217.0,,CN,CA,CA,2021,Q4,Elderly
200326794,20032679,54,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,QD,2021,Q4,Condition aggravated,,2021,Q4,4,F,,20211207.0,20211103,20211217,EXP,,CA-TEVA-2021-CA-1972981,TEVA,,65.0,YR,E,M,Y,,,20211217.0,,CN,CA,CA,2021,Q4,Elderly
200326794,20032679,54,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,QD,2021,Q4,Sleep disorder due to a general medical condition,,2021,Q4,4,F,,20211207.0,20211103,20211217,EXP,,CA-TEVA-2021-CA-1972981,TEVA,,65.0,YR,E,M,Y,,,20211217.0,,CN,CA,CA,2021,Q4,Elderly
200326794,20032679,54,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,QD,2021,Q4,Vasculitis,,2021,Q4,4,F,,20211207.0,20211103,20211217,EXP,,CA-TEVA-2021-CA-1972981,TEVA,,65.0,YR,E,M,Y,,,20211217.0,,CN,CA,CA,2021,Q4,Elderly
200326794,20032679,54,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,QD,2021,Q4,Wheezing,,2021,Q4,4,F,,20211207.0,20211103,20211217,EXP,,CA-TEVA-2021-CA-1972981,TEVA,,65.0,YR,E,M,Y,,,20211217.0,,CN,CA,CA,2021,Q4,Elderly
200326794,20032679,54,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,QD,2021,Q4,Pulmonary alveolar haemorrhage,,2021,Q4,4,F,,20211207.0,20211103,20211217,EXP,,CA-TEVA-2021-CA-1972981,TEVA,,65.0,YR,E,M,Y,,,20211217.0,,CN,CA,CA,2021,Q4,Elderly
200326794,20032679,54,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,QD,2021,Q4,Lung disorder,,2021,Q4,4,F,,20211207.0,20211103,20211217,EXP,,CA-TEVA-2021-CA-1972981,TEVA,,65.0,YR,E,M,Y,,,20211217.0,,CN,CA,CA,2021,Q4,Elderly
200326794,20032679,55,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 Dosage forms Daily;,,,U,,,,,,,,QD,2021,Q4,Therapeutic product effect incomplete,,2021,Q4,4,F,,20211207.0,20211103,20211217,EXP,,CA-TEVA-2021-CA-1972981,TEVA,,65.0,YR,E,M,Y,,,20211217.0,,CN,CA,CA,2021,Q4,Elderly
200326794,20032679,55,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 Dosage forms Daily;,,,U,,,,,,,,QD,2021,Q4,Neuritis,,2021,Q4,4,F,,20211207.0,20211103,20211217,EXP,,CA-TEVA-2021-CA-1972981,TEVA,,65.0,YR,E,M,Y,,,20211217.0,,CN,CA,CA,2021,Q4,Elderly
200326794,20032679,55,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 Dosage forms Daily;,,,U,,,,,,,,QD,2021,Q4,Pulmonary fibrosis,,2021,Q4,4,F,,20211207.0,20211103,20211217,EXP,,CA-TEVA-2021-CA-1972981,TEVA,,65.0,YR,E,M,Y,,,20211217.0,,CN,CA,CA,2021,Q4,Elderly
200326794,20032679,55,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 Dosage forms Daily;,,,U,,,,,,,,QD,2021,Q4,Haemoptysis,,2021,Q4,4,F,,20211207.0,20211103,20211217,EXP,,CA-TEVA-2021-CA-1972981,TEVA,,65.0,YR,E,M,Y,,,20211217.0,,CN,CA,CA,2021,Q4,Elderly
200326794,20032679,55,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 Dosage forms Daily;,,,U,,,,,,,,QD,2021,Q4,Neurological symptom,,2021,Q4,4,F,,20211207.0,20211103,20211217,EXP,,CA-TEVA-2021-CA-1972981,TEVA,,65.0,YR,E,M,Y,,,20211217.0,,CN,CA,CA,2021,Q4,Elderly
200326794,20032679,55,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 Dosage forms Daily;,,,U,,,,,,,,QD,2021,Q4,Dyspnoea,,2021,Q4,4,F,,20211207.0,20211103,20211217,EXP,,CA-TEVA-2021-CA-1972981,TEVA,,65.0,YR,E,M,Y,,,20211217.0,,CN,CA,CA,2021,Q4,Elderly
200326794,20032679,55,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 Dosage forms Daily;,,,U,,,,,,,,QD,2021,Q4,Respiratory symptom,,2021,Q4,4,F,,20211207.0,20211103,20211217,EXP,,CA-TEVA-2021-CA-1972981,TEVA,,65.0,YR,E,M,Y,,,20211217.0,,CN,CA,CA,2021,Q4,Elderly
200326794,20032679,55,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 Dosage forms Daily;,,,U,,,,,,,,QD,2021,Q4,Pulmonary vasculitis,,2021,Q4,4,F,,20211207.0,20211103,20211217,EXP,,CA-TEVA-2021-CA-1972981,TEVA,,65.0,YR,E,M,Y,,,20211217.0,,CN,CA,CA,2021,Q4,Elderly
200326794,20032679,55,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 Dosage forms Daily;,,,U,,,,,,,,QD,2021,Q4,Pain in extremity,,2021,Q4,4,F,,20211207.0,20211103,20211217,EXP,,CA-TEVA-2021-CA-1972981,TEVA,,65.0,YR,E,M,Y,,,20211217.0,,CN,CA,CA,2021,Q4,Elderly
200326794,20032679,55,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 Dosage forms Daily;,,,U,,,,,,,,QD,2021,Q4,Asthma,,2021,Q4,4,F,,20211207.0,20211103,20211217,EXP,,CA-TEVA-2021-CA-1972981,TEVA,,65.0,YR,E,M,Y,,,20211217.0,,CN,CA,CA,2021,Q4,Elderly
200326794,20032679,55,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 Dosage forms Daily;,,,U,,,,,,,,QD,2021,Q4,Obstructive airways disorder,,2021,Q4,4,F,,20211207.0,20211103,20211217,EXP,,CA-TEVA-2021-CA-1972981,TEVA,,65.0,YR,E,M,Y,,,20211217.0,,CN,CA,CA,2021,Q4,Elderly
200326794,20032679,55,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 Dosage forms Daily;,,,U,,,,,,,,QD,2021,Q4,Loss of personal independence in daily activities,,2021,Q4,4,F,,20211207.0,20211103,20211217,EXP,,CA-TEVA-2021-CA-1972981,TEVA,,65.0,YR,E,M,Y,,,20211217.0,,CN,CA,CA,2021,Q4,Elderly
200326794,20032679,55,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 Dosage forms Daily;,,,U,,,,,,,,QD,2021,Q4,Condition aggravated,,2021,Q4,4,F,,20211207.0,20211103,20211217,EXP,,CA-TEVA-2021-CA-1972981,TEVA,,65.0,YR,E,M,Y,,,20211217.0,,CN,CA,CA,2021,Q4,Elderly
200326794,20032679,55,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 Dosage forms Daily;,,,U,,,,,,,,QD,2021,Q4,Sleep disorder due to a general medical condition,,2021,Q4,4,F,,20211207.0,20211103,20211217,EXP,,CA-TEVA-2021-CA-1972981,TEVA,,65.0,YR,E,M,Y,,,20211217.0,,CN,CA,CA,2021,Q4,Elderly
200326794,20032679,55,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 Dosage forms Daily;,,,U,,,,,,,,QD,2021,Q4,Vasculitis,,2021,Q4,4,F,,20211207.0,20211103,20211217,EXP,,CA-TEVA-2021-CA-1972981,TEVA,,65.0,YR,E,M,Y,,,20211217.0,,CN,CA,CA,2021,Q4,Elderly
200326794,20032679,55,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 Dosage forms Daily;,,,U,,,,,,,,QD,2021,Q4,Wheezing,,2021,Q4,4,F,,20211207.0,20211103,20211217,EXP,,CA-TEVA-2021-CA-1972981,TEVA,,65.0,YR,E,M,Y,,,20211217.0,,CN,CA,CA,2021,Q4,Elderly
200326794,20032679,55,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 Dosage forms Daily;,,,U,,,,,,,,QD,2021,Q4,Pulmonary alveolar haemorrhage,,2021,Q4,4,F,,20211207.0,20211103,20211217,EXP,,CA-TEVA-2021-CA-1972981,TEVA,,65.0,YR,E,M,Y,,,20211217.0,,CN,CA,CA,2021,Q4,Elderly
200326794,20032679,55,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 Dosage forms Daily;,,,U,,,,,,,,QD,2021,Q4,Lung disorder,,2021,Q4,4,F,,20211207.0,20211103,20211217,EXP,,CA-TEVA-2021-CA-1972981,TEVA,,65.0,YR,E,M,Y,,,20211217.0,,CN,CA,CA,2021,Q4,Elderly
200334661,20033466,2,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,"38 iU, QD",,,,,,,,38.0,IU,Solution for injection,QD,2021,Q4,Pancreatitis acute,,2021,Q4,1,I,,20211029.0,20211104,20211104,EXP,,RO-BAUSCH-BL-2021-036126,BAUSCH AND LOMB,,62.0,YR,,,Y,,,20211104.0,,MD,RO,RO,2021,Q4,Adult
200337992,20033799,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Acute kidney injury,,2021,Q4,2,F,20210101.0,20211119.0,20211104,20211126,EXP,,NVSC2021US246476,NOVARTIS,,79.0,YR,,F,Y,68.0,KG,20211126.0,,MD,US,US,2021,Q4,Elderly
200337992,20033799,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Blood glucose increased,,2021,Q4,2,F,20210101.0,20211119.0,20211104,20211126,EXP,,NVSC2021US246476,NOVARTIS,,79.0,YR,,F,Y,68.0,KG,20211126.0,,MD,US,US,2021,Q4,Elderly
200337992,20033799,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Product use in unapproved indication,,2021,Q4,2,F,20210101.0,20211119.0,20211104,20211126,EXP,,NVSC2021US246476,NOVARTIS,,79.0,YR,,F,Y,68.0,KG,20211126.0,,MD,US,US,2021,Q4,Elderly
200337992,20033799,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Hypervolaemia,,2021,Q4,2,F,20210101.0,20211119.0,20211104,20211126,EXP,,NVSC2021US246476,NOVARTIS,,79.0,YR,,F,Y,68.0,KG,20211126.0,,MD,US,US,2021,Q4,Elderly
200337992,20033799,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Blood insulin decreased,,2021,Q4,2,F,20210101.0,20211119.0,20211104,20211126,EXP,,NVSC2021US246476,NOVARTIS,,79.0,YR,,F,Y,68.0,KG,20211126.0,,MD,US,US,2021,Q4,Elderly
200337992,20033799,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Cortisol free urine increased,,2021,Q4,2,F,20210101.0,20211119.0,20211104,20211126,EXP,,NVSC2021US246476,NOVARTIS,,79.0,YR,,F,Y,68.0,KG,20211126.0,,MD,US,US,2021,Q4,Elderly
200337992,20033799,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Off label use,,2021,Q4,2,F,20210101.0,20211119.0,20211104,20211126,EXP,,NVSC2021US246476,NOVARTIS,,79.0,YR,,F,Y,68.0,KG,20211126.0,,MD,US,US,2021,Q4,Elderly
200337992,20033799,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Hypoglycaemia,,2021,Q4,2,F,20210101.0,20211119.0,20211104,20211126,EXP,,NVSC2021US246476,NOVARTIS,,79.0,YR,,F,Y,68.0,KG,20211126.0,,MD,US,US,2021,Q4,Elderly
200337992,20033799,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Decreased appetite,,2021,Q4,2,F,20210101.0,20211119.0,20211104,20211126,EXP,,NVSC2021US246476,NOVARTIS,,79.0,YR,,F,Y,68.0,KG,20211126.0,,MD,US,US,2021,Q4,Elderly
200337992,20033799,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,2,F,20210101.0,20211119.0,20211104,20211126,EXP,,NVSC2021US246476,NOVARTIS,,79.0,YR,,F,Y,68.0,KG,20211126.0,,MD,US,US,2021,Q4,Elderly
200347361,20034736,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"28 IE, 28-0-0-0",,,U,U,,,,,,,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211029.0,20211104,20211104,EXP,,DE-MYLANLABS-2021M1079759,MYLAN,,77.0,YR,,M,Y,82.0,KG,20211104.0,,PH,DE,DE,2021,Q4,Elderly
200347361,20034736,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"28 IE, 28-0-0-0",,,U,U,,,,,,,,2021,Q4,Renal impairment,,2021,Q4,1,I,,20211029.0,20211104,20211104,EXP,,DE-MYLANLABS-2021M1079759,MYLAN,,77.0,YR,,M,Y,82.0,KG,20211104.0,,PH,DE,DE,2021,Q4,Elderly
200347361,20034736,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"28 IE, 28-0-0-0",,,U,U,,,,,,,,2021,Q4,Dizziness,,2021,Q4,1,I,,20211029.0,20211104,20211104,EXP,,DE-MYLANLABS-2021M1079759,MYLAN,,77.0,YR,,M,Y,82.0,KG,20211104.0,,PH,DE,DE,2021,Q4,Elderly
200347361,20034736,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"28 IE, 28-0-0-0",,,U,U,,,,,,,,2021,Q4,Hypotension,,2021,Q4,1,I,,20211029.0,20211104,20211104,EXP,,DE-MYLANLABS-2021M1079759,MYLAN,,77.0,YR,,M,Y,82.0,KG,20211104.0,,PH,DE,DE,2021,Q4,Elderly
200347361,20034736,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"28 IE, 28-0-0-0",,,U,U,,,,,,,,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,,20211029.0,20211104,20211104,EXP,,DE-MYLANLABS-2021M1079759,MYLAN,,77.0,YR,,M,Y,82.0,KG,20211104.0,,PH,DE,DE,2021,Q4,Elderly
200348891,20034889,5,C,Glargine biocon,,2,Unknown,"UNK, 25 units daily",,,,,,,,,,,,2021,Q4,Acute kidney injury,,2021,Q4,1,I,,20211022.0,20211104,20211104,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-21477,LUPIN,"Chetram VK, Ahmad AI, Farid S, Sood T. Acute kidney injury secondary to rhabdomyolysis and COVID-19: A case report and literature review. Case Reports in Nephrology. 2021;1-8",62.0,YR,,M,Y,,,20211104.0,,HP,US,US,2021,Q4,Adult
200348891,20034889,5,C,Glargine biocon,,2,Unknown,"UNK, 25 units daily",,,,,,,,,,,,2021,Q4,Rhabdomyolysis,,2021,Q4,1,I,,20211022.0,20211104,20211104,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-21477,LUPIN,"Chetram VK, Ahmad AI, Farid S, Sood T. Acute kidney injury secondary to rhabdomyolysis and COVID-19: A case report and literature review. Case Reports in Nephrology. 2021;1-8",62.0,YR,,M,Y,,,20211104.0,,HP,US,US,2021,Q4,Adult
200348891,20034889,5,C,Glargine biocon,,2,Unknown,"UNK, 25 units daily",,,,,,,,,,,,2021,Q4,Metabolic acidosis,,2021,Q4,1,I,,20211022.0,20211104,20211104,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-21477,LUPIN,"Chetram VK, Ahmad AI, Farid S, Sood T. Acute kidney injury secondary to rhabdomyolysis and COVID-19: A case report and literature review. Case Reports in Nephrology. 2021;1-8",62.0,YR,,M,Y,,,20211104.0,,HP,US,US,2021,Q4,Adult
200348891,20034889,5,C,Glargine biocon,,2,Unknown,"UNK, 25 units daily",,,,,,,,,,,,2021,Q4,Acute respiratory failure,,2021,Q4,1,I,,20211022.0,20211104,20211104,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-21477,LUPIN,"Chetram VK, Ahmad AI, Farid S, Sood T. Acute kidney injury secondary to rhabdomyolysis and COVID-19: A case report and literature review. Case Reports in Nephrology. 2021;1-8",62.0,YR,,M,Y,,,20211104.0,,HP,US,US,2021,Q4,Adult
200365421,20036542,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Platelet count decreased,,2021,Q4,1,I,20210915.0,20211029.0,20211105,20211105,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-116602,BRISTOL MYERS SQUIBB,,73.0,YR,,F,Y,65.4,KG,20211105.0,,PH,JP,JP,2021,Q4,Elderly
200375341,20037534,6,C,INSULIN GLARGINE W/LIXISENATIDE,,2,,"450 IE, 0-0-24-0",,,,,,,,24.0,IU,,QD,2021,Q4,Syncope,,2021,Q4,1,I,,20211029.0,20211105,20211105,EXP,,DE-MYLANLABS-2021M1079771,MYLAN,,77.0,YR,,F,Y,64.0,KG,20211105.0,,PH,DE,DE,2021,Q4,Elderly
200375341,20037534,6,C,INSULIN GLARGINE W/LIXISENATIDE,,2,,"450 IE, 0-0-24-0",,,,,,,,24.0,IU,,QD,2021,Q4,Dehydration,,2021,Q4,1,I,,20211029.0,20211105,20211105,EXP,,DE-MYLANLABS-2021M1079771,MYLAN,,77.0,YR,,F,Y,64.0,KG,20211105.0,,PH,DE,DE,2021,Q4,Elderly
200375341,20037534,6,C,INSULIN GLARGINE W/LIXISENATIDE,,2,,"450 IE, 0-0-24-0",,,,,,,,24.0,IU,,QD,2021,Q4,Hyponatraemia,,2021,Q4,1,I,,20211029.0,20211105,20211105,EXP,,DE-MYLANLABS-2021M1079771,MYLAN,,77.0,YR,,F,Y,64.0,KG,20211105.0,,PH,DE,DE,2021,Q4,Elderly
200376723,20037672,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Other,100 U,,,,,,,,,,Solution,QD,2021,Q4,Hyponatraemia,,2021,Q4,3,F,20211025.0,20211216.0,20211105,20211222,EXP,,US-ROCHE-2945935,ROCHE,,74.0,YR,,M,Y,79.0,KG,20211222.0,,MD,US,,2021,Q4,Elderly
200376723,20037672,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Other,100 U,,,,,,,,,,Solution,QD,2021,Q4,Adrenal insufficiency,,2021,Q4,3,F,20211025.0,20211216.0,20211105,20211222,EXP,,US-ROCHE-2945935,ROCHE,,74.0,YR,,M,Y,79.0,KG,20211222.0,,MD,US,,2021,Q4,Elderly
200379131,20037913,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (15 I.U in the morning),,,,,,,,,,,,2021,Q4,Epigastric discomfort,,2021,Q4,1,I,20180101.0,20211028.0,20211105,20211105,EXP,,DE-AstraZeneca-2021A778862,ASTRAZENECA,,65.0,YR,,M,Y,95.0,KG,20211105.0,,MD,DE,,2021,Q4,Elderly
200379131,20037913,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (15 I.U in the morning),,,,,,,,,,,,2021,Q4,Flatulence,,2021,Q4,1,I,20180101.0,20211028.0,20211105,20211105,EXP,,DE-AstraZeneca-2021A778862,ASTRAZENECA,,65.0,YR,,M,Y,95.0,KG,20211105.0,,MD,DE,,2021,Q4,Elderly
200379131,20037913,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (15 I.U in the morning),,,,,,,,,,,,2021,Q4,Gastrointestinal candidiasis,,2021,Q4,1,I,20180101.0,20211028.0,20211105,20211105,EXP,,DE-AstraZeneca-2021A778862,ASTRAZENECA,,65.0,YR,,M,Y,95.0,KG,20211105.0,,MD,DE,,2021,Q4,Elderly
200379131,20037913,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (15 I.U in the morning),,,,,,,,,,,,2021,Q4,Constipation,,2021,Q4,1,I,20180101.0,20211028.0,20211105,20211105,EXP,,DE-AstraZeneca-2021A778862,ASTRAZENECA,,65.0,YR,,M,Y,95.0,KG,20211105.0,,MD,DE,,2021,Q4,Elderly
200379912,20037991,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Off label use,,2021,Q4,2,F,,20211020.0,20211105,20211118,EXP,,US-009507513-2110USA006282,MERCK,"Vu CA, Riollano-Cruz M, Kowalsky SR. Supratherapeutic posaconazole concentration in a pediatric transplant patient with confirmed rhizopus infection. Journal of Pediatric Pharmacology and Therapeutics. 2021;26(7):753-7",10.0,YR,,F,Y,31.0,KG,20211118.0,,PH,US,US,2021,Q4,Child
200379912,20037991,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Labelled drug-drug interaction issue,,2021,Q4,2,F,,20211020.0,20211105,20211118,EXP,,US-009507513-2110USA006282,MERCK,"Vu CA, Riollano-Cruz M, Kowalsky SR. Supratherapeutic posaconazole concentration in a pediatric transplant patient with confirmed rhizopus infection. Journal of Pediatric Pharmacology and Therapeutics. 2021;26(7):753-7",10.0,YR,,F,Y,31.0,KG,20211118.0,,PH,US,US,2021,Q4,Child
200379912,20037991,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Transaminases increased,,2021,Q4,2,F,,20211020.0,20211105,20211118,EXP,,US-009507513-2110USA006282,MERCK,"Vu CA, Riollano-Cruz M, Kowalsky SR. Supratherapeutic posaconazole concentration in a pediatric transplant patient with confirmed rhizopus infection. Journal of Pediatric Pharmacology and Therapeutics. 2021;26(7):753-7",10.0,YR,,F,Y,31.0,KG,20211118.0,,PH,US,US,2021,Q4,Child
200379912,20037991,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Drug level above therapeutic,,2021,Q4,2,F,,20211020.0,20211105,20211118,EXP,,US-009507513-2110USA006282,MERCK,"Vu CA, Riollano-Cruz M, Kowalsky SR. Supratherapeutic posaconazole concentration in a pediatric transplant patient with confirmed rhizopus infection. Journal of Pediatric Pharmacology and Therapeutics. 2021;26(7):753-7",10.0,YR,,F,Y,31.0,KG,20211118.0,,PH,US,US,2021,Q4,Child
200383151,20038315,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 international unit,,,U,U,,,210605.0,16.0,IU,,,2021,Q4,Therapy partial responder,,2021,Q4,1,I,,20211031.0,20211105,20211105,EXP,,IT-MYLANLABS-2021M1080286,MYLAN,"Ciardullo S, Perseghin G.. Nonalcoholic fatty liver disease: not always a benign condition.. ildia.. 2021;33(2)",47.0,YR,,F,Y,115.0,KG,20211105.0,,HP,IT,IT,2021,Q4,Adult
200383151,20038315,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 international unit,,,U,U,,,210605.0,16.0,IU,,,2021,Q4,Hypothyroidism,,2021,Q4,1,I,,20211031.0,20211105,20211105,EXP,,IT-MYLANLABS-2021M1080286,MYLAN,"Ciardullo S, Perseghin G.. Nonalcoholic fatty liver disease: not always a benign condition.. ildia.. 2021;33(2)",47.0,YR,,F,Y,115.0,KG,20211105.0,,HP,IT,IT,2021,Q4,Adult
200383151,20038315,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,16 international unit,,,U,U,,,210605.0,16.0,IU,,,2021,Q4,Diabetic metabolic decompensation,,2021,Q4,1,I,,20211031.0,20211105,20211105,EXP,,IT-MYLANLABS-2021M1080286,MYLAN,"Ciardullo S, Perseghin G.. Nonalcoholic fatty liver disease: not always a benign condition.. ildia.. 2021;33(2)",47.0,YR,,F,Y,115.0,KG,20211105.0,,HP,IT,IT,2021,Q4,Adult
200402541,20040254,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,QD,2021,Q4,Wheezing,,2021,Q4,1,I,,20211027.0,20211106,20211106,EXP,,CA-TEVA-2021-CA-1951313,TEVA,,65.0,YR,E,M,Y,,,20211106.0,,CN,CA,CA,2021,Q4,Elderly
200402541,20040254,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,QD,2021,Q4,Therapeutic product effect incomplete,,2021,Q4,1,I,,20211027.0,20211106,20211106,EXP,,CA-TEVA-2021-CA-1951313,TEVA,,65.0,YR,E,M,Y,,,20211106.0,,CN,CA,CA,2021,Q4,Elderly
200402541,20040254,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,QD,2021,Q4,Dyspnoea,,2021,Q4,1,I,,20211027.0,20211106,20211106,EXP,,CA-TEVA-2021-CA-1951313,TEVA,,65.0,YR,E,M,Y,,,20211106.0,,CN,CA,CA,2021,Q4,Elderly
200402541,20040254,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,QD,2021,Q4,Respiratory symptom,,2021,Q4,1,I,,20211027.0,20211106,20211106,EXP,,CA-TEVA-2021-CA-1951313,TEVA,,65.0,YR,E,M,Y,,,20211106.0,,CN,CA,CA,2021,Q4,Elderly
200402541,20040254,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,QD,2021,Q4,Loss of personal independence in daily activities,,2021,Q4,1,I,,20211027.0,20211106,20211106,EXP,,CA-TEVA-2021-CA-1951313,TEVA,,65.0,YR,E,M,Y,,,20211106.0,,CN,CA,CA,2021,Q4,Elderly
200402541,20040254,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,QD,2021,Q4,Lung disorder,,2021,Q4,1,I,,20211027.0,20211106,20211106,EXP,,CA-TEVA-2021-CA-1951313,TEVA,,65.0,YR,E,M,Y,,,20211106.0,,CN,CA,CA,2021,Q4,Elderly
200402541,20040254,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,QD,2021,Q4,Vasculitis,,2021,Q4,1,I,,20211027.0,20211106,20211106,EXP,,CA-TEVA-2021-CA-1951313,TEVA,,65.0,YR,E,M,Y,,,20211106.0,,CN,CA,CA,2021,Q4,Elderly
200402541,20040254,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,QD,2021,Q4,Neurological symptom,,2021,Q4,1,I,,20211027.0,20211106,20211106,EXP,,CA-TEVA-2021-CA-1951313,TEVA,,65.0,YR,E,M,Y,,,20211106.0,,CN,CA,CA,2021,Q4,Elderly
200402541,20040254,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,QD,2021,Q4,Pulmonary alveolar haemorrhage,,2021,Q4,1,I,,20211027.0,20211106,20211106,EXP,,CA-TEVA-2021-CA-1951313,TEVA,,65.0,YR,E,M,Y,,,20211106.0,,CN,CA,CA,2021,Q4,Elderly
200402541,20040254,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,QD,2021,Q4,Obstructive airways disorder,,2021,Q4,1,I,,20211027.0,20211106,20211106,EXP,,CA-TEVA-2021-CA-1951313,TEVA,,65.0,YR,E,M,Y,,,20211106.0,,CN,CA,CA,2021,Q4,Elderly
200402541,20040254,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,QD,2021,Q4,Pulmonary vasculitis,,2021,Q4,1,I,,20211027.0,20211106,20211106,EXP,,CA-TEVA-2021-CA-1951313,TEVA,,65.0,YR,E,M,Y,,,20211106.0,,CN,CA,CA,2021,Q4,Elderly
200402541,20040254,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,QD,2021,Q4,Sleep disorder due to a general medical condition,,2021,Q4,1,I,,20211027.0,20211106,20211106,EXP,,CA-TEVA-2021-CA-1951313,TEVA,,65.0,YR,E,M,Y,,,20211106.0,,CN,CA,CA,2021,Q4,Elderly
200402541,20040254,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,QD,2021,Q4,Pulmonary fibrosis,,2021,Q4,1,I,,20211027.0,20211106,20211106,EXP,,CA-TEVA-2021-CA-1951313,TEVA,,65.0,YR,E,M,Y,,,20211106.0,,CN,CA,CA,2021,Q4,Elderly
200402541,20040254,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,QD,2021,Q4,Haemoptysis,,2021,Q4,1,I,,20211027.0,20211106,20211106,EXP,,CA-TEVA-2021-CA-1951313,TEVA,,65.0,YR,E,M,Y,,,20211106.0,,CN,CA,CA,2021,Q4,Elderly
200402541,20040254,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,QD,2021,Q4,Pain in extremity,,2021,Q4,1,I,,20211027.0,20211106,20211106,EXP,,CA-TEVA-2021-CA-1951313,TEVA,,65.0,YR,E,M,Y,,,20211106.0,,CN,CA,CA,2021,Q4,Elderly
200402541,20040254,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,QD,2021,Q4,Condition aggravated,,2021,Q4,1,I,,20211027.0,20211106,20211106,EXP,,CA-TEVA-2021-CA-1951313,TEVA,,65.0,YR,E,M,Y,,,20211106.0,,CN,CA,CA,2021,Q4,Elderly
200402541,20040254,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,QD,2021,Q4,Neuritis,,2021,Q4,1,I,,20211027.0,20211106,20211106,EXP,,CA-TEVA-2021-CA-1951313,TEVA,,65.0,YR,E,M,Y,,,20211106.0,,CN,CA,CA,2021,Q4,Elderly
200402541,20040254,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,QD,2021,Q4,Asthma,,2021,Q4,1,I,,20211027.0,20211106,20211106,EXP,,CA-TEVA-2021-CA-1951313,TEVA,,65.0,YR,E,M,Y,,,20211106.0,,CN,CA,CA,2021,Q4,Elderly
200412512,20041251,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Lipase increased,,2021,Q4,2,F,20211001.0,20211222.0,20211107,20211226,EXP,,US-ABBVIE-21K-163-4147609-00,ABBVIE,,75.0,YR,,F,Y,81.72,KG,20211226.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q4,Elderly
200412512,20041251,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Abscess,,2021,Q4,2,F,20211001.0,20211222.0,20211107,20211226,EXP,,US-ABBVIE-21K-163-4147609-00,ABBVIE,,75.0,YR,,F,Y,81.72,KG,20211226.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q4,Elderly
200412512,20041251,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Endodontic procedure,,2021,Q4,2,F,20211001.0,20211222.0,20211107,20211226,EXP,,US-ABBVIE-21K-163-4147609-00,ABBVIE,,75.0,YR,,F,Y,81.72,KG,20211226.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q4,Elderly
200412512,20041251,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Drug hypersensitivity,,2021,Q4,2,F,20211001.0,20211222.0,20211107,20211226,EXP,,US-ABBVIE-21K-163-4147609-00,ABBVIE,,75.0,YR,,F,Y,81.72,KG,20211226.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q4,Elderly
200412512,20041251,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Pancreatitis,,2021,Q4,2,F,20211001.0,20211222.0,20211107,20211226,EXP,,US-ABBVIE-21K-163-4147609-00,ABBVIE,,75.0,YR,,F,Y,81.72,KG,20211226.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q4,Elderly
200412512,20041251,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Abdominal pain upper,,2021,Q4,2,F,20211001.0,20211222.0,20211107,20211226,EXP,,US-ABBVIE-21K-163-4147609-00,ABBVIE,,75.0,YR,,F,Y,81.72,KG,20211226.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q4,Elderly
200419341,20041934,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,24.0,IU,,QD,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,20210928.0,20211101.0,20211108,20211108,EXP,FR-AFSSAPS-AN20214213,FR-BAUSCH-BL-2021-036384,BAUSCH AND LOMB,,44.0,YR,,M,Y,,,20211108.0,,PH,FR,FR,2021,Q4,Adult
200419341,20041934,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,24.0,IU,,QD,2021,Q4,Diabetic ketosis,,2021,Q4,1,I,20210928.0,20211101.0,20211108,20211108,EXP,FR-AFSSAPS-AN20214213,FR-BAUSCH-BL-2021-036384,BAUSCH AND LOMB,,44.0,YR,,M,Y,,,20211108.0,,PH,FR,FR,2021,Q4,Adult
200419341,20041934,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,24.0,IU,,QD,2021,Q4,Product dose omission in error,,2021,Q4,1,I,20210928.0,20211101.0,20211108,20211108,EXP,FR-AFSSAPS-AN20214213,FR-BAUSCH-BL-2021-036384,BAUSCH AND LOMB,,44.0,YR,,M,Y,,,20211108.0,,PH,FR,FR,2021,Q4,Adult
200438081,20043808,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"29 IU, QD (Injection)",,,U,,,,,29.0,IU,,QD,2021,Q4,Diabetic metabolic decompensation,,2021,Q4,1,I,,20211027.0,20211108,20211108,EXP,,NVSC2021SK247838,NOVARTIS,"Kollarova D, Martinka E, Urbanova M. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211108.0,,HP,SK,SK,2021,Q4,Adult
200438081,20043808,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"29 IU, QD (Injection)",,,U,,,,,29.0,IU,,QD,2021,Q4,Weight increased,,2021,Q4,1,I,,20211027.0,20211108,20211108,EXP,,NVSC2021SK247838,NOVARTIS,"Kollarova D, Martinka E, Urbanova M. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211108.0,,HP,SK,SK,2021,Q4,Adult
200438081,20043808,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"29 IU, QD (Injection)",,,U,,,,,29.0,IU,,QD,2021,Q4,Drug ineffective,,2021,Q4,1,I,,20211027.0,20211108,20211108,EXP,,NVSC2021SK247838,NOVARTIS,"Kollarova D, Martinka E, Urbanova M. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211108.0,,HP,SK,SK,2021,Q4,Adult
200438081,20043808,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"12 IU, QD (Injection)",,,U,,,,,12.0,IU,,QD,2021,Q4,Diabetic metabolic decompensation,,2021,Q4,1,I,,20211027.0,20211108,20211108,EXP,,NVSC2021SK247838,NOVARTIS,"Kollarova D, Martinka E, Urbanova M. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211108.0,,HP,SK,SK,2021,Q4,Adult
200438081,20043808,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"12 IU, QD (Injection)",,,U,,,,,12.0,IU,,QD,2021,Q4,Weight increased,,2021,Q4,1,I,,20211027.0,20211108,20211108,EXP,,NVSC2021SK247838,NOVARTIS,"Kollarova D, Martinka E, Urbanova M. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211108.0,,HP,SK,SK,2021,Q4,Adult
200438081,20043808,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"12 IU, QD (Injection)",,,U,,,,,12.0,IU,,QD,2021,Q4,Drug ineffective,,2021,Q4,1,I,,20211027.0,20211108,20211108,EXP,,NVSC2021SK247838,NOVARTIS,"Kollarova D, Martinka E, Urbanova M. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211108.0,,HP,SK,SK,2021,Q4,Adult
200438081,20043808,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,total daily insulin dose was 80 units/day (insulin lispro plus glargine) (INJECTION),,,U,,,,,,,,,2021,Q4,Diabetic metabolic decompensation,,2021,Q4,1,I,,20211027.0,20211108,20211108,EXP,,NVSC2021SK247838,NOVARTIS,"Kollarova D, Martinka E, Urbanova M. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211108.0,,HP,SK,SK,2021,Q4,Adult
200438081,20043808,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,total daily insulin dose was 80 units/day (insulin lispro plus glargine) (INJECTION),,,U,,,,,,,,,2021,Q4,Weight increased,,2021,Q4,1,I,,20211027.0,20211108,20211108,EXP,,NVSC2021SK247838,NOVARTIS,"Kollarova D, Martinka E, Urbanova M. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211108.0,,HP,SK,SK,2021,Q4,Adult
200438081,20043808,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,total daily insulin dose was 80 units/day (insulin lispro plus glargine) (INJECTION),,,U,,,,,,,,,2021,Q4,Drug ineffective,,2021,Q4,1,I,,20211027.0,20211108,20211108,EXP,,NVSC2021SK247838,NOVARTIS,"Kollarova D, Martinka E, Urbanova M. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211108.0,,HP,SK,SK,2021,Q4,Adult
200438081,20043808,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,28 units,,,U,,,,,,,,,2021,Q4,Diabetic metabolic decompensation,,2021,Q4,1,I,,20211027.0,20211108,20211108,EXP,,NVSC2021SK247838,NOVARTIS,"Kollarova D, Martinka E, Urbanova M. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211108.0,,HP,SK,SK,2021,Q4,Adult
200438081,20043808,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,28 units,,,U,,,,,,,,,2021,Q4,Weight increased,,2021,Q4,1,I,,20211027.0,20211108,20211108,EXP,,NVSC2021SK247838,NOVARTIS,"Kollarova D, Martinka E, Urbanova M. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211108.0,,HP,SK,SK,2021,Q4,Adult
200438081,20043808,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,28 units,,,U,,,,,,,,,2021,Q4,Drug ineffective,,2021,Q4,1,I,,20211027.0,20211108,20211108,EXP,,NVSC2021SK247838,NOVARTIS,"Kollarova D, Martinka E, Urbanova M. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211108.0,,HP,SK,SK,2021,Q4,Adult
200440711,20044071,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, qd (before bed)",,,Y,,,,,20.0,IU,,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20210908.0,20211026.0,20211108,20211108,EXP,CN-NMPA-4403101004842202100642,CN-NOVOPROD-861516,NOVO NORDISK,,32.0,YR,,M,Y,71.6,KG,20211108.0,,HP,CN,CN,2021,Q4,Young Adult
200440711,20044071,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, qd (before bed)",,,Y,,,,,20.0,IU,,QD,2021,Q4,Confusional state,,2021,Q4,1,I,20210908.0,20211026.0,20211108,20211108,EXP,CN-NMPA-4403101004842202100642,CN-NOVOPROD-861516,NOVO NORDISK,,32.0,YR,,M,Y,71.6,KG,20211108.0,,HP,CN,CN,2021,Q4,Young Adult
200440711,20044071,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, qd (before bed)",,,Y,,,,,12.0,IU,,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20210908.0,20211026.0,20211108,20211108,EXP,CN-NMPA-4403101004842202100642,CN-NOVOPROD-861516,NOVO NORDISK,,32.0,YR,,M,Y,71.6,KG,20211108.0,,HP,CN,CN,2021,Q4,Young Adult
200440711,20044071,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, qd (before bed)",,,Y,,,,,12.0,IU,,QD,2021,Q4,Confusional state,,2021,Q4,1,I,20210908.0,20211026.0,20211108,20211108,EXP,CN-NMPA-4403101004842202100642,CN-NOVOPROD-861516,NOVO NORDISK,,32.0,YR,,M,Y,71.6,KG,20211108.0,,HP,CN,CN,2021,Q4,Young Adult
200480342,20048034,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"24 iU, QD",,,,,,,206538.0,24.0,IU,Solution for injection,QD,2021,Q4,Product dose omission in error,,2021,Q4,2,F,,20211103.0,20211109,20211116,EXP,FR-AFSSAPS-AN20214213,FR-SA-2021SA367715,SANOFI AVENTIS,,44.0,YR,A,M,Y,,,20211116.0,,PH,FR,FR,2021,Q4,Adult
200480342,20048034,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"24 iU, QD",,,,,,,206538.0,24.0,IU,Solution for injection,QD,2021,Q4,Diabetic ketosis,,2021,Q4,2,F,,20211103.0,20211109,20211116,EXP,FR-AFSSAPS-AN20214213,FR-SA-2021SA367715,SANOFI AVENTIS,,44.0,YR,A,M,Y,,,20211116.0,,PH,FR,FR,2021,Q4,Adult
200480342,20048034,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"24 iU, QD",,,,,,,206538.0,24.0,IU,Solution for injection,QD,2021,Q4,Hyperglycaemia,,2021,Q4,2,F,,20211103.0,20211109,20211116,EXP,FR-AFSSAPS-AN20214213,FR-SA-2021SA367715,SANOFI AVENTIS,,44.0,YR,A,M,Y,,,20211116.0,,PH,FR,FR,2021,Q4,Adult
200494921,20049492,6,C,GLARGINE BIOCON,,2,Unknown,24 IU,,,,,Unknown,,,,,,,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,1,I,20210201.0,20211029.0,20211109,20211109,EXP,,BR-NOVOPROD-862699,NOVO NORDISK,,59.0,YR,,M,Y,,,20211109.0,,MD,BR,BR,2021,Q4,Adult
200494921,20049492,6,C,GLARGINE BIOCON,,2,Unknown,24 IU,,,,,Unknown,,,,,,,2021,Q4,COVID-19,,2021,Q4,1,I,20210201.0,20211029.0,20211109,20211109,EXP,,BR-NOVOPROD-862699,NOVO NORDISK,,59.0,YR,,M,Y,,,20211109.0,,MD,BR,BR,2021,Q4,Adult
200494921,20049492,6,C,GLARGINE BIOCON,,2,Unknown,24 IU,,,,,Unknown,,,,,,,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20210201.0,20211029.0,20211109,20211109,EXP,,BR-NOVOPROD-862699,NOVO NORDISK,,59.0,YR,,M,Y,,,20211109.0,,MD,BR,BR,2021,Q4,Adult
200498171,20049817,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Sepsis,,2021,Q4,1,I,,20211030.0,20211109,20211109,EXP,,CA-TEVA-2021-CA-1973817,TEVA,,76.0,YR,E,F,Y,90.0,KG,20211109.0,,PH,CA,CA,2021,Q4,Elderly
200498171,20049817,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Clostridium difficile infection,,2021,Q4,1,I,,20211030.0,20211109,20211109,EXP,,CA-TEVA-2021-CA-1973817,TEVA,,76.0,YR,E,F,Y,90.0,KG,20211109.0,,PH,CA,CA,2021,Q4,Elderly
200498171,20049817,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Diabetic foot infection,,2021,Q4,1,I,,20211030.0,20211109,20211109,EXP,,CA-TEVA-2021-CA-1973817,TEVA,,76.0,YR,E,F,Y,90.0,KG,20211109.0,,PH,CA,CA,2021,Q4,Elderly
200498171,20049817,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Osteomyelitis,,2021,Q4,1,I,,20211030.0,20211109,20211109,EXP,,CA-TEVA-2021-CA-1973817,TEVA,,76.0,YR,E,F,Y,90.0,KG,20211109.0,,PH,CA,CA,2021,Q4,Elderly
200503941,20050394,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"3 U, QD (every night)",,,,,,,,,,,QD,2021,Q4,Insulin resistance,,2021,Q4,1,I,20140801.0,20211102.0,20211109,20211109,EXP,,CN-SA-2021SA365134,SANOFI AVENTIS,"Li X.; Xiaoyan C,; Yan N,; Haiyan Y.. Choice of hypoglycemic regimen in insulin-resistant type 2 diabetic patients. Special Health Issue. 2021;unk:107 - 110",55.0,YR,A,F,Y,67.0,KG,20211109.0,,HP,CN,CN,2021,Q4,Adult
200503941,20050394,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"3 U, QD (every night)",,,,,,,,,,,QD,2021,Q4,Palpitations,,2021,Q4,1,I,20140801.0,20211102.0,20211109,20211109,EXP,,CN-SA-2021SA365134,SANOFI AVENTIS,"Li X.; Xiaoyan C,; Yan N,; Haiyan Y.. Choice of hypoglycemic regimen in insulin-resistant type 2 diabetic patients. Special Health Issue. 2021;unk:107 - 110",55.0,YR,A,F,Y,67.0,KG,20211109.0,,HP,CN,CN,2021,Q4,Adult
200503941,20050394,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"3 U, QD (every night)",,,,,,,,,,,QD,2021,Q4,Injection site reaction,,2021,Q4,1,I,20140801.0,20211102.0,20211109,20211109,EXP,,CN-SA-2021SA365134,SANOFI AVENTIS,"Li X.; Xiaoyan C,; Yan N,; Haiyan Y.. Choice of hypoglycemic regimen in insulin-resistant type 2 diabetic patients. Special Health Issue. 2021;unk:107 - 110",55.0,YR,A,F,Y,67.0,KG,20211109.0,,HP,CN,CN,2021,Q4,Adult
200503941,20050394,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"3 U, QD (every night)",,,,,,,,,,,QD,2021,Q4,Tremor,,2021,Q4,1,I,20140801.0,20211102.0,20211109,20211109,EXP,,CN-SA-2021SA365134,SANOFI AVENTIS,"Li X.; Xiaoyan C,; Yan N,; Haiyan Y.. Choice of hypoglycemic regimen in insulin-resistant type 2 diabetic patients. Special Health Issue. 2021;unk:107 - 110",55.0,YR,A,F,Y,67.0,KG,20211109.0,,HP,CN,CN,2021,Q4,Adult
200503941,20050394,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"3 U, QD (every night)",,,,,,,,,,,QD,2021,Q4,Blood glucose abnormal,,2021,Q4,1,I,20140801.0,20211102.0,20211109,20211109,EXP,,CN-SA-2021SA365134,SANOFI AVENTIS,"Li X.; Xiaoyan C,; Yan N,; Haiyan Y.. Choice of hypoglycemic regimen in insulin-resistant type 2 diabetic patients. Special Health Issue. 2021;unk:107 - 110",55.0,YR,A,F,Y,67.0,KG,20211109.0,,HP,CN,CN,2021,Q4,Adult
200503941,20050394,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"3 U, QD (every night)",,,,,,,,,,,QD,2021,Q4,Unevaluable event,,2021,Q4,1,I,20140801.0,20211102.0,20211109,20211109,EXP,,CN-SA-2021SA365134,SANOFI AVENTIS,"Li X.; Xiaoyan C,; Yan N,; Haiyan Y.. Choice of hypoglycemic regimen in insulin-resistant type 2 diabetic patients. Special Health Issue. 2021;unk:107 - 110",55.0,YR,A,F,Y,67.0,KG,20211109.0,,HP,CN,CN,2021,Q4,Adult
200503941,20050394,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"3 U, QD (every night)",,,,,,,,,,,QD,2021,Q4,Hunger,,2021,Q4,1,I,20140801.0,20211102.0,20211109,20211109,EXP,,CN-SA-2021SA365134,SANOFI AVENTIS,"Li X.; Xiaoyan C,; Yan N,; Haiyan Y.. Choice of hypoglycemic regimen in insulin-resistant type 2 diabetic patients. Special Health Issue. 2021;unk:107 - 110",55.0,YR,A,F,Y,67.0,KG,20211109.0,,HP,CN,CN,2021,Q4,Adult
200503941,20050394,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"3 U, QD (every night)",,,,,,,,,,,QD,2021,Q4,Blood glucose fluctuation,,2021,Q4,1,I,20140801.0,20211102.0,20211109,20211109,EXP,,CN-SA-2021SA365134,SANOFI AVENTIS,"Li X.; Xiaoyan C,; Yan N,; Haiyan Y.. Choice of hypoglycemic regimen in insulin-resistant type 2 diabetic patients. Special Health Issue. 2021;unk:107 - 110",55.0,YR,A,F,Y,67.0,KG,20211109.0,,HP,CN,CN,2021,Q4,Adult
200503941,20050394,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"3 U, QD (every night)",,,,,,,,,,,QD,2021,Q4,Cold sweat,,2021,Q4,1,I,20140801.0,20211102.0,20211109,20211109,EXP,,CN-SA-2021SA365134,SANOFI AVENTIS,"Li X.; Xiaoyan C,; Yan N,; Haiyan Y.. Choice of hypoglycemic regimen in insulin-resistant type 2 diabetic patients. Special Health Issue. 2021;unk:107 - 110",55.0,YR,A,F,Y,67.0,KG,20211109.0,,HP,CN,CN,2021,Q4,Adult
200503941,20050394,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"3 U, QD (every night)",,,,,,,,,,,QD,2021,Q4,Hyperinsulinaemia,,2021,Q4,1,I,20140801.0,20211102.0,20211109,20211109,EXP,,CN-SA-2021SA365134,SANOFI AVENTIS,"Li X.; Xiaoyan C,; Yan N,; Haiyan Y.. Choice of hypoglycemic regimen in insulin-resistant type 2 diabetic patients. Special Health Issue. 2021;unk:107 - 110",55.0,YR,A,F,Y,67.0,KG,20211109.0,,HP,CN,CN,2021,Q4,Adult
200503941,20050394,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"3 U, QD (every night)",,,,,,,,,,,QD,2021,Q4,Injection site induration,,2021,Q4,1,I,20140801.0,20211102.0,20211109,20211109,EXP,,CN-SA-2021SA365134,SANOFI AVENTIS,"Li X.; Xiaoyan C,; Yan N,; Haiyan Y.. Choice of hypoglycemic regimen in insulin-resistant type 2 diabetic patients. Special Health Issue. 2021;unk:107 - 110",55.0,YR,A,F,Y,67.0,KG,20211109.0,,HP,CN,CN,2021,Q4,Adult
200503941,20050394,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"3 U, QD (every night)",,,,,,,,,,,QD,2021,Q4,Therapeutic product effect incomplete,,2021,Q4,1,I,20140801.0,20211102.0,20211109,20211109,EXP,,CN-SA-2021SA365134,SANOFI AVENTIS,"Li X.; Xiaoyan C,; Yan N,; Haiyan Y.. Choice of hypoglycemic regimen in insulin-resistant type 2 diabetic patients. Special Health Issue. 2021;unk:107 - 110",55.0,YR,A,F,Y,67.0,KG,20211109.0,,HP,CN,CN,2021,Q4,Adult
200503941,20050394,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"3 U, QD (every night)",,,,,,,,,,,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20140801.0,20211102.0,20211109,20211109,EXP,,CN-SA-2021SA365134,SANOFI AVENTIS,"Li X.; Xiaoyan C,; Yan N,; Haiyan Y.. Choice of hypoglycemic regimen in insulin-resistant type 2 diabetic patients. Special Health Issue. 2021;unk:107 - 110",55.0,YR,A,F,Y,67.0,KG,20211109.0,,HP,CN,CN,2021,Q4,Adult
200503941,20050394,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 U,,,,,,,,,,,,2021,Q4,Insulin resistance,,2021,Q4,1,I,20140801.0,20211102.0,20211109,20211109,EXP,,CN-SA-2021SA365134,SANOFI AVENTIS,"Li X.; Xiaoyan C,; Yan N,; Haiyan Y.. Choice of hypoglycemic regimen in insulin-resistant type 2 diabetic patients. Special Health Issue. 2021;unk:107 - 110",55.0,YR,A,F,Y,67.0,KG,20211109.0,,HP,CN,CN,2021,Q4,Adult
200503941,20050394,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 U,,,,,,,,,,,,2021,Q4,Palpitations,,2021,Q4,1,I,20140801.0,20211102.0,20211109,20211109,EXP,,CN-SA-2021SA365134,SANOFI AVENTIS,"Li X.; Xiaoyan C,; Yan N,; Haiyan Y.. Choice of hypoglycemic regimen in insulin-resistant type 2 diabetic patients. Special Health Issue. 2021;unk:107 - 110",55.0,YR,A,F,Y,67.0,KG,20211109.0,,HP,CN,CN,2021,Q4,Adult
200503941,20050394,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 U,,,,,,,,,,,,2021,Q4,Injection site reaction,,2021,Q4,1,I,20140801.0,20211102.0,20211109,20211109,EXP,,CN-SA-2021SA365134,SANOFI AVENTIS,"Li X.; Xiaoyan C,; Yan N,; Haiyan Y.. Choice of hypoglycemic regimen in insulin-resistant type 2 diabetic patients. Special Health Issue. 2021;unk:107 - 110",55.0,YR,A,F,Y,67.0,KG,20211109.0,,HP,CN,CN,2021,Q4,Adult
200503941,20050394,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 U,,,,,,,,,,,,2021,Q4,Tremor,,2021,Q4,1,I,20140801.0,20211102.0,20211109,20211109,EXP,,CN-SA-2021SA365134,SANOFI AVENTIS,"Li X.; Xiaoyan C,; Yan N,; Haiyan Y.. Choice of hypoglycemic regimen in insulin-resistant type 2 diabetic patients. Special Health Issue. 2021;unk:107 - 110",55.0,YR,A,F,Y,67.0,KG,20211109.0,,HP,CN,CN,2021,Q4,Adult
200503941,20050394,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 U,,,,,,,,,,,,2021,Q4,Blood glucose abnormal,,2021,Q4,1,I,20140801.0,20211102.0,20211109,20211109,EXP,,CN-SA-2021SA365134,SANOFI AVENTIS,"Li X.; Xiaoyan C,; Yan N,; Haiyan Y.. Choice of hypoglycemic regimen in insulin-resistant type 2 diabetic patients. Special Health Issue. 2021;unk:107 - 110",55.0,YR,A,F,Y,67.0,KG,20211109.0,,HP,CN,CN,2021,Q4,Adult
200503941,20050394,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 U,,,,,,,,,,,,2021,Q4,Unevaluable event,,2021,Q4,1,I,20140801.0,20211102.0,20211109,20211109,EXP,,CN-SA-2021SA365134,SANOFI AVENTIS,"Li X.; Xiaoyan C,; Yan N,; Haiyan Y.. Choice of hypoglycemic regimen in insulin-resistant type 2 diabetic patients. Special Health Issue. 2021;unk:107 - 110",55.0,YR,A,F,Y,67.0,KG,20211109.0,,HP,CN,CN,2021,Q4,Adult
200503941,20050394,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 U,,,,,,,,,,,,2021,Q4,Hunger,,2021,Q4,1,I,20140801.0,20211102.0,20211109,20211109,EXP,,CN-SA-2021SA365134,SANOFI AVENTIS,"Li X.; Xiaoyan C,; Yan N,; Haiyan Y.. Choice of hypoglycemic regimen in insulin-resistant type 2 diabetic patients. Special Health Issue. 2021;unk:107 - 110",55.0,YR,A,F,Y,67.0,KG,20211109.0,,HP,CN,CN,2021,Q4,Adult
200503941,20050394,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 U,,,,,,,,,,,,2021,Q4,Blood glucose fluctuation,,2021,Q4,1,I,20140801.0,20211102.0,20211109,20211109,EXP,,CN-SA-2021SA365134,SANOFI AVENTIS,"Li X.; Xiaoyan C,; Yan N,; Haiyan Y.. Choice of hypoglycemic regimen in insulin-resistant type 2 diabetic patients. Special Health Issue. 2021;unk:107 - 110",55.0,YR,A,F,Y,67.0,KG,20211109.0,,HP,CN,CN,2021,Q4,Adult
200503941,20050394,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 U,,,,,,,,,,,,2021,Q4,Cold sweat,,2021,Q4,1,I,20140801.0,20211102.0,20211109,20211109,EXP,,CN-SA-2021SA365134,SANOFI AVENTIS,"Li X.; Xiaoyan C,; Yan N,; Haiyan Y.. Choice of hypoglycemic regimen in insulin-resistant type 2 diabetic patients. Special Health Issue. 2021;unk:107 - 110",55.0,YR,A,F,Y,67.0,KG,20211109.0,,HP,CN,CN,2021,Q4,Adult
200503941,20050394,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 U,,,,,,,,,,,,2021,Q4,Hyperinsulinaemia,,2021,Q4,1,I,20140801.0,20211102.0,20211109,20211109,EXP,,CN-SA-2021SA365134,SANOFI AVENTIS,"Li X.; Xiaoyan C,; Yan N,; Haiyan Y.. Choice of hypoglycemic regimen in insulin-resistant type 2 diabetic patients. Special Health Issue. 2021;unk:107 - 110",55.0,YR,A,F,Y,67.0,KG,20211109.0,,HP,CN,CN,2021,Q4,Adult
200503941,20050394,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 U,,,,,,,,,,,,2021,Q4,Injection site induration,,2021,Q4,1,I,20140801.0,20211102.0,20211109,20211109,EXP,,CN-SA-2021SA365134,SANOFI AVENTIS,"Li X.; Xiaoyan C,; Yan N,; Haiyan Y.. Choice of hypoglycemic regimen in insulin-resistant type 2 diabetic patients. Special Health Issue. 2021;unk:107 - 110",55.0,YR,A,F,Y,67.0,KG,20211109.0,,HP,CN,CN,2021,Q4,Adult
200503941,20050394,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 U,,,,,,,,,,,,2021,Q4,Therapeutic product effect incomplete,,2021,Q4,1,I,20140801.0,20211102.0,20211109,20211109,EXP,,CN-SA-2021SA365134,SANOFI AVENTIS,"Li X.; Xiaoyan C,; Yan N,; Haiyan Y.. Choice of hypoglycemic regimen in insulin-resistant type 2 diabetic patients. Special Health Issue. 2021;unk:107 - 110",55.0,YR,A,F,Y,67.0,KG,20211109.0,,HP,CN,CN,2021,Q4,Adult
200503941,20050394,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,12 U,,,,,,,,,,,,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20140801.0,20211102.0,20211109,20211109,EXP,,CN-SA-2021SA365134,SANOFI AVENTIS,"Li X.; Xiaoyan C,; Yan N,; Haiyan Y.. Choice of hypoglycemic regimen in insulin-resistant type 2 diabetic patients. Special Health Issue. 2021;unk:107 - 110",55.0,YR,A,F,Y,67.0,KG,20211109.0,,HP,CN,CN,2021,Q4,Adult
200505281,20050528,8,C,GLARGINE BIOCON,,2,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Death,,2021,Q4,1,I,,20211103.0,20211109,20211109,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-118500,BRISTOL MYERS SQUIBB,,70.0,YR,,M,Y,,,20211109.0,,HP,US,US,2021,Q4,Elderly
200512331,20051233,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"Injection fluid, 100 units/ml (units per milliliter)",,,,,,,,,,,,2021,Q4,Lactic acidosis,,2021,Q4,1,I,20211102.0,20211107.0,20211110,20211110,EXP,NL-LRB-00707598,NL-BAUSCH-BL-2021-036836,BAUSCH AND LOMB,,62.0,YR,,M,Y,90.0,KG,20211110.0,,MD,NL,NL,2021,Q4,Adult
200514751,20051475,2,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,"38 international unit, Once a Day(38 iU, QD)",,,,,,,,38.0,IU,Solution for injection,QD,2021,Q4,Pancreatitis acute,,2021,Q4,1,I,,20211027.0,20211110,20211110,EXP,,RO-AUROBINDO-AUR-APL-2021-045601,AUROBINDO,,62.0,YR,,,Y,,,20211110.0,,MD,RO,RO,2021,Q4,Adult
200529244,20052924,30,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,5 Units,,,,,,,,,,Unknown,QD,2021,Q4,Streptococcal bacteraemia,,2021,Q4,4,F,20211026.0,20211129.0,20211110,20211206,PER,,US-CELGENEUS-USA-20211101886,CELGENE,,78.0,YR,,F,Y,67.5,KG,20211206.0,,MD,US,US,2021,Q4,Elderly
200535641,20053564,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, qd (18 units in the morning and 08 units in the evening)",,,,,unk,,,26.0,IU,,QD,2021,Q4,Orthopaedic procedure,,2021,Q4,1,I,,20211030.0,20211110,20211110,EXP,,BR-NOVOPROD-863664,NOVO NORDISK,,52.0,YR,,F,Y,63.0,KG,20211110.0,,MD,BR,BR,2021,Q4,Adult
200535641,20053564,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, qd (18 units in the morning and 08 units in the evening)",,,,,unk,,,26.0,IU,,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211030.0,20211110,20211110,EXP,,BR-NOVOPROD-863664,NOVO NORDISK,,52.0,YR,,F,Y,63.0,KG,20211110.0,,MD,BR,BR,2021,Q4,Adult
200535641,20053564,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, qd (18 units in the morning and 08 units in the evening)",,,,,unk,,,26.0,IU,,QD,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,,20211030.0,20211110,20211110,EXP,,BR-NOVOPROD-863664,NOVO NORDISK,,52.0,YR,,F,Y,63.0,KG,20211110.0,,MD,BR,BR,2021,Q4,Adult
200535641,20053564,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, qd (18 units in the morning and 08 units in the evening)",,,,,unk,,,26.0,IU,,QD,2021,Q4,Mental disorder,,2021,Q4,1,I,,20211030.0,20211110,20211110,EXP,,BR-NOVOPROD-863664,NOVO NORDISK,,52.0,YR,,F,Y,63.0,KG,20211110.0,,MD,BR,BR,2021,Q4,Adult
200535641,20053564,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, qd (18 units in the morning and 08 units in the evening)",,,,,unk,,,26.0,IU,,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211030.0,20211110,20211110,EXP,,BR-NOVOPROD-863664,NOVO NORDISK,,52.0,YR,,F,Y,63.0,KG,20211110.0,,MD,BR,BR,2021,Q4,Adult
200540971,20054097,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,210605.0,,,,,2021,Q4,Drug ineffective,,2021,Q4,1,I,,20211102.0,20211110,20211110,EXP,,ES-MYLANLABS-2021M1082106,MYLAN,"Olate-Perez A, Diaz-Cespedes RA, Ruiz-Del-Rio N, Hernandez-Perez D, Duch-Samper A. Brevibacterium casei endophthalmitis after intravitreal dexamethasone implant. Arch-Soc-Esp-Oftalmol-(Engl-Ed) 2021;96(10):549-551.",49.0,YR,,M,Y,,,20211110.0,,HP,ES,ES,2021,Q4,Adult
200543241,20054324,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK (Injectievloeistof, 100 eenheden/ml (eenheden per milliliter)",,,D,,,,,,,,,2021,Q4,Lactic acidosis,,2021,Q4,1,I,20211102.0,20211108.0,20211110,20211110,EXP,NL-LRB-00707598,NVSC2021NL256331,NOVARTIS,,62.0,YR,,M,Y,90.0,KG,20211110.0,,MD,NL,NL,2021,Q4,Adult
200552741,20055274,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"24 international unit, daily",,,,,,,205692.0,24.0,IU,,QD,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,,20211029.0,20211110,20211110,EXP,FR-AFSSAPS-AN20214213,FR-ELI_LILLY_AND_COMPANY-FR202111000222,ELI LILLY AND CO,,44.0,YR,,M,Y,,,20211110.0,,CN,FR,FR,2021,Q4,Adult
200552741,20055274,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"24 international unit, daily",,,,,,,205692.0,24.0,IU,,QD,2021,Q4,Diabetic ketosis,,2021,Q4,1,I,,20211029.0,20211110,20211110,EXP,FR-AFSSAPS-AN20214213,FR-ELI_LILLY_AND_COMPANY-FR202111000222,ELI LILLY AND CO,,44.0,YR,,M,Y,,,20211110.0,,CN,FR,FR,2021,Q4,Adult
200552741,20055274,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"24 international unit, daily",,,,,,,205692.0,24.0,IU,,QD,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,,20211029.0,20211110,20211110,EXP,FR-AFSSAPS-AN20214213,FR-ELI_LILLY_AND_COMPANY-FR202111000222,ELI LILLY AND CO,,44.0,YR,,M,Y,,,20211110.0,,CN,FR,FR,2021,Q4,Adult
200552741,20055274,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"24 international unit, daily",,,,,,,205692.0,24.0,IU,,QD,2021,Q4,Diabetic ketosis,,2021,Q4,1,I,,20211029.0,20211110,20211110,EXP,FR-AFSSAPS-AN20214213,FR-ELI_LILLY_AND_COMPANY-FR202111000222,ELI LILLY AND CO,,44.0,YR,,M,Y,,,20211110.0,,CN,FR,FR,2021,Q4,Adult
200559601,20055960,32,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 international unit, Once a Day",,,U,,,,,20.0,IU,,QD,2021,Q4,Drug ineffective,,2021,Q4,1,I,,20211027.0,20211111,20211111,EXP,,US-AUROBINDO-AUR-APL-2021-043734,AUROBINDO,"Del Toro-Pagan NM, Matos A, Thacker D, Turgeon J, Amin NS, Michaud V. Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report. Medicina-Kaunas. 2021;57:1-9",66.0,YR,,F,Y,,,20211111.0,,HP,US,US,2021,Q4,Elderly
200559601,20055960,32,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 international unit, Once a Day",,,U,,,,,20.0,IU,,QD,2021,Q4,Depression,,2021,Q4,1,I,,20211027.0,20211111,20211111,EXP,,US-AUROBINDO-AUR-APL-2021-043734,AUROBINDO,"Del Toro-Pagan NM, Matos A, Thacker D, Turgeon J, Amin NS, Michaud V. Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report. Medicina-Kaunas. 2021;57:1-9",66.0,YR,,F,Y,,,20211111.0,,HP,US,US,2021,Q4,Elderly
200559601,20055960,32,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 international unit, Once a Day",,,U,,,,,20.0,IU,,QD,2021,Q4,Drug interaction,,2021,Q4,1,I,,20211027.0,20211111,20211111,EXP,,US-AUROBINDO-AUR-APL-2021-043734,AUROBINDO,"Del Toro-Pagan NM, Matos A, Thacker D, Turgeon J, Amin NS, Michaud V. Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report. Medicina-Kaunas. 2021;57:1-9",66.0,YR,,F,Y,,,20211111.0,,HP,US,US,2021,Q4,Elderly
200559601,20055960,32,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 international unit, Once a Day",,,U,,,,,20.0,IU,,QD,2021,Q4,Toxicity to various agents,,2021,Q4,1,I,,20211027.0,20211111,20211111,EXP,,US-AUROBINDO-AUR-APL-2021-043734,AUROBINDO,"Del Toro-Pagan NM, Matos A, Thacker D, Turgeon J, Amin NS, Michaud V. Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report. Medicina-Kaunas. 2021;57:1-9",66.0,YR,,F,Y,,,20211111.0,,HP,US,US,2021,Q4,Elderly
200559601,20055960,32,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 international unit, Once a Day",,,U,,,,,20.0,IU,,QD,2021,Q4,Bradycardia,,2021,Q4,1,I,,20211027.0,20211111,20211111,EXP,,US-AUROBINDO-AUR-APL-2021-043734,AUROBINDO,"Del Toro-Pagan NM, Matos A, Thacker D, Turgeon J, Amin NS, Michaud V. Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report. Medicina-Kaunas. 2021;57:1-9",66.0,YR,,F,Y,,,20211111.0,,HP,US,US,2021,Q4,Elderly
200560331,20056033,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 IU, bid",,,,,Unknown,,,14.0,IU,,BID,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20120101.0,20211031.0,20211111,20211111,EXP,,BR-NOVOPROD-863479,NOVO NORDISK,,73.0,YR,,M,Y,90.3,KG,20211111.0,,MD,BR,BR,2021,Q4,Elderly
200560331,20056033,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 IU, bid",,,,,Unknown,,,14.0,IU,,BID,2021,Q4,Sensory loss,,2021,Q4,1,I,20120101.0,20211031.0,20211111,20211111,EXP,,BR-NOVOPROD-863479,NOVO NORDISK,,73.0,YR,,M,Y,90.3,KG,20211111.0,,MD,BR,BR,2021,Q4,Elderly
200560331,20056033,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 IU, bid",,,,,Unknown,,,14.0,IU,,BID,2021,Q4,Peripheral artery occlusion,,2021,Q4,1,I,20120101.0,20211031.0,20211111,20211111,EXP,,BR-NOVOPROD-863479,NOVO NORDISK,,73.0,YR,,M,Y,90.3,KG,20211111.0,,MD,BR,BR,2021,Q4,Elderly
200560331,20056033,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 IU, bid",,,,,Unknown,,,14.0,IU,,BID,2021,Q4,Pulmonary oedema,,2021,Q4,1,I,20120101.0,20211031.0,20211111,20211111,EXP,,BR-NOVOPROD-863479,NOVO NORDISK,,73.0,YR,,M,Y,90.3,KG,20211111.0,,MD,BR,BR,2021,Q4,Elderly
200560331,20056033,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 IU, bid",,,,,Unknown,,,14.0,IU,,BID,2021,Q4,Aortic valve replacement,,2021,Q4,1,I,20120101.0,20211031.0,20211111,20211111,EXP,,BR-NOVOPROD-863479,NOVO NORDISK,,73.0,YR,,M,Y,90.3,KG,20211111.0,,MD,BR,BR,2021,Q4,Elderly
200560331,20056033,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 IU, bid",,,,,Unknown,,,14.0,IU,,BID,2021,Q4,Stent placement,,2021,Q4,1,I,20120101.0,20211031.0,20211111,20211111,EXP,,BR-NOVOPROD-863479,NOVO NORDISK,,73.0,YR,,M,Y,90.3,KG,20211111.0,,MD,BR,BR,2021,Q4,Elderly
200560331,20056033,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 IU, bid",,,,,Unknown,,,14.0,IU,,BID,2021,Q4,Nausea,,2021,Q4,1,I,20120101.0,20211031.0,20211111,20211111,EXP,,BR-NOVOPROD-863479,NOVO NORDISK,,73.0,YR,,M,Y,90.3,KG,20211111.0,,MD,BR,BR,2021,Q4,Elderly
200568942,20056894,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Anxiety,,2021,Q4,2,F,20211001.0,20211116.0,20211111,20211119,PER,,US-AMGEN-USASP2021174817,AMGEN,,60.0,YR,A,F,Y,,,20211119.0,,MD,US,US,2021,Q4,Adult
200568942,20056894,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Hypertensive emergency,,2021,Q4,2,F,20211001.0,20211116.0,20211111,20211119,PER,,US-AMGEN-USASP2021174817,AMGEN,,60.0,YR,A,F,Y,,,20211119.0,,MD,US,US,2021,Q4,Adult
200568942,20056894,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Acute respiratory failure,,2021,Q4,2,F,20211001.0,20211116.0,20211111,20211119,PER,,US-AMGEN-USASP2021174817,AMGEN,,60.0,YR,A,F,Y,,,20211119.0,,MD,US,US,2021,Q4,Adult
200568942,20056894,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Pulmonary oedema,,2021,Q4,2,F,20211001.0,20211116.0,20211111,20211119,PER,,US-AMGEN-USASP2021174817,AMGEN,,60.0,YR,A,F,Y,,,20211119.0,,MD,US,US,2021,Q4,Adult
200584401,20058440,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Drug resistance,,2021,Q4,1,I,,20211101.0,20211111,20211111,EXP,,GR-PFIZER INC-2021623799,PFIZER,"Liatsos, G.. Fatal Streptococcus pseudoporcinus disseminated infection in decompensated liver cirrhosis: a Case Report. Journal of Medical Case Reports. 2021;15(1):10.1186/s13256-021-02832-3",56.0,YR,,M,Y,,,20211111.0,,HP,GR,GR,2021,Q4,Adult
200584401,20058440,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Multiple organ dysfunction syndrome,,2021,Q4,1,I,,20211101.0,20211111,20211111,EXP,,GR-PFIZER INC-2021623799,PFIZER,"Liatsos, G.. Fatal Streptococcus pseudoporcinus disseminated infection in decompensated liver cirrhosis: a Case Report. Journal of Medical Case Reports. 2021;15(1):10.1186/s13256-021-02832-3",56.0,YR,,M,Y,,,20211111.0,,HP,GR,GR,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Sinusitis,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Blood triglycerides increased,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Product availability issue,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Synovial cyst,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Weight decreased,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Tooth infection,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Feeling abnormal,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Memory impairment,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Abdominal discomfort,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Hepatomegaly,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Platelet count decreased,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Red blood cell count decreased,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Blood iron increased,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Anxiety,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Full blood count abnormal,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Hepatic pain,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Blood iron decreased,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Epistaxis,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Blood glucose abnormal,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Diverticulitis,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Hypermetropia,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Intervertebral disc protrusion,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Chest discomfort,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Fatigue,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Influenza,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Atrial fibrillation,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Road traffic accident,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Nasopharyngitis,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Herpes zoster,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Depression,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Proteinuria,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Bone marrow disorder,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Mental impairment,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Bone marrow failure,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Gastrointestinal disorder,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Blood calcium decreased,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Myopia,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Splenomegaly,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Immune system disorder,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Pruritus,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Retinopathy,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Chronic kidney disease,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Blood uric acid increased,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Sneezing,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Meniscus injury,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594811,20059481,49,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Nephrolithiasis,,2021,Q4,1,I,,20211103.0,20211111,20211111,EXP,,US-MYLANLABS-2021M1081395,MYLAN,,60.0,YR,,F,Y,,,20211111.0,,CN,US,US,2021,Q4,Adult
200594902,20059490,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,25 units daily,,,U,,,,,,,,,2021,Q4,Metabolic acidosis,,2021,Q4,2,F,,20211112.0,20211111,20211122,EXP,,US-TEVA-2021-US-1975084,TEVA,"Chetram VK, Ahmad AI, Farid S, Sood T. Acute Kidney Injury Secondary to Rhabdomyolysis and COVID-19: A Case Report and Literature Review. Case-Rep-Nephrol 2021;:.",62.0,YR,A,M,Y,,,20211122.0,,HP,US,US,2021,Q4,Adult
200594902,20059490,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,25 units daily,,,U,,,,,,,,,2021,Q4,Metabolic acidosis,,2021,Q4,2,F,,20211112.0,20211111,20211122,EXP,,US-TEVA-2021-US-1975084,TEVA,"Chetram VK, Ahmad AI, Farid S, Sood T. Acute Kidney Injury Secondary to Rhabdomyolysis and COVID-19: A Case Report and Literature Review. Case-Rep-Nephrol 2021;:.",62.0,YR,A,M,Y,,,20211122.0,,HP,US,US,2021,Q4,Adult
200594902,20059490,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,25 units daily,,,U,,,,,,,,,2021,Q4,Off label use,,2021,Q4,2,F,,20211112.0,20211111,20211122,EXP,,US-TEVA-2021-US-1975084,TEVA,"Chetram VK, Ahmad AI, Farid S, Sood T. Acute Kidney Injury Secondary to Rhabdomyolysis and COVID-19: A Case Report and Literature Review. Case-Rep-Nephrol 2021;:.",62.0,YR,A,M,Y,,,20211122.0,,HP,US,US,2021,Q4,Adult
200594902,20059490,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,25 units daily,,,U,,,,,,,,,2021,Q4,Acute respiratory failure,,2021,Q4,2,F,,20211112.0,20211111,20211122,EXP,,US-TEVA-2021-US-1975084,TEVA,"Chetram VK, Ahmad AI, Farid S, Sood T. Acute Kidney Injury Secondary to Rhabdomyolysis and COVID-19: A Case Report and Literature Review. Case-Rep-Nephrol 2021;:.",62.0,YR,A,M,Y,,,20211122.0,,HP,US,US,2021,Q4,Adult
200594902,20059490,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,25 units daily,,,U,,,,,,,,,2021,Q4,Acute kidney injury,,2021,Q4,2,F,,20211112.0,20211111,20211122,EXP,,US-TEVA-2021-US-1975084,TEVA,"Chetram VK, Ahmad AI, Farid S, Sood T. Acute Kidney Injury Secondary to Rhabdomyolysis and COVID-19: A Case Report and Literature Review. Case-Rep-Nephrol 2021;:.",62.0,YR,A,M,Y,,,20211122.0,,HP,US,US,2021,Q4,Adult
200594902,20059490,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,25 units daily,,,U,,,,,,,,,2021,Q4,Rhabdomyolysis,,2021,Q4,2,F,,20211112.0,20211111,20211122,EXP,,US-TEVA-2021-US-1975084,TEVA,"Chetram VK, Ahmad AI, Farid S, Sood T. Acute Kidney Injury Secondary to Rhabdomyolysis and COVID-19: A Case Report and Literature Review. Case-Rep-Nephrol 2021;:.",62.0,YR,A,M,Y,,,20211122.0,,HP,US,US,2021,Q4,Adult
200618581,20061858,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 u, daily",,,Y,,,,,16.0,IU,,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211102.0,20211112,20211112,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202111002359,ELI LILLY AND CO,,88.0,YR,,F,Y,,,20211112.0,,CN,JP,JP,2021,Q4,Elderly
200618581,20061858,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 u, daily",,,Y,,,,,16.0,IU,,QD,2021,Q4,Agnosia,,2021,Q4,1,I,,20211102.0,20211112,20211112,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202111002359,ELI LILLY AND CO,,88.0,YR,,F,Y,,,20211112.0,,CN,JP,JP,2021,Q4,Elderly
200618581,20061858,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 u, daily",,,Y,,,,,16.0,IU,,QD,2021,Q4,Weight decreased,,2021,Q4,1,I,,20211102.0,20211112,20211112,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202111002359,ELI LILLY AND CO,,88.0,YR,,F,Y,,,20211112.0,,CN,JP,JP,2021,Q4,Elderly
200618581,20061858,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 u, daily",,,Y,,,,,16.0,IU,,QD,2021,Q4,Irritability,,2021,Q4,1,I,,20211102.0,20211112,20211112,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202111002359,ELI LILLY AND CO,,88.0,YR,,F,Y,,,20211112.0,,CN,JP,JP,2021,Q4,Elderly
200618581,20061858,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 u, daily",,,Y,,,,,16.0,IU,,QD,2021,Q4,Reduced facial expression,,2021,Q4,1,I,,20211102.0,20211112,20211112,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202111002359,ELI LILLY AND CO,,88.0,YR,,F,Y,,,20211112.0,,CN,JP,JP,2021,Q4,Elderly
200618581,20061858,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 u, daily",,,Y,,,,,16.0,IU,,QD,2021,Q4,Urinary incontinence,,2021,Q4,1,I,,20211102.0,20211112,20211112,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202111002359,ELI LILLY AND CO,,88.0,YR,,F,Y,,,20211112.0,,CN,JP,JP,2021,Q4,Elderly
200618581,20061858,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 u, daily",,,Y,,,,,16.0,IU,,QD,2021,Q4,Fluid intake reduced,,2021,Q4,1,I,,20211102.0,20211112,20211112,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202111002359,ELI LILLY AND CO,,88.0,YR,,F,Y,,,20211112.0,,CN,JP,JP,2021,Q4,Elderly
200618581,20061858,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 u, daily",,,Y,,,,,16.0,IU,,QD,2021,Q4,Hypophagia,,2021,Q4,1,I,,20211102.0,20211112,20211112,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202111002359,ELI LILLY AND CO,,88.0,YR,,F,Y,,,20211112.0,,CN,JP,JP,2021,Q4,Elderly
200618581,20061858,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 u, daily",,,Y,,,,,16.0,IU,,QD,2021,Q4,Diet refusal,,2021,Q4,1,I,,20211102.0,20211112,20211112,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202111002359,ELI LILLY AND CO,,88.0,YR,,F,Y,,,20211112.0,,CN,JP,JP,2021,Q4,Elderly
200618581,20061858,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 u, daily",,,Y,,,,,16.0,IU,,QD,2021,Q4,Apraxia,,2021,Q4,1,I,,20211102.0,20211112,20211112,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202111002359,ELI LILLY AND CO,,88.0,YR,,F,Y,,,20211112.0,,CN,JP,JP,2021,Q4,Elderly
200618581,20061858,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 u, daily",,,Y,,,,,16.0,IU,,QD,2021,Q4,Pemphigoid,,2021,Q4,1,I,,20211102.0,20211112,20211112,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202111002359,ELI LILLY AND CO,,88.0,YR,,F,Y,,,20211112.0,,CN,JP,JP,2021,Q4,Elderly
200618581,20061858,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"8 u, daily",,,Y,,,,,8.0,IU,,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211102.0,20211112,20211112,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202111002359,ELI LILLY AND CO,,88.0,YR,,F,Y,,,20211112.0,,CN,JP,JP,2021,Q4,Elderly
200618581,20061858,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"8 u, daily",,,Y,,,,,8.0,IU,,QD,2021,Q4,Agnosia,,2021,Q4,1,I,,20211102.0,20211112,20211112,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202111002359,ELI LILLY AND CO,,88.0,YR,,F,Y,,,20211112.0,,CN,JP,JP,2021,Q4,Elderly
200618581,20061858,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"8 u, daily",,,Y,,,,,8.0,IU,,QD,2021,Q4,Weight decreased,,2021,Q4,1,I,,20211102.0,20211112,20211112,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202111002359,ELI LILLY AND CO,,88.0,YR,,F,Y,,,20211112.0,,CN,JP,JP,2021,Q4,Elderly
200618581,20061858,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"8 u, daily",,,Y,,,,,8.0,IU,,QD,2021,Q4,Irritability,,2021,Q4,1,I,,20211102.0,20211112,20211112,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202111002359,ELI LILLY AND CO,,88.0,YR,,F,Y,,,20211112.0,,CN,JP,JP,2021,Q4,Elderly
200618581,20061858,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"8 u, daily",,,Y,,,,,8.0,IU,,QD,2021,Q4,Reduced facial expression,,2021,Q4,1,I,,20211102.0,20211112,20211112,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202111002359,ELI LILLY AND CO,,88.0,YR,,F,Y,,,20211112.0,,CN,JP,JP,2021,Q4,Elderly
200618581,20061858,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"8 u, daily",,,Y,,,,,8.0,IU,,QD,2021,Q4,Urinary incontinence,,2021,Q4,1,I,,20211102.0,20211112,20211112,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202111002359,ELI LILLY AND CO,,88.0,YR,,F,Y,,,20211112.0,,CN,JP,JP,2021,Q4,Elderly
200618581,20061858,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"8 u, daily",,,Y,,,,,8.0,IU,,QD,2021,Q4,Fluid intake reduced,,2021,Q4,1,I,,20211102.0,20211112,20211112,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202111002359,ELI LILLY AND CO,,88.0,YR,,F,Y,,,20211112.0,,CN,JP,JP,2021,Q4,Elderly
200618581,20061858,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"8 u, daily",,,Y,,,,,8.0,IU,,QD,2021,Q4,Hypophagia,,2021,Q4,1,I,,20211102.0,20211112,20211112,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202111002359,ELI LILLY AND CO,,88.0,YR,,F,Y,,,20211112.0,,CN,JP,JP,2021,Q4,Elderly
200618581,20061858,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"8 u, daily",,,Y,,,,,8.0,IU,,QD,2021,Q4,Diet refusal,,2021,Q4,1,I,,20211102.0,20211112,20211112,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202111002359,ELI LILLY AND CO,,88.0,YR,,F,Y,,,20211112.0,,CN,JP,JP,2021,Q4,Elderly
200618581,20061858,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"8 u, daily",,,Y,,,,,8.0,IU,,QD,2021,Q4,Apraxia,,2021,Q4,1,I,,20211102.0,20211112,20211112,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202111002359,ELI LILLY AND CO,,88.0,YR,,F,Y,,,20211112.0,,CN,JP,JP,2021,Q4,Elderly
200618581,20061858,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"8 u, daily",,,Y,,,,,8.0,IU,,QD,2021,Q4,Pemphigoid,,2021,Q4,1,I,,20211102.0,20211112,20211112,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202111002359,ELI LILLY AND CO,,88.0,YR,,F,Y,,,20211112.0,,CN,JP,JP,2021,Q4,Elderly
200624592,20062459,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 international unit, qd",,,,,,,210605.0,14.0,IU,Injection,QD,2021,Q4,Malnutrition,,2021,Q4,2,F,20210726.0,20211124.0,20211112,20211201,EXP,,BE-MYLANLABS-2021M1081559,MYLAN,,75.0,YR,,M,Y,,,20211201.0,,CN,BE,BE,2021,Q4,Elderly
200624592,20062459,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 international unit, qd",,,,,,,210605.0,14.0,IU,Injection,QD,2021,Q4,Hypotension,,2021,Q4,2,F,20210726.0,20211124.0,20211112,20211201,EXP,,BE-MYLANLABS-2021M1081559,MYLAN,,75.0,YR,,M,Y,,,20211201.0,,CN,BE,BE,2021,Q4,Elderly
200624592,20062459,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 international unit, qd",,,,,,,210605.0,14.0,IU,Injection,QD,2021,Q4,Pleural effusion,,2021,Q4,2,F,20210726.0,20211124.0,20211112,20211201,EXP,,BE-MYLANLABS-2021M1081559,MYLAN,,75.0,YR,,M,Y,,,20211201.0,,CN,BE,BE,2021,Q4,Elderly
200624592,20062459,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 international unit, qd",,,,,,,210605.0,14.0,IU,Injection,QD,2021,Q4,White blood cell count increased,,2021,Q4,2,F,20210726.0,20211124.0,20211112,20211201,EXP,,BE-MYLANLABS-2021M1081559,MYLAN,,75.0,YR,,M,Y,,,20211201.0,,CN,BE,BE,2021,Q4,Elderly
200624592,20062459,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 international unit, qd",,,,,,,210605.0,14.0,IU,Injection,QD,2021,Q4,Blood glucose decreased,,2021,Q4,2,F,20210726.0,20211124.0,20211112,20211201,EXP,,BE-MYLANLABS-2021M1081559,MYLAN,,75.0,YR,,M,Y,,,20211201.0,,CN,BE,BE,2021,Q4,Elderly
200624592,20062459,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 international unit, qd",,,,,,,210605.0,14.0,IU,Injection,QD,2021,Q4,Pancreatic sarcoma,,2021,Q4,2,F,20210726.0,20211124.0,20211112,20211201,EXP,,BE-MYLANLABS-2021M1081559,MYLAN,,75.0,YR,,M,Y,,,20211201.0,,CN,BE,BE,2021,Q4,Elderly
200624592,20062459,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 international unit, qd",,,,,DF770A,,210605.0,10.0,IU,Injection,QD,2021,Q4,Malnutrition,,2021,Q4,2,F,20210726.0,20211124.0,20211112,20211201,EXP,,BE-MYLANLABS-2021M1081559,MYLAN,,75.0,YR,,M,Y,,,20211201.0,,CN,BE,BE,2021,Q4,Elderly
200624592,20062459,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 international unit, qd",,,,,DF770A,,210605.0,10.0,IU,Injection,QD,2021,Q4,Hypotension,,2021,Q4,2,F,20210726.0,20211124.0,20211112,20211201,EXP,,BE-MYLANLABS-2021M1081559,MYLAN,,75.0,YR,,M,Y,,,20211201.0,,CN,BE,BE,2021,Q4,Elderly
200624592,20062459,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 international unit, qd",,,,,DF770A,,210605.0,10.0,IU,Injection,QD,2021,Q4,Pleural effusion,,2021,Q4,2,F,20210726.0,20211124.0,20211112,20211201,EXP,,BE-MYLANLABS-2021M1081559,MYLAN,,75.0,YR,,M,Y,,,20211201.0,,CN,BE,BE,2021,Q4,Elderly
200624592,20062459,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 international unit, qd",,,,,DF770A,,210605.0,10.0,IU,Injection,QD,2021,Q4,White blood cell count increased,,2021,Q4,2,F,20210726.0,20211124.0,20211112,20211201,EXP,,BE-MYLANLABS-2021M1081559,MYLAN,,75.0,YR,,M,Y,,,20211201.0,,CN,BE,BE,2021,Q4,Elderly
200624592,20062459,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 international unit, qd",,,,,DF770A,,210605.0,10.0,IU,Injection,QD,2021,Q4,Blood glucose decreased,,2021,Q4,2,F,20210726.0,20211124.0,20211112,20211201,EXP,,BE-MYLANLABS-2021M1081559,MYLAN,,75.0,YR,,M,Y,,,20211201.0,,CN,BE,BE,2021,Q4,Elderly
200624592,20062459,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 international unit, qd",,,,,DF770A,,210605.0,10.0,IU,Injection,QD,2021,Q4,Pancreatic sarcoma,,2021,Q4,2,F,20210726.0,20211124.0,20211112,20211201,EXP,,BE-MYLANLABS-2021M1081559,MYLAN,,75.0,YR,,M,Y,,,20211201.0,,CN,BE,BE,2021,Q4,Elderly
200626261,20062626,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,Unknown,,,,,,,,,,,,2021,Q4,COVID-19 pneumonia,,2021,Q4,1,I,20200325.0,20210909.0,20211112,20211112,EXP,,DE-SAMSUNG BIOEPIS-SB-2021-03161,SAMSUNG BIOEPIS,,53.0,YR,A,F,Y,,,20211112.0,,HP,DE,DE,2021,Q4,Adult
200626261,20062626,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,Unknown,,,,,,,,,,,,2021,Q4,Acute respiratory distress syndrome,,2021,Q4,1,I,20200325.0,20210909.0,20211112,20211112,EXP,,DE-SAMSUNG BIOEPIS-SB-2021-03161,SAMSUNG BIOEPIS,,53.0,YR,A,F,Y,,,20211112.0,,HP,DE,DE,2021,Q4,Adult
200637891,20063789,3,C,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,,(Suliqua 100 U / ml + 33 ug / ml) at a dose of 40 units,,,,,,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,1,I,,20211103.0,20211112,20211112,EXP,,CZ-EMD Serono-9278615,EMD SERONO INC,Unknown. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII (Case reports in diabetology). 2021;19(3):34-36.,73.0,YR,E,F,Y,98.0,KG,20211112.0,,MD,CZ,,2021,Q4,Elderly
200637891,20063789,3,C,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,,(Suliqua 100 U / ml + 33 ug / ml) at a dose of 40 units,,,,,,,,,,,,2021,Q4,Abdominal pain lower,,2021,Q4,1,I,,20211103.0,20211112,20211112,EXP,,CZ-EMD Serono-9278615,EMD SERONO INC,Unknown. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII (Case reports in diabetology). 2021;19(3):34-36.,73.0,YR,E,F,Y,98.0,KG,20211112.0,,MD,CZ,,2021,Q4,Elderly
200637891,20063789,3,C,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,,(Suliqua 100 U / ml + 33 ug / ml) at a dose of 40 units,,,,,,,,,,,,2021,Q4,Constipation,,2021,Q4,1,I,,20211103.0,20211112,20211112,EXP,,CZ-EMD Serono-9278615,EMD SERONO INC,Unknown. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII (Case reports in diabetology). 2021;19(3):34-36.,73.0,YR,E,F,Y,98.0,KG,20211112.0,,MD,CZ,,2021,Q4,Elderly
200637891,20063789,3,C,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,,(Suliqua 100 U / ml + 33 ug / ml) at a dose of 40 units,,,,,,,,,,,,2021,Q4,Seizure,,2021,Q4,1,I,,20211103.0,20211112,20211112,EXP,,CZ-EMD Serono-9278615,EMD SERONO INC,Unknown. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII (Case reports in diabetology). 2021;19(3):34-36.,73.0,YR,E,F,Y,98.0,KG,20211112.0,,MD,CZ,,2021,Q4,Elderly
200637891,20063789,3,C,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,,(Suliqua 100 U / ml + 33 ug / ml) at a dose of 40 units,,,,,,,,,,,,2021,Q4,Therapeutic product effect incomplete,,2021,Q4,1,I,,20211103.0,20211112,20211112,EXP,,CZ-EMD Serono-9278615,EMD SERONO INC,Unknown. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII (Case reports in diabetology). 2021;19(3):34-36.,73.0,YR,E,F,Y,98.0,KG,20211112.0,,MD,CZ,,2021,Q4,Elderly
200637891,20063789,4,C,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,,Suliqua at 100 U / ml + 33 ug / ml at a dose of 50 units,,,,,,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,1,I,,20211103.0,20211112,20211112,EXP,,CZ-EMD Serono-9278615,EMD SERONO INC,Unknown. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII (Case reports in diabetology). 2021;19(3):34-36.,73.0,YR,E,F,Y,98.0,KG,20211112.0,,MD,CZ,,2021,Q4,Elderly
200637891,20063789,4,C,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,,Suliqua at 100 U / ml + 33 ug / ml at a dose of 50 units,,,,,,,,,,,,2021,Q4,Abdominal pain lower,,2021,Q4,1,I,,20211103.0,20211112,20211112,EXP,,CZ-EMD Serono-9278615,EMD SERONO INC,Unknown. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII (Case reports in diabetology). 2021;19(3):34-36.,73.0,YR,E,F,Y,98.0,KG,20211112.0,,MD,CZ,,2021,Q4,Elderly
200637891,20063789,4,C,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,,Suliqua at 100 U / ml + 33 ug / ml at a dose of 50 units,,,,,,,,,,,,2021,Q4,Constipation,,2021,Q4,1,I,,20211103.0,20211112,20211112,EXP,,CZ-EMD Serono-9278615,EMD SERONO INC,Unknown. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII (Case reports in diabetology). 2021;19(3):34-36.,73.0,YR,E,F,Y,98.0,KG,20211112.0,,MD,CZ,,2021,Q4,Elderly
200637891,20063789,4,C,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,,Suliqua at 100 U / ml + 33 ug / ml at a dose of 50 units,,,,,,,,,,,,2021,Q4,Seizure,,2021,Q4,1,I,,20211103.0,20211112,20211112,EXP,,CZ-EMD Serono-9278615,EMD SERONO INC,Unknown. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII (Case reports in diabetology). 2021;19(3):34-36.,73.0,YR,E,F,Y,98.0,KG,20211112.0,,MD,CZ,,2021,Q4,Elderly
200637891,20063789,4,C,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,,Suliqua at 100 U / ml + 33 ug / ml at a dose of 50 units,,,,,,,,,,,,2021,Q4,Therapeutic product effect incomplete,,2021,Q4,1,I,,20211103.0,20211112,20211112,EXP,,CZ-EMD Serono-9278615,EMD SERONO INC,Unknown. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII (Case reports in diabetology). 2021;19(3):34-36.,73.0,YR,E,F,Y,98.0,KG,20211112.0,,MD,CZ,,2021,Q4,Elderly
200637891,20063789,5,C,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,,50 units,,,,,,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,1,I,,20211103.0,20211112,20211112,EXP,,CZ-EMD Serono-9278615,EMD SERONO INC,Unknown. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII (Case reports in diabetology). 2021;19(3):34-36.,73.0,YR,E,F,Y,98.0,KG,20211112.0,,MD,CZ,,2021,Q4,Elderly
200637891,20063789,5,C,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,,50 units,,,,,,,,,,,,2021,Q4,Abdominal pain lower,,2021,Q4,1,I,,20211103.0,20211112,20211112,EXP,,CZ-EMD Serono-9278615,EMD SERONO INC,Unknown. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII (Case reports in diabetology). 2021;19(3):34-36.,73.0,YR,E,F,Y,98.0,KG,20211112.0,,MD,CZ,,2021,Q4,Elderly
200637891,20063789,5,C,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,,50 units,,,,,,,,,,,,2021,Q4,Constipation,,2021,Q4,1,I,,20211103.0,20211112,20211112,EXP,,CZ-EMD Serono-9278615,EMD SERONO INC,Unknown. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII (Case reports in diabetology). 2021;19(3):34-36.,73.0,YR,E,F,Y,98.0,KG,20211112.0,,MD,CZ,,2021,Q4,Elderly
200637891,20063789,5,C,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,,50 units,,,,,,,,,,,,2021,Q4,Seizure,,2021,Q4,1,I,,20211103.0,20211112,20211112,EXP,,CZ-EMD Serono-9278615,EMD SERONO INC,Unknown. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII (Case reports in diabetology). 2021;19(3):34-36.,73.0,YR,E,F,Y,98.0,KG,20211112.0,,MD,CZ,,2021,Q4,Elderly
200637891,20063789,5,C,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,,50 units,,,,,,,,,,,,2021,Q4,Therapeutic product effect incomplete,,2021,Q4,1,I,,20211103.0,20211112,20211112,EXP,,CZ-EMD Serono-9278615,EMD SERONO INC,Unknown. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII (Case reports in diabetology). 2021;19(3):34-36.,73.0,YR,E,F,Y,98.0,KG,20211112.0,,MD,CZ,,2021,Q4,Elderly
200637891,20063789,6,C,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,,56 units,,,,,,,,,,,QD,2021,Q4,Diarrhoea,,2021,Q4,1,I,,20211103.0,20211112,20211112,EXP,,CZ-EMD Serono-9278615,EMD SERONO INC,Unknown. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII (Case reports in diabetology). 2021;19(3):34-36.,73.0,YR,E,F,Y,98.0,KG,20211112.0,,MD,CZ,,2021,Q4,Elderly
200637891,20063789,6,C,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,,56 units,,,,,,,,,,,QD,2021,Q4,Abdominal pain lower,,2021,Q4,1,I,,20211103.0,20211112,20211112,EXP,,CZ-EMD Serono-9278615,EMD SERONO INC,Unknown. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII (Case reports in diabetology). 2021;19(3):34-36.,73.0,YR,E,F,Y,98.0,KG,20211112.0,,MD,CZ,,2021,Q4,Elderly
200637891,20063789,6,C,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,,56 units,,,,,,,,,,,QD,2021,Q4,Constipation,,2021,Q4,1,I,,20211103.0,20211112,20211112,EXP,,CZ-EMD Serono-9278615,EMD SERONO INC,Unknown. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII (Case reports in diabetology). 2021;19(3):34-36.,73.0,YR,E,F,Y,98.0,KG,20211112.0,,MD,CZ,,2021,Q4,Elderly
200637891,20063789,6,C,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,,56 units,,,,,,,,,,,QD,2021,Q4,Seizure,,2021,Q4,1,I,,20211103.0,20211112,20211112,EXP,,CZ-EMD Serono-9278615,EMD SERONO INC,Unknown. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII (Case reports in diabetology). 2021;19(3):34-36.,73.0,YR,E,F,Y,98.0,KG,20211112.0,,MD,CZ,,2021,Q4,Elderly
200637891,20063789,6,C,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,,56 units,,,,,,,,,,,QD,2021,Q4,Therapeutic product effect incomplete,,2021,Q4,1,I,,20211103.0,20211112,20211112,EXP,,CZ-EMD Serono-9278615,EMD SERONO INC,Unknown. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII (Case reports in diabetology). 2021;19(3):34-36.,73.0,YR,E,F,Y,98.0,KG,20211112.0,,MD,CZ,,2021,Q4,Elderly
200637891,20063789,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 U / ml,,,,,,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,1,I,,20211103.0,20211112,20211112,EXP,,CZ-EMD Serono-9278615,EMD SERONO INC,Unknown. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII (Case reports in diabetology). 2021;19(3):34-36.,73.0,YR,E,F,Y,98.0,KG,20211112.0,,MD,CZ,,2021,Q4,Elderly
200637891,20063789,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 U / ml,,,,,,,,,,,,2021,Q4,Abdominal pain lower,,2021,Q4,1,I,,20211103.0,20211112,20211112,EXP,,CZ-EMD Serono-9278615,EMD SERONO INC,Unknown. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII (Case reports in diabetology). 2021;19(3):34-36.,73.0,YR,E,F,Y,98.0,KG,20211112.0,,MD,CZ,,2021,Q4,Elderly
200637891,20063789,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 U / ml,,,,,,,,,,,,2021,Q4,Constipation,,2021,Q4,1,I,,20211103.0,20211112,20211112,EXP,,CZ-EMD Serono-9278615,EMD SERONO INC,Unknown. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII (Case reports in diabetology). 2021;19(3):34-36.,73.0,YR,E,F,Y,98.0,KG,20211112.0,,MD,CZ,,2021,Q4,Elderly
200637891,20063789,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 U / ml,,,,,,,,,,,,2021,Q4,Seizure,,2021,Q4,1,I,,20211103.0,20211112,20211112,EXP,,CZ-EMD Serono-9278615,EMD SERONO INC,Unknown. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII (Case reports in diabetology). 2021;19(3):34-36.,73.0,YR,E,F,Y,98.0,KG,20211112.0,,MD,CZ,,2021,Q4,Elderly
200637891,20063789,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 U / ml,,,,,,,,,,,,2021,Q4,Therapeutic product effect incomplete,,2021,Q4,1,I,,20211103.0,20211112,20211112,EXP,,CZ-EMD Serono-9278615,EMD SERONO INC,Unknown. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII (Case reports in diabetology). 2021;19(3):34-36.,73.0,YR,E,F,Y,98.0,KG,20211112.0,,MD,CZ,,2021,Q4,Elderly
200640011,20064001,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,U,,,,,16.0,IU,,QD,2021,Q4,Thrombocytopenia,,2021,Q4,1,I,20210701.0,20211111.0,20211112,20211112,EXP,,NVSC2021KR200053,NOVARTIS,,74.0,YR,,F,Y,,,20211112.0,,MD,KR,KR,2021,Q4,Elderly
200640011,20064001,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,U,,,,,16.0,IU,,QD,2021,Q4,Thrombocytopenia,,2021,Q4,1,I,20210701.0,20211111.0,20211112,20211112,EXP,,NVSC2021KR200053,NOVARTIS,,74.0,YR,,F,Y,,,20211112.0,,MD,KR,KR,2021,Q4,Elderly
200668411,20066841,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,25 IU(dose reduce),,,,,Unknown,,,,,,,2021,Q4,Diabetic retinopathy,,2021,Q4,1,I,,20211103.0,20211115,20211115,EXP,,BR-NOVOPROD-864479,NOVO NORDISK,,43.0,YR,,F,Y,54.0,KG,20211115.0,,MD,BR,BR,2021,Q4,Adult
200668411,20066841,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,25 IU(dose reduce),,,,,Unknown,,,,,,,2021,Q4,Paraesthesia,,2021,Q4,1,I,,20211103.0,20211115,20211115,EXP,,BR-NOVOPROD-864479,NOVO NORDISK,,43.0,YR,,F,Y,54.0,KG,20211115.0,,MD,BR,BR,2021,Q4,Adult
200668411,20066841,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,25 IU(dose reduce),,,,,Unknown,,,,,,,2021,Q4,Road traffic accident,,2021,Q4,1,I,,20211103.0,20211115,20211115,EXP,,BR-NOVOPROD-864479,NOVO NORDISK,,43.0,YR,,F,Y,54.0,KG,20211115.0,,MD,BR,BR,2021,Q4,Adult
200668411,20066841,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,25 IU(dose reduce),,,,,Unknown,,,,,,,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211103.0,20211115,20211115,EXP,,BR-NOVOPROD-864479,NOVO NORDISK,,43.0,YR,,F,Y,54.0,KG,20211115.0,,MD,BR,BR,2021,Q4,Adult
200668411,20066841,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,25 IU(dose reduce),,,,,Unknown,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,1,I,,20211103.0,20211115,20211115,EXP,,BR-NOVOPROD-864479,NOVO NORDISK,,43.0,YR,,F,Y,54.0,KG,20211115.0,,MD,BR,BR,2021,Q4,Adult
200668411,20066841,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,25 IU(dose reduce),,,,,Unknown,,,,,,,2021,Q4,Blindness unilateral,,2021,Q4,1,I,,20211103.0,20211115,20211115,EXP,,BR-NOVOPROD-864479,NOVO NORDISK,,43.0,YR,,F,Y,54.0,KG,20211115.0,,MD,BR,BR,2021,Q4,Adult
200668411,20066841,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"30 IU, qd",,,,,Unknown,,,30.0,IU,,QD,2021,Q4,Diabetic retinopathy,,2021,Q4,1,I,,20211103.0,20211115,20211115,EXP,,BR-NOVOPROD-864479,NOVO NORDISK,,43.0,YR,,F,Y,54.0,KG,20211115.0,,MD,BR,BR,2021,Q4,Adult
200668411,20066841,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"30 IU, qd",,,,,Unknown,,,30.0,IU,,QD,2021,Q4,Paraesthesia,,2021,Q4,1,I,,20211103.0,20211115,20211115,EXP,,BR-NOVOPROD-864479,NOVO NORDISK,,43.0,YR,,F,Y,54.0,KG,20211115.0,,MD,BR,BR,2021,Q4,Adult
200668411,20066841,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"30 IU, qd",,,,,Unknown,,,30.0,IU,,QD,2021,Q4,Road traffic accident,,2021,Q4,1,I,,20211103.0,20211115,20211115,EXP,,BR-NOVOPROD-864479,NOVO NORDISK,,43.0,YR,,F,Y,54.0,KG,20211115.0,,MD,BR,BR,2021,Q4,Adult
200668411,20066841,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"30 IU, qd",,,,,Unknown,,,30.0,IU,,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211103.0,20211115,20211115,EXP,,BR-NOVOPROD-864479,NOVO NORDISK,,43.0,YR,,F,Y,54.0,KG,20211115.0,,MD,BR,BR,2021,Q4,Adult
200668411,20066841,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"30 IU, qd",,,,,Unknown,,,30.0,IU,,QD,2021,Q4,Diarrhoea,,2021,Q4,1,I,,20211103.0,20211115,20211115,EXP,,BR-NOVOPROD-864479,NOVO NORDISK,,43.0,YR,,F,Y,54.0,KG,20211115.0,,MD,BR,BR,2021,Q4,Adult
200668411,20066841,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"30 IU, qd",,,,,Unknown,,,30.0,IU,,QD,2021,Q4,Blindness unilateral,,2021,Q4,1,I,,20211103.0,20211115,20211115,EXP,,BR-NOVOPROD-864479,NOVO NORDISK,,43.0,YR,,F,Y,54.0,KG,20211115.0,,MD,BR,BR,2021,Q4,Adult
200668411,20066841,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,29 IU,,,,,Unknown,,,,,,,2021,Q4,Diabetic retinopathy,,2021,Q4,1,I,,20211103.0,20211115,20211115,EXP,,BR-NOVOPROD-864479,NOVO NORDISK,,43.0,YR,,F,Y,54.0,KG,20211115.0,,MD,BR,BR,2021,Q4,Adult
200668411,20066841,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,29 IU,,,,,Unknown,,,,,,,2021,Q4,Paraesthesia,,2021,Q4,1,I,,20211103.0,20211115,20211115,EXP,,BR-NOVOPROD-864479,NOVO NORDISK,,43.0,YR,,F,Y,54.0,KG,20211115.0,,MD,BR,BR,2021,Q4,Adult
200668411,20066841,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,29 IU,,,,,Unknown,,,,,,,2021,Q4,Road traffic accident,,2021,Q4,1,I,,20211103.0,20211115,20211115,EXP,,BR-NOVOPROD-864479,NOVO NORDISK,,43.0,YR,,F,Y,54.0,KG,20211115.0,,MD,BR,BR,2021,Q4,Adult
200668411,20066841,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,29 IU,,,,,Unknown,,,,,,,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211103.0,20211115,20211115,EXP,,BR-NOVOPROD-864479,NOVO NORDISK,,43.0,YR,,F,Y,54.0,KG,20211115.0,,MD,BR,BR,2021,Q4,Adult
200668411,20066841,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,29 IU,,,,,Unknown,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,1,I,,20211103.0,20211115,20211115,EXP,,BR-NOVOPROD-864479,NOVO NORDISK,,43.0,YR,,F,Y,54.0,KG,20211115.0,,MD,BR,BR,2021,Q4,Adult
200668411,20066841,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,29 IU,,,,,Unknown,,,,,,,2021,Q4,Blindness unilateral,,2021,Q4,1,I,,20211103.0,20211115,20211115,EXP,,BR-NOVOPROD-864479,NOVO NORDISK,,43.0,YR,,F,Y,54.0,KG,20211115.0,,MD,BR,BR,2021,Q4,Adult
200668411,20066841,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,27 IU,,,,,Unknown,,,,,,,2021,Q4,Diabetic retinopathy,,2021,Q4,1,I,,20211103.0,20211115,20211115,EXP,,BR-NOVOPROD-864479,NOVO NORDISK,,43.0,YR,,F,Y,54.0,KG,20211115.0,,MD,BR,BR,2021,Q4,Adult
200668411,20066841,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,27 IU,,,,,Unknown,,,,,,,2021,Q4,Paraesthesia,,2021,Q4,1,I,,20211103.0,20211115,20211115,EXP,,BR-NOVOPROD-864479,NOVO NORDISK,,43.0,YR,,F,Y,54.0,KG,20211115.0,,MD,BR,BR,2021,Q4,Adult
200668411,20066841,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,27 IU,,,,,Unknown,,,,,,,2021,Q4,Road traffic accident,,2021,Q4,1,I,,20211103.0,20211115,20211115,EXP,,BR-NOVOPROD-864479,NOVO NORDISK,,43.0,YR,,F,Y,54.0,KG,20211115.0,,MD,BR,BR,2021,Q4,Adult
200668411,20066841,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,27 IU,,,,,Unknown,,,,,,,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211103.0,20211115,20211115,EXP,,BR-NOVOPROD-864479,NOVO NORDISK,,43.0,YR,,F,Y,54.0,KG,20211115.0,,MD,BR,BR,2021,Q4,Adult
200668411,20066841,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,27 IU,,,,,Unknown,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,1,I,,20211103.0,20211115,20211115,EXP,,BR-NOVOPROD-864479,NOVO NORDISK,,43.0,YR,,F,Y,54.0,KG,20211115.0,,MD,BR,BR,2021,Q4,Adult
200668411,20066841,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,27 IU,,,,,Unknown,,,,,,,2021,Q4,Blindness unilateral,,2021,Q4,1,I,,20211103.0,20211115,20211115,EXP,,BR-NOVOPROD-864479,NOVO NORDISK,,43.0,YR,,F,Y,54.0,KG,20211115.0,,MD,BR,BR,2021,Q4,Adult
200668411,20066841,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 IU, qd",,,,,Unknown,,,28.0,IU,,QD,2021,Q4,Diabetic retinopathy,,2021,Q4,1,I,,20211103.0,20211115,20211115,EXP,,BR-NOVOPROD-864479,NOVO NORDISK,,43.0,YR,,F,Y,54.0,KG,20211115.0,,MD,BR,BR,2021,Q4,Adult
200668411,20066841,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 IU, qd",,,,,Unknown,,,28.0,IU,,QD,2021,Q4,Paraesthesia,,2021,Q4,1,I,,20211103.0,20211115,20211115,EXP,,BR-NOVOPROD-864479,NOVO NORDISK,,43.0,YR,,F,Y,54.0,KG,20211115.0,,MD,BR,BR,2021,Q4,Adult
200668411,20066841,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 IU, qd",,,,,Unknown,,,28.0,IU,,QD,2021,Q4,Road traffic accident,,2021,Q4,1,I,,20211103.0,20211115,20211115,EXP,,BR-NOVOPROD-864479,NOVO NORDISK,,43.0,YR,,F,Y,54.0,KG,20211115.0,,MD,BR,BR,2021,Q4,Adult
200668411,20066841,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 IU, qd",,,,,Unknown,,,28.0,IU,,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211103.0,20211115,20211115,EXP,,BR-NOVOPROD-864479,NOVO NORDISK,,43.0,YR,,F,Y,54.0,KG,20211115.0,,MD,BR,BR,2021,Q4,Adult
200668411,20066841,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 IU, qd",,,,,Unknown,,,28.0,IU,,QD,2021,Q4,Diarrhoea,,2021,Q4,1,I,,20211103.0,20211115,20211115,EXP,,BR-NOVOPROD-864479,NOVO NORDISK,,43.0,YR,,F,Y,54.0,KG,20211115.0,,MD,BR,BR,2021,Q4,Adult
200668411,20066841,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 IU, qd",,,,,Unknown,,,28.0,IU,,QD,2021,Q4,Blindness unilateral,,2021,Q4,1,I,,20211103.0,20211115,20211115,EXP,,BR-NOVOPROD-864479,NOVO NORDISK,,43.0,YR,,F,Y,54.0,KG,20211115.0,,MD,BR,BR,2021,Q4,Adult
200673342,20067334,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,UNK,,,U,,,,,,,Injection,,2021,Q4,Pulmonary toxicity,,2021,Q4,2,F,20211006.0,20211110.0,20211115,20211118,EXP,,JP-009507513-2111JPN001173J,MERCK,,68.0,YR,,M,Y,47.0,KG,20211118.0,,PH,JP,JP,2021,Q4,Elderly
200694201,20069420,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Dialysis,,2021,Q4,1,I,20211117.0,,20211113,20211113,DIR,590727,,FDA-CTU,,53.0,YR,,M,N,80.55,KG,20211113.0,N,MD,US,,2021,Q4,Adult
200694201,20069420,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Chronic kidney disease,,2021,Q4,1,I,20211117.0,,20211113,20211113,DIR,590727,,FDA-CTU,,53.0,YR,,M,N,80.55,KG,20211113.0,N,MD,US,,2021,Q4,Adult
200694201,20069420,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Organising pneumonia,,2021,Q4,1,I,20211117.0,,20211113,20211113,DIR,590727,,FDA-CTU,,53.0,YR,,M,N,80.55,KG,20211113.0,N,MD,US,,2021,Q4,Adult
200694201,20069420,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Acute respiratory failure,,2021,Q4,1,I,20211117.0,,20211113,20211113,DIR,590727,,FDA-CTU,,53.0,YR,,M,N,80.55,KG,20211113.0,N,MD,US,,2021,Q4,Adult
200694201,20069420,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Transplant rejection,,2021,Q4,1,I,20211117.0,,20211113,20211113,DIR,590727,,FDA-CTU,,53.0,YR,,M,N,80.55,KG,20211113.0,N,MD,US,,2021,Q4,Adult
200694541,20069454,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Acute respiratory failure,,2021,Q4,1,I,20200717.0,,20211113,20211113,DIR,590728,,FDA-CTU,,5.0,MON,,M,N,98.1,KG,20211113.0,N,MD,US,,2021,Q4,Child
200694541,20069454,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Chronic kidney disease,,2021,Q4,1,I,20200717.0,,20211113,20211113,DIR,590728,,FDA-CTU,,5.0,MON,,M,N,98.1,KG,20211113.0,N,MD,US,,2021,Q4,Child
200694541,20069454,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Lung transplant rejection,,2021,Q4,1,I,20200717.0,,20211113,20211113,DIR,590728,,FDA-CTU,,5.0,MON,,M,N,98.1,KG,20211113.0,N,MD,US,,2021,Q4,Child
200694541,20069454,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Acute kidney injury,,2021,Q4,1,I,20200717.0,,20211113,20211113,DIR,590728,,FDA-CTU,,5.0,MON,,M,N,98.1,KG,20211113.0,N,MD,US,,2021,Q4,Child
200699331,20069933,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,unk,,,D,,,,,,,,,2021,Q4,Completed suicide,,2021,Q4,1,I,20190101.0,20211101.0,20211115,20211115,EXP,,US-NORTHSTAR HEALTHCARE HOLDINGS-US-2021NSR000116,NORTHSTAR,"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Brooks DE, Dibert KW, et al.. 2019 Annual Report of the American Association of Poison Control Centers^ National Poison Data System (NPDS): 37th Annual Report. Clinical Toxicology. 2020;58(12):1360-1541",61.0,YR,,M,Y,,,20211115.0,,MD,US,US,2021,Q4,Adult
200699331,20069933,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,unk,,,D,,,,,,,,,2021,Q4,Toxicity to various agents,,2021,Q4,1,I,20190101.0,20211101.0,20211115,20211115,EXP,,US-NORTHSTAR HEALTHCARE HOLDINGS-US-2021NSR000116,NORTHSTAR,"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Brooks DE, Dibert KW, et al.. 2019 Annual Report of the American Association of Poison Control Centers^ National Poison Data System (NPDS): 37th Annual Report. Clinical Toxicology. 2020;58(12):1360-1541",61.0,YR,,M,Y,,,20211115.0,,MD,US,US,2021,Q4,Adult
200718502,20071850,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,21081.0,,,,,2021,Q4,Vomiting,,2021,Q4,2,F,20211004.0,20211108.0,20211116,20211117,EXP,,BR-SA-2021SA377290,SANOFI AVENTIS,,23.0,YR,A,F,Y,62.0,KG,20211117.0,,PH,BR,BR,2021,Q4,Youth
200718502,20071850,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,21081.0,,,,,2021,Q4,Ketoacidosis,,2021,Q4,2,F,20211004.0,20211108.0,20211116,20211117,EXP,,BR-SA-2021SA377290,SANOFI AVENTIS,,23.0,YR,A,F,Y,62.0,KG,20211117.0,,PH,BR,BR,2021,Q4,Youth
200718502,20071850,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,21081.0,,,,,2021,Q4,Skin mass,,2021,Q4,2,F,20211004.0,20211108.0,20211116,20211117,EXP,,BR-SA-2021SA377290,SANOFI AVENTIS,,23.0,YR,A,F,Y,62.0,KG,20211117.0,,PH,BR,BR,2021,Q4,Youth
200718502,20071850,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,21081.0,,,,,2021,Q4,Dyspnoea,,2021,Q4,2,F,20211004.0,20211108.0,20211116,20211117,EXP,,BR-SA-2021SA377290,SANOFI AVENTIS,,23.0,YR,A,F,Y,62.0,KG,20211117.0,,PH,BR,BR,2021,Q4,Youth
200745691,20074569,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q4,Akinesia,,2021,Q4,1,I,,20211102.0,20211116,20211116,EXP,,"US-AKCEA THERAPEUTICS, INC.-2021IS001484",AKCEA THERAPEUTICS,,58.0,YR,,M,Y,101.36,KG,20211116.0,,CN,US,US,2021,Q4,Adult
200745691,20074569,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q4,Pain in extremity,,2021,Q4,1,I,,20211102.0,20211116,20211116,EXP,,"US-AKCEA THERAPEUTICS, INC.-2021IS001484",AKCEA THERAPEUTICS,,58.0,YR,,M,Y,101.36,KG,20211116.0,,CN,US,US,2021,Q4,Adult
200745691,20074569,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q4,Dizziness,,2021,Q4,1,I,,20211102.0,20211116,20211116,EXP,,"US-AKCEA THERAPEUTICS, INC.-2021IS001484",AKCEA THERAPEUTICS,,58.0,YR,,M,Y,101.36,KG,20211116.0,,CN,US,US,2021,Q4,Adult
200745691,20074569,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q4,Asthenia,,2021,Q4,1,I,,20211102.0,20211116,20211116,EXP,,"US-AKCEA THERAPEUTICS, INC.-2021IS001484",AKCEA THERAPEUTICS,,58.0,YR,,M,Y,101.36,KG,20211116.0,,CN,US,US,2021,Q4,Adult
200755981,20075598,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Neurotoxicity,,2021,Q4,1,I,20211016.0,,20211116,20211116,DIR,591055,,FDA-CTU,,74.0,YR,,F,N,59.4,KG,20211116.0,N,,US,,2021,Q4,Elderly
200755981,20075598,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Cytokine release syndrome,,2021,Q4,1,I,20211016.0,,20211116,20211116,DIR,591055,,FDA-CTU,,74.0,YR,,F,N,59.4,KG,20211116.0,N,,US,,2021,Q4,Elderly
200762514,20076251,45,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,10 IU,,,,,,,,,,,QD,2021,Q4,Tumour associated fever,,2021,Q4,4,F,20211029.0,20211210.0,20211116,20211216,EXP,,ES-ROCHE-2949758,ROCHE,,70.0,YR,,M,Y,82.0,KG,20211216.0,,MD,ES,,2021,Q4,Elderly
200762514,20076251,45,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,10 IU,,,,,,,,,,,QD,2021,Q4,Pyrexia,,2021,Q4,4,F,20211029.0,20211210.0,20211116,20211216,EXP,,ES-ROCHE-2949758,ROCHE,,70.0,YR,,M,Y,82.0,KG,20211216.0,,MD,ES,,2021,Q4,Elderly
200777161,20077716,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100units/ml 3ml pre-filled SoloStar pens 60 units TEA,,,,,,,,,,Solution for injection,,2021,Q4,Gait disturbance,,2021,Q4,1,I,20210721.0,20211110.0,20211116,20211116,EXP,GB-MHRA-MIDB-d1ac8065-f8bd-4ecf-8ec6-a6b721f76b31,GB-MYLANLABS-2021M1083281,MYLAN,,66.0,YR,,F,Y,,,20211116.0,,PH,GB,GB,2021,Q4,Elderly
200777161,20077716,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100units/ml 3ml pre-filled SoloStar pens 60 units TEA,,,,,,,,,,Solution for injection,,2021,Q4,Dizziness,,2021,Q4,1,I,20210721.0,20211110.0,20211116,20211116,EXP,GB-MHRA-MIDB-d1ac8065-f8bd-4ecf-8ec6-a6b721f76b31,GB-MYLANLABS-2021M1083281,MYLAN,,66.0,YR,,F,Y,,,20211116.0,,PH,GB,GB,2021,Q4,Elderly
200777161,20077716,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100units/ml 3ml pre-filled SoloStar pens 60 units TEA,,,,,,,,,,Solution for injection,,2021,Q4,Dyspnoea,,2021,Q4,1,I,20210721.0,20211110.0,20211116,20211116,EXP,GB-MHRA-MIDB-d1ac8065-f8bd-4ecf-8ec6-a6b721f76b31,GB-MYLANLABS-2021M1083281,MYLAN,,66.0,YR,,F,Y,,,20211116.0,,PH,GB,GB,2021,Q4,Elderly
200777161,20077716,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100units/ml 3ml pre-filled SoloStar pens 60 units TEA,,,,,,,,,,Solution for injection,,2021,Q4,Dysarthria,,2021,Q4,1,I,20210721.0,20211110.0,20211116,20211116,EXP,GB-MHRA-MIDB-d1ac8065-f8bd-4ecf-8ec6-a6b721f76b31,GB-MYLANLABS-2021M1083281,MYLAN,,66.0,YR,,F,Y,,,20211116.0,,PH,GB,GB,2021,Q4,Elderly
200777161,20077716,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100units/ml 3ml pre-filled SoloStar pens 60 units TEA,,,,,,,,,,Solution for injection,,2021,Q4,Salivary hypersecretion,,2021,Q4,1,I,20210721.0,20211110.0,20211116,20211116,EXP,GB-MHRA-MIDB-d1ac8065-f8bd-4ecf-8ec6-a6b721f76b31,GB-MYLANLABS-2021M1083281,MYLAN,,66.0,YR,,F,Y,,,20211116.0,,PH,GB,GB,2021,Q4,Elderly
200777161,20077716,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100units/ml 3ml pre-filled SoloStar pens 60 units TEA,,,,,,,,,,Solution for injection,,2021,Q4,Cerebrovascular accident,,2021,Q4,1,I,20210721.0,20211110.0,20211116,20211116,EXP,GB-MHRA-MIDB-d1ac8065-f8bd-4ecf-8ec6-a6b721f76b31,GB-MYLANLABS-2021M1083281,MYLAN,,66.0,YR,,F,Y,,,20211116.0,,PH,GB,GB,2021,Q4,Elderly
200777161,20077716,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100units/ml 3ml pre-filled SoloStar pens 60 units TEA,,,,,,,,,,Solution for injection,,2021,Q4,Product dispensing error,,2021,Q4,1,I,20210721.0,20211110.0,20211116,20211116,EXP,GB-MHRA-MIDB-d1ac8065-f8bd-4ecf-8ec6-a6b721f76b31,GB-MYLANLABS-2021M1083281,MYLAN,,66.0,YR,,F,Y,,,20211116.0,,PH,GB,GB,2021,Q4,Elderly
200799231,20079923,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 international unit, qd",,,U,U,,,210605.0,18.0,IU,Injection,QD,2021,Q4,Hypoglycaemic coma,,2021,Q4,1,I,20170709.0,20211113.0,20211117,20211117,EXP,IT-MINISAL02-421825,IT-MYLANLABS-2021M1084592,MYLAN,,78.0,YR,,M,Y,,,20211117.0,,MD,IT,IT,2021,Q4,Elderly
200803631,20080363,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 iU, QD",,,D,,,,,50.0,IU,Solution for injection,QD,2021,Q4,Blindness unilateral,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,ES-MYLANLABS-2021M1083709,MYLAN,,67.0,YR,,F,Y,94.2,KG,20211117.0,,CN,ES,ES,2021,Q4,Elderly
200803631,20080363,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 iU, QD",,,D,,,,,50.0,IU,Solution for injection,QD,2021,Q4,Multiple use of single-use product,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,ES-MYLANLABS-2021M1083709,MYLAN,,67.0,YR,,F,Y,94.2,KG,20211117.0,,CN,ES,ES,2021,Q4,Elderly
200803631,20080363,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 iU, QD",,,D,,,,,50.0,IU,Solution for injection,QD,2021,Q4,Post procedural complication,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,ES-MYLANLABS-2021M1083709,MYLAN,,67.0,YR,,F,Y,94.2,KG,20211117.0,,CN,ES,ES,2021,Q4,Elderly
200803631,20080363,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 iU, QD",,,D,,,,,50.0,IU,Solution for injection,QD,2021,Q4,Diarrhoea,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,ES-MYLANLABS-2021M1083709,MYLAN,,67.0,YR,,F,Y,94.2,KG,20211117.0,,CN,ES,ES,2021,Q4,Elderly
200803631,20080363,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 iU, QD",,,D,,,,,50.0,IU,Solution for injection,QD,2021,Q4,Retinal injury,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,ES-MYLANLABS-2021M1083709,MYLAN,,67.0,YR,,F,Y,94.2,KG,20211117.0,,CN,ES,ES,2021,Q4,Elderly
200803631,20080363,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 iU, QD",,,D,,,,,50.0,IU,Solution for injection,QD,2021,Q4,Gait inability,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,ES-MYLANLABS-2021M1083709,MYLAN,,67.0,YR,,F,Y,94.2,KG,20211117.0,,CN,ES,ES,2021,Q4,Elderly
200803631,20080363,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 iU, QD",,,D,,,,,50.0,IU,Solution for injection,QD,2021,Q4,Exercise lack of,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,ES-MYLANLABS-2021M1083709,MYLAN,,67.0,YR,,F,Y,94.2,KG,20211117.0,,CN,ES,ES,2021,Q4,Elderly
200803631,20080363,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 iU, QD",,,D,,,,,50.0,IU,Solution for injection,QD,2021,Q4,Uterine operation,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,ES-MYLANLABS-2021M1083709,MYLAN,,67.0,YR,,F,Y,94.2,KG,20211117.0,,CN,ES,ES,2021,Q4,Elderly
200803631,20080363,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 iU, QD",,,D,,,,,50.0,IU,Solution for injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,ES-MYLANLABS-2021M1083709,MYLAN,,67.0,YR,,F,Y,94.2,KG,20211117.0,,CN,ES,ES,2021,Q4,Elderly
200803631,20080363,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 iU, QD",,,D,,,,,50.0,IU,Solution for injection,QD,2021,Q4,Cataract diabetic,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,ES-MYLANLABS-2021M1083709,MYLAN,,67.0,YR,,F,Y,94.2,KG,20211117.0,,CN,ES,ES,2021,Q4,Elderly
200803631,20080363,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 iU, QD",,,D,,,,,50.0,IU,Solution for injection,QD,2021,Q4,Disability,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,ES-MYLANLABS-2021M1083709,MYLAN,,67.0,YR,,F,Y,94.2,KG,20211117.0,,CN,ES,ES,2021,Q4,Elderly
200803631,20080363,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"52 iU, QD",,,D,,1F939A,,,52.0,IU,Solution for injection,QD,2021,Q4,Blindness unilateral,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,ES-MYLANLABS-2021M1083709,MYLAN,,67.0,YR,,F,Y,94.2,KG,20211117.0,,CN,ES,ES,2021,Q4,Elderly
200803631,20080363,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"52 iU, QD",,,D,,1F939A,,,52.0,IU,Solution for injection,QD,2021,Q4,Multiple use of single-use product,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,ES-MYLANLABS-2021M1083709,MYLAN,,67.0,YR,,F,Y,94.2,KG,20211117.0,,CN,ES,ES,2021,Q4,Elderly
200803631,20080363,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"52 iU, QD",,,D,,1F939A,,,52.0,IU,Solution for injection,QD,2021,Q4,Post procedural complication,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,ES-MYLANLABS-2021M1083709,MYLAN,,67.0,YR,,F,Y,94.2,KG,20211117.0,,CN,ES,ES,2021,Q4,Elderly
200803631,20080363,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"52 iU, QD",,,D,,1F939A,,,52.0,IU,Solution for injection,QD,2021,Q4,Diarrhoea,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,ES-MYLANLABS-2021M1083709,MYLAN,,67.0,YR,,F,Y,94.2,KG,20211117.0,,CN,ES,ES,2021,Q4,Elderly
200803631,20080363,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"52 iU, QD",,,D,,1F939A,,,52.0,IU,Solution for injection,QD,2021,Q4,Retinal injury,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,ES-MYLANLABS-2021M1083709,MYLAN,,67.0,YR,,F,Y,94.2,KG,20211117.0,,CN,ES,ES,2021,Q4,Elderly
200803631,20080363,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"52 iU, QD",,,D,,1F939A,,,52.0,IU,Solution for injection,QD,2021,Q4,Gait inability,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,ES-MYLANLABS-2021M1083709,MYLAN,,67.0,YR,,F,Y,94.2,KG,20211117.0,,CN,ES,ES,2021,Q4,Elderly
200803631,20080363,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"52 iU, QD",,,D,,1F939A,,,52.0,IU,Solution for injection,QD,2021,Q4,Exercise lack of,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,ES-MYLANLABS-2021M1083709,MYLAN,,67.0,YR,,F,Y,94.2,KG,20211117.0,,CN,ES,ES,2021,Q4,Elderly
200803631,20080363,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"52 iU, QD",,,D,,1F939A,,,52.0,IU,Solution for injection,QD,2021,Q4,Uterine operation,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,ES-MYLANLABS-2021M1083709,MYLAN,,67.0,YR,,F,Y,94.2,KG,20211117.0,,CN,ES,ES,2021,Q4,Elderly
200803631,20080363,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"52 iU, QD",,,D,,1F939A,,,52.0,IU,Solution for injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,ES-MYLANLABS-2021M1083709,MYLAN,,67.0,YR,,F,Y,94.2,KG,20211117.0,,CN,ES,ES,2021,Q4,Elderly
200803631,20080363,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"52 iU, QD",,,D,,1F939A,,,52.0,IU,Solution for injection,QD,2021,Q4,Cataract diabetic,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,ES-MYLANLABS-2021M1083709,MYLAN,,67.0,YR,,F,Y,94.2,KG,20211117.0,,CN,ES,ES,2021,Q4,Elderly
200803631,20080363,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"52 iU, QD",,,D,,1F939A,,,52.0,IU,Solution for injection,QD,2021,Q4,Disability,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,ES-MYLANLABS-2021M1083709,MYLAN,,67.0,YR,,F,Y,94.2,KG,20211117.0,,CN,ES,ES,2021,Q4,Elderly
200803631,20080363,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 iU, QD",,,D,,,,,48.0,IU,Solution for injection,QD,2021,Q4,Blindness unilateral,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,ES-MYLANLABS-2021M1083709,MYLAN,,67.0,YR,,F,Y,94.2,KG,20211117.0,,CN,ES,ES,2021,Q4,Elderly
200803631,20080363,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 iU, QD",,,D,,,,,48.0,IU,Solution for injection,QD,2021,Q4,Multiple use of single-use product,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,ES-MYLANLABS-2021M1083709,MYLAN,,67.0,YR,,F,Y,94.2,KG,20211117.0,,CN,ES,ES,2021,Q4,Elderly
200803631,20080363,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 iU, QD",,,D,,,,,48.0,IU,Solution for injection,QD,2021,Q4,Post procedural complication,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,ES-MYLANLABS-2021M1083709,MYLAN,,67.0,YR,,F,Y,94.2,KG,20211117.0,,CN,ES,ES,2021,Q4,Elderly
200803631,20080363,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 iU, QD",,,D,,,,,48.0,IU,Solution for injection,QD,2021,Q4,Diarrhoea,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,ES-MYLANLABS-2021M1083709,MYLAN,,67.0,YR,,F,Y,94.2,KG,20211117.0,,CN,ES,ES,2021,Q4,Elderly
200803631,20080363,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 iU, QD",,,D,,,,,48.0,IU,Solution for injection,QD,2021,Q4,Retinal injury,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,ES-MYLANLABS-2021M1083709,MYLAN,,67.0,YR,,F,Y,94.2,KG,20211117.0,,CN,ES,ES,2021,Q4,Elderly
200803631,20080363,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 iU, QD",,,D,,,,,48.0,IU,Solution for injection,QD,2021,Q4,Gait inability,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,ES-MYLANLABS-2021M1083709,MYLAN,,67.0,YR,,F,Y,94.2,KG,20211117.0,,CN,ES,ES,2021,Q4,Elderly
200803631,20080363,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 iU, QD",,,D,,,,,48.0,IU,Solution for injection,QD,2021,Q4,Exercise lack of,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,ES-MYLANLABS-2021M1083709,MYLAN,,67.0,YR,,F,Y,94.2,KG,20211117.0,,CN,ES,ES,2021,Q4,Elderly
200803631,20080363,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 iU, QD",,,D,,,,,48.0,IU,Solution for injection,QD,2021,Q4,Uterine operation,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,ES-MYLANLABS-2021M1083709,MYLAN,,67.0,YR,,F,Y,94.2,KG,20211117.0,,CN,ES,ES,2021,Q4,Elderly
200803631,20080363,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 iU, QD",,,D,,,,,48.0,IU,Solution for injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,ES-MYLANLABS-2021M1083709,MYLAN,,67.0,YR,,F,Y,94.2,KG,20211117.0,,CN,ES,ES,2021,Q4,Elderly
200803631,20080363,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 iU, QD",,,D,,,,,48.0,IU,Solution for injection,QD,2021,Q4,Cataract diabetic,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,ES-MYLANLABS-2021M1083709,MYLAN,,67.0,YR,,F,Y,94.2,KG,20211117.0,,CN,ES,ES,2021,Q4,Elderly
200803631,20080363,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 iU, QD",,,D,,,,,48.0,IU,Solution for injection,QD,2021,Q4,Disability,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,ES-MYLANLABS-2021M1083709,MYLAN,,67.0,YR,,F,Y,94.2,KG,20211117.0,,CN,ES,ES,2021,Q4,Elderly
200806321,20080632,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Drug-induced liver injury,,2021,Q4,1,I,,20211110.0,20211117,20211117,EXP,,US-MYLANLABS-2021M1084758,MYLAN,"Raza HMA, Wall BM. Effects of pseudohyponatremia on the diagnosis of severe metabolic acidosis. J-Am-Soc-Nephrol 2021;32:381 (plus poster) abstr. PO1164.",43.0,YR,,M,Y,,,20211117.0,,HP,US,US,2021,Q4,Adult
200806321,20080632,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Lactic acidosis,,2021,Q4,1,I,,20211110.0,20211117,20211117,EXP,,US-MYLANLABS-2021M1084758,MYLAN,"Raza HMA, Wall BM. Effects of pseudohyponatremia on the diagnosis of severe metabolic acidosis. J-Am-Soc-Nephrol 2021;32:381 (plus poster) abstr. PO1164.",43.0,YR,,M,Y,,,20211117.0,,HP,US,US,2021,Q4,Adult
200818511,20081851,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Cytokine release syndrome,,2021,Q4,1,I,20210921.0,,20211117,20211117,DIR,591206,,FDA-CTU,,73.0,YR,,M,N,116.1,KG,20211117.0,N,,US,,2021,Q4,Elderly
200818511,20081851,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Neurotoxicity,,2021,Q4,1,I,20210921.0,,20211117,20211117,DIR,591206,,FDA-CTU,,73.0,YR,,M,N,116.1,KG,20211117.0,N,,US,,2021,Q4,Elderly
200825812,20082581,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (1 IE, 0-0-20-0, Injektions-/Infusionslosung)",,,,,,,,,,Injection,,2021,Q4,Diarrhoea,,2021,Q4,2,F,,20211111.0,20211117,20211123,EXP,,DE-MYLANLABS-2021M1083632,MYLAN,,78.0,YR,,M,Y,80.0,KG,20211123.0,,PH,DE,DE,2021,Q4,Elderly
200825812,20082581,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (1 IE, 0-0-20-0, Injektions-/Infusionslosung)",,,,,,,,,,Injection,,2021,Q4,Duodenal ulcer haemorrhage,,2021,Q4,2,F,,20211111.0,20211117,20211123,EXP,,DE-MYLANLABS-2021M1083632,MYLAN,,78.0,YR,,M,Y,80.0,KG,20211123.0,,PH,DE,DE,2021,Q4,Elderly
200825812,20082581,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (1 IE, 0-0-20-0, Injektions-/Infusionslosung)",,,,,,,,,,Injection,,2021,Q4,Haematochezia,,2021,Q4,2,F,,20211111.0,20211117,20211123,EXP,,DE-MYLANLABS-2021M1083632,MYLAN,,78.0,YR,,M,Y,80.0,KG,20211123.0,,PH,DE,DE,2021,Q4,Elderly
200825812,20082581,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (1 IE, 0-0-20-0, Injektions-/Infusionslosung)",,,,,,,,,,Injection,,2021,Q4,Acute kidney injury,,2021,Q4,2,F,,20211111.0,20211117,20211123,EXP,,DE-MYLANLABS-2021M1083632,MYLAN,,78.0,YR,,M,Y,80.0,KG,20211123.0,,PH,DE,DE,2021,Q4,Elderly
200825812,20082581,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (1 IE, 0-0-20-0, Injektions-/Infusionslosung)",,,,,,,,,,Injection,,2021,Q4,Dyspnoea,,2021,Q4,2,F,,20211111.0,20211117,20211123,EXP,,DE-MYLANLABS-2021M1083632,MYLAN,,78.0,YR,,M,Y,80.0,KG,20211123.0,,PH,DE,DE,2021,Q4,Elderly
200825812,20082581,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (1 IE, 0-0-20-0, Injektions-/Infusionslosung)",,,,,,,,,,Injection,,2021,Q4,Oedema peripheral,,2021,Q4,2,F,,20211111.0,20211117,20211123,EXP,,DE-MYLANLABS-2021M1083632,MYLAN,,78.0,YR,,M,Y,80.0,KG,20211123.0,,PH,DE,DE,2021,Q4,Elderly
200829311,20082931,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Schema,,,,,,,,,,,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083719,MYLAN,,75.0,YR,,M,Y,111.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829311,20082931,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Schema,,,,,,,,,,,,2021,Q4,Electrocardiogram abnormal,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083719,MYLAN,,75.0,YR,,M,Y,111.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829311,20082931,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Schema,,,,,,,,,,,,2021,Q4,Wheezing,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083719,MYLAN,,75.0,YR,,M,Y,111.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829311,20082931,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Schema,,,,,,,,,,,,2021,Q4,Systemic infection,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083719,MYLAN,,75.0,YR,,M,Y,111.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829311,20082931,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Schema,,,,,,,,,,,,2021,Q4,Weight increased,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083719,MYLAN,,75.0,YR,,M,Y,111.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829311,20082931,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Schema,,,,,,,,,,,,2021,Q4,Renal impairment,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083719,MYLAN,,75.0,YR,,M,Y,111.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829311,20082931,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Schema,,,,,,,,,,,,2021,Q4,Pyrexia,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083719,MYLAN,,75.0,YR,,M,Y,111.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829311,20082931,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Schema,,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083719,MYLAN,,75.0,YR,,M,Y,111.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829311,20082931,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Schema,,,,,,,,,,,,2021,Q4,Oedema peripheral,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083719,MYLAN,,75.0,YR,,M,Y,111.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829311,20082931,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Schema,,,,,,,,,,,,2021,Q4,Jaundice,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083719,MYLAN,,75.0,YR,,M,Y,111.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829311,20082931,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Schema,,,,,,,,,,,,2021,Q4,Tachypnoea,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083719,MYLAN,,75.0,YR,,M,Y,111.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829311,20082931,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Schema,,,,,,,,,,,,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083719,MYLAN,,75.0,YR,,M,Y,111.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829311,20082931,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Schema,,,,,,,,,,,,2021,Q4,Anaemia,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083719,MYLAN,,75.0,YR,,M,Y,111.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829321,20082932,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Schema,,,,,,,,,,,,2021,Q4,Tachycardia,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083809,MYLAN,,76.0,YR,,M,Y,,,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829321,20082932,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Schema,,,,,,,,,,,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083809,MYLAN,,76.0,YR,,M,Y,,,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829321,20082932,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Schema,,,,,,,,,,,,2021,Q4,Renal impairment,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083809,MYLAN,,76.0,YR,,M,Y,,,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829321,20082932,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Schema,,,,,,,,,,,,2021,Q4,Skin pressure mark,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083809,MYLAN,,76.0,YR,,M,Y,,,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829321,20082932,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Schema,,,,,,,,,,,,2021,Q4,Loss of consciousness,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083809,MYLAN,,76.0,YR,,M,Y,,,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829321,20082932,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Schema,,,,,,,,,,,,2021,Q4,Pupils unequal,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083809,MYLAN,,76.0,YR,,M,Y,,,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829321,20082932,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Schema,,,,,,,,,,,,2021,Q4,Electrocardiogram abnormal,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083809,MYLAN,,76.0,YR,,M,Y,,,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829321,20082932,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Schema,,,,,,,,,,,,2021,Q4,Nuchal rigidity,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083809,MYLAN,,76.0,YR,,M,Y,,,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829321,20082932,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Schema,,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083809,MYLAN,,76.0,YR,,M,Y,,,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829321,20082932,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Schema,,,,,,,,,,,,2021,Q4,Electrolyte imbalance,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083809,MYLAN,,76.0,YR,,M,Y,,,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829321,20082932,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Schema,,,,,,,,,,,,2021,Q4,Hypotension,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083809,MYLAN,,76.0,YR,,M,Y,,,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829321,20082932,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Schema,,,,,,,,,,,,2021,Q4,Anuria,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083809,MYLAN,,76.0,YR,,M,Y,,,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829321,20082932,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Schema,,,,,,,,,,,,2021,Q4,Decubitus ulcer,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083809,MYLAN,,76.0,YR,,M,Y,,,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829321,20082932,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Schema,,,,,,,,,,,,2021,Q4,Disorientation,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083809,MYLAN,,76.0,YR,,M,Y,,,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829321,20082932,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Schema,,,,,,,,,,,,2021,Q4,Hypotonia,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083809,MYLAN,,76.0,YR,,M,Y,,,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829321,20082932,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Schema,,,,,,,,,,,,2021,Q4,Oedema peripheral,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083809,MYLAN,,76.0,YR,,M,Y,,,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829321,20082932,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Schema,,,,,,,,,,,,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083809,MYLAN,,76.0,YR,,M,Y,,,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829321,20082932,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Schema,,,,,,,,,,,,2021,Q4,Condition aggravated,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083809,MYLAN,,76.0,YR,,M,Y,,,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829321,20082932,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Schema,,,,,,,,,,,,2021,Q4,Apnoea,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083809,MYLAN,,76.0,YR,,M,Y,,,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829321,20082932,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Schema,,,,,,,,,,,,2021,Q4,Systemic infection,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083809,MYLAN,,76.0,YR,,M,Y,,,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829321,20082932,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Schema,,,,,,,,,,,,2021,Q4,Cyanosis,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083809,MYLAN,,76.0,YR,,M,Y,,,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829321,20082932,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Schema,,,,,,,,,,,,2021,Q4,Tachypnoea,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083809,MYLAN,,76.0,YR,,M,Y,,,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829321,20082932,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Schema,,,,,,,,,,,,2021,Q4,Skin irritation,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083809,MYLAN,,76.0,YR,,M,Y,,,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829321,20082932,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Schema,,,,,,,,,,,,2021,Q4,Dehydration,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083809,MYLAN,,76.0,YR,,M,Y,,,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829321,20082932,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Schema,,,,,,,,,,,,2021,Q4,Bradypnoea,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083809,MYLAN,,76.0,YR,,M,Y,,,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829542,20082954,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"80 units x 2, at 6 AM and 6PM",,,U,,,,,80.0,IU,,Q12H,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,2,F,,20211210.0,20211117,20211220,EXP,,FI-BAUSCH-BL-2021-037582,BAUSCH AND LOMB,"Kaseva N, Kuitunen M, Laitinen M, Lauhio A, Suomela J. Tukeva diabeetikko osa 1. Suomen Laakarilehti. 2021;76(44):2587.",49.0,YR,,F,Y,144.6,KG,20211220.0,,HP,FI,FI,2021,Q4,Adult
200829682,20082968,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Pyrexia,,2021,Q4,2,F,,20211111.0,20211117,20211124,EXP,,DE-MYLANLABS-2021M1084341,MYLAN,,70.0,YR,,F,Y,,,20211124.0,,PH,DE,DE,2021,Q4,Elderly
200829682,20082968,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,General physical health deterioration,,2021,Q4,2,F,,20211111.0,20211117,20211124,EXP,,DE-MYLANLABS-2021M1084341,MYLAN,,70.0,YR,,F,Y,,,20211124.0,,PH,DE,DE,2021,Q4,Elderly
200829682,20082968,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Systemic infection,,2021,Q4,2,F,,20211111.0,20211117,20211124,EXP,,DE-MYLANLABS-2021M1084341,MYLAN,,70.0,YR,,F,Y,,,20211124.0,,PH,DE,DE,2021,Q4,Elderly
200829682,20082968,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Musculoskeletal pain,,2021,Q4,2,F,,20211111.0,20211117,20211124,EXP,,DE-MYLANLABS-2021M1084341,MYLAN,,70.0,YR,,F,Y,,,20211124.0,,PH,DE,DE,2021,Q4,Elderly
200829682,20082968,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Electrocardiogram abnormal,,2021,Q4,2,F,,20211111.0,20211117,20211124,EXP,,DE-MYLANLABS-2021M1084341,MYLAN,,70.0,YR,,F,Y,,,20211124.0,,PH,DE,DE,2021,Q4,Elderly
200829682,20082968,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Hyperglycaemia,,2021,Q4,2,F,,20211111.0,20211117,20211124,EXP,,DE-MYLANLABS-2021M1084341,MYLAN,,70.0,YR,,F,Y,,,20211124.0,,PH,DE,DE,2021,Q4,Elderly
200829682,20082968,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Weight increased,,2021,Q4,2,F,,20211111.0,20211117,20211124,EXP,,DE-MYLANLABS-2021M1084341,MYLAN,,70.0,YR,,F,Y,,,20211124.0,,PH,DE,DE,2021,Q4,Elderly
200829682,20082968,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Oedema peripheral,,2021,Q4,2,F,,20211111.0,20211117,20211124,EXP,,DE-MYLANLABS-2021M1084341,MYLAN,,70.0,YR,,F,Y,,,20211124.0,,PH,DE,DE,2021,Q4,Elderly
200829682,20082968,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Tachypnoea,,2021,Q4,2,F,,20211111.0,20211117,20211124,EXP,,DE-MYLANLABS-2021M1084341,MYLAN,,70.0,YR,,F,Y,,,20211124.0,,PH,DE,DE,2021,Q4,Elderly
200829682,20082968,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Sepsis,,2021,Q4,2,F,,20211111.0,20211117,20211124,EXP,,DE-MYLANLABS-2021M1084341,MYLAN,,70.0,YR,,F,Y,,,20211124.0,,PH,DE,DE,2021,Q4,Elderly
200829682,20082968,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Renal impairment,,2021,Q4,2,F,,20211111.0,20211117,20211124,EXP,,DE-MYLANLABS-2021M1084341,MYLAN,,70.0,YR,,F,Y,,,20211124.0,,PH,DE,DE,2021,Q4,Elderly
200829682,20082968,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Condition aggravated,,2021,Q4,2,F,,20211111.0,20211117,20211124,EXP,,DE-MYLANLABS-2021M1084341,MYLAN,,70.0,YR,,F,Y,,,20211124.0,,PH,DE,DE,2021,Q4,Elderly
200829682,20082968,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Tachycardia,,2021,Q4,2,F,,20211111.0,20211117,20211124,EXP,,DE-MYLANLABS-2021M1084341,MYLAN,,70.0,YR,,F,Y,,,20211124.0,,PH,DE,DE,2021,Q4,Elderly
200829682,20082968,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Anaemia,,2021,Q4,2,F,,20211111.0,20211117,20211124,EXP,,DE-MYLANLABS-2021M1084341,MYLAN,,70.0,YR,,F,Y,,,20211124.0,,PH,DE,DE,2021,Q4,Elderly
200829711,20082971,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Renal impairment,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1084344,MYLAN,,69.0,YR,,F,Y,93.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829711,20082971,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Hypotension,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1084344,MYLAN,,69.0,YR,,F,Y,93.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829711,20082971,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Tachycardia,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1084344,MYLAN,,69.0,YR,,F,Y,93.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829711,20082971,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Anaemia,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1084344,MYLAN,,69.0,YR,,F,Y,93.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829711,20082971,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Vomiting,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1084344,MYLAN,,69.0,YR,,F,Y,93.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829711,20082971,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Abdominal pain,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1084344,MYLAN,,69.0,YR,,F,Y,93.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829711,20082971,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Sepsis,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1084344,MYLAN,,69.0,YR,,F,Y,93.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829711,20082971,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1084344,MYLAN,,69.0,YR,,F,Y,93.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829711,20082971,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1084344,MYLAN,,69.0,YR,,F,Y,93.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829711,20082971,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Systemic infection,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1084344,MYLAN,,69.0,YR,,F,Y,93.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829711,20082971,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Dysuria,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1084344,MYLAN,,69.0,YR,,F,Y,93.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829711,20082971,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Abdominal distension,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1084344,MYLAN,,69.0,YR,,F,Y,93.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829711,20082971,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Condition aggravated,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1084344,MYLAN,,69.0,YR,,F,Y,93.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829711,20082971,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Pyrexia,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1084344,MYLAN,,69.0,YR,,F,Y,93.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829711,20082971,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Weight increased,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1084344,MYLAN,,69.0,YR,,F,Y,93.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200831782,20083178,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 international unit, qd",,,U,U,,,,22.0,IU,Solution for injection,QD,2021,Q4,Hip fracture,,2021,Q4,2,F,20210801.0,20211130.0,20211117,20211206,EXP,,ES-MYLANLABS-2021M1083713,MYLAN,,84.0,YR,,F,Y,65.0,KG,20211206.0,,CN,ES,ES,2021,Q4,Elderly
200831782,20083178,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 international unit, qd",,,U,U,,,,22.0,IU,Solution for injection,QD,2021,Q4,Dizziness,,2021,Q4,2,F,20210801.0,20211130.0,20211117,20211206,EXP,,ES-MYLANLABS-2021M1083713,MYLAN,,84.0,YR,,F,Y,65.0,KG,20211206.0,,CN,ES,ES,2021,Q4,Elderly
200831782,20083178,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 international unit, qd",,,U,U,,,,22.0,IU,Solution for injection,QD,2021,Q4,Arthralgia,,2021,Q4,2,F,20210801.0,20211130.0,20211117,20211206,EXP,,ES-MYLANLABS-2021M1083713,MYLAN,,84.0,YR,,F,Y,65.0,KG,20211206.0,,CN,ES,ES,2021,Q4,Elderly
200831782,20083178,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 international unit, qd",,,U,U,,,,22.0,IU,Solution for injection,QD,2021,Q4,Fall,,2021,Q4,2,F,20210801.0,20211130.0,20211117,20211206,EXP,,ES-MYLANLABS-2021M1083713,MYLAN,,84.0,YR,,F,Y,65.0,KG,20211206.0,,CN,ES,ES,2021,Q4,Elderly
200831782,20083178,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 international unit, qd",,,U,U,,,,22.0,IU,Solution for injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,2,F,20210801.0,20211130.0,20211117,20211206,EXP,,ES-MYLANLABS-2021M1083713,MYLAN,,84.0,YR,,F,Y,65.0,KG,20211206.0,,CN,ES,ES,2021,Q4,Elderly
200831782,20083178,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 international unit (24 iU, UNK )",,,U,U,,,,24.0,IU,Solution for injection,,2021,Q4,Hip fracture,,2021,Q4,2,F,20210801.0,20211130.0,20211117,20211206,EXP,,ES-MYLANLABS-2021M1083713,MYLAN,,84.0,YR,,F,Y,65.0,KG,20211206.0,,CN,ES,ES,2021,Q4,Elderly
200831782,20083178,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 international unit (24 iU, UNK )",,,U,U,,,,24.0,IU,Solution for injection,,2021,Q4,Dizziness,,2021,Q4,2,F,20210801.0,20211130.0,20211117,20211206,EXP,,ES-MYLANLABS-2021M1083713,MYLAN,,84.0,YR,,F,Y,65.0,KG,20211206.0,,CN,ES,ES,2021,Q4,Elderly
200831782,20083178,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 international unit (24 iU, UNK )",,,U,U,,,,24.0,IU,Solution for injection,,2021,Q4,Arthralgia,,2021,Q4,2,F,20210801.0,20211130.0,20211117,20211206,EXP,,ES-MYLANLABS-2021M1083713,MYLAN,,84.0,YR,,F,Y,65.0,KG,20211206.0,,CN,ES,ES,2021,Q4,Elderly
200831782,20083178,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 international unit (24 iU, UNK )",,,U,U,,,,24.0,IU,Solution for injection,,2021,Q4,Fall,,2021,Q4,2,F,20210801.0,20211130.0,20211117,20211206,EXP,,ES-MYLANLABS-2021M1083713,MYLAN,,84.0,YR,,F,Y,65.0,KG,20211206.0,,CN,ES,ES,2021,Q4,Elderly
200831782,20083178,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 international unit (24 iU, UNK )",,,U,U,,,,24.0,IU,Solution for injection,,2021,Q4,Blood glucose increased,,2021,Q4,2,F,20210801.0,20211130.0,20211117,20211206,EXP,,ES-MYLANLABS-2021M1083713,MYLAN,,84.0,YR,,F,Y,65.0,KG,20211206.0,,CN,ES,ES,2021,Q4,Elderly
200831971,20083197,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 international unit, qd",,,U,U,1F975A,,,6.0,IU,Solution for injection,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,,20211112.0,20211117,20211117,EXP,,ES-MYLANLABS-2021M1084279,MYLAN,,78.0,YR,,F,Y,37.0,KG,20211117.0,,CN,ES,ES,2021,Q4,Elderly
200831971,20083197,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 international unit, qd",,,U,U,1F975A,,,6.0,IU,Solution for injection,QD,2021,Q4,Feeling abnormal,,2021,Q4,1,I,,20211112.0,20211117,20211117,EXP,,ES-MYLANLABS-2021M1084279,MYLAN,,78.0,YR,,F,Y,37.0,KG,20211117.0,,CN,ES,ES,2021,Q4,Elderly
200831971,20083197,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 international unit, qd",,,U,U,1F975A,,,6.0,IU,Solution for injection,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211112.0,20211117,20211117,EXP,,ES-MYLANLABS-2021M1084279,MYLAN,,78.0,YR,,F,Y,37.0,KG,20211117.0,,CN,ES,ES,2021,Q4,Elderly
200831971,20083197,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 international unit, qd",,,U,U,1F975A,,,6.0,IU,Solution for injection,QD,2021,Q4,Diarrhoea,,2021,Q4,1,I,,20211112.0,20211117,20211117,EXP,,ES-MYLANLABS-2021M1084279,MYLAN,,78.0,YR,,F,Y,37.0,KG,20211117.0,,CN,ES,ES,2021,Q4,Elderly
200831971,20083197,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 international unit, qd",,,U,U,1F975A,,,6.0,IU,Solution for injection,QD,2021,Q4,Decreased appetite,,2021,Q4,1,I,,20211112.0,20211117,20211117,EXP,,ES-MYLANLABS-2021M1084279,MYLAN,,78.0,YR,,F,Y,37.0,KG,20211117.0,,CN,ES,ES,2021,Q4,Elderly
200831971,20083197,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 international unit, qd",,,U,U,1F975A,,,6.0,IU,Solution for injection,QD,2021,Q4,Depressed level of consciousness,,2021,Q4,1,I,,20211112.0,20211117,20211117,EXP,,ES-MYLANLABS-2021M1084279,MYLAN,,78.0,YR,,F,Y,37.0,KG,20211117.0,,CN,ES,ES,2021,Q4,Elderly
200832491,20083249,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Tachycardia,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083799,MYLAN,,75.0,YR,,M,Y,90.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200832491,20083249,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Pyrexia,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083799,MYLAN,,75.0,YR,,M,Y,90.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200832491,20083249,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Anaemia,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083799,MYLAN,,75.0,YR,,M,Y,90.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200832491,20083249,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Electrocardiogram abnormal,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083799,MYLAN,,75.0,YR,,M,Y,90.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200832491,20083249,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Hypertension,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083799,MYLAN,,75.0,YR,,M,Y,90.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200832491,20083249,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Condition aggravated,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083799,MYLAN,,75.0,YR,,M,Y,90.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200832491,20083249,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083799,MYLAN,,75.0,YR,,M,Y,90.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200832491,20083249,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Systemic infection,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083799,MYLAN,,75.0,YR,,M,Y,90.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200832491,20083249,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Disorientation,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083799,MYLAN,,75.0,YR,,M,Y,90.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200832491,20083249,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Oedema peripheral,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083799,MYLAN,,75.0,YR,,M,Y,90.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200832491,20083249,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083799,MYLAN,,75.0,YR,,M,Y,90.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200832491,20083249,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Renal impairment,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083799,MYLAN,,75.0,YR,,M,Y,90.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200832491,20083249,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Tachypnoea,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083799,MYLAN,,75.0,YR,,M,Y,90.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200832862,20083286,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (450 E/1.5ml, 0-0-0-6)",,,,,,,,,,Injection,,2021,Q4,Decreased appetite,,2021,Q4,2,F,,20211111.0,20211117,20211122,EXP,,DE-MYLANLABS-2021M1083759,MYLAN,,69.0,YR,,M,Y,61.0,KG,20211122.0,,PH,DE,DE,2021,Q4,Elderly
200832862,20083286,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (450 E/1.5ml, 0-0-0-6)",,,,,,,,,,Injection,,2021,Q4,Pyrexia,,2021,Q4,2,F,,20211111.0,20211117,20211122,EXP,,DE-MYLANLABS-2021M1083759,MYLAN,,69.0,YR,,M,Y,61.0,KG,20211122.0,,PH,DE,DE,2021,Q4,Elderly
200832862,20083286,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (450 E/1.5ml, 0-0-0-6)",,,,,,,,,,Injection,,2021,Q4,Fluid intake reduced,,2021,Q4,2,F,,20211111.0,20211117,20211122,EXP,,DE-MYLANLABS-2021M1083759,MYLAN,,69.0,YR,,M,Y,61.0,KG,20211122.0,,PH,DE,DE,2021,Q4,Elderly
200832862,20083286,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (450 E/1.5ml, 0-0-0-6)",,,,,,,,,,Injection,,2021,Q4,Diarrhoea,,2021,Q4,2,F,,20211111.0,20211117,20211122,EXP,,DE-MYLANLABS-2021M1083759,MYLAN,,69.0,YR,,M,Y,61.0,KG,20211122.0,,PH,DE,DE,2021,Q4,Elderly
200832862,20083286,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (450 E/1.5ml, 0-0-0-6)",,,,,,,,,,Injection,,2021,Q4,Fine motor skill dysfunction,,2021,Q4,2,F,,20211111.0,20211117,20211122,EXP,,DE-MYLANLABS-2021M1083759,MYLAN,,69.0,YR,,M,Y,61.0,KG,20211122.0,,PH,DE,DE,2021,Q4,Elderly
200833351,20083335,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IU, 0-0-0-22, pre-filled syringes",,,,,,,,,,Injection,,2021,Q4,Insomnia,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083879,MYLAN,,77.0,YR,,F,Y,79.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200833351,20083335,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IU, 0-0-0-22, pre-filled syringes",,,,,,,,,,Injection,,2021,Q4,Tachycardia,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083879,MYLAN,,77.0,YR,,F,Y,79.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200833351,20083335,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IU, 0-0-0-22, pre-filled syringes",,,,,,,,,,Injection,,2021,Q4,Fatigue,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083879,MYLAN,,77.0,YR,,F,Y,79.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200833351,20083335,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IU, 0-0-0-22, pre-filled syringes",,,,,,,,,,Injection,,2021,Q4,Atrial fibrillation,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083879,MYLAN,,77.0,YR,,F,Y,79.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200833351,20083335,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IU, 0-0-0-22, pre-filled syringes",,,,,,,,,,Injection,,2021,Q4,Dehydration,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083879,MYLAN,,77.0,YR,,F,Y,79.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200833351,20083335,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IU, 0-0-0-22, pre-filled syringes",,,,,,,,,,Injection,,2021,Q4,Fall,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083879,MYLAN,,77.0,YR,,F,Y,79.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200833411,20083341,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-12, Zylinderampullen",,,,,,,,,,Injection,,2021,Q4,Acute kidney injury,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083872,MYLAN,,55.0,YR,,F,Y,62.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Adult
200833411,20083341,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-12, Zylinderampullen",,,,,,,,,,Injection,,2021,Q4,Headache,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083872,MYLAN,,55.0,YR,,F,Y,62.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Adult
200833411,20083341,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-12, Zylinderampullen",,,,,,,,,,Injection,,2021,Q4,Decreased appetite,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083872,MYLAN,,55.0,YR,,F,Y,62.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Adult
200833411,20083341,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-12, Zylinderampullen",,,,,,,,,,Injection,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083872,MYLAN,,55.0,YR,,F,Y,62.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Adult
200833411,20083341,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-12, Zylinderampullen",,,,,,,,,,Injection,,2021,Q4,Jaundice,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083872,MYLAN,,55.0,YR,,F,Y,62.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Adult
200833411,20083341,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-12, Zylinderampullen",,,,,,,,,,Injection,,2021,Q4,Fatigue,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083872,MYLAN,,55.0,YR,,F,Y,62.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Adult
200833411,20083341,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-12, Zylinderampullen",,,,,,,,,,Injection,,2021,Q4,Nausea,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083872,MYLAN,,55.0,YR,,F,Y,62.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Adult
200835211,20083521,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Death,,2021,Q4,1,I,,20211115.0,20211118,20211118,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-122827,BRISTOL MYERS SQUIBB,,45.0,YR,,M,Y,,,20211118.0,,HP,US,US,2021,Q4,Adult
200838332,20083833,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"U100, (Iglar100) 12 units per day",,,,,,,,,,,,2021,Q4,Off label use,,2021,Q4,2,F,,20211118.0,20211118,20211203,PER,,TR-LUPIN PHARMACEUTICALS INC.-2021-22234,LUPIN,"Topaloglu US, Eren E, Simsek Y. Management of type 2 diabetes mellitus in a patient with COVID-19: The window of insulin glargine U300. Klimik Dergisi. 2021;34(2):144-146",51.0,YR,,M,Y,,,20211203.0,,HP,TR,TR,2021,Q4,Adult
200838332,20083833,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"U300, (Iglar 300)",,,,,,,,,,,,2021,Q4,Off label use,,2021,Q4,2,F,,20211118.0,20211118,20211203,PER,,TR-LUPIN PHARMACEUTICALS INC.-2021-22234,LUPIN,"Topaloglu US, Eren E, Simsek Y. Management of type 2 diabetes mellitus in a patient with COVID-19: The window of insulin glargine U300. Klimik Dergisi. 2021;34(2):144-146",51.0,YR,,M,Y,,,20211203.0,,HP,TR,TR,2021,Q4,Adult
200838332,20083833,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"U100, (Iglar100) 12 units per day and  increased as 4-6 units / days, up to 28 units / day dose",,,,,,,,,,,,2021,Q4,Off label use,,2021,Q4,2,F,,20211118.0,20211118,20211203,PER,,TR-LUPIN PHARMACEUTICALS INC.-2021-22234,LUPIN,"Topaloglu US, Eren E, Simsek Y. Management of type 2 diabetes mellitus in a patient with COVID-19: The window of insulin glargine U300. Klimik Dergisi. 2021;34(2):144-146",51.0,YR,,M,Y,,,20211203.0,,HP,TR,TR,2021,Q4,Adult
200846491,20084649,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Drug level increased,,2021,Q4,1,I,,20211110.0,20211118,20211118,EXP,,US-APOTEX-2021AP045415,APOTEX,"Raza HMA, Wall BM.. Effects of pseudohyponatremia on the diagnosis of severe metabolic acidosis. Journal of the American Society of Nephrology. 2021;32:381",43.0,YR,,M,Y,,,20211118.0,,HP,US,US,2021,Q4,Adult
200846491,20084649,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Drug-induced liver injury,,2021,Q4,1,I,,20211110.0,20211118,20211118,EXP,,US-APOTEX-2021AP045415,APOTEX,"Raza HMA, Wall BM.. Effects of pseudohyponatremia on the diagnosis of severe metabolic acidosis. Journal of the American Society of Nephrology. 2021;32:381",43.0,YR,,M,Y,,,20211118.0,,HP,US,US,2021,Q4,Adult
200855821,20085582,3,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,210605.0,,,,,2021,Q4,Drug ineffective for unapproved indication,,2021,Q4,1,I,,20211111.0,20211118,20211118,EXP,,MA-MYLANLABS-2021M1085080,MYLAN,"Musoni L, Ezzouine H, Ettouki O, Mansour A, Nour M, Elkhaouri I, et al. Polymyositis and covid-19: A morbide association (a case report). Ann-Med-Surgery 2021;null:null.",62.0,YR,,F,Y,,,20211118.0,,HP,MA,MA,2021,Q4,Adult
200855821,20085582,3,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,210605.0,,,,,2021,Q4,Off label use,,2021,Q4,1,I,,20211111.0,20211118,20211118,EXP,,MA-MYLANLABS-2021M1085080,MYLAN,"Musoni L, Ezzouine H, Ettouki O, Mansour A, Nour M, Elkhaouri I, et al. Polymyositis and covid-19: A morbide association (a case report). Ann-Med-Surgery 2021;null:null.",62.0,YR,,F,Y,,,20211118.0,,HP,MA,MA,2021,Q4,Adult
200865591,20086559,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 units/mL solution for injection 3 mL pre-filled SoloStar pens 60 units TEA,,,U,,,,,,,Solution for injection in pre-filled pen,,2021,Q4,Dysarthria,,2021,Q4,1,I,20210721.0,20211110.0,20211118,20211118,EXP,GB-MHRA-MIDB-d1ac8065-f8bd-4ecf-8ec6-a6b721f76b31,GB-TORRENT-00026811,TORRENT,,66.0,YR,E,F,Y,,,20211118.0,,PH,GB,GB,2021,Q4,Elderly
200865591,20086559,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 units/mL solution for injection 3 mL pre-filled SoloStar pens 60 units TEA,,,U,,,,,,,Solution for injection in pre-filled pen,,2021,Q4,Cerebrovascular accident,,2021,Q4,1,I,20210721.0,20211110.0,20211118,20211118,EXP,GB-MHRA-MIDB-d1ac8065-f8bd-4ecf-8ec6-a6b721f76b31,GB-TORRENT-00026811,TORRENT,,66.0,YR,E,F,Y,,,20211118.0,,PH,GB,GB,2021,Q4,Elderly
200865591,20086559,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 units/mL solution for injection 3 mL pre-filled SoloStar pens 60 units TEA,,,U,,,,,,,Solution for injection in pre-filled pen,,2021,Q4,Dyspnoea,,2021,Q4,1,I,20210721.0,20211110.0,20211118,20211118,EXP,GB-MHRA-MIDB-d1ac8065-f8bd-4ecf-8ec6-a6b721f76b31,GB-TORRENT-00026811,TORRENT,,66.0,YR,E,F,Y,,,20211118.0,,PH,GB,GB,2021,Q4,Elderly
200865591,20086559,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 units/mL solution for injection 3 mL pre-filled SoloStar pens 60 units TEA,,,U,,,,,,,Solution for injection in pre-filled pen,,2021,Q4,Salivary hypersecretion,,2021,Q4,1,I,20210721.0,20211110.0,20211118,20211118,EXP,GB-MHRA-MIDB-d1ac8065-f8bd-4ecf-8ec6-a6b721f76b31,GB-TORRENT-00026811,TORRENT,,66.0,YR,E,F,Y,,,20211118.0,,PH,GB,GB,2021,Q4,Elderly
200865591,20086559,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 units/mL solution for injection 3 mL pre-filled SoloStar pens 60 units TEA,,,U,,,,,,,Solution for injection in pre-filled pen,,2021,Q4,Dizziness,,2021,Q4,1,I,20210721.0,20211110.0,20211118,20211118,EXP,GB-MHRA-MIDB-d1ac8065-f8bd-4ecf-8ec6-a6b721f76b31,GB-TORRENT-00026811,TORRENT,,66.0,YR,E,F,Y,,,20211118.0,,PH,GB,GB,2021,Q4,Elderly
200865591,20086559,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 units/mL solution for injection 3 mL pre-filled SoloStar pens 60 units TEA,,,U,,,,,,,Solution for injection in pre-filled pen,,2021,Q4,Product dispensing error,,2021,Q4,1,I,20210721.0,20211110.0,20211118,20211118,EXP,GB-MHRA-MIDB-d1ac8065-f8bd-4ecf-8ec6-a6b721f76b31,GB-TORRENT-00026811,TORRENT,,66.0,YR,E,F,Y,,,20211118.0,,PH,GB,GB,2021,Q4,Elderly
200865591,20086559,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 units/mL solution for injection 3 mL pre-filled SoloStar pens 60 units TEA,,,U,,,,,,,Solution for injection in pre-filled pen,,2021,Q4,Gait disturbance,,2021,Q4,1,I,20210721.0,20211110.0,20211118,20211118,EXP,GB-MHRA-MIDB-d1ac8065-f8bd-4ecf-8ec6-a6b721f76b31,GB-TORRENT-00026811,TORRENT,,66.0,YR,E,F,Y,,,20211118.0,,PH,GB,GB,2021,Q4,Elderly
200873011,20087301,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 iU, QD(injected every night)",,,U,,,,,20.0,IU,,QD,2021,Q4,Hypoaesthesia,,2021,Q4,1,I,,20211110.0,20211118,20211118,EXP,,CN-SA-2021SA380633,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20211118.0,,CN,CN,CN,2021,Q4,Elderly
200873011,20087301,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 iU, QD(injected every night)",,,U,,,,,20.0,IU,,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,,20211110.0,20211118,20211118,EXP,,CN-SA-2021SA380633,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20211118.0,,CN,CN,CN,2021,Q4,Elderly
200873011,20087301,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 iU, QD(injected every night)",,,U,,,,,20.0,IU,,QD,2021,Q4,Coronary artery disease,,2021,Q4,1,I,,20211110.0,20211118,20211118,EXP,,CN-SA-2021SA380633,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20211118.0,,CN,CN,CN,2021,Q4,Elderly
200873011,20087301,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 iU, QD(injected every night)",,,U,,,,,20.0,IU,,QD,2021,Q4,Pruritus,,2021,Q4,1,I,,20211110.0,20211118,20211118,EXP,,CN-SA-2021SA380633,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20211118.0,,CN,CN,CN,2021,Q4,Elderly
200873011,20087301,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 iU, QD(injected every night)",,,U,,,,,20.0,IU,,QD,2021,Q4,Retinal haemorrhage,,2021,Q4,1,I,,20211110.0,20211118,20211118,EXP,,CN-SA-2021SA380633,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20211118.0,,CN,CN,CN,2021,Q4,Elderly
200873611,20087361,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Arteriosclerosis coronary artery,,2021,Q4,1,I,20180101.0,20211109.0,20211118,20211118,EXP,,DE-TAKEDA-2021TUS071994,TAKEDA,,73.0,YR,,M,Y,,,20211118.0,,MD,DE,DE,2021,Q4,Elderly
200873611,20087361,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Acute lymphocytic leukaemia recurrent,,2021,Q4,1,I,20180101.0,20211109.0,20211118,20211118,EXP,,DE-TAKEDA-2021TUS071994,TAKEDA,,73.0,YR,,M,Y,,,20211118.0,,MD,DE,DE,2021,Q4,Elderly
200873611,20087361,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Haemangioma,,2021,Q4,1,I,20180101.0,20211109.0,20211118,20211118,EXP,,DE-TAKEDA-2021TUS071994,TAKEDA,,73.0,YR,,M,Y,,,20211118.0,,MD,DE,DE,2021,Q4,Elderly
200873611,20087361,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Adrenomegaly,,2021,Q4,1,I,20180101.0,20211109.0,20211118,20211118,EXP,,DE-TAKEDA-2021TUS071994,TAKEDA,,73.0,YR,,M,Y,,,20211118.0,,MD,DE,DE,2021,Q4,Elderly
200873611,20087361,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Gamma-glutamyltransferase increased,,2021,Q4,1,I,20180101.0,20211109.0,20211118,20211118,EXP,,DE-TAKEDA-2021TUS071994,TAKEDA,,73.0,YR,,M,Y,,,20211118.0,,MD,DE,DE,2021,Q4,Elderly
200873611,20087361,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Pancreatitis chronic,,2021,Q4,1,I,20180101.0,20211109.0,20211118,20211118,EXP,,DE-TAKEDA-2021TUS071994,TAKEDA,,73.0,YR,,M,Y,,,20211118.0,,MD,DE,DE,2021,Q4,Elderly
200873611,20087361,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Blood chloride increased,,2021,Q4,1,I,20180101.0,20211109.0,20211118,20211118,EXP,,DE-TAKEDA-2021TUS071994,TAKEDA,,73.0,YR,,M,Y,,,20211118.0,,MD,DE,DE,2021,Q4,Elderly
200873611,20087361,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Cytokine release syndrome,,2021,Q4,1,I,20180101.0,20211109.0,20211118,20211118,EXP,,DE-TAKEDA-2021TUS071994,TAKEDA,,73.0,YR,,M,Y,,,20211118.0,,MD,DE,DE,2021,Q4,Elderly
200873611,20087361,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Weight decreased,,2021,Q4,1,I,20180101.0,20211109.0,20211118,20211118,EXP,,DE-TAKEDA-2021TUS071994,TAKEDA,,73.0,YR,,M,Y,,,20211118.0,,MD,DE,DE,2021,Q4,Elderly
200873611,20087361,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Serum ferritin increased,,2021,Q4,1,I,20180101.0,20211109.0,20211118,20211118,EXP,,DE-TAKEDA-2021TUS071994,TAKEDA,,73.0,YR,,M,Y,,,20211118.0,,MD,DE,DE,2021,Q4,Elderly
200873611,20087361,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Euphoric mood,,2021,Q4,1,I,20180101.0,20211109.0,20211118,20211118,EXP,,DE-TAKEDA-2021TUS071994,TAKEDA,,73.0,YR,,M,Y,,,20211118.0,,MD,DE,DE,2021,Q4,Elderly
200873611,20087361,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Lymphadenopathy,,2021,Q4,1,I,20180101.0,20211109.0,20211118,20211118,EXP,,DE-TAKEDA-2021TUS071994,TAKEDA,,73.0,YR,,M,Y,,,20211118.0,,MD,DE,DE,2021,Q4,Elderly
200873611,20087361,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Blood bilirubin increased,,2021,Q4,1,I,20180101.0,20211109.0,20211118,20211118,EXP,,DE-TAKEDA-2021TUS071994,TAKEDA,,73.0,YR,,M,Y,,,20211118.0,,MD,DE,DE,2021,Q4,Elderly
200873611,20087361,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Procalcitonin increased,,2021,Q4,1,I,20180101.0,20211109.0,20211118,20211118,EXP,,DE-TAKEDA-2021TUS071994,TAKEDA,,73.0,YR,,M,Y,,,20211118.0,,MD,DE,DE,2021,Q4,Elderly
200873611,20087361,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Activated partial thromboplastin time prolonged,,2021,Q4,1,I,20180101.0,20211109.0,20211118,20211118,EXP,,DE-TAKEDA-2021TUS071994,TAKEDA,,73.0,YR,,M,Y,,,20211118.0,,MD,DE,DE,2021,Q4,Elderly
200873611,20087361,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Acute lymphocytic leukaemia,,2021,Q4,1,I,20180101.0,20211109.0,20211118,20211118,EXP,,DE-TAKEDA-2021TUS071994,TAKEDA,,73.0,YR,,M,Y,,,20211118.0,,MD,DE,DE,2021,Q4,Elderly
200873611,20087361,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Blood calcium increased,,2021,Q4,1,I,20180101.0,20211109.0,20211118,20211118,EXP,,DE-TAKEDA-2021TUS071994,TAKEDA,,73.0,YR,,M,Y,,,20211118.0,,MD,DE,DE,2021,Q4,Elderly
200873611,20087361,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Costal cartilage fracture,,2021,Q4,1,I,20180101.0,20211109.0,20211118,20211118,EXP,,DE-TAKEDA-2021TUS071994,TAKEDA,,73.0,YR,,M,Y,,,20211118.0,,MD,DE,DE,2021,Q4,Elderly
200873611,20087361,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Gastritis,,2021,Q4,1,I,20180101.0,20211109.0,20211118,20211118,EXP,,DE-TAKEDA-2021TUS071994,TAKEDA,,73.0,YR,,M,Y,,,20211118.0,,MD,DE,DE,2021,Q4,Elderly
200873611,20087361,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Enterococcal infection,,2021,Q4,1,I,20180101.0,20211109.0,20211118,20211118,EXP,,DE-TAKEDA-2021TUS071994,TAKEDA,,73.0,YR,,M,Y,,,20211118.0,,MD,DE,DE,2021,Q4,Elderly
200873611,20087361,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Lymphocyte count decreased,,2021,Q4,1,I,20180101.0,20211109.0,20211118,20211118,EXP,,DE-TAKEDA-2021TUS071994,TAKEDA,,73.0,YR,,M,Y,,,20211118.0,,MD,DE,DE,2021,Q4,Elderly
200873611,20087361,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Escherichia urinary tract infection,,2021,Q4,1,I,20180101.0,20211109.0,20211118,20211118,EXP,,DE-TAKEDA-2021TUS071994,TAKEDA,,73.0,YR,,M,Y,,,20211118.0,,MD,DE,DE,2021,Q4,Elderly
200873611,20087361,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Malignant neoplasm progression,,2021,Q4,1,I,20180101.0,20211109.0,20211118,20211118,EXP,,DE-TAKEDA-2021TUS071994,TAKEDA,,73.0,YR,,M,Y,,,20211118.0,,MD,DE,DE,2021,Q4,Elderly
200873611,20087361,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Neutropenia,,2021,Q4,1,I,20180101.0,20211109.0,20211118,20211118,EXP,,DE-TAKEDA-2021TUS071994,TAKEDA,,73.0,YR,,M,Y,,,20211118.0,,MD,DE,DE,2021,Q4,Elderly
200873611,20087361,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Myelocyte count increased,,2021,Q4,1,I,20180101.0,20211109.0,20211118,20211118,EXP,,DE-TAKEDA-2021TUS071994,TAKEDA,,73.0,YR,,M,Y,,,20211118.0,,MD,DE,DE,2021,Q4,Elderly
200873611,20087361,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Prothrombin time prolonged,,2021,Q4,1,I,20180101.0,20211109.0,20211118,20211118,EXP,,DE-TAKEDA-2021TUS071994,TAKEDA,,73.0,YR,,M,Y,,,20211118.0,,MD,DE,DE,2021,Q4,Elderly
200873611,20087361,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,C-reactive protein increased,,2021,Q4,1,I,20180101.0,20211109.0,20211118,20211118,EXP,,DE-TAKEDA-2021TUS071994,TAKEDA,,73.0,YR,,M,Y,,,20211118.0,,MD,DE,DE,2021,Q4,Elderly
200873611,20087361,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Monocyte count decreased,,2021,Q4,1,I,20180101.0,20211109.0,20211118,20211118,EXP,,DE-TAKEDA-2021TUS071994,TAKEDA,,73.0,YR,,M,Y,,,20211118.0,,MD,DE,DE,2021,Q4,Elderly
200873611,20087361,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Herpes simplex,,2021,Q4,1,I,20180101.0,20211109.0,20211118,20211118,EXP,,DE-TAKEDA-2021TUS071994,TAKEDA,,73.0,YR,,M,Y,,,20211118.0,,MD,DE,DE,2021,Q4,Elderly
200873611,20087361,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Metamyelocyte count increased,,2021,Q4,1,I,20180101.0,20211109.0,20211118,20211118,EXP,,DE-TAKEDA-2021TUS071994,TAKEDA,,73.0,YR,,M,Y,,,20211118.0,,MD,DE,DE,2021,Q4,Elderly
200873611,20087361,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Febrile infection,,2021,Q4,1,I,20180101.0,20211109.0,20211118,20211118,EXP,,DE-TAKEDA-2021TUS071994,TAKEDA,,73.0,YR,,M,Y,,,20211118.0,,MD,DE,DE,2021,Q4,Elderly
200873611,20087361,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20180101.0,20211109.0,20211118,20211118,EXP,,DE-TAKEDA-2021TUS071994,TAKEDA,,73.0,YR,,M,Y,,,20211118.0,,MD,DE,DE,2021,Q4,Elderly
200873611,20087361,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Platelet count decreased,,2021,Q4,1,I,20180101.0,20211109.0,20211118,20211118,EXP,,DE-TAKEDA-2021TUS071994,TAKEDA,,73.0,YR,,M,Y,,,20211118.0,,MD,DE,DE,2021,Q4,Elderly
200873611,20087361,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Hepatic calcification,,2021,Q4,1,I,20180101.0,20211109.0,20211118,20211118,EXP,,DE-TAKEDA-2021TUS071994,TAKEDA,,73.0,YR,,M,Y,,,20211118.0,,MD,DE,DE,2021,Q4,Elderly
200873611,20087361,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,White blood cell count increased,,2021,Q4,1,I,20180101.0,20211109.0,20211118,20211118,EXP,,DE-TAKEDA-2021TUS071994,TAKEDA,,73.0,YR,,M,Y,,,20211118.0,,MD,DE,DE,2021,Q4,Elderly
200873611,20087361,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Hypotension,,2021,Q4,1,I,20180101.0,20211109.0,20211118,20211118,EXP,,DE-TAKEDA-2021TUS071994,TAKEDA,,73.0,YR,,M,Y,,,20211118.0,,MD,DE,DE,2021,Q4,Elderly
200873611,20087361,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Lactose intolerance,,2021,Q4,1,I,20180101.0,20211109.0,20211118,20211118,EXP,,DE-TAKEDA-2021TUS071994,TAKEDA,,73.0,YR,,M,Y,,,20211118.0,,MD,DE,DE,2021,Q4,Elderly
200873611,20087361,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Neutrophil count decreased,,2021,Q4,1,I,20180101.0,20211109.0,20211118,20211118,EXP,,DE-TAKEDA-2021TUS071994,TAKEDA,,73.0,YR,,M,Y,,,20211118.0,,MD,DE,DE,2021,Q4,Elderly
200873611,20087361,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Blood lactate dehydrogenase increased,,2021,Q4,1,I,20180101.0,20211109.0,20211118,20211118,EXP,,DE-TAKEDA-2021TUS071994,TAKEDA,,73.0,YR,,M,Y,,,20211118.0,,MD,DE,DE,2021,Q4,Elderly
200873611,20087361,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Red cell distribution width increased,,2021,Q4,1,I,20180101.0,20211109.0,20211118,20211118,EXP,,DE-TAKEDA-2021TUS071994,TAKEDA,,73.0,YR,,M,Y,,,20211118.0,,MD,DE,DE,2021,Q4,Elderly
200873611,20087361,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Diaphragmatic disorder,,2021,Q4,1,I,20180101.0,20211109.0,20211118,20211118,EXP,,DE-TAKEDA-2021TUS071994,TAKEDA,,73.0,YR,,M,Y,,,20211118.0,,MD,DE,DE,2021,Q4,Elderly
200873611,20087361,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Blast cells present,,2021,Q4,1,I,20180101.0,20211109.0,20211118,20211118,EXP,,DE-TAKEDA-2021TUS071994,TAKEDA,,73.0,YR,,M,Y,,,20211118.0,,MD,DE,DE,2021,Q4,Elderly
200873611,20087361,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Pyrexia,,2021,Q4,1,I,20180101.0,20211109.0,20211118,20211118,EXP,,DE-TAKEDA-2021TUS071994,TAKEDA,,73.0,YR,,M,Y,,,20211118.0,,MD,DE,DE,2021,Q4,Elderly
200875431,20087543,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"Injection fluid, 100 units/ml (units per milliliter)",,,,,,,,,,Injection,,2021,Q4,Lactic acidosis,,2021,Q4,1,I,20211102.0,20211110.0,20211118,20211118,EXP,NL-LRB-00707598,NL-EMD Serono-E2B_90085788,EMD SERONO INC,,62.0,YR,A,M,Y,90.0,KG,20211118.0,,MD,NL,,2021,Q4,Adult
200893132,20089313,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q4,Dementia,,2021,Q4,2,F,,20211126.0,20211119,20211126,EXP,,"JP-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-139196",BOEHRINGER INGELHEIM,,85.0,YR,E,M,Y,45.0,KG,20211126.0,,MD,JP,JP,2021,Q4,Elderly
200893132,20089313,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q4,Therapeutic product effect incomplete,,2021,Q4,2,F,,20211126.0,20211119,20211126,EXP,,"JP-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-139196",BOEHRINGER INGELHEIM,,85.0,YR,E,M,Y,45.0,KG,20211126.0,,MD,JP,JP,2021,Q4,Elderly
200894311,20089431,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"50 Units, Daily",,,,,,,,,,,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,,20211105.0,20211119,20211119,EXP,,AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-317232,RANBAXY,Figtree P. Deprescribing diabetes meds with a low-carb approach. CLINICAL FOCUS CASE REPORT. -;-:-,72.0,YR,,M,Y,131.0,KG,20211119.0,,MD,AU,AU,2021,Q4,Elderly
200894311,20089431,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"50 Units, Daily",,,,,,,,,,,,2021,Q4,Dizziness postural,,2021,Q4,1,I,,20211105.0,20211119,20211119,EXP,,AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-317232,RANBAXY,Figtree P. Deprescribing diabetes meds with a low-carb approach. CLINICAL FOCUS CASE REPORT. -;-:-,72.0,YR,,M,Y,131.0,KG,20211119.0,,MD,AU,AU,2021,Q4,Elderly
200898501,20089850,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,Solution for injection,QD,2021,Q4,Gastrointestinal inflammation,,2021,Q4,1,I,20211028.0,20211117.0,20211119,20211119,EXP,,PR-ABBVIE-21K-131-4168263-00,ABBVIE,,17.0,YR,,M,Y,,,20211119.0,,CN,COUNTRY NOT SPECIFIED,PR,2021,Q4,Youth
200902881,20090288,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Blood creatinine increased,,2021,Q4,1,I,20211109.0,,20211118,20211118,DIR,591537,,FDA-CTU,,81.0,YR,,F,N,96.1,KG,20211118.0,Y,PH,US,,2021,Q4,Elderly
200902881,20090288,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Blood urea increased,,2021,Q4,1,I,20211109.0,,20211118,20211118,DIR,591537,,FDA-CTU,,81.0,YR,,F,N,96.1,KG,20211118.0,Y,PH,US,,2021,Q4,Elderly
200902881,20090288,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Hepatic enzyme increased,,2021,Q4,1,I,20211109.0,,20211118,20211118,DIR,591537,,FDA-CTU,,81.0,YR,,F,N,96.1,KG,20211118.0,Y,PH,US,,2021,Q4,Elderly
200902881,20090288,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Transaminases increased,,2021,Q4,1,I,20211109.0,,20211118,20211118,DIR,591537,,FDA-CTU,,81.0,YR,,F,N,96.1,KG,20211118.0,Y,PH,US,,2021,Q4,Elderly
200911511,20091151,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,24 IU,,,,,,,,,,,,2021,Q4,Weight increased,,2021,Q4,1,I,20160301.0,20211111.0,20211119,20211119,EXP,,DE-AstraZeneca-2021A805942,ASTRAZENECA,,52.0,YR,,F,Y,124.0,KG,20211119.0,,MD,DE,,2021,Q4,Adult
200911511,20091151,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,24 IU,,,,,,,,,,,,2021,Q4,Weight decreased,,2021,Q4,1,I,20160301.0,20211111.0,20211119,20211119,EXP,,DE-AstraZeneca-2021A805942,ASTRAZENECA,,52.0,YR,,F,Y,124.0,KG,20211119.0,,MD,DE,,2021,Q4,Adult
200911511,20091151,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,24 IU,,,,,,,,,,,,2021,Q4,Insulin resistance,,2021,Q4,1,I,20160301.0,20211111.0,20211119,20211119,EXP,,DE-AstraZeneca-2021A805942,ASTRAZENECA,,52.0,YR,,F,Y,124.0,KG,20211119.0,,MD,DE,,2021,Q4,Adult
200911511,20091151,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,66 IU per day,,,,,,,,,,,,2021,Q4,Weight increased,,2021,Q4,1,I,20160301.0,20211111.0,20211119,20211119,EXP,,DE-AstraZeneca-2021A805942,ASTRAZENECA,,52.0,YR,,F,Y,124.0,KG,20211119.0,,MD,DE,,2021,Q4,Adult
200911511,20091151,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,66 IU per day,,,,,,,,,,,,2021,Q4,Weight decreased,,2021,Q4,1,I,20160301.0,20211111.0,20211119,20211119,EXP,,DE-AstraZeneca-2021A805942,ASTRAZENECA,,52.0,YR,,F,Y,124.0,KG,20211119.0,,MD,DE,,2021,Q4,Adult
200911511,20091151,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,66 IU per day,,,,,,,,,,,,2021,Q4,Insulin resistance,,2021,Q4,1,I,20160301.0,20211111.0,20211119,20211119,EXP,,DE-AstraZeneca-2021A805942,ASTRAZENECA,,52.0,YR,,F,Y,124.0,KG,20211119.0,,MD,DE,,2021,Q4,Adult
200912751,20091275,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous bolus,"30 international unit, qd, long-acting basal-bolus 30 iU, HS",,,Y,,,,210605.0,30.0,IU,Injection,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211112.0,20211119,20211119,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20211119.0,,HP,IT,IT,2021,Q4,Elderly
200912751,20091275,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous bolus,"30 international unit, qd, long-acting basal-bolus 30 iU, HS",,,Y,,,,210605.0,30.0,IU,Injection,QD,2021,Q4,Condition aggravated,,2021,Q4,1,I,,20211112.0,20211119,20211119,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20211119.0,,HP,IT,IT,2021,Q4,Elderly
200912751,20091275,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous bolus,"30 international unit, qd, long-acting basal-bolus 30 iU, HS",,,Y,,,,210605.0,30.0,IU,Injection,QD,2021,Q4,Increased appetite,,2021,Q4,1,I,,20211112.0,20211119,20211119,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20211119.0,,HP,IT,IT,2021,Q4,Elderly
200912751,20091275,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous bolus,"30 international unit, qd, long-acting basal-bolus 30 iU, HS",,,Y,,,,210605.0,30.0,IU,Injection,QD,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,,20211112.0,20211119,20211119,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20211119.0,,HP,IT,IT,2021,Q4,Elderly
200912751,20091275,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous bolus,"30 international unit, qd, long-acting basal-bolus 30 iU, HS",,,Y,,,,210605.0,30.0,IU,Injection,QD,2021,Q4,Obesity,,2021,Q4,1,I,,20211112.0,20211119,20211119,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20211119.0,,HP,IT,IT,2021,Q4,Elderly
200912751,20091275,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous bolus,"30 international unit, qd, long-acting basal-bolus 30 iU, HS",,,Y,,,,210605.0,30.0,IU,Injection,QD,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,,20211112.0,20211119,20211119,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20211119.0,,HP,IT,IT,2021,Q4,Elderly
200912751,20091275,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous bolus,"30 international unit, qd, long-acting basal-bolus 30 iU, HS",,,Y,,,,210605.0,30.0,IU,Injection,QD,2021,Q4,Metabolic syndrome,,2021,Q4,1,I,,20211112.0,20211119,20211119,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20211119.0,,HP,IT,IT,2021,Q4,Elderly
200915961,20091596,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (100units/ml solution for injection 3ml pre-filled SoloStar pens 60 units TEA),,,U,,,,,,,Solution for injection in pre-filled pen,,2021,Q4,Salivary hypersecretion,,2021,Q4,1,I,20210721.0,20211110.0,20211119,20211119,EXP,GB-MHRA-MIDB-d1ac8065-f8bd-4ecf-8ec6-a6b721f76b31,NVSC2021GB257979,NOVARTIS,,66.0,YR,,F,Y,,,20211119.0,,PH,GB,GB,2021,Q4,Elderly
200915961,20091596,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (100units/ml solution for injection 3ml pre-filled SoloStar pens 60 units TEA),,,U,,,,,,,Solution for injection in pre-filled pen,,2021,Q4,Cerebrovascular accident,,2021,Q4,1,I,20210721.0,20211110.0,20211119,20211119,EXP,GB-MHRA-MIDB-d1ac8065-f8bd-4ecf-8ec6-a6b721f76b31,NVSC2021GB257979,NOVARTIS,,66.0,YR,,F,Y,,,20211119.0,,PH,GB,GB,2021,Q4,Elderly
200915961,20091596,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (100units/ml solution for injection 3ml pre-filled SoloStar pens 60 units TEA),,,U,,,,,,,Solution for injection in pre-filled pen,,2021,Q4,Dizziness,,2021,Q4,1,I,20210721.0,20211110.0,20211119,20211119,EXP,GB-MHRA-MIDB-d1ac8065-f8bd-4ecf-8ec6-a6b721f76b31,NVSC2021GB257979,NOVARTIS,,66.0,YR,,F,Y,,,20211119.0,,PH,GB,GB,2021,Q4,Elderly
200915961,20091596,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (100units/ml solution for injection 3ml pre-filled SoloStar pens 60 units TEA),,,U,,,,,,,Solution for injection in pre-filled pen,,2021,Q4,Product dispensing error,,2021,Q4,1,I,20210721.0,20211110.0,20211119,20211119,EXP,GB-MHRA-MIDB-d1ac8065-f8bd-4ecf-8ec6-a6b721f76b31,NVSC2021GB257979,NOVARTIS,,66.0,YR,,F,Y,,,20211119.0,,PH,GB,GB,2021,Q4,Elderly
200915961,20091596,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (100units/ml solution for injection 3ml pre-filled SoloStar pens 60 units TEA),,,U,,,,,,,Solution for injection in pre-filled pen,,2021,Q4,Gait disturbance,,2021,Q4,1,I,20210721.0,20211110.0,20211119,20211119,EXP,GB-MHRA-MIDB-d1ac8065-f8bd-4ecf-8ec6-a6b721f76b31,NVSC2021GB257979,NOVARTIS,,66.0,YR,,F,Y,,,20211119.0,,PH,GB,GB,2021,Q4,Elderly
200915961,20091596,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (100units/ml solution for injection 3ml pre-filled SoloStar pens 60 units TEA),,,U,,,,,,,Solution for injection in pre-filled pen,,2021,Q4,Dysarthria,,2021,Q4,1,I,20210721.0,20211110.0,20211119,20211119,EXP,GB-MHRA-MIDB-d1ac8065-f8bd-4ecf-8ec6-a6b721f76b31,NVSC2021GB257979,NOVARTIS,,66.0,YR,,F,Y,,,20211119.0,,PH,GB,GB,2021,Q4,Elderly
200915961,20091596,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (100units/ml solution for injection 3ml pre-filled SoloStar pens 60 units TEA),,,U,,,,,,,Solution for injection in pre-filled pen,,2021,Q4,Dyspnoea,,2021,Q4,1,I,20210721.0,20211110.0,20211119,20211119,EXP,GB-MHRA-MIDB-d1ac8065-f8bd-4ecf-8ec6-a6b721f76b31,NVSC2021GB257979,NOVARTIS,,66.0,YR,,F,Y,,,20211119.0,,PH,GB,GB,2021,Q4,Elderly
200917537,20091753,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 iU/mL, QD",,,,,,,,,,,QD,2021,Q4,Pneumonia,,2021,Q4,7,F,20211111.0,20211214.0,20211119,20211222,EXP,,IL-KARYOPHARM-2021KPT001423,KARYOPHARM THERAPEUTICS,,70.0,YR,,M,Y,55.1,KG,20211222.0,,MD,IL,IL,2021,Q4,Elderly
200919551,20091955,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 international unit, qd",,,U,U,,,210605.0,36.0,IU,Injection,QD,2021,Q4,Sopor,,2021,Q4,1,I,20180306.0,20211113.0,20211119,20211119,EXP,IT-MINISAL02-462085,IT-MYLANLABS-2021M1084698,MYLAN,,63.0,YR,,M,Y,,,20211119.0,,MD,IT,IT,2021,Q4,Adult
200919551,20091955,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 international unit, qd",,,U,U,,,210605.0,36.0,IU,Injection,QD,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,20180306.0,20211113.0,20211119,20211119,EXP,IT-MINISAL02-462085,IT-MYLANLABS-2021M1084698,MYLAN,,63.0,YR,,M,Y,,,20211119.0,,MD,IT,IT,2021,Q4,Adult
200919551,20091955,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 international unit, qd",,,U,U,,,210605.0,36.0,IU,Injection,QD,2021,Q4,Fall,,2021,Q4,1,I,20180306.0,20211113.0,20211119,20211119,EXP,IT-MINISAL02-462085,IT-MYLANLABS-2021M1084698,MYLAN,,63.0,YR,,M,Y,,,20211119.0,,MD,IT,IT,2021,Q4,Adult
200925701,20092570,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q4,Metabolic acidosis,,2021,Q4,1,I,,20211110.0,20211119,20211119,EXP,,US-BAXTER-2021BAX035917,BAXTER,"RAZA H, WALL B. EFFECTS OF PSEUDOHYPONATREMIA ON THE DIAGNOSIS OF SEVERE METABOLIC ACIDOSIS. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2021;32:.",43.0,YR,,M,Y,,,20211119.0,,HP,US,US,2021,Q4,Adult
200925701,20092570,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q4,Lactic acidosis,,2021,Q4,1,I,,20211110.0,20211119,20211119,EXP,,US-BAXTER-2021BAX035917,BAXTER,"RAZA H, WALL B. EFFECTS OF PSEUDOHYPONATREMIA ON THE DIAGNOSIS OF SEVERE METABOLIC ACIDOSIS. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2021;32:.",43.0,YR,,M,Y,,,20211119.0,,HP,US,US,2021,Q4,Adult
200925701,20092570,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q4,Drug-induced liver injury,,2021,Q4,1,I,,20211110.0,20211119,20211119,EXP,,US-BAXTER-2021BAX035917,BAXTER,"RAZA H, WALL B. EFFECTS OF PSEUDOHYPONATREMIA ON THE DIAGNOSIS OF SEVERE METABOLIC ACIDOSIS. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2021;32:.",43.0,YR,,M,Y,,,20211119.0,,HP,US,US,2021,Q4,Adult
200925701,20092570,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2021,Q4,Drug level increased,,2021,Q4,1,I,,20211110.0,20211119,20211119,EXP,,US-BAXTER-2021BAX035917,BAXTER,"RAZA H, WALL B. EFFECTS OF PSEUDOHYPONATREMIA ON THE DIAGNOSIS OF SEVERE METABOLIC ACIDOSIS. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2021;32:.",43.0,YR,,M,Y,,,20211119.0,,HP,US,US,2021,Q4,Adult
200927513,20092751,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Lactic acidosis,,2021,Q4,3,F,,20211126.0,20211120,20211207,EXP,,US-AUROBINDO-AUR-APL-2021-047104,AUROBINDO,"Raza HMA, Wall BM.. Effects of pseudohyponatremia on the diagnosis of severe metabolic acidosis.. Journal of the American Society of Nephrology. 2021;32:381",43.0,YR,,M,Y,,,20211207.0,,HP,US,US,2021,Q4,Adult
200927513,20092751,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Drug level increased,,2021,Q4,3,F,,20211126.0,20211120,20211207,EXP,,US-AUROBINDO-AUR-APL-2021-047104,AUROBINDO,"Raza HMA, Wall BM.. Effects of pseudohyponatremia on the diagnosis of severe metabolic acidosis.. Journal of the American Society of Nephrology. 2021;32:381",43.0,YR,,M,Y,,,20211207.0,,HP,US,US,2021,Q4,Adult
200927513,20092751,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Drug-induced liver injury,,2021,Q4,3,F,,20211126.0,20211120,20211207,EXP,,US-AUROBINDO-AUR-APL-2021-047104,AUROBINDO,"Raza HMA, Wall BM.. Effects of pseudohyponatremia on the diagnosis of severe metabolic acidosis.. Journal of the American Society of Nephrology. 2021;32:381",43.0,YR,,M,Y,,,20211207.0,,HP,US,US,2021,Q4,Adult
200927513,20092751,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Metabolic acidosis,,2021,Q4,3,F,,20211126.0,20211120,20211207,EXP,,US-AUROBINDO-AUR-APL-2021-047104,AUROBINDO,"Raza HMA, Wall BM.. Effects of pseudohyponatremia on the diagnosis of severe metabolic acidosis.. Journal of the American Society of Nephrology. 2021;32:381",43.0,YR,,M,Y,,,20211207.0,,HP,US,US,2021,Q4,Adult
200928871,20092887,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,Unknown,,2021,Q4,Drug-induced liver injury,,2021,Q4,1,I,,20211109.0,20211120,20211120,EXP,,US-JNJFOC-20211130526,JOHNSON AND JOHNSON,,43.0,YR,A,M,Y,,,20211120.0,,HP,US,US,2021,Q4,Adult
200928871,20092887,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,Unknown,,2021,Q4,Analgesic drug level increased,,2021,Q4,1,I,,20211109.0,20211120,20211120,EXP,,US-JNJFOC-20211130526,JOHNSON AND JOHNSON,,43.0,YR,A,M,Y,,,20211120.0,,HP,US,US,2021,Q4,Adult
200928871,20092887,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,Unknown,,2021,Q4,Lactic acidosis,,2021,Q4,1,I,,20211109.0,20211120,20211120,EXP,,US-JNJFOC-20211130526,JOHNSON AND JOHNSON,,43.0,YR,A,M,Y,,,20211120.0,,HP,US,US,2021,Q4,Adult
200928871,20092887,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,Unknown,,2021,Q4,Metabolic acidosis,,2021,Q4,1,I,,20211109.0,20211120,20211120,EXP,,US-JNJFOC-20211130526,JOHNSON AND JOHNSON,,43.0,YR,A,M,Y,,,20211120.0,,HP,US,US,2021,Q4,Adult
200929701,20092970,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,18.0,IU,,,2021,Q4,COVID-19 pneumonia,,2021,Q4,1,I,,20211111.0,20211120,20211120,EXP,,TR-Accord-245453,ACCORD,"Bayrak M, Cadirci K. Successful pulsed methylprednisolone and convalescent plasma treatment in a case of a renal transplant recipient with covid-19 positive pneumonia: A case report. Pan African Medical Journal. 2021;38:Article Number 273.",50.0,YR,,M,Y,,,20211120.0,,MD,TR,TR,2021,Q4,Adult
200948221,20094822,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,use as directed. This replaces Lantus. Continue...,,,,,unknown,,,,,,,2021,Q4,Feeling abnormal,,2021,Q4,1,I,20211109.0,20211111.0,20211122,20211122,EXP,GB-MHRA-TPP38064796C2797289YC1636467386304,GB-NOVOPROD-865919,NOVO NORDISK,,41.0,YR,,M,Y,94.0,KG,20211122.0,,HP,GB,GB,2021,Q4,Adult
200952031,20095203,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 U, HS",,,,,,,21081.0,,,,QD,2021,Q4,Chromaturia,,2021,Q4,1,I,20150422.0,20211116.0,20211122,20211122,EXP,,CN-SA-2021SA383175,SANOFI AVENTIS,"Qin D., Chendong Y.. Rhabdomyolysis caused by candesartan cilexetil. ADRJ. 2021;23 (10):557-559",74.0,YR,E,F,Y,,,20211122.0,,HP,CN,CN,2021,Q4,Elderly
200952031,20095203,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 U, HS",,,,,,,21081.0,,,,QD,2021,Q4,Rhabdomyolysis,,2021,Q4,1,I,20150422.0,20211116.0,20211122,20211122,EXP,,CN-SA-2021SA383175,SANOFI AVENTIS,"Qin D., Chendong Y.. Rhabdomyolysis caused by candesartan cilexetil. ADRJ. 2021;23 (10):557-559",74.0,YR,E,F,Y,,,20211122.0,,HP,CN,CN,2021,Q4,Elderly
200952031,20095203,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 U, HS",,,,,,,21081.0,,,,QD,2021,Q4,Asthenia,,2021,Q4,1,I,20150422.0,20211116.0,20211122,20211122,EXP,,CN-SA-2021SA383175,SANOFI AVENTIS,"Qin D., Chendong Y.. Rhabdomyolysis caused by candesartan cilexetil. ADRJ. 2021;23 (10):557-559",74.0,YR,E,F,Y,,,20211122.0,,HP,CN,CN,2021,Q4,Elderly
200952031,20095203,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 U, HS",,,,,,,21081.0,,,,QD,2021,Q4,Mental disorder,,2021,Q4,1,I,20150422.0,20211116.0,20211122,20211122,EXP,,CN-SA-2021SA383175,SANOFI AVENTIS,"Qin D., Chendong Y.. Rhabdomyolysis caused by candesartan cilexetil. ADRJ. 2021;23 (10):557-559",74.0,YR,E,F,Y,,,20211122.0,,HP,CN,CN,2021,Q4,Elderly
200952031,20095203,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 U, HS",,,,,,,21081.0,,,,QD,2021,Q4,Pain,,2021,Q4,1,I,20150422.0,20211116.0,20211122,20211122,EXP,,CN-SA-2021SA383175,SANOFI AVENTIS,"Qin D., Chendong Y.. Rhabdomyolysis caused by candesartan cilexetil. ADRJ. 2021;23 (10):557-559",74.0,YR,E,F,Y,,,20211122.0,,HP,CN,CN,2021,Q4,Elderly
200952031,20095203,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 U, HS",,,,,,,21081.0,,,,QD,2021,Q4,Condition aggravated,,2021,Q4,1,I,20150422.0,20211116.0,20211122,20211122,EXP,,CN-SA-2021SA383175,SANOFI AVENTIS,"Qin D., Chendong Y.. Rhabdomyolysis caused by candesartan cilexetil. ADRJ. 2021;23 (10):557-559",74.0,YR,E,F,Y,,,20211122.0,,HP,CN,CN,2021,Q4,Elderly
200952031,20095203,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 U, HS",,,,,,,21081.0,,,,QD,2021,Q4,Myalgia,,2021,Q4,1,I,20150422.0,20211116.0,20211122,20211122,EXP,,CN-SA-2021SA383175,SANOFI AVENTIS,"Qin D., Chendong Y.. Rhabdomyolysis caused by candesartan cilexetil. ADRJ. 2021;23 (10):557-559",74.0,YR,E,F,Y,,,20211122.0,,HP,CN,CN,2021,Q4,Elderly
200952031,20095203,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 U, HS",,,,,,,21081.0,,,,QD,2021,Q4,Decreased appetite,,2021,Q4,1,I,20150422.0,20211116.0,20211122,20211122,EXP,,CN-SA-2021SA383175,SANOFI AVENTIS,"Qin D., Chendong Y.. Rhabdomyolysis caused by candesartan cilexetil. ADRJ. 2021;23 (10):557-559",74.0,YR,E,F,Y,,,20211122.0,,HP,CN,CN,2021,Q4,Elderly
200952031,20095203,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 U, HS",,,,,,,21081.0,,,,QD,2021,Q4,Diabetes insipidus,,2021,Q4,1,I,20150422.0,20211116.0,20211122,20211122,EXP,,CN-SA-2021SA383175,SANOFI AVENTIS,"Qin D., Chendong Y.. Rhabdomyolysis caused by candesartan cilexetil. ADRJ. 2021;23 (10):557-559",74.0,YR,E,F,Y,,,20211122.0,,HP,CN,CN,2021,Q4,Elderly
200959651,20095965,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Cough,,2021,Q4,1,I,20211116.0,,20211119,20211119,DIR,591695,,FDA-CTU,,73.0,YR,,M,N,135.0,KG,20211119.0,N,PH,US,,2021,Q4,Elderly
200959651,20095965,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,1,I,20211116.0,,20211119,20211119,DIR,591695,,FDA-CTU,,73.0,YR,,M,N,135.0,KG,20211119.0,N,PH,US,,2021,Q4,Elderly
200959651,20095965,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Oxygen saturation decreased,,2021,Q4,1,I,20211116.0,,20211119,20211119,DIR,591695,,FDA-CTU,,73.0,YR,,M,N,135.0,KG,20211119.0,N,PH,US,,2021,Q4,Elderly
200959661,20095966,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Pulmonary oedema,,2021,Q4,1,I,20211119.0,,20211120,20211120,DIR,591802,,FDA-CTU,,65.0,YR,,M,N,78.5,KG,20211120.0,N,PH,US,,2021,Q4,Elderly
200959661,20095966,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Lung infiltration,,2021,Q4,1,I,20211119.0,,20211120,20211120,DIR,591802,,FDA-CTU,,65.0,YR,,M,N,78.5,KG,20211120.0,N,PH,US,,2021,Q4,Elderly
200959661,20095966,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Oxygen saturation decreased,,2021,Q4,1,I,20211119.0,,20211120,20211120,DIR,591802,,FDA-CTU,,65.0,YR,,M,N,78.5,KG,20211120.0,N,PH,US,,2021,Q4,Elderly
200959661,20095966,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Respiratory distress,,2021,Q4,1,I,20211119.0,,20211120,20211120,DIR,591802,,FDA-CTU,,65.0,YR,,M,N,78.5,KG,20211120.0,N,PH,US,,2021,Q4,Elderly
200959661,20095966,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Electrocardiogram ST segment depression,,2021,Q4,1,I,20211119.0,,20211120,20211120,DIR,591802,,FDA-CTU,,65.0,YR,,M,N,78.5,KG,20211120.0,N,PH,US,,2021,Q4,Elderly
200959661,20095966,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Troponin increased,,2021,Q4,1,I,20211119.0,,20211120,20211120,DIR,591802,,FDA-CTU,,65.0,YR,,M,N,78.5,KG,20211120.0,N,PH,US,,2021,Q4,Elderly
200959661,20095966,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Electrocardiogram T wave inversion,,2021,Q4,1,I,20211119.0,,20211120,20211120,DIR,591802,,FDA-CTU,,65.0,YR,,M,N,78.5,KG,20211120.0,N,PH,US,,2021,Q4,Elderly
200959661,20095966,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Cardiac arrest,,2021,Q4,1,I,20211119.0,,20211120,20211120,DIR,591802,,FDA-CTU,,65.0,YR,,M,N,78.5,KG,20211120.0,N,PH,US,,2021,Q4,Elderly
200959661,20095966,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Infusion related reaction,,2021,Q4,1,I,20211119.0,,20211120,20211120,DIR,591802,,FDA-CTU,,65.0,YR,,M,N,78.5,KG,20211120.0,N,PH,US,,2021,Q4,Elderly
200964771,20096477,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,25 units daily,,,,N,,,,,,,,2021,Q4,Rhabdomyolysis,,2021,Q4,1,I,,20211110.0,20211122,20211122,EXP,,US-CELLTRION-2021-US-024267,CELLTRION,"Chetram VK, Ahmad AI, Farid S, Sood T..Acute Kidney Injury Secondary to Rhabdomyolysis and COVID-19: A Case Report and Literature Review..Case Reports in Nephrology.2021;.",62.0,YR,,M,Y,,,20211122.0,,HP,US,US,2021,Q4,Adult
200970621,20097062,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,Unknown,,2021,Q4,Colitis,,2021,Q4,1,I,20210525.0,20211112.0,20211122,20211122,EXP,,US-CELGENEUS-USA-20211103835,CELGENE,,56.0,YR,,F,Y,,,20211122.0,,HP,US,US,2021,Q4,Adult
200975721,20097572,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,Unknown,,,U,,,,,,,,,2021,Q4,Metabolic acidosis,,2021,Q4,1,I,,20211110.0,20211122,20211122,EXP,,US-PERRIGO-21US031133,PERRIGO,"Raza HMA, Wall BM. Effects of pseudohyponatremia on the diagnosis of severe metabolic acidosis. Journal of the American Society of Nephrology. 2021;32:381.",43.0,YR,,M,Y,,,20211122.0,,HP,US,US,2021,Q4,Adult
200975721,20097572,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,Unknown,,,U,,,,,,,,,2021,Q4,Lactic acidosis,,2021,Q4,1,I,,20211110.0,20211122,20211122,EXP,,US-PERRIGO-21US031133,PERRIGO,"Raza HMA, Wall BM. Effects of pseudohyponatremia on the diagnosis of severe metabolic acidosis. Journal of the American Society of Nephrology. 2021;32:381.",43.0,YR,,M,Y,,,20211122.0,,HP,US,US,2021,Q4,Adult
200975721,20097572,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,Unknown,,,U,,,,,,,,,2021,Q4,Drug level increased,,2021,Q4,1,I,,20211110.0,20211122,20211122,EXP,,US-PERRIGO-21US031133,PERRIGO,"Raza HMA, Wall BM. Effects of pseudohyponatremia on the diagnosis of severe metabolic acidosis. Journal of the American Society of Nephrology. 2021;32:381.",43.0,YR,,M,Y,,,20211122.0,,HP,US,US,2021,Q4,Adult
200975721,20097572,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,Unknown,,,U,,,,,,,,,2021,Q4,Drug-induced liver injury,,2021,Q4,1,I,,20211110.0,20211122,20211122,EXP,,US-PERRIGO-21US031133,PERRIGO,"Raza HMA, Wall BM. Effects of pseudohyponatremia on the diagnosis of severe metabolic acidosis. Journal of the American Society of Nephrology. 2021;32:381.",43.0,YR,,M,Y,,,20211122.0,,HP,US,US,2021,Q4,Adult
200980641,20098064,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,Unknown,,2021,Q4,Platelet count decreased,,2021,Q4,1,I,20170518.0,20211117.0,20211122,20211122,EXP,,PA-CELGENEUS-PAN-20170902116,CELGENE,,49.0,YR,,F,Y,,,20211122.0,,HP,PA,PA,2021,Q4,Adult
200984411,20098441,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, unknown",,,,,,,,,,,,2021,Q4,Pyrexia,,2021,Q4,1,I,,20211116.0,20211122,20211122,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202111008107,ELI LILLY AND CO,,56.0,YR,,F,Y,52.5,KG,20211122.0,,CN,CN,CN,2021,Q4,Adult
200984411,20098441,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, unknown",,,,,,,,,,,,2021,Q4,Coma,,2021,Q4,1,I,,20211116.0,20211122,20211122,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202111008107,ELI LILLY AND CO,,56.0,YR,,F,Y,52.5,KG,20211122.0,,CN,CN,CN,2021,Q4,Adult
200984411,20098441,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, unknown",,,,,,,,,,,,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211116.0,20211122,20211122,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202111008107,ELI LILLY AND CO,,56.0,YR,,F,Y,52.5,KG,20211122.0,,CN,CN,CN,2021,Q4,Adult
200984411,20098441,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, unknown",,,,,,,,,,,,2021,Q4,Peripheral swelling,,2021,Q4,1,I,,20211116.0,20211122,20211122,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202111008107,ELI LILLY AND CO,,56.0,YR,,F,Y,52.5,KG,20211122.0,,CN,CN,CN,2021,Q4,Adult
200984411,20098441,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, unknown",,,,,,,,,,,,2021,Q4,Drug hypersensitivity,,2021,Q4,1,I,,20211116.0,20211122,20211122,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202111008107,ELI LILLY AND CO,,56.0,YR,,F,Y,52.5,KG,20211122.0,,CN,CN,CN,2021,Q4,Adult
200984411,20098441,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, unknown",,,,,,,,,,,,2021,Q4,Ketoacidosis,,2021,Q4,1,I,,20211116.0,20211122,20211122,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202111008107,ELI LILLY AND CO,,56.0,YR,,F,Y,52.5,KG,20211122.0,,CN,CN,CN,2021,Q4,Adult
200984411,20098441,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, unknown",,,,,,,,,,,,2021,Q4,Pyrexia,,2021,Q4,1,I,,20211116.0,20211122,20211122,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202111008107,ELI LILLY AND CO,,56.0,YR,,F,Y,52.5,KG,20211122.0,,CN,CN,CN,2021,Q4,Adult
200984411,20098441,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, unknown",,,,,,,,,,,,2021,Q4,Coma,,2021,Q4,1,I,,20211116.0,20211122,20211122,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202111008107,ELI LILLY AND CO,,56.0,YR,,F,Y,52.5,KG,20211122.0,,CN,CN,CN,2021,Q4,Adult
200984411,20098441,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, unknown",,,,,,,,,,,,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211116.0,20211122,20211122,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202111008107,ELI LILLY AND CO,,56.0,YR,,F,Y,52.5,KG,20211122.0,,CN,CN,CN,2021,Q4,Adult
200984411,20098441,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, unknown",,,,,,,,,,,,2021,Q4,Peripheral swelling,,2021,Q4,1,I,,20211116.0,20211122,20211122,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202111008107,ELI LILLY AND CO,,56.0,YR,,F,Y,52.5,KG,20211122.0,,CN,CN,CN,2021,Q4,Adult
200984411,20098441,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, unknown",,,,,,,,,,,,2021,Q4,Drug hypersensitivity,,2021,Q4,1,I,,20211116.0,20211122,20211122,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202111008107,ELI LILLY AND CO,,56.0,YR,,F,Y,52.5,KG,20211122.0,,CN,CN,CN,2021,Q4,Adult
200984411,20098441,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, unknown",,,,,,,,,,,,2021,Q4,Ketoacidosis,,2021,Q4,1,I,,20211116.0,20211122,20211122,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202111008107,ELI LILLY AND CO,,56.0,YR,,F,Y,52.5,KG,20211122.0,,CN,CN,CN,2021,Q4,Adult
200984761,20098476,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,210605.0,,,Injection,,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,20210715.0,20211115.0,20211122,20211122,EXP,IT-MINISAL02-785491,IT-MYLANLABS-2021M1085027,MYLAN,,85.0,YR,,M,Y,,,20211122.0,,PH,IT,IT,2021,Q4,Elderly
200985651,20098565,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Clostridium difficile colitis,,2021,Q4,1,I,,20211109.0,20211122,20211122,EXP,,CA-PFIZER INC-202101555869,PFIZER,,77.0,YR,,F,Y,102.0,KG,20211122.0,,HP,CA,CA,2021,Q4,Elderly
200988311,20098831,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Fall,,2021,Q4,1,I,20211006.0,20211116.0,20211122,20211122,EXP,FR-AFSSAPS-RE20212767,FR-MYLANLABS-2021M1078596,MYLAN,,74.0,YR,,F,Y,71.0,KG,20211122.0,,MD,FR,FR,2021,Q4,Elderly
200988311,20098831,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Anaemia,,2021,Q4,1,I,20211006.0,20211116.0,20211122,20211122,EXP,FR-AFSSAPS-RE20212767,FR-MYLANLABS-2021M1078596,MYLAN,,74.0,YR,,F,Y,71.0,KG,20211122.0,,MD,FR,FR,2021,Q4,Elderly
200988311,20098831,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Thrombocytopenia,,2021,Q4,1,I,20211006.0,20211116.0,20211122,20211122,EXP,FR-AFSSAPS-RE20212767,FR-MYLANLABS-2021M1078596,MYLAN,,74.0,YR,,F,Y,71.0,KG,20211122.0,,MD,FR,FR,2021,Q4,Elderly
200992173,20099217,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,6 international unit,,,,,,,,6.0,IU,Injection,,2021,Q4,Hyperpyrexia,,2021,Q4,3,F,20211112.0,20211119.0,20211122,20211208,EXP,,CN-BEH-2021138403,CSL BEHRING,,80.0,YR,E,F,Y,,,20211208.0,,MD,CN,CN,2021,Q4,Elderly
200992173,20099217,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,6 international unit,,,,,,,,6.0,IU,Injection,,2021,Q4,Chills,,2021,Q4,3,F,20211112.0,20211119.0,20211122,20211208,EXP,,CN-BEH-2021138403,CSL BEHRING,,80.0,YR,E,F,Y,,,20211208.0,,MD,CN,CN,2021,Q4,Elderly
201000481,20100048,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"30 IU, qd",,,,,,,,30.0,IU,,QD,2021,Q4,Diabetic metabolic decompensation,,2021,Q4,1,I,20200101.0,20211111.0,20211123,20211123,EXP,,BR-NOVOPROD-866687,NOVO NORDISK,,67.0,YR,,M,Y,78.0,KG,20211123.0,,MD,BR,BR,2021,Q4,Elderly
201000481,20100048,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"30 IU, qd",,,,,,,,30.0,IU,,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20200101.0,20211111.0,20211123,20211123,EXP,,BR-NOVOPROD-866687,NOVO NORDISK,,67.0,YR,,M,Y,78.0,KG,20211123.0,,MD,BR,BR,2021,Q4,Elderly
201000481,20100048,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"30 IU, qd",,,,,,,,30.0,IU,,QD,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,20200101.0,20211111.0,20211123,20211123,EXP,,BR-NOVOPROD-866687,NOVO NORDISK,,67.0,YR,,M,Y,78.0,KG,20211123.0,,MD,BR,BR,2021,Q4,Elderly
201000481,20100048,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"30 IU, qd",,,,,,,,30.0,IU,,QD,2021,Q4,Muscle disorder,,2021,Q4,1,I,20200101.0,20211111.0,20211123,20211123,EXP,,BR-NOVOPROD-866687,NOVO NORDISK,,67.0,YR,,M,Y,78.0,KG,20211123.0,,MD,BR,BR,2021,Q4,Elderly
201003741,20100374,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Product dispensing error,,2021,Q4,1,I,20210721.0,20211110.0,20211123,20211123,EXP,,GB-AUROBINDO-AUR-APL-2021-047430,AUROBINDO,,66.0,YR,,F,Y,,,20211123.0,,PH,GB,GB,2021,Q4,Elderly
201003741,20100374,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Cerebrovascular accident,,2021,Q4,1,I,20210721.0,20211110.0,20211123,20211123,EXP,,GB-AUROBINDO-AUR-APL-2021-047430,AUROBINDO,,66.0,YR,,F,Y,,,20211123.0,,PH,GB,GB,2021,Q4,Elderly
201003741,20100374,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Salivary hypersecretion,,2021,Q4,1,I,20210721.0,20211110.0,20211123,20211123,EXP,,GB-AUROBINDO-AUR-APL-2021-047430,AUROBINDO,,66.0,YR,,F,Y,,,20211123.0,,PH,GB,GB,2021,Q4,Elderly
201003741,20100374,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,1,I,20210721.0,20211110.0,20211123,20211123,EXP,,GB-AUROBINDO-AUR-APL-2021-047430,AUROBINDO,,66.0,YR,,F,Y,,,20211123.0,,PH,GB,GB,2021,Q4,Elderly
201003741,20100374,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Dysarthria,,2021,Q4,1,I,20210721.0,20211110.0,20211123,20211123,EXP,,GB-AUROBINDO-AUR-APL-2021-047430,AUROBINDO,,66.0,YR,,F,Y,,,20211123.0,,PH,GB,GB,2021,Q4,Elderly
201003741,20100374,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Gait disturbance,,2021,Q4,1,I,20210721.0,20211110.0,20211123,20211123,EXP,,GB-AUROBINDO-AUR-APL-2021-047430,AUROBINDO,,66.0,YR,,F,Y,,,20211123.0,,PH,GB,GB,2021,Q4,Elderly
201003741,20100374,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Dizziness,,2021,Q4,1,I,20210721.0,20211110.0,20211123,20211123,EXP,,GB-AUROBINDO-AUR-APL-2021-047430,AUROBINDO,,66.0,YR,,F,Y,,,20211123.0,,PH,GB,GB,2021,Q4,Elderly
201015841,20101584,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,15 unit once/day,,,,,Unknown,,,,,,QD,2021,Q4,Serotonin syndrome,,2021,Q4,1,I,,20201203.0,20211123,20211123,EXP,,US-SCIEGENPHARMA-2020SCILIT00488,SCIEGEN,Dehuti Pandya.Clinical Relevance of Pharmacogenetics in Serotonin Syndrome.Case Reports Psychiatry.2020,74.0,YR,E,M,Y,75.0,KG,20211123.0,,HP,US,US,2021,Q4,Elderly
201024751,20102475,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,unk,,,,,UNK,,,,,,,2021,Q4,Pneumocystis jirovecii pneumonia,,2021,Q4,1,I,20211029.0,20211115.0,20211123,20211123,EXP,FR-AFSSAPS-TS20215574,FR-ORG100014127-2021001430,HRA PHARMA,,36.0,YR,,F,Y,97.0,KG,20211123.0,,MD,FR,FR,2021,Q4,Adult
201047791,20104779,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100units/ml solution for injection 3ml pre-filled SoloStar pens 60 units TEA,,,U,,,,,,,,,2021,Q4,Gait disturbance,,2021,Q4,1,I,20210721.0,20211110.0,20211124,20211124,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-318054,RANBAXY,,66.0,YR,,F,Y,,,20211124.0,,PH,GB,GB,2021,Q4,Elderly
201047791,20104779,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100units/ml solution for injection 3ml pre-filled SoloStar pens 60 units TEA,,,U,,,,,,,,,2021,Q4,Product dispensing error,,2021,Q4,1,I,20210721.0,20211110.0,20211124,20211124,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-318054,RANBAXY,,66.0,YR,,F,Y,,,20211124.0,,PH,GB,GB,2021,Q4,Elderly
201047791,20104779,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100units/ml solution for injection 3ml pre-filled SoloStar pens 60 units TEA,,,U,,,,,,,,,2021,Q4,Cerebrovascular accident,,2021,Q4,1,I,20210721.0,20211110.0,20211124,20211124,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-318054,RANBAXY,,66.0,YR,,F,Y,,,20211124.0,,PH,GB,GB,2021,Q4,Elderly
201047791,20104779,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100units/ml solution for injection 3ml pre-filled SoloStar pens 60 units TEA,,,U,,,,,,,,,2021,Q4,Salivary hypersecretion,,2021,Q4,1,I,20210721.0,20211110.0,20211124,20211124,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-318054,RANBAXY,,66.0,YR,,F,Y,,,20211124.0,,PH,GB,GB,2021,Q4,Elderly
201047791,20104779,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100units/ml solution for injection 3ml pre-filled SoloStar pens 60 units TEA,,,U,,,,,,,,,2021,Q4,Dysarthria,,2021,Q4,1,I,20210721.0,20211110.0,20211124,20211124,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-318054,RANBAXY,,66.0,YR,,F,Y,,,20211124.0,,PH,GB,GB,2021,Q4,Elderly
201047791,20104779,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100units/ml solution for injection 3ml pre-filled SoloStar pens 60 units TEA,,,U,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,1,I,20210721.0,20211110.0,20211124,20211124,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-318054,RANBAXY,,66.0,YR,,F,Y,,,20211124.0,,PH,GB,GB,2021,Q4,Elderly
201047791,20104779,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100units/ml solution for injection 3ml pre-filled SoloStar pens 60 units TEA,,,U,,,,,,,,,2021,Q4,Dizziness,,2021,Q4,1,I,20210721.0,20211110.0,20211124,20211124,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-318054,RANBAXY,,66.0,YR,,F,Y,,,20211124.0,,PH,GB,GB,2021,Q4,Elderly
201048891,20104889,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Metabolic acidosis,,2021,Q4,1,I,,20211110.0,20211124,20211124,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-318547,RANBAXY,"Raza HMA, Wall BM.. Effects of Pseudohyponatremia on the Diagnosis of Severe Metabolic Acidosis. J Am Soc Nephrol. 2021;32381",43.0,YR,,M,Y,,,20211124.0,,HP,US,US,2021,Q4,Adult
201048891,20104889,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Hepatotoxicity,,2021,Q4,1,I,,20211110.0,20211124,20211124,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-318547,RANBAXY,"Raza HMA, Wall BM.. Effects of Pseudohyponatremia on the Diagnosis of Severe Metabolic Acidosis. J Am Soc Nephrol. 2021;32381",43.0,YR,,M,Y,,,20211124.0,,HP,US,US,2021,Q4,Adult
201048891,20104889,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,,20211110.0,20211124,20211124,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-318547,RANBAXY,"Raza HMA, Wall BM.. Effects of Pseudohyponatremia on the Diagnosis of Severe Metabolic Acidosis. J Am Soc Nephrol. 2021;32381",43.0,YR,,M,Y,,,20211124.0,,HP,US,US,2021,Q4,Adult
201063681,20106368,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,Solution for injection,,2021,Q4,Aplastic anaemia,,2021,Q4,1,I,,20211122.0,20211124,20211124,EXP,,CA-ABBVIE-21K-028-4174179-00,ABBVIE,,20.0,YR,,M,Y,84.0,KG,20211124.0,,HP,CA,CA,2021,Q4,Youth
201091571,20109157,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,bolus,,,U,U,,,210605.0,,,Injection,,2021,Q4,Maternal exposure during pregnancy,,2021,Q4,1,I,,20211117.0,20211124,20211124,EXP,,NL-MYLANLABS-2021M1087178,MYLAN,"Kamphof HD, De Smet V, Jansen NE, Tjan DHT, Heijligenberg R. [Euglycemic diabetic ketoacidosis during pregnancy]. [Dutch]. Ned-Tijdschr-Geneeskd 2021;165:No. 18.",34.0,YR,,F,Y,,,20211124.0,,MD,NL,NL,2021,Q4,Young Adult
201091571,20109157,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,bolus,,,U,U,,,210605.0,,,Injection,,2021,Q4,Drug ineffective,,2021,Q4,1,I,,20211117.0,20211124,20211124,EXP,,NL-MYLANLABS-2021M1087178,MYLAN,"Kamphof HD, De Smet V, Jansen NE, Tjan DHT, Heijligenberg R. [Euglycemic diabetic ketoacidosis during pregnancy]. [Dutch]. Ned-Tijdschr-Geneeskd 2021;165:No. 18.",34.0,YR,,F,Y,,,20211124.0,,MD,NL,NL,2021,Q4,Young Adult
201091571,20109157,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"3.6 international unit, qh,Pump",,,U,U,,,210605.0,3.6,IU,Injection,/HR,2021,Q4,Maternal exposure during pregnancy,,2021,Q4,1,I,,20211117.0,20211124,20211124,EXP,,NL-MYLANLABS-2021M1087178,MYLAN,"Kamphof HD, De Smet V, Jansen NE, Tjan DHT, Heijligenberg R. [Euglycemic diabetic ketoacidosis during pregnancy]. [Dutch]. Ned-Tijdschr-Geneeskd 2021;165:No. 18.",34.0,YR,,F,Y,,,20211124.0,,MD,NL,NL,2021,Q4,Young Adult
201091571,20109157,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"3.6 international unit, qh,Pump",,,U,U,,,210605.0,3.6,IU,Injection,/HR,2021,Q4,Drug ineffective,,2021,Q4,1,I,,20211117.0,20211124,20211124,EXP,,NL-MYLANLABS-2021M1087178,MYLAN,"Kamphof HD, De Smet V, Jansen NE, Tjan DHT, Heijligenberg R. [Euglycemic diabetic ketoacidosis during pregnancy]. [Dutch]. Ned-Tijdschr-Geneeskd 2021;165:No. 18.",34.0,YR,,F,Y,,,20211124.0,,MD,NL,NL,2021,Q4,Young Adult
201097081,20109708,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, unknown",,,U,,,,205692.0,,,,,2021,Q4,Ejection fraction decreased,,2021,Q4,1,I,20210701.0,20211112.0,20211124,20211124,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202111005891,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20211124.0,,MD,DE,DE,2021,Q4,Elderly
201097081,20109708,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, unknown",,,U,,,,205692.0,,,,,2021,Q4,Cardiac failure,,2021,Q4,1,I,20210701.0,20211112.0,20211124,20211124,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202111005891,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20211124.0,,MD,DE,DE,2021,Q4,Elderly
201097081,20109708,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, unknown",,,U,,,,205692.0,,,,,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20210701.0,20211112.0,20211124,20211124,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202111005891,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20211124.0,,MD,DE,DE,2021,Q4,Elderly
201097081,20109708,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, unknown",,,U,,,,205692.0,,,,,2021,Q4,Tachycardia induced cardiomyopathy,,2021,Q4,1,I,20210701.0,20211112.0,20211124,20211124,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202111005891,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20211124.0,,MD,DE,DE,2021,Q4,Elderly
201097081,20109708,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, unknown",,,U,,,,205692.0,,,,,2021,Q4,Weight decreased,,2021,Q4,1,I,20210701.0,20211112.0,20211124,20211124,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202111005891,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20211124.0,,MD,DE,DE,2021,Q4,Elderly
201097081,20109708,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, unknown",,,U,,,,205692.0,,,,,2021,Q4,Atrial fibrillation,,2021,Q4,1,I,20210701.0,20211112.0,20211124,20211124,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202111005891,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20211124.0,,MD,DE,DE,2021,Q4,Elderly
201097081,20109708,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, unknown",,,U,,,,205692.0,,,,,2021,Q4,Arteriosclerosis coronary artery,,2021,Q4,1,I,20210701.0,20211112.0,20211124,20211124,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202111005891,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20211124.0,,MD,DE,DE,2021,Q4,Elderly
201097081,20109708,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, unknown",,,U,,,,205692.0,,,,,2021,Q4,Musculoskeletal pain,,2021,Q4,1,I,20210701.0,20211112.0,20211124,20211124,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202111005891,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20211124.0,,MD,DE,DE,2021,Q4,Elderly
201097081,20109708,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, unknown",,,U,,,,205692.0,,,,,2021,Q4,Atrial fibrillation,,2021,Q4,1,I,20210701.0,20211112.0,20211124,20211124,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202111005891,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20211124.0,,MD,DE,DE,2021,Q4,Elderly
201098242,20109824,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 units/ml, 20 unit, SUB-Q",,,,,,,,,,Solution,QD,2021,Q4,Sepsis,,2021,Q4,2,F,,20211203.0,20211124,20211208,EXP,,US-BAUSCH-BL-2021-038500,BAUSCH AND LOMB,,62.0,YR,,M,Y,78.182,KG,20211208.0,,MD,US,US,2021,Q4,Adult
201098242,20109824,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 units/ml, 20 unit, SUB-Q",,,,,,,,,,Solution,QD,2021,Q4,Necrotising fasciitis,,2021,Q4,2,F,,20211203.0,20211124,20211208,EXP,,US-BAUSCH-BL-2021-038500,BAUSCH AND LOMB,,62.0,YR,,M,Y,78.182,KG,20211208.0,,MD,US,US,2021,Q4,Adult
201102533,20110253,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, (12 (units) UNK)",,,U,U,,,,,,,,2021,Q4,Gait disturbance,,2021,Q4,3,F,20200201.0,20211201.0,20211124,20211209,EXP,,HR-MYLANLABS-2021M1086084,MYLAN,,80.0,YR,,M,Y,82.0,KG,20211209.0,,MD,HR,HR,2021,Q4,Elderly
201102533,20110253,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, (12 (units) UNK)",,,U,U,,,,,,,,2021,Q4,Hyperkalaemia,,2021,Q4,3,F,20200201.0,20211201.0,20211124,20211209,EXP,,HR-MYLANLABS-2021M1086084,MYLAN,,80.0,YR,,M,Y,82.0,KG,20211209.0,,MD,HR,HR,2021,Q4,Elderly
201102533,20110253,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, (12 (units) UNK)",,,U,U,,,,,,,,2021,Q4,Vertigo,,2021,Q4,3,F,20200201.0,20211201.0,20211124,20211209,EXP,,HR-MYLANLABS-2021M1086084,MYLAN,,80.0,YR,,M,Y,82.0,KG,20211209.0,,MD,HR,HR,2021,Q4,Elderly
201102533,20110253,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, (12 (units) UNK)",,,U,U,,,,,,,,2021,Q4,Dizziness,,2021,Q4,3,F,20200201.0,20211201.0,20211124,20211209,EXP,,HR-MYLANLABS-2021M1086084,MYLAN,,80.0,YR,,M,Y,82.0,KG,20211209.0,,MD,HR,HR,2021,Q4,Elderly
201102533,20110253,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, (12 (units) UNK)",,,U,U,,,,,,,,2021,Q4,Hypotension,,2021,Q4,3,F,20200201.0,20211201.0,20211124,20211209,EXP,,HR-MYLANLABS-2021M1086084,MYLAN,,80.0,YR,,M,Y,82.0,KG,20211209.0,,MD,HR,HR,2021,Q4,Elderly
201102533,20110253,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, (12 (units) UNK)",,,U,U,,,,,,,,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,3,F,20200201.0,20211201.0,20211124,20211209,EXP,,HR-MYLANLABS-2021M1086084,MYLAN,,80.0,YR,,M,Y,82.0,KG,20211209.0,,MD,HR,HR,2021,Q4,Elderly
201102533,20110253,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, (12 (units) UNK)",,,U,U,,,,,,,,2021,Q4,Renal impairment,,2021,Q4,3,F,20200201.0,20211201.0,20211124,20211209,EXP,,HR-MYLANLABS-2021M1086084,MYLAN,,80.0,YR,,M,Y,82.0,KG,20211209.0,,MD,HR,HR,2021,Q4,Elderly
201102533,20110253,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, (12 (units) UNK)",,,U,U,,,,,,,,2021,Q4,N-terminal prohormone brain natriuretic peptide increased,,2021,Q4,3,F,20200201.0,20211201.0,20211124,20211209,EXP,,HR-MYLANLABS-2021M1086084,MYLAN,,80.0,YR,,M,Y,82.0,KG,20211209.0,,MD,HR,HR,2021,Q4,Elderly
201103641,20110364,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU,,,U,U,,,,,,,,2021,Q4,Skin discolouration,,2021,Q4,1,I,20210214.0,20210217.0,20211124,20211124,PER,,US-NOVOPROD-790331,NOVO NORDISK,,70.0,YR,,F,Y,,,20211124.0,,MD,US,US,2021,Q4,Elderly
201103641,20110364,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU,,,U,U,,,,,,,,2021,Q4,Peripheral coldness,,2021,Q4,1,I,20210214.0,20210217.0,20211124,20211124,PER,,US-NOVOPROD-790331,NOVO NORDISK,,70.0,YR,,F,Y,,,20211124.0,,MD,US,US,2021,Q4,Elderly
201103641,20110364,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 IU,,,U,U,,,,,,,,2021,Q4,Peripheral swelling,,2021,Q4,1,I,20210214.0,20210217.0,20211124,20211124,PER,,US-NOVOPROD-790331,NOVO NORDISK,,70.0,YR,,F,Y,,,20211124.0,,MD,US,US,2021,Q4,Elderly
201105021,20110502,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20210501.0,20210617.0,20211124,20211124,PER,,US-NOVOPROD-823461,NOVO NORDISK,,66.0,YR,,M,Y,128.7,KG,20211124.0,,HP,US,US,2021,Q4,Elderly
201105021,20110502,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Extra dose administered,,2021,Q4,1,I,20210501.0,20210617.0,20211124,20211124,PER,,US-NOVOPROD-823461,NOVO NORDISK,,66.0,YR,,M,Y,128.7,KG,20211124.0,,HP,US,US,2021,Q4,Elderly
201105021,20110502,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Vomiting,,2021,Q4,1,I,20210501.0,20210617.0,20211124,20211124,PER,,US-NOVOPROD-823461,NOVO NORDISK,,66.0,YR,,M,Y,128.7,KG,20211124.0,,HP,US,US,2021,Q4,Elderly
201118891,20111889,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Prothrombin time prolonged,,2021,Q4,1,I,20210101.0,20211115.0,20211125,20211125,PER,,DE-AMGEN-DEUSP2021180250,AMGEN,,73.0,YR,E,M,Y,96.0,KG,20211125.0,,MD,DE,DE,2021,Q4,Elderly
201118891,20111889,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Procalcitonin increased,,2021,Q4,1,I,20210101.0,20211115.0,20211125,20211125,PER,,DE-AMGEN-DEUSP2021180250,AMGEN,,73.0,YR,E,M,Y,96.0,KG,20211125.0,,MD,DE,DE,2021,Q4,Elderly
201118891,20111889,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Lymphadenopathy,,2021,Q4,1,I,20210101.0,20211115.0,20211125,20211125,PER,,DE-AMGEN-DEUSP2021180250,AMGEN,,73.0,YR,E,M,Y,96.0,KG,20211125.0,,MD,DE,DE,2021,Q4,Elderly
201118891,20111889,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Blood chloride increased,,2021,Q4,1,I,20210101.0,20211115.0,20211125,20211125,PER,,DE-AMGEN-DEUSP2021180250,AMGEN,,73.0,YR,E,M,Y,96.0,KG,20211125.0,,MD,DE,DE,2021,Q4,Elderly
201118891,20111889,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Weight decreased,,2021,Q4,1,I,20210101.0,20211115.0,20211125,20211125,PER,,DE-AMGEN-DEUSP2021180250,AMGEN,,73.0,YR,E,M,Y,96.0,KG,20211125.0,,MD,DE,DE,2021,Q4,Elderly
201118891,20111889,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Gamma-glutamyltransferase increased,,2021,Q4,1,I,20210101.0,20211115.0,20211125,20211125,PER,,DE-AMGEN-DEUSP2021180250,AMGEN,,73.0,YR,E,M,Y,96.0,KG,20211125.0,,MD,DE,DE,2021,Q4,Elderly
201118891,20111889,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Neutrophil count decreased,,2021,Q4,1,I,20210101.0,20211115.0,20211125,20211125,PER,,DE-AMGEN-DEUSP2021180250,AMGEN,,73.0,YR,E,M,Y,96.0,KG,20211125.0,,MD,DE,DE,2021,Q4,Elderly
201118891,20111889,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Serum ferritin increased,,2021,Q4,1,I,20210101.0,20211115.0,20211125,20211125,PER,,DE-AMGEN-DEUSP2021180250,AMGEN,,73.0,YR,E,M,Y,96.0,KG,20211125.0,,MD,DE,DE,2021,Q4,Elderly
201118891,20111889,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Platelet count decreased,,2021,Q4,1,I,20210101.0,20211115.0,20211125,20211125,PER,,DE-AMGEN-DEUSP2021180250,AMGEN,,73.0,YR,E,M,Y,96.0,KG,20211125.0,,MD,DE,DE,2021,Q4,Elderly
201118891,20111889,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Myelocyte count increased,,2021,Q4,1,I,20210101.0,20211115.0,20211125,20211125,PER,,DE-AMGEN-DEUSP2021180250,AMGEN,,73.0,YR,E,M,Y,96.0,KG,20211125.0,,MD,DE,DE,2021,Q4,Elderly
201118891,20111889,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Hypotension,,2021,Q4,1,I,20210101.0,20211115.0,20211125,20211125,PER,,DE-AMGEN-DEUSP2021180250,AMGEN,,73.0,YR,E,M,Y,96.0,KG,20211125.0,,MD,DE,DE,2021,Q4,Elderly
201118891,20111889,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Adrenomegaly,,2021,Q4,1,I,20210101.0,20211115.0,20211125,20211125,PER,,DE-AMGEN-DEUSP2021180250,AMGEN,,73.0,YR,E,M,Y,96.0,KG,20211125.0,,MD,DE,DE,2021,Q4,Elderly
201118891,20111889,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Metamyelocyte count increased,,2021,Q4,1,I,20210101.0,20211115.0,20211125,20211125,PER,,DE-AMGEN-DEUSP2021180250,AMGEN,,73.0,YR,E,M,Y,96.0,KG,20211125.0,,MD,DE,DE,2021,Q4,Elderly
201118891,20111889,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Lactose intolerance,,2021,Q4,1,I,20210101.0,20211115.0,20211125,20211125,PER,,DE-AMGEN-DEUSP2021180250,AMGEN,,73.0,YR,E,M,Y,96.0,KG,20211125.0,,MD,DE,DE,2021,Q4,Elderly
201118891,20111889,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,C-reactive protein increased,,2021,Q4,1,I,20210101.0,20211115.0,20211125,20211125,PER,,DE-AMGEN-DEUSP2021180250,AMGEN,,73.0,YR,E,M,Y,96.0,KG,20211125.0,,MD,DE,DE,2021,Q4,Elderly
201118891,20111889,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Herpes simplex,,2021,Q4,1,I,20210101.0,20211115.0,20211125,20211125,PER,,DE-AMGEN-DEUSP2021180250,AMGEN,,73.0,YR,E,M,Y,96.0,KG,20211125.0,,MD,DE,DE,2021,Q4,Elderly
201118891,20111889,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Euphoric mood,,2021,Q4,1,I,20210101.0,20211115.0,20211125,20211125,PER,,DE-AMGEN-DEUSP2021180250,AMGEN,,73.0,YR,E,M,Y,96.0,KG,20211125.0,,MD,DE,DE,2021,Q4,Elderly
201118891,20111889,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Lymphocyte count decreased,,2021,Q4,1,I,20210101.0,20211115.0,20211125,20211125,PER,,DE-AMGEN-DEUSP2021180250,AMGEN,,73.0,YR,E,M,Y,96.0,KG,20211125.0,,MD,DE,DE,2021,Q4,Elderly
201118891,20111889,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20210101.0,20211115.0,20211125,20211125,PER,,DE-AMGEN-DEUSP2021180250,AMGEN,,73.0,YR,E,M,Y,96.0,KG,20211125.0,,MD,DE,DE,2021,Q4,Elderly
201118891,20111889,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Pancreatitis chronic,,2021,Q4,1,I,20210101.0,20211115.0,20211125,20211125,PER,,DE-AMGEN-DEUSP2021180250,AMGEN,,73.0,YR,E,M,Y,96.0,KG,20211125.0,,MD,DE,DE,2021,Q4,Elderly
201118891,20111889,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Activated partial thromboplastin time prolonged,,2021,Q4,1,I,20210101.0,20211115.0,20211125,20211125,PER,,DE-AMGEN-DEUSP2021180250,AMGEN,,73.0,YR,E,M,Y,96.0,KG,20211125.0,,MD,DE,DE,2021,Q4,Elderly
201118891,20111889,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Hepatic calcification,,2021,Q4,1,I,20210101.0,20211115.0,20211125,20211125,PER,,DE-AMGEN-DEUSP2021180250,AMGEN,,73.0,YR,E,M,Y,96.0,KG,20211125.0,,MD,DE,DE,2021,Q4,Elderly
201118891,20111889,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Blood bilirubin increased,,2021,Q4,1,I,20210101.0,20211115.0,20211125,20211125,PER,,DE-AMGEN-DEUSP2021180250,AMGEN,,73.0,YR,E,M,Y,96.0,KG,20211125.0,,MD,DE,DE,2021,Q4,Elderly
201118891,20111889,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Acute lymphocytic leukaemia,,2021,Q4,1,I,20210101.0,20211115.0,20211125,20211125,PER,,DE-AMGEN-DEUSP2021180250,AMGEN,,73.0,YR,E,M,Y,96.0,KG,20211125.0,,MD,DE,DE,2021,Q4,Elderly
201118891,20111889,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Haemangioma,,2021,Q4,1,I,20210101.0,20211115.0,20211125,20211125,PER,,DE-AMGEN-DEUSP2021180250,AMGEN,,73.0,YR,E,M,Y,96.0,KG,20211125.0,,MD,DE,DE,2021,Q4,Elderly
201118891,20111889,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Cytokine release syndrome,,2021,Q4,1,I,20210101.0,20211115.0,20211125,20211125,PER,,DE-AMGEN-DEUSP2021180250,AMGEN,,73.0,YR,E,M,Y,96.0,KG,20211125.0,,MD,DE,DE,2021,Q4,Elderly
201118891,20111889,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Neutropenia,,2021,Q4,1,I,20210101.0,20211115.0,20211125,20211125,PER,,DE-AMGEN-DEUSP2021180250,AMGEN,,73.0,YR,E,M,Y,96.0,KG,20211125.0,,MD,DE,DE,2021,Q4,Elderly
201118891,20111889,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Malignant neoplasm progression,,2021,Q4,1,I,20210101.0,20211115.0,20211125,20211125,PER,,DE-AMGEN-DEUSP2021180250,AMGEN,,73.0,YR,E,M,Y,96.0,KG,20211125.0,,MD,DE,DE,2021,Q4,Elderly
201118891,20111889,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Blood lactate dehydrogenase increased,,2021,Q4,1,I,20210101.0,20211115.0,20211125,20211125,PER,,DE-AMGEN-DEUSP2021180250,AMGEN,,73.0,YR,E,M,Y,96.0,KG,20211125.0,,MD,DE,DE,2021,Q4,Elderly
201118891,20111889,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Pyrexia,,2021,Q4,1,I,20210101.0,20211115.0,20211125,20211125,PER,,DE-AMGEN-DEUSP2021180250,AMGEN,,73.0,YR,E,M,Y,96.0,KG,20211125.0,,MD,DE,DE,2021,Q4,Elderly
201118891,20111889,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Arteriosclerosis coronary artery,,2021,Q4,1,I,20210101.0,20211115.0,20211125,20211125,PER,,DE-AMGEN-DEUSP2021180250,AMGEN,,73.0,YR,E,M,Y,96.0,KG,20211125.0,,MD,DE,DE,2021,Q4,Elderly
201118891,20111889,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Diaphragmatic disorder,,2021,Q4,1,I,20210101.0,20211115.0,20211125,20211125,PER,,DE-AMGEN-DEUSP2021180250,AMGEN,,73.0,YR,E,M,Y,96.0,KG,20211125.0,,MD,DE,DE,2021,Q4,Elderly
201118891,20111889,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Blast cells present,,2021,Q4,1,I,20210101.0,20211115.0,20211125,20211125,PER,,DE-AMGEN-DEUSP2021180250,AMGEN,,73.0,YR,E,M,Y,96.0,KG,20211125.0,,MD,DE,DE,2021,Q4,Elderly
201118891,20111889,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Red cell distribution width increased,,2021,Q4,1,I,20210101.0,20211115.0,20211125,20211125,PER,,DE-AMGEN-DEUSP2021180250,AMGEN,,73.0,YR,E,M,Y,96.0,KG,20211125.0,,MD,DE,DE,2021,Q4,Elderly
201118891,20111889,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Monocyte count decreased,,2021,Q4,1,I,20210101.0,20211115.0,20211125,20211125,PER,,DE-AMGEN-DEUSP2021180250,AMGEN,,73.0,YR,E,M,Y,96.0,KG,20211125.0,,MD,DE,DE,2021,Q4,Elderly
201118891,20111889,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Blood calcium increased,,2021,Q4,1,I,20210101.0,20211115.0,20211125,20211125,PER,,DE-AMGEN-DEUSP2021180250,AMGEN,,73.0,YR,E,M,Y,96.0,KG,20211125.0,,MD,DE,DE,2021,Q4,Elderly
201123342,20112334,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q4,Haemoglobin decreased,,2021,Q4,2,F,20211111.0,20211214.0,20211125,20211222,EXP,,US-Taiho Oncology  Inc-EU-2021-03734,TAIHO ONCOLOGY INC,,81.0,YR,,F,Y,,,20211222.0,,CN,US,US,2021,Q4,Elderly
201123342,20112334,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q4,Vomiting,,2021,Q4,2,F,20211111.0,20211214.0,20211125,20211222,EXP,,US-Taiho Oncology  Inc-EU-2021-03734,TAIHO ONCOLOGY INC,,81.0,YR,,F,Y,,,20211222.0,,CN,US,US,2021,Q4,Elderly
201123342,20112334,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2021,Q4,Stoma site haemorrhage,,2021,Q4,2,F,20211111.0,20211214.0,20211125,20211222,EXP,,US-Taiho Oncology  Inc-EU-2021-03734,TAIHO ONCOLOGY INC,,81.0,YR,,F,Y,,,20211222.0,,CN,US,US,2021,Q4,Elderly
201124721,20112472,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,650 mg,,,,,,,,650.0,MG,Solution for injection,,2021,Q4,Aplastic anaemia,,2021,Q4,1,I,,20211112.0,20211125,20211125,EXP,,CA-PFIZER INC-202101583730,PFIZER,,20.0,YR,,M,Y,84.0,KG,20211125.0,,HP,CA,CA,2021,Q4,Youth
201125042,20112504,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2021,Q4,Enterococcal infection,,2021,Q4,2,F,20180101.0,20211125.0,20211125,20211201,EXP,,DE-PFIZER INC-2021255837,PFIZER,,73.0,YR,,M,Y,96.0,KG,20211201.0,,MD,DE,DE,2021,Q4,Elderly
201125042,20112504,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2021,Q4,Costal cartilage fracture,,2021,Q4,2,F,20180101.0,20211125.0,20211125,20211201,EXP,,DE-PFIZER INC-2021255837,PFIZER,,73.0,YR,,M,Y,96.0,KG,20211201.0,,MD,DE,DE,2021,Q4,Elderly
201125042,20112504,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2021,Q4,Blood lactate dehydrogenase increased,,2021,Q4,2,F,20180101.0,20211125.0,20211125,20211201,EXP,,DE-PFIZER INC-2021255837,PFIZER,,73.0,YR,,M,Y,96.0,KG,20211201.0,,MD,DE,DE,2021,Q4,Elderly
201125042,20112504,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2021,Q4,Escherichia urinary tract infection,,2021,Q4,2,F,20180101.0,20211125.0,20211125,20211201,EXP,,DE-PFIZER INC-2021255837,PFIZER,,73.0,YR,,M,Y,96.0,KG,20211201.0,,MD,DE,DE,2021,Q4,Elderly
201125042,20112504,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2021,Q4,Lactose intolerance,,2021,Q4,2,F,20180101.0,20211125.0,20211125,20211201,EXP,,DE-PFIZER INC-2021255837,PFIZER,,73.0,YR,,M,Y,96.0,KG,20211201.0,,MD,DE,DE,2021,Q4,Elderly
201125042,20112504,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2021,Q4,Blood calcium increased,,2021,Q4,2,F,20180101.0,20211125.0,20211125,20211201,EXP,,DE-PFIZER INC-2021255837,PFIZER,,73.0,YR,,M,Y,96.0,KG,20211201.0,,MD,DE,DE,2021,Q4,Elderly
201125042,20112504,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2021,Q4,Febrile infection,,2021,Q4,2,F,20180101.0,20211125.0,20211125,20211201,EXP,,DE-PFIZER INC-2021255837,PFIZER,,73.0,YR,,M,Y,96.0,KG,20211201.0,,MD,DE,DE,2021,Q4,Elderly
201125042,20112504,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2021,Q4,Fatigue,,2021,Q4,2,F,20180101.0,20211125.0,20211125,20211201,EXP,,DE-PFIZER INC-2021255837,PFIZER,,73.0,YR,,M,Y,96.0,KG,20211201.0,,MD,DE,DE,2021,Q4,Elderly
201125042,20112504,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2021,Q4,Pancreatitis chronic,,2021,Q4,2,F,20180101.0,20211125.0,20211125,20211201,EXP,,DE-PFIZER INC-2021255837,PFIZER,,73.0,YR,,M,Y,96.0,KG,20211201.0,,MD,DE,DE,2021,Q4,Elderly
201125042,20112504,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2021,Q4,Neutropenia,,2021,Q4,2,F,20180101.0,20211125.0,20211125,20211201,EXP,,DE-PFIZER INC-2021255837,PFIZER,,73.0,YR,,M,Y,96.0,KG,20211201.0,,MD,DE,DE,2021,Q4,Elderly
201125042,20112504,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2021,Q4,Neoplasm recurrence,,2021,Q4,2,F,20180101.0,20211125.0,20211125,20211201,EXP,,DE-PFIZER INC-2021255837,PFIZER,,73.0,YR,,M,Y,96.0,KG,20211201.0,,MD,DE,DE,2021,Q4,Elderly
201125042,20112504,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2021,Q4,Cytokine release syndrome,,2021,Q4,2,F,20180101.0,20211125.0,20211125,20211201,EXP,,DE-PFIZER INC-2021255837,PFIZER,,73.0,YR,,M,Y,96.0,KG,20211201.0,,MD,DE,DE,2021,Q4,Elderly
201125042,20112504,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2021,Q4,Weight decreased,,2021,Q4,2,F,20180101.0,20211125.0,20211125,20211201,EXP,,DE-PFIZER INC-2021255837,PFIZER,,73.0,YR,,M,Y,96.0,KG,20211201.0,,MD,DE,DE,2021,Q4,Elderly
201125042,20112504,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2021,Q4,Serum ferritin increased,,2021,Q4,2,F,20180101.0,20211125.0,20211125,20211201,EXP,,DE-PFIZER INC-2021255837,PFIZER,,73.0,YR,,M,Y,96.0,KG,20211201.0,,MD,DE,DE,2021,Q4,Elderly
201125042,20112504,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2021,Q4,Red cell distribution width increased,,2021,Q4,2,F,20180101.0,20211125.0,20211125,20211201,EXP,,DE-PFIZER INC-2021255837,PFIZER,,73.0,YR,,M,Y,96.0,KG,20211201.0,,MD,DE,DE,2021,Q4,Elderly
201125042,20112504,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2021,Q4,Neutrophil count decreased,,2021,Q4,2,F,20180101.0,20211125.0,20211125,20211201,EXP,,DE-PFIZER INC-2021255837,PFIZER,,73.0,YR,,M,Y,96.0,KG,20211201.0,,MD,DE,DE,2021,Q4,Elderly
201125042,20112504,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2021,Q4,Blast cells present,,2021,Q4,2,F,20180101.0,20211125.0,20211125,20211201,EXP,,DE-PFIZER INC-2021255837,PFIZER,,73.0,YR,,M,Y,96.0,KG,20211201.0,,MD,DE,DE,2021,Q4,Elderly
201125042,20112504,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2021,Q4,Hypotension,,2021,Q4,2,F,20180101.0,20211125.0,20211125,20211201,EXP,,DE-PFIZER INC-2021255837,PFIZER,,73.0,YR,,M,Y,96.0,KG,20211201.0,,MD,DE,DE,2021,Q4,Elderly
201125042,20112504,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2021,Q4,Pyrexia,,2021,Q4,2,F,20180101.0,20211125.0,20211125,20211201,EXP,,DE-PFIZER INC-2021255837,PFIZER,,73.0,YR,,M,Y,96.0,KG,20211201.0,,MD,DE,DE,2021,Q4,Elderly
201125042,20112504,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2021,Q4,Platelet count decreased,,2021,Q4,2,F,20180101.0,20211125.0,20211125,20211201,EXP,,DE-PFIZER INC-2021255837,PFIZER,,73.0,YR,,M,Y,96.0,KG,20211201.0,,MD,DE,DE,2021,Q4,Elderly
201125042,20112504,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2021,Q4,Blood glucose increased,,2021,Q4,2,F,20180101.0,20211125.0,20211125,20211201,EXP,,DE-PFIZER INC-2021255837,PFIZER,,73.0,YR,,M,Y,96.0,KG,20211201.0,,MD,DE,DE,2021,Q4,Elderly
201125042,20112504,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2021,Q4,Activated partial thromboplastin time prolonged,,2021,Q4,2,F,20180101.0,20211125.0,20211125,20211201,EXP,,DE-PFIZER INC-2021255837,PFIZER,,73.0,YR,,M,Y,96.0,KG,20211201.0,,MD,DE,DE,2021,Q4,Elderly
201125042,20112504,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2021,Q4,Blood bilirubin increased,,2021,Q4,2,F,20180101.0,20211125.0,20211125,20211201,EXP,,DE-PFIZER INC-2021255837,PFIZER,,73.0,YR,,M,Y,96.0,KG,20211201.0,,MD,DE,DE,2021,Q4,Elderly
201125042,20112504,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2021,Q4,Lymphadenopathy,,2021,Q4,2,F,20180101.0,20211125.0,20211125,20211201,EXP,,DE-PFIZER INC-2021255837,PFIZER,,73.0,YR,,M,Y,96.0,KG,20211201.0,,MD,DE,DE,2021,Q4,Elderly
201125042,20112504,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2021,Q4,Metamyelocyte count increased,,2021,Q4,2,F,20180101.0,20211125.0,20211125,20211201,EXP,,DE-PFIZER INC-2021255837,PFIZER,,73.0,YR,,M,Y,96.0,KG,20211201.0,,MD,DE,DE,2021,Q4,Elderly
201125042,20112504,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2021,Q4,Monocyte count decreased,,2021,Q4,2,F,20180101.0,20211125.0,20211125,20211201,EXP,,DE-PFIZER INC-2021255837,PFIZER,,73.0,YR,,M,Y,96.0,KG,20211201.0,,MD,DE,DE,2021,Q4,Elderly
201125042,20112504,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2021,Q4,Herpes simplex,,2021,Q4,2,F,20180101.0,20211125.0,20211125,20211201,EXP,,DE-PFIZER INC-2021255837,PFIZER,,73.0,YR,,M,Y,96.0,KG,20211201.0,,MD,DE,DE,2021,Q4,Elderly
201125042,20112504,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2021,Q4,Osteolysis,,2021,Q4,2,F,20180101.0,20211125.0,20211125,20211201,EXP,,DE-PFIZER INC-2021255837,PFIZER,,73.0,YR,,M,Y,96.0,KG,20211201.0,,MD,DE,DE,2021,Q4,Elderly
201125042,20112504,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2021,Q4,Gastritis,,2021,Q4,2,F,20180101.0,20211125.0,20211125,20211201,EXP,,DE-PFIZER INC-2021255837,PFIZER,,73.0,YR,,M,Y,96.0,KG,20211201.0,,MD,DE,DE,2021,Q4,Elderly
201125042,20112504,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2021,Q4,Prothrombin time prolonged,,2021,Q4,2,F,20180101.0,20211125.0,20211125,20211201,EXP,,DE-PFIZER INC-2021255837,PFIZER,,73.0,YR,,M,Y,96.0,KG,20211201.0,,MD,DE,DE,2021,Q4,Elderly
201125042,20112504,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2021,Q4,Blood chloride increased,,2021,Q4,2,F,20180101.0,20211125.0,20211125,20211201,EXP,,DE-PFIZER INC-2021255837,PFIZER,,73.0,YR,,M,Y,96.0,KG,20211201.0,,MD,DE,DE,2021,Q4,Elderly
201125042,20112504,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2021,Q4,Myelocyte count increased,,2021,Q4,2,F,20180101.0,20211125.0,20211125,20211201,EXP,,DE-PFIZER INC-2021255837,PFIZER,,73.0,YR,,M,Y,96.0,KG,20211201.0,,MD,DE,DE,2021,Q4,Elderly
201125042,20112504,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2021,Q4,Haemangioma,,2021,Q4,2,F,20180101.0,20211125.0,20211125,20211201,EXP,,DE-PFIZER INC-2021255837,PFIZER,,73.0,YR,,M,Y,96.0,KG,20211201.0,,MD,DE,DE,2021,Q4,Elderly
201125042,20112504,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2021,Q4,Adrenomegaly,,2021,Q4,2,F,20180101.0,20211125.0,20211125,20211201,EXP,,DE-PFIZER INC-2021255837,PFIZER,,73.0,YR,,M,Y,96.0,KG,20211201.0,,MD,DE,DE,2021,Q4,Elderly
201125042,20112504,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2021,Q4,Lymphocyte count decreased,,2021,Q4,2,F,20180101.0,20211125.0,20211125,20211201,EXP,,DE-PFIZER INC-2021255837,PFIZER,,73.0,YR,,M,Y,96.0,KG,20211201.0,,MD,DE,DE,2021,Q4,Elderly
201125042,20112504,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2021,Q4,Arteriosclerosis coronary artery,,2021,Q4,2,F,20180101.0,20211125.0,20211125,20211201,EXP,,DE-PFIZER INC-2021255837,PFIZER,,73.0,YR,,M,Y,96.0,KG,20211201.0,,MD,DE,DE,2021,Q4,Elderly
201125042,20112504,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2021,Q4,White blood cell count increased,,2021,Q4,2,F,20180101.0,20211125.0,20211125,20211201,EXP,,DE-PFIZER INC-2021255837,PFIZER,,73.0,YR,,M,Y,96.0,KG,20211201.0,,MD,DE,DE,2021,Q4,Elderly
201125042,20112504,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2021,Q4,Procalcitonin increased,,2021,Q4,2,F,20180101.0,20211125.0,20211125,20211201,EXP,,DE-PFIZER INC-2021255837,PFIZER,,73.0,YR,,M,Y,96.0,KG,20211201.0,,MD,DE,DE,2021,Q4,Elderly
201125042,20112504,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2021,Q4,Hepatic calcification,,2021,Q4,2,F,20180101.0,20211125.0,20211125,20211201,EXP,,DE-PFIZER INC-2021255837,PFIZER,,73.0,YR,,M,Y,96.0,KG,20211201.0,,MD,DE,DE,2021,Q4,Elderly
201125042,20112504,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2021,Q4,Diaphragmatic disorder,,2021,Q4,2,F,20180101.0,20211125.0,20211125,20211201,EXP,,DE-PFIZER INC-2021255837,PFIZER,,73.0,YR,,M,Y,96.0,KG,20211201.0,,MD,DE,DE,2021,Q4,Elderly
201125042,20112504,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2021,Q4,C-reactive protein increased,,2021,Q4,2,F,20180101.0,20211125.0,20211125,20211201,EXP,,DE-PFIZER INC-2021255837,PFIZER,,73.0,YR,,M,Y,96.0,KG,20211201.0,,MD,DE,DE,2021,Q4,Elderly
201125042,20112504,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2021,Q4,Gamma-glutamyltransferase increased,,2021,Q4,2,F,20180101.0,20211125.0,20211125,20211201,EXP,,DE-PFIZER INC-2021255837,PFIZER,,73.0,YR,,M,Y,96.0,KG,20211201.0,,MD,DE,DE,2021,Q4,Elderly
201138703,20113870,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 DF (22 Unit), qd",,,,,,,,,,,QD,2021,Q4,Pneumonia,,2021,Q4,3,F,20201201.0,20211209.0,20211125,20211213,EXP,,IT-GLAXOSMITHKLINE-IT2021GSK224286,GLAXOSMITHKLINE,,70.0,YR,,F,Y,82.0,KG,20211213.0,,MD,IT,IT,2021,Q4,Elderly
201187341,20118734,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Inappropriate antidiuretic hormone secretion,,2021,Q4,1,I,,20211111.0,20211126,20211126,EXP,,PT-SUNOVION-2021SUN004446,SUNOVION,,53.0,YR,,M,Y,,,20211126.0,,HP,QA,QA,2021,Q4,Adult
201187341,20118734,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Generalised tonic-clonic seizure,,2021,Q4,1,I,,20211111.0,20211126,20211126,EXP,,PT-SUNOVION-2021SUN004446,SUNOVION,,53.0,YR,,M,Y,,,20211126.0,,HP,QA,QA,2021,Q4,Adult
201187341,20118734,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Off label use,,2021,Q4,1,I,,20211111.0,20211126,20211126,EXP,,PT-SUNOVION-2021SUN004446,SUNOVION,,53.0,YR,,M,Y,,,20211126.0,,HP,QA,QA,2021,Q4,Adult
201187341,20118734,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Hyponatraemia,,2021,Q4,1,I,,20211111.0,20211126,20211126,EXP,,PT-SUNOVION-2021SUN004446,SUNOVION,,53.0,YR,,M,Y,,,20211126.0,,HP,QA,QA,2021,Q4,Adult
201189692,20118969,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Product use in unapproved indication,,2021,Q4,2,F,,20211130.0,20211126,20211203,EXP,,GR-009507513-2111GRC008105,MERCK,"Liatsos, G, Tsiriga Athanasia, Dourakis S.. Fatal Streptococcus pseudoporcinus disseminated infection in decompensated liver cirrhosis: a Case Report.. Journal of Medical Case Reports.. 2021;15:240",56.0,YR,,M,Y,,,20211203.0,,HP,GR,GR,2021,Q4,Adult
201203761,20120376,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Escherichia urinary tract infection,,2021,Q4,1,I,20180101.0,20211111.0,20211126,20211126,EXP,,DE-JAZZ-2021-DE-004405,JAZZ,,73.0,YR,,M,Y,96.0,KG,20211126.0,,MD,DE,DE,2021,Q4,Elderly
201203761,20120376,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,White blood cell count increased,,2021,Q4,1,I,20180101.0,20211111.0,20211126,20211126,EXP,,DE-JAZZ-2021-DE-004405,JAZZ,,73.0,YR,,M,Y,96.0,KG,20211126.0,,MD,DE,DE,2021,Q4,Elderly
201203761,20120376,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Hepatic calcification,,2021,Q4,1,I,20180101.0,20211111.0,20211126,20211126,EXP,,DE-JAZZ-2021-DE-004405,JAZZ,,73.0,YR,,M,Y,96.0,KG,20211126.0,,MD,DE,DE,2021,Q4,Elderly
201203761,20120376,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Adrenomegaly,,2021,Q4,1,I,20180101.0,20211111.0,20211126,20211126,EXP,,DE-JAZZ-2021-DE-004405,JAZZ,,73.0,YR,,M,Y,96.0,KG,20211126.0,,MD,DE,DE,2021,Q4,Elderly
201203761,20120376,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Monocyte count decreased,,2021,Q4,1,I,20180101.0,20211111.0,20211126,20211126,EXP,,DE-JAZZ-2021-DE-004405,JAZZ,,73.0,YR,,M,Y,96.0,KG,20211126.0,,MD,DE,DE,2021,Q4,Elderly
201203761,20120376,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Blast cells present,,2021,Q4,1,I,20180101.0,20211111.0,20211126,20211126,EXP,,DE-JAZZ-2021-DE-004405,JAZZ,,73.0,YR,,M,Y,96.0,KG,20211126.0,,MD,DE,DE,2021,Q4,Elderly
201203761,20120376,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Pancreatitis chronic,,2021,Q4,1,I,20180101.0,20211111.0,20211126,20211126,EXP,,DE-JAZZ-2021-DE-004405,JAZZ,,73.0,YR,,M,Y,96.0,KG,20211126.0,,MD,DE,DE,2021,Q4,Elderly
201203761,20120376,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Malignant neoplasm progression,,2021,Q4,1,I,20180101.0,20211111.0,20211126,20211126,EXP,,DE-JAZZ-2021-DE-004405,JAZZ,,73.0,YR,,M,Y,96.0,KG,20211126.0,,MD,DE,DE,2021,Q4,Elderly
201203761,20120376,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20180101.0,20211111.0,20211126,20211126,EXP,,DE-JAZZ-2021-DE-004405,JAZZ,,73.0,YR,,M,Y,96.0,KG,20211126.0,,MD,DE,DE,2021,Q4,Elderly
201203761,20120376,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Blood calcium increased,,2021,Q4,1,I,20180101.0,20211111.0,20211126,20211126,EXP,,DE-JAZZ-2021-DE-004405,JAZZ,,73.0,YR,,M,Y,96.0,KG,20211126.0,,MD,DE,DE,2021,Q4,Elderly
201203761,20120376,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Red cell distribution width increased,,2021,Q4,1,I,20180101.0,20211111.0,20211126,20211126,EXP,,DE-JAZZ-2021-DE-004405,JAZZ,,73.0,YR,,M,Y,96.0,KG,20211126.0,,MD,DE,DE,2021,Q4,Elderly
201203761,20120376,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Gastritis,,2021,Q4,1,I,20180101.0,20211111.0,20211126,20211126,EXP,,DE-JAZZ-2021-DE-004405,JAZZ,,73.0,YR,,M,Y,96.0,KG,20211126.0,,MD,DE,DE,2021,Q4,Elderly
201203761,20120376,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Febrile infection,,2021,Q4,1,I,20180101.0,20211111.0,20211126,20211126,EXP,,DE-JAZZ-2021-DE-004405,JAZZ,,73.0,YR,,M,Y,96.0,KG,20211126.0,,MD,DE,DE,2021,Q4,Elderly
201203761,20120376,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Herpes simplex,,2021,Q4,1,I,20180101.0,20211111.0,20211126,20211126,EXP,,DE-JAZZ-2021-DE-004405,JAZZ,,73.0,YR,,M,Y,96.0,KG,20211126.0,,MD,DE,DE,2021,Q4,Elderly
201203761,20120376,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Hypotension,,2021,Q4,1,I,20180101.0,20211111.0,20211126,20211126,EXP,,DE-JAZZ-2021-DE-004405,JAZZ,,73.0,YR,,M,Y,96.0,KG,20211126.0,,MD,DE,DE,2021,Q4,Elderly
201203761,20120376,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Serum ferritin increased,,2021,Q4,1,I,20180101.0,20211111.0,20211126,20211126,EXP,,DE-JAZZ-2021-DE-004405,JAZZ,,73.0,YR,,M,Y,96.0,KG,20211126.0,,MD,DE,DE,2021,Q4,Elderly
201203761,20120376,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Haemangioma,,2021,Q4,1,I,20180101.0,20211111.0,20211126,20211126,EXP,,DE-JAZZ-2021-DE-004405,JAZZ,,73.0,YR,,M,Y,96.0,KG,20211126.0,,MD,DE,DE,2021,Q4,Elderly
201203761,20120376,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Lymphadenopathy,,2021,Q4,1,I,20180101.0,20211111.0,20211126,20211126,EXP,,DE-JAZZ-2021-DE-004405,JAZZ,,73.0,YR,,M,Y,96.0,KG,20211126.0,,MD,DE,DE,2021,Q4,Elderly
201203761,20120376,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Acute lymphocytic leukaemia recurrent,,2021,Q4,1,I,20180101.0,20211111.0,20211126,20211126,EXP,,DE-JAZZ-2021-DE-004405,JAZZ,,73.0,YR,,M,Y,96.0,KG,20211126.0,,MD,DE,DE,2021,Q4,Elderly
201203761,20120376,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Activated partial thromboplastin time prolonged,,2021,Q4,1,I,20180101.0,20211111.0,20211126,20211126,EXP,,DE-JAZZ-2021-DE-004405,JAZZ,,73.0,YR,,M,Y,96.0,KG,20211126.0,,MD,DE,DE,2021,Q4,Elderly
201203761,20120376,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Gamma-glutamyltransferase increased,,2021,Q4,1,I,20180101.0,20211111.0,20211126,20211126,EXP,,DE-JAZZ-2021-DE-004405,JAZZ,,73.0,YR,,M,Y,96.0,KG,20211126.0,,MD,DE,DE,2021,Q4,Elderly
201203761,20120376,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Blood galactose increased,,2021,Q4,1,I,20180101.0,20211111.0,20211126,20211126,EXP,,DE-JAZZ-2021-DE-004405,JAZZ,,73.0,YR,,M,Y,96.0,KG,20211126.0,,MD,DE,DE,2021,Q4,Elderly
201203761,20120376,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Platelet count decreased,,2021,Q4,1,I,20180101.0,20211111.0,20211126,20211126,EXP,,DE-JAZZ-2021-DE-004405,JAZZ,,73.0,YR,,M,Y,96.0,KG,20211126.0,,MD,DE,DE,2021,Q4,Elderly
201203761,20120376,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Blood lactate dehydrogenase increased,,2021,Q4,1,I,20180101.0,20211111.0,20211126,20211126,EXP,,DE-JAZZ-2021-DE-004405,JAZZ,,73.0,YR,,M,Y,96.0,KG,20211126.0,,MD,DE,DE,2021,Q4,Elderly
201203761,20120376,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Enterococcal infection,,2021,Q4,1,I,20180101.0,20211111.0,20211126,20211126,EXP,,DE-JAZZ-2021-DE-004405,JAZZ,,73.0,YR,,M,Y,96.0,KG,20211126.0,,MD,DE,DE,2021,Q4,Elderly
201203761,20120376,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Blood chloride increased,,2021,Q4,1,I,20180101.0,20211111.0,20211126,20211126,EXP,,DE-JAZZ-2021-DE-004405,JAZZ,,73.0,YR,,M,Y,96.0,KG,20211126.0,,MD,DE,DE,2021,Q4,Elderly
201203761,20120376,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Neutrophil count decreased,,2021,Q4,1,I,20180101.0,20211111.0,20211126,20211126,EXP,,DE-JAZZ-2021-DE-004405,JAZZ,,73.0,YR,,M,Y,96.0,KG,20211126.0,,MD,DE,DE,2021,Q4,Elderly
201203761,20120376,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Arteriosclerosis coronary artery,,2021,Q4,1,I,20180101.0,20211111.0,20211126,20211126,EXP,,DE-JAZZ-2021-DE-004405,JAZZ,,73.0,YR,,M,Y,96.0,KG,20211126.0,,MD,DE,DE,2021,Q4,Elderly
201203761,20120376,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Diaphragmatic disorder,,2021,Q4,1,I,20180101.0,20211111.0,20211126,20211126,EXP,,DE-JAZZ-2021-DE-004405,JAZZ,,73.0,YR,,M,Y,96.0,KG,20211126.0,,MD,DE,DE,2021,Q4,Elderly
201203761,20120376,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Blood bilirubin increased,,2021,Q4,1,I,20180101.0,20211111.0,20211126,20211126,EXP,,DE-JAZZ-2021-DE-004405,JAZZ,,73.0,YR,,M,Y,96.0,KG,20211126.0,,MD,DE,DE,2021,Q4,Elderly
201203761,20120376,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Procalcitonin increased,,2021,Q4,1,I,20180101.0,20211111.0,20211126,20211126,EXP,,DE-JAZZ-2021-DE-004405,JAZZ,,73.0,YR,,M,Y,96.0,KG,20211126.0,,MD,DE,DE,2021,Q4,Elderly
201203761,20120376,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Myelocyte count increased,,2021,Q4,1,I,20180101.0,20211111.0,20211126,20211126,EXP,,DE-JAZZ-2021-DE-004405,JAZZ,,73.0,YR,,M,Y,96.0,KG,20211126.0,,MD,DE,DE,2021,Q4,Elderly
201203761,20120376,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Pyrexia,,2021,Q4,1,I,20180101.0,20211111.0,20211126,20211126,EXP,,DE-JAZZ-2021-DE-004405,JAZZ,,73.0,YR,,M,Y,96.0,KG,20211126.0,,MD,DE,DE,2021,Q4,Elderly
201203761,20120376,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Euphoric mood,,2021,Q4,1,I,20180101.0,20211111.0,20211126,20211126,EXP,,DE-JAZZ-2021-DE-004405,JAZZ,,73.0,YR,,M,Y,96.0,KG,20211126.0,,MD,DE,DE,2021,Q4,Elderly
201203761,20120376,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Costal cartilage fracture,,2021,Q4,1,I,20180101.0,20211111.0,20211126,20211126,EXP,,DE-JAZZ-2021-DE-004405,JAZZ,,73.0,YR,,M,Y,96.0,KG,20211126.0,,MD,DE,DE,2021,Q4,Elderly
201203761,20120376,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Prothrombin time prolonged,,2021,Q4,1,I,20180101.0,20211111.0,20211126,20211126,EXP,,DE-JAZZ-2021-DE-004405,JAZZ,,73.0,YR,,M,Y,96.0,KG,20211126.0,,MD,DE,DE,2021,Q4,Elderly
201203761,20120376,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Metamyelocyte count increased,,2021,Q4,1,I,20180101.0,20211111.0,20211126,20211126,EXP,,DE-JAZZ-2021-DE-004405,JAZZ,,73.0,YR,,M,Y,96.0,KG,20211126.0,,MD,DE,DE,2021,Q4,Elderly
201203761,20120376,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,C-reactive protein increased,,2021,Q4,1,I,20180101.0,20211111.0,20211126,20211126,EXP,,DE-JAZZ-2021-DE-004405,JAZZ,,73.0,YR,,M,Y,96.0,KG,20211126.0,,MD,DE,DE,2021,Q4,Elderly
201203761,20120376,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Cytokine release syndrome,,2021,Q4,1,I,20180101.0,20211111.0,20211126,20211126,EXP,,DE-JAZZ-2021-DE-004405,JAZZ,,73.0,YR,,M,Y,96.0,KG,20211126.0,,MD,DE,DE,2021,Q4,Elderly
201203761,20120376,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Weight decreased,,2021,Q4,1,I,20180101.0,20211111.0,20211126,20211126,EXP,,DE-JAZZ-2021-DE-004405,JAZZ,,73.0,YR,,M,Y,96.0,KG,20211126.0,,MD,DE,DE,2021,Q4,Elderly
201203761,20120376,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Neutropenia,,2021,Q4,1,I,20180101.0,20211111.0,20211126,20211126,EXP,,DE-JAZZ-2021-DE-004405,JAZZ,,73.0,YR,,M,Y,96.0,KG,20211126.0,,MD,DE,DE,2021,Q4,Elderly
201203761,20120376,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Enterococcal infection,,2021,Q4,1,I,20180101.0,20211111.0,20211126,20211126,EXP,,DE-JAZZ-2021-DE-004405,JAZZ,,73.0,YR,,M,Y,96.0,KG,20211126.0,,MD,DE,DE,2021,Q4,Elderly
201203761,20120376,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Lymphocyte count decreased,,2021,Q4,1,I,20180101.0,20211111.0,20211126,20211126,EXP,,DE-JAZZ-2021-DE-004405,JAZZ,,73.0,YR,,M,Y,96.0,KG,20211126.0,,MD,DE,DE,2021,Q4,Elderly
201236141,20123614,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,40 units/day,,,,,unknown,,,,,,,2021,Q4,Osteopenia,,2021,Q4,1,I,,20211117.0,20211129,20211129,EXP,,BR-NOVOPROD-869091,NOVO NORDISK,,61.0,YR,,F,Y,72.0,KG,20211129.0,,MD,BR,BR,2021,Q4,Adult
201236141,20123614,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,40 units/day,,,,,unknown,,,,,,,2021,Q4,Thyroid mass,,2021,Q4,1,I,,20211117.0,20211129,20211129,EXP,,BR-NOVOPROD-869091,NOVO NORDISK,,61.0,YR,,F,Y,72.0,KG,20211129.0,,MD,BR,BR,2021,Q4,Adult
201239491,20123949,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, unknown freq.",,,,,,,,,,Formulation unknown,,2021,Q4,Off label use,,2021,Q4,1,I,,20211117.0,20211129,20211129,EXP,,FR-ASTELLAS-2021US045330,ASTELLAS,"Chevalier K., Barde F., Benhamida S., Le MM, Thyrault M., Bentoumi Y., et al... Invasive aspergillosis and endocarditis.. Revue de Medecine Interne. 2021;42(10):678-685",58.0,YR,,M,Y,,,20211129.0,,HP,FR,FR,2021,Q4,Adult
201239491,20123949,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, unknown freq.",,,,,,,,,,Formulation unknown,,2021,Q4,Drug ineffective,,2021,Q4,1,I,,20211117.0,20211129,20211129,EXP,,FR-ASTELLAS-2021US045330,ASTELLAS,"Chevalier K., Barde F., Benhamida S., Le MM, Thyrault M., Bentoumi Y., et al... Invasive aspergillosis and endocarditis.. Revue de Medecine Interne. 2021;42(10):678-685",58.0,YR,,M,Y,,,20211129.0,,HP,FR,FR,2021,Q4,Adult
201244582,20124458,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,7 Dosage forms Daily;,,,,,,,,,,,QD,2021,Q4,Rib fracture,,2021,Q4,2,F,20211106.0,20211202.0,20211129,20211209,EXP,,JP-TEVA-2021-JP-005922J,TEVA,,74.0,YR,E,M,Y,,,20211209.0,,PH,JP,JP,2021,Q4,Elderly
201244582,20124458,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,7 Dosage forms Daily;,,,,,,,,,,,QD,2021,Q4,Fall,,2021,Q4,2,F,20211106.0,20211202.0,20211129,20211209,EXP,,JP-TEVA-2021-JP-005922J,TEVA,,74.0,YR,E,M,Y,,,20211209.0,,PH,JP,JP,2021,Q4,Elderly
201247431,20124743,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, each evening",,,U,,,,,,,,QD,2021,Q4,Hepatitis acute,,2021,Q4,1,I,,20211116.0,20211129,20211129,EXP,,US-ELI_LILLY_AND_COMPANY-US202111007252,ELI LILLY AND CO,"Sasidharan Pillai S, Quintos J.B, Topor L.S..Acute Hepatitis due to Hepatic Glycogenosis After Insulin Overdose and Oral Glucose Administration in an Adolescent.Journal of the Endocrine Society 2021;5 (11):1-6.DOI:doi.org/10.1210/jendso/bvab142",16.0,YR,,M,Y,,,20211129.0,,MD,US,US,2021,Q4,Youth
201247431,20124743,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, each evening",,,U,,,,,,,,QD,2021,Q4,Glycogen storage disease type VIII,,2021,Q4,1,I,,20211116.0,20211129,20211129,EXP,,US-ELI_LILLY_AND_COMPANY-US202111007252,ELI LILLY AND CO,"Sasidharan Pillai S, Quintos J.B, Topor L.S..Acute Hepatitis due to Hepatic Glycogenosis After Insulin Overdose and Oral Glucose Administration in an Adolescent.Journal of the Endocrine Society 2021;5 (11):1-6.DOI:doi.org/10.1210/jendso/bvab142",16.0,YR,,M,Y,,,20211129.0,,MD,US,US,2021,Q4,Youth
201247431,20124743,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, each evening",,,U,,,,,,,,QD,2021,Q4,Overdose,,2021,Q4,1,I,,20211116.0,20211129,20211129,EXP,,US-ELI_LILLY_AND_COMPANY-US202111007252,ELI LILLY AND CO,"Sasidharan Pillai S, Quintos J.B, Topor L.S..Acute Hepatitis due to Hepatic Glycogenosis After Insulin Overdose and Oral Glucose Administration in an Adolescent.Journal of the Endocrine Society 2021;5 (11):1-6.DOI:doi.org/10.1210/jendso/bvab142",16.0,YR,,M,Y,,,20211129.0,,MD,US,US,2021,Q4,Youth
201247431,20124743,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, each evening",,,U,,,,,,,,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211116.0,20211129,20211129,EXP,,US-ELI_LILLY_AND_COMPANY-US202111007252,ELI LILLY AND CO,"Sasidharan Pillai S, Quintos J.B, Topor L.S..Acute Hepatitis due to Hepatic Glycogenosis After Insulin Overdose and Oral Glucose Administration in an Adolescent.Journal of the Endocrine Society 2021;5 (11):1-6.DOI:doi.org/10.1210/jendso/bvab142",16.0,YR,,M,Y,,,20211129.0,,MD,US,US,2021,Q4,Youth
201251721,20125172,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 dosage form, qd",,,Y,U,,,210605.0,,,Injection,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20210722.0,20211118.0,20211129,20211129,EXP,IT-MINISAL02-772927,IT-MYLANLABS-2021M1084749,MYLAN,,84.0,YR,,F,Y,,,20211129.0,,MD,IT,IT,2021,Q4,Elderly
201251721,20125172,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 dosage form, qd",,,Y,U,,,210605.0,,,Injection,QD,2021,Q4,Medication error,,2021,Q4,1,I,20210722.0,20211118.0,20211129,20211129,EXP,IT-MINISAL02-772927,IT-MYLANLABS-2021M1084749,MYLAN,,84.0,YR,,F,Y,,,20211129.0,,MD,IT,IT,2021,Q4,Elderly
201274991,20127499,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (more than 80 units),,,D,,,,,,,,,2021,Q4,Illness,,2021,Q4,1,I,,20211125.0,20211129,20211129,EXP,,ES-MYLANLABS-2021M1087970,MYLAN,,52.0,YR,,M,Y,90.3,KG,20211129.0,,CN,ES,ES,2021,Q4,Adult
201274991,20127499,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (more than 80 units),,,D,,,,,,,,,2021,Q4,Medication error,,2021,Q4,1,I,,20211125.0,20211129,20211129,EXP,,ES-MYLANLABS-2021M1087970,MYLAN,,52.0,YR,,M,Y,90.3,KG,20211129.0,,CN,ES,ES,2021,Q4,Adult
201274991,20127499,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (more than 80 units),,,D,,,,,,,,,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,,20211125.0,20211129,20211129,EXP,,ES-MYLANLABS-2021M1087970,MYLAN,,52.0,YR,,M,Y,90.3,KG,20211129.0,,CN,ES,ES,2021,Q4,Adult
201274991,20127499,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (more than 80 units),,,D,,,,,,,,,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211125.0,20211129,20211129,EXP,,ES-MYLANLABS-2021M1087970,MYLAN,,52.0,YR,,M,Y,90.3,KG,20211129.0,,CN,ES,ES,2021,Q4,Adult
201274991,20127499,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (more than 80 units),,,D,,,,,,,,,2021,Q4,Angiopathy,,2021,Q4,1,I,,20211125.0,20211129,20211129,EXP,,ES-MYLANLABS-2021M1087970,MYLAN,,52.0,YR,,M,Y,90.3,KG,20211129.0,,CN,ES,ES,2021,Q4,Adult
201274991,20127499,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (more than 80 units),,,D,,,,,,,,,2021,Q4,Memory impairment,,2021,Q4,1,I,,20211125.0,20211129,20211129,EXP,,ES-MYLANLABS-2021M1087970,MYLAN,,52.0,YR,,M,Y,90.3,KG,20211129.0,,CN,ES,ES,2021,Q4,Adult
201274991,20127499,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (more than 80 units),,,D,,,,,,,,,2021,Q4,Product storage error,,2021,Q4,1,I,,20211125.0,20211129,20211129,EXP,,ES-MYLANLABS-2021M1087970,MYLAN,,52.0,YR,,M,Y,90.3,KG,20211129.0,,CN,ES,ES,2021,Q4,Adult
201274991,20127499,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (more than 80 units),,,D,,,,,,,,,2021,Q4,Confusional state,,2021,Q4,1,I,,20211125.0,20211129,20211129,EXP,,ES-MYLANLABS-2021M1087970,MYLAN,,52.0,YR,,M,Y,90.3,KG,20211129.0,,CN,ES,ES,2021,Q4,Adult
201274991,20127499,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (more than 80 units),,,D,,,,,,,,,2021,Q4,Cerebrovascular accident,,2021,Q4,1,I,,20211125.0,20211129,20211129,EXP,,ES-MYLANLABS-2021M1087970,MYLAN,,52.0,YR,,M,Y,90.3,KG,20211129.0,,CN,ES,ES,2021,Q4,Adult
201274991,20127499,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (more than 80 units),,,D,,,,,,,,,2021,Q4,Incorrect dose administered,,2021,Q4,1,I,,20211125.0,20211129,20211129,EXP,,ES-MYLANLABS-2021M1087970,MYLAN,,52.0,YR,,M,Y,90.3,KG,20211129.0,,CN,ES,ES,2021,Q4,Adult
201274991,20127499,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (more than 80 units),,,D,,,,,,,,,2021,Q4,Hospitalisation,,2021,Q4,1,I,,20211125.0,20211129,20211129,EXP,,ES-MYLANLABS-2021M1087970,MYLAN,,52.0,YR,,M,Y,90.3,KG,20211129.0,,CN,ES,ES,2021,Q4,Adult
201274991,20127499,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (more than 80 units),,,D,,,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,1,I,,20211125.0,20211129,20211129,EXP,,ES-MYLANLABS-2021M1087970,MYLAN,,52.0,YR,,M,Y,90.3,KG,20211129.0,,CN,ES,ES,2021,Q4,Adult
201274991,20127499,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (more than 80 units),,,D,,,,,,,,,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,,20211125.0,20211129,20211129,EXP,,ES-MYLANLABS-2021M1087970,MYLAN,,52.0,YR,,M,Y,90.3,KG,20211129.0,,CN,ES,ES,2021,Q4,Adult
201274991,20127499,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (more than 80 units),,,D,,,,,,,,,2021,Q4,Intentional product misuse,,2021,Q4,1,I,,20211125.0,20211129,20211129,EXP,,ES-MYLANLABS-2021M1087970,MYLAN,,52.0,YR,,M,Y,90.3,KG,20211129.0,,CN,ES,ES,2021,Q4,Adult
201274991,20127499,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"68 iU, QD",,,D,,0F861A,,,68.0,IU,,QD,2021,Q4,Illness,,2021,Q4,1,I,,20211125.0,20211129,20211129,EXP,,ES-MYLANLABS-2021M1087970,MYLAN,,52.0,YR,,M,Y,90.3,KG,20211129.0,,CN,ES,ES,2021,Q4,Adult
201274991,20127499,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"68 iU, QD",,,D,,0F861A,,,68.0,IU,,QD,2021,Q4,Medication error,,2021,Q4,1,I,,20211125.0,20211129,20211129,EXP,,ES-MYLANLABS-2021M1087970,MYLAN,,52.0,YR,,M,Y,90.3,KG,20211129.0,,CN,ES,ES,2021,Q4,Adult
201274991,20127499,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"68 iU, QD",,,D,,0F861A,,,68.0,IU,,QD,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,,20211125.0,20211129,20211129,EXP,,ES-MYLANLABS-2021M1087970,MYLAN,,52.0,YR,,M,Y,90.3,KG,20211129.0,,CN,ES,ES,2021,Q4,Adult
201274991,20127499,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"68 iU, QD",,,D,,0F861A,,,68.0,IU,,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211125.0,20211129,20211129,EXP,,ES-MYLANLABS-2021M1087970,MYLAN,,52.0,YR,,M,Y,90.3,KG,20211129.0,,CN,ES,ES,2021,Q4,Adult
201274991,20127499,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"68 iU, QD",,,D,,0F861A,,,68.0,IU,,QD,2021,Q4,Angiopathy,,2021,Q4,1,I,,20211125.0,20211129,20211129,EXP,,ES-MYLANLABS-2021M1087970,MYLAN,,52.0,YR,,M,Y,90.3,KG,20211129.0,,CN,ES,ES,2021,Q4,Adult
201274991,20127499,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"68 iU, QD",,,D,,0F861A,,,68.0,IU,,QD,2021,Q4,Memory impairment,,2021,Q4,1,I,,20211125.0,20211129,20211129,EXP,,ES-MYLANLABS-2021M1087970,MYLAN,,52.0,YR,,M,Y,90.3,KG,20211129.0,,CN,ES,ES,2021,Q4,Adult
201274991,20127499,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"68 iU, QD",,,D,,0F861A,,,68.0,IU,,QD,2021,Q4,Product storage error,,2021,Q4,1,I,,20211125.0,20211129,20211129,EXP,,ES-MYLANLABS-2021M1087970,MYLAN,,52.0,YR,,M,Y,90.3,KG,20211129.0,,CN,ES,ES,2021,Q4,Adult
201274991,20127499,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"68 iU, QD",,,D,,0F861A,,,68.0,IU,,QD,2021,Q4,Confusional state,,2021,Q4,1,I,,20211125.0,20211129,20211129,EXP,,ES-MYLANLABS-2021M1087970,MYLAN,,52.0,YR,,M,Y,90.3,KG,20211129.0,,CN,ES,ES,2021,Q4,Adult
201274991,20127499,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"68 iU, QD",,,D,,0F861A,,,68.0,IU,,QD,2021,Q4,Cerebrovascular accident,,2021,Q4,1,I,,20211125.0,20211129,20211129,EXP,,ES-MYLANLABS-2021M1087970,MYLAN,,52.0,YR,,M,Y,90.3,KG,20211129.0,,CN,ES,ES,2021,Q4,Adult
201274991,20127499,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"68 iU, QD",,,D,,0F861A,,,68.0,IU,,QD,2021,Q4,Incorrect dose administered,,2021,Q4,1,I,,20211125.0,20211129,20211129,EXP,,ES-MYLANLABS-2021M1087970,MYLAN,,52.0,YR,,M,Y,90.3,KG,20211129.0,,CN,ES,ES,2021,Q4,Adult
201274991,20127499,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"68 iU, QD",,,D,,0F861A,,,68.0,IU,,QD,2021,Q4,Hospitalisation,,2021,Q4,1,I,,20211125.0,20211129,20211129,EXP,,ES-MYLANLABS-2021M1087970,MYLAN,,52.0,YR,,M,Y,90.3,KG,20211129.0,,CN,ES,ES,2021,Q4,Adult
201274991,20127499,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"68 iU, QD",,,D,,0F861A,,,68.0,IU,,QD,2021,Q4,Diarrhoea,,2021,Q4,1,I,,20211125.0,20211129,20211129,EXP,,ES-MYLANLABS-2021M1087970,MYLAN,,52.0,YR,,M,Y,90.3,KG,20211129.0,,CN,ES,ES,2021,Q4,Adult
201274991,20127499,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"68 iU, QD",,,D,,0F861A,,,68.0,IU,,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,,20211125.0,20211129,20211129,EXP,,ES-MYLANLABS-2021M1087970,MYLAN,,52.0,YR,,M,Y,90.3,KG,20211129.0,,CN,ES,ES,2021,Q4,Adult
201274991,20127499,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"68 iU, QD",,,D,,0F861A,,,68.0,IU,,QD,2021,Q4,Intentional product misuse,,2021,Q4,1,I,,20211125.0,20211129,20211129,EXP,,ES-MYLANLABS-2021M1087970,MYLAN,,52.0,YR,,M,Y,90.3,KG,20211129.0,,CN,ES,ES,2021,Q4,Adult
201297502,20129750,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, qd",,,,,,,,,,Injection,QD,2021,Q4,Rib fracture,,2021,Q4,2,F,20211106.0,20211202.0,20211130,20211206,EXP,,JP-TAKEDA-2021TJP123348,TAKEDA,,74.0,YR,,M,Y,,,20211206.0,,PH,JP,JP,2021,Q4,Elderly
201297502,20129750,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, qd",,,,,,,,,,Injection,QD,2021,Q4,Fall,,2021,Q4,2,F,20211106.0,20211202.0,20211130,20211206,EXP,,JP-TAKEDA-2021TJP123348,TAKEDA,,74.0,YR,,M,Y,,,20211206.0,,PH,JP,JP,2021,Q4,Elderly
201298211,20129821,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, unknown",,,,,,,,,,,,2021,Q4,Headache,,2021,Q4,1,I,,20211117.0,20211130,20211130,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202111008347,ELI LILLY AND CO,,54.0,YR,,M,Y,,,20211130.0,,CN,CN,CN,2021,Q4,Adult
201298211,20129821,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, unknown",,,,,,,,,,,,2021,Q4,Noninfective gingivitis,,2021,Q4,1,I,,20211117.0,20211130,20211130,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202111008347,ELI LILLY AND CO,,54.0,YR,,M,Y,,,20211130.0,,CN,CN,CN,2021,Q4,Adult
201298211,20129821,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, unknown",,,,,,,,,,,,2021,Q4,Blood glucose fluctuation,,2021,Q4,1,I,,20211117.0,20211130,20211130,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202111008347,ELI LILLY AND CO,,54.0,YR,,M,Y,,,20211130.0,,CN,CN,CN,2021,Q4,Adult
201298211,20129821,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, unknown",,,,,,,,,,,,2021,Q4,Dizziness,,2021,Q4,1,I,,20211117.0,20211130,20211130,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202111008347,ELI LILLY AND CO,,54.0,YR,,M,Y,,,20211130.0,,CN,CN,CN,2021,Q4,Adult
201298211,20129821,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, unknown",,,,,,,,,,,,2021,Q4,Toothache,,2021,Q4,1,I,,20211117.0,20211130,20211130,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202111008347,ELI LILLY AND CO,,54.0,YR,,M,Y,,,20211130.0,,CN,CN,CN,2021,Q4,Adult
201304601,20130460,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 dosage form, HS (Dose: 20 units at bedtime)",,,U,U,,,,,,Injection,QD,2021,Q4,Acute myocardial infarction,,2021,Q4,1,I,,20211122.0,20211130,20211130,EXP,,US-MYLANLABS-2021M1088710,MYLAN,"Saeed M, Gil GS, Lopez PD, Visco F, Pekler G, Mushiyev S. Chest Pain Induced by Intravenous Nitroglycerin. Am-J-Ther 2020;27(3):e299-e301.",54.0,YR,,M,Y,,,20211130.0,,MD,US,US,2021,Q4,Adult
201304601,20130460,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 dosage form, HS (Dose: 20 units at bedtime)",,,U,U,,,,,,Injection,QD,2021,Q4,Off label use,,2021,Q4,1,I,,20211122.0,20211130,20211130,EXP,,US-MYLANLABS-2021M1088710,MYLAN,"Saeed M, Gil GS, Lopez PD, Visco F, Pekler G, Mushiyev S. Chest Pain Induced by Intravenous Nitroglycerin. Am-J-Ther 2020;27(3):e299-e301.",54.0,YR,,M,Y,,,20211130.0,,MD,US,US,2021,Q4,Adult
201304621,20130462,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,Y,U,,,210605.0,,,,,2021,Q4,Overdose,,2021,Q4,1,I,,20211122.0,20211130,20211130,EXP,,DE-MYLANLABS-2021M1088712,MYLAN,"van den Boom L, Stuecher T, Mader JK. Safe use of a once-a-week glucagon-like peptide-1 receptor agonist in a 16-year-old girl with type 2 diabetes when approved therapy options fail. Clin-Case-Rep 2021;9:No. 9.",16.0,YR,,F,Y,78.0,KG,20211130.0,,HP,DE,DE,2021,Q4,Youth
201304621,20130462,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,Y,U,,,210605.0,,,,,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211122.0,20211130,20211130,EXP,,DE-MYLANLABS-2021M1088712,MYLAN,"van den Boom L, Stuecher T, Mader JK. Safe use of a once-a-week glucagon-like peptide-1 receptor agonist in a 16-year-old girl with type 2 diabetes when approved therapy options fail. Clin-Case-Rep 2021;9:No. 9.",16.0,YR,,F,Y,78.0,KG,20211130.0,,HP,DE,DE,2021,Q4,Youth
201304621,20130462,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,Y,U,,,210605.0,,,,,2021,Q4,Treatment failure,,2021,Q4,1,I,,20211122.0,20211130,20211130,EXP,,DE-MYLANLABS-2021M1088712,MYLAN,"van den Boom L, Stuecher T, Mader JK. Safe use of a once-a-week glucagon-like peptide-1 receptor agonist in a 16-year-old girl with type 2 diabetes when approved therapy options fail. Clin-Case-Rep 2021;9:No. 9.",16.0,YR,,F,Y,78.0,KG,20211130.0,,HP,DE,DE,2021,Q4,Youth
201305571,20130557,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),Low-dose,,,U,U,,,210605.0,,,Injection,,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,,20211122.0,20211130,20211130,EXP,,US-MYLANLABS-2021M1088741,MYLAN,"Jerkins T, Bell DSH. Development of Exogenous Insulin Antibody Syndrome in a Patient with Newly Diagnosed Type 1 Diabetes Successfully Treated with Oral Immunosuppressive Monotherapy. Diabetes-Ther 2021;12(10):2795-2799.",51.0,YR,,F,Y,,,20211130.0,,HP,US,US,2021,Q4,Adult
201305571,20130557,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),Low-dose,,,U,U,,,210605.0,,,Injection,,2021,Q4,Ketoacidosis,,2021,Q4,1,I,,20211122.0,20211130,20211130,EXP,,US-MYLANLABS-2021M1088741,MYLAN,"Jerkins T, Bell DSH. Development of Exogenous Insulin Antibody Syndrome in a Patient with Newly Diagnosed Type 1 Diabetes Successfully Treated with Oral Immunosuppressive Monotherapy. Diabetes-Ther 2021;12(10):2795-2799.",51.0,YR,,F,Y,,,20211130.0,,HP,US,US,2021,Q4,Adult
201305571,20130557,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),Low-dose,,,U,U,,,210605.0,,,Injection,,2021,Q4,Drug specific antibody,,2021,Q4,1,I,,20211122.0,20211130,20211130,EXP,,US-MYLANLABS-2021M1088741,MYLAN,"Jerkins T, Bell DSH. Development of Exogenous Insulin Antibody Syndrome in a Patient with Newly Diagnosed Type 1 Diabetes Successfully Treated with Oral Immunosuppressive Monotherapy. Diabetes-Ther 2021;12(10):2795-2799.",51.0,YR,,F,Y,,,20211130.0,,HP,US,US,2021,Q4,Adult
201305571,20130557,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),Low-dose,,,U,U,,,210605.0,,,Injection,,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211122.0,20211130,20211130,EXP,,US-MYLANLABS-2021M1088741,MYLAN,"Jerkins T, Bell DSH. Development of Exogenous Insulin Antibody Syndrome in a Patient with Newly Diagnosed Type 1 Diabetes Successfully Treated with Oral Immunosuppressive Monotherapy. Diabetes-Ther 2021;12(10):2795-2799.",51.0,YR,,F,Y,,,20211130.0,,HP,US,US,2021,Q4,Adult
201305571,20130557,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),Low-dose,,,U,U,,,210605.0,,,Injection,,2021,Q4,Anti-insulin antibody positive,,2021,Q4,1,I,,20211122.0,20211130,20211130,EXP,,US-MYLANLABS-2021M1088741,MYLAN,"Jerkins T, Bell DSH. Development of Exogenous Insulin Antibody Syndrome in a Patient with Newly Diagnosed Type 1 Diabetes Successfully Treated with Oral Immunosuppressive Monotherapy. Diabetes-Ther 2021;12(10):2795-2799.",51.0,YR,,F,Y,,,20211130.0,,HP,US,US,2021,Q4,Adult
201305571,20130557,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),Increased to 50%,,,U,U,,,210605.0,,,Injection,,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,,20211122.0,20211130,20211130,EXP,,US-MYLANLABS-2021M1088741,MYLAN,"Jerkins T, Bell DSH. Development of Exogenous Insulin Antibody Syndrome in a Patient with Newly Diagnosed Type 1 Diabetes Successfully Treated with Oral Immunosuppressive Monotherapy. Diabetes-Ther 2021;12(10):2795-2799.",51.0,YR,,F,Y,,,20211130.0,,HP,US,US,2021,Q4,Adult
201305571,20130557,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),Increased to 50%,,,U,U,,,210605.0,,,Injection,,2021,Q4,Ketoacidosis,,2021,Q4,1,I,,20211122.0,20211130,20211130,EXP,,US-MYLANLABS-2021M1088741,MYLAN,"Jerkins T, Bell DSH. Development of Exogenous Insulin Antibody Syndrome in a Patient with Newly Diagnosed Type 1 Diabetes Successfully Treated with Oral Immunosuppressive Monotherapy. Diabetes-Ther 2021;12(10):2795-2799.",51.0,YR,,F,Y,,,20211130.0,,HP,US,US,2021,Q4,Adult
201305571,20130557,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),Increased to 50%,,,U,U,,,210605.0,,,Injection,,2021,Q4,Drug specific antibody,,2021,Q4,1,I,,20211122.0,20211130,20211130,EXP,,US-MYLANLABS-2021M1088741,MYLAN,"Jerkins T, Bell DSH. Development of Exogenous Insulin Antibody Syndrome in a Patient with Newly Diagnosed Type 1 Diabetes Successfully Treated with Oral Immunosuppressive Monotherapy. Diabetes-Ther 2021;12(10):2795-2799.",51.0,YR,,F,Y,,,20211130.0,,HP,US,US,2021,Q4,Adult
201305571,20130557,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),Increased to 50%,,,U,U,,,210605.0,,,Injection,,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211122.0,20211130,20211130,EXP,,US-MYLANLABS-2021M1088741,MYLAN,"Jerkins T, Bell DSH. Development of Exogenous Insulin Antibody Syndrome in a Patient with Newly Diagnosed Type 1 Diabetes Successfully Treated with Oral Immunosuppressive Monotherapy. Diabetes-Ther 2021;12(10):2795-2799.",51.0,YR,,F,Y,,,20211130.0,,HP,US,US,2021,Q4,Adult
201305571,20130557,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),Increased to 50%,,,U,U,,,210605.0,,,Injection,,2021,Q4,Anti-insulin antibody positive,,2021,Q4,1,I,,20211122.0,20211130,20211130,EXP,,US-MYLANLABS-2021M1088741,MYLAN,"Jerkins T, Bell DSH. Development of Exogenous Insulin Antibody Syndrome in a Patient with Newly Diagnosed Type 1 Diabetes Successfully Treated with Oral Immunosuppressive Monotherapy. Diabetes-Ther 2021;12(10):2795-2799.",51.0,YR,,F,Y,,,20211130.0,,HP,US,US,2021,Q4,Adult
201307541,20130754,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 dosage form, qd (50 U, QD)",,,U,,1F090A,,,,,Solution for injection,QD,2021,Q4,Negative thoughts,,2021,Q4,1,I,20210926.0,20211122.0,20211130,20211130,EXP,,ES-MYLANLABS-2021M1087099,MYLAN,,60.0,YR,,F,Y,80.0,KG,20211130.0,,CN,ES,ES,2021,Q4,Adult
201307541,20130754,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 dosage form, qd (50 U, QD)",,,U,,1F090A,,,,,Solution for injection,QD,2021,Q4,Headache,,2021,Q4,1,I,20210926.0,20211122.0,20211130,20211130,EXP,,ES-MYLANLABS-2021M1087099,MYLAN,,60.0,YR,,F,Y,80.0,KG,20211130.0,,CN,ES,ES,2021,Q4,Adult
201307541,20130754,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 dosage form, qd (50 U, QD)",,,U,,1F090A,,,,,Solution for injection,QD,2021,Q4,Nervousness,,2021,Q4,1,I,20210926.0,20211122.0,20211130,20211130,EXP,,ES-MYLANLABS-2021M1087099,MYLAN,,60.0,YR,,F,Y,80.0,KG,20211130.0,,CN,ES,ES,2021,Q4,Adult
201307541,20130754,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 dosage form, qd (50 U, QD)",,,U,,1F090A,,,,,Solution for injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20210926.0,20211122.0,20211130,20211130,EXP,,ES-MYLANLABS-2021M1087099,MYLAN,,60.0,YR,,F,Y,80.0,KG,20211130.0,,CN,ES,ES,2021,Q4,Adult
201307541,20130754,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 dosage form, qd (50 U, QD)",,,U,,1F090A,,,,,Solution for injection,QD,2021,Q4,Pollakiuria,,2021,Q4,1,I,20210926.0,20211122.0,20211130,20211130,EXP,,ES-MYLANLABS-2021M1087099,MYLAN,,60.0,YR,,F,Y,80.0,KG,20211130.0,,CN,ES,ES,2021,Q4,Adult
201307541,20130754,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 dosage form, qd (50 U, QD)",,,U,,1F090A,,,,,Solution for injection,QD,2021,Q4,Dizziness,,2021,Q4,1,I,20210926.0,20211122.0,20211130,20211130,EXP,,ES-MYLANLABS-2021M1087099,MYLAN,,60.0,YR,,F,Y,80.0,KG,20211130.0,,CN,ES,ES,2021,Q4,Adult
201307541,20130754,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 dosage form, qd (50 U, QD)",,,U,,1F090A,,,,,Solution for injection,QD,2021,Q4,Anxiety,,2021,Q4,1,I,20210926.0,20211122.0,20211130,20211130,EXP,,ES-MYLANLABS-2021M1087099,MYLAN,,60.0,YR,,F,Y,80.0,KG,20211130.0,,CN,ES,ES,2021,Q4,Adult
201307541,20130754,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 dosage form, qd (50 U, QD)",,,U,,1F090A,,,,,Solution for injection,QD,2021,Q4,Restlessness,,2021,Q4,1,I,20210926.0,20211122.0,20211130,20211130,EXP,,ES-MYLANLABS-2021M1087099,MYLAN,,60.0,YR,,F,Y,80.0,KG,20211130.0,,CN,ES,ES,2021,Q4,Adult
201307541,20130754,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 dosage form, qd (50 U, QD)",,,U,,1F090A,,,,,Solution for injection,QD,2021,Q4,Abnormal dreams,,2021,Q4,1,I,20210926.0,20211122.0,20211130,20211130,EXP,,ES-MYLANLABS-2021M1087099,MYLAN,,60.0,YR,,F,Y,80.0,KG,20211130.0,,CN,ES,ES,2021,Q4,Adult
201307541,20130754,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 dosage form, qd (50 U, QD)",,,U,,1F090A,,,,,Solution for injection,QD,2021,Q4,Cataract,,2021,Q4,1,I,20210926.0,20211122.0,20211130,20211130,EXP,,ES-MYLANLABS-2021M1087099,MYLAN,,60.0,YR,,F,Y,80.0,KG,20211130.0,,CN,ES,ES,2021,Q4,Adult
201307541,20130754,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 dosage form, qd (50 U, QD)",,,U,,1F090A,,,,,Solution for injection,QD,2021,Q4,Fatigue,,2021,Q4,1,I,20210926.0,20211122.0,20211130,20211130,EXP,,ES-MYLANLABS-2021M1087099,MYLAN,,60.0,YR,,F,Y,80.0,KG,20211130.0,,CN,ES,ES,2021,Q4,Adult
201313321,20131332,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 international unit, qd",,,U,U,1F090A,,,12.0,IU,Injection,QD,2021,Q4,Asthenia,,2021,Q4,1,I,,20211124.0,20211130,20211130,EXP,,ES-MYLANLABS-2021M1087661,MYLAN,,69.0,YR,,M,Y,69.0,KG,20211130.0,,CN,ES,ES,2021,Q4,Elderly
201313321,20131332,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 international unit, qd",,,U,U,1F090A,,,12.0,IU,Injection,QD,2021,Q4,Blood glucose fluctuation,,2021,Q4,1,I,,20211124.0,20211130,20211130,EXP,,ES-MYLANLABS-2021M1087661,MYLAN,,69.0,YR,,M,Y,69.0,KG,20211130.0,,CN,ES,ES,2021,Q4,Elderly
201317171,20131717,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 international unit, qd",,,,,,,,25.0,IU,,QD,2021,Q4,Cardioactive drug level increased,,2021,Q4,1,I,20210901.0,20211124.0,20211130,20211130,EXP,FR-AFSSAPS-AN20213915,FR-MYLANLABS-2021M1087758,MYLAN,,67.0,YR,,M,Y,81.8,KG,20211130.0,,PH,FR,FR,2021,Q4,Elderly
201317171,20131717,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 international unit, qd",,,,,,,,25.0,IU,,QD,2021,Q4,Sinus bradycardia,,2021,Q4,1,I,20210901.0,20211124.0,20211130,20211130,EXP,FR-AFSSAPS-AN20213915,FR-MYLANLABS-2021M1087758,MYLAN,,67.0,YR,,M,Y,81.8,KG,20211130.0,,PH,FR,FR,2021,Q4,Elderly
201333681,20133368,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,Solution,,2021,Q4,SARS-CoV-2 test positive,,2021,Q4,1,I,,20211126.0,20211201,20211201,EXP,,CA-ROCHE-2969271,ROCHE,,70.0,YR,,F,Y,,,20211201.0,,HP,CA,,2021,Q4,Elderly
201342025,20134202,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,COVID-19,,2021,Q4,5,F,20211029.0,20211203.0,20211201,20211215,EXP,,NVSC2021NL265354,NOVARTIS,,56.0,YR,,M,Y,162.0,KG,20211215.0,,MD,NL,NL,2021,Q4,Adult
201354451,20135445,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 iU, QD",,,Y,,ABJL021,,206538.0,8.0,IU,Solution for injection,QD,2021,Q4,Blood pressure decreased,,2021,Q4,1,I,,20211128.0,20211201,20211201,EXP,,CN-SA-2021SA400910,SANOFI AVENTIS,,57.0,YR,A,F,Y,61.0,KG,20211201.0,,HP,CN,CN,2021,Q4,Adult
201354451,20135445,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 iU, QD",,,Y,,ABJL021,,206538.0,8.0,IU,Solution for injection,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211128.0,20211201,20211201,EXP,,CN-SA-2021SA400910,SANOFI AVENTIS,,57.0,YR,A,F,Y,61.0,KG,20211201.0,,HP,CN,CN,2021,Q4,Adult
201368891,20136889,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 international unit, qd",,,Y,,1F935A,,,24.0,IU,,QD,2021,Q4,Hyperhidrosis,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 international unit, qd",,,Y,,1F935A,,,24.0,IU,,QD,2021,Q4,Product prescribing issue,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 international unit, qd",,,Y,,1F935A,,,24.0,IU,,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 international unit, qd",,,Y,,1F935A,,,24.0,IU,,QD,2021,Q4,Drug ineffective,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 international unit, qd",,,Y,,1F935A,,,24.0,IU,,QD,2021,Q4,Fatigue,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 international unit, qd",,,Y,,1F935A,,,24.0,IU,,QD,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 international unit, qd",,,Y,,1F935A,,,24.0,IU,,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 international unit, qd",,,Y,,1F935A,,,24.0,IU,,QD,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 international unit, qd",,,Y,,1F935A,,,24.0,IU,,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, qd",,,Y,,,,,,,,QD,2021,Q4,Hyperhidrosis,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, qd",,,Y,,,,,,,,QD,2021,Q4,Product prescribing issue,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, qd",,,Y,,,,,,,,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, qd",,,Y,,,,,,,,QD,2021,Q4,Drug ineffective,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, qd",,,Y,,,,,,,,QD,2021,Q4,Fatigue,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, qd",,,Y,,,,,,,,QD,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, qd",,,Y,,,,,,,,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, qd",,,Y,,,,,,,,QD,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, qd",,,Y,,,,,,,,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"36 international unit, qd",,,Y,,1F935A,,,36.0,IU,,QD,2021,Q4,Hyperhidrosis,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"36 international unit, qd",,,Y,,1F935A,,,36.0,IU,,QD,2021,Q4,Product prescribing issue,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"36 international unit, qd",,,Y,,1F935A,,,36.0,IU,,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"36 international unit, qd",,,Y,,1F935A,,,36.0,IU,,QD,2021,Q4,Drug ineffective,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"36 international unit, qd",,,Y,,1F935A,,,36.0,IU,,QD,2021,Q4,Fatigue,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"36 international unit, qd",,,Y,,1F935A,,,36.0,IU,,QD,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"36 international unit, qd",,,Y,,1F935A,,,36.0,IU,,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"36 international unit, qd",,,Y,,1F935A,,,36.0,IU,,QD,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"36 international unit, qd",,,Y,,1F935A,,,36.0,IU,,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 international unit, qd (dose reduced)",,,Y,,1F040A,,,36.0,IU,,QD,2021,Q4,Hyperhidrosis,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 international unit, qd (dose reduced)",,,Y,,1F040A,,,36.0,IU,,QD,2021,Q4,Product prescribing issue,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 international unit, qd (dose reduced)",,,Y,,1F040A,,,36.0,IU,,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 international unit, qd (dose reduced)",,,Y,,1F040A,,,36.0,IU,,QD,2021,Q4,Drug ineffective,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 international unit, qd (dose reduced)",,,Y,,1F040A,,,36.0,IU,,QD,2021,Q4,Fatigue,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 international unit, qd (dose reduced)",,,Y,,1F040A,,,36.0,IU,,QD,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 international unit, qd (dose reduced)",,,Y,,1F040A,,,36.0,IU,,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 international unit, qd (dose reduced)",,,Y,,1F040A,,,36.0,IU,,QD,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 international unit, qd (dose reduced)",,,Y,,1F040A,,,36.0,IU,,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 international unit, qd",,,Y,,,,,40.0,IU,,QD,2021,Q4,Hyperhidrosis,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 international unit, qd",,,Y,,,,,40.0,IU,,QD,2021,Q4,Product prescribing issue,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 international unit, qd",,,Y,,,,,40.0,IU,,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 international unit, qd",,,Y,,,,,40.0,IU,,QD,2021,Q4,Drug ineffective,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 international unit, qd",,,Y,,,,,40.0,IU,,QD,2021,Q4,Fatigue,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 international unit, qd",,,Y,,,,,40.0,IU,,QD,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 international unit, qd",,,Y,,,,,40.0,IU,,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 international unit, qd",,,Y,,,,,40.0,IU,,QD,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 international unit, qd",,,Y,,,,,40.0,IU,,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 international unit, qd (dose reduced)",,,Y,,1F040A,,,34.0,IU,,QD,2021,Q4,Hyperhidrosis,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 international unit, qd (dose reduced)",,,Y,,1F040A,,,34.0,IU,,QD,2021,Q4,Product prescribing issue,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 international unit, qd (dose reduced)",,,Y,,1F040A,,,34.0,IU,,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 international unit, qd (dose reduced)",,,Y,,1F040A,,,34.0,IU,,QD,2021,Q4,Drug ineffective,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 international unit, qd (dose reduced)",,,Y,,1F040A,,,34.0,IU,,QD,2021,Q4,Fatigue,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 international unit, qd (dose reduced)",,,Y,,1F040A,,,34.0,IU,,QD,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 international unit, qd (dose reduced)",,,Y,,1F040A,,,34.0,IU,,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 international unit, qd (dose reduced)",,,Y,,1F040A,,,34.0,IU,,QD,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 international unit, qd (dose reduced)",,,Y,,1F040A,,,34.0,IU,,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 international unit, qd",,,Y,,,,,28.0,IU,,QD,2021,Q4,Hyperhidrosis,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 international unit, qd",,,Y,,,,,28.0,IU,,QD,2021,Q4,Product prescribing issue,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 international unit, qd",,,Y,,,,,28.0,IU,,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 international unit, qd",,,Y,,,,,28.0,IU,,QD,2021,Q4,Drug ineffective,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 international unit, qd",,,Y,,,,,28.0,IU,,QD,2021,Q4,Fatigue,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 international unit, qd",,,Y,,,,,28.0,IU,,QD,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 international unit, qd",,,Y,,,,,28.0,IU,,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 international unit, qd",,,Y,,,,,28.0,IU,,QD,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201368891,20136889,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 international unit, qd",,,Y,,,,,28.0,IU,,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20200101.0,20211126.0,20211201,20211201,EXP,,ES-MYLANLABS-2021M1088351,MYLAN,,68.0,YR,,M,Y,83.0,KG,20211201.0,,CN,ES,ES,2021,Q4,Elderly
201371252,20137125,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Pyrexia,,2021,Q4,2,F,20211025.0,20211220.0,20211201,20211221,EXP,,US-GILEAD-2021-0555074,GILEAD,,69.0,YR,E,F,Y,,,20211221.0,,HP,US,US,2021,Q4,Elderly
201371252,20137125,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Acute respiratory failure,,2021,Q4,2,F,20211025.0,20211220.0,20211201,20211221,EXP,,US-GILEAD-2021-0555074,GILEAD,,69.0,YR,E,F,Y,,,20211221.0,,HP,US,US,2021,Q4,Elderly
201371252,20137125,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,2,F,20211025.0,20211220.0,20211201,20211221,EXP,,US-GILEAD-2021-0555074,GILEAD,,69.0,YR,E,F,Y,,,20211221.0,,HP,US,US,2021,Q4,Elderly
201387591,20138759,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 IU, QD (2 years ago)",,,,,,,,20.0,IU,,QD,2021,Q4,Oxygen saturation decreased,,2021,Q4,1,I,20210301.0,20211122.0,20211202,20211202,EXP,,NVSC2021MX192142,NOVARTIS,,70.0,YR,,F,Y,115.0,KG,20211202.0,,CN,MX,MX,2021,Q4,Elderly
201387591,20138759,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 IU, QD (2 years ago)",,,,,,,,20.0,IU,,QD,2021,Q4,Headache,,2021,Q4,1,I,20210301.0,20211122.0,20211202,20211202,EXP,,NVSC2021MX192142,NOVARTIS,,70.0,YR,,F,Y,115.0,KG,20211202.0,,CN,MX,MX,2021,Q4,Elderly
201387591,20138759,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 IU, QD (2 years ago)",,,,,,,,20.0,IU,,QD,2021,Q4,Insomnia,,2021,Q4,1,I,20210301.0,20211122.0,20211202,20211202,EXP,,NVSC2021MX192142,NOVARTIS,,70.0,YR,,F,Y,115.0,KG,20211202.0,,CN,MX,MX,2021,Q4,Elderly
201387591,20138759,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 IU, QD (2 years ago)",,,,,,,,20.0,IU,,QD,2021,Q4,Pain in extremity,,2021,Q4,1,I,20210301.0,20211122.0,20211202,20211202,EXP,,NVSC2021MX192142,NOVARTIS,,70.0,YR,,F,Y,115.0,KG,20211202.0,,CN,MX,MX,2021,Q4,Elderly
201387591,20138759,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 IU, QD (2 years ago)",,,,,,,,20.0,IU,,QD,2021,Q4,Sleep apnoea syndrome,,2021,Q4,1,I,20210301.0,20211122.0,20211202,20211202,EXP,,NVSC2021MX192142,NOVARTIS,,70.0,YR,,F,Y,115.0,KG,20211202.0,,CN,MX,MX,2021,Q4,Elderly
201417931,20141793,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Migraine,,2021,Q4,1,I,20211116.0,20211128.0,20211202,20211202,EXP,GB-MHRA-EYC 00267420,GB-MYLANLABS-2021M1088762,MYLAN,,69.0,YR,,M,Y,107.0,KG,20211202.0,,CN,GB,GB,2021,Q4,Elderly
201417931,20141793,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Dizziness,,2021,Q4,1,I,20211116.0,20211128.0,20211202,20211202,EXP,GB-MHRA-EYC 00267420,GB-MYLANLABS-2021M1088762,MYLAN,,69.0,YR,,M,Y,107.0,KG,20211202.0,,CN,GB,GB,2021,Q4,Elderly
201417931,20141793,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Pain in extremity,,2021,Q4,1,I,20211116.0,20211128.0,20211202,20211202,EXP,GB-MHRA-EYC 00267420,GB-MYLANLABS-2021M1088762,MYLAN,,69.0,YR,,M,Y,107.0,KG,20211202.0,,CN,GB,GB,2021,Q4,Elderly
201417931,20141793,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Feeling cold,,2021,Q4,1,I,20211116.0,20211128.0,20211202,20211202,EXP,GB-MHRA-EYC 00267420,GB-MYLANLABS-2021M1088762,MYLAN,,69.0,YR,,M,Y,107.0,KG,20211202.0,,CN,GB,GB,2021,Q4,Elderly
201417931,20141793,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Headache,,2021,Q4,1,I,20211116.0,20211128.0,20211202,20211202,EXP,GB-MHRA-EYC 00267420,GB-MYLANLABS-2021M1088762,MYLAN,,69.0,YR,,M,Y,107.0,KG,20211202.0,,CN,GB,GB,2021,Q4,Elderly
201417931,20141793,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Fatigue,,2021,Q4,1,I,20211116.0,20211128.0,20211202,20211202,EXP,GB-MHRA-EYC 00267420,GB-MYLANLABS-2021M1088762,MYLAN,,69.0,YR,,M,Y,107.0,KG,20211202.0,,CN,GB,GB,2021,Q4,Elderly
201417931,20141793,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Chills,,2021,Q4,1,I,20211116.0,20211128.0,20211202,20211202,EXP,GB-MHRA-EYC 00267420,GB-MYLANLABS-2021M1088762,MYLAN,,69.0,YR,,M,Y,107.0,KG,20211202.0,,CN,GB,GB,2021,Q4,Elderly
201417931,20141793,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Confusional state,,2021,Q4,1,I,20211116.0,20211128.0,20211202,20211202,EXP,GB-MHRA-EYC 00267420,GB-MYLANLABS-2021M1088762,MYLAN,,69.0,YR,,M,Y,107.0,KG,20211202.0,,CN,GB,GB,2021,Q4,Elderly
201430921,20143092,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,Injection,,2021,Q4,Hypotension,,2021,Q4,1,I,20201014.0,20211202.0,20211203,20211203,EXP,,CN-ABBVIE-21K-035-4183680-00,ABBVIE,,65.0,YR,,F,Y,,,20211202.0,,HP,CN,CN,2021,Q4,Elderly
201435791,20143579,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 IU,,,,,Unknown,,,,,,,2021,Q4,Balance disorder,,2021,Q4,1,I,,20211122.0,20211203,20211203,EXP,,BR-NOVOPROD-870390,NOVO NORDISK,,75.0,YR,,F,Y,54.3,KG,20211203.0,,MD,BR,BR,2021,Q4,Elderly
201435791,20143579,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 IU,,,,,Unknown,,,,,,,2021,Q4,Unevaluable event,,2021,Q4,1,I,,20211122.0,20211203,20211203,EXP,,BR-NOVOPROD-870390,NOVO NORDISK,,75.0,YR,,F,Y,54.3,KG,20211203.0,,MD,BR,BR,2021,Q4,Elderly
201435791,20143579,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 IU,,,,,Unknown,,,,,,,2021,Q4,Paraesthesia,,2021,Q4,1,I,,20211122.0,20211203,20211203,EXP,,BR-NOVOPROD-870390,NOVO NORDISK,,75.0,YR,,F,Y,54.3,KG,20211203.0,,MD,BR,BR,2021,Q4,Elderly
201435791,20143579,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 IU,,,,,Unknown,,,,,,,2021,Q4,Pruritus,,2021,Q4,1,I,,20211122.0,20211203,20211203,EXP,,BR-NOVOPROD-870390,NOVO NORDISK,,75.0,YR,,F,Y,54.3,KG,20211203.0,,MD,BR,BR,2021,Q4,Elderly
201435791,20143579,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 IU,,,,,Unknown,,,,,,,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,,20211122.0,20211203,20211203,EXP,,BR-NOVOPROD-870390,NOVO NORDISK,,75.0,YR,,F,Y,54.3,KG,20211203.0,,MD,BR,BR,2021,Q4,Elderly
201435791,20143579,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 IU,,,,,Unknown,,,,,,,2021,Q4,Cholecystectomy,,2021,Q4,1,I,,20211122.0,20211203,20211203,EXP,,BR-NOVOPROD-870390,NOVO NORDISK,,75.0,YR,,F,Y,54.3,KG,20211203.0,,MD,BR,BR,2021,Q4,Elderly
201435791,20143579,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 IU,,,,,Unknown,,,,,,,2021,Q4,Atrioventricular block first degree,,2021,Q4,1,I,,20211122.0,20211203,20211203,EXP,,BR-NOVOPROD-870390,NOVO NORDISK,,75.0,YR,,F,Y,54.3,KG,20211203.0,,MD,BR,BR,2021,Q4,Elderly
201435791,20143579,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 IU,,,,,Unknown,,,,,,,2021,Q4,Muscular weakness,,2021,Q4,1,I,,20211122.0,20211203,20211203,EXP,,BR-NOVOPROD-870390,NOVO NORDISK,,75.0,YR,,F,Y,54.3,KG,20211203.0,,MD,BR,BR,2021,Q4,Elderly
201435791,20143579,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 IU,,,,,Unknown,,,,,,,2021,Q4,Skin ulcer,,2021,Q4,1,I,,20211122.0,20211203,20211203,EXP,,BR-NOVOPROD-870390,NOVO NORDISK,,75.0,YR,,F,Y,54.3,KG,20211203.0,,MD,BR,BR,2021,Q4,Elderly
201435791,20143579,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 IU,,,,,Unknown,,,,,,,2021,Q4,Blood glucose increased,,2021,Q4,1,I,,20211122.0,20211203,20211203,EXP,,BR-NOVOPROD-870390,NOVO NORDISK,,75.0,YR,,F,Y,54.3,KG,20211203.0,,MD,BR,BR,2021,Q4,Elderly
201435791,20143579,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 IU,,,,,Unknown,,,,,,,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211122.0,20211203,20211203,EXP,,BR-NOVOPROD-870390,NOVO NORDISK,,75.0,YR,,F,Y,54.3,KG,20211203.0,,MD,BR,BR,2021,Q4,Elderly
201451591,20145159,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,22 U,,,,,,,,,,,,2021,Q4,Glomerular filtration rate decreased,,2021,Q4,1,I,,20211126.0,20211203,20211203,EXP,,AU-AstraZeneca-2021A847841,ASTRAZENECA,,87.0,YR,,F,Y,,,20211203.0,,MD,AU,,2021,Q4,Elderly
201451591,20145159,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,22 U,,,,,,,,,,,,2021,Q4,Urine albumin/creatinine ratio increased,,2021,Q4,1,I,,20211126.0,20211203,20211203,EXP,,AU-AstraZeneca-2021A847841,ASTRAZENECA,,87.0,YR,,F,Y,,,20211203.0,,MD,AU,,2021,Q4,Elderly
201451591,20145159,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,22 U,,,,,,,,,,,,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,1,I,,20211126.0,20211203,20211203,EXP,,AU-AstraZeneca-2021A847841,ASTRAZENECA,,87.0,YR,,F,Y,,,20211203.0,,MD,AU,,2021,Q4,Elderly
201451691,20145169,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,56.0,IU,Y,,ABJL021,,,8.0,IU,Injection,QD,2021,Q4,Blood pressure decreased,,2021,Q4,1,I,20211117.0,20211128.0,20211203,20211203,EXP,,CN-AstraZeneca-2021A848055,ASTRAZENECA,,2987.0,WK,,F,Y,,,20211203.0,,MD,CN,,2021,Q4,Elderly
201451691,20145169,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,56.0,IU,Y,,ABJL021,,,8.0,IU,Injection,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20211117.0,20211128.0,20211203,20211203,EXP,,CN-AstraZeneca-2021A848055,ASTRAZENECA,,2987.0,WK,,F,Y,,,20211203.0,,MD,CN,,2021,Q4,Elderly
201455591,20145559,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Aplastic anaemia,,2021,Q4,1,I,,20211125.0,20211203,20211203,EXP,,CA-TEVA-2021-CA-1983013,TEVA,,20.0,YR,A,M,Y,84.0,KG,20211203.0,,HP,CA,CA,2021,Q4,Youth
201524651,20152465,3,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Subcutaneous,"28 international unit, qd. in the morning 28 iu",,,U,,,,,28.0,IU,Injection,QD,2021,Q4,Bile duct stone,,2021,Q4,1,I,,20211130.0,20211206,20211206,EXP,,SK-MYLANLABS-2021M1089247,MYLAN,,66.0,YR,,M,Y,93.0,KG,20211206.0,,MD,SK,SK,2021,Q4,Elderly
201524651,20152465,3,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Subcutaneous,"28 international unit, qd. in the morning 28 iu",,,U,,,,,28.0,IU,Injection,QD,2021,Q4,Balanoposthitis,,2021,Q4,1,I,,20211130.0,20211206,20211206,EXP,,SK-MYLANLABS-2021M1089247,MYLAN,,66.0,YR,,M,Y,93.0,KG,20211206.0,,MD,SK,SK,2021,Q4,Elderly
201524651,20152465,3,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Subcutaneous,"28 international unit, qd. in the morning 28 iu",,,U,,,,,28.0,IU,Injection,QD,2021,Q4,Diabetic neuropathy,,2021,Q4,1,I,,20211130.0,20211206,20211206,EXP,,SK-MYLANLABS-2021M1089247,MYLAN,,66.0,YR,,M,Y,93.0,KG,20211206.0,,MD,SK,SK,2021,Q4,Elderly
201524651,20152465,3,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Subcutaneous,"28 international unit, qd. in the morning 28 iu",,,U,,,,,28.0,IU,Injection,QD,2021,Q4,Diabetic retinopathy,,2021,Q4,1,I,,20211130.0,20211206,20211206,EXP,,SK-MYLANLABS-2021M1089247,MYLAN,,66.0,YR,,M,Y,93.0,KG,20211206.0,,MD,SK,SK,2021,Q4,Elderly
201524651,20152465,4,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Subcutaneous,"26 international unit, qd in the morning",,,U,,,,,26.0,IU,Injection,QD,2021,Q4,Bile duct stone,,2021,Q4,1,I,,20211130.0,20211206,20211206,EXP,,SK-MYLANLABS-2021M1089247,MYLAN,,66.0,YR,,M,Y,93.0,KG,20211206.0,,MD,SK,SK,2021,Q4,Elderly
201524651,20152465,4,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Subcutaneous,"26 international unit, qd in the morning",,,U,,,,,26.0,IU,Injection,QD,2021,Q4,Balanoposthitis,,2021,Q4,1,I,,20211130.0,20211206,20211206,EXP,,SK-MYLANLABS-2021M1089247,MYLAN,,66.0,YR,,M,Y,93.0,KG,20211206.0,,MD,SK,SK,2021,Q4,Elderly
201524651,20152465,4,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Subcutaneous,"26 international unit, qd in the morning",,,U,,,,,26.0,IU,Injection,QD,2021,Q4,Diabetic neuropathy,,2021,Q4,1,I,,20211130.0,20211206,20211206,EXP,,SK-MYLANLABS-2021M1089247,MYLAN,,66.0,YR,,M,Y,93.0,KG,20211206.0,,MD,SK,SK,2021,Q4,Elderly
201524651,20152465,4,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Subcutaneous,"26 international unit, qd in the morning",,,U,,,,,26.0,IU,Injection,QD,2021,Q4,Diabetic retinopathy,,2021,Q4,1,I,,20211130.0,20211206,20211206,EXP,,SK-MYLANLABS-2021M1089247,MYLAN,,66.0,YR,,M,Y,93.0,KG,20211206.0,,MD,SK,SK,2021,Q4,Elderly
201524651,20152465,5,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Subcutaneous,"20 international unit, qd, 100 IU / 50 ?g before breakfast 20 IU",,,U,,,,,20.0,IU,Injection,QD,2021,Q4,Bile duct stone,,2021,Q4,1,I,,20211130.0,20211206,20211206,EXP,,SK-MYLANLABS-2021M1089247,MYLAN,,66.0,YR,,M,Y,93.0,KG,20211206.0,,MD,SK,SK,2021,Q4,Elderly
201524651,20152465,5,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Subcutaneous,"20 international unit, qd, 100 IU / 50 ?g before breakfast 20 IU",,,U,,,,,20.0,IU,Injection,QD,2021,Q4,Balanoposthitis,,2021,Q4,1,I,,20211130.0,20211206,20211206,EXP,,SK-MYLANLABS-2021M1089247,MYLAN,,66.0,YR,,M,Y,93.0,KG,20211206.0,,MD,SK,SK,2021,Q4,Elderly
201524651,20152465,5,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Subcutaneous,"20 international unit, qd, 100 IU / 50 ?g before breakfast 20 IU",,,U,,,,,20.0,IU,Injection,QD,2021,Q4,Diabetic neuropathy,,2021,Q4,1,I,,20211130.0,20211206,20211206,EXP,,SK-MYLANLABS-2021M1089247,MYLAN,,66.0,YR,,M,Y,93.0,KG,20211206.0,,MD,SK,SK,2021,Q4,Elderly
201524651,20152465,5,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Subcutaneous,"20 international unit, qd, 100 IU / 50 ?g before breakfast 20 IU",,,U,,,,,20.0,IU,Injection,QD,2021,Q4,Diabetic retinopathy,,2021,Q4,1,I,,20211130.0,20211206,20211206,EXP,,SK-MYLANLABS-2021M1089247,MYLAN,,66.0,YR,,M,Y,93.0,KG,20211206.0,,MD,SK,SK,2021,Q4,Elderly
201527821,20152782,1,PS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,Subcutaneous,"UNK, qd (once a day)",,,Y,U,BF20001998,,210605.0,,,Injection,QD,2021,Q4,Drug ineffective,,2021,Q4,1,I,,20211109.0,20211206,20211206,PER,,US-MYLANLABS-2021M1082922,MYLAN,,4.0,YR,,M,Y,14.0,KG,20211206.0,,CN,US,US,2021,Q4,Child
201527971,20152797,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, unknown",,,U,,D407387F,,,,,,,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,20210601.0,20211123.0,20211206,20211206,EXP,,FR-ELI_LILLY_AND_COMPANY-FR202112000366,ELI LILLY AND CO,,14.0,YR,,M,Y,,,20211206.0,,CN,FR,FR,2021,Q4,Youth
201527971,20152797,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, unknown",,,U,,D407387F,,,,,,,2021,Q4,Vomiting,,2021,Q4,1,I,20210601.0,20211123.0,20211206,20211206,EXP,,FR-ELI_LILLY_AND_COMPANY-FR202112000366,ELI LILLY AND CO,,14.0,YR,,M,Y,,,20211206.0,,CN,FR,FR,2021,Q4,Youth
201529553,20152955,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Pancreatitis,,2021,Q4,3,F,20211116.0,20211214.0,20211206,20211216,PER,,AR-AMGEN-ARGCT2021191088,AMGEN,,76.0,YR,E,F,Y,98.0,KG,20211215.0,,MD,AR,AR,2021,Q4,Elderly
201532441,20153244,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"56 international unit, daily",,,Y,,1F939A,,,56.0,IU,,QD,2021,Q4,Insomnia,,2021,Q4,1,I,20210101.0,20211124.0,20211206,20211206,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202111005316,ELI LILLY AND CO,,58.0,YR,,F,Y,82.5,KG,20211206.0,,CN,ES,ES,2021,Q4,Adult
201532441,20153244,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"56 international unit, daily",,,Y,,1F939A,,,56.0,IU,,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20210101.0,20211124.0,20211206,20211206,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202111005316,ELI LILLY AND CO,,58.0,YR,,F,Y,82.5,KG,20211206.0,,CN,ES,ES,2021,Q4,Adult
201532441,20153244,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"56 international unit, daily",,,Y,,1F939A,,,56.0,IU,,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20210101.0,20211124.0,20211206,20211206,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202111005316,ELI LILLY AND CO,,58.0,YR,,F,Y,82.5,KG,20211206.0,,CN,ES,ES,2021,Q4,Adult
201532441,20153244,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"56 international unit, daily",,,Y,,1F939A,,,56.0,IU,,QD,2021,Q4,Gastric disorder,,2021,Q4,1,I,20210101.0,20211124.0,20211206,20211206,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202111005316,ELI LILLY AND CO,,58.0,YR,,F,Y,82.5,KG,20211206.0,,CN,ES,ES,2021,Q4,Adult
201532441,20153244,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"56 international unit, daily",,,Y,,1F939A,,,56.0,IU,,QD,2021,Q4,Decreased appetite,,2021,Q4,1,I,20210101.0,20211124.0,20211206,20211206,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202111005316,ELI LILLY AND CO,,58.0,YR,,F,Y,82.5,KG,20211206.0,,CN,ES,ES,2021,Q4,Adult
201532441,20153244,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"56 international unit, daily",,,Y,,1F939A,,,56.0,IU,,QD,2021,Q4,Pain,,2021,Q4,1,I,20210101.0,20211124.0,20211206,20211206,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202111005316,ELI LILLY AND CO,,58.0,YR,,F,Y,82.5,KG,20211206.0,,CN,ES,ES,2021,Q4,Adult
201532441,20153244,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"56 international unit, daily",,,Y,,1F939A,,,56.0,IU,,QD,2021,Q4,Tremor,,2021,Q4,1,I,20210101.0,20211124.0,20211206,20211206,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202111005316,ELI LILLY AND CO,,58.0,YR,,F,Y,82.5,KG,20211206.0,,CN,ES,ES,2021,Q4,Adult
201532441,20153244,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"56 international unit, daily",,,Y,,1F939A,,,56.0,IU,,QD,2021,Q4,Drug intolerance,,2021,Q4,1,I,20210101.0,20211124.0,20211206,20211206,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202111005316,ELI LILLY AND CO,,58.0,YR,,F,Y,82.5,KG,20211206.0,,CN,ES,ES,2021,Q4,Adult
201532441,20153244,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"56 international unit, daily",,,Y,,1F939A,,,56.0,IU,,QD,2021,Q4,Abdominal distension,,2021,Q4,1,I,20210101.0,20211124.0,20211206,20211206,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202111005316,ELI LILLY AND CO,,58.0,YR,,F,Y,82.5,KG,20211206.0,,CN,ES,ES,2021,Q4,Adult
201532441,20153244,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"56 international unit, daily",,,Y,,1F939A,,,56.0,IU,,QD,2021,Q4,Discomfort,,2021,Q4,1,I,20210101.0,20211124.0,20211206,20211206,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202111005316,ELI LILLY AND CO,,58.0,YR,,F,Y,82.5,KG,20211206.0,,CN,ES,ES,2021,Q4,Adult
201532441,20153244,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"56 international unit, daily",,,Y,,1F939A,,,56.0,IU,,QD,2021,Q4,Eructation,,2021,Q4,1,I,20210101.0,20211124.0,20211206,20211206,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202111005316,ELI LILLY AND CO,,58.0,YR,,F,Y,82.5,KG,20211206.0,,CN,ES,ES,2021,Q4,Adult
201532441,20153244,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"56 international unit, daily",,,Y,,1F939A,,,56.0,IU,,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20210101.0,20211124.0,20211206,20211206,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202111005316,ELI LILLY AND CO,,58.0,YR,,F,Y,82.5,KG,20211206.0,,CN,ES,ES,2021,Q4,Adult
201532441,20153244,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 international unit, daily",,,Y,,,,,50.0,IU,,QD,2021,Q4,Insomnia,,2021,Q4,1,I,20210101.0,20211124.0,20211206,20211206,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202111005316,ELI LILLY AND CO,,58.0,YR,,F,Y,82.5,KG,20211206.0,,CN,ES,ES,2021,Q4,Adult
201532441,20153244,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 international unit, daily",,,Y,,,,,50.0,IU,,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20210101.0,20211124.0,20211206,20211206,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202111005316,ELI LILLY AND CO,,58.0,YR,,F,Y,82.5,KG,20211206.0,,CN,ES,ES,2021,Q4,Adult
201532441,20153244,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 international unit, daily",,,Y,,,,,50.0,IU,,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20210101.0,20211124.0,20211206,20211206,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202111005316,ELI LILLY AND CO,,58.0,YR,,F,Y,82.5,KG,20211206.0,,CN,ES,ES,2021,Q4,Adult
201532441,20153244,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 international unit, daily",,,Y,,,,,50.0,IU,,QD,2021,Q4,Gastric disorder,,2021,Q4,1,I,20210101.0,20211124.0,20211206,20211206,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202111005316,ELI LILLY AND CO,,58.0,YR,,F,Y,82.5,KG,20211206.0,,CN,ES,ES,2021,Q4,Adult
201532441,20153244,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 international unit, daily",,,Y,,,,,50.0,IU,,QD,2021,Q4,Decreased appetite,,2021,Q4,1,I,20210101.0,20211124.0,20211206,20211206,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202111005316,ELI LILLY AND CO,,58.0,YR,,F,Y,82.5,KG,20211206.0,,CN,ES,ES,2021,Q4,Adult
201532441,20153244,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 international unit, daily",,,Y,,,,,50.0,IU,,QD,2021,Q4,Pain,,2021,Q4,1,I,20210101.0,20211124.0,20211206,20211206,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202111005316,ELI LILLY AND CO,,58.0,YR,,F,Y,82.5,KG,20211206.0,,CN,ES,ES,2021,Q4,Adult
201532441,20153244,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 international unit, daily",,,Y,,,,,50.0,IU,,QD,2021,Q4,Tremor,,2021,Q4,1,I,20210101.0,20211124.0,20211206,20211206,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202111005316,ELI LILLY AND CO,,58.0,YR,,F,Y,82.5,KG,20211206.0,,CN,ES,ES,2021,Q4,Adult
201532441,20153244,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 international unit, daily",,,Y,,,,,50.0,IU,,QD,2021,Q4,Drug intolerance,,2021,Q4,1,I,20210101.0,20211124.0,20211206,20211206,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202111005316,ELI LILLY AND CO,,58.0,YR,,F,Y,82.5,KG,20211206.0,,CN,ES,ES,2021,Q4,Adult
201532441,20153244,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 international unit, daily",,,Y,,,,,50.0,IU,,QD,2021,Q4,Abdominal distension,,2021,Q4,1,I,20210101.0,20211124.0,20211206,20211206,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202111005316,ELI LILLY AND CO,,58.0,YR,,F,Y,82.5,KG,20211206.0,,CN,ES,ES,2021,Q4,Adult
201532441,20153244,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 international unit, daily",,,Y,,,,,50.0,IU,,QD,2021,Q4,Discomfort,,2021,Q4,1,I,20210101.0,20211124.0,20211206,20211206,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202111005316,ELI LILLY AND CO,,58.0,YR,,F,Y,82.5,KG,20211206.0,,CN,ES,ES,2021,Q4,Adult
201532441,20153244,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 international unit, daily",,,Y,,,,,50.0,IU,,QD,2021,Q4,Eructation,,2021,Q4,1,I,20210101.0,20211124.0,20211206,20211206,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202111005316,ELI LILLY AND CO,,58.0,YR,,F,Y,82.5,KG,20211206.0,,CN,ES,ES,2021,Q4,Adult
201532441,20153244,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 international unit, daily",,,Y,,,,,50.0,IU,,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20210101.0,20211124.0,20211206,20211206,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202111005316,ELI LILLY AND CO,,58.0,YR,,F,Y,82.5,KG,20211206.0,,CN,ES,ES,2021,Q4,Adult
201532441,20153244,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 international unit, daily",,,Y,,1F080A,,,48.0,IU,,QD,2021,Q4,Insomnia,,2021,Q4,1,I,20210101.0,20211124.0,20211206,20211206,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202111005316,ELI LILLY AND CO,,58.0,YR,,F,Y,82.5,KG,20211206.0,,CN,ES,ES,2021,Q4,Adult
201532441,20153244,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 international unit, daily",,,Y,,1F080A,,,48.0,IU,,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20210101.0,20211124.0,20211206,20211206,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202111005316,ELI LILLY AND CO,,58.0,YR,,F,Y,82.5,KG,20211206.0,,CN,ES,ES,2021,Q4,Adult
201532441,20153244,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 international unit, daily",,,Y,,1F080A,,,48.0,IU,,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20210101.0,20211124.0,20211206,20211206,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202111005316,ELI LILLY AND CO,,58.0,YR,,F,Y,82.5,KG,20211206.0,,CN,ES,ES,2021,Q4,Adult
201532441,20153244,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 international unit, daily",,,Y,,1F080A,,,48.0,IU,,QD,2021,Q4,Gastric disorder,,2021,Q4,1,I,20210101.0,20211124.0,20211206,20211206,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202111005316,ELI LILLY AND CO,,58.0,YR,,F,Y,82.5,KG,20211206.0,,CN,ES,ES,2021,Q4,Adult
201532441,20153244,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 international unit, daily",,,Y,,1F080A,,,48.0,IU,,QD,2021,Q4,Decreased appetite,,2021,Q4,1,I,20210101.0,20211124.0,20211206,20211206,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202111005316,ELI LILLY AND CO,,58.0,YR,,F,Y,82.5,KG,20211206.0,,CN,ES,ES,2021,Q4,Adult
201532441,20153244,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 international unit, daily",,,Y,,1F080A,,,48.0,IU,,QD,2021,Q4,Pain,,2021,Q4,1,I,20210101.0,20211124.0,20211206,20211206,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202111005316,ELI LILLY AND CO,,58.0,YR,,F,Y,82.5,KG,20211206.0,,CN,ES,ES,2021,Q4,Adult
201532441,20153244,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 international unit, daily",,,Y,,1F080A,,,48.0,IU,,QD,2021,Q4,Tremor,,2021,Q4,1,I,20210101.0,20211124.0,20211206,20211206,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202111005316,ELI LILLY AND CO,,58.0,YR,,F,Y,82.5,KG,20211206.0,,CN,ES,ES,2021,Q4,Adult
201532441,20153244,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 international unit, daily",,,Y,,1F080A,,,48.0,IU,,QD,2021,Q4,Drug intolerance,,2021,Q4,1,I,20210101.0,20211124.0,20211206,20211206,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202111005316,ELI LILLY AND CO,,58.0,YR,,F,Y,82.5,KG,20211206.0,,CN,ES,ES,2021,Q4,Adult
201532441,20153244,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 international unit, daily",,,Y,,1F080A,,,48.0,IU,,QD,2021,Q4,Abdominal distension,,2021,Q4,1,I,20210101.0,20211124.0,20211206,20211206,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202111005316,ELI LILLY AND CO,,58.0,YR,,F,Y,82.5,KG,20211206.0,,CN,ES,ES,2021,Q4,Adult
201532441,20153244,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 international unit, daily",,,Y,,1F080A,,,48.0,IU,,QD,2021,Q4,Discomfort,,2021,Q4,1,I,20210101.0,20211124.0,20211206,20211206,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202111005316,ELI LILLY AND CO,,58.0,YR,,F,Y,82.5,KG,20211206.0,,CN,ES,ES,2021,Q4,Adult
201532441,20153244,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 international unit, daily",,,Y,,1F080A,,,48.0,IU,,QD,2021,Q4,Eructation,,2021,Q4,1,I,20210101.0,20211124.0,20211206,20211206,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202111005316,ELI LILLY AND CO,,58.0,YR,,F,Y,82.5,KG,20211206.0,,CN,ES,ES,2021,Q4,Adult
201532441,20153244,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 international unit, daily",,,Y,,1F080A,,,48.0,IU,,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20210101.0,20211124.0,20211206,20211206,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202111005316,ELI LILLY AND CO,,58.0,YR,,F,Y,82.5,KG,20211206.0,,CN,ES,ES,2021,Q4,Adult
201545781,20154578,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Chills,,2021,Q4,1,I,20211116.0,20211128.0,20211207,20211207,EXP,GB-MHRA-ADR 26251629,GB-Accord-246727,ACCORD,,69.0,YR,,M,Y,107.0,KG,20211207.0,,CN,GB,GB,2021,Q4,Elderly
201545781,20154578,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Fatigue,,2021,Q4,1,I,20211116.0,20211128.0,20211207,20211207,EXP,GB-MHRA-ADR 26251629,GB-Accord-246727,ACCORD,,69.0,YR,,M,Y,107.0,KG,20211207.0,,CN,GB,GB,2021,Q4,Elderly
201545781,20154578,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Feeling cold,,2021,Q4,1,I,20211116.0,20211128.0,20211207,20211207,EXP,GB-MHRA-ADR 26251629,GB-Accord-246727,ACCORD,,69.0,YR,,M,Y,107.0,KG,20211207.0,,CN,GB,GB,2021,Q4,Elderly
201545781,20154578,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Headache,,2021,Q4,1,I,20211116.0,20211128.0,20211207,20211207,EXP,GB-MHRA-ADR 26251629,GB-Accord-246727,ACCORD,,69.0,YR,,M,Y,107.0,KG,20211207.0,,CN,GB,GB,2021,Q4,Elderly
201545781,20154578,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Migraine,,2021,Q4,1,I,20211116.0,20211128.0,20211207,20211207,EXP,GB-MHRA-ADR 26251629,GB-Accord-246727,ACCORD,,69.0,YR,,M,Y,107.0,KG,20211207.0,,CN,GB,GB,2021,Q4,Elderly
201545781,20154578,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Pain in extremity,,2021,Q4,1,I,20211116.0,20211128.0,20211207,20211207,EXP,GB-MHRA-ADR 26251629,GB-Accord-246727,ACCORD,,69.0,YR,,M,Y,107.0,KG,20211207.0,,CN,GB,GB,2021,Q4,Elderly
201545781,20154578,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Dizziness,,2021,Q4,1,I,20211116.0,20211128.0,20211207,20211207,EXP,GB-MHRA-ADR 26251629,GB-Accord-246727,ACCORD,,69.0,YR,,M,Y,107.0,KG,20211207.0,,CN,GB,GB,2021,Q4,Elderly
201545781,20154578,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Confusional state,,2021,Q4,1,I,20211116.0,20211128.0,20211207,20211207,EXP,GB-MHRA-ADR 26251629,GB-Accord-246727,ACCORD,,69.0,YR,,M,Y,107.0,KG,20211207.0,,CN,GB,GB,2021,Q4,Elderly
201552751,20155275,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Clostridium difficile infection,,2021,Q4,1,I,,20211127.0,20211207,20211207,EXP,,CA-TEVA-2021-CA-1984250,TEVA,,74.0,YR,E,M,Y,50.0,KG,20211207.0,,PH,CA,CA,2021,Q4,Elderly
201557781,20155778,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,Injection,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,,20211123.0,20211207,20211207,EXP,,CN-AstraZeneca-2021A837900,ASTRAZENECA,"Sun Jingbo, Xue Wenxin, et al.. A case of diabetic ketoacidosis caused by dapagliflozin. Chinese Journal of Drug Application and Monitoring 2021;18(5):345 to 348.",54.0,YR,,M,Y,,,20211207.0,,HP,CN,,2021,Q4,Adult
201567772,20156777,4,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,50 units,,,Y,,,,,,,,,2021,Q4,Drug intolerance,,2021,Q4,2,F,20200101.0,20211222.0,20211207,20211231,EXP,,CZ-TEVA-2021-CZ-1976546,TEVA,Nekvapilova L. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36.,8.0,DEC,E,F,Y,,,20211231.0,,MD,CZ,CZ,2021,Q4,Child
201567772,20156777,4,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,50 units,,,Y,,,,,,,,,2021,Q4,Constipation,,2021,Q4,2,F,20200101.0,20211222.0,20211207,20211231,EXP,,CZ-TEVA-2021-CZ-1976546,TEVA,Nekvapilova L. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36.,8.0,DEC,E,F,Y,,,20211231.0,,MD,CZ,CZ,2021,Q4,Child
201567772,20156777,4,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,50 units,,,Y,,,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,2,F,20200101.0,20211222.0,20211207,20211231,EXP,,CZ-TEVA-2021-CZ-1976546,TEVA,Nekvapilova L. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36.,8.0,DEC,E,F,Y,,,20211231.0,,MD,CZ,CZ,2021,Q4,Child
201567772,20156777,4,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,50 units,,,Y,,,,,,,,,2021,Q4,Treatment noncompliance,,2021,Q4,2,F,20200101.0,20211222.0,20211207,20211231,EXP,,CZ-TEVA-2021-CZ-1976546,TEVA,Nekvapilova L. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36.,8.0,DEC,E,F,Y,,,20211231.0,,MD,CZ,CZ,2021,Q4,Child
201567772,20156777,4,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,50 units,,,Y,,,,,,,,,2021,Q4,Seizure,,2021,Q4,2,F,20200101.0,20211222.0,20211207,20211231,EXP,,CZ-TEVA-2021-CZ-1976546,TEVA,Nekvapilova L. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36.,8.0,DEC,E,F,Y,,,20211231.0,,MD,CZ,CZ,2021,Q4,Child
201567772,20156777,4,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,50 units,,,Y,,,,,,,,,2021,Q4,Abdominal pain lower,,2021,Q4,2,F,20200101.0,20211222.0,20211207,20211231,EXP,,CZ-TEVA-2021-CZ-1976546,TEVA,Nekvapilova L. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36.,8.0,DEC,E,F,Y,,,20211231.0,,MD,CZ,CZ,2021,Q4,Child
201567772,20156777,5,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,,,,Y,,,,,,,,,2021,Q4,Drug intolerance,,2021,Q4,2,F,20200101.0,20211222.0,20211207,20211231,EXP,,CZ-TEVA-2021-CZ-1976546,TEVA,Nekvapilova L. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36.,8.0,DEC,E,F,Y,,,20211231.0,,MD,CZ,CZ,2021,Q4,Child
201567772,20156777,5,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,,,,Y,,,,,,,,,2021,Q4,Constipation,,2021,Q4,2,F,20200101.0,20211222.0,20211207,20211231,EXP,,CZ-TEVA-2021-CZ-1976546,TEVA,Nekvapilova L. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36.,8.0,DEC,E,F,Y,,,20211231.0,,MD,CZ,CZ,2021,Q4,Child
201567772,20156777,5,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,,,,Y,,,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,2,F,20200101.0,20211222.0,20211207,20211231,EXP,,CZ-TEVA-2021-CZ-1976546,TEVA,Nekvapilova L. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36.,8.0,DEC,E,F,Y,,,20211231.0,,MD,CZ,CZ,2021,Q4,Child
201567772,20156777,5,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,,,,Y,,,,,,,,,2021,Q4,Treatment noncompliance,,2021,Q4,2,F,20200101.0,20211222.0,20211207,20211231,EXP,,CZ-TEVA-2021-CZ-1976546,TEVA,Nekvapilova L. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36.,8.0,DEC,E,F,Y,,,20211231.0,,MD,CZ,CZ,2021,Q4,Child
201567772,20156777,5,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,,,,Y,,,,,,,,,2021,Q4,Seizure,,2021,Q4,2,F,20200101.0,20211222.0,20211207,20211231,EXP,,CZ-TEVA-2021-CZ-1976546,TEVA,Nekvapilova L. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36.,8.0,DEC,E,F,Y,,,20211231.0,,MD,CZ,CZ,2021,Q4,Child
201567772,20156777,5,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,,,,Y,,,,,,,,,2021,Q4,Abdominal pain lower,,2021,Q4,2,F,20200101.0,20211222.0,20211207,20211231,EXP,,CZ-TEVA-2021-CZ-1976546,TEVA,Nekvapilova L. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36.,8.0,DEC,E,F,Y,,,20211231.0,,MD,CZ,CZ,2021,Q4,Child
201567772,20156777,6,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,,,,Y,,,,,,,,,2021,Q4,Drug intolerance,,2021,Q4,2,F,20200101.0,20211222.0,20211207,20211231,EXP,,CZ-TEVA-2021-CZ-1976546,TEVA,Nekvapilova L. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36.,8.0,DEC,E,F,Y,,,20211231.0,,MD,CZ,CZ,2021,Q4,Child
201567772,20156777,6,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,,,,Y,,,,,,,,,2021,Q4,Constipation,,2021,Q4,2,F,20200101.0,20211222.0,20211207,20211231,EXP,,CZ-TEVA-2021-CZ-1976546,TEVA,Nekvapilova L. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36.,8.0,DEC,E,F,Y,,,20211231.0,,MD,CZ,CZ,2021,Q4,Child
201567772,20156777,6,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,,,,Y,,,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,2,F,20200101.0,20211222.0,20211207,20211231,EXP,,CZ-TEVA-2021-CZ-1976546,TEVA,Nekvapilova L. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36.,8.0,DEC,E,F,Y,,,20211231.0,,MD,CZ,CZ,2021,Q4,Child
201567772,20156777,6,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,,,,Y,,,,,,,,,2021,Q4,Treatment noncompliance,,2021,Q4,2,F,20200101.0,20211222.0,20211207,20211231,EXP,,CZ-TEVA-2021-CZ-1976546,TEVA,Nekvapilova L. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36.,8.0,DEC,E,F,Y,,,20211231.0,,MD,CZ,CZ,2021,Q4,Child
201567772,20156777,6,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,,,,Y,,,,,,,,,2021,Q4,Seizure,,2021,Q4,2,F,20200101.0,20211222.0,20211207,20211231,EXP,,CZ-TEVA-2021-CZ-1976546,TEVA,Nekvapilova L. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36.,8.0,DEC,E,F,Y,,,20211231.0,,MD,CZ,CZ,2021,Q4,Child
201567772,20156777,6,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,,,,Y,,,,,,,,,2021,Q4,Abdominal pain lower,,2021,Q4,2,F,20200101.0,20211222.0,20211207,20211231,EXP,,CZ-TEVA-2021-CZ-1976546,TEVA,Nekvapilova L. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36.,8.0,DEC,E,F,Y,,,20211231.0,,MD,CZ,CZ,2021,Q4,Child
201570631,20157063,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 units at bedtime,,,,,,,,,,,,2021,Q4,Acute myocardial infarction,,2021,Q4,1,I,,20211130.0,20211207,20211207,EXP,,US-AMERICAN REGENT INC-2021003169,AMERICAN REGENT,"Saeed M, Gil GS, Lopez PD, Visco F, Pekler G, Mushiyev S. Chest Pain Induced by Intravenous Nitroglycerin. American Journal of Therapeutics. 2020;27(3):e299-e301",54.0,YR,,M,Y,,,20211207.0,,MD,US,US,2021,Q4,Adult
201570631,20157063,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 units at bedtime,,,,,,,,,,,,2021,Q4,Product use in unapproved indication,,2021,Q4,1,I,,20211130.0,20211207,20211207,EXP,,US-AMERICAN REGENT INC-2021003169,AMERICAN REGENT,"Saeed M, Gil GS, Lopez PD, Visco F, Pekler G, Mushiyev S. Chest Pain Induced by Intravenous Nitroglycerin. American Journal of Therapeutics. 2020;27(3):e299-e301",54.0,YR,,M,Y,,,20211207.0,,MD,US,US,2021,Q4,Adult
201594331,20159433,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Headache,,2021,Q4,1,I,20211116.0,20211128.0,20211208,20211208,EXP,GB-MHRA-EYC 00267420,GB-TEVA-2021-GB-1984056,TEVA,,69.0,YR,E,M,Y,107.0,KG,20211208.0,,CN,GB,GB,2021,Q4,Elderly
201594331,20159433,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Pain in extremity,,2021,Q4,1,I,20211116.0,20211128.0,20211208,20211208,EXP,GB-MHRA-EYC 00267420,GB-TEVA-2021-GB-1984056,TEVA,,69.0,YR,E,M,Y,107.0,KG,20211208.0,,CN,GB,GB,2021,Q4,Elderly
201594331,20159433,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Feeling cold,,2021,Q4,1,I,20211116.0,20211128.0,20211208,20211208,EXP,GB-MHRA-EYC 00267420,GB-TEVA-2021-GB-1984056,TEVA,,69.0,YR,E,M,Y,107.0,KG,20211208.0,,CN,GB,GB,2021,Q4,Elderly
201594331,20159433,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Fatigue,,2021,Q4,1,I,20211116.0,20211128.0,20211208,20211208,EXP,GB-MHRA-EYC 00267420,GB-TEVA-2021-GB-1984056,TEVA,,69.0,YR,E,M,Y,107.0,KG,20211208.0,,CN,GB,GB,2021,Q4,Elderly
201594331,20159433,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Chills,,2021,Q4,1,I,20211116.0,20211128.0,20211208,20211208,EXP,GB-MHRA-EYC 00267420,GB-TEVA-2021-GB-1984056,TEVA,,69.0,YR,E,M,Y,107.0,KG,20211208.0,,CN,GB,GB,2021,Q4,Elderly
201594331,20159433,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Migraine,,2021,Q4,1,I,20211116.0,20211128.0,20211208,20211208,EXP,GB-MHRA-EYC 00267420,GB-TEVA-2021-GB-1984056,TEVA,,69.0,YR,E,M,Y,107.0,KG,20211208.0,,CN,GB,GB,2021,Q4,Elderly
201594331,20159433,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Dizziness,,2021,Q4,1,I,20211116.0,20211128.0,20211208,20211208,EXP,GB-MHRA-EYC 00267420,GB-TEVA-2021-GB-1984056,TEVA,,69.0,YR,E,M,Y,107.0,KG,20211208.0,,CN,GB,GB,2021,Q4,Elderly
201594331,20159433,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Confusional state,,2021,Q4,1,I,20211116.0,20211128.0,20211208,20211208,EXP,GB-MHRA-EYC 00267420,GB-TEVA-2021-GB-1984056,TEVA,,69.0,YR,E,M,Y,107.0,KG,20211208.0,,CN,GB,GB,2021,Q4,Elderly
201602411,20160241,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 international unit, single",4.0,IU,,,,,,4.0,IU,,,2021,Q4,Anaemia,,2021,Q4,1,I,20211029.0,20211124.0,20211208,20211208,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202111008290,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20211208.0,,CN,DE,JP,2021,Q4,Elderly
201602411,20160241,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 international unit, single",4.0,IU,,,,,,4.0,IU,,,2021,Q4,Malaise,,2021,Q4,1,I,20211029.0,20211124.0,20211208,20211208,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202111008290,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20211208.0,,CN,DE,JP,2021,Q4,Elderly
201602411,20160241,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 international unit, single",4.0,IU,,,,,,4.0,IU,,,2021,Q4,Decreased appetite,,2021,Q4,1,I,20211029.0,20211124.0,20211208,20211208,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202111008290,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20211208.0,,CN,DE,JP,2021,Q4,Elderly
201602411,20160241,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 international unit, single",4.0,IU,,,,,,4.0,IU,,,2021,Q4,Duodenal ulcer,,2021,Q4,1,I,20211029.0,20211124.0,20211208,20211208,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202111008290,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20211208.0,,CN,DE,JP,2021,Q4,Elderly
201602411,20160241,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 international unit, single",4.0,IU,,,,,,4.0,IU,,,2021,Q4,Altered state of consciousness,,2021,Q4,1,I,20211029.0,20211124.0,20211208,20211208,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202111008290,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20211208.0,,CN,DE,JP,2021,Q4,Elderly
201602411,20160241,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"2 international unit, daily",4.0,IU,,,,,,2.0,IU,,QD,2021,Q4,Anaemia,,2021,Q4,1,I,20211029.0,20211124.0,20211208,20211208,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202111008290,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20211208.0,,CN,DE,JP,2021,Q4,Elderly
201602411,20160241,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"2 international unit, daily",4.0,IU,,,,,,2.0,IU,,QD,2021,Q4,Malaise,,2021,Q4,1,I,20211029.0,20211124.0,20211208,20211208,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202111008290,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20211208.0,,CN,DE,JP,2021,Q4,Elderly
201602411,20160241,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"2 international unit, daily",4.0,IU,,,,,,2.0,IU,,QD,2021,Q4,Decreased appetite,,2021,Q4,1,I,20211029.0,20211124.0,20211208,20211208,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202111008290,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20211208.0,,CN,DE,JP,2021,Q4,Elderly
201602411,20160241,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"2 international unit, daily",4.0,IU,,,,,,2.0,IU,,QD,2021,Q4,Duodenal ulcer,,2021,Q4,1,I,20211029.0,20211124.0,20211208,20211208,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202111008290,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20211208.0,,CN,DE,JP,2021,Q4,Elderly
201602411,20160241,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"2 international unit, daily",4.0,IU,,,,,,2.0,IU,,QD,2021,Q4,Altered state of consciousness,,2021,Q4,1,I,20211029.0,20211124.0,20211208,20211208,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202111008290,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20211208.0,,CN,DE,JP,2021,Q4,Elderly
201609831,20160983,1,PS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,,UNK,,,,,BF20002498,,210605.0,,,Injection,,2021,Q4,Weight increased,,2021,Q4,1,I,20211028.0,20211029.0,20211208,20211208,PER,,US-MYLANLABS-2021M1079924,MYLAN,,59.0,YR,,F,Y,,,20211208.0,,CN,US,US,2021,Q4,Adult
201609831,20160983,1,PS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,,UNK,,,,,BF20002498,,210605.0,,,Injection,,2021,Q4,Device issue,,2021,Q4,1,I,20211028.0,20211029.0,20211208,20211208,PER,,US-MYLANLABS-2021M1079924,MYLAN,,59.0,YR,,F,Y,,,20211208.0,,CN,US,US,2021,Q4,Adult
201615081,20161508,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"100 U / mL,Therapy Start date :Therapy End date :ASKU,Additional information:ABASAGLAR",,,U,,"ASKU,Asked But Unknown",,,,,Solution for injection,,2021,Q4,Haematoma muscle,,2021,Q4,1,I,20210522.0,20211130.0,20211208,20211208,EXP,FR-EMA-DD-20211122-kumarvn_p-095443,FR-TEVA-2021-FR-1984323,TEVA,,59.0,YR,A,M,Y,64.0,KG,20211208.0,,HP,FR,FR,2021,Q4,Adult
201615081,20161508,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"100 U / mL,Therapy Start date :Therapy End date :ASKU,Additional information:ABASAGLAR",,,U,,"ASKU,Asked But Unknown",,,,,Solution for injection,,2021,Q4,Pyelocaliectasis,,2021,Q4,1,I,20210522.0,20211130.0,20211208,20211208,EXP,FR-EMA-DD-20211122-kumarvn_p-095443,FR-TEVA-2021-FR-1984323,TEVA,,59.0,YR,A,M,Y,64.0,KG,20211208.0,,HP,FR,FR,2021,Q4,Adult
201615081,20161508,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"100 U / mL,Therapy Start date :Therapy End date :ASKU,Additional information:ABASAGLAR",,,U,,"ASKU,Asked But Unknown",,,,,Solution for injection,,2021,Q4,Pain in extremity,,2021,Q4,1,I,20210522.0,20211130.0,20211208,20211208,EXP,FR-EMA-DD-20211122-kumarvn_p-095443,FR-TEVA-2021-FR-1984323,TEVA,,59.0,YR,A,M,Y,64.0,KG,20211208.0,,HP,FR,FR,2021,Q4,Adult
201615081,20161508,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"100 U / mL,Therapy Start date :Therapy End date :ASKU,Additional information:ABASAGLAR",,,U,,"ASKU,Asked But Unknown",,,,,Solution for injection,,2021,Q4,Abdominal pain,,2021,Q4,1,I,20210522.0,20211130.0,20211208,20211208,EXP,FR-EMA-DD-20211122-kumarvn_p-095443,FR-TEVA-2021-FR-1984323,TEVA,,59.0,YR,A,M,Y,64.0,KG,20211208.0,,HP,FR,FR,2021,Q4,Adult
201615081,20161508,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"100 U / mL,Therapy Start date :Therapy End date :ASKU,Additional information:ABASAGLAR",,,U,,"ASKU,Asked But Unknown",,,,,Solution for injection,,2021,Q4,Muscular weakness,,2021,Q4,1,I,20210522.0,20211130.0,20211208,20211208,EXP,FR-EMA-DD-20211122-kumarvn_p-095443,FR-TEVA-2021-FR-1984323,TEVA,,59.0,YR,A,M,Y,64.0,KG,20211208.0,,HP,FR,FR,2021,Q4,Adult
201615081,20161508,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"100 U / mL,Therapy Start date :Therapy End date :ASKU,Additional information:ABASAGLAR",,,U,,"ASKU,Asked But Unknown",,,,,Solution for injection,,2021,Q4,Arthralgia,,2021,Q4,1,I,20210522.0,20211130.0,20211208,20211208,EXP,FR-EMA-DD-20211122-kumarvn_p-095443,FR-TEVA-2021-FR-1984323,TEVA,,59.0,YR,A,M,Y,64.0,KG,20211208.0,,HP,FR,FR,2021,Q4,Adult
201615081,20161508,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"100 U / mL,Therapy Start date :Therapy End date :ASKU,Additional information:ABASAGLAR",,,U,,"ASKU,Asked But Unknown",,,,,Solution for injection,,2021,Q4,Ureteric compression,,2021,Q4,1,I,20210522.0,20211130.0,20211208,20211208,EXP,FR-EMA-DD-20211122-kumarvn_p-095443,FR-TEVA-2021-FR-1984323,TEVA,,59.0,YR,A,M,Y,64.0,KG,20211208.0,,HP,FR,FR,2021,Q4,Adult
201643371,20164337,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,,20211129.0,20211209,20211209,EXP,,CA-TEVA-2021-CA-1984239,TEVA,,88.0,YR,E,F,Y,,,20211209.0,,PH,CA,CA,2021,Q4,Elderly
201643371,20164337,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,,20211129.0,20211209,20211209,EXP,,CA-TEVA-2021-CA-1984239,TEVA,,88.0,YR,E,F,Y,,,20211209.0,,PH,CA,CA,2021,Q4,Elderly
201661111,20166111,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Septic shock,,2021,Q4,1,I,,20211202.0,20211209,20211209,EXP,,FR-MYLANLABS-2021M1091199,MYLAN,"Chevalier K, Barde F, Benhamida S, Le Meur M, Thyrault M, Bentoumi Y, et al. Invasive aspergillosis and endocarditis. Rev-Med-Interne 2021;42(10):678-685.",58.0,YR,,M,Y,,,20211209.0,,HP,FR,FR,2021,Q4,Adult
201661111,20166111,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Disseminated aspergillosis,,2021,Q4,1,I,,20211202.0,20211209,20211209,EXP,,FR-MYLANLABS-2021M1091199,MYLAN,"Chevalier K, Barde F, Benhamida S, Le Meur M, Thyrault M, Bentoumi Y, et al. Invasive aspergillosis and endocarditis. Rev-Med-Interne 2021;42(10):678-685.",58.0,YR,,M,Y,,,20211209.0,,HP,FR,FR,2021,Q4,Adult
201661111,20166111,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Fungal endocarditis,,2021,Q4,1,I,,20211202.0,20211209,20211209,EXP,,FR-MYLANLABS-2021M1091199,MYLAN,"Chevalier K, Barde F, Benhamida S, Le Meur M, Thyrault M, Bentoumi Y, et al. Invasive aspergillosis and endocarditis. Rev-Med-Interne 2021;42(10):678-685.",58.0,YR,,M,Y,,,20211209.0,,HP,FR,FR,2021,Q4,Adult
201661111,20166111,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Aspergillus infection,,2021,Q4,1,I,,20211202.0,20211209,20211209,EXP,,FR-MYLANLABS-2021M1091199,MYLAN,"Chevalier K, Barde F, Benhamida S, Le Meur M, Thyrault M, Bentoumi Y, et al. Invasive aspergillosis and endocarditis. Rev-Med-Interne 2021;42(10):678-685.",58.0,YR,,M,Y,,,20211209.0,,HP,FR,FR,2021,Q4,Adult
201661111,20166111,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Acute kidney injury,,2021,Q4,1,I,,20211202.0,20211209,20211209,EXP,,FR-MYLANLABS-2021M1091199,MYLAN,"Chevalier K, Barde F, Benhamida S, Le Meur M, Thyrault M, Bentoumi Y, et al. Invasive aspergillosis and endocarditis. Rev-Med-Interne 2021;42(10):678-685.",58.0,YR,,M,Y,,,20211209.0,,HP,FR,FR,2021,Q4,Adult
201661111,20166111,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Drug ineffective,,2021,Q4,1,I,,20211202.0,20211209,20211209,EXP,,FR-MYLANLABS-2021M1091199,MYLAN,"Chevalier K, Barde F, Benhamida S, Le Meur M, Thyrault M, Bentoumi Y, et al. Invasive aspergillosis and endocarditis. Rev-Med-Interne 2021;42(10):678-685.",58.0,YR,,M,Y,,,20211209.0,,HP,FR,FR,2021,Q4,Adult
201667031,20166703,2,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,"38 international unit, qd (38 iU, QD)",,,,,,,,38.0,IU,Solution for injection,QD,2021,Q4,Pancreatitis acute,,2021,Q4,1,I,,20211207.0,20211209,20211209,EXP,,RO-MYLANLABS-2021M1091308,MYLAN,,62.0,YR,,,Y,,,20211209.0,,MD,RO,RO,2021,Q4,Adult
201683471,20168347,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,Solution,,2021,Q4,Clostridium test positive,,2021,Q4,1,I,,20211126.0,20211210,20211210,EXP,,CA-AUROBINDO-AUR-APL-2021-050875,AUROBINDO,,88.0,YR,,F,Y,72.0,KG,20211210.0,,PH,CA,CA,2021,Q4,Elderly
201686861,20168686,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Pain in extremity,,2021,Q4,1,I,20211116.0,20211128.0,20211210,20211210,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-319981,RANBAXY,,69.0,YR,,M,Y,107.0,KG,20211210.0,,CN,GB,GB,2021,Q4,Elderly
201686861,20168686,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Chills,,2021,Q4,1,I,20211116.0,20211128.0,20211210,20211210,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-319981,RANBAXY,,69.0,YR,,M,Y,107.0,KG,20211210.0,,CN,GB,GB,2021,Q4,Elderly
201686861,20168686,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Fatigue,,2021,Q4,1,I,20211116.0,20211128.0,20211210,20211210,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-319981,RANBAXY,,69.0,YR,,M,Y,107.0,KG,20211210.0,,CN,GB,GB,2021,Q4,Elderly
201686861,20168686,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Headache,,2021,Q4,1,I,20211116.0,20211128.0,20211210,20211210,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-319981,RANBAXY,,69.0,YR,,M,Y,107.0,KG,20211210.0,,CN,GB,GB,2021,Q4,Elderly
201686861,20168686,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Dizziness,,2021,Q4,1,I,20211116.0,20211128.0,20211210,20211210,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-319981,RANBAXY,,69.0,YR,,M,Y,107.0,KG,20211210.0,,CN,GB,GB,2021,Q4,Elderly
201686861,20168686,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Confusional state,,2021,Q4,1,I,20211116.0,20211128.0,20211210,20211210,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-319981,RANBAXY,,69.0,YR,,M,Y,107.0,KG,20211210.0,,CN,GB,GB,2021,Q4,Elderly
201686861,20168686,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Feeling cold,,2021,Q4,1,I,20211116.0,20211128.0,20211210,20211210,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-319981,RANBAXY,,69.0,YR,,M,Y,107.0,KG,20211210.0,,CN,GB,GB,2021,Q4,Elderly
201686861,20168686,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Migraine,,2021,Q4,1,I,20211116.0,20211128.0,20211210,20211210,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-319981,RANBAXY,,69.0,YR,,M,Y,107.0,KG,20211210.0,,CN,GB,GB,2021,Q4,Elderly
201689661,20168966,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/mL (),,,U,,,,,,,Solution for injection,,2021,Q4,Arthralgia,,2021,Q4,1,I,20210522.0,20211126.0,20211210,20211210,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-320032,RANBAXY,,59.0,YR,,M,Y,64.0,KG,20211210.0,,HP,FR,FR,2021,Q4,Adult
201689661,20168966,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/mL (),,,U,,,,,,,Solution for injection,,2021,Q4,Muscular weakness,,2021,Q4,1,I,20210522.0,20211126.0,20211210,20211210,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-320032,RANBAXY,,59.0,YR,,M,Y,64.0,KG,20211210.0,,HP,FR,FR,2021,Q4,Adult
201689661,20168966,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/mL (),,,U,,,,,,,Solution for injection,,2021,Q4,Pain in extremity,,2021,Q4,1,I,20210522.0,20211126.0,20211210,20211210,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-320032,RANBAXY,,59.0,YR,,M,Y,64.0,KG,20211210.0,,HP,FR,FR,2021,Q4,Adult
201689661,20168966,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/mL (),,,U,,,,,,,Solution for injection,,2021,Q4,Haematoma muscle,,2021,Q4,1,I,20210522.0,20211126.0,20211210,20211210,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-320032,RANBAXY,,59.0,YR,,M,Y,64.0,KG,20211210.0,,HP,FR,FR,2021,Q4,Adult
201689661,20168966,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/mL (),,,U,,,,,,,Solution for injection,,2021,Q4,Ureteric compression,,2021,Q4,1,I,20210522.0,20211126.0,20211210,20211210,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-320032,RANBAXY,,59.0,YR,,M,Y,64.0,KG,20211210.0,,HP,FR,FR,2021,Q4,Adult
201689661,20168966,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/mL (),,,U,,,,,,,Solution for injection,,2021,Q4,Abdominal pain,,2021,Q4,1,I,20210522.0,20211126.0,20211210,20211210,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-320032,RANBAXY,,59.0,YR,,M,Y,64.0,KG,20211210.0,,HP,FR,FR,2021,Q4,Adult
201689661,20168966,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/mL (),,,U,,,,,,,Solution for injection,,2021,Q4,Pyelocaliectasis,,2021,Q4,1,I,20210522.0,20211126.0,20211210,20211210,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-320032,RANBAXY,,59.0,YR,,M,Y,64.0,KG,20211210.0,,HP,FR,FR,2021,Q4,Adult
201714711,20171471,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Drug ineffective,,2021,Q4,1,I,,20211201.0,20211210,20211210,EXP,,CA-PFIZER INC-2021348547,PFIZER,,50.0,YR,,F,Y,,,20211210.0,,HP,CA,CA,2021,Q4,Adult
201714711,20171471,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Nervousness,,2021,Q4,1,I,,20211201.0,20211210,20211210,EXP,,CA-PFIZER INC-2021348547,PFIZER,,50.0,YR,,F,Y,,,20211210.0,,HP,CA,CA,2021,Q4,Adult
201714711,20171471,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,COVID-19 pneumonia,,2021,Q4,1,I,,20211201.0,20211210,20211210,EXP,,CA-PFIZER INC-2021348547,PFIZER,,50.0,YR,,F,Y,,,20211210.0,,HP,CA,CA,2021,Q4,Adult
201714711,20171471,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Diverticulitis,,2021,Q4,1,I,,20211201.0,20211210,20211210,EXP,,CA-PFIZER INC-2021348547,PFIZER,,50.0,YR,,F,Y,,,20211210.0,,HP,CA,CA,2021,Q4,Adult
201714711,20171471,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Breast pain,,2021,Q4,1,I,,20211201.0,20211210,20211210,EXP,,CA-PFIZER INC-2021348547,PFIZER,,50.0,YR,,F,Y,,,20211210.0,,HP,CA,CA,2021,Q4,Adult
201714711,20171471,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Nausea,,2021,Q4,1,I,,20211201.0,20211210,20211210,EXP,,CA-PFIZER INC-2021348547,PFIZER,,50.0,YR,,F,Y,,,20211210.0,,HP,CA,CA,2021,Q4,Adult
201714711,20171471,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Hepatic enzyme increased,,2021,Q4,1,I,,20211201.0,20211210,20211210,EXP,,CA-PFIZER INC-2021348547,PFIZER,,50.0,YR,,F,Y,,,20211210.0,,HP,CA,CA,2021,Q4,Adult
201714711,20171471,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Eczema,,2021,Q4,1,I,,20211201.0,20211210,20211210,EXP,,CA-PFIZER INC-2021348547,PFIZER,,50.0,YR,,F,Y,,,20211210.0,,HP,CA,CA,2021,Q4,Adult
201714711,20171471,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,1,I,,20211201.0,20211210,20211210,EXP,,CA-PFIZER INC-2021348547,PFIZER,,50.0,YR,,F,Y,,,20211210.0,,HP,CA,CA,2021,Q4,Adult
201714711,20171471,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Body temperature increased,,2021,Q4,1,I,,20211201.0,20211210,20211210,EXP,,CA-PFIZER INC-2021348547,PFIZER,,50.0,YR,,F,Y,,,20211210.0,,HP,CA,CA,2021,Q4,Adult
201714711,20171471,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Pain in extremity,,2021,Q4,1,I,,20211201.0,20211210,20211210,EXP,,CA-PFIZER INC-2021348547,PFIZER,,50.0,YR,,F,Y,,,20211210.0,,HP,CA,CA,2021,Q4,Adult
201714711,20171471,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Productive cough,,2021,Q4,1,I,,20211201.0,20211210,20211210,EXP,,CA-PFIZER INC-2021348547,PFIZER,,50.0,YR,,F,Y,,,20211210.0,,HP,CA,CA,2021,Q4,Adult
201714711,20171471,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,SARS-CoV-2 test positive,,2021,Q4,1,I,,20211201.0,20211210,20211210,EXP,,CA-PFIZER INC-2021348547,PFIZER,,50.0,YR,,F,Y,,,20211210.0,,HP,CA,CA,2021,Q4,Adult
201714711,20171471,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Oropharyngeal pain,,2021,Q4,1,I,,20211201.0,20211210,20211210,EXP,,CA-PFIZER INC-2021348547,PFIZER,,50.0,YR,,F,Y,,,20211210.0,,HP,CA,CA,2021,Q4,Adult
201714711,20171471,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Injection site bruising,,2021,Q4,1,I,,20211201.0,20211210,20211210,EXP,,CA-PFIZER INC-2021348547,PFIZER,,50.0,YR,,F,Y,,,20211210.0,,HP,CA,CA,2021,Q4,Adult
201714711,20171471,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Feeling abnormal,,2021,Q4,1,I,,20211201.0,20211210,20211210,EXP,,CA-PFIZER INC-2021348547,PFIZER,,50.0,YR,,F,Y,,,20211210.0,,HP,CA,CA,2021,Q4,Adult
201714711,20171471,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Pain,,2021,Q4,1,I,,20211201.0,20211210,20211210,EXP,,CA-PFIZER INC-2021348547,PFIZER,,50.0,YR,,F,Y,,,20211210.0,,HP,CA,CA,2021,Q4,Adult
201714711,20171471,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,,20211201.0,20211210,20211210,EXP,,CA-PFIZER INC-2021348547,PFIZER,,50.0,YR,,F,Y,,,20211210.0,,HP,CA,CA,2021,Q4,Adult
201714711,20171471,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Rhinorrhoea,,2021,Q4,1,I,,20211201.0,20211210,20211210,EXP,,CA-PFIZER INC-2021348547,PFIZER,,50.0,YR,,F,Y,,,20211210.0,,HP,CA,CA,2021,Q4,Adult
201714711,20171471,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Rash,,2021,Q4,1,I,,20211201.0,20211210,20211210,EXP,,CA-PFIZER INC-2021348547,PFIZER,,50.0,YR,,F,Y,,,20211210.0,,HP,CA,CA,2021,Q4,Adult
201715891,20171589,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intramuscular,"1 dosage form, QD (solution), started 5 years ago",,,,,,,,,,,QD,2021,Q4,Syncope,,2021,Q4,1,I,20201101.0,20211130.0,20211210,20211210,EXP,,NVSC2021MX259105,NOVARTIS,,83.0,YR,,M,Y,69.0,KG,20211210.0,,CN,MX,MX,2021,Q4,Elderly
201715891,20171589,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intramuscular,"1 dosage form, QD (solution), started 5 years ago",,,,,,,,,,,QD,2021,Q4,Thyroid disorder,,2021,Q4,1,I,20201101.0,20211130.0,20211210,20211210,EXP,,NVSC2021MX259105,NOVARTIS,,83.0,YR,,M,Y,69.0,KG,20211210.0,,CN,MX,MX,2021,Q4,Elderly
201715891,20171589,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intramuscular,"1 dosage form, QD (solution), started 5 years ago",,,,,,,,,,,QD,2021,Q4,Hypertension,,2021,Q4,1,I,20201101.0,20211130.0,20211210,20211210,EXP,,NVSC2021MX259105,NOVARTIS,,83.0,YR,,M,Y,69.0,KG,20211210.0,,CN,MX,MX,2021,Q4,Elderly
201715891,20171589,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intramuscular,"1 dosage form, QD (solution), started 5 years ago",,,,,,,,,,,QD,2021,Q4,Blood pressure increased,,2021,Q4,1,I,20201101.0,20211130.0,20211210,20211210,EXP,,NVSC2021MX259105,NOVARTIS,,83.0,YR,,M,Y,69.0,KG,20211210.0,,CN,MX,MX,2021,Q4,Elderly
201715891,20171589,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK, QD (Stared 5 years ago)",,,,,,,,,,,QD,2021,Q4,Syncope,,2021,Q4,1,I,20201101.0,20211130.0,20211210,20211210,EXP,,NVSC2021MX259105,NOVARTIS,,83.0,YR,,M,Y,69.0,KG,20211210.0,,CN,MX,MX,2021,Q4,Elderly
201715891,20171589,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK, QD (Stared 5 years ago)",,,,,,,,,,,QD,2021,Q4,Thyroid disorder,,2021,Q4,1,I,20201101.0,20211130.0,20211210,20211210,EXP,,NVSC2021MX259105,NOVARTIS,,83.0,YR,,M,Y,69.0,KG,20211210.0,,CN,MX,MX,2021,Q4,Elderly
201715891,20171589,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK, QD (Stared 5 years ago)",,,,,,,,,,,QD,2021,Q4,Hypertension,,2021,Q4,1,I,20201101.0,20211130.0,20211210,20211210,EXP,,NVSC2021MX259105,NOVARTIS,,83.0,YR,,M,Y,69.0,KG,20211210.0,,CN,MX,MX,2021,Q4,Elderly
201715891,20171589,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK, QD (Stared 5 years ago)",,,,,,,,,,,QD,2021,Q4,Blood pressure increased,,2021,Q4,1,I,20201101.0,20211130.0,20211210,20211210,EXP,,NVSC2021MX259105,NOVARTIS,,83.0,YR,,M,Y,69.0,KG,20211210.0,,CN,MX,MX,2021,Q4,Elderly
201725191,20172519,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Pruritus,,2021,Q4,1,I,20210701.0,20211202.0,20211210,20211210,EXP,,JP-MALLINCKRODT-T202105395,MALLINCKRODT,,77.0,YR,,M,Y,50.0,KG,20211210.0,,PH,JP,JP,2021,Q4,Elderly
201741142,20174114,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IE, qd",,,U,,,,,,,,,2021,Q4,Anaphylactic reaction,,2021,Q4,2,F,20211118.0,20211217.0,20211213,20211223,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132523,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,,,20211223.0,,HP,DE,DE,2021,Q4,Elderly
201742251,20174225,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"40 IU, qd",,,,,unknown,,,40.0,IU,,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211202.0,20211213,20211213,EXP,,BR-NOVOPROD-873923,NOVO NORDISK,,71.0,YR,,M,Y,104.3,KG,20211213.0,,MD,BR,BR,2021,Q4,Elderly
201742251,20174225,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"40 IU, qd",,,,,unknown,,,40.0,IU,,QD,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,,20211202.0,20211213,20211213,EXP,,BR-NOVOPROD-873923,NOVO NORDISK,,71.0,YR,,M,Y,104.3,KG,20211213.0,,MD,BR,BR,2021,Q4,Elderly
201742251,20174225,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"40 IU, qd",,,,,unknown,,,40.0,IU,,QD,2021,Q4,Neurological symptom,,2021,Q4,1,I,,20211202.0,20211213,20211213,EXP,,BR-NOVOPROD-873923,NOVO NORDISK,,71.0,YR,,M,Y,104.3,KG,20211213.0,,MD,BR,BR,2021,Q4,Elderly
201746671,20174667,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 units/ml solution for injection in a cartridge for OptiClik,,,N,,,,,,,,,2021,Q4,Interstitial lung disease,,2021,Q4,1,I,20200101.0,20211201.0,20211213,20211213,EXP,FR-AFSSAPS-PV20213175,FR-Accord-247207,ACCORD,,73.0,YR,E,M,Y,99.0,KG,20211213.0,,MD,FR,FR,2021,Q4,Elderly
201746671,20174667,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 units/ml solution for injection in a cartridge for OptiClik,,,N,,,,,,,,,2021,Q4,Pulmonary fibrosis,,2021,Q4,1,I,20200101.0,20211201.0,20211213,20211213,EXP,FR-AFSSAPS-PV20213175,FR-Accord-247207,ACCORD,,73.0,YR,E,M,Y,99.0,KG,20211213.0,,MD,FR,FR,2021,Q4,Elderly
201749031,20174903,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q4,Productive cough,,2021,Q4,1,I,,20211201.0,20211213,20211213,EXP,,CA-Orion Corporation ORION PHARMA-21_00013950,ORION,,50.0,YR,,F,Y,,,20211213.0,,HP,CA,,2021,Q4,Adult
201749031,20174903,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q4,Body temperature increased,,2021,Q4,1,I,,20211201.0,20211213,20211213,EXP,,CA-Orion Corporation ORION PHARMA-21_00013950,ORION,,50.0,YR,,F,Y,,,20211213.0,,HP,CA,,2021,Q4,Adult
201749031,20174903,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,,20211201.0,20211213,20211213,EXP,,CA-Orion Corporation ORION PHARMA-21_00013950,ORION,,50.0,YR,,F,Y,,,20211213.0,,HP,CA,,2021,Q4,Adult
201749031,20174903,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q4,SARS-CoV-2 test positive,,2021,Q4,1,I,,20211201.0,20211213,20211213,EXP,,CA-Orion Corporation ORION PHARMA-21_00013950,ORION,,50.0,YR,,F,Y,,,20211213.0,,HP,CA,,2021,Q4,Adult
201749031,20174903,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q4,Drug ineffective,,2021,Q4,1,I,,20211201.0,20211213,20211213,EXP,,CA-Orion Corporation ORION PHARMA-21_00013950,ORION,,50.0,YR,,F,Y,,,20211213.0,,HP,CA,,2021,Q4,Adult
201749031,20174903,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q4,Eczema,,2021,Q4,1,I,,20211201.0,20211213,20211213,EXP,,CA-Orion Corporation ORION PHARMA-21_00013950,ORION,,50.0,YR,,F,Y,,,20211213.0,,HP,CA,,2021,Q4,Adult
201749031,20174903,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q4,Breast pain,,2021,Q4,1,I,,20211201.0,20211213,20211213,EXP,,CA-Orion Corporation ORION PHARMA-21_00013950,ORION,,50.0,YR,,F,Y,,,20211213.0,,HP,CA,,2021,Q4,Adult
201749031,20174903,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q4,Nervousness,,2021,Q4,1,I,,20211201.0,20211213,20211213,EXP,,CA-Orion Corporation ORION PHARMA-21_00013950,ORION,,50.0,YR,,F,Y,,,20211213.0,,HP,CA,,2021,Q4,Adult
201749031,20174903,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q4,Rash,,2021,Q4,1,I,,20211201.0,20211213,20211213,EXP,,CA-Orion Corporation ORION PHARMA-21_00013950,ORION,,50.0,YR,,F,Y,,,20211213.0,,HP,CA,,2021,Q4,Adult
201749031,20174903,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q4,Pain in extremity,,2021,Q4,1,I,,20211201.0,20211213,20211213,EXP,,CA-Orion Corporation ORION PHARMA-21_00013950,ORION,,50.0,YR,,F,Y,,,20211213.0,,HP,CA,,2021,Q4,Adult
201749031,20174903,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q4,COVID-19 pneumonia,,2021,Q4,1,I,,20211201.0,20211213,20211213,EXP,,CA-Orion Corporation ORION PHARMA-21_00013950,ORION,,50.0,YR,,F,Y,,,20211213.0,,HP,CA,,2021,Q4,Adult
201749031,20174903,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q4,Nausea,,2021,Q4,1,I,,20211201.0,20211213,20211213,EXP,,CA-Orion Corporation ORION PHARMA-21_00013950,ORION,,50.0,YR,,F,Y,,,20211213.0,,HP,CA,,2021,Q4,Adult
201749031,20174903,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,1,I,,20211201.0,20211213,20211213,EXP,,CA-Orion Corporation ORION PHARMA-21_00013950,ORION,,50.0,YR,,F,Y,,,20211213.0,,HP,CA,,2021,Q4,Adult
201749031,20174903,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q4,Oropharyngeal pain,,2021,Q4,1,I,,20211201.0,20211213,20211213,EXP,,CA-Orion Corporation ORION PHARMA-21_00013950,ORION,,50.0,YR,,F,Y,,,20211213.0,,HP,CA,,2021,Q4,Adult
201749031,20174903,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q4,Feeling abnormal,,2021,Q4,1,I,,20211201.0,20211213,20211213,EXP,,CA-Orion Corporation ORION PHARMA-21_00013950,ORION,,50.0,YR,,F,Y,,,20211213.0,,HP,CA,,2021,Q4,Adult
201749031,20174903,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q4,Rhinorrhoea,,2021,Q4,1,I,,20211201.0,20211213,20211213,EXP,,CA-Orion Corporation ORION PHARMA-21_00013950,ORION,,50.0,YR,,F,Y,,,20211213.0,,HP,CA,,2021,Q4,Adult
201749031,20174903,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q4,Pain,,2021,Q4,1,I,,20211201.0,20211213,20211213,EXP,,CA-Orion Corporation ORION PHARMA-21_00013950,ORION,,50.0,YR,,F,Y,,,20211213.0,,HP,CA,,2021,Q4,Adult
201749031,20174903,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q4,Hepatic enzyme increased,,2021,Q4,1,I,,20211201.0,20211213,20211213,EXP,,CA-Orion Corporation ORION PHARMA-21_00013950,ORION,,50.0,YR,,F,Y,,,20211213.0,,HP,CA,,2021,Q4,Adult
201749031,20174903,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q4,Diverticulitis,,2021,Q4,1,I,,20211201.0,20211213,20211213,EXP,,CA-Orion Corporation ORION PHARMA-21_00013950,ORION,,50.0,YR,,F,Y,,,20211213.0,,HP,CA,,2021,Q4,Adult
201750341,20175034,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"24 international unit, qd",,,D,,,,,24.0,IU,,QD,2021,Q4,Product dose omission in error,,2021,Q4,1,I,20210928.0,20211208.0,20211213,20211213,EXP,FR-AFSSAPS-AN20214213,FR-MYLANLABS-2021M1091600,MYLAN,,44.0,YR,,M,Y,,,20211213.0,,PH,FR,FR,2021,Q4,Adult
201750341,20175034,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"24 international unit, qd",,,D,,,,,24.0,IU,,QD,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,20210928.0,20211208.0,20211213,20211213,EXP,FR-AFSSAPS-AN20214213,FR-MYLANLABS-2021M1091600,MYLAN,,44.0,YR,,M,Y,,,20211213.0,,PH,FR,FR,2021,Q4,Adult
201750341,20175034,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"24 international unit, qd",,,D,,,,,24.0,IU,,QD,2021,Q4,Diabetic ketosis,,2021,Q4,1,I,20210928.0,20211208.0,20211213,20211213,EXP,FR-AFSSAPS-AN20214213,FR-MYLANLABS-2021M1091600,MYLAN,,44.0,YR,,M,Y,,,20211213.0,,PH,FR,FR,2021,Q4,Adult
201776731,20177673,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 iU, QD",406.0,IU,Y,,ABJL021,,206538.0,14.0,IU,Solution for injection,QD,2021,Q4,Hypoglycaemic coma,,2021,Q4,1,I,20211029.0,20211204.0,20211213,20211213,EXP,,CN-SA-2021SA409484,SANOFI AVENTIS,,67.0,YR,E,F,Y,51.0,KG,20211213.0,,HP,CN,CN,2021,Q4,Elderly
201776731,20177673,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 iU, QD",406.0,IU,Y,,ABJL021,,206538.0,14.0,IU,Solution for injection,QD,2021,Q4,Urinary incontinence,,2021,Q4,1,I,20211029.0,20211204.0,20211213,20211213,EXP,,CN-SA-2021SA409484,SANOFI AVENTIS,,67.0,YR,E,F,Y,51.0,KG,20211213.0,,HP,CN,CN,2021,Q4,Elderly
201776731,20177673,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 iU, QD",406.0,IU,Y,,ABJL021,,206538.0,14.0,IU,Solution for injection,QD,2021,Q4,Loss of consciousness,,2021,Q4,1,I,20211029.0,20211204.0,20211213,20211213,EXP,,CN-SA-2021SA409484,SANOFI AVENTIS,,67.0,YR,E,F,Y,51.0,KG,20211213.0,,HP,CN,CN,2021,Q4,Elderly
201781871,20178187,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 U ONCE AT BED TIME,,,,N,,,,,,,,2021,Q4,Rhabdomyolysis,,2021,Q4,1,I,20210427.0,20211209.0,20211213,20211213,EXP,,CN-ANIPHARMA-2021-CN-000398,ANI,"Qin D, Chendong Y.Rhabdomyolysis caused by candesartan cilexetil..Adverse Drug Reactions Journal.2021;23(10):557-558.",74.0,YR,,F,Y,,,20211213.0,,HP,CN,CN,2021,Q4,Elderly
201788181,20178818,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Staphylococcal infection,,2021,Q4,1,I,,20211202.0,20211214,20211214,EXP,,FR-STRIDES ARCOLAB LIMITED-2021SP030914,STRIDES,"Chevalier K, Barde F, Benhamida S, Le Meur M, Thyrault M, Bentoumi Y, et al.. Invasive aspergillosis and endocarditis.. Rev-Med-Interne. 2021;42(10):678-685",58.0,YR,,M,Y,,,20211214.0,,HP,FR,FR,2021,Q4,Adult
201788181,20178818,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Acute kidney injury,,2021,Q4,1,I,,20211202.0,20211214,20211214,EXP,,FR-STRIDES ARCOLAB LIMITED-2021SP030914,STRIDES,"Chevalier K, Barde F, Benhamida S, Le Meur M, Thyrault M, Bentoumi Y, et al.. Invasive aspergillosis and endocarditis.. Rev-Med-Interne. 2021;42(10):678-685",58.0,YR,,M,Y,,,20211214.0,,HP,FR,FR,2021,Q4,Adult
201788181,20178818,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Disseminated aspergillosis,,2021,Q4,1,I,,20211202.0,20211214,20211214,EXP,,FR-STRIDES ARCOLAB LIMITED-2021SP030914,STRIDES,"Chevalier K, Barde F, Benhamida S, Le Meur M, Thyrault M, Bentoumi Y, et al.. Invasive aspergillosis and endocarditis.. Rev-Med-Interne. 2021;42(10):678-685",58.0,YR,,M,Y,,,20211214.0,,HP,FR,FR,2021,Q4,Adult
201788181,20178818,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Aspergillus infection,,2021,Q4,1,I,,20211202.0,20211214,20211214,EXP,,FR-STRIDES ARCOLAB LIMITED-2021SP030914,STRIDES,"Chevalier K, Barde F, Benhamida S, Le Meur M, Thyrault M, Bentoumi Y, et al.. Invasive aspergillosis and endocarditis.. Rev-Med-Interne. 2021;42(10):678-685",58.0,YR,,M,Y,,,20211214.0,,HP,FR,FR,2021,Q4,Adult
201788181,20178818,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Septic shock,,2021,Q4,1,I,,20211202.0,20211214,20211214,EXP,,FR-STRIDES ARCOLAB LIMITED-2021SP030914,STRIDES,"Chevalier K, Barde F, Benhamida S, Le Meur M, Thyrault M, Bentoumi Y, et al.. Invasive aspergillosis and endocarditis.. Rev-Med-Interne. 2021;42(10):678-685",58.0,YR,,M,Y,,,20211214.0,,HP,FR,FR,2021,Q4,Adult
201788181,20178818,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Fungal endocarditis,,2021,Q4,1,I,,20211202.0,20211214,20211214,EXP,,FR-STRIDES ARCOLAB LIMITED-2021SP030914,STRIDES,"Chevalier K, Barde F, Benhamida S, Le Meur M, Thyrault M, Bentoumi Y, et al.. Invasive aspergillosis and endocarditis.. Rev-Med-Interne. 2021;42(10):678-685",58.0,YR,,M,Y,,,20211214.0,,HP,FR,FR,2021,Q4,Adult
201802351,20180235,7,C,insulin glargine 18 units daily,,2,,,,,,,,,,,,,,2021,Q4,Bradycardia,,2021,Q4,1,I,20211211.0,,20211213,20211213,DIR,594835,,FDA-CTU,,58.0,YR,,F,N,159.0,KG,20211213.0,N,HP,US,,2021,Q4,Adult
201802351,20180235,7,C,insulin glargine 18 units daily,,2,,,,,,,,,,,,,,2021,Q4,Therapy cessation,,2021,Q4,1,I,20211211.0,,20211213,20211213,DIR,594835,,FDA-CTU,,58.0,YR,,F,N,159.0,KG,20211213.0,N,HP,US,,2021,Q4,Adult
201861241,20186124,21,C,INSULIN GLARGINE(LANTUS SOLOSTAR),,2,,100 UNIT/ML SOPN INJECTION-PEN,,,,,,,,,,Injection,,2021,Q4,Inability to afford medication,,2021,Q4,1,I,,20211208.0,20211215,20211215,EXP,,US-BAUSCH-BL-2020-033963,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20211215.0,,CN,US,US,2021,Q4,Elderly
201861241,20186124,21,C,INSULIN GLARGINE(LANTUS SOLOSTAR),,2,,100 UNIT/ML SOPN INJECTION-PEN,,,,,,,,,,Injection,,2021,Q4,Disease complication,,2021,Q4,1,I,,20211208.0,20211215,20211215,EXP,,US-BAUSCH-BL-2020-033963,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20211215.0,,CN,US,US,2021,Q4,Elderly
201861241,20186124,21,C,INSULIN GLARGINE(LANTUS SOLOSTAR),,2,,100 UNIT/ML SOPN INJECTION-PEN,,,,,,,,,,Injection,,2021,Q4,Liver disorder,,2021,Q4,1,I,,20211208.0,20211215,20211215,EXP,,US-BAUSCH-BL-2020-033963,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20211215.0,,CN,US,US,2021,Q4,Elderly
201945863,20194586,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,16 iU,,,,,,,21081.0,16.0,IU,Solution for injection,,2021,Q4,Vitamin B12 deficiency,,2021,Q4,3,F,20201105.0,20211210.0,20211216,20211223,EXP,FR-AFSSAPS-AM20201369,FR-SA-2021SA417467,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20211223.0,,MD,FR,FR,2021,Q4,Elderly
201945863,20194586,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,dose increased,,,,,,,21081.0,16.0,IU,Solution for injection,,2021,Q4,Vitamin B12 deficiency,,2021,Q4,3,F,20201105.0,20211210.0,20211216,20211223,EXP,FR-AFSSAPS-AM20201369,FR-SA-2021SA417467,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20211223.0,,MD,FR,FR,2021,Q4,Elderly
201947411,20194741,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Productive cough,,2021,Q4,1,I,20211201.0,,20211216,20211216,DIR,595241,,FDA-CTU,,62.0,YR,,M,N,162.45,KG,20211216.0,Y,,US,,2021,Q4,Adult
201947411,20194741,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,1,I,20211201.0,,20211216,20211216,DIR,595241,,FDA-CTU,,62.0,YR,,M,N,162.45,KG,20211216.0,Y,,US,,2021,Q4,Adult
201947411,20194741,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Body temperature increased,,2021,Q4,1,I,20211201.0,,20211216,20211216,DIR,595241,,FDA-CTU,,62.0,YR,,M,N,162.45,KG,20211216.0,Y,,US,,2021,Q4,Adult
201952451,20195245,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Drug ineffective,,2021,Q4,1,I,,20211202.0,20211216,20211216,EXP,,FR-LUPIN PHARMACEUTICALS INC.-2021-24862,LUPIN,"Chevalier K, Barde F, Benhamida S, Le Meur M, Thyrault M, Bentoumi Y, et al. Invasive aspergillosis and endocarditis. La Revue de medecine interne. 2021;42(10):678-685",58.0,YR,,M,Y,,,20211216.0,,HP,FR,FR,2021,Q4,Adult
201952451,20195245,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Acute kidney injury,,2021,Q4,1,I,,20211202.0,20211216,20211216,EXP,,FR-LUPIN PHARMACEUTICALS INC.-2021-24862,LUPIN,"Chevalier K, Barde F, Benhamida S, Le Meur M, Thyrault M, Bentoumi Y, et al. Invasive aspergillosis and endocarditis. La Revue de medecine interne. 2021;42(10):678-685",58.0,YR,,M,Y,,,20211216.0,,HP,FR,FR,2021,Q4,Adult
201952451,20195245,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Aspergillus infection,,2021,Q4,1,I,,20211202.0,20211216,20211216,EXP,,FR-LUPIN PHARMACEUTICALS INC.-2021-24862,LUPIN,"Chevalier K, Barde F, Benhamida S, Le Meur M, Thyrault M, Bentoumi Y, et al. Invasive aspergillosis and endocarditis. La Revue de medecine interne. 2021;42(10):678-685",58.0,YR,,M,Y,,,20211216.0,,HP,FR,FR,2021,Q4,Adult
201952451,20195245,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Fungal endocarditis,,2021,Q4,1,I,,20211202.0,20211216,20211216,EXP,,FR-LUPIN PHARMACEUTICALS INC.-2021-24862,LUPIN,"Chevalier K, Barde F, Benhamida S, Le Meur M, Thyrault M, Bentoumi Y, et al. Invasive aspergillosis and endocarditis. La Revue de medecine interne. 2021;42(10):678-685",58.0,YR,,M,Y,,,20211216.0,,HP,FR,FR,2021,Q4,Adult
201952451,20195245,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Septic shock,,2021,Q4,1,I,,20211202.0,20211216,20211216,EXP,,FR-LUPIN PHARMACEUTICALS INC.-2021-24862,LUPIN,"Chevalier K, Barde F, Benhamida S, Le Meur M, Thyrault M, Bentoumi Y, et al. Invasive aspergillosis and endocarditis. La Revue de medecine interne. 2021;42(10):678-685",58.0,YR,,M,Y,,,20211216.0,,HP,FR,FR,2021,Q4,Adult
201952451,20195245,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Disseminated aspergillosis,,2021,Q4,1,I,,20211202.0,20211216,20211216,EXP,,FR-LUPIN PHARMACEUTICALS INC.-2021-24862,LUPIN,"Chevalier K, Barde F, Benhamida S, Le Meur M, Thyrault M, Bentoumi Y, et al. Invasive aspergillosis and endocarditis. La Revue de medecine interne. 2021;42(10):678-685",58.0,YR,,M,Y,,,20211216.0,,HP,FR,FR,2021,Q4,Adult
201952893,20195289,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Encephalitis autoimmune,,2021,Q4,3,F,20211210.0,20211217.0,20211216,20211228,EXP,,CN-ROCHE-2979034,ROCHE,,56.0,YR,,F,Y,59.0,KG,20211228.0,,MD,CN,,2021,Q4,Adult
201961482,20196148,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, unknown freq.",,,,,UNKNOWN,,,,,Formulation unknown,,2021,Q4,COVID-19,,2021,Q4,2,F,20211116.0,20211213.0,20211216,20211221,EXP,FR-AFSSAPS-NY20215308,FR-ASTELLAS-2021US048001,ASTELLAS,,80.0,YR,,F,Y,62.0,KG,20211221.0,,CN,FR,FR,2021,Q4,Elderly
201963141,20196314,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 u, daily",,,U,,,,205692.0,20.0,IU,Injection,QD,2021,Q4,Product monitoring error,,2021,Q4,1,I,20210220.0,20211210.0,20211216,20211216,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112005568,ELI LILLY AND CO,,57.0,YR,,F,Y,120.0,KG,20211216.0,,CN,DE,DE,2021,Q4,Adult
201963141,20196314,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 u, daily",,,U,,,,205692.0,20.0,IU,Injection,QD,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,1,I,20210220.0,20211210.0,20211216,20211216,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112005568,ELI LILLY AND CO,,57.0,YR,,F,Y,120.0,KG,20211216.0,,CN,DE,DE,2021,Q4,Adult
201963141,20196314,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 u, daily",,,U,,,,205692.0,20.0,IU,Injection,QD,2021,Q4,Labelled drug-drug interaction medication error,,2021,Q4,1,I,20210220.0,20211210.0,20211216,20211216,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112005568,ELI LILLY AND CO,,57.0,YR,,F,Y,120.0,KG,20211216.0,,CN,DE,DE,2021,Q4,Adult
201963141,20196314,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 u, daily",,,U,,,,205692.0,20.0,IU,Injection,QD,2021,Q4,Pain,,2021,Q4,1,I,20210220.0,20211210.0,20211216,20211216,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112005568,ELI LILLY AND CO,,57.0,YR,,F,Y,120.0,KG,20211216.0,,CN,DE,DE,2021,Q4,Adult
201963141,20196314,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 u, daily",,,U,,,,205692.0,20.0,IU,Injection,QD,2021,Q4,Pain in extremity,,2021,Q4,1,I,20210220.0,20211210.0,20211216,20211216,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112005568,ELI LILLY AND CO,,57.0,YR,,F,Y,120.0,KG,20211216.0,,CN,DE,DE,2021,Q4,Adult
201963141,20196314,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 u, daily",,,U,,,,205692.0,20.0,IU,Injection,QD,2021,Q4,Fracture blisters,,2021,Q4,1,I,20210220.0,20211210.0,20211216,20211216,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112005568,ELI LILLY AND CO,,57.0,YR,,F,Y,120.0,KG,20211216.0,,CN,DE,DE,2021,Q4,Adult
201963241,20196324,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, daily (40 IE 0-0-0-1)",,,U,,,,205692.0,,,,QD,2021,Q4,Bradycardia,,2021,Q4,1,I,,20211210.0,20211216,20211216,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112005595,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20211216.0,,CN,DE,DE,2021,Q4,Elderly
201963241,20196324,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, daily (40 IE 0-0-0-1)",,,U,,,,205692.0,,,,QD,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211210.0,20211216,20211216,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112005595,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20211216.0,,CN,DE,DE,2021,Q4,Elderly
201963241,20196324,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, daily (40 IE 0-0-0-1)",,,U,,,,205692.0,,,,QD,2021,Q4,Fatigue,,2021,Q4,1,I,,20211210.0,20211216,20211216,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112005595,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20211216.0,,CN,DE,DE,2021,Q4,Elderly
201963241,20196324,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, daily (40 IE 0-0-0-1)",,,U,,,,205692.0,,,,QD,2021,Q4,Product administration error,,2021,Q4,1,I,,20211210.0,20211216,20211216,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112005595,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20211216.0,,CN,DE,DE,2021,Q4,Elderly
201963381,20196338,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 international unit, unknown",,,U,,,,,300.0,IU,,,2021,Q4,Peripheral coldness,,2021,Q4,1,I,,20211210.0,20211216,20211216,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112005573,ELI LILLY AND CO,,64.0,YR,,F,Y,63.0,KG,20211216.0,,CN,DE,DE,2021,Q4,Adult
201963381,20196338,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 international unit, unknown",,,U,,,,,300.0,IU,,,2021,Q4,Pain,,2021,Q4,1,I,,20211210.0,20211216,20211216,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112005573,ELI LILLY AND CO,,64.0,YR,,F,Y,63.0,KG,20211216.0,,CN,DE,DE,2021,Q4,Adult
201963431,20196343,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 IE, 0-0-0-30, Injections",,,U,,,,205692.0,,,,,2021,Q4,Confusional state,,2021,Q4,1,I,,20211210.0,20211216,20211216,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112005581,ELI LILLY AND CO,,77.0,YR,,F,Y,77.0,KG,20211216.0,,CN,DE,DE,2021,Q4,Elderly
201963431,20196343,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 IE, 0-0-0-30, Injections",,,U,,,,205692.0,,,,,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,,20211210.0,20211216,20211216,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112005581,ELI LILLY AND CO,,77.0,YR,,F,Y,77.0,KG,20211216.0,,CN,DE,DE,2021,Q4,Elderly
201963431,20196343,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 IE, 0-0-0-30, Injections",,,U,,,,205692.0,,,,,2021,Q4,Fall,,2021,Q4,1,I,,20211210.0,20211216,20211216,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112005581,ELI LILLY AND CO,,77.0,YR,,F,Y,77.0,KG,20211216.0,,CN,DE,DE,2021,Q4,Elderly
201978262,20197826,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Blast cell count increased,,2021,Q4,2,F,20210101.0,20211221.0,20211217,20211229,PER,,JP-AMGEN-JPNSP2021197501,AMGEN,,59.0,YR,A,M,Y,,,20211229.0,,MD,JP,JP,2021,Q4,Adult
201985321,20198532,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Pallor,,2021,Q4,1,I,20210317.0,20210426.0,20211217,20211217,PER,,US-ALLERGAN-2116565US,ALLERGAN,,51.0,YR,,F,Y,,,20211217.0,,PH,US,US,2021,Q4,Adult
201985321,20198532,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Hypertension,,2021,Q4,1,I,20210317.0,20210426.0,20211217,20211217,PER,,US-ALLERGAN-2116565US,ALLERGAN,,51.0,YR,,F,Y,,,20211217.0,,PH,US,US,2021,Q4,Adult
201985321,20198532,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Hyperhidrosis,,2021,Q4,1,I,20210317.0,20210426.0,20211217,20211217,PER,,US-ALLERGAN-2116565US,ALLERGAN,,51.0,YR,,F,Y,,,20211217.0,,PH,US,US,2021,Q4,Adult
201985321,20198532,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Retching,,2021,Q4,1,I,20210317.0,20210426.0,20211217,20211217,PER,,US-ALLERGAN-2116565US,ALLERGAN,,51.0,YR,,F,Y,,,20211217.0,,PH,US,US,2021,Q4,Adult
201985321,20198532,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,1,I,20210317.0,20210426.0,20211217,20211217,PER,,US-ALLERGAN-2116565US,ALLERGAN,,51.0,YR,,F,Y,,,20211217.0,,PH,US,US,2021,Q4,Adult
201985321,20198532,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Chest pain,,2021,Q4,1,I,20210317.0,20210426.0,20211217,20211217,PER,,US-ALLERGAN-2116565US,ALLERGAN,,51.0,YR,,F,Y,,,20211217.0,,PH,US,US,2021,Q4,Adult
201985321,20198532,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Off label use,,2021,Q4,1,I,20210317.0,20210426.0,20211217,20211217,PER,,US-ALLERGAN-2116565US,ALLERGAN,,51.0,YR,,F,Y,,,20211217.0,,PH,US,US,2021,Q4,Adult
201985321,20198532,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Nausea,,2021,Q4,1,I,20210317.0,20210426.0,20211217,20211217,PER,,US-ALLERGAN-2116565US,ALLERGAN,,51.0,YR,,F,Y,,,20211217.0,,PH,US,US,2021,Q4,Adult
201985371,20198537,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Vomiting,,2021,Q4,1,I,,20210426.0,20211217,20211217,PER,,US-ALLERGAN-2115634US,ALLERGAN,,61.0,YR,,M,Y,,,20211217.0,,PH,US,US,2021,Q4,Adult
201985371,20198537,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Hyperhidrosis,,2021,Q4,1,I,,20210426.0,20211217,20211217,PER,,US-ALLERGAN-2115634US,ALLERGAN,,61.0,YR,,M,Y,,,20211217.0,,PH,US,US,2021,Q4,Adult
201985371,20198537,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Product quality issue,,2021,Q4,1,I,,20210426.0,20211217,20211217,PER,,US-ALLERGAN-2115634US,ALLERGAN,,61.0,YR,,M,Y,,,20211217.0,,PH,US,US,2021,Q4,Adult
201985371,20198537,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,1,I,,20210426.0,20211217,20211217,PER,,US-ALLERGAN-2115634US,ALLERGAN,,61.0,YR,,M,Y,,,20211217.0,,PH,US,US,2021,Q4,Adult
201991292,20199129,7,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,UNK,,,Y,U,,,,,,,,2021,Q4,Drug intolerance,,2021,Q4,2,F,20200101.0,20211224.0,20211217,20211230,EXP,,CZ-MYLANLABS-2021M1082107,MYLAN,Nekvapilova L.. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36,80.0,YR,,F,Y,86.0,KG,20211230.0,,MD,CZ,CZ,2021,Q4,Elderly
201991292,20199129,7,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,UNK,,,Y,U,,,,,,,,2021,Q4,Adverse event,,2021,Q4,2,F,20200101.0,20211224.0,20211217,20211230,EXP,,CZ-MYLANLABS-2021M1082107,MYLAN,Nekvapilova L.. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36,80.0,YR,,F,Y,86.0,KG,20211230.0,,MD,CZ,CZ,2021,Q4,Elderly
201991292,20199129,7,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,UNK,,,Y,U,,,,,,,,2021,Q4,Insomnia,,2021,Q4,2,F,20200101.0,20211224.0,20211217,20211230,EXP,,CZ-MYLANLABS-2021M1082107,MYLAN,Nekvapilova L.. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36,80.0,YR,,F,Y,86.0,KG,20211230.0,,MD,CZ,CZ,2021,Q4,Elderly
201991292,20199129,7,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,UNK,,,Y,U,,,,,,,,2021,Q4,Seizure,,2021,Q4,2,F,20200101.0,20211224.0,20211217,20211230,EXP,,CZ-MYLANLABS-2021M1082107,MYLAN,Nekvapilova L.. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36,80.0,YR,,F,Y,86.0,KG,20211230.0,,MD,CZ,CZ,2021,Q4,Elderly
201991292,20199129,7,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,UNK,,,Y,U,,,,,,,,2021,Q4,Hospitalisation,,2021,Q4,2,F,20200101.0,20211224.0,20211217,20211230,EXP,,CZ-MYLANLABS-2021M1082107,MYLAN,Nekvapilova L.. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36,80.0,YR,,F,Y,86.0,KG,20211230.0,,MD,CZ,CZ,2021,Q4,Elderly
201991292,20199129,7,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,UNK,,,Y,U,,,,,,,,2021,Q4,Constipation,,2021,Q4,2,F,20200101.0,20211224.0,20211217,20211230,EXP,,CZ-MYLANLABS-2021M1082107,MYLAN,Nekvapilova L.. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36,80.0,YR,,F,Y,86.0,KG,20211230.0,,MD,CZ,CZ,2021,Q4,Elderly
201991292,20199129,7,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,UNK,,,Y,U,,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,2,F,20200101.0,20211224.0,20211217,20211230,EXP,,CZ-MYLANLABS-2021M1082107,MYLAN,Nekvapilova L.. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36,80.0,YR,,F,Y,86.0,KG,20211230.0,,MD,CZ,CZ,2021,Q4,Elderly
201991292,20199129,7,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,UNK,,,Y,U,,,,,,,,2021,Q4,Adverse drug reaction,,2021,Q4,2,F,20200101.0,20211224.0,20211217,20211230,EXP,,CZ-MYLANLABS-2021M1082107,MYLAN,Nekvapilova L.. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36,80.0,YR,,F,Y,86.0,KG,20211230.0,,MD,CZ,CZ,2021,Q4,Elderly
201991292,20199129,7,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,UNK,,,Y,U,,,,,,,,2021,Q4,Treatment noncompliance,,2021,Q4,2,F,20200101.0,20211224.0,20211217,20211230,EXP,,CZ-MYLANLABS-2021M1082107,MYLAN,Nekvapilova L.. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36,80.0,YR,,F,Y,86.0,KG,20211230.0,,MD,CZ,CZ,2021,Q4,Elderly
201991292,20199129,7,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,UNK,,,Y,U,,,,,,,,2021,Q4,Abdominal pain lower,,2021,Q4,2,F,20200101.0,20211224.0,20211217,20211230,EXP,,CZ-MYLANLABS-2021M1082107,MYLAN,Nekvapilova L.. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36,80.0,YR,,F,Y,86.0,KG,20211230.0,,MD,CZ,CZ,2021,Q4,Elderly
201991292,20199129,8,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,UNK,,,Y,U,,,,,,,,2021,Q4,Drug intolerance,,2021,Q4,2,F,20200101.0,20211224.0,20211217,20211230,EXP,,CZ-MYLANLABS-2021M1082107,MYLAN,Nekvapilova L.. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36,80.0,YR,,F,Y,86.0,KG,20211230.0,,MD,CZ,CZ,2021,Q4,Elderly
201991292,20199129,8,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,UNK,,,Y,U,,,,,,,,2021,Q4,Adverse event,,2021,Q4,2,F,20200101.0,20211224.0,20211217,20211230,EXP,,CZ-MYLANLABS-2021M1082107,MYLAN,Nekvapilova L.. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36,80.0,YR,,F,Y,86.0,KG,20211230.0,,MD,CZ,CZ,2021,Q4,Elderly
201991292,20199129,8,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,UNK,,,Y,U,,,,,,,,2021,Q4,Insomnia,,2021,Q4,2,F,20200101.0,20211224.0,20211217,20211230,EXP,,CZ-MYLANLABS-2021M1082107,MYLAN,Nekvapilova L.. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36,80.0,YR,,F,Y,86.0,KG,20211230.0,,MD,CZ,CZ,2021,Q4,Elderly
201991292,20199129,8,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,UNK,,,Y,U,,,,,,,,2021,Q4,Seizure,,2021,Q4,2,F,20200101.0,20211224.0,20211217,20211230,EXP,,CZ-MYLANLABS-2021M1082107,MYLAN,Nekvapilova L.. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36,80.0,YR,,F,Y,86.0,KG,20211230.0,,MD,CZ,CZ,2021,Q4,Elderly
201991292,20199129,8,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,UNK,,,Y,U,,,,,,,,2021,Q4,Hospitalisation,,2021,Q4,2,F,20200101.0,20211224.0,20211217,20211230,EXP,,CZ-MYLANLABS-2021M1082107,MYLAN,Nekvapilova L.. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36,80.0,YR,,F,Y,86.0,KG,20211230.0,,MD,CZ,CZ,2021,Q4,Elderly
201991292,20199129,8,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,UNK,,,Y,U,,,,,,,,2021,Q4,Constipation,,2021,Q4,2,F,20200101.0,20211224.0,20211217,20211230,EXP,,CZ-MYLANLABS-2021M1082107,MYLAN,Nekvapilova L.. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36,80.0,YR,,F,Y,86.0,KG,20211230.0,,MD,CZ,CZ,2021,Q4,Elderly
201991292,20199129,8,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,UNK,,,Y,U,,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,2,F,20200101.0,20211224.0,20211217,20211230,EXP,,CZ-MYLANLABS-2021M1082107,MYLAN,Nekvapilova L.. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36,80.0,YR,,F,Y,86.0,KG,20211230.0,,MD,CZ,CZ,2021,Q4,Elderly
201991292,20199129,8,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,UNK,,,Y,U,,,,,,,,2021,Q4,Adverse drug reaction,,2021,Q4,2,F,20200101.0,20211224.0,20211217,20211230,EXP,,CZ-MYLANLABS-2021M1082107,MYLAN,Nekvapilova L.. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36,80.0,YR,,F,Y,86.0,KG,20211230.0,,MD,CZ,CZ,2021,Q4,Elderly
201991292,20199129,8,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,UNK,,,Y,U,,,,,,,,2021,Q4,Treatment noncompliance,,2021,Q4,2,F,20200101.0,20211224.0,20211217,20211230,EXP,,CZ-MYLANLABS-2021M1082107,MYLAN,Nekvapilova L.. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36,80.0,YR,,F,Y,86.0,KG,20211230.0,,MD,CZ,CZ,2021,Q4,Elderly
201991292,20199129,8,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,UNK,,,Y,U,,,,,,,,2021,Q4,Abdominal pain lower,,2021,Q4,2,F,20200101.0,20211224.0,20211217,20211230,EXP,,CZ-MYLANLABS-2021M1082107,MYLAN,Nekvapilova L.. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36,80.0,YR,,F,Y,86.0,KG,20211230.0,,MD,CZ,CZ,2021,Q4,Elderly
201991292,20199129,9,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,UNK (50 units),,,Y,U,,,,,,,,2021,Q4,Drug intolerance,,2021,Q4,2,F,20200101.0,20211224.0,20211217,20211230,EXP,,CZ-MYLANLABS-2021M1082107,MYLAN,Nekvapilova L.. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36,80.0,YR,,F,Y,86.0,KG,20211230.0,,MD,CZ,CZ,2021,Q4,Elderly
201991292,20199129,9,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,UNK (50 units),,,Y,U,,,,,,,,2021,Q4,Adverse event,,2021,Q4,2,F,20200101.0,20211224.0,20211217,20211230,EXP,,CZ-MYLANLABS-2021M1082107,MYLAN,Nekvapilova L.. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36,80.0,YR,,F,Y,86.0,KG,20211230.0,,MD,CZ,CZ,2021,Q4,Elderly
201991292,20199129,9,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,UNK (50 units),,,Y,U,,,,,,,,2021,Q4,Insomnia,,2021,Q4,2,F,20200101.0,20211224.0,20211217,20211230,EXP,,CZ-MYLANLABS-2021M1082107,MYLAN,Nekvapilova L.. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36,80.0,YR,,F,Y,86.0,KG,20211230.0,,MD,CZ,CZ,2021,Q4,Elderly
201991292,20199129,9,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,UNK (50 units),,,Y,U,,,,,,,,2021,Q4,Seizure,,2021,Q4,2,F,20200101.0,20211224.0,20211217,20211230,EXP,,CZ-MYLANLABS-2021M1082107,MYLAN,Nekvapilova L.. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36,80.0,YR,,F,Y,86.0,KG,20211230.0,,MD,CZ,CZ,2021,Q4,Elderly
201991292,20199129,9,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,UNK (50 units),,,Y,U,,,,,,,,2021,Q4,Hospitalisation,,2021,Q4,2,F,20200101.0,20211224.0,20211217,20211230,EXP,,CZ-MYLANLABS-2021M1082107,MYLAN,Nekvapilova L.. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36,80.0,YR,,F,Y,86.0,KG,20211230.0,,MD,CZ,CZ,2021,Q4,Elderly
201991292,20199129,9,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,UNK (50 units),,,Y,U,,,,,,,,2021,Q4,Constipation,,2021,Q4,2,F,20200101.0,20211224.0,20211217,20211230,EXP,,CZ-MYLANLABS-2021M1082107,MYLAN,Nekvapilova L.. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36,80.0,YR,,F,Y,86.0,KG,20211230.0,,MD,CZ,CZ,2021,Q4,Elderly
201991292,20199129,9,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,UNK (50 units),,,Y,U,,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,2,F,20200101.0,20211224.0,20211217,20211230,EXP,,CZ-MYLANLABS-2021M1082107,MYLAN,Nekvapilova L.. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36,80.0,YR,,F,Y,86.0,KG,20211230.0,,MD,CZ,CZ,2021,Q4,Elderly
201991292,20199129,9,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,UNK (50 units),,,Y,U,,,,,,,,2021,Q4,Adverse drug reaction,,2021,Q4,2,F,20200101.0,20211224.0,20211217,20211230,EXP,,CZ-MYLANLABS-2021M1082107,MYLAN,Nekvapilova L.. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36,80.0,YR,,F,Y,86.0,KG,20211230.0,,MD,CZ,CZ,2021,Q4,Elderly
201991292,20199129,9,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,UNK (50 units),,,Y,U,,,,,,,,2021,Q4,Treatment noncompliance,,2021,Q4,2,F,20200101.0,20211224.0,20211217,20211230,EXP,,CZ-MYLANLABS-2021M1082107,MYLAN,Nekvapilova L.. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36,80.0,YR,,F,Y,86.0,KG,20211230.0,,MD,CZ,CZ,2021,Q4,Elderly
201991292,20199129,9,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,UNK (50 units),,,Y,U,,,,,,,,2021,Q4,Abdominal pain lower,,2021,Q4,2,F,20200101.0,20211224.0,20211217,20211230,EXP,,CZ-MYLANLABS-2021M1082107,MYLAN,Nekvapilova L.. Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes. KAZUISTIKY V DIABETOLOGII. 2021;19(3):34-36,80.0,YR,,F,Y,86.0,KG,20211230.0,,MD,CZ,CZ,2021,Q4,Elderly
202026481,20202648,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,8 iU,,,Y,,ABJA014,,21081.0,8.0,IU,Solution for injection,,2021,Q4,Diarrhoea,,2021,Q4,1,I,20210307.0,20211209.0,20211218,20211218,EXP,,CN-SA-2021SA418967,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20211218.0,,HP,CN,CN,2021,Q4,Elderly
202027691,20202769,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2021,Q4,Hypotension,,2021,Q4,1,I,,20211208.0,20211218,20211218,EXP,,US-SA-2021SA419342,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20211218.0,,CN,US,US,2021,Q4,Adult
202027691,20202769,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2021,Q4,Hypophagia,,2021,Q4,1,I,,20211208.0,20211218,20211218,EXP,,US-SA-2021SA419342,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20211218.0,,CN,US,US,2021,Q4,Adult
202027691,20202769,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2021,Q4,Dizziness,,2021,Q4,1,I,,20211208.0,20211218,20211218,EXP,,US-SA-2021SA419342,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20211218.0,,CN,US,US,2021,Q4,Adult
202027691,20202769,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2021,Q4,Asthenia,,2021,Q4,1,I,,20211208.0,20211218,20211218,EXP,,US-SA-2021SA419342,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20211218.0,,CN,US,US,2021,Q4,Adult
202027691,20202769,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2021,Q4,Atrioventricular block,,2021,Q4,1,I,,20211208.0,20211218,20211218,EXP,,US-SA-2021SA419342,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20211218.0,,CN,US,US,2021,Q4,Adult
202027691,20202769,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2021,Q4,Vomiting,,2021,Q4,1,I,,20211208.0,20211218,20211218,EXP,,US-SA-2021SA419342,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20211218.0,,CN,US,US,2021,Q4,Adult
202027691,20202769,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2021,Q4,Syncope,,2021,Q4,1,I,,20211208.0,20211218,20211218,EXP,,US-SA-2021SA419342,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20211218.0,,CN,US,US,2021,Q4,Adult
202027691,20202769,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2021,Q4,Faeces discoloured,,2021,Q4,1,I,,20211208.0,20211218,20211218,EXP,,US-SA-2021SA419342,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20211218.0,,CN,US,US,2021,Q4,Adult
202027691,20202769,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2021,Q4,Diarrhoea haemorrhagic,,2021,Q4,1,I,,20211208.0,20211218,20211218,EXP,,US-SA-2021SA419342,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20211218.0,,CN,US,US,2021,Q4,Adult
202027691,20202769,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2021,Q4,Decreased appetite,,2021,Q4,1,I,,20211208.0,20211218,20211218,EXP,,US-SA-2021SA419342,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20211218.0,,CN,US,US,2021,Q4,Adult
202027691,20202769,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2021,Q4,Acute myocardial infarction,,2021,Q4,1,I,,20211208.0,20211218,20211218,EXP,,US-SA-2021SA419342,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20211218.0,,CN,US,US,2021,Q4,Adult
202027691,20202769,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2021,Q4,Rectal haemorrhage,,2021,Q4,1,I,,20211208.0,20211218,20211218,EXP,,US-SA-2021SA419342,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20211218.0,,CN,US,US,2021,Q4,Adult
202027691,20202769,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,1,I,,20211208.0,20211218,20211218,EXP,,US-SA-2021SA419342,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20211218.0,,CN,US,US,2021,Q4,Adult
202027691,20202769,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2021,Q4,Anaemia,,2021,Q4,1,I,,20211208.0,20211218,20211218,EXP,,US-SA-2021SA419342,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20211218.0,,CN,US,US,2021,Q4,Adult
202027691,20202769,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2021,Q4,Lower gastrointestinal haemorrhage,,2021,Q4,1,I,,20211208.0,20211218,20211218,EXP,,US-SA-2021SA419342,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20211218.0,,CN,US,US,2021,Q4,Adult
202029901,20202990,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 international unit (0-0-12-0),,,,,,,,12.0,IU,,,2021,Q4,Pulse absent,,2021,Q4,1,I,,20211208.0,20211218,20211218,EXP,,DE-AUROBINDO-AUR-APL-2021-051656,AUROBINDO,,68.0,YR,,F,Y,62.0,KG,20211218.0,,PH,DE,DE,2021,Q4,Elderly
202029901,20202990,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 international unit (0-0-12-0),,,,,,,,12.0,IU,,,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,,20211208.0,20211218,20211218,EXP,,DE-AUROBINDO-AUR-APL-2021-051656,AUROBINDO,,68.0,YR,,F,Y,62.0,KG,20211218.0,,PH,DE,DE,2021,Q4,Elderly
202029901,20202990,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 international unit (0-0-12-0),,,,,,,,12.0,IU,,,2021,Q4,Peripheral coldness,,2021,Q4,1,I,,20211208.0,20211218,20211218,EXP,,DE-AUROBINDO-AUR-APL-2021-051656,AUROBINDO,,68.0,YR,,F,Y,62.0,KG,20211218.0,,PH,DE,DE,2021,Q4,Elderly
202029901,20202990,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 international unit (0-0-12-0),,,,,,,,12.0,IU,,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211208.0,20211218,20211218,EXP,,DE-AUROBINDO-AUR-APL-2021-051656,AUROBINDO,,68.0,YR,,F,Y,62.0,KG,20211218.0,,PH,DE,DE,2021,Q4,Elderly
202029901,20202990,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 international unit (0-0-12-0),,,,,,,,12.0,IU,,,2021,Q4,Lividity,,2021,Q4,1,I,,20211208.0,20211218,20211218,EXP,,DE-AUROBINDO-AUR-APL-2021-051656,AUROBINDO,,68.0,YR,,F,Y,62.0,KG,20211218.0,,PH,DE,DE,2021,Q4,Elderly
202029901,20202990,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 international unit (0-0-12-0),,,,,,,,12.0,IU,,,2021,Q4,Renal impairment,,2021,Q4,1,I,,20211208.0,20211218,20211218,EXP,,DE-AUROBINDO-AUR-APL-2021-051656,AUROBINDO,,68.0,YR,,F,Y,62.0,KG,20211218.0,,PH,DE,DE,2021,Q4,Elderly
202029901,20202990,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 international unit (0-0-12-0),,,,,,,,12.0,IU,,,2021,Q4,Anaemia,,2021,Q4,1,I,,20211208.0,20211218,20211218,EXP,,DE-AUROBINDO-AUR-APL-2021-051656,AUROBINDO,,68.0,YR,,F,Y,62.0,KG,20211218.0,,PH,DE,DE,2021,Q4,Elderly
202029901,20202990,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 international unit (0-0-12-0),,,,,,,,12.0,IU,,,2021,Q4,Systemic infection,,2021,Q4,1,I,,20211208.0,20211218,20211218,EXP,,DE-AUROBINDO-AUR-APL-2021-051656,AUROBINDO,,68.0,YR,,F,Y,62.0,KG,20211218.0,,PH,DE,DE,2021,Q4,Elderly
202048451,20204845,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (Scheme),,,,,,,,,,,,2021,Q4,Acute respiratory failure,,2021,Q4,1,I,,20211209.0,20211220,20211220,EXP,,DE-AUROBINDO-AUR-APL-2021-051832,AUROBINDO,,78.0,YR,,F,Y,,,20211220.0,,PH,DE,DE,2021,Q4,Elderly
202048451,20204845,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (Scheme),,,,,,,,,,,,2021,Q4,Atrial fibrillation,,2021,Q4,1,I,,20211209.0,20211220,20211220,EXP,,DE-AUROBINDO-AUR-APL-2021-051832,AUROBINDO,,78.0,YR,,F,Y,,,20211220.0,,PH,DE,DE,2021,Q4,Elderly
202048451,20204845,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (Scheme),,,,,,,,,,,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211209.0,20211220,20211220,EXP,,DE-AUROBINDO-AUR-APL-2021-051832,AUROBINDO,,78.0,YR,,F,Y,,,20211220.0,,PH,DE,DE,2021,Q4,Elderly
202048451,20204845,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (Scheme),,,,,,,,,,,,2021,Q4,Chronic obstructive pulmonary disease,,2021,Q4,1,I,,20211209.0,20211220,20211220,EXP,,DE-AUROBINDO-AUR-APL-2021-051832,AUROBINDO,,78.0,YR,,F,Y,,,20211220.0,,PH,DE,DE,2021,Q4,Elderly
202048451,20204845,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (Scheme),,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,1,I,,20211209.0,20211220,20211220,EXP,,DE-AUROBINDO-AUR-APL-2021-051832,AUROBINDO,,78.0,YR,,F,Y,,,20211220.0,,PH,DE,DE,2021,Q4,Elderly
202048451,20204845,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (Scheme),,,,,,,,,,,,2021,Q4,Condition aggravated,,2021,Q4,1,I,,20211209.0,20211220,20211220,EXP,,DE-AUROBINDO-AUR-APL-2021-051832,AUROBINDO,,78.0,YR,,F,Y,,,20211220.0,,PH,DE,DE,2021,Q4,Elderly
202054461,20205446,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-12, pre-filled syringe",,,,,,,,,,Solution for injection in pre-filled syringe,,2021,Q4,Liver function test abnormal,,2021,Q4,1,I,,20211214.0,20211220,20211220,EXP,,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-143461",BOEHRINGER INGELHEIM,,78.0,YR,E,F,Y,90.0,KG,20211220.0,,PH,DE,DE,2021,Q4,Elderly
202054461,20205446,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-12, pre-filled syringe",,,,,,,,,,Solution for injection in pre-filled syringe,,2021,Q4,Pruritus,,2021,Q4,1,I,,20211214.0,20211220,20211220,EXP,,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-143461",BOEHRINGER INGELHEIM,,78.0,YR,E,F,Y,90.0,KG,20211220.0,,PH,DE,DE,2021,Q4,Elderly
202056581,20205658,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, unknown freq.",,,,,,,,,,Formulation unknown,,2021,Q4,Drug ineffective,,2021,Q4,1,I,20210605.0,20211213.0,20211220,20211220,EXP,,IR-ASTELLAS-2021US048669,ASTELLAS,"Heydarifard Z, Safaei M, Zadheidar S, Ehsan S, Shafiei-Jandaghi N.. Mucormycosis infection in severe COVID-19 patient with multiple underlying health conditions. Clinical Case Reports. 2021;9(10):UNK",62.0,YR,,M,Y,,,20211220.0,,HP,IR,IR,2021,Q4,Adult
202059021,20205902,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Hypercalcaemia,,2021,Q4,1,I,,20211210.0,20211220,20211220,EXP,,US-Accord-247465,ACCORD,"Flowers RC, Ocampo J, Krautbauer J, Kupin WL. Hypercalcaemia in Mycobacterium kansasii pulmonary infection. BMJ Case Rep. 2021 Nov 30;14(11):e245800",6.0,DEC,,M,Y,,,20211220.0,,MD,US,US,2021,Q4,Child
202059021,20205902,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Mycobacterium kansasii infection,,2021,Q4,1,I,,20211210.0,20211220,20211220,EXP,,US-Accord-247465,ACCORD,"Flowers RC, Ocampo J, Krautbauer J, Kupin WL. Hypercalcaemia in Mycobacterium kansasii pulmonary infection. BMJ Case Rep. 2021 Nov 30;14(11):e245800",6.0,DEC,,M,Y,,,20211220.0,,MD,US,US,2021,Q4,Child
202059021,20205902,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Pancytopenia,,2021,Q4,1,I,,20211210.0,20211220,20211220,EXP,,US-Accord-247465,ACCORD,"Flowers RC, Ocampo J, Krautbauer J, Kupin WL. Hypercalcaemia in Mycobacterium kansasii pulmonary infection. BMJ Case Rep. 2021 Nov 30;14(11):e245800",6.0,DEC,,M,Y,,,20211220.0,,MD,US,US,2021,Q4,Child
202059021,20205902,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Anaemia,,2021,Q4,1,I,,20211210.0,20211220,20211220,EXP,,US-Accord-247465,ACCORD,"Flowers RC, Ocampo J, Krautbauer J, Kupin WL. Hypercalcaemia in Mycobacterium kansasii pulmonary infection. BMJ Case Rep. 2021 Nov 30;14(11):e245800",6.0,DEC,,M,Y,,,20211220.0,,MD,US,US,2021,Q4,Child
202059021,20205902,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Acute kidney injury,,2021,Q4,1,I,,20211210.0,20211220,20211220,EXP,,US-Accord-247465,ACCORD,"Flowers RC, Ocampo J, Krautbauer J, Kupin WL. Hypercalcaemia in Mycobacterium kansasii pulmonary infection. BMJ Case Rep. 2021 Nov 30;14(11):e245800",6.0,DEC,,M,Y,,,20211220.0,,MD,US,US,2021,Q4,Child
202064271,20206427,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,U,UNKNOWN,,,40.0,IU,,QD,2021,Q4,Product administration error,,2021,Q4,1,I,,20211215.0,20211220,20211220,EXP,,DE-drreddys-SPO/GER/21/0144942,DR REDDYS,,82.0,YR,E,M,Y,,,20211220.0,,MD,DE,DE,2021,Q4,Elderly
202064271,20206427,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,U,UNKNOWN,,,40.0,IU,,QD,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211215.0,20211220,20211220,EXP,,DE-drreddys-SPO/GER/21/0144942,DR REDDYS,,82.0,YR,E,M,Y,,,20211220.0,,MD,DE,DE,2021,Q4,Elderly
202064271,20206427,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,U,UNKNOWN,,,40.0,IU,,QD,2021,Q4,Bradycardia,,2021,Q4,1,I,,20211215.0,20211220,20211220,EXP,,DE-drreddys-SPO/GER/21/0144942,DR REDDYS,,82.0,YR,E,M,Y,,,20211220.0,,MD,DE,DE,2021,Q4,Elderly
202064271,20206427,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,U,UNKNOWN,,,40.0,IU,,QD,2021,Q4,Fatigue,,2021,Q4,1,I,,20211215.0,20211220,20211220,EXP,,DE-drreddys-SPO/GER/21/0144942,DR REDDYS,,82.0,YR,E,M,Y,,,20211220.0,,MD,DE,DE,2021,Q4,Elderly
202095501,20209550,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"28 U, QD",,,U,,,,21081.0,,,,QD,2021,Q4,Cerebral atrophy,,2021,Q4,1,I,,20211214.0,20211221,20211221,EXP,,CN-SA-2021SA419131,SANOFI AVENTIS,"Sheng Zhao, Zhang Wei, Chen Ruoling, An Minmin, Ji Xuelei, Wu Xue, et al.. Intermediate healthy elderly patients with type 2 diabetes treated with insulin. Chin J Diabetes Mellitus. 2021;13:23-26",82.0,YR,E,F,Y,,,20211221.0,,HP,CN,CN,2021,Q4,Elderly
202095501,20209550,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"28 U, QD",,,U,,,,21081.0,,,,QD,2021,Q4,Atrioventricular block first degree,,2021,Q4,1,I,,20211214.0,20211221,20211221,EXP,,CN-SA-2021SA419131,SANOFI AVENTIS,"Sheng Zhao, Zhang Wei, Chen Ruoling, An Minmin, Ji Xuelei, Wu Xue, et al.. Intermediate healthy elderly patients with type 2 diabetes treated with insulin. Chin J Diabetes Mellitus. 2021;13:23-26",82.0,YR,E,F,Y,,,20211221.0,,HP,CN,CN,2021,Q4,Elderly
202095501,20209550,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"28 U, QD",,,U,,,,21081.0,,,,QD,2021,Q4,Insomnia,,2021,Q4,1,I,,20211214.0,20211221,20211221,EXP,,CN-SA-2021SA419131,SANOFI AVENTIS,"Sheng Zhao, Zhang Wei, Chen Ruoling, An Minmin, Ji Xuelei, Wu Xue, et al.. Intermediate healthy elderly patients with type 2 diabetes treated with insulin. Chin J Diabetes Mellitus. 2021;13:23-26",82.0,YR,E,F,Y,,,20211221.0,,HP,CN,CN,2021,Q4,Elderly
202095501,20209550,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"28 U, QD",,,U,,,,21081.0,,,,QD,2021,Q4,Dizziness,,2021,Q4,1,I,,20211214.0,20211221,20211221,EXP,,CN-SA-2021SA419131,SANOFI AVENTIS,"Sheng Zhao, Zhang Wei, Chen Ruoling, An Minmin, Ji Xuelei, Wu Xue, et al.. Intermediate healthy elderly patients with type 2 diabetes treated with insulin. Chin J Diabetes Mellitus. 2021;13:23-26",82.0,YR,E,F,Y,,,20211221.0,,HP,CN,CN,2021,Q4,Elderly
202095501,20209550,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"28 U, QD",,,U,,,,21081.0,,,,QD,2021,Q4,Hepatic steatosis,,2021,Q4,1,I,,20211214.0,20211221,20211221,EXP,,CN-SA-2021SA419131,SANOFI AVENTIS,"Sheng Zhao, Zhang Wei, Chen Ruoling, An Minmin, Ji Xuelei, Wu Xue, et al.. Intermediate healthy elderly patients with type 2 diabetes treated with insulin. Chin J Diabetes Mellitus. 2021;13:23-26",82.0,YR,E,F,Y,,,20211221.0,,HP,CN,CN,2021,Q4,Elderly
202095501,20209550,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"28 U, QD",,,U,,,,21081.0,,,,QD,2021,Q4,Left atrial enlargement,,2021,Q4,1,I,,20211214.0,20211221,20211221,EXP,,CN-SA-2021SA419131,SANOFI AVENTIS,"Sheng Zhao, Zhang Wei, Chen Ruoling, An Minmin, Ji Xuelei, Wu Xue, et al.. Intermediate healthy elderly patients with type 2 diabetes treated with insulin. Chin J Diabetes Mellitus. 2021;13:23-26",82.0,YR,E,F,Y,,,20211221.0,,HP,CN,CN,2021,Q4,Elderly
202095501,20209550,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"28 U, QD",,,U,,,,21081.0,,,,QD,2021,Q4,Product use issue,,2021,Q4,1,I,,20211214.0,20211221,20211221,EXP,,CN-SA-2021SA419131,SANOFI AVENTIS,"Sheng Zhao, Zhang Wei, Chen Ruoling, An Minmin, Ji Xuelei, Wu Xue, et al.. Intermediate healthy elderly patients with type 2 diabetes treated with insulin. Chin J Diabetes Mellitus. 2021;13:23-26",82.0,YR,E,F,Y,,,20211221.0,,HP,CN,CN,2021,Q4,Elderly
202095501,20209550,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"28 U, QD",,,U,,,,21081.0,,,,QD,2021,Q4,Palpitations,,2021,Q4,1,I,,20211214.0,20211221,20211221,EXP,,CN-SA-2021SA419131,SANOFI AVENTIS,"Sheng Zhao, Zhang Wei, Chen Ruoling, An Minmin, Ji Xuelei, Wu Xue, et al.. Intermediate healthy elderly patients with type 2 diabetes treated with insulin. Chin J Diabetes Mellitus. 2021;13:23-26",82.0,YR,E,F,Y,,,20211221.0,,HP,CN,CN,2021,Q4,Elderly
202095501,20209550,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"28 U, QD",,,U,,,,21081.0,,,,QD,2021,Q4,Enterococcal infection,,2021,Q4,1,I,,20211214.0,20211221,20211221,EXP,,CN-SA-2021SA419131,SANOFI AVENTIS,"Sheng Zhao, Zhang Wei, Chen Ruoling, An Minmin, Ji Xuelei, Wu Xue, et al.. Intermediate healthy elderly patients with type 2 diabetes treated with insulin. Chin J Diabetes Mellitus. 2021;13:23-26",82.0,YR,E,F,Y,,,20211221.0,,HP,CN,CN,2021,Q4,Elderly
202095501,20209550,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"28 U, QD",,,U,,,,21081.0,,,,QD,2021,Q4,Bundle branch block right,,2021,Q4,1,I,,20211214.0,20211221,20211221,EXP,,CN-SA-2021SA419131,SANOFI AVENTIS,"Sheng Zhao, Zhang Wei, Chen Ruoling, An Minmin, Ji Xuelei, Wu Xue, et al.. Intermediate healthy elderly patients with type 2 diabetes treated with insulin. Chin J Diabetes Mellitus. 2021;13:23-26",82.0,YR,E,F,Y,,,20211221.0,,HP,CN,CN,2021,Q4,Elderly
202095501,20209550,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"28 U, QD",,,U,,,,21081.0,,,,QD,2021,Q4,Internal carotid artery deformity,,2021,Q4,1,I,,20211214.0,20211221,20211221,EXP,,CN-SA-2021SA419131,SANOFI AVENTIS,"Sheng Zhao, Zhang Wei, Chen Ruoling, An Minmin, Ji Xuelei, Wu Xue, et al.. Intermediate healthy elderly patients with type 2 diabetes treated with insulin. Chin J Diabetes Mellitus. 2021;13:23-26",82.0,YR,E,F,Y,,,20211221.0,,HP,CN,CN,2021,Q4,Elderly
202095571,20209557,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,300 iU,,,D,,,,21081.0,300.0,IU,,,2021,Q4,Confusional state,,2021,Q4,1,I,,20211215.0,20211221,20211221,EXP,,DE-SA-2021SA421398,SANOFI AVENTIS,,77.0,YR,E,F,Y,77.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202095571,20209557,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,300 iU,,,D,,,,21081.0,300.0,IU,,,2021,Q4,Therapeutic drug monitoring analysis not performed,,2021,Q4,1,I,,20211215.0,20211221,20211221,EXP,,DE-SA-2021SA421398,SANOFI AVENTIS,,77.0,YR,E,F,Y,77.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202095571,20209557,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,300 iU,,,D,,,,21081.0,300.0,IU,,,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,,20211215.0,20211221,20211221,EXP,,DE-SA-2021SA421398,SANOFI AVENTIS,,77.0,YR,E,F,Y,77.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202095571,20209557,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,300 iU,,,D,,,,21081.0,300.0,IU,,,2021,Q4,Fall,,2021,Q4,1,I,,20211215.0,20211221,20211221,EXP,,DE-SA-2021SA421398,SANOFI AVENTIS,,77.0,YR,E,F,Y,77.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202095621,20209562,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 iU, QD, 0-0-0-1",,,D,,,,21081.0,40.0,IU,,QD,2021,Q4,Bradycardia,,2021,Q4,1,I,,20211215.0,20211221,20211221,EXP,,DE-SA-2021SA422110,SANOFI AVENTIS,,82.0,YR,E,M,Y,,,20211221.0,,MD,DE,DE,2021,Q4,Elderly
202095621,20209562,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 iU, QD, 0-0-0-1",,,D,,,,21081.0,40.0,IU,,QD,2021,Q4,Product administration error,,2021,Q4,1,I,,20211215.0,20211221,20211221,EXP,,DE-SA-2021SA422110,SANOFI AVENTIS,,82.0,YR,E,M,Y,,,20211221.0,,MD,DE,DE,2021,Q4,Elderly
202095621,20209562,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 iU, QD, 0-0-0-1",,,D,,,,21081.0,40.0,IU,,QD,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211215.0,20211221,20211221,EXP,,DE-SA-2021SA422110,SANOFI AVENTIS,,82.0,YR,E,M,Y,,,20211221.0,,MD,DE,DE,2021,Q4,Elderly
202095621,20209562,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 iU, QD, 0-0-0-1",,,D,,,,21081.0,40.0,IU,,QD,2021,Q4,Fatigue,,2021,Q4,1,I,,20211215.0,20211221,20211221,EXP,,DE-SA-2021SA422110,SANOFI AVENTIS,,82.0,YR,E,M,Y,,,20211221.0,,MD,DE,DE,2021,Q4,Elderly
202096801,20209680,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 IE, 0-0-0-30, Injektions-/Infusionsl???sung",,,U,U,,,,,,,,2021,Q4,Confusional state,,2021,Q4,1,I,,20211210.0,20211221,20211221,EXP,DE-ADRED-07429-01,DE-NOVOPROD-875304,NOVO NORDISK,,77.0,YR,,F,Y,77.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202096801,20209680,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 IE, 0-0-0-30, Injektions-/Infusionsl???sung",,,U,U,,,,,,,,2021,Q4,Therapeutic drug monitoring analysis not performed,,2021,Q4,1,I,,20211210.0,20211221,20211221,EXP,DE-ADRED-07429-01,DE-NOVOPROD-875304,NOVO NORDISK,,77.0,YR,,F,Y,77.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202096801,20209680,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 IE, 0-0-0-30, Injektions-/Infusionsl???sung",,,U,U,,,,,,,,2021,Q4,Fall,,2021,Q4,1,I,,20211210.0,20211221,20211221,EXP,DE-ADRED-07429-01,DE-NOVOPROD-875304,NOVO NORDISK,,77.0,YR,,F,Y,77.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202096801,20209680,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 IE, 0-0-0-30, Injektions-/Infusionsl???sung",,,U,U,,,,,,,,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,,20211210.0,20211221,20211221,EXP,DE-ADRED-07429-01,DE-NOVOPROD-875304,NOVO NORDISK,,77.0,YR,,F,Y,77.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202096911,20209691,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"0-0-0-20, Fertigspritzen",,,U,U,,,,,,,,2021,Q4,Labelled drug-drug interaction medication error,,2021,Q4,1,I,20210220.0,20211210.0,20211221,20211221,EXP,DE-BFARM-21011534,DE-NOVOPROD-875313,NOVO NORDISK,,57.0,YR,,F,Y,120.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Adult
202096911,20209691,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"0-0-0-20, Fertigspritzen",,,U,U,,,,,,,,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,1,I,20210220.0,20211210.0,20211221,20211221,EXP,DE-BFARM-21011534,DE-NOVOPROD-875313,NOVO NORDISK,,57.0,YR,,F,Y,120.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Adult
202096911,20209691,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"0-0-0-20, Fertigspritzen",,,U,U,,,,,,,,2021,Q4,Product monitoring error,,2021,Q4,1,I,20210220.0,20211210.0,20211221,20211221,EXP,DE-BFARM-21011534,DE-NOVOPROD-875313,NOVO NORDISK,,57.0,YR,,F,Y,120.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Adult
202096911,20209691,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"0-0-0-20, Fertigspritzen",,,U,U,,,,,,,,2021,Q4,Fracture blisters,,2021,Q4,1,I,20210220.0,20211210.0,20211221,20211221,EXP,DE-BFARM-21011534,DE-NOVOPROD-875313,NOVO NORDISK,,57.0,YR,,F,Y,120.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Adult
202096911,20209691,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"0-0-0-20, Fertigspritzen",,,U,U,,,,,,,,2021,Q4,Pain in extremity,,2021,Q4,1,I,20210220.0,20211210.0,20211221,20211221,EXP,DE-BFARM-21011534,DE-NOVOPROD-875313,NOVO NORDISK,,57.0,YR,,F,Y,120.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Adult
202096911,20209691,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"0-0-0-20, Fertigspritzen",,,U,U,,,,,,,,2021,Q4,Pain,,2021,Q4,1,I,20210220.0,20211210.0,20211221,20211221,EXP,DE-BFARM-21011534,DE-NOVOPROD-875313,NOVO NORDISK,,57.0,YR,,F,Y,120.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Adult
202097631,20209763,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IE, 0-0-10-0",,,U,,,,,,,,,2021,Q4,Fall,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-135635,BRISTOL MYERS SQUIBB,,85.0,YR,,F,Y,60.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202097631,20209763,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IE, 0-0-10-0",,,U,,,,,,,,,2021,Q4,COVID-19,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-135635,BRISTOL MYERS SQUIBB,,85.0,YR,,F,Y,60.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202097631,20209763,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IE, 0-0-10-0",,,U,,,,,,,,,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-135635,BRISTOL MYERS SQUIBB,,85.0,YR,,F,Y,60.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202097631,20209763,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IE, 0-0-10-0",,,U,,,,,,,,,2021,Q4,Pyrexia,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-135635,BRISTOL MYERS SQUIBB,,85.0,YR,,F,Y,60.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202097631,20209763,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IE, 0-0-10-0",,,U,,,,,,,,,2021,Q4,Renal impairment,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-135635,BRISTOL MYERS SQUIBB,,85.0,YR,,F,Y,60.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202097631,20209763,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IE, 0-0-10-0",,,U,,,,,,,,,2021,Q4,Systemic infection,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-135635,BRISTOL MYERS SQUIBB,,85.0,YR,,F,Y,60.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202097631,20209763,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IE, 0-0-10-0",,,U,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-135635,BRISTOL MYERS SQUIBB,,85.0,YR,,F,Y,60.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202098711,20209871,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IE, 0-0-10-0",,,U,,,,,,,,,2021,Q4,Death,,2021,Q4,1,I,20201115.0,20211213.0,20211221,20211221,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-138901,BRISTOL MYERS SQUIBB,,85.0,YR,,F,Y,60.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202108041,20210804,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IU, QD",,,U,,,,,10.0,IU,,QD,2021,Q4,Fall,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,NVSC2021DE286561,NOVARTIS,,85.0,YR,,F,Y,60.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202108041,20210804,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IU, QD",,,U,,,,,10.0,IU,,QD,2021,Q4,Pyrexia,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,NVSC2021DE286561,NOVARTIS,,85.0,YR,,F,Y,60.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202108041,20210804,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IU, QD",,,U,,,,,10.0,IU,,QD,2021,Q4,Dyspnoea,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,NVSC2021DE286561,NOVARTIS,,85.0,YR,,F,Y,60.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202108041,20210804,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IU, QD",,,U,,,,,10.0,IU,,QD,2021,Q4,Coronavirus test positive,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,NVSC2021DE286561,NOVARTIS,,85.0,YR,,F,Y,60.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202108041,20210804,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IU, QD",,,U,,,,,10.0,IU,,QD,2021,Q4,Renal impairment,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,NVSC2021DE286561,NOVARTIS,,85.0,YR,,F,Y,60.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202108041,20210804,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IU, QD",,,U,,,,,10.0,IU,,QD,2021,Q4,Systemic infection,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,NVSC2021DE286561,NOVARTIS,,85.0,YR,,F,Y,60.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202108041,20210804,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IU, QD",,,U,,,,,10.0,IU,,QD,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,NVSC2021DE286561,NOVARTIS,,85.0,YR,,F,Y,60.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202108211,20210821,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 IU, QD (300 IE, 0-0-0-50, Injektions-/Infusionslosung)",,,U,,,,,300.0,IU,Solution for infusion,QD,2021,Q4,Peripheral coldness,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,NVSC2021DE286294,NOVARTIS,,64.0,YR,,F,Y,63.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Adult
202108211,20210821,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 IU, QD (300 IE, 0-0-0-50, Injektions-/Infusionslosung)",,,U,,,,,300.0,IU,Solution for infusion,QD,2021,Q4,Pain,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,NVSC2021DE286294,NOVARTIS,,64.0,YR,,F,Y,63.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Adult
202108211,20210821,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 IU, QD (300 IE, 0-0-0-50, Injektions-/Infusionslosung)",,,U,,,,,300.0,IU,Solution for infusion,QD,2021,Q4,Therapeutic drug monitoring analysis not performed,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,NVSC2021DE286294,NOVARTIS,,64.0,YR,,F,Y,63.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Adult
202114231,20211423,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,0-0-10-0,,,,,UNKNOWN,,,10.0,IU,,QD,2021,Q4,Nausea,,2021,Q4,1,I,,20211215.0,20211221,20211221,EXP,,DE-drreddys-SPO/GER/21/0144890,DR REDDYS,,84.0,YR,E,F,Y,80.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202114231,20211423,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,0-0-10-0,,,,,UNKNOWN,,,10.0,IU,,QD,2021,Q4,Flank pain,,2021,Q4,1,I,,20211215.0,20211221,20211221,EXP,,DE-drreddys-SPO/GER/21/0144890,DR REDDYS,,84.0,YR,E,F,Y,80.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202114231,20211423,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,0-0-10-0,,,,,UNKNOWN,,,10.0,IU,,QD,2021,Q4,Systemic infection,,2021,Q4,1,I,,20211215.0,20211221,20211221,EXP,,DE-drreddys-SPO/GER/21/0144890,DR REDDYS,,84.0,YR,E,F,Y,80.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202114231,20211423,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,0-0-10-0,,,,,UNKNOWN,,,10.0,IU,,QD,2021,Q4,Renal impairment,,2021,Q4,1,I,,20211215.0,20211221,20211221,EXP,,DE-drreddys-SPO/GER/21/0144890,DR REDDYS,,84.0,YR,E,F,Y,80.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202114231,20211423,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,0-0-10-0,,,,,UNKNOWN,,,10.0,IU,,QD,2021,Q4,Pain,,2021,Q4,1,I,,20211215.0,20211221,20211221,EXP,,DE-drreddys-SPO/GER/21/0144890,DR REDDYS,,84.0,YR,E,F,Y,80.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202122461,20212246,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IU, 0-0-0-6, pre-filled syringes",,,U,,,,,,,,,2021,Q4,Weight decreased,,2021,Q4,1,I,20201108.0,20211213.0,20211221,20211221,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202106011339,ELI LILLY AND CO,,69.0,YR,,M,Y,65.0,KG,20211221.0,,CN,DE,DE,2021,Q4,Elderly
202122461,20212246,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IU, 0-0-0-6, pre-filled syringes",,,U,,,,,,,,,2021,Q4,Fatigue,,2021,Q4,1,I,20201108.0,20211213.0,20211221,20211221,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202106011339,ELI LILLY AND CO,,69.0,YR,,M,Y,65.0,KG,20211221.0,,CN,DE,DE,2021,Q4,Elderly
202122461,20212246,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IU, 0-0-0-6, pre-filled syringes",,,U,,,,,,,,,2021,Q4,Jaundice,,2021,Q4,1,I,20201108.0,20211213.0,20211221,20211221,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202106011339,ELI LILLY AND CO,,69.0,YR,,M,Y,65.0,KG,20211221.0,,CN,DE,DE,2021,Q4,Elderly
202122461,20212246,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IU, 0-0-0-6, pre-filled syringes",,,U,,,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,1,I,20201108.0,20211213.0,20211221,20211221,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202106011339,ELI LILLY AND CO,,69.0,YR,,M,Y,65.0,KG,20211221.0,,CN,DE,DE,2021,Q4,Elderly
202122461,20212246,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IU, 0-0-0-6, pre-filled syringes",,,U,,,,,,,,,2021,Q4,Decreased appetite,,2021,Q4,1,I,20201108.0,20211213.0,20211221,20211221,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202106011339,ELI LILLY AND CO,,69.0,YR,,M,Y,65.0,KG,20211221.0,,CN,DE,DE,2021,Q4,Elderly
202122461,20212246,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IU, 0-0-0-6, pre-filled syringes",,,U,,,,,,,,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,20201108.0,20211213.0,20211221,20211221,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202106011339,ELI LILLY AND CO,,69.0,YR,,M,Y,65.0,KG,20211221.0,,CN,DE,DE,2021,Q4,Elderly
202122461,20212246,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IU, 0-0-0-6, pre-filled syringes",,,U,,,,,,,,,2021,Q4,Pyrexia,,2021,Q4,1,I,20201108.0,20211213.0,20211221,20211221,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202106011339,ELI LILLY AND CO,,69.0,YR,,M,Y,65.0,KG,20211221.0,,CN,DE,DE,2021,Q4,Elderly
202132131,20213213,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IE, 0-0-1-0",,,U,,,,,,,,QD,2021,Q4,Haematochezia,,2021,Q4,1,I,,20211215.0,20211221,20211221,EXP,,DE-SA-2021SA421841,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202132131,20213213,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IE, 0-0-1-0",,,U,,,,,,,,QD,2021,Q4,Gastrointestinal haemorrhage,,2021,Q4,1,I,,20211215.0,20211221,20211221,EXP,,DE-SA-2021SA421841,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202132131,20213213,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IE, 0-0-1-0",,,U,,,,,,,,QD,2021,Q4,Balance disorder,,2021,Q4,1,I,,20211215.0,20211221,20211221,EXP,,DE-SA-2021SA421841,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202132131,20213213,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IE, 0-0-1-0",,,U,,,,,,,,QD,2021,Q4,Anaemia,,2021,Q4,1,I,,20211215.0,20211221,20211221,EXP,,DE-SA-2021SA421841,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202132131,20213213,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IE, 0-0-1-0",,,U,,,,,,,,QD,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211215.0,20211221,20211221,EXP,,DE-SA-2021SA421841,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202136541,20213654,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"0-0-0-20, pre-filled syringes",,,U,,,,21081.0,,,Solution for injection,,2021,Q4,Labelled drug-drug interaction medication error,,2021,Q4,1,I,20210220.0,20211216.0,20211221,20211221,EXP,,DE-SA-2021SA423826,SANOFI AVENTIS,,57.0,YR,A,F,Y,120.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Adult
202136541,20213654,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"0-0-0-20, pre-filled syringes",,,U,,,,21081.0,,,Solution for injection,,2021,Q4,Pain,,2021,Q4,1,I,20210220.0,20211216.0,20211221,20211221,EXP,,DE-SA-2021SA423826,SANOFI AVENTIS,,57.0,YR,A,F,Y,120.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Adult
202136541,20213654,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"0-0-0-20, pre-filled syringes",,,U,,,,21081.0,,,Solution for injection,,2021,Q4,Fracture blisters,,2021,Q4,1,I,20210220.0,20211216.0,20211221,20211221,EXP,,DE-SA-2021SA423826,SANOFI AVENTIS,,57.0,YR,A,F,Y,120.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Adult
202136541,20213654,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"0-0-0-20, pre-filled syringes",,,U,,,,21081.0,,,Solution for injection,,2021,Q4,Product monitoring error,,2021,Q4,1,I,20210220.0,20211216.0,20211221,20211221,EXP,,DE-SA-2021SA423826,SANOFI AVENTIS,,57.0,YR,A,F,Y,120.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Adult
202136541,20213654,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"0-0-0-20, pre-filled syringes",,,U,,,,21081.0,,,Solution for injection,,2021,Q4,Pain in extremity,,2021,Q4,1,I,20210220.0,20211216.0,20211221,20211221,EXP,,DE-SA-2021SA423826,SANOFI AVENTIS,,57.0,YR,A,F,Y,120.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Adult
202144611,20214461,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,Unknown,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,20211213.0,20211214.0,20211221,20211221,EXP,GB-MHRA-EYC 00268999,GB-JNJFOC-20211233276,JOHNSON AND JOHNSON,,46.0,YR,A,F,Y,,,20211222.0,,PH,GB,GB,2021,Q4,Adult
202149051,20214905,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (12 IE, 0-0-1-0)",,,,,,,,,,,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,,DE-AUROBINDO-AUR-APL-2021-052304,AUROBINDO,,68.0,YR,,M,Y,,,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202149051,20214905,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (12 IE, 0-0-1-0)",,,,,,,,,,,,2021,Q4,Gastrointestinal haemorrhage,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,,DE-AUROBINDO-AUR-APL-2021-052304,AUROBINDO,,68.0,YR,,M,Y,,,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202149051,20214905,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (12 IE, 0-0-1-0)",,,,,,,,,,,,2021,Q4,Haematochezia,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,,DE-AUROBINDO-AUR-APL-2021-052304,AUROBINDO,,68.0,YR,,M,Y,,,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202149051,20214905,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (12 IE, 0-0-1-0)",,,,,,,,,,,,2021,Q4,Anaemia,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,,DE-AUROBINDO-AUR-APL-2021-052304,AUROBINDO,,68.0,YR,,M,Y,,,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202149051,20214905,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (12 IE, 0-0-1-0)",,,,,,,,,,,,2021,Q4,Balance disorder,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,,DE-AUROBINDO-AUR-APL-2021-052304,AUROBINDO,,68.0,YR,,M,Y,,,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202149281,20214928,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,U,,,,,,,,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20211102.0,20211211.0,20211222,20211222,EXP,CN-NMPA-3303011655707202100791,CN-NOVOPROD-876056,NOVO NORDISK,,78.0,YR,,M,Y,60.0,KG,20211222.0,,HP,CN,CN,2021,Q4,Elderly
202149281,20214928,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,U,,,,,,,,2021,Q4,Hyperhidrosis,,2021,Q4,1,I,20211102.0,20211211.0,20211222,20211222,EXP,CN-NMPA-3303011655707202100791,CN-NOVOPROD-876056,NOVO NORDISK,,78.0,YR,,M,Y,60.0,KG,20211222.0,,HP,CN,CN,2021,Q4,Elderly
202149281,20214928,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,U,,,,,,,,2021,Q4,Hunger,,2021,Q4,1,I,20211102.0,20211211.0,20211222,20211222,EXP,CN-NMPA-3303011655707202100791,CN-NOVOPROD-876056,NOVO NORDISK,,78.0,YR,,M,Y,60.0,KG,20211222.0,,HP,CN,CN,2021,Q4,Elderly
202149281,20214928,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,U,,,,,,,,2021,Q4,Asthenia,,2021,Q4,1,I,20211102.0,20211211.0,20211222,20211222,EXP,CN-NMPA-3303011655707202100791,CN-NOVOPROD-876056,NOVO NORDISK,,78.0,YR,,M,Y,60.0,KG,20211222.0,,HP,CN,CN,2021,Q4,Elderly
202149281,20214928,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,U,ABJA002,,,20.0,IU,,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20211102.0,20211211.0,20211222,20211222,EXP,CN-NMPA-3303011655707202100791,CN-NOVOPROD-876056,NOVO NORDISK,,78.0,YR,,M,Y,60.0,KG,20211222.0,,HP,CN,CN,2021,Q4,Elderly
202149281,20214928,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,U,ABJA002,,,20.0,IU,,QD,2021,Q4,Hyperhidrosis,,2021,Q4,1,I,20211102.0,20211211.0,20211222,20211222,EXP,CN-NMPA-3303011655707202100791,CN-NOVOPROD-876056,NOVO NORDISK,,78.0,YR,,M,Y,60.0,KG,20211222.0,,HP,CN,CN,2021,Q4,Elderly
202149281,20214928,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,U,ABJA002,,,20.0,IU,,QD,2021,Q4,Hunger,,2021,Q4,1,I,20211102.0,20211211.0,20211222,20211222,EXP,CN-NMPA-3303011655707202100791,CN-NOVOPROD-876056,NOVO NORDISK,,78.0,YR,,M,Y,60.0,KG,20211222.0,,HP,CN,CN,2021,Q4,Elderly
202149281,20214928,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,U,ABJA002,,,20.0,IU,,QD,2021,Q4,Asthenia,,2021,Q4,1,I,20211102.0,20211211.0,20211222,20211222,EXP,CN-NMPA-3303011655707202100791,CN-NOVOPROD-876056,NOVO NORDISK,,78.0,YR,,M,Y,60.0,KG,20211222.0,,HP,CN,CN,2021,Q4,Elderly
202150133,20215013,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,12.0,IU,,,2021,Q4,Respiratory failure,,2021,Q4,3,F,20210101.0,20211227.0,20211222,20211231,EXP,,RU-ABBVIE-21K-251-4206470-00,ABBVIE,,67.0,YR,,F,Y,75.0,KG,20211231.0,,MD,COUNTRY NOT SPECIFIED,RU,2021,Q4,Elderly
202150133,20215013,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,12.0,IU,,,2021,Q4,COVID-19,,2021,Q4,3,F,20210101.0,20211227.0,20211222,20211231,EXP,,RU-ABBVIE-21K-251-4206470-00,ABBVIE,,67.0,YR,,F,Y,75.0,KG,20211231.0,,MD,COUNTRY NOT SPECIFIED,RU,2021,Q4,Elderly
202153871,20215387,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 international unit, Once a Day",,,U,,,,,10.0,IU,,QD,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,,DE-AUROBINDO-AUR-APL-2021-052323,AUROBINDO,,85.0,YR,,F,Y,60.0,KG,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202153871,20215387,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 international unit, Once a Day",,,U,,,,,10.0,IU,,QD,2021,Q4,Fall,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,,DE-AUROBINDO-AUR-APL-2021-052323,AUROBINDO,,85.0,YR,,F,Y,60.0,KG,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202153871,20215387,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 international unit, Once a Day",,,U,,,,,10.0,IU,,QD,2021,Q4,Renal impairment,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,,DE-AUROBINDO-AUR-APL-2021-052323,AUROBINDO,,85.0,YR,,F,Y,60.0,KG,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202153871,20215387,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 international unit, Once a Day",,,U,,,,,10.0,IU,,QD,2021,Q4,Dyspnoea,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,,DE-AUROBINDO-AUR-APL-2021-052323,AUROBINDO,,85.0,YR,,F,Y,60.0,KG,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202153871,20215387,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 international unit, Once a Day",,,U,,,,,10.0,IU,,QD,2021,Q4,Systemic infection,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,,DE-AUROBINDO-AUR-APL-2021-052323,AUROBINDO,,85.0,YR,,F,Y,60.0,KG,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202153871,20215387,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 international unit, Once a Day",,,U,,,,,10.0,IU,,QD,2021,Q4,Pyrexia,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,,DE-AUROBINDO-AUR-APL-2021-052323,AUROBINDO,,85.0,YR,,F,Y,60.0,KG,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202153871,20215387,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 international unit, Once a Day",,,U,,,,,10.0,IU,,QD,2021,Q4,Coronavirus test positive,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,,DE-AUROBINDO-AUR-APL-2021-052323,AUROBINDO,,85.0,YR,,F,Y,60.0,KG,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202162051,20216205,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"12 IU, QD (0-0-12-0)",,,U,,,,,12.0,IU,,QD,2021,Q4,Renal impairment,,2021,Q4,1,I,,20211210.0,20211222,20211222,EXP,,NVSC2021DE284631,NOVARTIS,,68.0,YR,,F,Y,62.0,KG,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202162051,20216205,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"12 IU, QD (0-0-12-0)",,,U,,,,,12.0,IU,,QD,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211210.0,20211222,20211222,EXP,,NVSC2021DE284631,NOVARTIS,,68.0,YR,,F,Y,62.0,KG,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202162051,20216205,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"12 IU, QD (0-0-12-0)",,,U,,,,,12.0,IU,,QD,2021,Q4,Anaemia,,2021,Q4,1,I,,20211210.0,20211222,20211222,EXP,,NVSC2021DE284631,NOVARTIS,,68.0,YR,,F,Y,62.0,KG,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202162051,20216205,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"12 IU, QD (0-0-12-0)",,,U,,,,,12.0,IU,,QD,2021,Q4,Lividity,,2021,Q4,1,I,,20211210.0,20211222,20211222,EXP,,NVSC2021DE284631,NOVARTIS,,68.0,YR,,F,Y,62.0,KG,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202162051,20216205,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"12 IU, QD (0-0-12-0)",,,U,,,,,12.0,IU,,QD,2021,Q4,Peripheral coldness,,2021,Q4,1,I,,20211210.0,20211222,20211222,EXP,,NVSC2021DE284631,NOVARTIS,,68.0,YR,,F,Y,62.0,KG,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202162051,20216205,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"12 IU, QD (0-0-12-0)",,,U,,,,,12.0,IU,,QD,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,,20211210.0,20211222,20211222,EXP,,NVSC2021DE284631,NOVARTIS,,68.0,YR,,F,Y,62.0,KG,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202162051,20216205,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"12 IU, QD (0-0-12-0)",,,U,,,,,12.0,IU,,QD,2021,Q4,Systemic infection,,2021,Q4,1,I,,20211210.0,20211222,20211222,EXP,,NVSC2021DE284631,NOVARTIS,,68.0,YR,,F,Y,62.0,KG,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202162051,20216205,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"12 IU, QD (0-0-12-0)",,,U,,,,,12.0,IU,,QD,2021,Q4,Pulse absent,,2021,Q4,1,I,,20211210.0,20211222,20211222,EXP,,NVSC2021DE284631,NOVARTIS,,68.0,YR,,F,Y,62.0,KG,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202162071,20216207,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (Schema),,,U,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,DE-ADRED-05958-07,NVSC2021DE285445,NOVARTIS,,78.0,YR,,F,Y,,,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202162071,20216207,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (Schema),,,U,,,,,,,,,2021,Q4,Condition aggravated,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,DE-ADRED-05958-07,NVSC2021DE285445,NOVARTIS,,78.0,YR,,F,Y,,,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202162071,20216207,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (Schema),,,U,,,,,,,,,2021,Q4,Acute respiratory failure,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,DE-ADRED-05958-07,NVSC2021DE285445,NOVARTIS,,78.0,YR,,F,Y,,,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202162071,20216207,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (Schema),,,U,,,,,,,,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,DE-ADRED-05958-07,NVSC2021DE285445,NOVARTIS,,78.0,YR,,F,Y,,,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202162071,20216207,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (Schema),,,U,,,,,,,,,2021,Q4,Chronic obstructive pulmonary disease,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,DE-ADRED-05958-07,NVSC2021DE285445,NOVARTIS,,78.0,YR,,F,Y,,,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202162071,20216207,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (Schema),,,U,,,,,,,,,2021,Q4,Atrial fibrillation,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,DE-ADRED-05958-07,NVSC2021DE285445,NOVARTIS,,78.0,YR,,F,Y,,,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202170431,20217043,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IE, 0-0-1-0",,,U,,,,,12.0,IU,UNK,QD,2021,Q4,Anaemia,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,DE-ADRED-07658-02,DE-TORRENT-00021707,TORRENT,,68.0,YR,E,M,Y,,,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202170431,20217043,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IE, 0-0-1-0",,,U,,,,,12.0,IU,UNK,QD,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,DE-ADRED-07658-02,DE-TORRENT-00021707,TORRENT,,68.0,YR,E,M,Y,,,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202170431,20217043,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IE, 0-0-1-0",,,U,,,,,12.0,IU,UNK,QD,2021,Q4,Balance disorder,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,DE-ADRED-07658-02,DE-TORRENT-00021707,TORRENT,,68.0,YR,E,M,Y,,,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202170431,20217043,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IE, 0-0-1-0",,,U,,,,,12.0,IU,UNK,QD,2021,Q4,Gastrointestinal haemorrhage,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,DE-ADRED-07658-02,DE-TORRENT-00021707,TORRENT,,68.0,YR,E,M,Y,,,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202170431,20217043,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IE, 0-0-1-0",,,U,,,,,12.0,IU,UNK,QD,2021,Q4,Haematochezia,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,DE-ADRED-07658-02,DE-TORRENT-00021707,TORRENT,,68.0,YR,E,M,Y,,,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202171071,20217107,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-6, solution for injection/infusion",,,,,UNKNOWN,,,,,,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,,DE-Fresenius Kabi-FK202114174,FRESENIUS KABI,,69.0,YR,,M,Y,,,20211222.0,,HP,NL,DE,2021,Q4,Elderly
202171071,20217107,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-6, solution for injection/infusion",,,,,UNKNOWN,,,,,,,2021,Q4,Jaundice,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,,DE-Fresenius Kabi-FK202114174,FRESENIUS KABI,,69.0,YR,,M,Y,,,20211222.0,,HP,NL,DE,2021,Q4,Elderly
202171071,20217107,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-6, solution for injection/infusion",,,,,UNKNOWN,,,,,,,2021,Q4,Decreased appetite,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,,DE-Fresenius Kabi-FK202114174,FRESENIUS KABI,,69.0,YR,,M,Y,,,20211222.0,,HP,NL,DE,2021,Q4,Elderly
202171071,20217107,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-6, solution for injection/infusion",,,,,UNKNOWN,,,,,,,2021,Q4,Pyrexia,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,,DE-Fresenius Kabi-FK202114174,FRESENIUS KABI,,69.0,YR,,M,Y,,,20211222.0,,HP,NL,DE,2021,Q4,Elderly
202171071,20217107,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-6, solution for injection/infusion",,,,,UNKNOWN,,,,,,,2021,Q4,Weight decreased,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,,DE-Fresenius Kabi-FK202114174,FRESENIUS KABI,,69.0,YR,,M,Y,,,20211222.0,,HP,NL,DE,2021,Q4,Elderly
202171071,20217107,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-6, solution for injection/infusion",,,,,UNKNOWN,,,,,,,2021,Q4,Fatigue,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,,DE-Fresenius Kabi-FK202114174,FRESENIUS KABI,,69.0,YR,,M,Y,,,20211222.0,,HP,NL,DE,2021,Q4,Elderly
202171071,20217107,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-6, solution for injection/infusion",,,,,UNKNOWN,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,,DE-Fresenius Kabi-FK202114174,FRESENIUS KABI,,69.0,YR,,M,Y,,,20211222.0,,HP,NL,DE,2021,Q4,Elderly
202191352,20219135,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Septic shock,,2021,Q4,2,F,20211120.0,20211222.0,20211222,20211230,EXP,,US-PFIZER INC-202101806399,PFIZER,,71.0,YR,,F,Y,115.0,KG,20211230.0,,HP,US,US,2021,Q4,Elderly
202191352,20219135,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Respiratory distress,,2021,Q4,2,F,20211120.0,20211222.0,20211222,20211230,EXP,,US-PFIZER INC-202101806399,PFIZER,,71.0,YR,,F,Y,115.0,KG,20211230.0,,HP,US,US,2021,Q4,Elderly
202197101,20219710,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"80 u, each morning",,,,,D390018K,,205692.0,80.0,IU,Injection,QD,2021,Q4,Accidental underdose,,2021,Q4,1,I,20211217.0,20211217.0,20211222,20211222,EXP,,FR-ELI_LILLY_AND_COMPANY-FR202112008190,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20211222.0,,CN,FR,FR,2021,Q4,Adult
202197101,20219710,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"80 u, each morning",,,,,D390018K,,205692.0,80.0,IU,Injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20211217.0,20211217.0,20211222,20211222,EXP,,FR-ELI_LILLY_AND_COMPANY-FR202112008190,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20211222.0,,CN,FR,FR,2021,Q4,Adult
202197101,20219710,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"80 u, each morning",,,,,D390018K,,205692.0,80.0,IU,Injection,QD,2021,Q4,Fall,,2021,Q4,1,I,20211217.0,20211217.0,20211222,20211222,EXP,,FR-ELI_LILLY_AND_COMPANY-FR202112008190,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20211222.0,,CN,FR,FR,2021,Q4,Adult
202197101,20219710,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"80 u, each morning",,,,,D390018K,,205692.0,80.0,IU,Injection,QD,2021,Q4,Inappropriate schedule of product administration,,2021,Q4,1,I,20211217.0,20211217.0,20211222,20211222,EXP,,FR-ELI_LILLY_AND_COMPANY-FR202112008190,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20211222.0,,CN,FR,FR,2021,Q4,Adult
202197101,20219710,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"80 u, each morning",,,,,D390018K,,205692.0,80.0,IU,Injection,QD,2021,Q4,Tendon disorder,,2021,Q4,1,I,20211217.0,20211217.0,20211222,20211222,EXP,,FR-ELI_LILLY_AND_COMPANY-FR202112008190,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20211222.0,,CN,FR,FR,2021,Q4,Adult
202197101,20219710,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"80 u, daily (in mid-day)",,,,,D390018K,,205692.0,80.0,IU,Injection,QD,2021,Q4,Accidental underdose,,2021,Q4,1,I,20211217.0,20211217.0,20211222,20211222,EXP,,FR-ELI_LILLY_AND_COMPANY-FR202112008190,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20211222.0,,CN,FR,FR,2021,Q4,Adult
202197101,20219710,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"80 u, daily (in mid-day)",,,,,D390018K,,205692.0,80.0,IU,Injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20211217.0,20211217.0,20211222,20211222,EXP,,FR-ELI_LILLY_AND_COMPANY-FR202112008190,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20211222.0,,CN,FR,FR,2021,Q4,Adult
202197101,20219710,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"80 u, daily (in mid-day)",,,,,D390018K,,205692.0,80.0,IU,Injection,QD,2021,Q4,Fall,,2021,Q4,1,I,20211217.0,20211217.0,20211222,20211222,EXP,,FR-ELI_LILLY_AND_COMPANY-FR202112008190,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20211222.0,,CN,FR,FR,2021,Q4,Adult
202197101,20219710,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"80 u, daily (in mid-day)",,,,,D390018K,,205692.0,80.0,IU,Injection,QD,2021,Q4,Inappropriate schedule of product administration,,2021,Q4,1,I,20211217.0,20211217.0,20211222,20211222,EXP,,FR-ELI_LILLY_AND_COMPANY-FR202112008190,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20211222.0,,CN,FR,FR,2021,Q4,Adult
202197101,20219710,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"80 u, daily (in mid-day)",,,,,D390018K,,205692.0,80.0,IU,Injection,QD,2021,Q4,Tendon disorder,,2021,Q4,1,I,20211217.0,20211217.0,20211222,20211222,EXP,,FR-ELI_LILLY_AND_COMPANY-FR202112008190,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20211222.0,,CN,FR,FR,2021,Q4,Adult
202197101,20219710,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"80 u, each evening",,,,,D390018K,,205692.0,80.0,IU,Injection,QD,2021,Q4,Accidental underdose,,2021,Q4,1,I,20211217.0,20211217.0,20211222,20211222,EXP,,FR-ELI_LILLY_AND_COMPANY-FR202112008190,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20211222.0,,CN,FR,FR,2021,Q4,Adult
202197101,20219710,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"80 u, each evening",,,,,D390018K,,205692.0,80.0,IU,Injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20211217.0,20211217.0,20211222,20211222,EXP,,FR-ELI_LILLY_AND_COMPANY-FR202112008190,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20211222.0,,CN,FR,FR,2021,Q4,Adult
202197101,20219710,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"80 u, each evening",,,,,D390018K,,205692.0,80.0,IU,Injection,QD,2021,Q4,Fall,,2021,Q4,1,I,20211217.0,20211217.0,20211222,20211222,EXP,,FR-ELI_LILLY_AND_COMPANY-FR202112008190,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20211222.0,,CN,FR,FR,2021,Q4,Adult
202197101,20219710,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"80 u, each evening",,,,,D390018K,,205692.0,80.0,IU,Injection,QD,2021,Q4,Inappropriate schedule of product administration,,2021,Q4,1,I,20211217.0,20211217.0,20211222,20211222,EXP,,FR-ELI_LILLY_AND_COMPANY-FR202112008190,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20211222.0,,CN,FR,FR,2021,Q4,Adult
202197101,20219710,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"80 u, each evening",,,,,D390018K,,205692.0,80.0,IU,Injection,QD,2021,Q4,Tendon disorder,,2021,Q4,1,I,20211217.0,20211217.0,20211222,20211222,EXP,,FR-ELI_LILLY_AND_COMPANY-FR202112008190,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20211222.0,,CN,FR,FR,2021,Q4,Adult
202198601,20219860,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Skin mass,,2021,Q4,1,I,20210301.0,20211222.0,20211222,20211222,EXP,SE-MPA-2021-097992,"SE-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145009",BOEHRINGER INGELHEIM,,81.0,YR,E,M,Y,,,20211222.0,,MD,SE,SE,2021,Q4,Elderly
202202481,20220248,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-6, Solution for injection/infusion",,,,,,,,,,Solution for injection/infusion,,2021,Q4,Weight decreased,,2021,Q4,1,I,,20211211.0,20211223,20211223,PER,DE-ADRED-05815-04,DE-Shilpa Medicare Limited-SML-DE-2021-01503,SHILPA MEDICARE,,69.0,YR,E,M,Y,,,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202202481,20220248,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-6, Solution for injection/infusion",,,,,,,,,,Solution for injection/infusion,,2021,Q4,Pyrexia,,2021,Q4,1,I,,20211211.0,20211223,20211223,PER,DE-ADRED-05815-04,DE-Shilpa Medicare Limited-SML-DE-2021-01503,SHILPA MEDICARE,,69.0,YR,E,M,Y,,,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202202481,20220248,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-6, Solution for injection/infusion",,,,,,,,,,Solution for injection/infusion,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211211.0,20211223,20211223,PER,DE-ADRED-05815-04,DE-Shilpa Medicare Limited-SML-DE-2021-01503,SHILPA MEDICARE,,69.0,YR,E,M,Y,,,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202202481,20220248,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-6, Solution for injection/infusion",,,,,,,,,,Solution for injection/infusion,,2021,Q4,Jaundice,,2021,Q4,1,I,,20211211.0,20211223,20211223,PER,DE-ADRED-05815-04,DE-Shilpa Medicare Limited-SML-DE-2021-01503,SHILPA MEDICARE,,69.0,YR,E,M,Y,,,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202202481,20220248,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-6, Solution for injection/infusion",,,,,,,,,,Solution for injection/infusion,,2021,Q4,Fatigue,,2021,Q4,1,I,,20211211.0,20211223,20211223,PER,DE-ADRED-05815-04,DE-Shilpa Medicare Limited-SML-DE-2021-01503,SHILPA MEDICARE,,69.0,YR,E,M,Y,,,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202202481,20220248,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-6, Solution for injection/infusion",,,,,,,,,,Solution for injection/infusion,,2021,Q4,Diarrhoea,,2021,Q4,1,I,,20211211.0,20211223,20211223,PER,DE-ADRED-05815-04,DE-Shilpa Medicare Limited-SML-DE-2021-01503,SHILPA MEDICARE,,69.0,YR,E,M,Y,,,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202202481,20220248,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-6, Solution for injection/infusion",,,,,,,,,,Solution for injection/infusion,,2021,Q4,Decreased appetite,,2021,Q4,1,I,,20211211.0,20211223,20211223,PER,DE-ADRED-05815-04,DE-Shilpa Medicare Limited-SML-DE-2021-01503,SHILPA MEDICARE,,69.0,YR,E,M,Y,,,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202205261,20220526,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1.5 milliliter (1.5 ml, 8-0-0-0, Injektions-/Infusionsl?sung)",,,U,,,,,1.5,ML,Solution for Injection or Infusion,,2021,Q4,Abdominal pain,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,,DE-AUROBINDO-AUR-APL-2021-052436,AUROBINDO,,84.0,YR,,M,Y,101.4,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202205261,20220526,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1.5 milliliter (1.5 ml, 8-0-0-0, Injektions-/Infusionsl?sung)",,,U,,,,,1.5,ML,Solution for Injection or Infusion,,2021,Q4,Decreased appetite,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,,DE-AUROBINDO-AUR-APL-2021-052436,AUROBINDO,,84.0,YR,,M,Y,101.4,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202205261,20220526,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1.5 milliliter (1.5 ml, 8-0-0-0, Injektions-/Infusionsl?sung)",,,U,,,,,1.5,ML,Solution for Injection or Infusion,,2021,Q4,Dysuria,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,,DE-AUROBINDO-AUR-APL-2021-052436,AUROBINDO,,84.0,YR,,M,Y,101.4,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202205261,20220526,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1.5 milliliter (1.5 ml, 8-0-0-0, Injektions-/Infusionsl?sung)",,,U,,,,,1.5,ML,Solution for Injection or Infusion,,2021,Q4,Constipation,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,,DE-AUROBINDO-AUR-APL-2021-052436,AUROBINDO,,84.0,YR,,M,Y,101.4,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202205261,20220526,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1.5 milliliter (1.5 ml, 8-0-0-0, Injektions-/Infusionsl?sung)",,,U,,,,,1.5,ML,Solution for Injection or Infusion,,2021,Q4,Nausea,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,,DE-AUROBINDO-AUR-APL-2021-052436,AUROBINDO,,84.0,YR,,M,Y,101.4,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202205261,20220526,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1.5 milliliter (1.5 ml, 8-0-0-0, Injektions-/Infusionsl?sung)",,,U,,,,,1.5,ML,Solution for Injection or Infusion,,2021,Q4,Abdominal distension,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,,DE-AUROBINDO-AUR-APL-2021-052436,AUROBINDO,,84.0,YR,,M,Y,101.4,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202205261,20220526,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1.5 milliliter (1.5 ml, 8-0-0-0, Injektions-/Infusionsl?sung)",,,U,,,,,1.5,ML,Solution for Injection or Infusion,,2021,Q4,Decreased appetite,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,,DE-AUROBINDO-AUR-APL-2021-052436,AUROBINDO,,84.0,YR,,M,Y,101.4,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202206641,20220664,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK(30 IU, 0-0-0-1, solution for injection / infusion)",,,,,,,,,,,,2021,Q4,Haematochezia,,2021,Q4,1,I,20200630.0,20211213.0,20211223,20211223,EXP,,DE-AUROBINDO-AUR-APL-2021-052050,AUROBINDO,,67.0,YR,,M,Y,95.0,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202212281,20221228,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"12 IU, 0-0-12-0",,,,,,,,12.0,IU,,,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,,DE-TEVA-2021-DE-1989997,TEVA,,68.0,YR,E,F,Y,62.0,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202212281,20221228,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"12 IU, 0-0-12-0",,,,,,,,12.0,IU,,,2021,Q4,Systemic infection,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,,DE-TEVA-2021-DE-1989997,TEVA,,68.0,YR,E,F,Y,62.0,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202212281,20221228,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"12 IU, 0-0-12-0",,,,,,,,12.0,IU,,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,,DE-TEVA-2021-DE-1989997,TEVA,,68.0,YR,E,F,Y,62.0,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202212281,20221228,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"12 IU, 0-0-12-0",,,,,,,,12.0,IU,,,2021,Q4,Renal impairment,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,,DE-TEVA-2021-DE-1989997,TEVA,,68.0,YR,E,F,Y,62.0,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202212281,20221228,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"12 IU, 0-0-12-0",,,,,,,,12.0,IU,,,2021,Q4,Anaemia,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,,DE-TEVA-2021-DE-1989997,TEVA,,68.0,YR,E,F,Y,62.0,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202212281,20221228,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"12 IU, 0-0-12-0",,,,,,,,12.0,IU,,,2021,Q4,Peripheral coldness,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,,DE-TEVA-2021-DE-1989997,TEVA,,68.0,YR,E,F,Y,62.0,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202212281,20221228,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"12 IU, 0-0-12-0",,,,,,,,12.0,IU,,,2021,Q4,Lividity,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,,DE-TEVA-2021-DE-1989997,TEVA,,68.0,YR,E,F,Y,62.0,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202212281,20221228,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"12 IU, 0-0-12-0",,,,,,,,12.0,IU,,,2021,Q4,Pulse absent,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,,DE-TEVA-2021-DE-1989997,TEVA,,68.0,YR,E,F,Y,62.0,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202214321,20221432,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,unk,,,D,,,,,,,,,2021,Q4,Altered state of consciousness,,2021,Q4,1,I,,20211217.0,20211223,20211223,EXP,,CA-SA-2021SA424806,SANOFI AVENTIS,,96.0,YR,E,F,Y,,,20211223.0,,PH,CA,CA,2021,Q4,Elderly
202214321,20221432,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,unk,,,D,,,,,,,,,2021,Q4,Overdose,,2021,Q4,1,I,,20211217.0,20211223,20211223,EXP,,CA-SA-2021SA424806,SANOFI AVENTIS,,96.0,YR,E,F,Y,,,20211223.0,,PH,CA,CA,2021,Q4,Elderly
202214321,20221432,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,unk,,,D,,,,,,,,,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211217.0,20211223,20211223,EXP,,CA-SA-2021SA424806,SANOFI AVENTIS,,96.0,YR,E,F,Y,,,20211223.0,,PH,CA,CA,2021,Q4,Elderly
202216641,20221664,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 international unit (0-0-0-50, solution for injection / infusion)",,,U,,,,,300.0,IU,,,2021,Q4,Therapeutic drug monitoring analysis not performed,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,,DE-AUROBINDO-AUR-APL-2021-052205,AUROBINDO,,64.0,YR,,F,Y,63.0,KG,20211223.0,,PH,DE,DE,2021,Q4,Adult
202216641,20221664,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 international unit (0-0-0-50, solution for injection / infusion)",,,U,,,,,300.0,IU,,,2021,Q4,Peripheral coldness,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,,DE-AUROBINDO-AUR-APL-2021-052205,AUROBINDO,,64.0,YR,,F,Y,63.0,KG,20211223.0,,PH,DE,DE,2021,Q4,Adult
202216641,20221664,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 international unit (0-0-0-50, solution for injection / infusion)",,,U,,,,,300.0,IU,,,2021,Q4,Pain,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,,DE-AUROBINDO-AUR-APL-2021-052205,AUROBINDO,,64.0,YR,,F,Y,63.0,KG,20211223.0,,PH,DE,DE,2021,Q4,Adult
202223731,20222373,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1.5 ml, 8-0-0-0",,,U,,,,,1.5,ML,,,2021,Q4,Abdominal distension,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,DE-ADRED-07342-01,DE-TORRENT-00021756,TORRENT,,84.0,YR,E,M,Y,101.0,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202223731,20222373,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1.5 ml, 8-0-0-0",,,U,,,,,1.5,ML,,,2021,Q4,Dysuria,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,DE-ADRED-07342-01,DE-TORRENT-00021756,TORRENT,,84.0,YR,E,M,Y,101.0,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202223731,20222373,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1.5 ml, 8-0-0-0",,,U,,,,,1.5,ML,,,2021,Q4,Abdominal pain,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,DE-ADRED-07342-01,DE-TORRENT-00021756,TORRENT,,84.0,YR,E,M,Y,101.0,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202223731,20222373,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1.5 ml, 8-0-0-0",,,U,,,,,1.5,ML,,,2021,Q4,Constipation,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,DE-ADRED-07342-01,DE-TORRENT-00021756,TORRENT,,84.0,YR,E,M,Y,101.0,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202223731,20222373,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1.5 ml, 8-0-0-0",,,U,,,,,1.5,ML,,,2021,Q4,Decreased appetite,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,DE-ADRED-07342-01,DE-TORRENT-00021756,TORRENT,,84.0,YR,E,M,Y,101.0,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202223731,20222373,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1.5 ml, 8-0-0-0",,,U,,,,,1.5,ML,,,2021,Q4,Nausea,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,DE-ADRED-07342-01,DE-TORRENT-00021756,TORRENT,,84.0,YR,E,M,Y,101.0,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202225681,20222568,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,UNKNOWN,,,10.0,IU,,QD,2021,Q4,Coronavirus test positive,,2021,Q4,1,I,,20211215.0,20211223,20211223,EXP,,DE-drreddys-SPO/GER/21/0145005,DR REDDYS,,85.0,YR,E,F,Y,60.0,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202225681,20222568,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,UNKNOWN,,,10.0,IU,,QD,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,,20211215.0,20211223,20211223,EXP,,DE-drreddys-SPO/GER/21/0145005,DR REDDYS,,85.0,YR,E,F,Y,60.0,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202225681,20222568,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,UNKNOWN,,,10.0,IU,,QD,2021,Q4,Dyspnoea,,2021,Q4,1,I,,20211215.0,20211223,20211223,EXP,,DE-drreddys-SPO/GER/21/0145005,DR REDDYS,,85.0,YR,E,F,Y,60.0,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202225681,20222568,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,UNKNOWN,,,10.0,IU,,QD,2021,Q4,Fall,,2021,Q4,1,I,,20211215.0,20211223,20211223,EXP,,DE-drreddys-SPO/GER/21/0145005,DR REDDYS,,85.0,YR,E,F,Y,60.0,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202225681,20222568,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,UNKNOWN,,,10.0,IU,,QD,2021,Q4,Pyrexia,,2021,Q4,1,I,,20211215.0,20211223,20211223,EXP,,DE-drreddys-SPO/GER/21/0145005,DR REDDYS,,85.0,YR,E,F,Y,60.0,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202225681,20222568,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,UNKNOWN,,,10.0,IU,,QD,2021,Q4,Renal impairment,,2021,Q4,1,I,,20211215.0,20211223,20211223,EXP,,DE-drreddys-SPO/GER/21/0145005,DR REDDYS,,85.0,YR,E,F,Y,60.0,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202225681,20222568,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,UNKNOWN,,,10.0,IU,,QD,2021,Q4,Systemic infection,,2021,Q4,1,I,,20211215.0,20211223,20211223,EXP,,DE-drreddys-SPO/GER/21/0145005,DR REDDYS,,85.0,YR,E,F,Y,60.0,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202225701,20222570,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,8-0-0-0,,,,,UNKNOWN,,,1.5,ML,Solution for injection/infusion,QD,2021,Q4,Constipation,,2021,Q4,1,I,,20211215.0,20211223,20211223,EXP,,DE-drreddys-SPO/GER/21/0145031,DR REDDYS,,84.0,YR,E,M,Y,101.4,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202225701,20222570,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,8-0-0-0,,,,,UNKNOWN,,,1.5,ML,Solution for injection/infusion,QD,2021,Q4,Dysuria,,2021,Q4,1,I,,20211215.0,20211223,20211223,EXP,,DE-drreddys-SPO/GER/21/0145031,DR REDDYS,,84.0,YR,E,M,Y,101.4,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202225701,20222570,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,8-0-0-0,,,,,UNKNOWN,,,1.5,ML,Solution for injection/infusion,QD,2021,Q4,Nausea,,2021,Q4,1,I,,20211215.0,20211223,20211223,EXP,,DE-drreddys-SPO/GER/21/0145031,DR REDDYS,,84.0,YR,E,M,Y,101.4,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202225701,20222570,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,8-0-0-0,,,,,UNKNOWN,,,1.5,ML,Solution for injection/infusion,QD,2021,Q4,Decreased appetite,,2021,Q4,1,I,,20211215.0,20211223,20211223,EXP,,DE-drreddys-SPO/GER/21/0145031,DR REDDYS,,84.0,YR,E,M,Y,101.4,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202225701,20222570,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,8-0-0-0,,,,,UNKNOWN,,,1.5,ML,Solution for injection/infusion,QD,2021,Q4,Decreased appetite,,2021,Q4,1,I,,20211215.0,20211223,20211223,EXP,,DE-drreddys-SPO/GER/21/0145031,DR REDDYS,,84.0,YR,E,M,Y,101.4,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202225701,20222570,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,8-0-0-0,,,,,UNKNOWN,,,1.5,ML,Solution for injection/infusion,QD,2021,Q4,Abdominal pain,,2021,Q4,1,I,,20211215.0,20211223,20211223,EXP,,DE-drreddys-SPO/GER/21/0145031,DR REDDYS,,84.0,YR,E,M,Y,101.4,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202225701,20222570,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,8-0-0-0,,,,,UNKNOWN,,,1.5,ML,Solution for injection/infusion,QD,2021,Q4,Abdominal distension,,2021,Q4,1,I,,20211215.0,20211223,20211223,EXP,,DE-drreddys-SPO/GER/21/0145031,DR REDDYS,,84.0,YR,E,M,Y,101.4,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202226551,20222655,4,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,UNK,,,Y,,,,,,,,,2021,Q4,Drug intolerance,,2021,Q4,1,I,20200101.0,20211209.0,20211223,20211223,EXP,,CZ-AUROBINDO-AUR-APL-2021-053045,AUROBINDO,Nekvapilova L.. Dosazeni lepsi compliance u starsiho diabetika 2. (Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes). KAZUISTIKY V DIABETOLOGII.. 2021;19(3):34-36,8.0,DEC,,F,Y,,,20211223.0,,MD,CZ,CZ,2021,Q4,Child
202226551,20222655,4,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,UNK,,,Y,,,,,,,,,2021,Q4,Treatment noncompliance,,2021,Q4,1,I,20200101.0,20211209.0,20211223,20211223,EXP,,CZ-AUROBINDO-AUR-APL-2021-053045,AUROBINDO,Nekvapilova L.. Dosazeni lepsi compliance u starsiho diabetika 2. (Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes). KAZUISTIKY V DIABETOLOGII.. 2021;19(3):34-36,8.0,DEC,,F,Y,,,20211223.0,,MD,CZ,CZ,2021,Q4,Child
202226551,20222655,4,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,UNK,,,Y,,,,,,,,,2021,Q4,Abdominal pain lower,,2021,Q4,1,I,20200101.0,20211209.0,20211223,20211223,EXP,,CZ-AUROBINDO-AUR-APL-2021-053045,AUROBINDO,Nekvapilova L.. Dosazeni lepsi compliance u starsiho diabetika 2. (Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes). KAZUISTIKY V DIABETOLOGII.. 2021;19(3):34-36,8.0,DEC,,F,Y,,,20211223.0,,MD,CZ,CZ,2021,Q4,Child
202226551,20222655,4,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,UNK,,,Y,,,,,,,,,2021,Q4,Constipation,,2021,Q4,1,I,20200101.0,20211209.0,20211223,20211223,EXP,,CZ-AUROBINDO-AUR-APL-2021-053045,AUROBINDO,Nekvapilova L.. Dosazeni lepsi compliance u starsiho diabetika 2. (Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes). KAZUISTIKY V DIABETOLOGII.. 2021;19(3):34-36,8.0,DEC,,F,Y,,,20211223.0,,MD,CZ,CZ,2021,Q4,Child
202226551,20222655,4,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,UNK,,,Y,,,,,,,,,2021,Q4,Seizure,,2021,Q4,1,I,20200101.0,20211209.0,20211223,20211223,EXP,,CZ-AUROBINDO-AUR-APL-2021-053045,AUROBINDO,Nekvapilova L.. Dosazeni lepsi compliance u starsiho diabetika 2. (Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes). KAZUISTIKY V DIABETOLOGII.. 2021;19(3):34-36,8.0,DEC,,F,Y,,,20211223.0,,MD,CZ,CZ,2021,Q4,Child
202226551,20222655,4,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,UNK,,,Y,,,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,1,I,20200101.0,20211209.0,20211223,20211223,EXP,,CZ-AUROBINDO-AUR-APL-2021-053045,AUROBINDO,Nekvapilova L.. Dosazeni lepsi compliance u starsiho diabetika 2. (Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes). KAZUISTIKY V DIABETOLOGII.. 2021;19(3):34-36,8.0,DEC,,F,Y,,,20211223.0,,MD,CZ,CZ,2021,Q4,Child
202226551,20222655,5,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,50 UNITS,,,Y,,,,,,,,,2021,Q4,Drug intolerance,,2021,Q4,1,I,20200101.0,20211209.0,20211223,20211223,EXP,,CZ-AUROBINDO-AUR-APL-2021-053045,AUROBINDO,Nekvapilova L.. Dosazeni lepsi compliance u starsiho diabetika 2. (Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes). KAZUISTIKY V DIABETOLOGII.. 2021;19(3):34-36,8.0,DEC,,F,Y,,,20211223.0,,MD,CZ,CZ,2021,Q4,Child
202226551,20222655,5,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,50 UNITS,,,Y,,,,,,,,,2021,Q4,Treatment noncompliance,,2021,Q4,1,I,20200101.0,20211209.0,20211223,20211223,EXP,,CZ-AUROBINDO-AUR-APL-2021-053045,AUROBINDO,Nekvapilova L.. Dosazeni lepsi compliance u starsiho diabetika 2. (Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes). KAZUISTIKY V DIABETOLOGII.. 2021;19(3):34-36,8.0,DEC,,F,Y,,,20211223.0,,MD,CZ,CZ,2021,Q4,Child
202226551,20222655,5,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,50 UNITS,,,Y,,,,,,,,,2021,Q4,Abdominal pain lower,,2021,Q4,1,I,20200101.0,20211209.0,20211223,20211223,EXP,,CZ-AUROBINDO-AUR-APL-2021-053045,AUROBINDO,Nekvapilova L.. Dosazeni lepsi compliance u starsiho diabetika 2. (Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes). KAZUISTIKY V DIABETOLOGII.. 2021;19(3):34-36,8.0,DEC,,F,Y,,,20211223.0,,MD,CZ,CZ,2021,Q4,Child
202226551,20222655,5,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,50 UNITS,,,Y,,,,,,,,,2021,Q4,Constipation,,2021,Q4,1,I,20200101.0,20211209.0,20211223,20211223,EXP,,CZ-AUROBINDO-AUR-APL-2021-053045,AUROBINDO,Nekvapilova L.. Dosazeni lepsi compliance u starsiho diabetika 2. (Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes). KAZUISTIKY V DIABETOLOGII.. 2021;19(3):34-36,8.0,DEC,,F,Y,,,20211223.0,,MD,CZ,CZ,2021,Q4,Child
202226551,20222655,5,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,50 UNITS,,,Y,,,,,,,,,2021,Q4,Seizure,,2021,Q4,1,I,20200101.0,20211209.0,20211223,20211223,EXP,,CZ-AUROBINDO-AUR-APL-2021-053045,AUROBINDO,Nekvapilova L.. Dosazeni lepsi compliance u starsiho diabetika 2. (Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes). KAZUISTIKY V DIABETOLOGII.. 2021;19(3):34-36,8.0,DEC,,F,Y,,,20211223.0,,MD,CZ,CZ,2021,Q4,Child
202226551,20222655,5,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,50 UNITS,,,Y,,,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,1,I,20200101.0,20211209.0,20211223,20211223,EXP,,CZ-AUROBINDO-AUR-APL-2021-053045,AUROBINDO,Nekvapilova L.. Dosazeni lepsi compliance u starsiho diabetika 2. (Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes). KAZUISTIKY V DIABETOLOGII.. 2021;19(3):34-36,8.0,DEC,,F,Y,,,20211223.0,,MD,CZ,CZ,2021,Q4,Child
202226551,20222655,6,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,UNK,,,Y,,,,,,,,,2021,Q4,Drug intolerance,,2021,Q4,1,I,20200101.0,20211209.0,20211223,20211223,EXP,,CZ-AUROBINDO-AUR-APL-2021-053045,AUROBINDO,Nekvapilova L.. Dosazeni lepsi compliance u starsiho diabetika 2. (Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes). KAZUISTIKY V DIABETOLOGII.. 2021;19(3):34-36,8.0,DEC,,F,Y,,,20211223.0,,MD,CZ,CZ,2021,Q4,Child
202226551,20222655,6,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,UNK,,,Y,,,,,,,,,2021,Q4,Treatment noncompliance,,2021,Q4,1,I,20200101.0,20211209.0,20211223,20211223,EXP,,CZ-AUROBINDO-AUR-APL-2021-053045,AUROBINDO,Nekvapilova L.. Dosazeni lepsi compliance u starsiho diabetika 2. (Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes). KAZUISTIKY V DIABETOLOGII.. 2021;19(3):34-36,8.0,DEC,,F,Y,,,20211223.0,,MD,CZ,CZ,2021,Q4,Child
202226551,20222655,6,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,UNK,,,Y,,,,,,,,,2021,Q4,Abdominal pain lower,,2021,Q4,1,I,20200101.0,20211209.0,20211223,20211223,EXP,,CZ-AUROBINDO-AUR-APL-2021-053045,AUROBINDO,Nekvapilova L.. Dosazeni lepsi compliance u starsiho diabetika 2. (Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes). KAZUISTIKY V DIABETOLOGII.. 2021;19(3):34-36,8.0,DEC,,F,Y,,,20211223.0,,MD,CZ,CZ,2021,Q4,Child
202226551,20222655,6,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,UNK,,,Y,,,,,,,,,2021,Q4,Constipation,,2021,Q4,1,I,20200101.0,20211209.0,20211223,20211223,EXP,,CZ-AUROBINDO-AUR-APL-2021-053045,AUROBINDO,Nekvapilova L.. Dosazeni lepsi compliance u starsiho diabetika 2. (Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes). KAZUISTIKY V DIABETOLOGII.. 2021;19(3):34-36,8.0,DEC,,F,Y,,,20211223.0,,MD,CZ,CZ,2021,Q4,Child
202226551,20222655,6,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,UNK,,,Y,,,,,,,,,2021,Q4,Seizure,,2021,Q4,1,I,20200101.0,20211209.0,20211223,20211223,EXP,,CZ-AUROBINDO-AUR-APL-2021-053045,AUROBINDO,Nekvapilova L.. Dosazeni lepsi compliance u starsiho diabetika 2. (Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes). KAZUISTIKY V DIABETOLOGII.. 2021;19(3):34-36,8.0,DEC,,F,Y,,,20211223.0,,MD,CZ,CZ,2021,Q4,Child
202226551,20222655,6,SS,INSULIN GLARGINE\LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,UNK,,,Y,,,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,1,I,20200101.0,20211209.0,20211223,20211223,EXP,,CZ-AUROBINDO-AUR-APL-2021-053045,AUROBINDO,Nekvapilova L.. Dosazeni lepsi compliance u starsiho diabetika 2. (Achieving better compliance with Suliqua in an elderly patient with type 2 diabetes). KAZUISTIKY V DIABETOLOGII.. 2021;19(3):34-36,8.0,DEC,,F,Y,,,20211223.0,,MD,CZ,CZ,2021,Q4,Child
202237961,20223796,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IE, 0-0-10-0",,,,,,,,,,,,2021,Q4,Death,,2021,Q4,1,I,20201115.0,20211213.0,20211223,20211223,EXP,,DE-PFIZER INC-202101831397,PFIZER,,85.0,YR,,F,Y,60.0,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202242451,20224245,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-12,",,,,,,,,,,,,2021,Q4,Pruritus,,2021,Q4,1,I,,20211215.0,20211223,20211223,EXP,,DE-AstraZeneca-2021A875184,ASTRAZENECA,,78.0,YR,,F,Y,90.0,KG,20211223.0,,MD,DE,,2021,Q4,Elderly
202242451,20224245,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-12,",,,,,,,,,,,,2021,Q4,Liver function test abnormal,,2021,Q4,1,I,,20211215.0,20211223,20211223,EXP,,DE-AstraZeneca-2021A875184,ASTRAZENECA,,78.0,YR,,F,Y,90.0,KG,20211223.0,,MD,DE,,2021,Q4,Elderly
202246531,20224653,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Multiple fractures,,2021,Q4,1,I,20160101.0,20211220.0,20211223,20211223,EXP,,IR-GILEAD-2021-0562632,GILEAD,"Saremi Z, Fakharian T. Fanconi Syndrome Induced by Tenofovir in a Diabetic Patient with a History of Chronic Hepatitis B: A Case Report. Middle East J Dig Dis. 2021;13:374-77. doi:10.34172/mejdd.2021.250",62.0,YR,A,F,Y,,,20211223.0,,HP,IR,IR,2021,Q4,Adult
202246531,20224653,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Fanconi syndrome acquired,,2021,Q4,1,I,20160101.0,20211220.0,20211223,20211223,EXP,,IR-GILEAD-2021-0562632,GILEAD,"Saremi Z, Fakharian T. Fanconi Syndrome Induced by Tenofovir in a Diabetic Patient with a History of Chronic Hepatitis B: A Case Report. Middle East J Dig Dis. 2021;13:374-77. doi:10.34172/mejdd.2021.250",62.0,YR,A,F,Y,,,20211223.0,,HP,IR,IR,2021,Q4,Adult
202252291,20225229,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (0-0-0-20, Fertigspritzen)",,,U,,,,,,,,,2021,Q4,Fracture blisters,,2021,Q4,1,I,20210220.0,20211213.0,20211223,20211223,EXP,,DE-AUROBINDO-AUR-APL-2021-052440,AUROBINDO,,57.0,YR,,F,Y,120.0,KG,20211224.0,,PH,DE,DE,2021,Q4,Adult
202252291,20225229,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (0-0-0-20, Fertigspritzen)",,,U,,,,,,,,,2021,Q4,Pain in extremity,,2021,Q4,1,I,20210220.0,20211213.0,20211223,20211223,EXP,,DE-AUROBINDO-AUR-APL-2021-052440,AUROBINDO,,57.0,YR,,F,Y,120.0,KG,20211224.0,,PH,DE,DE,2021,Q4,Adult
202252291,20225229,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (0-0-0-20, Fertigspritzen)",,,U,,,,,,,,,2021,Q4,Pain,,2021,Q4,1,I,20210220.0,20211213.0,20211223,20211223,EXP,,DE-AUROBINDO-AUR-APL-2021-052440,AUROBINDO,,57.0,YR,,F,Y,120.0,KG,20211224.0,,PH,DE,DE,2021,Q4,Adult
202252291,20225229,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (0-0-0-20, Fertigspritzen)",,,U,,,,,,,,,2021,Q4,Product monitoring error,,2021,Q4,1,I,20210220.0,20211213.0,20211223,20211223,EXP,,DE-AUROBINDO-AUR-APL-2021-052440,AUROBINDO,,57.0,YR,,F,Y,120.0,KG,20211224.0,,PH,DE,DE,2021,Q4,Adult
202252291,20225229,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (0-0-0-20, Fertigspritzen)",,,U,,,,,,,,,2021,Q4,Labelled drug-drug interaction medication error,,2021,Q4,1,I,20210220.0,20211213.0,20211223,20211223,EXP,,DE-AUROBINDO-AUR-APL-2021-052440,AUROBINDO,,57.0,YR,,F,Y,120.0,KG,20211224.0,,PH,DE,DE,2021,Q4,Adult
202264673,20226467,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 iU, 0-0-10-0",,,,,,,,10.0,IU,,QD,2021,Q4,Death,,2021,Q4,3,F,,20211228.0,20211224,20211229,EXP,,DE-PFIZER INC-202101795215,PFIZER,,85.0,YR,,F,Y,60.0,KG,20211229.0,,PH,DE,DE,2021,Q4,Elderly
202264673,20226467,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 iU, 0-0-10-0",,,,,,,,10.0,IU,,QD,2021,Q4,Systemic infection,,2021,Q4,3,F,,20211228.0,20211224,20211229,EXP,,DE-PFIZER INC-202101795215,PFIZER,,85.0,YR,,F,Y,60.0,KG,20211229.0,,PH,DE,DE,2021,Q4,Elderly
202264673,20226467,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 iU, 0-0-10-0",,,,,,,,10.0,IU,,QD,2021,Q4,Hyperglycaemia,,2021,Q4,3,F,,20211228.0,20211224,20211229,EXP,,DE-PFIZER INC-202101795215,PFIZER,,85.0,YR,,F,Y,60.0,KG,20211229.0,,PH,DE,DE,2021,Q4,Elderly
202264673,20226467,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 iU, 0-0-10-0",,,,,,,,10.0,IU,,QD,2021,Q4,COVID-19,,2021,Q4,3,F,,20211228.0,20211224,20211229,EXP,,DE-PFIZER INC-202101795215,PFIZER,,85.0,YR,,F,Y,60.0,KG,20211229.0,,PH,DE,DE,2021,Q4,Elderly
202264673,20226467,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 iU, 0-0-10-0",,,,,,,,10.0,IU,,QD,2021,Q4,Fall,,2021,Q4,3,F,,20211228.0,20211224,20211229,EXP,,DE-PFIZER INC-202101795215,PFIZER,,85.0,YR,,F,Y,60.0,KG,20211229.0,,PH,DE,DE,2021,Q4,Elderly
202264673,20226467,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 iU, 0-0-10-0",,,,,,,,10.0,IU,,QD,2021,Q4,Pyrexia,,2021,Q4,3,F,,20211228.0,20211224,20211229,EXP,,DE-PFIZER INC-202101795215,PFIZER,,85.0,YR,,F,Y,60.0,KG,20211229.0,,PH,DE,DE,2021,Q4,Elderly
202264673,20226467,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 iU, 0-0-10-0",,,,,,,,10.0,IU,,QD,2021,Q4,Renal impairment,,2021,Q4,3,F,,20211228.0,20211224,20211229,EXP,,DE-PFIZER INC-202101795215,PFIZER,,85.0,YR,,F,Y,60.0,KG,20211229.0,,PH,DE,DE,2021,Q4,Elderly
202264673,20226467,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 iU, 0-0-10-0",,,,,,,,10.0,IU,,QD,2021,Q4,Dyspnoea,,2021,Q4,3,F,,20211228.0,20211224,20211229,EXP,,DE-PFIZER INC-202101795215,PFIZER,,85.0,YR,,F,Y,60.0,KG,20211229.0,,PH,DE,DE,2021,Q4,Elderly
202264811,20226481,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,0-0-0-20,,,U,U,UNKNOWN,,,,,Ready-to-fill syringes,QD,2021,Q4,Pain,,2021,Q4,1,I,20210220.0,20211215.0,20211224,20211224,EXP,,DE-drreddys-SPO/GER/21/0144929,DR REDDYS,,57.0,YR,A,F,Y,120.0,KG,20211224.0,,PH,DE,DE,2021,Q4,Adult
202264811,20226481,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,0-0-0-20,,,U,U,UNKNOWN,,,,,Ready-to-fill syringes,QD,2021,Q4,Product monitoring error,,2021,Q4,1,I,20210220.0,20211215.0,20211224,20211224,EXP,,DE-drreddys-SPO/GER/21/0144929,DR REDDYS,,57.0,YR,A,F,Y,120.0,KG,20211224.0,,PH,DE,DE,2021,Q4,Adult
202264811,20226481,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,0-0-0-20,,,U,U,UNKNOWN,,,,,Ready-to-fill syringes,QD,2021,Q4,Labelled drug-drug interaction medication error,,2021,Q4,1,I,20210220.0,20211215.0,20211224,20211224,EXP,,DE-drreddys-SPO/GER/21/0144929,DR REDDYS,,57.0,YR,A,F,Y,120.0,KG,20211224.0,,PH,DE,DE,2021,Q4,Adult
202264811,20226481,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,0-0-0-20,,,U,U,UNKNOWN,,,,,Ready-to-fill syringes,QD,2021,Q4,Fracture blisters,,2021,Q4,1,I,20210220.0,20211215.0,20211224,20211224,EXP,,DE-drreddys-SPO/GER/21/0144929,DR REDDYS,,57.0,YR,A,F,Y,120.0,KG,20211224.0,,PH,DE,DE,2021,Q4,Adult
202264811,20226481,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,0-0-0-20,,,U,U,UNKNOWN,,,,,Ready-to-fill syringes,QD,2021,Q4,Pain in extremity,,2021,Q4,1,I,20210220.0,20211215.0,20211224,20211224,EXP,,DE-drreddys-SPO/GER/21/0144929,DR REDDYS,,57.0,YR,A,F,Y,120.0,KG,20211224.0,,PH,DE,DE,2021,Q4,Adult
202269631,20226963,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,Injection,,2021,Q4,Decreased appetite,,2021,Q4,1,I,,20211215.0,20211224,20211224,EXP,,DE-JNJFOC-20211240149,JOHNSON AND JOHNSON,,84.0,YR,E,M,Y,101.4,KG,20211224.0,,PH,DE,DE,2021,Q4,Elderly
202269631,20226963,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,Injection,,2021,Q4,Abdominal distension,,2021,Q4,1,I,,20211215.0,20211224,20211224,EXP,,DE-JNJFOC-20211240149,JOHNSON AND JOHNSON,,84.0,YR,E,M,Y,101.4,KG,20211224.0,,PH,DE,DE,2021,Q4,Elderly
202269631,20226963,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,Injection,,2021,Q4,Nausea,,2021,Q4,1,I,,20211215.0,20211224,20211224,EXP,,DE-JNJFOC-20211240149,JOHNSON AND JOHNSON,,84.0,YR,E,M,Y,101.4,KG,20211224.0,,PH,DE,DE,2021,Q4,Elderly
202269631,20226963,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,Injection,,2021,Q4,Constipation,,2021,Q4,1,I,,20211215.0,20211224,20211224,EXP,,DE-JNJFOC-20211240149,JOHNSON AND JOHNSON,,84.0,YR,E,M,Y,101.4,KG,20211224.0,,PH,DE,DE,2021,Q4,Elderly
202269631,20226963,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,Injection,,2021,Q4,Decreased appetite,,2021,Q4,1,I,,20211215.0,20211224,20211224,EXP,,DE-JNJFOC-20211240149,JOHNSON AND JOHNSON,,84.0,YR,E,M,Y,101.4,KG,20211224.0,,PH,DE,DE,2021,Q4,Elderly
202269631,20226963,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,Injection,,2021,Q4,Abdominal pain,,2021,Q4,1,I,,20211215.0,20211224,20211224,EXP,,DE-JNJFOC-20211240149,JOHNSON AND JOHNSON,,84.0,YR,E,M,Y,101.4,KG,20211224.0,,PH,DE,DE,2021,Q4,Elderly
202269631,20226963,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,Injection,,2021,Q4,Dysuria,,2021,Q4,1,I,,20211215.0,20211224,20211224,EXP,,DE-JNJFOC-20211240149,JOHNSON AND JOHNSON,,84.0,YR,E,M,Y,101.4,KG,20211224.0,,PH,DE,DE,2021,Q4,Elderly
202276841,20227684,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Scheme,,,,,,,,,,,,2021,Q4,Chronic obstructive pulmonary disease,,2021,Q4,1,I,,20211216.0,20211224,20211224,EXP,,DE-TEVA-2021-DE-1990909,TEVA,,78.0,YR,E,F,Y,,,20211224.0,,PH,DE,DE,2021,Q4,Elderly
202276841,20227684,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Scheme,,,,,,,,,,,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211216.0,20211224,20211224,EXP,,DE-TEVA-2021-DE-1990909,TEVA,,78.0,YR,E,F,Y,,,20211224.0,,PH,DE,DE,2021,Q4,Elderly
202276841,20227684,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Scheme,,,,,,,,,,,,2021,Q4,Acute respiratory failure,,2021,Q4,1,I,,20211216.0,20211224,20211224,EXP,,DE-TEVA-2021-DE-1990909,TEVA,,78.0,YR,E,F,Y,,,20211224.0,,PH,DE,DE,2021,Q4,Elderly
202276841,20227684,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Scheme,,,,,,,,,,,,2021,Q4,Atrial fibrillation,,2021,Q4,1,I,,20211216.0,20211224,20211224,EXP,,DE-TEVA-2021-DE-1990909,TEVA,,78.0,YR,E,F,Y,,,20211224.0,,PH,DE,DE,2021,Q4,Elderly
202276841,20227684,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Scheme,,,,,,,,,,,,2021,Q4,Condition aggravated,,2021,Q4,1,I,,20211216.0,20211224,20211224,EXP,,DE-TEVA-2021-DE-1990909,TEVA,,78.0,YR,E,F,Y,,,20211224.0,,PH,DE,DE,2021,Q4,Elderly
202276841,20227684,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Scheme,,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,1,I,,20211216.0,20211224,20211224,EXP,,DE-TEVA-2021-DE-1990909,TEVA,,78.0,YR,E,F,Y,,,20211224.0,,PH,DE,DE,2021,Q4,Elderly
202279301,20227930,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK (100 U/mL; 8 IU),,,U,,,,,,,Rectal gel,,2021,Q4,Atrial fibrillation,,2021,Q4,1,I,,20211213.0,20211224,20211224,EXP,,NVSC2021PT290997,NOVARTIS,,58.0,YR,,M,Y,111.0,KG,20211224.0,,PH,PT,PT,2021,Q4,Adult
202279301,20227930,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK (100 U/mL; 8 IU),,,U,,,,,,,Rectal gel,,2021,Q4,Arrhythmia,,2021,Q4,1,I,,20211213.0,20211224,20211224,EXP,,NVSC2021PT290997,NOVARTIS,,58.0,YR,,M,Y,111.0,KG,20211224.0,,PH,PT,PT,2021,Q4,Adult
202279301,20227930,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK (100 U/mL; 8 IU),,,U,,,,,,,Rectal gel,,2021,Q4,Atrial fibrillation,,2021,Q4,1,I,,20211213.0,20211224,20211224,EXP,,NVSC2021PT290997,NOVARTIS,,58.0,YR,,M,Y,111.0,KG,20211224.0,,PH,PT,PT,2021,Q4,Adult
202279301,20227930,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK (100 U/mL; 8 IU),,,U,,,,,,,Rectal gel,,2021,Q4,COVID-19 pneumonia,,2021,Q4,1,I,,20211213.0,20211224,20211224,EXP,,NVSC2021PT290997,NOVARTIS,,58.0,YR,,M,Y,111.0,KG,20211224.0,,PH,PT,PT,2021,Q4,Adult
202279301,20227930,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK (100 U/mL; 8 IU),,,U,,,,,,,Rectal gel,,2021,Q4,Palpitations,,2021,Q4,1,I,,20211213.0,20211224,20211224,EXP,,NVSC2021PT290997,NOVARTIS,,58.0,YR,,M,Y,111.0,KG,20211224.0,,PH,PT,PT,2021,Q4,Adult
202279301,20227930,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK (100 U/mL; 8 IU),,,U,,,,,,,Rectal gel,,2021,Q4,Pyrexia,,2021,Q4,1,I,,20211213.0,20211224,20211224,EXP,,NVSC2021PT290997,NOVARTIS,,58.0,YR,,M,Y,111.0,KG,20211224.0,,PH,PT,PT,2021,Q4,Adult
202279301,20227930,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK (100 U/mL; 8 IU),,,U,,,,,,,Rectal gel,,2021,Q4,Chronic kidney disease,,2021,Q4,1,I,,20211213.0,20211224,20211224,EXP,,NVSC2021PT290997,NOVARTIS,,58.0,YR,,M,Y,111.0,KG,20211224.0,,PH,PT,PT,2021,Q4,Adult
202279301,20227930,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK (100 U/mL; 8 IU),,,U,,,,,,,Rectal gel,,2021,Q4,COVID-19,,2021,Q4,1,I,,20211213.0,20211224,20211224,EXP,,NVSC2021PT290997,NOVARTIS,,58.0,YR,,M,Y,111.0,KG,20211224.0,,PH,PT,PT,2021,Q4,Adult
202281251,20228125,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, qd",,,,,,,,,,,QD,2021,Q4,Nausea,,2021,Q4,1,I,,20211214.0,20211224,20211224,EXP,,DE-TAKEDA-2021TUS081888,TAKEDA,,84.0,YR,,F,Y,80.0,KG,20211224.0,,HP,DE,DE,2021,Q4,Elderly
202281251,20228125,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, qd",,,,,,,,,,,QD,2021,Q4,Renal impairment,,2021,Q4,1,I,,20211214.0,20211224,20211224,EXP,,DE-TAKEDA-2021TUS081888,TAKEDA,,84.0,YR,,F,Y,80.0,KG,20211224.0,,HP,DE,DE,2021,Q4,Elderly
202281251,20228125,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, qd",,,,,,,,,,,QD,2021,Q4,Flank pain,,2021,Q4,1,I,,20211214.0,20211224,20211224,EXP,,DE-TAKEDA-2021TUS081888,TAKEDA,,84.0,YR,,F,Y,80.0,KG,20211224.0,,HP,DE,DE,2021,Q4,Elderly
202281251,20228125,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, qd",,,,,,,,,,,QD,2021,Q4,Pain,,2021,Q4,1,I,,20211214.0,20211224,20211224,EXP,,DE-TAKEDA-2021TUS081888,TAKEDA,,84.0,YR,,F,Y,80.0,KG,20211224.0,,HP,DE,DE,2021,Q4,Elderly
202281251,20228125,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, qd",,,,,,,,,,,QD,2021,Q4,Systemic infection,,2021,Q4,1,I,,20211214.0,20211224,20211224,EXP,,DE-TAKEDA-2021TUS081888,TAKEDA,,84.0,YR,,F,Y,80.0,KG,20211224.0,,HP,DE,DE,2021,Q4,Elderly
202284191,20228419,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Drug ineffective,,2021,Q4,1,I,20210605.0,20211213.0,20211224,20211224,EXP,,IR-GILEAD-2021-0561657,GILEAD,"Heydarifard Z, Safaei M, Zadheidar S, Ehsan S, Shafiei-Jandaghi N. Mucormycosis infection in severe COVID-19 patient with multiple underlying health conditions. Clinical Case Reports. 2021;9(10):Unk. doi:10.1002/ccr3.5009",62.0,YR,A,M,Y,,,20211224.0,,HP,IR,IR,2021,Q4,Adult
202294831,20229483,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1.5 ml, QD (8-0-0-0)",,,U,,,,,1.5,ML,Solution for injection/infusion,QD,2021,Q4,Abdominal distension,,2021,Q4,1,I,,20211213.0,20211225,20211225,EXP,,NVSC2021DE286198,NOVARTIS,,84.0,YR,,M,Y,101.4,KG,20211225.0,,PH,DE,DE,2021,Q4,Elderly
202294831,20229483,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1.5 ml, QD (8-0-0-0)",,,U,,,,,1.5,ML,Solution for injection/infusion,QD,2021,Q4,Dysuria,,2021,Q4,1,I,,20211213.0,20211225,20211225,EXP,,NVSC2021DE286198,NOVARTIS,,84.0,YR,,M,Y,101.4,KG,20211225.0,,PH,DE,DE,2021,Q4,Elderly
202294831,20229483,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1.5 ml, QD (8-0-0-0)",,,U,,,,,1.5,ML,Solution for injection/infusion,QD,2021,Q4,Decreased appetite,,2021,Q4,1,I,,20211213.0,20211225,20211225,EXP,,NVSC2021DE286198,NOVARTIS,,84.0,YR,,M,Y,101.4,KG,20211225.0,,PH,DE,DE,2021,Q4,Elderly
202294831,20229483,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1.5 ml, QD (8-0-0-0)",,,U,,,,,1.5,ML,Solution for injection/infusion,QD,2021,Q4,Nausea,,2021,Q4,1,I,,20211213.0,20211225,20211225,EXP,,NVSC2021DE286198,NOVARTIS,,84.0,YR,,M,Y,101.4,KG,20211225.0,,PH,DE,DE,2021,Q4,Elderly
202294831,20229483,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1.5 ml, QD (8-0-0-0)",,,U,,,,,1.5,ML,Solution for injection/infusion,QD,2021,Q4,Decreased appetite,,2021,Q4,1,I,,20211213.0,20211225,20211225,EXP,,NVSC2021DE286198,NOVARTIS,,84.0,YR,,M,Y,101.4,KG,20211225.0,,PH,DE,DE,2021,Q4,Elderly
202294831,20229483,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1.5 ml, QD (8-0-0-0)",,,U,,,,,1.5,ML,Solution for injection/infusion,QD,2021,Q4,Abdominal pain,,2021,Q4,1,I,,20211213.0,20211225,20211225,EXP,,NVSC2021DE286198,NOVARTIS,,84.0,YR,,M,Y,101.4,KG,20211225.0,,PH,DE,DE,2021,Q4,Elderly
202294831,20229483,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1.5 ml, QD (8-0-0-0)",,,U,,,,,1.5,ML,Solution for injection/infusion,QD,2021,Q4,Constipation,,2021,Q4,1,I,,20211213.0,20211225,20211225,EXP,,NVSC2021DE286198,NOVARTIS,,84.0,YR,,M,Y,101.4,KG,20211225.0,,PH,DE,DE,2021,Q4,Elderly
202307161,20230716,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Hypokalaemia,,2021,Q4,1,I,20210101.0,20211213.0,20211227,20211227,EXP,,CZ-AUROBINDO-AUR-APL-2021-052409,AUROBINDO,,78.0,YR,,M,Y,,,20211227.0,,MD,CZ,CZ,2021,Q4,Elderly
202307161,20230716,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Product dose omission issue,,2021,Q4,1,I,20210101.0,20211213.0,20211227,20211227,EXP,,CZ-AUROBINDO-AUR-APL-2021-052409,AUROBINDO,,78.0,YR,,M,Y,,,20211227.0,,MD,CZ,CZ,2021,Q4,Elderly
202307161,20230716,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Atrial fibrillation,,2021,Q4,1,I,20210101.0,20211213.0,20211227,20211227,EXP,,CZ-AUROBINDO-AUR-APL-2021-052409,AUROBINDO,,78.0,YR,,M,Y,,,20211227.0,,MD,CZ,CZ,2021,Q4,Elderly
202307161,20230716,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Accelerated hypertension,,2021,Q4,1,I,20210101.0,20211213.0,20211227,20211227,EXP,,CZ-AUROBINDO-AUR-APL-2021-052409,AUROBINDO,,78.0,YR,,M,Y,,,20211227.0,,MD,CZ,CZ,2021,Q4,Elderly
202307161,20230716,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Peripheral swelling,,2021,Q4,1,I,20210101.0,20211213.0,20211227,20211227,EXP,,CZ-AUROBINDO-AUR-APL-2021-052409,AUROBINDO,,78.0,YR,,M,Y,,,20211227.0,,MD,CZ,CZ,2021,Q4,Elderly
202307161,20230716,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Low density lipoprotein increased,,2021,Q4,1,I,20210101.0,20211213.0,20211227,20211227,EXP,,CZ-AUROBINDO-AUR-APL-2021-052409,AUROBINDO,,78.0,YR,,M,Y,,,20211227.0,,MD,CZ,CZ,2021,Q4,Elderly
202307161,20230716,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,1,I,20210101.0,20211213.0,20211227,20211227,EXP,,CZ-AUROBINDO-AUR-APL-2021-052409,AUROBINDO,,78.0,YR,,M,Y,,,20211227.0,,MD,CZ,CZ,2021,Q4,Elderly
202307161,20230716,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Blood creatinine increased,,2021,Q4,1,I,20210101.0,20211213.0,20211227,20211227,EXP,,CZ-AUROBINDO-AUR-APL-2021-052409,AUROBINDO,,78.0,YR,,M,Y,,,20211227.0,,MD,CZ,CZ,2021,Q4,Elderly
202307161,20230716,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Dyspnoea exertional,,2021,Q4,1,I,20210101.0,20211213.0,20211227,20211227,EXP,,CZ-AUROBINDO-AUR-APL-2021-052409,AUROBINDO,,78.0,YR,,M,Y,,,20211227.0,,MD,CZ,CZ,2021,Q4,Elderly
202307161,20230716,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q4,Troponin increased,,2021,Q4,1,I,20210101.0,20211213.0,20211227,20211227,EXP,,CZ-AUROBINDO-AUR-APL-2021-052409,AUROBINDO,,78.0,YR,,M,Y,,,20211227.0,,MD,CZ,CZ,2021,Q4,Elderly
202311021,20231102,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 IU (12x in the night),,,,,,,,,,,,2021,Q4,Pruritus,,2021,Q4,1,I,,20211214.0,20211227,20211227,EXP,DE-ADRED-07070-01,DE-PFIZER INC-202101795283,PFIZER,,78.0,YR,,F,Y,90.0,KG,20211227.0,,PH,DE,DE,2021,Q4,Elderly
202311021,20231102,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 IU (12x in the night),,,,,,,,,,,,2021,Q4,Liver function test abnormal,,2021,Q4,1,I,,20211214.0,20211227,20211227,EXP,DE-ADRED-07070-01,DE-PFIZER INC-202101795283,PFIZER,,78.0,YR,,F,Y,90.0,KG,20211227.0,,PH,DE,DE,2021,Q4,Elderly
202355921,20235592,13,C,Insulin Glargine [Insulin Glargine],,2,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Fall,,2021,Q4,1,I,,20211213.0,20211228,20211228,EXP,DE-ADRED-05289-03,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2021-08026,ALKEM,,85.0,YR,,F,Y,60.0,KG,20211228.0,,PH,DE,DE,2021,Q4,Elderly
202355921,20235592,13,C,Insulin Glargine [Insulin Glargine],,2,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Pyrexia,,2021,Q4,1,I,,20211213.0,20211228,20211228,EXP,DE-ADRED-05289-03,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2021-08026,ALKEM,,85.0,YR,,F,Y,60.0,KG,20211228.0,,PH,DE,DE,2021,Q4,Elderly
202355921,20235592,13,C,Insulin Glargine [Insulin Glargine],,2,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Systemic infection,,2021,Q4,1,I,,20211213.0,20211228,20211228,EXP,DE-ADRED-05289-03,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2021-08026,ALKEM,,85.0,YR,,F,Y,60.0,KG,20211228.0,,PH,DE,DE,2021,Q4,Elderly
202355921,20235592,13,C,Insulin Glargine [Insulin Glargine],,2,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,1,I,,20211213.0,20211228,20211228,EXP,DE-ADRED-05289-03,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2021-08026,ALKEM,,85.0,YR,,F,Y,60.0,KG,20211228.0,,PH,DE,DE,2021,Q4,Elderly
202355921,20235592,13,C,Insulin Glargine [Insulin Glargine],,2,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Coronavirus test positive,,2021,Q4,1,I,,20211213.0,20211228,20211228,EXP,DE-ADRED-05289-03,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2021-08026,ALKEM,,85.0,YR,,F,Y,60.0,KG,20211228.0,,PH,DE,DE,2021,Q4,Elderly
202355921,20235592,13,C,Insulin Glargine [Insulin Glargine],,2,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Renal impairment,,2021,Q4,1,I,,20211213.0,20211228,20211228,EXP,DE-ADRED-05289-03,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2021-08026,ALKEM,,85.0,YR,,F,Y,60.0,KG,20211228.0,,PH,DE,DE,2021,Q4,Elderly
202355921,20235592,13,C,Insulin Glargine [Insulin Glargine],,2,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,,20211213.0,20211228,20211228,EXP,DE-ADRED-05289-03,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2021-08026,ALKEM,,85.0,YR,,F,Y,60.0,KG,20211228.0,,PH,DE,DE,2021,Q4,Elderly
202364282,20236428,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,Injection,,2021,Q4,Refractory anaemia with an excess of blasts,,2021,Q4,2,F,20181212.0,20211221.0,20211228,20211230,PER,,JP-AMGEN-JPNCT2020028609,AMGEN,,64.0,YR,A,M,Y,,,20211229.0,,MD,JP,JP,2021,Q4,Adult
202364282,20236428,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,Injection,,2021,Q4,Transformation to acute myeloid leukaemia,,2021,Q4,2,F,20181212.0,20211221.0,20211228,20211230,PER,,JP-AMGEN-JPNCT2020028609,AMGEN,,64.0,YR,A,M,Y,,,20211229.0,,MD,JP,JP,2021,Q4,Adult
202371321,20237132,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Septic shock,,2021,Q4,1,I,20211120.0,20211216.0,20211228,20211228,EXP,,US-MYLANLABS-2021M1094624,MYLAN,,71.0,YR,,F,Y,115.0,KG,20211228.0,,HP,US,US,2021,Q4,Elderly
202371321,20237132,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2021,Q4,Respiratory distress,,2021,Q4,1,I,20211120.0,20211216.0,20211228,20211228,EXP,,US-MYLANLABS-2021M1094624,MYLAN,,71.0,YR,,F,Y,115.0,KG,20211228.0,,HP,US,US,2021,Q4,Elderly
202376271,20237627,1,PS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,,UNK,,,U,U,BF20002660,,210605.0,,,Injection,,2021,Q4,Device malfunction,,2021,Q4,1,I,20211209.0,20211209.0,20211228,20211228,PER,,US-MYLANLABS-2021M1092543,MYLAN,,57.0,YR,,M,Y,,,20211228.0,,CN,US,US,2021,Q4,Adult
202376271,20237627,1,PS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,,UNK,,,U,U,BF20002660,,210605.0,,,Injection,,2021,Q4,Incorrect dose administered,,2021,Q4,1,I,20211209.0,20211209.0,20211228,20211228,PER,,US-MYLANLABS-2021M1092543,MYLAN,,57.0,YR,,M,Y,,,20211228.0,,CN,US,US,2021,Q4,Adult
202382931,20238293,1,PS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,Subcutaneous,"100 international unit, qd",,,U,U,,,210605.0,100.0,IU,Injection,QD,2021,Q4,Device mechanical issue,,2021,Q4,1,I,20211116.0,20211130.0,20211228,20211228,PER,,US-MYLANLABS-2021M1089710,MYLAN,,56.0,YR,,F,Y,,,20211228.0,,CN,US,US,2021,Q4,Adult
202382931,20238293,1,PS,SEMGLEE (INSULIN GLARGINE),INSULIN GLARGINE,1,Subcutaneous,"100 international unit, qd",,,U,U,,,210605.0,100.0,IU,Injection,QD,2021,Q4,Incorrect dose administered,,2021,Q4,1,I,20211116.0,20211130.0,20211228,20211228,PER,,US-MYLANLABS-2021M1089710,MYLAN,,56.0,YR,,F,Y,,,20211228.0,,CN,US,US,2021,Q4,Adult
202426902,20242690,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Lung neoplasm malignant,,2021,Q4,2,F,,20211228.0,20211228,20211230,EXP,,SE-TAKEDA-2021TUS082111,TAKEDA,,58.0,YR,,F,Y,60.0,KG,20211230.0,,MD,SE,SE,2021,Q4,Adult
202468161,20246816,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,Dose: 80.0 Units 1 every 1 Days,,,U,,,,21081.0,80.0,IU,,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211227.0,20211229,20211229,EXP,,CA-SA-2021SA432502,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20211229.0,,PH,CA,CA,2021,Q4,Elderly
202468161,20246816,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,Dose: 80.0 Units 1 every 1 Days,,,U,,,,21081.0,80.0,IU,,QD,2021,Q4,Hypophagia,,2021,Q4,1,I,,20211227.0,20211229,20211229,EXP,,CA-SA-2021SA432502,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20211229.0,,PH,CA,CA,2021,Q4,Elderly
202470581,20247058,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"57 iU, QD",,,U,,,,206538.0,57.0,IU,Solution for injection,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,,20211227.0,20211229,20211229,EXP,,CA-SA-2021SA432470,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20211229.0,,CN,CA,CA,2021,Q4,Elderly
202470581,20247058,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"57 iU, QD",,,U,,,,206538.0,57.0,IU,Solution for injection,QD,2021,Q4,Loss of consciousness,,2021,Q4,1,I,,20211227.0,20211229,20211229,EXP,,CA-SA-2021SA432470,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20211229.0,,CN,CA,CA,2021,Q4,Elderly
202470581,20247058,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 iU, QD",,,U,,,,206538.0,20.0,IU,Solution for injection,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,,20211227.0,20211229,20211229,EXP,,CA-SA-2021SA432470,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20211229.0,,CN,CA,CA,2021,Q4,Elderly
202470581,20247058,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 iU, QD",,,U,,,,206538.0,20.0,IU,Solution for injection,QD,2021,Q4,Loss of consciousness,,2021,Q4,1,I,,20211227.0,20211229,20211229,EXP,,CA-SA-2021SA432470,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20211229.0,,CN,CA,CA,2021,Q4,Elderly
202472431,20247243,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2021,Q4,Sepsis,,2021,Q4,1,I,20211020.0,20211222.0,20211229,20211229,EXP,,TH-BAXTER-2021BAX041934,BAXTER,,83.0,YR,,M,Y,,,20211229.0,,MD,TH,TH,2021,Q4,Elderly
202474221,20247422,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IU (International Unit) Daily; 0-0-0-1,Additional information:Medication errors",,,U,,Unknown,,,40.0,IU,,QD,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211219.0,20211229,20211229,EXP,,DE-TEVA-2021-DE-1992228,TEVA,,82.0,YR,E,M,Y,,,20211229.0,,MD,DE,DE,2021,Q4,Elderly
202474221,20247422,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IU (International Unit) Daily; 0-0-0-1,Additional information:Medication errors",,,U,,Unknown,,,40.0,IU,,QD,2021,Q4,Product administration error,,2021,Q4,1,I,,20211219.0,20211229,20211229,EXP,,DE-TEVA-2021-DE-1992228,TEVA,,82.0,YR,E,M,Y,,,20211229.0,,MD,DE,DE,2021,Q4,Elderly
202474221,20247422,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IU (International Unit) Daily; 0-0-0-1,Additional information:Medication errors",,,U,,Unknown,,,40.0,IU,,QD,2021,Q4,Fatigue,,2021,Q4,1,I,,20211219.0,20211229,20211229,EXP,,DE-TEVA-2021-DE-1992228,TEVA,,82.0,YR,E,M,Y,,,20211229.0,,MD,DE,DE,2021,Q4,Elderly
202474221,20247422,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IU (International Unit) Daily; 0-0-0-1,Additional information:Medication errors",,,U,,Unknown,,,40.0,IU,,QD,2021,Q4,Bradycardia,,2021,Q4,1,I,,20211219.0,20211229,20211229,EXP,,DE-TEVA-2021-DE-1992228,TEVA,,82.0,YR,E,M,Y,,,20211229.0,,MD,DE,DE,2021,Q4,Elderly
202474271,20247427,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 IU, 0-0-0-50",,,U,,Unknown,,,,,Solution for injection/infusion,,2021,Q4,Pain,,2021,Q4,1,I,,20211219.0,20211229,20211229,EXP,,DE-TEVA-2021-DE-1992242,TEVA,,64.0,YR,A,F,Y,63.0,KG,20211229.0,,PH,DE,DE,2021,Q4,Adult
202474271,20247427,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 IU, 0-0-0-50",,,U,,Unknown,,,,,Solution for injection/infusion,,2021,Q4,Therapeutic drug monitoring analysis not performed,,2021,Q4,1,I,,20211219.0,20211229,20211229,EXP,,DE-TEVA-2021-DE-1992242,TEVA,,64.0,YR,A,F,Y,63.0,KG,20211229.0,,PH,DE,DE,2021,Q4,Adult
202474271,20247427,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 IU, 0-0-0-50",,,U,,Unknown,,,,,Solution for injection/infusion,,2021,Q4,Peripheral coldness,,2021,Q4,1,I,,20211219.0,20211229,20211229,EXP,,DE-TEVA-2021-DE-1992242,TEVA,,64.0,YR,A,F,Y,63.0,KG,20211229.0,,PH,DE,DE,2021,Q4,Adult
202479131,20247913,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,206538.0,,,Solution for injection,,2021,Q4,Aggression,,2021,Q4,1,I,,20211227.0,20211229,20211229,EXP,,CA-SA-2021SA432422,SANOFI AVENTIS,,80.0,YR,E,M,Y,,,20211229.0,,PH,CA,CA,2021,Q4,Elderly
202479131,20247913,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,206538.0,,,Solution for injection,,2021,Q4,Confusional state,,2021,Q4,1,I,,20211227.0,20211229,20211229,EXP,,CA-SA-2021SA432422,SANOFI AVENTIS,,80.0,YR,E,M,Y,,,20211229.0,,PH,CA,CA,2021,Q4,Elderly
202479131,20247913,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,206538.0,,,Solution for injection,,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211227.0,20211229,20211229,EXP,,CA-SA-2021SA432422,SANOFI AVENTIS,,80.0,YR,E,M,Y,,,20211229.0,,PH,CA,CA,2021,Q4,Elderly
202496471,20249647,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU (International Unit) Daily; 12 IU, 0-0-1-0",,,,,,,,12.0,IU,,QD,2021,Q4,Anaemia,,2021,Q4,1,I,,20211219.0,20211229,20211229,EXP,,DE-TEVA-2021-DE-1992231,TEVA,,68.0,YR,E,M,Y,,,20211229.0,,PH,DE,DE,2021,Q4,Elderly
202496471,20249647,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU (International Unit) Daily; 12 IU, 0-0-1-0",,,,,,,,12.0,IU,,QD,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211219.0,20211229,20211229,EXP,,DE-TEVA-2021-DE-1992231,TEVA,,68.0,YR,E,M,Y,,,20211229.0,,PH,DE,DE,2021,Q4,Elderly
202496471,20249647,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU (International Unit) Daily; 12 IU, 0-0-1-0",,,,,,,,12.0,IU,,QD,2021,Q4,Haematochezia,,2021,Q4,1,I,,20211219.0,20211229,20211229,EXP,,DE-TEVA-2021-DE-1992231,TEVA,,68.0,YR,E,M,Y,,,20211229.0,,PH,DE,DE,2021,Q4,Elderly
202496471,20249647,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU (International Unit) Daily; 12 IU, 0-0-1-0",,,,,,,,12.0,IU,,QD,2021,Q4,Balance disorder,,2021,Q4,1,I,,20211219.0,20211229,20211229,EXP,,DE-TEVA-2021-DE-1992231,TEVA,,68.0,YR,E,M,Y,,,20211229.0,,PH,DE,DE,2021,Q4,Elderly
202496471,20249647,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU (International Unit) Daily; 12 IU, 0-0-1-0",,,,,,,,12.0,IU,,QD,2021,Q4,Gastrointestinal haemorrhage,,2021,Q4,1,I,,20211219.0,20211229,20211229,EXP,,DE-TEVA-2021-DE-1992231,TEVA,,68.0,YR,E,M,Y,,,20211229.0,,PH,DE,DE,2021,Q4,Elderly
202507681,20250768,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Hypoxia,,2021,Q4,1,I,20211018.0,,20211229,20211229,DIR,596924,,FDA-CTU,,85.0,YR,,F,N,86.0,KG,20211229.0,N,PH,US,,2021,Q4,Elderly
202507681,20250768,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Condition aggravated,,2021,Q4,1,I,20211018.0,,20211229,20211229,DIR,596924,,FDA-CTU,,85.0,YR,,F,N,86.0,KG,20211229.0,N,PH,US,,2021,Q4,Elderly
202508241,20250824,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Hypoxia,,2021,Q4,1,I,20211020.0,,20211229,20211229,DIR,596929,,FDA-CTU,,93.0,YR,,M,N,80.0,KG,20211229.0,N,PH,US,,2021,Q4,Elderly
202508241,20250824,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,COVID-19 pneumonia,,2021,Q4,1,I,20211020.0,,20211229,20211229,DIR,596929,,FDA-CTU,,93.0,YR,,M,N,80.0,KG,20211229.0,N,PH,US,,2021,Q4,Elderly
202508941,20250894,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2021,Q4,Respiratory distress,,2021,Q4,1,I,20211102.0,,20211229,20211229,DIR,596937,,FDA-CTU,,56.0,YR,,F,N,110.0,KG,20211229.0,N,PH,US,,2021,Q4,Adult
202547201,20254720,5,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"0-0-0-20, Pre-filled syringes",,,U,,Unknown,,,,,,,2021,Q4,Fracture blisters,,2021,Q4,1,I,20210220.0,20211220.0,20211230,20211230,EXP,,DE-TEVA-2021-DE-1992256,TEVA,,57.0,YR,A,F,Y,120.0,KG,20211230.0,,PH,DE,DE,2021,Q4,Adult
202547201,20254720,5,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"0-0-0-20, Pre-filled syringes",,,U,,Unknown,,,,,,,2021,Q4,Labelled drug-drug interaction medication error,,2021,Q4,1,I,20210220.0,20211220.0,20211230,20211230,EXP,,DE-TEVA-2021-DE-1992256,TEVA,,57.0,YR,A,F,Y,120.0,KG,20211230.0,,PH,DE,DE,2021,Q4,Adult
202547201,20254720,5,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"0-0-0-20, Pre-filled syringes",,,U,,Unknown,,,,,,,2021,Q4,Pain in extremity,,2021,Q4,1,I,20210220.0,20211220.0,20211230,20211230,EXP,,DE-TEVA-2021-DE-1992256,TEVA,,57.0,YR,A,F,Y,120.0,KG,20211230.0,,PH,DE,DE,2021,Q4,Adult
202547201,20254720,5,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"0-0-0-20, Pre-filled syringes",,,U,,Unknown,,,,,,,2021,Q4,Product monitoring error,,2021,Q4,1,I,20210220.0,20211220.0,20211230,20211230,EXP,,DE-TEVA-2021-DE-1992256,TEVA,,57.0,YR,A,F,Y,120.0,KG,20211230.0,,PH,DE,DE,2021,Q4,Adult
202547201,20254720,5,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"0-0-0-20, Pre-filled syringes",,,U,,Unknown,,,,,,,2021,Q4,Pain,,2021,Q4,1,I,20210220.0,20211220.0,20211230,20211230,EXP,,DE-TEVA-2021-DE-1992256,TEVA,,57.0,YR,A,F,Y,120.0,KG,20211230.0,,PH,DE,DE,2021,Q4,Adult
202548011,20254801,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 IU (International Unit) Daily; 0-0-0-1,,,,,,,,30.0,IU,Solution for injection/infusion,QD,2021,Q4,Haematochezia,,2021,Q4,1,I,20200630.0,20211220.0,20211230,20211230,EXP,,DE-TEVA-2021-DE-1992419,TEVA,,67.0,YR,E,M,Y,95.0,KG,20211230.0,,PH,DE,DE,2021,Q4,Elderly
202551721,20255172,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"10 Dosage forms Daily; 10 IU, 0-0-10-0",,,,,,,,,,,QD,2021,Q4,Fall,,2021,Q4,1,I,,20211220.0,20211230,20211230,EXP,,DE-TEVA-2021-DE-1992743,TEVA,,85.0,YR,E,F,Y,60.0,KG,20211230.0,,PH,DE,DE,2021,Q4,Elderly
202551721,20255172,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"10 Dosage forms Daily; 10 IU, 0-0-10-0",,,,,,,,,,,QD,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,,20211220.0,20211230,20211230,EXP,,DE-TEVA-2021-DE-1992743,TEVA,,85.0,YR,E,F,Y,60.0,KG,20211230.0,,PH,DE,DE,2021,Q4,Elderly
202551721,20255172,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"10 Dosage forms Daily; 10 IU, 0-0-10-0",,,,,,,,,,,QD,2021,Q4,Renal impairment,,2021,Q4,1,I,,20211220.0,20211230,20211230,EXP,,DE-TEVA-2021-DE-1992743,TEVA,,85.0,YR,E,F,Y,60.0,KG,20211230.0,,PH,DE,DE,2021,Q4,Elderly
202551721,20255172,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"10 Dosage forms Daily; 10 IU, 0-0-10-0",,,,,,,,,,,QD,2021,Q4,Dyspnoea,,2021,Q4,1,I,,20211220.0,20211230,20211230,EXP,,DE-TEVA-2021-DE-1992743,TEVA,,85.0,YR,E,F,Y,60.0,KG,20211230.0,,PH,DE,DE,2021,Q4,Elderly
202551721,20255172,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"10 Dosage forms Daily; 10 IU, 0-0-10-0",,,,,,,,,,,QD,2021,Q4,Coronavirus test positive,,2021,Q4,1,I,,20211220.0,20211230,20211230,EXP,,DE-TEVA-2021-DE-1992743,TEVA,,85.0,YR,E,F,Y,60.0,KG,20211230.0,,PH,DE,DE,2021,Q4,Elderly
202551721,20255172,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"10 Dosage forms Daily; 10 IU, 0-0-10-0",,,,,,,,,,,QD,2021,Q4,Pyrexia,,2021,Q4,1,I,,20211220.0,20211230,20211230,EXP,,DE-TEVA-2021-DE-1992743,TEVA,,85.0,YR,E,F,Y,60.0,KG,20211230.0,,PH,DE,DE,2021,Q4,Elderly
202551721,20255172,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"10 Dosage forms Daily; 10 IU, 0-0-10-0",,,,,,,,,,,QD,2021,Q4,Systemic infection,,2021,Q4,1,I,,20211220.0,20211230,20211230,EXP,,DE-TEVA-2021-DE-1992743,TEVA,,85.0,YR,E,F,Y,60.0,KG,20211230.0,,PH,DE,DE,2021,Q4,Elderly
202554771,20255477,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 Dosage forms Daily; 1 IU, 0-0-0-12, pre-filled syringes",,,,,,,,,,,QD,2021,Q4,Pruritus,,2021,Q4,1,I,,20211220.0,20211230,20211230,EXP,,DE-TEVA-2021-DE-1992363,TEVA,,78.0,YR,E,F,Y,90.0,KG,20211230.0,,PH,DE,DE,2021,Q4,Elderly
202554771,20255477,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 Dosage forms Daily; 1 IU, 0-0-0-12, pre-filled syringes",,,,,,,,,,,QD,2021,Q4,Liver function test abnormal,,2021,Q4,1,I,,20211220.0,20211230,20211230,EXP,,DE-TEVA-2021-DE-1992363,TEVA,,78.0,YR,E,F,Y,90.0,KG,20211230.0,,PH,DE,DE,2021,Q4,Elderly
202555091,20255509,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 Dosage forms Daily; 1 IU, 0-0-0-6, solution for injection / infusion",,,,,,,,,,Solution for injection/infusion,QD,2021,Q4,Pyrexia,,2021,Q4,1,I,,20211220.0,20211230,20211230,EXP,,DE-TEVA-2021-DE-1992745,TEVA,,69.0,YR,E,M,Y,,,20211230.0,,PH,DE,DE,2021,Q4,Elderly
202555091,20255509,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 Dosage forms Daily; 1 IU, 0-0-0-6, solution for injection / infusion",,,,,,,,,,Solution for injection/infusion,QD,2021,Q4,Fatigue,,2021,Q4,1,I,,20211220.0,20211230,20211230,EXP,,DE-TEVA-2021-DE-1992745,TEVA,,69.0,YR,E,M,Y,,,20211230.0,,PH,DE,DE,2021,Q4,Elderly
202555091,20255509,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 Dosage forms Daily; 1 IU, 0-0-0-6, solution for injection / infusion",,,,,,,,,,Solution for injection/infusion,QD,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211220.0,20211230,20211230,EXP,,DE-TEVA-2021-DE-1992745,TEVA,,69.0,YR,E,M,Y,,,20211230.0,,PH,DE,DE,2021,Q4,Elderly
202555091,20255509,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 Dosage forms Daily; 1 IU, 0-0-0-6, solution for injection / infusion",,,,,,,,,,Solution for injection/infusion,QD,2021,Q4,Decreased appetite,,2021,Q4,1,I,,20211220.0,20211230,20211230,EXP,,DE-TEVA-2021-DE-1992745,TEVA,,69.0,YR,E,M,Y,,,20211230.0,,PH,DE,DE,2021,Q4,Elderly
202555091,20255509,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 Dosage forms Daily; 1 IU, 0-0-0-6, solution for injection / infusion",,,,,,,,,,Solution for injection/infusion,QD,2021,Q4,Jaundice,,2021,Q4,1,I,,20211220.0,20211230,20211230,EXP,,DE-TEVA-2021-DE-1992745,TEVA,,69.0,YR,E,M,Y,,,20211230.0,,PH,DE,DE,2021,Q4,Elderly
202555091,20255509,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 Dosage forms Daily; 1 IU, 0-0-0-6, solution for injection / infusion",,,,,,,,,,Solution for injection/infusion,QD,2021,Q4,Diarrhoea,,2021,Q4,1,I,,20211220.0,20211230,20211230,EXP,,DE-TEVA-2021-DE-1992745,TEVA,,69.0,YR,E,M,Y,,,20211230.0,,PH,DE,DE,2021,Q4,Elderly
202555091,20255509,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 Dosage forms Daily; 1 IU, 0-0-0-6, solution for injection / infusion",,,,,,,,,,Solution for injection/infusion,QD,2021,Q4,Weight decreased,,2021,Q4,1,I,,20211220.0,20211230,20211230,EXP,,DE-TEVA-2021-DE-1992745,TEVA,,69.0,YR,E,M,Y,,,20211230.0,,PH,DE,DE,2021,Q4,Elderly
202572351,20257235,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 Dosage forms Daily; 1.5 ml, 8-0-0-0, solution for injection / infusion",,,,,,,,,,Solution for injection/infusion,QD,2021,Q4,Decreased appetite,,2021,Q4,1,I,,20211220.0,20211230,20211230,EXP,,DE-TEVA-2021-DE-1992798,TEVA,,84.0,YR,E,M,Y,101.4,KG,20211230.0,,PH,DE,DE,2021,Q4,Elderly
202572351,20257235,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 Dosage forms Daily; 1.5 ml, 8-0-0-0, solution for injection / infusion",,,,,,,,,,Solution for injection/infusion,QD,2021,Q4,Abdominal pain,,2021,Q4,1,I,,20211220.0,20211230,20211230,EXP,,DE-TEVA-2021-DE-1992798,TEVA,,84.0,YR,E,M,Y,101.4,KG,20211230.0,,PH,DE,DE,2021,Q4,Elderly
202572351,20257235,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 Dosage forms Daily; 1.5 ml, 8-0-0-0, solution for injection / infusion",,,,,,,,,,Solution for injection/infusion,QD,2021,Q4,Constipation,,2021,Q4,1,I,,20211220.0,20211230,20211230,EXP,,DE-TEVA-2021-DE-1992798,TEVA,,84.0,YR,E,M,Y,101.4,KG,20211230.0,,PH,DE,DE,2021,Q4,Elderly
202572351,20257235,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 Dosage forms Daily; 1.5 ml, 8-0-0-0, solution for injection / infusion",,,,,,,,,,Solution for injection/infusion,QD,2021,Q4,Dysuria,,2021,Q4,1,I,,20211220.0,20211230,20211230,EXP,,DE-TEVA-2021-DE-1992798,TEVA,,84.0,YR,E,M,Y,101.4,KG,20211230.0,,PH,DE,DE,2021,Q4,Elderly
202572351,20257235,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 Dosage forms Daily; 1.5 ml, 8-0-0-0, solution for injection / infusion",,,,,,,,,,Solution for injection/infusion,QD,2021,Q4,Nausea,,2021,Q4,1,I,,20211220.0,20211230,20211230,EXP,,DE-TEVA-2021-DE-1992798,TEVA,,84.0,YR,E,M,Y,101.4,KG,20211230.0,,PH,DE,DE,2021,Q4,Elderly
202572351,20257235,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 Dosage forms Daily; 1.5 ml, 8-0-0-0, solution for injection / infusion",,,,,,,,,,Solution for injection/infusion,QD,2021,Q4,Decreased appetite,,2021,Q4,1,I,,20211220.0,20211230,20211230,EXP,,DE-TEVA-2021-DE-1992798,TEVA,,84.0,YR,E,M,Y,101.4,KG,20211230.0,,PH,DE,DE,2021,Q4,Elderly
202572351,20257235,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 Dosage forms Daily; 1.5 ml, 8-0-0-0, solution for injection / infusion",,,,,,,,,,Solution for injection/infusion,QD,2021,Q4,Abdominal distension,,2021,Q4,1,I,,20211220.0,20211230,20211230,EXP,,DE-TEVA-2021-DE-1992798,TEVA,,84.0,YR,E,M,Y,101.4,KG,20211230.0,,PH,DE,DE,2021,Q4,Elderly
202584561,20258456,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 Dosage forms Daily; 300 IU / 3ml, 0-0-0-5, pre-filled syringes",,,,,,,,,,,QD,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211220.0,20211230,20211230,EXP,,DE-TEVA-2021-DE-1992360,TEVA,,62.0,YR,A,M,Y,56.0,KG,20211230.0,,PH,DE,DE,2021,Q4,Adult
202584561,20258456,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 Dosage forms Daily; 300 IU / 3ml, 0-0-0-5, pre-filled syringes",,,,,,,,,,,QD,2021,Q4,Abdominal pain upper,,2021,Q4,1,I,,20211220.0,20211230,20211230,EXP,,DE-TEVA-2021-DE-1992360,TEVA,,62.0,YR,A,M,Y,56.0,KG,20211230.0,,PH,DE,DE,2021,Q4,Adult
202584561,20258456,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 Dosage forms Daily; 300 IU / 3ml, 0-0-0-5, pre-filled syringes",,,,,,,,,,,QD,2021,Q4,Decreased appetite,,2021,Q4,1,I,,20211220.0,20211230,20211230,EXP,,DE-TEVA-2021-DE-1992360,TEVA,,62.0,YR,A,M,Y,56.0,KG,20211230.0,,PH,DE,DE,2021,Q4,Adult
202585411,20258541,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Schema,,,,,,,,,,,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211224.0,20211230,20211230,EXP,,DE-MYLANLABS-2021M1096832,MYLAN,,78.0,YR,,F,Y,,,20211230.0,,PH,DE,DE,2021,Q4,Elderly
202585411,20258541,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Schema,,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,1,I,,20211224.0,20211230,20211230,EXP,,DE-MYLANLABS-2021M1096832,MYLAN,,78.0,YR,,F,Y,,,20211230.0,,PH,DE,DE,2021,Q4,Elderly
202585411,20258541,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Schema,,,,,,,,,,,,2021,Q4,Chronic obstructive pulmonary disease,,2021,Q4,1,I,,20211224.0,20211230,20211230,EXP,,DE-MYLANLABS-2021M1096832,MYLAN,,78.0,YR,,F,Y,,,20211230.0,,PH,DE,DE,2021,Q4,Elderly
202585411,20258541,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Schema,,,,,,,,,,,,2021,Q4,Condition aggravated,,2021,Q4,1,I,,20211224.0,20211230,20211230,EXP,,DE-MYLANLABS-2021M1096832,MYLAN,,78.0,YR,,F,Y,,,20211230.0,,PH,DE,DE,2021,Q4,Elderly
202585411,20258541,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Schema,,,,,,,,,,,,2021,Q4,Acute respiratory failure,,2021,Q4,1,I,,20211224.0,20211230,20211230,EXP,,DE-MYLANLABS-2021M1096832,MYLAN,,78.0,YR,,F,Y,,,20211230.0,,PH,DE,DE,2021,Q4,Elderly
202585411,20258541,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,Schema,,,,,,,,,,,,2021,Q4,Atrial fibrillation,,2021,Q4,1,I,,20211224.0,20211230,20211230,EXP,,DE-MYLANLABS-2021M1096832,MYLAN,,78.0,YR,,F,Y,,,20211230.0,,PH,DE,DE,2021,Q4,Elderly
202642201,20264220,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,150.0,IU,Solution,,2021,Q4,Back pain,,2021,Q4,1,I,20211115.0,20211222.0,20211231,20211231,EXP,,"US-Melinta Therapeutics, LLC-US-MLNT-21-00184",MELINTA THERAPEUTICS,,74.0,YR,,M,Y,122.6,KG,20211231.0,,PH,US,US,2021,Q4,Elderly
202642201,20264220,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,150.0,IU,Solution,,2021,Q4,Infusion related reaction,,2021,Q4,1,I,20211115.0,20211222.0,20211231,20211231,EXP,,"US-Melinta Therapeutics, LLC-US-MLNT-21-00184",MELINTA THERAPEUTICS,,74.0,YR,,M,Y,122.6,KG,20211231.0,,PH,US,US,2021,Q4,Elderly
202642201,20264220,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,150.0,IU,Solution,,2021,Q4,Dyspnoea,,2021,Q4,1,I,20211115.0,20211222.0,20211231,20211231,EXP,,"US-Melinta Therapeutics, LLC-US-MLNT-21-00184",MELINTA THERAPEUTICS,,74.0,YR,,M,Y,122.6,KG,20211231.0,,PH,US,US,2021,Q4,Elderly
202642201,20264220,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,150.0,IU,Solution,,2021,Q4,Chest pain,,2021,Q4,1,I,20211115.0,20211222.0,20211231,20211231,EXP,,"US-Melinta Therapeutics, LLC-US-MLNT-21-00184",MELINTA THERAPEUTICS,,74.0,YR,,M,Y,122.6,KG,20211231.0,,PH,US,US,2021,Q4,Elderly
202642201,20264220,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,150.0,IU,Solution,,2021,Q4,Abdominal pain,,2021,Q4,1,I,20211115.0,20211222.0,20211231,20211231,EXP,,"US-Melinta Therapeutics, LLC-US-MLNT-21-00184",MELINTA THERAPEUTICS,,74.0,YR,,M,Y,122.6,KG,20211231.0,,PH,US,US,2021,Q4,Elderly
202642201,20264220,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,150.0,IU,Solution,,2021,Q4,Respiratory arrest,,2021,Q4,1,I,20211115.0,20211222.0,20211231,20211231,EXP,,"US-Melinta Therapeutics, LLC-US-MLNT-21-00184",MELINTA THERAPEUTICS,,74.0,YR,,M,Y,122.6,KG,20211231.0,,PH,US,US,2021,Q4,Elderly
202652271,20265227,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,1.5 milliliter (300units/ml),,,U,,,,,1.5,ML,Solution for injection,,2021,Q4,Myalgia,,2021,Q4,1,I,20171001.0,20211228.0,20211231,20211231,EXP,GB-MHRA-MIDB-8f29e04f-73b0-413a-a705-4a98f8523672,PHFR2017GB008459,NOVARTIS,,61.0,YR,,M,Y,73.0,KG,20211231.0,,PH,GB,GB,2021,Q4,Adult
202652271,20265227,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,1.5 milliliter (300units/ml),,,U,,,,,1.5,ML,Solution for injection,,2021,Q4,Malaise,,2021,Q4,1,I,20171001.0,20211228.0,20211231,20211231,EXP,GB-MHRA-MIDB-8f29e04f-73b0-413a-a705-4a98f8523672,PHFR2017GB008459,NOVARTIS,,61.0,YR,,M,Y,73.0,KG,20211231.0,,PH,GB,GB,2021,Q4,Adult
202652271,20265227,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,1.5 milliliter (300units/ml),,,U,,,,,1.5,ML,Solution for injection,,2021,Q4,Peripheral swelling,,2021,Q4,1,I,20171001.0,20211228.0,20211231,20211231,EXP,GB-MHRA-MIDB-8f29e04f-73b0-413a-a705-4a98f8523672,PHFR2017GB008459,NOVARTIS,,61.0,YR,,M,Y,73.0,KG,20211231.0,,PH,GB,GB,2021,Q4,Adult
202652271,20265227,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,1.5 milliliter (300units/ml),,,U,,,,,1.5,ML,Solution for injection,,2021,Q4,Vomiting,,2021,Q4,1,I,20171001.0,20211228.0,20211231,20211231,EXP,GB-MHRA-MIDB-8f29e04f-73b0-413a-a705-4a98f8523672,PHFR2017GB008459,NOVARTIS,,61.0,YR,,M,Y,73.0,KG,20211231.0,,PH,GB,GB,2021,Q4,Adult
202652271,20265227,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,3 milliliter(100 units per ml) Solution for injection in pre-filled syringe,,,U,,,,,3.0,ML,Solution for injection,,2021,Q4,Myalgia,,2021,Q4,1,I,20171001.0,20211228.0,20211231,20211231,EXP,GB-MHRA-MIDB-8f29e04f-73b0-413a-a705-4a98f8523672,PHFR2017GB008459,NOVARTIS,,61.0,YR,,M,Y,73.0,KG,20211231.0,,PH,GB,GB,2021,Q4,Adult
202652271,20265227,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,3 milliliter(100 units per ml) Solution for injection in pre-filled syringe,,,U,,,,,3.0,ML,Solution for injection,,2021,Q4,Malaise,,2021,Q4,1,I,20171001.0,20211228.0,20211231,20211231,EXP,GB-MHRA-MIDB-8f29e04f-73b0-413a-a705-4a98f8523672,PHFR2017GB008459,NOVARTIS,,61.0,YR,,M,Y,73.0,KG,20211231.0,,PH,GB,GB,2021,Q4,Adult
202652271,20265227,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,3 milliliter(100 units per ml) Solution for injection in pre-filled syringe,,,U,,,,,3.0,ML,Solution for injection,,2021,Q4,Peripheral swelling,,2021,Q4,1,I,20171001.0,20211228.0,20211231,20211231,EXP,GB-MHRA-MIDB-8f29e04f-73b0-413a-a705-4a98f8523672,PHFR2017GB008459,NOVARTIS,,61.0,YR,,M,Y,73.0,KG,20211231.0,,PH,GB,GB,2021,Q4,Adult
202652271,20265227,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,3 milliliter(100 units per ml) Solution for injection in pre-filled syringe,,,U,,,,,3.0,ML,Solution for injection,,2021,Q4,Vomiting,,2021,Q4,1,I,20171001.0,20211228.0,20211231,20211231,EXP,GB-MHRA-MIDB-8f29e04f-73b0-413a-a705-4a98f8523672,PHFR2017GB008459,NOVARTIS,,61.0,YR,,M,Y,73.0,KG,20211231.0,,PH,GB,GB,2021,Q4,Adult
202652271,20265227,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK,100 units per ml",,,U,,,,,,,Solution for injection,,2021,Q4,Myalgia,,2021,Q4,1,I,20171001.0,20211228.0,20211231,20211231,EXP,GB-MHRA-MIDB-8f29e04f-73b0-413a-a705-4a98f8523672,PHFR2017GB008459,NOVARTIS,,61.0,YR,,M,Y,73.0,KG,20211231.0,,PH,GB,GB,2021,Q4,Adult
202652271,20265227,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK,100 units per ml",,,U,,,,,,,Solution for injection,,2021,Q4,Malaise,,2021,Q4,1,I,20171001.0,20211228.0,20211231,20211231,EXP,GB-MHRA-MIDB-8f29e04f-73b0-413a-a705-4a98f8523672,PHFR2017GB008459,NOVARTIS,,61.0,YR,,M,Y,73.0,KG,20211231.0,,PH,GB,GB,2021,Q4,Adult
202652271,20265227,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK,100 units per ml",,,U,,,,,,,Solution for injection,,2021,Q4,Peripheral swelling,,2021,Q4,1,I,20171001.0,20211228.0,20211231,20211231,EXP,GB-MHRA-MIDB-8f29e04f-73b0-413a-a705-4a98f8523672,PHFR2017GB008459,NOVARTIS,,61.0,YR,,M,Y,73.0,KG,20211231.0,,PH,GB,GB,2021,Q4,Adult
202652271,20265227,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK,100 units per ml",,,U,,,,,,,Solution for injection,,2021,Q4,Vomiting,,2021,Q4,1,I,20171001.0,20211228.0,20211231,20211231,EXP,GB-MHRA-MIDB-8f29e04f-73b0-413a-a705-4a98f8523672,PHFR2017GB008459,NOVARTIS,,61.0,YR,,M,Y,73.0,KG,20211231.0,,PH,GB,GB,2021,Q4,Adult
202660251,20266025,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,Ingestion,,,D,,,,,,,,,2021,Q4,Completed suicide,,2021,Q4,1,I,,20211223.0,20211231,20211231,EXP,,US-BAUSCH-BL-2021-042532,BAUSCH AND LOMB,"Gummin D, Mowry J, Beuhler M, Spyker D, Bronstein A, Rivers L, Pham N, Weber J. 2020 Annual Report of the American Association of Poison Control Centers^ National Poison Data System (NPDS): 38th Annual Report. Clinical Toxicology. 2021 DEC 10;59 (12):1282-1501. doi:10.1080/15563650.2021.1989785",38.0,YR,,M,Y,,,20211231.0,,MD,US,US,2021,Q4,Adult
